PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Caley, P; Ramsey, DSL; Barry, SC				Caley, Peter; Ramsey, David S. L.; Barry, Simon C.			Inferring the Distribution and Demography of an Invasive Species from Sighting Data: The Red Fox Incursion into Tasmania	PLOS ONE			English	Article							APPROXIMATE BAYESIAN COMPUTATION; VULPES-VULPES; MODEL SELECTION; UNCERTAINTY; POPULATION; EXTINCTION; PARAMETER; RECORDS	A recent study has inferred that the red fox (Vulpes vulpes) is now widespread in Tasmania as of 2010, based on the extraction of fox DNA from predator scats. Heuristically, this inference appears at first glance to be at odds with the lack of recent confirmed discoveries of either road-killed foxes-the last of which occurred in 2006, or hunter killed foxes-the most recent in 2001. This paper demonstrates a method to codify this heuristic analysis and produce inferences consistent with assumptions and data. It does this by formalising the analysis in a transparent and repeatable manner to make inference on the past, present and future distribution of an invasive species. It utilizes Approximate Bayesian Computation to make inferences. Importantly, the method is able to inform management of invasive species within realistic time frames, and can be applied widely. We illustrate the technique using the Tasmanian fox data. Based on the pattern of carcass discoveries of foxes in Tasmania, we infer that the population of foxes in Tasmania is most likely extinct, or restricted in distribution and demographically weak as of 2013. It is possible, though unlikely, that that population is widespread and/or demographically robust. This inference is largely at odds with the inference from the predator scat survey data. Our results suggest the chances of successfully eradicating the introduced red fox population in Tasmania may be significantly higher than previously thought.	[Caley, Peter; Barry, Simon C.] Commonwealth Sci & Ind Res Org, Canberra, ACT, Australia; [Ramsey, David S. L.] Arthur Rylah Inst, Dept Sustainabil & Environm, Victoria, Australia	Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Caley, P (corresponding author), Commonwealth Sci & Ind Res Org, Canberra, ACT, Australia.	peter.caley@csiro.au	Caley, Peter/D-8638-2011	Caley, Peter/0000-0002-8077-6460	Australian Pest Animal Research Program Round 3 [GMS1520]; CSIRO Biosecurity Flagship	Australian Pest Animal Research Program Round 3; CSIRO Biosecurity Flagship	Funding was provided by the Australian Pest Animal Research Program Round 3 2011-12 (Project GMS1520) and the CSIRO Biosecurity Flagship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beaumont MA, 2010, ANNU REV ECOL EVOL S, V41, P379, DOI 10.1146/annurev-ecolsys-102209-144621; Blackman D, 2013, ARE THERE REALLY FOX; Caley P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095857; Catterall S, 2012, ECOGRAPHY, V35, P901, DOI 10.1111/j.1600-0587.2011.07190.x; COMAN BJ, 1991, WILDLIFE RES, V18, P215, DOI 10.1071/WR9910215; Field SA, 2005, WILDLIFE RES, V32, P253, DOI 10.1071/WR05010; Fisher DO, 2012, CONSERV BIOL, V26, P57, DOI 10.1111/j.1523-1739.2011.01797.x; Gilks WR, 1996, MARKOV CHAIN MONTE C; Heydon MJ, 2000, J ZOOL, V251, P237, DOI 10.1111/j.1469-7998.2000.tb00607.x; Hijmans RJ, 2014, INTRO RASTER PACKAGE; Keith JM, 2013, P NATL ACAD SCI USA, V110, P13428, DOI 10.1073/pnas.1216146110; Kirkwood R, 2005, PROTECTING PENGUINS, P177; Marion G, 2012, J BIOGEOGR, V39, P2225, DOI 10.1111/j.1365-2699.2012.02772.x; Marks CA, 2014, J APPL ECOL, V51, P1033, DOI 10.1111/1365-2664.12278; McCallum H, 2007, ECOHEALTH, V4, P318, DOI 10.1007/s10393-007-0118-0; O'Hara RB, 2002, ECOLOGY, V83, P2408, DOI 10.1890/0012-9658(2002)083[2408:BAOMD]2.0.CO;2; Pagel J, 2012, GLOBAL ECOL BIOGEOGR, V21, P293, DOI 10.1111/j.1466-8238.2011.00663.x; Petzoldt T, 2007, SIMECOL OBJECT ORIEN; R Development Core Team, 2014, R LANG ENV STAT COMP; Rasmussen R, 2012, ENVIRON MODELL SOFTW, V29, P1, DOI 10.1016/j.envsoft.2011.10.005; Reynolds JC, 2003, MAMMAL REV, V33, P69, DOI 10.1046/j.1365-2907.2003.00002.x; Roberts DL, 2006, BIOL CONSERV, V128, P285, DOI 10.1016/j.biocon.2005.09.033; Rolls EC, 1984, THEY ALL RAN WILD AN; Sarre SD, 2013, J APPL ECOL, V50, P459, DOI 10.1111/1365-2664.12011; Saunders G., 2006, FOXES TASMANIA REPOR; Saunders G., 1995, MANAGING VERTEBRATE; Sisson SA, 2007, P NATL ACAD SCI USA, V104, P1760, DOI 10.1073/pnas.0607208104; Snow NP, 2012, J WILDLIFE MANAGE, V76, P243, DOI 10.1002/jwmg.247; Solow A, 2008, J APPL ECOL, V45, P424, DOI 10.1111/j.1365-2664.2007.01446.x; Statham M, 1991, ADELAIDE, P169; Toni T, 2010, BIOINFORMATICS, V26, P104, DOI 10.1093/bioinformatics/btp619; Toni T, 2009, J R SOC INTERFACE, V6, P187, DOI 10.1098/rsif.2008.0172; Van Dyk DA, 2001, J COMPUTATIONAL GRAP, V10; Willson JD, 2011, BIOL INVASIONS, V13, P1493, DOI 10.1007/s10530-010-9908-3	34	11	11	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2015	10	1							e0116631	10.1371/journal.pone.0116631	http://dx.doi.org/10.1371/journal.pone.0116631			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ4OZ	25602618	Green Submitted, Green Published, gold			2022-12-27	WOS:000348203500030
J	Chen, YJ; Roohani-Esfahani, SI; Lu, ZF; Zreiqat, H; Dunstan, CR				Chen, Yongjuan; Roohani-Esfahani, Seyed-Iman; Lu, Zufu; Zreiqat, Hala; Dunstan, Colin R.			Zirconium Ions Up-Regulate the BMP/SMAD Signaling Pathway and Promote the Proliferation and Differentiation of Human Osteoblasts	PLOS ONE			English	Article							BONE MORPHOGENETIC PROTEIN-2; IN-VITRO BIOCOMPATIBILITY; ALPHA-2-BETA-1 INTEGRIN; PHOSPHATE COATINGS; ALUMINA CERAMICS; CELLS; EXPRESSION; TITANIUM; SURFACE; OSTEOCONDUCTIVITY	Zirconium (Zr) is an element commonly used in dental and orthopedic implants either as zirconia (ZrO2) or in metal alloys. It can also be incorporated into calcium silicate-based ceramics. However, the effects of in vitro culture of human osteoblasts (HOBs) with soluble ionic forms of Zr have not been determined. In this study, primary culture of human osteoblasts was conducted in the presence of medium containing either ZrCl4 or Zirconium (IV) oxynitrate (ZrO(NO3)(2)) at concentrations of 0, 5, 50 and 500 mu M, and osteoblast proliferation, differentiation and calcium deposition were assessed. Incubation of human osteoblast cultures with Zr ions increased the proliferation of human osteoblasts and also gene expression of genetic markers of osteoblast differentiation. In 21 and 28 day cultures, Zr ions at concentrations of 50 and 500 mu M increased the deposition of calcium phosphate. In addition, the gene expression of BMP2 and BMP receptors was increased in response to culture with Zr ions and this was associated with increased phosphorylation of SMAD1/5. Moreover, Noggin suppressed osteogenic gene expression in HOBs co-treated with Zr ions. In conclusion, Zr ions appear able to induce both the proliferation and the differentiation of primary human osteoblasts. This is associated with up-regulation of BMP2 expression and activation of BMP signaling suggesting this action is, at least in part, mediated by BMP signaling.	[Chen, Yongjuan; Roohani-Esfahani, Seyed-Iman; Lu, Zufu; Zreiqat, Hala; Dunstan, Colin R.] Univ Sydney, Sch AMME, Biomat & Tissue Engn Res Unit, Sydney, NSW 2006, Australia	University of Sydney	Dunstan, CR (corresponding author), Univ Sydney, Sch AMME, Biomat & Tissue Engn Res Unit, Sydney, NSW 2006, Australia.	colin.dunstan@sydney.edu.au	Dunstan, Colin/G-6214-2013	Dunstan, Colin/0000-0001-7586-4071; Lu, ZuFu/0000-0003-4843-4441; Zreiqat, Hala/0000-0003-0521-7711; Roohani, Iman/0000-0001-6618-8577	National Health and Medical Research Council of Australia; National Health and Medical Research Council [632654]; Rebecca Cooper Medical Research Foundation	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Rebecca Cooper Medical Research Foundation	The work was supported by the following: National Health and Medical Research Council of Australia; Project grant 632654, National Health and Medical Research Council https://www.nhmrc.gov.au and Rebecca Cooper Medical Research Foundation http://cooperfoundation.org.au/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adair JH, 1997, MATER RES SOC SYMP P, V432, P101, DOI 10.1557/PROC-432-101; Carinci F, 2004, BIOMATERIALS, V25, P215, DOI 10.1016/S0142-9612(03)00486-1; GHOSH S, 1992, BIOL TRACE ELEM RES, V35, P247, DOI 10.1007/BF02783770; Gronthos S, 1999, J BONE MINER RES, V14, P47, DOI 10.1359/jbmr.1999.14.1.47; GRZESIK WJ, 1994, J BONE MINER RES, V9, P487, DOI 10.1002/jbmr.5650090408; Hallab N, 2006, J ASTM INT, V3, P1, DOI [10.1520/JAI1281710.1002/(SICI)1097-4636(19991215)47:4%3C481::AID-JBM4%3E3.0.CO;2-Y, DOI 10.1520/JAI1281710.1002/(SICI)1097-4636(19991215)47:4%3C481::AID-JBM4%3E3.0.CO;2]; Josset Y, 1999, J BIOMED MATER RES, V47, P481, DOI 10.1002/(SICI)1097-4636(19991215)47:4<481::AID-JBM4>3.0.CO;2-Y; KASSEM M, 1994, EUR J ENDOCRINOL, V130, P381, DOI 10.1530/eje.0.1300381; Kim HW, 2004, J BIOMED MATER RES A, V68A, P522, DOI 10.1002/jbm.a.20094; Knabe C, 2004, BIOMATERIALS, V25, P4911, DOI 10.1016/j.biomaterials.2004.01.059; Kohal RJ, 2009, CLIN ORAL IMPLAN RES, V20, P1265, DOI 10.1111/j.1600-0501.2009.01735.x; Kulakov O B, 2005, Morfologiia, V127, P52; Lecanda F, 1997, J CELL BIOCHEM, V67, P386, DOI 10.1002/(SICI)1097-4644(19971201)67:3<386::AID-JCB10>3.3.CO;2-5; LU Z, 2013, TISSUE ENG A; Lu ZF, 2013, J CELL PHYSIOL, V228, P1737, DOI 10.1002/jcp.24330; Lu ZF, 2012, NANOMED-NANOTECHNOL, V8, P507, DOI 10.1016/j.nano.2011.07.012; Lu ZL, 2010, TISSUE ENG PT A, V16, P3075, DOI 10.1089/ten.tea.2010.0204; Lu ZF, 2010, BIOCHEM BIOPH RES CO, V394, P323, DOI 10.1016/j.bbrc.2010.02.178; Oum'hamed Z, 2004, J BIOMED MATER RES A, V68A, P114, DOI 10.1002/jbm.a.20001; Ramaswamy Y, 2008, BIOMATERIALS, V29, P4392, DOI 10.1016/j.biomaterials.2008.08.006; Randeniya L, 2010, ACTA BIOMATER, V6, P4154, DOI 10.1016/j.actbio.2010.04.014; Roohani-Esfahani SI, 2012, ACTA BIOMATER, V8, P4162, DOI 10.1016/j.actbio.2012.07.036; Saldana L, 2007, BIOMATERIALS, V28, P4343, DOI 10.1016/j.biomaterials.2007.06.015; Sherepo KM, 2004, BIOMED ENG, V38, P77, DOI DOI 10.1023/B:BIEN.0000035726.31175.F8; Sollazzo V, 2008, J BIOMED MATER RES B, V84B, P550, DOI 10.1002/jbm.b.30903; Verberckmoes SC, 2003, KIDNEY INT, V64, P534, DOI 10.1046/j.1523-1755.2003.00123.x; Verron E, 2010, BRIT J PHARMACOL, V159, P1681, DOI 10.1111/j.1476-5381.2010.00665.x; Wang GC, 2010, ACTA BIOMATER, V6, P990, DOI 10.1016/j.actbio.2009.09.021; Zhou FY, 2013, J BIOMED MATER RES B, V101B, P237, DOI 10.1002/jbm.b.32833; Zreiqat H, 2005, BIOMATERIALS, V26, P7579, DOI 10.1016/j.biomaterials.2005.05.024	30	28	28	2	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2015	10	1							e0113426	10.1371/journal.pone.0113426	http://dx.doi.org/10.1371/journal.pone.0113426			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ4OZ	25602473	Green Published, gold, Green Submitted			2022-12-27	WOS:000348203500002
J	Kajala, I; Shi, Q; Nyyssola, A; Maina, NH; Hou, YX; Katina, K; Tenkanen, M; Juvonen, R				Kajala, Ilkka; Shi, Qiao; Nyyssola, Antti; Maina, Ndegwa Henry; Hou, Yaxi; Katina, Kati; Tenkanen, Maija; Juvonen, Riikka			Cloning and Characterization of a Weissella confusa Dextransucrase and Its Application in High Fibre Baking	PLOS ONE			English	Article							LACTIC-ACID BACTERIA; WHEAT BRAN; MOLECULAR CHARACTERIZATION; GLUCANSUCRASE; GENES; EXOPOLYSACCHARIDES; LACTOBACILLUS; CIBARIA; OPTIMIZATION; SPECIFICITY	Wheat bran offers health benefits as a baking ingredient, but is detrimental to bread textural quality. Dextran production by microbial fermentation improves sourdough bread volume and freshness, but extensive acid production during fermentation may negate this effect. Enzymatic production of dextran in wheat bran was tested to determine if dextran-containing bran could be used in baking without disrupting bread texture. The Weissella confusa VTT E-90392 dextransucrase gene was sequenced and His-tagged dextransucrase Wc392-rDSR was produced in Lactococcus lactis. Purified enzyme was characterized using C-14-sucrose radioisotope and reducing value-based assays, the former yielding K-m and V-max values of 14.7 mM and 8.2 mu mol/(mg min), respectively, at the pH optimum of 5.4. The structure and size of in vitro dextran product was similar to dextran produced in vivo. Dextran (8.1% dry weight) was produced in wheat bran in 6 h using Wc392-rDSR. Bran with and without dextran was used in wheat baking at 20% supplementation level. Dextran presence improved bread softness and neutralized bran-induced volume loss, clearly demonstrating the potential of using dextransucrases in bran bioprocessing for use in baking.	[Kajala, Ilkka; Nyyssola, Antti; Juvonen, Riikka] VTT, Tech Res Ctr Finland, Espoo, Finland; [Shi, Qiao; Maina, Ndegwa Henry; Hou, Yaxi; Katina, Kati; Tenkanen, Maija] Univ Helsinki, Dept Food & Environm Sci, Helsinki, Finland	VTT Technical Research Center Finland; University of Helsinki	Kajala, I (corresponding author), VTT, Tech Res Ctr Finland, Espoo, Finland.	ilkka.kajala@vtt.fi	Tenkanen, Maija/F-9080-2016	Katina, Kati/0000-0002-8147-3146; Nyyssola, Antti/0000-0002-8195-3967; Juvonen, Riikka/0000-0001-8145-3359; Tenkanen, Maija/0000-0003-2883-2717; Maina, Ndegwa/0000-0001-8955-2458	Academy of Finland via the WISE-Dextran project [255755]; ABS Graduate School via a PhD scholarship	Academy of Finland via the WISE-Dextran project; ABS Graduate School via a PhD scholarship	This study was supported by the Academy of Finland (contract number 255755) via the WISE-Dextran project and the ABS Graduate School via a PhD scholarship to Qiao Shi. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amari M, 2013, APPL MICROBIOL BIOT, V97, P5413, DOI 10.1007/s00253-012-4447-8; BASEDOW A, 1979, J POLYM SCI       PS, V66, P101, DOI DOI 10.1002/POLC.5070660113; Bejar W, 2013, INT J BIOL MACROMOL, V52, P125, DOI 10.1016/j.ijbiomac.2012.09.014; Bounaix MS, 2009, J AGR FOOD CHEM, V57, P10889, DOI 10.1021/jf902068t; Clarke CI, 2005, ADV FOOD NUTR RES, V49, P137, DOI 10.1016/S1043-4526(05)49004-X; DE MAN J. C., 1960, JOUR APPL BACT, V23, P130, DOI 10.1111/j.1365-2672.1960.tb00188.x; deRuyter PGGA, 1996, APPL ENVIRON MICROB, V62, P3662, DOI 10.1128/AEM.62.10.3662-3667.1996; Di Cagno R, 2006, J AGR FOOD CHEM, V54, P9873, DOI 10.1021/jf061393+; Freitas F, 2011, TRENDS BIOTECHNOL, V29, P388, DOI 10.1016/j.tibtech.2011.03.008; Galle S, 2012, INT J FOOD MICROBIOL, V155, P105, DOI 10.1016/j.ijfoodmicro.2012.01.009; Galle S, 2010, J AGR FOOD CHEM, V58, P5834, DOI 10.1021/jf1002683; Holm L, 2000, BIOINFORMATICS, V16, P566, DOI 10.1093/bioinformatics/16.6.566; Holo H, 1995, Methods Mol Biol, V47, P195; Irague R, 2012, BIOMACROMOLECULES, V13, P187, DOI 10.1021/bm201453r; Kaditzky S, 2008, EUR FOOD RES TECHNOL, V228, P291, DOI 10.1007/s00217-008-0934-7; Kang HK, 2009, FEMS MICROBIOL LETT, V292, P33, DOI 10.1111/j.1574-6968.2008.01460.x; Katina K, 2012, CEREAL CHEM, V89, P126, DOI 10.1094/CCHEM-08-11-0106; Katina K, 2009, FOOD MICROBIOL, V26, P734, DOI 10.1016/j.fm.2009.07.008; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kralj S, 2004, MICROBIOL-SGM, V150, P3681, DOI 10.1099/mic.0.27321-0; Kralj S, 2003, BIOCATAL BIOTRANSFOR, V21, P181, DOI 10.1080/10242420310001618519; Lacaze G, 2007, FOOD MICROBIOL, V24, P155, DOI 10.1016/j.fm.2006.07.015; Leemhuis H, 2013, J BIOTECHNOL, V163, P250, DOI 10.1016/j.jbiotec.2012.06.037; LILJA S, 1993, EFFECTS NACL ACIDITY, P3946; Maina NH, 2008, CARBOHYD RES, V343, P1446, DOI 10.1016/j.carres.2008.04.012; Maina NH, 2014, CARBOHYD POLYM, V99, P199, DOI 10.1016/j.carbpol.2013.08.021; Maina NH, 2011, BIOMACROMOLECULES, V12, P409, DOI 10.1021/bm1011536; Malik A, 2009, FEMS MICROBIOL LETT, V300, P131, DOI 10.1111/j.1574-6968.2009.01772.x; McIntyre AP, 2013, CARBOHYD RES, V380, P118, DOI 10.1016/j.carres.2013.06.008; Nelson N, 1944, J BIOL CHEM, V153, P375; Pakarinen A, 2011, BIOMASS BIOENERG, V35, P3071, DOI 10.1016/j.biombioe.2011.04.022; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Pruckler M, 2014, LWT-FOOD SCI TECHNOL, V56, P211, DOI 10.1016/j.lwt.2013.12.004; Rantanen H, 2007, CARBOHYD POLYM, V68, P350, DOI 10.1016/j.carbpol.2006.11.022; Rao TJM, 2013, PREP BIOCHEM BIOTECH, V43, P329, DOI 10.1080/10826068.2012.737400; Sandra C, 2012, J CEREAL SCI, V56, P531, DOI 10.1016/j.jcs.2012.07.001; Seegers JFML, 2000, MICROBIOL-UK, V146, P435, DOI 10.1099/00221287-146-2-435; Shukla S, 2014, CARBOHYD POLYM, V101, P554, DOI 10.1016/j.carbpol.2013.09.087; Shukla Shraddha, 2011, Enzyme Res, V2011, P250842, DOI 10.4061/2011/250842; SOMOGYI M, 1945, J BIOL CHEM, V160, P61; Stevenson L, 2012, INT J FOOD SCI NUTR, V63, P1001, DOI 10.3109/09637486.2012.687366; Van der Meulen R, 2007, INT J FOOD MICROBIOL, V118, P250, DOI 10.1016/j.ijfoodmicro.2007.07.014; Vettori MHPB, 2011, CARBOHYD RES, V346, P1077, DOI 10.1016/j.carres.2011.02.015; Vujicic-Zagar A, 2010, P NATL ACAD SCI USA, V107, P21406, DOI 10.1073/pnas.1007531107; Zhang D, 1999, J SCI FOOD AGR, V79, P805, DOI 10.1002/(SICI)1097-0010(19990501)79:6<805::AID-JSFA285>3.0.CO;2-E	45	28	30	1	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2015	10	1							e0116418	10.1371/journal.pone.0116418	http://dx.doi.org/10.1371/journal.pone.0116418			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ4OZ	25603169	Green Submitted, Green Published, gold			2022-12-27	WOS:000348203500024
J	Minias, AE; Brzostek, AM; Minias, P; Dziadek, J				Minias, Alina E.; Brzostek, Anna M.; Minias, Piotr; Dziadek, Jaroslaw			The Deletion of rnhB in Mycobacterium smegmatis Does Not Affect the Level of RNase HII Substrates or Influence Genome Stability	PLOS ONE			English	Article							DNA-POLYMERASE-I; H-DEFECTIVE-MUTANTS; ESCHERICHIA-COLI; SACCHAROMYCES-CEREVISIAE; BACILLUS-SUBTILIS; REPLICATION; RIBONUCLEOTIDES; TUBERCULOSIS; GENES; GROWTH	RNase HII removes RNA from RNA/DNA hybrids, such as single ribonucleotides and RNA primers generated during DNA synthesis. Both, RNase HII substrates and RNase HII deficiency have been associated with genome instability in several organisms, and genome instability is a major force leading to the acquisition of drug resistance in bacteria. Understanding the mechanisms that underlie this phenomenon is one of the challenges in identifying efficient methods to combat bacterial pathogens. The aim of the present study was set to investigate the role of rnhB, presumably encoding RNase HII, in maintaining genome stability in the M. tuberculosis model organism Mycobacterium smegmatis. We performed gene replacement through homologous recombination to obtain mutant strains of Mycobacterium smegmatis lacking the rnhB gene. The mutants did not present an altered phenotype, according to the growth rate in liquid culture or susceptibility to hydroxyurea, and did not show an increase in the spontaneous mutation rate, determined using the Luria-Delbru fluctuation test for streptomycin resistance in bacteria. The mutants also did not present an increase in the level of RNase HII substrates, measured as the level of alkaline degradation of chromosomal DNA or determined through immunodetection. We conclude that proteins other than RnhB proteins efficiently remove RNase HII substrates in M. smegmatis. These results highlight differences in the basic biology between Mycobacteria and eukaryotes and between different species of bacteria.	[Minias, Alina E.; Brzostek, Anna M.; Dziadek, Jaroslaw] Polish Acad Sci, Inst Med Biol, Dept Genet & Physiol Mycobacterium, Lodz, Poland; [Minias, Alina E.] Univ Lodz, Dept Microbiol Biotechnol & Immunol, PL-90131 Lodz, Poland; [Minias, Piotr] Univ Lodz, Dept Teacher Training & Biodivers Studies, PL-90131 Lodz, Poland	Polish Academy of Sciences; Institute of Medical Biology of the Polish Academy of Sciences; University of Lodz; University of Lodz	Minias, AE (corresponding author), Polish Acad Sci, Inst Med Biol, Dept Genet & Physiol Mycobacterium, Lodz, Poland.	alinagrna@gmail.pl; jdziadek@cbm.pan.pl		Dziadek, Jaroslaw/0000-0003-1427-884X; Minias, Alina/0000-0002-3210-6737; Minias, Piotr/0000-0002-7742-6750	Innovative Economy Operational Programme [POIG.01.01.02-10-107/09]; Polish National Center of Science [2011/01/N/NZ6/04186]	Innovative Economy Operational Programme; Polish National Center of Science	The study was supported by POIG.01.01.02-10-107/09 project implemented under Innovative Economy Operational Programme, years 2007-2013 "Studies of the molecular mechanisms at the interface the human organism-the pathogen-environmental factors." and by grant of Polish National Center of Science 2011/01/N/NZ6/04186 "Identification of a novel mechanism of initiation of DNA replication in Mycobacterium smegmatis".	Arudchandran A, 2000, GENES CELLS, V5, P789, DOI 10.1046/j.1365-2443.2000.00373.x; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Bayliss CD, 2005, NUCLEIC ACIDS RES, V33, P400, DOI 10.1093/nar/gki180; Bubeck D, 2011, NUCLEIC ACIDS RES, V39, P3652, DOI 10.1093/nar/gkq980; Chen JJZ, 2000, NUCLEIC ACIDS RES, V28, P3649, DOI 10.1093/nar/28.18.3649; Chon HG, 2009, NUCLEIC ACIDS RES, V37, P96, DOI 10.1093/nar/gkn913; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; DELUCIA P, 1969, NATURE, V224, P1164, DOI 10.1038/2241164a0; Dziadek J, 2002, J BACTERIOL, V184, P3848, DOI 10.1128/JB.184.14.3848-3855.2002; EDER PS, 1993, BIOCHIMIE, V75, P123, DOI 10.1016/0300-9084(93)90033-O; Fukushima S, 2007, J BACTERIOL, V189, P8575, DOI 10.1128/JB.00653-07; Gerdes SY, 2003, J BACTERIOL, V185, P5673, DOI 10.1128/JB.185.19.5673-5684.2003; Ghodgaonkar MM, 2013, MOL CELL, V50, P323, DOI 10.1016/j.molcel.2013.03.019; Ginno PA, 2013, GENOME RES, V23, P1590, DOI 10.1101/gr.158436.113; Gordhan BG, 1996, GENE, V178, P125, DOI 10.1016/0378-1119(96)00350-2; Hiller B, 2012, J EXP MED, V209, P1419, DOI 10.1084/jem.20120876; HORIUCHI T, 1984, MOL GEN GENET, V195, P17, DOI 10.1007/BF00332717; HUANG L, 1994, J BIOL CHEM, V269, P25922; Itaya M, 1999, J BACTERIOL, V181, P2118, DOI 10.1128/JB.181.7.2118-2123.1999; JOYCE CM, 1984, J BACTERIOL, V158, P636, DOI 10.1128/JB.158.2.636-643.1984; KANAYA S, 1984, P NATL ACAD SCI-BIOL, V81, P3447, DOI 10.1073/pnas.81.11.3447; KELLEY WS, 1980, GENETICS, V95, P15; Kim N, 2011, SCIENCE, V332, P1561, DOI 10.1126/science.1205016; KLENOW H, 1970, P NATL ACAD SCI USA, V65, P168, DOI 10.1073/pnas.65.1.168; Kochiwa H, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-128; Kolberg M, 2004, BBA-PROTEINS PROTEOM, V1699, P1, DOI 10.1016/j.bbapap.2004.02.007; Lazzaro F, 2012, MOL CELL, V45, P99, DOI 10.1016/j.molcel.2011.12.019; Le Laz S, 2010, J BACTERIOL, V192, P3689, DOI 10.1128/JB.00268-10; LEHMAN IR, 1976, SCIENCE, V193, P963, DOI 10.1126/science.781842; Liang RB, 2007, MICROBIOL-SGM, V153, P787, DOI 10.1099/mic.0.2006/003434-0; LU AL, 1987, J BACTERIOL, V169, P1254, DOI 10.1128/jb.169.3.1254-1259.1987; Luria SE, 1943, GENETICS, V28, P491; McElhinny SAN, 2010, NAT CHEM BIOL, V6, P774, DOI [10.1038/NCHEMBIO.424, 10.1038/nchembio.424]; Murante RS, 1998, P NATL ACAD SCI USA, V95, P2244, DOI 10.1073/pnas.95.5.2244; Murdeshwar MS, 2012, J BACTERIOL, V194, P4003, DOI 10.1128/JB.00258-12; Nagata Y, 2002, GENETICS, V160, P13; OGAWA T, 1984, MOL GEN GENET, V193, P231, DOI 10.1007/BF00330673; Ohtani N, 1999, BIOCHEMISTRY-US, V38, P605, DOI 10.1021/bi982207z; OKAZAKI R, 1971, P NATL ACAD SCI USA, V68, P2954, DOI 10.1073/pnas.68.12.2954; OLIVERA BM, 1974, NATURE, V250, P513, DOI 10.1038/250513a0; Parish T, 2000, MICROBIOL-SGM, V146, P1969, DOI 10.1099/00221287-146-8-1969; Pawelczyk J, 2011, J BACTERIOL, V193, P6960, DOI 10.1128/JB.05638-11; Qiu JZ, 1999, MOL CELL BIOL, V19, P8361, DOI 10.1128/mcb.19.12.8361; Reijns MAM, 2012, CELL, V149, DOI 10.1016/j.cell.2012.04.011; RICCHETTI M, 1993, EMBO J, V12, P387, DOI 10.1002/j.1460-2075.1993.tb05670.x; Rumbaugh JA, 1997, J BIOL CHEM, V272, P22591, DOI 10.1074/jbc.272.36.22591; Sato A, 2003, BIOCHEM BIOPH RES CO, V309, P247, DOI 10.1016/j.bbrc.2003.08.003; Spies FS, 2011, J CLIN MICROBIOL, V49, P2625, DOI 10.1128/JCM.00168-11; TORREY TA, 1984, MOL GEN GENET, V196, P350, DOI 10.1007/BF00328070; TURCHI JJ, 1994, P NATL ACAD SCI USA, V91, P9803, DOI 10.1073/pnas.91.21.9803; Vaisman A, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003878; Villellas C, 2013, J CLIN MICROBIOL, V51, P2124, DOI 10.1128/JCM.01944-12; Wahba L, 2013, ELIFE, V2, DOI 10.7554/eLife.00505; Watkins HA, 2010, J BACTERIOL, V192, P2878, DOI 10.1128/JB.01615-09; WINDER FG, 1973, J GEN MICROBIOL, V76, P189, DOI 10.1099/00221287-76-1-189; Yao NY, 2013, P NATL ACAD SCI USA, V110, P12942, DOI 10.1073/pnas.1309506110; Zheng L, 2011, J MOL CELL BIOL, V3, P23, DOI 10.1093/jmcb/mjq048; ZWIETERING MH, 1990, APPL ENVIRON MICROB, V56, P1875	58	8	8	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2015	10	1							e0115521	10.1371/journal.pone.0115521	http://dx.doi.org/10.1371/journal.pone.0115521			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ4OZ	25603150	gold, Green Published, Green Submitted			2022-12-27	WOS:000348203500015
J	Gauci, PJ; McAllister, J; Mitchell, IR; Boyle, DB; Bulach, DM; Weir, RP; Melville, LF; Gubala, AJ				Gauci, Penelope J.; McAllister, Jane; Mitchell, Ian R.; Boyle, David B.; Bulach, Dieter M.; Weir, Richard P.; Melville, Lorna F.; Gubala, Aneta J.			Genomic Characterisation of Three Mapputta Group Viruses, a Serogroup of Australian and Papua New Guinean Bunyaviruses Associated with Human Disease	PLOS ONE			English	Article							NONSTRUCTURAL PROTEIN NSS; SEQUENCE DETERMINATION; NUCLEOCAPSID PROTEIN; FAMILY BUNYAVIRIDAE; RNA SEGMENT; MAIN-DRAIN; ARBOVIRUSES; MOSQUITOS; QUEENSLAND; VALLEY	The Mapputta serogroup tentatively contains the mosquito-associated viruses Mapputta, Maprik, Trubanaman and Gan Gan. Interestingly, this serogroup has previously been associated with an acute epidemic polyarthritis-like illness in humans; however, there has been no ensuing genetic characterisation. Here we report the complete genome sequences of Mapputta and Maprik viruses, and a new Mapputta group candidate, Buffalo Creek virus, previously isolated from mosquitoes and detected by serology in a hospitalised patient. Phylogenetic analyses indicate that the group is one of the earliest diverged groups within the genus Orthobunyavirus of the family Bunyaviridae. Analyses show that these three viruses are related to the recently sequenced Australian bunyaviruses from mosquitoes, Salt Ash and Murrumbidgee. A notable feature of the Mapputta group viruses is the absence of the NSs (non-structural) ORF commonly found on the S segment of other orthobunya-viruses. Viruses of the Mapputta group have been isolated from geographically diverse regions ranging from tropical Papua New Guinea to the semi-arid climate of south-eastern Australia. The relevance of this group to human health in the region merits further investigation.	[Gauci, Penelope J.; McAllister, Jane; Mitchell, Ian R.; Gubala, Aneta J.] Def Sci & Technol Org, Land Div, Fishermans Bend, Vic, Australia; [Boyle, David B.; Bulach, Dieter M.] Commonwealth Sci & Ind Res Org, Australian Anim Hlth Lab, Geelong, Vic, Australia; [Weir, Richard P.; Melville, Lorna F.] Berrimah Vet Labs, Dept Primary Ind & Fisheries, Berrimah, NT, Australia	Defence Science & Technology; Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Gauci, PJ (corresponding author), Def Sci & Technol Org, Land Div, Fishermans Bend, Vic, Australia.	Penny.Gauci@dsto.defence.gov.au	Bulach, Dieter M/D-5793-2011	Bulach, Dieter M/0000-0001-9823-6078				Akashi H, 1997, J GEN VIROL, V78, P2847, DOI 10.1099/0022-1317-78-11-2847; Aquino VH, 2003, ARCH VIROL, V148, P19, DOI 10.1007/s00705-002-0913-4; Barr JN, 2004, J VIROL, V78, P1129, DOI 10.1128/JVI.78.3.1129-1138.2004; Barr JN, 2003, VIROLOGY, V311, P326, DOI 10.1016/S0042-6822(03)00130-2; Beer M, 2013, EPIDEMIOL INFECT, V141, P1, DOI 10.1017/S0950268812002245; BISHOP DHL, 1980, INTERVIROLOGY, V14, P125, DOI 10.1159/000149174; Blakqori G, 2007, J VIROL, V81, P4991, DOI 10.1128/JVI.01933-06; BOUGHTON CR, 1990, AUST NZ J MED, V20, P51, DOI 10.1111/j.1445-5994.1990.tb00371.x; BOWEN MD, 1995, J GEN VIROL, V76, P559, DOI 10.1099/0022-1317-76-3-559; Boyle DB, 2012, J VIROL, V86, P6724, DOI 10.1128/JVI.00182-12; BRANDT WE, 1967, AM J TROP MED HYG, V16, P339, DOI 10.4269/ajtmh.1967.16.339; Bridgen A, 2001, P NATL ACAD SCI USA, V98, P664, DOI 10.1073/pnas.98.2.664; Briese T, 2007, ARCH VIROL, V152, P2237, DOI 10.1007/s00705-007-1069-z; Briese T, 2004, J GEN VIROL, V85, P3071, DOI 10.1099/vir.0.80122-0; Briese T, 2013, VIROLOGY, V446, P207, DOI 10.1016/j.virol.2013.07.030; Chowdhary R, 2012, J GEN VIROL, V93, P1023, DOI 10.1099/vir.0.039479-0; Coffey LL, 2014, VIROLOGY, V448, P146, DOI 10.1016/j.virol.2013.09.026; DOHERTY RL, 1973, T ROY SOC TROP MED H, V67, P536, DOI 10.1016/0035-9203(73)90084-9; DOHERTY RL, 1970, T ROY SOC TROP MED H, V64, P748, DOI 10.1016/0035-9203(70)90017-9; DOHERTY RL, 1968, T ROY SOC TROP MED H, V62, P430, DOI 10.1016/0035-9203(68)90095-3; DOHERTY RL, 1963, AUST J EXP BIOL MED, V41, P17, DOI 10.1038/icb.1963.2; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; DUNN EF, 1995, VIROLOGY, V211, P133, DOI 10.1006/viro.1995.1386; DUNN EF, 1994, J GEN VIROL, V75, P597, DOI 10.1099/0022-1317-75-3-597; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Eifan SA, 2009, J VIROL, V83, P11307, DOI 10.1128/JVI.01460-09; Elliott RM, 2011, BUNYAVIRIDAE: MOLECULAR AND CELLULAR BIOLOGY, P1; FAZAKERLEY JK, 1988, VIROLOGY, V167, P422, DOI 10.1016/0042-6822(88)90104-3; GARD G, 1973, AM J TROP MED HYG, V22, P551, DOI 10.4269/ajtmh.1973.22.551; Gubala AJ, 2008, VIROLOGY, V376, P13, DOI 10.1016/j.virol.2008.03.004; Hooper PT, 1997, B I PASTEUR, V95, P209, DOI 10.1016/S0020-2452(97)83529-5; Huppatz C, 2009, COMMUN DIS INTELL, V33, P192; Huppatz C, 2009, EMERG INFECT DIS, V15, P1359, DOI 10.3201/eid1509.081540; KARABATSOS N, 1985, THE AMERICAN COMMITT; Kohl A, 2004, J GEN VIROL, V85, P3269, DOI 10.1099/vir.0.80407-0; MARSHALL ID, 1982, AUST J EXP BIOL MED, V60, P457, DOI 10.1038/icb.1982.51; Mir MA, 2004, J VIROL, V78, P8281, DOI 10.1128/jvi.78.15.8281-8288.2004; Mohamed M, 2009, J VIROL, V83, P7612, DOI 10.1128/JVI.02080-08; MULLER R, 1994, J GEN VIROL, V75, P1345, DOI 10.1099/0022-1317-75-6-1345; NEWTON SE, 1983, AUST J EXP BIOL MED, V61, P201, DOI 10.1038/icb.1983.19; Nunes MRT, 2005, J VIROL, V79, P10561, DOI 10.1128/JVI.79.16.10561-10570.2005; Osborne JC, 2000, J VIROL, V74, P9946, DOI 10.1128/JVI.74.21.9946-9952.2000; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Plyusnin A, 2012, VIRUS TAXONOMY, P725; POCH O, 1989, EMBO J, V8, P3867, DOI 10.1002/j.1460-2075.1989.tb08565.x; REED L. J., 1938, AMER JOUR HYG, V27, P493; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Rost B, 2003, CELL MOL LIFE SCI, V60, P2637, DOI 10.1007/s00018-003-3114-8; Rutherford K, 2000, BIOINFORMATICS, V16, P944, DOI 10.1093/bioinformatics/16.10.944; Saeed MF, 2000, J GEN VIROL, V81, P743, DOI 10.1099/0022-1317-81-3-743; Savji N, 2011, J GEN VIROL, V92, P1676, DOI 10.1099/vir.0.028308-0; Shi XH, 2005, J VIROL, V79, P13725, DOI 10.1128/JVI.79.21.13725-13734.2005; STANDFAST HA, 1984, AUST J BIOL SCI, V37, P351, DOI 10.1071/BI9840351; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Weber F, 2002, J VIROL, V76, P7949, DOI 10.1128/JVI.76.16.7949-7955.2002; WEIR R, 2002, THESIS U SYDNEY; Yanase T, 2003, VIRUS RES, V93, P63, DOI 10.1016/S0168-1702(03)00066-2; Yu XJ, 2011, NEW ENGL J MED, V364, P1523, DOI 10.1056/NEJMoa1010095; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	59	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2015	10	1							e0116561	10.1371/journal.pone.0116561	http://dx.doi.org/10.1371/journal.pone.0116561			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ0ID	25588016	Green Published, gold, Green Submitted			2022-12-27	WOS:000347928300017
J	Xavier, R; Faria, PJ; Paladini, G; van Oosterhout, C; Johnson, M; Cable, J				Xavier, Raquel; Faria, Patricia J.; Paladini, Giuseppe; van Oosterhout, Cock; Johnson, Mireille; Cable, Jo			Evidence for Cryptic Speciation in Directly Transmitted Gyrodactylid Parasites of Trinidadian Guppies	PLOS ONE			English	Article							MITOCHONDRIAL-DNA EVOLUTION; N.-SP MONOGENEA; POECILIA-RETICULATA; EXPERIMENTAL INFECTIONS; NATURAL-POPULATIONS; WILD POPULATIONS; RIBOSOMAL DNA; MATE CHOICE; PLATYHELMINTHES; HISTORY	Cryptic species complexes are common among parasites, which tend to have large populations and are subject to rapid evolution. Such complexes may arise through host-parasite co-evolution and/or host switching. For parasites that reproduce directly on their host, there might be increased opportunities for sympatric speciation, either by exploiting different hosts or different micro-habitats within the same host. The genus Gyrodactylus is a specious group of viviparous monogeneans. These ectoparasites transfer between teleosts during social contact and cause significant host mortality. Their impact on the guppy ( Poecilia reticulata), an iconic evolutionary and ecological model species, is well established and yet the population genetics and phylogenetics of these parasites remains understudied. Using mtDNA sequencing of the host and its parasites, we provide evidence of cryptic speciation in Gyrodactylus bullatarudis, G. poeciliae and G. turnbulli. For the COII gene, genetic divergence of lineages within each parasite species ranged between 5.7 and 17.2%, which is typical of the divergence observed between described species in this genus. Different lineages of G. turnbulli and G. poeciliae appear geographically isolated, which could imply allopatric speciation. In addition, for G. poeciliae, co-evolution with a different host species cannot be discarded due to its host range. This parasite was originally described on P. caucana, but for the first time here it is also recorded on the guppy. The two cryptic lineages of G. bullatarudis showed considerable geographic overlap. G. bullatarudis has a known wide host range and it can also utilize a killifish (Anablepsoides hartii) as a temporary host. This killifish is capable of migrating overland and it could act as a transmission vector between otherwise isolated populations. Additional genetic markers are needed to confirm the presence of these cryptic Gyrodactylus species complexes, potentially leading to more in-depth genetic, ecological and evolutionary analyses on this multi-host-parasite system.	[Xavier, Raquel; Faria, Patricia J.; Johnson, Mireille; Cable, Jo] Cardiff Univ, Sch Biol Sci, Cardiff CF10 3AX, S Glam, Wales; [Xavier, Raquel] Univ Porto, CIBIO, Ctr Invest Biodiversidade & Recursos Genet, P-4485661 Vairao, Portugal; [Paladini, Giuseppe] Univ Stirling, Inst Aquaculture, Sch Nat Sci, Stirling FK9 4LA, Scotland; [van Oosterhout, Cock] Univ E Anglia, Sch Environm Sci, Norwich NR4 7TJ, Norfolk, England	Cardiff University; Universidade do Porto; University of Stirling; University of East Anglia	Cable, J (corresponding author), Cardiff Univ, Sch Biol Sci, Cardiff CF10 3AX, S Glam, Wales.	cablej@cardiff.ac.uk	Cable, Joanne/A-4360-2010; Xavier, Raquel/A-8393-2012	Cable, Joanne/0000-0002-8510-7055; Xavier, Raquel/0000-0001-8800-3924; Paladini, Giuseppe/0000-0003-4944-0499; van Oosterhout, Cock/0000-0002-5653-738X	European Community [MTKD-CT-2005-030018]; FEDER (COMPETE); Fundacao para a Ciencia e a Tecnologia (FCT) [EXPL/MAR-BIO/1034/2012]; FCT [SFRH/BPD/75851/2011]; Earth and Life Systems Alliance (ELSA)	European Community(European Commission); FEDER (COMPETE)(European Commission); Fundacao para a Ciencia e a Tecnologia (FCT)(Portuguese Foundation for Science and TechnologyEuropean Commission); FCT(Portuguese Foundation for Science and TechnologyEuropean Commission); Earth and Life Systems Alliance (ELSA)	This study was funded by a European Community Framework Programme 6 Marie Curie Host Fellowship for transfer of knowledge (MTKD-CT-2005-030018) coordinated by JC, by FEDER (COMPETE program), and Fundacao para a Ciencia e a Tecnologia (FCT) funds through the project EXPL/MAR-BIO/1034/2012. RX is currently supported by a post-doctoral grant awarded by FCT (SFRH/BPD/75851/2011) and CvO by the Earth and Life Systems Alliance (ELSA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAKKE TA, 1990, J FISH BIOL, V37, P577, DOI 10.1111/j.1095-8649.1990.tb05890.x; BAKKE TA, 2007, ADV PARASIT, V64, P459; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Barson M, 2010, PARASITOLOGY, V137, P1585, DOI 10.1017/S0031182010000302; Barson NJ, 2009, J EVOLUTION BIOL, V22, P485, DOI 10.1111/j.1420-9101.2008.01675.x; Bueno-Silva M, 2014, FOLIA PARASIT, V61, P213, DOI 10.14411/fp.2014.028; Cable J, 2007, INT J PARASITOL, V37, P1449, DOI 10.1016/j.ijpara.2007.04.013; Cable J, 2007, BIOL J LINN SOC, V90, P647, DOI 10.1111/j.1095-8312.2006.00755.x; Cable J, 1996, TISSUE CELL, V28, P515, DOI 10.1016/S0040-8166(96)80054-1; Cable J, 1999, CAN J ZOOL, V77, P1439, DOI 10.1139/cjz-77-9-1439; Cable J, 2005, SYST PARASITOL, V60, P159, DOI 10.1007/s11230-004-6348-4; Cable J, 1998, MICROSC RES TECHNIQ, V42, P186, DOI 10.1002/(SICI)1097-0029(19980801)42:3<186::AID-JEMT3>3.0.CO;2-R; Cable J, 2013, PARASITOLOGY, V140, P1138, DOI 10.1017/S003118201300067X; Crispo E, 2006, MOL ECOL, V15, P49, DOI 10.1111/j.1365-294X.2005.02764.x; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Dowton M, 1995, J MOL EVOL, V41, P958, DOI 10.1007/BF00173176; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; FAJEN A, 1992, EVOLUTION, V46, P1457, DOI 10.1111/j.1558-5646.1992.tb01136.x; Faria PJ, 2011, CONSERV GENET RESOUR, V3, P177, DOI 10.1007/s12686-010-9317-z; Faria PJ, 2010, BIOL CONSERV, V143, P35, DOI 10.1016/j.biocon.2009.06.002; HAFNER MS, 1995, PHILOS T R SOC B, V349, P77, DOI 10.1098/rstb.1995.0093; Hansen H, 2007, TRENDS PARASITOL, V23, P363, DOI 10.1016/j.pt.2007.06.007; Harris PD, 1999, J PARASITOL, V85, P188, DOI 10.2307/3285617; Harris PD, 2000, SYST PARASITOL, V47, P79, DOI 10.1023/A:1006413804061; Harris PD, 2008, TRENDS PARASITOL, V24, P109, DOI 10.1016/j.pt.2007.12.004; Hoberg EP, 2008, J BIOGEOGR, V35, P1533, DOI 10.1111/j.1365-2699.2008.01951.x; Hughes J, 2007, SYST BIOL, V56, P232, DOI 10.1080/10635150701311370; Huyse T, 2005, TRENDS PARASITOL, V21, P469, DOI 10.1016/j.pt.2005.08.009; Huyse T, 2002, INT J PARASITOL, V32, P907, DOI 10.1016/S0020-7519(02)00026-7; Huyse T, 2008, GENE, V417, P27, DOI 10.1016/j.gene.2008.03.008; Jeswiet SB, 2011, ANIM BEHAV, V81, P639, DOI 10.1016/j.anbehav.2010.12.013; Johnson MB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022634; Jorge F, 2011, SYST PARASITOL, V80, P53, DOI 10.1007/s11230-011-9311-1; KENNEDY CEJ, 1987, BEHAV ECOL SOCIOBIOL, V21, P291, DOI 10.1007/BF00299966; King TA, 2007, INT J PARASITOL, V37, P663, DOI 10.1016/j.ijpara.2006.11.015; King TA, 2009, PARASITOL INT, V58, P249, DOI 10.1016/j.parint.2009.04.005; KOCHER TD, 1989, P NATL ACAD SCI USA, V86, P6196, DOI 10.1073/pnas.86.16.6196; Kolluru GR, 2009, BEHAV ECOL, V20, P131, DOI 10.1093/beheco/arn124; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Light JE, 2007, MOL PHYLOGENET EVOL, V45, P997, DOI 10.1016/j.ympev.2007.09.001; MALMBERG G, 1970, ARK ZOOL, V23, P1; Page RDM, 1998, MOL PHYLOGENET EVOL, V9, P276, DOI 10.1006/mpev.1997.0458; Paladini G, 2009, VET PARASITOL, V165, P290, DOI 10.1016/j.vetpar.2009.07.025; Pariselle Antoine, 2011, International Journal of Evolutionary Biology, V2011, P1, DOI 10.4061/2011/471480; Perez-Jvostov F, 2012, OECOLOGIA, V170, P77, DOI 10.1007/s00442-012-2289-9; Peterson KR, 2010, MYCOLOGIA, V102, P1417, DOI 10.3852/10-048; Plaisance L, 2007, MOL BIOCHEM PARASIT, V154, P190, DOI 10.1016/j.molbiopara.2007.04.012; Poulin R, 2000, Q REV BIOL, V75, P277, DOI 10.1086/393500; Reznick D, 1996, NETH J ZOOL, V46, P172, DOI 10.1163/156854295X00140; Richards EL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013285; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; SCOTT ME, 1985, J FISH DIS, V8, P495, DOI 10.1111/j.1365-2761.1985.tb00964.x; SHAW PW, 1991, J FISH BIOL, V39, P203, DOI 10.1111/j.1095-8649.1991.tb05084.x; SHIELDS GF, 1991, EVOLUTION, V45, P218, DOI 10.1111/j.1558-5646.1991.tb05279.x; Shinn AP, 2004, FOLIA PARASIT, V51, P239, DOI 10.14411/fp.2004.029; Simkova A, 2004, EVOLUTION, V58, P1001, DOI 10.1111/j.0014-3820.2004.tb00434.x; STEPHENSON JF, 2014, ECOLOGY IN PRESS; Suk HY, 2009, HEREDITY, V102, P425, DOI 10.1038/hdy.2009.7; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Truett GE, 2000, BIOTECHNIQUES, V29, P52, DOI 10.2144/00291bm09; Van Oosterhout C, 2007, CONSERV BIOL, V21, P1573, DOI 10.1111/j.1523-1739.2007.00809.x; van Oosterhout C, 2006, EVOLUTION, V60, P2562, DOI 10.1111/j.0014-3820.2006.tb01890.x; Willing EM, 2010, MOL ECOL, V19, P968, DOI 10.1111/j.1365-294X.2010.04528.x; WU CI, 1985, P NATL ACAD SCI USA, V82, P1741, DOI 10.1073/pnas.82.6.1741; Xia X, 2001, J HERED, V92, P371, DOI 10.1093/jhered/92.4.371; Xia XH, 2003, MOL PHYLOGENET EVOL, V26, P1, DOI 10.1016/S1055-7903(02)00326-3; Xia XH, 2009, PHYLOGENETIC HANDBOOK: A PRACTICAL APPROACH TO PHYLOGENETIC ANALYSIS AND HYPOTHESIS TESTING, 2ND EDITION, P615; Zietara MS, 2010, ACTA PARASITOL, V55, P20, DOI 10.2478/s11686-010-0016-4; Zwickl DJ., 2006, GENETIC ALGORITHM AP	69	23	23	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2015	10	1							e0117096	10.1371/journal.pone.0117096	http://dx.doi.org/10.1371/journal.pone.0117096			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ4BU	25574955	Green Accepted, Green Published, gold			2022-12-27	WOS:000348168100011
J	Huang, JH; Savini, G; Chen, H; Bao, FJ; Li, YG; Chen, HS; Lu, WC; Yu, Y; Wang, QM				Huang, Jinhai; Savini, Giacomo; Chen, Hao; Bao, Fangjun; Li, Yuanguang; Chen, Haisi; Lu, Weicong; Yu, Ye; Wang, Qinmei			Precision and Agreement of Corneal Power Measurements Obtained Using a New Corneal Topographer OphthaTOP	PLOS ONE			English	Article							IN-SITU KERATOMILEUSIS; CATARACT-SURGERY; REPEATABILITY; PENTACAM; REPRODUCIBILITY; VIDEOKERATOGRAPHY; PERFORMANCE; CURVATURE; EYES; KERATOMETRY	Purpose: To evaluate repeatability and reproducibility of anterior corneal power measurements obtained with a new corneal topographer OphthaTOP (Hummel AG, Germany) and agreement with measurements by a rotating Scheimpflug camera (Pentacam HR, Oculus, Germany) and an automated keratometer (IOLMaster, Carl Zeiss Meditec, Germany). Methods: The right eyes of 79 healthy subjects were prospectively measured three times with all three devices. Another examiner performed three additional scans with the OphthaTOP in the same session. Within one week, the first examiner repeated the measurements using the OphthaTOP. The flat simulated keratometry (Kf), steep K (Ks), mean K (Km), J(0), and J(45) were noted. Repeatability and reproducibility of measurements were assessed by within-subject standard deviation (Sw), repeatability (2.77 Sw), coefficient of variation (CoV), and intraclass correlation coefficient (ICC). Agreement between devices was assessed using 95% limits of agreement (LoA). Results: Intraobserver repeatability and interobserver and intersession reproducibility of all measured parameters showed a 2.77 Sw of 0.29 diopter or less, a CoV of less than 0.24%, and an ICC of more than 0.906. Statistically significant differences (P<0.001) were found between the parameters analyzed by the three devices, except J(0) and J(45). The mean differences between OphthaTOP and the other two devices were small, and the 95% LoA was narrow for all results. Conclusions: The OphthaTOP showed excellent intraobserver repeatability and interobserver and intersession reproducibility of corneal power measurements. Good agreements with the other two devices in these parameters were found in healthy eyes.	[Huang, Jinhai; Savini, Giacomo; Chen, Hao; Bao, Fangjun; Li, Yuanguang; Chen, Haisi; Lu, Weicong; Yu, Ye; Wang, Qinmei] Wenzhou Med Univ, Sch Optometry & Ophthalmol, Wenzhou, Zhejiang, Peoples R China; [Huang, Jinhai; Savini, Giacomo; Chen, Hao; Bao, Fangjun; Li, Yuanguang; Chen, Haisi; Lu, Weicong; Yu, Ye; Wang, Qinmei] Wenzhou Med Univ, Hosp Eye, Wenzhou, Zhejiang, Peoples R China; [Huang, Jinhai; Bao, Fangjun; Yu, Ye; Wang, Qinmei] Minist Hlth, Key Lab Vis Sci, Wenzhou, Zhejiang, Peoples R China; [Savini, Giacomo] Studio Oculist Azeglio, Bologna, Italy	Wenzhou Medical University; Wenzhou Medical University	Wang, QM (corresponding author), Wenzhou Med Univ, Sch Optometry & Ophthalmol, Wenzhou, Zhejiang, Peoples R China.	wqm6@mail.eye.ac.cn	Huang, Jinhai/ABH-4519-2020; Savini, Giacomo/J-9196-2018	Savini, Giacomo/0000-0003-0075-3582; Huang, Jinhai/0000-0001-9952-3175	Foundation of Wenzhou City Science & Technology Bureau [Y20110045, Y20120176]; Natural Science Foundation of China [81300807]; National Science and Technology Ministry [2012BAI08B04]; health Bureau of Zhejiang Province [2012KYB135]; Scientific Research Fund of Zhejiang Provincial Education Department [Y201223147]	Foundation of Wenzhou City Science & Technology Bureau; Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science and Technology Ministry; health Bureau of Zhejiang Province; Scientific Research Fund of Zhejiang Provincial Education Department	This study was supported in part by the Foundation of Wenzhou City Science & Technology Bureau (Y20110045, Y20120176; www.wzkj.gov.cn); the Natural Science Foundation of China (81300807; www.nsfc.gov.cn); the National Science and Technology Ministry (2012BAI08B04; www.most.gov.cn); the health Bureau of Zhejiang Province (2012KYB135; www.zjmed.org.cn); and the Scientific Research Fund of Zhejiang Provincial Education Department (Y201223147; www.zjedu.gov.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation.	Aristodemou P, 2011, J CATARACT REFR SURG, V37, P63, DOI 10.1016/j.jcrs.2010.07.032; Bland JM, 1996, BRIT MED J, V313, P744; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Chen D, 2007, J CATARACT REFR SURG, V33, P448, DOI 10.1016/j.jcrs.2006.11.008; Chen WH, 2012, J CATARACT REFR SURG, V38, P1626, DOI 10.1016/j.jcrs.2012.04.031; Cho P, 2002, OPTOMETRY VISION SCI, V79, P175, DOI 10.1097/00006324-200203000-00012; Chui WS, 2005, OPTOMETRY VISION SCI, V82, P420, DOI 10.1097/01.OPX.0000162642.24885.71; Collins MJ, 2006, ACTA OPHTHALMOL SCAN, V84, P216, DOI 10.1111/j.1600-0420.2005.00547.x; Delrivo M, 2014, J REFRACT SURG, V30, P49, DOI 10.3928/1081597X-20131217-06; Elbaz U, 2007, AM J OPHTHALMOL, V143, P48, DOI 10.1016/j.ajo.2006.08.031; Frings A, 2014, J CATARACT REFR SURG, V40, P232, DOI 10.1016/j.jcrs.2013.11.015; Gatinel D, 2002, J FR OPHTALMOL, V25, P81; He L, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0033735, 10.1371/journal.pone.0045607]; Huynh SC, 2006, CORNEA, V25, P383, DOI 10.1097/01.ico.0000214203.84081.ec; Institution BS, 1994, 5725 BS ISO 1; Jeandervin M, 1998, OPTOMETRY VISION SCI, V75, P663, DOI 10.1097/00006324-199809000-00021; Kamiya K, 2014, BR J OPHTHALMOL; Kawamorita T, 2009, J REFRACT SURG, V25, P539, DOI 10.3928/1081597X-20090512-08; Kawamorita T, 2009, J CATARACT REFR SURG, V35, P127, DOI 10.1016/j.jcrs.2008.10.019; KRAMER MS, 1981, CLIN PHARMACOL THER, V29, P111, DOI 10.1038/clpt.1981.18; Ladas JG, 2001, AM J OPHTHALMOL, V132, P254, DOI 10.1016/S0002-9394(01)00894-7; Liu Z, 2001, Zhonghua Yan Ke Za Zhi, V37, P125; Mao XJ, 2013, J CATARACT REFR SURG, V39, P1561, DOI 10.1016/j.jcrs.2013.04.029; McAlinden C, 2011, INVEST OPHTH VIS SCI, V52, P7731, DOI 10.1167/iovs.10-7093; McKernan AL, 2014, CONTACT LENS ANTERIO, V37, P31, DOI 10.1016/j.clae.2013.07.014; Mehravaran S, 2014, INT OPHTHALMOL; Mihaltz K, 2009, CORNEA, V28, P976, DOI 10.1097/ICO.0b013e31819e34de; Moura RCMR, 1998, CORNEA, V17, P522; Muller LJ, 2001, BRIT J OPHTHALMOL, V85, P437, DOI 10.1136/bjo.85.4.437; MULLER R, 1994, STAT MED, V13, P2465, DOI 10.1002/sim.4780132310; PEREZ JG, 2004, EYE CONTACT LENS, V30, P74; Rao SN, 2002, OPHTHALMOLOGY, V109, P1642, DOI 10.1016/S0161-6420(02)01121-1; Read SA, 2006, INVEST OPHTH VIS SCI, V47, P1404, DOI 10.1167/iovs.05-1181; Read SA, 2009, J CATARACT REFR SURG, V35, P1072, DOI 10.1016/j.jcrs.2009.01.020; Parede TRR, 2013, ARQ BRAS OFTALMOL, V76, P386, DOI 10.1590/S0004-27492013000600016; Santodomingo-Rubido J, 2002, BRIT J OPHTHALMOL, V86, P458, DOI 10.1136/bjo.86.4.458; Savini G, 2009, J REFRACT SURG, V25, P534, DOI 10.3928/1081597X-20090512-07; Tang ML, 2006, J CATARACT REFR SURG, V32, P1843, DOI 10.1016/j.jcrs.2006.04.046; Tang W, 2000, OPTOMETRY VISION SCI, V77, P483, DOI 10.1097/00006324-200009000-00009; Thibos LN, 1997, OPTOMETRY VISION SCI, V74, P367, DOI 10.1097/00006324-199706000-00019; Varssano D, 1997, J CATARACT REFR SURG, V23, P419, DOI 10.1016/S0886-3350(97)80187-3	41	9	11	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2015	10	1							e109414	10.1371/journal.pone.0109414	http://dx.doi.org/10.1371/journal.pone.0109414			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ3BG	25559203	Green Published, Green Submitted, gold			2022-12-27	WOS:000348102200001
J	Acuna-Marrero, D; Jimenez, J; Smith, F; Doherty, PF; Hearn, A; Green, JR; Paredes-Jarrin, J; Salinas-de-Leon, P				Acuna-Marrero, David; Jimenez, Jesus; Smith, Franz; Doherty, Paul F., Jr.; Hearn, Alex; Green, Jonathan R.; Paredes-Jarrin, Jules; Salinas-de-Leon, Pelayo			Whale Shark (Rhincodon typus) Seasonal Presence, Residence Time and Habitat Use at Darwin Island, Galapagos Marine Reserve	PLOS ONE			English	Article							GULF-OF-CALIFORNIA; NINGALOO REEF; POPULATION-SIZE; MOVEMENTS; FISH; PATTERNS; PROGRAM; ECOLOGY; BIOLOGY; OCEAN	The life history of the whale shark (Rhincodon typus), including its reproductive ecology, still remains largely unknown. Here, we present results from the first whale shark population study around Darwin Island, Galapagos Marine Reserve. Following a diversified approach we characterized seasonal occurrence, population structure and size, and described habitat use of whale sharks based on fine scale movements around the island. Whale shark presence at Darwin Island was negatively correlated with Sea Surface Temperature (SST), with highest abundance corresponding to a cool season between July and December over six years of monitoring. From 2011 to 2013 we photo-identified 82 whale sharks ranging from 4 to 13.1 m Total Length (TL). Size distribution was bimodal, with a great majority (91.5%) of adult female individuals averaging 11.35 m +/- 0.12 m (TL +/- SE), all but one showing signs of a potential pregnancy. Population dynamics models for apparently pregnant sharks estimated the presence of 3.76 +/- 0.90 (mean +/- SE) sharks in the study area per day with an individual residence time of 2.09 +/- 0.51 (mean +/- SE) days. Movement patterns analysis of four apparently pregnant individuals tracked with acoustic tags at Darwin Island revealed an intense use of Darwin's Arch, where no feeding or specific behavior has been recorded, together with periodic excursions around the island's vicinity. Sharks showed a preference for intermediate depths (20-30 m) with occasional dives mostly to mid-water, remaining the majority of their time at water temperatures between 24-25 degrees C. All of our results point to Darwin Island as an important stopover in a migration, possibly with reproductive purposes, rather than an aggregation site. Current studies carried out in this area to investigate regional scale movement patterns may provide essential information about possible pupping grounds for this enigmatic species.	[Acuna-Marrero, David; Jimenez, Jesus; Smith, Franz; Green, Jonathan R.; Salinas-de-Leon, Pelayo] Charles Darwin Res Stn, Puerto Ayora, Galapagos Islan, Ecuador; [Doherty, Paul F., Jr.] Colorado State Univ, Dept Fish Wildlife & Conservat Biol, Ft Collins, CO 80523 USA; [Hearn, Alex] Turtle Isl Restorat Network, Olema, CA USA; [Paredes-Jarrin, Jules] Galapagos Natl Pk Directorate, Puerto Ayora, Galapagos Islan, Ecuador	Colorado State University	Acuna-Marrero, D (corresponding author), Charles Darwin Res Stn, Puerto Ayora, Galapagos Islan, Ecuador.	david.acuna@fcdarwin.org.ec	Hearn, Alex/AAK-6461-2020		Rapier Family Trust; Galapagos Conservancy; Lindblad Expeditions/National Geographic Funds; IWC Schaffhausen	Rapier Family Trust; Galapagos Conservancy; Lindblad Expeditions/National Geographic Funds; IWC Schaffhausen	This study has been funded by: Rapier Family Trust (www.rapiertrust.com), Galapagos Conservancy (www.galapagos.org), Lindblad Expeditions/National Geographic Funds (www.expeditions.com), IWC Schaffhausen (www.iwc.com). The funders provided funds to cover field trips to collect data.	Aca EQ, 2011, ASIA LIFE SCI, V20, P361; Acuna-Marrero David, 2013, Marine Biodiversity Records, V6, pe74, DOI 10.1017/S1755267213000456; Arnason AN, 1999, BIRD STUDY, V46, P157; ARNBOM T, 1988, NOTICIAS GALAPAGOS, V46, P3; Arzoumanian Z, 2005, J APPL ECOL, V42, P999, DOI 10.1111/j.1365-2664.2005.01117.x; Banks SJ., 2002, RESERVA MARINA GAL P, P22; Beebe W, 1926, ARCTURUS ADVENTURE; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Calenge C, 2006, ECOL MODEL, V197, P516, DOI 10.1016/j.ecolmodel.2006.03.017; Colman JG, 1997, J FISH BIOL, V51, P1219, DOI 10.1111/j.1095-8649.1997.tb01138.x; Eckert SA, 2001, ENVIRON BIOL FISH, V60, P299, DOI 10.1023/A:1007674716437; Edgar G.J., 2002, RESERVA MARINA GALAP, P68; Fox S, 2013, J FISH BIOL, V83, P574, DOI 10.1111/jfb.12195; Gleiss AC, 2011, FUNCT ECOL, V25, P595, DOI 10.1111/j.1365-2435.2010.01801.x; Graham RT, 2007, FISH RES, V84, P71, DOI 10.1016/j.fishres.2006.11.026; GUDGER E. W., 1927, SCIENCE, V65, P545, DOI 10.1126/science.65.1692.545; Gudger EW, 1933, NATURE, V132, P569, DOI 10.1038/132569a0; Gunn JS, 1999, MAR BIOL, V135, P553, DOI 10.1007/s002270050656; Hearn A, 2010, MAR BIOL, V157, P1899, DOI 10.1007/s00227-010-1460-2; Hearn AR, 2013, ANIMAL BIOTELEMETRY, V1, P1, DOI DOI 10.1186/2050-3385-1-11; Heyman WD, 2001, MAR ECOL PROG SER, V215, P275, DOI 10.3354/meps215275; Holmberg Jason, 2009, Endangered Species Research, V7, P39, DOI 10.3354/esr00186; Hueter RE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071883; Kasteleyn H, 1986, NOTIC GALAPAGOS, P43; Kendall WL, 2001, BIOMETRICS, V57, P1113, DOI 10.1111/j.0006-341X.2001.01113.x; Ketchum JT, 2014, MAR BIOL, V161, P755, DOI 10.1007/s00227-013-2375-5; Ketchum JT, 2013, ENVIRON BIOL FISH, V96, P779, DOI 10.1007/s10641-012-0071-9; Klimley AP, 2005, ENVIRON BIOL FISH, V74, P79, DOI 10.1007/s10641-005-3997-3; Martin RA, 2007, FISH RES, V84, P10, DOI 10.1016/j.fishres.2006.11.010; Meekan MG, 2006, MAR ECOL PROG SER, V319, P275, DOI 10.3354/meps319275; Norman B, 2004, REV CURRENT CONSERVA; Norman B, 2005, IUCN 2013 IUCN RED L; Palacios DM, 2004, DEEP-SEA RES PT II, V51, P43, DOI 10.1016/j.dsr2.2003.08.001; Penaherrera C, 2013, RAPID SEAFLOOR MAPPI, V68; Pierce S, 2008, 2 INT WHAL SHARK C H; Ramirez-Macias D, 2012, J FISH BIOL, V80, P1401, DOI 10.1111/j.1095-8649.2012.03258.x; Ramirez-Macias D, 2007, FISH RES, V84, P87, DOI 10.1016/j.fishres.2006.11.038; Ramirez-Macias Deni, 2012, Endangered Species Research, V18, P115, DOI 10.3354/esr00437; Rohner CA, 2011, J FISH BIOL, V78, P378, DOI 10.1111/j.1095-8649.2010.02861.x; Rowat D, 2007, FISH RES, V84, P32, DOI 10.1016/j.fishres.2006.11.009; Rowat D, 2012, J FISH BIOL, V80, P1019, DOI 10.1111/j.1095-8649.2012.03252.x; Rowat D, 2011, MAR FRESHWATER RES, V62, P621, DOI 10.1071/MF10135; Schmidt Jennifer V., 2010, Endangered Species Research, V12, P117, DOI 10.3354/esr00300; Schwarz CJ, 1996, BIOMETRICS, V52, P860, DOI 10.2307/2533048; Schwarz CJ, 2009, GENTLE INTRO MARK, P53; Sequeira AMM, 2013, J FISH BIOL, V82, P367, DOI 10.1111/jfb.12017; Silverman B. W., 1986, DENSITY ESTIMATION S, V26; Snell HM, 1996, J BIOGEOGR, V23, P619, DOI 10.1111/j.1365-2699.1996.tb00022.x; Van Tienhoven AM, 2007, J APPL ECOL, V44, P273, DOI 10.1111/j.1365-2664.2006.01273.x; VANWINKLE W, 1975, J WILDLIFE MANAGE, V39, P118; White GC, 1999, BIRD STUDY, V46, P120, DOI 10.1080/00063659909477239; Wilson SG, 2006, MAR BIOL, V148, P1157, DOI 10.1007/s00227-005-0153-8; WORTON BJ, 1989, ECOLOGY, V70, P164, DOI 10.2307/1938423	53	40	41	4	137	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2014	9	12							e115946	10.1371/journal.pone.0115946	http://dx.doi.org/10.1371/journal.pone.0115946			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UC	25551553	Green Published, gold, Green Submitted			2022-12-27	WOS:000347119100080
J	Ballesta, S; Reymond, G; Pozzobon, M; Duhamel, JR				Ballesta, Sebastien; Reymond, Gilles; Pozzobon, Mathieu; Duhamel, Jean-Rene			Compete to Play: Trade-Off with Social Contact in Long-Tailed Macaques (Macaca fascicularis)	PLOS ONE			English	Article							OBJECT MANIPULATION; BEHAVIORAL TRADITION; RHESUS MACAQUES; CAPTIVE TROOP; MONKEYS; DOMINANCE; PERFORMANCE; MECHANISMS; BABOONS; TOOLS	Many animal species engage in various forms of solitary object play, but this activity seems to be of particular importance in primates. If playing objects constitute a valuable resource, and access to such objects is limited, a competitive context may arise. We inserted a unique toy within a mini-colony of long-tailed macaque (Macaca fascicularis) and compared their behaviors to sessions without playing object. An automatic color-based 3D video device was used to track the positions of each animal and the toy, and this data was categorized into 5 exclusive behaviors (resting, locomotion, foraging, social contact and object play). As expected, the delay to first access to the object reflected the hierarchy of the colony, indicating that a competition took place to own this unique resource of entertainment. In addition, we found that the amount of object play was not correlated with social or foraging behavior, suggesting independent motivational mechanisms. Conversely, object playing time was negatively correlated with idling time, thus indicating its relation to pastime activities. Interestingly, the amount of social contacts in the group was significantly reduced by the heightened competitive context, suggesting that competitors are more likely to be perceived as potential threat requiring caution, as shown in humans. Experimental manipulation of competitive contexts in primates reveals common mental processes involved in social judgment, and shows that access to valuable resources can be a sufficient cause for variations in group cohesion.	[Ballesta, Sebastien; Reymond, Gilles; Pozzobon, Mathieu; Duhamel, Jean-Rene] CNRS, Ctr Neurosci Cognit, Bron, France; [Ballesta, Sebastien; Reymond, Gilles; Pozzobon, Mathieu; Duhamel, Jean-Rene] Univ Lyon 1, Dept Biol Humaine, F-69365 Lyon, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Claude Bernard Lyon 1	Duhamel, JR (corresponding author), CNRS, Ctr Neurosci Cognit, Bron, France.	duhamel@isc.cnrs.fr	Duhamel, Jean-René/M-4723-2017	Duhamel, Jean-René/0000-0003-0210-1027; Ballesta, Sebastien/0000-0002-7854-5735	LABEX of University de Lyon [ANR-11-IDEX-0007]; Rhone-Alpes Region; Agence Nationale de la Recherche [ANR-2010-BLAN- 1431-01, ANR-13-BSV4-0010-01]	LABEX of University de Lyon; Rhone-Alpes Region(Region Auvergne-Rhone-Alpes); Agence Nationale de la Recherche(French National Research Agency (ANR))	This work was supported by the LABEX (ANR-11-IDEX-0007) of University de Lyon within the program "Investissement d'Avenir'' and by grants from the Rhone-Alpes Region and from the Agence Nationale de la Recherche (ANR-2010-BLAN- 1431-01, ANR-13-BSV4-0010-01) to JRD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ballestaa S, 2014, J NEUROSCI METH, V234, P147, DOI 10.1016/j.jneumeth.2014.05.022; BARBER N, 1991, Q REV BIOL, V66, P129, DOI 10.1086/417142; Burghardt G.M., 1988, DEV PSYCHOL, P107; Burghardt GM, 2005, THE GENESIS OF ANIMA; CHAMOVE AS, 1983, MOTIV EMOTION, V7, P213, DOI 10.1007/BF00992904; Decety J, 2004, NEUROIMAGE, V23, P744, DOI 10.1016/j.neuroimage.2004.05.025; Dubuc C, 2007, INT J PRIMATOL, V28, P357, DOI 10.1007/s10764-007-9118-8; Gil-Burmann C, 1998, PRIMATES, V39, P473, DOI 10.1007/BF02557570; GLICKMAN SE, 1966, BEHAVIOUR, V26, P151, DOI 10.1163/156853966X00074; Graham KL, 2010, Q REV BIOL, V85, P393, DOI 10.1086/656903; Hanya G, 2008, PRIMATES, V49, P116, DOI 10.1007/s10329-007-0073-y; JALLES E, 2009, INT J COMP PSYCHOL, V21; Jaman MF, 2013, PRIMATES, V54, P49, DOI 10.1007/s10329-012-0330-6; JANSON CH, 1988, BEHAVIOUR, V105, P165, DOI 10.1163/156853988X00502; JOUBERT A, 1986, BEHAVIOUR, V96, P92, DOI 10.1163/156853986X00234; Kessel A L, 1998, J Appl Anim Welf Sci, V1, P227, DOI 10.1207/s15327604jaws0103_3; KNAPP L, 2009, BEHAVIOUR, V146, P113, DOI DOI 10.1163/156853908X390959; Koenig A, 2002, INT J PRIMATOL, V23, P759, DOI 10.1023/A:1015524931226; Kuba MJ, 2006, J COMP PSYCHOL, V120, P184, DOI 10.1037/0735-7036.120.3.184; KUMMER H, 1991, ANIM BEHAV, V42, P529, DOI 10.1016/S0003-3472(05)80238-6; Le Bouc R, 2013, J NEUROSCI, V33, P15894, DOI 10.1523/JNEUROSCI.0143-13.2013; Leca JB, 2007, J HUM EVOL, V53, P691, DOI 10.1016/j.jhevol.2007.05.009; Leca JB, 2008, AM J PHYS ANTHROPOL, V135, P233, DOI 10.1002/ajpa.20726; Marquez-Arias A, 2010, J MED PRIMATOL, V39, P32, DOI 10.1111/j.1600-0684.2009.00392.x; Nahallage CAD, 2008, INT J PRIMATOL, V29, P795, DOI 10.1007/s10764-008-9268-3; Nahallage CAD, 2012, PRIMATES, V53, P71, DOI 10.1007/s10329-011-0279-x; PARKER ST, 1977, J HUM EVOL, V6, P623, DOI 10.1016/S0047-2484(77)80135-8; Ram S, 2003, CURR SCI INDIA, V84, P780; Rilling JK, 2004, BIOL PSYCHIAT, V56, P364, DOI 10.1016/j.biopsych.2004.06.027; SCHAPIRO SJ, 1993, LAB ANIM SCI, V43, P315; SCHAUB H, 1995, J COMP PSYCHOL, V109, P196, DOI 10.1037/0735-7036.109.2.196; TORIGOE T, 1987, PRIMATES, V28, P497, DOI 10.1007/BF02380863; TORIGOE T, 1987, PRIMATES, V28, P533, DOI 10.1007/BF02380867; TORIGOE T, 1985, Primates, V26, P182, DOI 10.1007/BF02382017; Turner PV, 2002, CONTEMP TOP LAB ANIM, V41, P13; VARLEY M, 1966, BEHAVIOUR, V27, P54, DOI 10.1163/156853966X00100; Vonk R, 1998, J EXP SOC PSYCHOL, V34, P265, DOI 10.1006/jesp.1998.1350; WASHBURN DA, 1990, J COMP PSYCHOL, V104, P115, DOI 10.1037/0735-7036.104.2.115; Westergaard GC, 1998, J COMP PSYCHOL, V112, P207, DOI 10.1037/0735-7036.112.2.207; WESTERGAARD GC, 1992, J COMP PSYCHOL, V106, P398, DOI 10.1037/0735-7036.106.4.398; Wobber V, 2010, P NATL ACAD SCI USA, V107, P12457, DOI 10.1073/pnas.1007411107	41	9	9	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2014	9	12							e115965	10.1371/journal.pone.0115965	http://dx.doi.org/10.1371/journal.pone.0115965			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UC	25551755	Green Published, Green Submitted, gold			2022-12-27	WOS:000347119100083
J	Baumert, J; Huang, J; McKnight, B; Sabater-Lleal, M; Steri, M; Chu, AY; Trompet, S; Lopez, LM; Fornage, M; Teumer, A; Tang, WH; Rudnicka, AR; Malarstig, A; Hottenga, JJ; Kavousi, M; Lahti, J; Tanaka, T; Hayward, C; Huffman, JE; Morange, PE; Rose, LM; Basu, S; Rumley, A; Stott, DJ; Buckley, BM; de Craen, AJM; Sanna, S; Masala, M; Biffar, R; Homuth, G; Silveira, A; Sennblad, B; Goel, A; Watkins, H; Muller-Nurasyid, M; Ruckerl, R; Taylor, K; Chen, MH; de Geus, EJC; Hofman, A; Witteman, JCM; de Maat, MPM; Palotie, A; Davies, G; Siscovick, DS; Kolcic, I; Wild, SH; Song, J; McArdle, WL; Ford, I; Sattar, N; Schlessinger, D; Grotevendt, A; Franzosi, MG; Illig, T; Waldenberger, M; Lumley, T; Tofler, GH; Willemsen, G; Uitterlinden, AG; Rivadeneira, F; Raikkonen, K; Chasman, DI; Folsom, AR; Lowe, GD; Westendorp, RGJ; Slagboom, PE; Cucca, F; Wallaschofski, H; Strawbridge, RJ; Seedorf, U; Koenig, W; Bis, JC; Mukamal, KJ; van Dongen, J; Widen, E; Franco, OH; Starr, JM; Liu, K; Ferrucci, L; Polasek, O; Wilson, JF; Oudot-Mellakh, T; Campbell, H; Navarro, P; Bandinelli, S; Eriksson, J; Boomsma, DI; Dehghan, A; Clarke, R; Hamsten, A; Boerwinkle, E; Jukema, JW; Naitza, S; Ridker, PM; Volzke, H; Deary, IJ; Reiner, AP; Tregouet, DA; O'Donnell, CJ; Strachan, DP; Peters, A; Smith, NL				Baumert, Jens; Huang, Jie; McKnight, Barbara; Sabater-Lleal, Maria; Steri, Maristella; Chu, Audrey Y.; Trompet, Stella; Lopez, Lorna M.; Fornage, Myriam; Teumer, Alexander; Tang, Weihong; Rudnicka, Alicja R.; Maelarstig, Anders; Hottenga, Jouke-Jan; Kavousi, Maryam; Lahti, Jari; Tanaka, Toshiko; Hayward, Caroline; Huffman, Jennifer E.; Morange, Pierre-Emmanuel; Rose, Lynda M.; Basu, Saonli; Rumley, Ann; Stott, David J.; Buckley, Brendan M.; de Craen, Anton J. M.; Sanna, Serena; Masala, Marco; Biffar, Reiner; Homuth, Georg; Silveira, Angela; Sennblad, Bengt; Goel, Anuj; Watkins, Hugh; Mueller-Nurasyid, Martina; Rueckerl, Regina; Taylor, Kent; Chen, Ming-Huei; de Geus, Eco J. C.; Hofman, Albert; Witteman, Jacqueline C. M.; de Maat, Moniek P. M.; Palotie, Aarno; Davies, Gail; Siscovick, David S.; Kolcic, Ivana; Wild, Sarah H.; Song, Jaejoon; McArdle, Wendy L.; Ford, Ian; Sattar, Naveed; Schlessinger, David; Grotevendt, Anne; Franzosi, Maria Grazia; Illig, Thomas; Waldenberger, Melanie; Lumley, Thomas; Tofler, Geoffrey H.; Willemsen, Gonneke; Uitterlinden, Andre G.; Rivadeneira, Fernando; Raeikkonen, Katri; Chasman, Daniel I.; Folsom, Aaron R.; Lowe, Gordon D.; Westendorp, Rudi G. J.; Slagboom, P. Eline; Cucca, Francesco; Wallaschofski, Henri; Strawbridge, Rona J.; Seedorf, Udo; Koenig, Wolfgang; Bis, Joshua C.; Mukamal, Kenneth J.; van Dongen, Jenny; Widen, Elisabeth; Franco, Oscar H.; Starr, John M.; Liu, Kiang; Ferrucci, Luigi; Polasek, Ozren; Wilson, James F.; Oudot-Mellakh, Tiphaine; Campbell, Harry; Navarro, Pau; Bandinelli, Stefania; Eriksson, Johan; Boomsma, Dorret I.; Dehghan, Abbas; Clarke, Robert; Hamsten, Anders; Boerwinkle, Eric; Jukema, J. Wouter; Naitza, Silvia; Ridker, Paul M.; Voezke, Henry; Deary, Ian J.; Reiner, Alexander P.; Tregoueet, David-Alexandre; O'Donnell, Christopher J.; Strachan, David P.; Peters, Annette; Smith, Nicholas L.			No Evidence for Genome-Wide Interactions on Plasma Fibrinogen by Smoking, Alcohol Consumption and Body Mass Index: Results from Meta-Analyses of 80,607 Subjects	PLOS ONE			English	Article							INDIVIDUAL PARTICIPANT METAANALYSIS; CARDIOVASCULAR-DISEASE RISK; CIRCULATING FIBRINOGEN; MYOCARDIAL-INFARCTION; LUNG-CANCER; INFLAMMATORY MARKERS; CIGARETTE-SMOKING; GENETIC-VARIATION; ASSOCIATION; LOCI	Plasma fibrinogen is an acute phase protein playing an important role in the blood coagulation cascade having strong associations with smoking, alcohol consumption and body mass index (BMI). Genome-wide association studies (GWAS) have identified a variety of gene regions associated with elevated plasma fibrinogen concentrations. However, little is yet known about how associations between environmental factors and fibrinogen might be modified by genetic variation. Therefore, we conducted large-scale meta-analyses of genome-wide interaction studies to identify possible interactions of genetic variants and smoking status, alcohol consumption or BMI on fibrinogen concentration. The present study included 80,607 subjects of European ancestry from 22 studies. Genome-wide interaction analyses were performed separately in each study for about 2.6 million single nucleotide polymorphisms (SNPs) across the 22 autosomal chromosomes. For each SNP and risk factor, we performed a linear regression under an additive genetic model including an interaction term between SNP and risk factor. Interaction estimates were meta-analysed using a fixed-effects model. No genome-wide significant interaction with smoking status, alcohol consumption or BMI was observed in the meta-analyses. The most suggestive interaction was found for smoking and rs10519203, located in the LOC123688 region on chromosome 15, with a p value of 6.2x10(-8). This large genome-wide interaction study including 80,607 participants found no strong evidence of interaction between genetic variants and smoking status, alcohol consumption or BMI on fibrinogen concentrations. Further studies are needed to yield deeper insight in the interplay between environmental factors and gene variants on the regulation of fibrinogen concentrations.	[Baumert, Jens; Rueckerl, Regina; Peters, Annette] Helmholtz Zentrum Munchen, Inst Epidemiol 2, German Res Ctr Environm Hlth, Neuherberg, Germany; [Huang, Jie] NHLBI, Framingham Heart Study, Framingham, MA USA; [Huang, Jie] NHLBI, Div Intramural Res, Bethesda, MD 20892 USA; [Huang, Jie] Wellcome Trust Sanger Inst, Dept Human Genet, Cambridge, England; [McKnight, Barbara] Univ Washington, Dept Biostat, Seattle, WA 98195 USA; [Sabater-Lleal, Maria; Maelarstig, Anders; Silveira, Angela; Sennblad, Bengt; Strawbridge, Rona J.; Hamsten, Anders] Karolinska Univ Hosp Solna, Karolinska Inst, Dept Med, Cardiovasc Genet & Genom Grp,Atherosclerosis Res, Stockholm, Sweden; [Steri, Maristella; Sanna, Serena; Masala, Marco; Cucca, Francesco; Naitza, Silvia] CNR, Ist Ric Genet & Biomed, Cagliari, Italy; [Chu, Audrey Y.; Rose, Lynda M.] Brigham & Womens Hosp, Div Prevent Med, Boston, MA 02115 USA; [Trompet, Stella; Jukema, J. Wouter] Leiden Univ, Med Ctr, Dept Cardiol, Leiden, Netherlands; [Trompet, Stella; de Craen, Anton J. M.; Westendorp, Rudi G. J.] Leiden Univ, Med Ctr, Dept Gerontol & Geriatr, Leiden, Netherlands; [Lopez, Lorna M.; Davies, Gail; Deary, Ian J.] Univ Edinburgh, Dept Psychol, Edinburgh, Midlothian, Scotland; [Lopez, Lorna M.; Davies, Gail; Starr, John M.; Deary, Ian J.; Reiner, Alexander P.] Univ Edinburgh, Ctr Cognit Ageing & Cognit Epidemiol, Edinburgh, Midlothian, Scotland; [Fornage, Myriam] Univ Texas Hlth Sci Ctr Houston, Brown Fdn Inst Mol Med, Div Epidemiol, Sch Publ Hlth, Houston, TX 77030 USA; [Teumer, Alexander; Homuth, Georg] Ernst Moritz Arndt Univ Greifswald, Interfac Inst Genet & Funct Genom, Greifswald, Germany; [Tang, Weihong; Folsom, Aaron R.] Univ Minnesota, Div Epidemiol & Community Hlth, Minneapolis, MN USA; [Rudnicka, Alicja R.; Strachan, David P.] Univ London, Div Populat Hlth Sci & Educ, London, England; [Hottenga, Jouke-Jan; Willemsen, Gonneke; van Dongen, Jenny; Boomsma, Dorret I.] Vrije Univ Amsterdam, Dept Biol Psychol, Amsterdam, Netherlands; [Hottenga, Jouke-Jan; Willemsen, Gonneke; van Dongen, Jenny; Boomsma, Dorret I.] Vrije Univ Amsterdam Med Ctr, EMGO Inst, Amsterdam, Netherlands; [Kavousi, Maryam; Hofman, Albert; Witteman, Jacqueline C. M.; Uitterlinden, Andre G.; Franco, Oscar H.; Dehghan, Abbas] Erasmus MC, Dept Epidemiol, Rotterdam, Netherlands; [Kavousi, Maryam; Hofman, Albert; Witteman, Jacqueline C. M.; Uitterlinden, Andre G.; Franco, Oscar H.; Dehghan, Abbas] NCHA, NGI, Rotterdam, Netherlands; [Lahti, Jari; Raeikkonen, Katri] Univ Helsinki, Inst Behav Sci, Helsinki, Finland; [Lahti, Jari; Eriksson, Johan] Folkhalsan Res Ctr, Helsinki, Finland; [Tanaka, Toshiko; Ferrucci, Luigi] NIA, Translat Gerontol Branch, Baltimore, MD 21224 USA; [Hayward, Caroline; Huffman, Jennifer E.; Navarro, Pau] Western Gen Hosp, MRC Human Genet Unit, Inst Genet & Mol Med, Edinburgh EH4 2XU, Midlothian, Scotland; [Morange, Pierre-Emmanuel] Aix Marseille Univ, INSERM, UMR S 1062, Marseille, France; [Basu, Saonli; Song, Jaejoon] Univ Minnesota, Div Biostat, Minneapolis, MN USA; [Rumley, Ann] Univ Glasgow, Div Cardiovasc & Med Sci, Glasgow, Lanark, Scotland; [Stott, David J.] Univ Glasgow, Fac Med, Inst Cardiovasc & Med Sci, Glasgow, Lanark, Scotland; [Buckley, Brendan M.] Natl Univ Ireland Univ Coll Cork, Dept Pharmacol & Therapeut, Cork, Ireland; [Biffar, Reiner] Univ Med Greifswald, Dept Prosthet Dent Gerostomatol & Dent Mat, Greifswald, Germany; [Sennblad, Bengt] Karolinska Inst, Sci Life Lab, Stockholm, Sweden; [Goel, Anuj; Watkins, Hugh] Univ Oxford, John Radcliffe Hosp, Dept Cardiovasc Med, Oxford OX3 9DU, England; [Goel, Anuj; Watkins, Hugh] Univ Oxford, Dept Cardiovasc Med, Wellcome Trust Ctr Human Genet, Oxford, England; [Mueller-Nurasyid, Martina] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Genet Epidemiol, Neuherberg, Germany; [Mueller-Nurasyid, Martina] Univ Munich, Inst Med Informat Biometry & Epidemiol, Chair Genet Epidemiol, Munich, Germany; [Mueller-Nurasyid, Martina] Univ Munich, Dept Med 1, Univ Hosp Grosshadern, Munich, Germany; [Rueckerl, Regina] Univ Augsburg, ESC Environm Sci Ctr, D-86159 Augsburg, Germany; [Taylor, Kent] Cedars Sinai Med Ctr, Inst Med Genet, Los Angeles, CA 90048 USA; [Chen, Ming-Huei] Boston Univ, Dept Biostat, Boston, MA 02215 USA; [de Geus, Eco J. C.; de Maat, Moniek P. M.] Erasmus MC, Dept Haematol, Rotterdam, Netherlands; [Palotie, Aarno; Widen, Elisabeth] Wellcome Trust Sanger Inst, Cambridge, England; [Palotie, Aarno] Univ Helsinki, Inst Mol Med Finland FIMM, Helsinki, Finland; [Palotie, Aarno; O'Donnell, Christopher J.; Smith, Nicholas L.] Univ Helsinki, Dept Med Genet, Helsinki, Finland; [Palotie, Aarno; O'Donnell, Christopher J.; Smith, Nicholas L.] Univ Cent Hosp, Helsinki, Finland; [Siscovick, David S.; Polasek, Ozren] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Kolcic, Ivana; Wilson, James F.; Campbell, Harry] Univ Split, Sch Med, Dept Publ Hlth, Split, Croatia; [Wild, Sarah H.] Univ Edinburgh, Ctr Populat Hlth Sci, Edinburgh, Midlothian, Scotland; [McArdle, Wendy L.] Univ Bristol, Sch Social & Community Med, Bristol, Avon, England; [Ford, Ian] Univ Glasgow, Robertson Ctr Biostat, Glasgow, Lanark, Scotland; [Sattar, Naveed] BHF Glasgow Cardiovasc Res Ctr, Fac Med, Glasgow, Lanark, Scotland; [Schlessinger, David; Wallaschofski, Henri] NIA, Intramural Res Program, Baltimore, MD 21224 USA; [Grotevendt, Anne] Univ Med Greifswald, Inst Clin Chem & Lab Med, Greifswald, Germany; [Franzosi, Maria Grazia] IRCCS Ist Ric Farmacol Mario Negri, Dept Cardiovasc Res, Milan, Italy; [Illig, Thomas; Waldenberger, Melanie] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Res Unit Mol Epidemiol, Neuherberg, Germany; [Illig, Thomas] Hannover Med Sch, Hannover Unified Biobank, Hannover, Germany; [Lumley, Thomas] Univ Auckland, Dept Stat, Auckland 1, New Zealand; [Tofler, Geoffrey H.] Univ Sydney, Royal N Shore Hosp, Sydney, NSW 2006, Australia; [Uitterlinden, Andre G.] Erasmus MC, Dept Internal Med, Rotterdam, Netherlands; [Rivadeneira, Fernando; Chasman, Daniel I.] Brigham & Womens Hosp, Div Prevent Med, Div Genet, Boston, MA 02115 USA; [Rivadeneira, Fernando; Chasman, Daniel I.] Harvard Univ, Sch Med, Boston, MA USA; [Lowe, Gordon D.] Univ Glasgow, Inst Cardiovasc & Med Sci, Glasgow, Lanark, Scotland; Leiden Univ, Dept Mol Epidemiol, Med Ctr, Leiden, Netherlands; [Wallaschofski, Henri] DZHK German Ctr Cardiovasc Res, Greifswald, Germany; [Seedorf, Udo] Univ Munster, Leibniz Inst Arterioskleroseforsch, Munster, Germany; [Koenig, Wolfgang] Univ Ulm, Dept Internal Med Cardiol 2, Med Ctr, D-89069 Ulm, Germany; [Bis, Joshua C.] Univ Washington, Dept Med, Cardiovasc Hlth Res Unit, Seattle, WA USA; [Mukamal, Kenneth J.] Harvard Univ, Sch Med, Boston, MA USA; [Mukamal, Kenneth J.] Beth Israel Deaconess Med Ctr, Div Gen Med & Primary Care, Boston, MA 02215 USA; [Starr, John M.] Univ Edinburgh, Alzheimer Scotland Dementia Res Ctr, Edinburgh, Midlothian, Scotland; [Liu, Kiang] Northwestern Univ, Dept Prevent Med, Sch Med, Chicago, IL 60611 USA; [Oudot-Mellakh, Tiphaine; Tregoueet, David-Alexandre] INSERM, UMRS 1166, Paris, France; [Oudot-Mellakh, Tiphaine; Tregoueet, David-Alexandre] Univ Paris 06, Univ Sorbonne, UMRS 1166, Team Genom & Pathophysiol Cardiovasc Dis, Paris, France; [Oudot-Mellakh, Tiphaine; Tregoueet, David-Alexandre] ICAN Inst Cardiometabolism & Nutr, Paris, France; [Bandinelli, Stefania] Azienda Sanitaria Firenze ASF, Geriatr Unit, Florence, Italy; [Eriksson, Johan] Natl Inst Hlth & Welf, Helsinki, Finland; [Eriksson, Johan] Univ Helsinki, Dept Gen Practice & Primary Hlth Care, Helsinki, Finland; [Eriksson, Johan] Univ Helsinki, Cent Hosp, Unit Gen Practice, Helsinki, Finland; [Clarke, Robert] Univ Oxford, Clin Trial Serv Unit, Oxford, England; [Boerwinkle, Eric] Univ Texas Hlth Sci Ctr Houston, Human Genet Ctr & Inst Mol Med, Houston, TX 77030 USA; [Jukema, J. Wouter] Durrer Ctr Cardiogenet Res, Amsterdam, Netherlands; [Jukema, J. Wouter] Interuniv Cardiol Inst Netherlands, Utrecht, Netherlands; [Ridker, Paul M.] Brigham & Womens Hosp, Div Cardiol, Div Prevent Med, Boston, MA 02115 USA; [Ridker, Paul M.] Harvard Univ, Sch Med, Boston, MA USA; [Voezke, Henry] Univ Med Greifswald, Inst Community Med, Greifswald, Germany; [Peters, Annette] DZHK German Ctr Cardiovascr Res, Munich, Germany; [Smith, Nicholas L.] Grp Hlth Cooperat Puget Sound, Grp Hlth Res Inst, Seattle, WA USA; [Smith, Nicholas L.] Vet Affairs Off Res & Dev, Seattle Epidemiol Res & Informat Ctr, Seattle, WA USA	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Framingham Heart Study; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Wellcome Trust Sanger Institute; University of Washington; University of Washington Seattle; Karolinska Institutet; Karolinska University Hospital; Consiglio Nazionale delle Ricerche (CNR); Istituto di Ricerca Genetica e Biomedica (IRGB-CNR); Harvard University; Brigham & Women's Hospital; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Edinburgh; University of Edinburgh; University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health; Ernst Moritz Arndt Universitat Greifswald; University of Minnesota System; University of Minnesota Twin Cities; University of London; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Erasmus University Rotterdam; Erasmus MC; University of Helsinki; Folkhalsan Research Center; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); University of Edinburgh; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; University of Minnesota System; University of Minnesota Twin Cities; University of Glasgow; University of Glasgow; University College Cork; Greifswald Medical School; Karolinska Institutet; University of Oxford; University of Oxford; Wellcome Centre for Human Genetics; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Munich; University of Munich; University of Augsburg; Cedars Sinai Medical Center; Boston University; Erasmus University Rotterdam; Erasmus MC; Wellcome Trust Sanger Institute; University of Helsinki; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; University of Washington; University of Washington Seattle; University of Split; University of Edinburgh; University of Bristol; University of Glasgow; University of Glasgow; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Greifswald Medical School; Istituto di Ricerche Farmacologiche Mario Negri IRCCS; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Hannover Medical School; University of Auckland; Royal North Shore Hospital; University of Sydney; Erasmus University Rotterdam; Erasmus MC; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; University of Glasgow; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; German Centre for Cardiovascular Research; University of Munster; Ulm University; University of Washington; University of Washington Seattle; Harvard University; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; University of Edinburgh; Northwestern University; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; Azienda Sanitaria di Firenze; Finland National Institute for Health & Welfare; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; University of Oxford; University of Texas System; University of Texas Health Science Center Houston; Interuniversity Cardiology Institute of the Netherlands; Utrecht University; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Greifswald Medical School; German Centre for Cardiovascular Research; Group Health Cooperative	Peters, A (corresponding author), Helmholtz Zentrum Munchen, Inst Epidemiol 2, German Res Ctr Environm Hlth, Neuherberg, Germany.	peters@helmholtz-muenchen.de; nlsmith@u.washington.edu	NAITZA, SILVIA/AAB-8775-2022; Steri, Maristella/AAX-8760-2020; Lleal, Maria Sabater/I-5832-2013; Lahti, Jari/P-2283-2019; Waldenberger, Melanie/B-5355-2014; Wilson, James F/A-5704-2009; Dehghan, Abbas/ABE-7377-2020; Campbell, Harry/E-2959-2010; Naitza, Silvia/D-5620-2017; Boomsma, Dorret I/AAX-4470-2020; Kavousi, Maryam/F-1174-2018; de Geus, Eco J.C./M-9318-2015; Slagboom, P. Eline/R-4790-2016; Rivadeneira, Fernando/O-5385-2015; Franco, Óscar H/ABE-2305-2020; Strawbridge, Rona/H-5422-2012; Peters, Annette/A-6117-2011; sanna, serena/H-3009-2019; Mukamal, Kenneth/GVR-7978-2022; Teumer, Alexander/S-7438-2019; Navarro, Pau/AAJ-8091-2021; Jukema, J. Wouter/ABD-6503-2021; Müller-Nurasyid, Martina/I-8735-2018; Ford, Ian/ABE-6145-2020; Kolcic, Ivana/E-2713-2017; Masala, Marco/Q-2748-2018; Deary, Ian J/C-6297-2009; Tregouet, David-Alexandre/E-3961-2016; Lahti, Jari/P-7987-2018; Lopez, Lorna/AAR-4912-2020; bandinelli, stefania/AAL-4570-2020; Trégouët, David-Alexandre/P-9210-2019; Polasek, Ozren/B-6002-2011; Morange, Pierre/T-9070-2019; Dehghan, Abbas/B-9896-2008	NAITZA, SILVIA/0000-0002-0108-757X; Steri, Maristella/0000-0001-5869-3872; Lleal, Maria Sabater/0000-0002-0128-379X; Lahti, Jari/0000-0002-4310-5297; Waldenberger, Melanie/0000-0003-0583-5093; Wilson, James F/0000-0001-5751-9178; Campbell, Harry/0000-0002-6169-6262; Kavousi, Maryam/0000-0001-5976-6519; de Geus, Eco J.C./0000-0001-6022-2666; Slagboom, P. Eline/0000-0002-2875-4723; Rivadeneira, Fernando/0000-0001-9435-9441; Franco, Óscar H/0000-0002-4606-4929; Strawbridge, Rona/0000-0001-8506-3585; Peters, Annette/0000-0001-6645-0985; sanna, serena/0000-0002-3768-1749; Teumer, Alexander/0000-0002-8309-094X; Navarro, Pau/0000-0001-5576-8584; Jukema, J. Wouter/0000-0002-3246-8359; Müller-Nurasyid, Martina/0000-0003-3793-5910; Kolcic, Ivana/0000-0001-7918-6052; Masala, Marco/0000-0001-5556-9964; Deary, Ian J/0000-0002-1733-263X; Lahti, Jari/0000-0002-4310-5297; Lopez, Lorna/0000-0002-0241-9783; Trégouët, David-Alexandre/0000-0001-9084-7800; Polasek, Ozren/0000-0002-5765-1862; Morange, Pierre/0000-0002-9065-722X; Palotie, Aarno/0000-0002-2527-5874; Dehghan, Abbas/0000-0001-6403-016X; Basu, Saonli/0000-0003-1200-4546; Willemsen, Gonneke/0000-0003-3755-0236; Goel, Anuj/0000-0003-2307-4021; Eriksson, Johan/0000-0002-2516-2060; Malarstig, Anders/0000-0003-2608-1358; van Dongen, Jenny/0000-0003-2063-8741; Venkatasubramanian, Siddharth/0000-0002-5860-0768; Koenig, Wolfgang/0000-0002-2064-9603; Bandinelli, Stefania/0000-0002-6491-0850; Raikkonen, Katri/0000-0003-3124-3470; CUCCA, Francesco/0000-0002-7414-1995; Watkins, Hugh/0000-0002-5287-9016; Rudnicka, Alicja R/0000-0003-0369-8574; Chen, Ming-Huei/0000-0003-3551-8726; Silveira, Angela/0000-0003-2063-4935	National Heart, Lung and Blood Institute's Framingham Heart Study [N01-HC-25195]; Affymetrix, Inc [N02-HL-6-4278]; Bristol-Myers Squibb; AXA Research Fund; Nestle Nutrition (Nestec Ltd); Metagenics Inc; AXA; Siemens Healthcare, Erlangen, Germany; Federal State of Mecklenburg; MRC [MC_PC_U127592696, G0700704] Funding Source: UKRI; Medical Research Council [MR/K026992/1, G0700704, MC_PC_U127592696] Funding Source: researchfish; Chief Scientist Office [CZB/4/710] Funding Source: researchfish; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC025195] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA016672] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL059367, R01HL064278, R01HL105756] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA018673] Funding Source: NIH RePORTER	National Heart, Lung and Blood Institute's Framingham Heart Study(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Affymetrix, Inc; Bristol-Myers Squibb(Bristol-Myers Squibb); AXA Research Fund(AXA Research Fund); Nestle Nutrition (Nestec Ltd)(Nestle SA); Metagenics Inc; AXA; Siemens Healthcare, Erlangen, Germany(Siemens AG); Federal State of Mecklenburg; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Chief Scientist Office; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	The Framingham Heart Study (FHS) was supported by the National Heart, Lung and Blood Institute's Framingham Heart Study (Contract No. N01-HC-25195) and its contract with Affymetrix, Inc for genotyping services (Contract No. N02-HL-6-4278). The PROSPER/PHASE study was supported by an investigator initiated grant obtained from Bristol-Myers Squibb. Dr. Kavousi is supported by AXA Research Fund. Oscar H. Franco works in ErasmusAGE, a center for aging research across the life course funded by Nestle Nutrition (Nestec Ltd), Metagenics Inc, and AXA. Part of the SHIP study was funded by a joint grant from Siemens Healthcare, Erlangen, Germany and the Federal State of Mecklenburg	Burger M, 2004, EUR J CLIN NUTR, V58, P605, DOI 10.1038/sj.ejcn.1601854; CLAUSS A., 1957, ACTA HAEMATOL, V17, P237; CREMER P, 1994, EUR J CLIN INVEST, V24, P444, DOI 10.1111/j.1365-2362.1994.tb02373.x; Cushman M, 1996, AM J EPIDEMIOL, V143, P665; Danesh J, 2005, JAMA-J AM MED ASSOC, V294, P1799, DOI 10.1001/jama.294.14.1799; Danik JS, 2009, CIRC-CARDIOVASC GENE, V2, P134, DOI 10.1161/CIRCGENETICS.108.825273; de Lange M, 2001, LANCET, V357, P101, DOI 10.1016/S0140-6736(00)03541-8; de Maat MPM, 2001, ANN NY ACAD SCI, V936, P509; Dehghan A, 2009, CIRC-CARDIOVASC GENE, V2, P125, DOI 10.1161/CIRCGENETICS.108.825224; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; FOLSOM AR, 1995, EUR HEART J, V16, P21, DOI 10.1093/eurheartj/16.suppl_A.21; GREEN F, 1993, THROMB HAEMOSTASIS, V70, P915; HAMSTEN A, 1987, LANCET, V2, P988; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hung RJ, 2008, NATURE, V452, P633, DOI 10.1038/nature06885; Jacquemin B, 2008, J AM COLL CARDIOL, V52, P941, DOI 10.1016/j.jacc.2008.06.016; Kaptoge S, 2007, AM J EPIDEMIOL, V166, P867, DOI 10.1093/aje/kwm191; Kaptoge S, 2012, NEW ENGL J MED, V367, P1310, DOI 10.1056/NEJMoa1107477; Kathiresan S, 2006, ARTERIOSCL THROM VAS, V26, P1405, DOI 10.1161/01.ATV.0000222011.13026.25; Koenig W, 2003, THROMB HAEMOSTASIS, V89, P601; KROBOT K, 1992, ARTERIOSCLER THROMB, V12, P780, DOI 10.1161/01.ATV.12.7.780; Li Y, 2010, GENET EPIDEMIOL, V34, P816, DOI 10.1002/gepi.20533; Liu PY, 2008, JNCI-J NATL CANCER I, V100, P1326, DOI 10.1093/jnci/djn268; Marchini J, 2007, NAT GENET, V39, P906, DOI 10.1038/ng2088; Psaty BM, 2009, CIRC-CARDIOVASC GENE, V2, P73, DOI 10.1161/CIRCGENETICS.108.829747; Sabater-Lleal M, 2013, CIRCULATION, V128, P1310, DOI 10.1161/CIRCULATIONAHA.113.002251; Sinha S, 2005, EUR J CARDIOV PREV R, V12, P144, DOI 10.1097/00149831-200504000-00009; Souto JC, 2000, CIRCULATION, V101, P1546, DOI 10.1161/01.CIR.101.13.1546; Thomas AE, 1996, CLIN GENET, V50, P184; Truong T, 2010, JNCI-J NATL CANCER I, V102, P959, DOI 10.1093/jnci/djq178; Wannamethee SG, 2005, EUR HEART J, V26, P1765, DOI 10.1093/eurheartj/ehi183; Willer CJ, 2010, BIOINFORMATICS, V26, P2190, DOI 10.1093/bioinformatics/btq340; Yang Q, 2003, THROMB RES, V110, P57, DOI 10.1016/S0049-3848(03)00288-3	33	4	4	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2014	9	12							e111156	10.1371/journal.pone.0111156	http://dx.doi.org/10.1371/journal.pone.0111156			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UC	25551457	Green Accepted, Green Published, gold			2022-12-27	WOS:000347119100003
J	Covo, S; Chiou, E; Gordenin, DA; Resnick, MA				Covo, Shay; Chiou, Eric; Gordenin, Dmitry A.; Resnick, Michael A.			Suppression of Allelic Recombination and Aneuploidy by Cohesin Is Independent of Chk1 in Saccharomyces cerevisiae	PLOS ONE			English	Article							SISTER-CHROMATID COHESION; DOUBLE-STRAND BREAKS; DNA-DAMAGE RESPONSE; S-PHASE; REPAIR; ECO1; AMPLIFICATION; ESTABLISHMENT; CONDENSATION; CHECKPOINT	Sister chromatid cohesion (SCC), which is established during DNA replication, ensures genome stability. Establishment of SCC is inhibited in G2. However, this inhibition is relived and SCC is established as a response to DNA damage, a process known as Damage Induced Cohesion (DIC). In yeast, Chk1, which is a kinase that functions in DNA damage signal transduction, is considered an activator of SCC through DIC. Nonetheless, here we show that, unlike SCC mutations, loss of CHK1 did not increase spontaneous or damage-induced allelic recombination or aneuploidy. We suggest that Chk1 has a redundant role in the control of DIC or that DIC is redundant for maintaining genome stability.	[Covo, Shay; Chiou, Eric; Gordenin, Dmitry A.; Resnick, Michael A.] NIEHS, Mol Genet Lab, Res Triangle Pk, NC 27709 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Covo, S (corresponding author), Hebrew Univ Jerusalem, Dept Plant Pathol & Microbiol, Robert H Smith Fac Agr, IL-76100 Rehovot, Israel.	shay.covo@mail.huji.ac.il	Covo, Shay/GRJ-0608-2022; Dmitry, Gordenin/C-3907-2018; resnick, Michael/F-1668-2019	Dmitry, Gordenin/0000-0002-8399-1836; resnick, Michael/0000-0002-8473-7506	Intramural Research Program of the National Institute of Environmental Health Sciences (NIEHS NIH, DHHS) [1Z01ES065073]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES021016, Z01ES065073] Funding Source: NIH RePORTER	Intramural Research Program of the National Institute of Environmental Health Sciences (NIEHS NIH, DHHS); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by the Intramural Research Program of the National Institute of Environmental Health Sciences (NIEHS NIH, DHHS) under project 1Z01ES065073 to MAR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Branzei D, 2009, DNA REPAIR, V8, P1038, DOI 10.1016/j.dnarep.2009.04.014; Covo S, 2014, GENETICS, V196, P373, DOI 10.1534/genetics.113.159202; Covo S, 2012, CELL CYCLE, V11, P3937, DOI 10.4161/cc.21945; Covo S, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001006; Fasullo M, 2008, CELL CYCLE, V7, P2418, DOI 10.4161/cc.6411; Guacci V, 1997, CELL, V91, P47, DOI 10.1016/S0092-8674(01)80008-8; Harper JW, 2007, MOL CELL, V28, P739, DOI 10.1016/j.molcel.2007.11.015; Heidinger-Pauli JM, 2008, MOL CELL, V31, P47, DOI 10.1016/j.molcel.2008.06.005; Heidinger-Pauli JM, 2010, CURR BIOL, V20, P957, DOI 10.1016/j.cub.2010.04.018; Heidinger-Pauli JM, 2009, MOL CELL, V34, P311, DOI 10.1016/j.molcel.2009.04.008; Lundin C, 2005, NUCLEIC ACIDS RES, V33, P3799, DOI 10.1093/nar/gki681; Narayanan V, 2006, CELL, V125, P1283, DOI 10.1016/j.cell.2006.04.042; Onn I, 2008, ANNU REV CELL DEV BI, V24, P105, DOI 10.1146/annurev.cellbio.24.110707.175350; Putnam CD, 2009, DNA REPAIR, V8, P974, DOI 10.1016/j.dnarep.2009.04.021; Rowland BD, 2009, MOL CELL, V33, P763, DOI 10.1016/j.molcel.2009.02.028; Sanchez Y, 1999, SCIENCE, V286, P1166, DOI 10.1126/science.286.5442.1166; Sjogren C, 2010, EXP CELL RES, V316, P1445, DOI 10.1016/j.yexcr.2009.12.018; Strom L, 2007, SCIENCE, V317, P242, DOI 10.1126/science.1140649; Strom L, 2004, MOL CELL, V16, P1003, DOI 10.1016/j.molcel.2004.11.026; Strom L, 2010, CELL CYCLE, V9, P3644, DOI 10.4161/cc.9.18.13182; Sutani T, 2009, CURR BIOL, V19, P492, DOI 10.1016/j.cub.2009.01.062; Theis JF, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001227; Unal E, 2007, SCIENCE, V317, P245, DOI 10.1126/science.1140637; Unal E, 2004, MOL CELL, V16, P991, DOI 10.1016/j.molcel.2004.11.027; Unal E, 2008, SCIENCE, V321, P566, DOI 10.1126/science.1157880; Westmoreland J, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000656; Xiong B, 2010, ANNU REV BIOCHEM, V79, P131, DOI 10.1146/annurev-biochem-061708-092640	27	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2014	9	12							e113435	10.1371/journal.pone.0113435	http://dx.doi.org/10.1371/journal.pone.0113435			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UC	25551702	Green Published, Green Submitted, gold			2022-12-27	WOS:000347119100006
J	Cruz-Izquierdo, A; Pico, EA; Lopez, C; Serra, JL; Llama, MJ				Cruz-Izquierdo, Alvaro; Pico, Enrique A.; Lopez, Carmen; Serra, Juan L.; Llama, Maria J.			Magnetic Cross-Linked Enzyme Aggregates (mCLEAs) of Candida antarctica Lipase: An Efficient and Stable Biocatalyst for Biodiesel Synthesis	PLOS ONE			English	Article							IRON-OXIDE NANOPARTICLES; ENANTIOSELECTIVE HYDROLYSIS; COVALENT IMMOBILIZATION; POTENTIAL APPLICATIONS; CATALYTIC-PROPERTIES; FE3O4 NANOPARTICLES; STABILIZATION; PERFORMANCE; TRANSESTERIFICATION; OPTIMIZATION	Enzyme-catalyzed production of biodiesel is the object of extensive research due to the global shortage of fossil fuels and increased environmental concerns. Herein we report the preparation and main characteristics of a novel biocatalyst consisting of Cross-Linked Enzyme Aggregates (CLEAs) of Candida antarctica lipase B (CALB) which are covalently bound to magnetic nanoparticles, and tackle its use for the synthesis of biodiesel from non-edible vegetable and waste frying oils. For this purpose, insolubilized CALB was covalently cross-linked to magnetic nanoparticles of magnetite which the surface was functionalized with -NH2 groups. The resulting biocatalyst combines the relevant catalytic properties of CLEAs (as great stability and feasibility for their reutilization) and the magnetic character, and thus the final product (mCLEAs) are superparamagnetic particles of a robust catalyst which is more stable than the free enzyme, easily recoverable from the reaction medium and reusable for new catalytic cycles. We have studied the main properties of this biocatalyst and we have assessed its utility to catalyze transesterification reactions to obtain biodiesel from non-edible vegetable oils including unrefined soybean, jatropha and cameline, as well as waste frying oil. Using 1% mCLEAs (w/w of oil) conversions near 80% were routinely obtained at 30 degrees C after 24 h of reaction, this value rising to 92% after 72 h. Moreover, the magnetic biocatalyst can be easily recovered from the reaction mixture and reused for at least ten consecutive cycles of 24 h without apparent loss of activity. The obtained results suggest that mCLEAs prepared from CALB can become a powerful biocatalyst for application at industrial scale with better performance than those currently available.	[Cruz-Izquierdo, Alvaro; Pico, Enrique A.; Lopez, Carmen; Serra, Juan L.; Llama, Maria J.] Univ Basque Country UPV EHU, Dept Biochem & Mol Biol, Bilbao, Spain; [Lopez, Carmen] Basque Fdn Sci, Ikerbasque, Bilbao, Spain	University of Basque Country; Basque Foundation for Science	Lopez, C (corresponding author), Univ Politecn Madrid, Dept Chem & Food Technol, Madrid, Spain.	carmen.lopez@ehu.es	López, Carmen/K-2934-2017	López, Carmen/0000-0003-1417-3087; Pico, Enrique A./0000-0001-6681-3862; Cruz-Izquierdo, Alvaro/0000-0003-4212-8822	University of the Basque Country (UPV/EHU) [GIU11/25]; Spanish Ministry of Economy and Competitiveness [CTQ2011-25052]; Basque Government [SAIOTEK S-PE12UN041]; Ikerbasque; Basque Foundation for Science; European Union (project Energreen) [POCTEFA EFA217/11]	University of the Basque Country (UPV/EHU); Spanish Ministry of Economy and Competitiveness(Spanish Government); Basque Government(Basque Government); Ikerbasque; Basque Foundation for Science; European Union (project Energreen)	This work was supported by grants from the University of the Basque Country (UPV/EHU, project GIU11/25 and scholarship for AC-I, http://www.ehu.es), the Spanish Ministry of Economy and Competitiveness (project CTQ2011-25052, http://www.mineco.es), the Basque Government (project SAIOTEK S-PE12UN041, http://www.euskadi.net), Ikerbasque, the Basque Foundation for Science (fellowship for CL, www.ikerbasque.net) and European Union (project Energreen, POCTEFA EFA217/11, http://www.poctefa.eu/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal PK, 2012, J PHYS CHEM LETT, V3, P1142, DOI 10.1021/jz201675m; Azocar L, 2010, J BIOSCI BIOENG, V109, P609, DOI 10.1016/j.jbiosc.2009.12.001; Bajaj A, 2010, J MOL CATAL B-ENZYM, V62, P9, DOI 10.1016/j.molcatb.2009.09.018; Bayramoglu G, 2008, BIOCHEM ENG J, V38, P180, DOI 10.1016/j.bej.2007.06.018; Bisen PS, 2010, BIOTECHNOL LETT, V32, P1019, DOI 10.1007/s10529-010-0275-z; Charpe TW, 2011, WASTE MANAGE, V31, P85, DOI 10.1016/j.wasman.2010.09.003; Contesini FJ, 2013, INT J MOL SCI, V14, P1335, DOI 10.3390/ijms14011335; Cruz-Izquierdo A, 2012, NEW BIOTECHNOL, V29, pS100, DOI 10.1016/j.nbt.2012.08.283; del Campo A, 2005, J MAGN MAGN MATER, V293, P33, DOI 10.1016/j.jmmm.2005.01.040; Devi BLAP, 2009, J AM OIL CHEM SOC, V86, P637, DOI 10.1007/s11746-009-1401-8; Dizge N, 2008, BIOMASS BIOENERG, V32, P1274, DOI 10.1016/j.biombioe.2008.03.005; Fernandez-Lorente G, 2007, BIOTECHNOL BIOENG, V97, P242, DOI 10.1002/bit.21230; Fernandez-Lorente G, 2006, BIOMACROMOLECULES, V7, P2610, DOI 10.1021/bm060408+; Gao L, 2004, J IND MICROBIOL BIOT, V31, P525, DOI 10.1007/s10295-004-0182-1; Gupta P, 2009, BIORESOURCE TECHNOL, V100, P4074, DOI 10.1016/j.biortech.2009.03.076; Han JY, 2011, J MICROBIOL BIOTECHN, V21, P1159, DOI 10.4014/jmb.1106.06048; Harris LA, 2003, CHEM MATER, V15, P1367, DOI 10.1021/cm020994n; Holcapek M, 1999, J CHROMATOGR A, V858, P13; Huang SH, 2003, BIOTECHNOL PROGR, V19, P1095, DOI 10.1021/bp025587v; Idris A, 2012, BIOTECHNOL ADV, V30, P550, DOI 10.1016/j.biotechadv.2011.10.002; Iso M, 2001, J MOL CATAL B-ENZYM, V16, P53, DOI 10.1016/S1381-1177(01)00045-5; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lai JQ, 2012, PROCESS BIOCHEM, V47, P2058, DOI 10.1016/j.procbio.2012.07.024; Lee J, 2009, J MATER CHEM, V19, P7864, DOI 10.1039/b909109b; Leung DYC, 2010, APPL ENERG, V87, P1083, DOI 10.1016/j.apenergy.2009.10.006; Liu YY, 2000, J MOL CATAL B-ENZYM, V10, P523, DOI 10.1016/S1381-1177(00)00093-X; Liu ZL, 2002, J MATER SYNTH PROCES, V10, P83, DOI 10.1023/A:1021231527095; Lopez C, 2014, FRONT CHEM, V2, DOI 10.3389/fchem.2014.00072; Lopez-Serrano P, 2002, BIOTECHNOL LETT, V24, P1379, DOI 10.1023/A:1019863314646; Maity D, 2007, J MAGN MAGN MATER, V308, P46, DOI 10.1016/j.jmmm.2006.05.001; Mateo C, 2000, BIOMACROMOLECULES, V1, P739, DOI 10.1021/bm000071q; Mendes AA, 2011, J MOL CATAL B-ENZYM, V68, P109, DOI 10.1016/j.molcatb.2010.10.002; Morales MP, 1999, CHEM MATER, V11, P3058, DOI 10.1021/cm991018f; NAKAMURA K, 1984, ANAL BIOCHEM, V142, P406, DOI 10.1016/0003-2697(84)90484-6; Netto CGCM, 2013, J MOL CATAL B-ENZYM, V85-86, P71, DOI 10.1016/j.molcatb.2012.08.010; Netto CGCM, 2009, TETRAHEDRON-ASYMMETR, V20, P2299, DOI 10.1016/j.tetasy.2009.08.022; Ngo TPN, 2013, BIORESOURCE TECHNOL, V145, P233, DOI 10.1016/j.biortech.2012.12.053; Ramirez LP, 2003, MACROMOL CHEM PHYSIC, V204, P22, DOI 10.1002/macp.200290052; Ren YH, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-63; Sahoo Y, 2005, J PHYS CHEM B, V109, P3879, DOI 10.1021/jp045402y; Samukawa T, 2000, J BIOSCI BIOENG, V90, P180, DOI 10.1016/S1389-1723(00)80107-3; Schoevaart R, 2004, BIOTECHNOL BIOENG, V87, P754, DOI 10.1002/bit.20184; Sheldon RA, 2007, BIOCHEM SOC T, V35, P1583, DOI 10.1042/BST0351583; Sheldon RA, 2013, CHEM SOC REV, V42, P6223, DOI 10.1039/c3cs60075k; Sheldon RA, 2011, APPL MICROBIOL BIOT, V92, P467, DOI 10.1007/s00253-011-3554-2; Shen XC, 2004, CHEM LETT, V33, P1468, DOI 10.1246/cl.2004.1468; Sohn OJ, 2008, BIOTECHNOL BIOPROC E, V13, P716, DOI 10.1007/s12257-008-0096-2; Talekar S, 2013, RSC ADV, V3, P12485, DOI 10.1039/c3ra40818c; Talekar S, 2012, BIORESOURCE TECHNOL, V123, P542, DOI 10.1016/j.biortech.2012.07.044; Tudorache M, 2013, RSC ADV, V3, P4052, DOI 10.1039/c3ra23222k; Verma ML, 2013, APPL MICROBIOL BIOT, V97, P23, DOI 10.1007/s00253-012-4535-9; Wang X, 2009, CHEMSUSCHEM, V2, P947, DOI 10.1002/cssc.200900174; Xie WL, 2010, BIOMASS BIOENERG, V34, P890, DOI 10.1016/j.biombioe.2010.01.034; Xie WL, 2009, ENERG FUEL, V23, P1347, DOI 10.1021/ef800648y; Yong Y, 2008, J MAGN MAGN MATER, V320, P2350, DOI 10.1016/j.jmmm.2008.04.158	55	58	59	3	94	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2014	9	12							e115202	10.1371/journal.pone.0115202	http://dx.doi.org/10.1371/journal.pone.0115202			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UC	25551445	gold, Green Published, Green Submitted			2022-12-27	WOS:000347119100031
J	Pennebaker, JW; Chung, CK; Frazee, J; Lavergne, GM; Beaver, DI				Pennebaker, James W.; Chung, Cindy K.; Frazee, Joey; Lavergne, Gary M.; Beaver, David I.			When Small Words Foretell Academic Success: The Case of College Admissions Essays	PLOS ONE			English	Article								The smallest and most commonly used words in English are pronouns, articles, and other function words. Almost invisible to the reader or writer, function words can reveal ways people think and approach topics. A computerized text analysis of over 50,000 college admissions essays from more than 25,000 entering students found a coherent dimension of language use based on eight standard function word categories. The dimension, which reflected the degree students used categorical versus dynamic language, was analyzed to track college grades over students' four years of college. Higher grades were associated with greater article and preposition use, indicating categorical language (i.e., references to complexly organized objects and concepts). Lower grades were associated with greater use of auxiliary verbs, pronouns, adverbs, conjunctions, and negations, indicating more dynamic language (i.e., personal narratives). The links between the categorical-dynamic index (CDI) and academic performance hint at the cognitive styles rewarded by higher education institutions.	[Pennebaker, James W.; Chung, Cindy K.; Frazee, Joey; Lavergne, Gary M.; Beaver, David I.] Univ Texas Austin, Austin, TX 78712 USA	University of Texas System; University of Texas Austin	Pennebaker, JW (corresponding author), Univ Texas Austin, Austin, TX 78712 USA.	Pennebaker@mail.utexas.edu	Pennebaker, James/GLR-6058-2022; Pennebaker, James W/E-5997-2013	Pennebaker, James W/0000-0001-9091-214X	Army Research Institute [W5J9CQ12C0043]; National Science Foundation [IIS-1344257]	Army Research Institute; National Science Foundation(National Science Foundation (NSF))	Preparation of this manuscript was aided in part by grants from the Army Research Institute (W5J9CQ12C0043) and the National Science Foundation (IIS-1344257). The views, opinions, and/or findings contained in this report are those of the authors and should not be construed as official positions, policies, or decisions of the National Science Foundation or the Department of the Army, unless so designated by other documents. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atkinson R, 2001, STANDARDIZED TESTS A; Biber D., 1988, VARIATION SPEECH WRI, DOI 10.1017/CBO9780511621024; Graesser AC, 2001, CONTEMP PSYCHOL, V46, P261, DOI 10.1037/002486; Heylighen F., 2002, FOUND SCI, V7, P293, DOI [10.1023/A:1019661126744, DOI 10.1023/A:1019661126744]; Joachims T Thorsten, 2002, LEARNING CLASSIFY TE; Jurafsky D., 2009, P HUM LANG TECHN 200, P638, DOI DOI 10.3115/1620754.1620847; Landauer T. K., 2003, ASSESS EDUC, V10, P295, DOI [10.1080/0969594032000148154, DOI 10.1080/0969594032000148154]; Larkey L. S., 1998, Proceedings of the 21st Annual International ACM SIGIR Conference on Research and Development in Information Retrieval, P90, DOI 10.1145/290941.290965; Lavergne Gary M., 2001, DEV CONCORDANCE ACT; Nisbett RE, 2001, PSYCHOL REV, V108, P291, DOI 10.1037//0033-295X.108.2.291; Pennebaker, 2011, SECRET LIFE PRONOUNS, DOI 10.1387/gogoa.17916; Pennebaker J. W., 2007, DEV PSYCHOMETRIC PRO; Pennebaker JW, 1999, J PERS SOC PSYCHOL, V77, P1296, DOI 10.1037/0022-3514.77.6.1296; Pennebaker JW, 2007, LINGUISTIC INQUIRY W; Robinson RL, 2013, J LANG SOC PSYCHOL, V32, P469, DOI 10.1177/0261927X13476869; Schank RC, 1999, DYNAMIC MEMORY REVIS; Tausczik YR, 2010, J LANG SOC PSYCHOL, V29, P24, DOI 10.1177/0261927X09351676; Walker B, 2012, REV USE STANDARDIZED; Zenisky AL, 2002, APPL MEAS EDUC, V15, P337, DOI 10.1207/S15324818AME1504_02	19	227	229	5	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2014	9	12							e115844	10.1371/journal.pone.0115844	http://dx.doi.org/10.1371/journal.pone.0115844			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AX7UC	25551217	gold, Green Published, Green Submitted			2022-12-27	WOS:000347119100070
J	Ciechomska, M; O'Reilly, S; Suwara, M; Bogunia-Kubik, K; van Laar, JM				Ciechomska, Marzena; O'Reilly, Steven; Suwara, Monika; Bogunia-Kubik, Katarzyna; van Laar, Jacob M.			MiR-29a Reduces TIMP-1 Production by Dermal Fibroblasts via Targeting TGF-beta Activated Kinase 1 Binding Protein 1, Implications for Systemic Sclerosis	PLOS ONE			English	Article							GROWTH-FACTOR; TISSUE INHIBITOR; MATRIX METALLOPROTEINASES; MYOCARDIAL-INFARCTION; COLLAGEN EXPRESSION; GENE-EXPRESSION; LIVER FIBROSIS; TAK1; MICRORNAS; PATHOGENESIS	Background: Systemic sclerosis (SSc) is an autoimmune connective tissue disease characterised by skin and internal organs fibrosis due to accumulation of extra cellular matrix (ECM) proteins. Tissue inhibitor of metalloproteinases 1 (TIMP-1) plays a key role in ECM deposition. Aim: To investigate the role of miR-29a in regulation of TAB1-mediated TIMP-1 production in dermal fibroblasts in systemic sclerosis. Methods: Healthy control (HC) and SSc fibroblasts were cultured from skin biopsies. The expression of TIMP-1, MMP-1 and TGF-beta activated kinase 1 binding protein 1 (TAB1) was measured following miR-29a transfection using ELISA, qRT-PCR, and Western Blotting. The functional effect of miR-29a on dermal fibroblasts was assessed in collagen gel assay. In addition, HeLa cells were transfected with 3'UTR of TAB1 plasmid cloned downstream of firefly luciferase gene to assess TAB1 activity. HC fibroblasts and HeLa cells were also transfected with Target protectors in order to block the endogenous miR-29a activity. Results: We found that TAB1 is a novel target gene of miR-29a, also regulating downstream TIMP-1 production. TAB1 is involved in TGF-beta signal transduction, a key cytokine triggering TIMP-1 production. To confirm that TAB1 is a bona fide target gene of miR-29a, we used a TAB1 3'UTR luciferase assay and Target protector system. We showed that miR-29a not only reduced TIMP-1 secretion via TAB1 repression, but also increased functional MMP-1 production resulting in collagen degradation. Blocking TAB1 activity by pharmacological inhibition or TAB1 knockdown resulted in TIMP-1 reduction, confirming TAB1-dependent TIMP-1 regulation. Enhanced expression of miR-29a was able to reverse the profibrotic phenotype of SSc fibroblasts via downregulation of collagen and TIMP-1. Conclusions: miR-29a repressed TAB1-mediated TIMP-1 production in dermal fibroblasts, demonstrating that miR-29a may be a therapeutic target in SSc.	[Ciechomska, Marzena; O'Reilly, Steven; van Laar, Jacob M.] Newcastle Univ, Musculoskeletal Res Grp, Inst Cellular Med, Newcastle Upon Tyne, Tyne & Wear, England; [Suwara, Monika] Newcastle Univ, Fibrosis Res Grp, Inst Cellular Med, Newcastle Upon Tyne, Tyne & Wear, England; [Ciechomska, Marzena; Bogunia-Kubik, Katarzyna] Polish Acad Sci, L Hirszferd Inst Immunol & Expt Therapy, Wroclaw, Poland; [van Laar, Jacob M.] Univ Med Ctr Utrecht, Dept Rheumatol & Clin Immunol, Utrecht, Netherlands	Newcastle University - UK; Newcastle University - UK; Polish Academy of Sciences; Hirszfeld Institute of Immunology & Experimental Therapy of the Polish Academy of Sciences; Utrecht University; Utrecht University Medical Center	Ciechomska, M (corresponding author), Newcastle Univ, Musculoskeletal Res Grp, Inst Cellular Med, Newcastle Upon Tyne, Tyne & Wear, England.	m.m.ciechomska@gmail.com	O'Reilly, Steven/AAX-7038-2020	O'Reilly, Steven/0000-0001-7483-740X; Ciechomska, Marzena/0000-0002-0961-6130; Bogunia-Kubik, Katarzyna/0000-0001-9744-0376	National Institute for Health Research Newcastle Biomedical Research Centre based at Newcastle Hospitals Foundation Trust; Newcastle University; Foundation for Polish Science [2013-8/4]; JGW Patterson Foundation	National Institute for Health Research Newcastle Biomedical Research Centre based at Newcastle Hospitals Foundation Trust; Newcastle University; Foundation for Polish Science(Foundation for Polish ScienceEuropean Commission); JGW Patterson Foundation	Study design, data collection and analysis was supported by National Institute for Health Research Newcastle Biomedical Research Centre based at Newcastle Hospitals Foundation Trust and Newcastle University, JGW Patterson Foundation and Homing Plus grant/2013-8/4 from Foundation for Polish Science.	Bhattacharyya S, 2013, AM J PATHOL, V182, P192, DOI 10.1016/j.ajpath.2012.09.007; Bujak M, 2007, CARDIOVASC RES, V74, P184, DOI 10.1016/j.cardiores.2006.10.002; Choi ME, 2012, SEMIN NEPHROL, V32, P244, DOI 10.1016/j.semnephrol.2012.04.003; Ciechomska M, 2014, GENES IMMUN, V15, P433, DOI 10.1038/gene.2014.44; Ciechomska M, 2013, EXPERT REV MOL MED, V15, DOI 10.1017/erm.2013.10; Ciechomska M, 2013, ANN RHEUM DIS, V72, P1382, DOI 10.1136/annrheumdis-2012-201958; Cushing L, 2011, AM J RESP CELL MOL, V45, P287, DOI 10.1165/rcmb.2010-0323OC; Derk CT, 2007, RECENT PATENTS INFLA, V1, P142, DOI 10.2174/187221307780979883; Du B, 2010, FEBS LETT, V584, P811, DOI 10.1016/j.febslet.2009.12.053; EDWARDS DR, 1992, BIOCHIM BIOPHYS ACTA, V1171, P41, DOI 10.1016/0167-4781(92)90138-P; Eickelberg O, 1999, AM J PHYSIOL-LUNG C, V276, pL814, DOI 10.1152/ajplung.1999.276.5.L814; Fang QH, 2006, AM J RESP CELL MOL, V35, P714, DOI 10.1165/rcmb.2005-0026OC; Frost J, 2012, RHEUMATOLOGY, V51, P1049, DOI 10.1093/rheumatology/ker367; Gardner A, 2012, AM J PATHOL, V180, P2293, DOI 10.1016/j.ajpath.2012.02.022; Guo F, 2013, J INVEST DERMATOL, V133, P1646, DOI 10.1038/jid.2013.28; Hall MC, 2003, J BIOL CHEM, V278, P10304, DOI 10.1074/jbc.M212334200; Hoffmann A, 2005, J BIOL CHEM, V280, P27271, DOI 10.1074/jbc.M503368200; Ihn H, 2008, J DERMATOL SCI, V49, P103, DOI 10.1016/j.jdermsci.2007.05.014; Kikuchi K, 1997, J INVEST DERMATOL, V108, P281, DOI 10.1111/1523-1747.ep12286457; Sung I, 2009, J BIOL CHEM, V284, P22285, DOI 10.1074/jbc.M109.007146; Kwak HJ, 2006, MOL CANCER RES, V4, P209, DOI 10.1158/1541-7786.MCR-05-0140; Larner-Svensson HM, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-68; Leivonen SK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057474; Lovelock JD, 2005, AM J PHYSIOL-HEART C, V288, pH461, DOI 10.1152/ajpheart.00402.2004; Luna C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051688; MacFarlane LA, 2010, CURR GENOMICS, V11, P537, DOI 10.2174/138920210793175895; Margulis A, 2009, AM J PHYSIOL-LUNG C, V296, pL236, DOI 10.1152/ajplung.90462.2008; Maurer B, 2010, ARTHRITIS RHEUM-US, V62, P1733, DOI 10.1002/art.27443; Nie QH, 2006, WORLD J GASTROENTERO, V12, P3044, DOI 10.3748/wjg.v12.i19.3044; Ninomiya-Tsuji J, 2003, J BIOL CHEM, V278, P18485, DOI 10.1074/jbc.M207453200; NORMAND J, 1995, IN VITRO CELL DEV-AN, V31, P447; O'Reilly S., 2014, J BIOL CHEM; Pandit KV, 2011, TRANSL RES, V157, P191, DOI 10.1016/j.trsl.2011.01.012; Patel V, 2012, CURR OPIN NEPHROL HY, V21, P410, DOI 10.1097/MNH.0b013e328354e559; Peng WJ, 2012, EXPERT OPIN THER TAR, V16, P875, DOI 10.1517/14728222.2012.708339; Safwat N, 2005, ENDOCRINOLOGY, V146, P4814, DOI 10.1210/en.2005-0457; Sano Y, 1999, J BIOL CHEM, V274, P8949, DOI 10.1074/jbc.274.13.8949; Sheridan CM, 2001, AM J PATHOL, V159, P1555, DOI 10.1016/S0002-9440(10)62540-0; Shi-wen X, 2009, ARTHRITIS RHEUM-US, V60, P234, DOI 10.1002/art.24223; Silacci P, 1998, J BIOL CHEM, V273, P13625, DOI 10.1074/jbc.273.22.13625; Staton AA, 2011, NAT PROTOC, V6, P2035, DOI 10.1038/nprot.2011.423; van Rooij E, 2008, P NATL ACAD SCI USA, V105, P13027, DOI 10.1073/pnas.0805038105; van Rooij E, 2012, CIRC RES, V110, P496, DOI 10.1161/CIRCRESAHA.111.247916; Wang B, 2012, J AM SOC NEPHROL, V23, P252, DOI 10.1681/ASN.2011010055; Wong WR, 2001, J FORMOS MED ASSOC, V100, P377; Yang T, 2013, J CELL BIOCHEM, V114, P1336, DOI 10.1002/jcb.24474; Yoshiji H, 2000, HEPATOLOGY, V32, P1248, DOI 10.1053/jhep.2000.20521; Young-Min SA, 2001, ANN RHEUM DIS, V60, P846; Zhu HL, 2013, EXP MOL MED, V45, DOI 10.1038/emm.2013.71	49	70	73	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2014	9	12							e115596	10.1371/journal.pone.0115596	http://dx.doi.org/10.1371/journal.pone.0115596			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX6YH	25549087	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000347063500019
J	An, R; Jia, Y; Wan, BH; Zhang, YF; Dong, P; Li, J; Liang, XG				An, Ran; Jia, Yu; Wan, Baihui; Zhang, Yanfang; Dong, Ping; Li, Jing; Liang, Xingguo			Non-Enzymatic Depurination of Nucleic Acids: Factors and Mechanisms	PLOS ONE			English	Article							CATALYZED HYDROLYSIS; DNA DEPURINATION; CHAIN BREAKAGE; NUCLEOSIDES; MUTAGENESIS; MUTATIONS; KINETICS; BOND	Depurination has attracted considerable attention since a long time for it is closely related to the damage and repair of nucleic acids. In the present study, depurination using a pool of 30-nt short DNA pieces with various sequences at diverse pH values was analyzed by High Performance Liquid Chromatography (HPLC). Kinetic analysis results showed that non-enzymatic depurination of oligodeoxynucleotides exhibited typical first-order kinetics, and its temperature dependence obeyed Arrhenius' law very well. Our results also clearly showed that the linear relationship between the logarithms of rate constants and pH values had a salient point around pH 2.5. Interestingly and unexpectedly, depurination depended greatly on the DNA sequences. The depurination of poly (dA) was found to be extremely slow, and thymine rich sequences depurinated faster than other sequences. These results could be explained to some extent by the protonation of nucleotide bases. Moreover, two equations were obtained based on our data for predicting the rate of depurination under various conditions. These results provide basic data for gene mutagenesis and nucleic acids metabolism in acidic gastric juice and some acidic organelles, and may also help to rectify some misconceptions about depurination.	[An, Ran; Jia, Yu; Wan, Baihui; Zhang, Yanfang; Dong, Ping; Li, Jing; Liang, Xingguo] Ocean Univ China, Coll Food Sci & Engn, Qingdao 266003, Peoples R China	Ocean University of China	Liang, XG (corresponding author), Ocean Univ China, Coll Food Sci & Engn, Qingdao 266003, Peoples R China.	liangxg@ouc.edu.cn	jia, yu/HHR-9047-2022		"Fund for Distinguished Young Scholars'' of Shandong province [JQ201204]; Program for Changjiang Scholars and Innovative Research Team in University [IRT1188]; National Youth Qianren Plan	"Fund for Distinguished Young Scholars'' of Shandong province; Program for Changjiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); National Youth Qianren Plan	This work was supported by "Fund for Distinguished Young Scholars'' of Shandong province [JQ201204], Program for Changjiang Scholars and Innovative Research Team in University [IRT1188], and "National Youth Qianren Plan.'' Funding for open access charge: "Fund for Distinguished Young Scholars'' of Shandong province [JQ201204]; http://www.sdnsf.gov.cn/portal/. XL is the author who received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amosova O, 2006, P NATL ACAD SCI USA, V103, P4392, DOI 10.1073/pnas.0508499103; Amosova O, 2011, J BIOL CHEM, V286, P36316, DOI 10.1074/jbc.M111.272047; Baik MH, 2002, J AM CHEM SOC, V124, P4495, DOI 10.1021/ja017588+; Cavalieri EL, 2000, THEOR CHEM ACC, V104, P235, DOI 10.1007/s002140000142; Cavalieri E, 2012, IUBMB LIFE, V64, P169, DOI 10.1002/iub.586; Chakravarti D, 2001, ONCOGENE, V20, P7945, DOI 10.1038/sj.onc.1204969; DEKKER CA, 1960, ANNU REV BIOCHEM, V29, P453, DOI 10.1146/annurev.bi.29.070160.002321; FREDERICO LA, 1990, BIOCHEMISTRY-US, V29, P2532, DOI 10.1021/bi00462a015; FRESCO JR, 2011, SITE SPECIFIC SELF C, P3; GARRETT ER, 1972, J AM CHEM SOC, V94, P8532, DOI 10.1021/ja00779a040; GARRETT ER, 1960, J AM CHEM SOC, V82, P827, DOI 10.1021/ja01489a018; GREER SHELDON, 1962, JOUR MOLECULAR BIOL, V4, P123; Gut IG, 1997, INT J MASS SPECTROM, V169, P313, DOI 10.1016/S0168-1176(97)00208-5; HEVESI L, 1972, J AM CHEM SOC, V94, P4715, DOI 10.1021/ja00768a046; Hotokka M, 1996, J MOL STRUC-THEOCHEM, V363, P191, DOI 10.1016/0166-1280(95)04440-X; LAWLEY PD, 1963, BIOCHEM J, V89, P127, DOI 10.1042/bj0890127; LINDAHL T, 1993, NATURE, V362, P709, DOI 10.1038/362709a0; LINDAHL T, 1972, BIOCHEMISTRY-US, V11, P3610, DOI 10.1021/bi00769a018; LINDAHL T, 1972, BIOCHEMISTRY-US, V11, P3618, DOI 10.1021/bi00769a019; LOEB LA, 1986, ANNU REV GENET, V20, P201, DOI 10.1146/annurev.ge.20.120186.001221; Luzio JP, 2007, NAT REV MOL CELL BIO, V8, P622, DOI 10.1038/nrm2217; LYONS JW, 1965, J AM CHEM SOC, V87, P1781, DOI 10.1021/ja01086a030; Neidle S, 2010, PRINCIPLES NUCL ACID; Nelson D.L., 2017, LEHNINGER PRINCIPLES, V7th; OSBORNE M, 1985, CHEM-BIOL INTERACT, V53, P183, DOI 10.1016/S0009-2797(85)80095-8; Rios-Font R, 2007, J PHYS CHEM B, V111, P6071, DOI 10.1021/jp070822j; SCHAAPER RM, 1982, CANCER RES, V42, P3480; SCHAAPER RM, 1981, P NATL ACAD SCI-BIOL, V78, P1773, DOI 10.1073/pnas.78.3.1773; Sherchan J, 2009, B KOREAN CHEM SOC, V30, P2309; SUZUKI T, 1994, NUCLEIC ACIDS RES, V22, P4997, DOI 10.1093/nar/22.23.4997; TAMM C, 1952, J BIOL CHEM, V195, P49; TSUBOI M, 1962, BIOCHIM BIOPHYS ACTA, V55, P1; Zhang L, 2012, CELL RES, V22, P107, DOI 10.1038/cr.2011.158; ZOLTEWICZ JA, 1970, J AM CHEM SOC, V92, P1741, DOI 10.1021/ja00709a055	34	61	65	9	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2014	9	12							e115950	10.1371/journal.pone.0115950	http://dx.doi.org/10.1371/journal.pone.0115950			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UN	25546310	Green Submitted, gold, Green Published			2022-12-27	WOS:000347120200084
J	Jajamovich, GH; Calcagno, C; Dyvorne, HA; Rusinek, H; Taouli, B				Jajamovich, Guido H.; Calcagno, Claudia; Dyvorne, Hadrien A.; Rusinek, Henry; Taouli, Bachir			DCE-MRI of the Liver: Reconstruction of the Arterial Input Function Using a Low Dose Pre-Bolus Contrast Injection	PLOS ONE			English	Article							ENHANCED MRI; MYOCARDIAL-PERFUSION; TEMPORAL-RESOLUTION; SINGLE-BOLUS; BLOOD-FLOW; QUANTIFICATION; PERMEABILITY; PARAMETERS; DIAGNOSIS; CIRRHOSIS	Purpose: To assess the quality of the arterial input function (AIF) reconstructed using a dedicated pre-bolus low-dose contrast material injection imaged with a high temporal resolution and the resulting estimated liver perfusion parameters. Materials and Methods: In this IRB-approved prospective study, 24 DCE-MRI examinations were performed in 21 patients with liver disease (M/F 17/4, mean age 56 y). The examination consisted of 1.3 mL and 0.05 mmol/kg of gadobenate dimeglumine for pre-bolus and main bolus acquisitions, respectively. The concentration-curve of the abdominal aorta in the pre-bolus acquisition was used to reconstruct the AIF. AIF quality and shape parameters obtained with pre-bolus and main bolus acquisitions and the resulting estimated hepatic perfusion parameters obtained with a dual-input single compartment model were compared between the 2 methods. Test-retest reproducibility of perfusion parameters were assessed in three patients. Results: The quality of the pre-bolus AIF curve was significantly better than that of main bolus AIF. Shape parameters peak concentration, area under the time activity curve of gadolinium contrast at 60 s and upslope of pre-bolus AIF were all significantly higher, while full width at half maximum was significantly lower than shape parameters of main bolus AIF. Improved liver perfusion parameter reproducibility was observed using pre-bolus acquisition [coefficient of variation (CV) of 4.2%-38.7% for pre-bolus vs. 12.1-71.4% for main bolus] with the exception of distribution volume (CV of 23.6% for pre-bolus vs. 15.8% for main bolus). The CVs between pre-bolus and main bolus for the perfusion parameters were lower than 14%. Conclusion: The AIF reconstructed with pre-bolus low dose contrast injection displays better quality and shape parameters and enables improved liver perfusion parameter reproducibility, although the resulting liver perfusion parameters demonstrated no clinically significant differences between pre-bolus and main bolus acquisitions.	[Jajamovich, Guido H.; Calcagno, Claudia; Dyvorne, Hadrien A.; Taouli, Bachir] Icahn Sch Med Mt Sinai, Translat & Mol Imaging Inst, Dept Radiol, New York, NY 10029 USA; [Rusinek, Henry] NYU, Dept Radiol, Langone Med Ctr, New York, NY 10016 USA	Icahn School of Medicine at Mount Sinai; New York University; NYU Langone Medical Center	Taouli, B (corresponding author), Icahn Sch Med Mt Sinai, Translat & Mol Imaging Inst, Dept Radiol, New York, NY 10029 USA.	bachir.taouli@mountsinai.org	Taouli, Bachir/ABB-5044-2020		National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Grant [1R01DK087877, NCT01600105]; National Cancer Institute (NCI) grant [T32CA78207]; NATIONAL CANCER INSTITUTE [T32CA078207] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK087877] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Grant; National Cancer Institute (NCI) grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was funded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Grant 1R01DK087877, (Clinicaltrials.gov) # NCT01600105, and the National Cancer Institute (NCI) Grant T32CA78207. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Annet L, 2003, RADIOLOGY, V229, P409, DOI 10.1148/radiol.2292021128; Aronhime S, 2014, J MAGN RESON IMAGING, V40, P90, DOI 10.1002/jmri.24341; Baxter S, 2009, J MAGN RESON IMAGING, V29, P1317, DOI 10.1002/jmri.21795; Bentzen L, 2005, INT J RADIAT ONCOL, V61, P1208, DOI 10.1016/j.ijrobp.2004.12.020; Brodsky EK, 2013, MAGN RESON MED; Chandarana H, 2010, EUR J RADIOL, V76, P348, DOI 10.1016/j.ejrad.2010.03.016; Cheng HLM, 2008, J MAGN RESON IMAGING, V28, P736, DOI 10.1002/jmri.21489; Christian TF, 2004, RADIOLOGY, V232, P677, DOI 10.1148/radiol.2323030573; Christian TF, 2008, J MAGN RESON IMAGING, V27, P1271, DOI 10.1002/jmri.21383; de Bazelaire C, 2006, EUR RADIOL, V16, P2083, DOI 10.1007/s00330-006-0198-1; Do RKG, 2009, MAGN RESON IMAGING C, V17, P339, DOI 10.1016/j.mric.2009.01.009; Flaherty KT, 2008, CANCER BIOL THER, V7, P496, DOI 10.4161/cbt.7.4.5624; FritzHansen T, 1996, MAGNET RESON MED, V36, P225, DOI 10.1002/mrm.1910360209; Gill AB, 2014, PHYS MED BIOL, V59, P3187, DOI 10.1088/0031-9155/59/12/3187; Hagiwara M, 2008, RADIOLOGY, V246, P926, DOI 10.1148/radiol.2463070077; Hsu LY, 2006, J MAGN RESON IMAGING, V23, P315, DOI 10.1002/jmri.20502; Ivancevic MK, 2003, MAGNET RESON MED, V50, P885, DOI 10.1002/mrm.10633; Jackson A, 2002, NMR BIOMED, V15, P164, DOI 10.1002/nbm.729; Jajamovich GH, 2013, ISMRM 21 ANN M EXH S; Jajamovich GH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097355; Kostler H, 2008, J MAGN RESON IMAGING, V28, P382, DOI 10.1002/jmri.21443; Kostler H, 2004, MAGN RESON MED, V52, P296, DOI 10.1002/mrm.20160; Li KL, 2012, MAGN RESON MED, V68, P452, DOI 10.1002/mrm.23252; Makkat S, 2010, J MAGN RESON IMAGING, V31, P556, DOI 10.1002/jmri.22077; Materne R, 2002, MAGNET RESON MED, V47, P135, DOI 10.1002/mrm.10045; Oechsner M, 2009, J MAGN RESON IMAGING, V30, P104, DOI 10.1002/jmri.21793; Parker GJM, 2006, MAGN RESON MED, V56, P993, DOI 10.1002/mrm.21066; Patel J, 2010, J MAGN RESON IMAGING, V31, P589, DOI 10.1002/jmri.22081; Risse F, 2006, J MAGN RESON IMAGING, V24, P1284, DOI 10.1002/jmri.20747; Schabel MC, 2008, PHYS MED BIOL, V53, P2345, DOI 10.1088/0031-9155/53/9/010; Subashi E, 2013, MED PHYS, V40, DOI 10.1118/1.4774050; Taouli B, 2013, AM J ROENTGENOL, V201, P795, DOI 10.2214/AJR.12.9798; Utz W, 2008, MAGN RESON MED, V59, P1373, DOI 10.1002/mrm.21611; Wang HS, 2012, J MAGN RESON IMAGING, V36, P411, DOI 10.1002/jmri.23636; Xu B, 2013, MAGN RESON MED, V69, P370, DOI 10.1002/mrm.24253; Yankeelov TE, 2007, MAGN RESON MED, V57, P353, DOI 10.1002/mrm.21131	36	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2014	9	12							e115667	10.1371/journal.pone.0115667	http://dx.doi.org/10.1371/journal.pone.0115667			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UN	25546176	Green Submitted, Green Published, gold			2022-12-27	WOS:000347120200052
J	Mariman, R; Tielen, F; Koning, F; Nagelkerken, L				Mariman, Rob; Tielen, Frans; Koning, Frits; Nagelkerken, Lex			The Probiotic Mixture VSL#3 Dampens LPS-Induced Chemokine Expression in Human Dendritic Cells by Inhibition of STAT-1 Phosphorylation	PLOS ONE			English	Article							GENE-EXPRESSION; SIGNAL-TRANSDUCTION; IMMUNE REGULATION; RESPONSES; MACROPHAGES; BACTERIA; RECEPTORS; PATHWAYS; HOMEOSTASIS; ACTIVATION	VSL#3, a mixture of 8 different probiotic bacteria, has successfully been used in the clinic to treat Ulcerative Colitis. We previously identified the modulation of chemokines as a major mechanism in the protective effect of the VSL#3 in a mouse model of colitis. This was supported by in vitro studies that implicated a role for VSL#3 in the suppression of LPS-induced chemokine production by mouse bone marrow-derived dendritic cells (DC). Herein, we validated these findings employing human monocyte-derived DC. Stimulation of human DC with LPS, VSL#3, or a combination of both resulted in their maturation, evident from enhanced expression of activation markers on the cell-surface, as well as the induction of various chemokines and cytokines. Interestingly, a set of LPS-induced chemokines was identified that were suppressed by VSL#3. These included CXCL9, CXCL10, CCL2, CCL7, and CCL8. In silico approaches identified STAT-1 as a dominant regulator of these chemokines, and this was confirmed by demonstrating that LPS-induced phosphorylation of this transcription factor was inhibited by VSL#3. This indicates that VSL#3 may contribute to the control of inflammation by selective suppression of STAT-1 induced chemokines.	[Mariman, Rob; Tielen, Frans; Nagelkerken, Lex] TNO, Dept Metab Hlth Res, Leiden, Netherlands; [Mariman, Rob; Koning, Frits] Leiden Univ, Dept Immunohematol & Bloodtransfus, Ctr Med, Leiden, Netherlands	Netherlands Organization Applied Science Research; Leiden University; Leiden University - Excl LUMC	Mariman, R (corresponding author), TNO, Dept Metab Hlth Res, Leiden, Netherlands.	r.m.mariman@gmail.com; lex.nagelkerken@xs4all.nl		Mariman, Rob/0000-0001-6405-1091; Koning, Frits/0000-0002-4007-5715	Dutch Top Institute Pharma project [D1-101]	Dutch Top Institute Pharma project	This study was performed in the framework of the Dutch Top Institute Pharma project D1-101. The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2009, IMMUNOL REV, V227, P5, DOI 10.1111/j.1600-065X.2008.00739.x; Bandow K, 2012, FEBS LETT, V586, P1540, DOI 10.1016/j.febslet.2012.04.018; Boirivant M, 2007, CURR OPIN GASTROEN, V23, P679, DOI 10.1097/MOG.0b013e3282f0cffc; Christensen HR, 2002, J IMMUNOL, V168, P171, DOI 10.4049/jimmunol.168.1.171; Chung EY, 2011, J NUTR BIOCHEM, V22, P902, DOI 10.1016/j.jnutbio.2010.07.012; Chung EY, 2010, J PHARMACOL SCI, V112, P405, DOI 10.1254/jphs.09247FP; Coombes JL, 2008, NAT REV IMMUNOL, V8, P435, DOI 10.1038/nri2335; Evrard B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018735; Fink LN, 2007, FEMS IMMUNOL MED MIC, V51, P535, DOI 10.1111/j.1574-695X.2007.00333.x; Garrett WS, 2010, CELL, V140, P859, DOI 10.1016/j.cell.2010.01.023; Geijtenbeek TBH, 2009, NAT REV IMMUNOL, V9, P465, DOI 10.1038/nri2569; Gomez-Llorente C, 2010, P NUTR SOC, V69, P381, DOI 10.1017/S0029665110001527; Kagan JC, 2012, TRENDS IMMUNOL, V33, P442, DOI 10.1016/j.it.2012.06.005; Kayama H, 2012, INT IMMUNOL; Kelly D, 2012, NUTR REV, V70, pS18, DOI 10.1111/j.1753-4887.2012.00498.x; Latvala S, 2008, WORLD J GASTROENTERO, V14, P5570, DOI 10.3748/wjg.14.5570; Maloy KJ, 2011, NATURE, V474, P298, DOI 10.1038/nature10208; Mariman R, 2014, BR J NUTR, P1; Mariman R, 2012, INFLAMM BOWEL DIS, V18, P1424, DOI 10.1002/ibd.22849; Mastrangeli G, 2009, INT ARCH ALLERGY IMM, V150, P133, DOI 10.1159/000218116; Ohmori Y, 2001, J LEUKOCYTE BIOL, V69, P598; Pabst O, 2012, MUCOSAL IMMUNOL, V5, P232, DOI 10.1038/mi.2012.4; Pamer EG, 2007, NAT IMMUNOL, V8, P1173, DOI 10.1038/ni1526; Powrie F, 2004, ANN NY ACAD SCI, V1029, P132, DOI 10.1196/annals.1309.030; Ramana CV, 2002, TRENDS IMMUNOL, V23, P96, DOI 10.1016/S1471-4906(01)02118-4; Rescigno M, 2001, NAT IMMUNOL, V2, P361, DOI 10.1038/86373; Siegemund S, 2012, NAT IMMUNOL, V13, P1031, DOI 10.1038/ni.2452; Soler C, 2003, BIOCHEM J, V375, P777, DOI 10.1042/BJ20030260; Staab J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069903; Toshchakov V, 2002, NAT IMMUNOL, V3, P392, DOI 10.1038/ni774; van Baarlen P, 2011, P NATL ACAD SCI USA, V108, P4562, DOI 10.1073/pnas.1000079107; Vanderpool C, 2008, INFLAMM BOWEL DIS, V14, P1585, DOI 10.1002/ibd.20525; Verbeek R, 2010, BENEF MICROBES, V1, P109, DOI 10.3920/BM2009.0026	33	16	16	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2014	9	12							e115676	10.1371/journal.pone.0115676	http://dx.doi.org/10.1371/journal.pone.0115676			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UN	25546330	gold, Green Published, Green Submitted			2022-12-27	WOS:000347120200053
J	Kubesova, A; Tejkalova, H; Syslova, K; Kacer, P; Vondrousova, J; Tyls, F; Fujakova, M; Palenicek, T; Horacek, J				Kubesova, Anna; Tejkalova, Hana; Syslova, Kamila; Kacer, Petr; Vondrousova, Jana; Tyls, Filip; Fujakova, Michaela; Palenicek, Tomas; Horacek, Jiri			Biochemical, Histopathological and Morphological Profiling of a Rat Model of Early Immune Stimulation: Relation to Psychopathology	PLOS ONE			English	Article							POSTTRAUMATIC-STRESS-DISORDER; GAMMA-AMINOBUTYRIC-ACID; NEONATAL EXPOSURE; MICROGLIAL ACTIVATION; PLASMA TRYPTOPHAN; QUINOLINIC ACID; LATER-LIFE; BRAIN; LIPOPOLYSACCHARIDE; SCHIZOPHRENIA	Perinatal immune challenge leads to neurodevelopmental dysfunction, permanent immune dysregulation and abnormal behaviour, which have been shown to have translational validity to findings in human neuropsychiatric disorders (e.g. schizophrenia, mood and anxiety disorders, autism, Parkinson's disease and Alzheimer's disease). The aim of this animal study was to elucidate the influence of early immune stimulation triggered by systemic postnatal lipopolysaccharide administration on biochemical, histopathological and morphological measures, which may be relevant to the neurobiology of human psychopathology. In the present study of adult male Wistar rats we examined the brain and plasma levels of monoamines (dopamine, serotonin), their metabolites, the levels of the main excitatory and inhibitory neurotransmitters glutamate and Y-aminobutyric acid and the levels of tryptophan and its metabolites from the kynurenine catabolic pathway. Further, we focused on histopathological and morphological markers related to pathogenesis of brain diseases - glial cell activation, neurodegeneration, hippocampal volume reduction and dopaminergic synthesis in the substantia nigra. Our results show that early immune stimulation in adult animals alters the levels of neurotransmitters and their metabolites, activates the kynurenine pathway of tryptophan metabolism and leads to astrogliosis, hippocampal volume reduction and a decrease of tyrosine hydroxylase immunoreactivity in the substantia nigra. These findings support the crucial pathophysiological role of early immune stimulation in the above mentioned neuropsychiatric disorders.	[Kubesova, Anna; Tejkalova, Hana; Tyls, Filip; Fujakova, Michaela; Palenicek, Tomas; Horacek, Jiri] Prague Psychiat Ctr, Prague, Czech Republic; [Kubesova, Anna; Tejkalova, Hana; Tyls, Filip; Fujakova, Michaela; Palenicek, Tomas; Horacek, Jiri] Natl Inst Mental Hlth, Klecany, Czech Republic; [Kubesova, Anna; Tyls, Filip; Fujakova, Michaela; Palenicek, Tomas; Horacek, Jiri] Charles Univ Prague, Fac Med 3, Prague, Czech Republic; [Syslova, Kamila; Kacer, Petr; Vondrousova, Jana] Inst Chem Technol, CR-16628 Prague, Czech Republic	National Institute of Mental Health - Czech Republic; Charles University Prague; University of Chemistry & Technology, Prague	Kubesova, A (corresponding author), Prague Psychiat Ctr, Prague, Czech Republic.	kubesova@pcp.lf3.cuni.cz	Horacek, Jiri/X-6851-2018; Kacer, Petr/AAW-2355-2021; Horacek, Jiri/M-7054-2019; Palenicek, Tomas/AAA-2549-2021; Tyls, Filip/C-4542-2018	Horacek, Jiri/0000-0003-0114-7306; Horacek, Jiri/0000-0003-0114-7306; Palenicek, Tomas/0000-0002-3109-9539; Tyls, Filip/0000-0002-8337-6999; Kacer, Petr/0000-0002-5905-3516	Ministry of Health of the Czech Republic - Internal Grant Agency, Development of Research Organization (PCP) [NT13843, 00023752]; Charles University in Prague - Specific Academic Research, Charles University Research Development Schemes [260045/SVV/2014, PRVOUK P34]; Ministry of Education, Youth and Sports of the Czech Republic - National Programme of Sustainability (NPU I (LO)	Ministry of Health of the Czech Republic - Internal Grant Agency, Development of Research Organization (PCP); Charles University in Prague - Specific Academic Research, Charles University Research Development Schemes; Ministry of Education, Youth and Sports of the Czech Republic - National Programme of Sustainability (NPU I (LO)	The study was supported by The Ministry of Health of the Czech Republic (www.mzcr.cz) - Internal Grant Agency (NT13843), Development of Research Organization (PCP, 00023752); Charles University in Prague (www.cuni.cz) - Specific Academic Research (260045/SVV/2014), Charles University Research Development Schemes (PRVOUK P34); The Ministry of Education, Youth and Sports of the Czech Republic (www.msmt.cz) - The National Programme of Sustainability (NPU I (LO)	Almeida-Montes LG, 2000, J PSYCHIATR NEUROSCI, V25, P371; Bell C, 2001, BRIT J PSYCHIAT, V178, P399, DOI 10.1192/bjp.178.5.399; Bilbo SD, 2009, FRONT BEHAV NEUROSCI, V3, DOI 10.3389/neuro.08.014.2009; Bohmer C, 2005, BIOCHEM J, V389, P745; Brambilla Paolo, 2008, Curr Psychiatry Rep, V10, P505; Bremner JD, 2000, AM J PSYCHIAT, V157, P115, DOI 10.1176/ajp.157.1.115; Brisch R, 2014, FRONT PSYCHIATRY, V5, DOI 10.3389/fpsyt.2014.00047; Bsibsi M, 2006, GLIA, V53, P688, DOI 10.1002/glia.20328; Cai ZW, 2013, DEV NEUROSCI-BASEL, V35, P155, DOI 10.1159/000346156; Campbell BM, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00012; Carson MJ, 2006, CLIN NEUROSCI RES, V6, P237, DOI 10.1016/j.cnr.2006.09.004; Catts VS, 2014, AUST NZ J PSYCHIAT, V48, P722, DOI 10.1177/0004867414531078; Chung DW, 2010, CELL MOL NEUROBIOL, V30, P531, DOI 10.1007/s10571-009-9477-0; Craig A, 2003, EXP NEUROL, V181, P231, DOI 10.1016/S0014-4886(03)00032-3; Dong YS, 2001, GLIA, V36, P180, DOI 10.1002/glia.1107; Doosti MH, 2013, PROG NEURO-PSYCHOPH, V43, P55, DOI 10.1016/j.pnpbp.2012.12.003; Fan LW, 2011, NEUROBIOL DIS, V44, P304, DOI 10.1016/j.nbd.2011.07.011; Fan LW, 2011, BRAIN BEHAV IMMUN, V25, P286, DOI 10.1016/j.bbi.2010.09.020; Feleder C, 2010, BIOL PSYCHIAT, V67, P386, DOI 10.1016/j.biopsych.2009.09.028; FORNO LS, 1992, PROG BRAIN RES, V94, P429; Gauthier C, 2014, PSYCHONEUROENDOCRINO, V39, P170, DOI 10.1016/j.psyneuen.2013.09.009; Guillemin GJ, 2012, FEBS J, V279, P1356, DOI 10.1111/j.1742-4658.2012.08485.x; Gulyas B, 2011, NEUROCHEM INT, V58, P60, DOI 10.1016/j.neuint.2010.10.013; Haukvik Unn Kristin, 2013, Tidsskr Nor Laegeforen, V133, P850, DOI 10.4045/tidsskr.12.1084; Huang F, 2014, J NEUROSCI METH, V229, P8, DOI 10.1016/j.jneumeth.2014.04.004; ISSA F, 1994, PSYCHIAT RES, V52, P237, DOI 10.1016/0165-1781(94)90069-8; Jack CS, 2005, J IMMUNOL, V175, P4320, DOI 10.4049/jimmunol.175.7.4320; Kettenmann H, 2011, PHYSIOL REV, V91, P461, DOI 10.1152/physrev.00011.2010; Kirsten TB, 2012, J NEUROSCI RES, V90, P1903, DOI 10.1002/jnr.23089; Krystal JH, 2002, MOL PSYCHIATR, V7, pS71, DOI 10.1038/sj.mp.4001021; Laakso MP, 1996, NEUROLOGY, V46, P678, DOI 10.1212/WNL.46.3.678; Lee M, 2011, PSYCHIAT RES, V185, P328, DOI 10.1016/j.psychres.2010.07.013; Lehnardt S, 2002, J NEUROSCI, V22, P2478, DOI 10.1523/JNEUROSCI.22-07-02478.2002; Linderholm KR, 2012, SCHIZOPHRENIA BULL, V38, P426, DOI 10.1093/schbul/sbq086; Maes M, 2011, PROG NEURO-PSYCHOPH, V35, P702, DOI 10.1016/j.pnpbp.2010.12.017; Meyer-Franke A, 1999, MOL CELL NEUROSCI, V14, P385, DOI 10.1006/mcne.1999.0788; Meyerhoff DJ, 2014, SLEEP, V37, P893, DOI 10.5665/sleep.3654; Miller CL, 2008, NEUROCHEM INT, V52, P1297, DOI 10.1016/j.neuint.2008.01.013; Molofsky AV, 2012, GENE DEV, V26, P891, DOI 10.1101/gad.188326.112; Najmanova V, 2011, CHROMATOGRAPHIA, V73, pS143, DOI 10.1007/s10337-011-1959-9; Okada Kazumasa, 2005, Journal of UOEH, V27, P161; Ong LK, 2012, NEUROCHEM RES, V37, P1938, DOI 10.1007/s11064-012-0812-3; Ortinski PI, 2010, NAT NEUROSCI, V13, P584, DOI 10.1038/nn.2535; Pang Y, 2003, DEV BRAIN RES, V140, P205, DOI 10.1016/S0165-3806(02)00606-5; Patro N, 2013, INDIAN J EXP BIOL, V51, P606; PAXINOS G, 2007, RAT BRAIN STREREOTAC; Pollack MH, 2008, PROG NEURO-PSYCHOPH, V32, P739, DOI 10.1016/j.pnpbp.2007.11.023; Potvin S, 2008, BIOL PSYCHIAT, V63, P801, DOI 10.1016/j.biopsych.2007.09.024; PRATT OE, 1979, J NEURAL TRANSM S, V29; Quaak I, 2013, INT J ENV RES PUB HE, V10, P3384, DOI 10.3390/ijerph10083384; Rajkowska G, 2013, CURR DRUG TARGETS, V14, P1225; Ratnayake U, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00180; Ravikumar A, 2000, NEUROL INDIA, V48, P231; Rolls A, 2007, NAT CELL BIOL, V9, P1081, DOI 10.1038/ncb1629; Schmitt A, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00019; Schwarcz R, 2001, BIOL PSYCHIAT, V50, P521, DOI 10.1016/S0006-3223(01)01078-2; SHANKS N, 1995, J NEUROSCI, V15, P376, DOI 10.1523/jneurosci.15-01-00376.1995; Shanks N, 2000, P NATL ACAD SCI USA, V97, P5645, DOI 10.1073/pnas.090571897; Smith PLP, 2014, DEV NEUROSCI-BASEL, V36, P119, DOI 10.1159/000359950; Sominsky L, 2012, BEHAV BRAIN RES, V226, P351, DOI 10.1016/j.bbr.2011.08.038; Sominsky L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057700; Spencer SJ, 2011, AM J PHYSIOL-ENDOC M, V300, pE11, DOI 10.1152/ajpendo.00516.2010; St'astny F, 2000, BRAIN RES BULL, V53, P415, DOI 10.1016/S0361-9230(00)00368-3; Stone TW, 2012, FEBS J, V279, P1386, DOI 10.1111/j.1742-4658.2012.08487.x; Stone TW, 2002, NAT REV DRUG DISCOV, V1, P609, DOI 10.1038/nrd870; TEJKALOVA H, 2010, PSYCHIATRIE, V14, P19; TEJKALOVA H, 2008, PSYCHIATRIE, V12, P68; Tejkalova H., 2007, PSYCHIATRIE, V11, P12; Terrazzino S, 2002, J NEUROIMMUNOL, V124, P45, DOI 10.1016/S0165-5728(02)00013-9; VANBEMMELEN FJ, 1985, J NEUROCHEM, V45, P1471; Vargas DL, 2005, ANN NEUROL, V57, P67, DOI 10.1002/ana.20315; Wang KC, 2013, NEUROSCIENCE, V234, P146, DOI 10.1016/j.neuroscience.2012.12.049; Wang XY, 2006, SEMIN FETAL NEONAT M, V11, P343, DOI 10.1016/j.siny.2006.04.002; WHITE HL, 1981, MOL CELL BIOCHEM, V39, P253, DOI 10.1007/BF00232578; WISNIEWSKI HM, 1991, NEUROBIOL AGING, V12, P593, DOI 10.1016/0197-4580(91)90091-W; Woon FL, 2010, PROG NEURO-PSYCHOPH, V34, P1181, DOI 10.1016/j.pnpbp.2010.06.016; Zhu FR, 2014, BRAIN BEHAV IMMUN, V38, P166, DOI 10.1016/j.bbi.2014.01.017	77	20	21	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2015	10	1							e0115439	10.1371/journal.pone.0115439	http://dx.doi.org/10.1371/journal.pone.0115439			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ4OZ	25602957	gold, Green Published, Green Submitted			2022-12-27	WOS:000348203500014
J	Jones, SP; Dwyer, DM; Lewis, MB				Jones, Scott P.; Dwyer, Dominic M.; Lewis, Michael B.			Learning Faces: Similar Comparator Faces Do Not Improve Performance	PLOS ONE			English	Article							RECOGNITION MEMORY; UNFAMILIAR FACES; UNIFIED ACCOUNT; FLAVOR AVERSION; PERCEPTION; FAMILIAR; RACE; DISTINCTIVENESS; INHIBITION; INVERSION	Recent evidence indicates that comparison of two similar faces can aid subsequent discrimination between them. However, the fact that discrimination between two faces is facilitated by comparing them directly does not demonstrate that comparison produces a general improvement in the processing of faces. It remains an open question whether the opportunity to compare a "target" face to similar faces can facilitate the discrimination of the exposed target face from other nonexposed faces. In Experiment 1, selection of a target face from an array of novel foils was not facilitated by intermixed exposure to the target and comparators of the same sex. Experiment 2 also found no advantage for similar comparators (morphed towards the target) over unmorphed same sex comparators, or over repeated target exposure alone. But all repeated exposure conditions produced better performance than a single brief presentation of the target. Experiment 3 again demonstrated that repeated exposure produced equivalent learning in same sex and different sex comparator conditions, and also showed that increasing the number of same sex or different sex comparators failed to improve identification. In all three experiments, exposure to a target alongside similar comparators failed to support selection of the target from novel test stimuli to a greater degree than exposure alongside dissimilar comparators or repeated target exposure alone. The current results suggest that the facilitatory effects of comparison during exposure may be limited to improving discrimination between exposed stimuli, and thus our results do not support the idea that providing the opportunity for comparison is a practical means for improving face identification.	[Jones, Scott P.] Anglia Ruskin Univ, Dept Psychol, Cambridge, England; [Dwyer, Dominic M.; Lewis, Michael B.] Cardiff Univ, Sch Psychol, Cardiff CF10 3AX, S Glam, Wales; [Dwyer, Dominic M.] Univ New S Wales, Sch Psychol, Sydney, NSW, Australia	Anglia Ruskin University; Cardiff University; University of New South Wales Sydney	Jones, SP (corresponding author), Anglia Ruskin Univ, Dept Psychol, Cambridge, England.	scott.jones@anglia.ac.uk	Dwyer, Dominic Michael/D-1498-2009; Lewis, Michael/D-1488-2009	Dwyer, Dominic Michael/0000-0001-8069-5508; Lewis, Michael/0000-0002-5735-5318; Jones, Scott/0000-0001-5516-4385	School of Psychology, Cardiff University [EP/P504864/1]; EPSRC [EP/P504864/1]	School of Psychology, Cardiff University; EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This research was funded by a PhD studentship awarded to SJ. This was jointly funded by the School of Psychology, Cardiff University, and the EPSRC Doctoral Training Grant (EP/P504864/1) awarded to Cardiff University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAHRICK HP, 1975, J EXP PSYCHOL GEN, V104, P54, DOI 10.1037/0096-3445.104.1.54; BIEDERMAN I, 1987, J EXP PSYCHOL LEARN, V13, P640, DOI 10.1037/0278-7393.13.4.640; Bindemann M, 2011, PERCEPTION, V40, P625, DOI 10.1068/p7008; Blair CAJ, 2003, J EXP PSYCHOL-ANIM B, V29, P39, DOI 10.1037//0097-7403.29.1.39; Blanz V, 1999, MORPHABLE MODEL SYNT, P178; Bonner L, 2003, VIS COGN, V10, P527, DOI 10.1080/13506280244000168; Brogden WJ, 1939, J EXP PSYCHOL, V25, P323, DOI 10.1037/h0058944; Bruce V, 1999, J EXP PSYCHOL-APPL, V5, P339, DOI 10.1037/1076-898X.5.4.339; BRUCE V, 1982, BRIT J PSYCHOL, V73, P105, DOI 10.1111/j.2044-8295.1982.tb01795.x; Burton AM, 1999, PSYCHOL SCI, V10, P243, DOI 10.1111/1467-9280.00144; Buttle H, 2003, PERCEPT PSYCHOPHYS, V65, P1296, DOI 10.3758/BF03194853; Clutterbuck R, 2005, EUR J COGN PSYCHOL, V17, P97, DOI 10.1080/09541440340000439; Cohen J.E., 1988, STAT POWER ANAL BEHA; Dwyer DM, 2009, VIS COGN, V17, P334, DOI 10.1080/13506280701757577; Dwyer DM, 2011, J EXP PSYCHOL ANIM B, V37, P300, DOI 10.1037/a0023078; Dwyer DM, 2009, Q J EXP PSYCHOL, V62, P2055, DOI 10.1080/17470210802661736; ELLIS HD, 1979, PERCEPTION, V8, P431, DOI 10.1068/p080431; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; FLEISHMAN JJ, 1976, PERCEPT MOTOR SKILL, V43, P709, DOI 10.2466/pms.1976.43.3.709; GIBSON EJ, 1963, ANNU REV PSYCHOL, V14, P29, DOI 10.1146/annurev.ps.14.020163.000333; Gibson Eleanor Jack, 1969, PRINCIPLES PERCEPTUA; Hall G, 2003, J EXP PSYCHOL GEN, V132, P266, DOI 10.1037/0096-3445.132.2.266; Hancock PJB, 2000, TRENDS COGN SCI, V4, P330, DOI 10.1016/S1364-6613(00)01519-9; Hancock PJB, 1996, MEM COGNITION, V24, P26, DOI 10.3758/BF03197270; Hill H, 1997, COGNITION, V62, P201, DOI 10.1016/S0010-0277(96)00785-8; Hill H, 1996, J EXP PSYCHOL HUMAN, V22, P986, DOI 10.1037/0096-1523.22.4.986; HONEY RC, 1994, Q J EXP PSYCHOL-B, V47, P83; Jeffreys H., 1961, THEORY PROBABILITY; Johnston RA, 2009, MEMORY, V17, P577, DOI 10.1080/09658210902976969; Kemp R, 1997, APPL COGNITIVE PSYCH, V11, P211; Kemp R, 1996, PERCEPTION, V25, P37, DOI 10.1068/p250037; Lewis MB, 2004, VIS COGN, V11, P29, DOI 10.1080/13506280344000194; LIGHT LL, 1979, J EXP PSYCHOL-HUM L, V5, P212, DOI 10.1037/0278-7393.5.3.212; LOGIE RH, 1987, APPL COGNITIVE PSYCH, V1, P53, DOI 10.1002/acp.2350010108; Longmore CA, 2008, J EXP PSYCHOL HUMAN, V34, P77, DOI 10.1037/0096-1523.34.1.77; McLaren IPL, 2002, ANIM LEARN BEHAV, V30, P177, DOI 10.3758/BF03192828; Minear M, 2004, BEHAV RES METH INS C, V36, P630, DOI 10.3758/BF03206543; Mitchell C, 2008, J EXP PSYCHOL-ANIM B, V34, P475, DOI 10.1037/0097-7403.34.4.475; Mundy ME, 2007, J EXP PSYCHOL ANIM B, V33, P124, DOI 10.1037/0097-7403.33.2.124; Mundy ME, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101011; Mundy ME, 2009, NEUROREPORT, V20, P1397, DOI 10.1097/WNR.0b013e32832f81f4; Mundy ME, 2006, J EXP PSYCHOL ANIM B, V32, P178, DOI 10.1037/0097-7403.32.2.178; O'Donnell C, 2001, PERCEPTION, V30, P755, DOI 10.1068/p3027; OTOOLE AJ, 1994, MEM COGNITION, V22, P208, DOI 10.3758/BF03208892; PATTERSON KE, 1977, J EXP PSYCHOL-HUM L, V3, P406, DOI 10.1037/0278-7393.3.4.406; Robbins R, 2003, COGNITION, V88, P79, DOI 10.1016/S0010-0277(03)00020-9; Rouder JN, 2009, PSYCHON B REV, V16, P225, DOI 10.3758/PBR.16.2.225; SHAPIRO PN, 1986, PSYCHOL BULL, V100, P139, DOI 10.1037/0033-2909.100.2.139; Solomon GEA, 1997, J LEARN SCI, V6, P41, DOI 10.1207/s15327809jls0601_3; Sowden PT, 2000, J EXP PSYCHOL HUMAN, V26, P379, DOI 10.1037/0096-1523.26.1.379; Stevenage SV, 1998, BRIT J PSYCHOL, V89, P39, DOI 10.1111/j.2044-8295.1998.tb02672.x; SYMONDS M, 1995, LEARN MOTIV, V26, P203, DOI 10.1016/0023-9690(95)90005-5; VALENTINE T, 1986, ACTA PSYCHOL, V61, P259, DOI 10.1016/0001-6918(86)90085-5; VALENTINE T, 1991, Q J EXP PSYCHOL-A, V43, P161, DOI 10.1080/14640749108400966; Vetter T, 1997, IEEE T PATTERN ANAL, V19, P733, DOI 10.1109/34.598230; White D, 2014, PSYCHON B REV, V21, P100, DOI 10.3758/s13423-013-0475-3; YOUNG AW, 1985, BRIT J PSYCHOL, V76, P495, DOI 10.1111/j.2044-8295.1985.tb01972.x; Yu T, 2014, HUM BRAIN MAPP, V35, P1297, DOI 10.1002/hbm.22253	58	3	3	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2015	10	1							e0116707	10.1371/journal.pone.0116707	http://dx.doi.org/10.1371/journal.pone.0116707			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CC9HN	25590574	Green Accepted, gold, Green Published, Green Submitted			2022-12-27	WOS:000350679400021
J	Bolton, L; Reiman, A; Lucas, K; Timms, J; Cree, IA				Bolton, Louise; Reiman, Anne; Lucas, Katie; Timms, Judith; Cree, Ian A.			KRAS Mutation Analysis by PCR: A Comparison of Two Methods	PLOS ONE			English	Article							METASTATIC COLORECTAL-CANCER; PARAFFIN-EMBEDDED SAMPLES; BRAF MUTATIONS; CETUXIMAB; DNA; SPECIMENS; PATHOLOGY; BIOMARKER; CONSENSUS; THERAPY	Background KRAS mutation assays are important companion diagnostic tests to guide anti-EGFR antibody treatment of metastatic colorectal cancer. Direct comparison of newer diagnostic methods with existing methods is an important part of validation of any new technique. In this this study, we have compared the Therascreen (Qiagen) ARMS assay with Competitive Allele-Specific TaqMan PCR (castPCR, Life Technologies) to determine equivalence for KRAS mutation analysis. Methods DNA was extracted by Maxwell (Promega) from 99 colorectal cancers. The ARMS-based Therascreen and a customized castPCR assay were performed according to the manufacturer's instructions. All assays were performed on either an Applied Biosystems 7500 Fast Dx or a ViiA7 real-time PCR machine (both from Life Technologies). The data were collected and discrepant results re-tested with newly extracted DNA from the same blocks in both assay types. Results Of the 99 tumors included, Therascreen showed 62 tumors to be wild-type (WT) for KRAS, while 37 had KRAS mutations on initial testing. CastPCR showed 61 tumors to be wild-type (WT) for KRAS, while 38 had KRAS mutations. Thirteen tumors showed BRAF mutation in castPCR and in one of these there was also a KRAS mutation. The custom castPCR plate included several other KRAS mutations and BRAF V600E, not included in Therascreen, explaining the higher number of mutations detected by castPCR. Re-testing of discrepant results was required in three tumors, all of which then achieved concordance for KRAS. CastPCR assay Ct values were on average 2 cycles lower than Therascreen. Conclusion There was excellent correlation between the two methods. Although castPCR assay shows lower Ct values than Therascreen, this is unlikely to be clinically significant.	[Bolton, Louise] Queen Alexandra Hosp, Dept Pathol, Portsmouth, Hants, England; [Reiman, Anne; Lucas, Katie; Timms, Judith; Cree, Ian A.] Univ Hosp Coventry, Dept Pathol, Coventry, W Midlands, England; [Reiman, Anne; Lucas, Katie; Timms, Judith; Cree, Ian A.] Univ Hosp Coventry, Warwick Med Sch, Coventry, W Midlands, England; [Reiman, Anne; Lucas, Katie; Timms, Judith; Cree, Ian A.] Univ Hosp Warwickshire, Dept Pathol, Coventry, W Midlands, England; [Reiman, Anne; Lucas, Katie; Timms, Judith; Cree, Ian A.] Univ Hosp Warwickshire, Warwick Med Sch, Coventry, W Midlands, England	Portsmouth Hospitals NHS Trust; Queen Alexandra Hospital; University of Warwick; University of Warwick; University of Warwick; University of Warwick	Cree, IA (corresponding author), Univ Hosp Coventry, Dept Pathol, Coventry, W Midlands, England.	i.a.cree@warwick.ac.uk			Merck Serono	Merck Serono(Merck & Company)	The authors are grateful to Life Technologies Ltd for their assistance and to Merck Serono for funding the testing of colorectal cancer for KRAS mutations in both Portsmouth and Coventry. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams JA, 2014, APPL IMMUNOHISTO M M, V22, P231, DOI 10.1097/PDM.0b013e3182a127f9; Ahlquist DA, 2012, GASTROENTEROLOGY, V142, P248, DOI 10.1053/j.gastro.2011.10.031; Altimari A, 2013, ONCOTARGETS THER, V6, P1057, DOI 10.2147/OTT.S42369; Andreyev HJN, 1998, J NATL CANCER I, V90, P675, DOI 10.1093/jnci/90.9.675; Arends MJ, 2013, APPL IMMUNOHISTO M M, V21, P97, DOI 10.1097/PAI.0b013e31827ea79e; Aubin F, 2011, CURR ONCOL, V18, pE180; Cavallini A, 2010, ANTICANCER RES, V30, P5251; Chang SC, 2013, CLIN COLORECTAL CANC, V12, P195, DOI 10.1016/j.clcc.2013.05.001; Crowley E, 2013, NAT REV CLIN ONCOL, V10, P472, DOI 10.1038/nrclinonc.2013.110; de Castro DG, 2012, BRIT J CANCER, V107, P345, DOI 10.1038/bjc.2012.259; De Roock W, 2010, JAMA-J AM MED ASSOC, V304, P1812, DOI 10.1001/jama.2010.1535; De Roock W, 2010, LANCET ONCOL, V11, P753, DOI 10.1016/S1470-2045(10)70130-3; Di Nicolantonio F, 2008, J CLIN ONCOL, V26, P5705, DOI 10.1200/JCO.2008.18.0786; Didelot A, 2012, EXP MOL PATHOL, V92, P275, DOI 10.1016/j.yexmp.2012.03.001; Diehl F, 2008, GASTROENTEROLOGY, V135, P489, DOI 10.1053/j.gastro.2008.05.039; Edkins S, 2006, CANCER BIOL THER, V5, P928, DOI 10.4161/cbt.5.8.3251; Evaluation of Genomic Applications in P Prevention Working G, 2013, GENET MED, V15, P517, DOI [10.1038/gim.2012.184, DOI 10.1038/GIM.2012.184]; Garcia-Alfonso P, 2012, CLIN TRANSL ONCOL, V14, P726, DOI 10.1007/s12094-012-0856-5; Gasch C, 2013, CLIN CHEM, V59, P252, DOI 10.1373/clinchem.2012.188557; Jancik S, 2012, J EXP CLIN CANC RES, V31, DOI 10.1186/1756-9966-31-79; Kinzler KW, 1996, CELL, V87, P159, DOI 10.1016/S0092-8674(00)81333-1; Krol LC, 2012, EUR J CANCER, V48, P1108, DOI 10.1016/j.ejca.2012.02.054; Lievre A, 2006, CANCER RES, V66, P3992, DOI 10.1158/0008-5472.CAN-06-0191; Loupakis F, 2009, BRIT J CANCER, V101, P715, DOI 10.1038/sj.bjc.6605177; Macedo MP, 2011, INT J COLORECTAL DIS, V26, P1241, DOI 10.1007/s00384-011-1238-0; Mead R, 2011, BRIT J CANCER, V105, P239, DOI 10.1038/bjc.2011.230; NEWTON CR, 1989, NUCLEIC ACIDS RES, V17, P2503, DOI 10.1093/nar/17.7.2503; Pritchard CC, 2011, GUT, V60, P116, DOI 10.1136/gut.2009.206250; Sartore-Bianchi A, 2009, CANCER RES, V69, P1851, DOI 10.1158/0008-5472.CAN-08-2466; Sundstrom M, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-660; Thelwell N, 2000, NUCLEIC ACIDS RES, V28, P3752, DOI 10.1093/nar/28.19.3752; Therkildsen C, 2014, ACTA ONCOL, V53, P852, DOI 10.3109/0284186X.2014.895036; Tsiatis AC, 2010, J MOL DIAGN, V12, P425, DOI 10.2353/jmoldx.2010.090188; van Krieken JH, 2013, VIRCHOWS ARCH, V462, P27, DOI 10.1007/s00428-012-1354-4; VOGELSTEIN B, 1988, NEW ENGL J MED, V319, P525, DOI 10.1056/NEJM198809013190901; Whitcombe D, 1999, NAT BIOTECHNOL, V17, P804, DOI 10.1038/11751; Woo J, 2013, CANCER-AM CANCER SOC, V119, P1941, DOI 10.1002/cncr.27994; Young EC, 2013, DIAGN MOL PATHOL, V22, P190, DOI 10.1097/PDM.0b013e318294936c	38	16	16	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2015	10	1							e0115672	10.1371/journal.pone.0115672	http://dx.doi.org/10.1371/journal.pone.0115672			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ4BT	25568935	Green Submitted, Green Published, gold			2022-12-27	WOS:000348168000003
J	Li, Y; Li, Y; Meng, L; Zheng, LS				Li, Ying; Li, Yue; Meng, Lu; Zheng, LianShun			Association between Serum C-Peptide as a Risk Factor for Cardiovascular Disease and High-Density Lipoprotein Cholesterol Levels in Nondiabetic Individuals	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; OXIDATIVE STRESS; INSULIN-RESISTANCE; METABOLIC SYNDROME; NEUROPATHY; CORONARY; CHEMOTAXIS; ADULTS; HEART	Objective: Objective: Although serum C-peptide has increasingly received attention as a new and important risk factor for cardiovascular disease (CVD), the potential mechanisms remain unclear. This study aimed to investigate the association between serum C-peptide as a risk factor for CVD and high-density lipoprotein cholesterol (HDL-C) levels. Methods: The present study included 13,185 participants aged >= 20 years. Serum C-peptide and HDL-C levels were measured according to a standard protocol. Stratified analysis of covariance was used to compare serum HDL-C levels between different quartiles of serum C-peptide levels. Logistic regression analysis was used to determine the association between serum C-peptide and HDL-C levels. Cox proportional hazard regression analysis was conducted to determine the hazard ratio of serum HDL-C for CVD-related mortality. Results: The results of the ANCOVA analysis showed a significant linear trend between the mean serum HDL-C level and the different quartiles of serum C-peptide. Compared to the first quartile (25th percentile), the second, third, and fourth quartiles had gradual reduction in serum HDL-C levels. Logistic regression analyses showed a strong negative association between serum C-peptide levels and HDL-C levels; the p value for the linear trend was <0.001. In men, compared with the lowest quartile of the serum C-peptide level, the relative risk was 1.75, 2.79, and 3.07 for the upper three quartiles of the serum C-peptide level. The relative risk was 1.60, 2.61, and 3.67 for women. The results of the survival analysis showed that serum HDL-C levels were negatively associated with CVD-related death in both men and women. Conclusion: Serum C-peptide as a risk factor for CVD was significantly and negatively associated with serum HDL-C levels in individuals without diabetes. These findings suggest that serum C-peptide levels association with CVD death can be caused, at least in part, by the low serum HDL-C level.	[Li, Ying; Meng, Lu] Zhejiang Univ, Sch Publ Hlth, Dept Social Med, Hangzhou, Zhejiang, Peoples R China; [Li, Yue; Zheng, LianShun] Zhejiang Univ, Sch Basic Med Sci, Hangzhou, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University	Li, Y (corresponding author), Zhejiang Univ, Sch Publ Hlth, Dept Social Med, Hangzhou, Zhejiang, Peoples R China.	ying_li@zju.edu.cn; zhenglianshun@zju.edu.cn			National Science Foundation of China (NSFC) [61375049]; Zhejiang Provincial Natural Science Foundation of China [Y14H260013]	National Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province)	This work was supported in part by National Science Foundation of China (NSFC 61375049), and in part by Zhejiang Provincial Natural Science Foundation of China (Y14H260013). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1988, LAB PROCEDURES USED; Baigent C, 2005, LANCET, V366, P1267, DOI 10.1016/S0140-6736(05)67394-1; *CDCP, 1994, VITAL HLTH STAT, V1; Chan WB, 2004, DIABETIC MED, V21, P349, DOI 10.1111/j.1464-5491.2004.01158.x; Chen CH, 1999, INT J CARDIOL, V68, P179, DOI 10.1016/S0167-5273(98)00366-0; Cotter MA, 2003, DIABETES, V52, P1812, DOI 10.2337/diabetes.52.7.1812; Di Angelantonio E, 2009, JAMA-J AM MED ASSOC, V302, P1993, DOI 10.1001/jama.2009.1619; Ekberg K, 2007, DIABETES CARE, V30, P71, DOI 10.2337/dc06-1274; Everson-Rose SA, 2005, ANNU REV PUBL HEALTH, V26, P469, DOI 10.1146/annurev.publhealth.26.021304.144542; Ford ES, 2002, JAMA-J AM MED ASSOC, V287, P356, DOI 10.1001/jama.287.3.356; Genest J, 2008, J AM COLL CARDIOL, V51, P643, DOI 10.1016/j.jacc.2007.10.033; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Heitzer T, 2001, CIRCULATION, V104, P2673, DOI 10.1161/hc4601.099485; Higashi Y, 2002, NEW ENGL J MED, V346, P1954, DOI 10.1056/NEJMoa013591; Johansson BL, 2000, DIABETIC MED, V17, P181, DOI 10.1046/j.1464-5491.2000.00274.x; Kamiya H, 2006, DIABETES, V55, P3581, DOI 10.2337/db06-0396; Li Y, 2014, J STROKE CEREBROVASC, V23, pE163, DOI 10.1016/j.jstrokecerebrovasdis.2013.09.013; Manolio T A, 1992, Ann Epidemiol, V2, P161, DOI 10.1016/1047-2797(92)90051-Q; Marx N, 2004, ARTERIOSCL THROM VAS, V24, P540, DOI 10.1161/01.ATV.0000116027.81513.68; Min JY, 2013, CAN MED ASSOC J, V185, pE402, DOI 10.1503/cmaj.121950; Patel N, 2012, J AM HEART ASSOC, V1, DOI 10.1161/JAHA.112.003152; Ramahi TM, 2010, ASIA-PAC J PUBLIC HE, V22, p83S, DOI 10.1177/1010539510373034; Reaven G, 2005, PANMINERVA MED, V47, P201; Reaven GM, 2011, MED CLIN N AM, V95, P875, DOI 10.1016/j.mcna.2011.06.002; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Shepherd J, 2002, LANCET, V360, P1623, DOI 10.1016/S0140-6736(02)11600-X; Shlipak MG, 2008, AM J MED, V121, P50, DOI 10.1016/j.amjmed.2007.06.030; STAMLER J, 1993, CARDIOLOGY, V82, P191, DOI 10.1159/000175868; Stevens MJ, 2004, AM J PHYSIOL-ENDOC M, V287, pE497, DOI 10.1152/ajpendo.00048.2004; TOFFOLO G, 1995, DIABETES, V44, P845, DOI 10.2337/diabetes.44.7.845; Wahren J, 2007, DIABETOLOGIA, V50, P503, DOI 10.1007/s00125-006-0559-y; Walcher D, 2004, DIABETES, V53, P1664, DOI 10.2337/diabetes.53.7.1664; Wallerath T, 2003, NITRIC OXIDE-BIOL CH, V9, P95, DOI 10.1016/j.niox.2003.08.004; Williams RB, 2008, ANNU REV CLIN PSYCHO, V4, P349, DOI 10.1146/annurev.clinpsy.4.022007.141237; Yusuf S, 2001, CIRCULATION, V104, P2746, DOI 10.1161/hc4601.099487	35	10	11	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2015	10	1							e112281	10.1371/journal.pone.0112281	http://dx.doi.org/10.1371/journal.pone.0112281			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ3BG	25559358	Green Submitted, Green Published, gold			2022-12-27	WOS:000348102200004
J	Chen, YH; Robinson, EJH				Chen, Yi-Huei; Robinson, Elva J. H.			The Relationship between Canopy Cover and Colony Size of the Wood Ant Formica lugubris - Implications for the Thermal Effects on a Keystone Ant Species	PLOS ONE			English	Article							HYMENOPTERA-FORMICIDAE; FIRE ANT; FORAGING BEHAVIOR; POGONOMYRMEX-BADIUS; SOLENOPSIS-INVICTA; HARVESTER ANT; NEST MOUNDS; BODY-SIZE; CLIMATE; TEMPERATURE	Climate change may affect ecosystems and biodiversity through the impacts of rising temperature on species' body size. In terms of physiology and genetics, the colony is the unit of selection for ants so colony size can be considered the body size of a colony. For polydomous ant species, a colony is spread across several nests. This study aims to clarify how climate change may influence an ecologically significant ant species group by investigating thermal effects on wood ant colony size. The strong link between canopy cover and the local temperatures of wood ant's nesting location provides a feasible approach for our study. Our results showed that nests were larger in shadier areas where the thermal environment was colder and more stable compared to open areas. Colonies (sum of nests in a polydomous colony) also tended to be larger in shadier areas than in open areas. In addition to temperature, our results supported that food resource availability may be an additional factor mediating the relationship between canopy cover and nest size. The effects of canopy cover on total colony size may act at the nest level because of the positive relationship between total colony size and mean nest size, rather than at the colony level due to lack of link between canopy cover and number of nests per colony. Causal relationships between the environment and the life-history characteristics may suggest possible future impacts of climate change on these species.	[Chen, Yi-Huei; Robinson, Elva J. H.] Univ York, Dept Biol, York Ctr Complex Syst Anal, York YO10 5DD, N Yorkshire, England	University of York - UK	Chen, YH (corresponding author), Univ York, Dept Biol, York Ctr Complex Syst Anal, Wentworth Way, York YO10 5DD, N Yorkshire, England.	dennisyhchen@gmail.com	Robinson, Elva J H/AAC-9785-2019	Robinson, Elva/0000-0003-4914-9327	Studying Abroad Scholarship, Ministry of Education, Taiwan [SAS-100-1-16-1-UK-042]; Department of Biology at the University of York	Studying Abroad Scholarship, Ministry of Education, Taiwan; Department of Biology at the University of York	Funding was provided by the Studying Abroad Scholarship, Ministry of Education, Taiwan (SAS-100-1-16-1-UK-042) to YHC. Publication of this article was funded by the Department of Biology at the University of York. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACIA, 2004, IMPACTS WARMING ARCT; Andrew NR, 2013, J INSECT PHYSIOL, V59, P870, DOI 10.1016/j.jinsphys.2013.06.003; Asano E, 2012, J THEOR BIOL, V305, P70, DOI 10.1016/j.jtbi.2012.03.011; ATKINSON D, 1994, ADV ECOL RES, V25, P1, DOI 10.1016/s0065-2504(08)60212-3; Bernasconi C, 2005, ANN ZOOL FENN, V42, P189; Bernasconi C, 2011, MYRMECOL NEWS, V14, P37; Bertelsmeier C, 2013, CONSERV BIOL, V27, P1458, DOI 10.1111/cobi.12093; Bertelsmeier C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075438; Blanckenhorn WU, 2004, INTEGR COMP BIOL, V44, P413, DOI 10.1093/icb/44.6.413; BRANDT DC, 1980, NETH J ZOOL, V30, P326, DOI 10.1163/002829679X00449; Brown J. H., 1998, BIOGEOGRAPHY; Chen YH, 2013, INSECT SOC, V60, P351, DOI 10.1007/s00040-013-0300-z; Chen YH, 2008, INTEGR ZOOL, V3, P166, DOI 10.1111/j.1749-4877.2008.00095.x; COENENSTASS D, 1980, ECOLOGY, V61, P238, DOI 10.2307/1935180; Cotti G., 1996, Insect Social Life, V1, P133; Debout G, 2007, BIOL J LINN SOC, V90, P319, DOI 10.1111/j.1095-8312.2007.00728.x; Diamond SE, 2013, INTEGR COMP BIOL, V53, P965, DOI 10.1093/icb/ict085; Diamond SE, 2012, GLOBAL CHANGE BIOL, V18, P448, DOI 10.1111/j.1365-2486.2011.02542.x; Domisch T, 2008, BIOL FERT SOILS, V44, P539, DOI 10.1007/s00374-007-0248-0; ECKERT CD, 1994, OECOLOGIA, V97, P248, DOI 10.1007/BF00323157; Eeva T, 2004, ENVIRON POLLUT, V132, P533, DOI 10.1016/j.envpol.2004.05.004; Ellis S, 2014, INSECT SOC, V61, P111, DOI 10.1007/s00040-013-0337-z; Ellis S, 2014, BEHAV ECOL, V25, P1183, DOI 10.1093/beheco/aru108; Ellison AM, 2012, MYRMECOL NEWS, V17, P105; Forero-Medina G, 2011, CONSERV BIOL, V25, P163, DOI 10.1111/j.1523-1739.2010.01572.x; Frazer G.W., 1999, GAP LIGHT ANAL GLA V, P36; Frouz J, 2000, INSECT SOC, V47, P229, DOI 10.1007/PL00001708; Frouz J, 2007, INSECT SOC, V54, P251, DOI 10.1007/s00040-007-0939-4; Geiger R., 2009, CLIMATE NEAR GROUND; GORDON DM, 1992, ECOL ENTOMOL, V17, P114, DOI 10.1111/j.1365-2311.1992.tb01167.x; HAEMIG PD, 1992, OIKOS, V65, P479, DOI 10.2307/3545565; Herbers JM, 1996, ANIM BEHAV, V51, P141, DOI 10.1006/anbe.1996.0012; Huang SP, 2014, OECOLOGIA, V175, P25, DOI 10.1007/s00442-014-2882-1; Hughes L, 2000, TRENDS ECOL EVOL, V15, P56, DOI 10.1016/S0169-5347(99)01764-4; Hunt G, 2006, P NATL ACAD SCI USA, V103, P1347, DOI 10.1073/pnas.0510550103; IUCN, 2016, NARDOSTACHYS JATAMAN, DOI DOI 10.2305/IUCN.UK.20213.RLTS.T50126627A88304158.EN; Jurgensen MF, 2008, J APPL ENTOMOL, V132, P266, DOI 10.1111/j.1439-0418.2008.01280.x; KASPARI M, 1995, AM NAT, V145, P610, DOI 10.1086/285758; Kilpelainen J, 2005, ANN ZOOL FENN, V42, P243; Laakso J, 1997, OECOLOGIA, V111, P565, DOI 10.1007/s004420050272; Laakso J, 1998, OIKOS, V81, P266, DOI 10.2307/3547047; Maeder A, 2005, ANN ZOOL FENN, V42, P201; Morrison LW, 2005, DIVERS DISTRIB, V11, P199, DOI 10.1111/j.1366-9516.2005.00142.x; ODONNELL S, 1992, INSECT SOC, V39, P73, DOI 10.1007/BF01240532; Palmer TM, 2004, ANIM BEHAV, V68, P993, DOI 10.1016/j.anbehav.2004.02.005; PAMILO P, 1992, INSECT SOC, V39, P15, DOI 10.1007/BF01240528; Parmesan C, 1996, NATURE, V382, P765, DOI 10.1038/382765a0; Pelini SL, 2012, ECOL EVOL, V2, P3009, DOI 10.1002/ece3.407; PORTER SD, 1993, BEHAV ECOL SOCIOBIOL, V32, P321, DOI 10.1007/BF00183787; PUNTTILA P, 1994, ANN ZOOL FENN, V31, P131; Punttila P, 1996, OIKOS, V75, P291, DOI 10.2307/3546252; Punttila P, 2004, ANN ZOOL FENN, V41, P429; Punttila P, 2009, ANN ZOOL FENN, V46, P1, DOI 10.5735/086.046.0101; Robinson N.A., 2013, British Journal of Entomology and Natural History, V26, P67; Rodriguez-Garcia E, 2011, ANN FOREST SCI, V68, P337, DOI 10.1007/s13595-011-0039-5; Rolstad J, 2000, OECOLOGIA, V124, P116, DOI 10.1007/s004420050031; ROSENGREN R, 1991, ANT - PLANT INTERACTIONS, P80; ROSENGREN R, 1987, ANN ZOOL FENN, V24, P147; Roura-Pascual N, 2004, P ROY SOC B-BIOL SCI, V271, P2527, DOI 10.1098/rspb.2004.2898; SAVOLAINEN R, 1988, OIKOS, V51, P135, DOI 10.2307/3565636; SMITH FA, 1995, SCIENCE, V270, P2012, DOI 10.1126/science.270.5244.2012; SMITH R. L., 2003, ELEMENTS ECOLOGY; Sorvari J, 2005, ANN ZOOL FENN, V42, P259; Stuble KL, 2013, ECOL EVOL, V3, P482, DOI 10.1002/ece3.473; Styrsky JD, 2007, P ROY SOC B-BIOL SCI, V274, P151, DOI 10.1098/rspb.2006.3701; SUDD JH, 1981, BIOL CONSERV, V20, P133, DOI 10.1016/0006-3207(81)90024-0; SUDD JH, 1977, ECOL ENTOMOL, V2, P301, DOI 10.1111/j.1365-2311.1977.tb00895.x; Suggitt AJ, 2011, OIKOS, V120, P1, DOI 10.1111/j.1600-0706.2010.18270.x; TSCHINKEL WR, 1993, ECOL MONOGR, V63, P425, DOI 10.2307/2937154; Tschinkel WR, 1998, INSECT SOC, V45, P385, DOI 10.1007/s000400050097; Tschinkel WR, 1999, ECOL ENTOMOL, V24, P222, DOI 10.1046/j.1365-2311.1999.00184.x; van Gils HAJA, 2012, FLA ENTOMOL, V95, P914, DOI 10.1653/024.095.0414; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a	73	20	20	4	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2014	9	12							e116113	10.1371/journal.pone.0116113	http://dx.doi.org/10.1371/journal.pone.0116113			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UC	25551636	Green Published, gold, Green Accepted			2022-12-27	WOS:000347119100095
J	Choi, JW; Cho, HJ; Park, JH; Baek, SY; Chung, JW; Kim, DD; Kim, HC				Choi, Jin Woo; Cho, Hyun-Jong; Park, Ju-Hwan; Baek, Song Yi; Chung, Jin Wook; Kim, Dae-Duk; Kim, Hyo-Cheol			Comparison of Drug Release and Pharmacokinetics after Transarterial Chemoembolization Using Diverse Lipiodol Emulsions and Drug-Eluting Beads	PLOS ONE			English	Article							HEPATOCELLULAR-CARCINOMA; DELIVERY SYSTEM; IN-VITRO; DC BEAD; TOXICITY; CANCER; LIVER; MODEL; TACE	In many studies for chemoembolization of hepatocellular carcinoma, the Lipiodol emulsion preparation protocols, especially the mixing steps, were unclear or even unrevealed at all. However, doxorubicin (DOX) release may depend on the composition and volume ratio (Lipiodol to DOX solution) of a Lipiodol emulsion. Therefore, we conducted a preclinical study to compare in-vitro drug release and in-vivo pharmacokinetics of DOX from diverse Lipiodol emulsions and drug-eluting beads (DEBs) and to compare the tumor response in a rabbit VX2 carcinoma model. DOX release profiles of four types of Lipiodol emulsions with different media (normal saline or Pamiray as an iodinated contrast medium), volume ratio (Lipiodol to DOX solution), and DEBs were investigated in-vitro. For the in-vivo study, 15 rabbits bearing VX2 carcinoma in the liver were treated with 4:1 volume ratio Lipiodol emulsion (group A), 1:1 volume ratio Lipiodol emulsion (group B), and DEBs (group C) chemoembolization. Blood and tissue sampling was conducted to evaluate DOX concentration in plasma and tissues, histological changes, and liver toxicity. The most stable emulsion was formed with Pamiray (including DOX) at a 4:1 volume ratio. The AUC value of group A was significantly lower than that of group B (p=0.003) but comparable to that of group C (p=0.071). The C-max value of group A was significantly different compared with those of group B (p=0.004) and C (p=0.015). The tissue drug concentration in group A was comparable to that in group C (p=0.251). No viable tumor was detected in rabbits of group A and B. In group C, viable tumor less than 10% was seen in two of the five rabbits. There were no significant differences in liver enzyme levels after the procedure. In conclusion, DOX release and pharmacokinetics of presented emulsion systems depend substantially on their composition. Therefore, Lipiodol emulsion type should be considered when interpreting data and designing new studies dealing with chemoembolization.	[Choi, Jin Woo; Baek, Song Yi; Chung, Jin Wook; Kim, Hyo-Cheol] Seoul Natl Univ Hosp, Dept Radiol, Seoul 110744, South Korea; [Cho, Hyun-Jong] Kangwon Natl Univ, Coll Pharm, Chunchon, South Korea; [Park, Ju-Hwan; Kim, Dae-Duk] Seoul Natl Univ, Coll Pharm, Seoul, South Korea; [Park, Ju-Hwan; Kim, Dae-Duk] Seoul Natl Univ, Pharmaceut Sci Res Inst, Seoul, South Korea	Seoul National University (SNU); Seoul National University Hospital; Kangwon National University; Seoul National University (SNU); Seoul National University (SNU)	Kim, DD (corresponding author), Seoul Natl Univ, Coll Pharm, Seoul, South Korea.	ddkim@snu.ac.kr; angiointervention@gmail.com	Kim, Dae Duk/D-8864-2013	Chung, Jin Wook/0000-0002-1090-6872; Kim, Hyo-Cheol/0000-0002-6016-247X; Cho, Hyun-Jong/0000-0002-5070-9371	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology [2013R1A1A2A10011007]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology	This study was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (2013R1A1A2A10011007). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bruix J, 2011, HEPATOLOGY, V53, P1020, DOI 10.1002/hep.24199; Buijs M, 2008, RADIOLOGY, V249, P346, DOI 10.1148/radiol.2483071902; Chung GE, 2011, RADIOLOGY, V258, P627, DOI 10.1148/radiol.10101058; Chung JW, 1996, RADIOLOGY, V198, P33, DOI 10.1148/radiology.198.1.8539401; CHUNG JW, 1993, RADIOLOGY, V187, P689, DOI 10.1148/radiology.187.3.8388567; deBaere T, 1996, RADIOLOGY, V201, P731, DOI 10.1148/radiology.201.3.8939223; Dhanasekaran R, 2010, J SURG ONCOL, V101, P476, DOI 10.1002/jso.21522; HERESBACH D, 1989, GASTROEN CLIN BIOL, V13, P775; Hong K, 2006, CLIN CANCER RES, V12, P2563, DOI 10.1158/1078-0432.CCR-05-2225; Idee JM, 2013, CRIT REV ONCOL HEMAT, V88, P530, DOI 10.1016/j.critrevonc.2013.07.003; JOHNSON PJ, 1991, J HEPATOL, V13, P120, DOI 10.1016/0168-8278(91)90873-A; Kan ZX, 1997, ACAD RADIOL, V4, P275, DOI 10.1016/S1076-6332(97)80029-3; Kim HC, 2013, J VASC INTERV RADIOL, V24, P274, DOI 10.1016/j.jvir.2012.11.002; KONNO T, 1983, EUR J CANCER CLIN ON, V19, P1053, DOI 10.1016/0277-5379(83)90028-7; Lammer J, 2010, CARDIOVASC INTER RAD, V33, P41, DOI 10.1007/s00270-009-9711-7; Larson AC, 2008, RADIOLOGY, V246, P964, DOI 10.1148/radiol.2463070725; Lencioni R, 2012, CARDIOVASC INTER RAD, V35, P980, DOI 10.1007/s00270-011-0287-7; LEUNG WT, 1992, CANCER CHEMOTH PHARM, V29, P401, DOI 10.1007/BF00686011; Lewis AL, 2006, J VASC INTERV RADIOL, V17, P335, DOI 10.1097/01.RVI.0000195323.46152.B3; Lewis AL, 2006, J VASC INTERV RADIOL, V17, P1335, DOI 10.1097/01.RVI.0000228416.21560.7F; Malagari K, 2008, EXPERT REV ANTICANC, V8, P1643, DOI 10.1586/14737140.8.10.1643; Osuga K, 2012, INT J CLIN ONCOL, V17, P306, DOI 10.1007/s10147-012-0445-1; Park JH, 2014, J CONTROL RELEASE, V174, P98, DOI 10.1016/j.jconrel.2013.11.016; Sakaguchi H, 1991, Gan To Kagaku Ryoho, V18, P1349; Shin SW, 2009, KOREAN J RADIOL, V10, P425, DOI 10.3348/kjr.2009.10.5.425; Song MJ, 2012, J HEPATOL, V57, P1244, DOI 10.1016/j.jhep.2012.07.017; Varela M, 2007, J HEPATOL, V46, P474, DOI 10.1016/j.jhep.2006.10.020; Vogl TJ, 2011, AM J ROENTGENOL, V197, pW562, DOI 10.2214/AJR.10.4379	28	36	37	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2014	9	12							e115898	10.1371/journal.pone.0115898	http://dx.doi.org/10.1371/journal.pone.0115898			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UC	25551760	Green Published, Green Submitted, gold			2022-12-27	WOS:000347119100075
J	Chopra, R; Burow, G; Farmer, A; Mudge, J; Simpson, CE; Burow, MD				Chopra, Ratan; Burow, Gloria; Farmer, Andrew; Mudge, Joann; Simpson, Charles E.; Burow, Mark D.			Comparisons of De Novo Transcriptome Assemblers in Diploid and Polyploid Species Using Peanut (Arachis spp.) RNA-Seq Data	PLOS ONE			English	Article							READ ALIGNMENT; HYPOGAEA; GENERATION; DISCOVERY; RELATIVES	The narrow genetic base and limited genetic information on Arachis species have hindered the process of marker-assisted selection of peanut cultivars. However, recent developments in sequencing technologies have expanded opportunities to exploit genetic resources, and at lower cost. To use the genetic information for Arachis species available at the transcriptome level, it is important to have a good quality reference transcriptome. The available Tifrunner 454 FLEX transcriptome sequences have an assembly with 37,000 contigs and low N50 values of 500-751bp. Therefore, we generated de novo transcriptome assemblies, with about 38 million reads in the tetraploid cultivar OLin, and 16 million reads in each of the diploids, A. duranensis K38901 and A. ipaensis KGBSPSc30076 using three different de novo assemblers, Trinity, SOAPdenovo-Trans and TransAByss. All these assemblers can use single kmer analysis, and the latter two also permit multiple kmer analysis. Assemblies generated for all three samples had N50 values ranging from 1278-1641 bp in Arachis hypogaea (AABB), 1401-1492 bp in Arachis duranensis (AA), and 1107-1342 bp in Arachis ipaensis (BB). Comparison with legume ESTs and protein databases suggests that assemblies generated had more than 40% full length transcripts with good continuity. Also, on mapping the raw reads to each of the assemblies generated, Trinity had a high success rate in assembling sequences compared to both TransAByss and SOAPdenovo-Trans. De novo assembly of OLin had a greater number of contigs (67,098) and longer contig length (N50=1,641) compared to the Tifrunner TSA. Despite having shorter read length (2x50) than the Tifrunner 454FLEX TSA, de novo assembly of OLin proved superior in comparison. Assemblies generated to represent different genome combinations may serve as a valuable resource for the peanut research community.	[Chopra, Ratan; Burow, Mark D.] Texas Tech Univ, Dept Plant & Soil Sci, Lubbock, TX 79409 USA; [Burow, Gloria] ARS, USDA, CSRL, Lubbock, TX 79415 USA; [Farmer, Andrew; Mudge, Joann] Natl Ctr Genome Resources, Santa Fe, NM 87505 USA; [Simpson, Charles E.] Texas A&M AgriLife Res, Stephenville, TX 76401 USA; [Burow, Mark D.] Texas A&M AgriLife Res, Lubbock, TX 79403 USA	Texas Tech University System; Texas Tech University; United States Department of Agriculture (USDA); National Center for Genome Resources (NCGR); Texas A&M University System; Texas A&M University College Station; Texas A&M AgriLife Research; Texas A&M University System; Texas A&M University College Station; Texas A&M AgriLife Research	Burow, MD (corresponding author), Texas Tech Univ, Dept Plant & Soil Sci, Lubbock, TX 79409 USA.	mburow@tamu.edu	Chopra, Ratan/AAQ-9047-2021	Chopra, Ratan/0000-0003-2088-3341; Mudge, Joann/0000-0002-2972-1640	Texas Peanut Producers Board; National Peanut Board [332/TX-99/1139, 332/TX-99/1213]; CES; Peanut Foundation [04-810-08]; Ogallala Aquifer Initiative [IPM12.06]; United States Department of Agriculture/National Institute of Food and Agriculture Hatch Act [TEX08835]; ARS [ARS-0425249] Funding Source: Federal RePORTER	Texas Peanut Producers Board; National Peanut Board; CES; Peanut Foundation; Ogallala Aquifer Initiative; United States Department of Agriculture/National Institute of Food and Agriculture Hatch Act; ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	This work was supported by awards from the Texas Peanut Producers Board (http://www.texaspeanutboard.com) award CY2008-Burow-TTU-Development to MDB and CES, and 2009-TTU-Burow-Genotyping to MDB, National Peanut Board (http://nationalpeanutboard.org) grant #332/TX-99/1139 to MDB, and #332/TX-99/1213 to MDB and CES, Peanut Foundation (http://peanutfoundation.org) grant 04-810-08 to MDB, Ogallala Aquifer Initiative (http://ogallala.ars.usda.gov) award IPM12.06 to MDB, and United States Department of Agriculture/National Institute of Food and Agriculture Hatch Act (http://www.csrees.usda.gov/business/awards/formula/hatch.html) award TEX08835 to MDB funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Benson DA, 2011, NUCLEIC ACIDS RES, V39, pD32, DOI [10.1093/nar/gkw1070, 10.1093/nar/gks1195, 10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkx1094, 10.1093/nar/gkn723, 10.1093/nar/gkp1024, 10.1093/nar/gkr1202]; Birol I, 2009, BIOINFORMATICS, V25, P2872, DOI 10.1093/bioinformatics/btp367; Burow MD, 2001, GENETICS, V159, P823; Chopra R, NEXT GENERA IN PRESS; Duan JL, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-392; Feng C, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-19; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Gregory W. C., 1980, Advances in legume science, P469; Guimaraes PM, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-387; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; Kaur S, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-104; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Mizrachi E, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-681; Nagy ED, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-469; Ness RW, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-298; Pellny TK, 2012, PLANT PHYSIOL, V158, P612, DOI 10.1104/pp.111.189191; Pont C, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-12-r119; Robertson G, 2010, NAT METHODS, V7, P909, DOI 10.1038/nmeth.1517; Sayers EW, 2010, NUCLEIC ACIDS RES, V38, pD5, DOI 10.1093/nar/gkp967; Schulz MH, 2012, BIOINFORMATICS, V28, P1086, DOI 10.1093/bioinformatics/bts094; Seijo G, 2007, AM J BOT, V94, P1963, DOI 10.3732/ajb.94.12.1963; Simpson CE, 2003, CROP SCI, V43, P1880, DOI 10.2135/cropsci2003.1880a; States D J, 1994, J Comput Biol, V1, P39; Surget-Groba Y, 2010, GENOME RES, V20, P1432, DOI 10.1101/gr.103846.109; Temsch EM, 2000, GENOME, V43, P449, DOI 10.1139/gen-43-3-449; Trick M, 2009, PLANT BIOTECHNOL J, V7, P334, DOI 10.1111/j.1467-7652.2008.00396.x; Wendel JF, 2000, PLANT MOL BIOL, V42, P225, DOI 10.1023/A:1006392424384; Xie Y, 2014, SOAPDENOVO T NOVO TR; Zhang GJ, 2010, GENOME RES, V20, P646, DOI 10.1101/gr.100677.109; Zhang JA, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-90	34	44	45	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2014	9	12							e115055	10.1371/journal.pone.0115055	http://dx.doi.org/10.1371/journal.pone.0115055			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UC	25551607	Green Published, Green Submitted, gold			2022-12-27	WOS:000347119100026
J	Jiang, YL; Zhang, SH; Feng, SS; Sun, JS; Xu, P				Jiang, Yanliang; Zhang, Songhao; Feng, Shuaisheng; Sun, Jinsheng; Xu, Peng			Genome Wide Identification, Phylogeny and Expression of Zinc Transporter Genes in Common Carp	PLOS ONE			English	Article							MAMMALIAN ZINC; SLC30 FAMILY; DIETARY ZINC; FUNCTIONAL-CHARACTERIZATION; GROWTH-HORMONE; DUPLICATION; MICE; ZIP1; ZNT7	Background: Zinc is an essential trace element in organisms, which serves as a cofactor for hundreds of enzymes that are involved in many pivotal biological processes including growth, development, reproduction and immunity. Therefore, the homeostasis of zinc in the cell is fundamental. The zinc transporter gene family is a large gene family that encodes proteins which regulate the movement of zinc across cellular and intracellular membranes. However, studies on teleost zinc transporters are mainly limited to model species. Methodology/Principal Findings: We identified a set of 37 zinc transporters in common carp genome, including 17 from SLC30 family (ZnT), and 20 from SLC39 family (ZIP). Phylogenetic and syntenic analysis revealed that most of the zinc transporters are highly conserved, though recent gene duplication and gene losses do exist. Through examining the copy number of zinc transporter genes across several vertebrate genomes, thirteen zinc transporters in common carp are found to have undergone the gene duplications, including SLC30A1, SLC30A2, SLC30A5, SLC30A7, SLC30A9, SLC30A10, SLC39A1, SLC39A3, SLC39A4, SLC39A5, SLC39A6, SLC39A7 and SLC39A9. The expression patterns of all zinc transporters were established in various tissues, including blood, brain, gill, heart, intestine, liver, muscle, skin, spleen and kidney, and showed that most of the zinc transporters were ubiquitously expressed, indicating the critical role of zinc transporters in common carp. Conclusions: To some extent, examination of gene families with detailed phylogenetic or orthology analysis could verify the authenticity and accuracy of assembly and annotation of the recently published common carp whole genome sequences. The gene families are also considered as a unique source for evolutionary studies. Moreover, the whole set of common carp zinc transporters provides an important genomic resource for future biochemical, toxicological and physiological studies of zinc in teleost.	[Jiang, Yanliang; Zhang, Songhao; Feng, Shuaisheng; Xu, Peng] Chinese Acad Fishery Sci, Ctr Appl Aquat Genom, CAFS Key Lab Aquat Genom, Beijing 100141, Peoples R China; [Jiang, Yanliang; Zhang, Songhao; Feng, Shuaisheng; Xu, Peng] Chinese Acad Fishery Sci, Ctr Appl Aquat Genom, Beijing Key Lab Fishery Biotechnol, Beijing 100141, Peoples R China; [Zhang, Songhao; Sun, Jinsheng] Tianjin Normal Univ, Coll Life Sci, Tianjin 300387, Peoples R China	Chinese Academy of Fishery Sciences; Chinese Academy of Fishery Sciences; Tianjin Normal University	Xu, P (corresponding author), Chinese Acad Fishery Sci, Ctr Appl Aquat Genom, CAFS Key Lab Aquat Genom, Beijing 100141, Peoples R China.	xupeng@cafs.ac.cn	Xu, Peng/J-4018-2012	Xu, Peng/0000-0002-1531-5078	National High-Technology Research and Development Program of China (863 program) [2011AA100401]; Special Scientific Research Funds for Central Non-profit Institutes, Chinese Academy of Fishery Sciences [2014C011, 2013C010]	National High-Technology Research and Development Program of China (863 program)(National High Technology Research and Development Program of China); Special Scientific Research Funds for Central Non-profit Institutes, Chinese Academy of Fishery Sciences	This project was supported by the National High-Technology Research and Development Program of China (863 program; 2011AA100401) and Special Scientific Research Funds for Central Non-profit Institutes, Chinese Academy of Fishery Sciences (2014C011 and 2013C010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews GK, 2004, GENESIS, V40, P74, DOI 10.1002/gene.20067; Aydemir TB, 2009, J LEUKOCYTE BIOL, V86, P337, DOI 10.1189/jlb.1208759; Chai FG, 1999, IMMUNOL CELL BIOL, V77, P272, DOI 10.1046/j.1440-1711.1999.00825.x; Christoffels A, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-S5-S2; Cousins RJ, 2010, INT J VITAM NUTR RES, V80, P243, DOI 10.1024/0300-9831/a000030; David L, 2003, MOL BIOL EVOL, V20, P1425, DOI 10.1093/molbev/msg173; Dehal P, 2005, PLOS BIOL, V3, P1700, DOI 10.1371/journal.pbio.0030314; Dufner-Beattie J, 2004, J BIOL CHEM, V279, P49082, DOI 10.1074/jbc.M409962200; Eide DJ, 2004, PFLUG ARCH EUR J PHY, V447, P796, DOI 10.1007/s00424-003-1074-3; Feeney GP, 2005, BBA-GENE STRUCT EXPR, V1732, P88, DOI 10.1016/j.bbaexp.2005.12.002; FOSMIRE GJ, 1990, AM J CLIN NUTR, V51, P225, DOI 10.1093/ajcn/51.2.225; Fraker PJ, 2000, J NUTR, V130, p1399S, DOI 10.1093/jn/130.5.1399S; Gaither LA, 2000, J BIOL CHEM, V275, P5560, DOI 10.1074/jbc.275.8.5560; Gaither LA, 2001, J BIOL CHEM, V276, P22258, DOI 10.1074/jbc.M101772200; Geiser J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082149; Glasauer SM, 2014, MOL GENET GENOMICS, P1; Hambidge M, 2000, J NUTR, V130, p1344S, DOI 10.1093/jn/130.5.1344S; Haney CJ, 2005, J IND MICROBIOL BIOT, V32, P215, DOI 10.1007/s10295-005-0224-3; Hojyo S, 2014, P NATL ACAD SCI USA, V111, P11786, DOI 10.1073/pnas.1323557111; HOLLAND PWH, 1994, DEVELOPMENT, P125; Huang L, 2007, J BIOL CHEM, V282, P37053, DOI 10.1074/jbc.M706631200; Huang LP, 2013, MOL ASPECTS MED, V34, P548, DOI 10.1016/j.mam.2012.05.008; Huang LP, 2002, J BIOL CHEM, V277, P26389, DOI 10.1074/jbc.M200462200; Huang LP, 1997, NAT GENET, V17, P292, DOI 10.1038/ng1197-292; Inoue K, 2002, HUM MOL GENET, V11, P1775, DOI 10.1093/hmg/11.15.1775; Jeong J, 2013, MOL ASPECTS MED, V34, P612, DOI 10.1016/j.mam.2012.05.011; Ji PF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035152; Jiang YL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108200; Kelleher SL, 2005, AM J PHYSIOL-CELL PH, V288, pC1042, DOI 10.1152/ajpcell.00471.2004; Kitamura H, 2006, NAT IMMUNOL, V7, P971, DOI 10.1038/ni1373; Liu SK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063895; Liuzzi JP, 2004, ANNU REV NUTR, V24, P151, DOI 10.1146/annurev.nutr.24.012003.132402; Liuzzi JP, 2005, P NATL ACAD SCI USA, V102, P6843, DOI 10.1073/pnas.0502257102; Liuzzi JP, 2001, J NUTR, V131, P46, DOI 10.1093/jn/131.1.46; Lopez V, 2009, BIOCHEM J, V422, P43, DOI 10.1042/BJ20081189; McLysaght A, 2002, NAT GENET, V31, P200, DOI 10.1038/ng884; Miletta MC, 2013, INT J ENDOCRINOL, V2013, DOI 10.1155/2013/259189; Miyai T, 2014, P NATL ACAD SCI USA, V111, P11780, DOI 10.1073/pnas.1323549111; Ohno S., 1970, EVOLUTION GENE DUPLI; Palmiter RD, 2004, PFLUG ARCH EUR J PHY, V447, P744, DOI 10.1007/s00424-003-1070-7; PALMITER RD, 1995, EMBO J, V14, P639, DOI 10.1002/j.1460-2075.1995.tb07042.x; Petkovic V, 2014, HORM RES PAEDIAT, V82, P245, DOI 10.1159/000365924; PILETZ JE, 1978, AM J CLIN NUTR, V31, P560, DOI 10.1093/ajcn/31.4.560; Pocanschi CL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072446; Postlethwait JH, 1998, NAT GENET, V18, P345, DOI 10.1038/ng0498-345; Seve M, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-32; Sun P, 2013, BIOL TRACE ELEM RES, V155, P11, DOI 10.1007/s12011-013-9764-y; VALLEE BL, 1993, PHYSIOL REV, V73, P79, DOI 10.2466/pr0.1993.73.1.79; Wang JT, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-96; Xu J, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-307; Xu P., 2014, NAT GENET; Xu P, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-537; Xu P, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-188; Yan G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042939; Yu YY, 2007, J HISTOCHEM CYTOCHEM, V55, P223, DOI 10.1369/jhc.6A7032.2006; Zhang X, 2012, MAR BIOTECHNOL NY, V15, P275; Zhao L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063928; Zheng DL, 2008, PHYSIOL GENOMICS, V34, P205, DOI 10.1152/physiolgenomics.90206.2008	58	17	18	8	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2014	9	12							e116043	10.1371/journal.pone.0116043	http://dx.doi.org/10.1371/journal.pone.0116043			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UC	25551462	Green Published, Green Submitted, gold			2022-12-27	WOS:000347119100093
J	Johansson, G; Peng, PC; Huang, PY; Chien, HF; Hua, KT; Kuo, ML; Chen, CT; Lee, MJ				Johansson, Gunnar; Peng, Po-Chun; Huang, Po-Yuan; Chien, Hsiung-Fei; Hua, Kuo-Tai; Kuo, Min-Liang; Chen, Chin-Tin; Lee, Ming-Jen			Soluble AXL: A Possible Circulating Biomarker for Neurofibromatosis Type 1 Related Tumor Burden	PLOS ONE			English	Article							NERVE SHEATH TUMORS; RECEPTOR TYROSINE KINASE; GROWTH-FACTOR; SCHWANN-CELLS; PHOTODYNAMIC INACTIVATION; OVARIAN-CANCER; IN-VITRO; EXPRESSION; INVASION; GAS6	Neurofibromatosis type 1 (NF1) is the most common tumor predisposition disorder affecting 1/3500 worldwide. Patients are at risk of developing benign (neurofibromas) and malignant peripheral nerve sheath tumors (MPNST). The AXL receptor tyrosine kinase has been implicated in several kinds of cancers, but so far no studies have investigated the role of AXL in NF1 related tumorigenesis. Recently, the soluble fraction from the extracellular domain of AXL (sAXL) has been found in human plasma, and its level was correlated to poor prognosis in patients with renal cancer. Compared to normal human Schwann cells, a significantly high expression level of AXL was found in three of the four MPNST cell lines and two of the three primary MPNST tissues. Similarly, the level of sAXL in conditioned media corresponded to the protein and mRNA levels of AXL in the MPNST cell lines. Furthermore, in two different human MPNST xenograft models, the human sAXL could be detected in the mouse plasma. Its level was proportionate to the size of the xenograft tumors, while no human sAXL was detect prior to the formation of the tumors. Treatment with a newly developed photodynamic therapy, prevented further tumor growth and resulted in drastically reduced the levels of sAXL compared to that of the control group. Finally, the level of sAXL was significantly increased in patients with plexiform tumors compared to patients with only dermal neurofibromas, further supporting the role of sAXL as a marker for NF1 related tumor burden.	[Johansson, Gunnar; Huang, Po-Yuan; Lee, Ming-Jen] Natl Taiwan Univ Hosp, Dept Neurol, Taipei, Taiwan; [Peng, Po-Chun; Chen, Chin-Tin] Inst Syst Biol, Seattle, WA USA; [Chien, Hsiung-Fei] Natl Taiwan Univ Hosp, Dept Surg, Taipei 100, Taiwan; [Hua, Kuo-Tai; Kuo, Min-Liang] Natl Taiwan Univ, Coll Med, Grad Inst Toxicol, Taipei 10764, Taiwan; [Kuo, Min-Liang] Natl Taiwan Univ, Coll Life Sci, Inst Biochem Sci, Taipei 10764, Taiwan; [Lee, Ming-Jen] Natl Taiwan Univ Hosp, Dept Med Genet, Taipei, Taiwan	National Taiwan University; National Taiwan University Hospital; Institute for Systems Biology (ISB); National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University; National Taiwan University; National Taiwan University Hospital	Lee, MJ (corresponding author), Natl Taiwan Univ Hosp, Dept Neurol, Taipei, Taiwan.	mjlee@ntu.edu.tw	Hsiao, Wei-Hung/B-9931-2013	Hua, Kuo-Tai/0000-0002-8468-4977; KUO, MIN-LIANG/0000-0002-7139-0144	Ministry of Science and Technology, Taiwan [NSC 99-3112-B-002-012]; National Taiwan University Hospital [NTUH 103-002464]	Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan); National Taiwan University Hospital(National Taiwan University)	The project was supported by the Ministry of Science and Technology, Taiwan (NSC 99-3112-B-002-012) and National Taiwan University Hospital (NTUH 103-002464), for Gunnar Johansson and Ming-Jen Lee. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albritton KH, 2006, J CLIN ONCOL, V24, p524S; Ammoun S, 2014, ONCOGENE, V33, P336, DOI 10.1038/onc.2012.587; Aoki M, 2007, LAB INVEST, V87, P767, DOI 10.1038/labinvest.3700591; Badache A, 1998, J CELL PHYSIOL, V177, P334, DOI 10.1002/(SICI)1097-4652(199811)177:2<334::AID-JCP15>3.0.CO;2-9; Baron AT, 2003, CANCER EPIDEM BIOMAR, V12, P103; BARTLETT GR, 1959, J BIOL CHEM, V234, P459; Chen MW, 2010, CANCER RES, V70, P7830, DOI 10.1158/0008-5472.CAN-10-0833; Costa M, 1996, J CELL PHYSIOL, V168, P737, DOI 10.1002/(SICI)1097-4652(199609)168:3<737::AID-JCP27>3.0.CO;2-U; DAHLBERG WK, 1993, INT J RADIAT BIOL, V63, P191, DOI 10.1080/09553009314550251; De Windt LJ, 2000, J BIOL CHEM, V275, P13571, DOI 10.1074/jbc.275.18.13571; DECLUE JE, 1992, CELL, V69, P265, DOI 10.1016/0092-8674(92)90407-4; DeClue JE, 2000, J CLIN INVEST, V105, P1233, DOI 10.1172/JCI7610; Ekman C, 2010, J THROMB HAEMOST, V8, P838, DOI 10.1111/j.1538-7836.2010.03752.x; Gustafsson A, 2009, CLIN CANCER RES, V15, P4742, DOI 10.1158/1078-0432.CCR-08-2514; Johansson G, 2008, MOL CANCER THER, V7, P1237, DOI 10.1158/1535-7163.MCT-07-2335; Korf BR, 1999, AM J MED GENET, V89, P31, DOI 10.1002/(SICI)1096-8628(19990326)89:1<31::AID-AJMG7>3.0.CO;2-W; Li RH, 1996, J NEUROSCI, V16, P2012; Linger RMA, 2008, ADV CANCER RES, V100, P35, DOI 10.1016/S0065-230X(08)00002-X; Liu L, 2009, CANCER RES, V69, P6871, DOI 10.1158/0008-5472.CAN-08-4490; Mahadevan D, 2007, ONCOGENE, V26, P3909, DOI 10.1038/sj.onc.1210173; Mahller YY, 2008, CANCER RES, V68, P1170, DOI 10.1158/0008-5472.CAN-07-2734; Mantripragada KK, 2008, CLIN CANCER RES, V14, P1015, DOI 10.1158/1078-0432.CCR-07-1305; Miller SJ, 2006, CANCER RES, V66, P2584, DOI 10.1158/0008-5472.CAN-05-3330; Moon YH, 2009, ONCOL REP, V22, P1085, DOI 10.3892/or_00000540; Namiki Y, 2004, PHARMACOL RES, V50, P65, DOI 10.1016/j.phrs.2003.12.015; Nielsen-Preiss SM, 2007, ENDOCRINOLOGY, V148, P2806, DOI 10.1210/en.2007-0039; OBRYAN JP, 1995, J BIOL CHEM, V270, P551, DOI 10.1074/jbc.270.2.551; Rankin EB, 2010, CANCER RES, V70, P7570, DOI 10.1158/0008-5472.CAN-10-1267; Rao UNM, 1997, HUM PATHOL, V28, P1066, DOI 10.1016/S0046-8177(97)90060-5; Rasmussen SA, 2001, AM J HUM GENET, V68, P1110, DOI 10.1086/320121; Riccardi VM, 1999, NEUROFIBROMATOSIS PH; Robinson DR, 2000, ONCOGENE, V19, P5548, DOI 10.1038/sj.onc.1203957; Rosenbaum T, 2000, J NEUROSCI RES, V61, P524, DOI 10.1002/1097-4547(20000901)61:5<524::AID-JNR7>3.3.CO;2-Q; Su WP, 2004, GLIA, V45, P297, DOI 10.1002/glia.10340; TIESMAN J, 1993, J BIOL CHEM, V268, P9621; Tsai T, 2009, LASER SURG MED, V41, P316, DOI 10.1002/lsm.20754; WEINER TM, 1994, ANN SURG ONCOL, V1, P18, DOI 10.1007/BF02303537; Yang YT, 2013, LASER SURG MED, V45, P175, DOI 10.1002/lsm.22124	38	20	21	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2014	9	12							e115916	10.1371/journal.pone.0115916	http://dx.doi.org/10.1371/journal.pone.0115916			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UC	25551830	Green Published, Green Submitted, gold			2022-12-27	WOS:000347119100076
J	Li, G; Huan, D; Roehner, B; Xu, YJ; Zeng, L; Di, ZR; Han, ZG				Li, Geng; Huan, Di; Roehner, Bertrand; Xu, Yijuan; Zeng, Ling; Di, Zengru; Han, Zhangang			Symmetry Breaking on Density in Escaping Ants: Experiment and Alarm Pheromone Model	PLOS ONE			English	Article							TRANSITION; SYSTEM	The symmetry breaking observed in nature is fascinating. This symmetry breaking is observed in both human crowds and ant colonies. In such cases, when escaping from a closed space with two symmetrically located exits, one exit is used more often than the other. Group size and density have been reported as having no significant impact on symmetry breaking, and the alignment rule has been used to model symmetry breaking. Density usually plays important roles in collective behavior. However, density is not well-studied in symmetry breaking, which forms the major basis of this paper. The experiment described in this paper on an ant colony displays an increase then decrease of symmetry breaking versus ant density. This result suggests that a Vicsek-like model with an alignment rule may not be the correct model for escaping ants. Based on biological facts that ants use pheromones to communicate, rather than seeing how other individuals move, we propose a simple yet effective alarm pheromone model. The model results agree well with the experimental outcomes. As a measure, this paper redefines symmetry breaking as the collective asymmetry by deducing the random fluctuations. This research indicates that ants deposit and respond to the alarm pheromone, and the accumulation of this biased information sharing leads to symmetry breaking, which suggests true fundamental rules of collective escape behavior in ants.	[Li, Geng; Huan, Di; Di, Zengru; Han, Zhangang] Beijing Normal Univ, Sch Syst Sci, Beijing 100875, Peoples R China; [Roehner, Bertrand] Univ Paris 06, Inst Theoret & High Energy Phys, F-75005 Paris, France; [Xu, Yijuan; Zeng, Ling] South China Agr Univ, Coll Nat Resources & Environm, Guangzhou, Guangdong, Peoples R China	Beijing Normal University; UDICE-French Research Universities; Sorbonne Universite; South China Agricultural University	Han, ZG (corresponding author), Beijing Normal Univ, Sch Syst Sci, Beijing 100875, Peoples R China.	zhan@bnu.edu.cn			China National Natural Science Foundation [61074116, 61374165, 31261160495]; Fundamental Research Funds for the Central Universities of China; BNU State Key Laboratory of ESPRE [2012-TDZY-21]	China National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities of China(Fundamental Research Funds for the Central Universities); BNU State Key Laboratory of ESPRE	This research is supported by China National Natural Science Foundation grants 61074116, 61374165 and 31261160495, as well as the Fundamental Research Funds for the Central Universities of China. This work was also supported by BNU State Key Laboratory of ESPRE grant 2012-TDZY-21. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler E, 2005, AM NAT, V166, P643, DOI 10.1086/498139; Ballerini M, 2008, P NATL ACAD SCI USA, V105, P1232, DOI 10.1073/pnas.0711437105; Becco C, 2006, PHYSICA A, V367, P487, DOI 10.1016/j.physa.2005.11.041; Buhl J, 2006, SCIENCE, V312, P1402, DOI 10.1126/science.1125142; Cavagna A, 2010, P NATL ACAD SCI USA, V105, P1232; Dombrowski C, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.098103; Dorigo M, 2006, IEEE COMPUT INTELL M, V1, P28, DOI 10.1109/MCI.2006.329691; Helbing D, 2000, NATURE, V407, P487, DOI 10.1038/35035023; Helfman GS, 2007, DIVERSITY FISHES; Herbert-Read JE, 2011, P NATL ACAD SCI USA, V108, P18726, DOI 10.1073/pnas.1109355108; Holldobler B., 1990, pi; Lalor PF, 2011, ANIM BEHAV, V10, P159; Makris NC, 2009, SCIENCE, V323, P1734, DOI 10.1126/science.1169441; Meer RKV, 2010, J CHEM ECOL, V36, P163, DOI 10.1007/s10886-010-9743-0; Nagy M, 2010, NATURE, V464, P890, DOI 10.1038/nature08891; Narayan V, 2007, SCIENCE, V317, P105, DOI 10.1126/science.1140414; Ordemann A, 2003, PHYSICA A, V325, P260, DOI 10.1016/S0378-4371(03)00204-8; POTTS WK, 1984, NATURE, V309, P344, DOI 10.1038/309344a0; REGNIER FE, 1968, J LIPID RES, V9, P541; Schaller V, 2010, NATURE, V467, P73, DOI 10.1038/nature09312; Sumpter DJT, 2007, INTRO COLLECTIVE ANI; Szabo B, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.061908; Vander Meer R. K., 1998, PHEROMONE COMMUNICAT; VICSEK T, 1995, PHYS REV LETT, V75, P1226, DOI 10.1103/PhysRevLett.75.1226; Vicsek T, 2012, PHYS REP, V517, P71, DOI 10.1016/j.physrep.2012.03.004; WILSON EDWARD O., 1962, ANIMAL BEHAVIOUR, V10, P159, DOI 10.1016/0003-3472(62)90143-4; WILSON EO, 1963, RECENT PROG HORM RES, V19, P673; WILSON EO, 1971, AM NAT, V105, P279, DOI 10.1086/282724	28	14	17	1	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2014	9	12							e114517	10.1371/journal.pone.0114517	http://dx.doi.org/10.1371/journal.pone.0114517			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UC	25551611	gold, Green Submitted, Green Published			2022-12-27	WOS:000347119100012
J	Pootakham, W; Shearman, JR; Ruang-areerate, P; Sonthirod, C; Sangsrakru, D; Jomchai, N; Yoocha, T; Triwitayakorn, K; Tragoonrung, S; Tangphatsornruang, S				Pootakham, Wirulda; Shearman, Jeremy R.; Ruang-areerate, Panthita; Sonthirod, Chutima; Sangsrakru, Duangjai; Jomchai, Nukoon; Yoocha, Thippawan; Triwitayakorn, Kanokporn; Tragoonrung, Somvong; Tangphatsornruang, Sithichoke			Large-Scale SNP Discovery through RNA Sequencing and SNP Genotyping by Targeted Enrichment Sequencing in Cassava (Manihot esculenta Crantz)	PLOS ONE			English	Article							SINGLE NUCLEOTIDE POLYMORPHISMS; MOLECULAR-GENETIC MAP; ARABIDOPSIS-THALIANA; GENOME; IDENTIFICATION; DROSOPHILA; DIVERSITY; MARKERS; STARCH; SEQ	Cassava (Manihot esculenta Crantz) is one of the most important crop species being the main source of dietary energy in several countries. Marker-assisted selection has become an essential tool in plant breeding. Single nucleotide polymorphism (SNP) discovery via transcriptome sequencing is an attractive strategy for genome complexity reduction in organisms with large genomes. We sequenced the transcriptome of 16 cassava accessions using the Illumina HiSeq platform and identified 675,559 EST-derived SNP markers. A subset of those markers was subsequently genotyped by capture-based targeted enrichment sequencing in 100 F-1 progeny segregating for starch viscosity phenotypes. A total of 2,110 non-redundant SNP markers were used to construct a genetic map. This map encompasses 1,785 cM and consists of 19 linkage groups. A major quantitative trait locus (QTL) controlling starch pasting properties was identified and shown to coincide with the QTL previously reported for this trait. With a high-density SNP-based linkage map presented here, we also uncovered a novel QTL associated with starch pasting time on LG 10.	[Pootakham, Wirulda; Shearman, Jeremy R.; Ruang-areerate, Panthita; Sonthirod, Chutima; Sangsrakru, Duangjai; Jomchai, Nukoon; Yoocha, Thippawan; Tragoonrung, Somvong; Tangphatsornruang, Sithichoke] Natl Sci & Technol Dev Agcy NSTDA, Natl Ctr Genet Engn & Biotechnol BIOTEC, Pathum Thani, Thailand; [Triwitayakorn, Kanokporn] Mahidol Univ, Inst Mol Biosci, Nakhon Pathom, Thailand	National Science & Technology Development Agency - Thailand; National Center Genetic Engineering & Biotechnology (BIOTEC); Mahidol University	Tangphatsornruang, S (corresponding author), Natl Sci & Technol Dev Agcy NSTDA, Natl Ctr Genet Engn & Biotechnol BIOTEC, 113 Thailand Sci Pk, Pathum Thani, Thailand.	sithichoke.tan@biotec.or.th	Pootakham, Wirulda/Q-9366-2019; Tangphatsornruang, Sithichoke/G-3633-2010; Pootakham, Wirulda/F-2358-2011; Shearman, Jeremy/F-1618-2010	Pootakham, Wirulda/0000-0001-6721-6453; Tangphatsornruang, Sithichoke/0000-0003-2673-0012; Pootakham, Wirulda/0000-0001-6721-6453; Triwitayakorn, Kanokporn/0000-0002-2179-1070	National Research Council of Thailand [P-12-00212]	National Research Council of Thailand(National Research Council of Thailand (NRCT))	This work was supported by the National Research Council of Thailand (http://en.nrct.go.th/en/home.aspx) grant number P-12-00212. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atwell S, 2010, NATURE, V465, P627, DOI 10.1038/nature08800; AWOLEYE F, 1994, EUPHYTICA, V76, P195, DOI 10.1007/BF00022164; Baird NA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003376; Balat M, 2009, APPL ENERG, V86, P2273, DOI 10.1016/j.apenergy.2009.03.015; Barakat A, 1999, FEBS LETT, V463, P139, DOI 10.1016/S0014-5793(99)01587-2; Barakat A, 1998, P NATL ACAD SCI USA, V95, P10044, DOI 10.1073/pnas.95.17.10044; Barchi L, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-304; Burrell MM, 2003, J EXP BOT, V54, P451, DOI 10.1093/jxb/erg049; Ceballos H, 2006, ACTA HORTIC, P63, DOI 10.17660/ActaHortic.2006.703.6; Chen X, 2010, PLANT MOL BIOL REP, V28, P676, DOI 10.1007/s11105-010-0198-9; Chepelev I, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp507; CHURCHILL GA, 1994, GENETICS, V138, P963; Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695; Clark RM, 2007, SCIENCE, V317, P338, DOI 10.1126/science.1138632; Collard BCY, 2008, PHILOS T R SOC B, V363, P557, DOI 10.1098/rstb.2007.2170; COULONDRE C, 1978, NATURE, V274, P775, DOI 10.1038/274775a0; Elshire RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019379; Ferguson ME, 2012, THEOR APPL GENET, V124, P685, DOI 10.1007/s00122-011-1739-9; Fregene M, 1997, THEOR APPL GENET, V95, P431, DOI 10.1007/s001220050580; Giraut L, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002354; Gnirke A, 2009, NAT BIOTECHNOL, V27, P182, DOI 10.1038/nbt.1523; Gore MA, 2009, PLANT GENOME-US, V2, P121, DOI 10.3835/plantgenome2009.01.0002; Haseneyer G, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-131; Hedges DJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018595; Henderson IR, 2012, CURR OPIN PLANT BIOL, V15, P556, DOI 10.1016/j.pbi.2012.09.002; Hershey CH, 2012, ECOEFFICIENT INTERVE; Jabbari K, 2000, GENE, V247, P287, DOI 10.1016/S0378-1119(00)00128-1; Jimenez-Gomez JM, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-85; Kawuki RS, 2009, MOL BREEDING, V23, P669, DOI 10.1007/s11032-009-9264-0; Kaya HB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073674; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kunkeaw S, 2011, MOL BREEDING, V27, P67, DOI 10.1007/s11032-010-9414-4; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lopez C, 2005, THEOR APPL GENET, V110, P425, DOI 10.1007/s00122-004-1833-3; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Moriyama EN, 1996, MOL BIOL EVOL, V13, P261, DOI 10.1093/oxfordjournals.molbev.a025563; Nuwamanya E., 2010, African Journal of Food Science, V4, P8; Okogbenin E, 2006, EUPHYTICA, V147, P433, DOI 10.1007/s10681-005-9042-y; Okogbenin E, 2003, THEOR APPL GENET, V107, P1452, DOI 10.1007/s00122-003-1383-0; Paritosh K, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-463; Pegadaraju V, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-556; Pootakham W, 2013, PLANT BREEDING, V132, P711, DOI 10.1111/pbr.12095; Pootakham W, 2011, AM J BOT, V98, pE337, DOI 10.3732/ajb.1100228; Prochnik S, 2012, TROP PLANT BIOL, V5, P88, DOI 10.1007/s12042-011-9088-z; Rabbi I, 2012, THEOR APPL GENET, V125, P329, DOI 10.1007/s00122-012-1836-4; Rafalski A, 2002, CURR OPIN PLANT BIOL, V5, P94, DOI 10.1016/S1369-5266(02)00240-6; Sakurai T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074056; Schueler MG, 2001, SCIENCE, V294, P109, DOI 10.1126/science.1065042; Sraphet S, 2011, THEOR APPL GENET, V122, P1161, DOI 10.1007/s00122-010-1520-5; SUMNER AT, 1993, J MOL EVOL, V37, P117, DOI 10.1007/BF02407346; Thanyasiriwat T, 2014, PLANT BIOLOGY, V16, P197, DOI 10.1111/plb.12022; Turner EH, 2009, NAT METHODS, V6, P315, DOI 10.1038/nmeth.f.248; van Ooijen J.W., 2001, JOINMAP 3 0 SOFTWARE; van Ooijen JW, 2002, MAPQTL 4 0 SOFTWARE; Van Tassell CP, 2008, NAT METHODS, V5, P247, DOI 10.1038/NMETH.1185; Vidal RO, 2012, GENET MOL BIOL, V35, P331, DOI 10.1590/S1415-47572012000200014; Yin TF, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-8-r77; Zhang XL, 2005, PLANT PHYSIOL, V138, P663, DOI 10.1104/pp.105.060319; Zheng Y, 2011, J BIOL CHEM, V286, P36108, DOI 10.1074/jbc.M111.275974	59	34	40	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2014	9	12							e116028	10.1371/journal.pone.0116028	http://dx.doi.org/10.1371/journal.pone.0116028			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UC	25551642	Green Published, Green Submitted, gold			2022-12-27	WOS:000347119100089
J	Razavi, MS; Shirani, E; Salimpour, MR; Kassab, GS				Razavi, Mohammad S.; Shirani, Ebrahim; Salimpour, Mohammad Reza; Kassab, Ghassan S.			Constructal Law of Vascular Trees for Facilitation of Flow	PLOS ONE			English	Article							CORONARY ARTERIAL TREE; BLOOD-FLOW; MORPHOMETRY; NETWORKS; DESIGN; RESISTANCE; EVOLUTION; TRANSPORT; PRESSURE; SYSTEMS	Diverse tree structures such as blood vessels, branches of a tree and river basins exist in nature. The constructal law states that the evolution of flow structures in nature has a tendency to facilitate flow. This study suggests a theoretical basis for evaluation of flow facilitation within vascular structure from the perspective of evolution. A novel evolution parameter (Ev) is proposed to quantify the flow capacity of vascular structures. Ev is defined as the ratio of the flow conductance of an evolving structure (configuration with imperfection) to the flow conductance of structure with least imperfection. Attaining higher Ev enables the structure to expedite flow circulation with less energy dissipation. For both Newtonian and non-Newtonian fluids, the evolution parameter was developed as a function of geometrical shape factors in laminar and turbulent fully developed flows. It was found that the non-Newtonian or Newtonian behavior of fluid as well as flow behavior such as laminar or turbulent behavior affects the evolution parameter. Using measured vascular morphometric data of various organs and species, the evolution parameter was calculated. The evolution parameter of the tree structures in biological systems was found to be in the range of 0.95 to 1. The conclusion is that various organs in various species have high capacity to facilitate flow within their respective vascular structures.	[Razavi, Mohammad S.; Salimpour, Mohammad Reza] Isfahan Univ Technol, Dept Mech Engn, Esfahan, Iran; [Shirani, Ebrahim] Foolad Inst Technol, Dept Engn, Fooladshahr, Isfahan, Iran; [Kassab, Ghassan S.] Indiana Univ Purdue Univ, Dept Biomed Engn, Indianapolis, IN 46202 USA; [Kassab, Ghassan S.] Indiana Univ Purdue Univ, Dept Surg, Indianapolis, IN 46202 USA; [Kassab, Ghassan S.] Indiana Univ Purdue Univ, Dept Cellular & Integrat Physiol, Indianapolis, IN 46202 USA	Isfahan University of Technology; Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis	Kassab, GS (corresponding author), Indiana Univ Purdue Univ, Dept Biomed Engn, Indianapolis, IN 46202 USA.	gkassab@iupui.edu	Salimpour, Mohammad Reza/S-5314-2017; ANIKUZHIYIL, ANISH/Y-8609-2018; Shirani, Ebrahim/AAZ-6539-2021	Salimpour, Mohammad Reza/0000-0002-5871-8360; ANIKUZHIYIL, ANISH/0000-0001-9686-1283; Razavi Rizi, Mohammad/0000-0002-8991-6087				Bai C, 2010, J APPL PHYS, V108, DOI 10.1063/1.3486501; Bai C, 2009, J HEAT TRANS-T ASME, V131, DOI 10.1115/1.3155002; Bejan A, 1997, INT J HEAT MASS TRAN, V40, P799, DOI 10.1016/0017-9310(96)00175-5; Bejan A, 2004, INT J HEAT MASS TRAN, V47, P3203, DOI 10.1016/j.ijheatmasstransfer.2004.02.007; Bejan A, 2001, INT J HEAT MASS TRAN, V44, P699, DOI 10.1016/S0017-9310(00)00138-1; Bejan A., 2008, DESIGN CONSTRUCTAL T; Bejan A., 2000, SHAPE STRUCTURE ENG; Bejan A, 2013, J APPL PHYS, V113, DOI 10.1063/1.4798429; Bejan A, 2011, PHYS LIFE REV, V8, P209, DOI 10.1016/j.plrev.2011.05.010; Bejan A, 2010, PHILOS T R SOC B, V365, P1335, DOI 10.1098/rstb.2009.0302; Bejan A, 2006, J APPL PHYS, V100, DOI 10.1063/1.2221896; BERTUGLIA S, 1991, AM J PHYSIOL, V260, pH362, DOI 10.1152/ajpheart.1991.260.2.H362; Bieupoude P, 2012, COMPUT ENVIRON URBAN, V36, P434, DOI 10.1016/j.compenvurbsys.2012.03.007; CHILIAN WM, 1991, CIRC RES, V69, P561, DOI 10.1161/01.RES.69.3.561; ELLSWORTH ML, 1987, MICROVASC RES, V34, P168, DOI 10.1016/0026-2862(87)90051-3; Errera MR, 1998, FRACTALS, V6, P245, DOI 10.1142/S0218348X98000298; Fan J, 2010, INT J HEAT MASS TRAN, V53, P4238, DOI 10.1016/j.ijheatmasstransfer.2010.05.050; FENTON BM, 1981, ANN BIOMED ENG, V9, P303, DOI 10.1007/BF02364653; Finet G, 2010, EUROINTERVENTION, V6, pJ10, DOI 10.4244/EIJV6SUPJA3; GAN RZ, 1993, J APPL PHYSIOL, V75, P432, DOI 10.1152/jappl.1993.75.1.432; HORSFIELD K, 1981, LUNG, V159, P211, DOI 10.1007/BF02713917; Huang W, 1996, J APPL PHYSIOL, V81, P2123, DOI 10.1152/jappl.1996.81.5.2123; Huo YL, 2006, AM J PHYSIOL-HEART C, V291, pH1074, DOI 10.1152/ajpheart.00200.2006; Huo YL, 2012, J R SOC INTERFACE, V9, P190, DOI 10.1098/rsif.2011.0270; Huo YL, 2009, BIOPHYS J, V96, P339, DOI 10.1016/j.bpj.2008.09.038; Huo YL, 2009, BIOPHYS J, V96, P347, DOI 10.1016/j.bpj.2008.09.039; Jayaweera AR, 1999, AM J PHYSIOL-HEART C, V277, pH2363, DOI 10.1152/ajpheart.1999.277.6.H2363; JIANG ZL, 1994, J APPL PHYSIOL, V76, P882, DOI 10.1152/jappl.1994.76.2.882; Kaimovitz B, 2008, AM J PHYSIOL-HEART C, V294, pH714, DOI 10.1152/ajpheart.00818.2007; KANATSUKA H, 1991, CIRC RES, V68, P726, DOI 10.1161/01.RES.68.3.726; KASSAB GS, 1993, AM J PHYSIOL, V265, pH350, DOI 10.1152/ajpheart.1993.265.1.H350; Kassab GS, 1997, ANN BIOMED ENG, V25, P204, DOI 10.1007/BF02738551; Kleidon A, 2010, PHILOS T R SOC B, V365, P1297, DOI 10.1098/rstb.2010.0018; KOLLER A, 1987, AM J PHYSIOL, V253, pH154, DOI 10.1152/ajpheart.1987.253.1.H154; Ku DN, 1997, ANNU REV FLUID MECH, V29, P399, DOI 10.1146/annurev.fluid.29.1.399; LABARBERA M, 1990, SCIENCE, V249, P992, DOI 10.1126/science.2396104; LEY K, 1986, MICROVASC RES, V32, P315, DOI 10.1016/0026-2862(86)90068-3; McCulloh KA, 2003, NATURE, V421, P939, DOI 10.1038/nature01444; Miguel AF, 2010, J FLUID STRUCT, V26, P330, DOI 10.1016/j.jfluidstructs.2009.11.004; Mittal N, 2005, AM J PHYSIOL-HEART C, V289, pH439, DOI 10.1152/ajpheart.00730.2004; Price CA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0085420; Razavi MS, 2013, J BIOMECH, V46, P2303, DOI 10.1016/j.jbiomech.2013.06.005; Reddy BVK, 2008, INT J THERM SCI, V47, P1482, DOI 10.1016/j.ijthermalsci.2007.11.003; Sciacovelli A, 2011, INT J THERMODYNAMICS, V14; SINGHAL S, 1973, CIRC RES, V33, P190, DOI 10.1161/01.RES.33.2.190; TILLMANNS H, 1981, CIRC RES, V49, P1202, DOI 10.1161/01.RES.49.5.1202; VANBAVEL E, 1992, CIRC RES, V71, P1200, DOI 10.1161/01.RES.71.5.1200; Williams HR, 2008, J R SOC INTERFACE, V5, P55, DOI 10.1098/rsif.2007.1022; Wu F, 2009, CRYOGENICS, V49, P107, DOI 10.1016/j.cryogenics.2008.09.009; YEN RT, 1984, J BIOMECH ENG-T ASME, V106, P131, DOI 10.1115/1.3138469; YEN RT, 1983, J APPL PHYSIOL, V55, P236, DOI 10.1152/jappl.1983.55.1.236; ZAMIR M, 1983, J GEN PHYSIOL, V81, P325, DOI 10.1085/jgp.81.3.325; Zhou YF, 1999, PHYS MED BIOL, V44, P2929, DOI 10.1088/0031-9155/44/12/306	53	10	10	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2014	9	12							e116260	10.1371/journal.pone.0116260	http://dx.doi.org/10.1371/journal.pone.0116260			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UC	25551617	Green Published, gold, Green Submitted			2022-12-27	WOS:000347119100116
J	Goyal, M; Chaudhuri, TK; Kuwajima, K				Goyal, Megha; Chaudhuri, Tapan K.; Kuwajima, Kunihiro			Irreversible Denaturation of Maltodextrin Glucosidase Studied by Differential Scanning Calorimetry, Circular Dichroism, and Turbidity Measurements	PLOS ONE			English	Article							PROTEIN KINETIC STABILITY; THERMAL-DENATURATION; ESCHERICHIA-COLI; HEAT DENATURATION; BETA-LACTOGLOBULIN; RESIDUAL STRUCTURE; GLOBULAR-PROTEINS; TRANSITION-STATE; LENTIL LECTIN; AGGREGATION	Thermal denaturation of Escherichia coli maltodextrin glucosidase was studied by differential scanning calorimetry, circular dichroism (230 nm), and UV-absorption measurements (340 nm), which were respectively used to monitor heat absorption, conformational unfolding, and the production of solution turbidity. The denaturation was irreversible, and the thermal transition recorded at scan rates of 0.5-1.5 K/min was significantly scan-rate dependent, indicating that the thermal denaturation was kinetically controlled. The absence of a protein-concentration effect on the thermal transition indicated that the denaturation was rate-limited by a mono-molecular process. From the analysis of the calorimetric thermograms, a one-step irreversible model well represented the thermal denaturation of the protein. The calorimetrically observed thermal transitions showed excellent coincidence with the turbidity transitions monitored by UV-absorption as well as with the unfolding transitions monitored by circular dichroism. The thermal denaturation of the protein was thus rate-limited by conformational unfolding, which was followed by a rapid irreversible formation of aggregates that produced the solution turbidity. It is thus important to note that the absence of the protein-concentration effect on the irreversible thermal denaturation does not necessarily means the absence of protein aggregation itself. The turbidity measurements together with differential scanning calorimetry in the irreversible thermal denaturation of the protein provided a very effective approach for understanding the mechanisms of the irreversible denaturation. The Arrhenius-equation parameters obtained from analysis of the thermal denaturation were compared with those of other proteins that have been reported to show the one-step irreversible thermal denaturation. Maltodextrin glucosidase had sufficiently high kinetic stability with a half-life of 68 days at a physiological temperature (37 degrees C).	[Goyal, Megha; Kuwajima, Kunihiro] Natl Inst Nat Sci, Okazaki Inst Integrat Biosci, Okazaki, Aichi 4448787, Japan; [Goyal, Megha; Kuwajima, Kunihiro] Natl Inst Nat Sci, Inst Mol Sci, Okazaki, Aichi 4448787, Japan; [Goyal, Megha; Chaudhuri, Tapan K.] Indian Inst Technol, Sch Biol Sci, New Delhi 110016, India; [Kuwajima, Kunihiro] Grad Univ Adv Studies Sokendai, Sch Phys Sci, Dept Funct Mol Sci, Okazaki, Aichi 4448787, Japan; [Kuwajima, Kunihiro] Grad Univ Adv Studies Sokendai, CPIS, Hayama, Kanagawa 2400193, Japan; [Kuwajima, Kunihiro] Korea Inst Adv Study, Sch Computat Sci, Seoul 130722, South Korea	National Institutes of Natural Sciences (NINS) - Japan; Okazaki Institute for Integrative Bioscience (OIIB); National Institutes of Natural Sciences (NINS) - Japan; Institute for Molecular Science (IMS); Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Delhi; Graduate University for Advanced Studies - Japan; Graduate University for Advanced Studies - Japan; Korea Institute for Advanced Study (KIAS)	Chaudhuri, TK (corresponding author), Indian Inst Technol, Sch Biol Sci, Hauz Khas, New Delhi 110016, India.	tkchaudhuri@bioschool.iitd.ernet.in; kuwajima_kunihiro@soken.ac.jp			Department of Science and Technology, Govt of India under Science and Engineering Board [SR/SO/BB-0040/2012]; Council of Scientific and Industrial Research, Govt. of India [37(1565)/12/EMR-II]; Ministry of Education, Culture, Sports, Science and Technology of Japan [20107009]; Japan Society for the Promotion of Science [25440075]	Department of Science and Technology, Govt of India under Science and Engineering Board; Council of Scientific and Industrial Research, Govt. of India(Council of Scientific & Industrial Research (CSIR) - India); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This study was supported by funds to TKC from Department of Science and Technology, Govt of India under Science and Engineering Board, Grant No. SR/SO/BB-0040/2012, and by another grant from Council of Scientific and Industrial Research, Govt. of India, Grant No. 37(1565)/12/EMR-II. It was also supported by a Grant-in-Aid for Scientific Research on Innovative Areas to KK from the Ministry of Education, Culture, Sports, Science and Technology of Japan (grant number 20107009), and by a Grant-in-Aid for Scientific Research (C) to KK from the Japan Society for the Promotion of Science (grant number 25440075). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHERN TJ, 1988, METHOD BIOCHEM ANAL, V33, P91; Amani M, 2007, BIOPHYS CHEM, V125, P254, DOI 10.1016/j.bpc.2006.08.006; Aymard P, 1996, J CHIM PHYS PCB, V93, P987, DOI 10.1051/jcp/1996930987; BAKER D, 1992, NATURE, V356, P263, DOI 10.1038/356263a0; Baussay K, 2004, INT J BIOL MACROMOL, V34, P21, DOI 10.1016/j.ijbiomac.2003.11.003; Benjwal S, 2006, PROTEIN SCI, V15, P635, DOI 10.1110/ps.051917406; Chiti F, 2009, NAT CHEM BIOL, V5, P15, DOI 10.1038/nchembio.131; CONEJEROLARA F, 1991, BIOCHEMISTRY-US, V30, P2067, DOI 10.1021/bi00222a010; Corley SC, 2011, BIOPHYS J, V100, P2946, DOI 10.1016/j.bpj.2011.05.015; Costas M, 2009, J MOL BIOL, V385, P924, DOI 10.1016/j.jmb.2008.10.056; Daniel RM, 1996, BIOCHEM J, V317, P1, DOI 10.1042/bj3170001; del Pino IMP, 2000, PROTEINS, V40, P58, DOI 10.1002/(SICI)1097-0134(20000701)40:1<58::AID-PROT80>3.0.CO;2-M; Durand D, 2002, PHYSICA A, V304, P253, DOI 10.1016/S0378-4371(01)00514-3; Duy C, 2005, J BIOL CHEM, V280, P37360, DOI 10.1074/jbc.M507530200; Dzwolak W, 2003, BIOCHEMISTRY-US, V42, P11347, DOI 10.1021/bi034879h; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; Godoy-Ruiz R, 2006, J MOL BIOL, V362, P966, DOI 10.1016/j.jmb.2006.07.065; Golub N, 2007, FEBS LETT, V581, P4223, DOI 10.1016/j.febslet.2007.07.066; Guzzi R, 2008, BBA-PROTEINS PROTEOM, V1784, P1997, DOI 10.1016/j.bbapap.2008.07.005; Idakieva K, 2005, BBA-PROTEINS PROTEOM, V1748, P50, DOI 10.1016/j.bbapap.2004.12.004; Janis J, 2008, INT J BIOL MACROMOL, V42, P75, DOI 10.1016/j.ijbiomac.2007.09.012; Johnson SM, 2012, J MOL BIOL, V421, P185, DOI 10.1016/j.jmb.2011.12.060; Kedracka-Krok S, 2003, EUR J BIOCHEM, V270, P4564, DOI 10.1046/j.1432-1033.2003.03856.x; Khanova HA, 2005, BIOCHEMISTRY-US, V44, P15480, DOI 10.1021/bi051175u; Klimtchuk ES, 2010, BIOCHEMISTRY-US, V49, P9848, DOI 10.1021/bi101351c; Kurganov BI, 1997, BIOPHYS CHEM, V69, P125, DOI 10.1016/S0301-4622(97)80552-2; LOHNER K, 1991, BIOCHEMISTRY-US, V30, P6620, DOI 10.1021/bi00240a035; LUMRY R, 1954, J PHYS CHEM-US, V58, P110, DOI 10.1021/j150512a005; Lyubarev AE, 1999, BIOPHYS CHEM, V79, P199, DOI 10.1016/S0301-4622(99)00050-2; Lyubarev AE, 2000, J THERM ANAL CALORIM, V62, P51, DOI 10.1023/A:1010102525964; Marcos MJ, 1999, FEBS LETT, V443, P192, DOI 10.1016/S0014-5793(98)01708-6; Marcos MJ, 2000, EUR J BIOCHEM, V267, P2127, DOI 10.1046/j.1432-1327.2000.01233.x; Markossian KA, 2006, BIOCHEMISTRY-US, V45, P13375, DOI 10.1021/bi0610707; Nielsen AD, 2003, BBA-PROTEINS PROTEOM, V1652, P52, DOI 10.1016/j.bbapap.2003.08.002; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; Paul S, 2007, FEBS J, V274, P6000, DOI 10.1111/j.1742-4658.2007.06122.x; Paul S, 2007, FASEB J, V21, P2874, DOI 10.1096/fj.06-7958com; Pey AL, 2013, BIOCHEMISTRY-US, V52, P1160, DOI 10.1021/bi301565m; Pey AL, 2011, AMINO ACIDS, V41, P1233, DOI 10.1007/s00726-010-0801-2; Pey AL, 2009, J BIOL INORG CHEM, V14, P521, DOI 10.1007/s00775-009-0467-y; Piatek R, 2009, BIOCHEMISTRY-US, V48, P11807, DOI 10.1021/bi900920k; Pina DG, 2001, EUR J BIOCHEM, V268, P120, DOI 10.1046/j.1432-1033.2001.01855.x; Potekhin SA, 1999, BIOCHEMISTRY-US, V38, P4121, DOI 10.1021/bi982789k; Potekhin SA, 1998, BIOPHYS CHEM, V73, P241, DOI 10.1016/S0301-4622(98)00149-5; Potekhin SA, 1998, BIOFIZIKA+, V43, P223; Potekhin SA, 2000, J THERM ANAL CALORIM, V62, P111, DOI 10.1023/A:1010114828690; Privalov P L, 1986, Methods Enzymol, V131, P4; Quesada-Soriano I, 2006, BBA-PROTEINS PROTEOM, V1764, P979, DOI 10.1016/j.bbapap.2006.03.002; Rodriguez A, 2002, EUR J BIOCHEM, V269, P2584, DOI 10.1046/j.1432-1033.2002.02930.x; Rodriguez-Larrea D, 2006, J MOL BIOL, V360, P715, DOI 10.1016/j.jmb.2006.05.009; Sanchez-Ruiz J M, 1995, Subcell Biochem, V24, P133; Sanchez-Ruiz JM, 2011, ANNU REV PHYS CHEM, V62, P231, DOI 10.1146/annurev-physchem-032210-103504; Sanchez-Ruiz JM, 2010, BIOPHYS CHEM, V148, P1, DOI 10.1016/j.bpc.2010.02.004; SANCHEZRUIZ JM, 1992, BIOPHYS J, V61, P921, DOI 10.1016/S0006-3495(92)81899-4; SANCHEZRUIZ JM, 1988, BIOCHEMISTRY-US, V27, P1648, DOI 10.1021/bi00405a039; Sandberg A, 2003, BIOCHEMISTRY-US, V42, P10301, DOI 10.1021/bi034371e; Sandberg A, 2002, BIOCHEMISTRY-US, V41, P1060, DOI 10.1021/bi0157621; Shnyrov VL, 1999, THERMOCHIM ACTA, V325, P143, DOI 10.1016/S0040-6031(98)00571-1; Song KM, 2010, BIOCHEM BIOPH RES CO, V397, P87, DOI 10.1016/j.bbrc.2010.05.073; Stirpe A, 2005, BBA-PROTEINS PROTEOM, V1752, P47, DOI 10.1016/j.bbapap.2005.07.004; Strucksberg KH, 2007, BBA-PROTEINS PROTEOM, V1774, P1591, DOI 10.1016/j.bbapap.2007.09.005; STURTEVANT JM, 1987, ANNU REV PHYS CHEM, V38, P463, DOI 10.1146/annurev.pc.38.100187.002335; TAPIO S, 1991, J BIOL CHEM, V266, P19450; Tur-Arlandis G, 2010, BIOPHYS J, V98, pL12, DOI 10.1016/j.bpj.2009.11.028; Vermeer AWP, 2000, BIOPHYS J, V78, P394, DOI 10.1016/S0006-3495(00)76602-1; Weijers M, 2003, PROTEIN SCI, V12, P2693, DOI 10.1110/ps.03242803; Zamorano LS, 2008, BIOCHIMIE, V90, P1737, DOI 10.1016/j.biochi.2008.07.010; Zoldak G, 2004, J BIOL CHEM, V279, P47601, DOI 10.1074/jbc.M406883200	68	26	28	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2014	9	12							e115877	10.1371/journal.pone.0115877	http://dx.doi.org/10.1371/journal.pone.0115877			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX6YH	25548918	Green Published, gold, Green Submitted			2022-12-27	WOS:000347063500033
J	Li, L; Tan, HP; Gu, ZT; Liu, ZF; Geng, Y; Liu, YS; Tong, HS; Tang, YQ; Qiu, JM; Su, L				Li, Li; Tan, Hongping; Gu, Zhengtao; Liu, Zhifeng; Geng, Yan; Liu, Yunsong; Tong, Huasheng; Tang, Youqing; Qiu, Junmin; Su, Lei			Heat Stress Induces Apoptosis through a Ca2+-Mediated Mitochondrial Apoptotic Pathway in Human Umbilical Vein Endothelial Cells	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; OXIDATIVE STRESS; SARCOPLASMIC-RETICULUM; HEPATOCELLULAR INJURY; RYANODINE RECEPTOR; SMOOTH-MUSCLE; CA2+ RELEASE; HELA-CELLS; CALCIUM; HYPERTHERMIA	Background: Heat stress can be acutely cytotoxic, and heat stress-induced apoptosis is a prominent pathological feature of heat-related illnesses, although the precise mechanisms by which heat stress triggers apoptosis are poorly defined. Methods: The percentages of viability and cell death were assessed by WST-1 and LDH release assays. Apoptosis was assayed by DNA fragmentation and caspase activity. Expression of cleaved PARP, Apaf-1, phospho-PERK, Phospho-eIF2a, ATF4, XBP-1s, ATF6, GRP78, phospho-IP3R, RYR and SERCA was estimated by Western blot. The effect of calcium overload was determined using flow cytometric analysis with the fluorescent probe Fluo-3/AM. The generation of ROS (O-2(-), H2O2, NO) was labeled by confocal laser scanning microscopy images of fluorescently and flow cytometry. Results: In this study, we found that heat stress in HUVEC cells activated initiators of three major unfolded protein response (UPR) signaling transduction pathways: PERK-eIF2a-ATF4, IRE1-XBP-1S and ATF6 to protect against ER stress, although activation declined over time following cessation of heat stress. Furthermore, we show that intense heat stress may induce apoptosis in HUVEC cells through the calcium-mediated mitochondrial apoptotic pathway, as indicated by elevation of cytoplasmic Ca2+, expression of Apaf-1, activation of caspase-9 and caspase-3, PARP cleavage, and ultimately nucleosomal DNA fragmentation; Reactive oxygenspecies (ROS) appear to act upstream in this process. In addition, we provide evidence that IP3R upregulation may promote influx of Ca2+ into the cytoplasm after heat stress. Conclusion: Our findings describe a novel mechanism for heat stress-induced apoptosis in HUVEC cells: following elevation of cytoplasm Ca2+, activation of the mitochondrial apoptotic pathway via the IP3R upregulation, with ROS acting as an upstream regulator of the process.	[Li, Li; Liu, Zhifeng; Geng, Yan; Liu, Yunsong; Tong, Huasheng; Tang, Youqing; Qiu, Junmin; Su, Lei] PLA, Key Lab Trop Zone Trauma Care & Tissue Repair, Guangzhou Gen Hosp Guangzhou Mil Command, Dept Intens Care Unit, Guangzhou, Peoples R China; [Li, Li] Southern Med Univ, Guangzhou, Peoples R China; [Tan, Hongping] Guangdong Sanjiu Brain Hosp, Dept Epilepsy Surg, Guangzhou, Peoples R China; [Gu, Zhengtao] Southern Med Univ, Affiliated Hosp 3, Dept Intens Care Unit, Guangzhou, Peoples R China	Southern Theater Command General Hospital; Southern Medical University - China; Southern Medical University - China	Su, L (corresponding author), PLA, Key Lab Trop Zone Trauma Care & Tissue Repair, Guangzhou Gen Hosp Guangzhou Mil Command, Dept Intens Care Unit, Guangzhou, Peoples R China.	sulei_ICU@163.com			project team of the Natural Science Foundation of Guangdong Province [s2013030013217]; Project of Medical Research of PLA [BWS12J108]; Natural Science Fund of Guangdong Province [10151001002000001];  [81101467];  [81071529]	project team of the Natural Science Foundation of Guangdong Province; Project of Medical Research of PLA; Natural Science Fund of Guangdong Province(National Natural Science Foundation of Guangdong Province); ; 	This work was supported by China (No. 81101467, 81071529), the project team of the Natural Science Foundation of Guangdong Province (s2013030013217), the Project of Medical Research of PLA BWS12J108, and Natural Science Fund of Guangdong Province (No. 10151001002000001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi T, 2014, J CLIN BIOCHEM NUTR, V54, P129, DOI 10.3164/jcbn.13-46; Aubier M, 1998, EUR RESPIR J, V11, P758; Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; Bhandary B, 2013, INT J MOL SCI, V14, P434, DOI 10.3390/ijms14010434; Bouchama A, 2005, J APPL PHYSIOL, V98, P697, DOI 10.1152/japplphysiol.00461.2004; Bouchama A, 2002, NEW ENGL J MED, V346, P1978, DOI 10.1056/NEJMra011089; Breitwieser GE, 2006, CURR TOP DEV BIOL, V73, P85, DOI 10.1016/S0070-2153(05)73003-9; Brinton MR, 2012, INT J HYPERTHER, V28, P163, DOI 10.3109/02656736.2011.638963; BUCKLEY IK, 1972, LAB INVEST, V26, P201; Burdon R H, 1987, Free Radic Res Commun, V3, P129, DOI 10.3109/10715768709069778; Cao XH, 2011, CHEM-BIOL INTERACT, V190, P16, DOI 10.1016/j.cbi.2011.01.010; Carafoli E, 2002, P NATL ACAD SCI USA, V99, P1115, DOI 10.1073/pnas.032427999; CDC (Centers for Disease Control and Prevention), 2000, MMWR-MORBID MORTAL W, V49, P470; Chang CK, 2007, PROG BRAIN RES, V162, P525, DOI 10.1016/S0079-6123(06)62025-6; Crompton M, 2002, BIOCHIMIE, V84, P143, DOI 10.1016/S0300-9084(02)01368-8; Glembotski CC, 2013, J MOL CELL CARDIOL; Gu ZT, 2014, SCI REP-UK, V4, DOI 10.1038/srep04469; Hajnoczky G, 2003, BIOCHEM BIOPH RES CO, V304, P445, DOI 10.1016/S0006-291X(03)00616-8; Hemon D, 2004, REV EPIDEMIOL SANTE, V52, P3, DOI 10.1016/S0398-7620(04)99017-7; Horimoto K, 2006, TOXICOLOGY, V225, P97, DOI 10.1016/j.tox.2006.05.004; Hsu YL, 2011, EXP EYE RES, V93, P405, DOI 10.1016/j.exer.2011.06.005; Hyun DH, 2007, J NEUROCHEM, V100, P1364, DOI 10.1111/j.1471-4159.2006.04411.x; Jaimovich E, 2005, FEBS LETT, V579, P2051, DOI 10.1016/j.febslet.2005.02.053; Laver DR, 2007, BIOPHYS J, V92, P3541, DOI 10.1529/biophysj.106.099028; Lee SJ, 2008, FREE RADICAL BIO MED, V45, P167, DOI 10.1016/j.freeradbiomed.2008.03.026; Lugo-Amador NM, 2004, EMERG MED CLIN N AM, V22, P315, DOI 10.1016/j.emc.2004.01.004; Lynch K, 2000, ENDOCRINOLOGY, V141, P4209, DOI 10.1210/en.141.11.4209; McAnulty SR, 2005, INT J SPORTS MED, V26, P188, DOI 10.1055/s-2004-820990; McCarron JG, 2008, J CELL SCI, V121, P86, DOI 10.1242/jcs.017541; Milleron RS, 2006, J BIOL CHEM, V281, P16991, DOI 10.1074/jbc.M512754200; Naranjo JR, 2012, J BIOL CHEM, V287, P31674, DOI 10.1074/jbc.R112.384982; NIXON GF, 1994, J MUSCLE RES CELL M, V15, P682, DOI 10.1007/BF00121075; Ortega-Camarillo C, 2006, MOL CELL BIOCHEM, V281, P163, DOI 10.1007/s11010-006-0829-5; OTSU K, 1990, J BIOL CHEM, V265, P13472; Oyadomari S, 2004, CELL DEATH DIFFER, V11, P381, DOI 10.1038/sj.cdd.4401373; Pallepati P, 2010, ARCH BIOCHEM BIOPHYS, V495, P97, DOI 10.1016/j.abb.2009.12.014; Park CH, 2004, J INVEST DERMATOL, V123, P1012, DOI 10.1111/j.0022-202X.2004.23487.x; Patz JA, 2005, NATURE, V438, P310, DOI 10.1038/nature04188; Roberts GT, 2008, ARTERIOSCL THROM VAS, V28, P1130, DOI 10.1161/ATVBAHA.107.158709; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; SAKAGUCHI Y, 1995, CANCER RES, V55, P5459; SKIBBA JL, 1991, INT J HYPERTHER, V7, P749, DOI 10.3109/02656739109056444; Tabas I, 2011, NAT CELL BIOL, V13, P184, DOI 10.1038/ncb0311-184; Tombal B, 1999, CELL CALCIUM, V25, P19, DOI 10.1054/ceca.1998.0005; Tsai Yien Che, 2010, Genes Cancer, V1, P764; Verfaillie T, 2012, CELL DEATH DIFFER, V19, P1880, DOI 10.1038/cdd.2012.74; Wold LE, 2006, FREE RADICAL BIO MED, V40, P1419, DOI 10.1016/j.freeradbiomed.2005.12.009; Xu YF, 2009, CANCER LETT, V284, P229, DOI 10.1016/j.canlet.2009.04.028; Yamaguchi H, 2009, J BIOL CHEM, V284, P11171, DOI 10.1074/jbc.M809268200; Yeo Theresa Pluth, 2004, AACN Clin Issues, V15, P280, DOI 10.1097/00044067-200404000-00013	50	55	64	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2014	9	12							e111083	10.1371/journal.pone.0111083	http://dx.doi.org/10.1371/journal.pone.0111083			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX6YH	25549352	Green Published, Green Submitted, gold			2022-12-27	WOS:000347063500002
J	Tian, H; Wang, LL; Cai, RQ; Zheng, L; Guo, L				Tian, Han; Wang, Leilei; Cai, Ruiqi; Zheng, Ling; Guo, Lin			Identification of Protein Network Alterations upon Retinal Ischemia-Reperfusion Injury by Quantitative Proteomics Using a Rattus norvegicus Model	PLOS ONE			English	Article							EXPRESSION; MECHANISMS; GLUTAMATE; CLASSIFICATION; INFLAMMATION; MTOR; TAU	Retinal ischemia is a common feature associated with several ocular diseases, including diabetic retinopathy. In this study, we investigated the effect of a retinal ischemia and reperfusion (I/R) injury on protein levels via a quantitative shotgun strategy using stable isotope dimethyl labeling combined with LC-MS/MS analysis. Based on the relative quantitation data of 1088 proteins, 234 proteins showed a greater than 1.5-fold change following I/R injury, 194 of which were up-regulated and 40 were down-regulated. Gene ontology analysis revealed that after I/R injury, there was an increase in the metabolic-process related proteins but a decline in cell communication, system process and transport-related proteins. A ribosome protein network and a secreted protein network consisting of many protease inhibitors were identified among the up-regulated proteins, despite a suppression of the mammalian target of rapamycin (mTOR) pathway following the I/R injury. A synaptic-related protein network was found to be significantly down-regulated, implicating a functional reduction of neurons following a retinal I/R injury. Our results provide new systems-biology clues for the study of retinal ischemia.	[Tian, Han; Wang, Leilei; Cai, Ruiqi; Zheng, Ling; Guo, Lin] Wuhan Univ, Coll Life Sci, Wuhan 430072, Peoples R China	Wuhan University	Zheng, L (corresponding author), Wuhan Univ, Coll Life Sci, Wuhan 430072, Peoples R China.	lzheng@whu.edu.cn; guol@whu.edu.cn		Zheng, Ling/0000-0002-6545-4180	National Basic Research Program of China [2012CB524901]; Natural Science Foundation of China [31271370, 81100687]; Ministry of Science and Technology of China [2013CB911102]; 111 Project of China [B06018]	National Basic Research Program of China(National Basic Research Program of China); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China); 111 Project of China(Ministry of Education, China - 111 Project)	This work was supported by the National Basic Research Program of China (2012CB524901; http://www.973.gov.cn/AreaAppl.aspx), the Natural Science Foundation of China (no. 31271370 and 81100687; http://www.nsfc.gov.cn/), the Ministry of Science and Technology of China (2013CB911102; http://www.most.gov.cn/), and the 111 Project of China (B06018; http://www.dost.moe.edu.cn/dostmoe/) provided to Wuhan University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aebersold R, 2003, NATURE, V422, P198, DOI 10.1038/nature01511; Aoyagi T, 2012, AM J PHYSIOL-HEART C, V303, pH75, DOI 10.1152/ajpheart.00241.2012; Azuma M, 2008, SURV OPHTHALMOL, V53, P150, DOI 10.1016/j.survophthal.2007.12.006; Berntson AK, 2003, J VISION, V3, P274, DOI 10.1167/3.4.3; Boersema PJ, 2009, NAT PROTOC, V4, P484, DOI 10.1038/nprot.2009.21; Bonne C, 1998, GEN PHARMACOL, V30, P275, DOI 10.1016/S0306-3623(97)00357-1; Chen FT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064262; Chen X, 2011, J CHROMATOGR B, V879, P25, DOI 10.1016/j.jchromb.2010.11.004; Dan C, 2008, ACTA HISTOCHEM CYTOC, V41, P173, DOI 10.1267/ahc.08034; Danton GH, 2003, J NEUROPATH EXP NEUR, V62, P127, DOI 10.1093/jnen/62.2.127; Dijk F, 2004, INVEST OPHTH VIS SCI, V45, P330, DOI 10.1167/iovs.03-0285; Franceschini A, 2013, NUCLEIC ACIDS RES, V41, pD808, DOI 10.1093/nar/gks1094; Guertin DA, 2007, CANCER CELL, V12, P9, DOI 10.1016/j.ccr.2007.05.008; He MH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084800; Jahn R, 2012, NATURE, V490, P201, DOI 10.1038/nature11320; Jiang M, 2010, AM J PATHOL, V176, P1181, DOI 10.2353/ajpath.2010.090594; Krishnan MN, 2008, NATURE, V455, P242, DOI 10.1038/nature07207; Kwon SE, 2011, NEURON, V70, P847, DOI 10.1016/j.neuron.2011.04.001; Lewis J, 2000, NAT GENET, V25, P402, DOI 10.1038/78078; Liu G, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.382549; Mi HY, 2013, NAT PROTOC, V8, P1551, DOI 10.1038/nprot.2013.092; Neufeld AH, 2002, EXP EYE RES, V75, P521, DOI 10.1006/exer.2002.2042; Nucci C, 2005, NEUROTOXICOLOGY, V26, P935, DOI 10.1016/j.neuro.2005.06.002; Ong SE, 2005, NAT CHEM BIOL, V1, P252, DOI 10.1038/nchembio736; Osborne NN, 2004, PROG RETIN EYE RES, V23, P91, DOI 10.1016/j.preteyeres.2003.12.001; Park KK, 2008, SCIENCE, V322, P963, DOI 10.1126/science.1161566; Portillo JAC, 2008, J IMMUNOL, V181, P8719, DOI 10.4049/jimmunol.181.12.8719; Saito R, 2012, NAT METHODS, V9, P1069, DOI [10.1038/nmeth.2212, 10.1038/NMETH.2212]; Stoll G, 2002, ADV EXP MED BIOL, V513, P87; Stowell Cheri, 2010, Int J Physiol Pathophysiol Pharmacol, V2, P148; Tanemura K, 2002, J NEUROSCI, V22, P133, DOI 10.1523/JNEUROSCI.22-01-00133.2002; Wang LL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023194; Wu L, 2013, WORLD J DIABETES, V4, P290, DOI 10.4239/wjd.v4.i6.290; Ying Z, 2009, HUM MOL GENET, V18, P4268, DOI 10.1093/hmg/ddp380; Zhao X, 2014, J PROTEOME RES; Zheng L, 2007, INVEST OPHTH VIS SCI, V48, P361, DOI 10.1167/iovs.06-0510; Zheng L, 2009, PROTEOMICS, V9, P1869, DOI 10.1002/pmic.200701071; Zhou LH, 2013, ACTA HISTOCHEM CYTOC, V46, P11, DOI 10.1267/ahc.12029	38	3	3	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2014	9	12							e116453	10.1371/journal.pone.0116453	http://dx.doi.org/10.1371/journal.pone.0116453			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX6YH	25549249	Green Published, Green Submitted, gold			2022-12-27	WOS:000347063500085
J	Grecucci, A; De Pisapia, N; Thero, DK; Paladino, MP; Venuti, P; Job, R				Grecucci, Alessandro; De Pisapia, Nicola; Thero, Derangala Kusalagnana; Paladino, Maria Paola; Venuti, Paola; Job, Remo			Baseline and Strategic Effects behind Mindful Emotion Regulation: Behavioral and Physiological Investigation	PLOS ONE			English	Article							COGNITIVE CONTROL; DECISION-MAKING; MEDITATION; INTERVENTION; SENSITIVITY; MECHANISMS; DEPRESSION; RUMINATION; ULTIMATUM; PROGRAM	One of the consequences of extensive mindfulness practice is a reduction of anxiety and depression, but also a capacity to regulate negative emotions. In this study, we explored four key questions concerning mindfulness training: (1) What are the processes by which mindfulness regulates our emotions? (2) Can mindfulness be applied to social emotions? (3) Does mindfulness training affect emotionally driven behavior towards others? (4) Does mindfulness alter physiological reactivity? To address these questions, we tested, in two experiments, the ability of mindfulness meditators to regulate interpersonal emotions (Experiment 1) and interactive behaviors (Experiment 2) as compared to naive controls. To better understand the mechanisms by which mindfulness regulates emotions, we asked participants to apply two strategies: a cognitive strategy (mentalizing, a form of reappraisal focused on the intentions of others) and an experiential strategy derived from mindfulness principles (mindful detachment). Both groups were able to regulate interpersonal emotions by means of cognitive (mentalizing) and experiential (mindful detachment) strategies. In Experiment 1, a simple effect of meditation, independent from the implementation of the strategies, resulted in reduced emotional and physiological reactivity, as well as in increased pleasantness for meditators when compared to controls, providing evidence of baseline regulation. In Experiment 2, one visible effect of the strategy was that meditators outperformed controls in the experiential (mindful detachment) but not in the cognitive (mentalize) strategy, showing stronger modulation of their interactive behavior (less punishments) and providing evidence of a strategic behavioral regulation. Based on these results, we suggest that mindfulness can influence interpersonal emotional reactions through an experiential mechanism, both at a baseline level and a strategic level, thereby altering the subjective and physiological perception of emotions, but also biasing interactive social behavior.	[Grecucci, Alessandro; De Pisapia, Nicola; Thero, Derangala Kusalagnana; Paladino, Maria Paola; Venuti, Paola; Job, Remo] Univ Trento, Dept Psychol & Cognit Sci, Rovereto, TN, Italy	University of Trento	Grecucci, A (corresponding author), Univ Trento, Dept Psychol & Cognit Sci, Rovereto, TN, Italy.	alessandro.grecucci@unitn.it	grecucci, alessandro/O-4609-2019; Venuti, Paola/J-8540-2014; De Pisapia, Nicola/AHE-1410-2022	grecucci, alessandro/0000-0001-6043-2196; Venuti, Paola/0000-0002-1827-0549; De Pisapia, Nicola/0000-0002-1089-8841; Paladino, Maria Paola/0000-0002-1664-9475	Comune of Rovereto	Comune of Rovereto	The authors would like to thank Comune of Rovereto for the grant given to Remo Job. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baer RA, 2003, CLIN PSYCHOL-SCI PR, V10, P125, DOI 10.1093/clipsy/bpg015; Balzarotti S, 2010, EUR J PSYCHOL ASSESS, V26, P61, DOI 10.1027/1015-5759/a000009; Benedek M, 2010, J NEUROSCI METH, V190, P80, DOI 10.1016/j.jneumeth.2010.04.028; Bishop SR, 2004, CLIN PSYCHOL-SCI PR, V11, P230, DOI 10.1093/clipsy/bph077; Bondolfi G, 2010, J AFFECT DISORDERS, V122, P224, DOI 10.1016/j.jad.2009.07.007; BRADLEY MM, 1994, J BEHAV THER EXP PSY, V25, P49, DOI 10.1016/0005-7916(94)90063-9; Brefczynski-Lewis JA, 2007, P NATL ACAD SCI USA, V104, P11483, DOI 10.1073/pnas.0606552104; Broderick P, 2005, COGNITIVE THER RES, V29, P501, DOI 10.1007/s10608-005-3888-0; Civai C, 2010, COGNITION, V114, P89, DOI 10.1016/j.cognition.2009.09.001; Corcoran KM., 2010, EMOTION REGULATION P, P339; Creswell JD, 2007, PERS SOC PSYCHOL B, V33, P238, DOI 10.1177/0146167206294412; Davidson RJ, 2010, EMOTION, V10, P8, DOI 10.1037/a0018480; DELMONTE MM, 1985, BIOL PSYCHOL, V21, P107, DOI 10.1016/0301-0511(85)90009-2; Erisman SM, 2010, EMOTION, V10, P72, DOI 10.1037/a0017162; Frederikson J., 2013, COCREATING CHANGE EF; Gard T, 2012, CEREB CORTEX, V22, P2692, DOI 10.1093/cercor/bhr352; Garland EL, 2012, J BEHAV MED, V35, P591, DOI 10.1007/s10865-011-9391-z; Garnefski N., 2002, CERQ MANUAL USE COGN; Goldin PR, 2010, EMOTION, V10, P83, DOI 10.1037/a0018441; GOLEMAN DJ, 1976, J CONSULT CLIN PSYCH, V44, P456, DOI 10.1037/0022-006X.44.3.456; Grant JA, 2011, PAIN, V152, P150, DOI 10.1016/j.pain.2010.10.006; Grecucci A, 2012, II CONFLITTO EPISTEM; Grecucci A, BIOMED RES IN PRESS; Grecucci A, BEHAV PHYSL IN UNPUB; Grecucci A, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00523; Grecucci A, 2013, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00616; Grecucci A, 2013, CEREB CORTEX, V23, P399, DOI 10.1093/cercor/bhs028; Hayes S. C, 2011, ACCEPTANCE COMMITMEN; Holzel BK, 2011, PERSPECT PSYCHOL SCI, V6, P537, DOI 10.1177/1745691611419671; Jain S, 2007, ANN BEHAV MED, V33, P11, DOI 10.1207/s15324796abm3301_2; Jha AP, 2007, COGN AFFECT BEHAV NE, V7, P109, DOI 10.3758/CABN.7.2.109; Kabat-Zinn J, 1990, FULL CATASTROPHE LIV, P33; KABATZINN J, 1982, GEN HOSP PSYCHIAT, V4, P33, DOI 10.1016/0163-8343(82)90026-3; KABATZINN J, 1992, AM J PSYCHIAT, V149, P936; Linehan M. M., 1993, COGNITIVE BEHAV TREA; Lush E, 2009, J CLIN PSYCHOL MED S, V16, P200, DOI 10.1007/s10880-009-9153-z; Lutz A, 2008, TRENDS COGN SCI, V12, P163, DOI 10.1016/j.tics.2008.01.005; Modinos G, 2010, SOC COGN AFFECT NEUR, V5, P369, DOI 10.1093/scan/nsq006; Ochsner KN, 2005, TRENDS COGN SCI, V9, P242, DOI 10.1016/j.tics.2005.03.010; Ortner CNM, 2007, MOTIV EMOTION, V31, P271, DOI 10.1007/s11031-007-9076-7; Safran, 2003, PSYCHOANALYSIS BUDDH; Sanfey AG, 2003, SCIENCE, V300, P1755, DOI 10.1126/science.1082976; Sanfey AG, 2007, SCIENCE, V318, P598, DOI 10.1126/science.1142996; Segal Z. V., 2002, MINDFULNESS BASED CO; Taylor VA, 2011, NEUROIMAGE, V57, P1524, DOI 10.1016/j.neuroimage.2011.06.001; Teasdale JD, 2000, J CONSULT CLIN PSYCH, V68, P615, DOI 10.1037//0022-006X.68.4.615; WATSON D, 1988, J PERS SOC PSYCHOL, V54, P1063, DOI 10.1037/0022-3514.54.6.1063	47	26	26	2	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2015	10	1							e0116541	10.1371/journal.pone.0116541	http://dx.doi.org/10.1371/journal.pone.0116541			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CC9HN	25590627	Green Published, gold, Green Submitted			2022-12-27	WOS:000350679400016
J	Jeanray, N; Maree, R; Pruvot, B; Stern, O; Geurts, P; Wehenkel, L; Muller, M				Jeanray, Nathalie; Maree, Raphael; Pruvot, Benoist; Stern, Olivier; Geurts, Pierre; Wehenkel, Louis; Muller, Marc			Phenotype Classification of Zebrafish Embryos by Supervised Learning	PLOS ONE			English	Article							SCREENS	Zebrafish is increasingly used to assess biological properties of chemical substances and thus is becoming a specific tool for toxicological and pharmacological studies. The effects of chemical substances on embryo survival and development are generally evaluated manually through microscopic observation by an expert and documented by several typical photographs. Here, we present a methodology to automatically classify brightfield images of wildtype zebrafish embryos according to their defects by using an image analysis approach based on supervised machine learning. We show that, compared to manual classification, automatic classification results in 90 to 100% agreement with consensus voting of biological experts in nine out of eleven considered defects in 3 days old zebrafish larvae. Automation of the analysis and classification of zebrafish embryo pictures reduces the workload and time required for the biological expert and increases the reproducibility and objectivity of this classification.	[Jeanray, Nathalie; Pruvot, Benoist; Muller, Marc] Univ Liege, GIGA Dev Stem Cells & Regenerat Med, Liege, Belgium; [Jeanray, Nathalie; Stern, Olivier; Geurts, Pierre; Wehenkel, Louis] Univ Liege, GIGA Syst Biol & Chem Biol, Dept EE & CS, Liege, Belgium; [Maree, Raphael; Wehenkel, Louis] Univ Liege, GIGA Bioinformat Core Facil, Liege, Belgium	University of Liege; University of Liege; University of Liege	Muller, M (corresponding author), Univ Liege, GIGA Dev Stem Cells & Regenerat Med, Liege, Belgium.	m.muller@ulg.ac.be		Maree, Raphael/0000-0002-9587-1954	Walloon Region (FEDER); European Interreg Program Almain-silico (AIS); European Space Agency (ESA); Fonds National de la Recherche Scientifique (F.N.R.S.)	Walloon Region (FEDER); European Interreg Program Almain-silico (AIS); European Space Agency (ESA)(European Space Agency); Fonds National de la Recherche Scientifique (F.N.R.S.)(Fonds de la Recherche Scientifique - FNRS)	This study was suppported by The Walloon Region (FEDER. GIGA2 Bioindustry support: (www.wallonie.be), The European Interreg Program Almain-silico (AIS): (www.euregio-mr.com), The European Space Agency (ESA): (http://www.esa.int/ESA), The Fonds National de la Recherche Scientifique (F.N.R.S.): (www.fnrs.be), M.M. is a "Chercheur Qualifie du F.N.R.S." The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alshut R, 2010, LECT NOTES ARTIF INT, V6359, P219, DOI 10.1007/978-3-642-16111-7_25; Arslanova D, 2010, BMC BIOTECHNOL, V10, DOI 10.1186/1472-6750-10-24; Cao Y, 2009, P NATL ACAD SCI USA, V106, P21819, DOI 10.1073/pnas.0911987106; Chang TY, 2012, LAB CHIP, V12, P711, DOI 10.1039/c1lc20849g; Chen YH, 2012, REPROD TOXICOL, V33, P233, DOI 10.1016/j.reprotox.2011.12.008; David A, 2009, J APPL TOXICOL, V29, P597, DOI 10.1002/jat.1446; Dooley K, 2000, CURR OPIN GENET DEV, V10, P252, DOI 10.1016/S0959-437X(00)00074-5; Fraysse B, 2006, ECOTOX ENVIRON SAFE, V63, P253, DOI 10.1016/j.ecoenv.2004.10.015; Geurts P, 2006, MACH LEARN, V63, P3, DOI 10.1007/s10994-006-6226-1; Gurvich N, 2005, FASEB J, V19, P1166, DOI 10.1096/fj.04-3425fje; JEANRAY N, 2011, 20TH ANNUAL BELGIAN; JIANGFEI C, 2012, NEUROTOXICOLOGY AND, V34, P581, DOI DOI 10.1016/J.NTT.2012.09.001; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kucukoglu M, 2013, TURK J BIOL, V37, P158, DOI 10.3906/biy-1203-27; Liu R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035014; LIXIN Y, 2010, TOXICOL SCI, V115, P379; Love DR, 2004, CURR OPIN BIOTECH, V15, P564, DOI 10.1016/j.copbio.2004.09.004; MAREE R, 2013, PROC 12TH EUROPEAN C, P526; Maree R, 2007, BMC CELL BIOL, V8, DOI 10.1186/1471-2121-8-S1-S2; Mikut R, 2013, ZEBRAFISH, V10, P401, DOI 10.1089/zeb.2013.0886; OECD, 2013, OECD GUIDELINES FOR; Pardo-Martin C, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2475; Peter ALJ, 2005, ENVIRON INT, V31, P493, DOI 10.1016/j.envint.2004.09.003; Peterson RT, 2000, P NATL ACAD SCI USA, V97, P12965, DOI 10.1073/pnas.97.24.12965; Pruvot B, 2012, REPROD TOXICOL, V34, P568, DOI 10.1016/j.reprotox.2012.07.010; Shamir L, 2011, J MICROSC-OXFORD, V243, P284, DOI 10.1111/j.1365-2818.2011.03502.x; Shamir L, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000974; Spitsbergen Jan M., 2003, Toxicologic Pathology, V31, P62, DOI 10.1080/01926230309774; STERN O, 2011, PROCEEDINGS OF THE 6; TAT J, 2012, DRUG DISCOVERY TODAY; Teraoka Hiroki, 2003, Congenital Anomalies, V43, P123, DOI 10.1111/j.1741-4520.2003.tb01036.x; Teresa G, 2002, TOXICOL LETT, V132, P57, DOI 10.1016/S0378-4274(02)00066-8; Tornova E, 2008, J ENVIRON BIOL, V29, P897; Vogt A, 2009, DEV DYNAM, V238, P656, DOI 10.1002/dvdy.21892; Weigt S, 2010, TOXICOLOGY, V275, P36, DOI 10.1016/j.tox.2010.05.012; Westerfield M., 2007, THE ZEBRAFISH BOOK	36	25	25	4	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2015	10	1							e0116989	10.1371/journal.pone.0116989	http://dx.doi.org/10.1371/journal.pone.0116989			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ4BU	25574849	Green Submitted, Green Published, gold			2022-12-27	WOS:000348168100010
J	Baronio, D; Castro, K; Gonchoroski, T; de Melo, GM; Nunes, GD; Bambini, V; Gottfried, C; Riesgo, R				Baronio, Diego; Castro, Kamila; Gonchoroski, Taylor; de Melo, Gabriela Mueller; Della Flora Nunes, Gustavo; Bambini-Junior, Victorio; Gottfried, Carmem; Riesgo, Rudimar			Effects of an H3R Antagonist on the Animal Model of Autism Induced by Prenatal Exposure to Valproic Acid	PLOS ONE			English	Article							RECEPTOR ANTAGONISTS; WORKING-MEMORY; HISTAMINE; CHILDREN; ANTINOCICEPTION; SCHIZOPHRENIA; FAMOTIDINE; DISORDERS; DEFICITS; SENSITIZATION	Autism spectrum disorders (ASD) are a group of neurodevelopmental disorders primarily characterized by impaired social interaction and communication, and by restricted repetitive behaviors and interests. Ligands of histamine receptor 3 (H3R) are considered potential therapeutic agents for the treatment of different brain disorders and cognitive impairments. Considering this, the aim of the present study is to evaluate the actions of ciproxifan (CPX), an H3R antagonist, on the animal model of autism induced by prenatal exposure to valproic acid (VPA). Swiss mice were prenatally exposed to VPA on embryonic day 11 and assessed for social behavior, nociceptive threshold and repetitive behavior at 50 days of life. The treatment with CPX (3 mg/kg) or saline was administered 30 minutes before each behavioral test. The VPA group presented lower sociability index compared to VPA animals that were treated with CPX. Compared to the Control group, VPA animals presented a significantly higher nociceptive threshold, and treatment with CPX was not able to modify this parameter. In the marble burying test, the number of marbles buried by VPA animals was consistent with markedly repetitive behavior. VPA animals that received CPX buried a reduced amount of marbles. In summary, we report that an acute dose of CPX is able to attenuate sociability deficits and stereotypies present in the VPA model of autism. Our findings have the potential to help the investigations of both the molecular underpinnings of ASD and of possible treatments to ameliorate the ASD symptomatology, although more research is still necessary to corroborate and expand this initial data.	[Baronio, Diego; Castro, Kamila; Gonchoroski, Taylor; de Melo, Gabriela Mueller; Della Flora Nunes, Gustavo; Bambini-Junior, Victorio; Gottfried, Carmem; Riesgo, Rudimar] Univ Fed Rio Grande do Sul, Translat Res Grp Autism Spectrum Disorders, Porto Alegre, RS, Brazil; [Baronio, Diego; Castro, Kamila; Riesgo, Rudimar] Univ Fed Rio Grande do Sul, Postgrad Program Child & Adolescent Hlth, Porto Alegre, RS, Brazil; [Baronio, Diego; Castro, Kamila; Gonchoroski, Taylor; de Melo, Gabriela Mueller; Della Flora Nunes, Gustavo; Bambini-Junior, Victorio; Gottfried, Carmem; Riesgo, Rudimar] Univ Fed Rio Grande do Sul, Dept Biochem, Res Grp Neuroglial Plast, Porto Alegre, RS, Brazil; [Riesgo, Rudimar] Univ Fed Rio Grande do Sul, Hosp Clin Porto Alegre, Child Neurol Unit, Porto Alegre, RS, Brazil	Universidade Federal do Rio Grande do Sul; Universidade Federal do Rio Grande do Sul; Universidade Federal do Rio Grande do Sul; Universidade Federal do Rio Grande do Sul	Baronio, D (corresponding author), Univ Fed Rio Grande do Sul, Translat Res Grp Autism Spectrum Disorders, Porto Alegre, RS, Brazil.	diego@baronio.com.br	Riesgo, Rudimar/Q-3821-2016; Nunes, Gustavo Della-Flora/AAR-9617-2021; Bambini-Junior, Victorio/O-7563-2014; Grokoski, Kamila Castro/M-2068-2015; Gottfried, Carmem/AAG-2355-2019; Bambini-Junior, Victorio/AAO-7056-2021	Nunes, Gustavo Della-Flora/0000-0001-9323-3556; Gottfried, Carmem/0000-0001-8838-1300; Bambini-Junior, Victorio/0000-0002-8590-6770; Grokoski, Kamila Castro/0000-0003-0100-1788; Mueller de Melo, Gabriela/0000-0003-0429-2023	Fundo de Incentivo a Pesquisa e Eventos do Hospital de Clinicas de Porto Alegre (FIPE-HCPA); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)	Fundo de Incentivo a Pesquisa e Eventos do Hospital de Clinicas de Porto Alegre (FIPE-HCPA); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was funded by Fundo de Incentivo a Pesquisa e Eventos do Hospital de Clinicas de Porto Alegre (FIPE-HCPA), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) and Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAMBINI V, 2014, PRENATAL EXPOSURE VA, P1779; da Silveira CKB, 2013, NEUROBIOL LEARN MEM, V103, P64, DOI 10.1016/j.nlm.2013.04.001; Brioni JD, 2011, J PHARMACOL EXP THER, V336, P38, DOI 10.1124/jpet.110.166876; Bromley RL, 2013, J NEUROL NEUROSUR PS, V84, P637, DOI 10.1136/jnnp-2012-304270; Brown JW, 2013, INT J NEUROPSYCHOPH, V16, P889, DOI 10.1017/S1461145712000739; Burban A, 2010, PSYCHOPHARMACOLOGY, V210, P591, DOI 10.1007/s00213-010-1863-2; Carroll LS, 2009, GENOME MED, V1, DOI 10.1186/gm102; CHRISTIANSON AL, 1994, DEV MED CHILD NEUROL, V36, P361; Ellenbroek BA, 2014, TRENDS NEUROSCI, V37, P191, DOI 10.1016/j.tins.2014.02.007; Farzin D, 2002, PHARMACOL BIOCHEM BE, V72, P751, DOI 10.1016/S0091-3057(02)00748-7; Ferstl R, 2012, FRONT BIOSCI-LANDMRK, V17, P40, DOI 10.2741/3914; Fox GB, 2005, J PHARMACOL EXP THER, V313, P176, DOI 10.1124/jpet.104.078402; GLICK SD, 1978, NATURE, V273, P547, DOI 10.1038/273547a0; Griebel G, 2012, PHARMACOL BIOCHEM BE, V102, P203, DOI 10.1016/j.pbb.2012.04.004; Haas HL, 2008, PHYSIOL REV, V88, P1183, DOI 10.1152/physrev.00043.2007; Happe F, 2008, NEUROPSYCHOL REV, V18, P287, DOI 10.1007/s11065-008-9076-8; Huang L, 2007, REGION ANESTH PAIN M, V32, P124, DOI 10.1016/j.rapm.2006.11.009; Huguet G, 2013, ANNU REV GENOM HUM G, V14, P191, DOI 10.1146/annurev-genom-091212-153431; Ito C, 1997, PSYCHOPHARMACOLOGY, V130, P362, DOI 10.1007/s002130050251; JOSHI VV, 1981, EUR J PHARMACOL, V69, P499, DOI 10.1016/0014-2999(81)90456-8; KAMINSKY R, 1990, LANCET, V335, P1351, DOI 10.1016/0140-6736(90)91237-5; Konstantareas MM, 2001, J AUTISM DEV DISORD, V31, P19, DOI 10.1023/A:1005605528309; Linday LA, 1997, MED HYPOTHESES, V48, P381, DOI 10.1016/S0306-9877(97)90032-3; Linday LA, 2001, J NEURAL TRANSM, V108, P593, DOI 10.1007/s007020170059; MALMBERGAIELLO P, 1994, BRIT J PHARMACOL, V111, P1269, DOI 10.1111/j.1476-5381.1994.tb14883.x; Martin HGS, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00023; Motawaj M, 2011, EUR J NEUROSCI, V33, P1197, DOI 10.1111/j.1460-9568.2011.07618.x; NADDAFI F, 2013, AM J ALZHEIMERS DIS; Noland JS, 2010, DEVELOPMENTAL SCI, V13, P244, DOI 10.1111/j.1467-7687.2009.00882.x; Nuutinen S, 2011, NEUROPHARMACOLOGY, V60, P1193, DOI 10.1016/j.neuropharm.2010.10.027; OWEN SM, 1994, AGENTS ACTIONS, V41, pC62, DOI 10.1007/BF02007768; Paschou P, 2013, NEUROSCI BIOBEHAV R, V37, P1026, DOI 10.1016/j.neubiorev.2013.01.016; Passani MB, 2011, TRENDS PHARMACOL SCI, V32, P242, DOI 10.1016/j.tips.2011.01.003; Rodier PM, 1996, J COMP NEUROL, V370, P247, DOI 10.1002/(SICI)1096-9861(19960624)370:2<247::AID-CNE8>3.0.CO;2-2; Rossi PG, 1999, J CHILD NEUROL, V14, P547, DOI 10.1177/088307389901400814; Roullet FI, 2010, NEUROSCIENCE, V170, P514, DOI 10.1016/j.neuroscience.2010.06.069; John A, 2013, AUTISM RES, V6, P69, DOI 10.1002/aur.1264; Schneider T, 2005, NEUROPSYCHOPHARMACOL, V30, P80, DOI 10.1038/sj.npp.1300518; Schwartz JC, 2011, BRIT J PHARMACOL, V163, P713, DOI 10.1111/j.1476-5381.2011.01286.x; Shan L, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.10.016; Silvestrin RB, 2013, BRAIN RES, V1495, P52, DOI 10.1016/j.brainres.2012.11.048; Steele SD, 2007, J AUTISM DEV DISORD, V37, P605, DOI 10.1007/s10803-006-0202-2; SUZUKI T, 1994, LIFE SCI, V54, P203, DOI 10.1016/0024-3205(94)00589-3; Tiligada E, 2011, CNS NEUROSCI THER, V17, P620, DOI 10.1111/j.1755-5949.2010.00212.x; Trofimiuk E, 2014, PSYCHOPHARMACOLOGY, V231, P209, DOI 10.1007/s00213-013-3227-1; Zhang DD, 2012, INFLAMM RES, V61, P1283, DOI 10.1007/s00011-012-0528-5	46	60	61	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2015	10	1							e0116363	10.1371/journal.pone.0116363	http://dx.doi.org/10.1371/journal.pone.0116363			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ3BG	25560049	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000348102200015
J	Dong, RL; Zhao, GY				Dong, Ruilan; Zhao, Guangyong			Predicting In Vitro Rumen VFA Production Using CNCPS Carbohydrate Fractions with Multiple Linear Models and Artificial Neural Networks	PLOS ONE			English	Article							VOLATILE FATTY-ACIDS; GAS-PRODUCTION; FERMENTATION PATTERN; NET CARBOHYDRATE; PROTEIN SYSTEM; DAIRY-COWS; MILK-YIELD; FEED; SHEEP; CATTLE	The objectives of this trial were to develop multiple linear regression (MLR) models and three-layer Levenberg-Marquardt back propagation (BP3) neural network models using the Cornell Net Carbohydrate and Protein System (CNCPS) carbohydrate fractions as dietary variables for predicting in vitro rumen volatile fatty acid (VFA) production and further compare MLR and BP3 models. Two datasets were established for the trial, of which the first dataset containing 45 feed mixtures with concentrate/roughage ratios of 10:90, 20:80, 30:70, 40:60, and 50:50 were used for establishing the models and the second dataset containing 10 feed mixtures with the same concentrate/roughage ratios with the first dataset were used for testing the models. The VFA production of feed samples was determined using an in vitro incubation technique. The CNCPS carbohydrate fractions (g), i.e. CA (sugars), CB1 (starch and pectin), CB2 (available cell wall) of feed samples were calculated based on chemical analysis. The performance of MLR models and BP3 models were compared using a paired t-test, the determination coefficient (R-2) and the root mean square prediction error (RMSPE) between observed and predicted values. Statistical analysis indicated that VFA production (mmol) was significantly correlated with CNCPS carbohydrate fractions (g) CA, CB1, and CB2 in a multiple linear pattern. Compared with MLR models, BP3 models were more accurate in predicting acetate, propionate, and total VFA production while similar in predicting butyrate production. The trial indicated that both MLR and BP3 models were suitable for predicting in vitro rumen VFA production of feed mixtures using CNCPS carbohydrate fractions CA, CB1, and CB2 as input dietary variables while BP3 models showed greater accuracy for prediction.	[Dong, Ruilan; Zhao, Guangyong] China Agr Univ, Coll Anim Sci & Technol, State Key Lab Anim Nutr, Beijing 100094, Peoples R China	China Agricultural University	Zhao, GY (corresponding author), China Agr Univ, Coll Anim Sci & Technol, State Key Lab Anim Nutr, Beijing 100094, Peoples R China.	zhaogy@cau.edu.cn		, Ruilan/0000-0002-1681-2279	National Natural Science Foundation of China [31072155]; Ministry of Science and Technology of China [2011BAD26B03-4]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China)	This work was financially supported by the National Natural Science Foundation of China (Project no. 31072155) and The Ministry of Science and Technology of China (Project no. 2011BAD26B03-4). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida JS, 2002, CURR OPIN BIOTECH, V13, P72, DOI 10.1016/S0958-1669(02)00288-4; Ankinakatte S, 2013, COMPUT ELECTRON AGR, V99, P1, DOI 10.1016/j.compag.2013.08.024; AOAC, 2007, OFFICIAL METHODS ANA, V18th; BALDWIN RL, 1987, J DAIRY RES, V54, P107, DOI 10.1017/S0022029900025231; Bannink A, 2006, J THEOR BIOL, V238, P36, DOI 10.1016/j.jtbi.2005.05.026; Bhagwat AM, 2012, J DAIRY SCI, V95, P3926, DOI 10.3168/jds.2011-4850; BLUMMEL M, 1993, ANIM FEED SCI TECH, V40, P109, DOI 10.1016/0377-8401(93)90150-I; Blummel M, 2005, ANIM FEED SCI TECH, V123, P379, DOI 10.1016/j.anifeedsci.2005.06.001; Brown VE, 2002, ANIM FEED SCI TECH, V98, P13, DOI 10.1016/S0377-8401(01)00341-8; Cavero D, 2008, LIVEST SCI, V114, P280, DOI 10.1016/j.livsci.2007.05.012; Chen LJ, 2008, J DAIRY SCI, V91, P4822, DOI 10.3168/jds.2007-0978; Chen LJ, 2008, BIOSYST ENG, V101, P341, DOI 10.1016/j.biosystemseng.2008.09.005; Craninx M, 2008, COMPUT ELECTRON AGR, V60, P226, DOI 10.1016/j.compag.2007.08.005; DIJKSTRA J, 1992, J NUTR, V122, P2239, DOI 10.1093/jn/122.11.2239; Dong RL, 2013, ASIAN AUSTRAL J ANIM, V26, P1708, DOI 10.5713/ajas.2013.13245; Dongre VB, 2012, LIVEST SCI, V147, P192, DOI 10.1016/j.livsci.2012.04.002; Fernandez C, 2007, NEURAL COMPUT APPL, V16, P373, DOI 10.1007/s00521-006-0061-y; Friggens NC, 1998, J DAIRY SCI, V81, P1331, DOI 10.3168/jds.S0022-0302(98)75696-6; Goering H. K, 1970, FORAGE FIBER ANALYSE, V379; Goyal S, 2012, J ADV COMPUTER SCI T, V1, P101; Hassan KJ, 2009, J DAIRY SCI, V92, P1493, DOI 10.3168/jds.2008-1539; Hecht-Nielsen R., 1991, NEUROCOMPUTING; Ince D, 2013, SMALL RUMINANT RES, V113, P15, DOI 10.1016/j.smallrumres.2013.01.013; Kominakis AP, 2002, COMPUT ELECTRON AGR, V35, P35, DOI 10.1016/S0168-1699(02)00051-0; Lanzas C, 2007, ANIM FEED SCI TECH, V136, P167, DOI 10.1016/j.anifeedsci.2006.08.025; Liu JX, 2002, J ANIM SCI, V80, P517; Menke K.H, 1988, ANIM RES DEV, V28, P7, DOI DOI 10.1016/S0301-6226(01)00298-6.PALMQUIST; Njubi DM, 2010, TROP ANIM HEALTH PRO, V42, P639, DOI 10.1007/s11250-009-9468-7; Norouzian MA, 2012, NEURAL COMPUT APPL, V21, P905, DOI 10.1007/s00521-011-0579-5; Noziere P, 2010, ANIMAL, V4, P1057, DOI 10.1017/S1751731110000844; Pitt RE, 1996, J ANIM SCI, V74, P226; PRASAD CS, 1994, J SCI FOOD AGR, V65, P457, DOI 10.1002/jsfa.2740650414; Raja TV, 2012, NEURAL COMPUT APPL, V21, P119, DOI 10.1007/s00521-011-0637-z; Sanzogni L, 2001, COMPUT ELECTRON AGR, V32, P21, DOI 10.1016/S0168-1699(01)00151-X; Shi HY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035781; SNIFFEN CJ, 1992, J ANIM SCI, V70, P3562, DOI 10.2527/1992.70113562x; Stefanon B, 2001, J NUTR, V131, P3307, DOI 10.1093/jn/131.12.3307; Tahmoorespur M, 2012, LIVEST SCI, V148, P221, DOI 10.1016/j.livsci.2012.06.008; Tang ZH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070571; VANSOEST PJ, 1991, J DAIRY SCI, V74, P3583, DOI 10.3168/jds.S0022-0302(91)78551-2; Vlaeminck B, 2006, J DAIRY SCI, V89, P3954, DOI 10.3168/jds.S0022-0302(06)72437-7	41	2	2	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2014	9	12							e116290	10.1371/journal.pone.0116290	http://dx.doi.org/10.1371/journal.pone.0116290			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UC	25551220	Green Published, gold, Green Submitted			2022-12-27	WOS:000347119100126
J	Dumonceaux, TJ; Green, M; Hammond, C; Perez, E; Olivier, C				Dumonceaux, Tim J.; Green, Margaret; Hammond, Christine; Perez, Edel; Olivier, Chrystel			Molecular Diagnostic Tools for Detection and Differentiation of Phytoplasmas Based on Chaperonin-60 Reveal Differences in Host Plant Infection Patterns	PLOS ONE			English	Article							16S RIBOSOMAL-RNA; FINER DIFFERENTIATION; SEQUENCE-ANALYSIS; GENE-SEQUENCES; GROEL GENE; IDENTIFICATION; CLASSIFICATION; AMPLIFICATION; YELLOWS; STRAINS	Phytoplasmas ('Candidatus Phytoplasma' spp.) are insect-vectored bacteria that infect a wide variety of plants, including many agriculturally important species. The infections can cause devastating yield losses by inducing morphological changes that dramatically alter inflorescence development. Detection of phytoplasma infection typically utilizes sequences located within the 16S-23S rRNA-encoding locus, and these sequences are necessary for strain identification by currently accepted standards for phytoplasma classification. However, these methods can generate PCR products >1400 bp that are less divergent in sequence than protein-encoding genes, limiting strain resolution in certain cases. We describe a method for accessing the chaperonin-60 (cpn60) gene sequence from a diverse array of 'Ca. Phytoplasma' spp. Two degenerate primer sets were designed based on the known sequence diversity of cpn60 from 'Ca. Phytoplasma' spp. and used to amplify cpn60 gene fragments from various reference samples and infected plant tissues. Forty three cpn60 sequences were thereby determined. The cpn60 PCR-gel electrophoresis method was highly sensitive compared to 16S-23S-targeted PCR-gel electrophoresis. The topology of a phylogenetic tree generated using cpn60 sequences was congruent with that reported for 16S rRNA-encoding genes. The cpn60 sequences were used to design a hybridization array using oligonucleotide-coupled fluorescent microspheres, providing rapid diagnosis and typing of phytoplasma infections. The oligonucleotide-coupled fluorescent microsphere assay revealed samples that were infected simultaneously with two subtypes of phytoplasma. These tools were applied to show that two host plants, Brassica napus and Camelina sativa, displayed different phytoplasma infection patterns.	[Dumonceaux, Tim J.; Hammond, Christine; Olivier, Chrystel] Agr & Agri Food Canada, Saskatoon Res Ctr, Saskatoon, SK, Canada; [Dumonceaux, Tim J.] Univ Saskatchewan, Dept Vet Microbiol, Saskatoon, SK S7N 0W0, Canada; [Green, Margaret] Canadian Food Inspect Agcy, Ctr Plant Hlth, Sidney, BC, Canada; [Perez, Edel] Univ Veracruzana, Inst Biotecnol & Ecol Aplicada INBIOTECA, Xalapa 91000, Veracruz, Mexico	Agriculture & Agri Food Canada; University of Saskatchewan; Canadian Food Inspection Agency; Universidad Veracruzana	Dumonceaux, TJ (corresponding author), Agr & Agri Food Canada, Saskatoon Res Ctr, Saskatoon, SK, Canada.	tim.dumonceaux@agr.gc.ca	Olivier, chrystel/AAG-2673-2020; Dumonceaux, Tim/H-4751-2019; Pérez-López, Edel/B-2148-2016	Olivier, chrystel/0000-0002-5982-9775; Dumonceaux, Tim/0000-0001-5165-0343; Pérez-López, Edel/0000-0002-3708-8558	Genomics Research and Development Initiative for the shared priority project on quarantine and invasive species	Genomics Research and Development Initiative for the shared priority project on quarantine and invasive species	This work was supported by the Genomics Research and Development Initiative for the shared priority project on quarantine and invasive species. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angelini E, 2007, J MICROBIOL METH, V68, P613, DOI 10.1016/j.mimet.2006.11.015; Banoo S, 2010, NAT REV MICROBIOL, pS17, DOI [10.1038/nrmico1523, 10.1038/nrmicro1523]; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Chaban B, 2009, APPL ENVIRON MICROB, V75, P3055, DOI 10.1128/AEM.00101-09; Chung WC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062770; Clark GW, 2010, BIOCHEM CELL BIOL, V88, P185, DOI [10.1139/o09-157, 10.1139/O09-157]; Contaldo N, 2012, PHYTOPATHOL MEDITERR, V51, P607; Daire X, 1997, EUR J PLANT PATHOL, V103, P507, DOI 10.1023/A:1008641411025; DENG SJ, 1991, J MICROBIOL METH, V14, P53, DOI 10.1016/0167-7012(91)90007-D; DORSCH M, 1992, J MICROBIOL METH, V16, P271, DOI 10.1016/0167-7012(92)90017-X; Dumonceaux TJ, 2011, JOVE-J VIS EXP, DOI 10.3791/3344; Dumonceaux Tim J, 2009, J Clin Microbiol, V47, P4067, DOI 10.1128/JCM.00112-09; Dumonceaux TJ, 2006, J MICROBIOL METH, V64, P46, DOI 10.1016/j.mimet.2005.04.006; Firrao G, 2013, SYST APPL MICROBIOL, V36, P539, DOI 10.1016/j.syapm.2013.07.003; Gasparich GE, 2010, BIOLOGICALS, V38, P193, DOI 10.1016/j.biologicals.2009.11.007; Goh SH, 1996, J CLIN MICROBIOL, V34, P818, DOI 10.1128/JCM.34.4.818-823.1996; Goh SH, 2000, J CLIN MICROBIOL, V38, P3953, DOI 10.1128/JCM.38.11.3953-3959.2000; Hill JE, 2006, J MED MICROBIOL, V55, P393, DOI 10.1099/jmm.0.46282-0; Hill JE, 2006, ENVIRON MICROBIOL, V8, P741, DOI 10.1111/j.1462-2920.2005.00944.x; Hill JE, 2004, GENOME RES, V14, P1669, DOI 10.1101/gr.2649204; Hoorfar J, 2004, J CLIN MICROBIOL, V42, P1863, DOI 10.1128/JCM.42.5.1863-1868.2004; Jayaprakash TP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043009; Lee IM, 2010, INT J SYST EVOL MICR, V60, P2887, DOI 10.1099/ijs.0.019695-0; Lee IM, 2006, MOL CELL PROBE, V20, P87, DOI 10.1016/j.mcp.2005.10.001; LEE IM, 1993, PHYTOPATHOLOGY, V83, P834, DOI 10.1094/Phyto-83-834; Lee IM, 1998, INT J SYST BACTERIOL, V48, P1153, DOI 10.1099/00207713-48-4-1153; Lee IM, 2000, ANNU REV MICROBIOL, V54, P221, DOI 10.1146/annurev.micro.54.1.221; Links MG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049755; Maejima K, 2014, J GEN PLANT PATHOL, V80, P210, DOI 10.1007/s10327-014-0512-8; Makarova O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052092; Marcone C, 2000, INT J SYST EVOL MICR, V50, P1703, DOI 10.1099/00207713-50-5-1703; Martini M, 2007, INT J SYST EVOL MICR, V57, P2037, DOI 10.1099/ijs.0.65013-0; Mende DR, 2013, NAT METHODS, V10, P881, DOI [10.1038/NMETH.2575, 10.1038/nmeth.2575]; Mitrovic J, 2011, ANN APPL BIOL, V159, P41, DOI 10.1111/j.1744-7348.2011.00472.x; Mitrovic J, 2011, B INSECTOL, V64, pS17; Namba S, 2011, J GEN PLANT PATHOL, V77, P345, DOI 10.1007/s10327-011-0341-y; Nikolic P, 2010, MOL CELL PROBE, V24, P303, DOI 10.1016/j.mcp.2010.06.005; Olivier C, 2011, AM J PLANT SCI BIOTE, V141, P425; Richter M, 2009, P NATL ACAD SCI USA, V106, P19126, DOI 10.1073/pnas.0906412106; Saccardo F, 2012, MICROBIOL-SGM, V158, P2805, DOI 10.1099/mic.0.061432-0; Schellenberg JJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041217; Seemuller E, 2010, PHYTOPATHOLOGY, V100, P863, DOI 10.1094/PHYTO-100-9-0863; Smart CD, 1996, APPL ENVIRON MICROB, V62, P2988, DOI 10.1128/AEM.62.8.2988-2993.1996; Sugawara K, 2012, J GEN PLANT PATHOL, V78, P389, DOI 10.1007/s10327-012-0403-9; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Valiunas D, 2013, INT J SYST EVOL MICR, V63, P3904, DOI 10.1099/ijs.0.051912-0; Wei W, 2007, INT J SYST EVOL MICR, V57, P1855, DOI 10.1099/ijs.0.65000-0; Weintraub PG, 2006, ANNU REV ENTOMOL, V51, P91, DOI 10.1146/annurev.ento.51.110104.151039; Zeigler DR, 2003, INT J SYST EVOL MICR, V53, P1893, DOI 10.1099/ijs.0.02713-0; Zhao Y., 2014, GENOMICS PLANT ASS B, P235	52	28	28	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2014	9	12							e116039	10.1371/journal.pone.0116039	http://dx.doi.org/10.1371/journal.pone.0116039			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UC	25551224	Green Submitted, Green Published, gold			2022-12-27	WOS:000347119100091
J	Frerker, K; Sabo, A; Waller, D				Frerker, Katie; Sabo, Autumn; Waller, Donald			Long-Term Regional Shifts in Plant Community Composition Are Largely Explained by Local Deer Impact Experiments	PLOS ONE			English	Article							WHITE-TAILED DEER; ODOCOILEUS-VIRGINIANUS ZIMMERMAN; ALTERNATE STABLE STATES; GROUND-LAYER VEGETATION; GREAT-LAKES REGION; OLD-GROWTH FOREST; ECOLOGICAL RESEARCH; NORTHERN WISCONSIN; TREE REGENERATION; OVERABUNDANT DEER	The fact that herbivores and predators exert top-down effects to alter community composition and dynamics at lower trophic levels is no longer controversial, yet we still lack evidence of the full nature, extent, and longer-term effects of these impacts. Here, we use results from a set of replicated experiments on the local impacts of white-tailed deer to evaluate the extent to which such impacts could account for half-century shifts in forest plant communities across the upper Midwest, USA. We measured species' responses to deer at four sites using 10-20 year-old deer exclosures. Among common species, eight were more abundant outside the exclosures, seven were commoner inside, and 16 had similar abundances in-and outside. Deer herbivory greatly increased the abundance of ferns and graminoids and doubled the abundance of exotic plants. In contrast, deer greatly reduced tree regeneration, shrub cover (100200 fold in two species), plant height, plant reproduction, and the abundance of forbs. None of 36 focal species increased in reproduction or grew taller in the presence of deer, contrary to expectations. We compared these results to data on 50-year regional shifts in species abundances across 62 sites. The effects of herbivory by white-tailed deer accurately account for many of the long-term regional shifts observed in species' abundances (R-2=0.41). These results support the conjecture that deer impacts have driven many of the regional shifts in forest understory cover and composition observed in recent decades. Our ability to link results from shorter-term, local experiments to regional long-term studies of ecological change strengthens the inferences we can draw from both approaches.	[Frerker, Katie; Waller, Donald] Univ Wisconsin, Dept Bot, Madison, WI 53706 USA; [Sabo, Autumn] Univ Wisconsin, Dept Forest & Wildlife Ecol, Madison, WI USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Waller, D (corresponding author), Univ Wisconsin, Dept Bot, Madison, WI 53706 USA.	dmwaller@wisc.edu			UW-Madison Botany Department; Friends of Peninsula State Park; McIntire-Stennis Program	UW-Madison Botany Department; Friends of Peninsula State Park; McIntire-Stennis Program	The authors thank the UW-Madison Botany Department (www.botany.wisc.edu/), Friends of Peninsula State Park (http://peninsulafriends.org/), and the McIntire-Stennis Program (http://www.csrees.usda.gov/business/awards/formula/mcintire_stennis.html) for funding portions of this research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allombert S, 2005, CONSERV BIOL, V19, P1917, DOI 10.1111/j.1523-1739.2005.00280.x; Alverson William S., 1997, P280; ALVERSON WS, 1988, CONSERV BIOL, V2, P348, DOI 10.1111/j.1523-1739.1988.tb00199.x; ANDERSON RC, 1994, ECOL APPL, V4, P104, DOI 10.2307/1942119; ANDERSON RC, 1993, BIOL CONSERV, V63, P203, DOI 10.1016/0006-3207(93)90713-B; Augustine DJ, 1998, J WILDLIFE MANAGE, V62, P1165, DOI 10.2307/3801981; Augustine DJ, 1998, ECOL APPL, V8, P1260, DOI 10.1890/1051-0761(1998)008[1260:EFTASS]2.0.CO;2; Augustine DJ, 1998, CONSERV BIOL, V12, P995, DOI 10.1046/j.1523-1739.1998.97248.x; Augustine DJ, 1997, GRAZING PATTERNS IMP; BALGOOYEN CP, 1995, NAT AREA J, V15, P308; CALLAHAN JT, 1984, BIOSCIENCE, V34, P363, DOI 10.2307/1309727; Canterbury GE, 2000, CONSERV BIOL, V14, P544, DOI 10.1046/j.1523-1739.2000.98235.x; Cardinal E, 2012, CAN J ZOOL, V90, P704, DOI [10.1139/Z2012-037, 10.1139/z2012-037]; Cardinal E, 2012, ECOSCIENCE, V19, P38, DOI 10.2980/19-1-3441; Chollet S, 2015, BIOL INVASIONS, V17, P777, DOI 10.1007/s10530-014-0768-0; Chollet S, 2013, DIVERS DISTRIB, V19, P481, DOI 10.1111/ddi.12003; Christopher CC, 2012, AM MIDL NAT, V167, P256, DOI 10.1674/0003-0031-167.2.256; Collard A, 2010, FOREST ECOL MANAG, V260, P649, DOI 10.1016/j.foreco.2010.05.021; Cornett MW, 2000, BIOL CONSERV, V93, P359, DOI 10.1016/S0006-3207(99)00129-9; Cote SD, 2004, ANNU REV ECOL EVOL S, V35, P113, DOI 10.1146/annurev.ecolsys.35.021103.105725; Curtis JT, 1959, VEGETATION WISCONSIN; de la Cretaz AL, 2002, RESTOR ECOL, V10, P416, DOI 10.1046/j.1526-100X.2002.02037.x; Fletcher JD, 2001, NAT AREA J, V21, P172; Frerker K, 2012, COMP EVALUATION METH; Frerker KL, 2012, WHITE TAILED DEER OD; Hurley PM, 2012, BIOL CONSERV, V146, P62, DOI 10.1016/j.biocon.2011.10.034; Lapointe L, 2010, AM J BOT, V97, P913, DOI 10.3732/ajb.0900200; LEVIN SA, 1992, ECOLOGY, V73, P1943, DOI 10.2307/1941447; MAGNUSON JJ, 1990, BIOSCIENCE, V40, P495, DOI 10.2307/1311317; Martin JL, 2010, BIOL INVASIONS, V12, P353, DOI 10.1007/s10530-009-9628-8; Martin JL, 2002, CAN J FOREST RES, V32, P1254, DOI [10.1139/x02-043, 10.1139/X02-043]; McGraw JB, 2005, SCIENCE, V307, P920, DOI 10.1126/science.1107036; McShea WJ, 2012, ANN NY ACAD SCI, V1249, P45, DOI 10.1111/j.1749-6632.2011.06376.x; McShea WJ, 1992, VIRGINIA J SCI, V43, P177; MILLER S C, 1992, Natural Areas Journal, V12, P67; MLADENOFF DJ, 1993, CONSERV BIOL, V7, P889, DOI 10.1046/j.1523-1739.1993.740889.x; Morecroft MD, 2001, FORESTRY, V74, P251, DOI 10.1093/forestry/74.3.251; Mudrak EL, 2009, NAT AREA J, V29, P167, DOI 10.3375/043.029.0209; Newson SE, 2012, J APPL ECOL, V49, P278, DOI 10.1111/j.1365-2664.2011.02077.x; Patel A, 2000, NAT AREA J, V20, P250; PAULY D, 1995, TRENDS ECOL EVOL, V10, P430, DOI 10.1016/S0169-5347(00)89171-5; Rogers DA, 2009, CONSERV BIOL, V23, P1497, DOI 10.1111/j.1523-1739.2009.01256.x; Rooney TP, 2009, PLANT ECOL, V202, P103, DOI 10.1007/s11258-008-9489-8; Rooney TP, 2004, CONSERV BIOL, V18, P787, DOI 10.1111/j.1523-1739.2004.00515.x; Rooney TP, 2003, FOREST ECOL MANAG, V181, P165, DOI 10.1016/S0378-1127(03)00130-0; Rooney TP, 1997, NAT AREA J, V17, P297; Rooney TP, 2001, FORESTRY, V74, P201, DOI 10.1093/forestry/74.3.201; Rooney TP, 1998, FOREST ECOL MANAG, V111, P211, DOI 10.1016/S0378-1127(98)00333-8; Royo AA, 2006, CAN J FOREST RES, V36, P1345, DOI 10.1139/X06-025; Royo AA, 2010, BIOL CONSERV, V143, P2425, DOI 10.1016/j.biocon.2010.05.020; Russell FL, 2001, AM MIDL NAT, V146, P1, DOI 10.1674/0003-0031(2001)146[0001:EOWTDO]2.0.CO;2; Stromayer KAK, 1997, WILDLIFE SOC B, V25, P227; Suominen O, 1999, OIKOS, V84, P215, DOI 10.2307/3546716; SWANSON FJ, 1990, BIOSCIENCE, V40, P502, DOI 10.2307/1311318; Tanentzap AJ, 2012, FOREST ECOL MANAG, V264, P159, DOI 10.1016/j.foreco.2011.10.005; Tanentzap AJ, 2009, J APPL ECOL, V46, P1064, DOI 10.1111/j.1365-2664.2009.01683.x; Trumbull V. L., 1989, Northern Journal of Applied Forestry, V6, P162; Urbanek RE, 2012, NAT AREA J, V32, P6, DOI 10.3375/043.032.0103; Waller DM, 2004, TRENDS ECOL EVOL, V19, P6, DOI 10.1016/j.tree.2003.10.011; Waller DM, 1997, WILDLIFE SOC B, V25, P217; Webster CR, 2005, BIOL CONSERV, V125, P297, DOI 10.1016/j.biocon.2005.03.027; White MA, 2012, FOREST ECOL MANAG, V269, P222, DOI 10.1016/j.foreco.2011.12.043; Wiegmann SM, 2006, BIOL CONSERV, V129, P109, DOI 10.1016/j.biocon.2005.10.027; Wisconsin Department of Natural Resources, 2014, DEER POP GOALS	64	53	53	2	70	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2014	9	12							e115843	10.1371/journal.pone.0115843	http://dx.doi.org/10.1371/journal.pone.0115843			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UC	25551827	Green Published, Green Submitted, gold			2022-12-27	WOS:000347119100069
J	Liu, B; Chen, HT; Xu, Y; An, CY; Zhong, LQ; Wang, XH; Zhang, Y; Chen, HQ; Zhang, JX; Wang, ZL				Liu, Bin; Chen, Haitian; Xu, Yun; An, Chongyou; Zhong, Lieqiang; Wang, Xiaohui; Zhang, Ying; Chen, Hanqing; Zhang, Jinxin; Wang, Zilian			Fetal Growth Is Associated with Maternal Fasting Plasma Glucose at First Prenatal Visit	PLOS ONE			English	Article							GESTATIONAL DIABETES-MELLITUS; ADVERSE PREGNANCY OUTCOMES; DEVELOPMENTAL ORIGINS; METABOLIC SYNDROME; RANDOMIZED-TRIAL; WEIGHT-GAIN; WOMEN; OVERWEIGHT; HYPERGLYCEMIA; MULTICENTER	Aims: Fasting plasma glucose (FPG) concentration measured at the first prenatal visit is a predictor of gestational diabetes mellitus (GDM); however, whether this test is indicative of fetal growth has not been clarified. Thus, the purpose of this study was to determine whether birth weight and birth length were related to FPG levels at the first prenatal visit. Materials and Methods: Research samples were collected from pregnant women who took an FPG test at their first prenatal visit (10-24 gestational weeks), received regular prenatal care, and delivered in our center. FPG value, maternal pre-gravid BMI, weight gain before FPG test, before and after Oral Glucose Tolerance Test (OGTT), neonatal birthweight, birth length, Ponderal Index and birthing method were recorded for analysis. Data were analyzed by independent sample t test, Pearson correlation, and Chi-square test, followed by partial correlation or logistic regression to confirm differences. Statistical significance level was alpha=0.05. Results: 2284 pregnant women, including 462 GDM and 1822 with normal glucose tolerance (NGT) were recruited for the present study. FPG concentration at the first prenatal visit was associated with neonatal birth weight (partial correlation coefficient r'=0.089, P< 0.001) and birth length (partial correlation coefficient r'=0.061, P=0.005), but not with Ponderal Index or birthing method. Maternal pregravid BMI was associated with FPG value (partial correlation coefficient r'=0.113, P< 0.001). FPG concentration at the first prenatal visit (OR=2.945, P< 0.001), weight gain before OGTT test (OR=1.039, P=0.010), and age (OR=1.107, P<0.001) were independent related factors of GDM. Conclusion: Fasting plasma glucose concentration at the first prenatal visit is associated with fetal growth. Maternal pre-gravid BMI and weight gain are related to glucose metabolism.	[Liu, Bin; Chen, Haitian; An, Chongyou; Zhong, Lieqiang; Wang, Xiaohui; Zhang, Ying; Chen, Hanqing; Wang, Zilian] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Obstet & Gynecol, Guangzhou 510275, Guangdong, Peoples R China; [Xu, Yun] Sun Yat Sen Univ, Affiliated Hosp 6, Dept Endocrinol, Guangzhou 510275, Guangdong, Peoples R China; [Zhang, Jinxin] Sun Yat Sen Univ, Sch Publ Hlth, Dept Med Stat & Epidemiol, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University	Zhang, JX (corresponding author), Sun Yat Sen Univ, Sch Publ Hlth, Dept Med Stat & Epidemiol, Guangzhou 510275, Guangdong, Peoples R China.	zhjinx@mail.sysu.edu.cn; wzlsums@163.com			Sun Yat-Sen University Clinical Research 5010 Program	Sun Yat-Sen University Clinical Research 5010 Program	The present study is granted by Sun Yat-Sen University Clinical Research 5010 Program(to Zilian Wang). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberico S, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-23; Bateson P, 2004, NATURE, V430, P419, DOI 10.1038/nature02725; Clausen TD, 2008, DIABETES CARE, V31, P340, DOI 10.2337/dc07-1596; Clausen TD, 2009, J CLIN ENDOCR METAB, V94, P2464, DOI 10.1210/jc.2009-0305; Dodd JM, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g1285; Dong L, 2013, DIABETES RES CLIN PR, V102, P210, DOI 10.1016/j.diabres.2013.10.017; Egan AM, 2014, J CLIN ENDOCR METAB, V99, P212, DOI 10.1210/jc.2013-2684; Gillman MW, 2005, NEW ENGL J MED, V353, P1848, DOI 10.1056/NEJMe058187; Jovanovic L, 2001, JAMA-J AM MED ASSOC, V286, P2516, DOI 10.1001/jama.286.20.2516; Kim SY, 2011, EXP DIABETES RES, DOI 10.1155/2011/541308; Landon MB, 2009, NEW ENGL J MED, V361, P1339, DOI 10.1056/NEJMoa0902430; Li N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082310; McMillen IC, 2005, PHYSIOL REV, V85, P571, DOI 10.1152/physrev.00053.2003; Morrison JL, 2010, PEDIATR NEPHROL, V25, P669, DOI 10.1007/s00467-009-1407-3; Negrato CA, 2012, DIABETOL METAB SYNDR, V4, DOI 10.1186/1758-5996-4-41; PEDERSEN J, 1954, ACTA ENDOCRINOL-COP, V16, P330, DOI 10.1530/acta.0.0160330; Rattanatray L, 2010, ENDOCRINOLOGY, V151, P5195, DOI 10.1210/en.2010-0501; Riskin-Mashiah S, 2009, DIABETES CARE, V32, P1639, DOI 10.2337/dc09-0688; Solomon CG, 1997, JAMA-J AM MED ASSOC, V278, P1078, DOI 10.1001/jama.278.13.1078; Tomedi LE, 2013, MATERN CHILD HLTH J; Zhang S, 2011, PROG BIOPHYS MOL BIO, V106, P307, DOI 10.1016/j.pbiomolbio.2010.12.004; Zhang S, 2010, FASEB J, V24, P2772, DOI 10.1096/fj.09-154294; Zhu WW, 2012, DIABETES CARE	23	12	13	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2014	9	12							e116352	10.1371/journal.pone.0116352	http://dx.doi.org/10.1371/journal.pone.0116352			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UC	25551824	Green Published, gold, Green Submitted			2022-12-27	WOS:000347119100132
J	Melia, U; Burgos, F; Vallverdu, M; Velickovski, F; Lluch-Ariet, M; Roca, J; Caminal, P				Melia, Umberto; Burgos, Felip; Vallverdu, Montserrat; Velickovski, Filip; Lluch-Ariet, Magi; Roca, Josep; Caminal, Pere			Algorithm for Automatic Forced Spirometry Quality Assessment: Technological Developments	PLOS ONE			English	Article							STANDARDIZATION	We hypothesized that the implementation of automatic real-time assessment of quality of forced spirometry (FS) may significantly enhance the potential for extensive deployment of a FS program in the community. Recent studies have demonstrated that the application of quality criteria defined by the ATS/ERS (American Thoracic Society/European Respiratory Society) in commercially available equipment with automatic quality assessment can be markedly improved. To this end, an algorithm for assessing quality of FS automatically was reported. The current research describes the mathematical developments of the algorithm. An innovative analysis of the shape of the spirometric curve, adding 23 new metrics to the traditional 4 recommended by ATS/ERS, was done. The algorithm was created through a two-step iterative process including: (1) an initial version using the standard FS curves recommended by the ATS; and, (2) a refined version using curves from patients. In each of these steps the results were assessed against one expert's opinion. Finally, an independent set of FS curves from 291 patients was used for validation purposes. The novel mathematical approach to characterize the FS curves led to appropriate FS classification with high specificity (95%) and sensitivity (96%). The results constitute the basis for a successful transfer of FS testing to non-specialized professionals in the community.	[Melia, Umberto; Vallverdu, Montserrat; Caminal, Pere] Univ Politecn Cataluna, Dept Engn Sistemes Automat & Informat Ind ESAII, CREB, CIBER BBN, Barcelona, Spain; [Burgos, Felip; Roca, Josep] Univ Barcelona, IDIBAPS, Dept Pulm Med, Hosp Clin Barcelona ICT, Barcelona, Spain; [Burgos, Felip; Roca, Josep] Ctr Invest Red Enfermedades Resp CibeRes, Palma De Mallorca, Spain; [Velickovski, Filip; Lluch-Ariet, Magi] Barcelona Digital Technol Ctr, Barcelona, Spain; [Velickovski, Filip; Lluch-Ariet, Magi] Univ Politecn Cataluna, Dept Engn Telemat ENTEL, Barcelona, Spain; [Velickovski, Filip] Univ Girona, ViCOROB, Girona, Spain	CIBER - Centro de Investigacion Biomedica en Red; CIBERBBN; Universitat Politecnica de Catalunya; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; CIBER - Centro de Investigacion Biomedica en Red; CIBERES; Universitat Politecnica de Catalunya; Universitat de Girona	Melia, U (corresponding author), Univ Politecn Cataluna, Dept Engn Sistemes Automat & Informat Ind ESAII, CREB, CIBER BBN, Barcelona, Spain.	umberto.melia@upc.edu	Roca, Josep/J-2583-2015; LLUCH-ARIET, Magí/E-2233-2017; Burgos, Felip/E-5734-2015	Roca, Josep/0000-0003-4768-8722; LLUCH-ARIET, Magí/0000-0001-6926-7190; Burgos, Felip/0000-0002-4938-4581; Melia, Umberto/0000-0003-3033-0505	Inforegio (AGAUR); NEXES (Supporting Healthier and Independent Living for Chronic Patients and Elderly) [CIP-ICT-PSP-2007-225025]; FIS [PI09/90634]; Servicios Innovadores de Atencion Integrada para Pacientes Cronicos [PITES- ISCIII 2010-12]; EC-FP7 Programme, Synergy-COPD, GA [270086]; Catalan Master Plan of Respiratory Diseases (PDMAR); TAMESIS (Spanish Government) [TEC2011-22746]	Inforegio (AGAUR); NEXES (Supporting Healthier and Independent Living for Chronic Patients and Elderly); FIS(Instituto de Salud Carlos III); Servicios Innovadores de Atencion Integrada para Pacientes Cronicos; EC-FP7 Programme, Synergy-COPD, GA; Catalan Master Plan of Respiratory Diseases (PDMAR); TAMESIS (Spanish Government)	This work was supported by Inforegio (AGAUR) 2009; NEXES (Supporting Healthier and Independent Living for Chronic Patients and Elderly, CIP-ICT-PSP-2007-225025); FIS PI09/90634; Servicios Innovadores de Atencion Integrada para Pacientes Cronicos - PITES- ISCIII 2010-12; EC-FP7 Programme, Synergy-COPD, GA no 270086; Catalan Master Plan of Respiratory Diseases (PDMAR); and TAMESIS (TEC2011-22746, Spanish Government). CIBER of Bioengineering, Biomaterials and Nanomedicine is an initiative of ISCIII. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1995, AM J RESP CRIT CARE, V152, P1107, DOI 10.1164/ajrccm.152.3.7663792; Bellia V, 2000, AM J RESP CRIT CARE, V161, P1094, DOI 10.1164/ajrccm.161.4.9810093; Burgos F, 2013, BUYERS GUIDE RESP CA, V14, P11; Burgos F., 2013, THESIS U BARCELONA; Burgos F, 2012, EUR RESPIR J, V39, P1313, DOI 10.1183/09031936.00168010; de Oca MM, 2008, RESP MED, V102, P642, DOI 10.1016/j.rmed.2007.12.025; de Oliveira Camargo-Brunetto Maria Angelica, 2013, Proceedings of the 6th International Conference on Health Informatics (HEALTHINF 2013), P207; Devi GM, 2013, INT J SCI TECHNOLOGY, V3, P74; Enright Paul L, 2003, Respir Care, V48, P773; Enright PL, 2010, RESP CARE, V55, P303; GARDNER RM, 1988, J OCCUP ENVIRON MED, V30, P272; Janssens W, 2013, RESP MED, V25; LAMBERT R K, 1989, Journal of Biomechanical Engineering, V111, P200, DOI 10.1115/1.3168366; Masa JF, 2011, EUR RESPIR J, V37, P911, DOI 10.1183/09031936.00011510; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; Muller-Brandes C, 2014, EUR RESPIR J, V43, P1347, DOI 10.1183/09031936.00058813; PARDAENS J, 1975, J APPL PHYSIOL, V39, P191, DOI 10.1152/jappl.1975.39.2.191; Perez-Padilla R, 2008, RESP CARE, V53, P1019; Polak AG, 1998, COMPUT BIOL MED, V28, P613, DOI 10.1016/S0010-4825(98)00041-9; Quanjer PH, 2012, EUR RESPIR J, V40, P1324, DOI 10.1183/09031936.00080312; Salas T, 2011, ARCH BRONCONEUMOL, V47, P466, DOI 10.1016/j.arbres.2011.06.005; Sankar AB, 2013, SADHANA-ACAD P ENG S, V38, P377, DOI 10.1007/s12046-013-0140-6; Spirometry Monitoring Technology - SPIROLA, NIOSH SPIR OCC MED	23	10	11	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2014	9	12							e116238	10.1371/journal.pone.0116238	http://dx.doi.org/10.1371/journal.pone.0116238			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UC	25551213	Green Published, Green Submitted, gold			2022-12-27	WOS:000347119100112
J	Yu, PF; Ye, L; Wang, HB; Du, GY; Zhang, JZ; Zuo, YH; Zhang, JH; Tian, JW				Yu, Pengfei; Ye, Liang; Wang, Hongbo; Du, Guangying; Zhang, Jianzhao; Zuo, Yanhua; Zhang, Jinghai; Tian, Jingwei			NSK-01105, a Novel Sorafenib Derivative, Inhibits Human Prostate Tumor Growth via Suppression of VEGFR2/EGFR-Mediated Angiogenesis	PLOS ONE			English	Article							TYROSINE KINASE INHIBITORS; CELL LUNG-CANCER; PHASE-II TRIAL; FACTOR RECEPTOR; ANTITUMOR-ACTIVITY; POTENT INHIBITOR; VEGF; DESIGN; PROGRESSION; MANAGEMENT	The purpose of this study is to investigate the anti-angiogenic activities of NSK01105, a novel sorafenib derivative, in in vitro, ex vivo and in vivo models, and explore the potential mechanisms. NSK-01105 significantly inhibited vascular endothelial growth factor (VEGF)-induced migration and tube formation of human umbilical vein endothelial cells at non-cytotoxic concentrations as shown by wound-healing, transwell migration and endothelial cell tube formation assays, respectively. Cell viability and invasion of LNCaP and PC-3 cells were significantly inhibited by cytotoxicity assay and matrigel invasion assay. Furthermore, NSK01105 also inhibited ex vivo angiogenesis in matrigel plug assay. Western blot analysis showed that NSK-01105 down-regulated VEGF-induced phosphorylation of VEGF receptor 2 (VEGFR2) and the activation of epidermal growth factor receptor (EGFR). Tumor volumes were significantly reduced by NSK-01105 at 60 mg/kg/day in both xenograft models. Immunohistochemical staining demonstrated a close association between inhibition of tumor growth and neovascularization. Collectively, our results suggest a role of NSK-01105 in treatment for human prostate tumors, and one of the potential mechanisms may be attributed to anti-angiogenic activities.	[Yu, Pengfei; Zhang, Jinghai] Shenyang Pharmaceut Univ, Sch Life Sci & Biopharmaceut, Shenyang 110016, Liaoning, Peoples R China; [Ye, Liang; Wang, Hongbo; Du, Guangying; Zhang, Jianzhao; Tian, Jingwei] Luye Pharma Grp Ltd, Nonclin Res Dept, State Key Lab Long Acting & Targeting Drug Delive, Yantai 264003, Shandong, Peoples R China; [Wang, Hongbo; Du, Guangying; Tian, Jingwei] Yantai Univ, Sch Pharm, Yantai 264005, Shandong, Peoples R China; [Ye, Liang] Binzhou Med Univ, Sch Pharmaceut Sci, Yantai 264005, Shandong, Peoples R China; [Ye, Liang] Binzhou Med Univ, Inst Mat Med, Yantai 264005, Shandong, Peoples R China; [Zuo, Yanhua] Qingdao Univ, Coll Med, Affiliated Hosp, Qingdao 266001, Shandong, Peoples R China	Shenyang Pharmaceutical University; Yantai University; Binzhou Medical University; Binzhou Medical University; Qingdao University	Zhang, JH (corresponding author), Shenyang Pharmaceut Univ, Sch Life Sci & Biopharmaceut, Shenyang 110016, Liaoning, Peoples R China.	hazacar.2012@gmail.com; tianjingwei@luye.cn	王, 洪波/A-6767-2019; Wang, Hongbo/AHC-7831-2022; Tian, Jingwei/GPJ-9819-2022	王, 洪波/0000-0001-8530-2339; Wang, Hongbo/0000-0001-8530-2339; 	National Natural Science Foundation of China [81473188, 81202038]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by National Natural Science Foundation of China No. 81473188 (JT) and National Natural Science Foundation of China No. 81202038 (HW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abouzid K, 2008, BIOORGAN MED CHEM, V16, P7543, DOI 10.1016/j.bmc.2008.07.038; Adams J, 2002, CURR OPIN CHEM BIOL, V6, P486, DOI 10.1016/S1367-5931(02)00357-5; Carlomagno F, 2006, JNCI-J NATL CANCER I, V98, P326, DOI 10.1093/jnci/djj069; Chan JM, 2005, J CLIN ONCOL, V23, P8152, DOI 10.1200/JCO.2005.03.1492; Chi KN, 2008, ANN ONCOL, V19, P746, DOI 10.1093/annonc/mdm554; Ciocca DR, 2010, INT J HYPERTHER, V26, P737, DOI 10.3109/02656731003776968; Ciraolo E, 2011, CURR MED CHEM, V18, P2674, DOI 10.2174/092986711796011193; Dahut WL, 2008, CLIN CANCER RES, V14, P209, DOI 10.1158/1078-0432.CCR-07-1355; Deslandres M, 2008, ANN DERMATOL VENER, P16, DOI 10.1016/S0151-9638(08)70093-0; Du GY, 2013, EUR J PHARMACOL, V700, P173, DOI 10.1016/j.ejphar.2012.12.013; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; Fu JJ, 2007, CANCER LETT, V248, P153, DOI 10.1016/j.canlet.2006.06.012; Gravis G, 2008, ANN ONCOL, V19, P1624, DOI 10.1093/annonc/mdn174; Hartmann JT, 2009, CURR DRUG METAB, V10, P470, DOI 10.2174/138920009788897975; Jiang N, 2012, MOLECULES, V17, P5870, DOI 10.3390/molecules17055870; Joensuu G, 2010, INT J RADIAT ONCOL, V78, P42, DOI 10.1016/j.ijrobp.2009.07.1731; Joseph IBJK, 1997, CANCER RES, V57, P1054; Kafousi M, 2012, PATHOL ONCOL RES, V18, P33, DOI 10.1007/s12253-011-9413-8; Kohli M, 2010, MAYO CLIN PROC, V85, P77, DOI 10.4065/mcp.2009.0442; Koistinen P, 2001, LEUKEMIA, V15, P1433, DOI 10.1038/sj.leu.2402217; Laird AD, 2003, EXPERT OPIN INV DRUG, V12, P51, DOI 10.1517/eoid.12.1.51.21253; Lin C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031708; Matsurnori Y, 2006, ONCOL RES, V16, P15, DOI 10.3727/000000006783981260; McMahon G, 2000, Oncologist, V5 Suppl 1, P3; Oh SJ, 2012, ENDOCR-RELAT CANCER, V19, P305, DOI 10.1530/ERC-11-0298; Pal HC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077270; Patan S, 2004, CANC TREAT, V117, P3; Peraldo-Neia C, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-31; Pratheeshkumar P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052279; Qi JH, 2001, EXP CELL RES, V263, P173, DOI 10.1006/excr.2000.5102; Randi AM, 2013, MEDITERR J HEMATOL I, V5, DOI 10.4084/MJHID.2013.060; Small EJ, 2007, BJU INT, V100, P765, DOI 10.1111/j.1464-410X.2007.07121.x; Steinbild S, 2007, BRIT J CANCER, V97, P1480, DOI 10.1038/sj.bjc.6604064; Trojan L, 2005, ANTICANCER RES, V25, P551; Vishnu P, 2010, ONCOTARGETS THER, V3, P39; Vulky J, 2009, CANCER, V115, P784, DOI 10.1002/cncr.24092; Wallace TJ, 2014, J CANCER, V5, P3, DOI 10.7150/jca.7709; Wedge SR, 2002, CANCER RES, V62, P4645; Wilhelm SM, 2004, CANCER RES, V64, P7099, DOI 10.1158/0008-5472.CAN-04-1443; Wolk A, 2005, ACTA ONCOL, V44, P277, DOI 10.1080/02841860510029572; Wood JM, 2000, CANCER RES, V60, P2178; Yang JC, 2003, NEW ENGL J MED, V349, P427, DOI 10.1056/NEJMoa021491; Zhang S, 2011, CLIN CANCER RES, V17, P4439, DOI 10.1158/1078-0432.CCR-10-3109	43	9	9	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2014	9	12							e115041	10.1371/journal.pone.0115041	http://dx.doi.org/10.1371/journal.pone.0115041			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UC	25551444	Green Published, gold, Green Submitted			2022-12-27	WOS:000347119100024
J	Lee, LC; Chen, CM; Wang, PR; Su, MT; Lee-Chen, GJ; Chang, CY				Lee, Li-Ching; Chen, Chiung-Mei; Wang, Pin-Rong; Su, Ming-Tsan; Lee-Chen, Guey-Jen; Chang, Chun-Yen			Role of High Mobility Group Box 1 (HMGB1) in SCA17 Pathogenesis	PLOS ONE			English	Article							TATA-BINDING PROTEIN; POLYGLUTAMINE DISEASES; EXPANDED POLYGLUTAMINE; TRANSCRIPTION FACTOR; DNA-BINDING; AUTOPHAGY; TOXICITY; DOMAIN; ATAXIA; ACTIVATION	Spinocerebellar ataxia type 17 (SCA17) involves the expression of a polyglutamine (polyQ) expanded TATA-binding protein (TBP), a general transcription initiation factor. TBP interacts with other protein factors, including high mobility group box 1 (HMGB1), to regulate gene expression. Previously, our proteomic analysis of soluble proteins prepared from mutant TBP (TBP/Q(61)) expressing cells revealed a reduced concentration of HMGB1. Here, we show that HMGB1 can be incorporated into mutant TBP aggregates, which leads to reduced soluble HMGB1 levels in TBP/Q(61 similar to 79) expressing cells. HMGB1 overexpression reduced mutant TBP aggregation. HMGB1 cDNA and siRNA co-transfection, as well as an HSPA5 immunoblot and luciferase reporter assay demonstrated the important role of HMGB1 in the regulation of HSPA5 transcription. In starvation-stressed TBP/Q(36) and TBP/Q(79) cells, increased reactive oxygen species generation accelerated the cytoplasmic translocation of HMGB1, which accompanied autophagy activation. However, TBP/Q(79) cells displayed a decrease in autophagy activation as a result of the reduction in the cytoplasmic HMGB1 level. In neuronal SH-SY5Y cells with induced TBP/Q(61 similar to 79) expression, HMGB1 expression was reduced and accompanied by a significant reduction in the total outgrowth and branches in the TBP/Q(61 similar to 79) expressing cells compared with the non-induced cells. The decreased soluble HMGB1 and impaired starvation-induced autophagy in cells suggest that HMGB1 may be a critical modulator of polyQ disease pathology and may represent a target for drug development.	[Lee, Li-Ching; Wang, Pin-Rong; Su, Ming-Tsan; Lee-Chen, Guey-Jen] Natl Taiwan Normal Univ, Dept Life Sci, Taipei, Taiwan; [Chen, Chiung-Mei] Chang Gung Univ, Coll Med, Dept Neurol, Chang Gung Mem Hosp, Taipei, Taiwan; [Chang, Chun-Yen] Natl Taiwan Normal Univ, Sci Educ Ctr, Taipei, Taiwan	National Taiwan Normal University; Chang Gung Memorial Hospital; Chang Gung University; National Taiwan Normal University	Lee-Chen, GJ (corresponding author), Natl Taiwan Normal Univ, Dept Life Sci, Taipei, Taiwan.	t43019@ntnu.edu.tw; chunyenc@gmail.com	Chang, Chun-Yen/B-1307-2008; Chen, Chiung-Mei/AAL-6260-2020	Chang, Chun-Yen/0000-0003-2373-2004; 	Ministry of Science and Technology [NSC102-2325-B-003-002]; Chang Gung Memorial Hospital [CMRPG3D0091, CMRPG3D005]; Aim for the Top University Project of National Taiwan Normal University, Taipei, Taiwan	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Chang Gung Memorial Hospital(Chang Gung Memorial Hospital); Aim for the Top University Project of National Taiwan Normal University, Taipei, Taiwan	This work was supported by grants NSC102-2325-B-003-002 from the Ministry of Science and Technology, CMRPG3D0091 and CMRPG3D005 from Chang Gung Memorial Hospital, and Aim for the Top University Project of National Taiwan Normal University, Taipei, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Burley SK, 1996, ANNU REV BIOCHEM, V65, P769, DOI 10.1146/annurev.bi.65.070196.004005; Chen CM, 2010, CLIN CHIM ACTA, V411, P375, DOI 10.1016/j.cca.2009.12.002; Das D, 2001, J BIOL CHEM, V276, P32597, DOI 10.1074/jbc.M011792200; Friedman MJ, 2007, NAT NEUROSCI, V10, P1519, DOI 10.1038/nn2011; GE H, 1994, J BIOL CHEM, V269, P17136; GOSTOUT B, 1993, AM J HUM GENET, V52, P1182; HORIKOSHI M, 1990, CELL, V61, P1171, DOI 10.1016/0092-8674(90)90681-4; Huang SS, 2011, BRAIN, V134, P1943, DOI 10.1093/brain/awr146; Jimenez-Sanchez M, 2012, PROG NEUROBIOL, V97, P67, DOI 10.1016/j.pneurobio.2011.08.013; Koide R, 1999, HUM MOL GENET, V8, P2047, DOI 10.1093/hmg/8.11.2047; LANDSMAN D, 1993, BIOESSAYS, V15, P539, DOI 10.1002/bies.950150807; Lee LC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035302; Lee LC, 2009, CLIN CHIM ACTA, V400, P56, DOI 10.1016/j.cca.2008.10.013; LESCURE A, 1994, EMBO J, V13, P1166, DOI 10.1002/j.1460-2075.1994.tb06366.x; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Maity SN, 1998, TRENDS BIOCHEM SCI, V23, P174, DOI 10.1016/S0968-0004(98)01201-8; Maltecca F, 2003, NEUROLOGY, V61, P1441, DOI 10.1212/01.WNL.0000094123.09098.A0; Mantovani R, 1999, GENE, V239, P15, DOI 10.1016/S0378-1119(99)00368-6; Menzies FM, 2010, BRAIN, V133, P93, DOI 10.1093/brain/awp292; Min HJ, 2013, J IMMUNOL, V190, P1797, DOI 10.4049/jimmunol.1202472; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Nakamura K, 2001, HUM MOL GENET, V10, P1441, DOI 10.1093/hmg/10.14.1441; Park JS, 2004, J BIOL CHEM, V279, P7370, DOI 10.1074/jbc.M306793200; Qi ML, 2007, NAT CELL BIOL, V9, P402, DOI 10.1038/ncb1553; Scaffidi P, 2002, NATURE, V418, P191, DOI 10.1038/nature00858; Scherz-Shouval R, 2007, EMBO J, V26, P1749, DOI 10.1038/sj.emboj.7601623; Shimohata T, 2000, NEUROPATHOLOGY, V20, P326, DOI 10.1046/j.1440-1789.2000.00350.x; Silveira I, 2002, ARCH NEUROL-CHICAGO, V59, P623, DOI 10.1001/archneur.59.4.623; Stros M, 2009, NUCLEIC ACIDS RES, V37, P2070, DOI 10.1093/nar/gkp067; Sutrias-Grau M, 1999, J BIOL CHEM, V274, P1628, DOI 10.1074/jbc.274.3.1628; Takahashi T, 2010, J MOL CELL BIOL, V2, P180, DOI 10.1093/jmcb/mjq005; Tang DL, 2011, ANTIOXID REDOX SIGN, V15, P2185, DOI 10.1089/ars.2010.3666; Tang DL, 2010, J CELL BIOL, V190, P881, DOI 10.1083/jcb.200911078; Tanida I, 2004, INT J BIOCHEM CELL B, V36, P2503, DOI 10.1016/j.biocel.2004.05.009; Wang M, 2010, CELL DEATH DIFFER, V17, P488, DOI 10.1038/cdd.2009.144; Wyttenbach A, 2002, HUM MOL GENET, V11, P1137, DOI 10.1093/hmg/11.9.1137; Zappavigna V, 1996, EMBO J, V15, P4981, DOI 10.1002/j.1460-2075.1996.tb00878.x	37	16	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2014	9	12							e115809	10.1371/journal.pone.0115809	http://dx.doi.org/10.1371/journal.pone.0115809			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX6YH	25549101	Green Submitted, Green Published, gold			2022-12-27	WOS:000347063500029
J	Feliu, J; Salud, A; Safont, MJ; Garcia-Giron, C; Aparicio, J; Losa, F; Bosch, C; Escudero, P; Casado, E; Jorge, M; Bohn, U; Perez-Carrion, R; Carmona, A; Custodio, AB; Maurel, J				Feliu, Jaime; Salud, Antonieta; Safont, Maria J.; Garcia-Giron, Carlos; Aparicio, Jorge; Losa, Ferran; Bosch, Carlos; Escudero, Pilar; Casado, Enrique; Jorge, Monica; Bohn, Uriel; Perez-Carrion, Ramon; Carmona, Alberto; Custodio, Ana B.; Maurel, Joan			Correlation of Hypertension and Proteinuria with Outcome in Elderly Bevacizumab-Treated Patients with Metastatic Colorectal Cancer	PLOS ONE			English	Article							PACLITAXEL PLUS BEVACIZUMAB; ENDOTHELIAL GROWTH-FACTOR; 1ST-LINE TREATMENT; BREAST-CANCER; PHASE-II; CAPECITABINE; CHEMOTHERAPY; ASSOCIATION; OXALIPLATIN; BIOMARKER	Background Studies suggest a relationship between hypertension and outcome in bevacizumab-treated patients with metastatic colorectal cancer (mCRC). We performed a retrospective analysis of two phase II studies (BECA and BECOX) to determine if hypertension and proteinuria predict outcome in elderly patients with mCRC treated with bevacizumab. Patients and Methods Patients >= 70 years of age received either capecitabine 1250 mg/m(2) bid days 1-14 + bevacizumab 7.5 mg/kg day 1 every 21 days (BECA study) or capecitabine 1000 mg/m(2) bid days 1-14 with bevacizumab 7.5 mg/kg and oxaliplatin 130 mg/m(2) day 1 (BECOX study). The primary objective was to correlate hypertension and proteinuria with overall response rate (ORR), time to progression (TTP) and overall survival (OS). Secondary objectives included identification of risk factors associated with the development of hypertension and proteinuria and determining whether development of hypertension or proteinuria in the first 2 cycles was related to ORR, disease-control rate (DCR), TTP or OS. Results In total, 127 patients (median age 75.5 years) were included in the study. Hypertension correlated with DCR and OS; proteinuria correlated with ORR and DCR. Proteinuria or hypertension in the first 2 cycles did not correlate with efficacy. Risk factors for hypertension were female gender (odds ratio [OR] 0.241; P = 0.011) and more bevacizumab cycles (OR 1.112; P = 0.002); risk factors for proteinuria were diabetes (OR 3.869; P = 0.006) and more bevacizumab cycles (OR 1.181; P<0.0001). Multivariate analysis identified as having prognostic value: baseline lactate dehydrogenase, haemoglobin, number of metastatic lesions and DCR. Conclusion This analysis of two phase II studies suggests that hypertension is significantly correlated with OS but not with ORR and TTP, whereas proteinuria is correlated with ORR but not with OS and TTP. Both hypertension and proteinuria are associated with the duration of bevacizumab treatment and do not represent an independent prognostic factor.	[Feliu, Jaime; Custodio, Ana B.] Hosp Univ La Paz, Serv Oncol Med, Madrid, Spain; [Salud, Antonieta] Hosp Arnau Vilanova, Serv Oncol Med, Lleida, Spain; [Safont, Maria J.] Hosp Univ Clinico Valencia, Serv Oncol Med, Valencia, Spain; [Garcia-Giron, Carlos] Hosp Gen Yague, Serv Oncol Med, Burgos, Spain; [Aparicio, Jorge] Hosp La Fe Valencia, Serv Oncol Med, Valencia, Spain; [Losa, Ferran] Hosp La Creu Roja Hosp, Serv Oncol Med, Barcelona, Spain; [Bosch, Carlos] Hosp Gen Valencia, Serv Oncol Med, Valencia, Spain; [Escudero, Pilar] Univ Lozano Blesa, Hosp Clin, Serv Oncol Med, Zaragoza, Spain; [Casado, Enrique] Hosp Infanta Sofia, Serv Oncol Med, Madrid, Spain; [Jorge, Monica] Complejo Hosp Xeral Cies, Serv Oncol Med, Vigo, Spain; [Bohn, Uriel] Hosp Univ Gran Canaria Doctor Negrin, Serv Oncol Med, Las Palmas Gran Canaria, Spain; [Perez-Carrion, Ramon] Hosp Univ Quiron Madrid, Serv Oncol Med, Madrid, Spain; [Carmona, Alberto] Univ Morales Messeguer, Serv Hematol & Oncol Med, Gen Hosp, Murcia, Spain; [Maurel, Joan] Hosp Clin Prov Barcelona, Serv Oncol Med, Barcelona, Spain	Hospital Universitario La Paz; University Hospital Arnau de Vilanova; Hospital General Yague; Hospital Universitari i Politecnic La Fe; Lozano Blesa University Clinical Hospital; Complexo Hospitalario Universitario de Vigo; University of Barcelona; Hospital Clinic de Barcelona	Feliu, J (corresponding author), Hosp Univ La Paz, Serv Oncol Med, Madrid, Spain.	jaime.feliu@salud.madrid.org	García-Girón, Carlos/ABH-3045-2020	Carmona-Bayonas, Alberto/0000-0002-1930-9660; salud, antonia/0000-0002-7399-7484	Hoffmann-La Roche, Nutley, USA; BECOX study - Grupo Espanol Multidisciplinario del Cancer Digestivo, Spain	Hoffmann-La Roche, Nutley, USA; BECOX study - Grupo Espanol Multidisciplinario del Cancer Digestivo, Spain	The BECA study was supported by Hoffmann-La Roche, Nutley, USA, and the BECOX study was sponsored by Grupo Espanol Multidisciplinario del Cancer Digestivo, Spain. Support for third-party writing assistance for this manuscript was provided by Roche Farma, Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berruti A, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-184; Cancer Research UK, BOW CANC INC STAT; Dahlberg SE, 2010, J CLIN ONCOL, V28, P949, DOI 10.1200/JCO.2009.25.4482; De Stefano A, 2011, CANCER CHEMOTH PHARM, V68, P1207, DOI 10.1007/s00280-011-1604-1; Dewdney A, 2012, BRIT J CANCER, V106, P1718, DOI 10.1038/bjc.2012.152; Eremina V, 2003, J CLIN INVEST, V111, P707, DOI 10.1172/JCI200317423; Feliu J, 2014, BRIT J CANCER, V111, P241, DOI 10.1038/bjc.2014.346; Feliu J, 2010, BRIT J CANCER, V102, P1468, DOI 10.1038/sj.bjc.6605663; Ferlay J, 2013, EUR J CANCER, V49, P1374, DOI 10.1016/j.ejca.2012.12.027; Garcia-Donas J, 2011, LANCET ONCOL, V12, P1143, DOI 10.1016/S1470-2045(11)70266-2; Hurwitz HI, 2013, ONCOLOGIST, V18, P273, DOI 10.1634/theoncologist.2012-0339; Iwasa S, 2013, ANTICANCER RES, V33, P309; Kabbinavar FF, 2009, J CLIN ONCOL, V27, P199, DOI 10.1200/JCO.2008.17.7931; Karachaliou N, 2010, ANN ONCOL, V21, P1729, DOI 10.1093/annonc/mdq328; Lambrechts D, 2012, LANCET ONCOL, V13, P724, DOI 10.1016/S1470-2045(12)70231-0; Laskin J, 2012, J THORAC ONCOL, V7, P203, DOI 10.1097/JTO.0b013e3182370e02; McKibbin T, 2008, ONCOLOGIST, V13, P876, DOI 10.1634/theoncologist.2008-0061; Mir O, 2011, ONCOLOGIST, V16, P1325, DOI 10.1634/theoncologist.2010-0002; Morita S, 2013, CANCER CHEMOTH PHARM, V71, P405, DOI 10.1007/s00280-012-2028-2; Osterlund P, 2011, BRIT J CANCER, V104, P599, DOI 10.1038/bjc.2011.2; Quipourt V, 2011, J AM GERIATR SOC, V59, P694, DOI 10.1111/j.1532-5415.2011.03334.x; Robinson ES, 2010, HYPERTENSION, V56, P1131, DOI 10.1161/HYPERTENSIONAHA.110.160481; Rosati G, 2013, CANCER CHEMOTH PHARM, V71, P257, DOI 10.1007/s00280-012-2004-x; Saloustros E, 2010, CASE REP ONCOL, V3, P368, DOI 10.1159/000321630; Schmoll HJ, 2012, ANN ONCOL, V23, P2479, DOI 10.1093/annonc/mds236; Schneider BP, 2008, J CLIN ONCOL, V26, P4672, DOI 10.1200/JCO.2008.16.1612; Schuster C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038364; Tahover E, 2013, MED ONCOL, V30, DOI 10.1007/s12032-012-0327-4	28	28	30	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2015	10	1							e0116527	10.1371/journal.pone.0116527	http://dx.doi.org/10.1371/journal.pone.0116527			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ4OZ	25602286	Green Submitted, Green Published, gold			2022-12-27	WOS:000348203500027
J	Guisoni, N; Ferrero, P; Layana, C; Diambra, L				Guisoni, Nara; Ferrero, Paola; Layana, Carla; Diambra, Luis			Abortive and Propagating Intracellular Calcium Waves: Analysis from a Hybrid Model	PLOS ONE			English	Article							XENOPUS-LAEVIS OOCYTES; CA2+ WAVES; INOSITOL TRISPHOSPHATE; ENDOPLASMIC-RETICULUM; CYTOSOLIC CALCIUM; GATED CHANNELS; IP3 RECEPTORS; RELEASE; COORDINATION; OSCILLATIONS	The functional properties of inositol(1,4,5)-triphosphate (IP3) receptors allow a variety of intracellular Ca2+ phenomena. In this way, global phenomena, such as propagating and abortive Ca2+ waves, as well as local events such as puffs, have been observed. Several experimental studies suggest that many features of global phenomena (e. g., frequency, amplitude, speed wave) depend on the interplay of biophysical processes such as diffusion, buffering, efflux and influx rates, which in turn depend on parameters such as buffer concentration, Ca2+ pump density, cytosolic IP3 level, and intercluster distance. Besides, it is known that cells are able to modify some of these parameters in order to regulate the Ca2+ signaling. By using a hybrid model, we analyzed different features of the hierarchy of calcium events as a function of two relevant parameters for the calcium signaling, the intercluster distance and the pump strength or intensity. In the space spanned by these two parameters, we found two modes of calcium dynamics, one dominated by abortive calcium waves and the other by propagating waves. Smaller distances between the release sites promote propagating calcium waves, while the increase of the efflux rate makes the transition from propagating to abortive waves occur at lower values of intercluster distance. We determined the frontier between these two modes, in the parameter space defined by the intercluster distance and the pump strength. Furthermore, we found that the velocity of simulated calcium waves accomplishes Luther's law, and that an effective rate constant for autocatalytic calcium production decays linearly with both the intercluster distance and the pump strength.	[Guisoni, Nara] Univ Nacl La Plata, CONICET, CCT La Plata, Inst Fis Liquidos & Sistemas Biol IFLYSIB, RA-1900 La Plata, Argentina; [Ferrero, Paola] Fac Ciencias Med, Ctr Invest Cardiovasc, RA-1900 La Plata, Argentina; [Layana, Carla; Diambra, Luis] Univ Nacl La Plata, CREG, RA-1900 La Plata, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of La Plata; National University of La Plata	Guisoni, N (corresponding author), Univ Nacl La Plata, CONICET, CCT La Plata, Inst Fis Liquidos & Sistemas Biol IFLYSIB, Calle 59-789, RA-1900 La Plata, Argentina.	naraguisoni@conicet.gov.ar; ldiambra@gmail.com	L, Diambra/F-6319-2015; Guisoni, Nara/AAV-8107-2020	L, Diambra/0000-0001-8052-4880; Guisoni, Nara/0000-0002-2025-7765; Ferrero, Paola/0000-0002-5582-642X; layana, carla/0000-0002-2313-2028	CONICET [PIP 0143]	CONICET(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET))	This research has been partially supported by CONICET (Grant: PIP 0143). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bar M, 2000, PHYS REV LETT, V84, P5664, DOI 10.1103/PhysRevLett.84.5664; BEZPROZVANNY I, 1991, NATURE, V351, P751, DOI 10.1038/351751a0; BEZPROZVANNY I, 1994, CELL CALCIUM, V16, P151, DOI 10.1016/0143-4160(94)90019-1; Bugrim AE, 1997, BIOPHYS J, V73, P2897, DOI 10.1016/S0006-3495(97)78318-8; Callamaras N, 1998, J PHYSIOL-LONDON, V509, P81, DOI 10.1111/j.1469-7793.1998.081bo.x; CAMACHO P, 1995, CELL, V82, P765, DOI 10.1016/0092-8674(95)90473-5; CAMACHO P, 1993, SCIENCE, V260, P226, DOI 10.1126/science.8385800; Chang JB, 2013, NATURE, V500, P603, DOI 10.1038/nature12321; Coombes S, 2003, PHYS REV E, V68, DOI 10.1103/PhysRevE.68.021915; Diambra L, 2005, CELL CALCIUM, V37, P321, DOI 10.1016/j.ceca.2004.12.001; Diambra L, 2011, BIOPHYS J, V100, P822, DOI 10.1016/j.bpj.2011.01.003; Diambra L, 2009, CHAOS, V19, DOI 10.1063/1.3147425; DUPONT G, 1994, BIOPHYS J, V67, P2191, DOI 10.1016/S0006-3495(94)80705-2; Falcke M, 2003, BIOPHYS J, V85, P1474, DOI 10.1016/S0006-3495(03)74580-9; Guisoni N, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.061910; Guisoni N, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.061905; JAFFE LF, 1991, P NATL ACAD SCI USA, V88, P9883, DOI 10.1073/pnas.88.21.9883; Jaffe LF, 2008, PHILOS T R SOC B, V363, P1311, DOI 10.1098/rstb.2007.2249; Keizer J, 1998, BIOPHYS J, V75, P595, DOI 10.1016/S0006-3495(98)77550-2; Kupferman R, 1997, BIOPHYS J, V72, P2430, DOI 10.1016/S0006-3495(97)78888-X; LECHLEITER J, 1991, SCIENCE, V252, P123, DOI 10.1126/science.2011747; Lechleiter JD, 1998, BIOPHYS CHEM, V72, P123, DOI 10.1016/S0301-4622(98)00128-8; Lopez L, 2014, BIOPHYS J, V106, p531A, DOI 10.1016/j.bpj.2013.11.2967; Lopez L, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00350; Luther R, 1906, Z ELKTROCHEM ANGEW P, V12, P596, DOI 10.1002/bbpc.19060123208; Marchant J, 1999, EMBO J, V18, P5285, DOI 10.1093/emboj/18.19.5285; Marchant JS, 1997, CURR BIOL, V7, P510, DOI 10.1016/S0960-9822(06)00222-3; Nguyen T, 1998, NATURE, V395, P908, DOI 10.1038/27686; NOVAK B, 1993, J THEOR BIOL, V165, P101, DOI 10.1006/jtbi.1993.1179; OTHMER HG, 1993, OSCILLATIONS WAVES M, P277; Parker I, 1996, J PHYSIOL-LONDON, V491, P663, DOI 10.1113/jphysiol.1996.sp021247; Pencea CS, 2000, PHYS REV E, V62, P8420, DOI 10.1103/PhysRevE.62.8420; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; SHOWALTER K, 1987, J CHEM EDUC, V64, P742, DOI 10.1021/ed064p742; Solovey G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008997; Taylor CW, 2004, TRENDS BIOCHEM SCI, V29, P210, DOI 10.1016/j.tibs.2004.02.010; THASTRUP O, 1990, P NATL ACAD SCI USA, V87, P2466, DOI 10.1073/pnas.87.7.2466; Ur-Rahman T., 2009, NATURE, V458, P655, DOI [10.1038/nature07763, DOI 10.1038/NATURE07763]; YAO Y, 1995, J PHYSIOL-LONDON, V482, P533, DOI 10.1113/jphysiol.1995.sp020538; Zhao Q, 2009, PHYSICA A, V388, P4105, DOI 10.1016/j.physa.2009.06.033	40	26	26	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2015	10	1							e0115187	10.1371/journal.pone.0115187	http://dx.doi.org/10.1371/journal.pone.0115187			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ4OZ	25602295	Green Published, gold			2022-12-27	WOS:000348203500010
J	Hamashima, K; Mori, M; Andachi, Y; Tomita, M; Kohara, Y; Kanai, A				Hamashima, Kiyofumi; Mori, Masaru; Andachi, Yoshiki; Tomita, Masaru; Kohara, Yuji; Kanai, Akio			Analysis of Genetic Code Ambiguity Arising from Nematode-Specific Misacylated tRNAs	PLOS ONE			English	Article							AMINO-ACID; CAENORHABDITIS-ELEGANS; PROTEIN-SYNTHESIS; UNIFORM BINDING; SYNTHETASE; MISTRANSLATION; TRNA(LEU); LEUCINE; NEURODEGENERATION; RECOGNITION	The faithful translation of the genetic code requires the highly accurate aminoacylation of transfer RNAs (tRNAs). However, it has been shown that nematode-specific V-arm-containing tRNAs (nev-tRNAs) are misacylated with leucine in vitro in a manner that transgresses the genetic code. nev-tRNA(Gly) (CCC) and nev-tRNA(lle) (UAU), which are the major nev-tRNA isotypes, could theoretically decode the glycine (GGG) codon and isoleucine (AUA) codon as leucine, causing GGG and AUA codon ambiguity in nematode cells. To test this hypothesis, we investigated the functionality of nev-tRNAs and their impact on the proteome of Caenorhabditis elegans. Analysis of the nucleotide sequences in the 3' end regions of the nev-tRNAs showed that they had matured correctly, with the addition of CCA, which is a crucial post-transcriptional modification required for tRNA aminoacylation. The nuclear export of nev-tRNAs was confirmed with an analysis of their subcellular localization. These results show that nev-tRNAs are processed to their mature forms like common tRNAs and are available for translation. However, a whole-cell proteome analysis found no detectable level of nev-tRNA-induced mistranslation in C. elegans cells, suggesting that the genetic code is not ambiguous, at least under normal growth conditions. Our findings indicate that the translational fidelity of the nematode genetic code is strictly maintained, contrary to our expectations, although deviant tRNAs with misacylation properties are highly conserved in the nematode genome.	[Hamashima, Kiyofumi; Mori, Masaru; Tomita, Masaru; Kanai, Akio] Keio Univ, Inst Adv Biosci, Tsuruoka, Yamagata, Japan; [Hamashima, Kiyofumi; Mori, Masaru; Tomita, Masaru; Kanai, Akio] Keio Univ, Grad Sch Media & Governance, Syst Biol Program, Fujisawa, Kanagawa, Japan; [Andachi, Yoshiki; Kohara, Yuji] Natl Inst Genet, Genome Biol Lab, Mishima, Shizuoka 411, Japan; [Andachi, Yoshiki; Kohara, Yuji] SOKENDAI, Dept Genet, Mishima, Shizuoka, Japan; [Tomita, Masaru; Kanai, Akio] Keio Univ, Fac Environm & Informat Studies, Fujisawa, Kanagawa, Japan	Keio University; Keio University; Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; Graduate University for Advanced Studies - Japan; Keio University	Kanai, A (corresponding author), Keio Univ, Inst Adv Biosci, Tsuruoka, Yamagata, Japan.	akio@sfc.keio.ac.jp	Kanai, Akio/C-4921-2014	Kanai, Akio/0000-0002-6362-2419	Yamagata Prefectural Government and Tsuruoka City, Japan; Japan Society for the Promotion of Science; STFC [ST/K000853/1] Funding Source: UKRI	Yamagata Prefectural Government and Tsuruoka City, Japan; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC))	This research was supported, in part, by research funds from the Yamagata Prefectural Government and Tsuruoka City, Japan, and by a research grant from the Japan Society for the Promotion of Science (to KH). The funding bodies had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe T, 2011, NUCLEIC ACIDS RES, V39, pD210, DOI 10.1093/nar/gkq1007; Bezerra AR, 2013, P NATL ACAD SCI USA, V110, P11079, DOI 10.1073/pnas.1302094110; BREITSCHOPF K, 1995, NUCLEIC ACIDS RES, V23, P3633, DOI 10.1093/nar/23.18.3633; BRENNER S, 1974, GENETICS, V77, P71; Creasy DM, 2002, PROTEOMICS, V2, P1426, DOI 10.1002/1615-9861(200210)2:10<1426::AID-PROT1426>3.0.CO;2-5; Drummond DA, 2009, NAT REV GENET, V10, P715, DOI 10.1038/nrg2662; Dunn JG, 2013, ELIFE, V2, DOI 10.7554/eLife.01179; El Yacoubi B, 2012, ANNU REV GENET, V46, P69, DOI 10.1146/annurev-genet-110711-155641; Fahlman RP, 2004, MOL CELL, V16, P799, DOI 10.1016/j.molcel.2004.10.030; Fukunaga R, 2005, NAT STRUCT MOL BIOL, V12, P915, DOI 10.1038/nsmb985; Hamashima Kiyofumi, 2013, Biomol Concepts, V4, P309, DOI 10.1515/bmc-2013-0002; Hamashima K, 2012, NUCLEIC ACIDS RES, V40, P3653, DOI 10.1093/nar/gkr1226; Hao B, 2002, SCIENCE, V296, P1462, DOI 10.1126/science.1069556; Harris RP, 2014, CURR OPIN BIOTECH, V30, P45, DOI 10.1016/j.copbio.2014.05.003; Iben JR, 2012, RNA, V18, P1358, DOI 10.1261/rna.032151.111; Ishihama Y, 2002, J CHROMATOGR A, V979, P233, DOI 10.1016/S0021-9673(02)01402-4; Ishimura R, 2014, SCIENCE, V345, P455, DOI 10.1126/science.1249749; Javid B, 2014, P NATL ACAD SCI USA, V111, P1132, DOI 10.1073/pnas.1317580111; Jones TE, 2011, P NATL ACAD SCI USA, V108, P6933, DOI 10.1073/pnas.1019033108; LaRiviere FJ, 2001, SCIENCE, V294, P165, DOI 10.1126/science.1064242; Lee JW, 2006, NATURE, V443, P50, DOI 10.1038/nature05096; Lee YS, 2009, GENE DEV, V23, P2639, DOI 10.1101/gad.1837609; Levine RL, 1996, P NATL ACAD SCI USA, V93, P15036, DOI 10.1073/pnas.93.26.15036; Marck C, 2002, RNA, V8, P1189, DOI 10.1017/S1355838202022021; MCCLAIN WH, 1993, J MOL BIOL, V234, P257, DOI 10.1006/jmbi.1993.1582; MITANI S, 1995, DEV GROWTH DIFFER, V37, P551; Moura GR, 2010, FEBS LETT, V584, P334, DOI 10.1016/j.febslet.2009.11.066; Moura GR, 2009, CURR OPIN MICROBIOL, V12, P631, DOI 10.1016/j.mib.2009.09.004; Netzer N, 2009, NATURE, V462, P522, DOI 10.1038/nature08576; Olsen JV, 2004, MOL CELL PROTEOMICS, V3, P608, DOI 10.1074/mcp.T400003-MCP200; Pan T, 2013, ANNU REV GENET, V47, P121, DOI 10.1146/annurev-genet-111212-133522; Rappsilber J, 2003, ANAL CHEM, V75, P663, DOI 10.1021/ac026117i; Reynolds NM, 2010, NAT REV MICROBIOL, V8, P849, DOI 10.1038/nrmicro2472; de Pouplana LR, 2014, TRENDS BIOCHEM SCI, V39, P355, DOI 10.1016/j.tibs.2014.06.002; Santos MAS, 1999, MOL MICROBIOL, V31, P937, DOI 10.1046/j.1365-2958.1999.01233.x; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; SOLL D, 1988, NATURE, V331, P662; Soma A, 1999, J MOL BIOL, V293, P1029, DOI 10.1006/jmbi.1999.3219; Sprinzl M, 1998, NUCLEIC ACIDS RES, V26, P148, DOI 10.1093/nar/26.1.148; Srinivasan G, 2002, SCIENCE, V296, P1459, DOI 10.1126/science.1069588; Sugita T, 1999, SYST APPL MICROBIOL, V22, P79, DOI 10.1016/S0723-2020(99)80030-7; Wiltrout E, 2012, NUCLEIC ACIDS RES, V40, P10494, DOI 10.1093/nar/gks805; Yu XC, 2009, ANAL CHEM, V81, P9282, DOI 10.1021/ac901541h; Zhang ZQ, 2013, BIOCHEMISTRY-US, V52, P8165, DOI 10.1021/bi401002c; Zisoulis DG, 2012, NATURE, V486, P541, DOI 10.1038/nature11134	45	5	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2015	10	1							e0116981	10.1371/journal.pone.0116981	http://dx.doi.org/10.1371/journal.pone.0116981			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ4OZ	25602944	gold, Green Published, Green Submitted			2022-12-27	WOS:000348203500039
J	Kanageswaran, N; Demond, M; Nagel, M; Schreiner, BSP; Baumgart, S; Scholz, P; Altmuller, J; Becker, C; Doerner, JF; Conrad, H; Oberland, S; Wetzel, CH; Neuhaus, EM; Hatt, H; Gisselmann, G				Kanageswaran, Ninthujah; Demond, Marilen; Nagel, Maximilian; Schreiner, Benjamin S. P.; Baumgart, Sabrina; Scholz, Paul; Altmueller, Janine; Becker, Christian; Doerner, Julia F.; Conrad, Heike; Oberland, Sonja; Wetzel, Christian H.; Neuhaus, Eva M.; Hatt, Hanns; Gisselmann, Guenter			Deep Sequencing of the Murine Olfactory Receptor Neuron Transcriptome	PLOS ONE			English	Article							INOSITOL 1,4,5-TRISPHOSPHATE RECEPTOR; EXCHANGER REGULATORY FACTOR; MAMMALIAN ODORANT RECEPTORS; PROTEIN-COUPLED RECEPTORS; NUCLEOTIDE-GATED CHANNELS; BETA-GAMMA-SUBUNITS; G-ALPHA-OLF; SENSORY NEURONS; SIGNAL-TRANSDUCTION; RNA-SEQ	The ability of animals to sense and differentiate among thousands of odorants relies on a large set of olfactory receptors (OR) and a multitude of accessory proteins within the olfactory epithelium (OE). ORs and related signaling mechanisms have been the subject of intensive studies over the past years, but our knowledge regarding olfactory processing remains limited. The recent development of next generation sequencing (NGS) techniques encouraged us to assess the transcriptome of the murine OE. We analyzed RNA from OEs of female and male adult mice and from fluorescence-activated cell sorting (FACS)-sorted olfactory receptor neurons (ORNs) obtained from transgenic OMP-GFP mice. The Illumina RNA-Seq protocol was utilized to generate up to 86 million reads per transcriptome. In OE samples, nearly all OR and trace amine-associated receptor (TAAR) genes involved in the perception of volatile amines were detectably expressed. Other genes known to participate in olfactory signaling pathways were among the 200 genes with the highest expression levels in the OE. To identify OE-specific genes, we compared olfactory neuron expression profiles with RNA-Seq transcriptome data from different murine tissues. By analyzing different transcript classes, we detected the expression of non-olfactory GPCRs in ORNs and established an expression ranking for GPCRs detected in the OE. We also identified other previously undescribed membrane proteins as potential new players in olfaction. The quantitative and comprehensive transcriptome data provide a virtually complete catalogue of genes expressed in the OE and present a useful tool to uncover candidate genes involved in, for example, olfactory signaling, OR trafficking and recycling, and proliferation.	[Kanageswaran, Ninthujah; Demond, Marilen; Nagel, Maximilian; Schreiner, Benjamin S. P.; Baumgart, Sabrina; Scholz, Paul; Doerner, Julia F.; Conrad, Heike; Hatt, Hanns; Gisselmann, Guenter] Ruhr Univ Bochum, Dept Cell Physiol, Bochum, Germany; [Demond, Marilen] Univ Duisburg Essen, Inst Med Radiat Biol, Essen, Germany; [Altmueller, Janine; Becker, Christian] Univ Cologne, Cologne Ctr Genom, D-50931 Cologne, Germany; [Conrad, Heike] Cluster Excellence, Gottingen, Germany; [Conrad, Heike] DFG Res Ctr Nanoscale Microscopy & Mol Physiol Br, Gottingen, Germany; [Oberland, Sonja; Neuhaus, Eva M.] Univ Hosp Jena, Pharmacol & Toxicol, D-07747 Jena, Germany; [Oberland, Sonja; Neuhaus, Eva M.] Charite, Cluster Excellence NeuroCure, D-10117 Berlin, Germany; [Wetzel, Christian H.] Univ Regensburg, Dept Psychiat & Psychotherapy, Mol Neurosci, D-93053 Regensburg, Germany	Ruhr University Bochum; University of Duisburg Essen; University of Cologne; Friedrich Schiller University of Jena; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Regensburg	Kanageswaran, N (corresponding author), Ruhr Univ Bochum, Dept Cell Physiol, Univ Str 150, Bochum, Germany.	ninthujah@hotmail.com	Wetzel, Christian/F-1366-2018; Wetzel, Christian/C-2501-2009; Neuhaus, Eva M./L-1428-2015; Wetzel, Christian H/N-9880-2017	Wetzel, Christian/0000-0002-5762-0003; Neuhaus, Eva M./0000-0003-3363-1231; Wetzel, Christian H/0000-0002-5762-0003; Altmuller, Janine/0000-0003-4372-1521	DFG [Sonderforschungsbereich 642]	DFG(German Research Foundation (DFG))	Hanns Hatt was funded by the DFG-Sonderforschungsbereich 642 "GTP- and ATP dependent membrane processes". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ache BW, 2010, CHEM SENSES, V35, P533, DOI 10.1093/chemse/bjq045; Ango F, 2000, J NEUROSCI, V20, P8710; Ango F, 2001, NATURE, V411, P962, DOI 10.1038/35082096; ANHOLT RRH, 1987, BIOCHEMISTRY-US, V26, P788, DOI 10.1021/bi00377a020; Armstrong A, 2011, J NEUROSCI, V31, P2371, DOI 10.1523/JNEUROSCI.4243-10.2011; BAKALYAR HA, 1990, SCIENCE, V250, P1403, DOI 10.1126/science.2255909; Barbour J, 2008, J PROTEOME RES, V7, P1594, DOI 10.1021/pr7005796; Barros SA, 2003, GENE, V307, P191, DOI 10.1016/S0378-1119(03)00465-7; Bassani S, 2012, NEURON, V73, P1143, DOI 10.1016/j.neuron.2012.01.021; Bates-Withers C, 2011, ADV EXP MED BIOL, V704, P173, DOI 10.1007/978-94-007-0265-3_9; Bauer S, 2008, BIOINFORMATICS, V24, P1650, DOI 10.1093/bioinformatics/btn250; Billig GM, 2011, NAT NEUROSCI, V14, P763, DOI 10.1038/nn.2821; Bjarnadottir TK, 2006, GENOMICS, V88, P263, DOI 10.1016/j.ygeno.2006.04.001; BOEKHOFF I, 1994, J BIOL CHEM, V269, P37; BOEKHOFF I, 1992, P NATL ACAD SCI USA, V89, P471, DOI 10.1073/pnas.89.2.471; Bruch RC, 1996, COMP BIOCHEM PHYS B, V113, P451, DOI 10.1016/0305-0491(95)02040-3; Brunert D, 2010, CHEM SENSES, V35, P301, DOI 10.1093/chemse/bjq020; BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X; Cao SL, 2006, BIOCHEM BIOPH RES CO, V345, P310, DOI 10.1016/j.bbrc.2006.04.091; Cao TT, 1999, NATURE, V401, P286, DOI 10.1038/45816; Chadli A, 2006, MOL CELL BIOL, V26, P1722, DOI 10.1128/MCB.26.5.1722-1730.2006; Chang JT, 2012, DEV BIOL, V368, P312, DOI 10.1016/j.ydbio.2012.05.034; Chang K, 1996, P NATL ACAD SCI USA, V93, P136, DOI 10.1073/pnas.93.1.136; Chaudhari N, 2009, AM J CLIN NUTR, V90, p738S, DOI 10.3945/ajcn.2009.27462H; CHERRY JA, 1995, J NEUROBIOL, V28, P102, DOI 10.1002/neu.480280109; Cintron NS, 2006, J BIOL CHEM, V281, P26235, DOI 10.1074/jbc.M605417200; Clapham DE, 2003, NATURE, V426, P517, DOI 10.1038/nature02196; Cote RH, 2004, INT J IMPOT RES, V16, pS28, DOI 10.1038/sj.ijir.3901212; Cote Rick H., 2005, V307, P141; CUNNINGHAM AM, 1993, NEUROSCIENCE, V57, P339, DOI 10.1016/0306-4522(93)90067-P; Cygnar KD, 2009, NAT NEUROSCI, V12, P454, DOI 10.1038/nn.2289; DAVIS RL, 1995, MOL CELL BIOCHEM, V149, P271, DOI 10.1007/BF01076588; DAWSON TM, 1993, SCIENCE, V259, P825, DOI 10.1126/science.8381559; DeMaria S, 2010, J CELL BIOL, V191, P443, DOI 10.1083/jcb.201008163; Dooley R, 2009, FEBS J, V276, P7279, DOI 10.1111/j.1742-4658.2009.07435.x; Dubacq C, 2009, J NEUROSCI, V29, P10184, DOI 10.1523/JNEUROSCI.2443-09.2009; Eldstrom J, 2002, FEBS LETT, V531, P529, DOI 10.1016/S0014-5793(02)03572-X; Elsaesser R, 2005, EUR J NEUROSCI, V21, P2692, DOI 10.1111/j.1460-9568.2005.04108.x; Engel KMY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029400; FADOOL DA, 1992, NEURON, V9, P907, DOI 10.1016/0896-6273(92)90243-7; FIRESTEIN S, 1990, J PHYSIOL-LONDON, V430, P135, DOI 10.1113/jphysiol.1990.sp018286; Fried HU, 2010, CELL TISSUE RES, V339, P463, DOI 10.1007/s00441-009-0904-9; FULLE HJ, 1995, P NATL ACAD SCI USA, V92, P3571, DOI 10.1073/pnas.92.8.3571; Garitaonandia I, 2009, J RECEPT SIG TRANSD, V29, P67, DOI 10.1080/10799890902729456; Geisert EE, 2009, MOL VIS, V15, P1730; Gloriam DE, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-338; Glusman G, 2001, GENOME RES, V11, P685, DOI 10.1101/gr.171001; Godfrey PA, 2004, P NATL ACAD SCI USA, V101, P2156, DOI 10.1073/pnas.0308051100; Goldstein BJ, 2003, JARO-J ASSOC RES OTO, V4, P74, DOI 10.1007/s10162-002-2039-5; GRAZIADEI GAM, 1979, J NEUROCYTOL, V8, P197; Hagendorf S, 2009, J NEUROSCI, V29, P206, DOI 10.1523/JNEUROSCI.3656-08.2009; Hague C, 2004, MOL INTERV, V4, P321, DOI 10.1124/mi.4.6.4; Hahn Y, 2009, INT J MOL MED, V24, P51, DOI 10.3892/ijmm_00000205; Hall RA, 1998, NATURE, V392, P626, DOI 10.1038/33458; Hardman RM, 2009, J PHYSIOL-LONDON, V587, P2487, DOI 10.1113/jphysiol.2009.170548; Harr B, 2010, MOL ECOL, V19, P228, DOI 10.1111/j.1365-294X.2009.04490.x; Hass N, 2008, CELL TISSUE RES, V334, P187, DOI 10.1007/s00441-008-0677-6; Heldens L, 2010, CELL MOL LIFE SCI, V67, P4035, DOI 10.1007/s00018-010-0430-7; Hengl T, 2010, P NATL ACAD SCI USA, V107, P6052, DOI 10.1073/pnas.0909032107; Hjelmqvist L, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-6-research0027; Huard JMT, 1998, J COMP NEUROL, V400, P469; Hwang JI, 2000, J BIOL CHEM, V275, P16632, DOI 10.1074/jbc.M001410200; Irmer H, 1997, J BIOL CHEM, V272, P2230; Jacobsson JA, 2007, GENOMICS, V90, P595, DOI 10.1016/j.ygeno.2007.03.017; Jin J, 2008, SCIENCE, V322, P756, DOI 10.1126/science.1163493; Jin J, 2012, P NATL ACAD SCI USA, V109, pE225, DOI 10.1073/pnas.1120033109; JONES DT, 1989, SCIENCE, V244, P790, DOI 10.1126/science.2499043; Jones KA, 1998, NATURE, V396, P674, DOI 10.1038/25348; Juilfs DM, 1997, P NATL ACAD SCI USA, V94, P3388, DOI 10.1073/pnas.94.7.3388; Kadowaki T, 2005, ENDOCR REV, V26, P439, DOI 10.1210/er.2005-0005; Kajiya K, 2001, J NEUROSCI, V21, P6018, DOI 10.1523/JNEUROSCI.21-16-06018.2001; KALINOSKI DL, 1992, BIOCHEM J, V281, P449, DOI 10.1042/bj2810449; Kaneko H, 2004, J NEUROSCI, V24, P7931, DOI 10.1523/JNEUROSCI.2115-04.2004; Kelliher KR, 2003, P NATL ACAD SCI USA, V100, P4299, DOI 10.1073/pnas.0736071100; Kerr DS, 2008, MOL CELL NEUROSCI, V38, P341, DOI 10.1016/j.mcn.2008.03.006; Kerstein PC, 2013, J NEUROSCI, V33, P273, DOI 10.1523/JNEUROSCI.2142-12.2013; Keydar I, 2013, HUM MUTAT, V34, P32, DOI 10.1002/humu.22212; Khan M, 2011, CELL, V147, P907, DOI 10.1016/j.cell.2011.09.049; Khananshvili D, 2013, MOL ASPECTS MED, V34, P220, DOI 10.1016/j.mam.2012.07.003; Kim AY, 2008, CELL, V133, P475, DOI 10.1016/j.cell.2008.02.053; Klasen K, 2010, CELL SIGNAL, V22, P150, DOI 10.1016/j.cellsig.2009.09.026; KLEENE SJ, 1991, J NEUROSCI, V11, P3624; Klimmeck D, 2008, NEUROSCIENCE, V151, P901, DOI 10.1016/j.neuroscience.2007.11.023; Kolmakov NN, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-429; KREAM RM, 1984, J NEUROSCI, V4, P868; Kurtenbach S, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-234; Lai Peter C., 2008, Journal of Structural and Functional Genomics, V9, P29, DOI 10.1007/s10969-008-9043-x; Langenhan T, 2010, ADV EXP MED BIOL, V706, P37; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lesage F, 2000, J BIOL CHEM, V275, P28398, DOI 10.1074/jbc.M002822200; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li JG, 2002, J BIOL CHEM, V277, P27545, DOI 10.1074/jbc.M200058200; Li YR, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001230; Liberles SD, 2006, NATURE, V442, P645, DOI 10.1038/nature05066; Liberles SD, 2009, P NATL ACAD SCI USA, V106, P9842, DOI 10.1073/pnas.0904464106; Lin W, 2007, P NATL ACAD SCI USA, V104, P2471, DOI 10.1073/pnas.0610201104; Ling GY, 2004, CHEM-BIOL INTERACT, V147, P247, DOI 10.1016/j.cbi.2004.02.003; Liu D, 2003, P NATL ACAD SCI USA, V100, P15160, DOI 10.1073/pnas.2334159100; Liu L, 2008, J BIOL CHEM, V283, P13185, DOI 10.1074/jbc.M800757200; Madsen CP, 2012, AM J PHYSIOL-CELL PH, V303, pC625, DOI 10.1152/ajpcell.00287.2011; Magalhaes AC, 2012, BRIT J PHARMACOL, V165, P1717, DOI 10.1111/j.1476-5381.2011.01552.x; Mahon MJ, 2002, NATURE, V417, P858, DOI 10.1038/nature00816; Malnic B, 1999, CELL, V96, P713, DOI 10.1016/S0092-8674(00)80581-4; MARGOLIS FL, 1991, PROG BRAIN RES, V89, P97; Mashukova A, 2006, J NEUROSCI, V26, P9902, DOI 10.1523/JNEUROSCI.2897-06.2006; Mast TG, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-61; Mayer U, 2008, CHEM SENSES, V33, P145, DOI 10.1093/chemse/bjm073; Mayer U, 2009, PROTEOMICS, V9, P322, DOI 10.1002/pmic.200800149; McClintock TS, 2008, PHYSIOL GENOMICS, V32, P198, DOI 10.1152/physiolgenomics.00128.2007; MENINI A, 1995, BIOPHYS CHEM, V55, P185, DOI 10.1016/0301-4622(94)00153-B; Menini A, 1999, CURR OPIN NEUROBIOL, V9, P419, DOI 10.1016/S0959-4388(99)80063-4; Michalakis S, 2006, J BIOL CHEM, V281, P35156, DOI 10.1074/jbc.M606409200; Michibata H, 2009, STEM CELLS DEV, V18, P629, DOI 10.1089/scd.2008.0215; Mombaerts P, 2004, CURR OPIN NEUROBIOL, V14, P31, DOI 10.1016/j.conb.2004.01.014; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Munger SD, 2000, J BIOL CHEM, V275, P20450, DOI 10.1074/jbc.M001989200; Munger SD, 2001, SCIENCE, V294, P2172, DOI 10.1126/science.1063224; Mustata RC, 2011, EMBO REP, V12, P558, DOI 10.1038/embor.2011.52; NAKAMURA T, 1987, NATURE, V325, P442, DOI 10.1038/325442a0; Nancy V, 2002, J BIOL CHEM, V277, P15076, DOI 10.1074/jbc.M109983200; Nepravishta R, 2012, METALLOMICS, V4, P480, DOI 10.1039/c2mt20035j; Neuhaus EM, 2006, CHEM SENSES, V31, P445, DOI 10.1093/chemse/bjj049; Neuhaus EM, 2006, J CELL SCI, V119, P3047, DOI 10.1242/jcs.03046; Nickell MD, 2012, J COMP NEUROL, V520, P2608, DOI 10.1002/cne.23052; Nickell WT, 2007, J PHYSIOL-LONDON, V583, P1005, DOI 10.1113/jphysiol.2007.129601; Niedernberg A, 2003, CELL SIGNAL, V15, P435, DOI 10.1016/S0898-6568(02)00119-5; Niimura Y, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000708; Nikolova S, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-146; Nilius B, 2008, EMBO J, V27, P2809, DOI 10.1038/emboj.2008.217; Nisar SP, 2012, J BIOL CHEM, V287, P24505, DOI 10.1074/jbc.M112.347104; Noel J, 2009, EMBO J, V28, P1308, DOI 10.1038/emboj.2009.57; Ohmoto M, 2008, MOL CELL NEUROSCI, V38, P505, DOI 10.1016/j.mcn.2008.04.011; Olianas MC, 1999, BIOCHEM PHARMACOL, V57, P649, DOI 10.1016/S0006-2952(98)00326-8; Oort PJ, 2007, MOL CELL ENDOCRINOL, V276, P24, DOI 10.1016/j.mce.2007.06.005; Palty R, 2012, CELL, V149, P425, DOI 10.1016/j.cell.2012.01.055; Peppel K, 1997, J BIOL CHEM, V272, P25425, DOI 10.1074/jbc.272.41.25425; PES D, 1995, COMP BIOCHEM PHYS B, V112, P471, DOI 10.1016/0305-0491(95)00063-1; Pho V, 2005, BEHAV BRAIN RES, V161, P245, DOI 10.1016/j.bbr.2005.02.011; Pifferi S, 2006, FEBS LETT, V580, P2853, DOI 10.1016/j.febslet.2006.03.086; Pifferi S, 2009, J PHYSIOL-LONDON, V587, P4265, DOI 10.1113/jphysiol.2009.176131; Pluznick JL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019694; Potter SM, 2001, J NEUROSCI, V21, P9713, DOI 10.1523/JNEUROSCI.21-24-09713.2001; Priest CA, 2004, J NEUROBIOL, V60, P154, DOI 10.1002/neu.20011; Radhakrishnan K, 2011, CELL PHYSIOL BIOCHEM, V28, P603, DOI 10.1159/000335756; Rasche S, 2010, CHEM SENSES, V35, P239, DOI 10.1093/chemse/bjq007; Reisert J, 2005, NEURON, V45, P553, DOI 10.1016/j.neuron.2005.01.012; Reisert J, 2003, J GEN PHYSIOL, V122, P349, DOI 10.1085/jgp.200308888; Rengaraj D, 2011, DEV DYNAM, V240, P850, DOI 10.1002/dvdy.22575; RESTREPO D, 1992, AM J PHYSIOL, V263, pC667, DOI 10.1152/ajpcell.1992.263.3.C667; RESTREPO D, 1990, SCIENCE, V249, P1166, DOI 10.1126/science.2168580; Riviere S, 2009, NATURE, V459, P574, DOI 10.1038/nature08029; Roberts A, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-3-r22; Runnels LW, 2002, NAT CELL BIOL, V4, P329, DOI 10.1038/ncb781; Saito H, 2004, CELL, V119, P679, DOI 10.1016/j.cell.2004.11.021; Sammeta N, 2007, J COMP NEUROL, V502, P1138, DOI 10.1002/cne.21365; Sammeta N, 2010, MOL CELL NEUROSCI, V45, P398, DOI 10.1016/j.mcn.2010.07.013; Savigner A, 2009, J NEUROPHYSIOL, V101, P2898, DOI 10.1152/jn.91169.2008; SCHLEICHER S, 1993, P NATL ACAD SCI USA, V90, P1420, DOI 10.1073/pnas.90.4.1420; Schobel N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048005; SCHULTZ J, 1990, MOL CELL BIOL, V10, P4744, DOI 10.1128/MCB.10.9.4744; Serizawa S, 2003, SCIENCE, V302, P2088, DOI 10.1126/science.1089122; Shiao MS, 2012, GENOME BIOL EVOL, V4, P703, DOI 10.1093/gbe/evs039; SIKORSKI RS, 1991, COLD SH Q B, V56, P663; Spehr M, 2002, NEURON, V33, P731, DOI 10.1016/S0896-6273(02)00610-4; Sreedharan S, 2011, FEBS J, V278, P4881, DOI 10.1111/j.1742-4658.2011.08388.x; Stephan AB, 2012, NAT NEUROSCI, V15, P131, DOI 10.1038/nn.2943; Stephan AB, 2009, P NATL ACAD SCI USA, V106, P11776, DOI 10.1073/pnas.0903304106; Storch U, 2012, J BIOL CHEM, V287, P3530, DOI 10.1074/jbc.M111.283218; Sugasawa T, 2001, GENE, V273, P227, DOI 10.1016/S0378-1119(01)00587-X; Takami S, 2001, CHEM SENSES, V26, P517, DOI 10.1093/chemse/26.5.517; Talley EM, 2001, J NEUROSCI, V21, P7491, DOI 10.1523/JNEUROSCI.21-19-07491.2001; TAYLOR SS, 1990, ANNU REV BIOCHEM, V59, P971, DOI 10.1146/annurev.bi.59.070190.004543; Tillerson JL, 2006, BEHAV BRAIN RES, V172, P97, DOI 10.1016/j.bbr.2006.04.025; Tissir F, 2010, NAT NEUROSCI, V13, P700, DOI 10.1038/nn.2555; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Trifonov S, 2012, EUR J NEUROSCI, V35, P711, DOI 10.1111/j.1460-9568.2012.08001.x; Ukhanov K, 2011, J NEUROSCI, V31, P273, DOI 10.1523/JNEUROSCI.3698-10.2011; Ukhanov K, 2010, J NEUROPHYSIOL, V103, P1114, DOI 10.1152/jn.00980.2009; VANDERLEIJ I, 1993, P NATL ACAD SCI USA, V90, P11782, DOI 10.1073/pnas.90.24.11782; Von Dannecker LEC, 2005, J NEUROSCI, V25, P3793, DOI 10.1523/JNEUROSCI.4595-04.2005; Von Dannecker LEC, 2006, P NATL ACAD SCI USA, V103, P9310, DOI 10.1073/pnas.0600697103; Wakabayashi Y, 2002, CHEM SENSES, V27, P207, DOI 10.1093/chemse/27.3.207; Wei J, 1996, J BIOL CHEM, V271, P24231, DOI 10.1074/jbc.271.39.24231; Weiss J, 2011, NATURE, V472, P186, DOI 10.1038/nature09975; Wheeler D, 2008, MOL ENDOCRINOL, V22, P1163, DOI 10.1210/me.2007-0461; Xiang MH, 2005, J BIOL CHEM, V280, P11608, DOI 10.1074/jbc.M413116200; Xu FQ, 2005, J COMP NEUROL, V489, P491, DOI 10.1002/cne.20652; YAN C, 1995, P NATL ACAD SCI USA, V92, P9677, DOI 10.1073/pnas.92.21.9677; Yan C, 1996, J BIOL CHEM, V271, P25699, DOI 10.1074/jbc.271.41.25699; Yu HMI, 2010, DEV DYNAM, V239, P2102, DOI 10.1002/dvdy.22336; Yu TT, 2005, J COMP NEUROL, V483, P251, DOI 10.1002/cne.20429; Zhainazarov AB, 2001, J NEUROPHYSIOL, V85, P2537, DOI 10.1152/jn.2001.85.6.2537; Zhang XF, 2010, NAT NEUROSCI, V13, P1056, DOI 10.1038/nn.2610; Zhao J, 2008, MOL VIS, V14, P1623; Zheng J, 2004, NEURON, V42, P411, DOI 10.1016/S0896-6273(04)00253-3; Zou AR, 2003, AM J PHYSIOL-CELL PH, V285, pC1356, DOI 10.1152/ajpcell.00179.2003; Zufall F, 2000, CHEM SENSES, V25, P473, DOI 10.1093/chemse/25.4.473; Zufall F, 2005, Naunyn Schmiedebergs Arch Pharmacol, V371, P245, DOI 10.1007/s00210-005-1028-8; Zufall F, 2002, MICROSC RES TECHNIQ, V58, P251, DOI 10.1002/jemt.10152	201	53	55	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2015	10	1							e0113170	10.1371/journal.pone.0113170	http://dx.doi.org/10.1371/journal.pone.0113170			47	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9HN	25590618	Green Published, Green Submitted, gold			2022-12-27	WOS:000350679400001
J	Beasley, JC; Atwood, TC; Byrne, ME; Vercauteren, KC; Johnson, SR; Rhodes, OE				Beasley, James C.; Atwood, Todd C.; Byrne, Michael E.; Vercauteren, Kurt C.; Johnson, Shylo R.; Rhodes, Olin E., Jr.			A Behaviorally-Explicit Approach for Delivering Vaccine Baits to Mesopredators to Control Epizootics in Fragmented Landscapes	PLOS ONE			English	Article							ORAL RABIES VACCINATION; STRIPED SKUNKS; HABITAT SELECTION; ONRAB(R) BAITS; RHODAMINE-B; RACCOONS; FOXES; ATTRIBUTES; DENSITY; POPULATION	Despite the widespread use of aerial baiting to manage epizootics among free-ranging populations, particularly in rabies management, bait acceptance and seroconversion rates often are lower than required to eliminate spread of disease. Our objectives in this study, therefore, were to evaluate the performance of stratified bait distribution models derived from resource selection functions (RSF) on uptake of placebo rabies baits by raccoons (Procyon lotor) and Virginia opossums (Didelphis virginiana), as well as the probability of bait uptake as a function of proximity to bait distribution areas in fragmented agricultural ecosystems. Among 478 raccoons and 108 opossums evaluated for presence of Rhodamine B (RB) across 8 sites, only 26% of raccoons and 20% of opossums exhibited marking consistent with bait consumption 14-24 days post-baiting. The effective area treated, based on 90% kernel density estimators of marked individuals, ranged from 99-240 ha larger than bait distribution zones, with RB marked individuals captured up to 753m beyond the bait zone. Despite incorporation of RSF data into bait distribution models, no differences in uptake rates were observed between treatment and control sites. These data likely reflect the underlying constraints imposed by the loss and fragmentation of habitat on animal movement in heterogeneous landscapes, forcing individuals to optimize movements at coarse (i.e., patch-level) rather than fine spatial scales in highly fragmented environments. Our data also confirm that the probability of bait acceptance decreases with increasing distance from bait zone interiors, even within the zone itself. Thus, although bait acceptance was confirmed beyond bait zone boundaries, the proportion of vaccinated individuals may comprise a small minority of the population at increasing distances from baiting interiors. These data suggest focal baiting creates a buffered area of treated individuals around bait zones or bait stations, but repeated treatments may be needed to achieve sufficient uptake to eradicate disease.	[Beasley, James C.; Byrne, Michael E.; Rhodes, Olin E., Jr.] Univ Georgia, Savannah River Ecol Lab, Aiken, SC 29802 USA; [Atwood, Todd C.; Vercauteren, Kurt C.; Johnson, Shylo R.] USDA, APHIS Wildlife Serv, Natl Wildlife Res Ctr, Ft Collins, CO USA	United States Department of Energy (DOE); Savannah River Ecology Laboratory; University System of Georgia; University of Georgia; United States Department of Agriculture (USDA)	Beasley, JC (corresponding author), Univ Georgia, Savannah River Ecol Lab, Aiken, SC 29802 USA.	beasley@srel.uga.edu			U.S. Department of Agriculture, Animal Plant Health Inspection Service, Wildlife Services, National Wildlife Research Center; U.S. Department of Agriculture, Animal Plant Health Inspection Service, Wildlife Services, National Rabies Management Program; Department of Forestry and Natural Resources at Purdue University; U.S. Department of Energy [DE-FC09-07SR22506]	U.S. Department of Agriculture, Animal Plant Health Inspection Service, Wildlife Services, National Wildlife Research Center; U.S. Department of Agriculture, Animal Plant Health Inspection Service, Wildlife Services, National Rabies Management Program; Department of Forestry and Natural Resources at Purdue University; U.S. Department of Energy(United States Department of Energy (DOE))	Funding for this research was provided by the U.S. Department of Agriculture, Animal Plant Health Inspection Service, Wildlife Services, National Wildlife Research Center (http://www.aphis.usda.gov/wildlife_damage/nwrc), the U.S. Department of Agriculture, Animal Plant Health Inspection Service, Wildlife Services, National Rabies Management Program, the Department of Forestry and Natural Resources at Purdue University, and the U.S. Department of Energy under Award Number DE-FC09-07SR22506 to the University of Georgia Research Foundation. Researchers at the USDA-APHIS National Wildlife Research Center participated in the design of this study and preparation of the manuscript.	Atwood TC, 2009, J WILDLIFE MANAGE, V73, P647, DOI 10.2193/2008-215; Beasley JC, 2010, CAN J ZOOL, V88, P161, DOI 10.1139/Z09-137; Beasley JC, 2007, J WILDLIFE MANAGE, V71, P1125, DOI 10.2193/2006-228; Beasley JC, 2007, J WILDLIFE MANAGE, V71, P844, DOI 10.2193/2006-022; Beasley JC, 2012, J WILDLIFE MANAGE, V76, P1290, DOI 10.1002/jwmg.379; Beasley JC, 2011, LANDSCAPE ECOL, V26, P937, DOI 10.1007/s10980-011-9619-x; Beatty WS, 2014, CAN J ZOOL, V92, P41, DOI 10.1139/cjz-2013-0225; Blancou J, 2008, DEV BIOLOGICALS, V131, P3; Blanton JD, 2011, JAVMA-J AM VET MED A, V239, P773, DOI 10.2460/javma.239.6.773; Boyer JP, 2011, J WILDLIFE DIS, V47, P593, DOI 10.7589/0090-3558-47.3.593; Burnham K. P., 2002, MODEL SELECTION AND; Byrne ME, 2012, ANIM BEHAV, V84, P593, DOI 10.1016/j.anbehav.2012.06.012; Cagnacci F, 2007, WILDLIFE RES, V34, P454, DOI 10.1071/WR07026; Calenge C, 2006, ECOL MODEL, V197, P516, DOI 10.1016/j.ecolmodel.2006.03.017; Cliquet F, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001535; Fehlner-Gardiner C, 2012, J WILDLIFE DIS, V48, P157, DOI 10.7589/0090-3558-48.1.157; Freuling CM, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0142; Fry Tricia L., 2010, Human-Wildlife Interactions, V4, P275; Gehrt S. D., 2003, WILD MAMMALS N AM BI, P611; Gross J, 2012, URBAN ECOSYST, V15, P667, DOI 10.1007/s11252-011-0218-z; Hegglin D, 2003, EMERG INFECT DIS, V9, P1266; Hegglin D, 2008, EMERG INFECT DIS, V14, P1626, DOI 10.3201/eid1410.080522; Henner CM, 2004, J WILDLIFE MANAGE, V68, P179, DOI 10.2193/0022-541X(2004)068[0179:AMAORD]2.0.CO;2; Hosmer DW, 1997, STAT MED, V16, P965; Houle M, 2011, CAN J ZOOL, V89, P1107, DOI [10.1139/Z11-085, 10.1139/z11-085]; Kelly DJ, 2011, EUR J WILDLIFE RES, V57, P767, DOI 10.1007/s10344-010-0485-7; Konig A, 2012, WILDLIFE RES, V39, P488, DOI 10.1071/WR11077; Linhart SB, 2002, J WILDLIFE DIS, V38, P363, DOI 10.7589/0090-3558-38.2.363; Mainguy J, 2012, J WILDLIFE DIS, V48, P979, DOI 10.7589/2011-12-316; Mulatti P, 2011, GEOSPATIAL HEALTH, V5, P217, DOI 10.4081/gh.2011.174; Page K, 2011, EMERG INFECT DIS, V17, P90, DOI 10.3201/eid1701.100876; PULLIAM HR, 1988, AM NAT, V132, P652, DOI 10.1086/284880; R Development Core Team, 2014, R LANG ENV STAT COMP; Ramey PC, 2008, J WILDLIFE DIS, V44, P553, DOI 10.7589/0090-3558-44.3.553; Recuenco S, 2009, ZOONOSES PUBLIC HLTH, V56, P16, DOI 10.1111/j.1863-2378.2008.01168.x; Rosatte RC, 2011, J WILDLIFE DIS, V47, P459, DOI 10.7589/0090-3558-47.2.459; Rosatte RC, 2009, J WILDLIFE DIS, V45, P363, DOI 10.7589/0090-3558-45.2.363; Sattler AC, 2009, VACCINE, V27, P7187, DOI 10.1016/j.vaccine.2009.09.035; Selhorst T, 2012, BERL MUNCH TIERARZTL, V125, P191, DOI 10.2376/0005-9366-125-191; Sidwa TJ, 2005, JAVMA-J AM VET MED A, V227, P785, DOI 10.2460/javma.2005.227.785; Sikes RS, 2011, J MAMMAL, V92, P235, DOI 10.1644/10-MAMM-F-355.1; Slate D, 2005, VIRUS RES, V111, P68, DOI 10.1016/j.virusres.2005.03.012; Slate D, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000549; Smyser TJ, 2013, J WILDLIFE MANAGE, V77, P1372, DOI 10.1002/jwmg.585; Smyser TJ, 2010, J WILDLIFE MANAGE, V74, P1405, DOI 10.2193/2009-299; Sterner RT, 2009, EMERG INFECT DIS, V15, P1176, DOI 10.3201/eid1508.081061; Thulke HH, 2008, DEV BIOLOGICALS, V131, P291; Tinline R. R., 2007, ONTARIO RABIES MODEL; Tsukada H, 2002, PARASITOLOGY, V125, P119, DOI 10.1017/S0031182002001968; Vos A, 2004, BERL MUNCH TIERARZTL, V117, P360; White GC, 1999, BIRD STUDY, V46, P120, DOI 10.1080/00063659909477239	51	9	9	2	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2015	10	1							e0113206	10.1371/journal.pone.0113206	http://dx.doi.org/10.1371/journal.pone.0113206			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ0ID	25587900	gold, Green Published, Green Submitted			2022-12-27	WOS:000347928300002
J	Cerbini, T; Funahashl, R; Luo, YQ; Liu, CY; Park, K; Rao, M; Malik, N; Zou, JH				Cerbini, Trevor; Funahashl, Ray; Luo, Yongquan; Liu, Chengyu; Park, Kyeyoon; Rao, Mahendra; Malik, Nasir; Zou, Jizhong			Transcription Activator-Like Effector Nuclease (TALEN)-Mediated CLYBL Targeting Enables Enhanced Transgene Expression and One-Step Generation of Dual Reporter Human Induced Pluripotent Stem Cell (iPSC) and Neural Stem Cell (NSC) Lines	PLOS ONE			English	Article							GENE CORRECTION; DISEASE; TALEN; SPECIFICITY; MUTATIONS; CLONES; CAS9	Targeted genome engineering to robustly express transgenes is an essential methodology for stem cell-based research and therapy. Although designer nucleases have been used to drastically enhance gene editing efficiency, targeted addition and stable expression of transgenes to date is limited at single gene/locus and mostly PPP1R12C/AAVS1 in human stem cells. Here we constructed transcription activator-like effector nucleases (TALENs) targeting the safe-harbor like gene CLYBL to mediate reporter gene integration at 38%-58% efficiency, and used both AAVS1-TALENs and CLYBL-TALENs to simultaneously knock-in multiple reporter genes at dual safe-harbor loci in human induced pluripotent stem cells (iPSCs) and neural stem cells (NSCs). The CLYBL-TALEN engineered cell lines maintained robust reporter expression during self-renewal and differentiation, and revealed that CLYBL targeting resulted in stronger transgene expression and less perturbation on local gene expression than PPP1R12C/AAVS1. TALEN-mediated CLYBL engineering provides improved transgene expression and options for multiple genetic modification in human stem cells.	[Cerbini, Trevor; Funahashl, Ray; Luo, Yongquan; Rao, Mahendra; Malik, Nasir; Zou, Jizhong] NIAMSD, NIH, Ctr Regenerat Med, Lab Stem Cell Biol, Bethesda, MD 20892 USA; [Liu, Chengyu; Zou, Jizhong] NHLBI, Ctr Mol Med, Div Intramural Res, Bethesda, MD 20892 USA; [Park, Kyeyoon] NINDS, Stem Cell Unit, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	Zou, JH (corresponding author), NIAMSD, NIH, Ctr Regenerat Med, Lab Stem Cell Biol, Bethesda, MD 20892 USA.	zouj2@mail.nih.gov		Zou, Jizhong/0000-0003-1021-0549	National Institutes of Health Common Fund; National Heart, Lung, and Blood Institute; National Institute of Neurological Disorders and Stroke; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZICHL005907, ZICHL006145] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [ZICNS003008] Funding Source: NIH RePORTER	National Institutes of Health Common Fund(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This research was supported by the National Institutes of Health Common Fund and Intramural Research Programs of the National Heart, Lung, and Blood Institute and National Institute of Neurological Disorders and Stroke. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brown AJ, 2013, NAT METHODS, V10, P638, DOI 10.1038/nmeth.2516; Chen SJ, 2013, NUCLEIC ACIDS RES, V41, P2769, DOI 10.1093/nar/gks1356; Cong L, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1962; Ding QR, 2013, CELL STEM CELL, V12, P393, DOI 10.1016/j.stem.2013.03.006; Ding QR, 2013, CELL STEM CELL, V12, P238, DOI 10.1016/j.stem.2012.11.011; Du ZW, 2009, STEM CELLS, V27, P1032, DOI 10.1002/stem.38; Eyquem J, 2013, BIOTECHNOL BIOENG, V110, P2225, DOI 10.1002/bit.24892; Fu YF, 2013, NAT BIOTECHNOL, V31, P822, DOI 10.1038/nbt.2623; Gaj T, 2013, TRENDS BIOTECHNOL, V31, P397, DOI 10.1016/j.tibtech.2013.04.004; Grau J, 2013, BIOINFORMATICS, V29, P2931, DOI 10.1093/bioinformatics/btt501; Guilinger JP, 2014, NAT METHODS, V11, P429, DOI 10.1038/nmeth.2845; Hockemeyer D, 2011, NAT BIOTECHNOL, V29, P731, DOI 10.1038/nbt.1927; Irion S, 2007, NAT BIOTECHNOL, V25, P1477, DOI 10.1038/nbt1362; Liu Y, 2009, STEM CELLS DEV, V18, P1459, DOI 10.1089/scd.2009.0047; Lombardo A, 2011, NAT METHODS, V8, P861, DOI [10.1038/NMETH.1674, 10.1038/nmeth.1674]; Luo YQ, 2014, STEM CELL TRANSL MED, V3, P821, DOI 10.5966/sctm.2013-0212; Ma AC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065259; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Papapetrou EP, 2011, NAT BIOTECHNOL, V29, P73, DOI 10.1038/nbt.1717; Ran FA, 2013, CELL, V154, P1380, DOI 10.1016/j.cell.2013.08.021; Smith C, 2014, CELL STEM CELL, V15, P13, DOI 10.1016/j.stem.2014.06.011; Streubel J, 2012, NAT BIOTECHNOL, V30, P593, DOI 10.1038/nbt.2304; Suzuki K, 2014, CELL STEM CELL, V15, P31, DOI 10.1016/j.stem.2014.06.016; Swistowski A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006233; Thyagarajan B, 2008, STEM CELLS, V26, P119, DOI 10.1634/stemcells.2007-0283; Valton J, 2012, J BIOL CHEM, V287, P38427, DOI 10.1074/jbc.C112.408864; Veres A, 2014, CELL STEM CELL, V15, P27, DOI 10.1016/j.stem.2014.04.020; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Wang YM, 2012, CIRC RES, V111, P1494, DOI 10.1161/CIRCRESAHA.112.274969; Zou JZ, 2011, BLOOD, V118, P4599, DOI 10.1182/blood-2011-02-335554; Zou JZ, 2011, BLOOD, V117, P5561, DOI 10.1182/blood-2010-12-328161; Zou JZ, 2009, CELL STEM CELL, V5, P97, DOI 10.1016/j.stem.2009.05.023	32	46	48	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2015	10	1							e0116032	10.1371/journal.pone.0116032	http://dx.doi.org/10.1371/journal.pone.0116032			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ0ID	25587899	Green Published, gold, Green Submitted			2022-12-27	WOS:000347928300008
J	Sorensen, MCH; Gencay, YE; Birk, T; Baldvinsson, SB; Jackel, C; Hammerl, JA; Vegge, CS; Neve, H; Brondsted, L				Sorensen, Martine C. Holst; Gencay, Yilmaz Emre; Birk, Tina; Baldvinsson, Signe Berg; Jaeckel, Claudia; Hammerl, Jens A.; Vegge, Christina S.; Neve, Horst; Brondsted, Lone			Primary Isolation Strain Determines Both Phage Type and Receptors Recognised by Campylobacter jejuni Bacteriophages	PLOS ONE			English	Article							CAPSULAR POLYSACCHARIDE; FREE-RANGE; CHICKEN SKIN; COLI; INFECTION; DIVERSITY; SURFACE; GENOME; LIPOOLIGOSACCHARIDE; IDENTIFICATION	In this study we isolated novel bacteriophages, infecting the zoonotic bacterium Campylobacter jejuni. These phages may be used in phage therapy of C. jejuni colonized poultry to prevent spreading of the bacteria to meat products causing disease in humans. Many C. jejuni phages have been isolated using NCTC12662 as the indicator strain, which may have biased the selection of phages. A large group of C. jejuni phages rely on the highly diverse capsular polysaccharide (CPS) for infection and recent work identified the O-methyl phosphoramidate modification (MeOPN) of CPS as a phage receptor. We therefore chose seven C. jejuni strains each expressing different CPS structures as indicator strains in a large screening for phages in samples collected from free-range poultry farms. Forty-three phages were isolated using C. jejuni NCTC12658, NCTC12662 and RM1221 as host strains and 20 distinct phages were identified based on host range analysis and genome restriction profiles. Most phages were isolated using C. jejuni strains NCTC12662 and RM1221 and interestingly phage genome size (140 kb vs. 190 kb), host range and morphological appearance correlated with the isolation strain. Thus, according to C. jejuni phage grouping, NCTC12662 and NCTC12658 selected for CP81-type phages, while RM1221 selected for CP220-type phages. Furthermore, using acapsular Delta kpsM mutants we demonstrated that phages isolated on NCTC12658 and NCTC12662 were dependent on the capsule for infection. In contrast, CP220-type phages isolated on RM1221 were unable to infect non-motile Delta motA mutants, hence requiring motility for successful infection. Hence, the primary phage isolation strain determines both phage type (CP81 or CP220) as well as receptors (CPS or flagella) recognised by the isolated phages.	[Sorensen, Martine C. Holst; Gencay, Yilmaz Emre; Baldvinsson, Signe Berg; Vegge, Christina S.; Brondsted, Lone] Univ Copenhagen, Dept Vet Dis Biol, Frederiksberg, Denmark; [Birk, Tina] Tech Univ Denmark, Natl Food Inst, Soborg, Denmark; [Jaeckel, Claudia; Hammerl, Jens A.] Fed Inst Risk Assessment, Dept Biol Safety, Berlin, Germany; [Neve, Horst] Fed Res Inst Nutr & Food, Max Rubner Inst, Dept Microbiol & Biotechnol, Kiel, Germany	University of Copenhagen; Technical University of Denmark; Federal Institute for Risk Assessment	Brondsted, L (corresponding author), Univ Copenhagen, Dept Vet Dis Biol, Frederiksberg, Denmark.	lobr@sund.ku.dk	Gencay, Yilmaz Emre/A-6746-2011; Hammerl, Jens Andre/Y-6406-2018	Gencay, Yilmaz Emre/0000-0002-2154-9663; Hammerl, Jens Andre/0000-0002-6930-4358; Brondsted, Lone/0000-0002-7930-5725; Birk, Tina/0000-0001-7186-0575; Sorensen, Martine Camilla Holst/0000-0001-8900-3176	Danish Research Council for Technology and Production Sciences [09-070555]	Danish Research Council for Technology and Production Sciences	This work was supported by the Danish Research Council for Technology and Production Sciences by grant 09-070555 (http://ufm.dk/en/research-and-innovation/councils-and-commissions/thedanish- council-for-independent-research/the-council1/the-danish-council-for-independent-research-technology-and-production-sciences). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackermann Hans-W., 2009, V501, P113, DOI 10.1007/978-1-60327-164-6_12; Atterbury RJ, 2005, APPL ENVIRON MICROB, V71, P4885, DOI 10.1128/AEM.71.8.4885-4887.2005; Atterbury RJ, 2003, APPL ENVIRON MICROB, V69, P6302, DOI 10.1128/AEM.69.10.6302-6306.2003; Atterbury RJ, 2003, APPL ENVIRON MICROB, V69, P4511, DOI 10.1128/AEM.69.8.4511-4518.2003; Baldvinsson SB, 2014, APPL ENVIRON MICROB, V80, P7096, DOI 10.1128/AEM.02057-14; Bigwood T, 2009, LETT APPL MICROBIOL, V48, P343, DOI 10.1111/j.1472-765X.2008.02538.x; Bigwood T, 2008, FOOD MICROBIOL, V25, P400, DOI 10.1016/j.fm.2007.11.003; Brathwaite KJ, 2013, GENOME ANNOUNCEMENTS, V1, DOI 10.1128/genomeA.00969-13; Carrillo CML, 2007, ANTON LEEUW INT J G, V92, P275, DOI 10.1007/s10482-007-9156-4; Carrillo CL, 2005, APPL ENVIRON MICROB, V71, P6554, DOI 10.1128/AEM.71.11.6554-6563.2005; Carvalho C, 2010, LETT APPL MICROBIOL, V50, P192, DOI 10.1111/j.1472-765X.2009.02774.x; Carvalho CM, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-35; Carvalho CM, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-232; Chen YH, 2008, CARBOHYD RES, V343, P1034, DOI 10.1016/j.carres.2008.02.024; Choi Y, 2013, APPL ENVIRON MICROB, V79, P4829, DOI 10.1128/AEM.00706-13; Connerton PL, 2011, J APPL MICROBIOL, V111, P255, DOI 10.1111/j.1365-2672.2011.05012.x; Connerton PL, 2004, APPL ENVIRON MICROB, V70, P3877, DOI 10.1128/AEM.70.7.3877-3883.2004; Coward C, 2006, APPL ENVIRON MICROB, V72, P4638, DOI 10.1128/AEM.00184-06; El-Shibiny A, 2005, APPL ENVIRON MICROB, V71, P1259, DOI 10.1128/AEM.71.3.1259-1266.2005; El-Shibiny A, 2009, J FOOD PROTECT, V72, P733, DOI 10.4315/0362-028X-72.4.733; European Food Safety Authority, 2014, EFSA J, V12, DOI 10.2903/j.efsa.2014.3547; Fischer S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078543; Fouts DE, 2005, PLOS BIOL, V3, P72, DOI 10.1371/journal.pbio.0030015; Frost JA, 1999, EPIDEMIOL INFECT, V123, P47, DOI 10.1017/S095026889900254X; Gilbert M, 2007, CHEMBIOCHEM, V8, P625, DOI 10.1002/cbic.200600508; Goode D, 2003, APPL ENVIRON MICROB, V69, P5032, DOI 10.1128/AEM.69.8.5032-5036.2003; GRAJEWSKI BA, 1985, J CLIN MICROBIOL, V22, P13, DOI 10.1128/JCM.22.1.13-18.1985; Hammerl JA, 2012, J VIROL, V86, P8896, DOI 10.1128/JVI.01252-12; Hammerl JA, 2011, J VIROL, V85, P8597, DOI 10.1128/JVI.00395-11; Hansen VM, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-90; Hofreuter D, 2006, INFECT IMMUN, V74, P4694, DOI 10.1128/IAI.00210-06; Hwang S, 2009, MICROBIOL IMMUNOL, V53, P559, DOI 10.1111/j.1348-0421.2009.00163.x; Javed MA, 2014, ARCH VIROL, V159, P181, DOI 10.1007/s00705-013-1788-2; Kanipes MI, 2008, J BACTERIOL, V190, P1568, DOI 10.1128/JB.01696-07; Kanipes MI, 2006, J BACTERIOL, V188, P3273, DOI 10.1128/JB.188.9.3273-3279.2006; Karlyshev AV, 2005, MOL MICROBIOL, V55, P90, DOI 10.1111/j.1365-2958.2004.04374.x; KHAKHRIA R, 1992, EPIDEMIOL INFECT, V108, P403, DOI 10.1017/S0950268800049918; Kropinski AM, 2011, APPL ENVIRON MICROB, V77, P8265, DOI 10.1128/AEM.05562-11; McKay D, 2001, J CLIN MICROBIOL, V39, P1917, DOI 10.1128/JCM.39.5.1917-1921.2001; McNally DJ, 2007, J BIOL CHEM, V282, P28566, DOI 10.1074/jbc.M704413200; McNally DJ, 2006, FEBS J, V273, P3975, DOI 10.1111/j.1742-4658.2006.05401.x; McNally DJ, 2005, FEBS J, V272, P4407, DOI 10.1111/j.1742-4658.2005.04856.x; Muldoon J, 2002, CARBOHYD RES, V337, P2223, DOI 10.1016/S0008-6215(02)00182-9; Orquera Stefanie, 2012, J Mol Genet Med, V6, P273; Owens J, 2013, VET MICROBIOL, V162, P144, DOI 10.1016/j.vetmic.2012.08.017; Penner JL, 1997, J INFECT DIS, V176, pS135, DOI 10.1086/513778; Rakhuba DV, 2010, POL J MICROBIOL, V59, P145, DOI 10.33073/pjm-2010-023; Sails AD, 1998, J MED MICROBIOL, V47, P123, DOI 10.1099/00222615-47-2-123; SALAMA S, 1989, LETT APPL MICROBIOL, V8, P5, DOI 10.1111/j.1472-765X.1989.tb00211.x; Scott AE, 2007, PLOS PATHOG, V3, P1142, DOI 10.1371/journal.ppat.0030119; Scott AE, 2007, ENVIRON MICROBIOL, V9, P2341, DOI 10.1111/J.1462-2920.2007.01351.x; Shin H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043392; Sorensen MCH, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00011; Sorensen MCH, 2011, J BACTERIOL, V193, P6742, DOI 10.1128/JB.05276-11; SORENSEN MCH, 2011, THESIS U COPENHAGEN; ST MF, 2002, EUR J BIOCHEM, V269, P5119, DOI DOI 10.1046/J.1432-1033.2002.03201.X; Szymanski CM, 2003, J BIOL CHEM, V278, P24509, DOI 10.1074/jbc.M301273200; Tsuei AC, 2007, INT J FOOD MICROBIOL, V116, P121, DOI 10.1016/j.ijfoodmicro.2006.12.028; van Alphen LB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087051; Wagenaar JA, 2005, VET MICROBIOL, V109, P275, DOI 10.1016/j.vetmic.2005.06.002; Yen JY, 2012, APPL ENVIRON MICROB, V78, P7216, DOI 10.1128/AEM.01082-12	61	55	58	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2015	10	1							e0116287	10.1371/journal.pone.0116287	http://dx.doi.org/10.1371/journal.pone.0116287			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ4OG	25585385	Green Submitted, Green Published, gold			2022-12-27	WOS:000348201300007
J	Froy, H; Lewis, S; Catry, P; Bishop, CM; Forster, IP; Fukuda, A; Higuchi, H; Phalan, B; Xavier, JC; Nussey, DH; Phillips, RA				Froy, Hannah; Lewis, Sue; Catry, Paulo; Bishop, Charles M.; Forster, Isaac P.; Fukuda, Akira; Higuchi, Hiroyoshi; Phalan, Ben; Xavier, Jose C.; Nussey, Daniel H.; Phillips, Richard A.			Age-Related Variation in Foraging Behaviour in the Wandering Albatross at South Georgia: No Evidence for Senescence	PLOS ONE			English	Article							DIOMEDEA-EXULANS; NATURAL-POPULATIONS; BIRD-ISLAND; HABITAT USE; PERFORMANCE; PATTERNS; SUCCESS; LIFE; IMPROVEMENT; EXPERIENCE	Age-related variation in demographic rates is now widely documented in wild vertebrate systems, and has significant consequences for population and evolutionary dynamics. However, the mechanisms underpinning such variation, particularly in later life, are less well understood. Foraging efficiency is a key determinant of fitness, with implications for individual life history trade-offs. A variety of faculties known to decline in old age, such as muscular function and visual acuity, are likely to influence foraging performance. We examine age-related variation in the foraging behaviour of a long-lived, wide-ranging oceanic seabird, the wandering albatross Diomedea exulans. Using miniaturised tracking technologies, we compared foraging trip characteristics of birds breeding at Bird Island, South Georgia. Based on movement and immersion data collected during the incubation phase of a single breeding season, and from extensive tracking data collected in previous years from different stages of the breeding cycle, we found limited evidence for age-related variation in commonly reported trip parameters, and failed to detect signs of senescent decline. Our results contrast with the limited number of past studies that have examined foraging behaviour in later life, since these have documented changes in performance consistent with senescence. This highlights the importance of studies across different wild animal populations to gain a broader perspective on the processes driving variation in ageing rates.	[Froy, Hannah; Lewis, Sue; Nussey, Daniel H.] Univ Edinburgh, Inst Evolutionary Biol, Edinburgh, Midlothian, Scotland; [Froy, Hannah; Phillips, Richard A.] British Antarctic Survey, Nat Environm Res Council, Cambridge CB3 0ET, England; [Catry, Paulo] ISPA Inst Univ, Marine & Environm Sci Ctr, Lisbon, Portugal; [Bishop, Charles M.] Bangor Univ, Sch Biol Sci, Bangor, Gwynedd, Wales; [Forster, Isaac P.] Univ Tasmania, Australian Antarctic Div, Kingston, Tas, Australia; [Fukuda, Akira] Shizuoka Univ, Shizuoka, Japan; [Higuchi, Hiroyoshi] Keio Univ, Fujisawa, Kanagawa, Japan; [Phalan, Ben] Univ Cambridge, Dept Zool, Cambridge, England; [Xavier, Jose C.] Univ Coimbra, Marine & Environm Sci Ctr, Coimbra, Portugal	University of Edinburgh; UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); NERC British Antarctic Survey; Instituto Superior Psicologia Aplicada (ISPA); Bangor University; Australian Antarctic Division; University of Tasmania; Shizuoka University; Keio University; University of Cambridge; Universidade de Coimbra	Froy, H (corresponding author), Univ Edinburgh, Inst Evolutionary Biol, Edinburgh, Midlothian, Scotland.	hannah.froy@ed.ac.uk	Phalan, Ben/A-5783-2009; Nussey, Daniel H/F-4155-2010; Lewis, Sue/D-3380-2012; Catry, Paulo/I-5408-2013	Phalan, Ben/0000-0001-7876-7226; /0000-0002-9621-6660; Froy, Hannah/0000-0003-2965-3526; Catry, Paulo/0000-0003-3000-0522	George Macdougal Mackintosh Scholarship; Natural Environment Research Council; Biotechnology and Biological Sciences Research Council; British Antarctic Survey Polar Science for Planet Earth Programme; BBSRC [BB/H021868/1] Funding Source: UKRI; NERC [bas0100025, NE/E012906/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/H021868/1] Funding Source: researchfish; Natural Environment Research Council [NE/E012906/1, bas0100025] Funding Source: researchfish	George Macdougal Mackintosh Scholarship; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); British Antarctic Survey Polar Science for Planet Earth Programme; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	HF was funded by a George Macdougal Mackintosh Scholarship. SL was supported by a Natural Environment Research Council postdoctoral fellowship (www.nerc.ac.uk) and DHN was supported by a Biotechnology and Biological Sciences Research Council David Phillips fellowship (www.bbsrc.ac.uk). The fieldwork in 2012 was funded by the Natural Environment Research Council Collaborative Gearing Scheme, and the British Antarctic Survey Polar Science for Planet Earth Programme (www.antarctica.ac.uk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold TW, 2010, J WILDLIFE MANAGE, V74, P1175, DOI 10.2193/2009-367; Berrow SD, 2001, CONDOR, V103, P230, DOI 10.1650/0010-5422(2001)103[0230:PRAAPO]2.0.CO;2; Brunet-Rossinni A.K., 2006, HDB BIOL AGING, V6, P243; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Calenge C, 2006, ECOL MODEL, V197, P516, DOI 10.1016/j.ecolmodel.2006.03.017; Caswell H, 2000, MATRIX POPULATION MO, V2nd; Catry P, 2006, P ROY SOC B-BIOL SCI, V273, P1625, DOI 10.1098/rspb.2006.3482; Catry P, 2011, J ORNITHOL, V152, P549, DOI 10.1007/s10336-010-0616-7; Clutton-Brock TH, 1988, REPROD SUCCESS STUDI; CROXALL JP, 1990, J ANIM ECOL, V59, P775, DOI 10.2307/4895; Daunt F, 2007, FUNCT ECOL, V21, P561, DOI 10.1111/j.1365-2435.2007.01260.x; Delord K, 2008, BIOL CONSERV, V141, P1840, DOI 10.1016/j.biocon.2008.05.001; DESROCHERS A, 1992, ANIM BEHAV, V43, P885, DOI 10.1016/0003-3472(92)90002-Q; FORSLUND P, 1995, TRENDS ECOL EVOL, V10, P374, DOI 10.1016/S0169-5347(00)89141-7; Froy H, 2013, ECOL LETT, V16, P642, DOI 10.1111/ele.12092; Gaillard JM, 2000, ANNU REV ECOL SYST, V31, P367, DOI 10.1146/annurev.ecolsys.31.1.367; Hassrick JL, 2013, FUNCT ECOL, V27, P1055, DOI 10.1111/1365-2435.12108; Hindle AG, 2009, J EXP BIOL, V212, P790, DOI 10.1242/jeb.025387; HOLMES DJ, 1995, J GERONTOL A-BIOL, V50, pB59, DOI 10.1093/gerona/50A.2.B59; Jones OR, 2008, ECOL LETT, V11, P664, DOI 10.1111/j.1461-0248.2008.01187.x; Lecomte VJ, 2010, P NATL ACAD SCI USA, V107, P6370, DOI 10.1073/pnas.0911181107; Lewis S, 2012, OIKOS, V121, P2061, DOI 10.1111/j.1600-0706.2012.20293.x; Limmer B, 2009, ANIM BEHAV, V77, P1095, DOI 10.1016/j.anbehav.2009.01.015; LIND AJ, 1994, ANIM BEHAV, V48, P1261, DOI 10.1006/anbe.1994.1362; MacNulty DR, 2009, ECOL LETT, V12, P1347, DOI 10.1111/j.1461-0248.2009.01385.x; Montgomery RA, 2013, J ANIM ECOL, V82, P301, DOI 10.1111/1365-2656.12000; Nel DC, 2002, IBIS, V144, pE141, DOI 10.1046/j.1474-919X.2002.00092.x; Nevoux M, 2007, J ANIM ECOL, V76, P159, DOI 10.1111/j.1365-2656.2006.01191.x; Nevoux M, 2010, ECOLOGY, V91, P2416, DOI 10.1890/09-0143.1; Newton I, 1989, LIFETIME REPROD BIRD; Nisbet ICT, 2001, EXP GERONTOL, V36, P833, DOI 10.1016/S0531-5565(00)00244-8; Noren SR, 2001, J COMP PHYSIOL B, V171, P127, DOI 10.1007/s003600000161; Nussey DH, 2008, FUNCT ECOL, V22, P393, DOI 10.1111/j.1365-2435.2008.01408.x; Nussey DH, 2013, AGEING RES REV, V12, P214, DOI 10.1016/j.arr.2012.07.004; Nussey DH, 2011, ECOLOGY, V92, P1936, DOI 10.1890/11-0308.1; Palacios MG, 2011, ECOLOGY, V92, P952, DOI 10.1890/10-0662.1; Phalan B, 2007, MAR ECOL PROG SER, V340, P271, DOI 10.3354/meps340271; Phillips RA, 2007, AQUAT CONSERV, V17, pS6, DOI 10.1002/aqc.906; Phillips RA, 2003, AUK, V120, P1082, DOI 10.1642/0004-8038(2003)120[1082:EOSTOA]2.0.CO;2; Phillips RA, 2009, MAR ECOL PROG SER, V391, P279, DOI 10.3354/meps08028; PRINCE PA, 1992, ANTARCT SCI, V4, P31, DOI 10.1017/S0954102092000075; PROMISLOW DEL, 1991, EVOLUTION, V45, P1869, DOI 10.1111/j.1558-5646.1991.tb02693.x; Rebke M, 2010, P NATL ACAD SCI USA, V107, P7841, DOI 10.1073/pnas.1002645107; Reed TE, 2008, AM NAT, V171, pE89, DOI 10.1086/524957; Riotte-Lambert L, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1434; Rutz C, 2006, P ROY SOC B-BIOL SCI, V273, P579, DOI 10.1098/rspb.2005.3353; Sallis JF, 2000, MED SCI SPORT EXER, V32, P963, DOI 10.1097/00005768-200009000-00012; Schmolesky MT, 2000, NAT NEUROSCI, V3, P384, DOI 10.1038/73957; Shaffer SA, 2001, FUNCT ECOL, V15, P203, DOI 10.1046/j.1365-2435.2001.00514.x; Stephens D., 2007, FORAGING BEHAV ECOLO; Tanaka H, 2003, J APPL PHYSIOL, V95, P2152, DOI 10.1152/japplphysiol.00320.2003; Tuck GN, 2001, J APPL ECOL, V38, P1182, DOI 10.1046/j.0021-8901.2001.00661.x; Weimerskirch H, 2005, ECOLOGY, V86, P2611, DOI 10.1890/04-1866; Weimerskirch H, 1997, MAR ECOL PROG SER, V151, P245, DOI 10.3354/meps151245; Weimerskirch H, 2000, POLAR BIOL, V23, P733, DOI 10.1007/s003000000144; WEIMERSKIRCH H, 1993, AUK, V110, P325; WEIMERSKIRCH H, 1995, OECOLOGIA, V102, P37, DOI 10.1007/BF00333308; Weimerskirch H, 2014, J EXP MAR BIOL ECOL, V450, P68, DOI 10.1016/j.jembe.2013.10.021; Weimerskirch H, 2012, SCIENCE, V335, P211, DOI 10.1126/science.1210270; Wood S, 2017, GEN ADDITIVE MODELS, DOI 10.1201/9781315370279; WOOLLER RD, 1992, TRENDS ECOL EVOL, V7, P111, DOI 10.1016/0169-5347(92)90143-Y; WUNDERLE JM, 1991, CURR ORNITHOL, V8, P273; Xavier Jose C., 2005, P74; Yoda K, 2004, P ROY SOC B-BIOL SCI, V271, pS240, DOI 10.1098/rsbl.2003.0157; Zimmer I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016098	65	27	27	2	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2015	10	1							e0116415	10.1371/journal.pone.0116415	http://dx.doi.org/10.1371/journal.pone.0116415			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ4BU	25574995	Green Published, Green Accepted, gold			2022-12-27	WOS:000348168100005
J	Porcal, P; Kopacek, J; Tomkova, I				Porcal, Petr; Kopacek, Jiri; Tomkova, Iva			Seasonal Photochemical Transformations of Nitrogen Species in a Forest Stream and Lake	PLOS ONE			English	Article							DISSOLVED ORGANIC-MATTER; BIOLOGICALLY AVAILABLE NITROGEN; INORGANIC NITROGEN; BOHEMIAN FOREST; ACIDIFICATION; DYNAMICS; AMMONIUM; NITRATE; WATERS; CARBON	The photochemical release of inorganic nitrogen from dissolved organic matter is an important source of bio-available nitrogen (N) in N-limited aquatic ecosystems. We conducted photochemical experiments and used mathematical models based on pseudo-first-order reaction kinetics to quantify the photochemical transformations of individual N species and their seasonal effects on N cycling in a mountain forest stream and lake (Plesne Lake, Czech Republic). Results from laboratory experiments on photochemical changes in N speciation were compared to measured lake N budgets. Concentrations of organic nitrogen (N-org; 40-58 mu mol L-1) decreased from 3 to 26% during 48-hour laboratory irradiation (an equivalent of 4-5 days of natural solar insolation) due to photochemical mineralization to ammonium (NH4+) and other N forms (N-x; possibly N oxides and N-2). In addition to N-org mineralization, N-x also originated from photochemical nitrate (NO3-) reduction. Laboratory exposure of a first-order forest stream water samples showed a high amount of seasonality, with the maximum rates of N-org mineralization and NH4+ production in winter and spring, and the maximum NO3- reduction occurring in summer. These photochemical changes could have an ecologically significant effect on NH4+ concentrations in streams (doubling their terrestrial fluxes from soils) and on concentrations of dissolved N-org in the lake. In contrast, photochemical reactions reduced NO3- fluxes by a negligible (<1%) amount and had a negligible effect on the aquatic cycle of this N form.	[Porcal, Petr; Kopacek, Jiri] Acad Sci Czech Republ, Inst Hydrobiol, Ctr Biol, Ceske Budejovice, Czech Republic; [Tomkova, Iva] Univ South Bohemia Ceske Budejovice, Fac Sci, Ceske Budejovice, Czech Republic	Czech Academy of Sciences; Biology Centre of the Czech Academy of Sciences; University of South Bohemia Ceske Budejovice	Porcal, P (corresponding author), Acad Sci Czech Republ, Inst Hydrobiol, Ctr Biol, Ceske Budejovice, Czech Republic.	porcal@hbu.cas.cz	Kopacek, Jiri/A-7373-2014; Porcal, Petr/A-7350-2014; Porcal, Petr/R-4687-2019	Kopacek, Jiri/0000-0002-4409-4032; Porcal, Petr/0000-0002-7787-4924; 	Czech Science Foundation [P503/12/0781]	Czech Science Foundation(Grant Agency of the Czech Republic)	This study was supported by the Czech Science Foundation, project number P503/12/0781 (www.gacr.cz). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarnos H, 2012, J GEOPHYS RES-BIOGEO, V117, DOI 10.1029/2010JG001633; Anastasio C, 2000, AEROSOL SCI TECH, V32, P106, DOI 10.1080/027868200303812; Bertilsson S, 1999, AQUAT MICROB ECOL, V19, P47, DOI 10.3354/ame019047; Bevington P. R., 2003, DATA REDUCTION ERROR, DOI 10.2307/2284752; Brezonik PL, 1998, ENVIRON SCI TECHNOL, V32, P3004, DOI 10.1021/es9802908; Brooks PD, 1998, BIOGEOCHEMISTRY, V43, P1, DOI 10.1023/A:1005947511910; Bushaw KL, 1996, NATURE, V381, P404, DOI 10.1038/381404a0; Bushaw-Newton KL, 1999, AQUAT MICROB ECOL, V18, P285, DOI 10.3354/ame018285; CNI, 2014, 751400 CNI CSN CZECH; Edwards KA, 2006, SOIL BIOL BIOCHEM, V38, P2843, DOI 10.1016/j.soilbio.2006.04.042; Fanning JC, 2000, COORDIN CHEM REV, V199, P159, DOI 10.1016/S0010-8545(99)00143-5; Gao HZ, 1998, ENVIRON SCI TECHNOL, V32, P2940, DOI 10.1021/es9803660; Gardner WS, 1998, LIMNOL OCEANOGR, V43, P1814; Helms JR, 2008, LIMNOL OCEANOGR, V53, P955, DOI 10.4319/lo.2008.53.3.0955; Jones DL, 2004, SOIL BIOL BIOCHEM, V36, P749, DOI 10.1016/j.soilbio.2004.01.003; Kieber DJ, 2003, COMP SER PHOTOCHEM, V1, P251; Kieber RJ, 1999, ENVIRON SCI TECHNOL, V33, P993, DOI 10.1021/es980188a; Kitidis V, 2008, DEEP SEA RES 2, V53, P1666; Koopmans DJ, 2002, AQUAT MICROB ECOL, V26, P295, DOI 10.3354/ame026295; Kopacek J, 2004, LIMNOL OCEANOGR, V49, P1202; KOPACEK J, 1993, INT J ENVIRON AN CH, V53, P243, DOI 10.1080/03067319308045993; Kopacek J, 2006, BIOLOGIA, V61, pS427, DOI 10.2478/s11756-007-0067-7; Lipson DA, 2000, SOIL BIOL BIOCHEM, V32, P441, DOI 10.1016/S0038-0717(99)00068-1; Majer V, 2003, HYDROL EARTH SYST SC, V7, P494, DOI 10.5194/hess-7-494-2003; Porcal P, 2013, BIOGEOSCIENCES, V10, P5533, DOI 10.5194/bg-10-5533-2013; Porcal P, 2013, AQUAT SCI, V75, P469, DOI 10.1007/s00027-013-0293-8; Porcal P, 2009, J ENVIRON MONITOR, V11, P1064, DOI 10.1039/b812330f; Spokes LJ, 1996, MAR CHEM, V54, P1, DOI 10.1016/0304-4203(96)00033-3; Stedmon CA, 2007, MAR CHEM, V104, P227, DOI 10.1016/j.marchem.2006.11.005; Stevenson F.J, 1982, NITROGEN AGR SOILS, DOI DOI 10.2134/AGRONMONOGR22.C17; Stone A., 1990, AQUATIC CHEM KINETIC, V2, P1; Takeda K, 2004, ANAL SCI, V20, P153, DOI 10.2116/analsci.20.153; Tranvik LJ, 2001, ECOL LETT, V4, P458, DOI 10.1046/j.1461-0248.2001.00245.x; Vahatalo AV, 2007, LIMNOL OCEANOGR, V52, P132; Vahatalo AV, 2003, ARCH HYDROBIOL, V156, P287, DOI 10.1127/0003-9136/2003/0156-0287; Van der Perk M, 2006, SOIL WATER CONTAMINA; Vione D, 2006, ENVIRON SCI TECHNOL, V40, P3775, DOI 10.1021/es052206b; Voelker BM, 1996, ENVIRON SCI TECHNOL, V30, P1106, DOI 10.1021/es9502132; Vrba J, 2003, SCI TOTAL ENVIRON, V310, P73, DOI 10.1016/S0048-9697(02)00624-1; Wang WW, 2000, AQUAT GEOCHEM, V6, P275, DOI 10.1023/A:1009679730079; Wiegner TN, 2001, AQUAT MICROB ECOL, V24, P27, DOI 10.3354/ame024027	41	10	10	4	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2014	9	12							e116364	10.1371/journal.pone.0116364	http://dx.doi.org/10.1371/journal.pone.0116364			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UC	25551441	Green Published, Green Submitted, gold			2022-12-27	WOS:000347119100135
J	Carneiro, BR; Pernambuco, PCA; Mesquita, APD; da Silva, DS; Pinhal, MAS; Nader, HB; Lopes, CC				Carneiro, Bruna Ribeiro; Pernambuco Filho, Paulo Castanho A.; de Sousa Mesquita, Ana Paula; da Silva, Douglas Santos; Pinhal, Maria Aparecida S.; Nader, Helena B.; Lopes, Carla Cristina			Acquisition of Anoikis Resistance Up-Regulates Syndecan-4 Expression in Endothelial Cells	PLOS ONE			English	Article							HEPARAN-SULFATE PROTEOGLYCAN; FIBROBLAST-GROWTH-FACTOR; PROTEIN-KINASE-C; BREAST-CANCER; TISSUE TRANSGLUTAMINASE; MAMMALIAN HEPARANASE; TUMOR PROGRESSION; ADHESION; SURFACE; SURVIVAL	Anoikis is a programmed cell death induced upon cell detachment from extracellular matrix, behaving as a critical mechanism in preventing adherent-independent cell growth and attachment to an inappropriate matrix, thus avoiding colonization of distant organs. Cell adhesion plays an important role in neoplastic transformation. Tumors produce several molecules that facilitate their proliferation, invasion and maintenance, especially proteoglycans. The syndecan-4, a heparan sulfate proteoglycan, can act as a co-receptor of growth factors and proteins of the extracellular matrix by increasing the affinity of adhesion molecules to their specific receptors. It participates together with integrins in cell adhesion at focal contacts connecting the extracellular matrix to the cytoskeleton. Changes in the expression of syndecan-4 have been observed in tumor cells, indicating its involvement in cancer. This study investigates the role of syndecan-4 in the process of anoikis and cell transformation. Endothelial cells were submitted to sequential cycles of forced anchorage impediment and distinct lineages were obtained. Anoikis-resistant endothelial cells display morphological alterations, high rate of proliferation, poor adhesion to fibronectin, laminin and collagen IV and deregulation of the cell cycle, becoming less serum-dependent. Furthermore, anoikis-resistant cell lines display a high invasive potential and a low rate of apoptosis. This is accompanied by an increase in the levels of heparan sulfate and chondroitin sulfate as well as by changes in the expression of syndecan-4 and heparanase. These results indicate that syndecan-4 plays a important role in acquisition of anoikis resistance and that the conferral of anoikis resistance may suffice to transform endothelial cells.	[Carneiro, Bruna Ribeiro; Pernambuco Filho, Paulo Castanho A.; de Sousa Mesquita, Ana Paula; da Silva, Douglas Santos; Lopes, Carla Cristina] Univ Fed Sao Paulo, Dept Ciencias Biol, Diadema, SP, Brazil; [Carneiro, Bruna Ribeiro; Pernambuco Filho, Paulo Castanho A.; de Sousa Mesquita, Ana Paula; da Silva, Douglas Santos; Pinhal, Maria Aparecida S.; Nader, Helena B.; Lopes, Carla Cristina] Univ Fed Sao Paulo, Dept Bioquim, Sao Paulo, SP, Brazil	Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal de Sao Paulo (UNIFESP)	Lopes, CC (corresponding author), Univ Fed Sao Paulo, Dept Ciencias Biol, Diadema, SP, Brazil.	lopesazevedo.bioq@epm.br	Lopes, Carla C/D-6236-2013; Nader, Helena Bonciani/D-9253-2012; Pinhal, Maria Aparecida Silva/J-1797-2012; Azevedo, Carla/GRF-0374-2022	Lopes, Carla C/0000-0002-0840-5702; Pinhal, Maria Aparecida Silva/0000-0003-4001-1663; NADER, HELENA/0000-0002-7569-2166	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP); Equipamentos Multiusuario (EMU - FAPESP); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Coordenacao de Aperfeicoamento de Pessoal do Ensino Superior (CAPES); Financiadora de Estudos e Projetos (FINEP), Brazil	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Equipamentos Multiusuario (EMU - FAPESP); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal do Ensino Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Financiadora de Estudos e Projetos (FINEP), Brazil(Financiadora de Inovacao e Pesquisa (Finep))	Supported by grants from Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP); Equipamentos Multiusuario (EMU - FAPESP); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Coordenacao de Aperfeicoamento de Pessoal do Ensino Superior (CAPES) and Financiadora de Estudos e Projetos (FINEP), Brazil. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BACIU PC, 1995, MOL BIOL CELL, V6, P1503, DOI 10.1091/mbc.6.11.1503; Batista LTEA, 2012, INT J UROL, V19, P1036, DOI 10.1111/j.1442-2042.2012.03086.x; Beauvais DeannaLee M, 2004, Reprod Biol Endocrinol, V2, P3, DOI 10.1186/1477-7827-2-3; Beauvais DM, 2003, EXP CELL RES, V286, P219, DOI 10.1016/S0014-4827(03)00126-5; Bernfield M, 1999, ANNU REV BIOCHEM, V68, P729, DOI 10.1146/annurev.biochem.68.1.729; BERNFIELD M, 1992, ANNU REV CELL BIOL, V8, P365, DOI 10.1146/annurev.cb.08.110192.002053; Bianchi-Smiraglia A, 2013, ONCOGENE, V32, P3049, DOI 10.1038/onc.2012.320; Bissell MJ, 2001, NAT REV CANCER, V1, P46, DOI 10.1038/35094059; BUONASSISI V, 1976, P NATL ACAD SCI USA, V73, P1612, DOI 10.1073/pnas.73.5.1612; Carey DJ, 1997, BIOCHEM J, V327, P1; Caseli L, 2012, BBA-BIOMEMBRANES, V1818, P1211, DOI 10.1016/j.bbamem.2012.01.012; CASTELLOT JJ, 1984, J CELL PHYSIOL, V120, P315, DOI 10.1002/jcp.1041200309; Chiarugi P, 2008, IUBMB LIFE, V60, P301, DOI 10.1002/iub.45; Chiarugi P, 2008, BIOCHEM PHARMACOL, V76, P1352, DOI 10.1016/j.bcp.2008.07.023; Chiodoni C, 2010, CANCER METAST REV, V29, P295, DOI 10.1007/s10555-010-9221-8; Choi Y, 2011, MATRIX BIOL, V30, P93, DOI 10.1016/j.matbio.2010.10.006; Clasper S, 1999, J BIOL CHEM, V274, P24113, DOI 10.1074/jbc.274.34.24113; Coombe DR, 2005, CELL MOL LIFE SCI, V62, P410, DOI 10.1007/s00018-004-4293-7; Couchman JR, 2010, ANNU REV CELL DEV BI, V26, P89, DOI 10.1146/annurev-cellbio-100109-104126; Couchman JR, 2003, NAT REV MOL CELL BIO, V4, P926, DOI 10.1038/nrm1257; DIETRICH CP, 1977, BIOCHEM BIOPH RES CO, V75, P329, DOI 10.1016/0006-291X(77)91046-4; DIETRICH CP, 1984, BRAZ J MED BIOL RES, V17, P5; DIETRICH CP, 1983, BIOCHEM BIOPH RES CO, V111, P865, DOI 10.1016/0006-291X(83)91379-7; Eble JA, 2006, CURR CANCER DRUG TAR, V6, P89, DOI 10.2174/156800906776056518; Elkin M, 2001, FASEB J, V15, P1661, DOI 10.1096/fj.00-0895fje; Erdem M, 2014, UROL ONCOL-SEMIN ORI, V32, DOI 10.1016/j.urolonc.2012.08.022; Esko JD, 2001, J CLIN INVEST, V108, P169, DOI 10.1172/JCI200113530; Eswarakumar VP, 2005, CYTOKINE GROWTH F R, V16, P139, DOI 10.1016/j.cytogfr.2005.01.001; Fiore MM, 2001, BIOCHEM BIOPH RES CO, V284, P384, DOI 10.1006/bbrc.2001.4978; Fjeldstad K, 2005, CURR DRUG TARGETS, V6, P665, DOI 10.2174/1389450054863662; GAMBARINI AG, 1993, MOL CELL BIOCHEM, V124, P121, DOI 10.1007/BF00929204; Gengrinovitch S, 1999, J BIOL CHEM, V274, P10816, DOI 10.1074/jbc.274.16.10816; Gilmore AP, 2005, CELL DEATH DIFFER, V12, P1473, DOI 10.1038/sj.cdd.4401723; Gulyas M, 2003, J PATHOL, V199, P479, DOI 10.1002/path.1312; Hay E. D., 1981, CELL BIOL EXTRACELLU; Horowitz A, 2002, J CELL BIOL, V157, P715, DOI 10.1083/jcb.200112145; HYATT SL, 1990, MOL CARCINOGEN, V3, P45, DOI 10.1002/mc.2940030202; Hynes RO, 1990, FIBRONECTINS; Iozzo RV, 1998, ANNU REV BIOCHEM, V67, P609, DOI 10.1146/annurev.biochem.67.1.609; KJELLEN L, 1991, ANNU REV BIOCHEM, V60, P443, DOI 10.1146/annurev.bi.60.070191.002303; Kotsakis P, 2007, AMINO ACIDS, V33, P373, DOI 10.1007/s00726-007-0516-1; KRAEMER PM, 1972, J CELL BIOL, V55, P713, DOI 10.1083/jcb.55.3.713; Kram V, 2006, J CELL PHYSIOL, V207, P784, DOI 10.1002/jcp.20625; Labropoulou VT, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/214864; Lin XH, 2004, DEVELOPMENT, V131, P6009, DOI 10.1242/dev.01522; Liotta LA, 2004, NATURE, V430, P973, DOI 10.1038/430973a; Liu DF, 2002, SEMIN THROMB HEMOST, V28, P67, DOI 10.1055/s-2002-20565; Lopes CC, 2006, BIOCHIMIE, V88, P1493, DOI 10.1016/j.biochi.2006.04.009; Lopes CC, 2006, BRAZ J MED BIOL RES, V39, P157, DOI 10.1590/S0100-879X2006000200001; Matsuda K, 2001, CANCER RES, V61, P5562; Morgan MR, 2007, NAT REV MOL CELL BIO, V8, P957, DOI 10.1038/nrm2289; Mundhenke C, 2002, AM J PATHOL, V160, P185, DOI 10.1016/S0002-9440(10)64362-3; Na KY, 2012, PATHOLOGY, V44, P325, DOI 10.1097/PAT.0b013e328353447b; Nader HB, 2004, CURR PHARM DESIGN, V10, P951, DOI 10.2174/1381612043452758; NADER HB, 1987, P NATL ACAD SCI USA, V84, P3565, DOI 10.1073/pnas.84.11.3565; NADER HB, 1989, J CELL PHYSIOL, V140, P305, DOI 10.1002/jcp.1041400216; Oba-Shinjo SM, 2006, NEOPLASIA, V8, P231, DOI 10.1593/neo.05781; Oh ES, 1997, J BIOL CHEM, V272, P11805, DOI 10.1074/jbc.272.18.11805; Oh ES, 1997, J BIOL CHEM, V272, P8133, DOI 10.1074/jbc.272.13.8133; Pazos MDC, 2007, INT J BIOCHEM CELL B, V39, P1130, DOI 10.1016/j.biocel.2007.02.008; Porcionatto MA, 1998, J CELL BIOCHEM, V70, P563, DOI 10.1002/(SICI)1097-4644(19980915)70:4<563::AID-JCB12>3.0.CO;2-I; Purushothaman A, 2008, J BIOL CHEM, V283, P32628, DOI 10.1074/jbc.M806266200; Reddig PJ, 2005, CANCER METAST REV, V24, P425, DOI 10.1007/s10555-005-5134-3; Rennebeck G, 2005, CANCER RES, V65, P11230, DOI 10.1158/0008-5472.CAN-05-2763; Rosenberg RD, 1997, J CLIN INVEST, V99, P2062, DOI 10.1172/JCI119377; Roskams T, 1998, J PATHOL, V185, P290, DOI 10.1002/(SICI)1096-9896(199807)185:3<290::AID-PATH91>3.0.CO;2-I; Sanderson RD, 2001, SEMIN CELL DEV BIOL, V12, P89, DOI 10.1006/scdb.2000.0241; Sasisekharan R, 2002, NAT REV CANCER, V2, P521, DOI 10.1038/nrc842; Sastry SK, 1993, CURR OPIN CELL BIOL, V5, P819, DOI 10.1016/0955-0674(93)90031-K; Shimazu A, 1999, J DENT RES, V78, P1791, DOI 10.1177/00220345990780120501; Stupack DG, 2002, SCI STKE, V2002, ppe7; Sudhalter J, 1996, GLIA, V17, P28, DOI 10.1002/(SICI)1098-1136(199605)17:1<28::AID-GLIA3>3.0.CO;2-3; Theodoro TR, 2007, NEOPLASIA, V9, P504, DOI 10.1593/neo.07241; THOMPSON JA, 1988, SCIENCE, V241, P1349, DOI 10.1126/science.2457952; Valentijn AJ, 2004, BIOCHEM SOC T, V32, P421, DOI 10.1042/BST0320421; Vlodavsky I, 2001, J CLIN INVEST, V108, P341, DOI 10.1172/JCI200113662; Vlodavsky I, 1999, NAT MED, V5, P793, DOI 10.1038/10518; VLODAVSKY I, 1993, BASEMENT MEMBRANES C, P327; Wang LH, 2004, MT SINAI J MED, V71, P361; Wang Z, 2011, EXP CELL RES, V317, P367, DOI 10.1016/j.yexcr.2010.10.015; Wiedlocha A, 2004, CURR TOP MICROBIOL, V286, P45; WOODS A, 1994, MOL BIOL CELL, V5, P183, DOI 10.1091/mbc.5.2.183; Woods A, 2001, CURR OPIN CELL BIOL, V13, P578, DOI 10.1016/S0955-0674(00)00254-4; YAYON A, 1991, CELL, V64, P841, DOI 10.1016/0092-8674(91)90512-W; Zhang YF, 2003, AM J PHYSIOL-HEART C, V284, pH2078, DOI 10.1152/ajpheart.00942.2001	86	17	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2014	9	12							e116001	10.1371/journal.pone.0116001	http://dx.doi.org/10.1371/journal.pone.0116001			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX6YH	25549223	Green Published, gold, Green Submitted			2022-12-27	WOS:000347063500045
J	Ferraro, A; Boni, T; Pintzas, A				Ferraro, Angelo; Boni, Themis; Pintzas, Alexander			EZH2 Regulates Cofilin Activity and Colon Cancer Cell Migration by Targeting ITGA2 Gene	PLOS ONE			English	Article							ACTIN REORGANIZATION; ALPHA(2)BETA(1) INTEGRIN; METASTASIS SUPPRESSOR; BREAST-CARCINOMA; PROTEIN EZH2; INVASION; PHOSPHORYLATION; ADF/COFILIN; REPRESSION; TRANSFORMATION	Reorganization of cytoskeleton via actin remodeling is a basic step of cell locomotion. Although cell migration of normal and cancer cells can be stimulated by a variety of intra-and extra-cellular factors, all paths ultimate on the regulation of cofilin activity. Cofilin is a small actin-binding protein able to bind both forms of actin, globular and filament, and is regulated by phosphorylation at Serine 3. Following phosphorylation at serine 3 cofilin is inactive, therefore cannot bind actin molecules and cytoskeleton remodeling is impaired. The histone methyltransferase EZH2 is frequently over expressed in many tumour types including colorectal cancer (CRC). EZH2 over activity, which results in epigenetic gene-silencing, has been associated with many tumour properties including invasion, angiogenesis and metastasis but little is known about the underneath molecular mechanisms. Herein, we report that EZH2 is able to control cofilin activity and consequently cell locomotion of CRC cell lines through a non-conventional novel axis that involves integrin signaling. Indeed, we show how genetic and pharmacological inhibition (DZNep and GSK343) of EZH2 function produces hyper phosphorylation of cofilin and reduces cell migration. We previously demonstrated by chromatin immuno-precipitation that Integrin alpha 2 (ITG alpha 2) expression is regulated by EZH2. In the present study we provide evidence that in EZH2-silenced cells the signaling activity of the derepressed ITG alpha 2 is able to increase cofilin phosphorylation, which in turn reduces cell migration. This study also proposes novel mechanisms that might provide new anti-metastatic strategies for CRC treatment based on the inhibition of the epigenetic factor EZH2 and/or its target gene.	[Ferraro, Angelo; Boni, Themis; Pintzas, Alexander] Natl Hellen Res Fdn, Inst Biol Med Chem & Biotechnol, Lab Signal Mediated Gene Express, Athens 11635, Greece	National Hellenic Research Foundation	Pintzas, A (corresponding author), Natl Hellen Res Fdn, Inst Biol Med Chem & Biotechnol, Lab Signal Mediated Gene Express, 48 Vas Constantinou Ave, Athens 11635, Greece.	apint@eie.gr	Ferraro, Angelo/H-3193-2019	Ferraro, Angelo/0000-0002-2044-7569	EU [FP7-241783]	EU(European Commission)	This work was supported by the EU FP7 grant FP7-241783 EpiDiaCan to AP.	AGNEW BJ, 1995, J BIOL CHEM, V270, P17582, DOI 10.1074/jbc.270.29.17582; Bernstein BW, 2010, TRENDS CELL BIOL, V20, P187, DOI 10.1016/j.tcb.2010.01.001; Bernstein BW, 2000, CELL MOTIL CYTOSKEL, V47, P319, DOI 10.1002/1097-0169(200012)47:4<319::AID-CM6>3.0.CO;2-I; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Condeelis J, 2003, NAT REV CANCER, V3, P921, DOI 10.1038/nrc1231; Dawe HR, 2003, CURR BIOL, V13, P252, DOI 10.1016/S0960-9822(03)00040-X; Ellinger-Ziegelbauer H, 1999, MOL CELL BIOL, V19, P3857; Ferraro A, 2013, INT J BIOCHEM CELL B, V45, P243, DOI 10.1016/j.biocel.2012.10.009; Frantz C, 2008, J CELL BIOL, V183, P865, DOI 10.1083/jcb.200804161; Gohla A, 2005, NAT CELL BIOL, V7, P21, DOI 10.1038/ncb1201; Gonzalez ME, 2009, ONCOGENE, V28, P843, DOI 10.1038/onc.2008.433; Huttenlocher A, 1998, J CELL BIOL, V141, P515, DOI 10.1083/jcb.141.2.515; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Ivaska J, 1999, J CELL BIOL, V147, P401, DOI 10.1083/jcb.147.2.401; Kleer CG, 2003, P NATL ACAD SCI USA, V100, P11606, DOI 10.1073/pnas.1933744100; LaLonde DP, 2005, J BIOL CHEM, V280, P21680, DOI 10.1074/jbc.m500752200; Liotta LA, 2001, NATURE, V411, P375, DOI 10.1038/35077241; Lu CH, 2010, CANCER CELL, V18, P185, DOI 10.1016/j.ccr.2010.06.016; Madak-Erdogan Z, 2014, MOL CANCER RES, V12, P714, DOI 10.1158/1541-7786.MCR-13-0588; Makrodouli E, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-118; Min J, 2010, NAT MED, V16, P286, DOI 10.1038/nm.2100; Mizuno K, 2013, CELL SIGNAL, V25, P457, DOI 10.1016/j.cellsig.2012.11.001; Niwa R, 2002, CELL, V108, P233, DOI 10.1016/S0092-8674(01)00638-9; Oser M, 2009, J CELL BIOL, V186, P571, DOI 10.1083/jcb.200812176; Ramirez NE, 2011, J CLIN INVEST, V121, P226, DOI 10.1172/JCI42328; Rao ZY, 2010, CARCINOGENESIS, V31, P1576, DOI 10.1093/carcin/bgq150; Ren G, 2012, CANCER RES, V72, P3091, DOI 10.1158/0008-5472.CAN-11-3546; Shaikhibrahim Z, 2011, INT J MOL MED, V28, P605, DOI 10.3892/ijmm.2011.746; Tan J, 2007, GENE DEV, V21, P1050, DOI 10.1101/gad.1524107; Toshima J, 2001, MOL BIOL CELL, V12, P1131, DOI 10.1091/mbc.12.4.1131; van Rheenen J, 2009, J CELL SCI, V122, P305, DOI 10.1242/jcs.031146; Varambally S, 2002, NATURE, V419, P624, DOI 10.1038/nature01075; Verma SK, 2012, ACS MED CHEM LETT, V3, P1091, DOI 10.1021/ml3003346; Wang WG, 2007, NAT REV CANCER, V7, P429, DOI 10.1038/nrc2148; Yamaguchi H, 2005, CURR OPIN CELL BIOL, V17, P559, DOI 10.1016/j.ceb.2005.08.002; Yang N, 1998, NATURE, V393, P809, DOI 10.1038/31735; Yu J, 2007, CANCER RES, V67, P10657, DOI 10.1158/0008-5472.CAN-07-2498; ZUTTER MM, 1995, P NATL ACAD SCI USA, V92, P7411, DOI 10.1073/pnas.92.16.7411	38	46	50	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2014	9	12							e115276	10.1371/journal.pone.0115276	http://dx.doi.org/10.1371/journal.pone.0115276			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX6YH	25549357	Green Submitted, Green Published, gold			2022-12-27	WOS:000347063500012
J	Lean, IJ; Thompson, JM; Dunshea, FR				Lean, Ian J.; Thompson, John M.; Dunshea, Frank R.			A Meta-Analysis of Zilpaterol and Ractopamine Effects on Feedlot Performance, Carcass Traits and Shear Strength of Meat in Cattle	PLOS ONE			English	Article							STRIP LOIN STEAKS; GROWTH-PERFORMANCE; HYDROCHLORIDE SUPPLEMENTATION; TRENBOLONE ACETATE; BEEF STEERS; VITAMIN-D-3 SUPPLEMENTATION; ANIMAL PERFORMANCE; HYDROGEN-CHLORIDE; WARNER-BRATZLER; META-REGRESSION	This study is a meta-analysis of the effects of the beta-agonists zilpaterol hydrochloride (ZH) and ractopamine hydrochloride (RAC) on feedlot performance, carcase characteristics of cattle and Warner Bratzler shear force (WBSF) of muscles. It was conducted to evaluate the effect of the use of these agents on beef production and meat quality and to provide data that would be useful in considerations on the effect of these agents on meat quality in Meat Standards Australia evaluations. We conducted a comprehensive literature search and study assessment using PubMed, Google Scholar, ScienceDirect, Scirus, and CAB and identification of other studies from reference lists in papers and searches. Searches were based on the key words: zilpaterol, zilmax, ractopamine, optaflexx, cattle and beef. Studies from theses obtained were included. Data were extracted from more than 50 comparisons for both agents and analysed using meta-analysis and meta-regression. Both agents markedly increased weight gain, hot carcase weight and longissimus muscle area and increased the efficiency of gain: feed. These effects were particularly large for ZH, however, fat thickness was decreased by ZH, but not RAC. Zilpaterol also markedly increased WBSF by 1.2 standard deviations and more than 0.8 kg, while RAC increased WBSF by 0.43 standard deviations and 0.2 kg. There is evidence in the ZH studies, in particular, of profound re-partitioning of nutrients from fat to protein depots. This work has provided critically needed information on the effects of ZH and RAC on production, efficiency and meat quality.	[Lean, Ian J.] SBScibus, Camden, NSW, Australia; [Thompson, John M.] Univ New England, Armidale, NSW, Australia; [Dunshea, Frank R.] Univ Melbourne, Sch Land & Environm, Parkville, Vic 3052, Australia	University of New England; University of Melbourne	Lean, IJ (corresponding author), SBScibus, Camden, NSW, Australia.	ianl@sbscibus.com.au	Lean, Ian/K-4628-2019; Lean, Ian/N-6159-2019	Dunshea, Frank/0000-0003-3998-1240	Meat and Livestock Australia	Meat and Livestock Australia(Meat and Livestock Australia)	Funding for this study came from Meat and Livestock Australia that supported the investigation in order to improve understandings of the effects of these agents on meat quality. The funders did identify papers, but these were not different to those found on literature search. The funders had no other role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abney CS, 2007, J ANIM SCI, V85, P3090, DOI 10.2527/jas.2007-0263; Allen JD, 2009, J ANIM SCI, V87, P2400, DOI 10.2527/jas.2008-1630; Avendano-Reyes L, 2006, J ANIM SCI, V84, P3259, DOI 10.2527/jas.2006-173; Bass P. D., 2009, Professional Animal Scientist, V25, P195; Baxa TJ, 2010, J ANIM SCI, V88, P330, DOI 10.2527/jas.2009-1797; Beckett JL, 2009, J ANIM SCI, V87, P4092, DOI 10.2527/jas.2009-1808; Beermann D. H., 2002, J ANIM SCI, V80, pE18, DOI DOI 10.2527/ANIMALSCI2002.0021881200800ES10004X; BEERMANN DH, 1993, ENDOCRINOLOGY GROWTH, P345; Boler DD, 2012, MEAT SCI, V92, P458, DOI 10.1016/j.meatsci.2012.05.011; Boler DD, 2009, J ANIM SCI, V87, P3722, DOI 10.2527/jas.2009-1830; Brooks JC, 2010, J ANIM SCI, V88, P1809, DOI 10.2527/jas.2009-2383; Brooks JC, 2009, J ANIM SCI, V87, P3764, DOI 10.2527/jas.2009-1885; Bryant TC, 2010, J ANIM SCI, V88, P4102, DOI 10.2527/jas.2010-2901; Claus HL, 2010, MEAT SCI, V85, P347, DOI 10.1016/j.meatsci.2010.02.002; Cohen J., 1988, STAT POWER ANAL BEHA, V2nd; Cooprider KL, 2011, J ANIM SCI, V89, P2643, DOI 10.2527/jas.2010-3539; Crome PK, 1996, J ANIM SCI, V74, P709; Delmore RJ, 2010, J ANIM SCI, V88, P2825, DOI 10.2527/jas.2009-2473; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Dijkhuis R. D., 2008, Professional Animal Scientist, V24, P634; Donkersgoed J. van, 2011, Professional Animal Scientist, V27, P116; Dunshea FR, 2005, MEAT SCI, V71, P8, DOI 10.1016/j.meatsci.2005.05.001; DUNSHEA FR, 1993, J ANIM SCI, V71, P1966, DOI 10.2527/1993.7171966x; Edrington TS, 2006, CURR MICROBIOL, V53, P340, DOI 10.1007/s00284-006-0200-9; Edrington TS, 2009, J FOOD PROTECT, V72, P2587, DOI 10.4315/0362-028X-72.12.2587; Egger M, 2001, SYSTEMATIC REV HLTH; Eisemann JH, 1998, J NUTR, V128, P505, DOI 10.1093/jn/128.3.505; Elam NA, 2009, J ANIM SCI, V87, P2133, DOI 10.2527/jas.2008-1563; Etherton TD, 2009, J ANIM SCI, V87, P3060, DOI 10.2527/jas.2009-1805; Garmyn AJ, 2011, J ANIM SCI, V89, P3783, DOI 10.2527/jas.2011-4134; Garmyn AJ, 2010, J ANIM SCI, V88, P2476, DOI 10.2527/jas.2009-2635; Glanc DL, 2013, EFFECTS SOURCE LEVEL; Gonzalez JM, 2007, J ANIM SCI, V85, P1893, DOI 10.2527/jas.2006-624; Gonzalez JM, 2009, J ANIM SCI, V87, P1764, DOI 10.2527/jas.2008-1469; Gonzalez JM, 2008, J ANIM SCI, V86, P3568, DOI 10.2527/jas.2008-1049; Griffin W. A., 2009, Professional Animal Scientist, V25, P273; Griffin W. A., 2009, Professional Animal Scientist, V25, P33; Gruber SL, 2008, J ANIM SCI, V86, P205, DOI 10.2527/jas.2007-0201; Gruber SL, 2007, J ANIM SCI, V85, P1809, DOI 10.2527/jas.2006-634; Gunderson JA, 2009, J ANIM SCI, V87, P3739, DOI 10.2527/jas.2009-1843; Gunderson JA, 2009, J ANIM SCI, V87, P3751, DOI 10.2527/jas.2009-1844; Guzman A, 2012, ANIM REPROD SCI, V130, P1, DOI 10.1016/j.anireprosci.2011.12.001; Haneklaus AN, 2011, J ANIM SCI, V89, P2867, DOI 10.2527/jas.2010-3823; Hansen S, 2012, MEAT SCI, V90, P145, DOI 10.1016/j.meatsci.2011.06.014; Harbord R, 2004, STAT SOFTWARE COMPON; Harbord RM, 2008, STATA J, V8, P493, DOI 10.1177/1536867X0800800403; Higgins JPT, 2004, STAT MED, V23, P1663, DOI 10.1002/sim.1752; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Hilton GG, 2010, J ANIM SCI, V88, P1817, DOI 10.2527/jas.2009-2386; Hilton GG, 2009, J ANIM SCI, V87, P1394, DOI 10.2527/jas.2008-1170; Holland BP, 2010, J ANIM SCI, V88, P338, DOI 10.2527/jas.2009-1798; Holmer SF, 2009, J ANIM SCI, V87, P3730, DOI 10.2527/jas.2009-1838; Holmer SF, 2009, J MUSCLE FOODS, V20, P307, DOI 10.1111/j.1745-4573.2009.00150.x; Holmer SF, 2009, J MUSCLE FOODS, V20, P293, DOI 10.1111/j.1745-4573.2009.00149.x; Jennings MA, 2012, INTERACTION OPTAFLEX; Kellermeier JD, 2009, J ANIM SCI, V87, P3702, DOI 10.2527/jas.2009-1823; Knapp G, 2003, STAT MED, V22, P2693, DOI 10.1002/sim.1482; Koohmaraie M, 2002, MEAT SCI, V62, P345, DOI 10.1016/S0309-1740(02)00127-4; Laudert SB, 2004, OPTAFLEXX EXCHANGE S; Lawrence TE, 2011, J ANIM SCI, V89, P2170, DOI 10.2527/jas.2010-3422; Lawrence TE, 2011, MEAT SCI, V88, P209, DOI 10.1016/j.meatsci.2010.12.031; Lawrence TE, 2010, J ANIM SCI, V88, P2139, DOI 10.2527/jas.2009-2739; Lean IJ, 2009, J DAIRY SCI, V92, P3545, DOI 10.3168/jds.2009-2140; Lean IJ, 2012, ANIM FEED SCI TECH, V171, P31, DOI 10.1016/j.anifeedsci.2011.09.017; Leheska JM, 2009, J ANIM SCI, V87, P1384, DOI 10.2527/jas.2008-1168; Li CY, 2012, J FOOD AGRIC ENVIRON, V10, P1349; LIU CY, 1989, J ANIM SCI, V67, P2937, DOI 10.2527/jas1989.67112937x; Loneragan GH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091177; Luque LD, 2011, J ANIM SCI, V89, P817, DOI 10.2527/jas.2010-3317; Mehaffey JM, 2009, J ANIM SCI, V87, P3712, DOI 10.2527/jas.2009-1837; Mersmann HJ, 1998, J ANIM SCI, V76, P160; Miller EK, 2012, J ANIM SCI, V90, P1317, DOI 10.2527/jas.2011-4589; Montgomery JL, 2009, J ANIM SCI, V87, P1374, DOI 10.2527/jas.2008-1162; Montgomery JL, 2009, J ANIM SCI, V87, P1013, DOI 10.2527/jas.2008-1169; Moody DE, 2000, FARM ANIMAL METABOLISM AND NUTRITION, P65, DOI 10.1079/9780851993782.0065; Neill S, 2009, J ANIM SCI, V87, P704, DOI 10.2527/jas.2008-1254; Paddock ZD, 2011, J ANIM SCI, V89, P2829, DOI 10.2527/jas.2010-3793; Parr SL, 2011, J ANIM SCI, V89, P560, DOI 10.2527/jas.2010-3101; Peterson RK, 2011, EFFECT CRUDE PROTEIN; Ponnampalam EN, 2012, DOMEST ANIM ENDOCRIN, V42, P94, DOI 10.1016/j.domaniend.2011.10.001; PRINGLE TD, 1993, J ANIM SCI, V71, P636, DOI 10.2527/1993.713636x; Quinn MJ, 2008, J ANIM SCI, V86, P902, DOI 10.2527/jas.2007-0117; Rabiee AR, 2012, J DAIRY SCI, V95, P3225, DOI 10.3168/jds.2011-4895; Rathmann RJ, 2012, J ANIM SCI, V90, P3301, DOI 10.2527/jas.2011-4375; Rathmann RJ, 2009, J ANIM SCI, V87, P3686, DOI 10.2527/jas.2009-1818; Robles-Estrada JC, 2009, J ANIM SCI, V87, P1759, DOI 10.2527/jas.2008-1071; Rodas-Gonzalez A, 2012, J ANIM SCI, V90, P3584, DOI 10.2527/jas.2012-5159; Rogers HR, 2010, J ANIM SCI, V88, P1168, DOI 10.2527/jas.2009-2369; Romero M, 2009, J APPL ANIM RES, V35, P77, DOI 10.1080/09712119.2009.9706989; Schluter AR, 1991, RACTOPAMINE HYDROCHL; Schroeder A, 2005, J ANIM SCI, V83, P1; Schroeder AL, 2003, OPTAFLEXX EXCHANGE S; Scramlin SM, 2010, J ANIM SCI, V88, P1823, DOI 10.2527/jas.2009-2405; Shelver WL, 2002, J AGR FOOD CHEM, V50, P2742, DOI 10.1021/jf011372+; Shook JN, 2009, J ANIM SCI, V87, P3677, DOI 10.2527/jas.2009-1816; Sissom EK, 2007, J ANIM SCI, V85, P2125, DOI 10.2527/jas.2006-660; Stephany RW, 2001, APMIS, V109, pS357, DOI 10.1111/j.1600-0463.2001.tb05787.x; Strydom PE, 2011, MEAT SCI, V89, P462, DOI 10.1016/j.meatsci.2011.05.012; Strydom PE, 2009, MEAT SCI, V81, P557, DOI 10.1016/j.meatsci.2008.10.011; Talton CS, 2006, EFFECTS OPTAFLEXX FE; Tempelman RJ, 2009, J DAIRY SCI, V92, P1, DOI 10.3168/jds.2008-1404; Vasconcelos JT, 2008, J ANIM SCI, V86, P2005, DOI 10.2527/jas.2008-1032; Vogel G. J., 2009, Professional Animal Scientist, V25, P26; Walker DK, 2006, J ANIM SCI, V84, P2795, DOI 10.2527/jas.2005-614; White IR, 2005, CLIN TRIALS, V2, P141, DOI 10.1191/1740774505cn081oa; Winterholler SJ, 2008, J ANIM SCI, V86, P2401, DOI 10.2527/jas.2007-0482; Winterholler SJ, 2007, J ANIM SCI, V85, P413, DOI 10.2527/jas.2006-555; Woerner DR, 2011, J ANIM SCI, V89, P201, DOI 10.2527/jas.2010-2857; Zobel G, 2011, LIVEST SCI, V137, P1, DOI 10.1016/j.livsci.2010.09.022	109	79	80	0	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2014	9	12							e115904	10.1371/journal.pone.0115904	http://dx.doi.org/10.1371/journal.pone.0115904			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX6YH	25548908	Green Published, gold			2022-12-27	WOS:000347063500038
J	Sobrino-Vegas, P; Corella, SM; Serrano-Villar, S; Gutierrez, F; Blanco, JR; Santos, I; del Romero, J; Segura, F; Portilla, J; Guillen, SM; del Amo, J				Sobrino-Vegas, Paz; Monge Corella, Susana; Serrano-Villar, Sergio; Gutierrez, Felix; Ramon Blanco, Jose; Santos, Ignacio; del Romero, Jorge; Segura, Ferran; Portilla, Joaquin; Moreno Guillen, Santiago; del Amo, Julia		CoRIS	Incidence of Hepatitis C Virus (HCV) in a Multicenter Cohort of HIV-Positive Patients in Spain 2004-2011: Increasing Rates of HCV Diagnosis but Not of HCV Seroconversions	PLOS ONE			English	Article							INFECTED MEN; SEXUAL TRANSMISSION; EPIDEMIC; OUTBREAK; CLUSTER	Objectives: We aim to describe rates and risk factors of Hepatitis C Virus (HCV) diagnoses, follow-up HCV testing and HCV seroconversion from 2004-2011 in a cohort of HIV-positive persons in Spain. Methods: CoRIS is a multicentre, open and prospective cohort recruiting adult HIV-positive patients naive to antiretroviral therapy. We analysed patients with at least one negative and one follow-up HCV serology. Incidence Rates (IR) were calculated and multivariate Poisson regression was used to estimate adjusted Rates Ratios (aIRR). Results: Of 2112 subjects, 53 HCV diagnoses were observed, IR=0.93/100py (95% CI: 0.7-1.2). IR increased from 0.88 in 2004-05 to 1.36 in 2010-11 (aIRR=1.55; 95% CI: 0.37-6.55). In men who have sex with men (MSM) from 0.76 to 1.10 (aIRR=1.45; 95% CI: 0.31-6.82); in heterosexual (HTX) subjects from 1.19 to 1.28 (aIRR=1.08; 95% CI: 0.11-10.24). HCV seroconversion rates decreased from 1.77 to 0.65 (aIRR=0.37; 95% CI: 0.12-1.11); in MSM from 1.06 to 0.49 (aIRR=0.46; 95% CI: 0.09-2.31); in HTX from 2.55 to 0.59 (aIRR=0.23; 95% CI: 0.06-0.98). HCV infection risk was higher for injecting drug users (IDU) compared to HTX (aIRR=9.63; 95% CI: 2.9-32.2); among MSM, for subjects aged 40-50 compared to 30 or less (IRR=3.21; 95% CI: 1.7-6.2); and among HTX, for female sex (aIRR=2.35; 95% CI: 1.03-5.34) and <200 CD4-count (aIRR=2.39; 95% CI: 0.83-6.89). Conclusion: We report increases in HCV diagnoses rates which seem secondary to intensification of HCV follow-up testing but not to rises in HCV infection rates. HCV IR is higher in IDU. In MSM, HCV IR increases with age. Among HTX, HCV IR is higher in women and in subjects with impaired immunological situation.	[Sobrino-Vegas, Paz; Monge Corella, Susana; del Amo, Julia] Inst Salud Carlos III, Ctr Nacl Epidemiol, Madrid, Spain; [Serrano-Villar, Sergio; Moreno Guillen, Santiago] Hosp Univ Ramon y Cajal, Madrid, Spain; [Gutierrez, Felix] Hosp Gen Univ Elche, Elche, Spain; [Ramon Blanco, Jose] Hosp San Pedro, Logrono, Spain; [Santos, Ignacio] Hosp Univ La Princesa, Madrid, Spain; [del Romero, Jorge] Ctr Sanitario Sandoval, Madrid, Spain; [Segura, Ferran] Hosp Gen Alicante, Alicante, Spain; [Segura, Ferran] Hosp Univ Parc Tauli, Sabadell, Spain; [Portilla, Joaquin] Hosp Gen Alicante, Alicante, Spain; [CoRIS] Cohorte Red Invest Sida, Madrid, Spain	Instituto de Salud Carlos III; Centro Nacional de Epidemiologia (CNE); Hospital Universitario Ramon y Cajal; Hospital de La Princesa; General University Hospital of Alicante; Autonomous University of Barcelona; Parc Tauli Hospital Universitari; General University Hospital of Alicante	Sobrino-Vegas, P (corresponding author), Inst Salud Carlos III, Ctr Nacl Epidemiol, Madrid, Spain.	psobrino@isciii.es	Valero, Ignacio Pérez/AAD-6566-2020; Berenguer, Juan/A-1347-2009; , Felipe/F-4242-2014; Oteo, Jose A./AAB-3134-2020; Valero, Ignacio Pérez/G-5909-2016; Sobrino-Vegas, Paz/E-1741-2015; Blanco, Jose-Ramon/L-6768-2018; Monge, Susana/H-9210-2017; IBIS, VIH/O-8856-2015; Soriano, Vicente/O-5730-2018; Padilla, Sergio/U-7682-2017; Masiá, Mar/U-7510-2017; Pulido, Federico/B-8417-2009; Alvarez-del Arco, Debora/E-1744-2015; Cuellar, Sandra/I-3069-2015; Valle-Garay, Eulalia/AAG-6664-2020; Rodero, Félix Gutiérrez/Q-7880-2018; Muga, Roberto/AAY-8655-2021; Macias, Juan/I-9133-2019; gonzalez, cristina/U-2024-2019; DEL AMO VALERO, JULIA/M-7020-2015; Portilla, Joaquín/O-7609-2018; Perez, Laura/AAC-8394-2020; Pineda, Juan A./AAO-9312-2021; Montero, Marta/H-7555-2017; Bernardino, Jose Ignacio/H-7898-2017; Arribas, Jose/A-1595-2015; Blanco Garcia, Francisco J/C-3192-2014; Lopez.Cortes, Luis Fernando/S-5625-2018; Asensi Alvarez, Victor/AAH-2171-2020	Valero, Ignacio Pérez/0000-0002-3488-7135; Berenguer, Juan/0000-0001-8541-8200; , Felipe/0000-0001-7658-5832; Oteo, Jose A./0000-0001-7080-6542; Valero, Ignacio Pérez/0000-0002-3488-7135; Sobrino-Vegas, Paz/0000-0002-0775-1558; Blanco, Jose-Ramon/0000-0002-4268-0150; Soriano, Vicente/0000-0002-4624-5199; Masiá, Mar/0000-0001-9878-2458; Pulido, Federico/0000-0002-7414-8812; Alvarez-del Arco, Debora/0000-0003-4079-9219; Valle-Garay, Eulalia/0000-0002-5998-699X; Rodero, Félix Gutiérrez/0000-0002-9485-6867; Muga, Roberto/0000-0001-6301-431X; Macias, Juan/0000-0002-4778-790X; gonzalez, cristina/0000-0002-6924-990X; DEL AMO VALERO, JULIA/0000-0002-3104-540X; Portilla, Joaquín/0000-0002-3676-9511; Pineda, Juan A./0000-0002-3751-0296; /0000-0001-7808-5479; Llenas-Garcia, Jara/0000-0001-9125-7706; Ibanez, Laura/0000-0003-2381-7059; Casado, Jose Luis/0000-0002-7639-8591; Vilades, Consuelo/0000-0002-2991-9593; Montero, Marta/0000-0002-3432-5394; Navarro Ruiz, Andres/0000-0001-7009-280X; SIRVENT, JUAN JOSE/0000-0002-7486-8916; Munoz-Fernandez/0000-0002-0813-4500; De Los Santos Gil, Ignacio/0000-0001-7073-5211; JARRIN, INMA/0000-0002-7485-2252; PENARANDA VERA, MARIA/0000-0001-6290-3457; Vidal, Francesc/0000-0002-6692-6186; Bernardino, Jose Ignacio/0000-0003-3501-8529; Padilla, Sergio/0000-0002-8420-7310; Calabuig, Eva/0000-0002-0177-0037; Mallolas Masferrer, Josep/0000-0002-8365-141X; Sanvisens, Arantza/0000-0001-6269-5491; Vera, Mar/0000-0002-3841-7747; Estebanez, Miriam/0000-0003-4509-9123; Barreiro, Pablo/0000-0002-3819-5371; Gijon, Paloma/0000-0002-5011-1927; Arribas, Jose/0000-0002-7410-9450; MARTIN CARBONERO, LUZ/0000-0001-8102-4079; Serrano-Villar, Sergio/0000-0002-5447-3554; Vargas Laguna, Montserrat/0000-0001-7650-0587; ALBA ELVIRA, VERONICA/0000-0002-5925-9573; Monge, Susana/0000-0003-1412-3012; Rubio Garcia, Rafael/0000-0001-8132-4303; Blanco Garcia, Francisco J/0000-0001-9821-7635; Lopez Dupla, Jesus Miguel/0000-0002-9141-2523; Perez Elias/0000-0001-5700-5257; Amengual, Maria Jose/0000-0002-5385-3061; Lopez.Cortes, Luis Fernando/0000-0002-3804-3458; Veloso Esteban, Sergio/0000-0001-7943-1169; Gonzalez-Garcia, Juan/0000-0002-3652-002X; Asensi Alvarez, Victor/0000-0003-4211-456X	Instituto de Salud Carlos III through the Red Tematica de Investigacion Cooperativa en Sida [RD06/006]; Plan Nacional R+D+ I [RD12/0017/0018]; ISCIII-Subdireccion General de Evaluacion and the European Regional Development Fund (ERDF)	Instituto de Salud Carlos III through the Red Tematica de Investigacion Cooperativa en Sida; Plan Nacional R+D+ I; ISCIII-Subdireccion General de Evaluacion and the European Regional Development Fund (ERDF)	The RIS Cohort (CoRIS) is funded by the Instituto de Salud Carlos III through the Red Tematica de Investigacion Cooperativa en Sida (RD06/006), by the RD12/0017/0018 project as part of the Plan Nacional R+D+ I and cofinanced by ISCIII-Subdireccion General de Evaluacion and the European Regional Development Fund (ERDF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, INFORM HEMOVIGILANCI; Bottieau E, 2010, EUROSURVEILLANCE, V15, P18; Danta M, 2007, AIDS, V21, P983, DOI 10.1097/QAD.0b013e3281053a0c; Esteban J, 2003, MED CLIN-BARCELONA, V120, P765, DOI 10.1157/13048329; Fierer Daniel S., 2011, Morbidity and Mortality Weekly Report, V60, P945; Gamage DG, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-39; Gambotti L, 2005, Euro Surveill, V10, P115, DOI 10.2807/esm.10.05.00535-en; Ghosn J, 2006, SEX TRANSM INFECT, V82, P458, DOI 10.1136/sti.2006.021493; Giraudon I, 2008, SEX TRANSM INFECT, V84, P111, DOI 10.1136/sti.2007.027334; Gotz HM, 2005, AIDS, V19, P969, DOI 10.1097/01.aids.0000171412.61360.f8; Hernando V, 2012, J HEPATOL, V57, P743, DOI 10.1016/j.jhep.2012.06.010; Hsieh MH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094791; Laguno M, 2012, AIDS RES HUM RETROV, V28, P1294, DOI 10.1089/aid.2011.0289; Cachafeiro SP, 2009, CLIN INFECT DIS, V48, P1467, DOI 10.1086/598333; Rockstroh J, 2012, J INT AIDS SOC S4, V15, P18116; Rubin DB, 2004, MULTIPLE IMPUTATION; Serrano-Villar S, 2015, J VIRAL HEPATITIS, V22, P496, DOI 10.1111/jvh.12353; Sobrino-Vegas P, 2011, ENFERM INFEC MICR CL, V29, P645, DOI 10.1016/j.eimc.2011.06.002; Spradling PR, 2010, JAIDS-J ACQ IMM DEF, V53, P388, DOI 10.1097/QAI.0b013e3181b67527; Taylor LE, 2011, CLIN INFECT DIS, V52, P812, DOI 10.1093/cid/ciq201; van de Laar T, 2009, GASTROENTEROLOGY, V136, P1609, DOI 10.1053/j.gastro.2009.02.006; van de Laar TJW, 2007, J INFECT DIS, V196, P230, DOI 10.1086/518796; van der Helm JJ, 2011, AIDS, V25, P1083, DOI 10.1097/QAD.0b013e3283471cce; Wandeler G, 2012, CLIN INFECT DIS, V55, P1408, DOI 10.1093/cid/cis694; Williams RL, 2000, BIOMETRICS, V56, P645, DOI 10.1111/j.0006-341X.2000.00645.x; Witt MD, 2013, CLIN INFECT DIS, V57, P77, DOI 10.1093/cid/cit197	26	18	18	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2014	9	12							e116226	10.1371/journal.pone.0116226	http://dx.doi.org/10.1371/journal.pone.0116226			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX6YH	25549224	Green Published, Green Submitted, gold			2022-12-27	WOS:000347063500065
J	Zheng, LF; Zhang, ZL; Khazaie, K; Saha, S; Lewandowski, RJ; Zhang, GX; Larson, AC				Zheng, Linfeng; Zhang, Zhuoli; Khazaie, Khashayarsha; Saha, Saurabh; Lewandowski, Robert J.; Zhang, Guixiang; Larson, Andrew C.			MRI-Monitored Intra-Tumoral Injection of Iron-Oxide Labeled Clostridium novyi-NT Anaerobes in Pancreatic Carcinoma Mouse Model	PLOS ONE			English	Article							BACTERIOLYTIC THERAPY; SALMONELLA-TYPHIMURIUM; TRACKING; CELLS; CANCER; PARTICLES; DELIVERY; SPORES	Objectives: To validate the feasibility of labeling Clostridium novyi-NT (C.novyi-NT) anaerobes with iron-oxide nanoparticles for magnetic resonance imaging (MRI) and demonstrate the potential to use MRI to visualize intra-tumoral delivery of these iron-oxide labeled C. novyi-NT during percutaneous injection procedures. Materials and Methods: All studies were approved by IACUC. C. novyi-NT were labeled with hybrid iron-oxide Texas red nanoparticles. Growth of labeled and control samples were evaluated with optical density. Labeling was confirmed with confocal fluorescence and transmission electron microscopy (TEM). MRI were performed using a 7 Tesla scanner with T2*-weighted (T2*W) sequence. Contrast-to-noise ratio (CNR) measurements were performed for phantoms and signal-to-noise ratio (SNR) measurements performed in C57BL/6 mice (n=12) with Panc02 xenografts before and after percutaneous injection of iron-oxide labeled C. novyi-NT. MRI was repeated 3 and 7 days post-injection. Hematoxylin-eosin (HE), Prussian blue and Gram staining of tumor specimens were performed for confirmation of intra-tumoral delivery. Results: Iron-oxide labeling had no influence upon C. novyi-NT growth. The signal intensity (SI) within T2*W images was significantly decreased for iron-oxide labeled C. novyi-NT phantoms compared to unlabeled controls. Under confocal fluorescence microscopy, the iron-oxide labeled C. novyi-NT exhibited a uniform red fluorescence consistent with observed regions of DAPI staining and overall labeling efficiency was 100% (all DAPI stained C. novyi-NT exhibited red fluorescence). Within TEM images, a large number iron granules were observed within the iron-oxide labeled C.novyi-NT; these were not observed within unlabeled controls. Intra-procedural MRI measurements permitted in vivo visualization of the intra-tumoral distribution of iron-oxide labeled C.novyi-NT following percutaneous injection (depicted as punctate regions of SI reductions within T2*-weighted images); tumor SNR decreased significantly following intra-tumoral injection of C.novyi-NT (p<0.05); these SNR reductions were maintained at 3 and 7 day follow-up intervals. Prussian blue and Gram staining confirmed presence of the iron-oxide labeled anaerobes. Conclusions: C.novyi-NT can be labeled with iron-oxide nanoparticles for MRI visualization of intra-tumoral deposition following percutaneous injection during bacteriolytic therapy.	[Zheng, Linfeng; Zhang, Guixiang] Shanghai Jiao Tong Univ, Peoples Hosp 1, Dept Radiol, Shanghai 200030, Peoples R China; [Zheng, Linfeng; Zhang, Zhuoli; Lewandowski, Robert J.; Larson, Andrew C.] Northwestern Univ, Feinberg Sch Med, Dept Radiol, Chicago, IL 60208 USA; [Zhang, Zhuoli; Larson, Andrew C.] Robert H Lurie Comprehens Canc Ctr, Chicago, IL USA; [Khazaie, Khashayarsha] Mayo Clin, Coll Med, Dept Immunol, Rochester, MN USA; [Saha, Saurabh] BioMed Valley Discoveries, Kansas City, MO USA	Shanghai Jiao Tong University; Northwestern University; Feinberg School of Medicine; Ann & Robert H. Lurie Children's Hospital of Chicago; Robert H. Lurie Comprehensive Cancer Center; Mayo Clinic	Larson, AC (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Radiol, Chicago, IL 60208 USA.	a-larson@northwestern.edu			National Cancer Institute [R01CA159178, RO1CA141047, R21CA173491]; State Scholarship Fund by China Scholarship Council; Shanghai First People's Hospital, Shanghai Jiao Tong University; NATIONAL CANCER INSTITUTE [P30CA060553, R01CA141047, R21CA173491, R01CA159178] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); State Scholarship Fund by China Scholarship Council; Shanghai First People's Hospital, Shanghai Jiao Tong University; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grants (R01CA159178, RO1CA141047 and R21CA173491) from the National Cancer Institute, the State Scholarship Fund by China Scholarship Council (for LZ), the award for the best youth medical scholars by Shanghai First People's Hospital, Shanghai Jiao Tong University (for LZ). This work was also supported by the Center for Translational Imaging at Northwestern University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Agrawal N, 2004, P NATL ACAD SCI USA, V101, P15172, DOI 10.1073/pnas.0406242101; Ahrens ET, 2013, NAT REV IMMUNOL, V13, P755, DOI 10.1038/nri3531; Benincasa M, 2009, ANTIMICROB AGENTS CH, V53, P3501, DOI 10.1128/AAC.01620-08; Benoit MR, 2009, CLIN CANCER RES, V15, P5170, DOI 10.1158/1078-0432.CCR-08-3206; Bettegowda C, 2003, P NATL ACAD SCI USA, V100, P15083, DOI 10.1073/pnas.2036598100; Bulte JWM, 2013, RADIOLOGY, V269, P1, DOI 10.1148/radiol.13131753; Daldrup-Link HE, 2005, RADIOLOGY, V234, P197, DOI 10.1148/radiol.2341031236; Dang LH, 2001, P NATL ACAD SCI USA, V98, P15155, DOI 10.1073/pnas.251543698; Elbing KL, 2001, CURR PROTOC PROTEIN; Fleige G, 2002, INVEST RADIOL, V37, P482, DOI 10.1097/00004424-200209000-00002; Gupta T, 2008, RADIOLOGY, V249, P845, DOI 10.1148/radiol.2491072027; Hayashi K, 2009, J CELL BIOCHEM, V106, P992, DOI 10.1002/jcb.22078; Hill PJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025409; Hoerr V, 2013, BMC BIOL, V11, DOI 10.1186/1741-7007-11-63; Husain K, 2013, CANCER PREV RES, V6, P1074, DOI 10.1158/1940-6207.CAPR-13-0157; Khurana A, 2013, RADIOLOGY, V269, P186, DOI 10.1148/radiol.13130858; Killock David, 2014, Nat Rev Clin Oncol, V11, P562, DOI 10.1038/nrclinonc.2014.151; Krick EL, 2012, AM J VET RES, V73, P112, DOI 10.2460/ajvr.73.1.112; Liu GS, 2013, MAGN RESON MED, V70, P1690, DOI 10.1002/mrm.24955; Maletzki C, 2008, GUT, V57, P483, DOI 10.1136/gut.2007.125419; Maletzki C, 2010, WORLD J GASTROENTERO, V16, P3546, DOI 10.3748/wjg.v16.i28.3546; Meng YF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031137; Plomp M, 2007, J BACTERIOL, V189, P6457, DOI 10.1128/JB.00757-07; Roberts NJ, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008982; Sheu AY, 2013, INVEST RADIOL, V48, P492, DOI 10.1097/RLI.0b013e31827994e5; Torres MP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080580; Wagner M, 2011, J MAGN RESON IMAGING, V34, P816, DOI 10.1002/jmri.22683; Zhang Z, 2014, RADIOLOGY; Zhang ZL, 2013, J IMMUNOL METHODS, V400, P23, DOI 10.1016/j.jim.2013.06.013; Zhang ZL, 2009, MOL IMAGING, V8, P148, DOI 10.2310/7290.2009.00008; Zhang ZL, 2004, MAGN RESON MATER PHY, V17, P201, DOI 10.1007/s10334-004-0054-8; Zhao M, 2005, P NATL ACAD SCI USA, V102, P755, DOI 10.1073/pnas.0408422102	32	9	9	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2014	9	12							e116204	10.1371/journal.pone.0116204	http://dx.doi.org/10.1371/journal.pone.0116204			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX6YH	25549324	gold, Green Submitted, Green Published			2022-12-27	WOS:000347063500061
J	Andersson, IM; Christensson, K; Gemzell-Danielsson, K				Andersson, Inga-Maj; Christensson, Kyllike; Gemzell-Danielsson, Kristina			Experiences, Feelings and Thoughts of Women Undergoing Second Trimester Medical Termination of Pregnancy	PLOS ONE			English	Article							SURGICAL TERMINATION; INDUCED-ABORTION; PERCEPTIONS; DISTRESS; CARE	Main Objective: The objective of this study was to explore women's expectations and experiences of undergoing second trimester abortion. Methods: This is a cross-sectional study using a screening questionnaire and semi-structured interviews for data collection. Thirty-one women filled out the questionnaire and 23 of them were later interviewed. The questionnaires were analyzed by descriptive statistics. The interviews were recorded, transcribed verbatim and analyzed with qualitative content analysis. Most Important Findings: Indications for the abortion were fetal malformation or unintended pregnancy. The women expressed similar feelings and these were irrespective for the reason for having an abortion. Both physical and mental pain was experienced during the abortion process and described by the women. Taking the mifepristone-pill was experienced as especially emotionally difficult for many participants. Professional support from the staff together with support from the partner, a friend or relative helped in transforming the worries related to something unknown to feelings of coping with a new and hard experience. Prior to the abortion most women stated that they did not want to view the fetus but women who chose to view the fetus described this as a way of confronting the reality and an opportunity to say farewell to the pregnancy/fetus. The analysis of the interview transcripts revealed five themes mirroring the women's experiences, thoughts and feelings related to the abortion. Conclusions: The decision to undergo second trimester abortion sometimes exposes women to strong and conflicting emotions which are irrespective for the reason for having an abortion. Despite this women do not regret their decision to terminate the pregnancy. This analysis shows that their rational thinking outweighs their emotionally difficult feelings. It is important for the attending staff to be responsive to the needs of each individual woman whatever the indication is for the abortion.	[Andersson, Inga-Maj] Stockholm South Gen Hosp, Karolinska Inst, Dept Womens & Childrens Hlth, Stockholm, Sweden; [Christensson, Kyllike] Karolinska Inst, Dept Womens & Childrens Hlth, Div Reprod Hlth, Stockholm, Sweden; [Gemzell-Danielsson, Kristina] Karolinska Univ Hosp, Karolinska Inst, WHO Ctr, Dept Womens & Childrens Hlth,Div Obstet & Gynecol, Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital	Andersson, IM (corresponding author), Stockholm South Gen Hosp, Karolinska Inst, Dept Womens & Childrens Hlth, Stockholm, Sweden.	Inga-Maj.Andersson@ki.se			Swedish Research Council [0855]; ALF (Karolinska Institutet - Stockholm County Council); Karolinska Institutet; Stockholm South General Hospital	Swedish Research Council(Swedish Research CouncilEuropean Commission); ALF (Karolinska Institutet - Stockholm County Council); Karolinska Institutet(Karolinska Institutet); Stockholm South General Hospital	The study was supported by grants from the Swedish Research Council (grant no 0855), ALF (Karolinska Institutet - Stockholm County Council, Agreement on Medical Research and Training) funding, the Karolinska Institutet, and Stockholm South General Hospital. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alex L, 2004, SCAND J CARING SCI, V18, P160, DOI 10.1111/j.1471-6712.2004.00257.x; Andersson IM, 2014, CONTRACEPTION, V89, P460, DOI 10.1016/j.contraception.2014.01.012; Becker S, 2008, CONTRACEPTION, V78, P424, DOI 10.1016/j.contraception.2008.06.011; Benute GRG, 2012, MIDWIFERY, V28, P472, DOI 10.1016/j.midw.2011.06.011; Cheng L, 2008, SURG VERSUS MED METH; Escott D, 2004, MIDWIFERY, V20, P144, DOI 10.1016/j.midw.2003.11.001; Fergusson DM, 2009, BRIT J PSYCHIAT, V195, P420, DOI 10.1192/bjp.bp.109.066068; Geerinck-Vercammen CR, 2003, PRENATAL DIAG, V23, P543, DOI 10.1002/pd.636; Gewell-Danielsson K, 2008, REPROD HEALTH MATTER, V16, P162, DOI 10.1016/S0968-8080(08)31371-8; Graneheim UH, 2004, NURS EDUC TODAY, V24, P105, DOI 10.1016/j.nedt.2003.10.001; Grossman D, 2008, REPROD HEALTH MATTER, V16, P173, DOI 10.1016/S0968-8080(08)31379-2; Hallden BM, 2009, SCAND J CARING SCI, V23, P243, DOI 10.1111/j.1471-6712.2008.00612.x; HAMARK B, 1995, ACTA OBSTET GYN SCAN, V74, P302, DOI 10.3109/00016349509024454; Hamoda H, 2005, HUM REPROD, V20, P2348, DOI 10.1093/humrep/dei037; Kelly T, 2010, BJOG-INT J OBSTET GY, V117, P1512, DOI 10.1111/j.1471-0528.2010.02712.x; Kero A, 2001, SOC SCI MED, V53, P1481, DOI 10.1016/S0277-9536(00)00436-6; Kimport K, 2013, CONTRACEPTION, V88, P666, DOI 10.1016/j.contraception.2013.07.006; Lafarge C, 2013, QUAL HEALTH RES, V23, P924, DOI 10.1177/1049732313484198; Lauzon P, 2000, CAN FAM PHYSICIAN, V46, P2033; Lee E, 2010, BEST PRACT RES CL OB, V24, P479, DOI 10.1016/j.bpobgyn.2010.02.005; LORENZEN J, 1995, FETAL DIAGN THER, V10, P147, DOI 10.1159/000264225; Lowenstein L, 2006, GEN HOSP PSYCHIAT, V28, P43, DOI 10.1016/j.genhosppsych.2005.07.006; Mukkavaara I, 2012, MIDWIFERY, V28, pE720, DOI 10.1016/j.midw.2011.07.011; Powell J, 2011, J MED INTERNET RES, V13, DOI 10.2196/jmir.1600; Price B, 2002, J ADV NURS, V37, P273, DOI 10.1046/j.1365-2648.2002.02086.x; Purcell C, 2014, PERSPECT SEX REPRO H, V46, P101, DOI 10.1363/46e1214; Sandelowski M, 2003, QUAL HEALTH RES, V13, P905, DOI 10.1177/1049732303253488; Sihvo S, 1998, ACTA OBSTET GYN SCAN, V77, P210, DOI 10.1034/j.1600-0412.1998.770216.x; Slade P, 2001, J FAM PLAN REPROD H, V27, P72, DOI 10.1783/147118901101195281; Sloan EP, 2008, JOGNN-J OBST GYN NEO, V37, P395, DOI 10.1111/j.1552-6909.2008.00260.x; Stalhandske ML, 2011, J PSYCHOSOM OBST GYN, V32, P35, DOI 10.3109/0167482X.2010.545457; Stalhandske ML, 2012, J PSYCHOSOM OBST GYN, V33, P53, DOI 10.3109/0167482X.2012.677877; Taylor D, 2013, AM J MED QUAL, V28, P510, DOI 10.1177/1062860613484295; Vandamme J, 2013, EUR J CONTRACEP REPR, V18, P309, DOI 10.3109/13625187.2013.796586; Wiebe ER, 2009, CONTRACEPTION, V80, P575, DOI 10.1016/j.contraception.2009.07.005; Wiebe ER, 2009, EUR J CONTRACEP REPR, V14, P97, DOI 10.1080/13625180902745130; Woodcock S, 2011, BIOETHICS, V25, P495, DOI 10.1111/j.1467-8519.2009.01798.x; World Health Organization, 2014, CLIN PRACT HDB SAF A	38	29	31	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2014	9	12							e115957	10.1371/journal.pone.0115957	http://dx.doi.org/10.1371/journal.pone.0115957			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AX7UN	25546416	Green Published, gold, Green Submitted			2022-12-27	WOS:000347120200086
J	de Hollander, G; Wagenmakers, EJ; Waldorp, L; Forstmann, B				de Hollander, Gilles; Wagenmakers, Eric-Jan; Waldorp, Lourens; Forstmann, Birte			An Antidote to the Imager's Fallacy, or How to Identify Brain Areas That Are in Limbo	PLOS ONE			English	Article							DECISION-MAKING; FMRI; NEUROSCIENCE	Traditionally, fMRI data are analyzed using statistical parametric mapping approaches. Regardless of the precise thresholding procedure, these approaches ultimately divide the brain in regions that do or do not differ significantly across experimental conditions. This binary classification scheme fosters the so-called imager's fallacy, where researchers prematurely conclude that region A is selectively involved in a certain cognitive task because activity in that region reaches statistical significance and activity in region B does not. For such a conclusion to be statistically valid, however, a test on the differences in activation across these two regions is required. Here we propose a simple GLM-based method that defines an "in-between" category of brain regions that are neither significantly active nor inactive, but rather "in limbo". For regions that are in limbo, the activation pattern is inconclusive: it does not differ significantly from baseline, but neither does it differ significantly from regions that do show significant changes from baseline. This pattern indicates that measurement was insufficiently precise. By directly testing differences in activation, our procedure helps reduce the impact of the imager's fallacy. The method is illustrated using concrete examples.	[de Hollander, Gilles; Forstmann, Birte] Univ Amsterdam, ABC, Amsterdam, Netherlands; [de Hollander, Gilles; Wagenmakers, Eric-Jan; Waldorp, Lourens; Forstmann, Birte] Univ Amsterdam, Dept Psychol, Amsterdam, Netherlands	University of Amsterdam; University of Amsterdam	de Hollander, G (corresponding author), Univ Amsterdam, ABC, Amsterdam, Netherlands.	Gilles.de.Hollander@gmail.com	Forstmann, Birte/AAS-8515-2020; Wagenmakers, Eric-Jan/AAH-7065-2019	Wagenmakers, Eric-Jan/0000-0003-1596-1034; de Hollander, Gilles/0000-0003-1988-5091	Netherlands Organization for Scientific Research (NWO; Vidi-grant); European Research Council	Netherlands Organization for Scientific Research (NWO; Vidi-grant)(Netherlands Organization for Scientific Research (NWO)); European Research Council(European Research Council (ERC)European Commission)	This work was supported by The Netherlands Organization for Scientific Research (NWO; Vidi-grant "When the brain takes a break: A model-based cognitive neuroscience account of task unrelated thoughts'', BUF) and the European Research Council (Starting Grant "speeded decision-making in the basal ganglia: An integrative model-based approach'', BUF and GH, and the starting grant "Bayes or bust: sensible hypothesis tests for social scientists.'' EJW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Button KS, 2013, NAT REV NEUROSCI, V14, P365, DOI 10.1038/nrn3475; Forstmann BU, 2008, P NATL ACAD SCI USA, V105, P17538, DOI 10.1073/pnas.0805903105; Friston K., 2007, STAT PARAMETRIC MAPP, DOI [10.1016/B978-0-12-372560-8.X5000-1, DOI 10.1016/B978-0-12-372560-8.X5000-1]; Friston KJ, 2000, NEUROIMAGE, V12, P196, DOI 10.1006/nimg.2000.0609; Friston KJ, 2003, NEUROIMAGE, V19, P1273, DOI 10.1016/S1053-8119(03)00202-7; Gelman A, 2006, AM STAT, V60, P328, DOI 10.1198/000313006X152649; Gonzalez-Castillo J, 2012, P NATL ACAD SCI USA, V109, P5487, DOI 10.1073/pnas.1121049109; Gorgolewski  K., 2011, FRONTIERS NEUROINFOR, V5; Hare TA, 2009, SCIENCE, V324, P646, DOI 10.1126/science.1168450; Henson R, 2005, Q J EXP PSYCHOL-A, V58, P193, DOI 10.1080/02724980443000502; Koechlin E, 2006, NEURON, V50, P963, DOI 10.1016/j.neuron.2006.05.017; Kriegeskorte N, 2006, P NATL ACAD SCI USA, V103, P3863, DOI 10.1073/pnas.0600244103; Mumford JA, 2007, SOC COGN AFFECT NEUR, V2, P251, DOI 10.1093/scan/nsm019; Nichols T, 2003, STAT METHODS MED RES, V12, P419, DOI 10.1191/0962280203sm341ra; Nieuwenhuis S, 2011, NAT NEUROSCI, V14, P1105, DOI 10.1038/nn.2886; O'Reilly JX, 2012, SOC COGN AFFECT NEUR, V7, P604, DOI 10.1093/scan/nss055; Poldrack RA, 2011, HDB FUNCTIONAL MRI D; Poldrack RA, 2008, NEUROIMAGE, V40, P409, DOI 10.1016/j.neuroimage.2007.11.048; Waldorp L, 2009, INT J BIOMEDICAL IMA, V2009, P1; Welvaert M, 2011, BERL WORKSH STAT NEU; WORSLEY KJ, 1995, NEUROIMAGE, V2, P173, DOI 10.1006/nimg.1995.1023	21	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2014	9	12							e115700	10.1371/journal.pone.0115700	http://dx.doi.org/10.1371/journal.pone.0115700			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UN	25546581	Green Published, gold, Green Submitted			2022-12-27	WOS:000347120200056
J	Mugasha, C; Kigozi, J; Kiragga, A; Muganzi, A; Sewankambo, N; Coutinho, A; Nakanjako, D				Mugasha, Christine; Kigozi, Joanita; Kiragga, Agnes; Muganzi, Alex; Sewankambo, Nelson; Coutinho, Alex; Nakanjako, Damalie			Intra-Facility Linkage of HIV-Positive Mothers and HIV-Exposed Babies into HIV Chronic Care: Rural and Urban Experience in a Resource Limited Setting	PLOS ONE			English	Article							TO-CHILD TRANSMISSION; FOLLOW-UP; PREVENTION; PROGRAM; PMTCT; ATTENDANCE; ADHERENCE; UGANDA; MALAWI	Introduction: Linkage of HIV-infected pregnant women to HIV care remains critical for improvement of maternal and child outcomes through prevention of maternal-to-child transmission of HIV (PMTCT) and subsequent chronic HIV care. This study determined proportions and factors associated with intra-facility linkage to HIV care and Early Infant Diagnosis care (EID) to inform strategic scale up of PMTCT programs. Methods: A cross-sectional review of records was done at 2 urban and 3 rural public health care facilities supported by the Infectious Diseases Institute (IDI). HIV-infected pregnant mothers, identified through routine antenatal care (ANC) and HIV-exposed babies were evaluated for enrollment in HIV clinics by 6 weeks post-delivery. Results: Overall, 1,025 HIV-infected pregnant mothers were identified during ANC between January and June, 2012; 267/1,025 (26%) in rural and 743/1,025 (74%) in urban facilities. Of these 375/1,025 (37%) were linked to HIV clinics [67/267(25%) rural and 308/758(41%) urban]. Of 636 HIV-exposed babies, 193 (30%) were linked to EID. Linkage of mother-baby pairs to HIV chronic care and EID was 16% (101/636); 8/179 (4.5%)] in rural and 93/457(20.3%) in urban health facilities. Within rural facilities, ANC registration <28 weeks-of-gestation was associated with mothers' linkage to HIV chronic care [AoR, 2.0 95% CI, 1.1-3.7, p=0.019] and mothers' multi-parity was associated with baby's linkage to EID; AoR 4.4 (1.3-15.1), p=0.023. Stigma, long distance to health facilities and vertical PMTCT services affected linkage in rural facilities, while peer mothers, infant feeding services, long patient queues and limited privacy hindered linkage to HIV care in urban settings. Conclusion: Post-natal linkage of HIV-infected mothers to chronic HIV care and HIV-exposed babies to EID programs was low. Barriers to linkage to HIV care vary in urban and rural settings. We recommend targeted interventions to rapidly improve linkage to antiretroviral therapy for elimination of MTCT.	[Mugasha, Christine; Kigozi, Joanita; Muganzi, Alex; Coutinho, Alex; Nakanjako, Damalie] Infect Dis Inst, Kampala, Uganda; [Kiragga, Agnes; Sewankambo, Nelson; Nakanjako, Damalie] Makerere Univ Coll Hlth Sci, Kampala, Uganda	Makerere University	Nakanjako, D (corresponding author), Infect Dis Inst, Kampala, Uganda.	dnakanjako@gmail.com		Nakanjako, Damalie/0000-0002-0935-2112; Sewankambo, Nelson/0000-0001-9362-053X	NIH Office of AIDS Research; Fogarty International Center [R24TW008907-01S1]; FOGARTY INTERNATIONAL CENTER [R24TW008907, R25TW009343] Funding Source: NIH RePORTER	NIH Office of AIDS Research; Fogarty International Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	The authors acknowledge funding by NIH Office of AIDS Research and Fogarty International Center, grant # R24TW008907-01S1, that supported Christine Mugasha to conduct this study during her Afya Bora Consortium Fellowship in Global Health Leadership. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aluisio A, 2011, JAIDS-J ACQ IMM DEF, V56, P76, DOI 10.1097/QAI.0b013e3181fdb4c4; [Anonymous], PROGR REP 2011 GLOB; [Anonymous], 2017, 2013 UNAIDS REP GLOB; AVERT, 2012, AV HIV AIDS AIDS SUB; Bajunirwe Francis, 2005, AIDS Res Ther, V2, P10, DOI 10.1186/1742-6405-2-10; Bwirire LD, 2008, T ROY SOC TROP MED H, V102, P1195, DOI 10.1016/j.trstmh.2008.04.002; Cook RE, 2011, JAIDS-J ACQ IMM DEF, V56, pE104, DOI 10.1097/QAI.0b013e318207a535; Ediau M, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-189; Esiru G, 2013, 20 C RETR OPP INF CR; Hardon A, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-26; JOFFE H, 2003, RES METHODS CLIN HLT; Larsson EC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037590; Manzi M, 2005, TROP MED INT HEALTH, V10, P1242, DOI 10.1111/j.1365-3156.2005.01526.x; Mbonye AK, 2010, J BIOSOC SCI, V42, P271, DOI 10.1017/S002193200999040X; Mepham S, 2011, AIDS CARE, V23, P741, DOI 10.1080/09540121.2010.516341; Nakanjako D, 2013, SCALING HIV AIDS CAR, P249; Nassali M, 2009, AIDS CARE, V21, P1124, DOI 10.1080/09540120802707467; Uganda AIDS commission, 2011, NAT PRIOR ACT PLAN 2; Uganda aids Commission, 2012, GLOB AIDS RESP PROGR; Ujiji OA, 2011, CULT HEALTH SEX, V13, P829, DOI 10.1080/13691058.2011.583682; UNAIDS, 2012, GLOBAL REPORT UNAIDS; UNAIDS, 2010, UN ACC SCAL PRIOR HI; UNAIDS, 2012, TOG WE WILL END AIDS; UNAIDS, 2011, UNAIDS 2011 WORLD AI	24	20	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2014	9	12							e115171	10.1371/journal.pone.0115171	http://dx.doi.org/10.1371/journal.pone.0115171			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AX7UN	25546453	Green Published, Green Submitted, gold			2022-12-27	WOS:000347120200025
J	Hayford, BL; Caires, AM; Chandra, S; Girdner, SF				Hayford, Barbara L.; Caires, Andrea M.; Chandra, Sudeep; Girdner, Scott F.			Patterns in Benthic Biodiversity Link Lake Trophic Status to Structure and Potential Function of Three Large, Deep Lakes	PLOS ONE			English	Article							SPECIES RICHNESS; CRATER LAKE; NUTRIENT ENRICHMENT; FRESH-WATER; 4 DECADES; EUTROPHICATION; CHIRONOMIDAE; HOVSGOL; OREGON; COMMUNITIES	Relative to their scarcity, large, deep lakes support a large proportion of the world's freshwater species. This biodiversity is threatened by human development and is in need of conservation. Direct comparison of biodiversity is the basis of biological monitoring for conservation but is difficult to conduct between large, insular ecosystems. The objective of our study was to conduct such a comparison of benthic biodiversity between three of the world's largest lakes: Lake Tahoe, USA; Lake Hovsgol, Mongolia; and Crater Lake, USA. We examined biodiversity of common benthic organism, the non-biting midges (Chironomidae) and determined lake trophic status using chironomid-based lake typology, tested whether community structure was similar between the three lakes despite geographic distance; and tested whether chironomid diversity would show significant variation within and between lakes. Typology analysis indicated that Lake Hovsgol was ultra-oligotrophic, Crater Lake was oligotrophic, and Lake Tahoe was borderline oligotrophic/mesotrophic. These results were similar to traditional pelagic measures of lake trophic status for Lake Hovsgol and Crater Lake but differed for Lake Tahoe, which has been designated as ultra-oligotrophic by traditional pelagic measures such as transparency found in the literature. Analysis of similarity showed that Lake Tahoe and Lake Hovsgol chironomid communities were more similar to each other than either was to Crater Lake communities. Diversity varied between the three lakes and spatially within each lake. This research shows that chironomid communities from these large lakes were sensitive to trophic conditions. Chironomid communities were similar between the deep environments of Lake Hovsgol and Lake Tahoe, indicating that chironomid communities from these lakes may be useful in comparing trophic state changes in large lakes. Spatial variation in Lake Tahoe's diversity is indicative of differential response of chironomid communities to nutrient enrichment which may be an indication of changes in trophic state within and across habitats.	[Hayford, Barbara L.] Wayne State Coll, Dept Life Sci, Wayne, NE 68787 USA; [Caires, Andrea M.; Chandra, Sudeep] Univ Nevada, Dept Biol, Reno, NV 89557 USA; [Girdner, Scott F.] Crater Lake Natl Pk, Crater Lake, OR USA	Nebraska State College System; Wayne State College; Nevada System of Higher Education (NSHE); University of Nevada Reno	Hayford, BL (corresponding author), Wayne State Coll, Dept Life Sci, Wayne, NE 68787 USA.	bahayfo1@wsc.edu			California Tahoe Conservancy; Cooperative Ecosystems Studies Unit at the University of Nevada; Crater Lake National Park [J8R07080010]; US National Science Foundation, Division of International Studies [9504867]	California Tahoe Conservancy; Cooperative Ecosystems Studies Unit at the University of Nevada; Crater Lake National Park; US National Science Foundation, Division of International Studies	This work was supported by funding provided by the California Tahoe Conservancy (http://tahoe.ca.gov/) to G. Schladow at UC Davis and SC, a cooperative agreement between the Cooperative Ecosystems Studies Unit at the University of Nevada (http://environment.unr.edu/gbcesu/) and Crater Lake National Park (http://www.nps.gov/crla/) (Agreement # J8R07080010) to SC, and by the US National Science Foundation (www.nsf.gov), Division of International Studies grant (INT # 9504867) to BH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON RO, 1959, LIMNOL OCEANOGR, V4, P223, DOI 10.4319/lo.1959.4.2.0223; Blumenshine SC, 1997, J N AM BENTHOL SOC, V16, P466, DOI 10.2307/1468138; Brinkhurst RO., 1974, BENTHOS LAKES, DOI 10.1007/978-1-349-15556-9; Caires AM, 2013, FRESHW SCI, V32, P692, DOI 10.1899/12-064.1; Chandra S, 2005, LIMNOL OCEANOGR, V50, P1368, DOI 10.4319/lo.2005.50.5.1368; Crawford GB, 2007, HYDROBIOLOGIA, V574, P47, DOI 10.1007/s10750-006-0345-3; Cuffney TE, 2007, J N AM BENTHOL SOC, V26, P286, DOI 10.1899/0887-3593(2007)26[286:ATEOTC]2.0.CO;2; Dodson SI, 2000, ECOLOGY, V81, P2662, DOI 10.1890/0012-9658(2000)081[2662:TRILCB]2.0.CO;2; Donohue I, 2009, ECOLOGY, V90, P3470, DOI 10.1890/09-0415.1; Downing JA, 2006, LIMNOL OCEANOGR, V51, P2388, DOI 10.4319/lo.2006.51.5.2388; Evans-White MA, 2009, J N AM BENTHOL SOC, V28, P855, DOI 10.1899/08-113.1; Ferrington LC, 2008, INTRO AQUATIC INSECT, P847; Ferrington LC, 2008, HYDROBIOLOGIA, V595, P447, DOI 10.1007/s10750-007-9130-1; Goldman CR, 2000, INT VER THEOR ANGEW, V27, P7; GOLDMAN CR, 1981, VERH INT VER LIMNOL, V21, P45; Goulden CE, 2006, BIO INL WAT, P1; Hammer O, 2012, REFERENCE MANUAL; Hayford B, 2006, BIO INL WAT, P433; Hayford Barbara, 2013, Journal of Species Research, V2, P159; HERDENDORF C E, 1982, Journal of Great Lakes Research, V8, P379, DOI 10.1016/S0380-1330(82)71982-3; HEYVAERT A.C., 2013, LAKE TAHOE NEARSHORE; Hintze J, 2007, NUMBER CRUNCHER STAT; Jeppesen E, 2000, FRESHWATER BIOL, V45, P201, DOI 10.1046/j.1365-2427.2000.00675.x; Jyvasjarvi J, 2014, FRESHW SCI, V33, P995, DOI 10.1086/676914; Kalbe Lothar, 1996, Limnologica, V26, P293; Larson GL, 2007, HYDROBIOLOGIA, V574, P69, DOI 10.1007/s10750-006-0346-2; Larson GL, 2007, HYDROBIOLOGIA, V574, P1, DOI 10.1007/s10750-006-0342-6; Mykra H, 2007, GLOBAL ECOL BIOGEOGR, V16, P149, DOI 10.1111/j.1466-8238.2006.00272.x; Nyman MT, 2005, BOREAL ENVIRON RES, V10, P239; Pilotto F, 2012, FUND APPL LIMNOL, V180, P101, DOI 10.1127/1863-9135/2012/0206; PINDER LCV, 1986, ANNU REV ENTOMOL, V31, P1, DOI 10.1146/annurev.en.31.010186.000245; Rosenberg D.M., 1992, NETHERLANDS J AQUATI, V26, P101, DOI DOI 10.1007/BF02255231; Rossaro Bruno, 2012, Fauna Norvegica, V31, P95, DOI 10.5324/fn.v31i0.1364; SAETHER O A, 1979, Holarctic Ecology, V2, P65; Suther, 1975, VERH INT VER LIMNOL, V19, P3127, DOI DOI 10.1080/03680770.1974.11896422; Vadeboncoeur Y, 2011, BIOSCIENCE, V61, P526, DOI 10.1525/bio.2011.61.7.7; WIEDERHOLM T, 1980, J WATER POLLUT CON F, V52, P537; WIEDERHOLM T, 1983, ENTOMOLOGICA SCAND S, V19; Wiens JJ, 2004, TRENDS ECOL EVOL, V19, P639, DOI 10.1016/j.tree.2004.09.011	39	5	6	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2015	10	1							e0117024	10.1371/journal.pone.0117024	http://dx.doi.org/10.1371/journal.pone.0117024			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ4OS	25594516	Green Submitted, Green Published, gold			2022-12-27	WOS:000348202900006
J	Arellano, CJ; McDermott, WJ; Kram, R; Grabowski, AM				Arellano, Christopher J.; McDermott, William J.; Kram, Rodger; Grabowski, Alena M.			Effect of Running Speed and Leg Prostheses on Mediolateral Foot Placement and Its Variability	PLOS ONE			English	Article							GROUND REACTION FORCES; STIFFNESS	This study examined the effects of speed and leg prostheses on mediolateral (ML) foot placement and its variability in sprinters with and without transtibial amputations. We hypothesized that ML foot placement variability would: 1. increase with running speed up to maximum speed and 2. be symmetrical between the legs of non-amputee sprinters but asymmetrically greater for the affected leg of sprinters with a unilateral transtibial amputation. We measured the midline of the body (kinematic data) and center of pressure (kinetic data) in the ML direction while 12 non-amputee sprinters and 7 Paralympic sprinters with transtibial amputations (6 unilateral, 1 bilateral) ran across a range of speeds up to maximum speed on a high-speed force measuring treadmill. We quantified ML foot placement relative to the body's midline and its variability. We interpret our results with respect to a hypothesized relation between ML foot placement variability and lateral balance. We infer that greater ML foot placement variability indicates greater challenges with maintaining lateral balance. In non-amputee sprinters, ML foot placement variability for each leg increased substantially and symmetrically across speed. In sprinters with a unilateral amputation, ML foot placement variability for the affected and unaffected leg also increased substantially, but was asymmetric across speeds. In general, ML foot placement variability for sprinters with a unilateral amputation was within the range observed in non-amputee sprinters. For the sprinter with bilateral amputations, both affected legs exhibited the greatest increase in ML foot placement variability with speed. Overall, we find that maintaining lateral balance becomes increasingly challenging at faster speeds up to maximum speed but was equally challenging for sprinters with and without a unilateral transtibial amputation. Finally, when compared to all other sprinters in our subject pool, maintaining lateral balance appears to be the most challenging for the Paralympic sprinter with bilateral transtibial amputations.	[Arellano, Christopher J.; Kram, Rodger; Grabowski, Alena M.] Univ Colorado, Integrat Physiol Dept, Boulder, CO 80309 USA; [McDermott, William J.] Orthoped Specialty Hosp, Biomech Lab, Murray, UT USA; [Grabowski, Alena M.] Eastern Colorado Healthcare Syst, Denver, CO USA	University of Colorado System; University of Colorado Boulder	Arellano, CJ (corresponding author), Brown Univ, Ecol & Evolutionary Biol Dept, Providence, RI 02912 USA.	christopher_arellano@brown.edu		GRABOWSKI, ALENA/0000-0002-4432-618X	Colorado Diversity Initiative	Colorado Diversity Initiative	Funding from the Colorado Diversity Initiative awarded to CJA supported the preparation of this manuscript. The funding agency had no role in study design, data collection and analysis, decision to publish, or preparation of this manuscript.	Arellano CJ, 2012, J APPL PHYSIOL, V112, P427, DOI 10.1152/japplphysiol.00554.2011; Arellano CJ, 2011, J BIOMECH, V44, P1291, DOI 10.1016/j.jbiomech.2011.01.002; Buckley JG, 1999, ARCH PHYS MED REHAB, V80, P501, DOI 10.1016/S0003-9993(99)90189-2; Buckley JG, 2000, CLIN BIOMECH, V15, P352, DOI 10.1016/S0268-0033(99)00094-7; CAVANAGH PR, 1980, J BIOMECH, V13, P397, DOI 10.1016/0021-9290(80)90033-0; Cohen J.E., 1988, STAT POWER ANAL BEHA; Dietz V, 2002, NAT REV NEUROSCI, V3, P781, DOI 10.1038/nrn939; ENOKA RM, 1982, AM J PHYS MED REHAB, V61, P66; Ferris DP, 1998, P ROY SOC B-BIOL SCI, V265, P989, DOI 10.1098/rspb.1998.0388; Grabowski AM, 2010, BIOL LETTERS, V6, P201, DOI 10.1098/rsbl.2009.0729; Hanavan EP, 1964, MATH MODEL HUMAN BOD, P1; Jordan K, 2009, HUM MOVEMENT SCI, V28, P113, DOI 10.1016/j.humov.2008.09.001; Look N, 2013, CHAOS, V23, DOI 10.1063/1.4837095; MCCLAY IS, 1994, CLIN BIOMECH, V9, P117, DOI 10.1016/0268-0033(94)90034-5; McGowan CP, 2012, J R SOC INTERFACE, V9, P1975, DOI 10.1098/rsif.2011.0877; MERO A, 1992, SPORTS MED, V13, P376, DOI 10.2165/00007256-199213060-00002; PRINCE F, 1992, PROSTHET ORTHOT INT, V16, P19; Sanderson DJ, 1996, ARCH PHYS MED REHAB, V77, P1279, DOI 10.1016/S0003-9993(96)90193-8; SMITH PJ, 1982, TECHNOMETRICS, V24, P123, DOI 10.2307/1268489; Weyand PG, 2009, J APPL PHYSIOL, V107, P903, DOI 10.1152/japplphysiol.00174.2009	20	11	13	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2015	10	1							e0115637	10.1371/journal.pone.0115637	http://dx.doi.org/10.1371/journal.pone.0115637			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9HN	25590634	gold, Green Submitted, Green Published			2022-12-27	WOS:000350679400010
J	Holzknecht, BJ; Franck, KT; Nielsen, RT; Bottiger, B; Fischer, TK; Fonager, J				Holzknecht, Barbara Juliane; Franck, Kristina Traeholt; Nielsen, Rikke Thoft; Bottiger, Blenda; Fischer, Thea Kolsen; Fonager, Jannik			Sequence Analysis of the Capsid Gene during a Genotype II. 4 Dominated Norovirus Season in One University Hospital: Identification of Possible Transmission Routes	PLOS ONE			English	Article							P2 DOMAIN; GASTROENTERITIS; OUTBREAKS; EPIDEMIOLOGY; EVOLUTION; DYNAMICS; PRIMERS; VIRUSES; SPREAD	Norovirus (NoV) is a leading cause of gastroenteritis and genotype II. 4 (GII. 4) is responsible for the majority of nosocomial NoV infections. Our objective was to examine whether sequencing of the capsid gene might be a useful tool for the hospital outbreak investigation to define possible transmission routes. All NoV positive samples submitted from one university hospital during the 2007/8 season were selected. Genotyping of selected samples by partial polymerase gene sequencing had shown that the majority belonged to the GII. 4 variant Den Haag 2006b and had identical polymerase sequences. Sequences of the capsid gene (1412 nucleotides) were obtained from the first available sample from 55 patients. From six immunocompromised patients with persistent infections a second sample was also included. As a control for a point-source outbreak, five samples from a foodborne outbreak caused by the same GII. 4 variant were analyzed. Forty-seven of the inpatients (85%) were infected with the GII. 4 variant Den Haag 2006b. Phylogenetic analysis of the Den Haag 2006b sequences identified four distinct outbreaks in different departments and a fifth outbreak with possible inter-department spread. In addition, a more heterogeneous cluster with evidence of repeated introductions from the community, but also possible inter-department spread was observed. In all six patients with paired sequences, evidence for in vivo evolution of the virus was found. Capsid gene sequencing showed substantial sequence variation among NoV GII. 4 variant Den Haag 2006b strains from one single institution during a nine months' period. This method proved useful to understand the local epidemiology and, when used promptly, has the potential to make infection control measures more targeted.	[Holzknecht, Barbara Juliane; Franck, Kristina Traeholt; Bottiger, Blenda; Fischer, Thea Kolsen; Fonager, Jannik] Statens Serum Inst, Dept Microbiol Diagnost & Virol, DK-2300 Copenhagen, Denmark; [Holzknecht, Barbara Juliane; Nielsen, Rikke Thoft] Univ Copenhagen, Herlev Hosp, Dept Clin Microbiol, DK-2730 Herlev, Denmark; [Franck, Kristina Traeholt] Univ Southern Denmark, Res Unit Clin Microbiol, Odense, Denmark; [Nielsen, Rikke Thoft] Odense Univ Hosp, Dept Clin Microbiol, DK-5000 Odense, Denmark; [Bottiger, Blenda] Lund Univ, Dept Lab Med Malmo, Med Microbiol, Malmo, Sweden	Statens Serum Institut; University of Copenhagen; Herlev & Gentofte Hospital; University of Southern Denmark; University of Southern Denmark; Odense University Hospital; Lund University	Holzknecht, BJ (corresponding author), Statens Serum Inst, Dept Microbiol Diagnost & Virol, DK-2300 Copenhagen, Denmark.	barbarah@web.de	Fischer, Thea K/AAH-9892-2019; Fonager, Jannik/AAJ-8292-2020	Fischer, Thea K/0000-0003-4812-980X; Fonager, Jannik/0000-0003-1688-1482; Traeholt Franck, Kristina/0000-0001-8375-3443				Ahmed SM, 2014, LANCET INFECT DIS, V14, P725, DOI 10.1016/S1473-3099(14)70767-4; Barclay L, 2014, CLIN MICROBIOL INFEC, V20, P731, DOI 10.1111/1469-0691.12674; Bok K, 2012, NEW ENGL J MED, V367, P2126, DOI 10.1056/NEJMra1207742; Bull RA, 2012, J VIROL, V86, P3219, DOI 10.1128/JVI.06712-11; Bull RA, 2011, TRENDS MICROBIOL, V19, P233, DOI 10.1016/j.tim.2011.01.002; Bull RA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000831; Debbink K, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002921; Dingle KE, 2004, J CLIN MICROBIOL, V42, P3950, DOI 10.1128/JCM.42.9.3950-3957.2004; Fonager J, 2013, EURO SURVEILL, V18; Franck KT, 2014, EMERG INFECT DIS, V20, P1123, DOI 10.3201/eid2007.130781; Gallimore CI, 2005, INT J FOOD MICROBIOL, V103, P323, DOI 10.1016/j.ijfoodmicro.2005.02.003; Glass RI, 2009, NEW ENGL J MED, V361, P1776, DOI 10.1056/NEJMra0804575; Hoebe CJPA, 2004, J INFECT DIS, V189, P699, DOI 10.1086/381534; Kageyama T, 2003, J CLIN MICROBIOL, V41, P1548, DOI 10.1128/JCM.41.4.1548-1557.2003; Kojima S, 2002, J VIROL METHODS, V100, P107, DOI 10.1016/S0166-0934(01)00404-9; Kroneman A, 2011, J CLIN VIROL, V51, P121, DOI 10.1016/j.jcv.2011.03.006; Kroneman A, 2013, ARCH VIROL, V158, P2059, DOI 10.1007/s00705-013-1708-5; Kundu S, 2013, CLIN INFECT DIS, V57, P407, DOI 10.1093/cid/cit287; Lindesmith LC, 2008, PLOS MED, V5, P269, DOI 10.1371/journal.pmed.0050031; Lopman B, 2012, CURR OPIN VIROL, V2, P96, DOI 10.1016/j.coviro.2011.11.005; Nilsson M, 2003, J VIROL, V77, P13117, DOI 10.1128/JVI.77.24.13117-13124.2003; Patel MM, 2008, EMERG INFECT DIS, V14, P1224, DOI 10.3201/eid1408.071114; Payne DC, 2013, NEW ENGL J MED, V368, P1121, DOI 10.1056/NEJMsa1206589; Rahamat-Langendoen JC, 2013, J CLIN VIROL, V58, P245, DOI 10.1016/j.jcv.2013.06.034; Schreier E, 2000, ARCH VIROL, V145, P443, DOI 10.1007/s007050050038; Siebenga JJ, 2007, J VIROL, V81, P9932, DOI 10.1128/JVI.00674-07; Siebenga JJ, 2009, J INFECT DIS, V200, P802, DOI 10.1086/605127; Sukhrie FHA, 2013, J CLIN VIROL, V56, P286, DOI 10.1016/j.jcv.2012.12.006; Sukhrie FHA, 2011, J CLIN MICROBIOL, V49, P602, DOI 10.1128/JCM.01443-10; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tu ETV, 2008, CLIN INFECT DIS, V46, P413, DOI 10.1086/525259; van Beek J, 2013, EUROSURVEILLANCE, V18, P8; Vega E, 2011, EMERG INFECT DIS, V17, P1389, DOI 10.3201/eid1708.101837; Vennema H, 2002, J CLIN VIROL, V25, P233, DOI 10.1016/S1386-6532(02)00126-9; Workowski Kimberly A, 2010, MMWR Recomm Rep, V59, P1; Xerry J, 2008, J CLIN MICROBIOL, V46, P947, DOI 10.1128/JCM.02240-07; Xerry J, 2009, J MED VIROL, V81, P1298, DOI 10.1002/jmv.21517; Zakikhany K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041625	38	13	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2015	10	1							e0115331	10.1371/journal.pone.0115331	http://dx.doi.org/10.1371/journal.pone.0115331			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9HN	25590635	Green Submitted, gold, Green Published			2022-12-27	WOS:000350679400003
J	Peacock, E; Sonsthagen, SA; Obbard, ME; Boltunov, A; Regehr, EV; Ovsyanikov, N; Aars, J; Atkinson, SN; Sage, GK; Hope, AG; Zeyl, E; Bachmann, L; Ehrich, D; Scribner, KT; Amstrup, SC; Belikov, S; Born, EW; Derocher, AE; Stirling, I; Taylor, MK; Wiig, O; Paetkau, D; Talbot, SL				Peacock, Elizabeth; Sonsthagen, Sarah A.; Obbard, Martyn E.; Boltunov, Andrei; Regehr, Eric V.; Ovsyanikov, Nikita; Aars, Jon; Atkinson, Stephen N.; Sage, George K.; Hope, Andrew G.; Zeyl, Eve; Bachmann, Lutz; Ehrich, Dorothee; Scribner, Kim T.; Amstrup, Steven C.; Belikov, Stanislav; Born, Erik W.; Derocher, Andrew E.; Stirling, Ian; Taylor, Mitchell K.; Wiig, Oystein; Paetkau, David; Talbot, Sandra L.			Implications of the Circumpolar Genetic Structure of Polar Bears for Their Conservation in a Rapidly Warming Arctic	PLOS ONE			English	Article							GENOMIC SEQUENCES REVEAL; MAXIMUM-LIKELIHOOD-ESTIMATION; URSUS-MARITIMUS; MITOCHONDRIAL-DNA; BROWN BEARS; POPULATION-GROWTH; HUDSON-BAY; COMPREHENSIVE ANALYSIS; BAYESIAN-INFERENCE; MIGRATION RATES	We provide an expansive analysis of polar bear (Ursus maritimus) circumpolar genetic variation during the last two decades of decline in their sea-ice habitat. We sought to evaluate whether their genetic diversity and structure have changed over this period of habitat decline, how their current genetic patterns compare with past patterns, and how genetic demography changed with ancient fluctuations in climate. Characterizing their circumpolar genetic structure using microsatellite data, we defined four clusters that largely correspond to current ecological and oceanographic factors: Eastern Polar Basin, Western Polar Basin, Canadian Archipelago and Southern Canada. We document evidence for recent (ca. last 1-3 generations) directional gene flow from Southern Canada and the Eastern Polar Basin towards the Canadian Archipelago, an area hypothesized to be a future refugium for polar bears as climate-induced habitat decline continues. Our data provide empirical evidence in support of this hypothesis. The direction of current gene flow differs from earlier patterns of gene flow in the Holocene. From analyses of mitochondrial DNA, the Canadian Archipelago cluster and the Barents Sea subpopulation within the Eastern Polar Basin cluster did not show signals of population expansion, suggesting these areas may have served also as past interglacial refugia. Mismatch analyses of mitochondrial DNA data from polar and the paraphyletic brown bear (U. arctos) uncovered offset signals in timing of population expansion between the two species, that are attributed to differential demographic responses to past climate cycling. Mitogenomic structure of polar bears was shallow and developed recently, in contrast to the multiple clades of brown bears. We found no genetic signatures of recent hybridization between the species in our large, circumpolar sample, suggesting that recently observed hybrids represent localized events. Documenting changes in subpopulation connectivity will allow polar nations to proactively adjust conservation actions to continuing decline in sea-ice habitat.	[Peacock, Elizabeth; Sonsthagen, Sarah A.; Sage, George K.; Hope, Andrew G.; Talbot, Sandra L.] US Geol Survey, Alaska Sci Ctr, Anchorage, AK 99508 USA; [Peacock, Elizabeth; Atkinson, Stephen N.] Govt Nunavut, Dept Environm, Igloolik, NU, Canada; [Obbard, Martyn E.] Ontario Minist Nat Resources & Forestry, Peterborough, ON, Canada; [Boltunov, Andrei; Belikov, Stanislav] All Russian Res Inst Nat Protect, Moscow, Russia; [Regehr, Eric V.] US Fish & Wildlife Serv, Anchorage, AK USA; [Ovsyanikov, Nikita] Wrangel Isl State Nat Reserve, Moscow, Russia; [Aars, Jon] Norwegian Polar Res Inst, Tromso, Norway; [Zeyl, Eve; Bachmann, Lutz; Ehrich, Dorothee; Wiig, Oystein] Univ Oslo, Nat Hist Museum, Oslo, Norway; [Scribner, Kim T.] Michigan State Univ, Dept Zool, E Lansing, MI 48824 USA; [Amstrup, Steven C.] Polar Bears Int, Bozeman, MT USA; [Born, Erik W.] Greenland Inst Nat Resources, Copenhagen, Denmark; [Derocher, Andrew E.] Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada; [Stirling, Ian] Environm Canada, Sci & Technol Branch, Edmonton, AB, Canada; [Taylor, Mitchell K.] Lakehead Univ, Fac Sci & Environm Studies, Thunder Bay, ON P7B 5E1, Canada; [Paetkau, David] Wildlife Genet Int, Nelson, BC, Canada	United States Department of the Interior; United States Geological Survey; Ministry of Natural Resources & Forestry; United States Department of the Interior; US Fish & Wildlife Service; Norwegian Polar Institute; University of Oslo; Michigan State University; Greenland Institute of Natural Resources; University of Alberta; Environment & Climate Change Canada; Lakehead University	Peacock, E (corresponding author), US Geol Survey, Alaska Sci Ctr, Anchorage, AK 99508 USA.	lpeacock@usgs.gov	aars, jon/AAB-3076-2021; Wiig, Øystein/AAT-9518-2020; Derocher, Andrew/J-4469-2012; /AAD-5814-2021; Ehrich, Dorothee/F-6492-2015; Belikov, Stanislav/AAU-9597-2021; Wiig, Øystein/J-8383-2012; Obbard, Martyn/AFU-0326-2022	aars, jon/0000-0002-0574-6712; Wiig, Øystein/0000-0003-0395-5251; Derocher, Andrew/0000-0002-1104-7774; /0000-0002-6858-1978; Ehrich, Dorothee/0000-0002-3028-9488; Wiig, Øystein/0000-0003-0395-5251; Obbard, Martyn/0000-0003-2064-0155; Sonsthagen, Sarah/0000-0001-6215-5874	U.S. Geological Survey's Changing Arctic Ecosystem Initiative; Wildlife Program of the USGS Ecosystem Mission Area; US Fish and Wildlife Service; Ontario Ministry of Natural Resources; Toronto Zoo Endangered Species Fund; Government of Nunavut; Nunavut Wildlife Management Board; Makivik Corporation; Polar Continental Shelf Program; Norwegian Polar Institute; World Wildlife Fund; Natural Sciences and Engineering Research Council of Canada; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016466] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103395] Funding Source: NIH RePORTER	U.S. Geological Survey's Changing Arctic Ecosystem Initiative; Wildlife Program of the USGS Ecosystem Mission Area; US Fish and Wildlife Service(US Fish & Wildlife Service); Ontario Ministry of Natural Resources; Toronto Zoo Endangered Species Fund; Government of Nunavut; Nunavut Wildlife Management Board; Makivik Corporation; Polar Continental Shelf Program; Norwegian Polar Institute; World Wildlife Fund; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding for collection and analysis of new samples was provided by the U.S. Geological Survey's Changing Arctic Ecosystem Initiative and is supported by funding from the Wildlife Program of the USGS Ecosystem Mission Area, US Fish and Wildlife Service, Ontario Ministry of Natural Resources, Toronto Zoo Endangered Species Fund, Government of Nunavut, Nunavut Wildlife Management Board, Makivik Corporation, Polar Continental Shelf Program, Norwegian Polar Institute, World Wildlife Fund, and Natural Sciences and Engineering Research Council of Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The author D. Paetkau is an owner of the Canadian company, Wildlife Genetics International. Wildlife Genetics International provided support in the form of salary for author DP, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	Amstrup SC, 2004, WILDLIFE SOC B, V32, P661, DOI 10.2193/0091-7648(2004)032[0661:USRDTD]2.0.CO;2; Amstrup SC, 2001, CAN J ZOOL, V79, P2147, DOI 10.1139/cjz-79-12-2147; Amstrup SC, 2010, NATURE, V468, P955, DOI 10.1038/nature09653; Amstrup SC, 2008, GEOPHYS MONOGR SER, V180, P213, DOI 10.1029/180GM14; Barnes I, 2002, SCIENCE, V295, P2267, DOI 10.1126/science.1067814; Beerli P, 1999, GENETICS, V152, P763; Beerli P, 2001, P NATL ACAD SCI USA, V98, P4563, DOI 10.1073/pnas.081068098; Bidon T, 2014, MOL BIOL EVOL, V31, P1353, DOI 10.1093/molbev/msu109; Cahill JA, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003345; Cherry SG, 2013, J ANIM ECOL, V82, P912, DOI 10.1111/1365-2656.12050; COLONY R, 1984, J GEOPHYS RES-OCEANS, V89, P623, DOI 10.1029/JC089iC06p10623; Corander J, 2006, MOL ECOL, V15, P2833, DOI 10.1111/j.1365-294X.2006.02994.x; Crompton AE, 2008, BIOL CONSERV, V141, P2528, DOI 10.1016/j.biocon.2008.07.018; CRONIN MA, 1991, CAN J ZOOL, V69, P2985, DOI 10.1139/z91-421; Cronin MA, 2014, J HERED, V105, P312, DOI 10.1093/jhered/est133; Cronin MA, 2012, J HERED, V103, P873, DOI 10.1093/jhered/ess090; Davison J, 2011, QUATERNARY SCI REV, V30, P418, DOI 10.1016/j.quascirev.2010.11.023; Dawson NG, 2013, J BIOGEOGR, V40, P415; Derocher AE, 2004, INTEGR COMP BIOL, V44, P163, DOI 10.1093/icb/44.2.163; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Durner GM, 2009, ECOL MONOGR, V79, P25, DOI 10.1890/07-2089.1; Edwards CJ, 2011, CURR BIOL, V21, P1251, DOI 10.1016/j.cub.2011.05.058; Elliot HW, 1875, HARPERS WEEKLY  0501, P1; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; EWENS WJ, 1972, THEOR POPUL BIOL, V3, P87, DOI 10.1016/0040-5809(72)90035-4; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Fu YX, 1997, GENETICS, V147, P915; Gillett NP, 2008, NAT GEOSCI, V1, P750, DOI 10.1038/ngeo338; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; Hailer F, 2013, SCIENCE, V339, DOI 10.1126/science.1228066; Hailer F, 2012, SCIENCE, V336, P344, DOI 10.1126/science.1216424; HARPENDING HC, 1994, HUM BIOL, V66, P591; Heled J, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-289; Hope AG, 2014, EVOLUTION, V68, P2689, DOI 10.1111/evo.12469; Hope AG, 2013, NAT CLIM CHANGE, V3, P931, DOI 10.1038/NCLIMATE1926; Iverson SJ, 2006, CONSERV BIOL SER, P98, DOI 10.1017/CBO9780511541964.008; Jackson JV, 2008, CAN J ZOOL, V86, P756, DOI 10.1139/Z08-043; Kuhner MK, 2006, BIOINFORMATICS, V22, P768, DOI 10.1093/bioinformatics/btk051; Laidre KL, 2012, P BIOL SCI, V280; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lindqvist C, 2010, P NATL ACAD SCI USA, V107, P5053, DOI 10.1073/pnas.0914266107; Liu S, 2014, CELL, V157, P1; Lone K, 2013, POLAR BIOL, V36, P27, DOI 10.1007/s00300-012-1235-y; Lorenzen ED, 2011, NATURE, V479, P359, DOI 10.1038/nature10574; Mauritzen M, 2002, J APPL ECOL, V39, P79, DOI 10.1046/j.1365-2664.2002.00690.x; Meirmans PG, 2006, EVOLUTION, V60, P2399, DOI 10.1111/j.0014-3820.2006.tb01874.x; Miller W, 2012, P NATL ACAD SCI USA, V109, pE2382, DOI 10.1073/pnas.1210506109; Molnar PK, 2010, BIOL CONSERV, V143, P1612, DOI 10.1016/j.biocon.2010.04.004; Mourier T, 2012, MOL BIOL EVOL, V29, P2241, DOI 10.1093/molbev/mss094; Nakagome S, 2013, SCIENCE, V339, DOI 10.1126/science.1227339; Nei M., 1987, MOL EVOLUTIONARY GEN; Obbard M.E., 2010, P 15 WORK M IUCN SSC; Obbard ME, 2012, URSUS, V23, P134, DOI 10.2192/URSUS-D-11-00030.1; Overland JE, 2013, GEOPHYS RES LETT, V40, P2097, DOI 10.1002/grl.50316; Packard AS, 1886, AM NAT, V20, P655; Paetkau D, 1999, MOL ECOL, V8, P1571, DOI 10.1046/j.1365-294x.1999.00733.x; Parks SDE, 2001, TRYPANOTOLERANCE W A; Peacock E, 2011, CAN J ZOOL, V89, P371, DOI [10.1139/z11-021, 10.1139/Z11-021]; Peacock E, 2010, LITTLE LESS ARCTIC: TOP PREDATORS IN THE WORLDS LARGEST NORTHERN INLAND SEA, HUDSON BAY, P93, DOI 10.1007/978-90-481-9121-5_5; Peacock E, 2013, J WILDLIFE MANAGE, V77, P463, DOI 10.1002/jwmg.489; Peacock E, 2012, ARCTIC, V65, P391; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Post E, 2013, SCIENCE, V341, P519, DOI 10.1126/science.1235225; Pritchard JK, 2000, GENETICS, V155, P945; Prost S, 2013, GLOBAL CHANGE BIOL, V19, P1854, DOI 10.1111/gcb.12157; Rausch R., 1954, Murrelet, V34, P18, DOI 10.2307/3535866; Raymond M, 1995, EVOLUTION, V49, P1280, DOI 10.1111/j.1558-5646.1995.tb04456.x; Regehr EV, 2007, J WILDLIFE MANAGE, V71, P2673, DOI 10.2193/2006-180; Regehr EV, 2010, J ANIM ECOL, V79, P117, DOI 10.1111/j.1365-2656.2009.01603.x; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; Rode KD, 2014, GLOBAL CHANGE BIOL, V20, P76, DOI 10.1111/gcb.12339; Rode KD, 2012, POPUL ECOL, V54, P3, DOI 10.1007/s10144-011-0299-9; Rode KD, 2010, ECOL APPL, V20, P768, DOI 10.1890/08-1036.1; ROGERS AR, 1995, EVOLUTION, V49, P608, DOI 10.1111/j.1558-5646.1995.tb02297.x; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; Saarma U, 2007, MOL ECOL, V16, P401, DOI 10.1111/j.1365-294X.2006.03130.x; Sahanatien V, 2012, ANIM CONSERV, V15, P397, DOI 10.1111/j.1469-1795.2012.00529.x; Smith P, 1975, PROGR NOTES, V53; STIRLING I, 1993, ARCTIC, V46, P240; Stirling I, 1999, ARCTIC, V52, P294; Stirling I, 1980, 44 CAN WILDL SERV; Stirling I., 2011, POLAR BEARS NATURAL; Stirling I, 2006, ARCTIC, V59, P261; Stirling I, 2011, ECOL APPL, V21, P859, DOI 10.1890/10-0849.1; Stirling Ian, 1993, Polar Record, V29, P13; Stroeve J, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL029703; Swofford D. L., 2011, PAUP PHYLOGENETIC AN; SWOFFORD DL, 1981, J HERED, V72, P281, DOI 10.1093/oxfordjournals.jhered.a109497; TAJIMA F, 1989, GENETICS, V123, P585; Talbot SL, 1996, MOL PHYLOGENET EVOL, V5, P567, DOI 10.1006/mpev.1996.0051; Talbot SL, 1996, MOL PHYLOGENET EVOL, V5, P477, DOI 10.1006/mpev.1996.0044; TAYLOR M, 1995, ARCTIC, V48, P147; Taylor MK, 2001, CAN J ZOOL, V79, P690, DOI 10.1139/cjz-79-4-690; Thiemann GW, 2008, ORYX, V42, P504, DOI 10.1017/S0030605308001877; Vongraven Dag, 2012, Ursus Monograph Series, V5, P1; WATTERSON GA, 1975, THEOR POPUL BIOL, V7, P256, DOI 10.1016/0040-5809(75)90020-9; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Wilson GA, 2003, GENETICS, V163, P1177; Zeyl E, 2009, MOL ECOL, V18, P735, DOI 10.1111/j.1365-294X.2008.04049.x; Zink RM, 2008, MOL ECOL, V17, P2107, DOI 10.1111/j.1365-294X.2008.03737.x	101	35	36	1	234	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2015	10	1							e112021	10.1371/journal.pone.0112021	http://dx.doi.org/10.1371/journal.pone.0112021			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ3YO	25562525	Green Published, gold, Green Submitted			2022-12-27	WOS:000348160000001
J	Falagas, ME; Karagiannis, AKA; Nakouti, T; Tansarli, GS				Falagas, Matthew E.; Karagiannis, Apostolos K. A.; Nakouti, Theodora; Tansarli, Giannoula S.			Compliance with Once-Daily versus Twice or Thrice-Daily Administration of Antibiotic Regimens: A Meta-Analysis of Randomized Controlled Trials	PLOS ONE			English	Article							ACUTE OTITIS-MEDIA; RESPIRATORY-TRACT INFECTIONS; CLARITHROMYCIN EXTENDED-RELEASE; ACUTE BACTERIAL EXACERBATION; DOUBLE-BLIND; STREPTOCOCCAL PHARYNGITIS; PENICILLIN-V; DAILY AMOXICILLIN; ADULT PATIENTS; DAILY AMOXYCILLIN/CLAVULANATE	Objective To investigate whether compliance of patients to antibiotic treatment is better when antibiotics are administered once than multiple times daily. Methods We performed a systematic search in PubMed and Scopus databases. Only randomized controlled trials were considered eligible for inclusion. Compliance to antibiotic treatment was the outcome of the meta-analysis. Results Twenty-six studies including 8246 patients with upper respiratory tract infections in the vast majority met the inclusion criteria. In total, higher compliance was found among patients treated with once-daily treatment than those receiving treatment twice, thrice or four times daily [5011 patients, RR=1.22 (95% CI, 1.11, 1.34]. Adults receiving an antibiotic once-daily were more compliant than those receiving the same antibiotic multiple times daily [380 patients, RR=1.09 (95% CI, 1.02, 1.16)]. Likewise, children that received an antibiotic twice-daily were more compliant than those receiving the same antibiotic thrice-daily [2118 patients, RR=1.10 (95% CI, 1.02, 1.19)]. Higher compliance was also found among patients receiving an antibiotic once compared to those receiving an antibiotic of different class thrice or four times daily [395 patients, RR=1.20 (95% CI, 1.12, 1.28)]. The finding of better compliance with lower frequency daily was consistent regardless of the study design, and treatment duration. Conclusion This meta-analysis showed that compliance to antibiotic treatment might be associated with higher when an antibiotic is administered once than multiple times daily for the treatment of specific infections and for specific classes of antibiotics.	[Falagas, Matthew E.; Karagiannis, Apostolos K. A.; Nakouti, Theodora; Tansarli, Giannoula S.] Alfa Inst Biomed Sci, Athens, Greece; [Falagas, Matthew E.] Iaso Gen Hosp, Iaso Grp, Dept Internal Med Infect Dis, Athens, Greece; [Falagas, Matthew E.] Tufts Univ, Sch Med, Dept Med, Boston, MA 02111 USA	Alfa Institute Of Biomedical Sciences; Tufts University	Falagas, ME (corresponding author), Alfa Inst Biomed Sci, Athens, Greece.	m.falagas@aibs.gr						Adam D, 2001, Fortschr Med Orig, V119 Suppl 2, P63; ADAM D, 1993, INFECTION, V21, P265, DOI 10.1007/BF01728910; Adler JL, 2000, CLIN THER, V22, P1410, DOI 10.1016/S0149-2918(00)83040-4; Balgos AA, 1999, INT J CLIN PRACT, V53, P325; BALLANTYNE FN, 1985, CLIN THER, V7, P487; Behre U, 1997, INFECTION, V25, P163, DOI 10.1007/BF02113605; Benner JS, 2002, JAMA-J AM MED ASSOC, V288, P455, DOI 10.1001/jama.288.4.455; CALOZA DL, 1978, SCAND J INFECT DIS, V10, P75, DOI 10.3109/inf.1978.10.issue-1.17; Cals JWL, 2008, INT J ANTIMICROB AG, V31, P531, DOI 10.1016/j.ijantimicag.2008.01.029; Campbell JH, 2013, CURR MED RES OPIN, V29, P1201, DOI 10.1185/03007995.2013.815160; CHEUNG R, 1988, BRIT J CLIN PHARMACO, V26, P391, DOI 10.1111/j.1365-2125.1988.tb03396.x; Claxton AJ, 2001, CLIN THER, V23, P1296, DOI 10.1016/S0149-2918(01)80109-0; Clegg HW, 2006, PEDIATR INFECT DIS J, V25, P761, DOI 10.1097/01.inf.0000235678.46805.92; Cohen R, 1996, PEDIATR INFECT DIS J, V15, P678, DOI 10.1097/00006454-199608000-00008; Cook RC, 1996, BRIT J CLIN PRACT, V50, P125; CRAMER JA, 1990, ARCH INTERN MED, V150, P1509, DOI 10.1001/archinte.150.7.1509; Damrikarnlert L, 2000, J CHEMOTHERAPY, V12, P79; De Geest Sabina, 2003, Eur J Cardiovasc Nurs, V2, P323; DEMEYERE M, 1992, EUR J CLIN PHARMACOL, V43, P581, DOI 10.1007/BF02284954; DISNEY F A, 1990, Advances in Therapy, V7, P312; EDELSTEIN DR, 1993, LARYNGOSCOPE, V103, P33; Evon DM, 2013, J VIRAL HEPATITIS, V20, P536, DOI 10.1111/jvh.12079; Falagas ME, 2008, ALIMENT PHARM THERAP, V27, P919, DOI 10.1111/j.1365-2036.2008.03642.x; Falagas ME, 2006, J ANTIMICROB CHEMOTH, V57, P1251, DOI 10.1093/jac/dkl130; Falagas ME, 2010, INT J ANTIMICROB AG, V36, P1, DOI 10.1016/j.ijantimicag.2010.03.020; Feldman SR, 2007, J AM ACAD DERMATOL, V57, P81, DOI 10.1016/j.jaad.2007.04.005; File TM, 2007, J ANTIMICROB CHEMOTH, V60, P112, DOI 10.1093/jac/dkm119; FYLLINGEN G, 1991, SCAND J INFECT DIS, V23, P755, DOI 10.3109/00365549109024304; Garcia Callejo F J, 1998, Acta Otorrinolaringol Esp, V49, P306; GEHANNO P, 1994, SCAND J INFECT DIS, V26, P577, DOI 10.3109/00365549409011816; GERBER MA, 1985, AM J DIS CHILD, V139, P1145, DOI 10.1001/archpedi.1985.02140130083035; GOOCH WM, 1993, ANTIMICROB AGENTS CH, V37, P159, DOI 10.1128/AAC.37.2.159; Gooch WM, 1997, PEDIATR INFECT DIS J, V16, pS21, DOI 10.1097/00006454-199702001-00006; Henry DC, 2003, ANTIMICROB AGENTS CH, V47, P2770, DOI 10.1128/AAC.47.9.2770-2774.2003; HOSIE J, 1995, J ANTIMICROB CHEMOTH, V36, P173, DOI 10.1093/jac/36.1.173; Iskedjian M, 2002, CLIN THER, V24, P302, DOI 10.1016/S0149-2918(02)85026-3; Jin Jing, 2008, Ther Clin Risk Manag, V4, P269; Kardas P, 2007, J ANTIMICROB CHEMOTH, V59, P531, DOI 10.1093/jac/dkl528; Lan AJ, 2000, PEDIATRICS, V105, part. no., DOI 10.1542/peds.105.2.e19; Leenen FHH, 1997, CAN J CARDIOL, V13, P914; Lennon DR, 2008, ARCH DIS CHILD, V93, P474, DOI 10.1136/adc.2006.113506; Lertmaharit Somrat, 2005, J Med Assoc Thai, V88 Suppl 4, pS149; Lieveld FI, 2013, ANN HEPATOL, V12, P380, DOI 10.1016/S1665-2681(19)31000-2; LINDER CW, 1993, CLIN THER, V15, P46; Llor C, 2009, J ANTIMICROB CHEMOTH, V63, P396, DOI 10.1093/jac/dkn472; Llor Carl, 2009, Int J Chron Obstruct Pulmon Dis, V4, P45; Martinot JB, 2001, ADV THER, V18, P1, DOI 10.1007/BF02850246; Mavros MN, 2011, J ANTIMICROB CHEMOTH, V66, P251, DOI 10.1093/jac/dkq451; MITA Y, 2003, KITAKANTO MED J, V53, P251, DOI DOI 10.2974/KMJ.53.251; Murray JJ, 2000, CLIN THER, V22, P1421, DOI 10.1016/S0149-2918(00)83041-6; Nalepa P, 2003, CURR MED RES OPIN, V19, P411, DOI 10.1185/030079903125002018; Osterberg L, 2005, NEW ENGL J MED, V353, P487, DOI 10.1056/NEJMra050100; OWEN MJ, 1993, AM J DIS CHILD, V147, P81, DOI 10.1001/archpedi.1993.02160250083027; Pastor Scott, 2013, Mo Med, V110, P52; Pichichero ME, 1999, ARCH PEDIAT ADOL MED, V153, P565; Pimentel FL, 1998, J CHEMOTHERAPY, V10, P122, DOI 10.1179/joc.1998.10.2.122; Price D, 2010, BMC PULM MED, V10, DOI 10.1186/1471-2466-10-1; RICHARD GA, 1981, REV INFECT DIS, V3, P159; Samonis G, 2012, EUR J CLIN MICROBIOL, V31, P1389, DOI 10.1007/s10096-011-1454-0; Schouenborg P, 2000, J INT MED RES, V28, P101, DOI 10.1177/147323000002800301; SCHUPBACH CW, 1992, CLIN THER, V14, P470; SCLAR DA, 1994, INFECT AGENT DIS, V3, P266; Siempos II, 2010, SHOCK, V33, P590, DOI 10.1097/SHK.0b013e3181cc0418; Takker U, 2003, CURR MED RES OPIN, V19, P421, DOI 10.1185/030079903125002027; Tan X, 2013, AM J CLIN DERMATOL, V14, P243, DOI 10.1007/s40257-013-0016-x; TARPAY MM, 1984, INFECTION, V12, P181, DOI 10.1007/BF01640895; vanBalen FAM, 1996, LANCET, V348, P713, DOI 10.1016/S0140-6736(96)02511-1; Vardakas KZ, 2013, J INFECTION, V66, P401, DOI 10.1016/j.jinf.2012.10.028; Venuta A, 1998, J INT MED RES, V26, P152, DOI 10.1177/030006059802600306; Vrijens B, 2005, J ANTIMICROB CHEMOTH, V55, P616, DOI 10.1093/jac/dki066; Wahl LM, 2000, P ROY SOC B-BIOL SCI, V267, P835, DOI 10.1098/rspb.2000.1079; Yu YF, 2005, VALUE HEALTH, V8, P495, DOI 10.1111/j.1524-4733.2005.00041.x	72	21	22	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2015	10	1							e0116207	10.1371/journal.pone.0116207	http://dx.doi.org/10.1371/journal.pone.0116207			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ3BG	25559848	Green Published, Green Submitted, gold			2022-12-27	WOS:000348102200013
J	Cooper, EA; Garlick, J; Featherstone, E; Voon, V; Singer, T; Critchley, HD; Harrison, NA				Cooper, Ella A.; Garlick, John; Featherstone, Eric; Voon, Valerie; Singer, Tania; Critchley, Hugo D.; Harrison, Neil A.			You Turn Me Cold: Evidence for Temperature Contagion	PLOS ONE			English	Article							SKIN TEMPERATURE; PERIPHERAL TEMPERATURE; INDIVIDUAL-DIFFERENCES; PREMOTOR CORTEX; EMPATHY; PAIN; BIOFEEDBACK; PERCEPTION; OWNERSHIP; NEURONS	Introduction: During social interactions, our own physiological responses influence those of others. Synchronization of physiological (and behavioural) responses can facilitate emotional understanding and group coherence through inter-subjectivity. Here we investigate if observing cues indicating a change in another's body temperature results in a corresponding temperature change in the observer. Methods: Thirty-six healthy participants (age; 22.9+/-3.1 yrs) each observed, then rated, eight purpose-made videos (3 min duration) that depicted actors with either their right or left hand in visibly warm (warm videos) or cold water (cold videos). Four control videos with the actors' hand in front of the water were also shown. Temperature of participant observers' right and left hands was concurrently measured using a thermistor within a Wheatstone bridge with a theoretical temperature sensitivity of <0.0001 degrees C. Temperature data were analysed in a repeated measures ANOVA (temperature 6 actor's hand 6 observer's hand). Results: Participants rated the videos showing hands immersed in cold water as being significantly cooler than hands immersed in warm water, F-(1,F-34)=256.67, p<0.001. Participants' own hands also showed a significant temperature-dependent effect: hands were significantly colder when observing cold vs. warm videos F-(1,F-34)=13.83, p = 0.001 with post-hoc t-test demonstrating a significant reduction in participants' own left (t((35))=-3.54, p=0.001) and right (t((35))=-2.33, p=0.026) hand temperature during observation of cold videos but no change to warm videos (p>0.1). There was however no evidence of left-right mirroring of these temperature effects p>0.1). Sensitivity to temperature contagion was also predicted by inter-individual differences in self-report empathy. Conclusions: We illustrate physiological contagion of temperature in healthy individuals, suggesting that empathetic understanding for primary low-level physiological challenges (as well as more complex emotions) are grounded in somatic simulation.	[Cooper, Ella A.; Critchley, Hugo D.; Harrison, Neil A.] Univ Sussex, Brighton & Sussex Med Sch, Brighton, E Sussex, England; [Garlick, John; Singer, Tania; Critchley, Hugo D.; Harrison, Neil A.] UCL, Inst Cognit Neurosci, London, England; [Featherstone, Eric] UCL, Wellcome Trust Ctr Neuroimaging, London, England; [Voon, Valerie] Univ Cambridge, Behav & Clin Neurosci Inst, Cambridge, England; [Singer, Tania] Max Planck Inst Human Cognit & Brain Sci, Dept Social Neurosci, Leipzig, Germany; [Critchley, Hugo D.; Harrison, Neil A.] Univ Sussex, Sackler Ctr Consciousness Sci, Brighton, E Sussex, England; [Critchley, Hugo D.; Harrison, Neil A.] Sussex Partnership NHS Trust, Brighton, E Sussex, England	University of Brighton; University of Sussex; University of London; University College London; University of London; University College London; University of Cambridge; Max Planck Society; University of Sussex	Harrison, NA (corresponding author), Univ Sussex, Brighton & Sussex Med Sch, Brighton, E Sussex, England.	n.harrison@bsms.ac.uk	Voon, Valerie/O-7038-2017; critchley, hugo d/G-9267-2011	Voon, Valerie/0000-0001-6790-1776; critchley, hugo d/0000-0002-2445-9284; Harrison, Neil/0000-0002-9584-3769	Wellcome Trust Intermediate Clinical Fellowships; European Research Council; Medical Research Council [G1000183B, G0001354B, G0001354] Funding Source: researchfish	Wellcome Trust Intermediate Clinical Fellowships(Wellcome Trust); European Research Council(European Research Council (ERC)European Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by Wellcome Trust Intermediate Clinical Fellowships awarded to NAH; Wellcome Trust Intermediate Clinical Fellowships awarded to VV; and European Research Council support to HDC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrew D, 2001, J PHYSIOL-LONDON, V537, P489, DOI 10.1111/j.1469-7793.2001.00489.x; Blakemore SJ, 2005, BRAIN, V128, P1571, DOI 10.1093/brain/awh500; Chartrand TL, 1999, J PERS SOC PSYCHOL, V76, P893, DOI 10.1037/0022-3514.76.6.893; Chong TW, 2004, SCHIZOPHR RES, V69, P149, DOI 10.1016/S0920-9964(03)00222-6; Craig AD, 2002, NAT REV NEUROSCI, V3, P655, DOI 10.1038/nrn894; Craig AD, 2001, J NEUROPHYSIOL, V86, P1459, DOI 10.1152/jn.2001.86.3.1459; Craig AD, 2000, NAT NEUROSCI, V3, P184, DOI 10.1038/72131; Critchley HD, 2013, NEURON, V77, P624, DOI 10.1016/j.neuron.2013.02.008; Davis M. H, 1980, MULTIDIMENSIONAL APP; DAVIS MH, 1983, J PERS SOC PSYCHOL, V44, P113, DOI 10.1037/0022-3514.44.1.113; de Vignemont F, 2006, TRENDS COGN SCI, V10, P435, DOI 10.1016/j.tics.2006.08.008; Loarte MD, 2009, J NEUROL, V256, P127, DOI 10.1007/s00415-009-0821-6; DIKEL W, 1980, PEDIATRICS, V66, P335; DIMASCIO A, 1957, PSYCHOSOM MED, V19, P99, DOI 10.1097/00006842-195703000-00002; Dimberg U, 2000, PSYCHOL SCI, V11, P86, DOI 10.1111/1467-9280.00221; DIPELLEGRINO G, 1992, EXP BRAIN RES, V91, P176, DOI 10.1007/BF00230027; DUGAN M, 1976, PERCEPT MOTOR SKILL, V42, P14, DOI 10.2466/pms.1976.42.1.14; Ebisch SJ, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00060; Ebisch SJ, 2012, BIOL PSYCHOL, V89, P123, DOI 10.1016/j.biopsycho.2011.09.018; Ebisch SJH, 2008, J COGNITIVE NEUROSCI, V20, P1611, DOI 10.1162/jocn.2008.20111; Ehrsson HH, 2004, SCIENCE, V305, P875, DOI 10.1126/science.1097011; EKMAN P, 1983, SCIENCE, V221, P1208, DOI 10.1126/science.6612338; Engert V, 2014, PSYCHONEUROENDOCRINO, V45, P192, DOI 10.1016/j.psyneuen.2014.04.005; Fan Y, 2011, NEUROSCI BIOBEHAV R, V35, P903, DOI 10.1016/j.neubiorev.2010.10.009; Hadfield JA, 1920, LANCET, V2, P68; Harrison NA, 2007, EMOTION, V7, P724, DOI 10.1037/1528-3542.7.4.724; Harrison NA, 2006, SOC COGN AFFECT NEUR, V1, P5, DOI 10.1093/scan/nsl006; Hatfield E., 1994, REV PERSONALITY SOCI; HORI T, 1986, BRAIN RES BULL, V17, P75, DOI 10.1016/0361-9230(86)90163-2; Jabbi M, 2007, NEUROIMAGE, V34, P1744, DOI 10.1016/j.neuroimage.2006.10.032; JACOBSON AM, 1979, AM J PSYCHIAT, V136, P844; JACOBSON AM, 1973, JAMA-J AM MED ASSOC, V225, P739, DOI 10.1001/jama.225.7.739; Janowski V, 2013, SOC COGN AFFECT NEUR, V8, P201, DOI 10.1093/scan/nsr086; Keefe F J, 1978, J Behav Med, V1, P383, DOI 10.1007/BF00846694; KENDON A, 1970, ACTA PSYCHOL, V32, P100; Keysers C, 2004, NEURON, V42, P335, DOI 10.1016/S0896-6273(04)00156-4; KING NJ, 1980, PSYCHOL BULL, V88, P738; KING NJ, 1980, BIOL PSYCHOL, V10, P139, DOI 10.1016/0301-0511(80)90034-4; Lamm C, 2011, NEUROIMAGE, V54, P2492, DOI 10.1016/j.neuroimage.2010.10.014; MASLACH C, 1972, PSYCHOPHYSIOLOGY, V9, P600, DOI 10.1111/j.1469-8986.1972.tb00769.x; Matarazzo J.D., 1972, INTERVIEW RES ITS AN; McAllen RM, 2010, EUR J APPL PHYSIOL, V109, P27, DOI 10.1007/s00421-009-1295-z; Mehrabian A, 1997, J PSYCHOL, V131, P101, DOI 10.1080/00223989709603508; Mobbs D, 2009, SCIENCE, V324, P900, DOI 10.1126/science.1170539; Morrison I, 2004, COGN AFFECT BEHAV NE, V4, P270, DOI 10.3758/CABN.4.2.270; Moseley GL, 2008, P NATL ACAD SCI USA, V105, P13169, DOI 10.1073/pnas.0803768105; Moseley GL, 2012, BRAIN, V135, P3676, DOI 10.1093/brain/aws297; Nakamura K, 2011, AM J PHYSIOL-REG I, V301, pR1207, DOI 10.1152/ajpregu.00109.2011; Nakamura K, 2010, P NATL ACAD SCI USA, V107, P8848, DOI 10.1073/pnas.0913358107; Nakayama K, 2005, PHYSIOL BEHAV, V84, P783, DOI 10.1016/j.physbeh.2005.03.009; Ootsuka Y, 2006, AM J PHYSIOL-REG I, V291, pR589, DOI 10.1152/ajpregu.00850.2005; Preston SD, 2002, BEHAV BRAIN SCI, V25, P1, DOI 10.1017/S0140525X02000018; Prinz W, 1997, EUR J COGN PSYCHOL, V9, P129, DOI 10.1080/713752551; Rizzolatti G, 1996, COGNITIVE BRAIN RES, V3, P131, DOI 10.1016/0926-6410(95)00038-0; ROBERTS AH, 1973, J ABNORM PSYCHOL, V82, P163, DOI 10.1037/h0034852; ROBERTS AH, 1975, J ABNORM PSYCHOL, V84, P272, DOI 10.1037/h0076655; Salomon R, 2013, FRONT BEHAV NEUROSCI, V7, DOI 10.3389/fnbeh.2013.00065; Satoshi T, 2000, J KYORIN MED SOC, V31, P357; Silani G, 2013, J NEUROSCI, V33, P15466, DOI 10.1523/JNEUROSCI.1488-13.2013; Singer T, 2004, SCIENCE, V303, P1157, DOI 10.1126/science.1093535; Sonnby-Borgstrom M, 2002, SCAND J PSYCHOL, V43, P433, DOI 10.1111/1467-9450.00312; TAUB E, 1976, BIOFEEDBACK SELF-REG, V1, P147, DOI 10.1007/BF00998583; Wicker B, 2003, NEURON, V40, P655, DOI 10.1016/S0896-6273(03)00679-2; Wigley FM, 2000, ARCH INTERN MED, V160, P1101	64	13	13	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2014	9	12							e116126	10.1371/journal.pone.0116126	http://dx.doi.org/10.1371/journal.pone.0116126			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AX7UC	25551826	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000347119100097
J	Lapi, D; Federighi, G; Fantozzi, MP; del Seppia, C; Ghione, S; Colantuoni, A; Scuri, R				Lapi, Dominga; Federighi, Giuseppe; Fantozzi, M. Paola; del Seppia, Cristina; Ghione, Sergio; Colantuoni, Antonio; Scuri, Rossana			Trigeminocardiac Reflex by Mandibular Extension on Rat Pial Microcirculation: Role of Nitric Oxide	PLOS ONE			English	Article							CEREBRAL-BLOOD-FLOW; CARDIAC REFLEX; ELECTRICAL-STIMULATION; KNOWLEDGE; MODEL	In the present study we have extended our previous findings about the effects of 10 minutes of passive mandibular extension in anesthetized Wistar rats. By prolonging the observation time to 3 hours, we showed that 10 minutes mandibular extension caused a significant reduction of the mean arterial blood pressure and heart rate respect to baseline values, which persisted up to 160 minutes after mandibular extension. These effects were accompanied by a characteristic biphasic response of pial arterioles: during mandibular extension, pial arterioles constricted and after mandibular extension dilated for the whole observation period. Interestingly, the administration of the opioid receptor antagonist naloxone abolished the vasoconstriction observed during mandibular extension, while the administration of N-omega-Nitro-L-arginine methyl ester, a nitric oxide synthase inhibitor, abolished the vasodilation observed after mandibular extension. Either drug did not affect the reduction of mean arterial blood pressure and heart rate induced by mandibular extension. By qRT-PCR, we also showed that neuronal nitric oxide synthase gene expression was significantly increased compared with baseline conditions during and after mandibular extension and endothelial nitric oxide synthase gene expression markedly increased at 2 hours after mandibular extension. Finally, western blotting detected a significant increase in neuronal and endothelial nitric oxide synthase protein expression. In conclusion mandibular extension caused complex effects on pial microcirculation involving opioid receptor activation and nitric oxide release by both neurons and endothelial vascular cells at different times.	[Lapi, Dominga; Colantuoni, Antonio] Univ Naples Federico II, Sch Med, Dept Clin Med & Surg, Naples, Italy; [Federighi, Giuseppe; Fantozzi, M. Paola; Scuri, Rossana] Univ Pisa, Dept Translat Res New Technol Med & Surg, Pisa, Italy; [del Seppia, Cristina; Ghione, Sergio] Natl Council Res CNR, Inst Clin Physiol, Pisa, Italy; [Ghione, Sergio] Fdn Toscana Gabriele Monasterio Med & Publ Hlth R, Pisa, Italy	University of Naples Federico II; University of Pisa; Consiglio Nazionale delle Ricerche (CNR); Istituto di Fisiologia Clinica (IFC-CNR)	Scuri, R (corresponding author), Univ Pisa, Dept Translat Res New Technol Med & Surg, Pisa, Italy.	r.scuri@dsf.unipi.it	Tramonti Fantozzi, Maria Paola/AAB-5912-2022	Tramonti Fantozzi, Maria Paola/0000-0001-5146-4997; Colantuoni, Antonio/0000-0003-1152-5630; DELSEPPIA, CRISTINA/0000-0001-7459-8680	ATENEO Pisa	ATENEO Pisa	This work was supported by a grant from ATENEO Pisa, 2013-14. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alderton WK, 2001, BIOCHEM J, V357, P593, DOI 10.1042/0264-6021:3570593; Atochin DN, 2011, CURR PHARM BIOTECHNO, V12, P1334; Brunelli M, 2012, ARCH ITAL BIOL, V150, P231, DOI 10.4449/aib.v150i4.1420; Capuano A, 2010, NEUROPHARMACOLOGY, V58, P784, DOI 10.1016/j.neuropharm.2009.12.012; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; Cornelius JF, 2010, EXPERT REV CARDIOVAS, V8, P895, DOI [10.1586/erc.10.74, 10.1586/ERC.10.74]; FLORENCE G, 1992, J CEREBR BLOOD F MET, V12, P674, DOI 10.1038/jcbfm.1992.92; Gong L, 2004, CURR OPIN HEMATOL, V11, P7, DOI 10.1097/00062752-200401000-00003; KASSAB GS, 1993, AM J PHYSIOL, V265, pH350, DOI 10.1152/ajpheart.1993.265.1.H350; KUMADA M, 1977, BRAIN RES, V119, P305, DOI 10.1016/0006-8993(77)90313-4; Lambert GA, 1997, CLIN EXP PHARMACOL P, V24, P377, DOI 10.1111/j.1440-1681.1997.tb01206.x; Lapi D, 2008, J VASC RES, V45, P69, DOI 10.1159/000109078; Lapi D, 2013, ARCH ITAL BIOL, V151, P11, DOI 10.4449/aib.v151i1.1470; Lee H, 2013, ANESTHESIOLOGY, V64, P257; Lindauer U, 1999, AM J PHYSIOL-HEART C, V277, pH799, DOI 10.1152/ajpheart.1999.277.2.H799; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; McCulloch PF, 1999, BRAIN RES, V830, P24, DOI 10.1016/S0006-8993(99)01374-8; Mchedlishvili G I, 1980, Usp Fiziol Nauk, V11, P3; Moncada S, 2006, J NEUROCHEM, V97, P1676, DOI 10.1111/j.1471-4159.2006.03988.x; NGAI AC, 1988, AM J PHYSIOL, V254, pH133, DOI 10.1152/ajpheart.1988.254.1.H133; Oriji GK, 1999, PROSTAG LEUKOTR ESS, V61, P45, DOI 10.1054/plef.1999.0072; Samdani AF, 1997, STROKE, V28, P1283, DOI 10.1161/01.STR.28.6.1283; Sandu N, 2010, THESCIENTIFICWORLDJO, V10, P1416, DOI 10.1100/tsw.2010.136; Sandu N, 2010, THESCIENTIFICWORLDJO, V10, P811, DOI 10.1100/tsw.2010.71; Sandu N, 2010, ARCH MED SCI, V6, P138, DOI 10.5114/aoms.2010.13523; Schaller B, 2004, J NEUROL, V251, P658, DOI 10.1007/s00415-004-0458-4; Schaller B, 2009, ACTA NEUROCHIR, V151, P1727, DOI 10.1007/s00701-009-0390-6; Schaller B, 2009, J NEUROSURG ANESTH, V21, P187, DOI 10.1097/ANA.0b013e3181a2bf22; Schaller BJ, 2007, J NEUROSURG, V107, P243, DOI 10.3171/JNS-07/07/0243; Toda N, 2009, PHARMACOL REV, V61, P62, DOI 10.1124/pr.108.000547; WEIJS WA, 1975, J MORPHOL, V146, P1, DOI 10.1002/jmor.1051460102	31	13	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2014	9	12							e115767	10.1371/journal.pone.0115767	http://dx.doi.org/10.1371/journal.pone.0115767			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UC	25551566	Green Published, Green Submitted, gold			2022-12-27	WOS:000347119100060
J	Pei, HJ; Wu, YJ; Wei, YJ; Yang, YJ; Teng, SY; Zhang, HT				Pei, Hanjun; Wu, Yongjian; Wei, Yingjie; Yang, Yuejin; Teng, Siyong; Zhang, Haitao			Remote Ischemic Preconditioning Reduces Perioperative Cardiac and Renal Events in Patients Undergoing Elective Coronary Intervention: A Meta-Analysis of 11 Randomized Trials	PLOS ONE			English	Article							ACUTE KIDNEY INJURY; ACUTE MYOCARDIAL-INFARCTION; INDUCED NEPHROPATHY; CARDIOPROTECTION; IMPACT; PREVENTION; PROTECTION; STENT; SIZE; ATORVASTATIN	Background: Results from randomized controlled trials (RCT) concerning cardiac and renal effect of remote ischemic preconditioning(RIPC) in patients with stable coronary artery disease(CAD) are inconsistent. The aim of this study was to explore whether RIPC reduce cardiac and renal events after elective percutaneous coronary intervention (PCI). Methods and Results: RCTs with data on cardiac or renal effect of RIPC in PCI were searched from Pubmed, EMBase, and Cochrane library (up to July 2014). Meta-regression and subgroup analysis were performed to identify the potential sources of significant heterogeneity(I-2 >= 40%). Eleven RCTs enrolling a total of 1713 study subjects with stable CAD were selected. Compared with controls, RIPC significantly reduced perioperative incidence of myocardial infarction (MI) [odds ratio(OR) =0.68; 95% CI, 0.51 to 0.91; P=0.01; I(2=)41.0%] and contrast-induced acute kidney injury(AKI) (OR=0.61; 95% CI, 0.38 to 0.98; P=0.04; I-2=39.0%). Meta-regression and subgroup analyses confirmed that the major source of heterogeneity for the incidence of MI was male proportion (coefficient =-0.049; P=0.047; adjusted R-2=0.988; P=0.02 for subgroup difference). Conclusions: The present meta-analysis of RCTs suggests that RIPC may offer cardiorenal protection by reducing the incidence of MI and AKI in patients undergoing elective PCI. Moreover, this effect on MI is more pronounced in male subjects. Future high-quality, large-scale clinical trials should focus on the long-term clinical effect of RIPC.	[Pei, Hanjun; Wu, Yongjian; Yang, Yuejin; Teng, Siyong; Zhang, Haitao] Chinese Acad Med Sci, Natl Ctr Cardiovasc Dis, Fuwai Hosp, Dept Cardiol, Beijing 100037, Peoples R China; [Pei, Hanjun; Wu, Yongjian; Wei, Yingjie; Yang, Yuejin; Teng, Siyong; Zhang, Haitao] Peking Union Med Coll, Beijing 100037, Peoples R China; [Wei, Yingjie] Chinese Acad Med Sci, Natl Ctr Cardiovasc Dis, State Key Lab Cardiovasc Dis, Beijing 100037, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS	Wu, YJ (corresponding author), Chinese Acad Med Sci, Natl Ctr Cardiovasc Dis, Fuwai Hosp, Dept Cardiol, Beijing 100037, Peoples R China.	wuyongjianfw@sina.com; weiyingjiefw@sina.com		Wu, Yongjian/0000-0002-5590-8396	Capital Medical Development Foundation [2009-1007]	Capital Medical Development Foundation	This research was supported by the Capital Medical Development Foundation (2009-1007). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed RM, 2013, CATHETER CARDIO INTE, V82, pE647, DOI 10.1002/ccd.24825; Boengler K, 2009, CARDIOVASC RES, V83, P247, DOI 10.1093/cvr/cvp033; Botker HE, 2010, LANCET, V375, P727, DOI 10.1016/S0140-6736(09)62001-8; Carrasco-Chinchilla F, 2013, HEART, V99, P1431, DOI 10.1136/heartjnl-2013-304172; Crisostomo PR, 2006, J SURG RES, V134, P342, DOI 10.1016/j.jss.2006.01.030; Deftereos S, 2013, J AM COLL CARDIOL, V61, P1949, DOI 10.1016/j.jacc.2013.02.023; Er F, 2012, CIRCULATION, V126, P296, DOI 10.1161/CIRCULATIONAHA.112.096370; Fan Y, 2013, CARDIOVASC THER, V31, P187, DOI 10.1111/j.1755-5922.2012.00318.x; Ferdinandy P, 2007, PHARMACOL REV, V59, P418, DOI 10.1124/pr.107.06002; Ghaemian Ali, 2012, Asian Cardiovasc Thorac Ann, V20, P548, DOI 10.1177/0218492312439999; Heusch G, 2013, LANCET, V381, P166, DOI 10.1016/S0140-6736(12)60916-7; Heusch G, 2012, EUR HEART J, V33, P13, DOI 10.1093/eurheartj/ehr341; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hoole SP, 2009, CIRCULATION, V119, P820, DOI 10.1161/CIRCULATIONAHA.108.809723; Igarashi G, 2013, CIRC J IN PRESS; Igarashi G, 2013, CIRC J, V77, P3037, DOI 10.1253/circj.CJ-13-0171; Iliodromitis EK, 2006, HEART, V92, P1821, DOI 10.1136/hrt.2006.089060; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; Kanoria S, 2007, TRANSPLANTATION, V84, P445, DOI 10.1097/01.tp.0000228235.55419.e8; Kay J, 2003, JAMA-J AM MED ASSOC, V289, P553, DOI 10.1001/jama.289.5.553; Lavi S, 2014, CIRC CARDIO IN PRESS; Leonardi S, 2012, J AM COLL CARDIOL, V60, P2296, DOI 10.1016/j.jacc.2012.09.005; Lindsey JB, 2009, JACC-CARDIOVASC INTE, V2, P1074, DOI 10.1016/j.jcin.2009.09.002; Lonborg J, 2010, CIRC-CARDIOVASC INTE, V3, P34, DOI 10.1161/CIRCINTERVENTIONS.109.905521; Loukogeorgakis SP, 2005, J AM COLL CARDIOL, V46, P450, DOI 10.1016/j.jacc.2005.04.044; Luo SJ, 2013, CAN J CARDIOL, V29, P1084, DOI 10.1016/j.cjca.2012.11.022; Luo WJ, 2008, EUR J CARDIO-THORAC, V33, P203, DOI 10.1016/j.ejcts.2007.11.010; Mehran R, 2004, J AM COLL CARDIOL, V44, P1393, DOI 10.1016/j.jacc.2004.06.068; Melo RMV, 2013, EUR HEART J, V34, P1009; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Munk K, 2010, CIRC-CARDIOVASC IMAG, V3, P656, DOI 10.1161/CIRCIMAGING.110.957340; Penna C, 2009, BASIC RES CARDIOL, V104, P390, DOI 10.1007/s00395-008-0762-8; Prasad A, 2013, CATHETER CARDIO INTE, V81, P930, DOI 10.1002/ccd.24443; PRZYKLENK K, 1993, CIRCULATION, V87, P893, DOI 10.1161/01.CIR.87.3.893; Quintavalle C, 2012, CIRCULATION, V126, P3008, DOI 10.1161/CIRCULATIONAHA.112.103317; Thuny F, 2012, J AM COLL CARDIOL, V59, P2175, DOI 10.1016/j.jacc.2012.03.026; Thygesen K, 2007, CIRCULATION, V116, P2634, DOI 10.1161/CIRCULATIONAHA.107.187397; Wi J, 2011, HEART, V97, P1753, DOI 10.1136/hrt.2010.218677; Wong PCY, 2012, INT J CARDIOL, V158, P186, DOI 10.1016/j.ijcard.2011.06.115; Xin P, 2010, AM J PHYSIOL-HEART C, V298, pH1819, DOI 10.1152/ajpheart.01102.2009; Xu X, 2013, ANGIOLOGY IN PRESS; Yellon DM, 2007, NEW ENGL J MED, V357, P1121, DOI 10.1056/NEJMra071667; Zhou CH, 2013, J CARDIOTHOR VASC AN, V27, P305, DOI 10.1053/j.jvca.2012.09.028; Zhou CH, 2012, EUR HEART J, V33, P3070, DOI 10.1093/eurheartj/ehs265; Zimmerman RF, 2011, KIDNEY INT, V80, P861, DOI 10.1038/ki.2011.156	45	43	48	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2014	9	12							e115500	10.1371/journal.pone.0115500	http://dx.doi.org/10.1371/journal.pone.0115500			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UC	25551671	Green Submitted, Green Published, gold			2022-12-27	WOS:000347119100041
J	Protopopova, A; Mehrkam, LR; Boggess, MM; Wynne, CDL				Protopopova, Alexandra; Mehrkam, Lindsay Renee; Boggess, May Meredith; Wynne, Clive David Lawrence			In-Kennel Behavior Predicts Length of Stay in Shelter Dogs	PLOS ONE			English	Article							ENVIRONMENTAL ENRICHMENT; HOUSING CONDITIONS; ADOPTION SUCCESS; DOMESTIC DOGS; INDICATORS; WELFARE; NOISE	Previous empirical evaluations of training programs aimed at improving dog adoption rates assume that dogs exhibiting certain behaviors are more adoptable. However, no systematic data are available to indicate that the spontaneous behavior of shelter dogs has an effect on adopter preference. The aim of the present study was to determine whether any behaviors that dogs exhibit spontaneously in the presence of potential adopters were associated with the dogs' length of stay in the shelter. A sample of 289 dogs was videotaped for 1 min daily throughout their stay at a county shelter. To account for differences in adopter behavior, experimenters varied from solitary passive observers to pairs of interactive observers. Dogs behaved more attentively to active observers. To account for adopter preference for morphology, dogs were divided into "morphologically preferred" and "non-preferred" groups. Morphologically preferred dogs were small, long coated, ratters, herders, and lap dogs. No theoretically significant differences in behavior were observed between the two different dog morphologies. When accounting for morphological preference, three behaviors were found to have a significant effect on length of stay in all dogs: leaning or rubbing on the enclosure wall (increased median length of stay by 30 days), facing away from the front of the enclosure (increased by 15 days), and standing (increased by 7 days). When combinations of behaviors were assessed, back and forth motion was found to predict a longer stay (increased by 24 days). No consistent behavioral changes were observed due to time spent at the shelter. These findings will allow shelters to focus behavioral modification efforts only on behaviors likely to influence adopters' choices.	[Protopopova, Alexandra; Mehrkam, Lindsay Renee] Univ Florida, Dept Psychol, Gainesville, FL 32611 USA; [Boggess, May Meredith] Arizona State Univ, Sch Math & Stat Sci, Tempe, AZ 85281 USA; [Boggess, May Meredith] Univ Newcastle, Fac Hlth & Med, Callaghan, NSW 2308, Australia; [Wynne, Clive David Lawrence] Arizona State Univ, Dept Psychol, Tempe, AZ 85281 USA	State University System of Florida; University of Florida; Arizona State University; Arizona State University-Tempe; University of Newcastle; Arizona State University; Arizona State University-Tempe	Protopopova, A (corresponding author), Univ Florida, Dept Psychol, Room 114,Psychol Bldg,POB 112250, Gainesville, FL 32611 USA.	aprotopo@ufl.edu						Beerda B, 2000, ANIM WELFARE, V9, P49; Bollen K, 2012, ORAL PRESENTATION AT; Braun G., 2011, J VET BEHAV, V6, P100, DOI [DOI 10.1016/J.JVEB.2010.08.004, https://doi.org/10.1016/j.jveb.2010.08.004]; Brown WP, 2013, J APPL ANIM WELF SCI, V16, P2, DOI 10.1080/10888705.2013.740967; Clevenger J, 2003, J VET MED EDUC, V30, P372, DOI 10.3138/jvme.30.4.372; Coppola Crista L., 2006, Journal of Applied Animal Welfare Science, V9, P1, DOI 10.1207/s15327604jaws0901_1; Fox MW, 1978, THE DOG ITS DOMESTIC; Graham L, 2005, APPL ANIM BEHAV SCI, V91, P143, DOI 10.1016/j.applanim.2004.08.024; Herron ME, 2014, JAVMA-J AM VET MED A, V244, P687, DOI 10.2460/javma.244.6.687; HETTS S, 1992, APPL ANIM BEHAV SCI, V34, P137, DOI 10.1016/S0168-1591(05)80063-2; HUBRECHT RC, 1992, APPL ANIM BEHAV SCI, V34, P365, DOI 10.1016/S0168-1591(05)80096-6; Lepper Merry, 2002, Journal of Applied Animal Welfare Science, V5, P29, DOI 10.1207/S15327604JAWS0501_3; Lord K, 2012, POSTER SESSION PRESE; LORE RK, 1986, APPL ANIM BEHAV SCI, V15, P261, DOI 10.1016/0168-1591(86)90096-1; Luescher AU, 2009, APPL ANIM BEHAV SCI, V117, P63, DOI 10.1016/j.applanim.2008.11.001; LUESCHER UA, 1993, CAN VET J, V34, P368; Mehrkam LR, 2014, APPL ANIM BEHAV SCI, V155, P12, DOI 10.1016/j.applanim.2014.03.005; Protopopova A, 2014, APPL ANIM BEHAV SCI, V157, P109, DOI 10.1016/j.applanim.2014.04.007; Protopopova A, 2012, APPL ANIM BEHAV SCI, V142, P61, DOI 10.1016/j.applanim.2012.09.009; Rehn T, 2011, APPL ANIM BEHAV SCI, V129, P129, DOI 10.1016/j.applanim.2010.11.015; Rozin P, 2001, PERS SOC PSYCHOL REV, V5, P296, DOI 10.1207/S15327957PSPR0504_2; Sales G, 1997, APPL ANIM BEHAV SCI, V52, P321, DOI 10.1016/S0168-1591(96)01132-X; Schipper LL, 2008, APPL ANIM BEHAV SCI, V114, P182, DOI 10.1016/j.applanim.2008.01.001; Stephen Jacqueline M., 2005, Journal of Applied Animal Welfare Science, V8, P79, DOI 10.1207/s15327604jaws0802_1; The American Society for the Prevention of Cruelty to Animals, 2011, PET STATISTICS; Vas J, 2005, APPL ANIM BEHAV SCI, V94, P99, DOI 10.1016/j.applanim.2005.02.001; Voith VL, 2009, J APPL ANIM WELF SCI, V12, P253, DOI 10.1080/10888700902956151; Waller BM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082686; Weiss E., 2012, ANIMALS, V2, P1; Wells D, 1992, ANIM WELFARE, V1, P171; Wells DL, 1999, APPL ANIM BEHAV SCI, V61, P341, DOI 10.1016/S0168-1591(98)00202-0; Wells DL, 2004, APPL ANIM BEHAV SCI, V85, P307, DOI 10.1016/j.applanim.2003.11.005; Wells DL, 2001, ANTHROZOOS, V14, P12, DOI 10.2752/089279301786999661	33	38	38	1	82	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2014	9	12							e114319	10.1371/journal.pone.0114319	http://dx.doi.org/10.1371/journal.pone.0114319			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UC	25551460	Green Published, gold			2022-12-27	WOS:000347119100010
J	Rishworth, GM; Tremblay, Y; Green, DB; Connan, M; Pistorius, PA				Rishworth, Gavin M.; Tremblay, Yann; Green, David B.; Connan, Maelle; Pistorius, Pierre A.			Drivers of Time-Activity Budget Variability during Breeding in a Pelagic Seabird	PLOS ONE			English	Article							INTRA-SPECIFIC COMPETITION; GANNETS MORUS-CAPENSIS; FORAGING BEHAVIOR; PROVISIONING BEHAVIOR; MONOMORPHIC SEABIRD; WANDERING ALBATROSSES; BIRD ISLAND; FOOD; COLONY; ALLOCATION	During breeding, animal behaviour is particularly sensitive to environmental and food resource availability. Additionally, factors such as sex, body condition, and offspring developmental stage can influence behaviour. Amongst seabirds, behaviour is generally predictably affected by local foraging conditions and has therefore been suggested as a potentially useful proxy to indicate prey state. However, besides prey availability and distribution, a range of other variables also influence seabird behavior, and these need to be accounted for to increase the signal-to-noise ratio when assessing specific characteristics of the environment based on behavioural attributes. The aim of this study was to use continuous, fine-scale time-activity budget data from a pelagic seabird (Cape gannet, Morus capensis) to determine the influence of intrinsic (sex and body condition) and extrinsic (offspring and time) variables on parent behaviour during breeding. Foraging trip duration and chick provisioning rates were clearly sex-specific and associated with chick developmental stage. Females made fewer, longer foraging trips and spent less time at the nest during chick provisioning. These sex-specific differences became increasingly apparent with chick development. Additionally, parents in better body condition spent longer periods at their nests and those which returned later in the day had longer overall nest attendance bouts. Using recent technological advances, this study provides new insights into the foraging behaviour of breeding seabirds, particularly during the post-guarding phase. The biparental strategy of chick provisioning revealed in this study appears to be an example where the costs of egg development to the female are balanced by paternal-dominated chick provisioning particularly as the chick nears fledging.	[Rishworth, Gavin M.; Green, David B.; Connan, Maelle; Pistorius, Pierre A.] Nelson Mandela Metropolitan Univ, Dept Zool, Percy FitzPatrick Inst, DST NRF Ctr Excellence, Summerstrand, South Africa; [Tremblay, Yann] Ctr Rech Halieut Mediterraneenne & Trop, UMR EME Exploited Marine Ecosyst 212, Inst Rech Dev, Sete, France; [Tremblay, Yann] Inst Mar Peru IMARPE, Chucuito Callao, Peru	National Research Foundation - South Africa; Nelson Mandela University; Ifremer; Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; Instituto del Mar del Peru	Rishworth, GM (corresponding author), Nelson Mandela Metropolitan Univ, Dept Zool, Percy FitzPatrick Inst, DST NRF Ctr Excellence, Summerstrand, South Africa.	gavin.rishworth@gmail.com	Green, David/U-5570-2019	Green, David/0000-0002-0346-3129; Connan, Maelle/0000-0002-1308-9118; Tremblay, Yann/0000-0002-4653-9269; Pistorius, Pierre/0000-0001-6561-7069	National Research Foundation (NRF) of South Africa	National Research Foundation (NRF) of South Africa(National Research Foundation - South Africa)	This research was funded by the National Research Foundation (NRF) of South Africa, who also provided a bursary to GMR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS NJ, 1991, MAR ECOL PROG SER, V70, P1, DOI 10.3354/meps070001; BATCHELOR AL, 1984, OSTRICH, V55, P45, DOI 10.1080/00306525.1984.9634757; BELL G, 1980, AM NAT, V116, P45, DOI 10.1086/283611; Bijleveld AI, 2009, BEHAV ECOL, V20, P736, DOI 10.1093/beheco/arp054; Bolnick DI, 2003, AM NAT, V161, P1, DOI 10.1086/343878; Burger A.E., 1990, Studies in Avian Biology, P71; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; CAIRNS D K, 1987, Biological Oceanography, V5, P261; CAIRNS DK, 1987, AUK, V104, P218, DOI 10.1093/auk/104.2.218; Carey MJ, 2009, NEW ZEAL J ZOOL, V36, P367, DOI 10.1080/03014220909510161; Catry P., 2006, SEXUAL SEGREGATION V, P351, DOI DOI 10.1017/CBO9780511525629.019; Clutton-Brock T, 2010, TRENDS ECOL EVOL, V25, P562, DOI 10.1016/j.tree.2010.08.002; Crawford RJM, 2007, ICES J MAR SCI, V64, P169, DOI 10.1093/icesjms/fsl011; Cuthill Innes C., 1997, P97; Dall'Antonia L, 2001, CONDOR, V103, P469, DOI 10.1650/0010-5422(2001)103[0469:TAAFPO]2.0.CO;2; Durant JM, 2009, CLIM RES, V39, P115, DOI 10.3354/cr00798; Elliott KH, 2010, BEHAV ECOL, V21, P1024, DOI 10.1093/beheco/arq076; FURNESS RW, 1984, NATURE, V311, P655, DOI 10.1038/311655a0; Garthe S, 2003, CAN J ZOOL, V81, P453, DOI 10.1139/Z03-027; Gremillet D, 2004, MAR ECOL PROG SER, V268, P265, DOI 10.3354/meps268265; Gremillet D, 2010, ECOL APPL, V20, P1498, DOI 10.1890/09-1586.1; Harding AMA, 2004, IBIS, V146, P642, DOI 10.1111/j.1474-919x.2004.00297.x; HATCH SA, 1990, ORNIS SCAND, V21, P89, DOI 10.2307/3676803; Jarvis MJF, 1971, ETHOLOGY ECOLOGY S A; Jonsson KI, 1997, OIKOS, V78, P57, DOI 10.2307/3545800; Kadin M, 2012, MAR ECOL PROG SER, V444, P239, DOI 10.3354/meps09417; KLAGES NTW, 1992, S AFR J MARINE SCI, V12, P761; KLAGES NTW, 1994, OSTRICH, V65, P218, DOI 10.1080/00306525.1994.9639685; LEMAHO Y, 1993, MAR ECOL PROG SER, V95, P1, DOI 10.3354/meps095001; Lewis S, 2006, OECOLOGIA, V147, P606, DOI 10.1007/s00442-005-0321-z; Lewis S, 2005, IBIS, V147, P408, DOI 10.1111/j.1474-919x.2005.00428.x; Lewis S, 2004, ANIM BEHAV, V68, P1331, DOI 10.1016/j.anbehav.2004.04.007; Lewis S, 2004, BEHAV ECOL SOCIOBIOL, V56, P81, DOI 10.1007/s00265-004-0762-0; Lewis S, 2002, P ROY SOC B-BIOL SCI, V269, P1687, DOI 10.1098/rspb.2002.2083; Lewis S, 2001, NATURE, V412, P816, DOI 10.1038/35090566; Litzow MA, 2003, J AVIAN BIOL, V34, P54, DOI 10.1034/j.1600-048X.2003.02995.x; McNamara JM, 2009, TRENDS ECOL EVOL, V24, P670, DOI 10.1016/j.tree.2009.05.011; Monaghan P, 1997, TRENDS ECOL EVOL, V12, P270, DOI 10.1016/S0169-5347(97)01094-X; Monaghan P, 1996, OIKOS, V77, P227, DOI 10.2307/3546061; Moseley C, 2012, J EXP MAR BIOL ECOL, V422, P29, DOI 10.1016/j.jembe.2012.04.002; Mullers Ralf H. E., 2010, Endangered Species Research, V12, P193, DOI 10.3354/esr00306; Mullers RHE, 2009, ICES J MAR SCI, V66, P2244, DOI 10.1093/icesjms/fsp210; Mullers RHE, 2009, ARDEA, V97, P89, DOI 10.5253/078.097.0111; Mullers RHE, 2007, BREEDING DYNAMIC SYS, P155; Nelson JB, 1978, SULIDAE GANNETS BOOB, P231; NEVITT GA, 1995, NATURE, V376, P680, DOI 10.1038/376680ao; Orians G.H., 1979, P155; Phillips RA, 2004, P ROY SOC B-BIOL SCI, V271, P1283, DOI 10.1098/rspb.2004.2718; Piatt JF, 2007, MAR ECOL PROG SER, V352, P199, DOI 10.3354/meps07070; Pichegru L, 2007, MAR ECOL PROG SER, V350, P127, DOI 10.3354/meps07128; Pinaud D, 2002, OIKOS, V99, P141, DOI 10.1034/j.1600-0706.2002.990114.x; Pinet P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027663; Posada D, 2004, SYST BIOL, V53, P793, DOI 10.1080/10635150490522304; Reynolds AM, 2012, ANIM BEHAV, V83, P1225, DOI 10.1016/j.anbehav.2012.02.014; Rishworth GM, 2014, METHODS ECOL EVOL, V5, P854, DOI 10.1111/2041-210X.12213; Rishworth GM, 2014, AFR ZOOL, V49, P107, DOI 10.3377/004.049.0115; Ropert-Coudert Y, 2004, ANIM BEHAV, V67, P985, DOI 10.1016/j.anbehav.2003.09.010; Sandberg R, 1996, OIKOS, V77, P577, DOI 10.2307/3545949; Shaffer SA, 2003, FUNCT ECOL, V17, P66, DOI 10.1046/j.1365-2435.2003.00705.x; Sommerfeld J, 2013, J AVIAN BIOL, V44, P531, DOI 10.1111/j.1600-048X.2013.00135.x; STEARNS SC, 1989, FUNCT ECOL, V3, P259, DOI 10.2307/2389364; Thaxter CB, 2009, J AVIAN BIOL, V40, P75, DOI 10.1111/j.1600-048X.2008.04507.x; Thiebault A, 2014, BEHAV ECOL, V25, P1302, DOI 10.1093/beheco/aru132; Thiebault A, 2014, AUK, V131, P595, DOI 10.1642/AUK-13-209.1; Thiebault A, 2013, BEHAV ECOL SOCIOBIOL, V67, P1013, DOI 10.1007/s00265-013-1546-1; Tremblay Y, 2003, MAR ECOL PROG SER, V251, P279, DOI 10.3354/meps251279; Tremblay Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088424; Trivers R. L., 1972, SEXUAL SELECTION DES, P136, DOI DOI 10.1002/AJPA.1330400226; Wakefield ED, 2013, SCIENCE, V341, P68, DOI 10.1126/science.1236077; Weimerskirch H, 2000, POLAR BIOL, V23, P733, DOI 10.1007/s003000000144; WEIMERSKIRCH H, 1992, MAR ECOL PROG SER, V86, P297, DOI 10.3354/meps086297; Weimerskirch H, 1998, J ANIM ECOL, V67, P99, DOI 10.1046/j.1365-2656.1998.00180.x; Weimerskirch H, 1997, ECOLOGY, V78, P2051; Welcker J, 2009, IBIS, V151, P502, DOI 10.1111/j.1474-919X.2009.00931.x; Zuur Alain F., 2009, P1	75	23	23	1	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2014	9	12							e116544	10.1371/journal.pone.0116544	http://dx.doi.org/10.1371/journal.pone.0116544			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UC	25551620	Green Published, gold, Green Submitted			2022-12-27	WOS:000347119100144
J	Sato, F; Miyaoka, Y; Miyajima, A; Tanaka, M				Sato, Fumi; Miyaoka, Yuichiro; Miyajima, Atsushi; Tanaka, Minoru			Oncostatin M Maintains the Hematopoietic Microenvironment in the Bone Marrow by Modulating Adipogenesis and Osteogenesis	PLOS ONE			English	Article							STEM-CELL NICHE; SELF-RENEWAL; STROMAL CELLS; PROGENITORS; DIFFERENTIATION; ENGRAFTMENT; ADIPOCYTES; INDUCTION; REGULATOR	The bone marrow (BM) is an essential organ for hematopoiesis in adult, in which proliferation and differentiation of hematopoietic stem/progenitor cells (HSPC) is orchestrated by various stromal cells. Alterations of BM hematopoietic environment lead to various hematopoietic disorders as exemplified by the linking of fatty marrow with increased adipogenesis to anemia or pancytopenia. Therefore, the composition of mesenchymal stromal cell (MSC)-derived cells in the BM could be crucial for proper hematopoiesis, but the mechanisms underlying the MSC differentiation for hematopoiesis remain poorly understood. In this study, we show that Oncostatin M (OSM) knock out mice exhibited pancytopenia advancing fatty marrow with age. OSM strongly inhibited adipogenesis from BM MSC in vitro, whereas it enhanced their osteogenesis but suppressed the terminal differentiation. Intriguingly, OSM allowed the MSC-derived cells to support the ex vivo expansion of HSPC effectively as feeder cells. Furthermore, the administration of OSM in lethally irradiated wild-type mice blocked fatty marrow and enhanced the recovery of HSPC number in the BM and peripheral blood cells after engraftment of HSPC. Collectively, OSM plays multiple critical roles in the maintenance and development of the hematopoietic microenvironment in the BM at a steady state as well as after injury.	[Sato, Fumi; Miyaoka, Yuichiro; Miyajima, Atsushi] Univ Tokyo, Inst Mol & Cellular Biosci, Lab Cell Growth & Differentiat, Tokyo, Japan; [Tanaka, Minoru] Univ Tokyo, Inst Mol & Cellular Biosci, Lab Stem Cell Regulat, Tokyo, Japan; [Tanaka, Minoru] Natl Ctr Global Hlth & Med, Res Inst, Dept Regenerat Med, Tokyo, Japan	University of Tokyo; University of Tokyo; National Center for Global Health & Medicine - Japan	Tanaka, M (corresponding author), Univ Tokyo, Inst Mol & Cellular Biosci, Lab Stem Cell Regulat, Tokyo, Japan.	tanaka@iam.u-tokyo.ac.jp		Miyaoka, Yuichiro/0000-0002-8874-4738	Japan Society for the Promotion of Science, Japan [22118006]	Japan Society for the Promotion of Science, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by Grants-in-Aid for Scientific Research on Innovative Areas 22118006 from the Japan Society for the Promotion of Science, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams GB, 2006, NATURE, V439, P599, DOI 10.1038/nature04247; Asada N, 2013, CELL STEM CELL, V12, P737, DOI 10.1016/j.stem.2013.05.001; Beck GR, 2003, J CELL BIOCHEM, V90, P234, DOI 10.1002/jcb.10622; BROWN TJ, 1987, J IMMUNOL, V139, P2977; Butler JM, 2010, CELL STEM CELL, V6, P251, DOI 10.1016/j.stem.2010.02.001; Calvi LM, 2003, NATURE, V425, P841, DOI 10.1038/nature02040; CORNELIUS P, 1994, ANNU REV NUTR, V14, P99, DOI 10.1146/annurev.nu.14.070194.000531; Ding L, 2013, NATURE, V495, P231, DOI 10.1038/nature11885; Ding L, 2012, NATURE, V481, P457, DOI 10.1038/nature10783; Gimble JM, 1996, BONE, V19, P421, DOI 10.1016/S8756-3282(96)00258-X; Greenbaum A, 2013, NATURE, V495, P227, DOI 10.1038/nature11926; Guihard P, 2012, STEM CELLS, V30, P762, DOI 10.1002/stem.1040; Haase VH, 2013, BLOOD REV, V27, P41, DOI 10.1016/j.blre.2012.12.003; Kamiya A, 1999, EMBO J, V18, P2127, DOI 10.1093/emboj/18.8.2127; Kuk JL, 2009, AGEING RES REV, V8, P339, DOI 10.1016/j.arr.2009.06.001; LEBOY PS, 1991, J CELL PHYSIOL, V146, P370, DOI 10.1002/jcp.1041460306; MALIK N, 1989, MOL CELL BIOL, V9, P2847, DOI 10.1128/MCB.9.7.2847; MCMANUS PM, 1984, BLOOD, V64, P1036; Mendez-Ferrer S, 2010, NATURE, V466, P829, DOI 10.1038/nature09262; Minehata K, 2006, INT J HEMATOL, V84, P319, DOI 10.1532/IJH97.06090; Miyaoka Y, 2006, J BIOL CHEM, V281, P37913, DOI 10.1074/jbc.M606089200; Morikawa S, 2009, J EXP MED, V206, P2483, DOI 10.1084/jem.20091046; Morrison SJ, 2014, NATURE, V505, P327, DOI 10.1038/nature12984; Mukouyama YS, 1998, IMMUNITY, V8, P105, DOI 10.1016/S1074-7613(00)80463-X; Naveiras O, 2009, NATURE, V460, P259, DOI 10.1038/nature08099; Nilsson SK, 2005, BLOOD, V106, P1232, DOI 10.1182/blood-2004-11-4422; Perry JM, 2011, GENE DEV, V25, P1928, DOI 10.1101/gad.17421911; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Porter RM, 2003, J CELL BIOCHEM, V90, P13, DOI 10.1002/jcb.10592; Prockop DJ, 1997, SCIENCE, V276, P71, DOI 10.1126/science.276.5309.71; Raaijmakers MHGP, 2010, NATURE, V464, P852, DOI 10.1038/nature08851; Sacchetti B, 2007, CELL, V131, P324, DOI 10.1016/j.cell.2007.08.025; Scheinberg P, 2012, HEMATOL-AM SOC HEMAT, P292, DOI 10.1182/asheducation-2012.1.292; Shen Y, 2012, CURR OPIN HEMATOL, V19, P250, DOI 10.1097/MOH.0b013e328353c714; Song HY, 2007, J CELL BIOCHEM, V101, P1238, DOI 10.1002/jcb.21245; Sugiyama T, 2006, IMMUNITY, V25, P977, DOI 10.1016/j.immuni.2006.10.016; Takeuchi M, 2002, BLOOD, V99, P1190, DOI 10.1182/blood.V99.4.1190; Tanaka M, 2004, REV PHYSIOL BIOCH P, V149, P39, DOI 10.1007/s10254-003-0013-1; Tanaka M, 2003, BLOOD, V102, P3154, DOI 10.1182/blood-2003-02-0367; Tansey JT, 2004, IUBMB LIFE, V56, P379, DOI 10.1080/15216540400009968; Tokoyoda K, 2004, IMMUNITY, V20, P707, DOI 10.1016/j.immuni.2004.05.001; Walker EC, 2010, J CLIN INVEST, V120, P582, DOI 10.1172/JCI40568; Wang LD, 2011, NAT REV MOL CELL BIO, V12, P643, DOI 10.1038/nrm3184; Winkler IG, 2012, NAT MED, V18, P1651, DOI 10.1038/nm.2969; Yin T, 2006, J CLIN INVEST, V116, P1195, DOI 10.1172/JCI28568; Yoshihara H, 2007, CELL STEM CELL, V1, P685, DOI 10.1016/j.stem.2007.10.020; Yoshimi A, 2008, BIOL BLOOD MARROW TR, V14, P1057, DOI 10.1016/j.bbmt.2008.07.003; Yoshimura A, 1996, EMBO J, V15, P1055, DOI 10.1002/j.1460-2075.1996.tb00443.x; Young NS, 1997, NEW ENGL J MED, V336, P1365, DOI 10.1056/NEJM199705083361906; Zhang JW, 2003, NATURE, V425, P836, DOI 10.1038/nature02041	50	22	23	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2014	9	12							e116209	10.1371/journal.pone.0116209	http://dx.doi.org/10.1371/journal.pone.0116209			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UC	25551451	Green Submitted, Green Published, gold			2022-12-27	WOS:000347119100107
J	Uhrig-Schmidt, S; Geiger, M; Luippold, G; Birk, G; Mennerich, D; Neubauer, H; Grimm, D; Wolfrum, C; Kreuz, S				Uhrig-Schmidt, Silke; Geiger, Matthias; Luippold, Gerd; Birk, Gerald; Mennerich, Detlev; Neubauer, Heike; Grimm, Dirk; Wolfrum, Christian; Kreuz, Sebastian			Gene Delivery to Adipose Tissue Using Transcriptionally Targeted rAAV8 Vectors	PLOS ONE			English	Article							EXPRESSION; OBESITY; STRATEGIES; TROPISM; FAMILY; MOUSE; WHITE	In recent years, the increasing prevalence of obesity and obesity-related co-morbidities fostered intensive research in the field of adipose tissue biology. To further unravel molecular mechanisms of adipose tissue function, genetic tools enabling functional studies in vitro and in vivo are essential. While the use of transgenic animals is well established, attempts using viral and non-viral vectors to genetically modify adipocytes in vivo are rare. Therefore, we here characterized recombinant Adeno-associated virus (rAAV) vectors regarding their potency as gene transfer vehicles for adipose tissue. Our results demonstrate that a single dose of systemically applied rAAV8-CMV-eGFP can give rise to remarkable transgene expression in murine adipose tissues. Upon transcriptional targeting of the rAAV8 vector to adipocytes using a 2.2 kb fragment of the murine adiponectin (mAP2.2) promoter, eGFP expression was significantly decreased in off-target tissues while efficient transduction was maintained in subcutaneous and visceral fat depots. Moreover, rAAV8-mAP2.2-mediated expression of perilipin A - a lipid-droplet-associated protein - resulted in significant changes in metabolic parameters only three weeks post vector administration. Taken together, our findings indicate that rAAV vector technology is applicable as a flexible tool to genetically modify adipocytes for functional proof-of-concept studies and the assessment of putative therapeutic targets in vivo.	[Uhrig-Schmidt, Silke; Luippold, Gerd; Birk, Gerald; Mennerich, Detlev; Neubauer, Heike; Kreuz, Sebastian] Boehringer Ingelheim Pharma GmbH & Co KG, Biberach, Germany; [Geiger, Matthias; Wolfrum, Christian] Swiss Fed Inst Technol, Swiss Fed Inst Technol, SLA C92, Inst Food Nutr & Hlth, Schwerzenbach, Switzerland; [Grimm, Dirk] Univ Heidelberg Hosp, Ctr Infect Dis Virol, Heidelberg, Germany; [Grimm, Dirk] Heidelberg Univ, Cluster Excellence CellNetworks, Heidelberg, Germany	Boehringer Ingelheim; Swiss Federal Institutes of Technology Domain; ETH Zurich; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg	Kreuz, S (corresponding author), Boehringer Ingelheim Pharma GmbH & Co KG, Biberach, Germany.	sebastian.kreuz@boehringer-ingelheim.com		Wolfrum, Christian/0000-0002-3862-6805	Boehringer Ingelheim; Swiss National Fund; FP7 DIABAT Project of the European Union; Cluster of Excellence CellNetworks DFG EXC81	Boehringer Ingelheim(Boehringer Ingelheim); Swiss National Fund(Swiss National Science Foundation (SNSF)); FP7 DIABAT Project of the European Union; Cluster of Excellence CellNetworks DFG EXC81	The research described was funded by Boehringer Ingelheim (SUS, GL, GB, DM, HN, SK), by the Swiss National Fund and the FP7 DIABAT Project of the European Union (MG, CW) and by the Cluster of Excellence CellNetworks DFG EXC81 (SUS, DG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asokan A, 2012, MOL THER, V20, P699, DOI 10.1038/mt.2011.287; Asokan A, 2010, NAT BIOTECHNOL, V28, P79, DOI 10.1038/nbt.1599; Barness LA, 2007, AM J MED GENET A, V143A, P3016, DOI 10.1002/ajmg.a.32035; Brasaemle DL, 2007, J LIPID RES, V48, P2547, DOI 10.1194/jlr.R700014-JLR200; Brown BD, 2009, NAT REV GENET, V10, P578, DOI 10.1038/nrg2628; Buning H, 2008, J GENE MED, V10, P717, DOI 10.1002/jgm.1205; Casteilla L, 2008, CURR GENE THER, V8, P79, DOI 10.2174/156652308784049354; Coughlan L, 2010, VIRUSES-BASEL, V2, P2290, DOI 10.3390/v2102290; Cristancho AG, 2011, NAT REV MOL CELL BIO, V12, P722, DOI 10.1038/nrm3198; Enerback S, 2009, NEW ENGL J MED, V360, P2021, DOI 10.1056/NEJMcibr0809610; Geisler A, 2011, GENE THER, V18, P199, DOI 10.1038/gt.2010.141; Grimm D, 2003, MOL THER, V7, P839, DOI 10.1016/S1525-0016(03)00095-9; Grimm D, 2008, J VIROL, V82, P5887, DOI 10.1128/JVI.00254-08; Halder S, 2012, FUTURE VIROL, V7, P253, DOI 10.2217/FVL.12.12; Ishibashi J, 2010, SCIENCE, V328, P1113, DOI 10.1126/science.1190816; Jimenez V, 2013, DIABETES, V62, P4012, DOI 10.2337/db13-0311; Koshfishi C, 2008, GENE, V424, P141, DOI 10.1016/j.gene.2008.07.039; Liu Q, 2003, GENE THER, V10, P935, DOI 10.1038/sj.gt.3302036; Martinez-Botas J, 2000, NAT GENET, V26, P474, DOI 10.1038/82630; Mingozzi F, 2011, NAT REV GENET, V12, P341, DOI 10.1038/nrg2988; Mizukami H, 2006, HUM GENE THER, V17, P921, DOI 10.1089/hum.2006.17.921; Moullier P, 2008, MOL THER, V16, P1185, DOI 10.1038/mt.2008.125; Nedergaard J, 2007, AM J PHYSIOL-ENDOC M, V293, pE444, DOI 10.1152/ajpendo.00691.2006; Nguyen T, 2012, CAN J CARDIOL, V28, P326, DOI 10.1016/j.cjca.2012.01.001; O'Neill SM, 2014, GENE THER, V21, P653, DOI 10.1038/gt.2014.38; Petrovic N, 2010, J BIOL CHEM, V285, P7153, DOI 10.1074/jbc.M109.053942; Rabinowitz JE, 2002, J VIROL, V76, P791, DOI 10.1128/JVI.76.2.791-801.2002; Raupp C, 2012, J VIROL, V86, P9396, DOI 10.1128/JVI.00209-12; Rauschhuber C, 2012, EUR J CELL BIOL, V91, P2, DOI 10.1016/j.ejcb.2011.01.006; Richardson VR, 2013, IMMUNOBIOLOGY, V218, P1497, DOI 10.1016/j.imbio.2013.05.002; Rosenwald M, 2013, NAT CELL BIOL, V15, P659, DOI 10.1038/ncb2740; Schagen FHE, 2004, CRIT REV ONCOL HEMAT, V50, P51, DOI 10.1016/S1040-8428(03)00172-0; Schievenbusch S, 2010, MOL THER, V18, P1302, DOI 10.1038/mt.2010.71; Seale P, 2011, J CLIN INVEST, V121, P96, DOI 10.1172/JCI44271; SRIVASTAVA A, 1983, J VIROL, V45, P555, DOI 10.1128/JVI.45.2.555-564.1983; Tansey JT, 2001, P NATL ACAD SCI USA, V98, P6494, DOI 10.1073/pnas.101042998; Urabe M, 2002, HUM GENE THER, V13, P1935, DOI 10.1089/10430340260355347; Xie J, 2011, MOL THER, V19, P526, DOI 10.1038/mt.2010.279; Zincarelli C, 2008, MOL THER, V16, P1073, DOI 10.1038/mt.2008.76	39	8	8	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2014	9	12							e116288	10.1371/journal.pone.0116288	http://dx.doi.org/10.1371/journal.pone.0116288			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UC	25551639	Green Published, gold, Green Submitted			2022-12-27	WOS:000347119100124
J	Barbosa, TM; Phelan, RW; Leong, D; Morrissey, JP; Adams, C; Dobson, ADW; O'Gara, F				Barbosa, Teresa M.; Phelan, Robert W.; Leong, Dara; Morrissey, John P.; Adams, Claire; Dobson, Alan D. W.; O'Gara, Fergal			A Novel Erythromycin Resistance Plasmid from Bacillus Sp Strain HS24, Isolated from the Marine Sponge Haliclona Simulans	PLOS ONE			English	Article							SUBTILIS TRANSFORMATION SYSTEM; STAPHYLOCOCCUS-AUREUS ST398; ANTIBIOTIC-RESISTANCE; BACTERIAL PLASMIDS; BORNE ERM(T); HUMAN HEALTH; GENES; STREPTOCOCCUS; IDENTIFICATION; DIVERSITY	A better understanding of the origin and natural reservoirs of resistance determinants is fundamental to efficiently tackle antibiotic resistance. This paper reports the identification of a novel 5.8 kb erythromycin resistance plasmid, from Bacillus sp. HS24 isolated from the marine sponge Haliclona simulans. pBHS24B has a mosaic structure and carries the erythromycin resistance gene erm(T). This is the first report of an erythromycin resistance plasmid from a sponge associated bacteria and of the Erm(T) determinant in the genus Bacillus.	[Barbosa, Teresa M.] Natl Univ Ireland Univ Coll Cork, Sch Pharm, Cork, Ireland; [Phelan, Robert W.; Leong, Dara; Morrissey, John P.; Adams, Claire; Dobson, Alan D. W.; O'Gara, Fergal] Natl Univ Ireland Univ Coll Cork, Dept Microbiol, Cork, Ireland; [Phelan, Robert W.; Adams, Claire; O'Gara, Fergal] Natl Univ Ireland Univ Coll Cork, Biomerit Res Ctr, Cork, Ireland; [Morrissey, John P.; Dobson, Alan D. W.; O'Gara, Fergal] Natl Univ Ireland Univ Coll Cork, Environm Res Inst, Ctr Marine Biotechnol, Cork, Ireland; [O'Gara, Fergal] Curtin Univ, Sch Biomed Sci, Perth, WA 6845, Australia	University College Cork; University College Cork; University College Cork; University College Cork; Curtin University	Barbosa, TM (corresponding author), Natl Univ Ireland Univ Coll Cork, Sch Pharm, Cork, Ireland.	t.barbosa@ucc.ie; f.ogara@ucc.ie	Morrissey, John/AAD-2255-2019; Dobson, Alan D W/M-7844-2017	Dobson, Alan D W/0000-0002-7713-5574; Leong, Dara/0000-0002-2269-8927; O'Gara, Fergal/0000-0002-2659-0673; Barbosa, Teresa M./0000-0001-7151-3418; Morrissey, John/0000-0001-7960-2001	Science Foundation of Ireland [SSPC2 12/RC/2275, 13-TIDA-B2625, 07/IN.1/B948, 12/TIDA/B2411, 12/TIDA/B2405, 09/RFP/BMT 2350]; Department of Agriculture, Fisheries and Food (FIRM/RSF/CoFoRD) [DAFF11/F/009 MabS, FIRM 08/RDC/629]; Environmental Protection Agency (EPA) [2008-PhD/S-2]; Irish Research Council for Science, Engineering and Technology [PD/2011/2414, RS/2010/2413]; European Commission (FP7-PEOPLE-ITN) [607786]; European Commission (OCEAN) [287589]; European Commission (FP7-KBBE-6) [CP-TP 311975]; European Commission (Marie Curie) [256596]; Marine Institute [C2CRA 2007/082]; Teagasc; Health Research Board [HRA/2009/146]	Science Foundation of Ireland(Science Foundation Ireland); Department of Agriculture, Fisheries and Food (FIRM/RSF/CoFoRD); Environmental Protection Agency (EPA)(United States Environmental Protection Agency); Irish Research Council for Science, Engineering and Technology(Irish Research Council for Science, Engineering and Technology); European Commission (FP7-PEOPLE-ITN); European Commission (OCEAN); European Commission (FP7-KBBE-6); European Commission (Marie Curie)(European CommissionEuropean Commission Joint Research Centre); Marine Institute; Teagasc; Health Research Board	This research was supported in parts by grants awarded to FOG by the Science Foundation of Ireland (SSPC2 12/RC/2275, 13-TIDA-B2625, 07/IN.1/B948, 12/TIDA/B2411, 12/TIDA/B2405, 09/RFP/BMT 2350); the Department of Agriculture, Fisheries and Food (DAFF11/F/009 MabS, FIRM/RSF/CoFoRD; FIRM 08/RDC/629); the Environmental Protection Agency (EPA 2008-PhD/S-2), the Irish Research Council for Science, Engineering and Technology (PD/2011/2414; RS/2010/2413), the European Commission (FP7-PEOPLE-2013-ITN, 607786; OCEAN2012, 287589; FP7-KBBE-2012-6, CP-TP 311975; FP7-KBBE-2012-6, CP-TP-312184; Marie Curie 256596); and the Marine Institute (Beaufort award C2CRA 2007/082); Teagasc (Walsh Fellowship 2013) and the Health Research Board (HRA/2009/146). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adimpong DB, 2012, APPL ENVIRON MICROB, V78, P7903, DOI 10.1128/AEM.00730-12; Allen HK, 2010, NAT REV MICROBIOL, V8, P251, DOI 10.1038/nrmicro2312; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Aminov RI, 2009, ENVIRON MICROBIOL, V11, P2970, DOI 10.1111/j.1462-2920.2009.01972.x; Baquero F, 2008, CURR OPIN BIOTECH, V19, P260, DOI 10.1016/j.copbio.2008.05.006; Barbosa TM, 2005, APPL ENVIRON MICROB, V71, P968, DOI 10.1128/AEM.71.2.968-978.2005; Barbosa TM, 2000, DRUG RESIST UPDATE, V3, P303, DOI 10.1054/drup.2000.0167; Bhullar K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034953; Bories G, 2008, EFSA J, V6, DOI 10.2903/j.efsa.2008.732; BOTT KF, 1967, J BACTERIOL, V94, P562, DOI 10.1128/JB.94.3.562-570.1967; Cabello FC, 2006, ENVIRON MICROBIOL, V8, P1137, DOI 10.1111/j.1462-2920.2006.01054.x; Cabello FC, 2013, ENVIRON MICROBIOL, V15, P1917, DOI 10.1111/1462-2920.12134; Chen J, 2007, APPL ENVIRON MICROB, V73, P4407, DOI 10.1128/AEM.02799-06; Chen YG, 2011, INT J SYST EVOL MICR, V61, P2095, DOI 10.1099/ijs.0.026286-0; D'Costa VM, 2011, NATURE, V477, P457, DOI 10.1038/nature10388; del Solar G, 1998, MICROBIOL MOL BIOL R, V62, P434, DOI 10.1128/MMBR.62.2.434-464.1998; DiPersio LP, 2011, DIAGN MICR INFEC DIS, V71, P217, DOI 10.1016/j.diagmicrobio.2011.07.010; Duitman EH, 2007, APPL ENVIRON MICROB, V73, P3490, DOI 10.1128/AEM.02751-06; Esposito A, 2007, ANTIMICROB AGENTS CH, V51, P1043, DOI 10.1128/AAC.01002-06; Feld L, 2009, PLASMID, V61, P159, DOI 10.1016/j.plasmid.2009.01.002; Francia MV, 2004, FEMS MICROBIOL REV, V28, P79, DOI 10.1016/j.femsre.2003.09.001; Frost LS, 2005, NAT REV MICROBIOL, V3, P722, DOI 10.1038/nrmicro1235; Gomez-Sanz E, 2013, ANTIMICROB AGENTS CH, V57, P3275, DOI 10.1128/AAC.00171-13; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; IMANAKA T, 1984, J GEN MICROBIOL, V130, P1399; Jackson SA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084438; Kadlec K, 2010, ANTIMICROB AGENTS CH, V54, P915, DOI 10.1128/AAC.01091-09; Kennedy J, 2008, ENVIRON MICROBIOL, V10, P1888, DOI 10.1111/j.1462-2920.2008.01614.x; Kennedy J, 2010, MAR DRUGS, V8, P608, DOI 10.3390/md8030608; Lane D.J., 1991, NUCL ACID TECH BACT, P115, DOI DOI 10.1007/S00227-012-2133-0; Marshall BM, 2011, CLIN MICROBIOL REV, V24, P718, DOI 10.1128/CMR.00002-11; Osborn AM, 2000, MICROBIOL-UK, V146, P2267, DOI 10.1099/00221287-146-9-2267; PERKINS JB, 1983, J BACTERIOL, V155, P607, DOI 10.1128/JB.155.2.607-615.1983; Phelan RW, 2012, J APPL MICROBIOL, V112, P65, DOI 10.1111/j.1365-2672.2011.05173.x; Phelan RW, 2013, MAR DRUGS, V11, P1878, DOI 10.3390/md11061878; Phelan RW, 2011, APPL ENVIRON MICROB, V77, P327, DOI 10.1128/AEM.01239-10; Rolain JM, 2012, CLIN MICROBIOL INFEC, V18, P615, DOI 10.1111/j.1469-0691.2012.03902.x; Salyers AA, 2004, TRENDS MICROBIOL, V12, P412, DOI 10.1016/j.tim.2004.07.004; Sanchez C, 2003, PLASMID, V49, P118, DOI 10.1016/S0147-619X(03)00013-1; Selvin J, 2009, MICROBIOL RES, V164, P352, DOI 10.1016/j.micres.2007.05.005; Sprincova A, 2005, PLASMID, V54, P39, DOI 10.1016/j.plasmid.2004.11.004; TANNOCK GW, 1994, PLASMID, V31, P60, DOI 10.1006/plas.1994.1007; Taylor MW, 2007, MICROBIOL MOL BIOL R, V71, P295, DOI 10.1128/MMBR.00040-06; Teng LJ, 2001, ANTIMICROB AGENTS CH, V45, P3362, DOI 10.1128/AAC.45.12.3362-3365.2001; Whitehead TR, 2001, CURR MICROBIOL, V43, P17, DOI 10.1007/s002840010253; WILSON GA, 1968, J BACTERIOL, V95, P1439, DOI 10.1128/JB.95.4.1439-1449.1968; Woodbury RL, 2008, ANTIMICROB AGENTS CH, V52, P1140, DOI 10.1128/AAC.01352-07; Zhang Z, 2000, J COMPUT BIOL, V7, P203, DOI 10.1089/10665270050081478	49	8	8	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2014	9	12							e115583	10.1371/journal.pone.0115583	http://dx.doi.org/10.1371/journal.pone.0115583			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX6YH	25548909	gold, Green Published			2022-12-27	WOS:000347063500018
J	Singh, S; Guttula, PK; Guruprasad, L				Singh, Swati; Guttula, Praveen Kumar; Guruprasad, Lalitha			Structure Based Annotation of Helicobacter pylori Strain 26695 Proteome	PLOS ONE			English	Article							2-NITROPROPANE DIOXYGENASE; STRUCTURE PREDICTION; CRYSTAL-STRUCTURE; CATALYTIC BASE; SERVER; FOLD; INFECTION; CLASSIFICATION; PATHOGENESIS; RECOGNITION	The availability of complete genome sequences of H. pylori 26695 has provided a wealth of information enabling us to carry out in silico studies to identify new molecular targets for pharmaceutical treatment. In order to construe the structural and functional information of complete proteome, use of computational methods are more relevant since these methods are reliable and provide a solution to the time consuming and expensive experimental methods. Out of 1590 predicted protein coding genes in H. pylori, experimentally determined structures are available for only 145 proteins in the PDB. In the absence of experimental structures, computational studies on the three dimensional (3D) structural organization would help in deciphering the protein fold, structure and active site. Functional annotation of each protein was carried out based on structural fold and binding site based ligand association. Most of these proteins are uncharacterized in this proteome and through our annotation pipeline we were able to annotate most of them. We could assign structural folds to 464 uncharacterized proteins from an initial list of 557 sequences. Of the 1195 known structural folds present in the SCOP database, 411 (34% of all known folds) are observed in the whole H. pylori 26695 proteome, with greater inclination for domains belonging to alpha/beta class (36.63%). Top folds include P-loop containing nucleoside triphosphate hydrolases (22.6%), TIM barrel (16.7%), transmembrane helix hairpin (16.05%), alpha-alpha superhelix (11.1%) and S-adenosyl-L-methionine-dependent methyltransferases (10.7%).	[Singh, Swati; Guttula, Praveen Kumar; Guruprasad, Lalitha] Univ Hyderabad, Sch Chem, Hyderabad 500046, Andhra Pradesh, India	University of Hyderabad	Guruprasad, L (corresponding author), Univ Hyderabad, Sch Chem, Hyderabad 500046, Andhra Pradesh, India.	lgpsc@uohyd.enet.in	Guttula, Praveen Kumar/AAG-2456-2019		CSIR, New Delhi, India; DST, New Delhi, India [SR/S5/MBD-05/2207]	CSIR, New Delhi, India(Council of Scientific & Industrial Research (CSIR) - India); DST, New Delhi, India(Department of Science & Technology (India))	SS thanks CSIR, New Delhi, India, for the senior research fellowship. LGP thanks DST, New Delhi, India, for research funding (Ref. No. SR/S5/MBD-05/2207). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARGOS P, 1983, J BIOL CHEM, V258, P6450; Boneca IG, 2003, NUCLEIC ACIDS RES, V31, P1704, DOI 10.1093/nar/gkg250; BOWIE JU, 1991, SCIENCE, V253, P164, DOI 10.1126/science.1853201; Carbon S, 2009, BIOINFORMATICS, V25, P288, DOI 10.1093/bioinformatics/btn615; Chow CS, 2007, ACS CHEM BIOL, V2, P610, DOI 10.1021/cb7001494; Cover TL, 1996, ADV INTERNAL MED, V41, P85; Decatur WA, 2002, TRENDS BIOCHEM SCI, V27, P344, DOI 10.1016/S0968-0004(02)02109-6; Dundas J, 2006, NUCLEIC ACIDS RES, V34, pW116, DOI 10.1093/nar/gkl282; Dutta Shuchismita, 2008, V426, P81, DOI 10.1007/978-1-60327-058-8_5; Eramian D, 2006, PROTEIN SCI, V15, P1653, DOI 10.1110/ps.062095806; Francis K, 2006, BIOCHEMISTRY-US, V45, P13889, DOI 10.1021/bi060566l; Gorlatova N, 1998, APPL ENVIRON MICROB, V64, P1029; Ha JY, 2006, J BIOL CHEM, V281, P18660, DOI 10.1074/jbc.M601658200; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; HOVEJENSEN B, 1986, J BIOL CHEM, V261, P6765; Hunt RH, 1996, SCAND J GASTROENTERO, V31, P3, DOI 10.3109/00365529609094743; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; KIKUCHI S, 1995, CANCER, V75, P2789, DOI 10.1002/1097-0142(19950615)75:12<2789::AID-CNCR2820751202>3.0.CO;2-4; Kukimoto-Niino M, 2005, PROTEIN SCI, V14, P823, DOI 10.1110/ps.041229405; Labigne A, 1996, INFECT AGENT DIS, V5, P191; Lehoux IE, 1999, BIOCHEMISTRY-US, V38, P9948, DOI 10.1021/bi9907532; Lobley A, 2009, BIOINFORMATICS, V25, P1761, DOI 10.1093/bioinformatics/btp302; Mandal RS, 2014, J BIOMOL STRUCT DYN, P1; McColl KEL, 1997, GASTROENTEROLOGY, V113, pS158, DOI 10.1016/S0016-5085(97)80031-5; McGuffin LJ, 2000, BIOINFORMATICS, V16, P404, DOI 10.1093/bioinformatics/16.4.404; Meurer LN, 2002, AM FAM PHYSICIAN, V65, P1327; MURZIN AG, 1995, J MOL BIOL, V247, P536, DOI 10.1006/jmbi.1995.0159; Pearson WR, 2013, CURR PROTOC BIOINFOR, V42, DOI 10.1002/0471250953.bi0301s42; Peek RM, 2005, SPRINGER SEMIN IMMUN, V27, P197, DOI 10.1007/s00281-005-0204-8; Pieper U, 2011, NUCLEIC ACIDS RES, V39, pD465, DOI 10.1093/nar/gkq1091; Qian J, 2001, J MOL BIOL, V313, P673, DOI 10.1006/jmbi.2001.5079; RAea Laskowski, 1993, J APPL CRYST, V26; Resende T, 2013, J INTEGR BIOINFORMAT, V10, DOI 10.2390/biecoll-jib-2013-233; Roy A, 2012, NUCLEIC ACIDS RES, V40, pW471, DOI 10.1093/nar/gks372; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Schramm VL, 2004, PROG NUCLEIC ACID RE, V78, P261, DOI 10.1016/S0079-6603(04)78007-1; Shen MY, 2006, PROTEIN SCI, V15, P2507, DOI 10.1110/ps.062416606; Shi JY, 2001, J MOL BIOL, V310, P243, DOI 10.1006/jmbi.2001.4762; Smith JL, 1995, CURR OPIN STRUC BIOL, V5, P752, DOI 10.1016/0959-440X(95)80007-7; Tomb JF, 1997, NATURE, V388, P539, DOI 10.1038/41483; WARREN JR, 1983, LANCET, V1, P1273; Yang JM, 2006, NUCLEIC ACIDS RES, V34, P3646, DOI 10.1093/nar/gkl395; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40	43	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2014	9	12							e115020	10.1371/journal.pone.0115020	http://dx.doi.org/10.1371/journal.pone.0115020			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX6YH	25549250	Green Published, gold, Green Submitted			2022-12-27	WOS:000347063500010
J	Huang, B; Xu, S; Miao, AJ; Xiao, L; Yang, LY				Huang, Bin; Xu, Shen; Miao, Ai-Jun; Xiao, Lin; Yang, Liu-Yan			Cadmium Toxicity to Microcystis aeruginosa PCC 7806 and Its Microcystin-Lacking Mutant	PLOS ONE			English	Article							HEAVY-METAL DETOXIFICATION; CHLAMYDOMONAS-REINHARDTII; POLYPHOSPHATE METABOLISM; INORGANIC POLYPHOSPHATE; MARINE-PHYTOPLANKTON; NUTRIENT LIMITATION; DIFFERENT PHOSPHATE; COPPER TOXICITY; GREEN-ALGAE; LAKE TAIHU	The adverse effects of microcystin (MC) produced by cyanobacteria have drawn considerable attention from the public. Yet it remains unclear whether MC confers any benefits to the cyanobacteria themselves. One suggested function of MC is complexation, which may influence the bioaccumulation and toxicity of trace metals. To test this hypothesis, we examined Cd toxicity to wild-type Microcystis aeruginosa PCC 7806 (WT) and its MC-lacking mutant (MT) under nutrient-enriched (+ NP), phosphorus-limited (-P), and nitrogen-limited (-N) conditions. The accumulation of Cd and the biochemical parameters associated with its detoxification [total phosphorus (TP), inorganic polyphosphate (Poly-P), and glutathione (GSH) in the cells as well as intra-and extra-cellular carbohydrates] were quantified. Although the -P cyanobacteria accumulated less Cd than their + NP and -N counterparts, the different nutrient-conditioned cyanobacteria were similarly inhibited by similar free ion concentration of Cd in the medium ([Cd2+](F)). Such good toxicity predictability of [Cd2+](F) was ascribed to the synchronous decrease in the intracellular concentrations of Cd and TP. Nevertheless, Cd toxicity was still determined by the intracellular Cd to phosphorus ratio (Cd/P), in accordance with what has been reported in the literature. On the other hand, the concentrations of TP, Poly-P, and carbohydrates went up, but GSH concentration dropped down with the enhancement of [Cd2+](F), indicating their association with Cd detoxification. Although the inactivation of MC peptide synthetase gene had some nutrient and Cd concentration dependent effects on the parameters above, both cyanobacterial strains showed the same Cd accumulation ability and displayed similar Cd sensitivity. These results suggest that MC cannot affect metal toxicity either by regulating metal accumulation or by altering the detoxification ability of the cyanobacteria. Other possible functions of MC need to be further investigated.					Huang, Bin/A-3639-2017; liu, yang/HHY-8583-2022; yang, liu/GVU-8760-2022	Huang, Bin/0000-0002-1025-9775; 	National Natural Science Foundation of China [21237001, 41001338, 41271486]; Agricultural Science and Technology Independent Innovation Foundation of Jiangsu Province [CX(14)2094]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Agricultural Science and Technology Independent Innovation Foundation of Jiangsu Province	This research was funded by the National Natural Science Foundation of China (http://www.nsfc.gov.cn/) (grant numbers: 21237001, 41001338, and 41271486) and by the Agricultural Science and Technology Independent Innovation Foundation of Jiangsu Province (http://home.jaas.ac.cn/) (grant number: CX(14)2094) to AJM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHNER BA, 1995, LIMNOL OCEANOGR, V40, P649, DOI 10.4319/lo.1995.40.4.0649; ALLEN MM, 1968, J GEN MICROBIOL, V51, P199, DOI 10.1099/00221287-51-2-199; [Anonymous], 1994, METAL SPECIATION BIO; Babica P, 2006, J PHYCOL, V42, P9, DOI 10.1111/j.1529-8817.2006.00176.x; Cobbett CS, 2000, PLANT PHYSIOL, V123, P825, DOI 10.1104/pp.123.3.825; Diaz JM, 2011, INORGANIC POLYPHOSPH; Dittmann E, 1997, MOL MICROBIOL, V26, P779, DOI 10.1046/j.1365-2958.1997.6131982.x; Eixler S, 2005, HYDROBIOLOGIA, V533, P135, DOI 10.1007/s10750-004-2406-9; Frausto da Silva J. J. R., 1993, BIOL CHEM ELEMENTS I, DOI 10.1021/ed069pA326.1; Freire-Nordi CS, 2005, PROCESS BIOCHEM, V40, P2215, DOI 10.1016/j.procbio.2004.09.003; Fujii M, 2011, APPL ENVIRON MICROB, V77, P7068, DOI 10.1128/AEM.05270-11; Harada E, 2004, PHYTOCHEMISTRY, V65, P3179, DOI 10.1016/j.phytochem.2004.09.017; Hassinen VH, 2011, PLANT BIOLOGY, V13, P225, DOI 10.1111/j.1438-8677.2010.00398.x; Haye JM, 2006, ENVIRON CHEM, V3, P172, DOI 10.1071/EN06015; Hesse K, 2001, FEMS MICROBIOL ECOL, V37, P39, DOI 10.1111/j.1574-6941.2001.tb00851.x; HOAGLAND KD, 1993, J PHYCOL, V29, P537, DOI 10.1111/j.0022-3646.1993.00537.x; Kaebernick M, 2000, APPL ENVIRON MICROB, V66, P3387, DOI 10.1128/AEM.66.8.3387-3392.2000; Keyhani S, 1996, MICROBIOS, V88, P105; Kilham SS, 1997, FRESHWATER BIOL, V38, P591, DOI 10.1046/j.1365-2427.1997.00231.x; Kim IG, 2002, BIOTECHNOL LETT, V24, P1299, DOI 10.1023/A:1019812202099; KORNBERG A, 1995, J BACTERIOL, V177, P491, DOI 10.1128/jb.177.3.491-496.1995; Kulaev I, 1999, J BIOSCI BIOENG, V88, P111, DOI 10.1016/S1389-1723(99)80189-3; Lavoie M, 2009, AQUAT TOXICOL, V92, P65, DOI 10.1016/j.aquatox.2008.12.007; Lombardi AT, 1998, PHYCOLOGIA, V37, P34, DOI 10.2216/i0031-8884-37-1-34.1; Lynn SG, 2000, J PHYCOL, V36, P510, DOI 10.1046/j.1529-8817.2000.98251.x; Mason A.Z., 1995, METAL SPECIATION BIO; McIntyre AM, 2013, CHEMOSPHERE, V90, P620, DOI 10.1016/j.chemosphere.2012.08.057; Miao AJ, 2007, ENVIRON SCI TECHNOL, V41, P1777, DOI 10.1021/es0613963; Miao AJ, 2006, MAR ECOL PROG SER, V318, P141, DOI 10.3354/meps318141; Miao AJ, 2006, AQUAT TOXICOL, V78, P114, DOI 10.1016/j.aquatox.2006.02.008; Miao AJ, 2009, ENVIRON POLLUT, V157, P3034, DOI 10.1016/j.envpol.2009.05.047; Miao AJ, 2004, MAR ECOL PROG SER, V275, P103, DOI 10.3354/meps275103; MYKLESTAD S, 1972, Journal of Experimental Marine Biology and Ecology, V9, P125, DOI 10.1016/0022-0981(72)90041-X; MYKLESTAD SM, 1995, SCI TOTAL ENVIRON, V165, P155, DOI 10.1016/0048-9697(95)04549-G; Nishikawa K, 2003, FEMS MICROBIOL ECOL, V44, P253, DOI 10.1016/S0168-6496(03)00049-7; Ou-Yang HL, 2013, ENVIRON TOXICOL CHEM, V32, P2762, DOI 10.1002/etc.2362; Parsons T.R., 1984, MANUAL BIOL CHEM MET; Perales-Vela HV, 2006, CHEMOSPHERE, V64, P1, DOI 10.1016/j.chemosphere.2005.11.024; Pistocchi R, 2000, J APPL PHYCOL, V12, P469, DOI 10.1023/A:1008162812651; Ramanan S, 2000, J CHROMATOGR A, V883, P103, DOI 10.1016/S0021-9673(00)00378-2; Rijstenbil JW, 1998, AQUAT TOXICOL, V42, P187, DOI 10.1016/S0166-445X(97)00091-X; Salgado LT, 2005, PROTOPLASMA, V225, P123, DOI 10.1007/s00709-004-0066-2; Satoh M, 1999, J PHYCOL, V35, P989, DOI 10.1046/j.1529-8817.1999.3550989.x; Shi XL, 2003, MICROBIOL RES, V158, P345, DOI 10.1078/0944-5013-00214; Song LR, 2007, WATER RES, V41, P2853, DOI 10.1016/j.watres.2007.02.013; Tsuji N, 2004, BIOCHEM BIOPH RES CO, V315, P751, DOI 10.1016/j.bbrc.2004.01.122; TWISS MR, 1992, J PHYCOL, V28, P291, DOI 10.1111/j.0022-3646.1992.00291.x; Underwood GJC, 2004, J PHYCOL, V40, P293, DOI 10.1111/j.1529-8817.2004.03076.x; UTKILEN H, 1995, APPL ENVIRON MICROB, V61, P797, DOI 10.1128/AEM.61.2.797-800.1995; Wang NX, 2013, WATER RES, V47, P2497, DOI 10.1016/j.watres.2013.02.034; Wang NX, 2012, WATER RES, V46, P369, DOI 10.1016/j.watres.2011.10.035; Wang WX, 2001, ENVIRON POLLUT, V111, P233, DOI 10.1016/S0269-7491(00)00071-3; Wang WX, 2005, ENVIRON TOXICOL CHEM, V24, P161, DOI 10.1897/04-125R.1; Wang WX, 2006, ENVIRON POLLUT, V142, P303, DOI 10.1016/j.envpol.2005.10.005; Wei LP, 2003, ENVIRON SCI TECHNOL, V37, P3609, DOI 10.1021/es0340026; Xu S, 2013, ECOTOX ENVIRON SAFE, V94, P190, DOI 10.1016/j.ecoenv.2013.05.006; Yu RQ, 2004, AQUAT MICROB ECOL, V35, P163, DOI 10.3354/ame035163; Yu RQ, 2004, ENVIRON POLLUT, V129, P443, DOI 10.1016/j.envpol.2003.11.013; Zeng J, 2009, ENVIRON TOXICOL CHEM, V28, P1618, DOI 10.1897/08-639.1; Zeng J, 2009, AQUAT TOXICOL, V91, P212, DOI 10.1016/j.aquatox.2008.11.004; ZHANG WX, 1994, ENVIRON SCI TECHNOL, V28, P1577, DOI 10.1021/es00058a007; Zhou WB, 2006, CHEMOSPHERE, V65, P1738, DOI 10.1016/j.chemosphere.2006.04.078	62	9	9	4	84	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2015	10	1							e0116659	10.1371/journal.pone.0116659	http://dx.doi.org/10.1371/journal.pone.0116659			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9HN	25590420	Green Submitted, gold, Green Published			2022-12-27	WOS:000350679400020
J	Helgadottir, B; Forsell, Y; Ekblom, O				Helgadottir, Bjorg; Forsell, Yvonne; Ekblom, Orjan			Physical Activity Patterns of People Affected by Depressive and Anxiety Disorders as Measured by Accelerometers: A Cross-Sectional Study	PLOS ONE			English	Article							SEDENTARY TIME; PSYCHOMOTOR SYMPTOMS; EXERCISE; ADULTS; VALIDATION; CALIBRATION; VERSION; HEALTH	Background Exercise can relieve both depressive and anxiety disorders and it is therefore of importance to establish movement patterns of mildly to moderately affected sufferers to estimate the treatment potential. The aim is to describe the physical activity patterns of people affected by mild to moderate depressive and/or anxiety symptoms using objective measures of physical activity. Methods The design of the study was cross-sectional using data from 165 people aged 18-65 years, with mild to moderate depressive and/or anxiety disorder symptoms (scoring >= 10 on the PHQ-9). Diagnoses were made using Mini International Neuropsychiatric Interview (MINI) and symptom severity was measured with the Montgomery-Asberg Depression Rating Scale (MADRS). The participants wore accelerometers for a week to evaluate physical activity patterns. Results No statistically significant differences were detected between different diagnoses, though depressed participants tended to be less active and more sedentary. Only one-fifth of the sample followed public health guidelines regarding physical activity. Each one point increase in MADRS was associated with a 2.4 minute reduction in light physical activity, independent of moderate-to-vigorous physical activity and sedentary time. MADRS was positively associated with number of sedentary bouts. Conclusions The physical activity pattern of people with depressive and/or anxiety disorders was characterized by large amounts of sedentary time and low fulfillment of physical activity guidelines. There is therefore a large treatment potential for this group by increasing exercise. The results suggest that instead of focusing exclusively on high intensity exercise for treating depressive and anxiety disorders, health care providers might encourage patients to reduce sedentary time by increasing light physical activity and decreasing the number of sedentary bouts, though further studies are needed that can determine directionality.	[Helgadottir, Bjorg; Forsell, Yvonne] Karolinska Inst, Dept Publ Hlth Sci, Stockholm, Sweden; [Ekblom, Orjan] Swedish Sch Sport & Hlth Sci, Astrand Lab Work Physiol, Stockholm, Sweden	Karolinska Institutet; Swedish School of Sport & Health Sciences	Helgadottir, B (corresponding author), Karolinska Inst, Dept Publ Hlth Sci, Stockholm, Sweden.	bjorg.helgadottir@ki.se	Forsell, Yvonne/ABB-8879-2020	Helgadottir, Bjorg/0000-0002-6170-8251; Ekblom, Orjan/0000-0001-6058-4982	Vardal Foundation [RS2009/27]; Stockholm; Kronoberg; Blekinge; Skane; Vastra Gotaland; Vastmanland	Vardal Foundation; Stockholm; Kronoberg; Blekinge; Skane; Vastra Gotaland; Vastmanland	Funding for the Regassa study came from the Vardal Foundation (http://www.vardal.se/) [RS2009/27] and from the six County Councils involved in the study (Stockholm, Kronoberg, Blekinge, Skane, Vastra Gotaland and Vastmanland). The County Councils are the provider of funding of all health care in Sweden through tax money. The funders had no role in study design, and analysis, decision to publish, or preparation of the manuscript but the employees of the county councils were involved in the data collection.	Anastasopoulou P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090606; Burton C, 2013, J AFFECT DISORDERS, V145, P21, DOI 10.1016/j.jad.2012.07.001; Carek PJ, 2011, INT J PSYCHIAT MED, V41, P15, DOI 10.2190/PM.41.1.c; Cooney GM, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004366.pub6; DeBoer LB, 2012, EXPERT REV NEUROTHER, V12, P1011, DOI 10.1586/ERN.12.73; Demirkan A, 2011, MOL PSYCHIATR, V16, P773, DOI 10.1038/mp.2010.65; Dunstan DW, 2012, DIABETES CARE, V35, P976, DOI 10.2337/dc11-1931; Fava M, 2000, COMPR PSYCHIAT, V41, P97, DOI 10.1016/S0010-440X(00)90140-8; First MB, 2002, DSM 4 T HDB DIFFEREN; Freedson PS, 1998, MED SCI SPORT EXER, V30, P777, DOI 10.1097/00005768-199805000-00021; Hagstromer M, 2007, MED SCI SPORT EXER, V39, P1502, DOI 10.1249/mss.0b013e3180a76de5; Hansen AW, 2014, J PHYS ACT HEALTH, V11, P654, DOI 10.1123/jpah.2012-0040; Healy GN, 2008, DIABETES CARE, V31, P369, DOI 10.2337/dc07-1795; Healy GN, 2008, DIABETES CARE, V31, P661, DOI 10.2337/dc07-2046; Healy GN, 2011, EUR HEART J, V32, P590, DOI 10.1093/eurheartj/ehq451; Jayakody K, 2014, BRIT J SPORT MED, V48, P187, DOI 10.1136/bjsports-2012-091287; Josefsson T, 2014, SCAND J MED SCI SPOR, V24, P259, DOI 10.1111/sms.12050; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Matthews CE, 2005, MED SCI SPORT EXER, V37, pS512, DOI 10.1249/01.mss.0000185659.11982.3d; Matthews CE, 2008, AM J EPIDEMIOL, V167, P875, DOI 10.1093/aje/kwm390; Perraton LG, 2010, J EVAL CLIN PRACT, V16, P597, DOI 10.1111/j.1365-2753.2009.01188.x; Powell KE, 2011, ANNU REV PUBL HEALTH, V32, P349, DOI 10.1146/annurev-publhealth-031210-101151; Schrijvers D, 2008, J AFFECT DISORDERS, V109, P1, DOI 10.1016/j.jad.2007.10.019; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P34, DOI 10.4088/JCP.09m05305whi; Sobin C, 1997, AM J PSYCHIAT, V154, P4; Song MR, 2012, PUBLIC HEALTH NURS, V29, P208, DOI 10.1111/j.1525-1446.2011.00986.x; Spitzer RL, 1999, JAMA-J AM MED ASSOC, V282, P1737, DOI 10.1001/jama.282.18.1737; Teychenne M, 2008, PREV MED, V46, P397, DOI 10.1016/j.ypmed.2008.01.009; Teychenne M, 2011, INT J BEHAV MED, V17, P246, DOI 10.1007/s12529-010-9075-z; Tudor-Locke C, 2012, PREV CHRONIC DIS, V9, DOI 10.5888/pcd9.110332; Uher R, 2008, PSYCHOL MED, V38, P289, DOI 10.1017/S0033291707001730; World Health Organization, 2011, GLOB REC PHYS ACT HL	32	62	63	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2015	10	1							e0115894	10.1371/journal.pone.0115894	http://dx.doi.org/10.1371/journal.pone.0115894			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ4OG	25585123	Green Published, Green Submitted, gold			2022-12-27	WOS:000348201300004
J	Al Khamici, H; Brown, LJ; Hossain, KR; Hudson, AL; Sinclair-Burton, AA; Ng, JPM; Daniel, EL; Hare, JE; Cornell, BA; Curmi, PMG; Davey, MW; Valenzuela, SM				Al Khamici, Heba; Brown, Louise J.; Hossain, Khondker R.; Hudson, Amanda L.; Sinclair-Burton, Alxcia A.; Jane Phui Mun Ng; Daniel, Elizabeth L.; Hare, Joanna E.; Cornell, Bruce A.; Curmi, Paul M. G.; Davey, Mary W.; Valenzuela, Stella M.			Members of the Chloride Intracellular Ion Channel Protein Family Demonstrate Glutaredoxin-Like Enzymatic Activity	PLOS ONE			English	Article							GLUTATHIONE S-TRANSFERASES; CRYSTAL-STRUCTURE; MOLECULAR-CLONING; ETHACRYNIC-ACID; MEMBRANE INTERACTION; THIOREDOXIN SYSTEMS; ACTIN CYTOSKELETON; SOLUBLE FORM; CELL-CYCLE; CLIC1	The Chloride Intracellular Ion Channel (CLIC) family consists of six evolutionarily conserved proteins in humans. Members of this family are unusual, existing as both monomeric soluble proteins and as integral membrane proteins where they function as chloride selective ion channels, however no function has previously been assigned to their soluble form. Structural studies have shown that in the soluble form, CLIC proteins adopt a glutathione S-transferase (GST) fold, however, they have an active site with a conserved glutaredoxin monothiol motif, similar to the omega class GSTs. We demonstrate that CLIC proteins have glutaredoxin-like glutathione-dependent oxidoreductase enzymatic activity. CLICs 1, 2 and 4 demonstrate typical glutaredoxin-like activity using 2-hydroxyethyl disulfide as a substrate. Mutagenesis experiments identify cysteine 24 as the catalytic cysteine residue in CLIC1, which is consistent with its structure. CLIC1 was shown to reduce sodium selenite and dehydroascorbate in a glutathione-dependent manner. Previous electrophysiological studies have shown that the drugs IAA-94 and A9C specifically block CLIC channel activity. These same compounds inhibit CLIC1 oxidoreductase activity. This work for the first time assigns a functional activity to the soluble form of the CLIC proteins. Our results demonstrate that the soluble form of the CLIC proteins has an enzymatic activity that is distinct from the channel activity of their integral membrane form. This CLIC enzymatic activity may be important for protecting the intracellular environment against oxidation. It is also likely that this enzymatic activity regulates the CLIC ion channel function.	[Al Khamici, Heba; Hossain, Khondker R.; Hudson, Amanda L.; Sinclair-Burton, Alxcia A.; Jane Phui Mun Ng; Davey, Mary W.; Valenzuela, Stella M.] Univ Technol Sydney, Sch Med & Mol Biosci, Sydney, NSW 2007, Australia; [Valenzuela, Stella M.] Univ Technol Sydney, Ctr Hlth Technol, Sydney, NSW 2007, Australia; [Brown, Louise J.; Daniel, Elizabeth L.; Hare, Joanna E.] Macquarie Univ, Dept Chem & Bimolecular Sci, Sydney, NSW 2109, Australia; [Cornell, Bruce A.] Roseville, Surg Diagnost, Sydney, NSW 2069, Australia; [Curmi, Paul M. G.] Univ New S Wales, Sch Phys, Sydney, NSW 2052, Australia; [Curmi, Paul M. G.] St Vincents Hosp, Ctr Appl Med Res, Sydney, NSW 2010, Australia; [Hossain, Khondker R.] Australian Nucl Sci & Technol Org, Bragg Inst, Sydney, NSW 2234, Australia	University of Technology Sydney; University of Technology Sydney; Macquarie University; University of New South Wales Sydney; St Vincents Hospital Sydney; Australian Nuclear Science & Technology Organisation	Valenzuela, SM (corresponding author), Univ Technol Sydney, Sch Med & Mol Biosci, Sydney, NSW 2007, Australia.	Stella.Valenzuela@uts.edu.au	Valenzuela, Stella/R-6387-2019; Curmi, Paul/G-7185-2011; Hossain, Khondker/C-1814-2019; Hossain, Khondker Rufaka/AAR-6301-2020	Valenzuela, Stella/0000-0001-5934-6047; Curmi, Paul/0000-0001-5762-7638; Hossain, Khondker/0000-0003-4506-1491; Hossain, Khondker Rufaka/0000-0003-4506-1491; Brown, Louise/0000-0001-8592-2431; cornell, bruce/0000-0003-4166-3241	Centre for Health Technologies, University of Technology Sydney; Australian Research Council [LP120200078]; Australian Institute of Nuclear Science and Engineering (AINSE)	Centre for Health Technologies, University of Technology Sydney; Australian Research Council(Australian Research Council); Australian Institute of Nuclear Science and Engineering (AINSE)	Funding: The authors thank the following organisations for financial support of this research: the Centre for Health Technologies, University of Technology Sydney (funding support to SMV); the Australian Research Council (grant LP120200078 to SMV and BAC) and the Australian Institute of Nuclear Science and Engineering (AINSE Award to SMV, HA, KRH). ARC website URL: http://www.arc.gov.au/; AINSE website URL: http://www.ainse.edu.au/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atkinson HJ, 2009, BIOCHEMISTRY-US, V48, P11108, DOI 10.1021/bi901180v; Berryman M, 2000, MOL BIOL CELL, V11, P1509, DOI 10.1091/mbc.11.5.1509; BJORNSTEDT M, 1994, J BIOL CHEM, V269, P29382; BJORNSTEDT M, 1995, METHOD ENZYMOL, V252, P209; Board PG, 2000, J BIOL CHEM, V275, P24798, DOI 10.1074/jbc.M001706200; Board PG, 2004, INT J BIOCHEM CELL B, V36, P1599, DOI 10.1016/j.biocel.2004.01.026; Bohman S, 2005, J BIOL CHEM, V280, P42397, DOI 10.1074/jbc.M506724200; BOOTH J, 1961, BIOCHEM J, V79, P516, DOI 10.1042/bj0790516; BROPHY PM, 1989, BIOCHEM J, V262, P939, DOI 10.1042/bj2620939; Caccuri AM, 2002, J BIOL CHEM, V277, P18777, DOI 10.1074/jbc.M201137200; CAMERON AD, 1995, STRUCTURE, V3, P717, DOI 10.1016/S0969-2126(01)00206-4; Chalothorn D, 2009, CIRC RES, V105, P89, DOI 10.1161/CIRCRESAHA.109.197145; Cheng NH, 2011, FEBS J, V278, P2525, DOI 10.1111/j.1742-4658.2011.08178.x; Cromer BA, 2002, EUR BIOPHYS J BIOPHY, V31, P356, DOI 10.1007/s00249-002-0219-1; Dalle-Donne I, 2009, TRENDS BIOCHEM SCI, V34, P85, DOI 10.1016/j.tibs.2008.11.002; DAS AK, 1988, BIOCHEM CELL BIOL, V66, P460, DOI 10.1139/o88-057; DEVAMANOHARAN PS, 1991, EXP EYE RES, V52, P563, DOI 10.1016/0014-4835(91)90057-L; Dulhunty A, 2001, J BIOL CHEM, V276, P3319, DOI 10.1074/jbc.M007874200; Duncan RR, 1997, J BIOL CHEM, V272, P23880, DOI 10.1074/jbc.272.38.23880; Edwards JC, 2010, KIDNEY INT, V78, P831, DOI 10.1038/ki.2010.238; Elter A, 2007, J BIOL CHEM, V282, P8786, DOI 10.1074/jbc.M607241200; Fujimura K, 2012, NUCLEIC ACIDS RES, V40, P8099, DOI 10.1093/nar/gks566; Gagnon LH, 2006, J NEUROSCI, V26, P10188, DOI 10.1523/JNEUROSCI.2166-06.2006; Goodchild SC, 2011, BIOCHEMISTRY-US, V50, P10887, DOI 10.1021/bi2012564; Goodchild SC, 2010, BIOCHEMISTRY-US, V49, P5278, DOI 10.1021/bi100111c; Goodchild SC, 2009, EUR BIOPHYS J BIOPHY, V39, P129, DOI 10.1007/s00249-009-0450-0; HABIG WH, 1974, J BIOL CHEM, V249, P7130; Harrop SJ, 2001, J BIOL CHEM, V276, P44993, DOI 10.1074/jbc.M107804200; Hayes JD, 2005, ANNU REV PHARMACOL, V45, P51, DOI 10.1146/annurev.pharmtox.45.120403.095857; Heiss NS, 1997, GENOMICS, V45, P224, DOI 10.1006/geno.1997.4922; Herrero E, 2007, CELL MOL LIFE SCI, V64, P1518, DOI 10.1007/s00018-007-6554-8; HOLMGREN A, 1988, BIOCHEM SOC T, V16, P95, DOI 10.1042/bst0160095; HOLMGREN A, 1995, STRUCTURE, V3, P239, DOI 10.1016/S0969-2126(01)00153-8; HOLMGREN A, 1995, METHOD ENZYMOL, V252, P199; HOLMGREN A, 1979, J BIOL CHEM, V254, P9627; Howell S, 1996, FEBS LETT, V390, P207, DOI 10.1016/0014-5793(96)00676-X; Jeffery CJ, 1999, TRENDS BIOCHEM SCI, V24, P8, DOI 10.1016/S0968-0004(98)01335-8; Jiang L, 2014, BBA-BIOMEMBRANES, V1838, P643, DOI 10.1016/j.bbamem.2013.05.025; Jiang LL, 2012, J CELL SCI, V125, P5479, DOI 10.1242/jcs.110072; Kanaoka Y, 1997, CELL, V90, P1085, DOI 10.1016/S0092-8674(00)80374-8; KEEN JH, 1978, J BIOL CHEM, V253, P5654; LANDRY DW, 1989, SCIENCE, V244, P1469, DOI 10.1126/science.2472007; Littler DR, 2010, FEBS LETT, V584, P2093, DOI 10.1016/j.febslet.2010.01.027; Littler DR, 2005, FEBS J, V272, P4996, DOI 10.1111/j.1742-4658.2005.04909.x; Littler DR, 2004, J BIOL CHEM, V279, P9298, DOI 10.1074/jbc.M308444200; Menon D, 2013, J BIOL CHEM, V288, P25769, DOI 10.1074/jbc.M113.487785; Meyer Y, 2009, ANNU REV GENET, V43, P335, DOI 10.1146/annurev-genet-102108-134201; Nishizawa T, 2000, J BIOL CHEM, V275, P11164, DOI 10.1074/jbc.275.15.11164; Oakley AJ, 1997, BIOCHEMISTRY-US, V36, P576, DOI 10.1021/bi962316i; Pastore A, 2012, EUR J PHARM SCI, V46, P279, DOI 10.1016/j.ejps.2012.03.010; PLOEMEN JHTM, 1993, XENOBIOTICA, V23, P913, DOI 10.3109/00498259309059418; Qian ZJ, 1999, J BIOL CHEM, V274, P1621, DOI 10.1074/jbc.274.3.1621; Qiu MR, 2010, GENESIS, V48, P127, DOI 10.1002/dvg.20590; Redhead C, 1997, MOL BIOL CELL, V8, P691, DOI 10.1091/mbc.8.4.691; Ronnov-Jessen L, 2002, AM J PATHOL, V161, P471, DOI 10.1016/S0002-9440(10)64203-4; Shanks RA, 2002, J BIOL CHEM, V277, P40973, DOI 10.1074/jbc.M112277200; Sheehan D, 2001, BIOCHEM J, V360, P1, DOI 10.1042/0264-6021:3600001; Singh H, 2010, FEBS LETT, V584, P2112, DOI 10.1016/j.febslet.2010.03.013; Sotirchos IM, 2009, FREE RADICAL BIO MED, V46, P579, DOI 10.1016/j.freeradbiomed.2008.11.009; Suh KS, 2004, J BIOL CHEM, V279, P4632, DOI 10.1074/jbc.M311632200; Tang ZX, 2013, MOL BIOL REP, V40, P5105, DOI 10.1007/s11033-013-2612-5; Tulk BM, 2002, AM J PHYSIOL-CELL PH, V282, pC1103, DOI 10.1152/ajpcell.00402.2001; Ulmasov B, 2009, AM J PATHOL, V174, P1084, DOI 10.2353/ajpath.2009.080625; Valenzuela SM, 2000, J PHYSIOL-LONDON, V529, P541, DOI 10.1111/j.1469-7793.2000.00541.x; Valenzuela SM, 1997, J BIOL CHEM, V272, P12575, DOI 10.1074/jbc.272.19.12575; Valenzuela SM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056948; Vlamis-Gardikas A, 2002, METHOD ENZYMOL, V347, P286; Wallenberg M, 2010, BIOCHEM J, V429, P85, DOI 10.1042/BJ20100368; Warton K, 2002, J BIOL CHEM, V277, P26003, DOI 10.1074/jbc.M203666200; WELLS WW, 1990, J BIOL CHEM, V265, P15361	70	53	53	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2015	10	1							e115699	10.1371/journal.pone.0115699	http://dx.doi.org/10.1371/journal.pone.0115699			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ4CF	25581026	Green Published, Green Submitted, gold			2022-12-27	WOS:000348169100002
J	Jang, SY; Shin, YK; Park, SY; Park, JY; Rha, SH; Kim, JK; Lee, HJ; Park, HT				Jang, So Young; Shin, Yoon Kyung; Park, So Young; Park, Joo Youn; Rha, Seo-Hee; Kim, Jong Kuk; Lee, Hye Jeong; Park, Hwan Tae			Autophagy Is Involved in the Reduction of Myelinating Schwann Cell Cytoplasm during Myelin Maturation of the Peripheral Nerve	PLOS ONE			English	Article							MICE; GROWTH; SYSTEM; NEUROPATHY; MTOR; AXON	Peripheral nerve myelination involves dynamic changes in Schwann cell morphology and membrane structure. Recent studies have demonstrated that autophagy regulates organelle biogenesis and plasma membrane dynamics. In the present study, we investigated the role of autophagy in the development and differentiation of myelinating Schwann cells during sciatic nerve myelination. Electron microscopy and biochemical assays have shown that Schwann cells remove excess cytoplasmic organelles during myelination through macroautophagy. Inhibition of autophagy via Schwann cell-specific removal of ATG7, an essential molecule for macroautophagy, using a conditional knockout strategy, resulted in abnormally enlarged abaxonal cytoplasm in myelinating Schwann cells that contained a large number of ribosomes and an atypically expanded endoplasmic reticulum. Small fiber hypermyelination and minor anomalous peripheral nerve functions are observed in this mutant. Rapamycin-induced suppression of mTOR activity during the early postnatal period enhanced not only autophagy but also developmental reduction of myelinating Schwann cells cytoplasm in vivo. Together, our findings suggest that autophagy is a regulatory mechanism of Schwann cells structural plasticity during myelination.	[Jang, So Young; Shin, Yoon Kyung; Park, Joo Youn; Park, Hwan Tae] Mitochondria Hub Regulat Ctr, Dept Physiol, Pusan, South Korea; [Park, So Young; Lee, Hye Jeong] Mitochondria Hub Regulat Ctr, Dept Pharmacol, Pusan, South Korea; [Rha, Seo-Hee] Dong A Univ, Coll Med, Dept Pathol, Pusan, South Korea; [Kim, Jong Kuk] Dong A Univ, Coll Med, Dept Neurol, Pusan, South Korea	Dong A University; Dong A University	Park, HT (corresponding author), Mitochondria Hub Regulat Ctr, Dept Physiol, Pusan, South Korea.	phwantae@dau.ac.kr	Kim, Jong Kuk/C-6426-2018; Kuk, Kim Jong/ABH-5221-2020	Kim, Jong Kuk/0000-0001-9204-3718; Kuk, Kim Jong/0000-0001-9204-3718	National Research Foundation of Korea (NRF) - Korean government (MSIP) [2014-001483, 2014R1A2A2A01002566]	National Research Foundation of Korea (NRF) - Korean government (MSIP)	Funding: This research was supported by the National Research Foundation of Korea (NRF) grant funded by the Korean government (MSIP) (2014-001483, 2014R1A2A2A01002566). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bakhti M, 2014, CELL MOL LIFE SCI, V71, P1265, DOI 10.1007/s00018-013-1492-0; Bjorkoy G, 2005, J CELL BIOL, V171, P603, DOI 10.1083/jcb.200507002; Court FA, 2009, J NEUROSCI, V29, P3908, DOI 10.1523/JNEUROSCI.5672-08.2009; Feltri ML, 1999, ANN NY ACAD SCI, V883, P116, DOI 10.1111/j.1749-6632.1999.tb08574.x; Friedman LG, 2012, J NEUROSCI, V32, P7585, DOI 10.1523/JNEUROSCI.5809-11.2012; Garbay B, 2000, PROG NEUROBIOL, V61, P267, DOI 10.1016/S0301-0082(99)00049-0; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; Komatsu M, 2005, J CELL BIOL, V169, P425, DOI 10.1083/jcb.200412022; Komatsu M, 2007, CELL, V131, P1149, DOI 10.1016/j.cell.2007.10.035; Komatsu M, 2006, NATURE, V441, P880, DOI 10.1038/nature04723; LOW PA, 1976, J NEUROL SCI, V30, P343, DOI 10.1016/0022-510X(76)90139-8; Masiero E, 2009, CELL METAB, V10, P507, DOI 10.1016/j.cmet.2009.10.008; Mizushima N, 2007, GENE DEV, V21, P2861, DOI 10.1101/gad.1599207; Pereira JA, 2012, TRENDS NEUROSCI, V35, P123, DOI 10.1016/j.tins.2011.11.006; Ravikumar B, 2010, PHYSIOL REV, V90, P1383, DOI 10.1152/physrev.00030.2009; Sherman DL, 2012, J NEUROSCI, V32, P1817, DOI 10.1523/JNEUROSCI.4814-11.2012; Shin YK, 2010, GLIA, V58, P1961, DOI 10.1002/glia.21065; Singh R, 2009, J CLIN INVEST, V119, P3329, DOI 10.1172/JCI39228; WEBSTER HD, 1971, J CELL BIOL, V48, P348, DOI 10.1083/jcb.48.2.348; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025	20	32	33	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2015	10	1							e0116624	10.1371/journal.pone.0116624	http://dx.doi.org/10.1371/journal.pone.0116624			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ4CF	25581066	Green Published, Green Submitted, gold			2022-12-27	WOS:000348169100004
J	Yen, WY; Cai, B; Yang, JL; Zhang, L; Zeng, M; Tarbell, JM; Fu, BMM				Yen, Wanyi; Cai, Bin; Yang, Jinlin; Zhang, Lin; Zeng, Min; Tarbell, John M.; Fu, Bingmei M.			Endothelial Surface Glycocalyx Can Regulate Flow-Induced Nitric Oxide Production in Microvessels In Vivo	PLOS ONE			English	Article							FLUID SHEAR-STRESS; HEPARAN-SULFATE; NO PRODUCTION; HYDRAULIC CONDUCTIVITY; VASCULAR-PERMEABILITY; INTACT MICROVESSELS; CELL-ADHESION; TUMOR-CELLS; MECHANOTRANSDUCTION; ARTERIES	Due to its unique location, the endothelial surface glycocalyx ( ESG) at the luminal side of the microvessel wall may serve as a mechano-sensor and transducer of blood flow and thus regulate endothelial functions. To examine this role of the ESG, we used fluorescence microscopy to measure nitric oxide ( NO) production in post-capillary venules and arterioles of rat mesentery under reduced ( low) and normal ( high) flow conditions, with and without enzyme pretreatment to remove heparan sulfate ( HS) of the ESG and in the presence of an endothelial nitric oxide synthase ( eNOS) inhibitor, N-G-monomethyl-L-arginine ( L-NMMA). Rats ( SD, 250-300g) were anesthetized. The mesentery was gently taken out from the abdominal cavity and arranged on the surface of a glass coverslip for the measurement. An individual post-capillary venule or arteriole was cannulated and loaded for 45 min with 5 mu M 4, 5-Diaminofluorescein diacetate, a membrane permeable fluorescent indictor for NO, then the NO production was measured for similar to 10 min under a low flow (similar to 300 mu m/s) and for similar to 60 min under a high flow (similar to 1000 mu m/s). In the 15 min after switching to the high flow, DAF-2-NO fluorescence intensity increased to 1.27-fold of its baseline, DAF-2-NO continuously increased under the high flow, to 1.53-fold of its baseline in 60 min. Inhibition of eNOS by 1 mM L-NMMA attenuated the flow-induced NO production to 1.13-fold in 15 min and 1.30-fold of its baseline in 60 min, respectively. In contrast, no significant increase in NO production was observed after switching to the high flow for 60 min when 1 h pretreatment with 50 mU/mL heparanase III to degrade the ESG was applied. Similar NO production was observed in arterioles under low and high flows and under eNOS inhibition. Our results suggest that ESG participates in endothelial cell mechanosensing and transduction through its heparan sulfate to activate eNOS.	[Yen, Wanyi; Cai, Bin; Yang, Jinlin; Zhang, Lin; Zeng, Min; Tarbell, John M.; Fu, Bingmei M.] CUNY City Coll, Dept Biomed Engn, New York, NY 10031 USA	City University of New York (CUNY) System; City College of New York (CUNY)	Fu, BMM (corresponding author), CUNY City Coll, Dept Biomed Engn, New York, NY 10031 USA.	fu@ccny.cuny.edu	Fu, Bingmei M/I-3295-2013		NIH [1R01HL094889-01, SC1CA153325-01]; NATIONAL CANCER INSTITUTE [SC1CA153325] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL094889] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Supported by NIH 1R01HL094889-01 and NIH SC1CA153325-01. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAKER M, 1974, MICROVASC RES, V7, P131, DOI 10.1016/0026-2862(74)90043-0; Barakat AI, 2008, CIRC RES, V102, P747, DOI 10.1161/CIRCRESAHA.108.174839; Becker BF, 2010, BASIC RES CARDIOL, V105, P687, DOI 10.1007/s00395-010-0118-z; Cai B, 2012, J APPL PHYSIOL, V113, P1141, DOI 10.1152/japplphysiol.00479.2012; Chang YS, 2000, ARTERIOSCL THROM VAS, V20, P35, DOI 10.1161/01.ATV.20.1.35; Chappell D, 2008, BIOL CHEM, V389, P79, DOI 10.1515/BC.2008.005; Chappell D, 2011, ANESTHESIOLOGY, V115, P483, DOI 10.1097/ALN.0b013e3182289988; Constantinescu AA, 2003, ARTERIOSCL THROM VAS, V23, P1541, DOI 10.1161/01.ATV.0000085630.24353.3D; COOKE JP, 1990, AM J PHYSIOL, V259, pH804, DOI 10.1152/ajpheart.1990.259.3.H804; Curry FRE, 2010, CARDIOVASC RES, V87, P218, DOI 10.1093/cvr/cvq115; Ebong EE, 2014, INTEGR BIOL-UK, V6, P338, DOI 10.1039/c3ib40199e; Egorova AD, 2012, DIFFERENTIATION, V83, pS56, DOI 10.1016/j.diff.2011.11.007; Florian JA, 2003, CIRC RES, V93, pE136, DOI 10.1161/01.RES.0000101744.47866.D5; Forstermann U, 2012, EUR HEART J, V33, P829, DOI 10.1093/eurheartj/ehr304; Forstermann U, 2006, CIRCULATION, V113, P1708, DOI 10.1161/CIRCULATIONAHA.105.602532; Fu BMM, 2013, WIRES SYST BIOL MED, V5, P381, DOI 10.1002/wsbm.1211; Fu BMM, 2004, MICROVASC RES, V68, P51, DOI 10.1016/j.mvr.2004.03.004; Gao LJ, 2010, MICROVASC RES, V80, P394, DOI 10.1016/j.mvr.2010.06.005; Gautam M, 2006, J BIOL CHEM, V281, P36492, DOI 10.1074/jbc.M605866200; Giantsos-Adams KM, 2013, CELL MOL BIOENG, V6, P160, DOI 10.1007/s12195-013-0273-z; Gojova A, 2005, J APPL PHYSIOL, V98, P2355, DOI 10.1152/japplphysiol.01136.2004; Guo P, 2014, BIOMECH MODEL MECHAN, V13, P537, DOI 10.1007/s10237-013-0515-y; Guo X, 2009, ACTA PHYSIOL, V197, P99, DOI 10.1111/j.1748-1716.2009.01999.x; Juffer P, 2014, CELL BIOCHEM BIOPHYS, V69, P411, DOI 10.1007/s12013-013-9812-4; Kang HY, 2011, AM J PHYSIOL-HEART C, V300, pH76, DOI 10.1152/ajpheart.00905.2010; Kojima H, 1998, NEUROREPORT, V9, P3345, DOI 10.1097/00001756-199810260-00001; Koo A, 2013, BIOPHYS J, V104, P2295, DOI 10.1016/j.bpj.2013.03.052; Koo A, 2013, AM J PHYSIOL-CELL PH, V304, pC137, DOI 10.1152/ajpcell.00187.2012; KUCHAN MJ, 1994, AM J PHYSIOL, V266, pC628, DOI 10.1152/ajpcell.1994.266.3.C628; Kumagai R, 2009, FREE RADICAL BIO MED, V47, P600, DOI 10.1016/j.freeradbiomed.2009.05.034; Liu Q, 2008, J BIOMECH, V41, P2726, DOI 10.1016/j.jbiomech.2008.06.013; Lopez-Quintero SV, 2009, AM J PHYSIOL-HEART C, V296, pH1451, DOI 10.1152/ajpheart.00894.2008; Matsui TS, 2011, INTERFACE FOCUS, V1, P754, DOI 10.1098/rsfs.2011.0031; Mochizuki S, 2003, AM J PHYSIOL-HEART C, V285, pH722, DOI 10.1152/ajpheart.00691.2002; Morgan JT, 2011, MOL BIOL CELL, V22, P4324, DOI 10.1091/mbc.E11-04-0287; Mulivor AW, 2009, MICROCIRCULATION, V16, P657, DOI 10.3109/10739680903133714; Padberg JS, 2014, ATHEROSCLEROSIS, V234, P335, DOI 10.1016/j.atherosclerosis.2014.03.016; Pahakis MY, 2007, BIOCHEM BIOPH RES CO, V355, P228, DOI 10.1016/j.bbrc.2007.01.137; POHL U, 1991, AM J PHYSIOL, V261, pH2016, DOI 10.1152/ajpheart.1991.261.6.H2016; Pries AR, 2000, PFLUG ARCH EUR J PHY, V440, P653, DOI 10.1007/s004240000307; PRITCHARD KA, 1995, CIRC RES, V77, P510, DOI 10.1161/01.RES.77.3.510; Reitsma S, 2007, PFLUG ARCH EUR J PHY, V454, P345, DOI 10.1007/s00424-007-0212-8; Reitsma S, 2011, J VASC RES, V48, P297, DOI 10.1159/000322176; Rosenberg RD, 1997, J CLIN INVEST, V100, pS67; Schwartz MA, 2008, CURR OPIN CELL BIOL, V20, P551, DOI 10.1016/j.ceb.2008.05.005; Shen S, 2010, EXP PHYSIOL, V95, P369, DOI 10.1113/expphysiol.2009.050260; Stevens HY, 2008, DIS MODEL MECH, V1, P175, DOI 10.1242/dmm.000547; Tabouillot T, 2011, CELL MOL BIOENG, V4, P169, DOI 10.1007/s12195-010-0136-9; Tarbell JM, 2006, J INTERN MED, V259, P339, DOI 10.1111/j.1365-2796.2006.01620.x; Tarbell JM, 2010, CARDIOVASC RES, V87, P320, DOI 10.1093/cvr/cvq146; van den Berg BM, 2003, CIRC RES, V92, P592, DOI 10.1161/01.RES.0000065917.53950.75; van Haaren PMA, 2003, AM J PHYSIOL-HEART C, V285, pH2848, DOI 10.1152/ajpheart.00117.2003; VanTeeffelen JWGE, 2007, HYPERTENSION, V50, P261, DOI 10.1161/HYPERTENSIONAHA.107.089250; VanTeeffelen JWGE, 2010, CARDIOVASC RES, V87, P311, DOI 10.1093/cvr/cvq114; Wang N, 2009, NAT REV MOL CELL BIO, V10, P75, DOI 10.1038/nrm2594; Weinbaum S, 2007, ANNU REV BIOMED ENG, V9, P121, DOI 10.1146/annurev.bioeng.9.060906.151959; Williams DA, 2007, MICROVASC RES, V73, P48, DOI 10.1016/j.mvr.2006.08.003; Wu QH, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.194501; Yamamoto K, 2011, J PHARMACOL SCI, V116, P323, DOI 10.1254/jphs.10R29FM; Yao Y, 2007, AM J PHYSIOL-HEART C, V293, pH1023, DOI 10.1152/ajpheart.00162.2007; Yen WY, 2012, MICROVASC RES, V83, P337, DOI 10.1016/j.mvr.2012.02.005; Yi FX, 2002, AM J PHYSIOL-HEART C, V283, pH2725, DOI 10.1152/ajpheart.00428.2002; Zeng Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086249; Zeng Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043168; Zhou XP, 2011, AM J PHYSIOL-HEART C, V301, pH108, DOI 10.1152/ajpheart.00195.2011; Zhu LK, 2005, AM J PHYSIOL-HEART C, V288, pH2869, DOI 10.1152/ajpheart.01080.2004; Ziegler T, 1998, ARTERIOSCL THROM VAS, V18, P686, DOI 10.1161/01.ATV.18.5.686	67	67	69	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2015	10	1							e0117133	10.1371/journal.pone.0117133	http://dx.doi.org/10.1371/journal.pone.0117133			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ4BU	25575016	Green Published, gold			2022-12-27	WOS:000348168100012
J	Meissner, AM; Christiansen, F; Martinez, E; Pawley, MDM; Orams, MB; Stockin, KA				Meissner, Anna M.; Christiansen, Fredrik; Martinez, Emmanuelle; Pawley, Matthew D. M.; Orams, Mark B.; Stockin, Karen A.			Behavioural Effects of Tourism on Oceanic Common Dolphins, Delphinus sp., in New Zealand: The Effects of Markov Analysis Variations and Current Tour Operator Compliance with Regulations	PLOS ONE			English	Article							BOTTLE-NOSED DOLPHINS; EAST AUCKLAND CURRENT; TURSIOPS-TRUNCATUS; HAURAKI GULF; HECTORS DOLPHINS; FEEDING PROGRAM; DOUBTFUL SOUND; SOUTH-EAST; BOATS; WHALES	Common dolphins, Delphinus sp., are one of the marine mammal species tourism operations in New Zealand focus on. While effects of cetacean-watching activities have previously been examined in coastal regions in New Zealand, this study is the first to investigate effects of commercial tourism and recreational vessels on common dolphins in an open oceanic habitat. Observations from both an independent research vessel and aboard commercial tour vessels operating off the central and east coast Bay of Plenty, North Island, New Zealand were used to assess dolphin behaviour and record the level of compliance by permitted commercial tour operators and private recreational vessels with New Zealand regulations. Dolphin behaviour was assessed using two different approaches to Markov chain analysis in order to examine variation of responses of dolphins to vessels. Results showed that, regardless of the variance in Markov methods, dolphin foraging behaviour was significantly altered by boat interactions. Dolphins spent less time foraging during interactions and took significantly longer to return to foraging once disrupted by vessel presence. This research raises concerns about the potential disruption to feeding, a biologically critical behaviour. This may be particularly important in an open oceanic habitat, where prey resources are typically widely dispersed and unpredictable in abundance. Furthermore, because tourism in this region focuses on common dolphins transiting between adjacent coastal locations, the potential for cumulative effects could exacerbate the local effects demonstrated in this study. While the overall level of compliance by commercial operators was relatively high, non-compliance to the regulations was observed with time restriction, number or speed of vessels interacting with dolphins not being respected. Additionally, prohibited swimming with calves did occur. The effects shown in this study should be carefully considered within conservation management plans, in order to reduce the risk of detrimental effects on common dolphins within the region.	[Meissner, Anna M.; Martinez, Emmanuelle; Pawley, Matthew D. M.; Orams, Mark B.; Stockin, Karen A.] Massey Univ, Coastal Marine Res Grp, Inst Nat & Math Sci, Auckland, New Zealand; [Christiansen, Fredrik] Deakin Univ, Ctr Integrat Ecol, Sch Life & Environm Sci, Warrnambool, Vic, Australia; [Christiansen, Fredrik] Murdoch Univ, Cetacean Res Unit, Sch Vet & Life Sci, Murdoch, WA 6150, Australia; [Martinez, Emmanuelle] Pacific Whale Fdn, Wailuku, HI USA; [Orams, Mark B.] Auckland Univ Technol, New Zealand Tourism Res Inst, Sch Hospitality & Tourism, Auckland, New Zealand	Massey University; Deakin University; Murdoch University; Auckland University of Technology	Meissner, AM (corresponding author), Massey Univ, Coastal Marine Res Grp, Inst Nat & Math Sci, Private Bag 102904, Auckland, New Zealand.	anna.meissner@gmail.com	Stockin, Karen A/B-4452-2010; Christiansen, Fredrik/O-3655-2017	Christiansen, Fredrik/0000-0001-9090-8458; Stockin, Karen/0000-0002-2981-3983; Martinez, Emmanuelle/0000-0001-6492-2643; Meissner, Anna/0000-0002-4997-3538	East Coast Bay of Plenty Conservancy of the Department of Conservation; Massey University; Massey University Institute of Natural and Mathematical Sciences Fees Scholarship; Massey University Doctoral Scholarship	East Coast Bay of Plenty Conservancy of the Department of Conservation; Massey University; Massey University Institute of Natural and Mathematical Sciences Fees Scholarship; Massey University Doctoral Scholarship	This project was funded by the East Coast Bay of Plenty Conservancy of the Department of Conservation and Massey University. AMM is the recipient of a Massey University Institute of Natural and Mathematical Sciences Fees Scholarship and a Massey University Doctoral Scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTMANN J, 1974, BEHAVIOUR, V49, P227, DOI 10.1163/156853974X00534; Arcangeli Antonella, 2009, Journal of Marine Animals and their Ecology, V2, P3; Baker CS, 2010, NEW ZEAL J MAR FRESH, V44, P101, DOI 10.1080/00288330.2010.482970; Barr K, 1997, THESIS U OTAGO; Bearzi G, 2005, AQUAT CONSERV, V15, P243, DOI 10.1002/aqc.667; Bearzi G, 1997, MAR MAMMAL SCI, V13, P650, DOI 10.1111/j.1748-7692.1997.tb00089.x; Bearzi G, 2011, MAR MAMMAL SCI, V27, pE165, DOI 10.1111/j.1748-7692.2010.00448.x; Bejder L, 1999, MAR MAMMAL SCI, V15, P738, DOI 10.1111/j.1748-7692.1999.tb00840.x; Bejder L, 2006, CONSERV BIOL, V20, P1791, DOI 10.1111/j.1523-1739.2006.00540.x; BOGGS CL, 1992, FUNCT ECOL, V6, P508, DOI 10.2307/2390047; Burgess L, 2006, THESIS MASSEY U; Chen CL, 2011, MAR POLICY, V35, P10, DOI 10.1016/j.marpol.2010.07.002; Christiansen F, 2014, J EXP MAR BIOL ECOL, V459, P96, DOI 10.1016/j.jembe.2014.05.014; Christiansen F, 2013, BEHAV ECOL, V24, P1415, DOI 10.1093/beheco/art086; Christiansen Fredrik, 2010, Endangered Species Research, V11, P91, DOI 10.3354/esr00265; Constantine R, 2001, MAR MAMMAL SCI, V17, P689, DOI 10.1111/j.1748-7692.2001.tb01293.x; Constantine R, 2004, BIOL CONSERV, V117, P299, DOI 10.1016/j.biocon.2003.12.009; Constantine R., 1997, MONITORING COMMERCIA; Courbis S, 2009, MAR MAMMAL SCI, V25, P430, DOI 10.1111/j.1748-7692.2008.00254.x; de la Brosse N, 2010, THESIS MASSEY U; Donaldson R., 2010, Pacific Conservation Biology, V16, P157; Draheim M., 2010, Tourism in Marine Environments, V6, P175, DOI 10.3727/154427310X12764412619046; Dwyer SL, 2014, NEW ZEAL J MAR FRESH, V48, P294, DOI 10.1080/00288330.2013.866578; Dwyer SL, 2014, ENDANGER SPECIES RES, V25, P97, DOI 10.3354/esr00613; Filby NE, 2014, GLOB ECOL CONSERV, V2, P62, DOI 10.1016/j.gecco.2014.08.006; Foroughirad V, 2013, BIOL CONSERV, V160, P242, DOI 10.1016/j.biocon.2013.01.001; Gaborit-Haverkort T, 2011, E COAST BAY PLENTY C; GASKIN DE, 1992, CAN FIELD NAT, V106, P55; Guerra M, 2014, ENDANGER SPECIES RES, V24, P221, DOI 10.3354/esr00598; Hammond, 2008, DELPHINUS DELPHIS IU; Hammond PS, 2008, DELPHINUS CAPENSIS I; Higham J., 2014, WHALE WATCHING SUSTA; Hollingworth K, 2001, DEMOGRAPHY DISPERSIO; Hoyt E., 2001, WHALE WATCHING 2001; Hughes P, 2001, TOURISM MANAGE, V22, P321, DOI 10.1016/S0261-5177(00)00070-4; International Fund for Animal Welfare, 2005, GROWTH NZ WHAL WATCH; International Whaling Commision, 2001, J CET RES MAN SUPPL, V3, P297; InternationalWhaling Commission, 2014, J CETACEAN RES MAN S, V15, P380; Jensen FH, 2009, MAR ECOL PROG SER, V395, P161, DOI 10.3354/meps08204; Lachmuth CL, 2011, MAR POLLUT BULL, V62, P792, DOI 10.1016/j.marpolbul.2011.01.002; Laist DW, 2001, MAR MAMMAL SCI, V17, P35, DOI 10.1111/j.1748-7692.2001.tb00980.x; Dans SL, 2012, CONSERV BIOL, V26, P708, DOI 10.1111/j.1523-1739.2012.01844.x; Luksenburg JA, 2014, AQUAT CONSERV, V24, P135, DOI 10.1002/aqc.2348; Lundquist D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041969; Lusseau D, 2003, CONSERV BIOL, V17, P1785, DOI 10.1111/j.1523-1739.2003.00054.x; Lusseau D, 2004, ECOL SOC, V9; Lusseau D, 2003, MAR ECOL PROG SER, V257, P267, DOI 10.3354/meps257267; Lusseau D, 2006, MAR MAMMAL SCI, V22, P802, DOI 10.1111/j.1748-7692.2006.00052.x; Lusseau David, 2009, Endangered Species Research, V6, P211, DOI 10.3354/esr00154; Mann J, 1999, MAR MAMMAL SCI, V15, P102, DOI 10.1111/j.1748-7692.1999.tb00784.x; Mann J, 2000, BEHAV ECOL, V11, P210, DOI 10.1093/beheco/11.2.210; Markowitz T. M., 2009, TOURISM EFFECTS DUSK; Martinez E., 2013, Pacific Conservation Biology, V19, P19; Martinez E, 2010, THESIS MASSEY U; Martinez E, 2011, TOURISM MARINE ENV, V7, P191, DOI [10.3727/154427311X13195453162895, DOI 10.3727/154427311X13195453162895]; Martinez E, 2010, TOUR REV INT, V14, P99, DOI 10.3727/154427211X13044361606379; Martinez E, 2012, MAR MAMMAL SCI, V28, pE295, DOI 10.1111/j.1748-7692.2011.00528.x; Meissner AM, 2014, EFFECTS COMMERCIAL T; Meynier L, 2008, MAR ECOL PROG SER, V354, P277, DOI 10.3354/meps07246; Miller LJ, 2008, J MAR BIOL ASSOC UK, V88, P1139, DOI 10.1017/S0025315408000908; Neumann Dirk R., 2006, Aquatic Mammals, V32, P1, DOI 10.1578/AM.32.1.2006.1; Neumann Dirk R., 2003, Aquatic Mammals, V29, P137, DOI 10.1578/016754203101023997; Neumann Dirk R., 2001, Aquatic Mammals, V27, P121; Neumann DR, 2002, NEW ZEAL J MAR FRESH, V36, P593, DOI 10.1080/00288330.2002.9517115; Neumann DR, 2001, NEW ZEAL J MAR FRESH, V35, P371, DOI 10.1080/00288330.2001.9517007; Neumann DR, 2001, THESIS MASSEY U; Nichols C., 2001, OBSERVATIONS INTERAC; Nowacek SM, 2001, MAR MAMMAL SCI, V17, P673, DOI 10.1111/j.1748-7692.2001.tb01292.x; O'Connor S., 2009, WHALE WATCHING WORLD; Orams M., 2004, Tourism in Marine Environments, V1, P17; Orams MB, 2002, TOURISM MANAGE, V23, P281, DOI 10.1016/S0261-5177(01)00080-2; Orams MB, 1996, MAR MAMMAL SCI, V12, P107, DOI 10.1111/j.1748-7692.1996.tb00308.x; Parsons ECM, 2009, CURR ISSUES TOUR, V12, P397, DOI 10.1080/13683500902730460; Parsons ECM, 2006, J CETACEAN RES MAN S, V8, P249; PARSONS ECM, 2012, J MAR BIOL, V2012, DOI DOI 10.1155/2012/807294; R Core Team, 2021, R LANGUAGE ENV STAT; Rafic M, 1999, J CETACEAN RES MAN S, V1, P230; Samuels Amy, 2004, Journal of Cetacean Research and Management, V6, P69; Scarpaci C, 2013, J CETACEAN RES MANAG, P1; Scarpaci Carol, 2000, Journal of Cetacean Research and Management, V2, P183; Schaffar-Delaney A, 2004, THESIS MASSEY U; Shane S.H., 1990, P245; Sharples J, 1997, CONT SHELF RES, V17, P835, DOI 10.1016/S0278-4343(96)00060-X; Smith H, 2008, TOURISM MANAGE, V29, P994, DOI 10.1016/j.tourman.2008.01.001; Stamation KA, 2010, MAR MAMMAL SCI, V26, P98, DOI 10.1111/j.1748-7692.2009.00320.x; Stanton BR, 1997, NEW ZEAL J MAR FRESH, V31, P537, DOI 10.1080/00288330.1997.9516787; Steckenreuter A, 2012, J ENVIRON MANAGE, V97, P14, DOI 10.1016/j.jenvman.2011.11.002; Stensland E, 2007, MAR ECOL PROG SER, V332, P225, DOI 10.3354/meps332225; Stockin KA, 2007, SCI TOTAL ENVIRON, V387, P333, DOI 10.1016/j.scitotenv.2007.05.016; Stockin K.A., 2009, J CETACEAN RES MANAG, VSC/61/SM20, P1; Stockin KA, 2011, 19 BIENN C BIOL MAR; Stockin KA, 2008, MAR ECOL PROG SER, V355, P287, DOI 10.3354/meps07386; Stockin Karen A., 2009, Pacific Conservation Biology, V15, P217; Stockin KA, 2009, MAR MAMMAL SCI, V25, P283, DOI 10.1111/j.1748-7692.2008.00262.x; Stockin Karen A., 2008, Aquatic Mammals, V34, P200, DOI 10.1578/AM.34.2.2008.200; Suisted R, 2004, DEP CONSERVATION MAR; Thompson PM, 2000, CONSERV BIOL, V14, P1253, DOI 10.1046/j.1523-1739.2000.00099-410.x; Tilburg CE, 2001, J PHYS OCEANOGR, V31, P2917, DOI 10.1175/1520-0485(2001)031<2917:TDOTEA>2.0.CO;2; Townsend A.J., 2008, NZ THREAT CLASSIFICA; Waltzek TB, 2012, ZOONOSES PUBLIC HLTH, V59, P521, DOI 10.1111/j.1863-2378.2012.01492.x; Wells RS, 1997, MAR MAMMAL SCI, V13, P475, DOI 10.1111/j.1748-7692.1997.tb00654.x; Williams R, 2006, BIOL CONSERV, V133, P301, DOI 10.1016/j.biocon.2006.06.010; Williams Rob, 2009, Endangered Species Research, V6, P199, DOI 10.3354/esr00150; Wilson B, 1999, ECOL APPL, V9, P288, DOI 10.1890/1051-0761(1999)009[0288:ESAATI]2.0.CO;2; Young DD, 1995, Z SAUGETIERKD, V60, P343; YOUNG DD, 1994, J ZOOL, V234, P41, DOI 10.1111/j.1469-7998.1994.tb06055.x; Zaeschmar JR, 2014, MAR MAMMAL SCI, V30, P594, DOI 10.1111/mms.12065	107	59	63	1	99	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2015	10	1							e0116962	10.1371/journal.pone.0116962	http://dx.doi.org/10.1371/journal.pone.0116962			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AZ4BS	25565523	gold, Green Submitted, Green Published			2022-12-27	WOS:000348167900006
J	Narusaka, M; Minami, T; Iwabuchi, C; Hamasaki, T; Takasaki, S; Kawamura, K; Narusaka, Y				Narusaka, Mari; Minami, Taichi; Iwabuchi, Chikako; Hamasaki, Takashi; Takasaki, Satoko; Kawamura, Kimito; Narusaka, Yoshihiro			Yeast Cell Wall Extract Induces Disease Resistance against Bacterial and Fungal Pathogens in Arabidopsis thaliana and Brassica Crop	PLOS ONE			English	Article							SYSTEMIC ACQUIRED-RESISTANCE; MICROBE INTERACTIONS; DEFENSE RESPONSES; GENE-EXPRESSION; SALICYLIC-ACID; PLANT; GROWTH; SUPPRESSORS; ACTIVATION; PATHWAYS	Housaku Monogatari (HM) is a plant activator prepared from a yeast cell wall extract. We examined the efficacy of HM application and observed that HM treatment increased the resistance of Arabidopsis thaliana and Brassica rapa leaves to bacterial and fungal infections. HM reduced the severity of bacterial leaf spot and anthracnose on A. thaliana and Brassica crop leaves with protective effects. In addition, gene expression analysis of A. thaliana plants after treatment with HM indicated increased expression of several plant defense-related genes. HM treatment appears to induce early activation of jasmonate/ethylene and late activation of salicylic acid (SA) pathways. Analysis using signaling mutants revealed that HM required SA accumulation and SA signaling to facilitate resistance to the bacterial pathogen Pseudomonas syringae pv. maculicola and the fungal pathogen Colletotrichum higginsianum. In addition, HM-induced resistance conferred chitin-independent disease resistance to bacterial pathogens in A. thaliana. These results suggest that HM contains multiple microbe-associated molecular patterns that activate defense responses in plants. These findings suggest that the application of HM is a useful tool that may facilitate new disease control methods.	[Narusaka, Mari; Narusaka, Yoshihiro] Res Inst Biol Sci Okayama, Okayama, Japan; [Minami, Taichi; Iwabuchi, Chikako; Hamasaki, Takashi; Takasaki, Satoko; Kawamura, Kimito] Asahi Grp Holdings Ltd, Res & Dev Labs Sustainable Value Creat, Ibaraki, Japan	Asahi Group Holdings Ltd.	Narusaka, Y (corresponding author), Res Inst Biol Sci Okayama, Okayama, Japan.	yo_narusaka@bio-ribs.com			Industrial Technology Research Grant Program from New Energy and Industrial Technology Development Organization (NEDO) of Japan; Japan Society for the Promotion of Science (JSPS) KAKENHI Grant [24580071, 25450523]	Industrial Technology Research Grant Program from New Energy and Industrial Technology Development Organization (NEDO) of Japan(New Energy and Industrial Technology Development Organization (NEDO)); Japan Society for the Promotion of Science (JSPS) KAKENHI Grant(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the Industrial Technology Research Grant Program in 2004 and 2009 from the New Energy and Industrial Technology Development Organization (NEDO) of Japan to YN, and by Japan Society for the Promotion of Science (JSPS) KAKENHI Grant Numbers 24580071 to YN and 25450523 to MN. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. TM, CI, TH, ST and KK are employed by Asahi Group Holdings, Ltd. Asahi Group Holdings, Ltd. provided support in the form of salaries for authors TM, CI, TH, ST and KK, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Aguilar-Uscanga B, 2003, LETT APPL MICROBIOL, V37, P268, DOI 10.1046/j.1472-765X.2003.01394.x; BASSE CW, 1993, J BIOL CHEM, V268, P14724; Bull CT, 2010, SYST APPL MICROBIOL, V33, P105, DOI 10.1016/j.syapm.2010.02.001; CAO H, 1994, PLANT CELL, V6, P1583, DOI 10.1105/tpc.6.11.1583; Chisholm ST, 2006, CELL, V124, P803, DOI 10.1016/j.cell.2006.02.008; de Torres M, 2003, PLANT J, V33, P665, DOI 10.1046/j.1365-313X.2003.01653.x; DELANEY TP, 1994, SCIENCE, V266, P1247, DOI 10.1126/science.266.5188.1247; Dewdney J, 2000, PLANT J, V24, P205, DOI 10.1046/j.1365-313x.2000.00870.x; DUNNETT CW, 1955, J AM STAT ASSOC, V50, P1096, DOI 10.2307/2281208; GUZMAN P, 1990, PLANT CELL, V2, P513, DOI 10.1105/tpc.2.6.513; He P, 2007, CELL MICROBIOL, V9, P1385, DOI 10.1111/j.1462-5822.2007.00944.x; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Klis FM, 2006, YEAST, V23, P185, DOI 10.1002/yea.1349; Lawton KA, 1996, PLANT J, V10, P71, DOI 10.1046/j.1365-313X.1996.10010071.x; Minami T, 2011, PLANT BIOTECHNOL-NAR, V28, P481, DOI 10.5511/plantbiotechnology.11.1020a; Miya A, 2007, P NATL ACAD SCI USA, V104, P19613, DOI 10.1073/pnas.0705147104; Narusaka M, 2011, J GEN PLANT PATHOL, V77, P75, DOI 10.1007/s10327-011-0298-x; Narusaka M, 2010, J GEN PLANT PATHOL, V76, P1, DOI 10.1007/s10327-009-0211-z; Narusaka M, 2009, PLANT J, V60, P218, DOI 10.1111/j.1365-313X.2009.03949.x; Narusaka Y, 2009, PLANT BIOTECHNOL, V26, P345, DOI 10.5511/plantbiotechnology.26.345; Obara N., 2007, Japanese Journal of Phytopathology, V73, P94, DOI 10.3186/jjphytopath.73.94; Penninckx IAMA, 1996, PLANT CELL, V8, P2309, DOI 10.1105/tpc.8.12.2309; Petersen M, 2000, CELL, V103, P1111, DOI 10.1016/S0092-8674(00)00213-0; Ryals JA, 1996, PLANT CELL, V8, P1809, DOI 10.1105/tpc.8.10.1809; Sano H, 1996, PLANT CELL PHYSIOL, V37, P762, DOI 10.1093/oxfordjournals.pcp.a029011; Shibuya N, 2001, PHYSIOL MOL PLANT P, V59, P223, DOI 10.1006/pmpp.2001.0364; Silipo A, 2010, GLYCOBIOLOGY, V20, P406, DOI 10.1093/glycob/cwp201; Spoel SH, 2003, PLANT CELL, V15, P760, DOI 10.1105/tpc.009159; STASWICK PE, 1992, P NATL ACAD SCI USA, V89, P6837, DOI 10.1073/pnas.89.15.6837; Thomma BPHJ, 1998, P NATL ACAD SCI USA, V95, P15107, DOI 10.1073/pnas.95.25.15107; UKNES S, 1992, PLANT CELL, V4, P645, DOI 10.1105/tpc.4.6.645; WELCH BL, 1947, BIOMETRIKA, V34, P28, DOI 10.2307/2332510; Yasuda M, 2008, PLANT CELL, V20, P1678, DOI 10.1105/tpc.107.054296; Zimmerli L, 2000, P NATL ACAD SCI USA, V97, P12920, DOI 10.1073/pnas.230416897; Zipfel C, 2005, CURR OPIN PLANT BIOL, V8, P353, DOI 10.1016/j.pbi.2005.05.004; Zipfel C, 2006, CELL, V125, P749, DOI 10.1016/j.cell.2006.03.037	36	29	30	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2015	10	1							e0115864	10.1371/journal.pone.0115864	http://dx.doi.org/10.1371/journal.pone.0115864			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ4BS	25565273	Green Published, Green Submitted, gold			2022-12-27	WOS:000348167900002
J	Laffont, C; Rey, T; Andre, O; Novero, M; Kazmierczak, T; Debelle, F; Bonfante, P; Jacquet, C; Frugier, F				Laffont, Carole; Rey, Thomas; Andre, Olivier; Novero, Mara; Kazmierczak, Theophile; Debelle, Frederic; Bonfante, Paola; Jacquet, Christophe; Frugier, Florian			The CRE1 Cytokinin Pathway Is Differentially Recruited Depending on Medicago truncatula Root Environments and Negatively Regulates Resistance to a Pathogen	PLOS ONE			English	Article							NOD FACTOR PERCEPTION; ABSCISIC-ACID; SALT STRESS; ARBUSCULAR MYCORRHIZA; HORMONE INTERACTIONS; SIGNALING PATHWAY; PLANT IMMUNITY; FOUNDER CELLS; ARABIDOPSIS; GENE	Cytokinins are phytohormones that regulate many developmental and environmental responses. The Medicago truncatula cytokinin receptor MtCRE1 (Cytokinin Response 1) is required for the nitrogen-fixing symbiosis with rhizobia. As several cytokinin signaling genes are modulated in roots depending on different biotic and abiotic conditions, we assessed potential involvement of this pathway in various root environmental responses. Phenotyping of cre1 mutant roots infected by the Gigaspora margarita arbuscular mycorrhizal (AM) symbiotic fungus, the Aphanomyces euteiches root oomycete, or subjected to an abiotic stress (salt), were carried out. Detailed histological analysis and quantification of cre1 mycorrhized roots did not reveal any detrimental phenotype, suggesting that MtCRE1 does not belong to the ancestral common symbiotic pathway shared by rhizobial and AM symbioses. cre1 mutants formed an increased number of emerged lateral roots compared to wild-type plants, a phenotype which was also observed under non-stressed conditions. In response to A. euteiches, cre1 mutants showed reduced disease symptoms and an increased plant survival rate, correlated to an enhanced formation of lateral roots, a feature previously linked to Aphanomyces resistance. Overall, we showed that the cytokinin CRE1 pathway is not only required for symbiotic nodule organogenesis but also affects both root development and resistance to abiotic and biotic environmental stresses.	[Laffont, Carole; Kazmierczak, Theophile; Frugier, Florian] CNRS, ISV, F-91198 Gif Sur Yvette, France; [Rey, Thomas; Andre, Olivier; Jacquet, Christophe] Univ Toulouse, UPS, Lab Rech Sci Vegetales, F-31326 Castanet Tolosan, France; [Rey, Thomas; Andre, Olivier; Jacquet, Christophe] CNRS, Lab Rech Sci Vegetales, F-31326 Castanet Tolosan, France; [Novero, Mara; Bonfante, Paola] Univ Turin, Dipartimento Sci Vita & Biol Sistemi, I-10125 Turin, Italy; [Debelle, Frederic] INRA, LIPM, UMR441, F-31326 Castanet Tolosan, France; [Debelle, Frederic] CNRS, LIPM, UMR2594, F-31326 Castanet Tolosan, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); University of Turin; INRAE; Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite Toulouse III - Paul Sabatier; Institut National des Sciences Appliquees de Toulouse; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite Toulouse III - Paul Sabatier; Institut National des Sciences Appliquees de Toulouse	Frugier, F (corresponding author), CNRS, ISV, Ave Terrasse, F-91198 Gif Sur Yvette, France.	frugier@isv.cnrs-gif.fr	jacquet, Christophe/B-2563-2009; Rey, Thomas/AAF-4454-2019; Rey, Thomas/K-8969-2019; Bonfante, Paola/ABE-6733-2020	jacquet, Christophe/0000-0002-7377-5638; Rey, Thomas/0000-0002-9454-074X; Bonfante, Paola/0000-0003-3576-8530	LEGUROOT French ANR project; CNRS; Ministere de l'Enseignement Supeieur et de la Recherche; Universite Paul Sabatier; "Immunit-Ae" French ANR project [ANR-10-GENM-0007]; Italian project PROROOT	LEGUROOT French ANR project(French National Research Agency (ANR)); CNRS(Centre National de la Recherche Scientifique (CNRS)); Ministere de l'Enseignement Supeieur et de la Recherche; Universite Paul Sabatier; "Immunit-Ae" French ANR project(French National Research Agency (ANR)); Italian project PROROOT	Work in F.F.'s laboratory was supported by the LEGUROOT French ANR project, CNRS, and the "Ministere de l'Enseignement Supeieur et de la Recherche" (PhD grant to T.K.). Work in C.J.'s laboratory (LRSV) was funded by the "Universite Paul Sabatier", CNRS, and the "Immunit-Ae" French ANR project (ANR-10-GENM-0007; PhD grant to O.A.). Work in P.B.'s laboratory was funded by the Italian project PROROOT (Call Prin 2010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Argueso CT, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002448; Argueso CT, 2009, PLANT CELL ENVIRON, V32, P1147, DOI 10.1111/j.1365-3040.2009.01940.x; Ariel F, 2010, PLANT CELL, V22, P2171, DOI 10.1105/tpc.110.074823; Badreddine I, 2008, EUKARYOT CELL, V7, P1980, DOI 10.1128/EC.00091-08; BECARD G, 1988, NEW PHYTOL, V108, P211, DOI 10.1111/j.1469-8137.1988.tb03698.x; Benkova E, 2009, PLANT MOL BIOL, V69, P383, DOI 10.1007/s11103-008-9393-6; BERTA G, 1990, NEW PHYTOL, V114, P207, DOI 10.1111/j.1469-8137.1990.tb00392.x; Bonfante P, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1046; Bonhomme M, 2014, NEW PHYTOL, V201, P1328, DOI 10.1111/nph.12611; Choi J, 2011, TRENDS PLANT SCI, V16, P388, DOI 10.1016/j.tplants.2011.03.003; Choi J, 2010, DEV CELL, V19, P284, DOI 10.1016/j.devcel.2010.07.011; COSTACURTA A, 1995, CRIT REV MICROBIOL, V21, P1, DOI 10.3109/10408419509113531; de Lorenzo L, 2007, PLANT PHYSIOL, V145, P1521, DOI 10.1104/pp.107.106146; de Zelicourt A, 2012, PLANT J, V70, P220, DOI 10.1111/j.1365-313X.2011.04859.x; Del Bianco M, 2013, NEW PHYTOL, V199, P324, DOI 10.1111/nph.12338; Dello Ioio R, 2008, SCIENCE, V322, P1380, DOI 10.1126/science.1164147; den Camp RHMO, 2011, PLANT PHYSIOL, V157, P2013, DOI 10.1104/pp.111.187526; Djebali N, 2011, EUR J PLANT PATHOL, V131, P559, DOI 10.1007/s10658-011-9831-1; Djebali N, 2009, MOL PLANT MICROBE IN, V22, P1043, DOI 10.1094/MPMI-22-9-1043; DUC G, 1989, PLANT SCI, V60, P215, DOI 10.1016/0168-9452(89)90169-6; Evangelisti E, 2014, CURR OPIN PLANT BIOL, V20, P118, DOI 10.1016/j.pbi.2014.05.014; Frugier F, 2008, TRENDS PLANT SCI, V13, P115, DOI 10.1016/j.tplants.2008.01.003; Fukaki H, 2009, PLANT MOL BIOL, V69, P437, DOI 10.1007/s11103-008-9417-2; Giron D, 2014, J CHEM ECOL, V40, P826, DOI 10.1007/s10886-014-0466-5; Gomez SK, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-10; Gonzalez-Rizzo S, 2006, PLANT CELL, V18, P2680, DOI 10.1105/tpc.106.043778; Gough C, 2013, TRENDS PLANT SCI, V18, P566, DOI 10.1016/j.tplants.2013.06.001; Gough C, 2011, MOL PLANT MICROBE IN, V24, P867, DOI 10.1094/MPMI-01-11-0019; Gutjahr C, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00204; Havlova M, 2008, PLANT CELL ENVIRON, V31, P341, DOI 10.1111/j.1365-3040.2007.01766.x; Heyl A, 2013, PLANT PHYSIOL, V161, P1063, DOI 10.1104/pp.112.213207; Truong HN, 2015, PLANT CELL ENVIRON, V38, P73, DOI 10.1111/pce.12370; Hwang I, 2012, ANNU REV PLANT BIOL, V63, P353, DOI 10.1146/annurev-arplant-042811-105503; Jeon J, 2010, J BIOL CHEM, V285, P23369, DOI 10.1074/jbc.M109.096644; Kaiser W, 2010, P ROY SOC B-BIOL SCI, V277, P2311, DOI 10.1098/rspb.2010.0214; Kiba T, 2011, J EXP BOT, V62, P1399, DOI 10.1093/jxb/erq410; KOCH B, 1966, PLANT PHYSIOL, V41, P1748, DOI 10.1104/pp.41.10.1748; Laplaze L, 2007, PLANT CELL, V19, P3889, DOI 10.1105/tpc.107.055863; Le Signor C., 2005, Plant Genetic Resources Characterization and Utilization, V3, P59, DOI 10.1079/PGR200562; Li DF, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-517; Li X, 2006, PLANT CELL PHYSIOL, V47, P1112, DOI 10.1093/pcp/pcj082; Lohar DP, 2006, PLANT PHYSIOL, V140, P221, DOI 10.1104/pp.105.070326; Ludwig-Muller J, 2010, ARBUSCULAR MYCORRHIZAS: PHYSIOLOGY AND FUNCTION, P169, DOI 10.1007/978-90-481-9489-6_8; Mahonen AP, 2000, GENE DEV, V14, P2938, DOI 10.1101/gad.189200; Mason MG, 2005, PLANT CELL, V17, P3007, DOI 10.1105/tpc.105.035451; Mason MG, 2010, PLANT J, V64, P753, DOI 10.1111/j.1365-313X.2010.04366.x; Merchan F, 2007, PLANT J, V51, P1, DOI 10.1111/j.1365-313X.2007.03117.x; Moreau S, 2014, NEW PHYTOL, V201, P1343, DOI 10.1111/nph.12636; Murray JD, 2007, SCIENCE, V315, P101, DOI 10.1126/science.1132514; Nishiyama R, 2013, P NATL ACAD SCI USA, V110, P4840, DOI 10.1073/pnas.1302265110; Nishiyama R, 2011, PLANT CELL, V23, P2169, DOI 10.1105/tpc.111.087395; Novero M, 2002, NEW PHYTOL, V154, P741, DOI 10.1046/j.1469-8137.2002.00424.x; Olah B, 2005, PLANT J, V44, P195, DOI 10.1111/j.1365-313X.2005.02522.x; Ortu G, 2012, MOL PLANT, V5, P951, DOI 10.1093/mp/sss027; Parniske M, 2008, NAT REV MICROBIOL, V6, P763, DOI 10.1038/nrmicro1987; Penmetsa RV, 2008, PLANT J, V55, P580, DOI 10.1111/j.1365-313X.2008.03531.x; Pepper AN, 2007, ANN BOT-LONDON, V99, P765, DOI 10.1093/aob/mcm013; Pertry I, 2009, P NATL ACAD SCI USA, V106, P929, DOI 10.1073/pnas.0811683106; Plet J, 2011, PLANT J, V65, P622, DOI 10.1111/j.1365-313X.2010.04447.x; Rey T, 2013, NEW PHYTOL, V198, P875, DOI 10.1111/nph.12198; Riefler M, 2006, PLANT CELL, V18, P40, DOI 10.1105/tpc.105.037796; Saur IML, 2011, NEW PHYTOL, V190, P865, DOI 10.1111/j.1469-8137.2011.03738.x; Stes E, 2011, ANNU REV PHYTOPATHOL, V49, P69, DOI 10.1146/annurev-phyto-072910-095217; Tirichine L, 2007, SCIENCE, V315, P104, DOI 10.1126/science.1132397; Tran LSP, 2007, P NATL ACAD SCI USA, V104, P20623, DOI 10.1073/pnas.0706547105; Trouvelot A., 1986, MYCORRHIZAE PHYSL GE, V1986, P217, DOI DOI 10.1177/004057368303900411; Truernit E, 2008, PLANT CELL, V20, P1494, DOI 10.1105/tpc.107.056069; Uppalapati SR, 2009, MOL PLANT MICROBE IN, V22, P7, DOI 10.1094/MPMI-22-1-0007; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Werner T, 2010, PLANT CELL, V22, P3905, DOI 10.1105/tpc.109.072694; Werner T, 2009, CURR OPIN PLANT BIOL, V12, P527, DOI 10.1016/j.pbi.2009.07.002; Zahaf O, 2012, MOL PLANT, V5, P1068, DOI 10.1093/mp/sss009	72	28	29	2	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2015	10	1							0116819	10.1371/journal.pone.0116819	http://dx.doi.org/10.1371/journal.pone.0116819			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ3YO	25562779	Green Published, Green Submitted, gold			2022-12-27	WOS:000348160000004
J	Almeida, H; Meurs, MJ; Kosseim, L; Butler, G; Tsang, A				Almeida, Hayda; Meurs, Marie-Jean; Kosseim, Leila; Butler, Greg; Tsang, Adrian			Machine Learning for Biomedical Literature Triage	PLOS ONE			English	Article							SUPPORT VECTOR MACHINES; IMBALANCED DATA; TEXT	This paper presents a machine learning system for supporting the first task of the biological literature manual curation process, called triage. We compare the performance of various classification models, by experimenting with dataset sampling factors and a set of features, as well as three different machine learning algorithms (Naive Bayes, Support Vector Machine and Logistic Model Trees). The results show that the most fitting model to handle the imbalanced datasets of the triage classification task is obtained by using domain relevant features, an under-sampling technique, and the Logistic Model Trees algorithm.	[Almeida, Hayda; Kosseim, Leila; Butler, Greg] Concordia Univ, Dept Comp Sci & Software Engn, Montreal, PQ, Canada; [Meurs, Marie-Jean; Butler, Greg; Tsang, Adrian] Concordia Univ, Ctr Struct & Funct Genom, Montreal, PQ, Canada	Concordia University - Canada; Concordia University - Canada	Meurs, MJ (corresponding author), Concordia Univ, Ctr Struct & Funct Genom, Montreal, PQ, Canada.	marie-jean.meurs@concordia.ca			Genome Canada; Genome Quebec; Genome Alberta	Genome Canada(Genome Canada); Genome Quebec; Genome Alberta	This work was supported by funding from Genome Canada (http://www.genomecanada.ca), Genome Quebec (http://www.genomequebec.com/), and Genome Alberta (http://genomealberta.ca/), to AT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akbani R, 2004, LECT NOTES COMPUT SC, V3201, P39, DOI 10.1007/978-3-540-30115-8_7; Antonie Maria-Luiza, 2001, P 2 INT WORKSH MULT, P94; Aronson AR, 2001, J AM MED INFORM ASSN, P17; Bolton RJ, 2002, STAT SCI, V17, P235; Borrajo L, 2011, J INTEGR BIOINFORMAT, V8, DOI 10.2390/biecoll-jib-2011-176; Charton E, 2013, INFORMATICS, V2014, P32; Chawla NV, 2002, J ARTIF INTELL RES, V16, P321, DOI 10.1613/jair.953; Cohen G, 2006, ARTIF INTELL MED, V37, P7, DOI 10.1016/j.artmed.2005.03.002; Hall M., 2009, SIGKDD EXPLORATIONS, V11, P10, DOI [10.1145/1656274.1656278, DOI 10.1145/1656274.1656278]; Hirschman L, 2012, DATABASE J BIOL DATA; Howe D, 2008, NATURE, V455, P47, DOI 10.1038/455047a; Hunter L, 2006, MOL CELL, V21, P589, DOI 10.1016/j.molcel.2006.02.012; Landwehr N, 2005, MACH LEARN, V59, P161, DOI 10.1007/s10994-005-0466-3; Liu Y, 2006, COMPUT SPEECH LANG, V20, P468, DOI 10.1016/j.csl.2005.06.002; Maloof MA, 2003, ICML 2003 WORKSH LEA, V2; Marsland S, 2009, CH CRC MACH LEARN PA, P1; Meurs MJ, 2012, BMC MED INFORM DECIS, V12, DOI 10.1186/1472-6947-12-S1-S5; Morris BD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065848; Mountassir A, 2012, IEEE SYS MAN CYBERN, P3298, DOI 10.1109/ICSMC.2012.6378300; Mudunuri US, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080503; Murphy C, 2011, DATABASE-OXFORD, DOI 10.1093/database/bar020; National Center for Biotechnology Information, 2005, PUBMED; Quan CQ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102039; Quinlan J.R., 1993, C4 5 PROGRAMS MACHIN; Raskutti B., 2004, SIGKDD EXPLOR NEWSL, V6, P60, DOI [10.1145/1007730.1007739, DOI 10.1145/1007730.1007739]; Ruch P, 2006, BIOINFORMATICS, V22, P658, DOI 10.1093/bioinformatics/bti783; Tang YC, 2005, ARTIF INTELL MED, V35, P121, DOI 10.1016/j.artmed.2005.02.003; Tang YC, 2009, IEEE T SYST MAN CY B, V39, P281, DOI 10.1109/TSMCB.2008.2002909; Vapnik V., 2013, NATURE STAT LAERNING; Wang MC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091315; Weiss Gary M., 2007, Proceedings of the International Conference on Data Mining. DMIN 2007, P35; Weiss G. M., 2001, MLTR44 RUTG U	33	18	18	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2014	9	12							e115892	10.1371/journal.pone.0115892	http://dx.doi.org/10.1371/journal.pone.0115892			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UC	25551575	Green Accepted, Green Submitted, Green Published, gold			2022-12-27	WOS:000347119100073
J	McDonald, JS; Adibi, M; Clifford, CWG; Arabzadeh, E				McDonald, James S.; Adibi, Mehdi; Clifford, Colin W. G.; Arabzadeh, Ehsan			Sampling Time and Performance in Rat Whisker Sensory System	PLOS ONE			English	Article							FREQUENCY DISCRIMINATION; BEHAVIORAL DETECTION; SPEED; VIBRATION; ACCURACY; NEURONS; PERCEPTION; STIMULI	We designed a behavioural paradigm for vibro-tactile detection to characterise the sampling time and performance in the rat whisker sensory system. Rats initiated a trial by nose-poking into an aperture where their whiskers came into contact with two meshes. A continuous nose-poke for a random duration triggered stimulus presentation. Stimuli were a sequence of discrete Gaussian deflections of the mesh that increased in amplitude over time - across 5 conditions, time to maximum amplitude varied from 0.5 to 8 seconds. Rats indicated the detected stimulus by choosing between two reward spouts. Two rats completed more than 500 trials per condition. Rats' stimulus sampling duration increased and performance dropped with increasing task difficulty. For all conditions the median reaction time was longer for correct trials than incorrect trials. Higher rates of increment in stimulus amplitude resulted in faster rise in performance as a function of stimulus sampling duration. Rats' behaviour indicated a dynamic stimulus sampling whereby nose-poke was maintained until a stimulus was correctly identified or the rat experienced a false alarm. The perception was then manifested in behaviour after a motor delay. We thus modelled the results with 3 parameters: signal detection, false alarm, and motor delay. The model captured the main features of the data and produced parameter estimates that were biologically plausible and highly similar across the two rats.	[McDonald, James S.; Clifford, Colin W. G.; Arabzadeh, Ehsan] Univ New S Wales, Sch Psychol, Sydney, NSW, Australia; [Adibi, Mehdi; Arabzadeh, Ehsan] Australian Natl Univ, John Curtin Sch Med Res, Eccles Inst Neurosci, Canberra, ACT 2601, Australia; [Adibi, Mehdi; Arabzadeh, Ehsan] Australian Natl Univ Node, ARC Ctr Excellence Integrat Brain Funct, Canberra, ACT, Australia	University of New South Wales Sydney; Australian National University; John Curtin School of Medical Research; Australian National University	McDonald, JS (corresponding author), Univ New S Wales, Sch Psychol, Sydney, NSW, Australia.	jamesscottmcdonald@gmail.com	Adibi, Mehdi/L-9276-2016; Adibi, Mehdi/AAL-7760-2020	Adibi, Mehdi/0000-0001-8874-3586; Adibi, Mehdi/0000-0001-8874-3586; Mcdonald, James/0000-0003-1362-1095; Arabzadeh, Ehsan/0000-0001-9632-0735	Australian Research Council Centre of Excellence for Integrative Brain Function (ARC Centre) [CE140100007]; Australian Research Council Centre of Excellence for Integrative Brain Function [DP130101364]; Australian National Health & Medical Research Council [1028670]; Australian Research Council	Australian Research Council Centre of Excellence for Integrative Brain Function (ARC Centre)(Australian Research Council); Australian Research Council Centre of Excellence for Integrative Brain Function(Australian Research Council); Australian National Health & Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council)	This work was supported by the Australian Research Council Centre of Excellence for Integrative Brain Function (ARC Centre Grant CE140100007), Discovery Project DP130101364, and the Australian National Health & Medical Research Council Project Grant 1028670. EA and CC are supported by Future Fellowships from the Australian Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham NM, 2004, NEURON, V44, P865, DOI 10.1016/j.neuron.2004.11.017; Adibi M, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003415; Adibi M, 2013, J NEUROSCI, V33, P2108, DOI 10.1523/JNEUROSCI.3449-12.2013; Adibi M, 2012, P NATL ACAD SCI USA, V109, P971, DOI 10.1073/pnas.1116726109; Adibi M, 2011, J NEUROPHYSIOL, V105, P356, DOI 10.1152/jn.00794.2010; Arabzadeh E, 2004, J NEUROSCI, V24, P6011, DOI 10.1523/JNEUROSCI.1389-04.2004; Arabzadeh E, 2003, J NEUROSCI, V23, P9146; Berg RW, 2003, J NEUROPHYSIOL, V89, P104, DOI 10.1152/jn.00600.2002; CARVELL GE, 1990, J NEUROSCI, V10, P2638; Diamond ME, 2008, NAT REV NEUROSCI, V9, P601, DOI 10.1038/nrn2411; Diamond ME, 2013, PROG NEUROBIOL, V103, P28, DOI 10.1016/j.pneurobio.2012.05.013; Diamond ME, 2008, PLOS BIOL, V6, P1627, DOI 10.1371/journal.pbio.0060220; Fassihi A, 2014, P NATL ACAD SCI USA, V111, P2331, DOI 10.1073/pnas.1315171111; Gerdjikov TV, 2010, NEURON, V65, P530, DOI 10.1016/j.neuron.2010.02.007; HUTSON KA, 1986, J NEUROPHYSIOL, V56, P1196, DOI 10.1152/jn.1986.56.4.1196; KALASKA JF, 1992, SCIENCE, V255, P1517, DOI 10.1126/science.1549781; Kirchner H, 2006, VISION RES, V46, P1762, DOI 10.1016/j.visres.2005.10.002; Knutsen PM, 2006, J NEUROSCI, V26, P8451, DOI 10.1523/JNEUROSCI.1516-06.2006; Mayrhofer JM, 2013, J NEUROPHYSIOL, V109, P273, DOI 10.1152/jn.00488.2012; Miyashita T, 2013, CEREB CORTEX, V23, P1655, DOI 10.1093/cercor/bhs155; Musall S, 2014, NAT NEUROSCI, V17, P1567, DOI 10.1038/nn.3821; Reinagel P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068505; Rinberg D, 2006, NEURON, V51, P351, DOI 10.1016/j.neuron.2006.07.013; Roitman JD, 2002, J NEUROSCI, V22, P9475; Schiller PH, 2004, EXP BRAIN RES, V154, P154, DOI 10.1007/s00221-003-1653-8; Smith PL, 2004, TRENDS NEUROSCI, V27, P161, DOI 10.1016/j.tins.2004.01.006; Stanford TR, 2010, NAT NEUROSCI, V13, P379, DOI 10.1038/nn.2485; Stuttgen MC, 2008, J NEUROPHYSIOL, V100, P1879, DOI 10.1152/jn.90511.2008; Stuttgen MC, 2010, J NEUROSCI, V30, P2060, DOI 10.1523/JNEUROSCI.3943-09.2010; Uchida N, 2003, NAT NEUROSCI, V6, P1224, DOI 10.1038/nn1142; WAIBLINGER C, 2013, CEREBRAL CORTEX	31	8	8	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2014	9	12							e116357	10.1371/journal.pone.0116357	http://dx.doi.org/10.1371/journal.pone.0116357			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UC	25551373	Green Published, Green Submitted, gold			2022-12-27	WOS:000347119100134
J	Pasquier, C; Clement, M; Dombrovsky, A; Penaud, S; Da Rocha, M; Rancurel, C; Ledger, N; Capovilla, M; Robichon, A				Pasquier, Claude; Clement, Mathilde; Dombrovsky, Aviv; Penaud, Stephanie; Da Rocha, Martine; Rancurel, Corinne; Ledger, Neil; Capovilla, Maria; Robichon, Alain			Environmentally Selected Aphid Variants in Clonality Context Display Differential Patterns of Methylation in the Genome	PLOS ONE			English	Article							DNA METHYLATION; EPIGENETIC VARIATION; GENE-EXPRESSION; PEA APHID; STABILITY; SYMBIONTS; ONTOLOGY; SITES; LOCUS	Heritability of acquired phenotypic traits is an adaptive evolutionary process that appears more complex than the basic allele selection guided by environmental pressure. In insects, the trans-generational transmission of epigenetic marks in clonal and/or sexual species is poorly documented. Aphids were used as a model to explore this feature because their asexual phase generates a stochastic and/or environment-oriented repertoire of variants. The a priori unchanged genome in clonal individuals prompts us to hypothesize whether covalent methyl DNA marks might be associated to the phenotypic variability and fitness selection. The full differential transcriptome between two environmentally selected clonal variants that originated from the same founder mother was mapped on the entire genomic scaffolds, in parallel with the methyl cytosine distribution. Data suggest that the assortments of heavily methylated DNA sites are distinct in these two clonal phenotypes. This might constitute an epigenetic mechanism that confers the robust adaptation of insect species to various environments involving clonal reproduction.	[Clement, Mathilde; Dombrovsky, Aviv; Da Rocha, Martine; Rancurel, Corinne; Ledger, Neil; Capovilla, Maria; Robichon, Alain] Univ Nice Sophia Antipolis, Inst Sophia Agrobiotech, INRA CNRS UNS, Sophia Antipolis, France; [Dombrovsky, Aviv] Volcani Ctr, Inst Plant Protect, Rehovot, Israel; [Pasquier, Claude] Univ Nice Sophia Antipolis, CNRS, Inst Dev Biol & Canc, Sophia Antipolis, France; [Penaud, Stephanie] Beckman Coulter Genom SA, Grenoble, France	INRAE; UDICE-French Research Universities; Universite Cote d'Azur; VOLCANI INSTITUTE OF AGRICULTURAL RESEARCH; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur; Beckman Coulter Inc.	Robichon, A (corresponding author), Univ Nice Sophia Antipolis, Inst Sophia Agrobiotech, INRA CNRS UNS, Sophia Antipolis, France.	Alain.Robichon@sophia.inra.fr	Capovilla, Maria/O-8483-2016; Pasquier, Claude/C-6163-2008	Pasquier, Claude/0000-0001-7498-395X; Rancurel, Corinne/0000-0001-9355-5491; Capovilla, Maria/0000-0002-1308-7964; robichon, alain/0000-0003-1075-9646	ANR "Exdisum''; grant PEPS CNRS; ANR "Methylclonome''; French National Research Agency (ANR) through the "Investments for the Future'' LABEX SIGNALIFE [ANR-11-LABX-0028-01]	ANR "Exdisum''(French National Research Agency (ANR)); grant PEPS CNRS; ANR "Methylclonome''(French National Research Agency (ANR)); French National Research Agency (ANR) through the "Investments for the Future'' LABEX SIGNALIFE(French National Research Agency (ANR))	The authors were supported by ANR "Exdisum'' 2006-2009, grant PEPS CNRS 2010 and ANR "Methylclonome'' 2011-2015. The authors are thankful for the support of the French National Research Agency (ANR) for PhD students through the "Investments for the Future'' LABEX SIGNALIFE (#ANR-11-LABX-0028-01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bastow R, 2004, NATURE, V427, P164, DOI 10.1038/nature02269; Becker C, 2011, NATURE, V480, P245, DOI 10.1038/nature10555; BHAGWAT AS, 1986, J BACTERIOL, V166, P751, DOI 10.1128/jb.166.3.751-755.1986; Bird A, 2004, COLD SPRING HARB SYM, V69, P113, DOI 10.1101/sqb.2004.69.113; Braendle C, 2003, PLOS BIOL, V1, P70, DOI 10.1371/journal.pbio.0000021; Cohen HM, 2002, NUCLEIC ACIDS RES, V30, P3880, DOI 10.1093/nar/gkf507; Dale C, 2006, CELL, V126, P453, DOI 10.1016/j.cell.2006.07.014; Degnan PH, 2008, APPL ENVIRON MICROB, V74, P6782, DOI 10.1128/AEM.01285-08; Dixon AF G, 1998, APHID ECOLOGY; Dixon AFG, 1973, STUDIES BIOL; Dombrovsky A, 2009, GENOME RES, V19, P2052, DOI 10.1101/gr.091611.109; Fazzari MJ, 2004, NAT REV GENET, V5, P446, DOI 10.1038/nrg1349; Hilliou F, 2013, P INT C BIOINF MOD M, DOI [10.5220/0004312002020211, DOI 10.5220/0004312002020211]; Hunt BG, 2010, GENOME BIOL EVOL, V2, P719, DOI 10.1093/gbe/evq057; Jacobsen SE, 2000, CURR BIOL, V10, P179, DOI 10.1016/S0960-9822(00)00324-9; Jaenisch R, 2003, NAT GENET, V33, P245, DOI 10.1038/ng1089; Johannes F, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000530; Kornblihtt AR, 2005, CURR OPIN CELL BIOL, V17, P262, DOI 10.1016/j.ceb.2005.04.014; Kucharski R, 2008, SCIENCE, V319, P1827, DOI 10.1126/science.1153069; LANGE C, 1991, GENE, V100, P213, DOI 10.1016/0378-1119(91)90369-M; Lyko F, 2011, TRENDS GENET, V27, P127, DOI 10.1016/j.tig.2011.01.003; Lyko F, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000506; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Mathieu O, 2007, CELL, V130, P851, DOI 10.1016/j.cell.2007.07.007; Maunakea AK, 2010, NATURE, V466, P253, DOI 10.1038/nature09165; Miura T, 2003, J EXP ZOOL PART B, V295B, P59, DOI 10.1002/jez.b.00003; Moran NA, 2000, TRENDS ECOL EVOL, V15, P321, DOI 10.1016/S0169-5347(00)01902-9; Moran NA, 2010, SCIENCE, V328, P624, DOI 10.1126/science.1187113; Morgan HD, 1999, NAT GENET, V23, P314, DOI 10.1038/15490; Niu BF, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-187; Oliver KM, 2010, ANNU REV ENTOMOL, V55, P247, DOI 10.1146/annurev-ento-112408-085305; Perales R, 2009, MOL CELL, V36, P178, DOI 10.1016/j.molcel.2009.09.018; Rando OJ, 2007, CELL, V128, P655, DOI 10.1016/j.cell.2007.01.023; Reinders J, 2009, EPIGENETICS-US, V4, P557, DOI 10.4161/epi.4.8.10347; Reinders J, 2009, GENE DEV, V23, P939, DOI 10.1101/gad.524609; Richards EJ, 2006, NAT REV GENET, V7, P395, DOI 10.1038/nrg1834; Richards S, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000313; Scarborough CL, 2005, SCIENCE, V310, P1781, DOI 10.1126/science.1120180; Schumann J, 1996, J MOL BIOL, V257, P949, DOI 10.1006/jmbi.1996.0214; Shen HS, 2012, PLANT CELL, V24, P875, DOI 10.1105/tpc.111.094870; TERSCHUREN PA, 1987, J GEN MICROBIOL, V133, P945; Tsuchida T, 2010, SCIENCE, V330, P1102, DOI 10.1126/science.1195463; Valmalette JC, 2012, LIGHT INDUCED ELECT; Vilkaitis G, 2005, J BIOL CHEM, V280, P64, DOI 10.1074/jbc.M411126200; Wang Y, 2006, SCIENCE, V314, P645, DOI 10.1126/science.1135213; Weaver ICG, 2004, NAT NEUROSCI, V7, P847, DOI 10.1038/nn1276; Weese D, 2009, GENOME RES, V19, P1646, DOI 10.1101/gr.088823.108; Zheng Q, 2008, NUCLEIC ACIDS RES, V36, pW358, DOI 10.1093/nar/gkn276	50	12	12	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2014	9	12							e115022	10.1371/journal.pone.0115022	http://dx.doi.org/10.1371/journal.pone.0115022			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UC	25551225	Green Published, Green Submitted, gold			2022-12-27	WOS:000347119100022
J	Zhou, QY; Chen, TJ; Bozkanat, M; Ibe, JCF; Christman, JW; Raj, JU; Zhou, GF				Zhou, Qiyuan; Chen, Tianji; Bozkanat, Melike; Ibe, Joyce Christina F.; Christman, John W.; Raj, J. Usha; Zhou, Guofei			Intratracheal Instillation of High Dose Adenoviral Vectors Is Sufficient to Induce Lung Injury and Fibrosis in Mice	PLOS ONE			English	Article							IDIOPATHIC PULMONARY-FIBROSIS; MEDIATED GENE-TRANSFER; HIPPEL-LINDAU-PROTEIN; IN-VIVO; ANIMAL-MODELS; EXPRESSION; DISEASE; MATRIX; PATHOGENESIS; ACTIVATION	Rationale: Replication deficient adenoviruses (Ad) vectors are common tools in gene therapy. Since Ad vectors are known to activate innate and adaptive immunity, we investigated whether intratracheal administration of Ad vectors alone is sufficient to induce lung injury and pulmonary fibrosis. Methods: We instilled Ad viruses ranging from 10(7) to 1.625 x 10(9) ifu/mouse as well as the same volume of PBS and bleomycin. 14 and 21 days after administration, we collected bronchoalveolar lavage fluid (BALF) and mouse lung tissues. We measured the protein concentration, total and differential cell counts, and TGF-beta 1 production, performed Trichrome staining and Sircol assay, determined gene and protein levels of profibrotic cytokines, MMPs, and Wnt signaling proteins, and conducted TUNEL staining and co-immunofluorescence for GFP and alpha-SMA staining. Results: Instillation of high dose Ad vectors (1.6256109 ifu/mouse) into mouse lungs induced high levels of protein content, inflammatory cells, and TGF-beta 1 in BALF, comparable to those in bleomycin-instilled lungs. The collagen content and mRNA levels of Col1a1, Col1a2, PCNA, and alpha-SMA were also increased in the lungs. Instillation of both bleomycin and Ad vectors increased expression levels of TNF alpha and IL-1 beta but not IL-10. Instillation of bleomycin but not Ad increased the expression of IL-1 alpha, IL-13 and IL-16. Treatment with bleomycin or Ad vectors increased expression levels of integrin alpha 1, alpha 5, and alpha v, MMP9, whereas treatment with bleomycin but not Ad vectors induced MMP2 expression levels. Both bleomycin and Ad vectors induced mRNA levels of Wnt2, 2b, 5b, and Lrp6. Intratracheal instillation of Ad viruses also induced DNA damages and Ad viral infection-mediated fibrosis is not limited to the infection sites. Conclusions: Our results suggest that administration of Ad vectors induces an inflammatory response, lung injury, and pulmonary fibrosis in a dose dependent manner.	[Zhou, Qiyuan; Chen, Tianji; Bozkanat, Melike; Ibe, Joyce Christina F.; Raj, J. Usha; Zhou, Guofei] Univ Illinois, Dept Pediat, Chicago, IL 60607 USA; [Ibe, Joyce Christina F.; Raj, J. Usha] Childrens Hosp Univ Illinois, Chicago, IL USA; [Christman, John W.] Ohio State Univ, Div Pulm Allergy Crit Care & Sleep Med, Columbus, OH 43210 USA; [Zhou, Guofei] Univ Illinois, Ctr Canc, Chicago, IL USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Ohio State University; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Zhou, GF (corresponding author), Univ Illinois, Dept Pediat, Chicago, IL 60607 USA.	guofei@uic.edu		Bozkanat, Kubra Melike/0000-0001-7623-6288	American Lung Association Biomedical Research Grant [RG-266090-N]; University of Illinois at Chicago Faculty Scholarship Support Program; University of Illinois Cancer Center Pilot Subsidy Program; UIC Center for Clinical and Translational Science [UL1RR029879]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL075557] Funding Source: NIH RePORTER	American Lung Association Biomedical Research Grant; University of Illinois at Chicago Faculty Scholarship Support Program; University of Illinois Cancer Center Pilot Subsidy Program; UIC Center for Clinical and Translational Science; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The work was supported in part by an American Lung Association Biomedical Research Grant (RG-266090-N) (GZ), the University of Illinois at Chicago Faculty Scholarship Support Program (GZ), the University of Illinois Cancer Center Pilot Subsidy Program (GZ), and supplemental funding from the UIC Center for Clinical and Translational Science (UL1RR029879). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aumiller V, 2013, AM J RESP CELL MOL, V49, P96, DOI 10.1165/rcmb.2012-0524OC; Belperio JA, 2002, AM J RESP CELL MOL, V27, P419, DOI 10.1165/rcmb.2002-0009OC; Budinger GRS, 2006, P NATL ACAD SCI USA, V103, P4604, DOI 10.1073/pnas.0507604103; Chilosi M, 2003, AM J PATHOL, V162, P1495, DOI 10.1016/S0002-9440(10)64282-4; Degryse AL, 2011, AM J MED SCI, V341, P444, DOI 10.1097/MAJ.0b013e31821aa000; Degryse AL, 2010, AM J PHYSIOL-LUNG C, V299, pL442, DOI 10.1152/ajplung.00026.2010; Di Paolo NC, 2009, IMMUNITY, V31, P110, DOI 10.1016/j.immuni.2009.04.015; Dumasius V, 2003, VIROLOGY, V308, P243, DOI 10.1016/S0042-6822(02)00138-1; Fitzgerald KA, 2009, IMMUNITY, V31, P7, DOI 10.1016/j.immuni.2009.07.001; Fodde R, 2007, CURR OPIN CELL BIOL, V19, P150, DOI 10.1016/j.ceb.2007.02.007; Garcia-Alvarez J, 2006, SARCOIDOSIS VASC DIF, V23, P13; Garcia-Prieto E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013242; Gasse P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023185; Gharaee-Kermani M, 2005, AM J PATHOL, V166, P1593, DOI 10.1016/S0002-9440(10)62470-4; Glass WG, 2009, CYTOKINE, V46, P17, DOI 10.1016/j.cyto.2008.11.007; Hoshino T, 2009, AM J RESP CELL MOL, V41, P661, DOI 10.1165/rcmb.2008-0182OC; Hunninghake Gary W, 2007, Proc Am Thorac Soc, V4, P449, DOI 10.1513/pats.200702-036MS; Kim KK, 2006, P NATL ACAD SCI USA, V103, P13180, DOI 10.1073/pnas.0605669103; Konigshoff M, 2010, AM J RESP CELL MOL, V42, P21, DOI 10.1165/rcmb.2008-0485TR; Kuwano K, 1997, EUR RESPIR J, V10, P1445, DOI 10.1183/09031936.97.10071445; Lagares D, 2012, AM J RESP CELL MOL, V47, P834, DOI 10.1165/rcmb.2011-0446OC; Lam AP, 2011, AM J RESP CELL MOL, V45, P915, DOI 10.1165/rcmb.2010-0113OC; Lasaro MO, 2009, MOL THER, V17, P1333, DOI 10.1038/mt.2009.130; Ley B, 2011, AM J RESP CRIT CARE, V183, P431, DOI 10.1164/rccm.201006-0894CI; Liu Q, 2003, GENE THER, V10, P935, DOI 10.1038/sj.gt.3302036; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; McManus TE, 2007, RESP MED, V101, P2084, DOI 10.1016/j.rmed.2007.05.015; Moore BB, 2008, AM J PHYSIOL-LUNG C, V294, pL152, DOI 10.1152/ajplung.00313.2007; Moore BB, 2013, AM J RESP CELL MOL, V49, P167, DOI 10.1165/rcmb.2013-0094TR; Noble PW, 2012, J CLIN INVEST, V122, P2756, DOI 10.1172/JCI60323; Nusse R, 2005, CELL RES, V15, P28, DOI 10.1038/sj.cr.7290260; Oikonomou N, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000108; Orjalo AV, 2009, P NATL ACAD SCI USA, V106, P17031, DOI 10.1073/pnas.0905299106; Pardo A, 2005, PLOS MED, V2, P891, DOI 10.1371/journal.pmed.0020251; Pardo Annie, 2006, Proc Am Thorac Soc, V3, P383, DOI 10.1513/pats.200601-012TK; PIGUET PF, 1989, J EXP MED, V170, P655, DOI 10.1084/jem.170.3.655; Ramirez G, 2011, LAB INVEST, V91, P1206, DOI 10.1038/labinvest.2011.80; Reya T, 2005, NATURE, V434, P843, DOI 10.1038/nature03319; Saito F, 2008, AM J RESP CELL MOL, V38, P566, DOI 10.1165/rcmb.2007-0299OC; Selman M, 2006, AM J RESP CRIT CARE, V173, P188, DOI 10.1164/rccm.200504-644OC; Selman M, 2008, PLOS MED, V5, P373, DOI 10.1371/journal.pmed.0050062; Sheppard D, 2004, CURR OPIN CELL BIOL, V16, P552, DOI 10.1016/j.ceb.2004.06.017; Sime PJ, 1997, J CLIN INVEST, V100, P768, DOI 10.1172/JCI119590; Wynn TA, 2004, NAT REV IMMUNOL, V4, P583, DOI 10.1038/nri1412; Yang IV, 2007, AM J RESP CRIT CARE, V175, P45, DOI 10.1164/rccm.200601-062OC; Zhou G, 2008, FASEB J, V22, P1335, DOI 10.1096/fj.07-8369com; Zhou QY, 2011, FASEB J, V25, P3032, DOI 10.1096/fj.10-177824; Zhou Z, 1999, J CLIN INVEST, V103, P779, DOI 10.1172/JCI5909; Ziegler RJ, 2002, HUM GENE THER, V13, P935, DOI 10.1089/10430340252939041; Zuo FR, 2002, P NATL ACAD SCI USA, V99, P6292, DOI 10.1073/pnas.092134099	50	8	8	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2014	9	12							e116142	10.1371/journal.pone.0116142	http://dx.doi.org/10.1371/journal.pone.0116142			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UC	25551570	Green Published, Green Submitted, gold			2022-12-27	WOS:000347119100101
J	Huby, RDJ; Glaves, P; Jackson, R				Huby, Russell D. J.; Glaves, Philip; Jackson, Richard			The Incidence of Sexually Dimorphic Gene Expression Varies Greatly between Tissues in the Rat	PLOS ONE			English	Article							MESSENGER-RNA; GROWTH-HORMONE; MOUSE-BRAIN; SEX; CELLS; LIVER; LOCALIZATION; INACTIVATION; RECEPTOR; PROTEIN	The sexually dimorphic expression of genes across 26 somatic rat tissues was using Affymetrix RAE-230 genechips. We considered probesets to be sexually dimorphically expressed (SDE) if they were measurably expressed above background in at least one sex, there was at least a two-fold difference in expression (dimorphism) between the sexes, and the differences were statistically significant after correcting for false discovery. 14.5% of expressed probesets were SDE in at least one tissue, with higher expression nearly twice as prevalent in males compared to females. Most were SDE in a single tissue. Surprisingly, nearly half of the probesets that were (SDE) in multiple tissues were oppositely sex biased in different tissues, and most SDE probesets were also expressed without sex bias in other tissues. Two genes were widely SDE: Xist (female-only) and Eif2s3y (male-only). The frequency of SDE probesets varied widely between tissues, and was highest in the duodenum (6.2%), whilst less than 0.05% in over half of the surveyed tissues. The occurrence of SDE probesets was not strongly correlated between tissues. Within individual tissues, however, relational networks of SDE genes were identified. In the liver, networks relating to differential metabolism between the sexes were seen. The estrogen receptor was implicated in differential gene expression in the duodenum. To conclude, sexually dimorphic gene expression is common, but highly tissue-dependent. Sexually dimorphic gene expression may provide insights into mechanisms underlying phenotypic sex differences. Online data are provided as a resource for further analyses (GEO reference GSE63362).	[Huby, Russell D. J.; Glaves, Philip; Jackson, Richard] AstraZeneca, Global Safety Assessment, Dept Mol Toxicol, Macclesfield, Cheshire, England	AstraZeneca	Huby, RDJ (corresponding author), AstraZeneca R&D, Mol Pathol, Alderley Pk, Macclesfield, Cheshire, England.	Russell.huby@astrazeneca.com		Jackson, Richard/0000-0002-3278-8547	AstraZeneca PLC	AstraZeneca PLC(AstraZeneca)	This work was funded by AstraZeneca PLC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold AP, 2004, TRENDS ENDOCRIN MET, V15, P6, DOI 10.1016/j.tem.2003.11.001; Berchtold NC, 2008, P NATL ACAD SCI USA, V105, P15605, DOI 10.1073/pnas.0806883105; CHEN YF, 1992, HYPERTENSION, V19, P456, DOI 10.1161/01.HYP.19.5.456; Ciaudo C, 2006, PLOS GENET, V2, P874, DOI 10.1371/journal.pgen.0020094; Coelho DJ, 2005, NEUROSCIENCE, V134, P907, DOI 10.1016/j.neuroscience.2005.04.060; Dennis C, 2004, NATURE, V427, P390, DOI 10.1038/427390a; Dudoit S, 2002, STAT SINICA, V12, P111; Ehrmann IE, 1998, HUM MOL GENET, V7, P1725, DOI 10.1093/hmg/7.11.1725; Georgiadi A, 2012, PHYSIOL GENOMICS, V44, P352, DOI 10.1152/physiolgenomics.00115.2011; Gerhold D, 2007, GENOMICS, V89, P731, DOI 10.1016/j.ygeno.2007.01.009; Hirao J, 2011, J TOXICOL SCI, V36, P9, DOI 10.2131/jts.36.9; Isensee J, 2008, J MOL MED, V86, P61, DOI 10.1007/s00109-007-0240-z; Jover R, 2009, CURR DRUG METAB, V10, P508, DOI 10.2174/138920009788898000; Li HY, 2008, J BIOL CHEM, V283, P28988, DOI 10.1074/jbc.M710528200; Markle JGM, 2013, SCIENCE, V339, P1084, DOI 10.1126/science.1233521; Mazeyrat S, 2001, NAT GENET, V29, P49, DOI 10.1038/ng717; McClelland EE, 2011, ARCH IMMUNOL THER EX, V59, P203, DOI 10.1007/s00005-011-0124-3; McCombe PA, 2009, CURR MOL MED, V9, P1058, DOI 10.2174/156652409789839116; Mode A, 1998, GROWTH HORM IGF RES, V8, P61, DOI 10.1016/S1096-6374(98)80025-7; SMIRNOVA OV, 1994, MOL CELL ENDOCRINOL, V105, P77, DOI 10.1016/0303-7207(94)90037-X; Wauthier V, 2008, MOL ENDOCRINOL, V22, P1962, DOI 10.1210/me.2007-0549; Wu Z, 2004, BIOCHEMISTRY-US, P1; Xu J, 2006, GENE EXPR PATTERNS, V6, P146, DOI 10.1016/j.modgep.2005.06.011; Yang X, 2006, GENOME RES, V16, P995, DOI 10.1101/gr.5217506	24	13	15	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2014	9	12							e115792	10.1371/journal.pone.0115792	http://dx.doi.org/10.1371/journal.pone.0115792			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX6YH	25548914	Green Published, gold, Green Submitted			2022-12-27	WOS:000347063500028
J	Toots, M; Mannik, A; Kivi, G; Ustav, M; Ustav, E; Ustav, M				Toots, Mart; Maennik, Andres; Kivi, Gaily; Ustav, Mart, Jr.; Ustav, Ene; Ustav, Mart			The Transcription Map of Human Papillomavirus Type 18 during Genome Replication in U2OS Cells	PLOS ONE			English	Article							EPITHELIAL RAFT CULTURES; MESSENGER-RNA; IN-VITRO; VIRAL TRANSCRIPTION; TRANSFORMED CELLS; E2 TRANSACTIVATOR; GENE-EXPRESSION; TERMINAL DOMAIN; EARLY REGION; LIFE-CYCLE	The human osteosarcoma cell line U2OS is useful for studying genome replication of human papillomavirus (HPVs) subtypes that belong to different phylogenetic genera. In this study, we defined the HPV18 transcription map in U2OS cells during transient replication, stable maintenance and vegetative amplification by identifying viral promoter regions, transcription polyadenylation and splicing sites during HPV18 genome replication. Mapping of the HPV18 transcription start sites in U2OS cells revealed five distinct promoter regions (P-102, P-520, P-811, P-1193 and P-3000). With the exception of P-3000, all of these regions have been previously identified during productive HPV18 infection. Collectively, the data suggest that U2OS cells are suitable for studying the replication and transcription properties of HPVs and to serve as a platform for conducting high-throughput drug screens to identify HPV replication inhibitors. In addition, we have identified mRNA species that are initiated from the promoter region P-3000, which can encode two E2C regulator proteins that contain only the C-terminal hinge and DNA-binding and dimerization domains of E2. We show that these proteins regulate the initial amplification of HPV18 by modulating viral transcription. Moreover, we show that one of these proteins can act as a transcriptional activator of promoter P-102.	[Toots, Mart; Kivi, Gaily; Ustav, Mart, Jr.; Ustav, Mart] Univ Tartu, Inst Technol, EE-50090 Tartu, Tartumaa, Estonia; [Maennik, Andres; Kivi, Gaily; Ustav, Mart] Icosagen Cell Factory OU, Tartumaa, Estonia; [Ustav, Ene] Estonian Bioctr, Tartu, Tartumaa, Estonia; [Ustav, Mart] Estonian Acad Sci, EE-200103 Tallinn, Harjumaa, Estonia	University of Tartu; Estonian Biocentre; Estonian Academy of Sciences	Ustav, M (corresponding author), Univ Tartu, Inst Technol, Ulikooli 18, EE-50090 Tartu, Tartumaa, Estonia.	mart.ustav@ut.ee	Ustav, Mart/G-6484-2017		Estonian Research Council [SF0180175A, SF0180175B]; Center of Excellence in Chemical Biology - European Regional Development Fund [3.2.0101.08-0017]; Estonian Science Foundation [9385, 9467]; Enterprise Estonia (EAS) Project [EU42266]	Estonian Research Council; Center of Excellence in Chemical Biology - European Regional Development Fund; Estonian Science Foundation; Enterprise Estonia (EAS) Project	This work was supported by targeted financing to projects SF0180175A and SF0180175B by the Estonian Research Council; by the Center of Excellence in Chemical Biology (3.2.0101.08-0017) financed by the European Regional Development Fund; by research grants 9385 and 9467 from the Estonian Science Foundation; and by Enterprise Estonia (EAS) Project EU42266. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed Firoz, 2009, In Silico Biology, V9, P135, DOI 10.3233/ISB-2009-0395; Akgul B, 2006, J PATHOL, V208, P165, DOI 10.1002/path.1893; Andrei G, 2010, ANTIVIR RES, V85, P431, DOI 10.1016/j.antiviral.2009.10.019; Bernard HU, 2010, VIROLOGY, V401, P70, DOI 10.1016/j.virol.2010.02.002; Bouvard V, 2009, LANCET ONCOL, V10, P321, DOI 10.1016/S1470-2045(09)70096-8; Braunstein TH, 1999, J GEN VIROL, V80, P3241, DOI 10.1099/0022-1317-80-12-3241; Butler JEF, 2002, GENE DEV, V16, P2583, DOI 10.1101/gad.1026202; CHOE J, 1989, J VIROL, V63, P1743, DOI 10.1128/JVI.63.4.1743-1755.1989; Chow LT, 1997, CLIN DERMATOL, V15, P217, DOI 10.1016/S0738-081X(97)00069-2; DOLLARD SC, 1992, GENE DEV, V6, P1131, DOI 10.1101/gad.6.7.1131; DOORBAR J, 1990, VIROLOGY, V178, P254, DOI 10.1016/0042-6822(90)90401-C; Doorbar J, 2012, VACCINE, V30, pF55, DOI 10.1016/j.vaccine.2012.06.083; Flores ER, 1999, VIROLOGY, V262, P344, DOI 10.1006/viro.1999.9868; Frattini MG, 1997, J VIROL, V71, P7068, DOI 10.1128/JVI.71.9.7068-7072.1997; Geimanen J, 2011, J VIROL, V85, P3315, DOI 10.1128/JVI.01985-10; Grassmann K, 1996, J VIROL, V70, P2339, DOI 10.1128/JVI.70.4.2339-2349.1996; Gray E, 2010, CANCER RES, V70, P4081, DOI 10.1158/0008-5472.CAN-09-3335; Howett MK, 1997, CLIN DERMATOL, V15, P229; HUBBERT NL, 1988, P NATL ACAD SCI USA, V85, P5864, DOI 10.1073/pnas.85.16.5864; HUMMEL M, 1992, J VIROL, V66, P6070, DOI 10.1128/JVI.66.10.6070-6080.1992; Kadaja M, 2009, VIROLOGY, V384, P360, DOI 10.1016/j.virol.2008.11.032; Karagas MR, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c2986; KARLEN S, 1993, J VIROL, V67, P4296, DOI 10.1128/JVI.67.7.4296-4306.1993; Kay MA, 2010, NAT BIOTECHNOL, V28, P1287, DOI 10.1038/nbt.1708; KIYONO T, 1989, VIROLOGY, V173, P551, DOI 10.1016/0042-6822(89)90567-9; Kurg R, 2010, VIROLOGY, V408, P159, DOI 10.1016/j.virol.2010.09.010; Lace MJ, 2008, J VIROL, V82, P10841, DOI 10.1128/JVI.01481-08; Lace MJ, 2012, VIROLOGY, V429, P99, DOI 10.1016/j.virol.2012.03.020; LAMBERT PF, 1990, J VIROL, V64, P950, DOI 10.1128/JVI.64.2.950-956.1990; LAMBERT PF, 1987, CELL, V50, P69, DOI 10.1016/0092-8674(87)90663-5; LAMBERT PF, 1989, J VIROL, V63, P3151, DOI 10.1128/JVI.63.7.3151-3154.1989; LIU JS, 1995, J BIOL CHEM, V270, P27283, DOI 10.1074/jbc.270.45.27283; Malik H, 2014, ARCH VIROL, V159, P199, DOI 10.1007/s00705-013-1827-z; MCBRIDE AA, 1989, P NATL ACAD SCI USA, V86, P510, DOI 10.1073/pnas.86.2.510; Mighty KK, 2014, RECENT RESULTS CANC, V193, P135, DOI 10.1007/978-3-642-38965-8_8; Millevoi S, 2010, NUCLEIC ACIDS RES, V38, P2757, DOI 10.1093/nar/gkp1176; MUNGAL S, 1992, J VIROL, V66, P3220, DOI 10.1128/JVI.66.5.3220-3224.1992; Nindl I, 2007, DIS MARKERS, V23, P247, DOI 10.1155/2007/942650; Ozbun MA, 1997, J VIROL, V71, P5161, DOI 10.1128/JVI.71.7.5161-5172.1997; PALERMODILTS DA, 1990, J VIROL, V64, P3144, DOI 10.1128/JVI.64.6.3144-3149.1990; Reinson T, 2013, J VIROL, V87, P951, DOI 10.1128/JVI.01943-12; Remm M, 1999, J VIROL, V73, P3062, DOI 10.1128/JVI.73.4.3062-3070.1999; Renaud KJ, 1996, VIROLOGY, V220, P177, DOI 10.1006/viro.1996.0298; ROHLFS M, 1991, VIROLOGY, V183, P331, DOI 10.1016/0042-6822(91)90146-3; ROMANCZUK H, 1990, J VIROL, V64, P2849, DOI 10.1128/JVI.64.6.2849-2859.1990; ROTENBERG MO, 1989, VIROLOGY, V172, P468, DOI 10.1016/0042-6822(89)90189-X; Sankovski E, 2014, J VIROL, V88, P961, DOI 10.1128/JVI.01841-13; SCHNEIDERGADICKE A, 1986, EMBO J, V5, P2285, DOI 10.1002/j.1460-2075.1986.tb04496.x; SNIJDERS PJF, 1992, J VIROL, V66, P3172, DOI 10.1128/JVI.66.5.3172-3178.1992; Steger G, 1996, METHOD ENZYMOL, V274, P173; Stubenrauch F, 2000, J VIROL, V74, P1178, DOI 10.1128/JVI.74.3.1178-1186.2000; Tan CL, 2012, VIROLOGY, V429, P47, DOI 10.1016/j.virol.2012.03.023; THIERRY F, 1987, J VIROL, V61, P134, DOI 10.1128/JVI.61.1.134-142.1987; VAILLANCOURT P, 1990, J VIROL, V64, P3927, DOI 10.1128/JVI.64.8.3927-3937.1990; Wang HK, 2009, GENE DEV, V23, P181, DOI 10.1101/gad.1735109; Wang XH, 2011, J VIROL, V85, P8080, DOI 10.1128/JVI.00670-11	56	23	24	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2014	9	12							e116151	10.1371/journal.pone.0116151	http://dx.doi.org/10.1371/journal.pone.0116151			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX6YH	25548925	Green Submitted, gold, Green Published			2022-12-27	WOS:000347063500053
J	Liang, MM; Zhang, FT; Jin, GL; Zhu, J				Liang, Meimei; Zhang, Futao; Jin, Gulei; Zhu, Jun			FastGCN: A GPU Accelerated Tool for Fast Gene Co-Expression Networks	PLOS ONE			English	Article							T-CELLS; ENTROPY; EXPRESSION; INFORMATION	Gene co-expression networks comprise one type of valuable biological networks. Many methods and tools have been published to construct gene co-expression networks; however, most of these tools and methods are inconvenient and time consuming for large datasets. We have developed a user-friendly, accelerated and optimized tool for constructing gene co-expression networks that can fully harness the parallel nature of GPU (Graphic Processing Unit) architectures. Genetic entropies were exploited to filter out genes with no or small expression changes in the raw data preprocessing step. Pearson correlation coefficients were then calculated. After that, we normalized these coefficients and employed the False Discovery Rate to control the multiple tests. At last, modules identification was conducted to construct the co-expression networks. All of these calculations were implemented on a GPU. We also compressed the coefficient matrix to save space. We compared the performance of the GPU implementation with those of multi-core CPU implementations with 16 CPU threads, single-thread C/C++ implementation and single-thread R implementation. Our results show that GPU implementation largely outperforms single-thread C/C++ implementation and single-thread R implementation, and GPU implementation outperforms multi-core CPU implementation when the number of genes increases. With the test dataset containing 16,000 genes and 590 individuals, we can achieve greater than 63 times the speed using a GPU implementation compared with a single-thread R implementation when 50 percent of genes were filtered out and about 80 times the speed when no genes were filtered out.	[Liang, Meimei; Zhang, Futao; Jin, Gulei; Zhu, Jun] Zhejiang Univ, Inst Bioinformat, Hangzhou 310058, Zhejiang, Peoples R China	Zhejiang University	Zhu, J (corresponding author), Zhejiang Univ, Inst Bioinformat, Hangzhou 310058, Zhejiang, Peoples R China.	jzhu@zju.edu.cn	Zhang, Futao/D-2733-2017; Zhu, Jun/B-9945-2009	Zhang, Futao/0000-0002-6043-1756; 	National Natural Science Foundation of China [30470916]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research is supported by grant from the National Natural Science Foundation of China (30470916). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AREFIN AS, 2013, P 11 AUSTR S PAR DIS, V140, P3; Borelli FF, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-S18-S5; Canettieri G, 2009, P NATL ACAD SCI USA, V106, P1445, DOI 10.1073/pnas.0808749106; Elo LL, 2007, BIOINFORMATICS, V23, P2096, DOI 10.1093/bioinformatics/btm309; Gibson SM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055871; Gil J, 2011, J CLIN INVEST, V121, P3872, DOI 10.1172/JCI44254; Guo Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071462; HASEGAWA M, 1975, ORIGINS LIFE EVOL B, V6, P219, DOI 10.1007/BF01372408; Hausser J, 2009, J MACH LEARN RES, V10, P1469; Hudson TJ, 2010, NATURE, V464, P993, DOI 10.1038/nature08987; Joosten M, 2013, HAEMATOLOGICA, V98, P247, DOI 10.3324/haematol.2011.054619; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Lewontin R.C., 1972, EVOL BIOL, P381, DOI [10.1007/978-1-4684-9063-3_14, DOI 10.1007/978-1-4684-9063-3_14]; McArt DG, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-305; Ohno Y, 2011, GENETICS, V189, P83, DOI 10.1534/genetics.111.130062; Owens JD, 2007, COMPUT GRAPH FORUM, V26, P80, DOI 10.1111/j.1467-8659.2007.01012.x; Perkins AD, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S11-S4; Reverter A, 2008, BIOINFORMATICS, V24, P2491, DOI 10.1093/bioinformatics/btn482; SHANNON CE, 1948, BELL SYST TECH J, V27, P623, DOI 10.1002/j.1538-7305.1948.tb00917.x; Shi ZA, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-149; Shi ZA, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-74; Song L, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-328; Teschendorff AE, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-104; van Wieringen WN, 2011, BIOINFORMATICS, V27, P556, DOI 10.1093/bioinformatics/btq704; Wang L, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003414; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Wang ZX, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-153; West J, 2012, SCI REP-UK, V2, DOI 10.1038/srep00802; Yang Y, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4231; Yim WC, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-83; Zhang B, 2005, STAT APPL GENET MOL, V4, DOI 10.2202/1544-6115.1128; Zhang Q, 2006, PATTERN RECOGN LETT, V27, P676, DOI 10.1016/j.patrec.2005.06.016; Zhao SR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0078644; Zheng HF, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002745	35	23	24	3	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2015	10	1							e0116776	10.1371/journal.pone.0116776	http://dx.doi.org/10.1371/journal.pone.0116776			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ4OZ	25602758	Green Published, Green Submitted, gold			2022-12-27	WOS:000348203500031
J	Li, SY; Zou, YG; Wang, X; Huang, XB; Sun, Y; Wang, YQ; Dong, L; Jiang, H				Li, Siyue; Zou, Yuangao; Wang, Xia; Huang, Xunbei; Sun, Yong; Wang, Yuqing; Dong, Li; Jiang, Hong			Warfarin Dosage Response Related Pharmacogenetics in Chinese Population	PLOS ONE			English	Article							DOSE REQUIREMENTS; DOSING REGIMEN; GENE VARIANTS; HAN-CHINESE; BODY-WEIGHT; CYP2C9; VKORC1; POLYMORPHISM; GENOTYPE; DETERMINANTS	Objectives As the most frequently prescribed anticoagulant, warfarin has large inter-individual variability in dosage. Genetic polymorphisms could largely explain the differences in dosage requirement. rs9923231 (VKORC1), rs7294 (VKORC1), rs1057910 (CYP2C9), rs2108622 (CYP4F2), and rs699664 (GGCX) involved in the warfarin action mechanism and the circulatory vitamin K were selected to investigate their polymorphism characteristics and their effects on the pharmacodynamics and pharmacokinetics of warfarin in Chinese population. Methods 220 patients with cardiac valve replacement were recruited. International normalized ratio and plasma warfarin concentrations were determined. The five genetic polymorphisms were genotyping by pyro-sequencing. The relationships of maintenance dose, plasma warfarin concentration and INR were assessed among groups categorized by genotypes. Results rs9923231 and rs7294 in VKORC1 had the analogous genotype frequencies (D':0.969). 158 of 220 recruited individuals had the target INR (1.5-2.5). Patients with AA of rs9923231 and CC of rs7294 required a significantly lower maintenance dose and plasma concentration than those with AG and TC, respectively. The mean weekly maintenance dose was also significantly lower in CYP2C9 rs1057910 mutated heterozygote than in patients with the wild homozygote. Eliminating the influence from environment factors (age, body weight and gender), rs9923231 and rs1057910 could explain about 32.0% of the variability in warfarin maintenance dose; rs7294 could explain 26.7% of the variability in plasma concentration. For patients with allele G of rs9923231 and allele T of rs7294, higher plasma concentration was needed to achieve the similar goal INR. Conclusions A better understanding of the genetic variants in individuals can be the foundation of warfarin dosing algorithm and facilitate the reasonable and effective use of warfarin in Chinese.	[Li, Siyue; Zou, Yuangao; Wang, Xia; Huang, Xunbei; Sun, Yong; Jiang, Hong] Sichuan Univ, West China Hosp, Dept Lab Med, Chengdu 610064, Peoples R China; [Wang, Yuqing; Dong, Li] Sichuan Univ, West China Hosp, Dept Cardiac Surg, Chengdu 610064, Peoples R China	Sichuan University; Sichuan University	Dong, L (corresponding author), Sichuan Univ, West China Hosp, Dept Cardiac Surg, Chengdu 610064, Peoples R China.	ldong840@gmail.com; jianghong6656@gmail.com	Wang, yuqing/HIR-1604-2022		science and technology research project of Chengdu [12PPYBO64SF-002]; National Science and Technology [2011BAI11B18]	science and technology research project of Chengdu; National Science and Technology	This study was supported by grants from the science and technology research project of Chengdu (NO. 12PPYBO64SF-002) and the "Twelfth Five-Year" Plan key projects supported by National Science and Technology (2011BAI11B18). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ansell J, 2004, CHEST, V126, p204S, DOI 10.1378/chest.126.3_suppl.204S; Bodin L, 2005, BLOOD, V106, P135, DOI 10.1182/blood-2005-01-0341; Caldwell MD, 2008, BLOOD, V111, P4106, DOI 10.1182/blood-2007-11-122010; Carlquist JF, 2010, J THROMB THROMBOLYS, V30, P358, DOI 10.1007/s11239-010-0467-3; Chen JX, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105250; D'Andrea G, 2005, BLOOD, V105, P645, DOI 10.1182/blood-2004-06-2111; Gage BF, 2008, J THROMB THROMBOLYS, V25, P45, DOI 10.1007/s11239-007-0104-y; Gu QA, 2010, EUR J CLIN PHARMACOL, V66, P1217, DOI 10.1007/s00228-010-0863-9; Hirsh J, 2004, CHEST, V126, p172S, DOI 10.1378/chest.126.3_suppl.172S; Hirsh J, 2001, CHEST, V119, p8S, DOI 10.1378/chest.119.1_suppl.8S; Huang SW, 2011, THROMB RES, V127, P131, DOI 10.1016/j.thromres.2010.10.027; [黄盛文 Huang Shengwen], 2011, [临床检验杂志, Chinese Journal of Clinical Laboratory Science], V29, P349; Kamali X, 2013, LIPIDS HEALTH DIS, V12, DOI 10.1186/1476-511X-12-149; Lam MPS, 2012, BRIT J CLIN PHARMACO, V73, P340, DOI 10.1111/j.1365-2125.2011.04097.x; Lee MTM, 2009, PHARMACOGENOMICS, V10, P1905, DOI [10.2217/pgs.09.106, 10.2217/PGS.09.106]; Leitner JM, 2008, PHARMACOGENOMICS, V9, P423, DOI 10.2217/14622416.9.4.423; Li JH, 2012, J CARDIOTHORAC SURG, V7, DOI 10.1186/1749-8090-7-97; Liang RJ, 2012, J THROMB THROMBOLYS, V34, P120, DOI 10.1007/s11239-012-0725-7; Limdi NA, 2010, BLOOD, V115, P3827, DOI 10.1182/blood-2009-12-255992; Lindh JD, 2009, EUR J CLIN PHARMACOL, V65, P365, DOI 10.1007/s00228-008-0584-5; Liu Yuan, 2011, Beijing Da Xue Xue Bao Yi Xue Ban, V43, P798; Luxembourg B, 2011, THROMB HAEMOSTASIS, V105, P169, DOI 10.1160/TH10-03-0194; Mazzaccara C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071505; McDonald MG, 2009, MOL PHARMACOL, V75, P1337, DOI 10.1124/mol.109.054833; Miao LY, 2007, EUR J CLIN PHARMACOL, V63, P1135, DOI 10.1007/s00228-007-0381-6; Ross KA, 2010, J HUM GENET, V55, P582, DOI 10.1038/jhg.2010.73; Sagrieya H, 2010, PHARMACOGENET GENOM, V20, P407, DOI 10.1097/FPC.0b013e328338bac2; Sanderson S, 2005, GENET MED, V7, P97, DOI 10.1097/01.GIM.0000153664.65759.CF; Sconce EA, 2005, BLOOD, V106, P2329, DOI 10.1182/blood-2005-03-1108; Singh O, 2011, DRUG METAB PHARMACOK, V26, P130, DOI 10.2133/dmpk.DMPK-10-RG-080; Takahashi H, 2001, CLIN PHARMACOKINET, V40, P587, DOI 10.2165/00003088-200140080-00003; TANG XF, 2009, CLINICAL MEDICATION, V7, P42; Vecsler M, 2006, THROMB HAEMOSTASIS, V95, P205, DOI 10.1160/TH05-06-0446; Wadelius M, 2007, HUM GENET, V121, P23, DOI 10.1007/s00439-006-0260-8; Wang TL, 2008, CLIN CHIM ACTA, V396, P76, DOI 10.1016/j.cca.2008.07.005; Yang LM, 2010, THROMB RES, V125, pE159, DOI 10.1016/j.thromres.2009.10.017; Yu BN, 2004, CLIN CHIM ACTA, V348, P57, DOI 10.1016/j.cccn.2004.04.028; [张亚同 Zhang Yatong], 2010, [中国临床药理学与治疗学, Chinese Journal of Clinical Pharmacology and Therapeutics], V15, P1395	38	75	79	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2015	10	1							e0116463	10.1371/journal.pone.0116463	http://dx.doi.org/10.1371/journal.pone.0116463			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ4OS	25594941	Green Published, gold, Green Submitted			2022-12-27	WOS:000348202900002
J	Lara, E; Holmfeldt, K; Solonenko, N; Sa, EL; Ignacio-Espinoza, JC; Cornejo-Castillo, FM; Verberkmoes, NC; Vaque, D; Sullivan, MB; Acinas, SG				Lara, Elena; Holmfeldt, Karin; Solonenko, Natalie; Laia Sa, Elisabet; Ignacio-Espinoza, J. Cesar; Cornejo-Castillo, Francisco M.; Verberkmoes, Nathan C.; Vaque, Dolors; Sullivan, Matthew B.; Acinas, Silvia G.			Life-Style and Genome Structure of Marine Pseudoalteromonas Siphovirus B8b Isolated from the Northwestern Mediterranean Sea	PLOS ONE			English	Article							CONTAINING BACTERIAL-VIRUS; PLASMID-LIKE PROPHAGE; HOST-RANGE; EVOLUTIONARY RELATIONSHIPS; BACTERIOPHAGE-LAMBDA; VIRAL ASSEMBLAGES; ESCHERICHIA-COLI; OCEAN VIRUSES; GENE-TRANSFER; DNA VIRUSES	Marine viruses (phages) alter bacterial diversity and evolution with impacts on marine biogeochemical cycles, and yet few well-developed model systems limit opportunities for hypothesis testing. Here we isolate phage B8b from the Mediterranean Sea using Pseudoalteromonas sp. QC-44 as a host and characterize it using myriad techniques. Morphologically, phage B8b was classified as a member of the Siphoviridae family. One-step growth analyses showed that this siphovirus had a latent period of 70 min and released 172 new viral particles per cell. Host range analysis against 89 bacterial host strains revealed that phage B8b infected 3 Pseudoalteromonas strains (52 tested, >99.9% 16S rRNA gene nucleotide identity) and 1 non-Pseudoaltermonas strain belonging to Alteromonas sp. (37 strains from 6 genera tested), which helps bound the phylogenetic distance possible in a phage-mediated horizontal gene transfer event. The Pseudoalteromonas phage B8b genome size was 42.7 kb, with clear structural and replication modules where the former were delineated leveraging identification of 16 structural genes by virion structural proteomics, only 4 of which had any similarity to known structural proteins. In nature, this phage was common in coastal marine environments in both photic and aphotic layers (found in 26.5% of available viral metagenomes), but not abundant in any sample (average per sample abundance was 0.65% of the reads). Together these data improve our understanding of siphoviruses in nature, and provide foundational information for a new 'rare virosphere' phage-host model system.	[Lara, Elena; Laia Sa, Elisabet; Cornejo-Castillo, Francisco M.; Vaque, Dolors; Acinas, Silvia G.] CSIC, Inst Ciencia Mar, Dept Marine Biol & Oceanog, E-08003 Barcelona, Spain; [Holmfeldt, Karin; Solonenko, Natalie; Sullivan, Matthew B.] Univ Arizona, Dept Ecol & Evolutionary Biol, Tucson, AZ USA; [Ignacio-Espinoza, J. Cesar; Sullivan, Matthew B.] Univ Arizona, Dept Mol & Cellular Biol, Tucson, AZ 85721 USA; [Verberkmoes, Nathan C.] Oak Ridge Natl Lab, Div Chem Sci, Oak Ridge, TN 37831 USA	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Mediterraneo de Investigaciones Marinas y Ambientales (CMIMA); CSIC - Instituto de Ciencias del Mar (ICM); University of Arizona; University of Arizona; United States Department of Energy (DOE); Oak Ridge National Laboratory	Acinas, SG (corresponding author), CSIC, Inst Ciencia Mar, Dept Marine Biol & Oceanog, Passeig Maritim Barceloneta 37-49, E-08003 Barcelona, Spain.	sacinas@icm.csic.es	Sullivan, Matthew B/H-3256-2011; Acinas, Silvia/F-7462-2016; Vaque, Dolors/H-6973-2018	Sullivan, Matthew B/0000-0003-4040-9831; Acinas, Silvia/0000-0002-3439-0428; Cornejo-Castillo, Francisco M./0000-0001-8431-9278; Holmfeldt, Karin/0000-0002-6887-6661; Lara, Elena/0000-0002-4625-348X; Ignacio Espinoza, J. Cesar/0000-0001-9303-7504; Vaque, Dolors/0000-0002-0420-5914	FPI-predoc fellowship from the Spanish Ministry of Science and Innovation (MICINN); Ramon y Cajal contract from MICINN; MicroB3; Swedish Research Council [623-2010-6548]; MICROVIS from the MICINN [CTM2007-62140]; MEFISTO from the MICINN [CTM2013-43767-P]; MICRODIVERSITY from the MICINN [CGL2008-00762/BOS]; PANGENOMICS from the MICINN [CGL2011-26848/BOS]; Gordon and Betty Moore Foundation [2631]	FPI-predoc fellowship from the Spanish Ministry of Science and Innovation (MICINN); Ramon y Cajal contract from MICINN; MicroB3; Swedish Research Council(Swedish Research CouncilEuropean Commission); MICROVIS from the MICINN; MEFISTO from the MICINN; MICRODIVERSITY from the MICINN; PANGENOMICS from the MICINN; Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation)	EL was a recipient of the FPI-predoc fellowship from the Spanish Ministry of Science and Innovation (MICINN). SGA was supported by a Ramon y Cajal contract from MICINN and by MicroB3 (FP7-OCEAN-2011). KH was supported by a postdoctoral fellowship from the Swedish Research Council (623-2010-6548). This work was supported by grants MICROVIS (CTM2007-62140) and MEFISTO (CTM2013-43767-P) to DV, MICRODIVERSITY (CGL2008-00762/BOS) and PANGENOMICS (CGL2011-26848/BOS) to SGA from the MICINN, a Gordon and Betty Moore Foundation (grant #2631) to MBS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Allers E, 2013, ENVIRON MICROBIOL, V15, P2306, DOI 10.1111/1462-2920.12100; Angly F, 2009, ENVIRON MICROBIOL, V11, P2863, DOI 10.1111/j.1462-2920.2009.02021.x; Angly FE, 2006, PLOS BIOL, V4, P2121, DOI 10.1371/journal.pbio.0040368; Baudoux AC, 2012, ENVIRON MICROBIOL, V14, P2071, DOI 10.1111/j.1462-2920.2011.02685.x; Besemer J, 1999, NUCLEIC ACIDS RES, V27, P3911, DOI 10.1093/nar/27.19.3911; Boras JA, 2009, ENVIRON MICROBIOL, V11, P1181, DOI 10.1111/j.1462-2920.2008.01849.x; Breitbart M, 2002, P NATL ACAD SCI USA, V99, P14250, DOI 10.1073/pnas.202488399; Breitbart M, 2012, ANNU REV MAR SCI, V4, P425, DOI 10.1146/annurev-marine-120709-142805; Breitbart M, 2007, OCEANOGRAPHY, V20, P135, DOI 10.5670/oceanog.2007.58; Brum JR, 2013, ISME J, V7, P1738, DOI 10.1038/ismej.2013.67; Brussaard CPD, 2008, ISME J, V2, P575, DOI 10.1038/ismej.2008.31; Brussow H, 2004, MICROBIOL MOL BIOL R, V68, P560, DOI 10.1128/MMBR.68.3.560-602.2004; Casjens SR, 2005, CURR OPIN MICROBIOL, V8, P451, DOI 10.1016/j.mib.2005.06.014; CATALANO CE, 1995, MOL MICROBIOL, V16, P1075, DOI 10.1111/j.1365-2958.1995.tb02333.x; Chang HW, 2011, J MICROBIOL, V49, P927, DOI 10.1007/s12275-011-1577-0; Chen F, 1996, VIROLOGY, V219, P170, DOI 10.1006/viro.1996.0234; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; Comeau AM, 2004, J VIROL METHODS, V118, P95, DOI 10.1016/j.jviromet.2004.01.020; Comeau AM, 2006, ENVIRON MICROBIOL, V8, P1164, DOI 10.1111/j.1462-2920.2006.01006.x; Comeau AM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040102; Crespo BG, 2013, MICROBIOLOGYOPEN, V2, P541, DOI 10.1002/mbo3.92; Cui ZL, 2012, J VIROL, V86, P13843, DOI 10.1128/JVI.02435-12; Danovaro R, 2011, FEMS MICROBIOL REV, V35, P993, DOI 10.1111/j.1574-6976.2010.00258.x; Deng L, 2014, NATURE, V513, P242, DOI 10.1038/nature13459; Desiere F, 2001, VIROLOGY, V288, P325, DOI 10.1006/viro.2001.1085; Dinsdale EA, 2008, NATURE, V452, P629, DOI 10.1038/nature06810; Duhaime Melissa B, 2012, Environ Microbiol, V14, P2526, DOI 10.1111/j.1462-2920.2012.02791.x; Duhaime MB, 2012, VIROLOGY, V434, P181, DOI 10.1016/j.virol.2012.09.036; Duhaime MB, 2011, ISME J, V5, P107, DOI 10.1038/ismej.2010.94; Edwards RA, 2005, NAT REV MICROBIOL, V3, P504, DOI 10.1038/nrmicro1163; Erickson AR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049138; Ferrera I, 2011, APPL ENVIRON MICROB, V77, P7451, DOI 10.1128/AEM.00208-11; Filee J, 2002, J MOL EVOL, V54, P763, DOI 10.1007/s00239-001-0078-x; Fuhrman JA, 1999, NATURE, V399, P541, DOI 10.1038/21119; Garcia P, 2008, APPL ENVIRON MICROB, V74, P7552, DOI 10.1128/AEM.01709-08; Gasol JM, 2000, SCI MAR, V64, P197, DOI 10.3989/scimar.2000.64n2197; GEORGOPOULOS CP, 1973, J MOL BIOL, V76, P45, DOI 10.1016/0022-2836(73)90080-6; Goodridge L, 2003, APPL ENVIRON MICROB, V69, P5364, DOI 10.1128/AEM.69.9.5364-5371.2003; Haber JE, 1999, NATURE, V398, P665, DOI 10.1038/19423; Hadas H, 1997, MICROBIOL-UK, V143, P179, DOI 10.1099/00221287-143-1-179; HALL SD, 1994, P NATL ACAD SCI USA, V91, P3205, DOI 10.1073/pnas.91.8.3205; Hardies SC, 2013, J VIROL, V87, P9189, DOI 10.1128/JVI.01521-13; Hendrix RW, 1999, P NATL ACAD SCI USA, V96, P2192, DOI 10.1073/pnas.96.5.2192; Henn MR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009083; Hingamp P, 2013, ISME J, V7, P1678, DOI 10.1038/ismej.2013.59; Holmfeldt K, 2007, APPL ENVIRON MICROB, V73, P6730, DOI 10.1128/AEM.01399-07; Holmfeldt K, 2014, ENVIRON MICROBIOL, V16, P2501, DOI 10.1111/1462-2920.12391; Holmfeldt K, 2013, P NATL ACAD SCI USA, V110, P12798, DOI 10.1073/pnas.1305956110; Hopkins M, 2014, ISME J, V8, P2093, DOI 10.1038/ismej.2014.43; Huang SJ, 2012, ENVIRON MICROBIOL, V14, P540, DOI 10.1111/j.1462-2920.2011.02667.x; Hurwitz BL, 2015, ISME J, V9, P472, DOI 10.1038/ismej.2014.143; Hurwitz BL, 2014, P NATL ACAD SCI USA, V111, P10714, DOI 10.1073/pnas.1319778111; Hurwitz BL, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-11-r123; Hurwitz BL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057355; Hurwitz BL, 2013, ENVIRON MICROBIOL, V15, P1428, DOI 10.1111/j.1462-2920.2012.02836.x; Ignacio-Espinoza JC, 2013, CURR OPIN VIROL, V3, P566, DOI 10.1016/j.coviro.2013.07.004; Ignacio-Espinoza JC, 2012, ENVIRON MICROBIOL, V14, P2113, DOI 10.1111/j.1462-2920.2012.02704.x; Jensen EC, 1998, APPL ENVIRON MICROB, V64, P575; Jiang SC, 1998, APPL ENVIRON MICROB, V64, P2780; Joh RI, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002006; John SG, 2011, ENV MICROBIOL REP, V3, P195, DOI 10.1111/j.1758-2229.2010.00208.x; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Kang I, 2013, P NATL ACAD SCI USA, V110, P12343, DOI 10.1073/pnas.1219930110; Keppel F, 2002, EMBO REP, V3, P893, DOI 10.1093/embo-reports/kvf176; Kim M, 2011, APPL ENVIRON MICROB, V77, P2042, DOI 10.1128/AEM.02504-10; Kivela HM, 1999, VIROLOGY, V262, P364, DOI 10.1006/viro.1999.9838; Kogoma T, 1996, CELL, V85, P625, DOI 10.1016/S0092-8674(00)81229-5; KOURILSKY P, 1973, MOL GEN GENET, V122, P183, DOI 10.1007/BF00435190; Kurochkina LP, 2012, J VIROL, V86, P10103, DOI 10.1128/JVI.00940-12; Labonte JM, 2013, ISME J, V7, P2169, DOI 10.1038/ismej.2013.110; Lan SF, 2009, APPL ENVIRON MICROB, V75, P2659, DOI 10.1128/AEM.02483-08; LARKIN MA, 2007, BIOINFORMATICS, V23, P2947, DOI DOI 10.1093/BI0INF0RMATICS/BTM404; Lohr JE, 2005, APPL ENVIRON MICROB, V71, P1598, DOI 10.1128/AEM.71.3.1598-1609.2005; Mann NH, 2003, NATURE, V424, P741, DOI 10.1038/424741a; Mannisto RH, 1999, VIROLOGY, V262, P355, DOI 10.1006/viro.1999.9837; MATSUZAKI S, 1992, MICROBIOL IMMUNOL, V36, P93, DOI 10.1111/j.1348-0421.1992.tb01645.x; Mobberley JM, 2008, J VIROL, V82, P6618, DOI 10.1128/JVI.00140-08; MOEBUS K, 1992, HELGOLANDER MEERESUN, V46, P275, DOI 10.1007/BF02367099; Paul JH, 2005, APPL ENVIRON MICROB, V71, P3311, DOI 10.1128/AEM.71.6.3311-3320.2005; Paul JH, 2005, CURR OPIN BIOTECH, V16, P299, DOI 10.1016/j.copbio.2005.03.007; Paul JH, 2008, ISME J, V2, P579, DOI 10.1038/ismej.2008.35; Raes J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-1-r10; Rao VB, 2008, ANNU REV GENET, V42, P647, DOI 10.1146/annurev.genet.42.110807.091545; Rappe MS, 2003, ANNU REV MICROBIOL, V57, P369, DOI 10.1146/annurev.micro.57.030502.090759; Rodriguez-Brito B, 2010, ISME J, V4, P739, DOI 10.1038/ismej.2010.1; Rohwer F, 2003, CELL, V113, P141, DOI 10.1016/S0092-8674(03)00276-9; Rohwer F, 2009, NATURE, V459, P207, DOI 10.1038/nature08060; Roux S, 2014, ELIFE, V3, DOI 10.7554/eLife.03125; Ruiz-Gonzalez C, 2012, LIMNOL OCEANOGR, V57, P1376, DOI 10.4319/lo.2012.57.5.1376; Sambrock J, 1989, MOL CLONING LAB MANU, V1; SAMBROOK J, 2000, MOL CLONING LAB MANU; Seguritan V, 2003, J BACTERIOL, V185, P6434, DOI 10.1128/JB.185.21.6434-6447.2003; Serwer P, 2004, VIROLOGY, V329, P412, DOI 10.1016/j.virol.2004.08.021; Sharon I, 2011, ISME J, V5, P1178, DOI 10.1038/ismej.2011.2; Solonenko SA, 2013, METHOD ENZYMOL, V531, P143, DOI 10.1016/B978-0-12-407863-5.00008-3; Solonenko SA, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-320; St-Pierre F, 2008, P NATL ACAD SCI USA, V105, P20705, DOI 10.1073/pnas.0808831105; Steward GF, 2000, LIMNOL OCEANOGR, V45, P1697, DOI 10.4319/lo.2000.45.8.1697; Steward GF, 2001, METHOD MICROBIOL, V30, P85, DOI 10.1016/S0580-9517(01)30041-7; Steward GF, 2013, ISME J, V7, P672, DOI 10.1038/ismej.2012.121; STEWART FM, 1984, THEOR POPUL BIOL, V26, P93, DOI 10.1016/0040-5809(84)90026-1; Sullivan MB, 2006, PLOS BIOL, V4, P1344, DOI 10.1371/journal.pbio.0040234; Sullivan MB, 2010, ENVIRON MICROBIOL, V12, P3035, DOI 10.1111/j.1462-2920.2010.02280.x; Sullivan MB, 2009, ENVIRON MICROBIOL, V11, P2935, DOI 10.1111/j.1462-2920.2009.02081.x; Sullivan MB, 2005, PLOS BIOL, V3, P790, DOI 10.1371/journal.pbio.0030144; Sullivan MB, 2003, NATURE, V424, P1047, DOI 10.1038/nature01929; SUTTLE CA, 1993, MAR ECOL PROG SER, V92, P99, DOI 10.3354/meps092099; Suttle CA, 2005, NATURE, V437, P356, DOI 10.1038/nature04160; Suttle CA, 2007, NAT REV MICROBIOL, V5, P801, DOI 10.1038/nrmicro1750; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tapia P, 2012, J VIROL, V86, P12452, DOI 10.1128/JVI.02261-12; Thomas T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003252; van Regenmortel MHV, 2000, ARCH VIROL, V145, P2227, DOI 10.1007/s007050070053; Verberkmoes NC, 2009, ISME J, V3, P179, DOI 10.1038/ismej.2008.108; Weinbauer MG, 2004, FEMS MICROBIOL REV, V28, P127, DOI 10.1016/j.femsre.2003.08.001; Weinbauer MG, 2003, LIMNOL OCEANOGR, V48, P1457, DOI 10.4319/lo.2003.48.4.1457; WEISS BD, 1994, J BACTERIOL, V176, P3354, DOI 10.1128/jb.176.11.3354-3359.1994; Weitz JS, 2013, TRENDS MICROBIOL, V21, P82, DOI 10.1016/j.tim.2012.11.003; Wichels A, 1998, APPL ENVIRON MICROB, V64, P4128; Wichels A, 2002, AQUAT MICROB ECOL, V27, P233, DOI 10.3354/ame027233; Williamson SJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001456; Winget DM, 2008, APPL ENVIRON MICROB, V74, P2612, DOI 10.1128/AEM.02829-07; Wisniewski JR, 2009, J PROTEOME RES, V8, P5674, DOI 10.1021/pr900748n; Wommack KE, 2000, MICROBIOL MOL BIOL R, V64, P69, DOI 10.1128/MMBR.64.1.69-114.2000; Xie BB, 2012, J BACTERIOL, V194, P2746, DOI 10.1128/JB.00265-12; YASUIKE M, 2013, GENOME ANNOUNC, V1, DOI DOI 10.1128/GENOMEA.00248-12; Zhang YM, 1998, NAT GENET, V20, P123, DOI 10.1038/2417; Zhao YL, 2013, NATURE, V494, P357, DOI 10.1038/nature11921	129	9	9	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2015	10	1							e0114829	10.1371/journal.pone.0114829	http://dx.doi.org/10.1371/journal.pone.0114829			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ0ID	25587991	Green Submitted, gold, Green Published			2022-12-27	WOS:000347928300004
J	Rydzak, J; Kaczmarek, R; Czerwinski, M; Lukasiewicz, J; Tyborowska, J; Szewczyk, B; Jaskiewicz, E				Rydzak, Joanna; Kaczmarek, Radoslaw; Czerwinski, Marcin; Lukasiewicz, Jolanta; Tyborowska, Jolanta; Szewczyk, Boguslaw; Jaskiewicz, Ewa			The Baculovirus-Expressed Binding Region of Plasmodium falciparum EBA-140 Ligand and Its Glycophorin C Binding Specificity	PLOS ONE			English	Article							MURINE MONOCLONAL-ANTIBODIES; ERYTHROCYTE INVASION; RECEPTOR SPECIFICITY; MOLECULAR-BASIS; RECOMBINANT FORMS; ANTI-GLYCOPHORIN; MALARIA; PROTEINS; BAEBL; ACID	The erythrocyte binding ligand 140 (EBA-140) is a member of the Plasmodium falciparum DBL family of erythrocyte binding proteins, which are considered as prospective candidates for malaria vaccine development. The EBA-140 ligand is a paralogue of the well-characterized P. falciparum EBA-175 protein. They share homology of domain structure, including Region II, which consists of two homologous F1 and F2 domains and is responsible for ligand-erythrocyte receptor interaction during invasion. In this report we describe, for the first time, the glycophorin C specificity of the recombinant, baculovirus-expressed binding region (Region II) of P. falciparum EBA-140 ligand. It was found that the recombinant EBA-140 Region II binds to the endogenous and recombinant glycophorin C, but does not bind to Gerbich-type glycophorin C, neither normal nor recombinant, which lacks amino acid residues 36-63 of its polypeptide chain. Our results emphasize the crucial role of this glycophorin C region in EBA-140 ligand binding. Moreover, the EBA-140 Region II did not bind either to glycophorin D, the truncated form of glycophorin C lacking the N-glycan or to desialylated GPC. These results draw attention to the role of glycophorin C glycans in EBA-140 binding. The full identification of the EBA-140 binding site on glycophorin C molecule, consisting most likely of its glycans and peptide backbone, may help to design therapeutics or vaccines that target the erythrocyte binding merozoite ligands.	[Rydzak, Joanna; Kaczmarek, Radoslaw; Czerwinski, Marcin; Lukasiewicz, Jolanta; Jaskiewicz, Ewa] Polish Acad Sci, Ludwik Hirszfeld Inst Immunol & Expt Therapy, Wroclaw, Poland; [Czerwinski, Marcin] Opole Univ Technol, Fac Physiotherapy & Phys Educ, Opole, Poland; [Tyborowska, Jolanta; Szewczyk, Boguslaw] Univ Gdansk, Intercollegiate Fac Biotechnol, Dept Recombinant Vaccines, PL-80952 Gdansk, Poland; [Tyborowska, Jolanta; Szewczyk, Boguslaw] Med Univ Gdansk, Gdansk, Poland; [Jaskiewicz, Ewa] Univ Zielona Gora, Dept Mol Biol, Zielona Gora, Poland	Polish Academy of Sciences; Hirszfeld Institute of Immunology & Experimental Therapy of the Polish Academy of Sciences; Opole University of Technology; Fahrenheit Universities; University of Gdansk; Fahrenheit Universities; Medical University Gdansk; University of Zielona Gora	Jaskiewicz, E (corresponding author), Polish Acad Sci, Ludwik Hirszfeld Inst Immunol & Expt Therapy, Wroclaw, Poland.	jaskiew@iitd.pan.wroc.pl		Szewczyk, Boguslaw/0000-0003-4957-4059; Kaczmarek, Radoslaw/0000-0001-8084-1958; Lukasiewicz, Jolanta/0000-0001-8081-7261; Czerwinski, Marcin/0000-0003-2859-3699	Ministry of Science and Higher Education of Poland [N N302 281436]; National Centre of Science [2012/05/N/NZ6/00667]	Ministry of Science and Higher Education of Poland(Ministry of Science and Higher Education, Poland); National Centre of Science	The research was supported by grants No N N302 281436 from the Ministry of Science and Higher Education of Poland and grant No 2012/05/N/NZ6/00667 from National Centre of Science.	Adams JH, 2001, TRENDS PARASITOL, V17, P297, DOI 10.1016/S1471-4922(01)01948-1; Bei AK, 2012, INT J PARASITOL, V42, P575, DOI 10.1016/j.ijpara.2012.03.006; CARTRON JP, 1993, SEMIN HEMATOL, V30, P152; Chiu PCN, 2004, BIOL REPROD, V70, P1710, DOI 10.1095/biolreprod.103.023259; Cowman AF, 2012, J CELL BIOL, V198, P961, DOI 10.1083/jcb.201206112; Gaur D, 2011, CURR OPIN MICROBIOL, V14, P422, DOI 10.1016/j.mib.2011.07.018; Gilberger TW, 2003, J BIOL CHEM, V278, P14480, DOI 10.1074/jbc.M211446200; Ja kiewicz E, 2007, POST PY HIG MED DO W, V61, P718; Jaskiewicz E, 2002, TRANSFUS CLIN BIOL, V9, P121, DOI 10.1016/S1246-7820(02)00233-1; Jaskiewicz E, 2002, TRANSFUSION MED, V12, P141, DOI 10.1046/j.1365-3148.2002.00361.x; JASKIEWICZ E, 1994, BLOOD, V84, P2340; Jiang LB, 2009, MOL BIOCHEM PARASIT, V168, P49, DOI 10.1016/j.molbiopara.2009.06.006; Kim CLV, 1996, BLOOD, V88, P2364, DOI 10.1182/blood.V88.6.2364.bloodjournal8862364; Kobayashi K, 2010, J BIOL CHEM, V285, P1716, DOI 10.1074/jbc.M109.021576; KUSNIERZ-ALEJSKA G, 1990, Materia Medica Polona, V22, P8; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lin DH, 2012, J BIOL CHEM, V287, P36830, DOI 10.1074/jbc.M112.409276; LISOWSKA E, 1987, MOL IMMUNOL, V24, P605, DOI 10.1016/0161-5890(87)90041-1; Lisowska E, 1988, Adv Exp Med Biol, V228, P265; Lobo CA, 2003, BLOOD, V101, P4628, DOI 10.1182/blood-2002-10-3076; LOIRAT MJ, 1994, TRANSFUSION MED, V4, P147, DOI 10.1111/j.1365-3148.1994.tb00256.x; Maier AG, 2003, NAT MED, V9, P87, DOI 10.1038/nm807; Maier AG, 2009, INFECT IMMUN, V77, P1689, DOI 10.1128/IAI.01331-08; Malpede BM, 2013, J BIOL CHEM, V288, P12406, DOI 10.1074/jbc.M113.450643; Martin MJ, 2005, P NATL ACAD SCI USA, V102, P12819, DOI 10.1073/pnas.0503819102; Mayer DCG, 2006, P NATL ACAD SCI USA, V103, P2358, DOI 10.1073/pnas.0510648103; Mayer DCG, 2002, J EXP MED, V196, P1523, DOI 10.1084/jem.20020750; Narum DL, 2002, MOL BIOCHEM PARASIT, V119, P159, DOI 10.1016/S0166-6851(01)00428-5; Ockenhouse CF, 2001, MOL BIOCHEM PARASIT, V113, P9, DOI 10.1016/S0166-6851(00)00375-3; Pandey KC, 2002, MOL BIOCHEM PARASIT, V123, P23, DOI 10.1016/S0166-6851(02)00122-6; REID ME, 1987, BIOCHEM J, V244, P123, DOI 10.1042/bj2440123; Richards JS, 2010, CLIN INFECT DIS, V51, pE50, DOI 10.1086/656413; Rydzak J, 2013, POSTEP HIG MED DOSW, V67, P1331, DOI 10.5604/17322693.1081865; Rydzak J, 2012, ACTA BIOCHIM POL, V59, P685; Salinas ND, 2014, PROTEIN EXPRES PURIF, V95, P188, DOI 10.1016/j.pep.2013.12.008; SIM BKL, 1994, SCIENCE, V264, P1941, DOI 10.1126/science.8009226; Tham WH, 2012, TRENDS PARASITOL, V28, P23, DOI 10.1016/j.pt.2011.10.002; Thompson JK, 2001, MOL MICROBIOL, V41, P47, DOI 10.1046/j.1365-2958.2001.02484.x; Tolia NH, 2005, CELL, V122, P183, DOI 10.1016/j.cell.2005.05.033; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Walker P S, 2010, Immunohematology, V26, P60; Zhang DM, 2005, INFECT IMMUN, V73, P6530, DOI 10.1128/IAI.73.10.6530-6536.2005	42	16	16	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2015	10	1							e0115437	10.1371/journal.pone.0115437	http://dx.doi.org/10.1371/journal.pone.0115437			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ0ID	25588042	gold, Green Published, Green Submitted			2022-12-27	WOS:000347928300006
J	Perez-Cruz, C; Delgado, L; Lopez-Iglesias, C; Mercade, E				Perez-Cruz, Carla; Delgado, Lidia; Lopez-Iglesias, Carmen; Mercade, Elena			Outer-Inner Membrane Vesicles Naturally Secreted by Gram-Negative Pathogenic Bacteria	PLOS ONE			English	Article							PSEUDOMONAS-AERUGINOSA; CRYOELECTRON TOMOGRAPHY; PROTEOME ANALYSIS; ESCHERICHIA-COLI; VIRULENCE; DNA; BIOGENESIS; MECHANISM; PROTEINS; RELEASE	Outer-inner membrane vesicles (O-IMVs) were recently described as a new type of membrane vesicle secreted by the Antarctic bacterium Shewanella vesiculosa M7T. Their formation is characterized by the protrusion of both outer and plasma membranes, which pulls cytoplasmic components into the vesicles. To demonstrate that this is not a singular phenomenon in a bacterium occurring in an extreme environment, the identification of O-IMVs in pathogenic bacteria was undertaken. With this aim, a structural study by Transmission Electron Microscopy (TEM) and Cryo-transmission electron microscopy (Cryo-TEM) was carried out, confirming that O-IMVs are also secreted by Gram-negative pathogenic bacteria such as Neisseria gonorrhoeae, Pseudomonas aeruginosa PAO1 and Acinetobacter baumannii AB41, in which they represent between 0.23% and 1.2% of total vesicles produced. DNA and ATP, which are components solely found in the cell cytoplasm, were identified within membrane vesicles of these strains. The presence of DNA inside the O-IMVs produced by N. gonorrhoeae was confirmed by gold DNA immunolabeling with a specific monoclonal IgM against double-stranded DNA. A proteomic analysis of N. gonorrhoeae-derived membrane vesicles identified proteins from the cytoplasm and plasma membrane. This confirmation of O-IMV extends the hitherto uniform definition of membrane vesicles in Gram-negative bacteria and explains the presence of components in membrane vesicles such as DNA, cytoplasmic and inner membrane proteins, as well as ATP, detected for the first time. The production of these O-IMVs by pathogenic Gram-negative bacteria opens up new areas of study related to their involvement in lateral gene transfer, the transfer of cytoplasmic proteins, as well as the functionality and role of ATP detected in these new vesicles.	[Perez-Cruz, Carla; Mercade, Elena] Univ Barcelona, Fac Farm, Microbiol Lab, E-08028 Barcelona, Spain; [Delgado, Lidia; Lopez-Iglesias, Carmen] Univ Barcelona, Ctr Cient & Tecnol, Barcelona, Spain	University of Barcelona; University of Barcelona	Mercade, E (corresponding author), Univ Barcelona, Fac Farm, Microbiol Lab, E-08028 Barcelona, Spain.	mmercade@ub.edu	DELGADO, LIDIA/H-7939-2015; Mercade, Elena/L-5218-2014; Perez-Cruz, Carla/AAB-3540-2020	DELGADO, LIDIA/0000-0001-7351-6188; Mercade, Elena/0000-0001-7828-2210; 	Government of Spain (CICYT) [CTQ 2010-21183-C02-01/PPQ]; Autonomous Government of Catalonia [2009SGR1212]; University of Barcelona [FFAR2012.3]	Government of Spain (CICYT)(Consejo Interinstitucional de Ciencia y Tecnologia (CICYT)); Autonomous Government of Catalonia(Generalitat de Catalunya); University of Barcelona	Funding: This work received funding from the following sources: Government of Spain (CICYT grant CTQ 2010-21183-C02-01/PPQ)EM CP-C, Autonomous Government of Catalonia (grant 2009SGR1212)EM CL-I, and Fellowship FFAR2012.3 from the University of Barcelona (CP-C). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilera L, 2014, PROTEOMICS, V14, P222, DOI 10.1002/pmic.201300328; Beveridge TJ, 1999, J BACTERIOL, V181, P4725, DOI 10.1128/JB.181.16.4725-4733.1999; Choi DS, 2011, PROTEOMICS, V11, P3424, DOI 10.1002/pmic.201000212; Deatherage BL, 2012, INFECT IMMUN, V80, P1948, DOI 10.1128/IAI.06014-11; Deatherage BL, 2009, MOL MICROBIOL, V72, P1395, DOI 10.1111/j.1365-2958.2009.06731.x; Delgado L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073297; DORWARD DW, 1990, APPL ENVIRON MICROB, V56, P1960, DOI 10.1128/AEM.56.6.1960-1962.1990; DORWARD DW, 1989, J BACTERIOL, V171, P2499, DOI 10.1128/jb.171.5.2499-2505.1989; Ellis TN, 2010, MICROBIOL MOL BIOL R, V74, P81, DOI 10.1128/MMBR.00031-09; Henderson B, 2011, INFECT IMMUN, V79, P3476, DOI 10.1128/IAI.00179-11; Hironaka I, 2013, APPL ENVIRON MICROB, V79, P2328, DOI 10.1128/AEM.03871-12; Hurbain I, 2011, BIOL CELL, V103, P405, DOI 10.1042/BC20110015; KADURUGAMUWA JL, 1995, J BACTERIOL, V177, P3998, DOI 10.1128/jb.177.14.3998-4008.1995; Koning RI, 2013, RES MICROBIOL, V164, P397, DOI 10.1016/j.resmic.2013.02.007; Kudryashev M, 2009, MOL MICROBIOL, V71, P1415, DOI 10.1111/j.1365-2958.2009.06613.x; Kuehn MJ, 2005, GENE DEV, V19, P2645, DOI 10.1101/gad.1299905; Kulp A, 2010, ANNU REV MICROBIOL, V64, P163, DOI 10.1146/annurev.micro.091208.073413; Kunert A, 2007, J IMMUNOL, V179, P2979, DOI 10.4049/jimmunol.179.5.2979; Kwon SO, 2009, FEMS MICROBIOL LETT, V297, P150, DOI 10.1111/j.1574-6968.2009.01669.x; Lappann M, 2013, J BACTERIOL, V195, P4425, DOI 10.1128/JB.00625-13; Lee EY, 2008, MASS SPECTROM REV, V27, P535, DOI 10.1002/mas.20175; Lee EY, 2007, PROTEOMICS, V7, P3143, DOI [10.1002/pmic.200700196, 10.1002/pmic.200790083]; Lee JC, 2012, FEMS MICROBIOL LETT, V331, P17, DOI 10.1111/j.1574-6968.2012.02549.x; Li Z, 2009, CURR OPIN MICROBIOL, V12, P333, DOI 10.1016/j.mib.2009.03.007; Mashburn-Warren LM, 2006, MOL MICROBIOL, V61, P839, DOI 10.1111/j.1365-2958.2006.05272.x; McBroom AJ, 2006, J BACTERIOL, V188, P5385, DOI 10.1128/JB.00498-06; Mempin R, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-301; Mullaney E, 2009, PROTEOM CLIN APPL, V3, P785, DOI 10.1002/prca.200800192; Perez-Cruz C, 2013, APPL ENVIRON MICROB, V79, P1874, DOI 10.1128/AEM.03657-12; Pierson T, 2011, J PROTEOME RES, V10, P954, DOI 10.1021/pr1009756; Renelli M, 2004, MICROBIOL-SGM, V150, P2161, DOI 10.1099/mic.0.26841-0; Rumbo C, 2011, ANTIMICROB AGENTS CH, V55, P3084, DOI 10.1128/AAC.00929-10; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Sharpe SW, 2011, INFECT IMMUN, V79, P4361, DOI 10.1128/IAI.05332-11; Toyofuku M, 2012, J PROTEOME RES, V11, P4906, DOI 10.1021/pr300395j; Unal CM, 2011, SEMIN IMMUNOPATHOL, V33, P395, DOI 10.1007/s00281-010-0231-y; Xi CW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013355; Yaron S, 2000, APPL ENVIRON MICROB, V66, P4414, DOI 10.1128/AEM.66.10.4414-4420.2000; Yu NY, 2010, BIOINFORMATICS, V26, P1608, DOI 10.1093/bioinformatics/btq249	39	137	139	4	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2015	10	1							e0116896	10.1371/journal.pone.0116896	http://dx.doi.org/10.1371/journal.pone.0116896			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ4CF	25581302	gold, Green Published, Green Submitted			2022-12-27	WOS:000348169100006
J	Danies, G; Myers, K; Mideros, MF; Restrepo, S; Martin, FN; Cooke, DEL; Smart, CD; Ristaino, JB; Seaman, AJ; Gugino, BK; Grunwald, NJ; Fry, WE				Danies, Giovanna; Myers, Kevin; Mideros, Maria F.; Restrepo, Silvia; Martin, Frank N.; Cooke, David E. L.; Smart, Christine D.; Ristaino, Jean B.; Seaman, Abby J.; Gugino, Beth K.; Gruenwald, Niklaus J.; Fry, William E.			An Ephemeral Sexual Population of Phytophthora infestans in the Northeastern United States and Canada	PLOS ONE			English	Article							RECENT CLONAL LINEAGES; LATE BLIGHT; TOLUCA VALLEY; POTATO; GENOTYPES; OOSPORES; MEXICO; METALAXYL; INFERENCE; SOFTWARE	Phytophthora infestans, the causal agent of late blight disease, has been reported in North America since the mid-nineteenth century. In the United States the lack of or very limited sexual reproduction has resulted in largely clonal populations of P. infestans. In 2010 and 2011, but not in 2012 or 2013, 20 rare and diverse genotypes of P. infestans were detected in a region that centered around central New York State. The ratio of A1 to A2 mating types among these genotypes was close to the 50: 50 ratio expected for sexual recombination. These genotypes were diverse at the glucose-6-phosphate isomerase locus, differed in their microsatellite profiles, showed different banding patterns in a restriction fragment length polymorphism assay using a moderately repetitive and highly polymorphic probe (RG57), were polymorphic for four different nuclear genes and differed in their sensitivity to the systemic fungicide mefenoxam. The null hypothesis of linkage equilibrium was not rejected, which suggests the population could be sexual. These new genotypes were monomorphic in their mitochondrial haplotype that was the same as US-22. Through parentage exclusion testing using microsatellite data and sequences of four nuclear genes, recent dominant lineages US-8, US-11, US-23, and US-24 were excluded as possible parents for these genotypes. Further analyses indicated that US-22 could not be eliminated as a possible parent for 14 of the 20 genotypes. We conclude that US-22 could be a parent of some, but not all, of the new genotypes found in 2010 and 2011. There were at least two other parents for this population and the genotypic characteristics of the other parents were identified.	[Danies, Giovanna; Myers, Kevin; Fry, William E.] Cornell Univ, Sch Integrat Plant Sci, Plant Pathol & Plant Microbe Biol Sect, Ithaca, NY 14850 USA; [Mideros, Maria F.; Restrepo, Silvia] Univ Los Andes, Dept Biol Sci, Bogota, Colombia; [Martin, Frank N.] ARS, USDA, Salinas, CA USA; [Cooke, David E. L.] Invergowrie, James Hutton Inst, Dundee, Scotland; [Smart, Christine D.] Cornell Univ, Dept Plant Pathol & Plant Microbe Biol, Geneva, NY USA; [Ristaino, Jean B.] N Carolina State Univ, Dept Plant Pathol, Raleigh, NC 27695 USA; [Seaman, Abby J.] Cornell Cooperat Extens, New York State Integrated Pest Management Program, Geneva, NY USA; [Gugino, Beth K.] Penn State Univ, Dept Plant Pathol & Environm Microbiol, University Pk, PA 16802 USA; [Gruenwald, Niklaus J.] ARS, Hort Crops Res Lab, USDA, Corvallis, OR USA; [Gruenwald, Niklaus J.] Oregon State Univ, Dept Bot & Plant Pathol, Corvallis, OR 97331 USA; [Gruenwald, Niklaus J.] Oregon State Univ, Ctr Genome Biol & Biocomp, Corvallis, OR 97331 USA	Cornell University; Universidad de los Andes (Colombia); United States Department of Agriculture (USDA); James Hutton Institute; Cornell University; University of North Carolina; North Carolina State University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; United States Department of Agriculture (USDA); Oregon State University; Oregon State University	Fry, WE (corresponding author), Cornell Univ, Sch Integrat Plant Sci, Plant Pathol & Plant Microbe Biol Sect, Ithaca, NY 14850 USA.	wef1@cornell.edu	Grunwald, Niklaus` J/K-6041-2013; Cooke, David/D-1933-2012; MIDEROS, MARIA F/C-9932-2016; Myers, Kevin/GZK-8865-2022; MIDEROS, MARIA FERNANDA/GPG-1874-2022; Ristaino, Jean Beagle/N-3616-2018	Grunwald, Niklaus` J/0000-0003-1656-7602; Cooke, David/0000-0002-9154-7954; Ristaino, Jean Beagle/0000-0002-9458-0514; Smart, Christine/0000-0003-4162-9502	Agriculture and Food Research Initiative Competitive Grants Program from the USDA National Institute of Food and Agriculture [2011-68004-30154]; USDA Sustainable Agriculture Research and Education [SARE GNE13-056]; College of Agriculture and Life Sciences at Cornell University; ARS [ARS-0426096] Funding Source: Federal RePORTER	Agriculture and Food Research Initiative Competitive Grants Program from the USDA National Institute of Food and Agriculture; USDA Sustainable Agriculture Research and Education; College of Agriculture and Life Sciences at Cornell University; ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	This work was supported by the Agriculture and Food Research Initiative Competitive Grants Program Grant 2011-68004-30154 from the USDA National Institute of Food and Agriculture, by the USDA Sustainable Agriculture Research and Education (SARE GNE13-056), and by the College of Agriculture and Life Sciences at Cornell University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agapow PM, 2001, MOL ECOL NOTES, V1, P101, DOI 10.1046/j.1471-8278.2000.00014.x; Blair JE, 2008, FUNGAL GENET BIOL, V45, P266, DOI 10.1016/j.fgb.2007.10.010; Blair JE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037003; CATEN CE, 1968, CAN J BOTANY, V46, P329, DOI 10.1139/b68-055; Cooke DEL, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002940; Danies G, 2013, PLANT DIS, V97, P873, DOI 10.1094/PDIS-07-12-0682-RE; DRENTH A, 1995, PLANT PATHOL, V44, P86, DOI 10.1111/j.1365-3059.1995.tb02719.x; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Falush D, 2003, GENETICS, V164, P1567; Fernandez-Pavia SP, 2004, PLANT DIS, V88, P29, DOI 10.1094/PDIS.2004.88.1.29; Flier WG, 2001, MYCOL RES, V105, P998, DOI 10.1016/S0953-7562(08)61958-9; Fry WE, 2013, PLANT DIS, V97, P296, DOI 10.1094/PDIS-08-12-0791-FE; Fry WE, 1997, PLANT DIS, V81, P1349, DOI 10.1094/PDIS.1997.81.12.1349; Fry W, 2008, MOL PLANT PATHOL, V9, P385, DOI [10.1111/j.1364-3703.2007.00465.x, 10.1111/J.1364-3703.2007.00465.X]; Gavino PD, 2000, PLANT DIS, V84, P731, DOI 10.1094/PDIS.2000.84.7.731; GOODWIN SB, 1995, PLANT DIS, V79, P1181, DOI 10.1094/PD-79-1181; GOODWIN SB, 1995, PHYTOPATHOLOGY, V85, P669, DOI 10.1094/Phyto-85-669; Goodwin SB, 1996, PHYTOPATHOLOGY, V86, P793, DOI 10.1094/Phyto-86-793; Goodwin SB, 1997, PHYTOPATHOLOGY, V87, P462, DOI 10.1094/PHYTO.1997.87.4.462; GOODWIN SB, 1994, PHYTOPATHOLOGY, V84, P553, DOI 10.1094/Phyto-84-553; GOODWIN SB, 1994, P NATL ACAD SCI USA, V91, P11591, DOI 10.1073/pnas.91.24.11591; GOODWIN SB, 1992, CURR GENET, V22, P107, DOI 10.1007/BF00351469; Goss EM, 2014, P NATL ACAD SCI USA, V111, P8791, DOI 10.1073/pnas.1401884111; Grunwald NJ, 2012, TRENDS MICROBIOL, V20, P131, DOI 10.1016/j.tim.2011.12.006; Grunwald NJ, 2005, ANNU REV PHYTOPATHOL, V43, P171, DOI 10.1146/annurev.phyto.43.040204.135906; Grunwald NJ, 2001, PHYTOPATHOLOGY, V91, P882, DOI 10.1094/PHYTO.2001.91.9.882; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hu CH, 2012, PLANT DIS, V96, P1323, DOI 10.1094/PDIS-03-11-0156-RE; Jaime-Garcia R, 2000, PHYTOPATHOLOGY, V90, P1188, DOI 10.1094/PHYTO.2000.90.11.1188; Jombart T, 2010, BMC GENET, V11, DOI [DOI 10.1186/1471-2156-11-94, 10.1186/1471-2156-11-94]; Jombart T, 2008, BIOINFORMATICS, V24, P1403, DOI 10.1093/bioinformatics/btn129; Jones AG, 2003, MOL ECOL, V12, P2511, DOI 10.1046/j.1365-294X.2003.01928.x; Kamvar ZN, 2014, PEERJ, V2, DOI 10.7717/peerj.281; KARLOVSKY P, 1991, GENE, V109, P161, DOI 10.1016/0378-1119(91)90603-9; Lambert DH, 1997, AM POTATO J, V74, P39, DOI 10.1007/BF02849171; LEGARD DE, 1995, PHYTOPATHOLOGY, V85, P1356, DOI 10.1094/Phyto-85-1356; Li Y, 2013, J MICROBIOL METH, V92, P316, DOI 10.1016/j.mimet.2012.11.021; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; MARTIN FN, 2012, PHYTOPATHOLOGY S4, V102, P76; Miller JS, 1998, PHYTOPATHOLOGY, V88, P190, DOI 10.1094/PHYTO.1998.88.3.190; Miller M.A., 2010, P GAT COMP ENV WORKS; Myers K, 2011, PHYTOPATHOLOGY, V101, pS261; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Pritchard JK, 2000, GENETICS, V155, P945; Small IM, 2012, PHYTOPATHOLOGY, V102, P110; TAJIMA F, 1989, GENETICS, V123, P585; Taylor JW, 2000, FUNGAL GENET BIOL, V31, P21, DOI 10.1006/fgbi.2000.1228; THERRIEN CD, 1993, MYCOL RES, V97, P945, DOI 10.1016/S0953-7562(09)80860-5; Tyler BM, 2006, SCIENCE, V313, P1261, DOI 10.1126/science.1128796; Yuen JE, 2013, PLANT PATHOL, V62, P485, DOI 10.1111/j.1365-3059.2012.02685.x	52	28	30	1	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2014	9	12							e116354	10.1371/journal.pone.0116354	http://dx.doi.org/10.1371/journal.pone.0116354			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UC	25551215	gold, Green Submitted, Green Published			2022-12-27	WOS:000347119100133
J	Isensee, J; Wenzel, C; Buschow, R; Weissmann, R; Kuss, AW; Hucho, T				Isensee, Joerg; Wenzel, Carsten; Buschow, Rene; Weissmann, Robert; Kuss, Andreas W.; Hucho, Tim			Subgroup-Elimination Transcriptomics Identifies Signaling Proteins that Define Subclasses of TRPV1-Positive Neurons and a Novel Paracrine Circuit	PLOS ONE			English	Article							DORSAL-ROOT GANGLION; GENE-RELATED PEPTIDE; PROSTATIC ACID-PHOSPHATASE; PERIPHERAL SENSORY NEURONS; PRIMARY AFFERENT NEURONS; CAPSAICIN RECEPTOR; INFLAMMATORY PAIN; KINASE-II; VANILLOID RECEPTOR-1; MOLECULAR-MECHANISMS	Normal and painful stimuli are detected by specialized subgroups of peripheral sensory neurons. The understanding of the functional differences of each neuronal subgroup would be strongly enhanced by knowledge of the respective subgroup transcriptome. The separation of the subgroup of interest, however, has proven challenging as they can hardly be enriched. Instead of enriching, we now rapidly eliminated the subgroup of neurons expressing the heat-gated cation channel TRPV1 from dissociated rat sensory ganglia. Elimination was accomplished by brief treatment with TRPV1 agonists followed by the removal of compromised TRPV1(+) neurons using density centrifugation. By differential microarray and sequencing (RNA-Seq) based expression profiling we compared the transcriptome of all cells within sensory ganglia versus the same cells lacking TRPV1 expressing neurons, which revealed 240 differentially expressed genes (adj. p<.05, fold-change >1.5). Corroborating the specificity of the approach, many of these genes have been reported to be involved in noxious heat or pain sensitization. Beyond the expected enrichment of ion channels, we found the TRPV1 transcriptome to be enriched for GPCRs and other signaling proteins involved in adenosine, calcium, and phosphatidylinositol signaling. Quantitative population analysis using a recent High Content Screening (HCS) microscopy approach identified substantial heterogeneity of expressed target proteins even within TRPV1-positive neurons. Signaling components defined distinct further subgroups within the population of TRPV1-positive neurons. Analysis of one such signaling system showed that the pain sensitizing prostaglandin PGD2 activates DP1 receptors expressed predominantly on TRPV1(+) neurons. In contrast, we found the PGD2 producing prostaglandin D synthase to be expressed exclusively in myelinated large-diameter neurons lacking TRPV1, which suggests a novel paracrine neuron-neuron communication. Thus, subgroup analysis based on the elimination rather than enrichment of the subgroup of interest revealed proteins that define subclasses of TRPV1-positive neurons and suggests a novel paracrine circuit.	[Isensee, Joerg; Hucho, Tim] Univ Hosp, Dept Anesthesiol & Intens Care Med, Cologne, Germany; [Isensee, Joerg; Wenzel, Carsten; Buschow, Rene; Hucho, Tim] Max Planck Inst Mol Genet, Dept Human Mol Genet, D-14195 Berlin, Germany; [Weissmann, Robert; Kuss, Andreas W.] Univ Med Greifswald, Dept Human Genet, Greifswald, Germany; [Weissmann, Robert; Kuss, Andreas W.] Ernst Moritz Arndt Univ Greifswald, Interfaculty Inst Genet & Funct Gen, Greifswald, Germany	University of Cologne; Max Planck Society; Greifswald Medical School; Ernst Moritz Arndt Universitat Greifswald	Isensee, J (corresponding author), Univ Hosp, Dept Anesthesiol & Intens Care Med, Cologne, Germany.	joerg.isensee@uk-koeln.de	Isensee, Joerg/C-4745-2019; Hucho, Tim/Q-5218-2018; Buschow, René/AAZ-5533-2021	Isensee, Joerg/0000-0002-3390-0051; Hucho, Tim/0000-0002-4147-9308; Buschow, René/0000-0002-9800-2578; Kuss, Andreas/0000-0002-9401-4627	project 'Modelling pain switches (MoPS)' - Federal Ministry of Education and Research, Germany [FKZ0315449D]; project NoPain - Federal Ministry of Education and Research, Germany [FKZ0316177A, FKZ0316177FF]	project 'Modelling pain switches (MoPS)' - Federal Ministry of Education and Research, Germany; project NoPain - Federal Ministry of Education and Research, Germany	This work was supported by the projects 'Modelling pain switches (MoPS)' (FKZ0315449D) and NoPain (FKZ0316177A, FKZ0316177FF) funded by the Federal Ministry of Education and Research, Germany (http://www.bmbf.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahamsen B, 2008, SCIENCE, V321, P702, DOI 10.1126/science.1156916; Alloui A, 2006, EMBO J, V25, P2368, DOI 10.1038/sj.emboj.7601116; Amaya F, 2004, EUR J NEUROSCI, V20, P2303, DOI 10.1111/j.1460-9568.2004.03701.x; An WF, 2000, NATURE, V403, P553, DOI 10.1038/35000592; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Andres C, 2010, MOL PAIN, V6, DOI 10.1186/1744-8069-6-98; Bali KK, 2013, MOL PAIN, V9, DOI 10.1186/1744-8069-9-48; Basbaum AI, 2009, CELL, V139, P267, DOI 10.1016/j.cell.2009.09.028; Beck EJ, 2002, J PHYSIOL-LONDON, V538, P691, DOI 10.1113/jphysiol.2001.013127; Bhave G, 2003, P NATL ACAD SCI USA, V100, P12480, DOI 10.1073/pnas.2032100100; Brown DC, 2005, ANESTHESIOLOGY, V103, P1052, DOI 10.1097/00000542-200511000-00020; Bruggemann I, 2000, MOL BRAIN RES, V85, P239, DOI 10.1016/S0169-328X(00)00265-5; Carlton SM, 2002, J COMP NEUROL, V448, P102, DOI 10.1002/cne.10250; Caterina MJ, 2000, SCIENCE, V288, P306, DOI 10.1126/science.288.5464.306; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Cavanaugh DJ, 2009, P NATL ACAD SCI USA, V106, P9075, DOI 10.1073/pnas.0901507106; Chen LH, 2013, PROSTAG OTH LIPID M, V104, P58, DOI 10.1016/j.prostaglandins.2012.08.006; Chiu HY, 2010, REGUL PEPTIDES, V164, P90, DOI 10.1016/j.regpep.2010.05.012; Chiu HY, 2009, REGUL PEPTIDES, V158, P77, DOI 10.1016/j.regpep.2009.07.012; Choi SS, 2006, BRAIN RES, V1108, P28, DOI 10.1016/j.brainres.2006.06.048; Chuang HH, 2001, NATURE, V411, P957, DOI 10.1038/35082088; Costigan M, 2002, BMC NEUROSCI, V3, DOI 10.1186/1471-2202-3-16; Dhaka A, 2009, J NEUROSCI, V29, P153, DOI 10.1523/JNEUROSCI.4901-08.2009; Dib-Hajj SD, 2010, ANNU REV NEUROSCI, V33, P325, DOI 10.1146/annurev-neuro-060909-153234; Du P, 2008, BIOINFORMATICS, V24, P1547, DOI 10.1093/bioinformatics/btn224; Ebersberger A, 2011, PAIN, V152, P1114, DOI 10.1016/j.pain.2011.01.033; Enyedi P, 2012, MOL CELL ENDOCRINOL, V353, P75, DOI 10.1016/j.mce.2011.11.009; Fink CC, 2002, CURR OPIN NEUROBIOL, V12, P293, DOI 10.1016/S0959-4388(02)00327-6; Goswami C, 2007, J NEUROCHEM, V101, P250, DOI 10.1111/j.1471-4159.2006.04338.x; Goswami C, 2011, J NEUROCHEM; Goswami SC, 2014, J PAIN; Heurteaux C, 2004, EMBO J, V23, P2684, DOI 10.1038/sj.emboj.7600234; Huang CW, 2007, MOL CELL NEUROSCI, V36, P195, DOI 10.1016/j.mcn.2007.06.010; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang F, 2013, NAT NEUROSCI, V16, P1284, DOI 10.1038/nn.3468; Hucho T, 2007, NEURON, V55, P365, DOI 10.1016/j.neuron.2007.07.008; Iadarola MJ, 2011, CURR TOP MED CHEM, V11, P2171; Isensee J, 2014, J CELL SCI, V127, P216, DOI 10.1242/jcs.136580; Ivanusic JJ, 2012, NEUROPEPTIDES, V46, P55, DOI 10.1016/j.npep.2011.09.002; JEFTINIJA S, 1992, REGUL PEPTIDES, V39, P123, DOI 10.1016/0167-0115(92)90534-2; Jenkins DW, 2001, BRIT J PHARMACOL, V134, P1296, DOI 10.1038/sj.bjp.0704357; Jeske NA, 2011, J NEUROSCI, V31, P8681, DOI 10.1523/JNEUROSCI.0020-11.2011; Jimenez-Andrade JM, 2004, PAIN, V110, P10, DOI 10.1016/j.pain.2004.02.032; Jordt SE, 2002, CELL, V108, P421, DOI 10.1016/S0092-8674(02)00637-2; Kan KKW, 2004, EUR J PHARMACOL, V491, P37, DOI 10.1016/j.ejphar.2004.02.058; Karai L, 2004, J CLIN INVEST, V113, P1344, DOI 10.1172/JCI200420449; Kesingland AC, 2000, PAIN, V86, P113, DOI 10.1016/S0304-3959(00)00233-5; Kojundzic SL, 2010, J COMP NEUROL, V518, P64, DOI 10.1002/cne.22209; Kozsurek M, 2007, EUR J NEUROSCI, V26, P1624, DOI 10.1111/j.1460-9568.2007.05789.x; Kozsurek M, 2009, EUR J NEUROSCI, V29, P2375, DOI 10.1111/j.1460-9568.2009.06773.x; Ku GM, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002449; LaCroix-Fralish ML, 2007, PAIN, V131, DOI 10.1016/j.pain.2007.04.041; Landry M, 2000, EXP NEUROL, V162, P361, DOI 10.1006/exnr.1999.7329; Leipold E, 2013, NAT GENET, V45, P1399, DOI 10.1038/ng.2767; Li H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005705; Liu Q, 2009, CELL, V139, P1353, DOI 10.1016/j.cell.2009.11.034; Lu RR, 2014, PAIN, V155, P556, DOI 10.1016/j.pain.2013.12.005; Ludwig MG, 2003, NATURE, V425, P93, DOI 10.1038/nature01905; Luo F, 2008, J PHARMACOL EXP THER, V325, P267, DOI 10.1124/jpet.107.132167; Luo L, 1999, NAT MED, V5, P117, DOI 10.1038/4806; Mandadi S, 2006, PAIN, V123, P106, DOI 10.1016/j.pain.2006.02.016; Manteniotis S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079523; Matsumoto M, 2005, MOL BRAIN RES, V138, P58, DOI 10.1016/j.molbrainres.2005.04.002; McMahon SB, 2013, WALL MELZACKS TXB PA, P1; Mishra SK, 2012, J NEUROSCI, V32, P8686, DOI 10.1523/JNEUROSCI.1533-12.2012; Mishra SK, 2011, EMBO J, V30, P582, DOI 10.1038/emboj.2010.325; Mishra SK, 2010, MOL CELL NEUROSCI, V43, P157, DOI 10.1016/j.mcn.2009.10.006; Mohapatra DP, 2005, J BIOL CHEM, V280, P13424, DOI 10.1074/jbc.M410917200; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Murakami Y, 2003, ARTHRITIS RHEUM, V48, P2931, DOI 10.1002/art.11271; Neely GG, 2010, CELL, V143, P628, DOI 10.1016/j.cell.2010.09.047; Neely GG, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003071; Nuwer MO, 2010, J NEUROSCI, V30, P14165, DOI 10.1523/JNEUROSCI.3150-10.2010; Oka S, 2010, BIOCHEM BIOPH RES CO, V395, P232, DOI 10.1016/j.bbrc.2010.03.169; Olah Z, 2001, J BIOL CHEM, V276, P11021, DOI 10.1074/jbc.M008392200; Ozsolak F, 2011, NAT REV GENET, V12, P87, DOI 10.1038/nrg2934; Patapoutian A, 2009, NAT REV DRUG DISCOV, V8, P55, DOI 10.1038/nrd2757; Pattinson D, 2006, MOL CELL NEUROSCI, V33, P88, DOI 10.1016/j.mcn.2006.06.010; Peeters PJ, 2006, PHYSIOL GENOMICS, V24, P252, DOI 10.1152/physiolgenomics.00169.2005; Perkins JR, 2013, PAIN, V154, DOI 10.1016/j.pain.2013.09.003; Prescott ED, 2003, SCIENCE, V300, P1284, DOI 10.1126/science.1083646; Price TJ, 2007, J PAIN, V8, P263, DOI 10.1016/j.jpain.2006.09.005; Quick K, 2012, OPEN BIOL, V2, DOI 10.1098/rsob.120068; R Development Core Team, 2021, R PROJECT STAT COMPU; Rasband W., 2006, IMAGEJ; Rau KK, 2009, J NEUROSCI, V29, P8612, DOI 10.1523/JNEUROSCI.1057-09.2009; Reichling DB, 2013, PAIN, V154, pS2, DOI 10.1016/j.pain.2013.05.037; Risso D, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-480; Rogge G, 2008, NAT REV NEUROSCI, V9, P747, DOI 10.1038/nrn2493; Rosenbaum T, 2004, J GEN PHYSIOL, V123, P53, DOI 10.1085/jgp.200308906; RUEFF A, 1993, AGENTS ACTIONS, V38, pC13, DOI 10.1007/BF01991122; RUSSELL LC, 1984, BRAIN RES REV, V8, P165, DOI 10.1016/0165-0173(84)90005-5; Schmidtko A, 2009, TRENDS NEUROSCI, V32, P339, DOI 10.1016/j.tins.2009.01.010; Schnizler K, 2008, J NEUROSCI, V28, P4904, DOI 10.1523/JNEUROSCI.0233-08.2008; Shinohara T, 2004, J BIOL CHEM, V279, P23559, DOI 10.1074/jbc.M314240200; Simonetti M, 2006, MOL PAIN, V2, DOI 10.1186/1744-8069-2-11; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Sun YG, 2009, SCIENCE, V325, P1531, DOI 10.1126/science.1174868; SZALLASI A, 1989, NEUROSCIENCE, V30, P515, DOI 10.1016/0306-4522(89)90269-8; SZALLASI A, 1989, BRAIN RES, V503, P68, DOI 10.1016/0006-8993(89)91705-8; Taylor-Blake B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008674; Tender GC, 2005, J NEUROSURG, V102, P522, DOI 10.3171/jns.2005.102.3.0522; Tomassy GS, 2014, SCIENCE, V344, P319, DOI 10.1126/science.1249766; Tominaga M, 1998, NEURON, V21, P531, DOI 10.1016/S0896-6273(00)80564-4; Traynor J, 2010, ANN NY ACAD SCI, V1187, P341, DOI 10.1111/j.1749-6632.2009.05150.x; Traynor JR, 1998, BRIT J ANAESTH, V81, P69, DOI 10.1093/bja/81.1.69; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vay L, 2012, BRIT J PHARMACOL, V165, P787, DOI 10.1111/j.1476-5381.2011.01601.x; WAKISAKA S, 1991, NEUROSCI LETT, V124, P200, DOI 10.1016/0304-3940(91)90093-9; Wang HY, 2007, NAT NEUROSCI, V10, P32, DOI 10.1038/nn1822; Wei F, 2002, NAT NEUROSCI, V5, P573, DOI 10.1038/nn0602-855; Westlund KN, 2014, NEUROSCIENCE, V262, P165, DOI 10.1016/j.neuroscience.2013.12.043; Wilson SR, 2011, NAT NEUROSCI, V14, P595, DOI 10.1038/nn.2789; Woodbury CJ, 2004, J NEUROSCI, V24, P6410, DOI 10.1523/JNEUROSCI.1421-04.2004; Xu XJ, 2010, EXPERIENTIA SUPPL, V102, P39, DOI 10.1007/978-3-0346-0228-0_4; Yu L, 2008, MOL PAIN, V4, DOI 10.1186/1744-8069-4-61; Zayed N, 2008, ARTHRITIS RHEUM-US, V58, P3530, DOI 10.1002/art.23958; Zhang XM, 2005, EMBO J, V24, P4211, DOI 10.1038/sj.emboj.7600893; Zhao PW, 2010, MOL PHARMACOL, V78, P560, DOI 10.1124/mol.110.066746; Zylka MJ, 2008, NEURON, V60, P111, DOI 10.1016/j.neuron.2008.08.024	120	25	25	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2014	9	12							e115731	10.1371/journal.pone.0115731	http://dx.doi.org/10.1371/journal.pone.0115731			34	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UC	25551770	Green Submitted, Green Published, gold			2022-12-27	WOS:000347119100056
J	Scalfi, M; Mosca, E; Di Pierro, EA; Troggio, M; Vendramin, GG; Sperisen, C; La Porta, N; Neale, DB				Scalfi, Marta; Mosca, Elena; Di Pierro, Erica Adele; Troggio, Michela; Vendramin, Giovanni Giuseppe; Sperisen, Christoph; La Porta, Nicola; Neale, David B.			Micro- and Macro-Geographic Scale Effect on the Molecular Imprint of Selection and Adaptation in Norway Spruce	PLOS ONE			English	Article							PINE PINUS-TAEDA; GENETIC-STRUCTURE; PICEA-ABIES; LOCAL ADAPTATION; POPULATION DIFFERENTIATION; CLIMATE; MITOCHONDRIAL; DIVERSITY; GENOME; L.	Forest tree species of temperate and boreal regions have undergone a long history of demographic changes and evolutionary adaptations. The main objective of this study was to detect signals of selection in Norway spruce (Picea abies [L.] Karst), at different sampling-scales and to investigate, accounting for population structure, the effect of environment on species genetic diversity. A total of 384 single nucleotide polymorphisms (SNPs) representing 290 genes were genotyped at two geographic scales: across 12 populations distributed along two altitudinal-transects in the Alps (micro-geographic scale), and across 27 populations belonging to the range of Norway spruce in central and south-east Europe (macro-geographic scale). At the macrogeographic scale, principal component analysis combined with Bayesian clustering revealed three major clusters, corresponding to the main areas of southern spruce occurrence, i.e. the Alps, Carpathians, and Hercynia. The populations along the altitudinal transects were not differentiated. To assess the role of selection in structuring genetic variation, we applied a Bayesian and coalescent-based F-ST-outlier method and tested for correlations between allele frequencies and climatic variables using regression analyses. At the macrogeographic scale, the F-ST-outlier methods detected together 11 F-ST-outliers. Six outliers were detected when the same analyses were carried out taking into account the genetic structure. Regression analyses with population structure correction resulted in the identification of two (micro-geographic scale) and 38 SNPs (macro-geographic scale) significantly correlated with temperature and/or precipitation. Six of these loci overlapped with F-ST-outliers, among them two loci encoding an enzyme involved in riboflavin biosynthesis and a sucrose synthase. The results of this study indicate a strong relationship between genetic and environmental variation at both geographic scales. It also suggests that an integrative approach combining different outlier detection methods and population sampling at different geographic scales is useful to identify loci potentially involved in adaptation.	[Scalfi, Marta; Mosca, Elena; Di Pierro, Erica Adele; Troggio, Michela; La Porta, Nicola; Neale, David B.] Fdn Edmund Mach FEM, Res & Innovat Ctr, Trento, Italy; [Vendramin, Giovanni Giuseppe] CNR, Inst Biosci & Bioresources, Florence, Italy; [Sperisen, Christoph] Swiss Fed Inst Forest Snow & Landscape Res WSL, Birmensdorf, Switzerland; [Neale, David B.] Univ Calif Davis, Dept Plant Sci, Davis, CA 95616 USA	Fondazione Edmund Mach; Consiglio Nazionale delle Ricerche (CNR); Istituto di Bioscienze e Biorisorse (IBBR-CNR); Swiss Federal Institutes of Technology Domain; Swiss Federal Institute for Forest, Snow & Landscape Research; University of California System; University of California Davis	Mosca, E (corresponding author), Fdn Edmund Mach FEM, Res & Innovat Ctr, Trento, Italy.	elena.mosca@fmach.it	La Porta, Nicola/G-8461-2011; Di Pierro, Erica A/AAI-8868-2020; Sperisen, Christoph/S-1383-2019; Vendramin, Giovanni G/K-9731-2014	La Porta, Nicola/0000-0002-7080-3349; Sperisen, Christoph/0000-0003-1241-5636; Vendramin, Giovanni G/0000-0001-9921-7872; Mosca, Elena/0000-0001-6575-053X; Di Pierro, Erica Adele/0000-0002-3394-3190	project "PECC-Genetic and molecular analysis of Picea abies: Variability and adaptive evolution of the species under conditions of global change''; Autonomous Province of Trento (Italy) [23]; ACE-SAP project "Alpine Ecosystems in a Changing Environment: Biodiversity Sensitivity and Adaptive Potential" - Autonomous Province of Trento (Italy) [23]; European Commission through the FP7-project FORGER, "Towards the Sustainable Management of Forest Genetic Resources in Europe'' [KBBE-289119]	project "PECC-Genetic and molecular analysis of Picea abies: Variability and adaptive evolution of the species under conditions of global change''; Autonomous Province of Trento (Italy)(Autonomous Province of Trento); ACE-SAP project "Alpine Ecosystems in a Changing Environment: Biodiversity Sensitivity and Adaptive Potential" - Autonomous Province of Trento (Italy); European Commission through the FP7-project FORGER, "Towards the Sustainable Management of Forest Genetic Resources in Europe''	MS's study was financed by the project "PECC-Genetic and molecular analysis of Picea abies: Variability and adaptive evolution of the species under conditions of global change'', funded by the Autonomous Province of Trento (Italy), with the regulation N. 23, 2007. EM and EADP were supported by the ACE-SAP project "Alpine Ecosystems in a Changing Environment: Biodiversity Sensitivity and Adaptive Potential" partially funded by the Autonomous Province of Trento (Italy), with the regulation No. 23, June 12, 2008. GGV was supported by a grant of the European Commission through the FP7-project FORGER, "Towards the Sustainable Management of Forest Genetic Resources in Europe'' (KBBE-289119). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberto FJ, 2013, GLOBAL CHANGE BIOL, V19, P1645, DOI 10.1111/gcb.12181; Beaumont MA, 2004, MOL ECOL, V13, P969, DOI 10.1111/j.1365-294X.2004.02125.x; Beaumont MA, 1996, P ROY SOC B-BIOL SCI, V263, P1619, DOI 10.1098/rspb.1996.0237; Bedon F, 2010, J EXP BOT, V61, P3847, DOI 10.1093/jxb/erq196; Bucci G, 2000, MOL ECOL, V9, P923, DOI 10.1046/j.1365-294x.2000.00946.x; Cheddadi R, 2006, GLOBAL ECOL BIOGEOGR, V15, P271, DOI [10.1111/j.1466-822x.2006.00226.x, 10.1111/j.1466-822X.2006.00226.x]; Chen J, 2012, GENETICS, V191, P865, DOI 10.1534/genetics.112.140749; Collignon AM, 2002, CAN J FOREST RES, V32, P266, DOI [10.1139/x01-198, 10.1139/X01-198]; Coop G, 2010, GENETICS, V185, P1411, DOI 10.1534/genetics.110.114819; DABNEY A, 2012, QVALUE Q VALUE ESTIM; Doyle JJ, 1987, PHYTOCHEM B, V19, P11, DOI 10.1016/j.bse.2009.07.003; Eckert AJ, 2010, GENETICS, V185, P969, DOI 10.1534/genetics.110.115543; Eckert AJ, 2010, MOL ECOL, V19, P3789, DOI 10.1111/j.1365-294X.2010.04698.x; Eckert AJ, 2009, GENETICS, V183, P289, DOI 10.1534/genetics.109.103895; Excoffier L, 2009, HEREDITY, V103, P285, DOI 10.1038/hdy.2009.74; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Foll M, 2006, GENETICS, V174, P875, DOI 10.1534/genetics.106.059451; Gomory D, 2012, EUR J FOREST RES, V131, P401, DOI 10.1007/s10342-011-0512-6; Goudet J, 2005, MOL ECOL NOTES, V5, P184, DOI 10.1111/j.1471-8286.2004.00828.x; Grivet D, 2011, MOL BIOL EVOL, V28, P101, DOI 10.1093/molbev/msq190; Heuertz M, 2006, GENETICS, V174, P2095, DOI 10.1534/genetics.106.065102; Keller SR, 2012, MOL BIOL EVOL, V29, P3143, DOI 10.1093/molbev/mss121; Korner C, 2003, ALPINE PLANT LIFE FU, DOI DOI 10.1007/978-3-030-59538-8; Korves TM, 2007, AM NAT, V169, pE141, DOI 10.1086/513111; Kremer A, 2012, ECOL LETT, V15, P378, DOI 10.1111/j.1461-0248.2012.01746.x; Krutzsch P., 1974, Silvae Genetica, V23, P58; LAGERCRANTZ U, 1990, EVOLUTION, V44, P38, DOI 10.1111/j.1558-5646.1990.tb04278.x; Latalowa M, 2006, QUATERNARY SCI REV, V25, P2780, DOI 10.1016/j.quascirev.2006.06.007; Lindner M, 2010, FOREST ECOL MANAG, V259, P698, DOI 10.1016/j.foreco.2009.09.023; Lockwood JD, 2013, MOL PHYLOGENET EVOL, V69, P717, DOI 10.1016/j.ympev.2013.07.004; Loopstra CA, 2004, PINUS HALEPENS UNPUB; Maghuly F, 2006, FOREST ECOL MANAG, V222, P266, DOI 10.1016/j.foreco.2005.10.025; Magri D, 2006, NEW PHYTOL, V171, P199, DOI 10.1111/j.1469-8137.2006.01740.x; Mosca E, 2012, MOL ECOL, V21, P5530, DOI 10.1111/mec.12043; Mosca E, 2014, NEW PHYTOL, V201, P180, DOI 10.1111/nph.12476; Namroud MC, 2008, MOL ECOL, V17, P3599, DOI 10.1111/j.1365-294X.2008.03840.x; Neale DB, 2011, NAT REV GENET, V12, P111, DOI 10.1038/nrg2931; NEI M, 1975, GENETICS, V80, P395; Nielsen R, 2009, GENOME RES, V19, P838, DOI 10.1101/gr.088336.108; Olsson C, 2013, ECOL MODEL, V266, P103, DOI 10.1016/j.ecolmodel.2013.06.026; Piotti A, 2009, HEREDITY, V103, P136, DOI 10.1038/hdy.2009.42; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Pritchard JK, 2000, GENETICS, V155, P945; Prunier J, 2012, MOL ECOL, V21, P4270, DOI 10.1111/j.1365-294X.2012.05691.x; Prunier J, 2011, MOL ECOL, V20, P1702, DOI 10.1111/j.1365-294X.2011.05045.x; R Development Core Team, 2012, R LANG ENV STAT COMP; Rolland F, 2002, PLANT CELL, V14, pS185, DOI 10.1105/tpc.010455; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Ruan YL, 2010, MOL PLANT, V3, P942, DOI 10.1093/mp/ssq044; Savolainen O, 2007, ANNU REV ECOL EVOL S, V38, P595, DOI 10.1146/annurev.ecolsys.38.091206.095646; Sboarina C., 2004, 33 CTR EC ALP; Schmidt-Vogt H., 1974, Allgemeine Forst- und Jagdzeitung, V145, P185; Schmidt-Vogt H., 1974, DIE FICHTE; SKROPPA T, 1993, SILVAE GENET, V42, P111; Sogaard G, 2008, TREE PHYSIOL, V28, P311, DOI 10.1093/treephys/28.2.311; Sperisen C, 2001, MOL ECOL, V10, P257, DOI 10.1046/j.1365-294X.2001.01180.x; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Tollefsrud MM, 2009, HEREDITY, V102, P549, DOI 10.1038/hdy.2009.16; Tollefsrud MM, 2008, MOL ECOL, V17, P4134, DOI 10.1111/j.1365-294X.2008.03893.x; Wang TL, 2010, ECOL APPL, V20, P153, DOI 10.1890/08-2257.1; Wegrzyn JL, 2009, BIOINFORMATICS, V25, P2609, DOI 10.1093/bioinformatics/btp477; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Yang RC, 1998, EVOLUTION, V52, P950, DOI 10.1111/j.1558-5646.1998.tb01824.x; Zhang SJ, 2009, J INTEGR PLANT BIOL, V51, P167, DOI 10.1111/j.1744-7909.2008.00763.x	64	25	25	1	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2014	9	12							e115499	10.1371/journal.pone.0115499	http://dx.doi.org/10.1371/journal.pone.0115499			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UC	25551624	Green Published, gold, Green Submitted			2022-12-27	WOS:000347119100040
J	Shebl, FM; Hsing, AW; Park, Y; Hollenbeck, AR; Chu, LW; Meyer, TE; Koshiol, J				Shebl, Fatma M.; Hsing, Ann W.; Park, Yikyung; Hollenbeck, Albert R.; Chu, Lisa W.; Meyer, Tamra E.; Koshiol, Jill			Non-Steroidal Anti-Inflammatory Drugs Use Is Associated with Reduced Risk of Inflammation-Associated Cancers: NIH-AARP Study	PLOS ONE			English	Article							LONG-TERM USE; LARGE COHORT; ASPIRIN USE; COLORECTAL-CANCER; GASTRIC-CANCER; NSAID USE; INVERSE ASSOCIATION; ESOPHAGEAL CANCER; ACETAMINOPHEN USE; RANDOMIZED-TRIAL	Background: Chronic inflammation has been linked to cancers, and use of nonsteroidal anti-inflammatory drugs (NSAIDs) has been associated with reduced risk of several cancers. To further refine the magnitude of NSAID-related associations, in particular for cancers related to inflammation, such as alcohol-, infection-, obesity-, and smoking-related cancers, as well as for less common cancers, we evaluated the use of NSAIDs and cancer risk in a very large cohort. We used propensity scores to account for potential selection bias and hypothesized that NSAID use is associated with decreased cancer incidence. Methods: We conducted a prospective study among 314,522 participants in the NIH-AARP Diet and Health Study. Individuals who completed the lifestyle questionnaire, which included NSAID use, in 1996-1997 were followed through 2006. Information on cancer incidence was ascertained by linking to cancer registries and vital status databases. Findings: During 2,715,994 person-years of follow-up (median 10.1 person-years), there were 51,894 incident cancers. Compared with non-users of NSAIDs, individuals who reported use in the 12 months prior to interview had a significantly lower risk of all inflammation-related cancer, alcohol-related, infection-related, obesity-related, and smoking-related cancers [hazard ratio (HR) (95% CI)) 0.90 (0.87-0.93), 0.80 (0.74-0.85), 0.82 (0.78-0.87), 0.88 (0.84-0.92), and 0.88 (0.85-0.92) respectively)]. Conclusions: After accounting for potential selection bias, our data showed an inverse association between NSAID use and alcohol-related, infection-related, obesity-related, and smoking-related cancers and support the hypothesis that inflammation is related to an increased risk of certain cancers.	[Shebl, Fatma M.; Hsing, Ann W.; Park, Yikyung; Meyer, Tamra E.; Koshiol, Jill] NCI, Div Canc Epidemiol & Genet, NIH, Dept Human Hlth & Serv, Rockville, MD USA; [Hollenbeck, Albert R.] AARP, Washington, DC USA; [Chu, Lisa W.] Canc Prevent Inst Calif, Fremont, CA USA; [Chu, Lisa W.] Stanford Canc Inst, Palo Alto, CA USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); American Association of Retired Persons (AARP); Cancer Prevention Institute of California; Stanford Cancer Institute	Shebl, FM (corresponding author), Yale Univ, Dept Chron Dis Epidemiol, Sch Publ Hlth, New Haven, CT 06520 USA.	fatma.shebl@yale.edu	Hollenbeck, Albert/AAG-9461-2020; koshiol, Jill/L-8686-2014	koshiol, Jill/0000-0002-3832-6204	Intramural Research Program of the NIH, National Cancer Institute	Intramural Research Program of the NIH, National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported by the Intramural Research Program of the NIH, National Cancer Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allavena P, 2008, CURR OPIN GENET DEV, V18, P3, DOI 10.1016/j.gde.2008.01.003; Anderson KE, 2002, J NATL CANCER I, V94, P1168, DOI 10.1093/jnci/94.15.1168; [Anonymous], 2010, IARC MONOGRAPHS EVAL; Asgari MM, 2008, J NATL CANCER I, V100, P967, DOI 10.1093/jnci/djn154; Austin PC, 2009, COMMUN STAT-SIMUL C, V38, P1228, DOI 10.1080/03610910902859574; Bardou M, 2004, CLIN GASTROENTEROL H, V2, P880, DOI 10.1016/S1542-3565(04)00389-1; Baron JA, 2003, NEW ENGL J MED, V348, P891, DOI 10.1056/NEJMoa021735; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berasain C, 2009, ANN NY ACAD SCI, V1155, P206, DOI 10.1111/j.1749-6632.2009.03704.x; Bodelon C, 2009, AM J EPIDEMIOL, V170, P1512, DOI 10.1093/aje/kwp321; Bosetti C, 2003, BRIT J CANCER, V88, P672, DOI 10.1038/sj.bjc.6600820; Bosetti C, 2006, CANCER CAUSE CONTROL, V17, P871, DOI 10.1007/s10552-006-0033-7; Bosetti C, 2009, RECENT RESULTS CANC, V181, P231; Burn J, 2011, CANCER PREV RES, V4, P655, DOI 10.1158/1940-6207.CAPR-11-0106; Chan AT, 2008, GASTROENTEROLOGY, V134, P21, DOI 10.1053/j.gastro.2007.09.035; Chan AT, 2005, JAMA-J AM MED ASSOC, V294, P914, DOI 10.1001/jama.294.8.914; Chan AT, 2011, CANC PREV RES; Chang ET, 2010, CANCER EPIDEM BIOMAR, V19, P59, DOI 10.1158/1055-9965.EPI-09-0909; Cole BF, 2009, J NATL CANCER I, V101, P256, DOI 10.1093/jnci/djn485; Coogan PF, 2010, PHARMACOEPIDEM DR S, V19, P752, DOI 10.1002/pds.1970; Cook NR, 2005, JAMA-J AM MED ASSOC, V294, P47, DOI 10.1001/jama.294.1.47; Corley DA, 2003, GASTROENTEROLOGY, V124, P47, DOI 10.1053/gast.2003.50008; Curiel-Lewandrowski C, 2011, J INVEST DERMATOL, V131, P1460, DOI 10.1038/jid.2011.58; Danforth KN, 2009, CANCER PREV RES, V2, P466, DOI 10.1158/1940-6207.CAPR-08-0239; Daugherty SE, 2011, CANCER PREV RES, V4, P2027, DOI 10.1158/1940-6207.CAPR-11-0274; Daugherty SE, 2011, AM J EPIDEMIOL, V173, P721, DOI 10.1093/aje/kwq437; de Martel C, 2012, LANCET ONCOL, V13, DOI 10.1016/S1470-2045(12)70137-7; Flossmann E, 2007, LANCET, V369, P1603, DOI 10.1016/S0140-6736(07)60747-8; FUNKHOUSER EM, 1995, CANCER-AM CANCER SOC, V76, P1116, DOI 10.1002/1097-0142(19951001)76:7<1116::AID-CNCR2820760703>3.0.CO;2-I; Gallicchio L, 2007, INT J CANCER, V121, P211, DOI 10.1002/ijc.22656; Gao JC, 2004, CANCER SCI, V95, P901, DOI 10.1111/j.1349-7006.2004.tb02200.x; Gonzalez-Perez A, 2003, BMC CANCER, V3, DOI 10.1186/1471-2407-3-28; Greenspan EJ, 2011, CANCER PREV RES, V4, P161, DOI 10.1158/1940-6207.CAPR-10-0021; Grosch S, 2006, JNCI-J NATL CANCER I, V98, P736, DOI 10.1093/jnci/djj206; Haas M, 2011, VIRCHOWS ARCH, V458, P403, DOI 10.1007/s00428-011-1058-1; Harris RE, 2001, ONCOL REP, V8, P655; Hernandez-Diaz S, 2007, INT J CANCER, V120, P1565, DOI 10.1002/ijc.22514; Hossain MA, 2012, INT J ONCOL, V40, P1298, DOI 10.3892/ijo.2011.1304; Jacobs EJ, 2005, JNCI-J NATL CANCER I, V97, P975, DOI 10.1093/jnci/dji173; Jacobs EJ, 2007, JNCI-J NATL CANCER I, V99, P608, DOI 10.1093/jnci/djk132; Janssen A, 2006, EUR J PHARMACOL, V540, P24, DOI 10.1016/j.ejphar.2006.04.030; Jayaprakash V, 2006, ARCH OTOLARYNGOL, V132, P1231, DOI 10.1001/archotol.132.11.1231; Jeter JM, 2011, J SKIN CANCER, V2011, DOI 10.1155/2011/598571; Johannesdottir SA, 2012, CANCER; Joosse A, 2009, J INVEST DERMATOL, V129, P2620, DOI 10.1038/jid.2009.201; Kasum CM, 2003, CANCER EPIDEM BIOMAR, V12, P534; Khan Z, 2011, CURR DRUG TARGETS, V12, P1082, DOI 10.2174/138945011795677764; Legge F, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-214; Li GQ, 2008, HELICOBACTER, V13, P20, DOI 10.1111/j.1523-5378.2008.00585.x; Luo T, 2011, BREAST CANC RES TREA; Macfarlane TV, 2012, ANN ONCOL, V23, P1053, DOI 10.1093/annonc/mdr335; Mai SK, 2007, HLTH CONS SMOK REP S, V2, P30; Mantovani A, 2008, CANCER LETT, V267, P180, DOI 10.1016/j.canlet.2008.05.003; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; McCormack VA, 2011, CANCER CAUSE CONTROL, V22, P1709, DOI 10.1007/s10552-011-9847-z; Michaud D, 2005, J REGISTRY MANAGE, V2, P70; Moysich KB, 2005, CANCER EPIDEM BIOMAR, V14, P2923, DOI 10.1158/1055-9965.EPI-05-0457; National Cancer Institute, 2013, FACT SHEET ALC CANC; Prizment AE, 2010, CANCER EPIDEM BIOMAR, V19, P435, DOI 10.1158/1055-9965.EPI-09-0976; ROSENBAUM PR, 1984, J AM STAT ASSOC, V79, P516, DOI 10.2307/2288398; Ross JA, 2011, CANCER EPIDEM BIOMAR, V20, P1741, DOI 10.1158/1055-9965.EPI-11-0411; Rothwell PM, 2011, LANCET, V377, P31, DOI 10.1016/S0140-6736(10)62110-1; Ruder EH, 2011, AM J GASTROENTEROL, V106, P1340, DOI 10.1038/ajg.2011.38; Sahasrabuddhe VV, 2012, JNCI-J NATL CANCER I, V104, P1808, DOI 10.1093/jnci/djs452; Sandler RS, 2003, NEW ENGL J MED, V348, P883, DOI 10.1056/NEJMoa021633; Schatzkin A, 2001, AM J EPIDEMIOL, V154, P1119, DOI 10.1093/aje/154.12.1119; SCHREINEMACHERS DM, 1994, EPIDEMIOLOGY, V5, P138, DOI 10.1097/00001648-199403000-00003; Schror K, 2011, BEST PRACT RES CL GA, V25, P473, DOI 10.1016/j.bpg.2011.10.016; Singh R, 2011, APOPTOSIS, V16, P889, DOI 10.1007/s10495-011-0624-y; Sorensen HT, 2003, BRIT J CANCER, V88, P1687, DOI 10.1038/sj.bjc.6600945; Sudbo J, 2005, LANCET, V366, P1359, DOI 10.1016/S0140-6736(05)67488-0; Suh N, 2011, CANCER PREV RES, V4, P1895, DOI 10.1158/1940-6207.CAPR-11-0222; Sun L, 2011, DIS ESOPHAGUS, V24, P544, DOI 10.1111/j.1442-2050.2011.01198.x; Tsan YT, 2013, J CLIN ONCOL; Van Dyke AL, 2008, CANCER EPIDEM BIOMAR, V17, P148, DOI 10.1158/1055-9965.EPI-07-0517; Vaughan TL, 2005, LANCET ONCOL, V6, P945, DOI 10.1016/S1470-2045(05)70431-9; Viswanathan AN, 2008, CANCER RES, V68, P2507, DOI 10.1158/0008-5472.CAN-07-6257; Wang WH, 2003, JNCI-J NATL CANCER I, V95, P1784, DOI 10.1093/jnci/djg106; Wernli KJ, 2008, BRIT J CANCER, V98, P1781, DOI 10.1038/sj.bjc.6604392; Wilson JC, 2011, CANCER CAUSE CONTROL, V22, P803, DOI 10.1007/s10552-011-9751-6; Wu CY, 2010, J CLIN ONCOL, V28, P2952, DOI 10.1200/JCO.2009.26.0695; Xu J, 2011, CLIN LUNG CANC; Yang P, 2010, DIGEST DIS SCI, V55, P1533, DOI 10.1007/s10620-009-0915-0; Zaric J, 2011, ONCOGENE	84	37	37	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2014	9	12							e114633	10.1371/journal.pone.0114633	http://dx.doi.org/10.1371/journal.pone.0114633			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UC	25551641	Green Published, gold, Green Submitted			2022-12-27	WOS:000347119100013
J	Kuo, AJ; Su, LH; Shu, JC; Wang, JT; Wang, JH; Fung, CP; Chia, JH; Lu, JJ; Wu, TL				Kuo, An-Jing; Su, Lin-Hui; Shu, Jwu-Ching; Wang, Jann-Tay; Wang, Jen-Hsien; Fung, Chang-Phone; Chia, Ju-Hsin; Lu, Jang-Jih; Wu, Tsu-Lan			National Surveillance on Vancomycin-Resistant Enterococcus faecium in Taiwan: Emergence and Widespread of ST414 and a Tn1546-Like Element with Simultaneous Insertion of IS1251-like and IS1678	PLOS ONE			English	Article							MOLECULAR CHARACTERIZATION; GLYCOPEPTIDE RESISTANCE; VANA; DIVERSITY; HUMANS; FAECALIS; SEQUENCE; SPREAD; EPIDEMIOLOGY; BACTEREMIA	Cases of bacteremia caused by vancomycin-resistant E. faecium (VRE-fm) increased significantly in Taiwan. The present multicenter surveillance study was performed to reveal the associated epidemiological characteristics. In 2012, 134 non-repetitive VRE-fm isolates were prospectively collected from 12 hospitals in Taiwan. Antimicrobial susceptibility, pulsed-field gel electrophoresis (PFGE), multilocus sequence typing (MLST), and analysis of van genes and Tn1546 structures were investigated. Two isolates carried vanB genes, while all the remaining isolates carried vanA genes. Three isolates demonstrated a specific vanA genotype-vanB phenotype. Nine (6.7%) isolates demonstrated tigecycline resistance, and all were susceptible to daptomycin and linezolid. Molecular typing revealed 58 pulsotypes and 13 sequence types (STs), all belonged to three major lineages 17, 18, and 78. The most frequent STs were ST17 (n=48, 35.8%), ST414 (n=22, 16.4%), and ST78 (n=16, 11.9%). Among the vanA harboring isolates, eight structure types of the Tn1546-like element were demonstrated. Type I (a partial deletion in the orf1 and insertion of IS1251-like between the vanS-vanH genes) and Type II (Type I with an additional insertion of IS1678 between orf2-vanS genes) were the most predominant, consisted of 60 (45.5%) and 62 (47.0%) isolates, respectively. The increase of VRE-fm bacteremia in Taiwan may be associated with the inter-and intra-hospital spread of some major STs and horizontal transfer of vanA genes mostly carried on two efficient Tn1546-like elements. The prevailing ST414 and widespread of the Type II Tn1546-like elements are an emerging problem that requires continuous monitoring.	[Kuo, An-Jing; Su, Lin-Hui; Chia, Ju-Hsin; Lu, Jang-Jih; Wu, Tsu-Lan] Chang Gung Mem Hosp, Dept Lab Med, Taoyuan, Taiwan; [Kuo, An-Jing; Su, Lin-Hui; Shu, Jwu-Ching; Chia, Ju-Hsin; Lu, Jang-Jih; Wu, Tsu-Lan] Chang Gung Univ, Coll Med, Dept Med Biotechnol & Lab Sci, Taoyuan, Taiwan; [Shu, Jwu-Ching] Chang Gung Univ, Res Ctr Pathogen Bacteria, Taoyuan, Taiwan; [Wang, Jann-Tay] Natl Taiwan Univ Hosp, Dept Med, Div Infect Dis, Taipei, Taiwan; [Wang, Jen-Hsien] China Med Univ Hosp, Dept Internal Med, Div Infect Dis, Taichung, Taiwan; [Fung, Chang-Phone] Natl Yan Ming Univ, Taipei Vet Gen Hosp, Dept Med, Infect Dis Sect, Taipei, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Chang Gung University; National Taiwan University; National Taiwan University Hospital; China Medical University Taiwan; China Medical University Hospital - Taiwan; Taipei Veterans General Hospital	Wu, TL (corresponding author), Chang Gung Mem Hosp, Dept Lab Med, Taoyuan, Taiwan.	wutsulan@adm.cgmh.org.tw		WANG, JANN-TAY/0000-0002-0924-3469; Shu, Jwu-Ching/0000-0003-4862-6056	National Surveillance Program of Taiwan Centers for Disease Control [DOH101-DC-1204]	National Surveillance Program of Taiwan Centers for Disease Control	This work was supported by the grant DOH101-DC-1204 from the National Surveillance Program of Taiwan Centers for Disease Control to TLW, JTW, and CPF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arias CA, 2012, NAT REV MICROBIOL, V10, P266, DOI 10.1038/nrmicro2761; ARTHUR M, 1993, J BACTERIOL, V175, P117, DOI 10.1128/JB.175.1.117-127.1993; Ben RJ, 1996, J FORMOS MED ASSOC, V95, P946; Cattoir V, 2013, J ANTIMICROB CHEMOTH, V68, P731, DOI 10.1093/jac/dks469; Cha JO, 2013, J APPL MICROBIOL, V115, P969, DOI 10.1111/jam.12300; Chang CM, 2010, J HOSP INFECT, V74, P377, DOI 10.1016/j.jhin.2009.10.025; Cheng VCC, 2012, CHINESE MED J-PEKING, V125, P3450, DOI 10.3760/cma.j.issn.0366-6999.2012.19.017; Chiang Ping-Cherng, 2007, Chang Gung Med J, V30, P493; Clinical and Laboratory Standards Institute, 2012, M100S22 CLIN LAB STA; European Committee on Antimicrobial Susceptibility Testing, 2013, BREAKP TABL INT MICS; Fallico L, 2011, INFECTION, V39, P127, DOI 10.1007/s15010-011-0086-8; Freitas AR, 2009, APPL ENVIRON MICROB, V75, P4904, DOI 10.1128/AEM.02945-08; GOERING RV, 1992, J CLIN MICROBIOL, V30, P577, DOI 10.1128/JCM.30.3.577-580.1992; HANDWERGER S, 1995, ANTIMICROB AGENTS CH, V39, P362, DOI 10.1128/AAC.39.2.362; Hidron AI, 2008, INFECT CONT HOSP EP, V29, P996, DOI 10.1086/591861; Homan WL, 2002, J CLIN MICROBIOL, V40, P1963, DOI 10.1128/JCM.40.6.1963-1971.2002; Hsieh YC, 2010, EUR J CLIN MICROBIOL, V29, P25, DOI 10.1007/s10096-009-0810-9; Hsieh YC, 2009, J MICROBIOL IMMUNOL, V42, P63; Hsueh PR, 1999, J FORMOS MED ASSOC, V98, P45; Jung WK, 2005, ANTIMICROB AGENTS CH, V49, P1666, DOI 10.1128/AAC.49.4.1666-1667.2005; Khan MA, 2010, CLIN MICROBIOL INFEC, V16, P624, DOI 10.1111/j.1469-0691.2009.02898.x; Ko KS, 2005, J CLIN MICROBIOL, V43, P2303, DOI 10.1128/JCM.43.5.2303-2306.2005; Lauderdale TL, 2002, ANTIMICROB AGENTS CH, V46, P525, DOI 10.1128/AAC.46.2.525-527.2002; LECLERCQ R, 1988, NEW ENGL J MED, V319, P157, DOI 10.1056/NEJM198807213190307; Lee SC, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-163; Liu YM, 2011, MICROB DRUG RESIST, V17, P449, DOI 10.1089/mdr.2011.0025; Lu CL, 2012, J ANTIMICROB CHEMOTH, V67, P2243, DOI 10.1093/jac/dks181; Lu JJ, 2001, EPIDEMIOL INFECT, V126, P357, DOI 10.1017/S0950268801005453; McCracken M, 2013, J ANTIMICROB CHEMOTH, V68, P1505, DOI 10.1093/jac/dkt054; Oh JY, 2007, J MICROBIOL, V45, P466; da Silva LPP, 2012, DIAGN MICR INFEC DIS, V74, P267, DOI 10.1016/j.diagmicrobio.2012.07.012; Putnam SD, 2010, DIAGN MICR INFEC DIS, V67, P359, DOI 10.1016/j.diagmicrobio.2010.03.009; Rathnayake IU, 2011, J CLIN MICROBIOL, V49, P367, DOI 10.1128/JCM.01120-10; Sadowy E, 2013, EUR J CLIN MICROBIOL, V32, P1193, DOI 10.1007/s10096-013-1868-y; UTTLEY AHC, 1988, LANCET, V1, P57; Wang JT, 2013, DIAGN MICR INFEC DIS, V75, P406, DOI 10.1016/j.diagmicrobio.2013.01.004; Willems RJL, 1999, ANTIMICROB AGENTS CH, V43, P483, DOI 10.1128/AAC.43.3.483; Willems RJL, 2005, EMERG INFECT DIS, V11, P821, DOI 10.3201/1106.041204; Willems RJL, 2012, MBIO, V3, DOI 10.1128/mBio.00151-12; Woodford N, 1998, ANTIMICROB AGENTS CH, V42, P502, DOI 10.1128/AAC.42.3.502; Xu HT, 2011, CHINESE MED J-PEKING, V124, P498, DOI 10.3760/cma.j.issn.0366-6999.2011.04.003	41	14	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2014	9	12							e115555	10.1371/journal.pone.0115555	http://dx.doi.org/10.1371/journal.pone.0115555			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX6YH	25549328	Green Published, gold, Green Submitted			2022-12-27	WOS:000347063500016
J	Xu, N; Li, ZM; Yu, Z; Yan, F; Liu, Y; Lu, XF; Yang, WL				Xu, Ning; Li, Zimu; Yu, Zhange; Yan, Feng; Liu, Yang; Lu, Xiaofeng; Yang, Weiliang			RETRACTED: MicroRNA-33b Suppresses Migration and Invasion by Targeting c-Myc in Osteosarcoma Cells (Retracted article. See vol. 17, 2022)	PLOS ONE			English	Article; Retracted Publication							GASTRIC-CANCER; MESSENGER-RNA; EXPRESSION; PROLIFERATION; METASTASIS; BCL-2; GENE; P53	MicroRNAs have emerged as fundamental regulators in gene expression through silencing gene expression at the post-transcriptional and translational levels. Osteosarcoma is the most common type of primary malignant bone tumor and is characterized by complex genetic changes and resistance to conventional treatments. In our study, the role of miR-33b in the progression and metastasis of osteosarcoma was investigated. Our results showed that miR-33b was significantly downregulated in osteosarcoma tissue and cell lines. Overexpression of miR-33b significantly inhibited cell proliferation, migration, and invasion in the MG-63 osteosarcoma cell line. Moreover, we also showed that c-Myc was negatively regulated by miR-33b at the posttranscriptional level, via a specific target site within the 3'UTR. Overexpression of c-Myc impaired miR-33b-induced inhibition of proliferation and invasion in osteosarcoma cells. The expression of c-Myc was frequently downregulated in osteosarcoma tumors and cell lines and was inversely correlated with miR-33b expression. Thus, our findings suggest that miR-33b inhibits osteosarcoma cells migration and invasion by targeting the c-Myc gene, acting as tumor suppressor. The findings of this study contribute to current understanding of the functions of miR-33b in osteosarcoma.	[Xu, Ning; Li, Zimu; Yu, Zhange; Yan, Feng; Liu, Yang; Lu, Xiaofeng; Yang, Weiliang] Harbin Med Univ, Affiliated Hosp 1, Dept Orthoped Surg, Harbin, Heilongjiang, Peoples R China	Harbin Medical University	Yang, WL (corresponding author), Harbin Med Univ, Affiliated Hosp 1, Dept Orthoped Surg, 23 Youzheng St, Harbin, Heilongjiang, Peoples R China.	yangpaper@yeah.net						Benetatos L, 2014, CELL MOL LIFE SCI, V71, P257, DOI 10.1007/s00018-013-1426-x; Boxer LM, 2001, ONCOGENE, V20, P5595, DOI 10.1038/sj.onc.1204595; Campone M, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-110; Cirera-Salinas D, 2012, CELL CYCLE, V11, P922, DOI 10.4161/cc.11.5.19421; Gamberi G, 1998, ONCOLOGY-BASEL, V55, P556, DOI 10.1159/000011912; Gong JA, 2014, CARCINOGENESIS, V35, P497, DOI 10.1093/carcin/bgt337; Han S, 1999, J KOREAN MED SCI, V14, P526, DOI 10.3346/jkms.1999.14.5.526; HAYWARD WS, 1981, NATURE, V290, P475, DOI 10.1038/290475a0; Herrera-Merchan A, 2010, CELL CYCLE, V9, P3277, DOI 10.4161/cc.9.16.12598; Hughes DPM, 2009, CANCER TREAT RES, V152, P479, DOI 10.1007/978-1-4419-0284-9_28; Hummel R, 2010, EUR J CANCER, V46, P298, DOI 10.1016/j.ejca.2009.10.027; Kang W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033919; Kim YK, 2009, NUCLEIC ACIDS RES, V37, P1672, DOI 10.1093/nar/gkp002; Kurashige J, 2012, ANN SURG ONCOL, V19, pS656, DOI 10.1245/s10434-012-2217-6; Li CL, 2012, ONCOL REP, V27, P1960, DOI 10.3892/or.2012.1719; Li Xiaohua, 2011, J Cell Mol Med, V15, P1887, DOI 10.1111/j.1582-4934.2010.01194.x; Liang WQ, 2013, FRONT BIOSCI-LANDMRK, V18, P788, DOI 10.2741/4142; Lin CY, 2012, CELL, V151, P56, DOI 10.1016/j.cell.2012.08.026; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Osaki M, 2011, MOL THER, V19, P1123, DOI 10.1038/mt.2011.53; Planas-Silva MD, 2007, EXP MOL PATHOL, V82, P85, DOI 10.1016/j.yexmp.2006.09.001; Rainusso N, 2013, CURR ONCOL REP, V15, P296, DOI 10.1007/s11912-013-0321-9; SchmitzDrager BJ, 1997, UROL RES, V25, pS45, DOI 10.1007/BF00942047; Seo HK, 2014, ONCOTARGET; Shibuta K, 1996, INT J ONCOL, V9, P247; Song L, 2013, ARCH BIOCHEM BIOPHYS, V535, P128, DOI 10.1016/j.abb.2013.04.001; Spender LC, 2014, CANCER MANAG RES, V6, P27, DOI 10.2147/CMAR.S37745; Taniguchi M, 2014, MOL BIOL REP, V41, P1081, DOI 10.1007/s11033-013-2954-z; Wu WKK, 2010, ONCOGENE, V29, P5761, DOI 10.1038/onc.2010.352; Wu X, 2012, CANCER EPIDEMIOL, V36, P212, DOI 10.1016/j.canep.2011.08.002; Yan K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033778; Yang JL, 2013, CURR OPIN ONCOL, V25, P398, DOI 10.1097/CCO.0b013e3283622c1b; Zhou X, 2013, BIOCHEM BIOPH RES CO, V437, P653, DOI 10.1016/j.bbrc.2013.07.033	33	48	49	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2014	9	12							e115300	10.1371/journal.pone.0115300	http://dx.doi.org/10.1371/journal.pone.0115300			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UN	25546234	gold, Green Submitted, Green Published			2022-12-27	WOS:000347120200037
J	De Taeye, L; Pourtois, G; Meurs, A; Boon, P; Vonck, K; Carrette, E; Raedt, R				De Taeye, Leen; Pourtois, Gilles; Meurs, Alfred; Boon, Paul; Vonck, Kristl; Carrette, Evelien; Raedt, Robrecht			Event-Related Potentials Reveal Preserved Attention Allocation but Impaired Emotion Regulation in Patients with Epilepsy and Comorbid Negative Affect	PLOS ONE			English	Article							QUALITY-OF-LIFE; THREAT-RELATED STIMULI; NEURAL MECHANISMS; COGNITIVE-CONTROL; MAJOR DEPRESSION; BRAIN POTENTIALS; FACE; ANXIETY; DISORDER; PICTURES	Patients with epilepsy have a high prevalence of comorbid mood disorders. This study aims to evaluate whether negative affect in epilepsy is associated with dysfunction of emotion regulation. Event-related potentials (ERPs) are used in order to unravel the exact electrophysiological time course and investigate whether a possible dysfunction arises during early (attention) and/or late (regulation) stages of emotion control. Fifty epileptic patients with (n = 25) versus without (n = 25) comorbid negative affect plus twenty-five matched controls were recruited. ERPs were recorded while subjects performed a face-or house-matching task in which fearful, sad or neutral faces were presented either at attended or unattended spatial locations. Two ERP components were analyzed: the early vertex positive potential (VPP) which is normally enhanced for faces, and the late positive potential (LPP) that is typically larger for emotional stimuli. All participants had larger amplitude of the early face-sensitive VPP for attended faces compared to houses, regardless of their emotional content. By contrast, in patients with negative affect only, the amplitude of the LPP was significantly increased for unattended negative emotional expressions. These VPP results indicate that epilepsy with or without negative affect does not interfere with the early structural encoding and attention selection of faces. However, the LPP results suggest abnormal regulation processes during the processing of unattended emotional faces in patients with epilepsy and comorbid negative affect. In conclusion, this ERP study reveals that early object-based attention processes are not compromised by epilepsy, but instead, when combined with negative affect, this neurological disease is associated with dysfunction during the later stages of emotion regulation. As such, these new neurophysiological findings shed light on the complex interplay of epilepsy with negative affect during the processing of emotional visual stimuli and in turn might help to better understand the etiology and maintenance of mood disorders in epilepsy.	[De Taeye, Leen; Meurs, Alfred; Boon, Paul; Vonck, Kristl; Carrette, Evelien; Raedt, Robrecht] Ghent Univ Hosp, LCEN3, Dept Neurol, Ghent, Belgium; [Pourtois, Gilles] Univ Ghent, Dept Expt Clin & Hlth Psychol, B-9000 Ghent, Belgium	Ghent University; Ghent University Hospital; Ghent University	De Taeye, L (corresponding author), Ghent Univ Hosp, LCEN3, Dept Neurol, Ghent, Belgium.	leen.detaeye@ugent.be		Carrette, Evelien/0000-0002-9736-7401; Pourtois, Gilles/0000-0002-5109-2801; vonck, kristl/0000-0002-2671-2650; Boon, Paul/0000-0002-4180-8896; De Taeye, Leen/0000-0003-4494-3994; Raedt, Robrecht/0000-0002-8939-0169	Fonds voor Wetenschappelijk Onderzoek-Vlaanderen (FWO); Bijzonder Onderzoeksfonds (BOF) Grant from Ghent University; European Research Council; BOF-ZAP grant from Ghent University Hospital; FWO-Flanders; BOF; Clinical Epilepsy Grant from Ghent University Hospital; BOF-Tenure Track grant from Ghent University	Fonds voor Wetenschappelijk Onderzoek-Vlaanderen (FWO)(FWO); Bijzonder Onderzoeksfonds (BOF) Grant from Ghent University; European Research Council(European Research Council (ERC)European Commission); BOF-ZAP grant from Ghent University Hospital(Ghent University); FWO-Flanders(FWO); BOF; Clinical Epilepsy Grant from Ghent University Hospital(Ghent University); BOF-Tenure Track grant from Ghent University	LDT is supported by a Fonds voor Wetenschappelijk Onderzoek-Vlaanderen (FWO) aspirant grant. GP is supported by a Bijzonder Onderzoeksfonds (BOF) Grant from Ghent University and grants from the European Research Council. KV is supported by a BOF-ZAP grant from Ghent University Hospital. PB is supported by grants from FWO-Flanders, grants from BOF and by the Clinical Epilepsy Grant from Ghent University Hospital. RR is supported by a BOF-Tenure Track grant from Ghent University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beck AT, 1996, MANUAL FOR THE BECK; Bentley P, 2003, NEUROIMAGE, V20, P58, DOI 10.1016/S1053-8119(03)00302-1; Bishop S, 2004, NAT NEUROSCI, V7, P184, DOI 10.1038/nn1173; Bishop SJ, 2004, J NEUROSCI, V24, P10364, DOI 10.1523/JNEUROSCI.2550-04.2004; Blumer D, 2004, EPILEPSY BEHAV, V5, P826, DOI 10.1016/j.yebeh.2004.08.003; BOTZEL K, 1989, EXP BRAIN RES, V77, P349, DOI 10.1007/BF00274992; BOTZEL K, 1995, EXP BRAIN RES, V104, P135, DOI 10.1007/BF00229863; Boylan LS, 2004, NEUROLOGY, V62, P258, DOI 10.1212/01.WNL.0000103282.62353.85; CLARK LA, 1991, J ABNORM PSYCHOL, V100, P316, DOI 10.1037/0021-843X.100.3.316; Dennis TA, 2009, J CHILD PSYCHOL PSYC, V50, P1373, DOI 10.1111/j.1469-7610.2009.02168.x; Disner SG, 2011, NAT REV NEUROSCI, V12, P467, DOI 10.1038/nrn3027; Ekman P., 1976, PICTURES OF FACIAL A; Fales CL, 2008, BIOL PSYCHIAT, V63, P377, DOI 10.1016/j.biopsych.2007.06.012; Foti D, 2008, J COGNITIVE NEUROSCI, V20, P977, DOI 10.1162/jocn.2008.20066; Foti D, 2010, DEPRESS ANXIETY, V27, P813, DOI 10.1002/da.20712; George N, 1996, COGNITIVE BRAIN RES, V4, P65, DOI 10.1016/0926-6410(95)00045-3; Hajcak G, 2010, DEV NEUROPSYCHOL, V35, P129, DOI 10.1080/87565640903526504; Hesdorffer DC, 2012, ANN NEUROL, V72, P184, DOI 10.1002/ana.23601; Hesdorffer DC, 2000, ANN NEUROL, V47, P246, DOI 10.1002/1531-8249(200002)47:2<246::AID-ANA17>3.3.CO;2-5; Holmes A, 2003, COGNITIVE BRAIN RES, V16, P174, DOI 10.1016/S0926-6410(02)00268-9; Holtzheimer PE, 2011, TRENDS NEUROSCI, V34, P1, DOI 10.1016/j.tins.2010.10.004; Hoppe C, 2011, NAT REV NEUROL, V7, P462, DOI 10.1038/nrneurol.2011.104; JEFFREYS DA, 1989, EXP BRAIN RES, V78, P193; Johnson EK, 2004, EPILEPSIA, V45, P544, DOI 10.1111/j.0013-9580.2004.47003.x; Jones JE, 2003, EPILEPSY BEHAV, V4, pS31, DOI 10.1016/j.yebeh.2003.08.019; Jones JE, 2005, J NEUROPSYCH CLIN N, V17, P172, DOI 10.1176/appi.neuropsych.17.2.172; Kanner AM, 2012, EPILEPSY BEHAV, V24, P156, DOI 10.1016/j.yebeh.2012.01.007; Kanner AM, 2011, EPILEPSIA, V52, P21, DOI 10.1111/j.1528-1167.2010.02907.x; Kanner AM, 2010, EPILEPSIA, V51, P1152, DOI 10.1111/j.1528-1167.2010.02582.x; Kondziella D, 2007, J NEUROCHEM, V103, P2136, DOI 10.1111/j.1471-4159.2007.04926.x; Lang PJ, 2010, BIOL PSYCHOL, V84, P437, DOI 10.1016/j.biopsycho.2009.10.007; LANG PJ, 1995, AM PSYCHOL, V50, P372, DOI 10.1037/0003-066X.50.5.372; Luo WB, 2010, NEUROIMAGE, V49, P1857, DOI 10.1016/j.neuroimage.2009.09.018; MacNamara A, 2009, NEUROPSYCHOLOGIA, V47, P2975, DOI 10.1016/j.neuropsychologia.2009.06.026; Moser JS, 2006, PSYCHOPHYSIOLOGY, V43, P292, DOI 10.1111/j.1469-8986.2006.00402.x; Ochsner KN, 2005, TRENDS COGN SCI, V9, P242, DOI 10.1016/j.tics.2005.03.010; Olofsson JK, 2008, BIOL PSYCHOL, V77, P247, DOI 10.1016/j.biopsycho.2007.11.006; Pessoa L, 2009, TRENDS COGN SCI, V13, P160, DOI 10.1016/j.tics.2009.01.006; Picton TW, 2000, PSYCHOPHYSIOLOGY, V37, P127, DOI 10.1111/1469-8986.3720127; Pourtois G, 2013, BIOL PSYCHOL, V92, P492, DOI 10.1016/j.biopsycho.2012.02.007; Price JL, 2010, NEUROPSYCHOPHARMACOL, V35, P192, DOI 10.1038/npp.2009.104; Rosler J, 2014, CLIN NEUROPHYSIOL, V125, P526, DOI 10.1016/j.clinph.2013.08.015; Rossion B, 2003, NEUROIMAGE, V20, P1609, DOI 10.1016/j.neuroimage.2003.07.010; Sabatinelli D, 2007, CEREB CORTEX, V17, P1085, DOI 10.1093/cercor/bhl017; Schupp HT, 2006, PROG BRAIN RES, V156, P31, DOI 10.1016/S0079-6123(06)56002-9; Schupp HT, 2000, PSYCHOPHYSIOLOGY, V37, P257, DOI 10.1017/S0048577200001530; Spielberger CD, 1983, MANUAL FOR THE STATE; VANDERDOES AJW, 2002, HANDLEIDING BIJ DE N; VANDERPLOEG HM, 2000, HANDLEIDING BIJ DE Z; Vuilleumier P, 2005, TRENDS COGN SCI, V9, P585, DOI 10.1016/j.tics.2005.10.011; Vuilleumier P, 2001, NEURON, V30, P829, DOI 10.1016/S0896-6273(01)00328-2; Vuilleumier P, 2004, NAT NEUROSCI, V7, P1271, DOI 10.1038/nn1341; Weinberg A, 2011, PSYCHOPHYSIOLOGY, V48, P842, DOI 10.1111/j.1469-8986.2010.01149.x; Wojciulik E, 1998, J NEUROPHYSIOL, V79, P1574, DOI 10.1152/jn.1998.79.3.1574	54	5	5	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2015	10	1							e0116817	10.1371/journal.pone.0116817	http://dx.doi.org/10.1371/journal.pone.0116817			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AZ0ID	25587987	Green Published, Green Submitted, gold			2022-12-27	WOS:000347928300022
J	Krawczyk, A; Dirks, M; Kasper, M; Buch, A; Dittmer, U; Giebel, B; Wildschutz, L; Busch, M; Goergens, A; Schneweis, KE; Eis-Hubinger, AM; Sodeik, B; Heiligenhaus, A; Roggendorf, M; Bauer, D				Krawczyk, Adalbert; Dirks, Miriam; Kasper, Maren; Buch, Anna; Dittmer, Ulf; Giebel, Bernd; Wildschuetz, Lena; Busch, Martin; Goergens, Andre; Schneweis, Karl E.; Eis-Huebinger, Anna M.; Sodeik, Beate; Heiligenhaus, Arnd; Roggendorf, Michael; Bauer, Dirk			Prevention of Herpes Simplex Virus Induced Stromal Keratitis by a Glycoprotein B-Specific Monoclonal Antibody	PLOS ONE			English	Article							IN-VIVO; PASSIVE-IMMUNIZATION; AMNIOTIC MEMBRANE; CORNEAL INFECTION; CAPSID TRANSPORT; NERVOUS-SYSTEM; OCULAR DISEASE; T-LYMPHOCYTES; TYPE-1; SPREAD	The increasing incidence of acyclovir (ACV) and multidrug-resistant strains in patients with corneal HSV-1 infections leading to Herpetic Stromal Keratitis (HSK) is a major health problem in industrialized countries and often results in blindness. To overcome this obstacle, we have previously developed an HSV-gB-specific monoclonal antibody (mAb 2c) that proved to be highly protective in immunodeficient NOD/SCID-mice towards genital infections. In the present study, we examined the effectivity of mAb 2c in preventing the immunopathological disease HSK in the HSK BALB/c mouse model. Therefore, mice were inoculated with HSV-1 strain KOS on the scarified cornea to induce HSK and subsequently either systemically or topically treated with mAb 2c. Systemic treatment was performed by intravenous administration of mAb 2c 24 h prior to infection (pre-exposure prophylaxis) or 24, 40, and 56 hours after infection (post-exposure immunotherapy). Topical treatment was performed by periodical inoculations (5 times per day) of antibody-containing eye drops as control, starting at 24 h post infection. Systemic antibody treatment markedly reduced viral loads at the site of infection and completely protected mice from developing HSK. The administration of the antiviral antibody prior or post infection was equally effective. Topical treatment had no improving effect on the severity of HSK. In conclusion, our data demonstrate that mAb 2c proved to be an excellent drug for the treatment of corneal HSV-infections and for prevention of HSK and blindness. Moreover, the humanized counterpart (mAb hu2c) was equally effective in protecting mice from HSV-induced HSK when compared to the parental mouse antibody. These results warrant the future development of this antibody as a novel approach for the treatment of corneal HSV-infections in humans.	[Krawczyk, Adalbert; Dirks, Miriam; Dittmer, Ulf; Roggendorf, Michael] Univ Duisburg Essen, Univ Hosp Essen, Inst Virol, Essen, Germany; [Kasper, Maren; Wildschuetz, Lena; Busch, Martin; Heiligenhaus, Arnd; Bauer, Dirk] St Franziskus Hosp, Dept Ophthalmol, Ophtha Lab, Munster, Germany; [Buch, Anna; Sodeik, Beate] Hannover Med Sch, Inst Virol, Hannover, Germany; [Giebel, Bernd; Goergens, Andre] Univ Hosp Essen, Inst Transfus Med, Essen, Germany; [Schneweis, Karl E.; Eis-Huebinger, Anna M.] Univ Med Ctr Bonn, Inst Virol, Bonn, Germany	University of Duisburg Essen; St. Franziskus-Hospital; Hannover Medical School; University of Duisburg Essen; University of Bonn	Krawczyk, A (corresponding author), Univ Duisburg Essen, Univ Hosp Essen, Inst Virol, Essen, Germany.	adalbert.krawczyk@uni-due.de	Görgens, André/C-3835-2016; Kasper, Maren/AAS-1716-2021; Krawczyk, Adalbert/ABD-7193-2020; Giebel, Bernd/AAH-1083-2021	Görgens, André/0000-0001-9198-0857; Krawczyk, Adalbert/0000-0001-9502-9903; Giebel, Bernd/0000-0003-2446-948X; Sodeik, Beate/0000-0003-4650-3036; Buch, Anna/0000-0003-1415-4492	"Ernst und Berta Grimmke-Stiftung" Foundation [1/13]; Niedersachsen-Research Network on Neuroinfectiology (N-RENNT) of the Ministry of Science and Culture of Lower Saxony, Germany	"Ernst und Berta Grimmke-Stiftung" Foundation; Niedersachsen-Research Network on Neuroinfectiology (N-RENNT) of the Ministry of Science and Culture of Lower Saxony, Germany	This study was funded by the "Ernst und Berta Grimmke-Stiftung" Foundation (grant number 1/13, awarded to AK). Anna Buch and Beate Sodeik are supported by the Niedersachsen-Research Network on Neuroinfectiology (N-RENNT) of the Ministry of Science and Culture of Lower Saxony, Germany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLANSMITH M, 1979, INVEST OPHTH VIS SCI, V18, P947; ALLANSMITH MR, 1973, ARCH OPHTHALMOL-CHIC, V89, P36, DOI 10.1001/archopht.1973.01000040038010; Bauer D, 2000, CURR EYE RES, V20, P45; Bauer D, 2009, INVEST OPHTH VIS SCI, V50, P3188, DOI 10.1167/iovs.08-3041; Berdugo M, 2012, ANTIMICROB AGENTS CH, V56, P1390, DOI 10.1128/AAC.05145-11; Choong K, 2010, CLIN EXP OPHTHALMOL, V38, P309, DOI 10.1111/j.1442-9071.2010.02209.x; Cohen J, 2010, SCIENCE, V330, P304, DOI 10.1126/science.330.6002.304; Daumer MP, 2011, MED MICROBIOL IMMUN, V200, P85, DOI 10.1007/s00430-010-0174-x; Dastjerdi MH, 2011, INVEST OPHTH VIS SCI, V52, P8718, DOI 10.1167/iovs.11-7871; Dohner K, 2006, J VIROL, V80, P8211, DOI 10.1128/JVI.02528-05; Dohner K, 2002, MOL BIOL CELL, V13, P2795, DOI 10.1091/mbc.01-07-0348; Duan R, 2008, J INFECT DIS, V198, P659, DOI 10.1086/590668; Duan R, 2009, J INFECT DIS, V200, P1402, DOI 10.1086/606028; DUBIN G, 1990, J VIROL, V64, P2725, DOI 10.1128/JVI.64.6.2725-2731.1990; EISHUBINGER AM, 1993, J GEN VIROL, V74, P379, DOI 10.1099/0022-1317-74-3-379; EISHUBINGER AM, 1991, INTERVIROLOGY, V32, P351, DOI 10.1159/000150219; Erickson AL, 2008, CLIN VACCINE IMMUNOL, V15, P1745, DOI 10.1128/CVI.00247-08; Farooq AV, 2012, SURV OPHTHALMOL, V57, P448, DOI 10.1016/j.survophthal.2012.01.005; Ghiasi H, 1998, IMMUNOLOGY, V95, P352; GROTHE C, 1987, J NEUROSCI RES, V18, P539, DOI 10.1002/jnr.490180406; Heiligenhaus A, 2005, INVEST OPHTH VIS SCI, V46, P4079, DOI 10.1167/iovs.05-0192; Heiligenhaus A, 1999, GRAEF ARCH CLIN EXP, V237, P399, DOI 10.1007/s004170050251; Hennig M, 2012, EXP EYE RES, V105, P43, DOI 10.1016/j.exer.2012.09.003; Hjerling-Leffler J, 2007, J NEUROSCI, V27, P2435, DOI 10.1523/JNEUROSCI.5614-06.2007; Hoffman VF, 2000, EXPERT OPIN INV DRUG, V9, P207, DOI 10.1517/13543784.9.2.207; Johnson DC, 2011, NAT REV MICROBIOL, V9, P382, DOI 10.1038/nrmicro2559; Jones Cheryl A, 2004, Herpes, V11, P12; Kaye S, 2006, PROG RETIN EYE RES, V25, P355, DOI 10.1016/j.preteyeres.2006.05.001; Koyuncu OO, 2013, CELL HOST MICROBE, V13, P379, DOI 10.1016/j.chom.2013.03.010; Krawczyk A, 2013, P NATL ACAD SCI USA, V110, P6760, DOI 10.1073/pnas.1220019110; Krawczyk A, 2011, J VIROL, V85, P1793, DOI 10.1128/JVI.01924-10; LAUSCH RN, 1989, CURR EYE RES, V8, P499, DOI 10.3109/02713688909000030; Mabit H, 2002, J VIROL, V76, P9962, DOI 10.1128/JVI.76.19.9962-9971.2002; METCALF JF, 1987, CURR EYE RES, V6, P173, DOI 10.3109/02713688709020086; METCALF JF, 1988, INTERVIROLOGY, V29, P39, DOI 10.1159/000150027; Mikloska Z, 1999, J VIROL, V73, P5934, DOI 10.1128/JVI.73.7.5934-5944.1999; Mott KR, 2007, INVEST OPHTH VIS SCI, V48, P2185, DOI 10.1167/iovs.06-1276; NIEMIALTOWSKI MG, 1992, J IMMUNOL, V149, P3035; Osorio Y, 2002, OCUL IMMUNOL INFLAMM, V10, P105, DOI 10.1076/ocii.10.2.105.13982; PRICE RW, 1979, INFECT IMMUN, V23, P373, DOI 10.1128/IAI.23.2.373-383.1979; Quah BJC, 2007, NAT PROTOC, V2, P2049, DOI 10.1038/nprot.2007.296; Remeijer L, 2004, OCUL IMMUNOL INFLAMM, V12, P255, DOI 10.1080/092739490500363; Richter ER, 2009, J INFECT DIS, V200, P1901, DOI 10.1086/648474; RUSSELL RG, 1984, INVEST OPHTH VIS SCI, V25, P938; Sanna PP, 1999, J VIROL, V73, P8817, DOI 10.1128/JVI.73.10.8817-8823.1999; Sattentau Q, 2008, NAT REV MICROBIOL, V6, P815, DOI 10.1038/nrmicro1972; SHIMELD C, 1990, J GEN VIROL, V71, P681, DOI 10.1099/0022-1317-71-3-681; SIMMONS A, 1984, J VIROL, V52, P816, DOI 10.1128/JVI.52.3.816-821.1984; Snijder B, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.9; Sodeik B, 1997, J CELL BIOL, V136, P1007, DOI 10.1083/jcb.136.5.1007; Streilein JW, 1997, IMMUNOL TODAY, V18, P443, DOI 10.1016/S0167-5699(97)01114-6; Su YH, 1996, J VIROL, V70, P1277, DOI 10.1128/JVI.70.2.1277-1281.1996; Tang QZ, 1997, J IMMUNOL, V158, P1275; Tang QZ, 1996, J EXP MED, V184, P1435, DOI 10.1084/jem.184.4.1435; Thiel MA, 2002, CLIN EXP IMMUNOL, V128, P67, DOI 10.1046/j.1365-2249.2002.01808.x; WALZ MA, 1974, SCIENCE, V184, P1185, DOI 10.1126/science.184.4142.1185; Wasmuth S, 2008, GRAEF ARCH CLIN EXP, V246, P443, DOI 10.1007/s00417-007-0707-1; Whitbeck JC, 2014, J VIROL, V88, P7786, DOI 10.1128/JVI.00544-14	58	19	19	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2015	10	1							e0116800	10.1371/journal.pone.0116800	http://dx.doi.org/10.1371/journal.pone.0116800			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ0ID	25587898	gold, Green Published, Green Submitted			2022-12-27	WOS:000347928300020
J	Maiorka, PC; Favaron, PO; Mess, AM; dos Santos, CR; Alberto, ML; Meirelles, FV; Miglino, MA				Maiorka, Paulo Cesar; Favaron, Phelipe Oliveira; Mess, Andrea Maria; dos Santos, Caio Rodrigues; Alberto, Miryan Lanca; Meirelles, Flavio Vieira; Miglino, Maria Angelica			Vascular Alterations Underlie Developmental Problems Manifested in Cloned Cattle before or after Birth	PLOS ONE			English	Article							CELL NUCLEAR TRANSFER; TRANSFER PREGNANCIES; BOVINE PLACENTOMES; TRANSFER CLONING; FARM-ANIMALS; BOS-INDICUS; CALVES; GESTATION; TERM; PERTURBATIONS	Although assisted reproductive techniques are commonly applied in humans and animals, they are frequently associated with major developmental deficits and reduced viability. To explore abnormalities associated with cloning or nuclear transfer (NT) as the most invasive of these methods, we used a bovine model to characterize abnormalities. Detailed necropsy examinations were done on 13 calves that died soon after birth; in addition, we included data from embryos and fetuses (produced by NT) that terminated prematurely. Bovine clones that survived until the neonatal period differed quantitatively and qualitatively from in-vivo-derived cattle. Although alterations affected a variety of organs (e.g. heart, lung and liver), there was a clear association with abberant vascular developmental during the early intrauterine phase. Therefore, we concluded that vascular problems were key alterations induced by cloning (presumably via epigenetic modifications).	[Maiorka, Paulo Cesar; dos Santos, Caio Rodrigues] Univ Sao Paulo, Sch Vet Med, Dept Pathol, Sao Paulo, Brazil; [Favaron, Phelipe Oliveira; Mess, Andrea Maria; Alberto, Miryan Lanca; Miglino, Maria Angelica] Univ Sao Paulo, Sch Vet Med, Dept Surg, Sao Paulo, Brazil; [Meirelles, Flavio Vieira] Univ Sao Paulo, Fac Anim Sci & Food Engn, Pirassununga, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo	Miglino, MA (corresponding author), Univ Sao Paulo, Sch Vet Med, Dept Pathol, Sao Paulo, Brazil.	miglino@usp.br	Meirelles, Flavio V/B-5048-2010; Miglino, Maria Angelica/B-9519-2012; Maiorka, Paulo/ABG-1405-2020; CTC USP, CEPID 13 18/J-8951-2014	Meirelles, Flavio V/0000-0003-0372-4920; Miglino, Maria Angelica/0000-0003-4979-115X; Favaron, Phelipe/0000-0002-6431-6886; CTC USP, CEPID 13 18/0000-0002-7123-9524	FAPESP [05/60606-3]; CNPq [477740/2008-1]; NETCEM; CAPES [335/2013]	FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); NETCEM; CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This research was supported by grants from FAPESP and CNPq (Process number: 05/60606-3 and 477740/2008-1, respectively) and NETCEM. In addition, Dr. Andrea Mess received support from CAPES (Process: 335/2013). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberto MLV, 2013, REPROD FERT DEVELOP, V25, P907, DOI 10.1071/RD12092; [Anonymous], 2012, HUM FERTIL, V15, P62, DOI 10.3109/14647273.2012.663571; Baruselli P. S., 2003, Brazilian Journal of Veterinary Research and Animal Science, V40, P96; Beltrao-Braga PCB, 2011, CELL TRANSPLANT, V20, P1707, DOI 10.3727/096368911X566235; Bertolini M, 2002, THERIOGENOLOGY, V57, P181, DOI 10.1016/S0093-691X(01)00665-3; BIRGELJUNIOR E.H, 2011, Acta Scientiae Veterinariae, V39, P243; Brisville AC, 2011, J VET INTERN MED, V25, P373, DOI 10.1111/j.1939-1676.2011.0693.x; Campos DB, 2010, GENET MOL RES, V9, P309, DOI 10.4238/vol9-1gmr729; Chavatte-Palmer P, 2012, PLACENTA, V33, pS99, DOI 10.1016/j.placenta.2011.09.012; Cibelli JB, 2002, NAT BIOTECHNOL, V20, P13, DOI 10.1038/nbt0102-13; Constant F, 2006, BIOL REPROD, V75, P122, DOI 10.1095/biolreprod.106.051581; Constant F, 2011, THERIOGENOLOGY, V76, P1006, DOI 10.1016/j.theriogenology.2011.04.029; De Bem THC, 2011, CELL REPROGRAM, V13, P419, DOI 10.1089/cell.2011.0010; Edwards JL, 2003, AM J REPROD IMMUNOL, V50, P113, DOI 10.1034/j.1600-0897.2003.00064.x; Eroglu A, 2012, SEMIN REPROD MED, V30, P92, DOI 10.1055/s-0032-1307417; Garry FB, 1996, THERIOGENOLOGY, V45, P141, DOI 10.1016/0093-691X(95)00363-D; Hill JR, 1999, THERIOGENOLOGY, V51, P1451, DOI 10.1016/S0093-691X(99)00089-8; Hill JR, 2000, BIOL REPROD, V63, P1787, DOI 10.1095/biolreprod63.6.1787; Huang YY, 2013, BIOL OPEN, V2, P1223, DOI 10.1242/bio.20135983; Kohda T, 2013, J HUM GENET, V58, P416, DOI 10.1038/jhg.2013.61; Koot YEM, 2013, CURR OPIN OBSTET GYN, V25, P274, DOI 10.1097/GCO.0b013e3283630d94; Lai LX, 2002, SCIENCE, V295, P1089, DOI 10.1126/science.1068228; Li N, 2005, BIOL REPROD, V73, P139, DOI 10.1095/biolreprod.104.038018; Lopez-Saucedo J, 2012, ANIM REPROD SCI, V133, P129, DOI 10.1016/j.anireprosci.2012.07.003; Meirelles FV, 2010, REPROD FERT DEVELOP, V22, P88, DOI 10.1071/RD09229; MEIRELLES FV, 2006, ACTA SCI VET, V34, P235; Melo EO, 2007, J APPL GENET, V48, P47, DOI 10.1007/BF03194657; Miglino MA, 2007, THERIOGENOLOGY, V68, P604, DOI 10.1016/j.theriogenology.2007.04.060; Ogonuki N, 2002, NAT GENET, V30, P253, DOI 10.1038/ng841; Panarace M, 2007, THERIOGENOLOGY, V67, P142, DOI 10.1016/j.theriogenology.2006.09.036; PEREIRA FC, 2013, PLOS GENET, V9; REICHENBACH HD, 2003, EMBRIAO, V17, P3; Renard JP, 1999, LANCET, V353, P1489, DOI 10.1016/S0140-6736(98)12173-6; Rhind SM, 2003, NAT BIOTECHNOL, V21, P744, DOI 10.1038/nbt0703-744; Rodriguez-Alvarez L, 2013, IN VITRO CELL DEV-AN, V49, P657, DOI 10.1007/s11626-013-9650-0; Sa MF, 2010, ANIM REPROD SCI, V118, P182, DOI 10.1016/j.anireprosci.2009.10.004; Sangalli JR, 2012, CELL REPROGRAM, V14, P235, DOI 10.1089/cell.2011.0079; SANTOS CR, 2010, BRAZ J VET RES ANIM, V45, P447; Shen CJ, 2013, CELL REPROGRAM, V15, P413, DOI 10.1089/cell.2013.0012; Shimozawa N, 2006, REPRODUCTION, V132, P435, DOI 10.1530/rep.1.00745; Shufaro Y, 2013, FERTIL STERIL, V99, P605, DOI 10.1016/j.fertnstert.2013.01.126; Tanaka S, 2006, AM J REPROD IMMUNOL, V55, P28, DOI 10.1111/j.1600-0897.2005.00319.x; Watanabe S, 2013, ANIM SCI J, V84, P631, DOI 10.1111/asj.12087; Wells DN, 2004, CLONING STEM CELLS, V6, P101, DOI 10.1089/1536230041372300; Wells DN, 1997, BIOL REPROD, V57, P385, DOI 10.1095/biolreprod57.2.385; WILSON JM, 1995, ANIM REPROD SCI, V38, P73, DOI 10.1016/0378-4320(94)01353-N; Woelders H, 2012, REPROD DOMEST ANIM, V47, P264, DOI 10.1111/j.1439-0531.2012.02085.x; Young LE, 1998, REV REPROD, V3, P155, DOI 10.1530/revreprod/3.3.155	48	8	8	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2015	10	1							e0106663	10.1371/journal.pone.0106663	http://dx.doi.org/10.1371/journal.pone.0106663			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ4OG	25584533	gold, Green Published, Green Submitted			2022-12-27	WOS:000348201300001
J	Bhat, A; Heinzel, A; Mayer, B; Perco, P; Muhlberger, I; Husi, H; Merseburger, AS; Zoidakis, J; Vlahou, A; Schanstra, JP; Mischak, H; Jankowski, V				Bhat, Akshay; Heinzel, Andreas; Mayer, Bernd; Perco, Paul; Muehlberger, Irmgard; Husi, Holger; Merseburger, Axel S.; Zoidakis, Jerome; Vlahou, Antonia; Schanstra, Joost P.; Mischak, Harald; Jankowski, Vera			Protein Interactome of Muscle Invasive Bladder Cancer	PLOS ONE			English	Article							CHROMATOGRAPHY-MASS SPECTROMETRY; SYSTEMS BIOLOGY; DATABASE; PATHWAYS; GENE; CYTOSKELETON; ENDOCYTOSIS; METASTASIS; BIOMARKERS; CARCINOMA	Muscle invasive bladder carcinoma is a complex, multifactorial disease caused by disruptions and alterations of several molecular pathways that result in heterogeneous phenotypes and variable disease outcome. Combining this disparate knowledge may offer insights for deciphering relevant molecular processes regarding targeted therapeutic approaches guided by molecular signatures allowing improved phenotype profiling. The aim of the study is to characterize muscle invasive bladder carcinoma on a molecular level by incorporating scientific literature screening and signatures from omics profiling. Public domain omics signatures together with molecular features associated with muscle invasive bladder cancer were derived from literature mining to provide 286 unique protein-coding genes. These were integrated in a protein-interaction network to obtain a molecular functional map of the phenotype. This feature map educated on three novel disease-associated pathways with plausible involvement in bladder cancer, namely Regulation of actin cytoskeleton, Neurotrophin signalling pathway and Endocytosis. Systematic integration approaches allow to study the molecular context of individual features reported as associated with a clinical phenotype and could potentially help to improve the molecular mechanistic description of the disorder.	[Bhat, Akshay] Charite, Med Klin 4, D-13353 Berlin, Germany; [Bhat, Akshay; Mischak, Harald] Mosaiques Diagnost GmbH, Hannover, Germany; [Heinzel, Andreas; Mayer, Bernd; Perco, Paul; Muehlberger, Irmgard] Emergentec Biodev GmbH, Vienna, Austria; [Husi, Holger; Mischak, Harald] Univ Glasgow, BHF Glasgow Cardiovasc Res Ctr, Glasgow, Lanark, Scotland; [Merseburger, Axel S.] Hannover Med Sch, Dept Urol & Urol Oncol, Hannover, Germany; [Zoidakis, Jerome; Vlahou, Antonia] Biomed Res Fdn Acad Athens, Div Biotechnol, Athens, Greece; [Schanstra, Joost P.] Fac Med Toulouse, INSERM, U1048, Inst Cardiovasc & Metab Dis, F-31073 Toulouse, France; [Schanstra, Joost P.] Univ Toulouse 3, F-31062 Toulouse, France; [Jankowski, Vera] Inst Mol Cardiovasc Res IMCAR, Aachen, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Mosaiques Diagnostics GmbH (MOS); Emergentec Biodevelopment GmbH; University of Glasgow; Hannover Medical School; Academy of Athens; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier	Jankowski, V (corresponding author), Inst Mol Cardiovasc Res IMCAR, Aachen, Germany.	vjankowski@ukaachen.de	Zoidakis, Jerome/AAO-8236-2021; Perco, Paul/U-2489-2019; Schanstra, Joost P/X-7724-2018; Zoidakis, Jerome/P-9599-2018	Zoidakis, Jerome/0000-0002-4557-3430; Perco, Paul/0000-0003-2087-5691; Schanstra, Joost P/0000-0002-7471-372X; Zoidakis, Jerome/0000-0002-4557-3430; Vlahou, Antonia/0000-0003-3284-5713; Mischak, Harald/0000-0003-0323-0306	Marie Curie Actions - BCMolMed [FP7-PEOPLE-2012-ITN-EID]; European Community's Seventh Framework Programme [306157]	Marie Curie Actions - BCMolMed; European Community's Seventh Framework Programme	This work was supported by Marie Curie Actions - BCMolMed under grant agreement no. FP7-PEOPLE-2012-ITN-EID and the European Community's Seventh Framework Programme under grant agreement no. 306157. Harald Mischak is the founder and co-owner of Mosaiques Diagnostics, who developed the CE-MS technology for clinical application. Akshay Bhat is an employee of Mosaiques Diagnostics. Bernd Mayer is the managing partner of emergentec biodevelopment GmbH, Austria. Paul Perco, Andreas Heinzel and Irmgard Muhlberger are employees of emergentec. Neither Mosaiques Diagnostics GmbH nor emergentec biodevelopment GmbH were involved in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The companies involved only provided financial support in the form of authors' salaries and/or research materials. The specific roles of these authors are articulated in the 'author contributions' section.	Abu-Asab MS, 2011, OMICS, V15, P105, DOI 10.1089/omi.2010.0023; Alberice JV, 2013, J CHROMATOGR A, V1318, P163, DOI 10.1016/j.chroma.2013.10.002; Assimakopoulou M, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-202; Barrett T, 2013, NUCLEIC ACIDS RES, V41, pD991, DOI 10.1093/nar/gks1193; Bernthaler A, 2009, MOL BIOSYST, V5, P1720, DOI 10.1039/b903109j; Besaratinia A, 2013, EPIGENETICS-US, V8, P1013, DOI 10.4161/epi.25927; Bindea G, 2013, BIOINFORMATICS, V29, P661, DOI 10.1093/bioinformatics/btt019; Bindea G, 2009, BIOINFORMATICS, V25, P1091, DOI 10.1093/bioinformatics/btp101; Carbon S, 2009, BIOINFORMATICS, V25, P288, DOI 10.1093/bioinformatics/btn615; Chihara Y, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-275; Croft D, 2011, NUCLEIC ACIDS RES, V39, pD691, DOI 10.1093/nar/gkq1018; Dakna M, 2009, J CHROMATOGR B, V877, P1250, DOI 10.1016/j.jchromb.2008.10.048; De Las Rivas J, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000807; Di Pierro GB, 2012, CURR GENOMICS, V13, P395, DOI 10.2174/138920212801619232; Emmert-Streib F, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-12; Evelyne CCC, 2011, INDIAN J UROL, V27, P245, DOI 10.4103/0970-1591.82845; Ewald JA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055414; Frantzi M, 2014, CLIN TRANSL MED, V3, DOI 10.1186/2001-1326-3-7; GeneCards, 2013, HUM GEN COMP; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Hamosh A, 2005, NUCLEIC ACIDS RES, V33, pD514; Henning A, 2013, BJU INT, V112, P68, DOI 10.1111/j.1464-410X.2012.11661.x; Huang HZ, 2011, BIOINFORMATICS, V27, P1190, DOI 10.1093/bioinformatics/btr101; Jing X, 2013, GENET MOL BIOL, V36, P287, DOI 10.1590/S1415-47572013005000015; Kamai T, 2003, CLIN CANCER RES, V9, P2632; Karam JA, 2007, CLIN CANCER RES, V13, P4400, DOI 10.1158/1078-0432.CCR-07-0287; Kerrien S, 2012, NUCLEIC ACIDS RES, V40, pD841, DOI 10.1093/nar/gkr1088; Kircher M, 2010, BIOESSAYS, V32, P524, DOI 10.1002/bies.200900181; Koochekpour S, 2010, ASIAN J ANDROL, V12, P639, DOI 10.1038/aja.2010.89; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Kreeger PK, 2010, CARCINOGENESIS, V31, P2, DOI 10.1093/carcin/bgp261; Krishnamurthy L, 2003, BIOINFORMATICS, V19, P930, DOI 10.1093/bioinformatics/btg113; Maglott D, 2007, NUCLEIC ACIDS RES, V35, pD26, DOI 10.1093/nar/gkl993; Mayer G, 2011, METHODS MOL BIOL, V719, P479, DOI 10.1007/978-1-61779-027-0_22; Mayer P, 2012, NEPHROL DIAL TRANSPL, V27, P3995, DOI 10.1093/ndt/gfs489; McConkey DJ, 2010, UROL ONCOL-SEMIN ORI, V28, P429, DOI 10.1016/j.urolonc.2010.04.008; Mi HY, 2013, NUCLEIC ACIDS RES, V41, pD377, DOI 10.1093/nar/gks1118; Mischak H, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001249; Mischak H, 2011, PROTEOM CLIN APPL, V5, P9, DOI 10.1002/prca.201000058; Mitra AP, 2009, ANNU REV PATHOL-MECH, V4, P251, DOI 10.1146/annurev.pathol.4.110807.092230; Mitra AP, 2005, BJU INT, V96, P7, DOI 10.1111/j.1464-410X.2005.05557.x; Mosesson Y, 2008, NAT REV CANCER, V8, P835, DOI 10.1038/nrc2521; Philippi S, 2006, NAT REV GENET, V7, P482, DOI 10.1038/nrg1872; Polo S, 2004, CURR OPIN CELL BIOL, V16, P156, DOI 10.1016/j.ceb.2004.02.003; Price LS, 2001, SEMIN CANCER BIOL, V11, P167, DOI 10.1006/scbi.2000.0367; Raman JD, 2011, UROL ONCOL-SEMIN ORI, V29, P716, DOI 10.1016/j.urolonc.2009.11.007; Rapberger R, 2008, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-2; Reichardt LF, 2006, PHILOS T R SOC B, V361, P1545, DOI 10.1098/rstb.2006.1894; Rhodes DR, 2004, NEOPLASIA, V6, P1, DOI 10.1016/S1476-5586(04)80047-2; Ru YB, 2011, CURR OPIN UROL, V21, P420, DOI 10.1097/MOU.0b013e32834956d6; Rustici G, 2013, NUCLEIC ACIDS RES, V41, pD987, DOI 10.1093/nar/gks1174; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Stark C, 2011, NUCLEIC ACIDS RES, V39, pD698, DOI 10.1093/nar/gkq1116; Stein LD, 2003, NAT REV GENET, V4, P337, DOI 10.1038/nrg1065; Thiele CJ, 2009, CLIN CANCER RES, V15, P5962, DOI 10.1158/1078-0432.CCR-08-0651; Vishnu P, 2011, ONCOTARGETS THER, V4, P97, DOI 10.2147/OTT.S22875; Vlahou A, 2013, PROTEOM CLIN APPL, V7, P384, DOI 10.1002/prca.201200121; Weinstein JN, 2014, NATURE, V507, P315, DOI 10.1038/nature12965; Weiss GJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076438; Wishart DS, 2007, NUCLEIC ACIDS RES, V35, pD521, DOI 10.1093/nar/gkl923; Wixon J, 2000, YEAST, V17, P48, DOI 10.1002/(SICI)1097-0061(200004)17:1<48::AID-YEA2>3.0.CO;2-H; Wu XR, 2005, NAT REV CANCER, V5, P713, DOI 10.1038/nrc1697; Yu L, 2014, ONCOGENE, V33, P690, DOI 10.1038/onc.2013.20; Yuan XL, 2013, CANCER RES, V73, P3625, DOI 10.1158/0008-5472.CAN-12-3879; Zoidakis J, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.009449	65	12	12	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2015	10	1							e0116404	10.1371/journal.pone.0116404	http://dx.doi.org/10.1371/journal.pone.0116404			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ4BT	25569276	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000348168000007
J	Hengartner, NE; Fiedler, J; Schrezenmeier, H; Huber-Lang, M; Brenner, RE				Hengartner, Nina-Emily; Fiedler, Joerg; Schrezenmeier, Hubert; Huber-Lang, Markus; Brenner, Rolf E.			Crucial Role of IL1beta and C3a in the In Vitro-Response of Multipotent Mesenchymal Stromal Cells to Inflammatory Mediators of Polytrauma	PLOS ONE			English	Article							MULTIPLE ORGAN FAILURE; ANTIINFLAMMATORY PROTEIN TSG-6; RESPIRATORY-DISTRESS-SYNDROME; HUMAN ADIPOSE-TISSUE; STEM-CELLS; PROGENITOR CELLS; OSTEOARTHRITIC CARTILAGE; MYOCARDIAL-INFARCTION; COMPLEMENT ACTIVATION; INJURY SEVERITY	Multipotent mesenchymal stromal cells (MSC) exert immune-modulatory effects and support tissue regeneration in various local trauma models. In case of a polytrauma, high amounts of danger-associated molecular patterns are released, leading to a systemic increase of inflammatory mediators. The influence of such a complex inflammatory microenvironment on human MSC is mainly unknown so far. Therefore, we investigated the effects of a defined serum-free polytrauma "cocktail" containing IL beta, IL6, IL8 and the anaphylatoxins C3a and C5a, in concentrations corresponding to those measured in the blood of polytrauma patients, on human MSC in vitro. The polytrauma cocktail induced directed migration of MSC with C3a representing its major soluble chemoattractive agent. Furthermore, the polytrauma cocktail and IL1beta upregulated the expression of MMP1 indicating a potential role of IL1beta to enhance MSC migration in the tissue context. COX2, PTGES and TSG6 were also found to be upregulated upon stimulation with the polytrauma cocktail or IL1beta, but not through other single factors of the polytrauma cocktail in pathophysiologically relevant concentrations. An RNA expression array of 84 inflammation-related genes revealed that both the polytrauma cocktail and IL1beta induced C3, CSF1, TLR3 and various chemokines without major qualitative or quantitative differences. These results indicate that IL1beta is a crucial mediator of the polytrauma cocktail in terms of immune-modulation and MMP1 expression. Thus, upon encountering the primary sterile, inflammatory milieu of a polytrauma, endogenous or systemically transfused MSC might be able to migrate to sites of injury, secrete TSG6 and PGE2 and to influence macrophage biology as observed in local trauma models.	[Hengartner, Nina-Emily; Fiedler, Joerg; Brenner, Rolf E.] Univ Ulm, Dept Orthoped, Div Biochem Joint & Connect Tissue Dis, D-89069 Ulm, Germany; [Schrezenmeier, Hubert] German Red Cross Blood Transfus Serv Baden Wurtt, Inst Clin Transfus Med & Immunogenet Ulm, Ulm, Germany; [Schrezenmeier, Hubert] Univ Ulm, Univ Hosp Ulm, D-89069 Ulm, Germany; [Huber-Lang, Markus] Univ Ulm, Dept Orthoped Trauma Hand Plast & Reconstruct Sur, D-89069 Ulm, Germany	Ulm University; Ulm University; Ulm University	Brenner, RE (corresponding author), Univ Ulm, Dept Orthoped, Div Biochem Joint & Connect Tissue Dis, D-89069 Ulm, Germany.	rolf.brenner@uni-ulm.de	Huber-Lang, Markus/AAJ-2209-2020	Fiedler, Jorg/0000-0002-5834-3730	Center of Musculoskeletal Research Ulm; State of Baden-Wurttember (Perspektivfoderung)	Center of Musculoskeletal Research Ulm; State of Baden-Wurttember (Perspektivfoderung)	The study was funded in part by the Center of Musculoskeletal Research Ulm and the State of Baden-Wurttember (Perspektivfoderung). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alm JJ, 2010, J ORTHOP RES, V28, P1634, DOI 10.1002/jor.21167; Ames RS, 2001, J IMMUNOL, V166, P6341, DOI 10.4049/jimmunol.166.10.6341; Bartosh TJ, 2013, STEM CELLS, V31, P2443, DOI 10.1002/stem.1499; Bogner V, 2009, EUR J MED RES, V14, P284, DOI 10.1186/2047-783X-14-7-284; Burk AM, 2012, SHOCK, V37, P348, DOI 10.1097/SHK.0b013e3182471795; Carrero R, 2012, STEM CELL REV REP, V8, P905, DOI 10.1007/s12015-012-9364-9; Chiaretti A, 2005, CHILD NERV SYST, V21, P185, DOI 10.1007/s00381-004-1032-1; Choi H, 2011, BLOOD, V118, P330, DOI 10.1182/blood-2010-12-327353; Crop MJ, 2010, CLIN EXP IMMUNOL, V162, P474, DOI 10.1111/j.1365-2249.2010.04256.x; Meirelles LDS, 2006, J CELL SCI, V119, P2204, DOI 10.1242/jcs.02932; De Bari C, 2001, ARTHRITIS RHEUM-US, V44, P1928, DOI 10.1002/1529-0131(200108)44:8<1928::AID-ART331>3.0.CO;2-P; Devine MJ, 2002, J ORTHOP RES, V20, P1232, DOI 10.1016/S0736-0266(02)00051-7; Fickert S, 2004, ARTHRITIS RES THER, V6, pR422, DOI 10.1186/ar1210; Fiedler J, 2005, BIOCHEM BIOPH RES CO, V334, P561, DOI 10.1016/j.bbrc.2005.06.116; Fiedler J, 2004, J CELL BIOCHEM, V93, P990, DOI 10.1002/jcb.20219; Fiedler J, 2006, BIOCHEM BIOPH RES CO, V345, P1177, DOI 10.1016/j.bbrc.2006.05.034; Foraker JE, 2011, J NEUROCHEM, V119, P1052, DOI 10.1111/j.1471-4159.2011.07511.x; Francois S, 2006, STEM CELLS, V24, P1020, DOI 10.1634/stemcells.2005-0260; Ganter MT, 2007, SHOCK, V28, P29, DOI 10.1097/shk.0b013e3180342439; Gao JZ, 2001, CELLS TISSUES ORGANS, V169, P12, DOI 10.1159/000047856; Giannoudis PV, 1998, ACTA ORTHOP SCAND, V69, P184, DOI 10.3109/17453679809117625; Gronthos S, 2000, P NATL ACAD SCI USA, V97, P13625, DOI 10.1073/pnas.240309797; Hecke F, 1997, CRIT CARE MED, V25, P2015, DOI 10.1097/00003246-199712000-00019; Hengartner NE, 2013, MOL MED, V19, P36, DOI 10.2119/molmed.2012.00058; Hensler T, 2003, SHOCK, V20, P497, DOI 10.1097/01.shk.0000095058.62263.1f; Ignatius A, 2011, J TRAUMA, V71, P952, DOI 10.1097/TA.0b013e3181f8aa2d; Joos H, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4299; Kohl J, 2006, IMMUNOL RES, V34, P157, DOI 10.1385/IR:34:2:157; Kraitchman DL, 2005, CIRCULATION, V112, P1451, DOI 10.1161/CIRCULATIONAHA.105.537480; Krumina G, 2013, J TRAUMA ACUTE CARE, V74, P785, DOI 10.1097/TA.0b013e31827e1879; LeBlanc K, 2008, LANCET, V371, P1579, DOI 10.1016/S0140-6736(08)60690-X; Lee RH, 2009, CELL STEM CELL, V5, P54, DOI 10.1016/j.stem.2009.05.003; Liang J, 2010, ANN RHEUM DIS, V69, P1423, DOI 10.1136/ard.2009.123463; Liechty KW, 2000, NAT MED, V6, P1282, DOI 10.1038/81395; Lucia A, 2009, BRIT J SPORT MED, V43, P221, DOI 10.1136/bjsm.2007.044693; Maier B, 2007, SHOCK, V28, P668, DOI 10.1097/shk.0b013e318123e64e; Matthes G, 2001, ZBL CHIR, V126, P995, DOI 10.1055/s-2001-19658; Mishima Y, 2008, J ORTHOP RES, V26, P1407, DOI 10.1002/jor.20668; Nemeth K, 2009, NAT MED, V15, P42, DOI 10.1038/nm.1905; Qi Y, 2014, J INVEST DERMATOL, V134, P526, DOI 10.1038/jid.2013.328; Raffaghello L, 2008, STEM CELLS, V26, P151, DOI 10.1634/stemcells.2007-0416; Ramirez M, 2006, BRIT J SPORT MED, V40, P719, DOI 10.1136/bjsm.2006.028639; Rattigan Y, 2010, EXP CELL RES, V316, P3417, DOI 10.1016/j.yexcr.2010.07.002; Ries C, 2007, BLOOD, V109, P4055, DOI 10.1182/blood-2006-10-051060; Rochefort GY, 2006, STEM CELLS, V24, P2202, DOI 10.1634/stemcells.2006-0164; ROUMEN RMH, 1993, ANN SURG, V218, P769, DOI 10.1097/00000658-199312000-00011; Schmidt A, 2006, STEM CELLS, V24, P1750, DOI 10.1634/stemcells.2005-0191; Schraufstatter IU, 2009, J IMMUNOL, V182, P3827, DOI 10.4049/jimmunol.0803055; Tu ZD, 2010, STEM CELLS DEV, V19, P1803, DOI 10.1089/scd.2009.0418; Visse R, 2003, CIRC RES, V92, P827, DOI 10.1161/01.RES.0000070112.80711.3D; Weckbach S, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/890816; Williams JT, 1999, AM SURGEON, V65, P22; Yagi H, 2010, CELL TRANSPLANT, V19, P667, DOI 10.3727/096368910X508762; Ylostalo JH, 2012, STEM CELLS, V30, P2283, DOI 10.1002/stem.1191; Yukawa H, 2012, BIOMATERIALS, V33, P2177, DOI 10.1016/j.biomaterials.2011.12.009; Zhang QZ, 2010, STEM CELLS, V28, P1856, DOI 10.1002/stem.503; ZILOW G, 1990, CLIN EXP IMMUNOL, V79, P151; Zuk PA, 2001, TISSUE ENG, V7, P211, DOI 10.1089/107632701300062859	59	28	30	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2015	10	1							e0116772	10.1371/journal.pone.0116772	http://dx.doi.org/10.1371/journal.pone.0116772			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ3YO	25562599	Green Published, gold, Green Submitted			2022-12-27	WOS:000348160000002
J	Krychowiak, M; Grinholc, M; Banasiuk, R; Krauze-Baranowska, M; Glod, D; Kawiak, A; Krolicka, A				Krychowiak, Marta; Grinholc, Mariusz; Banasiuk, Rafal; Krauze-Baranowska, Miroslawa; Glod, Daniel; Kawiak, Anna; Krolicka, Aleksandra			Combination of Silver Nanoparticles and Drosera binata Extract as a Possible Alternative for Antibiotic Treatment of Burn Wound Infections Caused by Resistant Staphylococcus aureus	PLOS ONE			English	Article							IN-VITRO; NAPHTHOQUINONES; PLUMBAGIN; BACTERIA; SYNERGY; PLANTS; MODEL	Staphylococcus aureus is the most common infectious agent involved in the development of skin infections that are associated with antibiotic resistance, such as burn wounds. As drug resistance is a growing problem it is essential to establish novel antimicrobials. Currently, antibiotic resistance in bacteria is successfully controlled by multi-drug therapies. Here we demonstrate that secondary metabolites present in the extract obtained from Drosera binata in vitro cultures are effective antibacterial agents against S. aureus grown in planktonic culture and in biofilm. Moreover, this is the first report demonstrating the synergistic interaction between the D. binata extract and silver nanoparticles (AgNPs), which results in the spectacular enhancement of the observed bactericidal activity, while having no cytotoxic effects on human keratinocytes. Simultaneous use of these two agents in significantly reduced quantities produces the same effect, i.e. by killing 99.9% of bacteria in inoculum or eradicating the staphylococcal biofilm, as higher amounts of the agents used individually. Our data indicates that combining AgNPs with either the D. binata extract or with its pure compound (3-chloroplumbagin) may provide a safe and highly effective alternative to commonly used antibiotics, which are ineffective towards the antibiotic-resistant S. aureus.	[Krychowiak, Marta; Banasiuk, Rafal; Krolicka, Aleksandra] Univ Gdansk, Intercollegiate Fac Biotechnol, Dept Biotechnol, Lab Biol Act Cpds, PL-80952 Gdansk, Poland; [Krychowiak, Marta; Grinholc, Mariusz; Banasiuk, Rafal; Kawiak, Anna; Krolicka, Aleksandra] Med Univ Gdansk, Gdansk, Poland; [Grinholc, Mariusz] Univ Gdansk, Dept Biotechnol, Lab Mol Diagnost, IFB, Gdansk, Poland; [Krauze-Baranowska, Miroslawa; Glod, Daniel] Med Univ Gdansk, Dept Pharmacognosy Med Plant Garden, Gdansk, Poland; [Kawiak, Anna] Univ Gdansk, Dept Biotechnol, Lab Plant Protect & Biotechnol, IFB, Gdansk, Poland	Fahrenheit Universities; University of Gdansk; Fahrenheit Universities; Medical University Gdansk; Fahrenheit Universities; University of Gdansk; Fahrenheit Universities; Medical University Gdansk; Fahrenheit Universities; University of Gdansk	Krolicka, A (corresponding author), Univ Gdansk, Intercollegiate Fac Biotechnol, Dept Biotechnol, Lab Biol Act Cpds, PL-80952 Gdansk, Poland.	aleksandra.krolicka@biotech.ug.edu.pl	Królicka, Aleksandra/J-4170-2014; Krychowiak-Masnicka, Marta/ABB-2956-2021; Krychowiak-Masnicka, Marta/AAI-3977-2020; Kawiak, Anna/L-6060-2014; Krolicka, Aleksandra/AAC-3958-2019; Grinholc, Mariusz/F-5962-2011; Grinholc, Mariusz/N-8726-2019	Krychowiak-Masnicka, Marta/0000-0002-3617-6572; Krychowiak-Masnicka, Marta/0000-0002-3617-6572; Kawiak, Anna/0000-0001-8105-2555; Krolicka, Aleksandra/0000-0001-5231-283X; Grinholc, Mariusz/0000-0003-4041-0891; Banasiuk, Rafal/0000-0002-3774-1545; Krauze-Baranowska, Miroslawa/0000-0002-0344-7401	National Centre for Research and Development [LIDER/32/36/L-2/10/NCRiR/2011]; EU FP7 project MOBI4Health [GA. 316094]	National Centre for Research and Development(National Centre for Research & Development, Poland); EU FP7 project MOBI4Health	The research was supported by the National Centre for Research and Development (project LIDER/32/36/L-2/10/NCRiR/2011). Publication costs were covered by the EU FP7 project MOBI4Health, GA. 316094. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allaker RP, 2014, INT J ANTIMICROB AG, V43, P95, DOI 10.1016/j.ijantimicag.2013.11.002; BEHRMAN EJ, 1995, J CHEM RES-S, P164; BENDZ G, 1968, ACTA CHEM SCAND, V22, P2722, DOI 10.3891/acta.chem.scand.22-2722; BERENBAUM MC, 1978, J INFECT DIS, V137, P122, DOI 10.1093/infdis/137.2.122; Bringmann G, 2000, PHYTOCHEMISTRY, V53, P339, DOI 10.1016/S0031-9422(99)00543-9; Church D, 2006, CLIN MICROBIOL REV, V19, P403, DOI 10.1128/CMR.19.2.403-434.2006; Clinical and Laboratory Standards Institute (CLSI), 2014, CLIN LAB STANDARDS I; Daglia M, 2012, CURR OPIN BIOTECH, V23, P174, DOI 10.1016/j.copbio.2011.08.007; Davis SC, 2008, WOUND REPAIR REGEN, V16, P23, DOI 10.1111/j.1524-475X.2007.00303.x; ENGVILD KC, 1986, PHYTOCHEMISTRY, V25, P781, DOI 10.1016/0031-9422(86)80002-4; Garcia-Barrasa J, 2011, CENT EUR J CHEM, V9, P7, DOI 10.2478/s11532-010-0124-x; Harrison JJ, 2010, NAT PROTOC, V5, P1236, DOI 10.1038/nprot.2010.71; Hernandez-Munoz LS, 2009, ORG BIOMOL CHEM, V7, P1896, DOI 10.1039/b822684a; Higa M, 1998, CHEM PHARM BULL, V46, P1189, DOI 10.1248/cpb.46.1189; Kalishwaralal K, 2010, COLLOID SURFACE B, V79, P340, DOI 10.1016/j.colsurfb.2010.04.014; Kawiak A, 2003, PLANT CELL TISS ORG, V75, P175, DOI 10.1023/A:1025023800304; KREHER B, 1990, PHYTOCHEMISTRY, V29, P605, DOI 10.1016/0031-9422(90)85125-Y; KRISHNAN.V, 1969, PHYTOCHEMISTRY, V8, P1591, DOI 10.1016/S0031-9422(00)85936-1; Krolicka A, 2008, ENZYME MICROB TECH, V42, P216, DOI 10.1016/j.enzmictec.2007.09.011; Kuo PL, 2006, MOL CANCER THER, V5, P3209, DOI 10.1158/1535-7163.MCT-06-0478; LAKSHMI VV, 1987, CURR MICROBIOL, V16, P159; Lowy FD, 2003, J CLIN INVEST, V111, P1265, DOI 10.1172/JC1200318535; Machado TB, 2003, INT J ANTIMICROB AG, V21, P279, DOI 10.1016/S0924-8579(02)00349-7; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Murray CK, 2007, J TRAUMA, V62, pS73, DOI 10.1097/TA.0b013e318065af1a; NAIR A G R, 1990, Fitoterapia, V61, P85; RAZZAKOVA DM, 1973, KHIM PRIRODNYK SOEDI, P206; SIDHU GS, 1971, TETRAHEDRON LETT, P2385; Sondi I, 2004, J COLLOID INTERF SCI, V275, P177, DOI 10.1016/j.jcis.2004.02.012; Stewart PS, 2001, LANCET, V358, P135, DOI 10.1016/S0140-6736(01)05321-1; THORNSBERRY C, 1991, ANN OTO RHINOL LARYN, V100, P7, DOI 10.1177/00034894911000S904; Tsymbal A, 2005, LECT NOTES COMPUTER; Wagner H, 2009, PHYTOMEDICINE, V16, P97, DOI 10.1016/j.phymed.2008.12.018; Wikler M.A., 2012, CLIN LAB STANDARDS I, V26, pM07; Williamson EM, 2001, PHYTOMEDICINE, V8, P401, DOI 10.1078/0944-7113-00060; Zehl M, 2011, ANAL BIOANAL CHEM, V400, P2565, DOI 10.1007/s00216-011-4690-3	36	44	45	3	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2014	9	12							e115727	10.1371/journal.pone.0115727	http://dx.doi.org/10.1371/journal.pone.0115727			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UC	25551660	Green Published, Green Submitted, gold			2022-12-27	WOS:000347119100055
J	Mirzaei, MK; Eriksson, H; Kasuga, K; Haggard-Ljungquist, E; Nilsson, AS				Mirzaei, Mohammadali Khan; Eriksson, Harald; Kasuga, Kie; Haggard-Ljungquist, Elisabeth; Nilsson, Anders S.			Genomic, Proteomic, Morphological, and Phylogenetic Analyses of vB_EcoP_SU10, a Podoviridae Phage with C3 Morphology	PLOS ONE			English	Article							ESCHERICHIA-COLI; BACTERIOPHAGES; SEQUENCE; FREQUENCY; GENES; DNA	A recently isolated phage, vB_EcoP_SU10 (SU10), with the unusual elongated C3 morphotype, can infect a wide range of Escherichia coli strains. We have sequenced the genome of this phage and characterized it further by mass spectrometry based proteomics, transmission electron microscopy (TEM), scanning electron microscopy (SEM), and ultra-thin section electron microscopy. The genome size is 77,327 base pairs and its genes, and genome architecture, show high similarity to the phiEco32 phage genes and genome. The TEM images reveal that SU10 have a quite long tail for being a Podoviridae phage, and that the tail also changes conformation upon infection. The ultra-thin section electron microscopy images of phages at the stage of replication within the host cell show that the phages form a honeycomb-like structure under packaging of genomes and assembly of mature capsids. This implies a tight link between the replication and cutting of the concatemeric genome, genome packaging, and capsid assembly. We have also performed a phylogenetic analysis of the structural genes common between Podoviridae phages of the C1 and C3 morphotypes. The result shows that the structural genes have coevolved, and that they form two distinct groups linked to their morphotypes. The structural genes of C1 and C3 phages appear to have diverged around 280 million years ago applying a molecular clock calibrated according to the presumed split between the Escherichia - Salmonella genera.	[Mirzaei, Mohammadali Khan; Eriksson, Harald; Haggard-Ljungquist, Elisabeth; Nilsson, Anders S.] Stockholm Univ, Wenner Gren Inst, Dept Mol Biosci, SE-10691 Stockholm, Sweden; [Kasuga, Kie] Karolinska Inst, Dept Oncol Pathol, Sci Life Lab, SE-17121 Solna, Sweden	Stockholm University; Karolinska Institutet	Nilsson, AS (corresponding author), Stockholm Univ, Wenner Gren Inst, Dept Mol Biosci, SE-10691 Stockholm, Sweden.	anders.s.nilsson@su.se	Khan Mirzaei, Mohammadali/ABB-9778-2021; Kasuga, Kie/D-2308-2013	Khan Mirzaei, Mohammadali/0000-0003-2801-4474; Kasuga, Kie/0000-0003-0489-194X	Olle Enqvist foundation	Olle Enqvist foundation	This work was funded by the Olle Enqvist foundation. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACKERMAN.HW, 1974, J VIROL, V13, P706, DOI 10.1128/JVI.13.3.706-711.1974; Ackermann HW, 1996, ARCH VIROL, V141, P209, DOI 10.1007/BF01718394; Ackermann HW, 2001, ARCH VIROL, V146, P843, DOI 10.1007/s007050170120; Biomatters, 2013, GEN 6 1 2; Chopin A, 2007, VIROLOGY, V365, P1, DOI 10.1016/j.virol.2007.03.044; CHUNG YB, 1990, J MOL BIOL, V216, P911, DOI 10.1016/S0022-2836(99)80010-2; Cole C, 2008, NUCLEIC ACIDS RES, V36, pW197, DOI 10.1093/nar/gkn238; Delcher AL, 2007, BIOINFORMATICS, V23, P673, DOI 10.1093/bioinformatics/btm009; Hendrix RW, 2003, CURR OPIN MICROBIOL, V6, P506, DOI 10.1016/j.mib.2003.09.004; Kropinski AM, 2011, ARCH VIROL, V156, P149, DOI 10.1007/s00705-010-0835-5; Lawrence JG, 1998, P NATL ACAD SCI USA, V95, P9413, DOI 10.1073/pnas.95.16.9413; Li YZ, 2012, J VIROL, V86, P13874, DOI 10.1128/JVI.02727-12; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Mahadevan Padmanabhan, 2009, BMC Res Notes, V2, P168, DOI 10.1186/1756-0500-2-168; Matsushita K, 2009, FEMS MICROBIOL LETT, V291, P201, DOI 10.1111/j.1574-6968.2008.01455.x; Molineux IJ, 2006, BACTERIOPHAGES, P277; Nho SW, 2012, J VIROL, V86, P12439, DOI 10.1128/JVI.02141-12; OCHMAN H, 1984, J BACTERIOL, V157, P690, DOI 10.1128/JB.157.2.690-693.1984; Pavlova O, 2012, J MOL BIOL, V416, P389, DOI 10.1016/j.jmb.2012.01.002; Qimron U., 2010, MICROBE MAG, V5, P117; Sambrook J., 2001, MOL CLONING LAB MANU; Savalia D, 2008, J MOL BIOL, V377, P774, DOI 10.1016/j.jmb.2007.12.077; SAXELIN ML, 1979, CAN J MICROBIOL, V25, P1182, DOI 10.1139/m79-183; SAXELIN ML, 1986, APPL ENVIRON MICROB, V52, P771, DOI 10.1128/AEM.52.4.771-777.1986; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Solovjev V, 2011, METAGENOMICITAPP, P61; TAJIMA F, 1993, GENETICS, V135, P599; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Whelan S, 2001, MOL BIOL EVOL, V18, P691, DOI 10.1093/oxfordjournals.molbev.a003851; Wisniewski JR, 2009, NAT METHODS, V6, P359, DOI [10.1038/NMETH.1322, 10.1038/nmeth.1322]; Wommack KE, 2000, MICROBIOL MOL BIOL R, V64, P69, DOI 10.1128/MMBR.64.1.69-114.2000; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	32	25	26	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2014	9	12							e116294	10.1371/journal.pone.0116294	http://dx.doi.org/10.1371/journal.pone.0116294			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UC	25551446	Green Published, gold			2022-12-27	WOS:000347119100128
J	Goncalves-Souza, T; Romero, GQ; Cottenie, K				Goncalves-Souza, Thiago; Romero, Gustavo Q.; Cottenie, Karl			Metacommunity versus Biogeography: A Case Study of Two Groups of Neotropical Vegetation-Dwelling Arthropods	PLOS ONE			English	Article							COMPREHENSIVE FRAMEWORK; ATLANTIC FOREST; DISTANCE DECAY; COMMUNITY; DIVERSITY; HABITAT; CLIMATE; SCALE; DISPERSAL; DETERMINANTS	Biogeography and metacommunity ecology provide two different perspectives on species diversity. Both are spatial in nature but their spatial scales do not necessarily match. With recent boom of metacommunity studies, we see an increasing need for clear discrimination of spatial scales relevant for both perspectives. This discrimination is a necessary prerequisite for improved understanding of ecological phenomena across scales. Here we provide a case study to illustrate some spatial scale-dependent concepts in recent metacommunity studies and identify potential pitfalls. We presented here the diversity patterns of Neotropical lepidopterans and spiders viewed both from metacommunity and biogeographical perspectives. Specifically, we investigated how the relative importance of niche-and dispersal-based processes for community assembly change at two spatial scales: metacommunity scale, i.e. within a locality, and biogeographical scale, i.e. among localities widely scattered along a macroclimatic gradient. As expected, niche-based processes dominated the community assembly at metacommunity scale, while dispersal-based processes played a major role at biogeographical scale for both taxonomical groups. However, we also observed small but significant spatial effects at metacommunity scale and environmental effects at biogeographical scale. We also observed differences in diversity patterns between the two taxonomical groups corresponding to differences in their dispersal modes. Our results thus support the idea of continuity of processes interactively shaping diversity patterns across scales and emphasize the necessity of integration of metacommunity and biogeographical perspectives.	[Goncalves-Souza, Thiago] Univ Estadual Paulista, UNESP, Dept Zool & Bot, Programa Posgrad Biol Anim,IBILCE, Sao Jose Do Rio Preto, SP, Brazil; [Romero, Gustavo Q.] Univ Estadual Campinas, UNICAMP, Inst Biol, Dept Biol Anim, Campinas, SP, Brazil; [Cottenie, Karl] Univ Guelph, Dept Integrat Biol, Guelph, ON N1G 2W1, Canada	Universidade Estadual Paulista; Universidade de Sao Paulo; Universidade Estadual de Campinas; University of Guelph	Goncalves-Souza, T (corresponding author), Univ Estadual Paulista, UNESP, Dept Zool & Bot, Programa Posgrad Biol Anim,IBILCE, Sao Jose Do Rio Preto, SP, Brazil.	tgoncalves.souza@gmail.com	Souza, Thiago Gonçalves/E-3813-2012; Romero, Gustavo Q/N-1896-2019; Romero, Gustavo Q/H-8974-2012	Souza, Thiago Gonçalves/0000-0001-8471-7479; Romero, Gustavo Q/0000-0003-3736-4759; Romero, Gustavo Q/0000-0003-3736-4759; Cottenie, Karl/0000-0001-9498-8483	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [proc. 2008/11530-2, proc. 2010/51636-4]; State University of Campinas (FAEPEX/UNICAMP) [solic. 825/10]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [proc. 309815/2009-6]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); State University of Campinas (FAEPEX/UNICAMP); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	TG-S was supported by a fellowship from the Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP, proc. 2008/11530-2). GQR was supported by research grants from the State University of Campinas (FAEPEX/UNICAMP, solic. 825/10), Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP, proc. 2010/51636-4), and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq, proc. 309815/2009-6). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Astorga A, 2012, GLOBAL ECOL BIOGEOGR, V21, P365, DOI 10.1111/j.1466-8238.2011.00681.x; Bell JR, 2005, B ENTOMOL RES, V95, P69, DOI 10.1079/BER2004350; Borcard D, 2002, ECOL MODEL, V153, P51, DOI 10.1016/S0304-3800(01)00501-4; Borcard D, 2011, USE R, P1, DOI 10.1007/978-1-4419-7976-6; Brown KS, 2000, BIOTROPICA, V32, P934, DOI 10.1646/0006-3606(2000)032[0934:AFBIFL]2.0.CO;2; Carvalho JC, 2011, DIVERS DISTRIB, V17, P225, DOI 10.1111/j.1472-4642.2010.00731.x; Chase JM, 2011, PHILOS T R SOC B, V366, P2351, DOI 10.1098/rstb.2011.0063; Cofre H, 1999, BIOL CONSERV, V88, P53, DOI 10.1016/S0006-3207(98)00090-1; Cornell HV, 2013, OIKOS, V122, P288, DOI 10.1111/j.1600-0706.2012.20691.x; CORNELL HV, 1992, J ANIM ECOL, V61, P1, DOI 10.2307/5503; Cottenie K, 2005, ECOL LETT, V8, P1175, DOI 10.1111/j.1461-0248.2005.00820.x; Currie DJ, 2004, ECOL LETT, V7, P1121, DOI 10.1111/j.1461-0248.2004.00671.x; Assis André M. de, 2004, Braz. J. Bot., V27, P349, DOI 10.1590/S0100-84042004000200014; Declerck SAJ, 2011, ECOGRAPHY, V34, P296, DOI 10.1111/j.1600-0587.2010.06462.x; Dray S, 2012, ECOL MONOGR, V82, P257, DOI 10.1890/11-1183.1; Dray S, 2006, ECOL MODEL, V196, P483, DOI 10.1016/j.ecolmodel.2006.02.015; Dyer LA, 2007, NATURE, V448, P696, DOI 10.1038/nature05884; Dynesius M, 2000, P NATL ACAD SCI USA, V97, P9115, DOI 10.1073/pnas.97.16.9115; Entling MH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045875; Entling W, 2007, GLOBAL ECOL BIOGEOGR, V16, P440, DOI 10.1111/j.1466-8238.2006.00305.x; Goncalves-Souza T, 2011, AUSTRAL ECOL, V36, P476, DOI 10.1111/j.1442-9993.2010.02177.x; Goncalves-Souza T, 2010, J ARACHNOL, V38, P270, DOI 10.1636/P09-58.1; Gravel D, 2006, ECOL LETT, V9, P399, DOI 10.1111/j.1461-0248.2006.00884.x; Hajek M, 2011, J BIOGEOGR, V38, P1683, DOI 10.1111/j.1365-2699.2011.02503.x; Harrison S, 2008, ECOL LETT, V11, P969, DOI 10.1111/j.1461-0248.2008.01210.x; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hillebrand H, 2004, AM NAT, V163, P192, DOI 10.1086/381004; Holt R, 1993, SPECIES DIVERSITY EC; Hortal J, 2011, ECOL LETT, V14, P741, DOI 10.1111/j.1461-0248.2011.01634.x; Hubbell Stephen P., 2001, V32, pi; Jimenez-Valverde A, 2007, ECOL ENTOMOL, V32, P113, DOI 10.1111/j.1365-2311.2006.00848.x; Jocque M, 2010, GLOBAL ECOL BIOGEOGR, V19, P244, DOI 10.1111/j.1466-8238.2009.00510.x; LAWTON JH, 1983, ANNU REV ENTOMOL, V28, P23, DOI 10.1146/annurev.en.28.010183.000323; Leibold MA, 2004, ECOL LETT, V7, P601, DOI 10.1111/j.1461-0248.2004.00608.x; Lenoir J, 2012, GLOBAL ECOL BIOGEOGR, V21, P851, DOI 10.1111/j.1466-8238.2011.00733.x; Logue JB, 2011, TRENDS ECOL EVOL, V26, P482, DOI 10.1016/j.tree.2011.04.009; MacArthur R. H., 1984, GEOGRAPHICAL ECOLOGY; Marquez JC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054580; Mouquet N., 2005, METACOMMUNITIES SPAT, P237; Nekola JC, 1999, J BIOGEOGR, V26, P867, DOI 10.1046/j.1365-2699.1999.00305.x; Ng ISY, 2009, HYDROBIOLOGIA, V619, P133, DOI 10.1007/s10750-008-9605-8; Novotny V, 2002, P ROY SOC B-BIOL SCI, V269, P2337, DOI 10.1098/rspb.2002.2166; Peres-Neto PR, 2006, ECOLOGY, V87, P2614, DOI 10.1890/0012-9658(2006)87[2614:VPOSDM]2.0.CO;2; Purves DW, 2010, J ANIM ECOL, V79, P1215, DOI 10.1111/j.1365-2656.2010.01738.x; Quinn R, 2002, EXPT DESIGN DATA ANA; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Ribeiro MC, 2009, BIOL CONSERV, V142, P1141, DOI 10.1016/j.biocon.2009.02.021; Ricklefs R.E., 1993, J EVOLUTION BIOL, DOI DOI 10.1046/J.1420-9101.1993.6020171.X; RICKLEFS RE, 1987, SCIENCE, V235, P167, DOI 10.1126/science.235.4785.167; Ricklefs RE, 2004, ECOL LETT, V7, P1, DOI 10.1046/j.1461-0248.2003.00554.x; ROBINSON JV, 1981, ECOLOGY, V62, P73, DOI 10.2307/1936670; Samu F, 1999, J ARACHNOL, V27, P325; Scarano FR, 2002, ANN BOT-LONDON, V90, P517, DOI 10.1093/aob/mcf189; Schaffers AP, 2008, ECOLOGY, V89, P782, DOI 10.1890/07-0361.1; Summerville KS, 2003, ECOL ENTOMOL, V28, P747, DOI 10.1111/j.1365-2311.2003.00561.x; Thome MTC, 2010, MOL PHYLOGENET EVOL, V55, P1018, DOI 10.1016/j.ympev.2010.02.003; Vellend M, 2010, Q REV BIOL, V85, P183, DOI 10.1086/652373; von Humboldt A., 1807, ESSAY GEOGRAPHY PLAN; Weiher E, 2011, PHILOS T R SOC B, V366, P2403, DOI 10.1098/rstb.2011.0056; Willis J.C., 1922, AGE AREA STUDY GEOGR; World Wide Fund for Nature WWF, 2001, ATL COAST REST NT010	61	22	23	3	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2014	9	12							e115137	10.1371/journal.pone.0115137	http://dx.doi.org/10.1371/journal.pone.0115137			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX6YH	25549332	Green Published, Green Submitted, gold			2022-12-27	WOS:000347063500011
J	Wang, BH; Song, N; Yu, T; Zhou, LY; Zhang, HL; Duan, L; He, WS; Zhu, YH; Bai, YF; Zhu, MA				Wang, Baohua; Song, Ning; Yu, Tong; Zhou, Lianya; Zhang, Helin; Duan, Lin; He, Wenshu; Zhu, Yihua; Bai, Yunfei; Zhu, Miao			Expression of Tumor Necrosis Factor-Alpha-Mediated Genes Predicts Recurrence-Free Survival in Lung Cancer	PLOS ONE			English	Article							TNF-ALPHA; CARCINOMA; RECEPTOR; TRANSACTIVATION; IDENTIFICATION; METASTASIS; PROMOTION; BIOMARKER; CYTOKINE; GROWTH	In this study, we conducted a meta-analysis on high-throughput gene expression data to identify TNF-alpha-mediated genes implicated in lung cancer. We first investigated the gene expression profiles of two independent TNF-alpha/TNFR KO murine models. The EGF receptor signaling pathway was the top pathway associated with genes mediated by TNF-alpha. After matching the TNF-alpha-mediated mouse genes to their human orthologs, we compared the expression patterns of the TNF-alpha-mediated genes in normal and tumor lung tissues obtained from humans. Based on the TNF-alpha-mediated genes that were dysregulated in lung tumors, we developed a prognostic gene signature that effectively predicted recurrence-free survival in lung cancer in two validation cohorts. Resampling tests suggested that the prognostic power of the gene signature was not by chance, and multivariate analysis suggested that this gene signature was independent of the traditional clinical factors and enhanced the identification of lung cancer patients at greater risk for recurrence.	[Wang, Baohua; Zhou, Lianya; Zhang, Helin] HeBei Med Univ, Hosp 2, Dept Thorac Surg, Shijiazhuang 050000, Peoples R China; [Song, Ning; Duan, Lin; He, Wenshu] HeBei Med Univ, Hosp 2, Dept Resp Med, Shijiazhuang 050000, Peoples R China; [Yu, Tong; Zhu, Miao] Nanjing Decode Genom Biotechnol Co Ltd, Nanjing 210019, Jiangsu, Peoples R China; [Zhu, Yihua; Bai, Yunfei] Southeast Univ, Sch Biol Sci & Med Engn, Nanjing 210096, Jiangsu, Peoples R China; [Zhu, Yihua] Nanjing Agr Univ, Coll Informat Sci & Technol, Nanjing 210095, Jiangsu, Peoples R China	Hebei Medical University; Hebei Medical University; Southeast University - China; Nanjing Agricultural University	Wang, BH (corresponding author), HeBei Med Univ, Hosp 2, Dept Thorac Surg, Shijiazhuang 050000, Peoples R China.	xwkbh1972@sina.com; zm@decodegenomics.com			National Natural Science Foundation of China [61271054]; Fundamental Research Funds for the Central Universities [KYZ201320]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by project 61271054 of the National Natural Science Foundation of China and was also supported by project KYZ201320 of the Fundamental Research Funds for the Central Universities. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Argast GM, 2004, J BIOL CHEM, V279, P34530, DOI 10.1074/jbc.M405703200; Arnott CH, 2002, ONCOGENE, V21, P4728, DOI 10.1038/sj.onc.1205588; Arnott CH, 2004, ONCOGENE, V23, P1902, DOI 10.1038/sj.onc.1207317; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Balkwill F, 2009, NAT REV CANCER, V9, P361, DOI 10.1038/nrc2628; Botling J, 2013, CLIN CANCER RES, V19, P194, DOI 10.1158/1078-0432.CCR-12-1139; Bradley JR, 2008, J PATHOL, V214, P149, DOI 10.1002/path.2287; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Huang B, 2010, INT J MOL MED, V25, P687, DOI 10.3892/ijmm_00000392; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Ko JH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086569; Ko JH, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-106; Koscielny S, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000313; Kulbe H, 2007, CANCER RES, V67, P585, DOI 10.1158/0008-5472.CAN-06-2941; Lee CW, 2007, AM J PHYSIOL-LUNG C, V292, pL799, DOI 10.1152/ajplung.00311.2006; Lee ES, 2008, CLIN CANCER RES, V14, P7397, DOI 10.1158/1078-0432.CCR-07-4937; Li AM, 2013, BIOCHEM BIOPH RES CO, V436, P486, DOI 10.1016/j.bbrc.2013.05.131; Lu TP, 2010, CANCER EPIDEM BIOMAR, V19, P2590, DOI 10.1158/1055-9965.EPI-10-0332; Mi HY, 2013, NUCLEIC ACIDS RES, V41, pD377, DOI 10.1093/nar/gks1118; Murray J, 1997, BLOOD, V90, P2772, DOI 10.1182/blood.V90.7.2772.2772_2772_2783; Obama K, 2006, CLIN CANCER RES, V12, P70, DOI 10.1158/1078-0432.CCR-05-0588; Okayama H, 2012, CANCER RES, V72, P100, DOI 10.1158/0008-5472.CAN-11-1403; Pitroda SP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046104; Prevost-Blondel A, 2000, J IMMUNOL, V164, P3645, DOI 10.4049/jimmunol.164.7.3645; Rink L, 1996, INT ARCH ALLERGY IMM, V111, P199, DOI 10.1159/000237369; Sanchez-Palencia A, 2011, INT J CANCER, V129, P355, DOI 10.1002/ijc.25704; Scott KA, 2003, MOL CANCER THER, V2, P445; Smyth MJ, 2004, IMMUNOL REV, V202, P275, DOI 10.1111/j.0105-2896.2004.00199.x; TRACEY KJ, 1994, ANNU REV MED, V45, P491, DOI 10.1146/annurev.med.45.1.491; Tse BC, 2012, PROSTATE CANCER, V2012, DOI 10.1155/2012/128965; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Venet D, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002240; Wang PP, 2014, MOL CELL, V54, P378, DOI 10.1016/j.molcel.2014.03.007; WATANABE N, 1988, IMMUNOPHARM IMMUNOT, V10, P109, DOI 10.3109/08923978809014405; WATANABE N, 1988, CANCER RES, V48, P2179; Waters JP, 2013, J PATHOL, V230, P241, DOI 10.1002/path.4188; Westbrook L, 2007, CANCER RES, V67, P11393, DOI 10.1158/0008-5472.CAN-06-4173; Wu ZJ, 2004, J AM STAT ASSOC, V99, P909, DOI 10.1198/016214504000000683; Yamaoka T, 2008, P NATL ACAD SCI USA, V105, P11772, DOI 10.1073/pnas.0801463105; Yoo J, 2012, AM J PHYSIOL-GASTR L, V302, pG805, DOI 10.1152/ajpgi.00522.2011; Zhang HT, 2007, J CLIN INVEST, V117, P2051, DOI 10.1172/JCI32278; Zhou T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094325; Zhou ZJ, 2014, CANCER RES, V74, P2750, DOI 10.1158/0008-5472.CAN-13-2509	43	9	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2014	9	12							e115945	10.1371/journal.pone.0115945	http://dx.doi.org/10.1371/journal.pone.0115945			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX6YH	25548907	Green Submitted, Green Published, gold			2022-12-27	WOS:000347063500043
J	Ali, S; Magne, M; Chen, SY; Cote, O; Stare, BG; Obradovic, N; Jamshaid, L; Wang, XH; Belair, G; Moffett, P				Ali, Shawkat; Magne, Maxime; Chen, Shiyan; Cote, Olivier; Stare, Barbara Geric; Obradovic, Natasa; Jamshaid, Lubna; Wang, Xiaohong; Belair, Guy; Moffett, Peter			Analysis of Putative Apoplastic Effectors from the Nematode, Globodera rostochiensis, and Identification of an Expansin-Like Protein That Can Induce and Suppress Host Defenses	PLOS ONE			English	Article							DISEASE RESISTANCE; VIRUS-RESISTANCE; PARASITISM FACTOR; VARIABLE DOMAIN; PECTATE LYASE; COAT PROTEIN; PLANT; GENE; VIRULENCE; BINDING	The potato cyst nematode, Globodera rostochiensis, is an important pest of potato. Like other pathogens, plant parasitic nematodes are presumed to employ effector proteins, secreted into the apoplast as well as the host cytoplasm, to alter plant cellular functions and successfully infect their hosts. We have generated a library of ORFs encoding putative G. rostochiensis putative apoplastic effectors in vectors for expression in planta. These clones were assessed for morphological and developmental effects on plants as well as their ability to induce or suppress plant defenses. Several CLAVATA3/ESR-like proteins induced developmental phenotypes, whereas predicted cell wall-modifying proteins induced necrosis and chlorosis, consistent with roles in cell fate alteration and tissue invasion, respectively. When directed to the apoplast with a signal peptide, two effectors, an ubiquitin extension protein (GrUBCEP12) and an expansin-like protein (GrEXPB2), suppressed defense responses including NB-LRR signaling induced in the cytoplasm. GrEXPB2 also elicited defense response in species-and sequence-specific manner. Our results are consistent with the scenario whereby potato cyst nematodes secrete effectors that modulate host cell fate and metabolism as well as modifying host cell walls. Furthermore, we show a novel role for an apoplastic expansin-like protein in suppressing intra-cellular defense responses.	[Ali, Shawkat; Magne, Maxime; Cote, Olivier; Obradovic, Natasa; Jamshaid, Lubna; Moffett, Peter] Univ Sherbrooke, Dept Biol, Sherbrooke, PQ J1K 2R1, Canada; [Ali, Shawkat; Belair, Guy] Agr & Agri Food Canada, Hort R&D Ctr, St Jean, PQ, Canada; [Chen, Shiyan; Wang, Xiaohong] Cornell Univ, Dept Plant Pathol & Plant Microbe Biol, Ithaca, NY 14853 USA; [Stare, Barbara Geric] Agr Inst Slovenia, Dept Plant Protect, SI-1000 Ljubljana, Slovenia; [Wang, Xiaohong] USDA ARS, Robert W Holley Ctr Agr & Hlth, Ithaca, NY 14853 USA	University of Sherbrooke; Agriculture & Agri Food Canada; Cornell University; Agricultural Institute Slovenia; United States Department of Agriculture (USDA)	Moffett, P (corresponding author), Univ Sherbrooke, Dept Biol, 2500 Blvd Univ Sherbrooke, Sherbrooke, PQ J1K 2R1, Canada.	peter.moffett@usherbrooke.ca	Ali, Shawkat/AAN-2902-2020	Moffett, Peter/0000-0003-0678-4531; Ali, Shawkat/0000-0003-3282-3186; Geric Stare, Barbara/0000-0002-2334-8830	Agriculture and Agri-food Canada Growing Canadian Agri-Innovations Program; National Sciences and Engineering Research Council (NSERC); US Department of Agriculture, Agricultural Research Service; visiting fellowships in government laboratories program (NSERC); Fonds de Recherche Quebecois Nature et Technologie (FRQNT); ARS [ARS-0423113] Funding Source: Federal RePORTER	Agriculture and Agri-food Canada Growing Canadian Agri-Innovations Program(Agriculture & Agri Food Canada); National Sciences and Engineering Research Council (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); US Department of Agriculture, Agricultural Research Service(United States Department of Agriculture (USDA)USDA Agricultural Research Service); visiting fellowships in government laboratories program (NSERC); Fonds de Recherche Quebecois Nature et Technologie (FRQNT); ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	This work was supported by funds from the Agriculture and Agri-food Canada Growing Canadian Agri-Innovations Program to G.B. and P.M., a discovery grant from the National Sciences and Engineering Research Council (NSERC) to P.M., and funds from the US Department of Agriculture, Agricultural Research Service to X.W.S.A. was supported by the visiting fellowships in government laboratories program (NSERC) and by a postdoctoral fellowship from the Fonds de Recherche Quebecois Nature et Technologie (FRQNT), and this work benefited from links established under CropSustaIn FP7 Project.	Abad P, 2008, NAT BIOTECHNOL, V26, P909, DOI 10.1038/nbt.1482; Ali S, 2011, CAN J PLANT PATHOL, V33, P425, DOI 10.1080/07060661.2011.625448; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Bendahmane A, 1995, PLANT J, V8, P933, DOI 10.1046/j.1365-313X.1995.8060933.x; Bendahmane A, 2002, PLANT J, V32, P195, DOI 10.1046/j.1365-313X.2002.01413.x; Bendahmane A, 1999, PLANT CELL, V11, P781, DOI 10.1105/tpc.11.5.781; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Bhattacharjee S, 2009, PLANT J, V58, P940, DOI 10.1111/j.1365-313X.2009.03832.x; Bohlmann H, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00089; Boucher AC, 2013, MOL PHYLOGENET EVOL, V69, P75, DOI 10.1016/j.ympev.2013.05.020; Brotman Y, 2008, PLANT PHYSIOL, V147, P779, DOI 10.1104/pp.108.116293; Poch HLC, 2006, PLANT CELL ENVIRON, V29, P1372, DOI 10.1111/j.1365-3040.2006.01517.x; Carpentier J, 2012, MOL PLANT PATHOL, V13, P546, DOI 10.1111/j.1364-3703.2011.00769.x; Chisholm ST, 2006, CELL, V124, P803, DOI 10.1016/j.cell.2006.02.008; Chronis D, 2013, PLANT J, V74, P185, DOI 10.1111/tpj.12125; Collier SM, 2009, TRENDS PLANT SCI, V14, P521, DOI 10.1016/j.tplants.2009.08.001; Cotton JA, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-3-r43; Dangl JL, 2013, SCIENCE, V341, P746, DOI 10.1126/science.1236011; Davis EL, 2000, ANNU REV PHYTOPATHOL, V38, P365, DOI 10.1146/annurev.phyto.38.1.365; Davis EL, 2008, CURR OPIN PLANT BIOL, V11, P360, DOI 10.1016/j.pbi.2008.04.003; Dodds PN, 2010, NAT REV GENET, V11, P539, DOI 10.1038/nrg2812; Guo YF, 2011, PLANT PHYSIOL, V157, P476, DOI 10.1104/pp.111.180554; Haegeman A, 2012, GENE, V492, P19, DOI 10.1016/j.gene.2011.10.040; Haegeman A, 2009, MOL BIOCHEM PARASIT, V167, P32, DOI 10.1016/j.molbiopara.2009.04.004; Hemetsberger C, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002684; Igarashi D, 2012, PLANT J, V71, P194, DOI 10.1111/j.1365-313X.2012.04950.x; Jaouannet M, 2013, MOL PLANT MICROBE IN, V26, P97, DOI 10.1094/MPMI-05-12-0130-R; Kanneganti TD, 2006, MOL PLANT MICROBE IN, V19, P854, DOI 10.1094/MPMI-19-0854; KELEMU S, 1993, APPL ENVIRON MICROB, V59, P1756, DOI 10.1128/AEM.59.6.1756-1761.1993; Kikuchi T, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002219; Kudla U, 2007, MOL PLANT PATHOL, V8, P293, DOI 10.1111/J.1364-3703.2007.00394.X; Laine MJ, 2000, PHYSIOL MOL PLANT P, V57, P221, DOI 10.1006/pmpp.2000.0301; Laurie JD, 2012, PLANT CELL, V24, P1733, DOI 10.1105/tpc.112.097261; Lozano-Torres JL, 2012, P NATL ACAD SCI USA, V109, P10119, DOI 10.1073/pnas.1202867109; Lu SW, 2008, MOL BIOCHEM PARASIT, V162, P1, DOI 10.1016/j.molbiopara.2008.06.002; Lu SW, 2009, MOL PLANT MICROBE IN, V22, P1128, DOI 10.1094/MPMI-22-9-1128; Macho AP, 2014, MOL CELL, V54, P263, DOI 10.1016/j.molcel.2014.03.028; Mitchum MG, 2013, NEW PHYTOL, V199, P879, DOI 10.1111/nph.12323; Moffett P, 2011, METHODS MOL BIOL, V712, P9, DOI 10.1007/978-1-61737-998-7_2; Peng H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069579; Postma WJ, 2012, PLANT PHYSIOL, V160, P944, DOI 10.1104/pp.112.200188; Qin L, 2004, NATURE, V427, P30, DOI 10.1038/427030a; Qu F, 2003, J VIROL, V77, P511, DOI 10.1128/JVI.77.1.511-522.2003; Qutob D, 2006, TRENDS MICROBIOL, V14, P470, DOI 10.1016/j.tim.2006.09.004; Rairdan GJ, 2008, PLANT CELL, V20, P739, DOI 10.1105/tpc.107.056036; Rairdan GJ, 2006, PLANT CELL, V18, P2082, DOI 10.1105/tpc.106.042747; Rooney HCE, 2005, SCIENCE, V308, P1783, DOI 10.1126/science.1111404; Sacco MA, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000564; Sainsbury F, 2009, PLANT BIOTECHNOL J, V7, P682, DOI 10.1111/j.1467-7652.2009.00434.x; Sampedro J, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-12-242; Shabab M, 2008, PLANT CELL, V20, P1169, DOI 10.1105/tpc.107.056325; Song J, 2009, P NATL ACAD SCI USA, V106, P1654, DOI 10.1073/pnas.0809201106; Stam R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059517; Stare Barbara Geric, 2013, Acta Biologica Slovenica, V56, P75; Stare BG, 2012, PHYSIOL MOL PLANT P, V79, P49, DOI 10.1016/j.pmpp.2012.04.002; Tai TH, 1999, P NATL ACAD SCI USA, V96, P14153, DOI 10.1073/pnas.96.24.14153; Takken FLW, 2000, PLANT J, V24, P275, DOI 10.1046/j.1365-313x.2000.00866.x; Tian MY, 2007, PLANT PHYSIOL, V143, P364, DOI 10.1104/pp.106.090050; Tomalova I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038656; van den Burg HA, 2006, MOL PLANT MICROBE IN, V19, P1420, DOI 10.1094/MPMI-19-1420; van der Hoorn RAL, 2008, PLANT CELL, V20, P2009, DOI 10.1105/tpc.108.060194; van Esse HP, 2008, PLANT CELL, V20, P1948, DOI 10.1105/tpc.108.059394; van Esse HP, 2007, MOL PLANT MICROBE IN, V20, P1092, DOI 10.1094/MPMI-20-9-1092; Wang JY, 2010, PLANT SIGNAL BEHAV, V5, P1633, DOI 10.4161/psb.5.12.13774; Wang JY, 2011, MOL PLANT PATHOL, V12, P177, DOI 10.1111/j.1364-3703.2010.00660.x; Wang JY, 2010, NEW PHYTOL, V187, P1003, DOI 10.1111/j.1469-8137.2010.03300.x; Wang XH, 2001, MOL PLANT MICROBE IN, V14, P536, DOI 10.1094/MPMI.2001.14.4.536; Win J., 2012, COLD SPRING HARB SYM, V77, P235, DOI [10.1101/sqb.2012.77.015933, DOI 10.1101/SQB.2012.77.015933]; Yennawar NH, 2006, P NATL ACAD SCI USA, V103, P14664, DOI 10.1073/pnas.0605979103	69	43	46	1	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2015	10	1							e0115042	10.1371/journal.pone.0115042	http://dx.doi.org/10.1371/journal.pone.0115042			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ4PR	25606855	Green Published, Green Submitted, gold			2022-12-27	WOS:000348205300009
J	Copik, AJ; Baldys, A; Nguyen, K; Sahdeo, S; Ho, H; Kosaka, A; Dietrich, PJ; Fitch, B; Raymond, JR; Ford, APDW; Button, D; Milla, ME				Copik, Alicja J.; Baldys, Aleksander; Nguyen, Khanh; Sahdeo, Sunil; Ho, Hoangdung; Kosaka, Alan; Dietrich, Paul J.; Fitch, Bill; Raymond, John R.; Ford, Anthony P. D. W.; Button, Donald; Milla, Marcos E.			Isoproterenol Acts as a Biased Agonist of the Alpha-1A-Adrenoceptor that Selectively Activates the MAPK/ERK Pathway	PLOS ONE			English	Article							PROTEIN-KINASE PATHWAYS; PAROTID ACINAR-CELLS; ALPHA(1)-ADRENERGIC RECEPTOR SUBTYPES; BETA-ADRENERGIC-RECEPTORS; TRANSFECTED PC12 CELLS; BETA(2)-ADRENERGIC RECEPTOR; ALPHA(1A)-ADRENERGIC RECEPTORS; INTERNALIZATION PROPERTIES; SYMPATHOMIMETIC AMINES; FUNCTIONAL SELECTIVITY	The alpha(1A)-AR is thought to couple predominantly to the G alpha(q)/PLC pathway and lead to phosphoinositide hydrolysis and calcium mobilization, although certain agonists acting at this receptor have been reported to trigger activation of arachidonic acid formation and MAPK pathways. For several G protein-coupled receptors (GPCRs) agonists can manifest a bias for activation of particular effector signaling output, i.e. not all agonists of a given GPCR generate responses through utilization of the same signaling cascade(s). Previous work with G alpha(q) coupling-defective variants of alpha(1A)-AR, as well as a combination of Ca2+ channel blockers, uncovered cross-talk between alpha(1A)-AR and beta(2)-AR that leads to potentiation of a G alpha(q)-independent signaling cascade in response to alpha(1A)-AR activation. We hypothesized that molecules exist that act as biased agonists to selectively activate this pathway. In this report, isoproterenol (Iso), typically viewed as beta-AR-selective agonist, was examined with respect to activation of alpha(1A)-AR. alpha(1A)-AR selective antagonists were used to specifically block Iso evoked signaling in different cellular backgrounds and confirm its action at alpha(1A)-AR. Iso induced signaling at alpha(1A)-AR was further interrogated by probing steps along the G alpha(q)/PLC, G alpha(s) and MAPK/ERK pathways. In HEK-293/EBNA cells transiently transduced with alpha(1A)-AR, and CHO_alpha(1A)-AR stable cells, Iso evoked low potency ERK activity as well as Ca2+ mobilization that could be blocked by alpha(1A)-AR selective antagonists. The kinetics of Iso induced Ca2+ transients differed from typical G alpha(q)-mediated Ca2+ mobilization, lacking both the fast IP3R mediated response and the sustained phase of Ca2+ re-entry. Moreover, no inositol phosphate (IP) accumulation could be detected in either cell line after stimulation with Iso, but activation was accompanied by receptor internalization. Data are presented that indicate that Iso represents a novel type of alpha(1A)-AR partial agonist with signaling bias toward MAPK/ERK signaling cascade that is likely independent of coupling to G alpha(q).	[Copik, Alicja J.; Sahdeo, Sunil; Ford, Anthony P. D. W.; Button, Donald; Milla, Marcos E.] Roche Palo Alto LLC, Biochem Pharmacol Inflammat Discovery, Palo Alto, CA 94304 USA; [Nguyen, Khanh; Ho, Hoangdung; Kosaka, Alan; Dietrich, Paul J.; Fitch, Bill] Roche Palo Alto LLC, Discovery Technol, Palo Alto, CA 94304 USA; [Baldys, Aleksander; Raymond, John R.] Med Univ S Carolina, Dept Med, Div Nephrol, Charleston, SC 29425 USA; [Baldys, Aleksander; Raymond, John R.] Ralph H Johnson Vet Affairs Med Ctr, Med & Res Serv, Charleston, SC 29425 USA	Roche Holding; Roche Holding; Medical University of South Carolina; US Department of Veterans Affairs; Veterans Health Administration (VHA); Ralph H Johnson VA Medical Center	Milla, ME (corresponding author), Roche Palo Alto LLC, Biochem Pharmacol Inflammat Discovery, 3401 Hillview Dr, Palo Alto, CA 94304 USA.	mmilla22@its.jnj.com		Copik, Alicja/0000-0003-4109-5539	Department of Veterans Affairs Merit and Research Enhancement Award Program grants; National Institutes of Health [DK052448, GM063909]; Medical University of South Carolina Division of Nephrology, and Dialysis Clinics, Inc.; Roche Palo Alto LLC; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK052448, R01DK052448] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063909] Funding Source: NIH RePORTER	Department of Veterans Affairs Merit and Research Enhancement Award Program grants; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical University of South Carolina Division of Nephrology, and Dialysis Clinics, Inc.; Roche Palo Alto LLC; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Most of this work was performed at Roche Palo Alto LLC. Immunofluorescence microscopy studies were performed with support from the Department of Veterans Affairs Merit and Research Enhancement Award Program grants, by National Institutes of Health Grants DK052448 and GM063909, by laboratory endowment jointly supported by the Medical University of South Carolina Division of Nephrology, and Dialysis Clinics, Inc. (to JRR). Roche Palo Alto LLC, the funder, provided support in the form of salaries for authors AJC, KN, SS, HH, AK, PJD, BF, APDWF, DB and MEM, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	AHLQUIST RP, 1948, AM J PHYSIOL, V153, P586, DOI 10.1152/ajplegacy.1948.153.3.586; ARCH JRS, 1984, NATURE, V309, P163, DOI 10.1038/309163a0; BERTHELSEN S, 1977, LIFE SCI, V21, P595, DOI 10.1016/0024-3205(77)90066-2; Berts A, 1999, MOL PHARMACOL, V55, P296, DOI 10.1124/mol.55.2.296; BORDA ES, 1981, PHARMACOL RES COMMUN, V13, P487, DOI 10.1016/S0031-6989(81)80075-6; BRISTOL JA, 1994, TRENDS ENDOCRIN MET, V5, P402, DOI 10.1016/1043-2760(95)92522-K; BYLUND DB, 1992, MOL PHARMACOL, V42, P1; Chalothorn D, 2002, MOL PHARMACOL, V61, P1008, DOI 10.1124/mol.61.5.1008; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; Clapham DE, 2007, CELL, V131, P1047, DOI 10.1016/j.cell.2007.11.028; Copik AJ, 2009, MOL PHARMACOL, V75, P713, DOI 10.1124/mol.108.050765; Daaka Y, 1997, NATURE, V390, P88, DOI 10.1038/36362; DAngelo DD, 1997, P NATL ACAD SCI USA, V94, P8121, DOI 10.1073/pnas.94.15.8121; DeArcangelis V, 2008, MOL PHARM; Del Carmine R, 2002, BRIT J PHARMACOL, V135, P1715, DOI 10.1038/sj.bjp.0704622; DOREVITCH N, 1968, ARCH INT PHARMACOD T, V174, P98; FLEISCH JH, 1970, CIRC RES, V26, P151, DOI 10.1161/01.RES.26.2.151; FORD APDW, 1994, TRENDS PHARMACOL SCI, V15, P167, DOI 10.1016/0165-6147(94)90136-8; Ford APDW, 1997, BRIT J PHARMACOL, V121, P1127, DOI 10.1038/sj.bjp.0701207; FURCHGOTT RF, 1959, PHARMACOL REV, V11, P429; FURCHGOTT RF, 1953, J PHARMACOL EXP THER, V108, P129; Galandrin S, 2008, MOL PHARMACOL, V74, P162, DOI 10.1124/mol.107.043893; Galandrin S, 2006, MOL PHARMACOL, V70, P1575, DOI 10.1124/mol.106.026716; GIUDICELLI R, 1967, CR SOC BIOL, V161, P284; Grisanti LA, 2014, J MOL CELL CARDIOL, V72, P39, DOI 10.1016/j.yjmcc.2014.02.009; Guimaraes S, 2001, PHARMACOL REV, V53, P319; Hilal-Dandan R, 2000, J MOL CELL CARDIOL, V32, P1211, DOI 10.1006/jmcc.2000.1156; Hoffmann C, 2008, BRIT J PHARMACOL, V153, pS358, DOI 10.1038/sj.bjp.0707615; Hoffmann C, 2004, N-S ARCH PHARMACOL, V369, P151, DOI 10.1007/s00210-003-0860-y; HORN VJ, 1988, J BIOL CHEM, V263, P12454; Huang Y, 2007, CIRCULATION, V115, P763, DOI 10.1161/CIRCULATIONAHA.106.664862; Iwai-Kanai E, 1999, CIRCULATION, V100, P305, DOI 10.1161/01.CIR.100.3.305; KENAKIN T, 1995, TRENDS PHARMACOL SCI, V16, P232, DOI 10.1016/S0165-6147(00)89032-X; LANDS AM, 1967, NATURE, V214, P597, DOI 10.1038/214597a0; LANGER SZ, 1974, BIOCHEM PHARMACOL, V23, P1793, DOI 10.1016/0006-2952(74)90187-7; Lee D, 2003, J PHARMACOL EXP THER, V306, P471, DOI 10.1124/jpet.103.050500; Leftowitz RJ, 2005, SCIENCE, V308, P512, DOI 10.1126/science.1109237; Liu F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021520; Liu XD, 2009, RAPID COMMUN MASS SP, V23, P705, DOI 10.1002/rcm.3923; Lohse MJ, 2008, BRIT J PHARMACOL, V153, pS125, DOI 10.1038/sj.bjp.0707656; Mailman RB, 2007, TRENDS PHARMACOL SCI, V28, P390, DOI 10.1016/j.tips.2007.06.002; MINNEMAN KP, 1988, PHARMACOL REV, V40, P87; Morris DP, 2008, J BIOL CHEM, V283, P2973, DOI 10.1074/jbc.M705795200; Morris DP, 2004, MOL PHARMACOL, V66, P843, DOI 10.1124/mol.104.000430; Noma T, 2007, J CLIN INVEST, V117, P2445, DOI 10.1172/JCI31901; O'Connell TD, 2006, J CLIN INVEST, V116, P1005, DOI 10.1172/JCI22811; Oganesian A, 2011, P NATL ACAD SCI USA, V108, P19796, DOI 10.1073/pnas.1116271108; Perez DM, 2011, J RECEPT SIG TRANSD, V31, P98, DOI 10.3109/10799893.2010.550008; Perez DM., 2005, ADRENERGIC RECEPTORS; Perez-Aso M, 2013, BBA-MOL CELL RES, V1833, P2322, DOI 10.1016/j.bbamcr.2013.06.013; Sabri A, 2000, CIRC RES, V86, P1047, DOI 10.1161/01.RES.86.10.1047; Sakata Y, 1998, CIRCULATION, V97, P1488; Simmons MA, 2005, MOL INTERV, V5, P154, DOI 10.1124/mi.5.3.4; Simpson PC, 2011, J MOL CELL CARDIOL, V51, P435, DOI 10.1016/j.yjmcc.2011.08.005; Stanasila L, 2008, MOL PHARMACOL, V74, P562, DOI 10.1124/mol.107.043422; Sun YT, 2007, EMBO J, V26, P53, DOI 10.1038/sj.emboj.7601502; SUTTER MC, 1965, BRIT J PHARM CHEMOTH, V24, P742, DOI 10.1111/j.1476-5381.1965.tb01630.x; TAKEMURA H, 1985, BIOCHEM BIOPH RES CO, V131, P1048, DOI 10.1016/0006-291X(85)90196-2; TANIMURA A, 1990, BIOCHIM BIOPHYS ACTA, V1055, P273, DOI 10.1016/0167-4889(90)90043-D; Tojyo Y, 1998, EUR J PHARMACOL, V360, P73, DOI 10.1016/S0014-2999(98)00651-7; TURLAPATY PDMV, 1975, J PHARMACOL EXP THER, V192, P372; Violin JD, 2008, J BIOL CHEM, V283, P2949, DOI 10.1074/jbc.M707009200; WALZ DT, 1960, J PHARMACOL EXP THER, V129, P200; Waugh DJJ, 1999, J PHARMACOL EXP THER, V291, P1164; Williams NG, 1998, J BIOL CHEM, V273, P24624, DOI 10.1074/jbc.273.38.24624; Williams TJ, 1999, BRIT J PHARMACOL, V127, P252, DOI 10.1038/sj.bjp.0702541; Zhang XY, 2013, CIRC RES, V112, P498, DOI 10.1161/CIRCRESAHA.112.273896; Zhong HY, 1999, J NEUROCHEM, V72, P2388, DOI 10.1046/j.1471-4159.1999.0722388.x; Zou YZ, 1999, J BIOL CHEM, V274, P9760, DOI 10.1074/jbc.274.14.9760	69	19	19	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2015	10	1							e0115701	10.1371/journal.pone.0115701	http://dx.doi.org/10.1371/journal.pone.0115701			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ4PR	25606852	Green Submitted, gold, Green Published			2022-12-27	WOS:000348205300018
J	Gale, SD; Erickson, LD; Brown, BL; Hedges, DW				Gale, Shawn D.; Erickson, Lance D.; Brown, Bruce L.; Hedges, Dawson W.			Interaction between Helicobacter pylori and Latent Toxoplasmosis and Demographic Variables on Cognitive Function in Young to Middle-Aged Adults	PLOS ONE			English	Article							GONDII INFECTION; HEALTH; ASSOCIATION; DEFICIENCY; PERFORMANCE; GASTRITIS; DISEASE; IRON	Helicobacter pylori and latent toxoplasmosis are widespread diseases that have been associated with cognitive deficits and Alzheimer's disease. We sought to determine whether interactions between Helicobacter pylori and latent toxoplasmosis, age, race-ethnicity, educational attainment, economic status, and general health predict cognitive function in young and middle-aged adults. To do so, we used multivariable regression and multivariate models to analyze data obtained from the United States' National Health and Nutrition Examination Survey from the Centers for Disease Control and Prevention, which can be weighted to represent the US population. In this sample, we found that 31.6 percent of women and 36.2 percent of men of the overall sample had IgG Antibodies against Helicobacter pylori, although the seroprevalence of Helicobacter pylori varied with sociodemographic variables. There were no main effects for Helicobacter pylori or latent toxoplasmosis for any of the cognitive measures in models adjusting for age, sex, race-ethnicity, educational attainment, economic standing, and self-rated health predicting cognitive function. However, interactions between Helicobacter pylori and race-ethnicity, educational attainment, latent toxoplasmosis in the fully adjusted models predicted cognitive function. People seropositive for both Helicobacter pylori and latent toxoplasmosis - both of which appear to be common in the general population - appear to be more susceptible to cognitive deficits than are people seropositive for either Helicobacter pylori and or latent toxoplasmosis alone, suggesting a synergistic effect between these two infectious diseases on cognition in young to middle-aged adults.	[Gale, Shawn D.; Brown, Bruce L.; Hedges, Dawson W.] Brigham Young Univ, Dept Psychol, Provo, UT 84602 USA; [Gale, Shawn D.; Hedges, Dawson W.] Brigham Young Univ, Neurosci Ctr, Provo, UT 84602 USA; [Erickson, Lance D.] Brigham Young Univ, Dept Sociol, Provo, UT 84602 USA	Brigham Young University; Brigham Young University; Brigham Young University	Gale, SD (corresponding author), Brigham Young Univ, Dept Psychol, Provo, UT 84602 USA.	shawn_gale@byu.edu	Gale, Shawn/M-3144-2013	Gale, Shawn/0000-0002-8989-0964; Brown, Bruce L./0000-0002-5952-6475				Aiello AE, 2006, J AM GERIATR SOC, V54, P1046, DOI 10.1111/j.1532-5415.2006.00796.x; BAKER EL, 1985, NEUROBEH TOXICOL TER, V7, P369; Berenreiterova M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028925; Beydoun MA, 2013, PSYCHOSOM MED, V75, P486, DOI 10.1097/PSY.0b013e31829108c3; BLASER MJ, 1995, CANCER RES, V55, P2111; Brown B. L., 2012, MULTIVARIATE ANAL BI; Cardenas VM, 2006, AM J EPIDEMIOL, V163, P127, DOI 10.1093/aje/kwj018; [Centers for Disease Control and Prevention (CDC) NCfHS Services USDoHaH], 2012, SERV USDOHAH; Chen Y, 2012, J INFECT DIS, V205, P1195, DOI 10.1093/infdis/jis106; Ellawanda F, 2013, EPIDEMIOL REV, V35, P161, DOI 10.1093/epirev/mxs007; Flegr J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090203; Gale SD, 2015, PARASITOLOGY, V142, P557, DOI 10.1017/S0031182014001577; Gunter E.W., 1996, LAB METHODS USED THI, P1988; Havlicek J, 2001, PARASITOLOGY, V122, P515, DOI 10.1017/S0031182001007624; Henriquez SA, 2009, NEUROIMMUNOMODULAT, V16, P122, DOI 10.1159/000180267; Hinze-Selch D, 2007, SCHIZOPHRENIA BULL, V33, P782, DOI 10.1093/schbul/sbm010; Katan M, 2013, NEUROLOGY, V80, P1209, DOI 10.1212/WNL.0b013e3182896e79; Keppel KG, 2007, AM J EPIDEMIOL, V166, P97, DOI 10.1093/aje/kwm044; Kountouras J, 2007, EUR J NEUROL, V14, P976, DOI 10.1111/j.1468-1331.2007.01827.x; Kountouras J, 2006, NEUROLOGY, V66, P938, DOI 10.1212/01.wnl.0000203644.68059.5f; Kountouras J, 2007, AM J CLIN NUTR, V86, P805, DOI 10.1093/ajcn/86.3.805; Kountouras J, 2010, COGN BEHAV NEUROL, V23, P199, DOI 10.1097/WNN.0b013e3181df3034; Krieg EF, 2001, NEUROTOXICOL TERATOL, V23, P569, DOI 10.1016/S0892-0362(01)00177-5; Kusbeci OY, 2011, ALZ DIS ASSOC DIS, V25, P1, DOI 10.1097/WAD.0b013e3181f73bc2; Letz RE, 1988, NES 2 NEUROBEHAVIORA; Lovheim H, 2015, ALZHEIMERS DEMENT, V11, P587, DOI 10.1016/j.jalz.2014.07.157; Lurain NS, 2013, J INFECT DIS, V208, P564, DOI 10.1093/infdis/jit210; Malaguarnera Mariano, 2004, Eur J Intern Med, V15, P381, DOI 10.1016/j.ejim.2004.05.008; MARSHALL BJ, 1984, LANCET, V1, P1311; Montoya JG, 2004, LANCET, V363, P1965, DOI 10.1016/S0140-6736(04)16412-X; Muhsen K, 2011, BMC PEDIATR, V11, DOI 10.1186/1471-2431-11-43; Murray-Kolb LE, 2013, CURR OPIN CLIN NUTR, V16, P703, DOI 10.1097/MCO.0b013e3283653ef8; O'Connor JPA, 2012, IMMUNOGASTROENTEROLO, V1, P5, DOI [10.7178/ig.1.1.3, DOI 10.7178/IG.1.1.3]; Pearce BD, 2014, SOC PSYCH PSYCH EPID, V49, P1001, DOI 10.1007/s00127-014-0820-5; Peleteiro B, 2014, DIGEST DIS SCI, V59, P1698, DOI 10.1007/s10620-014-3063-0; Rencher A.C., 2012, METHODS MULTIVARIATE, DOI DOI 10.1002/9781118391686; RENCHER AC, 1990, COMMUN STAT SIMULAT, V19, P535, DOI 10.1080/03610919008812874; Serin E, 2002, HELICOBACTER, V7, P337, DOI 10.1046/j.1523-5378.2002.00106.x; Timm NH, 1997, COMMUN STAT-THEOR M, V26, P1083; Torrey EF, 2013, TRENDS PARASITOL, V29, P380, DOI 10.1016/j.pt.2013.06.001; Wang XL, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00066; Xiao J, 2012, NEUROSCIENCE, V206, P39, DOI 10.1016/j.neuroscience.2011.12.051; Zajacova A, 2011, AM J EPIDEMIOL, V174, P977, DOI 10.1093/aje/kwr204	43	11	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2015	10	1							e0116874	10.1371/journal.pone.0116874	http://dx.doi.org/10.1371/journal.pone.0116874			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CC9HN	25590622	Green Published, gold, Green Submitted			2022-12-27	WOS:000350679400024
J	Uettwiller, F; Chemin, A; Bonnemaison, E; Favrais, G; Saliba, E; Labarthe, F				Uettwiller, Florence; Chemin, Aude; Bonnemaison, Elisabeth; Favrais, Geraldine; Saliba, Elie; Labarthe, Francois			Real-Time Continuous Glucose Monitoring Reduces the Duration of Hypoglycemia Episodes: A Randomized Trial in Very Low Birth Weight Neonates	PLOS ONE			English	Article							GESTATIONAL-AGE; NEWBORN; INFANTS; BRAIN; DEFINITION; METABOLISM; SENSOR; BABIES; RISK; CARE	Objectives Hypoglycemia is frequent in very low birth weight (VLBW) neonates and compromises their neurological outcome. The aim of this study was to compare real-time continuous glucose monitoring system (RT-CGMS) to standard methods by intermittent capillary blood glucose testing in detecting and managing hypoglycemia. Study design Forty-eight VLBW neonates were enrolled in this prospective study. During their 3 first days of life, their glucose level was monitored either by RT-CGMS (CGM-group), or by intermittent capillary glucose testing (IGM-group) associated with a blind-CGMS to detect retrospectively missed hypoglycemia. Outcomes were the number and duration of hypoglycemic (<= 50mg/dl) episodes per patient detected by CGMS. Results Forty-three monitorings were analyzed (IGM n = 21, CGM n = 22), with a median recording time of 72 hours. In the IGM group, blind-CGMS revealed a significantly higher number of hypoglycemia episodes than capillary blood glucose testing (1.2 +/- 0.4 vs 0.4 +/- 0.2 episode/patient, p < 0.01). In the CGM-group, the use of RT-CGMS made it possible (i) to detect the same number of hypoglycemia episodes as blind-CGMS (1.2 +/- 0.4 episode/patient), (ii) to adapt the glucose supply in neonates with hypoglycemia (increased supply during days 1 and 2), and (iii) to significantly reduce the duration of hypoglycemia episodes per patient (CGM 44[10-140] min versus IGM 95[15-520] min, p<0.05). Furthermore, it reduced the number of blood samples (CGM 16.9 +/- 1.0 vs IGM 21.9 +/- 1.0 blood sample/patient, p<0.001). Conclusion RT-CGMS played a beneficial role in managing hypoglycemia in VLBW neonates by adjusting the carbohydrate supply to the individual needs and by reducing the duration of hypoglycemia episodes. The clinical significance of the biological differences observed in our study need to be explored.	[Uettwiller, Florence; Bonnemaison, Elisabeth; Labarthe, Francois] Univ Tours, CHRU Tours, Med Pediat, Tours, France; [Uettwiller, Florence; Chemin, Aude; Favrais, Geraldine; Saliba, Elie] Univ Tours, CHRU Tours, Reanimat Pediat & Neonatol, Tours, France; [Favrais, Geraldine; Saliba, Elie] Univ Tours, INSERM, U930, Tours, France; [Labarthe, Francois] Univ Tours, INSERM, U1069, Tours, France	CHU Tours; Universite de Tours; CHU Tours; Universite de Tours; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Tours; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Tours	Uettwiller, F (corresponding author), Univ Tours, CHRU Tours, Med Pediat, Tours, France.	florence.uettwiller@univ-tours.fr	Favrais, Geraldine/P-5060-2019	Favrais, Geraldine/0000-0002-0301-2053				ANDERSON JM, 1967, J NEUROL NEUROSUR PS, V30, P295, DOI 10.1136/jnnp.30.4.295; Barkovich AJ, 1998, AM J NEURORADIOL, V19, P523; Beardsall K, 2005, ARCH DIS CHILD-FETAL, V90, pF307, DOI 10.1136/adc.2004.051979; Beardsall K, 2012, JPEN-PARENTER ENTER, V36, P378, DOI 10.1177/0148607112448674; Beardsall K, 2010, EARLY HUM DEV, V86, P263, DOI 10.1016/j.earlhumdev.2010.05.005; Calhoun P, 2013, DIABETES TECHNOL THE, V15, P758, DOI 10.1089/dia.2013.0042; CORNBLATH M, 1993, J PEDIATR ENDOCRINOL, V6, P113; Cornblath M, 2000, PEDIATRICS, V105, P1141, DOI 10.1542/peds.105.5.1141; Duvanel CB, 1999, J PEDIATR-US, V134, P492, DOI 10.1016/S0022-3476(99)70209-X; FLUGE G, 1975, ACTA PAEDIATR SCAND, V64, P629, DOI 10.1111/j.1651-2227.1975.tb03894.x; FORSYTH JS, 1995, ARCH DIS CHILD-FETAL, V73, pF13, DOI 10.1136/fn.73.1.F13; Harris DL, 2012, J PEDIATR-US, V161, P787, DOI 10.1016/j.jpeds.2012.05.022; Harris DL, 2010, J PEDIATR-US, V157, P198, DOI 10.1016/j.jpeds.2010.02.003; Hulzebos CV, 2007, SEMIN FETAL NEONAT M, V12, P2, DOI 10.1016/j.siny.2006.10.008; Imai T, 1996, ACTA PAEDIATR JAPON, V38, P343; Jean-Louis WA, 2011, NEONATOLOGY, V100, P387, DOI 10.1159/000326936; Keenan D Barry, 2010, J Diabetes Sci Technol, V4, P111; Khan MR, 2012, PEDIATR NEUROL, V47, P109, DOI 10.1016/j.pediatrneurol.2012.05.010; KOH THHG, 1988, ARCH DIS CHILD, V63, P1353, DOI 10.1136/adc.63.11.1353; LUBCHENCO LO, 1971, PEDIATRICS, V47, P831; LUCAS A, 1988, BRIT MED J, V297, P1304, DOI 10.1136/bmj.297.6659.1304; McGowan JE, 2006, NEUROSCI LETT, V399, P111, DOI 10.1016/j.neulet.2006.01.034; Platas II, 2009, NEONATOLOGY, V95, P217, DOI 10.1159/000165980; Rozance PJ, 2010, EARLY HUM DEV, V86, P275, DOI 10.1016/j.earlhumdev.2010.05.002; Tamborlane WV, 2008, NEW ENGL J MED, V359, P1464, DOI 10.1056/NEJMoa0805017; Vannucci RC, 2000, SEMIN PERINATOL, V24, P107, DOI 10.1053/sp.2000.6361; WIELOCH T, 1985, SCIENCE, V230, P681, DOI 10.1126/science.2996146; Yalnizoglu D, 2007, BRAIN DEV-JPN, V29, P285, DOI 10.1016/j.braindev.2006.09.011	28	35	38	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2015	10	1							e0116255	10.1371/journal.pone.0116255	http://dx.doi.org/10.1371/journal.pone.0116255			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9HN	25590334	Green Published, Green Submitted, gold			2022-12-27	WOS:000350679400012
J	Didham, RK; Barker, GM; Bartlam, S; Deakin, EL; Denmead, LH; Fisk, LM; Peters, JMR; Tylianakis, JM; Wright, HR; Schipper, LA				Didham, Raphael K.; Barker, Gary M.; Bartlam, Scott; Deakin, Elizabeth L.; Denmead, Lisa H.; Fisk, Louise M.; Peters, Jennifer M. R.; Tylianakis, Jason M.; Wright, Hannah R.; Schipper, Louis A.			Agricultural Intensification Exacerbates Spillover Effects on Soil Biogeochemistry in Adjacent Forest Remnants	PLOS ONE			English	Article							NEW-ZEALAND AGRICULTURE; LAND-USE INTENSITY; FARMLAND BIODIVERSITY; WATER-QUALITY; MICROCLIMATE; COMMUNITIES; MANAGEMENT; CADMIUM; IMPACTS; INSECT	Land-use intensification is a central element in proposed strategies to address global food security. One rationale for accepting the negative consequences of land-use intensification for farmland biodiversity is that it could 'spare' further expansion of agriculture into remaining natural habitats. However, in many regions of the world the only natural habitats that can be spared are fragments within landscapes dominated by agriculture. Therefore, land-sparing arguments hinge on land-use intensification having low spillover effects into adjacent protected areas, otherwise net conservation gains will diminish with increasing intensification. We test, for the first time, whether the degree of spillover from farmland into adjacent natural habitats scales in magnitude with increasing land-use intensity. We identified a continuous land-use intensity gradient across pastoral farming systems in New Zealand (based on 13 components of farmer input and soil biogeochemistry variables), and measured cumulative off-site spillover effects of fertilisers and livestock on soil biogeochemistry in 21 adjacent forest remnants. Ten of 11 measured soil properties differed significantly between remnants and intact-forest reference sites, for both fenced and unfenced remnants, at both edge and interior. For seven variables, the magnitude of effects scaled significantly with magnitude of surrounding land-use intensity, through complex interactions with fencing and edge effects. In particular, total C, total N, delta N-15, total P and heavy-metal contaminants of phosphate fertilizers (Cd and U) increased significantly within remnants in response to increasing land-use intensity, and these effects were exac(erbated in unfenced relative to fenced remnants. This suggests movement of livestock into surrounding natural habitats is a significant component of agricultural spillover, but pervasive changes in soil biogeochemistry still occur through nutrient spillover channels alone, even in fenced remnants set aside for conservation. These results have important implications for the viability of land sparing as a strategy for balancing landscape-level conservation and production goals in agricultural landscapes.	[Didham, Raphael K.; Denmead, Lisa H.] Univ Western Australia, Sch Anim Biol, Perth, WA 6009, Australia; [Didham, Raphael K.] CSIRO Land & Water Flagship, Perth, WA, Australia; [Barker, Gary M.; Bartlam, Scott] Landcare Res, Hamilton, New Zealand; [Deakin, Elizabeth L.; Tylianakis, Jason M.] Univ Canterbury, Ctr Integrat Ecol, Sch Biol Sci, Christchurch 1, New Zealand; [Deakin, Elizabeth L.] CIFOR Ctr Int Forestry Res, Forests & Livelihoods Programme, Bogor, Indonesia; [Denmead, Lisa H.] Univ Gottingen, Dept Crop Sci, D-37073 Gottingen, Germany; [Fisk, Louise M.] Univ Western Australia, Inst Agr, Sch Earth & Environm, Perth, WA 6009, Australia; [Peters, Jennifer M. R.] Dept Conservat, Sci & Capabil Grp, Christchurch, New Zealand; [Tylianakis, Jason M.] Univ London Imperial Coll Sci Technol & Med, Dept Life Sci, Ascot, Berks, England; [Wright, Hannah R.; Schipper, Louis A.] Univ Waikato, Sch Sci, Hamilton, New Zealand; [Wright, Hannah R.] Univ Lancaster, Lancaster Environm Ctr, Lancaster, England	University of Western Australia; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Landcare Research - New Zealand; CGIAR; Center for International Forestry Research (CIFOR); University of Gottingen; University of Western Australia; Imperial College London; University of Waikato; Lancaster University	Didham, RK (corresponding author), Univ Western Australia, Sch Anim Biol, Perth, WA 6009, Australia.	raphael.didham@uwa.edu.au	Didham, Raphael K/B-5953-2011; Barker, Gary M/C-9974-2011; Schipper, Louis A/F-1605-2010	Barker, Gary M/0000-0002-0049-9804; Schipper, Louis A/0000-0001-9899-1276; Denmead, Lisa/0000-0001-7634-8335; Peters, Jennifer/0000-0003-4627-7788	Royal Society of New Zealand Marsden [UOC0803]; Australian Research Council Future Fellowship [FT100100040]; Natural Environment Research Council [ceh010010] Funding Source: researchfish	Royal Society of New Zealand Marsden(Royal Society of New ZealandMarsden Fund (NZ)); Australian Research Council Future Fellowship(Australian Research Council); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	Funding for the study was provided by the Royal Society of New Zealand Marsden grant UOC0803. RKD was supported during the writing of the manuscript by an Australian Research Council Future Fellowship FT100100040. JMT was supported during the writing of this manuscript by a Rutherford Discovery Fellowship, administered by the Royal Society of New Zealand. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allan JD, 2004, ANNU REV ECOL EVOL S, V35, P257, DOI 10.1146/annurev.ecolsys.35.120202.110122; [Anonymous], 2004, ETH SUST AGR INT; Baird D.B., 1996, P NZ GRASSL ASS, P123, DOI [10.33584/jnzg.1996.58.2233, DOI 10.33584/JNZG.1996.58.2233]; Barton K., 2013, MUMIN MULTIMODEL INF; Baskaran R, 2009, NEW ZEAL J AGR RES, V52, P377, DOI 10.1080/00288230909510520; Baudron F, 2014, BIOL CONSERV, V170, P232, DOI 10.1016/j.biocon.2013.12.009; Benton TG, 2003, TRENDS ECOL EVOL, V18, P182, DOI 10.1016/S0169-5347(03)00011-9; Benton TG, 2002, J APPL ECOL, V39, P673, DOI 10.1046/j.1365-2664.2002.00745.x; Berka C, 2001, WATER AIR SOIL POLL, V127, P389, DOI 10.1023/A:1005233005364; Bjornstad ON, 2001, ENVIRON ECOL STAT, V8, P53, DOI 10.1023/A:1009601932481; Blakemore LC, 1987, METHODS CHEM ANAL SO; Blitzer EJ, 2012, AGR ECOSYST ENVIRON, V146, P34, DOI 10.1016/j.agee.2011.09.005; Bluthgen N, 2012, BASIC APPL ECOL, V13, P207, DOI 10.1016/j.baae.2012.04.001; Boutin C, 1998, ECOL APPL, V8, P544, DOI 10.1890/1051-0761(1998)008[0544:IOAPAE]2.0.CO;2; Brady N.C, 2000, NATURE PROPERTIES SO; Brauman KA, 2007, ANNU REV ENV RESOUR, V32, P67, DOI 10.1146/annurev.energy.32.031306.102758; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Burns BR, 2011, AUSTRAL ECOL, V36, P153, DOI 10.1111/j.1442-9993.2010.02130.x; Cameron M, 2007, AUSTRAL NAT HIST SER, P1; Claessens L, 2009, AGR ECOSYST ENVIRON, V129, P157, DOI 10.1016/j.agee.2008.08.008; Clarke KR., 2001, CHANGE MARINE COMMUN, V2; Clough Y, 2011, P NATL ACAD SCI USA, V108, P8311, DOI 10.1073/pnas.1016799108; Colombo S, 2005, J AGR ECON, V56, P81, DOI 10.1111/j.1477-9552.2005.tb00123.x; Cornforth IS, 1984, FERTILISER LIME RECO, P24; Cornforth IS, 1980, SOILS FERTILISERS SO; Cunningham SA, 2013, AGR ECOSYST ENVIRON, V173, P20, DOI 10.1016/j.agee.2013.04.007; Davies-Colley RJ, 2000, NEW ZEAL J ECOL, V24, P111; Davis MA, 2000, J ECOL, V88, P528, DOI 10.1046/j.1365-2745.2000.00473.x; de Klein CAM, 1997, NEW ZEAL J AGR RES, V40, P541, DOI 10.1080/00288233.1997.9513277; de Sassi C, 2012, PHILOS T R SOC B, V367, P3033, DOI 10.1098/rstb.2012.0233; de Sassi C, 2012, ECOLOGY, V93, P1892, DOI 10.1890/11-1839.1; de Sassi C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040557; Didham RK, 2012, LAND USE INTENSIFICATION: EFFECTS ON AGRICULTURE, BIODIVERSITY AND ECOLOGICAL PROCESSES, P73; Didham RK, 2009, NEW ZEAL J ZOOL, V36, P135, DOI 10.1080/03014220909510148; Didham RK, 1999, BIOTROPICA, V31, P17, DOI 10.1111/j.1744-7429.1999.tb00113.x; Dudgeon D, 2006, BIOL REV, V81, P163, DOI 10.1017/S1464793105006950; Duncan DH, 2008, LANDSCAPE ECOL, V23, P107, DOI 10.1007/s10980-007-9160-0; Dupouey JL, 2002, ECOLOGY, V83, P2978, DOI 10.1890/0012-9658(2002)083[2978:IIOPLU]2.0.CO;2; Ewers RM, 2006, BIOL CONSERV, V133, P312, DOI 10.1016/j.biocon.2006.06.018; Ewers RM, 2009, GLOBAL CHANGE BIOL, V15, P1716, DOI 10.1111/j.1365-2486.2009.01849.x; Fahrig L, 2011, ECOL LETT, V14, P101, DOI 10.1111/j.1461-0248.2010.01559.x; Fischer J, 2008, FRONT ECOL ENVIRON, V6, P382, DOI 10.1890/070019; Flinn KM, 2007, ECOL APPL, V17, P452, DOI 10.1890/05-1963; Foley JA, 2005, SCIENCE, V309, P570, DOI 10.1126/science.1111772; Foley JA, 2011, NATURE, V478, P337, DOI 10.1038/nature10452; Fridley JD, 2002, OECOLOGIA, V132, P271, DOI 10.1007/s00442-002-0965-x; Frost CM, 2015, ECOLOGY, V96, P193, DOI 10.1890/14-0696.1; Gelman A, 2008, STAT MED, V27, P2865, DOI 10.1002/sim.3107; Gladbach DJ, 2011, OECOLOGIA, V166, P433, DOI 10.1007/s00442-010-1870-3; Godfray HCJ, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2012.0273; Godfray HCJ, 2010, SCIENCE, V327, P812, DOI 10.1126/science.1185383; Gorley C.K., 2006, GETTING STARTED PRIM; Green RE, 2005, SCIENCE, V307, P550, DOI 10.1126/science.1106049; Grueber CE, 2011, J EVOLUTION BIOL, V24, P699, DOI 10.1111/j.1420-9101.2010.02210.x; Gucker B, 2009, FRESHWATER BIOL, V54, P2069, DOI 10.1111/j.1365-2427.2008.02069.x; Harper KA, 2005, CONSERV BIOL, V19, P768, DOI 10.1111/j.1523-1739.2005.00045.x; Havlik P, 2014, P NATL ACAD SCI USA, V111, P3709, DOI 10.1073/pnas.1308044111; Hayward MW, 2009, BIOL CONSERV, V142, P1, DOI 10.1016/j.biocon.2008.09.022; Herzog F, 2006, EUR J AGRON, V24, P165, DOI 10.1016/j.eja.2005.07.006; Hill L, 2010, 122 LANDC RES LTD; Hole DG, 2005, BIOL CONSERV, V122, P113, DOI 10.1016/j.biocon.2004.07.018; Hooper DU, 2005, ECOL MONOGR, V75, P3, DOI 10.1890/04-0922; Kim N., 2005, 200551 ENV WAIK; Kleijn D, 2009, P R SOC B, V276, P903, DOI 10.1098/rspb.2008.1509; Krebs JR, 1999, NATURE, V400, P611, DOI 10.1038/23127; Laliberte E, 2013, OECOLOGIA, V171, P439, DOI 10.1007/s00442-012-2417-6; Laliberte E, 2012, ECOLOGY, V93, P145, DOI 10.1890/11-0338.1; Leathwick JR, 2003, CONSERV BIOL, V17, P1612, DOI 10.1111/j.1523-1739.2003.00469.x; Lee KH, 2000, J ENVIRON QUAL, V29, P1200, DOI 10.2134/jeq2000.2941200x; Lee WG, 2008, NEW ZEAL J AGR RES, V51, P457, DOI 10.1080/00288230809510475; MacLeod CJ, 2006, AGR ECOSYST ENVIRON, V115, P201, DOI 10.1016/j.agee.2006.01.003; Martin T.D., 1994, 2002 US EPA ENV MON; Matson PA, 1997, SCIENCE, V277, P504, DOI 10.1126/science.277.5325.504; McDowell RW, 2013, AGR ECOSYST ENVIRON, V165, P80, DOI 10.1016/j.agee.2012.12.011; McDowell RW, 2012, NEW ZEAL J AGR RES, V55, P133, DOI 10.1080/00288233.2012.662901; Moller H, 2008, NEW ZEAL J AGR RES, V51, P461, DOI 10.1080/00288230809510476; Moller H, 2008, NEW ZEAL J AGR RES, V51, P253, DOI 10.1080/00288230809510453; Mudge PL, 2013, SOIL SCI SOC AM J, V77, P830, DOI 10.2136/sssaj2012.0333; MURCIA C, 1995, TRENDS ECOL EVOL, V10, P58, DOI 10.1016/S0169-5347(00)88977-6; MURPHY J, 1962, ANAL CHIM ACTA, V26, P31; Nakagawa S, 2013, METHODS ECOL EVOL, V4, P133, DOI 10.1111/j.2041-210x.2012.00261.x; Norris V., 1993, Water Resources Management, V7, P257, DOI 10.1007/BF00872284; Norton David A., 2000, Ecological Management & Restoration, V1, P26; Olsen S., 1954, ESTIMATION AVAILABLE; Parn J, 2012, ECOL INDIC, V22, P4, DOI 10.1016/j.ecolind.2011.10.002; Parfitt RL, 2006, BIOGEOCHEMISTRY, V80, P71, DOI 10.1007/s10533-006-0002-y; Parkyn S, 2004, 200405 MAF, DOI [10.1007/s00267-003-2913-x, DOI 10.1007/S00267-003-2913-X]; PCE, 2004, GROW GOOD INT FARM S; Phalan B, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2012.0285; Phalan B, 2011, SCIENCE, V333, P1289, DOI 10.1126/science.1208742; Pinheiro J, 2013, NLME LINEAR NONLINEA; Polyakov Viktor, 2005, Environmental Reviews, V13, P129, DOI 10.1139/a05-010; Quinn JM, 2002, NEW ZEAL J MAR FRESH, V36, P409, DOI 10.1080/00288330.2002.9517097; R Core Team, 2016, R FDN STAT COMP; Rand TA, 2006, ECOL LETT, V9, P603, DOI 10.1111/j.1461-0248.2006.00911.x; Risser P. G., 1989, Ecology of arable land-perspectives and challenges. Proceedings of an International Symposium, 9-12 June 1987, Swedish Univ. Agric. Sci., Uppsala, Sweden., P247; Rowarth JS, 2008, NEW ZEAL J AGR RES, V51, P451, DOI 10.1080/00288230809510474; Rowarth JS, 2006, CLEAN AIR ENV QUALIT, V40, P33; Schielzeth H, 2009, BEHAV ECOL, V20, P416, DOI 10.1093/beheco/arn145; Schipper LA, 2014, AGR ECOSYST ENVIRON, V184, P67, DOI 10.1016/j.agee.2013.11.012; Schipper LA, 2011, AGR ECOSYST ENVIRON, V144, P95, DOI 10.1016/j.agee.2011.08.002; Schipper LA, 2004, SOIL USE MANAGE, V20, P281, DOI 10.1079/SUM2004255; Smale MC, 2008, NEW ZEAL J ECOL, V32, P57; Sparling G, 2004, AGR ECOSYST ENVIRON, V104, P545, DOI 10.1016/j.agee.2003.11.014; Sparling GP, 2004, AGR ECOSYST ENVIRON, V104, P523, DOI 10.1016/j.agee.2004.01.021; Sparling GP, 2002, J ENVIRON QUAL, V31, P1848, DOI 10.2134/jeq2002.1848; Stevens CJ, 2004, SCIENCE, V303, P1876, DOI 10.1126/science.1094678; Stevenson BA, 2010, AGR ECOSYST ENVIRON, V139, P736, DOI 10.1016/j.agee.2010.10.020; Stevenson BA, 2004, PLANT SOIL, V262, P317, DOI 10.1023/B:PLSO.0000037050.67578.f0; Tilman D, 2001, SCIENCE, V292, P281, DOI 10.1126/science.1057544; Tinker PB, 1997, PHILOS T R SOC B, V352, P1023, DOI 10.1098/rstb.1997.0080; Tscharntke T, 2012, BIOL CONSERV, V151, P53, DOI 10.1016/j.biocon.2012.01.068; Tscharntke T, 2011, J APPL ECOL, V48, P619, DOI 10.1111/j.1365-2664.2010.01939.x; Tylianakis JM, 2008, PLOS BIOL, V6, P947, DOI 10.1371/journal.pbio.0060122; van Noordwijk M, 2004, AGR ECOSYST ENVIRON, V104, P19, DOI 10.1016/j.agee.2004.01.004; van Noordwijk M, 2014, CURR OPIN ENV SUST, V8, P62, DOI 10.1016/j.cosust.2014.08.008; Wardle DA, 2004, SCIENCE, V304, P1629, DOI 10.1126/science.1094875; Wheeler D.M., 2003, P NZ GRASSLAND ASS, V65, P191, DOI DOI 10.33584/JNZG.2003.65; Wheeler DM, 2004, NEW ZEAL J AGR RES, V47, P155, DOI 10.1080/00288233.2004.9513583; Wheeler DM, 1997, NEW ZEAL J AGR RES, V40, P309, DOI 10.1080/00288233.1997.9513250; YOUNG A, 1994, BIOL CONSERV, V67, P63, DOI 10.1016/0006-3207(94)90010-8	121	32	33	1	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2015	10	1							e0116474	10.1371/journal.pone.0116474	http://dx.doi.org/10.1371/journal.pone.0116474			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ4BU	25575017	Green Published, Green Submitted			2022-12-27	WOS:000348168100006
J	Mondal, S; Pahan, K				Mondal, Susanta; Pahan, Kalipada			Cinnamon Ameliorates Experimental Allergic Encephalomyelitis in Mice via Regulatory T Cells: Implications for Multiple Sclerosis Therapy	PLOS ONE			English	Article							EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; CENTRAL-NERVOUS-SYSTEM; METABOLITE SODIUM BENZOATE; INHIBITS ADOPTIVE TRANSFER; NITRIC-OXIDE; IL-12P40 HOMODIMER; CUTTING EDGE; TH17 CELLS; FOXP3; ACID	Upregulation and/or maintenance of regulatory T cells (Tregs) during an autoimmune insult may have therapeutic efficacy in autoimmune diseases. Although several immunomodulatory drugs and molecules are available, most present significant side effects over long-term use. Cinnamon is a commonly used natural spice and flavoring material used for centuries throughout the world. Here, we have explored a novel use of cinnamon powder in protecting Tregs and treating the disease process of experimental allergic encephalomyelitis (EAE), an animal model of MS. Oral feeding of cinnamon (Cinnamonum verum) powder suppresses clinical symptoms of relapsing-remitting EAE in female PLP-TCR transgenic mice and adoptive transfer mouse model. Cinnamon also inhibited clinical symptoms of chronic EAE in male C57/BL6 mice. Dose-dependent study shows that cinnamon powder at a dose of 50 mg/kg body wt/d or higher significantly suppresses clinical symptoms of EAE in mice. Accordingly, oral administration of cinnamon also inhibited perivascular cuffing, maintained the integrity of blood-brain barrier and blood-spinal cord barrier, suppressed inflammation, normalized the expression of myelin genes, and blocked demyelination in the central nervous system of EAE mice. Interestingly, cinnamon treatment upregulated Tregs via reduction of nitric oxide production. Furthermore, we demonstrate that blocking of Tregs by neutralizing antibodies against CD25 abrogates cinnamon-mediated protection of EAE. Taken together, our results suggest that oral administration of cinnamon powder may be beneficial in MS patients and that no other existing anti-MS therapies could be so economical and trouble-free as this approach.	[Mondal, Susanta; Pahan, Kalipada] Rush Univ, Med Ctr, Dept Neurol Sci, Chicago, IL 60612 USA	Rush University	Pahan, K (corresponding author), Rush Univ, Med Ctr, Dept Neurol Sci, Chicago, IL 60612 USA.	Kalipada_Pahan@rush.edu			NIH [AT6681]; National Center for Complementary & Integrative Health [R01AT006681] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by NIH AT6681. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abd El-Mawla AMA, 2001, PLANTA, V212, P288, DOI 10.1007/s004250000394; Brahmachari S, 2007, J IMMUNOL, V179, P275, DOI 10.4049/jimmunol.179.1.275; Brahmachari S, 2010, J IMMUNOL, V184, P1799, DOI 10.4049/jimmunol.0804394; Brahmachari S, 2009, J IMMUNOL, V183, P5917, DOI 10.4049/jimmunol.0803336; Brahmachari S, 2009, J IMMUNOL, V183, P2045, DOI 10.4049/jimmunol.0800276; BRIDGES JW, 1970, BIOCHEM J, V118, P47, DOI 10.1042/bj1180047; Chaudhry A, 2009, SCIENCE, V326, P986, DOI 10.1126/science.1172702; Chun J, 2010, CLIN NEUROPHARMACOL, V33, P91, DOI 10.1097/WNF.0b013e3181cbf825; Coffer PJ, 2004, NAT REV IMMUNOL, V4, P889, DOI 10.1038/nri1488; Cohen JA, 2012, LANCET NEUROL, V11, P467, DOI 10.1016/S1474-4422(12)70059-5; Cosmetic Ingredient Review Expert, 2001, INT J TOXICOL, V20, P23; Dasgupta S, 2004, J IMMUNOL, V173, P1344, DOI 10.4049/jimmunol.173.2.1344; Dasgupta S, 2003, J IMMUNOL, V170, P3874, DOI 10.4049/jimmunol.170.7.3874; Dasgupta S, 2007, MOL PHARMACOL, V72, P934, DOI 10.1124/mol.106.033787; El-behi M, 2010, J NEUROIMMUNE PHARM, V5, P189, DOI 10.1007/s11481-009-9188-9; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Huan J, 2005, J NEUROSCI RES, V81, P45, DOI 10.1002/jnr.20522; Jana A, 2013, J NEUROIMMUNE PHARM, V8, P739, DOI 10.1007/s11481-013-9447-7; Khasnavis S, 2014, J NEUROIMMUNE PHARM, V9, P569, DOI 10.1007/s11481-014-9552-2; Kohm AP, 2002, J IMMUNOL, V169, P4712, DOI 10.4049/jimmunol.169.9.4712; KUBOTA K, 1991, EUR J CLIN PHARMACOL, V41, P363, DOI 10.1007/BF00314969; Kuerten S, 2011, J INTERF CYTOK RES, V31, P907, DOI 10.1089/jir.2011.0072; Leonard J V, 2002, Semin Neonatol, V7, P27, DOI 10.1053/siny.2001.0085; MARTIN R, 1992, ANNU REV IMMUNOL, V10, P153, DOI 10.1146/annurev.iy.10.040192.001101; McGeachy MJ, 2005, J IMMUNOL, V175, P3025, DOI 10.4049/jimmunol.175.5.3025; McKee AS, 2004, J IMMUNOL, V173, P1224, DOI 10.4049/jimmunol.173.2.1224; Miller A, 1997, SOUTH MED J, V90, P367, DOI 10.1097/00007611-199704000-00001; Mondal S, 2009, J IMMUNOL, V182, P5013, DOI 10.4049/jimmunol.0801734; Niedbala W, 2007, EUR J IMMUNOL, V37, P3021, DOI 10.1002/eji.200737810; Pahan K, 1997, J CLIN INVEST, V100, P2671, DOI 10.1172/JCI119812; Pahan K, 2011, IMMUNOPHARM IMMUNOT, V33, P586, DOI 10.3109/08923973.2011.561861; Pahan K, 2010, J NEUROIMMUNE PHARM, V5, P165, DOI 10.1007/s11481-010-9219-6; Paust S, 2005, IMMUNOL REV, V204, P195, DOI 10.1111/j.0105-2896.2005.00247.x; Reddy J, 2005, J IMMUNOL, V175, P5591, DOI 10.4049/jimmunol.175.9.5591; Sakaguchi S, 2005, NAT IMMUNOL, V6, P345, DOI 10.1038/ni1178; Scaglia F, 2004, MOL GENET METAB, V81, pS79, DOI 10.1016/j.ymgme.2003.11.017; Schrempf W, 2007, AUTOIMMUN REV, V6, P469, DOI 10.1016/j.autrev.2007.02.003; Shi GP, 2008, J IMMUNOL, V181, P7205, DOI 10.4049/jimmunol.181.10.7205; Venken K, 2008, IMMUNOLOGY, V123, P79, DOI 10.1111/j.1365-2567.2007.02690.x; Viglietta V, 2004, J EXP MED, V199, P971, DOI 10.1084/jem.20031579; Waldner H, 2000, P NATL ACAD SCI USA, V97, P3412, DOI 10.1073/pnas.97.7.3412; Xu DM, 2003, J IMMUNOL, V170, P394, DOI 10.4049/jimmunol.170.1.394; Zhu JF, 2010, IMMUNITY, V32, P11, DOI 10.1016/j.immuni.2010.01.001; Ziegler SF, 2006, ANNU REV IMMUNOL, V24, P209, DOI 10.1146/annurev.immunol.24.021605.090547	44	33	36	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2015	10	1							e0116566	10.1371/journal.pone.0116566	http://dx.doi.org/10.1371/journal.pone.0116566			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ4BT	25569428	gold, Green Submitted, Green Published			2022-12-27	WOS:000348168000008
J	de Almeida, SA; Claudio, ERG; Mengal, VF; de Oliveira, SG; Merlo, E; Podratz, PL; Gouvea, SA; Graceli, JB; de Abreu, GR				de Almeida, Simone Alves; Goncalves Claudio, Erick Roberto; Mengal, Vinicius Franskoviaky; de Oliveira, Suelen Guedes; Merlo, Eduardo; Podratz, Priscila Lang; Gouvea, Sonia Alves; Graceli, Jones Bernardes; de Abreu, Glaucia Rodrigues			Exercise Training Reduces Cardiac Dysfunction and Remodeling in Ovariectomized Rats Submitted to Myocardial Infarction	PLOS ONE			English	Article							ANGIOTENSIN-II RECEPTORS; HEART-FAILURE; NADPH OXIDASE; ESTROGEN; SYSTEM; PATHOPHYSIOLOGY; CONTRACTILITY; ACTIVATION; REDUCTION; GENDER	The aim of this study was to evaluate whether exercise training (ET) prevents or minimizes cardiac dysfunction and pathological ventricular remodeling in ovariectomized rats subjected to myocardial infarction (MI) and to examine the possible mechanisms involved in this process. Ovariectomized Wistar rats were subjected to either MI or fictitious surgery (Sham) and randomly divided into the following groups: Control, OVX+SHAM(SED), OVX+SHAM(ET), OVX+MISED and OVX+MIET. ET was performed on a motorized treadmill (5x/wk, 60 min/day, 8 weeks). Cardiac function was assessed by ventricular catheterization and Dihydroethidium fluorescence (DHE) was evaluated to analyze cardiac oxidative stress. Histological analyses were made to assess collagen deposition, myocyte hypertrophy and infarct size. Western Blotting was performed to analyze the protein expression of catalase and SOD-2, as well as Gp91phox and AT1 receptor (AT1R). MI-trained rats had significantly increased in +dP/dt and decreased left ventricular end-diastolic pressure compared with MI-sedentary rats. Moreover, oxidative stress and collagen deposition was reduced, as was myocyte hypertrophy. These effects occurred in parallel with a reduction in both AT1R and Gp91phox expression and an increase in catalase expression. SOD-2 expression was not altered. These results indicate that ET improves the functional cardiac parameters associated with attenuation of cardiac remodeling in ovariectomized rats subjected to MI. The mechanism seems to be related to a reduction in the expression of both the AT1 receptor and Gp91phox as well as an increase in the antioxidant enzyme catalase, which contributes to a reduction in oxidative stress. Therefore, ET may be an important therapeutic target for the prevention of heart failure in postmenopausal women affected by MI.	[de Almeida, Simone Alves; Goncalves Claudio, Erick Roberto; Mengal, Vinicius Franskoviaky; de Oliveira, Suelen Guedes; Gouvea, Sonia Alves; de Abreu, Glaucia Rodrigues] Univ Fed Espirito Santo, Ctr Ciencias Saude, Dept Ciencias Fisiol, Vitoria, ES, Brazil; [Merlo, Eduardo; Podratz, Priscila Lang; Graceli, Jones Bernardes] Univ Fed Espirito Santo, Ctr Ciencias Saude, Dept Morfol, Vitoria, ES, Brazil	Universidade Federal do Espirito Santo; Universidade Federal do Espirito Santo	de Almeida, SA (corresponding author), Univ Fed Espirito Santo, Ctr Ciencias Saude, Dept Ciencias Fisiol, Vitoria, ES, Brazil.	simoalves@yahoo.com.br	Bernardes Graceli, Jones/ABC-7439-2021	Merlo, Eduardo/0000-0003-0155-1472; Goncalves Claudio, Erick Roberto/0000-0001-7030-3558				ALP PR, 1976, BIOCHEM J, V154, P689, DOI 10.1042/bj1540689; Barbosa VA, 2012, INT J CARDIOL, V157, P422, DOI 10.1016/j.ijcard.2012.03.153; Bianchi PR, 2006, LIFE SCI, V78, P875, DOI 10.1016/j.lfs.2005.05.086; Braith RW, 1999, J AM COLL CARDIOL, V34, P1170, DOI 10.1016/S0735-1097(99)00339-3; Brower GL, 2006, EUR J CARDIO-THORAC, V30, P604, DOI 10.1016/j.ejcts.2006.07.006; Cabanelas LA, 2010, REV BRAS GINECOL OBS, V34, P447, DOI 10.1590/S0100-72032012001000003; Campos JC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052764; Cavasin MA, 2004, LIFE SCI, V75, P2181, DOI 10.1016/j.lfs.2004.04.024; Claudio ERG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064806; CRABOS M, 1994, J CLIN INVEST, V93, P2372, DOI 10.1172/JCI117243; de Tombe PP, 2010, J MOL CELL CARDIOL, V48, P851, DOI 10.1016/j.yjmcc.2009.12.017; Dimitrios N. T., 2003, HELL J CARDIOL, V44, P195; Distefano G, 2012, ITAL J PEDIATR, V38, DOI 10.1186/1824-7288-38-41; Dostal DE, 1997, J MOL CELL CARDIOL, V29, P2893, DOI 10.1006/jmcc.1997.0524; Dubach P, 2001, SWISS MED WKLY, V131, P510; Flores LJ, 2010, MENOPAUSE, V17, P712, DOI 10.1097/gme.0b013e3181cdebc9; Forechi L, 2012, PHARMACOL REP, V64, P643, DOI 10.1016/S1734-1140(12)70860-5; Giuberti K, 2007, ARCH MED RES, V38, P170, DOI 10.1016/j.arcmed.2006.09.015; Hafstad AD, 2013, BASIC RES CARDIOL, V108, DOI 10.1007/s00395-013-0359-8; Hingtgen SD, 2006, PHYSIOL GENOMICS, V26, P180, DOI 10.1152/physiolgenomics.00029.2005; Johar S, 2006, FASEB J, V20, P1546, DOI 10.1096/fj.05-4642fje; Ju HS, 1997, CARDIOVASC RES, V35, P223, DOI 10.1016/S0008-6363(97)00130-2; Kim JK, 2006, J BIOL CHEM, V281, P6760, DOI 10.1074/jbc.M511024200; Komajda M, 1998, HEART, V79, pS17, DOI 10.1136/hrt.79.2008.17S; Komukai K, 2010, FUND CLIN PHARMACOL, V24, P687, DOI 10.1111/j.1472-8206.2010.00854.x; Kraljevic J, 2013, CARDIOVASC RES, V99, P55, DOI 10.1093/cvr/cvt080; Lassegue B, 2012, CIRC RES, V110, P1364, DOI 10.1161/CIRCRESAHA.111.243972; Looi YH, 2008, HYPERTENSION, V51, P319, DOI 10.1161/HYPERTENSIONAHA.107.101980; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Bozi LHM, 2013, CLINICS, V68, P549, DOI 10.6061/clinics/2013(04)18; MEGGS LG, 1993, CIRC RES, V72, P1149, DOI 10.1161/01.RES.72.6.1149; Mendis S., 2011, GLOBAL ATLAS CARDIOV; Negrao CE, 2008, J APPL PHYSIOL, V104, P577, DOI 10.1152/japplphysiol.01368.2007; Pedram A, 2010, MOL ENDOCRINOL, V24, P2152, DOI 10.1210/me.2010-0154; PFEFFER JM, 1984, AM J MED, V76, P99, DOI 10.1016/0002-9343(84)90894-5; PFEFFER MA, 1979, CIRC RES, V44, P503, DOI 10.1161/01.RES.44.4.503; Pinho CA, 2012, LIFE SCI, V90, P553, DOI 10.1016/j.lfs.2012.01.018; Piro M, 2010, J AM COLL CARDIOL, V55, P1057, DOI 10.1016/j.jacc.2009.09.065; Shlipak MG, 2001, CIRCULATION, V104, P2300, DOI 10.1161/hc4401.98414; Smith PJW, 2000, CIRCULATION, V102, P2983; Strehlow K, 2003, CIRC RES, V93, P170, DOI 10.1161/01.RES.0000082334.17947.11; Stupka N, 2001, J APPL PHYSIOL, V91, P1828, DOI 10.1152/jappl.2001.91.4.1828; Sun Y, 2009, CARDIOVASC RES, V81, P482, DOI 10.1093/cvr/cvn333; Sutton MGS, 2000, CIRCULATION, V101, P2981, DOI 10.1161/01.CIR.101.25.2981; Touyz RM, 2004, BRAZ J MED BIOL RES, V37, P1263, DOI 10.1590/S0100-879X2004000800018; Wan WH, 2007, AM J MED SCI, V334, P265, DOI 10.1097/MAJ.0b013e318068b5ed; Wilson P, 2009, CLIN SCI, V116, P731, DOI 10.1042/CS20080247; Wisloff U, 2002, CARDIOVASC RES, V54, P162, DOI 10.1016/S0008-6363(01)00565-X; Yung LM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017437; Zornoff LAM, 2009, ARQ BRAS CARDIOL, V92, P157, DOI 10.1590/S0066-782X2009000200013	50	25	26	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2014	9	12							e115970	10.1371/journal.pone.0115970	http://dx.doi.org/10.1371/journal.pone.0115970			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UC	25551214	Green Published, gold			2022-12-27	WOS:000347119100084
J	Haffner-Luntzer, M; Heilmann, A; Rapp, AE; Beie, S; Schinke, T; Amling, M; Ignatius, A; Liedert, A				Haffner-Luntzer, Melanie; Heilmann, Aline; Rapp, Anna Elise; Beie, Simon; Schinke, Thorsten; Amling, Michael; Ignatius, Anita; Liedert, Astrid			Midkine-Deficiency Delays Chondrogenesis during the Early Phase of Fracture Healing in Mice	PLOS ONE			English	Article							GROWTH-FACTOR MIDKINE; COMPUTED TOMOGRAPHY; BONE; EXPRESSION; DIFFERENTIATION; ANGIOGENESIS; CHONDROCYTES; INHIBITION; CYTOKINE; PROTEIN	The growth and differentiation factor midkine (Mdk) plays an important role in bone development and remodeling. Mdk-deficient mice display a high bone mass phenotype when aged 12 and 18 months. Furthermore, Mdk has been identified as a negative regulator of mechanically induced bone formation and it induces prochondrogenic, pro-angiogenic and pro-inflammatory effects. Together with the finding that Mdk is expressed in chondrocytes during fracture healing, we hypothesized that Mdk could play a complex role in endochondral ossification during the bone healing process. Femoral osteotomies stabilized using an external fixator were created in wildtype and Mdk-deficient mice. Fracture healing was evaluated 4, 10, 21 and 28 days after surgery using 3-point-bending, micro-computed tomography, histology and immunohistology. We demonstrated that Mdk-deficient mice displayed delayed chondrogenesis during the early phase of fracture healing as well as significantly decreased flexural rigidity and moment of inertia of the fracture callus 21 days after fracture. Mdk-deficiency diminished beta-catenin expression in chondrocytes and delayed presence of macrophages during early fracture healing. We also investigated the impact of Mdk knockdown using siRNA on ATDC5 chondroprogenitor cells in vitro. Knockdown of Mdk expression resulted in a decrease of beta-catenin and chondrogenic differentiation-related matrix proteins, suggesting that delayed chondrogenesis during fracture healing in Mdk-deficient mice may be due to a cell-autonomous mechanism involving reduced beta-catenin signaling. Our results demonstrated that Mdk plays a crucial role in the early inflammation phase and during the development of cartilaginous callus in the fracture healing process.	[Haffner-Luntzer, Melanie; Heilmann, Aline; Rapp, Anna Elise; Beie, Simon; Ignatius, Anita; Liedert, Astrid] Univ Med Ctr Ulm, Inst Orthopaed Res & Biomech, Ulm, Germany; [Schinke, Thorsten; Amling, Michael] Univ Med Ctr Hamburg Eppendorf, Dept Osteol & Biomech, Hamburg, Germany	Ulm University; University of Hamburg; University Medical Center Hamburg-Eppendorf	Liedert, A (corresponding author), Univ Med Ctr Ulm, Inst Orthopaed Res & Biomech, Ulm, Germany.	astrid.liedert@uni-ulm.de	Ignatius, Anita/M-6012-2013; Rapp, Anna/L-8807-2016; Haffner-Luntzer, Melanie/L-3562-2019	Ignatius, Anita/0000-0002-4782-1979; Rapp, Anna/0000-0001-5122-765X; Haffner-Luntzer, Melanie/0000-0002-3333-2613	German Research Foundation [IG 18-3/3, AM103/10-3]	German Research Foundation(German Research Foundation (DFG))	This work was supported by a grant from the German Research Foundation (IG 18-3/3 and AM103/10-3) (www.dfg.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander KA, 2011, J BONE MINER RES, V26, P1517, DOI 10.1002/jbmr.354; Bouxsein ML, 2010, J BONE MINER RES, V25, P1468, DOI 10.1002/jbmr.141; Chen M, 2008, J CELL SCI, V121, P1455, DOI 10.1242/jcs.020362; Dao DY, 2010, J ORTHOP RES, V28, P89, DOI 10.1002/jor.20954; Dempster DW, 2013, J BONE MINER RES, V28, P1, DOI 10.1002/jbmr.1805; Heilmann A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084232; Heilmann A, 2013, J ORTHOP RES, V31, P1845, DOI 10.1002/jor.22426; Horiba M, 2000, J CLIN INVEST, V105, P489, DOI 10.1172/JCI7208; Huang Y, 2012, J ORTHOP RES, V30, P304, DOI 10.1002/jor.21505; Ikutomo M, 2014, ACTA HISTOCHEM, V116, P319, DOI 10.1016/j.acthis.2013.08.009; Johnson K, 2003, J BONE MINER RES, V18, P994, DOI 10.1359/jbmr.2003.18.6.994; KADOMATSU K, 1990, J CELL BIOL, V110, P607, DOI 10.1083/jcb.110.3.607; Kadomatsu K, 2013, J BIOCHEM, V153, P511, DOI 10.1093/jb/mvt035; Komatsu DE, 2010, J ORTHOP RES, V28, P928, DOI 10.1002/jor.21078; Kosugi T, 2007, LAB INVEST, V87, P903, DOI 10.1038/labinvest.3700599; Liedert A, 2014, BRIT J PHARMACOL, V171, P870, DOI 10.1111/bph.12412; Liedert A, 2011, BONE, V48, P945, DOI 10.1016/j.bone.2010.12.019; Ling YF, 2005, J BONE MINER RES, V20, P2169, DOI 10.1359/JBMR.050815; Lu CY, 2011, J ORTHOP TRAUMA, V25, P494, DOI 10.1097/BOT.0b013e31822511e0; Morgan EF, 2009, BONE, V44, P335, DOI 10.1016/j.bone.2008.10.039; Nakamura E, 1998, GENES CELLS, V3, P811, DOI 10.1046/j.1365-2443.1998.00231.x; Nam HK, 2011, J BIOL CHEM, V286, P39059, DOI 10.1074/jbc.M111.221689; Neunaber C, 2010, J BONE MINER RES, V25, P1724, DOI 10.1002/jbmr.75; Ohta S, 1999, J BONE MINER RES, V14, P1132, DOI 10.1359/jbmr.1999.14.7.1132; Ominsky MS, 2011, J BONE MINER RES, V26, P1012, DOI 10.1002/jbmr.307; Ramakers C, 2003, NEUROSCI LETT, V339, P62, DOI 10.1016/S0304-3940(02)01423-4; Rontgen V, 2010, J ORTHOP RES, V28, P1456, DOI 10.1002/jor.21148; Shukunami C, 1996, J CELL BIOL, V133, P457, DOI 10.1083/jcb.133.2.457; Takada T, 1997, J BIOCHEM-TOKYO, V122, P453; Tian J, 2014, TUMOUR BIOL; Toyosawa S, 2004, BONE, V35, P553, DOI 10.1016/j.bone.2004.03.030; Weckbach LT, 2012, AM J PHYSIOL-HEART C, V303, pH429, DOI 10.1152/ajpheart.00934.2011; Wehrle E, 2014, J ORTHOP RES, V32, P1006, DOI 10.1002/jor.22629; Xing ZQ, 2010, DIS MODEL MECH, V3, P451, DOI 10.1242/dmm.003186; Zhang ZH, 2010, CELL PROLIFERAT, V43, P184, DOI 10.1111/j.1365-2184.2010.00668.x	35	26	28	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2014	9	12							e116282	10.1371/journal.pone.0116282	http://dx.doi.org/10.1371/journal.pone.0116282			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UC	25551381	Green Published, gold, Green Submitted			2022-12-27	WOS:000347119100120
J	Lakatos, G; Marta, G; Konok, V; Bruder, I; Bereczky, B; Korondi, P; Miklosi, A				Lakatos, Gabriella; Marta, Gacsi; Konok, Veronika; Bruder, Ildiko; Bereczky, Boroka; Korondi, Peter; Miklosi, Adam			Emotion Attribution to a Non-Humanoid Robot in Different Social Situations	PLOS ONE			English	Article							CANIS-FAMILIARIS; DOG; BEHAVIOR; MODEL; BOND	In the last few years there was an increasing interest in building companion robots that interact in a socially acceptable way with humans. In order to interact in a meaningful way a robot has to convey intentionality and emotions of some sort in order to increase believability. We suggest that human-robot interaction should be considered as a specific form of inter-specific interaction and that human-animal interaction can provide a useful biological model for designing social robots. Dogs can provide a promising biological model since during the domestication process dogs were able to adapt to the human environment and to participate in complex social interactions. In this observational study we propose to design emotionally expressive behaviour of robots using the behaviour of dogs as inspiration and to test these dog-inspired robots with humans in inter-specific context. In two experiments (wizard-of-oz scenarios) we examined humans' ability to recognize two basic and a secondary emotion expressed by a robot. In Experiment 1 we provided our companion robot with two kinds of emotional behaviour ("happiness" and "fear"), and studied whether people attribute the appropriate emotion to the robot, and interact with it accordingly. In Experiment 2 we investigated whether participants tend to attribute guilty behaviour to a robot in a relevant context by examining whether relying on the robot's greeting behaviour human participants can detect if the robot transgressed a predetermined rule. Results of Experiment 1 showed that people readily attribute emotions to a social robot and interact with it in accordance with the expressed emotional behaviour. Results of Experiment 2 showed that people are able to recognize if the robot transgressed on the basis of its greeting behaviour. In summary, our findings showed that dog-inspired behaviour is a suitable medium for making people attribute emotional states to a non-humanoid robot.	[Lakatos, Gabriella; Marta, Gacsi; Bereczky, Boroka] Eotvos Lorand Univ, Hungarian Acad Sci, Comparat Ethol Res Grp, H-1117 Budapest, Hungary; [Konok, Veronika; Bruder, Ildiko; Miklosi, Adam] Eotvos Lorand Univ, Dept Ethol, H-1117 Budapest, Hungary; [Korondi, Peter] Univ Technol & Econ, Dept Mechatron Opt & Informat Engn, H-1111 Budapest, Hungary; [Korondi, Peter] MTA BME Control Res Grp, H-1111 Budapest, Hungary	Eotvos Lorand University; Hungarian Academy of Sciences; MTA-ELTE Comparative Ethology Research Group; Eotvos Lorand University; Budapest University of Technology & Economics	Lakatos, G (corresponding author), Eotvos Lorand Univ, Hungarian Acad Sci, Comparat Ethol Res Grp, Pazmany Peter Setany 1-C, H-1117 Budapest, Hungary.	gabriella.lakatos@gmail.com	Konok, Veronika/AAF-3889-2020; Miklosi, Adam/N-5147-2017	Gacsi, Marta/0000-0003-3080-7545; Miklosi, Adam/0000-0003-4831-8985	European Union [LIREC 215554]; MTA-ELTE Comparative Ethology Research Group [01 031]; Hungarian Research Fund [OTKA K100951]; ESF Research Networking Programme "CompCog'': The Evolution of Social Cognition [06-RNP-020]	European Union(European Commission); MTA-ELTE Comparative Ethology Research Group; Hungarian Research Fund(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); ESF Research Networking Programme "CompCog'': The Evolution of Social Cognition	This study was supported by grants received from the European Union (EU FP7 ICT: Living with robots and interactive companions, LIREC 215554), the MTA-ELTE Comparative Ethology Research Group (01 031), the Hungarian Research Fund (OTKA K100951), and the ESF Research Networking Programme "CompCog'': The Evolution of Social Cognition (www.compcog.org) (06-RNP-020). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BATES J, 1994, COMMUN ACM, V37, P122, DOI 10.1145/176789.176803; Becker C, 2005, PROCEEDINGS OF THE 2005 INTERNATIONAL CONFERENCE ON ACTIVE MEDIA TECHNOLOGY (AMT 2005), P541, DOI 10.1109/AMT.2005.1505417; Becker-Asano C, 2008, WASABI AFFECT SIMULA; Blackwell EJ, 2013, APPL ANIM BEHAV SCI, V145, P15, DOI 10.1016/j.applanim.2012.12.004; Breazeal C., 1999, Proceedings 1999 IEEE/RSJ International Conference on Intelligent Robots and Systems. Human and Environment Friendly Robots with High Intelligence and Emotional Quotients (Cat. No.99CH36289), P858, DOI 10.1109/IROS.1999.812787; Breazeal C, 2003, INT J HUM-COMPUT ST, V59, P119, DOI 10.1016/S1071-5819(03)00018-1; Bruce A, 2002, 2002 IEEE INTERNATIONAL CONFERENCE ON ROBOTICS AND AUTOMATION, VOLS I-IV, PROCEEDINGS, P4138, DOI 10.1109/ROBOT.2002.1014396; Canamero LD, 2002, MU S ART SOC SIM ORG, V3, P69; Chaminade T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011577; Coppinger R, 2001, DOGS; Craig R., 2010, 2010 10th IEEE-RAS International Conference on Humanoid Robots (Humanoids 2010), P647, DOI 10.1109/ICHR.2010.5686272; Dautenhahn K, 2004, RO-MAN 2004: 13TH IEEE INTERNATIONAL WORKSHOP ON ROBOT AND HUMAN INTERACTIVE COMMUNICATION, PROCEEDINGS, P17, DOI 10.1109/ROMAN.2004.1374720; Delaunay Frederic, 2009, RO-MAN 2009 - The 18th IEEE International Symposium on Robot and Human Interactive Communication, P306, DOI 10.1109/ROMAN.2009.5326314; Donath J., 2004, ENCY ANIMAL BEHAV; EKMAN P, 1992, COGNITION EMOTION, V6, P169, DOI 10.1080/02699939208411068; EKMAN P, 1971, J PERS SOC PSYCHOL, V17, P124, DOI 10.1037/h0030377; Farago T, 2014, INTERACT STUD, V15, P224, DOI 10.1075/is.15.2.11far; Fong T, 2003, ROBOT AUTON SYST, V42, P143, DOI 10.1016/S0921-8890(02)00372-X; Fox MW., 1978, DOG ITS DOMESTICATIO; Fujita M, 2004, P IEEE, V92, P1804, DOI 10.1109/JPROC.2004.835364; Gacsi M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058475; Hart Lynette A., 1995, P161; Hecht J, 2012, APPL ANIM BEHAV SCI, V139, P134, DOI 10.1016/j.applanim.2012.02.015; Heider F, 1944, AM J PSYCHOL, V57, P243, DOI 10.2307/1416950; Horowitz A, 2009, BEHAV PROCESS, V81, P447, DOI 10.1016/j.beproc.2009.03.014; Horvath Z, 2008, HORM BEHAV, V54, P107, DOI 10.1016/j.yhbeh.2008.02.002; Johnston O., 1981, ILLUSION LIFE DISNEY; Kaplan F., 2001, P HUMANOIDS, P125; Kerepesi A, 2005, BEHAV PROCESS, V70, P69, DOI 10.1016/j.beproc.2005.04.006; Koppensteiner M, 2011, J RES PERS, V45, P358, DOI 10.1016/j.jrp.2011.04.003; Kramer NC, 2011, APPL ARTIF INTELL, V25, P474, DOI 10.1080/08839514.2011.587153; Kubinyi E, 2007, COMP COGN BEHAV REV, V2, P26; Kuhnlenz K, 2010, ADV ROBOTICS, V24, P1239, DOI 10.1163/016918610X501309; Leite I., 2008, P 7 INT JOINT C AUT, P1229; LUTKEBOHLE I, 2010, P IEEE INT C ROB AUT, P3384; Melson GF, 2009, J SOC ISSUES, V65, P545, DOI 10.1111/j.1540-4560.2009.01613.x; Miklosi A, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00075; Mori M., 1970, ENERGY, V7, P33, DOI DOI 10.1109/MRA.2012.2192811; Morris PH, 2008, COGNITION EMOTION, V22, P3, DOI 10.1080/02699930701273716; Nitsch V, 2014, BIOL CYBERN, V108, P621, DOI 10.1007/s00422-014-0594-6; Nomura T, 2004, RO-MAN 2004: 13TH IEEE INTERNATIONAL WORKSHOP ON ROBOT AND HUMAN INTERACTIVE COMMUNICATION, PROCEEDINGS, P35, DOI 10.1109/ROMAN.2004.1374726; Nomura T, 2006, AI SOC, V20, P138, DOI 10.1007/s00146-005-0012-7; Padgham L, 1997, LECT NOTES ARTIF INT, V1209, P59; Pitsch K., 2010, P 2 INT S NEW FRONTI, P80; Poggi I, 2005, TEXT SPEECH LANG TEC, V27, P3, DOI 10.1007/1-4020-3051-7_1; Pongracz P, 2005, J COMP PSYCHOL, V119, P136, DOI 10.1037/0735-7036.119.2.136; Prato-Previde E, 2003, BEHAVIOUR, V140, P225, DOI 10.1163/156853903321671514; Reeves B, 1996, CSLI PUBLICATIONS ST; Rolls ET, 2000, BEHAV BRAIN SCI, V23, P177, DOI 10.1017/S0140525X00002429; Rose R, 2010, INTERACT STUD, V11, P314, DOI 10.1075/is.11.2.21ros; Saerbeck M, 2010, ACMIEEE INT CONF HUM, P53, DOI 10.1109/HRI.2010.5453269; Saldien J, 2010, INT J SOC ROBOT, V2, P377, DOI 10.1007/s12369-010-0067-6; Salem M, 2013, INT J SOC ROBOT, V5, P313, DOI 10.1007/s12369-013-0196-9; Saygin AP, 2012, SOC COGN AFFECT NEUR, V7, P413, DOI 10.1093/scan/nsr025; Scott JP., 1965, GENETICS SOCIAL BEHA; Shibata T, 2011, GERONTOLOGY, V57, P378, DOI 10.1159/000319015; Sosnowski S, 2006, 2006 IEEE/RSJ INTERNATIONAL CONFERENCE ON INTELLIGENT ROBOTS AND SYSTEMS, VOLS 1-12, P3113, DOI 10.1109/IROS.2006.282330; Tami G, 2009, APPL ANIM BEHAV SCI, V120, P159, DOI 10.1016/j.applanim.2009.06.009; Thomaz AL, 2008, ARTIF INTELL, V172, P716, DOI 10.1016/j.artint.2007.09.009; Topal J, 1998, J COMP PSYCHOL, V112, P219, DOI 10.1037/0735-7036.112.3.219; Topal J, 2009, ADV STUD BEHAV, V39, P71, DOI 10.1016/S0065-3454(09)39003-8; Trone A, 2005, APPL ANIM BEHAV SCI, V93, P363, DOI 10.1016/j.applanim.2005.01.003; Velasquez J. D., 1999, Proceedings 1999 IEEE/RSJ International Conference on Intelligent Robots and Systems. Human and Environment Friendly Robots with High Intelligence and Emotional Quotients (Cat. No.99CH36289), P235, DOI 10.1109/IROS.1999.813010; Vincze D, 2012, P 2012 JOINT INT C H; Wan M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051775	65	24	24	2	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2014	9	12							e114207	10.1371/journal.pone.0114207	http://dx.doi.org/10.1371/journal.pone.0114207			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AX7UC	25551218	Green Published, Green Submitted, gold			2022-12-27	WOS:000347119100008
J	Salyer, A; Bennett, GW; Buczkowski, GA				Salyer, Adam; Bennett, Gary W.; Buczkowski, Grzegorz A.			Odorous House Ants (Tapinoma sessile) as Back-Seat Drivers of Localized Ant Decline in Urban Habitats	PLOS ONE			English	Article							HYMENOPTERA-FORMICIDAE; LINEPITHEMA-HUMILE; BIOLOGICAL INVASIONS; ECOLOGICAL CHANGE; FUNCTIONAL-GROUPS; ARGENTINE ANTS; NATIVE ANTS; COMMUNITIES; URBANIZATION; SUCCESS	Invasive species and habitat disturbance threaten biodiversity worldwide by modifying ecosystem performance and displacing native organisms. Similar homogenization impacts manifest locally when urbanization forces native species to relocate or reinvade perpetually altered habitat. This study investigated correlations between ant richness and abundance in response to urbanization and the nearby presence of invasive ant species, odorous house ants (Tapinoma sessile), within its native region. Surveying localized ant composition within natural, semi-natural, and urban habitat supported efforts to determine whether T. sessile appear to be primary (drivers) threats as instigators or secondary (passengers) threats as inheritors of indigenous ant decline. Sampling 180 sites, evenly split between all habitats with and without T. sessile present, yielded 45 total species. Although urbanization and T. sessile presence factors were significantly linked to ant decline, their interaction correlated to the greatest reduction of total ant richness (74%) and abundance (81%). Total richness appeared to decrease from 27 species to 18 when natural habitat is urbanized and from 18 species to 7 with T. sessile present in urban plots. Odorous house ant presence minimally influenced ant communities within natural and semi-natural habitat, highlighting the importance of habitat alteration and T. sessile presence interactions. Results suggest urbanization releases T. sessile from unknown constraints by decreasing ant richness and competition. Within urban environment, T. sessile are pre-adapted to quickly exploit new resources and grow to supercolony strength wherein T. sessile drive adjacent biodiversity loss. Odorous house ants act as passengers and drivers of ecological change throughout different phases of urban 'invasion'. This progression through surviving habitat alteration, exploiting new resources, thriving, and further reducing interspecific competition supports a "back-seat driver" role and affects pest management strategies. As demonstrated by T. sessile, this article concludes native species can become back-seat drivers of biodiversity loss and potentially thrive as "metro-invasive" species.	[Salyer, Adam; Bennett, Gary W.; Buczkowski, Grzegorz A.] Purdue Univ, Dept Entomol, W Lafayette, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus	Salyer, A (corresponding author), Purdue Univ, Dept Entomol, W Lafayette, IN 47907 USA.	asalyer@purdue.edu			Industrial Affiliates Program at Purdue University	Industrial Affiliates Program at Purdue University	The authors were supported by the Industrial Affiliates Program at Purdue University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSEN AN, 1995, J BIOGEOGR, V22, P15, DOI 10.2307/2846070; Bauer JT, 2012, BIOL INVASIONS, V14, P1295, DOI 10.1007/s10530-011-0165-x; Berman M, 2013, BIOL INVASIONS, V15, P2311, DOI 10.1007/s10530-013-0455-6; Bolton B., 1994, Identification guide to the ant genera of the world.; BOLTON B., 2007, BOLTONS CATALOGUE AN; Bolton B, 1995, NEW GEN CATALOGUE AN, P504; Buczkowski G, 2009, INSECT SOC, V56, P185, DOI 10.1007/s00040-009-0011-7; Buczkowski G, 2008, ECOL ENTOMOL, V33, P780, DOI 10.1111/j.1365-2311.2008.01034.x; Buczkowski G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041729; Buczkowski G, 2012, MYRMECOL NEWS, V16, P61; Buczkowski G, 2010, BIOL INVASIONS, V12, P3343, DOI 10.1007/s10530-010-9727-6; Carney SE, 2003, OECOLOGIA, V135, P576, DOI 10.1007/s00442-003-1200-0; Cover, 2007, ANTS N AM GUIDE GENE, P145; Covert GA, 2005, ANTS OHIO HYMENOPTER, P196; Didham RK, 2005, TRENDS ECOL EVOL, V20, P470, DOI 10.1016/j.tree.2005.07.006; FELLERS JH, 1987, ECOLOGY, V68, P1466, DOI 10.2307/1939230; Friedrich R, 2009, ENVIRON ENTOMOL, V38, P600, DOI 10.1603/022.038.0311; Gibb H, 2004, BIOL CONSERV, V106, P91; Goodisman MAD, 2007, BIOL INVASIONS, V9, P571, DOI 10.1007/s10530-006-9059-8; Gurevitch J, 2004, TRENDS ECOL EVOL, V19, P470, DOI 10.1016/j.tree.2004.07.005; Halpern BS, 2008, SCIENCE, V319, P948, DOI 10.1126/science.1149345; Heterick BE, 2013, URBAN ECOSYST, V16, P145, DOI 10.1007/s11252-012-0257-0; Hoffmann BD, 2003, AUSTRAL ECOL, V28, P444, DOI 10.1046/j.1442-9993.2003.01301.x; Holway DA, 1998, SCIENCE, V282, P949, DOI 10.1126/science.282.5390.949; Holway DA, 2006, BIOL CONSERV, V127, P319, DOI 10.1016/j.biocon.2005.05.016; Holway DA, 2002, ANNU REV ECOL SYST, V33, P181, DOI 10.1146/annurev.ecolsys.33.010802.150444; Human KG, 1996, OECOLOGIA, V105, P405, DOI 10.1007/BF00328744; Kennedy TA, 2002, NATURE, V417, P636, DOI 10.1038/nature00776; King JR, 2008, P NATL ACAD SCI USA, V105, P20339, DOI 10.1073/pnas.0809423105; Laeger Thomas, 2005, Myrmecologische Nachrichten, V7, P17; Leprieur F, 2008, PLOS BIOL, V6, P404, DOI 10.1371/journal.pbio.0060028; Lopez-Moreno IR, 2003, SOCIOBIOLOGY, V42, P605; MacDougall AS, 2005, ECOLOGY, V86, P42, DOI 10.1890/04-0669; Mack RN, 2000, ECOL APPL, V10, P689, DOI 10.1890/1051-0761(2000)010[0689:BICEGC]2.0.CO;2; MAJER J D, 1986, Journal of the Royal Society of Western Australia, V69, P13; McGlynn TP, 1999, J BIOGEOGR, V26, P535, DOI 10.1046/j.1365-2699.1999.00310.x; Menke SB, 2011, URBAN ECOSYST, V14, P135, DOI 10.1007/s11252-010-0150-7; Menke SB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009194; Milford ER, 1999, SOUTHWEST NAT, V44, P278; Oliver TH, 2008, INSECT CONSERV DIVER, V1, P208, DOI 10.1111/j.1752-4598.2008.00026.x; Pacheco R, 2007, LANDSCAPE URBAN PLAN, V81, P193, DOI 10.1016/j.landurbplan.2006.11.004; PASSERA L, 1994, WESTV STUD, P23; PORTER SD, 1990, ECOLOGY, V71, P2095, DOI 10.2307/1938623; Ricciardi A, 2004, TRENDS ECOL EVOL, V19, P619, DOI 10.1016/j.tree.2004.09.021; Sanford MP, 2009, CONSERV BIOL, V23, P131, DOI 10.1111/j.1523-1739.2008.01040.x; SEIFERT B, 1990, Entomologische Nachrichten und Berichte, V34, P21; Shochat E, 2006, TRENDS ECOL EVOL, V21, P186, DOI 10.1016/j.tree.2005.11.019; Suarez AV, 2001, P NATL ACAD SCI USA, V98, P1095, DOI 10.1073/pnas.98.3.1095; Taylor BW, 2004, P NATL ACAD SCI USA, V101, P17725, DOI 10.1073/pnas.0405176101; THOMPSON CR, 1990, WESTV STUD, P51; Toennisson TA, 2011, ENVIRON ENTOMOL, V40, P1397, DOI 10.1603/EN11110; Tsutsui ND, 2000, P NATL ACAD SCI USA, V97, P5948, DOI 10.1073/pnas.100110397; Vepsalainen K, 2000, ANN ZOOL FENN, V37, P135; Vitousek PM, 1996, AM SCI, V84, P468; Wheeler GC, 1986, ANTS NEVADA, P138; Wilder SM, 2011, P NATL ACAD SCI USA, V108, P20639, DOI 10.1073/pnas.1115263108; Witt A. B. R., 2006, African Plant Protection, V12, P60; Yamaguchi T, 2004, ECOL RES, V19, P209, DOI 10.1111/j.1440-1703.2003.00625.x	58	11	13	0	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2014	9	12							e113878	10.1371/journal.pone.0113878	http://dx.doi.org/10.1371/journal.pone.0113878			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UC	25551819	gold, Green Published, Green Submitted			2022-12-27	WOS:000347119100007
J	Chang, HC; Gaur, P; Chou, YH; Chu, ML; Chen, NK				Chang, Hing-Chiu; Gaur, Pooja; Chou, Ying-hui; Chu, Mei-Lan; Chen, Nan-kuei			Interleaved EPI Based fMRI Improved by Multiplexed Sensitivity Encoding (MUSE) and Simultaneous Multi-Band Imaging	PLOS ONE			English	Article							ECHO; MRI; RECONSTRUCTION; ACCELERATION; DISTORTIONS; ACQUISITION; ARTIFACTS; IMAGES	Functional magnetic resonance imaging (fMRI) is a non-invasive and powerful imaging tool for detecting brain activities. The majority of fMRI studies are performed with single-shot echo-planar imaging (EPI) due to its high temporal resolution. Recent studies have demonstrated that, by increasing the spatial-resolution of fMRI, previously unidentified neuronal networks can be measured. However, it is challenging to improve the spatial resolution of conventional single-shot EPI based fMRI. Although multi-shot interleaved EPI is superior to single-shot EPI in terms of the improved spatial-resolution, reduced geometric distortions, and sharper point spread function (PSF), interleaved EPI based fMRI has two main limitations: 1) the imaging throughput is lower in interleaved EPI; 2) the magnitude and phase signal variations among EPI segments (due to physiological noise, subject motion, and B-0 drift) are translated to significant in-plane aliasing artifact across the field of view (FOV). Here we report a method that integrates multiple approaches to address the technical limitations of interleaved EPI-based fMRI. Firstly, the multiplexed sensitivity-encoding (MUSE) post-processing algorithm is used to suppress in-plane aliasing artifacts resulting from time-domain signal instabilities during dynamic scans. Secondly, a simultaneous multi-band interleaved EPI pulse sequence, with a controlled aliasing scheme incorporated, is implemented to increase the imaging throughput. Thirdly, the MUSE algorithm is then generalized to accommodate fMRI data obtained with our multi-band interleaved EPI pulse sequence, suppressing both in-plane and through-plane aliasing artifacts. The blood-oxygenation-level-dependent (BOLD) signal detectability and the scan throughput can be significantly improved for interleaved EPI-based fMRI. Our human fMRI data obtained from 3 Tesla systems demonstrate the effectiveness of the developed methods. It is expected that future fMRI studies requiring high spatial-resolvability and fidelity will largely benefit from the reported techniques.	[Chang, Hing-Chiu; Chou, Ying-hui; Chu, Mei-Lan; Chen, Nan-kuei] Duke Univ, Med Ctr, Brain Imaging & Anal Ctr, Durham, NC 27708 USA; [Gaur, Pooja] Vanderbilt Univ, Dept Chem & Phys Biol, Nashville, TN 37235 USA; [Gaur, Pooja] Vanderbilt Univ, Inst Imaging Sci, Nashville, TN 37235 USA; [Chou, Ying-hui] Duke Univ, Med Ctr, Dept Psychiat & Behav Sci, Durham, NC USA; [Chu, Mei-Lan] Natl Taiwan Univ, Grad Inst Biomed Elect & Bioinformat, Taipei 10764, Taiwan	Duke University; Vanderbilt University; Vanderbilt University; Duke University; National Taiwan University	Chen, NK (corresponding author), Duke Univ, Med Ctr, Brain Imaging & Anal Ctr, Durham, NC 27708 USA.	nankuei.chen@duke.edu	Chen, Nan-Kuei/E-7791-2016; Chou, Ying-hui/GPT-0971-2022	Chen, Nan-Kuei/0000-0001-6564-4219; Gaur, Pooja/0000-0003-0433-975X; Chang, Hing-Chiu/0000-0001-8634-328X	NIH [R01 NS-074045]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS074045] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This research was supported by NIH R01 NS-074045. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bammer P, 1999, RADIOLOGY, V211, P799, DOI 10.1148/radiology.211.3.r99jn15799; Breuer FA, 2005, MAGNET RESON MED, V53, P684, DOI 10.1002/mrm.20401; Chen NK, 2008, MAGN RESON MED, V59, P916, DOI 10.1002/mrm.21529; Chen NK, 2013, NEUROIMAGE, V72, P41, DOI 10.1016/j.neuroimage.2013.01.038; Chen NK, 2011, MAGN RESON MED, V66, P1057, DOI 10.1002/mrm.22896; Chen NK, 1999, MAGNET RESON MED, V41, P1206, DOI 10.1002/(SICI)1522-2594(199906)41:6<1206::AID-MRM17>3.0.CO;2-L; Chou MC, 2007, AM J NEURORADIOL, V28, P1099, DOI 10.3174/ajnr.A0532; D'Ardenne K, 2008, SCIENCE, V319, P1264, DOI 10.1126/science.1150605; Hyde JS, 2001, MAGN RESON MED, V46, P114, DOI 10.1002/mrm.1166; JEZZARD P, 1995, MAGNET RESON MED, V34, P65, DOI 10.1002/mrm.1910340111; KWONG KK, 1995, MAGN RESON QUART, V11, P1; KWONG KK, 1992, P NATL ACAD SCI USA, V89, P5675, DOI 10.1073/pnas.89.12.5675; Larkman DJ, 2001, J MAGN RESON IMAGING, V13, P313, DOI 10.1002/1522-2586(200102)13:2<313::AID-JMRI1045>3.0.CO;2-W; Madore B, 1999, MAGNET RESON MED, V42, P813, DOI 10.1002/(SICI)1522-2594(199911)42:5<813::AID-MRM1>3.0.CO;2-S; OGAWA S, 1990, P NATL ACAD SCI USA, V87, P9868, DOI 10.1073/pnas.87.24.9868; Pruessmann KP, 1999, MAGNET RESON MED, V42, P952, DOI 10.1002/(SICI)1522-2594(199911)42:5<952::AID-MRM16>3.0.CO;2-S; Setsompop K, 2012, NEUROIMAGE, V63, P569, DOI 10.1016/j.neuroimage.2012.06.033; Vincent JL, 2008, J NEUROPHYSIOL, V100, P3328, DOI 10.1152/jn.90355.2008; WEAVER JB, 1988, MAGNET RESON MED, V8, P275, DOI 10.1002/mrm.1910080305; Yun SD, 2013, NEUROIMAGE, V73, P135, DOI 10.1016/j.neuroimage.2013.01.070	20	8	8	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2014	9	12							e116378	10.1371/journal.pone.0116378	http://dx.doi.org/10.1371/journal.pone.0116378			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX6YH	25549271	gold, Green Published, Green Submitted			2022-12-27	WOS:000347063500080
J	Kong, PF; Cai, QQ; Geng, QR; Wang, J; Lan, YD; Zhan, YQ; Xu, DZ				Kong, Pengfei; Cai, Qingqing; Geng, Qirong; Wang, Jing; Lan, Yadong; Zhan, Youqing; Xu, Dazhi			Vitamin Intake Reduce the Risk of Gastric Cancer: Meta-Analysis and Systematic Review of Randomized and Observational Studies	PLOS ONE			English	Article							BETA-CAROTENE SUPPLEMENTATION; STOMACH-CANCER; NUTRIENT INTAKE; ANTIOXIDANT VITAMINS; HELICOBACTER-PYLORI; NUTRITIONAL FACTORS; ALPHA-TOCOPHEROL; GASTROINTESTINAL CANCERS; MINERAL SUPPLEMENTATION; CARDIOVASCULAR-DISEASE	Aim: The association between vitamin intake and gastric cancer (GC) has been widely debated due to the relatively weak evidence. In this study, ameta-analysis of prospective and well designed observational studies were performed to explore this association. Methods: MEDLINE, Cochrane Library, and Sciencedirect were searched for studies of vitamin consumption and gastric cancer. This produced 47 relevant studies covering 1,221,392 human subjects. Random effects models were used to estimate summary relative risk (RR). Dose-response, subgroup, sensitivity, meta-regression, and publication bias analyses were conducted. Results: The RR of gastric cancer in the group with the highest vitamin intake was compared to that of the lowest intake group. Total vitamin intake was 0.78 (95% CI, 0.71-0.83). In 9 studies that individuals were given doses at least 4 times above the tolerable upper intake (UL) vitamins, the RR was 1.20 (95% CI, 0.99-1.44). However, in 17 studies that individuals received doses below the UL, the RR was 0.76 (95% CI, 0.68-0.86). Dose-response analysis was conducted on different increments in different types of vitamins (vitamin A: 1.5 mg/day, vitamin C: 100 mg/day, vitamin E: 10 mg/day) intake with a significant reduction in the risk of gastric cancer, respectively, 29% in vitamin A, 26% in vitamin C, and 24% in vitamin E. Conclusion: This meta-analysis clearly demonstrated that low doses of vitamins can significantly reduce the risk of GC, especially vitamin A, vitamin C, vitamin E.	[Kong, Pengfei; Cai, Qingqing; Geng, Qirong; Wang, Jing; Zhan, Youqing; Xu, Dazhi] Collaborat Innovat Ctr Canc Med, State Key Lab Oncol South China, Guangzhou, Guangdong, Peoples R China; [Kong, Pengfei; Zhan, Youqing; Xu, Dazhi] Sun Yat Sen Univ, Ctr Canc, Dept Gastr & Pancreat Surg, Guangzhou 510275, Guangdong, Peoples R China; [Cai, Qingqing] Sun Yat Sen Univ, Ctr Canc, Dept Med Oncol, Guangzhou 510275, Guangdong, Peoples R China; [Wang, Jing] Sun Yat Sen Univ, Ctr Canc, Dept Hematol Oncol, Guangzhou 510275, Guangdong, Peoples R China; [Wang, Jing] Sun Yat Sen Univ, Ctr Canc, Dept Mol Diag, Guangzhou 510275, Guangdong, Peoples R China; [Lan, Yadong] Bengbu Med Coll, Affiliated Hosp 1, Dept Surg Oncol, Bengbu, Peoples R China	State Key Lab Oncology South China; Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University; Bengbu Medical College	Xu, DZ (corresponding author), Collaborat Innovat Ctr Canc Med, State Key Lab Oncol South China, Guangzhou, Guangdong, Peoples R China.	xudzh@sysucc.org.cn			National Science Foundation of China [81172341]	National Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by National Science Foundation of China (No. 81172341). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBANES D, 1995, AM J CLIN NUTR, V62, P1427, DOI 10.1093/ajcn/62.6.1427S; Ames BN, 2001, MUTAT RES-FUND MOL M, V475, P7, DOI 10.1016/S0027-5107(01)00070-7; Bandera EV, 2009, CANCER CAUSE CONTROL, V20, P699, DOI 10.1007/s10552-008-9283-x; BEGG CB, 1989, J NATL CANCER I, V81, P107, DOI 10.1093/jnci/81.2.107; Bjelakovic G, 2008, ALIMENT PHARM THER, V28, P689, DOI 10.1111/j.1365-2036.2008.03785.x; Bjelakovic G, 2004, LANCET, V364, P1219, DOI 10.1016/S0140-6736(04)17138-9; Bjelakovic Goran, 2008, Cochrane Database Syst Rev, pCD004183, DOI 10.1002/14651858.CD004183.pub3; BOEING H, 1991, INT J CANCER, V47, P858, DOI 10.1002/ijc.2910470612; Borrill Z, 2003, BRIT MED J, V327, P1136, DOI 10.1136/bmj.327.7424.1136; Botterweck AAM, 2000, CANCER-AM CANCER SOC, V88, P737, DOI [10.1002/(SICI)1097-0142(20000215)88:4<737::AID-CNCR2>3.0.CO;2-H, 10.1002/(SICI)1097-0142(20000215)88:4&lt;737::AID-CNCR2&gt;3.0.CO;2-H]; BUIATTI E, 1991, INT J CANCER, V48, P369, DOI 10.1002/ijc.2910480310; Carman S, 2009, INT J CANCER, V125, P165, DOI 10.1002/ijc.24342; Carr AC, 2013, NUTRIENTS, V5, P4451, DOI 10.3390/nu5114451; Chen HL, 2002, NUTR CANCER, V42, P33, DOI 10.1207/S15327914NC421_5; Cook NR, 2000, CANCER CAUSE CONTROL, V11, P617, DOI 10.1023/A:1008995430664; CORNEE J, 1995, EUR J EPIDEMIOL, V11, P55, DOI 10.1007/BF01719946; CORREA P, 1985, JNCI-J NATL CANCER I, V75, P645; Correa P, 2000, JNCI-J NATL CANCER I, V92, P1881, DOI 10.1093/jnci/92.23.1881; DARTIGUES JF, 1990, EUR J EPIDEMIOL, V6, P261, DOI 10.1007/BF00150430; DAWSEY SM, 1994, CANCER EPIDEM BIOMAR, V3, P167; De Stefani E, 2000, EUR J CANCER PREV, V9, P329, DOI 10.1097/00008469-200010000-00007; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Ekstrom AM, 2000, INT J CANCER, V87, P133, DOI 10.1002/1097-0215(20000701)87:1&lt;133::AID-IJC20&gt;3.0.CO;2-E; Epplein M, 2010, AM J EPIDEMIOL, V172, P397, DOI 10.1093/aje/kwq144; Feldman D, 2014, NAT REV CANCER, V14, P342, DOI 10.1038/nrc3691; Gail MH, 2006, J NUTR, V136, p813S, DOI 10.1093/jn/136.3.813S; Garcia-Closas R, 1999, CANCER CAUSE CONTROL, V10, P71, DOI 10.1023/A:1008867108960; GONZALEZ CA, 1994, AM J EPIDEMIOL, V139, P466, DOI 10.1093/oxfordjournals.aje.a117029; Haga K, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-283; HANSSON LE, 1994, INT J CANCER, V57, P638, DOI 10.1002/ijc.2910570505; Harrison LE, 1997, CANCER-AM CANCER SOC, V80, P1021; Heart Protection Study Collaborative G, 2002, LANCET, V360, P23, DOI DOI 10.1016/S0140-6736(02)09328-5.; HEINONEN OP, 1994, NEW ENGL J MED, V330, P1029; Hennekens CH, 1996, NEW ENGL J MED, V334, P1145, DOI 10.1056/NEJM199605023341801; Hercberg S, 2004, ARCH INTERN MED, V164, P2335, DOI 10.1001/archinte.164.21.2335; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Jedrychowski W, 2001, Int J Occup Med Environ Health, V14, P391; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Ji BT, 1998, INT J CANCER, V76, P659, DOI 10.1002/(SICI)1097-0215(19980529)76:5&lt;659::AID-IJC8&gt;3.0.CO;2-P; KABAT GC, 1993, CANCER CAUSE CONTROL, V4, P123, DOI 10.1007/BF00053153; Kim HJ, 2005, NUTR CANCER, V52, P138, DOI 10.1207/s15327914nc5202_4; Lam TK, 2013, AM J CLIN NUTR, V98, P1289, DOI 10.3945/ajcn.113.061267; Larsson SC, 2007, AM J CLIN NUTR, V85, P497, DOI 10.1093/ajcn/85.2.497; Larsson SC, 2006, CANCER EPIDEM BIOMAR, V15, P1409, DOI 10.1158/1055-9965.EPI-05-0830; LAVECCHIA C, 1994, CANCER EPIDEM BIOMAR, V3, P393; Lee IM, 2005, JAMA-J AM MED ASSOC, V294, P56, DOI 10.1001/jama.294.1.56; Lei ZD, 2013, GASTROENTEROLOGY, V145, P554, DOI 10.1053/j.gastro.2013.05.010; LI JY, 1993, J NATL CANCER I, V85, P1492, DOI 10.1093/jnci/85.18.1492; Lissowska J, 2004, NUTR CANCER, V48, P149, DOI 10.1207/s15327914nc4802_4; Lopez-Carrillo L, 1999, INT J CANCER, V83, P601, DOI 10.1002/(SICI)1097-0215(19991126)83:5&lt;601::AID-IJC5&gt;3.0.CO;2-6; Lunet N, 2006, NUTR CANCER, V55, P71, DOI 10.1207/s15327914nc5501_9; Ma JL, 2012, J NATL CANCER I, V104, P488, DOI 10.1093/jnci/djs003; Malila N, 2002, CANCER CAUSE CONTROL, V13, P617, DOI 10.1023/A:1019556227014; Mayne ST, 2001, CANCER EPIDEM BIOMAR, V10, P1055; McAlister FA, 2007, PLOS MED, V4, P1325, DOI 10.1371/journal.pmed.0040250; Mera R, 2005, GUT, V54, P1536, DOI 10.1136/gut.2005.072009; Miyazaki M, 2012, GASTRIC CANCER, V15, P162, DOI 10.1007/s10120-011-0092-7; Munoz N, 2001, INT J CANCER, V93, P417, DOI 10.1002/ijc.1333; Neuhouser ML, 2009, ARCH INTERN MED, V169, P294, DOI 10.1001/archinternmed.2008.540; Nomura AMY, 2003, CANCER CAUSE CONTROL, V14, P547, DOI 10.1023/A:1024887411846; Omenn GS, 1996, NEW ENGL J MED, V334, P1150, DOI 10.1056/NEJM199605023341802; Palli D, 2001, CANCER CAUSE CONTROL, V12, P163, DOI 10.1023/A:1008970310963; Pelucchi C, 2009, ANN ONCOL, V20, P160, DOI 10.1093/annonc/mdn536; Plummer M, 2007, JNCI-J NATL CANCER I, V99, P137, DOI 10.1093/jnci/djk017; Qiu JL, 2005, WORLD J GASTROENTERO, V11, P4311; RAJAN R, 1995, J CLIN ONCOL, V13, P42, DOI 10.1200/JCO.1995.13.1.42; RAMON JM, 1993, INT J EPIDEMIOL, V22, P983, DOI 10.1093/ije/22.6.983; RISCH HA, 1985, AM J EPIDEMIOL, V122, P947, DOI 10.1093/oxfordjournals.aje.a114199; TAYLOR PR, 1995, AM J CLIN NUTR, V62, P1420; Terry P, 2000, INT J CANCER, V87, P750, DOI 10.1002/1097-0215(20000901)87:5&lt;750::AID-IJC19&gt;3.0.CO;2-6; Varis K, 1998, SCAND J GASTROENTERO, V33, P294, DOI 10.1080/00365529850170892; Virtamo J, 2003, JAMA-J AM MED ASSOC, V290, P476, DOI 10.1001/jama.290.4.476; Wu Y., 2014, CLIN NUTR; YOU WC, 1988, CANCER RES, V48, P3518; ZHENG W, 1995, AM J EPIDEMIOL, V142, P955, DOI 10.1093/oxfordjournals.aje.a117743; Zhou Y, 2011, GASTROENTEROLOGY, V141, P80, DOI 10.1053/j.gastro.2011.03.057; Zhu AL, 2012, J CLIN GASTROENTEROL, V46, P804, DOI 10.1097/MCG.0b013e3182604254; Zhu SS, 2003, CHINESE MED J-PEKING, V116, P15	78	31	32	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2014	9	12							e116060	10.1371/journal.pone.0116060	http://dx.doi.org/10.1371/journal.pone.0116060			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX6YH	25549091	gold, Green Published, Green Submitted			2022-12-27	WOS:000347063500049
J	Machado, JD; Chatkin, JM; Zimmer, AR; Goulart, APS; Thiesen, FV				Machado, Julia de Barros; Chatkin, Jose Miguel; Zimmer, Aline Rigon; Goulart, Ana Paula Szezepaniak; Thiesen, Flavia Valladao			Cotinine and Polycyclic Aromatic Hydrocarbons Levels in the Amniotic Fluid and Fetal Cord at Birth and in the Urine from Pregnant Smokers	PLOS ONE			English	Article							AMBIENT AIR-POLLUTION; SELF-REPORTED SMOKING; PRENATAL EXPOSURE; TOBACCO-SMOKE; DNA-ADDUCTS; OCCUPATIONAL-EXPOSURE; DETERMINING NICOTINE; GROWTH RESTRICTION; CIGARETTE-SMOKING; MATERNAL EXPOSURE	Cigarette smoking during pregnancy has several impacts on fetal development, including teratogenic effects. The objective of this study was to assess whether the toxic substances (cotinine and polycyclic aromatic hydrocarbons) found in pregnant smokers are transmitted to their fetuses. The outcomes were analyzed measuring cotinine and 1-hydroxypyrene in the amniotic fluid and maternal urine, benzopyrene and cotinine in the umbilical cord blood. Through a controlled cross-sectional design, 125 pregnant women were selected and classified according to their smoking status: 37 current smokers, 25 passive smokers and 63 non-smokers (controls). We performed high-performance liquid chromatography to measure substances' concentrations. A post-hoc Tukey's test was used to analyze the differences between the groups. All variables were significantly different between controls and smokers. The mean ratios between the concentration of cotinine in smokers compared to controls were as follows: 5.9 [2.5-13.5], p<0.001 in the urine; 25 [11.9-52.9], p<0.001 in the amniotic fluid; and 2.6 [1.0-6.8], p=0.044 in the umbilical cord blood. The mean ratios of 1-hydroxypyrene concentration between smokers and controls were 7.3 [1.6-29.6], p=0.003 in the urine and 1.3 [1.0-1.7], p=0.012 in the amniotic fluid, and of benzopyrene in umbilical cord blood was 2.9 [1.7-4.7], p<0.001. There were no significant differences between controls and passive smokers. When comparing the three groups together, there were statistical differences between all variables. Thus, the fetuses of pregnant smokers are exposed to toxic and carcinogens substances. To our knowledge, this is the first study to measure 1-hydroxypyrene in the amniotic fluid and benzopyrene in umbilical cord blood by high-performance liquid chromatography when considering pregnant women in relation to smoking exposure only.	[Machado, Julia de Barros; Chatkin, Jose Miguel; Goulart, Ana Paula Szezepaniak] Pontificia Univ Catolica, Sch Med, Porto Alegre, RS, Brazil; [Zimmer, Aline Rigon; Thiesen, Flavia Valladao] Pontificia Univ Catolica, Sch Pharm, Porto Alegre, RS, Brazil	Pontificia Universidade Catolica Do Rio Grande Do Sul; Pontificia Universidade Catolica Do Rio Grande Do Sul	Machado, JD (corresponding author), Pontificia Univ Catolica, Sch Med, Porto Alegre, RS, Brazil.	juliamachado@terra.com.br	Chatkin, Jose M/Q-3925-2016; Zimmer, Aline R/A-3330-2016; thiesen, flavia/A-3470-2017	Chatkin, Jose M/0000-0002-4343-025X; Zimmer, Aline R/0000-0002-8309-7068; thiesen, flavia/0000-0003-4907-6789				Ananth CV, 1999, OBSTET GYNECOL, V93, P622, DOI 10.1016/S0029-7844(98)00408-6; Anonymous, 2005, Morbidity and Mortality Weekly Report, V54, P297; [Anonymous], 2009, MMWR MORB MORTAL WKL, V58, P1232; Benowitz NL, 1996, EPIDEMIOL REV, V18, P188, DOI 10.1093/oxfordjournals.epirev.a017925; Binnie V, 2004, ORAL DIS, V10, P287, DOI 10.1111/j.1601-0825.2004.01018.x; Bocskay KA, 2005, CANCER EPIDEM BIOMAR, V14, P506, DOI 10.1158/1055-9965.EPI-04-0566; Bostrom CE, 2002, ENVIRON HEALTH PERSP, V110, P451, DOI 10.1289/ehp.02110s3451; BUCHET JP, 1992, BRIT J IND MED, V49, P761; Cattaneo RAAP, 2007, BRAZILIAN J TOXICOLO, V19, P6; Centers for Disease Control and Prevention (CDC), 2004, MMWR Morb Mortal Wkly Rep, V53, P54; Choi H, 2008, ENVIRON HEALTH PERSP, V116, P658, DOI 10.1289/ehp.10958; Dejmek J, 2000, ENVIRON HEALTH PERSP, V108, P1159, DOI 10.2307/3434828; Dolinoy DC, 2007, REPROD TOXICOL, V23, P297, DOI 10.1016/j.reprotox.2006.08.012; Dwyer Jennifer B., 2008, Birth Defects Research, V84, P30, DOI 10.1002/bdrc.20118; Edwards SC, 2010, ENVIRON HEALTH PERSP, V118, P1326, DOI 10.1289/ehp.0901070; Gilboa SM, 2005, AM J EPIDEMIOL, V162, P238, DOI 10.1093/aje/kwi189; HALEY NJ, 1989, AM J PUBLIC HEALTH, V79, P1046, DOI 10.2105/AJPH.79.8.1046; Harmonization ICot, 2005, VAL AN PROC TEXT MET; Hellstrom-Lindahl E, 2002, RESPIRATION, V69, P289, DOI 10.1159/000063261; Jedrychowski W, 2012, NUTRITION, V28, P372, DOI 10.1016/j.nut.2011.07.020; Jongeneelen FJ, 2001, ANN OCCUP HYG, V45, P3, DOI 10.1016/S0003-4878(00)00009-0; Jules GE, 2012, TOXICOLOGY, V295, P56, DOI 10.1016/j.tox.2012.01.017; Kim H, 2011, EUR J CLIN NUTR, V65, P1118, DOI 10.1038/ejcn.2011.77; Klebanoff MA, 1998, AM J EPIDEMIOL, V148, P259; Kohler E, 2007, HUM EXP TOXICOL, V26, P535, DOI 10.1177/0960327107072391; Kohler E, 2001, HUM EXP TOXICOL, V20, P1, DOI 10.1191/096032701669841404; Kriek E, 1998, MUTAT RES-FUND MOL M, V400, P215, DOI 10.1016/S0027-5107(98)00065-7; Langlois PH, 2013, CLEFT PALATE-CRAN J, V50, P337, DOI 10.1597/12-104; Leem JH, 2006, ENVIRON HEALTH PERSP, V114, P905, DOI 10.1289/ehp.8733; Liu SL, 2007, J EXPO SCI ENV EPID, V17, P426, DOI 10.1038/sj.jes.7500503; Llop S, 2008, SCI TOTAL ENVIRON, V407, P97, DOI 10.1016/j.scitotenv.2008.07.070; Machado JD, 2011, BMC PREGNANCY CHILDB, V11, DOI 10.1186/1471-2393-11-24; Mannes T, 2005, OCCUP ENVIRON MED, V62, P524, DOI 10.1136/oem.2004.014282; Maritz Gert S., 2008, Birth Defects Research, V84, P45, DOI 10.1002/bdrc.20116; Obolenskaya MY, 2010, TOXICOL LETT, V196, P80, DOI 10.1016/j.toxlet.2010.03.1115; OSTREA EM, 1994, J PEDIATR-US, V124, P471, DOI 10.1016/S0022-3476(94)70378-7; Perera F, 2005, CANCER EPIDEM BIOMAR, V14, P709, DOI 10.1158/1055-9965.EPI-04-0457; Perera F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004488; Perera FP, 2009, PEDIATRICS, V124, pE195, DOI 10.1542/peds.2008-3506; Petersen GO, 2010, J SEP SCI, V33, P516, DOI 10.1002/jssc.200900575; Pichini S, 2000, ENVIRON HEALTH PERSP, V108, P1079, DOI 10.2307/3434962; Polanska K, 2011, INT J OCCUP MED ENV, V24, P8, DOI 10.2478/s13382-011-0003-5; Ramesh A, 2004, INT J TOXICOL, V23, P301, DOI 10.1080/10915810490517063; Ritz B, 2007, AM J EPIDEMIOL, V166, P1045, DOI 10.1093/aje/kwm181; Rogers JM, 2009, REPROD TOXICOL, V28, P152, DOI 10.1016/j.reprotox.2009.03.012; Rossner P, 2009, MUTAT RES-FUND MOL M, V669, P20, DOI 10.1016/j.mrfmmm.2009.04.010; Rundle A, 2012, AM J EPIDEMIOL, V175, P1163, DOI 10.1093/aje/kwr455; Santos S, 2008, PNEUMOLOGIA PAULISTA, V21; Sasco AJ, 1999, HUM EXP TOXICOL, V18, P192, DOI 10.1191/096032799678839905; Shi Min, 2008, Birth Defects Research, V84, P16, DOI 10.1002/bdrc.20117; Stejskalova L, 2011, CURR PHARM BIOTECHNO, V12, P715, DOI 10.2174/138920111795470994; Suzuki Y, 2010, ENVIRON INT, V36, P699, DOI 10.1016/j.envint.2010.05.003; Wang Lei, 2008, Birth Defects Research, V84, P54, DOI 10.1002/bdrc.20114; WHO, 2011, CENT EUR J PUBL HEAL, V19, P151; WHO urges more countries to require large, 2011, CENT EUR J PUBL HEAL, V19, P133; WHO (World Health Organization), 1998, SEL NONH POL AR HYDR; Whyatt RM, 1998, CARCINOGENESIS, V19, P1389, DOI 10.1093/carcin/19.8.1389; Wilhelm M, 2005, ENVIRON HEALTH PERSP, V113, P1212, DOI 10.1289/ehp.7751; World Health Organization, 2011, IMPL TOB CONTR; World Health Organization, 2013, REP GLOB TOB EP ENF; Ziaei S, 2005, PAEDIATR PERINAT EP, V19, P27, DOI 10.1111/j.1365-3016.2004.00619.x	61	11	13	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2014	9	12							e116293	10.1371/journal.pone.0116293	http://dx.doi.org/10.1371/journal.pone.0116293			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX6YH	25549364	Green Published, gold, Green Submitted			2022-12-27	WOS:000347063500072
J	Tijet, N; Sheth, PM; Lastovetska, O; Chung, C; Patel, SN; Melano, RG				Tijet, Nathalie; Sheth, Prameet M.; Lastovetska, Olga; Chung, Catherine; Patel, Samir N.; Melano, Roberto G.			Molecular Characterization of Klebsiella pneumoniae Carbapenemase (KPC)-Producing Enterobacteriaceae in Ontario, Canada, 2008-2011	PLOS ONE			English	Article							BETA-LACTAMASE; SEQUENCE; PLASMIDS; OUTBREAK; DISSEMINATION; EPIDEMIOLOGY; KPC; PLANTICOLA; EXPANSION; CLOACAE	Due to the lack of detailed reports of Klebsiella pneumoniae carbapenemase (KPC)-producing enterobacteria in Ontario, Canada, we perform a molecular characterization of KPC-producing Enterobacteriaceae submitted to the provincial reference laboratory from 2008 to 2011. Susceptibility profiles were accessed by E-test. Molecular types of isolates were determined by pulse-field gel electrophoresis (PFGE) and multilocus sequence typing. Screening of beta-lactamase genes was performed by multiplex PCR and alleles were identified by DNA sequencing. The genetic platform of bla(KPC) gene was analyzed by PCR. Plasmid replicons were typed using PCR-based typing approach. KPC-plasmids were also evaluated by S1 nuclease-PFGE and Southern blot. Thirty unique clinical isolates (26 Klebsiella pneumoniae, 2 Enterobacter cloacae, 1 Citrobacter freundii and 1 Raoultella ornithinolytica) were identified as blaKPC positive: 4 in 2008, 3 in 2009, 10 in 2010 and 13 in 2011. The majority exhibited resistance to carbapenems, cephalosporins and fluoroquinolones and two isolates were also resistant to colistin. The isolates harbored bla(KPC-2) (n=23) or bla(KPC-3) (n=7). bla(TEM-1) (n=27) was commonly detected and occasionally bla(OXA-1) (n=3) and bla(CTX-M-15) (n=1). As expected, all K. pneumoniae isolates carried bla(SHV-11). blaKPC genes were identified on Tn4401a (n=20) or b (n=10) isoforms, on plasmids of different sizes belonging to the incompatibility groups IncFIIA (n=19), IncN (n=3), IncI2 (n=3), IncFrep (n=2) and IncA/C (n=1). The occurrence of KPC beta-lactamase in Ontario was mainly associated with the spread of the K. pneumoniae clone ST258.	[Tijet, Nathalie; Lastovetska, Olga; Chung, Catherine; Patel, Samir N.; Melano, Roberto G.] Publ Hlth Ontario Labs, Toronto, ON, Canada; [Sheth, Prameet M.] Queens Univ, Dept Pathol & Mol Med, Kingston, ON, Canada; [Patel, Samir N.; Melano, Roberto G.] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada; [Melano, Roberto G.] Mt Sinai Hosp, Dept Microbiol, Toronto, ON M5G 1X5, Canada	McMaster University; Queens University - Canada; University of Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute	Melano, RG (corresponding author), Publ Hlth Ontario Labs, Toronto, ON, Canada.	roberto.melano@oahpp.ca			Public Health Ontario	Public Health Ontario	This work was supported by Public Health Ontario internal funding. The authors received no specific funding for this work. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrade LN, 2011, ANTIMICROB AGENTS CH, V55, P3579, DOI 10.1128/AAC.01783-10; BARTON BM, 1995, ANAL BIOCHEM, V226, P235, DOI 10.1006/abio.1995.1220; Bennett JW, 2009, ANTIMICROB AGENTS CH, V53, P292, DOI 10.1128/AAC.00931-08; Borgia S, 2012, CLIN INFECT DIS, V55, pE109, DOI 10.1093/cid/cis737; Carattoli A, 2005, J MICROBIOL METH, V63, P219, DOI 10.1016/j.mimet.2005.03.018; Carattoli A, 2013, INT J MED MICROBIOL, V303, P298, DOI 10.1016/j.ijmm.2013.02.001; Castanheira M, 2009, J CLIN MICROBIOL, V47, P4129, DOI 10.1128/JCM.01502-09; Chan WW, 2013, DIAGN MICR INFEC DIS, V75, P317, DOI 10.1016/j.diagmicrobio.2012.12.003; Chen L, 2013, ANTIMICROB AGENTS CH, V57, P5019, DOI 10.1128/AAC.01397-13; Clinical and Laboratory Standards Institute, 2014, M100S24 CLSI; Cuzon G, 2010, EMERG INFECT DIS, V16, P1349, DOI 10.3201/eid1609.091389; Dallenne C, 2010, J ANTIMICROB CHEMOTH, V65, P490, DOI 10.1093/jac/dkp498; Deleo FR, 2014, P NATL ACAD SCI USA, V111, P4988, DOI 10.1073/pnas.1321364111; Denisuik AJ, 2013, J ANTIMICROB CHEMOTH, V68, pi57, DOI 10.1093/jac/dkt027; Diancourt L, 2005, J CLIN MICROBIOL, V43, P4178, DOI 10.1128/JCM.43.8.4178-4182.2005; Drancourt M, 2001, INT J SYST EVOL MICR, V51, P925, DOI 10.1099/00207713-51-3-925; Goldfarb D, 2009, J CLIN MICROBIOL, V47, P1920, DOI 10.1128/JCM.00098-09; Gomez SA, 2011, CLIN MICROBIOL INFEC, V17, P1520, DOI 10.1111/j.1469-0691.2011.03600.x; Haraoui LP, 2013, J CLIN MICROBIOL, V51, P2406, DOI 10.1128/JCM.02480-12; Hunter SB, 2005, J CLIN MICROBIOL, V43, P1045, DOI 10.1128/JCM.43.3.1045-1050.2005; Kitchel B, 2009, ANTIMICROB AGENTS CH, V53, P3365, DOI 10.1128/AAC.00126-09; Leung V, 2012, CAN J INFECT DIS MED, V23, P117, DOI 10.1155/2012/725151; Mataseje LF, 2012, J ANTIMICROB CHEMOTH, V67, P1359, DOI 10.1093/jac/dks046; Munoz-Price LS, 2013, LANCET INFECT DIS, V13, P785, DOI 10.1016/S1473-3099(13)70190-7; Naas T, 2008, ANTIMICROB AGENTS CH, V52, P1257, DOI 10.1128/AAC.01451-07; Nordberg V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076597; Nordmann P, 2009, LANCET INFECT DIS, V9, P228, DOI 10.1016/S1473-3099(09)70054-4; Osborn AM, 2000, MICROBIOL-UK, V146, P2267, DOI 10.1099/00221287-146-9-2267; Osterblad M, 2012, J ANTIMICROB CHEMOTH, V67, P2860, DOI 10.1093/jac/dks299; Oteo J, 2013, ANTIMICROB AGENTS CH, V57, P6344, DOI 10.1128/AAC.01513-13; Peirano G, 2014, J CLIN MICROBIOL, V52, P1575, DOI 10.1128/JCM.00162-14; Pillai DR, 2009, EMERG INFECT DIS, V15, P827, DOI 10.3201/eid1505.081536; Robledo IE, 2010, ANTIMICROB AGENTS CH, V54, P1354, DOI 10.1128/AAC.00899-09; Sanchez-Romero I, 2012, ANTIMICROB AGENTS CH, V56, P420, DOI 10.1128/AAC.05036-11; Tanne JH, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e1646; Tijet N, 2011, EMERG INFECT DIS, V17, P306, DOI 10.3201/eid1702.101561; Tijet N, 2011, ANTIMICROB AGENTS CH, V55, P904, DOI 10.1128/AAC.00962-10; Tzouvelekis LS, 2012, CLIN MICROBIOL REV, V25, P682, DOI 10.1128/CMR.05035-11; Walckenaer E, 2004, ANTIMICROB AGENTS CH, V48, P305, DOI 10.1128/AAC.48.1.305-312.2004; Walsh TR, 2010, INT J ANTIMICROB AG, V36, pS8, DOI 10.1016/S0924-8579(10)70004-2; Woodford N, 2011, FEMS MICROBIOL REV, V35, P736, DOI 10.1111/j.1574-6976.2011.00268.x; Yigit H, 2001, ANTIMICROB AGENTS CH, V45, P1151, DOI 10.1128/AAC.45.4.1151-1161.2001	42	28	30	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2014	9	12							e116421	10.1371/journal.pone.0116421	http://dx.doi.org/10.1371/journal.pone.0116421			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX6YH	25549365	Green Submitted, Green Published, gold			2022-12-27	WOS:000347063500082
J	Wilson, ACC; Delgado, RN; Vorburger, C				Wilson, Alex C. C.; Delgado, Ryan N.; Vorburger, Christoph			Biased Transmission of Sex Chromosomes in the Aphid Myzus persicae Is Not Associated with Reproductive Mode	PLOS ONE			English	Article							PEACH-POTATO APHID; X-CHROMOSOME; SULZER HEMIPTERA; RECOMBINATION; SITOBION	Commonly, a single aphid species exhibits a wide range of reproductive strategies including cyclical parthenogenesis and obligate parthenogenesis. Sex determination in aphids is chromosomal; females have two X chromosomes, while males have one. X chromosome elimination at male production is generally random, resulting in equal representation of both X chromosomes in sons. However, two studies have demonstrated deviations from randomness in some lineages. One hypothesis to account for such deviations is that recessive deleterious mutations accumulate during bouts of asexual reproduction and affect male viability, resulting in overrepresentation of males with the least deleterious of the two maternal X chromosomes. This hypothesis results in a testable prediction: X chromosome transmission bias will increase with time spent in the asexual phase and should therefore be most extreme in the least sexual aphid life cycle class. Here we test this prediction in Myzus persicae. We used multiple heterozygous X-linked microsatellite markers to screen 1085 males from 95 lines of known life cycle. We found significant deviations from equal representation of X chromosomes in 15 lines; however, these lines included representatives of all life cycles. Our results are inconsistent with the hypothesis that deviations from randomness are attributable to mutation accumulation.	[Wilson, Alex C. C.; Delgado, Ryan N.] Univ Arizona, Dept Ecol & Evolutionary Biol, Tucson, AZ USA; [Vorburger, Christoph] ETH, Inst Integrat Biol, Zurich, Switzerland; [Vorburger, Christoph] Swiss Fed Inst Aquat Sci & Technol, Eawag, Dubendorf, Switzerland	University of Arizona; Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; Swiss Federal Institute of Aquatic Science & Technology (EAWAG)	Wilson, ACC (corresponding author), Univ Miami, Dept Biol, Coral Gables, FL 33124 USA.	acwilson@bio.miami.edu	Vorburger, Christoph/A-1650-2008	Vorburger, Christoph/0000-0002-3627-0841	National Institutes of Health Training Grant [1 K12 Gm00708]; Swiss National Science Foundation; Faculty of Science, Technology and Engineering, La Trobe University [104084]; National Science Foundation [0313737, 1121847]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K12GM000708] Funding Source: NIH RePORTER	National Institutes of Health Training Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Faculty of Science, Technology and Engineering, La Trobe University; National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Training Grant #1 K12 Gm00708 to the Center for Insect Science, University of Arizona, Swiss National Science Foundation Fellowship to Christoph Vorburger, Small Grant (104084) from the Faculty of Science, Technology and Engineering, La Trobe University to Paul Sunnucks, National Science Foundation 0313737 funds to Nancy Moran, and National Science Foundation Award 1121847 to Alex Wilson. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], APHIDS THEIR BIOL NA; Blackman RL, 1996, CHROMOSOME RES, V4, P314, DOI 10.1007/BF02263684; Blackman RL, 2000, HEREDITY, V84, P254, DOI 10.1046/j.1365-2540.2000.00667.x; Frantz A, 2005, GENET RES, V85, P111, DOI 10.1017/S0016672305007482; Frantz A, 2010, B ENTOMOL RES, V100, P59, DOI 10.1017/S0007485309006750; Hales DF, 2002, GENET RES, V79, P203, DOI 10.1017/S0016672302005657; Hales DF, 2002, GENET RES, V79, P119, DOI 10.1017/S001667230100550X; Jaenike J, 2001, ANNU REV ECOL SYST, V32, P25, DOI 10.1146/annurev.ecolsys.32.081501.113958; Jaquiery J, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003690; Jiggins FM, 1999, AM NAT, V154, P481, DOI 10.1086/303251; Mandrioli M, 1999, CHROMOSOME RES, V7, P157, DOI 10.1023/A:1009215721904; MULLER HJ, 1964, MUTAT RES, V1, P2, DOI 10.1016/0027-5107(64)90047-8; RCore Team, 2020, R LANG ENV STAT COMP; SANDLER L, 1957, AM NAT, V91, P105, DOI 10.1086/281969; Sloane MA, 2001, GENET RES, V77, P251, DOI 10.1017/S0016672301005018; Sokal R.R., 2012, BIOMETRY; Vorburger C, 2003, MOL ECOL, V12, P3493, DOI 10.1046/j.1365-294X.2003.01998.x; White M. J. D, 1973, ANIMAL CYTOLOGY EVOL; Wilson ACC, 2004, MOL ECOL NOTES, V4, P104, DOI 10.1046/j.1471-8286.2004.00584.x; Wilson ACC, 2003, BIOL J LINN SOC, V79, P115, DOI 10.1046/j.1095-8312.2003.00176.x; Wilson ACC, 1997, GENET RES, V69, P233, DOI 10.1017/S0016672397002747; Wilson ACC, 2000, REPROD STRATEGY GENE; Wilson ACC, 2006, GENET RES, V87, P175, DOI 10.1017/S0016672306008202	23	2	2	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2014	9	12							e116348	10.1371/journal.pone.0116348	http://dx.doi.org/10.1371/journal.pone.0116348			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX6YH	25548924	gold, Green Published, Green Submitted			2022-12-27	WOS:000347063500078
J	Chen, CC; Hung, TH; Lee, CY; Wang, LF; Wu, CH; Ke, CH; Chen, SF				Chen, Chien-Cheng; Hung, Tai-Ho; Lee, Chao Yu; Wang, Liang-Fei; Wu, Chun-Hu; Ke, Chia-Hua; Chen, Szu-Fu			Berberine Protects against Neuronal Damage via Suppression of Glia-Mediated Inflammation in Traumatic Brain Injury	PLOS ONE			English	Article							CONTROLLED CORTICAL IMPACT; COPTIDIS-RHIZOMA EXTRACT; CEREBRAL-ISCHEMIA; INTESTINAL INJURY; TYROSINE KINASE; NERVOUS-SYSTEM; NITRIC-OXIDE; IN-VITRO; MICROGLIA; MICE	Traumatic brain injury (TBI) triggers a series of neuroinflammatory processes that contribute to evolution of neuronal injury. The present study investigated the neuroprotective effects and anti-inflammatory actions of berberine, an isoquinoline alkaloid, in both in vitro and in vivo TBI models. Mice subjected to controlled cortical impact injury were injected with berberine (10 mg.kg(-1)) or vehicle 10 min after injury. In addition to behavioral studies and histology analysis, blood-brain barrier (BBB) permeability and brain water content were determined. Expression of PI3K/Akt and Erk signaling and inflammatory mediators were also analyzed. The protective effect of berberine was also investigated in cultured neurons either subjected to stretch injury or exposed to conditioned media with activated microglia. Berberine significantly attenuated functional deficits and brain damage associated with TBI up to day 28 post-injury. Berberine also reduced neuronal death, apoptosis, BBB permeability, and brain edema at day 1 post-injury. These changes coincided with a marked reduction in leukocyte infiltration, microglial activation, matrix metalloproteinase-9 activity, and expression of inflammatory mediators. Berberine had no effect on Akt or Erk 1/2 phosphorylation. In mixed glial cultures, berberine reduced TLR4/MyD88/NF-kappa B signaling. Berberine also attenuated neuronal death induced by microglial conditioned media; however, it did not directly protect cultured neurons subjected to stretch injury. Moreover, administration of berberine at 3 h post-injury also reduced TBI-induced neuronal damage, apoptosis and inflammation in vivo. Berberine reduces TBI-induced brain damage by limiting the production of inflammatory mediators by glial cells, rather than by a direct neuroprotective effect.	[Chen, Chien-Cheng; Lee, Chao Yu; Ke, Chia-Hua; Chen, Szu-Fu] Cheng Hsin Gen Hosp, Dept Phys Med & Rehabil, Taipei, Taiwan; [Hung, Tai-Ho] Chang Gung Mem Hosp, Dept Obstet & Gynecol, Taipei 10591, Taiwan; [Hung, Tai-Ho] Chang Gung Univ, Coll Med, Taipei, Taiwan; [Wang, Liang-Fei; Wu, Chun-Hu; Ke, Chia-Hua; Chen, Szu-Fu] Natl Def Med Ctr, Dept Physiol, Taipei, Taiwan; [Wang, Liang-Fei; Wu, Chun-Hu; Ke, Chia-Hua; Chen, Szu-Fu] Natl Def Med Ctr, Dept Biophys, Taipei, Taiwan; [Wang, Liang-Fei; Wu, Chun-Hu] Natl Def Med Ctr, Grad Inst Life Sci, Taipei, Taiwan	Cheng Hsin General Hospital; Chang Gung Memorial Hospital; Chang Gung University; National Defense Medical Center; National Defense Medical Center; National Defense Medical Center	Chen, SF (corresponding author), Cheng Hsin Gen Hosp, Dept Phys Med & Rehabil, Taipei, Taiwan.	szufuchen@yahoo.com.tw	Hung, Tai-Ho/ABD-1800-2020; Hung, Tai-Ho/C-7584-2011; WU, CHUN-HU/P-3958-2018	Hung, Tai-Ho/0000-0003-2354-7060; WU, CHUN-HU/0000-0001-6851-7936	National Science Council of Taiwan, R.O.C. (NSC) [101-2314-B-350-001-MY3]; Cheng Hsin General Hospital	National Science Council of Taiwan, R.O.C. (NSC)(Ministry of Science and Technology, Taiwan); Cheng Hsin General Hospital	This work was supported by 1. SFC: Grants from the National Science Council of Taiwan, R.O.C. (NSC 101-2314-B-350-001-MY3); 2. SFC and CCC: Cheng Hsin General Hospital. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057208; Amasheh M, 2010, J CELL SCI, V123, P4145, DOI 10.1242/jcs.070896; Barreto George, 2011, Central Nervous System Agents in Medicinal Chemistry, V11, P164; Baskaya MK, 1997, NEUROSCI LETT, V226, P33; Batchelor PE, 1999, J NEUROSCI, V19, P1708; Block ML, 2005, PROG NEUROBIOL, V76, P77, DOI 10.1016/j.pneurobio.2005.06.004; Bramlett HM, 2004, J CEREBR BLOOD F MET, V24, P133, DOI 10.1097/01.WCB.0000111614.19196.04; Brown GC, 2010, MOL NEUROBIOL, V41, P242, DOI 10.1007/s12035-010-8105-9; Campanella M, 2002, STROKE, V33, P586, DOI 10.1161/hs0202.103399; Carson MJ, 1998, GLIA, V22, P72, DOI 10.1002/(SICI)1098-1136(199801)22:1<72::AID-GLIA7>3.0.CO;2-A; Chai YS, 2013, EUR J PHARMACOL, V708, P44, DOI 10.1016/j.ejphar.2013.02.041; Chang CF, 2011, AM J PATHOL, V178, P1749, DOI 10.1016/j.ajpath.2010.12.023; Chen CC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030294; Chen S, 2003, EXP NEUROL, V182, P87, DOI 10.1016/S0014-4886(03)00002-5; Chen SF, 2008, BRIT J PHARMACOL, V155, P1279, DOI 10.1038/bjp.2008.345; Chen SF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045763; Das M, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-236; Downes CE, 2010, BRIT J PHARMACOL, V160, P1872, DOI 10.1111/j.1476-5381.2010.00864.x; Durairajan SSK, 2012, NEUROBIOL AGING, V33, P2903, DOI 10.1016/j.neurobiolaging.2012.02.016; Gladstone DJ, 2002, STROKE, V33, P2123, DOI 10.1161/01.STR.0000025518.34157.51; Haase G, 2008, CURR OPIN NEUROBIOL, V18, P284, DOI 10.1016/j.conb.2008.07.013; Helmy A, 2011, J CEREBR BLOOD F MET, V31, P658, DOI 10.1038/jcbfm.2010.142; Hu J, 2012, EUR J PHARMACOL, V674, P132, DOI 10.1016/j.ejphar.2011.11.014; Jara JH, 2007, J NEUROCHEM, V100, P1407, DOI 10.1111/j.1471-4159.2006.04330.x; Jia LY, 2012, J PHARM PHARMACOL, V64, P1510, DOI 10.1111/j.2042-7158.2012.01529.x; Jiang-Shieh YF, 2005, J NEUROSCI RES, V82, P515, DOI 10.1002/jnr.20663; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; Kong LY, 1996, BRAIN RES, V729, P102, DOI 10.1016/0006-8993(96)00417-9; Koshinaga M, 2007, HISTOL HISTOPATHOL, V22, P129, DOI 10.14670/HH-22.129; Kulkarni SK, 2010, PHYTOTHER RES, V24, P317, DOI 10.1002/ptr.2968; Li HM, 2011, ACTA PHARMACOL SIN, V32, P1364, DOI 10.1038/aps.2011.102; Liao YJ, 2013, NEW ENGL J MED, V368, P2014, DOI 10.1056/NEJMicm1205007; Lu DY, 2010, J CELL BIOCHEM, V110, P697, DOI 10.1002/jcb.22580; Lucas SM, 2006, BRIT J PHARMACOL, V147, pS232, DOI 10.1038/sj.bjp.0706400; Ma YY, 2004, NAT IMMUNOL, V5, P380, DOI 10.1038/ni1054; McConeghy KW, 2012, CNS DRUGS, V26, P613, DOI 10.2165/11634020-000000000-00000; Nag S, 2009, ACTA NEUROPATHOL, V118, P197, DOI 10.1007/s00401-009-0541-0; Numakawa T, 2010, HISTOL HISTOPATHOL, V25, P237, DOI 10.14670/HH-25.237; Sato S, 2000, P NATL ACAD SCI USA, V97, P10832, DOI 10.1073/pnas.170276797; Semple BD, 2010, J CEREBR BLOOD F MET, V30, P769, DOI 10.1038/jcbfm.2009.262; Singhal A, 2002, J NEUROTRAUM, V19, P929, DOI 10.1089/089771502320317087; Siopi E, 2011, J NEUROTRAUM, V28, P2135, DOI 10.1089/neu.2010.1738; Song B, 2012, CELL IMMUNOL, V276, P91, DOI 10.1016/j.cellimm.2012.04.006; Tan XS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077969; Truettner JS, 2007, J NEUROTRAUM, V24, P599, DOI 10.1089/neu.2006.0186; Wang XL, 2005, AM J CHINESE MED, V33, P935, DOI 10.1142/S0192415X05003557; Wang XL, 2005, LIFE SCI, V77, P3058, DOI 10.1016/j.lfs.2005.02.033; Wang XY, 2000, J NEUROSCI, V20, P7037, DOI 10.1523/JNEUROSCI.20-18-07037.2000; Wang YQ, 2009, CARDIOVASC RES, V82, P484, DOI 10.1093/cvr/cvp078; Zhang QA, 2011, FOOD CHEM TOXICOL, V49, P61, DOI 10.1016/j.fct.2010.09.032; Zhang XL, 2012, BRAIN RES, V1459, P61, DOI 10.1016/j.brainres.2012.03.065; Zhao X, 2008, AM J PHYSIOL-LUNG C, V295, pL497, DOI 10.1152/ajplung.90210.2008; Zhou XQ, 2008, NEUROSCI LETT, V447, P31, DOI 10.1016/j.neulet.2008.09.064; Zweckberger K, 2006, J NEUROTRAUM, V23, P1083, DOI 10.1089/neu.2006.23.1083	54	42	49	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2014	9	12							e115694	10.1371/journal.pone.0115694	http://dx.doi.org/10.1371/journal.pone.0115694			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UN	25546475	Green Submitted, Green Published, gold			2022-12-27	WOS:000347120200055
J	Nie, P; Yang, GJ; Wang, XM; Duan, YH; Xu, WJ; Li, HO; Cao, T; Liu, XJ; Ji, XP; Cheng, ZP; Wang, AB				Nie, Pei; Yang, Guangjie; Wang, Ximing; Duan, Yanhua; Xu, Wenjian; Li, Haiou; Cao, Ting; Liu, Xuejun; Ji, Xiaopeng; Cheng, Zhaoping; Wang, Anbiao			Application of Prospective ECG-Gated High-Pitch 128-Slice Dual-Source CT Angiography in the Diagnosis of Congenital Extracardiac Vascular Anomalies in Infants and Children	PLOS ONE			English	Article							HEART-DISEASE; MULTIDETECTOR CT; ABNORMALITIES; MULTISLICE; ANATOMY; AORTA	Purpose: To investigate the value of prospective ECG-gated high-pitch 128-slice dual-source CT (DSCT) angiography in the diagnosis of congenital extracardiac vascular anomalies in infants and children in comparison with transthoracic echocardiography (TTE). Methods: Eighty consecutive infants or children clinically diagnosed of congenital heart disease and suspected with extracardiac vascular anomaly were enrolled, and 75 patients were finally included in this prospective study. All patients underwent prospective ECG-gated high-pitch DSCT angiography after TTE with an interval of 1-7 days. The diagnostic accuracy and sensitivity of high-pitch DSCT angiography and TTE were compared according to the surgical/CCA findings. The image quality of DSCT was assessed using a five-point scale. The effective radiation dose (ED) was calculated. Results: A total of 17 congenital heart diseases and 162 separate extracardiac vascular anomalies were confirmed by surgical/CCA findings in 75 patients. The diagnostic accuracy of high-pitch DSCT angiography and TTE was 99.67% and 97.89%, respectively. The sensitivity of high-pitch DSCT angiography and TTE was 97.53% and 79.62%, respectively. There was significant difference regarding to the diagnostic accuracy and the sensitivity between high-pitch DSCT angiography and TTE (chi(2) = 23.561 and 28.013, P<0.05). The agreement on the image quality scoring of DSCT between the two observers was excellent (kappa=0.81), and the mean score of image quality was 4.1 +/- 0.7. The mean ED of DSCT was 0.29 +/- 0.08 mSv. Conclusions: Prospective ECG-gated high-pitch 128-slice DSCT angiography with low radiation dose and high diagnostic accuracy has higher sensitivity compared to TTE in the detection of congenital extracardiac vascular anomalies in infants and children.	[Nie, Pei; Xu, Wenjian; Liu, Xuejun] Qingdao Univ, Dept Radiol, Affiliated Hosp, Qingdao 266071, Shandong, Peoples R China; [Yang, Guangjie] Shandong Univ, Dept Nucl Med, Qilu Hosp, Jinan 250100, Shandong, Peoples R China; [Wang, Ximing; Duan, Yanhua; Li, Haiou; Cao, Ting; Ji, Xiaopeng; Cheng, Zhaoping] Shandong Med Imaging Res Inst, Shandong Prov Key Lab Diag & Treatment Cardiocere, Jinan, Shandong, Peoples R China; [Wang, Anbiao] Shandong Prov Hosp, Dept Cardiovasc Surg, Jinan, Shandong, Peoples R China	Qingdao University; Shandong University; Shandong First Medical University & Shandong Academy of Medical Sciences	Wang, XM (corresponding author), Shandong Med Imaging Res Inst, Shandong Prov Key Lab Diag & Treatment Cardiocere, Jinan, Shandong, Peoples R China.	Wangximing369@hotmail.com		Cheng, Zhaoping/0000-0001-7217-7284	Natural Science Foundation of Shandong Province [ZR2011HQ022]	Natural Science Foundation of Shandong Province(Natural Science Foundation of Shandong Province)	This study was supported by grants from the Natural Science Foundation of Shandong Province (Liu X, ZR2011HQ022). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achenbach S, 2011, JACC-CARDIOVASC IMAG, V4, P328, DOI 10.1016/j.jcmg.2011.01.012; Ben Saad M, 2009, PEDIATR RADIOL, V39, P668, DOI 10.1007/s00247-009-1209-6; Chandrashekhar G, 2012, EUR J RADIOL, V81, P4211, DOI 10.1016/j.ejrad.2012.08.010; Cheng ZP, 2010, EUR RADIOL, V20, P2503, DOI 10.1007/s00330-010-1822-7; Chung Jonathan H, 2009, J Cardiovasc Comput Tomogr, V3, pS35, DOI 10.1016/j.jcct.2008.11.005; Flohr TG, 2009, MED PHYS, V36, P5641, DOI 10.1118/1.3259739; Goetti R, 2010, AM J ROENTGENOL, V194, P938, DOI 10.2214/AJR.09.3482; Goo HW, 2003, RADIOGRAPHICS, V23, pS147, DOI 10.1148/rg.23si035501; Goo HW, 2010, KOREAN J RADIOL, V11, P4, DOI 10.3348/kjr.2010.11.1.4; Greil GF, 2006, PEDIATR RADIOL, V36, P502, DOI 10.1007/s00247-006-0143-0; Hughes D, 2010, RADIOL CLIN N AM, V48, P817, DOI 10.1016/j.rcl.2010.04.005; Kim JE, 2010, AM J ROENTGENOL, V194, P1188, DOI 10.2214/AJR.09.3726; Kimura-Hayama ET, 2010, RADIOGRAPHICS, V30, P79, DOI 10.1148/rg.301095061; Krishnamurthy R, 2010, PEDIATR RADIOL, V40, P518, DOI 10.1007/s00247-010-1549-2; Krishnamurthy Rajesh, 2009, Pediatr Radiol, V39 Suppl 2, pS196, DOI 10.1007/s00247-009-1166-0; Lell M, 2009, EUR RADIOL, V19, P2576, DOI 10.1007/s00330-009-1558-4; Long YG, 2010, PEDIATR NEONATOL, V51, P227, DOI 10.1016/S1875-9572(10)60043-5; Maldonado JA, 2010, RADIOL CLIN N AM, V48, P85, DOI 10.1016/j.rcl.2009.09.004; Nie P, 2012, CLIN RADIOL, V67, P738, DOI 10.1016/j.crad.2011.12.007; Nie P, 2012, EUR RADIOL, V22, P2057, DOI 10.1007/s00330-012-2479-1; Oguz B, 2007, BRIT J RADIOL, V80, P376, DOI 10.1259/bjr/47124005; Pache G, 2011, EUR J RADIOL, V80, pE440, DOI 10.1016/j.ejrad.2011.01.032; Paul JF, 2011, PEDIATR RADIOL, V41, P244, DOI 10.1007/s00247-010-1804-6; Paul JF, 2010, PEDIATR RADIOL, V40, P869, DOI 10.1007/s00247-010-1614-x; Tsai IC, 2008, PEDIATR RADIOL, V38, P438, DOI 10.1007/s00247-008-0761-9; Vyas HV, 2012, RADIOGRAPHICS, V32, P87, DOI 10.1148/rg.321105764; Wolf F, 2010, EUR RADIOL, V20, P2084, DOI 10.1007/s00330-010-1792-9; Yang DH, 2008, PEDIATR RADIOL, V38, P89, DOI 10.1007/s00247-007-0662-3; Young C, 2011, EUR RADIOL, V21, P518, DOI 10.1007/s00330-010-2036-8	29	14	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2014	9	12							e115793	10.1371/journal.pone.0115793	http://dx.doi.org/10.1371/journal.pone.0115793			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UN	25546178	Green Published, gold, Green Submitted			2022-12-27	WOS:000347120200068
J	Vasquez, D; Scharcanski, J; Wong, A				Vasquez, Dionicio; Scharcanski, Jacob; Wong, Alexander			Automatic Framework for Extraction and Characterization of Wetting Front Propagation Using Tomographic Image Sequences of Water Infiltrated Soils	PLOS ONE			English	Article							NEUTRON-RADIOGRAPHY; TEXTURE ANALYSIS; POROUS-MEDIA; PROFILES	This paper presents a new automatic framework for extracting and characterizing the dynamic shape of the 3D wetting front and its propagation, based in a sequence of tomographic images acquired as water (moisture) infiltrates in unsaturated soils. To the best of the authors' knowledge, the shape of the 3D wetting front and its propagation and progress over time has not been previously produced as a whole by methods in existing literature. The proposed automatic framework is composed two important and integrated modules: i) extraction of the 3D wetting front, and ii) characterization and description of the 3D wetting front to obtain important information about infiltration process. The 3D wetting front surface is segmented from 3D CT imagery provided as input via a 3D stochastic region merging strategy using quadric-regressed bilateral space-scale representations. Based on the 3D segmentation results, the normal directions at local curvature maxima of the wetting front surface are computed for 3D images of soil moisture, and its propagation is analyzed at the local directions in sites of maximal water adsorption, and described using histograms of curvature changes over time in response to sample saturation. These curvature change descriptors provide indirect measurements of moisture infiltration in soils, and soil saturation. Results using a field tomograph equipment specific for soil studies are encouraging, and suggest that the proposed automatic framework can be applied to estimate the infiltration of water in soils in 3D and in time.	[Vasquez, Dionicio; Scharcanski, Jacob] Univ Fed Rio Grande do Sul, Grad Program Comp Sci, BR-91501970 Porto Alegre, RS, Brazil; [Vasquez, Dionicio; Scharcanski, Jacob] Univ Fed Rio Grande do Sul, Grad Program Elect Engn, BR-91501970 Porto Alegre, RS, Brazil; [Wong, Alexander] U Waterloo, Dept Syst Design Engn, Waterloo, ON, Canada	Universidade Federal do Rio Grande do Sul; Universidade Federal do Rio Grande do Sul	Scharcanski, J (corresponding author), Univ Fed Rio Grande do Sul, Grad Program Comp Sci, POB 15064, BR-91501970 Porto Alegre, RS, Brazil.	jacobs@inf.ufrgs.br	Scharcanski, Jacob/AAA-4799-2021; Wong, Alexander/GZM-2929-2022	Scharcanski, Jacob/0000-0002-9223-4693; Wong, Alexander/0000-0002-5295-2797	CAPES (Coordenadoria de Aperfeicoamento de Pessoal de Ensino Superior, Brazil); Canada Research Chairs program; Natural Sciences and Engineering Research Council (NSERC) of Canada; Ontario Ministry of Research and Innovation	CAPES (Coordenadoria de Aperfeicoamento de Pessoal de Ensino Superior, Brazil)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Canada Research Chairs program(Canada Research Chairs); Natural Sciences and Engineering Research Council (NSERC) of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Ontario Ministry of Research and Innovation(Ministry of Research and Innovation, Ontario)	This work was supported by CAPES (Coordenadoria de Aperfeicoamento de Pessoal de Ensino Superior, Brazil), the Canada Research Chairs program, the Natural Sciences and Engineering Research Council (NSERC) of Canada, and the Ontario Ministry of Research and Innovation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARWINI K, 2008, INFORMATION GEOMETRY, P200; CHEN WW, 1993, J AM CERAM SOC, V76, P2086, DOI 10.1111/j.1151-2916.1993.tb08337.x; COHENSTEINER D, 2003, COMP GEOM 2003 19 AC, P312; CRESTANA S, 1985, SOIL SCI, V140, P326, DOI 10.1097/00010694-198511000-00002; Deinert MR, 2004, J HYDROL, V290, P192, DOI 10.1016/j.jhydrol.2003.11.018; Dodson CTJ, 2003, IEEE T SYST MAN CY A, V33, P435, DOI 10.1109/TSMCA.2003.809185; Felipussi SC, 2008, IEEE T INSTRUM MEAS, V57, P2502, DOI 10.1109/TIM.2008.925010; FREDRICH JT, 1995, SCIENCE, V268, P276, DOI 10.1126/science.268.5208.276; Gong YH, 2013, IEEE IMAGE PROC, P534, DOI 10.1109/ICIP.2013.6738110; JASTI JK, 1992, AICHE J, V38, P481, DOI 10.1002/aic.690380402; Jung CR, 2004, J ELECTRON IMAGING, V13, P278, DOI 10.1117/1.1683247; KWIECIEN MJ, 1990, J MICROSC-OXFORD, V159, P343, DOI 10.1111/j.1365-2818.1990.tb03039.x; Liao PS, 2001, J INF SCI ENG, V17, P713; Libardi P. L., 2005, DINAMICA AGUA SOLO; Martin RL, 2012, CHEMPHYSCHEM, V13, P3595, DOI 10.1002/cphc.201200554; Matko V, 2004, SENSOR ACTUAT A-PHYS, V112, P320, DOI 10.1016/j.sna.2003.10.065; MEYER K, 1994, CRYST RES TECHNOL, V29, P903, DOI 10.1002/crat.2170290702; Mohebi A, 2008, IEEE IMAGE PROC, P1312, DOI 10.1109/ICIP.2008.4712004; Naime J.M., 2001, THESIS U SAO PAULO; Scharcanski J, 1996, OPT ENG, V35, P2302, DOI 10.1117/1.600804; SCHARCANSKI J, 1993, IEE PROC-E, V140, P109, DOI 10.1049/ip-e.1993.0016; SCHWARTZMAN M, 1986, J IRRIG DRAIN ENG, V112, P242, DOI 10.1061/(ASCE)0733-9437(1986)112:3(242); Vasquez D, 2013, IEEE IMTC P, P1540; Votrubova J, 2000, GEODERMA, V95, P267, DOI 10.1016/S0016-7061(99)00091-9; Wong A, 2011, IEEE T INF TECHNOL B, V15, P929, DOI 10.1109/TITB.2011.2157829; Wong A, 2009, IEEE T BIO-MED ENG, V56, P2748, DOI 10.1109/TBME.2009.2027225	26	2	2	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2015	10	1							e0115218	10.1371/journal.pone.0115218	http://dx.doi.org/10.1371/journal.pone.0115218			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ4OZ	25602498	Green Published, Green Submitted, gold			2022-12-27	WOS:000348203500011
J	Zhao, XM; Luo, JY; Li, BB; Liu, SG; Li, DT				Zhao, Xiaoming; Luo, Jingyu; Li, Bobo; Liu, Shuguang; Li, Daotang			The Association between Preoperative Serum C-Reactive Protein and Hepatocellular Carcinoma Recurrence in Patients with Chronic Hepatitis B Virus (HBV) Infection-A Retrospective Study	PLOS ONE			English	Article							INTRAHEPATIC RECURRENCE; COLORECTAL-CANCER; RISK-FACTORS; PROGNOSIS; INTERLEUKIN-6; INFLAMMATION; RESECTION; IMPACT; INDICATOR; ELEVATION	The prognosis of the patients with hepatocellular carcinoma (HCC) recurrence following curative hepatectomy is usually dismal. Whether preoperative serum C-reactive protein (CRP) can predict the recurrence of HCC in patients with chronic HBV infection is not clear. Total 232 patients with chronic HBV infection were included in this retrospective study. We investigated the association between detailed preoperative serum CRP levels and early (<= 2 year) and late (> 2 year) HCC recurrence following curative hepatectomy. After adjusting for potential confounders, we found a saturation effect for preoperative serum CRP of 2.1 mg/dl existed for early HCC recurrence (ER). The incidence of ER increased with preoperative serum CRP less than 2.1 mg/dl (OR = 3.5, 95% CI 1.6-7.6, P = 0.001), and higher preoperative serum CRP (> 2.1 mg/dl) did not increase the incidence of ER (OR = 0.8, 95% CI 0.2-2.7, P = 0.703). Whereas there is a linear relationship between preoperative serum CRP and late HCC recurrence (LR) (OR = 0.2, 95% CI, 0.1-0.4) (OR = 1.8, 95% CI, 1.2-2.5, P = 0.002). In addition, the optimal cutoff point for serum CRP level was 1.5 mg/dl, instead of 1.0 mg/dl, in predicting both ER and LR. Patients with higher preoperative serum CRP level (> 1.5 mg/dl) had lower recurrence free survival rates and overall survival rates (P < 0.01). These results suggest that preoperative serum CRP played different roles on ER and LR following curative hepatectomy, thus further predictingthe prognosis in patients with chronic HBV infection.	[Zhao, Xiaoming] Univ Jinan, Sch Med & Life Sci, Jinan 250022, Shandong, Peoples R China; [Zhao, Xiaoming] Shandong Acad Med Sci, Jinan 250022, Shandong, Peoples R China; [Zhao, Xiaoming; Luo, Jingyu; Li, Bobo; Liu, Shuguang; Li, Daotang] Shandong Canc Hosp & Inst, Dept Thorac Surg, Jinan 250117, Shandong, Peoples R China	University of Jinan; Shandong First Medical University & Shandong Academy of Medical Sciences; University of Jinan; Shandong First Medical University & Shandong Academy of Medical Sciences	Li, DT (corresponding author), Shandong Canc Hosp & Inst, Dept Thorac Surg, 440 Jiyan Rd, Jinan 250117, Shandong, Peoples R China.	daotang_li@hotmail.com						Alison MR, 2011, RECENT RESULTS CANC, V185, P135, DOI 10.1007/978-3-642-03503-6_8; Berasain C, 2009, ANN NY ACAD SCI, V1155, P206, DOI 10.1111/j.1749-6632.2009.03704.x; Budhu A, 2006, J LEUKOCYTE BIOL, V80, P1197, DOI 10.1189/jlb.0506297; Canna K, 2005, BRIT J CANCER, V92, P651, DOI 10.1038/sj.bjc.6602419; CASTELL JV, 1990, HEPATOLOGY, V12, P1179, DOI 10.1002/hep.1840120517; Chun JM, 2011, J SURG ONCOL, V103, P148, DOI 10.1002/jso.21786; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; DEMELLO J, 1983, BRIT J CANCER, V48, P341, DOI 10.1038/bjc.1983.198; Hashimoto K, 2005, CANCER-AM CANCER SOC, V103, P1856, DOI 10.1002/cncr.20976; Hoshida Y, 2008, NEW ENGL J MED, V359, P1995, DOI 10.1056/NEJMoa0804525; Imamura H, 2003, J HEPATOL, V38, P200, DOI 10.1016/S0168-8278(02)00360-4; Ishizuka M, 2012, AM J SURG, V203, P101, DOI 10.1016/j.amjsurg.2010.09.030; Jang JW, 2012, CYTOKINE, V60, P686, DOI 10.1016/j.cyto.2012.07.017; LEMOINE O, 1994, J HEPATOL, V20, P819; Nozoe T, 1998, AM J SURG, V176, P335, DOI 10.1016/S0002-9610(98)00204-9; Poon D, 2009, LANCET ONCOL, V10, P1111, DOI 10.1016/S1470-2045(09)70241-4; Poon RTP, 2000, CANCER, V89, P500, DOI 10.1002/1097-0142(20000801)89:3<500::AID-CNCR4>3.3.CO;2-F; Porta C, 2008, ANN ONCOL, V19, P353, DOI 10.1093/annonc/mdm448; Sakata J, 2008, EJSO-EUR J SURG ONC, V34, P900, DOI 10.1016/j.ejso.2008.01.031; Shimada H, 2003, J SURG ONCOL, V83, P248, DOI 10.1002/jso.10275; Siegel R, 2011, CA-CANCER J CLIN, V61, P212, DOI 10.3322/caac.20121; Sieghart W, 2013, HEPATOLOGY, V57, P2224, DOI 10.1002/hep.26057; Taketomi A, 2007, J AM COLL SURGEONS, V204, P580, DOI 10.1016/j.jamcollsurg.2007.01.035; Taura K, 2006, ANN SURG, V244, P265, DOI 10.1097/01.sla.0000217921.28563.55; TILG H, 1992, GASTROENTEROLOGY, V103, P264, DOI 10.1016/0016-5085(92)91122-K; Tsai HT, 2008, INT REV IMMUNOL, V27, P427, DOI 10.1080/08830180802295757; Xavier Pedro, 2006, Archives of Gynecology and Obstetrics, V273, P227, DOI 10.1007/s00404-005-0080-4	27	10	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2015	10	1							e0116909	10.1371/journal.pone.0116909	http://dx.doi.org/10.1371/journal.pone.0116909			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ4OZ	25602444	Green Published, Green Submitted, gold			2022-12-27	WOS:000348203500036
J	Zheng, YT; Cui, QQ; Hong, YM; Yao, WG				Zheng, Ya Ting; Cui, Qi Qi; Hong, Yi Min; Yao, Wei Guang			A Meta-Analysis of High Dose, Intermittent Vitamin D Supplementation among Older Adults	PLOS ONE			English	Article							DOUBLE-BLIND; CALCIUM SUPPLEMENTATION; CONTROLLED-TRIAL; POOLED ANALYSIS; FALLS; PEOPLE; FRACTURES; MORTALITY; WOMEN; PREVENTION	Background The effects of intermittent, high dose vitamin D treatment in older adults have not been documented. We conducted a meta-analysis to provide a quantitative assessment of the efficiency of intermittent, high dose vitamin D treatment on falls, fractures, and mortality among older adults. Methods Electronic databases were searched for randomized controlled trials (RCTs) on high dose, intermittent vitamin D supplementation among older adults. Two researchers independently screened the literature according to specified inclusive and exclusive criteria to extract the data. Meta-analysis was performed by using Review Manager 5.1.0 software. Results Nine trials were included in this meta-analysis. High dose, intermittent vitamin D therapy did not decrease all-cause mortality among older adults. The risk ratio (95% CI) was 1.04 (0.91-1.17). No benefit was seen in fracture or fall prevention. The risk ratio for hip fractures (95% CI) was 1.17 (0.97-1.41) while for non-vertebral fractures (95% CI) it was 1.06 (0.91-1.22), and the risk ratio for falls (95% CI) was 1.02 (0.96-1.08). Results remained robust after sensitivity analysis. Conclusion Supplementation of intermittent, high dose vitamin D may not be effective in preventing overall mortality, fractures, or falls among older adults. The route of administration of vitamin D supplements may well change the physiological effects.	[Zheng, Ya Ting; Cui, Qi Qi; Hong, Yi Min; Yao, Wei Guang] Soouthern Med Univ, Coll Humanities & Management, Guangzhou, Guangdong, Peoples R China		Yao, WG (corresponding author), Soouthern Med Univ, Coll Humanities & Management, Guangzhou, Guangdong, Peoples R China.	yaoweiguang2014@yeah.net						Abrahamsen B, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.b5463; Autier P, 2007, ARCH INTERN MED, V167, P1730, DOI 10.1001/archinte.167.16.1730; Bacon CJ, 2009, OSTEOPOROSIS INT, V20, P1407, DOI 10.1007/s00198-008-0814-9; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Bischoff HA, 2003, J BONE MINER RES, V18, P343, DOI 10.1359/jbmr.2003.18.2.343; Bischoff-Ferrari HA, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b3692; Bischoff-Ferrari HA, 2012, NEW ENGL J MED, V367, P40, DOI 10.1056/NEJMoa1109617; Bjelakovic G, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007470.pub2; Buell JS, 2008, MOL ASPECTS MED, V29, P415, DOI 10.1016/j.mam.2008.05.001; Chung Mei, 2009, Evid Rep Technol Assess (Full Rep), P1; Dhesi JK, 2004, AGE AGEING, V33, P589, DOI 10.1093/ageing/afh209; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Flicker L, 2005, J AM GERIATR SOC, V53, P1881, DOI 10.1111/j.1532-5415.2005.00468.x; Glendenning P, 2012, J BONE MINER RES, V27, P170, DOI 10.1002/jbmr.524; Harwood RH, 2004, AGE AGEING, V33, P45, DOI 10.1093/ageing/afh002; Higgins JPT., 2008, COCHRANE HDB SYSTEMA, V1 edn; Higgins JPT, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5928; Hollis BW, 2013, J CLIN ENDOCR METAB, V98, P4619, DOI 10.1210/jc.2013-2653; Latham NK, 2003, J AM GERIATR SOC, V51, P291, DOI 10.1046/j.1532-5415.2003.51101.x; Law M, 2006, AGE AGEING, V35, P482, DOI 10.1093/ageing/afj080; Lyons RA, 2007, OSTEOPOROSIS INT, V18, P811, DOI 10.1007/s00198-006-0309-5; Murad MH, 2011, J CLIN ENDOCR METAB, V96, P2997, DOI 10.1210/jc.2011-1193; Pfeifer M, 2009, OSTEOPOROSIS INT, V20, P315, DOI 10.1007/s00198-008-0662-7; Prince RL, 2008, ARCH INTERN MED, V168, P103, DOI 10.1001/archinternmed.2007.31; Rejnmark L, 2012, J CLIN ENDOCR METAB, V97, P2670, DOI 10.1210/jc.2011-3328; Rossini M, 2012, J CLIN ENDOCR METAB, V97, pE622, DOI 10.1210/jc.2011-2448; Sanders KM, 2013, CALCIFIED TISSUE INT, V92, P191, DOI 10.1007/s00223-012-9679-1; Sanders KM, 2010, JAMA-J AM MED ASSOC, V303, P1815, DOI 10.1001/jama.2010.594; Smith H, 2007, RHEUMATOLOGY, V46, P1852, DOI 10.1093/rheumatology/kem240; Trivedi DP, 2003, BMJ-BRIT MED J, V326, P469, DOI 10.1136/bmj.326.7387.469; van den Bergh Joop P W, 2011, Curr Osteoporos Rep, V9, P36, DOI 10.1007/s11914-010-0041-0; Wahl D A, 2012, Arch Osteoporos, V7, P155, DOI 10.1007/s11657-012-0093-0; Wigg AER, 2006, MED J AUSTRALIA, V185, P195, DOI 10.5694/j.1326-5377.2006.tb00530.x	33	35	36	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2015	10	1							e0115850	10.1371/journal.pone.0115850	http://dx.doi.org/10.1371/journal.pone.0115850			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ4OZ	25602255	Green Published, Green Submitted, gold			2022-12-27	WOS:000348203500017
J	Huang, CY; Hung, YT; Chang, CM; Juang, SY; Lee, CC				Huang, Chih-Yuan; Hung, Yeh-Ting; Chang, Chun-Ming; Juang, Shiun-Yang; Lee, Ching-Chih			The Association between Individual Income and Aggressive End-of-Life Treatment in Older Cancer Decedents in Taiwan	PLOS ONE			English	Article							ETHNIC-DIFFERENCES; NEW-ZEALAND; LAST YEAR; CARE; DEATH; QUALITY; TRENDS; IMPACT; PLACE; ONTARIO	Objectives To examine the association of individual income and end of life (EOL) care in older cancer decedents in Taiwan. Design Retrospective cohort study. Setting National Health Insurance Research Database (NHIRD) in Taiwan. Participants 28,978 decedents >65 years were diagnosed with cancer and died during 2009-2011 in Taiwan. Of these decedents, 10941, 16535, and 1502 were categorized by individual income as having low, moderate, and high SES, respectively. Main outcome measures Indicators of aggressiveness of EOL care: chemotherapy use before EOL, more than one emergency department (ER) visit, more than one hospital admission, hospital length of stay >4 days, intensive care unit (ICU) admission, and dying in a hospital. Results Low individual income was associated with more aggressive EOL treatment (estimate -0.30 for moderate income, -0.27 for high income, both p<0.01). The major source of aggressiveness was the tendency for older decedents with low income to die in the acute care hospital. The indicators had an increasing trend from 2009 to 2011, except for hospital stay >14 days. Conclusions Low individual income is associated with more aggressive EOL treatment in older cancer decedents. Public health providers should make available appropriate education and hospice resources to these decedents and their families, to reduce the amount of aggressive terminal care such decedents receive.	[Huang, Chih-Yuan] Buddhist Tzu Chi Med Fdn, Dalin Tzu Chi Hosp, Dept Internal Med, Div Nephrol, Chiayi, Taiwan; [Huang, Chih-Yuan] Buddhist Tzu Chi Med Fdn, Dalin Tzu Chi Hosp, Dept Pediat, Chiayi, Taiwan; [Chang, Chun-Ming] Buddhist Tzu Chi Med Fdn, Dalin Tzu Chi Hosp, Dept Surg, Chiayi, Taiwan; [Juang, Shiun-Yang] Buddhist Tzu Chi Med Fdn, Dalin Tzu Chi Hosp, Dept Med Res, Chiayi, Taiwan; [Lee, Ching-Chih] Tzu Chi Univ, Sch Med, Hualien, Taiwan; [Lee, Ching-Chih] Buddhist Tzu Chi Med Fdn, Dalin Tzu Chi Hosp, Dept Otolaryngol, Chiayi, Taiwan; [Lee, Ching-Chih] Buddhist Tzu Chi Med Fdn, Dalin Tzu Chi Hosp, Ctr Clin Epidemiol & Biostat, Chiayi, Taiwan; [Huang, Chih-Yuan; Hung, Yeh-Ting; Chang, Chun-Ming; Juang, Shiun-Yang; Lee, Ching-Chih] Buddhist Tzu Chi Med Fdn, Dalin Tzu Chi Hosp, Ctr Clin Epidemiol & Biostatist, Chiayi 622, Taiwan	Buddhist Tzu Chi General Hospital; Dalin Tzu Chi Hospital; Buddhist Tzu Chi General Hospital; Dalin Tzu Chi Hospital; Buddhist Tzu Chi General Hospital; Dalin Tzu Chi Hospital; Buddhist Tzu Chi General Hospital; Dalin Tzu Chi Hospital; Tzu Chi University; Buddhist Tzu Chi General Hospital; Dalin Tzu Chi Hospital; Buddhist Tzu Chi General Hospital; Dalin Tzu Chi Hospital; Buddhist Tzu Chi General Hospital; Dalin Tzu Chi Hospital	Lee, CC (corresponding author), Tzu Chi Univ, Sch Med, Hualien, Taiwan.	hematcd@hotmail.com						Chang CM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044325; Chawla Neetu, 2013, Journal of the National Cancer Institute Monographs, P36, DOI 10.1093/jncimonographs/lgt009; Cheng CL, 2011, PHARMACOEPIDEM DR S, V20, P236, DOI 10.1002/pds.2087; Cohen J, 2010, J CLIN ONCOL, V28, P2267, DOI 10.1200/JCO.2009.23.2850; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; Earle CC, 2003, J CLIN ONCOL, V21, P1133, DOI 10.1200/JCO.2003.03.059; Earle CC, 2004, J CLIN ONCOL, V22, P315, DOI 10.1200/JCO.2004.08.136; Earle CC, 2008, J CLIN ONCOL, V26, P3860, DOI 10.1200/JCO.2007.15.8253; Fassbender K, 2009, J PAIN SYMPTOM MANAG, V38, P75, DOI 10.1016/j.jpainsymman.2009.04.007; Felder S, 2000, J HEALTH ECON, V19, P679, DOI 10.1016/S0167-6296(00)00039-4; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Hanchate A, 2009, ARCH INTERN MED, V169, P493, DOI 10.1001/archinternmed.2008.616; Hanratty Barbara, 2007, J Health Serv Res Policy, V12, P90, DOI 10.1258/135581907780279585; Ho TH, 2011, J CLIN ONCOL, V29, P1587, DOI 10.1200/JCO.2010.31.9897; Hogan C, 2001, HEALTH AFFAIR, V20, P188, DOI 10.1377/hlthaff.20.4.188; Hollowell J, 2010, J EVAL CLIN PRACT, V16, P529, DOI 10.1111/j.1365-2753.2009.01154.x; HU W, 2013, J PAIN SYMPTOM MANAG; HUANG WCT, 2009, THESIS NATL DIGITAL; Johnson KS, 2005, J AM GERIATR SOC, V53, P2209, DOI 10.1111/j.1532-5415.2005.00502.x; Kwok J, 2010, CANCER-AM CANCER SOC, V116, P476, DOI 10.1002/cncr.24774; Law HZ, 2011, J ASTHMA, V48, P405, DOI 10.3109/02770903.2011.565849; Lin HC, 2008, STROKE, V39, P2744, DOI 10.1161/STROKEAHA.108.519090; Lin YH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062492; Ministry of Health and Welfare, 2013, 2013 STAT CAUS DEATH; Motiwala SS, 2006, CAN J AGING, V25, P363, DOI 10.1353/cja.2007.0019; Nakamura S, 2010, GERIATR GERONTOL INT, V10, P154, DOI 10.1111/j.1447-0594.2009.00570.x; Perelman J, 2011, J HEALTH SERV RES PO, V16, P197, DOI 10.1258/jhsrp.2011.010047; Reyes-Ortiz CA, 2011, CAN J AGING, V30, P143, DOI 10.1017/S0714980810000796; Riley GF, 2010, HEALTH SERV RES, V45, P565, DOI 10.1111/j.1475-6773.2010.01082.x; Saito AM, 2011, BMC PALLIAT CARE, V10, DOI 10.1186/1472-684X-10-14; Tang ST, 2009, ANN ONCOL, V20, P343, DOI 10.1093/annonc/mdn602; Tang ST, 2012, PALLIATIVE MED, V26, P80, DOI 10.1177/0269216311406989; Tang ST, 2009, J CLIN ONCOL, V27, P4613, DOI 10.1200/JCO.2008.20.5096; Tang ST, 2003, CANCER NURS, V26, P245, DOI 10.1097/00002820-200306000-00012; Tang ST, 2002, CANCER NURS, V25, P158, DOI 10.1097/00002820-200204000-00013; Taylor EJ, 2012, PALLIATIVE MED, V26, P342, DOI 10.1177/0269216311412229; Tseng CH, 2004, DIABETES CARE, V27, P1605, DOI 10.2337/diacare.27.7.1605; Wang HM, 2011, J PAIN SYMPTOM MANAG, V42, P400, DOI 10.1016/j.jpainsymman.2010.12.011; Wang JY, 2014, INT J CARDIOL, V172, P82, DOI 10.1016/j.ijcard.2013.12.082; 2013, ACTA ONCOL, V52, P1062, DOI DOI 10.3109/0284186X.2012.758872; 1975, 4 FACTOR INDEX SOCIA	41	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2015	10	1							e0116913	10.1371/journal.pone.0116913	http://dx.doi.org/10.1371/journal.pone.0116913			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AZ4OG	25585131	gold, Green Submitted, Green Published			2022-12-27	WOS:000348201300011
J	Zhou, XY; Li, LZ; Xiang, JH; Gao, GF; Xu, FX; Liu, AL; Zhang, XW; Peng, Y; Chen, XB; Wan, XY				Zhou, Xiaoyun; Li, Linzhi; Xiang, Jianhua; Gao, Guofu; Xu, Faxi; Liu, Ailing; Zhang, Xianwen; Peng, Yan; Chen, Xinbo; Wan, Xiangyuan			OsGL1-3 is Involved in Cuticular Wax Biosynthesis and Tolerance to Water Deficit in Rice	PLOS ONE			English	Article							ARABIDOPSIS ECERIFERUM1; ALKANE BIOSYNTHESIS; CUTICLE MEMBRANE; GENE; DROUGHT; OVEREXPRESSION; ACCUMULATION; EXPRESSION; COENZYME; ENCODES	Cuticular wax covers aerial organs of plants and functions as the outermost barrier against non-stomatal water loss. We reported here the functional characterization of the Glossy1(GL1)-homologous gene OsGL1-3 in rice using overexpression and RNAi transgenic rice plants. OsGL1-3 gene was ubiquitously expressed at different level in rice plants except root and its expression was up-regulated under ABA and PEG treatments. The transient expression of OsGL1-3-GFP fusion protein indicated that OsGL1-3 is mainly localized in the plasma membrane. Compared to the wild type, overexpression rice plants exhibited stunted growth, more wax crystallization on leaf surface, and significantly increased total cuticular wax load due to the prominent changes of C-30-C-32 aldehydes and C-30 primary alcohols. While the RNAi knockdown mutant of OsGL1-3 exhibited no significant difference in plant height, but less wax crystallization and decreased total cuticular wax accumulation on leaf surface. All these evidences, together with the effects of OsGL1-3 on the expression of some wax synthesis related genes, suggest that OsGL1-3 is involved in cuticular wax biosynthesis. Overexpression of OsGL1-3 decreased chlorophyll leaching and water loss rate whereas increased tolerance to water deficit at both seedling and late-tillering stages, suggesting an important role of OsGL1-3 in drought tolerance.	[Zhou, Xiaoyun; Li, Linzhi; Xiang, Jianhua; Gao, Guofu; Xu, Faxi; Liu, Ailing; Zhang, Xianwen; Peng, Yan; Chen, Xinbo; Wan, Xiangyuan] Hunan Agr Univ, Key Lab Crop Germplasm Innovat & Utilizat Hunan P, Changsha, Hunan, Peoples R China; [Zhou, Xiaoyun; Li, Linzhi; Xu, Faxi; Liu, Ailing; Zhang, Xianwen; Chen, Xinbo] Hunan Agr Univ, Coll Biosci & Biotechnol, Changsha, Hunan, Peoples R China; [Wan, Xiangyuan] State Key Lab Main Crop Germplasm Innovat, Beijing, Peoples R China; [Xiang, Jianhua] Hunan Univ Sci & Technol, Sch Life Sci, Xiangtan, Peoples R China; [Gao, Guofu] Hunan Acad Agr Sci, Res Inst Sci & Technol Informat, Changsha, Hunan, Peoples R China	Hunan Agricultural University; Hunan Agricultural University; Hunan University of Science & Technology; Hunan Academy of Agricultural Sciences	Chen, XB (corresponding author), Hunan Agr Univ, Key Lab Crop Germplasm Innovat & Utilizat Hunan P, Changsha, Hunan, Peoples R China.	xinbochen@live.cn; wanxy2005@163.com	Wan, Xiangyuan/GRJ-1567-2022; Chen, Xinbo/J-6708-2012	Chen, Xinbo/0000-0002-8758-0591; Peng, Yan/0000-0003-3374-3209	Specialized Research Fund for the Doctoral Program of Higher Education of China [20124320110012]; Open Research Fund of the State Key Laboratory of Main Crop Germplasm Innovation, Key Science and Technology Project of Hunan Province [2014WK2004]; Construct Program of the Key Discipline in Hunan Province	Specialized Research Fund for the Doctoral Program of Higher Education of China(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Open Research Fund of the State Key Laboratory of Main Crop Germplasm Innovation, Key Science and Technology Project of Hunan Province; Construct Program of the Key Discipline in Hunan Province	This study was supported by Specialized Research Fund for the Doctoral Program of Higher Education of China (20124320110012), Open Research Fund of the State Key Laboratory of Main Crop Germplasm Innovation, Key Science and Technology Project of Hunan Province (2014WK2004), and Construct Program of the Key Discipline in Hunan Province. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aharoni A, 2004, PLANT CELL, V16, P2463, DOI 10.1105/tpc.104.022897; Bach L, 2008, P NATL ACAD SCI USA, V105, P14727, DOI 10.1073/pnas.0805089105; Beaudoin F, 2009, PLANT PHYSIOL, V150, P1174, DOI 10.1104/pp.109.137497; Bernard A, 2013, PROG LIPID RES, V52, P110, DOI 10.1016/j.plipres.2012.10.002; Bernard A, 2012, PLANT CELL, V24, P3106, DOI 10.1105/tpc.112.099796; Bourdenx B, 2011, PLANT PHYSIOL, V156, P29, DOI 10.1104/pp.111.172320; Cameron KD, 2006, PLANT PHYSIOL, V140, P176, DOI 10.1104/pp.105.069724; Chen XB, 2003, PLANT CELL, V15, P1170, DOI 10.1105/tpc.010926; DHINDSA RS, 1981, J EXP BOT, V32, P93, DOI 10.1093/jxb/32.1.93; Greer S, 2007, PLANT PHYSIOL, V145, P653, DOI 10.1104/pp.107.107300; Hadiarto T, 2011, PLANT CELL REP, V30, P297, DOI 10.1007/s00299-010-0956-z; Haslam TM, 2012, PLANT PHYSIOL, V160, P1164, DOI 10.1104/pp.112.201640; Hooker TS, 2002, PLANT PHYSIOL, V129, P1568, DOI 10.1104/pp.003707; Islam MA, 2009, PLANT MOL BIOL, V70, P443, DOI 10.1007/s11103-009-9483-0; JENKS MA, 1995, PLANT PHYSIOL, V108, P369, DOI 10.1104/pp.108.1.369; Jung KH, 2006, PLANT CELL, V18, P3015, DOI 10.1105/tpc.106.042044; Kim J, 2013, PLANT PHYSIOL, V162, P567, DOI 10.1104/pp.112.210450; Kosma DK, 2009, PLANT PHYSIOL, V151, P1918, DOI 10.1104/pp.109.141911; Kunst L, 2009, CURR OPIN PLANT BIOL, V12, P721, DOI 10.1016/j.pbi.2009.09.009; Kurata T, 2003, PLANT J, V36, P55, DOI 10.1046/j.1365-313X.2003.01854.x; Lu SY, 2009, PLANT J, V59, P553, DOI 10.1111/j.1365-313X.2009.03892.x; Mao BG, 2012, PLANTA, V235, P39, DOI 10.1007/s00425-011-1481-1; PostBeittenmiller D, 1996, ANNU REV PLANT PHYS, V47, P405, DOI 10.1146/annurev.arplant.47.1.405; Qin BX, 2011, MOL PLANT, V4, P985, DOI 10.1093/mp/ssr028; Rowland O, 2007, FEBS LETT, V581, P3538, DOI 10.1016/j.febslet.2007.06.065; Rowland O, 2006, PLANT PHYSIOL, V142, P866, DOI 10.1104/pp.106.086785; Samuels L, 2008, ANNU REV PLANT BIOL, V59, P683, DOI 10.1146/annurev.arplant.59.103006.093219; Seo PJ, 2011, PLANT CELL, V23, P1138, DOI 10.1105/tpc.111.083485; Sturaro M, 2005, PLANT PHYSIOL, V138, P478, DOI 10.1104/pp.104.058164; Xu DQ, 2008, FEBS LETT, V582, P1037, DOI 10.1016/j.febslet.2008.02.052; Yeats TH, 2013, PLANT PHYSIOL, V163, P5, DOI 10.1104/pp.113.222737; Zheng HQ, 2005, PLANT CELL, V17, P1467, DOI 10.1105/tpc.104.030155; Zhou L, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0057382, 10.1371/journal.pone.0073724]; Zhou XY, 2014, PLANT MOL BIOL REP, V32, P719, DOI 10.1007/s11105-013-0687-8; Zhu XY, 2013, P NATL ACAD SCI USA, V110, P17790, DOI 10.1073/pnas.1316412110; Zou J, 2009, J PLANT PHYSIOL, V166, P851, DOI 10.1016/j.jplph.2008.11.007	36	18	20	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2015	10	1							e116676	10.1371/journal.pone.0116676	http://dx.doi.org/10.1371/journal.pone.0116676			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ3XP	25555239	Green Published, gold, Green Submitted			2022-12-27	WOS:000348157400004
J	Citro, L; Naidu, S; Hassan, F; Kuppusamy, ML; Kuppusamy, P; Angelos, MG; Khan, M				Citro, Lucas; Naidu, Shan; Hassan, Fatemat; Kuppusamy, M. Lakshmi; Kuppusamy, Periannan; Angelos, Mark G.; Khan, Mahmood			Comparison of Human Induced Pluripotent Stem-Cell Derived Cardiomyocytes with Human Mesenchymal Stem Cells following Acute Myocardial Infarction	PLOS ONE			English	Article							STROMAL CELLS; ISCHEMIC CARDIOMYOPATHY; CARDIAC-FUNCTION; IN-VITRO; HEART; REGENERATION; EXPRESS; DISEASE; MARKERS; REPAIR	Introduction: Human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs) have recently been shown to express key cardiac proteins and improve in vivo cardiac function when administered following myocardial infarction. However, the efficacy of hiPSC-derived cell therapies, in direct comparison to current, well-established stem cell-based therapies, is yet to be elucidated. The goal of the current study was to compare the therapeutic efficacy of human mesenchymal stem cells (hMSCs) with hiPSC-CMs in mitigating myocardial infarction (MI). Methods: Male athymic nude hyrats were subjected to permanent ligation of the left-anterior-descending (LAD) coronary artery to induce acute MI. Four experimental groups were studied: 1) control (non-MI), 2) MI, 3) hMSCs (MI+MSC), and 4) hiPSC-CMs (MI+hiPSC-derived cardiomyocytes). The hiPSC-CMs and hMSCs were labeled with superparamagnetic iron oxide (SPIO) in vitro to track the transplanted cells in the ischemic heart by high-field cardiac MRI. These cells were injected into the ischemic heart 30-min after LAD ligation. Four-weeks after MI, cardiac MRI was performed to track the transplanted cells in the infarct heart. Additionally, echocardiography (M-mode) was performed to evaluate the cardiac function. Immunohistological and western blot studies were performed to assess the cell tracking, engraftment and cardiac fibrosis in the infarct heart tissues. Results: Echocardiography data showed a significantly improved cardiac function in the hiPSC-CMs and hMSCs groups, when compared to MI. Immunohistological studies showed expression of connexin-43, alpha-actinin and myosin heavy chain in engrafted hiPSC-CMs. Cardiac fibrosis was significantly decreased in hiPSC-CMs group when compared to hMSCs or MI groups. Overall, this study demonstrated improved cardiac function with decreased fibrosis with both hiPSC-CMs and hMSCs groups when compared with MI group.	[Citro, Lucas; Naidu, Shan; Hassan, Fatemat; Angelos, Mark G.; Khan, Mahmood] Ohio State Univ, Davis Heart & Lung Res Inst, Columbus, OH 43210 USA; [Citro, Lucas; Naidu, Shan; Hassan, Fatemat] Ohio State Univ, Div Cardiovasc Med, Columbus, OH 43210 USA; [Angelos, Mark G.; Khan, Mahmood] Ohio State Univ, Dept Emergency Med, Columbus, OH 43210 USA; [Kuppusamy, M. Lakshmi; Kuppusamy, Periannan] Dartmouth Coll, Dept Radiol, Geisel Sch Med Dartmouth, Lebanon, NH 03766 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Dartmouth College	Khan, M (corresponding author), Ohio State Univ, Davis Heart & Lung Res Inst, Columbus, OH 43210 USA.	mahmood.khan@osumc.edu						Ahmed RPH, 2011, CIRC RES, V109, P60, DOI 10.1161/CIRCRESAHA.110.240010; Alpert JS, 2000, J AM COLL CARDIOL, V36, P959, DOI 10.1016/S0735-1097(00)00804-4; Blin G, 2010, J CLIN INVEST, V120, P1125, DOI 10.1172/JCI40120; Carpenter L, 2012, STEM CELLS DEV, V21, P977, DOI 10.1089/scd.2011.0075; Feng YL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088685; Gu M, 2012, CIRC RES; Hare JM, 2012, JAMA-J AM MED ASSOC, V308, P2369, DOI 10.1001/jama.2012.25321; Hassan F, 2012, J PHARM EXP THER; Kawamura M, 2012, CIRCULATION, V126, pS29, DOI 10.1161/CIRCULATIONAHA.111.084343; Khan M, 2012, CARDIOVASC RES, V93, P89, DOI 10.1093/cvr/cvr277; Khan M, 2009, J MOL CELL CARDIOL, V47, P275, DOI 10.1016/j.yjmcc.2009.04.005; KUSUOKA H, 1987, J CLIN INVEST, V79, P950, DOI 10.1172/JCI112906; Laflamme MA, 2007, NAT BIOTECHNOL, V25, P1015, DOI 10.1038/nbt1327; Malliaras K, 2014, J AM COLL CARDIOL, V63, P110, DOI 10.1016/j.jacc.2013.08.724; Mauritz C, 2011, EUR HEART J, V32, P2634, DOI 10.1093/eurheartj/ehr166; Miki K, 2012, STEM CELL TRANSL MED, V1, P430, DOI 10.5966/sctm.2011-0038; Naftilan AJ, 2011, HEART FAIL CLIN, V7, P345, DOI 10.1016/j.hfc.2011.03.006; Nakagawa M, 2008, NAT BIOTECHNOL, V26, P101, DOI 10.1038/nbt1374; Pasha Z, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023667; Psaltis PJ, 2008, STEM CELLS, V26, P2201, DOI 10.1634/stemcells.2008-0428; Rangappa S, 2010, J CARDIOVASC PHARM T, V15, P338, DOI 10.1177/1074248410376382; Roger VL, 2012, CIRCULATION, V125, pE2, DOI 10.1161/CIR.0b013e31823ac046; Rose RA, 2008, STEM CELLS, V26, P2884, DOI 10.1634/stemcells.2008-0329; Shamblott MJ, 2001, P NATL ACAD SCI USA, V98, P113, DOI 10.1073/pnas.021537998; Singla DK, 2011, MOL PHARMACEUT, V8, P1573, DOI 10.1021/mp2001704; Song H, 2010, EXPERT OPIN BIOL TH, V10, P309, DOI 10.1517/14712590903455997; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Yannarelli G, 2014, STEM CELL REV REP, V10, P304, DOI 10.1007/s12015-013-9483-y; Zafari A. M., 2012, MYOCARDIAL INFARCTIO; Zhang JH, 2009, CIRC RES, V104, pE30, DOI 10.1161/CIRCRESAHA.108.192237; Zhang YZ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019012; Zhao YS, 2012, STEM CELL TRANSL MED, V1, P685, DOI 10.5966/sctm.2012-0027	33	40	40	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2014	9	12							e116281	10.1371/journal.pone.0116281	http://dx.doi.org/10.1371/journal.pone.0116281			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UC	25551230	Green Published, Green Submitted, gold			2022-12-27	WOS:000347119100119
J	Dutta, A; Tandon, D; Mohammed, MH; Bose, T; Mande, SS				Dutta, Anirban; Tandon, Disha; Mohammed, M. H.; Bose, Tungadri; Mande, Sharmila S.			Binpairs: Utilization of Illumina Paired-End Information for Improving Efficiency of Taxonomic Binning of Metagenomic Sequences	PLOS ONE			English	Article							PHYLOGENETIC CLASSIFICATION	Motivation: Paired-end sequencing protocols, offered by next generation sequencing (NGS) platforms like Illumia, generate a pair of reads for every DNA fragment in a sample. Although this protocol has been utilized for several metagenomics studies, most taxonomic binning approaches classify each of the reads (forming a pair), independently. The present work explores some simple but effective strategies of utilizing pairing-information of Illumina short reads for improving the accuracy of taxonomic binning of metagenomic datasets. The strategies proposed can be used in conjunction with all genres of existing binning methods. Results: Validation results suggest that employment of these "Binpairs" strategies can provide significant improvements in the binning outcome. The quality of the taxonomic assignments thus obtained are often comparable to those that can only be achieved with relatively longer reads obtained using other NGS platforms (such as Roche). Availability: An implementation of the proposed strategies of utilizing pairing information is freely available for academic users at https://metagenomics.atc.tcs.com/binning/binpairs.	[Dutta, Anirban; Tandon, Disha; Mohammed, M. H.; Bose, Tungadri; Mande, Sharmila S.] Tata Consultancy Serv Ltd, Biosci R&D Div, TCS Innovat Labs, Tata Res Dev & Design Ctr, Pune 411013, Maharashtra, India	Tata Sons; Tata Consultancy Services Limited (TCS)	Mande, SS (corresponding author), Tata Consultancy Serv Ltd, Biosci R&D Div, TCS Innovat Labs, Tata Res Dev & Design Ctr, 54-B Hadapsar Ind Estate, Pune 411013, Maharashtra, India.	sharmila.mande@tcs.com	Dutta, Anirban/B-1519-2010	Dutta, Anirban/0000-0002-8209-026X	Indian Institute of Technology, Bombay	Indian Institute of Technology, Bombay	Mr. Tungadri Bose is a PhD scholar in the Indian Institute of Technology, Bombay and would like to acknowledge the Institute for its support. We thank Hemang Gandhi for his help in setting up a web server for 'Binpairs'.	Belda-Ferre P, 2012, ISME J, V6, P46, DOI 10.1038/ismej.2011.85; Brady A, 2009, NAT METHODS, V6, P673, DOI [10.1038/NMETH.1358, 10.1038/nmeth.1358]; Ghosh TS, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S7-S14; Haque MM, 2009, BIOINFORMATICS, V25, P1722, DOI 10.1093/bioinformatics/btp317; Huson DH, 2007, GENOME RES, V17, P377, DOI 10.1101/gr.5969107; Mande SS, 2012, BRIEF BIOINFORM, V13, P669, DOI 10.1093/bib/bbs054; Mitra S, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S1-S12; Mohammed MH, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-S3-S4; Mohammed MH, 2011, BIOINFORMATICS, V27, P22, DOI 10.1093/bioinformatics/btq608; Reddy RM, 2012, GENE, V505, P259, DOI 10.1016/j.gene.2012.06.014; Wommack KE, 2008, APPL ENVIRON MICROB, V74, P1453, DOI 10.1128/AEM.02181-07	11	2	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2014	9	12							e114814	10.1371/journal.pone.0114814	http://dx.doi.org/10.1371/journal.pone.0114814			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UC	25551450	Green Submitted, Green Published, gold			2022-12-27	WOS:000347119100017
J	Iskandar, DT; Evans, BJ; McGuire, JA				Iskandar, Djoko T.; Evans, Ben J.; McGuire, Jimmy A.			A Novel Reproductive Mode in Frogs: A New Species of Fanged Frog with Internal Fertilization and Birth of Tadpoles	PLOS ONE			English	Article							ELEUTHERODACTYLUS-COQUI; EVOLUTION; LEPTODACTYLIDAE; SYSTEMATICS; AMPHIBIA; SULAWESI; BIOLOGY; ANURA	We describe a new species of fanged frog (Limnonectes larvaepartus) that is unique among anurans in having both internal fertilization and birth of tadpoles. The new species is endemic to Sulawesi Island, Indonesia. This is the fourth valid species of Limnonectes described from Sulawesi despite that the radiation includes at least 15 species and possibly many more. Fewer than a dozen of the 6455 species of frogs in the world are known to have internal fertilization, and of these, all but the new species either deposit fertilized eggs or give birth to froglets.	[Iskandar, Djoko T.] Inst Teknol Bandung, Sch Life Sci & Technol, Bandung, Indonesia; [Evans, Ben J.] McMaster Univ, Dept Biol, Ctr Environm Genom, Hamilton, ON, Canada; [McGuire, Jimmy A.] Univ Calif Berkeley, Museum Vertebrate Zool, Berkeley, CA 94720 USA; [McGuire, Jimmy A.] Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA	Institute Technology of Bandung; McMaster University; University of California System; University of California Berkeley; University of California System; University of California Berkeley	McGuire, JA (corresponding author), Univ Calif Berkeley, Museum Vertebrate Zool, Berkeley, CA 94720 USA.	mcguirej@berkeley.edu	McGuire, Jimmy/N-7357-2019; Iskasndar, Djoko/AAD-2204-2021	Iskasndar, Djoko/0000-0002-8923-6081; Evans, Ben/0000-0002-9512-8845	United States National Science Foundation Division of Environmental Biology [DEB 0328700, DEB 0640967]; Natural Science and Engineering Research Council of Canada [RGPIN/283102-2012]; Indonesian Directorate General of Higher Education, Ministry of Education and Culture (Basic Science Grant) [60/P4M/DPPM/L-3311/MS/1993]	United States National Science Foundation Division of Environmental Biology; Natural Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Indonesian Directorate General of Higher Education, Ministry of Education and Culture (Basic Science Grant)	This research was funded by the United States National Science Foundation Division of Environmental Biology (DEB 0328700, DEB 0640967) to JAM, the Natural Science and Engineering Research Council of Canada (RGPIN/283102-2012) to BJE, and the Indonesian Directorate General of Higher Education, Ministry of Education and Culture (Basic Science Grant No. 60/P4M/DPPM/L-3311/MS/1993) to DTI. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brown RM, 2000, J HERPETOL, V34, P404, DOI 10.2307/1565364; Buckley CR, 2005, FUNCT ECOL, V19, P67, DOI 10.1111/j.0269-8463.2005.00931.x; Duellman W. E., 1986, BIOL AMPHIBIANS; Emerson SB, 2000, MOL PHYLOGENET EVOL, V16, P131, DOI 10.1006/mpev.2000.0778; Evans BJ, 2003, SYST BIOL, V52, P794, DOI 10.1080/10635150390251063; Gosner K. L., 1960, Herpetologica, V16, P183; Guayasamin JM, 2006, ZOOL J LINN SOC-LOND, V147, P489, DOI 10.1111/j.1096-3642.2006.00223.x; Haddad CFB, 2005, BIOSCIENCE, V55, P207, DOI 10.1641/0006-3568(2005)055[0207:RMIFAT]2.0.CO;2; Inger RF, 2001, J BIOGEOGR, V28, P863, DOI 10.1046/j.1365-2699.2001.00580.x; Iskandar Djoko T., 1996, P39; Kusrini MD, 2014, PLOS ONE IN PRESS, V10; LUTZ B, 1948, EVOLUTION, V2, P29, DOI 10.2307/2405613; Lynn W. Gardner, 1942, CARNEGIE INST WASHINGTON PUBL, V541, P27; McDiarmid R. W., 1999, TADPOLES BIOL ANURAN; McGuire JA, 2007, HERPETOL MONOGR, V21, P179, DOI 10.1655/07-012.1; Merker S, 2010, INT J PRIMATOL, V31, P1107, DOI 10.1007/s10764-010-9452-0; Setiadi MI, 2011, AM NAT, V178, P221, DOI 10.1086/660830; Tlibaudeau G, 1999, TADPOLES, P170; TOWNSEND DS, 1985, COPEIA, P423, DOI 10.2307/1444854; WAKE MH, 1980, COPEIA, P193; WAKE MH, 1978, J HERPETOL, V12, P121, DOI 10.2307/1563398; Wake MH, 2003, ANIM BIOL, V53, P209, DOI 10.1163/157075603322539426; Warkentin KM, 2011, INTEGR COMP BIOL, V51, P111, DOI 10.1093/icb/icr046; Wells KD., 2008, ECOLOGY BEHAV AMPHIB	24	36	36	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2014	9	12							e115884	10.1371/journal.pone.0115884	http://dx.doi.org/10.1371/journal.pone.0115884			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UC	25551466	gold, Green Published			2022-12-27	WOS:000347119100072
J	Malanson, K; Jacque, B; Faux, R; Meiri, KF				Malanson, Katherine; Jacque, Berri; Faux, Russell; Meiri, Karina F.			Modeling for Fidelity: Virtual Mentorship by Scientists Fosters Teacher Self-Efficacy and Promotes Implementation of Novel High School Biomedical Curricula	PLOS ONE			English	Article							PROFESSIONAL-DEVELOPMENT; CONTENT KNOWLEDGE; SCIENCE; EDUCATION; PROGRAM; OUTCOMES; BELIEFS; SUPPORT; PROJECT; IMPACT	This small-scale comparison case study evaluates the impact of an innovative approach to teacher professional development designed to promote implementation of a novel cutting edge high school neurological disorders curriculum. 'Modeling for Fidelity' (MFF) centers on an extended mentor relationship between teachers and biomedical scientists carried out in a virtual format in conjunction with extensive online educative materials. Four teachers from different diverse high schools in Massachusetts and Ohio who experienced MFF contextualized to a 6-week Neurological Disorders curriculum with the same science mentor were compared to a teacher who had experienced an intensive in-person professional development contextualized to the same curriculum with the same mentor. Fidelity of implementation was measured directly using an established metric and indirectly via student performance. The results show that teachers valued MFF, particularly the mentor relationship and were able to use it effectively to ensure critical components of the learning objectives were preserved. Moreover their students performed equivalently to those whose teacher had experienced intensive in-person professional development. Participants in all school settings demonstrated large (Cohen's d>2.0) and significant (p<0.0001 per-post) changes in conceptual knowledge as well as self-efficacy towards learning about neurological disorders (Cohen's d>1.5, p<0.0001 pre-post). The data demonstrates that the virtual mentorship format in conjunction with extensive online educative materials is an effective method of developing extended interactions between biomedical scientists and teachers that are scalable and not geographically constrained, facilitating teacher implementation of novel cuttingedge curricula.	[Malanson, Katherine; Jacque, Berri; Meiri, Karina F.] Tufts Univ, Sch Med, Dept Dev Chem & Mol Biol, Boston, MA 02111 USA; [Malanson, Katherine; Jacque, Berri; Meiri, Karina F.] Tufts Univ, Sch Med, Ctr Translat Sci Educ, Boston, MA 02111 USA; [Faux, Russell] Davis Sq Res Associates, Somerville, MA USA	Tufts University; Tufts University	Meiri, KF (corresponding author), Tufts Univ, Sch Med, Dept Dev Chem & Mol Biol, Boston, MA 02111 USA.	Karina.meiri@tufts.edu			National Center for Research Resources; Division of Program Coordination, Planning, and Strategic Initiatives of the National Institutes of Health [R25OD010953-04]; National Institutes of Allergy and Infectious Disease [R25A1098781-01A1]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R25AI098781] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [R25OD010953] Funding Source: NIH RePORTER	National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Division of Program Coordination, Planning, and Strategic Initiatives of the National Institutes of Health; National Institutes of Allergy and Infectious Disease(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This project was supported by the National Center for Research Resources and the Division of Program Coordination, Planning, and Strategic Initiatives of the National Institutes of Health through Grant Number R25OD010953-04 and the National Institutes of Allergy and Infectious Disease through grant number R25A1098781-01A1.	Adamson, 2010, PROFESSIONAL DEV US; Alexander D., 1999, STATUS ED REFORM PUB; Annetta LA, 2006, J RES SCI TEACH, V43, P1019, DOI 10.1002/tea.20106; [Anonymous], 1999, TEACHER QUALITY STUD; Austin EW, 2012, J AM COLL HEALTH, V60, P548, DOI 10.1080/07448481.2012.726302; Ball D., 1999, PRACTICE BASED THEOR; Ball D.L., 2015, EDUC RESEARCHER, V25, p6, DOI [10.12691/education-3-2-10, DOI 10.12691/EDUCATION-3-2-10, 10.3102/0013189X025009006, DOI 10.3102/0013189X025009006]; Ball DL, 2008, J TEACH EDUC, V59, P389, DOI 10.1177/0022487108324554; Bao L, 2009, SCIENCE, V323, P586, DOI 10.1126/science.1167740; Basu A, 2008, HEALTH COMMUN, V23, P70, DOI 10.1080/10410230701807121; Berkman N. D, 2011, HLTH LITERACY INTERV, P1; Beyer CJ, 2009, J RES SCI TEACH, V46, P977, DOI 10.1002/tea.20293; Bhanji F, 2012, ACAD EMERG MED, V19, P189, DOI 10.1111/j.1553-2712.2011.01270.x; Borko H., 2004, EDUC RESEARCHER, V33, P3; Britner SL, 2006, J RES SCI TEACH, V43, P485, DOI 10.1002/tea.20131; Brooks J., 1999, SEARCH UNDERSTANDING; Carroll C, 2007, IMPLEMENT SCI, V2, DOI 10.1186/1748-5908-2-40; CEMSE, 2014, OUTL RES EV; Cohen AK, 2013, AM J PUBLIC HEALTH, V103, P997, DOI 10.2105/AJPH.2012.300993; COHEN S, 1988, HEALTH PSYCHOL, V7, P269, DOI 10.1037/0278-6133.7.3.269; Darling-Hammond L., 2009, PROFESSIONAL LEARNIN; DARLINGHAMMOND L, 1995, PHI DELTA KAPPAN, V76, P597; Davis EA., 2005, ED RES, V34, P3, DOI [10.3102/0013189X034003003, DOI 10.3102/0013189X034003003]; DECI EL, 1991, EDUC PSYCHOL-US, V26, P325, DOI 10.1207/s15326985ep2603&4_6; Dede C, 2009, J TEACH EDUC, V60, P8, DOI 10.1177/0022487108327554; Desimone LM, 2009, EDUC RESEARCHER, V38, P181, DOI 10.3102/0013189X08331140; Dusenbury L, 2003, HEALTH EDUC RES, V18, P237, DOI 10.1093/her/18.2.237; Fishman B, 2013, J TEACH EDUC, V64, P426, DOI 10.1177/0022487113494413; Fishman BJ, 2003, TEACH TEACH EDUC, V19, P643, DOI 10.1016/S0742-051X(03)00059-3; Garet MS, 2001, AM EDUC RES J, V38, P915, DOI 10.3102/00028312038004915; Hagay G, 2013, RES SCI EDUC, V43, P895, DOI 10.1007/s11165-012-9289-y; HIDI S, 1990, REV EDUC RES, V60, P549, DOI 10.3102/00346543060004549; Jacque B, 2013, ACAD MED, V88, P620, DOI 10.1097/ACM.0b013e31828b50fb; King K. P., 2002, Internet and Higher Education, V5, P231, DOI 10.1016/S1096-7516(02)00104-5; Lieberman A., 1995, INNOVATING EVALUATIN, P67; Lock J. V., 2006, J TECHNOLOGY TEACHER, V14, P663, DOI DOI 10.1080/00220270903079237; Loucks-Horsley S., 1998, DESIGNING PROFESSION; Malone T.W., 1987, APTITUDE LEARNING IN, V1st ed., P223, DOI [10.4324/9781003163244, DOI 10.4324/9781003163244]; Moore D, 2009, AM J EVAL, V30, P189, DOI 10.1177/1098214009334506; Mowbray CT, 2003, AM J EVAL, V24, P315, DOI 10.1177/109821400302400303; National Academies of Sciences Engineering and Medicine, 2013, NEXT GENERATION SCIE, Vone; National Center for Education Statistics, 2012, 2012465 NCES; Nielsen-Bohlman L, 2004, HLTH LITERACY PRESCR; O'Donnell CL, 2008, REV EDUC RES, V78, P33, DOI 10.3102/0034654307313793; OECD, 2014, PISA 2012 RES CREAT, VV; Penuel WR, 2007, AM EDUC RES J, V44, P921, DOI 10.3102/0002831207308221; Pratt CC, 2000, AM J EVAL, V21, P341, DOI 10.1177/109821400002100305; Provasnik S., 2012, 2013009 NCES; Quinn  Helen, 2012, FRAMEWORK K 12 SCI E; Renninger K. A, 1992, ROLE INTEREST LEARNI, V26, P361; SANDOVAL J, 1995, ANNU REV PSYCHOL, V46, P355, DOI 10.1146/annurev.ps.46.020195.002035; Schneider RM, 2011, REV EDUC RES, V81, P530, DOI 10.3102/0034654311423382; SHULMAN LS, 1987, HARVARD EDUC REV, V57, P1, DOI 10.17763/haer.57.1.j463w79r56455411; Shulman LS, 1994, TEACHING LEARNING SE, P125; SKEFF KM, 1992, EVAL HEALTH PROF, V15, P350, DOI 10.1177/016327879201500307; Tanner Kimberly, 2004, Cell Biol Educ, V3, P197, DOI 10.1187/cbe.04-07-0050; TOBIAS S, 1994, REV EDUC RES, V64, P37, DOI 10.3102/00346543064001037; Vansteenkiste M, 2006, EDUC PSYCHOL-US, V41, P19, DOI 10.1207/s15326985ep4101_4; Zeldin AL, 2008, J RES SCI TEACH, V45, P1036, DOI 10.1002/tea.20195	59	2	2	2	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2014	9	12							e114929	10.1371/journal.pone.0114929	http://dx.doi.org/10.1371/journal.pone.0114929			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AX7UC	25551645	gold, Green Published, Green Submitted			2022-12-27	WOS:000347119100020
J	Mohamed, MF; Hammac, GK; Guptill, L; Seleem, MN				Mohamed, Mohamed F.; Hammac, G. Kenitra; Guptill, Lynn; Seleem, Mohamed N.			Antibacterial Activity of Novel Cationic Peptides against Clinical Isolates of Multi-Drug Resistant Staphylococcus pseudintermedius from Infected Dogs	PLOS ONE			English	Article							CELL-PENETRATING PEPTIDES; ANTIMICROBIAL PEPTIDES; PSEUDOMONAS-AERUGINOSA; BACTERIA; AUREUS; MEMBRANE; MECHANISMS; SEQUENCE; DESIGN	Staphylococcus pseudintermedius is a major cause of skin and soft tissue infections in companion animals and has zoonotic potential. Additionally, methicillin-resistant S. pseudintermedius (MRSP) has emerged with resistance to virtually all classes of antimicrobials. Thus, novel treatment options with new modes of action are required. Here, we investigated the antimicrobial activity of six synthetic short peptides against clinical isolates of methicillin-susceptible and MRSP isolated from infected dogs. All six peptides demonstrated potent antistaphylococcal activity regardless of existing resistance phenotype. The most effective peptides were RRIKA (with modified C terminus to increase amphipathicity and hydrophobicity) and WR-12 (a-helical peptide consisting exclusively of arginine and tryptophan) with minimum inhibitory concentration(50) (MIC50) of 1 mu M and MIC90 of 2 mu M. RR (short anti-inflammatory peptide) and IK8 "D isoform" demonstrated good antimicrobial activity with MIC50 of 4 mu M and MIC90 of 8 mu M. Penetratin and (KFF) 3K (two cell penetrating peptides) were the least effective with MIC50 of 8 mu M and MIC90 of 16 mu M. Killing kinetics revealed a major advantage of peptides over conventional antibiotics, demonstrating potent bactericidal activity within minutes. Studies with propidium iodide and transmission electron microscopy revealed that peptides damaged the bacterial membrane leading to leakage of cytoplasmic contents and consequently, cell death. A potent synergistic increase in the antibacterial effect of the cell penetrating peptide (KFF) 3K was noticed when combined with other peptides and with antibiotics. In addition, all peptides displayed synergistic interactions when combined together. Furthermore, peptides demonstrated good therapeutic indices with minimal toxicity toward mammalian cells. Resistance to peptides did not evolve after 10 passages of S. pseudintermedius at sub-inhibitory concentration. However, the MICs of amikacin and ciprofloxacin increased 32 and 8 fold, respectively; under similar conditions. Taken together, these results support designing of peptide-based therapeutics for combating MRSP infections, particularly for topical application.	[Mohamed, Mohamed F.; Hammac, G. Kenitra; Seleem, Mohamed N.] Purdue Univ, Coll Vet Med, Dept Comparat Pathobiol, W Lafayette, IN 47907 USA; [Guptill, Lynn] Purdue Univ, Dept Vet Clin Sci, Coll Vet Med, W Lafayette, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Seleem, MN (corresponding author), Purdue Univ, Coll Vet Med, Dept Comparat Pathobiol, W Lafayette, IN 47907 USA.	mseleem@purdue.edu	Seleem, Mohamed/H-2774-2018; Guptill, Lynn/O-2881-2015	Seleem, Mohamed/0000-0003-0939-0458; Mohamed, Mohamed/0000-0003-1967-119X	Egyptian Cultural and Educational Bureau (ECEB) in Washington DC, USA	Egyptian Cultural and Educational Bureau (ECEB) in Washington DC, USA(Egyptian Cultural & Educational Bureau)	The authors received no specific funding for this work. Mohamed F. Mohamed is supported by a scholarship from the Egyptian Cultural and Educational Bureau (ECEB) in Washington DC, USA. ECEB had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALVAREZBRAVO J, 1994, BIOCHEM J, V302, P535, DOI 10.1042/bj3020535; Bahnsen JS, 2013, BBA-BIOMEMBRANES, V1828, P223, DOI 10.1016/j.bbamem.2012.10.010; Bond PJ, 2010, PROTEIN PEPTIDE LETT, V17, P1313; Brogden KA, 2005, NAT REV MICROBIOL, V3, P238, DOI 10.1038/nrmicro1098; Chu HL, 2013, ANTIMICROB AGENTS CH, V57, P4050, DOI 10.1128/AAC.00252-13; CLSI, 2007, METH DIL ANT SUSC TE; Deslouches B, 2013, ANTIMICROB AGENTS CH, V57, P2511, DOI 10.1128/AAC.02218-12; Fazakerley J, 2010, VET DERMATOL, V21, P463, DOI 10.1111/j.1365-3164.2010.00893.x; FIDAI S, 1997, METH MOL B, V78, P187; Friedrich CL, 2000, ANTIMICROB AGENTS CH, V44, P2086, DOI 10.1128/AAC.44.8.2086-2092.2000; Hancock REW, 2006, NAT BIOTECHNOL, V24, P1551, DOI 10.1038/nbt1267; Henriques ST, 2006, BIOCHEM J, V399, P1, DOI 10.1042/BJ20061100; Jenssen H, 2006, CLIN MICROBIOL REV, V19, P491, DOI 10.1128/CMR.00056-05; Kuriakose J, 2013, ANGEW CHEM INT EDIT, V52, P9664, DOI 10.1002/anie.201302693; Laarhoven LM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027788; Mohamed MF, 2014, DRUG DES DEV THER, V8, P1979, DOI 10.2147/DDDT.S72129; Mohamed MF, 2014, ANTIMICROB AGENTS CH, V58, P4113, DOI 10.1128/AAC.02578-14; Mohammad H, 2014, J ANTIBIOT TOKYO; Nagant C, 2012, ANTIMICROB AGENTS CH, V56, P5698, DOI 10.1128/AAC.00918-12; Ong ZY, 2014, BIOMATERIALS, V35, P1315, DOI 10.1016/j.biomaterials.2013.10.053; Papich MG, 2012, VET DERMATOL, V23, P352, DOI 10.1111/j.1365-3164.2011.01030.x; Perreten V, 2010, J ANTIMICROB CHEMOTH, V65, P1145, DOI 10.1093/jac/dkq078; PIERS KL, 1994, MOL MICROBIOL, V12, P951, DOI 10.1111/j.1365-2958.1994.tb01083.x; RUHR E, 1985, ANTIMICROB AGENTS CH, V27, P841, DOI 10.1128/AAC.27.5.841; Santoro D, 2014, VET DERMATOL, V25, P35, DOI 10.1111/vde.12091; Sasaki T, 2007, J CLIN MICROBIOL, V45, P1118, DOI 10.1128/JCM.02193-06; SHIMODA M, 1995, INFECT IMMUN, V63, P2886, DOI 10.1128/IAI.63.8.2886-2891.1995; Splith K, 2011, EUR BIOPHYS J BIOPHY, V40, P387, DOI 10.1007/s00249-011-0682-7; Stegmann R, 2010, J ANTIMICROB CHEMOTH, V65, P2047, DOI 10.1093/jac/dkq241; van Duijkeren E, 2011, J ANTIMICROB CHEMOTH, V66, P2705, DOI 10.1093/jac/dkr367; VANNUFFEL P, 1995, J CLIN MICROBIOL, V33, P2864, DOI 10.1128/JCM.33.11.2864-2867.1995; Wadhwani P, 2012, EUR BIOPHYS J BIOPHY, V41, P177, DOI 10.1007/s00249-011-0771-7; Walther B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035197; Ward B, 2009, J PEPT SCI, V15, P668, DOI 10.1002/psc.1168; Weese JS, 2010, VET MICROBIOL, V140, P418, DOI 10.1016/j.vetmic.2009.01.039; Yeaman MR, 2003, PHARMACOL REV, V55, P27, DOI 10.1124/pr.55.1.2; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a; Zhang LJ, 1999, BIOCHEMISTRY-US, V38, P8102, DOI 10.1021/bi9904104	38	34	35	1	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2014	9	12							e116259	10.1371/journal.pone.0116259	http://dx.doi.org/10.1371/journal.pone.0116259			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UC	25551573	gold, Green Published, Green Submitted			2022-12-27	WOS:000347119100115
J	Sharma, A; Wongkham, C; Prasongwattana, V; Boonnate, P; Thanan, R; Reungjui, S; Cha'on, U				Sharma, Amod; Wongkham, Chaisiri; Prasongwattana, Vitoon; Boonnate, Piyanard; Thanan, Raynoo; Reungjui, Sirirat; Cha'on, Ubon			Proteomic Analysis of Kidney in Rats Chronically Exposed to Monosodium Glutamate	PLOS ONE			English	Article							OXIDATIVE STRESS; DEHYDROGENASE; EXPRESSION; DECARBOXYLASE; CONTRIBUTES; TRYPTOPHAN; NEURONS; SERINE; DAMAGE; DIET	Background: Chronic monosodium glutamate (MSG) intake causes kidney dysfunction and renal oxidative stress in the animal model. To gain insight into the renal changes induced by MSG, proteomic analysis of the kidneys was performed. Methods: Six week old male Wistar rats were given drinking water with or without MSG (2 mg/g body weight, n=10 per group) for 9 months. Kidneys were removed, frozen, and stored at -75 degrees C. After protein extraction, 2-D gel electrophoresis was performed and renal proteome profiles were examined with Colloidal Coomassie Brilliant Blue staining. Statistically significant protein spots (ANOVA, p<0.05) with 1.2-fold difference were excised and analyzed by LC-MS. Proteomic data were confirmed by immunohistochemistry and Western blot analyses. Results: The differential image analysis showed 157 changed spots, of which 71 spots were higher and 86 spots were lower in the MSG-treated group compared with those in the control group. Eight statistically significant and differentially expressed proteins were identified: glutathione S-transferase class-pi, heat shock cognate 71 kDa, phosphoserine phosphatase, phosphoglycerate kinase, cytosolic glycerol-3-phosphate dehydrogenase, 2-amino-3-carboxymuconate-6-semialdehyde decarboxylase, alpha-ketoglutarate dehydrogenase and succinyl-CoA ligase. Conclusion: The identified proteins are mainly related to oxidative stress and metabolism. They provide a valuable clue to explore the mechanism of renal handling and toxicity on chronic MSG intake.	[Sharma, Amod; Wongkham, Chaisiri; Prasongwattana, Vitoon; Boonnate, Piyanard; Thanan, Raynoo; Cha'on, Ubon] Khon Kaen Univ, Fac Med, Dept Biochem, Khon Kaen, Thailand; [Reungjui, Sirirat] Khon Kaen Univ, Dept Internal Med, Fac Med, Khon Kaen, Thailand	Khon Kaen University; Khon Kaen University	Cha'on, U (corresponding author), Khon Kaen Univ, Fac Med, Dept Biochem, Khon Kaen, Thailand.	ubocha@kku.ac.th	sharma, amod/ABT-8672-2022; Sharma, Amod/AAA-3679-2022	Sharma, Amod/0000-0002-2860-7790	Research and Technology affairs division, Khon Kaen University; Faculty of Medicine [I57137]	Research and Technology affairs division, Khon Kaen University; Faculty of Medicine	UC received the grants from the Research and Technology affairs division, Khon Kaen University, under incubation research project and the invitation research fund from the Faculty of Medicine (I57137). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAYLIS LL, 1991, PHYSIOL BEHAV, V49, P973, DOI 10.1016/0031-9384(91)90210-F; Bunik VI, 2009, BIOCHEM J, V422, P405, DOI 10.1042/BJ20090722; Colussi C, 2000, FASEB J, V14, P2266, DOI 10.1096/fj.00-0074com; Corthals GL, 2000, ELECTROPHORESIS, V21, P1104, DOI 10.1002/(SICI)1522-2683(20000401)21:6<1104::AID-ELPS1104>3.3.CO;2-3; De Koning TJ, 2003, BIOCHEM J, V371, P653, DOI 10.1042/BJ20021785; Diniz YS, 2004, FOOD CHEM TOXICOL, V42, P313, DOI 10.1016/j.fct.2003.09.006; Dixit SG, 2014, RENAL FAILURE, V36, P266, DOI 10.3109/0886022X.2013.846865; Farombi EO, 2006, HUM EXP TOXICOL, V25, P251, DOI 10.1191/0960327106ht621oa; Gill SS, 2001, TOXICOL PATHOL, V29, P208, DOI 10.1080/019262301317052486; Haugen E, 1999, BLOOD PURIFICAT, V17, P58, DOI 10.1159/000014377; Hayes JD, 1995, CRIT REV BIOCHEM MOL, V30, P445, DOI 10.3109/10409239509083491; IKEDA M, 1965, J BIOL CHEM, V240, P1395; Mannervik B, 2005, METHOD ENZYMOL, V401, P1, DOI 10.1016/S0076-6879(05)01001-3; Merrick B. Alex, 2009, V99, P367; Mracek T, 2013, BBA-BIOENERGETICS, V1827, P401, DOI 10.1016/j.bbabio.2012.11.014; NEUHAUS FC, 1958, BIOCHIM BIOPHYS ACTA, V28, P223, DOI 10.1016/0006-3002(58)90464-5; Ortiz GG, 2006, BIOMED PHARMACOTHER, V60, P86, DOI 10.1016/j.biopha.2005.07.012; Panatier A, 2006, CELL, V125, P775, DOI 10.1016/j.cell.2006.02.051; Paul MVS, 2012, TOXICOL MECH METHOD, V22, P625, DOI 10.3109/15376516.2012.714008; Pucci L, 2007, FEBS J, V274, P827, DOI 10.1111/j.1742-4658.2007.05635.x; Schroer KT, 2011, J ALLERGY CLIN IMMUN, V128, P539, DOI 10.1016/j.jaci.2011.04.018; Sharma A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075546; Starkov AA, 2004, J NEUROSCI, V24, P7779, DOI 10.1523/JNEUROSCI.1899-04.2004; Tanabe A, 2002, J NUTR, V132, P1153, DOI 10.1093/jn/132.6.1153; Tretter L, 2004, J NEUROSCI, V24, P7771, DOI 10.1523/JNEUROSCI.1842-04.2004; Zhang HX, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020862; Zundorf G, 2009, NEUROSCIENCE, V158, P610, DOI 10.1016/j.neuroscience.2008.10.015	27	22	22	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2014	9	12							e116233	10.1371/journal.pone.0116233	http://dx.doi.org/10.1371/journal.pone.0116233			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UC	25551610	Green Published, Green Submitted, gold			2022-12-27	WOS:000347119100109
J	Sharma, GS; Kumar, T; Singh, LR				Sharma, Gurumayum Suraj; Kumar, Tarun; Singh, Laishram Rajendrakumar			N-Homocysteinylation Induces Different Structural and Functional Consequences on Acidic and Basic Proteins	PLOS ONE			English	Article							TRANSFER RNA-SYNTHETASE; PATHOLOGICAL CONSEQUENCES; POSSIBLE MECHANISM; ENDOTHELIAL-CELLS; MOLECULAR-BASIS; THIOLACTONE; PLASMA; METABOLISM; TOXICITY; FIBRILLATION	One of the proposed mechanisms of homocysteine toxicity in human is the modification of proteins by the metabolite of Hcy, homocysteine thilolactone (HTL). Incubation of proteins with HTL has earlier been shown to form covalent adducts with e-amino group of lysine residues of protein (called N-homocysteinylation). It has been believed that protein N-homocysteinylation is the pathological hallmark of cardiovascular and neurodegenerative disorders as homocysteinylation induces structural and functional alterations in proteins. In the present study, reactivity of HTL towards proteins with different physico-chemical properties and hence their structural and functional alterations were studied using different spectroscopic approaches. We found that N-homocysteinylation has opposite consequences on acidic and basic proteins suggesting that pI of the protein determines the extent of homocysteinylation, and the structural and functional consequences due to homocysteinylation. Mechanistically, pI of protein determines the extent of N-homocysteinylation and the associated structural and functional alterations. The study suggests the role of HTL primarily targeting acidic proteins in eliciting its toxicity that could yield mechanistic insights for the associated neurodegeneration.	[Sharma, Gurumayum Suraj; Kumar, Tarun; Singh, Laishram Rajendrakumar] Univ Delhi, Dr BR Ambedkar Ctr Biomed Res, Delhi 110007, India	University of Delhi	Singh, LR (corresponding author), Univ Delhi, Dr BR Ambedkar Ctr Biomed Res, Delhi 110007, India.	lairksingh@gmail.com		Sharma, Gurumayum Suraj/0000-0002-7924-2031				Arora B, 2014, J CHROMATOGR B, V944, P49, DOI 10.1016/j.jchromb.2013.11.011; BIGELOW C C, 1960, C R Trav Lab Carlsberg, V31, P305; Chwatko G, 2005, CLIN CHEM, V51, P408, DOI 10.1373/clinchem.2004.042531; Chwatko G, 2005, ANAL BIOCHEM, V337, P271, DOI 10.1016/j.ab.2004.11.035; CROOK EM, 1960, BIOCHEM J, V74, P234, DOI 10.1042/bj0740234; de Koning ABL, 2003, CLIN BIOCHEM, V36, P431, DOI 10.1016/S0009-9120(03)00062-6; Dodds L, 2008, CLIN CHEM, V54, P326, DOI 10.1373/clinchem.2007.097469; DUDMAN NPB, 1991, ARTERIOSCLER THROMB, V11, P663, DOI 10.1161/01.ATV.11.3.663; ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6; Ferretti G, 2004, J CELL BIOCHEM, V92, P351, DOI 10.1002/jcb.20069; Gellekink Henkjan, 2005, Semin Vasc Med, V5, P98, DOI 10.1055/s-2005-872396; Glowacki R, 2004, J BIOL CHEM, V279, P10864, DOI 10.1074/jbc.M313268200; HAMAGUCHI K, 1963, J BIOCHEM-TOKYO, V54, P111; Hong L, 2007, J BIOL CHEM, V282, P34684, DOI 10.1074/jbc.M707231200; Hubmacher D, 2006, CURR TOP DEV BIOL, V75, P93, DOI 10.1016/S0070-2153(06)75004-9; Hubmacher D, 2010, J BIOL CHEM, V285, P1188, DOI 10.1074/jbc.M109.021246; JAKUBOWSKI H, 1993, FEBS LETT, V317, P237, DOI 10.1016/0014-5793(93)81283-6; Jakubowski H, 2000, J BIOL CHEM, V275, P3957, DOI 10.1074/jbc.275.6.3957; Jakubowski H, 2000, CIRC RES, V87, P45, DOI 10.1161/01.RES.87.1.45; Jakubowski H, 1997, J BIOL CHEM, V272, P1935; Jakubowski H, 2004, CELL MOL LIFE SCI, V61, P470, DOI 10.1007/s00018-003-3204-7; Jakubowski H, 2002, J BIOL CHEM, V277, P30425, DOI 10.1074/jbc.C200267200; Jakubowski H, 2003, CLIN CHEM LAB MED, V41, P1462, DOI 10.1515/CCLM.2003.224; Jakubowski H, 2002, ANAL BIOCHEM, V308, P112, DOI 10.1016/S0003-2697(02)00224-5; JAKUBOWSKI H, 1991, EMBO J, V10, P593, DOI 10.1002/j.1460-2075.1991.tb07986.x; Jakubowski H, 1999, FASEB J, V13, P2277, DOI 10.1096/fasebj.13.15.2277; Jakubowski H, 2000, J NUTR, V130, p377S, DOI 10.1093/jn/130.2.377S; Jakubowski H, 2007, CLIN CHEM LAB MED, V45, P1704, DOI 10.1515/CCLM.2007.338; Jakubowski H, 2006, J NUTR, V136, p1741S, DOI 10.1093/jn/136.6.1741S; Jalili S, 2011, PROTEIN J, V30, P299, DOI 10.1007/s10930-011-9333-1; Karima O, 2012, FEBS LETT, V586, P3914, DOI 10.1016/j.febslet.2012.09.024; Khazaei S, 2012, PROTEIN J, V31, P717, DOI 10.1007/s10930-012-9451-4; Khodadadi S, 2012, FEBS LETT, V586, P127, DOI 10.1016/j.febslet.2011.12.018; Kielty CM, 2005, ADV PROTEIN CHEM, V70, P405, DOI 10.1016/S0065-3233(04)70012-1; Mattson MP, 2003, TRENDS NEUROSCI, V26, P137, DOI 10.1016/S0166-2236(03)00032-8; MAUREL P, 1976, J MOL BIOL, V102, P253, DOI 10.1016/S0022-2836(76)80052-6; Obeid R, 2006, FEBS LETT, V580, P2994, DOI 10.1016/j.febslet.2006.04.088; Pace C N, 1986, Methods Enzymol, V131, P266; PANCHARUNITI N, 1994, AM J CLIN NUTR, V59, P940, DOI 10.1093/ajcn/59.4.940; Paoli P, 2010, J MOL BIOL, V400, P889, DOI 10.1016/j.jmb.2010.05.039; Perla-Kajan J, 2007, AMINO ACIDS, V32, P561, DOI 10.1007/s00726-006-0432-9; Perla-Kajan J, 2007, BIOCHEMISTRY-US, V46, P6225, DOI 10.1021/bi602463m; Refsum H, 1998, ANNU REV MED, V49, P31, DOI 10.1146/annurev.med.49.1.31; Seshadri S, 2006, J ALZHEIMERS DIS, V9, P393; Sikora M, 2014, AMINO ACIDS, V46, P235, DOI 10.1007/s00726-013-1617-7; Sinha A, 2000, BIOCHEM J, V345, P711, DOI 10.1042/0264-6021:3450711; Sontag E, 2007, J NEUROSCI, V27, P2751, DOI 10.1523/JNEUROSCI.3316-06.2007; Spence JD, 2005, STROKE, V36, P2404, DOI 10.1161/01.STR.0000185929.38534.f3; Stroylova YY, 2012, ARCH BIOCHEM BIOPHYS, V526, P29, DOI 10.1016/j.abb.2012.06.008; Stroylova YY, 2011, BBA-PROTEINS PROTEOM, V1814, P1234, DOI 10.1016/j.bbapap.2011.05.017; Stuhlinger MC, 2001, CIRCULATION, V104, P2569, DOI 10.1161/hc4601.098514; SUGAI S, 1973, BIOCHIM BIOPHYS ACTA, V328, P35, DOI 10.1016/0005-2795(73)90327-9; Thorn DC, 2005, BIOCHEMISTRY-US, V44, P17027, DOI 10.1021/bi051352r; Topal G, 2004, FREE RADICAL BIO MED, V36, P1532, DOI 10.1016/j.freeradbiomed.2004.03.019; YANG JT, 1986, METHOD ENZYMOL, V130, P208; Yazdanparast R, 2005, ARCH BIOCHEM BIOPHYS, V437, P178, DOI 10.1016/j.abb.2005.03.003; Yousefi R, 2012, INT J BIOL MACROMOL, V51, P291, DOI 10.1016/j.ijbiomac.2012.05.021; Zang TZ, 2009, ANAL CHEM, V81, P9065, DOI 10.1021/ac9017132; Zimny J, 2006, J BIOL CHEM, V281, P22485, DOI 10.1074/jbc.M603656200	59	18	18	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2014	9	12							e116386	10.1371/journal.pone.0116386	http://dx.doi.org/10.1371/journal.pone.0116386			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UC	25551634	gold, Green Published, Green Submitted			2022-12-27	WOS:000347119100138
J	Stathias, V; Pastori, C; Griffin, TZ; Komotar, R; Clarke, J; Zhang, M; Ayad, NG				Stathias, Vasileios; Pastori, Chiara; Griffin, Tess Z.; Komotar, Ricardo; Clarke, Jennifer; Zhang, Ming; Ayad, Nagi G.			Identifying Glioblastoma Gene Networks Based on Hypergeometric Test Analysis	PLOS ONE			English	Article							DIFFERENTIAL EXPRESSION ANALYSIS; RNA-SEQ; COEXPRESSION NETWORK; BIOLOGICAL NETWORKS; CANCER-CELLS; MICROARRAY; NORMALIZATION; INSIGHTS	Patient specific therapy is emerging as an important possibility for many cancer patients. However, to identify such therapies it is essential to determine the genomic and transcriptional alterations present in one tumor relative to control samples. This presents a challenge since use of a single sample precludes many standard statistical analysis techniques. We reasoned that one means of addressing this issue is by comparing transcriptional changes in one tumor with those observed in a large cohort of patients analyzed by The Cancer Genome Atlas (TCGA). To test this directly, we devised a bioinformatics pipeline to identify differentially expressed genes in tumors resected from patients suffering from the most common malignant adult brain tumor, glioblastoma (GBM). We performed RNA sequencing on tumors from individual GBM patients and filtered the results through the TCGA database in order to identify possible gene networks that are overrepresented in GBM samples relative to controls. Importantly, we demonstrate that hypergeometric-based analysis of gene pairs identifies gene networks that validate experimentally. These studies identify a putative workflow for uncovering differentially expressed patient specific genes and gene networks for GBM and other cancers.	[Stathias, Vasileios] Univ Miami, Miller Sch Med, Dept Human Genet & Genom, Miami, FL 33136 USA; [Stathias, Vasileios; Pastori, Chiara; Ayad, Nagi G.] Univ Miami, Miller Sch Med, Ctr Therapeut Innovat, Dept Psychiat & Behav Sci, Miami, FL 33136 USA; [Griffin, Tess Z.; Zhang, Ming] Univ Georgia, Dept Epidemiol & Biostat, Athens, GA 30602 USA; [Griffin, Tess Z.; Zhang, Ming] Univ Georgia, Inst Bioinformat, Athens, GA 30602 USA; [Komotar, Ricardo] Univ Miami, Miller Sch Med, Dept Neurosurg, Miami, FL 33136 USA; [Clarke, Jennifer] Univ Nebraska, Dept Stat, Dept Food Sci & Technol, Lincoln, NE 68588 USA	University of Miami; University of Miami; University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; University of Miami; University of Nebraska System; University of Nebraska Lincoln	Ayad, NG (corresponding author), Univ Miami, Miller Sch Med, Ctr Therapeut Innovat, Dept Psychiat & Behav Sci, Miami, FL 33136 USA.	nayad@med.miami.edu	Stathias, Vasileios/AAN-5323-2021	Clarke, Jennifer/0000-0002-2723-7249	National Institutes of Health, National Institutes of Neurological Disease and Stroke;  [1R01NS067289]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS067289] Funding Source: NIH RePORTER	National Institutes of Health, National Institutes of Neurological Disease and Stroke; ; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	1R01NS067289. The funders (National Institutes of Health, National Institutes of Neurological Disease and Stroke)had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Arzate-Mejia RG, 2011, IUBMB LIFE, V63, P881, DOI 10.1002/iub.557; Clarke J, 2013, EPIGENETICS-US, V8, P785, DOI 10.4161/epi.25440; Cline MS, 2007, NAT PROTOC, V2, P2366, DOI 10.1038/nprot.2007.324; Dunn GP, 2012, GENE DEV, V26, P756, DOI 10.1101/gad.187922.112; Erkan EP, 2013, ONCOGENE; Fanelli M, 2008, ONCOGENE, V27, P358, DOI 10.1038/sj.onc.1210642; Foltz G, 2009, ONCOGENE, V28, P2667, DOI 10.1038/onc.2009.122; Franceschini A, 2013, NUCLEIC ACIDS RES, V41, pD808, DOI 10.1093/nar/gks1094; Guo Ya, 2013, PLOS ONE, V8; Haar CP, 2012, NEUROCHEM RES, V37, P1192, DOI 10.1007/s11064-011-0701-1; Hardcastle TJ, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-422; Horvath S, 2006, P NATL ACAD SCI USA, V103, P17402, DOI 10.1073/pnas.0608396103; Hu HY, 2005, BIOINFORMATICS, V21, pI213, DOI 10.1093/bioinformatics/bti1049; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Kim HJ, 2012, RADIAT ONCOL, V7, DOI 10.1186/1748-717X-7-39; Lei M, 2005, CURR CANCER DRUG TAR, V5, P365, DOI 10.2174/1568009054629654; Li J, 2010, PHARMACOGN PERS MED, V3, P111, DOI 10.2147/PGPM.S6852; Nookaew I, 2012, NUCLEIC ACIDS RES, V40, P10084, DOI 10.1093/nar/gks804; Ostrom QT, 2013, NEURO-ONCOLOGY, V15, P1, DOI 10.1093/neuonc/not151; Pastori C, 2014, EPIGENETICS-US, V9, P611, DOI 10.4161/epi.27906; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Seyednasrollah F, 2013, BRIEF BIOINFORM; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Stuart JM, 2003, SCIENCE, V302, P249, DOI 10.1126/science.1087447; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Vartanian A, 2014, NEUROONCOL; Xu X, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-S9-S1; Yang YH, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.4.e15; Zhang B, 2005, STAT APPL GENET MOL, V4, DOI 10.2202/1544-6115.1128; Zhao SR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0078644	34	15	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2014	9	12							e115842	10.1371/journal.pone.0115842	http://dx.doi.org/10.1371/journal.pone.0115842			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UC	25551752	Green Published, gold			2022-12-27	WOS:000347119100068
J	Xing, S; Martinon-Torres, M; de Castro, JMB; Zhang, YQ; Fan, XX; Zheng, LT; Huang, WB; Liu, W				Xing, Song; Martinon-Torres, Maria; Bermudez de Castro, Jose Maria; Zhang, Yingqi; Fan, Xiaoxiao; Zheng, Longting; Huang, Wanbo; Liu, Wu			Middle Pleistocene Hominin Teeth from Longtan Cave, Hexian, China	PLOS ONE			English	Article							GEOMETRIC MORPHOMETRIC-ANALYSIS; ENAMEL-DENTIN JUNCTION; HOMO-ERECTUS; MORPHOLOGICAL DESCRIPTION; TISSUE PROPORTIONS; FOSSIL HOMINIDS; HADAR FORMATION; REMAINS; SANGIRAN; MOLARS	Excavations at the Longtan Cave, Hexian, Anhui Province of Eastern China, have yielded several hominin fossils including crania, mandibular fragments, and teeth currently dated to 412 +/- 25 ka. While previous studies have focused on the cranial remains, there are no detailed analyses of the dental evidence. In this study, we provide metric and morphological descriptions and comparisons of ten teeth recovered from Hexian, including microcomputed tomography analyses. Our results indicate that the Hexian teeth are metrically and morphologically primitive and overlap with H. ergaster and East Asian Early and mid-Middle Pleistocene hominins in their large dimensions and occlusal complexities. However, the Hexian teeth differ from H. ergaster in features such as conspicuous vertical grooves on the labial/buccal surfaces of the central incisor and the upper premolar, the crown outline shapes of upper and lower molars and the numbers, shapes, and divergences of the roots. Despite their close geological ages, the Hexian teeth are also more primitive than Zhoukoudian specimens, and resemble Sangiran Early Pleistocene teeth. In addition, no typical Neanderthal features have been identified in the Hexian sample. Our study highlights the metrical and morphological primitive status of the Hexian sample in comparison to contemporaneous or even earlier populations of Asia. Based on this finding, we suggest that the primitive-derived gradients of the Asian hominins cannot be satisfactorily fitted along a chronological sequence, suggesting complex evolutionary scenarios with the coexistence and/or survival of different lineages in Eurasia. Hexian could represent the persistence in time of a H. erectus group that would have retained primitive features that were lost in other Asian populations such as Zhoukoudian or Panxian Dadong. Our study expands the metrical and morphological variations known for the East Asian hominins before the mid-Middle Pleistocene and warns about the possibility that the Asian hominin variability may have been taxonomically oversimplified.	[Xing, Song; Zhang, Yingqi; Liu, Wu] Chinese Acad Sci, Inst Vertebrate Paleontol & Paleoanthropol, Key Lab Vertebrate Evolut & Human Origins, Beijing, Peoples R China; [Martinon-Torres, Maria; Bermudez de Castro, Jose Maria] Natl Res Ctr Human Evolut CENIEH, Burgos, Spain; [Fan, Xiaoxiao] Hexian Museum Anhui Prov, Hexian, Peoples R China; [Zheng, Longting] Anhui Museum, Hefei, Peoples R China; [Huang, Wanbo] China Three Gorges Museum, Chongqing Three Gorges Inst Paleoanthropol, Chongqing, Peoples R China	Chinese Academy of Sciences; Institute of Vertebrate Paleontology & Paleoanthropology, CAS; Centro Nacional de Investigacion de La Evolucion Humana (CENIEH); Chongqing Three Gorges University	Martinon-Torres, M (corresponding author), Natl Res Ctr Human Evolut CENIEH, Burgos, Spain.	maria.martinon.torres@gmail.com	ZHANG, Yingqi/D-4350-2013	ZHANG, Yingqi/0000-0001-7783-8336; Bermudez de Castro, Jose Maria/0000-0003-1314-3273	Chinese Academy of Sciences [GJHZ201314, KZZD-EW03, XDA05130100]; National Natural Science Foundation of China [41302016, 41272034]; Direccion General de Investigacion of the Spanish Ministerio de Educacion y Ciencia [CGL2012-38434-C03-02, HF2007-0115]; Consejeria de Educacion de Junta de Castilla y Leon [CEN074A12-2]; Leakey Foundation	Chinese Academy of Sciences(Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Direccion General de Investigacion of the Spanish Ministerio de Educacion y Ciencia(Spanish Government); Consejeria de Educacion de Junta de Castilla y Leon; Leakey Foundation	This work has been supported by the grants from Chinese Academy of Sciences (GJHZ201314, KZZD-EW03, and XDA05130100), National Natural Science Foundation of China (41302016 and 41272034), Direccion General de Investigacion of the Spanish Ministerio de Educacion y Ciencia (CGL2012-38434-C03-02 and Accion Integrada Espana Francia HF2007-0115), Consejeria de Educacion de Junta de Castilla y Leon (CEN074A12-2), and Leakey Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anton SC, 2003, YEARB PHYS ANTHROPOL, V46, P126, DOI 10.1002/ajpa.10399; Anton SC, 2002, AM J PHYS ANTHROPOL, V118, P301, DOI 10.1002/ajpa.10091; Asfaw B, 2002, NATURE, V416, P317, DOI 10.1038/416317a; Baba H, 2003, SCIENCE, V299, P1384, DOI 10.1126/science.1081676; Bailey SE, 2004, J HUM EVOL, V47, P183, DOI 10.1016/j.jhevol.2004.07.001; Bailey SE, 2011, AM J PHYS ANTHROPOL, V145, P505, DOI 10.1002/ajpa.21468; Bailey Shara E., 2002, Anatomical Record, V269, P148, DOI 10.1002/ar.10116; Bailey SE, 2010, QUATERN INT, V211, P14, DOI 10.1016/j.quaint.2009.01.008; Bettis EA, 2009, J HUM EVOL, V56, P11, DOI 10.1016/j.jhevol.2008.09.003; Brink JS, 2012, J HUM EVOL, V63, P527, DOI 10.1016/j.jhevol.2012.06.004; Carbonell E, 2005, P NATL ACAD SCI USA, V102, P5674, DOI 10.1073/pnas.0501841102; Carlsen O, 1987, DENTAL MORPHOLOGY; Chen T, 1987, ACTA ANTHR SINICA, V6, P249; [陈铁梅 CHEN Tie-mei], 2009, [人类学学报, Acta Anthropologica Sinica], V28, P285; de Castro JMB, 1999, J HUM EVOL, V37, P523, DOI 10.1006/jhev.1999.0323; DECASTRO JMB, 1988, J HUM EVOL, V17, P279; deCastro JMB, 1997, SCIENCE, V276, P1392; Dennell R, 2013, QUATERN INT, V300, P13, DOI 10.1016/j.quaint.2012.12.002; Dennell RW, 2013, QUATERN INT, V295, P223, DOI 10.1016/j.quaint.2012.02.012; Dennell RW, 2011, QUATERNARY SCI REV, V30, P1511, DOI 10.1016/j.quascirev.2009.11.027; Durband AC, 2005, ANTHROPOL SCI, V113, P147, DOI 10.1537/ase.040303; Etler DA, 1996, ANNU REV ANTHROPOL, V25, P275, DOI 10.1146/annurev.anthro.25.1.275; FRAYER DW, 1977, AM J PHYS ANTHROPOL, V46, P109, DOI 10.1002/ajpa.1330460114; Gabunia L, 2000, SCIENCE, V288, P1019, DOI 10.1126/science.288.5468.1019; Gomez-Robles A, 2007, J HUM EVOL, V53, P272, DOI 10.1016/j.jhevol.2007.02.002; Gomez-Robles A, 2008, J HUM EVOL, V55, P627, DOI 10.1016/j.jhevol.2008.03.011; Gomez-Robles A, 2012, J HUM EVOL, V63, P512, DOI 10.1016/j.jhevol.2012.06.002; Gomez-Robles A, 2011, J HUM EVOL, V61, P688, DOI 10.1016/j.jhevol.2011.09.004; Grine Frederick Edward, 1994, Courier Forschungsinstitut Senckenberg, V171, P75; Grun R, 1998, J HUM EVOL, V34, P555, DOI 10.1006/jhev.1997.0211; Grun R, 1997, J HUM EVOL, V32, P83; Hlusko LJ, 2004, J HUM EVOL, V46, P579, DOI 10.1016/j.jhevol.2004.03.003; Huang P, 1994, CHINESE SCI BULL, V40, P1318; Huang P, 1995, NUCL TECH, V18, P491; HUANG W, 1982, VERTEBRAT PALASIATIC, V20, P248; Huang W, 1981, CHINESE SCI BULL, V26, P1116; Huang WB, 2001, HEXIAN HOMINID SITE; HYODO M, 1993, ANTHROPOL SCI, V101, P157, DOI 10.1537/ase.101.157; Hyodo M, 2002, J HUM EVOL, V43, P27, DOI 10.1006/jhev.2002.0555; Hyodo M., 2001, SANGIRAN MAN CULTURE, P320; Hyodo M, 2011, P NATL ACAD SCI USA, V108, P19563, DOI 10.1073/pnas.1113106108; Irish JD, 2003, J HUM EVOL, V45, P113, DOI 10.1016/S0047-2484(03)00090-3; Irish JD, 1998, J HUM EVOL, V34, P81, DOI 10.1006/jhev.1997.0191; IRISH JD, 1993, THESIS ARIZONA STATE; JOHANSON DC, 1982, AM J PHYS ANTHROPOL, V57, P545, DOI 10.1002/ajpa.1330570406; Kaifu Y, 2005, AM J PHYS ANTHROPOL, V128, P709, DOI 10.1002/ajpa.10425; Kaifu Y, 2005, AM J PHYS ANTHROPOL, V128, P497, DOI 10.1002/ajpa.10427; Kaifu Y, 2006, ANTHROPOL SCI, V114, P35, DOI 10.1537/ase.040729; Kaifu Y, 2011, J HUM EVOL, V61, P270, DOI 10.1016/j.jhevol.2011.04.002; Keith A, 1913, Proc R Soc Med, V6, P103; Kidder JH, 2004, J HUM EVOL, V46, P299, DOI 10.1016/j.jhevol.2003.12.003; Kupczik K, 2010, J HUM EVOL, V59, P525, DOI 10.1016/j.jhevol.2010.05.009; Larick R, 2001, P NATL ACAD SCI USA, V98, P4866, DOI 10.1073/pnas.081077298; LIEBERMAN DE, 1988, J HUM EVOL, V17, P503, DOI 10.1016/0047-2484(88)90039-5; Liu TS, 1999, QUATERNARY SCI REV, V18, P1205, DOI 10.1016/S0277-3791(98)00110-3; Liu W, 2005, AM J PHYS ANTHROPOL, V127, P253, DOI 10.1002/ajpa.20066; Liu W, 2013, J HUM EVOL, V64, P337, DOI 10.1016/j.jhevol.2012.10.012; MacDonald K, 2012, QUATERN INT, V271, P84, DOI 10.1016/j.quaint.2011.10.009; Martin-Frances L, 2014, CR PALEVOL, V13, P189, DOI 10.1016/j.crpv.2013.10.007; de Pinillos MM, 2014, CR PALEVOL, V13, P205, DOI 10.1016/j.crpv.2013.10.008; Martinon-~Torres M, 2006, THESIS U SANTIAGO CO; Martinon-Torres M, 2007, P NATL ACAD SCI USA, V104, P13279, DOI 10.1073/pnas.0706152104; Martinon-Torres M, 2006, J HUM EVOL, V50, P523, DOI 10.1016/j.jhevol.2005.12.004; Martinon-Torres M, 2008, J HUM EVOL, V55, P249, DOI 10.1016/j.jhevol.2007.12.008; Martinon-Torres M, 2014, CR PALEVOL, V13, P223, DOI 10.1016/j.crpv.2013.12.002; Martinon-Torres M, 2013, J ANAT, V223, P353, DOI 10.1111/joa.12090; Martinon-Torres M, 2012, J HUM EVOL, V62, P7, DOI 10.1016/j.jhevol.2011.08.007; Moggi-Cecchi J, 2006, J HUM EVOL, V50, P239, DOI 10.1016/j.jhevol.2005.08.012; MOLNAR S, 1971, AM J PHYS ANTHROPOL, V34, P175, DOI 10.1002/ajpa.1330340204; Olejniczak AJ, 2006, THESIS STONY BROOK U; Olejniczak AJ, 2008, J HUM EVOL, V55, P12, DOI 10.1016/j.jhevol.2007.11.004; Ortiz A, 2012, J HUM EVOL, V63, P586, DOI 10.1016/j.jhevol.2012.06.003; Quam R, 2009, J ANAT, V214, P655, DOI 10.1111/j.1469-7580.2009.01064.x; Rightmire G. Philip, 1992, Evolutionary Anthropology, V1, P43, DOI 10.1002/evan.1360010204; RIGHTMIRE GP, 1993, AM J PHYS ANTHROPOL, V90, P1, DOI 10.1002/ajpa.1330900102; Rukang W., 1982, ACTA ANTHR SIN, V1, P2; Scott G.R., 1997, ANTHR MODERN HUMAN T, DOI 10.1017/CBO9781316529843; Semah F, 2000, J ARCHAEOL SCI, V27, P763, DOI 10.1006/jasc.1999.0482; Shen GJ, 2001, J HUM EVOL, V41, P679, DOI 10.1006/jhev.2001.0516; Shen GJ, 2009, NATURE, V458, P198, DOI 10.1038/nature07741; Skinner MM, 2009, J HUM EVOL, V56, P76, DOI 10.1016/j.jhevol.2008.08.021; Smith TM, 2012, J HUM EVOL, V62, P395, DOI 10.1016/j.jhevol.2011.12.004; Suwa G, 2007, ANTHROPOL SCI, V115, P133, DOI 10.1537/ase.061203; Tobias P. V., 1991, SKULLS ENDOCASTS TEE, VIV; Turner C G 2nd, 1969, Am J Phys Anthropol, V30, P421; Turner II C. G., 1991, ADV DENT ANTHR, P13; von Koenigswald G.H.R., 1950, INT GEOL C REP 18 9, P59; Walker A., 1993, NARIOKOTOME HOMO ERE; WARD SC, 1982, AM J PHYS ANTHROPOL, V57, P605, DOI 10.1002/ajpa.1330570407; Weidenreich F., 1935, Bull Geol Soc Peiping, V14, P427; Weidenreich F., 1937, DENTITION SINANTHROP; WHITE TD, 1980, AM J PHYS ANTHROPOL, V53, P487, DOI 10.1002/ajpa.1330530405; WHITE TD, 1977, AM J PHYS ANTHROPOL, V46, P197, DOI 10.1002/ajpa.1330460203; Wolpoff M. H., 1999, PALEOANTHROPOLOGY; Wolpoff M. H., 1971, STUDIES ANTHR, V2; WOOD B, 1992, NATURE, V355, P397, DOI 10.1038/355397a0; Wood B., 1991, HOMINID CRANIAL REMA, V4; WOOD BA, 1988, J ANAT, V161, P1; Wu X, 2006, AM J PHYS ANTHROPOL, V26, P445; Wu X.Z., 1995, HUMAN EVOLUTION CHIN; Wu XJ, 2010, QUATERN INT, V211, P4, DOI 10.1016/j.quaint.2009.07.002; Wu XJ, 2010, P ROY SOC B-BIOL SCI, V277, P337, DOI 10.1098/rspb.2009.0149; Wu XZ, 2004, QUATERN INT, V117, P131, DOI 10.1016/S1040-6182(03)00123-X; Wu XZ, 2004, INT J PRIMATOL, V25, P1093, DOI 10.1023/B:IJOP.0000043353.24043.19; Xing S, 2012, THESIS CHINESE ACAD; Xing S, 2015, AM J PHYS ANTHROPOL, V156, P224, DOI 10.1002/ajpa.22641; Xing Song, 2012, Acta Anthropologica Sinica, V31, P250; Zanolli C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067233; Zanolli C, 2010, CR PALEVOL, V9, P341, DOI 10.1016/j.crpv.2010.07.019; 黄培华, 1995, 人类学学报, V14, P262	110	45	52	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2014	9	12							e114265	10.1371/journal.pone.0114265	http://dx.doi.org/10.1371/journal.pone.0114265			38	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AX7UC	25551383	Green Published, Green Submitted, gold			2022-12-27	WOS:000347119100009
J	Yuan, QY; Zhang, L; Xiao, D; Zhao, K; Lin, C; Si, LY				Yuan, Qiao-Ying; Zhang, Ling; Xiao, Dan; Zhao, Kun; Lin, Chun; Si, Liang-Yi			An Accurate, Flexible and Small Optical Fiber Sensor: A Novel Technological Breakthrough for Real-Time Analysis of Dynamic Blood Flow Data In Vivo	PLOS ONE			English	Article							PRESSURE SENSOR; MEMS PRESSURE; SPECTROSCOPY	Because of the limitations of existing methods and techniques for directly obtaining real-time blood data, no accurate microflow in vivo real-time analysis method exists. To establish a novel technical platform for real-time in vivo detection and to analyze average blood pressure and other blood flow parameters, a small, accurate, flexible, and nontoxic Fabry-Perot fiber sensor was designed. The carotid sheath was implanted through intubation of the rabbit carotid artery (n=8), and the blood pressure and other detection data were determined directly through the veins. The fiber detection results were compared with test results obtained using color Doppler ultrasound and a physiological pressure sensor recorder. Pairwise comparisons among the blood pressure results obtained using the three methods indicated that real-time blood pressure information obtained through the fiber sensor technique exhibited better correlation than the data obtained with the other techniques. The highest correlation (correlation coefficient of 0.86) was obtained between the fiber sensor and pressure sensor. The blood pressure values were positively related to the total cholesterol level, low-density lipoprotein level, number of red blood cells, and hemoglobin level, with correlation coefficients of 0.033, 0.129, 0.358, and 0.373, respectively. The blood pressure values had no obvious relationship with the number of white blood cells and high-density lipoprotein and had a negative relationship with triglyceride levels, with a correlation coefficient of -0.031. The average ambulatory blood pressure measured by the fiber sensor exhibited a negative correlation with the quantity of blood platelets (correlation coefficient of -0.839, P<0.05). The novel fiber sensor can thus obtain in vivo blood pressure data accurately, stably, and in real time; the sensor can also determine the content and status of the blood flow to some extent. Therefore, the fiber sensor can obtain partially real-time vascular rheology information and may thus enable the early diagnosis of blood rheology disorders and diseases.	[Yuan, Qiao-Ying; Xiao, Dan; Zhao, Kun; Si, Liang-Yi] Third Mil Med Univ, Dept Geriatr, Southwest Hosp, Chongqing, Peoples R China; [Zhang, Ling] Third Mil Med Univ, Southwest Hosp, Dept Outpatient Clin OPD, Chongqing, Peoples R China; [Lin, Chun] Xiamen Univ, Sch Phys & Mech & Elect Engn, Xiamen, Peoples R China	Army Medical University; Army Medical University; Xiamen University	Si, LY (corresponding author), Third Mil Med Univ, Dept Geriatr, Southwest Hosp, Chongqing, Peoples R China.	Liangyisi2014@163.com			National Natural Science Foundation of China (NSFC) [81271657]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (NSFC) Project No: 81271657. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdiche YN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092451; Abeysinghe DC, 2002, J MICROMECH MICROENG, V12, P229, DOI 10.1088/0960-1317/12/3/306; Abeysinghe DC, 2001, IEEE PHOTONIC TECH L, V13, P993, DOI 10.1109/68.942671; BELLEVILLE C, 2006, Patent No. 20060133715; Cibula E, 2005, APPL OPTICS, V44, P2736, DOI 10.1364/AO.44.002736; Cohen AE, 2000, SENSOR ACTUAT B-CHEM, V62, P23, DOI 10.1016/S0925-4005(99)00372-X; Hill GC, 2007, SENSOR ACTUAT A-PHYS, V138, P52, DOI 10.1016/j.sna.2007.04.047; Lim JKH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098393; Liu XD, 2006, PHYS MED BIOL, V51, P173, DOI 10.1088/0031-9155/51/1/013; MacPherson WN, 1999, REV SCI INSTRUM, V70, P1868, DOI 10.1063/1.1149682; Nesson S, 2008, J BIOMED OPT, V13, DOI 10.1117/1.2967908; Neudel F, 2002, MED ENG PHYS, V24, P301, DOI 10.1016/S1350-4533(02)00012-7; OBERG PA, 1984, ACTA MED SCAND, P17; Olson ES, 1998, J ACOUST SOC AM, V103, P3445, DOI 10.1121/1.423083; SHERRER DW, 2002, Patent No. 20020003917; Skora A, 2004, TECHNOL HEALTH CARE, V12, P87; Spielman AJ, 2000, BRAIN RES, V866, P313, DOI 10.1016/S0006-8993(00)02320-9; Takeuchi A, 2010, J CLIN MONIT COMPUT, V24, P363, DOI 10.1007/s10877-010-9255-z; Totsu K, 2005, J MICROMECH MICROENG, V15, P71, DOI 10.1088/0960-1317/15/1/011; Urquiza SA, 2006, COMPUT METHOD APPL M, V195, P4002, DOI 10.1016/j.cma.2005.07.014; Wang X., 2005, 2005 Quantum Electronics and Laser Science Conference (QELS) (IEEE Cat. No. 05CH37696), P916; Wang XW, 2006, OPT LETT, V31, P885, DOI 10.1364/OL.31.000885; Watson S, 2006, APPL OPTICS, V45, P5590, DOI 10.1364/AO.45.005590	23	4	4	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2014	9	12							e114794	10.1371/journal.pone.0114794	http://dx.doi.org/10.1371/journal.pone.0114794			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UC	25551384	Green Submitted, Green Published, gold			2022-12-27	WOS:000347119100016
J	Adamowicz, MS; Stasulli, DM; Sobestanovich, EM; Bille, TW				Adamowicz, Michael S.; Stasulli, Dominique M.; Sobestanovich, Emily M.; Bille, Todd W.			Evaluation of Methods to Improve the Extraction and Recovery of DNA from Cotton Swabs for Forensic Analysis	PLOS ONE			English	Article							COLLECTION; SAMPLES; PROFILES; PCR; FINGERPRINTS; SENSITIVITY; TIME; SKIN	Samples for forensic DNA analysis are often collected from a wide variety of objects using cotton or nylon tipped swabs. Testing has shown that significant quantities of DNA are retained on the swab, however, and subsequently lost. When processing evidentiary samples, the recovery of the maximum amount of available DNA is critical, potentially dictating whether a usable profile can be derived from a piece of evidence or not. The QIAamp DNA Investigator extraction kit was used with its recommended protocol for swabs (one hour incubation at 56 degrees C) as a baseline. Results indicate that over 50% of the recoverable DNA may be retained on the cotton swab tip, or otherwise lost, for both blood and buccal cell samples when using this protocol. The protocol's incubation time and temperature were altered, as was incubating while shaking or stationary to test for increases in recovery efficiency. An additional step was then tested that included periodic re-suspension of the swab tip in the extraction buffer during incubation. Aliquots of liquid blood or a buccal cell suspension were deposited and dried on cotton swabs and compared with swab-less controls. The concentration of DNA in each extract was quantified and STR analysis was performed to assess the quality of the extracted DNA. Stationary incubations and those performed at 65 degrees C did not result in significant gains in DNA yield. Samples incubated for 24 hours yielded less DNA. Increased yields were observed with three and 18 hour incubation periods. Increases in DNA yields were also observed using a swab re-suspension method for both cell types. The swab re-suspension method yielded an average two-fold increase in recovered DNA yield with buccal cells and an average three-fold increase with blood cells. These findings demonstrate that more of the DNA collected on swabs can be recovered with specific protocol alterations.	[Adamowicz, Michael S.; Stasulli, Dominique M.; Sobestanovich, Emily M.] Univ New Haven, Henry C Lee Coll Criminal Justice & Forens Sci, Dept Forens Sci, West Haven, CT 06516 USA; [Bille, Todd W.] Bur Alcohol Tobacco Firearms & Explos, Natl Lab Ctr, Ammendale, MD USA	University New Haven	Adamowicz, MS (corresponding author), Univ New Haven, Henry C Lee Coll Criminal Justice & Forens Sci, Dept Forens Sci, West Haven, CT 06516 USA.	madamowicz@newhaven.edu		Bille, Todd/0000-0003-2976-5085	University of New Haven Summer Undergraduate Research Fellowship program	University of New Haven Summer Undergraduate Research Fellowship program	This work was supported by the University of New Haven Summer Undergraduate Research Fellowship program. MSA, DMS, and EMS received summer stipends; DMS and EMS also received summer housing. Limited funds were provided for reagents. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2006, APPL BIOSYSTEMS LIFE; [Anonymous], 2010, QIAGEN QIAAMP DNA IN, P14; Benschop CCG, 2010, FORENSIC SCI INT-GEN, V4, P115, DOI 10.1016/j.fsigen.2009.07.003; Bille TW, 2009, J FORENSIC SCI, V54, P1059, DOI 10.1111/j.1556-4029.2009.01128.x; Brownlow RJ, 2012, J FORENSIC SCI, V57, P713, DOI 10.1111/j.1556-4029.2011.02022.x; Butler JM, 2012, ADV TOPICS FORENSIC, P311; Cook O, 2007, FORENSIC SCI INT-GEN, V1, P62, DOI 10.1016/j.fsigen.2006.10.009; de Bruin KG, 2012, FORENSIC SCI INT-GEN, V6, P219, DOI 10.1016/j.fsigen.2011.04.019; Dowlman EA, 2010, SCI JUSTICE, V50, P64, DOI 10.1016/j.scijus.2009.03.005; GILL P, 1985, NATURE, V318, P577, DOI 10.1038/318577a0; Hoffmann SG, 2012, J FORENSIC SCI, V57, P602, DOI 10.1111/j.1556-4029.2011.01982.x; Kopka J, 2011, J FORENSIC SCI, V56, P1235, DOI 10.1111/j.1556-4029.2011.01853.x; Leclair B, 2003, J FORENSIC SCI, V48, P1001; Lee HC, 1998, AM J FOREN MED PATH, V19, P10, DOI 10.1097/00000433-199803000-00002; Lee HC, 1991, J FORENSIC IDENTIF, V41, P344; Marshall PL, 2014, FORENSIC SCI INT-GEN, V12, P192, DOI 10.1016/j.fsigen.2014.05.014; Mulligan CM, 2011, J FORENSIC SCI, V56, P485, DOI 10.1111/j.1556-4029.2010.01659.x; Norris JV, 2007, J FORENSIC SCI, V52, P800, DOI 10.1111/j.1556-4029.2007.00453.x; Opel KL, 2010, J FORENSIC SCI, V55, P25, DOI 10.1111/j.1556-4029.2009.01245.x; Pang B. C. M., 2007, Legal Medicine, V9, P181, DOI 10.1016/j.legalmed.2006.12.003; Schiffner LA, 2005, CROAT MED J, V46, P578; Smith PJ, 2007, J FORENSIC SCI, V52, P820, DOI 10.1111/j.1556-4029.2007.00470.x; Sweet D, 1997, J FORENSIC SCI, V42, P320; Thomasma SM, 2013, J FORENSIC SCI, V58, P465, DOI 10.1111/1556-4029.12036; Verdon TJ, 2014, J FORENSIC SCI, V59, P1080, DOI 10.1111/1556-4029.12427; Verdon TJ, 2013, FORENSIC SCI INT-GEN, V7, P167, DOI 10.1016/j.fsigen.2012.09.004; Westen AA, 2009, J FORENSIC SCI, V54, P591, DOI 10.1111/j.1556-4029.2009.01022.x; Whitaker JP, 2001, FORENSIC SCI INT, V123, P215, DOI 10.1016/S0379-0738(01)00557-6; Zech WD, 2012, J FORENSIC SCI, V57, P1036, DOI 10.1111/j.1556-4029.2012.02105.x	29	36	36	1	83	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2014	9	12							e116351	10.1371/journal.pone.0116351	http://dx.doi.org/10.1371/journal.pone.0116351			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX6YH	25549111	Green Published, Green Submitted, gold			2022-12-27	WOS:000347063500079
J	Borin, TF; Zuccari, DAPC; Jardim-Perassi, BV; Ferreira, LC; Iskander, ASM; Varma, NRS; Shankar, A; Guo, AM; Scicli, G; Arbab, AS				Borin, Thaiz Ferraz; Zuccari, Debora A. P. C.; Jardim-Perassi, Bruna V.; Ferreira, Livia C.; Iskander, A. S. M.; Varma, Nadimpalli Ravi S.; Shankar, Adarsh; Guo, Austin M.; Scicli, Guillermo; Arbab, Ali S.			HET0016, a Selective Inhibitor of 20-HETE Synthesis, Decreases Pro-Angiogenic Factors and Inhibits Growth of Triple Negative Breast Cancer in Mice	PLOS ONE			English	Article							TUMOR ANGIOGENESIS; CELL-PROLIFERATION; DOWN-REGULATION; ANGIOSTATIN; METASTASIS; EXPRESSION; MANAGEMENT; REGULATOR; SURVIVAL; ENZYMES	A selective inhibitor of 20-HETE synthesis, HET0016, has been reported to inhibit angiogenesis. 20-HETE has been known as a second mitogenic messenger of angiogenesis inducing growth factors. HET0016 effects were analyzed on MDA-MB-231 derived breast cancer in mouse and in vitro cell line. MDA-MB-231 tumor cells were implanted in animals' right flank and randomly assigned to early (1 and 2), starting treatments on day 0, or delayed groups (3 and 4) on day 8 after implantation of tumor. Animals received HET0016 (10 mg/kg) treatment via intraperitoneal injection for 5 days/week for either 3 or 4 weeks. Control group received vehicle treatment. Tumor sizes were measured on days 7, 14, 21, and 28 and the animals were euthanized on day 22 and 29. Proteins were extracted from the whole tumor and from cells treated with 10 mM HET0016 for 4 and 24 hrs. Protein array kits of 20 different cytokines/factors were used. ELISA was performed to observe the HIF-1 alpha and MMP-2 protein expression. Other markers were confirmed by IHC. HET0016 significantly inhibited tumor growth in all treatment groups at all-time points compared to control (p<0.05). Tumor growth was completely inhibited on three of ten animals on early treatment group. Treatment groups showed significantly lower expression of pro-angiogenic factors compared to control at 21 days; however, there was no significant difference in HIF-1 alpha expression after treatments. Similar results were found in vitro at 24 hrs of HET0016 treatment. After 28 days, significant increase of angiogenin, angiopoietin-1/2, EGF-R and IGF-1 pro-angiogenic factors were found (p<0.05) compared to control, as well as an higher intensity of all factors were found when compared to that of 21 day's data, suggesting a treatment resistance. HET0016 inhibited tumor growth by reducing expression of different set of pro-angiogenic factors; however, a resistance to treatment seemed to happen after 21 days.	[Borin, Thaiz Ferraz; Zuccari, Debora A. P. C.; Jardim-Perassi, Bruna V.; Ferreira, Livia C.] Fac Med Sao Jose Rio Preto FAMERP, LIMC, BR-15090000 Sao Jose Do Rio Preto, SP, Brazil; [Borin, Thaiz Ferraz; Iskander, A. S. M.; Varma, Nadimpalli Ravi S.; Shankar, Adarsh; Scicli, Guillermo; Arbab, Ali S.] Henry Ford Hosp, Cellular & Mol Imaging Lab, Detroit, MI 48202 USA; [Guo, Austin M.] New York Med Coll, Dept Pharmacol, Valhalla, NY 10595 USA	Henry Ford Health System; Henry Ford Hospital; New York Medical College	Arbab, AS (corresponding author), Henry Ford Hosp, Cellular & Mol Imaging Lab, Detroit, MI 48202 USA.	aarbab@gru.edu	Jardim-Perassi, Bruna V/H-8633-2014; Arbab, Ali/AAS-1933-2020; de Campos Zuccari, Debora Aparecida Pires/M-3560-2014; Borin, Thaiz Ferraz/E-8013-2012	de Campos Zuccari, Debora Aparecida Pires/0000-0002-0146-9041; Borin, Thaiz Ferraz/0000-0003-1464-9823	National Institutes of Health [R01CA160216]; FAPESP-BEPE [2012/12114-8]; NATIONAL CANCER INSTITUTE [R01CA172048, R01CA160216] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); FAPESP-BEPE; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was funded by grants from National Institutes of Health R01CA160216 and from FAPESP-BEPE 2012/12114-8. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexanian A, 2013, ONCOTARGETS THER, V6, P243, DOI 10.2147/OTT.S31586; Alexanian A, 2012, CANCER GENOM PROTEOM, V9, P163; Alexanian A, 2009, ANTICANCER RES, V29, P3819; Blankenberg FG, 2006, EUR J NUCL MED MOL I, V33, P841, DOI 10.1007/s00259-006-0099-1; Chen JC, 2013, INT J MOL SCI, V14, P88, DOI 10.3390/ijms14010088; Chen L, 2012, PROSTAG OTH LIPID M, V98, P63, DOI 10.1016/j.prostaglandins.2011.12.005; Chen P, 2005, AM J PATHOL, V166, P615, DOI 10.1016/S0002-9440(10)62282-1; Chung AWY, 2006, CIRC RES, V99, P140, DOI 10.1161/01.RES.0000232352.90786.fa; Cornelius LA, 1998, J IMMUNOL, V161, P6845; Dhanasekaran A, 2009, AM J PHYSIOL-HEART C, V296, pH777, DOI 10.1152/ajpheart.01087.2008; Folkman J, 1996, CELL, V87, P1153, DOI 10.1016/S0092-8674(00)81810-3; Guo AM, 2007, J PHARMACOL EXP THER, V321, P18, DOI 10.1124/jpet.106.115360; Guo AM, 2011, J PHARMACOL EXP THER, V338, P421, DOI 10.1124/jpet.111.179036; Guo AM, 2009, AM J PHYSIOL-HEART C, V297, pH602, DOI 10.1152/ajpheart.00874.2008; Guo M, 2006, J PHARMACOL EXP THER, V317, P97, DOI 10.1124/jpet.105.097782; Guo M, 2005, J PHARMACOL EXP THER, V315, P526, DOI 10.1124/jpet.105.088567; Holash J, 1999, ONCOGENE, V18, P5356, DOI 10.1038/sj.onc.1203035; Janic B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009173; Koch S, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006502; Laakkonen P, 2007, CANCER RES, V67, P593, DOI 10.1158/0008-5472.CAN-06-3567; Longatto A, 2010, J ONCOL, V2010, DOI 10.1155/2010/576384; Miyata N, 2001, BRIT J PHARMACOL, V133, P325, DOI 10.1038/sj.bjp.0704101; Nielsen DL, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2642; Orozco LD, 2013, J PHARMACOL EXP THER, V346, P67, DOI 10.1124/jpet.113.203844; Park F, 2008, J AM SOC NEPHROL, V19, P1929, DOI 10.1681/ASN.2007070771; Pozzi A, 2000, P NATL ACAD SCI USA, V97, P2202, DOI 10.1073/pnas.040378497; Pytel D, 2009, ANTI-CANCER AGENT ME, V9, P66, DOI 10.2174/187152009787047752; Saidi A, 2008, INT J CANCER, V122, P2187, DOI 10.1002/ijc.23313; Seki T, 2005, BIOL PHARM BULL, V28, P1651, DOI 10.1248/bpb.28.1651; Smith NR, 2010, CLIN CANCER RES, V16, P3548, DOI 10.1158/1078-0432.CCR-09-2797; Turner NC, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a540; Turner NC, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a421; WEIDNER N, 1991, NEW ENGL J MED, V324, P1, DOI 10.1056/NEJM199101033240101; Yu W, 2010, CANC CHEMOTHER PHARM; Yu W, 2012, TOXICOL APPL PHARM, V264, P73, DOI 10.1016/j.taap.2012.07.019; Zhang W, 2012, MOL THER, V20, P37, DOI 10.1038/mt.2011.187; Zheng H, 2014, TOXICOL APPL PHARM, V280, P10, DOI 10.1016/j.taap.2014.07.018	37	26	27	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2014	9	12							e116247	10.1371/journal.pone.0116247	http://dx.doi.org/10.1371/journal.pone.0116247			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX6YH	25549350	Green Published, Green Submitted, gold			2022-12-27	WOS:000347063500067
J	Gret-Regamey, A; Weibel, B; Bagstad, KJ; Ferrari, M; Geneletti, D; Klug, H; Schirpke, U; Tappeiner, U				Gret-Regamey, Adrienne; Weibel, Bettina; Bagstad, Kenneth J.; Ferrari, Marika; Geneletti, Davide; Klug, Hermann; Schirpke, Uta; Tappeiner, Ulrike			On the Effects of Scale for Ecosystem Services Mapping	PLOS ONE			English	Article							LANDSCAPE PATTERN-ANALYSIS; LAND-USE; SPATIAL AUTOCORRELATION; TRADE-OFFS; BIODIVERSITY; MULTISCALE; VALUATION; CONSERVATION; INDICATORS; SCENARIOS	Ecosystems provide life-sustaining services upon which human civilization depends, but their degradation largely continues unabated. Spatially explicit information on ecosystem services (ES) provision is required to better guide decision making, particularly for mountain systems, which are characterized by vertical gradients and isolation with high topographic complexity, making them particularly sensitive to global change. But while spatially explicit ES quantification and valuation allows the identification of areas of abundant or limited supply of and demand for ES, the accuracy and usefulness of the information varies considerably depending on the scale and methods used. Using four case studies from mountainous regions in Europe and the U.S., we quantify information gains and losses when mapping five ES -carbon sequestration, flood regulation, agricultural production, timber harvest, and scenic beauty - at coarse and fine resolution (250 m vs. 25 m in Europe and 300 m vs. 30 m in the U.S.). We analyze the effects of scale on ES estimates and their spatial pattern and show how these effects are related to different ES, terrain structure and model properties. ES estimates differ substantially between the fine and coarse resolution analyses in all case studies and across all services. This scale effect is not equally strong for all ES. We show that spatially explicit information about non-clustered, isolated ES tends to be lost at coarse resolution and against expectation, mainly in less rugged terrain, which calls for finer resolution assessments in such contexts. The effect of terrain ruggedness is also related to model properties such as dependency on land use-land cover data. We close with recommendations for mapping ES to make the resulting maps more comparable, and suggest a four-step approach to address the issue of scale when mapping ES that can deliver information to support ES-based decision making with greater accuracy and reliability.	[Gret-Regamey, Adrienne; Weibel, Bettina] ETH, Swiss Fed Inst Technol, CH-8093 Zurich, Switzerland; [Bagstad, Kenneth J.] US Geol Survey, Geosci & Environm Change Sci Ctr, Denver, CO 80225 USA; [Ferrari, Marika; Geneletti, Davide] Univ Trento, Dept Civil Environm & Mech Engn, I-38123 Trento, Italy; [Klug, Hermann] Salzburg Univ, Interfaculty Dept Geoinformat Z GIS, A-5020 Salzburg, Austria; [Schirpke, Uta; Tappeiner, Ulrike] EURAC Res, Inst Alpine Environm, I-39100 Bolzano, Italy; [Schirpke, Uta; Tappeiner, Ulrike] Univ Innsbruck, Inst Ecol, A-6020 Innsbruck, Austria	Swiss Federal Institutes of Technology Domain; ETH Zurich; United States Department of the Interior; United States Geological Survey; University of Trento; Salzburg University; European Academy of Bozen-Bolzano; University of Innsbruck	Gret-Regamey, A (corresponding author), ETH, Swiss Fed Inst Technol, Stefano Franscini Pl 5, CH-8093 Zurich, Switzerland.	gret@ethz.ch	Geneletti, Davide/AAH-5407-2019; BITOUN, RACHEL Elisabeth/AAC-9538-2021; Tappeiner, Ulrike/B-8727-2009; Geneletti, Davide/D-5266-2014; Klug, Hermann/C-3183-2011; Schirpke, Uta/AAF-5256-2020; Grêt-Regamey, Adrienne/AAZ-7546-2021	Geneletti, Davide/0000-0002-5528-3365; BITOUN, RACHEL Elisabeth/0000-0002-3614-9910; Tappeiner, Ulrike/0000-0002-0195-7459; Geneletti, Davide/0000-0002-5528-3365; Klug, Hermann/0000-0002-0545-9721; Schirpke, Uta/0000-0002-2075-6118; Grêt-Regamey, Adrienne/0000-0001-8156-9503; Bagstad, Kenneth/0000-0001-8857-5615	U.S. Geological Survey's Mendenhall Postdoctoral Research program; U.S. Geological Survey's Land Change Science program; Competence Center Environment and Sustainability of the Swiss Federal Institute of Technology, Mountland project	U.S. Geological Survey's Mendenhall Postdoctoral Research program(United States Geological Survey); U.S. Geological Survey's Land Change Science program; Competence Center Environment and Sustainability of the Swiss Federal Institute of Technology, Mountland project	We are grateful to the Mountain Research Initiative, which initiated this study in a workshop held 2012 in Switzerland. Partial support in the frame of the Puyallup case study was provided by the U.S. Geological Survey's Mendenhall Postdoctoral Research and Land Change Science programs. Zach Ancona, Gary Johnson, Ferdinando Villa, Brian Voigt, and Earth Economics assisted with data and model development and testing for the Puyallup case study. The Stubai case study was conducted on the LTER site 'Stubai Valley', a member of the Austrian LTSER Platform 'Tyrolean Alps'. We thank Dieter Stohr from the Forest Department of the Province of the Tyrol and Peter Frank from the Chamber of Agriculture Tyrol for the useful information and data. The Davos case study was supported by the Competence Center Environment and Sustainability of the Swiss Federal Institute of Technology as part of the Mountland project. The ASTER global digital elevation model GDEM V1 data product which is a product of METI and NASA was obtained through the online Data Pool at the NASA Land Processes Distributed Active Archive Center (LP DAAC), USGS/Earth Resources Observation and Science (EROS) Center, Sioux Falls, South Dakota (https://lpdaac.usgs.gov/data_access). Jay Diffendorfer, Miguel Villareal, and two anonymous reviewers provided constructive reviews of earlier drafts of this manuscript. Any use of trade, firm, or product names is for descriptive purposes only and does not imply endorsement by the U.S. Government.	Agarwal C., 2002, 297 NE DEP AGR FOR S, DOI 10.2737/NE-GTR-297; Anton C, 2010, BIODIVERS CONSERV, V19, P2979, DOI 10.1007/s10531-010-9853-6; Bagstad KJ, 2014, ECOL SOC, V19, DOI 10.5751/ES-06523-190264; Bagstad KJ, 2013, ECOSYST SERV, V5, pE40, DOI 10.1016/j.ecoser.2013.07.007; Bagstad KJ, 2013, ECOSYST SERV, V5, pE27, DOI 10.1016/j.ecoser.2013.07.004; Bagstad KJ, 2013, ECOSYST SERV, V4, P117, DOI 10.1016/j.ecoser.2012.07.012; Balmford A, 2011, ENVIRON RESOUR ECON, V48, P161, DOI 10.1007/s10640-010-9413-2; Bourassa SC, 2004, ENVIRON PLANN A, V36, P1427, DOI 10.1068/a36103; Bridgham SD, 2006, WETLANDS, V26, P889, DOI 10.1672/0277-5212(2006)26[889:TCBONA]2.0.CO;2; Burns I. S., 2007, AUTOMATED GEOSPATIAL; Capistrano D, 2005, ECOSYSTEMS HUMAN WEL; Carpenter SR, 2009, P NATL ACAD SCI USA, V106, P1305, DOI 10.1073/pnas.0808772106; Chapin FS, 2010, TRENDS ECOL EVOL, V25, P241, DOI 10.1016/j.tree.2009.10.008; Crossman ND, 2013, ECOSYST SERV, V4, P4, DOI 10.1016/j.ecoser.2013.02.001; Daily GC, 2011, NATURAL CAPITAL: THEORY & PRACTICE OF MAPPING ECOSYSTEM SERVICES, P3; Dale MRT, 2002, ECOGRAPHY, V25, P558, DOI 10.1034/j.1600-0587.2002.250506.x; de Groot R, 2006, LANDSCAPE URBAN PLAN, V75, P175, DOI 10.1016/j.landurbplan.2005.02.016; de Groot RS, 2010, ECOL COMPLEX, V7, P260, DOI 10.1016/j.ecocom.2009.10.006; EC, 2011, OUR LIF INS OUR NAT; Egoh B., 2012, VIA ENRICO FERMI 274, DOI [10.2788/41823, DOI 10.2788/41823]; Eppink FV, 2012, GAIA, V21, P55, DOI 10.14512/gaia.21.1.14; Ferrari M, 2014, ANN BOT-ITALY, V4, P65, DOI 10.4462/annbotrm-11729; Ferrari M, 2014, THESIS U TRENTO; Folke C, 2007, ECOL SOC, V12; Fortin M-J, 2006, ENCY ENV; Fortin MJ, 1999, LANDSCAPE ECOLOGICAL ANALYSIS: ISSUES AND APPLICATIONS, P253; Getis A., 2010, HDB APPL SPATIAL ANA, P255, DOI [10.1007/978-3-642-03647-7_14, DOI 10.1007/978-3-642-03647-7_14, 10.1007/978-3-642-03647-7]; Gret-Regamey A, 2013, ECOL SOC, V18, DOI 10.5751/ES-05800-180334; Harflinger O, 1999, KLIMATOGRAPHIE 1; Heffernan JB, 2014, FRONT ECOL ENVIRON, V12, P5, DOI 10.1890/130017; Hein L, 2006, ECOL ECON, V57, P209, DOI 10.1016/j.ecolecon.2005.04.005; Huber U. M., 2005, Global change and mountain regions: an overview of current knowledge; Jelinski DE, 1996, LANDSCAPE ECOL, V11, P129, DOI 10.1007/BF02447512; Jose Martinez-Harms Maria, 2012, International Journal of Biodiversity Science Ecosystem Services & Management, V8, P17, DOI 10.1080/21513732.2012.663792; Kandziora M, 2013, ECOSYST SERV, V4, P47, DOI 10.1016/j.ecoser.2013.04.001; Klein JA, 2011, ADV GLOB CHANGE RES, V42, P423, DOI 10.1007/978-94-007-0567-8_31; Konarska KM, 2002, ECOL ECON, V41, P491, DOI 10.1016/S0921-8009(02)00096-4; Landesforstinspektion fur Tirol, 1979, WALDW JAHR 1978 BIS; Landesforstinspektion fur Tirol, 2004, WALDW AGR NEUST STUB; Leitinger G, 2010, J HYDROL, V385, P95, DOI 10.1016/j.jhydrol.2010.02.006; LEVIN SA, 1992, ECOLOGY, V73, P1943, DOI 10.2307/1941447; Liu S, 2012, BASELINE PROJECTED F; LP DAAC, 2009, AST GDEM V1 DAT PROD; MA, 2005, ECOSYSTEMS HUMAN WEL; Mace GM, 2012, TRENDS ECOL EVOL, V27, P19, DOI 10.1016/j.tree.2011.08.006; Maes J., 2013, MAPPING ASSESSMENT E, DOI [10.2779/12398, DOI 10.2779/12398]; Maes J, 2012, ECOSYST SERV, V1, P31, DOI 10.1016/j.ecoser.2012.06.004; Martin-Lopez B, 2014, ECOL INDIC, V37, P220, DOI 10.1016/j.ecolind.2013.03.003; MCGILL R, 1978, AM STAT, V32, P12, DOI 10.2307/2683468; McKenzie E, 2011, NATURAL CAPITAL; Millennium Ecosystem Assessment, 2005, EC HUM WELL BEING SY; Moody A, 1995, PHOTOGRAMMETRIC ENG, V60; MORAN PAP, 1950, BIOMETRIKA, V37, P17, DOI 10.1093/biomet/37.1-2.17; Nedkov S, 2012, ECOL INDIC, V21, P67, DOI 10.1016/j.ecolind.2011.06.022; Nelson E, 2009, FRONT ECOL ENVIRON, V7, P4, DOI 10.1890/080023; NOSS RF, 1990, CONSERV BIOL, V4, P355, DOI 10.1111/j.1523-1739.1990.tb00309.x; O'Neill RV, 1989, LANDSCAPE ECOL, V3, P193, DOI 10.1007/BF00131538; O'Neill R.V., 1991, HETEROGENEITY SPATIA, P85; OANDA corporation, 2013, HIST EXCH RAT; ONeill RV, 1996, LANDSCAPE ECOL, V11, P169, DOI 10.1007/BF02447515; Openshaw S., 1983, MODIFIABLE AREAL UNI; Ostrom E, 2007, P NATL ACAD SCI USA, V104, P15181, DOI 10.1073/pnas.0702288104; Overmars KP, 2003, ECOL MODEL, V164, P257, DOI 10.1016/S0304-3800(03)00070-X; Palomo I, 2013, ECOSYST SERV, V4, P104, DOI 10.1016/j.ecoser.2012.09.001; PAT, 2010, PROV AUT TRENT SERV; Perry JN, 2002, ECOGRAPHY, V25, P578, DOI 10.1034/j.1600-0587.2002.250507.x; President's Council of Advisors on Science and Technology (PCAST), 2011, REP PRES SUST ENV CA; Province of Tyrol, 2013, HOLZM; PUP, 2008, PIAN URB PROV; Qi Y, 1996, LANDSCAPE ECOL, V11, P39, DOI 10.1007/BF02087112; Qiu JX, 2013, P NATL ACAD SCI USA, V110, P12149, DOI 10.1073/pnas.1310539110; R Core Team, 2021, R LANGUAGE ENV STAT; Raudsepp-Hearne C, 2010, Proc Natl Acad Sci U S A, V107, P5242, DOI 10.1073/pnas.0907284107; Riley S.J., 1999, INTERMOUNTAIN J SCI, V5, P23, DOI DOI 10.1016/j.geomorph.2010.11.003; Schagner JP, 2013, ECOSYST SERV, V4, P33, DOI 10.1016/j.ecoser.2013.02.003; Schirpke Uta, 2013, International Journal of Biodiversity Science Ecosystem Services & Management, V9, P123, DOI 10.1080/21513732.2012.751936; Schirpke U, 2013, LANDSCAPE URBAN PLAN, V111, P1, DOI 10.1016/j.landurbplan.2012.11.010; Scholes RJ, 2013, CURR OPIN ENV SUST, V5, P16, DOI 10.1016/j.cosust.2013.01.004; Seppelt R, 2013, CURR OPIN ENV SUST, V5, P458, DOI 10.1016/j.cosust.2013.05.002; Smith JE., 2006, METHODS CALCULATING; Syrbe RU, 2012, ECOL INDIC, V21, P80, DOI 10.1016/j.ecolind.2012.02.013; Tallis H, 2009, ANN NY ACAD SCI, V1162, P265, DOI 10.1111/j.1749-6632.2009.04152.x; Tappeiner U, 2008, ECOSYSTEMS, V11, P1383, DOI 10.1007/s10021-008-9195-3; Thurig E., 2008, Schweizerische Zeitschrift fur Forstwesen, V159, P31, DOI 10.3188/szf.2008.0031; TOBLER WR, 1970, ECON GEOGR, V46, P234, DOI 10.2307/143141; Tonolli S, 2008, INFOCARB INVENTARIO; Turner M.G., 2001, LANDSCAPE ECOLOGY TH; Turner MG, 1989, LANDSCAPE ECOL, V3, P153, DOI 10.1007/BF00131534; U.S. Department of Agriculture,, 1986, URB HYDR SMALL WAT T, V2nd; USDA (U. S. Department of Agriculture), 2007, 2007 CENS AGR; Veldkamp A, 1996, ECOL MODEL, V91, P231, DOI 10.1016/0304-3800(95)00158-1; Villa F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091001; Washington Department of Natural Resources, 2012, EC REV FOR NOV 2012; Washington Department of Natural Resources, 2011, WASH TIMB HARV 2011; WIENS JA, 1989, FUNCT ECOL, V3, P385, DOI 10.2307/2389612; WILCOXON F, 1946, J ECON ENTOMOL, V39, P269, DOI 10.1093/jee/39.2.269; WSL, 2010, ORD DAT LAND LFI; Wu J., 2000, ANN GIS, V6, P6, DOI DOI 10.1080/10824000009480529; Wu JG, 2004, LANDSCAPE ECOL, V19, P125, DOI 10.1023/B:LAND.0000021711.40074.ae; Wu JG, 2002, LANDSCAPE ECOL, V17, P761, DOI 10.1023/A:1022995922992; Wu JG, 2002, LANDSCAPE ECOL, V17, P355, DOI 10.1023/A:1020561630963	101	89	91	1	132	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2014	9	12							e112601	10.1371/journal.pone.0112601	http://dx.doi.org/10.1371/journal.pone.0112601			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX6YH	25549256	Green Submitted, Green Published, gold			2022-12-27	WOS:000347063500005
J	Obry, A; Lequerre, T; Hardouin, J; Boyer, O; Fardellone, P; Philippe, P; Le Loet, X; Cosette, P; Vittecoq, O				Obry, Antoine; Lequerre, Thierry; Hardouin, Julie; Boyer, Olivier; Fardellone, Patrice; Philippe, Peggy; Le Loet, Xavier; Cosette, Pascal; Vittecoq, Olivier			Identification of S100A9 as Biomarker of Responsiveness to the Methotrexate/Etanercept Combination in Rheumatoid Arthritis Using a Proteomic Approach	PLOS ONE			English	Article							INFLAMMATORY JOINT DISEASES; MASS-SPECTROMETRY; SYNOVIAL-FLUID; SERUM-LEVELS; BLOOD-CELLS; PROTEINS; CALPROTECTIN; ETANERCEPT; THERAPY; INFLIXIMAB	Objectives: One way to optimize the drug prescription in rheumatoid arthritis (RA) is to identify predictive biomarkers of drug responsiveness. Here, we investigated the potential "theranostic" value of proteins of the S100 family by monitoring levels of both S100A8 and S100A9 in blood samples from RA patients. Design: For proteomic analysis, peripheral blood mononuclear cells (PBMC) and serum samples were collected in patients prior to initiation of the methotrexate/etanercept (MTX/ETA) combination. Firstly, relative mass spectrometry (MS) quantification focusing on S100A8 and S100A9 proteins was carried out from PBMCs samples to identify potential biomarkers. The same approach was also performed from serum samples from responder (R) and non responder (NR) patients. Finally, to confirm these results, an absolute quantification of S100A8, S100A9 proteins and calprotectin (heterodimer of S100A8/S100A9) was carried out on the serum samples using ELISA. Results: MS analyses revealed that both S100A8 and S100A9 proteins were significantly accumulated in PBMC from responders. In contrast to PBMC, only the S100A9 protein was significantly overexpressed in the serum of R patients. Absolute quantification by ELISA confirmed this result and pointed out a similar expression level of S100A8 protein and calprotectin in sera from both R and NR groups. Thus, the S100A9 protein revealed to be predictive of MTX/ETA responsiveness, contrarily to parameters of inflammation and auto-antibodies which did not allow significant discrimination. Conclusion: This is the first report of an overexpression of S100A9 protein in both PBMCs and serum of patients with subsequent response to the MTX/ETA combination. This protein thus represents an interesting biomarker candidate of therapeutic response in RA.	[Obry, Antoine; Lequerre, Thierry; Boyer, Olivier; Le Loet, Xavier; Vittecoq, Olivier] INSERM, U905, F-76000 Rouen, France; [Obry, Antoine; Hardouin, Julie; Cosette, Pascal] CNRS, UMR 6270, F-76821 Mont St Aignan, France; [Obry, Antoine; Hardouin, Julie; Cosette, Pascal] PISSARO Prote Facil, F-76821 Mont St Aignan, France; [Obry, Antoine; Lequerre, Thierry; Hardouin, Julie; Boyer, Olivier; Le Loet, Xavier; Vittecoq, Olivier] Normandy Univ, Inst Res & Innovat Biomed, F-76821 Mont St Aignan, France; [Lequerre, Thierry; Le Loet, Xavier; Vittecoq, Olivier] Rouen Univ Hosp, Dept Rheumatol, F-76000 Rouen, France; [Lequerre, Thierry; Vittecoq, Olivier] INSERM, Ctr Invest Clin 1404, F-76000 Rouen, France; [Boyer, Olivier] Rouen Univ Hosp, Dept Immunol, F-76000 Rouen, France; [Fardellone, Patrice] Amiens Univ Hosp, Dept Rheumatol, F-80000 Amiens 1, France; [Philippe, Peggy] Univ Hosp Lille, F-59037 Lille, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); CHU de Rouen; Institut National de la Sante et de la Recherche Medicale (Inserm); CHU de Rouen; Picardie Universites; Universite de Picardie Jules Verne (UPJV); CHU Amiens; Universite de Lille - ISITE; CHU Lille	Cosette, P (corresponding author), CNRS, UMR 6270, F-76821 Mont St Aignan, France.	pascal.cosette@univ-rouen.fr	Boyer, Olivier/N-6552-2013	Boyer, Olivier/0000-0002-7591-307X; Cosette, Pascal/0000-0002-7588-0167; Hardouin, Julie/0000-0003-4588-9811	French Ministry of Health; European Regional Development Fund (FEDER program) [33267]; Interreg IVA PeReNE project [4230]	French Ministry of Health; European Regional Development Fund (FEDER program); Interreg IVA PeReNE project	This study was supported by the French Ministry of Health, European Regional Development Fund (FEDER program 33267) and the the Interreg IVA PeReNE project (project 4230). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Baillet A, 2010, RHEUMATOLOGY, V49, P671, DOI 10.1093/rheumatology/kep452; BARTHE C, 1991, BIOCHIM BIOPHYS ACTA, V1096, P175, DOI 10.1016/0925-4439(91)90057-G; Bathon JM, 2000, NEW ENGL J MED, V343, P1586, DOI 10.1056/NEJM200011303432201; Benoit S, 2006, BRIT J DERMATOL, V155, P62, DOI 10.1111/j.1365-2133.2006.07198.x; Brennan FM, 1998, SPRINGER SEMIN IMMUN, V20, P133, DOI 10.1007/BF00832003; Cerezo LA, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3426; de Seny D, 2005, ARTHRITIS RHEUM-US, V52, P3801, DOI 10.1002/art.21607; Drynda S, 2004, PATHOL RES PRACT, V200, P165, DOI 10.1016/j.prp.2004.02.011; Fabre S, 2008, CLIN EXP IMMUNOL, V153, P188, DOI 10.1111/j.1365-2249.2008.03691.x; Foell D, 2004, CLIN CHIM ACTA, V344, P37, DOI 10.1016/j.cccn.2004.02.023; HAGA HJ, 1993, LUPUS, V2, P47, DOI 10.1177/096120339300200108; Hammer HB, 2007, ANN RHEUM DIS, V66, P1093, DOI 10.1136/ard.2006.064741; Hammer HB, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3503; HESSIAN PA, 1993, J LEUKOCYTE BIOL, V53, P197, DOI 10.1002/jlb.53.2.197; Hueber W, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2706; Keystone EC, 2004, ARTHRITIS RHEUM, V50, P353, DOI 10.1002/art.20019; Keystone EC, 2004, ARTHRITIS RHEUM, V50, P1400, DOI 10.1002/art.20217; Lequerre T, 2007, RHEUMATOLOGY, V46, P446, DOI 10.1093/rheumatology/kel262; Lequerre T, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1990; Liao H, 2004, ARTHRITIS RHEUM-US, V50, P3792, DOI 10.1002/art.20720; Lugering N, 1997, IMMUNOLOGY, V91, P130, DOI 10.1046/j.1365-2567.1997.00221.x; Meugnier E, 2011, PHYSIOL GENOMICS, V43, P365, DOI 10.1152/physiolgenomics.00127.2010; Old WM, 2005, MOL CELL PROTEOMICS, V4, P1487, DOI 10.1074/mcp.M500084-MCP200; Singh JA, 2009, CAN MED ASSOC J, V181, P787, DOI 10.1503/cmaj.091391; Sinz A, 2002, ELECTROPHORESIS, V23, P3445, DOI 10.1002/1522-2683(200210)23:19<3445::AID-ELPS3445>3.0.CO;2-J; Summerton CB, 2002, EUR J GASTROEN HEPAT, V14, P841, DOI 10.1097/00042737-200208000-00005; Sweet SP, 2001, ORAL MICROBIOL IMMUN, V16, P119, DOI 10.1034/j.1399-302x.2001.016002119.x; Uchida T, 2002, J PROTEOME RES, V1, P495, DOI 10.1021/pr025531w; vanGestel AM, 1996, ARTHRITIS RHEUM, V39, P34, DOI 10.1002/art.1780390105; Vogl T, 2004, BLOOD, V104, P4260, DOI 10.1182/blood-2004-02-0446	31	38	41	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2014	9	12							e115800	10.1371/journal.pone.0115800	http://dx.doi.org/10.1371/journal.pone.0115800			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UN	25546405	Green Published, gold, Green Submitted			2022-12-27	WOS:000347120200070
J	Ferdinandus; Arai, S; Ishiwata, S; Suzuki, M; Sato, H				Ferdinandus; Arai, Satoshi; Ishiwata, Shin'ichi; Suzuki, Madoka; Sato, Hirotaka			Oral Dosing of Chemical Indicators for In Vivo Monitoring of Ca2+ Dynamics in Insect Muscle	PLOS ONE			English	Article							REMOTE RADIO CONTROL; FREE-FLIGHT; MEMBRANE-POTENTIALS; IMAGING CALCIUM; NEURONS; TRANSMISSION; LOCUST; ELECTROPHYSIOLOGY; DIBAC(4)(3); HAWKMOTH	This paper proposes a remarkably facile staining protocol to visually investigate dynamic physiological events in insect tissues. We attempted to monitor Ca2+ dynamics during contraction of electrically stimulated living muscle. Advances in circuit miniaturization and insect neuromuscular physiology have enabled the hybridization of living insects and man-made electronic components, such as microcomputers, the result of which has been often referred as a Living Machine, Biohybrid, or Cyborg Insect. In order for Cyborg Insects to be of practical use, electrical stimulation parameters need to be optimized to induce desired muscle response (motor action) and minimize the damage in the muscle due to the electrical stimuli. Staining tissues and organs as well as measuring the dynamics of chemicals of interest in muscle should be conducted to quantitatively and systematically evaluate the effect of various stimulation parameters on the muscle response. However, existing staining processes require invasive surgery and/or arduous procedures using genetically encoded sensors. In this study, we developed a non-invasive and remarkably facile method for staining, in which chemical indicators can be orally administered (oral dosing). A chemical Ca2+ indicator was orally introduced into an insect of interest via food containing the chemical indicator and the indicator diffused from the insect digestion system to the target muscle tissue. We found that there was a positive relationship between the fluorescence intensity of the indicator and the frequency of electrical stimulation which indicates the orally dosed indicator successfully monitored Ca2+ dynamics in the muscle tissue. This oral dosing method has a potential to globally stain tissues including neurons, and investigating various physiological events in insects.	[Ferdinandus; Sato, Hirotaka] Nanyang Technol Univ, Sch Mech & Aerosp Engn, Singapore 639798, Singapore; [Arai, Satoshi; Ishiwata, Shin'ichi; Suzuki, Madoka] WASEDA Biosci Res Inst Singapore WABIOS, Singapore, Singapore; [Ishiwata, Shin'ichi; Suzuki, Madoka] Waseda Univ, Org Univ Res Initiat, Tokyo, Japan; [Ishiwata, Shin'ichi] Waseda Univ, Dept Phys, Fac Sci & Engn, Tokyo 169, Japan	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Waseda University; Waseda University	Sato, H (corresponding author), Nanyang Technol Univ, Sch Mech & Aerosp Engn, Singapore 639798, Singapore.	hirosato@ntu.edu.sg	Sato, Hirotaka/D-5203-2014; ARAI, SATOSHI/L-6709-2018; Suzuki, Madoka/E-5420-2013	Sato, Hirotaka/0000-0003-4634-1639; ARAI, SATOSHI/0000-0003-4807-8248; Suzuki, Madoka/0000-0002-3270-1755; , Ferdinandus/0000-0002-7197-3841	Nanyang Assistant Professorship (NAP) [M4080740]; Agency for Science, Technology and Research (A<INF>*</INF>STAR) Public Sector Research Funding (PSF) [M4070190]; A*STAR-JST (The Japan Science and Technology Agency) joint grant [M4070198]; Ministry of Education, Culture, Sports, Science, and Technology of Japan [2306]	Nanyang Assistant Professorship (NAP); Agency for Science, Technology and Research (A<INF>*</INF>STAR) Public Sector Research Funding (PSF); A*STAR-JST (The Japan Science and Technology Agency) joint grant; Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This material is based on the work supported by Nanyang Assistant Professorship (NAP, No. M4080740, http://www3.ntu.edu.sg/NAP/index.html) awarded to HS, Agency for Science, Technology and Research (A<INF>*</INF>STAR) Public Sector Research Funding (PSF, No. M4070190) awarded to HS, and A<INF>*</INF>STAR-JST (The Japan Science and Technology Agency) joint grant (No. M4070198) awarded to HS, and a Grant-in-Aid for Scientific Research on Innovative Areas "Nanomedicine Molecular Science" from Ministry of Education, Culture, Sports, Science, and Technology of Japan (No. 2306, http://www.mext.go.jp/english/) awarded to MS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AAT Bioquest Inc, 2013, PHYSIOLOGICAL PROBES; Adrian ED, 1912, J PHYSIOL-LONDON, V44, P68; Ando N, 2004, ZOOL SCI, V21, P123, DOI 10.2108/zsj.21.123; Ando N, 2002, J NEUROSCI METH, V115, P181, DOI 10.1016/S0165-0270(02)00013-4; [Anonymous], 2010, MOL PROBES HDB A GUI, P664; Bozkurt A, 2009, IEEE T BIO-MED ENG, V56, P2304, DOI 10.1109/TBME.2009.2022551; Bozkurt A, 2009, IEEE T BIO-MED ENG, V56, P1727, DOI 10.1109/TBME.2009.2015460; BRAUNER T, 1984, BIOCHIM BIOPHYS ACTA, V771, P208, DOI 10.1016/0005-2736(84)90535-2; Cao F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105389; Chapman R.F., 1998, INSECTS STRUCTURE FU, V4th ed.; CORNELIUS F, 1982, J GEN PHYSIOL, V79, P821, DOI 10.1085/jgp.79.5.821; Daly DC, 2010, IEEE J SOLID-ST CIRC, V45, P153, DOI 10.1109/JSSC.2009.2034433; EPPS DE, 1994, CHEM PHYS LIPIDS, V69, P137, DOI 10.1016/0009-3084(94)90035-3; Falk S, 2009, NEUROSCI LETT, V450, P229, DOI 10.1016/j.neulet.2008.11.042; Fischer H, 1996, J NEUROSCI METH, V64, P39, DOI 10.1016/0165-0270(95)00083-6; Fischer H, 1999, J EXP BIOL, V202, P711; Fox JL, 2010, P NATL ACAD SCI USA, V107, P3840, DOI 10.1073/pnas.0912548107; Galizia CG, 2004, J COMP PHYSIOL A, V190, P21, DOI 10.1007/s00359-003-0469-0; Garaschuk O, 2007, CELL CALCIUM, V42, P351, DOI 10.1016/j.ceca.2007.02.011; Georgakoudi I, 2002, CANCER RES, V62, P682; Gonzalez JE, 1999, DRUG DISCOV TODAY, V4, P431, DOI 10.1016/S1359-6446(99)01383-5; Gordon S, 2006, P NATL ACAD SCI USA, V103, P4311, DOI 10.1073/pnas.0510109103; Grienberger C, 2012, NEURON, V73, P862, DOI 10.1016/j.neuron.2012.02.011; Gross M, 2013, CURR BIOL, V23, pR821, DOI 10.1016/j.cub.2013.09.004; Guschlbauer C, 2007, J EXP BIOL, V210, P1092, DOI 10.1242/jeb.02729; Hinterwirth AJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052725; Holzer R., 1997, Proceedings of the 1997 IEEE/RSJ International Conference on Intelligent Robot and Systems. Innovative Robotics for Real-World Applications. IROS '97 (Cat. No.97CH36108), P1514, DOI 10.1109/IROS.1997.656559; Houdebine LM, 2002, J BIOTECHNOL, V98, P145, DOI 10.1016/S0168-1656(02)00129-3; Huang M, 2007, ANN BIOMED ENG, V35, P1276, DOI 10.1007/s10439-007-9265-2; Joerges J, 1997, NATURE, V387, P285, DOI 10.1038/387285a0; KUBIN RF, 1982, J LUMIN, V27, P455, DOI 10.1016/0022-2313(82)90045-X; KUTSCH W, 1993, J EXP BIOL, V185, P367; Maharbiz MM, 2010, SCI AM, V303, P94, DOI 10.1038/scientificamerican1210-94; Martin JP, 2010, FRONT BEHAV NEUROSCI, V4, DOI 10.3389/fnbeh.2010.00159; MAY TE, 1979, J INSECT PHYSIOL, V25, P169, DOI 10.1016/0022-1910(79)90096-9; Miyawaki A, 1999, P NATL ACAD SCI USA, V96, P2135, DOI 10.1073/pnas.96.5.2135; Namiki S, 2008, FRONT NEURAL CIRCUIT, V2, DOI 10.3389/neuro.04.001.2008; ORCHARD I, 1986, J NEUROBIOL, V17, P359, DOI 10.1002/neu.480170502; Paredes RM, 2008, METHODS, V46, P143, DOI 10.1016/j.ymeth.2008.09.025; Piegari E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095860; Plasek J, 1996, J PHOTOCH PHOTOBIO B, V33, P101, DOI 10.1016/1011-1344(96)07283-1; RONOT X, 1986, BIOL CELL, V57, P1; Russell JT, 2011, BRIT J PHARMACOL, V163, P1605, DOI 10.1111/j.1476-5381.2010.00988.x; Sato H, 2010, FRONT NEUROSCI-SWITZ, V4, DOI 10.3389/fnins.2010.00199; Sato H, 2009, FRONT INTEGR NEUROSC, V3, DOI 10.3389/neuro.07.024.2009; SZENTGYORGYI AG, 1975, BIOPHYS J, V15, P707, DOI 10.1016/S0006-3495(75)85849-8; Takahashi A, 1999, PHYSIOL REV, V79, P1089, DOI 10.1152/physrev.1999.79.4.1089; Tian L, 2009, NAT METHODS, V6, P875, DOI 10.1038/nmeth.1398; Titushkin IA, 2004, IEEE T PLASMA SCI, V32, P1614, DOI 10.1109/TPS.2004.832625; Tsang WM, 2010, IEEE T BIO-MED ENG, V57, P1757, DOI 10.1109/TBME.2010.2041778; VonSteyern FV, 1996, J HISTOCHEM CYTOCHEM, V44, P267, DOI 10.1177/44.3.8648087; Wang HZ, 2008, J EXP BIOL, V211, P423, DOI 10.1242/jeb.011791; Wang JW, 2003, CELL, V112, P271, DOI 10.1016/S0092-8674(03)00004-7; Webb B, 2004, ARTHROPOD STRUCT DEV, V33, P301, DOI 10.1016/j.asd.2004.05.009; Westneat MW, 2003, SCIENCE, V299, P558, DOI 10.1126/science.1078008; Yamada A, 2001, JPN J PHARMACOL, V86, P342, DOI 10.1254/jjp.86.342	57	4	4	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2015	10	1							e0116655	10.1371/journal.pone.0116655	http://dx.doi.org/10.1371/journal.pone.0116655			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9HN	25590329	gold, Green Published			2022-12-27	WOS:000350679400019
J	Barton, R; Palacio, D; Iovine, MK; Berger, BW				Barton, Rachael; Palacio, Danica; Iovine, M. Kathryn; Berger, Bryan W.			A Cytosolic Juxtamembrane Interface Modulates Plexin A3 Oligomerization and Signal Transduction	PLOS ONE			English	Article							AXON GUIDANCE; SEMAPHORINS; RECEPTORS; TRANSMEMBRANE; ZEBRAFISH; PROTEINS; REVEALS; GTPASES; DESIGN; CANCER	Plexins (plxns) are transmembrane (TM) receptors involved in the guidance of vascular, lymphatic vessel, and neuron growth as well as cancer metastasis. Plxn signaling results in cytosolic GTPase-activating protein activity, and previous research implicates dimerization as important for activation of plxn signaling. Purified, soluble plxn extracellular and cytosolic domains exhibit only weak homomeric interactions, suggesting a role for the plxn TM and juxtamembrane regions in homooligomerization. In this study, we consider a heptad repeat in the Danio rerio PlxnA3 cytosolic juxtamembrane domain (JM) for its ability to influence PlxnA3 homooligomerization in TM-domain containing constructs. Site-directed mutagenesis in conjunction with the AraTM assay and bioluminescent energy transfer (BRET2) suggest an interface involving a JM heptad repeat, in particular residue M1281, regulates PlxnA3 homomeric interactions when examined in constructs containing an ectodomain, TM and JM domain. In the presence of a neuropilin-2a co-receptor and semaphorin 3F ligand, disruption to PlxnA3 homodimerization caused by an M1281F mutation is eliminated, suggesting destabilization of the PlxnA3 homodimer in the JM is not sufficient to disrupt co-receptor complex formation. In contrast, enhanced homodimerization of PlxnA3 caused by mutation M1281L remains even in the presence of ligand semaphorin 3F and co-receptor neuropilin-2a. Consistent with this pattern of PlxnA3 dimerization in the presence of ligand and co-receptor, destabilizing mutations to PlxnA3 homodimerization (M1281F) are able to rescue motor patterning defects in sidetracked zebrafish embryos, whereas mutations that enhance PlxnA3 homodimerization (M1281L) are not. Collectively, our results indicate the JM heptad repeat, in particular residue M1281, forms a switchable interface that modulates both PlxnA3 homomeric interactions and signal transduction.	[Barton, Rachael; Berger, Bryan W.] Lehigh Univ, Dept Chem & Biomol Engn, Bethlehem, PA 18015 USA; [Palacio, Danica; Iovine, M. Kathryn] Lehigh Univ, Dept Biol Sci, Bethlehem, PA 18015 USA; [Berger, Bryan W.] Lehigh Univ, Bioengn Program, Bethlehem, PA 18015 USA	Lehigh University; Lehigh University; Lehigh University	Berger, BW (corresponding author), Lehigh Univ, Dept Chem & Biomol Engn, Bethlehem, PA 18015 USA.	berger@lehigh.edu	Berger, Bryan/D-7985-2014	Berger, Bryan/0000-0002-6135-8677	National Science Foundation [CBET-1227924]; National Institutes of Health [R03 HD070172]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R03HD070172] Funding Source: NIH RePORTER; Div Of Chem, Bioeng, Env, & Transp Sys [1227924] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Div Of Chem, Bioeng, Env, & Transp Sys(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG))	Funding provided by National Science Foundation (CBET-1227924) to BWB and National Institutes of Health (R03 HD070172) to MKI. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aci-Seche S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097779; Balakrishnan A, 2009, HUM MUTAT, V30, P1167, DOI 10.1002/humu.21017; Bell CH, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001134; Berger BW, 2010, P NATL ACAD SCI USA, V107, P703, DOI 10.1073/pnas.0910873107; Birely J, 2005, DEV BIOL, V280, P162, DOI 10.1016/j.ydbio.2005.01.012; Carriba P, 2008, NAT METHODS, V5, P727, DOI 10.1038/nmeth.1229; CHENG HJ, 1994, CELL, V79, P157, DOI 10.1016/0092-8674(94)90408-1; Cirino Patrick C, 2003, Methods Mol Biol, V231, P3; COHEN C, 1990, PROTEINS, V7, P1, DOI 10.1002/prot.340070102; Driessens MHE, 2001, CURR BIOL, V11, P339, DOI 10.1016/S0960-9822(01)00092-6; Feldner J, 2007, J NEUROSCI, V27, P4978, DOI 10.1523/JNEUROSCI.1132-07.2007; Grigoryan G, 2008, CURR OPIN STRUC BIOL, V18, P477, DOI 10.1016/j.sbi.2008.04.008; He HW, 2009, P NATL ACAD SCI USA, V106, P15610, DOI 10.1073/pnas.0906923106; Janssen BJC, 2012, NAT STRUCT MOL BIOL, V19, P1293, DOI 10.1038/nsmb.2416; Janssen BJC, 2010, NATURE, V467, P1118, DOI 10.1038/nature09468; Kruger RR, 2005, NAT REV MOL CELL BIO, V6, P789, DOI 10.1038/nrm1740; Negishi M, 2005, CELL MOL LIFE SCI, V62, P1363, DOI 10.1007/s00018-005-5018-2; Palaisa KA, 2007, DEVELOPMENT, V134, P3251, DOI 10.1242/dev.007112; Pfleger KDG, 2006, NAT PROTOC, V1, P337, DOI 10.1038/nprot.2006.52; Rohm B, 2000, FEBS LETT, V486, P68, DOI 10.1016/S0014-5793(00)02240-7; Roney K, 2013, PROTEIN CELL, V4, P17, DOI 10.1007/s13238-012-2108-4; Su PC, 2012, J BIOL CHEM, V287, P31515, DOI 10.1074/jbc.M112.396895; Takahashi T, 2001, NEURON, V29, P429, DOI 10.1016/S0896-6273(01)00216-1; Takahashi T, 1999, CELL, V99, P59, DOI 10.1016/S0092-8674(00)80062-8; Takahashi T, 1998, NAT NEUROSCI, V1, P487, DOI 10.1038/2203; Tamagnone L, 1999, CELL, V99, P71, DOI 10.1016/S0092-8674(00)80063-X; Ton QV, 2012, DEV BIOL, V366, P195, DOI 10.1016/j.ydbio.2012.03.020; Tong Y, 2007, J BIOL CHEM, V282, P37215, DOI 10.1074/jbc.M703800200; Tong YF, 2009, J BIOL CHEM, V284, P35962, DOI 10.1074/jbc.M109.056275; Wang YX, 2013, ELIFE, V2, DOI 10.7554/eLife.01279; WANG YX, 2012, SCI SIGNAL, V5, DOI DOI 10.1126/SCISIGNAL; Wong OGW, 2007, P NATL ACAD SCI USA, V104, P19040, DOI 10.1073/pnas.0702544104; Woolfson DN, 2005, ADV PROTEIN CHEM, V70, P79, DOI 10.1016/S0065-3233(04)70004-2; Xiang X, 2012, NEUROSCI LETT, V530, P127, DOI 10.1016/j.neulet.2012.09.058; Zanata SM, 2002, J NEUROSCI, V22, P471, DOI 10.1523/JNEUROSCI.22-02-00471.2002	35	6	6	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2015	10	1							e0116368	10.1371/journal.pone.0116368	http://dx.doi.org/10.1371/journal.pone.0116368			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ4BS	25565389	Green Submitted, Green Published, gold			2022-12-27	WOS:000348167900005
J	Blanco, A; Puertolas-Pascual, E; Marmi, J; Vila, B; Selles, AG				Blanco, Alejandro; Puertolas-Pascual, Eduardo; Marmi, Josep; Vila, Bernat; Selles, Albert G.			Allodaposuchus palustris sp nov from the Upper Cretaceous of Fumanya (South-Eastern Pyrenees, Iberian Peninsula): Systematics, Palaeoecology and Palaeobiogeography of the Enigmatic Allodaposuchian Crocodylians	PLOS ONE			English	Article							EUSUCHIA; EUROPE; ALLIGATOROIDEA; REASSESSMENT; DINOSAURS; PRECEDENS; HUNGARY; FRANCE; SPAIN; BASIN	The controversial European genus Allodaposuchus is currently composed of two species (A. precedens, A. subjuniperus) and it has been traditionally considered a basal eusuchian clade of crocodylomorphs. In the present work, the new species A. palustris is erected on the base of cranial and postcranial remains from the lower Maastrichtian of the southern Pyrenees. Phylogenetic analyses here including both cranial and postcranial data support the hypothesis that Allodaposuchus is included within Crocodylia. The studied specimen suggests little change in postcranial skeleton along the evolutionary history of crocodylians, except for some bone elements such as the axis, the first caudal vertebra and the ilium. The specimen was found in an organic mudstone corresponding to a coastal wetland environment. Thus, A. palustris from Fumanya is the first Allodaposuchus reported in lacustrine-palustrine settings that expand the ecological range for this genus. The S-DIVA palaeobiogeographic reconstruction of ancestral area suggests that early members of Crocodylia rapidly widespread for the Northern Hemisphere landmasses no later than the Campanian, leading the apparition of endemic groups. In that way "Allodaposuchia'' represents an endemic European clade probably originated in the Ibero-Armorican domain in the late Campanian and dispersed by the Southern European archipelago prior to the early Maastrichtian.	[Blanco, Alejandro; Marmi, Josep; Selles, Albert G.] Univ Autonoma Barcelona, Inst Catala Paleontol Miquel Crusafont, E-08201 Sabadell, Spain; [Puertolas-Pascual, Eduardo; Vila, Bernat] Univ Zaragoza, Fac Ciencias, Area Paleontol, Grp Aragosaurus IUCA, E-50009 Zaragoza, Spain	Autonomous University of Barcelona; Institut Catala de Paleontologia Miquel Crusafont (ICP); University of Zaragoza	Blanco, A (corresponding author), Univ Autonoma Barcelona, Inst Catala Paleontol Miquel Crusafont, C Escola Ind 23, E-08201 Sabadell, Spain.	alejandro.blanco@icp.cat	Pascual, Eduardo Puértolas/A-3309-2012; Blanco, Alejandro/I-7352-2015; VILA, BERNAT/AAA-7367-2021; Selles, Albert G./ACZ-6076-2022	Pascual, Eduardo Puértolas/0000-0003-0759-7105; Blanco, Alejandro/0000-0003-2527-932X; VILA, BERNAT/0000-0002-5935-1732; Selles, Albert G./0000-0002-4637-6084	Ministerio de Economia y Competitividad [CGL2011-30069-C02-01/BTE]; INTERREG III-A (European Council); FI AGAUR grant from DGR of Generalitat de Catalunya [2013FI_B 01059]; Ministerio de Ciencia e Innovacion (Subprograma Juan de la Cierva (MICINN-JDC))	Ministerio de Economia y Competitividad(Spanish Government); INTERREG III-A (European Council); FI AGAUR grant from DGR of Generalitat de Catalunya; Ministerio de Ciencia e Innovacion (Subprograma Juan de la Cierva (MICINN-JDC))(Ministry of Science and Innovation, Spain (MICINN))	The present work was funded by the project CGL2011-30069-C02-01/BTE (Ministerio de Economia y Competitividad) and INTERREG III-A (European Council). A. B. is supported by FI AGAUR grant from DGR of Generalitat de Catalunya (2013FI_B 01059). B. V. acknowledges support from the Ministerio de Ciencia e Innovacion (Subprograma Juan de la Cierva (MICINN-JDC) 2011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aepler R, 1967, THESIS FREIN U BERLI; Badiola A, 2009, PALAIOS, V24, P522, DOI 10.2110/palo.2008.p08-126r; Behrensmeyer Anna K., 1992, P15; Benton MJ, 2010, PALAEOGEOGR PALAEOCL, V293, P438, DOI 10.1016/j.palaeo.2010.01.026; Brochu C.A., 1997, THESIS U TEXAS; Brochu CA, 1996, J VERTEBR PALEONTOL, V16, P49, DOI 10.1080/02724634.1996.10011283; Brochu CA, 2011, ZOOL J LINN SOC-LOND, V163, pS228, DOI 10.1111/j.1096-3642.2011.00716.x; Buscalioni AD, 2001, J VERTEBR PALEONTOL, V21, P74, DOI 10.1671/0272-4634(2001)021[0074:AROTCA]2.0.CO;2; Buscalioni AD, 1997, CR ACAD SCI II A, V325, P525, DOI 10.1016/S1251-8050(97)89872-2; Buscalioni Angela D., 2003, Coloquios de Paleontologia Volumen Extraordinario, V1, P77; Buscalioni AD, 2011, ZOOL J LINN SOC-LOND, V163, pS199, DOI 10.1111/j.1096-3642.2011.00718.x; Dalla Vecchia FM, 2009, J VERTEBR PALEONTOL, V29, P1100, DOI 10.1671/039.029.0428; Delfino M, 2008, PALAEONTOLOGY, V51, P1091, DOI 10.1111/j.1475-4983.2008.00800.x; Delfino M, 2008, J VERTEBR PALEONTOL, V28, P111, DOI 10.1671/0272-4634(2008)28[111:ACSOAP]2.0.CO;2; Erickson GM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031781; Feist M., 1983, GEOLOGIE MEDITERRANE, V10, P303, DOI 10.3406/geolm.1983.1273; Goloboff PA, 2008, CLADISTICS, V24, P774, DOI 10.1111/j.1096-0031.2008.00217.x; Isaji Shinji, 2005, Bulletin of the Kitakyushu Museum of Natural History and Human History Series A Natural History, V3, P123; LELOEUFF J, 1991, CRETACEOUS RES, V12, P93, DOI 10.1016/S0195-6671(05)80019-9; Leymerie A., 1862, B SOC GEOLOGIQUE FRA, V19, P1091; Marmi J, 2009, CRETACEOUS RES, V30, P1307, DOI 10.1016/j.cretres.2009.07.008; Martin JE, 2008, ZOOL J LINN SOC-LOND, V152, P567, DOI 10.1111/j.1096-3642.2007.00358.x; Martin JE, 2010, PALAEOGEOGR PALAEOCL, V293, P406, DOI 10.1016/j.palaeo.2009.10.021; Martin JE, 2010, J VERTEBR PALEONTOL, V30, P756, DOI 10.1080/02724631003758318; Martin Jeremy Emiland, 2005, Kaupia Darmstaedter Beitraege zur Naturgeschichte, V14, P33; Mey P.H.W., 1968, LEIDSE GEOL MEDED, V41, P221; Mook C, 1921, B AM MUS NAT HIST, VXLIV; Narvaez I, 2011, ACT 9 EJIP, P223; Narvaez I., 2013, 6 JORN INT PAL DIN E, P96; Narvaez I, 2012, FUNDAMENTAL, V20, P169; Nopcsa F, 1928, ACTA GEOL HUNGARIC P, V1, P75; Oms O, 2007, PALAEOGEOGR PALAEOCL, V255, P35, DOI 10.1016/j.palaeo.2007.02.039; Osi A, 2007, NEUES JAHRB GEOL P-A, V243, P169, DOI 10.1127/0077-7749/2007/0243-0169; Osi A, 2013, CRETACEOUS RES, V44, P58, DOI 10.1016/j.cretres.2013.03.006; Osi A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044318; Osi A, 2010, CRETACEOUS RES, V31, P304, DOI 10.1016/j.cretres.2010.01.001; Osi A, 2010, NATURE, V465, P466, DOI 10.1038/nature09019; Owen R, 1874, PALAEONTOGR SOC M S6, V27; Pereda-Suberbiola X, 1999, ZUBIA, V17, P259; Puertolas E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020011; Puertolas-Pascual E, 2014, HIST BIOL, V26, P91, DOI 10.1080/08912963.2012.763034; Rosell J., 2001, REV SOC GEOLOGICA ES, V14, P47; Salisbury SW, 2006, P ROY SOC B-BIOL SCI, V273, P2439, DOI 10.1098/rspb.2006.3613; Salisbury SW, 1999, SPEC PAP PALAEONTOL, P121; Scotese CR, 1992, 200692 U TEX ARL DEP; Smith A.G., 1994, ATLAS MESOZOIC CENOZ; Verdade L. M., 2000, Revista Brasileira de Biologia, V60, P469; Vila B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057408; Villalba-Breva S, 2012, GEOL ACTA, V10, P189, DOI 10.1344/105.000001711; Villalba-Breva S, 2011, J PHYCOL, V47, P131, DOI 10.1111/j.1529-8817.2010.00947.x; Weishampel DB, 2010, PALAEOGEOGR PALAEOCL, V293, P419, DOI 10.1016/j.palaeo.2010.03.024; Yu Y., 2013, RASP RECONSTRUCT ANC; Yu Y, 2010, MOL PHYLOGENET EVOL, V56, P848, DOI 10.1016/j.ympev.2010.04.011	53	35	36	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2014	9	12							e115837	10.1371/journal.pone.0115837	http://dx.doi.org/10.1371/journal.pone.0115837			34	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UC	25551630	Green Published, gold, Green Submitted			2022-12-27	WOS:000347119100067
J	Lim, JH; Muguet-Chanoit, AC; Smith, DT; Laber, E; Olby, NJ				Lim, Ji-Hey; Muguet-Chanoit, Audrey C.; Smith, Daniel T.; Laber, Eric; Olby, Natasha J.			Potassium Channel Antagonists 4-Aminopyridine and the T-Butyl Carbamate Derivative of 4-Aminopyridine Improve Hind Limb Function in Chronically Non-Ambulatory Dogs; A Blinded, Placebo-Controlled Trial	PLOS ONE			English	Article							SPINAL-CORD-INJURY; MULTIPLE-SCLEROSIS; AXONAL CONDUCTION; CLINICAL-TRIALS; FAMPRIDINE-SR; RESPONSES; DEFICITS; PHARMACOKINETICS; TRANSPLANTATION; DEMYELINATION	4-Aminopyridine (4-AP) blocks voltage gated potassium channels, restoring conduction to demyelinated axons and improving function in demyelinating conditions, but its use is associated with adverse effects and benefit in spinal cord injury is limited. Derivatives of 4-AP have been developed to improve clinical efficacy while reducing toxicity. We compared the therapeutic effects of orally administered 4-AP and its t-butyl carbamate derivative (t-butyl) with placebo in dogs that had suffered an acute spinal cord injury that left them chronically paralyzed. Nineteen dogs were entered into the trial, conducted in two-week treatment blocks starting with placebo, followed by random assignment to 4-AP or t-butyl, a washout and then the opposite medication followed by placebo. Investigators and owners were blinded to treatment group. Primary outcome measures included open field gait score (OFS), and treadmill based stepping score and regularity index, with additional secondary measures also considered. Thirteen of 19 dogs completed the protocol. Two were euthanized due to unrelated heath problems, two developed side effects and two were unable to complete for unrelated reasons. Dogs showed significant improvement in supported stepping score (from 17.39 to 37.24% with 4-AP; 16.85 to 29.18% with t-butyl p<0.0001) and OFS (from 3.63 to 4.73 with 4-AP; 3.78 to 4.45 with t-butyl, p=0.005). Response was individually variable and most dramatic in three dogs that were able to walk without support with treatment. No significant difference was found between 4-AP and t-butyl. No adverse effects were reported with t-butyl but gastrointestinal upset and seizures were observed in two dogs with 4-AP. In conclusion, both 4-AP and t-butyl significantly improved supported stepping ability in dogs with chronic spinal cord injury with no adverse effects noted with t-butyl. Drug response varied widely between individuals, highlighting the need to understand the factors that influence canine and human patients' response to therapy.	[Lim, Ji-Hey; Muguet-Chanoit, Audrey C.; Olby, Natasha J.] N Carolina State Univ, Coll Vet Med, Dept Clin Sci, Raleigh, NC 27695 USA; [Smith, Daniel T.] Purdue Univ, Dept Ind & Phys Pharm, W Lafayette, IN 47907 USA; [Lim, Ji-Hey; Olby, Natasha J.] N Carolina State Univ, Ctr Comparat Med & Translat Res, Raleigh, NC 27695 USA; [Laber, Eric] N Carolina State Univ, Dept Stat, Raleigh, NC 27695 USA	University of North Carolina; North Carolina State University; Purdue University System; Purdue University; Purdue University West Lafayette Campus; University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University	Olby, NJ (corresponding author), N Carolina State Univ, Coll Vet Med, Dept Clin Sci, Raleigh, NC 27695 USA.	Natasha_olby@ncsu.edu		Lim, Ji-Hey/0000-0001-6922-3155; Olby, Natasha/0000-0003-1349-3484	Neurometrix	Neurometrix	Neurometrix provided funding for this research study (http://www.neurometrix.com/). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	AGOSTON S, 1982, CLIN EXP PHARMACOL P, V9, P21, DOI 10.1111/j.1440-1681.1982.tb00775.x; Blight A R, 1985, Cent Nerv Syst Trauma, V2, P299; Blight AR, 1991, J NEUROTRAUM, V8, P103, DOI 10.1089/neu.1991.8.103; BLIGHT AR, 1989, BRAIN RES BULL, V22, P47, DOI 10.1016/0361-9230(89)90126-3; BLIGHT AR, 1987, J NEUROL SCI, V82, P145, DOI 10.1016/0022-510X(87)90014-1; Borgens RB, 1999, J NEUROTRAUM, V16, P639, DOI 10.1089/neu.1999.16.639; Bunge MB, 2003, J REHABIL RES DEV, V40, P55, DOI 10.1682/JRRD.2003.08.0055; BUNGE RP, 1993, ADV NEUROL, V59, P75; Cardenas DD, 2014, SPINAL CORD, V52, P70, DOI 10.1038/sc.2013.137; D Cardenas D, 2007, SPINAL CORD, V45, P158, DOI 10.1038/sj.sc.3101947; Goodman AD, 2007, MULT SCLER, V13, P357, DOI 10.1177/1352458506069538; Goodman AD, 2010, ANN NEUROL, V68, P494, DOI 10.1002/ana.22240; Granger N, 2012, BRAIN, V135, P3227, DOI 10.1093/brain/aws268; GRIFFITHS IR, 1972, J SMALL ANIM PRACT, V13, P439, DOI 10.1111/j.1748-5827.1972.tb06871.x; Grijalva I, 2010, ARCH MED RES, V41, P567, DOI 10.1016/j.arcmed.2010.10.001; Guest J, 2013, CURR OPIN ORGAN TRAN, V18, P682, DOI 10.1097/MOT.0000000000000026; Guest JD, 2005, EXP NEUROL, V192, P384, DOI 10.1016/j.expneurol.2004.11.033; HANSEBOUT RR, 1993, J NEUROTRAUM, V10, P1, DOI 10.1089/neu.1993.10.1; Hayes KC, 2004, CNS DRUG REV, V10, P295; HAYES KC, 1994, J NEUROTRAUM, V11, P433, DOI 10.1089/neu.1994.11.433; HAYES KC, 1993, PARAPLEGIA, V31, P216, DOI 10.1038/sc.1993.40; JANKOWSKA E, 1982, BRAIN RES, V240, P117, DOI 10.1016/0006-8993(82)90649-7; Jeffery ND, 2011, VET REC, V168, P102, DOI 10.1136/vr.d475; Judge SI, 2006, PHARMACOL THERAPEUT, V111, P224, DOI 10.1016/j.pharmthera.2005.10.006; Kakulas B A, 1999, J Spinal Cord Med, V22, P119; Koopmans GC, 2005, J NEUROTRAUM, V22, P214, DOI 10.1089/neu.2005.22.214; Lammertse D, 2007, SPINAL CORD, V45, P232, DOI 10.1038/sj.sc.3102010; Levine GJ, 2009, PREV VET MED, V89, P121, DOI 10.1016/j.prevetmed.2009.02.016; Levine JM, 2011, J NEUROTRAUM, V28, P675, DOI 10.1089/neu.2010.1645; Lorenz MD, 2004, HDB VET NEUROLOGY, P14; Mcbride JM, 2007, NEUROSCIENCE, V148, P44, DOI 10.1016/j.neuroscience.2007.05.039; McBride JM, 2006, EUR J PHARM SCI, V27, P237, DOI 10.1016/j.ejps.2005.10.003; Muguet-Chanoit AC, 2011, VET SURG, V40, P781, DOI 10.1111/j.1532-950X.2011.00888.x; Nashmi R, 2001, BRAIN RES REV, V38, P165, DOI 10.1016/S0165-0173(01)00134-5; Norenberg MD, 2004, J NEUROTRAUM, V21, P429, DOI 10.1089/089771504323004575; Olby N, 2004, J NEUROTRAUM, V21, P49, DOI 10.1089/089771504772695940; Olby N, 2003, J AM VET MED ASSOC, V222, P762, DOI 10.2460/javma.2003.222.762; Olby NJ, 2009, J VET PHARMACOL THER, V32, P485, DOI 10.1111/j.1365-2885.2009.01072.x; Olby NJ, 2014, BMC VET RES, V10, DOI 10.1186/1746-6148-10-58; Olby NJ, 2001, AM J VET RES, V62, P1624, DOI 10.2460/ajvr.2001.62.1624; OLBY NJ, 2008, J VET INTERN MED, V22, P722; SHERRATT RM, 1980, NATURE, V283, P570, DOI 10.1038/283570a0; Shi R, 1997, NEUROSCIENCE, V77, P553, DOI 10.1016/S0306-4522(96)00477-0; Siegenthaler MM, 2008, EXP NEUROL, V213, P363, DOI 10.1016/j.expneurol.2008.06.015; Smith DT, 2005, EUR J MED CHEM, V40, P908, DOI 10.1016/j.ejmech.2005.04.017; Smith KJ, 2000, BRAIN, V123, P171, DOI 10.1093/brain/123.1.171; Smith PM, 2006, BRAIN PATHOL, V16, P99, DOI 10.1111/j.1750-3639.2006.00001.x; Totoiu MO, 2005, J COMP NEUROL, V486, P373, DOI 10.1002/cne.20517; Vollmer T, 2009, CLIN THER, V31, P2215, DOI 10.1016/j.clinthera.2009.10.007; Watson RA, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-113; Wu B, 2009, J NEUROTRAUM, V26, P1847, DOI 10.1089/neu.2008.0551	51	17	17	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2014	9	12							e116139	10.1371/journal.pone.0116139	http://dx.doi.org/10.1371/journal.pone.0116139			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UC	25551385	Green Published, Green Submitted, gold			2022-12-27	WOS:000347119100099
J	Nemeth, M; Millesi, E; Wagner, KH; Wallner, B				Nemeth, Matthias; Millesi, Eva; Wagner, Karl-Heinz; Wallner, Bernard			Effects of Diets High in Unsaturated Fatty Acids on Socially Induced Stress Responses in Guinea Pigs	PLOS ONE			English	Article							PITUITARY-ADRENAL-AXIS; DOCOSAHEXAENOIC ACID; LOCOMOTOR-ACTIVITY; DEFICIENT DIET; BRAIN; CORTISOL; BEHAVIOR; N-3; METABOLISM; ALLOSTASIS	Unsaturated fatty acids (UFAs), such as omega-3 and omega-6 poly- and omega-9 monounsaturated fatty acids are important nutrients and major components of neuronal cell membranes. They play a major role in modulating brain functions and physiology and may therefore diminish behavioral and physiological stress reactions in corroboration with decreased cortisol concentrations. Functionally, cortisol itself can modulate several behaviors and also the fatty acid metabolism in the long term. But only little is known about the behavioral and physiological influences of dietary UFAs in a social group, where individuals are regularly exposed to stressful situations. Therefore, the aim of this study was to determine the effects of dietary UFAs on saliva cortisol concentrations and behavioral responses in socially confronted guinea pigs. Three groups of animals were additionally supplemented with 500 mg chia seeds (high in omega-3), walnuts (high in omega-6), or peanuts (high in omega-9) per kg bodyweight each day and compared to a control group. During social confrontation saliva cortisol concentrations significantly increased in all groups, which was accompanied by a loss in bodyweight. However, cortisol levels remained lower in the chia and walnut groups compared to controls. Additionally, the walnut group displayed significantly increased locomotion, while no differences between groups were detected in socio-positive, sexual, or aggressive behaviors. Total plasma omega-3, omega-6, and omega-9 fatty acids were significantly increased in the corresponding groups, due to the dietary supplementations. However, a significant decrease in plasma omega-3 and an increase in plasma n-6 fatty acids were detected in the chia group when comparing the measurements before and after social confrontation. We conclude that both omega-3 and omega-6 polyunsaturated fatty acids can diminish behavioral and physiological stress responses to the social environment, enabling individuals to cope with social stressors, but at the expense of plasma derived omega-3 fatty acids.	[Nemeth, Matthias; Millesi, Eva; Wallner, Bernard] Univ Vienna, Dept Behav Biol, Vienna, Austria; [Wagner, Karl-Heinz] Univ Vienna, Dept Nutr Sci, Vienna, Austria; [Wallner, Bernard] Univ Vienna, Vienna, Austria	University of Vienna; University of Vienna; University of Vienna	Nemeth, M (corresponding author), Univ Vienna, Dept Behav Biol, Vienna, Austria.	matthias.nemeth@univie.ac.at	Wallner, Bernard/B-1089-2009; Wagner, Karl-Heinz/B-9098-2013	Wagner, Karl-Heinz/0000-0002-1683-7265; Millesi, Eva/0000-0003-0740-0413	dean's office of the faculty of life sciences, University of Vienna; Open Access Publishing Fund of the University of Vienna	dean's office of the faculty of life sciences, University of Vienna; Open Access Publishing Fund of the University of Vienna	This study was part of an "intrafaculty networks" research activity by the departments of Behavioural Biology, Anthropology, and Nutritional Sciences, funded by the dean's office of the faculty of life sciences, University of Vienna. This article was supported by the Open Access Publishing Fund of the University of Vienna. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTMANN J, 1974, BEHAVIOUR, V49, P227, DOI 10.1163/156853974X00534; [Anonymous], J NUTR HLTH AGING, V10, P386; Appleton KM, 2008, NUTR RES REV, V21, P13, DOI 10.1017/S0954422408998620; Augier S, 2003, BRAIN RES BULL, V60, P161, DOI 10.1016/S0361-9230(03)00029-7; Barbadoro P, 2013, MOL NUTR FOOD RES, V57, P1110, DOI 10.1002/mnfr.201200676; Barcelo-Coblijn G, 2009, PROG LIPID RES, V48, P355, DOI 10.1016/j.plipres.2009.07.002; Bauer B, 2008, GEN COMP ENDOCR, V155, P680, DOI 10.1016/j.ygcen.2007.09.015; BAYARD J, 1957, J COMP PHYSIOL PSYCH, V50, P130, DOI 10.1037/h0042304; Benatti P, 2004, J AM COLL NUTR, V23, P281, DOI 10.1080/07315724.2004.10719371; Bernardi JR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062031; BEZARD J, 1994, REPROD NUTR DEV, V34, P539, DOI 10.1051/rnd:19940603; Blanchard RJ, 2001, PHYSIOL BEHAV, V73, P261, DOI 10.1016/S0031-9384(01)00449-8; Bourre J M, 2004, J Nutr Health Aging, V8, P163; Brenner RR, 2003, PROSTAG LEUKOTR ESS, V68, P151, DOI 10.1016/S0952-3278(02)00265-X; Chen HF, 2013, J NUTR BIOCHEM, V24, P70, DOI 10.1016/j.jnutbio.2012.02.006; Coiro V, 2007, CLIN ENDOCRINOL, V66, P740, DOI 10.1111/j.1365-2265.2007.02792.x; de Alaniz MJT, 2003, PROSTAG LEUKOTR ESS, V68, P163, DOI 10.1016/S0952-3278(02)00266-1; De Rosario-Martinez H, 2013, PHIA POST HOC INTERA; De Vriese SR, 2004, PROSTAG LEUKOTR ESS, V71, P13, DOI 10.1016/j.plefa.2003.12.002; DeMar JC, 2006, J LIPID RES, V47, P172, DOI 10.1194/jlr.M500362-JLR200; DeVries AC, 2002, HORM BEHAV, V41, P405, DOI 10.1006/hbeh.2002.1780; Du Bois TM, 2006, NEUROSCIENCE, V139, P1397, DOI 10.1016/j.neuroscience.2006.02.068; Fedorova I, 2006, PROSTAG LEUKOTR ESS, V75, P271, DOI 10.1016/j.plefa.2006.07.006; Fenske M, 1996, STEROIDS, V61, P647, DOI 10.1016/S0039-128X(96)00185-7; Fenske M, 1997, EXP CLIN ENDOCR DIAB, V105, P163, DOI 10.1055/s-0029-1211746; Ferraz AC, 2011, BEHAV BRAIN RES, V219, P116, DOI 10.1016/j.bbr.2010.12.028; Fu Z, 2000, LIPIDS, V35, P395, DOI 10.1007/s11745-000-537-7; Gamoh S, 2001, CLIN EXP PHARMACOL P, V28, P266, DOI 10.1046/j.1440-1681.2001.03437.x; Haider S, 2011, PLANT FOOD HUM NUTR, V66, P335, DOI 10.1007/s11130-011-0260-2; Hamazaki T, 2008, PROG LIPID RES, V47, P221, DOI 10.1016/j.plipres.2008.02.001; Hennebelle M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042142; Hu FB, 2001, J AM COLL NUTR, V20, P5, DOI 10.1080/07315724.2001.10719008; KAPLAN JR, 1991, PSYCHOSOM MED, V53, P634, DOI 10.1097/00006842-199111000-00005; Kaplan JR, 1996, AM J PRIMATOL, V38, P333, DOI 10.1002/(SICI)1098-2345(1996)38:4<333::AID-AJP4>3.0.CO;2-#; Kien CL, 2013, AM J CLIN NUTR, V97, P689, DOI 10.3945/ajcn.112.051730; Korte SM, 2005, NEUROSCI BIOBEHAV R, V29, P3, DOI 10.1016/j.neubiorev.2004.08.009; Kuratko CN, 2009, PROSTAG LEUKOTR ESS, V81, P111, DOI 10.1016/j.plefa.2009.05.007; Laugero KD, 2011, PROSTAG LEUKOTR ESS, V84, P71, DOI 10.1016/j.plefa.2010.12.003; Lavialle M, 2008, J NUTR, V138, P1719, DOI 10.1093/jn/138.9.1719; Lucki I, 1998, BIOL PSYCHIAT, V44, P151, DOI 10.1016/S0006-3223(98)00139-5; Macfarlane DP, 2008, J ENDOCRINOL, V197, P189, DOI 10.1677/JOE-08-0054; Machatschke IH, 2004, ETHOLOGY, V110, P161, DOI 10.1111/j.1439-0310.2004.00966.x; Machatschke IH, 2008, BEHAV ECOL SOCIOBIOL, V62, P1341, DOI 10.1007/s00265-008-0562-z; Marin MT, 2007, PHYSIOL BEHAV, V90, P29, DOI 10.1016/j.physbeh.2006.08.021; MATTSON FH, 1985, J LIPID RES, V26, P194; McEwen BS, 2003, HORM BEHAV, V43, P2, DOI 10.1016/S0018-506X(02)00024-7; Nieuwenhuizen AG, 2008, PHYSIOL BEHAV, V94, P169, DOI 10.1016/j.physbeh.2007.12.011; PALME R, 1994, ADVANCES IN STEROID ANALYSIS '93, P111; Palme R, 1997, Z SAUGETIERKD, V62, P192; Pinheiro J, 2013, NLME LINEAR AND NONL; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; Rabinovitz S, 2004, PSYCHONEUROENDOCRINO, V29, P113, DOI 10.1016/S0306-4530(02)00149-X; Rapoport SI, 2001, J LIPID RES, V42, P678; Raygada M, 1998, J NUTR, V128, P2505; Re S, 2008, VET RES COMMUN, V32, P225, DOI 10.1007/s11259-007-9021-y; Rogers PJ, 2001, P NUTR SOC, V60, P135, DOI 10.1079/PNS200061; Romero LM, 2009, HORM BEHAV, V55, P375, DOI 10.1016/j.yhbeh.2008.12.009; Rood J.P., 1972, Animal Behav Monogr, V5, P1; Rui LY, 2013, REV ENDOCR METAB DIS, V14, P387, DOI 10.1007/s11154-013-9261-9; SACHSER N, 1986, BEHAVIOUR, V97, P252, DOI 10.1163/156853986X00630; SACHSER N, 1984, AGGRESSIVE BEHAV, V10, P285, DOI 10.1002/1098-2337(1984)10:4<285::AID-AB2480100402>3.0.CO;2-8; Sachser N, 1998, PSYCHONEUROENDOCRINO, V23, P891, DOI 10.1016/S0306-4530(98)00059-6; Sapolsky RM, 2000, ENDOCR REV, V21, P55, DOI 10.1210/er.21.1.55; Sartorius T, 2012, DIABETES, V61, P1669, DOI 10.2337/db11-1521; Song C, 2003, J LIPID RES, V44, P1984, DOI 10.1194/jlr.M300217-JLR200; Sprecher H, 2000, BBA-MOL CELL BIOL L, V1486, P219, DOI 10.1016/S1388-1981(00)00077-9; Stillwell W, 2003, CHEM PHYS LIPIDS, V126, P1, DOI 10.1016/S0009-3084(03)00101-4; SVENNERHOLM L, 1968, J LIPID RES, V9, P570; Tu WC, 2013, PROSTAG LEUKOTR ESS, V88, P53, DOI 10.1016/j.plefa.2012.04.005; Vinot N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020491; Wagner KH, 2000, EUR FOOD RES TECHNOL, V210, P237, DOI 10.1007/s002179900080; Wallner B., 2009, CAB Reviews: Perspectives in Agriculture, Veterinary Science, Nutrition and Natural Resources, V4, P1, DOI 10.1079/PAVSNNR20094075; Wallner B, 2003, ACTA ETHOL, V5, P101, DOI DOI 10.1007/S10211-003-0076-7; Wallner B, 2009, PROG NEURO-PSYCHOPH, V33, P391, DOI 10.1016/j.pnpbp.2009.02.006; WEISINGER HS, 1995, LIPIDS, V30, P471, DOI 10.1007/BF02536307; WIDMAIER EP, 1995, PROSTAG LEUKOTR ESS, V52, P179, DOI 10.1016/0952-3278(95)90019-5; Yehuda S, 2003, WORLD REV NUTR DIET, V92, P37; Yehuda S, 2005, NEUROBIOL AGING, V26, pS98, DOI 10.1016/j.neurobiolaging.2005.09.013	78	19	19	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2014	9	12							e116292	10.1371/journal.pone.0116292	http://dx.doi.org/10.1371/journal.pone.0116292			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UC	25551380	gold, Green Published, Green Submitted			2022-12-27	WOS:000347119100127
J	Obishakin, E; Stijlemans, B; Santi-Rocca, J; Vandenberghe, I; Devreese, B; Muldermans, S; Bastin, P; Magez, S				Obishakin, Emmanuel; Stijlemans, Benoit; Santi-Rocca, Julien; Vandenberghe, Isabel; Devreese, Bart; Muldermans, Serge; Bastin, Philippe; Magez, Stefan			Generation of a Nanobody Targeting the Paraflagellar Rod Protein of Trypanosomes	PLOS ONE			English	Article							DETECTION ENZYME IMMUNOASSAYS; DOMAIN ANTIBODY FRAGMENTS; AFRICAN TRYPANOSOMIASIS; BRUCEI; INFECTIONS; CONGOLENSE; VIVAX; RNA; COMPONENTS; DIAGNOSIS	Trypanosomes are protozoan parasites that cause diseases in humans and livestock for which no vaccines are available. Disease eradication requires sensitive diagnostic tools and efficient treatment strategies. Immunodiagnostics based on antigen detection are preferable to antibody detection because the latter cannot differentiate between active infection and cure. Classical monoclonal antibodies are inaccessible to cryptic epitopes (based on their size-150 kDa), costly to produce and require cold chain maintenance, a condition that is difficult to achieve in trypanosomiasis endemic regions, which are mostly rural. Nanobodies are recombinant, heat-stable, small-sized (15 kDa), antigen-specific, single-domain, variable fragments derived from heavy chain-only antibodies in camelids. Because of numerous advantages over classical antibodies, we investigated the use of nanobodies for the targeting of trypanosome-specific antigens and diagnostic potential. An alpaca was immunized using lysates of Trypanosoma evansi. Using phage display and bio-panning techniques, a cross-reactive nanobody (Nb392) targeting all trypanosome species and isolates tested was selected. Imunoblotting, immunofluorescence microscopy, immunoprecipitation and mass spectrometry assays were combined to identify the target recognized. Nb392 targets paraflagellar rod protein (PFR1) of T. evansi, T. brucei, T. congolense and T. vivax. Two different RNAi mutants with defective PFR assembly (PFR2(RNAi) and KIF9B(RNAi)) were used to confirm its specificity. In conclusion, using a complex protein mixture for alpaca immunization, we generated a highly specific nanobody (Nb392) that targets a conserved trypanosome protein, i.e., PFR1 in the flagella of trypanosomes. Nb392 is an excellent marker for the PFR and can be useful in the diagnosis of trypanosomiasis. In addition, as demonstrated, Nb392 can be a useful research or PFR protein isolation tool.	[Obishakin, Emmanuel; Stijlemans, Benoit; Muldermans, Serge; Magez, Stefan] Vrije Univ Brussel, B-1050 Brussels, Belgium; [Obishakin, Emmanuel; Muldermans, Serge; Magez, Stefan] VIB Flanders Inst Biotechnol, Struct Biol Res Ctr, B-1050 Brussels, Belgium; [Stijlemans, Benoit] VIB, Lab Myeloid Cell Immunol, Flanders Inst Biotechnol, B-1050 Brussels, Belgium; [Vandenberghe, Isabel; Devreese, Bart] Univ Ghent, Dept Biochem & Microbiol, Lab Prot Biochem & Biomol Engn L ProBE, B-9000 Ghent, Belgium; [Santi-Rocca, Julien; Bastin, Philippe] Inst Pasteur, Trypanosome Cell Biol Unit, F-75015 Paris, France; [Santi-Rocca, Julien; Bastin, Philippe] CNRS, URA 2581, F-75015 Paris, France	Vrije Universiteit Brussel; Flanders Institute for Biotechnology (VIB); Flanders Institute for Biotechnology (VIB); Ghent University; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS)	Obishakin, E (corresponding author), Vrije Univ Brussel, Pleinlaan 2, B-1050 Brussels, Belgium.	eobishak@vub.ac.be	Stijlemans, Benoit/AAD-9122-2021; Muyldermans, Serge V/C-6418-2016; Bastin, Philippe/E-6688-2017; Magez, Stefan/D-9497-2014; Bastin, Philippe/O-4230-2019; Magez, Stefan/AAC-5682-2021; Devreese, Bart/K-2841-2019; Devreese, Bart/B-2011-2009; Santi-Rocca, Julien/AAD-2448-2020	Stijlemans, Benoit/0000-0003-0082-9751; Muyldermans, Serge V/0000-0002-3678-3575; Magez, Stefan/0000-0003-3760-7968; Bastin, Philippe/0000-0002-3042-8679; Magez, Stefan/0000-0003-3760-7968; Devreese, Bart/0000-0002-9764-2581; Devreese, Bart/0000-0002-9764-2581; Santi-Rocca, Julien/0000-0002-9791-3521; OBISHAKIN, EMMANUEL/0000-0001-6026-492X	European Union/FP7 Nanotryp [FP7-HEALTH 2007-2.3.4-1]; Fund for Scientific Research Flanders (FWO); French Government Investissement d'Avenir program, Laboratoire d'Excellence "Integrative Biology of Emerging Infectious Diseases'' [ANR-10-LABX-62- IBEID]; Institut Carnot Maladies Infectieuses; Fondation pour la Recherche Medicale	European Union/FP7 Nanotryp; Fund for Scientific Research Flanders (FWO)(FWO); French Government Investissement d'Avenir program, Laboratoire d'Excellence "Integrative Biology of Emerging Infectious Diseases''(French National Research Agency (ANR)); Institut Carnot Maladies Infectieuses; Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale)	This work was supported by the European Union/FP7 Nanotryp (FP7-HEALTH 2007-2.3.4-1) and the Fund for Scientific Research Flanders (FWO). Work at the Institut Pasteur was funded by a French Government Investissement d'Avenir program, Laboratoire d'Excellence "Integrative Biology of Emerging Infectious Diseases'' (ANR-10-LABX-62- IBEID), the Institut Carnot Maladies Infectieuses and the Fondation pour la Recherche Medicale. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbady AQ, 2011, VET IMMUNOL IMMUNOP, V142, P49, DOI 10.1016/j.vetimm.2011.04.004; Abdille MH, 2008, EXP PARASITOL, V120, P411, DOI 10.1016/j.exppara.2008.08.007; Baral TN, 2007, J INFECT DIS, V195, P1513, DOI 10.1086/515577; Baral TN, 2006, NAT MED, V12, P580, DOI 10.1038/nm1395; Bastin P, 1996, PARASITOL TODAY, V12, P302, DOI 10.1016/0169-4758(96)10031-4; Bastin P, 1998, NATURE, V391, P548, DOI 10.1038/35300; Bastin P, 2000, J CELL SCI, V113, P3321; Bockstal V, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002089; Broadhead R, 2006, NATURE, V440, P224, DOI 10.1038/nature04541; Chamond N, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000792; Conrath KE, 2001, ANTIMICROB AGENTS CH, V45, P2807, DOI 10.1128/AAC.45.10.2807-2812.2001; Coustou V, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000618; De Vooght L, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-23; DEFLORIN J, 1994, J BIOL CHEM, V269, P28745; Delespaux V, 2007, DRUG RESIST UPDATE, V10, P30, DOI 10.1016/j.drup.2007.02.004; Demonchy R, 2009, J CELL BIOL, V187, P615, DOI 10.1083/jcb.200903139; Desquesnes M, 2013, TRYPANOSOMA EVANSI S; Ditlev SB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084981; Durand-Dubief M, 2003, MOL BIOCHEM PARASIT, V129, P11, DOI 10.1016/S0166-6851(03)00071-9; Gadelha C, 2005, EUKARYOT CELL, V4, P516, DOI 10.1128/EC.4.3.516-525.2005; Ghahroudi MA, 1997, FEBS LETT, V414, P521, DOI 10.1016/S0014-5793(97)01062-4; Griffiths S, 2007, EUKARYOT CELL, V6, P1248, DOI 10.1128/EC.00110-07; HAMERSCASTERMAN C, 1993, NATURE, V363, P446, DOI 10.1038/363446a0; Kohl L, 1999, J EUKARYOT MICROBIOL, V46, P105, DOI 10.1111/j.1550-7408.1999.tb04592.x; La Greca F, 2011, HUM VACCINES, V7, P1225, DOI 10.4161/hv.7.11.18203; Manual OT, 2008, TRYPANOSOMA EVANSI I; Michailowsky V, 2003, INFECT IMMUN, V71, P3165, DOI 10.1128/IAI.71.6.3165-3171.2003; Muyldermans S, 2013, ANN REV BIOCH; NANTULYA VM, 1987, PARASITE IMMUNOL, V9, P421, DOI 10.1111/j.1365-3024.1987.tb00520.x; NANTULYA VM, 1989, TROP MED PARASITOL, V40, P267; Njiru ZK, 2011, DIAGN MICR INFEC DIS, V69, P205, DOI 10.1016/j.diagmicrobio.2010.08.026; Oberholzer M, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.010538; OLAHOMUKANI W, 1993, VET PARASITOL, V45, P231, DOI 10.1016/0304-4017(93)90078-2; Pardon E, 2014, NAT PROTOC, V9, P674, DOI 10.1038/nprot.2014.039; Portman N, 2010, INT J PARASITOL, V40, P135, DOI 10.1016/j.ijpara.2009.10.005; Portman N, 2009, J BIOL CHEM, V284, P5610, DOI 10.1074/jbc.M808859200; Pradel LC, 2006, J CELL SCI, V119, P1852, DOI 10.1242/jcs.02900; Reid SA, 2002, TRENDS PARASITOL, V18, P219, DOI 10.1016/S1471-4922(02)02250-X; Saerens D, 2008, J IMMUNOL METHODS, V329, P138, DOI 10.1016/j.jim.2007.10.005; SCHLAEPPI K, 1989, J CELL BIOL, V109, P1695, DOI 10.1083/jcb.109.4.1695; SCHNEIDER A, 1987, J CELL BIOL, V104, P431, DOI 10.1083/jcb.104.3.431; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; SKERRA A, 1988, SCIENCE, V240, P1038, DOI 10.1126/science.3285470; Stijlemans B, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002072; Subota I, 2014, MOL CELL PROTEOMICS, V13, P1769, DOI 10.1074/mcp.M113.033357; Subota I, 2011, MOL BIOL CELL, V22, P4205, DOI 10.1091/mbc.E11-06-0511; Vaneycken I, 2011, FASEB J, V25, P2433, DOI 10.1096/fj.10-180331; Wrightsman RA, 2000, VACCINE, V18, P1419, DOI 10.1016/S0264-410X(99)00380-1	48	27	27	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2014	9	12							e115893	10.1371/journal.pone.0115893	http://dx.doi.org/10.1371/journal.pone.0115893			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UC	25551637	Green Submitted, Green Published, gold			2022-12-27	WOS:000347119100074
J	Shi, J; Mao, NF; Wang, L; Zhang, HB; Chen, Q; Liu, H; Tang, X; Jin, T; Zhu, CT; Li, FB; Sun, LH; Xu, XM; Xu, YQ				Shi, Jian; Mao, Ning-Fang; Wang, Li; Zhang, Han-Bo; Chen, Qian; Liu, Hua; Tang, Xun; Jin, Tao; Zhu, Chong-Tao; Li, Fu-Bing; Sun, Lin-Hui; Xu, Xin-Ming; Xu, Yong-Qing			Efficacy of Combined Vancomycin and Fosfomycin against Methicillin-Resistant Staphylococcus aureus in Biofilms In Vivo	PLOS ONE			English	Article							BACTERIAL BIOFILMS; VITRO EFFICACY; COMBINATION; MODEL; INFECTIONS; DAPTOMYCIN; RIFAMPIN; SUSCEPTIBILITY; ANTIBIOTICS; PENETRATION	Infection by methicillin-resistant Staphylococcus aureus (MRSA) is a life-threatening condition, and formation of biofilms can lead to treatment failure in a clinical setting. The aim of this study was to demonstrate the in vivo bactericidal effects of a combination of vancomycin (VAN) and fosfomycin (FOS) against MRSA in a rat carboxymethyl cellulose-pouch biofilm model. The results of the time-kill assay showed that the combination therapy was capable of killing at low minimal inhibitory concentrations (MIC) (1/2 x MIC VAN + 1 x MIC FOS and 1 x MIC VAN + 1 x MIC FOS). In the in vivo study, a synergistically bactericidal effect was observed when using the combination therapy on MRSA embedded in the mature biofilm model. In comparison with the untreated control group and the groups receiving either VAN or FOS alone, the rats treated with combination therapy had lower MRSA colony counts in exudates from the pouch, lower white blood cell and neutrophil counts, and C-reactive protein (CRP) in peripheral blood. Furthermore, histological analysis of the pouch wall indicated combination therapy resulted in disappearance of biofilm-like structures, marked decrease in necrosis, and formation of granular tissue. In conclusion, the combination of VAN with FOS had a synergistic bactericidal effect on chronic MRSA infection embedded in biofilm, providing an alternative approach to treating this condition.	[Shi, Jian; Liu, Hua; Tang, Xun; Jin, Tao; Zhu, Chong-Tao; Li, Fu-Bing; Sun, Lin-Hui; Xu, Xin-Ming; Xu, Yong-Qing] Kunming Gen Hosp Chengdu Mil Reg, Dept Orthoped, Kunming, Peoples R China; [Mao, Ning-Fang] Changhai Hosp, Dept Orthoped, Shanghai, Peoples R China; [Wang, Li] Kunming Gen Hosp Chengdu Mil Reg, Dept Pathol, Kunming, Peoples R China; [Zhang, Han-Bo] Yunnan Univ, Lab Conservat & Utilizat Bioresources, Minist Educ, Kunming, Peoples R China; [Zhang, Han-Bo] Yunnan Univ, Key Lab Microbial Resources, Minist Educ, Kunming, Peoples R China; [Chen, Qian] Kunming Gen Hosp Chengdu Mil Reg, Dept Infect Control, Kunming, Peoples R China	Kunming General Hospital; Naval Medical University; Kunming General Hospital; Yunnan University; Yunnan University; Kunming General Hospital	Xu, YQ (corresponding author), Kunming Gen Hosp Chengdu Mil Reg, Dept Orthoped, Kunming, Peoples R China.	YongQingXu97@126.com			National Natural Science Foundation of China [81171734]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by a research grant from National Natural Science Foundation of China (No. 81171734). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318; Deleo FR, 2009, J CLIN INVEST, V119, P2464, DOI 10.1172/JCI38226; Hall-Stoodley L, 2004, NAT REV MICROBIOL, V2, P95, DOI 10.1038/nrmicro821; HAMMES WP, 1974, ANTIMICROB AGENTS CH, V6, P722, DOI 10.1128/AAC.6.6.722; Jefferson KK, 2005, ANTIMICROB AGENTS CH, V49, P2467, DOI 10.1128/AAC.49.6.2467-2473.2005; Klevens RM, 2007, JAMA-J AM MED ASSOC, V298, P1763, DOI 10.1001/jama.298.15.1763; LaPlante KL, 2009, ANTIMICROB AGENTS CH, V53, P3880, DOI 10.1128/AAC.00134-09; Masadeh MM, 2013, INFECT DRUG RESISTAN, V6, P27; McCaughey G, 2012, J CYST FIBROS, V11, P163, DOI 10.1016/j.jcf.2011.11.003; Morikawa K, 2005, INT J ANTIMICROB AG, V25, P44, DOI 10.1016/j.ijantimicag.2004.07.015; O'Neill E, 2007, J CLIN MICROBIOL, V45, P1379, DOI 10.1128/JCM.02280-06; Pachon-Ibanez ME, 2011, EUR J CLIN MICROBIOL, V30, P89, DOI 10.1007/s10096-010-1058-0; Parra-Ruiz J, 2010, ANTIMICROB AGENTS CH, V54, P4329, DOI 10.1128/AAC.00455-10; Perlroth J, 2008, ARCH INTERN MED, V168, P805, DOI 10.1001/archinte.168.8.805; Pistella Eleonora, 2005, Infez Med, V13, P97; Raad I, 2007, ANTIMICROB AGENTS CH, V51, P1656, DOI 10.1128/AAC.00350-06; Rose WE, 2009, J ANTIMICROB CHEMOTH, V63, P485, DOI 10.1093/jac/dkn513; Roussos N, 2009, INT J ANTIMICROB AG, V34, P506, DOI 10.1016/j.ijantimicag.2009.08.013; Salem AH, 2011, J PHARM PHARMACOL, V63, P73, DOI 10.1111/j.2042-7158.2010.01183.x; Simoes M, 2011, CURR MED CHEM, V18, P2129, DOI 10.2174/092986711795656216; Singh R, 2010, J ANTIMICROB CHEMOTH, V65, P1955, DOI 10.1093/jac/dkq257; Steinkraus G, 2007, J ANTIMICROB CHEMOTH, V60, P788, DOI 10.1093/jac/dkm258; Tang HJ, 2012, J ANTIMICROB CHEMOTH, V67, P944, DOI 10.1093/jac/dkr535; Tang HJ, 2011, INT J ANTIMICROB AG, V38, P46, DOI 10.1016/j.ijantimicag.2011.02.013; TOMASZ A, 1986, REV INFECT DIS, V8, pS260; Tre-Hardy M, 2009, INT J ANTIMICROB AG, V33, P40, DOI 10.1016/j.ijantimicag.2008.07.012; Wayne PA, 2006, M7A7 CLIN LAB STAND; Wikler M.A., 2006, PERFORMANCE STANDARD; Yasuda H, 1999, METHOD ENZYMOL, V310, P577; Yoshiyama Y, 2001, J Infect Chemother, V7, P243, DOI 10.1007/s101560170020	30	21	24	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2014	9	12							e113133	10.1371/journal.pone.0113133	http://dx.doi.org/10.1371/journal.pone.0113133			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UC	25551618	gold, Green Submitted, Green Published			2022-12-27	WOS:000347119100005
J	Delannoy, M; Schwarz, J; Fournier, A; Rychen, G; Feidt, C				Delannoy, Matthieu; Schwarz, Jessica; Fournier, Agnes; Rychen, Guido; Feidt, Cyril			Effects of Standard Humic Materials on Relative Bioavailability of NDL-PCBs in Juvenile Swine	PLOS ONE			English	Article							POLYCYCLIC AROMATIC-HYDROCARBONS; SOIL ORGANIC-MATTER; POLYCHLORINATED-BIPHENYLS; SURFACE SOILS; LAYING HENS; SORPTION; EXPOSURE; ABSORPTION; CONTAMINANTS; MECHANISMS	Young children with their hand-to-mouth activity may be exposed to contaminated soils. However few studies assessing exposure of organic compounds sequestrated in soil were realized. The present study explores the impact of different organic matters on retention of NDL-PCBs during digestive processes using commercial humic substances in a close digestive model of children: the piglet. Six artificial soils were used. One standard soil, devoid of organic matter, and five amended versions of this standard soil with either fulvic acid, humic acid, Sphagnum peat, activated carbon or a mix of Sphagnum peat and activated carbon (95:5) (SPAC) were prepared. In order to compare the different treatments, we use spiked oil and negative control animals. Forty male piglets were randomly distributed in 7 contaminated and one control groups (n = 5 for each group). During 10 days, the piglets were fed artificial soil or a corn oil spiked with 19 200 ng of Aroclor 1254 per g of dry matter (6 000 ng.g(-1) of NDL-PCBs) to achieve an exposure dose of 1 200 ng NDL-PCBs.Kg(-1) of body weight per day. NDL-PCBs in adipose tissue were analyzed by GC-MS. Fulvic acid reduced slightly the bioavailability of NDL-PCBs compared to oil. Humic acid and Sphagnum peat reduced it significantly higher whereas activated carbon reduced the most. Piglets exposed to soil containing both activated carbon and Shagnum peat exhibited a lower reduction than soil with only activated carbon. Therefore, treatment groups are ordered by decreasing value of relative bioavailability as following: oil >= fulvic acid > Sphagnum peat >= Sphagnum peat and activated carbon >= Humic acid >> activated carbon. This suggests competition between Sphagnum peat and activated carbon. The present study highlights that quality of organic matter does have a significant effect on bioavailability of sequestrated organic compounds.	[Delannoy, Matthieu; Schwarz, Jessica; Fournier, Agnes; Rychen, Guido; Feidt, Cyril] Univ Lorraine, UR AFPA, Vandoeuvre Les Nancy, France; [Delannoy, Matthieu; Schwarz, Jessica; Fournier, Agnes; Rychen, Guido; Feidt, Cyril] INRA, UR AFPA, USC 340, Vandoeuvre Les Nancy, France	Universite de Lorraine; INRAE	Delannoy, M (corresponding author), Univ Lorraine, UR AFPA, Vandoeuvre Les Nancy, France.	matthieu.delannoy@univ-lorraine.fr	FEIDT, Cyril/AAY-6066-2020	Feidt, Cyril/0000-0003-3828-9543; Delannoy, Matthieu/0000-0002-9699-6513	French Ministry for Agriculture; Agence de l'Environnement et de la Maitrise de l'Energie (ADEME) (ADEME-university of Lorraine) [1072C0054]	French Ministry for Agriculture; Agence de l'Environnement et de la Maitrise de l'Energie (ADEME) (ADEME-university of Lorraine)	The authors are grateful to the French Ministry for Agriculture and Agence de l'Environnement et de la Maitrise de l'Energie (ADEME) for their financial support (contract ADEME-university of Lorraine, number: 1072C0054) (http://www2.ademe.fr/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ATSDR, 2000, TOXICOLOGICAL PROFIL; Boix J, 2010, NEUROSCIENCE, V167, P994, DOI 10.1016/j.neuroscience.2010.02.068; Boix J, 2011, NEUROCHEM INT, V58, P69, DOI 10.1016/j.neuint.2010.10.014; Bouveret C, 2013, J AGR FOOD CHEM, V61, P9269, DOI 10.1021/jf400697r; Budinsky RA, 2008, CHEMOSPHERE, V70, P1774, DOI 10.1016/j.chemosphere.2007.08.035; Casteel SW, 2006, ENVIRON HEALTH PERSP, V114, P1162, DOI 10.1289/ehp.8852; CHIOU CT, 1987, ENVIRON SCI TECHNOL, V21, P1231, DOI 10.1021/es00165a012; Corey DA, 1996, GROWTH DEVELOP AGING, V60, P131; Delannoy M, 2014, CHEMOSPHERE, V104, P105, DOI 10.1016/j.chemosphere.2013.10.072; Doick KJ, 2005, ENVIRON SCI TECHNOL, V39, P6575, DOI 10.1021/es050523c; Drouillard KG, 2000, ENVIRON TOXICOL CHEM, V19, P2707, DOI 10.1002/etc.5620191114; E.F.S. Authority, 2010, EFSA J, V8, P1701, DOI DOI 10.2903/J.EFSA.2010.1701; Elnar AA, 2012, TOXICOLOGY, V299, P44, DOI 10.1016/j.tox.2012.05.004; Fournier A, 2012, CHEMOSPHERE, V88, P300, DOI 10.1016/j.chemosphere.2012.02.041; Gomez-Eyles JL, 2013, ENVIRON SCI TECHNOL, V47, P13721, DOI 10.1021/es403712q; Graber ER, 1998, ENVIRON SCI TECHNOL, V32, P3286, DOI 10.1021/es9801238; Jondreville C, 2013, ENVIRON SCI POLLUT R, V20, P292, DOI 10.1007/s11356-012-1010-1; Jonker MTO, 2002, ENVIRON SCI TECHNOL, V36, P3725, DOI 10.1021/es020019x; Kelly BC, 2004, ENVIRON TOXICOL CHEM, V23, P2324, DOI 10.1897/03-545; Lesan HM, 2003, WATER RES, V37, P1644, DOI 10.1016/S0043-1354(02)00497-9; LILIENTHAL H, 1991, FUND APPL TOXICOL, V17, P368, DOI 10.1016/0272-0590(91)90226-T; Meijer SN, 2003, ENVIRON SCI TECHNOL, V37, P667, DOI 10.1021/es025809l; Mirza MA, 2011, SCI ADV MATER, V3, P223, DOI 10.1166/sam.2011.1149; Niederer C, 2007, ENVIRON SCI TECHNOL, V41, P6711, DOI 10.1021/es0709932; OECD, 1984, GUIDELINE FOR TESTIN; Oomen AG, 2004, ARCH ENVIRON CON TOX, V46, P183, DOI 10.1007/s00244-003-2138-2; Pignatello JJ, 1996, ENVIRON SCI TECHNOL, V30, P1, DOI 10.1021/es940683g; Pignatello JJ, 1998, ADV COLLOID INTERFAC, V76, P445, DOI 10.1016/S0001-8686(98)00055-4; Schantz SL, 2003, ENVIRON HEALTH PERSP, V111, P357, DOI 10.1289/ehp.5461; Schlummer M, 1998, TOXICOL APPL PHARM, V152, P128, DOI 10.1006/taap.1998.8487; Sharma B, 2009, ENVIRON ENG SCI, V26, P1371, DOI 10.1089/ees.2008.0231; Soares M, 2002, ANIM FEED SCI TECH, V95, P169, DOI 10.1016/S0377-8401(01)00324-8; Sutton R, 2005, ENVIRON SCI TECHNOL, V39, P9009, DOI 10.1021/es050778q; *US EPA, 2007, GUIDANCE AND TECHNIC; WILSON FA, 1974, BIOCHIM BIOPHYS ACTA, V363, P112, DOI 10.1016/0005-2736(74)90010-8; Wittsiepe J, 2007, CHEMOSPHERE, V67, pS355, DOI 10.1016/j.chemosphere.2006.05.129; Xing BS, 1996, ENVIRON TOXICOL CHEM, V15, P1282, DOI [10.1002/etc.5620150805, 10.1897/1551-5028(1996)015&lt;1282:TDISOO&gt;2.3.CO;2]; Yan MQ, 2012, CHEMOSPHERE, V87, P879, DOI 10.1016/j.chemosphere.2012.01.029; Yang Y, 2010, ENVIRON POLLUT, V158, P2170, DOI 10.1016/j.envpol.2010.02.019	39	12	12	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2014	9	12							e115759	10.1371/journal.pone.0115759	http://dx.doi.org/10.1371/journal.pone.0115759			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX6YH	25549096	Green Submitted, Green Published, gold			2022-12-27	WOS:000347063500024
J	Park, JW; Park, KH				Park, Jae Woo; Park, Kee Hwan			Validation of the Bipolar Disorder Etiology Scale Based on Psychological Behaviorism Theory and Factors Related to the Onset of Bipolar Disorder	PLOS ONE			English	Article							EXPRESSED EMOTION; SCHIZOPHRENIA	Objectives: The aim of this study was to identify psychosocial factors related to the onset of bipolar I disorder (BD). To do so, the Bipolar Disorder Etiology Scale (BDES), based on psychological behaviorism, was developed and validated. Using the BDES, common factors related to both major depressive disorder (MDD) and BD and specific factors related only to BD were investigated. Method: The BDES, which measures 17 factors based on psychological behaviorism hypotheses, was developed and validated. This scale was administered to 113 non-clinical control subjects, 30 subjects with MDD, and 32 people with BD. ANOVA and post hoc analyses were conducted. Subscales on which MDD and BD groups scored higher than controls were classified as common factors, while those on which the BD group scored higher than MDD and control groups were classified as specific factors. Results: The BDES has acceptable reliability and validity. Twelve common factors influence both MDD and BD and one specific factor influences only BD. Common factors include the following: learning grandiose self-labeling, learning dangerous behavior, reinforcing impulsive behavior, exposure to irritability, punishment of negative emotional expression, lack of support, sleep problems, antidepressant problems, positive arousal to threat, lack of social skills, and pursuit of short-term pleasure. The specific factor is manic emotional response. Conclusions: Manic emotional response was identified as a specific factor related to the onset of BD, while parents' grandiose labeling is a candidate for a specific factor. Many factors are related to the onset of both MDD and BD.	[Park, Jae Woo] Korea Counseling Grad Sch, Dept Gen Counseling, Seoul, South Korea; [Park, Kee Hwan] Catholic Univ Korea, Coll Social Sci, Puchon, South Korea	Catholic University of Korea	Park, KH (corresponding author), Catholic Univ Korea, Coll Social Sci, Puchon, South Korea.	psyclinic@catholic.ac.kr						Akiskal KK, 2005, J AFFECT DISORDERS, V85, P231, DOI 10.1016/j.jad.2004.08.002; Bruno E, 2008, BIPOLAR DISORD, V10, P867; DOCHERTY NM, 1995, SCHIZOPHRENIA BULL, V21, P411, DOI 10.1093/schbul/21.3.411; HAHLWEG K, 1989, J CONSULT CLIN PSYCH, V57, P11, DOI 10.1037/0022-006X.57.1.11; Hans W, 1986, SCHIZOPHR B, V12, P236; Irene P, 2001, BIPOLAR DISORD, V3, P1; Lam D, 2002, BIPOLAR DISORD S, V4, P104; Marom S, 2002, SCHIZOPHRENIA BULL, V28, P731, DOI 10.1093/oxfordjournals.schbul.a006976; Merikangas KR, 2007, ARCH GEN PSYCHIAT, V64, P543, DOI 10.1001/archpsyc.64.5.543; Muller-Oerlinghausen B, 2002, LANCET, V359, P241, DOI 10.1016/S0140-6736(02)07450-0; Novick DM, 2010, BIPOLAR DISORD, V12, P1, DOI 10.1111/j.1399-5618.2009.00786.x; Polina E, 2012, BIPOLAR DISORD, V14, P628; Riedel HPR, 2001, PSYCHOL REC, V51, P507; Roberto M, 2013, BIPOLAR DISORD, V15, P341; Staats A. W., 1996, BEHAV PERSONALITY PS; Staats A. W., 1975, SOCIAL BEHAV; STAATS AW, 1986, BEHAV ANALYST, V9, P231, DOI 10.1007/BF03391956; Suzanne K, 1999, SCHIZOPHR B, V25, P377; Yoon-Kyoung C, 2011, DANGEROUS COMPLIMENT	19	0	0	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2014	9	12							e116265	10.1371/journal.pone.0116265	http://dx.doi.org/10.1371/journal.pone.0116265			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AX6YH	25549262	gold, Green Published, Green Submitted			2022-12-27	WOS:000347063500070
J	Pereira, J; Johnson, WE; O'Brien, SJ; Jarvis, ED; Zhang, GJ; Gilbert, MTP; Vasconcelos, V; Antunes, A				Pereira, Joana; Johnson, Warren E.; O'Brien, Stephen J.; Jarvis, Erich D.; Zhang, Guojie; Gilbert, M. Thomas P.; Vasconcelos, Vitor; Antunes, Agostinho			Evolutionary Genomics and Adaptive Evolution of the Hedgehog Gene Family (Shh, Ihh and Dhh) in Vertebrates	PLOS ONE			English	Article							AMINO-ACID SITES; PROTEIN-STRUCTURE PREDICTION; SONIC-HEDGEHOG; I-TASSER; FUNCTIONAL DIVERGENCE; MAXIMUM-LIKELIHOOD; STRUCTURAL DIVERGENCE; PHYLOGENETIC ANALYSIS; POSITIVE SELECTION; SEQUENCE ALIGNMENT	The Hedgehog (Hh) gene family codes for a class of secreted proteins composed of two active domains that act as signalling molecules during embryo development, namely for the development of the nervous and skeletal systems and the formation of the testis cord. While only one Hh gene is found typically in invertebrate genomes, most vertebrates species have three (Sonic hedgehog - Shh; Indian hedgehog - Ihh; and Desert hedgehog - Dhh), each with different expression patterns and functions, which likely helped promote the increasing complexity of vertebrates and their successful diversification. In this study, we used comparative genomic and adaptive evolutionary analyses to characterize the evolution of the Hh genes in vertebrates following the two major whole genome duplication (WGD) events. To overcome the lack of Hh-coding sequences on avian publicly available databases, we used an extensive dataset of 45 avian and three non-avian reptilian genomes to show that birds have all three Hh paralogs. We find suggestions that following the WGD events, vertebrate Hh paralogous genes evolved independently within similar linkage groups and under different evolutionary rates, especially within the catalytic domain. The structural regions around the ion-binding site were identified to be under positive selection in the signaling domain. These findings contrast with those observed in invertebrates, where different lineages that experienced gene duplication retained similar selective constraints in the Hh orthologs. Our results provide new insights on the evolutionary history of the Hh gene family, the functional roles of these paralogs in vertebrate species, and on the location of mutational hotspots.	[Pereira, Joana; Vasconcelos, Vitor; Antunes, Agostinho] Univ Porto, Interdisciplinary Ctr Marine & Environm Res, CIMAR, CIIMAR, P-4100 Oporto, Portugal; [Johnson, Warren E.] Smithsonian Conservat Biol Inst, Front Royal, VA USA; [O'Brien, Stephen J.] St Petersburg State Univ, Theodosius Dobzhansky Ctr Genome Bioinformat, St Petersburg 199034, Russia; [O'Brien, Stephen J.] Nova SE Univ, Oceanog Ctr, Ft Lauderdale, FL 33314 USA; [Zhang, Guojie] Beishan Ind Zoon, BGI Shenzhen, Shenzhen, Peoples R China; [Gilbert, M. Thomas P.] Univ Copenhagen, Nat Hist Museum Denmark, Ctr GeoGenet, Copenhagen, Denmark; [Vasconcelos, Vitor; Antunes, Agostinho] Univ Porto, Fac Sci, Dept Biol, P-4100 Oporto, Portugal	Universidade do Porto; Smithsonian Institution; Smithsonian National Zoological Park & Conservation Biology Institute; Saint Petersburg State University; Nova Southeastern University; Beijing Genomics Institute (BGI); University of Copenhagen; Universidade do Porto	Antunes, A (corresponding author), Univ Porto, Interdisciplinary Ctr Marine & Environm Res, CIMAR, CIIMAR, Rua Campo Alegre 823, P-4100 Oporto, Portugal.	aantunes@ciimar.up.pt	Zhang, Guojie/J-7273-2019; OBRIEN, STEPHEN/ABD-1346-2020; Pereira, Joana/AAU-6247-2020; Gilbert, Marcus TP/A-8936-2013; Jarvis, Erich D/A-2319-2008; Vasconcelos, Vitor/A-8933-2008; Zhang, Guojie/B-6188-2014; Johnson, Warren/D-4149-2016	Zhang, Guojie/0000-0001-6860-1521; Pereira, Joana/0000-0002-5588-6588; Gilbert, Marcus TP/0000-0002-5805-7195; Jarvis, Erich D/0000-0001-8931-5049; Vasconcelos, Vitor/0000-0003-3585-2417; Zhang, Guojie/0000-0001-6860-1521; Antunes, Agostinho/0000-0002-1328-1732; OBRIEN, STEPHEN/0000-0001-7857-0757; Johnson, Warren/0000-0002-5954-186X	BII from Portuguese Foundation for Science and Technology (FCT) [CIIMAR/C2008/BII/01-25]; Russian Ministry of Science [11.G34.31.0068]; FCT [PEst-C/MAR/LA0015/2013, PTDC/BIA-BDE/69144/2006 (FCOMP-01-0124-FEDER-007065), PTDC/AAC-AMB/104983/2008 (FCOMP-01-0124-FEDER-008610), PTDC/AAC-AMB/121301/2010 (FCOMP-01-0124-FEDER-019490)]; HHMI; European Regional Development Fund (ERDF) through the COMPETE - Operational Competitiveness Programme	BII from Portuguese Foundation for Science and Technology (FCT); Russian Ministry of Science; FCT(Portuguese Foundation for Science and TechnologyEuropean Commission); HHMI(Howard Hughes Medical Institute); European Regional Development Fund (ERDF) through the COMPETE - Operational Competitiveness Programme	Joana Pereira was funded by a BII grant (CIIMAR/C2008/BII/01-25) from the Portuguese Foundation for Science and Technology (FCT). SJO was supported as Principal Investigator by Russian Ministry of Science Mega-grant no. 11.G34.31.0068. Erich D. Jarvis was funded by HHMI. Agostinho Antunes was partially supported by the European Regional Development Fund (ERDF) through the COMPETE - Operational Competitiveness Programme and national funds through FCT under the projects PEst-C/MAR/LA0015/2013 and PTDC/BIA-BDE/69144/2006 (FCOMP-01-0124-FEDER-007065), PTDC/AAC-AMB/ 104983/2008 (FCOMP-01-0124-FEDER-008610) and PTDC/AAC-AMB/121301/2010 (FCOMP-01-0124-FEDER-019490). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfoldi J, 2011, NATURE, V477, P587, DOI 10.1038/nature10390; [Anonymous], PYMOL MOL GRAPH SYST; Avaron F, 2006, DEV DYNAM, V235, P478, DOI 10.1002/dvdy.20619; Battey JND, 2007, PROTEINS, V69, P68, DOI 10.1002/prot.21761; Beachy PA, 1997, COLD SPRING HARB SYM, V62, P191; Beachy PA, 2010, GENE DEV, V24, P2001, DOI 10.1101/gad.1951710; Benson DA, 2011, NUCLEIC ACIDS RES, V39, pD32, DOI [10.1093/nar/gkw1070, 10.1093/nar/gks1195, 10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkx1094, 10.1093/nar/gkn723, 10.1093/nar/gkp1024, 10.1093/nar/gkr1202]; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bingham S, 2001, GENESIS, V30, P170, DOI 10.1002/gene.1057; Burglin TR, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-11-241; Burglin TR, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-127; Burt DW, 2002, CYTOGENET GENOME RES, V96, P97, DOI 10.1159/000063018; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Chamoun Z, 2001, SCIENCE, V293, P2080, DOI 10.1126/science.1064437; Chen MH, 2004, GENE DEV, V18, P641, DOI 10.1101/gad.1185804; Chen X, 2011, J CELL BIOL, V192, P825, DOI 10.1083/jcb.201008090; Cozzetto D, 2009, PROTEINS, V77, P18, DOI 10.1002/prot.22561; da Fonseca RR, 2007, GENE, V387, P58, DOI 10.1016/j.gene.2006.08.017; da Fonseca RR, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-119; Darling AE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011147; Darling ACE, 2004, GENOME RES, V14, P1394, DOI 10.1101/gr.2289704; Davis JC, 2005, J MOL EVOL, V60, P774, DOI 10.1007/s00239-004-0241-2; Delport W, 2010, BIOINFORMATICS, V26, P2455, DOI 10.1093/bioinformatics/btq429; Dessimoz C, 2010, GENOME BIOL, V11; DJABALI M, 1992, NAT GENET, V2, P113, DOI 10.1038/ng1092-113; Dutcher SK, 2001, CURR OPIN CELL BIOL, V13, P49, DOI 10.1016/S0955-0674(00)00173-3; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; EKKER SC, 1995, DEVELOPMENT, V121, P2337; Eugster C, 2007, DEV CELL, V13, P57, DOI 10.1016/j.devcel.2007.04.019; Flicek P, 2012, NUCLEIC ACIDS RES, V40, pD84, DOI 10.1093/nar/gkr991; Fujita P. A., 2010, NUCL ACIDS RES; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Gu X, 1999, MOL BIOL EVOL, V16, P1664, DOI 10.1093/oxfordjournals.molbev.a026080; Gu X, 2002, BIOINFORMATICS, V18, P500, DOI 10.1093/bioinformatics/18.3.500; Gu X, 2001, MOL BIOL EVOL, V18, P453, DOI 10.1093/oxfordjournals.molbev.a003824; Gu X, 2006, MOL BIOL EVOL, V23, P1937, DOI 10.1093/molbev/msl056; Guindon S, 2009, METHODS MOL BIOL, V537, P113, DOI 10.1007/978-1-59745-251-9_6; Gunbin Konstantin V., 2007, In Silico Biology, V7, P333; Hadzhiev Y, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-r106; Hammerschmidt M, 1997, TRENDS GENET, V13, P14, DOI 10.1016/S0168-9525(96)10051-2; Hao LM, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-280; Hillier LW, 2004, NATURE, V432, P695, DOI 10.1038/nature03154; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Ingham PW, 2011, NAT REV GENET, V12, P393, DOI 10.1038/nrg2984; Ingham PW, 2001, GENE DEV, V15, P3059, DOI 10.1101/gad.938601; Irimia M, 2012, SCI REP-UK, V2, DOI 10.1038/srep00433; Jeffreys H., 1948, INT SERIES MONOGRAPH, V2a; Kano S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013332; Kinch L, 2011, PROTEINS, V79, P59, DOI 10.1002/prot.23181; KOONIN EV, 1995, TRENDS BIOCHEM SCI, V20, P141, DOI 10.1016/S0968-0004(00)88989-6; Krivtsov AV, 2007, NAT REV CANCER, V7, P823, DOI 10.1038/nrc2253; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Kumar S, 1996, GENETICS, V142, P965; Kuraku S, 2009, MOL BIOL EVOL, V26, P47, DOI 10.1093/molbev/msn222; Ladjali-Mohammedi K, 1999, CYTOGENET CELL GENET, V86, P271, DOI 10.1159/000015318; LEE JJ, 1994, SCIENCE, V266, P1528, DOI 10.1126/science.7985023; Magrane M, 2011, DATABASE-OXFORD, DOI 10.1093/database/bar009; Masabanda JS, 2004, GENETICS, V166, P1367, DOI 10.1534/genetics.166.3.1367; McClellan DA, 2005, MOL BIOL EVOL, V22, P437, DOI 10.1093/molbev/msi028; McClellan DA, 2001, MOL BIOL EVOL, V18, P917, DOI 10.1093/oxfordjournals.molbev.a003892; McKean PG, 2001, J CELL SCI, V114, P2723; McLellan JS, 2008, NATURE, V455, P979, DOI 10.1038/nature07358; Meyer A, 2005, BIOESSAYS, V27, P937, DOI 10.1002/bies.20293; Misawa H, 2000, INT J MOL MED, V6, P191; Morisson M, 2007, CYTOGENET GENOME RES, V117, P14, DOI 10.1159/000103160; Mortier GR, 2003, J MED GENET, V40, P201, DOI 10.1136/jmg.40.3.201; Muffato M, 2010, BIOINFORMATICS, V26, P1119, DOI 10.1093/bioinformatics/btq079; Murone M, 1999, EXP CELL RES, V253, P25, DOI 10.1006/excr.1999.4676; Nagase T, 2007, ANN NY ACAD SCI, V1101, P412, DOI 10.1196/annals.1389.029; Nanni L, 1999, HUM MOL GENET, V8, P2479, DOI 10.1093/hmg/8.13.2479; Nichols SA, 2006, P NATL ACAD SCI USA, V103, P12451, DOI 10.1073/pnas.0604065103; Odent S, 1999, HUM MOL GENET, V8, P1683, DOI 10.1093/hmg/8.9.1683; Okonechnikov K, 2012, BIOINFORMATICS, V28, P1166, DOI 10.1093/bioinformatics/bts091; Pond SLK, 2005, MOL BIOL EVOL, V22, P1208, DOI 10.1093/molbev/msi105; Pond SLK, 2005, BIOINFORMATICS, V21, P2531, DOI 10.1093/bioinformatics/bti320; Porter ML, 2007, MOL BIOL EVOL, V24, P253, DOI 10.1093/molbev/msl152; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Roux J, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000311; Roy A, 2011, JOVE-J VIS EXP, DOI 10.3791/3259; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Rubin LL, 2006, NAT REV DRUG DISCOV, V5, P1026, DOI 10.1038/nrd2086; Sobrinho IS, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-293; St John JA, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-1-415; Sun XJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001499; Swanson WJ, 2002, NAT REV GENET, V3, P137, DOI 10.1038/nrg733; Taipale J, 2001, NATURE, V411, P349, DOI 10.1038/35077219; Takatori N, 2002, MECH DEVELOP, V116, P235, DOI 10.1016/S0925-4773(02)00150-8; Talavera G, 2007, SYST BIOL, V56, P564, DOI 10.1080/10635150701472164; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Trukhina A V, 2010, Genetika, V46, P509; Umehara F, 2000, AM J HUM GENET, V67, P1302, DOI 10.1016/S0002-9297(07)62958-9; Varjosalo M, 2008, GENE DEV, V22, P2454, DOI 10.1101/gad.1693608; Wang YF, 2001, GENETICS, V158, P1311; Woolley S, 2003, BIOINFORMATICS, V19, P671, DOI 10.1093/bioinformatics/btg043; Wu ST, 2011, STRUCTURE, V19, P1182, DOI 10.1016/j.str.2011.05.004; Xia X, 2001, J HERED, V92, P371, DOI 10.1093/jhered/92.4.371; Xia XH, 2003, MOL PHYLOGENET EVOL, V26, P1, DOI 10.1016/S1055-7903(02)00326-3; Yang ZH, 2000, GENETICS, V155, P431; Yang ZH, 2005, MOL BIOL EVOL, V22, P1107, DOI 10.1093/molbev/msi097; Yang ZH, 2002, CURR OPIN GENET DEV, V12, P688, DOI 10.1016/S0959-437X(02)00348-9; Yang ZH, 1998, MOL BIOL EVOL, V15, P568, DOI 10.1093/oxfordjournals.molbev.a025957; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Yao HHC, 2002, GENE DEV, V16, P1433, DOI 10.1101/gad.981202; Zardoya R, 1996, TRENDS GENET, V12, P496, DOI 10.1016/S0168-9525(96)20014-9; Zhan X, 2013, NAT GENET; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40; Zhang Y, 2007, PROTEINS, V69, P108, DOI 10.1002/prot.21702; Zhang Y, 2007, PROTEINS, V68, P1020, DOI 10.1002/prot.21643; Zhang Y, 2009, PROTEINS, V77, P100, DOI 10.1002/prot.22588; Zheng XY, 2010, GENE DEV, V24, P57, DOI 10.1101/gad.1870310	112	31	33	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2014	9	12							e74132	10.1371/journal.pone.0074132	http://dx.doi.org/10.1371/journal.pone.0074132			35	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX6YH	25549322	Green Published, gold, Green Submitted			2022-12-27	WOS:000347063500001
J	Shi, YF; Liu, JQ; Han, Z; Zheng, QJ; Zhang, R; Qiu, S				Shi, Yanfeng; Liu, Jiqiang; Han, Zhen; Zheng, Qingji; Zhang, Rui; Qiu, Shuo			Attribute-Based Proxy Re-Encryption with Keyword Search	PLOS ONE			English	Article								Keyword search on encrypted data allows one to issue the search token and conduct search operations on encrypted data while still preserving keyword privacy. In the present paper, we consider the keyword search problem further and introduce a novel notion called attribute-based proxy re-encryption with keyword search (ABRKS), which introduces a promising feature: In addition to supporting keyword search on encrypted data, it enables data owners to delegate the keyword search capability to some other data users complying with the specific access control policy. To be specific, ABRKS allows (i) the data owner to outsource his encrypted data to the cloud and then ask the cloud to conduct keyword search on outsourced encrypted data with the given search token, and (ii) the data owner to delegate other data users keyword search capability in the fine-grained access control manner through allowing the cloud to re-encrypted stored encrypted data with a re-encrypted data (embedding with some form of access control policy). We formalize the syntax and security definitions for ABRKS, and propose two concrete constructions for ABRKS: key-policy ABRKS and ciphertext-policy ABRKS. In the nutshell, our constructions can be treated as the integration of technologies in the fields of attribute-based cryptography and proxy re-encryption cryptography.	[Shi, Yanfeng; Liu, Jiqiang; Han, Zhen; Qiu, Shuo] Beijing Jiaotong Univ, Sch Comp & Informat Technol, Beijing, Peoples R China; [Zhang, Rui] Chinese Acad Sci, Inst Informat Engn, State Key Lab Informat Secur, Beijing, Peoples R China; [Zheng, Qingji] Univ Texas San Antonio, Dept Comp Sci, San Antonio, TX USA	Beijing Jiaotong University; Chinese Academy of Sciences; Institute of Information Engineering, CAS; University of Texas System; University of Texas at San Antonio (UTSA)	Shi, YF (corresponding author), Beijing Jiaotong Univ, Sch Comp & Informat Technol, Beijing, Peoples R China.	schwannfeng@bjtu.edu.cn			111 project; Program for New Century Excellent Talents in University [NCET-11-0565]; Fundamental Research Funds for the Central Universities [2012JBZ010]; PCSIRT [IRT 201206]	111 project(Ministry of Education, China - 111 Project); Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); PCSIRT(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT))	This work is supported by the 111 project, Program for New Century Excellent Talents in University (NCET-11-0565), the Fundamental Research Funds for the Central Universities (2012JBZ010) and PCSIRT (No. IRT 201206). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Attrapadung N, 2011, LECT NOTES COMPUT SC, V6571, P90, DOI 10.1007/978-3-642-19379-8_6; Bethencourt J, 2007, P IEEE S SECUR PRIV, P321, DOI 10.1109/sp.2007.11; Boneh D., 2003, CONT MATH, V324, P71, DOI DOI 10.1090/CONM/324/05731; Chen X, 2011, INT J COMPUTER NETWO, V3, P50; Coron JS, 2013, LECT NOTES COMPUT SC, V8042, P476, DOI 10.1007/978-3-642-40041-4_26; Ding S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097762; Ding S, 2014, KNOWL-BASED SYST, V56, P216, DOI 10.1016/j.knosys.2013.11.014; Fang LM, 2012, THEOR COMPUT SCI, V462, P39, DOI 10.1016/j.tcs.2012.08.017; Garg S, 2013, LECT NOTES COMPUT SC, V7881, P1, DOI 10.1007/978-3-642-38348-9_1; Goyal V., 2006, P 13 ACM C COMP COMM, P89; Guo Shanqing, 2008, Wuhan University Journal of Natural Sciences, V13, P621, DOI 10.1007/s11859-008-0522-5; Huang HQ, 2011, 27TH ANNUAL COMPUTER SECURITY APPLICATIONS CONFERENCE (ACSAC 2011), P31; Ibraimi L, 2009, LECT NOTES COMPUT SC, V5451, P1, DOI 10.1007/978-3-642-00843-6_1; Kaitai Liang, 2013, 2013 5th International Conference on Intelligent Networking and Collaborative Systems, P552, DOI 10.1109/INCoS.2013.103; Li KY, 2014, J INERNET SERVICES I, V4, P70; Liang X, 2009, P 4 INT S INF COMP C, P276, DOI [DOI 10.1145/1533057.1533094, 10.1145/1533057.1533094]; Luo S, 2010, LECT NOTES COMPUT SC, V6476, P401, DOI 10.1007/978-3-642-17650-0_28; Mizuno T, 2010, LECT NOTES COMPUT SC, V6151, P288, DOI 10.1007/978-3-642-16342-5_21; Rao Y. Sreenivasa, 2013, Information and Communications Security. 15th International Conference, ICICS 2013. Proceedings: LNCS 8233, P346, DOI 10.1007/978-3-319-02726-5_25; Sahai A, 2005, LECT NOTES COMPUT SC, V3494, P457, DOI 10.1007/11426639_27; Sahai A, 2012, LECT NOTES COMPUT SC, V7417, P199; Shao J, 2010, INFORM SCIENCES, V180, P2576, DOI 10.1016/j.ins.2010.03.026; Su Zhang, 2011, Database and Expert Systems Applications. Proceedings 22nd International Conference, DEXA 2011, P217, DOI 10.1007/978-3-642-23088-2_15; Sun WH, 2014, IEEE INFOCOM SER, P226, DOI 10.1109/INFOCOM.2014.6847943; Wang XA, 2012, J SYST SOFTWARE, V85, P643, DOI 10.1016/j.jss.2011.09.035; Waters B, 2011, LECT NOTES COMPUT SC, V6571, P53, DOI 10.1007/978-3-642-19379-8_4; WeiDong Zhong, 2011, Proceedings of the 2011 Seventh International Conference on Computational Intelligence and Security (CIS 2011), P969, DOI 10.1109/CIS.2011.217; Yau WC, 2010, COMM COM INF SC, V122, P149; Zhang S, 2014, P 9 ACM S INF COMP C, P317, DOI [10.1145/2590296.2590300, DOI 10.1145/2590296.2590300]; Zheng QJ, 2014, IEEE INFOCOM SER, P522, DOI 10.1109/INFOCOM.2014.6847976	30	20	22	1	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2014	9	12							e116325	10.1371/journal.pone.0116325	http://dx.doi.org/10.1371/journal.pone.0116325			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX6YH	25549257	Green Submitted, gold, Green Published			2022-12-27	WOS:000347063500075
J	Toda, T; Ishida, K; Kiyama, H; Yamashita, T; Lee, S				Toda, Takuya; Ishida, Kazuto; Kiyama, Hiroshi; Yamashita, Toshihide; Lee, Sachiko			Down-Regulation of KCC2 Expression and Phosphorylation in Motoneurons, and Increases the Number of in Primary Afferent Projections to Motoneurons in Mice with Post-Stroke Spasticity	PLOS ONE			English	Article							SPINAL-CORD-INJURY; VESICULAR GLUTAMATE TRANSPORTERS; CHLORIDE COTRANSPORTER KCC2; DORSAL-ROOT GANGLIA; STROKE SURVIVORS; NEUROPATHIC PAIN; RAT; DEPRESSION; INHIBITION; ACTIVATION	Spasticity obstructs motor function recovery post-stroke, and has been reported to occur in spinal cord injury and electrophysiological studies. The purpose of the present study was to assess spinal cord circuit spasticity in post-stroke mice. At 3, 7, 21, and 42 d after photothrombotic ischemic cortical injury in C57BL/6J mice, we observed decreased rate-dependent depression (RDD) of the Hoffmann reflex (H reflex) in the affected forelimb of mice compared with the limbs of sham mice and the non-affected forelimb. This finding suggests a hyper-excitable stretch reflex in the affected forelimb. We then performed immunohistochemical and western blot analyses to examine the expression of the potassium-chloride cotransporter 2 (KCC2) and phosphorylation of the KCC2 serine residue, 940 (S940), since this is the main chloride extruder that affects neuronal excitability. We also performed immunohistochemical analyses on the number of vesicular glutamate transporter 1 (vGluT1)-positive boutons to count the number of la afferent fibers that connect to motoneurons. Western bolts revealed that, compared with sham mice, experimental mice had significantly reduced KCC2 expression at 7 d post-stroke, and dephosphorylated S940 at 3 and 7 d post-stroke in motoneuron plasma membranes. We also observed a lower density of KCC2-positive areas in the plasma membrane of motoneurons at 3 and 7 d post-stroke. However, western blot and immunohistochemical analyses revealed that there were no differences between groups 21 and 42 d post-stroke, respectively. In addition, at 7 and 42 d post-stroke, experimental mice exhibited a significant increase in vGluT1 boutons compared with sham mice. Our findings suggest that both the down-regulation of KCC2 and increases in la afferent fibers are involved in post-stroke spasticity.	[Toda, Takuya; Ishida, Kazuto; Lee, Sachiko] Nagoya Univ, Grad Sch Med, Dept Phys & Occupat Therapy, Nagoya, Aichi 4648601, Japan; [Kiyama, Hiroshi] Nagoya Univ, Grad Sch Med, Dept Funct Anat & Neurosci, Nagoya, Aichi 4648601, Japan; [Yamashita, Toshihide] Osaka Univ, Grad Sch Med, Dept Mol Neurosci, Osaka, Japan	Nagoya University; Nagoya University; Osaka University	Lee, S (corresponding author), Nagoya Univ, Grad Sch Med, Dept Phys & Occupat Therapy, Nagoya, Aichi 4648601, Japan.	lee@met.nagoya-u.ac.jp	Kiyama, Hiroshi/M-8867-2014; Lee, Sachiko/I-6252-2014	Kiyama, Hiroshi/0000-0001-5963-046X; Yamashita, Toshihide/0000-0003-4559-7018	JSPS KAKENHI [23700598]; Hayashi Memorial Foundation for Female Nature Scientists; Grants-in-Aid for Scientific Research [25750201] Funding Source: KAKEN	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Hayashi Memorial Foundation for Female Nature Scientists; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	The work was supported by the following: JSPS KAKENHI (Grant Number: 23700598, http://www.jsps.go.jp/english/index.html), and the Hayashi Memorial Foundation for Female Nature Scientists (http://www.smtb.jp/personal/entrustment/management/public/example/list.html).	Alvarez FJ, 2004, J COMP NEUROL, V472, P257, DOI 10.1002/cne.20012; Alvarez FJ, 2011, J NEUROPHYSIOL, V106, P2450, DOI 10.1152/jn.01095.2010; Bennett DJ, 2004, J NEUROPHYSIOL, V91, P2247, DOI 10.1152/jn.00946.2003; Blaesse P, 2006, J NEUROSCI, V26, P10407, DOI 10.1523/JNEUROSCI.3257-06.2006; Blaesse P, 2009, NEURON, V61, P820, DOI 10.1016/j.neuron.2009.03.003; Bos R, 2013, P NATL ACAD SCI USA, V110, P348, DOI 10.1073/pnas.1213680110; Boulenguez P, 2010, NAT MED, V16, P302, DOI 10.1038/nm.2107; Chamma I, 2012, FRONT CELL NEUROSCI, V6, DOI 10.3389/fncel.2012.00005; Chen CF, 2002, NEURON, V33, P779, DOI 10.1016/S0896-6273(02)00611-6; Coull JAM, 2003, NATURE, V424, P938, DOI 10.1038/nature01868; Crone C, 2003, BRAIN, V126, P495, DOI 10.1093/brain/awg036; Delpire E, 2010, J PHYSIOL-LONDON, V588, P3365, DOI 10.1113/jphysiol.2010.190769; DELWAIDE PJ, 1988, J NEUROL NEUROSUR PS, V51, P1546, DOI 10.1136/jnnp.51.12.1546; Du Beau A, 2012, NEUROSCIENCE, V227, P67, DOI 10.1016/j.neuroscience.2012.09.037; FAIST M, 1994, BRAIN, V117, P1449, DOI 10.1093/brain/117.6.1449; Foster KA, 2004, NEURON, V43, P119, DOI 10.1016/j.neuron.2004.06.022; Fuchs A, 2010, J NEUROPATH EXP NEUR, V69, P1057, DOI 10.1097/NEN.0b013e3181f4dcef; Fulton J. F., 1934, RES PUBL ASS NERV ME, V13, P158; Higashi T, 2001, ARCH PHYS MED REHAB, V82, P1604, DOI 10.1053/apmr.2001.25081; Hosoido T, 2011, NEUROSCI LETT, V505, P263, DOI 10.1016/j.neulet.2011.10.035; Hubner CA, 2001, NEURON, V30, P515, DOI 10.1016/S0896-6273(01)00297-5; Jaenisch N, 2010, STROKE, V41, pE151, DOI 10.1161/STROKEAHA.109.570424; Kahle KT, 2013, TRENDS NEUROSCI, V36, P726, DOI 10.1016/j.tins.2013.08.006; Khirug S, 2010, J NEUROSCI, V30, P12028, DOI 10.1523/JNEUROSCI.3154-10.2010; Lamy JC, 2009, BRAIN, V132, P734, DOI 10.1093/brain/awn310; Lee H, 2011, NAT NEUROSCI; Lee HHC, 2007, J BIOL CHEM, V282, P29777, DOI 10.1074/jbc.M705053200; Lee S, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2013.544; Li H, 2007, NEURON, V56, P1019, DOI 10.1016/j.neuron.2007.10.039; Li YR, 2004, J NEUROPHYSIOL, V91, P767, DOI 10.1152/jn.00788.2003; Malet M, 2013, NEUROSCIENCE, V248, P95, DOI 10.1016/j.neuroscience.2013.05.044; Mazzocchio R, 1997, BRAIN, V120, P991, DOI 10.1093/brain/120.6.991; McPherson JG, 2008, J NEUROPHYSIOL, V100, P3236, DOI 10.1152/jn.90563.2008; Mottram CJ, 2010, J NEUROPHYSIOL, V104, P3168, DOI 10.1152/jn.00463.2010; Mottram CJ, 2009, J NEUROPHYSIOL, V102, P2026, DOI 10.1152/jn.00151.2009; Murray KC, 2010, NAT MED, V16, P694, DOI 10.1038/nm.2160; Navarro X, 2009, INT REV NEUROBIOL, V87, P105, DOI 10.1016/S0074-7742(09)87006-2; Nielsen JB, 2007, ACTA PHYSIOL, V189, P171, DOI 10.1111/j.1748-1716.2006.01652.x; Oliveira ALR, 2003, SYNAPSE, V50, P117, DOI 10.1002/syn.10249; Pizzi A, 2005, ARCH PHYS MED REHAB, V86, P410, DOI 10.1016/j.apmr.2004.10.022; Puskarjov M, 2012, J NEUROSCI, V32, P11356, DOI 10.1523/JNEUROSCI.6265-11.2012; Sakaba T, 2001, J NEUROSCI, V21, P462, DOI 10.1523/JNEUROSCI.21-02-00462.2001; Sheean G, 2002, EUR J NEUROL, V9, P3, DOI 10.1046/j.1468-1331.2002.0090s1003.x; Szabadics J, 2006, SCIENCE, V311, P233, DOI 10.1126/science.1121325; Tan AM, 2012, J NEUROSCI, V32, P12896, DOI 10.1523/JNEUROSCI.6451-11.2012; Tennant KA, 2011, CEREB CORTEX, V21, P865, DOI 10.1093/cercor/bhq159; Todd AJ, 2003, EUR J NEUROSCI, V17, P13, DOI 10.1046/j.1460-9568.2003.02406.x; Urban PP, 2010, STROKE, V41, P2016, DOI 10.1161/STROKEAHA.110.581991; Wissel J, 2010, J NEUROL, V257, P1067, DOI 10.1007/s00415-010-5463-1; Wong AYC, 2003, J NEUROSCI, V23, P4868; Wu LG, 1999, NEURON, V23, P821, DOI 10.1016/S0896-6273(01)80039-8; Wu SX, 2004, BRAIN RES, V1011, P247, DOI 10.1016/brainres.2004.03.047; Xu JH, 2007, CURR OPIN NEUROBIOL, V17, P352, DOI 10.1016/j.conb.2007.04.005; Zhang LL, 2006, J COMP NEUROL, V499, P132, DOI 10.1002/cne.21100; Zhou HY, 2012, J BIOL CHEM, V287, P33853, DOI 10.1074/jbc.M112.395830	55	26	29	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2014	9	12							e114328	10.1371/journal.pone.0114328	http://dx.doi.org/10.1371/journal.pone.0114328			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UN	25546454	gold, Green Submitted, Green Published			2022-12-27	WOS:000347120200009
J	Adam, CL; Williams, PA; Garden, KE; Thomson, LM; Ross, AW				Adam, Clare L.; Williams, Patricia A.; Garden, Karen E.; Thomson, Lynn M.; Ross, Alexander W.			Dose-Dependent Effects of a Soluble Dietary Fibre (Pectin) on Food Intake, Adiposity, Gut Hypertrophy and Gut Satiety Hormone Secretion in Rats	PLOS ONE			English	Article							CHAIN FATTY-ACIDS; GLUCAGON-LIKE PEPTIDE-1; INTESTINAL EPITHELIAL PROLIFERATION; BODY-WEIGHT GAIN; APPETITE REGULATION; CELL PROLIFERATION; INDUCED OBESITY; ENERGY-INTAKE; HEALTH; GLP-2	Soluble fermentable dietary fibre elicits gut adaptations, increases satiety and potentially offers a natural sustainable means of body weight regulation. Here we aimed to quantify physiological responses to graded intakes of a specific dietary fibre (pectin) in an animal model. Four isocaloric semi-purified diets containing 0, 3.3%, 6.7% or 10% w/w apple pectin were offered ad libitum for 8 or 28 days to young adult male rats (n = 8/group). Measurements were made of voluntary food intake, body weight, initial and final body composition by magnetic resonance imaging, final gut regional weights and histology, and final plasma satiety hormone concentrations. In both 8- and 28-day cohorts, dietary pectin inclusion rate was negatively correlated with food intake, body weight gain and the change in body fat mass, with no effect on lean mass gain. In both cohorts, pectin had no effect on stomach weight but pectin inclusion rate was positively correlated with weights and lengths of small intestine and caecum, jejunum villus height and crypt depth, ileum crypt depth, and plasma total glucagon- like peptide-1 (GLP-1) and peptide tyrosine tyrosine (PYY) concentrations, and at 8 days was correlated with weight and length of colon and with caecal mucosal depth. Therefore, the gut's morphological and endocrine adaptations were dose-dependent, occurred within 8 days and were largely sustained for 28 days during continued dietary intervention. Increasing amounts of the soluble fermentable fibre pectin in the diet proportionately decreased food intake, body weight gain and body fat content, associated with proportionately increased satiety hormones GLP-1 and PYY and intestinal hypertrophy, supporting a role for soluble dietary fibre-induced satiety in healthy body weight regulation.	[Adam, Clare L.; Williams, Patricia A.; Garden, Karen E.; Thomson, Lynn M.; Ross, Alexander W.] Univ Aberdeen, Rowett Inst Nutr & Hlth, Obes & Metab Hlth Div, Ingest Behav Grp, Aberdeen AB21 9SB, Scotland	University of Aberdeen	Adam, CL (corresponding author), Univ Aberdeen, Rowett Inst Nutr & Hlth, Obes & Metab Hlth Div, Ingest Behav Grp, Aberdeen AB21 9SB, Scotland.	c.adam@abdn.ac.uk		Ross, Alexander/0000-0002-1799-1432	Scottish Government's Rural and Environment Science and Analytical Services Division	Scottish Government's Rural and Environment Science and Analytical Services Division	This work was funded by the Scottish Government's Rural and Environment Science and Analytical Services Division. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam CL, 2014, NUTR METAB, V11, DOI 10.1186/1743-7075-11-36; ALLEN JM, 1984, DIGESTION, V30, P255, DOI 10.1159/000199117; Borg CM, 2007, OBES SURG, V17, P1193, DOI 10.1007/s11695-007-9211-2; BROWN RC, 1979, BRIT J NUTR, V42, P357, DOI 10.1079/BJN19790125; Cani PD, 2004, BRIT J NUTR, V92, P521, DOI 10.1079/BJN20041225; Chelikani PK, 2006, PEPTIDES, V27, P3193, DOI 10.1016/j.peptides.2006.08.001; CHUN W, 1989, DIGESTION, V42, P22, DOI 10.1159/000199821; Clark MJ, 2013, J AM COLL NUTR, V32, P200, DOI 10.1080/07315724.2013.791194; Drucker DJ, 1996, P NATL ACAD SCI USA, V93, P7911, DOI 10.1073/pnas.93.15.7911; Gallwitz Baptist, 2012, Handb Exp Pharmacol, P185, DOI 10.1007/978-3-642-24716-3_8; Ghatei MA, 2001, DIGEST DIS SCI, V46, P1255, DOI 10.1023/A:1010615429639; GOODLAD RA, 1989, GUT, V30, P820, DOI 10.1136/gut.30.6.820; Hansen CF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065696; Hansen CF, 2013, AM J TRANSL RES, V5, P347; Holst JJ, 2007, PHYSIOL REV, V87, P1409, DOI 10.1152/physrev.00034.2006; Huang XF, 2011, MOL NUTR FOOD RES, V55, P1118, DOI 10.1002/mnfr.201100095; Ichikawa H, 1997, DIGEST DIS SCI, V42, P1598, DOI 10.1023/A:1018884625737; Institute of Medicine of the National Academies of Science IOM, 2005, DIET REF INT EN CARB; Kaji I, 2011, J MOL HISTOL, V42, P27, DOI 10.1007/s10735-010-9304-4; Knapp BK, 2013, NUTRIENTS, V5, P396, DOI 10.3390/nu5020396; KRIPKE SA, 1989, JPEN-PARENTER ENTER, V13, P109, DOI 10.1177/0148607189013002109; le Roux CW, 2010, ANN SURG, V252, P50, DOI 10.1097/SLA.0b013e3181d3d21f; Licht TR, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-13; Lin N, 2013, MOL NUTR FOOD RES, V57, P1291, DOI 10.1002/mnfr.201200695; Maljaars PWJ, 2008, PHYSIOL BEHAV, V95, P271, DOI 10.1016/j.physbeh.2008.07.018; McCullough JS, 1998, GUT, V42, P799, DOI 10.1136/gut.42.6.799; Mudgil D, 2013, INT J BIOL MACROMOL, V61, P1, DOI 10.1016/j.ijbiomac.2013.06.044; Nadkarni PP, 2011, DIABETES OBES METAB, V13, P408, DOI 10.1111/j.1463-1326.2011.01363.x; ORSKOV C, 1986, ENDOCRINOLOGY, V119, P1467, DOI 10.1210/endo-119-4-1467; Parnell JA, 2012, BRIT J NUTR, V107, P601, DOI 10.1017/S0007114511003163; Pedersen C, 2013, APPETITE, V66, P44, DOI 10.1016/j.appet.2013.02.017; SAKATA T, 1983, COMP BIOCHEM PHYS A, V74, P459, DOI 10.1016/0300-9629(83)90631-X; Sengupta P, 2013, INT J PREVENTIVE MED, V4, P624; Sleeth ML, 2010, NUTR RES REV, V23, P135, DOI 10.1017/S0954422410000089; Tazoe H, 2008, J PHYSIOL PHARMACOL, V59, P251; Thulesen J, 2004, CURR PROTEIN PEPT SC, V5, P51, DOI 10.2174/1389203043486946; Tolhurst G, 2012, DIABETES, V61, P364, DOI 10.2337/db11-1019; Turner ND, 2011, ADV NUTR, V2, P151, DOI 10.3945/an.110.000281; Verdich C, 2001, J CLIN ENDOCR METAB, V86, P4382, DOI 10.1210/jc.86.9.4382; Wanders AJ, 2014, INT J OBESITY, V38, P794, DOI 10.1038/ijo.2013.176; Wikiera A, 2014, POSTEP HIG MED DOSW, V68, P590, DOI 10.5604/17322693.1102342; Willis HJ, 2010, FOOD NUTR RES, V54, DOI 10.3402/fnr.v54i0.5135	42	42	46	1	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2015	10	1							e0115438	10.1371/journal.pone.0115438	http://dx.doi.org/10.1371/journal.pone.0115438			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ4OZ	25602757	Green Published, gold, Green Submitted			2022-12-27	WOS:000348203500013
J	Ostendorf, F; Dolan, RJ				Ostendorf, Florian; Dolan, Raymond J.			Integration of Retinal and Extraretinal Information across Eye Movements	PLOS ONE			English	Article							POSITION-INFORMATION; PERISACCADIC MISLOCALIZATION; PSYCHOPHYSICS TOOLBOX; VISUAL TARGETS; SACCADE TARGET; PERCEPTION; LOCALIZATION; WORLD; DISPLACEMENT; COMPRESSION	Visual perception is burdened with a highly discontinuous input stream arising from saccadic eye movements. For successful integration into a coherent representation, the visuomotor system needs to deal with these self-induced perceptual changes and distinguish them from external motion. Forward models are one way to solve this problem where the brain uses internal monitoring signals associated with oculomotor commands to predict the visual consequences of corresponding eye movements during active exploration. Visual scenes typically contain a rich structure of spatial relational information, providing additional cues that may help disambiguate self-induced from external changes of perceptual input. We reasoned that a weighted integration of these two inherently noisy sources of information should lead to better perceptual estimates. Volunteer subjects performed a simple perceptual decision on the apparent displacement of a visual target, jumping unpredictably in sync with a saccadic eye movement. In a critical test condition, the target was presented together with a flanker object, where perceptual decisions could take into account the spatial distance between target and flanker object. Here, precision was better compared to control conditions in which target displacements could only be estimated from either extraretinal or visual relational information alone. Our findings suggest that under natural conditions, integration of visual space across eye movements is based upon close to optimal integration of both retinal and extraretinal pieces of information.	[Ostendorf, Florian; Dolan, Raymond J.] Humboldt Univ, Berlin Sch Mind & Brain, D-10099 Berlin, Germany; [Ostendorf, Florian] Charite, Dept Neurol, D-13353 Berlin, Germany; [Dolan, Raymond J.] UCL, Wellcome Trust Ctr Neuroimaging, London, England; [Dolan, Raymond J.] Max Planck UCL Ctr Computat Psychiat & Ageing Res, London, England	Humboldt University of Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of London; University College London	Ostendorf, F (corresponding author), Humboldt Univ, Berlin Sch Mind & Brain, D-10099 Berlin, Germany.	florian.ostendorf@charite.de	Ostendorf, Florian/E-8342-2013; Ostendorf, Florian/AAE-1348-2019	Ostendorf, Florian/0000-0002-4544-7610; Ostendorf, Florian/0000-0002-4544-7610; Dolan, Ray/0000-0001-9356-761X	Einstein Foundation (Berlin); Wellcome Trust [098362/Z/12/Z]	Einstein Foundation (Berlin); Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by the Einstein Foundation (Berlin) with a Visiting Fellowship grant to R. J. Dolan. R. J. Dolan is supported by the Wellcome Trust (Senior Investigator Award 098362/Z/12/Z). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alais D, 2004, CURR BIOL, V14, P257, DOI 10.1016/j.cub.2004.01.029; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; BRIDGEMAN B, 1981, ACTA PSYCHOL, V48, P111, DOI 10.1016/0001-6918(81)90053-6; BRIDGEMAN B, 1975, VISION RES, V15, P719, DOI 10.1016/0042-6989(75)90290-4; Burr DC, 2001, CURR BIOL, V11, P798, DOI 10.1016/S0960-9822(01)00183-X; Clark JJ, 1990, DATA FUSION FOR SENS; Collins T, 2010, J VISION, V10, DOI 10.1167/10.14.7; Collins T, 2009, J VISION, V9, DOI 10.1167/9.5.29; Cornelissen FW, 2002, BEHAV RES METH INS C, V34, P613, DOI 10.3758/BF03195489; Cousineau D, 2005, TUTOR QUANT METHODS, V1, P42, DOI 10.20982/tqmp.01.1.p042; Crawford JD, 2011, ANNU REV NEUROSCI, V34, P309, DOI 10.1146/annurev-neuro-061010-113749; Currie CB, 2000, PERCEPT PSYCHOPHYS, V62, P673, DOI 10.3758/BF03206914; Deubel H, 1996, VISION RES, V36, P985, DOI 10.1016/0042-6989(95)00203-0; Deubel H, 2004, VIS COGN, V11, P173, DOI 10.1080/13506280344000284; Ernst MO, 2002, NATURE, V415, P429, DOI 10.1038/415429a; Fetsch CR, 2009, J NEUROSCI, V29, P15601, DOI 10.1523/JNEUROSCI.2574-09.2009; GAUTHIER GM, 1990, SCIENCE, V249, P58, DOI 10.1126/science.2367852; Germeys F, 2002, J EXP PSYCHOL HUMAN, V28, P868, DOI 10.1037//0096-1523.28.4.868; Gibson J.J., 1966, SENSES CONSIDERED PE; GUTHRIE BL, 1983, SCIENCE, V221, P1193, DOI 10.1126/science.6612334; HALLETT PE, 1976, VISION RES, V16, P99, DOI 10.1016/0042-6989(76)90083-3; Hamker FH, 2011, PHILOS T R SOC B, V366, P554, DOI 10.1098/rstb.2010.0229; Joiner WM, 2013, J NEUROPHYSIOL, V110, P2402, DOI 10.1152/jn.00362.2013; Lappe M, 2000, NATURE, V403, P892, DOI 10.1038/35002588; LENNIE P, 1978, NATURE, V275, P766, DOI 10.1038/275766a0; Ma WJ, 2006, NAT NEUROSCI, V9, P1432, DOI 10.1038/nn1790; MACK A, 1970, PERCEPT PSYCHOPHYS, V8, P291, DOI 10.3758/BF03212596; Morel P, 2011, J NEUROSCI, V31, P10039, DOI 10.1523/JNEUROSCI.0492-11.2011; Morrone MC, 1997, J NEUROSCI, V17, P7941; Niemeier M, 2003, NATURE, V422, P76, DOI 10.1038/nature01439; Ostendorf F, 2006, NEUROSCIENCE, V137, P737, DOI 10.1016/j.neuroscience.2005.09.032; Ostendorf F, 2007, J NEUROSCI, V27, P7559, DOI 10.1523/JNEUROSCI.2074-07.2007; Ostendorf F, 2013, FRONT SYST NEUROSCI, V7, DOI 10.3389/fnsys.2013.00010; Ostendorf F, 2010, P NATL ACAD SCI USA, V107, P1229, DOI 10.1073/pnas.0910742107; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Poletti M, 2013, J NEUROSCI, V33, P14259, DOI 10.1523/JNEUROSCI.0523-13.2013; ROCK I, 1964, SCIENCE, V143, P594, DOI 10.1126/science.143.3606.594; Rolfs M, 2011, NAT NEUROSCI, V14, P252, DOI 10.1038/nn.2711; Sherrington CS, 1918, BRAIN, V41, P332, DOI 10.1093/brain/41.3-4.332; Sommer MA, 2002, SCIENCE, V296, P1480, DOI 10.1126/science.1069590; SPERRY RW, 1950, J COMP PHYSIOL PSYCH, V43, P482, DOI 10.1037/h0055479; van Beers RJ, 1999, J NEUROPHYSIOL, V81, P1355, DOI 10.1152/jn.1999.81.3.1355; van Beers RJ, 2007, J NEUROSCI, V27, P8757, DOI 10.1523/JNEUROSCI.2311-07.2007; Van Grootel TJ, 2009, EUR J NEUROSCI, V29, P2233, DOI 10.1111/j.1460-9568.2009.06761.x; van Wetter SMCI, 2008, J NEUROPHYSIOL, V100, P1848, DOI 10.1152/jn.90276.2008; Vaziri S, 2006, J NEUROSCI, V26, P4188, DOI 10.1523/JNEUROSCI.4747-05.2006; von Helmholtz H., 1866, HDB PHYSL OPTIK; Wichmann FA, 2001, PERCEPT PSYCHOPHYS, V63, P1293, DOI 10.3758/BF03194544; Zimmermann E, 2013, J NEUROSCI, V33, P18396, DOI 10.1523/JNEUROSCI.1864-13.2013	49	6	6	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2015	10	1							e0116810	10.1371/journal.pone.0116810	http://dx.doi.org/10.1371/journal.pone.0116810			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AZ4OZ	25602956	gold, Green Published, Green Submitted			2022-12-27	WOS:000348203500032
J	Sookhak, M; Akhundzada, A; Sookhak, A; Eslaminejad, M; Gani, A; Khan, MK; Li, X; Wang, XM				Sookhak, Mehdi; Akhundzada, Adnan; Sookhak, Alireza; Eslaminejad, Mohammadreza; Gani, Abdullah; Khan, Muhammad Khurram; Li, Xiong; Wang, Xiaomin			Geographic Wormhole Detection in Wireless Sensor Networks	PLOS ONE			English	Article							AD HOC NETWORKS; ATTACKS; SECURITY; THREATS	Wireless sensor networks (WSNs) are ubiquitous and pervasive, and therefore; highly susceptible to a number of security attacks. Denial of Service (DoS) attack is considered the most dominant and a major threat to WSNs. Moreover, the wormhole attack represents one of the potential forms of the Denial of Service (DoS) attack. Besides, crafting the wormhole attack is comparatively simple; though, its detection is nontrivial. On the contrary, the extant wormhole defense methods need both specialized hardware and strong assumptions to defend against static and dynamic wormhole attack. The ensuing paper introduces a novel scheme to detect wormhole attacks in a geographic routing protocol (DWGRP). The main contribution of this paper is to detect malicious nodes and select the best and the most reliable neighbors based on pairwise key pre-distribution technique and the beacon packet. Moreover, this novel technique is not subject to any specific assumption, requirement, or specialized hardware, such as a precise synchronized clock. The proposed detection method is validated by comparisons with several related techniques in the literature, such as Received Signal Strength (RSS), Authentication of Nodes Scheme (ANS), Wormhole Detection uses Hound Packet (WHOP), and Wormhole Detection with Neighborhood Information (WDI) using the NS-2 simulator. The analysis of the simulations shows promising results with low False Detection Rate (FDR) in the geographic routing protocols.	[Sookhak, Mehdi; Akhundzada, Adnan; Gani, Abdullah] Univ Malaya, Ctr Mobile Cloud Comp C4MCC, Kuala Lumpur, Malaysia; [Sookhak, Alireza] Fars Reg Elect Co, Fiber Opt Commun Networks Project Manager, Shiraz, Iran; [Eslaminejad, Mohammadreza] Univ Teknol Malaysia, Fac Comp & Informat Syst, Johor Baharu, Malaysia; [Khan, Muhammad Khurram] King Saud Univ, CoEIA, Riyadh, Saudi Arabia; [Li, Xiong] Hunan Univ Sci & Technol, Sch Comp Sci & Engn, Xiangtan 411201, Hunan, Peoples R China; [Wang, Xiaomin] Southwest Jiaotong Univ, Sch Informat Sci & Technol, Chengdu, Peoples R China	Universiti Malaya; Universiti Teknologi Malaysia; King Saud University; Hunan University of Science & Technology; Southwest Jiaotong University	Sookhak, M (corresponding author), Univ Malaya, Ctr Mobile Cloud Comp C4MCC, Kuala Lumpur, Malaysia.	m.sookhak@ieee.org	KHAN, MUHAMMAD KHURRAM/E-4836-2014; Gani, Abdullah/C-2888-2009; Sookhak, Mehdi/D-4684-2016; Akhunzada, Adnan/N-7917-2017; Li, Xiong/K-7233-2012	KHAN, MUHAMMAD KHURRAM/0000-0001-6636-0533; Gani, Abdullah/0000-0002-4388-020X; Sookhak, Mehdi/0000-0001-5822-3432; Akhunzada, Adnan/0000-0001-8370-9290; Li, Xiong/0000-0001-6619-554X	Malaysian Ministry of Higher Education under the University of Malaya High Impact Research [UM.C/HIR/MOHE/FCSIT/03]; National Natural Science Foundation of China NSFC [61300220, 61371098]	Malaysian Ministry of Higher Education under the University of Malaya High Impact Research; National Natural Science Foundation of China NSFC(National Natural Science Foundation of China (NSFC))	This work is carried out as a part of the Mobile Cloud Computing research project funded by the Malaysian Ministry of Higher Education under the University of Malaya High Impact Research Grant with reference UM.C/HIR/MOHE/FCSIT/03. This work also is partly supported by the National Natural Science Foundation of China under Grant no. 61300220 and NSFC project 61371098. Fars Regional Electric Co. provided support in the form of a salary for author AS, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the author contributions' section.	AKHUNZADA A, 2014, JOURNAL OF NETWORK A; Akkaya K., 2005, Ad Hoc Networks, V3, P325, DOI 10.1016/j.adhoc.2003.09.010; Al-Karaki JN, 2004, IEEE WIREL COMMUN, V11, P6, DOI 10.1109/MWC.2004.1368893; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Barrat A, 2008, DYNAMICAL PROCESSES, V1; CAPKUN S, 2003, SECTOR SECURE TRACKI; CAYIRCI E, 2008, SECURITY WIRELESS HO; Du W., 2005, ACM Transactions on Information and Systems Security, V8, P228, DOI 10.1145/1065545.1065548; Eslaminejad M. R., 2011, INT J COMPUTER SCI T, V2, P1; Eslaminejad M, 2013, AD HOC SENS WIREL NE, V17, P103; Eslaminejad M, 2012, SENSORS-BASEL, V12, P13508, DOI 10.3390/s121013508; Giruka VC, 2008, WIREL COMMUN MOB COM, V8, P1, DOI 10.1002/wcm.422; Gomez S, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.028701; Gupta S., 2011, 2011 International Conference on Innovations in Information Technology (IIT), P226, DOI 10.1109/INNOVATIONS.2011.5893822; HU L, 2004, 11 ANN NETW DISTR SY, P11; Hu YC, 2006, IEEE J SEL AREA COMM, V24, P370, DOI 10.1109/JSAC.2005.861394; Jen SM, 2009, SENSORS-BASEL, V9, P5022, DOI 10.3390/s90605022; Karlof C, 2003, PROCEEDINGS OF THE FIRST IEEE INTERNATIONAL WORKSHOP ON SENSOR NETWORK PROTOCOLS AND APPLICATIONS, P113, DOI 10.1109/SNPA.2003.1203362; Karlsson J, 2011, SENSORS-BASEL, V11, P11122, DOI 10.3390/s111211122; Khalil I, 2007, COMPUT NETW, V51, P3750, DOI 10.1016/j.comnet.2007.04.001; Khan MK, 2008, NEUROCOMPUTING, V71, P3026, DOI 10.1016/j.neucom.2007.12.017; Kim DU, 2013, INT J DISTRIB SENS N, DOI 10.1155/2013/184931; Kim J, 2008, PHYSICA A, V387, P2637, DOI 10.1016/j.physa.2008.01.015; Lazos L, 2005, IEEE WCNC, P1193; Li G, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.018701; Li SD, 2011, PHYSICA A, V390, P1182, DOI 10.1016/j.physa.2010.11.034; Loo CE, 2006, INT J DISTRIB SENS N, V2, P313, DOI 10.1080/15501320600692044; Lu XP, 2012, INT J DISTRIB SENS N, DOI 10.1155/2012/145702; Maheshwari R, 2007, IEEE INFOCOM SER, P107, DOI 10.1109/INFCOM.2007.21; Newman M., 2010, NETWORKS INTRO, DOI [10.1162/artl_r_00062, 10.1093/acprof:oso/9780199206650.001.0001, DOI 10.1093/ACPROF:OSO/9780199206650.001.0001]; Parshani R, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.048701; POORNIMA E, 2010, INT J COMPUTER NETWO, P42; Poovendran R, 2007, WIREL NETW, V13, P27, DOI 10.1007/s11276-006-3723-x; Qazi S, 2013, J NETW COMPUT APPL, V36, P582, DOI 10.1016/j.jnca.2012.12.019; Qian LJ, 2007, J NETW COMPUT APPL, V30, P308, DOI 10.1016/j.jnca.2005.07.003; Sanz J, 2014, PHYS REV X, V4, DOI 10.1103/PhysRevX.4.041005; Sohraby K., 2007, WIRELESS SENSOR NETW; SOOKHAK M, 2011, INT J COMPUTER SCI I, V8, P382; SOOKHAK M, 2011, INT J COMPUTER SCI T, V2, P28; SOOKHAK M, 2012, INT C ED E LEARN INN, P1; Sookhak M, 2014, J NETW COMPUT APPL, V43, P121, DOI 10.1016/j.jnca.2014.04.011; Su Z, 2014, SCI REP-UK, V4, DOI 10.1038/srep05413; SUN CH, 2006, 1 INT S WIR PERV COM; von Mulert J, 2012, J NETW COMPUT APPL, V35, P1249, DOI 10.1016/j.jnca.2012.01.019; Wang WC, 2006, WIREL COMMUN MOB COM, V6, P483, DOI 10.1002/wcm.292; Wang X, 2007, P INT COMP SOFTW APP, P39, DOI 10.1061/40952(317)39; Wang XM, 2013, TELECOMMUN SYST, V52, P515, DOI 10.1007/s11235-011-9457-9; Whaiduzzaman M, 2014, J NETW COMPUT APPL, V40, P325, DOI 10.1016/j.jnca.2013.08.004; Xia CY, 2013, PHYSICA A, V392, P1577, DOI 10.1016/j.physa.2012.11.043; Xie M, 2011, J NETW COMPUT APPL, V34, P1302, DOI 10.1016/j.jnca.2011.03.004; Xu YR, 2008, INT FED INFO PROC, V253, P267; YIFENG Z, 2009, IEEE C MIL COMM BOST, P1; YUN W, 2010, 5 INT C NETW ARCH ST, P63; Zhang L, 2013, TELECOMMUN SYST, V52, P2163, DOI 10.1007/s11235-011-9539-8; Zhao DW, 2014, PHYS LETT A, V378, P770, DOI 10.1016/j.physleta.2014.01.014; Zhu S., 2006, ACM T SENSOR NETWORK, V2, P500, DOI [DOI 10.1145/1218556.1218559, 10.1145/1218556.1218559]; Znaidi W, 2012, TELECOMMUN SYST, V50, P113, DOI 10.1007/s11235-010-9391-2	57	20	20	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2015	10	1							e0115324	10.1371/journal.pone.0115324	http://dx.doi.org/10.1371/journal.pone.0115324			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ4OZ	25602616	Green Published, Green Submitted, gold			2022-12-27	WOS:000348203500012
J	Gu, Z; Hong, SL; Ke, X; Shen, Y; Wang, XQ; Hu, D; Hu, GH; Kang, HY				Gu, Zheng; Hong, Su-Ling; Ke, Xia; Shen, Yang; Wang, Xiao-Qiang; Hu, Di; Hu, Guo-Hua; Kang, Hou-Yong			FCRL3 Gene Polymorphisms Confer Autoimmunity Risk for Allergic Rhinitis in a Chinese Han Population	PLOS ONE			English	Article							FC RECEPTOR HOMOLOGS; BEHCETS-DISEASE; FCRL3-169T-GREATER-THAN-C POLYMORPHISM; RHEUMATOID-ARTHRITIS; ASSOCIATION; ASTHMA; IMPACT; SUSCEPTIBILITY; IDENTIFICATION; PATHOGENESIS	Background Heredity and environmental exposures may contribute to a predisposition to allergic rhinitis (AR). Autoimmunity may also involve into this pathologic process. FCRL3 (Fc receptor-like 3 gene), a novel immunoregulatory gene, has recently been reported to play a role in autoimmune diseases. Objective This study was performed to evaluate the potential association of FCRL3 polymorphisms with AR in a Chinese Han population. Methods Five single-nucleotide polymorphisms of FCRL3, rs945635, rs3761959, rs7522061, rs10489678 and rs7528684 were genotyped in 540 AR patients and 600 healthy controls using a PCR-restriction fragment length polymorphism assay. Allele, genotype and haplotype frequencies were compared between patients and controls using the X-2 test. The online software platform SHEsis was used to analyze their haplotypes. Results This study identified three strong risk SNPs rs7528684, rs10489678, rs7522061 and one weak risk SNP rs945635 of FCRL3 in Chinese Han AR patients. For rs7528684, a significantly increased prevalence of the AA genotype and A allele in AR patients was recorded. The frequency of the GG genotype and G allele of rs10489678 was markedly higher in AR patients than those in controls. For rs7522061, a higher frequency of the TT genotype, and a lower frequency of the CT genotype were found in AR patients. Concerning rs945635, a lower frequency of the CC genotype, and a higher frequency of G allele were observed in AR patients. According to the analysis of the three strong positive SNPs, the haplotype of AGT increased significantly in AR cases (AR = 38.8%, Controls = 24.3%, P = 8.29x10-14, OR [95% CI] 1.978 [1.652 similar to 2.368]). Conclusions This study found a significant association between the SNPs in FCRL3 gene and AR in Chinese Han patients. The results suggest these gene polymorphisms might be the autoimmunity risk for AR.	[Gu, Zheng; Hong, Su-Ling; Ke, Xia; Shen, Yang; Wang, Xiao-Qiang; Hu, Di; Hu, Guo-Hua; Kang, Hou-Yong] Chongqing Med Univ, Affiliated Hosp 1, Dept Otorhinolaryngol, Chongqing, Peoples R China	Chongqing Medical University	Kang, HY (corresponding author), Chongqing Med Univ, Affiliated Hosp 1, Dept Otorhinolaryngol, Chongqing, Peoples R China.	khydoctor@gmail.com			National Natural Science Foundation [81271061]; National key clinic center construction Project, China [[2012]649]	National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); National key clinic center construction Project, China	This work was supported by National Natural Science Foundation Grant (No. 81271061) and National key clinic center construction Project ([2012]649), China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bousquet J, 2008, ALLERGY, V63, P8, DOI 10.1111/j.1398-9995.2007.01620.x; Bousquet J, 2012, J ALLERGY CLIN IMMUN, V130, P1049, DOI 10.1016/j.jaci.2012.07.053; Bousquet J, 2001, J ALLERGY CLIN IMMUN, V108, pS147, DOI 10.1067/mai.2001.118891; Chistiakov DA, 2007, HUM IMMUNOL, V68, P375, DOI 10.1016/j.humimm.2007.01.013; Davila I, 2009, J INVEST ALLERG CLIN, V19, P25; Davis RS, 2007, ANNU REV IMMUNOL, V25, P525, DOI 10.1146/annurev.immunol.25.022106.141541; Davis RS, 2001, P NATL ACAD SCI USA, V98, P9772, DOI 10.1073/pnas.171308498; Davis RS, 2002, IMMUNOL REV, V190, P123, DOI 10.1034/j.1600-065X.2002.19009.x; Eyre S, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar2006; Gaddam SL, 2012, GENET TEST MOL BIOMA, V16, P632, DOI 10.1089/gtmb.2011.0255; Hi G, 2012, AM J RHINOL ALLERGY; Holgate ST, 1999, NATURE, V402, pB2, DOI 10.1038/35037000; Hou SP, 2008, CLIN IMMUNOL, V129, P170, DOI 10.1016/j.clim.2008.06.006; Hou SP, 2012, ARTHRITIS RHEUM-US, V64, P4104, DOI 10.1002/art.37708; Hou SP, 2012, HUM GENET, V131, P1841, DOI 10.1007/s00439-012-1200-4; Hou SP, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3789; Hou SP, 2010, HUM IMMUNOL, V71, P79, DOI 10.1016/j.humimm.2009.09.354; Hu D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063858; Kochi Y, 2005, NAT GENET, V37, P478, DOI 10.1038/ng1540; Leynaert Benedicte, 2000, Journal of Allergy and Clinical Immunology, V106, pS201; Li K, 2008, MOL VIS, V14, P2136; Martinez A, 2007, J NEUROIMMUNOL, V189, P132, DOI 10.1016/j.jneuroim.2007.06.018; Matesanz F, 2008, J NEUROIMMUNOL, V195, P146, DOI 10.1016/j.jneuroim.2008.01.004; Piotrowski P, 2014, MOD RHEUMATOL, V24, P296, DOI 10.3109/14397595.2013.854066; Shen J, 2011, J HUAZHONG U SCI-MED, V31, P433, DOI 10.1007/s11596-011-0469-1; Shen Y, 2014, HUM IMMUNOL, V75, P991, DOI 10.1016/j.humimm.2014.07.004; Simmonds MJ, 2010, CLIN ENDOCRINOL, V73, P654, DOI 10.1111/j.1365-2265.2010.03843.x; Simmonds MJ, 2006, J CLIN ENDOCR METAB, V91, P1056, DOI 10.1210/jc.2005-1634; Szczepanska M, 2013, ARCH GYNECOL OBSTET, V288, P799, DOI 10.1007/s00404-013-2829-5; Togias A, 2003, J ALLERGY CLIN IMMUN, V111, P1171, DOI 10.1067/mai.2003.1592; Wei P, 2015, EUR ARCH OTO-RHINO-L, V272, P889, DOI 10.1007/s00405-014-3145-9; Xia G, 2010, MOL BIOL REP, V37, P297, DOI 10.1007/s11033-009-9690-4; Yang Y, 2013, AUTOIMMUNITY, V46, P547, DOI 10.3109/08916934.2013.835804; You Y, 2008, J DERMATOL SCI, V52, P118, DOI 10.1016/j.jdermsci.2008.04.011; Young MC, 1998, ALLERGY ASTHMA PROC, V19, P211, DOI 10.2500/108854198778557890; Zhao SX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057758	36	14	16	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2015	10	1							e0116419	10.1371/journal.pone.0116419	http://dx.doi.org/10.1371/journal.pone.0116419			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ4OS	25594855	gold, Green Submitted, Green Published			2022-12-27	WOS:000348202900001
J	Altun, M; Walter, TS; Kramer, HB; Herr, P; Iphofer, A; Bostrom, J; David, Y; Komsany, A; Ternette, N; Navon, A; Stuart, DI; Ren, JS; Kessler, BM				Altun, Mikael; Walter, Thomas S.; Kramer, Holger B.; Herr, Patrick; Iphoefer, Alexander; Bostrom, Johan; David, Yael; Komsany, Alia; Ternette, Nicola; Navon, Ami; Stuart, David I.; Ren, Jingshan; Kessler, Benedikt M.			The Human Otubain2-Ubiquitin Structure Provides Insights into the Cleavage Specificity of Poly-Ubiquitin-Linkages	PLOS ONE			English	Article							DAMAGE-DEPENDENT UBIQUITINATION; CYSTEINE PROTEASES; CRYSTAL-STRUCTURE; RECOGNITION; INHIBITION; REVEALS; FAMILY	Ovarian tumor domain containing proteases cleave ubiquitin (Ub) and ubiquitin-like polypeptides from proteins. Here we report the crystal structure of human otubain 2 (OTUB2) in complex with a ubiquitin-based covalent inhibitor, Ub-Br2. The ubiquitin binding mode is oriented differently to how viral otubains (vOTUs) bind ubiquitin/ISG15, and more similar to yeast and mammalian OTUs. In contrast to OTUB1 which has exclusive specificity towards Lys48 poly-ubiquitin chains, OTUB2 cleaves different poly-Ub linked chains. N-terminal tail swapping experiments between OTUB1 and OTUB2 revealed how the N-terminal structural motifs in OTUB1 contribute to modulating enzyme activity and Ub-chain selectivity, a trait not observed in OTUB2, supporting the notion that OTUB2 may affect a different spectrum of substrates in Ub-dependent pathways.	[Altun, Mikael; Komsany, Alia; Ternette, Nicola; Kessler, Benedikt M.] Univ Oxford, Nuffield Dept Med, Target Discovery Inst, Oxford OX3 7FZ, England; [Walter, Thomas S.; Stuart, David I.; Ren, Jingshan] Univ Oxford, Nuffield Dept Med, Div Struct Biol, Oxford OX3 7BN, England; [Kramer, Holger B.] Dept Physiol Anat & Genet, Oxford OX1 3DQ, England; [Altun, Mikael; Herr, Patrick; Bostrom, Johan] Karolinska Inst, Div Translat Med & Chem Biol, Dept Med Biochem & Biophys, Sci Life Lab, SE-17121 Stockholm, Sweden; [Iphoefer, Alexander] Helmholtz Ctr Infect Res, D-38124 Braunschweig, Germany; [David, Yael; Navon, Ami] Weizmann Inst Sci, Dept Regulat Biol, IL-76100 Rehovot, Israel	University of Oxford; University of Oxford; Karolinska Institutet; Helmholtz Association; Helmholtz-Center for Infection Research; Weizmann Institute of Science	Ren, JS (corresponding author), Univ Oxford, Nuffield Dept Med, Div Struct Biol, Roosevelt Dr, Oxford OX3 7BN, England.	ren@strubi.ox.ac.uk; benedikt.kessler@ndm.ox.ac.uk	Kessler, Benedikt/AAY-8614-2021; Altun, Mikael/AAI-9527-2020; Kramer, Holger/AAL-4433-2020; Herr, Patrick/ABA-6092-2021; Walter, Thomas/S-8636-2017; Altun, Mikael/AAF-5496-2020; Ren, Jingshan/AAT-7729-2021; Walter, Thomas S/S-5104-2019	Kessler, Benedikt/0000-0002-8160-2446; Altun, Mikael/0000-0002-6937-6124; Kramer, Holger/0000-0002-6400-0945; Herr, Patrick/0000-0003-2945-966X; Walter, Thomas/0000-0002-0030-7235; Ren, Jingshan/0000-0003-4015-1404; Walter, Thomas S/0000-0002-0030-7235; Ternette, Nicola/0000-0002-9283-0743; Stuart, David/0000-0002-3426-4210	Biomedical Research Centre, Oxford, UK; Swedish Medical Research Council; StratNeuro; foundation of Ake Wiberg; foundation of Jeanssons; foundation of Ahlen; foundation of Magnus Bergvalls; foundation of Wenner-Gren; Medical Research Council [G1000099, G0501068, G1100525, MR/N00065X/1] Funding Source: researchfish; MRC [MR/N00065X/1, G0501068, G1000099] Funding Source: UKRI	Biomedical Research Centre, Oxford, UK; Swedish Medical Research Council(Swedish Medical Research Council (SMRC)); StratNeuro; foundation of Ake Wiberg; foundation of Jeanssons; foundation of Ahlen; foundation of Magnus Bergvalls; foundation of Wenner-Gren; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the Biomedical Research Centre, Oxford, UK (B.M.K.). M.A. is supported as a Hallsten Academy fellow, the Swedish Medical Research Council, StratNeuro, the foundations of Ake Wiberg, Jeanssons, Ahlen, Magnus Bergvalls and Wenner-Gren. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Akutsu M, 2011, P NATL ACAD SCI USA, V108, P2228, DOI 10.1073/pnas.1015287108; Balakirev MY, 2003, EMBO REP, V4, P517, DOI 10.1038/sj.embor.embor824; Beck A, 2013, DIABETOLOGIA, V56, P1317, DOI 10.1007/s00125-013-2889-x; Borek D, 2010, ACTA CRYSTALLOGR D, V66, P426, DOI 10.1107/S0907444909040177; Borodovsky A, 2002, CHEM BIOL, V9, P1149, DOI 10.1016/S1074-5521(02)00248-X; Bosanac I, 2010, MOL CELL, V40, P548, DOI 10.1016/j.molcel.2010.10.009; Capodagli GC, 2011, J VIROL, V85, P3621, DOI 10.1128/JVI.02496-10; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Edelmann MJ, 2010, FEBS J, V277, P2515, DOI 10.1111/j.1742-4658.2010.07665.x; Edelmann MJ, 2009, BIOCHEM J, V418, P379, DOI 10.1042/BJ20081318; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Frias-Staheli N, 2007, CELL HOST MICROBE, V2, P404, DOI 10.1016/j.chom.2007.09.014; Goncharov T, 2013, EMBO J, V32, P1103, DOI 10.1038/emboj.2013.62; James TW, 2011, P NATL ACAD SCI USA, V108, P2222, DOI 10.1073/pnas.1013388108; Juang YC, 2012, MOL CELL, V45, P384, DOI 10.1016/j.molcel.2012.01.011; Kato K, 2014, MOL CELL, V53, P617, DOI 10.1016/j.molcel.2014.01.030; Kattenhorn LM, 2005, MOL CELL, V19, P547, DOI 10.1016/j.molcel.2005.07.003; Kayagaki N, 2007, SCIENCE, V318, P1628, DOI 10.1126/science.1145918; Li S, 2010, J BIOL CHEM, V285, P4291, DOI 10.1074/jbc.M109.074971; Makarova KS, 2000, TRENDS BIOCHEM SCI, V25, P50, DOI 10.1016/S0968-0004(99)01530-3; Messick TE, 2008, J BIOL CHEM, V283, P11038, DOI 10.1074/jbc.M704398200; Mevissen TET, 2013, CELL, V154, P169, DOI 10.1016/j.cell.2013.05.046; Nakada S, 2010, NATURE, V466, P941, DOI 10.1038/nature09297; Nanao MH, 2004, EMBO REP, V5, P783, DOI 10.1038/sj.embor.7400201; Pickart CM, 2004, BBA-MOL CELL RES, V1695, P55, DOI 10.1016/j.bbamcr.2004.09.019; Reyes-Turcu FE, 2009, ANNU REV BIOCHEM, V78, P363, DOI 10.1146/annurev.biochem.78.082307.091526; Ritorto MS, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5763; Ruschak AM, 2011, J NATL CANCER I, V103, P1007, DOI 10.1093/jnci/djr160; Soares L, 2004, NAT IMMUNOL, V5, P45, DOI 10.1038/ni1017; STUART DI, 1979, J MOL BIOL, V134, P109, DOI 10.1016/0022-2836(79)90416-9; Sun XX, 2011, EMBO J; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; van der Veen AG, 2012, ANNU REV BIOCHEM, V81, P323, DOI 10.1146/annurev-biochem-093010-153308; Virdee S, 2010, NAT CHEM BIOL, V6, P750, DOI [10.1038/nchembio.426, 10.1038/NCHEMBIO.426]; Walter TS, 2005, ACTA CRYSTALLOGR D, V61, P651, DOI 10.1107/S0907444905007808; Wiener R, 2013, NAT STRUCT MOL BIOL, V20, P1033, DOI 10.1038/nsmb.2655; Wiener R, 2012, NATURE, V483, P618, DOI 10.1038/nature10911	38	25	25	3	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2015	10	1							e0115344	10.1371/journal.pone.0115344	http://dx.doi.org/10.1371/journal.pone.0115344			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9HN	25590432	Green Submitted, Green Published, gold			2022-12-27	WOS:000350679400006
J	Liu, YQ; Huang, LY; Lu, Y; Xi, XE; Huang, XL; Lu, QH; Huang, XM; Li, S; Qin, X				Liu, Yanqiong; Huang, Liying; Lu, Yu; Xi, Xue-E; Huang, Xiu-Li; Lu, Qinghua; Huang, Xiamei; Li, Shan; Qin, Xue			Relationships between the Osteocalcin Gene Polymorphisms, Serum Osteocalcin Levels, and Hepatitis B Virus-Related Hepatocellular Carcinoma in a Chinese Population	PLOS ONE			English	Article							BONE-MINERAL DENSITY; FATTY LIVER-DISEASE; PROSTATE-CANCER; GLA PROTEIN; JAPANESE WOMEN; BREAST-CANCER; RISK-FACTORS; ASSOCIATION; OSTEOPOROSIS; INFECTION	Background Available evidence has demonstrated that osteocalcin may play a role in pathogenesis of cancer, and mutation of the osteocalcin gene may be involved in the cancer development. The aim of this study is to determine whether osteocalcin gene polymorphisms are associated with hepatitis B virus (HBV) related hepatocellular carcinoma (HCC) among Chinese population. Methods A total of 515 subjects were divided into four groups: 129 patients with chronic hepatitis B (CHB), 62 patients with HBV-related liver cirrhosis (LC), 154 patients with HBV-related HCC, and 170 healthy controls. The polymerase chain reaction-restriction fragment length polymorphism strategy was used to detect osteocalcin gene rs1800247 and rs1543297 polymorphisms. Results Compared with healthy controls, the rs1800247 HH and Hh genotypes were associated with a significantly increased susceptibility to HCC (HH versus hh: OR = 6.828, 95% CI 2.620-17.795, P < 0.001; Hh versus hh: OR = 6.306, 95% CI 3.480-11.423, P < 0.001, respectively). Similarly, the subjects bearing the H allele of rs1800247 had more than a 2.4-fold increased risk for development of HCC (OR = 2.484, 95% CI 1.747-3.532, P < 0.001) compared with those bearing the h allele. In addition, we found significant decreased serum osteocalcin levels in HBV-related HCC patients (11.73 +/- 8.18 ng/mL) compared with healthy controls (15.3 +/- 6.06 ng/mL). Furthermore, the serum osteocalcin levels were significantly lower in HCC patients than healthy controls among the individuals with heterozygous Hh genotype (P = 0.003) and CT genotype (P < 0.001). In contrast, there were no significant differences in the genotype and allele of rs1543297 polymorphisms between the groups of patients and healthy controls. Conclusions These findings for the first time suggest that genetic variant in osteocalcin gene rs1800247 polymorphisms may be a risk factor for HBV-related HCC. We also find an inverse association of serum osteocalcin levels with HCC.	[Liu, Yanqiong; Huang, Liying; Lu, Yu; Huang, Xiu-Li; Lu, Qinghua; Huang, Xiamei; Li, Shan; Qin, Xue] Guangxi Med Univ, Dept Clin Lab, Affiliated Hosp 1, Nanning, Guangxi, Peoples R China; [Xi, Xue-E] Nanning Social Welf Hosp, Dept Clin Lab, Nanning, Guangxi, Peoples R China	Guangxi Medical University	Li, S (corresponding author), Guangxi Med Univ, Dept Clin Lab, Affiliated Hosp 1, Nanning, Guangxi, Peoples R China.	lis8858@126.com; qinxue919@126.com			National Natural Science Foundation of China [81260302, 81460431]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by National Natural Science Foundation of China (No. 81260302 and No. 81460431). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aller R, 2011, ANN HEPATOL, V10, P50, DOI 10.1016/S1665-2681(19)31587-X; Aravalli RN, 2013, ARCH TOXICOL, V87, P227, DOI 10.1007/s00204-012-0931-2; Chen CJ, 1997, J GASTROEN HEPATOL, V12, pS294, DOI 10.1111/j.1440-1746.1997.tb00513.x; Chen HY, 2001, J CLIN LAB ANAL, V15, P251, DOI 10.1002/jcla.1036; Chuang SC, 2009, CANCER LETT, V286, P9, DOI 10.1016/j.canlet.2008.10.040; Dohi Y, 1998, J BONE MINER RES, V13, P1633, DOI 10.1359/jbmr.1998.13.10.1633; Elston RC, 1998, GENET EPIDEMIOL, V15, P565, DOI 10.1002/(SICI)1098-2272(1998)15:6<565::AID-GEPI2>3.0.CO;2-J; Farazi PA, 2006, NAT REV CANCER, V6, P674, DOI 10.1038/nrc1934; Ferlay J, 2013, IARC CANCERBASE; FRANCINI G, 1988, AM J CLIN ONCOL-CANC, V11, pS83, DOI 10.1097/00000421-198801102-00021; Ivaska KK, 2004, J BIOL CHEM, V279, P18361, DOI 10.1074/jbc.M314324200; KAMBY C, 1993, SCAND J CLIN LAB INV, V53, P439, DOI 10.3109/00365519309092538; Kim JG, 2006, MENOPAUSE, V13, P467, DOI 10.1097/01.gme.0000182803.06762.fb; Koeneman KS, 2000, WORLD J UROL, V18, P102, DOI 10.1007/s003450050181; Li S, 2011, INFECT GENET EVOL, V11, P2083, DOI 10.1016/j.meegid.2011.09.025; LIAN JB, 1988, CLIN ORTHOP RELAT R, P267; Liu JJ, 2013, INT J MOL SCI, V14, P19782, DOI 10.3390/ijms141019782; Liu YQ, 2014, INFECT GENET EVOL, V27, P69, DOI 10.1016/j.meegid.2014.07.002; Liu YQ, 2014, MED ONCOL, V31, DOI 10.1007/s12032-014-0200-8; Lu Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110061; Mahdy KA, 2007, WORLD J GASTROENTERO, V13, P785, DOI 10.3748/wjg.v13.i5.785; MARCELLINI M, 1992, EUR UROL, V21, P102; Mathew S, 2014, INFECT GENET EVOL, V26, P327, DOI 10.1016/j.meegid.2014.06.014; McGuigan F, 2010, J BONE MINER RES, V25, P1392, DOI 10.1002/jbmr.32; PIETSCHMANN P, 1989, J CANCER RES CLIN, V115, P456, DOI 10.1007/BF00393337; PRICE PA, 1980, J CLIN INVEST, V66, P878, DOI 10.1172/JCI109954; Qin X, 2014, CLIN LAB, V60, P1177, DOI 10.7754/Clin.Lab.2013.130331; Qin X, 2012, DNA CELL BIOL, V31, P1125, DOI 10.1089/dna.2011.1438; Raymond MH, 1999, GENOMICS, V60, P210, DOI 10.1006/geno.1999.5893; Shi YY, 2005, CELL RES, V15, P97, DOI 10.1038/sj.cr.7290272; Strohmaier WL, 1996, EUR UROL, V30, P103; Sugiyama T, 2001, J BONE MINER METAB, V19, P146, DOI 10.1007/s007740170034; Tan AH, 2011, METABOLISM, V60, P1186, DOI 10.1016/j.metabol.2011.01.002; Wu HC, 2003, EUR UROL, V43, P197, DOI 10.1016/S0302-2838(02)00541-9; Xi XE, 2015, MED ONCOL, V32, DOI 10.1007/s12032-014-0355-3; Yamada Y, 2003, J CLIN ENDOCR METAB, V88, P3372, DOI 10.1210/jc.2002-021449; Yeung F, 2002, J BIOL CHEM, V277, P2468, DOI 10.1074/jbc.M105947200; Yilmaz Y, 2011, SCAND J CLIN LAB INV, V71, P631, DOI 10.3109/00365513.2011.604427	38	4	7	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2015	10	1							e0116479	10.1371/journal.pone.0116479	http://dx.doi.org/10.1371/journal.pone.0116479			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ0ID	25587715	Green Published, gold, Green Submitted			2022-12-27	WOS:000347928300013
J	Takahashi, T; Takase, Y; Yoshino, T; Saito, D; Tadokoro, R; Takahashi, Y				Takahashi, Teruaki; Takase, Yuta; Yoshino, Takashi; Saito, Daisuke; Tadokoro, Ryosuke; Takahashi, Yoshiko			Angiogenesis in the Developing Spinal Cord: Blood Vessel Exclusion from Neural Progenitor Region Is Mediated by VEGF and Its Antagonists	PLOS ONE			English	Article							ENDOTHELIAL-GROWTH-FACTOR; CHICKEN EMBRYOS; NERVOUS-SYSTEM; NEUROVASCULAR DEVELOPMENT; ADHERENS JUNCTIONS; TYROSINE KINASE; SOLUBLE FLT-1; DORSAL AORTA; IN-VIVO; CELLS	Blood vessels in the central nervous systemsupply a considerable amount of oxygen via intricate vascular networks. We studied how the initial vasculature of the spinal cord is formed in avian (chicken and quail) embryos. Vascular formation in the spinal cord starts by the ingression of intra-neural vascular plexus (INVP) from the peri-neural vascular plexus (PNVP) that envelops the neural tube. At the ventral region of the PNVP, the INVP grows dorsally in the neural tube, and we observed that these vessels followed the defined path at the interface between the medially positioned and undifferentiated neural progenitor zone and the laterally positioned differentiated zone. When the interface between these two zones was experimentally displaced, INVP faithfully followed a newly formed interface, suggesting that the growth path of the INVP is determined by surrounding neural cells. The progenitor zone expressed mRNA of vascular endothelial growth factor-A whereas its receptor VEGFR2 and FLT-1 (VEGFR1), a decoy for VEGF, were expressed in INVP. By manipulating the neural tube with either VEGF or the soluble form of FLT-1, we found that INVP grew in a VEGF-dependent manner, where VEGF signals appear to be fine-tuned by counteractions with anti-angiogenic activities including FLT-1 and possibly semaphorins. These results suggest that the stereotypic patterning of early INVP is achieved by interactions between these vessels and their surrounding neural cells, where VEGF and its antagonists play important roles.	[Takahashi, Teruaki; Takase, Yuta; Yoshino, Takashi; Tadokoro, Ryosuke; Takahashi, Yoshiko] Kyoto Univ, Grad Sch Sci, Dept Zool, Kyoto, Japan; [Takahashi, Teruaki] Nara Inst Sci & Technol, Grad Sch Biol Sci, Ikoma, Japan; [Saito, Daisuke] Tohoku Univ, Frontier Res Inst Interdisciplinary Sci, Sendai, Miyagi 980, Japan; [Takahashi, Yoshiko] JST, CREST, Tokyo, Japan	Kyoto University; Nara Institute of Science & Technology; Tohoku University; Japan Science & Technology Agency (JST)	Takahashi, Y (corresponding author), Kyoto Univ, Grad Sch Sci, Dept Zool, Kyoto, Japan.		Saito, Daisuke/AAL-8492-2021	Saito, Daisuke/0000-0002-5999-2505	Ministry of Education, Culture, Sports, Science and Technology of Japan, MEXT, Japan; CREST (JST); Mitsubishi Foundation; Takeda Science Foundation	Ministry of Education, Culture, Sports, Science and Technology of Japan, MEXT, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); CREST (JST)(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST)); Mitsubishi Foundation; Takeda Science Foundation(Takeda Science Foundation (TSF))	This work was supported by a Grant-in-Aid for Scientific Research on Innovative Areas from the Ministry of Education, Culture, Sports, Science and Technology of Japan, MEXT, Japan, CREST (JST), The Mitsubishi Foundation, and Takeda Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams RH, 2007, NAT REV MOL CELL BIO, V8, P464, DOI 10.1038/nrm2183; Ambati BK, 2006, NATURE, V443, P993, DOI 10.1038/nature05249; Atsuta Y, 2013, DEV GROWTH DIFFER, V55, P579, DOI 10.1111/dgd.12047; Bautch VL, 2009, CELL ADHES MIGR, V3, P199, DOI 10.4161/cam.3.2.8397; Bron R, 2007, NEURAL DEV, V2, DOI 10.1186/1749-8104-2-21; Carmeliet P, 1996, NATURE, V380, P435, DOI 10.1038/380435a0; Chappell JC, 2009, DEV CELL, V17, P377, DOI 10.1016/j.devcel.2009.07.011; Chauvet S, 2013, CELL MOL LIFE SCI, V70, P1685, DOI 10.1007/s00018-013-1278-4; Chen L, 2009, DEV BIOL, V325, P162, DOI 10.1016/j.ydbio.2008.10.023; Christensen CRL, 1998, CANCER RES, V58, P1238; de Almodovar CR, 2011, NEURON, V70, P966, DOI 10.1016/j.neuron.2011.04.014; Dringen R, 2000, PROG NEUROBIOL, V62, P649, DOI 10.1016/S0301-0082(99)00060-X; DUVERNOY HM, 1981, BRAIN RES BULL, V7, P519, DOI 10.1016/0361-9230(81)90007-1; Eichmann A, 2005, INT J DEV BIOL, V49, P259, DOI 10.1387/ijdb.041941ae; Eichmann A, 2012, COLD SPRING HARBOR P, V3; Eilken HM, 2010, CURR OPIN CELL BIOL, V22, P617, DOI 10.1016/j.ceb.2010.08.010; FEENEY JF, 1946, J MORPHOL, V78, P231, DOI 10.1002/jmor.1050780205; Ferrara N, 1999, NAT MED, V5, P1359, DOI 10.1038/70928; FONG GH, 1995, NATURE, V376, P66, DOI 10.1038/376066a0; Gerhardt H, 2004, DEV DYNAM, V231, P503, DOI 10.1002/dvdy.20148; Gerhardt H, 2003, J CELL BIOL, V161, P1163, DOI 10.1083/jcb.200302047; Geudens I, 2011, DEVELOPMENT, V138, P4569, DOI 10.1242/dev.062323; Ghosh S, 2008, P NATL ACAD SCI USA, V105, P335, DOI 10.1073/pnas.0705713105; Greenberg DA, 2005, NATURE, V438, P954, DOI 10.1038/nature04481; Gu CH, 2005, SCIENCE, V307, P265, DOI 10.1126/science.1105416; Haigh JJ, 2003, DEV BIOL, V262, P225, DOI 10.1016/S0012-1606(03)00356-7; HAMBURGER V, 1992, DEV DYNAM, V195, P231, DOI 10.1002/dvdy.1001950404; Hiratsuka S, 1998, P NATL ACAD SCI USA, V95, P9349, DOI 10.1073/pnas.95.16.9349; Hirota S, 2011, DEVELOPMENT, V138, P5157, DOI 10.1242/dev.069153; James JM, 2011, SEMIN CELL DEV BIOL, V22, P1019, DOI 10.1016/j.semcdb.2011.09.010; James JM, 2009, DEVELOPMENT, V136, P833, DOI 10.1242/dev.028845; Katayama KI, 2011, P NATL ACAD SCI USA, V108, P7607, DOI 10.1073/pnas.1101347108; Kim J, 2011, GENE DEV, V25, P1399, DOI 10.1101/gad.2042011; Kurz H, 1996, DEV BIOL, V173, P133, DOI 10.1006/dbio.1996.0012; Kurz H, 2009, CELL ADHES MIGR, V3, P205, DOI 10.4161/cam.3.2.7855; Lyuksyutova AI, 2003, SCIENCE, V302, P1984, DOI 10.1126/science.1089610; Ma S, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001469; Mackenzie F, 2012, DEVELOPMENT, V139, P1371, DOI 10.1242/dev.072348; Mauti O, 2007, NEURAL DEV, V2, DOI 10.1186/1749-8104-2-28; Meadows SM, 2011, CIRC RES, V110, P34; Meadows SM, 2013, DEV DYNAM, V242, P580, DOI 10.1002/dvdy.23949; Meszar Z, 2008, BRAIN RES BULL, V75, P414, DOI 10.1016/j.brainresbull.2007.10.052; Momose T, 1999, DEV GROWTH DIFFER, V41, P335; Morest AK, 2003, GLIA, V43, P6, DOI [10.1002/glia.10288, 10.1002/glia.10238]; Moyon D, 2001, DEVELOPMENT, V128, P3359; Nagase T, 2005, GENES CELLS, V10, P595, DOI 10.1111/j.1365-2443.2005.00861.x; Nimmagadda S, 2004, ANAT EMBRYOL, V208, P219, DOI 10.1007/s00429-004-0396-z; Oh WJ, 2013, NEURON, V80, P458, DOI 10.1016/j.neuron.2013.09.005; Oh WJ, 2013, SEMIN CELL DEV BIOL, V24, P156, DOI 10.1016/j.semcdb.2012.12.001; Ohata E, 2009, DEV BIOL, V335, P33, DOI 10.1016/j.ydbio.2009.08.010; PARDANAUD L, 1987, DEVELOPMENT, V100, P339; Phng LK, 2009, DEV CELL, V16, P196, DOI 10.1016/j.devcel.2009.01.015; Pouget C, 2006, DEVELOPMENT, V133, P1013, DOI 10.1242/dev.02269; Quaegebeur A, 2011, NEURON, V71, P406, DOI 10.1016/j.neuron.2011.07.013; Risau W, 1997, NATURE, V386, P671, DOI 10.1038/386671a0; Rowitch DH, 2010, NATURE, V468, P214, DOI 10.1038/nature09611; Roztocil T, 1997, DEVELOPMENT, V124, P3263; Ruhrberg C, 2002, GENE DEV, V16, P2684, DOI 10.1101/gad.242002; Ruhrberg C, 2013, CELL MOL LIFE SCI, V70, P1675, DOI 10.1007/s00018-013-1277-5; Saito D, 2012, SCIENCE, V336, P1578, DOI 10.1126/science.1222369; Sakurai A, 2010, MOL CELL BIOL, V30, P3086, DOI 10.1128/MCB.01652-09; Sato Y, 2008, DEV CELL, V14, P890, DOI 10.1016/j.devcel.2008.03.024; Sato Y, 2007, DEV BIOL, V305, P616, DOI 10.1016/j.ydbio.2007.01.043; Shibuya M, 2008, BMB REP, V41, P278, DOI 10.5483/BMBRep.2008.41.4.278; Shibuya M, 2013, J BIOCHEM, V153, P13, DOI 10.1093/jb/mvs136; Stenman JM, 2008, SCIENCE, V322, P1247, DOI 10.1126/science.1164594; Stenzel D, 2011, DEVELOPMENT, V138, P4451, DOI 10.1242/dev.071381; Takase Y, 2013, DEV GROWTH DIFFER, V55, P792, DOI 10.1111/dgd.12106; Tonegawa A, 2003, DEV BIOL, V262, P32, DOI 10.1016/S0012-1606(03)00327-0; Vieira JM, 2007, DEVELOPMENT, V134, P1833, DOI 10.1242/dev.002402; Watanabe T, 2007, DEV BIOL, V305, P625, DOI 10.1016/j.ydbio.2007.01.042; Wiley DM, 2011, NAT CELL BIOL, V13, P686, DOI 10.1038/ncb2232; Wolf AM, 2008, J NEUROSCI, V28, P3456, DOI 10.1523/JNEUROSCI.0029-08.2008; Xie ZH, 2011, P NATL ACAD SCI USA, V108, P12119, DOI 10.1073/pnas.1100160108; Yamaguchi S, 2002, BIOCHEM BIOPH RES CO, V291, P554, DOI 10.1006/bbrc.2002.6478; Yancopoulos GD, 2000, NATURE, V407, P242, DOI 10.1038/35025215; Yokota Y, 2011, DEV BIOL, V353, P382, DOI 10.1016/j.ydbio.2011.02.001; Yoshino T, 2011, DEV GROWTH DIFFER, V53, P378, DOI 10.1111/j.1440-169X.2011.01252.x	78	14	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2015	10	1							e0116119	10.1371/journal.pone.0116119	http://dx.doi.org/10.1371/journal.pone.0116119			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ4OG	25585380	Green Published, gold, Green Submitted			2022-12-27	WOS:000348201300006
J	Kai, M; Ueno, N; Kinoshita, N				Kai, Masatake; Ueno, Naoto; Kinoshita, Noriyuki			Phosphorylation-Dependent Ubiquitination of Paraxial Protocadherin (PAPC) Controls Gastrulation Cell Movements	PLOS ONE			English	Article							BETA-CATENIN PHOSPHORYLATION; NONCANONICAL WNT PATHWAY; CONVERGENT EXTENSION; XENOPUS EMBRYOS; C-CADHERIN; MESODERM; ADHESION; MORPHOGENESIS; SOMITOGENESIS; TARGET	Paraxial protocadherin (PAPC) has been shown to be involved in gastrulation cell movements during early embryogenesis. It is first expressed in the dorsal marginal zone at the early gastrula stage and subsequently restricted to the paraxial mesoderm in Xenopus and zebrafish. Using Xenopus embryos, we found that PAPC is also regulated at the protein level and is degraded and excluded from the plasma membrane in the axial mesoderm by the late gastrula stage. Regulation of PAPC requires poly-ubiquitination that is dependent on phosphorylation. PAPC is phosphorylated by GKS3 in the evolutionarily conserved cytoplasmic domain, and this in turn is necessary for poly-ubiquitination by an E3 ubiquitin ligase beta-TrCP. We also show that precise control of PAPC by phosphorylation/ubiquitination is essential for normal Xenopus gastrulation cell movements. Taken together, our findings unveil a novel mechanism of regulation of a cell adhesion protein and show that this system plays a crucial role in vertebrate embryogenesis.	[Kai, Masatake; Ueno, Naoto; Kinoshita, Noriyuki] Natl Inst Nat Sci, Natl Inst Basic Biol, Dept Dev Biol, Okazaki, Aichi 4448585, Japan; [Ueno, Naoto; Kinoshita, Noriyuki] SOKENDAI, Dept Mol Biomech, Okazaki, Aichi 4448585, Japan	National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); Graduate University for Advanced Studies - Japan	Kinoshita, N (corresponding author), Natl Inst Nat Sci, Natl Inst Basic Biol, Dept Dev Biol, 38 Nishigonaka,Myodaiji Cho, Okazaki, Aichi 4448585, Japan.	nkinoshi@nibb.ac.jp		Kinoshita, Noriyuki/0000-0002-1362-4045; Ueno, Naoto/0000-0002-8375-2317	MEXT KAKENHI [23111528]; JSPS KAKENHI [23570262, 12640066]; Grants-in-Aid for Scientific Research [22127007] Funding Source: KAKEN	MEXT KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	Funding: The work was supported by the following: MEXT KAKENHI 23111528 to NK; JSPS KAKENHI 23570262 to NK; and JSPS KAKENHI 12640066 to MK (http://www.jsps.go.jp/english/e-grants/index.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bax B, 2001, STRUCTURE, V9, P1143, DOI 10.1016/S0969-2126(01)00679-7; Chen X, 2007, J BIOL CHEM, V282, P32128, DOI 10.1074/jbc.M705337200; Chen X, 2006, J CELL BIOL, V174, P301, DOI 10.1083/jcb.200602062; CHRISTIAN JL, 1993, GENE DEV, V7, P13, DOI 10.1101/gad.7.1.13; Chung HA, 2007, CURR BIOL, V17, P932, DOI 10.1016/j.cub.2007.04.034; Haglund K, 2005, EMBO J, V24, P3353, DOI 10.1038/sj.emboj.7600808; Hoppler S, 1996, GENE DEV, V10, P2805, DOI 10.1101/gad.10.21.2805; Iioka H, 2004, J CELL BIOL, V164, P169, DOI 10.1083/jcb.200310027; Iioka H, 2007, NAT CELL BIOL, V9, P813, DOI 10.1038/ncb1607; Keller R, 2002, SCIENCE, V298, P1950, DOI 10.1126/science.1079478; Kim SH, 1998, DEVELOPMENT, V125, P4681; Kim SH, 2000, CURR BIOL, V10, P821, DOI 10.1016/S0960-9822(00)00580-7; Kinoshita N, 2003, GENE DEV, V17, P1663, DOI 10.1101/gad.1101303; Komander D, 2012, ANNU REV BIOCHEM, V81, P203, DOI 10.1146/annurev-biochem-060310-170328; Kraft B, 2012, J CELL BIOL, V198, P695, DOI 10.1083/jcb.201110076; Lee RHK, 2007, EMBO J, V26, P3592, DOI 10.1038/sj.emboj.7601781; Liu CM, 1999, P NATL ACAD SCI USA, V96, P6273, DOI 10.1073/pnas.96.11.6273; Martin BL, 2012, DEV CELL, V22, P223, DOI 10.1016/j.devcel.2011.11.001; Medina A, 2004, EMBO J, V23, P3249, DOI 10.1038/sj.emboj.7600329; Meyer H, 2012, NAT CELL BIOL, V14, P117, DOI 10.1038/ncb2407; Mukhopadhyay D, 2007, SCIENCE, V315, P201, DOI 10.1126/science.1127085; Nakayama KI, 2005, SEMIN CELL DEV BIOL, V16, P323, DOI 10.1016/j.semcdb.2005.02.010; NIEUWKOOP PD, 1975, NORMAL TABLE OF XENO; Nowotschin S, 2012, DEV BIOL, V367, P1, DOI 10.1016/j.ydbio.2012.04.012; PENG HB, 1991, METHOD CELL BIOL, V36, P657; PIERCE SB, 1995, DEVELOPMENT, V121, P755; Redies C, 2005, CELL MOL LIFE SCI, V62, P2840, DOI 10.1007/s00018-005-5320-z; Rhee J, 2003, DEV BIOL, V254, P248, DOI 10.1016/S0012-1606(02)00085-4; Uemura M, 2007, NAT NEUROSCI, V10, P1151, DOI 10.1038/nn1960; Unterseher F, 2004, EMBO J, V23, P3259, DOI 10.1038/sj.emboj.7600332; Wang Y, 2008, GENE DEV, V22, P878, DOI 10.1101/gad.452908; Weidinger G, 2003, J CELL BIOL, V162, P753, DOI 10.1083/jcb.200307181; Winklbauer R, 2009, INT REV CEL MOL BIO, V278, P215, DOI 10.1016/S1937-6448(09)78005-0; Yamamoto A, 1998, DEVELOPMENT, V125, P3389	34	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2015	10	1							e0115111	10.1371/journal.pone.0115111	http://dx.doi.org/10.1371/journal.pone.0115111			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ4CF	25580871	Green Submitted, Green Published, gold			2022-12-27	WOS:000348169100001
J	Ma, QF; Chu, CB; Song, HQ				Ma, Qing-feng; Chu, Chang-biao; Song, Hai-qing			Intravenous versus Intra-Arterial Thrombolysis in Ischemic Stroke: A Systematic Review and Meta-Analysis	PLOS ONE			English	Article							TISSUE-PLASMINOGEN ACTIVATOR; RECANALIZATION; OCCLUSION; TIME; PROUROKINASE; IMPROVEMENT; PREDICTORS; HEMORRHAGE; EXPERIENCE; PROACT	Background: Reperfusion following ischemic stroke can be attained by either intravenous thrombolysis (IVT) or intra-arterial thrombolysis (IAT). Only a limited number of randomized prospective studies have compared the efficacy and safety of IVT and IAT. This meta-analysis investigated possible clinical benefits of IAT relative to IVT in patients with acute ischemic stroke. Methods: We searched the PubMed, Cochrane, and Google Scholar databases through October 2013 for manuscripts that describe the findings of randomized controlled or prospective studies that evaluated the outcomes of patients with ischemic stroke who were treated with IVT or IAT. The clinical outcome measures were score on the modified Rankin scale (mRS) and mortality at 90 days. A favorable outcome was defined as an mRS score of 0 to 2. Results: For the mRS, the combined odds ratio (OR) of 3.28 (95% confidence interval (CI), 1.91 to 5.65, P < 0.001) indicated that patients who received IAT had a significantly higher chance for a favorable outcome than did those who received IVT. For mortality, the OR indicated that IAT therapy significantly reduced the proportion of patients who died within 90 days of the procedure (combined OR, 0.40; 95% CI, 0.17 to 0.92; P = 0.032). Conclusion: This meta-analysis determined that IAT conferred a significantly greater probability of achieving a favorable outcome compared with IVT. There was also a significant difference in mortality rates between IAT and IVT. The studies included in this analysis were small and heterogeneous; therefore, larger randomized prospective clinical studies are necessary to further investigate this issue.	[Ma, Qing-feng; Chu, Chang-biao; Song, Hai-qing] Capital Med Univ, Xuan Wu Hosp, Dept Neurol, Beijing, Peoples R China	Capital Medical University	Song, HQ (corresponding author), Capital Med Univ, Xuan Wu Hosp, Dept Neurol, Beijing, Peoples R China.	songhq@vip.sina.com						Bhatia R, 2010, STROKE, V41, P2254, DOI 10.1161/STROKEAHA.110.592535; Bivard A, 2013, J STROKE, V15, P90, DOI 10.5853/jos.2013.15.2.90; Campbell BC, 2013, NEW ENGL J MED, V368, P2431, DOI [10.1056/NEJMc1304759, 10.1056/NEJMoa1213701]; Christoforidis GA, 2010, INTERV NEURORADIOL, V16, P297, DOI 10.1177/159101991001600312; Christou I, 2002, J NEUROIMAGING, V12, P119, DOI 10.1111/j.1552-6569.2002.tb00107.x; Ciccone A, 2010, J NEUROINTERV SURG, V2, P74, DOI 10.1136/jnis.2009.001388; del Zoppo GJ, 1998, STROKE, V29, P4, DOI 10.1161/01.STR.29.1.4; DELZOPPO GJ, 2009, STROKE, V40, P2945, DOI [10.1161/STROKEAHA.109.192535, DOI 10.1161/STR0KEAHA.109.192535]; Ducrocq X, 2005, J NEURORADIOLOGY, V32, P26, DOI 10.1016/S0150-9861(05)83018-4; Endo S, 1998, AM J NEURORADIOL, V19, P1169; Furlan A, 1999, JAMA-J AM MED ASSOC, V282, P2003, DOI 10.1001/jama.282.21.2003; Heo JH, 2003, NEUROLOGY, V60, P1684, DOI 10.1212/01.WNL.0000063323.23493.98; Khatri P, 2009, NEUROLOGY, V73, P1066, DOI 10.1212/WNL.0b013e3181b9c847; Kim JW, 2012, CLIN NEUROL NEUROSUR, V114, P1316, DOI 10.1016/j.clineuro.2012.04.022; Lees KR, 2010, LANCET, V375, P1695, DOI 10.1016/S0140-6736(10)60491-6; Lewandowski CA, 1999, STROKE, V30, P2598, DOI 10.1161/01.STR.30.12.2598; Mattle HP, 2008, STROKE, V39, P379, DOI 10.1161/STROKEAHA.107.492348; Mullen MT, 2012, STROKE, V43, P2350, DOI 10.1161/STROKEAHA.111.639211; Nam J, 2015, INT J STROKE, V10, P13, DOI 10.1111/j.1747-4949.2012.00914.x; Natarajan SK, 2009, STROKE, V40, P3269, DOI 10.1161/STROKEAHA.109.555102; Qureshi AI, 2006, NEUROSURGERY, V59, P789, DOI 10.1227/01.NEU.0000232862.06246.3D; Qureshi AI, 2004, LANCET, V363, P804, DOI 10.1016/S0140-6736(04)15697-3; Rabinstein AA, 2002, AM J NEURORADIOL, V23, P1596; Rha JH, 2007, STROKE, V38, P967, DOI 10.1161/01.STR.0000258112.14918.24; Saqqur M, 2007, STROKE, V38, P948, DOI 10.1161/01.STR.0000257304.21967.ba; Sen S, 2009, NEUROCRIT CARE, V11, P76, DOI 10.1007/s12028-009-9204-1; Smith WS, 2008, STROKE, V39, P1205, DOI 10.1161/STROKEAHA.107.497115; Suarez JI, 1999, STROKE, V30, P2094, DOI 10.1161/01.STR.30.10.2094; Sutton AJ, 2000, BMJ-BRIT MED J, V320, P1574, DOI 10.1136/bmj.320.7249.1574; Tomsick T, 1996, AM J NEURORADIOL, V17, P79; van Houwelingen HC, 2002, STAT MED, V21, P589, DOI 10.1002/sim.1040; Wardlaw JM, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000514.pub3; Wardlaw JM, 2012, LANCET, V379, P2364, DOI 10.1016/S0140-6736(12)60738-7; Zangerle A, 2007, NEUROLOGY, V68, P39, DOI 10.1212/01.wnl.0000250341.38014.d2; Zhang B, 2010, CAN J NEUROL SCI, V37, P240, DOI 10.1017/S0317167100009999	35	35	35	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2015	10	1							e0116120	10.1371/journal.pone.0116120	http://dx.doi.org/10.1371/journal.pone.0116120			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ4BT	25569136	Green Published, Green Submitted, gold			2022-12-27	WOS:000348168000004
J	Tang, WM; Huan, XP; Zhang, Y; Mahapatra, T; Li, JJ; Liu, XY; Mahapatra, S; Yan, HJ; Fu, GF; Zhao, JK; Gu, CH; Detels, R				Tang, Weiming; Huan, Xiping; Zhang, Ye; Mahapatra, Tanmay; Li, Jianjun; Liu, Xiaoyan; Mahapatra, Sanchita; Yan, Hongjing; Fu, Gengfeng; Zhao, Jinkou; Gu, Chenghua; Detels, Roger			Factors Associated with Loss-to-Follow-Up during Behavioral Interventions and HIV Testing Cohort among Men Who Have Sex with Men in Nanjing, China	PLOS ONE			English	Article							RISK; PREVENTION; INFECTION; TRANSMISSION; POPULATION; PREVALENCE; SHANGHAI; SYPHILIS; METAANALYSIS; RETENTION	Background: Behavioral interventions (BIs) remained the cornerstone of HIV prevention in resource-limited settings. One of the major concerns for such efforts is the loss-to-follow-up (LTFU) that threatens almost every HIV control program involving high-risk population groups. Methods: To evaluate the factors associated with LTFU during BIs and HIV testing among men who have sex with men (MSM), 410 HIV sero-negatives MSM were recruited using respondent driven sampling (RDS) in Nanjing, China during 2008, they were further followed for 18 months. At baseline and each follow-up visits, each participant was counseled about various HIV risk-reductions BIs at a designated sexually transmitted infection (STI) clinic. Results: Among 410 participants recruited at baseline, altogether 221 (53.9%) were LTFU at the 18-month follow-up visit. Overall, 46 participants were found to be positive for syphilis infection at baseline while 13 participants were HIV seroconverted during the follow-up period. Increasing age was less (Adjusted Odds Ratio(aOR) of 0.90, 95% confidence Interval (CI) 0.86-0.94) and official residency of provinces other than Nanjing (AOR of 2.49, 95% CI 1.32-4.71), lower level of education (AOR of 2.01, 95% CI 1.10-3.66) and small social network size (AOR of 1.75, 95% CI 1.09-2.80) were more likely to be associated with higher odds of LTFU. Conclusion: To improve retention in the programs for HIV control, counseling and testing among MSM in Nanjing, focused intensified intervention targeting those who were more likely to be LTFU, especially the young, less educated, unofficial residents of Nanjing who had smaller social network size, might be helpful.	[Tang, Weiming; Zhang, Ye] Guangdong Prov Ctr Skin Dis & STI Control, Guangzhou 510095, Guangdong, Peoples R China; [Tang, Weiming; Huan, Xiping; Li, Jianjun; Liu, Xiaoyan; Yan, Hongjing; Fu, Gengfeng; Gu, Chenghua] Jiangsu Prov Cent Dis Control & Prevent, Nanjing 210009, Jiangsu, Peoples R China; [Tang, Weiming] Univ North Carolina Project China, Guangzhou 510095, Guangdong, Peoples R China; [Mahapatra, Sanchita; Detels, Roger] Sch Natl Inst Cholera & Enter Dis, Dept Epidemiol, Kolkata, W Bengal, India; [Zhao, Jinkou] Global Fund Fight AIDS TB & Malaria, Investment & Impact Div, Geneva, Switzerland	Jiangsu Provincial Center for Disease Control & Prevention; Indian Council of Medical Research (ICMR); ICMR - National Institute of Cholera & Enteric Diseases (NICED)	Gu, CH (corresponding author), Jiangsu Prov Cent Dis Control & Prevent, Nanjing 210009, Jiangsu, Peoples R China.	guchenghua@jscdc.cn; detels@ucla.edu		Tang, Weiming/0000-0002-9026-707X; Zhao, Jinkou/0000-0001-9184-3385; Zhang, Ye/0000-0001-6159-7427	National Natural Science Foundation of China [81373125]; Jiangsu Provincial Technologies Research Program [BE2009685]; Jiangsu Province's Outstanding Medical Academic Leader Program [RC2011086, 2011087]; NIH program [1D43TW009532-01]; FOGARTY INTERNATIONAL CENTER [D43TW009532] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI114310] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P30MH058107] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jiangsu Provincial Technologies Research Program; Jiangsu Province's Outstanding Medical Academic Leader Program; NIH program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by National Natural Science Foundation of China (grant no. 81373125), Jiangsu Provincial Technologies Research Program (BE2009685), Jiangsu Province's Outstanding Medical Academic Leader Program (RC2011086, 2011087) and NIH program (1D43TW009532-01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson AF, 2003, AIDS CARE, V15, P177, DOI 10.1080/0954012031000068326; [Anonymous], 2012, CHIN AIDS RESP PROGR; [Anonymous], UNAIDS WORLD AIDS DA; Auerbach JD, 2000, AM J PUBLIC HLTH, V90; Beyrer C, 2012, LANCET, V380, P367, DOI 10.1016/S0140-6736(12)60821-6; Bull SS, 2004, AIDS CARE, V16, P931, DOI 10.1080/09540120412331292507; Centers for Disease Control and Prevention (CDC), 2013, EFF BEH INT HIV AIDS; Choi KH, 2006, AIDS EDUC PREV, V18, P33, DOI 10.1521/aeap.2006.18.1.33; Choi KH, 2002, AIDS BEHAV, V6, P255, DOI DOI 10.1023/A:1019895909291; Choi KH, 2007, JAIDS-J ACQ IMM DEF, V45, P77, DOI 10.1097/QAI.0b013e3180415dd7; Coates TJ, 2008, LANCET, V372, P669, DOI 10.1016/S0140-6736(08)60886-7; Denison JA, 2008, AIDS BEHAV, V12, P363, DOI 10.1007/s10461-007-9349-x; Dilley JW, 2007, JAIDS-J ACQ IMM DEF, V44, P569, DOI 10.1097/QAI.0b013e318033ffbd; Gao L, 2009, SEX TRANSM INFECT, V85, P354, DOI 10.1136/sti.2008.034702; Gao MY, 2007, AIDS CARE, V19, P799, DOI 10.1080/09540120601114832; Granich RM, 2009, LANCET, V373, P48, DOI 10.1016/S0140-6736(08)61697-9; He N, 2007, AIDS CARE, V19, P109, DOI 10.1080/09540120600888394; Herbst JH, 2005, JAIDS-J ACQ IMM DEF, V39, P228; Hightow LB, 2006, SEX TRANSM DIS, V33, P585, DOI 10.1097/01.olq.0000216031.93089.68; Huan XP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069740; Institute S, 1996, SAS SYST WIND; Koblin B, 2004, LANCET, V364, P41, DOI 10.1016/S0140-6736(04)16588-4; Lau JTF, 2008, AIDS CARE, V20, P820, DOI 10.1080/09540120701694048; Lau JTF, 2011, PUBLIC HEALTH, V125, P260, DOI 10.1016/j.puhe.2011.01.007; Lauritsen J, 2003, EPIDATA VERSION 3 CO; Liu H, 2006, SEX TRANSM DIS, V33, P68, DOI 10.1097/01.olq.0000187266.29927.11; Liu HJ, 2009, AIDS BEHAV, V13, P652, DOI 10.1007/s10461-008-9475-0; Marks G, 2005, JAIDS-J ACQ IMM DEF, V39, P446, DOI 10.1097/01.qai.0000151079.33935.79; Meda N, 1999, AIDS, V13, P1397, DOI 10.1097/00002030-199907300-00018; Rojanapithayakorn W, 1996, AIDS, V10, P1, DOI 10.1097/00002030-199601000-00001; Ruan YH, 2009, JAIDS-J ACQ IMM DEF, V52, P604, DOI 10.1097/QAI.0b013e3181b31f5c; Segura M, 2007, AIDS RES HUM RETROV, V23, P1322, DOI 10.1089/aid.2007.0063; Shang H, 2012, NATURE, V485, P576, DOI 10.1038/485576a; Smith AMA, 2004, SEX TRANSM INFECT, V80, P455, DOI 10.1136/sti.2004.010355; Song Y, 2011, AIDS CARE, V23, P179, DOI 10.1080/09540121.2010.487088; Stoneburner RL, 2004, SCIENCE, V304, P714, DOI 10.1126/science.1093166; Tang W, 2013, AIDS BEHAV, P1; UNAIDS, 2001, HIV PREV NEEDS SUCC; Wong FY, 2008, AIDS CARE, V20, P170, DOI 10.1080/09540120701534707; Wong FY, 2009, AIDS EDUC PREV, V21, P430, DOI 10.1521/aeap.2009.21.5.430; World Health Organization, 2011, PREVENTION TREATMENT; Wu ZY, 2013, CLIN INFECT DIS, V57, P298, DOI 10.1093/cid/cit210; Zhang HB, 2010, JAIDS-J ACQ IMM DEF, V53, pS88, DOI 10.1097/QAI.0b013e3181c7de63; Zhang L, 2013, LANCET INFECT DIS, V13, P955, DOI 10.1016/S1473-3099(13)70245-7	44	9	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2015	10	1							e115691	10.1371/journal.pone.0115691	http://dx.doi.org/10.1371/journal.pone.0115691			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AZ3BG	25559678	Green Published, gold			2022-12-27	WOS:000348102200010
J	Both, J; Krijgsman, O; Bras, J; Schaap, GR; Baas, F; Ylstra, B; Hulsebos, TJM				Both, Joeri; Krijgsman, Oscar; Bras, Johannes; Schaap, Gerard R.; Baas, Frank; Ylstra, Bauke; Hulsebos, Theo J. M.			Focal Chromosomal Copy Number Aberrations Identify CMTM8 and GPR177 as New Candidate Driver Genes in Osteosarcoma	PLOS ONE			English	Article							HIGH-GRADE OSTEOSARCOMA; INTEGRATIVE ANALYSIS; ARRAY CGH; EXPRESSION; CANCER; GENOME; TUMORS; IDENTIFICATION; RECEPTOR; CD147	Osteosarcoma is an aggressive bone tumor that preferentially develops in adolescents. The tumor is characterized by an abundance of genomic aberrations, which hampers the identification of the driver genes involved in osteosarcoma tumorigenesis. Our study aims to identify these genes by the investigation of focal copy number aberrations (CNAs, <3 Mb). For this purpose, we subjected 26 primary tumors of osteosarcoma patients to high-resolution single nucleotide polymorphism array analyses and identified 139 somatic focal CNAs. Of these, 72 had at least one gene located within or overlapping the focal CNA, with a total of 94 genes. For 84 of these genes, the expression status in 31 osteosarcoma samples was determined by expression microarray analysis. This enabled us to identify the genes of which the over-or underexpression was in more than 35% of cases in accordance to their copy number status (gain or loss). These candidate genes were subsequently validated in an independent set and furthermore corroborated as driver genes by verifying their role in other tumor types. We identified CMTM8 as a new candidate tumor suppressor gene and GPR177 as a new candidate oncogene in osteosarcoma. In osteosarcoma, CMTM8 has been shown to suppress EGFR signaling. In other tumor types, CMTM8 is known to suppress the activity of the oncogenic protein c-Met and GPR177 is known as an overexpressed upstream regulator of the Wnt-pathway. Further studies are needed to determine whether these proteins also exert the latter functions in osteosarcoma tumorigenesis.	[Both, Joeri; Baas, Frank; Hulsebos, Theo J. M.] Univ Amsterdam, Acad Med Ctr, Dept Genome Anal, NL-1105 AZ Amsterdam, Netherlands; [Krijgsman, Oscar; Ylstra, Bauke] Vrije Univ Amsterdam, Med Ctr, Dept Pathol, Amsterdam, Netherlands; [Bras, Johannes] Univ Amsterdam, Acad Med Ctr, Dept Pathol, NL-1105 AZ Amsterdam, Netherlands; [Schaap, Gerard R.] Univ Amsterdam, Acad Med Ctr, Dept Orthoped Surg, NL-1105 AZ Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam	Hulsebos, TJM (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Genome Anal, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	t.j.hulsebos@amc.uva.nl	Baas, Frank/F-9574-2010; Ylstra, Bauke/D-2906-2012	Baas, Frank/0000-0003-3912-5428; Ylstra, Bauke/0000-0001-9479-3010	VUMC-CCA (Cancer Centre Amsterdam, VU medical centre); Dutch Cancer society [UVA 2006-3525]	VUMC-CCA (Cancer Centre Amsterdam, VU medical centre); Dutch Cancer society(KWF Kankerbestrijding)	OK is supported by VUMC-CCA (Cancer Centre Amsterdam, VU medical centre). J. Both is supported by the Dutch Cancer society, grant no. UVA 2006-3525. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Astolfi A, 2010, LAB INVEST, V90, P1285, DOI 10.1038/labinvest.2010.110; Augustin I, 2012, EMBO MOL MED, V4, P38, DOI 10.1002/emmm.201100186; Bacci G, 2001, EUR J CANCER, V37, P2030, DOI 10.1016/S0959-8049(01)00229-5; Benayahu D, 2002, J CELL BIOCHEM, V84, P108, DOI 10.1002/jcb.1270; Both J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030907; Brazier H, 2006, J BONE MINER RES, V21, P1387, DOI 10.1359/JBMR.060613; Briccoli A, 2010, SURG ONCOL, V19, P193, DOI 10.1016/j.suronc.2009.05.002; Brosens RPM, 2010, J PATHOL, V221, P411, DOI 10.1002/path.2724; Cai YP, 2010, J PATHOL, V220, P24, DOI 10.1002/path.2628; Calicchio ML, 2009, AM J PATHOL, V174, P1638, DOI 10.2353/ajpath.2009.080517; Cappellari AR, 2012, MOL CELL BIOCHEM, V359, P315, DOI 10.1007/s11010-011-1025-9; Conrad DF, 2010, NATURE, V464, P704, DOI 10.1038/nature08516; Di Sano F, 2007, J NEUROCHEM, V102, P345, DOI 10.1111/j.1471-4159.2007.04479.x; Du XL, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-450; Fazi B, 2010, NEUROBIOL DIS, V40, P634, DOI 10.1016/j.nbd.2010.08.007; Ferguson WS, 2001, CANCER INVEST, V19, P292, DOI 10.1081/CNV-100102557; Feuk L, 2006, NAT REV GENET, V7, P85, DOI 10.1038/nrg1767; Freeman SS, 2008, CANCER-AM CANCER SOC, V113, P1453, DOI 10.1002/cncr.23782; Fujimoto Yoko, 2006, Journal of Medical and Dental Sciences, V53, P85; Futreal PA, 2004, NAT REV CANCER, V4, P177, DOI 10.1038/nrc1299; Futreal PA, 2001, NATURE, V409, P850, DOI 10.1038/35057046; Horak CE, 2007, CANCER RES, V67, P7238, DOI 10.1158/0008-5472.CAN-07-0962; Iwaya K, 2003, CLIN EXP METASTAS, V20, P525, DOI 10.1023/A:1025821229013; Jin CN, 2007, J CELL PHYSIOL, V211, P112, DOI 10.1002/jcp.20914; Jin CN, 2005, FEBS LETT, V579, P6375, DOI 10.1016/j.febslet.2005.10.021; Kansara M, 2009, J CLIN INVEST, V119, P837, DOI 10.1172/JCI37175; Katoh M, 2002, INT J MOL MED, V10, P221; Kresse SH, 2009, GENE CHROMOSOME CANC, V48, P679, DOI 10.1002/gcc.20675; Krijgsman O, 2014, BBA-MOL CELL RES, V1843, P2698, DOI 10.1016/j.bbamcr.2014.08.001; Kuijjer ML, 2013, INT J CANCER, V133, P2512, DOI 10.1002/ijc.28124; Kuijjer ML, 2012, GENE CHROMOSOME CANC, V51, P696, DOI 10.1002/gcc.21956; Leary RJ, 2008, P NATL ACAD SCI USA, V105, P16224, DOI 10.1073/pnas.0808041105; Lee JA, 2012, CANCER RES TREAT, V44, P202, DOI 10.4143/crt.2012.44.3.202; Li D, 2007, INT J BIOCHEM CELL B, V39, P2107, DOI 10.1016/j.biocel.2007.06.002; Li Q, 1999, MOL CELL BIOL, V19, P5339; Martin Jeff W., 2012, Sarcoma, V2012, P627254, DOI 10.1155/2012/627254; Maruyama EO, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056644; Molenaar JJ, 2012, NATURE, V483, P589, DOI 10.1038/nature10910; Nakamura K, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-191; Omi Y, 2012, THYROID, V22, P383, DOI 10.1089/thy.2010.0426; Ottaviani G, 2009, CANCER TREAT RES, V152, P421, DOI 10.1007/978-1-4419-0284-9_2; Pan YQ, 2012, ONCOL REP, V27, P2003, DOI 10.3892/or.2012.1729; Radig K, 1998, PATHOL RES PRACT, V194, P669, DOI 10.1016/S0344-0338(98)80125-8; Rauch TA, 2012, TUMOR BIOL, V33, P287, DOI 10.1007/s13277-011-0282-2; Ritter J, 2010, ANN ONCOL, V21, P320, DOI 10.1093/annonc/mdq276; Sadikovic B, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-202; Salvi A, 2007, INT J ONCOL, V31, P451; Sandberg AA, 2003, CANCER GENET CYTOGEN, V140, P1, DOI 10.1016/S0165-4608(02)00848-8; Smyth GK, 2005, BIOINFORMATICS, V21, P2067, DOI 10.1093/bioinformatics/bti270; Sweeny L, 2012, J CUTAN PATHOL, V39, P603, DOI 10.1111/j.1600-0560.2012.01912.x; Teicher BA, 2012, BIOCHEM PHARMACOL, V84, P1, DOI 10.1016/j.bcp.2012.02.009; van de Wiel MA, 2011, BRIEF BIOINFORM, V12, P10, DOI 10.1093/bib/bbq004; van Wieringen WN, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-80; Venkatraman ES, 2007, BIOINFORMATICS, V23, P657, DOI 10.1093/bioinformatics/btl646; Wang H, 2012, BRIT J CANCER, V106, P1446, DOI 10.1038/bjc.2012.95; Weir BA, 2007, NATURE, V450, P893, DOI 10.1038/nature06358; Zhang WJ, 2012, J BIOL CHEM, V287, P11850, DOI 10.1074/jbc.M111.258236; Zhong ZD, 2012, P NATL ACAD SCI USA, V109, pE2197, DOI 10.1073/pnas.1120407109; Zhu J, 2011, J CELL BIOCHEM, V112, P1749, DOI 10.1002/jcb.23094	59	27	30	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2014	9	12							e115835	10.1371/journal.pone.0115835	http://dx.doi.org/10.1371/journal.pone.0115835			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UC	25551557	Green Submitted, gold, Green Published			2022-12-27	WOS:000347119100066
J	Giordano, BL; Egermann, H; Bresin, R				Giordano, Bruno L.; Egermann, Hauke; Bresin, Roberto			The Production and Perception of Emotionally Expressive Walking Sounds: Similarities between Musical Performance and Everyday Motor Activity	PLOS ONE			English	Article							COMMUNICATION; MODEL; LOCOMOTION; BRAIN	Several studies have investigated the encoding and perception of emotional expressivity in music performance. A relevant question concerns how the ability to communicate emotions in music performance is acquired. In accordance with recent theories on the embodiment of emotion, we suggest here that both the expression and recognition of emotion in music might at least in part rely on knowledge about the sounds of expressive body movements. We test this hypothesis by drawing parallels between musical expression of emotions and expression of emotions in sounds associated with a non-musical motor activity: walking. In a combined production-perception design, two experiments were conducted, and expressive acoustical features were compared across modalities. An initial performance experiment tested for similar feature use in walking sounds and music performance, and revealed that strong similarities exist. Features related to sound intensity, tempo and tempo regularity were identified as been used similarly in both domains. Participants in a subsequent perception experiment were able to recognize both non-emotional and emotional properties of the sound-generating walkers. An analysis of the acoustical correlates of behavioral data revealed that variations in sound intensity, tempo, and tempo regularity were likely used to recognize expressed emotions. Taken together, these results lend support the motor origin hypothesis for the musical expression of emotions.	[Giordano, Bruno L.] Univ Glasgow, Inst Neurosci & Psychol, Glasgow, Lanark, Scotland; [Egermann, Hauke] Tech Univ Berlin, Audio Commun Grp, Berlin, Germany; [Bresin, Roberto] KTH Royal Inst Technol, Sound & Mus Comp Grp, Stockholm, Sweden	University of Glasgow; Technical University of Berlin; Royal Institute of Technology	Bresin, R (corresponding author), KTH Royal Inst Technol, Sound & Mus Comp Grp, Stockholm, Sweden.	roberto@kth.se	Bresin, Roberto/I-3458-2019; Giordano, Bruno L./A-4398-2008; Bresin, Roberto/J-4240-2012	Bresin, Roberto/0000-0002-3086-0322; Giordano, Bruno L./0000-0001-7002-0486; Bresin, Roberto/0000-0002-3086-0322	ConGAS COST Action [287]; EU [FP6-2004-NEST-PATH-028570]; Swedish Research Council [2010-4654]	ConGAS COST Action(European Cooperation in Science and Technology (COST)); EU(European Commission); Swedish Research Council(Swedish Research CouncilEuropean Commission)	Bruno L. Giordano was partially supported by the ConGAS COST Action 287. Roberto Bresin's work was supported by EU funded project Brain-Tuning FP6-2004-NEST-PATH-028570, EU funded FET-Open coordination action Sound to Sense, Sense to Sound, and by the Swedish Research Council, Grant Nr. 2010-4654. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bangert M, 2006, NEUROIMAGE, V30, P917, DOI 10.1016/j.neuroimage.2005.10.044; Bangert M, 2003, BMC NEUROSCI, V4, DOI 10.1186/1471-2202-4-26; Bigand E, 2005, COGNITION EMOTION, V19, P1113, DOI 10.1080/02699930500204250; Bresin R, 2000, COMPUT MUSIC J, V24, P44, DOI 10.1162/014892600559515; Bresin R, 2003, THE SOUNDING OBJECT, P111; Bresin R, 2011, CORTEX, V47, P1068, DOI 10.1016/j.cortex.2011.05.009; Cochrane T, 2010, AUSTRALAS J PHILOS, V88, P191, DOI 10.1080/00048400902941257; DAVIES S, 1980, MIND, V89, P67; de Gelder B, 2006, NAT REV NEUROSCI, V7, P242, DOI 10.1038/nrn1872; Efron Bradley, 1993, INTRO BOOTSTRAP, V57; Friberg A, 1999, J ACOUST SOC AM, V105, P1469, DOI 10.1121/1.426687; Gabrielsson A., 1996, PSYCHOL MUSIC, V24, P68, DOI DOI 10.1177/0305735696241007; Gibson E. J., 2000, ECOLOGICAL APPROACH; HAJDA JM, 1997, PERCEPTION COGNITION, P253; Hartmann W. M., 1997, SIGNALS SOUND SENSAT; IMAN RL, 1979, TECHNOMETRICS, V21, P499, DOI 10.2307/1268289; Janata P, 2003, NAT NEUROSCI, V6, P682, DOI 10.1038/nn1081; Juslin PN, 2006, J EXP PSYCHOL-APPL, V12, P79, DOI 10.1037/1076-898X.12.2.79; Juslin PN, 2003, PSYCHOL BULL, V129, P770, DOI 10.1037/0033-2909.129.5.770; Juslin PN, 1997, MUSIC PERCEPT, V14, P383; Juslin PN., 1997, MUSIC SCI, V1, P225, DOI [10.1177/102986499700100205, DOI 10.1177/102986499700100205]; Keysers C, 2009, CURR OPIN NEUROBIOL, V19, P666, DOI 10.1016/j.conb.2009.10.006; Koelsch S, 2006, HUM BRAIN MAPP, V27, P239, DOI 10.1002/hbm.20180; Kohler E, 2002, SCIENCE, V297, P846, DOI 10.1126/science.1070311; LEMAN M, 2008, EMBODIED MUSIC COGNI; LI XF, 1991, J ACOUST SOC AM, V90, P3036, DOI 10.1121/1.401778; McAdams S, 2004, J ACOUST SOC AM, V115, P1306, DOI 10.1121/1.1645855; McKean JW, 2001, PSYCHOL REP, V89, P267, DOI 10.2466/PR0.89.6.267-273; Molnar-Szakacs I, 2006, SOC COGN AFFECT NEUR, V1, P235, DOI 10.1093/scan/nsl029; NILSSON J, 1989, ACTA PHYSIOL SCAND, V136, P217, DOI 10.1111/j.1748-1716.1989.tb08655.x; NILSSON J, 1987, ACTA PHYSIOL SCAND, V129, P107, DOI 10.1111/j.1748-1716.1987.tb08045.x; Pastore RE, 2008, PERCEPT PSYCHOPHYS, V70, P13, DOI 10.3758/PP.70.1.13; Peretz I, 1998, COGNITION, V68, P111, DOI 10.1016/S0010-0277(98)00043-2; RUSSELL JA, 1980, J PERS SOC PSYCHOL, V39, P1161, DOI 10.1037/h0077714; SCHERER KR, 1986, PSYCHOL BULL, V99, P143, DOI 10.1037/0033-2909.99.2.143; SUNDBERG J, 1991, MUSIC PERCEPT, V9, P71; TUCKER LR, 1960, PSYCHOL SCALING THEO, P155; Varela FJ, 2017, EMBODIED MIND COGNIT; VONHAUSEGGER F, 1887, MUSIK ALS AUSDRUCK; Wallbott HG, 1998, EUR J SOC PSYCHOL, V28, P879, DOI 10.1002/(SICI)1099-0992(1998110)28:6<879::AID-EJSP901>3.0.CO;2-W; Williamon A., 2003, RES STUD MUSIC EDUC, V20, P23, DOI DOI 10.1177/1321103X030200010201	41	15	15	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2014	9	12							e115587	10.1371/journal.pone.0115587	http://dx.doi.org/10.1371/journal.pone.0115587			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	AX7UC	25551392	gold, Green Published, Green Submitted, Green Accepted			2022-12-27	WOS:000347119100044
J	Maganga, GD; Bourgarel, M; Nkoghe, JO; N'Dilimabaka, N; Drosten, C; Paupy, C; Morand, S; Drexler, JF; Leroy, EM				Maganga, Gael D.; Bourgarel, Mathieu; Nkoghe, Judicael Obame; N'Dilimabaka, Nadine; Drosten, Christian; Paupy, Christophe; Morand, Serge; Drexler, Jan Felix; Leroy, Eric M.			Identification of an Unclassified Paramyxovirus in Coleura afra: A Potential Case of Host Specificity	PLOS ONE			English	Article							RESERVOIR HOSTS; VIRUS-INFECTION; HENDRA VIRUS; RISK-FACTORS; FRUIT BATS; ENCEPHALITIS; LYSSAVIRUS; GENOME	Bats are known to harbor multiple paramyxoviruses. Despite the creation of two new genera, Aquaparamyxovirus and Ferlavirus, to accommodate this increasing diversity, several recently isolated or characterized viruses remain unclassified beyond the subfamily level. In the present study, among 985 bats belonging to 6 species sampled in the Belinga caves of Gabon, RNA of an unclassified paramyxovirus (Belinga bat virus, BelPV) was discovered in 14 African sheathtailed bats (Coleura afra), one of which exhibited several hemorrhagic lesions at necropsy, and viral sequence was obtained in two animals. Phylogenetically, BelPV is related to J virus and Beilong virus (BeiPV), two other unclassified paramyxoviruses isolated from rodents. In the diseased BelPV-infected C. afra individual, high viral load was detected in the heart, and the lesions were consistent with those reported in wild rodents and mice experimentally infected by J virus. BelPV was not detected in other tested bat species sharing the same roosting sites and living in very close proximity with C. afra in the two caves sampled, suggesting that this virus may be host-specific for C. afra. The mode of transmission of this paramyxovirus in bat populations remains to be discovered.	[Maganga, Gael D.; Bourgarel, Mathieu; Nkoghe, Judicael Obame; N'Dilimabaka, Nadine; Paupy, Christophe; Leroy, Eric M.] Ctr Int Rech Med Franceville, Franceville, Gabon; [Maganga, Gael D.] Inst Natl Super Agron & Biotechnol, Franceville, Gabon; [Bourgarel, Mathieu; Morand, Serge] UPR AGIRs, Ctr Cooperat Int Rech Agron Dev CIRAD, Montpellier, France; [Bourgarel, Mathieu] UPR AGIRs, Ctr Cooperat Int Rech Agron Dev CIRAD, Harare, Zimbabwe; [Nkoghe, Judicael Obame; Paupy, Christophe; Leroy, Eric M.] Inst Rech Dev, UMR MIVEGEC 224, IRD CNRS UM1 UM2, Montpellier, France; [Drosten, Christian; Drexler, Jan Felix] Univ Bonn, Med Ctr, Inst Virol, Bonn, Germany; [Morand, Serge] Univ Montpellier 2, CNRS UM2, CC065, Montpellier, France	CIRAD; CIRAD; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; University of Bonn; Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier	Maganga, GD (corresponding author), Ctr Int Rech Med Franceville, BP 769, Franceville, Gabon.	gael_maganga@yahoo.fr	LEROY, Eric M/I-4347-2016; Morand, Serge/M-5433-2018; OBAME-NKOGHE, Judicaël/ABD-3456-2020; Paupy, Christophe/I-4847-2017; Bourgarel, Mathieu/F-1750-2017; Drexler, Jan Felix/GMW-5098-2022	LEROY, Eric M/0000-0003-0022-0890; Morand, Serge/0000-0003-3986-7659; Paupy, Christophe/0000-0002-7122-2079; Bourgarel, Mathieu/0000-0001-9774-7669; Drexler, Jan Felix/0000-0002-3509-0232	Global Viral Forecasting, a 'Fonds de Solidarite Prioritaire'' grant from the Ministere des Affaires Etrangeres de la France (FSP) [2002005700]; government of Gabon; Total-Fina-Elf Gabon; Ministere des Affaires Etrangeres de la France	Global Viral Forecasting, a 'Fonds de Solidarite Prioritaire'' grant from the Ministere des Affaires Etrangeres de la France (FSP); government of Gabon; Total-Fina-Elf Gabon; Ministere des Affaires Etrangeres de la France	This work was supported by Global Viral Forecasting, a 'Fonds de Solidarite Prioritaire'' grant from the Ministere des Affaires Etrangeres de la France (FSP no 2002005700). CIRMF is supported by the government of Gabon, Total-Fina-Elf Gabon, and the Ministere des Affaires Etrangeres de la France. This study was also made possible by the generous support of the American people through the United States Agency for International Development (USAID), Emerging Pandemic Threats PREDICT. The contents are the responsibility of the authors and do not necessarily reflect the views of USAID or the United States Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Baer G.M., 1991, P341; Banyard AC, 2011, ADV VIRUS RES, V79, P239, DOI 10.1016/B978-0-12-387040-7.00012-3; Blehert DS, 2009, SCIENCE, V323, P227, DOI 10.1126/science.1163874; Calisher CH, 2006, CLIN MICROBIOL REV, V19, P531, DOI 10.1128/CMR.00017-06; CAMPBELL RW, 1977, SEARCH, V8, P435; Chu DKW, 2008, J VIROL, V82, P9107, DOI 10.1128/JVI.00857-08; Chu DKW, 2008, J GEN VIROL, V89, P1282, DOI 10.1099/vir.0.83605-0; Drexler JF, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1796; Duval L, 2012, INFECT GENET EVOL, V12, P1558, DOI 10.1016/j.meegid.2012.06.006; Frank G. H., 1981, Comparative diagnosis of viral diseases. Volume IV, part B, P187; Fraser GC, 1996, EMERG INFECT DIS, V2, P327, DOI 10.3201/eid0204.960408; Gannon WL, 2007, J MAMMAL, V88, P809, DOI 10.1644/06-MAMM-F-185R1.1; Halpin K, 2000, J GEN VIROL, V81, P1927, DOI 10.1099/0022-1317-81-8-1927; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Johnson N, 2006, J MED MICROBIOL, V55, P785, DOI 10.1099/jmm.0.46370-0; JUN MH, 1977, AUST J EXP BIOL MED, V55, P645, DOI 10.1038/icb.1977.63; Jun MH, 1976, THESIS JAMES COOK U; Kunz T.H., 2009, ECOLOGICAL BEHAV MET; LAMB R., 2001, FIELDS VIROLOGY, V1, P1305; LANDAU I, 1980, ANN PARASIT HUM COMP, V55, P271, DOI 10.1051/parasite/1980553271; Lau SKP, 2005, P NATL ACAD SCI USA, V102, P14040, DOI 10.1073/pnas.0506735102; Leroy EM, 2005, NATURE, V438, P575, DOI 10.1038/438575a; Li WD, 2005, SCIENCE, V310, P676, DOI 10.1126/science.1118391; Li Z, 2006, VIROLOGY, V346, P219, DOI 10.1016/j.virol.2005.10.039; Maganga GD, 2011, J INFECT DIS, V204, pS800, DOI 10.1093/infdis/jir358; McColl KA, 2002, AUST VET J, V80, P636, DOI 10.1111/j.1751-0813.2002.tb10973.x; Montgomery JM, 2008, EMERG INFECT DIS, V14, P1526, DOI 10.3201/eid1410.060507; Negredo A, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002304; Plowright RK, 2008, P ROY SOC B-BIOL SCI, V275, P861, DOI 10.1098/rspb.2007.1260; Renshaw RW, 2000, VIROLOGY, V270, P417, DOI 10.1006/viro.2000.0305; Swanepoel R, 2007, EMERG INFECT DIS, V13, P1847, DOI 10.3201/eid1312.071115; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tidona CA, 1999, VIROLOGY, V258, P425, DOI 10.1006/viro.1999.9693; TIKASING.ES, 1966, AM J TROP MED HYG, V15, P235, DOI 10.4269/ajtmh.1966.15.235; Tong S, 2008, J CLIN MICROBIOL, V46, P2652, DOI 10.1128/JCM.00192-08; Towner JS, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000764; Towner JS, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000536; Towner JS, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000212; Warnecke L, 2012, P NATL ACAD SCI USA, V109, P6999, DOI 10.1073/pnas.1200374109; Wong S, 2007, REV MED VIROL, V17, P67, DOI 10.1002/rmv.520; Woo PCY, 2011, J VIROL, V85, P13473, DOI 10.1128/JVI.06356-11	42	5	5	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2014	9	12							e115588	10.1371/journal.pone.0115588	http://dx.doi.org/10.1371/journal.pone.0115588			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UC	25551455	Green Published, gold			2022-12-27	WOS:000347119100045
J	Yang, ZM; Chang, ZL; Sun, LH; Yu, JJ; Huang, BR				Yang, Zhimin; Chang, Zuoliang; Sun, Lihong; Yu, Jingjin; Huang, Bingru			Physiological and Metabolic Effects of 5-Aminolevulinic Acid for Mitigating Salinity Stress in Creeping Bentgrass	PLOS ONE			English	Article							PHOTOSYNTHETIC GAS-EXCHANGE; BRASSICA-NAPUS; SALT TOLERANCE; OILSEED RAPE; HEAT TOLERANCE; RESPONSES; DROUGHT; GROWTH; SEEDLINGS; TOXICITY	The objectives of this study were to determine whether foliar application of a chlorophyll precursor, 5-aminolevulinic acid (ALA), could mitigate salinity stress damages in perennial grass species by regulating photosynthetic activities, ion content, antioxidant metabolism, or metabolite accumulation. A salinity-sensitive perennial grass species, creeping bentgrass (Agrostis stolonifera), was irrigated daily with 200 mM NaCl for 28 d, which were foliar sprayed with water or ALA (0.5 mg L-1) weekly during the experiment in growth chamber. Foliar application of ALA was effective in mitigating physiological damage resulting from salinity stress, as manifested by increased turf quality, shoot growth rate, leaf relative water content, chlorophyll content, net photosynthetic rate, stomatal conductance and transpiration rate. Foliar application of ALA also alleviated membrane damages, as shown by lower membrane electrolyte leakage and lipid peroxidation, which was associated with increases in the activities of antioxidant enzymes. Leaf content of Na+ was reduced and the ratio of K+/Na+ was increased with ALA application under salinity stress. The positive effects of ALA for salinity tolerance were also associated with the accumulation of organic acids (alpha-ketoglutaric acid, succinic acid, and malic acid), amino acids (alanine, 5-oxoproline, aspartic acid, and gamma - aminobutyric acid), and sugars (glucose, fructose, galactose, lyxose, allose, xylose, sucrose, and maltose). ALA-mitigation of physiological damages by salinity could be due to suppression of Na+ accumulation and enhanced physiological and metabolic activities related to photosynthesis, respiration, osmotic regulation, and antioxidant defense.	[Yang, Zhimin; Chang, Zuoliang; Sun, Lihong; Yu, Jingjin] Nanjing Agr Univ, Coll Agrograssland Sci, Nanjing 210095, Jiangsu, Peoples R China; [Huang, Bingru] Rutgers State Univ, Dept Plant Biol & Pathol, New Brunswick, NJ 08901 USA	Nanjing Agricultural University; Rutgers State University New Brunswick	Yang, ZM (corresponding author), Nanjing Agr Univ, Coll Agrograssland Sci, Nanjing 210095, Jiangsu, Peoples R China.	nauyzm@njau.edu.cn; huang@aesop.rutgers.edu						Ali B, 2014, IND CROP PROD, V52, P617, DOI 10.1016/j.indcrop.2013.11.033; Ali B, 2013, J PLANT GROWTH REGUL, V32, P604, DOI 10.1007/s00344-013-9328-6; [Anonymous], 1991, TURFGRASS MANAGEMENT; ARNON DI, 1949, PLANT PHYSIOL, V24, P1, DOI 10.1104/pp.24.1.1; Azevedo RA, 2006, AMINO ACIDS, V30, P143, DOI 10.1007/s00726-005-0245-2; BLUM A, 1981, CROP SCI, V21, P43, DOI 10.2135/cropsci1981.0011183X002100010013x; Bouche N, 2004, TRENDS PLANT SCI, V9, P110, DOI 10.1016/j.tplants.2004.01.006; CAKMAK I, 1994, J EXP BOT, V45, P1259, DOI 10.1093/jxb/45.9.1259; Carrow R.N., 1998, SALT AFFECTED TURFGR; Couee I, 2006, J EXP BOT, V57, P449, DOI 10.1093/jxb/erj027; DHINDSA RS, 1981, J EXP BOT, V32, P93, DOI 10.1093/jxb/32.1.93; Du HM, 2011, PHYSIOL PLANTARUM, V141, P251, DOI 10.1111/j.1399-3054.2010.01432.x; FOUGERE F, 1991, PLANT PHYSIOL, V96, P1228, DOI 10.1104/pp.96.4.1228; GIANNOPOLITIS CN, 1977, PLANT PHYSIOL, V59, P315, DOI 10.1104/pp.59.2.309; HEATH RL, 1968, ARCH BIOCHEM BIOPHYS, V125, P189, DOI 10.1016/0003-9861(68)90654-1; HOAGLAND D. R., 1950, Circular. California Agricultural Experiment Station, V347; Hotta Y, 1997, BIOSCI BIOTECH BIOCH, V61, P2025, DOI 10.1271/bbb.61.2025; Hotta Y, 2000, J JAPANESE SOC TURFG, V28, P97; Kaplan F, 2004, PLANT PHYSIOL, V136, P4159, DOI 10.1104/pp.104.052142; Kinnersley AM, 2000, CRIT REV PLANT SCI, V19, P479, DOI 10.1016/S0735-2689(01)80006-X; Korkmaz A, 2012, ABIOTIC STRESS RESPONSES IN PLANTS: METABOLISM, PRODUCTIVITY AND SUSTAINABILITY, P215, DOI 10.1007/978-1-4614-0634-1_12; LAI FM, 1994, PLANT SCI, V103, P209, DOI 10.1016/0168-9452(94)90209-7; Liu D, 2013, ACTA PHYSIOL PLANT, V35, P2747, DOI 10.1007/s11738-013-1307-9; Liu H, 2006, J FRUIT SCI, V6, P15; Maathuis FJM, 1999, ANN BOT-LONDON, V84, P123, DOI 10.1006/anbo.1999.0912; Marrs KA, 1996, ANNU REV PLANT PHYS, V47, P127, DOI 10.1146/annurev.arplant.47.1.127; Merewitz EB, 2012, J EXP BOT, V63, P1315, DOI 10.1093/jxb/err372; Miyashita Y, 2007, PLANT J, V49, P1108, DOI 10.1111/j.1365-313X.2006.03023.x; Morales-Payan J. P., 2004, Proceedings of the Florida State Horticultural Society, V117, P282; MUNNS R, 1993, PLANT CELL ENVIRON, V16, P15, DOI 10.1111/j.1365-3040.1993.tb00840.x; Munns R, 2002, PLANT CELL ENVIRON, V25, P239, DOI 10.1046/j.0016-8025.2001.00808.x; Naeem MS, 2011, ACTA PHYSIOL PLANT, V33, P517, DOI 10.1007/s11738-010-0575-x; Naeem MS, 2010, PLANT SOIL, V332, P405, DOI 10.1007/s11104-010-0306-5; Naeem MS, 2012, PLANT PHYSIOL BIOCH, V57, P84, DOI 10.1016/j.plaphy.2012.05.018; Nilsen ET, 1996, FIELD CROP RES, P192; Nishihara E, 2003, J PLANT PHYSIOL, V160, P1085, DOI 10.1078/0176-1617-00991; Parida AK, 2005, ECOTOX ENVIRON SAFE, V60, P324, DOI 10.1016/j.ecoenv.2004.06.010; Pessarakli M., 1999, HDB PLANT CROP STRES, P1; Qiu Y, 2007, ANAL CHIM ACTA, V583, P277, DOI 10.1016/j.aca.2006.10.025; Rizhsky L, 2004, PLANT PHYSIOL, V134, P1683, DOI 10.1104/pp.103.033431; Roessner U, 2000, PLANT J, V23, P131, DOI 10.1046/j.1365-313x.2000.00774.x; Sanchez DH, 2008, PHYSIOL PLANTARUM, V132, P209, DOI 10.1111/j.1399-3054.2007.00993.x; Sun YP, 2009, PHOTOSYNTHETICA, V47, P347, DOI 10.1007/s11099-009-0055-y; Urbonaviciute A, 2006, POL J ENVIRON STUD, V15, P921; Wang B., 1995, PLANT PHYSL COMMUN, V31, P50; Watanabe K, 2000, PLANT GROWTH REGUL, V32, P99, DOI 10.1023/A:1006369404273; Wongkantrakorn N, 2009, J PESTIC SCI, V34, P89, DOI 10.1584/jpestics.G08-43; Wu DZ, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0056624, 10.1371/journal.pone.0053932, 10.1371/journal.pone.0055431]; WU L, 1994, J PLANT NUTR, V17, P1905, DOI 10.1080/01904169409364854; Xu Y, 2013, CROP SCI, V53, P1626, DOI 10.2135/cropsci2013.01.0045; Youssef T, 2008, J PLANT GROWTH REGUL, V27, P1, DOI 10.1007/s00344-007-9025-4; Zhang CP, 2013, BOT STUD, V54, DOI 10.1186/1999-3110-54-18; Zhang JX, 1996, NEW PHYTOL, V132, P361, DOI 10.1111/j.1469-8137.1996.tb01856.x; Zhang WF, 2008, J PLANT GROWTH REGUL, V27, P159, DOI 10.1007/s00344-008-9042-y; Zhang ZJ, 2006, PLANT GROWTH REGUL, V49, P27, DOI 10.1007/s10725-006-0011-9; Zhen A, 2012, BIOL PLANTARUM, V56, P566, DOI 10.1007/s10535-012-0118-y	56	32	35	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2014	9	12							e116283	10.1371/journal.pone.0116283	http://dx.doi.org/10.1371/journal.pone.0116283			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UC	25551443	Green Submitted, Green Published, gold			2022-12-27	WOS:000347119100121
J	Casagrande, S; Pinxten, R; Zaid, E; Eens, M				Casagrande, Stefania; Pinxten, Rianne; Zaid, Erika; Eens, Marcel			Carotenoids, Birdsong and Oxidative Status: Administration of Dietary Lutein Is Associated with an Increase in Song Rate and Circulating Antioxidants (Albumin and Cholesterol) and a Decrease in Oxidative Damage	PLOS ONE			English	Article							OPEN-ENDED LEARNER; IMMUNE-RESPONSE; GREAT TITS; INFORMATION-CONTENT; SINGING BEHAVIOR; STRESS; TESTOSTERONE; SUPPLEMENTATION; ECOLOGY; SIGNALS	Despite the appealing hypothesis that carotenoid-based colouration signals oxidative status, evidence supporting the antioxidant function of these pigments is scarce. Recent studies have shown that lutein, the most common carotenoid used by birds, can enhance the expression of non-visual traits, such as birdsong. Nevertheless, the underlying physiological mechanisms remain unclear. In this study we hypothesized that male European starlings (Sturnus vulgaris) fed extra lutein increase their song rate as a consequence of an improved oxidative status. Although birdsong may be especially sensitive to the redox status, this has, to the best of our knowledge, never been tested. Together with the determination of circulating oxidative damage (ROMs, reactive oxygen metabolites), we quantified uric acid, albumin, total proteins, cholesterol, and testosterone, which are physiological parameters potentially sensitive to oxidation and/or related to both carotenoid functions and birdsong expression. We found that the birds fed extra lutein sang more frequently than control birds and showed an increase of albumin and cholesterol together with a decrease of oxidative damage. Moreover, we could show that song rate was associated with high levels of albumin and cholesterol and low levels of oxidative damage, independently from testosterone levels. Our study shows for the first time that song rate honestly signals the oxidative status of males and that dietary lutein is associated with the circulation of albumin and cholesterol in birds, providing a novel insight to the theoretical framework related to the honest signalling of carotenoid-based traits.	[Casagrande, Stefania; Pinxten, Rianne; Zaid, Erika; Eens, Marcel] Univ Antwerp, Dept Biol, Ethol Grp, B-2020 Antwerp, Belgium; [Pinxten, Rianne] Univ Antwerp, Res Unit Didact, Inst Educ & Informat Sci, B-2020 Antwerp, Belgium	University of Antwerp; University of Antwerp	Casagrande, S (corresponding author), Univ Antwerp, Dept Biol, Ethol Grp, Campus Drie Eiken, B-2020 Antwerp, Belgium.	stefania.casagrande@uantwerpen.be	Casagrande, Stefania/I-3725-2019; Eens, Marcel/AAC-8466-2020	Casagrande, Stefania/0000-0002-4264-8062; Zaid, Erika/0000-0002-4637-6711	FWO postdoctoral Pegasus Marie Curie Fellowship [05-05-1.2.205.13N]; University of Antwerp (TOPBOF); FWO-Flanders; Erasmus Placement program	FWO postdoctoral Pegasus Marie Curie Fellowship; University of Antwerp (TOPBOF); FWO-Flanders(FWO); Erasmus Placement program	S.C. was supported by an FWO postdoctoral Pegasus Marie Curie Fellowship (grant 05-05-1.2.205.13N). RP and ME were supported by the University of Antwerp (TOPBOF) and FWO-Flanders. EZ was supported by an Erasmus Placement program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso-Alvarez C, 2007, P ROY SOC B-BIOL SCI, V274, P819, DOI 10.1098/rspb.2006.3764; Ball GF, 1998, AM PSYCHOL, V53, P37, DOI 10.1037/0003-066X.53.1.37; Ben-Dor A, 2005, MOL CANCER THER, V4, P177; Berthouly A, 2007, FUNCT ECOL, V21, P335, DOI 10.1111/j.1365-2435.2006.01236.x; Bertrand S, 2006, J EXP BIOL, V209, P4414, DOI 10.1242/jeb.02540; Blount JD, 2004, ARCH BIOCHEM BIOPHYS, V430, P10, DOI 10.1016/j.abb.2004.03.039; Boogert NJ, 2008, ANIM BEHAV, V76, P1735, DOI 10.1016/j.anbehav.2008.08.009; Brown AJ, 2010, EVOLUTION, V64, P2179, DOI 10.1111/j.1558-5646.2010.01011.x; Buchanan KL, 2013, TRENDS ECOL EVOL, V28, P290, DOI 10.1016/j.tree.2013.02.004; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Casagrande S, 2012, BEHAV ECOL SOCIOBIOL, V66, P1319, DOI 10.1007/s00265-012-1387-3; Casagrande S, 2011, COMP BIOCHEM PHYS A, V160, P16, DOI 10.1016/j.cbpa.2011.04.011; Cohen A, 2007, COMP BIOCHEM PHYS B, V147, P110, DOI 10.1016/j.cbpb.2006.12.015; Costantini D, 2008, ECOL LETT, V11, P1238, DOI 10.1111/j.1461-0248.2008.01246.x; Costantini D, 2011, METHODS ECOL EVOL, V2, P321, DOI 10.1111/j.2041-210X.2010.00080.x; Costantini D, 2009, COMP BIOCHEM PHYS A, V153, P339, DOI 10.1016/j.cbpa.2009.03.010; Costantini D, 2009, FUNCT ECOL, V23, P506, DOI 10.1111/j.1365-2435.2009.01546.x; Deng JM, 2013, FISH SHELLFISH IMMUN, V34, P324, DOI 10.1016/j.fsi.2012.11.008; EENS M, 1991, BEHAVIOUR, V116, P210, DOI 10.1163/156853991X00049; Eens M, 1997, ADV STUD BEHAV, V26, P355, DOI 10.1016/S0065-3454(08)60384-8; El-Agamey A, 2004, ARCH BIOCHEM BIOPHYS, V430, P37, DOI 10.1016/j.abb.2004.03.007; Ewen JG, 2006, COMP BIOCHEM PHYS A, V143, P149, DOI 10.1016/j.cbpa.2005.11.006; Ewen JG, 2009, P NATL ACAD SCI USA, V106, P12798, DOI 10.1073/pnas.0902575106; Farrell TM, 2012, BEHAV ECOL, V23, P101, DOI 10.1093/beheco/arr162; Fitze PS, 2007, AM NAT, V169, pS137, DOI 10.1086/510094; Freeman-Gallant CR, 2011, BIOL LETTERS, V7, P429, DOI 10.1098/rsbl.2010.1186; Garamszegi LZ, 2004, BRAIN RES REV, V44, P187, DOI 10.1016/j.brainresrev.2003.12.001; Garratt M, 2014, P NATL ACAD SCI USA, V111, P8119, DOI 10.1073/pnas.1322282111; Garratt M, 2012, P ROY SOC B-BIOL SCI, V279, P3121, DOI 10.1098/rspb.2012.0568; Geens A, 2009, COMP BIOCHEM PHYS C, V150, P155, DOI 10.1016/j.cbpc.2009.04.007; Gentner TQ, 2000, ANIM BEHAV, V59, P443, DOI 10.1006/anbe.1999.1313; Halliwell B., 2007, FREE RADICALS BIOL M; Harding CF, 2004, ANN NY ACAD SCI, V1016, P524, DOI 10.1196/annals.1298.030; Hartley RC, 2004, TRENDS ECOL EVOL, V19, P353, DOI 10.1016/j.tree.2004.04.002; HARVEY R, 2011, BIOCHEMISTRY-US, P219; Hasselquist D, 2008, J AVIAN BIOL, V39, P384, DOI 10.1111/j.0908-8857.2008.04427.x; Helfenstein F, 2010, ECOL LETT, V13, P213, DOI 10.1111/j.1461-0248.2009.01419.x; HILL EG, 1966, J NUTR, V89, P143, DOI 10.1093/jn/89.2.143; Hill GE, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1314; Hill GE, 2011, ECOL LETT, V14, P625, DOI 10.1111/j.1461-0248.2011.01622.x; Horak P, 2010, FUNCT ECOL, V24, P960, DOI 10.1111/j.1365-2435.2010.01755.x; KAZUYOSHI T, 1995, BRAIN RES, V678, P1, DOI DOI 10.1016/0006-8993(95)00116-8; Kubli SP, 2014, AM NAT, V183, P660, DOI 10.1086/675757; MacDonald IF, 2006, P ROY SOC B-BIOL SCI, V273, P2559, DOI 10.1098/rspb.2006.3547; MANSON MM, 1992, ARCH TOXICOL, V66, P51, DOI 10.1007/BF02307270; McGraw KJ, 2006, ETHOLOGY, V112, P1209, DOI 10.1111/j.1439-0310.2006.01280.x; McGraw KJ, 2006, AUK, V123, P1161, DOI 10.1642/0004-8038(2006)123[1161:CIAICI]2.0.CO;2; McGraw KJ, 2006, PHYSIOL BEHAV, V87, P103, DOI 10.1016/j.physbeh.2005.09.001; McGraw KJ, 2003, AM NAT, V162, P704, DOI 10.1086/378904; Medina-Navarro R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008971; Meitern R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067545; Metcalfe NB, 2010, FUNCT ECOL, V24, P984, DOI 10.1111/j.1365-2435.2010.01750.x; Moreno J, 2013, ACTA ETHOL, V16, P65, DOI 10.1007/s10211-012-0138-9; Mortensen A, 2001, ARCH BIOCHEM BIOPHYS, V385, P13, DOI 10.1006/abbi.2000.2172; Muller W, 2009, HORM BEHAV, V55, P175, DOI 10.1016/j.yhbeh.2008.09.012; Navarro C, 2010, BEHAV ECOL SOCIOBIOL, V64, P1057, DOI 10.1007/s00265-010-0920-5; Ophir AG, 2010, J EVOLUTION BIOL, V23, P1564, DOI 10.1111/j.1420-9101.2010.02005.x; Pattison DI, 2009, CHEM RES TOXICOL, V22, P807, DOI 10.1021/tx800372d; Perez-Rodriguez L, 2009, BIOESSAYS, V31, P1116, DOI 10.1002/bies.200900070; Pinxten R, 2003, HORM BEHAV, V43, P394, DOI 10.1016/S0018-506X(03)00012-6; Pinxten R, 2002, HORM BEHAV, V42, P307, DOI 10.1006/hbeh.2002.1824; Remes V, 2007, FUNCT ECOL, V21, P776, DOI 10.1111/j.1365-2435.2007.01277.x; Riters LV, 2002, J COMP NEUROL, V444, P63, DOI 10.1002/cne.10131; Ritschard M, 2011, PHYSIOL BEHAV, V102, P30, DOI 10.1016/j.physbeh.2010.10.005; Roche M, 2008, FEBS LETT, V582, P1783, DOI 10.1016/j.febslet.2008.04.057; Sahin K, 2006, J THERM BIOL, V31, P307, DOI 10.1016/j.jtherbio.2005.12.006; Seifried HE, 2007, J NUTR BIOCHEM, V18, P567, DOI 10.1016/j.jnutbio.2006.10.007; Sewall KB, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2013.0344; SMITH LL, 1991, FREE RADICAL BIO MED, V11, P47, DOI 10.1016/0891-5849(91)90187-8; Sorce S, 2009, ANTIOXID REDOX SIGN, V11, P2481, DOI [10.1089/ars.2009.2578, 10.1089/ARS.2009.2578]; Stier A, 2012, FRONT ZOOL, V9, DOI 10.1186/1742-9994-9-37; STOCKER R, 1987, P NATL ACAD SCI USA, V84, P5918, DOI 10.1073/pnas.84.16.5918; Svensson PA, 2011, BEHAVIOUR, V148, P131, DOI 10.1163/000579510X548673; Taverna M, 2013, ANN INTENSIVE CARE, V3, DOI 10.1186/2110-5820-3-4; Thorogood R, 2008, FUNCT ECOL, V22, P1044, DOI 10.1111/j.1365-2435.2008.01455.x; Tummeleht L, 2006, COMP BIOCHEM PHYS C, V144, P166, DOI 10.1016/j.cbpc.2006.08.004; Turell L, 2013, FREE RADICAL BIO MED, V65, P244, DOI 10.1016/j.freeradbiomed.2013.05.050; Van Hout AJM, 2012, HORM BEHAV, V62, P563, DOI 10.1016/j.yhbeh.2012.09.008; Van Hout AJM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036547; Van Hout AJM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016326; Van Hout AJM, 2009, HORM BEHAV, V56, P564, DOI 10.1016/j.yhbeh.2009.09.010; Vinkler M, 2010, NATURWISSENSCHAFTEN, V97, P19, DOI 10.1007/s00114-009-0595-9; von Schantz T, 1999, P ROY SOC B-BIOL SCI, V266, P1, DOI 10.1098/rspb.1999.0597; Ward S, 2004, BEHAV ECOL, V15, P477, DOI 10.1093/beheco/arh038; ZAHAVI A, 1975, J THEOR BIOL, V53, P205, DOI 10.1016/0022-5193(75)90111-3; ZHANG LX, 1992, CANCER RES, V52, P5707; Zollinger SA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023198	87	17	17	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2014	9	12							e115899	10.1371/journal.pone.0115899	http://dx.doi.org/10.1371/journal.pone.0115899			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX6YH	25549336	Green Submitted, Green Published, gold			2022-12-27	WOS:000347063500036
J	Fukui, S; Araki, KS				Fukui, Shin; Araki, Kiwako S.			Spatial Niche Facilitates Clonal Reproduction in Seed Plants under Temporal Disturbance	PLOS ONE			English	Article							ASEXUAL REPRODUCTION; DISPERSAL; POPULATION; DIVERSITY; CORAL; METAPOPULATION; MAINTENANCE; ADAPTATION; SIMULATION; ALLOCATION	The evolutionary origins and advantages of clonal reproduction relative to sexual reproduction have been discussed for several taxonomic groups. In particular, organisms with a sessile lifestyle are often exposed to spatial and temporal environmental fluctuations. Thus, clonal propagation may be advantageous in such fluctuating environments, for sessile species that can reproduce both sexually and clonally. Here we introduce the concept of niche to a lattice space that changes spatially and temporally, by incorporating the compatibility between the characteristics of a sessile clonal plant with its habitat into a spatially explicit individual-based model. We evaluate the impact of spatially and temporally heterogeneous environments on the evolution of reproductive strategies: the optimal balance between seed and clonal reproduction of a clonal plant. The spatial niche case with local habitats led to avoidance of specialization in reproductive strategy, whereas stable environments or intensive environmental change tended to result in specialization in either clonal or seed reproduction under neutral conditions. Furthermore, an increase in spatial niches made clonal reproduction advantageous, as a consequence of competition among several genets under disturbed conditions, because a ramet reached a favorable habitat through a rare long-distance dispersal event via seed production. Thus, the existence of spatial niches could explain the advantages of clonal propagation.	[Fukui, Shin; Araki, Kiwako S.] Kyoto Univ, Ctr Ecol Res, Otsu, Shiga, Japan; [Fukui, Shin] Natl Inst Agroenvironm Sci, Agrometeorol Div, Tsukuba, Ibaraki 305, Japan; [Araki, Kiwako S.] Ritsumeikan Univ, Fac Life Sci, Dept Biotechnol, Kusatsu, Shiga, Japan	Kyoto University; National Institute for Agro-Environmental Sciences (NIAES) Japan; Ritsumeikan University	Fukui, S (corresponding author), Kyoto Univ, Ctr Ecol Res, Otsu, Shiga, Japan.	fshin3@gmail.com			Japan Society for the Promotion of Science (JSPS) for Young Scientists [201100907]; JSPS through the "Funding Program for Next Generation World-Leading Researchers (NEXT Program) [GS013]; Global COE program (A06) of Kyoto University; Grants for Excellent Graduate Schools program of MEXT, Japan; Grants-in-Aid for Scientific Research [26840148] Funding Source: KAKEN	Japan Society for the Promotion of Science (JSPS) for Young Scientists(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); JSPS through the "Funding Program for Next Generation World-Leading Researchers (NEXT Program); Global COE program (A06) of Kyoto University; Grants for Excellent Graduate Schools program of MEXT, Japan; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was funded by a research fellowship of the Japan Society for the Promotion of Science (JSPS) for Young Scientists (201100907 to KSA), JSPS through the "Funding Program for Next Generation World-Leading Researchers (NEXT Program, GS013)'' initiated by the Council for Science and Technology Policy (CSTP), Japan, Global COE program (A06) of Kyoto University, and the Grants for Excellent Graduate Schools program of MEXT, Japan. The funders had no role in study design, data collection or analysis, decision to publish, or preparation of the manuscript.	Barrett RDH, 2008, TRENDS ECOL EVOL, V23, P38, DOI 10.1016/j.tree.2007.09.008; Becks L, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001317; Cain ML, 1997, J ECOL, V85, P883, DOI 10.2307/2960609; Coffroth MA, 1998, EVOLUTION, V52, P379, DOI 10.1111/j.1558-5646.1998.tb01639.x; CONNELL J H, 1971, P298; COOK RE, 1979, AM NAT, V113, P769, DOI 10.1086/283435; de Kroon J.M, 1990, CLONAL GROWTH PLANTS; Dietz H, 1999, OECOLOGIA, V120, P225, DOI 10.1007/s004420050852; ELLSTRAND NC, 1987, AM J BOT, V74, P123, DOI 10.2307/2444338; Eriksson O, 1997, ECOLOGY AND EVOLUTION OF CLONAL PLANTS, P211; EVANS JP, 1995, ECOLOGY, V76, P1147, DOI 10.2307/1940922; Fischer M, 2001, EVOL ECOL, V15, P565, DOI 10.1023/A:1016013721469; Foster NL, 2007, J ANIM ECOL, V76, P384, DOI 10.1111/j.1365-2656.2006.01207.x; Fournier D, 2005, NATURE, V435, P1230, DOI 10.1038/nature03705; Gruntman M, 2004, P NATL ACAD SCI USA, V101, P3863, DOI 10.1073/pnas.0306604101; HAMILTON WD, 1977, NATURE, V269, P578, DOI 10.1038/269578a0; Harada Y, 1997, J ECOL, V85, P591, DOI 10.2307/2960530; HICKS DJ, 1985, PHYSL ECOLOGY N AM P, P257, DOI DOI 10.1007/978-94-009-4830-3_12; Hiebeler D, 2004, THEOR POPUL BIOL, V66, P205, DOI 10.1016/j.tpb.2004.06.004; Hubbell Stephen P., 2001, V32, pi; Jackson J. B. C., 1985, POPULATION BIOL EVOL; JANZEN DH, 1970, AM NAT, V104, P501, DOI 10.1086/282687; Karlson RH, 1996, ECOLOGY, V77, P1592, DOI 10.2307/2265554; King KC, 2009, CURR BIOL, V19, P1438, DOI 10.1016/j.cub.2009.06.062; Klimes L, 1997, ECOLOGY AND EVOLUTION OF CLONAL PLANTS, P1; KONDRASHOV AS, 1988, NATURE, V336, P435, DOI 10.1038/336435a0; Lande R, 1996, EVOLUTION, V50, P434, DOI 10.2307/2410812; LIVELY CM, 1987, NATURE, V328, P519, DOI 10.1038/328519a0; Lovett-Doust L., 1988, PLANT REPROD ECOLOGY; MULLER HJ, 1964, MUTAT RES, V1, P2, DOI 10.1016/0027-5107(64)90047-8; Nakamaru M, 2007, J THEOR BIOL, V248, P288, DOI 10.1016/j.jtbi.2007.05.012; Nishitani S, 1999, PLANT ECOL, V141, P179, DOI 10.1023/A:1009896111536; Ohkawara K, 2006, BIOL LETTERS, V2, P359, DOI 10.1098/rsbl.2006.0491; Pearcy M, 2011, P ROY SOC B-BIOL SCI, V278, P2677, DOI 10.1098/rspb.2010.2562; Reisch C, 2009, PLANT ECOL, V201, P699, DOI 10.1007/s11258-008-9458-2; Reusch TBH, 2006, MOL ECOL, V15, P277, DOI 10.1111/j.1365-294X.2005.02779.x; Roff Derek A., 1992; Skalova H, 1999, PLANT ECOL, V143, P129, DOI 10.1023/A:1009899803229; Skold HN, 2009, STEM CELLS IN MARINE ORGANISMS, P105, DOI 10.1007/978-90-481-2767-2_5; SMITH JM, 1971, J THEOR BIOL, V30, P319, DOI 10.1016/0022-5193(71)90058-0; Stearns S.C., 1992, pi; Stocklin J, 2004, EVOL ECOL, V18, P563, DOI 10.1007/s10682-004-5144-6; Tani T, 2001, ANN BOT-LONDON, V88, P393, DOI 10.1006/anbo.2001.1483; Travis JMJ, 1998, P ROY SOC B-BIOL SCI, V265, P17, DOI 10.1098/rspb.1998.0258; Tubay JM, 2013, SCI REP-UK, V3, DOI 10.1038/srep02835; Van Groenendael J. M., 1997, P191; Van Valen L., 1973, EVOL THEORY, V1, P1, DOI DOI 10.1038/344864A0; WATKINSON AR, 1993, J ECOL, V81, P707, DOI 10.2307/2261668; Winkler E, 2001, EVOL ECOL, V15, P281, DOI 10.1023/A:1016080714200; Wright S, 1943, GENETICS, V28, P114; Yanai RD, 2000, FOREST ECOL MANAG, V138, P273, DOI 10.1016/S0378-1127(00)00402-3	51	8	11	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2014	9	12							e116111	10.1371/journal.pone.0116111	http://dx.doi.org/10.1371/journal.pone.0116111			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX6YH	25549330	Green Published, gold, Green Submitted			2022-12-27	WOS:000347063500051
J	Guedj, K; Khallou-Laschet, J; Clement, M; Morvan, M; Delbosc, S; Gaston, AT; Andreata, F; Castier, Y; Deschildre, C; Michel, JB; Caligiuri, G; Nicoletti, A				Guedj, Kevin; Khallou-Laschet, Jamila; Clement, Marc; Morvan, Marion; Delbosc, Sandrine; Gaston, Anh-Thu; Andreata, Francesco; Castier, Yves; Deschildre, Catherine; Michel, Jean-Baptiste; Caligiuri, Giuseppina; Nicoletti, Antonino			Inflammatory Micro-Environmental Cues of Human Atherothrombotic Arteries Confer to Vascular Smooth Muscle Cells the Capacity to Trigger Lymphoid Neogenesis	PLOS ONE			English	Article							NF-KAPPA-B; RHEUMATOID-ARTHRITIS; CHRONIC REJECTION; ATHEROSCLEROSIS; TISSUE; MICE; EXPRESSION; RESPONSES; SYNOVIUM; DISEASES	Background: Experimental atherosclerosis is characterized by the formation of tertiary lymphoid structures (TLOs) within the adventitial layer, which involves the chemokine-expressing aortic smooth muscle cells (SMCs). TLOs have also been described around human atherothrombotic arteries but the mechanisms of their formation remain poorly investigated. Herein, we tested whether human vascular SMCs play the role of chemokine-expressing cells that would trigger the formation of TLOs in atherothrombotic arteries. Results: We first characterized, by flow cytometry and immunofluorescence analysis, the prevalence and cell composition of TLOs in human abdominal aneurysms of the aorta (AAAs), an evolutive form of atherothrombosis. Chemotaxis experiments revealed that the conditioned medium from AAA tissues recruited significantly more B and T lymphocytes than the conditioned medium from control (N-AAA) tissues. This was associated with an increase in the concentration of CXCL13, CXCL16, CCL19, CCL20, and CCL21 chemokines in the conditioned medium from AAA tissues. Immunofluorescence analysis of AAA cryosections revealed that alpha-SMA-positive SMCs were the main contributors to the chemokine production. These results were confirmed by RT-qPCR assays where we found that primary vascular SMCs from AAA tissues expressed significantly more chemokines than SMCs from N-AAA. Finally, in vitro experiments demonstrated that the inflammatory cytokines found to be increased in the conditioned medium from AAA were able to trigger the production of chemokines by primary SMCs. Conclusion: Together, these results suggest that human vascular SMCs in atherothrombotic arteries, in response to inflammatory signals, are converted into chemokine-expressing cells that trigger the recruitment of immune cells and the formation of aortic TLOs.	[Guedj, Kevin; Khallou-Laschet, Jamila; Clement, Marc; Morvan, Marion; Delbosc, Sandrine; Gaston, Anh-Thu; Andreata, Francesco; Castier, Yves; Deschildre, Catherine; Michel, Jean-Baptiste; Caligiuri, Giuseppina; Nicoletti, Antonino] Hop Xavier Bichat, INSERM, Unite 1148, Paris, France; [Guedj, Kevin; Khallou-Laschet, Jamila; Clement, Marc; Andreata, Francesco; Nicoletti, Antonino] Univ Paris 07, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	Nicoletti, A (corresponding author), Hop Xavier Bichat, INSERM, Unite 1148, Paris, France.	antonino.nicoletti@inserm.fr	Nicoletti, Antonino/A-9460-2015; Caligiuri, Giuseppina/G-4810-2015; Michel, Jean-Baptiste/AAH-9336-2020; CLEMENT, Marc/GVS-8052-2022; DELBOSC, Sandrine/ABB-4618-2021	Nicoletti, Antonino/0000-0002-2623-0897; Caligiuri, Giuseppina/0000-0003-4973-2205; CLEMENT, Marc/0000-0002-6479-8360; Laschet, Jamila/0000-0002-5090-4417; Andreata, Francesco/0000-0002-5710-3671; Delbosc, Sandrine/0000-0001-8076-6927	Agence Nationale de la Recherche (ANR); Institut National de la Sante et de la Recherche Medicale (INSERM); Universite Paris 7 Denis Diderot; Fondation de France	Agence Nationale de la Recherche (ANR)(French National Research Agency (ANR)); Institut National de la Sante et de la Recherche Medicale (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Universite Paris 7 Denis Diderot; Fondation de France(Fondation de France)	This work was supported by Agence Nationale de la Recherche (ANR); Institut National de la Sante et de la Recherche Medicale (INSERM); Universite Paris 7 Denis Diderot and Fondation de France. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aloisi F, 2006, NAT REV IMMUNOL, V6, P205, DOI 10.1038/nri1786; Baddoura FK, 2005, AM J TRANSPLANT, V5, P510, DOI 10.1111/j.1600-6143.2004.00714.x; Bilsborough J, 2006, J ALLERGY CLIN IMMUN, V117, P418, DOI 10.1016/j.jaci.2005.10.046; Branen L, 2004, ARTERIOSCL THROM VAS, V24, P2137, DOI 10.1161/01.ATV.0000143933.20616.1b; Carrero R, 2012, STEM CELL REV REP, V8, P905, DOI 10.1007/s12015-012-9364-9; Drayton DL, 2006, NAT IMMUNOL, V7, P344, DOI 10.1038/ni1330; Dutertre CA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089983; Gao Q, 2010, J IMMUNOL, V185, P5820, DOI 10.4049/jimmunol.1000116; GERLIS LM, 1956, BRIT HEART J, V18, P166; Grabner R, 2009, J EXP MED, V206, P233, DOI 10.1084/jem.20080752; Guedj K, 2013, CARDIOVASC RES; Guedj K, 2014, CARDIOVASC RES, V101, P434, DOI 10.1093/cvr/cvt263; Hansson GK, 2001, ARTERIOSCL THROM VAS, V21, P1876, DOI 10.1161/hq1201.100220; Hosokawa Y, 2007, CLIN EXP IMMUNOL, V149, P146, DOI 10.1111/j.1365-2249.2007.03398.x; Houtkamp MA, 2001, J PATHOL, V193, P263, DOI 10.1002/1096-9896(2000)9999:9999<::AID-PATH774>3.0.CO;2-N; Kirii H, 2003, ARTERIOSCL THROM VAS, V23, P656, DOI 10.1161/01.ATV.0000064374.15232.C3; Lotzer K, 2010, ARTERIOSCL THROM VAS, V30, P395, DOI 10.1161/ATVBAHA.109.191395; Lutgens E, 2000, P NATL ACAD SCI USA, V97, P7464, DOI 10.1073/pnas.97.13.7464; Mabuchi T, 2013, J INVEST DERMATOL, V133, P164, DOI 10.1038/jid.2012.260; McLaren JE, 2009, CYTOKINE GROWTH F R, V20, P125, DOI 10.1016/j.cytogfr.2008.11.003; Michel JB, 2007, ARTERIOSCL THROM VAS, V27, P1259, DOI 10.1161/ATVBAHA.106.137851; Pablos JL, 2005, BMC IMMUNOL, V6, DOI 10.1186/1471-2172-6-6; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pickens SR, 2011, ARTHRITIS RHEUM-US, V63, P914, DOI 10.1002/art.30232; Pietila TE, 2007, J IMMUNOL, V178, P253, DOI 10.4049/jimmunol.178.1.253; SAPHIR O, 1950, ARCH PATHOL, V49, P418; Shahrara S, 2010, J IMMUNOL, V184, P4479, DOI 10.4049/jimmunol.0901942; STEERE AC, 1988, ARTHRITIS RHEUM, V31, P487, DOI 10.1002/art.1780310405; Stott DI, 1998, J CLIN INVEST, V102, P938, DOI 10.1172/JCI3234; Thaunat O, 2010, J IMMUNOL, V185, P717, DOI 10.4049/jimmunol.0903589	30	20	21	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2014	9	12							e116295	10.1371/journal.pone.0116295	http://dx.doi.org/10.1371/journal.pone.0116295			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX6YH	25548922	Green Submitted, Green Published, gold			2022-12-27	WOS:000347063500073
J	Lin, AYM; Huynh, A; Lanckriet, G; Barrington, L				Lin, Albert Yu-Min; Huynh, Andrew; Lanckriet, Gert; Barrington, Luke			Crowdsourcing the Unknown: The Satellite Search for Genghis Khan	PLOS ONE			English	Article								Massively parallel collaboration and emergent knowledge generation is described through a large scale survey for archaeological anomalies within ultra-high resolution earth-sensing satellite imagery. Over 10K online volunteers contributed 30K hours (3.4 years), examined 6,000 km(2), and generated 2.3 million feature categorizations. Motivated by the search for Genghis Khan's tomb, participants were tasked with finding an archaeological enigma that lacks any historical description of its potential visual appearance. Without a pre-existing reference for validation we turn towards consensus, defined by kernel density estimation, to pool human perception for "out of the ordinary" features across a vast landscape. This consensus served as the training mechanism within a self-evolving feedback loop between a participant and the crowd, essential driving a collective reasoning engine for anomaly detection. The resulting map led a National Geographic expedition to confirm 55 archaeological sites across a vast landscape. A increased ground-truthed accuracy was observed in those participants exposed to the peer feedback loop over those whom worked in isolation, suggesting collective reasoning can emerge within networked groups to outperform the aggregate independent ability of individuals to define the unknown.	[Lin, Albert Yu-Min] Univ Calif San Diego, Calif Inst Telecommun & Informat Technol, San Diego, CA 92103 USA; [Huynh, Andrew] Univ Calif San Diego, Dept Comp Sci & Engn, San Diego, CA 92103 USA; [Lanckriet, Gert; Barrington, Luke] Univ Calif San Diego, Dept Elect & Comp Engn, San Diego, CA 92103 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Lin, AYM (corresponding author), Univ Calif San Diego, Calif Inst Telecommun & Informat Technol, San Diego, CA 92103 USA.	a5lin@ucsd.edu			National Science Foundation [EAGER ISS-1145291, HCC IIS-1219138]	National Science Foundation(National Science Foundation (NSF))	This work was funded by National Science Foundation (EAGER ISS-1145291 and HCC IIS-1219138). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allard F, 2005, ANTIQUITY, V79, P547, DOI 10.1017/S0003598X00114498; Alstott J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095140; Barrington L., 2012, ANN GEOPHYS, V54; Boudreau KJ, 2013, HARVARD BUS REV, V91, P60; Cooper S, 2010, NATURE, V466, P756, DOI 10.1038/nature09304; Couzin ID, 2003, ADV STUD BEHAV, V32, P1, DOI 10.1016/S0065-3454(03)01001-5; Goodchild MF, 2007, GEOJOURNAL, V69, P211, DOI 10.1007/s10708-007-9111-y; Haklay M, 2008, IEEE PERVAS COMPUT, V7, P12, DOI 10.1109/MPRV.2008.80; Hand E, 2010, NATURE, V465, P673, DOI 10.1038/465673a; Ipeirotis PG, 2014, DATA MIN KNOWL DISC, V28, P402, DOI 10.1007/s10618-013-0306-1; Jacobson E, 1993, DEER GODDESS ANCIENT, V55; JACOBSON-TEPFER Esther, 2010, ARCHAEOLOGY LANDSCAP; Kittur A, 2008, CHI 2008: 26TH ANNUAL CHI CONFERENCE ON HUMAN FACTORS IN COMPUTING SYSTEMS VOLS 1 AND 2, CONFERENCE PROCEEDINGS, P453; Kosinski M, 2012, CROWD IQ MEASURING I; Krumme C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033785; Lin Albert Yu-Min, 2011, Advances in Visual Computing. Proceedings 7th International Symposium, ISVC 2011, P229, DOI 10.1007/978-3-642-24031-7_23; Lin AYM, 2011, IEEE J-STARS, V4, P870, DOI 10.1109/JSTARS.2011.2143696; Lin AY-M, 2013, HDB HUMAN COMPUTATIO, P171; Lintott CJ, 2008, MON NOT R ASTRON SOC, V389, P1179, DOI 10.1111/j.1365-2966.2008.13689.x; Oishi K, 2014, SCI REP-UK, V4, DOI 10.1038/srep04100; PARZEN E, 1962, ANN MATH STAT, V33, P1065, DOI 10.1214/aoms/1177704472; Pickard G, 2011, SCIENCE, V334, P509, DOI 10.1126/science.1205869; Rahwan I, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2013.1211; Rahwan I, 2013, COMPUTER, V46, P68, DOI 10.1109/MC.2012.295; ROSENBLATT M, 1956, ANN MATH STAT, V27, P832, DOI 10.1214/aoms/1177728190; Rutherford A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074628; Salganik MJ, 2006, SCIENCE, V311, P854, DOI 10.1126/science.1121066; Scott D, 1992, MULTIVARIATE DENSITY, P1; Sorokin A, 2008, PROC CVPR IEEE, P23; von Ahn L, 2004, 22 INT C HUM FACT CO; von Ahn L, 2006, COMPUTER, V39, P92, DOI 10.1109/MC.2006.196; Woolley AW, 2010, SCIENCE, V330, P686, DOI 10.1126/science.1193147	32	24	24	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2014	9	12							e114046	10.1371/journal.pone.0114046	http://dx.doi.org/10.1371/journal.pone.0114046			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX6YH	25549335	Green Published, Green Submitted, gold			2022-12-27	WOS:000347063500006
J	Yan, CZ; Wang, ZH; Luo, ZX				Yan, Changzhou; Wang, Zhenhong; Luo, Zhuanxi			Arsenic Efflux from Microcystis aeruginosa under Different Phosphate Regimes	PLOS ONE			English	Article							SPECIATION; FOOD; BIOTRANSFORMATION; BIOACCUMULATION; ACCUMULATION; TOXICITY; DYNAMICS; BIOMETHYLATION; TRANSFORMATION; INHIBITION	Phytoplankton plays an important role in arsenic speciation, distribution, and cycling in freshwater environments. Little information, however, is available on arsenic efflux from the cyanobacteria Microcystis aeruginosa under different phosphate regimes. This study investigated M. aeruginosa arsenic efflux and speciation by pre-exposing it to 10 mu M arsenate or arsenite for 24 h during limited (12 h) and extended (13 d) depuration periods under phosphate enriched (+P) and phosphate depleted (-P) treatments. Arsenate was the predominant species detected in algal cells throughout the depuration period while arsenite only accounted for no greater than 45% of intracellular arsenic. During the limited depuration period, arsenic efflux occurred rapidly and only arsenate was detected in solutions. During the extended depuration period, however, arsenate and dimethylarsinic acid (DMA) were found to be the two predominant arsenic species detected in solutions under -P treatments, but arsenate was the only species detected under +P treatments. Experimental results also suggest that phosphorus has a significant effect in accelerating arsenic efflux and promoting arsenite bio-oxidation in M. aeruginosa. Furthermore, phosphorus depletion can reduce arsenic efflux from algal cells as well as accelerate arsenic reduction and methylation. These findings can contribute to our understanding of arsenic biogeochemistry in aquatic environments and its potential environmental risks under different phosphorus levels.	[Yan, Changzhou; Wang, Zhenhong; Luo, Zhuanxi] Chinese Acad Sci, Inst Urban Environm, Key Lab Urban Environm & Hlth, Xiamen 361021, Peoples R China; [Wang, Zhenhong] Minnan Normal Univ, Coll Chem & Environm, Zhangzhou 363000, Peoples R China	Chinese Academy of Sciences; Institute of Urban Environment, CAS; MinNan Normal University	Yan, CZ (corresponding author), Chinese Acad Sci, Inst Urban Environm, Key Lab Urban Environm & Hlth, Xiamen 361021, Peoples R China.	czyan@iue.ac.cn	CAS, KLUEH/T-5743-2019; luo, Zhuanxi/B-8441-2009	luo, Zhuanxi/0000-0003-0164-4492	National Nature Science Foundation of China [21277136]; International Science & Technology Cooperation Program of China [2011DFB91710]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); International Science & Technology Cooperation Program of China	This work was jointly supported by the National Nature Science Foundation of China (Project No. 21277136), International Science & Technology Cooperation Program of China (2011DFB91710). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali W, 2009, CELL MOL LIFE SCI, V66, P2329, DOI 10.1007/s00018-009-0021-7; Croteau MN, 2004, ENVIRON SCI TECHNOL, V38, P5002, DOI 10.1021/es049432q; Elias M, 2012, NATURE, V491, P134, DOI 10.1038/nature11517; Guo PR, 2011, ENVIRON TOXICOL CHEM, V30, P1754, DOI 10.1002/etc.567; Hasegawa H, 2001, CHEMOSPHERE, V43, P265, DOI 10.1016/S0045-6535(00)00137-5; Heikens A, 2007, REV ENVIRON CONTAM T, V189, P43, DOI 10.1007/978-0-387-35368-5_3; Hellweger FL, 2004, ENVIRON SCI TECHNOL, V38, P6716, DOI 10.1021/es049660k; Huang ZC, 2007, J ENVIRON SCI-CHINA, V19, P714, DOI 10.1016/S1001-0742(07)60119-3; Kaise T, 1997, APPL ORGANOMET CHEM, V11, P297, DOI 10.1002/(SICI)1099-0739(199704)11:4<297::AID-AOC584>3.0.CO;2-0; Khan FR, 2012, ENVIRON SCI TECHNOL, V46, P7621, DOI 10.1021/es301253s; Levy JL, 2005, ENVIRON TOXICOL CHEM, V24, P2630, DOI 10.1897/04-580R.1; Liu GJ, 2006, WA SCI TECHNOL, V6, P175, DOI 10.2166/ws.2006.954; Liu J, 2002, ENVIRON HEALTH PERSP, V110, P119, DOI 10.1289/ehp.02110119; Lloyd JR, 2006, ELEMENTS, V2, P85, DOI 10.2113/gselements.2.2.85; MAEDA S, 1992, APPL ORGANOMET CHEM, V6, P407, DOI 10.1002/aoc.590060416; Meharg AA, 2002, NEW PHYTOL, V154, P29, DOI 10.1046/j.1469-8137.2002.00363.x; MEHARG AA, 1994, PLANT CELL ENVIRON, V17, P989, DOI 10.1111/j.1365-3040.1994.tb02032.x; MORRIS RJ, 1984, MAR CHEM, V14, P259, DOI 10.1016/0304-4203(84)90046-X; Pigna M, 2010, J SOIL SCI PLANT NUT, V10, P428, DOI 10.4067/S0718-95162010000200004; Quaghebeur M, 2003, PLANT PHYSIOL, V132, P1600, DOI 10.1104/pp.103.021741; Quisel JD, 1996, PLANT PHYSIOL, V111, P839, DOI 10.1104/pp.111.3.839; Rahman MA, 2014, AQUAT TOXICOL, V146, P212, DOI 10.1016/j.aquatox.2013.11.009; Rahman MA, 2012, ENVIRON RES, V116, P118, DOI 10.1016/j.envres.2012.03.014; Rahman MA, 2012, APPL GEOCHEM, V27, P304, DOI 10.1016/j.apgeochem.2011.09.020; Ruttens A, 2012, J GEOCHEM EXPLOR, V121, P55, DOI 10.1016/j.gexplo.2012.07.003; SANDERS JG, 1980, ESTUAR COAST MAR SCI, V10, P555, DOI 10.1016/S0302-3524(80)80075-2; Sharma VK, 2009, ENVIRON INT, V35, P743, DOI 10.1016/j.envint.2009.01.005; Signes-Pastor A, 2007, GEODERMA, V137, P504, DOI 10.1016/j.geoderma.2006.10.012; Slaughter DC, 2012, MICROBIOL RES, V167, P151, DOI 10.1016/j.micres.2011.05.007; Wang LH, 2009, J ENVIRON SCI, V21, P346, DOI 10.1016/S1001-0742(08)62275-5; Wang NX, 2013, WATER RES, V47, P2497, DOI 10.1016/j.watres.2013.02.034; Wang ZH, 2013, ENVIRON SCI POLLUT R, V20, P7286, DOI 10.1007/s11356-013-1741-7; Xue PY, 2012, ENVIRON SCI POLLUT R, V19, P3969, DOI 10.1007/s11356-012-0856-6; Ye J, 2013, ENVIRON SCI TECHNOL, V47, P3893, DOI 10.1021/es304593c; Yin XX, 2012, WATER AIR SOIL POLL, V223, P1183, DOI 10.1007/s11270-011-0936-0; Yin XX, 2011, J ENVIRON SCI, V23, P1186, DOI 10.1016/S1001-0742(10)60492-5; Zhao FJ, 2010, ANNU REV PLANT BIOL, V61, P535, DOI 10.1146/annurev-arplant-042809-112152	37	16	18	4	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2014	9	12							e116099	10.1371/journal.pone.0116099	http://dx.doi.org/10.1371/journal.pone.0116099			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX6YH	25549253	Green Published, Green Submitted, gold			2022-12-27	WOS:000347063500050
J	Hu, Q; Wang, XY; He, HG; Wei, HM; Kang, LK; Qin, GC				Hu, Qiao; Wang, Xiao-Yan; He, Hong-Guang; Wei, Hai-Ming; Kang, Li-Ke; Qin, Gui-Can			Acoustic Radiation Force Impulse Imaging for Non-Invasive Assessment of Renal Histopathology in Chronic Kidney Disease	PLOS ONE			English	Article							TISSUE ELASTICITY QUANTIFICATION; SHEAR-WAVE ELASTOGRAPHY; TRANSIENT ELASTOGRAPHY; SERUM CREATININE; LIVER FIBROSIS; BLOOD-PRESSURE; FEASIBILITY; PREVALENCE; VELOCITY	Objective: To investigate the stiffness values obtained by acoustic radiation force impulse (ARFI) quantification in assessing renal histological fibrosis of chronic kidney disease (CKD). Methods: 163 patients with CKD and 32 healthy volunteers were enrolled between June 2013 and April 2014. ARFI quantification, given as shear wave velocity (SWV), was performed to measure renal parenchyma stiffness. Diagnostic performance of ARFI imaging and conventional ultrasound (US) were compared with histologic scores at renal biopsy. Intra- and inter-observer reliability of SWV measurement was analyzed. Results: In CKD patients, SWV measurements correlated significantly with pathological parameters (r=-0.422--0.511, P< 0.001), serum creatinine (r=-0.503, P<0.001), and glomerular filtration rate (r=0.587, P<0.001). The mean SWV in kidneys with severely impaired (histologic score: >= 19 points) was significant lower than that mildly impaired (histologic score: <= 9 points), moderately impaired (histologic score: 10-18 points), and control groups (all P<0.001). Receiver operating characteristic (ROC) curves analyses indicated that the area under the ROC curve for the diagnosis of renal histological fibrosis using ARFI imaging was superior to these conventional US parameters. Using the optimal cut-off value of 2.65 m/s for the diagnosis of mildly impaired kidneys, 2.50 m/s for moderately impaired kidneys, and 2.33 m/s for severely impaired kidneys, the corresponding area under the ROC curves were 0.735, 0.744, and 0.895, respectively. Intra- and intre-observer agreement of SWV measurements were 0.709 (95% CI: 0.390-0.859, P<0.001) and 0.627 (95% CI: 0.233-0.818, P=0.004), respectively. Conclusions: ARFI may be an effective tool for evaluating renal histological fibrosis in CKD patients.	[Hu, Qiao; Wang, Xiao-Yan; Kang, Li-Ke; Qin, Gui-Can] Peoples Hosp Guangxi Zhuang Autonomous Reg, Dept Diagnost Ultrasound, Nanning, Peoples R China; [He, Hong-Guang] Peoples Hosp Guangxi Zhuang Autonomous Reg, Dept Nephrol, Nanning, Peoples R China; [Wei, Hai-Ming] Peoples Hosp Guangxi Zhuang Autonomous Reg, Dept Pathol, Nanning, Peoples R China		Hu, Q (corresponding author), Peoples Hosp Guangxi Zhuang Autonomous Reg, Dept Diagnost Ultrasound, Nanning, Peoples R China.	xyyxyhq@163.com			Guangxi Natural Science Foundation project [2012GXNSFBA053083]; National Natural Science Foundation of China [81260223]	Guangxi Natural Science Foundation project; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by Guangxi Natural Science Foundation project (2012GXNSFBA053083) and the National Natural Science Foundation of China (No. 81260223). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asano K, 2014, J ULTRAS MED, V33, P793, DOI 10.7863/ultra.33.5.793; Bojunga J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042735; Brosius FC, 2006, CIRCULATION, V114, P1083, DOI 10.1161/CIRCULATIONAHA.106.177321; Chen J, 2005, KIDNEY INT, V68, P2837, DOI 10.1111/j.1523-1755.2005.00757.x; Cosgrove DO, 2012, EUR RADIOL, V22, P1023, DOI 10.1007/s00330-011-2340-y; Cui GH, 2014, EXP THER MED, V7, P233, DOI 10.3892/etm.2013.1377; Dhaun N, 2014, KIDNEY INT, V85, P1039, DOI 10.1038/ki.2013.512; Eknoyan G, 2002, AM J KIDNEY DIS, V39, pS14, DOI 10.1053/ajkd.2002.30939; Fahey BJ, 2005, ULTRASOUND MED BIOL, V31, P1185, DOI 10.1016/j.ultrasmedbio.2005.05.004; Gennisson JL, 2012, ULTRASOUND MED BIOL, V38, P1559, DOI 10.1016/j.ultrasmedbio.2012.04.013; Goertz RS, 2011, EUR J RADIOL, V80, pE226, DOI 10.1016/j.ejrad.2010.09.025; Guo LH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068925; He WY, 2014, ULTRASOUND MED BIOL, V40, P322, DOI 10.1016/j.ultrasmedbio.2013.10.003; Katafuchi R, 1998, CLIN NEPHROL, V49, P1; Kircheis G, 2012, WORLD J GASTROENTERO, V18, P1077, DOI 10.3748/wjg.v18.i10.1077; Kwon HJ, 2011, WORLD J GASTROENTERO, V17, P1874, DOI 10.3748/wjg.v17.i14.1874; Levey AS, 2006, ANN INTERN MED, V145, P247, DOI 10.7326/0003-4819-145-4-200608150-00004; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Li GL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076322; Li QH, 2014, EUR J RADIOL, V83, P756, DOI 10.1016/j.ejrad.2014.01.024; Moghazi S, 2005, KIDNEY INT, V67, P1515, DOI 10.1111/j.1523-1755.2005.00230.x; Rizzo L, 2011, AM J GASTROENTEROL, V106, P2112, DOI 10.1038/ajg.2011.341; Stock KF, 2010, CLIN HEMORHEOL MICRO, V46, P139, DOI 10.3233/CH-2010-1340; Sugiura T, 2004, CLIN NEPHROL, V61, P119; Syversveen T, 2012, EUR RADIOL, V22, P2130, DOI 10.1007/s00330-012-2476-4; Syversveen T, 2011, TRANSPL INT, V24, P100, DOI 10.1111/j.1432-2277.2010.01165.x; Wang L, 2014, EUR RADIOL, V24, P1694, DOI 10.1007/s00330-014-3162-5; Wojcinski S, 2013, INT J WOMENS HEALTH, V5, P619, DOI 10.2147/IJWH.S50953; Yashima Y, 2012, J GASTROENTEROL, V47, P427, DOI 10.1007/s00535-011-0491-x; Ye XP, 2012, J ULTRAS MED, V31, P1245; Zhang QL, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-117	31	47	50	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2014	9	12							e115051	10.1371/journal.pone.0115051	http://dx.doi.org/10.1371/journal.pone.0115051			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UN	25546304	Green Submitted, Green Published, gold			2022-12-27	WOS:000347120200021
J	Morris, GC; Wiggins, RC; Woodhall, SC; Bland, JM; Taylor, CR; Jespers, V; Vcelar, BA; Lacey, CJ				Morris, Georgina C.; Wiggins, Rebecca C.; Woodhall, Sarah C.; Bland, J. Martin; Taylor, Carol R.; Jespers, Vicky; Vcelar, Brigitta A.; Lacey, Charles J.			MABGEL 1: First Phase 1 Trial of the Anti-HIV-1 Monoclonal Antibodies 2F5, 4E10 and 2G12 as a Vaginal Microbicide	PLOS ONE			English	Article							DIAGNOSING BACTERIAL VAGINOSIS; HIV-INFECTION; PREEXPOSURE PROPHYLAXIS; PASSIVE TRANSFER; IMMUNOGLOBULIN-G; SHIV CHALLENGE; VIRUS; NEUTRALIZATION; PROTECTION; MACAQUES	Background: Monoclonal antibodies (mAbs) which potently neutralize a broad range of HIV isolates are potential microbicide candidates. To date, topical application of mAbs in humans and their stability in vaginal secretions has not been studied. Objectives: To assess the pharmacokinetics and safety of the mAbs 2F5, 4E10 and 2G12 when applied vaginally in women. Design: A randomized, double-blind, placebo-controlled phase 1 trial. Methods: Twenty-eight healthy, sexually abstinent women administered 2.5 g of gel daily for 12 days containing either 10 or 20 mg/g of each mAb (MABGEL) or placebo. Main clinical evaluations and sampling occurred at baseline, 1, 8, and 24 hours post-1st dose and 12 and 36 hours post-12th dose. Results: After adjustment for dilution factors, median levels of 2F5, 4E10 and 2G12 in vaginal secretions at 1 hour post high-dose MABGEL were 7.74, 5.28 and 7.48 mg/ml respectively. Levels of 2F5 and 4E10 declined exponentially thereafter with similar estimated half-lives (4.6 and 4.3 hours). In contrast, 2G12 levels declined more rapidly in the first 8 hours, with an estimated half-life of 1.4 hours during this period. There was no evidence of systemic absorption. There were no significant differences in local or systemic adverse event rates or vaginal flora changes (by qPCR) between active and placebo gel arms. Whilst at least 1 adverse event was recorded in 96% of participants, 95% were mild and none were serious. Conclusions: Vaginal application of 50 mg of each mAb daily was safe over a 12 day period. Median mAb concentrations detected at 8 hours post dose were potentially sufficient to block HIV transmission. 2G12 exhibited more rapid elimination from the human vagina than 4E10 and 2F5, likely due to poor stability of 2G12 in acidic human vaginal secretions. Further research is needed to develop mAb-based vaginal microbicides and delivery systems.	[Morris, Georgina C.; Wiggins, Rebecca C.; Woodhall, Sarah C.; Lacey, Charles J.] Univ York, Hull York Med Sch, Ctr Immunol & Infect, York YO10 5DD, N Yorkshire, England; [Bland, J. Martin] Univ York, Dept Hlth Sci, York YO10 5DD, N Yorkshire, England; [Taylor, Carol R.] York Teaching Hosp NHS Fdn Trust, Hull York Med Sch, Expt Med Unit, York, N Yorkshire, England; [Jespers, Vicky] Inst Trop Med, B-2000 Antwerp, Belgium; [Vcelar, Brigitta A.] Polymun Sci Immunbiol Forsch GmbH, Vienna, Austria	University of Hull; University of York - UK; University of York - UK; University of Hull; University of York - UK; Institute of Tropical Medicine (ITM)	Lacey, CJ (corresponding author), Univ York, Hull York Med Sch, Ctr Immunol & Infect, York YO10 5DD, N Yorkshire, England.	charles.lacey@hyms.ac.uk			European Microbicides Programme (EMPRO) through a European Commission Framework 6 award; Polymun Scientific Immunbiologische Forschung GmbH	European Microbicides Programme (EMPRO) through a European Commission Framework 6 award; Polymun Scientific Immunbiologische Forschung GmbH	This trial was funded by the European Microbicides Programme (EMPRO) through a European Commission Framework 6 award, but was designed and conducted independently by the investigators. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. BAV is employed by Polymun Scientific Immunbiologische Forschung GmbH. Polymun Scientific Immunbiologische Forschung GmbH provided support in the form of salary for author BAV, and research materials, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author are articulated in the 'author contributions' section.	Abdel-Motal UM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026473; Abuaf N, 1997, THROMB HAEMOSTASIS, V77, P856; Alam SM, 2009, P NATL ACAD SCI USA, V106, P20234, DOI 10.1073/pnas.0908713106; Armbruster C, 2002, AIDS, V16, P227, DOI 10.1097/00002030-200201250-00012; Armbruster C, 2004, J ANTIMICROB CHEMOTH, V54, P915, DOI 10.1093/jac/dkh428; Baba TW, 2000, NAT MED, V6, P200, DOI 10.1038/72309; Baeten JM, 2012, NEW ENGL J MED, V367, P399, DOI 10.1056/NEJMoa1108524; Balazs AB, 2014, NAT MED, V20, P296, DOI 10.1038/nm.3471; Balazs AB, 2012, NATURE, V481, P81, DOI 10.1038/nature10660; Binley JA, 2004, J VIROL, V78, P13232, DOI 10.1128/JVI.78.23.13232-13252.2004; Blaskewicz CD, 2011, BIOL REPROD, V85, P97, DOI 10.1095/biolreprod.110.090423; Boswell CA, 2010, BIOCONJUGATE CHEM, V21, P2153, DOI 10.1021/bc100261d; Burton DR, 2011, P NATL ACAD SCI USA, V108, P11181, DOI 10.1073/pnas.1103012108; Byun R, 2004, J CLIN MICROBIOL, V42, P3128, DOI 10.1128/JCM.42.7.3128-3136.2004; Calarese DA, 2003, SCIENCE, V300, P2065, DOI 10.1126/science.1083182; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; *CONRAD WHO, 2004, MAN STAND COLP EV VA; De Backer E, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-115; De los Santos GE, 2004, CONTEMP TOP LAB ANIM, V43, P39; DEVENNY JJ, 1985, MICROCIRC ENDOTH LYM, V2, P15; Dhillon AK, 2007, J VIROL, V81, P6548, DOI 10.1128/JVI.02749-06; Doores KJ, 2010, J VIROL, V84, P10690, DOI 10.1128/JVI.01110-10; Dunlop DC, 2008, AIDS, V22, P2214, DOI 10.1097/QAD.0b013e328314b5df; Guedou FA, 2012, SEX TRANSM INFECT, V88, P545, DOI 10.1136/sextrans-2011-050319; Gupta S, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003776; Haynes Barton F., 2005, Human Antibodies, V14, P59; Haynes BF, 2005, SCIENCE, V308, P1906, DOI 10.1126/science.1111781; Hessell AJ, 2010, J VIROL, V84, P1302, DOI 10.1128/JVI.01272-09; Hong GY, 2000, J DRUG TARGET, V8, P67, DOI 10.3109/10611860008996853; Huang JH, 2012, NATURE, V491, P406, DOI 10.1038/nature11544; Jespers V, 2012, MICR C SYDN AUSTR OR; Jespers V, 2013, SEX TRANSM DIS, V40, P729, DOI 10.1097/01.olq.0000431070.38601.03; Jespers V, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-83; Joint United Nations Programme on HIV/AIDS (UNAIDS), 2012, UNAIDS REP GLOB AIDS; Kamali A, 2010, SEX TRANSM INFECT, V86, P222, DOI 10.1136/sti.2009.038372; Karim QA, 2011, SCIENCE, V333, P524; Karim QA, 2010, SCIENCE, V329, P1168, DOI 10.1126/science.1193748; Klein K, 2013, J VIROL IN PRESS; KROHN MA, 1989, J CLIN MICROBIOL, V27, P1266, DOI 10.1128/JCM.27.6.1266-1271.1989; Lewis DJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025165; Liu HC, 2008, J PHARM SCI-US, V97, P2426, DOI 10.1002/jps.21180; Loizou S, 2003, ANN RHEUM DIS, V62, P1106, DOI 10.1136/ard.62.11.1106; Marrazzo J.M., 2015, C RETR OPP INF ATL M, P509; Mascola JR, 1999, J VIROL, V73, P4009, DOI 10.1128/JVI.73.5.4009-4018.1999; Mascola JR, 2000, NAT MED, V6, P207, DOI 10.1038/72318; Mehandru S, 2007, J VIROL, V81, P11016, DOI 10.1128/JVI.01340-07; Microbicides Development Programme (MDP), 2007, TRIAL PROT MDP 301 I; Moher D, 2001, JAMA-J AM MED ASSOC, V285, P1987, DOI 10.1001/jama.285.15.1987; Moldt B, 2012, J VIROL, V86, P6189, DOI 10.1128/JVI.00491-12; Moog C, 2014, MUCOSAL IMMUNOL, V7, P46, DOI 10.1038/mi.2013.23; Myer L, 2005, LANCET INFECT DIS, V5, P786, DOI 10.1016/S1473-3099(05)70298-X; NUGENT RP, 1991, J CLIN MICROBIOL, V29, P297, DOI 10.1128/JCM.29.2.297-301.1991; Patton DL, 2004, J MED PRIMATOL, V33, P105, DOI 10.1111/j.1600-0684.2004.00059.x; Patton DL, 1996, SEX TRANSM DIS, V23, P489, DOI 10.1097/00007435-199611000-00009; Paul M, 2011, BIOTECHNOL APPL BIOC, V58, P58, DOI 10.1002/bab.6; Petrovas C, 1999, J AUTOIMMUN, V13, P347, DOI 10.1006/jaut.1999.0324; Ravel J, 2012, MBIO, V3, DOI 10.1128/mBio.00370-12; Ruprecht CR, 2011, J EXP MED, V208, P439, DOI 10.1084/jem.20101907; Scherer EM, 2007, AIDS, V21, P2131, DOI 10.1097/QAD.0b013e3282a4a632; Schulz KF, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000251; Scott Y, 2013, 20 C RETR OPP INF AT; Shen XY, 2009, J VIROL, V83, P3617, DOI 10.1128/JVI.02631-08; Stiegler G, 2001, AIDS RES HUM RETROV, V17, P1757, DOI 10.1089/08892220152741450; Tamrakar R, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-128; Thigpen MC, 2012, NEW ENGL J MED, V367, P423, DOI 10.1056/NEJMoa1110711; Trkola A, 2005, NAT MED, V11, P615, DOI 10.1038/nm1244; United States National Institutes of Health Division of AIDS, 2004, TABL GRAD SEV AD PED; Van Damme L, 2012, NEW ENGL J MED, V367, P411, DOI 10.1056/NEJMoa1202614; van de Wijgert JHHM, 2009, SEX TRANSM DIS, V36, P357, DOI 10.1097/OLQ.0b013e3181a4f695; Vcelar B, 2007, AIDS, V21, P2161, DOI 10.1097/QAD.0b013e328285da15; Walker LM, 2011, NATURE, V477, P466, DOI 10.1038/nature10373; Walker LM, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001028; Walker LM, 2009, SCIENCE, V326, P285, DOI 10.1126/science.1178746; Wang WR, 2011, DRUG METAB DISPOS, V39, P1469, DOI 10.1124/dmd.111.039453; WEISS L, 1995, CLIN IMMUNOL IMMUNOP, V77, P69, DOI 10.1016/0090-1229(95)90138-8; Wu XL, 2010, SCIENCE, V329, P856, DOI 10.1126/science.1187659; Xu JF, 2012, BIOTECHNOL ADV, V30, P1171, DOI 10.1016/j.biotechadv.2011.08.020; Zariffard MR, 2002, FEMS IMMUNOL MED MIC, V34, P277, DOI 10.1111/j.1574-695X.2002.tb00634.x	78	24	27	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2014	9	12							e116153	10.1371/journal.pone.0116153	http://dx.doi.org/10.1371/journal.pone.0116153			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UN	25546420	Green Published, gold			2022-12-27	WOS:000347120200103
J	Zhang, XM; Barberan, A; Zhu, XZ; Zhang, GM; Han, XG				Zhang, Ximei; Barberan, Albert; Zhu, Xunzhi; Zhang, Guangming; Han, Xingguo			Water Content Differences Have Stronger Effects than Plant Functional Groups on Soil Bacteria in a Steppe Ecosystem	PLOS ONE			English	Article							MICROBIAL COMMUNITIES; RHIZOSPHERE MICROBIOME; CURRENT KNOWLEDGE; DIVERSITY; BIODIVERSITY; MICROORGANISMS; GRASSLAND; REDUNDANCY; RESISTANCE; IDENTITY	Many investigations across natural and artificial plant diversity gradients have reported that both soil physicochemical factors and plant community composition affect soil microbial communities. To test the effect of plant diversity loss on soil bacterial communities, we conducted a five-year plant functional group removal experiment in a steppe ecosystem in Inner Mongolia (China). We found that the number and composition type of plant functional groups had no effect on bacterial diversity and community composition, or on the relative abundance of major taxa. In contrast, bacterial community patterns were significantly structured by soil water content differences among plots. Our results support researches that suggest that water availability is the key factor structuring soil bacterial communities in this semiarid ecosystem.	[Zhang, Ximei; Han, Xingguo] Chinese Acad Sci, Inst Appl Ecol, State Key Lab Forest & Soil Ecol, Shenyang 110016, Peoples R China; [Barberan, Albert] Univ Colorado, Cooperat Inst Res Environm Sci, Boulder, CO 80309 USA; [Zhu, Xunzhi] Jiangsu Univ Sci & Technol, Sch Biol & Chem Engn, Zhenjiang 212018, Jiangsu, Peoples R China; [Zhang, Guangming; Han, Xingguo] Chinese Acad Sci, State Key Lab Vegetat & Environm Change, Inst Bot, Beijing 100093, Peoples R China	Chinese Academy of Sciences; Shenyang Institute of Applied Ecology, CAS; University of Colorado System; University of Colorado Boulder; Jiangsu University of Science & Technology; Chinese Academy of Sciences; Institute of Botany, CAS	Zhang, GM (corresponding author), Chinese Acad Sci, State Key Lab Vegetat & Environm Change, Inst Bot, Beijing 100093, Peoples R China.	zhanggm@ibcas.ac.cn; xghan@ibcas.ac.cn	Barberan, Albert/A-5319-2013; Han, Xingguo/K-7552-2016	Han, Xingguo/0000-0002-1836-975X; BARBERAN, ALBERT/0000-0002-3066-7530	State Key Laboratory of Forest and Soil Ecology [LFSE201315]; "Strategic Priority Research Program'' of Chinese Academy of Sciences [XDB15010404]; National Natural Science Foundation of China [31300431]	State Key Laboratory of Forest and Soil Ecology; "Strategic Priority Research Program'' of Chinese Academy of Sciences(Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by State Key Laboratory of Forest and Soil Ecology (LFSE201315), "Strategic Priority Research Program'' of Chinese Academy of Sciences (XDB15010404), and National Natural Science Foundation (31300431) of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison SD, 2008, P NATL ACAD SCI USA, V105, P11512, DOI 10.1073/pnas.0801925105; [Anonymous], 2010, R LANG ENV STAT COMP; Bai YF, 2004, NATURE, V431, P181, DOI 10.1038/nature02850; Balvanera P, 2006, ECOL LETT, V9, P1146, DOI 10.1111/j.1461-0248.2006.00963.x; Bardgett RD, 1998, SOIL BIOL BIOCHEM, V30, P1867, DOI 10.1016/S0038-0717(98)00069-8; Batten KM, 2006, BIOL INVASIONS, V8, P217, DOI 10.1007/s10530-004-3856-8; Belnap J, 2005, ECOLOGY, V86, P298, DOI 10.1890/03-0567; Benjamini Y, 1995, J R STAT SOC B, V57, P57, DOI DOI 10.2307/2346101; Berendsen RL, 2012, TRENDS PLANT SCI, V17, P478, DOI 10.1016/j.tplants.2012.04.001; Broughton LC, 2000, OECOLOGIA, V125, P420, DOI 10.1007/s004420000456; Chu HY, 2010, ENVIRON MICROBIOL, V12, P2998, DOI 10.1111/j.1462-2920.2010.02277.x; Dirzo R, 2003, ANNU REV ENV RESOUR, V28, P137, DOI 10.1146/annurev.energy.28.050302.105532; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Eisenhauer N, 2010, ECOLOGY, V91, P485, DOI 10.1890/08-2338.1; Fierer N, 2006, P NATL ACAD SCI USA, V103, P626, DOI 10.1073/pnas.0507535103; Fierer N, 2003, MICROB ECOL, V45, P63, DOI 10.1007/s00248-002-1007-2; Fierer N, 2007, ECOLOGY, V88, P1354, DOI 10.1890/05-1839; Gastine A, 2003, APPL SOIL ECOL, V24, P101, DOI 10.1016/S0929-1393(02)00137-3; Hamady M, 2008, NAT METHODS, V5, P235, DOI 10.1038/NMETH.1184; Hector A, 2007, FUNCT ECOL, V21, P998, DOI 10.1111/j.1365-2435.2007.01308.x; Hooper DU, 2005, ECOL MONOGR, V75, P3, DOI 10.1890/04-0922; Horner-Devine MC, 2004, NATURE, V432, P750, DOI 10.1038/nature03073; Kong DL, 2011, PLANT SOIL, V346, P133, DOI 10.1007/s11104-011-0803-1; Krauss J, 2010, ECOL LETT, V13, P597, DOI 10.1111/j.1461-0248.2010.01457.x; Legendre P, 2001, OECOLOGIA, V129, P271, DOI 10.1007/s004420100716; Lennon JT, 2012, ECOLOGY, V93, P1867, DOI 10.1890/11-1745.1; Li S, 1990, REPORTS INNER MONGOL, P207; Liu ZF, 2010, SOIL BIOL BIOCHEM, V42, P445, DOI 10.1016/j.soilbio.2009.11.027; Liu ZZ, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm541; Loranger-Merciris G, 2006, SOIL BIOL BIOCHEM, V38, P2336, DOI 10.1016/j.soilbio.2006.02.009; Loreau M, 1998, P NATL ACAD SCI USA, V95, P5632, DOI 10.1073/pnas.95.10.5632; Loreau M, 2001, SCIENCE, V294, P804, DOI 10.1126/science.1064088; Lozupone CA, 2008, FEMS MICROBIOL REV, V32, P557, DOI 10.1111/j.1574-6976.2008.00111.x; Lozupone CA, 2007, APPL ENVIRON MICROB, V73, P1576, DOI 10.1128/AEM.01996-06; Lundberg DS, 2012, NATURE, V488, P86, DOI 10.1038/nature11237; McArdle BH, 2001, ECOLOGY, V82, P290, DOI 10.1890/0012-9658(2001)082[0290:FMMTCD]2.0.CO;2; McLaren JR, 2010, GLOBAL CHANGE BIOL, V16, P3075, DOI 10.1111/j.1365-2486.2009.02151.x; Mendes R, 2013, FEMS MICROBIOL REV, V37, P634, DOI 10.1111/1574-6976.12028; Mendes R, 2011, SCIENCE, V332, P1097, DOI 10.1126/science.1203980; NAEEM S, 1994, NATURE, V368, P734, DOI 10.1038/368734a0; Oksanen J., 2016, R PACKAG; Rodriguez-Loinaz G, 2008, SOIL BIOL BIOCHEM, V40, P49, DOI 10.1016/j.soilbio.2007.04.015; Schimel J, 2007, ECOLOGY, V88, P1386, DOI 10.1890/06-0219; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Stachowicz JJ, 2002, ECOLOGY, V83, P2575; STACKEBRANDT E, 1994, INT J SYST BACTERIOL, V44, P846, DOI 10.1099/00207713-44-4-846; Sun Y, 2010, SCI CHINA EARTH SCI, V53, P284, DOI 10.1007/s11430-009-0123-y; Tilman D, 1997, P NATL ACAD SCI USA, V94, P1857, DOI 10.1073/pnas.94.5.1857; Vogel A, 2013, GLOBAL CHANGE BIOL, V19, P2795, DOI 10.1111/gcb.12225; Wallenstein MD, 2012, BIOGEOCHEMISTRY, V109, P35, DOI 10.1007/s10533-011-9641-8; Zak DR, 2003, ECOLOGY, V84, P2042, DOI 10.1890/02-0433; Zhang XM, 2014, SOIL BIOL BIOCHEM, V72, P26, DOI 10.1016/j.soilbio.2014.01.034; Zhang XM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084210; Zhang XM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078616; Zhang XM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076500	55	7	8	11	77	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2014	9	12							e115798	10.1371/journal.pone.0115798	http://dx.doi.org/10.1371/journal.pone.0115798			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UN	25546333	Green Published, Green Submitted, gold			2022-12-27	WOS:000347120200069
J	Soden, B; Christopher, ME; Hulslander, J; Olson, RK; Cutting, L; Keenan, JM; Thompson, LA; Wadsworth, SJ; Willcutt, EG; Petrill, SA				Soden, Brooke; Christopher, Micaela E.; Hulslander, Jacqueline; Olson, Richard K.; Cutting, Laurie; Keenan, Janice M.; Thompson, Lee A.; Wadsworth, Sally J.; Willcutt, Erik G.; Petrill, Stephen A.			Longitudinal Stability in Reading Comprehension Is Largely Heritable from Grades 1 to 6	PLOS ONE			English	Article							GENERAL COGNITIVE-ABILITY; ENVIRONMENTAL-INFLUENCES; GENETIC-ANALYSIS; WORD RECOGNITION; INDIVIDUAL-DIFFERENCES; EARLY LITERACY; SKILLS; CHILDREN; KINDERGARTEN; DISABILITIES	Reading comprehension is a foundational academic skill and significant attention has focused on reading development. This report is the first to examine the stability and change in genetic and environmental influences on reading comprehension across Grades 1 to 6. This developmental range is particularly important because it encompasses the timespan in which most children move from learning how to read to using reading for learning. Longitudinal simplex models were fitted separately for two independent twin samples (N = 706; N = 976). Results suggested that the shared environment contributed to variance in early but not later reading. Instead, stability in reading development was largely mediated by continuous genetic influences. Thus, although reading is clearly a learned skill and the environment remains important for reading development, individual differences in reading comprehension appear to be also influenced by a core of genetic stability that persists through the developmental course of reading.	[Soden, Brooke; Petrill, Stephen A.] Ohio State Univ, Dept Psychol, Columbus, OH 43210 USA; [Christopher, Micaela E.; Olson, Richard K.; Willcutt, Erik G.] Univ Colorado, Dept Psychol & Neurosci, Boulder, CO 80309 USA; [Christopher, Micaela E.; Hulslander, Jacqueline; Olson, Richard K.; Wadsworth, Sally J.; Willcutt, Erik G.] Univ Colorado, Inst Behav Genet, Boulder, CO 80309 USA; [Cutting, Laurie] Vanderbilt Univ, Dept Special Educ Psychol Radiol & Pediat, Nashville, TN 37235 USA; [Keenan, Janice M.] Univ Denver, Dept Psychol, Denver, CO 80208 USA; [Thompson, Lee A.] Case Western Reserve Univ, Dept Psychol Sci, Cleveland, OH 44106 USA	University System of Ohio; Ohio State University; University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; Vanderbilt University; University of Denver; Case Western Reserve University	Soden, B (corresponding author), Ohio State Univ, Dept Psychol, Columbus, OH 43210 USA.	soden.6@osu.edu			Eunice Kennedy Shriver National Institute of Child Health and Human Development [HD038075, HD075460, HD068728, HD027802, HD038526]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD068728, R24HD075460, P50HD027802, P01HD001994] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD038075, R01HD038526] Funding Source: NIH RePORTER	Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	The Western Reserve Reading and Math Project and International Longitudinal Twin Study were funded by the Eunice Kennedy Shriver National Institute of Child Health and Human Development (www.nichd.nih.gov; HD038075, HD075460, HD068728, HD027802, HD038526). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1998, WOODCOCK READING MAS; Betjemann RS, 2011, SCI STUD READ, V15, P363, DOI 10.1080/10888438.2010.493965; Bishop EG, 2003, INTELLIGENCE, V31, P31, DOI 10.1016/S0160-2896(02)00112-5; BOOMSMA DI, 1987, BEHAV GENET, V17, P111, DOI 10.1007/BF01065991; Byrne B, 2006, J RES READ, V29, P33, DOI 10.1111/j.1467-9817.2006.00291.x; Byrne B, 2009, J NEUROLINGUIST, V22, P219, DOI 10.1016/j.jneuroling.2008.09.003; Cain K, 2006, BRIT J EDUC PSYCHOL, V76, P683, DOI 10.1348/000709905X67610; Chall J. S, 1983, LEARNING READ GREAT; Cutting LE, 2006, SCI STUD READ, V10, P277, DOI 10.1207/s1532799xssr1003_5; Dieterich SE, 2006, J SCHOOL PSYCHOL, V43, P481, DOI 10.1016/j.jsp.2005.10.003; Elwer A, 2013, J EXP CHILD PSYCHOL, V115, P497, DOI 10.1016/j.jecp.2012.12.001; Gayan J, 2003, J EXP CHILD PSYCHOL, V84, P97, DOI 10.1016/S0022-0965(02)00181-9; Gayan J, 2001, DEV NEUROPSYCHOL, V20, P483, DOI 10.1207/S15326942DN2002_3; GOLDSMITH HH, 1991, BEHAV GENET, V21, P257; Harlaar N, 2007, CHILD DEV, V78, P116, DOI 10.1111/j.1467-8624.2007.00988.x; Harlaar N, 2011, CHILD DEV, V82, P2123, DOI 10.1111/j.1467-8624.2011.01658.x; Harlaar N, 2010, ANN DYSLEXIA, V60, P265, DOI 10.1007/s11881-010-0044-7; Hart SA, 2013, DEV PSYCHOL, V49, P1971, DOI 10.1037/a0031348; Hart SA, 2009, J EDUC PSYCHOL, V101, P388, DOI 10.1037/a0015115; HOOVER WA, 1990, READ WRIT, V2, P127, DOI 10.1007/BF00401799; JUEL C, 1988, J EDUC PSYCHOL, V80, P437, DOI 10.1037/0022-0663.80.4.437; Keenan JM, 2008, SCI STUD READ, V12, P281, DOI 10.1080/10888430802132279; Keenan JM, 2006, J RES READ, V29, P75, DOI 10.1111/j.1467-9817.2006.00293.x; Keller MC, 2005, BEHAV GENET, V35, P707, DOI 10.1007/s10519-005-6041-7; MCGUE M, 1984, BEHAV GENET, V14, P325, DOI 10.1007/BF01080045; Neale M. C., 2006, MX STAT MODELING VER; NICHOLS RC, 1966, ACTA GENET STAT MED, V16, P265; Olson RK, 2014, SCI STUD READ, V18, P38, DOI 10.1080/10888438.2013.800521; Olson RK, 2011, SCI STUD READ, V15, P26, DOI 10.1080/10888438.2011.536128; Parrila R, 2005, J EDUC PSYCHOL, V97, P299, DOI 10.1037/0022-0663.97.3.299; Pennington BF, 2005, BL HBK DEV PSYCHOL, P453, DOI 10.1002/9780470757642.ch24; Petrill SA, 2006, J LEARN DISABIL-US, V39, P48, DOI 10.1177/00222194060390010501; Petrill SA, 2004, DEV PSYCHOL, V40, P805, DOI 10.1037/0012-1649.40.5.805; Petrill SA, 2007, READ WRIT, V20, P127, DOI 10.1007/s11145-006-9021-2; Plomin R, 2005, PSYCHOL BULL, V131, P592, DOI 10.1037/0033-2909.131.4.592; Price T S, 2000, Twin Res, V3, P129, DOI 10.1375/136905200320565391; Raskind WH, 2013, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00601; Rimrodt SL, 2009, CEREB CORTEX, V19, P402, DOI 10.1093/cercor/bhn092; Roehrig AD, 2008, J SCHOOL PSYCHOL, V46, P343, DOI 10.1016/j.jsp.2007.06.006; Senechal M, 2006, SCI STUD READ, V10, P59, DOI 10.1207/s1532799xssr1001_4; Smith SD, 2010, J DEV BEHAV PEDIATR, V31, P555, DOI 10.1097/DBP.0b013e3181ee3d9e; Soden-Hensler B, 2012, SCI STUD READ, V16, P457, DOI 10.1080/10888438.2011.599902; Wagner RK, 1997, DEV PSYCHOL, V33, P468, DOI 10.1037/0012-1649.33.3.468	43	16	16	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2015	10	1							e0113807	10.1371/journal.pone.0113807	http://dx.doi.org/10.1371/journal.pone.0113807			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AZ4OZ	25602760	Green Submitted, Green Published, gold			2022-12-27	WOS:000348203500004
J	Gibertoni, D; Corvaglia, L; Vandini, S; Rucci, P; Savini, S; Alessandroni, R; Sansavini, A; Fantini, MP; Faldella, G				Gibertoni, Dino; Corvaglia, Luigi; Vandini, Silvia; Rucci, Paola; Savini, Silvia; Alessandroni, Rosina; Sansavini, Alessandra; Fantini, Maria Pia; Faldella, Giacomo			Positive Effect of Human Milk Feeding during NICU Hospitalization on 24 Month Neurodevelopment of Very Low Birth Weight Infants: An Italian Cohort Study	PLOS ONE			English	Article							INTENSIVE-CARE-UNIT; PRETERM INFANTS; BREAST-MILK; COGNITIVE-DEVELOPMENT; GESTATIONAL-AGE; CHILDREN BORN; FIT INDEXES; GROWTH; OUTCOMES; CYTOMEGALOVIRUS	The aim of this study was to determine the effect of human milk feeding during NICU hospitalization on neurodevelopment at 24 months of corrected age in very low birth weight infants. A cohort of 316 very low birth weight newborns (weight <= 1500 g) was prospectively enrolled in a follow-up program on admission to the Neonatal Intensive Care Unit of S. Orsola Hospital, Bologna, Italy, from January 2005 to June 2011. Neurodevelopment was evaluated at 24 months corrected age using the Griffiths Mental Development Scale. The effect of human milk nutrition on neurodevelopment was first investigated using a multiple linear regression model, to adjust for the effects of gestational age, small for gestational age, complications at birth and during hospitalization, growth restriction at discharge and socio-economic status. Path analysis was then used to refine the multiple regression model, taking into account the relationships among predictors and their temporal sequence. Human milk feeding during NICU hospitalization and higher socio-economic status were associated with better neurodevelopment at 24 months in both models. In the path analysis model intraventricular hemorrhage-periventricular leukomalacia and growth restriction at discharge proved to be directly and independently associated with poorer neurodevelopment. Gestational age and growth restriction at birth had indirect significant effects on neurodevelopment, which were mediated by complications that occurred at birth and during hospitalization, growth restriction at discharge and type of feeding. In conclusion, our findings suggest that mother's human milk feeding during hospitalization can be encouraged because it may improve neurodevelopment at 24 months corrected age.	[Gibertoni, Dino; Rucci, Paola; Fantini, Maria Pia] Univ Bologna, Unit Hyg & Biostat, Dept Biomed & Neuromotor Sci, Bologna, Italy; [Corvaglia, Luigi; Vandini, Silvia; Alessandroni, Rosina; Faldella, Giacomo] Univ Bologna, Dept Med & Surg Sci, S Orsola Malpighi Hosp, Neonatol & Neonatal Intens Care Unit, Bologna, Italy; [Savini, Silvia; Sansavini, Alessandra] Univ Bologna, Dept Psychol, Bologna, Italy	University of Bologna; IRCCS Azienda Ospedaliero-Universitaria di Bologna; University of Bologna; University of Bologna	Corvaglia, L (corresponding author), Univ Bologna, Dept Med & Surg Sci, S Orsola Malpighi Hosp, Neonatol & Neonatal Intens Care Unit, Bologna, Italy.	luigi.corvaglia@unibo.it	Gibertoni, Dino/H-4443-2017	Gibertoni, Dino/0000-0002-1722-3724; Rucci, Paola/0000-0002-7704-0831; Sansavini, Alessandra/0000-0002-1991-9864				Aggett PJ, 2006, J PEDIATR GASTR NUTR, V42, P596, DOI 10.1097/01.mpg.0000221915.73264.c7; Agostoni C, 2010, J PEDIATR GASTR NUTR, V50, P85, DOI 10.1097/MPG.0b013e3181adaee0; Als H, 2004, PEDIATRICS, V113, P846, DOI 10.1542/peds.113.4.846; American Academy of Pediatrics. Committee on Infectious Diseases, 2003, RED BOOK 2003 REPORT; Belfort MB, 2013, JAMA PEDIATR, V167, P836, DOI 10.1001/jamapediatrics.2013.455; BENTLER PM, 1990, PSYCHOL BULL, V107, P238, DOI 10.1037/0033-2909.88.3.588; Bernard JY, 2013, J PEDIATR-US, V163, P36, DOI 10.1016/j.jpeds.2012.11.090; Bertino E, 2010, J PEDIATR GASTR NUTR, V51, P353, DOI 10.1097/MPG.0b013e3181da213e; Brandt I, 2003, J PEDIATR-US, V142, P463, DOI 10.1067/mpd.2003.149; Browne M.W., 1992, SOCIOL METHOD RES, V21, P230, DOI 10.1177/0049124192021002005; Capretti MG, 2009, J PEDIATR-US, V154, P842, DOI 10.1016/j.jpeds.2008.12.046; Cooke R, 2011, ANN NUTR METAB, V58, P32, DOI 10.1159/000323385; Cooke RWI, 2006, ARCH DIS CHILD-FETAL, V91, pF17, DOI 10.1136/adc.2005.077438; Cooke RWI, 2003, ARCH DIS CHILD, V88, P482, DOI 10.1136/adc.88.6.482; Corpeleijn WE, 2012, NEONATOLOGY, V102, P276, DOI 10.1159/000341335; Corvaglia L, 2010, EARLY HUM DEV, V86, P237, DOI 10.1016/j.earlhumdev.2010.04.001; De Curtis M, 2004, ACTA PAEDIATR, V93, P1563, DOI 10.1080/08035250410022198; Dessardo NS, 2012, AM J PERINAT, V29, P133, DOI 10.1055/s-0031-1295654; Ehrenkranz RA, 2006, PEDIATRICS, V117, P1253, DOI 10.1542/peds.2005-1368; Gianni ML, 2007, PEDIATRICS, V120, P1012, DOI 10.1542/peds.2006-3364; Gianni ML, 2014, BMC PEDIATR, V14, DOI 10.1186/1471-2431-14-74; Gole GA, 2005, ARCH OPHTHALMOL-CHIC, V123, P991, DOI 10.1001/archopht.123.7.991; Griffiths R., 1996, GRIFFITHS MENTAL DEV; Hamprecht K, 2001, LANCET, V357, P513, DOI 10.1016/S0140-6736(00)04043-5; Haschke F, 2000, J PEDIATR GASTR NUTR, V31, pS60, DOI 10.1097/00005176-200007001-00006; Henderson G, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004862.pub2; Hollingshead A. B., 1975, 4 FACTOR INDEX UNPUB; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Isaacs EB, 2010, PEDIATR RES, V67, P357, DOI 10.1203/PDR.0b013e3181d026da; Johnson S, 2006, EARLY HUM DEV, V82, P173, DOI 10.1016/j.earlhumdev.2006.01.008; Kline R.B., 2011, PRINCIPLES PRACTICE; Lanzieri TM, 2013, PEDIATRICS, V131, pE1937, DOI 10.1542/peds.2013-0076; Larroque B, 2008, LANCET, V371, P813, DOI 10.1016/S0140-6736(08)60380-3; Lucas A, 1992, RANDOMISED TRIAL NUT; Marlow N, 2005, NEW ENGL J MED, V352, P9, DOI 10.1056/NEJMoa041367; McCormick FM, 2010, COCHRANE DATABASE SY; Meinzen-Derr J, 2009, J PERINATOL, V29, P57, DOI 10.1038/jp.2008.117; Mercier CE, 2010, NEONATOLOGY, V97, P329, DOI 10.1159/000260136; Montjaux-Regis N, 2011, ACTA PAEDIATR, V100, P1548, DOI 10.1111/j.1651-2227.2011.02389.x; Morgan JA, 2012, ARCH DIS CHILD-FETAL, V97, pF295, DOI 10.1136/adc.2009.170910; Morley R, 2004, NEURODEVELOPMENT CHI; Muthen B.O., 2012, MPLUS USERS GUIDE, V7th; O'Connor DL, 2008, PEDIATRICS, V121, P766, DOI 10.1542/peds.2007-0054; Ostrea EM, 2012, NEUROTOXICOLOGY, V33, P669, DOI 10.1016/j.neuro.2011.11.006; PAPILE LA, 1978, J PEDIATR-US, V92, P529, DOI 10.1016/S0022-3476(78)80282-0; Potijk MR, 2013, J PEDIATR-US, V163, P1289, DOI 10.1016/j.jpeds.2013.07.001; Quigley MA, 2012, J PEDIATR-US, V160, P25, DOI 10.1016/j.jpeds.2011.06.035; Roze JC, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-000834; Sansavini A, 2011, CHILD CARE HLTH DEV, V37, P26, DOI 10.1111/j.1365-2214.2010.01143.x; Schafer JL, 2002, PSYCHOL METHODS, V7, P147, DOI 10.1037//1082-989X.7.2.147; Schanler RJ, 1999, FEEDING STRATEGIES P; Steiger JH, 1980, ANN M PSY CHOM SOC; TUCKER LR, 1973, PSYCHOMETRIKA, V38, P1, DOI 10.1007/bf02291170; Tudehope DI, 2013, J PEDIATR-US, V162, pS17, DOI 10.1016/j.jpeds.2012.11.049; Vohr BR, 2007, PEDIATRICS, V120, pe953, DOI 10.1542/peds.2006-3227; Vohr BR, 2006, PEDIATRICS, V118, pE115, DOI 10.1542/peds.2005-2382; ZIEGLER EE, 1976, GROWTH, V40, P329	57	34	37	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2015	10	1							e0116552	10.1371/journal.pone.0116552	http://dx.doi.org/10.1371/journal.pone.0116552			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CC9HN	25590630	gold, Green Published, Green Submitted			2022-12-27	WOS:000350679400017
J	Lim, YP; Lin, CL; Lin, YN; Ma, WC; Chen, WC; Hung, DZ; Kao, CH				Lim, Yun-Ping; Lin, Cheng-Li; Lin, Yen-Ning; Ma, Wei-Chih; Chen, Wei-Cheng; Hung, Dong-Zong; Kao, Chia-Hung			Antiarrhythmic Agents and the Risk of Malignant Neoplasm of Liver and Intrahepatic Bile Ducts	PLOS ONE			English	Article							AMIODARONE-INDUCED THYROTOXICOSIS; PROPAFENONE HEPATOTOXICITY; DRUG-THERAPY; TOXICITY; CANCER; RECOMMENDATIONS; PREVENTION; CARCINOMA; UPDATE	Background The objective of this study was to determine the association between the use of antiarrhythmic agents and the risk of malignant neoplasm of liver and intrahepatic bile ducts (MNLIHD). Methods We used the research database of the Taiwan National Health Insurance Program to conduct a population-based, case-control study. We identified 9944 patients with antiarrhythmic history who were first diagnosed as having MNLIHD between 2005 and 2010. We identified an additional 19,497 patients with antiarrhythmic history in the same period who did not develop MNLIHD and were frequency-matched using age, sex, and index year to form a control group. Five commercially available antiarrhythmic agents, amiodarone, mexiletine, propafenone, quinidine, and procainamide, were analyzed. Results The adjusted odds ratio (OR) of MNLIHD was 1.60 (95% confidence interval [CI], 1.45-1.77) for amiodarone users versus nonamiodarone users. In subgroup analysis, amiodarone use was significantly associated with an increased risk of MNLIHD with an adjusted OR of 18.0 (95% CI, 15.7-20.5) for patients with comorbidities compared to an OR of 2.43 (95% CI, 1.92-3.06) for those without comorbidities. After adjustment for age, sex, statins, anti-diabetes medications, non-steroidal antiinflammatory drugs, propafenone use, quinidine use, and comorbidities, the ORs were 1.49, 1.66, and 1.79 for MNLIHD associated with annual mean defined daily doses of <= 30, 31-145, and >145, respectively. Conclusions The results of the present study indicated that amiodarone might be associated with the development of MNLIHD in a dose-dependent manner, particularly among patients with comorbidities.	[Lim, Yun-Ping; Lin, Yen-Ning; Ma, Wei-Chih; Chen, Wei-Cheng; Hung, Dong-Zong] China Med Univ, Coll Pharm, Dept Pharm, Taichung, Taiwan; [Lim, Yun-Ping; Hung, Dong-Zong] China Med Univ Hosp, Dept Emergency, Toxicol Ctr, Taichung, Taiwan; [Lin, Cheng-Li] China Med Univ Hosp, Management Off Hlth Data, Taichung, Taiwan; [Chen, Wei-Cheng] Natl Cheng Kung Univ Hosp, Dou Liou Branch, Dept Pharm, Yunlin, Taiwan; [Kao, Chia-Hung] China Med Univ, Coll Med, Grad Inst Clin Med Sci, Taichung, Taiwan; [Kao, Chia-Hung] China Med Univ, Coll Med, Sch Med, Taichung, Taiwan; [Kao, Chia-Hung] China Med Univ Hosp, Dept Nucl Med, Taichung, Taiwan; [Kao, Chia-Hung] China Med Univ Hosp, PET Ctr, Taichung, Taiwan	China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; National Cheng Kung University; National Cheng Kung University Hospital; China Medical University Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan	Kao, CH (corresponding author), China Med Univ, Coll Med, Grad Inst Clin Med Sci, Taichung, Taiwan.	d10040@mail.cmuh.org.tw						Arkun A, 2010, J EMERG MED, V38, P337, DOI 10.1016/j.jemermed.2008.01.006; ARNON R, 1988, CHEST, V93, P425, DOI 10.1378/chest.93.2.425; Azzam I, 2006, POSTGRAD MED J, V82, P73, DOI 10.1136/pgmj.2005.040105; Babatin M, 2008, CURR VASC PHARMACOL, V6, P228, DOI 10.2174/157016108784912019; Brambilla G, 2009, MUTAT RES-REV MUTAT, V681, P209, DOI 10.1016/j.mrrev.2008.09.002; CHUANG LC, 1993, ANN PHARMACOTHER, V27, P434, DOI 10.1177/106002809302700407; Cocozzella D, 2003, DIGEST DIS SCI, V48, P354, DOI 10.1023/A:1021943930424; Department of Health, TAIW MAIN CAUS DEATH; Dowman JK, 2014, AM J PATHOL, V184, P1550, DOI 10.1016/j.ajpath.2014.01.034; Farver DK, 1999, ANN PHARMACOTHER, V33, P32, DOI 10.1345/aph.18172; Fuchs BC, 2014, HEPATOLOGY, V59, P1577, DOI 10.1002/hep.26898; Hall MA, 2004, BRIT J DERMATOL, V151, P932, DOI 10.1111/j.1365-2133.2004.06193.x; Higa K, 1997, PAIN, V73, P97, DOI 10.1016/S0304-3959(97)00066-3; Inaba H, 2012, MED PRIN PRACT, V21, P190, DOI 10.1159/000333697; LEWIS JH, 1989, HEPATOLOGY, V9, P679, DOI 10.1002/hep.1840090504; LEWIS JH, 1990, HUM PATHOL, V21, P59, DOI 10.1016/0046-8177(90)90076-H; Malek NP, 2014, DTSCH ARZTEBL INT, V111, P101, DOI 10.3238/arztebl.2014.0101; Maoz KBA, 2009, INT J DERMATOL, V48, P1398, DOI 10.1111/j.1365-4632.2008.03819.x; MASON JW, 1987, NEW ENGL J MED, V316, P455; Mellemgaard A, 1998, THYROID, V8, P751, DOI 10.1089/thy.1998.8.751; MONDARDINI A, 1993, GASTROENTEROLOGY, V104, P1524, DOI 10.1016/0016-5085(93)90365-J; MONK BE, 1995, BRIT J DERMATOL, V133, P148; MORSE RM, 1988, ANN INTERN MED, V109, P838, DOI 10.7326/0003-4819-109-10-838; Piccini JP, 2009, EUR HEART J, V30, P1245, DOI 10.1093/eurheartj/ehp100; PICCIONE W, 1989, ANN THORAC SURG, V47, P918, DOI 10.1016/0003-4975(89)90037-4; Raja K, 2009, SEMIN LIVER DIS, V29, P423, DOI 10.1055/s-0029-1240011; Rodriguez-Garcia J L., 2001, Eur J Intern Med, V12, P372, DOI 10.1016/S0953-6205(01)00127-3; Skanes AC, 2012, CAN J CARDIOL, V28, P125, DOI 10.1016/j.cjca.2012.01.021; Stelfox HT, 2004, CLIN PHARMACOL THER, V75, P110, DOI 10.1016/j.clpt.2003.09.010; Su VYF, 2013, CANCER-AM CANCER SOC, V119, P1699, DOI 10.1002/cncr.27881; TRIP MD, 1991, AM J MED, V91, P507, DOI 10.1016/0002-9343(91)90187-3; US Food and Drug Administration, 2004, NDA 18 972 S 038 039; Waldhauser KM, 2006, J PHARMACOL EXP THER, V319, P1413, DOI 10.1124/jpet.106.108993; Younan L, 2013, SAUDI J GASTROENTERO, V19, P235, DOI 10.4103/1319-3767.118137; Zahno A, 2011, BIOCHEM PHARMACOL, V81, P432, DOI 10.1016/j.bcp.2010.11.002; Zimetbaum P, 2012, CIRCULATION, V125, P381, DOI 10.1161/CIRCULATIONAHA.111.019927	36	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2015	10	1							e0116960	10.1371/journal.pone.0116960	http://dx.doi.org/10.1371/journal.pone.0116960			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9HN	25590332	Green Published, gold, Green Submitted			2022-12-27	WOS:000350679400026
J	Mate, S; Kopcke, F; Toddenroth, D; Martin, M; Prokosch, HU; Burkle, T; Ganslandt, T				Mate, Sebastian; Koepcke, Felix; Toddenroth, Dennis; Martin, Marcus; Prokosch, Hans-Ulrich; Buerkle, Thomas; Ganslandt, Thomas			Ontology-Based Data Integration between Clinical and Research Systems	PLOS ONE			English	Article							ELECTRONIC HEALTH RECORDS; MEDICAL INFORMATICS; NCI THESAURUS; DATA ELEMENTS; INTEROPERABILITY; CANCER; FRAMEWORK; IDENTIFICATION; ARCHITECTURE; EXTRACTION	Data from the electronic medical record comprise numerous structured but uncoded elements, which are not linked to standard terminologies. Reuse of such data for secondary research purposes has gained in importance recently. However, the identification of relevant data elements and the creation of database jobs for extraction, transformation and loading (ETL) are challenging: With current methods such as data warehousing, it is not feasible to efficiently maintain and reuse semantically complex data extraction and trans-formation routines. We present an ontology-supported approach to overcome this challenge by making use of abstraction: Instead of defining ETL procedures at the database level, we use ontologies to organize and describe the medical concepts of both the source system and the target system. Instead of using unique, specifically developed SQL statements or ETL jobs, we define declarative transformation rules within ontologies and illustrate how these constructs can then be used to automatically generate SQL code to perform the desired ETL procedures. This demonstrates how a suitable level of abstraction may not only aid the interpretation of clinical data, but can also foster the reutilization of methods for un-locking it.	[Mate, Sebastian; Toddenroth, Dennis; Prokosch, Hans-Ulrich] Univ Erlangen Nurnberg, Inst Med Informat, Erlangen, Germany; [Koepcke, Felix; Prokosch, Hans-Ulrich; Ganslandt, Thomas] Erlangen Univ Hosp, Ctr Med Informat & Commun, Erlangen, Germany; [Martin, Marcus] Erlangen Univ Hosp, Tumor Ctr, Erlangen, Germany; [Buerkle, Thomas] Bern Univ Appl Sci, Inst Med Informat, Bern, Switzerland	University of Erlangen Nuremberg; University of Erlangen Nuremberg; University of Erlangen Nuremberg	Mate, S (corresponding author), Univ Erlangen Nurnberg, Inst Med Informat, Erlangen, Germany.	sebastian.mate@imi.med.uni-erlangen.de	Ganslandt, Thomas/AAC-6690-2019; Bürkle, Thomas/X-2054-2019	Ganslandt, Thomas/0000-0001-6864-8936; Mate, Sebastian/0000-0002-1389-3384; Burkle, Thomas/0000-0002-2936-5375	Deutsche Forschungsgemeinschaft (DFG); Friedrich-Alexander-University Erlangen-Nuremberg	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Friedrich-Alexander-University Erlangen-Nuremberg	The authors acknowledge support by Deutsche Forschungsgemeinschaft (DFG) and Friedrich-Alexander-University Erlangen-Nuremberg within the funding programme Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANITHA J, 2014, INT J COMPUTER SCI M, V3, P610; Assele Kama A, 2012, STUD HEALTH TECHNOL, V180, P38, DOI 10.3233/978-1-61499-101-4-38; Bache R, 2013, J AM MED INFORM ASSN, V20, pE327, DOI 10.1136/amiajnl-2013-001858; Berners-Lee T, 2001, SCI AM, V284, P34, DOI 10.1038/scientificamerican0501-34; BIZER C, 2004, P 3 INT SEM WEB C IC; BLEICH HL, 1992, M D COMPUT, V9, P293; Breil B, 2011, BMC MED INFORM DECIS, V11, DOI 10.1186/1472-6947-11-11; Brickley D, 2004, RDF VOCABULARY DESCR; Brownstein JS, 2010, DIABETES CARE, V33, P526, DOI 10.2337/dc09-1506; Burkle T, 1999, METHOD INFORM MED, V38, P321; Cheung KH, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S10-S10; Cimino JJ, 1998, METHOD INFORM MED, V37, P394; Dean BB, 2009, MED CARE RES REV, V66, P611, DOI 10.1177/1077558709332440; Dugas M, 2010, CLIN TRIALS, V7, P183, DOI 10.1177/1740774510363013; Eggebraaten TJ, 2007, IBM SYST J, V46, P5, DOI 10.1147/sj.461.0005; El Fadly AbdenNaji, 2011, J Biomed Inform, V44 Suppl 1, pS94, DOI 10.1016/j.jbi.2011.07.007; El Fadly A, 2010, STUD HEALTH TECHNOL, V160, P1324, DOI 10.3233/978-1-60750-588-4-1324; Embi PJ, 2005, ARCH INTERN MED, V165, P2272, DOI 10.1001/archinte.165.19.2272; Ethier JF, 2013, J AM MED INFORM ASSN, V20, P986, DOI 10.1136/amiajnl-2012-001312; Farley T, 2013, J AM MED INFORM ASSN, V20, P128, DOI 10.1136/amiajnl-2011-000646; Garde S, 2007, INT J MED INFORM, V76, pS334, DOI 10.1016/j.ijmedinf.2007.02.004; HARLAND L, 2012, OPEN PHACTS SEMANTIC, P1; Haux R, 2003, METHOD INFORM MED, V42, P25; Hebeler J, 2009, SEMANTIC WEB PROGRAM; HUSSAIN S, 2012, EHR4CR SEMANTIC WEB; *IBM CORP, 2014, COGN; *IBM CORP, 2014, INFOSPHERE INF SERV; *INF CORP, 2014, POWERCENTER BIG DAT; JAVLIN AS, 2014, CLOVERETL RAPID DATA; Jensen PB, 2012, NAT REV GENET, V13, P395, DOI 10.1038/nrg3208; KIMBALL R, 1998, DAT WAREHOUSE LIFECY; Klyne G., 2004, RESOURCE DESCRIPTION; Kopcke F, 2013, INT J MED INFORM, V82, P185, DOI 10.1016/j.ijmedinf.2012.11.008; KROGH B, 2011, DBLINT TOOL AUTOMATE; Kush R, 2007, J AM MED INFORM ASSN, V14, P662, DOI 10.1197/jamia.M2157; LASTIC PY, 2012, CDISC SHARE BRIDG BA, P1; Lee MK, 2010, HEALTHC INFORM RES, V16, P82, DOI 10.4258/hir.2010.16.2.82; Lin Ching-Ping, 2010, Summit Transl Bioinform, V2010, P16; LOBE M, 2010, GI JAHRESTAGUNG, V2010, P734; MAJEED RW, 2013, BIOMETRIE EPIDEMIOLO, P1; MASSMANN S, 2011, P 6 INT C ONT MATCH, V814, P49; Mate S, 2011, STUD HEALTH TECHNOL, V169, P502, DOI 10.3233/978-1-60750-806-9-502; McCarty CA, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-13; McMurry AJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055811; MICHEL A, 1989, MEDINFO, V89, P805; *MICR CORP, 2014, SQL SERV INT SERV; Mn Ngouongo S, 2011, STUD HEALTH TECHNOL, V169, P744, DOI 10.3233/978-1-60750-806-9-744; MORRISON Z, 2013, J AM MED INFORM ASS; Murphy SN, 2010, J AM MED INFORM ASSN, V17, P124, DOI 10.1136/jamia.2009.000893; Musen M A, 2008, AMIA Annu Symp Proc, P1223; NADKAMI PM, 2012, USING ELECT MED RECO; Nadkarni PM, 2006, METHOD INFORM MED, V45, P594; Nadkarni PM, 1998, J AM MED INFORM ASSN, V5, P511, DOI 10.1136/jamia.1998.0050511; Nadkarni PM, 1999, J AM MED INFORM ASSN, V6, P478, DOI 10.1136/jamia.1999.0060478; Noy NF, 2008, APPL ONTOL, V3, P173, DOI 10.3233/AO-2008-0051; O'Malley KJ, 2005, HEALTH SERV RES, V40, P1620, DOI 10.1111/j.1475-6773.2005.00444.x; Ohmann C, 2009, METHOD INFORM MED, V48, P45, DOI 10.3414/ME9137; *OR INT CORP, 2014, DAT INT; *OR INT CORP, 2014, WAR BUILD; Papatheodorou I, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-66; Pathak J, 2011, J AM MED INFORM ASSN, V18, P376, DOI 10.1136/amiajnl-2010-000061; Pearson JF, 2011, CLIN CHEM, V57, P196, DOI 10.1373/clinchem.2010.148668; *PENT CORP, 2014, KETTL DAT INT; Prokosch HU, 2009, METHOD INFORM MED, V48, P38, DOI 10.3414/ME9132; Prokosch HU, 2012, STUD HEALTH TECHNOL, V180, P559, DOI 10.3233/978-1-61499-101-4-559; Prokosch HU, 2011, STUD HEALTH TECHNOL, V169, P892, DOI 10.3233/978-1-60750-806-9-892; PRUDHOMMEAUX E, 2009, SPARQL QUERY LANGUAG; Rahm E, 2001, VLDB J, V10, P334, DOI 10.1007/s007780100057; RODRIGUESMURO M, 2012, OWLED 2012; Safran C, 2007, J AM MED INFORM ASSN, V14, P1, DOI 10.1197/jamia.M2273; *SAP AKT, 2014, BUS OBJ DAT INT; Savova GK, 2010, J AM MED INFORM ASSN, V17, P507, DOI 10.1136/jamia.2009.001560; Sioutos N, 2007, J BIOMED INFORM, V40, P30, DOI 10.1016/j.jbi.2006.02.013; Smith M K, 2004, OWL WEB ONTOLOGY LAN; Sobin LH, 2010, CANCER-AM CANCER SOC, V116, P5336, DOI 10.1002/cncr.25537; Sun Y, 2004, J BIOMED INFORM, V37, P162, DOI 10.1016/j.jbi.2004.03.003; *TAL INC, 2014, TAL OP STUD; Tao C, 2013, J AM MED INFORM ASSN, V20, P554, DOI 10.1136/amiajnl-2012-001326; Veseli H, 2012, STUD HEALTH TECHNOL, V180, P646, DOI 10.3233/978-1-61499-101-4-646; W3C, 2009, SKOS SIMPLE KNOWLEDG; Weiner Mark G, 2007, Inform Prim Care, V15, P121; Weiner MG, 2009, ANN INTERN MED, V151, P359, DOI 10.7326/0003-4819-151-5-200909010-00141; Williams AJ, 2012, DRUG DISCOV TODAY, V17, P1188, DOI 10.1016/j.drudis.2012.05.016	83	49	51	3	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2015	10	1							e0116656	10.1371/journal.pone.0116656	http://dx.doi.org/10.1371/journal.pone.0116656			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AZ0ID	25588043	Green Published, Green Submitted, gold			2022-12-27	WOS:000347928300018
J	Gotts, ZM; Ellis, JG; Deary, V; Barclay, N; Newton, JL				Gotts, Zoe M.; Ellis, Jason G.; Deary, Vincent; Barclay, Nicola; Newton, Julia L.			The Association between Daytime Napping and Cognitive Functioning in Chronic Fatigue Syndrome	PLOS ONE			English	Article							SLEEP; PERFORMANCE; QUALITY; ILLNESS; MOOD; EEG	Objectives The precise relationship between sleep and physical and mental functioning in chronic fatigue syndrome (CFS) has not been examined directly, nor has the impact of daytime napping. This study aimed to examine self-reported sleep in patients with CFS and explore whether sleep quality and daytime napping, specific patient characteristics (gender, illness length) and levels of anxiety and depression, predicted daytime fatigue severity, levels of daytime sleepiness and cognitive functioning, all key dimensions of the illness experience. Methods 118 adults meeting the 1994 CDC case criteria for CFS completed a standardised sleep diary over 14 days. Momentary functional assessments of fatigue, sleepiness, cognition and mood were completed by patients as part of usual care. Levels of daytime functioning and disability were quantified using symptom assessment tools, measuring fatigue (Chalder Fatigue Scale), sleepiness (Epworth Sleepiness Scale), cognitive functioning ( Trail Making Test, Cognitive Failures Questionnaire), and mood ( Hospital Anxiety and Depression Scale). Results Hierarchical Regressions demonstrated that a shorter time since diagnosis, higher depression and longer wake time after sleep onset predicted 23.4% of the variance in fatigue severity ( p <.001). Being male, higher depression and more afternoon naps predicted 25.6% of the variance in objective cognitive dysfunction ( p <.001). Higher anxiety and depression and morning napping predicted 32.2% of the variance in subjective cognitive dysfunction ( p <.001). When patients were classified into groups of mild and moderate sleepiness, those with longer daytime naps, those who mainly napped in the afternoon, and those with higher levels of anxiety, were more likely to be in the moderately sleepy group. Conclusions Napping, particularly in the afternoon is associated with poorer cognitive functioning and more daytime sleepiness in CFS. These findings have clinical implications for symptom management strategies.	[Gotts, Zoe M.; Ellis, Jason G.; Deary, Vincent; Barclay, Nicola] Northumbria Univ, Fac Hlth & Life Sci, Newcastle Upon Tyne NE1 8ST, Tyne & Wear, England; [Newton, Julia L.] Newcastle Univ, Sch Med, Inst Cellular Med, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Newton, Julia L.] Newcastle Hosp NHS Fdn Trust, Newcastle Upon Tyne, Tyne & Wear, England; [Newton, Julia L.] UK NIHR Biomed Res Ctr Ageing, Newcastle Upon Tyne, Tyne & Wear, England	Northumbria University; Newcastle University - UK; Newcastle University - UK; Newcastle Upon Tyne Hospitals NHS Foundation Trust	Gotts, ZM (corresponding author), Northumbria Univ, Fac Hlth & Life Sci, Newcastle Upon Tyne NE1 8ST, Tyne & Wear, England.	zoe.gotts@northumbria.ac.uk	; Barclay, Nicola/D-8981-2013; Ellis, Jason/E-7783-2013	Newton, Julia/0000-0002-1249-5253; Gotts, Zoe/0000-0003-0040-1720; Barclay, Nicola/0000-0002-6500-9909; Deary, Vincent/0000-0001-6115-9259; Ellis, Jason/0000-0002-8496-520X	Action for ME; ME Research UK; ME Association Ramsay Research Fund	Action for ME; ME Research UK; ME Association Ramsay Research Fund	This work was supported by Action for ME, ME Research UK, and the ME Association Ramsay Research Fund. The organizations had no role in the study design, data collection and analysis, decision to publish and preparation of the manuscript.	Anderson JS, 1997, J NERV MENT DIS, V185, P359, DOI 10.1097/00005053-199706000-00001; Fernandez AA, 2009, BMC PSYCHIATRY, V9, DOI 10.1186/1471-244X-9-S1-S1; BROADBENT DE, 1982, BRIT J CLIN PSYCHOL, V21, P1, DOI 10.1111/j.2044-8260.1982.tb01421.x; CATHEBRAS PJ, 1992, J GEN INTERN MED, V7, P276, DOI 10.1007/BF02598083; CHALDER T, 1993, J PSYCHOSOM RES, V37, P147, DOI 10.1016/0022-3999(93)90081-P; Chellappa SL, 2006, REV BRAS PSIQUIATR, V28, P126, DOI 10.1590/S1516-44462006000200010; Crawford JR, 2001, BRIT J CLIN PSYCHOL, V40, P429, DOI 10.1348/014466501163904; DIJK DJ, 1989, EUR J PHARMACOL, V171, P207, DOI 10.1016/0014-2999(89)90109-X; Edinger JD, 2004, SLEEP, V27, P1567, DOI 10.1093/sleep/27.8.1567; FEINBERG I, 1985, ELECTROEN CLIN NEURO, V61, P134, DOI 10.1016/0013-4694(85)91051-X; Fossey M, 2004, J BEHAV MED, V27, P581, DOI 10.1007/s10865-004-0004-y; FUKUDA K, 1994, ANN INTERN MED, V121, P953, DOI 10.7326/0003-4819-121-12-199412150-00009; Gotts ZM, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-002999; Groeger JA, 2011, BEHAV NEUROSCI, V125, P252, DOI 10.1037/a0022692; Hamaguchi M, 2011, CLIN RHEUMATOL, V30, P895, DOI 10.1007/s10067-011-1702-9; Jason LA, 1999, ARCH INTERN MED, V159, P2129, DOI 10.1001/archinte.159.18.2129; JASON LA, 2001, J CHRONIC FATIGUE SY, V8, P1, DOI DOI 10.1300/J092V08N03_04; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; KARACAN I, 1970, Biological Psychiatry, V2, P391; Lichstein KL, 1997, BEHAV RES THER, V35, P733, DOI 10.1016/S0005-7967(97)00029-6; Manber R, 2012, J CLIN SLEEP MED, V8, P209, DOI 10.5664/jcsm.1786; Morin CM, 1993, INSOMNIA PSYCHOLOGIC; MORRISS R, 1993, BRIT MED J, V306, P1161, DOI 10.1136/bmj.306.6886.1161; Morriss RK, 2002, PSYCHOPHARMACOLOGY, V163, P166, DOI 10.1007/s00213-002-1129-8; Morriss RK, 1997, J PSYCHOSOM RES, V42, P597, DOI 10.1016/S0022-3999(97)89895-9; MOSSMORRIS R, 2013, HANDB CLINICAL NEURO, P301; *NAT I HLTH CLIN E, 2007, NICE CLINICAL GUIDEL; Neu D, 2008, J SLEEP RES, V17, P427, DOI 10.1111/j.1365-2869.2008.00679.x; Nisenbaum R, 2004, J PSYCHOSOM RES, V56, P171, DOI 10.1016/S0022-3999(03)00039-4; Nisenbaum Rosane, 2003, Health Qual Life Outcomes, V1, P49, DOI 10.1186/1477-7525-1-49; Pigeon WR, 2003, J PSYCHOSOM RES, V54, P61, DOI 10.1016/S0022-3999(02)00542-1; REITAN R. M., 1958, PERCEPT MOT SKILLS, V8, P271; Santamarina-Perez P, 2011, APPL NEUROPSYCHOL, V18, P216, DOI 10.1080/09084282.2011.595448; Shen JH, 2006, SLEEP MED REV, V10, P63, DOI 10.1016/j.smrv.2005.05.004; SMITH AP, 1993, BRIT J PSYCHOL, V84, P411, DOI 10.1111/j.2044-8295.1993.tb02492.x; Tiersky LA, 2003, J NERV MENT DIS, V191, P324, DOI 10.1097/00005053-200305000-00008; VERCOULEN JHMM, 1994, J PSYCHOSOM RES, V38, P383, DOI 10.1016/0022-3999(94)90099-X; Wearden A, 1997, PSYCHOL MED, V27, P81, DOI 10.1017/S0033291796004035; Werth E, 1996, AM J PHYSIOL-REG I, V271, pR501, DOI 10.1152/ajpregu.1996.271.3.R501; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	40	19	21	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2015	10	1							e0117136	10.1371/journal.pone.0117136	http://dx.doi.org/10.1371/journal.pone.0117136			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AZ4BU	25575044	Green Accepted, Green Submitted, Green Published, gold			2022-12-27	WOS:000348168100013
J	Guo, H; Sa, ZH				Guo, Hong; Sa, Zhihong			Socioeconomic Differentials in Smoking Duration among Adult Male Smokers in China: Result from the 2006 China Health and Nutrition Survey	PLOS ONE			English	Article							LUNG-CANCER; TOBACCO USE; PREVALENCE; CONSUMPTION; CESSATION; EDUCATION; INEQUALITIES; POPULATION; VALIDATION; MORTALITY	Background A smoker's risk of diseases and death from smoking is closely related to his/her smoking duration. But little is known about the average length of smoking and the association between smoking duration and socio-economic status (SES) among Chinese smokers. Methods A sample of male ever smokers (N = 2,637) aged 18+ years was drawn from the 2006 China Health and Nutrition Survey to examine the average length of smoking and socioeconomic differentials in smoking duration. Kaplan-Meier analysis was used to obtain median smoking duration. Log-logistic regression models were employed to estimate the relative duration of smoking, adjusted for demographic characteristics, smoking history, and health status. Results Results showed that Chinese male ever smokers aged 18 years and older had a median duration of smoking of 58 years ( 95% CI: 56-61). Male ever smokers with a lower status job (i.e. farmers, manual and skilled workers, service workers, and office staff) had a significantly longer duration of smoking than those with a professional or administrative job after adjusted for demographic characteristics, smoking history, and health status. Individuals who earned the lowest income and who had no education or were being illiterate smoked for 11% and 14% longer, respectively, relative to those who had the highest income or who had college or above education. Conclusion The findings demonstrated the problem of long smoking duration and a pattern of social disparities in smoking duration among Chinese male smokers. Social disparities in smoking behavior may exacerbate the already existing social inequalities in health. Thus, policies and interventions to promote smoking cessation should pay more attention to disadvantaged social groups.	[Sa, Zhihong] Beijing Normal Univ, Sch Social Dev & Publ Policy, Beijing 100875, Peoples R China	Beijing Normal University	Sa, ZH (corresponding author), Beijing Normal Univ, Sch Social Dev & Publ Policy, Beijing 100875, Peoples R China.	zsa@bnu.edu.cn						Alberg AJ, 2003, CHEST, V123, p21S, DOI 10.1378/chest.123.1_suppl.21S; Burns EK, 2007, NICOTINE TOB RES, V9, P731, DOI 10.1080/14622200701397882; Center for Disease Prevention and Control Chinese Ministry of Health, 2010, GATS CHIN REP; Ceraso M, 2009, PREV CHRONIC DIS, V6; Cleves MA, 2002, INTRO SURVIVAL ANAL; Dikotter F, 2002, BRIT J CRIMINOL, V42, P317, DOI 10.1093/bjc/42.2.317; Du SF, 2002, PUBLIC HEALTH NUTR, V5, P169, DOI 10.1079/PHN2001290; Entwisle B, 2002, EUR J POPUL, V18, P99, DOI 10.1023/A:1015507114559; Ferri CP, 2011, INT J GERIATR PSYCH, V26, P1177, DOI 10.1002/gps.2661; Flanders WD, 2003, CANCER RES, V63, P6556; Gu DF, 2009, NEW ENGL J MED, V360, P150, DOI 10.1056/NEJMsa0802902; Hosmer D. W., 1999, APPL SURVIVAL ANAL; Hu J, 2005, ANN ONCOL, V16, P1605, DOI 10.1093/annonc/mdi312; Huisman M, 2005, PREV MED, V40, P756, DOI 10.1016/j.ypmed.2004.09.022; Islam M S, 2013, Mymensingh Med J, V22, P547; Kendzor DE, 2010, AM J PUBLIC HEALTH, V100, P702, DOI 10.2105/AJPH.2009.172676; Kenkel D, 2009, HEALTH ECON, V18, pS147, DOI 10.1002/hec.1507; Kohrman M, 2007, CHINA J, V58, P85, DOI 10.1086/tcj.58.20066308; Le C, 2009, SE ASIAN J TROP MED, V40, P370; Levy DT, 2006, J EPIDEMIOL COMMUN H, V60, P20, DOI 10.1136/jech.2005.045542; LIU ZY, 1992, INT J EPIDEMIOL, V21, P197, DOI 10.1093/ije/21.2.197; McDonald SP, 2003, AUST NZ J PUBL HEAL, V27, P57, DOI 10.1111/j.1467-842X.2003.tb00380.x; Najman JM, 2006, B WORLD HEALTH ORGAN, V84, P976, DOI 10.2471/BLT.05.028928; Pan ZF, 2004, HEALTH PROMOT INT, V19, P309, DOI 10.1093/heapro/dah304; Pan Z, 2008, J PUBLIC HEALTH POL, V29, P72, DOI 10.1057/palgrave.jphp.3200163; Peto R, 2000, BRIT MED J, V321, P323, DOI 10.1136/bmj.321.7257.323; Sanderson DM, 2005, PREV MED, V41, P757, DOI 10.1016/j.ypmed.2005.06.002; Siahpush M, 2005, PUBLIC HEALTH, V119, P1105, DOI 10.1016/j.puhe.2005.03.004; Siahpush M, 2003, TOB CONTROL, V12, P60, DOI 10.1136/tc.12.1.60; Siahpush M, 2010, J PUBLIC HEALTH-UK, V32, P210, DOI 10.1093/pubmed/fdp104; Siahpush M, 2009, ADDICTION, V104, P1382, DOI 10.1111/j.1360-0443.2009.02599.x; SUADICANI P, 1994, INT J EPIDEMIOL, V23, P293, DOI 10.1093/ije/23.2.293; Tu Shin-Ping, 2000, Asian Am Pac Isl J Health, V8, P46; Vartiainen E, 2002, J EPIDEMIOL COMMUN H, V56, P167, DOI 10.1136/jech.56.3.167; Wang Hong, 2006, Salud pública Méx, V48, ps140, DOI 10.1590/S0036-36342006000700017; Wank D, 2000, CIGARETTES DOMINATIO, P268; WHO, 2008, REP GLOB TOB EP 2008; Wipfli H, 2009, CLIN PHARMACOL THER, V86, P263, DOI 10.1038/clpt.2009.93; World Health Organization, 1999, WORLD HLTH REP 1999; Yan J, 2008, NICOTINE TOB RES, V10, P737, DOI 10.1080/14622200801901930; Yan W, 2004, CHINA PUBLIC HLTH, V20, P2; Yang GH, 1999, JAMA-J AM MED ASSOC, V282, P1247, DOI 10.1001/jama.282.13.1247; Yang Y, 2010, BIOMED ENVIRON SCI, V23, P437, DOI 10.1016/S0895-3988(11)60004-4; Zhang J, 2011, RESPIROLOGY, V16, P1165, DOI 10.1111/j.1440-1843.2011.02062.x; Zhu Zh, 1999, CHINESE MENTAL HLTH, V13, P105	45	15	15	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2015	10	1							e0117354	10.1371/journal.pone.0117354	http://dx.doi.org/10.1371/journal.pone.0117354			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AZ4BU	25575097	Green Published, gold, Green Submitted			2022-12-27	WOS:000348168100014
J	Guo, WH; Grewe, F; Mower, JP				Guo, Wenhu; Grewe, Felix; Mower, Jeffrey P.			Variable Frequency of Plastid RNA Editing among Ferns and Repeated Loss of Uridine-to-Cytidine Editing from Vascular Plants	PLOS ONE			English	Article							MITOCHONDRIAL GENOME SEQUENCE; GROUP-II INTRON; CHLOROPLAST GENOME; EQUISETUM-ARVENSE; MESSENGER-RNAS; TRANSCRIPTS; SITES; EVOLUTION; LIVERWORT; LYCOPHYTE	The distinct distribution and abundance of C-to-U and U-to-C RNA editing among land plants suggest that these two processes originated and evolve independently, but the paucity of information from several key lineages limits our understanding of their evolution. To examine the evolutionary diversity of RNA editing among ferns, we sequenced the plastid transcriptomes from two early diverging species, Ophioglossum californicum and Psilotum nudum. Using a relaxed automated approach to minimize false negatives combined with manual inspection to eliminate false positives, we identified 297 C-to-U and three U-to-C edit sites in the O. californicum plastid transcriptome but only 27 C-to-U and no U-to-C edit sites in the P. nudum plastid transcriptome. A broader comparison of editing content with the leptosporangiate fern Adiantum capillus-veneris and the hornwort Anthoceros formosae uncovered large variance in the abundance of plastid editing, indicating that the frequency and type of RNA editing is highly labile in ferns. Edit sites that increase protein conservation among species are more abundant and more efficiently edited than silent and non-conservative sites, suggesting that selection maintains functionally important editing. The absence of U-to-C editing from P. nudum plastid transcripts and other vascular plants demonstrates that U-to-C editing loss is a recurrent phenomenon in vascular plant evolution.	[Guo, Wenhu; Grewe, Felix; Mower, Jeffrey P.] Univ Nebraska, Ctr Plant Sci Innovat, Lincoln, NE 68588 USA; [Guo, Wenhu] Univ Nebraska, Sch Biol Sci, Lincoln, NE USA; [Guo, Wenhu] ACGT Inc, Wheeling, IL USA; [Grewe, Felix; Mower, Jeffrey P.] Univ Nebraska, Dept Agron & Hort, Lincoln, NE USA	University of Nebraska System; University of Nebraska Lincoln; University of Nebraska System; University of Nebraska Lincoln; University of Nebraska System; University of Nebraska Lincoln	Mower, JP (corresponding author), Univ Nebraska, Ctr Plant Sci Innovat, Lincoln, NE 68588 USA.	jpmower@unl.edu	Mower, Jeff/P-5893-2019; Mower, Jeff/B-7875-2008; Guo, Wenhu/C-7803-2016	Mower, Jeff/0000-0002-1501-5809; Mower, Jeff/0000-0002-1501-5809; Guo, Wenhu/0000-0002-2515-2161; Grewe, Felix/0000-0002-2805-5930	University of Nebraska-Lincoln; National Science Foundation [IOS-1027529, MCB-1125386]	University of Nebraska-Lincoln; National Science Foundation(National Science Foundation (NSF))	This work was supported by start-up funds from the University of Nebraska-Lincoln and by the National Science Foundation (awards IOS-1027529 and MCB-1125386 to JPM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. ACGT, Inc. provided support in the form of salaries for author WG, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Begu D, 2009, CURR GENET, V55, P69, DOI 10.1007/s00294-008-0225-7; Begu D, 2011, CURR GENET, V57, P317, DOI 10.1007/s00294-011-0349-z; Bentolila S, 2008, GENETICS, V178, P1693, DOI 10.1534/genetics.107.073585; BORNER GV, 1995, MOL GEN GENET, V246, P739, DOI 10.1007/BF00290721; Carrillo C, 1997, NUCLEIC ACIDS RES, V25, P403, DOI 10.1093/nar/25.2.403; Carrillo C, 2001, MOL GEN GENET, V264, P595, DOI 10.1007/s004380000345; Castandet B, 2010, NUCLEIC ACIDS RES, V38, P7112, DOI 10.1093/nar/gkq591; Chateigner-Boutin AL, 2011, WIRES RNA, V2, P493, DOI 10.1002/wrna.72; Chaw SM, 2008, MOL BIOL EVOL, V25, P603, DOI 10.1093/molbev/msn009; Drescher A, 2002, MOL GENET GENOMICS, V267, P262, DOI 10.1007/s00438-002-0662-9; Duff RJ, 2005, J MOL EVOL, V61, P571, DOI 10.1007/s00239-004-0146-0; Farre JC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052644; Finster S, 2012, GENOMICS CHLOROPLAST, P293; Freyer R, 1997, P NATL ACAD SCI USA, V94, P6285, DOI 10.1073/pnas.94.12.6285; Giege P, 1999, P NATL ACAD SCI USA, V96, P15324, DOI 10.1073/pnas.96.26.15324; Grewe F, 2014, MITOCHONDRION, V19, P135, DOI 10.1016/j.mito.2014.05.008; Grewe F, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-8; Grewe F, 2011, NUCLEIC ACIDS RES, V39, P2890, DOI 10.1093/nar/gkq1227; Grimes BT, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-31; Grosche C, 2012, GENOME BIOL EVOL, V4, P1349, DOI 10.1093/gbe/evs114; Groth-Malonek M, 2005, MOL BIOL EVOL, V22, P117, DOI 10.1093/molbev/msh259; Groth-Malonek M, 2007, MOL BIOL EVOL, V24, P1068, DOI 10.1093/molbev/msm026; GUALBERTO JM, 1990, NUCLEIC ACIDS RES, V18, P3771, DOI 10.1093/nar/18.13.3771; Hansen KD, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq224; Hecht J, 2011, GENOME BIOL EVOL, V3, P344, DOI 10.1093/gbe/evr027; Hepburn NJ, 2012, MOL BIOL EVOL, V29, P3111, DOI 10.1093/molbev/mss130; HIESEL R, 1994, P NATL ACAD SCI USA, V91, P629, DOI 10.1073/pnas.91.2.629; Karcher D, 2002, J BIOL CHEM, V277, P5570, DOI 10.1074/jbc.M107074200; Karol KG, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-321; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kim HT, 2014, MOL CELLS, V37, P372, DOI 10.14348/molcells.2014.2296; Kugita M, 2003, NUCLEIC ACIDS RES, V31, P2417, DOI 10.1093/nar/gkg327; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Li LB, 2009, J MOL EVOL, V68, P665, DOI 10.1007/s00239-009-9240-7; Li-Pook-Than J, 2007, PHYSIOL PLANTARUM, V129, P23, DOI 10.1111/j.1399-3054.2006.00770.x; Liu Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035168; Miyata Y, 2004, J PLANT PHYSIOL, V161, P113, DOI 10.1078/0176-1617-01220; Mower JP, 2006, MOL GENET GENOMICS, V276, P285, DOI 10.1007/s00438-006-0139-3; Oldenkott B, 2014, RNA, V20, P1499, DOI 10.1261/rna.045575.114; Ong HC, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-55; Picardi E, 2010, NUCLEIC ACIDS RES, V38, P4755, DOI 10.1093/nar/gkq202; Qiu YL, 2006, P NATL ACAD SCI USA, V103, P15511, DOI 10.1073/pnas.0603335103; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Richardson E, 2014, MOL BIOL EVOL, V31, P2376, DOI 10.1093/molbev/msu189; Rudinger M, 2012, J MOL EVOL, V74, P37, DOI 10.1007/s00239-012-9486-3; Rudinger M, 2009, MOL GENET GENOMICS, V281, P473, DOI 10.1007/s00438-009-0424-z; Ruhfel BR, 2014, BMC EVOL BIOL, V14, DOI 10.1186/1471-2148-14-23; Ruwe H, 2013, FEBS LETT, V587, P1429, DOI 10.1016/j.febslet.2013.03.022; SCHUSTER W, 1990, MOL CELL BIOL, V10, P2428, DOI 10.1128/MCB.10.5.2428; SCHUSTER W, 1991, NUCLEIC ACIDS RES, V19, P6923, DOI 10.1093/nar/19.24.6923; Sloan DB, 2010, GENETICS, V185, P1369, DOI 10.1534/genetics.110.118000; SPERWHITIS GL, 1994, BBA-GENE STRUCT EXPR, V1218, P218, DOI 10.1016/0167-4781(94)90016-7; Stone JD, 2015, MOL GENET GENOMICS, V290, P1, DOI 10.1007/s00438-014-0905-6; Takenaka M, 2013, ANNU REV GENET, V47, P335, DOI 10.1146/annurev-genet-111212-133519; van Gurp TP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0085583; Wakasugi T, 1996, P NATL ACAD SCI USA, V93, P8766, DOI 10.1073/pnas.93.16.8766; Wolf PG, 2011, PLANT MOL BIOL, V76, P251, DOI 10.1007/s11103-010-9706-4; Wolf PG, 2005, GENE, V350, P117, DOI 10.1016/j.gene.2005.01.018; Wolf PG, 2004, GENE, V339, P89, DOI 10.1016/j.gene.2004.06.018; Xue JY, 2010, CURR GENET, V56, P53, DOI 10.1007/s00294-009-0279-1; Yura K, 2008, DNA RES, V15, P309, DOI 10.1093/dnares/dsn016; Zehrmann A, 2008, MITOCHONDRION, V8, P319, DOI 10.1016/j.mito.2008.07.003; Zeng WH, 2007, PLANT CELL PHYSIOL, V48, P362, DOI 10.1093/pcp/pcl058	65	47	49	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2015	10	1							e0117075	10.1371/journal.pone.0117075	http://dx.doi.org/10.1371/journal.pone.0117075			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ4BT	25568947	Green Published, Green Submitted, gold			2022-12-27	WOS:000348168000011
J	Allema, B; van der Werf, W; van Lenteren, JC; Hemerik, L; Rossing, WAH				Allema, Bas; van der Werf, Wopke; van Lenteren, Joop C.; Hemerik, Lia; Rossing, Walter A. H.			Movement Behaviour of the Carabid Beetle Pterostichus melanarius in Crops and at a Habitat Interface Explains Patterns of Population Redistribution in the Field	PLOS ONE			English	Article							COLEOPTERA CARABIDAE; GENERALIST PREDATORS; DISPERSAL; EDGES; DYNAMICS; DENSITY; MODELS	Animals may respond to habitat quality and habitat edges and these responses may affect their distribution between habitats. We studied the movement behaviour of a ground-dwelling generalist predator, the carabid beetle Pterostichus melanarius (Illiger). We performed a mark-recapture experiment in two adjacent habitats; a large plot with oilseed radish (Raphanus sativus) and a plot with rye (Secale cereale). We used model selection to identify a minimal model representing the mark-recapture data, and determine whether habitat-specific motility and boundary behaviour affected population redistribution. We determined movement characteristics of P. melanarius in laboratory arenas with the same plant species using video recording. Both the field and arena results showed preference behaviour of P. melanarius at the habitat interface. In the field, significantly more beetles moved from rye to oilseed radish than from radish to rye. In the arena, habitat entry was more frequent into oilseed radish than into rye. In the field, movement was best described by a Fokker-Planck diffusion model that contained preference behaviour at the interface and did not account for habitat specific motility. Likewise, motility calculated from movement data using the Patlak model was not different between habitats in the arena studies. Motility (m(2) d(-1)) calculated from behavioural data resulted in estimates that were similar to those determined in the field. Thus individual behaviour explained population redistribution in the field qualitatively as well as quantitatively. The findings provide a basis for evaluating movement within and across habitats in complex agricultural landscapes with multiple habitats and habitat interfaces.	[Allema, Bas; Hemerik, Lia; Rossing, Walter A. H.] Wageningen Univ, NL-6700 AP Wageningen, Netherlands; [Allema, Bas; van Lenteren, Joop C.] Wageningen Univ, Entomol Lab, NL-6700 AP Wageningen, Netherlands; [van der Werf, Wopke] Wageningen Univ, Ctr Crop Syst Anal, Crop & Weed Ecol Grp, NL-6700 AP Wageningen, Netherlands	Wageningen University & Research; Wageningen University & Research; Wageningen University & Research	Rossing, WAH (corresponding author), Wageningen Univ, NL-6700 AP Wageningen, Netherlands.	walter.rossing@wur.nl	van Lenteren, Joop/J-1748-2014; van der Werf, Wopke/A-2557-2009	van Lenteren, Joop/0000-0003-3620-1392; van der Werf, Wopke/0000-0002-5506-4699; Hemerik, Lia/0000-0002-6892-2840	strategic research funds of the C.T. de Wit Graduate School for Production Ecology and Resource Conservation; strategic research program "Sustainable spatial development of ecosystems, landscapes, seas and regions'' - Dutch Ministry of Agriculture, Nature Conservation and Food Quality; Wageningen University and Research Centre [KB-01-008-024-ALT]	strategic research funds of the C.T. de Wit Graduate School for Production Ecology and Resource Conservation; strategic research program "Sustainable spatial development of ecosystems, landscapes, seas and regions'' - Dutch Ministry of Agriculture, Nature Conservation and Food Quality; Wageningen University and Research Centre	This project was financially supported by the strategic research funds of the C.T. de Wit Graduate School for Production Ecology and Resource Conservation (http://www.pe-rc.nl/) and the strategic research program "Sustainable spatial development of ecosystems, landscapes, seas and regions,'' which is funded by the Dutch Ministry of Agriculture, Nature Conservation and Food Quality, and carried out by Wageningen University and Research Centre (KB-01-008-024-ALT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allema AB, 2012, J APPL ENTOMOL, V136, P793, DOI 10.1111/j.1439-0418.2012.01728.x; Batschelet E, 1981, CIRCULAR STAT BIOL; Bohan DA, 2000, J ANIM ECOL, V69, P367, DOI 10.1046/j.1365-2656.2000.00399.x; Bolker B, 2008, ECOLOGICAL MODELS DA; Bommarco R, 2002, AGR FOREST ENTOMOL, V4, P21, DOI 10.1046/j.1461-9563.2002.00117.x; Cantrell RS, 1999, THEOR POPUL BIOL, V55, P189, DOI 10.1006/tpbi.1998.1397; Chapman PA, 1999, ENTOMOL EXP APPL, V91, P477, DOI 10.1023/A:1003779613048; CREED RP, 1990, EXPERIENTIA, V46, P758, DOI 10.1007/BF01939959; Fagan WE, 1999, AM NAT, V153, P165, DOI 10.1086/303162; Fournier E, 2002, AGR ECOSYST ENVIRON, V89, P253, DOI 10.1016/S0167-8809(01)00216-X; FRAMPTON GK, 1995, BIOL CONSERV, V71, P347, DOI 10.1016/0006-3207(94)00072-X; Garcia AF, 2000, ANN APPL BIOL, V137, P89, DOI 10.1111/j.1744-7348.2000.tb00040.x; Groot JCJ, 2012, COMPASS FRAMEWORK NA; Haynes KJ, 2003, ECOLOGY, V84, P2856, DOI 10.1890/02-0611; Hilborn Ray, 1997, V28; Kuczma M, 2009, INTODUCTION THEORY F; Maciel GA, 2013, AM NAT, V182, P42, DOI 10.1086/670661; MAUREMOOTO JR, 1995, AGR ECOSYST ENVIRON, V52, P141, DOI 10.1016/0167-8809(94)00548-S; Musgrave J, 2014, J MATH BIOL, V69, P617, DOI [10.1007/s00285-013-0714-2, 10.1007/s00285-013-0715-1]; Ovaskainen O, 2004, ECOLOGY, V85, P242, DOI 10.1890/02-0706; Ovaskainen O, 2003, J APPL PROBAB, V40, P557, DOI 10.1239/jap/1059060888; Ovaskainen O, 2008, AM NAT, V171, P610, DOI 10.1086/587070; Patterson TA, 2008, TRENDS ECOL EVOL, V23, P87, DOI 10.1016/j.tree.2007.10.009; Rand TA, 2006, ECOL LETT, V9, P603, DOI 10.1111/j.1461-0248.2006.00911.x; Ries L, 2004, ECOLOGY, V85, P2917, DOI 10.1890/03-8021; Schick RS, 2008, ECOL LETT, V11, P1338, DOI 10.1111/j.1461-0248.2008.01249.x; Snyder WE, 2001, ECOLOGY, V82, P705, DOI 10.1890/0012-9658(2001)082[0705:GPDBCB]2.0.CO;2; Storn R, 1997, J GLOBAL OPTIM, V11, P341, DOI 10.1023/A:1008202821328; Symondson WOC, 1996, J APPL ECOL, V33, P741, DOI 10.2307/2404945; Trefas H, 2001, AGR FOREST ENTOMOL, V3, P71, DOI 10.1046/j.1461-9563.2001.00089.x; Trefas H, 2008, B INSECTOL, V61, P225; Tscharntke T, 2012, BIOL REV, V87, P661, DOI 10.1111/j.1469-185X.2011.00216.x; Turchin Peter, 1998; Turin H, 2000, NEDERLANDSE LOOPKEVE; Winder L, 2005, J ANIM ECOL, V74, P443, DOI 10.1111/j.1365-2656.2005.00939.x	36	13	13	1	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2014	9	12							e115751	10.1371/journal.pone.0115751	http://dx.doi.org/10.1371/journal.pone.0115751			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UC	25551222	Green Submitted, gold, Green Published			2022-12-27	WOS:000347119100057
J	Facco, M; Nespeca, M; Simonato, M; Isak, I; Verlato, G; Ciambra, G; Giorgetti, C; Carnielli, VP; Cogo, PE				Facco, Maddalena; Nespeca, Matteo; Simonato, Manuela; Isak, Ilena; Verlato, Giovanna; Ciambra, Gianluca; Giorgetti, Chiara; Carnielli, Virgilio P.; Cogo, Paola E.			In Vivo Effect of Pneumonia on Surfactant Disaturated-Phosphatidylcholine Kinetics in Newborn Infants	PLOS ONE			English	Article							RESPIRATORY-DISTRESS-SYNDROME; POSITIVE-PRESSURE VENTILATION; ESCHERICHIA-COLI PNEUMONIA; INDUCED LUNG INJURY; PRETERM INFANTS; BRONCHOPULMONARY DYSPLASIA; PULMONARY INFLAMMATION; BOVINE SURFACTANT; STABLE-ISOTOPES; THERAPY	Background: Bacterial pneumonia in newborns often leads to surfactant deficiency or dysfunction, as surfactant is inactivated or its production/turnover impaired. No data are available in vivo in humans on the mechanism of surfactant depletion in neonatal pneumonia. We studied the kinetics of surfactant's major component, disaturated-phosphatidylcholine (DSPC), in neonatal pneumonia, and we compared our findings with those obtained from control newborn lungs. Methods: We studied thirty-one term or near-term newborns (gestational age 39.7 +/- 1.7 weeks, birth weight 3185 +/- 529 g) requiring mechanical ventilation. Fifteen newborns had pneumonia, while 16 newborns were on mechanical ventilation but had no lung disease. Infants received an intratracheal dose of C-13 labeled dipalmitoyl-phosphatidylcholine at the study start. We measured the amount and the isotopic enrichment of DSPC-palmitate from serial tracheal aspirates by gas chromatography and gas chromatography-mass spectrometry, respectively, and we calculated the DSPC half-life (HL) and pool size (PS) from the isotopic enrichment curves of surfactant DSPC-palmitate. Results: The mean DSPC amount obtained from all tracheal aspirates did not differ between the two groups. DSPC HL was 12.7 (6.5-20.2) h and 25.6 (17.9-60.6) h in infants with pneumonia compared with control infants (p=0.003). DSPC PS was 14.1 (6.6-30.9) mg/kg in infants with pneumonia and 34.1 (25.6-65.0) mg/kg in controls, p=0.042. Myeloperoxidase (MPO) activity, as a marker of lung inflammation, was 1322 (531-2821) mU/ml of Epithelial Lining Fluid (ELF) and 371(174-1080) mU/ml ELF in infants with pneumonia and in controls, p=0.047. In infants with pneumonia, DSPC PS and HL significantly and inversely correlated with mean Oxygenation Index (OI) during the study (DSPC PS vs. OI R=-0.710, p=0.004 and HL vs. OI R=-0.525, p=0.044, respectively). Conclusions: We demonstrated for the first time in vivo in humans that DSPC HL and PS were markedly impaired in neonatal pneumonia and that they inversely correlated with the degree of respiratory failure.	[Facco, Maddalena; Simonato, Manuela; Isak, Ilena; Verlato, Giovanna] Univ Padua, Dept Womens & Childrens Hlth, Padua, Italy; [Nespeca, Matteo; Ciambra, Gianluca; Giorgetti, Chiara; Carnielli, Virgilio P.] Polytech Univ Marche, Salesi Childrens Hosp, Ancona, Italy; [Nespeca, Matteo; Ciambra, Gianluca; Giorgetti, Chiara; Carnielli, Virgilio P.] Univ Ancona, Ancona, Italy; [Cogo, Paola E.] Bambino Gesu Pediat Hosp, Pediat Cardiac Anesthesia Intens Care Unit, Dept Pediat Cardiol & Cardiac Surg, Rome, Italy	University of Padua; Marche Polytechnic University; Marche Polytechnic University; IRCCS Bambino Gesu	Facco, M (corresponding author), Univ Padua, Dept Womens & Childrens Hlth, Padua, Italy.	maddalena.facco@unipd.it	Cogo, Paola P/J-6918-2018; Simonato, Manuela/AAX-5656-2020; Verlato, Giovanna/H-2202-2018	Cogo, Paola P/0000-0002-6235-140X; Simonato, Manuela/0000-0002-2745-7305; Verlato, Giovanna/0000-0003-4613-7427; Isak, Ilena/0000-0002-2462-4710				Bauer TT, 2006, CLIN INFECT DIS, V43, P748, DOI 10.1086/506430; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; BREHMER U, 1993, KLIN PADIATR, V205, P78, DOI 10.1055/s-2008-1034532; Cogo PE, 2008, PEDIATR RES, V63, P433, DOI 10.1203/PDR.0b013e3181659759; Cogo PE, 2011, INTENS CARE MED, V37, P510, DOI 10.1007/s00134-010-2091-2; Cogo PE, 2007, RESP RES, V8, DOI 10.1186/1465-9921-8-13; Cogo PE, 2009, PEDIATRICS, V124, pE950, DOI 10.1542/peds.2009-0126; Cogo PE, 1999, PEDIATR RES, V45, P242, DOI 10.1203/00006450-199902000-00015; Cogo PE, 2003, CRIT CARE MED, V31, P1532, DOI 10.1097/01.CCM.0000063043.25167.99; Dargaville PA, 2005, DRUGS, V65, P2569, DOI 10.2165/00003495-200565180-00003; Dargaville PA, 1999, AM J RESP CRIT CARE, V160, P778, DOI 10.1164/ajrccm.160.3.9811049; El Shahed AI, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002054.pub2; GORTNER L, 1990, MONATSSCHR KINDERH, V138, P274; GRIESE M, 1995, AM J RESP CRIT CARE, V152, P1050, DOI 10.1164/ajrccm.152.3.7663782; Halbertsma FJJ, 2005, NETH J MED, V63, P382; HALLMAN M, 1986, PEDIATR RES, V20, P1228, DOI 10.1203/00006450-198612000-00008; HARMS K, 1994, RESPIRATION, V61, P348; Herting E, 1999, AM J RESP CRIT CARE, V159, P1862, DOI 10.1164/ajrccm.159.6.9810047; Herting E, 2000, PEDIATRICS, V106, P957, DOI 10.1542/peds.106.5.957; Herting E, 2002, ACTA PAEDIATR, V91, P1174, DOI 10.1080/080352502320777397; Hilgendorff Anne, 2008, BMC Pulm Med, V8, P10, DOI 10.1186/1471-2466-8-10; Horan TC, 2008, AM J INFECT CONTROL, V36, P309, DOI 10.1016/j.ajic.2008.03.002; Ikegami M, 2006, RESPIROLOGY, V11, pS24, DOI 10.1111/j.1440-1843.2006.00803.x; Lotze A, 1998, J PEDIATR-US, V132, P40, DOI 10.1016/S0022-3476(98)70482-2; Malloy JL, 2004, RESP RES, V5, DOI 10.1186/1465-9921-5-8; Plataki Maria, 2010, Expert Rev Respir Med, V4, P373, DOI 10.1586/ers.10.28; Quintero OA, 2002, AM J PHYSIOL-LUNG C, V282, pL330, DOI 10.1152/ajplung.00190.2001; Rudiger M, 2001, BIOL NEONATE, V79, P73, DOI 10.1159/000047070; Seger N, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007836; Soll Roger F, 2009, Neonatology, V95, P368, DOI 10.1159/000209303; Song GW, 1996, ACTA ANAESTH SCAND, V40, P1154, DOI 10.1111/j.1399-6576.1996.tb05580.x; Stichtenoth G, 2010, PEDIATR RES, V67, P369, DOI 10.1203/PDR.0b013e3181d026f6; Tan K, 2012, COCHRANE DB SYST REV, V2; Torresin M, 2000, AM J RESP CRIT CARE, V161, P1584, DOI 10.1164/ajrccm.161.5.9905088; TOUCHSTONE JC, 1980, LIPIDS, V15, P61, DOI 10.1007/BF02534120; van Kaam AH, 2003, BIOL NEONATE, V83, P273, DOI 10.1159/000069482; van Kaam AH, 2003, PEDIATR RES, V53, P245, DOI 10.1203/01.PDR.0000047520.44168.22; Verlato G, 2003, ITAL J PEDIATR, V29, P414; Zuo YY, 2008, BBA-BIOMEMBRANES, V1778, P1947, DOI 10.1016/j.bbamem.2008.03.021	39	12	14	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2014	9	12							e93612	10.1371/journal.pone.0093612	http://dx.doi.org/10.1371/journal.pone.0093612			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UC	25551219	Green Submitted, gold, Green Published			2022-12-27	WOS:000347119100001
J	Kruger, S; Reid, T; Amar, A				Krueger, Sonja; Reid, Timothy; Amar, Arjun			Differential Range Use between Age Classes of Southern African Bearded Vultures Gypaetus barbatus	PLOS ONE			English	Article							SPANISH IMPERIAL EAGLES; HOME-RANGE; GYPS-FULVUS; BEHAVIOR; DISPERSAL; POPULATION; SELECTION; DENSITY; ESTIMATORS; DECLINE	Bearded Vulture Gypaetus barbatus movements were investigated in southern Africa to determine whether an individual's age, sex or breeding status influenced its ranging behaviour and to provide the information required to guide conservation activities. Data from satellite transmitters fitted to 18 individuals of four age classes were used to determine range size and use. Because of the nature of the movements of marked individuals, these data could be used to determine the overall foraging range of the entire population, which was estimated to be 51 767 km(2). Although juvenile, immature and sub-adult birds used different parts of the overall range, their combined foraging range was 65% (33 636 km(2)) of the overall range. Average adult home ranges (286 km(2)) were only around 1% the size of the average foraging ranges of non-adults (10 540 -25 985 km(2)), with those of breeding adults being even smaller (95 km(2)). Home ranges of breeding adults did not vary in size between seasons but adults utilized their home range more intensively whilst breeding, moving greater distances during the incubation and chick hatching period. Range size and use increased as non-adults aged. Immatures and sub-adults had larger range sizes during winter, but range use of non-adults did not vary seasonally. Range size and use did not differ between the sexes in any of the age classes. Information on home range size and use enables specific areas within the species' range to be targeted for management planning, education and conservation action.	[Krueger, Sonja; Reid, Timothy; Amar, Arjun] Univ Cape Town, Percy Fitzpatrick Inst African Ornithol, DST NRF Ctr Excellence, ZA-7700 Rondebosch, South Africa; [Krueger, Sonja] Ezemvelo KZN Wildlife, Cascades, South Africa	National Research Foundation - South Africa; University of Cape Town	Kruger, S (corresponding author), Univ Cape Town, Percy Fitzpatrick Inst African Ornithol, DST NRF Ctr Excellence, ZA-7700 Rondebosch, South Africa.	sonja.krueger@kznwildlife.com	Arjun, Amar/F-3815-2011; Amar, Arjun/L-4493-2019	Arjun, Amar/0000-0002-7405-1180; 	Maloti Drakensberg Transfrontier Programme; Wildlands Conservation Trust; Terra de Natura; Aspen Pharmaceuticals; McAdams family	Maloti Drakensberg Transfrontier Programme; Wildlands Conservation Trust; Terra de Natura; Aspen Pharmaceuticals; McAdams family	GPS satellite tags were funded by the Maloti Drakensberg Transfrontier Programme (12), the Wildlands Conservation Trust (3), Terra de Natura (1), Aspen Pharmaceuticals (1) and the McAdams family (1). Vulture capture related expenses were covered by Ezemvelo KwaZulu-Natal Wildlife and Sasol through the Endangered Wildlife Trust. In all cases the funding was received by SK. Ezemvelo KwaZulu-Natal Wildlife and the Maloti Drakensberg Transfrontier Programme approved the study design and data collection. The other funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharya R, 2010, FORKTAIL, P117; Bamford AJ, 2007, BIRD CONSERV INT, V17, P331, DOI 10.1017/S0959270907000846; BATES DM, 2012, CONSERVING BIRD DIVE, P105; Beissinger SR, 2000, P NATL ACAD SCI USA, V97, P11688, DOI 10.1073/pnas.97.22.11688; Garcia CB, 2009, EUR J WILDLIFE RES, V55, P309, DOI 10.1007/s10344-008-0239-y; Bell BD, 2002, CONSERV BIOL SER, V7, P105; Bennett PM, 1997, P ROY SOC B-BIOL SCI, V264, P401, DOI 10.1098/rspb.1997.0057; Bertran J, 2002, J FIELD ORNITHOL, V73, P86, DOI 10.1648/0273-8570-73.1.86; Beyer H. L, 2012, GEOSPATIAL MODELLING; Bivand R, 2013, RGDAL BINDINGS GEOSP; Boggie MA, 2014, LANDSCAPE URBAN PLAN, V124, P34, DOI 10.1016/j.landurbplan.2014.01.001; Boshoff Andre, 2011, Vulture News, V61, P4; Brown C. J., 1988, THESIS U NATAL PIETE; BROWN CJ, 1991, BIOL CONSERV, V57, P315, DOI 10.1016/0006-3207(91)90075-K; BROWN CJ, 1989, OSTRICH, V60, P165, DOI 10.1080/00306525.1989.9633751; Brown CJ, 1997, AFR J ECOL, V35, P53, DOI 10.1111/j.1365-2028.1997.048-89048.x; BROWN CJ, 1990, OSTRICH, V61, P24, DOI 10.1080/00306525.1990.9633934; BROWN CJ, 1992, OSTRICH, V63, P1, DOI 10.1080/00306525.1992.9634172; BROWN LH, 1982, BIRDS OF AFRICA, V1; Butchart SHM, 2010, SCIENCE, V328, P1164, DOI 10.1126/science.1187512; Calenge C., 2011, HOME RANGE ESTIMATIO; Calenge C, 2006, ECOL MODEL, V197, P516, DOI 10.1016/j.ecolmodel.2006.03.017; Carrete M, 2006, ECOL APPL, V16, P1674, DOI 10.1890/1051-0761(2006)016[1674:DPDIPB]2.0.CO;2; Clark RG, 2004, CONDOR, V106, P717, DOI 10.1650/7644; Cumming GS, 2012, DIVERS DISTRIB, V18, P1057, DOI 10.1111/j.1472-4642.2012.00908.x; Donazar J.A., 1993, BUITRES IBERICOS BIO; Donazar JA, 2002, ECOL APPL, V12, P1445, DOI 10.1890/1051-0761(2002)012[1445:EOFAOL]2.0.CO;2; Fahrig L, 2007, FUNCT ECOL, V21, P1003, DOI 10.1111/j.1365-2435.2007.01326.x; FERRER M, 1993, IBIS, V135, P132, DOI 10.1111/j.1474-919X.1993.tb02824.x; Ferrer M, 1997, J APPL ECOL, V34, P1359, DOI 10.2307/2405253; Fieberg J, 2007, ECOLOGY, V88, P1059, DOI 10.1890/06-0930; FREY H, 1996, MONOGRAFIAS SEO; Fuller MR, 1987, J RAPTOR RES, V21, P126; Garcia-Ripolles C, 2011, ACTA ORNITHOL, V46, P127, DOI 10.3161/000164511X625892; Gavashelishvili A, 2006, ANIM CONSERV, V9, P159, DOI 10.1111/j.1469-1795.2005.00017.x; Gil JA, 2010, JUVENILE DISPERSAL B; GIL JA, 2014, HOME RANGE IN PRESS; Gonzalez LM, 2006, ANIM CONSERV, V9, P85, DOI 10.1111/j.1469-1795.2005.00016.x; Hegglin D., 2004, SATELLITE TRACKING B, P52; HIRALDO F, 1979, MONOGRAFIAS ICONA; Kenward RE, 2001, ECOLOGY, V82, P1905, DOI 10.2307/2680056; Kenward RE, 2000, OIKOS, V91, P271, DOI 10.1034/j.1600-0706.2000.910207.x; Kruger SC, 2014, BIRD CONSERV INT, V24, P162, DOI 10.1017/S0959270913000440; KRUGER S, 2014, ESKOM RED D IN PRESS; KRUGER S, 2013, 37620 GOV GAZ; Lenth RV, 2013, USING ISMEANS PACKAG; Margalida A, 2005, ETHOL ECOL EVOL, V17, P51; Margalida A, 2000, IBIS, V142, P225, DOI 10.1111/j.1474-919X.2000.tb04862.x; Margalida A, 2008, BIRD CONSERV INT, V18, P1, DOI 10.1017/S0959270908000026; Margalida A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065857; Mingozzi T, 1997, BIOL CONSERV, V79, P155, DOI 10.1016/S0006-3207(96)00110-3; Morrison JL, 2009, J RAPTOR RES, V43, P81, DOI 10.3356/JRR-08-33.1; Mundy P., 1992, VULTURES AFRICA; Naidoo V, 2009, REGUL TOXICOL PHARM, V53, P205, DOI 10.1016/j.yrtph.2009.01.010; Newton I., 1979, POPULATION ECOLOGY R; Ogada DL, 2012, ANN NY ACAD SCI, V1249, P57, DOI 10.1111/j.1749-6632.2011.06293.x; Penteriani V, 2005, P ROY SOC B-BIOL SCI, V272, P1265, DOI 10.1098/rspb.2005.3075; Penteriani V, 2005, OIKOS, V108, P523, DOI 10.1111/j.0030-1299.2005.13514.x; Penteriani V, 2009, J RAPTOR RES, V43, P90, DOI 10.3356/JRR-08-39.1; Phipps WL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052813; PIMM SL, 1988, AM NAT, V132, P757, DOI 10.1086/284889; R Core Team, 2021, R LANGUAGE ENV STAT; Reed JM, 1999, CONSERV BIOL, V13, P232, DOI 10.1046/j.1523-1739.1999.013002232.x; REID T, 2014, SPATIAL ANA IN PRESS; Rushworth I, 2014, OSTRICH, V85, P13, DOI 10.2989/00306525.2014.913211; Serrano D, 2008, BASIC APPL ECOL, V9, P771, DOI 10.1016/j.baae.2007.08.013; Sycholt A., 2002, GUIDE DRAKENSBERG; TERRASSE J. F., 1961, ALAUDA, V29, P1; Tukey JW, 1977, EXPLORATORY DATA ANA; Urios V, 2010, ORNIS FENNICA, V87, P114; VANWINKLE W, 1975, J WILDLIFE MANAGE, V39, P118; Virani MZ, 2011, BIOL CONSERV, V144, P746, DOI 10.1016/j.biocon.2010.10.024; Wand MP., 1994, KERNEL SMOOTHING; White C.M., 1994, NEW WORLD VULTURES G; WORTON BJ, 1989, ECOLOGY, V70, P164, DOI 10.2307/1938423; WORTON BJ, 1995, J WILDLIFE MANAGE, V59, P794, DOI 10.2307/3801959	76	42	43	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2014	9	12							e114920	10.1371/journal.pone.0114920	http://dx.doi.org/10.1371/journal.pone.0114920			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UC	25551614	gold, Green Published, Green Submitted			2022-12-27	WOS:000347119100019
J	Lao, M; Caro, V; Thiberge, JM; Bounmany, P; Vongpayloth, K; Buchy, P; Duong, V; Vanhlasy, C; Hospied, JM; Thongsna, M; Choumlivong, K; Vongkhamchanh, P; Oudavong, B; Brey, PT; Grandadam, M				Lao, Malayvanh; Caro, Valerie; Thiberge, Jean-Michel; Bounmany, Phaitong; Vongpayloth, Khamsing; Buchy, Philippe; Duong, Veasna; Vanhlasy, Chansamone; Hospied, Jean-Marie; Thongsna, Manichanh; Choumlivong, Khamla; Vongkhamchanh, Phonesavanh; Oudavong, Bounleua; Brey, Paul T.; Grandadam, Marc			Co-Circulation of Dengue Virus Type 3 Genotypes in Vientiane Capital, Lao PDR	PLOS ONE			English	Article							SURVEILLANCE; CAMBODIA	During the 2012 epidemic of dengue in Vientiane capital, Lao PDR, a major serotype switch from dengue 1 to 3 was observed. A molecular epidemiology study demonstrated that dengue 3 remained the predominant serotype in 2013, but also revealed the co-circulation of two genotypes, supporting the hypothesis of multiple geographic origins of dengue 3 strains circulating in Vientiane capital.	[Lao, Malayvanh; Bounmany, Phaitong; Vongpayloth, Khamsing; Brey, Paul T.; Grandadam, Marc] Inst Pasteur Laos, Viangchan, Laos; [Caro, Valerie; Thiberge, Jean-Michel] Inst Pasteur, Paris, France; [Buchy, Philippe; Duong, Veasna] Inst Pasteur Cambodge, Phnom Penh, Cambodia; [Vanhlasy, Chansamone] Mil Hosp 103, Viangchan, Laos; [Hospied, Jean-Marie] Ctr Med Ambassade France, Viangchan, Laos; [Thongsna, Manichanh] Mittaphab Hosp, Viangchan, Laos; [Choumlivong, Khamla] Setthathirath Hosp, Viangchan, Laos; [Vongkhamchanh, Phonesavanh] 5 April Police Hosp, Viangchan, Laos; [Oudavong, Bounleua] Children Hosp, Viangchan, Laos	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Cambodia	Grandadam, M (corresponding author), Inst Pasteur Laos, Viangchan, Laos.	m.grandadam@pasteur.la	VONGPHAYLOTH, Khamsing/AAR-7293-2020; Veasna, Duong/I-9684-2014; GRANDADAM, Marc/GNP-7470-2022	Veasna, Duong/0000-0003-0353-1678; VONGPHAYLOTH, Khamsing/0000-0002-4844-8547; BUCHY, Philippe/0000-0003-1372-3008	Institut Pasteur's International Division [ACIP 2016-16]	Institut Pasteur's International Division	This work was supported by the Institut Pasteur's International Division (ACIP 2016-16). Diagnosis and surveillance activities benefitted the support of Institut Pasteur's International Division (Emergency fund) and donations from AusAID/WHO; ST Bank; Phongsavanh Bank; Exotissimo travel Co., ltd; Lao Brewery Co., LTD; Phu Bai Mining limited; and the Banque Franco-Lao ltd. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Dubot-Peres A, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002360; Gharbi M, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-166; Gupta E, 2012, J VECTOR DIS, V49, P82; Huy R, 2010, B WORLD HEALTH ORGAN, V88, P650, DOI 10.2471/BLT.09.073908; Ito M, 2004, J CLIN MICROBIOL, V42, P5935, DOI 10.1128/JCM.42.12.5935-5937.2004; Jiang T, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-125; Khampapongpane B, 2014, WEST PAC SURVEILL RE, V5, DOI [10.5365/wpsar.2014.5.1.001, 10.5365/WPSAR.2014.5.1.001]; Manakkadan A, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-37; RicoHesse R, 1997, VIROLOGY, V230, P244, DOI 10.1006/viro.1997.8504; Undurraga EA, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002056; Vong S, 2012, EPIDEMIOL INFECT, V140, P491, DOI 10.1017/S0950268811001191; Warrilow D, 2002, J MED VIROL, V66, P524, DOI 10.1002/jmv.2176; Weaver SC, 2009, INFECT GENET EVOL, V9, P523, DOI 10.1016/j.meegid.2009.02.003; Yamanaka A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027322	14	27	27	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2014	9	12							e115569	10.1371/journal.pone.0115569	http://dx.doi.org/10.1371/journal.pone.0115569			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UC	25551768	Green Published, Green Submitted, gold			2022-12-27	WOS:000347119100042
J	Wallmeier, L; Wiegrebe, L				Wallmeier, Ludwig; Wiegrebe, Lutz			Ranging in Human Sonar: Effects of Additional Early Reflections and Exploratory Head Movements	PLOS ONE			English	Article							AUDITORY DISTANCE PERCEPTION; SOUND LOCALIZATION; HUMAN ECHOLOCATION; SIGHTED SUBJECTS; ECHO PERCEPTION; BLIND HUMANS; TEST SCORE; LISTENERS; ABILITY; CUES	Many blind people rely on echoes from self-produced sounds to assess their environment. It has been shown that human subjects can use echolocation for directional localization and orientation in a room, but echo-acoustic distance perception - e.g. to determine one's position in a room - has received little scientific attention, and systematic studies on the influence of additional early reflections and exploratory head movements are lacking. This study investigates echo-acoustic distance discrimination in virtual echo-acoustic space, using the impulse responses of a real corridor. Six blindfolded sighted subjects and a blind echolocation expert had to discriminate between two positions in the virtual corridor, which differed by their distance to the front wall, but not to the lateral walls. To solve this task, participants evaluated echoes that were generated in real time from self-produced vocalizations. Across experimental conditions, we systematically varied the restrictions for head rotations, the subjects' orientation in virtual space and the reference position. Three key results were observed. First, all participants successfully solved the task with discrimination thresholds below 1 m for all reference distances (0.75-4 m). Performance was best for the smallest reference distance of 0.75 m, with thresholds around 20 cm. Second, distance discrimination performance was relatively robust against additional early reflections, compared to other echolocation tasks like directional localization. Third, free head rotations during echolocation can improve distance discrimination performance in complex environmental settings. However, head movements do not necessarily provide a benefit over static echolocation from an optimal single orientation. These results show that accurate distance discrimination through echolocation is possible over a wide range of reference distances and environmental conditions. This is an important functional benefit of human echolocation, which may also play a major role in the calibration of auditory space representations.	[Wallmeier, Ludwig; Wiegrebe, Lutz] Univ Munich, Grad Sch Syst Neurosci, Planegg Martinsried, Germany; [Wallmeier, Ludwig; Wiegrebe, Lutz] Univ Munich, Dept Biol, Div Neurobiol, Planegg Martinsried, Germany	University of Munich; University of Munich	Wiegrebe, L (corresponding author), Univ Munich, Grad Sch Syst Neurosci, Planegg Martinsried, Germany.	lutzw@lmu.de			DFG [wi1518/9]; Studienstiftung des Deutschen Volkes; Bernstein Center for Computational Neuroscience, Munich [B3]	DFG(German Research Foundation (DFG)); Studienstiftung des Deutschen Volkes; Bernstein Center for Computational Neuroscience, Munich	This work was supported by DFG wi1518/9 to Lutz Wiegrebe; Studienstiftung des Deutschen Volkes, Stipend to Ludwig Wallmeier; and Bernstein Center for Computational Neuroscience, Munich, Project B3 to Lutz Wiegrebe. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashmead DH, 1998, J VISUAL IMPAIR BLIN, V92, P615, DOI 10.1177/0145482X9809200905; ASHMEAD DH, 1995, J EXP PSYCHOL HUMAN, V21, P239, DOI 10.1037/0096-1523.21.2.239; Au W. W., 1993, SONAR DOLPHINS; BASSETT IG, 1964, J ACOUST SOC AM, V36, P911, DOI 10.1121/1.1919117; Crawford JR, 2002, NEUROPSYCHOLOGIA, V40, P1196, DOI 10.1016/S0028-3932(01)00224-X; Crawford JR, 1998, CLIN NEUROPSYCHOL, V12, P482, DOI 10.1076/clin.12.4.482.7241; Crawford JR, 2010, COGNITIVE NEUROPHSYC, V1, P1; DeLong CM, 2007, J ACOUST SOC AM, V121, P605, DOI 10.1121/1.2400848; Dufour A, 2005, EXP BRAIN RES, V165, P515, DOI 10.1007/s00221-005-2329-3; Griffin DR, 1986, LISTENING DARK ACOUS; HAUSFELD S, 1982, PERCEPT MOTOR SKILL, V55, P623, DOI 10.2466/pms.1982.55.2.623; KELLOGG WN, 1962, SCIENCE, V137, P399, DOI 10.1126/science.137.3528.399; Kolarik AJ, 2014, HEARING RES, V310, P60, DOI 10.1016/j.heares.2014.01.010; Kolarik AJ, 2013, EXP BRAIN RES, V224, P623, DOI 10.1007/s00221-012-3340-0; Krumbholz K, 2004, J ACOUST SOC AM, V115, P1696, DOI 10.1121/1.1649334; Lessard N, 1998, NATURE, V395, P278, DOI 10.1038/26228; LEVITT H, 1971, J ACOUST SOC AM, V49, P467, DOI 10.1121/1.1912375; Lewald J, 2002, NEUROPSYCHOLOGIA, V40, P1868, DOI 10.1016/S0028-3932(02)00071-4; Lewald J, 2013, NEUROPSYCHOLOGIA, V51, P181, DOI 10.1016/j.neuropsychologia.2012.11.017; Litovsky RY, 1999, J ACOUST SOC AM, V106, P1633, DOI 10.1121/1.427914; McDonald J.H., 2014, HDB BIOL STAT; Milne JL, 2014, ATTEN PERCEPT PSYCHO, DOI [10.3758/s13414-13014-10695-13412, DOI 10.3758/S13414-13014-10695-13412]; Moore, 2012, INTRO PSYCHOL HEARIN; Moore JM, 2008, HEARING RES, V238, P94, DOI 10.1016/j.heares.2007.11.006; Plack C.J., 2005, PITCH NEURAL CODING, DOI [10.1007/0-387-28958-5, DOI 10.1007/0-387-28958-5]; RICE CE, 1965, J EXP PSYCHOL, V70, P246, DOI 10.1037/h0022215; RICE CE, 1967, SCIENCE, V155, P656, DOI 10.1126/science.155.3763.656; RICE CE, 1969, PSYCHOL REC, V19, P1; RICE CE, 1965, SCIENCE, V148, P1107, DOI 10.1126/science.148.3673.1107; Rosenblum LD, 2000, ECOL PSYCHOL, V12, P181, DOI 10.1207/S15326969ECO1203_1; Rowan D, 2013, HEARING RES, V300, P56, DOI 10.1016/j.heares.2013.03.005; Schenkman BN, 2010, PERCEPTION, V39, P483, DOI 10.1068/p6473; Schornich S, 2012, JARO-J ASSOC RES OTO, V13, P673, DOI 10.1007/s10162-012-0338-z; Shinn-Cunningham B, 2003, P ICAD 2003, P21; Shinn-Cunningham BG, 2005, J ACOUST SOC AM, V117, P3100, DOI 10.1121/1.1872572; Speigle J. M., 1993, Proceedings IEEE 1993 Symposium on Research Frontiers in Virtual Reality (Cat. No.93TH0585-0), P92, DOI 10.1109/VRAIS.1993.378257; Stoffregen TA, 1995, ECOL PSYCHOL, V7, P181; Supa M, 1944, AM J PSYCHOL, V57, P133, DOI 10.2307/1416946; Teng S, 2012, EXP BRAIN RES, V216, P483, DOI 10.1007/s00221-011-2951-1; Teng S, 2011, J VISUAL IMPAIR BLIN, V105, P20, DOI 10.1177/0145482X1110500103; Thaler L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020162; Voss P, 2004, CURR BIOL, V14, P1734, DOI 10.1016/j.cub.2004.09.051; Wallach H, 1940, J EXP PSYCHOL, V27, P339, DOI 10.1037/h0054629; Wallmeier L, 2014, ROYAL SOC O IN PRESS; Wallmeier L, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1428; Zahorik P, 2002, J ACOUST SOC AM, V111, P1832, DOI 10.1121/1.1458027; Zahorik P, 2005, ACTA ACUST UNITED AC, V91, P409	47	17	17	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2014	9	12							e115363	10.1371/journal.pone.0115363	http://dx.doi.org/10.1371/journal.pone.0115363			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AX7UC	25551226	Green Submitted, Green Published, gold			2022-12-27	WOS:000347119100036
J	Li, H; Jiang, YM; Sun, YF; Li, P; Dang, RJ; Ning, HM; Li, YH; Zhang, YJ; Jiang, XX; Guo, XM; Wen, N; Han, Y; Mao, N; Chen, H; Zhang, Y				Li, Hong; Jiang, Yan-Ming; Sun, Yan-Feng; Li, Ping; Dang, Rui-Jie; Ning, Hong-Mei; Li, Yu-Hang; Zhang, Ying-Jie; Jiang, Xiao-Xia; Guo, Xi-Min; Wen, Ning; Han, Yan; Mao, Ning; Chen, Hu; Zhang, Yi			CCR7 Expressing Mesenchymal Stem Cells Potently Inhibit Graft-versus-Host Disease by Spoiling the Fourth Supplemental Billingham's Tenet	PLOS ONE			English	Article							REGULATORY T-CELLS; SECONDARY LYMPHOID ORGANS; HUMAN BONE-MARROW; IN-VITRO; IMMUNOSUPPRESSIVE ACTIVITY; AUTOIMMUNE-DISEASES; CHEMOKINE RECEPTORS; IMMUNE-RESPONSE; DENDRITIC CELLS; TRAFFICKING	The clinical acute graft-versus-host disease (GvHD)-therapy of mesenchymal stem cells (MSCs) is not as satisfactory as expected. Secondary lymphoid organs (SLOs) are the major niches serve to initiate immune responses or induce tolerance. Our previous study showed that CCR7 guide murine MSC line C3H10T1/2 migrating to SLOs. In this study, CCR7 gene was engineered into murine MSCs by lentivirus transfection system (MSCs/CCR7). The immunomodulatory mechanism of MSCs/CCR7 was further investigated. Provoked by inflammatory cytokines, MSCs/CCR7 increased the secretion of nitric oxide and calmed down the T cell immune response in vitro. Immunofluorescent staining results showed that transfused MSCs/CCR7 can migrate to and relocate at the appropriate T cell-rich zones within SLOs in vivo. MSCs/CCR7 displayed enhanced effect in prolonging the survival and alleviating the clinical scores of the GvHD mice than normal MSCs. Owing to the critical relocation sites, MSCs/CCR7 co-infusion potently made the T cells in SLOs more naive like, thus control T cells trafficking from SLOs to the target organs. Through spoiling the fourth supplemental Billingham's tenet, MSCs/CCR7 potently inhibited the development of GvHD. The study here provides a novel therapeutic strategy of MSCs/CCR7 infusion at a low dosage to give potent immunomodulatory effect for clinical immune disease therapy.	[Li, Hong; Jiang, Xiao-Xia; Guo, Xi-Min; Mao, Ning; Zhang, Yi] Inst Basic Med Sci, Dept Cell Biol, Beijing 100850, Peoples R China; [Li, Hong; Ning, Hong-Mei; Li, Yu-Hang; Chen, Hu] Acad Mil Med Sci, Affiliated Hosp, Dept Hematopoiet Stem Cell Transplantat, Beijing 100071, Peoples R China; [Jiang, Yan-Ming] Second Artillery Gen Hosp, Dept Ophthalmol, Beijing 100088, Peoples R China; [Sun, Yan-Feng] Gen Hosp Chinese Peoples Armed Police Forces, Dept Pediat, Beijing 100039, Peoples R China; [Li, Ping; Dang, Rui-Jie; Wen, Ning] Chinese Peoples Liberat Army Gen Hosp, Dept Stomatol, Beijing 100853, Peoples R China; [Zhang, Ying-Jie; Han, Yan] Chinese Peoples Liberat Army Gen Hosp, Dept Plast & Reconstruct Surg, Beijing 100853, Peoples R China	Academy of Military Medical Sciences - China; Chinese People's Liberation Army General Hospital; Chinese People's Liberation Army General Hospital	Chen, H (corresponding author), Inst Basic Med Sci, Dept Cell Biol, Beijing 100850, Peoples R China.	msc_lihong@163.com; Chenhu217@aliyun.com; zhangyi0216@yeah.com	张, 西京/HIK-3273-2022; Zhang, Yingjie/HHM-3016-2022		National High-tech Research and Development Program of China [2011AA020114, 2010CB529904]; National Natural Science Foundation of China [30900568, 81170523, 31370916, 31170926, 81271936]; Clinical Feature and Application Research of Capital [Z111107058811107]	National High-tech Research and Development Program of China(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Clinical Feature and Application Research of Capital	This study was supported by the National High-tech Research and Development Program of China (Grant no. 2011AA020114, 2010CB529904), the National Natural Science Foundation of China (Grant nos. 30900568, 81170523, 31370916, 31170926, 81271936), and Clinical Feature and Application Research of Capital (Grant no. Z111107058811107). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beilhack A, 2005, BLOOD, V106, P1113, DOI 10.1182/blood-2005-02-0509; Beres AJ, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00163; Billingham R E, 1966, Harvey Lect, V62, P21; Blazar BR, 1998, BLOOD, V92, P3949, DOI 10.1182/blood.V92.10.3949.422k26_3949_3959; Brooke G, 2008, STEM CELLS DEV, V17, P929, DOI 10.1089/scd.2007.0156; Chamberlain G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002934; Chauhan SK, 2014, J IMMUNOL, V192, P817, DOI 10.4049/jimmunol.1203469; Coghill JM, 2010, BLOOD, V115, P4914, DOI 10.1182/blood-2009-08-239848; Duramad O, 2011, BIOL BLOOD MARROW TR, V17, P1154, DOI 10.1016/j.bbmt.2010.11.022; Forster R, 1999, CELL, V99, P23, DOI 10.1016/S0092-8674(00)80059-8; Guo ZK, 2006, STEM CELLS, V24, P992, DOI 10.1634/stemcells.2005-0224; Haase D, 2012, IMMUNOL RES, V53, P200, DOI 10.1007/s12026-012-8267-9; Ho LP, 2013, J IMMUNOL, V191, P5603, DOI 10.4049/jimmunol.1301175; Honczarenko M, 2006, STEM CELLS, V24, P1030, DOI 10.1634/stemcells.2005-0319; Jiang XX, 2005, BLOOD, V105, P4120, DOI 10.1182/blood-2004-02-0586; Johnson LA, 2014, ANGIOGENESIS, V17, P335, DOI 10.1007/s10456-013-9407-0; Karakhanova S, 2006, J IMMUNOTHER, V29, P336, DOI 10.1097/01.cji.0000203080.43235.9e; Kataoka H, 2005, TRANSPL P, V37, P107, DOI 10.1016/j.transproceed.2004.12.287; Kim YM, 2003, J CLIN INVEST, V111, P659, DOI 10.1172/JCI200316950; Li H, 2014, STEM CELLS, V32, P1890, DOI 10.1002/stem.1656; Li W, 2012, CELL DEATH DIFFER, V19, P1505, DOI 10.1038/cdd.2012.26; Lin Y, 2011, ADV HEMATOL, V2011, DOI DOI 10.1155/2011/427863; Mafi R, 2011, Open Orthop J, V5 Suppl 2, P242, DOI 10.2174/1874325001105010242; Martin I, 2010, TISSUE ENG PT A, V16, P2419, DOI [10.1089/ten.tea.2010.0056, 10.1089/ten.TEA.2010.0056]; Mempel TR, 2004, NATURE, V427, P154, DOI 10.1038/nature02238; Miller MJ, 2002, SCIENCE, V296, P1869, DOI 10.1126/science.1070051; Nemeth K, 2009, NAT MED, V15, P42, DOI 10.1038/nm.1905; Oswald J, 2004, STEM CELLS, V22, P377, DOI 10.1634/stemcells.22-3-377; Panoskaltsis-Mortari A, 2004, BLOOD, V103, P3590, DOI 10.1182/blood-2003-08-2827; Papatriantafyllou M, 2011, NAT REV IMMUNOL, V11, P644, DOI 10.1038/nri3068; Parmar S, 2014, CYTOTHERAPY, V16, P90, DOI 10.1016/j.jcyt.2013.07.009; Paunescu V, 2007, J CELL MOL MED, V11, P502, DOI 10.1111/j.1582-4934.2007.00041.x; Prockop DJ, 2012, J CELL BIOCHEM, V113, P1460, DOI 10.1002/jcb.24046; Ruddle NH, 2009, J IMMUNOL, V183, P2205, DOI 10.4049/jimmunol.0804324; Sackstein R, 2006, BIOL BLOOD MARROW TR, V12, P2, DOI 10.1016/j.bbmt.2005.09.015; Sato K, 2007, BLOOD, V109, P228, DOI 10.1182/blood-2006-02-002246; Schneider MA, 2007, J EXP MED, V204, P735, DOI 10.1084/jem.20061405; Sordi V, 2005, BLOOD, V106, P419, DOI 10.1182/blood-2004-09-3507; Stoll S, 2002, SCIENCE, V296, P1873, DOI 10.1126/science.1071065; Su J, 2014, CELL DEATH DIFFER, V21, P388, DOI 10.1038/cdd.2013.149; Taylor PA, 2007, BLOOD, V110, P3480, DOI 10.1182/blood-2007-05-087940; Teschner D, 2014, BONE MARROW TRANSPL, V49, P138, DOI 10.1038/bmt.2013.114; Tran TC, 2011, J CELL PHYSIOL, V226, P224, DOI 10.1002/jcp.22329; Tyndall A, 2011, HEMATOL-AM SOC HEMAT, P280, DOI 10.1182/asheducation-2011.1.280; Tyndall A, 2010, ANN RHEUM DIS, V69, P1413, DOI 10.1136/ard.2010.132639; Unsoeld H, 2005, J VIROL, V79, P4510, DOI 10.1128/JVI.79.7.4510-4513.2005; van den Brink MRM, 2000, J IMMUNOL, V164, P469, DOI 10.4049/jimmunol.164.1.469; Verneris MR, 2013, HEMATOL-AM SOC HEMAT, P335, DOI 10.1182/asheducation-2013.1.335; Viola A, 2006, TRENDS IMMUNOL, V27, P421, DOI 10.1016/j.it.2006.07.004; von Andrian UH, 2003, NAT REV IMMUNOL, V3, P867, DOI 10.1038/nri1222; Wolf D, 2005, J AM SOCNEPHROL, V2005; Worbs T, 2007, TRENDS IMMUNOL, V28, P274, DOI 10.1016/j.it.2007.04.002	52	2	3	4	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2014	9	12							e115720	10.1371/journal.pone.0115720	http://dx.doi.org/10.1371/journal.pone.0115720			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX6YH	25549354	Green Published, Green Submitted, gold			2022-12-27	WOS:000347063500022
J	Chen, Z; Cao, SS; Wang, HR; Li, YQ; Kishen, A; Deng, XL; Yang, XP; Wang, YH; Cong, CH; Wang, HJ; Zhang, X				Chen, Zhen; Cao, Shansong; Wang, Haorong; Li, Yanqiu; Kishen, Anil; Deng, Xuliang; Yang, Xiaoping; Wang, Yinghui; Cong, Changhong; Wang, Huajun; Zhang, Xu			Biomimetic Remineralization of Demineralized Dentine Using Scaffold of CMC/ACP Nanocomplexes in an In Vitro Tooth Model of Deep Caries	PLOS ONE			English	Article							PHOSPHORYLATED CHITOSAN; CARBOXYMETHYL CHITOSAN; COLLAGENOUS MATRIX; MINERALIZATION; NUCLEATION; LESIONS; BONE; BIOACTIVITY; MECHANISMS; MICROSCOPY	Currently, it is still a tough task for dentists to remineralize dentine in deep caries. The aim of this study was to remineralize demineralized dentine in a tooth model of deep caries using nanocomplexes of carboxymethyl chitosan/amorphous calcium phosphate (CMC/ACP) based on mimicking the stabilizing effect of dentine matrix protein 1 (DMP1) on ACP in the biomineralization of dentine. The experimental results indicate that CMC can stabilize ACP to form nanocomplexes of CMC/ACP, which is able to be processed into scaffolds by lyophilization. In the single-layer collagen model, ACP nanoparticles are released from scaffolds of CMC/ACP nanocomplexes dissolved and then infiltrate into collagen fibrils via the gap zones (40 nm) to accomplish intrafibrillar mineralization of collagen. With this method, the completely demineralized dentine was partially remineralized in the tooth mode. This is a bottom-up remineralizing strategy based on non-classical crystallization theory. Since nanocomplexes of CMC/ACP show a promising effect of remineralization on demineralized dentine via biomimetic strategy, thereby preserving dentinal tissue to the maximum extent possible, it would be a potential indirect pulp capping (IPC) material for the management of deep caries during vital pulp therapy based on the concept of minimally invasive dentistry (MID).	[Chen, Zhen; Cao, Shansong; Wang, Haorong; Li, Yanqiu; Wang, Yinghui; Cong, Changhong; Zhang, Xu] Tianjin Med Univ, Hosp Stomatol, Sch Stomatol, Tianjin, Peoples R China; [Kishen, Anil] Univ Toronto, Fac Dent, Discipline Endodont, Toronto, ON, Canada; [Deng, Xuliang] Peking Univ Sch & Hosp Stomatol, Dept Geriatr Dent, Beijing, Peoples R China; [Yang, Xiaoping] Beijing Univ Chem Technol, Key Lab Beijing City Preparat & Proc Novel Polyme, Beijing 100029, Peoples R China; [Wang, Huajun] Hebei Univ Technol, Sch Energy & Environm Engn, Tianjin, Peoples R China	Tianjin Medical University; University of Toronto; Peking University; Beijing University of Chemical Technology; Hebei University of Technology	Zhang, X (corresponding author), Tianjin Med Univ, Hosp Stomatol, Sch Stomatol, Tianjin, Peoples R China.	zhxden@gmail.com		Kishen, Anil/0000-0002-6953-2633	National Natural Science Foundation of China [81200817]; Tianjin Research Program of Application Foundation and Advanced Technology (Youth Research Program) [12JCQNJC09200]; National Basic Research Program of China [2012CB933900]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Tianjin Research Program of Application Foundation and Advanced Technology (Youth Research Program); National Basic Research Program of China(National Basic Research Program of China)	This work was funded by 1) National Natural Science Foundation of China (Grant No: 81200817), http://www.nsfc.gov.cn/; 2) Tianjin Research Program of Application Foundation and Advanced Technology (Youth Research Program) (Grant No: 12JCQNJC09200), http://www.tstc.gov.cn/ 3) National Basic Research Program of China (2012CB933900), http://www.most.gov.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold WH, 2003, ANN ANAT, V185, P419, DOI 10.1016/S0940-9602(03)80099-7; ARSENAULT AL, 1988, CALCIFIED TISSUE INT, V43, P202, DOI 10.1007/BF02555136; Bertassoni LE, 2009, CARIES RES, V43, P70, DOI 10.1159/000201593; Budiraharjo R, 2010, INT ENDOD J, V43, P930, DOI 10.1111/j.1365-2591.2010.01771.x; Burwell AK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038852; BYSTROM A, 1985, Endodontics and Dental Traumatology, V1, P170; Chen XG, 2003, CARBOHYD POLYM, V53, P355, DOI 10.1016/S0144-8617(03)00051-1; Chesnick IE, 2008, BIOPHYS J, V95, P2017, DOI 10.1529/biophysj.107.120923; Christensen GJ, 2005, J AM DENT ASSOC, V136, P1563, DOI 10.14219/jada.archive.2005.0088; Combes C, 2010, ACTA BIOMATER, V6, P3362, DOI 10.1016/j.actbio.2010.02.017; Eidelman E, 1965, J Dent Child, V32, P218; Featherstone JDB, 2000, J AM DENT ASSOC, V131, P887, DOI 10.14219/jada.archive.2000.0307; Gebauer D, 2011, NANO TODAY, V6, P564, DOI 10.1016/j.nantod.2011.10.005; George A, 2008, CHEM REV, V108, P4670, DOI 10.1021/cr0782729; Gower LB, 2008, CHEM REV, V108, P4551, DOI 10.1021/cr800443h; Gupta A, 2011, J Conserv Dent, V14, P113, DOI 10.4103/0972-0707.82603; He G, 2004, J BIOL CHEM, V279, P11649, DOI 10.1074/jbc.M309296200; Jayakumar R, 2008, INT J BIOL MACROMOL, V42, P335, DOI 10.1016/j.ijbiomac.2007.12.011; Kawasaki K, 1999, CARIES RES, V33, P275, DOI 10.1159/000016529; Kim J, 2010, ACTA BIOMATER, V6, P2740, DOI 10.1016/j.actbio.2009.12.052; Kinney JH, 2003, J DENT RES, V82, P957, DOI 10.1177/154405910308201204; KLONT B, 1991, CARIES RES, V25, P39, DOI 10.1159/000261340; KLONT B, 1991, CARIES RES, V25, P46, DOI 10.1159/000261341; Kokubo T, 2006, BIOMATERIALS, V27, P2907, DOI 10.1016/j.biomaterials.2006.01.017; Landis WJ, 1996, MICROSC RES TECHNIQ, V33, P192; Lee JY, 2007, BIOMATERIALS, V28, P4257, DOI 10.1016/j.biomaterials.2007.05.040; Liang P, 2004, J CRYST GROWTH, V261, P571, DOI 10.1016/j.jcrysgro.2003.03.001; Liu Y, 2011, BIOMATERIALS, V32, P1291, DOI 10.1016/j.biomaterials.2010.10.018; Marchi Juliana J, 2006, J Clin Pediatr Dent, V31, P68; Mourya V.K., 2010, ADV MAT LETT, V1, P11; Nakornchai S, 2004, ARCH ORAL BIOL, V49, P267, DOI 10.1016/j.archoralbio.2003.11.003; Niederberger M, 2006, PHYS CHEM CHEM PHYS, V8, P3271, DOI 10.1039/b604589h; Nudelman F, 2010, NAT MATER, V9, P1004, DOI 10.1038/NMAT2875; Olszta MJ, 2003, CONNECT TISSUE RES, V44, P326, DOI 10.1080/03008200390181852; Preston KP, 2008, ARCH ORAL BIOL, V53, P20, DOI 10.1016/j.archoralbio.2007.08.001; Sakoolnamarka R, 2002, AUST DENT J, V47, P116, DOI 10.1111/j.1834-7819.2002.tb00314.x; Sangwan P, 2013, INT ENDOD J, V46, P3, DOI 10.1111/j.1365-2591.2012.02101.x; Tay FR, 2008, BIOMATERIALS, V29, P1127, DOI 10.1016/j.biomaterials.2007.11.001; ten Cate J M, 2008, Aust Dent J, V53, P281, DOI 10.1111/j.1834-7819.2008.00063.x; ten Cate JM, 2001, J DENT RES, V80, P1407, DOI 10.1177/00220345010800050401; TERMINE J. D., 1967, CALCIFIED TISSUE RES, V1, P8, DOI 10.1007/BF02008070; TRAUB W, 1989, P NATL ACAD SCI USA, V86, P9822, DOI 10.1073/pnas.86.24.9822; Wan ACA, 1998, BIOMATERIALS, V19, P1309; XU Z, 2012, J MATER SCI-MATER M, V23, P733, DOI DOI 10.1007/S10856-012-4550-5; Xu Z, 2011, J BIOMED MATER RES B, V98B, P150, DOI 10.1002/jbm.b.31844; Xu Z, 2010, MAT SCI ENG C-MATER, V30, P822, DOI 10.1016/j.msec.2010.03.014; Zhao J, 2011, CHEM CENT J, V5, DOI 10.1186/1752-153X-5-40; Zhou H, 2012, J BIOMED MATER RES B, V100B, P1142, DOI 10.1002/jbm.b.32681	48	81	85	12	91	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2015	10	1							e0116553	10.1371/journal.pone.0116553	http://dx.doi.org/10.1371/journal.pone.0116553			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ0ID	25587986	Green Published, gold, Green Submitted			2022-12-27	WOS:000347928300016
J	Hamaoui, A; Hassaine, M; Zanone, PG				Hamaoui, Alain; Hassaine, Myriam; Zanone, Pier-Giorgio			Sitting on a Sloping Seat Does Not Reduce the Strain Sustained by the Postural Chain	PLOS ONE			English	Article							PAIN-FREE POPULATION; LOW-BACK-PAIN; INTRADISCAL PRESSURE; SCHOOL FURNITURE; MUSCLE-ACTIVITY; TRUNK	The objective of this study was to explore the effect of a forward sloping seat on posture and muscular activity of the trunk and lower limbs. To this aim, twelve asymptomatic participants were tested in six conditions varying seat slope (0 degrees, 15 degrees forward) and height (high, medium, low). Angular position of head, trunk and pelvis was assessed with an inertial orientation system, and muscular activity of 11 superficial postural muscles located in the trunk and lower limbs was estimated using normalized EMG. Results showed that a forward sloping seat, compared to a flat seat, induced a greater activity of the soleus (p < 0.01), vastus lateralis (p < 0.05) and vastus medialis (p < 0.05), as well a lower hip flexion (p < 0.01). In contrast, no significant variation of head, trunk and pelvis angular position was observed according to seat slope. It was concluded that forward sloping seats increase the load sustained by the lower limbs, without a systematic improvement of body posture.	[Hamaoui, Alain; Hassaine, Myriam] Univ Champoll, Lab Posture & Movement Physiol, Albi, France; [Hamaoui, Alain; Hassaine, Myriam; Zanone, Pier-Giorgio] Univ Toulouse 3, PRISSMH, F-31062 Toulouse, France	Universite de Toulouse; Universite Toulouse III - Paul Sabatier	Hamaoui, A (corresponding author), Univ Champoll, Lab Posture & Movement Physiol, Albi, France.	alain.hamaoui@univ-jfc.fr	Zanone, Pier-Giorgio/B-7165-2011; Hamaoui, Alain/H-4118-2019	Zanone, Pier-Giorgio/0000-0002-6744-9772; Hamaoui, Alain/0000-0001-7410-2710	University JF Champollion; Conseil Regional Midi-Pyrenees, France	University JF Champollion; Conseil Regional Midi-Pyrenees, France(Region Occitanie)	This work has been funded by University JF Champollion and Conseil Regional Midi-Pyrenees, France. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson EA, 1996, CLIN BIOMECH, V11, P392, DOI 10.1016/0268-0033(96)00033-2; BENDIX T, 1984, HUM FACTORS, V26, P695, DOI 10.1177/001872088402600609; BENDIX T, 1983, SCAND J REHABIL MED, V15, P197; BRIDGER RS, 1988, HUM FACTORS, V30, P237, DOI 10.1177/001872088803000210; Caneiro JP, 2010, MANUAL THER, V15, P54, DOI 10.1016/j.math.2009.06.002; Claus AP, 2009, SPINE, V34, pE208, DOI 10.1097/BRS.0b013e3181908ead; Eklund J., 1991, INT J IND ERGONOM, V8, P67, DOI [DOI 10.1016/0169-8141(91)90026-I, 10.1016/0169-8141(91)90026-I]; Gouvali MK, 2006, APPL ERGON, V37, P765, DOI 10.1016/j.apergo.2005.11.009; GURFINKEL VS, 1995, NEUROSCIENCE, V68, P229, DOI 10.1016/0306-4522(95)00136-7; Hoy D, 2010, BEST PRACT RES CL RH, V24, P155, DOI 10.1016/j.berh.2009.11.002; Jonsson B, 1970, Electromyography, V10, P5; KEEGAN JJ, 1953, J BONE JOINT SURG AM, V35-A, P589, DOI 10.2106/00004623-195335030-00007; LUNDERVOLD A J S, 1951, Acta Physiol Scand Suppl, V24, P1; MANDAL AC, 1981, APPL ERGON, V12, P19, DOI 10.1016/0003-6870(81)90089-2; MANDAL AC, 1982, HUM FACTORS, V24, P257, DOI 10.1177/001872088202400301; MANDAL AC, 1976, ERGONOMICS, V19, P157, DOI 10.1080/00140137608931528; Mandal AC, 1991, INT J IND ERGONOM, V8, P75, DOI [dx.doi.org/10.1016/0169-8141(91)90027-J, DOI 10.1016/0169-8141(91)90027-J]; NACHEMSON A, 1975, Rheumatology and Rehabilitation, V14, P129; NACHEMSON A, 1964, J BONE JOINT SURG AM, V46, P1077, DOI 10.2106/00004623-196446050-00012; Nairn BC, 2013, MANUAL THER, V18, P498, DOI 10.1016/j.math.2013.03.003; O'Sullivan PB, 2002, SPINE, V27, P1238, DOI 10.1097/00007632-200206010-00019; O'Sullivan PB, 2006, SPINE, V31, pE707, DOI 10.1097/01.brs.0000234735.98075.50; OKADA M, 1972, Journal of Human Ergology, V1, P75; PAPAGEORGIOU AC, 1995, SPINE, V20, P1889, DOI 10.1097/00007632-199509000-00009; Sato K, 1999, SPINE, V24, P2468, DOI 10.1097/00007632-199912010-00008; Schoberth H., 1962, SITZHALTUNG SITZSCHA; Wilke HJ, 1999, SPINE, V24, P755, DOI 10.1097/00007632-199904150-00005	27	3	4	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2015	10	1							e0116353	10.1371/journal.pone.0116353	http://dx.doi.org/10.1371/journal.pone.0116353			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ0ID	25587989	Green Submitted, Green Published, gold			2022-12-27	WOS:000347928300010
J	Schaarschmidt, BM; Buchbender, C; Nensa, F; Grueneien, J; Gomez, B; Kohler, J; Reis, H; Ruhlmann, V; Umutlu, L; Heusch, P				Schaarschmidt, Benedikt Michael; Buchbender, Christian; Nensa, Felix; Grueneien, Johannes; Gomez, Benedikt; Koehler, Jens; Reis, Henning; Ruhlmann, Verena; Umutlu, Lale; Heusch, Philipp			Correlation of the Apparent Diffusion Coefficient (ADC) with the Standardized Uptake Value (SUV) in Lymph Node Metastases of Non-Small Cell Lung Cancer (NSCLC) Patients Using Hybrid 18F-FDG PET/MRI	PLOS ONE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; PULMONARY NODULES; WEIGHTED MRI; PET/CT; LESIONS; CHEST; REPEATABILITY; BRAIN; FDG	Objective To compare the apparent diffusion coefficient (ADC) in lymph node metastases of non-small cell lung cancer (NSCLC) patients with standardized uptake values (SUV) derived from combined 18F-fluoro-deoxy-glucose-positron emission tomography/magnetic resonance imaging (18F-FDG PET/MRI). Material and Methods 38 patients with histopathologically proven NSCLC (mean age 60.1 +/- 9.5y) received wholebody PET/CT (Siemens mCT (TM)) 60min after injection of a mean dose of 280 +/- 50 MBq 18F-FDG and subsequent PET/MRI (mean time after tracer injection: 139 +/- 26 min, Siemens Biograph mMR). During PET acquisition, simultaneous diffusion-weighted imaging (DWI, b values: 0, 500, 1000 s/mm(2)) was performed. A maximum of 10 lymph nodes per patient suspicious for malignancy were analyzed. Regions of interest (ROI) were drawn covering the entire lymph node on the attenuation-corrected PET-image and the monoexponential ADC-map. According to histopathology or radiological follow-up, lymph nodes were classified as benign or malignant. Pearson's correlation coefficients were calculated for all lymph node metastases correlating SUVmax and SUVmean with ADC(mean). Results A total of 146 suspicious lymph nodes were found in 25 patients. One hundred lymph nodes were eligible for final analysis. Ninety-one lymph nodes were classified as malignant and 9 as benign according to the reference standard. In malignant lesions, mean SUVmax was 9.1 +/- 3.8 and mean SUVmean was 6.0 +/- 2.5 while mean ADC(mean) was 877.0 +/- 128.6 x 10(-5) mm(2)/s in PET/MRI. For all malignant lymph nodes, a weak, inverse correlation between SUVmax and ADCmean as well as SUVmean and ADCmean (r = -0.30, p<0.05 and r = -0.36, p<0.05) existed. Conclusion The present data show a weak inverse correlation between increased glucose-metabolism and cellularity in lymph node metastases of NSCLC patients. 18F-FDG-PET and DWI thus may offer complementary information for the evaluation of treatment response in lymph node metastases of NSCLC.	[Schaarschmidt, Benedikt Michael; Buchbender, Christian; Heusch, Philipp] Univ Dusseldorf, Fac Med, Dept Diagnost & Intervent Radiol, Dusseldorf, Germany; [Schaarschmidt, Benedikt Michael; Nensa, Felix; Grueneien, Johannes; Umutlu, Lale] Univ Duisburg Essen, Fac Med, Dept Diagnost & Intervent Radiol & Neuroradiol, Essen, Germany; [Gomez, Benedikt; Ruhlmann, Verena] Univ Duisburg Essen, Fac Med, Dept Nucl Med, Essen, Germany; [Koehler, Jens] Univ Duisburg Essen, Fac Med, Dept Med Oncol, Essen, Germany; [Reis, Henning] Univ Duisburg Essen, Fac Med, Inst Pathol, Essen, Germany	Heinrich Heine University Dusseldorf; University of Duisburg Essen; University of Duisburg Essen; University of Duisburg Essen; University of Duisburg Essen	Schaarschmidt, BM (corresponding author), Univ Dusseldorf, Fac Med, Dept Diagnost & Intervent Radiol, Dusseldorf, Germany.	Benedikt.Schaarschmidt@med.uni-duesseldorf.de	Reis, Henning/AAX-9545-2020; Köhler, Jens/AAK-1541-2021	Reis, Henning/0000-0003-1373-5295; Schaarschmidt, Benedikt Michael/0000-0001-6331-7679; Nensa, Felix/0000-0002-5811-7100; Kohler (MD), Jens/0000-0002-9922-6469				Akbarzadeh A, 2013, ANN NUCL MED, V27, P152, DOI 10.1007/s12149-012-0667-3; Antoch G, 2003, RADIOLOGY, V229, P526, DOI 10.1148/radiol.2292021598; Antoch G, 2009, EUR J NUCL MED MOL I, V36, P113, DOI 10.1007/s00259-008-0951-6; Bernardin L, 2014, EUR RADIOL, V24, P502, DOI 10.1007/s00330-013-3048-y; Biederer J, 2003, RADIOLOGY, V227, P475, DOI 10.1148/radiol.2272020635; Buchbender C, 2012, J NUCL MED, V53, P928, DOI 10.2967/jnumed.112.105338; Bunyaviroch T, 2006, J NUCL MED, V47, P451; Chen W, 2010, MAGN RESON IMAGING, V28, P613, DOI 10.1016/j.mri.2010.02.009; Cheng G, 2013, MOL IMAGING BIOL, V15, P345, DOI 10.1007/s11307-012-0600-0; De Leyn P, 2007, EUR J CARDIO-THORAC, V32, P1, DOI 10.1016/j.ejcts.2007.01.075; Donati OF, 2014, RADIOLOGY, V270, P454, DOI 10.1148/radiol.13130819; Goeckenjan G, 2010, Pneumologie, V64 Suppl 2, pe1, DOI 10.1055/s-0029-1243837; Grueneisen J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096751; Heusch P, 2013, ROFO-FORTSCHR RONTG, V185, P1059, DOI 10.1055/s-0033-1350110; Heusch P, 2014, J NUCL MED, V55, P373, DOI 10.2967/jnumed.113.129825; Heusch P, 2013, EUR J RADIOL, V82, P2055, DOI 10.1016/j.ejrad.2013.05.027; Heusch P, 2013, EUR J RADIOL, V82, P870, DOI 10.1016/j.ejrad.2013.01.008; Kosucu P, 2009, J MAGN RESON IMAGING, V30, P292, DOI 10.1002/jmri.21850; Landwehr P, 1999, EUR RADIOL, V9, P1737, DOI 10.1007/s003300050917; Lardinois D, 2003, NEW ENGL J MED, V348, P2500, DOI 10.1056/NEJMoa022136; Leslie H., 2011, TNM CLASSIFICATION M, V7th ed., P138; Mac Manus MP, 2001, INT J RADIAT ONCOL, V50, P287, DOI 10.1016/S0360-3016(01)01477-8; Malyarenko D, 2013, J MAGN RESON IMAGING, V37, P1238, DOI 10.1002/jmri.23825; Martinez-Moller A, 2009, J NUCL MED, V50, P520, DOI 10.2967/jnumed.108.054726; Matoba M, 2007, RADIOLOGY, V243, P570, DOI 10.1148/radiol.2432060131; Mori T, 2008, J THORAC ONCOL, V3, P358, DOI 10.1097/JTO.0b013e318168d9ed; Nomori H, 2008, J THORAC CARDIOV SUR, V135, P816, DOI 10.1016/j.jtcvs.2007.10.035; Ohba Y, 2009, J THORAC CARDIOV SUR, V138, P439, DOI 10.1016/j.jtcvs.2008.12.026; Ohno Y, 2012, AM J ROENTGENOL, V198, P75, DOI 10.2214/AJR.11.6525; Pieterman RM, 2000, NEW ENGL J MED, V343, P254, DOI 10.1056/NEJM200007273430404; Quick HH, 2014, J MAGN RESON IMAGING, V39, P243, DOI 10.1002/jmri.24523; Rakheja R, 2013, AM J ROENTGENOL, V201, P1115, DOI 10.2214/AJR.13.11304; Regier M, 2012, EUR J RADIOL, V81, P2913, DOI 10.1016/j.ejrad.2011.11.050; Rosset A, 2004, J DIGIT IMAGING, V17, P205, DOI 10.1007/s10278-004-1014-6; Satoh S, 2008, AM J ROENTGENOL, V191, P464, DOI 10.2214/AJR.07.3133; Schmidt H, 2013, INVEST RADIOL, V48, P247, DOI 10.1097/RLI.0b013e31828d56a1; Schwenzer NF, 2012, RADIOLOGY, V264, P551, DOI 10.1148/radiol.12111942; Travis WD, 2004, TUMOURS LUNG PLEURA, P9; van Tinteren H, 2002, LANCET, V359, P1388, DOI 10.1016/S0140-6736(02)08352-6; Wu XC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084999; Yi CA, 2013, CANCER-AM CANCER SOC, V119, P1784, DOI 10.1002/cncr.28000	41	30	32	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2015	10	1							e0116277	10.1371/journal.pone.0116277	http://dx.doi.org/10.1371/journal.pone.0116277			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ4BU	25574968	Green Submitted, Green Published, gold			2022-12-27	WOS:000348168100004
J	Juliao, GR; Venticinque, EM; Fernandes, GW; Price, PW				Juliao, Genimar R.; Venticinque, Eduardo M.; Wilson Fernandes, G.; Price, Peter W.			Unexpected High Diversity of Galling Insects in the Amazonian Upper Canopy: The Savanna Out There	PLOS ONE			English	Article							SPECIES RICHNESS; VERTICAL STRATIFICATION; RAINFALL GRADIENT; SOIL FERTILITY; VARZEA FORESTS; LEAF; PATTERNS; VEGETATION; HERBIVORY; TRAITS	A relatively large number of studies reassert the strong relationship between galling insect diversity and extreme hydric and thermal status in some habitats, and an overall pattern of a greater number of galling species in the understory of scleromorphic vegetation. We compared galling insect diversity in the forest canopy and its relationship with tree richness among upland terra firme, varzea, and igapo floodplains in Amazonia, Brazil. The soils of these forest types have highly different hydric and nutritional status. Overall, we examined the upper layer of 1,091 tree crowns. Galling species richness and abundance were higher in terra firme forests compared to varzea and igapo forests. GLM-ANCOVA models revealed that the number of tree species sampled in each forest type was determinant in the gall-forming insect diversity. The ratio between galling insect richness and number of tree species sampled (GIR/TSS ratio) was higher in the terra firme forest and in seasonally flooded igapo, while the varzea presented the lowest GIR/TSS ratio. In this study, we recorded unprecedented values of galling species diversity and abundance per sampling point. The GIR/TSS ratio from varzea was approximately 2.5 times higher than the highest value of this ratio ever reported in the literature. Based on this fact, we ascertained that varzea and igapo floodplain forests (with lower GIA and GIR), together with the speciose terra firme galling community emerge as the gall diversity apex landscape among all biogeographic regions already investigated. Contrary to expectation, our results also support the "harsh environment hypothesis", and unveil the Amazonian upper canopy as similar to Mediterranean vegetation habitats, hygrothermically stressed environments with leaf temperature at lethal limits and high levels of leaf sclerophylly.	[Juliao, Genimar R.] Inst Nacl Pesquisa Amazonia INPA, Manaus, Amazonas, Brazil; [Juliao, Genimar R.] Fiocruz Rondonia, Lab Entomol, Porto Velho, Rondonia, Brazil; [Venticinque, Eduardo M.] CB Univ Fed Rio Grande Norte, Dept Ecol, Natal, RN, Brazil; [Wilson Fernandes, G.] ICB Univ Fed Minas Gerais UFMG, Ecol Evolut & Biodiversidade DBG, Belo Horizonte, MG, Brazil; [Price, Peter W.] No Arizona Univ, Dept Biol Sci, Flagstaff, AZ 86011 USA	Institute Nacional de Pesquisas da Amazonia; Fundacao Oswaldo Cruz; Universidade Federal do Rio Grande do Norte; Northern Arizona University	Fernandes, GW (corresponding author), ICB Univ Fed Minas Gerais UFMG, Ecol Evolut & Biodiversidade DBG, CP 486, Belo Horizonte, MG, Brazil.	gw.fernandes@gmail.com	Fernandes, Geraldo/AAN-5602-2021; Venticinque, Eduardo M/G-8961-2015; Juliao, Genimar R/K-7872-2012	Fernandes, Geraldo/0000-0003-1559-6049; Venticinque, Eduardo M/0000-0002-3455-9107; Reboucas Juliao, Genimar/0000-0002-3850-9182	Mamiraua Sustainable Development Institute; Mamiraua Civil Society; Biological Dynamics of Forest Fragment Project (INPA/Smithsonian Institution); CNPq [141415/2003-7, 30 3352/2010-8, 403781/2012-4, 457519/2012-6, 309458/2013-7]; Fapemig [APQ-04105-10]	Mamiraua Sustainable Development Institute; Mamiraua Civil Society; Biological Dynamics of Forest Fragment Project (INPA/Smithsonian Institution); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fapemig(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG))	Funds were provided by the Mamiraua Sustainable Development Institute, Mamiraua Civil Society, and Biological Dynamics of Forest Fragment Project (INPA/Smithsonian Institution). G. R. Juliao was a PhD grant holder supported by CNPq (Process Number: 141415/2003-7); GWF acknowledges the support provided by CNPq (30 3352/2010-8, 403781/2012-4, 457519/2012-6) and Fapemig (APQ-04105-10); and EMV acknowledges the support provided by CNPq no309458/2013-7. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bell AD, 1999, BIOL J LINN SOC, V66, P481, DOI 10.1111/j.1095-8312.1999.tb01922.x; BLANCHE KR, 1995, ECOLOGY, V76, P2334, DOI 10.2307/1941706; Blanche KR, 2000, AUSTRAL ECOL, V25, P311, DOI 10.1046/j.1442-9993.2000.01040.x; Blanche KR, 2001, AM MIDL NAT, V145, P219, DOI 10.1674/0003-0031(2001)145[0219:SROGII]2.0.CO;2; Camargo MAB, 2012, REV ARVORE, V36, P7, DOI 10.1590/S0100-67622012000100002; Carvalho-Fernandes SP, 2010, THESIS I NACL PESQUI; Crawley M.J., 2007, R BOOK; Cuevas-Reyes P, 2004, OIKOS, V107, P181, DOI 10.1111/j.0030-1299.2004.13263.x; De Oliveira AA, 1999, BIODIVERS CONSERV, V8, P1219, DOI 10.1023/A:1008908615271; de Souza Mendonça Jr. Milton, 2007, Bol. Soc. Argent. Bot., V42, P347; Doughty CE, 2008, J GEOPHYS RES-BIOGEO, V113, DOI [10.1029/2007JG000632, 10.1029/2007JG000590]; Espirito-Santo MM, 2007, ANN ENTOMOL SOC AM, V100, P95, DOI 10.1603/0013-8746(2007)100[95:HMSOGI]2.0.CO;2; Fagundes M, 2005, ECOL ENTOMOL, V30, P28, DOI 10.1111/j.0307-6946.2005.00668.x; Fernandes G. Wilson, 1997, Naturalia (Rio Claro), V22, P221; Fernandes G. Wilson, 1993, Biodiversity Letters, V1, P186, DOI 10.2307/2999743; Fernandes Geraldo Wilson, 2005, P693; FERNANDES GW, 1988, OECOLOGIA, V76, P161, DOI 10.1007/BF00379948; FERNANDES GW, 1992, OECOLOGIA, V90, P14, DOI 10.1007/BF00317803; FERNANDES GW, 1992, GLOBAL ECOL BIOGEOGR, V2, P71, DOI 10.2307/2997508; Fernandes GW, 1991, PLANT ANIMAL INTERAC, P91; Franklin Elizabeth, 1997, Ecological Studies, V126, P331; Gonçalves José Francisco de C., 2005, Acta Amaz., V35, P23, DOI 10.1590/S0044-59672005000100004; Groom PK, 1999, ECOSCIENCE, V6, P471, DOI 10.1080/11956860.1999.11682537; Haugaasen Torbjørn, 2006, Acta Amaz., V36, P25, DOI 10.1590/S0044-59672006000100005; Hill RS, 1998, AUST SYST BOT, V11, P391, DOI 10.1071/SB97016; Hofer Hubert, 1997, Ecological Studies, V126, P373; Juliao GR, 2005, UAKARI, V1, P39; Junk W.J., 1989, TROPICAL FORESTS BOT, P47, DOI [DOI 10.1016/B978-0-12-353550-4.50012-5, 10.1016/b978-0-12-353550-4.50012-5]; Junk W.J., 2010, AMAZONIAN FLOODPLAIN, V210, P511, DOI [10.1007/978-90-481-8725-6_24, DOI 10.1007/978-90-481-8725-6_24]; Junk W. J., 1983, AMAZONIA DESENVOLVIM, P45; Junk WJ, 1984, AMAZON LIMNOLOGY LAN, P215; KUBITZKI K, 1989, PLANT SYST EVOL, V162, P285, DOI 10.1007/BF00936922; Lara ACF, 2002, TROP ZOOL, V15, P219, DOI 10.1080/03946975.2002.10531176; Lara Angela Christina F., 1996, Biodiversity Letters, V3, P111, DOI 10.2307/2999724; MALCOLM JR, 1991, J MAMMAL, V72, P188, DOI 10.2307/1381995; Marenco RA, 2001, TREE PHYSIOL, V21, P1311, DOI 10.1093/treephys/21.18.1311; MEDIANERO E, 2001, SCIENTIA PANAMA, V16, P17; Medianero Enrique, 2003, Acta Zool. Mex, P153; Medianero E, 2010, NEOTROP ENTOMOL, V39, P365, DOI 10.1590/S1519-566X2010000300009; MONTEIRO R.F, 2002, ARQUIVOS MUSEU NACL, V61, P31; Paniagua MR, 2009, ECOL ENTOMOL, V34, P310, DOI 10.1111/j.1365-2311.2008.01079.x; Pires JM, 1985, KEY ENV AMAZONIA, P83; Powers JS, 2005, NEW PHYTOL, V165, P913, DOI 10.1111/j.1469-8137.2004.01279.x; PRANCE GT, 1979, BRITTONIA, V31, P26, DOI 10.2307/2806669; PRANCE GT, 1989, TROPICAL RAIN FOREST, P99; Price P.W., 1991, P51; Price PW, 1998, J BIOGEOGR, V25, P581, DOI 10.1046/j.1365-2699.1998.2530581.x; Pereira MJR, 2010, CURR ZOOL, V56, P469, DOI 10.1093/czoolo/56.4.469; Ribeiro KT, 1998, ECOL ENTOMOL, V23, P491, DOI 10.1046/j.1365-2311.1998.00162.x; Ribeiro Servio P., 2011, Memoirs of the Queensland Museum, V55, P481; Ribeiro SP, 2007, ECOGRAPHY, V30, P663, DOI 10.1111/j.2007.0906-7590.05083.x; Ribeiro SP, 2005, ECOGRAPHY, V28, P315, DOI 10.1111/j.0906-7590.2005.04104.x; Ribeiro SP, 2003, ARTHROPODS OF TROPICAL FORESTS, P348; Sanches MC, 2010, TREES-STRUCT FUNCT, V24, P79, DOI 10.1007/s00468-009-0380-6; Schongart J, 2005, OECOLOGIA, V145, P454, DOI 10.1007/s00442-005-0147-8; Sereneski-de Lima C, 2013, REV MEX BIODIVERS, V84, P1159, DOI 10.7550/rmb.32149; Sioli H., 1991, AMAZONIA FUNDAMENTOS; Sobrado MA, 2010, J TROP ECOL, V26, P215, DOI 10.1017/S0266467409990538; Southwood T. R. E., 1960, P HAWAII ENTOMOL SOC, V17, P229; Sullivan LL, 2011, ECOLOGY, V92, P1559, DOI 10.1890/10-1116.1; Tooker JF, 2008, NEW PHYTOL, V178, P657, DOI 10.1111/j.1469-8137.2008.02392.x; Tribuzy ES, 2003, 7 LBA ECO SCI TEAM B, P94; TRIBUZY ES, 2005, THESIS U SAO PAULO B; TURNER IM, 1994, FUNCT ECOL, V8, P669, DOI 10.2307/2390225; Veldtman R, 2003, AUSTRAL ECOL, V28, P1, DOI 10.1046/j.1442-9993.2003.01234.x; Victoria RL, 2000, AMAZONIA ECOSSISTEMA, P163; Waldhoff D., 2010, AMAZONIAN FLOODPLAIN, V210, DOI [10.1007/978-90-481-8725-6_9, DOI 10.1007/978-90-481-8725-6_9]; Fernandes GW, 2010, ENVIRON ENTOMOL, V39, P1134, DOI 10.1603/EN09199; Wittmann F, 2004, FOREST ECOL MANAG, V196, P199, DOI 10.1016/j.foreco.2004.02.060; Wittmann F, 2002, J TROP ECOL, V18, P805, DOI 10.1017/S0266467402002523; Worbes M., 1997, CENTRAL AMAZON FLOOD, VVol. 126, P223, DOI [DOI 10.1007/978-3-662-03416-3_11, 10.1007/978-3-662-03416-3_11]; Wright Mark G., 1996, Biodiversity Letters, V3, P151, DOI 10.2307/2999733; Wright MG, 1998, OECOLOGIA, V115, P427, DOI 10.1007/s004420050537; Yang MM, 1998, US FOR SERV T R NC, V199, P44; Yukawa Junichi, 2001, Esakia, V41, P11	75	26	29	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2014	9	12							e114986	10.1371/journal.pone.0114986	http://dx.doi.org/10.1371/journal.pone.0114986			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UC	25551769	gold, Green Published, Green Submitted			2022-12-27	WOS:000347119100021
J	Kao, LT; Liu, SP; Lin, HC; Lee, HC; Tsai, MC; Chung, SD				Kao, Li-Ting; Liu, Shih-Ping; Lin, Herng-Ching; Lee, Hsin-Chien; Tsai, Ming-Chieh; Chung, Shiu-Dong			Poor Clinical Outcomes among Pneumonia Patients with Depressive Disorder	PLOS ONE			English	Article							COMMUNITY-ACQUIRED PNEUMONIA; COMMON COLD; PSYCHOLOGICAL STRESS; MORTALITY; MORBIDITY; PSYCHONEUROIMMUNOLOGY; HOSPITALIZATION; SUSCEPTIBILITY; EPIDEMIOLOGY; PERSPECTIVES	Background: Some studies suggested that psychological stress may be associated with the severity and duration of infectious diseases. In this population-based study, we investigated associations between depressive disorder (DD) and pneumonia outcomes in Taiwan with a large-scale database from the National Health Insurance. Methods: Our study defined 112,198 patients who were hospitalized with a principal diagnosis of pneumonia. We defined their admission date for treatment of pneumonia as the index date. Subsequently, we selected 2,394 patients with DD within 3 years prior to their index date and 11,970 matched patients without DD. We carried out separate conditional logistic regressions to explore the association of clinical pneumonia treatment outcome (ICU admission, use of mechanical ventilation, acute respiratory failure and in-hospital death) with previously diagnosed DD. Results: Patients with DD had a significantly higher probability of an intensive care unit admission (18.1% vs. 12.9%; p< 0.001), need for mechanical ventilation (21.9% vs. 18.1%; p< 0.001) and in-hospital death (10.4% vs. 9.0%; p=0.025) than patients without DD. The study showed that pneumonia patients with DD were respectively 1.41- (95% CI: 1.25 similar to 1.59, p< 0.001), 1.28- (95% CI: 1.14 similar to 1.43, p< 0.001), and 1.17- times (95% CI: 1.01 similar to 1.36, p=0.039) greater odds of being admitted to the ICU, need for mechanical ventilation, and in-hospital death than patients without DD after adjusting for monthly income, urbanization level, geographic region and Charlson Comorbidity Index score. Conclusions: In conclusion, we found that pneumonia patients with DD were associated with poor treatment outcomes compared to patients without DD.	[Kao, Li-Ting] Natl Def Med Ctr, Grad Inst Life Sci, Taipei, Taiwan; [Kao, Li-Ting; Lin, Herng-Ching; Chung, Shiu-Dong] Taipei Med Univ Hosp, Sleep Res Ctr, Taipei, Taiwan; [Liu, Shih-Ping] Natl Taiwan Univ Hosp, Dept Urol, Taipei, Taiwan; [Liu, Shih-Ping] Coll Med, Taipei, Taiwan; [Lin, Herng-Ching; Tsai, Ming-Chieh] Taipei Med Univ, Sch Hlth Care Adm, Taipei, Taiwan; [Lee, Hsin-Chien] Taipei Med Univ, Sch Med, Dept Psychiat, Taipei, Taiwan; [Tsai, Ming-Chieh] Cathay Gen Hosp, Dept Internal Med, Div Gastroenterol, Taipei, Taiwan; [Chung, Shiu-Dong] Far Eastern Mem Hosp, Dept Surg, Div Urol, Taipei, Taiwan	National Defense Medical Center; Taipei Medical University; Taipei Medical University Hospital; National Taiwan University; National Taiwan University Hospital; Taipei Medical University; Taipei Medical University; Cathay General Hospital; Far Eastern Memorial Hospital	Chung, SD (corresponding author), Taipei Med Univ Hosp, Sleep Res Ctr, Taipei, Taiwan.	chungshiudong@gmail.com	Kao, Li-Ting/W-9287-2018	Kao, Li-Ting/0000-0003-0692-7408; lee, hsin-chien/0000-0002-7557-8259; LIU, SHIH-PING/0000-0002-8015-0695	Ministry of Science and Technology in Taiwan [102-2632-B-038-001-MY3]	Ministry of Science and Technology in Taiwan(Ministry of Science and Technology, Taiwan)	This study was supported partially by a grant from the Ministry of Science and Technology in Taiwan (Project No. 102-2632-B-038-001-MY3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barlow GD, 2003, LANCET INFECT DIS, V3, P476, DOI 10.1016/S1473-3099(03)00721-7; Chen YH, 2011, SCHIZOPHRENIA BULL, V37, P1088, DOI 10.1093/schbul/sbq019; Cheng CL, 2011, PHARMACOEPIDEM DR S, V20, P236, DOI 10.1002/pds.2087; COHEN S, 1991, NEW ENGL J MED, V325, P606, DOI 10.1056/NEJM199108293250903; Cohen S, 1998, HEALTH PSYCHOL, V17, P214, DOI 10.1037/0278-6133.17.3.214; Davydow DS, 2013, AM J MED, V126, P615, DOI 10.1016/j.amjmed.2012.12.006; Davydow DS, 2014, J PSYCHOSOM RES; DiMatteo MR, 2000, ARCH INTERN MED, V160, P2101, DOI 10.1001/archinte.160.14.2101; Gan WQ, 2004, THORAX, V59, P574, DOI 10.1136/thx.2003.019588; Godbout JP, 2006, J NEUROIMMUNE PHARM, V1, P421, DOI 10.1007/s11481-006-9036-0; Gutierrez F, 2008, DRUG AGING, V25, P585, DOI 10.2165/00002512-200825070-00005; Hak E, 2005, FAM PRACT, V22, P375, DOI 10.1093/fampra/cmi020; Hasin DS, 2005, ARCH GEN PSYCHIAT, V62, P1097, DOI 10.1001/archpsyc.62.10.1097; Insel TR, 2003, JAMA-J AM MED ASSOC, V289, P3167, DOI 10.1001/jama.289.23.3167; Kang JH, 2010, ANN RHEUM DIS, V69, P1165, DOI 10.1136/ard.2009.116178; Kessler RC, 2003, JAMA-J AM MED ASSOC, V289, P3095, DOI 10.1001/jama.289.23.3095; Kiecolt-Glaser JK, 1998, AM PSYCHOL, V53, P1209, DOI 10.1037/0003-066X.53.11.1209; Kiecolt-Glaser JK, 2002, J PSYCHOSOM RES, V53, P873, DOI 10.1016/S0022-3999(02)00309-4; Kiecolt-Glaser JK, 2002, ANNU REV PSYCHOL, V53, P83, DOI 10.1146/annurev.psych.53.100901.135217; KIECOLTGLASER JK, 1995, LANCET, V346, P1194, DOI 10.1016/S0140-6736(95)92899-5; Kornum JB, 2007, DIABETES CARE, V30, P2251, DOI 10.2337/dc06-2417; Lepine Jean-Pierre, 2011, Neuropsychiatr Dis Treat, V7, P3, DOI 10.2147/NDT.S19617; Leserman J, 1999, PSYCHOSOM MED, V61, P397, DOI 10.1097/00006842-199905000-00021; McAlister FA, 2005, DIABETES CARE, V28, P810, DOI 10.2337/diacare.28.4.810; Petretta M, 2000, Am Heart J, V140, pE28, DOI 10.1067/mhj.2000.110935; Polverino E, 2011, MINERVA ANESTESIOL, V77, P196; Prince M, 2007, LANCET, V370, P859, DOI 10.1016/S0140-6736(07)61238-0; Restrepo MI, 2006, EUR RESPIR J, V28, P346, DOI 10.1183/09031936.06.00131905; STONE AA, 1992, BEHAV MED, V18, P115, DOI 10.1080/08964289.1992.9936961; Yende S, 2005, AM J RESP CRIT CARE, V172, P1440, DOI 10.1164/rccm.200506-888OC	30	18	18	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2014	9	12							e116436	10.1371/journal.pone.0116436	http://dx.doi.org/10.1371/journal.pone.0116436			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UC	25551389	Green Submitted, Green Published, gold			2022-12-27	WOS:000347119100141
J	Ohtani, T; Nestor, PG; Bouix, S; Saito, Y; Hosokawa, T; Kubicki, M				Ohtani, Toshiyuki; Nestor, Paul G.; Bouix, Sylvain; Saito, Yukiko; Hosokawa, Taiga; Kubicki, Marek			Medial Frontal White and Gray Matter Contributions to General Intelligence	PLOS ONE			English	Article							ANTERIOR CINGULATE CORTEX; VENTROMEDIAL PREFRONTAL CORTEX; ORBITOFRONTAL CORTEX; P-FIT; CONNECTIVITY; ARCHITECTURE; REWARD; INTEGRITY	The medial orbitofrontal cortex (mOFC) and rostral anterior cingulate cortex (rACC) are part of a wider neural network that plays an important role in general intelligence and executive function. We used structural brain imaging to quantify magnetic resonance gray matter volume and diffusion tensor white matter integrity of the mOFC-rACC network in 26 healthy participants who also completed neuropsychological tests of intellectual abilities and executive function. Stochastic tractography, the most effective Diffusion Tensor Imaging method for examining white matter connections between adjacent gray matter regions, was employed to assess the integrity of mOFC-rACC pathways. Fractional anisotropy (FA), which reflects the integrity of white matter connections, was calculated. Results indicated that higher intelligence correlated with greater gray matter volumes for both mOFC and rACC, as well as with increased FA for left posterior mOFC-rACC connectivity. Hierarchical regression analyses revealed that DTI-derived FA of left posterior mOFC-rACC uniquely accounted for 29%-34% of the variance in IQ, in comparison to 11%-16% uniquely explained by gray matter volume of the left rACC. Together, left rACC gray matter volume and white matter connectivity between left posterior mOFC and rACC accounted for up to 50% of the variance in general intelligence. This study is to our knowledge the first to examine white matter connectivity between OFC and ACC, two gray matter regions of interests that are very close in physical proximity, and underscores the important independent contributions of variations in rACC gray matter volume and mOFC-rACC white matter connectivity to individual differences in general intelligence.	[Ohtani, Toshiyuki; Bouix, Sylvain; Saito, Yukiko; Hosokawa, Taiga; Kubicki, Marek] Harvard Univ, Brigham & Womens Hosp, Sch Med, Psychiat Neuroimaging Lab,Dept Psychiat & Radiol, Boston, MA 02115 USA; [Ohtani, Toshiyuki; Nestor, Paul G.; Hosokawa, Taiga] Harvard Univ, Sch Med, Vet Affairs VA Boston Healthcare Syst, Clin Neurosci Div,Lab Neurosci,Dept Psychiat, Brockton, MA 02401 USA; [Nestor, Paul G.] Univ Massachusetts, Dept Psychol, Boston, MA 02125 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; University of Massachusetts System; University of Massachusetts Boston	Kubicki, M (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med, Psychiat Neuroimaging Lab,Dept Psychiat & Radiol, Boston, MA 02115 USA.	kubicki@bwh.harvard.edu	Ohtani, Toshiyuki/I-2042-2018	Bouix, Sylvain/0000-0003-1326-6054; Ohtani, Toshiyuki/0000-0002-8013-0424	National Institutes of Health [R01 AG042512, R01 MH102377, R01 MH 082918, R01MH 074794]; National Institutes of Health through the NIH Roadmap for Medical Research [U54 EB005149]; Center for Integration of Medicine and Innovative Technology Soldier in Medicine Award; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [U54EB005149] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH082918, R01MH102377, R01MH074794] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG042512] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health through the NIH Roadmap for Medical Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Center for Integration of Medicine and Innovative Technology Soldier in Medicine Award; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research was supported by the National Institutes of Health (R01 AG042512 and R01 MH102377 to MK, R01 MH 082918 to SB and R01MH 074794 to CFW). This work is also part of the National Alliance for Medical Image Computing (NAMIC), funded by the National Institutes of Health through the NIH Roadmap for Medical Research, Grant U54 EB005149 (MK, CFW). In addition, this work has been funded in part by the Center for Integration of Medicine and Innovative Technology Soldier in Medicine Award (to SB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander AL, 1997, MAGN RESON MED, V38, P1016, DOI 10.1002/mrm.1910380623; Allman JM, 2001, ANN NY ACAD SCI, V935, P107, DOI 10.1111/j.1749-6632.2001.tb03476.x; Arbuthnott K, 2000, J CLIN EXP NEUROPSYC, V22, P518, DOI 10.1076/1380-3395(200008)22:4;1-0;FT518; Barbey AK, 2012, BRAIN, V135, P1154, DOI 10.1093/brain/aws021; BASSER PJ, 1994, BIOPHYS J, V66, P259, DOI 10.1016/S0006-3495(94)80775-1; Basser PJ, 1996, J MAGN RESON SER B, V111, P209, DOI [10.1006/jmrb.1996.0086, 10.1016/j.jmr.2011.09.022]; Bjornemo M, 2002, LECT NOTES COMPUT SC, V2488, P435; Bush G, 2000, TRENDS COGN SCI, V4, P215, DOI 10.1016/S1364-6613(00)01483-2; Chiang MC, 2009, J NEUROSCI, V29, P2212, DOI 10.1523/JNEUROSCI.4184-08.2009; Choi JS, 2004, J PSYCHIATR RES, V38, P193, DOI 10.1016/j.jpsychires.2003.08.001; Colom R, 2009, INTELLIGENCE, V37, P124, DOI 10.1016/j.intell.2008.07.007; de Marco G, 2006, NEUROIMAGE, V30, P1030, DOI 10.1016/j.neuroimage.2005.10.001; Deary IJ, 2010, NAT REV NEUROSCI, V11, P201, DOI 10.1038/nrn2793; Deary IJ, 2006, NEUROLOGY, V66, P505, DOI 10.1212/01.wnl.0000199954.81900.e2; DEVINSKY O, 1995, BRAIN, V118, P279, DOI 10.1093/brain/118.1.279; Elliott R, 2000, CEREB CORTEX, V10, P308, DOI 10.1093/cercor/10.3.308; Etkin A, 2011, TRENDS COGN SCI, V15, P85, DOI 10.1016/j.tics.2010.11.004; First MB, 2002, STRUCTURED CLIN INTE; Garlick D, 2002, PSYCHOL REV, V109, P116, DOI 10.1037//0033-295X.109.1.116; Glascher J, 2009, CEREB CORTEX, V19, P483, DOI 10.1093/cercor/bhn098; Gottfried JA, 2003, SCIENCE, V301, P1104, DOI 10.1126/science.1087919; Gray JR, 2004, NAT REV NEUROSCI, V5, P471, DOI 10.1038/nrn1405; Haber SN, 2010, NEUROPSYCHOPHARMACOL, V35, P4, DOI 10.1038/npp.2009.129; Haier RJ, 2004, NEUROIMAGE, V23, P425, DOI 10.1016/j.neuroimage.2004.04.025; Hampton AN, 2006, J NEUROSCI, V26, P8360, DOI 10.1523/JNEUROSCI.1010-06.2006; Heaton, 1981, WISCONSIN CARD SORTI; Heid O., 2000, P 8 ANN M ISMRM, V8, P799; Hollingshead AB, 1965, 2 FACTOR INDEX SOCIA; Jung RE, 2007, BEHAV BRAIN SCI, V30, P135, DOI 10.1017/S0140525X07001185; Koski L, 2000, EXP BRAIN RES, V133, P55, DOI 10.1007/s002210000400; Kreher BW, 2008, NEUROIMAGE, V43, P81, DOI 10.1016/j.neuroimage.2008.06.023; Kringelbach ML, 2005, NAT REV NEUROSCI, V6, P691, DOI 10.1038/nrn1747; Kubicki M, 2002, HARVARD REV PSYCHIAT, V10, P324, DOI 10.1093/hrp/10.6.324; Kubicki M, 2011, NEUROIMAGE, V55, P1657, DOI 10.1016/j.neuroimage.2011.01.047; Nestor PG, 2008, NEUROPSYCHOLOGY, V22, P246, DOI 10.1037/0894-4105.22.2.246; Neubauer AC, 2009, NEUROSCI BIOBEHAV R, V33, P1004, DOI 10.1016/j.neubiorev.2009.04.001; Oishi K, 2009, J NEUROIMAGING, V19, P127, DOI 10.1111/j.1552-6569.2008.00262.x; Ongur D, 2003, J COMP NEUROL, V460, P425, DOI 10.1002/cne.10609; Penke L, 2012, MOL PSYCHIATR, V17, P1026, DOI 10.1038/mp.2012.66; Pernice V, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002059; Powell HWR, 2006, NEUROIMAGE, V32, P388, DOI 10.1016/j.neuroimage.2006.03.011; Reitan RM, 1992, TRAIL MAKING TEST MA; Schmithorst VJ, 2005, HUM BRAIN MAPP, V26, P139, DOI 10.1002/hbm.20149; Song SK, 2003, NEUROIMAGE, V20, P1714, DOI 10.1016/j.neuroimage.2003.07.005; Szatkowska I, 2011, NEUROBIOL LEARN MEM, V96, P385, DOI 10.1016/j.nlm.2011.06.014; Thompson PM, 2001, NAT NEUROSCI, V4, P1253, DOI 10.1038/nn758; van den Heuvel MP, 2009, J NEUROSCI, V29, P7619, DOI 10.1523/JNEUROSCI.1443-09.2009; Wechsler D., 1997, WECHSLER ADULT INTEL; Zald DH, 1996, J NEUROPSYCH CLIN N, V8, P249	49	15	16	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2014	9	12							e112691	10.1371/journal.pone.0112691	http://dx.doi.org/10.1371/journal.pone.0112691			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UC	25551572	gold, Green Published, Green Submitted			2022-12-27	WOS:000347119100004
J	Shoji, T; Kuroda, H; Suzuki, M; Baba, M; Hangai, M; Araie, M; Yoneya, S				Shoji, Takuhei; Kuroda, Hiroto; Suzuki, Masayuki; Baba, Motoyoshi; Hangai, Masanori; Araie, Makoto; Yoneya, Shin			Correlation between Lamina Cribrosa Tilt Angles, Myopia and Glaucoma Using OCT with a Wide Bandwidth Femtosecond Mode-Locked Laser	PLOS ONE			English	Article							OPTICAL COHERENCE TOMOGRAPHY; NORMAL-TENSION GLAUCOMA; DISC MARGIN ANATOMY; NERVE HEAD; DISPLACEMENT; THICKNESS; DAMAGE; REVERSAL; EYES	Purpose: To measure horizontal and vertical lamina cribrosa (LC) tilt angles and investigate associated factors using prototype optical coherence tomography (OCT) with a broad wavelength laser light source. Design: Cross sectional study. Methods: Twenty-eight no glaucoma eyes (from 15 subjects) and 25 glaucoma eyes (from 14 patients) were enrolled. A total of 300 optic nerve head B-scans were obtained in 10 mm steps and the inner edge of Bruch's membrane opening (BMO) was identified as the reference plane. The vertical and horizontal angles between BMO line and approximate the best-fitting line for the surface of the LC were measured and potential associated factors were estimated with univariate and multivariate logistic regression analyses. Results: The median (interquartile range) horizontal and vertical tilt angles were 7.10 (2.43-11.45) degrees and 4.15 (2.60-6.85) degrees in eyes without glaucoma and 8.50 (4.40-14.10) degrees and 9.30 (6.90-14.15) degrees in glaucoma eyes, respectively. The refractive errors had a statistically significant association with horizontal LC tilt angles (coefficients, -1.53 per diopter) and glaucoma had a significant correlation with vertical tilt angles (coefficients, 6.56) using multiple logistic regression analysis (p<0.001). Conclusions: OCT allowed evaluation of the internal tilting of the LC compared with the BMO. The horizontal internal LC tilt angle was correlated with refractive errors, corresponding to myopic physiological changes, and vertical internal LC tilt was correlated with glaucoma, corresponding to glaucomatous pathological changes. These parameters have important implications for investigation of the correlation between myopia, glaucoma and LC morphological features.	[Shoji, Takuhei; Kuroda, Hiroto; Suzuki, Masayuki; Hangai, Masanori; Araie, Makoto; Yoneya, Shin] Saitama Med Univ, Dept Ophthalmol, Iruma, Saitama, Japan; [Shoji, Takuhei; Kuroda, Hiroto; Suzuki, Masayuki; Baba, Motoyoshi; Hangai, Masanori; Yoneya, Shin] Saitama Med Univ, Dept Ophthalmol, Adv Laser Med Ctr, Iruma, Saitama, Japan; [Araie, Makoto] Kanto Cent Hosp, Dept Ophthalmol, Tokyo, Japan	Saitama Medical University; Saitama Medical University	Shoji, T (corresponding author), Saitama Med Univ, Dept Ophthalmol, Iruma, Saitama, Japan.	shoojii@saitama-med.ac.jp	Shoji, Takuhei/W-1856-2017	Shoji, Takuhei/0000-0002-5464-2573	Suda Memorial Fund for Glaucoma Research, Chiyoda, Tokyo, Japan; Takeda Science Foundation, Tokyo, Japan; Japan Society for the Promotion of Science [25870678, 24760048]; Ministry of Education, Culture, Sports, Science and Technology of Japan; Grants-in-Aid for Scientific Research [25870678] Funding Source: KAKEN	Suda Memorial Fund for Glaucoma Research, Chiyoda, Tokyo, Japan; Takeda Science Foundation, Tokyo, Japan(Takeda Science Foundation (TSF)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported in part by the Suda Memorial Fund for Glaucoma Research, Chiyoda, Tokyo, Japan; by the Takeda Science Foundation, Tokyo, Japan; and by a Grant-in-Aid for Young Scientists (B) (number 25870678 and 24760048) from the Japan Society for the Promotion of Science and the Ministry of Education, Culture, Sports, Science and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson DR, 2000, AM J OPHTHALMOL, V130, P827, DOI 10.1016/S0002-9394(00)00665-6; Furlanetto RL, 2013, INVEST OPHTH VIS SCI, V54, P4836, DOI 10.1167/iovs.12-11530; Hosseini H, 2013, AM J OPHTHALMOL, V156, P737, DOI 10.1016/j.ajo.2013.05.036; Inoue R, 2009, OPHTHALMOLOGY, V116, P214, DOI 10.1016/j.ophtha.2008.09.008; JONAS JB, 1991, INVEST OPHTH VIS SCI, V32, P401; Jonas JB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047237; Kim TW, 2012, OPHTHALMOLOGY, V119, P21, DOI 10.1016/j.ophtha.2011.07.051; Kuroda H, 2013, APPL PHYS LETT, V103, DOI 10.1063/1.4824493; Kuroda H, 2013, APPL PHYS LETT, V102, DOI 10.1063/1.4812342; Lee EJ, 2013, OPHTHALMOLOGY, V120, P553, DOI 10.1016/j.ophtha.2012.08.047; Lee EJ, 2012, OPHTHALMOLOGY, V119, DOI 10.1016/j.ophtha.2012.01.034; Mari JM, 2013, INVEST OPHTH VIS SCI, V54, P2238, DOI 10.1167/iovs.12-11327; Nakazawa M, 2008, ACTA OPHTHALMOL, V86, P626, DOI 10.1111/j.1600-0420.2007.01139.x; Park HYL, 2012, OPHTHALMOLOGY, V119, P1844, DOI 10.1016/j.ophtha.2012.03.006; Park HYL, 2013, OPHTHALMOLOGY, V120, P745, DOI 10.1016/j.ophtha.2012.09.051; Park HYL, 2012, OPHTHALMOLOGY, V119, P10, DOI 10.1016/j.ophtha.2011.07.033; Park SC, 2012, OPHTHALMOLOGY, V119, P3, DOI 10.1016/j.ophtha.2011.07.012; QUIGLEY HA, 1981, ARCH OPHTHALMOL-CHIC, V99, P137; QUIGLEY HA, 1983, AM J OPHTHALMOL, V95, P673, DOI 10.1016/0002-9394(83)90389-6; QUIGLEY HA, 1981, ARCH OPHTHALMOL-CHIC, V99, P635, DOI 10.1001/archopht.1981.03930010635009; RADIUS RL, 1981, ARCH OPHTHALMOL-CHIC, V99, P2159; Reis ASC, 2012, OPHTHALMOLOGY, V119, P738, DOI 10.1016/j.ophtha.2011.09.054; Roberts MD, 2010, INVEST OPHTH VIS SCI, V51, P5675, DOI 10.1167/iovs.10-5411; Sigal IA, 2011, INVEST OPHTH VIS SCI, V52, P1896, DOI 10.1167/iovs.10-5500; Strouthidis NG, 2009, INVEST OPHTH VIS SCI, V50, P2165, DOI 10.1167/iovs.08-2786; Strouthidis NG, 2009, INVEST OPHTH VIS SCI, V50, P214, DOI 10.1167/iovs.08-2302; Tay E, 2005, AM J OPHTHALMOL, V139, P247, DOI 10.1016/j.ajo.2004.08.076; WILCZEK M, 1947, BRIT J OPHTHALMOL, V31, P551, DOI 10.1136/bjo.31.9.551; Yang HL, 2007, INVEST OPHTH VIS SCI, V48, P4597, DOI 10.1167/iovs.07-0349; Yang HL, 2011, INVEST OPHTH VIS SCI, V52, P7109, DOI 10.1167/iovs.11-7448; Yang HL, 2011, INVEST OPHTH VIS SCI, V52, P345, DOI 10.1167/iovs.09-5122	31	15	16	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2014	9	12							e116305	10.1371/journal.pone.0116305	http://dx.doi.org/10.1371/journal.pone.0116305			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UC	25551632	Green Submitted, Green Published, gold			2022-12-27	WOS:000347119100130
J	Tagliaferri, C; Davicco, MJ; Lebecque, P; George, S; Amiot, MJ; Mercier, S; Dhaussy, A; Huertas, A; Walrand, S; Wittrant, Y; Coxam, V				Tagliaferri, Camille; Davicco, Marie-Jeanne; Lebecque, Patrice; George, Stephane; Amiot, Marie-Jo; Mercier, Sylvie; Dhaussy, Amelie; Huertas, Alain; Walrand, Stephane; Wittrant, Yohann; Coxam, Veronique			Olive Oil and Vitamin D Synergistically Prevent Bone Loss in Mice	PLOS ONE			English	Article							OVARIECTOMY/INFLAMMATION EXPERIMENTAL-MODEL; INFLAMMATION-INDUCED OSTEOPOROSIS; OXIDATIVE STRESS; MEDITERRANEAN DIET; MINERAL DENSITY; OVARIECTOMIZED MICE; NITRIC-OXIDE; MACROPHAGE ACTIVATION; ANTIOXIDANT SYSTEM; PHENOLIC-COMPOUNDS	As the Mediterranean diet (and particularly olive oil) has been associated with bone health, we investigated the impact of extra virgin oil as a source of polyphenols on bone metabolism. In that purpose sham-operated (SH) or ovariectomized (OVX) mice were subjected to refined or virgin olive oil. Two supplementary OVX groups were given either refined or virgin olive oil fortified with vitamin D3, to assess the possible synergistic effects with another liposoluble nutrient. After 30 days of exposure, bone mineral density and gene expression were evaluated. Consistent with previous data, ovariectomy was associated with increased bone turnover and led to impaired bone mass and micro-architecture. The expression of oxidative stress markers were enhanced as well. Virgin olive oil fortified with vitamin D3 prevented such changes in terms of both bone remodeling and bone mineral density. The expression of inflammation and oxidative stress mRNA was also lower in this group. Overall, our data suggest a protective impact of virgin olive oil as a source of polyphenols in addition to vitamin D3 on bone metabolism through improvement of oxidative stress and inflammation.	[Tagliaferri, Camille; Davicco, Marie-Jeanne; Lebecque, Patrice; Mercier, Sylvie; Walrand, Stephane; Wittrant, Yohann; Coxam, Veronique] INRA, Unite Mixte Rech UMR 1019, Unite Nutr Humaine, Ctr Rech Nutr Humaine CRNH Auvergne, Clermont Ferrand, France; [Tagliaferri, Camille; Davicco, Marie-Jeanne; Lebecque, Patrice; Mercier, Sylvie; Walrand, Stephane; Wittrant, Yohann; Coxam, Veronique] Univ Auvergne, Clermont Univ, Clermont Ferrand, France; [Tagliaferri, Camille; Dhaussy, Amelie; Huertas, Alain] Lesieur, F-92665 Asnieres, France; [George, Stephane] CTCPA, Dept Biochem, F-84911 Avignon 9, France; [Amiot, Marie-Jo] INRA, UMR 1260, Marseille, France; [Amiot, Marie-Jo] INSERM, UMR 1260, F-13258 Marseille, France; [Amiot, Marie-Jo] Univ Aix Marseille, Fac Med, Marseille, France	INRAE; Universite Clermont Auvergne (UCA); INRAE; UDICE-French Research Universities; Aix-Marseille Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite	Coxam, V (corresponding author), INRA, Unite Mixte Rech UMR 1019, Unite Nutr Humaine, Ctr Rech Nutr Humaine CRNH Auvergne, Clermont Ferrand, France.	veronique.coxam@clermont.inra.fr	Amiot, Marie Josephe/M-1203-2017; AMIOT, MARIE JOSEPHE/N-8894-2019; Amiot, Marie Josephe/C-4457-2015	Amiot, Marie Josephe/0000-0003-4563-4587; AMIOT, MARIE JOSEPHE/0000-0003-4563-4587; Walrand, Stephane/0000-0002-4349-3664	Conventions Industrielles de Formation par la REcherche grant (CIFRE) grant from the French National Association for Research and Technology [2011/99]; Lesieur; CIFRE; pOLIVd3 ANR (French National Research Agency) [ANR-10-ALIA-0008]	Conventions Industrielles de Formation par la REcherche grant (CIFRE) grant from the French National Association for Research and Technology; Lesieur; CIFRE; pOLIVd3 ANR (French National Research Agency)(French National Research Agency (ANR))	CT was funded by a Conventions Industrielles de Formation par la REcherche grant (CIFRE; no 2011/99) from the French National Association for Research and Technology (http://www.anrt.asso.fr/) in partnership with Lesieur. This work was supported by both the CIFRE grant and the pOLIVd3 ANR (French National Research Agency; http://www.agence-nationale-recherche.fr/) program ANR-10-ALIA-0008. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adami S, 2009, OSTEOPOROSIS INT, V20, P239, DOI 10.1007/s00198-008-0650-y; Almeida M, 2007, J BIOL CHEM, V282, P27285, DOI 10.1074/jbc.M702810200; Arai M, 2007, IUBMB LIFE, V59, P27, DOI 10.1080/15216540601156188; Armour KE, 1999, J BONE MINER RES, V14, P2137, DOI 10.1359/jbmr.1999.14.12.2137; Armour KJ, 2001, ARTHRITIS RHEUM, V44, P2790, DOI 10.1002/1529-0131(200112)44:12<2790::AID-ART466>3.0.CO;2-X; Basu S, 2001, BIOCHEM BIOPH RES CO, V288, P275, DOI 10.1006/bbrc.2001.5747; Beauchamp GK, 2005, NATURE, V437, P45, DOI 10.1038/437045a; Benetou V, 2013, OSTEOPOROSIS INT, V24, P1587, DOI 10.1007/s00198-012-2187-3; Bischoff-Ferrari HA, 2012, NEW ENGL J MED, V367, P40, DOI 10.1056/NEJMoa1109617; Boonen S, 2007, J CLIN ENDOCR METAB, V92, P1415, DOI 10.1210/jc.2006-1404; Boskou D., 2006, OLIVE OIL, V2nd, P41, DOI [DOI 10.1016/B978-1-893997-88-2.50008-0, 10.1016/B978-1-893997-88-2.50008-0]; Cano A, 2008, OSTEOPOROSIS INT, V19, P793, DOI 10.1007/s00198-007-0498-6; CANTATORE FP, 1995, CLIN RHEUMATOL, V14, P157, DOI 10.1007/BF02214935; Cicerale S, 2010, INT J MOL SCI, V11, P458, DOI 10.3390/ijms11020458; Cuzzocrea S, 2003, ENDOCRINOLOGY, V144, P1098, DOI 10.1210/en.2002-220597; Dai J, 2008, AM J CLIN NUTR, V88, P1364, DOI 10.3945/ajcn.2008.26528; de la Puerta R, 1999, BIOCHEM PHARMACOL, V57, P445, DOI 10.1016/S0006-2952(98)00320-7; De Stefano D, 2007, EUR J PHARMACOL, V566, P192, DOI 10.1016/j.ejphar.2007.03.051; Faine LA, 2006, CAN J PHYSIOL PHARM, V84, P239, DOI 10.1139/Y05-124; FINKELMAN RD, 1992, P NATL ACAD SCI USA, V89, P12190, DOI 10.1073/pnas.89.24.12190; Fito M, 2008, EUR J CLIN NUTR, V62, P570, DOI 10.1038/sj.ejcn.1602724; Galtier O, 2007, ANAL CHIM ACTA, V595, P136, DOI 10.1016/j.aca.2007.02.033; Gonzalez-Correa JA, 2007, LIPIDS, V42, P921, DOI 10.1007/s11745-007-3097-6; Gregory LS, 2006, BONE, V39, P134, DOI 10.1016/j.bone.2005.12.017; Hagiwara K, 2011, EUR J PHARMACOL, V662, P78, DOI 10.1016/j.ejphar.2011.04.023; Hilger J, 2014, BRIT J NUTR, V111, P23, DOI 10.1017/S0007114513001840; Iacono A, 2010, ARTHRITIS RHEUM-US, V62, P1675, DOI 10.1002/art.27437; IKEDA T, 1993, BIOCHEM BIOPH RES CO, V194, P1228, DOI 10.1006/bbrc.1993.1954; JOHNELL O, 1992, OSTEOPOROSIS INT, V2, P298, DOI 10.1007/BF01623186; KALU DN, 1991, BONE MINER, V15, P175, DOI 10.1016/0169-6009(91)90124-I; KANIS JA, 1993, OSTEOPOROSIS INT, V3, pS10; Keiler AM, 2013, EUR J NUTR; Khanal P, 2011, CARCINOGENESIS, V32, P545, DOI 10.1093/carcin/bgr001; Kontogianni MD, 2009, NUTRITION, V25, P165, DOI 10.1016/j.nut.2008.07.019; Liang HD, 2013, MOL BIOL REP, V40, P757, DOI 10.1007/s11033-012-2065-2; Lips P, 2010, J STEROID BIOCHEM, V121, P297, DOI 10.1016/j.jsbmb.2010.02.021; Mailer A.R., 2006, PRIME FACTS, V227, P1; Maiuri MC, 2005, N-S ARCH PHARMACOL, V371, P457, DOI 10.1007/s00210-005-1078-y; Fernandez-Real JM, 2012, J CLIN ENDOCR METAB, V97, P3792, DOI 10.1210/jc.2012-2221; Martinez-Dominguez E, 2001, INFLAMM RES, V50, P102, DOI 10.1007/s000110050731; Moreno JJ, 2003, FREE RADICAL BIO MED, V35, P1073, DOI 10.1016/S0891-5849(03)00465-9; Musumeci G, 2013, ACTA HISTOCHEM; Muthusami S, 2005, CLIN CHIM ACTA, V360, P81, DOI 10.1016/j.cccn.2005.04.014; Ovesen L, 2003, P NUTR SOC, V62, P813, DOI 10.1079/PNS2003297; Park Y, 2013, FOOD CHEM, V140, P280, DOI 10.1016/j.foodchem.2012.12.067; PECK WA, 1993, AM J MED, V94, P646; Perez-Lopez FR, 2009, MATURITAS, V64, P67, DOI 10.1016/j.maturitas.2009.07.013; Puel C, 2004, BRIT J NUTR, V92, P119, DOI 10.1079/BJN20041181; Puel C, 2008, J AGR FOOD CHEM, V56, P9417, DOI 10.1021/jf801794q; Puel C, 2007, BRIT J NUTR, V97, P1012, DOI 10.1017/S0007114507659030; Puel C, 2006, CLIN NUTR, V25, P859, DOI 10.1016/j.clnu.2006.03.009; Ranalli A, 1999, J AGR FOOD CHEM, V47, P417, DOI 10.1021/jf9800256; Rivas A, 2013, INT J FOOD SCI NUTR, V64, P155, DOI 10.3109/09637486.2012.718743; Saleh NK, 2011, BMC COMPLEM ALTERN M, V11, DOI 10.1186/1472-6882-11-10; Santiago-Mora R, 2011, OSTEOPOROSIS INT, V22, P675, DOI 10.1007/s00198-010-1270-x; Servili M, 2004, J CHROMATOGR A, V1054, P113, DOI 10.1016/S0021-9673(04)01423-2; Spilmont M, 2013, EUR J NUTR; Stark AH, 2002, NUTR REV, V60, P170, DOI 10.1301/002966402320243250; Strom O, 2011, Arch Osteoporos, V6, P59, DOI 10.1007/s11657-011-0060-1; Trichopoulou A, 1997, PREV MED, V26, P395, DOI 10.1006/pmed.1997.0160; van Driel M, 2006, J CELL BIOCHEM, V99, P922, DOI 10.1002/jcb.20875; Virruso C, 2013, REJUVENATION RES; Visioli F, 1998, BIOCHEM BIOPH RES CO, V247, P60, DOI 10.1006/bbrc.1998.8735; Wauquier F, 2009, TRENDS MOL MED, V15, P468, DOI 10.1016/j.molmed.2009.08.004; WILLETT WC, 1995, AM J CLIN NUTR, V61, p1402S, DOI 10.1093/ajcn/61.6.1402S; WRONSKI TJ, 1988, CALCIFIED TISSUE INT, V43, P179, DOI 10.1007/BF02571317; Zhang XM, 2009, N-S ARCH PHARMACOL, V379, P581, DOI 10.1007/s00210-009-0399-7	67	20	20	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2014	9	12							e115817	10.1371/journal.pone.0115817	http://dx.doi.org/10.1371/journal.pone.0115817			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UC	25551374	Green Published, gold			2022-12-27	WOS:000347119100064
J	Trammell, SA; Zabetakis, D; Moore, M; Verbarg, J; Stenger, DA				Trammell, Scott A.; Zabetakis, Dan; Moore, Martin; Verbarg, Jasenka; Stenger, David A.			Square Wave Voltammetry of TNT at Gold Electrodes Modified with Self-Assembled Monolayers Containing Aromatic Structures	PLOS ONE			English	Article							BRIDGES; EXPLOSIVES; 2,4,6-TRINITROTOLUENE; REDUCTION; MOLECULES	Square wave voltammetry for the reduction of 2,4,6-trinitrotoluene (TNT) was measured in 100 mM potassium phosphate buffer (pH 8) at gold electrodes modified with self-assembled monolayers (SAMs) containing either an alkane thiol or aromatic ring thiol structures. At 15 Hz, the electrochemical sensitivity (mu A/ppm) was similar for all SAMs tested. However, at 60 Hz, the SAMs containing aromatic structures had a greater sensitivity than the alkane thiol SAM. In fact, the alkane thiol SAM had a decrease in sensitivity at the higher frequency. When comparing the electrochemical response between simulations and experimental data, a general trend was observed in which most of the SAMs had similar heterogeneous rate constants within experimental error for the reduction of TNT. This most likely describes a rate limiting step for the reduction of TNT. However, in the case of the alkane SAM at higher frequency, the decrease in sensitivity suggests that the rate limiting step in this case may be electron tunneling through the SAM. Our results show that SAMs containing aromatic rings increased the sensitivity for the reduction of TNT when higher frequencies were employed and at the same time suppressed the electrochemical reduction of dissolved oxygen.	[Trammell, Scott A.; Zabetakis, Dan; Moore, Martin; Verbarg, Jasenka; Stenger, David A.] Ctr Bio Mol Sci & Engn, Naval Res Lab, Washington, DC 20375 USA	United States Department of Defense; United States Navy; Naval Research Laboratory	Zabetakis, D (corresponding author), Ctr Bio Mol Sci & Engn, Naval Res Lab, Washington, DC 20375 USA.	daniel.zabetakis@nrl.navy.mil	Trammell, Scott A./ABB-7140-2020; moore, martin/K-4559-2017	Trammell, Scott A./0000-0002-7996-590X; moore, martin/0000-0002-4214-0920	Office of Naval Research	Office of Naval Research(Office of Naval Research)	This work was funded by the Office of Naval Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agui L, 2005, ANAL BIOANAL CHEM, V382, P381, DOI 10.1007/s00216-004-3017-z; Alkire R., 2009, CHEM MODIFIED ELECTR; Bard A. J., 2001, ELECTROCHEMICAL METH; Bozic RG, 2008, SENSOR ACTUAT B-CHEM, V133, P509, DOI 10.1016/j.snb.2008.03.017; Britz D., 2005, DIGITAL SIMULATIONS; Creager S, 1999, J AM CHEM SOC, V121, P1059, DOI 10.1021/ja983204c; de Boer B, 2003, LANGMUIR, V19, P4272, DOI 10.1021/la0341052; Dudek SP, 2001, J AM CHEM SOC, V123, P8033, DOI 10.1021/ja0043340; Finklea HO, 1996, ELECTROANAL CHEM, V19, P109; Galik M, 2011, ELECTROANAL, V23, P1193, DOI 10.1002/elan.201000754; Gryko DT, 2000, J ORG CHEM, V65, P7345, DOI 10.1021/jo000487u; Honeychurch KC, 2003, BIOSENS BIOELECTRON, V19, P305, DOI 10.1016/S0956-5663(03)00208-2; Kaifer A. E., 1999, SUPRAMOLECULAR ELECT; Mandler D, 2011, J SOLID STATE ELECTR, V15, P1535, DOI 10.1007/s10008-011-1493-6; PEARSON J, 1948, T FARADAY SOC, V44, P683, DOI 10.1039/tf9484400683; SABATANI E, 1993, LANGMUIR, V9, P2974, DOI 10.1021/la00035a040; Sachs SB, 1997, J AM CHEM SOC, V119, P10563, DOI 10.1021/ja972244y; Schmelling DC, 1996, ENVIRON SCI TECHNOL, V30, P2547, DOI 10.1021/es950896l; Sikes HD, 2001, SCIENCE, V291, P1519, DOI 10.1126/science.1055745; Stapleton JJ, 2003, LANGMUIR, V19, P8245, DOI 10.1021/la035172z; Tour JM, 2001, CHEM-EUR J, V7, P5118, DOI 10.1002/1521-3765(20011203)7:23<5118::AID-CHEM5118>3.0.CO;2-1; Trammell SA, 2008, ANAL CHEM, V80, P4627, DOI 10.1021/ac702263t; Trammell SA, 2007, LANGMUIR, V23, P942, DOI 10.1021/la061555w; Trammell SA, 2011, SENSOR ACTUAT B-CHEM, V155, P737, DOI 10.1016/j.snb.2011.01.039; Trammell SA, 2009, J ELECTROANAL CHEM, V632, P127, DOI 10.1016/j.jelechem.2009.04.007; Ulman A., 1991, INTRO ULTRATHIN ORGA; WALCZAK MM, 1991, LANGMUIR, V7, P2687, DOI 10.1021/la00059a048; Wang J, 1998, TALANTA, V46, P1405, DOI 10.1016/S0039-9140(98)00005-8; Wang J, 2003, ANAL CHIM ACTA, V485, P139, DOI 10.1016/S0003-2670(03)00419-7; Wang J, 2007, ELECTROANAL, V19, P415, DOI 10.1002/elan.200603748; ZUMAN P, 1990, J ELECTROANAL CHEM, V296, P589, DOI 10.1016/0022-0728(90)87275-O	31	3	3	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2014	9	12							e115966	10.1371/journal.pone.0115966	http://dx.doi.org/10.1371/journal.pone.0115966			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX6YH	25549081	Green Submitted, Green Published, gold			2022-12-27	WOS:000347063500044
J	Bogaerts, K; Rayen, L; Lavrysen, A; Van Diest, I; Janssens, T; Schruers, K; Van den Bergh, O				Bogaerts, Katleen; Rayen, Liselotte; Lavrysen, Ann; Van Diest, Ilse; Janssens, Thomas; Schruers, Koen; Van den Bergh, Omer			Unraveling the Relationship between Trait Negative Affectivity and Habitual Symptom Reporting	PLOS ONE			English	Article							MEDICALLY UNEXPLAINED SYMPTOMS; SUBJECTIVE HEALTH COMPLAINTS; HYPNOTIC RESPONSIVENESS; PSYCHOSOMATIC SYMPTOMS; SOMATIC COMPLAINTS; ABSORPTION; FIBROMYALGIA; HYPNOTIZABILITY; SUSCEPTIBILITY; SOMATIZATION	Objective In two studies, we aimed at further elucidating the relationship between trait negative affectivity (NA) and habitual symptom reporting (HSR) by relating these variables to measures of executive function, trait questionnaires, and effects of emotion induction. Methods Healthy female participants (N = 75) were selected on their scores for trait NA and for the Checklist for Symptoms in Daily Life. Three groups were compared: (1) low NA-low HSR; (2) high NA-low HSR; and (3) high NA-high HSR (low NA-high HSR did not occur). In study 1, participants underwent a Parametric Go/No-go Task and a Stroop Color-Word test, and trait questionnaires measured alexithymia and absorption. Forty-five participants (N = 15 in each group) were further engaged in study 2 to induce state NA using an affective picture paradigm. Results Impaired inhibition on the Stroop and Go/No go Task characterized high trait NA, but not high HSR, whereas alexithymia and absorption were elevated in HSR, regardless of trait NA. Negative picture viewing induced elevated state NA in all groups, but only high HSR also reported more bodily symptoms. This effect was moderated, but not mediated by state NA. Conclusion High trait NA is a vulnerability factor but not a sufficient condition to develop HSR. Deficient inhibition is related to the broad trait of NA, whereas the moderating effect of state NA on symptom reporting is specific for high HSR. Understanding processes related to alexithymia and absorption may specifically help to explain elevated HSR.	[Bogaerts, Katleen; Rayen, Liselotte; Van Diest, Ilse; Janssens, Thomas; Van den Bergh, Omer] Univ Leuven, Leuven, Belgium; [Lavrysen, Ann] Univ Leuven, Movement Control & Neuroplast Res Grp, Leuven, Belgium; [Schruers, Koen] Maastricht Univ, Sch Mental Hlth & Neurosci, Maastricht, Netherlands	KU Leuven; KU Leuven; Maastricht University	Van den Bergh, O (corresponding author), Univ Leuven, Leuven, Belgium.	omer.vandenbergh@ppw.kuleuven.be	Janssens, Thomas/D-2077-2011; Schruers, Koen/AAV-2922-2021	Janssens, Thomas/0000-0003-3140-9952; Schruers, Koen/0000-0003-0134-406X; Van den Bergh, Omer/0000-0001-6394-7363; Lavrysen, Ann/0000-0002-6852-2230; Bogaerts, Katleen/0000-0002-0247-0941; Van Diest, Ilse/0000-0002-0048-774X	Research Council of the University of Leuven	Research Council of the University of Leuven(KU Leuven)	The authors (OVDB, KD, and IVD) received funding from the Research Council of the University of Leuven (http://www.kuleuven.be/wieiswie/en/unit/50000079). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bachner-Melman R, 2005, PLOS GENET, V1, P394, DOI 10.1371/journal.pgen.0010042; Barsky AJ, 1998, PSYCHOSOM MED, V60, P604, DOI 10.1097/00006842-199809000-00016; Bogaerts K, 2005, J PSYCHOSOM RES, V58, P537, DOI 10.1016/j.jpsychores.2004.12.005; Bogaerts K, 2008, J PSYCHOSOM RES, V65, P417, DOI 10.1016/j.jpsychores.2008.03.019; Bogaerts K, 2010, PSYCHOL HEALTH, V25, P685, DOI 10.1080/08870440902814639; Bogaerts K, 2010, J ABNORM PSYCHOL, V119, P226, DOI 10.1037/a0017780; Brown R. J., 2004, HIGHLY HYPNOTIZABLE, P152; Brown RJ, 2004, PSYCHOL BULL, V130, P793, DOI 10.1037/0033-2909.130.5.793; Cohen S, 2003, PSYCHOSOM MED, V65, P652, DOI 10.1097/01.PSY.0000077508.57784.DA; COMBS AL, 1988, PERCEPT MOTOR SKILL, V67, P453, DOI 10.2466/pms.1988.67.2.453; Constantinou E, 2013, J PSYCHOSOM RES, V74, P191, DOI 10.1016/j.jpsychores.2012.12.015; Correa A, 2011, BRAIN COGNITION, V75, P211, DOI 10.1016/j.bandc.2010.11.005; COSTA PT, 1987, J PERS, V55, P299, DOI 10.1111/j.1467-6494.1987.tb00438.x; CRAWFORD HJ, 1982, J PERS SOC PSYCHOL, V42, P915, DOI 10.1037/0022-3514.42.5.915; De Gucht V, 2003, J PSYCHOSOM RES, V54, P425, DOI 10.1016/S0022-3999(02)00467-1; Everitt B. S., 2006, HDB STAT ANAL USING; Glass JM, 2011, J PAIN, V12, P1219, DOI 10.1016/j.jpain.2011.06.007; GLISKY ML, 1991, J PERS SOC PSYCHOL, V60, P263, DOI 10.1037/0022-3514.60.2.263; Green JP, 2011, INT J CLIN EXP HYP, V59, P103, DOI 10.1080/00207144.2011.522914; Han JN, 2000, J PSYCHOSOM RES, V49, P319, DOI 10.1016/S0022-3999(00)00165-3; HERMANS D, 2005, AFFECT VERSION 4 0 C; HILGARD ER, 1981, INT J CLIN EXP HYP, V29, P66, DOI 10.1080/00207148108409144; Ihlebaek C, 2002, SCAND J PUBLIC HEALT, V30, P20, DOI 10.1080/140349401753481547; Ito LM, 2001, BRIT J PSYCHIAT, V178, P331, DOI 10.1192/bjp.178.4.331; Kirmayer L. J., 1997, ADULT PSYCHOPATHOLOG, P333; Krull JL, 2001, MULTIVAR BEHAV RES, V36, P249, DOI 10.1207/S15327906MBR3602_06; Lang P. J., 1999, INT AFFECTIVE PICTUR; Langenecker SA, 2007, J CLIN EXP NEUROPSYC, V29, P842, DOI 10.1080/13803390601147611; Leavitt F, 2008, JCR-J CLIN RHEUMATOL, V14, P214, DOI 10.1097/RHU.0b013e31817a2472; Lezak M.D., 1995, NEUROPSYCHOLOGICAL A; Mayer EA, 2006, GASTROENTEROLOGY, V131, P1925, DOI 10.1053/j.gastro.2006.10.026; Mikels JA, 2005, BEHAV RES METHODS, V37, P626, DOI 10.3758/BF03192732; Miyake A, 2000, COGNITIVE PSYCHOL, V41, P49, DOI 10.1006/cogp.1999.0734; Montoya P, 2005, PSYCHOSOM MED, V67, P957, DOI 10.1097/01.psy.0000188401.55394.18; Mora PA, 2007, ANN BEHAV MED, V34, P77, DOI 10.1007/BF02879923; Nemiah JC, 1976, MODERN TRENDS PSYCHO, V3; Nimnuan C, 2001, J PSYCHOSOM RES, V51, P361, DOI 10.1016/S0022-3999(01)00223-9; Reid S, 2001, BRIT MED J, V322, P767, DOI 10.1136/bmj.322.7289.767; RHODES LA, 1988, PERCEPT MOTOR SKILL, V66, P737, DOI 10.2466/pms.1988.66.3.737; Rief W, 2007, CLIN PSYCHOL REV, V27, P821, DOI 10.1016/j.cpr.2007.07.005; SHIPKO S, 1982, PSYCHOTHER PSYCHOSOM, V37, P193, DOI 10.1159/000287573; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; Taylor G.J., 1997, DISORDERS AFFECT REG; TELLEGEN A, 1974, J ABNORM PSYCHOL, V83, P268, DOI 10.1037/h0036681; Tellegen A., 1982, CONTENT CATEGO UNPUB; Van den Bergh O, 2002, SCAND J PSYCHOL, V43, P147, DOI 10.1111/1467-9450.00280; Van den Bergh O, 1998, HEALTH PSYCHOL, V17, P241, DOI 10.1037/0278-6133.17.3.241; Van Den Bergh O., 2006, GEDRAG GEZONDHEID TI, V34, P89, DOI [10.1007/BF03087979, DOI 10.1007/BF03087979]; Van Diest I, 2005, SOC SCI MED, V61, P1835, DOI 10.1016/j.socscimed.2005.03.031; VandenBergh O, 1997, PSYCHOSOM MED, V59, P13, DOI 10.1097/00006842-199701000-00003; VASSEND O, 1989, SOC SCI MED, V28, P29, DOI 10.1016/0277-9536(89)90303-1; WATSON D, 1988, J PERS SOC PSYCHOL, V54, P1063, DOI 10.1037/0022-3514.54.6.1063; WATSON D, 1989, PSYCHOL REV, V96, P234, DOI 10.1037/0033-295X.96.2.234; WATSON D, 1984, PSYCHOL BULL, V96, P465, DOI 10.1037/0033-2909.96.3.465; Weissman-Fogel I, 2011, PAIN, V152, P384, DOI 10.1016/j.pain.2010.10.046; WIENTJES CJE, 1994, PSYCHOSOM MED, V56, P533, DOI 10.1097/00006842-199411000-00009; Witthoft M, 2008, J TOXICOL ENV HEAL A, V71, P795, DOI 10.1080/15287390801985687; WMA - Wold-Medical-Association. Declaration of Helsinki, 2008, ETH PRINC MED RES IN	58	17	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2015	10	1							e0115748	10.1371/journal.pone.0115748	http://dx.doi.org/10.1371/journal.pone.0115748			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AZ4OZ	25603317	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000348203500016
J	Chen, YL; de Bernardis, F; Yu, SJ; Sandini, S; Kauffman, S; Tams, RN; Bethea, E; Reynolds, TB				Chen, Ying-Lien; de Bernardis, Flavia; Yu, Shang-Jie; Sandini, Silvia; Kauffman, Sarah; Tams, Robert N.; Bethea, Emily; Reynolds, Todd B.			Candida albicans OPI1 Regulates Filamentous Growth and Virulence in Vaginal Infections, but Not Inositol Biosynthesis	PLOS ONE			English	Article							YEAST SACCHAROMYCES-CEREVISIAE; SECRETED ASPARTYL PROTEINASES; PHOSPHOLIPID BIOSYNTHESIS; TRANSCRIPTIONAL ACTIVATION; NEGATIVE REGULATOR; GENE FAMILY; EXPRESSION; SAP2; TRANSFORMATION; PATHOGENICITY	ScOpi1p is a well-characterized transcriptional repressor and master regulator of inositol and phospholipid biosynthetic genes in the baker's yeast Saccharomyces cerevisiae. An ortholog has been shown to perform a similar function in the pathogenic fungus Candida glabrata, but with the distinction that CgOpi1p is essential for growth in this organism. However, in the more distantly related yeast Yarrowia lipolytica, the OPI1 homolog was not found to regulate inositol biosynthesis, but alkane oxidation. In Candida albicans, the most common cause of human candidiasis, its Opi1p homolog, CaOpi1p, has been shown to complement a S. cerevisiae opi1. mutant for inositol biosynthesis regulation when heterologously expressed, suggesting it might serve a similar role in this pathogen. This was tested in the pathogen directly in this report by disrupting the OPI1 homolog and examining its phenotypes. It was discovered that the OPI1 homolog does not regulate INO1 expression in C. albicans, but it does control SAP2 expression in response to bovine serum albumin containing media. Meanwhile, we found that CaOpi1 represses filamentous growth at lower temperatures (30 degrees C) on agar, but not in liquid media. Although, the mutant does not affect virulence in a mouse model of systemic infection, it does affect virulence in a rat model of vaginitis. This may be because Opi1p regulates expression of the SAP2 protease, which is required for rat vaginal infections.	[Chen, Ying-Lien; Yu, Shang-Jie] Natl Taiwan Univ, Dept Plant Pathol & Microbiol, Taipei 10764, Taiwan; [de Bernardis, Flavia; Sandini, Silvia] Dept Infect Parasit & Immunomediated Dis, Rome, Italy; [Kauffman, Sarah; Tams, Robert N.; Bethea, Emily; Reynolds, Todd B.] Univ Tennessee, Dept Microbiol, Knoxville, TN 37996 USA	National Taiwan University; University of Tennessee System; University of Tennessee Knoxville	Bethea, E (corresponding author), Brandon High Sch Hlth Sci, Brandon, MS 39042 USA.	ychen28@ntu.edu.tw; treynol6@utk.edu	DE BERNARDIS, FLAVIA/C-9589-2016; SANDINI, SILVIA/C-9593-2016; SANDINI, SILVIA/ABA-7711-2021	DE BERNARDIS, FLAVIA/0000-0001-9440-8629; SANDINI, SILVIA/0000-0002-1289-9098; SANDINI, SILVIA/0000-0002-1289-9098; Reynolds, Todd/0000-0002-2867-7182; Chen, Ying-Lien/0000-0002-1966-470X	NSC [102-2320-B-002-041-MY2]; AHA [0765366B, NIH-1R03AI071863, NIH-1 R01AL105690]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI105690, R03AI071863] Funding Source: NIH RePORTER	NSC(Ministry of Science and Technology, Taiwan); AHA(American Heart Association); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by grants NSC 102-2320-B-002-041-MY2 (YLC) and AHA 0765366B, NIH-1R03AI071863, NIH-1 R01AL105690 (TBR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht A, 2006, J BIOL CHEM, V281, P688, DOI 10.1074/jbc.M509297200; Bethea EK, 2010, MICROBIOL-SGM, V156, P452, DOI 10.1099/mic.0.030072-0; Calderone R.A.C.C.J., 2012, CANDIDA CANDIDIASIS; Chen M, 2007, BBA-MOL CELL BIOL L, V1771, P310, DOI 10.1016/j.bbalip.2006.05.017; Chen YC, 2002, MICROBIOL-SGM, V148, P3743, DOI 10.1099/00221287-148-11-3743; Chen YL, 2008, INFECT IMMUN, V76, P2793, DOI 10.1128/IAI.01514-07; Chen YL, 2010, MOL MICROBIOL, V75, P1112, DOI 10.1111/j.1365-2958.2009.07018.x; Csank C, 1997, MOL BIOL CELL, V8, P2539, DOI 10.1091/mbc.8.12.2539; Dabas N, 2008, MOL MICROBIOL, V69, P586, DOI 10.1111/j.1365-2958.2008.06297.x; De Backer MD, 1999, YEAST, V15, P1609, DOI 10.1002/(SICI)1097-0061(199911)15:15&lt;1609::AID-YEA485&gt;3.0.CO;2-Y; De Bernardis F, 1999, J INFECT DIS, V179, P201, DOI 10.1086/314546; De Bernardis F, 2001, MED MYCOL, V39, P303, DOI 10.1080/mmy.39.4.303.313; DEBERNARDIS F, 1995, INFECT IMMUN, V63, P1887, DOI 10.1128/IAI.63.5.1887-1892.1995; DONAHUE TF, 1981, J BIOL CHEM, V256, P7077; Felk A, 2002, INFECT IMMUN, V70, P3689, DOI 10.1128/IAI.70.7.3689-3700.2002; FISCHL AS, 1983, J BACTERIOL, V154, P304, DOI 10.1128/JB.154.1.304-311.1983; Guhad FA, 1998, APMIS, V106, P1049, DOI 10.1111/j.1699-0463.1998.tb00257.x; Heitman J, 2006, MOLECULAR PRINCIPLES OF FUNGAL PATHOGENESIS, P1; Henry SA, 2012, GENETICS, V190, P317, DOI 10.1534/genetics.111.130286; Heyken WT, 2003, YEAST, V20, P1177, DOI 10.1002/yea.1031; Hirakawa K, 2009, J BIOL CHEM, V284, P7126, DOI 10.1074/jbc.M806864200; HOFFMAN CS, 1987, GENE, V57, P267, DOI 10.1016/0378-1119(87)90131-4; Hoppen J, 2007, MOL GENET GENOMICS, V278, P317, DOI 10.1007/s00438-007-0253-x; Hube B, 1997, INFECT IMMUN, V65, P3529, DOI 10.1128/IAI.65.9.3529-3538.1997; KLIG LS, 1985, J BACTERIOL, V162, P1135, DOI 10.1128/JB.162.3.1135-1141.1985; KLIG LS, 1988, CURR GENET, V13, P7, DOI 10.1007/BF00365749; Kohrer K., 1991, METHOD ENZYMOL, V194, P398, DOI DOI 10.1016/0076-6879(91)94030-G; Lermann U, 2008, MICROBIOL-SGM, V154, P3281, DOI 10.1099/mic.0.2008/022525-0; Loewen CJR, 2004, SCIENCE, V304, P1644, DOI 10.1126/science.1096083; Loewen CJR, 2003, EMBO J, V22, P2025, DOI 10.1093/emboj/cdg201; Martchenko M, 2007, EUKARYOT CELL, V6, P291, DOI 10.1128/EC.00183-06; Martinez P, 2005, MOL CELL BIOL, V25, P9435, DOI 10.1128/MCB.25.21.9435-9446.2005; Murad AMA, 2001, EMBO J, V20, P4742, DOI 10.1093/emboj/20.17.4742; Murray M, 2000, MOL MICROBIOL, V36, P651, DOI 10.1046/j.1365-2958.2000.01886.x; Naglik JR, 2003, MICROBIOL MOL BIOL R, V67, P400, DOI 10.1128/MMBR.67.3.400-428.2003; Naglik JR, 2008, MICROBIOL-SGM, V154, P3266, DOI 10.1099/mic.0.2008/022293-0; Reynolds TB, 2006, EUKARYOT CELL, V5, P1266, DOI 10.1128/EC.00022-06; Schaller M, 2003, INFECT IMMUN, V71, P3227, DOI 10.1128/IAI.71.6.3227-3234.2003; Schroppel K, 2000, INFECT IMMUN, V68, P7159, DOI 10.1128/IAI.68.12.7159-7161.2000; Shen JQ, 2005, INFECT IMMUN, V73, P1239, DOI 10.1128/IAI.73.2.1239-1242.2005; SHEPHERD MG, 1985, INFECT IMMUN, V50, P541, DOI 10.1128/IAI.50.2.541-544.1985; Staib P, 2008, ANTIMICROB AGENTS CH, V52, P146, DOI 10.1128/AAC.01072-07; Styles C, 2002, METHOD ENZYMOL, V350, P42, DOI 10.1016/S0076-6879(02)50955-1; Uhl MA, 2001, MICROBIOL-SGM, V147, P1189, DOI 10.1099/00221287-147-5-1189; Wagner C, 1999, YEAST, V15, P843, DOI 10.1002/(SICI)1097-0061(199907)15:10A<843::AID-YEA424>3.0.CO;2-M; Wagner C, 2001, MOL MICROBIOL, V41, P155, DOI 10.1046/j.1365-2958.2001.02495.x; WHITE MJ, 1991, J BIOL CHEM, V266, P863	47	4	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2015	10	1							e0116974	10.1371/journal.pone.0116974	http://dx.doi.org/10.1371/journal.pone.0116974			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ4OZ	25602740	Green Submitted, gold, Green Published			2022-12-27	WOS:000348203500038
J	Tewawong, N; Suwannakarn, K; Prachayangprecha, S; Korkong, S; Vichiwattana, P; Vongpunsawad, S; Poovorawan, Y				Tewawong, Nipaporn; Suwannakarn, Kamol; Prachayangprecha, Slinporn; Korkong, Sumeth; Vichiwattana, Preeyaporn; Vongpunsawad, Sompong; Poovorawan, Yong			Molecular Epidemiology and Phylogenetic Analyses of Influenza B Virus in Thailand during 2010 to 2014	PLOS ONE			English	Article							COCIRCULATING LINEAGES; STRUCTURAL BASIS; HEMAGGLUTININ; EVOLUTION; REASSORTMENT; RESISTANCE; DELETION; GENES	Influenza B virus remains a major contributor to the seasonal influenza outbreak and its prevalence has increased worldwide. We investigated the epidemiology and analyzed the full genome sequences of influenza B virus strains in Thailand between 2010 and 2014. Samples from the upper respiratory tract were collected from patients diagnosed with influenza like-illness. All samples were screened for influenza A/B viruses by one-step multiplex real-time RT-PCR. The whole genome of 53 influenza B isolates were amplified, sequenced, and analyzed. From 14,418 respiratory samples collected during 2010 to 2014, a total of 3,050 tested positive for influenza virus. Approximately 3.27% (471/14,418) were influenza B virus samples. Fifty three isolates of influenza B virus were randomly chosen for detailed whole genome analysis. Phylogenetic analysis of the HA gene showed clusters in Victoria clades 1A, 1B, 3, 5 and Yamagata clades 2 and 3. Both B/Victoria and B/Yamagata lineages were found to co-circulate during this time. The NA sequences of all isolates belonged to lineage II and consisted of viruses from both HA Victoria and Yamagata lineages, reflecting possible reassortment of the HA and NA genes. No significant changes were seen in the NA protein. The phylogenetic trees generated through the analysis of the PB1 and PB2 genes closely resembled that of the HA gene, while trees generated from the analysis of the PA, NP, and M genes showed similar topology. The NS gene exhibited the pattern of genetic reassortment distinct from those of the PA, NP or M genes. Thus, antigenic drift and genetic reassortment among the influenza B virus strains were observed in the isolates examined. Our findings indicate that the co-circulation of two distinct lineages of influenza B viruses and the limitation of cross-protection of the current vaccine formulation provide support for quadrivalent influenza vaccine in this region.	[Tewawong, Nipaporn; Suwannakarn, Kamol; Prachayangprecha, Slinporn; Korkong, Sumeth; Vichiwattana, Preeyaporn; Vongpunsawad, Sompong; Poovorawan, Yong] Chulalongkorn Univ, Fac Med, Ctr Excellence Clin Virol, Bangkok 10330, Thailand	Chulalongkorn University	Poovorawan, Y (corresponding author), Chulalongkorn Univ, Fac Med, Ctr Excellence Clin Virol, Bangkok 10330, Thailand.	Yong.P@chula.ac.th	ภู่วรวรรณ, ศนพ.ยง/GZK-8615-2022	Tewawong, Nipaporn/0000-0003-1098-3701; vongpunsawad, sompong/0000-0001-7520-8728; Poovorawan, Yong/0000-0002-2337-6807	National Research University Project, Office of Higher Education Commission [HA1155A]; Research Chair Grant from NSTDA; Chulalongkorn University Centenary Academic Development Project [CU56-HR01]; Ratchadaphiseksomphot Endowment Fund of Chulalongkorn University [RES560530093]; Outstanding Professor of the Thailand Research Fund [DPG5480002]; MK Restaurant Company Limited [WCU007-HR-57, WCU001-HR-57]; 100th anniversary Chulalongkorn University Fund for doctoral scholarship; Rachadapisek Sompote Fund for postdoctoral fellowship; Chulalongkorn University	National Research University Project, Office of Higher Education Commission; Research Chair Grant from NSTDA; Chulalongkorn University Centenary Academic Development Project; Ratchadaphiseksomphot Endowment Fund of Chulalongkorn University(Chulalongkorn University); Outstanding Professor of the Thailand Research Fund; MK Restaurant Company Limited; 100th anniversary Chulalongkorn University Fund for doctoral scholarship; Rachadapisek Sompote Fund for postdoctoral fellowship; Chulalongkorn University(Chulalongkorn University)	This work was supported by grant HA1155A from the National Research University Project, Office of Higher Education Commission, the Research Chair Grant from NSTDA, CU56-HR01 from Chulalongkorn University Centenary Academic Development Project, RES560530093 from the Ratchadaphiseksomphot Endowment Fund of Chulalongkorn University, DPG5480002 from the Outstanding Professor of the Thailand Research Fund, and WCU007-HR-57 and WCU001-HR-57 from MK Restaurant Company Limited. The authors thank the 100th anniversary Chulalongkorn University Fund for doctoral scholarship awarded to Nipaporn Tewawong. This research is also supported by Rachadapisek Sompote Fund for postdoctoral fellowship, Chulalongkorn University, to Sompong Vongpunsawad. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors received funding from a commercial source, MK Restaurant Company Limited. However, this does not alter the authors' adherence to PLOS ONE policies on sharing data and materials.	Alonso WJ, 2007, AM J EPIDEMIOL, V165, P1434, DOI 10.1093/aje/kwm012; Ambrose CS, 2012, HUM VACC IMMUNOTHER, V8, P81, DOI 10.4161/hv.8.1.17623; [Anonymous], 2014, Wkly Epidemiol Rec, V89, P245; Barr IG, 2010, VACCINE, V28, P1156, DOI 10.1016/j.vaccine.2009.11.043; Beran J, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-2; Burnham AJ, 2014, ANTIMICROB AGENTS CH, V58, P2718, DOI 10.1128/AAC.02628-13; Byarugaba DK, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-11; Chan PKS, 2009, J MED VIROL, V81, P1797, DOI 10.1002/jmv.21551; Chen RB, 2008, J MOL EVOL, V66, P655, DOI 10.1007/s00239-008-9119-z; CHIEOCHANSIN TMJ, 2009, ASIAN BIOMED, V3, P7; Chittaganpitch M, 2012, INFLUENZA OTHER RESP, V6, P276, DOI 10.1111/j.1750-2659.2011.00302.x; COLMAN PM, 1983, NATURE, V303, P41, DOI 10.1038/303041a0; Cox NJ, 1995, SEMIN VIROL, V6, P359, DOI 10.1016/S1044-5773(05)80013-7; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Dowell SF, 2001, EMERG INFECT DIS, V7, P369; Dreyfus C, 2012, SCIENCE, V337, P1343, DOI 10.1126/science.1222908; Gutierrez-Pizarraya A, 2012, J INFECTION, V65, P423, DOI 10.1016/j.jinf.2012.07.004; Heikkinen T, 2014, CLIN INFECT DIS, V59, P1519, DOI 10.1093/cid/ciu664; HEMMES JH, 1960, NATURE, V188, P430, DOI 10.1038/188430a0; Hiromoto Y, 2000, J GEN VIROL, V81, P929, DOI 10.1099/0022-1317-81-4-929; Hoffmann E, 2001, ARCH VIROL, V146, P2275, DOI 10.1007/s007050170002; KANEGAE Y, 1990, J VIROL, V64, P2860, DOI 10.1128/JVI.64.6.2860-2865.1990; Kimura Y, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-36; KRYSTAL M, 1982, P NATL ACAD SCI-BIOL, V79, P4800, DOI 10.1073/pnas.79.15.4800; KRYSTAL M, 1983, P NATL ACAD SCI-BIOL, V80, P4527, DOI 10.1073/pnas.80.14.4527; Lindstrom SE, 1999, J VIROL, V73, P4413, DOI 10.1128/JVI.73.5.4413-4426.1999; Lowen AC, 2007, PLOS PATHOG, V3, P1470, DOI 10.1371/journal.ppat.0030151; MANISAN V, 1995, TECHNICAL DOCUMENT O; McCullers JA, 1999, J VIROL, V73, P7343, DOI 10.1128/JVI.73.9.7343-7348.1999; McCullers JA, 2004, J VIROL, V78, P12817, DOI 10.1128/JVI.78.23.12817-12828.2004; Nerome R, 1998, ARCH VIROL, V143, P1569, DOI 10.1007/s007050050399; Ni FY, 2013, VIROLOGY, V446, P112, DOI 10.1016/j.virol.2013.07.035; Oakley AJ, 2010, J MED CHEM, V53, P6421, DOI 10.1021/jm100621s; Osterhaus ADME, 2000, SCIENCE, V288, P1051, DOI 10.1126/science.288.5468.1051; ROTA PA, 1990, VIROLOGY, V175, P59, DOI 10.1016/0042-6822(90)90186-U; SULLIVAN KM, 1993, AM J PUBLIC HEALTH, V83, P1712, DOI 10.2105/AJPH.83.12.1712; Suwannakarn K, 2008, J VIROL METHODS, V152, P25, DOI 10.1016/j.jviromet.2008.06.002; Virk RK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088345; Wang QH, 2008, J VIROL, V82, P3011, DOI 10.1128/JVI.02477-07; Wang QH, 2007, P NATL ACAD SCI USA, V104, P16874, DOI 10.1073/pnas.0708363104; Yang JR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047179; Yen HL, 2006, J VIROL, V80, P8787, DOI 10.1128/JVI.00477-06; Yen HL, 2009, CURR TOP MICROBIOL, V333, P3, DOI 10.1007/978-3-540-92165-3_1	43	37	40	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2015	10	1							e0116302	10.1371/journal.pone.0116302	http://dx.doi.org/10.1371/journal.pone.0116302			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ4OZ	25602617	Green Published, gold, Green Submitted			2022-12-27	WOS:000348203500021
J	Nakazawa, H; Yamada, M; Tanaka, T; Kramer, J; Yu, YM; Fischman, AJ; Martyn, JAJ; Tompkins, RG; Kaneki, M				Nakazawa, Harumasa; Yamada, Marina; Tanaka, Tomokazu; Kramer, Joshua; Yu, Yong-Ming; Fischman, Alan J.; Martyn, J. A. Jeevendra; Tompkins, Ronald G.; Kaneki, Masao			Role of Protein Farnesylation in Burn-Induced Metabolic Derangements and Insulin Resistance in Mouse Skeletal Muscle	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; ENDOPLASMIC-RETICULUM STRESS; CRITICALLY-ILL PATIENTS; FARNESYLTRANSFERASE INHIBITOR; GLUCOSE-TOLERANCE; POTENTIAL ROLE; BASE DEFICIT; KINASE B; MICE; LACTATE	Objective Metabolic derangements, including insulin resistance and hyperlactatemia, are a major complication of major trauma (e.g., burn injury) and affect the prognosis of burn patients. Protein farnesylation, a posttranslational lipid modification of cysteine residues, has been emerging as a potential component of inflammatory response in sepsis. However, farnesylation has not yet been studied in major trauma. To study a role of farnesylation in burn-induced metabolic aberration, we examined the effects of farnesyltransferase (FTase) inhibitor, FTI-277, on burn-induced insulin resistance and metabolic alterations in mouse skeletal muscle. Methods A full thickness burn (30% total body surface area) was produced under anesthesia in male C57BL/6 mice at 8 weeks of age. After the mice were treated with FTI-277 (5 mg/kg/day, IP) or vehicle for 3 days, muscle insulin signaling, metabolic alterations and inflammatory gene expression were evaluated. Results Burn increased FTase expression and farnesylated proteins in mouse muscle compared with sham-burn at 3 days after burn. Simultaneously, insulin-stimulated phosphorylation of insulin receptor (IR), insulin receptor substrate (IRS)-1, Akt and GSK-3 beta was decreased. Protein expression of PTP-1B (a negative regulator of IR-IRS-1 signaling), PTEN (a negative regulator of Akt-mediated signaling), protein degradation and lactate release by muscle, and plasma lactate levels were increased by burn. Burn-induced impaired insulin signaling and metabolic dysfunction were associated with increased inflammatory gene expression. These burn-induced alterations were reversed or ameliorated by FTI-277. Conclusions Our data demonstrate that burn increased FTase expression and protein farnesylation along with insulin resistance, metabolic alterations and inflammatory response in mouse skeletal muscle, all of which were prevented by FTI-277 treatment. These results indicate that increased protein farnesylation plays a pivotal role in burn-induced metabolic dysfunction and inflammatory response. Our study identifies FTase as a novel potential molecular target to reverse or ameliorate metabolic derangements in burn patients.	[Nakazawa, Harumasa; Yamada, Marina; Tanaka, Tomokazu; Martyn, J. A. Jeevendra; Kaneki, Masao] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Anesthesia Crit Care & Pain Med, Charlestown, MA 02129 USA; [Yamada, Marina; Yu, Yong-Ming; Fischman, Alan J.; Martyn, J. A. Jeevendra; Kaneki, Masao] Shriners Hosp Children, Boston, MA USA; [Kramer, Joshua] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Yu, Yong-Ming; Tompkins, Ronald G.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Surg, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital	Kaneki, M (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Anesthesia Crit Care & Pain Med, Charlestown, MA 02129 USA.	mkaneki@helix.mgh.harvard.edu		Nakazawa, Harumasa/0000-0002-3258-9310	Shriners Hospitals for Children [71000, 85800, 84203]; National Institutes of Health(NIGMS) [P50GM02700]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM021700] Funding Source: NIH RePORTER	Shriners Hospitals for Children; National Institutes of Health(NIGMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by a research grant to MK (71000, 85800) and a fellowship to MY (84203) from Shriners Hospitals for Children, and to RGT (P50GM02700) from National Institutes of Health(NIGMS). The funders had no role in study design, date collection and analysis, decision to publish, or preparation of the manuscript.	Andel D, 2007, BURNS, V33, P973, DOI 10.1016/j.burns.2007.06.016; Beffa DC, 2011, BURNS, V37, P222, DOI 10.1016/j.burns.2010.10.010; Birle D, 2002, J IMMUNOL, V169, P286, DOI 10.4049/jimmunol.169.1.286; Bonab AA, 2010, INT J MOL MED, V26, P311, DOI 10.3892/ijmm_00000467; Bruning JC, 1998, MOL CELL, V2, P559, DOI 10.1016/S1097-2765(00)80155-0; Calisto KL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014232; Callahan Leigh Ann, 2009, Crit Care Med, V37, pS354, DOI 10.1097/CCM.0b013e3181b6e439; Cree MG, 2008, AM J PHYSIOL-ENDOC M, V294, pE1, DOI 10.1152/ajpendo.00562.2007; Crossland H, 2008, J PHYSIOL-LONDON, V586, P5589, DOI 10.1113/jphysiol.2008.160150; Dare AJ, 2009, FREE RADICAL BIO MED, V47, P1517, DOI 10.1016/j.freeradbiomed.2009.08.019; DeFronzo RA, 2011, NEW ENGL J MED, V364, P1104, DOI 10.1056/NEJMoa1010949; Elchebly M, 1999, SCIENCE, V283, P1544, DOI 10.1126/science.283.5407.1544; Fogerty MD, 2010, J TRAUMA, V69, P99, DOI 10.1097/TA.0b013e3181df61b1; Gore DC, 2000, J TRAUMA, V49, P673, DOI 10.1097/00005373-200010000-00015; Gunst J, 2010, SEMIN DIALYSIS, V23, P157, DOI 10.1111/j.1525-139X.2010.00702.x; Hojlund K, 2006, CURR DIABETES REV, V2, P375, DOI 10.2174/1573399810602040375; Jeng JC, 2002, BURNS, V28, P161, DOI 10.1016/S0305-4179(01)00098-5; Jeschke MG, 2014, ANN SURG, V259, P814, DOI 10.1097/SLA.0b013e31828dfbf1; Jeschke MG, 2012, ANN SURG, V255, P370, DOI 10.1097/SLA.0b013e31823e76e7; Kamolz LP, 2005, BURNS, V31, P986, DOI 10.1016/j.burns.2005.06.019; Kaneki M, 2007, ANTIOXID REDOX SIGN, V9, P319, DOI 10.1089/ars.2006.1464; Kaneki M, 2013, METABOLISM, V62, P341, DOI 10.1016/j.metabol.2012.08.010; Kaneki M, 2009, CRIT CARE MED, V37, P2856, DOI 10.1097/CCM.0b013e3181aff7bb; Kido Y, 2000, J CLIN INVEST, V105, P199, DOI 10.1172/JCI7917; KREISBERG RA, 1972, NEW ENGL J MED, V287, P132, DOI 10.1056/NEJM197207202870307; Krinsley J, 2010, CRIT CARE, V14, DOI 10.1186/cc9275; Lantos J, 2010, SHOCK, V33, P562, DOI 10.1097/SHK.0b013e3181cd8c88; Lee HY, 2011, SHOCK, V36, P580, DOI 10.1097/SHK.0b013e3182366872; Li YQ, 2011, SURGERY, V150, P442, DOI 10.1016/j.surg.2011.07.003; Long YC, 2011, MOL CELL BIOL, V31, P430, DOI 10.1128/MCB.00983-10; LOVEJOY J, 1992, METABOLISM, V41, P22, DOI 10.1016/0026-0495(92)90185-D; Lu XM, 2013, INT J BURNS TRAUMA, V3, P37; Martyn JAJ, 2008, ANESTHESIOLOGY, V109, P137, DOI 10.1097/ALN.0b013e3181799d45; Nantais DE, 1996, J LEUKOCYTE BIOL, V60, P423, DOI 10.1002/jlb.60.3.423; PEDROSO FE, 2012, J CACHEXIA SARCOPENI; Riesenman PJ, 2007, J BURN CARE RES, V28, P342, DOI 10.1097/BCR.0B013E318031A1FE; Robinson K, 2011, BEST PRACT RES CL EN, V25, P835, DOI 10.1016/j.beem.2011.04.008; Schernthaner G, 2010, DIABETES OBES METAB, V12, P1023, DOI 10.1111/j.1463-1326.2010.01262.x; Sekiya M, 2009, CELL METAB, V10, P219, DOI 10.1016/j.cmet.2009.08.004; Shinozaki S, 2011, J BIOL CHEM, V286, P34959, DOI 10.1074/jbc.M110.187666; Shinozaki S, 2010, BIOCHEM BIOPH RES CO, V391, P1459, DOI 10.1016/j.bbrc.2009.12.094; Sinha R, 2002, DIABETES, V51, P1022, DOI 10.2337/diabetes.51.4.1022; Stein W, 2011, J HEART LUNG TRANSPL, V30, P761, DOI 10.1016/j.healun.2011.01.720; Sugita H, 2005, AM J PHYSIOL-ENDOC M, V288, pE585, DOI 10.1152/ajpendo.00321.2004; Sugita H, 2005, J BIOL CHEM, V280, P14203, DOI 10.1074/jbc.M411226200; Sugita M, 2007, ARTERIOSCL THROM VAS, V27, P1390, DOI 10.1161/ATVBAHA.107.140673; Sugita M, 2012, METABOLISM, V61, P127, DOI 10.1016/j.metabol.2011.06.001; Sun H, 1999, P NATL ACAD SCI USA, V96, P6199, DOI 10.1073/pnas.96.11.6199; Ueki K, 1998, J BIOL CHEM, V273, P5315, DOI 10.1074/jbc.273.9.5315; Van den Berghe G, 2001, NEW ENGL J MED, V345, P1359, DOI 10.1056/NEJMoa011300; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vazquez F, 2000, MOL CELL BIOL, V20, P5010, DOI 10.1128/MCB.20.14.5010-5018.2000; VESTAL DJ, 1995, J LEUKOCYTE BIOL, V58, P607, DOI 10.1002/jlb.58.5.607; Wang HC, 1999, SCIENCE, V285, P248, DOI 10.1126/science.285.5425.248; Wei W, 2005, AM J PHYSIOL-REG I, V288, pR580, DOI 10.1152/ajpregu.00341.2004; Xue XH, 2006, J PHARMACOL EXP THER, V317, P53, DOI 10.1124/jpet.105.095976; Yang W, 2011, J PHARMACOL EXP THER, V339, P832, DOI 10.1124/jpet.111.183558; Zhang LT, 2008, SHOCK, V30, P449, DOI 10.1097/SHK.0b013e3181672495	58	15	15	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2015	10	1							e0116633	10.1371/journal.pone.0116633	http://dx.doi.org/10.1371/journal.pone.0116633			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ4OS	25594415	Green Published, Green Submitted, gold			2022-12-27	WOS:000348202900004
J	Platt, WJ; Orzell, SL; Slocum, MG				Platt, William J.; Orzell, Steve L.; Slocum, Matthew G.			Seasonality of Fire Weather Strongly Influences Fire Regimes in South Florida Savanna-Grassland Landscapes	PLOS ONE			English	Article							EVERGLADES-NATIONAL-PARK; EAST-CENTRAL FLORIDA; LONGLEAF PINE; PRESCRIBED FIRE; INTERANNUAL VARIABILITY; VEGETATION FIRES; UNITED-STATES; LIFE-HISTORY; EL-NINO; CLIMATE	Fire seasonality, an important characteristic of fire regimes, commonly is delineated using seasons based on single weather variables (rainfall or temperature). We used nonparametric cluster analyses of a 17-year (1993-2009) data set of weather variables that influence likelihoods and spread of fires (relative humidity, air temperature, solar radiation, wind speed, soil moisture) to explore seasonality of fire in pine savanna-grassland landscapes at the Avon Park Air Force Range in southern Florida. A four-variable, three-season model explained more variation within fire weather variables than models with more seasons. The three-season model also delineated intra-annual timing of fire more accurately than a conventional rainfall-based two-season model. Two seasons coincided roughly with dry and wet seasons based on rainfall. The third season, which we labeled the fire season, occurred between dry and wet seasons and was characterized by fire-promoting conditions present annually: drought, intense solar radiation, low humidity, and warm air temperatures. Fine fuels consisting of variable combinations of pyrogenic pine needles, abundant C4 grasses, and flammable shrubs, coupled with low soil moisture, and lightning ignitions early in the fire season facilitate natural landscape-scale wildfires that burn uplands and across wetlands. We related our three season model to fires with different ignition sources (lightning, military missions, and prescribed fires) over a 13-year period with fire records (1997-2009). Largest wildfires originate from lightning and military ignitions that occur within the early fire season substantially prior to the peak of lightning strikes in the wet season. Prescribed ignitions, in contrast, largely occur outside the fire season. Our delineation of a pronounced fire season provides insight into the extent to which different human-derived fire regimes mimic lightning fire regimes. Delineation of a fire season associated with timing of natural lightning ignitions should be useful as a basis for ecological fire management of humid savanna-grassland landscapes worldwide.	[Platt, William J.; Slocum, Matthew G.] Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA 70803 USA; [Orzell, Steve L.] Avon Pk Air Force Range, Avon Pk, FL USA	Louisiana State University System; Louisiana State University	Platt, WJ (corresponding author), Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA 70803 USA.	btplat@lsu.edu			NSF [0950302]	NSF(National Science Foundation (NSF))	The Avon Park Air Force Range (Department of Defense, United States Air Force) provided funding for most of this study. Additional support for this study was provided through NSF Award 0950302 (WJP, PI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldersley A, 2011, SCI TOTAL ENVIRON, V409, P3472, DOI 10.1016/j.scitotenv.2011.05.032; Alsop TJ, 1989, J CLIMATE, V2, P888, DOI 10.1175/1520-0442(1989)002<0888:TNSOWO>2.0.CO;2; Andela N, 2014, NAT CLIM CHANGE, V4, P791, DOI [10.1038/NCLIMATE2313, 10.1038/nclimate2313]; [Anonymous], 1996, CLUSTERING VALIDATIO, DOI DOI 10.1142/9789812832153_0010; [Anonymous], 2009, JFSP SYNTHESIS REPOR; Archibald S, 2010, GLOBAL ECOL BIOGEOGR, V19, P794, DOI 10.1111/j.1466-8238.2010.00568.x; Archibald S, 2013, P NATL ACAD SCI USA, V110, P6442, DOI 10.1073/pnas.1211466110; Baiser B, 2008, ANIM CONSERV, V11, P190, DOI 10.1111/j.1469-1795.2008.00167.x; Beckage B, 2003, FRONT ECOL ENVIRON, V1, P235, DOI 10.2307/3868010; Beckage B, 2003, ECOLOGY, V84, P3124, DOI 10.1890/02-0183; Beckage B, 2009, AM NAT, V174, P805, DOI 10.1086/648458; Beerling DJ, 2006, GLOBAL CHANGE BIOL, V12, P2023, DOI 10.1111/j.1365-2486.2006.01239.x; Bond WJ, 2010, BIOL CONSERV, V143, P2395, DOI 10.1016/j.biocon.2009.12.012; Bond WJ, 2005, TRENDS ECOL EVOL, V20, P387, DOI 10.1016/j.tree.2005.04.025; Bowman DMJS, 2013, ANNU REV ENV RESOUR, V38, P57, DOI 10.1146/annurev-environ-082212-134049; Bowman DMJS, 2011, J BIOGEOGR, V38, P2223, DOI 10.1111/j.1365-2699.2011.02595.x; Bowman DMJS, 2009, SCIENCE, V324, P481, DOI 10.1126/science.1163886; BRADSHAW LS, 1984, INT169 INT FOR RANG; Bridges E.L., 2006, P FLOR DRY PRAIR C A, P14; Camberlin P, 2003, CLIMATE RES, V23, P159, DOI 10.3354/cr023159; Chen E., 1990, ECOSYSTEMS FLORIDA, P11; Chen Y, 2013, CARBON MANAG, V4, P617, DOI [10.4155/CMT.13.61, 10.4155/cmt.13.61]; Christian HJ, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD002347; Chuvieco E, 2008, GLOBAL CHANGE BIOL, V14, P1488, DOI 10.1111/j.1365-2486.2008.01585.x; Cooke WF, 1996, J GEOPHYS RES-ATMOS, V101, P21051, DOI 10.1029/96JD01835; Craighead F. C., 1971, TREES S FLORIDA, V1; Crandall RM, 2012, PLANT ECOL, V213, P1643, DOI 10.1007/s11258-012-0119-0; DEEMING JE, 1977, INT39 INT FOR RANG E; DIAB RD, 1991, INT J CLIMATOL, V11, P877, DOI 10.1002/joc.3370110806; DOREN RF, 1993, FOREST ECOL MANAG, V59, P295, DOI 10.1016/0378-1127(93)90009-C; Drewa PB, 2002, PLANT ECOL, V160, P61, DOI 10.1023/A:1015875828742; Drewa PB, 2002, ECOLOGY, V83, P755, DOI 10.1890/0012-9658(2002)083[0755:FEOROS]2.0.CO;2; Duncan BW, 2010, CAN J FOREST RES, V40, P286, DOI 10.1139/X09-193; Duncan BW, 2009, FOREST ECOL MANAG, V258, P132, DOI 10.1016/j.foreco.2009.03.053; Duncan BW, 1999, LANDSCAPE ECOL, V14, P291, DOI 10.1023/A:1008029831187; Edwards EJ, 2010, SCIENCE, V328, P587, DOI 10.1126/science.1177216; Everitt B. S, 2011, CLUSTER ANAL, DOI DOI 10.1002/9780470977811; Evett RR, 2008, AGR FOREST METEOROL, V148, P1478, DOI 10.1016/j.agrformet.2008.05.002; Fowler C, 2007, HUM ECOL REV, V14, P165; FREEMAN DL, 2004, LIGHTNING IGNITED WI; Gagnon PR, 2010, ECOLOGY, V91, P3481, DOI 10.1890/10-0291.1; Giglio L, 2006, J GEOPHYS RES-BIOGEO, V111, DOI 10.1029/2005JG000142; Gill AM, 2008, INT J WILDLAND FIRE, V17, P688, DOI 10.1071/WF07145; GLITZENSTEIN JS, 1995, ECOL MONOGR, V65, P441, DOI 10.2307/2963498; Goodrick SL, 2009, INT J WILDLAND FIRE, V18, P476, DOI 10.1071/WF07034; Hall BL, 2008, INT J WILDLAND FIRE, V17, P317, DOI 10.1071/WF06110; Hall BL, 2007, INT J WILDLAND FIRE, V16, P242, DOI 10.1071/WF06075; Hantson S, 2015, GLOBAL ECOL BIOGEOGR, V24, P77, DOI 10.1111/geb.12246; Hantson S, 2013, REMOTE SENS ENVIRON, V131, P152, DOI 10.1016/j.rse.2012.12.004; Hardy JW, 2003, PHYS GEOGR, V24, P120, DOI 10.2747/0272-3646.24.2.120; HARPER RM, 1927, 18 ANN REPORT FLORID; HARSHBERGER JW, 1914, WAGNER FREE I PHIL 3, V3, P51; Hawbaker TJ, 2013, ECOL APPL, V23, P565, DOI 10.1890/12-1816.1; HERNDON A, 1991, WETLANDS, V11, P17, DOI 10.1007/BF03160838; Hiers JK, 2000, OECOLOGIA, V125, P521, DOI 10.1007/s004420000469; HUBER O, 1987, TRENDS ECOL EVOL, V2, P67, DOI 10.1016/0169-5347(87)90151-0; Huffman J. M., 2006, HIST FIRE REGIMES SE; Huffman JM, 2004, NAT AREA J, V24, P258; HUTH R, 1993, INT J CLIMATOL, V13, P817, DOI 10.1002/joc.3370130802; Johnson S.D., 2006, FIRE ECOL, V2, P60; Keeley JE, 2005, ECOL LETT, V8, P683, DOI 10.1111/j.1461-0248.2005.00767.x; KEELEY JE, 2011, TRENDS PLANT SCI, P1360; Keetch J.J., 1968, SE38 SE FOR EXP STAT; Komarek EV., 1964, P TALL TIMBERS FIRE, V3, P139; Krawchuk MA, 2014, ENVIRONMETRICS, V25, P472, DOI 10.1002/env.2287; KUSHLAN JA, 1990, ECOSYSTEMS FLORIDA; Laris P, 2002, HUM ECOL, V30, P155, DOI 10.1023/A:1015685529180; Le Page Y, 2010, GLOBAL ECOL BIOGEOGR, V19, P575, DOI 10.1111/j.1466-8238.2010.00525.x; Lockwood JL, 2003, FRONT ECOL ENVIRON, V1, P462, DOI 10.1890/1540-9295(2003)001[0462:SOTWTI]2.0.CO;2; Loehle C, 2009, ENVIRON MANAGE, V44, P1136, DOI 10.1007/s00267-009-9389-2; Mensing SA, 1999, QUATERNARY RES, V51, P295, DOI 10.1006/qres.1999.2035; Meyn A, 2007, PROG PHYS GEOG, V31, P287, DOI 10.1177/0309133307079365; Millan MM, 1998, J APPL METEOROL, V37, P83, DOI 10.1175/1520-0450(1998)037<0083:MPRTFF>2.0.CO;2; Mimmack GM, 2001, J CLIMATE, V14, P2790, DOI 10.1175/1520-0442(2001)014<2790:CODMIC>2.0.CO;2; Mitchell RJ, 2006, CAN J FOREST RES, V36, P2724, DOI 10.1139/X06-100; Morton DC, 2013, BIOGEOSCIENCES, V10, P247, DOI 10.5194/bg-10-247-2013; Myers Ronald L., 2009, P557, DOI 10.1007/978-3-540-77381-8_20; Noss R.F., 2013, FORGOTTEN GRASSLANDS; Noss RF, 2015, DIVERS DISTRIB, V21, P236, DOI 10.1111/ddi.12278; O'Brien JJ, 2008, AMBIO, V37, P542, DOI 10.1579/0044-7447-37.7.542; OLSON MS, 1995, VEGETATIO, V119, P101, DOI 10.1007/BF00045593; Orzell SL, 2006, LAND FIRE WATER FLOR, P100135; Outcalt KW, 2008, FOREST ECOL MANAG, V255, P3351, DOI 10.1016/j.foreco.2008.02.016; Palmer W.C., 1965, WEATHER BUREAU RES P; Parr CL, 2014, TRENDS ECOL EVOL, V29, P205, DOI 10.1016/j.tree.2014.02.004; Pausas JG, 2012, NEW PHYTOL, V193, P301, DOI 10.1111/j.1469-8137.2011.04010.x; Pausas JG, 2009, BIOSCIENCE, V59, P593, DOI 10.1525/bio.2009.59.7.10; Pedhazur EJ., 1997, MULTIPLE REGRESSION, V3rd ed; Peters DPC, 2004, P NATL ACAD SCI USA, V101, P15130, DOI 10.1073/pnas.0403822101; Platt W.J., 2006, LAND FIRE WATER, P3; Platt William J., 1999, P23; PLATT WJ, 1988, OECOLOGIA, V76, P353, DOI 10.1007/BF00377029; Platt WJ, 2002, ECOLOGY, V83, P1566, DOI 10.1890/0012-9658(2002)083[1566:IOLSDP]2.0.CO;2; *PROGR JFS, 2008, FIRE SCI DIGEST, V2; Putz F.E., 2003, WILD EARTH, V13, P10; Ramos-Neto MB, 2000, ENVIRON MANAGE, V26, P675, DOI 10.1007/s002670010124; Robbins L. E., 1992, MISCELLANEOUS PUBLIC, V8; Robertson W.B., 1953, SURVEY EFFECTS FIRE; Robertson WB, 1954, EVERGLADES NAT HIST, V2, P9; ROBERTSON WB, 1962, P TALL TIMBERS FIRE, V1, P67; Romero-Ruiz M, 2010, GLOBAL CHANGE BIOL, V16, P2013, DOI 10.1111/j.1365-2486.2009.02081.x; ROTHERMEL R. C., 1991, INT438 USDA FOR SERV; ROTHERMEL RC, 1972, INT115 DEP AGR FOR S; ROTHERMEL RC, 1983, INT143 DEP AGR FOR S; Russell-Smith J, 2006, INT J WILDLAND FIRE, V15, P541, DOI 10.1071/WF05111; Ryan KC, 2013, FRONT ECOL ENVIRON, V11, pE15, DOI 10.1890/120329; Sarmiento G., 1975, TROPICAL ECOLOGICAL, P223, DOI 10.1007/978-3-642-88533-4_16; Schmitz M, 2002, PLANT ECOL, V160, P137, DOI 10.1023/A:1015848300802; Simon MF, 2012, INT J PLANT SCI, V173, P711, DOI 10.1086/665973; Simon MF, 2009, P NATL ACAD SCI USA, V106, P20359, DOI 10.1073/pnas.0903410106; Slocum MG, 2007, NAT AREA J, V27, P41, DOI 10.3375/0885-8608(2007)27[41:DNAAFR]2.0.CO;2; Slocum MG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075946; Slocum MG, 2010, J APPL METEOROL CLIM, V49, P2559, DOI 10.1175/2010JAMC2532.1; Slocum MG, 2010, ECOSYSTEMS, V13, P828, DOI 10.1007/s10021-010-9357-y; Slocum MG, 2003, RESTOR ECOL, V11, P91, DOI 10.1046/j.1526-100X.2003.00115.x; SNYDER JP, 2000, LONG TERM STUD UNPUB; Snyder JR, 1986, 8606 S FLOR RES CTR; SNYDER JR, 1987, B ECOL SOC AM, V68, P419; Snyder JR, 1991, P TALL TIMBERS FIRE, V17, P303; Stephenson KE, 2011, AM MIDL NAT, V165, P50, DOI 10.1674/0003-0031-165.1.50; Streng DR, 1993, LONGLEAF PINE ECOSYS, P227; SWETNAM TW, 1990, SCIENCE, V249, P1017, DOI 10.1126/science.249.4972.1017; TAYLOR DL, 1981, FIRE HISTORY AND FIR; Ursino N, 2014, J THEOR BIOL, V355, P68, DOI 10.1016/j.jtbi.2014.04.002; van der Werf GR, 2008, GLOBAL BIOGEOCHEM CY, V22, DOI 10.1029/2007GB003122; Veldman JW, 2013, ECOLOGY, V94, P424, DOI 10.1890/12-1019.1; Vidrine M.F., 2010, CAJUN PRAIRIE NATURA; Wade D., 1980, SE17 USDA FOR SERV; Werner PA, 2013, ECOL MONOGR, V83, P67, DOI 10.1890/12-1153.1; Westerling AL, 2006, SCIENCE, V313, P940, DOI 10.1126/science.1128834; Willard DA, 2011, CLIMATIC CHANGE, V107, P59, DOI 10.1007/s10584-011-0078-9; Williams RJ, 2008, INT J WILDLAND FIRE, V17, P685, DOI 10.1071/WF07155; WOOD AW, 2008, U WASHINGTON SURFACE, P13; Zhang XY, 2014, J GEOPHYS RES-BIOGEO, V119, P1147, DOI 10.1002/2013JG002518	134	52	52	1	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2015	10	1							e0116952	10.1371/journal.pone.0116952	http://dx.doi.org/10.1371/journal.pone.0116952			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ4BU	25574667	Green Published, gold, Green Submitted			2022-12-27	WOS:000348168100009
J	Xu, D; Chen, ZM; Chen, HZ; Huang, RY; Zhao, SY; Liu, XY; Zhou, CJ; Peng, Y; Yuan, XY; Zou, JZ; Zhang, HL; Zhao, DY; Liu, EM; Zheng, YJ; Zhong, LL; Lu, M; Lu, JR; Nong, GM				Xu, Dan; Chen, Zhimin; Chen, Huizhong; Huang, Rongyan; Zhao, Shunying; Liu, Xiuyun; Zhou, Chunju; Peng, Yun; Yuan, Xinyu; Zou, Jizhen; Zhang, Hailing; Zhao, Deyu; Liu, Enmei; Zheng, Yuejie; Zhong, Lili; Lu, Min; Lu, Jirong; Nong, Guangmin			Application of Clinico-Radiologic-Pathologic Diagnosis of Diffuse Parenchymal Lung Diseases in Children in China	PLOS ONE			English	Article							INTERSTITIAL PNEUMONIA; CT; GENE	Diffuse parenchymal lung diseases in children (chDPLD) or interstitial lung diseases in children (chILD) represent a heterogeneous group of respiratory disorders that are mostly chronic and associated with high morbidity and mortality. However, the incidence of chDPLD is so low that most pediatricians lack sufficient knowledge of chDPLD, especially in China. Based on the clinico-radiologic-pathologic (CRP) diagnosis, we tried to describe (1) the characteristics of chDPLD and (2) the ratio of each constituent of chDPLD in China. Data were evaluated, including clinical, radiographic, and pathologic results from lung biopsies. We collected 25 cases of chDPLD, 18 boys and 7 girls with a median age of 6.0 years, from 16 hospitals in China. The most common manifestations included cough (n = 24), dyspnea (n = 21), and fever (n = 4). There were three cases of exposure-related interstitial lung disease (ILD), three cases of systemic disease-associated ILD, nineteen cases of alveolar structure disorder-associated ILD, and no cases of ILD specific to infancy. Non-specific interstitial pneumonia (n = 9) was the two largest groups. Conclusion: Non-specific interstitial pneumonia is the main categories of chDPLD in China. Lung biopsy is always a crucial step in the final diagnosis. However, clinical and imaging studies should be carefully evaluated for their value in indicating a specific chDPLD.	[Xu, Dan; Chen, Zhimin] Zhejiang Univ, Sch Med, Childrens Hosp, Dept Pulmonol, Hangzhou 310003, Zhejiang, Peoples R China; [Chen, Huizhong; Huang, Rongyan] Capital Inst Pediat, Childrens Hosp, Dept Resp Dis, Beijing, Peoples R China; [Zhao, Shunying; Liu, Xiuyun] Capital Med Univ, Beijing Childrens Hosp, Dept Pediat Internal Med, Beijing, Peoples R China; [Zhou, Chunju] Capital Med Univ, Beijing Childrens Hosp, Dept Pathol, Beijing, Peoples R China; [Peng, Yun] Capital Med Univ, Beijing Childrens Hosp, Dept Radiol, Beijing, Peoples R China; [Yuan, Xinyu] Capital Inst Pediat, Childrens Hosp, Dept Radiol, Beijing, Peoples R China; [Zou, Jizhen] Capital Inst Pediat, Childrens Hosp C, Dept Pathol, Beijing, Peoples R China; [Zhang, Hailing] Wenzhou Med Coll, Yuying Childrens Hosp, Dept Resp Dis, Wenzhou, Peoples R China; [Zhao, Deyu] Nanjing Med Univ, Nanjing Childrens Hosp, Dept Resp Dis, Nanjing, Jiangsu, Peoples R China; [Liu, Enmei] Chongqing Med Univ, Childrens Hosp, Resp Ctr, Chongqing, Peoples R China; [Zheng, Yuejie] Shenzhen Childrens Hosp, Dept Resp Dis, Shenzhen, Peoples R China; [Zhong, Lili] Hunan Normal Univ, Affiliated Hosp 1, Dept Pediat, Changsha, Hunan, Peoples R China; [Lu, Min] Jiao Tong Univ, Shanghai Childrens Hosp, Dept Pulmonol, Shanghai 200030, Peoples R China; [Lu, Jirong] Jilin Univ, Hosp 1, Dept Pediat, Changchun 130023, Peoples R China; [Nong, Guangmin] Guangxi Med Univ, Affiliated Hosp 1, Dept Pediat, Nanning, Peoples R China	Zhejiang University; Capital Institute of Pediatrics (CIP); Capital Medical University; Capital Medical University; Capital Medical University; Capital Institute of Pediatrics (CIP); Capital Institute of Pediatrics (CIP); Wenzhou Medical University; Nanjing Medical University; Chongqing Medical University; Hunan Normal University; Shanghai Jiao Tong University; Jilin University; Guangxi Medical University	Chen, ZM (corresponding author), Zhejiang Univ, Sch Med, Childrens Hosp, Dept Pulmonol, Hangzhou 310003, Zhejiang, Peoples R China.	drchenzm@163.com; chenhzvip@126.com						Amenomori M, 2010, RESP MED, V104, P895, DOI 10.1016/j.rmed.2010.01.011; American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias, 2002, AM J RESP CRIT CARE, V165, P277, DOI [DOI 10.1164/AJRCCM.165.2.ATS01, 10.1164/ajrccm.165.2.ats01]; Brasch F, 2004, EUR RESPIR J, V24, P30, DOI 10.1183/09031936.04.00000104; Gomes VCC, 2013, J BRAS PNEUMOL, V39, P569, DOI 10.1590/S1806-37132013000500007; Clement A, 2010, ORPHANET J RARE DIS, V5, DOI 10.1186/1750-1172-5-22; COULTAS DB, 1994, AM J RESP CRIT CARE, V150, P967, DOI 10.1164/ajrccm.150.4.7921471; Deterding R, 2007, SEMIN RESP CRIT CARE, V28, P333, DOI 10.1055/s-2007-981654; Dinwiddle R, 2002, PEDIATR PULM, V34, P23, DOI 10.1002/ppul.10125; Griese M, 2009, ORPHANET J RARE DIS, V4, DOI 10.1186/1750-1172-4-26; KIDO S, 1992, Nippon Acta Radiologica, V52, P382; KIDO S, 1992, Nippon Acta Radiologica, V52, P392; Kornum Jette B, 2008, BMC Pulm Med, V8, P24, DOI 10.1186/1471-2466-8-24; Lloyd CR, 2011, BRIT J RADIOL, V84, P581, DOI 10.1259/bjr/65090500; Martin SG, 2010, EUR RADIOL, V20, P1297, DOI 10.1007/s00330-009-1671-4; Park SC, 2011, PHYS MED BIOL, V56, P1139, DOI 10.1088/0031-9155/56/4/016; Venkatesh Purnima, 2005, Paediatr Drugs, V7, P235, DOI 10.2165/00148581-200507040-00003; Wagner M, 2011, REV MAL RESPIR, V28, P1207, DOI 10.1016/j.rmr.2011.04.016; Wang Ping, 2009, Chinese Medical Sciences Journal, V24, P202; Wuyts W, 2008, EUR J CARDIO-THORAC, V34, P1271, DOI 10.1016/j.ejcts.2008.09.018; Yang IV, 2007, AM J RESP CRIT CARE, V175, P45, DOI 10.1164/rccm.200601-062OC; Zacharisen MC, 2011, IMMUNOL ALLERGY CLIN, V31, P769, DOI 10.1016/j.iac.2011.07.004; Zar HJ, 2008, PEDIATR PULM, V43, P1, DOI 10.1002/ppul.20676	22	3	4	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2015	10	1							e0116930	10.1371/journal.pone.0116930	http://dx.doi.org/10.1371/journal.pone.0116930			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ4BT	25569558	Green Published, Green Submitted, gold			2022-12-27	WOS:000348168000009
J	Lee, CH; Lee, WC; Chang, SH; Wen, MS; Hung, KC				Lee, Cheng-Hung; Lee, Wen-Chen; Chang, Shang-Hung; Wen, Ming-Shien; Hung, Kuo-Chun			The N-Terminal Propeptide of Type III Procollagen in Patients with Acute Coronary Syndrome: A Link between Left Ventricular End-Diastolic Pressure and Cardiovascular Events	PLOS ONE			English	Article							ACUTE MYOCARDIAL-INFARCTION; LEFT ATRIAL SIZE; CONGESTIVE-HEART-FAILURE; EJECTION FRACTION; PROGNOSTIC IMPLICATIONS; METABOLIC SYNDROME; ARTERY-DISEASE; TISSUE; DYSFUNCTION; FIBROSIS	Background: Despite the usefulness of N-terminal propeptide of type III procollagen (PIIINP) in detecting enhanced collagen turnover in patients with congestive heart failure, the value added by PIIINP to the use of clinical variables and echocardiography in relation to directly measured left ventricular (LV) enddiastolic pressure (EDP) and the outcome of acute coronary syndrome (ACS) has not been clearly defined. Methods and Results: This study involved 168 adult patients with ACS, who underwent echocardiography, measurement of serum PIIINP levels, and cardiac catheterization. Pulsed wave tissue Doppler imaging (PWTDI), which revealed mean peak systolic (s'), early (e'), and late diastolic (a') velocities, was carried out and the eas index of LV function was evaluated: e'/(a'xs'). The patients were divided into three study groups based on the degree of LVEDP - normal (<16 mmHg), intermediate (16-30 mmHg), and high (. 30 mmHg) LVEDP. All patients were followed-up to determine cardiac-related death and revascularization. Patients with high LVEDP had significantly more PIIINP than those with intermediate or normal LVEDP (all post hoc p<0.05). The presence of coronary artery disease, the left atrial volume index (LAVI), the ratio of transmitral early and late diastolic flow velocities, a', and the eas index were significantly correlated with LVEDP. According to multiple stepwise analysis, PIIINP, LAVI and the eas index were the three independent predictors of the level of LVEDP (PIIINP, p<0.001; LAVI, p=0.007; eas index, p=0.021). During follow-up (median, 24 months), 32 participants suffered from cardiac events, PIIINP and LAVI were significant predictors of cardiac mortality and hospitalization (PIIINP, hazard ratio (HR) 2.589, p=0.002; LAVI, HR 1.040, p=0.027). Conclusions: PIIINP is a highly effective means to evaluate LVEDP in patients with ACS. The PIIINP is also correlated with cardiac mortality and revascularization, providing an additional means of evaluating and managing patients with ACS.	[Lee, Cheng-Hung; Lee, Wen-Chen; Chang, Shang-Hung; Wen, Ming-Shien; Hung, Kuo-Chun] Chang Gung Univ, Coll Med, Chang Gung Mem Hosp, Dept Internal Med,Div Cardiol, Taoyuan, Taiwan	Chang Gung Memorial Hospital; Chang Gung University	Hung, KC (corresponding author), Chang Gung Univ, Coll Med, Chang Gung Mem Hosp, Dept Internal Med,Div Cardiol, Taoyuan, Taiwan.	hkuo.chun@gmail.com	Lee, Cheng-Hung/ABA-8070-2021		National Science Council of Taiwan [NSC-102-2314-B-182A-109)]; Chang Gung Memorial Hospital [CMRPG390991]	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan); Chang Gung Memorial Hospital(Chang Gung Memorial Hospital)	The authors would like to thank the National Science Council of Taiwan (Contract No. NSC-102-2314-B-182A-109) and Chang Gung Memorial Hospital (Contract No. CMRPG390991) for financially supporting this research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe M, 1999, JPN CIRC J, V63, P763, DOI 10.1253/jcj.63.763; Abhayaratna WP, 2006, J AM COLL CARDIOL, V47, P2357, DOI 10.1016/j.jacc.2006.02.048; APPLETON CP, 1993, J AM COLL CARDIOL, V22, P1972, DOI 10.1016/0735-1097(93)90787-2; Armstrong PW, 1998, CIRCULATION, V98, P1860, DOI 10.1161/01.CIR.98.18.1860; Bagai A, 2013, AM HEART J, V166, P913, DOI 10.1016/j.ahj.2013.08.006; Banerjee T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090527; Baranova A, 2011, BMC GASTROENTEROL, V11, DOI 10.1186/1471-230X-11-91; Berger PB, 1997, CIRCULATION, V96, P122; Campbell DJ, 2011, CARDIOVASC DIABETOL, V10, DOI 10.1186/1475-2840-10-80; CAPASSO JM, 1991, AM J PHYSIOL, V260, pH651, DOI 10.1152/ajpheart.1991.260.3.H651; CARROLL JD, 1985, CIRCULATION, V72, P119, DOI 10.1161/01.CIR.72.1.119; Cerisano G, 2001, J AM COLL CARDIOL, V37, P793, DOI 10.1016/S0735-1097(00)01203-1; Doi R, 2000, J HYPERTENS, V18, P111, DOI 10.1097/00004872-200018010-00016; Du X, 2012, INT J CARDIOL, V156, P24, DOI 10.1016/j.ijcard.2010.10.036; GOLDSTEIN JA, 1990, CIRCULATION, V82, P359, DOI 10.1161/01.CIR.82.2.359; GOULD KL, 1974, AM J CARDIOL, V34, P48, DOI 10.1016/0002-9149(74)90092-7; Gressner OA, 2007, CLIN CHIM ACTA, V381, P107, DOI 10.1016/j.cca.2007.02.038; Hayashi M, 2003, CIRCULATION, V107, P2559, DOI 10.1161/01.CIR.0000068340.96506.0F; Hayashi M, 2001, J AM COLL CARDIOL, V38, P1375, DOI 10.1016/S0735-1097(01)01539-X; Herlitz J, 2002, INT J CARDIOL, V82, P259, DOI 10.1016/S0167-5273(02)00006-2; HORSLEVPETERSEN K, 1988, APMIS, V96, P793, DOI 10.1111/j.1699-0463.1988.tb00946.x; HOST NB, 1995, AM J CARDIOL, V76, P869, DOI 10.1016/S0002-9149(99)80251-3; Jellis C, 2011, CIRC-CARDIOVASC IMAG, V4, P693, DOI 10.1161/CIRCIMAGING.111.963587; JOHNSON LW, 1989, CATHETER CARDIO DIAG, V17, P5, DOI 10.1002/ccd.1810170103; Kawamura M, 2012, EUROPACE, V14, P1719, DOI 10.1093/europace/eus162; Kern MJ, 1998, CATHETER CARDIO DIAG, V44, P70, DOI 10.1002/(SICI)1097-0304(199805)44:1<70::AID-CCD17>3.0.CO;2-T; Kosmala W, 2012, EUR HEART J-CARD IMG, V13, P459, DOI 10.1093/ejechocard/jer291; LASKEY W, 1993, CATHETER CARDIO DIAG, V30, P185, DOI 10.1002/ccd.1810300302; Leber AW, 2004, J AM COLL CARDIOL, V43, P1241, DOI 10.1016/j.jacc.2003.10.059; Lee CH, 2011, INT J CLIN PRACT, V65, P852, DOI 10.1111/j.1742-1241.2011.02699.x; Levine GN, 2005, CATHETER CARDIO INTE, V66, P149, DOI 10.1002/ccd.20469; Li BS, 1997, AM J PHYSIOL-HEART C, V273, pH2508, DOI 10.1152/ajpheart.1997.273.5.H2508; LITTLE WC, 1995, CIRCULATION, V92, P1933, DOI 10.1161/01.CIR.92.7.1933; Lopez B, 2010, CIRCULATION, V121, P1645, DOI 10.1161/CIRCULATIONAHA.109.912774; Martos R, 2007, CIRCULATION, V115, P888, DOI 10.1161/CIRCULATIONAHA.106.638569; Meyer O, 2006, JOINT BONE SPINE, V73, P490, DOI 10.1016/j.jbspin.2006.01.022; Mielniczuk Lisa M, 2007, Congest Heart Fail, V13, P209, DOI 10.1111/j.1527-5299.2007.06624.x; Mornos C, 2009, INT J CARDIOL, V136, P120, DOI 10.1016/j.ijcard.2008.04.029; Olariu A, 2003, Eur J Echocardiogr, V4, P162, DOI 10.1016/S1525-2167(02)00160-9; Paulus WJ, 2007, EUR HEART J, V28, P2539, DOI 10.1093/eurheartj/ehm037; Poulsen SH, 2000, CIRCULATION, V101, P1527, DOI 10.1161/01.CIR.101.13.1527; Rossi A, 2004, HEART, V90, P650, DOI 10.1136/hrt.2002.005371; Simpson IA, 1997, HEART, V78, P211, DOI 10.1136/hrt.78.3.211; Tsang TSM, 2006, J AM COLL CARDIOL, V47, P1018, DOI 10.1016/j.jacc.2005.08.077; Tsang TSM, 2003, J AM COLL CARDIOL, V42, P1199, DOI 10.1016/S0735-1097(03)00943-4; Van Herck PL, 2007, HEART, V93, P1231, DOI 10.1136/hrt.2006.100818; Vanderheyden Marc, 2005, Eur J Echocardiogr, V6, P47, DOI 10.1016/j.euje.2004.06.006; Vasan RS, 1999, J AM COLL CARDIOL, V33, P1948, DOI 10.1016/S0735-1097(99)00118-7; Wang TJ, 2007, AM HEART J, V154, P291, DOI 10.1016/j.ahj.2007.04.006; Westermann D, 2008, CIRCULATION, V117, P2051, DOI 10.1161/CIRCULATIONAHA.107.716886; Zannad F, 2000, CIRCULATION, V102, P2700, DOI 10.1161/01.CIR.102.22.2700	51	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2015	10	1							e114097	10.1371/journal.pone.0114097	http://dx.doi.org/10.1371/journal.pone.0114097			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ3BG	25559610	Green Submitted, Green Published, gold			2022-12-27	WOS:000348102200007
J	Li, HE; Yao, WJ; Fu, YR; Li, SK; Guo, QQ				Li, Huie; Yao, Weijie; Fu, Yaru; Li, Shaoke; Guo, Qiqiang			De Novo Assembly and Discovery of Genes That Are Involved in Drought Tolerance in Tibetan Sophora moorcroftiana	PLOS ONE			English	Article							DEHYDRIN GENES; DIFFERENTIAL EXPRESSION; TRANSCRIPTOME PROFILES; RESPONSIVE GENES; ABIOTIC STRESSES; LOW-TEMPERATURE; IDENTIFICATION; COLD; ARABIDOPSIS; PLANT	Sophora moorcroftiana, a Leguminosae shrub species that is restricted to the arid and semi-arid regions of the Qinghai-Tibet Plateau, is an ecologically important foundation species and exhibits substantial drought tolerance in the Plateau. There are no functional genomics resources in public databases for understanding the molecular mechanism underlying the drought tolerance of S. moorcroftiana. Therefore, we performed a large-scale transcriptome sequencing of this species under drought stress using the Illumina sequencing technology. A total of 62,348,602 clean reads were obtained. The assembly of the clean reads resulted in 146,943 transcripts, including 66,026 unigenes. In the assembled sequences, 1534 transcription factors were identified and classified into 23 different common families, and 9040 SSR loci, from di-to hexa-nucleotides, whose repeat number is greater than five, were presented. In addition, we performed a gene expression profiling analysis upon dehydration treatment. The results indicated significant differences in the gene expression profiles among the control, mild stress and severe stress. In total, 4687, 5648 and 5735 genes were identified from the comparison of mild versus control, severe versus control and severe versus mild stress, respectively. Based on the differentially expressed genes, a Gene Ontology annotation analysis indicated many dehydration-relevant categories, including 'response to water 'stimulus' and 'response to water deprivation'. Meanwhile, the Kyoto Encyclopedia of Genes and Genomes pathway analysis uncovered some important pathways, such as 'metabolic pathways' and 'plant hormone signal transduction'. In addition, the expression patterns of 25 putative genes that are involved in drought tolerance resulting from quantitative real-time PCR were consistent with their transcript abundance changes as identified by RNA-seq. The globally sequenced genes covered a considerable proportion of the S. moorcroftiana transcriptome, and the expression results may be useful to further extend the knowledge on the drought tolerance of this plant species that survives under Plateau conditions.	[Li, Huie; Yao, Weijie; Fu, Yaru; Li, Shaoke; Guo, Qiqiang] Tibet Univ, Agr & Anim Husb Coll, Nyingchi, Tibet, Peoples R China; [Yao, Weijie; Fu, Yaru; Li, Shaoke; Guo, Qiqiang] Tibet Univ, Minist Educ, Key Lab Forest Ecol Tibet Plateau, Nyingchi, Tibet, Peoples R China; [Yao, Weijie; Fu, Yaru; Li, Shaoke; Guo, Qiqiang] Natl Key Stn Field Sci Observat & Expt, Nyingchi, Tibet, Peoples R China	Tibet University; Tibet University	Guo, QQ (corresponding author), Tibet Univ, Agr & Anim Husb Coll, Nyingchi, Tibet, Peoples R China.	hnguoqiqiang@126.com			National Natural Science Foundation of China [31260189]; Collaborative Innovation Center Construction of Research and development on Tibetan characteristic agricultural and animal husbandry resources----plateau ecology	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Collaborative Innovation Center Construction of Research and development on Tibetan characteristic agricultural and animal husbandry resources----plateau ecology	This research was supported by the National Natural Science Foundation of China (31260189) and Collaborative Innovation Center Construction of Research and development on Tibetan characteristic agricultural and animal husbandry resources----plateau ecology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An D, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-64; Bak Soren, 2011, Arabidopsis Book, V9, pe0144, DOI 10.1199/tab.0144; Chen D, 2008, ACTA PHYSIOL PLANT, V30, P183, DOI 10.1007/s11738-007-0107-5; Cui XF, 2009, CLIMATIC CHANGE, V94, P47, DOI 10.1007/s10584-009-9556-8; da Silva MD, 2013, J NUCLEIC ACIDS, V2013, DOI 10.1155/2013/763945; Dang ZH, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-29; Dobra J, 2011, J PLANT PHYSIOL, V168, P1588, DOI 10.1016/j.jplph.2011.02.009; Dugas DV, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-514; Eriksson SK, 2011, ECOL STUD-ANAL SYNTH, V215, P289, DOI 10.1007/978-3-642-19106-0_14; Farooq M, 2009, SUSTAINABLE AGRICULTURE, P153, DOI 10.1051/agro:2008021; Fujita Y, 2011, J PLANT RES, V124, P509, DOI 10.1007/s10265-011-0412-3; Gao CQ, 2012, INT J MOL SCI, V13, P3751, DOI 10.3390/ijms13033751; Gao CQ, 2010, PLANT MOL BIOL REP, V28, P77, DOI 10.1007/s11105-009-0129-9; Guimaraes PM, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-387; Hadiarto T, 2011, PLANT CELL REP, V30, P297, DOI 10.1007/s00299-010-0956-z; Huang DQ, 2008, J EXP BOT, V59, P2991, DOI 10.1093/jxb/ern155; Kang Y, 2011, PLANT J, V68, P871, DOI 10.1111/j.1365-313X.2011.04738.x; Kantartzi Stella K., 2013, MICROSATELLITES METH; Liu CH, 2013, PLANT GROWTH REGUL, V70, P187, DOI 10.1007/s10725-013-9791-x; Liu MQ, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-88; Liu TM, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-130; Ma DY, 2014, PLANT PHYSIOL BIOCH, V80, P60, DOI 10.1016/j.plaphy.2014.03.024; Mao XZ, 2005, BIOINFORMATICS, V21, P3787, DOI 10.1093/bioinformatics/bti430; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Moumeni A, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-174; Mowla SB, 2002, PLANTA, V215, P716, DOI 10.1007/s00425-002-0819-0; Nakashima K, 2009, PLANT PHYSIOL, V149, P88, DOI 10.1104/pp.108.129791; Nam KH, 2013, FOOD SCI BIOTECHNOL, V22, P1351, DOI 10.1007/s10068-013-0222-6; Nishiyama R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032124; Qian G, 2008, CAN J PLANT SCI, V88, P899, DOI 10.4141/CJPS08015; Reddy AR, 2004, J PLANT PHYSIOL, V161, P1189, DOI 10.1016/j.jplph.2004.01.013; Seki M, 2002, PLANT J, V31, P279, DOI 10.1046/j.1365-313X.2002.01359.x; Seo PJ, 2009, PLANT PHYSIOL, V151, P275, DOI 10.1104/pp.109.144220; Shen WY, 2006, PLANT CELL, V18, P422, DOI 10.1105/tpc.105.039750; Silva PIT, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-17; Suprunova T, 2004, PLANT CELL ENVIRON, V27, P1297, DOI 10.1111/j.1365-3040.2004.01237.x; Tang WJ, 2013, PLANT PHYSIOL, V163, P857, DOI 10.1104/pp.113.224386; Tian DQ, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-827; Torales SL, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-705; Wang XC, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-415; Wisniewski ME, 2006, TREE PHYSIOL, V26, P575, DOI 10.1093/treephys/26.5.575; Xu YJ, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-662; Xue X, 2009, GEOMORPHOLOGY, V108, P182, DOI 10.1016/j.geomorph.2009.01.004; Yang MX, 2004, COLD REG SCI TECHNOL, V39, P47, DOI 10.1016/j.coldregions.2004.01.002; Yang YZ, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-140; Yoshimura K, 2008, PLANT CELL PHYSIOL, V49, P226, DOI 10.1093/pcp/pcm180; Young MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r14; Yu SC, 2012, PLANT MOL BIOL REP, V30, P17, DOI 10.1007/s11105-011-0313-6; Zhao ZG, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-222	49	169	183	11	84	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2015	10	1							e111054	10.1371/journal.pone.0111054	http://dx.doi.org/10.1371/journal.pone.0111054			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ3BG	25559297	Green Published, Green Submitted, gold			2022-12-27	WOS:000348102200003
J	Yin, F; Zhang, JN; Wang, SW; Zhou, CH; Zhao, MM; Fan, WH; Fan, M; Liu, S				Yin, Feng; Zhang, Jian Ning; Wang, Shu Wei; Zhou, Chun Hui; Zhao, Ming Ming; Fan, Wen Hong; Fan, Ming; Liu, Shuang			MiR-125a-3p Regulates Glioma Apoptosis and Invasion by Regulating Nrg1	PLOS ONE			English	Article							MICRORNAS; PROLIFERATION; EXPRESSION; MIGRATION; GROWTH; CANCER; CELLS; DIFFERENTIATION; IDENTIFICATION; SUPPRESSES	The current study was designed to examine the functional role and mechanism of miR-125a-3p in glioma development. Quantitative RT-PCR was used to evaluate miR-125a-3p expression in 60 glioma cases of different malignant grades. Then, the clinic pathologic significance of miR-125a-3p expression was determined in combination with the prognosis of the patients. In addition, the effects and mechanisms of miR-125a-3p on the proliferation, apoptosis and invasion of glioma cells were further investigated. The results showed that the expression of miR-125a-3p was decreased significantly in most malignant glioma samples relative to normal brain tissues and glioma tissues of low-malignant degree. Further kaplan-meier survival analysis showed that the lower expression of miR-125a-3p was associated with a poor prognosis of GBM patients. Functional analysis showed that the reintroduction of miR-125a-3p into glioblastoma cell lines induces markedly the apoptosis and suppresses the proliferation and migration of glioblastoma cells in vitro and in vivo. Luciferase assay and Western blot analysis revealed that Nrg1 is a direct target of miR-125a-3p. Furthermore, an increased expression of Nrg1 could reverse the effects of overexpression of miR-125a-3p on the proliferation, apoptosis and migration of glioblastoma cells. These findings suggest that miR-125a-3p performed an important role in glioma development mediated by directly regulating the expression of Nrg1. This study also provides a potential target for diagnosis and treatment of malignant glioma.	[Yin, Feng; Zhang, Jian Ning; Wang, Shu Wei; Zhou, Chun Hui; Zhao, Ming Ming; Liu, Shuang] Chinese PLA Navy Gen Hosp, Dept Neurosurg, Beijing 100048, Peoples R China; [Fan, Wen Hong; Fan, Ming] Beijing Inst Basic Med Sci, Dept Brain Protect Plast Res, Beijing 100850, Peoples R China	Sixth Medical Center of Chinese PLA General Hospital; Academy of Military Medical Sciences - China	Fan, M (corresponding author), Beijing Inst Basic Med Sci, Dept Brain Protect Plast Res, Beijing 100850, Peoples R China.	fanmingchina@126.com; shuangff@sina.com			National Nature Science Foundation of China [81172384, 30873029]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the National Nature Science Foundation of China (grants no. 81172384, no. 30873029) (http://www.nsfc.gov.cn/) SL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asangani IA, 2008, ONCOGENE, V27, P2128, DOI 10.1038/sj.onc.1210856; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; BEMSTEIN HG, 2006, BRAIN RES BULL, V69, P546, DOI DOI 10.1016/J.BRAINRESBULL.2006.02.017; CARRAWAY KL, 1995, CURR OPIN NEUROBIOL, V5, P606, DOI 10.1016/0959-4388(95)80065-4; Chan JA, 2005, CANCER RES, V65, P6029, DOI 10.1158/0008-5472.CAN-05-0137; Chiang HR, 2010, GENE DEV, V24, P992, DOI 10.1101/gad.1884710; Ciafre SA, 2005, BIOCHEM BIOPH RES CO, V334, P1351, DOI 10.1016/j.bbrc.2005.07.030; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Ferretti E, 2009, INT J CANCER, V124, P568, DOI 10.1002/ijc.23948; Gebeshuber CA, 2009, EMBO REP, V10, P400, DOI 10.1038/embor.2009.9; Godlewski J, 2008, CANCER RES, V68, P9125, DOI 10.1158/0008-5472.CAN-08-2629; Guo X, 2009, RNA BIOL, V6, P575, DOI 10.4161/rna.6.5.10079; He XY, 2010, J CANCER RES CLIN, V136, P1023, DOI 10.1007/s00432-009-0747-5; Hijazi MM, 2000, INT J ONCOL, V17, P629; Hisaoka M, 2011, GENE CHROMOSOME CANC, V50, P137, DOI 10.1002/gcc.20837; Jiang LL, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-318; Kleihues P, 2002, J NEUROPATH EXP NEUR, V61, P215, DOI 10.1093/jnen/61.3.215; Laneve P, 2007, P NATL ACAD SCI USA, V104, P7957, DOI 10.1073/pnas.0700071104; Li W, 2009, J MED GENET, V46, P358, DOI 10.1136/jmg.2008.063123; Liu S, 2014, J CELL BIOCHEM, V115, P1368, DOI 10.1002/jcb.24786; Miller MW, 2006, J NEUROCHEM, V97, P1182, DOI 10.1111/j.1471-4159.2006.03858.x; Nam EJ, 2008, CLIN CANCER RES, V14, P2690, DOI 10.1158/1078-0432.CCR-07-1731; Nicoloso MS, 2009, NAT REV CANCER, V9, P293, DOI 10.1038/nrc2619; Nilsson P, 2001, TUMOR BIOL, V22, P229, DOI 10.1159/000050621; Nishida N, 2011, CLIN CANCER RES, V17, P2725, DOI 10.1158/1078-0432.CCR-10-2132; O'Day E, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2484; Prevot V, 2003, J NEUROSCI, V23, P230; Ritch PA, 2003, J BIOL CHEM, V278, P20971, DOI 10.1074/jbc.M213074200; Ritch PS, 2005, GLIA, V51, P217, DOI 10.1002/glia.20197; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Sheng Q, 2010, CANCER CELL, V17, P298, DOI 10.1016/j.ccr.2009.12.047; Silber J, 2008, BMC MED, V6, DOI 10.1186/1741-7015-6-14; Spizzo R, 2009, CELL, V137, P586, DOI 10.1016/j.cell.2009.04.040; Thuringer D, 2011, J BIOL CHEM, V286, P3418, DOI 10.1074/jbc.M110.154823; Wang GF, 2009, FEBS J, V276, P5571, DOI 10.1111/j.1742-4658.2009.07238.x; Wen PY, 2008, NEW ENGL J MED, V359, P492, DOI 10.1056/NEJMra0708126; Wilson TR, 2011, CANCER CELL, V20, P158, DOI 10.1016/j.ccr.2011.07.011; Wu LG, 2005, MOL CELL BIOL, V25, P9198, DOI 10.1128/MCB.25.21.9198-9208.2005; Xu XF, 2011, INT J ONCOL, V38, P1385, DOI 10.3892/ijo.2011.961; Yang JS, 2011, RNA, V17, P312, DOI 10.1261/rna.2537911; Zhao WJ, 2013, J NEUROPATH EXP NEUR, V72, P244, DOI 10.1097/NEN.0b013e3182863dc5; Zhao WJ, 2011, CELL TISSUE RES, V344, P313, DOI 10.1007/s00441-011-1157-y; Zhou X, 2010, LAB INVEST, V90, P144, DOI 10.1038/labinvest.2009.126	43	44	48	3	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2015	10	1							e0116759	10.1371/journal.pone.0116759	http://dx.doi.org/10.1371/journal.pone.0116759			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ3BG	25560389	Green Published, Green Submitted, gold			2022-12-27	WOS:000348102200017
J	Barnes, S; Xu, YH; Zhang, WJ; Liou, B; Setchell, KDR; Bao, LM; Grabowski, GA; Sun, Y				Barnes, Sonya; Xu, You-Hai; Zhang, Wujuan; Liou, Benjamin; Setchell, Kenneth D. R.; Bao, Liming; Grabowski, Gregory A.; Sun, Ying			Ubiquitous Transgene Expression of the Glucosylceramide-Synthesizing Enzyme Accelerates Glucosylceramide Accumulation and Storage Cells in a Gaucher Disease Mouse Model	PLOS ONE			English	Article							ACID BETA-GLUCOSIDASE; HUMAN METACHROMATIC LEUKODYSTROPHY; SUBSTRATE REDUCTION THERAPY; GLYCOSPHINGOLIPID SYNTHESIS; GLUCOCEREBROSIDASE GENE; DEFICIENT MICE; CERAMIDE GLUCOSYLTRANSFERASE; GANGLIOSIDE METABOLISM; ELIGLUSTAT TARTRATE; SANDHOFF DISEASES	Gaucher disease is a lysosomal storage disease caused by defective activity of acid beta-glucosidase (GCase), which leads to the accumulation of its major substrates, glucosylceramide (GlcCer) and glucosylsphingosine (GlcSph) in many cells. To modulate cellular substrate concentration in viable mouse models of Gaucher disease (Gba1 mutants), a novel mouse model was created with enhanced glycosphingolipid biosynthesis. This was accomplished by crossbreeding Gba1 mutant mice with mice expressing a transgene (GCStg) containing the mouse glucosylceramide synthase (GCS, Ugcg) cDNA driven by the ROSA promoter, yielding GCStg/Gba1 mice. The GCStg rescued Ugcg null mice from embryonic lethality. GCStg/Gba1 mice showed 2-3 fold increases in tissue GCS activity as well as accelerated GlcCer accumulation and the appearance of lipid-laden CD68 positive macrophages in visceral organs. Although GlcCer/GlcSph concentrations were elevated in the brain, there was no neurodegenerative phenotype up to 1 yr of age conceivably due to the greater residual GCase hydrolytic activity in the brains than in the visceral tissues of 9V/null mice. These studies provide 'proof of principle' for threshold substrate flux that modifies phenotypic development in Gaucher disease and other lysosomal storage diseases.	[Barnes, Sonya; Xu, You-Hai; Liou, Benjamin; Grabowski, Gregory A.; Sun, Ying] Cincinnati Childrens Hosp Med Ctr, Div Human Genet, Cincinnati, OH 45229 USA; [Zhang, Wujuan; Setchell, Kenneth D. R.] Cincinnati Childrens Hosp Med Ctr, Div Pathol & Lab Med, Cincinnati, OH 45229 USA; [Xu, You-Hai; Setchell, Kenneth D. R.; Sun, Ying] Univ Cincinnati, Coll Med, Dept Pediat, Cincinnati, OH USA; [Bao, Liming] Dartmouth Coll, Geisel Sch Med, Dartmouth Hitchcock Med Ctr, Lebanon, NH 03756 USA; [Grabowski, Gregory A.] Synageva BioPharma Corp, Lexington, MA USA	Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; Dartmouth College	Sun, Y (corresponding author), Cincinnati Childrens Hosp Med Ctr, Div Human Genet, Cincinnati, OH 45229 USA.	ying.sun@cchmc.org			National Institutes of Health (NIH) [DK 36729]; Synageva; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK036729] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Synageva; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by a grant from the National Institutes of Health (NIH) (DK 36729) to GAG. Synageva provided support in the form of a salary for author GAG, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ankleshwaria C, 2014, J HUM GENET, V59, P223, DOI 10.1038/jhg.2014.5; ARORA RC, 1972, J LIPID RES, V13, P86; Ashe KM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021758; BASU S, 1968, J BIOL CHEM, V243, P5802; Belmatoug N, 2011, J INHERIT METAB DIS, V34, P991, DOI 10.1007/s10545-011-9368-7; Bennett LL, 2013, ANN PHARMACOTHER, V47, P1182, DOI 10.1177/1060028013500469; Choy FYM, 2007, BLOOD CELL MOL DIS, V38, P287, DOI 10.1016/j.bcmd.2006.11.003; CONRADI NG, 1984, ACTA NEUROPATHOL, V65, P99, DOI 10.1007/BF00690463; COSTE H, 1986, BIOCHIM BIOPHYS ACTA, V858, P6, DOI 10.1016/0005-2736(86)90285-3; D'Angelo G, 2007, NATURE, V449, P62, DOI 10.1038/nature06097; Elliot-Smith E, 2008, MOL GENET METAB, V94, P204, DOI 10.1016/j.ymgme.2008.02.005; Enquist IB, 2007, P NATL ACAD SCI USA, V104, P17483, DOI 10.1073/pnas.0708086104; Farley FW, 2000, GENESIS, V28, P106, DOI 10.1002/1526-968X(200011/12)28:3/4<106::AID-GENE30>3.0.CO;2-T; Furukawa K, 2004, SEMIN CELL DEV BIOL, V15, P389, DOI 10.1016/j.semcdb.2004.03.006; FUTERMAN AH, 1991, BIOCHEM J, V280, P295, DOI 10.1042/bj2800295; Fyrst H, 2010, NAT CHEM BIOL, V6, P489, DOI [10.1038/NCHEMBIO.392, 10.1038/nchembio.392]; Gillard BK, 1998, GLYCOBIOLOGY, V8, P885, DOI 10.1093/glycob/8.9.885; Ginns EI, 2014, MOL GENET METAB, V111, P152, DOI 10.1016/j.ymgme.2013.12.003; Grabowski G. A., 2010, METABOLIC MOL BASES; Halter D, 2007, J CELL BIOL, V179, P101, DOI 10.1083/jcb.200704091; Hess B, 1996, P NATL ACAD SCI USA, V93, P14821, DOI 10.1073/pnas.93.25.14821; Hruska KS, 2008, HUM MUTAT, V29, P567, DOI 10.1002/humu.20676; Ichikawa S, 1996, P NATL ACAD SCI USA, V93, P4638, DOI 10.1073/pnas.93.10.4638; Ichikawa S, 1998, BIOCHEM BIOPH RES CO, V253, P707, DOI 10.1006/bbrc.1998.9855; JECKEL D, 1992, J CELL BIOL, V117, P259, DOI 10.1083/jcb.117.2.259; Jennemann R, 2005, P NATL ACAD SCI USA, V102, P12459, DOI 10.1073/pnas.0500893102; Jeong SY, 2011, BLOOD CELL MOL DIS, V46, P11, DOI 10.1016/j.bcmd.2010.07.010; Jeyakumar M, 1999, P NATL ACAD SCI USA, V96, P6388, DOI 10.1073/pnas.96.11.6388; Karaca E, 2012, J PEDIATR ENDOCR MET, V25, P957, DOI 10.1515/jpem-2012-0155; KATTLOVE HE, 1969, BLOOD-J HEMATOL, V33, P379, DOI 10.1182/blood.V33.2.379.379; KELSEY PR, 1988, J CLIN PATHOL, V41, P960, DOI 10.1136/jcp.41.9.960; Kitatani K, 2008, CELL SIGNAL, V20, P1010, DOI 10.1016/j.cellsig.2007.12.006; Koprivica V, 2000, AM J HUM GENET, V66, P1777, DOI 10.1086/302925; Kuter DJ, 2013, BLOOD CELL MOL DIS, V51, P116, DOI 10.1016/j.bcmd.2013.04.005; Le Stunff H, 2007, J BIOL CHEM, V282, P34372, DOI 10.1074/jbc.M703329200; Lloyd-Evans E, 2008, NAT MED, V14, P1247, DOI 10.1038/nm.1876; Lukina E, 2014, BLOOD CELL MOL DIS, V53, P274, DOI 10.1016/j.bcmd.2014.04.002; Lukina E, 2010, BLOOD, V116, P893, DOI 10.1182/blood-2010-03-273151; Mao CG, 2008, BBA-MOL CELL BIOL L, V1781, P424, DOI 10.1016/j.bbalip.2008.06.002; Marks DL, 1999, J BIOL CHEM, V274, P451, DOI 10.1074/jbc.274.1.451; Marshall J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015033; Marshall J, 2010, J INHERIT METAB DIS, V33, P281, DOI 10.1007/s10545-010-9072-z; Mizukami H, 2002, J CLIN INVEST, V109, P1215, DOI 10.1172/JCI200214530; Nordstrom V, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001506; Phaneuf D, 1996, HUM MOL GENET, V5, P1, DOI 10.1093/hmg/5.1.1; Platt FM, 2001, J INHERIT METAB DIS, V24, P275, DOI 10.1023/A:1010335505357; Poole RM, 2014, DRUGS, V74, P1829, DOI 10.1007/s40265-014-0296-3; QI XY, 1994, J BIOL CHEM, V269, P16746; Ramakrishnan H, 2007, J NEUROSCI, V27, P9482, DOI 10.1523/JNEUROSCI.2287-07.2007; Sabourdy F, 2008, BBA-MOL CELL BIOL L, V1781, P145, DOI 10.1016/j.bbalip.2008.01.004; SANGO K, 1995, NAT GENET, V11, P170, DOI 10.1038/ng1095-170; Sardi SP, 2011, P NATL ACAD SCI USA, V108, P12101, DOI 10.1073/pnas.1108197108; Shayman JA, 2010, DRUG FUTURE, V35, P613, DOI 10.1358/dof.2010.035.08.1505566; Shayman JA, 2014, J LIPID RES, V55, P1215, DOI 10.1194/jlr.R047167; Shen W, 2014, J NEUROCHEM; Sidransky E, 2004, MOL GENET METAB, V83, P6, DOI 10.1016/j.ymgme.2004.08.015; SMITH WC, 1968, LANCET, V2, P780; Sun Y, 2005, J LIPID RES, V46, P2102, DOI 10.1194/jlr.M500202-JLR200; Sun Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057560; Sun Y, 2012, J BIOL CHEM, V287, P4275, DOI 10.1074/jbc.M111.280016; Tammachote R, 2013, J HUM GENET, V58, P594, DOI 10.1038/jhg.2013.60; Tepper AD, 2000, J BIOL CHEM, V275, P34810, DOI 10.1074/jbc.M005142200; TYBULEWICZ VLJ, 1992, NATURE, V357, P407, DOI 10.1038/357407a0; Veldman RJ, 2003, FASEB J, V17, P1144, DOI 10.1096/fj.02-1053fje; VUNNAM RR, 1980, CHEM PHYS LIPIDS, V26, P265; Xu YH, 2003, AM J PATHOL, V163, P2093, DOI 10.1016/S0002-9440(10)63566-3; Xu YH, 1998, MOL GENET METAB, V64, P87, DOI 10.1006/mgme.1998.2709; Xu YH, 2008, MOL GENET METAB, V94, P190, DOI 10.1016/j.ymgme.2008.01.013; Xu YH, 2010, J LIPID RES, V51, P1643, DOI 10.1194/jlr.R003996; Xu YH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010750; YAMAGUCHI Y, 1994, J BIOCHEM-TOKYO, V116, P704, DOI 10.1093/oxfordjournals.jbchem.a124584; Yamashita T, 1999, P NATL ACAD SCI USA, V96, P9142, DOI 10.1073/pnas.96.16.9142	72	8	8	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2014	9	12							e116023	10.1371/journal.pone.0116023	http://dx.doi.org/10.1371/journal.pone.0116023			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UC	25551612	Green Published, Green Submitted, gold			2022-12-27	WOS:000347119100088
J	Chen, Y; Lin, PX; Hsieh, CL; Peng, CC; Peng, RY				Chen, Yeh; Lin, Ping-Xiao; Hsieh, Chiu-Lan; Peng, Chiung-Chi; Peng, Robert Y.			The Proteomic and Genomic Teratogenicity Elicited by Valproic Acid Is Preventable with Resveratrol and alpha-Tocopherol	PLOS ONE			English	Article							HISTONE DEACETYLASE; SKELETAL-MUSCLE; INSULIN SENSITIVITY; N-ACETYLCYSTEINE; GENE-EXPRESSION; MECHANISM; PROTEIN; INHIBITORS; METABOLISM; DIFFERENTIATION	Background: Previously, we reported that valproic acid (VPA), a common antiepileptic drug and a potent teratogenic, dowregulates RBP4 in chicken embryo model (CEM) when induced by VPA. Whether such teratogenicity is associated with more advanced proteomic and genomic alterations, we further performed this present study. Methodology/Principal Findings: VPA (60 mu M) was applied to 36 chicken embryos at HH stage 10 (day-1.5). Resveratrol (RV) and vitamin E (vit E) (each at 0.2 and 2.0 mu M) were applied simultaneously to explore the alleviation effect. The proteins in the cervical muscles of the day-1 chicks were analyzed using 2D-electrophoresis and LC/MS/MS. While the genomics associated with each specific protein alteration was examined with RT-PCR and qPCR. At earlier embryonic stage, VPA downregulated PEBP1 and BHMT genes and at the same time upregulated MYL1, ALB and FLNC genes significantly (p<0.05) without affecting PKM2 gene. Alternatively, VPA directly inhibited the folate-independent (or the betaine-dependent) remethylation pathway. These features were effectively alleviated by RV and vit E. Conclusions: VPA alters the expression of PEBP1, BHMT, MYL1, ALB and FLNC that are closely related with metabolic myopathies, myogenesis, albumin gene expression, and haemolytic anemia. On the other hand, VPA directly inhibits the betaine-dependent remethylation pathway. Taken together, VPA elicits hemorrhagic myoliposis via these action mechanisms, and RV and vit E are effective for alleviation of such adverse effects.	[Chen, Yeh; Peng, Robert Y.] Hungkuang Univ, Biotechnol Res Inst, Taichung 43302, Shalu County, Taiwan; [Lin, Ping-Xiao; Hsieh, Chiu-Lan] Changhua Univ Educ, Grad Inst Biotechnol, Changhua 50007, Taiwan; [Peng, Chiung-Chi] Taipei Med Univ, Coll Med, Grad Inst Clin Med, Taipei 11031, Taiwan; [Peng, Robert Y.] Taipei Med Univ, Coll Med, Res Inst Med Sci, Taipei 11031, Taiwan	Hungkuang University; National Changhua University of Education; Taipei Medical University; Taipei Medical University	Hsieh, CL (corresponding author), Changhua Univ Educ, Grad Inst Biotechnol, 1 Jin De Rd, Changhua 50007, Taiwan.	clhsieh@cc.ncue.edu.tw; ypeng@seed.net.tw			National Science Council [NSC 102-2313-B-018 -001 -MY3, NSC 101-2320-B-039-040]; Taipei Medical University [TMU101-AE1-B11]	National Science Council(Ministry of Science and Technology, Taiwan); Taipei Medical University	This work was funded by the National Science Council NSC 102-2313-B-018 -001 -MY3 and NSC 101-2320-B-039-040 and the Taipei Medical University [TMU101-AE1-B11]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amorim MR, 2007, AM J MED GENET A, V143A, P1726, DOI 10.1002/ajmg.a.31812; Bettaieb A, 2013, J BIOL CHEM, V288, P17360, DOI 10.1074/jbc.M112.441469; BOLLENGIER F, 1988, J NEUROCHEM, V50, P1210, DOI 10.1111/j.1471-4159.1988.tb10594.x; Canepari M, 2010, ACTA PHYSIOL, V199, P465, DOI 10.1111/j.1748-1716.2010.02118.x; Chango A, 2009, J NUTR BIOCHEM, V20, P312, DOI 10.1016/j.jnutbio.2008.04.004; Chuang CM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043692; Combs AP, 2010, J MED CHEM, V53, P2333, DOI 10.1021/jm901090b; D'Amico A, 2013, HAND CLINIC, V113, P1437, DOI 10.1016/B978-0-444-59565-2.00013-7; Dashwood RH, 2007, SEMIN CANCER BIOL, V17, P363, DOI 10.1016/j.semcancer.2007.04.001; Elchebly M, 1999, SCIENCE, V283, P1544, DOI 10.1126/science.283.5407.1544; Frayne J, 1999, CELL TISSUE RES, V298, P415, DOI 10.1007/s004419900113; Gelfi C, 2011, J PROTEOMICS, V74, P774, DOI 10.1016/j.jprot.2011.02.028; GORG A, 1988, ELECTROPHORESIS, V9, P531, DOI 10.1002/elps.1150090913; Gottlicher M, 2001, EMBO J, V20, P6969, DOI 10.1093/emboj/20.24.6969; Gultekin GI, 2012, J VET INTERN MED, V26, P935, DOI 10.1111/j.1939-1676.2012.00958.x; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; Hrzenjak A, 2006, MOL CANCER THER, V5, P2203, DOI 10.1158/1535-7163.MCT-05-0480; Hsieh CL, 2014, CLIN EXP PHARMACOL P, V41, P210, DOI 10.1111/1440-1681.12205; Hsieh CL, 2013, ROM J MORPHOL EMBRYO, V54, P993; Hsieh CL, 2012, TOXICOLOGY, V291, P32, DOI 10.1016/j.tox.2011.10.015; Iezzi S, 2002, P NATL ACAD SCI USA, V99, P7757, DOI 10.1073/pnas.112218599; Johannessen CU, 2000, NEUROCHEM INT, V37, P103, DOI 10.1016/S0197-0186(00)00013-9; Karabiber H, 2003, BRAIN DEV-JPN, V25, P113, DOI 10.1016/S0387-7604(02)00163-8; Ker YB, 2013, CHEM RES TOXICOL, V26, P325, DOI 10.1021/tx300456t; Klaman LD, 2000, MOL CELL BIOL, V20, P5479, DOI 10.1128/MCB.20.15.5479-5489.2000; Kolling J, 2013, CELL BIOCHEM FUNCT, V31, P575, DOI 10.1002/cbf.2938; Lee BR, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-60; Lheureux PER, 2005, CRIT CARE, V9, P431, DOI 10.1186/cc3742; Lin CY, 2009, PROTEOMICS, V9, P696, DOI 10.1002/pmic.200700470; LUDER AS, 1990, J CLIN INVEST, V86, P1574, DOI 10.1172/JCI114877; Mal A, 2001, EMBO J, V20, P1739, DOI 10.1093/emboj/20.7.1739; MCNALLY EM, 1989, NUCLEIC ACIDS RES, V17, P2753, DOI 10.1093/nar/17.7.2753; Menegola Elena, 2006, Birth Defects Research, V78, P345, DOI 10.1002/bdrc.20082; Moresi V, 2012, P NATL ACAD SCI USA, V109, P1649, DOI 10.1073/pnas.1121159109; Neri P, 2008, BRIT J HAEMATOL, V143, P520, DOI 10.1111/j.1365-2141.2008.07387.x; Ohlendieck K, 2011, FRONT PHYSIOL, V2, DOI 10.3389/fphys.2011.00105; Ou XP, 2007, BIOCHEM J, V401, P87, DOI 10.1042/BJ20061119; Phiel CJ, 2001, J BIOL CHEM, V276, P36734, DOI 10.1074/jbc.M101287200; Rosenberg G, 2007, CELL MOL LIFE SCI, V64, P2090, DOI 10.1007/s00018-007-7079-x; Roy M, 2008, J CELL BIOCHEM, V105, P467, DOI 10.1002/jcb.21847; Rugino TA, 2003, PEDIATR NEUROL, V29, P440, DOI 10.1016/S0887-8994(03)00310-2; Ruthenburg AJ, 2007, NAT REV MOL CELL BIO, V8, P983, DOI 10.1038/nrm2298; Schiaffino S, 2010, ACTA PHYSIOL, V199, P451, DOI 10.1111/j.1748-1716.2010.02130.x; Schulpis KH, 2006, TOXICOLOGY, V217, P228, DOI 10.1016/j.tox.2005.10.004; Sun WJ, 2012, ACTA BIOCH BIOPH SIN, V44, P80, DOI 10.1093/abbs/gmr113; Tabatabaei AR, 1999, CHEM RES TOXICOL, V12, P323, DOI 10.1021/tx9801864; Ubeda N, 2002, J NUTR, V132, P2737, DOI 10.1093/jn/132.9.2737; van Gelder MMHJ, 2010, HUM REPROD UPDATE, V16, P378, DOI 10.1093/humupd/dmp052; van Woudenberg AB, 2014, REPROD TOXICOL, V49, P101, DOI 10.1016/j.reprotox.2014.07.082; Venturelli S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073097; Vercellati C, 2013, CLIN LAB, V59, P421, DOI 10.7754/Clin.Lab.2012.120905; Warang P, 2013, BLOOD CELL MOL DIS, V51, P133, DOI 10.1016/j.bcmd.2013.05.006; Woods KM, 2008, INT J RADIAT ONCOL, V72, P153, DOI 10.1016/j.ijrobp.2008.04.072; Yeung K, 2000, MOL CELL BIOL, V20, P3079, DOI 10.1128/MCB.20.9.3079-3085.2000; Yeung K, 1999, NATURE, V401, P173, DOI 10.1038/43686	55	7	7	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2014	9	12							e116534	10.1371/journal.pone.0116534	http://dx.doi.org/10.1371/journal.pone.0116534			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UC	25551574	gold, Green Published, Green Submitted			2022-12-27	WOS:000347119100143
J	Franklin, AM; Squires, ZE; Stuart-Fox, D				Franklin, Amanda M.; Squires, Zoe E.; Stuart-Fox, Devi			Does Predation Risk Affect Mating Behavior? An Experimental Test in Dumpling Squid (Euprymna tasmanica)	PLOS ONE			English	Article							COPULATION DURATION; MULTIPLE PATERNITY; FEMALE CHOICE; MATE CHOICE; COURTSHIP; REPRODUCTION; CUTTLEFISH; DECISIONS; COMPETITION; SURVIVAL	Introduction: One of the most important trade-offs for many animals is that between survival and reproduction. This is particularly apparent when mating increases the risk of predation, either by increasing conspicuousness, reducing mobility or inhibiting an individual's ability to detect predators. Individuals may mitigate the risk of predation by altering their reproductive behavior (e.g. increasing anti-predator responses to reduce conspicuousness). The degree to which individuals modulate their reproductive behavior in relation to predation risk is difficult to predict because both the optimal investment in current and future reproduction (due to life-history strategies) and level of predation risk may differ between the sexes and among species. Here, we investigate the effect of increased predation risk on the reproductive behavior of dumpling squid (Euprymna tasmanica). Results: Females, but not males, showed a substantial increase in the number of inks (an anti-predator behavior) before mating commenced in the presence of a predator (sand flathead Platycephalus bassensis). However, predation risk did not affect copulation duration, the likelihood of mating, female anti-predator behavior during or after mating or male anti-predator behavior at any time. Conclusions: Inking is a common anti-predator defense in cephalopods, thought to act like a smokescreen, decoy or distraction. Female dumpling squid are probably using this form of defense in response to the increase in predation risk prior to mating. Conversely, males were undeterred by the increase in predation risk. A lack of change in these variables may occur if the benefit of completing mating outweighs the risk of predation. Prioritizing current reproduction, even under predation risk, can occur when the chance of future reproduction is low, there is substantial energetic investment into mating, or the potential fitness payoffs of mating are high.	[Franklin, Amanda M.; Squires, Zoe E.; Stuart-Fox, Devi] Univ Melbourne, Dept Zool, Melbourne, Vic 3010, Australia	University of Melbourne	Franklin, AM (corresponding author), Univ Melbourne, Dept Zool, Melbourne, Vic 3010, Australia.	amanda.franklin@tufts.edu		Stuart-Fox, Devi/0000-0003-3362-1412; Squires, Zoe/0000-0002-3878-6753; Franklin, Amanda/0000-0002-8650-8344	Hermon Slade Foundation [HSF 08/2]	Hermon Slade Foundation	Hermon Slade Foundation, HSF 08/2, http://www.hermonslade.org.au/, DS-F. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrade MCB, 2003, BEHAV ECOL, V14, P531, DOI 10.1093/beheco/arg015; Andres JA, 2000, ANIM BEHAV, V59, P695, DOI 10.1006/anbe.1999.1372; BLOODGOOD RA, 1977, TISSUE CELL, V9, P197, DOI 10.1016/0040-8166(77)90016-7; Boal JG, 1997, BEHAVIOUR, V134, P975, DOI 10.1163/156853997X00340; Bonachea LA, 2011, ETHOLOGY, V117, P400, DOI 10.1111/j.1439-0310.2011.01889.x; Candolin U, 1998, P ROY SOC B-BIOL SCI, V265, P1171, DOI 10.1098/rspb.1998.0415; Candolin U, 1997, BEHAV ECOL SOCIOBIOL, V41, P81, DOI 10.1007/s002650050367; Dunn AM, 2008, ANIM BEHAV, V76, P1289, DOI 10.1016/j.anbehav.2008.06.013; Emery AM, 2001, MOL ECOL, V10, P1265, DOI 10.1046/j.1365-294X.2001.01258.x; Fisher DO, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015226; Franklin AM, 2012, BIOL LETTERS, V8, P754, DOI 10.1098/rsbl.2012.0556; Fuller R, 1996, BEHAV ECOL, V7, P69, DOI 10.1093/beheco/7.1.69; Godin JGJ, 1996, ANIM BEHAV, V51, P117, DOI 10.1006/anbe.1996.0010; Guerra C, 2012, AQUAC RES, V43, P756, DOI 10.1111/j.1365-2109.2011.02885.x; Guerrero-Ferreira RC, 2007, CLADISTICS, V23, P497, DOI 10.1111/j.1096-0031.2007.00155.x; GWYNNE DT, 1989, TRENDS ECOL EVOL, V4, P54, DOI 10.1016/0169-5347(89)90144-4; Hanlon R, 2007, CURR BIOL, V17, pR400, DOI 10.1016/j.cub.2007.03.034; Hanlon RT, 1999, MAR BIOL, V134, P719, DOI 10.1007/s002270050588; Hanlon RT, 1996, CEPHALOPOD BEHAV; Herberstein ME, 2011, J ETHOL, V29, P9, DOI 10.1007/s10164-010-0213-5; Kelly CD, 2001, BEHAV ECOL SOCIOBIOL, V51, P95, DOI 10.1007/s002650100410; Kemp DJ, 2012, BEHAV ECOL, V23, P191, DOI 10.1093/beheco/arr173; KLUMPP DW, 1983, AUST J MAR FRESH RES, V34, P745; Koga T, 1998, P ROY SOC B-BIOL SCI, V265, P1385, DOI 10.1098/rspb.1998.0446; LIMA SL, 1990, CAN J ZOOL, V68, P619, DOI 10.1139/z90-092; MAGNHAGEN C, 1990, BEHAV ECOL SOCIOBIOL, V26, P331; MAGNHAGEN C, 1991, TRENDS ECOL EVOL, V6, P183, DOI 10.1016/0169-5347(91)90210-O; MCCAULEY DE, 1986, AM NAT, V127, P112, DOI 10.1086/284472; McLean CA, 2010, BEHAVIOUR, V147, P1803, DOI 10.1163/000579510X537378; Moltschaniwskyj NA, 2007, REV FISH BIOL FISHER, V17, P455, DOI 10.1007/s11160-007-9056-8; Naud MJ, 2005, P ROY SOC B-BIOL SCI, V272, P1047, DOI 10.1098/rspb.2004.3031; Norman MD, 1997, J MAR BIOL ASSOC UK, V77, P1109, DOI 10.1017/S0025315400038662; Quinn GP, 2003, EXPT DESIGN DATA ANA; Rodriguez-Munoz R, 2011, CURR BIOL, V21, P1716, DOI 10.1016/j.cub.2011.08.053; Roff Derek A., 1992; ROWE L, 1994, ANIM BEHAV, V48, P1049, DOI 10.1006/anbe.1994.1338; RYAN MJ, 1982, AM NAT, V119, P136, DOI 10.1086/283899; Shaw PW, 2004, MAR ECOL PROG SER, V270, P173, DOI 10.3354/meps270173; SIH A, 1990, AM NAT, V135, P284, DOI 10.1086/285044; SIH A, 1994, J FISH BIOL, V45, P111, DOI 10.1111/j.1095-8649.1994.tb01087.x; Squires ZE, 2014, MAR ECOL PROG SER, V511, P93, DOI 10.3354/meps10898; Squires ZE, 2013, J MOLLUS STUD, V79, P263, DOI 10.1093/mollus/eyt025; Staudinger MD, 2011, ANIM BEHAV, V81, P585, DOI 10.1016/j.anbehav.2010.12.002; Stearns S.C., 1992, pi; Taylor AR, 2005, J ARACHNOL, V33, P76, DOI 10.1636/S03-59; TRAVERS SE, 1991, ECOLOGY, V72, P2123, DOI 10.2307/1941564; Velde LV, 2012, BEHAV ECOL SOCIOBIOL, V66, P347, DOI 10.1007/s00265-011-1281-4; Wong BBM, 2009, BIOL LETTERS, V5, P600, DOI 10.1098/rsbl.2009.0350; Wood JB, 2010, J EXP MAR BIOL ECOL, V388, P20, DOI 10.1016/j.jembe.2010.03.010	49	12	12	0	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2014	9	12							e115027	10.1371/journal.pone.0115027	http://dx.doi.org/10.1371/journal.pone.0115027			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UC	25551378	gold, Green Published, Green Submitted			2022-12-27	WOS:000347119100023
J	Han, ST; Wong, RKW; Lee, TCM; Shen, LH; Li, SYR; Fan, XD				Han, Shengtong; Wong, Raymond K. W.; Lee, Thomas C. M.; Shen, Linghao; Li, Shuo-Yen R.; Fan, Xiaodan			A Full Bayesian Approach for Boolean Genetic Network Inference	PLOS ONE			English	Article							FLAT FOOT; FLEXIBLE FLATFOOT; OVERWEIGHT; CHILDREN; FEET; PREVALENCE; ARCH	Boolean networks are a simple but efficient model for describing gene regulatory systems. A number of algorithms have been proposed to infer Boolean networks. However, these methods do not take full consideration of the effects of noise and model uncertainty. In this paper, we propose a full Bayesian approach to infer Boolean genetic networks. Markov chain Monte Carlo algorithms are used to obtain the posterior samples of both the network structure and the related parameters. In addition to regular link addition and removal moves, which can guarantee the irreducibility of the Markov chain for traversing the whole network space, carefully constructed mixture proposals are used to improve the Markov chain Monte Carlo convergence. Both simulations and a real application on cell-cycle data show that our method is more powerful than existing methods for the inference of both the topology and logic relations of the Boolean network from observed data.	[Han, Shengtong; Fan, Xiaodan] Chinese Univ Hong Kong, Dept Stat, Shatin, Hong Kong, Peoples R China; [Wong, Raymond K. W.] Iowa State Univ, Dept Stat, Ames, IA USA; [Lee, Thomas C. M.] Univ Calif Davis, Dept Stat, Davis, CA 95616 USA; [Shen, Linghao; Li, Shuo-Yen R.] Chinese Univ Hong Kong, Dept Informat Engn, Shatin, Hong Kong, Peoples R China; [Li, Shuo-Yen R.] Univ Elect Sci & Technol China, Chengdu 610054, Peoples R China	Chinese University of Hong Kong; Iowa State University; University of California System; University of California Davis; Chinese University of Hong Kong; University of Electronic Science & Technology of China	Fan, XD (corresponding author), Chinese Univ Hong Kong, Dept Stat, Shatin, Hong Kong, Peoples R China.	xfan@sta.cuhk.edu.hk	Han, Shengtong/T-1358-2019; Li, Shuo/GXV-6545-2022; Fan, Xiaodan/Q-2208-2018; Li, Shuo/N-5364-2019	Han, Shengtong/0000-0002-7203-1143; Fan, Xiaodan/0000-0002-2744-9030; Li, Shuo/0000-0002-5184-3230; Wong, Raymond K. W./0000-0001-9342-3755; Lee, Thomas/0000-0001-7067-405X	Research Grants Council of the Hong Kong SAR [CUHK 400913]; CUHK direct grant [CUHK 2060419]; University Grants Committee of the Hong Kong Special Administrative Region, China [AoE/E-02/08]; National Science Foundation of USA [1007520, 1209226, 1209232]; National Basic Research Program of China (973 Program) [2012CB315901, 2012CB315904]	Research Grants Council of the Hong Kong SAR(Hong Kong Research Grants Council); CUHK direct grant(Chinese University of Hong Kong); University Grants Committee of the Hong Kong Special Administrative Region, China; National Science Foundation of USA(National Science Foundation (NSF)); National Basic Research Program of China (973 Program)(National Basic Research Program of China)	This research is partially supported by a grant from the Research Grants Council of the Hong Kong SAR (Project no. CUHK 400913), a CUHK direct grant (Project no. CUHK 2060419), a grant from the University Grants Committee of the Hong Kong Special Administrative Region, China (Project No. AoE/E-02/08), three grants from the National Science Foundation of USA (Grant No. 1007520, 1209226, and 1209232), and a grant from the National Basic Research Program of China (973 Program, No. 2012CB315901, No. 2012CB315904). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benaglia T, 2009, MIXTOOLS R PACKAGE A; Berger V.W, 2005, ENCY STAT BEHAV SCI; CAVANAGH PR, 1987, J BIOMECH, V20, P547, DOI 10.1016/0021-9290(87)90255-7; Chang JH, 2010, EUR J PEDIATR, V169, P447, DOI 10.1007/s00431-009-1050-9; Chen KC, 2011, EUR J PEDIATR, V170, P931, DOI 10.1007/s00431-010-1380-7; Dyal CM, 1997, FOOT ANKLE INT, V18, P85, DOI 10.1177/107110079701800208; El O, 2006, RHEUMATOL INT, V26, P1050, DOI 10.1007/s00296-006-0128-1; FORRIOL F, 1990, FOOT ANKLE, V11, P101, DOI 10.1177/107110079001100208; Harris Edwin J, 2004, J Foot Ankle Surg, V43, P341; Kaufman KR, 1999, AM J SPORT MED, V27, P585, DOI 10.1177/03635465990270050701; Kohls-Gatzoulis J, 2004, BMJ-BRIT MED J, V329, P1328, DOI 10.1136/bmj.329.7478.1328; Levinger P, 2010, GAIT POSTURE, V32, P519, DOI 10.1016/j.gaitpost.2010.07.013; Lin CH, 2006, PHYSIOL MEAS, V27, P119, DOI 10.1088/0967-3334/27/2/003; Lin CJ, 2001, J PEDIATR ORTHOPED, V21, P378, DOI 10.1097/00004694-200105000-00022; Mathieson I., 1999, FOOT, V9, P145, DOI [10.1054/foot.1999.0544, DOI 10.1054/FOOT.1999.0544]; Mauch M, 2008, INT J OBESITY, V32, P1068, DOI 10.1038/ijo.2008.52; Mickle KJ, 2006, OBESITY, V14, P1949, DOI 10.1038/oby.2006.227; Nikolaidou M., 2006, FOOT, V16, P82, DOI [DOI 10.1016/J.F00T.2006.02.001, 10.1016/j.foot.2006.02.001]; Onodera Andrea Naomi, 2008, Foot (Edinb), V18, P142, DOI 10.1016/j.foot.2008.03.003; Pfeiffer M, 2006, PEDIATRICS, V118, P634, DOI 10.1542/peds.2005-2126; RAO UB, 1992, J BONE JOINT SURG BR, V74, P525, DOI 10.1302/0301-620X.74B4.1624509; ROSE GK, 1985, J BONE JOINT SURG BR, V67, P71, DOI 10.1302/0301-620X.67B1.3968149; SILVINO N, 1980, CLIN ORTHOP RELAT R, P265; STAHELI LT, 1987, J BONE JOINT SURG AM, V69A, P426; Tudor A, 2009, PEDIATRICS, V123, pe386, DOI 10.1542/peds.2008-2262; Tweed JL, 2008, J AM PODIAT MED ASSN, V98, P436, DOI 10.7547/0980436; Villarroya MA, 2008, INT J PEDIATR OBES, V3, P39, DOI 10.1080/17477160701520298; Welton E A, 1992, Foot Ankle, V13, P462	28	11	11	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2014	9	12							e115806	10.1371/journal.pone.0115806	http://dx.doi.org/10.1371/journal.pone.0115806			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UC	25551820	Green Published, Green Submitted, gold			2022-12-27	WOS:000347119100063
J	Hayashi, M; Takeshita, K; Uchida, Y; Yamamoto, K; Kikuchi, R; Nakayama, T; Nomura, E; Cheng, XW; Matsushita, T; Nakamura, S; Murohara, T				Hayashi, Motoharu; Takeshita, Kyosuke; Uchida, Yasuhiro; Yamamoto, Koji; Kikuchi, Ryosuke; Nakayama, Takayuki; Nomura, Emiko; Cheng, Xian Wu; Matsushita, Tadashi; Nakamura, Shigeo; Murohara, Toyoaki			Angiotensin II Receptor Blocker Ameliorates Stress-Induced Adipose Tissue Inflammation and Insulin Resistance	PLOS ONE			English	Article							PLASMINOGEN-ACTIVATOR INHIBITOR-1; SYSTEM; GENE; HYPERTENSION; TARGET; EXPRESSION; IRBESARTAN; OBESITY; MICE; LINK	A strong causal link exists between psychological stress and insulin resistance as well with hypertension. Meanwhile, stress-related responses play critical roles in glucose metabolism in hypertensive patients. As clinical trials suggest that angiotensin-receptor blocker delays the onset of diabetes in hypertensive patients, we investigated the effects of irbesartan on stress-induced adipose tissue inflammation and insulin resistance. C57BL/6J mice were subjected to 2-week intermittent restraint stress and orally treated with vehicle, 3 and 10 mg/kg/day irbesartan. The plasma concentrations of lipid and proinflammatory cytokines [Monocyte Chemoattractant Protein-1 (MCP-1), tumor necrosis factor-alpha, and interleukin-6] were assessed with enzyme-linked immunosorbent assay. Monocyte/macrophage accumulation in inguinal white adipose tissue (WAT) was observed with CD11b-positive cell counts and mRNA expressions of CD68 and F4/80 using immunohistochemistry and RT-PCR methods respectively. The mRNA levels of angiotensinogen, proinflammatory cytokines shown above, and adiponectin in WAT were also assessed with RT-PCR method. Glucose metabolism was assessed by glucose tolerance tests (GTTs) and insulin tolerance tests, and mRNA expression of insulin receptor substrate-1 (IRS-1) and glucose transporter 4 (GLUT4) in WAT. Restraint stress increased monocyte accumulation, plasma free fatty acids, expression of angiotensinogen and proinflammatory cytokines including MCP-1, and reduced adiponectin. Irbesartan reduced stress-induced monocyte accumulation in WAT in a dose dependent manner. Irbesartan treatment also suppressed induction of adipose angiotensinogen and proinflammatory cytokines in WAT and blood, and reversed changes in adiponectin expression. Notably, irbesartan suppressed stress-induced reduction in adipose tissue weight and free fatty acid release, and improved insulin tolerance with restoration of IRS-1 and GLUT4 mRNA expressions in WAT. The results indicate that irbesartan improves stress-induced adipose tissue inflammation and insulin resistance. Our results suggests that irbesartan treatment exerts additive benefits for glucose metabolism in hypertensive patients with mental stress.	[Hayashi, Motoharu; Takeshita, Kyosuke; Uchida, Yasuhiro; Cheng, Xian Wu; Murohara, Toyoaki] Nagoya Univ, Grad Sch Med, Dept Cardiol, Nagoya, Aichi 4648601, Japan; [Takeshita, Kyosuke; Kikuchi, Ryosuke] Nagoya Univ Hosp, Dept Clin Lab, Nagoya, Aichi, Japan; [Yamamoto, Koji; Nomura, Emiko; Matsushita, Tadashi] Nagoya Univ Hosp, Dept Blood Transfus, Nagoya, Aichi, Japan; [Nakamura, Shigeo] Nagoya Univ Hosp, Dept Pathol, Nagoya, Aichi, Japan; [Nakayama, Takayuki] Aichi Med Univ Hosp, Dept Blood Transfus, Nagakute, Aichi, Japan	Nagoya University; Nagoya University; Nagoya University; Nagoya University; Aichi Medical University	Takeshita, K (corresponding author), Nagoya Univ, Grad Sch Med, Dept Cardiol, Nagoya, Aichi 4648601, Japan.	kyousuke@med.nagoya-u.ac.jp	Murohara, Toyoaki/M-4958-2014; Takeshita, Kyosuke/B-7008-2012; Kikuchi, Ryosuke/AAX-4971-2021; Takeshita, Kyosuke/AAD-9515-2020; Matsushita, Tadadshi/I-7349-2014	Takeshita, Kyosuke/0000-0002-8283-3799; Takeshita, Kyosuke/0000-0002-8283-3799; Nakayama, Takayuki/0000-0003-2389-2542	SENSHIN Medical Research Foundation; Suzuken Memorial Foundation;  [25461336]	SENSHIN Medical Research Foundation(SENSHIN Medical Research Foundation); Suzuken Memorial Foundation; 	This study was supported by research grants from SENSHIN Medical Research Foundation (to KT), Suzuken Memorial Foundation (to KT), and a Grant-in-Aid for Scientific Research (Kakenhi 25461336 to KT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel ED, 2001, NATURE, V409, P729, DOI 10.1038/35055575; Aoyama T, 2009, BIOCHEM BIOPH RES CO, V383, P216, DOI 10.1016/j.bbrc.2009.03.154; Arnaldi G, 2010, NEUROENDOCRINOLOGY, V92, P86, DOI 10.1159/000314213; Benito Manuel, 2011, Archives of Physiology and Biochemistry, V117, P96, DOI 10.3109/13813455.2011.563748; Brasier AR, 1996, HYPERTENSION, V27, P465, DOI 10.1161/01.HYP.27.3.465; Cheung BMY, 2012, CURR ATHEROSCLER REP, V14, P160, DOI 10.1007/s11883-012-0227-2; Cox SS, 2014, BRAIN BEHAV IMMUN, V36, P183, DOI 10.1016/j.bbi.2013.11.018; Elliott WJ, 2007, LANCET, V369, P201, DOI 10.1016/S0140-6736(07)60108-1; Fliers E, 2003, J NEUROENDOCRINOL, V15, P1005, DOI 10.1046/j.1365-2826.2003.01096.x; Groeschel M, 2011, AM J PHYSIOL-RENAL, V300, pF1, DOI 10.1152/ajprenal.00208.2010; Hamer M, 2010, NEUROSCI BIOBEHAV R, V35, P76, DOI 10.1016/j.neubiorev.2009.11.004; Harte A, 2005, CIRCULATION, V111, P1954, DOI 10.1161/01.CIR.0000161954.17870.5D; Hussey SE, 2013, DIABETOLOGIA; Jain S, 2007, AM J PHYSIOL-CELL PH, V293, pC401, DOI 10.1152/ajpcell.00433.2006; Kalupahana NS, 2012, OBES REV, V13, P136, DOI 10.1111/j.1467-789X.2011.00942.x; Kintscher U, 2007, CARDIOVASC DIABETOL, V6, DOI 10.1186/1475-2840-6-12; Nieto-Vazquez Iria, 2008, Archives of Physiology and Biochemistry, V114, P183, DOI [10.1080/13813450802181047, 10.1080/13813450802181047 ]; Prasad A, 2004, CIRCULATION, V110, P1507, DOI 10.1161/01.CIR.0000141736.76561.78; Putnam K, 2012, AM J PHYSIOL-HEART C, V302, pH1219, DOI 10.1152/ajpheart.00796.2011; Ruan H, 2002, DIABETES, V51, P3176, DOI 10.2337/diabetes.51.11.3176; Schupp M, 2005, DIABETES, V54, P3442, DOI 10.2337/diabetes.54.12.3442; Smith MM, 2012, J PHYSIOL-LONDON, V590, P1787, DOI 10.1113/jphysiol.2011.221036; Suganami T, 2010, J LEUKOCYTE BIOL, V88, P33, DOI 10.1189/jlb.0210072; Takeshita K, 2004, CIRCULATION, V109, P1776, DOI 10.1161/01.CIR.0000124224.48962.32; Takeshita K, 2002, SEMIN THROMB HEMOST, V28, P545, DOI 10.1055/s-2002-36699; Takeshita K, 2014, HYPERTENS RES; Tamura Y, 2008, ARTERIOSCL THROM VAS, V28, P2195, DOI 10.1161/ATVBAHA.108.168633; Tsukuda K, 2011, BIOCHEM BIOPH RES CO, V409, P275, DOI 10.1016/j.bbrc.2011.04.142; Uchida Y, 2012, DIABETES, V61, P1552, DOI 10.2337/db11-0828; Wang CH, 2007, J BIOL CHEM, V282, P7991, DOI 10.1074/jbc.M700098200; Yamamoto K, 2002, P NATL ACAD SCI USA, V99, P890, DOI 10.1073/pnas.022608799; Yang Y, 2013, METABOLISM, V62, P1858, DOI 10.1016/j.metabol.2013.08.008; Yasue S, 2010, AM J HYPERTENS, V23, P425, DOI 10.1038/ajh.2009.263; Yvan-Charvet L, 2011, KIDNEY INT, V79, P162, DOI 10.1038/ki.2010.391	34	21	23	0	73	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2014	9	12							e116163	10.1371/journal.pone.0116163	http://dx.doi.org/10.1371/journal.pone.0116163			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UC	25551221	Green Submitted, Green Published, gold			2022-12-27	WOS:000347119100105
J	Prigozhin, DM; Krieger, IV; Huizar, JP; Mavrici, D; Waldo, GS; Hung, LW; Sacchettini, JC; Terwilliger, TC; Alber, T				Prigozhin, Daniil M.; Krieger, Inna V.; Huizar, John P.; Mavrici, Daniela; Waldo, Geoffrey S.; Hung, Li-Wei; Sacchettini, James C.; Terwilliger, Thomas C.; Alber, Tom			Subfamily-Specific Adaptations in the Structures of Two Penicillin-Binding Proteins from Mycobacterium tuberculosis	PLOS ONE			English	Article							PEPTIDOGLYCAN BIOSYNTHESIS; CELL-WALLS; IN-VITRO; MODEL; RESOLUTION; COMPLEX; SYSTEM; SUITE	Beta-lactam antibiotics target penicillin-binding proteins including several enzyme classes essential for bacterial cell-wall homeostasis. To better understand the functional and inhibitor-binding specificities of penicillin-binding proteins from the pathogen, Mycobacterium tuberculosis, we carried out structural and phylogenetic analysis of two predicted D,D-carboxypeptidases, Rv2911 and Rv3330. Optimization of Rv2911 for crystallization using directed evolution and the GFP folding reporter method yielded a soluble quadruple mutant. Structures of optimized Rv2911 bound to phenylmethylsulfonyl fluoride and Rv3330 bound to meropenem show that, in contrast to the nonspecific inhibitor, meropenem forms an extended interaction with the enzyme along a conserved surface. Phylogenetic analysis shows that Rv2911 and Rv3330 belong to different clades that emerged in Actinobacteria and are not represented in model organisms such as Escherichia coli and Bacillus subtilis. Clade-specific adaptations allow these enzymes to fulfill distinct physiological roles despite strict conservation of core catalytic residues. The characteristic differences include potential protein-protein interaction surfaces and specificity-determining residues surrounding the catalytic site. Overall, these structural insights lay the groundwork to develop improved beta-lactam therapeutics for tuberculosis.	[Prigozhin, Daniil M.; Huizar, John P.; Mavrici, Daniela; Alber, Tom] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Prigozhin, Daniil M.; Huizar, John P.; Mavrici, Daniela; Alber, Tom] Univ Calif Berkeley, Calif Inst Quantitat Biosci, Berkeley, CA 94720 USA; [Krieger, Inna V.; Waldo, Geoffrey S.; Hung, Li-Wei; Terwilliger, Thomas C.] Los Alamos Natl Lab, Los Alamos, NM 87545 USA; [Krieger, Inna V.; Sacchettini, James C.] Texas A&M Univ, Dept Biochem & Biophys, College Stn, TX 77843 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; United States Department of Energy (DOE); Los Alamos National Laboratory; Texas A&M University System; Texas A&M University College Station	Prigozhin, DM (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA.	daniil.prigozhin@gmail.com	Terwilliger, Thomas/AAM-4079-2020; Terwilliger, Thomas/AEF-4827-2022; Terwilliger, Thomas C/K-4109-2012	Terwilliger, Thomas/0000-0001-6384-0320; Terwilliger, Thomas C/0000-0001-6384-0320; Prigozhin, Daniil M/0000-0003-2075-0231; Hung, Li-Wei/0000-0001-6690-8458	National Institute of Allergy and Infectious Diseases (NIAID)/National Institutes of Health (NIH) [AI095208]; Office of Science, Office of Basic Energy Sciences, of the United States Department of Energy [DE-AC02-05CH11231]; NIH, National Institute of General Medical Sciences; Howard Hughes Medical Institute; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI095208] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases (NIAID)/National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Office of Science, Office of Basic Energy Sciences, of the United States Department of Energy(United States Department of Energy (DOE)); NIH, National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work has been supported by the National Institute of Allergy and Infectious Diseases (NIAID)/National Institutes of Health (NIH) grant AI095208. The Advanced Light Source is supported by the Director, Office of Science, Office of Basic Energy Sciences, of the United States Department of Energy under Contract No. DE-AC02-05CH11231. The BCSB is supported in part by the NIH, National Institute of General Medical Sciences, and the Howard Hughes Medical Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Bourai N, 2012, MICROB PATHOGENESIS, V52, P109, DOI 10.1016/j.micpath.2011.11.003; Chen Y, 2009, J AM CHEM SOC, V131, P14345, DOI 10.1021/ja903773f; Cordillot M, 2013, ANTIMICROB AGENTS CH, V57, P5940, DOI 10.1128/AAC.01663-13; Crick DC, 2001, GLYCOBIOLOGY, V11, p107R, DOI 10.1093/glycob/11.9.107R; Doublie S, 1997, METHOD ENZYMOL, V276, P523, DOI 10.1016/S0076-6879(97)76075-0; Eddy SR, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002195; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fedarovich A, 2012, J MOL BIOL, V418, P316, DOI 10.1016/j.jmb.2012.02.021; Finn RD, 2010, NUCLEIC ACIDS RES, V38, pD211, DOI 10.1093/nar/gkp985; Hugonnet JE, 2009, SCIENCE, V323, P1215, DOI 10.1126/science.1167498; Janin YL, 2007, BIOORGAN MED CHEM, V15, P2479, DOI 10.1016/j.bmc.2007.01.030; Koul A, 2011, NATURE, V469, P483, DOI 10.1038/nature09657; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Kumar P, 2012, MOL MICROBIOL, V86, P367, DOI 10.1111/j.1365-2958.2012.08199.x; Lavollay M, 2008, J BACTERIOL, V190, P4360, DOI 10.1128/JB.00239-08; LEDERER E, 1975, MOL CELL BIOCHEM, V7, P87, DOI 10.1007/BF01792076; Lovering AL, 2012, ANNU REV BIOCHEM, V81, P451, DOI 10.1146/annurev-biochem-061809-112742; MacDowell AA, 2004, J SYNCHROTRON RADIAT, V11, P447, DOI 10.1107/S0909049504024835; Mahapatra S, 2005, J BACTERIOL, V187, P2341, DOI 10.1128/JB.187.7.2341-2347.2005; Malen H, 2007, PROTEOMICS, V7, P1702, DOI 10.1002/pmic.200600853; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Russell DG, 2010, SCIENCE, V328, P852, DOI 10.1126/science.1184784; Sauvage E, 2008, FEMS MICROBIOL REV, V32, P234, DOI 10.1111/j.1574-6976.2008.00105.x; Sauvage E, 2007, J MOL BIOL, V371, P528, DOI 10.1016/j.jmb.2007.05.071; SCHLEIFER KH, 1972, BACTERIOL REV, V36, P407, DOI 10.1128/MMBR.36.4.407-477.1972; Sheldrick GM, 1997, METHOD ENZYMOL, V277, P319, DOI 10.1016/S0076-6879(97)77018-6; STEMMER WPC, 1994, NATURE, V370, P389, DOI 10.1038/370389a0; Szwedziak P, 2013, CURR OPIN MICROBIOL, V16, P745, DOI 10.1016/j.mib.2013.09.003; Terwilliger TC, 2003, ACTA CRYSTALLOGR D, V59, P38, DOI 10.1107/S0907444902018036; Waldo GS, 1999, NAT BIOTECHNOL, V17, P691, DOI 10.1038/10904; WANG BC, 1985, METHOD ENZYMOL, V115, P90; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Wong S, 2004, P NATL ACAD SCI USA, V101, P17456, DOI 10.1073/pnas.0407061101	38	5	5	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2014	9	12							e116249	10.1371/journal.pone.0116249	http://dx.doi.org/10.1371/journal.pone.0116249			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UC	25551456	Green Submitted, Green Published, gold			2022-12-27	WOS:000347119100114
J	Teng, YK; Huang, JL; Yeh, KW; Fu, LS; Lin, CH; Ma, WF; Lee, SD; Chiang, LC				Teng, Yu-Kuei; Huang, Jing-Long; Yeh, Kuo-Wei; Fu, Lin-Shien; Lin, Chia-Huei; Ma, Wei-Fen; Lee, Shin-Da; Chiang, Li-Chi			Influential Factors of Insufficient Physical Activity among Adolescents with Asthma in Taiwan	PLOS ONE			English	Article							LIFE-STYLE; CHILDREN; OVERWEIGHT; YOUTH; ASSOCIATIONS; EXERCISE; PREVALENCE; BEHAVIOR; SUPPORT; FITNESS	Purpose: Little research has been reported concerning insufficient physical activity in Taiwanese adolescents with asthma. The aims of this paper are to compare the amount of physical activity between asthmatic and non-asthmatic adolescents in Taiwan, as well as to investigate the influential factors associated with insufficient physical activity in asthmatic adolescents. Methods: Self-reporting structured questionnaires (socio-economic status, scale of family support for physical activity, amount of physical activity) and peak expiratory flow were assessed from 286 adolescents with asthma and 588 non-asthmatic adolescents in a cross-sectional design. Insufficient amount of physical activity was based on less than 300 minutes per week of moderate and vigorous physical activity. Results: Adolescents with asthma have a greater amount of physical activity and a higher level of family support than those who are non-asthmatic. In Taiwan, adolescents with asthma, girls relative to boys, obesity relative to average weight, and low family support relative to high family support were found to be associated with insufficient physical activity. Conclusion: Physical activity in adolescents with asthma is insufficient especially in girls, in asthmatics with obesity, and in those with low family support. We suggest that physical activity programs should be applied to Taiwan adolescents with asthma in order to match the criteria of 300 minutes per week of moderate and vigorous physical activity, especially for girls, the obese and those with a low level of family support.	[Teng, Yu-Kuei; Lee, Shin-Da] China Med Univ, Grad Inst Clin Med Sci, Taichung, Taiwan; [Teng, Yu-Kuei; Ma, Wei-Fen; Chiang, Li-Chi] China Med Univ, Sch Nursing, Taichung, Taiwan; [Huang, Jing-Long; Yeh, Kuo-Wei] Chang Gung Mem Hosp, Div Allergy Asthma & Rheumatol, Dept Pediat, Taoyuan, Taiwan; [Huang, Jing-Long; Yeh, Kuo-Wei] Chang Gung Univ, Taoyuan, Taiwan; [Fu, Lin-Shien] Taichung Vet Gen Hosp, Dept Pediat, Div Pediat Immunol & Nephrol, Taichung, Taiwan; [Lin, Chia-Huei] Grad Inst Med Sci, Taipei, Taiwan; [Lin, Chia-Huei; Chiang, Li-Chi] Natl Def Med Ctr, Sch Nursing, Taipei, Taiwan; [Lin, Chia-Huei] Triserv Gen Hosp, Dept Nursing, Taipei, Taiwan; [Lee, Shin-Da] China Med Univ, Grad Inst Rehabil Sci, Dept Phys Therapy, Taichung, Taiwan; [Lee, Shin-Da] Asia Univ, Dept Healthcare Adm, Taichung, Taiwan	China Medical University Taiwan; China Medical University Taiwan; Chang Gung Memorial Hospital; Chang Gung University; Taichung Veterans General Hospital; National Defense Medical Center; Tri-Service General Hospital; China Medical University Taiwan; Asia University Taiwan	Lee, SD (corresponding author), China Med Univ, Grad Inst Clin Med Sci, Taichung, Taiwan.	shinda@mail.cmu.edu.tw; lichichiang@gmail.com	Lee, Shin-Da/Q-2798-2015; Yeh, Kuo-Wei/V-3725-2019; Chiang, Li-Chi/AAW-9661-2020; Lin, Chia-Huei/GLQ-5499-2022	Lee, Shin-Da/0000-0002-8393-8349; Huang, Jing-Long/0000-0001-9280-920X	National Science Council, Republic of China [NSC-95-2314-B-039-020-MY2]	National Science Council, Republic of China(Ministry of Science and Technology, Taiwan)	This work was supported by the National Science Council, Republic of China (NSC-95-2314-B-039-020-MY2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AARON DJ, 1993, MED SCI SPORT EXER, V25, P847, DOI 10.1249/00005768-199307000-00014; Basaran S, 2006, J REHABIL MED, V38, P130, DOI 10.1080/16501970500476142; Beets MW, 2010, HEALTH EDUC BEHAV, V37, P621, DOI 10.1177/1090198110363884; Butcher K, 2008, J ADOLESCENT HEALTH, V42, P360, DOI 10.1016/j.jadohealth.2007.09.025; Cardon G, 2005, PUBLIC HEALTH NUTR, V8, P896, DOI 10.1079/PHN2005738; Chen W, 2010, PEDIATR NEONATOL, V51, P69, DOI 10.1016/S1875-9572(10)60014-9; Chen YH, 2006, THESIS CHINA MED U T; Chiang LC, 2006, J ADV NURS, V54, P653, DOI 10.1111/j.1365-2648.2006.03873.x; De Cocker K, 2011, PUBLIC HEALTH NUTR, V14, P246, DOI 10.1017/S1368980010000558; Eijkemans M, 2008, PEDIATRICS, V121, pE666, DOI 10.1542/peds.2007-1236; Eijkemans M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050775; de Moraes ACF, 2013, NUTR HOSP, V28, P575, DOI 10.3305/nh.2013.28.3.6398; Fredricks JA, 2005, J SPORT EXERCISE PSY, V27, P3, DOI 10.1123/jsep.27.1.3; FUCHS R, 1988, PREV MED, V17, P746, DOI 10.1016/0091-7435(88)90093-X; Glazebrook C, 2006, PEDIATRICS, V118, P2443, DOI 10.1542/peds.2006-1846; Hoefer WR, 2001, AM J PREV MED, V21, P48, DOI 10.1016/S0749-3797(01)00314-2; Hollingshead August B., 1958, SOCIAL CLASS MENTAL; Hong ZR, 2003, SEX ROLES, V48, P495, DOI 10.1023/A:1023571111617; Huang SJ, 2004, HEALTH PLACE, V16, P470; Janssen I, 2005, OBES REV, V6, P123, DOI 10.1111/j.1467-789X.2005.00176.x; Janssen I, 2004, J ADOLESCENT HEALTH, V35, P360, DOI [10.1016/j.jadohealth.2003.11.095, 10.1016/S1054-139X(04)00058-8]; Kim JW, 2012, EUR J PUBLIC HEALTH, V22, P864, DOI 10.1093/eurpub/ckr175; Kuo J, 2007, AM J PUBLIC HEALTH, V97, P101, DOI 10.2105/AJPH.2005.072348; Lang DM, 2004, PEDIATRICS, V113, pE341, DOI 10.1542/peds.113.4.e341; Lasheras L, 2001, PREV MED, V32, P455, DOI 10.1006/pmed.2001.0843; Lee PH, 2000, THESIS NAT TAIWAN NO; Liou Yiing Mei, 2008, J Nurs Res, V16, P252; Lowry R, 2002, J SCHOOL HEALTH, V72, P413, DOI 10.1111/j.1746-1561.2002.tb03551.x; Malina RM, 2004, GROWTH MATURATION PH, P101; McGuire MT, 2002, J ADOLESCENT HEALTH, V30, P253, DOI 10.1016/S1054-139X(01)00392-5; Milgrom H, 1999, PEDIATRICS, V104, DOI 10.1542/peds.104.3.e38; Mo Frank, 2005, Int J Adolesc Med Health, V17, P49; Nelson MC, 2006, PEDIATRICS, V118, pE1627, DOI 10.1542/peds.2006-0926; Oguma Y, 2002, BRIT J SPORT MED, V36, P162, DOI 10.1136/bjsm.36.3.162; Rasmussen F, 2000, EUR RESPIR J, V16, P866, DOI 10.1183/09031936.00.16586600; Sallis JF, 2000, MED SCI SPORT EXER, V32, P963, DOI 10.1097/00005768-200009000-00012; Saunders RP, 2004, AM J HEALTH BEHAV, V28, P426; Taylor ED, 2006, PEDIATRICS, V117, P2167, DOI 10.1542/peds.2005-1832; Vahlkvist S, 2010, ALLERGY, V65, P1464, DOI 10.1111/j.1398-9995.2010.02406.x; Van der Horst K, 2007, MED SCI SPORT EXER, V39, P1241, DOI 10.1249/mss.0b013e318059bf35; WESTON AR, 1989, J ASTHMA, V26, P279, DOI 10.3109/02770908909073264; WHO, 2010, SCREENING DONATED BLOOD FOR TRANSFUSION: TRANSMISSIBLE INFECTIONS, P1; Williams B, 2008, BMC FAM PRACT, V9, DOI 10.1186/1471-2296-9-40; Wu TY, 2003, INT J BEHAV MED, V10, P93, DOI 10.1207/S15327558IJBM1002_01; ZAKARIAN JM, 1994, PREV MED, V23, P314, DOI 10.1006/pmed.1994.1044	45	9	9	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2014	9	12							e116417	10.1371/journal.pone.0116417	http://dx.doi.org/10.1371/journal.pone.0116417			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AX7UC	25551759	Green Submitted, gold, Green Published			2022-12-27	WOS:000347119100139
J	Waschbisch, A; Sanderson, N; Krumbholz, M; Vlad, G; Theil, D; Schwab, S; Maurer, M; Derfuss, T				Waschbisch, Anne; Sanderson, Nicholas; Krumbholz, Markus; Vlad, George; Theil, Diethilde; Schwab, Stefan; Maeurer, Mathias; Derfuss, Tobias			Interferon Beta and Vitamin D Synergize to Induce Immunoregulatory Receptors on Peripheral Blood Monocytes of Multiple Sclerosis Patients	PLOS ONE			English	Article							T-CELL RESPONSES; DENDRITIC CELLS; SUPPRESSOR-CELLS; RELAPSE RISK; 25-HYDROXYVITAMIN D; SOLUBLE ILT3; TRANSCRIPT 3; EXPRESSION; ACTIVATION; B7-H1	Immunoglobulin-like transcript (ILT) 3 and 4 are inhibitory receptors that modulate immune responses. Their expression has been reported to be affected by interferon, offering a possible mechanism by which this cytokine exerts its therapeutic effect in multiple sclerosis, a condition thought to involve excessive immune activity. To investigate this possibility, we measured expression of ILT3 and ILT4 on immune cells from multiple sclerosis patients, and in post-mortem brain tissue. We also studied the ability of interferon beta, alone or in combination with vitamin D, to induce upregulation of these receptors in vitro, and compared expression levels between interferon-treated and untreated multiple sclerosis patients. In vitro interferon beta treatment led to a robust upregulation of ILT3 and ILT4 on monocytes, and dihydroxyvitamin D3 increased expression of ILT3 but not ILT4. ILT3 was abundant in demyelinating lesions in postmortem brain, and expression on monocytes in the cerebrospinal fluid was higher than in peripheral blood, suggesting that the central nervous system milieu induces ILT3, or that ILT3 positive monocytes preferentially enter the brain. Our data are consistent with involvement of ILT3 and ILT4 in the modulation of immune responsiveness in multiple sclerosis by both interferon and vitamin D.	[Waschbisch, Anne; Schwab, Stefan; Maeurer, Mathias] Univ Erlangen Nurnberg, Dept Neurol, Erlangen, Germany; [Sanderson, Nicholas; Derfuss, Tobias] Univ Basel Hosp, Dept Neurol & Biomed, CH-4031 Basel, Switzerland; [Krumbholz, Markus] Univ Munich, Klinikum Grosshadern, Inst Clin Neuroimmunol, D-80539 Munich, Germany; [Vlad, George] Columbia Univ, Dept Pathol & Cell Biol, New York, NY USA; [Theil, Diethilde] Univ Munich, Klinikum Grosshadern, Dept Neurol, Munich, Germany	University of Erlangen Nuremberg; University of Basel; University of Munich; Columbia University; University of Munich	Waschbisch, A (corresponding author), Univ Erlangen Nurnberg, Dept Neurol, Erlangen, Germany.	Anne.Waschbisch@uk-erlangen.de	sanderson, nicholas/GQH-2848-2022	sanderson, nicholas/0000-0003-1711-7275; Derfuss, Tobias/0000-0001-8656-4250	Merck Serono GmbH, a division of Merck KGaA, Darmstadt, Germany; Else-Kroner Fresenius Stiftung [A_123]	Merck Serono GmbH, a division of Merck KGaA, Darmstadt, Germany; Else-Kroner Fresenius Stiftung	This study was in part funded by the Merck Serono GmbH, a division of Merck KGaA, Darmstadt, Germany, and the Else-Kroner Fresenius Stiftung (A_123). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, JAMA NEUROL; Ascherio A, 2010, LANCET NEUROL, V9, P599, DOI 10.1016/S1474-4422(10)70086-7; Cella M, 1997, J EXP MED, V185, P1743, DOI 10.1084/jem.185.10.1743; Chang CC, 2002, NAT IMMUNOL, V3, P237, DOI 10.1038/ni760; Chang CC, 2009, J IMMUNOL, V182, P5208, DOI 10.4049/jimmunol.0804048; Gleissner CA, 2007, EUR J IMMUNOL, V37, P177, DOI 10.1002/eji.200636498; James E, 2013, MULT SCLER J, V19, P1571, DOI 10.1177/1352458513489756; Jensen MA, 2010, MULT SCLER, V16, P30, DOI 10.1177/1352458509352794; Joller N, 2012, IMMUNOL REV, V248, P122, DOI 10.1111/j.1600-065X.2012.01136.x; Kim-Schulze S, 2006, J IMMUNOL, V176, P2790, DOI 10.4049/jimmunol.176.5.2790; Korn T, 2008, J NEUROL, V255, P2, DOI 10.1007/s00415-008-6001-2; Lassmann H, 1998, J NEUROIMMUNOL, V86, P213, DOI 10.1016/S0165-5728(98)00031-9; Lu HK, 2009, J BIOL CHEM, V284, P34839, DOI 10.1074/jbc.M109.035683; Manavalan JS, 2003, TRANSPL IMMUNOL, V11, P245, DOI 10.1016/S0966-3274(03)00058-3; Mueller DL, 2010, NAT IMMUNOL, V11, P21, DOI 10.1038/ni.1817; Ortler S, 2008, EUR J IMMUNOL, V38, P1734, DOI 10.1002/eji.200738071; Penna G, 2005, BLOOD, V106, P3490, DOI 10.1182/blood-2005-05-2044; Polman CH, 2005, ANN NEUROL, V58, P840, DOI 10.1002/ana.20703; Rottman JB, 2001, NAT IMMUNOL, V2, P605, DOI 10.1038/89750; Runia TF, 2012, NEUROLOGY, V79, P261, DOI 10.1212/WNL.0b013e31825fdec7; Salama AD, 2003, J EXP MED, V198, P71, DOI 10.1084/jem.20022119; Schreiner B, 2004, J NEUROIMMUNOL, V155, P172, DOI 10.1016/j.jneuroim.2004.06.013; Simpson S, 2010, ANN NEUROL, V68, P193, DOI 10.1002/ana.22043; Smith-Garvin JE, 2009, ANNU REV IMMUNOL, V27, P591, DOI 10.1146/annurev.immunol.021908.132706; Stewart N, 2012, NEUROLOGY, V79, P254, DOI 10.1212/WNL.0b013e31825fded9; Suciu-Foca N, 2007, J IMMUNOL, V178, P7432, DOI 10.4049/jimmunol.178.11.7432; Vlad G, 2008, DIABETES, V57, P1878, DOI 10.2337/db08-0054; Vlad George, 2013, Methods Mol Biol, V1034, P359, DOI 10.1007/978-1-62703-493-7_23; Vlad G, 2012, EXP MOL PATHOL, V93, P294, DOI 10.1016/j.yexmp.2012.09.011; Vlad G, 2010, INT REV IMMUNOL, V29, P119, DOI 10.3109/08830180903281185; Wiendl H, 2003, FASEB J, V17, P1892, DOI 10.1096/fj.03-0039fje	31	30	30	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2014	9	12							e115488	10.1371/journal.pone.0115488	http://dx.doi.org/10.1371/journal.pone.0115488			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UC	25551576	Green Published, gold, Green Submitted			2022-12-27	WOS:000347119100039
J	Nizhnikov, AA; Alexandrov, AI; Ryzhova, TA; Mitkevich, OV; Dergalev, AA; Ter-Avanesyan, MD; Galkin, AP				Nizhnikov, Anton A.; Alexandrov, Alexander I.; Ryzhova, Tatyana A.; Mitkevich, Olga V.; Dergalev, Alexander A.; Ter-Avanesyan, Michael D.; Galkin, Alexey P.			Proteomic Screening for Amyloid Proteins	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; EXPANDED POLYGLUTAMINE; TRANSCRIPTION FACTOR; YEAST PRION; PSI+ PRION; HUNTINGTIN FRAGMENT; CELLULAR TOXICITY; Q/N-RICH; SUP35; PURIFICATION	Despite extensive study, progress in elucidation of biological functions of amyloids and their role in pathology is largely restrained due to the lack of universal and reliable biochemical methods for their discovery. All biochemical methods developed so far allowed only identification of glutamine/asparagine-rich amyloid-forming proteins or proteins comprising amyloids that form large deposits. In this article we present a proteomic approach which may enable identification of a broad range of amyloid-forming proteins independently of specific features of their sequences or levels of expression. This approach is based on the isolation of protein fractions enriched with amyloid aggregates via sedimentation by ultracentrifugation in the presence of strong ionic detergents, such as sarkosyl or SDS. Sedimented proteins are then separated either by 2D difference gel electrophoresis or by SDS-PAGE, if they are insoluble in the buffer used for 2D difference gel electrophoresis, after which they are identified by mass-spectrometry. We validated this approach by detection of known yeast prions and mammalian proteins with established capacity for amyloid formation and also revealed yeast proteins forming detergent-insoluble aggregates in the presence of human huntingtin with expanded polyglutamine domain. Notably, with one exception, all these proteins contained glutamine/asparagine-rich stretches suggesting that their aggregates arose due to polymerization cross-seeding by human huntingtin. Importantly, though the approach was developed in a yeast model, it can easily be applied to any organism thus representing an efficient and universal tool for screening for amyloid proteins.	[Nizhnikov, Anton A.; Ryzhova, Tatyana A.; Galkin, Alexey P.] St Petersburg State Univ, Dept Genet & Biotechnol, St Petersburg 199034, Russia; [Nizhnikov, Anton A.; Ryzhova, Tatyana A.; Galkin, Alexey P.] Russian Acad Sci, Vavilov Inst Gen Genet, St Petersburg Branch, St Petersburg, Russia; [Alexandrov, Alexander I.; Mitkevich, Olga V.; Dergalev, Alexander A.; Ter-Avanesyan, Michael D.] Russian Acad Sci, AN Bach Inst Biochem, Moscow, Russia	Saint Petersburg State University; Russian Academy of Sciences; St. Petersburg Scientific Centre of the Russian Academy of Sciences; Vavilov Institute of General Genetics; Research Center of Biotechnology RAS; Russian Academy of Sciences	Galkin, AP (corresponding author), St Petersburg State Univ, Dept Genet & Biotechnol, St Petersburg 199034, Russia.	apgalkin@mail.ru	Belashova, Tatyana A/G-2156-2015; Dergalev, Alexander/AAU-5972-2021; Nizhnikov, Anton A./H-9983-2013; Alexandrov, Alexander/C-9579-2019; Galkin, Alexey Petrovich/K-2968-2013	Belashova, Tatyana A/0000-0001-9433-6987; Nizhnikov, Anton A./0000-0002-8338-3494; Alexandrov, Alexander/0000-0001-7250-4740; Galkin, Alexey Petrovich/0000-0002-7362-8857	Russian Academy of Sciences; Russian Foundation for Basic Research [13-04-01247, 14-04-00073]; St. Petersburg Government for young PhDs; St. Petersburg State University [0.37.696.2013, 1.50.2543.2013]	Russian Academy of Sciences(Russian Academy of Sciences); Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); St. Petersburg Government for young PhDs; St. Petersburg State University	This work was supported by the Molecular and Cellular Biology Program from the Russian Academy of Sciences (MDT), by the grants of Russian Foundation for Basic Research (APG #13-04-01247 and AIA, AAD, MDT #14-04-00073) and the grant from St. Petersburg Government for young PhDs (AAN). The authors acknowledge St. Petersburg State University for research grants (0.37.696.2013 and 1.50.2543.2013). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti S, 2009, CELL, V137, P146, DOI 10.1016/j.cell.2009.02.044; Bhak G, 2009, BMB REP, V42, P541, DOI 10.5483/BMBRep.2009.42.9.541; BLUM H, 1987, ELECTROPHORESIS, V8, P93, DOI 10.1002/elps.1150080203; Chernoff YO, 2000, MOL MICROBIOL, V35, P865, DOI 10.1046/j.1365-2958.2000.01761.x; Chernoff YO, 1999, MOL CELL BIOL, V19, P8103; CHERNOFF YO, 1995, SCIENCE, V268, P880, DOI 10.1126/science.7754373; Coalier KA, 2013, BBA-PROTEINS PROTEOM, V1834, P65, DOI 10.1016/j.bbapap.2012.08.017; Coustou V, 1997, P NATL ACAD SCI USA, V94, P9773, DOI 10.1073/pnas.94.18.9773; Derkatch IL, 2004, P NATL ACAD SCI USA, V101, P12934, DOI 10.1073/pnas.0404968101; Derkatch IL, 1997, GENETICS, V147, P507; Derkatch IL, 2001, CELL, V106, P171, DOI 10.1016/S0092-8674(01)00427-5; Du ZQ, 2008, NAT GENET, V40, P460, DOI 10.1038/ng.112; Duennwald ML, 2006, P NATL ACAD SCI USA, V103, P11051, DOI 10.1073/pnas.0604548103; Furukawa Y, 2009, J NEUROSCI, V29, P5153, DOI 10.1523/JNEUROSCI.0783-09.2009; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Giorgini F, 2005, NAT GENET, V37, P526, DOI 10.1038/ng1542; GLENNER GG, 1984, BIOCHEM BIOPH RES CO, V120, P885, DOI 10.1016/S0006-291X(84)80190-4; Gong H, 2012, PLOS GENET, V8, P223, DOI 10.1371/journal.pgen.1002634; Halfmann R, 2012, PRION, V6, P391, DOI 10.4161/pri.20199; Harrison PM, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-6-r40; Hazeki N, 2000, BIOCHEM BIOPH RES CO, V277, P386, DOI 10.1006/bbrc.2000.3682; INABA K, 1993, J CELL SCI, V104, P907; Iranzo M, 2002, MICROBIOL-SGM, V148, P1329, DOI 10.1099/00221287-148-5-1329; Iuchi S, 2003, P NATL ACAD SCI USA, V100, P2409, DOI 10.1073/pnas.0437660100; Kiktev DA, 2012, MOL CELL BIOL, V32, P4960, DOI 10.1128/MCB.00875-12; Kochneva-Pervukhova NV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029832; Kryndushkin D, 2013, J BIOL CHEM, V288, P27100, DOI 10.1074/jbc.M113.485359; Kryndushkin DS, 2003, J BIOL CHEM, V278, P49636, DOI 10.1074/jbc.M307996200; Kushnirov VV, 2006, METHODS, V39, P50, DOI 10.1016/j.ymeth.2006.04.007; Mazan M, 2007, BIOLOGIA, V62, P128, DOI 10.2478/s11756-007-0038-z; MCKINLEY MP, 1983, CELL, V35, P57, DOI 10.1016/0092-8674(83)90207-6; Meriin AB, 2003, MOL CELL BIOL, V23, P7554, DOI 10.1128/MCB.23.21.7554-7565.2003; Mitkevich OV, 2012, PRION, V6, P400, DOI 10.4161/pri.20678; Mitsui K, 2006, METHOD ENZYMOL, V412, P63, DOI 10.1016/S0076-6879(06)12005-4; Moreno-Gonzalez I, 2011, SEMIN CELL DEV BIOL, V22, P482, DOI 10.1016/j.semcdb.2011.04.002; Nucifora FC, 2001, SCIENCE, V291, P2423, DOI 10.1126/science.1056784; Patel BK, 2009, NAT CELL BIOL, V11, P344, DOI 10.1038/ncb1843; Peretz D, 2006, J VIROL, V80, P322, DOI 10.1128/JVI.80.1.322-331.2006; PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762; Rogoza T, 2010, P NATL ACAD SCI USA, V107, P10573, DOI 10.1073/pnas.1005949107; Rose MD., 1990, METHODS YEAST GENETI; Rubel AA, 2008, MOL BIOL+, V42, P110, DOI 10.1134/S0026893308010160; Rubel AA, 2013, PRION, V7, P469, DOI 10.4161/pri.26867; Schaffar G, 2004, MOL CELL, V15, P95, DOI 10.1016/j.molcel.2004.06.029; Sipe JD, 2012, AMYLOID, V19, P167, DOI 10.3109/13506129.2012.734345; Sondheimer N, 2000, MOL CELL, V5, P163, DOI 10.1016/S1097-2765(00)80412-8; Suzuki G, 2012, SCIENCE, V336, P355, DOI 10.1126/science.1219491; Unlu M, 1997, ELECTROPHORESIS, V18, P2071, DOI 10.1002/elps.1150181133; Urakov VN, 2010, PRION, V4, P45, DOI 10.4161/pri.4.1.11074; Vishveshwara N, 2009, MOL MICROBIOL, V73, P1101, DOI 10.1111/j.1365-2958.2009.06836.x; Wang Y, 2007, PRION, V1, P128, DOI 10.4161/pri.1.2.4440; Wang Y, 2009, FASEB J, V23, P451, DOI 10.1096/fj.08-117614; WICKNER RB, 1994, SCIENCE, V264, P566, DOI 10.1126/science.7909170; Yamanaka T, 2008, EMBO J, V27, P827, DOI 10.1038/emboj.2008.23; Yamanaka T, 2010, HUM MOL GENET, V19, P2099, DOI 10.1093/hmg/ddq087; Zhao XH, 2012, J BIOL CHEM, V287, P23346, DOI 10.1074/jbc.M111.287748	56	40	44	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2014	9	12							e116003	10.1371/journal.pone.0116003	http://dx.doi.org/10.1371/journal.pone.0116003			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX6YH	25549323	Green Published, gold, Green Submitted			2022-12-27	WOS:000347063500046
J	Wessel, SW; van der Mei, HC; Morando, D; Slomp, AM; van de Belt-Gritter, B; Maitra, A; Busscher, HJ				Wessel, Stefan W.; van der Mei, Henny C.; Morando, David; Slomp, Anje M.; van de Belt-Gritter, Betsy; Maitra, Amarnath; Busscher, Henk J.			Quantification and Qualification of Bacteria Trapped in Chewed Gum	PLOS ONE			English	Article							FREE CHEWING GUM; REAL-TIME PCR; PORPHYROMONAS-GINGIVALIS; BIOFILM FORMATION; DENTAL BIOFILM; HUMAN SALIVA; ORAL-HEALTH; PLAQUE; XYLITOL; CARIES	Chewing of gum contributes to the maintenance of oral health. Many oral diseases, including caries and periodontal disease, are caused by bacteria. However, it is unknown whether chewing of gum can remove bacteria from the oral cavity. Here, we hypothesize that chewing of gum can trap bacteria and remove them from the oral cavity. To test this hypothesis, we developed two methods to quantify numbers of bacteria trapped in chewed gum. In the first method, known numbers of bacteria were finger-chewed into gum and chewed gums were molded to standard dimensions, sonicated and plated to determine numbers of colony- forming-units incorporated, yielding calibration curves of colony-forming-units retrieved versus finger-chewed in. In a second method, calibration curves were created by finger-chewing known numbers of bacteria into gum and subsequently dissolving the gum in a mixture of chloroform and tris-ethylenediaminetetraacetic-acid (TE)-buffer. The TE-buffer was analyzed using quantitative Polymerase-Chain-Reaction (qPCR), yielding calibration curves of total numbers of bacteria versus finger-chewed in. Next, five volunteers were requested to chew gum up to 10 min after which numbers of colony-forming-units and total numbers of bacteria trapped in chewed gum were determined using the above methods. The qPCR method, involving both dead and live bacteria yielded higher numbers of retrieved bacteria than plating, involving only viable bacteria. Numbers of trapped bacteria were maximal during initial chewing after which a slow decrease over time up to 10 min was observed. Around 108 bacteria were detected per gum piece depending on the method and gum considered. The number of species trapped in chewed gum increased with chewing time. Trapped bacteria were clearly visualized in chewed gum using scanning-electron-microscopy. Summarizing, using novel methods to quantify and qualify oral bacteria trapped in chewed gum, the hypothesis is confirmed that chewing of gum can trap and remove bacteria from the oral cavity.	[Wessel, Stefan W.; van der Mei, Henny C.; Slomp, Anje M.; van de Belt-Gritter, Betsy; Busscher, Henk J.] Univ Groningen, Univ Med Ctr Groningen, Dept Biomed Engn, NL-9713 AV Groningen, Netherlands; [Morando, David; Maitra, Amarnath] William Wrigley Jr Co, Chicago, IL USA	University of Groningen; Mars	van der Mei, HC (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Biomed Engn, NL-9713 AV Groningen, Netherlands.	h.c.van.der.mei@umcg.nl	Busscher, Henk/AAU-2113-2020	Busscher, Henk/0000-0002-3644-5533	Wm. Wrigley Jr. Co, Chicago, USA; SASA BV, Thesinge, NL	Wm. Wrigley Jr. Co, Chicago, USA; SASA BV, Thesinge, NL	This work was funded by Wm. Wrigley Jr. Co, Chicago, USA and SASA BV, Thesinge, NL. Authors were employed by their own organizations. Wm. Wrigley Jr. Co, Chicago had a role in study design (qPCR experiments), decision to publish and preparation of manuscript. SASA BV had a role in study design, data analysis and preparation of manuscript.	Al-Ahmad A, 2008, ARCH ORAL BIOL, V53, P765, DOI 10.1016/j.archoralbio.2008.02.014; Balakrishnan M, 2000, AUST DENT J, V45, P235, DOI 10.1111/j.1834-7819.2000.tb00257.x; BIRKHED D, 1994, ACTA ODONTOL SCAND, V52, P116, DOI 10.3109/00016359409029065; Burt BA, 2006, J AM DENT ASSOC, V137, P190, DOI 10.14219/jada.archive.2006.0144; Chaudhari Lalit Kumar D, 2012, J Contemp Dent Pract, V13, P71; Dawes C, 2001, ARCH ORAL BIOL, V46, P625, DOI 10.1016/S0003-9969(01)00017-6; Diaz PI, 2012, MOL ORAL MICROBIOL, V27, P182, DOI 10.1111/j.2041-1014.2012.00642.x; Dige I, 2009, MICROBIOL-SGM, V155, P2116, DOI 10.1099/mic.0.027706-0; Drakopoulou S, 2009, ULTRASON SONOCHEM, V16, P629, DOI 10.1016/j.ultsonch.2008.11.011; Edgar M., 2004, SALIVA ORAL HLTH; Ferreira A.V.B., 1996, FUNGAL GENETICS NEWS, V43, P25; Fritz D., 2006, FORMULATION PRODUCTI; Greenberg M, 2007, J AGR FOOD CHEM, V55, P9465, DOI 10.1021/jf072122h; Hanham A, 2001, J CLIN PERIODONTOL, V28, P255, DOI 10.1034/j.1600-051x.2001.028003255.x; Hetherington MM, 2011, APPETITE, V57, P475, DOI 10.1016/j.appet.2011.06.008; Imfeld T, 1999, CRIT REV ORAL BIOL M, V10, P405, DOI 10.1177/10454411990100030901; Imfeld Thomas, 2006, Schweiz Monatsschr Zahnmed, V116, P476; Johnson AJ, 2011, APPETITE, V56, P408, DOI 10.1016/j.appet.2010.12.025; Kakodkar P, 2011, DENT RES J ISFAHAN, V7, P64; Keukenmeester RS, 2013, INT J DENT HYG, V11, P2, DOI 10.1111/j.1601-5037.2012.00562.x; Kreth J, 2009, DNA CELL BIOL, V28, P397, DOI 10.1089/dna.2009.0868; LOESCHE WJ, 1986, MICROBIOL REV, V50, P353, DOI 10.1128/MMBR.50.4.353-380.1986; Ly KA, 2008, J AM DENT ASSOC, V139, P553, DOI 10.14219/jada.archive.2008.0215; Lyons SR, 2000, J CLIN MICROBIOL, V38, P2362; Maeda H, 2003, FEMS IMMUNOL MED MIC, V39, P81, DOI 10.1016/S0928-8244(03)00224-4; Mickenautsch S, 2007, J APPL ORAL SCI, V15, P83, DOI 10.1590/S1678-77572007000200002; Milgrom P, 2006, J DENT RES, V85, P177, DOI 10.1177/154405910608500212; MOUTON C, 1975, ACTA ODONTOL SCAND, V33, P33, DOI 10.3109/00016357509004624; MUYZER G, 1993, APPL ENVIRON MICROB, V59, P695, DOI 10.1128/AEM.59.3.695-700.1993; Pitt WG, 2003, BIOTECHNOL PROGR, V19, P1038, DOI 10.1021/bp0340685; Quirynen M, 2003, J PERIODONTOL, V74, P312, DOI 10.1902/jop.2003.74.3.312; Quirynen M, 2001, J CLIN PERIODONTOL, V28, P1106, DOI 10.1034/j.1600-051X.2001.281204.x; Rasooli I, 2009, INT J DENT HYG, V7, P196, DOI 10.1111/j.1601-5037.2009.00389.x; ROSENHEK M, 1993, ARCH ORAL BIOL, V38, P885, DOI 10.1016/0003-9969(93)90098-7; Scholey A, 2004, APPETITE, V43, P215, DOI 10.1016/j.appet.2004.07.004; Sjogren K, 2002, CARIES RES, V36, P64, DOI 10.1159/000057593; Smith A, 2010, NUTR NEUROSCI, V13, P7, DOI 10.1179/147683010X12611460763526; STINSON MW, 1993, CRIT REV ORAL BIOL M, V4, P309, DOI 10.1177/10454411930040030801; SYED SA, 1972, APPL MICROBIOL, V24, P638, DOI 10.1128/AEM.24.4.638-644.1972; van der Mei H C, 2003, J Clin Dent, V14, P14; Weiger R, 1997, J PERIODONTAL RES, V32, P233, DOI 10.1111/j.1600-0765.1997.tb00529.x; Yamanaka A, 2000, Bull Tokyo Dent Coll, V41, P123, DOI 10.2209/tdcpublication.41.123; Zarco MF, 2012, ORAL DIS, V18, P109, DOI 10.1111/j.1601-0825.2011.01851.x	43	11	12	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2015	10	1							e0117191	10.1371/journal.pone.0117191	http://dx.doi.org/10.1371/journal.pone.0117191			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ4OZ	25602256	Green Published, Green Submitted, gold			2022-12-27	WOS:000348203500044
J	Prentice, K; Pertry, I; Christiaens, O; Bauters, L; Bailey, A; Niblett, C; Ghislain, M; Gheysen, G; Smagghe, G				Prentice, Katterinne; Pertry, Ine; Christiaens, Olivier; Bauters, Lander; Bailey, Ana; Niblett, Chuck; Ghislain, Marc; Gheysen, Godelieve; Smagghe, Guy			Transcriptome Analysis and Systemic RNAi Response in the African Sweetpotato Weevil (Cylas puncticollis, Coleoptera, Brentidae)	PLOS ONE			English	Article							DOUBLE-STRANDED-RNA; DISTINCT ROLES; INTERFERENCE; GENE; EXPRESSION; MICRORNAS; PROTEIN; BEETLE; IDENTIFICATION; PERSPECTIVE	The African sweetpotato weevil (SPW) Cylas puncticollis Boheman is one of the most important constraints of sweetpotato production in Sub-Saharan Africa and yet is largely an uncharacterized insect pest. Here, we report on the transcriptome analysis of SPW generated using an Illumina platform. More than 213 million sequencing reads were obtained and assembled into 89,599 contigs. This assembly was followed by a gene ontology annotation. Subsequently, a transcriptome search showed that the necessary RNAi components relevant to the three major RNAi pathways, were found to be expressed in SPW. To address the functionality of the RNAi mechanism in this species, dsRNA was injected into second instar larvae targeting laccase2, a gene which encodes an enzyme involved in the sclerotization of insect exoskeleton. The body of treated insects showed inhibition of sclerotization, leading eventually to death. Quantitative Real Time PCR (qPCR) confirmed this phenotype to be the result of gene silencing. Together, our results provide valuable sequence data on this important insect pest and demonstrate that a functional RNAi pathway with a strong and systemic effect is present in SPW and can further be explored as a new strategy for controlling this important pest.	[Prentice, Katterinne; Christiaens, Olivier; Smagghe, Guy] Univ Ghent, Fac Biosci Engn, Dept Crop Protect, B-9000 Ghent, Belgium; [Prentice, Katterinne; Bauters, Lander; Gheysen, Godelieve] Univ Ghent, Fac Biosci Engn, Dept Mol Biotechnol, B-9000 Ghent, Belgium; [Prentice, Katterinne; Ghislain, Marc] Int Potato Ctr CIP, Genom & Biotechnol Program, Nairobi 00603, Kenya; [Pertry, Ine] VIB, Inst Plant Biotechnol Outreach, B-9052 Ghent, Belgium; [Pertry, Ine] Univ Ghent, Dept Mol Biotechnol, Inst Plant Biotechnol Outreach, B-9052 Ghent, Belgium; [Bailey, Ana; Niblett, Chuck] Venganza Inc, St Augustine, FL 32080 USA	Ghent University; Ghent University; CGIAR; International Potato Center (CIP); Flanders Institute for Biotechnology (VIB); Ghent University	Smagghe, G (corresponding author), Univ Ghent, Fac Biosci Engn, Dept Crop Protect, B-9000 Ghent, Belgium.	guy.smagghe@ugent.be	Smagghe, Guy/AAE-8914-2019; Christiaens, Olivier/AAB-3634-2019	Smagghe, Guy/0000-0001-8334-3313; Christiaens, Olivier/0000-0001-5850-340X; Prentice, Katterinne/0000-0001-6631-4318	Ghent University (BOF, Gent, Belgium); Bill and Melinda Gates Foundation through the Sweetpotato Action for Security and Health in Africa (SASHA) project; Grand Challenge Exploration 9 [OPP1068494]	Ghent University (BOF, Gent, Belgium); Bill and Melinda Gates Foundation through the Sweetpotato Action for Security and Health in Africa (SASHA) project; Grand Challenge Exploration 9	Authors are grateful to the support of the Special Research Fund of the Ghent University (BOF, Gent, Belgium), the Bill and Melinda Gates Foundation through the Sweetpotato Action for Security and Health in Africa (SASHA) project and the Grand Challenge Exploration 9 (grant number: OPP1068494). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrade M., 2009, 20091 CIP; ANSARI A, 1995, EMBO J, V14, P4001, DOI 10.1002/j.1460-2075.1995.tb00071.x; Arakane Y, 2005, P NATL ACAD SCI USA, V102, P11337, DOI 10.1073/pnas.0504982102; Bachman PM, 2013, TRANSGENIC RES, V22, P1207, DOI 10.1007/s11248-013-9716-5; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Baum JA, 2007, NAT BIOTECHNOL, V25, P1322, DOI 10.1038/nbt1359; Billi AC, 2012, PLOS GENET, V8, P84, DOI 10.1371/journal.pgen.1002617; Bucher G, 2002, CURR BIOL, V12, pR85, DOI 10.1016/S0960-9822(02)00666-8; Carmell MA, 2004, NAT STRUCT MOL BIOL, V11, P214, DOI 10.1038/nsmb729; Cauchi RJ, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000265; CHALFANT RB, 1990, ANNU REV ENTOMOL, V35, P157, DOI 10.1146/annurev.en.35.010190.001105; Crawford JE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014202; Findley SD, 2003, DEVELOPMENT, V130, P859, DOI 10.1242/dev.00310; Fuglie KO, 2007, HORTSCIENCE, V42, P1200, DOI 10.21273/HORTSCI.42.5.1200; Gaynor JW, 2010, CHEM SOC REV, V39, P4169, DOI 10.1039/b920362c; Ghildiyal M, 2009, NAT REV GENET, V10, P94, DOI 10.1038/nrg2504; Gourley BL, 2003, J BIOL CHEM, V278, P3227, DOI 10.1074/jbc.M210333200; Han BW, 2011, CURR BIOL, V21, P1878, DOI 10.1016/j.cub.2011.09.034; Hartig JV, 2007, GENE DEV, V21, P1707, DOI 10.1101/gad.1567007; Hunter CP, 2006, COLD SPRING HARB SYM, V71, P95, DOI 10.1101/sqb.2006.71.060; Huvenne H, 2010, J INSECT PHYSIOL, V56, P227, DOI 10.1016/j.jinsphys.2009.10.004; Ishizuka A, 2002, GENE DEV, V16, P2497, DOI 10.1101/gad.1022002; Katoch R, 2013, APPL BIOCHEM BIOTECH, V171, P847, DOI 10.1007/s12010-013-0399-4; Keeling CI, 2012, INSECT BIOCHEM MOLEC, V42, P525, DOI 10.1016/j.ibmb.2012.03.010; Kennedy S, 2004, NATURE, V427, P645, DOI 10.1038/nature02302; Ketting RF, 2001, GENE DEV, V15, P2654, DOI 10.1101/gad.927801; Lee MH, 2001, GENE DEV, V15, P2408, DOI 10.1101/gad.915901; Lee YS, 2004, CELL, V117, P69, DOI 10.1016/S0092-8674(04)00261-2; Li H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065931; Lin HF, 2007, SCIENCE, V316, P397, DOI 10.1126/science.1137543; Lipardi C, 2010, FLY, V4, P30, DOI 10.4161/fly.4.1.10777; Liu JH, 2012, J INSECT PHYSIOL, V58, P1166, DOI 10.1016/j.jinsphys.2012.05.016; Liu QH, 2010, ANNU REV BIOCHEM, V79, P295, DOI 10.1146/annurev.biochem.052208.151733; Liu Y, 2009, SCIENCE, V325, P750, DOI 10.1126/science.1176325; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Miller SC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047431; Morlando M, 2008, NAT STRUCT MOL BIOL, V15, P902, DOI 10.1038/nsmb.1475; Mwanga R., 2011, PROC INT C AGRO BIOT, P25; Okamura K, 2004, GENE DEV, V18, P1655, DOI 10.1101/gad.1210204; Pek JW, 2011, P NATL ACAD SCI USA, V108, P12007, DOI 10.1073/pnas.1106245108; Price DRG, 2008, TRENDS BIOTECHNOL, V26, P393, DOI 10.1016/j.tibtech.2008.04.004; Ramachandran V, 2008, SCIENCE, V321, P1490, DOI 10.1126/science.1163728; Richards S, 2008, NATURE, V452, P949, DOI 10.1038/nature06784; Sabin LR, 2009, CELL, V138, P340, DOI 10.1016/j.cell.2009.04.045; Saito K, 2007, GENE DEV, V21, P1603, DOI 10.1101/gad.1563607; Saleh MC, 2009, NATURE, V458, P346, DOI 10.1038/nature07712; Saleh MC, 2006, J INSECT PHYSL, V56, P227; Schneider MD, 2006, J CELL BIOL, V174, P349, DOI 10.1083/jcb.200512103; Scott JG, 2013, J INSECT PHYSIOL, V59, P1212, DOI 10.1016/j.jinsphys.2013.08.014; Scully ED, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-850; Shabalina SA, 2008, TRENDS ECOL EVOL, V23, P578, DOI 10.1016/j.tree.2008.06.005; Skoglund L G, 1994, MAJOR DIS PEST SWEET; Smit NEJM, 2001, CROP PROT, V20, P643, DOI 10.1016/S0261-2194(01)00026-6; Smit NEJM, 1997, AGR ECOSYST ENVIRON, V64, P191, DOI 10.1016/S0167-8809(97)00022-4; Stathers TE, 2003, INT J PEST MANAGE, V49, P131, DOI 10.1080/0967087021000043085; Stevenson PC, 2009, PURE APPL CHEM, V81, P141, DOI 10.1351/PAC-CON-08-02-10; Swevers L, 2013, INSECT MOL BIOL, V22, P668, DOI 10.1111/imb.12054; Terenius O, 2011, J INSECT PHYSIOL, V57, P231, DOI 10.1016/j.jinsphys.2010.11.006; Tomari Y, 2005, GENE DEV, V19, P517, DOI 10.1101/gad.1284105; Tomoyasu Y, 2004, DEV GENES EVOL, V214, P575, DOI 10.1007/s00427-004-0434-0; Tomoyasu Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-1-r10; Ulvila J, 2006, J BIOL CHEM, V281, P14370, DOI 10.1074/jbc.M513868200; Vagin VV, 2006, SCIENCE, V313, P320, DOI 10.1126/science.1129333; Wolfe G.W., 1991, P13; Wu-Scharf D, 2000, SCIENCE, V290, P1159, DOI 10.1126/science.290.5494.1159; Xue JA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014233; Yamanaka S, 2013, NATURE, V493, P557, DOI 10.1038/nature11716; Yigit E, 2006, CELL, V127, P747, DOI 10.1016/j.cell.2006.09.033; Yu N, 2013, INSECT SCI, V20, P4, DOI 10.1111/j.1744-7917.2012.01534.x	69	26	29	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2015	10	1							e0115336	10.1371/journal.pone.0115336	http://dx.doi.org/10.1371/journal.pone.0115336			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9HN	25590333	Green Published, Green Submitted, gold			2022-12-27	WOS:000350679400005
J	Qian, Y; Lu, F; Dong, MH; Lin, YD; Li, HZ; Dai, JC; Jin, GF; Hu, ZB; Shen, HB				Qian, Yun; Lu, Feng; Dong, Meihua; Lin, Yudi; Li, Huizhang; Dai, Juncheng; Jin, Guangfu; Hu, Zhibin; Shen, Hongbing			Cumulative Effect and Predictive Value of Genetic Variants Associated with Type 2 Diabetes in Han Chinese: A Case-Control Study	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; IMPAIRED FASTING GLUCOSE; SUSCEPTIBILITY LOCI; COMMON VARIANTS; RISK LOCI; JAPANESE POPULATION; CDKAL1; POLYMORPHISMS; IGF2BP2; SLC30A8	Background Genome-wide association studies (GWAS) have identified dozens of single nucleotide polymorphisms (SNPs) associated with type 2 diabetes risk. We have previously confirmed the associations of genetic variants in HHEX, CDKAL1, VEGFA and FTO with type 2 diabetes in Han Chinese. However, the cumulative effect and predictive value of these GWAS identified SNPs on the risk of type 2 diabetes in Han Chinese are largely unknown. Methodology/Principal Findings We conducted a two-stage case-control study consisting of 2,925 cases and 3,281controls to examine the association of 30 SNPs identified by GWAS with type 2 diabetes in Han Chinese. Significant associations were found for proxy SNPs at KCNQ1 [odds ratio (OR) = 1.41, P = 9.91 x 10-16 for rs2237897], CDKN2A/CDKN2B (OR = 1.30, P = 1.34 x 10-10 for rs10811661), CENTD2 (OR = 1.28, P = 9.88 x 10-4 for rs1552224) and SLC30A8 (OR = 1.19, P = 1.43 x 10-5 for rs13266634). We further evaluated the cumulative effect on type 2 diabetes of these 4 SNPs, in combination with 5 SNPs at HHEX, CDKAL1, VEGFA and FTO reported previously. Individuals carrying 12 or more risk alleles had a nearly 4-fold increased risk for developing type 2 diabetes compared with those carrying less than 6 risk alleles [adjusted OR = 3.68, 95% confidence interval (CI): 2.76 - 4.91]. Adding the genetic factors to clinical factors slightly improved the prediction of type 2 diabetes, with the area under the receiver operating characteristic curve increasing from 0.76 to 0.78. However, the difference was statistically significant (P < 0.0001). Conclusions/Significance We confirmed associations of SNPs in KCNQ1, CDKN2A/CDKN2B, CENTD2 and SLC30A8 with type 2 diabetes in Han Chinese. The utilization of genetic information may improve the accuracy of risk prediction in combination with clinical characteristics for type 2 diabetes.	[Qian, Yun; Dong, Meihua; Lin, Yudi] Wuxi Ctr Dis Control & Prevent, Dept Chron Noncommunicable Dis Control, Wuxi 214023, Peoples R China; [Lu, Feng; Li, Huizhang; Dai, Juncheng; Jin, Guangfu; Hu, Zhibin; Shen, Hongbing] Nanjing Med Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Nanjing 210029, Jiangsu, Peoples R China	Nanjing Medical University	Qian, Y (corresponding author), Wuxi Ctr Dis Control & Prevent, Dept Chron Noncommunicable Dis Control, Wuxi 214023, Peoples R China.	wxqianyun111@sina.com; hbshen@njmu.edu.cn		Shen, Hongbing/0000-0002-2581-5906	Project of National Natural Science Foundation of China [81072379]; Ministry of Health Research Program [WKJ2010-2-032]; Wuxi Science & Technology Research Program [CSE01016]	Project of National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Health Research Program; Wuxi Science & Technology Research Program	This work was supported by grants from the Project of National Natural Science Foundation of China (81072379), Ministry of Health Research Program (WKJ2010-2-032) and Wuxi Science & Technology Research Program (CSE01016). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bao XY, 2012, MOL BIOL REP, V39, P2447, DOI 10.1007/s11033-011-0995-8; Been LF, 2011, BMC MED GENET, V12, DOI 10.1186/1471-2350-12-18; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Cauchi S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002031; Han XY, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-81; Hu C, 2009, DIABETOLOGIA, V52, P1322, DOI 10.1007/s00125-009-1335-6; Hu C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007643; International Diabetes Federation, 2006, DIABETES ATLAS; Jonsson A, 2009, DIABETES, V58, P2409, DOI 10.2337/db09-0246; Lango H, 2008, DIABETES, V57, P3129, DOI 10.2337/db08-0504; Lee YH, 2008, J HUM GENET, V53, P991, DOI 10.1007/s10038-008-0341-8; LIN Y, 2010, BMC BIOINFORMATIC S1, V11, P10393, DOI DOI 10.1186/1471-; Liu Y, 2009, DIABETOLOGIA, V52, P1315, DOI 10.1007/s00125-009-1375-y; Lu F, 2012, J HUM GENET, V57, P320, DOI 10.1038/jhg.2012.25; Ng MCY, 2008, DIABETES, V57, P2226, DOI 10.2337/db07-1583; Nielsen T, 2011, DIABETOLOGIA, V54, P1052, DOI 10.1007/s00125-011-2054-3; Ohshige T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026911; Qi L, 2010, HUM MOL GENET, V19, P2706, DOI 10.1093/hmg/ddq156; Qi QB, 2009, HUM MOL GENET, V18, P3508, DOI 10.1093/hmg/ddp294; Qian Y, 2013, BMC GENET, V14, DOI 10.1186/1471-2156-14-86; Qian Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035060; Rees SD, 2011, DIABETOLOGIA, V54, P1368, DOI 10.1007/s00125-011-2063-2; Rung J, 2009, NAT GENET, V41, P1110, DOI 10.1038/ng.443; Salonen JT, 2007, AM J HUM GENET, V81, P338, DOI 10.1086/520599; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382; Shu XO, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001127; Sladek R, 2007, NATURE, V445, P881, DOI 10.1038/nature05616; Steinthorsdottir V, 2007, NAT GENET, V39, P770, DOI 10.1038/ng2043; Strawbridge RJ, 2011, DIABETES, V60, P2624, DOI 10.2337/db11-0415; Takeuchi F, 2009, DIABETES, V58, P1690, DOI 10.2337/db08-1494; Tan JT, 2010, J CLIN ENDOCR METAB, V95, P390, DOI 10.1210/jc.2009-0688; Tsai FJ, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000847; Unoki H, 2008, NAT GENET, V40, P1098, DOI 10.1038/ng.208; van Hoek M, 2008, DIABETES, V57, P3122, DOI 10.2337/db08-0425; Vaxillaire M, 2008, DIABETES, V57, P244, DOI 10.2337/db07-0615; Voight BF, 2010, NAT GENET, V42, P579, DOI 10.1038/ng.609; Weedon MN, 2006, PLOS MED, V3, P1877, DOI 10.1371/journal.pmed.0030374; Wu Y, 2008, DIABETES, V57, P2834, DOI 10.2337/db08-0047; Xu M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014022; Yamauchi T, 2010, NAT GENET, V42, P864, DOI 10.1038/ng.660; Yang WY, 2010, NEW ENGL J MED, V362, P1090, DOI 10.1056/NEJMoa0908292; Yasuda K, 2008, NAT GENET, V40, P1092, DOI 10.1038/ng.207; Zeggini E, 2008, NAT GENET, V40, P638, DOI 10.1038/ng.120; Zeggini E, 2007, SCIENCE, V316, P1336, DOI 10.1126/science.1142364; Zhao Q, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091790; Zhou DZ, 2010, J HUM GENET, V55, P810, DOI 10.1038/jhg.2010.117	47	15	18	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2015	10	1							e0116537	10.1371/journal.pone.0116537	http://dx.doi.org/10.1371/journal.pone.0116537			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ0ID	25587982	Green Submitted, Green Published, gold			2022-12-27	WOS:000347928300015
J	Tomitaka, S; Kawasaki, Y; Furukawa, T				Tomitaka, Shinichiro; Kawasaki, Yohei; Furukawa, Toshiaki			Right Tail of the Distribution of Depressive Symptoms Is Stable and Follows an Exponential Curve during Middle Adulthood	PLOS ONE			English	Article							KOREAN ADULTS; PREVALENCE; SAMPLE; HEALTH; AGE	Background Previous research has reported that the mean of depressive symptoms is stable in the general population through middle adulthood. To understand the stability of depressive symptoms during middle adulthood, we investigated the nature of the distribution of depressive symptoms. Methods We analyzed 24,890 subjects aged 15 to 84 years who participated in the Active Survey of Health and Welfare, Japan. Depressive symptoms were assessed using the Japanese version of the Center for Epidemiologic Studies Depression Scale (CES-D). The descriptive statistics and frequency curves of the distributions were then compared according to age group. Results The distribution of depressive symptoms was stable through middle adulthood. The right tail which covers clinical depression was more stable than the left tail or peak of the distributions. The right tail of the distribution during middle adulthood exhibited a linear pattern with a log-normal scale. Conclusions The right tail of the distribution of depressive symptoms is stable and exhibits an exponential pattern during middle adulthood.	[Tomitaka, Shinichiro] Panasonic Hlth Ctr, Dept Mental Hlth, Tokyo, Japan; [Kawasaki, Yohei] Tokyo Univ Sci, Dept Math, Tokyo 162, Japan; [Furukawa, Toshiaki] Kyoto Univ, Grad Sch Med, Sch Publ Hlth, Dept Hlth Promot & Human Behav, Kyoto, Japan	Panasonic; Tokyo University of Science; Kyoto University	Tomitaka, S (corresponding author), Panasonic Hlth Ctr, Dept Mental Hlth, Tokyo, Japan.	tomitaka.shinichiro@jp.panasonic.com	Furukawa, Toshi A./B-9259-2011	Furukawa, Toshi A./0000-0003-2159-3776; Tomitaka, Shinichiro/0000-0002-7161-6967; Kawasaki, Yohei/0000-0002-7474-7647				Araujo AB, 1998, PSYCHOSOM MED, V60, P458, DOI 10.1097/00006842-199807000-00011; Bebbington PE, 1998, PSYCHOL MED, V28, P9, DOI 10.1017/S0033291797006077; Cho MJ, 1998, PSYCHIAT RES, V81, P341, DOI 10.1016/S0165-1781(98)00122-X; Dragulescu A, 2000, EUR PHYS J B, V17, P723, DOI 10.1007/s100510070114; EATON WW, 1992, AM J EPIDEMIOL, V135, P1051, DOI 10.1093/oxfordjournals.aje.a116399; Hek K, 2013, BIOL PSYCHIAT, V73, P667, DOI 10.1016/j.biopsych.2012.09.033; IWATA N, 1989, AM J PUBLIC HEALTH, V79, P1486, DOI 10.2105/AJPH.79.11.1486; Kaji T, 2010, PSYCHIAT CLIN NEUROS, V64, P426, DOI 10.1111/j.1440-1819.2010.02097.x; KESSLER RC, 1992, PSYCHOL AGING, V7, P119, DOI 10.1037/0882-7974.7.1.119; Melzer D, 2002, PSYCHOL MED, V32, P1195, DOI 10.1017/S0033291702006049; Ministry of Health Labor and Welfare Statistics and Information Department, 2002, ACT SURV HLTH WELF H; Moussavi S, 2007, LANCET, V370, P851, DOI 10.1016/S0140-6736(07)61415-9; NEWMANN JP, 1989, PSYCHOL AGING, V4, P150, DOI 10.1037/0882-7974.4.2.150; Oh DH, 2013, J KOREAN MED SCI, V28, P128, DOI 10.3346/jkms.2013.28.1.128; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Sutin AR, 2013, JAMA PSYCHIAT, V70, P803, DOI 10.1001/jamapsychiatry.2013.193	16	16	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2015	10	1							e0114624	10.1371/journal.pone.0114624	http://dx.doi.org/10.1371/journal.pone.0114624			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AZ0ID	25587985	Green Published, Green Submitted, gold			2022-12-27	WOS:000347928300003
J	Chu, HS; Chang, SC; Shen, EP; Hu, FR				Chu, Hsiao-Sang; Chang, Shan-Chwen; Shen, Elizabeth P.; Hu, Fung-Rong			Nontuberculous Mycobacterial Ocular Infections-Comparing the Clinical and Microbiological Characteristics between Mycobacterium abscessus and Mycobacterium massiliense	PLOS ONE			English	Article							ANTIMICROBIAL SUSCEPTIBILITY; KERATITIS; IDENTIFICATION; PENETRATION; UPDATE; COHORT	Purpose To analyze the clinical characteristics of nontuberculous mycobacterial (NTM) ocular infections and the species-specific in vitro antimicrobial susceptibility. Material and Methods In 2000 to 2011 at the National Taiwan University Hospital, multilocus sequencing of rpoB, hsp65 and secA was used to identify NTM isolates from ocular infections. The clinical presentation and treatment outcomes were retrospectively compared between species. Broth microdilution method was used to determine the minimum inhibitory concentrations of amikacin (AMK), clarithromycin (CLA), ciprofloxacin (CPF), levofloxacin (LVF), moxifloxacin (MXF) and gatifloxacin (GAF) against all strains. The activities of antimicrobial combinations were assessed by the checkerboard titration method. Results A total of 24 NTM strains (13 Mycobacterium abscessus and 11 Mycobacterium massiliense) were isolated from 13 keratitis, 10 buckle infections, and 1 canaliculitis cases. Clinically, manifestations and outcomes caused by these two species were similar and surgical intervention was necessary for medically unresponsive NTM infection. Microbiologically, 100% of M. abscessus and 90.9% of M. massiliense ocular isolates were susceptible to amikacin but all were resistant to fluoroquinolones. Inducible clarithromycin resistance existed in 69.3% of M. abscessus but not in M. massiliense isolates. None of the AMK-CLA, AMK-MXF, AMK-GAF, CLA-MXF and CLA-GAF combinations showed synergistic or antagonistic effect against both species in vitro. Conclusions M. abscessus and M. massiliense are the most commonly identified species for NTM ocular infections in Taiwan. Both species were resistant to fluoroquinolones, susceptible to amikacin, and differ in clarithromycin resistance. Combined antimicrobial treatments showed no interaction in vitro but could be considered in combination with surgical interventions for eradication of this devastating ocular infection.	[Chu, Hsiao-Sang; Shen, Elizabeth P.; Hu, Fung-Rong] Natl Taiwan Univ, Coll Med, Natl Taiwan Univ Hosp, Dept Ophthalmol, Taipei 10764, Taiwan; [Chang, Shan-Chwen] Natl Taiwan Univ, Coll Med, Dept Internal Med, Natl Taiwan Univ Hosp,Div Infect Dis, Taipei, Taiwan	National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital	Hu, FR (corresponding author), Natl Taiwan Univ, Coll Med, Natl Taiwan Univ Hosp, Dept Ophthalmol, Taipei 10764, Taiwan.	fungronghu@ntu.edu.tw		HU, FUNG-RONG/0000-0002-2102-5317; CHANG, SHAN-CHWEN/0000-0001-6505-4139	National Taiwan University Hospital Research Grant [102-N2276]; National Center of Excellence for Clinical Trial and Research Grant [DOH 101-TD-B-111-001]	National Taiwan University Hospital Research Grant; National Center of Excellence for Clinical Trial and Research Grant	Funding: Funding provided by 1. National Taiwan University Hospital Research Grant 102-N2276, http://www.ntuh.gov.tw/ntuh_chinese.aspx.2. The National Center of Excellence for Clinical Trial and Research Grant DOH 101-TD-B-111-001, http://www.ntuh.gov.tw/en/nctrc/default.aspx. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brown-Elliott BA, 2012, CORNEA, V31, P900, DOI 10.1097/ICO.0b013e31823f8bb9; Brown-Elliott BA, 2012, CLIN MICROBIOL REV, V25, P545, DOI 10.1128/CMR.05030-11; Bryant JM, 2013, LANCET, V381, P1551, DOI 10.1016/S0140-6736(13)60632-7; Chu HS, 2013, CLIN MICROBIOL INFEC, V19, P221, DOI 10.1111/1469-0691.12094; EIFERMAN RA, 1982, ARCH OPHTHALMOL-CHIC, V100, P1817, DOI 10.1001/archopht.1982.01030040797018; Ford JG, 1998, OPHTHALMOLOGY, V105, P1652, DOI 10.1016/S0161-6420(98)99034-0; Girgis DO, 2012, CLIN EXP OPHTHALMOL, V40, P467, DOI 10.1111/j.1442-9071.2011.02679.x; Griffith DE, 2007, AM J RESP CRIT CARE, V175, P367, DOI 10.1164/rccm.200604-571ST; Hu FR, 1998, OPHTHALMOLOGY, V105, P269; Hu FR, 1998, JPN J OPHTHALMOL, V42, P115, DOI 10.1016/S0021-5155(97)00117-2; Huang SCM, 1996, BRIT J OPHTHALMOL, V80, P962, DOI 10.1136/bjo.80.11.962; John T, 2005, CORNEA, V24, P245, DOI 10.1097/01.ico.0000151565.63107.64; Koh WJ, 2011, AM J RESP CRIT CARE, V183, P405, DOI 10.1164/rccm.201003-0395OC; Lai CC, 2010, EMERG INFECT DIS, V16, P294, DOI 10.3201/eid1602.090675; Macheras E, 2011, J CLIN MICROBIOL, V49, P491, DOI 10.1128/JCM.01274-10; Moorthy RS, 2012, SURV OPHTHALMOL, V57, P202, DOI 10.1016/j.survophthal.2011.10.006; Odds FC, 2003, J ANTIMICROB CHEMOTH, V52, P1, DOI 10.1093/jac/dkg301; Sasaki H, 1999, CRIT REV THER DRUG, V16, P85; Springer B, 1996, J CLIN MICROBIOL, V34, P296, DOI 10.1128/JCM.34.2.296-303.1996; Tortoli E, 2003, CLIN MICROBIOL REV, V16, P319, DOI 10.1128/CMR.16.2.319-354.2003; Tortoli E, 2006, FEMS IMMUNOL MED MIC, V48, P159, DOI 10.1111/j.1574-695X.2006.00123.x; van Ingen J, 2009, CLIN MICROBIOL INFEC, V15, P888, DOI 10.1111/j.1469-0691.2009.03013.x; Wallace R.J.J., 2011, M24A2 CLIN LAB STAND, V2nd; Zelazny AM, 2009, J CLIN MICROBIOL, V47, P1985, DOI 10.1128/JCM.01688-08	24	11	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2015	10	1							e0116236	10.1371/journal.pone.0116236	http://dx.doi.org/10.1371/journal.pone.0116236			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ4CF	25581038	Green Published, Green Submitted, gold			2022-12-27	WOS:000348169100003
J	Ellis, AM; Myers, SS; Ricketts, TH				Ellis, Alicia M.; Myers, Samuel S.; Ricketts, Taylor H.			Do Pollinators Contribute to Nutritional Health?	PLOS ONE			English	Article							INTAKE DISTRIBUTIONS; CHILDREN; PREVALENCE; NUTRIENTS; IMPACTS; THREATS; WOMEN	Despite suggestions that animal pollinators are crucial for human nutritional health, no studies have actually tested this claim. Here, we combined data on crop pollination requirements, food nutrient densities, and actual human diets to predict the effects of pollinator losses on the risk of nutrient deficiency. In four developing countries and across five nutrients, we found that 0 to 56% of populations would become newly at risk if pollinators were removed. Increases in risk were most pronounced for vitamin A in populations with moderate levels of total nutrient intake. Overall, the effects of pollinator decline varied widely among populations and nutrients. We conclude that the importance of pollinators to human nutrition depends critically on the composition of local diets, and cannot be reliably predicted from global commodity analyses. We identify conditions under which severe health effects of pollinator loss are most likely to occur.	[Ellis, Alicia M.; Ricketts, Taylor H.] Univ Vermont, Gund Inst Ecol Econ, Burlington, VT 05405 USA; [Myers, Samuel S.] Harvard Univ, Sch Publ Hlth, Dept Environm Hlth, Boston, MA 02215 USA; [Myers, Samuel S.] Harvard Univ, Ctr Environm, Cambridge, MA 02138 USA	University of Vermont; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University	Ricketts, TH (corresponding author), Univ Vermont, Gund Inst Ecol Econ, 617 Main St, Burlington, VT 05405 USA.	taylor.ricketts@uvm.edu			Gordon and Betty Moore Foundation; Rockefeller Foundation [26862]; Bill & Melinda Gates Foundation	Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); Rockefeller Foundation; Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR)	This work was supported by The Gordon and Betty Moore Foundation and The Rockefeller Foundation as part of the Health & Ecosystems: Analysis of Linkages (HEAL) program (UVM grant #26862). Additional support was received from the Bill & Melinda Gates Foundation (no grant #). Any opinions expressed herein are those of the authors and do not necessarily reflect those of the program's supporters.	[Anonymous], 2013, SCIENCEDAILY; Arsenault JE, 2010, J NUTR, V140, P1683, DOI 10.3945/jn.110.123059; Burkle LA, 2013, SCIENCE, V339, P1611, DOI 10.1126/science.1232728; Carriquiry AL, 2003, J NUTR, V133, p601S, DOI 10.1093/jn/133.2.601S; Carriquiry AL, 1999, PUBLIC HEALTH NUTR, V2, P23, DOI 10.1017/S1368980099000038; Chaplin-Kramer R, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.1799; Dodd KW, 2006, J AM DIET ASSOC, V106, P1640, DOI 10.1016/j.jada.2006.07.011; Eilers EJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021363; Fishman SM, 2004, COMP QUANTIFICATION, P39; Garibaldi LA, 2013, SCIENCE, V339, P1608, DOI 10.1126/science.1230200; Guenther PM, 1997, J NUTR, V127, P1106, DOI 10.1093/jn/127.6.1106; Hotz C, 2012, J NUTR, V142, P1871, DOI 10.3945/jn.111.151829; Hotz C, 2012, PUBLIC HEALTH NUTR, V15, P1688, DOI 10.1017/S1368980012000924; Hotz C, 2012, BRIT J NUTR, V108, P163, DOI 10.1017/S0007114511005174; Klein AM, 2007, P ROY SOC B-BIOL SCI, V274, P303, DOI 10.1098/rspb.2006.3721; Kubena KS, 1996, J AM DIET ASSOC, V96, P1156, DOI 10.1016/S0002-8223(96)00297-0; Martens WJM, 1997, B WORLD HEALTH ORGAN, V75, P583; Muller O, 2005, CAN MED ASSOC J, V173, P279, DOI 10.1503/cmaj.050342; Myers SS, 2013, P NATL ACAD SCI USA, V110, P18753, DOI 10.1073/pnas.1218656110; Myers SS, 2009, ANNU REV ENV RESOUR, V34, P223, DOI 10.1146/annurev.environ.033108.102650; Nusser SM, 1996, J AM STAT ASSOC, V91, P1440, DOI 10.2307/2291570; Potts SG, 2010, TRENDS ECOL EVOL, V25, P345, DOI 10.1016/j.tree.2010.01.007; R Core Team, 2021, R LANGUAGE ENV STAT; Rice AL., 2004, COMP QUANTIFICATION, V1, P0211; Sala O.E., 2009, BIODIVERSITY CHANGE; Sandstrom B, 2001, BRIT J NUTR, V85, pS181, DOI 10.1079/BJN2000312; Souverein OW, 2011, EUR J CLIN NUTR, V65, pS92, DOI 10.1038/ejcn.2011.93; Tulchinsky TH, 2010, PUBLIC HEALTH REV, V32, P243, DOI 10.1007/BF03391600; Vanbergen AJ, 2013, FRONT ECOL ENVIRON, V11, P251, DOI 10.1890/120126; Willett WC, 2013, NUTR EPIDEMIOLOGY, P34	30	79	82	0	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2015	10	1							e114805	10.1371/journal.pone.0114805	http://dx.doi.org/10.1371/journal.pone.0114805			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ4BU	25575027	Green Submitted, Green Published, gold			2022-12-27	WOS:000348168100001
J	Chiba, T; Sakurada, T; Watanabe, R; Yamaguchi, K; Kimura, Y; Kioka, N; Kawagishi, H; Matsuo, M; Ueda, K				Chiba, Tomohiro; Sakurada, Tsuyoshi; Watanabe, Rie; Yamaguchi, Kohji; Kimura, Yasuhisa; Kioka, Noriyuki; Kawagishi, Hirokazu; Matsuo, Michinori; Ueda, Kazumitsu			Fomiroid A, a Novel Compound from the Mushroom Fomitopsis nigra, Inhibits NPC1L1-Mediated Cholesterol Uptake via a Mode of Action Distinct from That of Ezetimibe	PLOS ONE			English	Article							INTESTINAL NPC1L1 EXPRESSION; PICK C1-LIKE 1; ABSORPTION INHIBITOR; DIETARY; PROTEIN; ATHEROSCLEROSIS; MEMBRANE; BINDING; TARGET; CELLS	Hypercholesterolemia is one of the key risk factors for coronary heart disease, a major cause of death in developed countries. Suppression of NPC1L1-mediated dietary and biliary cholesterol absorption is predicted to be one of the most effective ways to reduce the risk of hypercholesterolemia. In a screen for natural products that inhibit ezetimibe glucuronide binding to NPC1L1, we found a novel compound, fomiroid A, in extracts of the mushroom Fomitopsis nigra. Fomiroid A is a Ianosterone derivative with molecular formula C30H48O3. Fomiroid A inhibited ezetimibe glucuronide binding to NPC1L1, and dose-dependently prevented NPC1L1-mediated cholesterol uptake and formation of esterified cholesterol in NPC1L1-expressing Caco2 cells. Fomiroid A exhibited a pharmacological chaperone activity that corrected trafficking defects of the L1072T/L1168I mutant of NPC1L1. Because ezetimibe does not have such an activity, the binding site and mode of action of fomiroid A are likely to be distinct from those of ezetimibe.	[Chiba, Tomohiro; Sakurada, Tsuyoshi; Watanabe, Rie; Yamaguchi, Kohji] FANCL Corp, FANCL Res Inst, Totsuka Ku, Yokohama, Kanagawa 2440806, Japan; [Chiba, Tomohiro; Kimura, Yasuhisa; Kioka, Noriyuki; Matsuo, Michinori; Ueda, Kazumitsu] Kyoto Univ, Grad Sch Agr, Div Appl Life Sci, Sakyo Ku, Kyoto 6068502, Japan; [Chiba, Tomohiro; Ueda, Kazumitsu] Kyoto Univ, Inst Integrated Cell Mat Sci iCeMS, Sakyo Ku, Kyoto 6068502, Japan; [Kawagishi, Hirokazu] Shizuoka Univ, Grad Sch Sci & Technol, Suruga Ku, Shizuoka 4228529, Japan; [Kawagishi, Hirokazu] Shizuoka Univ, Res Inst Green Sci & Technol, Suruga Ku, Shizuoka 4228529, Japan; [Kawagishi, Hirokazu] Shizuoka Univ, Grad Sch Agr, Suruga Ku, Shizuoka 4228529, Japan; [Matsuo, Michinori] Kyoto Womens Univ, Dept Food & Nutr, Higashiyama Ku, Kyoto 6058501, Japan	FANCL Corporation; Kyoto University; Kyoto University; Shizuoka University; Shizuoka University; Shizuoka University; Kyoto Womens University	Ueda, K (corresponding author), Kyoto Univ, Grad Sch Agr, Div Appl Life Sci, Sakyo Ku, Kitashirakawa Oiwake Cho, Kyoto 6068502, Japan.	uedak@kais.kyoto-u.ac.jp		Kimura, Yasuhisa/0000-0001-6466-1324; Ueda, Kazumitsu/0000-0003-2980-6078; Kioka, Noriyuki/0000-0002-2708-537X	FANCL Corporation; Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT) [25221203, 24580139]; Program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation; World Premier International Research Center Initiative, MEXT	FANCL Corporation; Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation(National Institute of Biomedical Innovation); World Premier International Research Center Initiative, MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	Financial support for this study was partly provided by FANCL Corporation (http://www.fancl.co.jp/). This work was supported by Grants-in-aid for Scientific research (S) (25221203) for KU, Scientific Research (C) (24580139) for MM from the Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT). Additional support came from the Program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation for NK, MM, and KU. This work was also supported by the World Premier International Research Center Initiative, MEXT. These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altmann SW, 2004, SCIENCE, V303, P1201, DOI 10.1126/science.1093131; BURNETT DA, 1994, J MED CHEM, V37, P1733, DOI 10.1021/jm00038a001; Clader JW, 2004, J MED CHEM, V47, P1, DOI 10.1021/jm030283g; Davies JP, 2000, GENOMICS, V65, P137, DOI 10.1006/geno.2000.6151; Davis HR, 2007, J ATHEROSCLER THROMB, V14, P99, DOI 10.5551/jat.14.99; Davis HR, 2001, ARTERIOSCL THROM VAS, V21, P2032, DOI 10.1161/hq1201.100260; During A, 2005, J NUTR, V135, P2305, DOI 10.1093/jn/135.10.2305; Field FJ, 2007, J LIPID RES, V48, P1735, DOI 10.1194/jlr.M700029-JLR200; Gadgil MD, 2014, J ACAD NUTR DIET, V114, P238, DOI 10.1016/j.jand.2013.09.021; Garcia-Calvo M, 2005, P NATL ACAD SCI USA, V102, P8132, DOI 10.1073/pnas.0500269102; Garmy N, 2005, J LIPID RES, V46, P36, DOI 10.1194/jlr.M400199-JLR200; Ge L, 2008, CELL METAB, V7, P508, DOI 10.1016/j.cmet.2008.04.001; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Hawes BE, 2007, MOL PHARMACOL, V71, P19, DOI 10.1124/mol.106.027896; Karaki F, 2014, BIOORGAN MED CHEM, V22, P3587, DOI 10.1016/j.bmc.2014.05.022; Karaki F, 2013, BIOORGAN MED CHEM, V21, P5297, DOI 10.1016/j.bmc.2013.06.022; Kumar P, 2011, AM J PHYSIOL-GASTR L, V301, pG148, DOI 10.1152/ajpgi.00119.2011; Kwon HJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018722; Li PS, 2014, NAT MED, V20, P80, DOI 10.1038/nm.3417; Mathur SN, 2007, J LIPID RES, V48, P395, DOI 10.1194/jlr.M600325-JLR200; Matsumoto H, 2005, Japan Patent Tokkai, Patent No. [2005-213144, 2005213144]; Narushima K, 2008, MOL PHARMACOL, V74, P42, DOI 10.1124/mol.107.043034; Nekohashi M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097901; Reboul E, 2012, BRIT J NUTR, V107, P1296, DOI 10.1017/S0007114511004405; Sane AT, 2006, J LIPID RES, V47, P2112, DOI 10.1194/jlr.M600174-JLR200; Tang WQ, 2011, BBA-MOL CELL BIOL L, V1811, P549, DOI 10.1016/j.bbalip.2011.05.013; Temel RE, 2007, J CLIN INVEST, V117, P1968, DOI 10.1172/JCI30060; van Heek M, 2000, BRIT J PHARMACOL, V129, P1748, DOI 10.1038/sj.bjp.0703235; van Heek M, 2003, BRIT J PHARMACOL, V138, P1459, DOI 10.1038/sj.bjp.0705187; Wang J, 2009, J LIPID RES, V50, P1653, DOI 10.1194/jlr.M800669-JLR200; Weinglass AB, 2008, P NATL ACAD SCI USA, V105, P11140, DOI 10.1073/pnas.0800936105; Weinglass AB, 2008, MOL PHARMACOL, V73, P1072, DOI 10.1124/mol.107.043844; WILSON MD, 1994, J LIPID RES, V35, P943; Yamanashi Y, 2007, J PHARMACOL EXP THER, V320, P559, DOI 10.1124/jpet.106.114181; Zhang JH, 2011, J BIOL CHEM, V286, P25088, DOI 10.1074/jbc.M111.244475	35	9	9	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2014	9	12							e116162	10.1371/journal.pone.0116162	http://dx.doi.org/10.1371/journal.pone.0116162			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UC	25551765	Green Published, Green Submitted, gold			2022-12-27	WOS:000347119100104
J	Li, WL; Xie, H; Li, QD; Zhou, LP; Yin, ZP				Li, Wen-Long; Xie, He; Li, Qi-Dong; Zhou, Li-Ping; Yin, Zhou-Ping			Section Curve Reconstruction and Mean-Camber Curve Extraction of a Point-Sampled Blade Surface	PLOS ONE			English	Article							REGISTRATION; INSPECTION; REPAIR; ALGORITHM; GEOMETRY	The blade is one of the most critical parts of an aviation engine, and a small change in the blade geometry may significantly affect the dynamics performance of the aviation engine. Rapid advancements in 3D scanning techniques have enabled the inspection of the blade shape using a dense and accurate point cloud. This paper proposes a new method to achieving two common tasks in blade inspection: section curve reconstruction and mean-camber curve extraction with the representation of a point cloud. The mathematical morphology is expanded and applied to restrain the effect of the measuring defects and generate an ordered sequence of 2D measured points in the section plane. Then, the energy and distance are minimized to iteratively smoothen the measured points, approximate the section curve and extract the mean-camber curve. In addition, a turbine blade is machined and scanned to observe the curvature variation, energy variation and approximation error, which demonstrates the availability of the proposed method. The proposed method is simple to implement and can be applied in aviation casting-blade finish inspection, large forging-blade allowance inspection and visual-guided robot grinding localization.	[Li, Wen-Long; Xie, He; Li, Qi-Dong; Zhou, Li-Ping; Yin, Zhou-Ping] Huazhong Univ Sci & Technol, Sch Mech Sci & Engn, State Key Lab Digital Mfg Equipment & Technol, Wuhan 430074, Peoples R China	Huazhong University of Science & Technology	Yin, ZP (corresponding author), Huazhong Univ Sci & Technol, Sch Mech Sci & Engn, State Key Lab Digital Mfg Equipment & Technol, Wuhan 430074, Peoples R China.	yinzhp@mail.hust.edu.cn			National Natural Science Foundation of China [51475187, 51275192, 51421062]; National Key Projects [2014ZX04001051-05]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Projects	This work was supported by the National Natural Science Foundation of China (Grant Nos. 51475187, 51275192 and 51421062) and the National Key Projects (Grant No. 2014ZX04001051-05). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almukhtar A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093402; Aptoula E, 2007, PATTERN RECOGN, V40, P2914, DOI 10.1016/j.patcog.2007.02.004; Berger U., 1999, Information Control in Manufacturing 1998. (INCOM'98). Advances in Industrial Engineering. A Proceedings volume from the 9th IFAC Symposium, P295; BESL PJ, 1992, IEEE T PATTERN ANAL, V14, P239, DOI 10.1109/34.121791; Chang HC, 2005, INT J ADV MANUF TECH, V26, P789, DOI 10.1007/s00170-003-1877-6; Chen Q, 2008, 2008 IEEE CONFERENCE ON ROBOTICS, AUTOMATION, AND MECHATRONICS, VOLS 1 AND 2, P229; Gan ZX, 2007, LECT NOTES CONTR INF, V362, P1; Gao J, 2008, INT J ADV MANUF TECH, V36, P1170, DOI 10.1007/s00170-006-0923-6; Heo EY, 2008, ROBOT CIM-INT MANUF, V24, P788, DOI 10.1016/j.rcim.2008.03.012; Hsu TH, 2006, INT J ADV MANUF TECH, V30, P129, DOI 10.1007/s00170-005-0046-5; Hsu TH, 2005, INT J ADV MANUF TECH, V26, P797, DOI 10.1007/s00170-003-2040-0; Huang H, 2003, INT J ADV MANUF TECH, V21, P275, DOI 10.1007/s001700300032; Li WL, 2011, IET COMPUT VIS, V5, P68, DOI 10.1049/iet-cvi.2009.0032; Li YQ, 2009, J COMPUT INF SCI ENG, V9, DOI 10.1115/1.3184602; Makem JE, 2012, COMPUT AIDED DESIGN, V44, P858, DOI 10.1016/j.cad.2012.04.002; Pottmann H, 2006, INT J COMPUT VISION, V67, P277, DOI 10.1007/s11263-006-5167-2; Ravishankar S, 2010, INT J ADV MANUF TECH, V46, P227, DOI 10.1007/s00170-009-2067-y; Rong Y, 2014, P I MECH ENG G-J AER, V228, P1; Savio E, 2007, CIRP ANN-MANUF TECHN, V56, P810, DOI 10.1016/j.cirp.2007.10.008; Serra J, 1983, IMAGE ANAL MATH MORP; Tian Chen, 2010, 2010 2nd International Conference on Computer Engineering and Technology (ICCET 2010), P294, DOI 10.1109/ICCET.2010.5486027; Vizilter YV, 2011, PATTERN RECOGN, V21, P237; Yilmaz O, 2005, AIRCR ENG AEROSP TEC, V77, P455, DOI 10.1108/00022660510628444; Yilmaz O, 2010, ROBOT CIM-INT MANUF, V26, P190, DOI 10.1016/j.rcim.2009.07.001; Zhang X, 2005, INT J MACH TOOL MANU, V45, P641, DOI 10.1016/j.ijmachtools.2004.10.006; Zheng JM, 2006, INT J ADV MANUF TECH, V29, P1062, DOI 10.1007/s00170-003-1990-6; Zhu X, 2000, FREE CURVE SURFACE M	27	9	11	7	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2014	9	12							e115471	10.1371/journal.pone.0115471	http://dx.doi.org/10.1371/journal.pone.0115471			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UC	25551467	gold, Green Published, Green Submitted			2022-12-27	WOS:000347119100038
J	Dreischarf, M; Albiol, L; Rohlmann, A; Pries, E; Bashkuev, M; Zander, T; Duda, G; Druschel, C; Strube, P; Putzier, M; Schmidt, H				Dreischarf, Marcel; Albiol, Laia; Rohlmann, Antonius; Pries, Esther; Bashkuev, Maxim; Zander, Thomas; Duda, Georg; Druschel, Claudia; Strube, Patrick; Putzier, Michael; Schmidt, Hendrik			Age-Related Loss of Lumbar Spinal Lordosis and Mobility - A Study of 323 Asymptomatic Volunteers	PLOS ONE			English	Article							LOW-BACK-PAIN; SAGITTAL PLANE; RECIPROCAL ANGULATION; RADIOGRAPHIC ANALYSIS; NORMATIVE DATABASE; VERTEBRAL BODIES; ALIGNMENT; BALANCE; PELVIS; MOTION	Background: The understanding of the individual shape and mobility of the lumbar spine are key factors for the prevention and treatment of low back pain. The influence of age and sex on the total lumbar lordosis and the range of motion as well as on different lumbar sub-regions (lower, middle and upper lordosis) in asymptomatic subjects still merits discussion, since it is essential for patient-specific treatment and evidence-based distinction between painful degenerative pathologies and asymptomatic aging. Methods and Findings: A novel non-invasive measuring system was used to assess the total and local lumbar shape and its mobility of 323 asymptomatic volunteers (age: 20-75 yrs; BMI <26.0 kg/m(2); males/females: 139/184). The lumbar lordosis for standing and the range of motion for maximal upper body flexion (RoF) and extension (RoE) were determined. The total lordosis was significantly reduced by approximately 20%, the RoF by 12% and the RoE by 31% in the oldest (>50 yrs) compared to the youngest age cohort (20-29 yrs). Locally, these decreases mostly occurred in the middle part of the lordosis and less towards the lumbo-sacral and thoraco-lumbar transitions. The sex only affected the RoE. Conclusions: During aging, the lower lumbar spine retains its lordosis and mobility, whereas the middle part flattens and becomes less mobile. These findings lay the ground for a better understanding of the incidence of level-and age-dependent spinal disorders, and may have important implications for the clinical long-term success of different surgical interventions.	[Dreischarf, Marcel; Albiol, Laia; Rohlmann, Antonius; Pries, Esther; Bashkuev, Maxim; Zander, Thomas; Duda, Georg; Schmidt, Hendrik] Charite, Julius Wolff Inst, D-13353 Berlin, Germany; [Druschel, Claudia; Strube, Patrick; Putzier, Michael] Charite, Ctr Muskuloskeletale Chirurg, D-13353 Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Dreischarf, M (corresponding author), Charite, Julius Wolff Inst, D-13353 Berlin, Germany.	dreischarf@julius-wolff-institut.de	Duda, Georg N/H-2085-2016; Strube, Patrick/AAH-5408-2019; Rohlmann, Antonius/E-4778-2011	Duda, Georg N/0000-0001-7605-3908; Strube, Patrick/0000-0003-3210-5301; Bashkuev, Maxim/0000-0003-0339-6998; Schmidt, Hendrik/0000-0003-3300-8685; Rohlmann, Antonius/0000-0002-0083-2793	Deutsche Forschungsgemeinschaft (DFG), Bonn, Germany [PU 510/2-1]; Bundesinstitut fur Sportwissenschaft, Bonn, Germany (MiSpEx - Network)	Deutsche Forschungsgemeinschaft (DFG), Bonn, Germany(German Research Foundation (DFG)); Bundesinstitut fur Sportwissenschaft, Bonn, Germany (MiSpEx - Network)	This study was supported financially by the Deutsche Forschungsgemeinschaft (DFG PU 510/2-1), Bonn, Germany, and by the Bundesinstitut fur Sportwissenschaft, Bonn, Germany (MiSpEx - Network). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS MA, 1986, CLIN BIOMECH, V1, P130, DOI 10.1016/0268-0033(86)90002-1; AMONOOKUOFI HS, 1992, ACTA ANAT, V145, P373; Barrey C, 2007, EUR SPINE J, V16, P1459, DOI 10.1007/s00586-006-0294-6; BATTIE MC, 1987, PHYS THER, V67, P653, DOI 10.1093/ptj/67.5.653; Berthonnaud E, 2005, J SPINAL DISORD TECH, V18, P40, DOI 10.1097/01.bsd.0000117542.88865.77; Bible JE, 2008, SPINE, V33, P1793, DOI 10.1097/BRS.0b013e31817b8f3a; Boden SD, 1996, J BONE JOINT SURG AM, V78A, P114, DOI 10.2106/00004623-199601000-00017; Boulay C, 2006, EUR SPINE J, V15, P415, DOI 10.1007/s00586-005-0984-5; Consmuller T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050135; Consmuller T, 2012, EUR SPINE J, V21, P2170, DOI 10.1007/s00586-012-2312-1; Dvorak J, 1995, Eur Spine J, V4, P18, DOI 10.1007/BF00298413; GELB DE, 1995, SPINE, V20, P1351, DOI 10.1097/00007632-199506000-00005; Guermazi M., 2006, Annales de Readaptation et de Medecine Physique, V49, P172, DOI 10.1016/j.annrmp.2006.03.001; Hammerberg EM, 2003, J SPINAL DISORD TECH, V16, P44, DOI 10.1097/00024720-200302000-00008; HANSSON T, 1985, SPINE, V10, P154, DOI 10.1097/00007632-198503000-00008; Intolo P, 2009, MANUAL THER, V14, P596, DOI 10.1016/j.math.2009.08.006; JACKSON RP, 1994, SPINE, V19, P1611, DOI 10.1097/00007632-199407001-00010; Janik TJ, 1998, J ORTHOPAED RES, V16, P766, DOI 10.1002/jor.1100160620; Janssen MMA, 2009, SPINE, V34, pE826, DOI 10.1097/BRS.0b013e3181a9fd85; Korovessis P, 1999, J SPINAL DISORD, V12, P131; Korovessis PG, 1998, SPINE, V23, P700, DOI 10.1097/00007632-199803150-00010; Labelle H, 2005, SPINE, V30, pS27, DOI 10.1097/01.brs.0000155560.92580.90; Lang-Tapia M, 2011, J APPL BIOMECH, V27, P143, DOI 10.1123/jab.27.2.143; Legaye J, 1998, Eur Spine J, V7, P99, DOI 10.1007/s005860050038; Lin R M, 1992, J Formos Med Assoc, V91, P329; Mac-Thiong JM, 2007, EUR SPINE J, V16, P227, DOI 10.1007/s00586-005-0013-8; Mac-Thiong JM, 2010, SPINE, V35, pE1193, DOI 10.1097/BRS.0b013e3181e50808; MCGREGOR AH, 1995, SPINE, V20, P2421, DOI 10.1097/00007632-199511001-00009; MILNE JS, 1974, ANN HUM BIOL, V1, P327, DOI 10.1080/03014467400000351; National Research Council, 1989, DIET HLTH IMPL RED C; Nourbakhsh MR, 2001, J SPINAL DISORD, V14, P283, DOI 10.1097/00002517-200108000-00002; Pellet N, 2011, Eur Spine J, V20 Suppl 5, P647, DOI 10.1007/s00586-011-1933-0; Rajnics P, 2002, INT ORTHOP, V26, P104, DOI 10.1007/s00264-001-0317-1; Roussouly P, 2005, SPINE, V30, P346, DOI 10.1097/01.brs.0000152379.54463.65; Roussouly P, 2011, EUR SPINE J S5, V20, P578, DOI [10.1007/s00586-011-1924-1, DOI 10.1007/S00586-011-1924-1]; Schroder J, 2014, ORTHOPADE, V43, P841, DOI 10.1007/s00132-014-2316-0; Schwab F, 2006, SPINE, V31, pE959, DOI 10.1097/01.brs.0000248126.96737.0f; Schwab F, 2009, SPINE, V34, P1828, DOI 10.1097/BRS.0b013e3181a13c08; STAGNARA P, 1982, SPINE, V7, P335, DOI 10.1097/00007632-198207000-00003; STOKES IAF, 1987, SPINE, V12, P355, DOI 10.1097/00007632-198705000-00009; Strube P, 2012, J SPINAL DISORD TECH, DOI [10.1097/BSD.0b013e31827f434e, DOI 10.1097/BSD.0B013E31827F434E]; SULLIVAN MS, 1994, SPINE, V19, P682, DOI 10.1097/00007632-199403001-00007; Takeda N, 2009, J ORTHOP SCI, V14, P748, DOI 10.1007/s00776-009-1394-z; Taylor WR, 2010, MED ENG PHYS, V32, P1080, DOI 10.1016/j.medengphy.2010.07.011; Troke M, 2005, MANUAL THER, V10, P198, DOI 10.1016/j.math.2004.10.004; Troke M, 2001, CLIN REHABIL, V15, P371, DOI 10.1191/026921501678310171; Trudelle-Jackson E, 2010, SPINE, V35, P1539, DOI 10.1097/BRS.0b013e3181b0c3d1; Tsuji T, 2001, J Orthop Sci, V6, P307, DOI 10.1007/s007760100023; Tuzun C, 1999, CLIN RHEUMATOL, V18, P308, DOI 10.1007/s100670050107; Van Herp G, 2000, RHEUMATOLOGY, V39, P1337, DOI 10.1093/rheumatology/39.12.1337; Vaz G, 2002, EUR SPINE J, V11, P80, DOI 10.1007/s005860000224; Vialle R, 2005, J BONE JOINT SURG AM, V87A, P260, DOI 10.2106/JBJS.D.02043	52	43	43	4	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2014	9	12							e116186	10.1371/journal.pone.0116186	http://dx.doi.org/10.1371/journal.pone.0116186			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX6YH	25549085	Green Submitted, gold, Green Published			2022-12-27	WOS:000347063500059
J	Jaudszus, A; Degen, C; Barth, SW; Klempt, M; Schlormann, W; Roth, A; Rohrer, C; Sauerwein, H; Sachse, K; Jahreis, G				Jaudszus, Anke; Degen, Christian; Barth, Stephan W.; Klempt, Martin; Schloermann, Wiebke; Roth, Alexander; Rohrer, Carsten; Sauerwein, Helga; Sachse, Konrad; Jahreis, Gerhard			Loss of FADS2 Function Severely Impairs the Use of HeLa Cells as an In Vitro Model for Host Response Studies Involving Fatty Acid Effects	PLOS ONE			English	Article							TOLL-LIKE RECEPTOR-2; NF-KAPPA-B; EPITHELIAL-CELLS; CHLAMYDIA-TRACHOMATIS; GENE-CLUSTER; EXPRESSION; ACTIVATION; COX-2; METABOLISM; INFECTION	Scope: Established epithelial cell lines equipped with pattern recognition receptors such as the Toll-like receptor (TLR)-2 are common tools for immune response studies on invading pathogens, e.g. the obligate intracellular species of Chlamydia. Moreover, such models are widely used to elucidate fatty acid-mediated immune effects. In several transformed cell lines, however, unusual loss of metabolic functions was described. The cell lines A549 and HeLa are poorly characterized in this respect. Therefore, we comparatively assessed the metabolic capacity of A549 and HeLa prior to proposed application as in vitro model for fatty acid effects on chlamydial infection. Methodology/Principal Findings: We incubated both cell lines either with substrates (C18:2n-6 or C18:3n-3) or products (C18:3n-6, C18:4n-3) of fatty acid desaturase-2 (FADS2), and analysed the fatty acid profiles after 24 h and 72 h by gas chromatography. Based on these data, we suspected that the complete discontinuation of normal biosynthesis of long-chain polyunsaturated fatty acids (LC-PUFA) in HeLa was due to loss of FADS2 function. Consequently, prostaglandin E2 (PGE2) formation was less inducible by TLR2 stimulation in HeLa, likely as a result of not only insufficient supply of precursors but also weak cyclooxygenase-2 (COX-2) response. In accordance, Chlamydia infection rates were consistently lower in HeLa than in A549. Sequence analysis revealed no alteration within the FADS2 gene in HeLa. The FADS2 expression level, however, was significantly lower and, in contrast to A549, not regulated by C18: 2n-6. A549 exhibited regular fatty acid metabolism and enzyme functionality. Conclusions/Significance: Our data show that HeLa cells considerably differ from A549 at several stages of fatty acid metabolism. The poor metabolic potential of HeLa, mainly concerning FADS2 upstream of COX-2 function, calls into question whether these cells represent a good model to unveil fatty acid or downstream eicosanoid effects in the course of intracellular bacterial infection.	[Jaudszus, Anke; Barth, Stephan W.; Roth, Alexander] Max Rubner Inst, Fed Res Inst Nutr & Food, Dept Physiol & Biochem Nutr, Karlsruhe, Germany; [Degen, Christian; Schloermann, Wiebke; Rohrer, Carsten; Jahreis, Gerhard] Univ Jena, Inst Nutr, Dept Nutr Physiol, Jena, Germany; [Klempt, Martin] Max Rubner Inst, Fed Res Inst Nutr & Food, Dept Safety & Qual Milk & Fish Prod, Kiel, Germany; [Sauerwein, Helga] Univ Bonn, Inst Anim Sci, Physiol & Hyg Unit, Bonn, Germany; [Sachse, Konrad] Friedrich Loeffler Inst, Fed Res Inst Anim Hlth, Inst Mol Pathogenesis, Jena, Germany	Friedrich Schiller University of Jena; University of Bonn; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Friedrich Loeffler Institute	Jaudszus, A (corresponding author), Max Rubner Inst, Fed Res Inst Nutr & Food, Dept Physiol & Biochem Nutr, Karlsruhe, Germany.	anke.jaudszus@mri.bund.de	Sauerwein, Helga/R-8242-2019; Sachse, Konrad/GWC-4999-2022	Sachse, Konrad/0000-0003-1230-1786; Roth, Alexander/0000-0002-5975-0573	German Research Council DFG [Ja 893/5]; North Rhine-Westphalian Ministry of Environment, Conservation, Agriculture and Consumers Protection (MUNLV) within the Inter-Departmental Center of Sustainable Agriculture (USL)	German Research Council DFG(German Research Foundation (DFG)); North Rhine-Westphalian Ministry of Environment, Conservation, Agriculture and Consumers Protection (MUNLV) within the Inter-Departmental Center of Sustainable Agriculture (USL)	This study was financially supported by a grant from the German Research Council DFG Ja 893/5) and a grant provided by the North Rhine-Westphalian Ministry of Environment, Conservation, Agriculture and Consumers Protection (MUNLV) within the Inter-Departmental Center of Sustainable Agriculture (USL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANGELETTI C, 1995, MOL CELL BIOCHEM, V143, P99, DOI 10.1007/BF01816942; Baranova IN, 2008, J IMMUNOL, V181, P7147, DOI 10.4049/jimmunol.181.10.7147; Beckett EL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039460; Bernard JJ, 2010, J IMMUNOL, V185, P6535, DOI 10.4049/jimmunol.1002009; Birchler T, 2001, EUR J IMMUNOL, V31, P3131, DOI 10.1002/1521-4141(200111)31:11<3131::AID-IMMU3131>3.0.CO;2-G; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bokor S, 2010, J LIPID RES, V51, P2325, DOI 10.1194/jlr.M006205; Buwitt-Beckmann U, 2005, EUR J IMMUNOL, V35, P282, DOI 10.1002/eji.200424955; Calder PC, 2009, BIOCHIMIE, V91, P791, DOI 10.1016/j.biochi.2009.01.008; Chene G, 2007, BBA-MOL CELL BIOL L, V1771, P576, DOI 10.1016/j.bbalip.2007.02.014; Derecka K, 2008, MOL CELL ENDOCRINOL, V287, P65, DOI 10.1016/j.mce.2008.02.015; Deva R, 2003, J IMMUNOL, V171, P3047, DOI 10.4049/jimmunol.171.6.3047; Fukuda EY, 2005, INFECT IMMUN, V73, P4017, DOI 10.1128/IAI.73.7.4017-4024.2005; Goellner S, 2006, INFECT IMMUN, V74, P4801, DOI 10.1128/IAI.01487-05; GRAMMATIKOS SI, 1994, ANN NY ACAD SCI, V745, P92; Grun M, 2009, J MICROBIOL METH, V78, P360, DOI 10.1016/j.mimet.2009.06.016; Guillou H, 2010, PROG LIPID RES, V49, P186, DOI 10.1016/j.plipres.2009.12.002; HRELIA S, 1995, BIOCHEM BIOPH RES CO, V216, P11, DOI 10.1006/bbrc.1995.2585; Jakobsson PJ, 1999, P NATL ACAD SCI USA, V96, P7220, DOI 10.1073/pnas.96.13.7220; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; Jaudszus A, 2013, J LIPID RES, V54, P923, DOI 10.1194/jlr.P031260; Jaudszus A, 2012, BBA-MOL CELL BIOL L, V1821, P1316, DOI 10.1016/j.bbalip.2012.06.010; Jaudszus A, 2010, ANN NUTR METAB, V57, P103, DOI 10.1159/000319877; Joyee AG, 2008, CURR PHARM DESIGN, V14, P593, DOI 10.2174/138161208783885344; Lattka E, 2010, J LIPID RES, V51, P182, DOI 10.1194/jlr.M900289-JLR200; Liu W, 2006, MICROBES INFECT, V8, P478, DOI 10.1016/j.micinf.2005.07.026; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Massari P, 2013, INFECT IMMUN, V81, P303, DOI 10.1128/IAI.01062-12; NAVAL J, 1993, BIOCHEM J, V291, P841, DOI 10.1042/bj2910841; Nwankwo JO, 2003, J LIPID RES, V44, P2311, DOI 10.1194/jlr.M300273-JLR200; Park WJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028186; Park WJ, 2009, J LIPID RES, V50, P1195, DOI 10.1194/jlr.M800630-JLR200; Portolesi R, 2008, LIPIDS, V43, P91, DOI 10.1007/s11745-007-3122-9; Schaeffer L, 2006, HUM MOL GENET, V15, P1745, DOI 10.1093/hmg/ddl117; Serhan CN, 2005, CURR OPIN CLIN NUTR, V8, P115, DOI 10.1097/00075197-200503000-00003; Shimasaki S, 2010, BIOCHEM BIOPH RES CO, V402, P235, DOI 10.1016/j.bbrc.2010.09.132; Sprecher H, 1995, J LIPID RES, V36, P2471; Triantafilou M, 2006, J BIOL CHEM, V281, P31002, DOI 10.1074/jbc.M602794200; Xie P, 2012, POULTRY SCI, V91, P1670, DOI 10.3382/ps.2011-02097; Xu F, 2008, RESP RES, V9, DOI 10.1186/1465-9921-9-16	40	6	6	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2014	9	12							e115610	10.1371/journal.pone.0115610	http://dx.doi.org/10.1371/journal.pone.0115610			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX6YH	25549244	gold, Green Published, Green Submitted			2022-12-27	WOS:000347063500020
J	Jiang, Y; Chen, JH; Tong, J; Chen, T				Jiang, Yan; Chen, Jiahong; Tong, Jian; Chen, Tao			Trichloroethylene-Induced Gene Expression and DNA Methylation Changes in B6C3F1 Mouse Liver	PLOS ONE			English	Article							PPAR-ALPHA; HOMOLOGOUS RECOMBINATION; HUMAN CANCER; CELL-CYCLE; RAT-LIVER; C-JUN; MICE; METABOLITES; RAD51; PROTOONCOGENES	Trichloroethylene (TCE), widely used as an organic solvent in the industry, is a common contaminant in air, soil, and water. Chronic TCE exposure induced hepatocellular carcinoma in mice, and occupational exposure in humans was suggested to be associated with liver cancer. To understand the role of non-genotoxic mechanism(s) for TCE action, we examined the gene expression and DNA methylation changes in the liver of B6C3F1 mice orally administered with TCE (0, 100, 500 and 1000 mg/kg b.w. per day) for 5 days. After 5 days TCE treatment at a dose level of 1000 mg/kg b.w., a total of 431 differentially expressed genes were identified in mouse liver by microarray, of which 291 were up-regulated and 140 down-regulated. The expression changed genes were involved in key signal pathways including PPAR, proliferation, apoptosis and homologous recombination. Notably, the expression level of a number of vital genes involved in the regulation of DNA methylation, such as Utrf1, Tet2, DNMT1, DNMT3a and DNMT3b, were dysregulated. Although global DNA methylation change was not detected in the liver of mice exposed to TCE, the promoter regions of Cdkn1a and Ihh were found to be hypo- and hypermethylated respectively, which correlated negatively with their mRNA expression changes. Furthermore, the gene expression and DNA methylation changes induced by TCE were dose dependent. The overall data indicate that TCE exposure leads to aberrant DNA methylation changes, which might alter the expression of genes involved in the TCE-induced liver tumorgenesis.	[Jiang, Yan] Soochow Univ, Sch Biol & Basic Med Sci, Dept Physiol, Suzhou, Peoples R China; [Chen, Jiahong; Tong, Jian; Chen, Tao] Soochow Univ, Sch Publ Hlth, Dept Toxicol, Suzhou, Peoples R China; [Jiang, Yan; Chen, Jiahong; Tong, Jian; Chen, Tao] Soochow Univ, Jiangsu Key Lab Prevent & Translat Med Geriatr Di, Suzhou, Peoples R China	Soochow University - China; Soochow University - China; Soochow University - China	Chen, T (corresponding author), Soochow Univ, Sch Publ Hlth, Dept Toxicol, Suzhou, Peoples R China.	tchen@suda.edu.cn	chen, jiahong/GYR-2917-2022	Chen, Tao/0000-0002-6552-3457	Soochow University; Priority Academic Program Development of Jiangsu Higher Education Institutions	Soochow University; Priority Academic Program Development of Jiangsu Higher Education Institutions	This work was supported by the start-up funding of Soochow University and The Priority Academic Program Development of Jiangsu Higher Education Institutions. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alhosin M, 2011, J EXP CLIN CANC RES, V30, DOI 10.1186/1756-9966-30-41; Anwar SL, 2014, WORLD J GASTROENTERO, V20, P7894, DOI 10.3748/wjg.v20.i24.7894; Bachman AN, 2006, TOXICOL SCI, V91, P393, DOI 10.1093/toxsci/kfj155; Bradford BU, 2011, TOXICOL SCI, V120, P206, DOI 10.1093/toxsci/kfq362; Budke B, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt362; Buitrago-Molina LE, 2013, HEPATOLOGY, V58, P1143, DOI 10.1002/hep.26412; Chen T, 2012, TOXICOLOGY, V292, P63, DOI 10.1016/j.tox.2011.10.020; Chen T, 2010, ENVIRON HEALTH PERSP, V118, P1597, DOI 10.1289/ehp.1002153; Chiu WA, 2011, TOXICOL APPL PHARM, V253, P203, DOI 10.1016/j.taap.2011.03.020; Counts JL, 1996, CARCINOGENESIS, V17, P1251, DOI 10.1093/carcin/17.6.1251; Dunlop MH, 2012, J BIOL CHEM, V287, P12343, DOI 10.1074/jbc.C112.352161; Fu XS, 2010, MOL CELL BIOCHEM, V337, P185, DOI 10.1007/s11010-009-0298-8; Guha N, 2012, LANCET ONCOL, V13, P1192, DOI 10.1016/S1470-2045(12)70485-0; Hansen J, 2013, JNCI-J NATL CANCER I, V105, P869, DOI 10.1093/jnci/djt107; Kinney SRM, 2013, ADV EXP MED BIOL, V754, P57, DOI 10.1007/978-1-4419-9967-2_3; Klaunig JE, 2003, CRIT REV TOXICOL, V33, P655, DOI 10.1080/713608372; Laughter AR, 2004, TOXICOLOGY, V203, P83, DOI 10.1016/j.tox.2004.06.014; National Toxicology Program, 1990, 243 TR NTP; Palbykin B, 2011, CARDIOVASC TOXICOL, V11, P204, DOI 10.1007/s12012-011-9113-3; Pan HM, 2011, ANTI-CANCER AGENT ME, V11, P493, DOI 10.2174/187152011796011073; Phillips JM, 2008, TOXICOL SCI, V104, P86, DOI 10.1093/toxsci/kfn063; Plo I, 2008, CANCER RES, V68, P9404, DOI 10.1158/0008-5472.CAN-08-0861; Pogribny IP, 2014, CANCER LETT, V342, P223, DOI 10.1016/j.canlet.2012.01.038; Ramdhan DH, 2010, ENVIRON HEALTH PERSP, V118, P1557, DOI 10.1289/ehp.1001928; Risinger JI, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00139; Rusyn I, 2014, PHARMACOL THERAPEUT, V141, P55, DOI 10.1016/j.pharmthera.2013.08.004; Sano Y, 2009, ARCH TOXICOL, V83, P835, DOI 10.1007/s00204-009-0431-1; Taira N, 2012, J CLIN INVEST, V122, P859, DOI 10.1172/JCI60818; Takata M, 2000, MOL CELL BIOL, V20, P6476, DOI 10.1128/MCB.20.17.6476-6482.2000; Tao LH, 1999, J BIOCHEM MOL TOXIC, V13, P231; Tao LH, 2000, TOXICOL SCI, V54, P399, DOI 10.1093/toxsci/54.2.399; Teramen H, 2011, ACTA MED OKAYAMA, V65, P179; Tommasi S, 2013, NUCLEIC ACIDS RES, V41, P182, DOI 10.1093/nar/gks1051; U. S. EPA (U. S. Environmental Protection Agency), 2011, TRICHL TOX REV APP; Wiese C, 2007, MOL CELL, V28, P482, DOI 10.1016/j.molcel.2007.08.027	35	23	27	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2014	9	12							e116179	10.1371/journal.pone.0116179	http://dx.doi.org/10.1371/journal.pone.0116179			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX6YH	25549359	gold, Green Published, Green Submitted			2022-12-27	WOS:000347063500057
J	Wang, Y; Wang, Y; Xu, HQ; Dai, H; Meng, S; Ye, CY				Wang, Yi; Wang, Yan; Xu, Huaqing; Dai, Hang; Meng, Shuang; Ye, Changyun			Rapid and Sensitive Detection of Listeria ivanovii by Loop-Mediated Isothermal Amplification of the smcL Gene	PLOS ONE			English	Article							MONOCYTOGENES; VIRULENCE; SPHINGOMYELINASE; IDENTIFICATION; ABORTION; NOV.; LAMP	A loop-mediated isothermal amplification (LAMP) assay for rapid and sensitive detection of the L. ivanovii strains had been developed and evaluated in this study. Oligonucleotide primers specific for L. ivanovii species were designed corresponding to smcL gene sequences. The primers set comprise six primers targeting eight regions on the species-specific gene smcL. The LAMP assay could be completed within 1 h at 64 degrees C in a water bath. Amplification products were directly observed by the Loopamp Fluorescent Detection Reagent (FD) or detected by agarose gel electrophoresis. Moreover, the LAMP reactions were also detected by real-time measurement of turbidity. The exclusivity of 77 non-L. ivanovii and the inclusivity of 17 L. ivanovii were both 100% in the assay. Sensitivity of the LAMP assay was 250 fg DNA and 16 CFU per reaction for detection of L. ivanovii in pure cultures and simulated human stool. The LAMP assay was 10 and 100-fold more sensitive than quantitative PCR (qPCR) and conventional PCR assays, respectively. When applied to human stool samples spiked with low level (8 CFU/0.5 g) of L. ivanovii strains, the new LAMP assay described here achieved positive detection after 6 hours enrichment. In conclusion, the new LAMP assay in this study can be used as a valuable, rapid and sensitive detection tool for the detection of L. ivanovii in field, medical and veterinary laboratories.	[Wang, Yi; Wang, Yan; Dai, Hang; Meng, Shuang; Ye, Changyun] China CDC, Natl Inst Communicable Dis Control & Prevent, State Key Lab Infect Dis Prevent & Control, Beijing 102206, Peoples R China; [Xu, Huaqing] Collaborat Innovat Ctr Diag & Treatment Infect Di, Hangzhou, Zhejiang, Peoples R China; [Xu, Huaqing] Guiyang Med Univ, Guiyang, Peoples R China	Chinese Center for Disease Control & Prevention; National Institute for Communicable Disease Control & Prevention, Chinese Center for Disease Control & Prevention; Collaborative Innovation Center for Diagnosis & Treatment of Infectious Diseases; Guizhou Medical University	Ye, CY (corresponding author), China CDC, Natl Inst Communicable Dis Control & Prevent, State Key Lab Infect Dis Prevent & Control, Changbai Rd 155, Beijing 102206, Peoples R China.	yechangyun@icdc.cn			Ministry of Science and Technology, People's Republic of China [2011ZX10004-001, 2013ZX10004-101]	Ministry of Science and Technology, People's Republic of China(Ministry of Science and Technology, China)	This work was supported by grants (Mega Project of Research on The Prevention and Control of HIV/AIDS, Viral Hepatitis Infectious Diseases 2011ZX10004-001, 2013ZX10004-101 to Changyun Ye) from the Ministry of Science and Technology, People's Republic of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ammendolia MG, 2007, INT J IMMUNOPATH PH, V20, P509, DOI 10.1177/039463200702000309; Bubert A, 1999, APPL ENVIRON MICROB, V65, P4688; Buchrieser C, 2011, J BACTERIOL, V193, P6787, DOI 10.1128/JB.06120-11; Chand P, 1999, VET REC, V145, P83, DOI 10.1136/vr.145.3.83; Chen ZY, 2011, MOL BIOL REP, V38, P4063, DOI 10.1007/s11033-010-0525-0; CUMMINS AJ, 1994, J INFECTION, V28, P89, DOI 10.1016/S0163-4453(94)94347-8; den Bakker HC, 2014, INT J SYST EVOL MICR, V64, P1882, DOI 10.1099/ijs.0.052720-0; den Bakker HC, 2013, INT J SYST EVOL MICR, V63, P3257, DOI 10.1099/ijs.0.048587-0; Dominguez-Bernal G, 2006, MOL MICROBIOL, V59, P415, DOI 10.1111/j.1365-2958.2005.04955.x; Gill PA, 1997, AUST VET J, V75, P214, DOI 10.1111/j.1751-0813.1997.tb10069.x; Gonzalez-Zorn B, 1999, MOL MICROBIOL, V33, P510, DOI 10.1046/j.1365-2958.1999.01486.x; Gonzalez-Zorn B, 2000, INT J MED MICROBIOL, V290, P369; Guillet C, 2010, EMERG INFECT DIS, V16, P136, DOI 10.3201/eid1601.091155; Liu DY, 2004, VET MICROBIOL, V101, P83, DOI 10.1016/j.vetmic.2004.03.015; MCLAUCHLIN J, 1987, J APPL BACTERIOL, V63, P1, DOI 10.1111/j.1365-2672.1987.tb02411.x; Mendonca M, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-275; Mori Y, 2001, BIOCHEM BIOPH RES CO, V289, P150, DOI 10.1006/bbrc.2001.5921; Mori Y, 2009, J INFECT CHEMOTHER, V15, P62, DOI 10.1007/s10156-009-0669-9; Nagamine K, 2002, MOL CELL PROBE, V16, P223, DOI 10.1006/mcpr.2002.0415; Notomi T, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.12.e63; Nyenje ME, 2012, SCI WORLD J, DOI 10.1100/2012/873909; Reissbrodt R, 2004, INT J FOOD MICROBIOL, V95, P1, DOI 10.1016/j.ijfoodmicro.2004.01.025; Rodriguez-Lazaro D, 2010, J APPL MICROBIOL, V109, P863, DOI 10.1111/j.1365-2672.2010.04712.x; Schmid MW, 2005, SYST APPL MICROBIOL, V28, P1, DOI 10.1016/j.syapm.2004.09.005; Snapir YM, 2006, EUR J INTERN MED, V17, P286, DOI 10.1016/j.ejim.2005.12.006; Tomita N, 2008, NAT PROTOC, V3, P877, DOI 10.1038/nprot.2008.57; Volokhov D, 2002, J CLIN MICROBIOL, V40, P4720, DOI 10.1128/JCM.40.12.4720-4728.2002; Wang L, 2012, MOL BIOL REP, V39, P445, DOI 10.1007/s11033-011-0757-7; WANG RF, 1993, FEMS MICROBIOL LETT, V106, P85, DOI 10.1111/j.1574-6968.1993.tb05939.x; Zhang XF, 2012, INT J FOOD MICROBIOL, V157, P309, DOI 10.1016/j.ijfoodmicro.2012.05.004	30	10	10	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2014	9	12							e115868	10.1371/journal.pone.0115868	http://dx.doi.org/10.1371/journal.pone.0115868			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX6YH	25549337	Green Submitted, gold, Green Published			2022-12-27	WOS:000347063500031
J	Dai, WJ; Wang, X; Di, ZR; Wu, JS				Dai, Wenjie; Wang, Xin; Di, Zengru; Wu, Jinshan			Logical Gaps in the Approximate Solutions of the Social Learning Game and an Exact Solution	PLOS ONE			English	Article							INFORMATIONAL CASCADES; BEHAVIOR; MODEL; FADS	After the social learning models were proposed, finding solutions to the games becomes a well-defined mathematical question. However, almost all papers on the games and their applications are based on solutions built either upon an ad-hoc argument or a twisted Bayesian analysis of the games. Here, we present logical gaps in those solutions and offer an exact solution of our own. We also introduce a minor extension to the original game so that not only logical differences but also differences in action outcomes among those solutions become visible.	[Dai, Wenjie; Wang, Xin; Di, Zengru; Wu, Jinshan] Beijing Normal Univ, Sch Syst Sci, Beijing 100875, Peoples R China	Beijing Normal University	Wu, JS (corresponding author), Beijing Normal Univ, Sch Syst Sci, Beijing 100875, Peoples R China.	jinshanw@bnu.edu.cn	Wu, Jinshan/C-1203-2010	Wu, Jinshan/0000-0001-5014-385X	Fundamental Research Funds for the Central Universities of China	Fundamental Research Funds for the Central Universities of China(Fundamental Research Funds for the Central Universities)	This work was supported by the Fundamental Research Funds for the Central Universities of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acemoglu D, 2011, REV ECON STUD, V78, P1201, DOI 10.1093/restud/rdr004; BANERJEE AV, 1992, Q J ECON, V107, P797, DOI 10.2307/2118364; BIKHCHANDANI S, 1992, J POLIT ECON, V100, P992, DOI 10.1086/261849; Bikhchandani S, 1998, J ECON PERSPECT, V12, P151, DOI 10.1257/jep.12.3.151; Bikhchandani Sushil, 2008, NEW PALGRAVE DICT EC; Bose S, 2008, ECON THEOR, V37, P203, DOI 10.1007/s00199-007-0313-9; Bose S, 2006, RAND J ECON, V37, P910, DOI 10.1111/j.1756-2171.2006.tb00063.x; Callander S, 2009, J ECON THEORY, V144, P1421, DOI 10.1016/j.jet.2009.02.001; Easley D, 2010, NETWORKS CROWDS MARK; Gill D, 2008, GAME ECON BEHAV, V63, P663, DOI 10.1016/j.geb.2006.07.004; Guarino A, 2011, GAME ECON BEHAV, V73, P167, DOI 10.1016/j.geb.2011.01.003; Liu T, 2012, ECON THEOR, V51, P627, DOI 10.1007/s00199-011-0614-x; Moscarini G, 1998, ECON THEOR, V11, P657, DOI 10.1007/s001990050207; Neill DB, 2005, RATION SOC, V17, P191, DOI 10.1177/1043463105051633; Smith L, 2000, ECONOMETRICA, V68, P371, DOI 10.1111/1468-0262.00113; Szolnoki A, 2012, SCI REP-UK, V2, DOI 10.1038/srep00576	16	0	0	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2014	9	12							e115706	10.1371/journal.pone.0115706	http://dx.doi.org/10.1371/journal.pone.0115706			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AX7UN	25546736	Green Published, gold, Green Submitted			2022-12-27	WOS:000347120200057
J	Fricke, S; Pfefferkorn, C; Wolf, D; Riemschneider, S; Kohlschmidt, J; Hilger, N; Fueldner, C; Knauer, J; Sack, U; Emmrich, F; Lehmann, J				Fricke, Stephan; Pfefferkorn, Cathleen; Wolf, Doris; Riemschneider, Sina; Kohlschmidt, Janine; Hilger, Nadja; Fueldner, Christiane; Knauer, Jens; Sack, Ulrich; Emmrich, Frank; Lehmann, Joerg			Characterization of the Murine Myeloid Precursor Cell Line MuMac-E8	PLOS ONE			English	Article							HEMATOPOIETIC STEM-CELL; BONE-MARROW-CELLS; SERUM DEPRIVATION; RHEUMATOID-ARTHRITIS; SYNOVIAL-MEMBRANE; SUPPRESSOR-CELLS; DENDRITIC CELLS; SCID MICE; IN-VITRO; NANOG	Starting point for the present work was the assumption that the cell line MuMac-E8 represents a murine cell population with stem cell properties. Preliminary studies already pointed to the expression of stem-cell associated markers and a self-regenerative potential of the cells. The cell line MuMac-E8 should be examined for their differential stage within stem cell hierarchy. MuMac-E8 cells were derived from a chimeric mouse model of arthritis. It could be shown that MuMac-E8 cells express mRNA of some genes associated with pluripotent stem cells (Nanog, Nucleostemin), of genes for hematopoietic markers (EPCR, Sca-1, CD11b, CD45), for the mesenchymal marker CD105 and of genes for the neural markers Pax-6 and Ezrin. In methylcellulose and May-Grunwald-Giemsa staining, hematopoietic colonies were obtained but the hematopoietic system of lethally irradiated mice could not be rescued. Osteogenic differentiation was not detectable. Thus, it became evident that MuMac-E8 represents not a stem cell line. However, MuMac-E8 cells expressed several myeloid surface markers (i.e. CD11b, F4/80, CD14, CD64), showed phagocytosis and is capable of producing nitric oxide. Thus, this cell line seems to be arrested an advanced stage of myeloid differentiation. Adherence data measured by impedance-based real-time cell analysis together with cell morphology data suggested that MuMac-E8 represents a new macrophage precursor cell line exhibiting weak adherence. This cell line is suitable as an in-vitro model for testing of macrophage functions. Moreover, it might be also useful for differentiation or reprogramming studies.	[Fricke, Stephan; Pfefferkorn, Cathleen; Wolf, Doris; Riemschneider, Sina; Kohlschmidt, Janine; Hilger, Nadja; Fueldner, Christiane; Knauer, Jens; Sack, Ulrich; Emmrich, Frank; Lehmann, Joerg] Fraunhofer Inst Cell Therapy & Immunol IZI, Leipzig, Germany; [Fricke, Stephan; Sack, Ulrich; Emmrich, Frank] Univ Leipzig, Inst Clin Immunol, Leipzig, Germany; [Fricke, Stephan; Sack, Ulrich; Emmrich, Frank] Univ Leipzig, Translat Ctr Regenerat Med, D-04109 Leipzig, Germany; [Wolf, Doris] Univ Leipzig, Dept Surg, Res Labs, Leipzig, Germany	Fraunhofer Gesellschaft; Leipzig University; Leipzig University; Leipzig University	Lehmann, J (corresponding author), Fraunhofer Inst Cell Therapy & Immunol IZI, Leipzig, Germany.	joerg.lehmann@izi.fraunhofer.de	Lehmann, Joerg/AAV-3264-2020; Sack, Ulrich/J-6301-2015; Fricke, Stephan/AAF-1629-2021	Sack, Ulrich/0000-0002-7813-0492; Lehmann, Jorg/0000-0001-8560-648X	German Federal Ministry of Education and Research (BMBF) [1315883]; Fraunhofer-Gesellschaft zur Forderung der angewandten Forschung e.V.	German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); Fraunhofer-Gesellschaft zur Forderung der angewandten Forschung e.V.	The work presented in this paper was made possible by funding from the German Federal Ministry of Education and Research (BMBF 1315883) and the Fraunhofer-Gesellschaft zur Forderung der angewandten Forschung e.V. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barry FP, 1999, BIOCHEM BIOPH RES CO, V265, P134, DOI 10.1006/bbrc.1999.1620; Bradfute SB, 2005, EXP HEMATOL, V33, P836, DOI 10.1016/j.exphem.2005.04.001; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Cho SK, 2001, BLOOD, V98, P3635, DOI 10.1182/blood.V98.13.3635; Chou RC, 2003, BRAIN RES PROTOC, V11, P162, DOI 10.1016/S1385-299X(03)00043-6; Condamine T, 2014, J CLIN INVEST, V124, P2626, DOI 10.1172/JCI74056; Dolhain RJEM, 1996, ARTHRITIS RHEUM-US, V39, P1961, DOI 10.1002/art.1780391204; Ezeh UI, 2005, CANCER-AM CANCER SOC, V104, P2255, DOI 10.1002/cncr.21432; Fricke S, 2014, CELL MOL LIFE SCI, V71, P2135, DOI 10.1007/s00018-013-1476-0; Fricke S, 2012, CYTOM PART A, V81A, P476, DOI 10.1002/cyto.a.22061; Fricke S, 2010, CELL MOL LIFE SCI, V67, P4095, DOI 10.1007/s00018-010-0427-2; Fricke S, 2011, METHODS MOL BIOL, V690, P315, DOI 10.1007/978-1-60761-962-8_21; Fricke S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006157; Gang EJ, 2007, BLOOD, V109, P1743, DOI 10.1182/blood-2005-11-010504; Ghassabeh GH, 2006, BLOOD, V108, P575, DOI 10.1182/blood-2005-04-1485; Goissis MD, 2007, REPROD DOMEST ANIM, V42, P660, DOI 10.1111/j.1439-0531.2006.00839.x; GREEN LC, 1982, ANAL BIOCHEM, V126, P131, DOI 10.1016/0003-2697(82)90118-X; Hart AH, 2005, CANCER, V104, P2092, DOI 10.1002/cncr.21435; HAYNESWORTH SE, 1992, BONE, V13, P69, DOI 10.1016/8756-3282(92)90363-2; Hoei-Hansen CE, 2005, HISTOPATHOLOGY, V47, P48, DOI 10.1111/j.1365-2559.2005.02182.x; Horwitz EM, 2005, CYTOTHERAPY, V7, P393, DOI 10.1080/14653240500319234; IKUTA K, 1992, P NATL ACAD SCI USA, V89, P1502, DOI 10.1073/pnas.89.4.1502; INABA K, 1993, P NATL ACAD SCI USA, V90, P3038, DOI 10.1073/pnas.90.7.3038; Ito CY, 2003, BLOOD, V101, P517, DOI 10.1182/blood-2002-06-1918; KARASUYAMA H, 1988, J EXP MED, V167, P1377, DOI 10.1084/jem.167.4.1377; Kostlin N, 2014, EUR J IMMUNOL, V44, P2582, DOI 10.1002/eji.201344200; Laoui D, 2014, CANCER RES, V74, P24, DOI 10.1158/0008-5472.CAN-13-1196; Laoui D, 2011, IMMUNOBIOLOGY, V216, P1192, DOI 10.1016/j.imbio.2011.06.007; Lehmann J, 2000, J AUTOIMMUN, V15, P301, DOI 10.1006/jaut.2000.0435; Liechtenstein T, 2014, ONCOTARGET, V5, P7843, DOI 10.18632/oncotarget.2279; MARLETTA MA, 1988, BIOCHEMISTRY-US, V27, P8706, DOI 10.1021/bi00424a003; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Movahedi K, 2008, BLOOD, V111, P4233, DOI 10.1182/blood-2007-07-099226; Movahedi K, 2010, CANCER RES, V70, P5728, DOI 10.1158/0008-5472.CAN-09-4672; Murray PJ, 2014, IMMUNITY, V41, P14, DOI 10.1016/j.immuni.2014.06.008; OCONNELL PJ, 1992, CLIN EXP IMMUNOL, V90, P154; Osawa M, 1996, SCIENCE, V273, P242, DOI 10.1126/science.273.5272.242; Pfefferkorn P, 2008, BIOCHEMICA, V4, P14; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Ploemacher RE, 1997, BAILLIERE CLIN HAEM, V10, P429, DOI 10.1016/S0950-3536(97)80019-4; Raes G, 2012, IMMUNOBIOLOGY, V217, P1223, DOI 10.1016/j.imbio.2012.10.001; Ramachandran M, 2014, J IMMUNOL, V193, P2287, DOI 10.4049/jimmunol.1400339; Sack U, 1999, J AUTOIMMUN, V13, P335, DOI 10.1006/jaut.1999.0328; SIMON AK, 1994, P NATL ACAD SCI USA, V91, P8562, DOI 10.1073/pnas.91.18.8562; SPANGRUDE GJ, 1988, SCIENCE, V241, P58, DOI 10.1126/science.2898810; SPANGRUDE GJ, 1993, BLOOD, V82, P3327; Tsai RYL, 2002, GENE DEV, V16, P2991, DOI 10.1101/gad.55671; Van der Jeught K, 2014, ONCOTARGET, V5, P10100; Van Ginderachter JA, 2010, EUR J IMMUNOL, V40, P2976, DOI 10.1002/eji.201040911; Vendramin A, 2014, BIOL BLOOD MARROW S, V1083-8791, P566; WALTHER C, 1991, DEVELOPMENT, V113, P1435; Yaghoobi MM, 2005, NEUROSCI LETT, V390, P81, DOI 10.1016/j.neulet.2005.08.011; Zhang EM, 2005, BIOCHEM BIOPH RES CO, V333, P1171, DOI 10.1016/j.bbrc.2005.05.200; Zhou DX, 2014, CELL SIGNAL, V26, P192, DOI 10.1016/j.cellsig.2013.11.004	54	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2014	9	12							e113743	10.1371/journal.pone.0113743	http://dx.doi.org/10.1371/journal.pone.0113743			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UN	25546418	Green Published, gold, Green Submitted			2022-12-27	WOS:000347120200007
J	Kessler, TM; Mordasini, L; Weisstanner, C; Juni, P; da Costa, BR; Wiest, R; Thalmann, GN				Kessler, Thomas M.; Mordasini, Livio; Weisstanner, Christian; Jueni, Peter; da Costa, Bruno R.; Wiest, Roland; Thalmann, George N.			Sono-Electro-Magnetic Therapy for Treating Chronic Pelvic Pain Syndrome in Men: A Randomized, Placebo-Controlled, Double-Blind Trial	PLOS ONE			English	Article							SACRAL NEUROMODULATION; NERVE-STIMULATION; MECHANISMS	Objective: To assess the efficacy and safety of sono-electro-magnetic therapy compared to placebo in men with refractory CPPS. Patients and Methods: In a randomized, placebo-controlled, double-blind single center trial, we assessed the effect of sono-electro-magnetic therapy in men with treatment refractory CPPS. Sixty male patients were randomly assigned to treatment with either sono-electro-magnetic (n=30) or placebo therapy (n=30) for 12 weeks. The primary outcome was a change in the National Institutes of Health Chronic Prostatitis Symptom Index (NIH-CPSI) from baseline to 12 weeks. Results: The 12-week difference between sono-electro-magnetic and placebo therapy in changes of the NIH-CPSI total score was 23.1 points (95% CI -6.8 to 0.6, p=0.11). In secondary comparisons of NIH-CPSI sub-scores, we found differences between groups most pronounced for the quality-of-life sub-score (difference at 12 weeks -1.6, 95% CI -2.8 to -0.4, p=0.015). In stratified analyses, the benefit of sono-electro-magnetic therapy appeared more pronounced among patients who had a symptom duration of 12 months or less (difference in NIH-CPSI total score -8.3, 95% CI -4.5 to 2.6) than in patients with a longer symptom duration (-0.8, 95% CI -4.6 to 3.1; p for interaction=0.023). Conclusions: Sono-electro-magnetic therapy did not result in a significant improvement of symptoms in the overall cohort of treatment refractory CPPS patients compared to placebo treatment. Subgroup analysis indicates, however, that patients with a symptom-duration of 12 months or less may benefit from sono-electro-magnetic therapy, warranting larger randomized controlled trials in this subpopulation.	[Kessler, Thomas M.; Mordasini, Livio; Thalmann, George N.] Univ Bern, Dept Urol, Bern, Switzerland; [Kessler, Thomas M.] Univ Zurich, Balgrist Univ Hosp, Neurourol Spinal Cord Injury Ctr & Res, Zurich, Switzerland; [Weisstanner, Christian; Wiest, Roland] Univ Bern, Inselspital, Univ Inst Diagnost & Intervent Neuroradiol, SCAN, CH-3010 Bern, Switzerland; [Jueni, Peter; da Costa, Bruno R.] Univ Bern, Inst Social & Prevent Med & Clin Trials Unit, CH-3010 Bern, Switzerland	University of Bern; University of Zurich; University of Bern; University Hospital of Bern; University of Bern	Thalmann, GN (corresponding author), Univ Bern, Dept Urol, Bern, Switzerland.	george.thalmann@insel.ch	Juni, Peter/Q-8700-2016	Juni, Peter/0000-0002-5985-0670; Weisstanner, Christian/0000-0003-2830-1000; R. da Costa, Bruno/0000-0002-1786-6332; , Livio/0000-0002-4087-6555	Sonodyn Corporation AG (Solothurn, Switzerland); University Hospital Inselspital (Bern, Switzerland)	Sonodyn Corporation AG (Solothurn, Switzerland); University Hospital Inselspital (Bern, Switzerland)	This research was supported by the Sonodyn Corporation AG (Solothurn, Switzerland) and the University Hospital Inselspital (Bern, Switzerland). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander RB, 2004, ANN INTERN MED, V141, P581, DOI 10.7326/0003-4819-141-8-200410190-00005; Anothaisintawee T, 2011, JAMA-J AM MED ASSOC, V305, P78, DOI 10.1001/jama.2010.1913; Brookes ST, 2004, J CLIN EPIDEMIOL, V57, P229, DOI 10.1016/j.jclinepi.2003.08.009; Butrick CW, 2009, OBSTET GYN CLIN N AM, V36, P699, DOI 10.1016/j.ogc.2009.08.006; Cohen J.E., 1988, STAT POWER ANAL BEHA; Duloy Anna M S, 2007, Curr Urol Rep, V8, P336, DOI 10.1007/s11934-007-0081-x; Fall M, 2010, EUR UROL, V57, P35, DOI 10.1016/j.eururo.2009.08.020; Farmer MA, 2011, J UROLOGY, V186, P117, DOI 10.1016/j.juro.2011.03.027; Hassouna MM, 2007, CUAJ-CAN UROL ASSOC, V1, P106; Hrobjartsson A, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003974.pub3; Kessler TM, 2008, EUR UROL SUPPL, V7, P159, DOI 10.1016/S1569-9056(08)60351-6; Kothari S, 2007, ACTA NEUROCHIR SUPPL, V97, P365; Lee SH, 2009, UROLOGY, V73, P1036, DOI 10.1016/j.urology.2008.10.047; Marcelissen T, 2011, J UROLOGY, V186, P387, DOI 10.1016/j.juro.2011.02.2694; McNaughton Collins M, 1998, Curr Opin Urol, V8, P33; Mehnert U, 2010, J UROLOGY, V184, P1011, DOI 10.1016/j.juro.2010.05.035; MELZACK R, 1965, SCIENCE, V150, P971, DOI 10.1126/science.150.3699.971; Mordasini L, 2012, J UROLOGY, V188, P2233, DOI 10.1016/j.juro.2012.08.043; Nickel JC, 2008, NEW ENGL J MED, V359, P2663, DOI 10.1056/NEJMoa0803240; Nickel JC, 2004, J UROLOGY, V172, P551, DOI 10.1097/01.ju.0000131592.98562.16; Nnoaham KE, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003222.pub2; Peters KM, 2007, BJU INT, V100, P835, DOI 10.1111/j.1464-410X.2007.07082.x; Peters KM, 2003, INT UROGYNECOL J PEL, V14, P223, DOI 10.1007/s00192-003-1070-3; Propert KJ, 2006, QUAL LIFE RES, V15, P299, DOI 10.1007/s11136-005-1317-1; Schaeffer AT, 2008, INT J ANTIMICROB AG, V31, pS108, DOI 10.1016/j.ijantimicag.2007.08.027; Shoskes Daniel A, 2005, Curr Urol Rep, V6, P296, DOI 10.1007/s11934-005-0027-0; Sluka KA, 2003, J PAIN, V4, P109, DOI 10.1054/jpai.2003.434; Vallejo Ricardo, 2007, Pain Physician, V10, P305; Vickers AJ, 2001, BMJ-BRIT MED J, V323, P1123, DOI 10.1136/bmj.323.7321.1123; Wollner J, 2012, BJU INT, V110, P146, DOI 10.1111/j.1464-410X.2012.10906.x	30	17	21	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2014	9	12							e113368	10.1371/journal.pone.0113368	http://dx.doi.org/10.1371/journal.pone.0113368			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UN	25546177	Green Published, Green Accepted, gold			2022-12-27	WOS:000347120200004
J	Okada, K; Fukai, A; Mori, D; Hosaka, Y; Yano, F; Chung, U; Kawaguchi, H; Tanaka, S; Ikeda, T; Saito, T				Okada, Keita; Fukai, Atsushi; Mori, Daisuke; Hosaka, Yoko; Yano, Fumiko; Chung, Ung-il; Kawaguchi, Hiroshi; Tanaka, Sakae; Ikeda, Toshiyuki; Saito, Taku			Identification of SCAN Domain Zinc-Finger Gene ZNF449 as a Novel Factor of Chondrogenesis	PLOS ONE			English	Article							CHONDROCYTE DIFFERENTIATION PATHWAY; OSTEOARTHRITIS DEVELOPMENT; ENDOCHONDRAL OSSIFICATION; COLLAGEN GENE; SOX9; L-SOX5; GROWTH; STEPS	Transcription factors SOX9, SOX5 and SOX6 are indispensable for generation and differentiation of chondrocytes. However, molecular mechanisms to induce the SOX genes are poorly understood. To address this issue, we previously determined the human embryonic enhancer of SOX6 by 5'RACE analysis, and identified the 46-bp core enhancer region (CES6). We initially performed yeast one-hybrid assay for screening other chondrogenic factors using CES6 as bait, and identified a zinc finger protein ZNF449. ZNF449 and Zfp449, a counterpart in mouse, transactivated enhancers or promoters of SOX6, SOX9 and COL2A1. Zfp449 was expressed in mesenchyme-derived tissues including cartilage, calvaria, muscle and tendon, as well as in other tissues including brain, lung and kidney. In limb cartilage of mouse embryo, Zfp449 protein was abundantly located in periarticular chondrocytes, and decreased in accordance with the differentiation. Zfp449 protein was also detected in articular cartilage of an adult mouse. During chondrogenic differentiation of human mesenchymal stem cells, ZNF449 was increased at an early stage, and its overexpression enhanced SOX9 and SOX6 only at the initial stage of the differentiation. We further generated Zfp449 knockout mice to examine the in vivo roles; however, no obvious abnormality was observed in skeletal development or articular cartilage homeostasis. ZNF449 may regulate chondrogenic differentiation from mesenchymal progenitor cells, although the underlying mechanisms are still unknown.	[Okada, Keita; Fukai, Atsushi; Mori, Daisuke; Hosaka, Yoko; Yano, Fumiko; Kawaguchi, Hiroshi; Tanaka, Sakae; Ikeda, Toshiyuki; Saito, Taku] Univ Tokyo, Fac Med, Tokyo 113, Japan; [Yano, Fumiko; Chung, Ung-il] Univ Tokyo, Fac Med, Ctr Dis Biol & Integrat Med, Tokyo 113, Japan; [Ikeda, Toshiyuki] Univ Tokyo, Fac Med, Div Transfus Med, Tokyo 113, Japan; [Fukai, Atsushi] Japan Labour Hlth & Welf Org, Kanto Rosai Hosp, Kanagawa, Japan; [Hosaka, Yoko] Tokyo Metropolitan Bokutoh Hosp, Tokyo, Japan; [Kawaguchi, Hiroshi] Japan Community Hlth Care Org, Tokyo Shinjuku Med Ctr, Spine Ctr, Tokyo, Japan	University of Tokyo; University of Tokyo; University of Tokyo	Saito, T (corresponding author), Univ Tokyo, Fac Med, Tokyo 113, Japan.	tasaitou-tky@umin.ac.jp	Ikeda, Toshiyuki/GVS-5588-2022; Tanaka, Sakae/Y-3061-2019	Tanaka, Sakae/0000-0001-9210-9414	Japanese Ministry of Education, Culture, Sports, Science and Technology [19109007, 24659664]; Grants-in-Aid for Scientific Research [25293316] Funding Source: KAKEN	Japanese Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by a Grant-in-aid for Scientific Research from the Japanese Ministry of Education, Culture, Sports, Science and Technology (#19109007, #24659664).	Akiyama H, 2002, GENE DEV, V16, P2813, DOI 10.1101/gad.1017802; Gamsjaeger R, 2007, TRENDS BIOCHEM SCI, V32, P63, DOI 10.1016/j.tibs.2006.12.007; Gosset M, 2008, NAT PROTOC, V3, P1253, DOI 10.1038/nprot.2008.95; Hosaka Y, 2013, P NATL ACAD SCI USA, V110, P1875, DOI 10.1073/pnas.1207458110; Ikeda T, 2007, BIOCHEM BIOPH RES CO, V357, P383, DOI 10.1016/j.bbrc.2007.03.133; Kamekura S, 2005, OSTEOARTHR CARTILAGE, V13, P632, DOI 10.1016/j.joca.2005.03.004; Kronenberg HM, 2003, NATURE, V423, P332, DOI 10.1038/nature01657; Lefebvre V, 2001, OSTEOARTHR CARTILAGE, V9, pS69, DOI 10.1053/joca.2001.0447; Lefebvre V, 1998, EMBO J, V17, P5718, DOI 10.1093/emboj/17.19.5718; Lefebvre V, 1997, MOL CELL BIOL, V17, P2336, DOI 10.1128/MCB.17.4.2336; Luo KT, 2006, MOL BIOL REP, V33, P51, DOI 10.1007/s11033-005-3966-0; Saito T, 2010, NAT MED, V16, P678, DOI 10.1038/nm.2146; Sekiya I, 2000, J BIOL CHEM, V275, P10738, DOI 10.1074/jbc.275.15.10738; Smits P, 2001, DEV CELL, V1, P277, DOI 10.1016/S1534-5807(01)00003-X; Tsutsumi S, 2001, BIOCHEM BIOPH RES CO, V288, P413, DOI 10.1006/bbrc.2001.5777	15	4	4	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2014	9	12							e115169	10.1371/journal.pone.0115169	http://dx.doi.org/10.1371/journal.pone.0115169			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UN	25546433	Green Submitted, Green Published, gold			2022-12-27	WOS:000347120200024
J	Khaldun, ABM; Huang, WJ; Liao, SH; Lv, HY; Wang, Y				Khaldun, A. B. M.; Huang, Wenjun; Liao, Sihong; Lv, Haiyan; Wang, Ying			Identification of MicroRNAs and Target Genes in the Fruit and Shoot Tip of Lycium chinense: A Traditional Chinese Medicinal Plant	PLOS ONE			English	Article							F-BOX PROTEINS; SMALL RNAS; EXPRESSION; TRANSCRIPTION; BIOGENESIS; ETHYLENE; ANNOTATION; EXTRACTS; BARBARUM; REVEALS	Although Lycium chinense (goji berry) is an important traditional Chinese medicinal plant, little genome information is available for this plant, particularly at the small-RNA level. Recent findings indicate that the evolutionary role of miRNAs is very important for a better understanding of gene regulation in different plant species. To elucidate small RNAs and their potential target genes in fruit and shoot tissues, high-throughput RNA sequencing technology was used followed by qRT-PCR and RLM 5'-RACE experiments. A total of 60 conserved miRNAs belonging to 31 families and 30 putative novel miRNAs were identified. A total of 62 significantly differentially expressed miRNAs were identified, of which 15 (14 known and 1 novel) were shoot-specific, and 12 (7 known and 5 novel) were fruit-specific. Additionally, 28 differentially expressed miRNAs were recorded as up-regulated in fruit tissues. The predicted potential targets were involved in a wide range of metabolic and regulatory pathways. GO (Gene Ontology) enrichment analysis and the KEGG (Kyoto Encyclopedia of Genes and Genomes) database revealed that "metabolic pathways" is the most significant pathway with respect to the rich factor and gene numbers. Moreover, five miRNAs were related to fruit maturation, lycopene biosynthesis and signaling pathways, which might be important for the further study of fruit molecular biology. This study is the first, to detect known and novel miRNAs, and their potential targets, of L. chinense. The data and findings that are presented here might be a good source for the functional genomic study of medicinal plants and for understanding the links among diversified biological pathways.	[Khaldun, A. B. M.; Huang, Wenjun; Liao, Sihong; Lv, Haiyan; Wang, Ying] Chinese Acad Sci, Wuhan Bot Garden, Key Lab Plant Germplasm Enhancement & Specialty A, Wuhan 430074, Hubei, Peoples R China; [Khaldun, A. B. M.; Liao, Sihong] Univ Chinese Acad Sci, Beijing 100039, Peoples R China; [Wang, Ying] Chinese Acad Sci, Northwest Ctr Agrobiotechnol Ningxia, Beijing, Peoples R China	Chinese Academy of Sciences; Wuhan Botanical Garden, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences	Wang, Y (corresponding author), Chinese Acad Sci, Wuhan Bot Garden, Key Lab Plant Germplasm Enhancement & Specialty A, Wuhan 430074, Hubei, Peoples R China.	yingwang@wbgcas.cn	Khaldun, A B M/ABE-4597-2020; HUANG, WENJUN/GXM-9167-2022		National Natural Science Foundation of China [31200242, 31470391]; Scientific Research Equipment Project of Chinese Academy of Sciences [YZ201227]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Scientific Research Equipment Project of Chinese Academy of Sciences	This work was supported by National Natural Science Foundation of China (Grant no. 31200242 and 31470391) and Scientific Research Equipment Project of Chinese Academy of Sciences (YZ201227) (YW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambros V, 2003, RNA, V9, P277, DOI 10.1261/rna.2183803; Bapat VA, 2010, BIOTECHNOL ADV, V28, P94, DOI 10.1016/j.biotechadv.2009.10.002; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Benson DA, 2011, NUCLEIC ACIDS RES, V39, pD32, DOI [10.1093/nar/gkw1070, 10.1093/nar/gks1195, 10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkx1094, 10.1093/nar/gkn723, 10.1093/nar/gkp1024, 10.1093/nar/gkr1202]; Bushati N, 2007, ANNU REV CELL DEV BI, V23, P175, DOI 10.1146/annurev.cellbio.23.090506.123406; *CAMS, 1980, DAT BOOK FOOD INGR; Cara B, 2008, PLANT SCI, V175, P106, DOI 10.1016/j.plantsci.2008.03.021; Carra A, 2009, PLANT J, V59, P750, DOI 10.1111/j.1365-313X.2009.03906.x; Carthew RW, 2009, CELL, V136, P642, DOI 10.1016/j.cell.2009.01.035; Chang RCC, 2008, CELL MOL NEUROBIOL, V28, P643, DOI 10.1007/s10571-007-9181-x; Elitzur T, 2010, J EXP BOT, V61, P1523, DOI 10.1093/jxb/erq017; Fahlgren N, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000219; Friedlander MR, 2012, NUCLEIC ACIDS RES, V40, P37, DOI 10.1093/nar/gkr688; Gan L, 2004, INT IMMUNOPHARMACOL, V4, P563, DOI 10.1016/j.intimp.2004.01.023; Gao ZH, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-371; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Guilfoyle TJ, 1998, CELL MOL LIFE SCI, V54, P619, DOI 10.1007/s000180050190; Hobert O, 2008, SCIENCE, V319, P1785, DOI 10.1126/science.1151651; HOU K, 1984, DICT FAMILIES GENERA; Jones-Rhoades MW, 2006, ANNU REV PLANT BIOL, V57, P19, DOI 10.1146/annurev.arplant.57.032905.105218; Jones-Rhoades MW, 2004, MOL CELL, V14, P787, DOI 10.1016/j.molcel.2004.05.027; Karlova R, 2013, J EXP BOT, V64, P1863, DOI 10.1093/jxb/ert049; Kolotilin I, 2007, PLANT PHYSIOL, V145, P389, DOI 10.1104/pp.107.102962; KOZOMARA SGJ, 2013, NUCLEIC ACIDS RES, V42, P68, DOI DOI 10.1093/NAR/GKT1181; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li F, 2012, P NATL ACAD SCI USA, V109, P1790, DOI 10.1073/pnas.1118282109; Lippman Z, 2004, NATURE, V431, P364, DOI 10.1038/nature02875; Liu HH, 2008, RNA, V14, P836, DOI 10.1261/rna.895308; Liu Q, 2009, FEBS LETT, V583, P723, DOI 10.1016/j.febslet.2009.01.020; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Llave C, 2002, SCIENCE, V297, P2053, DOI 10.1126/science.1076311; Lu C, 2005, SCIENCE, V309, P1567, DOI 10.1126/science.1114112; Lu C, 2006, GENOME RES, V16, P1276, DOI 10.1101/gr.5530106; Lu SF, 2005, PLANT CELL, V17, P2186, DOI 10.1105/tpc.105.033456; Luo Q, 2004, LIFE SCI, V76, P137, DOI 10.1016/j.lfs.2004.04.056; Luo XY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079090; Mallory AC, 2006, NAT GENET, V38, pS31, DOI 10.1038/ng1791; Mao F, 2011, MED ONCOL, V28, P121, DOI 10.1007/s12032-009-9415-5; Mao XZ, 2005, BIOINFORMATICS, V21, P3787, DOI 10.1093/bioinformatics/bti430; Meijer AH, 1997, PLANT J, V11, P263, DOI 10.1046/j.1365-313X.1997.11020263.x; Meyers BC, 2008, PLANT CELL, V20, P3186, DOI 10.1105/tpc.108.064311; Mohorianu I, 2011, PLANT J, V67, P232, DOI 10.1111/j.1365-313X.2011.04586.x; Morin RD, 2008, GENOME RES, V18, P571, DOI 10.1101/gr.6897308; Mosher Rebecca A, 2010, Silence, V1, P13, DOI 10.1186/1758-907X-1-13; Moxon S, 2008, GENOME RES, V18, P1602, DOI 10.1101/gr.080127.108; Oh YC, 2012, INT IMMUNOPHARMACOL, V13, P181, DOI 10.1016/j.intimp.2012.03.020; Ori N, 2007, NAT GENET, V39, P787, DOI 10.1038/ng2036; Qian JY, 2004, FOOD CHEM, V87, P283, DOI 10.1016/j.foodchem.2003.11.008; Qiao H, 2009, GENE DEV, V23, P512, DOI 10.1101/gad.1765709; Qiu DY, 2009, GENE, V436, P37, DOI 10.1016/j.gene.2009.01.006; Rajagopalan R, 2006, GENE DEV, V20, P3407, DOI 10.1101/gad.1476406; Shi R, 2005, BIOTECHNIQUES, V39, P519, DOI 10.2144/000112010; Song CNA, 2010, BMC GENOMICS, V11, DOI [10.1186/1471-2164-11-431, 10.1186/1471-2164-11-261]; Song CN, 2009, PLANTA, V230, P671, DOI 10.1007/s00425-009-0971-x; Storey JD, 2003, ANN STAT, V31, P2013, DOI 10.1214/aos/1074290335; Sunkar R, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-37; Szittya G, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-593; Voinnet O, 2009, CELL, V136, P669, DOI 10.1016/j.cell.2009.01.046; Wang XW, 2010, MOL BIOTECHNOL, V44, P61, DOI 10.1007/s12033-009-9204-6; Wang XL, 2009, GENE DEV, V23, P391, DOI 10.1101/gad.1781609; Welsch R, 2007, PLANT PHYSIOL, V145, P1073, DOI 10.1104/pp.107.104828; Wen M, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-140; Wu HJ, 2012, NUCLEIC ACIDS RES, V40, pW22, DOI 10.1093/nar/gks554; Wu L, 2010, MOL CELL, V38, P465, DOI 10.1016/j.molcel.2010.03.008; Xu MJ, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-521; Xu Q, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-246; Young MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r14; Zhang BH, 2006, DEV BIOL, V289, P3, DOI 10.1016/j.ydbio.2005.10.036; Zhou LA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015224; Zhu QH, 2011, J EXP BOT, V62, P487, DOI 10.1093/jxb/erq295; Zuo JH, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-7	71	27	31	3	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2015	10	1							e0116334	10.1371/journal.pone.0116334	http://dx.doi.org/10.1371/journal.pone.0116334			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ0ID	25587984	Green Published, Green Submitted, gold			2022-12-27	WOS:000347928300009
J	Steinke, JW; Liu, LX; Turner, RB; Braciale, TJ; Borish, L				Steinke, John W.; Liu, Lixia; Turner, Ronald B.; Braciale, Thomas J.; Borish, Larry			Immune Surveillance by Rhinovirus-Specific Circulating CD4(+) and CD8(+) T Lymphocytes	PLOS ONE			English	Article							ASTHMA EXACERBATIONS; LUNG INFLAMMATION; VIRAL-INFECTIONS; GENE-EXPRESSION; DENDRITIC CELLS; VIRUS-INFECTION; IN-VIVO; CHILDREN; RISK; HYPERRESPONSIVENESS	Background It is difficult to experimentally infect volunteers with RV strains to which the subject demonstrates serological immunity. However, in RV challenges, viral clearance begins before de novo adaptive immune responses would develop. We speculated that adaptive immunity to RV reflects heterologous immunity by effector memory cells. Methods DCs were generated from monocytes using GM-CSF and IL-4 and RV39 loading accomplished with a dose of similar to 350 TCID50/10(5) cells. RV-induced maturation was established as modulation of MHC class II, CD80, CD83, and CD86. Circulating RV targeting CD4 and CD8 T cells were investigated as induction of RV-specific proliferation (CFSE-dilution). Results Maturation of DC by RV was confirmed as upregulation of MHC Class II (83.3 +/- 5.0% to 87.8 +/- 4.1%), CD80 (39.4 +/- 7.2% to 47.6 +/- 7.7%) and CD86 (78.4 +/- 4.7% to 84.1 +/- 3.4%). Both CD4 and CD8 memory T cells were recognized in the circulation of healthy subjects. Conclusions RV drives DC maturation and results in their ability to present RV antigens to both T helper and cytotoxic lymphocytes. Both CD4 and CD8 cells capable of recognizing RV-associated antigens are present in the circulation of healthy subjects where they are presumably involved in immune surveillance and explain the rapid recruitment of an adaptive immune response during RV infection.	[Steinke, John W.; Liu, Lixia] Univ Virginia Hlth Syst, Dept Med, Charlottesville, VA 22908 USA; [Steinke, John W.; Braciale, Thomas J.; Borish, Larry] Univ Virginia, Carter Immunol Ctr, Charlottesville, VA USA; [Turner, Ronald B.] Univ Virginia Hlth Syst, Dept Pediat, Charlottesville, VA USA; [Braciale, Thomas J.] Univ Virginia Hlth Syst, Dept Pathol, Charlottesville, VA USA	University of Virginia; University of Virginia; University of Virginia; University of Virginia	Steinke, JW (corresponding author), Univ Virginia Hlth Syst, Dept Med, Charlottesville, VA 22908 USA.	js3ch@virginia.edu			National Institutes of Health [R21 AI1090413, UO1: AI057438, RO1: AI057438]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL033391] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI015608, U19AI083024, R01AI057438] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by grants from the National Institutes of Health: Grant numbers: R21 AI1090413 LB, UO1: AI057438 LB to TJB, RO1: AI057438 LB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barlow JL, 2012, J ALLERGY CLIN IMMUN, V129, P191, DOI 10.1016/j.jaci.2011.09.041; Cerwenka A, 1999, J EXP MED, V189, P423, DOI 10.1084/jem.189.2.423; Chen Y, 2006, AM J RESP CELL MOL, V34, P192, DOI 10.1165/rcmb.2004-0417OC; Contoli M, 2006, NAT MED, V12, P1023, DOI 10.1038/nm1462; Denlinger LC, 2011, AM J RESP CRIT CARE, V184, P1007, DOI 10.1164/rccm.201103-0585OC; Early SB, 2007, AM J RESP CELL MOL, V36, P715, DOI 10.1165/rcmb.2006-0252OC; Fleming HE, 1999, AM J RESP CRIT CARE, V160, P100, DOI 10.1164/ajrccm.160.1.9808074; HALPERIN SA, 1985, AM REV RESPIR DIS, V132, P976; Heymann PW, 2004, J ALLERGY CLIN IMMUN, V114, P239, DOI 10.1016/j.jaci.2004.04.006; Ikutani M, 2012, J IMMUNOL, V188, P703, DOI 10.4049/jimmunol.1101270; Jackson DJ, 2008, AM J RESP CRIT CARE, V178, P667, DOI 10.1164/rccm.200802-309OC; Jartti T, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-85; JOHNSTON SL, 1995, BRIT MED J, V310, P1225, DOI 10.1136/bmj.310.6989.1225; Kennedy JL, 2014, AM J RESP CRIT CARE, V189, P532, DOI 10.1164/rccm.201310-1767OC; Kirchberger S, 2005, J IMMUNOL, V175, P1145, DOI 10.4049/jimmunol.175.2.1145; Laza-Stanca V, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002114; Li L, 1997, J IMMUNOL, V158, P4152; Message SD, 2008, P NATL ACAD SCI USA, V105, P13562, DOI 10.1073/pnas.0804181105; Miyahara N, 2004, NAT MED, V10, P865, DOI 10.1038/nm1081; Nascimento CR, 2011, BLOOD, V117, P489, DOI 10.1182/blood-2010-03-272690; Papadopoulos NG, 2002, THORAX, V57, P328, DOI 10.1136/thorax.57.4.328; Peltola V, 2008, J CLIN VIROL, V43, P411, DOI 10.1016/j.jcv.2008.08.014; PRICE WH, 1956, P NATL ACAD SCI USA, V42, P892, DOI 10.1073/pnas.42.12.892; Proud D, 2008, AM J RESP CRIT CARE, V178, P962, DOI 10.1164/rccm.200805-670OC; Rakes CP, 1999, AM J RESP CRIT CARE, V159, P785, DOI 10.1164/ajrccm.159.3.9801052; Sawicka E, 2004, EUR J IMMUNOL, V34, P2599, DOI 10.1002/eji.200425018; Schempp S, 2011, VIRUS RES, V155, P446, DOI 10.1016/j.virusres.2010.11.014; Schrauf C, 2009, J IMMUNOL, V183, P4440, DOI 10.4049/jimmunol.0804147; Soto-Quiros M, 2012, J ALLERGY CLIN IMMUN, V129, P1499, DOI 10.1016/j.jaci.2012.03.040; Spencer LA, 2009, J LEUKOCYTE BIOL, V85, P117, DOI 10.1189/jlb.0108058; Steinke JW, 2007, CELL IMMUNOL, V249, P101, DOI 10.1016/j.cellimm.2007.12.001; Steinke JW, 2004, AM J RESP CELL MOL, V30, P212, DOI 10.1165/rcmb.2003-0071OC; Subrata LS, 2009, J IMMUNOL, V183, P2793, DOI 10.4049/jimmunol.0900695; Sun J, 2009, NAT MED, V15, P277, DOI 10.1038/nm.1929; Turner RB, 2005, NEW ENGL J MED, V353, P341, DOI 10.1056/NEJMoa044441; Wark PAB, 2005, J EXP MED, V201, P937, DOI 10.1084/jem.20041901; Williams JV, 2005, J ALLERGY CLIN IMMUN, V115, P1311, DOI 10.1016/j.jaci.2005.02.001; Zambrano JC, 2003, J ALLERGY CLIN IMMUN, V111, P1008, DOI 10.1067/mai.2003.1396	38	42	44	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2015	10	1							e0115271	10.1371/journal.pone.0115271	http://dx.doi.org/10.1371/journal.pone.0115271			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ4OG	25584821	Green Published, gold, Green Submitted			2022-12-27	WOS:000348201300002
J	Oner, J; Sengoz, B				Oner, Julide; Sengoz, Burak			Utilization of Recycled Asphalt Concrete with Warm Mix Asphalt and Cost-Benefit Analysis	PLOS ONE			English	Article							BINDERS; ADDITIVES	The asphalt paving industries are faced with two major problems. These two important challenges are generated with an increase in demand for environmentally friendly paving mixtures and the problem of rapidly rising raw materials. Recycling of reclaimed asphalt pavement (RAP) is a critical necessity to save precious aggregates and reduce the use of costly bitumen. Warm Mix Asphalt (WMA) technology provides not only the option of recycling asphalt pavement at a lower temperature than the temperature maintained in hot mixtures but also encourages the utilization of RAP and therefore saves energy and money. This paper describes the feasibility of utilizing three different WMA additives (organic, chemical and water containing) at recommended contents with different percentages of RAP. The mechanical properties and cost-benefit analysis of WMA containing RAP have been performed and compared with WMA without RAP. The results indicated that, 30%, 10% and 20% can be accepted as an optimum RAP addition related to organic, chemical and water containing additives respectively and organic additive with 30% RAP content has an appreciable increase in tensile strength over the control mix. It was also concluded that the RAP with WMA technology is the ability to reduce final cost compared to HMA and WMA mixtures.	[Oner, Julide] Dokuz Eylul Univ, Dept Civil Engn, Div Transportat, Grad Sch Nat & Appl Sci, Izmir, Turkey; [Sengoz, Burak] Dokuz Eylul Univ, Dept Civil Engn, Div Transportat, Izmir, Turkey	Dokuz Eylul University; Dokuz Eylul University	Sengoz, B (corresponding author), Dokuz Eylul Univ, Dept Civil Engn, Div Transportat, Izmir, Turkey.	burak.sengoz@deu.edu.tr	Sengoz, Burak/O-9005-2019; Sengoz, Burak/AAR-7612-2020	Sengoz, Burak/0000-0003-0684-4880; Sengoz, Burak/0000-0003-0684-4880				[Anonymous], 2012, D693112 ASTM INT; [Anonymous], D175497 ASTM, DOI [10.1520/D1754-97R02, DOI 10.1520/D1754-97R02]; [Anonymous], 2006, C13106 ASTM; [Anonymous], 1998, C1252 ASTM; [Anonymous], 2005, C88 ASTM; [Anonymous], 2010, D4791 ASTM; [Anonymous], 2000, D36 ASTM; [Anonymous], 2006, D506 ASTM; [Anonymous], 2008, C136 ASTM; ASTM, 2012, C128 ASTM; ASTM, 2002, D440206 ASTM; ASTM, 2012, C127 ASTM; ASTM International, 2011, D3549D3549M11 ASTM I; Austerman AJ, 2009, TRANSP RES BOARD 88; Button J. W., 2007, SYNTHESIS WARM MIX A; Chang CJ, 2012, INDIAN J ENG MATER S, V19, P31; CHOWDHURY A., 2008, REV WARM MIX ASPHALT; d'Angelo J, 2008, WARM MIX ASPHALT EUR; Estakhri C, 2010, FIELD LAB INVESTIGAT; Feih S, 2011, COMPOS PART B-ENG, V42, P350, DOI 10.1016/j.compositesb.2010.12.020; Iskender E, 2013, COMPOS PART B-ENG, V54, P255, DOI 10.1016/j.compositesb.2013.05.019; Jamshidi A, 2012, MATER RES-IBERO-AM J, V15, P628, DOI [10.1590/S1516-14392012005000083, 10.1590/S1516-14392012000400022]; Jones D., 2010, WARM MIX ASPHALT STU; Kanitpong K, 2008, PROC INST CIV ENG-CO, V161, P1, DOI 10.1680/coma.2008.161.1.1; Mallick R, 2007, EVALUATION HEATED RE; Mallick RB, 2008, TRANSPORT RES REC, P71, DOI 10.3141/2051-09; Newcomb D., 2007, INTRO WARM MIX ASPHA; O'Sullivan K, 2009, EFFECT WARM MIX ASPH; Prowell, 2005, EVALUATION SASOBIT U; Sengoz B, 2008, J HAZARD MATER, V150, P424, DOI 10.1016/j.jhazmat.2007.04.122; Sengupta S, 2011, COMPOS PART B-ENG, V42, P1834, DOI 10.1016/j.compositesb.2011.06.021; Shahadan Z, 2013, INDIAN J ENG MATER S, V20, P376; Specht Luciano Pivoto, 2007, Mat. Res., V10, P69, DOI 10.1590/S1516-14392007000100015; Tao M, 2009, 88 ANN M TRANSP RES; Wasiuddin NM, 2007, TRANSPORT RES REC, P82, DOI 10.3141/1998-10; Whiteoak D., 2003, SHELL BITUMEN HDB, VFifth; Wu SP, 2006, FUEL, V85, P1298, DOI 10.1016/j.fuel.2005.10.014; Xiao FP, 2012, FUEL, V94, P144, DOI 10.1016/j.fuel.2011.09.017; Zaumanis M., 2010, THESIS TU DENMARK KO; Zaumanis M, 2014, GREEN ENERGY TECHNOL, P309, DOI 10.1007/978-3-662-44719-2_10	40	21	22	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2015	10	1							e116180	10.1371/journal.pone.0116180	http://dx.doi.org/10.1371/journal.pone.0116180			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ4BU	25574851	Green Published, Green Submitted, gold			2022-12-27	WOS:000348168100003
J	Kato, S; Hayashi, S; Kitahara, Y; Nagasawa, K; Aono, H; Shibata, J; Utsumi, D; Amagase, K; Kadowaki, M				Kato, Shinichi; Hayashi, Shusaku; Kitahara, Yumeno; Nagasawa, Koyo; Aono, Hitomi; Shibata, Junichiro; Utsumi, Daichi; Amagase, Kikuko; Kadowaki, Makoto			Saireito (TJ-114), a Japanese Traditional Herbal Medicine, Reduces 5-Fluorouracil-Induced Intestinal Mucositis in Mice by Inhibiting Cytokine-Mediated Apoptosis in Intestinal Crypt Cells	PLOS ONE			English	Article							DAI-KENCHU-TO; RECOMMENDED GUIDELINES; POSTOPERATIVE ILEUS; DAIKENCHUTO TU-100; EPITHELIAL-CELLS; INDUCED DIARRHEA; CHEMOTHERAPY; CANCER; HUMANS; COLON	Clinical chemotherapy frequently causes intestinal mucositis as a side effect, which is accompanied by severe diarrhea. We recently showed that the cytokine-mediated apoptotic pathway might be important for the development of intestinal mucositis induced by 5-fluorouracil (5-FU). Saireito, the traditional Japanese herbal (Kampo) medicine, is widely used to treat diarrhea and various inflammatory diseases in Japan. In the present study, we investigated the effect of saireito on 5-FU-induced intestinal mucositis in mice, especially in relation to apoptosis in the intestinal crypt. Male C57BL/6 mice were given 5-FU (50 mg/kg), i.p. once daily for 6 days. Intestinal mucositis was evaluated histochemically. Saireito (1001000 mg/kg) was administered p.o. twice daily for 6 days. Repeated 5-FU treatment caused severe intestinal mucositis including morphological damage, which was accompanied by body weight loss and diarrhea. Daily administration of saireito reduced the severity of intestinal mucositis in a dose-dependent manner. Body weight loss and diarrhea during 5-FU treatment were also significantly attenuated by saireito administration. The number of apoptotic and caspase-3-activated cells in the intestinal crypt was increased, and was accompanied by up-regulated tumor necrosis factor (TNF)-alpha and interleukin (IL)-1 beta mRNA within 24 h of the first 5-FU injection. However, all of these measures were significantly lower after saireito administration. These results suggest that saireito attenuates 5-FU-induced intestinal mucositis. This action may come from the reduction of apoptosis in the intestinal crypt via suppression of the up-regulation of inflammatory cytokines. Therefore, saireito may be clinically useful for the prevention of intestinal mucositis during cancer chemotherapy.	[Kato, Shinichi; Kitahara, Yumeno; Nagasawa, Koyo; Aono, Hitomi; Shibata, Junichiro; Utsumi, Daichi; Amagase, Kikuko] Kyoto Pharmaceut Univ, Div Pathol Sci, Dept Pharmacol & Expt Therapeut, Yamashina Ku, Kyoto 6078414, Japan; [Hayashi, Shusaku; Kadowaki, Makoto] Toyama Univ, Div Gastrointestinal Pathophysiol, Dept Biosci, Inst Nat Med, Toyama 9300194, Japan	Kyoto Pharmaceutical University; University of Toyama	Kato, S (corresponding author), Kyoto Pharmaceut Univ, Div Pathol Sci, Dept Pharmacol & Expt Therapeut, Yamashina Ku, Kyoto 6078414, Japan.	skato@mb.kyoto-phu.ac.jp	UTSUMI, DAICHI/ABB-8650-2021; UTSUMI, DAICHI/W-6307-2019; Hayashi, Shusaku/AAP-1185-2020	UTSUMI, DAICHI/0000-0001-6602-8426; Hayashi, Shusaku/0000-0002-8304-7255	Institute of Natural Medicine, University of Toyama	Institute of Natural Medicine, University of Toyama	This study was supported by a Grant-in-Aid for the Cooperative Research Project from Institute of Natural Medicine, University of Toyama in 2012 and 2013.	ANILKUMAR TV, 1992, BRIT J CANCER, V65, P552, DOI 10.1038/bjc.1992.113; BEARD DV, 1993, INVEST RADIOL, V28, P732, DOI 10.1097/00004424-199308000-00015; Benson AB, 2004, J CLIN ONCOL, V22, P2918, DOI 10.1200/jco.2004.04.132; Bowen JM, 2005, PATHOLOGY, V37, P56, DOI 10.1080/00313020400023461; Bowen JM, 2006, SUPPORT CARE CANCER, V14, P713, DOI 10.1007/s00520-005-0004-7; Chikakiyo M, 2012, SURG TODAY, V42, P60, DOI 10.1007/s00595-011-0014-7; Daniele B, 2001, J CLIN GASTROENTEROL, V32, P228, DOI 10.1097/00004836-200103000-00010; Degterev A, 2003, ONCOGENE, V22, P8543, DOI 10.1038/sj.onc.1207107; Duncan M, 2003, ALIMENT PHARM THER, V18, P853, DOI 10.1046/j.1365-2036.2003.01784.x; Fulda S, 2006, ONCOGENE, V25, P4798, DOI 10.1038/sj.onc.1209608; Huang TY, 2009, BIOCHEM BIOPH RES CO, V389, P634, DOI 10.1016/j.bbrc.2009.09.041; Inomata A, 2002, TOXICOL LETT, V133, P231, DOI 10.1016/S0378-4274(02)00204-7; Ito T, 2002, J DERMATOL SCI, V28, P198, DOI 10.1016/S0923-1811(01)00161-X; Itoh T, 2002, J INT MED RES, V30, P428, DOI 10.1177/147323000203000410; Iwasa T, 2012, DIGEST DIS SCI, V57, P2571, DOI 10.1007/s10620-012-2218-0; Kaburaki T, 2013, GRAEF ARCH CLIN EXP, V251, P2733, DOI 10.1007/s00417-013-2473-6; Kaneko A, 2013, GASTROENT RES PRACT, V2013, DOI 10.1155/2013/384057; Keefe DMK, 2000, GUT, V47, P632, DOI 10.1136/gut.47.5.632; Kono T, 2011, J GASTROENTEROL, V46, P1187, DOI 10.1007/s00535-011-0438-2; Kumar S, 2007, CELL DEATH DIFFER, V14, P32, DOI 10.1038/sj.cdd.4402060; Li TS, 2009, CANCER CHEMOTH PHARM, V63, P873, DOI 10.1007/s00280-008-0809-4; Lu CN, 2012, INT IMMUNOPHARMACOL, V14, P121, DOI 10.1016/j.intimp.2012.06.010; Manabe N, 2010, AM J PHYSIOL-GASTR L, V298, pG970, DOI 10.1152/ajpgi.00043.2010; Matsuike T, 1999, PROG MED, V19, P879; Ohno S, 2007, J TRAD MED, V16, P73; Ono T, 2005, NEPHRON EXP NEPHROL, V100, pE132, DOI 10.1159/000085059; Perner A, 2003, GUT, V52, P231, DOI 10.1136/gut.52.2.231; Pritchard DM, 1998, CANCER RES, V58, P5453; Sonis ST, 2004, NAT REV CANCER, V4, P277, DOI 10.1038/nrc1318; Symonds RP, 1998, BRIT J CANCER, V77, P1689, DOI 10.1038/bjc.1998.279; Tokita Y., 2007, Inflammopharmacology, V15, P65, DOI 10.1007/s10787-006-1552-2; Tokita Y, 2007, J PHARMACOL SCI, V104, P303, DOI 10.1254/jphs.FP0070831; Tomita K, 2003, J PHARMACOL SCI, V93, P321, DOI 10.1254/jphs.93.321; Wadler S, 1998, J CLIN ONCOL, V16, P3169, DOI 10.1200/JCO.1998.16.9.3169; Watanabe T, 2010, INT ARCH ALLERGY IMM, V151, P98, DOI 10.1159/000235999; Wu ZQ, 2011, CANCER CHEMOTH PHARM, V68, P87, DOI 10.1007/s00280-010-1451-5; Yasuda M, 2013, BRIT J PHARMACOL, V168, P1388, DOI 10.1111/bph.12019; Yasuda M, 2012, AM J PHYSIOL-GASTR L, V302, pG1133, DOI 10.1152/ajpgi.00535.2011; Yoon SB, 2009, J ETHNOPHARMACOL, V125, P286, DOI 10.1016/j.jep.2009.06.027; Zhu J, 2013, EXP THER MED, V5, P1345, DOI 10.3892/etm.2013.988	40	35	38	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2015	10	1							e0116213	10.1371/journal.pone.0116213	http://dx.doi.org/10.1371/journal.pone.0116213			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ4BS	25565296	Green Published, Green Submitted, gold			2022-12-27	WOS:000348167900004
J	Hofmann, S; Braun, A; Pozgaj, R; Morowski, M; Vogtle, T; Nieswandt, B				Hofmann, Sebastian; Braun, Attila; Pozgaj, Rastislav; Morowski, Martina; Voegtle, Timo; Nieswandt, Bernhard			Mice Lacking the SLAM Family Member CD84 Display Unaltered Platelet Function in Hemostasis and Thrombosis	PLOS ONE			English	Article							DOMAIN-CONTAINING PROTEINS; ARTERIAL THROMBOSIS; ADHESION MOLECULE; GLYCOPROTEIN VI; ACTIVATION; INTEGRIN; CELLS; STABILITY; ANTIGEN; GROWTH	Background: Platelets are anuclear cell fragments derived from bone marrow megakaryocytes that safeguard vascular integrity by forming thrombi at sites of vascular injury. Although the early events of thrombus formation-platelet adhesion and aggregation-have been intensively studied, less is known about the mechanisms and receptors that stabilize platelet-platelet interactions once a thrombus has formed. One receptor that has been implicated in this process is the signaling lymphocyte activation molecule (SLAM) family member CD84, which can undergo homophilic interactions and becomes phosphorylated upon platelet aggregation. Objective: The role of CD84 in platelet physiology and thrombus formation was investigated in CD84-deficient mice. Methods and Results: We generated CD84-deficient mice and analyzed their platelets in vitro and in vivo. Cd84(-/-) platelets exhibited normal activation and aggregation responses to classical platelet agonists. Furthermore, CD84 deficiency did not affect integrin-mediated clot retraction and spreading of activated platelets on fibrinogen. Notably, also the formation of stable three-dimensional thrombi on collagen-coated surfaces under flow ex vivo was unaltered in the blood of Cd84(-/-) mice. In vivo, Cd84(-/-) mice exhibited unaltered hemostatic function and arterial thrombus formation. Conclusion: These results show that CD84 is dispensable for thrombus formation and stabilization, indicating that its deficiency may be functionally compensated by other receptors or that it may be important for platelet functions different from platelet-platelet interactions.	[Voegtle, Timo] Univ Wurzburg, Univ Hosp, Dept Expt Biomed, D-97070 Wurzburg, Germany; Univ Wurzburg, Rudolf Virchow Ctr, D-97070 Wurzburg, Germany	University of Wurzburg; University of Wurzburg	Vogtle, T (corresponding author), Univ Wurzburg, Univ Hosp, Dept Expt Biomed, D-97070 Wurzburg, Germany.	timo.voegtle@virchow.uni-wuerzburg.de; bernhard.nieswandt@virchow.uni-wuerzburg.de		Vogtle, Timo/0000-0002-9400-4701	German Research Foundation [SFB 688]; Rudolf Virchow Center; German Research Foundation (DFG); University of Wurzburg	German Research Foundation(German Research Foundation (DFG)); Rudolf Virchow Center; German Research Foundation (DFG)(German Research Foundation (DFG)); University of Wurzburg	This work was supported by the German Research Foundation (SFB 688 to BN) and the Rudolf Virchow Center. This publication was funded by the German Research Foundation (DFG) and the University of Wurzburg in the funding programme Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Errico D, 2011, J IMMUNOL, V187, P5577, DOI 10.4049/jimmunol.1101626; Andre P, 2002, NAT MED, V8, P247, DOI 10.1038/nm0302-247; Brass LF, 2005, J CLIN INVEST, V115, P3385, DOI 10.1172/JCI26869; Cannons JL, 2011, ANNU REV IMMUNOL, V29, P665, DOI 10.1146/annurev-immunol-030409-101302; Cannons JL, 2010, IMMUNITY, V32, P253, DOI 10.1016/j.immuni.2010.01.010; delaFuente MA, 1997, BLOOD, V90, P2398; Dutting S, 2012, TRENDS PHARMACOL SCI, V33, P583, DOI 10.1016/j.tips.2012.07.004; Elvers M, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000551; Ginsberg MH, 2005, CURR OPIN CELL BIOL, V17, P509, DOI 10.1016/j.ceb.2005.08.010; Gruner S, 2004, CIRCULATION, V110, P2946, DOI 10.1161/01.CIR.0000146341.63677.3C; Hofmann S, 2012, J THROMB HAEMOST, V10, P2581, DOI 10.1111/jth.12013; Jackson SP, 2011, NAT MED, V17, P1423, DOI 10.1038/nm.2515; Knight CG, 1999, CARDIOVASC RES, V41, P450, DOI 10.1016/S0008-6363(98)00306-X; Krause SW, 2000, BIOCHEM J, V346, P729, DOI 10.1042/0264-6021:3460729; Martin M, 2001, J IMMUNOL, V167, P3668, DOI 10.4049/jimmunol.167.7.3668; May F, 2009, BLOOD, V114, P3464, DOI 10.1182/blood-2009-05-222273; Morgenstern E, 1990, Blood Coagul Fibrinolysis, V1, P543, DOI 10.1097/00001721-199010000-00035; NAGY A, 1993, P NATL ACAD SCI USA, V90, P8424, DOI 10.1073/pnas.90.18.8424; Nanda N, 2006, BLOOD CELL MOL DIS, V36, P228, DOI 10.1016/j.bcmd.2005.12.026; Nanda N, 2005, BLOOD, V106, P3028, DOI 10.1182/blood-2005-01-0333; Nieswandt B, 2000, BLOOD, V96, P2520; Nieswandt B, 2005, J THROMB HAEMOST, V3, P1725, DOI 10.1111/j.1538-7836.2005.01488.x; Nieswandt B, 2011, J THROMB HAEMOST, V9, P92, DOI 10.1111/j.1538-7836.2011.04361.x; Nieswandt B, 2001, EMBO J, V20, P2120, DOI 10.1093/emboj/20.9.2120; Oliver-Vila I, 2008, MOL IMMUNOL, V45, P2138, DOI 10.1016/j.molimm.2007.12.006; Ozaki H, 2000, BIOCHEM BIOPH RES CO, V276, P873, DOI 10.1006/bbrc.2000.3574; Prevost N, 2005, P NATL ACAD SCI USA, V102, P9820, DOI 10.1073/pnas.0404065102; Romero X, 2005, J IMMUNOL, V174, P7033, DOI 10.4049/jimmunol.174.11.7033; SAVAGE B, 1992, J BIOL CHEM, V267, P11300; Tangye SG, 2003, J IMMUNOL, V171, P2485, DOI 10.4049/jimmunol.171.5.2485; Tangye SG, 2002, EUR J IMMUNOL, V32, P1640, DOI 10.1002/1521-4141(200206)32:6<1640::AID-IMMU1640>3.0.CO;2-S; Tucker KL, 2012, METHODS MOL BIOL, V788, P101, DOI 10.1007/978-1-61779-307-3_8; Wannemacher KM, 2010, BLOOD, V116, P5707, DOI 10.1182/blood-2010-04-279943; Watson SP, 2005, J THROMB HAEMOST, V3, P1752, DOI 10.1111/j.1538-7836.2005.01429.x	34	12	13	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2014	9	12							e115306	10.1371/journal.pone.0115306	http://dx.doi.org/10.1371/journal.pone.0115306			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UC	25551754	Green Published, Green Submitted, gold			2022-12-27	WOS:000347119100034
J	Roderer, K; Neuenschwander, M; Codoni, G; Sasso, S; Gamper, M; Kast, P				Roderer, Kathrin; Neuenschwander, Martin; Codoni, Giosiana; Sasso, Severin; Gamper, Marianne; Kast, Peter			Functional Mapping of Protein-Protein Interactions in an Enzyme Complex by Directed Evolution	PLOS ONE			English	Article							SECRETED CHORISMATE MUTASE; AMINO-ACID BIOSYNTHESIS; T7 RNA-POLYMERASE; ESCHERICHIA-COLI; MYCOBACTERIUM-TUBERCULOSIS; DAHP SYNTHASE; COMBINATORIAL MUTAGENESIS; CLONING VEHICLES; ACTIVE-SITE; EXPRESSION	The shikimate pathway enzyme chorismate mutase converts chorismate into prephenate, a precursor of Tyr and Phe. The intracellular chorismate mutase (MtCM) of Mycobacterium tuberculosis is poorly active on its own, but becomes >100-fold more efficient upon formation of a complex with the first enzyme of the shikimate pathway, 3-deoxy-D-arabino-heptulosonate-7-phosphate synthase (MtDS). The crystal structure of the enzyme complex revealed involvement of C-terminal MtCM residues with the MtDS interface. Here we employed evolutionary strategies to probe the tolerance to substitution of the C-terminal MtCM residues from positions 84-90. Variants with randomized positions were subjected to stringent selection in vivo requiring productive interactions with MtDS for survival. Sequence patterns identified in active library members coincide with residue conservation in natural chorismate mutases of the AroQ(delta) subclass to which MtCM belongs. An Arg-Gly dyad at positions 85 and 86, invariant in AroQ(delta) sequences, was intolerant to mutation, whereas Leu88 and Gly89 exhibited a preference for small and hydrophobic residues in functional MtCM-MtDS complexes. In the absence of MtDS, selection under relaxed conditions identifies positions 84-86 as MtCM integrity determinants, suggesting that the more C-terminal residues function in the activation by MtDS. Several MtCM variants, purified using a novel plasmid-based T7 RNA polymerase gene expression system, showed that a diminished ability to physically interact with MtDS correlates with reduced activatability and feedback regulatory control by Tyr and Phe. Mapping critical protein-protein interaction sites by evolutionary strategies may pinpoint promising targets for drugs that interfere with the activity of protein complexes.	[Roderer, Kathrin; Neuenschwander, Martin; Codoni, Giosiana; Sasso, Severin; Gamper, Marianne; Kast, Peter] ETH, Organ Chem Lab, CH-8093 Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich	Kast, P (corresponding author), ETH, Organ Chem Lab, CH-8093 Zurich, Switzerland.	kast@org.chem.ethz.ch		Sasso, Severin/0000-0002-2226-845X; Wurth-Roderer, Kathrin/0000-0002-0233-9863	ETH Zurich; Swiss National Science Foundation [31003A-116475, 31003A-135651]	ETH Zurich(ETH Zurich); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This study was supported by funds from the ETH Zurich and the Swiss National Science Foundation (grants no. 31003A-116475 and 31003A-135651 to PK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen JB, 1998, APPL ENVIRON MICROB, V64, P2240; Arora PS, 2009, NATURE, V462, P171, DOI 10.1038/462171a; BARTLETT PA, 1985, J AM CHEM SOC, V107, P7792, DOI 10.1021/ja00311a111; BERTRAND KP, 1983, GENE, V23, P149, DOI 10.1016/0378-1119(83)90046-X; Blackmore NJ, 2013, J MOL BIOL, V425, P1582, DOI 10.1016/j.jmb.2012.12.019; BOLIVAR F, 1977, GENE, V2, P95, DOI 10.1016/0378-1119(77)90000-2; BRAUS GH, 1991, MICROBIOL REV, V55, P349, DOI 10.1128/MMBR.55.3.349-370.1991; Butz M, 2011, BIOCHEMISTRY-US, V50, P8594, DOI 10.1021/bi2011338; CHANG ACY, 1978, J BACTERIOL, V134, P1141, DOI 10.1128/JB.134.3.1141-1156.1978; CHOTHIA C, 1984, ANNU REV BIOCHEM, V53, P537; DOPHEIDE TA, 1972, J BIOL CHEM, V247, P4447; EUVERINK GJW, 1995, APPL ENVIRON MICROB, V61, P3796, DOI 10.1128/AEM.61.11.3796-3803.1995; Fuller JC, 2009, DRUG DISCOV TODAY, V14, P155, DOI 10.1016/j.drudis.2008.10.009; Gamper M, 2000, BIOCHEMISTRY-US, V39, P14087, DOI 10.1021/bi0016570; Grisostomi C, 1997, BIOORG CHEM, V25, P297, DOI 10.1006/bioo.1997.1073; Haslam E., 1993, SHIKIMIC ACID METABO; HUDSON GS, 1983, J BIOL CHEM, V258, P3114; Imburgio D, 2000, BIOCHEMISTRY-US, V39, P10419, DOI 10.1021/bi000365w; Janssen BD, 2012, ADV PROTEIN CHEM STR, V86, P151, DOI 10.1016/B978-0-12-386497-0.00005-0; Karzai AW, 2000, NAT STRUCT BIOL, V7, P449; Kast P, 1996, TETRAHEDRON LETT, V37, P2691, DOI 10.1016/0040-4039(96)00338-3; Kast P, 1996, P NATL ACAD SCI USA, V93, P5043, DOI 10.1073/pnas.93.10.5043; KAST P, 1994, GENE, V138, P109, DOI 10.1016/0378-1119(94)90790-0; Kast P, 1997, J PHYS CHEM B, V101, P10976, DOI 10.1021/jp972501l; Kim SK, 2008, FEBS J, V275, P4824, DOI 10.1111/j.1742-4658.2008.06621.x; Kunzler D, 2005, J BIOL CHEM, V280, P32827, DOI 10.1074/jbc.M506883200; LEE AY, 1995, J AM CHEM SOC, V117, P3627, DOI 10.1021/ja00117a038; Li PP, 2013, APPL MICROBIOL BIOT, V97, P10373, DOI 10.1007/s00253-013-4806-0; Liberles JS, 2005, AMINO ACIDS, V28, P1, DOI 10.1007/s00726-004-0152-y; Liu DR, 1996, J AM CHEM SOC, V118, P1789, DOI 10.1021/ja953151o; Lutke-Eversloh T, 2005, APPL ENVIRON MICROB, V71, P7224, DOI 10.1128/AEM.71.11.7224-7228.2005; Maeda H, 2012, ANNU REV PLANT BIOL, V63, P73, DOI 10.1146/annurev-arplant-042811-105439; Moellering RE, 2009, NATURE, V462, P182, DOI 10.1038/nature08543; Neuenschwander M, 2009, PROTEIN ENG HDB, P537; Neuenschwander M, 2007, THESIS ETH ZURICH; Neuenschwander M, 2007, NAT BIOTECHNOL, V25, P1145, DOI [10.1038/nbt1341, 10.1038/nbtl341]; Okvist M, 2006, J MOL BIOL, V357, P1483, DOI 10.1016/j.jmb.2006.01.069; Okvist M, 2009, ACTA CRYSTALLOGR F, V65, P1048, DOI 10.1107/S1744309109035878; Pittard J., 1996, ESCHERICHIA COLI SAL, V1, P458; Roderer K, 2012, THESIS ETH ZURICH; Roderer K, 2009, CHIMIA, V63, P313, DOI 10.2533/chimia.2009.313; ROSENBERG AH, 1987, GENE, V56, P125, DOI 10.1016/0378-1119(87)90165-X; Sambrook J., 2001, MOL CLONING LAB MANU; Sasso S, 2005, FEBS J, V272, P375, DOI 10.1111/j.1742-4658.2004.04478.x; Sasso S, 2009, EMBO J, V28, P2128, DOI 10.1038/emboj.2009.165; SCHELL MA, 1986, J BACTERIOL, V166, P9, DOI 10.1128/jb.166.1.9-14.1986; SOGO SG, 1984, J AM CHEM SOC, V106, P2701, DOI 10.1021/ja00321a039; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; STUDIER FW, 1990, METHOD ENZYMOL, V185, P60; STUDIER FW, 1986, J MOL BIOL, V189, P113, DOI 10.1016/0022-2836(86)90385-2; Valkov E, 2012, TOP CURR CHEM, V317, P145, DOI 10.1007/128_2011_265	51	7	7	3	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2014	9	12							e116234	10.1371/journal.pone.0116234	http://dx.doi.org/10.1371/journal.pone.0116234			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UC	25551646	Green Published, gold, Green Submitted			2022-12-27	WOS:000347119100110
J	Battle, CE; Davies, G; Evans, PA				Battle, Ceri E.; Davies, Gareth; Evans, Phillip A.			Long Term Health-Related Quality of Life in Survivors of Sepsis in South West Wales: An Epidemiological Study	PLOS ONE			English	Article							SHORT-FORM 36; SEPTIC SHOCK; DISABILITY; SCORE	Introduction: Survivors of sepsis report persistent problems that can last years after hospital discharge. The main aim of this study was to investigate long-term health-related quality of life in survivors of SIRS and sepsis compared with Welsh normative data, controlling for age, length of stay and pre-existing conditions. The second aim was to investigate any differences in long-term health-related quality of life specifically with the patients categorised into three groups; SIRS, uncomplicated sepsis and severe sepsis/septic shock. Methods: A prospective study design was used in order to investigate all sepsis patients either presenting to the Emergency Department or admitted to the Intensive Care Unit of a regional trauma centre. Baseline demographics, clinical characteristics and outcomes were collected and surviving patients were sent a SF-12v2 survey at between six months to two years post-hospital discharge. Results: Quality of life was significantly reduced in all patients when compared to local normative data (all p<0.0001). Reductions in the physical components of health-related quality of life were more pronounced in severe sepsis/septic shock patients when compared to uncomplicated sepsis and SIRS patients, when controlling for age, pre-existing conditions, hospital and ICU length of stay. Conclusions: This is the first observational study to specifically focus on the different groups of SIRS and sepsis patients to assess long-term quality of life. Local population norms were used for comparison, rather than UK-wide norms that fail to reflect the intricacies of a country's population.	[Battle, Ceri E.; Davies, Gareth; Evans, Phillip A.] Morriston Hosp, NISCHR Haemostasis Biomed Res Unit, Swansea, W Glam, Wales	Morriston Hospital	Battle, CE (corresponding author), Morriston Hosp, NISCHR Haemostasis Biomed Res Unit, Swansea, W Glam, Wales.	ceri.battle@wales.nhs.uk	Battle, Ceri/AAK-5856-2021	Battle, Ceri/0000-0002-7503-1931; Evans, Phillip Adrian/0000-0002-0814-5162; Davies, Gareth Richard/0000-0002-0863-9234				Burholt V, 2011, J PUBLIC HEALTH-UK, V33, P587, DOI 10.1093/pubmed/fdr006; Cuthbertson BH, 2013, CRIT CARE, V17, DOI 10.1186/cc12616; Daniels R, 2011, EMERG MED J, V28, P507, DOI 10.1136/emj.2010.095067; Dellinger RP, 2013, INTENS CARE MED, V39, P165, DOI [10.1007/s00134-012-2769-8, 10.1097/CCM.0b013e31827e83af]; Dowdy DW, 2005, INTENS CARE MED, V31, P611, DOI 10.1007/s00134-005-2592-6; Gandek B, 1998, J CLIN EPIDEMIOL, V51, P1171, DOI 10.1016/S0895-4356(98)00109-7; Hall WH, 2004, BMC CANCER, V4, DOI 10.1186/1471-2407-4-94; Heyland DK, 2000, CRIT CARE MED, V28, P3599, DOI 10.1097/00003246-200011000-00006; Hofhuis JGM, 2008, ANESTH ANALG, V107, P1957, DOI 10.1213/ane.0b013e318187bbd8; Iwashyna TJ, 2010, JAMA-J AM MED ASSOC, V304, P1787, DOI 10.1001/jama.2010.1553; Levy MM, 2003, CRIT CARE MED, V31, P1250, DOI 10.1097/01.CCM.0000050454.01978.3B; Nesseler N, 2013, INTENS CARE MED, V39, P881, DOI 10.1007/s00134-013-2815-1; Oeyen SG, 2010, CRIT CARE MED, V38, P2386, DOI 10.1097/CCM.0b013e3181f3dec5; Parker SL, 2013, J NEUROSURG-SPINE, V18, P154, DOI 10.3171/2012.10.SPINE12312; Vincent JL, 1996, INTENS CARE MED, V22, P707, DOI 10.1007/BF01709751; Ware J., 1993, SF 36 HLTH SURVEY MA; Ware JE, 1996, MED CARE, V34, P220, DOI 10.1097/00005650-199603000-00003; Winters BD, 2010, CRIT CARE MED, V38, P1276, DOI 10.1097/CCM.0b013e3181d8cc1d	18	24	25	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2014	9	12							e116304	10.1371/journal.pone.0116304	http://dx.doi.org/10.1371/journal.pone.0116304			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX6YH	25549097	Green Published, gold, Green Submitted			2022-12-27	WOS:000347063500074
J	Bokman, CL; Pasquale, LR; Parrish, RK; Lee, RK				L. Bokman, Christine; Pasquale, Louis R.; Parrish, Richard K., II; Lee, Richard K.			Glaucoma Screening in the Haitian Afro-Caribbean Population of South Florida	PLOS ONE			English	Article							OPEN-ANGLE GLAUCOMA; DIABETES-MELLITUS; BARBADOS EYE; RISK-FACTORS; INTRAOCULAR-PRESSURE; UNITED-STATES; PREVALENCE; HYPERTENSION; VARIANTS; DISEASE	Objective: To evaluate the presence of clinical signs consistent with suspected glaucoma in Haitian Afro-Caribbean individuals residing in South Florida who do not receive regular eye examinations. Design: Retrospective, cross-sectional study. Methods: SETTING: Community health center in the Little Haiti district of Miami, Florida. PATIENT POPULATION: We reviewed medical records and screening forms from five health screenings between October 2011 to October 2013 of 939 Afro-Caribbean individuals older than 18 years, who were never diagnosed with glaucoma or had an eye examination within the last ten years. PROCEDURES: Measurements of distance visual acuity (VA), intraocular eye pressure (IOP), central corneal thickness (CCT), cup-to-disc ratio (CDR), frequency doubling technology (FDT) perimeter visual field (VF). Main Outcome Measures: Proportion of glaucoma suspects, based on IOP greater than or equal to 24 mm Hg or CDR greater than or equal to 0.7 in either eye, and determinants of CDR and IOP. Results: One hundred ninety-one (25.5%) of 750 patients were identified as glaucoma suspects. Glaucoma suspects were common in both the youngest and oldest age groups (<40 years, 20.9%; 95% confidence interval [CI], 17.9-23.9; >70 years, 25.0%; 95% CI, 21.8-28.2) and higher in men than women less than 70 years; the reverse was true after 70 years. Among all patients, mean IOP was 19.2 +/- 4.5 mmHg, mean CDR was 0.37 +/- 0.17, and mean CCT was 532 +/- 37.1 mu m. In multiple linear stepwise regression analysis, determinates of increased CDR included increasing age (P = 0.004), lack of insurance (P = 0.019), and higher IOP (P<0.001), while increasing CDR (P<0.001) and thicker CCT (P<0.001) were associated with higher IOP. Conclusions: This first glaucoma survey in a U.S. Haitian Afro-Caribbean population indicates glaucoma suspect status is high across all age groups, and suggests glaucoma monitoring in people less than 40 years of age is indicated in this population.	[L. Bokman, Christine; Parrish, Richard K., II; Lee, Richard K.] Univ Miami, Miller Sch Med, Bascom Palmer Eye Inst, Miami, FL 33136 USA; [Pasquale, Louis R.] Harvard Univ, Sch Med, Massachusetts Eye & Ear Infirm, Boston, MA 02115 USA; [Pasquale, Louis R.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Channing Div Network Med, Boston, MA 02115 USA	Bascom Palmer Eye Institute; University of Miami; Harvard University; Harvard Medical School; Massachusetts Eye & Ear Infirmary; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Lee, RK (corresponding author), Univ Miami, Miller Sch Med, Bascom Palmer Eye Inst, Miami, FL 33136 USA.	rlee@med.miami.edu			Friends of the Congressional Glaucoma Caucus	Friends of the Congressional Glaucoma Caucus	The authors received no specific funding for this work, although some of the vision screenings were funded by non-profit foundation the Friends of the Congressional Glaucoma Caucus (which is no longer active). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bcuhanan AB, 2009, POPULATION HAITIAN A; Camarota S. A., 2010, FACT SHEET HAITIAN I; Cao D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039278; Centers for Disease Control and Prevention, 2011, NAT DIAB FACT SHEET; Dielemans I, 1996, OPHTHALMOLOGY, V103, P1271, DOI 10.1016/S0161-6420(96)30511-3; Ellis JD, 2000, BRIT J OPHTHALMOL, V84, P1218, DOI 10.1136/bjo.84.11.1218; ERVIN AM, 2012, COMP EFFECTIVENESS R, V59; Fan BJ, 2011, INVEST OPHTH VIS SCI, V52, P1788, DOI 10.1167/iovs.10-6339; Foster PJ, 2002, BRIT J OPHTHALMOL, V86, P238, DOI 10.1136/bjo.86.2.238; Friedman DS, 2004, ARCH OPHTHALMOL-CHIC, V122, P532; Hennis A, 2003, OPHTHALMOLOGY, V110, P908, DOI 10.1016/S0161-6420(03)00075-7; Jiao XD, 2009, P NATL ACAD SCI USA, V106, P17105, DOI 10.1073/pnas.0907564106; KLEIN BEK, 1994, OPHTHALMOLOGY, V101, P1173; Kwon YH, 2009, NEW ENGL J MED, V360, P1113, DOI 10.1056/NEJMra0804630; Ladapo JA, 2012, ARCH OPHTHALMOL-CHIC, V130, P365, DOI 10.1001/archopthalmol.2011.1224; Leske MC, 2008, OPHTHALMOLOGY, V115, P85, DOI 10.1016/j.ophtha.2007.03.017; Leske MC, 2007, OPHTHALMOLOGY, V114, P1058, DOI 10.1016/j.ophtha.2006.08.051; LESKE MC, 1983, AM J EPIDEMIOL, V118, P166, DOI 10.1093/oxfordjournals.aje.a113626; LESKE MC, 1994, ARCH OPHTHALMOL-CHIC, V112, P821, DOI 10.1001/archopht.1994.01090180121046; Leske MC, 2001, ARCH OPHTHALMOL-CHIC, V119, P89; MASON RP, 1989, OPHTHALMOLOGY, V96, P1363; Mitchell P, 1997, OPHTHALMOLOGY, V104, P712, DOI 10.1016/S0161-6420(97)30247-4; Moyer VA, 2013, ANN INTERN MED, V159, P484, DOI 10.7326/0003-4819-159-6-201309170-00686; NEWSOME DA, 1983, J TROP MED HYG, V86, P37; Pasquale LR, 2006, OPHTHALMOLOGY, V113, P1081, DOI 10.1016/j.ophtha.2006.01.066; Quigley HA, 1997, INVEST OPHTH VIS SCI, V38, P83; Quigley HA, 2006, BRIT J OPHTHALMOL, V90, P262, DOI 10.1136/bjo.2005.081224; Quigley HA, 2009, ARCH OPHTHALMOL-CHIC, V127, P227, DOI 10.1001/archophthalmol.2008.596; Stein JD, 2008, OPHTHALMOLOGY, V115, P1315, DOI 10.1016/j.ophtha.2007.12.017; TIELSCH JM, 1991, JAMA-J AM MED ASSOC, V266, P369, DOI 10.1001/jama.266.3.369; VARMA R, 1994, ARCH OPHTHALMOL-CHIC, V112, P1068, DOI 10.1001/archopht.1994.01090200074026; Varma R, 2012, AM J OPHTHALMOL, V154, P315, DOI 10.1016/j.ajo.2012.02.014	32	15	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2014	9	12							e115942	10.1371/journal.pone.0115942	http://dx.doi.org/10.1371/journal.pone.0115942			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX6YH	25549331	Green Submitted, gold, Green Published			2022-12-27	WOS:000347063500041
J	Weobong, B; ten Asbroek, AHA; Soremekun, S; Manu, AA; Owusu-Agyei, S; Prince, M; Kirkwood, BR				Weobong, Benedict; ten Asbroek, Augustinus H. A.; Soremekun, Seyi; Manu, Alexander A.; Owusu-Agyei, Seth; Prince, Martin; Kirkwood, Betty R.			Association of Antenatal Depression with Adverse Consequences for the Mother and Newborn in Rural Ghana: Findings from the DON Population-Based Cohort Study	PLOS ONE			English	Article							LOW-BIRTH-WEIGHT; COMMON MENTAL-DISORDERS; LOW-INCOME COUNTRIES; MATERNAL DEPRESSION; INFANT GROWTH; RISK-FACTORS; HEALTH-CARE; PREGNANCY; WOMEN; OUTCOMES	Background: Whilst there is compelling evidence of an almost 2-fold increased risk of still births, and suggestive evidence of increased mortality among offspring of mothers with psychotic disorders, only three studies have addressed the role of antenatal depression (AND) on survival of the baby. We examined these associations in a large cohort of pregnant women in Ghana. Methods: A Cohort study nested within 4-weekly surveillance of all women of reproductive age to identify pregnancies and collect data on births and deaths in the Kintampo Health Research Centre study area of Ghana. Women were screened for AND using the Patient Health Questionnaire (PHQ-9) to ascertain DSM-IV major or minor depression. Outcomes were adverse birth outcomes, maternal/infant morbidity, and uptake of key newborn care practices, examined using logistic regression; effect sizes reported as relative risks with 95% confidence intervals. Results: 20679 (89.6%) pregnant women completed the PHQ-9. The prevalence of AND was 9.9% (n=2032) (95% confidence interval 9.4%-10.2%). AND was associated with: prolonged labour (RR 1.25, 95% CI 1.02-1.53); peripartum complications (RR 1.11, 95% CI 1.07-1.15); postpartum complications (RR 1.27, 96% CI 1.21-1.34); non-vaginal delivery (RR 1.19, 95% CI 1.02-1.40); newborn illness (RR 1.52, 95% CI 1.16-1.99); and bed net use during pregnancy (RR 0.93, 95% CI 0.89-0.98), but not neonatal deaths, still births, low birth weight, immediate breast feeding initiation, or exclusive breastfeeding. AND was marginally associated with preterm births (RR 1.32, 95% CI 0.98-1.76). Conclusion: This paper has contributed important evidence on the role of antenatal depression as a potential contributor to maternal and infant morbidity. Non-pharmacological treatments anchored on primary care delivery structures are recommended as an immediate step. We further recommend that trials are designed to assess if treating antenatal depression in conjunction with improving the quality of obstetric care results in improved maternal and newborn outcomes.	[Weobong, Benedict; Manu, Alexander A.; Owusu-Agyei, Seth] Kintampo Hlth Res Ctr, Ghana Hlth Serv, Kintampo, Ghana; [ten Asbroek, Augustinus H. A.] Univ Amsterdam, Acad Med Ctr, Dept Publ Hlth, NL-1105 AZ Amsterdam, Netherlands; [Weobong, Benedict; Soremekun, Seyi; Manu, Alexander A.; Owusu-Agyei, Seth; Kirkwood, Betty R.] London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, London WC1, England; [Prince, Martin] Kings Coll London, Inst Psychiat, Hlth Serv, London WC2R 2LS, England; [Prince, Martin] Kings Coll London, Inst Psychiat, Populat Res Dept, London WC2R 2LS, England	Ghana Health Service; Kintampo Health Research Centre; University of Amsterdam; Academic Medical Center Amsterdam; University of London; London School of Hygiene & Tropical Medicine; University of London; King's College London; University of London; King's College London	Weobong, B (corresponding author), Kintampo Hlth Res Ctr, Ghana Hlth Serv, Kintampo, Ghana.	bkweobong@gmail.com	Soremekun, Seyi/AAH-4018-2021; Prince, Martin J/A-9170-2010	Prince, Martin J/0000-0003-1379-7146; Soremekun, Seyi/0000-0002-5531-0220; Kirkwood, Betty/0000-0001-5274-6072; Owusu-Agyei, Seth/0000-0002-0807-1781	UK Department for International Development [EPHIHD66]; Save the Children's Saving Newborn Lives programme from The Bill & Melinda Gates Foundation [EPIDVA37]; World Health Organisation [EPNPVE28]; Psychiatric Research Trust (PALTHPA); London School of Hygiene and Tropical Medicine; UK Department for International Development	UK Department for International Development; Save the Children's Saving Newborn Lives programme from The Bill & Melinda Gates Foundation; World Health Organisation(World Health Organization); Psychiatric Research Trust (PALTHPA); London School of Hygiene and Tropical Medicine; UK Department for International Development	Funding for this study was provided by the UK Department for International Development (EPHIHD66), Save the Children's Saving Newborn Lives programme from The Bill & Melinda Gates Foundation (EPIDVA37), and World Health Organisation (EPNPVE28). WB also received support for his fees, travel, and subsistence from the Psychiatric Research Trust (PALTHPA), London School of Hygiene and Tropical Medicine, and the UK Department for International Development. The sponsors of the study had no role in study design, data collection, data analysis, data interpretation, or writing of the report. The corresponding author had full access to all the data in the study and had final responsibility for the decision to submit for publication.	ADERIBIGBE YA, 1993, BRIT J PSYCHIAT, V163, P645, DOI 10.1192/bjp.163.5.645; Ae-Ngibise K, 2010, INT REV PSYCHIATR, V22, P558, DOI 10.3109/09540261.2010.536149; Bodnar LM, 2009, J CLIN PSYCHIAT, V70, P1290, DOI 10.4088/JCP.08m04651; Bonari L, 2004, CAN J PSYCHIAT, V49, P726, DOI 10.1177/070674370404901103; Boy A, 2004, INT J FERTIL WOMEN M, V49, P159; Chung TKH, 2001, PSYCHOSOM MED, V63, P830, DOI 10.1097/00006842-200109000-00017; Cousens S, 2011, LANCET, V377, P1319, DOI 10.1016/S0140-6736(10)62310-0; COX JL, 1983, J AFFECT DISORDERS, V5, P1, DOI 10.1016/0165-0327(83)90030-7; Davalos DB, 2012, ARCH WOMEN MENT HLTH, V15, P1, DOI 10.1007/s00737-011-0251-1; Ferri CP, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-209; Field T, 2006, INFANT BEHAV DEV, V29, P445, DOI 10.1016/j.infbeh.2006.03.003; [GHS Ghana Health Service], 2011, GHAN HLTH SERV BRONG; Goedhart G, 2010, PSYCHOSOM MED, V72, P769, DOI 10.1097/PSY.0b013e3181ee4a62; Grote NK, 2010, ARCH GEN PSYCHIAT, V67, P1012, DOI 10.1001/archgenpsychiatry.2010.111; Benute GRG, 2010, CLINICS, V65, P1127, DOI 10.1590/S1807-59322010001100013; Halbreich U, 2005, AM J OBSTET GYNECOL, V193, P1312, DOI 10.1016/j.ajog.2005.02.103; Hanlon C, 2009, TROP MED INT HEALTH, V14, P156, DOI 10.1111/j.1365-3156.2008.02198.x; Hartley M, 2011, REPROD HEALTH, V8, DOI 10.1186/1742-4755-8-9; Kammerer M, 2009, ARCH WOMEN MENT HLTH, V12, P135, DOI 10.1007/s00737-009-0062-9; Kirkwood BR, 2010, TRIALS, V11, DOI 10.1186/1745-6215-11-58; Kirkwood BR, 2010, LANCET, V375, P1640, DOI 10.1016/S0140-6736(10)60311-X; Kroenke K, 2002, PSYCHIAT ANN, V32, P509, DOI 10.3928/0048-5713-20020901-06; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Lancaster CA, 2010, AM J OBSTET GYNECOL, V202, P5, DOI 10.1016/j.ajog.2009.09.007; Larsen DA, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-S3-S34; Lawn JE, 2006, INT J EPIDEMIOL, V35, P706, DOI 10.1093/ije/dyl043; Lawn JE, 2011, LANCET, V377, P1448, DOI 10.1016/S0140-6736(10)62187-3; Localio AR, 2007, J CLIN EPIDEMIOL, V60, P874, DOI 10.1016/j.jclinepi.2006.12.001; Nasreen HE, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-515; Nicholson WK, 2006, OBSTET GYNECOL, V107, P798, DOI 10.1097/01.AOG.0000204190.96352.05; Nylen KJ, 2006, INFANT MENT HEALTH J, V27, P327, DOI 10.1002/imhj.20095; PAARLBERG KM, 1995, J PSYCHOSOM RES, V39, P563, DOI 10.1016/0022-3999(95)00018-6; Patel V, 2004, BMJ-BRIT MED J, V328, P820, DOI 10.1136/bmj.328.7443.820; Patel V, 2003, ARCH DIS CHILD, V88, P34, DOI 10.1136/adc.88.1.34; Pollack H, 2000, AM J PUBLIC HEALTH, V90, P395, DOI 10.2105/AJPH.90.3.395; Rahman A, 2007, ARCH WOMEN MENT HLTH, V10, P211, DOI 10.1007/s00737-007-0193-9; Rahman A, 2007, ACTA PSYCHIAT SCAND, V115, P481, DOI 10.1111/j.1600-0447.2006.00950.x; Rahman A, 2004, ARCH GEN PSYCHIAT, V61, P946, DOI 10.1001/archpsyc.61.9.946; Rondo PHC, 2003, EUR J CLIN NUTR, V57, P266, DOI 10.1038/sj.ejcn.1601526; Ross LE, 2013, JAMA PSYCHIAT, V70, P436, DOI 10.1001/jamapsychiatry.2013.684; Sebire NJ, 2001, INT J OBESITY, V25, P1175, DOI 10.1038/sj.ijo.0801670; STATA, 2009, STAT DAT AN; Udechuku A, 2010, AUST NZ J PSYCHIAT, V44, P978, DOI 10.3109/00048674.2010.507543; Vyas S, 2006, HEALTH POLICY PLANN, V21, P459, DOI 10.1093/heapol/czl029; Webb R, 2005, AM J PSYCHIAT, V162, P1045, DOI 10.1176/appi.ajp.162.6.1045; WEISSMAN MM, 1995, SCIENCE, V269, P799, DOI 10.1126/science.7638596; Weobong B, 2013, DETERMINANTS POSTNAT; Weobong B, 2009, J AFFECT DISORDERS, V113, P109, DOI 10.1016/j.jad.2008.05.009; Weobong B, 2014, J AFFECT DISORDERS, V165, P1, DOI 10.1016/j.jad.2014.04.009; WHO, 2012, BOM TOO SOON GLOB AC; Wurst KE, 2010, BIRTH DEFECTS RES A, V88, P159, DOI 10.1002/bdra.20627; You D., 2011, LEVELS TRENDS CHILD; Zwane E, 2012, INTERNET J EPIDEMIOL, V10	53	31	32	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2014	9	12							e116333	10.1371/journal.pone.0116333	http://dx.doi.org/10.1371/journal.pone.0116333			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AX6YH	25549334	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000347063500076
J	Wielders, CCH; Boerman, AW; Schimmer, B; van den Brom, R; Notermans, DW; van der Hoek, W; Schneeberger, PM				Wielders, Cornelia C. H.; Boerman, Anneroos W.; Schimmer, Barbara; van den Brom, Rene; Notermans, Daan W.; van der Hoek, Wim; Schneeberger, Peter M.			Persistent High IgG Phase I Antibody Levels against Coxiella burnetii among Veterinarians Compared to Patients Previously Diagnosed with Acute Q Fever after Three Years of Follow-Up	PLOS ONE			English	Article							EPIDEMIC; HISTORY	Background Little is known about the development of chronic Q fever in occupational risk groups. The aim of this study was to perform long-term follow-up of Coxiella burnetii seropositive veterinarians and investigate the course of IgG phase I and phase II antibodies against C. burnetii antigens and to compare this course with that in patients previously diagnosed with acute Q fever. Methods Veterinarians with IgG phase I >= 1: 256 (immunofluorescence assay) that participated in a previous seroprevalence study were asked to provide a second blood sample three years later. IgG antibody profiles were compared to a group of acute Q fever patients who had IgG phase I >= 1: 256 twelve months after diagnosis. Results IgG phase I was detected in all veterinarians (n = 76) and in 85% of Q fever patients (n = 98) after three years (p<0.001). IgG phase I >= 1: 1,024, indicating possible chronic Q fever, was found in 36% of veterinarians and 12% of patients (OR 3.95, 95% CI: 1.84-8.49). Conclusions IgG phase I persists among veterinarians presumably because of continuous exposure to C. burnetii during their work. Serological and clinical follow-up of occupationally exposed risk groups should be considered.	[Wielders, Cornelia C. H.; Boerman, Anneroos W.; Schneeberger, Peter M.] Jeroen Bosch Hosp, Dept Med Microbiol & Infect Control, Shertogenbosch, Netherlands; [Wielders, Cornelia C. H.; Boerman, Anneroos W.; Schimmer, Barbara; Notermans, Daan W.; van der Hoek, Wim; Schneeberger, Peter M.] Ctr Infect Dis Control, Natl Inst Publ Hlth & Environm RIVM, Bilthoven, Netherlands; [van den Brom, Rene] GD Anim Hlth, Dept Small Ruminant Hlth, Deventer, Netherlands	Jeroen Bosch Ziekenhuis; Netherlands National Institute for Public Health & the Environment	Wielders, CCH (corresponding author), Jeroen Bosch Hosp, Dept Med Microbiol & Infect Control, Shertogenbosch, Netherlands.	wielders@jbz.nl	Wielders, Cornelia CH/I-1970-2019	Wielders, Cornelia CH/0000-0002-2413-9088	Netherlands Organisation for Health Research and Development [205520006]	Netherlands Organisation for Health Research and Development(Netherlands Organization for Health Research and Development)	The follow-up study of acute Q fever patients four years after diagnosis was financially supported by The Netherlands Organisation for Health Research and Development (ZonMw; grant number 205520006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angelakis E, 2010, VET MICROBIOL, V140, P297, DOI 10.1016/j.vetmic.2009.07.016; Bernard H, 2012, VECTOR-BORNE ZOONOT, V12, P552, DOI 10.1089/vbz.2011.0879; Bosnjak E, 2010, CLIN MICROBIOL INFEC, V16, P1285, DOI 10.1111/j.1469-0691.2009.03062.x; De Lange MMA, 2014, EPIDEMIOL INFECT, V142, P1231, DOI 10.1017/S0950268813001726; European Centre for Disease Prevention and Control (ECDC), 2010, RISK ASS Q FEV, DOI [10.2900/28860, DOI 10.2900/28860]; Fenollar F, 2001, CLIN INFECT DIS, V33, P312, DOI 10.1086/321889; Kampschreur LM, 2012, J INFECTION, V65, P362, DOI 10.1016/j.jinf.2012.08.002; Kampschreur LM, 2014, J CLIN MICROBIOL, V52, P1637, DOI 10.1128/JCM.03221-13; Kampschreur LM, 2012, EMERG INFECT DIS, V18, P563, DOI 10.3201/eid1804.111478; Maurin M, 1999, CLIN MICROBIOL REV, V12, P518, DOI 10.1128/CMR.12.4.518; Parker NR, 2006, LANCET, V367, P679, DOI 10.1016/S0140-6736(06)68266-4; Peters JB, 2009, QUAL LIFE RES, V18, P901, DOI 10.1007/s11136-009-9502-2; Raoult D, 2005, LANCET INFECT DIS, V5, P219, DOI 10.1016/S1473-3099(05)70052-9; Raoult D, 2012, J INFECTION, V65, P102, DOI 10.1016/j.jinf.2012.04.006; Roest HIJ, 2011, EPIDEMIOL INFECT, V139, P1, DOI 10.1017/S0950268810002268; Schimmer B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042364; Schneeberger Peter M, 2010, Clin Vaccine Immunol, V17, P286, DOI 10.1128/CVI.00454-09; Swart AN, 2012, EPIDEMICS-NETH, V4, P43, DOI 10.1016/j.epidem.2011.12.002; Teunis P, 2005, EPIDEMIOL INFECT, V133, P583, DOI 10.1017/S0950268805003912; Teunis PFM, 2013, EPIDEMIOL INFECT, V141, P2051, DOI 10.1017/S0950268812002774; Teunis PFM, 2013, EPIDEMIOL INFECT, V141, P62, DOI 10.1017/S0950268812000404; Van den Brom R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054021; Van Den Wijngaard CC, 2011, EPIDEMIOL INFECT, V139, P19, DOI 10.1017/S0950268810001032; van der Hoek W, 2012, EURO SURVEILL, V17; van der Hoek W, 2010, EURO SURVEILL, V15; Wattiau P, 2011, EMERG INFECT DIS, V17, P2368, DOI 10.3201/eid1712.101786; Wegdam-Blans MCA, 2012, J INFECTION, V64, P247, DOI 10.1016/j.jinf.2011.12.014; Whitney EAS, 2009, CLIN INFECT DIS, V48, P550, DOI 10.1086/596705; Wielders CCH, 2013, J CLIN MICROBIOL, V51, P3192, DOI 10.1128/JCM.00993-13; WILLIAMS A, 1990, HEALTH POLICY, V16, P199	30	14	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2015	10	1							e0116937	10.1371/journal.pone.0116937	http://dx.doi.org/10.1371/journal.pone.0116937			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ4OZ	25602602	Green Published, gold, Green Submitted			2022-12-27	WOS:000348203500037
J	Di Tella, M; Castelli, L; Colonna, F; Fusaro, E; Torta, R; Ardito, RB; Adenzato, M				Di Tella, Marialaura; Castelli, Lorys; Colonna, Fabrizio; Fusaro, Enrico; Torta, Riccardo; Ardito, Rita B.; Adenzato, Mauro			Theory of Mind and Emotional Functioning in Fibromyalgia Syndrome: An Investigation of the Relationship between Social Cognition and Executive Function	PLOS ONE			English	Article							IMPACT QUESTIONNAIRE FIQ; CHRONIC WIDESPREAD PAIN; HOSPITAL ANXIETY; NORMATIVE DATA; NEURODEGENERATIVE DISEASES; PSYCHOLOGICAL DISTRESS; ASPERGER-SYNDROME; EMPATHY QUOTIENT; ITALIAN VERSION; BRAIN	Background Fibromyalgia (FM) is a syndrome primarily characterised by chronic, widespread musculoskeletal pain. In the aetiology of this syndrome a crucial role is played by complex interactions among biological, genetic, psychological, and socio-cultural factors. Recently, researchers have started to explore emotional functioning in FM, with their attention focused on alexithymia, a personality construct that affects the regulation of a person's own emotions. On the other hand, the detection and experience of emotional signals from other people have only been sparsely investigated in FM syndrome and no studies have investigated the ability to represent other people's mental states (i.e. Theory of Mind, ToM) in these patients. Here we present the first study investigating a large set of social-cognitive abilities, and the possible relationships between these abilities and the performance on executive-function tasks, in a homogenous sample of patients with FM. Methodology Forty women with FM and forty-one healthy women matched for education and age were involved in the study. Social cognition was assessed with a set of validated experimental tasks. Measures of executive function were used to test the correlations between this dimension and the social-cognitive profile of patients with FM. Relationships between social-cognitive abilities and demographic, clinical and psychological variables were also investigated. Principal Findings Patients with FM have impairments both in the regulation of their own affect and in the recognition of other's emotions, as well as in representing other people's mental states. No significant correlations were found between social cognition tasks and the subcomponents of the executive function that were analysed. Conclusions The results show the presence of several impairments in social cognition skills in patients with FM, which are largely independent of both executive function deficits and symptoms of psychological distress. The impairments reported highlight the importance of adequately assessing ToM and emotional functioning in clinical practice.	[Di Tella, Marialaura; Castelli, Lorys; Ardito, Rita B.; Adenzato, Mauro] Univ Turin, Ctr Cognit Sci, Dept Psychol, Turin, Italy; [Colonna, Fabrizio; Torta, Riccardo] Univ Turin, Dept Neurosci, Clin Psychol & Psycho Oncol Unit, Turin, Italy; [Fusaro, Enrico] Citta Salute & Sci Univ Hosp Turin, Rheumatol Unit, Turin, Italy; [Adenzato, Mauro] Inst Neurosci, Turin, Italy	University of Turin; University of Turin; A.O.U. Citta della Salute e della Scienza di Torino	Castelli, L (corresponding author), Univ Turin, Ctr Cognit Sci, Dept Psychol, Turin, Italy.	lorys.castelli@unito.it	Adenzato, Mauro/I-5127-2012; Fusaro, Enrico/ABG-5071-2021; Adenzato, Mauro/AFQ-8675-2022; Di Tella, Marialaura/V-4975-2017; ARDITO, Rita/AFQ-8659-2022; Castelli, Lorys/G-9973-2012	Adenzato, Mauro/0000-0002-6997-9283; Adenzato, Mauro/0000-0002-6997-9283; ARDITO, Rita/0000-0002-5020-6598; Castelli, Lorys/0000-0001-5009-2271; DI TELLA, MARIALAURA/0000-0003-3616-2434; FUSARO, ENRICO/0000-0001-9888-2563	MIUR of Italy (FIRB) [RBFR12FOBD_001]; University of Turin ("Ricerca scientifica finanziata dall'Universita" Linea Generale and Linea Giovani)	MIUR of Italy (FIRB)(Ministry of Education, Universities and Research (MIUR)); University of Turin ("Ricerca scientifica finanziata dall'Universita" Linea Generale and Linea Giovani)	Mauro Adenzato was supported by MIUR of Italy (FIRB 2012, RBFR12FOBD_001; http://futuroinricerca.miur.it/). Lorys Castelli and Rita B. Ardito were supported by University of Turin grants ("Ricerca scientifica finanziata dall'Universita" Linea Generale and Linea Giovani; http://www.unito.it). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aboulafia-Brakha T, 2011, J NEUROPSYCHOL, V5, P39, DOI 10.1348/174866410X533660; Adenzato M, 2013, CLIN NEUROPSYCHIATR, V10, P226; Adenzato M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044414; Adenzato M, 2010, NEUROPSYCHOLOGIA, V48, P2, DOI 10.1016/j.neuropsychologia.2009.08.001; Adolphs R, 2001, CURR OPIN NEUROBIOL, V11, P231, DOI 10.1016/S0959-4388(00)00202-6; Adolphs R, 2003, NEUROPSYCHOLOGIA, V41, P119, DOI 10.1016/S0028-3932(02)00142-2; ALLAMANNO N, 1987, ITAL J NEUROL SCI, V8, P111, DOI 10.1007/BF02337583; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Anderberg UM, 2000, EUR PSYCHIAT, V15, P295, DOI 10.1016/S0924-9338(00)00397-7; Apkarian AV, 2005, EUR J PAIN, V9, P463, DOI 10.1016/j.ejpain.2004.11.001; Arnold LM, 2008, PATIENT EDUC COUNS, V73, P114, DOI 10.1016/j.pec.2008.06.005; Bara BG, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00007; Baron-Cohen S, 2001, J CHILD PSYCHOL PSYC, V42, P241, DOI 10.1017/S0021963001006643; Baron-Cohen S, 2004, J AUTISM DEV DISORD, V34, P163, DOI 10.1023/B:JADD.0000022607.19833.00; BARONCOHEN S, 1985, COGNITION, V21, P37, DOI 10.1016/0010-0277(85)90022-8; Bennett R, 2005, CLIN EXP RHEUMATOL, V23, pS154; Bjelland I, 2002, J PSYCHOSOM RES, V52, P69, DOI 10.1016/S0022-3999(01)00296-3; Branco JC, 2010, SEMIN ARTHRITIS RHEU, V39, P448, DOI 10.1016/j.semarthrit.2008.12.003; Bressi C, 1996, J PSYCHOSOM RES, V41, P551, DOI 10.1016/S0022-3999(96)00228-0; Burgmer M, 2010, J NEURAL TRANSM, V117, P123, DOI 10.1007/s00702-009-0339-1; Burgmer M, 2009, PSYCHOSOM MED, V71, P566, DOI 10.1097/PSY.0b013e3181a32da0; Carlesimo G. A., 1995, Archivio di Psicologia Neurologia e Psichiatria, V56, P471; Carlesimo GA, 1996, EUR NEUROL, V36, P378, DOI 10.1159/000117297; Castelli L, 2012, CLIN EXP RHEUMATOL, V30, pS70; Cavallo M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025948; Ciaramidaro A, 2007, NEUROPSYCHOLOGIA, V45, P3105, DOI 10.1016/j.neuropsychologia.2007.05.011; Cicerale A, 2013, CLIN NEUROPSYCHIATR, V10, P217; Collette F, 2005, HUM BRAIN MAPP, V25, P409, DOI 10.1002/hbm.20118; Costafreda SG, 2008, BRAIN RES REV, V58, P57, DOI 10.1016/j.brainresrev.2007.10.012; Costantini M, 1999, SUPPORT CARE CANCER, V7, P121, DOI 10.1007/s005200050241; Decety Jean, 2004, Behav Cogn Neurosci Rev, V3, P71, DOI 10.1177/1534582304267187; Decety J, 2010, DEV NEUROSCI-BASEL, V32, P257, DOI 10.1159/000317771; Di Tella M, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00909; Dodich A, 2014, NEUROL SCI, V35, P1015, DOI 10.1007/s10072-014-1631-x; Ekman P., 1976, PICTURES FACIAL AFFE; Enrici I, 2011, J COGNITIVE NEUROSCI, V23, P2415, DOI 10.1162/jocn.2010.21594; EPSTEIN SA, 1995, PSYCHOSOMATICS, V36, P192; Fietta Pierluigi, 2007, Acta Biomed, V78, P88; Fine C, 2001, BRAIN, V124, P287, DOI 10.1093/brain/124.2.287; Fisk JE, 2004, J CLIN EXP NEUROPSYC, V26, P874, DOI 10.1080/13803390490510680; FLOR H, 2006, TXB PAIN, P241; Gallagher HL, 2003, TRENDS COGN SCI, V7, P77, DOI 10.1016/S1364-6613(02)00025-6; Glass JM, 2009, RHEUM DIS CLIN N AM, V35, P299, DOI 10.1016/j.rdc.2009.06.002; Gracely RH, 2011, BEST PRACT RES CL RH, V25, P271, DOI 10.1016/j.berh.2011.02.003; Grant MAB, 2001, ARTHRITIS RHEUM, V44, pS394; HAWLEY DJ, 1988, J RHEUMATOL, V15, P1551; Huber A, 2009, J PSYCHOSOM RES, V66, P425, DOI 10.1016/j.jpsychores.2008.11.009; Jurado MB, 2007, NEUROPSYCHOL REV, V17, P213, DOI 10.1007/s11065-007-9040-z; LEDINGHAM J, 1993, BRIT J RHEUMATOL, V32, P139; Lee KH, 2012, SOC COGN AFFECT NEUR, V7, P521, DOI 10.1093/scan/nsp001; Lee SJ, 2013, NEUROSCI RES, V75, P305, DOI 10.1016/j.neures.2013.01.013; LESLIE AM, 1987, PSYCHOL REV, V94, P412, DOI 10.1037/0033-295X.94.4.412; Lezak M.D., 1995, NEUROPSYCHOLOGICAL A; Lieberman MD, 2007, ANNU REV PSYCHOL, V58, P259, DOI 10.1146/annurev.psych.58.110405.085654; Lough S, 2001, NEUROCASE, V7, P123, DOI 10.1076/neur.7.2.123.16266; Lumley MA, 2007, J PERS ASSESS, V89, P230, DOI 10.1080/00223890701629698; Macfarlane GJ, 1999, J RHEUMATOL, V26, P413; McBeth J, 2005, ARTHRITIS RES THER, V7, pR992, DOI 10.1186/ar1772; Mease P, 2005, J RHEUMATOL, V32, P6; Mease P, 2009, CLIN EXP RHEUMATOL, V27, pS2; Miro E, 2011, PSYCHOL HEALTH, V26, P765, DOI 10.1080/08870446.2010.493611; Miyake A, 2000, COGNITIVE PSYCHOL, V41, P49, DOI 10.1006/cogp.1999.0734; Montoya P, 2005, PSYCHOSOM MED, V67, P957, DOI 10.1097/01.psy.0000188401.55394.18; Ngian GS, 2011, INT J RHEUM DIS, V14, P6, DOI 10.1111/j.1756-185X.2010.01567.x; ORSINI A, 1987, ITAL J NEUROL SCI, V8, P539; Park DC, 2001, ARTHRITIS RHEUM, V44, P2125, DOI 10.1002/1529-0131(200109)44:9<2125::AID-ART365>3.0.CO;2-1; Pedrosa Gil Francisco, 2009, Depress Anxiety, V26, pE26, DOI 10.1002/da.20456; Pedrosa Gil Francisco, 2008, Psychosomatics, V49, P115, DOI 10.1176/appi.psy.49.2.115; Pellicano E, 2007, DEV PSYCHOL, V43, P974, DOI 10.1037/0012-1649.43.4.974; Phan KL, 2002, NEUROIMAGE, V16, P331, DOI 10.1006/nimg.2002.1087; Pickup GJ, 2008, PSYCHOPATHOLOGY, V41, P206, DOI 10.1159/000125554; Poletti M, 2012, NEUROSCI BIOBEHAV R, V36, P2147, DOI 10.1016/j.neubiorev.2012.07.004; Poletti M, 2011, BEHAV BRAIN RES, V219, P342, DOI 10.1016/j.bbr.2011.01.010; PREMACK D, 1978, BEHAV BRAIN SCI, V1, P515, DOI 10.1017/S0140525X00076512; Preti A, 2011, COGN NEUROPSYCHIATRY, V16, P50, DOI 10.1080/13546801003790982; REITAN R. M., 1958, PERCEPT MOT SKILLS, V8, P271; Ruby P, 2004, J COGNITIVE NEUROSCI, V16, P988, DOI 10.1162/0898929041502661; Sambataro F, 2006, EUR J NEUROSCI, V24, P2355, DOI 10.1111/j.1460-9568.2006.05120.x; Sarzi-Puttini P, 2003, CLIN EXP RHEUMATOL, V21, P459; Sayar K, 2004, CLIN RHEUMATOL, V23, P441, DOI 10.1007/s10067-004-0918-3; Schmidt-Wilcke T, 2011, NAT REV RHEUMATOL, V7, P518, DOI 10.1038/nrrheum.2011.98; Schnell K, 2011, NEUROIMAGE, V54, P1743, DOI 10.1016/j.neuroimage.2010.08.024; SHALLICE T, 1982, PHILOS T ROY SOC B, V298, P199, DOI 10.1098/rstb.1982.0082; Sifneos P.E., 1972, SHORT TERM PSYCHOTHE; Singer T, 2006, NEUROSCI BIOBEHAV R, V30, P855, DOI 10.1016/j.neubiorev.2006.06.011; Steinweg DL, 2011, PSYCHOSOMATICS, V52, P255, DOI 10.1016/j.psym.2010.12.022; Stone VE, 2006, SOC NEUROSCI-UK, V1, P309, DOI 10.1080/17470910601029221; Stuss DT, 2002, ANNU REV PSYCHOL, V53, P401, DOI 10.1146/annurev.psych.53.100901.135220; Subic-Wrana C, 2010, PSYCHOSOM MED, V72, P404, DOI 10.1097/PSY.0b013e3181d35e83; Taylor G.J., 1997, DISORDERS AFFECT REG; Taylor GJ, 2004, PSYCHOTHER PSYCHOSOM, V73, P68, DOI 10.1159/000075537; Van Houdenhove B, 2007, CURR RHEUMATOL REV, V3, P304, DOI 10.2174/157339707782408937; Van Overwalle F, 2009, HUM BRAIN MAPP, V30, P829, DOI 10.1002/hbm.20547; Verdejo-Garcia A, 2009, ARCH CLIN NEUROPSYCH, V24, P113, DOI 10.1093/arclin/acp014; Vollm BA, 2006, NEUROIMAGE, V29, P90, DOI 10.1016/j.neuroimage.2005.07.022; Vuilleumier P, 2003, NAT NEUROSCI, V6, P624, DOI 10.1038/nn1057; Vuilleumier P, 2007, NEUROPSYCHOLOGIA, V45, P174, DOI 10.1016/j.neuropsychologia.2006.06.003; Walter H, 2004, J COGNITIVE NEUROSCI, V16, P1854, DOI 10.1162/0898929042947838; Walter H, 2009, SOC COGN AFFECT NEUR, V4, P166, DOI 10.1093/scan/nsn047; Weiss S, 2013, BEHAV MED, V39, P146, DOI 10.1080/08964289.2013.818932; *WHO, 2008, WHO TREATM GUID NONM; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	102	52	56	2	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2015	10	1							e0116542	10.1371/journal.pone.0116542	http://dx.doi.org/10.1371/journal.pone.0116542			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AZ4OS	25594169	Green Published, gold, Green Submitted			2022-12-27	WOS:000348202900003
J	Kawamoto, A; Kato, T; Shioi, T; Okuda, J; Kawashima, T; Tamaki, Y; Niizuma, S; Tanada, Y; Takemura, G; Narazaki, M; Matsuda, T; Kimura, T				Kawamoto, Akira; Kato, Takao; Shioi, Tetsuo; Okuda, Junji; Kawashima, Tsuneaki; Tamaki, Yodo; Niizuma, Shinichiro; Tanada, Yohei; Takemura, Genzou; Narazaki, Michiko; Matsuda, Tetsuya; Kimura, Takeshi			Measurement of Technetium-99m Sestamibi Signals in Rats Administered a Mitochondrial Uncoupler and in a Rat Model of Heart Failure	PLOS ONE			English	Article							HEXAKIS 2-METHOXYISOBUTYL ISONITRILE; LEFT-VENTRICULAR HYPERTROPHY; CHICK MYOCARDIAL-CELLS; FATTY-ACID-METABOLISM; MEMBRANE-POTENTIALS; CARDIAC-HYPERTROPHY; DISEASE; PLASMA; EXERCISE; LIVER	Background Many methods have been used to assess mitochondrial function. Technetium-99m sestamibi ( Tc-99m-MIBI), a lipophilic cation, is rapidly incorporated into myocardial cells by diffusion and mainly localizes to the mitochondria. The purpose of this study was to investigate whether measurement of Tc-99m-MIBI signals in animal models could be used as a tool to quantify mitochondrial membrane potential at the organ level. Methods and Results We analyzed Tc-99m-MIBI signals in Sprague-Dawley (SD) rat hearts perfused with carbonyl cyanide m-chlorophenylhydrazone (CCCP), a mitochondrial uncoupler known to reduce the mitochondrial membrane potential. Tc-99m-MIBI signals could be used to detect changes in the mitochondrial membrane potential with sensitivity comparable to that obtained by two-photon laser microscopy with the cationic probe tetramethylrhodamine ethyl ester (TMRE). We also measured Tc-99m-MIBI signals in the hearts of SD rats administered CCCP (4 mg/kg intraperitoneally) or vehicle. Tc-99m-MIBI signals decreased in rat hearts administered CCCP, and the ATP content, as measured by P-31 magnetic resonance spectroscopy, decreased simultaneously. Next, we administered Tc-99m-MIBI to Dahl salt-sensitive rats fed a high-salt diet, which leads to hypertension and heart failure. The Tc-99m-MIBI signal per heart tissue weight was inversely correlated with heart weight, cardiac function, and the expression of atrial natriuretic factor, a marker of heart failure, and positively correlated with the accumulation of labeled fatty acid analog. The Tc-99m-MIBI signal per liver tissue weight was lower than that per heart tissue weight. Conclusion Measurement of Tc-99m-MIBI signals can be an effective tool for semiquantitative investigation of cardiac mitochondrial membrane potential in the SD rat model by using a chemical to decrease the mitochondrial membrane potential. The Tc-99m-MIBI signal per heart tissue weight was inversely correlated with the severity of heart failure in the Dahl rat model.	[Kawamoto, Akira; Kato, Takao; Shioi, Tetsuo; Okuda, Junji; Kawashima, Tsuneaki; Tamaki, Yodo; Niizuma, Shinichiro; Tanada, Yohei; Kimura, Takeshi] Kyoto Univ, Grad Sch Med, Dept Cardiovasc Med, Kyoto, Japan; [Kato, Takao] Kitano Hosp, Ctr Cardiovasc, Tazuke Kofukai Med Res Inst, Osaka, Japan; [Takemura, Genzou] Gifu Univ, Grad Sch Med, Div Cardiol, Gifu, Japan; [Narazaki, Michiko; Matsuda, Tetsuya] Kyoto Univ, Grad Sch Informat, Dept Syst Sci, Kyoto, Japan	Kyoto University; Kitano Hospital; Gifu University; Kyoto University	Shioi, T (corresponding author), Kyoto Univ, Grad Sch Med, Dept Cardiovasc Med, Kyoto, Japan.	tshioi@kuhp.kyoto-u.ac.jp	Tamaki, Yodo/AAF-8026-2020	Tamaki, Yodo/0000-0003-0217-6598; Kato, Takao/0000-0001-8213-7999	Japan Society for the Promotion of Science; Suzuken Memorial Foundation; Uehara Memorial Foundation; Tazuke Kofukai Medical Research Institutes	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Suzuken Memorial Foundation; Uehara Memorial Foundation(Uehara Memorial Foundation); Tazuke Kofukai Medical Research Institutes	This work was supported by grants from the Japan Society for the Promotion of Science, the Suzuken Memorial Foundation, the Uehara Memorial Foundation, and the Tazuke Kofukai Medical Research Institutes. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel ED, 2011, CARDIOVASC RES, V90, P234, DOI 10.1093/cvr/cvr015; BACHE RJ, 1979, AM J CARDIOL, V44, P1029, DOI 10.1016/0002-9149(79)90240-6; BACKUS M, 1993, AM J PHYSIOL, V265, pC178, DOI 10.1152/ajpcell.1993.265.1.C178; Bay J, 2013, J MOL CELL CARDIOL, V61, P20, DOI 10.1016/j.yjmcc.2013.05.010; BOTTOMLEY PA, 1985, SCIENCE, V229, P769, DOI 10.1126/science.4023711; Brand MD, 2011, BIOCHEM J, V435, P297, DOI 10.1042/BJ20110162; BUELL U, 1990, NUCL MED COMMUN, V11, P77, DOI 10.1097/00006231-199002000-00002; CARVALHO PA, 1992, J NUCL MED, V33, P1516; CHIU ML, 1990, J NUCL MED, V31, P1646; Cortese JD, 1999, AM J PHYSIOL-CELL PH, V276, pC611, DOI 10.1152/ajpcell.1999.276.3.C611; Cossarizza A, 1996, EXP CELL RES, V222, P84, DOI 10.1006/excr.1996.0011; COSTA LE, 1988, AM J PHYSIOL, V255, pC123, DOI 10.1152/ajpcell.1988.255.1.C123; CRANE P, 1993, EUR J NUCL MED, V20, P20, DOI 10.1007/BF02261241; da Silva EM, 1998, CHEMOSPHERE, V36, P2375, DOI 10.1016/S0045-6535(97)10206-5; DILLS RL, 1986, DRUG METAB DISPOS, V14, P190; DUNCKER DJ, 1995, AM J PHYSIOL-HEART C, V269, pH271, DOI 10.1152/ajpheart.1995.269.1.H271; ELSE PL, 1985, AM J PHYSIOL, V248, pR415, DOI 10.1152/ajpregu.1985.248.4.R415; FLYNN TG, 1985, BIOCHEM J, V232, P313, DOI 10.1042/bj2320313; Green DR, 2004, SCIENCE, V305, P626, DOI 10.1126/science.1099320; HOEK JB, 1980, J BIOL CHEM, V255, P1458; Huttemann M, 2008, J BIOENERG BIOMEMBR, V40, P445, DOI 10.1007/s10863-008-9169-3; Ide T, 2001, CIRC RES, V88, P529, DOI 10.1161/01.RES.88.5.529; INOKO M, 1994, AM J PHYSIOL-HEART C, V267, pH2471, DOI 10.1152/ajpheart.1994.267.6.H2471; JONES AG, 1984, INT J NUCL MED BIOL, V11, P225, DOI 10.1016/0047-0740(84)90004-4; KAHN JK, 1989, CIRCULATION, V79, P1282, DOI 10.1161/01.CIR.79.6.1282; Kapur A, 2002, EUR J NUCL MED MOL I, V29, P1608, DOI 10.1007/s00259-002-0998-8; Karamanlidis G, 2011, CIRC-HEART FAIL, V4, P707, DOI 10.1161/CIRCHEARTFAILURE.111.961474; Kato M, 2009, CARDIOVASC RES, V83, P335, DOI 10.1093/cvr/cvp094; Kato T, 2010, CIRC-HEART FAIL, V3, P420, DOI 10.1161/CIRCHEARTFAILURE.109.888479; Kawashima T, 2011, J MOL CELL CARDIOL, V51, P1026, DOI 10.1016/j.yjmcc.2011.09.013; KNAPP FF, 1995, EUR J NUCL MED, V22, P361, DOI 10.1007/BF00941855; Kyparos D, 2006, PHYSIOL RES, V55, P653, DOI 10.33549/physiolres.930890; Labajova A, 2006, ANAL BIOCHEM, V353, P37, DOI 10.1016/j.ab.2006.03.032; Langenickel T, 2000, AM J PHYSIOL-HEART C, V278, pH1500, DOI 10.1152/ajpheart.2000.278.5.H1500; Laskowski Karl R, 2008, Curr Heart Fail Rep, V5, P75, DOI 10.1007/s11897-008-0013-1; Matsumoto-Ida M, 2006, CIRCULATION, V114, P1497, DOI 10.1161/CIRCULATIONAHA.106.628834; Miyamoto T, 2004, EUR J CLIN INVEST, V34, P176, DOI 10.1111/j.1365-2362.2004.01312.x; Moreira PI, 2001, BIOSCIENCE REP, V21, P789, DOI 10.1023/A:1015536808304; Nakagawa M, 2008, CIRC RES, V103, P98, DOI 10.1161/CIRCRESAHA.108.177568; Nicholls DG, 2006, J BIOL CHEM, V281, P14864, DOI 10.1074/jbc.M510916200; NOBES CD, 1990, J BIOL CHEM, V265, P12903; O'Neill BT, 2007, CELL METAB, V6, P294, DOI 10.1016/j.cmet.2007.09.001; Okuda J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072173; OLSON MS, 1967, J BIOL CHEM, V242, P333; Padmaraj D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101793; Picard M, 2011, J PHYSIOL-LONDON, V589, P4413, DOI 10.1113/jphysiol.2011.212712; PIWNICAWORMS D, 1990, J NUCL MED, V31, P464; PIWNICAWORMS D, 1990, CIRCULATION, V82, P1826, DOI 10.1161/01.CIR.82.5.1826; POOL PE, 1966, CIRC RES, V19, P221, DOI 10.1161/01.RES.19.2.221; Rimbaud S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026391; Tang Y, 2014, CARDIOVASC PATHOL, V23, P101, DOI 10.1016/j.carpath.2013.11.002; TATE EL, 1976, J GERONTOL, V31, P129, DOI 10.1093/geronj/31.2.129; Veech RL, 2002, IUBMB LIFE, V54, P241, DOI 10.1080/15216540215678; WACKERS FJT, 1989, J NUCL MED, V30, P301; Wallbridge DR, 1996, HEART, V75, P369, DOI 10.1136/hrt.75.4.369; WAN B, 1993, AM J PHYSIOL, V265, pH453, DOI 10.1152/ajpheart.1993.265.2.H453; Ward MW, 2007, J NEUROSCI, V27, P8238, DOI 10.1523/JNEUROSCI.1984-07.2007; Watanabe K, 2000, J BIOL CHEM, V275, P22293, DOI 10.1074/jbc.M000248200; Zhang H, 2001, ANAL BIOCHEM, V298, P170, DOI 10.1006/abio.2001.5348	59	11	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2015	10	1							e0117091	10.1371/journal.pone.0117091	http://dx.doi.org/10.1371/journal.pone.0117091			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ4OS	25594546	Green Published, Green Submitted, gold			2022-12-27	WOS:000348202900007
J	Blackmore, KM; Knight, JA; Walter, J; Lilge, L				Blackmore, Kristina M.; Knight, Julia A.; Walter, Jane; Lilge, Lothar			The Association between Breast Tissue Optical Content and Mammographic Density in Pre- and Post-Menopausal Women	PLOS ONE			English	Article							NEAR-INFRARED SPECTROSCOPY; X-RAY MAMMOGRAPHY; CANCER-RISK; TRANSILLUMINATION SPECTROSCOPY; PARENCHYMAL PATTERNS; DIFFUSE-REFLECTANCE; OXYGEN-SATURATION; IN-VIVO; TOMOGRAPHY; HEMOGLOBIN	Mammographic density (MD), associated with higher water and lower fat content in the breast, is strongly related to breast cancer risk. Optical attenuation spectroscopy (OS) is a non-imaging method of evaluating breast tissue composition by red and near-infrared light transmitted through the breast that, unlike mammography, does not involve radiation. OS provides information on wavelength dependent light scattering of tissue and on absorption by water, lipid, oxy-, deoxy-hemoglobin. We propose that OS could be an alternative marker of breast cancer risk and that OS breast tissue measures will be associated with MD. In the present analysis, we developed an algorithm to estimate breast tissue composition and light scattering parameters using a spectrally constrained global fitting procedure employing a diffuse light transport model. OS measurements were obtained from 202 pre-and postmenopausal women with normal mammograms. Percent density (PD) and dense area (DA) were measured using Cumulus. The association between OS tissue composition and PD and DA was analyzed using linear regression adjusted for body mass index. Among premenopausal women, lipid content was significantly inversely associated with square root transformed PD (beta = -0.05, p = 0.0002) and DA (beta = -0.05, p = 0.019); water content was significantly positively associated with PD (beta = 0.06, p = 0.008). Tissue oxygen saturation was marginally inversely associated with PD (beta = -0.03, p = 0.057) but significantly inversely associated with DA (beta = -0.10, p = 0.002). Among post-menopausal women lipid and water content were significantly associated (negatively and positively, respectively) with PD (beta(lipid) = -0.08, beta(water) = 0.14, both p< 0.0001) and DA (beta(lipid) = -0.10, p< 0.0001; beta(water) = 0.11, p = 0.001). The association between OS breast content and PD and DA is consistent with more proliferation in dense tissue of younger women, greater lipid content in low density tissue and higher water content in high density tissue. OS may be useful for assessing physiologic tissue differences related to breast cancer risk, particularly when mammography is not feasible or easily accessible.	[Blackmore, Kristina M.; Knight, Julia A.] Mt Sinai Hosp, Lunenfeld Tanenbaum Res Inst, Toronto, ON M5G 1X5, Canada; [Blackmore, Kristina M.; Walter, Jane; Lilge, Lothar] Univ Toronto, Princess Margaret Canc Ctr, Toronto, ON M5S 1A1, Canada; [Blackmore, Kristina M.; Walter, Jane; Lilge, Lothar] Univ Toronto, Dept Med Biophys, Toronto, ON M5S 1A1, Canada	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Toronto	Blackmore, KM (corresponding author), Mt Sinai Hosp, Lunenfeld Tanenbaum Res Inst, Toronto, ON M5G 1X5, Canada.	blackmore@lunenfeld.ca	Knight, Julia/R-5617-2019; Knight, Julia/A-6843-2012	Knight, Julia/0000-0002-7610-7635; Blackmore, Kristina/0000-0001-6662-6741; lilge, lothar/0000-0001-5533-0005	CDMRP (Congress Directed Medical Research Plan) [DAMD 17-00-1-0393]; CIPI (Canadian Institute of Photonics Innovation); CBCRA (Canadian Breast Cancer Research Alliance)	CDMRP (Congress Directed Medical Research Plan); CIPI (Canadian Institute of Photonics Innovation); CBCRA (Canadian Breast Cancer Research Alliance)	This work was supported by CDMRP (Congress Directed Medical Research Plan) under DAMD 17-00-1-0393, CIPI (Canadian Institute of Photonics Innovation) and CBCRA (Canadian Breast Cancer Research Alliance). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2001, 6082511993 IEC, P54; Blackmore KM, 2007, BRIT J RADIOL, V80, P545, DOI 10.1259/bjr/26858614; Blackmore KM, 2008, CANCER EPIDEM BIOMAR, V17, P1043, DOI 10.1158/1055-9965.EPI-07-2658; Blyschak K, 2004, MED PHYS, V31, P1398, DOI 10.1118/1.1738191; Boyd N, 2002, CANCER EPIDEM BIOMAR, V11, P1048; Boyd NF, 1998, CANCER EPIDEM BIOMAR, V7, P1133; BOYD NF, 1995, J NATL CANCER I, V87, P670, DOI 10.1093/jnci/87.9.670; BOYD NF, 1982, BRIT J CANCER, V45, P185, DOI 10.1038/bjc.1982.32; Bryson J, 1982, AM J EPIDERNIOL, V115, P428; Byng JW, 1997, CANCER, V80, P66, DOI 10.1002/(SICI)1097-0142(19970701)80:1<66::AID-CNCR9>3.0.CO;2-D; Cerussi AE, 2001, ACAD RADIOL, V8, P211, DOI 10.1016/S1076-6332(03)80529-9; Durduran T, 2002, PHYS MED BIOL, V47, P2847, DOI 10.1088/0031-9155/47/16/302; FARRELL TJ, 1992, MED PHYS, V19, P879, DOI 10.1118/1.596777; Graham SJ, 1996, BRIT J CANCER, V73, P162, DOI 10.1038/bjc.1996.30; Harvey JA, 2004, RADIOLOGY, V230, P29, DOI 10.1148/radiol.2301020870; KATO I, 1995, CANCER CAUSE CONTROL, V6, P431, DOI 10.1007/BF00052183; Lee NA, 1997, AM J ROENTGENOL, V168, P501, DOI 10.2214/ajr.168.2.9016235; Maskarinec G, 2005, AM J EPIDEMIOL, V162, P743, DOI 10.1093/aje/kwi270; MATCHER SJ, 1994, PHYS MED BIOL, V39, P177, DOI 10.1088/0031-9155/39/1/011; McCormack VA, 2006, CANCER EPIDEM BIOMAR, V15, P1159, DOI 10.1158/1055-9965.EPI-06-0034; O'Sullivan TD, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3389; OZA AM, 1993, EPIDEMIOL REV, V15, P196, DOI 10.1093/oxfordjournals.epirev.a036105; Pogue BW, 2001, RADIOLOGY, V218, P261, DOI 10.1148/radiology.218.1.r01ja51261; Quaresima V, 1998, PHOTOCHEM PHOTOBIOL, V67, P4, DOI 10.1111/j.1751-1097.1998.tb05159.x; SAFTLAS AF, 1991, CANCER, V67, P2833, DOI 10.1002/1097-0142(19910601)67:11<2833::AID-CNCR2820671121>3.0.CO;2-U; Shah N, 2001, P NATL ACAD SCI USA, V98, P4420, DOI 10.1073/pnas.071511098; Simick MK, 2005, BRIT J RADIOL, V78, P1009, DOI 10.1259/bjr/14696165; Simick MK, 2004, J BIOMED OPT, V9, P794, DOI 10.1117/1.1758269; Sliney DH, 1990, P SPIE, V1207; Srinivasan S, 2006, ACAD RADIOL, V13, P195, DOI 10.1016/j.acra.2005.10.002; Srinivasan S, 2003, P NATL ACAD SCI USA, V100, P12349, DOI 10.1073/pnas.2032822100; Suzuki K, 1996, J Biomed Opt, V1, P330, DOI 10.1117/12.239902; Taroni P, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2699170; Taroni P, 2010, J BIOMED OPT, V15, DOI 10.1117/1.3506043; Torres-Mejia G, 2005, CANCER EPIDEM BIOMAR, V14, P1052, DOI 10.1158/1055-9965.EPI-04-0717; Tromberg BJ, 1997, PHILOS T R SOC B, V352, P661, DOI 10.1098/rstb.1997.0047; Vacek PM, 2004, CANCER EPIDEM BIOMAR, V13, P715; van Veen RLP, 2005, J BIOMED OPT, V10, DOI 10.1117/1.2085149; Wang X, 2006, J BIOMED OPT, V11, DOI 10.1117/1.2342747; WOLFE JN, 1987, AM J ROENTGENOL, V148, P1087, DOI 10.2214/ajr.148.6.1087; Yaffe MJ, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2102; Yaffe MJ, 1998, EUR J CANCER PREV, V7, pS47, DOI 10.1097/00008469-199802001-00010	42	15	15	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2015	10	1							e0115851	10.1371/journal.pone.0115851	http://dx.doi.org/10.1371/journal.pone.0115851			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9HN	25590139	Green Published, Green Submitted, gold			2022-12-27	WOS:000350679400011
J	Ruiz, JA; Bernar, EM; Jung, K				Ruiz, Jimena A.; Bernar, Evangelina M.; Jung, Kirsten			Production of Siderophores Increases Resistance to Fusaric Acid in Pseudomonas protegens Pf-5	PLOS ONE			English	Article							CHLAMYDOSPORE GERMINATION; SPECTROPHOTOMETRIC DETERMINATION; CHLORORAPHIS PCL1391; RADICIS-LYCOPERSICI; GENE-EXPRESSION; 1ST REPORT; FLUORESCENS; OXYSPORUM; AERUGINOSA; GROWTH	Fusaric acid is produced by pathogenic fungi of the genus Fusarium, and is toxic to plants and rhizobacteria. Many fluorescent pseudomonads can prevent wilt diseases caused by these fungi. This study was undertaken to evaluate the effect of fusaric acid on P. protegens Pf-5 and elucidate the mechanisms that enable the bacterium to survive in the presence of the mycotoxin. The results confirm that fusaric acid negatively affects growth and motility of P. protegens. Moreover, a notable increase in secretion of the siderophore pyoverdine was observed when P. protegens was grown in the presence of fusaric acid. Concomitantly, levels of enzymes involved in the biosynthesis of pyoverdine and enantio-pyochelin, the second siderophore encoded by P. protegens, increased markedly. Moreover, while similar levels of resistance to fusaric acid were observed for P. protegens mutants unable to synthesize either pyoverdine or enanto-pyochelin and the wild type strain, a double mutant unable to synthesize both kinds of siderophores showed a dramatically reduced resistance to this compound. This reduced resistance was not observed when this mutant was grown under conditions of iron excess. Spectrophotometric titrations revealed that fusaric acid binds not only Fe2+ and Fe3+, but also Zn2+, Mn2+ and Cu2+, with high affinity. Our results demonstrate that iron sequestration accounts at least in part for the deleterious effect of the mycotoxin on P. protegens.	[Ruiz, Jimena A.] Univ Buenos Aires, Fac Agron, Consejo Nacl Invest Cient & Tecn, Inst Invest Biociencias Agr & Ambientales, Buenos Aires, DF, Argentina; [Ruiz, Jimena A.; Jung, Kirsten] Univ Munich, Munich Ctr Integrated Prot Sci CiPSM, Dept Biol 1, Martinsried, Germany; [Ruiz, Jimena A.; Bernar, Evangelina M.] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Quim Biol, Buenos Aires, DF, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; University of Munich; University of Buenos Aires	Ruiz, JA (corresponding author), Univ Buenos Aires, Fac Agron, Consejo Nacl Invest Cient & Tecn, Inst Invest Biociencias Agr & Ambientales, Buenos Aires, DF, Argentina.	jruiz@agro.uba.ar; jung@lmu.de			Deutsche Forschungsgemeinschaft [Exc114/2]; Humboldt Foundation; Argentinean National Research Council (CONICET)	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Humboldt Foundation(Alexander von Humboldt Foundation); Argentinean National Research Council (CONICET)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET))	This work was supported by the Deutsche Forschungsgemeinschaft (Exc114/2) (KJ), the Humboldt Foundation (fellowship to JR) and the Argentinean National Research Council (CONICET). JR is a career researcher from CONICET. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almario J, 2013, MOL PLANT MICROBE IN, V26, P566, DOI 10.1094/MPMI-11-12-0274-R; BACHMANN BJ, 1996, ESCHERICHIA COLI SAL, P2460; Bacon CW, 2006, J APPL MICROBIOL, V100, P185, DOI 10.1111/j.1365-2672.2005.02770.x; Bacon CW, 1996, APPL ENVIRON MICROB, V62, P4039, DOI 10.1128/AEM.62.11.4039-4043.1996; Capasso R, 1996, PHYTOCHEMISTRY, V41, P1035, DOI 10.1016/0031-9422(95)00716-4; Chin-A-Woeng TFC, 1998, MOL PLANT MICROBE IN, V11, P1069, DOI 10.1094/MPMI.1998.11.11.1069; Choi KH, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-30; COX CD, 1981, P NATL ACAD SCI-BIOL, V78, P4256, DOI 10.1073/pnas.78.7.4256; de Weert S, 2004, MOL PLANT MICROBE IN, V17, P1185, DOI 10.1094/MPMI.2004.17.11.1185; DEWEGER LA, 1987, J BACTERIOL, V169, P2769, DOI 10.1128/jb.169.6.2769-2773.1987; Di Pietro A, 2003, MOL PLANT PATHOL, V4, P315, DOI [10.1046/j.1364-3703.2003.00180.x, 10.1046/J.1364-3703.2003.00180.X]; Duffy B, 2004, APPL ENVIRON MICROB, V70, P1836, DOI 10.1128/AEM.70.3.1836-1842.2004; Duffy BK, 1999, APPL ENVIRON MICROB, V65, P2429; ELAD Y, 1985, PHYTOPATHOLOGY, V75, P1053, DOI 10.1094/Phyto-75-1053; ELAD Y, 1985, PHYTOPATHOLOGY, V75, P1047, DOI 10.1094/Phyto-75-1047; FERNANDEZPOL JA, 1977, P NATL ACAD SCI USA, V74, P2889, DOI 10.1073/pnas.74.7.2889; FERNANDEZPOL JA, 1993, ANTICANCER RES, V13, P57; Gapillout I, 1996, EUR J PLANT PATHOL, V102, P127, DOI 10.1007/BF01877099; GAUMANN E, 1958, PHYTOPATHOLOGY, V48, P670; Gross H, 2007, CHEM BIOL, V14, P53, DOI 10.1016/j.chembiol.2006.11.007; Haas D, 2005, NAT REV MICROBIOL, V3, P307, DOI 10.1038/nrmicro1129; HENZEL WJ, 1993, P NATL ACAD SCI USA, V90, P5011, DOI 10.1073/pnas.90.11.5011; HILL-COTTINGHAM D. G., 1957, SOIL SCI, V84, P43, DOI 10.1097/00010694-195707000-00005; HILLCOTTINGHAM DG, 1957, ANALYST, V82, P524; HILLCOTTINGHAM DG, 1955, ANALYST, V80, P906; Hoang TT, 1998, GENE, V212, P77, DOI 10.1016/S0378-1119(98)00130-9; HOWELL CR, 1979, PHYTOPATHOLOGY, V69, P480, DOI 10.1094/Phyto-69-480; KING EO, 1954, J LAB CLIN MED, V44, P301; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAGEVEEN RG, 1988, APPL ENVIRON MICROB, V54, P2924, DOI 10.1128/AEM.54.12.2924-2932.1988; Landa BB, 2002, CAN J MICROBIOL, V48, P971, DOI 10.1139/W02-094; Lassak J, 2010, APPL ENVIRON MICROB, V76, P3263, DOI 10.1128/AEM.00512-10; Lim CK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039139; LIU PV, 1978, INFECT IMMUN, V22, P878, DOI 10.1128/IAI.22.3.878-890.1978; Lori GA, 2003, MICROBIOL RES, V158, P29, DOI 10.1078/0944-5013-00173; Lugtenberg BJJ, 2001, ANNU REV PHYTOPATHOL, V39, P461, DOI 10.1146/annurev.phyto.39.1.461; MALINI S., 1966, Phytopathologische Zeitschrift, V57, P221, DOI 10.1111/j.1439-0434.1966.tb02277.x; MEGNEGNEAU B, 1988, PLANT PHYSIOL BIOCH, V26, P585; Merritt Judith H, 2005, Curr Protoc Microbiol, VChapter 1, DOI 10.1002/9780471729259.mc01b01s00; MEYER JM, 1978, J GEN MICROBIOL, V107, P319, DOI 10.1099/00221287-107-2-319; MILLER VL, 1988, J BACTERIOL, V170, P2575, DOI 10.1128/JB.170.6.2575-2583.1988; Notz R, 2002, APPL ENVIRON MICROB, V68, P2229, DOI 10.1128/AEM.68.5.2229-2235.2002; PETERSON GL, 1977, ANAL BIOCHEM, V83, P346, DOI 10.1016/0003-2697(77)90043-4; Pioli RN, 2004, PLANT DIS, V88, P220, DOI 10.1094/PDIS.2004.88.2.220A; Ramautar A, 2003, THESIS U NATAL DURBA; Reynoso M, 2009, EUR J PLANT PATHOL, V123, P207, DOI 10.1007/s10658-008-9359-1; RINEHART KL, 1995, J ORG CHEM, V60, P2786, DOI 10.1021/jo00114a029; Rudrappa T, 2008, FEMS MICROBIOL ECOL, V64, P153, DOI 10.1111/j.1574-6941.2008.00465.x; Saikia R, 2009, MICROBIOL RES, V164, P365, DOI 10.1016/j.micres.2007.05.001; Schweizer Herbert P, 2003, Genet Mol Res, V2, P48; SIMON R, 1983, BIO-TECHNOL, V1, P784, DOI 10.1038/nbt1183-784; SNEH B, 1984, PHYTOPATHOLOGY, V74, P1115, DOI 10.1094/Phyto-74-1115; Stenglein S, 2009, PLANT PATHOL, V58, P401, DOI 10.1111/j.1365-3059.2008.01973.x; Stenglein SA, 2009, J PLANT PATHOL, V91, P25; TOYODA H, 1991, J PHYTOPATHOL, V133, P265, DOI 10.1111/j.1439-0434.1991.tb00162.x; UTSUMI R, 1991, AGR BIOL CHEM TOKYO, V55, P1913, DOI 10.1080/00021369.1991.10870864; van Rij ET, 2005, MICROBIOL-SGM, V151, P2805, DOI 10.1099/mic.0.28063-0; van Rij ET, 2004, MOL PLANT MICROBE IN, V17, P557, DOI 10.1094/MPMI.2004.17.5.557; VISCA P, 1992, APPL ENVIRON MICROB, V58, P2886, DOI 10.1128/AEM.58.9.2886-2893.1992; Weber A, 2006, J BACTERIOL, V188, P7165, DOI 10.1128/JB.00508-06; WEBER K, 1969, J BIOL CHEM, V244, P4406; WENDENBAUM S, 1983, TETRAHEDRON LETT, V24, P4877, DOI 10.1016/S0040-4039(00)94031-0; YANISCHPERRON C, 1985, GENE, V33, P103, DOI 10.1016/0378-1119(85)90120-9; Youard ZA, 2007, J BIOL CHEM, V282, P35546, DOI 10.1074/jbc.M707039200	64	28	28	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2015	10	1							e0117040	10.1371/journal.pone.0117040	http://dx.doi.org/10.1371/journal.pone.0117040			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ4BT	25569682	Green Published, Green Submitted, gold			2022-12-27	WOS:000348168000010
J	Guo, C; Li, L; Wang, XF; Liang, C				Guo, Cheng; Li, Li; Wang, Xifeng; Liang, Chun			Alterations in SiRNA and MiRNA Expression Profiles Detected by Deep Sequencing of Transgenic Rice with SiRNA-Mediated Viral Resistance	PLOS ONE			English	Article							SMALL RNAS; MICRORNA; VIRUS; ROLES; IDENTIFICATION; BIOGENESIS; EFFICIENT; STRESS	RNA-mediated gene silencing has been demonstrated to serve as a defensive mechanism against viral pathogens by plants. It is known that specifically expressed endogenous siRNAs and miRNAs are involved in the self-defense process during viral infection. However, research has been rarely devoted to the endogenous siRNA and miRNA expression changes under viral infection if the resistance has already been genetically engineered in plants. Aiming to gain a deeper understanding of the RNA-mediated gene silencing defense process in plants, the expression profiles of siRNAs and miRNAs before and after viral infection in both wild type and transgenic anti-Rice stripe virus (RSV) rice plants were examined by small RNA high-throughput sequencing. Our research confirms that the newly generated siRNAs, which are derived from the engineered inverted repeat construct, is the major contributor of the viral resistance in rice. Further analysis suggests the accuracy of siRNA biogenesis might be affected when siRNAs machinery is excessively used in the transgenic plants. In addition, the expression levels of many known miRNAs are dramatically changed due to RSV infection on both wild type and transgenic rice plants, indicating potential function of those miRNAs involved in plant-virus interacting process.	[Guo, Cheng; Liang, Chun] Miami Univ, Dept Biol, Oxford, OH 45056 USA; [Li, Li; Wang, Xifeng; Liang, Chun] Chinese Acad Agr Sci, State Key Lab Biol Plant Dis & Insect Pests, Inst Plant Protect, Beijing 100193, Peoples R China; [Liang, Chun] Miami Univ, Dept Comp Sci & Software Engn, Oxford, OH 45056 USA	University System of Ohio; Miami University; Chinese Academy of Agricultural Sciences; Institute of Plant Protection, CAAS; University System of Ohio; Miami University	Wang, XF (corresponding author), Chinese Acad Agr Sci, State Key Lab Biol Plant Dis & Insect Pests, Inst Plant Protect, Beijing 100193, Peoples R China.	xfwang@ippcaas.cn; liangc@miamioh.edu	Wang, Xifeng/A-6476-2016	Wang, Xifeng/0000-0002-4982-8947	Office for the Advancement of Research and Scholarship (OARS); Special Fund for Agro-scientific Research in the Public Interest in China [201303021]; National R&D Project of Transgenic Crops of China [2011ZX08002-001]; Botany Department, Miami University, Oxford, Ohio, USA	Office for the Advancement of Research and Scholarship (OARS); Special Fund for Agro-scientific Research in the Public Interest in China; National R&D Project of Transgenic Crops of China; Botany Department, Miami University, Oxford, Ohio, USA	This project is funded partially by Office for the Advancement of Research and Scholarship (OARS) and Botany Department, Miami University, Oxford, Ohio, USA; partially by The Special Fund for Agro-scientific Research in the Public Interest (201303021) in China; and National R&D Project of Transgenic Crops of China (2011ZX08002-001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Arikit S, 2013, CURR OPIN PLANT BIOL, V16, P170, DOI 10.1016/j.pbi.2013.01.006; Arvey A, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.24; Axtell MJ, 2013, ANNU REV PLANT BIOL, V64, P137, DOI 10.1146/annurev-arplant-050312-120043; Barrera-Figueroa BE, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-132; Boratyn GM, 2013, NUCLEIC ACIDS RES, V41, pW29, DOI 10.1093/nar/gkt282; Bottino MC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059423; Bouche N, 2006, EMBO J, V25, P3347, DOI 10.1038/sj.emboj.7601217; Buck AH, 2010, RNA, V16, P307, DOI 10.1261/rna.1819210; Chen XM, 2009, ANNU REV CELL DEV BI, V25, P21, DOI 10.1146/annurev.cellbio.042308.113417; Dai XB, 2011, NUCLEIC ACIDS RES, V39, pW155, DOI 10.1093/nar/gkr319; Dai Yang, 2010, Open Access Bioinformatics, V2, P29; de Lima JC, 2012, GENET MOL BIOL, V35, P1069, DOI 10.1590/S1415-47572012000600023; Ding SW, 2004, VIRUS RES, V102, P109, DOI 10.1016/j.virusres.2004.01.021; Du P, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002176; Frazier TP, 2011, MOL BIOTECHNOL, V49, P159, DOI 10.1007/s12033-011-9387-5; Guo WX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046443; Haasnoot J, 2011, METHODS MOL BIOL, V721, P23, DOI 10.1007/978-1-61779-037-9_2; Hily JM, 2007, J AM SOC HORTIC SCI, V132, P850, DOI 10.21273/JASHS.132.6.850; Jeang KT, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-58; Khan AA, 2009, NAT BIOTECHNOL, V27, P549, DOI 10.1038/nbt.1543; Khraiwesh B, 2012, BBA-GENE REGUL MECH, V1819, P137, DOI 10.1016/j.bbagrm.2011.05.001; Lee I, 2009, GENOME RES, V19, P1175, DOI 10.1101/gr.089367.108; Lee YS, 2004, CELL, V117, P69, DOI 10.1016/S0092-8674(04)00261-2; Li RQ, 2008, BIOINFORMATICS, V24, P713, DOI 10.1093/bioinformatics/btn025; Li Y, 2010, J VIROL, V84, P3023, DOI 10.1128/JVI.02203-09; Liang XH, 2013, BBA-GENE REGUL MECH, V1829, P455, DOI 10.1016/j.bbagrm.2013.01.011; Llave C, 2010, TRENDS PLANT SCI, V15, P701, DOI 10.1016/j.tplants.2010.09.001; Lund E, 2011, GENE DEV, V25, P1121, DOI 10.1101/gad.2038811; Matthew L, 2004, COMP FUNCT GENOM, V5, P240, DOI 10.1002/cfg.396; Metpally Raghu Prasad Rao, 2013, Frontiers in Genetics, V4, P20, DOI 10.3389/fgene.2013.00020; Okamura K, 2013, GENE DEV, V27, P778, DOI 10.1101/gad.211698.112; Parent JS, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00179; Schott G, 2012, EMBO J, V31, P2553, DOI 10.1038/emboj.2012.92; Shu LF, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-108; Szittya G, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000838; Tabara H, 2002, CELL, V109, P861, DOI 10.1016/S0092-8674(02)00793-6; Vodovar N, 2011, J VIROL, V85, P11016, DOI 10.1128/JVI.05647-11; Wesley SV, 2001, PLANT J, V27, P581, DOI 10.1046/j.1365-313X.2001.01105.x; Wu TD, 2010, BIOINFORMATICS, V26, P873, DOI 10.1093/bioinformatics/btq057; Yan F, 2010, ARCH VIROL, V155, P935, DOI 10.1007/s00705-010-0670-8; Yu X, 2012, J EXP BOT, V63, P1025, DOI 10.1093/jxb/err337; Zhang CQ, 2012, BIOINFORMATICS, V28, P2561, DOI 10.1093/bioinformatics/bts500	43	27	30	0	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2015	10	1							e0116175	10.1371/journal.pone.0116175	http://dx.doi.org/10.1371/journal.pone.0116175			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ3BG	25559820	gold, Green Published, Green Submitted			2022-12-27	WOS:000348102200012
J	He, CY; Sun, LP; Xu, Q; Liu, JW; Jiang, JY; Dong, NN; Yuan, Y				He, Cai-yun; Sun, Li-ping; Xu, Qian; Liu, Jing-wei; Jiang, Jing-yi; Dong, Nan-nan; Yuan, Yuan			PGC TagSNP and Its Interaction with H. pylori and Relation with Gene Expression in Susceptibility to Gastric Carcinogenesis	PLOS ONE			English	Article							PEPSINOGEN-C; HELICOBACTER-PYLORI; CLINICAL-SIGNIFICANCE; VIRULENCE FACTORS; CANCER; POLYMORPHISM; ASSOCIATION; INFECTION; CHINESE	Background: Pepsinogen C (PGC) plays an important role in sustaining the cellular differentiation during the process of gastric carcinogenesis. This study aimed to assess the role of PGC tagSNPs and their interactions with Helicobacter pylori (H. pylori) in the development of gastric cancer and its precursor, atrophic gastritis. Methods: Four PGC tagSNPs (rs6941539, rs6912200, rs3789210 and rs6939861) were genotyped by Sequenom MassARRAY platform in a total of 2311 subjects consisting of 642 gastric cancer, 774 atrophic gastritis, and 895 healthy control subjects. The mRNA and protein expression levels of PGC in gastric tissues and in serum were respectively measured by quantitative reverse transcriptase-polymerase chain reaction (qRT-PCR), immunohistochemistry, and Eenzyme-linked immunoabsorbent assay (ELISA). Results: We found associations between PGC rs3789210 CG/GG genotypes and reduced gastric cancer risk and between PGC rs6939861 A variant allele and increased risks of both gastric cancer and atrophic gastritis. As for the haplotypes of PGC rs6941539-rs6912200-rs3789210-rs6939861 loci, the TTCA and TTGG haplotypes were respectively associated with increased and reduced risks of both gastric cancer and atrophic gastritis; additionally, the CTCA haplotype was associated with increased atrophic gastritis risk. Very interestingly, rs6912200 CT/TT genotypes had a positive interaction with H. pylori, synergistically elevating the gastric cancer risk. Moreover, healthy subjects who carried rs6912200 CT, TT and CT/TT variant genotypes had lower histological and serum expression levels of PGC protein. Conclusions: Our findings highlight an important role of PGC rs3789210 and rs6939861 in altering susceptibility to atrophic gastritis and/or gastric cancer. Moreover, people who carry rs6912200 variant genotypes exhibit higher gastric cancer risk in case of getting H. pylori infection, which strongly suggest a necessity of preventing and/or eliminating H. pylori infection in those individuals.	[He, Cai-yun; Sun, Li-ping; Xu, Qian; Liu, Jing-wei; Jiang, Jing-yi; Dong, Nan-nan; Yuan, Yuan] China Med Univ, Affiliated Hosp 1, Tumor Etiol & Screening Dept, Inst Canc, Shenyang, Peoples R China; [He, Cai-yun; Sun, Li-ping; Xu, Qian; Liu, Jing-wei; Jiang, Jing-yi; Dong, Nan-nan; Yuan, Yuan] China Med Univ, Affiliated Hosp 1, Shenyang, Peoples R China; [He, Cai-yun; Sun, Li-ping; Xu, Qian; Liu, Jing-wei; Jiang, Jing-yi; Dong, Nan-nan; Yuan, Yuan] China Med Univ, Liaoning Prov Educ Dept, Key Lab Canc Etiol & Prevent, Shenyang, Peoples R China; [He, Cai-yun] Sun Yat Sen Univ, Ctr Canc, Dept Mol Diagnost, State Key Lab Oncol South China, Guangzhou 510275, Guangdong, Peoples R China	China Medical University; China Medical University; China Medical University; State Key Lab Oncology South China; Sun Yat Sen University	Yuan, Y (corresponding author), China Med Univ, Affiliated Hosp 1, Tumor Etiol & Screening Dept, Inst Canc, Shenyang, Peoples R China.	yyuan@mail.cmu.edu.cn	Yuan, Yuan/GVS-5120-2022		National Basic Research Program of China (973 Program) [2010CB529304]; National Natural Science Foundation of China [31200968]; Science Technology Project in Liaoning Province [2011225002]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science Technology Project in Liaoning Province	This study is supported by grants from National Basic Research Program of China (973 Program Ref No. 2010CB529304), the National Natural Science Foundation of China (Ref No. 31200968), and the Science Technology Project in Liaoning Province (Ref No. 2011225002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AZUMA T, 1993, GUT, V34, P450, DOI 10.1136/gut.34.4.450; Di Mario F, 2004, DIGESTION, V70, P167, DOI 10.1159/000081517; Di Mario F, 2006, DIGEST DIS SCI, V51, P1791, DOI 10.1007/s10620-006-9206-1; Diaz M, 2002, INT J BIOL MARKER, V17, P125, DOI 10.1177/172460080201700208; Dudbridge F, 2008, HUM HERED, V66, P87, DOI 10.1159/000119108; Fock KM, 2009, J GASTROEN HEPATOL, V24, P1587, DOI 10.1111/j.1440-1746.2009.05982.x; Gritti I, 2000, PHARMACOL RES, V41, P265, DOI 10.1006/phrs.1999.0586; He CY, 2011, J GASTROEN HEPATOL, V26, P1039, DOI 10.1111/j.1440-1746.2011.06692.x; He CY, 2014, MUTAT RES-REV MUTAT, V759, P14, DOI 10.1016/j.mrrev.2013.09.002; He CY, 2013, CARCINOGENESIS, V34, P1450, DOI 10.1093/carcin/bgt079; KONISHI N, 1995, J CLIN PATHOL, V48, P364, DOI 10.1136/jcp.48.4.364; Li P, 2013, BMC CLIN PATHOL, V13, DOI 10.1186/1472-6890-13-22; Liu HJ, 2003, WORLD J GASTROENTERO, V9, P50, DOI 10.3748/wjg.v9.i1.50; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Massarrat S, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/481607; Ning PF, 2005, WORLD J GASTROENTERO, V11, P2545, DOI 10.3748/wjg.v11.i17.2545; Nugalieva ZZ, 2006, HELICOBACTER, V11, P69, DOI 10.1111/j.1523-5378.2006.00380.x; Rojo JV, 2002, EUR J OBSTET GYN R B, V104, P58, DOI 10.1016/S0301-2115(01)00610-8; Roukos DH, 2009, EXPERT REV MOL DIAGN, V9, P1, DOI 10.1586/14737159.9.1.1; Scorilas A, 1999, CLIN CANCER RES, V5, P1778; Sun Li-Ping, 2009, Ai Zheng, V28, P487; Sun LP, 2009, J CANCER RES CLIN, V135, P1033, DOI 10.1007/s00432-008-0539-3; Truan N, 2001, INT J BIOL MARKER, V16, P31, DOI 10.1177/172460080101600104; Wen SC, 2009, CANCER LETT, V282, P1, DOI 10.1016/j.canlet.2008.11.016; Yasugi S, 2000, Hum Cell, V13, P177	25	10	10	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2014	9	12							e115955	10.1371/journal.pone.0115955	http://dx.doi.org/10.1371/journal.pone.0115955			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UC	25551587	Green Published, gold, Green Submitted			2022-12-27	WOS:000347119100081
J	Hulme, RS; Higginbottom, A; Palmer, J; Partridge, LJ; Monk, PN				Hulme, Rachel S.; Higginbottom, Adrian; Palmer, John; Partridge, Lynda J.; Monk, Peter N.			Distinct Regions of the Large Extracellular Domain of Tetraspanin CD9 Are Involved in the Control of Human Multinucleated Giant Cell Formation	PLOS ONE			English	Article							SPERM-EGG FUSION; STRUCTURAL DOMAINS; CD81 FUNCTION; IDENTIFICATION; PROTEINS; ASSOCIATION; RESIDUES; ADHESION; REQUIRES; BINDING	Multinucleated giant cells, formed by the fusion of monocytes/macrophages, are features of chronic granulomatous inflammation associated with infections or the persistent presence of foreign material. The tetraspanins CD9 and CD81 regulate multinucleated giant cell formation: soluble recombinant proteins corresponding to the large extracellular domain (EC2) of human but not mouse CD9 can inhibit multinucleated giant cell formation, whereas human CD81 EC2 can antagonise this effect. Tetraspanin EC2 are all likely to have a conserved three helix sub-domain and a much less well-conserved or hypervariable sub-domain formed by short helices and interconnecting loops stabilised by two or more disulfide bridges. Using CD9/CD81 EC2 chimeras and point mutants we have mapped the specific regions of the CD9 EC2 involved in multinucleated giant cell formation. These were primarily located in two helices, one in each sub-domain. The cysteine residues involved in the formation of the disulfide bridges in CD9 EC2 were all essential for inhibitory activity but a conserved glycine residue in the tetraspanin-defining 'CCG' motif was not. A tyrosine residue in one of the active regions that is not conserved between human and mouse CD9 EC2, predicted to be solvent-exposed, was found to be only peripherally involved in this activity. We have defined two spatially-distinct sites on the CD9 EC2 that are required for inhibitory activity. Agents that target these sites could have therapeutic applications in diseases in which multinucleated giant cells play a pathogenic role.	[Hulme, Rachel S.; Palmer, John; Partridge, Lynda J.] Univ Sheffield, Dept Mol Biol & Biotechnol, Sheffield S10 2TN, S Yorkshire, England; [Higginbottom, Adrian] Univ Sheffield, Sch Med, Dept Neurosci, Sheffield, S Yorkshire, England; [Monk, Peter N.] Univ Sheffield, Sch Med, Dept Infect & Immun, Sheffield, S Yorkshire, England	University of Sheffield; University of Sheffield; University of Sheffield	Monk, PN (corresponding author), Univ Sheffield, Sch Med, Dept Infect & Immun, Sheffield, S Yorkshire, England.	p.monk@shef.ac.uk	Monk, Peter/C-6155-2008	Monk, Peter/0000-0003-4637-3059	Humane Research Trust; Biotechnology and Biological Sciences Research Council [BB/F016832/1]; British Heart Foundation [PG/98163]	Humane Research Trust; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); British Heart Foundation(British Heart Foundation)	This study was supported by Humane Research Trust PM LJP (http://www.humaneresearch.org.uk), Biotechnology and Biological Sciences Research Council studentship BB/F016832/1 LJP (http://www.bbsrc.ac.uk/home/home.as), British Heart Foundation PG/98163 PM (http://www.bhf.org.uk/#&panel1-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson JM, 2000, CURR OPIN HEMATOL, V7, P40, DOI 10.1097/00062752-200001000-00008; Arduise C, 2008, J IMMUNOL, V181, P7002, DOI 10.4049/jimmunol.181.10.7002; Barreiro O, 2008, J CELL BIOL, V183, P527, DOI 10.1083/jcb.200805076; Burke ML, 2009, PARASITE IMMUNOL, V31, P163, DOI 10.1111/j.1365-3024.2009.01098.x; Charrin S, 2001, J BIOL CHEM, V276, P14329, DOI 10.1074/jbc.M011297200; Charrin S, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2675; Charrin S, 2009, BIOCHEM J, V420, P133, DOI 10.1042/BJ20082422; Cook GA, 2002, BLOOD, V100, P4502, DOI 10.1182/blood.V100.13.4502; Ellerman DA, 2003, MOL BIOL CELL, V14, P5098, DOI 10.1091/mbc.E03-04-0244; Espenel C, 2008, J CELL BIOL, V182, P765, DOI 10.1083/jcb.200803010; Fanaei M, 2011, BIOCHEM SOC T, V39, P524, DOI 10.1042/BST0390524; Gordon-Alonso M, 2006, J IMMUNOL, V177, P5129, DOI 10.4049/jimmunol.177.8.5129; Harris HJ, 2008, J VIROL, V82, P5007, DOI 10.1128/JVI.02286-07; Hassuna N, 2009, BIODRUGS, V23, P341, DOI 10.2165/11315650-000000000-00000; Hemler ME, 2005, NAT REV MOL CELL BIO, V6, P801, DOI 10.1038/nrm1736; Higginbottom A, 2000, J VIROL, V74, P3642, DOI 10.1128/JVI.74.8.3642-3649.2000; Higginbottom A, 2003, BIOCHEM BIOPH RES CO, V311, P208, DOI 10.1016/j.bbrc.2003.09.196; Ho SH, 2006, J VIROL, V80, P6487, DOI 10.1128/JVI.02539-05; Kazarov AR, 2002, J CELL BIOL, V158, P1299, DOI 10.1083/jcb.200204056; Kitadokoro K, 2002, BIOL CHEM, V383, P1447, DOI 10.1515/BC.2002.164; Kitadokoro K, 2001, EMBO J, V20, P12, DOI 10.1093/emboj/20.1.12; Kitadokoro K, 2001, ACTA CRYSTALLOGR D, V57, P156, DOI 10.1107/S0907444900015468; Klinovska K, 2014, INT J MOL SCI, V15, P10652, DOI 10.3390/ijms150610652; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lay G, 2007, J PATHOL, V211, P76, DOI 10.1002/path.2092; Le Naour F, 2006, PROTEOMICS, V6, P6447, DOI 10.1002/pmic.200600282; Min GW, 2006, J CELL BIOL, V173, P975, DOI 10.1083/jcb.200602086; Monk Peter N., 2012, Infectious Disorders - Drug Targets, V12, P4; Nordborg C, 2000, CLIN EXP RHEUMATOL, V18, pS18; Okamoto Hiroyuki, 2002, Nihon Rinsho, V60, P1801; Parthasarathy V, 2009, IMMUNOLOGY, V127, P237, DOI 10.1111/j.1365-2567.2008.02945.x; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Powner D, 2011, BIOCHEM SOC T, V39, P563, DOI 10.1042/BST0390563; Rana S, 2011, BIOCHEM SOC T, V39, P559, DOI 10.1042/BST0390559; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Rubinstein E, 2006, SEMIN CELL DEV BIOL, V17, P254, DOI 10.1016/j.semcdb.2006.02.012; Rubinstein E, 2011, BIOCHEM SOC T, V39, P501, DOI 10.1042/BST0390501; Schafer T, 2010, ALLERGY, V65, P1242, DOI 10.1111/j.1398-9995.2010.02350.x; Seigneuret M, 2006, BIOPHYS J, V90, P212, DOI 10.1529/biophysj.105.069666; Seigneuret M, 2001, J BIOL CHEM, V276, P40055, DOI 10.1074/jbc.M105557200; Shoham T, 2006, MOL CELL BIOL, V26, P1373, DOI 10.1128/MCB.26.4.1373-1385.2006; Symeonides M, 2014, VIRUSES-BASEL, V6, P1078, DOI 10.3390/v6031078; Tachibana I, 1999, J CELL BIOL, V146, P893, DOI 10.1083/jcb.146.4.893; Takeda Y, 2003, J CELL BIOL, V161, P945, DOI 10.1083/jcb.200212031; VANVOORHIS WC, 1982, NEW ENGL J MED, V307, P1593, DOI 10.1056/NEJM198212233072601; Vignery Agnes, 2008, V475, P149, DOI 10.1007/978-1-59745-250-2_9; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Wu C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019112; Yalaoui S, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000010; Yang XWH, 2012, J CELL SCI, V125, P1478, DOI 10.1242/jcs.093963; Zevian S, 2011, J BIOL CHEM, V286, P7496, DOI 10.1074/jbc.M110.173583; Zhu GZ, 2002, DEVELOPMENT, V129, P1995	52	10	11	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2014	9	12							e116289	10.1371/journal.pone.0116289	http://dx.doi.org/10.1371/journal.pone.0116289			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UC	25551757	Green Accepted, gold, Green Published			2022-12-27	WOS:000347119100125
J	Buchwald, UK; Adetifa, IMO; Bottomley, C; Owiafe, PK; Donkor, S; Bojang, AL; Sutherland, JS				Buchwald, Ulrike K.; Adetifa, Ifedayo M. O.; Bottomley, Christian; Owiafe, Patrick K.; Donkor, Simon; Bojang, Adama L.; Sutherland, Jayne S.			Broad Adaptive Immune Responses to M. tuberculosis Antigens Precede TST Conversion in Tuberculosis Exposed Household Contacts in a TB-Endemic Setting	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; INTERFERON-GAMMA; SKIN-TEST; GENE-EXPRESSION; HUMAN CD4; INFECTION; CELLS; ASSAY; MEMORY; CHILDREN	Background: The identification of Mycobacterium-tuberculosis (Mtb) infected individuals remains a challenge due to an insufficient understanding of immune responses detected with the current diagnostic tests for latent tuberculosis i.e. the tuberculin skin test (TST) or IFN-gamma release assays (IGRAs) and an inability to distinguish infection stages with current immunologic assays. Further classification based on markers other than IFN-gamma may help to define markers of early Mtb infection. Methods: We assessed the TST status of Mtb-exposed household contacts at baseline and at 6 months. Contacts were classified into those with initial positive TST (TST+); those with baseline negative TST but TST conversion at 6 months (TST converters, TSTC) and those with persistently negative TST (PTST-). We assessed their short-and long-term immune responses to PPD and ESAT-6/CFP-10 (EC) via IFN-gamma ELISPOT and a multiplex cytokine array in relation to TST status and compared them to those of TB cases to identify immune profiles associated with a spectrum of infection stages. Results: After 1 and 6 days stimulation with EC, 12 cytokines (IFN-gamma, IL-2, IP-10, TNF-alpha, IL-13, IL-17, IL-10, GMCSF, MIP-1 beta, MCP-3, IL-2RA and IL-1A) were not different in TSTC compared to TST+ suggesting that robust adaptive Mtb-specific immune responses precede TST conversion. Stratifying contacts by baseline IFN-gamma ELISPOT to EC in combination with TST results revealed that IP-10 and IL-17 were highest in the group of TST converters with positive baseline ELISPOT, suggesting they might be markers for recent infection. Conclusion: We describe a detailed analysis of Mtb-specific biomarker profiles in exposed household contacts in a TB endemic area that provides insights into the dynamic immune responses to Mtb infection and may help to identify biomarkers for 'at-risk' populations beyond TST and IGRA.	[Buchwald, Ulrike K.; Adetifa, Ifedayo M. O.; Owiafe, Patrick K.; Donkor, Simon; Bojang, Adama L.; Sutherland, Jayne S.] MRC Unit, Banjul, Gambia; [Bottomley, Christian] London Sch Hyg & Trop Med, Med Res Council Trop Epidemiol Grp, London WC1, England	University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine	Buchwald, UK (corresponding author), MRC Unit, Banjul, Gambia.	ubuchwald@som.umaryland.edu; jsutherland@mrc.gm	Buchwald, Ulrike Kirsten/ABE-9030-2020	Sutherland, Jayne/0000-0002-7083-4997; Bottomley, Christian/0000-0002-5241-8412; Kwasi Owiafe, Patrick/0000-0002-4287-3577	Infectious Diseases Society of America (IDSA) Education and Research Foundation (ERF); National Foundation for Infectious Diseases (NFID) Merle A. Sande/Pfizer Fellowship Award in International Infectious Diseases; Bill & Melinda Gates Foundation [6-74]; Medical Research Council Unit, The Gambia; MRC [MC_U190071468, MC_UP_A900_1122] Funding Source: UKRI; Medical Research Council [MC_U190071468, MC_UP_A900_1122, MR/K012126/1] Funding Source: researchfish	Infectious Diseases Society of America (IDSA) Education and Research Foundation (ERF); National Foundation for Infectious Diseases (NFID) Merle A. Sande/Pfizer Fellowship Award in International Infectious Diseases; Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation); Medical Research Council Unit, The Gambia(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	UKB was supported by the 2008 Infectious Diseases Society of America (IDSA) Education and Research Foundation (ERF) and the National Foundation for Infectious Diseases (NFID) Merle A. Sande/Pfizer Fellowship Award in International Infectious Diseases while a fellow in Infectious Diseases at New York University. This project was funded by the Bill & Melinda Gates Foundation (Grand Challenges for Global Health 6-74) and the Medical Research Council Unit, The Gambia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altet-Gomez N, 2011, EUR RESPIR J, V37, P1166, DOI 10.1183/09031936.00022710; Barry CE, 2009, NAT REV MICROBIOL, V7, P845, DOI 10.1038/nrmicro2236; Biselli R, 2009, CLIN MICROBIOL INFEC; Butera O, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-182; Cehovin A, 2007, CLIN VACCINE IMMUNOL, V14, P796, DOI 10.1128/CVI.00093-07; Desvignes L, 2009, IMMUNITY, V31, P974, DOI 10.1016/j.immuni.2009.10.007; Dheda K, 2008, THORAX, V63, P566, DOI 10.1136/thx.2007.092205; Felber A, 2013, TUBERCULOSIS, V93, P647, DOI 10.1016/j.tube.2013.07.006; Gallant CJ, 2010, CHEST, V137, P1071, DOI 10.1378/chest.09-1852; Goldsack L, 2007, TUBERCULOSIS, V87, P465, DOI 10.1016/j.tube.2007.07.001; Goletti D, 2006, J INFECT DIS, V194, P984, DOI 10.1086/507427; Goletti D, 2010, J INFECTION, V61, P133, DOI 10.1016/j.jinf.2010.05.002; Govender L, 2010, VACCINE, V29, P51, DOI 10.1016/j.vaccine.2010.10.022; Hill PC, 2005, CLIN INFECT DIS, V40, P273, DOI 10.1086/427030; Hill PC, 2004, CLIN INFECT DIS, V38, P966, DOI 10.1086/382362; Hill PC, 2007, PLOS MED, V4, P1061, DOI 10.1371/journal.pmed.0040192; Hill PC, 2010, LANCET INFECT DIS, V10, P723, DOI 10.1016/S1473-3099(10)70164-X; Hirsch CS, 1999, J INFECT DIS, V179, P945, DOI 10.1086/314667; Hur YG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079742; Hussain R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007444; Jacobsen M, 2007, J MOL MED, V85, P613, DOI 10.1007/s00109-007-0157-6; Jepson A, 2001, INFECT IMMUN, V69, P3989, DOI 10.1128/IAI.69.6.3989-3994.2001; Lalvani T, 1998, P NATL ACAD SCI USA, V95, P270, DOI 10.1073/pnas.95.1.270; Leyten EMS, 2007, CLIN VACCINE IMMUNOL, V14, P880, DOI 10.1128/CVI.00132-07; Mahan CS, 2012, AM J TROP MED HYG, V86, P690, DOI 10.4269/ajtmh.2012.11-0553; Mancuso JD, 2012, AM J RESP CRIT CARE, V185, P427, DOI 10.1164/rccm.201107-1244OC; Marin ND, 2013, TUBERCULOSIS, V93, P155, DOI 10.1016/j.tube.2012.12.002; Mihret A, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-257; Nunes-Alves C, 2014, NAT REV MICROBIOL, V12, P289, DOI 10.1038/nrmicro3230; Perreau M, 2013, EUR J IMMUNOL, V43, P939, DOI 10.1002/eji.201243090; Petruccioli E, 2013, J INFECTION, V66, P475, DOI 10.1016/j.jinf.2013.02.004; Prezzemolo T, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00180; Ruhwald Morten, 2009, BMC Res Notes, V2, P19, DOI 10.1186/1756-0500-2-19; Salaman MR, 2013, TUBERCULOSIS, V93, P688, DOI 10.1016/j.tube.2013.08.007; Scriba TJ, 2008, J IMMUNOL, V180, P1962, DOI 10.4049/jimmunol.180.3.1962; Sutherland JS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012365; Sutherland JS, 2009, EUR J IMMUNOL, V39, P723, DOI 10.1002/eji.200838693; Tao L, 2013, AM J TROP MED HYG, V89, P169, DOI 10.4269/ajtmh.12-0670; van Brummelen SE, 2010, CLIN VACCINE IMMUNOL, V17, P937, DOI 10.1128/CVI.00005-10; Winstone N, 2009, EUR J IMMUNOL, V39, P975, DOI 10.1002/eji.200839167; Wong HL, 2008, CANCER EPIDEM BIOMAR, V17, P3450, DOI 10.1158/1055-9965.EPI-08-0311	41	7	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2014	9	12							e116268	10.1371/journal.pone.0116268	http://dx.doi.org/10.1371/journal.pone.0116268			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX6YH	25549338	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000347063500071
J	Dalal, A; Pawaskar, A; Das, M; Desai, R; Prabhudesai, P; Chhajed, P; Rajan, S; Reddy, D; Babu, S; Jayalakshmi, TK; Saranchuk, P; Rodrigues, C; Isaakidis, P				Dalal, Alpa; Pawaskar, Akshay; Das, Mrinalini; Desai, Ranjan; Prabhudesai, Pralhad; Chhajed, Prashant; Rajan, Sujeet; Reddy, Deepesh; Babu, Sajit; Jayalakshmi, T. K.; Saranchuk, Peter; Rodrigues, Camilla; Isaakidis, Petros			Resistance Patterns among Multidrug-Resistant Tuberculosis Patients in Greater Metropolitan Mumbai: Trends over Time	PLOS ONE			English	Article							DRUG-RESISTANCE; INDIA	Background While the high burden of multidrug-resistant tuberculosis (MDR-TB) itself is a matter of great concern, the emergence and rise of advanced forms of drug-resistance such as extensively drug-resistant TB (XDR-TB) and extremely drug-resistant TB (XXDR-TB) is more troubling. The aim of this study was to investigate the trends over time of patterns of drug resistance in a sample of MDR-TB patients in greater metropolitan Mumbai, India. Methods This was a retrospective, observational study of drug susceptibility testing (DST) results among MDR-TB patients from eight health care facilities in greater Mumbai between 2005 and 2013. We classified resistance patterns into four categories: MDR-TB, pre-XDR-TB, XDR-TB and XXDR-TB. Results A total of 340 MDR-TB patients were included in the study. Pre-XDR-TB was the most common form of drug-resistant TB observed overall in this Mumbai population at 56.8% compared to 29.4% for MDR-TB. The proportion of patients with MDR-TB was 39.4% in the period 2005-2007 and 27.8% in 2011-2013, while the proportion of those with XDR-TB and XXDR-TB was changed from 6.1% and 0% respectively to 10.6% and 5.6% during the same time period. During the same periods, the proportions of patients with ofloxacin, moxifloxacin and ethionamide resistance significantly increased from 57.6% to 75.3%, from 60.0% to 69.5% and from 24.2% to 52.5% respectively (p<0.05). Discussion The observed trends in TB drug-resistance patterns in Mumbai highlight the need for individualized drug regimens, designed on the basis of DST results involving first- and second-line anti-TB drugs and treatment history of the patient. A drug-resistant TB case-finding strategy based on molecular techniques that identify only rifampicin resistance will lead to initiation of suboptimal treatment regimens for a significant number of patients, which may in turn contribute to amplification of resistance and transmission of strains with increasingly advanced resistance within the community.	[Dalal, Alpa] Jupiter Hosp, Thana, India; [Pawaskar, Akshay] Vasant Vihar, Thana, India; [Das, Mrinalini; Saranchuk, Peter; Isaakidis, Petros] Med Sans Frontieres MSF Doctors Borders, Bombay, Maharashtra, India; [Desai, Ranjan] GTB Hosp, Bombay, Maharashtra, India; [Prabhudesai, Pralhad] Lilavati Hosp, Bombay, Maharashtra, India; [Chhajed, Prashant] Fortis Hosp, Bombay, Maharashtra, India; [Rajan, Sujeet] Bhatia Hosp, Bombay, Maharashtra, India; [Reddy, Deepesh] Observer Res Fdn, Bombay, Maharashtra, India; [Babu, Sajit] LH Hiranandani Hosp, Bombay, Maharashtra, India; [Jayalakshmi, T. K.] Dr DY Patil Hosp, Navi Mumbai, India; [Rodrigues, Camilla] PD Hinduja Natl Hosp & Med Res Ctr, Bombay, Maharashtra, India		Isaakidis, P (corresponding author), Med Sans Frontieres MSF Doctors Borders, Bombay, Maharashtra, India.	msfocb-asia-epidemio@brussels.msf.org		Isaakidis, Petros/0000-0002-7881-1554				Agrawal D, 2009, INT J TUBERC LUNG D, V13, P79; [Anonymous], 2013, TIME MAGAZINE; Bhargava A, 2011, HYPOTHESIS, V9, pe7; Central TB Division, 2012, PROGR MAN DRUG RES T; Cox HS, 2007, CLIN INFECT DIS, V44, P1421, DOI 10.1086/517536; D'souza DTB, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-211; Division Central TB, 2013, RNTCP ANN REP; Gupta Harshita, 2013, Indian J Tuberc, V60, P154; Isaakidis P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110461; James P, 2011, CLIN RESPIR J, V5, P19, DOI 10.1111/j.1752-699X.2009.00184.x; Maurya AK, 2012, J POSTGRAD MED, V58, P185, DOI 10.4103/0022-3859.101379; Nagaraja C, 2012, Indian J Chest Dis Allied Sci, V54, P23; Nagaraja C, 2011, J POSTGRAD MED, V57, P181, DOI 10.4103/0022-3859.85197; Paramasivan CN, 2010, INT J TUBERC LUNG D, V14, P243; Sagar T, 2013, J POSTGRAD MED, V59, P173, DOI 10.4103/0022-3859.118031; Udwadia ZF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012023; Udwadia ZF, 2012, CLIN INFECT DIS, V54, P579, DOI 10.1093/cid/cir889; Uplekar M, 1998, INT J TUBERC LUNG D, V2, P324; World Health Organization, 2011, GUID PROGR MAN DRUG; World Health Organization, 2013, WHOHTMTB201311	20	48	48	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2015	10	1							e0116798	10.1371/journal.pone.0116798	http://dx.doi.org/10.1371/journal.pone.0116798			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ4PR	25606853	Green Published, gold			2022-12-27	WOS:000348205300036
J	Guenard, F; Lamontagne, M; Bosse, Y; Deshaies, Y; Cianflone, K; Kral, JG; Marceau, P; Vohl, MC				Guenard, Frederic; Lamontagne, Maxime; Bosse, Yohan; Deshaies, Yves; Cianflone, Katherine; Kral, John G.; Marceau, Picard; Vohl, Marie-Claude			Influences of Gestational Obesity on Associations between Genotypes and Gene Expression Levels in Offspring following Maternal Gastrointestinal Bypass Surgery for Obesity	PLOS ONE			English	Article							WHITE ADIPOSE-TISSUE; BODY-MASS INDEX; WEIGHT-LOSS; METABOLIC SYNDROME; PRENATAL EXPOSURE; ENZYME EXPRESSION; RISK-FACTORS; METHYLATION; COMPONENTS; VARIANTS	Maternal obesity and excess gestational weight gain with compromised metabolic fitness predispose offspring to lifelong obesity and its comorbidities. We demonstrated that compared to offspring born before maternal gastrointestinal bypass surgery (BMS) those born after (AMS) were less obese, with less cardiometabolic risk reflected in the expression and methylation of diabetes, immune and inflammatory pathway genes. Here we examine relationships between gestational obesity and offspring gene variations on expression levels. Methods Whole-genome genotyping and gene expression analyses in blood of 22 BMS and 23 AMS offspring from 19 mothers were conducted using Illumina HumanOmni-5-Quad and HumanHT-12 v4 Expression BeadChips, respectively. Using PLINK we analyzed interactions between offspring gene variations and maternal surgical status on offspring gene expression levels. Altered biological functions and pathways were identified and visualized using DAVID and Ingenuity Pathway Analysis. Results Significant interactions (p <= 1.22x10(-12)) were found for 525 among the 16,060 expressed transcripts: 1.9% of tested SNPs were involved. Gene function and pathway analysis demonstrated enrichment of transcription and of cellular metabolism functions and overrepresentation of cellular stress and signaling, immune response, inflammation, growth, proliferation and development pathways. Conclusion We suggest that impaired maternal gestational metabolic fitness interacts with offspring gene variations modulating gene expression levels, providing potential mechanisms explaining improved cardiometabolic risk profiles of AMS offspring related to ameliorated maternal lipid and carbohydrate metabolism.	[Guenard, Frederic; Vohl, Marie-Claude] Univ Laval, Inst Nutr & Funct Foods INAF, Quebec City, PQ G1K 7P4, Canada; [Guenard, Frederic; Vohl, Marie-Claude] Univ Laval, Dept Food Sci & Nutr, Quebec City, PQ G1K 7P4, Canada; [Guenard, Frederic; Vohl, Marie-Claude] CHU, Quebec Res Ctr, Quebec City, PQ, Canada; [Lamontagne, Maxime; Bosse, Yohan; Deshaies, Yves; Cianflone, Katherine; Marceau, Picard] Quebec Heart & Lung Inst, Quebec City, PQ, Canada; [Bosse, Yohan] Univ Laval, Dept Mol Med, Quebec City, PQ G1K 7P4, Canada; [Deshaies, Yves; Cianflone, Katherine] Univ Laval, Dept Med, Quebec City, PQ G1K 7P4, Canada; [Kral, John G.] Suny Downstate Med Ctr, Dept Surg, Brooklyn, NY 11203 USA; [Marceau, Picard] Univ Laval, Dept Surg, Quebec City, PQ G1K 7P4, Canada	Laval University; Laval University; Laval University; Quebec Heart & Lung Institute; Laval University; Laval University; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; Laval University	Vohl, MC (corresponding author), Univ Laval, Inst Nutr & Funct Foods INAF, Quebec City, PQ G1K 7P4, Canada.	marie-claude.vohl@fsaa.ulaval.ca	Vohl, Marie-Claude/AAQ-1378-2021	Vohl, Marie-Claude/0000-0002-7017-5848; Lamontagne, Maxime/0000-0001-6674-4983	Canadian Institutes of Health Research [CIHR MOP-209380]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This study was supported by a grant from the Canadian Institutes of Health Research (CIHR MOP-209380; http://www.cihr-irsc.gc.ca). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfaradhi Maria Z., 2011, Frontiers in Genetics, V2, P27, DOI 10.3389/fgene.2011.00027; Arim RG, 2007, CAN J PUBLIC HEALTH, V98, P91, DOI 10.1007/BF03404316; Baik JH, 2013, FRONT NEURAL CIRCUIT, V7, DOI 10.3389/fncir.2013.00152; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Berisha SZ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016729; Blazejczyk M., 2007, FLEXARRAY STAT DATA; Borengasser SJ, 2013, ENDOCRINOLOGY, V154, P4113, DOI 10.1210/en.2012-2255; Botden IPG, 2012, DIABETES CARE, V35, P424, DOI 10.2337/dc11-1203; Brem RB, 2002, SCIENCE, V296, P752, DOI 10.1126/science.1069516; Cannon MV, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090335; Cheung VG, 2009, NAT REV GENET, V10, P595, DOI 10.1038/nrg2630; Clement K, 2004, FASEB J, V18, P1657, DOI 10.1096/fj.04-2204com; Comuzzie AG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051954; Dabelea D, 2008, DIABETES CARE, V31, P1422, DOI 10.2337/dc07-2417; De Rooij SR, 2006, DIABETES CARE, V29, P1052, DOI 10.2337/dc05-1993; DELLORM, 2013, INT J OBES LOND, V37, P914, DOI DOI 10.1038/IJO.2013.35; Dimas AS, 2009, SCIENCE, V325, P1246, DOI 10.1126/science.1174148; Ding J, 2010, AM J HUM GENET, V87, P779, DOI 10.1016/j.ajhg.2010.10.024; Dixon AL, 2007, NAT GENET, V39, P1202, DOI 10.1038/ng2109; Edlow AG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088661; Emilsson V, 2008, NATURE, V452, P423, DOI 10.1038/nature06758; Fu JY, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002431; Gerrits A, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000692; Grundberg E, 2012, NAT GENET, V44, P1084, DOI 10.1038/ng.2394; Guenard F, 2013, P NATL ACAD SCI USA, V110, P11439, DOI 10.1073/pnas.1216959110; Guenard F, 2013, J OBES, V2013, DOI 10.1155/2013/492170; HALES CN, 1992, DIABETOLOGIA, V35, P595, DOI 10.1007/BF00400248; Hao K, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003029; Hochner H, 2012, CIRCULATION, V125, P1381, DOI 10.1161/CIRCULATIONAHA.111.070060; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Kitamoto A, 2013, ENDOCR J, V60, P991, DOI 10.1507/endocrj.EJ13-0100; Kotlarz D, 2012, GASTROENTEROLOGY, V143, P347, DOI 10.1053/j.gastro.2012.04.045; Kral JG, 2004, SURGERY, V135, P48, DOI 10.1016/j.surg.2003.10.003; Kral JG, 2006, PEDIATRICS, V118, pE1644, DOI 10.1542/peds.2006-1379; Laurie CC, 2010, GENET EPIDEMIOL, V34, P591, DOI 10.1002/gepi.20516; Lawlor DA, 2007, AM J EPIDEMIOL, V165, P418, DOI 10.1093/aje/kwk030; Ledue TB, 1998, ANN CLIN BIOCHEM, V35, P745, DOI 10.1177/000456329803500607; Lee W, 2011, DIAGN PATHOL, V6, DOI 10.1186/1746-1596-6-40; Ma J, 2007, ATHEROSCLEROSIS, V191, P63, DOI 10.1016/j.atherosclerosis.2006.05.032; Moran CJ, 2013, INFLAMM BOWEL DIS, V19, P115, DOI 10.1002/ibd.22974; Moschen AR, 2010, GUT, V59, P1259, DOI 10.1136/gut.2010.214577; Murabayashi N, 2013, EUR J OBSTET GYN R B, V169, P39, DOI 10.1016/j.ejogrb.2013.02.003; *NAT CTR HLTH STAT, 2007, NHANES 3 CLIN GROWTH; Nicholas LM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084594; Nicolae DL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000888; O'Shaughnessy PJ, 2013, MOL HUM REPROD, V19, P177, DOI 10.1093/molehr/gas059; O'Shaughnessy PJ, 2011, J CLIN ENDOCR METAB, V96, P2851, DOI 10.1210/jc.2011-1437; Palmer ND, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029202; Park HK, 2013, MOL BIOL REP, V40, P1785, DOI 10.1007/s11033-012-2232-5; Park JJ, 2006, PHYSIOL GENOMICS, V27, P114, DOI 10.1152/physiolgenomics.00045.2006; Paus T, 2012, CEREB CORTEX, V22, P2634, DOI 10.1093/cercor/bhr350; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rudkowska I, 2011, OMICS, V15, P1, DOI 10.1089/omi.2010.0073; Scopinaro N, 2005, DIABETES CARE, V28, P2406, DOI 10.2337/diacare.28.10.2406; Shankar K, 2011, ENDOCRINOLOGY, V152, P4158, DOI 10.1210/en.2010-1078; Sjostrom L, 2004, NEW ENGL J MED, V351, P2683, DOI 10.1056/NEJMoa035622; Smirnov DA, 2009, NATURE, V459, P587, DOI 10.1038/nature07940; Smith J, 2009, J CLIN ENDOCR METAB, V94, P4275, DOI 10.1210/jc.2009-0709; Speliotes EK, 2010, NAT GENET, V42, P937, DOI 10.1038/ng.686; Steck AK, 2011, CLIN CHEM, V57, P176, DOI 10.1373/clinchem.2010.148221; VAN HM, 2009, DIABETES, P58, DOI DOI 10.2337/DB08-1173; Vassy JL, 2012, BEST PRACT RES CL EN, V26, P189, DOI 10.1016/j.beem.2011.09.002; Vohl MC, 2004, OBES RES, V12, P1217, DOI 10.1038/oby.2004.153; Vucetic Z, 2010, ENDOCRINOLOGY, V151, P4756, DOI 10.1210/en.2010-0505; Wang K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018939; Whitaker KL, 2010, AM J CLIN NUTR, V91, P1560, DOI 10.3945/ajcn.2009.28838; Xia QH, 2013, ANN NY ACAD SCI, V1281, P178, DOI 10.1111/nyas.12020; Zarkesh M, 2012, GENET RES, V94, P331, DOI 10.1017/S001667231200050X	69	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2015	10	1							e0117011	10.1371/journal.pone.0117011	http://dx.doi.org/10.1371/journal.pone.0117011			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ4OZ	25603303	Green Published, gold, Green Submitted			2022-12-27	WOS:000348203500041
J	Wang, Q; Fu, AZ; Brenner, S; Kalmus, O; Banda, HT; De Allegri, M				Wang, Qun; Fu, Alex Z.; Brenner, Stephan; Kalmus, Olivier; Banda, Hastings Thomas; De Allegri, Manuela			Out-of-Pocket Expenditure on Chronic Non-Communicable Diseases in Sub-Saharan Africa: The Case of Rural Malawi	PLOS ONE			English	Article							HEALTH-CARE EXPENDITURE; DEVELOPING-COUNTRY; DIABETIC SUBJECTS; ECONOMIC BURDEN; COSTS; INDIA; STRATEGIES; HOUSEHOLDS; MODELS; CANCER	In Sub-Saharan Africa (SSA) the disease burden of chronic non-communicable diseases (CNCDs) is rising considerably. Given weaknesses in existing financial arrangements across SSA, expenditure on CNCDs is often borne directly by patients through out-of-pocket (OOP) payments. This study explored patterns and determinants of OOP expenditure on CNCDs in Malawi. We used data from the first round of a longitudinal household health survey conducted in 2012 on a sample of 1199 households in three rural districts in Malawi. We used a two-part model to analyze determinants of OOP expenditure on CNCDs. 475 respondents reported at least one CNCD. More than 60% of the 298 individuals who reported seeking care incurred OOP expenditure. The amount of OOP expenditure on CNCDs comprised 22% of their monthly per capita household expenditure. The poorer the household, the higher proportion of their monthly per capita household expenditure was spent on CNCDs. Higher severity of disease was significantly associated with an increased likelihood of incurring OOP expenditure. Use of formal care was negatively associated with the possibility of incurring OOP expenditure. The following factors were positively associated with the amount of OOP expenditure: being female, Alomwe and household head, longer duration of disease, CNCDs targeted through active screening programs, higher socio-economic status, household head being literate, using formal care, and fewer household members living with a CNCD within a household. Our study showed that, in spite of a context where care for CNCDs should in principle be available free of charge at point of use, OOP payments impose a considerable financial burden on rural households, especially among the poorest. This suggests the existence of important gaps in financial protection in the current coverage policy.	[Wang, Qun; Brenner, Stephan; Kalmus, Olivier; De Allegri, Manuela] Heidelberg Univ, Fac Med, Inst Publ Hlth, Heidelberg, Germany; [Fu, Alex Z.] Georgetown Univ, Med Ctr, Canc Prevent & Control Program, Washington, DC 20007 USA; [Banda, Hastings Thomas] Res Equ & Community Hlth Trust REACH Trust, Lilongwe, Malawi	Ruprecht Karls University Heidelberg; Georgetown University	Wang, Q (corresponding author), Heidelberg Univ, Fac Med, Inst Publ Hlth, Heidelberg, Germany.	qun.wang@uni-heidelberg.de			German Research Society (Deutsche Forschungsgemeinschaft); DFG-AL [1361/2-1]	German Research Society (Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG)); DFG-AL	This study was supported by a research grant of the German Research Society (Deutsche Forschungsgemeinschaft). The grant number is DFG-AL 1361/2-1. MDA received the funding. The URLs is http://www.dfg.de/en/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abegunde DO, 2008, SOC SCI MED, V66, P2296, DOI 10.1016/j.socscimed.2008.01.041; Abiiro GA, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-234; Acock AC, 2008, MULTIPLE REGRESSION, P243; [Anonymous], 2005, PREV CHRON DIS VIT I; Basu A, 2006, HEALTH ECON, V15, P1091, DOI 10.1002/hec.1099; Basu A, 2009, MED CARE, V47, pS109, DOI 10.1097/MLR.0b013e31819c94a1; Belotti F, 2015, STATA J, V15, P3, DOI 10.1177/1536867X1501500102; Bowie C, 2011, HEALTH RES POLICY SY, V9, DOI 10.1186/1478-4505-9-4; BOX GEP, 1964, J ROY STAT SOC B, V26, P211, DOI 10.1111/j.2517-6161.1964.tb00553.x; Campbell D. T., 1986, NEW DIR PROGRAM EVAL, V31, P67, DOI DOI 10.1002/EV.1434; Chadza E., 2012, Health, V4, P1015, DOI 10.4236/health.2012.411155; Chuma J, 2007, TROP MED INT HEALTH, V12, P673, DOI 10.1111/j.1365-3156.2007.01825.x; Cohen S, 1994, J OFF STAT, V10, P3; Costa-i-Font J, 2008, REVISITING HLTH CARE; Daar AS, 2007, NATURE, V450, P494, DOI 10.1038/450494a; Deb P, 2006, J APPL ECONOMET, V21, P1081, DOI 10.1002/jae.891; Dror DM, 2008, INDIAN J MED RES, V127, P347; Elrayah H, 2005, DIABETES RES CLIN PR, V70, P159, DOI 10.1016/j.diabres.2005.03.034; Elrayah-Eliadarous H, 2010, EXP CLIN ENDOCR DIAB, V118, P220, DOI 10.1055/s-0029-1246216; Finkelstein EA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099572; Fu AZ, 2011, BREAST CANCER RES TR, V130, P235, DOI 10.1007/s10549-011-1541-z; Getzen TE, 2000, J HEALTH ECON, V19, P259, DOI 10.1016/S0167-6296(99)00032-6; Gottret P. E., 2006, HLTH FINANCING REVIS; Goudge J, 2009, TROP MED INT HEALTH, V14, P458, DOI 10.1111/j.1365-3156.2009.02256.x; GROSSMAN M, 1972, J POLIT ECON, V80, P223, DOI 10.1086/259880; Hardin JW., 2007, GEN LINEAR MODELS EX, V2, DOI DOI 10.1016/j.marpol.2012.12.026; Huffman MD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020821; Ibanez-Gonzalez DL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078800; Kankeu HT, 2013, HEALTH RES POLICY SY, V11, DOI 10.1186/1478-4505-11-31; Kirigia JM, 2009, BMC INT HEALTH HUM R, V9, DOI 10.1186/1472-698X-9-6; Maher D, 2010, B WORLD HEALTH ORGAN, V88, P943, DOI 10.2471/BLT.10.077891; Malik AM, 2012, INT J EQUITY HEALTH, V11, DOI 10.1186/1475-9276-11-51; Manning WG, 1998, J HEALTH ECON, V17, P283, DOI 10.1016/S0167-6296(98)00025-3; Matsaganis M, 2009, EUR J HEALTH ECON, V10, P329, DOI 10.1007/s10198-008-0137-y; Ministry of Health Malawi, 2011, MAL HLTH SECT STRAT; Miszkurka M, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-24; Msyamboza KP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020316; Mueller DH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020741; Mwandira RH., 2011, EXAMINING EQUITY OUT; National Statistical Office-NSO/Malawi ICF Macro, 2011, MAL DEM HLTH SURV 20; National Statistics Office of Malawi, 2008, 2008 POP HOUS CENS P; Obi SN, 2008, J OBSTET GYNAECOL, V28, P526, DOI 10.1080/01443610802273507; Okunade AA, 2010, HEALTH ECON, V19, P365, DOI 10.1002/hec.1471; Onwujekwe OE, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-67; Orem JN, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-175; OSBORN CE, 2000, STAT APPL HLTH INFOR; PARK RE, 1966, ECONOMETRICA, V34, P888, DOI 10.2307/1910108; Phillips PP, 2013, SURVEY BASICS GUIDE; Rahman MM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056873; Ramachandran A, 2007, DIABETES CARE, V30, P252, DOI 10.2337/dc06-0144; Sauerborn R, 1996, Health Transit Rev, V6, P131; Schwarz J, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-103; Schwarzkopf L, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-165; Shobhana R, 2000, DIABETES RES CLIN PR, V48, P37, DOI 10.1016/S0168-8227(99)00130-8; Su Tin Tin, 2006, Eur J Health Econ, V7, P199; Suhrcke M., 2006, CHRONIC DIS EC PERSP; Tagoe HA, 2013, GHANA MED J, V46, P54; Trogdon JG, 2008, DIABETES CARE, V31, P2307, DOI 10.2337/dc08-1375; Wang Q, 2015, HEALTH POLICY PLANN, V30, P242, DOI 10.1093/heapol/czu004; WEDDERBURN RWM, 1974, BIOMETRIKA, V61, P439, DOI 10.2307/2334725; WHO, 2011, GLOBAL STATUS REPORT; World Health Organization, 2008, 2008 2013 ACT PLAN G; World Health Organization, 2011, NONCOMMUNICABLE DIS; World Health Organization, 2008, GLOB BURD DIS 2004 U; World Health Organization, 1980, INT CLASS IMP DIS HA; World Health Organization Regional Office for Africa, 2011, UN NCDS TIM ACT IS N; Xu K, 2006, EMPIRICAL MODEL ACCE; YAFFE R, 1978, MED CARE, V16, P641, DOI 10.1097/00005650-197808000-00003; Yardim MS, 2014, HEALTH POLICY PLANN, V29, P177, DOI 10.1093/heapol/czt002; Zere E, 2010, BMC INT HEALTH HUM R, V10, DOI 10.1186/1472-698X-10-27	70	64	67	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2015	10	1							e0116897	10.1371/journal.pone.0116897	http://dx.doi.org/10.1371/journal.pone.0116897			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AZ4OG	25584960	Green Published, Green Submitted, gold			2022-12-27	WOS:000348201300010
J	Bernitt, E; Koh, CG; Gov, N; Dobereiner, HG				Bernitt, Erik; Koh, Cheng Gee; Gov, Nir; Doebereiner, Hans-Guenther			Dynamics of Actin Waves on Patterned Substrates: A Quantitative Analysis of Circular Dorsal Ruffles	PLOS ONE			English	Article							TRAVELING-WAVES; GROWTH-FACTOR; CELLS; MOTILITY; MACROPINOCYTOSIS; OSCILLATIONS; ORGANIZATION; BEHAVIOR; STATES; MODEL	Circular Dorsal Ruffles (CDRs) have been known for decades, but the mechanism that organizes these actin waves remains unclear. In this article we systematically analyze the dynamics of CDRs on fibroblasts with respect to characteristics of current models of actin waves. We studied CDRs on heterogeneously shaped cells and on cells that we forced into disk-like morphology. We show that CDRs exhibit phenomena such as periodic cycles of formation, spiral patterns, and mutual wave annihilations that are in accord with an active medium description of CDRs. On cells of controlled morphologies, CDRs exhibit extremely regular patterns of repeated wave formation and propagation, whereas on random-shaped cells the dynamics seem to be dominated by the limited availability of a reactive species. We show that theoretical models of reaction-diffusion type incorporating conserved species capture partially the behavior we observe in our data.	[Bernitt, Erik; Doebereiner, Hans-Guenther] Univ Bremen, Inst Biophys, D-28359 Bremen, Germany; [Koh, Cheng Gee] Nanyang Technol Univ, Sch Biol Sci, Singapore 639798, Singapore; [Gov, Nir] Weizmann Inst Sci, Dept Chem Phys, IL-76100 Rehovot, Israel	University of Bremen; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Weizmann Institute of Science	Bernitt, E (corresponding author), Univ Bremen, Inst Biophys, D-28359 Bremen, Germany.	ebernitt@uni-bremen.de	Koh, Cheng Gee/A-2215-2011; Döbereiner, Hans-Günther/F-7302-2012; GOV, NIR/K-1415-2012	Koh, Cheng Gee/0000-0003-1905-8010; Döbereiner, Hans-Günther/0000-0003-1691-634X; GOV, NIR/0000-0001-7774-1139	German Research Foundation [DO 699/4-1]	German Research Foundation(German Research Foundation (DFG))	This work was supported by grant DO 699/4-1 of the German Research Foundation (http://www. dfg.de/en/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allard J, 2013, CURR OPIN CELL BIOL, V25, P107, DOI 10.1016/j.ceb.2012.08.012; Argentina M, 2000, J THEOR BIOL, V205, P47, DOI 10.1006/jtbi.2000.2044; Bretschneider T, 2009, BIOPHYS J, V96, P2888, DOI 10.1016/j.bpj.2008.12.3942; Buccione R, 2004, NAT REV MOL CELL BIO, V5, P647, DOI 10.1038/nrm1436; CROSS MC, 1993, REV MOD PHYS, V65, P851, DOI 10.1103/RevModPhys.65.851; Dobereiner HG, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.038102; Doubrovinski K, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.258103; Doubrovinski K, 2008, EPL-EUROPHYS LETT, V83, DOI 10.1209/0295-5075/83/18003; DOWRICK P, 1993, EUR J CELL BIOL, V61, P44; Dreher A, 2014, NEW J PHYS, V16, DOI 10.1088/1367-2630/16/5/055007; Dubin-Thaler BJ, 2004, BIOPHYS J, V86, P1794, DOI 10.1016/S0006-3495(04)74246-0; Edgar AJ, 1997, EUR J CELL BIOL, V73, P132; Gerisch G, 2004, BIOPHYS J, V87, P3493, DOI 10.1529/biophysj.104.047589; Gerisch G, 2012, BIOPHYS J, V103, P1170, DOI [10.1016/j.bpj.2012.08.004, 10.1016/j.bpj.2012.05.00.4]; Gholami A, 2012, NEW J PHYS, V14, DOI 10.1088/1367-2630/14/11/115002; Giannone G, 2007, CELL, V128, P561, DOI 10.1016/j.cell.2006.12.039; Hoon JL, 2012, MOL CELL BIOL, V32, P4246, DOI 10.1128/MCB.00551-12; Itoh T, 2013, J BIOCHEM, V153, P21, DOI 10.1093/jb/mvs138; Julicher F, 2007, PHYS REP, V449, P3, DOI 10.1016/j.physrep.2007.02.018; KEENER JP, 1986, SIAM J APPL MATH, V46, P1039, DOI 10.1137/0146062; Kruse K, 2005, CURR OPIN CELL BIOL, V17, P20, DOI 10.1016/j.ceb.2004.12.007; Marchetti MC, 2013, REV MOD PHYS, V85, DOI 10.1103/RevModPhys.85.1143; Mata MA, 2013, J THEOR BIOL, V334, P149, DOI 10.1016/j.jtbi.2013.06.020; MELLSTROM K, 1983, J MUSCLE RES CELL M, V4, P589, DOI 10.1007/BF00712117; Mercer J, 2009, NAT CELL BIOL, V11, P510, DOI 10.1038/ncb0509-510; Orth JD, 2006, CANCER RES, V66, P11094, DOI 10.1158/0008-5472.CAN-06-3397; Payne LJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108257; Peleg B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018635; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Ryan GL, 2012, BIOPHYS J, V102, P1493, DOI 10.1016/j.bpj.2012.03.005; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Schroth-Diez B, 2009, HFSP J, V3, P412, DOI 10.2976/1.3239407; Singh P, 2011, PROTEOMICS, V11, P2891, DOI 10.1002/pmic.201100044; Taniguchi D, 2013, P NATL ACAD SCI USA, V110, P5016, DOI 10.1073/pnas.1218025110; Thery M, 2009, COLD SPRING HARB PRO, V4, DOI 10.1101/pdb.prot5255; Vasiev BN, 2004, PHYS LETT A, V323, P194, DOI 10.1016/j.physleta.2004.01.068; Weiner OD, 2007, PLOS BIOL, V5, P2053, DOI 10.1371/journal.pbio.0050221; Whitelam S, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.198103; Wrholmes WR, 2012, PHYS BIOL, V9, DOI 10.1088/1478-3975/9/4/046005; Wu M, 2013, P NATL ACAD SCI USA, V110, P1339, DOI 10.1073/pnas.1221538110; Xu CY, 1998, IEEE T IMAGE PROCESS, V7, P359, DOI 10.1109/83.661186; Zeng YK, 2011, BIOPHYS J, V101, P2122, DOI 10.1016/j.bpj.2011.09.047	42	26	26	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2015	10	1							e0115857	10.1371/journal.pone.0115857	http://dx.doi.org/10.1371/journal.pone.0115857			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ4BU	25574668	Green Published, gold			2022-12-27	WOS:000348168100002
J	Schuster, A; Erpenbeck, D; Pisera, A; Hooper, J; Bryce, M; Fromont, J; Worheide, G				Schuster, Astrid; Erpenbeck, Dirk; Pisera, Andrzej; Hooper, John; Bryce, Monika; Fromont, Jane; Woerheide, Gert			Deceptive Desmas: Molecular Phylogenetics Suggests a New Classification and Uncovers Convergent Evolution of Lithistid Demosponges	PLOS ONE			English	Article							PORIFERA DEMOSPONGIAE; MORPHOLOGICAL CHARACTERS; PETROMICA TOPSENT; SPONGES PORIFERA; GENUS; DNA; TETRACTINELLIDA; HALICHONDRIDA; SYSTEMATICS; SEQUENCES	Reconciling the fossil record with molecular phylogenies to enhance the understanding of animal evolution is a challenging task, especially for taxa with a mostly poor fossil record, such as sponges (Porifera). 'Lithistida', a polyphyletic group of recent and fossil sponges, are an exception as they provide the richest fossil record among demosponges. Lithistids, currently encompassing 13 families, 41 genera and >300 recent species, are defined by the common possession of peculiar siliceous spicules (desmas) that characteristically form rigid articulated skeletons. Their phylogenetic relationships are to a large extent unresolved and there has been no (taxonomically) comprehensive analysis to formally reallocate lithistid taxa to their closest relatives. This study, based on the most comprehensive molecular and morphological investigation of 'lithistid' demosponges to date, corroborates some previous weakly-supported hypotheses, and provides novel insights into the evolutionary relationships of the previous 'order Lithistida'. Based on molecular data (partial mtDNA CO1 and 28S rDNA sequences), we show that 8 out of 13 'Lithistida' families belong to the order Astrophorida, whereas Scleritodermidae and Siphonidiidae form a separate monophyletic clade within Tetractinellida. Most lithistid astrophorids are dispersed between different clades of the Astrophorida and we propose to formally reallocate them, respectively. Corallistidae, Theonellidae and Phymatellidae are monophyletic, whereas the families Pleromidae and Scleritodermidae are polyphyletic. Family Desmanthidae is polyphyletic and groups within Halichondriidae - we formally propose a reallocation. The sister group relationship of the family Vetulinidae to Spongillida is confirmed and we propose here for the first time to include Vetulina into a new Order Sphaerocladina. Megascleres and microscleres possibly evolved and/or were lost several times independently in different 'lithistid' taxa, and microscleres might at least be four times more likely lost than megascleres. Desma spicules occasionally may have undergone secondary losses too. Our study provides a framework for further detailed investigations of this important demosponge group.	[Schuster, Astrid; Erpenbeck, Dirk; Woerheide, Gert] Univ Munich, Dept Earth & Environm Sci, D-80333 Munich, Germany; [Schuster, Astrid; Woerheide, Gert] SNSB Bavarian State Collect Palaeontol & Geol, D-80333 Munich, Germany; [Erpenbeck, Dirk; Woerheide, Gert] Univ Munich, GeoBio Ctr LMU, D-80333 Munich, Germany; [Pisera, Andrzej] Polish Acad Sci, Inst Paleobiol, PL-00818 Warsaw, Poland; [Hooper, John; Bryce, Monika] Queensland Museum, South Brisbane, Qld 4101, Australia; [Hooper, John] Griffith Univ, Eskitis Inst Drug Discovery, Nathan, Qld 4111, Australia; [Bryce, Monika; Fromont, Jane] Western Australian Museum, Dept Aquat Zool, Welshpool Dc, WA 6986, Australia	University of Munich; University of Munich; Polish Academy of Sciences; Institute of Paleobiology of the Polish Academy of Sciences; Queensland Museum; Griffith University; Western Australian Museum	Worheide, G (corresponding author), Univ Munich, Dept Earth & Environm Sci, Richard Wagner Str 10, D-80333 Munich, Germany.	woerheide@lmu.de	Pisera, Andrzej/AAX-7259-2020; Pisera, Andrzej/F-4429-2011; Wörheide, Gert/C-1080-2008	Pisera, Andrzej/0000-0001-7112-6063; Wörheide, Gert/0000-0002-6380-7421; Erpenbeck, Dirk/0000-0003-2716-1085; Hooper, John/0000-0003-1722-5954; Schuster, Astrid/0000-0001-8978-3256	PROSALMU; LMUMentoring GeoSciences program	PROSALMU; LMUMentoring GeoSciences program	AS wants to thank PROSALMU for financing the research visit to the Institute of Palaeobiology in Poland, the LMUMentoring GeoSciences program for funding her attendance to the 9th World Sponge Conference and the Sponge Training Workshop in Fremantle and Perth, Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addis JS, 2005, ZOOL SCR, V34, P549, DOI 10.1111/j.1463-6409.2005.00211.x; [Anonymous], 9 WORLD SPONG C FREM, P109; [Anonymous], 1998, P 5 INT SPONG S BRIS, P343; Bergquist P.R., 1978, SPONGES; Borchiellini C, 2004, MOL PHYLOGENET EVOL, V32, P823, DOI 10.1016/j.ympev.2004.02.021; Bowerbank JS, 1869, P ZOOL SOC LOND, V1869, p[66, 323]; Burton M, 1929, FISHERIES B FISHERIE, V2, P1; Cardenas P, 2012, ADV MAR BIOL, V61, P79, DOI 10.1016/B978-0-12-387787-1.00010-6; Cardenas P, 2012, ZOOTAXA, P1; Cardenas P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018318; Cardenas P, 2009, ZOOTAXA, P1; Carvalho FC, 2014, J MAR BIOL ASSOC UK, P1; Chombard C, 1998, SYST BIOL, V47, P351, DOI 10.1080/106351598260761; de Laubenfels M. W., 1936, Papers from the Tortugas Laboratory of the Carnegie Institution of Washington, V30, P1; Dendy A., 1905, REPORT GOVT CEYL S18, V3, P57; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Erpenbeck D, 2007, ZOOTAXA, P107, DOI 10.11646/zootaxa.1668.1.10; Erpenbeck D, 2007, CONTRIB ZOOL, V76, P95, DOI 10.1163/18759866-07602003; Erpenbeck D, 2012, MOL PHYLOGENET EVOL, V63, P809, DOI 10.1016/j.ympev.2012.02.024; Galtier N, 1997, J MOL EVOL, V44, P632, DOI 10.1007/PL00006186; Grant RE, 1861, ZOOLOGY, P1; Gruber Gabriele, 1993, Berliner Geowissenschaftliche Abhandlungen Reihe E Palaeobiologie, V10, P1; Hill MS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0050437; HOOPER J N A, 1989, Memoirs of the Queensland Museum, V27, P437; Huelsenbeck JP, 2004, SYST BIOL, V53, P904, DOI 10.1080/10635150490522629; Ivanova NV, 2006, MOL ECOL NOTES, V6, P998, DOI 10.1111/j.1471-8286.2006.01428.x; Jenner RA, 2004, EVOL DEV, V6, P372, DOI 10.1111/j.1525-142X.2004.04045.x; Kelly Borges M, 1994, MOL MARINE BIOL BIOT, V3, P87; Kelly Michelle, 2000, Zoosystema, V22, P265; Kelly-Borges Michelle, 1994, Molecular Marine Biology and Biotechnology, V3, P87; Le Hoc Lanh Van, 1993, Molecular Phylogenetics and Evolution, V2, P31, DOI 10.1006/mpev.1993.1005; Levi C., 1991, P72; Levi C., 1973, TRAITE ZOOLOGIE P GR, V3, P577; List-Armitage SE, 2002, INVERTEBR SYST, V16, P813, DOI 10.1071/IT00036; Maddison WP, 2011, MESQUITE MODULAR SYS; Maldonado M, 1999, NATURE, V401, P785, DOI 10.1038/44560; Manconi R, 2008, ZOOKEYS, P71, DOI 10.3897/zookeys.4.39; Meyer CP, 2005, EVOLUTION, V59, P113, DOI 10.1111/j.0014-3820.2005.tb00899.x; Morrow CC, 2012, MOL PHYLOGENET EVOL, V62, P174, DOI 10.1016/j.ympev.2011.09.016; Morrow CC, 2013, INTEGR COMP BIOL, V53, P428, DOI 10.1093/icb/ict065; Muricy G, 2001, HYDROBIOLOGIA, V443, P103, DOI 10.1023/A:1017504422239; Nichols SA, 2005, MOL PHYLOGENET EVOL, V34, P81, DOI 10.1016/j.ympev.2004.08.019; Ozdikmen Huseyin, 2009, Munis Entomology & Zoology, V4, P212; Pisera, 2002, SYSTEMA PORIFERA GUI, P380, DOI DOI 10.1007/978-1-4615-0747-5_46; Pisera A., 2002, SYSTEMA PORIFERA GUI, P356; Pisera A., 2002, SYSTEMA PORIFERA GUI, P302; Pisera A, 2002, SYSTEMA PORIFERA GUI, P363; Pisera A., 2002, SYSTEMA PORIFERA GUI, P299, DOI DOI 10.1007/978-1-4615-0747-5_33; Pisera A., 2002, SYSTEMA PORIFERA GUI, V1, P388; Pisera A, 2002, SYSTEMA PORIFERA GUI, P377; Pisera A, 2011, SCI MAR, V75, P17, DOI 10.3989/scsimar.2011.75n1017; Pisera Andrzej, 1999, Memoirs of the Queensland Museum, V44, P463; Redmond NE, 2013, INTEGR COMP BIOL, V53, P388, DOI 10.1093/icb/ict078; Reid R. B. H., 1963, Neues Jahrbuch fuer Geologie und Palaeontologie Monatshefte, V4, P196; Reid REH, 1970, BIOL PORIFERA, P415; Rigby JK, 2004, TREATISE INVERTEBR E; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Sambrook E., 1989, MOL CLONING; Schlacher-Hoenlinger MA, 2005, ZOOSYSTEMA, V27, P649; Schmidt EO, 1870, GRUNDZUGE SPONGIEN F, P1; Schrammen, 1924, MONOGRAPHIEN GEOLOGI, V1, P1; Schrammen A., 1910, PALAEONTOGRAPHICA S, V5, P1; Silvestro D., 2011, ORG DIVERS EVOL, V12, P335, DOI [10.1007/sI3127-011-0056-0, DOI 10.1007/S13127-011-0056-0]; Sollas D, 1885, ANN MAGAZINE NATURAL, V5, P395; Sollas WJ, 1888, REPORT SCI RESULTS V, P1; Stover BC, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-7; Szitenberg A, 2013, MOL PHYLOGENET EVOL, V67, P509, DOI 10.1016/j.ympev.2013.02.018; Thacker RW, 2013, INTEGR COMP BIOL, V53, P373, DOI 10.1093/icb/ict071; TOPSENT E, 1894, ARCH ZOOLOGIE EXPT G, V3, P259; URIZ MJ, 1995, BIOL J LINN SOC, V55, P1; Vacelet J., 1969, Memoires du Museum Nationale d'Histoire Naturelle Paris (Ser A), V59, P145; Van Soest, 2002, SYSTEMA PORIFERA GUI, V1, P921, DOI DOI 10.1007/978-1-4615-0747-5_97; Van Soest R. W, 2014, WORLD PORIFERA DATAB; van Soest R.W.M., 1986, Bulletin Zoologisch Museum Universiteit van Amsterdam, V10, P201; Van Soest Rob W. M., 2000, Zoosystema, V22, P299; VANSOEST RWM, 1988, STUD FAUNA CURACAO, V70, P1; Vargas S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039345; von Lendenfeld R, 1903, TIERREICH, V19, P1; Wilson H. V., 1925, Bulletin United States National Museum, V100, P273; Winder PL, 2011, MAR DRUGS, V9, P2643, DOI 10.3390/md9122643; Worheide G, 2012, ADV MAR BIOL, V61, P1, DOI 10.1016/B978-0-12-387787-1.00007-6; Wright AE, 2010, CURR OPIN BIOTECH, V21, P801, DOI 10.1016/j.copbio.2010.09.012; Xia X, 2001, J HERED, V92, P371, DOI 10.1093/jhered/92.4.371; Xia XH, 2003, MOL PHYLOGENET EVOL, V26, P1, DOI 10.1016/S1055-7903(02)00326-3	84	44	47	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2015	10	1							e116038	10.1371/journal.pone.0116038	http://dx.doi.org/10.1371/journal.pone.0116038			36	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ4BS	25565279	Green Published, Green Submitted, gold			2022-12-27	WOS:000348167900003
J	van Soldt, BJ; Metscher, BD; Poelmann, RE; Vervust, B; Vonk, FJ; Muller, GB; Richardson, MK				van Soldt, Benjamin J.; Metscher, Brian D.; Poelmann, Robert E.; Vervust, Bart; Vonk, Freek J.; Mueller, Gerd B.; Richardson, Michael K.			Heterochrony and Early Left-Right Asymmetry in the Development of the Cardiorespiratory System of Snakes	PLOS ONE			English	Article							EMBRYONIC-DEVELOPMENT; BULBUS CORDIS; PYTHON-SEBAE; LUNG; PULMONARY; MORPHOGENESIS; SERPENTES; TRACHEAL; CLASSIFICATION; MORPHOLOGY	Snake lungs show a remarkable diversity of organ asymmetries. The right lung is always fully developed, while the left lung is either absent, vestigial, or well-developed (but smaller than the right). A 'tracheal lung' is present in some taxa. These asymmetries are reflected in the pulmonary arteries. Lung asymmetry is known to appear at early stages of development in Thamnophis radix and Natrix natrix. Unfortunately, there is no developmental data on snakes with a well-developed or absent left lung. We examine the adult and developmental morphology of the lung and pulmonary arteries in the snakes Python curtus breitensteini, Pantherophis guttata guttata, Elaphe obsoleta spiloides, Calloselasma rhodostoma and Causus rhombeatus using gross dissection, MicroCT scanning and 3D reconstruction. We find that the right and tracheal lung develop similarly in these species. By contrast, the left lung either: (1) fails to develop; (2) elongates more slowly and aborts early without (2a) or with (2b) subsequent development of faveoli; (3) or develops normally. A right pulmonary artery always develops, but the left develops only if the left lung develops. No pulmonary artery develops in relation to the tracheal lung. We conclude that heterochrony in lung bud development contributes to lung asymmetry in several snake taxa. Secondly, the development of the pulmonary arteries is asymmetric at early stages, possibly because the splanchnic plexus fails to develop when the left lung is reduced. Finally, some changes in the topography of the pulmonary arteries are consequent on ontogenetic displacement of the heart down the body. Our findings show that the left-right asymmetry in the cardiorespiratory system of snakes is expressed early in development and may become phenotypically expressed through heterochronic shifts in growth, and changes in axial relations of organs and vessels. We propose a step-wise model for reduction of the left lung during snake evolution.	[van Soldt, Benjamin J.; Vonk, Freek J.; Richardson, Michael K.] Leiden Univ, Inst Biol, Leiden, Netherlands; [Metscher, Brian D.; Mueller, Gerd B.] Univ Vienna, Dept Theoret Biol, Vienna, Austria; [Poelmann, Robert E.] Leiden Univ, Med Ctr, Dept Anat & Embryol, Leiden, Netherlands; [Vervust, Bart] Univ Antwerp, Dept Biol, B-2020 Antwerp, Belgium; [Vonk, Freek J.] NCB Nat, Leiden, Netherlands	Leiden University; Leiden University - Excl LUMC; University of Vienna; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Antwerp	Richardson, MK (corresponding author), Leiden Univ, Inst Biol, Leiden, Netherlands.	m.k.richardson@biology.leidenuniv.nl	Metscher, Brian/I-1238-2019	Metscher, Brian/0000-0002-6514-4406; van Soldt, Benjamin/0000-0002-1670-6193	Leiden University Fund; Royal Dutch Zoological Society; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007088] Funding Source: NIH RePORTER	Leiden University Fund; Royal Dutch Zoological Society; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors were supported by the Leiden University Fund (LUF: http://www.luf.nl) and the Royal Dutch Zoological Society (KNDV: http:// www.kndv.nl) in their trip to Vienna to acquire data by MicroCT scanning. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson-Berry A, 2005, DEV DYNAM, V233, P145, DOI 10.1002/dvdy.20296; Arora R, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002866; Atwood W.H., 1918, T WISC ACAD SCI, V19, P531; Atwood WH, 1916, WASH U STUDIES, V4, P3; Bellusci S, 1997, DEVELOPMENT, V124, P53; Boback SM, 2012, ZOOLOGY, V115, P38, DOI 10.1016/j.zool.2011.09.001; Boughner JC, 2007, ZOOLOGY, V110, P212, DOI 10.1016/j.zool.2007.01.005; Brongersma L. D., 1949, Bijdragen tot de Dierkunde Leiden 1949, V28, P57; Brongersma L. D., 1957, Proceedings Nederlandse Akademie Amsterdam, V60C, P299; Brongersma L. D., 1951, Nederlands Tijdschrift voor Geneeskunde, V95, P2490; Brongersma L. D., 1960, Verslagen van de Gewone Vergadering Akademie Amsterdam, V69, P125; Brongersma L. D., 1952, Proceedings Akad Sci Amsterdam, V55C, P62; Brongersma L. D., 1952, Archives Neerlandaises de Zoologie, V9, P561; Brongersma L. D., 1957, Proceedings Nederlandse Akademie Amsterdam, V60C, P451; Brongersma L. D., 1951, Zoologische Mededeelingen Leiden, V31, P107; Brongersma LD, 1957, P K NED AKAD C BIOL, V60, P309; Brongersma LD, 1951, ZOOL VERH-LEIDEN, V14, P3; Brongersma LD, 1951, ARCH NEERLANDAISES Z, V10, P514; Buchtova M, 2007, ZOOLOGY, V110, P231, DOI 10.1016/j.zool.2007.01.006; Cardoso WV, 2001, ANNU REV PHYSIOL, V63, P471, DOI 10.1146/annurev.physiol.63.1.471; Cardoso WV, 2006, DEVELOPMENT, V133, P1611, DOI 10.1242/dev.02310; de Jong IML, 2009, EVOL DEV, V11, P625, DOI 10.1111/j.1525-142X.2009.00370.x; De Silva PHDH, 1953, SPOLIA ZEYLANICA, V27, P47; deMello DE, 1997, AM J RESP CELL MOL, V16, P568, DOI 10.1165/ajrcmb.16.5.9160839; DERUITER MC, 1993, CIRCULATION, V87, P1306, DOI 10.1161/01.CIR.87.4.1306; Fisher KA, 2006, CURR TOP DEV BIOL, V74, P117, DOI 10.1016/S0070-2153(06)74004-2; Goodrich E.S., 1958, STUDIES STRUCTURE DE; Gould S. J., 1977, ONTOGENY PHYLOGENY; Greil A., 1903, Morphologisches Jahrbuch, Vxxxi, P123; Hacohen N, 1998, CELL, V92, P253, DOI 10.1016/S0092-8674(00)80919-8; Hall SM, 2000, AM J RESP CELL MOL, V23, P194, DOI 10.1165/ajrcmb.23.2.3975; Harrison BM, 1929, ANAT REC, V44, P101, DOI 10.1002/ar.1090440204; HART NH, 1969, J MORPHOL, V129, P369, DOI 10.1002/jmor.1051290308; HART NH, 1968, J MORPHOL, V125, P1, DOI 10.1002/jmor.1051250102; Hislop A A, 2000, Paediatr Respir Rev, V1, P321, DOI 10.1053/prrv.2000.0071; Hislop AA, 2002, J ANAT, V201, P325, DOI 10.1046/j.1469-7580.2002.00097.x; Hislop Alison, 2005, Paediatr Respir Rev, V6, P35, DOI 10.1016/j.prrv.2004.11.009; Jackson K, 2002, ZOOLOGY, V105, P203, DOI 10.1078/0944-2006-00077; Jensen B, 2010, ANAT SCI INT, V85, P194, DOI 10.1007/s12565-010-0079-1; Kardong K.V., 1972, Gegenbaurs Morphologisches Jahrbuch, V117, P285; KASHYAP H V, 1973, Journal of the University of Bombay, V42, P34; Khannoon ER, 2014, ACTA ZOOL-STOCKHOLM, V95, P472, DOI 10.1111/azo.12043; KLAMBT C, 1992, GENE DEV, V6, P1668, DOI 10.1101/gad.6.9.1668; Klingenberg CP, 1998, BIOL REV, V73, P79, DOI 10.1017/S000632319800512X; LANGER A, 1894, MORPHOL JB, V21, P40; Lillywhite HB, 2012, COMP BIOCHEM PHYS A, V161, P230, DOI 10.1016/j.cbpa.2011.10.029; Lin CR, 1999, NATURE, V401, P279, DOI 10.1038/45803; Mabee PM, 2000, EVOLUTION, V54, P2091; Maina JN, 2012, FRONT ZOOL, V9, DOI 10.1186/1742-9994-9-16; McDonald H. S., 1959, Herpetologica, V15, P193; Metscher Brian D, 2011, Cold Spring Harb Protoc, V2011, P1462, DOI 10.1101/pdb.prot067033; Metscher BD, 2009, DEV DYNAM, V238, P632, DOI 10.1002/dvdy.21857; Metzger RJ, 1999, SCIENCE, V284, P1635, DOI 10.1126/science.284.5420.1635; Metzger RJ, 2008, NATURE, V453, P745, DOI 10.1038/nature07005; Molin DGM, 2002, CARDIOVASC RES, V56, P312, DOI 10.1016/S0008-6363(02)00542-4; O'Donoghue CH, 1912, P ZOOL SOC LOND, V1912, P612; Perry Steven F., 1998, V19, P1; Pyron RA, 2011, MOL PHYLOGENET EVOL, V58, P329, DOI 10.1016/j.ympev.2010.11.006; Rawlins EL, 2011, DEV DYNAM, V240, P463, DOI 10.1002/dvdy.22482; Ray HC, 1934, J MORPHOL, V56, P533, DOI 10.1002/jmor.1050560306; Richardson MK, 1995, DEV BIOL, V172, P412, DOI 10.1006/dbio.1995.8041; ROBB JOAN, 1960, AUSTRALIAN JOUR ZOOL, V8, P181, DOI 10.1071/ZO9600181; Sadler TW, 2012, RESP SYSTEM LANGMANS, P384; SALASSA JR, 1977, ANN THORAC SURG, V24, P100, DOI 10.1016/S0003-4975(10)63716-2; Schachtner SK, 2000, AM J RESP CELL MOL, V22, P157, DOI 10.1165/ajrcmb.22.2.3766; Schmalhausen J. J., 1905, Anatomischer Anzeiger, Vxxvii, P511; Schulz-Mirbach T, 2013, FRONT ZOOL, V10, DOI 10.1186/1742-9994-10-63; SHANER RF, 1962, ANAT RECORD, V142, P519, DOI 10.1002/ar.1091420409; Smith KK, 2003, INT J DEV BIOL, V47, P613; Starck JM, 2009, J MORPHOL, V270, P673, DOI 10.1002/jmor.10706; Sutherland D, 1996, CELL, V87, P1091, DOI 10.1016/S0092-8674(00)81803-6; TENHAVEOPBROEK AAW, 1991, EXP LUNG RES, V17, P111, DOI 10.3109/01902149109064406; VANBOURGONDIEN TM, 1969, AM MIDL NAT, V81, P107; Vidal N, 2002, CR BIOL, V325, P977, DOI 10.1016/S1631-0691(02)01510-X; Vidal N, 2002, J TOXICOL-TOXIN REV, V21, P21, DOI 10.1081/TXR-120004740; Vidal N, 2007, CR BIOL, V330, P182, DOI 10.1016/j.crvi.2006.10.001; Wallach Van, 1998, V19, P93; Wang Tobias, 1998, V19, P297; Zaher Hussam, 2009, Pap. Avulsos Zool., V49, P115; Zehr D. R., 1962, Copeia, V1962, P322, DOI 10.2307/1440898	80	13	14	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2015	10	1							e116416	10.1371/journal.pone.0116416	http://dx.doi.org/10.1371/journal.pone.0116416			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ3XP	25555231	Green Submitted, Green Published, gold			2022-12-27	WOS:000348157400003
J	Capel, E; Parera, M; Martinez, MA				Capel, Elena; Parera, Mariona; Angel Martinez, Miguel			Epistasis as a Determinant of the HIV-1 Protease's Robustness to Mutation	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; DELETERIOUS MUTATIONS; REVERSE-TRANSCRIPTASE; REPLICATION CAPACITY; CATALYTIC EFFICIENCY; GENETIC ROBUSTNESS; FITNESS LANDSCAPE; IN-VITRO; EVOLUTION; PROTEIN	The robustness of phenotypes to mutation is critical to protein evolution; robustness may be an adaptive trait if it promotes evolution. We hypothesised that native proteins subjected to natural selection in vivo should be more robust than proteins generated in vitro in the absence of natural selection. We compared the mutational robustness of two human immunodeficiency virus type 1 (HIV-1) proteases with comparable catalytic efficiencies, one isolated from an infected individual and the second generated in vitro via random mutagenesis. Single mutations in the protease (82 and 60 in the wild-type and mutant backgrounds, respectively) were randomly generated in vitro and the catalytic efficiency of each mutant was determined. No differences were observed between these two protease variants when lethal, neutral, and deleterious mutations were compared (P=0.8025, chi-squared test). Similarly, average catalytic efficiency (-72.6% and -64.5%, respectively) did not significantly differ between protease mutant libraries (P=0.3414, Mann Whitney test). Overall, the two parental proteins displayed similar mutational robustness. Importantly, strong and widespread epistatic interactions were observed when the effect of the same mutation was compared in both proteases, suggesting that epistasis can be a key determinant of the robustness displayed by the in vitro generated protease.	[Angel Martinez, Miguel] Hosp Badalona Germans Trias & Pujol, Fundacio IrsiCaixa, Badalona, Spain; Univ Autonoma Barcelona, E-08193 Barcelona, Spain	Hospital Germans Trias i Pujol; Institut de Recerca de la Sida - IrsiCaixa; Autonomous University of Barcelona	Martinez, MA (corresponding author), Hosp Badalona Germans Trias & Pujol, Fundacio IrsiCaixa, Badalona, Spain.	mmartinez@irsicaixa.es	Martinez, Miguel Angel/K-6435-2014	Martinez, Miguel Angel/0000-0002-6681-4950; Parera Sallent, Mariona/0000-0002-0756-8307; Capel Malo, Elena/0000-0002-6041-6724	Spanish Ministry of Economy and Competitiveness [SAF2013-41421-R]; Fundacion para la Investigacion y la prevencion del SIDA en Espana [FIPSE 360766/09]	Spanish Ministry of Economy and Competitiveness(Spanish Government); Fundacion para la Investigacion y la prevencion del SIDA en Espana	This study was supported by grants from the Spanish Ministry of Economy and Competitiveness (SAF2013-41421-R) and from Fundacion para la Investigacion y la prevencion del SIDA en Espana (FIPSE 360766/09). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aharoni A, 2005, NAT GENET, V37, P73, DOI 10.1038/ng1482; Bershtein S, 2006, NATURE, V444, P929, DOI 10.1038/nature05385; Bloom JD, 2006, P NATL ACAD SCI USA, V103, P5869, DOI 10.1073/pnas.0510098103; Bloom JD, 2005, P NATL ACAD SCI USA, V102, P606, DOI 10.1073/pnas.0406744102; Bloom JD, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100119; Bonhoeffer S, 2004, SCIENCE, V306, P1547, DOI 10.1126/science.1101786; Cabana M, 2002, VIROLOGY, V300, P71, DOI 10.1006/viro.2002.1520; Capel E, 2013, VIROLOGY, V444, P274, DOI 10.1016/j.virol.2013.06.023; Capel E, 2012, J GEN VIROL, V93, P2625, DOI 10.1099/vir.0.045492-0; Ceccherini-Silberstein F, 2004, AIDS, V18, pF11, DOI 10.1097/01.aids.0000131394.76221.02; CHAO SF, 1995, NUCLEIC ACIDS RES, V23, P803, DOI 10.1093/nar/23.5.803; de Visser JAGM, 2011, P ROY SOC B-BIOL SCI, V278, P3617, DOI 10.1098/rspb.2011.1537; de Visser JAGM, 2003, EVOLUTION, V57, P1959, DOI 10.1554/02-750R; Dean AM, 2007, NAT REV GENET, V8, P675, DOI 10.1038/nrg2160; Draghi JA, 2010, NATURE, V463, P353, DOI 10.1038/nature08694; Elena SF, 2006, EMBO REP, V7, P168, DOI 10.1038/sj.embor.7400636; Fernandez G, 2007, J VIROL, V81, P2485, DOI 10.1128/JVI.01594-06; Gervaix A, 1997, P NATL ACAD SCI USA, V94, P4653, DOI 10.1073/pnas.94.9.4653; Guo HH, 2004, P NATL ACAD SCI USA, V101, P9205, DOI 10.1073/pnas.0403255101; Hinkley T, 2011, NAT GENET, V43, P487, DOI 10.1038/ng.795; Johnson Victoria A, 2011, Top Antivir Med, V19, P156; KAWASHIMA H, 1992, PROTEIN ENG, V5, P171, DOI 10.1093/protein/5.2.171; Kouyos RD, 2007, TRENDS ECOL EVOL, V22, P308, DOI 10.1016/j.tree.2007.02.014; Lauring AS, 2013, NAT REV MICROBIOL, V11, P327, DOI 10.1038/nrmicro3003; LOEB DD, 1989, NATURE, V340, P397, DOI 10.1038/340397a0; MARKIEWICZ P, 1994, J MOL BIOL, V240, P421, DOI 10.1006/jmbi.1994.1458; Martinez MA, 2000, ANTIMICROB AGENTS CH, V44, P1132, DOI 10.1128/AAC.44.5.1132-1139.2000; Martinez MA, 1996, EMBO J, V15, P1203, DOI 10.1002/j.1460-2075.1996.tb00461.x; Mas A, 2010, J MOL BIOL, V397, P865, DOI 10.1016/j.jmb.2010.02.005; MASCHERA B, 1995, J VIROL, V69, P5431, DOI 10.1128/JVI.69.9.5431-5436.1995; Pannecouque C, 2008, NAT PROTOC, V3, P427, DOI 10.1038/nprot.2007.517; Parera M, 2007, MOL BIOL EVOL, V24, P382, DOI 10.1093/molbev/msl168; Parera M, 2014, MOL BIOL EVOL, V31, P1546, DOI 10.1093/molbev/msu113; Parera M, 2009, J MOL BIOL, V392, P243, DOI 10.1016/j.jmb.2009.07.015; Payne JL, 2014, SCIENCE, V343, P875, DOI 10.1126/science.1249046; Poelwijk FJ, 2007, NATURE, V445, P383, DOI 10.1038/nature05451; RATNER L, 1987, AIDS RES HUM RETROV, V3, P57, DOI 10.1089/aid.1987.3.57; RENNELL D, 1991, J MOL BIOL, V222, P67, DOI 10.1016/0022-2836(91)90738-R; Rihn SJ, 2014, J VIROL; Rihn SJ, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003461; Shao W, 1997, P NATL ACAD SCI USA, V94, P2243, DOI 10.1073/pnas.94.6.2243; Sices HJ, 1998, P NATL ACAD SCI USA, V95, P2828, DOI 10.1073/pnas.95.6.2828; Szendro IG, 2013, J STAT MECH-THEORY E, VP01; Vartanian JP, 1996, NUCLEIC ACIDS RES, V24, P2627, DOI 10.1093/nar/24.14.2627; Wagner A, 2005, FEBS LETT, V579, P1772, DOI 10.1016/j.febslet.2005.01.063; Weinreich DM, 2005, EVOLUTION, V59, P1165; Yasugi T, 1997, J VIROL, V71, P5942, DOI 10.1128/JVI.71.8.5942-5951.1997	47	1	1	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2014	9	12							e116301	10.1371/journal.pone.0116301	http://dx.doi.org/10.1371/journal.pone.0116301			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UC	25551558	Green Published, gold, Green Submitted			2022-12-27	WOS:000347119100129
J	Cheng, JS; Craft, R; Yu, GQ; Ho, K; Wang, X; Mohan, G; Mangnitsky, S; Ponnusamy, R; Mucke, L				Cheng, Jason S.; Craft, Ryan; Yu, Gui-Qiu; Ho, Kaitlyn; Wang, Xin; Mohan, Geetha; Mangnitsky, Sergey; Ponnusamy, Ravikumar; Mucke, Lennart			Tau Reduction Diminishes Spatial Learning and Memory Deficits after Mild Repetitive Traumatic Brain Injury in Mice	PLOS ONE			English	Article							CONTROLLED CORTICAL IMPACT; ALZHEIMERS-DISEASE; MOUSE MODELS; NETWORK	Objective: Because reduction of the microtubule-associated protein Tau has beneficial effects in mouse models of Alzheimer's disease and epilepsy, we wanted to determine whether this strategy can also improve the outcome of mild traumatic brain injury (TBI). Methods: We adapted a mild frontal impact model of TBI for wildtype C57Bl/6J mice and characterized the behavioral deficits it causes in these animals. The Barnes maze, Y maze, contextual and cued fear conditioning, elevated plus maze, open field, balance beam, and forced swim test were used to assess different behavioral functions. Magnetic resonance imaging (MRI, 7 Tesla) and histological analysis of brain sections were used to look for neuropathological alterations. We also compared the functional effects of this TBI model and of controlled cortical impact in mice with two, one or no Tau alleles. Results: Repeated (2-hit), but not single (1-hit), mild frontal impact impaired spatial learning and memory in wildtype mice as determined by testing of mice in the Barnes maze one month after the injury. Locomotor activity, anxiety, depression and fear related behaviors did not differ between injured and sham-injured mice. MRI imaging did not reveal focal injury or mass lesions shortly after the injury. Complete ablation or partial reduction of tau prevented deficits in spatial learning and memory after repeated mild frontal impact. Complete tau ablation also showed a trend towards protection after a single controlled cortical impact. Complete or partial reduction of tau also reduced the level of axonopathy in the corpus callosum after repeated mild frontal impact. Interpretation: Tau promotes or enables the development of learning and memory deficits and of axonopathy after mild TBI, and tau reduction counteracts these adverse effects.	[Cheng, Jason S.; Craft, Ryan; Yu, Gui-Qiu; Ho, Kaitlyn; Wang, Xin; Ponnusamy, Ravikumar; Mucke, Lennart] Gladstone Inst Neurol Dis, San Francisco, CA 94158 USA; [Cheng, Jason S.] Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA 94143 USA; [Mucke, Lennart] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA; [Mohan, Geetha; Mangnitsky, Sergey] Univ Calif San Francisco, Dept Radiol & Biomed Imaging, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Mucke, L (corresponding author), Gladstone Inst Neurol Dis, San Francisco, CA 94158 USA.	lmucke@gladstone.ucsf.edu		Mohan, Geetha/0000-0002-4192-5785	National Institute of Neurological Disorders and Stroke (NINDS) of the National Institutes of Health (NIH) [NS041787, NS065780]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS065780, R01NS041787] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke (NINDS) of the National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	LM received grants NS041787 and NS065780 from the National Institute of Neurological Disorders and Stroke (NINDS) of the National Institutes of Health (NIH). http://www.ninds.nih.gov/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adelson PD, 2001, J NEUROTRAUM, V18, P967, DOI 10.1089/08977150152693674; Andrews-Zwilling Y, 2010, J NEUROSCI, V30, P13707, DOI 10.1523/JNEUROSCI.4040-10.2010; Bazarian JJ, 2009, J HEAD TRAUMA REHAB, V24, P439, DOI 10.1097/HTR.0b013e3181c15600; Cornelius C, 2013, ANTIOXID REDOX SIGN, V19, P836, DOI 10.1089/ars.2012.4981; Crawley J. N., 2007, WHATS WRONG MY MOUSE; Dawson HN, 2001, J CELL SCI, V114, P1179; DeKosky ST, 2010, NEW ENGL J MED, V363, P1293, DOI 10.1056/NEJMp1007051; Devos SL, 2013, J NEUROSCI, V33, P12887, DOI 10.1523/JNEUROSCI.2107-13.2013; Donovan V, 2014, J CEREBR BLOOD F MET, V34, P715, DOI 10.1038/jcbfm.2014.6; Durazzo TC, 2013, J NEUROTRAUM, V30, P1013, DOI 10.1089/neu.2012.2676; Freire MAM, 2012, W INDIAN MED J, V61, P751; Gavett BE, 2010, ALZHEIMERS RES THER, V2, DOI 10.1186/alzrt42; Gheyara AL, 2014, ANN NEUROL, V76, P443, DOI 10.1002/ana.24230; Holth JK, 2013, J NEUROSCI, V33, P1651, DOI 10.1523/JNEUROSCI.3191-12.2013; Hylin MJ, 2013, J NEUROTRAUM, V30, P716, DOI 10.1089/neu.2012.2717; Ittner LM, 2010, CELL, V142, P387, DOI 10.1016/j.cell.2010.06.036; Johnson VE, 2010, NAT REV NEUROSCI, V11, P361, DOI 10.1038/nrn2808; Kilbourne M, 2009, J NEUROTRAUM, V26, P2233, DOI 10.1089/neu.2009.0968; Kiraly MA, 2007, THESCIENTIFICWORLDJO, V7, P1768, DOI 10.1100/tsw.2007.269; Krainin BM, 2011, J SPEC OPER MED, V11, P38; Lei P, 2012, NAT MED, V18, P291, DOI 10.1038/nm.2613; Li Z, 2014, NEUROBIOL AGING; Lighthall JW, 1988, J NEUROTRAUM, V5, P1, DOI 10.1089/neu.1988.5.1; Luethcke CA, 2011, J INT NEUROPSYCH SOC, V17, P36, DOI 10.1017/S1355617710001207; Mauri M, 2006, FUNCT NEUROL, V21, P223; Morris M, 2013, NEUROBIOL AGING, V34, P1523, DOI 10.1016/j.neurobiolaging.2012.12.003; Morris M, 2011, NEURON, V70, P410, DOI 10.1016/j.neuron.2011.04.009; Mouzon BC, 2014, ANN NEUROL, V75, P241, DOI 10.1002/ana.24064; PALMER AM, 1993, J NEUROCHEM, V61, P2015, DOI 10.1111/j.1471-4159.1993.tb07437.x; Palop JJ, 2007, NEURON, V55, P697, DOI 10.1016/j.neuron.2007.07.025; Pape TLB, 2013, PM&R, V5, P856, DOI 10.1016/j.pmrj.2013.06.007; Petraglia AL, 2014, J NEUROTRAUMA; Roberson ED, 2007, SCIENCE, V316, P750, DOI 10.1126/science.1141736; Roberson ED, 2011, J NEUROSCI, V31, P700, DOI 10.1523/JNEUROSCI.4152-10.2011; Sanchez PE, 2012, P NATL ACAD SCI USA, V109, pE2895, DOI 10.1073/pnas.1121081109; Sanders MJ, 2005, NEUROBIOL LEARN MEM, V84, P33, DOI 10.1016/j.nlm.2005.03.001; Turner RC, 2013, FRONT NEUROL, V3, DOI 10.3389/fneur.2012.00186; Ullmann J.F., 2013, BRAIN STRUCT FUNCT; Vossel KA, 2010, SCIENCE, V330, P198, DOI 10.1126/science.1194653; Woodcock T, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00018; Yi JH, 2006, NEUROCHEM INT, V48, P394, DOI 10.1016/j.neuint.2005.12.001; Zempel H, 2013, EMBO J, V32, P2920, DOI 10.1038/emboj.2013.207	42	68	69	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2014	9	12							e115765	10.1371/journal.pone.0115765	http://dx.doi.org/10.1371/journal.pone.0115765			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UC	25551452	Green Published, gold, Green Submitted			2022-12-27	WOS:000347119100059
J	Martin, LJ; Xu, BY; Yasui, Y				Martin, Leah J.; Xu, Biying; Yasui, Yutaka			Improving Google Flu Trends Estimates for the United States through Transformation	PLOS ONE			English	Article								Google Flu Trends (GFT) uses Internet search queries in an effort to provide early warning of increases in influenza-like illness (ILI). In the United States, GFT estimates the percentage of physician visits related to ILI (%ILINet) reported by the Centers for Disease Control and Prevention (CDC). However, during the 2012-13 influenza season, GFT overestimated %ILINet by an appreciable amount and estimated the peak in incidence three weeks late. Using data from 2010-14, we investigated the relationship between GFT estimates (%GFT) and %ILINet. Based on the relationship between the relative change in %GFT and the relative change in %ILINet, we transformed %GFT estimates to better correspond with %ILINet values. In 2010-13, our transformed %GFT estimates were within +/- 10% of %ILINet values for 17 of the 29 weeks that %ILINet was above the seasonal baseline value determined by the CDC; in contrast, the original %GFT estimates were within +/- 10% of %ILINet values for only two of these 29 weeks. Relative to the %ILINet peak in 2012-13, the peak in our transformed %GFT estimates was 2% lower and one week later, whereas the peak in the original %GFT estimates was 74% higher and three weeks later. The same transformation improved %GFT estimates using the recalibrated 2013 GFT model in early 2013-14. Our transformed %GFT estimates can be calculated approximately one week before %ILINet values are reported by the CDC and the transformation equation was stable over the time period investigated (2010-13). We anticipate our results will facilitate future use of GFT.	[Martin, Leah J.; Xu, Biying; Yasui, Yutaka] Univ Alberta, Sch Publ Hlth, Edmonton, AB, Canada; [Xu, Biying] Zhejiang Univ, Hangzhou 310003, Zhejiang, Peoples R China	University of Alberta; Zhejiang University	Martin, LJ (corresponding author), Univ Alberta, Sch Publ Hlth, Edmonton, AB, Canada.	leah.martin@ualberta.ca; yyasui@ualberta.ca	Yasui, Yutaka/E-2564-2015	Yasui, Yutaka/0000-0002-7717-8638	Alberta Innovates-Health Solutions Postdoctoral Fellowship; Canada Research Chair Program; Alberta Innovates-Technology Futures (AITF) Alberta Innovates Centre for Machine Learning (AICML); China Scholarship Council	Alberta Innovates-Health Solutions Postdoctoral Fellowship; Canada Research Chair Program(Canada Research Chairs); Alberta Innovates-Technology Futures (AITF) Alberta Innovates Centre for Machine Learning (AICML); China Scholarship Council(China Scholarship Council)	Dr. LJ Martin is supported by an Alberta Innovates-Health Solutions Postdoctoral Fellowship. Dr. Y Yasui is supported by the Canada Research Chair Program. Both Drs. Martin and Yasui are supported by the Alberta Innovates-Technology Futures (AITF) Alberta Innovates Centre for Machine Learning (AICML). B Xu was supported by the China Scholarship Council. The funders provided support in the form of salaries for the authors, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of the authors are articulated in the author contributions section.	Brammer L, 2013, MMWR-MORBID MORTAL W, V62, P473; Butler D, 2013, NATURE, V494, P155, DOI 10.1038/494155a; Centers for Disease Control and Prevention, 2010, 2010 2011 INFL SEAS; Centers for Disease Control and Prevention, 2013, OV INFL SURV US; Centers for Disease Control and Prevention, 2012, 2012 2013 INFL SEAS; Centers for Disease Control and Prevention, 2013, 2013 2014 INFL SEAS; Centers for Disease Control and Prevention, 2013, FLUVIEW NAT REG LEV; Centers for Disease Control and Prevention, 2011, 2011 2012 INFL SEAS; Cook S, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0023610, 10.1371/journal.pone.0025407]; Dugas AF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056176; Dugas AF, 2012, CLIN INFECT DIS, V54, P463, DOI 10.1093/cid/cir883; Ginsberg J, 2009, NATURE, V457, P1012, DOI 10.1038/nature07634; Google, 2014, GOOGL TRENDS; Google Flu Trends, 2013, GOOGL FLU TRENDS US; Kang M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055205; Lazer D, 2014, SCIENCE, V343, P1203, DOI 10.1126/science.1248506; Martin LJ, 2014, REPLICATION DATA IMP; Nsoesie Elaine, 2013, PLOS CURR, V5; Olson DR, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003256; Pelat C, 2009, EMERG INFECT DIS, V15, P1327, DOI 10.3201/eid1508.090299; R Core Team, 2013, LANG ENV STAT COMP; Santillana M, 2014, AM J PREV MED, V47, P341, DOI 10.1016/j.amepre.2014.05.020; Shaman J, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3837; Shaman J, 2012, P NATL ACAD SCI USA, V109, P20425, DOI 10.1073/pnas.1208772109; Stefansen C, 2013, FLU TRENDS UPDATES M	25	14	14	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2014	9	12							e109209	10.1371/journal.pone.0109209	http://dx.doi.org/10.1371/journal.pone.0109209			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UC	25551391	gold, Green Published, Green Submitted			2022-12-27	WOS:000347119100002
J	Shiraishi, R; Tamura, T; Sone, M; Okazawa, H				Shiraishi, Risa; Tamura, Takuya; Sone, Masaki; Okazawa, Hitoshi			Systematic Analysis of Fly Models with Multiple Drivers Reveals Different Effects of Ataxin-1 and Huntingtin in Neuron Subtype-Specific Expression	PLOS ONE			English	Article							DROSOPHILA-MELANOGASTER; DEPENDENT NEURODEGENERATION; DOPAMINERGIC-NEURONS; NERVOUS-SYSTEM; GLIAL-CELLS; DISEASE; SEQUENCES; PROTEINS; MEMORY; IDENTIFICATION	The fruit fly, Drosophila melanogaster, is a commonly used model organism for neurodegenerative diseases. Its major advantages include a short lifespan and its susceptibility to manipulation using sophisticated genetic techniques. Here, we report the systematic comparison of fly models of two polyglutamine (polyQ) diseases. We induced expression of the normal and mutant forms of full-length Ataxin-1 and Huntingtin exon 1 in cholinergic, dopaminergic, and motor neurons, and glial cells using cell type-specific drivers. We systematically analyzed their effects based on multiple phenotypes: eclosion rate, lifespan, motor performance, and circadian rhythms of spontaneous activity. This systematic assay system enabled us to quantitatively evaluate and compare the functional disabilities of different genotypes. The results suggest different effects of Ataxin-1 and Huntingtin on specific types of neural cells during development and in adulthood. In addition, we confirmed the therapeutic effects of LiCl and butyrate using representative models. These results support the usefulness of this assay system for screening candidate chemical compounds that modify the pathologies of polyQ diseases.	[Shiraishi, Risa; Tamura, Takuya; Okazawa, Hitoshi] Tokyo Med & Dent Univ, Med Res Inst, Dept Neuropathol, Bunkyo Ku, Tokyo, Japan; [Shiraishi, Risa; Tamura, Takuya; Okazawa, Hitoshi] Tokyo Med & Dent Univ, Ctr Brain Integrat Res, Bunkyo Ku, Tokyo, Japan; [Sone, Masaki] Toho Univ, Fac Sci, Dept Biomol Sci, Funabashi, Chiba 274, Japan	Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU); Toho University	Okazawa, H (corresponding author), Tokyo Med & Dent Univ, Med Res Inst, Dept Neuropathol, Bunkyo Ku, Tokyo, Japan.	okazawa.npat@mri.tmd.ac.jp	Sone, Masaki/Q-9058-2019		Strategic Research Program for Brain Sciences (SRPBS); (Foundation of Synapse and Neurocircuit Pathology) from the Ministry of Education, Culture, Sports, Science and Technology of Japan; CREST from Japan Science Technology Agency; Joint Usage/Research Program of Medical Research Institute, Tokyo Medical and Dental University; JSPS [24700374]	Strategic Research Program for Brain Sciences (SRPBS); (Foundation of Synapse and Neurocircuit Pathology) from the Ministry of Education, Culture, Sports, Science and Technology of Japan; CREST from Japan Science Technology Agency; Joint Usage/Research Program of Medical Research Institute, Tokyo Medical and Dental University; JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by the Strategic Research Program for Brain Sciences (SRPBS) and by a grant-in-aid for Scientific Research on Innovative Areas (Foundation of Synapse and Neurocircuit Pathology) from the Ministry of Education, Culture, Sports, Science and Technology of Japan, CREST from Japan Science Technology Agency, and the Joint Usage/Research Program of Medical Research Institute, Tokyo Medical and Dental University to H. O. and by a JSPS Grant-in-Aid for Young Scientists (24700374) to T. T. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambegaokar SS, 2010, NEUROBIOL DIS, V40, P29, DOI 10.1016/j.nbd.2010.05.026; Berger C, 2007, DEV DYNAM, V236, P3562, DOI 10.1002/dvdy.21372; Berger Z, 2005, HUM MOL GENET, V14, P3003, DOI 10.1093/hmg/ddi331; Chen XP, 2007, CELL TISSUE RES, V329, P169, DOI 10.1007/s00441-007-0401-y; Connolly JB, 1996, SCIENCE, V274, P2104, DOI 10.1126/science.274.5295.2104; DURA JM, 1993, J NEUROGENET, V9, P1, DOI 10.3109/01677069309167272; Fernandez-Funez P, 2000, NATURE, V408, P101, DOI 10.1038/35040584; Friggi-Grelin F, 2003, GENESIS, V35, P260, DOI 10.1002/gene.1082; Friggi-Grelin F, 2003, J NEUROBIOL, V54, P618, DOI 10.1002/neu.10185; Fujita K, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2828; Garcia-Lopez A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001595; Goldberg AL, 2003, NATURE, V426, P895, DOI 10.1038/nature02263; Green EW, 2012, BIOCHEM SOC T, V40, P739, DOI 10.1042/BST20120072; Groth AC, 2004, GENETICS, V166, P1775, DOI 10.1534/genetics.166.4.1775; HALTER DA, 1995, DEVELOPMENT, V121, P317; HOSOYA T, 1995, CELL, V82, P1025, DOI 10.1016/0092-8674(95)90281-3; Jackson GR, 1998, NEURON, V21, P633, DOI 10.1016/S0896-6273(00)80573-5; Kadener S, 2006, P NATL ACAD SCI USA, V103, P13537, DOI 10.1073/pnas.0605962103; LUO LQ, 1994, GENE DEV, V8, P1787, DOI 10.1101/gad.8.15.1787; Mao ZM, 2009, FRONT NEURAL CIRCUIT, V3, DOI 10.3389/neuro.04.005.2009; Muqit MMK, 2002, NAT REV NEUROSCI, V3, P237, DOI 10.1038/nrn751; Murata T, 2008, BIOSCI BIOTECH BIOCH, V72, P2255, DOI 10.1271/bbb.70829; Reiter LT, 2001, GENOME RES, V11, P1114, DOI 10.1101/gr.169101; Romero E, 2008, NEURON, V57, P27, DOI 10.1016/j.neuron.2007.11.025; Salvaterra P M, 2001, Brain Res Gene Expr Patterns, V1, P73; Sanyal S, 2009, GENE EXPR PATTERNS, V9, P371, DOI 10.1016/j.gep.2009.01.002; Selcho M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005897; Serra HG, 2006, CELL, V127, P697, DOI 10.1016/j.cell.2006.09.036; Sinadinos C, 2009, NEUROBIOL DIS, V34, P389, DOI 10.1016/j.nbd.2009.02.012; Steffan JS, 2001, NATURE, V413, P739, DOI 10.1038/35099568; Takeyama K, 2002, NEURON, V35, P855, DOI 10.1016/S0896-6273(02)00875-9; Tamura T, 2003, NEURON, V40, P1003, DOI 10.1016/S0896-6273(03)00732-3; Tamura T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027408; Tamura T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004262; Venkatraman P, 2004, MOL CELL, V14, P95, DOI 10.1016/S1097-2765(04)00151-0; Vomel M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001848; Wang WY, 2004, NEUROSCI RES, V48, P195, DOI 10.1016/j.neures.2003.10.012; Warrick JM, 1998, CELL, V93, P939, DOI 10.1016/S0092-8674(00)81200-3; Yeste-Velasco M, 2009, NEUROSCIENCE, V159, P1135, DOI 10.1016/j.neuroscience.2009.01.035; Yoshimura N, 2006, FEBS LETT, V580, P2335, DOI 10.1016/j.febslet.2006.03.056; Yu ZM, 2011, INT REV NEUROBIOL, V99, P191, DOI 10.1016/B978-0-12-387003-2.00008-2; Zhang S, 2009, DIS MODEL MECH, V2, P247, DOI 10.1242/dmm.000653	42	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2014	9	12							e116567	10.1371/journal.pone.0116567	http://dx.doi.org/10.1371/journal.pone.0116567			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UC	25551764	Green Published, Green Submitted, gold			2022-12-27	WOS:000347119100146
J	Coon, TA; McKelvey, AC; Weathington, NM; Birru, RL; Lear, T; Leikauf, GD; Chen, BB				Coon, Tiffany A.; McKelvey, Alison C.; Weathington, Nate M.; Birru, Rahel L.; Lear, Travis; Leikauf, George D.; Chen, Bill B.			Novel PDE4 Inhibitors Derived from Chinese Medicine Forsythia	PLOS ONE			English	Article							PHOSPHODIESTERASE-4 INHIBITOR; OXIDATIVE STRESS; CYCLIC-AMP; SUSPENSA; PROTEIN; RATS; HYPERTENSION; INFLAMMATION; MACROPHAGES; METABOLISM	Cyclic adenosine monophosphate (cAMP) is a crucial intracellular second messenger molecule that converts extracellular molecules to intracellular signal transduction pathways generating cell- and stimulus-specific effects. Importantly, specific phosphodiesterase (PDE) subtypes control the amplitude and duration of cAMP-induced physiological processes and are therefore a prominent pharmacological target currently used in a variety of fields. Here we tested the extracts from traditional Chinese medicine, Forsythia suspense seeds, which have been used for more than 2000 years to relieve respiratory symptoms. Using structural-functional analysis we found its major lignin, Forsynthin, acted as an immunosuppressant by inhibiting PDE4 in inflammatory and immune cell. Moreover, several novel, selective small molecule derivatives of Forsythin were tested in vitro and in murine models of viral and bacterial pneumonia, sepsis and cytokine-driven systemic inflammation. Thus, pharmacological targeting of PDE4 may be a promising strategy for immune-related disorders characterized by amplified host inflammatory response.	[Coon, Tiffany A.; McKelvey, Alison C.; Weathington, Nate M.; Lear, Travis; Chen, Bill B.] Univ Pittsburgh, Dept Med, Acute Lung Injury Ctr Excellence, Pittsburgh, PA 15213 USA; [Chen, Bill B.] Univ Pittsburgh, Vasc Med Inst, Pittsburgh, PA 15213 USA; [Birru, Rahel L.; Leikauf, George D.] Univ Pittsburgh, Dept Environm & Occupat Hlth, Pittsburgh, PA 15213 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Chen, BB (corresponding author), Univ Pittsburgh, Dept Med, Acute Lung Injury Ctr Excellence, 930 Scaife Hall, Pittsburgh, PA 15213 USA.	chenb@upmc.edu		Leikauf, George/0000-0002-4514-7060; Lear, Travis/0000-0001-9156-0844	National Institutes of Health R01 [HL116472, ES015675, HL077763]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL116472, R01HL077763] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [U01ES015675] Funding Source: NIH RePORTER	National Institutes of Health R01(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This material is based upon work supported by the National Institutes of Health R01 grants HL116472 (to B. B. C.), ES015675 and HL077763 (to G. D. L.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baeumer Wolfgang, 2007, Inflammation & Allergy Drug Targets, V6, P17, DOI 10.2174/187152807780077318; Beavo JA, 2002, NAT REV MOL CELL BIO, V3, P710, DOI 10.1038/nrm911; BEAVO JA, 1995, PHYSIOL REV, V75, P725, DOI 10.1152/physrev.1995.75.4.725; Beghe B, 2013, AM J RESP CRIT CARE, V188, P271, DOI 10.1164/rccm.201301-0021PP; Brown DM, 2007, TOXICOL LETT, V168, P1, DOI 10.1016/j.toxlet.2006.10.016; Chang MJ, 2008, BIOSCI BIOTECH BIOCH, V72, P2750, DOI 10.1271/bbb.80392; Chen BB, 2013, NAT IMMUNOL, V14, P470, DOI 10.1038/ni.2565; Christie P, 2005, DRUGS TODAY, V41, P667, DOI 10.1358/dot.2005.41.10.920428; Deree J, 2008, CLINICS, V63, P321, DOI 10.1590/S1807-59322008000300006; Dinarello CA, 2007, EUR J IMMUNOL, V37, pS34, DOI 10.1002/eji.200737772; Essayan DM, 2001, J ALLERGY CLIN IMMUN, V108, P671, DOI 10.1067/mai.2001.119555; Ghiadoni L, 2008, CURR HYPERTENS REP, V10, P52, DOI 10.1007/s11906-008-0011-4; Hassimotto NMA, 2008, NUTR RES, V28, P198, DOI 10.1016/j.nutres.2007.12.012; Hertz AL, 2009, P NATL ACAD SCI USA, V106, P21978, DOI 10.1073/pnas.0911684106; Iffland A, 2005, BIOCHEMISTRY-US, V44, P8312, DOI 10.1021/bi047313h; Ikeda Y, 1999, THROMB HAEMOSTASIS, V82, P435; Jacob C, 2004, BRIT J PHARMACOL, V143, P257, DOI 10.1038/sj.bjp.0705927; Jeon YH, 2005, CELL MOL LIFE SCI, V62, P1198, DOI 10.1007/s00018-005-4533-5; Ko WC, 2004, BIOCHEM PHARMACOL, V68, P2087, DOI 10.1016/j.bcp.2004.06.030; Koes DR, 2012, NUCLEIC ACIDS RES, V40, pW409, DOI 10.1093/nar/gks378; Lee J, 2012, J BIOL CHEM, V287, P22799, DOI 10.1074/jbc.M111.337378; Li HB, 2005, J CHROMATOGR A, V1083, P102, DOI 10.1016/j.chroma.2005.06.025; Li QY, 2013, ACTA PHARMACOL SIN, V34, P1116, DOI 10.1038/aps.2013.25; Mallampalli RK, 2013, J IMMUNOL, V191, P5247, DOI 10.4049/jimmunol.1300456; Nicholls JM, 2003, LANCET, V361, P1773, DOI 10.1016/S0140-6736(03)13413-7; Oger S, 2005, J IMMUNOL, V174, P8082, DOI 10.4049/jimmunol.174.12.8082; Osterholm MT, 2005, NEW ENGL J MED, V352, P1839, DOI 10.1056/NEJMp058068; Palmer D, 2000, MOL PHARMACOL, V58, P247, DOI 10.1124/mol.58.2.247; Piao XL, 2008, BIOORG MED CHEM LETT, V18, P1980, DOI 10.1016/j.bmcl.2008.01.115; Qu HH, 2008, J PHARM PHARMACOL, V60, P261, DOI 10.1211/jpp.60.2.0016; Rath HC, 2001, INFECT IMMUN, V69, P2277, DOI 10.1128/IAI.69.4.2277-2285.2001; Ruuskanen O, 2011, LANCET, V377, P1264, DOI 10.1016/S0140-6736(10)61459-6; Schroll S, 2013, RESP PHYSIOL NEUROBI, V186, P61, DOI 10.1016/j.resp.2012.11.003; Serezani CH, 2008, AM J RESP CELL MOL, V39, P127, DOI 10.1165/rcmb.2008-0091TR; Sheu CC, 2010, INTENS CARE MED, V36, P963, DOI 10.1007/s00134-010-1851-3; Sung BJ, 2003, NATURE, V425, P98, DOI 10.1038/nature01914; Toque HA, 2009, UROLOGY, V74, P216, DOI 10.1016/j.urology.2008.12.056; Tsuda T, 1999, FEBS LETT, V449, P179, DOI 10.1016/S0014-5793(99)00407-X; Uckert S, 2007, EXPERT OPIN EMERG DR, V12, P219, DOI 10.1517/14728214.12.2.219; Wang JR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029879	40	11	13	2	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2014	9	12							e115937	10.1371/journal.pone.0115937	http://dx.doi.org/10.1371/journal.pone.0115937			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX6YH	25549252	gold, Green Published, Green Accepted, Green Submitted			2022-12-27	WOS:000347063500040
J	Ichijo, S; Furuya, F; Shimura, H; Hayashi, Y; Takahashi, K; Ohta, K; Kobayashi, T; Kitamura, K				Ichijo, Sayaka; Furuya, Fumihiko; Shimura, Hiroki; Hayashi, Yoshitaka; Takahashi, Kazuya; Ohta, Kazuyasu; Kobayashi, Tetsuro; Kitamura, Kenichiro			Activation of the RhoB Signaling Pathway by Thyroid Hormone Receptor beta in Thyroid Cancer Cells	PLOS ONE			English	Article							TRANSCRIPTION FACTOR-I; HISTONE DEACETYLASE; ANAPLASTIC CARCINOMA; MOUSE MODEL; GENE; EXPRESSION; GROWTH; INHIBITORS; FARNESYLTRANSFERASE; CARCINOGENESIS	Thyroid hormone receptor (TR) mediates the crucial effects of the thyroid hormone (T3) on cellular growth, development, and differentiation. Decreased expression or inactivating somatic mutations of TRs have been found in human cancers of the liver, breast, lung, and thyroid. The mechanisms of TR-associated carcinogenesis are still not clear. To establish the function of TR beta in thyroid cancer cell proliferation, we constructed a recombinant adenovirus vector, AdTR beta, which expresses human TR beta 1 cDNA. Thyroid cancer cell lines in which TR beta protein levels were significantly decreased as compared to intact thyroid tissues were infected with AdTR beta and the function of TR beta on cell proliferation and migration was analyzed. Ligand-bound TR beta induced HDAC1 and HDAC3 dissociation from, and histone acetylation associated with the RhoB promoter and enhanced the expression of RhoB mRNA and protein. In AdTR beta-infected cells, T3 and farnesyl transferase inhibitor (FTI)-treatment induced the distribution of RhoB on the cell membrane and enhanced the abundance of active GTP-bound RhoB. This RhoB protein led to p21-associated cell-cycle arrest in the G0/G1 phase, following inhibition of cell proliferation and invasion. Conversely, lowering cellular RhoB by small interfering RNA knockdown in AdTR beta-infected cells led to downregulation of p21 and inhibited cell-cycle arrest. The growth of BHP18-21v tumor xenografts in vivo was significantly inhibited by AdTR beta injection with FTIs-treatment, as compared to control virus-injected tumors. This novel signaling pathway triggered by ligand-bound TR beta provides insight into possible mechanisms of proliferation and invasion of thyroid cancer and may provide new therapeutic targets for thyroid cancers.	[Ichijo, Sayaka; Furuya, Fumihiko; Takahashi, Kazuya; Ohta, Kazuyasu; Kobayashi, Tetsuro; Kitamura, Kenichiro] Univ Yamanashi, Interdisciplinary Grad Sch Med & Engn, Dept Internal Med 3, Yamanashi, Japan; [Shimura, Hiroki] Fukushima Med Univ, Dept Lab Med, Fukushima, Japan; [Hayashi, Yoshitaka] Nagoya Univ, Environm Med Res Inst, Div Mol & Cellular Adaptat, Dept Endocrinol & Metab, Nagoya, Aichi 464, Japan	University of Yamanashi; Fukushima Medical University; Nagoya University	Furuya, F (corresponding author), Univ Yamanashi, Interdisciplinary Grad Sch Med & Engn, Dept Internal Med 3, Yamanashi, Japan.	ffuruya@yamanashi.ac.jp	Hayashi, Yoshitaka/I-6168-2014	Hayashi, Yoshitaka/0000-0002-7557-4303	JSPS KAKENHI [24591359]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by JSPS KAKENHI (Grant Number 24591359). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Croft DR, 2011, TRANSCR-AUSTIN, V2, P211, DOI 10.4161/trns.2.5.16904; Delarue FL, 2007, ONCOGENE, V26, P633, DOI 10.1038/sj.onc.1209819; Du W, 1999, CANCER RES, V59, P5492; ESTOUR B, 1989, VIRCHOWS ARCH B, V57, P167, DOI 10.1007/BF02899078; FAGIN JA, 1993, J CLIN INVEST, V91, P179, DOI 10.1172/JCI116168; Furuya F, 2006, P NATL ACAD SCI USA, V103, P1780, DOI 10.1073/pnas.0510849103; Furuya F, 2004, ENDOCRINOLOGY, V145, P5397, DOI 10.1210/en.2004-0631; Furuya F, 2004, ENDOCRINOLOGY, V145, P2865, DOI 10.1210/en.2003-1258; Furuya F, 2010, J BIOL CHEM, V285, P24477, DOI 10.1074/jbc.M109.100222; Furuya F, 2009, STEROIDS, V74, P628, DOI 10.1016/j.steroids.2008.10.009; Gartel AL, 2005, CANCER RES, V65, P3980, DOI 10.1158/0008-5472.CAN-04-3995; HALEVY O, 1995, SCIENCE, V267, P1018, DOI 10.1126/science.7863327; Hashimoto K, 2001, P NATL ACAD SCI USA, V98, P3998, DOI 10.1073/pnas.051454698; Hayashi Y, 1996, MOL ENDOCRINOL, V10, P100, DOI 10.1210/me.10.1.100; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; Jiang K, 2004, MOL CELL BIOL, V24, P5565, DOI 10.1128/MCB.24.12.5565-5576.2004; Kamasani U, 2004, CANCER RES, V64, P8389, DOI 10.1158/0008-5472.CAN-04-2437; Kaneshige M, 2000, P NATL ACAD SCI USA, V97, P13209, DOI 10.1073/pnas.230285997; Kato Y, 2006, ONCOGENE, V25, P2736, DOI 10.1038/sj.onc.1209299; Kim WG, 2013, BBA-GEN SUBJECTS, V1830, P3928, DOI 10.1016/j.bbagen.2012.04.002; Li JW, 2000, MOL CELL BIOL, V20, P2031, DOI 10.1128/MCB.20.6.2031-2042.2000; Lin KH, 1997, ENDOCRINOLOGY, V138, P5308, DOI 10.1210/en.138.12.5308; Marlow LA, 2009, CANCER RES, V69, P1536, DOI 10.1158/0008-5472.CAN-08-3718; Mazieres J, 2004, CLIN CANCER RES, V10, P2742, DOI 10.1158/1078-0432.CCR-03-0149; NEL CJC, 1985, MAYO CLIN PROC, V60, P51, DOI 10.1016/S0025-6196(12)65285-9; Ohta K, 1997, J CLIN ENDOCR METAB, V82, P2633, DOI 10.1210/jc.82.8.2633; ONATE SA, 1995, SCIENCE, V270, P1354; Prendergast GC, 2001, NAT REV CANCER, V1, P162, DOI 10.1038/35101096; Rondanino C, 2007, TRAFFIC, V8, P932, DOI 10.1111/j.1600-0854.2007.00575.x; Sahai E, 2002, NAT REV CANCER, V2, P133, DOI 10.1038/nrc725; SAMUELS HH, 1979, ENDOCRINOLOGY, V105, P80, DOI 10.1210/endo-105-1-80; Shi YB, 2013, CURR TOP DEV BIOL, V105, P275, DOI 10.1016/B978-0-12-396968-2.00010-5; Shimura H, 2001, CANCER RES, V61, P3640; Suzuki H, 2002, THYROID, V12, P963, DOI 10.1089/105072502320908295; Vardouli L, 2008, FEBS J, V275, P4074, DOI 10.1111/j.1742-4658.2008.06549.x; VENKATESH YSS, 1990, CANCER-AM CANCER SOC, V66, P321, DOI 10.1002/1097-0142(19900715)66:2<321::AID-CNCR2820660221>3.0.CO;2-A; Wang SW, 2003, ONCOGENE, V22, P6204, DOI 10.1038/sj.onc.1206653; Weinberg WC, 2002, CRIT REV ORAL BIOL M, V13, P453, DOI 10.1177/154411130201300603; WEINBERGER C, 1986, NATURE, V324, P641, DOI 10.1038/324641a0; Ying H, 2007, MOL CELL BIOL, V27, P2359, DOI 10.1128/MCB.02189-06; Zhou JT, 2011, INT J CANCER, V128, P1057, DOI 10.1002/ijc.25445	41	11	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2014	9	12							e116252	10.1371/journal.pone.0116252	http://dx.doi.org/10.1371/journal.pone.0116252			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX6YH	25548921	Green Published, Green Submitted, gold			2022-12-27	WOS:000347063500068
J	Jackson, SA; Kleitman, S; Aidman, E				Jackson, Simon A.; Kleitman, Sabina; Aidman, Eugene			Low Cognitive Load and Reduced Arousal Impede Practice Effects on Executive Functioning, Metacognitive Confidence and Decision Making	PLOS ONE			English	Article							TEST-RETEST INTERVALS; INDIVIDUAL-DIFFERENCES; BOREDOM; FATIGUE; UNDERCONFIDENCE; INTELLIGENCE; PERFORMANCE; JUDGMENTS; SETTINGS; WORKLOAD	The present study investigated the effects of low cognitive workload and the absence of arousal induced via external physical stimulation (motion) on practice-related improvements in executive (inhibitory) control, short-term memory, metacognitive monitoring and decision making. A total of 70 office workers performed low and moderately engaging passenger tasks in two successive 20-minute simulated drives and repeated a battery of decision making and inhibitory control tests three times before, between and after these drives. For half the participants, visual simulation was synchronised with (moderately arousing) motion generated through LAnd Motion Platform, with vibration levels corresponding to a well-maintained unsealed road. The other half performed the same simulated drive without motion. Participants' performance significantly improved over the three test blocks, which is indicative of typical practice effects. The magnitude of these improvements was the highest when both motion and moderate cognitive load were present. The same effects declined either in the absence of motion (low arousal) or following a low cognitive workload task, thus suggesting two distinct pathways through which practice-related improvements in cognitive performance may be hampered. Practice, however, degraded certain aspects of metacognitive performance, as participants became less likely to detect incorrect decisions in the decision-making test with each subsequent test block. Implications include consideration of low cognitive load and arousal as factors responsible for performance decline and targets for the development of interventions/strategies in low load/arousal conditions such as autonomous vehicle operations and highway driving.	[Jackson, Simon A.; Kleitman, Sabina] Univ Sydney, Sch Psychol, Sydney, NSW 2006, Australia; [Aidman, Eugene] Def Sci & Technol Org, Land Div, Adelaide, SA, Australia	University of Sydney; Defence Science & Technology	Jackson, SA (corresponding author), Univ Sydney, Sch Psychol, Sydney, NSW 2006, Australia.	simon.jackson@sydney.edu.au		Kleitman, Sabina/0000-0001-5772-5019; AIDMAN, Eugene/0000-0002-7711-794X	Defence Capability Development Group Project Land 121 Phase 4 [558023]	Defence Capability Development Group Project Land 121 Phase 4	SAJ, SK and EA were funded by the Defence Capability Development Group Project Land 121 Phase 4 (http://www.army.gov.au/Ourfuture/Projects/Project-LAND-121) under the Research Agreement 558023. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bechara A, 2005, NAT NEUROSCI, V8, P1458, DOI 10.1038/nn1584; Bohemia Interactive, 2007, VIRT BATTLESPACE VER; Busch RM, 2005, USING NORMS NEUROPSY; Collie A, 2003, J INT NEUROPSYCH SOC, V9, P419, DOI 10.1017/S1355617703930074; Desmond PA, 2001, HUM FAC TRANSP, P455; Diamond A, 2013, ANNU REV PSYCHOL, V64, P135, DOI 10.1146/annurev-psych-113011-143750; Dunlosky J., 2008, METACOGNITION; Efklides A, 2008, EUR PSYCHOL, V13, P277, DOI 10.1027/1016-9040.13.4.277; Evans JST, 2013, PERSPECT PSYCHOL SCI, V8, P223, DOI 10.1177/1745691612460685; Falleti MG, 2006, J CLIN EXP NEUROPSYC, V28, P1095, DOI 10.1080/13803390500205718; Faul F, 2009, BEHAV RES METHODS, V41, P1149, DOI 10.3758/BRM.41.4.1149; Finn B, 2007, J EXP PSYCHOL LEARN, V33, P238, DOI 10.1037/0278-7393.33.1.238; FISHER CD, 1993, HUM RELAT, V46, P395, DOI 10.1177/001872679304600305; FLAVELL JH, 1979, AM PSYCHOL, V34, P906, DOI 10.1037/0003-066X.34.10.906; Golding JF, 1998, BRAIN RES BULL, V47, P507, DOI 10.1016/S0361-9230(98)00091-4; Guilford J.P., 1954, J EDUC PSYCHOL, V2nd ed.; Hart CS, 2010, THESIS MIT; HART S G, 1988, P139; Harvey N, 2001, THINK REASONING, V7, P103, DOI DOI 10.1080/13546780042000064; Jackson SA, 2014, METACOGN LEARN, V9, P25, DOI 10.1007/s11409-013-9110-y; Kahneman D, 2009, AM PSYCHOL, V64, P515, DOI 10.1037/a0016755; Koriat A, 1996, PSYCHOL REV, V103, P490, DOI 10.1037/0033-295X.103.3.490; Koriat A, 2002, J EXP PSYCHOL GEN, V131, P147, DOI 10.1037//0096-3445.131.2.147; Loukidou L, 2009, INT J MANAG REV, V11, P381, DOI 10.1111/j.1468-2370.2009.00267.x; Maassen GH, 2009, J CLIN EXP NEUROPSYC, V31, P339, DOI 10.1080/13803390802169059; Mann S, 2009, BRIT EDUC RES J, V35, P243, DOI 10.1080/01411920802042911; McGrew KS, 2009, INTELLIGENCE, V37, P1, DOI 10.1016/j.intell.2008.08.004; Neubauer C, 2012, HUM FACTORS, V54, P734, DOI 10.1177/0018720811423261; PAESE PW, 1991, ORGAN BEHAV HUM DEC, V48, P100, DOI 10.1016/0749-5978(91)90008-H; Parker AM, 2014, J BEHAV DECIS MAKING, V27, P134, DOI 10.1002/bdm.1787; Pattyn N, 2008, PHYSIOL BEHAV, V93, P369, DOI 10.1016/j.physbeh.2007.09.016; Pekrun R, 2010, J EDUC PSYCHOL, V102, P531, DOI 10.1037/a0019243; Phillips RO, 2013, ACCIDENT ANAL PREV, V50, P138, DOI 10.1016/j.aap.2012.04.003; Roelofs A, 2003, PSYCHOL REV, V110, P88, DOI 10.1037/0033-295X.110.1.88; Rubio S, 2004, APPL PSYCHOL-INT REV, V53, P61, DOI 10.1111/j.1464-0597.2004.00161.x; Sagberg F, 1999, ACCIDENT ANAL PREV, V31, P639, DOI 10.1016/S0001-4575(99)00023-8; Saxby DJ, 2013, J EXP PSYCHOL-APPL, V19, P287, DOI 10.1037/a0034386; Scerbo M. W., 1998, VIEWING PSYCHOL WHOL, P145, DOI [10.1037/10290-006, DOI 10.1037/10290-006]; Stankov L, 2000, INTELLIGENCE, V28, P121, DOI 10.1016/S0160-2896(99)00033-1; Stankov L, 2015, MEASURES OF PERSONALITY AND SOCIAL PSYCHOLOGICAL CONSTRUCTS, P158, DOI 10.1016/B978-0-12-386915-9.00007-3; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; Suchy Y, 2011, J INT NEUROPSYCH SOC, V17, P101, DOI 10.1017/S135561771000130X; Tangney JP, 2004, J PERS, V72, P271, DOI 10.1111/j.0022-3506.2004.00263.x; Thiffault P, 2003, ACCIDENT ANAL PREV, V35, P381, DOI 10.1016/S0001-4575(02)00014-3; Vogel-Walcutt JJ, 2012, EDUC PSYCHOL REV, V24, P89, DOI 10.1007/s10648-011-9182-7; Yerkes RM, 1908, J COMP NEUROL PSYCHO, V18, P459, DOI 10.1002/cne.920180503	47	19	19	3	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2014	9	12							e115689	10.1371/journal.pone.0115689	http://dx.doi.org/10.1371/journal.pone.0115689			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AX6YH	25549327	Green Published, gold, Green Submitted			2022-12-27	WOS:000347063500021
J	Sullivan, JH; Muhammad, D; Warpeha, KM				Sullivan, Joe H.; Muhammad, DurreShahwar; Warpeha, Katherine M.			Phenylalanine Is Required to Promote Specific Developmental Responses and Prevents Cellular Damage in Response to Ultraviolet Light in Soybean (Glycine max) during the Seed-to-Seedling Transition	PLOS ONE			English	Article							UV-B RADIATION; CHLOROPHYLL FLUORESCENCE; EPIDERMAL-TRANSMITTANCE; SCREENING EFFECTIVENESS; TERRESTRIAL ECOSYSTEMS; PLANT-SENSITIVITY; DROUGHT TOLERANCE; BALANCING DAMAGE; AMBIENT LEVELS; PINUS-TAEDA	UV-radiation elicits a suite of developmental (photomorphogenic) and protective responses in plants, but responses early post-germination have received little attention, particularly in intensively bred plants of economic importance. We examined germination, hypocotyl elongation, leaf pubescence and subcellular responses of germinating and/or etiolated soybean (Glycine max (L.) Merr.) seedlings in response to treatment with discrete wavelengths of UV-A or UV-B radiation. We demonstrate differential responses of germinating/young soybean seedlings to a range of UV wavelengths that indicate unique signal transduction mechanisms regulate UV-initiated responses. We have investigated how phenylalanine, a key substrate in the phenylpropanoid pathway, may be involved in these responses. Pubescence may be a key location for phenylalanine-derived protective compounds, as UV-B irradiation increased pubescence and accumulation of UV-absorbing compounds within primary leaf pubescence, visualized by microscopy and absorbance spectra. Mass spectrometry analysis of pubescence indicated that sinapic esters accumulate in the UV-irradiated hairs compared to unirradiated primary leaf tissue. Deleterious effects of some UV-B wavelengths on germination and seedling responses were reduced or entirely prevented by inclusion of phenylalanine in the growth media. Key effects of phenylalanine were not duplicated by tyrosine or tryptophan or sucrose, nor is the specificity of response due to the absorbance of phenylalanine itself. These results suggest that in the seed-to-seedling transition, phenylalanine may be a limiting factor in the development of initial mechanisms of UV protection in the developing leaf.	[Sullivan, Joe H.] Univ Maryland, Dept Plant Sci & Landscape Architecture, College Pk, MD 20742 USA; [Muhammad, DurreShahwar; Warpeha, Katherine M.] Univ Illinois, Dept Biol Sci, Mol Cell & Dev Program, Chicago, IL 60680 USA	University System of Maryland; University of Maryland College Park; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Warpeha, KM (corresponding author), Univ Illinois, Dept Biol Sci, Mol Cell & Dev Program, Chicago, IL 60680 USA.	kwarpeha@uic.edu	Sullivan, Joe H./AAC-2195-2020	Sullivan, Joe H./0000-0002-2082-0343; Warpeha, Katherine/0000-0001-6866-3028	United States Department of Agriculture; Illinois Soybean Association	United States Department of Agriculture(United States Department of Agriculture (USDA)); Illinois Soybean Association	Support was provided by the United States Department of Agriculture UV-B Monitoring Project to KMW, and check-off funds from the Illinois Soybean Association to KMW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agati G, 2010, NEW PHYTOL, V186, P786, DOI 10.1111/j.1469-8137.2010.03269.x; Aharoni A, 2004, PLANT CELL, V16, P2463, DOI 10.1105/tpc.104.022897; Anderson MB, 1999, PLANT CELL, V11, P1579, DOI 10.1105/tpc.11.8.1579; Ayres PG, 1995, FUNGI ENV CHANGE, P32; Barnes J., 1994, AIR POLLUTANTS LEAF, P195; BIGGS RH, 1981, PHYSIOL PLANTARUM, V53, P19, DOI 10.1111/j.1399-3054.1981.tb05039.x; Bilger W, 2001, J EXP BOT, V52, P2007, DOI 10.1093/jexbot/52.363.2007; BUCHHOLZ G, 1995, PLANT PHYSIOL, V108, P227, DOI 10.1104/pp.108.1.227; Burchard P, 2000, PLANT CELL ENVIRON, V23, P1373, DOI 10.1046/j.1365-3040.2000.00633.x; Caldwell MM, 2007, PHOTOCH PHOTOBIO SCI, V6, P252, DOI 10.1039/b700019g; CALDWELL MM, 1983, PHYSIOL PLANTARUM, V58, P445, DOI 10.1111/j.1399-3054.1983.tb04206.x; Caldwell MM., 1971, PHOTOPHYSIOLOGY, V6, P131, DOI [10.1016/b978-0-12-282606-1.50010-6, DOI 10.1016/B978-0-12-282606-1.50010-6, 10.1016/B978-0-12-282606-1.50010-6]; CEN YP, 1990, J EXP BOT, V41, P1489, DOI 10.1093/jxb/41.11.1489; Christie JM, 2012, SCIENCE, V335, P1492, DOI 10.1126/science.1218091; DACUNHA A, 1987, PHYTOCHEMISTRY, V26, P2723, DOI 10.1016/S0031-9422(00)83579-7; Day TA, 1996, PLANT CELL ENVIRON, V19, P101, DOI 10.1111/j.1365-3040.1996.tb00231.x; DAY TA, 1994, PHYSIOL PLANTARUM, V92, P207, DOI 10.1111/j.1399-3054.1994.tb05328.x; DAY TA, 1993, OECOLOGIA, V95, P542, DOI 10.1007/BF00317439; Essen LO, 2006, CELL MOL LIFE SCI, V63, P1266, DOI 10.1007/s00018-005-5447-y; Flint SD, 2004, PHOTOCHEM PHOTOBIOL, V79, P399, DOI 10.1562/0031-8655(2004)79<399:SFTOBS>2.0.CO;2; Frohnmeyer H, 2003, PLANT PHYSIOL, V133, P1420, DOI 10.1104/pp.103.030049; Gardner G, 2009, PLANT CELL ENVIRON, V32, P1573, DOI 10.1111/j.1365-3040.2009.02021.x; Gitz DC, 2005, ENVIRON EXP BOT, V53, P343, DOI 10.1016/j.envexpbot.2004.04.005; Holmes MG, 2002, PLANT CELL ENVIRON, V25, P85, DOI 10.1046/j.1365-3040.2002.00779.x; Jansen MAK, 1998, TRENDS PLANT SCI, V3, P131, DOI 10.1016/S1360-1385(98)01215-1; Jenkins GI, 2009, ANNU REV PLANT BIOL, V60, P407, DOI 10.1146/annurev.arplant.59.032607.092953; KARABOURNIOTIS G, 1993, ENVIRON EXP BOT, V33, P341, DOI 10.1016/0098-8472(93)90035-E; KARABOURNIOTIS G, 1992, PHYSIOL PLANTARUM, V86, P414, DOI 10.1111/j.1399-3054.1992.tb01337.x; Krizek DT, 1998, PHYSIOL PLANTARUM, V103, P1, DOI 10.1034/j.1399-3054.1998.1030101.x; LANDRY LG, 1995, PLANT PHYSIOL, V109, P1159, DOI 10.1104/pp.109.4.1159; Lee JH, 2013, J SCI FOOD AGR, V93, P3081, DOI 10.1002/jsfa.6142; Lepiniec L, 2006, ANNU REV PLANT BIOL, V57, P405, DOI 10.1146/annurev.arplant.57.032905.105252; Liakopoulos G, 2006, ANN BOT-LONDON, V98, P257, DOI 10.1093/aob/mcl097; LIU L, 1995, PHYSIOL PLANTARUM, V93, P725, DOI 10.1111/j.1399-3054.1995.tb05123.x; MANDOLI DF, 1981, PLANT PHYSIOL, V67, P733, DOI 10.1104/pp.67.4.733; MARGNA U, 1989, PHYTOCHEMISTRY, V28, P469, DOI 10.1016/0031-9422(89)80034-2; Mazza CA, 2000, PLANT PHYSIOL, V122, P117, DOI 10.1104/pp.122.1.117; Merzlyak MN, 2008, J EXP BOT, V59, P349, DOI 10.1093/jxb/erm316; MIRECKI RM, 1984, PLANT PHYSIOL, V74, P475, DOI 10.1104/pp.74.3.475; Morales LO, 2010, TREE PHYSIOL, V30, P923, DOI 10.1093/treephys/tpq051; MURALI NS, 1986, PHOTOCHEM PHOTOBIOL, V44, P215, DOI 10.1111/j.1751-1097.1986.tb03588.x; Murphy A, 2000, PLANTA, V211, P315, DOI 10.1007/s004250000300; Orozco-Nunnelly DA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093371; Pasko P, 2009, FOOD CHEM, V115, P994, DOI 10.1016/j.foodchem.2009.01.037; Peer WA, 2001, PLANT PHYSIOL, V126, P536, DOI 10.1104/pp.126.2.536; Percy KE, 1994, NATO ASI SERIES, V36; REED HE, 1992, CROP SCI, V32, P1214, DOI 10.2135/cropsci1992.0011183X003200050031x; Rizzini L, 2011, SCIENCE, V332, P103, DOI 10.1126/science.1200660; ROBBERECHT R, 1978, OECOLOGIA, V32, P277, DOI 10.1007/BF00345107; Rohde A, 2004, PLANT CELL, V16, P2749, DOI 10.1105/tpc.104.023705; Rozema J, 2002, J PHOTOCH PHOTOBIO B, V66, P2, DOI 10.1016/S1011-1344(01)00269-X; Searles PS, 2001, OECOLOGIA, V127, P1, DOI 10.1007/s004420000592; Sheahan JJ, 1996, AM J BOT, V83, P679, DOI 10.2307/2445845; Shinkle JR, 2010, PHYSIOL PLANTARUM, V138, P113, DOI 10.1111/j.1399-3054.2009.01298.x; SINCLAIR TR, 1990, J ENVIRON QUAL, V19, P478, DOI 10.2134/jeq1990.00472425001900030020x; Sullivan JH, 2005, ENVIRON POLLUT, V137, P380, DOI 10.1016/j.envpol.2005.01.029; Sullivan JH, 2003, P SOC PHOTO-OPT INS, V4896, P135, DOI 10.1117/12.466182; Sullivan JH, 1996, PHYSIOL PLANTARUM, V98, P349, DOI 10.1034/j.1399-3054.1996.980217.x; Sullivan JH, 2007, PHOTOCHEM PHOTOBIOL, V83, P863, DOI 10.1111/j.1751-1097.2007.00138.x; Sutherland BM, 1996, PHOTOCHEM PHOTOBIOL, V64, P464, DOI 10.1111/j.1751-1097.1996.tb03092.x; TAN EM, 1970, J INVEST DERMATOL, V55, P439, DOI 10.1111/1523-1747.ep12260585; Tattini M, 2000, NEW PHYTOL, V148, P69, DOI 10.1046/j.1469-8137.2000.00743.x; TERAMURA AH, 1987, AM J BOT, V74, P975, DOI 10.2307/2443936; vanHeerden PS, 1996, J BIOL CHEM, V271, P12350, DOI 10.1074/jbc.271.21.12350; Voll LM, 2004, PLANT PHYSIOL, V136, P3058, DOI 10.1104/pp.104.047506; Wargent JJ, 2011, PLANT CELL ENVIRON, V34, P1401, DOI 10.1111/j.1365-3040.2011.02342.x; Warpeha KM, 2008, PLANT CELL ENVIRON, V31, P1756, DOI 10.1111/j.1365-3040.2008.01878.x; Warpeha KM, 2006, PLANT PHYSIOL, V140, P844, DOI 10.1104/pp.105.071282; Wilson KE, 2001, PHOTOCHEM PHOTOBIOL, V73, P678, DOI 10.1562/0031-8655(2001)073&lt;0678:EOUAEO&gt;2.0.CO;2; WMO, 2010, WORLD METEOROLOGICAL, V52, P516; Xu CP, 2008, ENVIRON EXP BOT, V63, P39, DOI 10.1016/j.envexpbot.2007.10.029; Xu CP, 2008, PHYTOCHEMISTRY, V69, P38, DOI 10.1016/j.phytochem.2007.06.010; YANG XS, 1995, INT J BIOMETEOROL, V38, P60, DOI 10.1007/BF01270660; Zhang JY, 2005, PLANT J, V42, P689, DOI 10.1111/j.1365-313X.2005.02405.x; ZISKA LH, 1992, AM J BOT, V79, P863, DOI 10.2307/2444995; Zu YQ, 2003, ENVIRON EXP BOT, V50, P87, DOI 10.1016/S0098-8472(03)00004-2	76	11	11	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2014	9	12							e112301	10.1371/journal.pone.0112301	http://dx.doi.org/10.1371/journal.pone.0112301			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX6YH	25549094	Green Published, Green Submitted, gold			2022-12-27	WOS:000347063500004
J	Suzuki, A; Kobayashi, R; Okayasu, S; Kuze, B; Aoki, M; Mizuta, K; Itoh, Y				Suzuki, Akio; Kobayashi, Ryo; Okayasu, Shinji; Kuze, Bunya; Aoki, Mitsuhiro; Mizuta, Keisuke; Itoh, Yoshinori			Pharmacotherapy for Adverse Events Reduces the Length of Hospital Stay in Patients Admitted to Otolaryngology Ward: A Single Arm Intervention Study	PLOS ONE			English	Article							CLINICAL-PRACTICE GUIDELINE; NECK-CANCER; AMERICAN SOCIETY; ORAL MUCOSITIS; DRUG EVENTS; COSTS; CARE; DYSPHAGIA; HEAD; MORTALITY	Background: To determine whether adverse events extend the duration of hospitalization, and to evaluate the effectiveness of medical intervention in ameliorating adverse events and reducing the prolonged hospital stay associated with adverse events. Methods: A single arm intervention study was conducted from October 2012 to March 2014 in the otolaryngology ward of a 614-bed, university-affiliated hospital. Adverse events were monitored daily by physicians, pharmacists and nurses, and recorded in the electronic medical chart for each patient. Appropriate drug management of adverse events was performed by physicians in liaison with pharmacists. The Kaplan-Meier method was used to assess the length of hospitalization of patients who underwent medical intervention for adverse events. Results: Of 571 patients admitted to the otolaryngology ward in a year, 219 patients (38.4%) experienced adverse events of grade >= 2. The duration of hospitalization was affected by the grade of adverse events, with a mean duration of hospital stay of 9.2, 17.2, 28.3 and 47.0 days for grades 0, 1, 2, and 3-4, respectively. Medical intervention lowered the incidence of grade >= 2 adverse events to 14.5%. The length of hospitalization was significantly shorter in patients who showed an improvement of adverse events after medical intervention than those who did not (26.4 days vs. 41.6 days, hazard ratio 1.687, 95% confidence interval: 1.260-2.259, P<0.001). A multivariate Cox proportional hazard analysis indicated that insomnia, constipation, nausea/vomiting, infection, non-cancer pain, oral mucositis, odynophagia and neutropenia were significant risk factors for prolongation of hospital stay. Conclusion: Patients who experienced adverse events are at high risk of prolonged hospitalization. Medical intervention for adverse events was found to be effective in reducing the length of hospital stay associated with adverse events.	[Suzuki, Akio; Kobayashi, Ryo; Okayasu, Shinji; Itoh, Yoshinori] Gifu Univ Hosp, Dept Pharm, Gifu, Japan; [Kuze, Bunya; Aoki, Mitsuhiro; Mizuta, Keisuke] Gifu Univ, Grad Sch Med, Dept Otolaryngol, Gifu, Japan; [Aoki, Mitsuhiro] Gifu Univ Hosp, Dept Med Informat Div, Gifu, Japan	Gifu University; Gifu University; Gifu University	Suzuki, A (corresponding author), Gifu Univ Hosp, Dept Pharm, Gifu, Japan.	akio@gifu-u.ac.jp						Baker GR, 2004, CAN MED ASSOC J, V170, P1678, DOI 10.1503/cmaj.1040498; Basch E, 2011, J CLIN ONCOL, V29, P4189, DOI [10.1200/JCO.2010.34.4614, 10.1200/JOP.2011.000397]; Bates DW, 1997, JAMA-J AM MED ASSOC, V277, P307, DOI 10.1001/jama.277.4.307; Benson AB, 2004, J CLIN ONCOL, V22, P2918, DOI 10.1200/jco.2004.04.132; Bratzler DW, 2013, AM J HEALTH-SYST PH, V70, P540; BRENNAN TA, 1991, NEW ENGL J MED, V324, P370, DOI 10.1056/NEJM199102073240604; Classen DC, 1997, JAMA-J AM MED ASSOC, V277, P301, DOI 10.1001/jama.277.4.301; Evans R S, 1992, Proc Annu Symp Comput Appl Med Care, P437; Feng FY, 2007, INT J RADIAT ONCOL, V68, P1289, DOI 10.1016/j.ijrobp.2007.02.049; Forster AJ, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-259; Howard HH, 1989, NEW ENGL J MED, V324, P370; Kaushal R, 2007, CRIT CARE MED, V35, P2479, DOI 10.1097/01.CCM.0000284510.04248.66; Keefe DM, 2007, CANCER-AM CANCER SOC, V109, P820, DOI 10.1002/cncr.22484; Kronenberger Michael B., 1994, Dysphagia, V9, P236, DOI 10.1007/BF00301917; Kulbersh BD, 2006, LARYNGOSCOPE, V116, P883, DOI 10.1097/01.mlg.0000217278.96901.fc; Landrigan CP, 2010, NEW ENGL J MED, V363, P2124, DOI 10.1056/NEJMsa1004404; Manchikanti L, 2012, PAIN PHYSICIAN, V15, pS67; Mercadante S, 2010, INTERN EMERG MED, V5, pS31, DOI 10.1007/s11739-010-0448-8; NCCN, 2022, CLIN PRACTICE GUIDEL; Parmentier-Decrucq E, 2013, ANN INTENSIVE CARE, V3, DOI 10.1186/2110-5820-3-10; Schilling MB, 2011, EXP THER MED, V2, P859, DOI 10.3892/etm.2011.312; Shune SE, 2012, HEAD NECK-J SCI SPEC, V34, P776, DOI 10.1002/hed.21819; Smith TJ, 2006, J CLIN ONCOL, V24, P3187, DOI 10.1200/JCO.2006.06.4451; Sonis ST, 2001, J CLIN ONCOL, V19, P2201, DOI 10.1200/JCO.2001.19.8.2201; Vincent C, 2001, BRIT MED J, V322, P517, DOI 10.1136/bmj.322.7285.517; Watanabe T, 2010, INT J CANCER, V127, P1984, DOI 10.1002/ijc.25200; Zimlichman E, 2013, JAMA INTERN MED, V173, P2039, DOI 10.1001/jamainternmed.2013.9763	27	9	9	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2014	9	12							e115879	10.1371/journal.pone.0115879	http://dx.doi.org/10.1371/journal.pone.0115879			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX6YH	25549093	Green Published, Green Submitted, gold			2022-12-27	WOS:000347063500034
J	Adnan, WAHWM; Zaharan, NL; Wong, MH; Lim, SK				Adnan, Wan Ahmad Hafiz Wan Md; Zaharan, Nur Lisa; Wong, Mun Hoe; Lim, Soo Kun			The Effects of Intermittent Fasting during the Month of Ramadan in Chronic Haemodialysis Patients in a Tropical Climate Country	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; ELECTROLYTE BALANCE; LIPID-LEVELS; RECOMMENDATIONS; DIALYSIS; FLUID	Background: Chronic kidney disease is an emerging problem in the majority Muslim countries. Despite the uncertainties of the risks involved, some Muslim patients undergoing chronic haemodialysis choose to observe intermittent fasting during the month of Ramadan. This study aims to investigate the effect of Ramadan fasting in haemodialysis patients residing in a tropical climate country. Methods: This prospective cross sectional study recruited Muslim patients on regular haemodialysis from three haemodialysis centres in Kuala Lumpur from 15th July 2011 to 29th August 2011. Patients who fasted for any number of days were included (n=35, 54% female, age 54 +/- 11 years). 89% of patients fasted for more than 15 days and 49% were diabetics. Dialysis parameters and blood samples were obtained one week prior to Ramadan and during the last week of Ramadan. The differences in dialysis parameters and biochemical values pre- and end-Ramadan were examined using paired t-test. Results: Both pre- and post-dialysis weight were significantly decreased during Ramadan fasting compared to the month prior (p= <0.001). There was a significant decrease in the amount of ultrafiltration (p=0.002). There were no significant differences in dry weight, inter-dialytic weight gain, mean urea reduction ratio or blood pressure measurements comparing pre- and end of Ramadan fasting. There was a significant increase in serum albumin level (p=0.006) and decrease in serum phosphate level (p=0.02) at the end of Ramadan. Conclusion: Ramadan fasting is associated with reduced weight, improved serum albumin and phosphate level in our population of haemodialysis patients. A larger multi-centre study will allow us to understand more about the effects of fasting in this population.	[Adnan, Wan Ahmad Hafiz Wan Md; Wong, Mun Hoe; Lim, Soo Kun] Univ Malaya, Dept Med, Nephrol Unit, Fac Med, Kuala Lumpur 50603, Malaysia; [Zaharan, Nur Lisa] Univ Malaya, Dept Pharmacol, Fac Med, Kuala Lumpur 50603, Malaysia	Universiti Malaya; Universiti Malaya	Adnan, WAHWM (corresponding author), Univ Malaya, Dept Med, Nephrol Unit, Fac Med, Kuala Lumpur 50603, Malaysia.	wahafiz@um.edu.my	Lim, Soo Kun/Q-2012-2019; Zaharan, Nur Lisa/F-8835-2012; LIM, SOO KUN/B-8868-2010; Wan Md Adnan, Wan Ahmad Hafiz/D-9088-2016	Lim, Soo Kun/0000-0001-7589-5150; Zaharan, Nur Lisa/0000-0002-8150-0642; LIM, SOO KUN/0000-0001-7589-5150; Wan Md Adnan, Wan Ahmad Hafiz/0000-0003-0818-5831	Head, Division of Nephrology, Faculty of Medicine, University of Malaya, Kuala Lumpur	Head, Division of Nephrology, Faculty of Medicine, University of Malaya, Kuala Lumpur	We would like to acknowledge the managers and staffs of the participating haemodialysis centres for making it possible for us to conduct this research. Financial assistance was provided by Associate Professor Dr Lim Soo Kun, Head, Division of Nephrology, Faculty of Medicine, University of Malaya, Kuala Lumpur.	Abdalla AH, 1998, AM J NEPHROL, V18, P101, DOI 10.1159/000013316; Aksungar FB, 2005, ANN NUTR METAB, V49, P77, DOI 10.1159/000084739; Al Wakeel J, 2013, PERITON DIALYSIS INT, V33, P86, DOI 10.3747/pdi.2010.00095; Al-Arouj M, 2010, DIABETES CARE, V33, P1895, DOI 10.2337/dc10-0896; ALKHADER AA, 1991, SAUDI MED J, V12, P30; Bernieh B, 2010, SAUDI J KIDNEY DIS T, V21, P898; CHEAH SH, 1990, BRIT J NUTR, V63, P329, DOI 10.1079/BJN19900119; El-Wakil HS, 2007, SAUDI J KIDNEY DIS T, V18, P349; Farag YMK, 2012, NEPHRON CLIN PRACT, V121, pC120, DOI 10.1159/000345149; HALLAK MH, 1988, AM J CLIN NUTR, V48, P1197, DOI 10.1093/ajcn/48.5.1197; HUSAIN R, 1987, BRIT J NUTR, V58, P41, DOI 10.1079/BJN19870067; KENNEDY HJ, 1983, GUT, V24, P702, DOI 10.1136/gut.24.8.702; Khedmat H, 2010, SAUDI J KIDNEY DIS T, V21, P417; Leiper JB, 2003, EUR J CLIN NUTR, V57, pS30, DOI 10.1038/sj.ejcn.1601899; Lim Y N, 2008, Med J Malaysia, V63 Suppl C, P5; MUSTAFA KY, 1978, BRIT J NUTR, V40, P583, DOI 10.1079/BJN19780162; Perk G, 2001, J HUM HYPERTENS, V15, P723, DOI 10.1038/sj.jhh.1001262; Pew Research Center, 2009, MAPPING GLOBAL MUSLI; Prodjosudjadi W, 2009, NEPHROLOGY, V14, P669, DOI 10.1111/j.1440-1797.2009.01137.x; Qurashi S, 2012, EXP CLIN TRANSPLANT, V10, P551, DOI 10.6002/ect.2012.0139; RASHED AH, 1989, LANCET, V1, P1396; RASHED AH, 1992, BRIT MED J, V304, P521, DOI 10.1136/bmj.304.6826.521; Roky R, 2004, ANN NUTR METAB, V48, P296, DOI 10.1159/000081076; Sahin I, 2009, RENAL FAILURE, V31, P920, DOI 10.3109/08860220903219265; Salti I, 2004, DIABETES CARE, V27, P2306, DOI 10.2337/diacare.27.10.2306; Termorshuizen F, 2004, J AM SOC NEPHROL, V15, P1061, DOI 10.1097/01.ASN.0000117976.29592.93	26	11	11	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2014	9	12							e114262	10.1371/journal.pone.0114262	http://dx.doi.org/10.1371/journal.pone.0114262			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UN	25546434	Green Submitted, gold, Green Published			2022-12-27	WOS:000347120200008
J	Cui, D; Zhang, LL; Li, J; Zhao, YF; Hu, XX; Dai, YP; Zhang, R; Li, N				Cui, Dan; Zhang, Linlin; Li, Jia; Zhao, Yaofeng; Hu, Xiaoxiang; Dai, Yunping; Zhang, Ran; Li, Ning			Bovine FcRn-Mediated Human Immunoglobulin G Transfer across the Milk-Blood Barrier in Transgenic Mice	PLOS ONE			English	Article							I-RELATED RECEPTOR; PH-DEPENDENT BINDING; RAT SMALL-INTESTINE; MAMMARY-GLAND; IGG TRANSPORT; NEONATAL RAT; BIDIRECTIONAL TRANSCYTOSIS; ENDOTHELIAL-CELLS; EPITHELIAL-CELLS; HUMAN PLACENTA	Maternal-fetal IgGs transport occurs either prenatally or postnatally, which confers the newborns with passive immunity before their own immune system has matured. However, little is known about the mechanisms of postnatal IgGs passage in the mammary gland. To investigate how FcRn mediates the IgGs transport in the mammary gland, we first generated bFcRn and anti-HAV mAb transgenic mice, and then obtained HF transgenic mice expressing both transgenes by mating the above two strains. Transgene expression of bFcRn in the four lines was determined by qRT-PCR and western blot. We then localized the expression of bFcRn to the acinar epithelial cells in the mammary gland, and anti-HAV mAb was mainly detected in the acini with weak staining in the acinar epithelial cells. Human IgGs could be detected in both milk and serum of HF transgenic mice by western blot and ELISA. A significantly lower milk to serum ratio of human IgGs in HF mice compared with that of anti-HAV mAb mice, indicating that bFcRn could transport human IgGs across the milk-blood barrier from milk to serum during lactation in HF mice. While, there were no transport of murine IgGs, IgAs, or IgMs. These results provide understandings about the mechanisms of maternal-fetal immunity transfer in the mammary gland.	[Cui, Dan; Zhang, Linlin; Li, Jia; Zhao, Yaofeng; Hu, Xiaoxiang; Zhang, Ran; Li, Ning] China Agr Univ, State Key Lab Agrobiotechnol, Beijing 100094, Peoples R China; [Dai, Yunping] GenProt Biotech Ltd, Beijing, Peoples R China	China Agricultural University	Zhang, R (corresponding author), China Agr Univ, State Key Lab Agrobiotechnol, Beijing 100094, Peoples R China.	zhangran0628@gmail.com; ninglcau@cau.edu.cn			"863'' High-Tech Research Development Project [2011AA100601]; National Natural Scientific Foundation [81370840]	"863'' High-Tech Research Development Project(National High Technology Research and Development Program of China); National Natural Scientific Foundation(National Natural Science Foundation of China (NSFC))	This project was supported in part by the "863'' High-Tech Research Development Project (Project Grant No. 2011AA100601) to Professor Ning Li and the URL is http://www.most.gov.cn, and the National Natural Scientific Foundation (Project Grant No. 81370840) to Professor Ning Li and the URL is http://www.nsfc.gov.cn. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamski FM, 2000, MOL IMMUNOL, V37, P435, DOI 10.1016/S0161-5890(00)00065-1; AHOUSE JJ, 1993, J IMMUNOL, V151, P6076; Akilesh S, 2008, P NATL ACAD SCI USA, V105, P967, DOI 10.1073/pnas.0711515105; Andersen JT, 2006, EUR J IMMUNOL, V36, P3044, DOI 10.1002/eji.200636556; Antohe F, 2001, HUM IMMUNOL, V62, P93, DOI 10.1016/S0198-8859(00)00244-5; Bai Y, 2011, P NATL ACAD SCI USA, V108, P18406, DOI 10.1073/pnas.1115348108; Ben Suleiman Y, 2012, MUCOSAL IMMUNOL, V5, P87, DOI 10.1038/mi.2011.53; BENLOUNES N, 1995, BIOL NEONATE, V67, P254, DOI 10.1159/000244173; BLUMBERG RS, 1995, J CLIN INVEST, V95, P2397, DOI 10.1172/JCI117934; Borvak J, 1998, INT IMMUNOL, V10, P1289, DOI 10.1093/intimm/10.9.1289; Brambell F W, 1970, Biogr Mem Fellows R Soc, V16, P343; BRAMBELL FW, 1966, LANCET, V2, P1087, DOI 10.1016/S0140-6736(66)92190-8; BRAMBELL FWR, 1958, PROC R SOC SER B-BIO, V149, P1, DOI 10.1098/rspb.1958.0046; BUTLER JE, 1971, J DAIRY SCI, V54, P1315, DOI 10.3168/jds.S0022-0302(71)86026-5; Chaudhury C, 2003, J EXP MED, V197, P315, DOI 10.1084/jem.20021829; Cianga P, 1999, EUR J IMMUNOL, V29, P2515, DOI 10.1002/(SICI)1521-4141(199908)29:08&lt;2515::AID-IMMU2515&gt;3.0.CO;2-D; Claypool SM, 2004, MOL BIOL CELL, V15, P1746, DOI 10.1091/mbc.E03-11-0832; Dickinson BL, 1999, J CLIN INVEST, V104, P903, DOI 10.1172/JCI6968; Ellinger I, 1999, EUR J IMMUNOL, V29, P733, DOI 10.1002/(SICI)1521-4141(199903)29:03<733::AID-IMMU733>3.0.CO;2-C; Ghetie V, 1997, IMMUNOL TODAY, V18, P592, DOI 10.1016/S0167-5699(97)01172-9; Ghetie V, 2000, ANNU REV IMMUNOL, V18, P739, DOI 10.1146/annurev.immunol.18.1.739; Ghetie V, 1996, EUR J IMMUNOL, V26, P690, DOI 10.1002/eji.1830260327; HARADA E, 1994, COMP BIOCHEM PHYS A, V109, P667, DOI 10.1016/0300-9629(94)90208-9; Israel EJ, 1996, IMMUNOLOGY, V89, P573, DOI 10.1046/j.1365-2567.1996.d01-775.x; ISRAEL EJ, 1993, IMMUNOLOGY, V79, P77; Junghans RP, 1996, P NATL ACAD SCI USA, V93, P5512, DOI 10.1073/pnas.93.11.5512; Kacskovics I, 2000, J IMMUNOL, V164, P1889, DOI 10.4049/jimmunol.164.4.1889; Kacskovics I, 2006, DEV COMP IMMUNOL, V30, P1203, DOI 10.1016/j.dci.2006.02.006; KANDIL E, 1995, J IMMUNOL, V154, P5907; Kim JH, 2006, AM J PHYSIOL-GASTR L, V290, pG352, DOI 10.1152/ajpgi.00286.2005; Kuo TT, 2009, J BIOL CHEM, V284, P8292, DOI 10.1074/jbc.M805877200; LARSON BL, 1980, J DAIRY SCI, V63, P665, DOI 10.3168/jds.S0022-0302(80)82988-2; Leach JL, 1996, J IMMUNOL, V157, P3317; Li ZL, 2011, P NATL ACAD SCI USA, V108, P4388, DOI 10.1073/pnas.1012861108; Liu S, 2012, TRANSGENIC RES, V21, P407, DOI 10.1007/s11248-011-9536-4; Lu W, 2007, IMMUNOLOGY, V122, P401, DOI 10.1111/j.1365-2567.2007.02654.x; Mayer B, 2002, VET IMMUNOL IMMUNOP, V87, P327, DOI 10.1016/S0165-2427(02)00059-4; McCarthy KM, 2000, J CELL SCI, V113, P1277; Montoyo HP, 2009, P NATL ACAD SCI USA, V106, P2788, DOI 10.1073/pnas.0810796106; MORRIS IG, 1980, IMMUNOLOGY, V40, P273; Ober RJ, 2001, INT IMMUNOL, V13, P1551, DOI 10.1093/intimm/13.12.1551; Praetor A, 1999, J CELL SCI, V112, P2291; Qiao SW, 2008, P NATL ACAD SCI USA, V105, P9337, DOI 10.1073/pnas.0801717105; RAGHAVAN M, 1995, BIOCHEMISTRY-US, V34, P14649, DOI 10.1021/bi00045a005; ROBERTS DM, 1990, J CELL BIOL, V111, P1867, DOI 10.1083/jcb.111.5.1867; RODEWALD R, 1984, J CELL BIOL, V99, pS159, DOI 10.1083/jcb.99.1.159s; RODEWALD R, 1980, J CELL BIOL, V85, P18, DOI 10.1083/jcb.85.1.18; RODEWALD R, 1976, J CELL BIOL, V71, P666, DOI 10.1083/jcb.71.2.666; SCHEIFFELE P, 1995, NATURE, V378, P96, DOI 10.1038/378096a0; Schnulle PM, 2003, VET IMMUNOL IMMUNOP, V91, P227, DOI 10.1016/S0165-2427(02)00294-5; SIMISTER NE, 1985, EUR J IMMUNOL, V15, P733, DOI 10.1002/eji.1830150718; Simister NE, 1996, EUR J IMMUNOL, V26, P1527, DOI 10.1002/eji.1830260718; SIMISTER NE, 1989, NATURE, V337, P184, DOI 10.1038/337184a0; Stefaner I, 1999, J BIOL CHEM, V274, P8998, DOI 10.1074/jbc.274.13.8998; Telleman P, 2000, IMMUNOLOGY, V100, P245, DOI 10.1046/j.1365-2567.2000.00034.x; Tesar DB, 2006, TRAFFIC, V7, P1127, DOI 10.1111/j.1600-0854.2006.00457.x; Van de Perre P, 2003, VACCINE, V21, P3374, DOI 10.1016/S0264-410X(03)00336-0; Vaughn DE, 1998, STRUCTURE, V6, P63, DOI 10.1016/S0969-2126(98)00008-2; Waldmann T A, 1972, Ciba Found Symp, V9, P5; WALLACE KH, 1980, BIOCHEM J, V188, P9, DOI 10.1042/bj1880009; WATSON DL, 1980, AUST J BIOL SCI, V33, P403, DOI 10.1071/BI9800403; WEINER ML, 1988, FOOD CHEM TOXICOL, V26, P867, DOI 10.1016/0278-6915(88)90028-2; Wu Z, 2001, J BIOL CHEM, V276, P5240, DOI 10.1074/jbc.M006684200; Yu ZQ, 2006, DEV BIOL, V299, P122, DOI 10.1016/j.ydbio.2006.07.015; Zhang R, 2009, TRANSGENIC RES, V18, P445, DOI 10.1007/s11248-008-9241-0	65	11	11	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2014	9	12							e115972	10.1371/journal.pone.0115972	http://dx.doi.org/10.1371/journal.pone.0115972			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UN	25546424	Green Published, Green Submitted, gold			2022-12-27	WOS:000347120200087
J	Hoffmeister, M; Prelle, C; Kuchler, P; Kovacevic, I; Moser, M; Muller-Esterl, W; Oess, S				Hoffmeister, Meike; Prelle, Carola; Kuechler, Philipp; Kovacevic, Igor; Moser, Markus; Mueller-Esterl, Werner; Oess, Stefanie			The Ubiquitin E3 Ligase NOSIP Modulates Protein Phosphatase 2A Activity in Craniofacial Development	PLOS ONE			English	Article							INTERACTING PROTEIN; ERYTHROPOIETIN RECEPTOR; VENTRAL FOREBRAIN; OPITZ-SYNDROME; UBIQUITYLATION; SYNTHASE; IDENTIFICATION; MUTATIONS; MID1; GENE	Holoprosencephaly is a common developmental disorder in humans characterised by incomplete brain hemisphere separation and midface anomalies. The etiology of holoprosencephaly is heterogeneous with environmental and genetic causes, but for a majority of holoprosencephaly cases the genes associated with the pathogenesis could not be identified so far. Here we report the generation of knockout mice for the ubiquitin E3 ligase NOSIP. The loss of NOSIP in mice causes holoprosencephaly and facial anomalies including cleft lip/palate, cyclopia and facial midline clefting. By a mass spectrometry based protein interaction screen we identified NOSIP as a novel interaction partner of protein phosphatase PP2A. NOSIP mediates the monoubiquitination of the PP2A catalytic subunit and the loss of NOSIP results in an increase in PP2A activity in craniofacial tissue in NOSIP knockout mice. We conclude, that NOSIP is a critical modulator of brain and craniofacial development in mice and a candidate gene for holoprosencephaly in humans.	[Hoffmeister, Meike; Prelle, Carola; Kuechler, Philipp; Kovacevic, Igor; Mueller-Esterl, Werner; Oess, Stefanie] Goethe Univ Frankfurt, Sch Med, Inst Biochem 2, D-60054 Frankfurt, Germany; [Moser, Markus] Max Planck Inst Biochem, Dept Mol Med, D-82152 Martinsried, Germany	Goethe University Frankfurt; Max Planck Society	Oess, S (corresponding author), Goethe Univ Frankfurt, Sch Med, Inst Biochem 2, D-60054 Frankfurt, Germany.	oess@biochem2.de		Kovacevic, Igor/0000-0003-1834-2378	German research foundation (DFG) [SFB 834 A3]; Adolf Messer Foundation	German research foundation (DFG)(German Research Foundation (DFG)); Adolf Messer Foundation	This work was supported by the German research foundation (DFG http://www.dfg.de) grant number SFB 834 A3 and by the Adolf Messer Foundation (http://www.adolf-messer-stiftung.de) to SO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Batut J, 2008, DEVELOPMENT, V135, P2927, DOI 10.1242/dev.020842; Bengtsson L, 2009, J CELL SCI, V122, P1248, DOI 10.1242/jcs.039552; Brautigan DL, 2012, FEBS J; Chai Y, 2006, DEV DYNAM, V235, P2353, DOI 10.1002/dvdy.20833; Cho US, 2007, NATURE, V445, P53, DOI 10.1038/nature05351; Chu JH, 2005, DEVELOPMENT, V132, P5539, DOI 10.1242/dev.02157; Collison A, 2013, NATURE MED; de Bie P, 2011, CELL DEATH DIFFER, V18, P1393, DOI 10.1038/cdd.2011.16; Dedio J, 2001, FASEB J, V15, P79, DOI 10.1096/fj.00-0078com; Dreyer J, 2004, J NEUROSCI, V24, P10454, DOI 10.1523/JNEUROSCI.2265-04.2004; Dreyer J, 2003, NEUROSCI LETT, V350, P13, DOI 10.1016/S0304-3940(03)00771-7; Du HJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107428; FASSLER R, 1995, GENE DEV, V9, P1896, DOI 10.1101/gad.9.15.1896; Fernandes M, 2007, DEVELOPMENT, V134, P3789, DOI 10.1242/dev.004325; Friedman AD, 2003, J BIOL CHEM, V278, P26851, DOI 10.1074/jbc.M210039200; Fulda S, 2012, EMBO MOL MED, V4, P545, DOI 10.1002/emmm.201100707; Geng X, 2008, DEV CELL, V15, P236, DOI 10.1016/j.devcel.2008.07.003; Geng X, 2009, J CLIN INVEST, V119, P1403, DOI 10.1172/JCI38937; Grabbe C, 2011, NAT REV MOL CELL BIO, V12, P295, DOI 10.1038/nrm3099; Haglund K, 2005, EMBO J, V24, P3353, DOI 10.1038/sj.emboj.7600808; Hombauer H, 2007, PLOS BIOL, V5, P1355, DOI 10.1371/journal.pbio.0050155; Huang PL, 2000, J AM SOC NEPHROL, V11, pS120; Husnjak K, 2012, ANNU REV BIOCHEM, V81, P291, DOI 10.1146/annurev-biochem-051810-094654; Ikeda F, 2008, EMBO REP, V9, P536, DOI 10.1038/embor.2008.93; Janssens V, 2008, TRENDS BIOCHEM SCI, V33, P113, DOI 10.1016/j.tibs.2007.12.004; Jia H, 2009, DEVELOPMENT, V136, P307, DOI 10.1242/dev.030015; Konig P, 2005, J HISTOCHEM CYTOCHEM, V53, P155, DOI 10.1369/jhc.4A6453.2005; Konig P, 2002, GASTROENTEROLOGY, V123, P314, DOI 10.1053/gast.2002.34212; Krauss S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007471; Lancioni A, 2010, J NEUROSCI, V30, P2880, DOI 10.1523/JNEUROSCI.4196-09.2010; Latta EJ, 2012, MECH DEVELOP, V128, P560, DOI 10.1016/j.mod.2012.01.002; McConnell JL, 2010, BIOCHEMISTRY-US, V49, P1713, DOI 10.1021/bi901837h; Muenke M, 2000, CURR OPIN GENET DEV, V10, P262, DOI 10.1016/S0959-437X(00)00084-8; Murray JC, 2002, CLIN GENET, V61, P248, DOI 10.1034/j.1399-0004.2002.610402.x; Nagy V, 2010, BIOL CHEM, V391, P163, DOI 10.1515/bc.2010.021; Oess S, 2006, BIOCHEM J, V396, P401, DOI 10.1042/BJ20060321; Oshikawa K, 2012, J PROTEOME RES, V11, P796, DOI 10.1021/pr200668y; Pineda-Alvarez DE, 2012, HUM GENET, V131, P301, DOI 10.1007/s00439-011-1078-6; Quaderi NA, 1997, NAT GENET, V17, P285, DOI 10.1038/ng1197-285; Roessler E, 2010, AM J MED GENET C, V154C, P52, DOI 10.1002/ajmg.c.30236; Sadowski M, 2012, IUBMB LIFE, V64, P136, DOI 10.1002/iub.589; Schleicher M, 2005, MOL CELL BIOL, V25, P8251, DOI 10.1128/MCB.25.18.8251-8258.2005; Sents W, 2013, FEBS J, V280, P644, DOI 10.1111/j.1742-4658.2012.08579.x; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Shi YG, 2009, CELL, V139, P468, DOI 10.1016/j.cell.2009.10.006; Slupe Andrew M, 2011, Enzyme Res, V2011, P398751, DOI 10.4061/2011/398751; Su Y, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001747; Taniguchi K, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002524; Trockenbacher A, 2001, NAT GENET, V29, P287, DOI 10.1038/ng762; Tsai PT, 2006, J NEUROSCI, V26, P1269, DOI 10.1523/JNEUROSCI.4480-05.2006; Udeshi ND, 2013, NAT PROTOC, V8, P1950, DOI 10.1038/nprot.2013.120; van Wijk SJL, 2010, FASEB J, V24, P981, DOI 10.1096/fj.09-136259; Viallet J, 2003, BIOCHIMIE, V85, P753, DOI 10.1016/J.biochi.2003.09.009; Virshup DM, 2009, MOL CELL, V33, P537, DOI 10.1016/j.molcel.2009.02.015; Volpe P, 2009, PRENATAL DIAG, V29, P340, DOI 10.1002/pd.2208; Wagner SA, 2012, MOL CELL PROTEOMICS, V11, P1578, DOI 10.1074/mcp.M112.017905; Watkins GR, 2012, J BIOL CHEM, V287, P24207, DOI 10.1074/jbc.M112.368613; Wiszniak S, 2013, DEV BIOL, V383, P186, DOI 10.1016/j.ydbio.2013.09.024; Yu XB, 2002, DEVELOPMENT, V129, P505; Yu XW, 2012, J MOL HISTOL, V43, P661, DOI 10.1007/s10735-012-9460-9; Zambrowicz BP, 1998, NATURE, V392, P608, DOI 10.1038/33423; Zhang W, 2006, DEV CELL, V10, P657, DOI 10.1016/j.devcel.2006.04.005; Zhang W, 2011, DIS MODEL MECH, V4, P368, DOI 10.1242/dmm.005744; Zou WG, 2011, NAT CELL BIOL, V13, P59, DOI 10.1038/ncb2134	64	12	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2014	9	12							e0116150	10.1371/journal.pone.0116150	http://dx.doi.org/10.1371/journal.pone.0116150			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UN	25546391	Green Published, gold, Green Submitted			2022-12-27	WOS:000347120200101
J	Zaar, M; Fedyk, CG; Pidcoke, HF; Scherer, MR; Ryan, KL; Rickards, CA; Hinojosa-Laborde, C; Convertino, VA; Cap, AP				Zaar, Morten; Fedyk, Chriselda G.; Pidcoke, Heather F.; Scherer, Michael R.; Ryan, Kathy L.; Rickards, Caroline A.; Hinojosa-Laborde, Carmen; Convertino, Victor A.; Cap, Andrew P.			Platelet Activation after Presyncope by Lower Body Negative Pressure in Humans	PLOS ONE			English	Article							BLOOD; VASOPRESSIN; RESPONSES; MECHANISMS; TOLERANCE; STATE	Central hypovolemia elevates hemostatic activity which is essential for preventing exsanguination after trauma, but platelet activation to central hypovolemia has not been described. We hypothesized that central hypovolemia induced by lower body negative pressure (LBNP) activates platelets. Eight healthy subjects were exposed to progressive central hypovolemia by LBNP until presyncope. At baseline and 5 min after presyncope, hemostatic activity of venous blood was evaluated by flow cytometry, thrombelastography, and plasma markers of coagulation and fibrinolysis. Cell counts were also determined. Flow cytometry revealed that LBNP increased mean fluorescence intensity of PAC-1 by 1959 +/- 455 units (P< 0.001) and percent of fluorescence-positive platelets by 27 +/- 18%-points (P=0.013). Thrombelastography demonstrated that coagulation was accelerated (R-time decreased by 0.8 +/- 0.4 min (P=0.001)) and that clot lysis increased (LY60 by 6.0 +/- 5.8%-points (P=0.034)). Plasma coagulation factor VIII and von Willebrand factor ristocetin cofactor activity increased (P=0.011 and P=0.024, respectively), demonstrating increased coagulation activity, while von Willebrand factor antigen was unchanged. Plasma protein C activity and tissue-type plasminogen activator increased (P=0.007 and P=0.017, respectively), and D-dimer increased by 0.03 +/- 0.02 mg l(-1) (P=0.031), demonstrating increased fibrinolytic activity. Plasma prothrombin time and activated partial thromboplastin time were unchanged. Platelet count increased by 15 +/- 13% (P=0.014) and red blood cells by 9 +/- 4% (P=0.002). In humans, LBNP-induced presyncope activates platelets, as evidenced by increased exposure of active glycoprotein IIb/IIIa, accelerates coagulation. LBNP activates fibrinolysis, similar to hemorrhage, but does not alter coagulation screening tests, such as prothrombin time and activated partial thromboplastin time. LBNP results in increased platelet counts, but also in hemoconcentration.	[Zaar, Morten] Univ Texas Hlth Sci Ctr San Antonio, San Antonio, TX 78229 USA; [Fedyk, Chriselda G.; Pidcoke, Heather F.; Scherer, Michael R.; Ryan, Kathy L.; Hinojosa-Laborde, Carmen; Convertino, Victor A.; Cap, Andrew P.] US Army Inst Surg Res, Ft Sam Houston, TX USA; [Rickards, Caroline A.] Univ N Texas, Hlth Sci Ctr Ft Worth, Ft Worth, TX USA	University of Texas System; University of Texas Health San Antonio; United States Department of Defense; United States Army; University of North Texas System; University of North Texas Health Science Center	Zaar, M (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, San Antonio, TX 78229 USA.	zaar@uthscsa.edu	Pidcoke, Heather/K-7730-2019	Rickards, Caroline/0000-0002-5759-6912; Convertino, Victor/0000-0001-9246-0554	United States Army, Medical Research and Materiel Command	United States Army, Medical Research and Materiel Command(United States Department of DefenseUnited States ArmyU.S. Army Medical Research & Materiel Command (USAMRMC))	This study was funded by the United States Army, Medical Research and Materiel Command. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aleman MM, 2014, THROMB RES, V133, pS38, DOI 10.1016/j.thromres.2014.03.017; Austin AW, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/480648; BOUNAMEAUX H, 1994, THROMB HAEMOSTASIS, V71, P1; Brown NJ, 1999, HEART FAIL REV, V3, P193, DOI [10.1023/A:1009757416302, DOI 10.1023/A:1009757416302]; Cai Y, 2000, J APPL PHYSIOL, V89, P1569, DOI 10.1152/jappl.2000.89.4.1569; Convertino VA, 2000, CLIN PHYSIOL, V20, P177; Cvirn G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042221; Ebert RV, 1941, AM J MED SCI, V201, P655, DOI 10.1097/00000441-194105000-00005; Evans RG, 2001, CLIN EXP PHARMACOL P, V28, P479, DOI 10.1046/j.1440-1681.2001.03473.x; Greenleaf JE, 2000, AM J PHYSIOL-REG I, V279, pR822, DOI 10.1152/ajpregu.2000.279.3.R822; HARIMAN H, 1989, THROMB HAEMOSTASIS, V61, P298; HIRSCH AT, 1993, J APPL PHYSIOL, V75, P1984, DOI 10.1152/jappl.1993.75.5.1984; HJEMDAHL P, 1983, AM J PHYSIOL, V245, pH447, DOI 10.1152/ajpheart.1983.245.3.H447; Jacoby RC, 2001, J TRAUMA, V51, P639, DOI 10.1097/00005373-200110000-00003; Jennings LK, 2009, THROMB HAEMOSTASIS, V102, P248, DOI 10.1160/TH09-03-0192; LIBRE EP, 1968, BLOOD, V31, P358, DOI 10.1182/blood.V31.3.358.358; Masoud M, 2008, HYPERTENSION, V51, P1545, DOI 10.1161/HYPERTENSIONAHA.108.112003; Monroe DM, 2006, ARTERIOSCL THROM VAS, V26, P41, DOI 10.1161/01.ATV.0000193624.28251.83; NORDFANG O, 1993, THROMB HAEMOSTASIS, V70, P448; Nurden AT, 2013, SEMIN THROMB HEMOST, V39, P642, DOI 10.1055/s-0033-1353393; Park MS, 2009, J TRAUMA, V67, P266, DOI 10.1097/TA.0b013e3181ae6f1c; Roberts I, 2011, LANCET, V377, P1096, DOI 10.1016/S0140-6736(11)60278-X; Ruttmann TG, 2003, ANAESTH INTENS CARE, V31, P40, DOI 10.1177/0310057X0303100107; Ryan KL, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00110; Schagatay E, 2001, J APPL PHYSIOL, V90, P1623, DOI 10.1152/jappl.2001.90.4.1623; SHARE L, 1967, ENDOCRINOLOGY, V81, P1140, DOI 10.1210/endo-81-5-1140; Tomasiak M, 2008, BLOOD COAGUL FIBRIN, V19, P615, DOI 10.1097/MBC.0b013e328309905d; Vlot AJ, 1998, THROMB HAEMOSTASIS, V79, P456; von Kanel R, 2000, EUR J HAEMATOL, V65, P357, DOI 10.1034/j.1600-0609.2000.065006357.x; Zaar M, 2009, CLIN PHYSIOL FUNCT I, V29, P427, DOI 10.1111/j.1475-097X.2009.00890.x; Zaar M, 2014, BLOOD COAGUL FIBRIN, V25, P592, DOI 10.1097/MBC.0000000000000114	31	10	10	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2014	9	12							e0116174	10.1371/journal.pone.0116174	http://dx.doi.org/10.1371/journal.pone.0116174			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UN	25546432	gold, Green Published, Green Submitted			2022-12-27	WOS:000347120200104
J	Dasgupta, MG; Dharanishanthi, V; Agarwal, I; Krutovsky, KV				Dasgupta, Modhumita Ghosh; Dharanishanthi, Veeramuthu; Agarwal, Ishangi; Krutovsky, Konstantin V.			Development of Genetic Markers in Eucalyptus Species by Target Enrichment and Exome Sequencing	PLOS ONE			English	Article							SINGLE-NUCLEOTIDE POLYMORPHISMS; PINUS-TAEDA L.; COTTONWOOD POPULUS-TRICHOCARPA; DOMAIN TRANSCRIPTION FACTOR; THROUGHPUT SNP DISCOVERY; WOOD-FORMING TISSUES; CELL-WALL FORMATION; RAPD MARKERS; LIGNIN BIOSYNTHESIS; LINKAGE DISEQUILIBRIUM	The advent of next-generation sequencing has facilitated large-scale discovery, validation and assessment of genetic markers for high density genotyping. The present study was undertaken to identify markers in genes supposedly related to wood property traits in three Eucalyptus species. Ninety four genes involved in xylogenesis were selected for hybridization probe based nuclear genomic DNA target enrichment and exome sequencing. Genomic DNA was isolated from the leaf tissues and used for on-array probe hybridization followed by Illumina sequencing. The raw sequence reads were trimmed and high-quality reads were mapped to the E. grandis reference sequence and the presence of single nucleotide variants (SNVs) and insertions/deletions (InDels) were identified across the three species. The average read coverage was 216X and a total of 2294 SNVs and 479 InDels were discovered in E. camaldulensis, 2383 SNVs and 518 InDels in E. tereticornis, and 1228 SNVs and 409 InDels in E. grandis. Additionally, SNV calling and InDel detection were conducted in pair-wise comparisons of E. tereticornis vs. E. grandis, E. camaldulensis vs. E. tereticornis and E. camaldulensis vs. E. grandis. This study presents an efficient and high throughput method on development of genetic markers for family-based QTL and association analysis in Eucalyptus.	[Dasgupta, Modhumita Ghosh; Dharanishanthi, Veeramuthu] Inst Forest Genet & Tree Breeding, Div Plant Biotechnol, Coimbatore 641002, Tamil Nadu, India; [Agarwal, Ishangi] Genotyp Technol Private Ltd, Bangalore 560094, India; [Krutovsky, Konstantin V.] Univ Gottingen, Dept Forest Genet, D-37077 Gottingen, Germany; [Krutovsky, Konstantin V.] Univ Gottingen, Busgen Inst, D-37077 Gottingen, Germany; [Krutovsky, Konstantin V.] Texas A&M Univ, Dept Ecosystem Sci & Management, College Stn, TX 77843 USA; [Krutovsky, Konstantin V.] Russian Acad Sci, NI Vavilov Inst Gen Genet, Moscow 119333, Russia; [Krutovsky, Konstantin V.] Siberian Fed Univ, Genome Res & Educ Ctr, Krasnoyarsk 660036, Russia	Indian Council of Forestry Research & Education (ICFRE); Institute of Forest Genetics & Tree Breeding (IFGTB); University of Gottingen; University of Gottingen; Texas A&M University System; Texas A&M University College Station; Russian Academy of Sciences; Vavilov Institute of General Genetics; Siberian Federal University	Dasgupta, MG (corresponding author), Inst Forest Genet & Tree Breeding, Div Plant Biotechnol, PB 1061,R S Puram, Coimbatore 641002, Tamil Nadu, India.	modhumitaghosh@hotmail.com	Dasgupta, Modhumita Ghosh/AAX-9028-2020; Krutovsky, Konstantin V./A-5419-2012	Dasgupta, Modhumita Ghosh/0000-0001-8878-5911; Krutovsky, Konstantin V./0000-0002-8819-7084; , Dharanishanthi/0000-0001-6910-3524	Department of Biotechnology, Government of India under the DBT-CREST Awardship [BT/IN/CREST-Awards/15/MDG/2010-11]; Department of Biotechnology, Government of India [BT/PR10055/PBD/16/772/2007]	Department of Biotechnology, Government of India under the DBT-CREST Awardship; Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India)	The funding for the research work was provided to MDG by Department of Biotechnology, Government of India under the DBT-CREST Awardship with grant number BT/IN/CREST-Awards/15/MDG/2010-11 and under the research project with grant number BT/PR10055/PBD/16/772/2007. The funding support as research fellowship was provided to VD by Department of Biotechnology, Government of India under the research project with grant number BT/PR10055/PBD/16/772/2007. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen AM, 2011, PLANT BIOTECHNOL J, V9, P1086, DOI 10.1111/j.1467-7652.2011.00628.x; Andersson-Gunneras S, 2003, PLANT J, V34, P339, DOI 10.1046/j.1365-313X.2003.01727.x; Arumugasundaram S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028252; Balasaravanan T, 2005, TREE PHYSIOL, V25, P1295, DOI 10.1093/treephys/25.10.1295; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Brandstrom M, 2007, GENETICS, V176, P1691, DOI 10.1534/genetics.107.070805; Britten RJ, 2003, P NATL ACAD SCI USA, V100, P4661, DOI 10.1073/pnas.0330964100; Brooker MIH, 2000, AUST SYST BOT, V13, P79, DOI 10.1071/SB98008; Byers RL, 2012, THEOR APPL GENET, V124, P1201, DOI 10.1007/s00122-011-1780-8; Byrne M, 1998, HEREDITY, V81, P225, DOI 10.1038/sj.hdy.6883860; Chagne D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031745; Chezhian P, 2010, NEW FOREST, V40, P85, DOI 10.1007/s11056-009-9184-1; Ching A, 2002, BMC GENET, V3, DOI 10.1186/1471-2156-3-19; Chu YG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098334; Cseke LJ, 2003, GENE, V318, P55, DOI 10.1016/S0378-1119(03)00765-0; Doughty RW, 2000, EUCALYPTUS NATURAL C; Eckert AJ, 2009, TREE GENET GENOMES, V5, P225, DOI 10.1007/s11295-008-0183-8; Feltus FA, 2004, GENOME RES, V14, P1812, DOI 10.1101/gr.2479404; Gaiotto FA, 1997, P IUFRO C SILV IMPR, V2, P46; GRATTAPAGLIA D, 1994, GENETICS, V137, P1121; Grattapaglia D., 1992, RESOLVING TROPICAL F, P436; Grattapaglia D, 2012, TREE GENET GENOMES, V8, P463, DOI 10.1007/s11295-012-0491-x; Grattapaglia D, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-65; Hamilton JP, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-302; Harakava R, 2005, GENET MOL BIOL, V28, P601, DOI 10.1590/S1415-47572005000400015; Harismendy O, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r32; Hayashi K, 2006, THEOR APPL GENET, V113, P251, DOI 10.1007/s00122-006-0290-6; Hefer C., 2011, BMC P, V5, pO49, DOI [10.1186/1753-6561-5-S7-O49, DOI 10.1186/1753-6561-5-S7-O49]; Hendre PS, 2012, PLANT BIOTECHNOL J, V10, P646, DOI 10.1111/j.1467-7652.2012.00699.x; Hertzberg M, 2001, P NATL ACAD SCI USA, V98, P14732, DOI 10.1073/pnas.261293398; Hirakawa H, 2011, PLANT BIOTECHNOL-NAR, V28, P471, DOI 10.5511/plantbiotechnology.11.1027b; Hodges E, 2009, NAT PROTOC, V4, P960, DOI 10.1038/nprot.2009.68; Howe GT, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-137; Hu RB, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-145; Hyten DL, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-38; Iglesias I., 2009, EUCALYPTOLOGICS INFO; Jensen JK, 2011, PLANT J, V66, P387, DOI 10.1111/j.1365-313X.2010.04475.x; Jones E, 2009, MOL BREEDING, V24, P165, DOI 10.1007/s11032-009-9281-z; Junghans DT, 2003, THEOR APPL GENET, V108, P175, DOI 10.1007/s00122-003-1415-9; Jupe F, 2013, PLANT J, V76, P530, DOI 10.1111/tpj.12307; Kallarackal J, 1997, FOREST ECOL MANAG, V95, P53, DOI 10.1016/S0378-1127(97)00004-2; Kallarackal J., 2002, RECENT EUCALYPT RES, P94; Kalluri UC, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-59; Kaya HB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073674; Keller G, 2009, TREE GENET GENOMES, V5, P317, DOI 10.1007/s11295-008-0184-7; Kenny EM, 2011, DNA RES, V18, P31, DOI 10.1093/dnares/dsq029; Kirst M, 2003, P NATL ACAD SCI USA, V100, P7383, DOI 10.1073/pnas.1132171100; Kirst M, 2004, PLANT PHYSIOL, V135, P2368, DOI 10.1104/pp.103.037960; KLOCKO AL, 2013, P PLANT AN GEN 22 HE; KONG F, 2013, J PLANT BIOCH PHYSL, V1, P2; Kubo M, 2005, GENE DEV, V19, P1855, DOI 10.1101/gad.1331305; Kulheim C, 2011, NEW PHYTOL, V191, P1041, DOI 10.1111/j.1469-8137.2011.03769.x; Kulheim C, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-452; Kumar S., 2012, INT J COMP APP IRAFI, V5, P1; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Le Dantec L, 2004, PLANT MOL BIOL, V54, P461, DOI 10.1023/B:PLAN.0000036376.11710.6f; Lenhard M, 2002, DEVELOPMENT, V129, P3195; Li EY, 2012, NEW PHYTOL, V194, P102, DOI 10.1111/j.1469-8137.2011.04016.x; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li YL, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-6; Lijavetzky D, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-424; LIMA BM, 2011, BMC PROC SUPPL 7, V5, pP31, DOI DOI 10.1186/1753-6561-5-S7-P31; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mamanova L, 2010, NAT METHODS, V7, P111, DOI 10.1038/nmeth.1419; Mardis ER, 2008, TRENDS GENET, V24, P133, DOI 10.1016/j.tig.2007.12.007; Marques CM, 1999, THEOR APPL GENET, V99, P936, DOI 10.1007/s001220051400; Marques CM, 1998, THEOR APPL GENET, V96, P727, DOI 10.1007/s001220050795; Mauriat M, 2009, PLANT J, V58, P989, DOI 10.1111/j.1365-313X.2009.03836.x; Meirmans PG, 2007, CAN J BOT, V85, P1082, DOI 10.1139/B07-069; Mills RE, 2006, GENOME RES, V16, P1182, DOI 10.1101/gr.4565806; Mizrachi E, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-681; Moghaddam SM, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00185; Mokry M, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq072; Muchero W, 2009, P NATL ACAD SCI USA, V106, P18159, DOI 10.1073/pnas.0905886106; Muro-Abad J. I., 2005, Scientia Forestalis, P53; Myburg AA, 2003, THEOR APPL GENET, V107, P1028, DOI 10.1007/s00122-003-1347-4; Myburg AA, 2014, NATURE, V510, P356, DOI 10.1038/nature13308; Neves LG, 2014, G3-GENES GENOM GENET, V4, P29, DOI 10.1534/g3.113.008714; Nieminen K, 2008, P NATL ACAD SCI USA, V105, P20032, DOI 10.1073/pnas.0805617106; Nordborg M, 2008, NATURE, V456, P720, DOI 10.1038/nature07629; Novaes E, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-312; Ohashi-Ito K, 2010, CURR OPIN PLANT BIOL, V13, P670, DOI 10.1016/j.pbi.2010.08.011; Ollitrault F, 2012, AM J BOT, V99, pE268, DOI 10.3732/ajb.1100569; Ometto L, 2005, GENETICS, V169, P1521, DOI 10.1534/genetics.104.037689; Paiva JAP, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-137; Park S, 2004, MOL BREEDING, V14, P429, DOI 10.1007/s11032-004-0603-x; Paszkiewicz K, 2012, BIOINFORMATICS FOR HIGH THROUGHPUT SEQUENCING, P231, DOI 10.1007/978-1-4614-0782-9_14; Paux E, 2005, NEW PHYTOL, V167, P89, DOI 10.1111/j.1469-8137.2005.01396.x; Pavy N, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-21; Perdereau AC, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-114; Poltri SNM, 2003, TREE PHYSIOL, V23, P625, DOI 10.1093/treephys/23.9.625; Potts BM., 2004, ENCY FOREST SCI, P1480, DOI [10.1016/B0-12-145160-7/00084-3, DOI 10.1016/B0-12-145160-7/00084-3]; RASMUSSENPOBLET.S, 2008, ELECTRON J BIOTECHN, V11, pP1; Rengel D, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-36; Resende MDV, 2012, NEW PHYTOL, V194, P116, DOI 10.1111/j.1469-8137.2011.04038.x; Ruprecht C, 2011, FRONT PLANT SCI, V2, DOI 10.3389/fpls.2011.00023; Saintenac C, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-9-r88; Salathia N, 2007, PLANT J, V51, P727, DOI 10.1111/j.1365-313X.2007.03194.x; Sansaloni CP, 2010, PLANT METHODS, V6, DOI 10.1186/1746-4811-6-16; Schneeberger K, 2011, TRENDS PLANT SCI, V16, P282, DOI 10.1016/j.tplants.2011.02.006; Schroeder H., 2011, BMC P, V5, P1, DOI [10.1186/1753-6561-5-S7-P56, DOI 10.1186/1753-6561-5-S7-P56]; SEXTON T, 2011, THESIS SO CROSS U LI; Shao HJ, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks1143; Shendure J, 2008, NAT BIOTECHNOL, V26, P1135, DOI 10.1038/nbt1486; Shepherd M, 1999, THEOR APPL GENET, V99, P1207, DOI 10.1007/s001220051326; Shi R, 2010, PLANT CELL PHYSIOL, V51, P144, DOI 10.1093/pcp/pcp175; SINGH P, 2014, P PLANT AN GEN 22 HE; Singh TR, 2011, J GENET, V90, pE34; Southerton SG, 2010, AUST FORESTRY, V73, P259, DOI 10.1080/00049158.2010.10676337; Sterky F, 1998, P NATL ACAD SCI USA, V95, P13330, DOI 10.1073/pnas.95.22.13330; Teixeira J, 2011, BMC P S7, V5, pP40, DOI DOI 10.1186/1753-6561-5-S7-P40; Tennessen JA, 2013, G3-GENES GENOM GENET, V3, P1341, DOI 10.1534/g3.113.006288; Thamarus KA, 2002, THEOR APPL GENET, V104, P379, DOI 10.1007/s001220100717; Thavamanikumar S, 2011, AUST FORESTRY, V74, P23, DOI 10.1080/00049158.2011.10676342; Thumma BR, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-364; Thumma BR, 2005, GENETICS, V171, P1257, DOI 10.1534/genetics.105.042028; Trick M, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-14; Verhaegen D, 1997, THEOR APPL GENET, V95, P597, DOI 10.1007/s001220050601; Verhaegen D, 1996, GENOME, V39, P1051, DOI 10.1139/g96-132; Villar E, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-538; Waugh R, 2009, CURR OPIN PLANT BIOL, V12, P218, DOI 10.1016/j.pbi.2008.12.007; Wegrzyn JL, 2010, NEW PHYTOL, V188, P515, DOI 10.1111/j.1469-8137.2010.03415.x; Winfield MO, 2012, PLANT BIOTECHNOL J, V10, P733, DOI 10.1111/j.1467-7652.2012.00713.x; Wong MML, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-342; Wu XL, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-469; Yang XH, 2011, PLANT SCI, V181, P675, DOI 10.1016/j.plantsci.2011.01.020; Zhang X, 2009, GENETICS, V182, P943, DOI 10.1534/genetics.109.103499; Zhong RQ, 2006, PLANT CELL, V18, P3158, DOI 10.1105/tpc.106.047399; Zhou LC, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-703	130	28	30	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2015	10	1							e0116528	10.1371/journal.pone.0116528	http://dx.doi.org/10.1371/journal.pone.0116528			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ4OZ	25602379	gold, Green Published, Green Submitted			2022-12-27	WOS:000348203500028
J	Calve, S; Ready, A; Huppenbauer, C; Main, R; Neu, CP				Calve, Sarah; Ready, Andrew; Huppenbauer, Christopher; Main, Russell; Neu, Corey P.			Optical Clearing in Dense Connective Tissues to Visualize Cellular Connectivity In Situ	PLOS ONE			English	Article							ARTICULAR-CARTILAGE; BETA-CATENIN; MORPHOLOGY; CELLS; CHONDROCYTE; EXPRESSION; MOUSE; RECONSTRUCTION; CYTOSKELETON; MICROSCOPY	Visualizing the three-dimensional morphology and spatial patterning of cells embedded deep within dense connective tissues of the musculoskeletal system has been possible only by utilizing destructive techniques. Here we utilize fructose-based clearing solutions to image cell connectivity and deep tissue-scale patterning in situ by standard confocal microscopy. Optical clearing takes advantage of refractive index matching of tissue and the embedding medium to visualize light transmission through a broad range of bovine and whole mount murine tissues, including cartilage, bone, and ligament, of the head and hindlimb. Using non-destructive methods, we show for the first time intercellular chondrocyte connections throughout the bulk of cartilage, and we reveal in situ patterns of osteocyte processes and the lacunar-canalicular system deep within mineralized cortical bone. Optical clearing of connective tissues is expected to find broad application for the study of cell responses in normal physiology and disease pathology.	[Calve, Sarah; Ready, Andrew; Main, Russell; Neu, Corey P.] Purdue Univ, Weldon Sch Biomed Engn, W Lafayette, IN 47907 USA; [Huppenbauer, Christopher] W Nuhsbaum Inc, Mchenry, IL USA; [Main, Russell] Purdue Univ, Dept Basic Med Sci, W Lafayette, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Calve, S (corresponding author), Purdue Univ, Weldon Sch Biomed Engn, W Lafayette, IN 47907 USA.	scalve@purdue.edu; cpneu@purdue.edu			National Institutes of Health (NIH) [R01 AR063712, R21 AR064178, R21 AR066230, R21 AR065659, R03 AR065201]; NSF [1349735]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R21AR065659, R21AR064178, R01AR063712, R21AR066230, R03AR065201] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	Funding: This research was supported in part by National Institutes of Health (NIH) grants R01 AR063712, R21 AR064178, R21 AR066230, R21 AR065659, and R03 AR065201, and NSF CAREER 1349735. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bush PG, 2003, OSTEOARTHR CARTILAGE, V11, P242, DOI 10.1016/S1063-4584(02)00369-2; Calle E. A., 2014, TISSUE ENG C; Chen JQ, 2013, J BONE MINER RES, V28, P1160, DOI 10.1002/jbmr.1834; Chung K, 2013, NATURE, V497, P332, DOI 10.1038/nature12107; DENT JA, 1989, DEVELOPMENT, V105, P61; Erturk A, 2012, NAT MED, V18, P166, DOI 10.1038/nm.2600; Fu YY, 2013, AM J PHYSIOL-GASTR L, V304, pG1, DOI 10.1152/ajpgi.00209.2012; Genina EA, 2010, EXPERT REV MED DEVIC, V7, P825, DOI 10.1586/ERD.10.50; Hama H, 2011, NAT NEUROSCI, V14, P1481, DOI 10.1038/nn.2928; Hambach L, 1998, ARTHRITIS RHEUM, V41, P986, DOI 10.1002/1529-0131(199806)41:6<986::AID-ART5>3.0.CO;2-N; Himeno-Ando A, 2012, BIOCHEM BIOPH RES CO, V417, P765, DOI 10.1016/j.bbrc.2011.12.031; Holloway I, 2004, OSTEOARTHR CARTILAGE, V12, P17, DOI 10.1016/j.joca.2003.09.001; Hutcheson DA, 2009, GENE DEV, V23, P997, DOI 10.1101/gad.1769009; Jung Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094054; Ke MT, 2013, NAT NEUROSCI, V16, P1154, DOI 10.1038/nn.3447; Kerschnitzki M, 2011, J STRUCT BIOL, V173, P303, DOI 10.1016/j.jsb.2010.11.014; Kostrominova TY, 2011, MICROSC RES TECHNIQ, V74, P18, DOI 10.1002/jemt.20865; Kuwajima T, 2013, DEVELOPMENT, V140, P1364, DOI 10.1242/dev.091844; Lang D, 2005, NATURE, V433, P884, DOI 10.1038/nature03292; Langelier E, 2000, J HISTOCHEM CYTOCHEM, V48, P1307, DOI 10.1177/002215540004801002; Le Graverand MPH, 2001, J ANAT, V198, P525, DOI 10.1046/j.1469-7580.2000.19850525.x; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; McNeilly CM, 1996, J ANAT, V189, P593; Moy AJ, 2014, BIOMED OPT EXPRESS, V5, P69, DOI 10.1364/BOE.5.000069; Murray DH, 2010, J ORTHOP RES, V28, P1507, DOI 10.1002/jor.21155; Muzumdar MD, 2007, GENESIS, V45, P593, DOI 10.1002/dvg.20335; Neu CP, 2007, ARTHRITIS RHEUM-US, V56, P3706, DOI 10.1002/art.23024; Ralphs JR, 2002, MATRIX BIOL, V21, P67, DOI 10.1016/S0945-053X(01)00179-2; Rosenzweig DH, 2012, OSTEOARTHR CARTILAGE, V20, P1591, DOI 10.1016/j.joca.2012.08.012; Rylander CG, 2006, J BIOMED OPT, V11, DOI 10.1117/1.2343208; Sasazaki Y, 2008, RHEUMATOLOGY, V47, P1641, DOI 10.1093/rheumatology/ken341; Scott GD, 2014, AM J RESP CELL MOL B, DOI [10.1165/rcmb.2013-0284OC, DOI 10.1165/RCMB.2013-02840C]; Sharma D, 2012, BONE, V51, P488, DOI 10.1016/j.bone.2012.05.014; van Hove RP, 2009, BONE, V45, P321, DOI 10.1016/j.bone.2009.04.238; Wang J, 2012, LASER PHYS LETT, V9, P469, DOI 10.7452/lapl.201210017; Webster DJ, 2013, BONE, V54, P285, DOI 10.1016/j.bone.2013.01.004; Yang B, 2014, CELL, V158, P945, DOI 10.1016/j.cell.2014.07.017; Yang XQ, 2014, OPT EXPRESS, V22, P1094, DOI 10.1364/OE.22.001094; Yao W, 2008, ARTHRITIS RHEUM, V58, P1674, DOI 10.1002/art.23454; Youn I, 2006, OSTEOARTHR CARTILAGE, V14, P889, DOI 10.1016/j.joca.2006.02.017; Zhong ZD, 2012, P NATL ACAD SCI USA, V109, pE2197, DOI 10.1073/pnas.1120407109; Zhu D, 2010, J BIOMED OPT, V15, DOI 10.1117/1.3369739	42	31	31	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2015	10	1							e0116662	10.1371/journal.pone.0116662	http://dx.doi.org/10.1371/journal.pone.0116662			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ4CF	25581165	Green Submitted, Green Published, gold			2022-12-27	WOS:000348169100005
J	Zirpoli, H; Abdillahi, M; Quadri, N; Ananthakrishnan, R; Wang, LJ; Rosario, R; Zhu, ZB; Deckelbaum, RJ; Ramasamy, R				Zirpoli, Hylde; Abdillahi, Mariane; Quadri, Nosirudeen; Ananthakrishnan, Radha; Wang, Lingjie; Rosario, Rosa; Zhu, Zhengbin; Deckelbaum, Richard J.; Ramasamy, Ravichandran			Acute Administration of n-3 Rich Triglyceride Emulsions Provides Cardioprotection in Murine Models after Ischemia-Reperfusion	PLOS ONE			English	Article							GLYCOGEN-SYNTHASE KINASE-3-BETA; ACTIVATED RECEPTOR-GAMMA; FATTY-ACIDS; MYOCARDIAL-ISCHEMIA; FISH-OIL; INJURY; OMEGA-3-FATTY-ACIDS; EXPRESSION; AKT; MECHANISMS	Dietary n-3 fatty acids (FAs) may reduce cardiovascular disease risk. We questioned whether acute administration of n-3 rich triglyceride (TG) emulsions could preserve cardiac function and decrease injury after ischemia/reperfusion (I/R) insult. We used two different experimental models: in vivo, C57BL/6 mice were exposed to acute occlusion of the left anterior descending coronary artery (LAD), and ex-vivo, C57BL/6 murine hearts were perfused using Langendorff technique (LT). In the LAD model, mice treated with n-3 TG emulsion (1.5g/kg body weight), immediately after ischemia and 1h later during reperfusion, significantly reduced infarct size and maintained cardiac function (p<0.05). In the LT model, administration of n-3 TG emulsion (300mgTG/100ml) during reperfusion significantly improved functional recovery (p<0.05). In both models, lactate dehydrogenase (LDH) levels, as a marker of injury, were significantly reduced by n-3 TG emulsion. To investigate the mechanisms by which n-3 FAs protects hearts from I/R injury, we investigated changes in key pathways linked to cardioprotection. In the ex-vivo model, we showed that n-3 FAs increased phosphorylation of AKT and GSK3a proteins (p<0.05). Acute n-3 TG emulsion treatment also increased Bcl-2 protein level and reduced an autophagy marker, Beclin-1 (p<0.05). Additionally, cardioprotection by n-3 TG emulsion was linked to changes in PPAR. protein expression (p<0.05). Rosiglitazone and p-AKT inhibitor counteracted the positive effect of n-3 TG; GSK3 beta inhibitor plus n-3 TG significantly inhibited LDH release. We conclude that acute n-3 TG injection during reperfusion provides cardioprotection. This may prove to be a novel acute adjunctive reperfusion therapy after treating patients with myocardial infarction.	[Zirpoli, Hylde; Abdillahi, Mariane; Deckelbaum, Richard J.] Columbia Univ, Inst Human Nutr, Coll Phys & Surg, New York, NY 10032 USA; [Zirpoli, Hylde; Deckelbaum, Richard J.] Columbia Univ, Dept Pediat, Coll Phys & Surg, New York, NY 10027 USA; [Abdillahi, Mariane; Quadri, Nosirudeen; Ananthakrishnan, Radha; Wang, Lingjie; Rosario, Rosa; Zhu, Zhengbin; Ramasamy, Ravichandran] NYU, Sch Med, Dept Med, New York, NY USA	Columbia University; Columbia University; New York University	Deckelbaum, RJ (corresponding author), Columbia Univ, Inst Human Nutr, Coll Phys & Surg, New York, NY 10032 USA.	ramasr02@nyumc.org; rjd20@columbia.edu		Ramasamy, Ravichandran/0000-0002-3666-3346	NIH [AG026467, HL61783]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL061783, P01HL060901] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG026467] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Funding provided by NIH AG026467 and NIH HL61783. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelrahman M, 2005, CARDIOVASC RES, V65, P772, DOI 10.1016/j.cardiores.2004.12.008; Abdillahi M, 2012, AM J PHYSIOL-HEART C, V303, pH297, DOI 10.1152/ajpheart.00999.2011; Akbar M, 2005, P NATL ACAD SCI USA, V102, P10858, DOI 10.1073/pnas.0502903102; Aleshin A, 2008, AM J PHYSIOL-HEART C, V294, pH1823, DOI 10.1152/ajpheart.01210.2007; Barandon L, 2005, CIRC RES, V96, P1299, DOI 10.1161/01.RES.0000171895.06914.2c; Barros KV, 2013, CLIN NUTR, V32, P993, DOI 10.1016/j.clnu.2013.02.010; Bellot G, 2009, MOL CELL BIOL, V29, P2570, DOI 10.1128/MCB.00166-09; Birnbaum Y, 2011, BASIC RES CARDIOL, V106, P431, DOI 10.1007/s00395-011-0162-3; Brunet A, 2001, CURR OPIN NEUROBIOL, V11, P297, DOI 10.1016/S0959-4388(00)00211-7; Buja LM, 2005, CARDIOVASC PATHOL, V14, P170, DOI 10.1016/j.carpath.2005.03.006; Caputo M, 2011, J CELL PHYSIOL, V226, P187, DOI 10.1002/jcp.22323; CASTILLO RL, 2013, CELL BIOCHEMISTRY AN, V32, P274, DOI DOI 10.1002/CBF.3012PMID:24166314; Chang CL, 2013, CURR OPIN LIPIDOL, V24, P345, DOI 10.1097/MOL.0b013e3283616364; Chanoit G, 2008, AM J PHYSIOL-HEART C, V295, pH1227, DOI 10.1152/ajpheart.00610.2008; Chen ZY, 2001, AM J PHYSIOL-HEART C, V280, pH2313, DOI 10.1152/ajpheart.2001.280.5.H2313; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Delgado-Lista J, 2012, BRIT J NUTR, V107, pS201, DOI 10.1017/S0007114512001596; Densupsoontorn N, 2007, LIPIDS, V42, P885, DOI 10.1007/s11745-007-3093-x; Duan SZ, 2005, CIRC RES, V97, P372, DOI 10.1161/01.RES.0000179226.34112.6d; Filion KB, 2010, BMC CARDIOVASC DISOR, V10, DOI 10.1186/1471-2261-10-24; Fujio Y, 2000, CIRCULATION, V101, P660, DOI 10.1161/01.CIR.101.6.660; GAO JY, 2011, CIRC J, V75, P843; Griendling KK, 2003, CIRCULATION, V108, P1912, DOI 10.1161/01.CIR.0000093660.86242.BB; Hwang YYC, 2004, FASEB J, V18, P1192, DOI 10.1096/fj.03-1400com; Imahashi K, 2004, CIRC RES, V95, P734, DOI 10.1161/01.RES.0000143898.67182.4c; Juhaszova M, 2009, CIRC RES, V104, P1240, DOI 10.1161/CIRCRESAHA.109.197996; Jung UJ, 2008, AM J CLIN NUTR, V87, p2003S, DOI 10.1093/ajcn/87.6.2003S; Jung UJ, 2012, ARTERIOSCL THROM VAS, V32, P2929, DOI 10.1161/ATVBAHA.112.300188; Kilter H, 2009, DIABETES OBES METAB, V11, P1060, DOI 10.1111/j.1463-1326.2009.01097.x; Li JY, 2012, ANESTHESIOLOGY, V117, P836, DOI 10.1097/ALN.0b013e3182655e73; Lichtenstein AH, 2006, CIRCULATION, V114, P82, DOI 10.1161/CIRCULATIONAHA.106.176158; Lopaschuk GD, 2010, PHYSIOL REV, V90, P207, DOI 10.1152/physrev.00015.2009; Lou PH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087205; Marczin N, 2003, ARCH BIOCHEM BIOPHYS, V420, P222, DOI 10.1016/j.abb.2003.08.037; McKenney JM, 2007, PHARMACOTHERAPY, V27, P715, DOI 10.1592/phco.27.5.715; Morrison A, 2011, AM J PHYSIOL-HEART C, V301, pH895, DOI 10.1152/ajpheart.00137.2011; Mullonkal CJ, 2007, J INVEST SURG, V20, P195, DOI 10.1080/08941930701366471; Murphy E, 2005, EXPERT OPIN THER TAR, V9, P447, DOI 10.1517/14728222.9.3.447; Murphy E, 2004, J CLIN INVEST, V113, P1526, DOI 10.1172/JCI200421986; Murphy E, 2008, PHYSIOL REV, V88, P581, DOI 10.1152/physrev.00024.2007; Murphy E, 2007, ANNU REV PHYSIOL, V69, P51, DOI 10.1146/annurev.physiol.69.031905.163645; Pattingre S, 2005, CELL, V122, P927, DOI 10.1016/j.cell.2005.07.002; Qi KM, 2002, BIOCHEMISTRY-US, V41, P3119, DOI 10.1021/bi015770h; Rahman S, 2011, ANESTHESIOLOGY, V115, P242, DOI 10.1097/ALN.0b013e318223b8b9; Rauch B, 2010, CIRCULATION, V122, P2152, DOI 10.1161/CIRCULATIONAHA.110.948562; Rodrigo R, 2013, CLIN SCI, V124, P1, DOI 10.1042/CS20110663; Roger VL, 2012, CIRCULATION, V125, pE2, DOI 10.1161/CIR.0b013e31823ac046; Simoens CM, 2008, AM J CLIN NUTR, V88, P282, DOI 10.1093/ajcn/88.2.282; Skulas-Ray AC, 2011, AM J CLIN NUTR, V93, P243, DOI 10.3945/ajcn.110.003871; Son NH, 2007, J CLIN INVEST, V117, P2791, DOI 10.1172/JCI30335; Son NHP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046549; Sugden M C, 2012, Curr Mol Pharmacol, V5, P224; Vacek TP, 2012, CELL BIOCHEM BIOPHYS, V62, P1, DOI 10.1007/s12013-011-9281-6; Valagussa F, 1999, LANCET, V354, P447, DOI 10.1016/S0140-6736(99)07072-5; Wang G, 2005, METABOLISM, V54, P590, DOI 10.1016/j.metabol.2004.11.017; Williams JJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056233; Xu TD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102292; Xu ZL, 2014, J MOL CELL CARDIOL, V66, P12, DOI 10.1016/j.yjmcc.2013.10.016; Xue BZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045990; Zhu Y, 2013, CELL PHYSIOL BIOCHEM, V32, P663, DOI 10.1159/000354470	60	13	18	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2015	10	1							e0116274	10.1371/journal.pone.0116274	http://dx.doi.org/10.1371/journal.pone.0116274			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ3BG	25559887	Green Published, Green Submitted, gold			2022-12-27	WOS:000348102200014
J	Hazewindus, M; Haenen, GRMM; Weseler, AR; Bast, A				Hazewindus, Merel; Haenen, Guido R. M. M.; Weseler, Antje R.; Bast, Aalt			Protection against Chemotaxis in the Anti-Inflammatory Effect of Bioactives from Tomato Ketchup	PLOS ONE			English	Article							NF-KAPPA-B; OXIDATIVE STRESS; ALPHA-TOCOPHEROL; GENE-EXPRESSION; MEDITERRANEAN DIET; ENDOTHELIAL-CELLS; VITAMIN-C; LYCOPENE; PREVENTION; ATHEROSCLEROSIS	The consumption of tomato products has been associated with a decreased risk for chronic inflammatory diseases. In this study, the anti-inflammatory potential of tomato ketchup was evaluated by studying the effect of tomato ketchup extracts and bioactives from tomato ketchup on human monocytes and vascular endothelial cells (HUVEC). HUVEC were pre-treated for 1 h with either individual bioactives (7.5 mu M lycopene, 1.4 mu M alpha-tocopherol or 55 mu M ascorbic acid) or a combination of these three compounds, or with the hydrophilic or lipophilic tomato ketchup extracts or with the two extracts combined. After the pretreatment, the cells were washed and challenged with TNF-alpha (10 ng/ml) for 6 h. The medium was used for the determination of the release of cytokines and the chemotaxis of monocytes. Inflammatory protein expression and production were assayed with real-time RT-PCR and ELISA. It was found that tomato ketchup extracts significantly reduced gene expression and release of the pro-inflammatory cytokines TNF-alpha and IL-8 in HUVEC after the inflammatory challenge, whereas the release of the anti-inflammatory cytokine IL-10 was increased. Chemotaxis was effectively impeded as demonstrated by a reduced monocyte migration. This effect correlated with the reduction of IL-8 production in the presence of the test compounds and extracts. The results consistently emphasize the contribution of lycopene to the anti-inflammatory effect of tomato ketchup. Other compounds in tomato ketchup such as a-tocopherol and ascorbic acid appeared to strengthen the anti-inflammatory effect of lycopene. The tomato ketchup extracts subtly interfered with several inflammatory phases that inhibit chemotaxis. Such a pleotropic mode of action exemplifies its potential mitigation of diseases characterized by prolonged low grade inflammation.	[Hazewindus, Merel; Haenen, Guido R. M. M.; Weseler, Antje R.; Bast, Aalt] Maastricht Univ, Dept Toxicol, Fac Hlth Med & Life Sci, Maastricht, Netherlands	Maastricht University	Haenen, GRMM (corresponding author), Maastricht Univ, Dept Toxicol, Fac Hlth Med & Life Sci, Maastricht, Netherlands.	g.haenen@maastrichtuniversity.nl	Bast, Aalt/I-7809-2013	Haenen, Guido/0000-0001-6986-290X; Bast, Aalt/0000-0002-5383-2789	Maastricht University	Maastricht University	The funding of the study was primarily from Maastricht University. All people that contributed to the study were employed directly by Maastricht University. H.J. Heinz Company also had no role in the study design, the data collection and analysis, decision to publish, or preparation of the manuscript. The funding of H.J. Heinz Company was used to pay the salary of Merel Hazewindus and as bench fee for chemicals and equipment. In addition, H.J. Heinz Company provided the tomato ketchup.	Agarwal Anita, 2001, J Med Food, V4, P9, DOI 10.1089/10966200152053668; Bast A, 2013, TRENDS PHARMACOL SCI, V34, P430, DOI 10.1016/j.tips.2013.05.010; Blackwell TS, 1997, AM J RESP CELL MOL, V17, P3, DOI 10.1165/ajrcmb.17.1.f132; Blum A, 2007, CLIN INVEST MED, V30, pE70; Bose KSC, 2007, ANN NUTR METAB, V51, P477, DOI 10.1159/000111170; Canene-Adams K, 2005, J NUTR, V135, P1226, DOI 10.1093/jn/135.5.1226; Carcamo JM, 2002, BIOCHEMISTRY-US, V41, P12995, DOI 10.1021/bi0263210; Cascio G, 2012, CURR DIABETES REV, V8, P2, DOI 10.2174/157339912798829241; Christman JW, 2000, BRAIN PATHOL, V10, P153; Denton CP, 1998, CLIN EXP IMMUNOL, V114, P293; Di Tomo P, 2012, MOL NUTR FOOD RES, V56, P217, DOI 10.1002/mnfr.201100500; Djuric Z, 2001, INT J FOOD SCI NUTR, V52, P143, DOI 10.1080/713671775; Ellinger S, 2009, AKTUEL UROL, V40, P37, DOI 10.1055/s-2008-1077031; Engelmann NJ, 2011, ADV NUTR, V2, P51, DOI 10.3945/an.110.000075; Erl W, 1997, AM J PHYSIOL, P634; Esfahani A, 2011, J AM COLL NUTR, V30, P285, DOI 10.1080/07315724.2011.10719971; Feng D, 2010, INFLAMM RES, V59, P115, DOI 10.1007/s00011-009-0077-8; Frusciante L, 2007, MOL NUTR FOOD RES, V51, P609, DOI 10.1002/mnfr.200600158; Galkina E, 2007, ARTERIOSCL THROM VAS, V27, P2292, DOI 10.1161/ATVBAHA.107.149179; Galkina E, 2009, ANNU REV IMMUNOL, V27, P165, DOI 10.1146/annurev.immunol.021908.132620; Geraets L, 2007, EUR J PHARMACOL, V573, P241, DOI 10.1016/j.ejphar.2007.07.013; Gil A, 2011, PUBLIC HEALTH NUTR, V14, P2316, DOI 10.1017/S1368980011002576; Hayden MS, 2006, ONCOGENE, V25, P6758, DOI 10.1038/sj.onc.1209943; Hazewindus M, 2012, FOOD CHEM, V132, P954, DOI 10.1016/j.foodchem.2011.11.075; Hung CF, 2008, EUR J PHARMACOL, V586, P275, DOI 10.1016/j.ejphar.2008.03.001; Jacob K, 2008, BRIT J NUTR, V99, P137, DOI 10.1017/S0007114507791894; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lucier G, 2000, FACTORS AFFECTING TO, P282; Mackinnon ES, 2009, J MED FOOD, V12, P829, DOI 10.1089/jmf.2008.0118; Markovits N, 2009, ISR MED ASSOC J, V11, P598; Martin J, 2007, CURR PHARM DESIGN, V13, P1751, DOI 10.2174/138161207780831248; Minorsky PV, 2002, PLANT PHYSIOL, V130, P1077, DOI 10.1104/pp.900054; NIKI E, 1987, ANN NY ACAD SCI, V498, P186, DOI 10.1111/j.1749-6632.1987.tb23761.x; Niki E, 1987, FREE RADIC BIOL MED; Palozza P, 2011, CURR MED CHEM, V18, P1846, DOI 10.2174/092986711795496845; Palozza P, 2010, CURR MED CHEM, V17, P2547, DOI 10.2174/092986710791556041; Palozza P, 2011, J NUTR BIOCHEM, V22, P259, DOI 10.1016/j.jnutbio.2010.02.003; Palozza P, 2010, ARCH BIOCHEM BIOPHYS, V504, P26, DOI 10.1016/j.abb.2010.06.031; PEREZ P, 1995, MOL CELL BIOL, V15, P3523; Rao AV, 2002, EXP BIOL MED, V227, P908, DOI 10.1177/153537020222701011; Rao P, 2010, NATURE, V466, P1115, DOI 10.1038/nature09283; Re R, 2003, EUR J CLIN NUTR, V57, P1545, DOI 10.1038/sj.ejcn.1601723; Riccardi G, 2004, CLIN NUTR, V23, P447, DOI 10.1016/j.clnu.2004.02.006; Riso P, 2006, J AGR FOOD CHEM, V54, P2563, DOI 10.1021/jf053033c; Roberts LJ, 2007, FREE RADICAL BIO MED, V43, P1388, DOI 10.1016/j.freeradbiomed.2007.06.019; Sanchez-Moreno C, 2006, J NUTR BIOCHEM, V17, P183, DOI 10.1016/j.jnutbio.2005.07.001; Simone RE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019652; Singh U, 2004, ANN NY ACAD SCI, V1031, P195, DOI 10.1196/annals.1331.019; Soehnlein O, 2009, BLOOD, V114, P4613, DOI 10.1182/blood-2009-06-221630; van Haaften RIM, 2001, BIOCHEM BIOPH RES CO, V280, P631, DOI 10.1006/bbrc.2000.4174; Wang Y, 2011, DEV GROWTH DIFFER, V53, P495, DOI 10.1111/j.1440-169X.2011.01265.x; Weber C, 2011, NAT MED, V17, P1410, DOI 10.1038/nm.2538; Weisburger JH, 1999, FOOD CHEM TOXICOL, V37, P943, DOI 10.1016/S0278-6915(99)00086-1; Yang YY, 2004, ATHEROSCLEROSIS, V174, P207, DOI 10.1016/j.atherosclerosis.2004.01.024	54	18	18	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2014	9	12							e114387	10.1371/journal.pone.0114387	http://dx.doi.org/10.1371/journal.pone.0114387			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UC	25551565	gold, Green Published, Green Submitted			2022-12-27	WOS:000347119100011
J	Martin, C; Poudel-Tandukar, K; Poudel, KC				Martin, Catherine; Poudel-Tandukar, Kalpana; Poudel, Krishna C.			HIV Symptom Burden and Anemia among HIV-Positive Individuals: Cross-Sectional Results of a Community-Based Positive Living with HIV (POLH) Study in Nepal	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; ACTIVE ANTIRETROVIRAL THERAPY; INJECTION-DRUG USERS; C-REACTIVE PROTEIN; INFECTED PATIENTS; TREATMENT OPTIONS; KATHMANDU VALLEY; PREGNANT-WOMEN; RISK-FACTORS; PREVALENCE	Background: Previous research has reported high rates of anemia in people living with HIV/AIDS (PLWHA) in hospital or tertiary care settings. The objective of this community-based study was to measure the prevalence of anemia and describe the risk factors, with a specific emphasis on HIV symptom burden, in PLWHA in the Kathmandu Valley, Nepal. Methods: We conducted a cross-sectional survey of 319 PLWHA residing in the Kathmandu Valley, Nepal. We recruited participants from five non-governmental organizations in the Kathmandu Valley. Descriptive statistics and multivariable logistic regression analyses were used. Results: Our study found a 55.8% prevalence of anemia in PLWHA in the Kathmandu Valley. The prevalence of anemia among the participants with first, second, third, and fourth quartiles of HIV symptom burden was 44.8%, 49.3%, 60.3%, and 69.6%, respectively. Compared to the participants with lowest level of HIV symptom burden, the participants with highest level of HIV symptom burden were more likely to have anemia (adjusted odds ratio=2.14; 95% confidence interval=1.07 to 4.30). Conclusion: Due to a high prevalence of anemia in a community-based sample of PLWHA, HIV patients should be counseled on their risk of developing anemia and encouraged to seek timely care for HIV symptoms.	[Martin, Catherine; Poudel-Tandukar, Kalpana; Poudel, Krishna C.] Univ Massachusetts, Sch Publ Hlth & Hlth Sci, Dept Publ Hlth, Amherst, MA 01003 USA	University of Massachusetts System; University of Massachusetts Amherst	Poudel, KC (corresponding author), Univ Massachusetts, Sch Publ Hlth & Hlth Sci, Dept Publ Hlth, Amherst, MA 01003 USA.	krishna@schoolph.umass.edu			Japan Society for the Promotion of Science, The Ministry of Education, Culture, Sports, Science and Technology, Japan [22790581]; Waseda University Grants for Special Research Projects, General Grant/Ippan Josei, Japan [2012A-101]; National Center for Global Health and Medicine, Japan [21A-2]	Japan Society for the Promotion of Science, The Ministry of Education, Culture, Sports, Science and Technology, Japan; Waseda University Grants for Special Research Projects, General Grant/Ippan Josei, Japan; National Center for Global Health and Medicine, Japan	This study was partially supported by the Grant-in-Aid for Young Scientists (B) (22790581), Japan Society for the Promotion of Science, The Ministry of Education, Culture, Sports, Science and Technology, Japan; Waseda University Grants for Special Research Projects, General Grant/Ippan Josei, Japan, (2012A-101); and by the Grant for Research on Global Health and Medicine (No. 21A-2) from the National Center for Global Health and Medicine, Japan. The funding agency had no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the paper for publication.	Agrawal P K, 2012, Nepal Med Coll J, V14, P80; Amiya RM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090959; Amiya RM, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-677; Antelman G, 2000, J NUTR, V130, P1950, DOI 10.1093/jn/130.8.1950; Attili Suresh Venkata Satya, 2008, Turk J Haematol, V25, P13; Belperio PS, 2004, AM J MED, V116, P27, DOI 10.1016/j.amjmed.2003.12.010; Bhatta L, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-604; Bucceri A, 1997, EUR J OBSTET GYN R B, V72, P169, DOI 10.1016/S0301-2115(97)02699-7; CDC, 2009, NHIS AD TOB US GLOSS; Claster S, 2002, J INFECT DIS, V185, pS105, DOI 10.1086/340202; Commision on AIDS in Asia, 2008, RED AIDS AS CRAFT EF; Curkendall SM, 2007, HIV MED, V8, P483, DOI 10.1111/j.1468-1293.2007.00500.x; Devleesschauwer B, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002634; Dikshit Byomakesh, 2009, BMC Blood Disord, V9, P5, DOI 10.1186/1471-2326-9-5; Eluwa George I, 2012, BMC Clin Pharmacol, V12, P7, DOI 10.1186/1472-6904-12-7; GRAHAM NMH, 1993, J ACQ IMMUN DEF SYND, V6, P1258; HORSBURGH CR, 1991, NEW ENGL J MED, V324, P1332, DOI 10.1056/NEJM199105093241906; Huffam SE, 2007, HIV MED, V8, P465, DOI 10.1111/j.1468-1293.2007.00498.x; Justice AC, 2001, J CLIN EPIDEMIOL, V54, pS77, DOI 10.1016/S0895-4356(01)00449-8; Kasthuri A. S., 2006, Indian Journal of Sexually Transmitted Diseases, V27, P9; Khalili H, 2009, PHARMACOEPIDEM DR S, V18, P848, DOI 10.1002/pds.1793; Levine AM, 2001, J ACQ IMMUN DEF SYND, V26, P28, DOI 10.1097/00126334-200101010-00004; Lundgren JD, 2003, CLIN INFECT DIS, V37, pS297, DOI 10.1086/376909; Meda N, 1998, INT J GYNECOL OBSTET, V61, P65, DOI 10.1016/S0020-7292(98)00016-2; Meidani M, 2012, J RES MED SCI, V17, P138; Mildvan D, 2007, CURR MED RES OPIN, V23, P343, DOI 10.1185/030079906X162683; MIR N, 1989, EUR J HAEMATOL, V42, P339; MOHP, 2012, NEP COUNTR PROGR REP; MOHP, 1998, NEP MICR STAT SURV 1; MOHP New Era ICF International, 2012, 2011 NEP DEM HLTH SU; Moore RD, 1998, J ACQ IMMUN DEF SYND, V19, P29, DOI 10.1097/00042560-199809010-00004; MOORE RD, 1991, ARCH INTERN MED, V151, P981, DOI 10.1001/archinte.151.5.981; MORFELDTMANSON L, 1991, SCAND J INFECT DIS, V23, P443, DOI 10.3109/00365549109075092; Murdoch DR, 2004, AM J TROP MED HYG, V70, P670, DOI 10.4269/ajtmh.2004.70.670; NAIDES SJ, 1993, J INFECT DIS, V168, P101, DOI 10.1093/infdis/168.1.101; NCASC, 2009, NAT ANT THER GUID; Phe T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060206; Poudel KC, 2003, TROP MED INT HEALTH, V8, P933, DOI 10.1046/j.1365-3156.2003.01110.x; Poudel Krishna C, 2014, J Int Assoc Provid AIDS Care, V13, P277, DOI 10.1177/2325957413500989; Poudel KC, 2011, J HEALTH POPUL NUTR, V29, P191, DOI 10.3329/jhpn.v29i3.7866; Poudel KC, 2010, INT J DRUG POLICY, V21, P507, DOI 10.1016/j.drugpo.2010.03.006; Poudel KC, 2009, AIDS BEHAV, V13, P1143, DOI 10.1007/s10461-008-9454-5; Poudel-Tandukar K, 2014, BRAIN BEHAV IMMUN, V42, P89, DOI 10.1016/j.bbi.2014.06.004; Poudel-Tandukar K, 2013, AIDS RES HUM RETROV, V29, P528, DOI [10.1089/aid.2012.0120, 10.1089/AID.2012.0120]; Rajesh Radhakrishnan, 2011, Int J Risk Saf Med, V23, P171, DOI 10.3233/JRS-2011-0531; Ramezani A, 2008, IRANIAN J PATHOLOGY, V3, P125; Ramon R, 1999, T ROY SOC TROP MED H, V93, P419, DOI 10.1016/S0035-9203(99)90143-8; Semba RD, 2002, J ACQ IMMUN DEF SYND, V29, P142, DOI 10.1097/00042560-200202010-00005; Semba RD, 2001, J ACQ IMMUN DEF SYND, V26, P315, DOI 10.1097/00126334-200104010-00003; Semba RD, 2002, CLIN INFECT DIS, V34, P260, DOI 10.1086/338151; Shen YZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073807; Srikanth BA, 2012, J ADV PHARM TECHNOL, V3, P62, DOI 10.4103/2231-4040.93557; Subbaraman R, 2009, INT J STD AIDS, V20, P489, DOI 10.1258/ijsa.2008.008370; Sullivan PS, 1998, BLOOD, V91, P301, DOI 10.1182/blood.V91.1.301.301_301_308; Thein Mya, 2011, Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry, V10, P299; Van der Werf MJ, 2000, ADDICTION, V95, P383, DOI 10.1046/j.1360-0443.2000.9533839.x; Volberding P, 2000, CLIN THER, V22, P1004, DOI 10.1016/S0149-2918(00)80081-8; Volberding PA, 2004, CLIN INFECT DIS, V38, P1459, DOI 10.1086/383031; Wills Todd S, 2004, AIDS Read, V14, P305; Wills TS, 2004, AIDS READ, V14, P313; World Health Organization, 2011, SER FERR CONC ASS IR; ZON LI, 1987, BRIT J HAEMATOL, V66, P251, DOI 10.1111/j.1365-2141.1987.tb01307.x	62	11	11	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2014	9	12							e116263	10.1371/journal.pone.0116263	http://dx.doi.org/10.1371/journal.pone.0116263			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UC	25551656	Green Published, gold			2022-12-27	WOS:000347119100117
J	Newe, A; Becker, L; Schenk, A				Newe, Axel; Becker, Linda; Schenk, Andrea			Application and Evaluation of Interactive 3D PDF for Presenting and Sharing Planning Results for Liver Surgery in Clinical Routine	PLOS ONE			English	Article							PORTABLE DOCUMENT FORMAT; RANDOMIZED CONTROLLED-TRIAL; PATIENT EDUCATION; VISUALIZATION; MODELS; RECONSTRUCTION; PUBLICATIONS; RESECTION; DISPLAYS; SURFACE	Background & Objectives: The Portable Document Format (PDF) is the de-facto standard for the exchange of electronic documents. It is platform-independent, suitable for the exchange of medical data, and allows for the embedding of three-dimensional (3D) surface mesh models. In this article, we present the first clinical routine application of interactive 3D surface mesh models which have been integrated into PDF files for the presentation and the exchange of Computer Assisted Surgery Planning (CASP) results in liver surgery. We aimed to prove the feasibility of applying 3D PDF in medical reporting and investigated the user experience with this new technology. Methods: We developed an interactive 3D PDF report document format and implemented a software tool to create these reports automatically. After more than 1000 liver CASP cases that have been reported in clinical routine using our 3D PDF report, an international user survey was carried out online to evaluate the user experience. Results: Our solution enables the user to interactively explore the anatomical configuration and to have different analyses and various resection proposals displayed within a 3D PDF document covering only a single page that acts more like a software application than like a typical PDF file ("DF App''). The new 3D PDF report offers many advantages over the previous solutions. According to the results of the online survey, the users have assessed the pragmatic quality (functionality, usability, perspicuity, efficiency) as well as the hedonic quality (attractiveness, novelty) very positively. Conclusion: The usage of 3D PDF for reporting and sharing CASP results is feasible and well accepted by the target audience. Using interactive PDF with embedded 3D models is an enabler for presenting and exchanging complex medical information in an easy and platform-independent way. Medical staff as well as patients can benefit from the possibilities provided by 3D PDF. Our results open the door for a wider use of this new technology, since the basic idea can and should be applied for many medical disciplines and use cases.	[Newe, Axel] Univ Erlangen Nurnberg, Chair Med Informat, D-91054 Erlangen, Germany; [Becker, Linda] Univ Erlangen Nurnberg, Inst Psychol, D-91054 Erlangen, Germany; [Schenk, Andrea] Fraunhofer Inst Med Image Comp MEVIS, Bremen, Germany	University of Erlangen Nuremberg; University of Erlangen Nuremberg; Fraunhofer Gesellschaft	Newe, A (corresponding author), Univ Erlangen Nurnberg, Chair Med Informat, D-91054 Erlangen, Germany.	axel.newe@fau.de	Schenk, Andrea/AAF-1323-2021; Newe, Axel/J-8580-2015	Schenk, Andrea/0000-0003-1806-8380; Newe, Axel/0000-0003-0843-2900; Becker, Linda/0000-0002-9950-6882	Deutsche Forschungsgemeinschaft (DFG); Friedrich-Alexander-University Erlangen-Nuremberg	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Friedrich-Alexander-University Erlangen-Nuremberg	The authors acknowledge support by Deutsche Forschungsgemeinschaft (DFG) and Friedrich-Alexander-University Erlangen-Nuremberg within the funding programme Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adobe Systems Incorporated, 2007, JAVASCRIPT ACR API R; Adobe Systems Incorporated, 2013, PROT MOD ACR APPL SE; [Anonymous], 2006, PDF REF AD PORT DOC; Association for Information and Image Management, 2008, AIIM ASTM INT PUBL P; Association for Information and Image Management, 2008, BEST PRACT IMPL GUID; Barnes DG, 2008, NEW ASTRON, V13, P599, DOI 10.1016/j.newast.2008.03.008; Barnes DG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069446; Barrows RC, 1996, J AM MED INFORM ASSN, V3, P139, DOI 10.1136/jamia.1996.96236282; Blonce A., 2008, EUR BLACKHAT 2008 C; Bourquain H, 2002, CARS 2002: COMPUTER ASSISTED RADIOLOGY AND SURGERY, PROCEEDINGS, P341; Castiglione A, 2010, J SYST SOFTWARE, V83, P1813, DOI 10.1016/j.jss.2010.04.062; Danz JC, 2011, AM J ORTHOD DENTOFAC, V140, P274, DOI 10.1016/j.ajodo.2011.04.010; de Boer BA, 2011, DEVELOPMENT, V138, P159, DOI 10.1242/dev.051086; DeCarlo D, 2003, ACM T GRAPHIC, V22, P848, DOI 10.1145/882262.882354; ECMA International, 2007, STAND ECMA 363 UN 3D; Enzenhofer M, 2004, J MED INTERNET RES, V6, DOI 10.2196/jmir.6.2.e16; Favalora GE, 2005, COMPUTER, V38, P37, DOI 10.1109/MC.2005.276; Fox MP, 2009, PATIENT EDUC COUNS, V77, P6, DOI 10.1016/j.pec.2009.02.011; Grenacher L, 2005, ROFO-FORTSCHR RONTG, V177, P1219, DOI 10.1055/s-2005-858376; Hennemuth A, 2006, 36 GI JAHR DRESD, P544; Hiroshige S, 2001, TRANSPLANTATION, V72, P1993, DOI 10.1097/00007890-200112270-00022; Hogemann D, 2000, RADIOLOGE, V40, P267, DOI 10.1007/s001170050668; Holliman NS, 2011, IEEE T BROADCAST, V57, P362, DOI 10.1109/TBC.2011.2130930; Huber J, 2013, ANN SURG ONCOL, V20, P15, DOI 10.1245/s10434-012-2536-7; International Organization for Standardization (ISO), 2008, 3200012008 ISO 1; Jurgaitis J, 2008, MED LITH, V44, P428, DOI 10.3390/medicina44060056; Lang H, 2007, J AM COLL SURGEONS, V205, P626, DOI 10.1016/j.jamcollsurg.2007.01.074; Lang HK, 2005, ARCH SURG-CHICAGO, V140, P629, DOI 10.1001/archsurg.140.7.629; Laugwitz B, 2008, LECT NOTES COMPUT SC, V5298, P63, DOI 10.1007/978-3-540-89350-9_6; Liu F, 2013, EEFICIENT RENDERING, P437; Luo YL, 2013, COMPUT SCI ENG, V15, P41, DOI 10.1109/MCSE.2013.25; Meyer-Spradow J, 2008, MATH VIS, P121, DOI 10.1007/978-3-540-72630-2_7; Newe A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079004; Numminen K, 2005, EUR J RADIOL, V56, P179, DOI 10.1016/j.ejrad.2005.03.021; Oldhafer KJ, 1999, CHIRURG, V70, P233, DOI 10.1007/s001040050636; Petersson H, 2009, ANAT SCI EDUC, V2, P61, DOI 10.1002/ase.76; Phelps A, 2012, AM J ROENTGENOL, V199, P1342, DOI 10.2214/AJR.12.8716; Preimi B, 2008, MATH VIS, P39, DOI 10.1007/978-3-540-72630-2_3; Rauschenberger M, 2013, INT J INTERACT MULTI, V2, P39, DOI 10.9781/ijimai.2013.215; Ritter F, 2011, IEEE PULSE, V2, P60, DOI 10.1109/MPUL.2011.942929; Robb RA, 1996, COMPUTER, V29, P39, DOI 10.1109/2.481435; Rodt T, 2006, DENTOMAXILLOFAC RAD, V35, P227, DOI 10.1259/dmfr/22989395; Ruthensteiner B, 2008, MICROSC RES TECHNIQ, V71, P778, DOI 10.1002/jemt.20618; Schenk A, 2006, 36 GI JAHR DRESD, P529; Schenk A, 2008, PROC SPIE, V6915, DOI 10.1117/12.780270; Schenk A, 2011, IEEE PULSE, V2, P48, DOI 10.1109/MPUL.2011.942605; Shin DS, 2012, J KOREAN MED SCI, V27, P849, DOI 10.3346/jkms.2012.27.8.849; SIMPSON M, 1991, BRIT MED J, V303, P1385, DOI 10.1136/bmj.303.6814.1385; Tory M, 2004, IEEE T VIS COMPUT GR, V10, P72, DOI 10.1109/TVCG.2004.1260759; Zidowitz S, 2009, IFMBE PROC, V25, P205, DOI 10.1007/978-3-642-03906-5_56; Ziegler A, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-17	51	21	21	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2014	9	12							e115697	10.1371/journal.pone.0115697	http://dx.doi.org/10.1371/journal.pone.0115697			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UC	25551375	Green Submitted, Green Published, gold			2022-12-27	WOS:000347119100051
J	Ratkiewicz, M; Matosiuk, M; Saveljev, AP; Sidorovich, V; Ozolins, J; Mannil, P; Balciauskas, L; Kojola, I; Okarma, H; Kowalczyk, R; Schmidt, K				Ratkiewicz, Miroslaw; Matosiuk, Maciej; Saveljev, Alexander P.; Sidorovich, Vadim; Ozolins, Janis; Maennil, Peep; Balciauskas, Linas; Kojola, Ilpo; Okarma, Henryk; Kowalczyk, Rafal; Schmidt, Krzysztof			Long-Range Gene Flow and the Effects of Climatic and Ecological Factors on Genetic Structuring in a Large, Solitary Carnivore: The Eurasian Lynx	PLOS ONE			English	Article							MITOCHONDRIAL-DNA PHYLOGEOGRAPHY; BIALOWIEZA PRIMEVAL FOREST; LIONS PUMA-CONCOLOR; POPULATION-STRUCTURE; BROWN BEARS; ROE DEER; COMPUTER-PROGRAM; GLACIAL REFUGIA; EUROPEAN LYNX; URSUS-ARCTOS	Due to their high mobility, large terrestrial predators are potentially capable of maintaining high connectivity, and therefore low genetic differentiation among populations. However, previous molecular studies have provided contradictory findings in relation to this. To elucidate patterns of genetic structure in large carnivores, we studied the genetic variability of the Eurasian lynx, Lynx lynx throughout north-eastern Europe using microsatellite, mitochondrial DNA control region and Y chromosome-linked markers. Using SAMOVA we found analogous patterns of genetic structure based on both mtDNA and microsatellites, which coincided with a relatively little evidence for male-biased dispersal. No polymorphism for the cytochrome b and ATP6 mtDNA genes and Y chromosomelinked markers were found. Lynx inhabiting a large area encompassing Finland, the Baltic countries and western Russia formed a single genetic unit, while some marginal populations were clearly divergent from others. The existence of a migration corridor was suggested to correspond with distribution of continuous forest cover. The lowest variability (in both markers) was found in lynx from Norway and Bialowieza Primeval Forest (BPF), which coincided with a recent demographic bottleneck (Norway) or high habitat fragmentation (BPF). The Carpathian population, being monomorphic for the control region, showed relatively high microsatellite diversity, suggesting the effect of a past bottleneck (e.g. during Last Glacial Maximum) on its present genetic composition. Genetic structuring for the mtDNA control region was best explained by latitude and snow cover depth. Microsatellite structuring correlated with the lynx's main prey, especially the proportion of red deer (Cervus elaphus) in its diet. Eurasian lynx are capable of maintaining panmictic populations across eastern Europe unless they are severely limited by habitat continuity or a reduction in numbers. Different correlations of mtDNA and microsatellite population divergence patterns with climatic and ecological factors may suggest separate selective pressures acting on males and females in this solitary carnivore.	[Ratkiewicz, Miroslaw; Matosiuk, Maciej] Univ Bialystok, Inst Biol, Bialystok, Poland; [Saveljev, Alexander P.] Russian Acad Sci, BM Zhitkov Russian Res Inst Game Management & Far, Kirov, Russia; [Sidorovich, Vadim] Natl Acad Sci, Ctr Biol Resources, Minsk, BELARUS; [Ozolins, Janis] Latvian State Forest Res Inst Silava, Salaspils, Latvia; [Maennil, Peep] Estonian Environm Agcy, Tartu, Estonia; [Balciauskas, Linas] Nat Res Ctr, Vilnius, Lithuania; [Kojola, Ilpo] Univ Oulu, Finnish Game & Fisheries Res Inst, Oulu Game & Fisheries Res, SF-90100 Oulu, Finland; [Okarma, Henryk] Polish Acad Sci, Inst Nat Conservat, Krakow, Poland; [Kowalczyk, Rafal; Schmidt, Krzysztof] Polish Acad Sci, Mammal Res Inst, Bialowieza, Poland	University of Bialystok; Russian Academy of Sciences; Russian Institute of Game Management & Fur Farming; National Academy of Sciences of Belarus (NASB); Scientific & Practical Center for Bioresources of the National Academy of Sciences of Belarus; Latvian State Forest Research Institute "Silava"; Nature Research Center - Lithuania; Natural Resources Institute Finland (Luke); University of Oulu; Polish Academy of Sciences; Polish Academy of Sciences; Mammal Research Institute of the Polish Academy of Sciences	Schmidt, K (corresponding author), Polish Acad Sci, Mammal Res Inst, Bialowieza, Poland.	kschmidt@ibs.bialowieza.pl	Balciauskas, Linas/GRS-8910-2022; Okarma, Henryk/W-2050-2019; Saveljev, Alexander/AAF-1089-2019; Balčiauskas, Linas/ABE-2454-2021; Ratkiewicz, Mirosław/AAI-9035-2020; Schmidt, Krzysztof/L-6437-2013; Saveljev, Alexander P./A-4697-2014	Saveljev, Alexander/0000-0002-8103-5787; Balčiauskas, Linas/0000-0001-9672-5265; Ratkiewicz, Mirosław/0000-0003-2929-3612; Kowalczyk, Rafal/0000-0001-7264-2158; Schmidt, Krzysztof/0000-0002-9043-291X; Okarma, Henryk/0000-0002-8912-3546; Matosiuk, Maciej/0000-0001-9595-690X	Ministry of Science and Higher Education [NN304 142536]; European Commission [PIRSES-GA-2009-247652]; WWF Poland	Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland); European Commission(European CommissionEuropean Commission Joint Research Centre); WWF Poland	The study was financed by the Ministry of Science and Higher Education grant no: NN304 142536. Obtaining samples from Russia was possible with the European Commission's 7th Framework Programme, Marie Curie Actions project "Biodiversity of East-European and Siberian large mammals on the level of genetic variation of populations" (BIOGEAST), contract No. PIRSES-GA-2009-247652. Samples from Belarus were obtained with support of WWF Poland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson CR, 2004, J MAMMAL, V85, P1207, DOI 10.1644/BEL-111.1; Anderson GS, 1997, LANDSCAPE ECOL, V12, P261, DOI 10.1023/A:1007933623979; Anderson M.J., 2003, DISTLM FORWARD FORTR; Anderson MJ, 2004, DISTLM V 5 FORTRAN C; [Anonymous], 2013, INS PESTS POT GLOB, DOI DOI 10.1016/B978-0-12-386895-4.00005-3; Barnett R, 2014, BMC EVOL BIOL, V14, DOI 10.1186/1471-2148-14-70; Bednorz E, 2004, INT J CLIMATOL, V24, P591, DOI 10.1002/joc.1014; Biek R, 2006, BIOL LETT-UK, V2, P312, DOI 10.1098/rsbl.2005.0437; Castilho CS, 2011, MAMM BIOL, V76, P476, DOI 10.1016/j.mambio.2010.08.002; Cegelski CC, 2003, MOL ECOL, V12, P2907, DOI 10.1046/j.1365-294X.2003.01969.x; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Cornuet JM, 2014, BIOINFORMATICS, V30, P1187, DOI 10.1093/bioinformatics/btt763; Crawford NG, 2010, MOL ECOL RESOUR, V10, P556, DOI 10.1111/j.1755-0998.2009.02801.x; Culver M, 2000, J HERED, V91, P186, DOI 10.1093/jhered/91.3.186; Czarnomska SD, 2013, CONSERV GENET, V14, P573, DOI 10.1007/s10592-013-0446-2; Davoli F, 2013, MAMM BIOL, V78, P118, DOI 10.1016/j.mambio.2012.06.003; Dojlida M, 2006, THESIS WARSZAWA U LI; Dupanloup I, 2002, MOL ECOL, V11, P2571, DOI 10.1046/j.1365-294X.2002.01650.x; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; EXCOFFIER L, 1992, GENETICS, V131, P479; Fernandez N, 2012, BIOL CONSERV, V153, P134, DOI 10.1016/j.biocon.2012.04.013; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; Gugolz D, 2008, J ZOOL, V275, P201, DOI 10.1111/j.1469-7998.2008.00428.x; Hame T, 2001, REMOTE SENS ENVIRON, V77, P76, DOI 10.1016/S0034-4257(01)00195-X; Hardy OJ, 2002, MOL ECOL NOTES, V2, P618, DOI 10.1046/j.1471-8286.2002.00305.x; Hell Pavel, 1996, Acta Scientiarum Naturalium Academiae Scientiarum Bohemicae Brno, V30, P64; Hellborg L, 2003, MOL ECOL, V12, P283, DOI 10.1046/j.1365-294X.2003.01702.x; Hellborg L, 2002, CONSERV GENET, V3, P97, DOI 10.1023/A:1015217723287; Henaux V, 2011, METHODS ECOL EVOL, V2, P489, DOI 10.1111/j.2041-210X.2011.00107.x; Holbrook JD, 2012, J MAMMAL, V93, P989, DOI 10.1644/11-MAMM-A-326.2; Huck M, 2011, ACTA THERIOL, V56, P91, DOI 10.1007/s13364-010-0006-9; Hundertmark KJ, 2002, MOL PHYLOGENET EVOL, V22, P375, DOI 10.1006/mpev.2001.1058; HURRELL JW, 1995, SCIENCE, V269, P676, DOI 10.1126/science.269.5224.676; Jedrzejewski W, 1996, ECOGRAPHY, V19, P122, DOI 10.1111/j.1600-0587.1996.tb00163.x; JEDRZEJEWSKI W, 1993, ACTA THERIOL, V38, P385; Jensen JL, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-13; Jost L, 2008, MOL ECOL, V17, P4015, DOI 10.1111/j.1365-294X.2008.03887.x; Kalinowski ST, 2007, MOL ECOL, V16, P1099, DOI 10.1111/j.1365-294X.2007.03089.x; Keis M, 2013, J BIOGEOGR, V40, P915, DOI 10.1111/jbi.12043; Kojola I, 2006, J MAMMAL, V87, P281, DOI 10.1644/05-MAMM-A-061R2.1; Kozlovskiy IS, 2003, LYNX REGIONAL FEATUR, P168; Kyle CJ, 2002, J MAMMAL, V83, P1141, DOI 10.1644/1545-1542(2002)083<1141:COPACP>2.0.CO;2; Linnell JDC, 2010, ENVIRON MANAGE, V45, P1142, DOI 10.1007/s00267-010-9455-9; Lorenc H, 2005, ATLAS CLIMTAE POLAND; Luo SJ, 2007, J HERED, V98, P400, DOI 10.1093/jhered/esm063; Mcrae BH, 2005, MOL ECOL, V14, P1965, DOI 10.1111/j.1365-294X.2005.02571.x; Menotti-Raymond M, 1999, GENOMICS, V57, P9, DOI 10.1006/geno.1999.5743; Molinari-Jobin A, 2002, WILDLIFE BIOL, V8, P109, DOI 10.2981/wlb.2002.015; Musiani M, 2007, MOL ECOL, V16, P4149, DOI 10.1111/j.1365-294X.2007.03458.x; Niedzialkowska M, 2006, BIOL CONSERV, V133, P63, DOI 10.1016/j.biocon.2006.05.022; Nilsen EB, 2009, J ANIM ECOL, V78, P741, DOI 10.1111/j.1365-2656.2009.01547.x; Okarma H, 1997, ACTA THERIOL, V42, P203, DOI 10.4098/AT.arch.97-22; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Pilot M, 2006, MOL ECOL, V15, P4533, DOI 10.1111/j.1365-294X.2006.03110.x; Pilot M, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-104; Podgorski T, 2008, ACTA THERIOL, V53, P97, DOI 10.1007/BF03194243; Pritchard JK, 2000, GENETICS, V155, P945; PULLIAINEN E, 1995, ACTA THERIOL, V40, P181, DOI 10.4098/AT.arch.95-19; Ratkiewicz M, 2012, ANIM CONSERV, V15, P603, DOI 10.1111/j.1469-1795.2012.00556.x; Rousset F, 1997, GENETICS, V145, P1219; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Row JR, 2012, CONSERV GENET, V13, P1259, DOI 10.1007/s10592-012-0369-3; Rueness EK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093675; Saarma U, 2007, MOL ECOL, V16, P401, DOI 10.1111/j.1365-294X.2006.03130.x; Samelius G, 2012, J ZOOL, V286, P120, DOI 10.1111/j.1469-7998.2011.00857.x; Schmidt K, 2006, WILDLIFE SOC B, V34, P462, DOI 10.2193/0091-7648(2006)34[462:USSTCH]2.0.CO;2; Schmidt K, 1998, ACTA THERIOL, V43, P391, DOI 10.4098/AT.arch.98-50; Schmidt K, 2011, MAMMAL REV, V41, P112, DOI 10.1111/j.1365-2907.2010.00180.x; Schmidt K, 2009, CONSERV GENET, V10, P497, DOI 10.1007/s10592-008-9795-7; Schwartz MK, 2003, MOL ECOL, V12, P1807, DOI 10.1046/j.1365-294X.2003.01878.x; Schwartz MK, 2002, NATURE, V415, P520, DOI 10.1038/415520a; Sidorovich VE, 2006, ACTA THERIOL, V51, P265, DOI 10.1007/BF03192678; SMITH JLD, 1993, BEHAVIOUR, V124, P165, DOI 10.1163/156853993X00560; Smouse PE, 1999, HEREDITY, V82, P561, DOI 10.1038/sj.hdy.6885180; Sommer RS, 2006, MAMMAL REV, V36, P251, DOI 10.1111/j.1365-2907.2006.00093.x; Stenseth NC, 2004, P NATL ACAD SCI USA, V101, P10632, DOI 10.1073/pnas.0308674101; Stronen AV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076454; Sunde P, 1997, ACTA THERIOL, V42, P189, DOI 10.4098/AT.arch.97-21; Sunquist ME, 2002, WILD CATS WORLD; TABERLET P, 1995, CONSERV BIOL, V9, P1255, DOI 10.1046/j.1523-1739.1995.951255.x; Valdiosera CE, 2007, MOL ECOL, V16, P5140, DOI 10.1111/j.1365-294X.2007.03590.x; Valdmann H, 2005, ACTA THERIOL, V50, P521, DOI 10.1007/BF03192645; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Vila C, 1999, MOL ECOL, V8, P2089, DOI 10.1046/j.1365-294x.1999.00825.x; von Arx M., 2004, STATUS CONSERVATION; Waits L, 2000, MOL ECOL, V9, P421, DOI 10.1046/j.1365-294x.2000.00892.x; Wan QH, 2004, ELECTROPHORESIS, V25, P2165, DOI 10.1002/elps.200305922; WASER PM, 1983, Q REV BIOL, V58, P355, DOI 10.1086/413385; Wilson GA, 2003, GENETICS, V163, P1177; Yom-Tov Y, 2011, AMBIO, V40, P43, DOI 10.1007/s13280-010-0070-z	91	26	26	1	130	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2014	9	12							e115160	10.1371/journal.pone.0115160	http://dx.doi.org/10.1371/journal.pone.0115160			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UC	25551216	Green Published, Green Submitted, gold			2022-12-27	WOS:000347119100029
J	Yuan, C; Wu, VWC; Yip, SP; Kwong, DLW; Ying, M				Yuan, Chuang; Wu, Vincent W. C.; Yip, Shea Ping; Kwong, Dora L. W.; Ying, Michael			Predictors of the Extent of Carotid Atherosclerosis in Patients Treated with Radiotherapy for Nasopharyngeal Carcinoma	PLOS ONE			English	Article							STENOSIS; RISK; DEFINITION; STROKE	Objective: To determine the predictors of the extent of carotid atherosclerosis in patients treated with radiotherapy (RT) for nasopharyngeal carcinoma (NPC). Methods: The present study investigated 129 post-RT NPC patients. Carotid atherosclerotic parameters, such as carotid intima-media thickness, carotid arterial stiffness and carotid plaque burden (plaque score, the presence of plaque and >= 50% stenosis) were assessed using ultrasonography. The association between carotid atherosclerotic parameters and nine potential predictors, including age, gender, post-RT duration, radiation dose, chemotherapy, diabetes mellitus, hypertension, hypercholesterolemia, and smoking, were determined using multiple regression. The cutoff values of age, post-RT duration and number of cardiovascular risk factors for the presence of carotid plaque or >= 50% carotid stenosis were analyzed using receiver operating characteristic (ROC) curve analysis. Multiple testing was corrected using Benjamini-Hochberg false discovery rate. Results: Age, post-RT duration and number of cardiovascular risk factors were significantly associated with carotid plaque burden (corrected P value, P-cor<0.05). Age of 44.5 years (sensitivity=99.2% and specificity=50%, P-cor< 0.01) and post-RT duration of 8.5 years (sensitivity=75.7% and specificity=64.3%, P-cor < 0.001) were the cutoff values for detecting carotid plaque, while post-RT duration of 13.5 years (sensitivity=66.7% and specificity=71.6%, P-cor< 0.001) and 1.5 cardiovascular risk factors (sensitivity=40.7% and specificity=84.3%, P-cor< 0.05) were the cutoff values for screening >= 50% carotid stenosis. Conclusions: Age, post-RT duration and number of cardiovascular risk factors are significant predictors of carotid atherosclerosis in post-RT NPC patients. Post-RT NPC patients, who are at least 45 years old, with post-RT duration of 9 years or above, and/or have >= 2 cardiovascular risk factors, are more susceptible to carotid atherosclerosis.	[Yuan, Chuang; Wu, Vincent W. C.; Yip, Shea Ping; Ying, Michael] Hong Kong Polytech Univ, Dept Hlth Technol & Informat, Kowloon, Hong Kong, Peoples R China; [Kwong, Dora L. W.] Univ Hong Kong, Dept Clin Oncol, Pokfulam, Hong Kong, Peoples R China	Hong Kong Polytechnic University; University of Hong Kong	Ying, M (corresponding author), Hong Kong Polytech Univ, Dept Hlth Technol & Informat, Kowloon, Hong Kong, Peoples R China.	htmying@polyu.edu.hk	; Yip, Shea Ping/A-1185-2016	Ying, Michael/0000-0001-5979-6072; Yip, Shea Ping/0000-0002-2170-8185; WU, Wing Cheung Vincent/0000-0002-1257-4154	Hong Kong Polytechnic University (RU2R)	Hong Kong Polytechnic University (RU2R)	This research was funded by a research studentship for CY from the Hong Kong Polytechnic University (RU2R). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S; AUTRET A, 1987, LANCET, V1, P888; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Carretero OA, 2000, CIRCULATION, V101, P329, DOI 10.1161/01.CIR.101.3.329; Chang ET, 2006, CANCER EPIDEM BIOMAR, V15, P1765, DOI 10.1158/1055-9965.EPI-06-0353; Chang YJ, 2009, J VASC SURG, V50, P280, DOI 10.1016/j.jvs.2009.01.033; Ford ES, 2010, INT J CARDIOL, V140, P226, DOI 10.1016/j.ijcard.2008.11.033; Glastonbury Christine M, 2007, Top Magn Reson Imaging, V18, P225, DOI 10.1097/RMR.0b013e3181572b3a; Gujral DM, 2014, RADIOTHER ONCOL, V110, P31, DOI 10.1016/j.radonc.2013.08.009; Huang TL, 2013, RADIAT ONCOL, V8, DOI 10.1186/1748-717X-8-261; Lam WMM, 2001, CANCER, V92, P2357, DOI 10.1002/1097-0142(20011101)92:9<2357::AID-CNCR1583>3.0.CO;2-K; Lam WWM, 2001, HEAD NECK-J SCI SPEC, V23, P780, DOI 10.1002/hed.1111.abs; Li CS, 2010, CLIN NEUROL NEUROSUR, V112, P682, DOI 10.1016/j.clineuro.2010.05.007; Matthews KA, 2001, STROKE, V32, P1104, DOI 10.1161/01.STR.32.5.1104; Muzaffar K, 2000, LARYNGOSCOPE, V110, P1811, DOI 10.1097/00005537-200011000-00007; Nadareishvili ZG, 2002, ARCH NEUROL-CHICAGO, V59, P1162, DOI 10.1001/archneur.59.7.1162; Yuan C, 2014, J DIABETES RES	17	8	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2014	9	12							e116284	10.1371/journal.pone.0116284	http://dx.doi.org/10.1371/journal.pone.0116284			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UC	25551559	Green Submitted, Green Published, gold			2022-12-27	WOS:000347119100122
J	Bacchetta, J; Chun, RF; Gales, B; Zaritsky, JJ; Leroy, S; Wesseling-Perry, K; Boregaard, N; Rastogi, A; Salusky, IB; Hewison, M				Bacchetta, Justine; Chun, Rene F.; Gales, Barbara; Zaritsky, Joshua J.; Leroy, Sandrine; Wesseling-Perry, Katherine; Boregaard, Niels; Rastogi, Anjay; Salusky, Isidro B.; Hewison, Martin			Antibacterial Responses by Peritoneal Macrophages Are Enhanced Following Vitamin D Supplementation	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; SECONDARY HYPERPARATHYROIDISM; PARATHYROID-HORMONE; HYPOVITAMINOSIS-D; DIALYSIS PATIENTS; CAPD PATIENTS; D DEFICIENCY; CHILDREN; INFLAMMATION; METABOLISM	Patients with chronic kidney disease (CKD), who usually display low serum 25-hydroxyvitamin D (25D) and 1,25-dihydroxyvitamin D (1,25D), are at high risk of infection, notably those undergoing peritoneal dialysis (PD). We hypothesized that peritoneal macrophages from PD patients are an important target for vitamin D-induced antibacterial activity. Dialysate effluent fluid was obtained from 27 noninfected PD patients. Flow cytometry indicated that PD cells were mainly monocytic (37.9 +/- 17.7% cells CD14(+)/CD45(+)). Ex vivo analyses showed that PD cells treated with 25D (100 nM, 6 hrs) or 1,25D (5 nM, 6 hrs) induced mRNA for antibacterial cathelicidin (CAMP) but conversely suppressed mRNA for hepcidin (HAMP). PD cells from patients with peritonitis (n=3) showed higher baseline expression of CAMP (18-fold +/- 9, p<0.05) and HAMP (64-fold +/- 7) relative to cells from noninfected patients. In 12 non-infected PD patients, oral supplementation with a single dose of vitamin D-2 (100,000 IU) increased serum levels of 25D from 18 +/- 8 to 41 +/- 15 ng/ml (p=0.002). This had no significant effect on PD cell CD14/CD45 expression, but mRNA for HAMP was suppressed significantly (0.5-fold, p=0.04). Adjustment for PD cell CD14/CD45 expression using a mixed linear statistical model also revealed increased expression of CAMP (mRNA in PD cells and protein in effluent) in vitamin D-supplemented patients. These data show for the first time that vitamin D supplementation in vitro and in vivo promotes innate immune responses that may enhance macrophage antibacterial responses in patients undergoing PD. This highlights a potentially important function for vitamin D in preventing infection-related complications in CKD.	[Bacchetta, Justine; Chun, Rene F.; Hewison, Martin] Univ Calif Los Angeles, David Geffen Sch Med, Orthoped Hosp Res Ctr, Los Angeles, CA 90095 USA; [Bacchetta, Justine; Gales, Barbara; Zaritsky, Joshua J.; Wesseling-Perry, Katherine; Salusky, Isidro B.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pediat, Los Angeles, CA 90095 USA; [Bacchetta, Justine] Ecole Normale Super, Inst Genom Fonct, Ctr Reference Malad Renales Rares, Lyon, France; [Bacchetta, Justine] Univ Lyon, Lyon, France; [Leroy, Sandrine] Inst Pasteur, Unite Epidemiol Malad Emergentes, Paris, France; [Rastogi, Anjay] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Los Angeles, CA 90095 USA; [Boregaard, Niels] Univ Copenhagen, Dept Hematol, Copenhagen, Denmark	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; Centre National de la Recherche Scientifique (CNRS); Ecole Normale Superieure de Lyon (ENS de LYON); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of Copenhagen	Hewison, M (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Orthoped Hosp Res Ctr, Los Angeles, CA 90095 USA.	mhewison@mednet.ucla.edu	Chun, Rene/A-9415-2010; Leroy, Sandrine/I-9136-2014; Bacchetta, Justine/B-3842-2016	Chun, Rene/0000-0002-0190-0807; Leroy, Sandrine/0000-0002-2964-2002; Bacchetta, Justine/0000-0002-0578-2529	Academie Francaise/Jean Walter Zellidja; Reunion Pediatrique de la Region Rhone Alpes; Societe Francaise de Pediatrie/Evian; Fondation pour la Recherche Medicale; Philippe Foundation; National Institutes of Health [DK0911672]; USPHS [DK67563, DK35423, DK 80984]; CTSI [UL1TR000124]; Casey Lee Ball Foundation; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000124] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI028697] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P50AR063020] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K23DK080984, R01DK035423, R01DK067563] Funding Source: NIH RePORTER	Academie Francaise/Jean Walter Zellidja; Reunion Pediatrique de la Region Rhone Alpes; Societe Francaise de Pediatrie/Evian; Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Philippe Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); USPHS(United States Department of Health & Human ServicesUnited States Public Health Service); CTSI; Casey Lee Ball Foundation; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by educational grants (Academie Francaise/Jean Walter Zellidja, Reunion Pediatrique de la Region Rhone Alpes, Societe Francaise de Pediatrie/Evian, Fondation pour la Recherche Medicale, Philippe Foundation, JB), by National Institutes of Health grants DK0911672 (MH), by USPHS grants DK67563 (IBS), DK35423 (IBS), DK 80984 (KWP), by CTSI grant UL1TR000124 (IBS) and funds from the Casey Lee Ball Foundation (IBS and KWP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams JS, 2008, NAT CLIN PRACT ENDOC, V4, P80, DOI 10.1038/ncpendmet0716; Adams JS, 2009, J IMMUNOL, V182, P4289, DOI 10.4049/jimmunol.0803736; Bacchetta J ZJ, 2013, J AM SOC NEPHROLOGY; Bacchetta J, 2013, J BONE MINER RES, V28, P46, DOI 10.1002/jbmr.1740; Bacchetta J, 2010, J CLIN ENDOCR METAB, V95, P1741, DOI 10.1210/jc.2009-1576; Belostotsky V, 2008, ARCH DIS CHILD, V93, P959, DOI 10.1136/adc.2007.134866; BETJES MGH, 1993, KIDNEY INT, V43, P641, DOI 10.1038/ki.1993.93; Bouts AHM, 2005, PEDIATR NEPHROL, V20, P1161, DOI 10.1007/s00467-005-1850-8; Brown AJ, 2007, NAT CLIN PRACT ENDOC, V3, P134, DOI 10.1038/ncpendmet0394; Chonchol M, 2011, ANN MED, V43, P273, DOI 10.3109/07853890.2010.543923; COWLAND JB, 1995, FEBS LETT, V368, P173, DOI 10.1016/0014-5793(95)00634-L; Dalrymple LS, 2008, CLIN J AM SOC NEPHRO, V3, P1487, DOI 10.2215/CJN.01290308; Drakesmith H, 2012, SCIENCE, V338, P768, DOI 10.1126/science.1224577; Edfeldt K, 2010, P NATL ACAD SCI USA, V107, P22593, DOI 10.1073/pnas.1011624108; Ganz T, 2003, BLOOD, V102, P783, DOI 10.1182/blood-2003-03-0672; Ganz T, 2011, BLOOD, V117, P4425, DOI 10.1182/blood-2011-01-258467; Ganz T, 2009, CURR OPIN IMMUNOL, V21, P63, DOI 10.1016/j.coi.2009.01.011; GOLDSTEIN CS, 1986, J LEUKOCYTE BIOL, V39, P457, DOI 10.1002/jlb.39.4.457; GOLDSTEIN CS, 1984, KIDNEY INT, V26, P733, DOI 10.1038/ki.1984.209; Gombart AF, 2009, CLIN INFECT DIS; HAYES ME, 1987, FEBS LETT, V220, P307, DOI 10.1016/0014-5793(87)80836-0; Hewison M, 2011, NAT REV ENDOCRINOL, V7, P336, DOI 10.1038/nrendo.2010.226; Hewison M, 2010, MOL CELL ENDOCRINOL, V321, P103, DOI 10.1016/j.mce.2010.02.013; Holick MF, 2005, AM J KIDNEY DIS, V45, P1119, DOI 10.1053/j.ajkd.2005.04.015; KDOQI Work Group, 2009, Am J Kidney Dis, V53, pS11, DOI 10.1053/j.ajkd.2008.11.017; LEWIS S, 1991, PERITON DIALYSIS INT, V11, P14; Li M, 2009, KIDNEY INT, V76, P1219, DOI 10.1038/ki.2009.390; Li PKT, 2012, NAT REV NEPHROL, V8, P77, DOI 10.1038/nrneph.2011.194; Li YC, 2004, J STEROID BIOCHEM, V89-90, P387, DOI 10.1016/j.jsbmb.2004.03.004; Liberek T, 2002, PERITON DIALYSIS INT, V22, P663; Liu PT, 2006, SCIENCE, V311, P1770, DOI 10.1126/science.1123933; Mehrotra R, 2008, CLIN J AM SOC NEPHRO, V3, P1144, DOI 10.2215/CJN.05781207; Mehrotra R, 2009, KIDNEY INT, V76, P977, DOI 10.1038/ki.2009.288; Menon S, 2008, PEDIATR NEPHROL, V23, P1831, DOI 10.1007/s00467-008-0842-x; Nessim SJ, 2011, SEMIN NEPHROL, V31, P199, DOI 10.1016/j.semnephrol.2011.01.008; Perez-Fontan M, 2006, PERITON DIALYSIS INT, V26, P174; PETERSON PK, 1985, INFECT IMMUN, V49, P212, DOI 10.1128/IAI.49.1.212-218.1985; Ross AC, 2011, J CLIN ENDOCR METAB, V96, P53, DOI 10.1210/jc.2010-2704; SHANY S, 1991, KIDNEY INT, V39, P1005, DOI 10.1038/ki.1991.127; Shin DM, 2010, CELL MICROBIOL, V12, P1648, DOI 10.1111/j.1462-5822.2010.01497.x; Shroff R, 2012, CLIN J AM SOC NEPHRO, V7, P216, DOI 10.2215/CJN.04760511; Sorensen O, 1997, J IMMUNOL METHODS, V206, P53, DOI 10.1016/S0022-1759(97)00084-7; Stubbs JR, 2010, J AM SOC NEPHROL, V21, P353, DOI 10.1681/ASN.2009040451; Tjabringa GS, 2005, PULM PHARMACOL THER, V18, P321, DOI 10.1016/j.pupt.2005.01.001; VERBRUGH HA, 1983, J INFECT DIS, V147, P1018, DOI 10.1093/infdis/147.6.1018; Wesseling-Perry K, 2011, KIDNEY INT, V79, P112, DOI 10.1038/ki.2010.352; Wesseling-Perry K, 2009, CURR OPIN NEPHROL HY, V18, P308, DOI 10.1097/MNH.0b013e32832c7654; Zaritsky J, 2011, SEMIN NEPHROL, V31, P213, DOI 10.1016/j.semnephrol.2011.01.009; Zehnder D, 2008, KIDNEY INT, V74, P1343, DOI 10.1038/ki.2008.453; Zehnder D, 2007, NEPHRON CLIN PRACT, V107, pC109, DOI 10.1159/000108652	50	19	20	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2014	9	12							e116530	10.1371/journal.pone.0116530	http://dx.doi.org/10.1371/journal.pone.0116530			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX6YH	25549329	Green Submitted, Green Published, gold			2022-12-27	WOS:000347063500086
J	Oh, IH; Lee, JH; Park, DC; Kim, M; Chung, JH; Kim, SH; Yeo, SG				Oh, In-Hwan; Lee, Jong Hoon; Park, Dong Choon; Kim, MyungGu; Chung, Ji Hyun; Kim, Sang Hoon; Yeo, Seung Geun			Hearing Loss as a Function of Aging and Diabetes Mellitus: A Cross Sectional Study	PLOS ONE			English	Article							IMPAIRMENT; HYPERTENSION	Background: Although hearing loss may be caused by various factors, it is also a natural phenomenon associated with the aging process. This study was designed to assess the contributions of diabetes mellitus (DM) and hypertension, both chronic diseases associated with aging, as well as aging itself, to hearing loss in health screening examinees. Methods: This study included 37,773 individuals who underwent health screening examinations from 2009 to 2012. The relationships between hearing threshold and subject age, hearing threshold at each frequency based on age group, the degree of hearing loss and the presence or absence of hypertension and DM were evaluated. Results: The prevalence of hearing loss increased with age, being 1.6%, 1.8%, 4.6%, 14.0%, 30.8%, and 49.2% in subjects in their twenties, thirties, forties, fifties, sixties, and seventies, respectively (p<0.05). Hearing value per frequency showed aging-based changes, in the order of 6000, 4000, 2000, 1000 and 500 Hz, indicating greater hearing losses at high frequencies. The degree of hearing loss ranged from mild to severe. Aging and DM were correlated with the prevalence of hearing loss (p<0.05). There was no statistically significant association between hearing loss and hypertension after adjusting for age and DM. Conclusions: The prevalence of hearing loss increases with age and the presence of DM. Hearing loss was greatest at high frequencies. In all age groups, mild hearing loss was the most common form of hearing loss.	[Oh, In-Hwan] Kyung Hee Univ, Sch Med, Dept Prevent Med, Seoul, South Korea; [Lee, Jong Hoon] Catholic Univ Korea, Coll Med, St Vincents Hosp, Dept Radiat Oncol, Suwon, South Korea; [Park, Dong Choon] Catholic Univ Korea, Coll Med, St Vincents Hosp, Dept Obstet & Gynecol, Suwon, South Korea; [Kim, MyungGu] Sungkyunkwan Univ, Sch Med, Samsung Changwon Hosp, Dept Otorhinolaryngol Head & Neck Surg, Chang Won, South Korea; [Chung, Ji Hyun; Kim, Sang Hoon; Yeo, Seung Geun] Kyung Hee Univ, Sch Med, Dept Otorhinolaryngol Head & Neck Surg, Seoul, South Korea	Kyung Hee University; Catholic University of Korea; Catholic University of Korea; Sungkyunkwan University (SKKU); Samsung Medical Center; Kyung Hee University	Yeo, SG (corresponding author), Kyung Hee Univ, Sch Med, Dept Otorhinolaryngol Head & Neck Surg, Seoul, South Korea.	yeo2park@gmail.com	Oh, In Hwan/AAI-9070-2020	Oh, In Hwan/0000-0002-5450-9887	National Research Foundation of Korea (NRF) - Korea government(MSIP) [2011-0030072]; Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea [HI 13C0729]	National Research Foundation of Korea (NRF) - Korea government(MSIP); Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea	This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government(MSIP) (No. 2011-0030072) and by a grant of the Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea (Grant number HI 13C0729). URLs: http://www.nrf.re.kr/nrf_tot_cms/index.jsp?pmi-sso-return2=none and http://www.khidi.or.kr/www/run.do. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal S, 2013, INDIAN J OTOLARYNGOL, V65, pS614, DOI 10.1007/s12070-013-0630-1; [Anonymous], 2008, ASS HEAR ELD AG DEG; Bachor E, 2001, ACTA OTO-LARYNGOL, V121, P35; Bayazit Y, 2000, J NEUROL SCI, V181, P29, DOI 10.1016/S0022-510X(00)00400-7; Cohn ES, 1999, CLIN GERIATR MED, V15, P145; Dalton DS, 1998, DIABETES CARE, V21, P1540, DOI 10.2337/diacare.21.9.1540; Das T, 2001, J Indian Med Assoc, V99, P86; Das T, 2001, J INDIAN MED ASSOC, V84, P86; Davis A C, 1990, Acta Otolaryngol Suppl, V476, P23; de Leon-Morales LVD, 2005, ARCH MED RES, V36, P507, DOI 10.1016/j.arcmed.2005.02.002; de Moraes Marchiori Luciana Lozza, 2006, Braz J Otorhinolaryngol, V72, P533; deEspana R, 1995, ORL J OTO-RHINO-LARY, V57, P325, DOI 10.1159/000276774; Fransen E, 2003, EXP GERONTOL, V38, P353, DOI 10.1016/S0531-5565(03)00032-9; Frisina ST, 2006, HEARING RES, V211, P103, DOI 10.1016/j.heares.2005.09.002; GATES GA, 1993, ARCH OTOLARYNGOL, V119, P156; Huang Q, 2010, EUR ARCH OTO-RHINO-L, V267, P1179, DOI 10.1007/s00405-010-1270-7; Janssen GMC, 1999, J BIOL CHEM, V274, P29744, DOI 10.1074/jbc.274.42.29744; Kundu S, 2001, J INDIAN MED ASSOC, V99, P89; Kwon IS, 2007, J KOREAN MED ASSOC, V50, P208, DOI 10.5124/jkma.2007.50.3.208; Lim HW, 2011, J KOREAN MED ASSOC, V54, P910, DOI 10.5124/jkma.2011.54.9.910; Lisowska G, 2001, OTOL NEUROTOL, V22, P316, DOI 10.1097/00129492-200105000-00008; MOSCICKI EK, 1985, EAR HEARING, V6, P184, DOI 10.1097/00003446-198507000-00003; OHINATA Y, 1994, ACTA OTO-LARYNGOL, V114, P601, DOI 10.3109/00016489409126112; OSTERHAMMEL D, 1980, SCAND AUDIOL, V9, P13, DOI 10.3109/01050398009076329; Rarey KE, 1996, HEARING RES, V102, P63, DOI 10.1016/S0378-5955(96)00148-7; Rey JF, 2002, ACTA OTORRINOLAR ESP, V53, P572; ROSEN S, 1962, ANN OTO RHINOL LARYN, V71, P727, DOI 10.1177/000348946207100313; SIEGER A, 1983, ANN OTO RHINOL LARYN, V92, P237, DOI 10.1177/000348948309200305; Sugimoto S, 2013, ACTA OTO-LARYNGOL, V133, P1165, DOI 10.3109/00016489.2013.803599; Vaughan N, 2006, OTOL NEUROTOL, V27, P37, DOI 10.1097/01.mao.0000194812.69556.74; 김보형, 2006, [Korean Journal of Otorhinolaryngology Head and Neck Surgery, 대한이비인후과학회지 두경부외과학], V49, P962	31	28	30	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2014	9	12							e116161	10.1371/journal.pone.0116161	http://dx.doi.org/10.1371/journal.pone.0116161			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX6YH	25549095	Green Published, gold, Green Submitted			2022-12-27	WOS:000347063500054
J	Nestola, P; Martins, DL; Peixoto, C; Roederstein, S; Schleuss, T; Alves, PM; Mota, JPB; Carrondo, MJT				Nestola, Piergiuseppe; Martins, Duarte L.; Peixoto, Cristina; Roederstein, Susanne; Schleuss, Tobias; Alves, Paula M.; Mota, Jose P. B.; Carrondo, Manuel J. T.			Evaluation of Novel Large Cut-Off Ultrafiltration Membranes for Adenovirus Serotype 5 (Ad5) Concentration	PLOS ONE			English	Article							TANGENTIAL FLOW FILTRATION; PURIFICATION PROCESS; RETROVIRAL VECTORS; ANION-EXCHANGE; VIRUS; CHROMATOGRAPHY; TECHNOLOGY; MICROFILTRATION; PARTICLES; RECOVERY	The purification of virus particles and viral vectors for vaccine and gene therapy applications is gaining increasing importance in order to deliver a fast, efficient, and reliable production process. Ultrafiltration (UF) is a widely employed unit operation in bioprocessing and its use is present in several steps of the downstream purification train of biopharmaceuticals. However, to date few studies have thoroughly investigated the performance of several membrane materials and cutoffs for virus concentration/diafiltration. The present study aimed at developing a novel class of UF cassettes for virus concentration/ diafiltration. A detailed study was conducted to evaluate the effects of (i) membrane materials, namely polyethersulfone (PES), regenerated cellulose (RC), and highly cross-linked RC (xRC), (ii) nominal cut-off, and (iii) UF device geometry at different production scales. The results indicate that the xRC cassettes with a cut-off of approximately 500 kDa are able to achieve a 10-fold concentration factor with 100% recovery of particles with a process time twice as fast as that of a commercially available hollow fiber. DNA and host cell protein clearances, as well as hydraulic permeability and fouling behavior, were also assessed.	[Nestola, Piergiuseppe; Martins, Duarte L.; Peixoto, Cristina; Alves, Paula M.; Mota, Jose P. B.; Carrondo, Manuel J. T.] Inst Biol Expt & Tecnol, P-2781901 Oeiras, Portugal; [Nestola, Piergiuseppe; Peixoto, Cristina; Alves, Paula M.] Univ Nova Lisboa, Inst Tecnol Quim & Biol, P-2780157 Oeiras, Portugal; [Mota, Jose P. B.] Univ Nova Lisboa, Requimte CQFB, Dept Quim, Fac Ciencias & Tecnol, P-2829516 Caparica, Portugal; [Carrondo, Manuel J. T.] Univ Nova Lisboa, Dept Quim, Fac Ciencias & Tecnol, P-2829516 Caparica, Portugal; [Roederstein, Susanne; Schleuss, Tobias] Sartorius Stedim Biotech, D-37079 Gottingen, Germany	Universidade Nova de Lisboa; Universidade Nova de Lisboa; Universidade Nova de Lisboa	Carrondo, MJT (corresponding author), Inst Biol Expt & Tecnol, Apartado 12, P-2781901 Oeiras, Portugal.	mjtc@itqb.unl.pt	Mota, José P B/D-5812-2013; Alves, Paula M/C-1070-2008; Peixoto, Cristina/K-8945-2014	Mota, José P B/0000-0001-6752-5766; Alves, Paula M/0000-0003-1445-3556; Peixoto, Cristina/0000-0002-0995-6637; Nestola, Piergiuseppe/0000-0003-3186-5149; Carrondo, Manuel/0000-0002-4550-4574	Sartorius Stedim Biotech; Portuguese Science Foundation (FCT-MCTES) [SFRH/BD/82032/2011 PTDC/EBB-BIO/101992/2008 PTDC/EBB457BIO/119501/2010]	Sartorius Stedim Biotech; Portuguese Science Foundation (FCT-MCTES)(Portuguese Foundation for Science and Technology)	Financial support from Sartorius Stedim Biotech and from the Portuguese Science Foundation (FCT-MCTES) (SFRH/BD/82032/2011 PTDC/EBB-BIO/101992/2008 and PTDC/EBB457BIO/119501/2010). Sartorius Stedim Biotech provided support in the form of salaries for authors SR and TS, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Antony A, 2014, J MEMBRANE SCI, V454, P193, DOI 10.1016/j.memsci.2013.11.052; Bandeira V, 2012, HUM GENE THER METHOD, V23, P255, DOI 10.1089/hgtb.2012.059; BELFORT G, 1994, J MEMBRANE SCI, V96, P1, DOI 10.1016/0376-7388(94)00119-7; Burova E, 2005, GENE THER, V12, pS5, DOI 10.1038/sj.gt.3302611; Cheryan M., 1998, ULTRAFILTRATION MICR, DOI [10.1201/9781482278743, DOI 10.1201/9781482278743]; Cramer SM, 2011, CURR OPIN CHEM ENG, V1, P27, DOI 10.1016/j.coche.2011.08.008; Eglon MN, 2009, J GENE MED, V11, P978, DOI 10.1002/jgm.1383; Farid SS, 2007, J CHROMATOGR B, V848, P8, DOI 10.1016/j.jchromb.2006.07.037; Goerke AR, 2005, BIOTECHNOL BIOENG, V91, P12, DOI 10.1002/bit.20406; Grzenia DL, 2008, J MEMBRANE SCI, V321, P373, DOI 10.1016/j.memsci.2008.05.020; Peinador RI, 2011, J MEMBRANE SCI, V372, P366, DOI 10.1016/j.memsci.2011.02.022; Kalbfuss B, 2007, BIOTECHNOL BIOENG, V97, P73, DOI 10.1002/bit.21139; Kamen A, 2004, J GENE MED, V6, pS184, DOI 10.1002/jgm.503; KESTIN J, 1978, J PHYS CHEM REF DATA, V7, P941, DOI 10.1063/1.555581; Konz JO, 2005, HUM GENE THER, V16, P1346, DOI 10.1089/hum.2005.16.1346; Konz JO, 2005, BIOTECHNOL PROGR, V21, P466, DOI 10.1021/bp049644r; Konz JO, 2008, US Patent, Patent No. [0118970 A1, 0118970]; Liu HF, 2010, MABS-AUSTIN, V2, P480, DOI 10.4161/mabs.2.5.12645; Luitjens A, 2012, US Patent, Patent No. [0315696 A1, 0315696]; Mehta A, 2005, J MEMBRANE SCI, V249, P245, DOI 10.1016/j.memsci.2004.09.040; Segura MM, 2013, EXPERT OPIN BIOL TH, V13, P987, DOI 10.1517/14712598.2013.779249; Segura MM, 2012, HUM GENE THER METHOD, V23, P182, DOI 10.1089/hgtb.2012.058; Negrete A, 2014, J VIROL METHODS, V195, P240, DOI 10.1016/j.jviromet.2013.10.017; Nestola P, 2014, J BIOTECHNOL, V181, P1, DOI 10.1016/j.jbiotec.2014.04.003; Paulen R, 2012, J MEMBRANE SCI, V411, P160, DOI 10.1016/j.memsci.2012.04.028; Peixoto C, 2008, BIOTECHNOL PROGR, V24, P1290, DOI 10.1002/btpr.25; Rodrigues T, 2007, J GENE MED, V9, P233, DOI 10.1002/jgm.1021; Rodrigues T, 2007, J BIOTECHNOL, V127, P520, DOI 10.1016/j.jbiotec.2006.07.028; Silva AC, 2012, CLINIBOOK CLIN GENE, P245; Subramanian S, 2005, BIOTECHNOL PROGR, V21, P851, DOI 10.1021/bp049561a; Tatsis N, 2004, MOL THER, V10, P616, DOI 10.1016/j.ymthe.2004.07.013; van Reis R, 2007, J MEMBRANE SCI, V297, P16, DOI 10.1016/j.memsci.2007.02.045; Vellekamp G, 2001, HUM GENE THER, V12, P1923, DOI 10.1089/104303401753153974; Vicente T, 2009, GENE THER, V16, P766, DOI 10.1038/gt.2009.33; Weggeman M, 2005, European Patent, Patent No. [1780269 B1, 1780269]; Wickramasinghe SR, 2010, J MEMBRANE SCI, V365, P160, DOI 10.1016/j.memsci.2010.09.002; Wickramasinghe SR, 2005, BIOTECHNOL BIOENG, V92, P199, DOI 10.1002/bit.20599; Wolff MW, 2011, EXPERT REV VACCINES, V10, P1451, DOI [10.1586/erv.11.111, 10.1586/ERV.11.111]; Zydney AL, 2009, BIOTECHNOL BIOENG, V103, P227, DOI 10.1002/bit.22308	39	19	20	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2014	9	12							e115802	10.1371/journal.pone.0115802	http://dx.doi.org/10.1371/journal.pone.0115802			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UN	25546428	Green Published, Green Submitted, gold			2022-12-27	WOS:000347120200071
J	Niu, Y; Zhang, ZQ; Liu, CQ; Li, ZM; Sun, H				Niu, Yang; Zhang, Zhi-Qiang; Liu, Chang-Qiu; Li, Zhi-Min; Sun, Hang			A Sexually Dimorphic Corolla Appendage Affects Pollen Removal and Floral Longevity in Gynodioecious Cyananthus delavayi (Campanulaceae)	PLOS ONE			English	Article							MALE REPRODUCTIVE SUCCESS; EVOLUTION; SELECTION; PLANTS; POLLINATION; FITNESS; INTERFERENCE; DISPERSAL; STIGMAS; FLOWERS	The floral traits of bisexual flowers may evolve in response to selection on both male and female functions, but the relative importance of selection associated with each of these two aspects is poorly resolved. Sexually dimorphic traits in plants with unisexual flowers may reflect gender-specific selection, providing opportunities for gaining an increased understanding of the evolution of specific floral traits. We examined sexually dimorphic patterns of floral traits in perfect and female flowers of the gynodioecious species Cyananthus delavayi. A special corolla appendage, the throat hair, was investigated experimentally to examine its influences on male and female function. We found that perfect flowers have larger corollas and much longer throat hairs than female flowers, while female ones have much exerted stigmas. The presence of throat hairs prolonged the duration of pollen presentation by restricting the amount of pollen removed by pollen-collecting bees during each visit. Floral longevity was negatively related to the rate of pollen removal. When pollen removal rate was limited in perfect flowers, the duration of the female phases diminished with the increased male phase duration. There was a weak negative correlation between throat hair length and seed number per fruit in female flowers, but this correlation was not significant in perfect flowers. These results suggest that throat hairs may enhance male function in terms of prolonged pollen presentation. However, throat hairs have no obvious effect on female function in terms of seed number per fruit. The marked sexual dimorphism of this corolla appendage in C. delavayi is likely to have evolved and been maintained by gender-specific selection.	[Niu, Yang; Zhang, Zhi-Qiang; Liu, Chang-Qiu; Sun, Hang] Chinese Acad Sci, Kunming Inst Bot, Key Lab Plant Divers & Biogeog East Asia, Kunming, Yunnan, Peoples R China; [Li, Zhi-Min] Yunnan Normal Univ, Sch Life Sci, Kunming, Yunnan, Peoples R China	Chinese Academy of Sciences; Kunming Institute of Botany, CAS; Yunnan Normal University	Sun, H (corresponding author), Chinese Acad Sci, Kunming Inst Bot, Key Lab Plant Divers & Biogeog East Asia, Kunming, Yunnan, Peoples R China.	hsun@mail.kib.ac.cn	Zhi-Qiang, Zhang/GWZ-6955-2022; Niu, Yang/GPX-1099-2022	Zhi-Qiang, Zhang/0000-0002-6907-3481; 	Natural Science Foundation of China [31200183, 30625004, 40930209]; NSFC-Yunnan Natural Science Foundation Unite Project [U1136601]; "Strategic Priority Research Program (B)" of the Chinese Academy of Sciences [XDB03030112]; Hundred Talents Program of the Chinese Academy of Sciences [2011312D11022]; Science Foundation of the Key Laboratory for Plant Diversity and Biogeography of East Asia [KLBB201209]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NSFC-Yunnan Natural Science Foundation Unite Project; "Strategic Priority Research Program (B)" of the Chinese Academy of Sciences(Chinese Academy of Sciences); Hundred Talents Program of the Chinese Academy of Sciences(Chinese Academy of Sciences); Science Foundation of the Key Laboratory for Plant Diversity and Biogeography of East Asia	This work was supported by the Natural Science Foundation of China (http://www. nsfc.gov.cn/publish/portal1/) (grants 31200183 to YN and 30625004 and 40930209 to HS), the NSFC-Yunnan Natural Science Foundation Unite Project (U1136601 to HS), the "Strategic Priority Research Program (B)" of the Chinese Academy of Sciences, Grant No. XDB03030112, the Hundred Talents Program of the Chinese Academy of Sciences (2011312D11022 to HS), and the Science Foundation of the Key Laboratory for Plant Diversity and Biogeography of East Asia (KLBB201209 to YN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aizen MA, 1998, AM J BOT, V85, P245, DOI 10.2307/2446312; Armbruster WS, 2014, ANN BOT-LONDON, V113, P97, DOI 10.1093/aob/mct261; Armbruster WS, 2009, ANN BOT-LONDON, V103, P1529, DOI 10.1093/aob/mcp095; Ashman TL, 1997, EVOL ECOL, V11, P289, DOI 10.1023/A:1018416403530; Barrett SCH, 2002, HEREDITY, V88, P154, DOI 10.1038/sj/hdy/6800020; Barrett SCH, 2008, INT J PLANT SCI, V169, P1, DOI 10.1086/522511; Barrett SCH, 2013, J EXP BOT, V64, P67, DOI 10.1093/jxb/ers308; Castellanos MC, 2006, AM NAT, V167, P288, DOI 10.1086/498854; Cox RM, 2003, EVOLUTION, V57, P1653, DOI 10.1554/02-227; Cox RM, 2009, AM NAT, V173, P176, DOI 10.1086/595841; Delph LF, 2006, INTEGR COMP BIOL, V46, P465, DOI 10.1093/icb/icj038; Duffy KJ, 2011, PLANT BIOLOGY, V13, P556, DOI 10.1111/j.1438-8677.2011.00445.x; Eckhart V.M., 1999, GENDER SEXUAL DIMORP, P123, DOI [DOI 10.1007/978-3-662-03908-3_5, 10.1007/978-3-662-03908-3_5]; Evanhoe L, 2002, AM J BOT, V89, P587, DOI 10.3732/ajb.89.4.587; Giblin DE, 2005, AM J BOT, V92, P1714, DOI 10.3732/ajb.92.10.1714; HARDER LD, 1994, EVOL ECOL, V8, P542, DOI 10.1007/BF01238257; HARDER LD, 1989, AM NAT, V133, P323, DOI 10.1086/284922; Hargreaves AL, 2009, BIOL REV, V84, P259, DOI 10.1111/j.1469-185X.2008.00074.x; Hong D-Y, 2012, FLORA CHINA, V19; Ishii HS, 2000, FUNCT ECOL, V14, P122, DOI 10.1046/j.1365-2435.2000.00401.x; Lau JA, 2004, OECOLOGIA, V141, P577, DOI 10.1007/s00442-004-1677-1; LLOYD DG, 1982, EVOLUTION, V36, P903, DOI 10.1111/j.1558-5646.1982.tb05462.x; LLOYD DG, 1986, NEW ZEAL J BOT, V24, P135, DOI 10.1080/0028825X.1986.10409725; LLOYD DG, 1977, BOT REV, V43, P177, DOI 10.1007/BF02860717; LOVICH JE, 1992, GROWTH DEVELOP AGING, V56, P269; Marshall M, 2001, AM J BOT, V88, P1437, DOI 10.2307/3558451; MORGAN MT, 1994, AM NAT, V144, pS100, DOI 10.1086/285655; Niu Y, 2011, THESIS U CHINESE ACA; Niu Y, 2011, ANN BOT-LONDON, V108, P1257, DOI 10.1093/aob/mcr224; PERCIVAL M. S., 1955, NEW PHYTOL, V54, P353, DOI 10.1111/j.1469-8137.1955.tb06192.x; PLACK A, 1957, NATURE, V180, P1218, DOI 10.1038/1801218a0; PRIMACK RB, 1985, ANNU REV ECOL SYST, V16, P15, DOI 10.1146/annurev.es.16.110185.000311; Ramsey M, 2001, INT J PLANT SCI, V162, P589, DOI 10.1086/320142; Richards A.J, 1997, PLANT BREEDING SYSTE; Shykoff JA, 2003, OECOLOGIA, V135, P1, DOI 10.1007/s00442-002-1133-z; STANTON M, 1994, J EVOLUTION BIOL, V7, P271, DOI 10.1046/j.1420-9101.1994.7030271.x; Thomson JD, 2006, INTEGR COMP BIOL, V46, P390, DOI 10.1093/icb/icj046; THOMSON JD, 1992, ECOLOGY AND EVOLUTION OF PLANT REPRODUCTION, P1; vanDoorn WG, 1997, J EXP BOT, V48, P1615, DOI 10.1093/jexbot/48.314.1615; WEBB CJ, 1987, ANN MO BOT GARD, V74, P51, DOI 10.2307/2399261; WILSON P, 1995, BIOL J LINN SOC, V55, P355, DOI 10.1111/j.1095-8312.1995.tb01071.x; Zhou Z, 2013, MOL PHYLOGENET EVOL, V68, P482, DOI 10.1016/j.ympev.2013.04.027	42	4	6	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2015	10	1							e0117149	10.1371/journal.pone.0117149	http://dx.doi.org/10.1371/journal.pone.0117149			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ4OZ	25603479	gold, Green Published, Green Submitted			2022-12-27	WOS:000348203500043
J	Altena, R; Fehrmann, RSN; Boer, H; de Vries, EGE; Meijer, C; Gietema, JA				Altena, Renske; Fehrmann, Rudolf S. N.; Boer, Hink; de Vries, Elisabeth G. E.; Meijer, Coby; Gietema, Jourik A.			Growth Differentiation Factor 15 (GDF-15) Plasma Levels Increase during Bleomycin- and Cisplatin-Based Treatment of Testicular Cancer Patients and Relate to Endothelial Damage	PLOS ONE			English	Article							LONG-TERM SURVIVORS; MACROPHAGE INHIBITORY CYTOKINE-1; CARDIOVASCULAR-DISEASE; ACTIVATING TRANSCRIPTION; INDUCED APOPTOSIS; 5-YEAR SURVIVORS; CELL; CHEMOTHERAPY; EXPRESSION; PLATINUM	Introduction Chemotherapy-related endothelial damage contributes to the early development of cardiovascular morbidity in testicular cancer patients. We aimed to identify relevant mechanisms of and search for candidate biomarkers for this endothelial damage. Methods Human micro-vascular endothelial cells (HMEC-1) were exposed to bleomycin or cisplatin with untreated samples as control. 18k cDNA microarrays were used. Gene expression differences were analysed at single gene level and in gene sets clustered in biological pathways and validated by qRT-PCR. Protein levels of a candidate biomarker were measured in testicular cancer patient plasma before, during and after bleomycin-etoposide-cisplatin chemotherapy, and related to endothelial damage biomarkers (von Willebrand Factor (vWF), high-sensitivity C-Reactive Protein (hsCRP)). Results Microarray data identified several genes with highly differential expression; e.g. Growth Differentiation Factor 15 (GDF-15), Activating Transcription Factor 3 (ATF3) and Amphiregulin (AREG). Pathway analysis revealed strong associations with 'p53' and 'Diabetes Mellitus' gene sets. Based on known function, we measured GDF-15 protein levels in 41 testicular patients during clinical follow-up. Pre-chemotherapy GDF-15 levels equalled controls. Throughout chemotherapy GDF-15, vWF and hsCRP levels increased, and were correlated at different time-points. Conclusion An unbiased approach in a preclinical model revealed genes related to chemotherapy-induced endothelial damage, like GDF-15. The increases in plasma GDF-15 levels in testicular cancer patients during chemotherapy and its association with vWF and hsCRP suggest that GDF-15 is a potentially useful biomarker related to endothelial damage.	[Altena, Renske; Fehrmann, Rudolf S. N.; Boer, Hink; de Vries, Elisabeth G. E.; Meijer, Coby; Gietema, Jourik A.] Univ Groningen, Univ Med Ctr Groningen, Dept Med Oncol, Groningen, Netherlands; [Fehrmann, Rudolf S. N.] Univ Groningen, Univ Med Ctr Groningen, Dept Genet, Groningen, Netherlands	University of Groningen; University of Groningen	Gietema, JA (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Med Oncol, Groningen, Netherlands.	j.a.gietema@umcg.nl	Fehrmann, Rudolf/E-2551-2011	Fehrmann, Rudolf/0000-0002-7516-315X; Gietema, Jourik/0000-0003-0629-7354; Altena-Kornalijnslijper, Renske/0000-0001-6944-5209; de Vries, Elisabeth/0000-0002-8949-7425	Dutch Cancer Society [RUG 2009-4365]	Dutch Cancer Society(KWF Kankerbestrijding)	Support was provided by RUG 2009-4365 from the Dutch Cancer Society. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADES EW, 1992, J INVEST DERMATOL, V99, P683, DOI 10.1111/1523-1747.ep12613748; Ago T, 2006, CIRC RES, V98, P294, DOI 10.1161/01.RES.0000207919.83894.9d; ALBERTS DS, 1978, CANCER CHEMOTH PHARM, V1, P177; Breit SN, 2011, GROWTH FACTORS, V29, P187, DOI 10.3109/08977194.2011.607137; Brouwer CAJ, 2013, J CLIN ONCOL, V31, P3906, DOI 10.1200/JCO.2012.46.6086; Brown DA, 2002, LANCET, V359, P2159, DOI 10.1016/S0140-6736(02)09093-1; Cai Y, 2000, BLOOD, V96, P2140, DOI 10.1182/blood.V96.6.2140.h8002140_2140_2148; Chen SC, 2008, ATHEROSCLEROSIS, V201, P281, DOI 10.1016/j.atherosclerosis.2008.02.014; Dirix LY, 1997, ANTI-CANCER DRUG, V8, P859, DOI 10.1097/00001813-199710000-00007; Eckstein N, 2008, J BIOL CHEM, V283, P739, DOI 10.1074/jbc.M706287200; Eggers KM, 2012, SCAND J CLIN LAB INV, V72, P45, DOI 10.3109/00365513.2011.626072; Feldman DR, 2008, JAMA-J AM MED ASSOC, V299, P672, DOI 10.1001/jama.299.6.672; Fossa SD, 2004, BRIT J CANCER, V90, P607, DOI 10.1038/sj.bjc.6601558; Fu MG, 2003, GENE, V315, P33, DOI 10.1016/S0378-1119(03)00730-3; Gietema JA, 2000, LANCET, V355, P1075, DOI 10.1016/S0140-6736(00)02044-4; Hamdi M, 2008, DNA REPAIR, V7, P487, DOI 10.1016/j.dnarep.2007.12.004; Haugnes HS, 2010, J CLIN ONCOL, V28, P4649, DOI 10.1200/JCO.2010.29.9362; Hellemons ME, 2012, DIABETES CARE, V35, P2340, DOI 10.2337/dc12-0180; Herder M, 2013, OBESITY METABOLIS S3, V15, P39; Huang CY, 2007, CLIN CANCER RES, V13, P5825, DOI 10.1158/1078-0432.CCR-07-1037; Huddart RA, 2003, J CLIN ONCOL, V21, P1513, DOI 10.1200/JCO.2003.04.173; Ishii H, 2002, TOXICOL APPL PHARM, V184, P88, DOI 10.1006/taap.2002.9499; Kawauchi J, 2002, J BIOL CHEM, V277, P39025, DOI 10.1074/jbc.M202974200; Kempf T, 2006, CIRC RES, V98, P351, DOI 10.1161/01.RES.0000202805.73038.48; Kempf T, 2012, EUR J ENDOCRINOL, V167, P671, DOI 10.1530/EJE-12-0466; Kool J, 2005, ONCOGENE, V22, P4235, DOI [10.1038/sj.onc.1206611, DOI 10.1038/SJ.0NC.1206611]; L'Azou B, 2005, CELL BIOL TOXICOL, V21, P127, DOI 10.1007/s10565-005-0172-8; Lechner D, 2007, J THROMB HAEMOST, V5, P2445, DOI 10.1111/j.1538-7836.2007.02788.x; Lok DJ, 2013, AM J CARDIOL, V112, P831, DOI 10.1016/j.amjcard.2013.05.013; Mehta RS, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/dju016; Meinardi MT, 2000, J CLIN ONCOL, V18, P1725, DOI 10.1200/JCO.2000.18.8.1725; Montiel M, 2009, CELL PHYSIOL BIOCHEM, V23, P441, DOI 10.1159/000218191; Nawa T, 2002, ATHEROSCLEROSIS, V161, P281, DOI 10.1016/S0021-9150(01)00639-6; Nobori K, 2002, J MOL CELL CARDIOL, V34, P1387, DOI 10.1006/jmcc.2002.2091; Nuver J, 2005, J CLIN ONCOL, V23, P9130, DOI 10.1200/JCO.2005.01.4092; Nuver J, 2005, EUR J CLIN INVEST, V35, P99, DOI 10.1111/j.1365-2362.2005.01460.x; Nuver J, 2004, EUR J CANCER, V40, P701, DOI 10.1016/j.ejca.2003.12.012; Nuver J, 2010, ONCOL REP, V23, P247, DOI 10.3892/or_00000630; Shi YC, 1998, JPN J CANCER RES, V89, P757, DOI 10.1111/j.1349-7006.1998.tb03281.x; Song HJ, 2012, MOL BIOL REP, V39, P4017, DOI 10.1007/s11033-011-1182-7; Sprauten M, 2012, J CLIN ONCOL, V30, P300, DOI 10.1200/JCO.2011.37.4025; STEFENELLI T, 1988, EUR HEART J, V9, P552, DOI 10.1093/oxfordjournals.eurheartj.a062542; Strumberg D, 2002, ANN ONCOL, V13, P229, DOI 10.1093/annonc/mdf058; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Unsicker K, 2013, CYTOKINE GROWTH F R, V24, P373, DOI 10.1016/j.cytogfr.2013.05.003; Urien S, 2005, CANCER CHEMOTH PHARM, V55, P55, DOI 10.1007/s00280-004-0852-8; van den Belt-Dusebout AW, 2007, J CLIN ONCOL, V25, P4370, DOI 10.1200/JCO.2006.10.5296; van den Belt-Dusebout AW, 2006, J CLIN ONCOL, V24, P467, DOI 10.1200/JCO.2005.02.7193; Vaughn DJ, 2008, CANCER-AM CANCER SOC, V112, P1949, DOI 10.1002/cncr.23389; Weijl NI, 2000, J CLIN ONCOL, V18, P2169, DOI 10.1200/JCO.2000.18.10.2169; Wiklund FE, 2010, AGING CELL, V9, P1057, DOI 10.1111/j.1474-9726.2010.00629.x; Yu MH, 2008, CANCER SCI, V99, P391, DOI 10.1111/j.1349-7006.2008.00696.x	52	30	33	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2015	10	1							e0115372	10.1371/journal.pone.0115372	http://dx.doi.org/10.1371/journal.pone.0115372			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9HN	25590623	Green Published, Green Submitted, gold			2022-12-27	WOS:000350679400008
J	Mellou, K; Sideroglou, T; Papaevangelou, V; Katsiaflaka, A; Bitsolas, N; Verykouki, E; Triantafillou, E; Baka, A; Georgakopoulou, T; Hadjichristodoulou, C				Mellou, Kassiani; Sideroglou, Theologia; Papaevangelou, Vassiliki; Katsiaflaka, Anna; Bitsolas, Nikolaos; Verykouki, Eleni; Triantafillou, Eleni; Baka, Agoritsa; Georgakopoulou, Theano; Hadjichristodoulou, Christos			Considerations on the Current Universal Vaccination Policy against Hepatitis A in Greece after Recent Outbreaks	PLOS ONE			English	Article							COST-EFFECTIVENESS; UNITED-STATES; CHILDREN; VIRUS; SEROPREVALENCE; RISK; AREA; EPIDEMIOLOGY; ADOLESCENTS; INFECTION	Greece is the only European Union member state that in 2008 included hepatitis A (HAV) vaccine in the routine national childhood immunization program (NCIP). Given that the resources allocated to public health have dramatically decreased since 2008 and that Greece is a low endemicity country for the disease, the benefit from universal vaccination has been questioned. The aim of this paper is to summarize the available epidemiological data of the disease for 1982-2013, and discuss the effects of universal vaccination on disease morbidity. Descriptive analysis, ARIMA modeling and time series intervention analysis were conducted using surveillance data of acute HAV. A decreasing trend of HAV notification rate over the years was identified (p<0.001). However, universal vaccination (similar to 80% vaccine coverage of children) had no significant effect on the annual number of reported cases (p = 0.261) and has resulted to a progressive increase of the average age of infection in the general population. The mean age of cases before the inclusion of the vaccine to NCIP (24.1 years, SD = 1.5) was significantly lower than the mean age of cases after 2008 (31.7 years, SD = 2.1) (p<0.001). In the last decade, one third of all reported cases were Roma (a population accounting for 1.5% of the country's total population) and in 2013 three outbreaks with 16, 9 and 25 Roma cases respectively, were recorded, indicating the decreased effectiveness of the current immunization strategy in this group. Data suggest that universal vaccination may need to be re-considered. Probably a more cost effective approach would be to implement a program that will include: a) vaccination of high risk groups, b) universal vaccination of Roma children and improving conditions at Roma camps, c) education of the population and travel advice, and d) enhancement of the control measures to increase safety of shellfish and other foods.	[Mellou, Kassiani; Sideroglou, Theologia; Triantafillou, Eleni; Baka, Agoritsa; Georgakopoulou, Theano; Hadjichristodoulou, Christos] Hellen Ctr Dis Control & Prevent, Athens, Greece; [Papaevangelou, Vassiliki] Univ Athens, Gen Univ Hosp ATTIKON, Dept Pediat 3, Athens, Greece; [Katsiaflaka, Anna; Bitsolas, Nikolaos; Verykouki, Eleni; Hadjichristodoulou, Christos] Univ Thessaly, Fac Med, Dept Hyg & Epidemiol, Larisa, Greece	National & Kapodistrian University of Athens; University Hospital Attikon; University of Thessaly	Mellou, K (corresponding author), Hellen Ctr Dis Control & Prevent, Athens, Greece.	mellou@keelpno.gr	MELLOU, KASSIANI/AAD-5108-2020; SIderoglou, Theologia/ABG-5856-2021	MELLOU, KASSIANI/0000-0002-0065-5766; Hadjichristodoulou, Christos/0000-0002-4769-8376; Bitsolas, Nikolaos/0000-0001-6207-4441				Alexopoulou Z, 2013, ESPID 2013; Andre FE, 2006, CURR TOP MICROBIOL, V304, P95; Anonychuk AM, 2008, PHARMACOECONOMICS, V26, P17, DOI 10.2165/00019053-200826010-00003; Barkai G, 2009, PEDIATR INFECT DIS J, V28, P391, DOI 10.1097/INF.0b013e318190655c; Bell BP, 2002, VIRAL HEPATITIS LIVE, P359; Centers for Diseases Control and Prevention, 2012, PINK BOOK EP PREV VA; Drositis I, 2013, EUR J INTERN MED, V24, P839, DOI 10.1016/j.ejim.2013.08.003; Elam-Evans LD, 2014, MMWR-MORBID MORTAL W, V63, P741; Hanafiah KM, 2011, INT J HEALTH GEOGR, V10, DOI 10.1186/1476-072X-10-57; Hellenic Centre for Diseases Control and Prevention, 2014, NAT VACC COV STUDY 3; Jacobs RJ, 2003, PEDIATR INFECT DIS J, V22, P904, DOI 10.1097/01.inf.0000091295.53969.6a; Jacobsen KH, 2010, VACCINE, V28, P6653, DOI 10.1016/j.vaccine.2010.08.037; Jacobsen KH, 2009, GLOBAL PREVALENCE HE; KREMASTINOU J, 1984, AM J EPIDEMIOL, V120, P703, DOI 10.1093/oxfordjournals.aje.a113937; Kyrka A, 2009, J MED VIROL, V81, P582, DOI 10.1002/jmv.21434; Lim TA, 2013, EUR J PUBLIC HEALTH, V23, P663, DOI 10.1093/eurpub/cks182; Lopalco PL, 2000, VACCINE, V19, P470, DOI 10.1016/S0264-410X(00)00193-6; Martinelli D, 2010, VACCINE, V28, P6783, DOI 10.1016/j.vaccine.2010.07.069; Martinez A, 2011, HUM VACCINES, V7, P205, DOI 10.4161/hv.7.0.14598; Mayoral CJ, 2012, EUROSURVEILLANCE, V18, P17; Mazokopakis E, 2000, EUR J EPIDEMIOL, V16, P1069, DOI 10.1023/A:1010857128629; Michos A, 2008, J MED VIROL, V80, P791, DOI 10.1002/jmv.21134; Ott JJ, 2012, VACCINE, V31, P3, DOI 10.1016/j.vaccine.2012.04.104; Panagiotopoulos T, 2007, NATL STUDY VACCINATI; Panagiotopoulos T, 2013, NATL STUDY VACCINATI; PAPAEVANGELOU GJ, 1987, INFECTION, V15, P221, DOI 10.1007/BF01644116; Pervanidou D, 2010, EUROSURVEILLANCE, P15; Quezada A, 2008, REV PANAM SALUD PUBL, V23, P303, DOI 10.1590/S1020-49892008000500002; Rachiotis G, 2012, INT J ENV RES PUB HE, V9, P4498, DOI 10.3390/ijerph9124498; Rein DB, 2007, PEDIATRICS, V119, pE12, DOI 10.1542/peds.2006-1573; Sartori AMC, 2012, VACCINE, V30, P7489, DOI 10.1016/j.vaccine.2012.10.056; Scheifele DW, 2005, EXPERT OPIN PHARMACO, V6, P157, DOI 10.1517/14656566.6.2.157; Valenzuela MT, 2005, VACCINE, V23, P4110, DOI 10.1016/j.vaccine.2005.03.021; Van Herck K, 2011, J MED VIROL, V83, P1885, DOI 10.1002/jmv.22200; Vantarakis A, 2010, EPIDEMIOL INFECT, V138, P1025, DOI 10.1017/S0950268809991257; Vogt TM, 2008, J INFECT DIS, V197, P1282, DOI 10.1086/586899; Wei WWS, 1990, TIME SERIES ANAL UNI, P184; World Health Organization, 2012, WKLY EPIDEMIOL REC, V87, P176; World Health Organization, INT TRAV HLTH INT	39	26	26	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2015	10	1							e0116939	10.1371/journal.pone.0116939	http://dx.doi.org/10.1371/journal.pone.0116939			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9HN	25590132	Green Submitted, gold, Green Published			2022-12-27	WOS:000350679400025
J	Shieh, BS; Liang, SH; Chiu, YW				Shieh, Bao-Sen; Liang, Shih-Hsiung; Chiu, Yuh-Wen			Acoustic and Temporal Partitioning of Cicada Assemblages in City and Mountain Environments	PLOS ONE			English	Article							INTERFERENCE COMPETITION; DETERMINISTIC CHAOS; COMMUNITY; COMMUNICATION; COMPLEX; NOISE; FROGS; BIOACOUSTICS; CONSERVATION; HOMOPTERA	Comparing adaptations to noisy city environments with those to natural mountain environments on the community level can provide significant insights that allow an understanding of the impact of anthropogenic noise on invertebrates that employ loud calling songs for mate attraction, especially when each species has its distinct song, as in the case of cicadas. In this study, we investigated the partitioning strategy of cicada assemblages in city and mountain environments by comparing the acoustic features and calling activity patterns of each species, recorded using automated digital recording systems. Our comparison of activity patterns of seasonal and diel calling revealed that there was no significant temporal partitioning of cicada assemblages in either environment. In addition, there was no correlation between the acoustic distance based on spectral features and temporal segregation. Heterospecific spectral overlap was low in both city and mountain environments, although city and mountain cicada assemblages were subject to significantly different levels of anthropogenic or interspecific noise. Furthermore, for the common species found in both environments, the calling activity patterns at both seasonal and diel time scales were significantly consistent across sites and across environments. We suggest that the temporal calling activity is constrained by endogenous factors for each species and is less flexible in response to external factors, such as anthropogenic noise. As a result, cicada assemblages in city environments with low species diversity do not demonstrate a more significant temporal partitioning than those in mountain environments with high species diversity.	[Shieh, Bao-Sen] Kaohsiung Med Univ, Dept Biomed Sci & Environm Biol, Kaohsiung, Taiwan; [Liang, Shih-Hsiung] Natl Kaohsiung Normal Univ, Dept Biotechnol, Kaohsiung, Taiwan; [Chiu, Yuh-Wen] Natl Museum Marine Biol & Aquarium, Pingtung, Taiwan	Kaohsiung Medical University; National Kaohsiung Normal University; National Museum of Marine Biology & Aquarium	Shieh, BS (corresponding author), Kaohsiung Med Univ, Dept Biomed Sci & Environm Biol, Kaohsiung, Taiwan.	bsshieh@kmu.edu.tw		Shieh, Bao-Sen/0000-0002-5438-3735	National Science Council of Taiwan [NSC 98-2313-B-037-002-MY3]	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by the National Science Council of Taiwan (grant no. NSC 98-2313-B-037-002-MY3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht M, 2001, OECOLOGIA, V126, P134, DOI 10.1007/s004420000494; Amezquita A, 2011, P NATL ACAD SCI USA, V108, P17058, DOI 10.1073/pnas.1104773108; Barber JR, 2010, TRENDS ECOL EVOL, V25, P180, DOI 10.1016/j.tree.2009.08.002; Benko TP, 2006, J BIOL SYST, V14, P555, DOI 10.1142/S0218339006002008; Benko TP, 2007, J BIOSCIENCES, V32, P797, DOI 10.1007/s12038-007-0081-5; CAROTHERS JH, 1984, OIKOS, V42, P403, DOI 10.2307/3544413; CASE TJ, 1974, P NATL ACAD SCI USA, V71, P3073, DOI 10.1073/pnas.71.8.3073; Chek AA, 2003, ECOL LETT, V6, P235, DOI 10.1046/j.1461-0248.2003.00420.x; Chen C.S., 2004, CICADAS TAIWAN; CLARIDGE MF, 1985, ANNU REV ENTOMOL, V30, P297, DOI 10.1146/annurev.en.30.010185.001501; Diwakar S, 2007, BIOACOUSTICS, V16, P113, DOI 10.1080/09524622.2007.9753571; DREWRY GE, 1983, COPEIA, P941, DOI 10.2307/1445095; Francis CD, 2009, CURR BIOL, V19, P1415, DOI 10.1016/j.cub.2009.06.052; Gogala Matija, 1995, Malayan Nature Journal, V48, P297; Gottsberger B, 2004, J TROP ECOL, V20, P271, DOI 10.1017/S0266467403001172; Jain M, 2014, EVOL ECOL, V28, P1, DOI 10.1007/s10682-013-9658-7; Kronfeld-Schor N, 2003, ANNU REV ECOL EVOL S, V34, P153, DOI 10.1146/annurev.ecolsys.34.011802.132435; Laiolo P, 2010, BIOL CONSERV, V143, P1635, DOI 10.1016/j.biocon.2010.03.025; Lampe U, 2012, FUNCT ECOL, V26, P1348, DOI 10.1111/1365-2435.12000; Luddecke H, 2000, STUD NEOTROP FAUNA E, V35, P185, DOI 10.1076/snfe.35.3.185.8855; Luther D, 2009, BEHAV ECOL, V20, P864, DOI 10.1093/beheco/arp074; Marshall DC, 2000, EVOLUTION, V54, P1313, DOI 10.1111/j.0014-3820.2000.tb00564.x; Morley EL, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.2683; Pianka ER, 1973, ANNU REV ECOL SYST, V4, P53, DOI [DOI 10.1146/ANNUREV.ES.04.110173.000413, 10.1146/annurev.es.04.110173.000413]; Planque R, 2008, ETHOLOGY, V114, P262, DOI 10.1111/j.1439-0310.2007.01461.x; Romer H, 1998, SPR HDB AUD, V10, P63; Sanborn AF, 2001, ANN ENTOMOL SOC AM, V94, P159, DOI 10.1603/0013-8746(2001)094[0159:REOTDD]2.0.CO;2; Schmidt AKD, 2013, BEHAV ECOL, V24, P470, DOI 10.1093/beheco/ars187; SCHOENER TW, 1974, SCIENCE, V185, P27, DOI 10.1126/science.185.4145.27; Shieh BS, 2012, ACTA ETHOL, V15, P33, DOI 10.1007/s10211-011-0105-x; Shochat E, 2006, TRENDS ECOL EVOL, V21, P661, DOI 10.1016/j.tree.2006.09.007; Slabbekoorn H, 2008, MOL ECOL, V17, P72, DOI 10.1111/j.1365-294X.2007.03487.x; Sol D, 2013, ANIM BEHAV, V85, P1101, DOI 10.1016/j.anbehav.2013.01.023; Sueur J, 2002, BIOL J LINN SOC, V75, P379, DOI 10.1111/j.1095-8312.2002.tb02079.x; Tobias JA, 2014, P NATL ACAD SCI USA, V111, P1020, DOI 10.1073/pnas.1314337111; Warren PS, 2006, ANIM BEHAV, V71, P491, DOI 10.1016/j.anbehav.2005.07.014	36	9	9	0	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2015	10	1							e0116794	10.1371/journal.pone.0116794	http://dx.doi.org/10.1371/journal.pone.0116794			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9HN	25590620	Green Submitted, Green Published, gold			2022-12-27	WOS:000350679400023
J	Tarzemany, R; Jiang, GQ; Larjava, H; Hakkinen, L				Tarzemany, Rana; Jiang, Guoqiao; Larjava, Hannu; Haekkinen, Lari			Expression and Function of Connexin 43 in Human Gingival Wound Healing and Fibroblasts	PLOS ONE			English	Article							HEMICHANNEL-INDEPENDENT ACTIONS; GAP JUNCTIONAL COMMUNICATION; TGF-BETA; MIMETIC PEPTIDE; INTERCELLULAR COMMUNICATION; GROWTH-FACTOR; CELL; CX43; SKIN; MATRIX	Connexins (Cxs) are a family of transmembrane proteins that form hemichannels and gap junctions (GJs) on the cell membranes, and transfer small signaling molecules between the cytoplasm and extracellular space and between connecting cells, respectively. Among Cxs, suppressing Cx43 expression or function promotes skin wound closure and granulation tissue formation, and may alleviate scarring, but the mechanisms are not well understood. Oral mucosal gingiva is characterized by faster wound closure and scarless wound healing outcome as compared to skin wounds. Therefore, we hypothesized that Cx43 function is down regulated during human gingival wound healing, which in fibroblasts promotes expression of genes conducive for fast and scarless wound healing. Cultured gingival fibroblasts expressed Cx43 as their major connexin. Immunostaining of unwounded human gingiva showed that Cx43 was abundantly present in the epithelium, and in connective tissue formed large Cx43 plaques in fibroblasts. At the early stages of wound healing, Cx43 was strongly down regulated in wound epithelial cells and fibroblasts, returning to the level of normal tissue by day 60 post-wounding. Blocking of Cx43 function by Cx43 mimetic peptide Gap27 suppressed GJ-mediated dye transfer, promoted migration, and caused significant changes in the expression of wound healing-associated genes in gingival fibroblasts. In particular, out of 54 genes analyzed, several MMPs and TGF-beta 1, involved in regulation of inflammation and extracellular matrix (ECM) turnover, and VEGF-A, involved in angiogenesis, were significantly upregulated while pro-fibrotic ECM molecules, including Collagen type I, and cell contractility-related molecules were significantly down regulated. These responses involved MAPK, GSK3 alpha/beta and TGF-beta signaling pathways, and AP1 and SP1 transcription factors. Thus, suppressed function of Cx43 in fibroblasts promotes their migration, and regulates expression of wound healing-associated genes via AP1, SP1, MAPK, GSK3 alpha/beta and TGF-beta signaling pathways, and may promote fast and scarless wound healing in human gingiva.	[Tarzemany, Rana; Jiang, Guoqiao; Larjava, Hannu; Haekkinen, Lari] Univ British Columbia, Fac Dent, Dept Oral Biol & Med Sci, Vancouver, BC V5Z 1M9, Canada	University of British Columbia	Hakkinen, L (corresponding author), Univ British Columbia, Fac Dent, Dept Oral Biol & Med Sci, Vancouver, BC V5Z 1M9, Canada.	lhakkine@dentistry.ubc.ca	Hakkinen, Lari/B-2228-2016; Larjava, Hannu/GRO-4325-2022		Canadian Institutes of Health Research; University of British Columbia CIHR Skin Research Training Centre (SRTC) Award; CIHR IMHA Institute Community Support Travel Award	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); University of British Columbia CIHR Skin Research Training Centre (SRTC) Award; CIHR IMHA Institute Community Support Travel Award(Canadian Institutes of Health Research (CIHR))	Supported by Canadian Institutes of Health Research (LH), University of British Columbia CIHR Skin Research Training Centre (SRTC) Award (RT), and CIHR IMHA Institute Community Support Travel Award (RT).	Akita S, 2013, ADV WOUND CARE, V2, P44, DOI 10.1089/wound.2011.0324; Asazuma-Nakamura Y, 2009, EXP CELL RES, V315, P1190, DOI 10.1016/j.yexcr.2008.12.021; Becker DL, 2012, BBA-BIOMEMBRANES, V1818, P2068, DOI 10.1016/j.bbamem.2011.11.017; Brandner JM, 2004, J INVEST DERMATOL, V122, P1310, DOI 10.1111/j.0022-202X.2004.22529.x; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Caillou B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022567; Chaytor AT, 1997, J PHYSIOL-LONDON, V503, P99, DOI 10.1111/j.1469-7793.1997.099bi.x; Cheon SS, 2006, FASEB J, V20, P692, DOI 10.1096/fj.05-4759com; Churko JM, 2013, PHYSIOLOGY, V28, P190, DOI 10.1152/physiol.00058.2012; Churko JM, 2011, HUM MUTAT, V32, P456, DOI 10.1002/humu.21472; Coutinho P, 2005, BRIT J PLAST SURG, V58, P658, DOI 10.1016/j.bjps.2004.12.022; Coutinho P, 2003, CELL BIOL INT, V27, P525, DOI 10.1016/S1065-6995(03)00077-5; Dai P, 2007, MOL BIOL CELL, V18, P2264, DOI 10.1091/mbc.E06-12-1064; Davis NG, 2013, WOUND REPAIR REGEN, V21, P571, DOI 10.1111/wrr.12054; Degen KE, 2012, BIRTH DEFECTS RES C, V96, P258, DOI 10.1002/bdrc.21019; Desplantez T, 2012, PHARMACOL RES, V65, P546, DOI 10.1016/j.phrs.2012.02.002; Dufour A, 2013, TRENDS PHARMACOL SCI, V34, P233, DOI 10.1016/j.tips.2013.02.004; Ehrlich HP, 2013, ADV WOUND CARE, V2, P113, DOI 10.1089/wound.2012.0414; Ehrlich HP, 2000, J CELL PHYSIOL, V184, P86, DOI 10.1002/(SICI)1097-4652(200007)184:1<86::AID-JCP9>3.0.CO;2-5; Eslami A, 2009, J HISTOCHEM CYTOCHEM, V57, P543, DOI 10.1369/jhc.2009.952572; Evans WH, 2012, J MEMBRANE BIOL, V245, P437, DOI 10.1007/s00232-012-9488-5; Fournier BPJ, 2013, STEM CELLS DEV, V22, P3157, DOI 10.1089/scd.2013.0015; Fujita T, 2008, J PERIODONTAL RES, V43, P96, DOI 10.1111/j.1600-0765.2007.01000.x; GABBIANI G, 1978, J CELL BIOL, V76, P561, DOI 10.1083/jcb.76.3.561; Garcia-Dorado D, 2002, CARDIOVASC RES, V55, P456, DOI 10.1016/S0008-6363(02)00441-8; Ghatnekar GS, 2009, REGEN MED, V4, P205, DOI 10.2217/17460751.4.2.205; Ghersi G, 2002, J BIOL CHEM, V277, P29231, DOI 10.1074/jbc.M202770200; Glim JE, 2013, WOUND REPAIR REGEN, V21, P648, DOI 10.1111/wrr.12072; GOLIGER JA, 1995, MOL BIOL CELL, V6, P1491, DOI 10.1091/mbc.6.11.1491; Goodenough DA, 2003, NAT REV MOL CELL BIO, V4, P285, DOI 10.1038/nrm1072; Goodenough DA, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a002576; Gopalakrishnan A, 2006, ARCH PHARM RES, V29, P633, DOI 10.1007/BF02968247; Gourdie RG, 2006, ANN NY ACAD SCI, V1080, P49, DOI 10.1196/annals.1380.005; Hakkinen L, 2014, CYTOTHERAPY, V16, P1171, DOI 10.1016/j.jcyt.2014.04.004; Hakkinen L, 2000, PERIODONTOL 2000, V24, P127, DOI 10.1034/j.1600-0757.2000.2240107.x; HAKKINEN L, 1994, BBA-MOL CELL RES, V1224, P33, DOI 10.1016/0167-4889(94)90110-4; Hakkinen L, 2014, STEM CELL B IN PRESS; Hakkinen L., 2012, ORAL WOUND HEALING C, P125; Harks EGA, 2001, J PHARMACOL EXP THER, V298, P1033; Hatakeyama S, 2006, J PERIODONTAL RES, V41, P322, DOI 10.1111/j.1600-0765.2006.00875.x; Hawat G, 2012, J MOL CELL CARDIOL, V53, P559, DOI 10.1016/j.yjmcc.2012.07.008; Hawat G, 2010, PFLUG ARCH EUR J PHY, V460, P583, DOI 10.1007/s00424-010-0849-6; Hebert C, 2013, J CELL BIOCHEM, V114, P2542, DOI 10.1002/jcb.24603; Hematti P, 2012, CYTOTHERAPY, V14, P516, DOI 10.3109/14653249.2012.677822; Herve JC, 2012, BBA-BIOMEMBRANES, V1818, P1844, DOI 10.1016/j.bbamem.2011.12.009; Honardoust D, 2008, WOUND REPAIR REGEN, V16, P814, DOI 10.1111/j.1524-475X.2008.00435.x; Honardoust HA, 2006, HISTOPATHOLOGY, V49, P634, DOI 10.1111/j.1365-2559.2006.02559.x; Hunter AW, 2005, MOL BIOL CELL, V16, P5686, DOI 10.1091/mbc.E05-08-0737; Ishikawa S, 2012, AM J PHYSIOL-HEART C, V302, pH2536, DOI 10.1152/ajpheart.00940.2011; Jiang JX, 2005, BBA-BIOMEMBRANES, V1711, P208, DOI 10.1016/j.bbamem.2004.10.001; Kandyba EE, 2008, J INVEST DERMATOL, V128, P1039, DOI 10.1038/sj.jid.5701125; King SJ, 2011, METHODS MOL BIOL, V769, P53, DOI 10.1007/978-1-61779-207-6_5; Ko K, 2000, AM J PHYSIOL-CELL PH, V279, pC147, DOI 10.1152/ajpcell.2000.279.1.C147; Komatsu I, 2010, J HAND SURG-AM, V35A, P1580, DOI 10.1016/j.jhsa.2010.07.009; Kretz M, 2004, EUR J CELL BIOL, V83, P647, DOI 10.1078/0171-9335-00422; Kretz M, 2003, J CELL SCI, V116, P3443, DOI 10.1242/jcs.00638; LAL R, 1995, AM J PHYSIOL-CELL PH, V268, pC968, DOI 10.1152/ajpcell.1995.268.4.C968; Langevin HM, 2004, HISTOCHEM CELL BIOL, V122, P7, DOI 10.1007/s00418-004-0667-z; Lauf U, 2002, P NATL ACAD SCI USA, V99, P10446, DOI 10.1073/pnas.162055899; Mah W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090715; Mak K, 2009, J DERMATOL SCI, V56, P168, DOI 10.1016/j.jdermsci.2009.09.005; McCubrey JA, 2014, LEUKEMIA, V28, P15, DOI 10.1038/leu.2013.184; Mor-Vaknin N, 2003, NAT CELL BIOL, V5, P59, DOI 10.1038/ncb898; Mori R, 2006, J CELL SCI, V119, P5193, DOI 10.1242/jcs.03320; Moyer KE, 2002, EXP MOL PATHOL, V72, P10, DOI 10.1006/exmp.2001.2406; NAGASE H, 1991, BIOMED BIOCHIM ACTA, V50, P749; Nakano Y, 2008, INVEST OPHTH VIS SCI, V49, P93, DOI 10.1167/iovs.07-0255; Negoro H, 2013, FEBS LETT, V587, P98, DOI 10.1016/j.febslet.2012.11.021; Nielsen MS, 2012, COMPR PHYSIOL, V2, P1981, DOI 10.1002/cphy.c110051; Niger C, 2011, BONE, V49, P683, DOI 10.1016/j.bone.2011.07.027; Ongstad EL, 2013, ADV WOUND CARE, V2, P55, DOI 10.1089/wound.2011.0341; Penn JW, 2012, INT J BURNS TRAUMA, V2, P18; Pollok S, 2011, J CELL MOL MED, V15, P861, DOI 10.1111/j.1582-4934.2010.01057.x; Principi Mariabeatrice, 2013, World J Gastrointest Pathophysiol, V4, P100, DOI 10.4291/wjgp.v4.i4.100; Profyris C, 2012, J AM ACAD DERMATOL, V66, P1, DOI 10.1016/j.jaad.2011.05.055; Qiu C, 2003, CURR BIOL, V13, P1697, DOI 10.1016/j.cub.2003.09.007; Rhett JM, 2008, TRENDS BIOTECHNOL, V26, P173, DOI 10.1016/j.tibtech.2007.12.007; Richards TS, 2004, J CELL BIOL, V167, P555, DOI 10.1083/jcb.200404142; Rieu I, 2009, PLANT CELL, V21, P1031, DOI 10.1105/tpc.109.066001; Salameh A, 2008, J PHARMACOL EXP THER, V326, P315, DOI 10.1124/jpet.108.136663; SALOMON D, 1988, J CLIN INVEST, V82, P248, DOI 10.1172/JCI113578; Schalper KA, 2012, MOL BIOSYST, V8, P685, DOI 10.1039/c1mb05294b; SEGER R, 1995, FASEB J, V9, P726, DOI 10.1096/fasebj.9.9.7601337; Solan JL, 2014, FEBS LETT, V588, P1423, DOI 10.1016/j.febslet.2014.01.049; Solan JL, 2009, BIOCHEM J, V419, P261, DOI 10.1042/BJ20082319; Sosinsky GE, 2007, BIOCHEM J, V408, P375, DOI 10.1042/BJ20070550; Stains JP, 2014, CALCIFIED TISSUE INT, V94, P55, DOI 10.1007/s00223-013-9742-6; Steffensen B, 2001, CRIT REV ORAL BIOL M, V12, P373, DOI 10.1177/10454411010120050201; SULLIVAN R, 1993, GENE, V130, P191, DOI 10.1016/0378-1119(93)90419-4; Vinken M, 2012, BBA-BIOMEMBRANES, V1818, P2002, DOI 10.1016/j.bbamem.2011.06.011; Wang CM, 2007, DIABETES, V56, P2809, DOI 10.2337/db07-0613; Wang N, 2013, NEUROPHARMACOLOGY, V75, P506, DOI 10.1016/j.neuropharm.2013.08.021; Wong JW, 2009, WOUND REPAIR REGEN, V17, P717, DOI 10.1111/j.1524-475X.2009.00531.x; Wong VW, 2012, SEMIN CELL DEV BIOL, V23, P981, DOI 10.1016/j.semcdb.2012.09.010; Wright CS, 2012, J CELL PHYSIOL, V227, P77, DOI 10.1002/jcp.22705; Wright CS, 2009, WOUND REPAIR REGEN, V17, P240, DOI 10.1111/j.1524-475X.2009.00471.x; Yamaoka Y, 2002, TISSUE CELL, V34, P375, DOI 10.1016/S0040816602000381; Ye P, 2000, J PATHOL, V192, P58; Zhou JZ, 2014, FEBS LETT, V588, P1186, DOI 10.1016/j.febslet.2014.01.001	99	36	40	3	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2015	10	1							e0115524	10.1371/journal.pone.0115524	http://dx.doi.org/10.1371/journal.pone.0115524			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ4OG	25584940	Green Published, Green Submitted, gold			2022-12-27	WOS:000348201300003
J	Gazzolo, D; Pluchinotta, F; Bashir, M; Aboulgar, H; Said, HM; Iman, I; Ivani, G; Conio, A; Tina, LG; Nigro, F; Li Volti, G; Galvano, F; Michetti, F; Di Iorio, R; Marinoni, E; Zimmermann, LJ; Gavilanes, ADW; Vles, HJS; Kornacka, M; Gruszfeld, D; Frulio, R; Sacchi, R; Ciotti, S; Risso, FM; Sannia, A; Florio, P				Gazzolo, Diego; Pluchinotta, Francesca; Bashir, Moataza; Aboulgar, Hanna; Said, Hala Mufeed; Iman, Iskander; Ivani, Giorgio; Conio, Alessandra; Tina, Lucia Gabriella; Nigro, Francesco; Li Volti, Giovanni; Galvano, Fabio; Michetti, Fabrizio; Di Iorio, Romolo; Marinoni, Emanuela; Zimmermann, Luc J.; Gavilanes, Antonio D. W.; Vles, Hans J. S.; Kornacka, Maria; Gruszfeld, Darek; Frulio, Rosanna; Sacchi, Renata; Ciotti, Sabina; Risso, Francesco M.; Sannia, Andrea; Florio, Pasquale			Neurological Abnormalities in Full-Term Asphyxiated Newborns and Salivary S100B Testing: The "Cooperative Multitask against Brain Injury of Neonates" (CoMBINe) International Study	PLOS ONE			English	Article							NEURON-SPECIFIC ENOLASE; PROTEIN CONCENTRATIONS; EARLY IDENTIFICATION; GESTATIONAL-AGE; INTRAVENTRICULAR HEMORRHAGE; CEREBROSPINAL-FLUID; PRETERM INFANTS; EARLY INDICATOR; BLOOD; ENCEPHALOPATHY	Background Perinatal asphyxia (PA) is a leading cause of mortality and morbidity in newborns: its prognosis depends both on the severity of the asphyxia and on the immediate resuscitation to restore oxygen supply and blood circulation. Therefore, we investigated whether measurement of S100B, a consolidated marker of brain injury, in salivary fluid of PA newborns may constitute a useful tool for the early detection of asphyxia-related brain injury. Methods We conducted a cross-sectional study in 292 full-term newborns admitted to our NICUs, of whom 48 suffered PA and 244 healthy controls admitted at our NICUs. Saliva S100B levels measurement longitudinally after birth; routine laboratory variables, neurological patterns, cerebral ultrasound and, magnetic resonance imaging were performed. The primary end-point was the presence of neurological abnormalities at 12-months after birth. Results S100B salivary levels were significantly (P<0.001) higher in newborns with PA than in normal infants. When asphyxiated infants were subdivided according to a good (Group A; n = 15) or poor (Group B; n = 33) neurological outcome at 12-months, S100B was significantly higher at all monitoring time-points in Group B than in Group A or controls (P<0.001, for all). A cut-off >3.25 MoM S100B achieved a sensitivity of 100% (CI5-95%: 89.3%-100%) and a specificity of 100% (CI5-95%: 98.6%-100%) as a single marker for predicting the occurrence of abnormal neurological outcome (area under the ROC curve: 1.000; CI5-95%: 0.987-1.0). Conclusions S100B protein measurement in saliva, soon after birth, is a useful tool to identify which asphyxiated infants are at risk of neurological sequelae.	[Gazzolo, Diego] C Arrigo Childrens Hosp Alessandria, Dept Maternal Fetal & Neonatal Med, Alessandria, Italy; [Pluchinotta, Francesca] S Donato Milanese Univ Hosp, Dept Cardiol & Lab Reasearch, Milan, Italy; [Bashir, Moataza; Aboulgar, Hanna; Said, Hala Mufeed; Iman, Iskander] Cairo Univ, Dept Neonatol, Cairo, Egypt; [Ivani, Giorgio; Conio, Alessandra] Regina Margherita Childrens Hosp Turin, Pediat Intens Care Unit, Turin, Italy; [Tina, Lucia Gabriella; Nigro, Francesco] G Garibaldi Hosp, Dept Maternal Fetal & Neonatal Hlth, Catania, Italy; [Li Volti, Giovanni; Galvano, Fabio] Catania Univ, Dept Biochem, Catania, Italy; [Michetti, Fabrizio] Catholic Univ, Inst Anat & Cell Biol, Rome, Italy; [Di Iorio, Romolo; Marinoni, Emanuela] Univ Roma La Sapienza, Dept Obstet & Gynecol, Lab Perinatal Med, I-00185 Rome, Italy; [Zimmermann, Luc J.; Gavilanes, Antonio D. W.] Maastricht Univ, Dept Pediat & Neonatol, Maastricht, Netherlands; [Vles, Hans J. S.] Maastricht Univ, Dept Child Neurol, Maastricht, Netherlands; [Kornacka, Maria; Gruszfeld, Darek] Warsaw Univ, Dept Neonatol & Intens Care Neonate, Warsaw, Poland; [Frulio, Rosanna; Sacchi, Renata; Ciotti, Sabina; Risso, Francesco M.; Sannia, Andrea] G Gaslini Childrens Univ Hosp, Dept Pediat, Genoa, Italy; [Florio, Pasquale] S Iacopo Hosp, UOC Obstet & Gynecol, Pistoia, Italy	Egyptian Knowledge Bank (EKB); Cairo University; A.O.U. Citta della Salute e della Scienza di Torino; University of Catania; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Sapienza University Rome; Maastricht University; Maastricht University; University of Warsaw; University of Genoa; IRCCS AOU San Martino IST; IRCCS Istituto Giannina Gaslini	Gazzolo, D (corresponding author), C Arrigo Childrens Hosp Alessandria, Dept Maternal Fetal & Neonatal Med, Alessandria, Italy.	dgazzolo@hotmail.com	Gavilanes, Antonio W. Danilo/J-3656-2014; Pluchinotta, Francesca Romana/J-7680-2016; Volti, Giovanni Li/A-2435-2008; Galvano, Fabio/F-8122-2010	Gavilanes, Antonio W. Danilo/0000-0002-6670-3927; Pluchinotta, Francesca Romana/0000-0001-7185-7157; Volti, Giovanni Li/0000-0002-8678-2183; Galvano, Fabio/0000-0003-0644-0755; Gruszfeld, Dariusz/0000-0002-2414-4928; risso, francesco maria/0000-0002-5799-0522	Italian Society of Neonatology; Stella Cometa Foundation, Italy; I Colori della Vita Foundation, Italy	Italian Society of Neonatology; Stella Cometa Foundation, Italy; I Colori della Vita Foundation, Italy	This work is part of the I.O. PhD International Program under the auspices of the Italian Society of Neonatology and was partially supported by grants to DG from Stella Cometa, I Colori della Vita Foundations, Italy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American College of Obstetricians and Gynecologists, 2005, OBSTET GYNECOL, V106, P1469, DOI DOI 10.1097/00006250-200512000-00056; AMIELTISON C, 1968, ARCH DIS CHILD, V43, P89, DOI 10.1136/adc.43.227.89; Barkovich AJ, 2006, AM J NEURORADIOL, V27, P533; Barkovich AJ, 1998, AM J NEURORADIOL, V19, P143; Blennow M, 2001, ACTA PAEDIATR, V90, P1171, DOI 10.1080/080352501317061594; Cowan F, 2003, LANCET, V361, P736, DOI 10.1016/S0140-6736(03)12658-X; Florio P, 2004, LANCET, V364, P270, DOI 10.1016/S0140-6736(04)16677-4; Garnier Y, 2009, REPROD SCI, V16, P758, DOI 10.1177/1933719109335801; Gazzolo D, 2005, PEDIATR RES, V58, P1170, DOI 10.1203/01.pdr.0000185131.22985.30; Gazzolo D, 2005, CLIN BIOCHEM, V38, P229, DOI 10.1016/j.clinbiochem.2004.12.006; Gazzolo D, 2004, CRIT CARE MED, V32, P131, DOI 10.1097/01.CCM.0000104116.91462.CD; Gazzolo D, 2003, ARCH PEDIAT ADOL MED, V157, P1163, DOI 10.1001/archpedi.157.12.1163; Gazzolo D, 2002, CRIT CARE MED, V30, P1356, DOI 10.1097/00003246-200206000-00037; Gazzolo D, 2001, CLIN CHEM, V47, P1132; Gazzolo D, 2001, CLIN CHEM, V47, P1836; Gazzolo D, 1999, J NEUROL SCI, V170, P32, DOI 10.1016/S0022-510X(99)00194-X; Gazzolo D, 2000, CLIN CHEM, V46, P998; Gazzolo D, 2010, J MATERN-FETAL NEO M, V23, P66, DOI 10.3109/14767058.2010.507960; Gazzolo D, 2009, J MATERN-FETAL NEO M, V22, P57, DOI 10.1080/14767050903181468; Gazzolo D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004298; Giussani DA, 2005, PEDIATR RES, V58, P179, DOI 10.1203/01.PDR.0000169999.66157.C0; Higgins RD, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c397; Huang CC, 1999, NEW ENGL J MED, V341, P328, DOI 10.1056/NEJM199907293410504; Jaranyi Z, 2003, CLIN CHEM LAB MED, V41, P1320, DOI 10.1515/CCLM.2003.201; Jonsson H, 2000, J CARDIOTHOR VASC AN, V14, P698, DOI 10.1053/jcan.2000.18444; JURGENSVANDERZEE AD, 1979, EARLY HUM DEV, V3, P141, DOI 10.1016/0378-3782(79)90003-3; Kurinczuk JJ, 2010, EARLY HUM DEV, V86, P329, DOI 10.1016/j.earlhumdev.2010.05.010; Lawn JE, 2005, LANCET, V365, P891, DOI 10.1016/S0140-6736(05)71048-5; Lawrence R, 2009, J PEDIATR-US, V154, P835, DOI 10.1016/j.jpeds.2009.01.002; LEE SK, 1993, PATHOL RES PRACT, V189, P1036; Maas YGH, 2000, J PEDIATR-US, V137, P100, DOI 10.1067/mpd.2000.106901; MICHETTI F, 1980, J NEUROL SCI, V44, P259, DOI 10.1016/0022-510X(80)90133-1; Michetti F, 2012, J NEUROCHEM, V120, P644, DOI 10.1111/j.1471-4159.2011.07612.x; Prechtl H. F. R., 1977, NEUROLOGICAL EXAMINA, V2nd; Richardosn DK, 2001, J PEDIATR-US, V138, P92, DOI 10.1067/mpd.2001.109608; Richardson WS, 1999, JAMA-J AM MED ASSOC, V281, P1214, DOI 10.1001/jama.281.13.1214; Roka A, 2012, ACTA PAEDIATR, V101, P319, DOI 10.1111/j.1651-2227.2011.02480.x; Sanders RD, 2010, ANESTHESIOLOGY, V113, P233, DOI 10.1097/ALN.0b013e3181dc1b84; SARNAT HB, 1976, ARCH NEUROL-CHICAGO, V33, P696, DOI 10.1001/archneur.1976.00500100030012; van Wezel-Meijler G, 2010, SEMIN PERINATOL, V34, P28, DOI 10.1053/j.semperi.2009.10.002; ZWEIG MH, 1993, CLIN CHEM, V39, P561	41	20	20	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2015	10	1							e0115194	10.1371/journal.pone.0115194	http://dx.doi.org/10.1371/journal.pone.0115194			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ4BT	25569796	gold, Green Published, Green Submitted			2022-12-27	WOS:000348168000001
J	Mizokami, D; Araki, K; Tanaka, N; Suzuki, H; Tomifuji, M; Yamashita, T; Ueda, Y; Shimada, H; Matsushita, K; Shiotani, A				Mizokami, Daisuke; Araki, Koji; Tanaka, Nobuaki; Suzuki, Hiroshi; Tomifuji, Masayuki; Yamashita, Taku; Ueda, Yasuji; Shimada, Hideaki; Matsushita, Kazuyuki; Shiotani, Akihiro			Gene Therapy of c-myc Suppressor FUSE-Binding Protein-Interacting Repressor by Sendai Virus Delivery Prevents Tracheal Stenosis	PLOS ONE			English	Article							FAR-UPSTREAM ELEMENT; SUBGLOTTIC STENOSIS; LARYNGOTRACHEAL STENOSIS; IN-VIVO; EXPRESSION; VECTOR; DISEASE; DEATH; ADULTS	Acquired tracheal stenosis remains a challenging problem for otolaryngologists. The objective of this study was to determine whether the Sendai virus (SeV)-mediated c-myc suppressor, a far upstream element (FUSE)-binding protein (FBP)-interacting repressor (FIR), modulates wound healing of the airway mucosa, and whether it prevents tracheal stenosis in an animal model of induced mucosal injury. A fusion gene-deleted, non-transmissible SeV vector encoding FIR (FIR-SeV/Delta F) was prepared. Rats with scraped airway mucosae were administered FIR-SeV/Delta F through the tracheostoma. The pathological changes in the airway mucosa and in the tracheal lumen were assessed five days after scraping. Untreated animals showed hyperplasia of the airway epithelium and a thickened submucosal layer with extensive fibrosis, angiogenesis, and collagen deposition causing lumen stenosis. By contrast, the administration of FIR-SeV/Delta F decreased the degree of tracheal stenosis (P < 0.05) and improved the survival rate (P < 0.05). Immunohistochemical staining showed that c-Myc expression was downregulated in the tracheal basal cells of the FIRSeV/Delta F-treated animals, suggesting that c-myc was suppressed by FIR-SeV/Delta F in the regenerating airway epithelium of the injured tracheal mucosa. The airway-targeted gene therapy of the c-myc suppressor FIR, using a recombinant SeV vector, prevented tracheal stenosis in a rat model of airway mucosal injury.	[Mizokami, Daisuke; Araki, Koji; Tanaka, Nobuaki; Suzuki, Hiroshi; Tomifuji, Masayuki; Yamashita, Taku; Shiotani, Akihiro] Natl Def Med Coll, Dept Otolaryngol Head & Neck Surg, Tokorozawa, Saitama 359, Japan; [Ueda, Yasuji] DNAVEC Corp, Tsukuba, Ibaraki, Japan; [Shimada, Hideaki] Toho Univ, Sch Med, Dept Surg, Ota Ku, Tokyo, Japan; [Matsushita, Kazuyuki] Chiba Univ, Grad Sch Med, Dept Mol Diag F8, Chiba, Japan	National Defense Medical College - Japan; DNAVEC Corporation; Chiba University	Araki, K (corresponding author), Natl Def Med Coll, Dept Otolaryngol Head & Neck Surg, Tokorozawa, Saitama 359, Japan.	kojaraki@ndmc.ac.jp	Matsushita, Kazuyuki/AAJ-5380-2020	Matsushita, Kazuyuki/0000-0001-6742-0761	National Defense Medical College Special Research Grant; Research Promotion-Grant on Defense Medicine; DNAVEC Corporation;  [23592545];  [23592544];  [25462699];  [25670723]; Grants-in-Aid for Scientific Research [25670723] Funding Source: KAKEN	National Defense Medical College Special Research Grant; Research Promotion-Grant on Defense Medicine; DNAVEC Corporation; ; ; ; ; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by grants from the National Defense Medical College Special Research Grant, Research Promotion-Grant on Defense Medicine, and Grant-in-Aid for Scientific Research (C) (JSPS KAKENHI No. 23592545, 23592544 & 25462699), and Grant-in-Aid for Challenging Exploratory Research (JSPS KAKENHI No. 25670723). Co-author Yasuji Ueda is employed by DNAVEC Corporation. DNAVEC Corporation provided support in the form of salary for author YU, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	Ban H, 2007, GENE THER, V14, P1688, DOI 10.1038/sj.gt.3303032; Bent JP, 2010, ANN OTO RHINOL LARYN, V119, P619, DOI 10.1177/000348941011900909; Brooks TA, 2009, NAT REV CANCER, V9, P849, DOI 10.1038/nrc2733; Chan KH, 2007, BIOMATERIALS, V28, P1218, DOI 10.1016/j.biomaterials.2006.11.009; CHEN JC, 1995, ARCH OTOLARYNGOL, V121, P537; Cole BB, 2010, AM J PATHOL, V177, P362, DOI 10.2353/ajpath.2010.090870; DUNCAN R, 1994, GENE DEV, V8, P465, DOI 10.1101/gad.8.4.465; Ferrari S, 2004, GENE THER, V11, P1659, DOI 10.1038/sj.gt.3302334; Gallo A, 2012, ACTA OTORHINOLARYNGO, V32, P182; George M, 2005, EUR ARCH OTO-RHINO-L, V262, P609, DOI 10.1007/s00405-004-0887-9; Hacein-Bey-Abina S, 2003, SCIENCE, V302, P415, DOI 10.1126/science.1088547; Hartnick CJ, 2001, ANN OTO RHINOL LARYN, V110, P1109; Kajiwara T, 2013, CANCER SCI, V104, P149, DOI 10.1111/cas.12058; KIRSNER RS, 1993, DERMATOL CLIN, V11, P629, DOI 10.1016/S0733-8635(18)30216-X; Kitamura A, 2011, CANCER SCI, V102, P1366, DOI 10.1111/j.1349-7006.2011.01931.x; Liu JH, 2000, MOL CELL, V5, P331, DOI 10.1016/S1097-2765(00)80428-1; Liu JH, 2006, EMBO J, V25, P2119, DOI 10.1038/sj.emboj.7601101; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Marshall E, 1999, SCIENCE, V286, P2244, DOI 10.1126/science.286.5448.2244; Matsushita K, 2006, CANCER RES, V66, P1409, DOI 10.1158/0008-5472.CAN-04-4459; Matsushita K, 2014, WORLD J GASTROENTERO, V20, P4316, DOI 10.3748/wjg.v20.i15.4316; Matsushita K, 2013, MOL CANCER RES, V11, P689, DOI 10.1158/1541-7786.MCR-12-0673; Matsushita K, 2012, MOL CANCER RES, V10, P787, DOI 10.1158/1541-7786.MCR-11-0462; Matsushita K, 2009, FRONT BIOSCI-LANDMRK, V14, P3401, DOI 10.2741/3461; Mizokami D, 2013, LARYNGOSCOPE, V123, P1717, DOI 10.1002/lary.23917; Morita Y, 2012, REPROD BIOL ENDOCRIN, V10, DOI 10.1186/1477-7827-10-14; Pelengaris S, 2002, NAT REV CANCER, V2, P764, DOI 10.1038/nrc904; Rahmutulla B, 2014, ONCOTARGET, V5, P2404, DOI 10.18632/oncotarget.1650; Shirakura M, 2004, GENE THER, V11, P784, DOI 10.1038/sj.gt.3302224; Shoji F, 2003, GENE THER, V10, P213, DOI 10.1038/sj.gt.3301847; Singh T, 2010, ARCH OTOLARYNGOL, V136, P163, DOI 10.1001/archoto.2009.175; Slobod KS, 2004, VACCINE, V22, P3182, DOI 10.1016/j.vaccine.2004.01.053; Stojadinovic O, 2005, AM J PATHOL, V167, P59, DOI 10.1016/S0002-9440(10)62953-7; Takeda A, 2003, J VIROL, V77, P9710, DOI 10.1128/JVI.77.17.9710-9715.2003; Tan A, 1999, AM J RESP CRIT CARE, V159, P220, DOI 10.1164/ajrccm.159.1.9802104; Walner DL, 2001, LARYNGOSCOPE, V111, P48, DOI 10.1097/00005537-200101000-00009; Yonemitsu Y, 2000, NAT BIOTECHNOL, V18, P970, DOI 10.1038/79463; Yonemitsu Y, 2013, MOL THER, V21, P707, DOI 10.1038/mt.2012.279	38	7	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2015	10	1							e0116279	10.1371/journal.pone.0116279	http://dx.doi.org/10.1371/journal.pone.0116279			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ4BT	25569246	gold, Green Published, Green Submitted			2022-12-27	WOS:000348168000006
J	de Araujo, WS; Vieira, MC; Lewinsohn, TM; Almeida-Neto, M				de Araujo, Walter Santos; Vieira, Marcos Costa; Lewinsohn, Thomas M.; Almeida-Neto, Myrio			Contrasting Effects of Land Use Intensity and Exotic Host Plants on the Specialization of Interactions in Plant-Herbivore Networks	PLOS ONE			English	Article							INSECT HERBIVORES; HABITAT MODIFICATION; SPECIES RICHNESS; CONSEQUENCES; PREDATORS; DIVERSITY; COMMUNITY; TIME	Human land use tends to decrease the diversity of native plant species and facilitate the invasion and establishment of exotic ones. Such changes in land use and plant community composition usually have negative impacts on the assemblages of native herbivorous insects. Highly specialized herbivores are expected to be especially sensitive to land use intensification and the presence of exotic plant species because they are neither capable of consuming alternative plant species of the native flora nor exotic plant species. Therefore, higher levels of land use intensity might reduce the proportion of highly specialized herbivores, which ultimately would lead to changes in the specialization of interactions in plant-herbivore networks. This study investigates the community-wide effects of land use intensity on the degree of specialization of 72 plant-herbivore networks, including effects mediated by the increase in the proportion of exotic plant species. Contrary to our expectation, the net effect of land use intensity on network specialization was positive. However, this positive effect of land use intensity was partially canceled by an opposite effect of the proportion of exotic plant species on network specialization. When we analyzed networks composed exclusively of endophagous herbivores separately from those composed exclusively of exophagous herbivores, we found that only endophages showed a consistent change in network specialization at higher land use levels. Altogether, these results indicate that land use intensity is an important ecological driver of network specialization, by way of reducing the local host range of herbivore guilds with highly specialized feeding habits. However, because the effect of land use intensity is offset by an opposite effect owing to the proportion of exotic host species, the net effect of land use in a given herbivore assemblage will likely depend on the extent of the replacement of native host species with exotic ones.	[de Araujo, Walter Santos; Vieira, Marcos Costa] Univ Fed Goias, Programa Posgrad Ecol & Evolucao, Inst Ciencias Biol, Goiania, Go, Brazil; [de Araujo, Walter Santos; Vieira, Marcos Costa; Almeida-Neto, Myrio] Univ Fed Goias, Lab Interacoes Ecol & Biodiversidade, Inst Ciencias Biol, Dept Ecol, Goiania, Go, Brazil; [Lewinsohn, Thomas M.] Univ Estadual Campinas, Lab Interacoes Insetos Plantas, Inst Biol, Sao Paulo, Brazil	Universidade Federal de Goias; Universidade Federal de Goias; Universidade de Sao Paulo; Universidade Estadual de Campinas	de Araujo, WS (corresponding author), Univ Fed Goias, Programa Posgrad Ecol & Evolucao, Inst Ciencias Biol, Goiania, Go, Brazil.	walterbioaraujo@yahoo.com.br	Lewinsohn, Thomas M/D-5880-2012; de Araújo, Walter S/C-8546-2013; Almeida-Neto, M./A-6389-2009; de Araújo, Walter Santos/AAA-4606-2020	Lewinsohn, Thomas M/0000-0001-5950-5343; Almeida-Neto, M./0000-0002-2161-2968; de Araújo, Walter Santos/0000-0003-0157-6151	Coordenacao deAperfeicoamento de Pessoal de Nivel Superior (CAPES); Brazilian Research Council (CNPq)	Coordenacao deAperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Brazilian Research Council (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	The authors are thankful to the Coordenacao deAperfeicoamento de Pessoal de Nivel Superior (CAPES) for the grant to WSdA and to the Brazilian Research Council (CNPq) for a graduate fellowship to MCV and for a productivity grant to TML and MAN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araujo WS, 2014, BIODIVERS CONSERV; ARBUCKLE JL, 2003, AMOS USERS GUIDE 5 0; Brandle M, 2008, DIVERS DISTRIB, V14, P905, DOI 10.1111/j.1472-4642.2008.00511.x; Castagneyrol B, 2014, J APPL ECOL, V51, P134, DOI 10.1111/1365-2664.12175; Clarke KR, 1998, J APPL ECOL, V35, P523, DOI 10.1046/j.1365-2664.1998.3540523.x; Didham RK, 2007, TRENDS ECOL EVOL, V22, P489, DOI 10.1016/j.tree.2007.07.001; Dunne JA, 2002, P NATL ACAD SCI USA, V99, P12917, DOI 10.1073/pnas.192407699; Ellis EC, 2008, FRONT ECOL ENVIRON, V6, P439, DOI 10.1890/070062; Foley JA, 2005, SCIENCE, V309, P570, DOI 10.1126/science.1111772; Fonseca CR, 2009, CONSERV BIOL, V23, P1507, DOI 10.1111/j.1523-1739.2009.01327.x; Forister ML, 2012, ECOLOGY, V93, P981, DOI 10.1890/11-0650.1; FOX LR, 1981, SCIENCE, V211, P887, DOI 10.1126/science.211.4485.887; GASTON KJ, 1992, ECOL ENTOMOL, V17, P86, DOI 10.1111/j.1365-2311.1992.tb01044.x; Gorley C.K., 2006, GETTING STARTED PRIM; Grace JB., 2015, STRUCTURAL EQUATION; Gravel D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019374; Harvey JA, 2010, BIOL CONSERV, V143, P2251, DOI 10.1016/j.biocon.2010.03.004; Henneman ML, 2001, SCIENCE, V293, P1314, DOI 10.1126/science.1060788; JAENIKE J, 1990, ANNU REV ECOL SYST, V21, P243, DOI 10.1146/annurev.es.21.110190.001331; Kaartinen R, 2011, J ANIM ECOL, V80, P622, DOI 10.1111/j.1365-2656.2011.01811.x; Krauss J, 2010, ECOL LETT, V13, P597, DOI 10.1111/j.1461-0248.2010.01457.x; Laliberte E, 2010, ECOLOGY, V91, P1740, DOI 10.1890/09-1328.1; Lewinsohn T.M., 1991, P525; Lewinsohn TM, 2005, ANNU REV ECOL EVOL S, V36, P597, DOI 10.1146/annurev.ecolsys.36.091704.175520; MacCallum RC, 1996, PSYCHOL METHODS, V1, P130, DOI 10.1037/1082-989X.1.2.130; Masetti A, 2004, ANN ENTOMOL SOC AM, V97, P1252, DOI 10.1603/0013-8746(2004)097[1252:FSOTAD]2.0.CO;2; Memmott J, 2000, J ANIM ECOL, V69, P1, DOI 10.1046/j.1365-2656.2000.00367.x; Morais HC, 2011, BIOTROPICA, V43, P467, DOI 10.1111/j.1744-7429.2010.00736.x; Nakagawa M, 2003, B ENTOMOL RES, V93, P455, DOI 10.1079/BER2003257; Novotny V, 2005, P ROY SOC B-BIOL SCI, V272, P1083, DOI 10.1098/rspb.2004.3023; Nyman T, 2010, BIOL REV, V85, P393, DOI 10.1111/j.1469-185X.2009.00109.x; Odegaard F, 2005, ECOL LETT, V8, P612, DOI 10.1111/j.1461-0248.2005.00758.x; Perre P, 2011, URBAN ECOSYST, V14, P711, DOI 10.1007/s11252-011-0179-2; Petermann JS, 2010, J ANIM ECOL, V79, P709, DOI 10.1111/j.1365-2656.2010.01674.x; Piazzon M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019637; Prado PI, 2004, J ANIM ECOL, V73, P1168, DOI 10.1111/j.0021-8790.2004.00891.x; Preacher KJ, 2006, COMPUTING POWER MINI; Price PW, 2002, ECOL RES, V17, P241, DOI 10.1046/j.1440-1703.2002.00483.x; Santos J.P. dos, 2006, Arq. Inst. Biol., V73, P235, DOI 10.1590/1808-1657v73p2352006; Schweiger O, 2008, OECOLOGIA, V157, P485, DOI 10.1007/s00442-008-1082-2; Strauss SY, 2004, ANNU REV ECOL EVOL S, V35, P435, DOI 10.1146/annurev.ecolsys.35.112202.130215; Thebault E, 2008, OIKOS, V117, P555, DOI 10.1111/j.0030-1299.2008.16485.x; Thebault E, 2010, SCIENCE, V329, P853, DOI 10.1126/science.1188321; Tscharntke T, 2004, ANNU REV ENTOMOL, V49, P405, DOI 10.1146/annurev.ento.49.061802.123339; Tylianakis JM, 2007, NATURE, V445, P202, DOI 10.1038/nature05429; Vila M, 2004, OIKOS, V105, P229, DOI 10.1111/j.0030-1299.2004.12682.x; Villa-Galaviz E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053009; Vitousek PM, 1997, SCIENCE, V277, P494, DOI 10.1126/science.277.5325.494; With KA, 2011, LANDSCAPE ECOL, V26, P1035, DOI 10.1007/s10980-011-9627-x	49	47	49	3	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2015	10	1							e0115606	10.1371/journal.pone.0115606	http://dx.doi.org/10.1371/journal.pone.0115606			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ4BS	25565141	gold, Green Published, Green Submitted			2022-12-27	WOS:000348167900001
J	Barasona, JA; Mulero-Pazmany, M; Acevedo, P; Negro, JJ; Torres, MJ; Gortazar, C; Vicente, J				Barasona, Jose A.; Mulero-Pazmany, Margarita; Acevedo, Pelayo; Negro, Juan J.; Torres, Maria J.; Gortazar, Christian; Vicente, Joaquin			Unmanned Aircraft Systems for Studying Spatial Abundance of Ungulates: Relevance to Spatial Epidemiology	PLOS ONE			English	Article							TUBERCULOSIS-LIKE LESIONS; WILD BOAR; BOVINE TUBERCULOSIS; RED DEER; MYCOBACTERIUM-BOVIS; AERIAL VEHICLES; CATTLE; LIVESTOCK; TERRITORIALITY; TRANSMISSION	Complex ecological and epidemiological systems require multidisciplinary and innovative research. Low cost unmanned aircraft systems (UAS) can provide information on the spatial pattern of hosts' distribution and abundance, which is crucial as regards modelling the determinants of disease transmission and persistence on a fine spatial scale. In this context we have studied the spatial epidemiology of tuberculosis (TB) in the ungulate community of Donana National Park (South-western Spain) by modelling species host (red deer, fallow deer and cattle) abundance at fine spatial scale. The use of UAS high-resolution images has allowed us to collect data to model the environmental determinants of host abundance, and in a further step to evaluate their relationships with the spatial risk of TB throughout the ungulate community. We discuss the ecological, epidemiological and logistic conditions under which UAS may contribute to study the wildlife/livestock sanitary interface, where the spatial aggregation of hosts becomes crucial. These findings are relevant for planning and implementing research, fundamentally when managing disease in multi-host systems, and focusing on risky areas. Therefore, managers should prioritize the implementation of control strategies to reduce disease of conservation, economic and social relevance.	[Barasona, Jose A.; Acevedo, Pelayo; Gortazar, Christian; Vicente, Joaquin] Natl Wildlife Res Inst CSIC UCLM JCCM, SaBio IREC, Ciudad Real, Spain; [Mulero-Pazmany, Margarita; Negro, Juan J.] CSIC, Dept Evolutionary Ecol, Donana Biol Stn, E-41080 Seville, Spain; [Torres, Maria J.] Univ Seville, Dept Microbiol, Seville, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigacion en Recursos Cinegeticos (IREC); Universidad de Castilla-La Mancha; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD); University of Sevilla	Barasona, JA (corresponding author), Natl Wildlife Res Inst CSIC UCLM JCCM, SaBio IREC, Ciudad Real, Spain.	joseangel.barasona@uclm.es	Mulero-Pazmany, Margarita/M-5596-2013; Barasona, Jose/ABH-7368-2020; Torres, Maria/GVU-3391-2022; Gortazar, Christian/E-7918-2012; Negro, Juan Jose/I-2653-2015; Acevedo, Pelayo/L-6737-2013; IBIS, TUBERCULOSIS/O-9334-2015	Mulero-Pazmany, Margarita/0000-0002-0303-9360; Barasona, Jose/0000-0003-4066-8454; Gortazar, Christian/0000-0003-0012-4006; Negro, Juan Jose/0000-0002-8697-5647; Acevedo, Pelayo/0000-0002-3509-7696; 	Junta de Comunidades Castilla-La Mancha (JCCM) [PEII10-0262-7673]; Ministerio de Economia y Competitividad (MINECO) [AGL2013-48523-C3-1-R]; EU (FP7 grant) [613779 WildTBVac]; Aeromab Project [P07-RNM-03246]; PLANET Project (EU, Cooperation, 7th FP); FPU; MINECO-UCLM through 'Ramon y Cajal' contract [RYC-2012-11970]; European Research on Emerging and Major Infectious Diseases of Livestock [EMIDA-467 ERA-NET]; grant APHAEA [219235-FP7-ERA-NET-EMIDA]	Junta de Comunidades Castilla-La Mancha (JCCM); Ministerio de Economia y Competitividad (MINECO)(Spanish Government); EU (FP7 grant); Aeromab Project; PLANET Project (EU, Cooperation, 7th FP); FPU(Spanish Government); MINECO-UCLM through 'Ramon y Cajal' contract; European Research on Emerging and Major Infectious Diseases of Livestock; grant APHAEA	We would like to thank E. Guerrero and M.A. Aguilar, the pilots and technicians who controlled the UAS and prepared the image mosaic. The present work has benefited from the financial aid of research grants Junta de Comunidades Castilla-La Mancha (JCCM; PEII10-0262-7673), Ministerio de Economia y Competitividad (MINECO; AGL2013-48523-C3-1-R), EU (FP7 grant 613779 WildTBVac), Aeromab Project (P07-RNM-03246), and the PLANET Project (EU, Cooperation, 7th FP, 2010). J.A.B. holds an FPU pre-doctoral scholarship. P.A. is supported by MINECO-UCLM through 'Ramon y Cajal' contract (RYC-2012-11970) and partly by European Research on Emerging and Major Infectious Diseases of Livestock (EMIDA-467 ERA-NET) grant APHAEA (219235-FP7-ERA-NET-EMIDA; www.aphaea.eu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acevedo P, 2010, ECOL INDIC, V10, P1226, DOI 10.1016/j.ecolind.2010.04.006; Acevedo P, 2014, ECOL INDIC, V36, P594, DOI 10.1016/j.ecolind.2013.09.019; Acevedo P, 2011, LANDSCAPE ECOL, V26, P19, DOI 10.1007/s10980-010-9538-2; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Anderson K, 2013, FRONT ECOL ENVIRON, V11, P138, DOI 10.1890/120150; Apollonio M., 2010, EUROPEAN UNGULATES T; Barasona JA, 2013, PREV VET MED, V111, P42, DOI 10.1016/j.prevetmed.2013.03.009; BESAG J, 1991, ANN I STAT MATH, V43, P1, DOI 10.1007/BF00116466; Bisanzio D, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-230; Blanchong J. A., 2007, Biology Letters, V3, P104; Boadella M, 2012, PREV VET MED, V107, P214, DOI 10.1016/j.prevetmed.2012.06.001; BRAZA F, 1987, Miscellania Zoologica (Barcelona), V11, P363; Brezger A, 2006, COMPUT STAT DATA AN, V50, P967, DOI 10.1016/j.csda.2004.10.011; Bugalho MN, 2003, FOREST ECOL MANAG, V181, P23, DOI 10.1016/S0378-1127(03)00125-7; Cameron A.C., 2013, REGRESSION ANAL COUN, V53; CARRANZA J, 1990, ANIM BEHAV, V40, P79, DOI 10.1016/S0003-3472(05)80667-0; CARRANZA J, 1991, APPL ANIM BEHAV SCI, V30, P363, DOI 10.1016/0168-1591(91)90141-J; Cooper SM, 2010, J WILDLIFE DIS, V46, P152, DOI 10.7589/0090-3558-46.1.152; de Garine-Wichatitsky M, 2013, COMP IMMUNOL MICROB, V36, P321, DOI 10.1016/j.cimid.2012.10.007; Etherington TR, 2009, J BIOGEOGR, V36, P845, DOI 10.1111/j.1365-2699.2008.02041.x; Focardi S, 2001, WILDLIFE SOC B, V29, P133; Frolich K, 2002, ANN NY ACAD SCI, V969, P4, DOI 10.1111/j.1749-6632.2002.tb04343.x; Getzin S, 2012, METHODS ECOL EVOL, V3, P397, DOI 10.1111/j.2041-210X.2011.00158.x; Gortazar C, 2007, EUR J WILDLIFE RES, V53, P241, DOI 10.1007/s10344-007-0098-y; Gortazar C, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-27; Gortazar C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002776; Grenfell B. T., 1995, ECOLOGY INFECT DIS N; Held L, 2010, STATISTICAL MODELLING AND REGRESSION STRUCTURES, P91, DOI 10.1007/978-3-7908-2413-1_6; Jones GP, 2006, WILDLIFE SOC B, V34, P750, DOI 10.2193/0091-7648(2006)34[750:AAOSUA]2.0.CO;2; Kukielka E, 2013, PREV VET MED, V112, P213, DOI 10.1016/j.prevetmed.2013.08.008; Martinez-Lopez B, 2013, PREV VET ME IN PRESS; Meliker JR, 2011, SPAT SPATIO-TEMPORAL, V2, P1, DOI 10.1016/j.sste.2010.10.001; Morellet N, 2007, J APPL ECOL, V44, P634, DOI 10.1111/j.1365-2664.2007.01307.x; Mulero-Pazmany M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083873; Munyeme M, 2008, PREV VET MED, V85, P317, DOI 10.1016/j.prevetmed.2008.03.006; Osnas EE, 2009, ECOL APPL, V19, P1311, DOI 10.1890/08-0578.1; Ostfeld RS, 2005, TRENDS ECOL EVOL, V20, P328, DOI 10.1016/j.tree.2005.03.009; Phillips CJC, 2003, RES VET SCI, V74, P1, DOI 10.1016/S0034-5288(02)00145-5; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; Renwick AR, 2007, EPIDEMIOL INFECT, V135, P529, DOI 10.1017/S0950268806007205; Rodriguez A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050336; Rodriguez-Prieto V, 2012, BMC VET RES, V8, DOI 10.1186/1746-6148-8-148; Russo L, 1997, ETHOL ECOL EVOL, V9, P287, DOI 10.1080/08927014.1997.9522888; Schrodle B, 2011, ENVIRONMETRICS, V22, P725, DOI 10.1002/env.1065; Soberon J, 2007, ECOL LETT, V10, P1115, DOI 10.1111/j.1461-0248.2007.01107.x; Tuyttens FAM, 2000, J ANIM ECOL, V69, P815, DOI 10.1046/j.1365-2656.2000.00437.x; Vermeulen C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054700; Vicente J, 2006, VET RES, V37, P107, DOI 10.1051/vetres:2005044; Vicente J, 2013, TRANSBOUND EMERG DIS, V60, P92, DOI 10.1111/tbed.12167; Vicente J, 2007, VET RES, V38, P451, DOI 10.1051/vetres:2007002; Watts A. C., 2008, Ecological Restoration, V26, P13, DOI 10.3368/er.26.1.13; Zuur AF, 2010, METHODS ECOL EVOL, V1, P3, DOI 10.1111/j.2041-210X.2009.00001.x; [No title captured]; [No title captured]	54	56	60	1	76	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2014	9	12							e115608	10.1371/journal.pone.0115608	http://dx.doi.org/10.1371/journal.pone.0115608			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UC	25551673	Green Published, gold			2022-12-27	WOS:000347119100048
J	Blanchet, CL; Frank, M; Schouten, S				Blanchet, Cecile L.; Frank, Martin; Schouten, Stefan			Asynchronous Changes in Vegetation, Runoff and Erosion in the Nile River Watershed during the Holocene	PLOS ONE			English	Article							LONG-CHAIN ALKENONES; SIMULATED CLIMATE; LATE PLEISTOCENE; LAKE TANA; AFRICA; SEDIMENTS; FORAMINIFERA; EXTRACTION; QUATERNARY; INDICATORS	The termination of the African Humid Period in northeastern Africa during the early Holocene was marked by the southward migration of the rain belt and the disappearance of the Green Sahara. This interval of drastic environmental changes was also marked by the initiation of food production by North African hunter-gatherer populations and thus provides critical information on human-environment relationships. However, existing records of regional climatic and environmental changes exhibit large differences in timing and modes of the wet/dry transition at the end of the African Humid Period. Here we present independent records of changes in river runoff, vegetation and erosion in the Nile River watershed during the Holocene obtained from a unique sedimentary sequence on the Nile River fan using organic and inorganic proxy data. This high-resolution reconstruction allows to examine the phase relationship between the changes of these three parameters and provides a detailed picture of the environmental conditions during the Paleolithic/Neolithic transition. The data show that river runoff decreased gradually during the wet/arid transition at the end of the AHP whereas rapid shifts of vegetation and erosion occurred earlier between 8.7 and similar to 6 ka BP. These asynchronous changes are compared to other regional records and provide new insights into the threshold responses of the environment to climatic changes. Our record demonstrates that the degradation of the environment in northeastern Africa was more abrupt and occurred earlier than previously thought and may have accelerated the process of domestication in order to secure sustainable food resources for the Neolithic African populations.	[Blanchet, Cecile L.; Frank, Martin] GEOMAR Helmholtz Ctr Ocean Res Kiel, Kiel, Germany; [Blanchet, Cecile L.; Schouten, Stefan] NIOZ Royal Netherlands Inst Sea Res, Dept Marine Organ Biogeochem, T Horntje, Texel, Netherlands	Helmholtz Association; GEOMAR Helmholtz Center for Ocean Research Kiel; Utrecht University; Royal Netherlands Institute for Sea Research (NIOZ)	Blanchet, CL (corresponding author), GEOMAR Helmholtz Ctr Ocean Res Kiel, Kiel, Germany.	cblanchet@geomar.de	Blanchet, Cecile/C-6370-2013; Blanchet, Cecile/AAK-2270-2021	Blanchet, Cecile/0000-0002-7146-705X; Blanchet, Cecile/0000-0002-7146-705X; Frank, Martin/0000-0002-8606-4421	German Science Foundation (DFG) [BL1112-1/1]	German Science Foundation (DFG)(German Research Foundation (DFG))	CLB - Personal Grant by the German Science Foundation (DFG, http://www.dfg.de) BL1112-1/1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bemis BE, 1998, PALEOCEANOGRAPHY, V13, P150, DOI 10.1029/98PA00070; Blanchet CL, 2013, EARTH PLANET SC LETT, V364, P98, DOI 10.1016/j.epsl.2013.01.009; BRAY EE, 1961, GEOCHIM COSMOCHIM AC, V22, P2, DOI 10.1016/0016-7037(61)90069-2; Brooks N, 2006, QUATERN INT, V151, P29, DOI 10.1016/j.quaint.2006.01.013; Butzer K.W., 1976, EARLY HYDRAULIC CIVI; BUTZER KW, 1980, SAHARA NILE, P253, DOI DOI 10.1126/SCIENCE.208.4445.736-A; Castaneda IS, 2011, QUATERNARY SCI REV, V30, P2851, DOI 10.1016/j.quascirev.2011.07.009; Castaneda IS, 2010, PALEOCEANOGRAPHY, V25, DOI 10.1029/2009PA001740; Castaneda IS, 2009, P NATL ACAD SCI USA, V106, P20159, DOI 10.1073/pnas.0905771106; Claussen M, 2013, NAT GEOSCI, V6, P954, DOI [10.1038/ngeo1962, 10.1038/NGEO1962]; Claussen M, 1999, GEOPHYS RES LETT, V26, P2037, DOI 10.1029/1999GL900494; Cockerton HE, 2013, QUATERNARY SCI REV, V66, P4, DOI 10.1016/j.quascirev.2012.12.005; COHEN RW, 1988, ENTOMOL EXP APPL, V48, P303; Collins JA, 2011, NAT GEOSCI, V4, P42, DOI [10.1038/ngeo1039, 10.1038/NGEO1039]; Conte MH, 2006, GEOCHEM GEOPHY GEOSY, V7, DOI 10.1029/2005GC001054; Costa K, 2014, QUATERNARY SCI REV, V83, P58, DOI 10.1016/j.quascirev.2013.10.031; di Lernia S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056879; Diefendorf AF, 2011, GEOCHIM COSMOCHIM AC, V75, P7472, DOI 10.1016/j.gca.2011.09.028; Drake NA, 2011, P NATL ACAD SCI USA, V108, P458, DOI 10.1073/pnas.1012231108; Ducassou E, 2008, QUATERNARY RES, V70, P382, DOI 10.1016/j.yqres.2008.02.011; Dunne J, 2012, NATURE, V486, P390, DOI 10.1038/nature11186; EGLINTON G, 1967, SCIENCE, V156, P1322, DOI 10.1126/science.156.3780.1322; Emeis KC, 2003, PALEOCEANOGRAPHY, V18, DOI 10.1029/2000PA000617; Feseker T, 2010, GEO-MAR LETT, V30, P169, DOI 10.1007/s00367-010-0192-0; Fleitmann D, 2003, SCIENCE, V300, P1737, DOI 10.1126/science.1083130; Garcea EAA, 2004, J WORLD PREHIST, V18, P107, DOI 10.1007/s10963-004-2878-6; Garcin Y, 2012, EARTH PLANET SC LETT, V331, P322, DOI 10.1016/j.epsl.2012.03.016; Gat JR, 1996, J GEOPHYS RES-OCEANS, V101, P6441, DOI 10.1029/95JC02829; Gifford-Gonzalez D, 2011, J WORLD PREHIST, V24, P1, DOI DOI 10.1007/s10963-010-9042-2; Gutjahr M, 2007, CHEM GEOL, V242, P351, DOI 10.1016/j.chemgeo.2007.03.021; Hassan FA., 2002, DROUGHTS FOOD CULTUR, P11, DOI DOI 10.1007/0-306-47547-2_2; Hoefs MJL, 2002, GEOCHIM COSMOCHIM AC, V66, P2719, DOI 10.1016/S0016-7037(02)00864-5; Hopmans EC, 2004, EARTH PLANET SC LETT, V224, P107, DOI 10.1016/j.epsl.2004.05.012; Hopmans EC, 2000, RAPID COMMUN MASS SP, V14, P585, DOI 10.1002/(SICI)1097-0231(20000415)14:7<585::AID-RCM913>3.3.CO;2-E; HORWITZ EP, 1992, SOLVENT EXTR ION EXC, V10, P313, DOI 10.1080/07366299208918107; JACOBSEN SB, 1980, EARTH PLANET SC LETT, V50, P139, DOI 10.1016/0012-821X(80)90125-9; Jolly D, 1998, QUATERNARY SCI REV, V17, P629, DOI 10.1016/S0277-3791(98)00015-8; Jung SJA, 2004, EARTH PLANET SC LETT, V221, P27, DOI 10.1016/S0012-821X(04)00095-0; Kim JH, 2007, GEOLOGY, V35, P387, DOI 10.1130/G23251A.1; Kropelin S, 2008, SCIENCE, V320, P765, DOI 10.1126/science.1154913; Kuper R, 2006, SCIENCE, V313, P803, DOI 10.1126/science.1130989; Laskar J, 2004, ASTRON ASTROPHYS, V428, P261, DOI 10.1051/0004-6361:20041335; Leduc G, 2013, EARTH PLANET SC LETT, V362, P151, DOI 10.1016/j.epsl.2012.12.003; Linseele V, 2013, STUDIES EARLY NEAR E, P97; Liu ZY, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL028062; Marshall MH, 2011, GLOBAL PLANET CHANGE, V78, P147, DOI 10.1016/j.gloplacha.2011.06.004; Mayaux P, 2003, 20665 EUR EN; PACHUR HJ, 1987, SCIENCE, V237, P298, DOI 10.1126/science.237.4812.298; Padoan M, 2011, GEOCHIM COSMOCHIM AC, V75, P3627, DOI 10.1016/j.gca.2011.03.042; PRAHL FG, 1988, GEOCHIM COSMOCHIM AC, V52, P2303, DOI 10.1016/0016-7037(88)90132-9; Rohling EJ, 2007, PALEOCEANOGRAPHY, V22, DOI 10.1029/2007PA001437; Rohling EJ, 2002, DROUGHTS FOOD CULTUR, P35; Schouten S, 2007, ANAL CHEM, V79, P2940, DOI 10.1021/ac062339v; Shanahan TM, 2006, PALAEOGEOGR PALAEOCL, V242, P287, DOI 10.1016/j.palaeo.2006.06.007; Stock F, 2013, AFR ARCHAEOL REV, V30, P51, DOI 10.1007/s10437-013-9131-6; Ternois Y, 1997, DEEP-SEA RES PT I, V44, P271, DOI 10.1016/S0967-0637(97)89915-3; Tierney JE, 2013, SCIENCE, V342, P843, DOI 10.1126/science.1240411; Waelbroeck C, 2002, QUATERNARY SCI REV, V21, P295, DOI 10.1016/S0277-3791(01)00101-9; Williams M, 2006, QUATERNARY SCI REV, V25, P2651, DOI 10.1016/j.quascirev.2005.07.019	59	25	26	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2014	9	12							e115958	10.1371/journal.pone.0115958	http://dx.doi.org/10.1371/journal.pone.0115958			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UC	25551633	Green Published, gold, Green Accepted			2022-12-27	WOS:000347119100082
J	Ronn, PF; Smith, LS; Andersen, GS; Carstensen, B; Bjerregaard, P; Jorgensen, ME				Ronn, Pernille Falberg; Smith, Laerke Steenberg; Andersen, Gregers Stig; Carstensen, Bendix; Bjerregaard, Peter; Jorgensen, Marit Eika			Birth Weight and Risk of Adiposity among Adult Inuit in Greenland	PLOS ONE			English	Article							DEPENDENT DIABETES-MELLITUS; BODY-COMPOSITION; SUBCUTANEOUS FAT; VISCERAL FAT; OBESITY; ASSOCIATION; SIZE; ENVIRONMENT; POPULATION; DISEASE	Objective: The Inuit population in Greenland has undergone rapid socioeconomic and nutritional changes simultaneously with an increasing prevalence of obesity. Therefore, the objective was to examine fetal programming as part of the aetiology of obesity among Inuit in Greenland by investigating the association between birth weight and measures of body composition and fat distribution in adulthood. Methods: The study was based on cross-sectional data from a total of 1,473 adults aged 18-61 years in two population-based surveys conducted in Greenland between 1999-2001 and 2005-2010. Information on birth weight was collected from birth records. Adiposity was assessed by anthropometry, fat mass index (FMI), fat-free mass index (FFMI), and visceral (VAT) and subcutaneous adipose tissue (SAT) estimated by ultrasound. The associations to birth weight were analyzed using linear regression models and quadratic splines. Analyses were stratified by sex, and adjusted for age, birthplace, ancestry and family history of obesity. Results: Spline analyses showed linear relations between birth weight and adult adiposity. In multiple regression analyses, birth weight was positively associated with BMI, waist circumference, FMI, FFMI and SAT with generally weaker associations among women compared to men. Birth weight was only associated with VAT after additional adjustment for waist circumference and appeared to be specific and inverse for men only. Conclusions: Higher birth weight among Inuit was associated with adiposity in adulthood. More studies are needed to explore a potential inverse association between birth size and VAT.	[Ronn, Pernille Falberg; Smith, Laerke Steenberg; Andersen, Gregers Stig; Carstensen, Bendix; Jorgensen, Marit Eika] Steno Diabet Ctr AS, Clin Epidemiol, Gentofte, Denmark; [Bjerregaard, Peter] Univ Southern Denmark, Natl Inst Publ Hlth, Ctr Hlth Res Greenland, Copenhagen, Denmark	Steno Diabetes Center; University of Southern Denmark	Ronn, PF (corresponding author), Steno Diabet Ctr AS, Clin Epidemiol, Gentofte, Denmark.	prfr@steno.dk	Bjerregaard, Peter/ABD-8894-2020; andersen, gregers/AAG-3685-2021; Rønn, Pernille Falberg/AAT-3523-2021	Bjerregaard, Peter/0000-0001-7153-8447; andersen, gregers/0000-0001-6125-300X; Rønn, Pernille Falberg/0000-0001-6338-6615; Jorgensen, Marit Eika/0000-0001-8356-5565	Karen Elise Jensen's Foundation; NunaFonden; Medical Research Council of Denmark; Medical Research Council of Greenland; Commission for Scientific Research in Greenland	Karen Elise Jensen's Foundation; NunaFonden; Medical Research Council of Denmark; Medical Research Council of Greenland; Commission for Scientific Research in Greenland	The work was supported by Karen Elise Jensen's Foundation, NunaFonden, Medical Research Council of Denmark, Medical Research Council of Greenland, and the Commission for Scientific Research in Greenland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARKER DJP, 1993, DIABETOLOGIA, V36, P62, DOI 10.1007/BF00399095; Bjerregaard P, 1996, Arctic Med Res, V55, P156; Bjerregaard P, 2011, INUIT HLTH TRANSITIO; BJERREGAARD P, 2007, BEFOLKNINGSUNDERSOGE; Bjerregaard P., 2003, INT J CIRCUMPOL HEAL, V62, P3, DOI [10.3402/ijch.v62i0.18212, DOI 10.3402/IJCH.V62I0.18212]; CARSTENSEN B, PACKAGE STAT ANAL EP; Choi CS, 2000, DIABETES RES CLIN PR, V49, P53, DOI 10.1016/S0168-8227(00)00131-5; Chomtho S, 2008, AM J CLIN NUTR, V88, P1040, DOI 10.1093/ajcn/88.4.1040; Cottrell EC, 2008, PHYSIOL BEHAV, V94, P17, DOI 10.1016/j.physbeh.2007.11.017; Demerath EW, 2009, OBESITY, V17, P2060, DOI 10.1038/oby.2009.105; GLUCKMAN PD, 2009, EARLY LIFE ORIGINS O; Golan R, 2012, DIABETES CARE, V35, P640, DOI 10.2337/dc11-1583; HALES CN, 1992, DIABETOLOGIA, V35, P595, DOI 10.1007/BF00400248; Harding J., 2004, Fetal nutrition and adult disease: programming of chronic disease through fetal exposure to undernutrition, P21, DOI 10.1079/9780851998213.0021; Hu FB, 2011, DIABETES CARE, V34, P1249, DOI 10.2337/dc11-0442; Jorgensen ME, 2012, DIABETIC MED, V29, P755, DOI 10.1111/j.1464-5491.2011.03527.x; Jorgensen ME, 2008, ATHEROSCLEROSIS, V196, P772, DOI 10.1016/j.atherosclerosis.2007.01.008; Jorgensen ME, 2013, DIABETES CARE, V36, P2988, DOI 10.2337/dc12-2703; Jorgensen ME, 2003, INT J OBESITY, V27, P1507, DOI 10.1038/sj.ijo.0802434; Lucas A, 1999, BRIT MED J, V319, P245, DOI 10.1136/bmj.319.7204.245; McNeely MJ, 2007, OBESITY, V15, P816, DOI 10.1038/oby.2007.596; Montagne CT, 2000, DIABETES, V49, P883, DOI 10.2337/diabetes.49.6.883; Niclasen B, 2007, INT J CIRCUMPOL HEAL, V66, P215, DOI 10.3402/ijch.v66i3.18257; Philipsen A, 2013, NUTR DIABETES, V3, DOI 10.1038/nutd.2013.23; Pilgaard K, 2010, J DEV ORIG HLTH DIS, V1, P319, DOI 10.1017/S2040174410000413; Porter SA, 2009, DIABETES CARE, V32, P1068, DOI 10.2337/dc08-2280; Power C, 2010, ATHEROSCLEROSIS, V211, P643, DOI 10.1016/j.atherosclerosis.2010.03.015; Ravelli ACJ, 1999, AM J CLIN NUTR, V70, P811; Rogers I, 2003, INT J OBESITY, V27, P755, DOI 10.1038/sj.ijo.0802316; Rolfe ED, 2010, AM J CLIN NUTR, V92, P347, DOI 10.3945/ajcn.2010.29247; Sachdev HS, 2005, AM J CLIN NUTR, V82, P456, DOI 10.1093/ajcn/82.2.456; Schellong K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047776; Singhal A, 2003, AM J CLIN NUTR, V77, P726, DOI 10.1093/ajcn/77.3.726; Stolk RP, 2001, INT J OBESITY, V25, P1346, DOI 10.1038/sj.ijo.0801734; te Velde SJ, 2003, OBES RES, V11, P202, DOI 10.1038/oby.2003.32; Tu YK, 2008, EMERG THEMES EPIDEMI, V5, DOI 10.1186/1742-7622-5-2; Wells JCK, 2001, ARCH DIS CHILD, V85, P67, DOI 10.1136/adc.85.1.67; Wells JCK, 2002, AM J PHYS ANTHROPOL, V119, P276, DOI 10.1002/ajpa.10137; Wells JCK, 2002, J THEOR BIOL, V214, P413, DOI 10.1006/jtbi.2001.2465; Whincup PH, 2008, JAMA-J AM MED ASSOC, V300, P2886, DOI 10.1001/jama.2008.886; Yliharsila H, 2007, INT J OBESITY, V31, P1392, DOI 10.1038/sj.ijo.0803612	41	7	9	0	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2014	9	12							e115976	10.1371/journal.pone.0115976	http://dx.doi.org/10.1371/journal.pone.0115976			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UC	25551382	Green Published, Green Submitted, gold			2022-12-27	WOS:000347119100085
J	Shibahara, H; Higashi, M; Yokoyama, S; Rousseau, K; Kitazono, I; Osako, M; Shirahama, H; Tashiro, Y; Kurumiya, Y; Narita, M; Kuze, S; Hasagawa, H; Kato, T; Kubota, H; Suzuki, H; Arai, T; Sakai, Y; Yuasa, N; Fujino, M; Kondo, S; Okamoto, Y; Yamamoto, T; Hiromatsu, T; Sasaki, E; Shirai, K; Kawai, S; Hattori, K; Tsuji, H; Okochi, O; Sakamoto, M; Kondo, A; Konishi, N; Batra, SK; Yonezawa, S				Shibahara, Hiroaki; Higashi, Michiyo; Yokoyama, Seiya; Rousseau, Karine; Kitazono, Iwao; Osako, Masahiko; Shirahama, Hiroshi; Tashiro, Yukie; Kurumiya, Yasuhiro; Narita, Michihiko; Kuze, Shingo; Hasagawa, Hiroshi; Kato, Takehito; Kubota, Hitoshi; Suzuki, Hideaki; Arai, Toshiyuki; Sakai, Yu; Yuasa, Norihiro; Fujino, Masahiko; Kondo, Shinji; Okamoto, Yoshichika; Yamamoto, Tatsuyoshi; Hiromatsu, Takashi; Sasaki, Eiji; Shirai, Kazuhisa; Kawai, Satoru; Hattori, Koutarou; Tsuji, Hideki; Okochi, Osamu; Sakamoto, Masaki; Kondo, Akinobu; Konishi, Naomi; Batra, Surinder K.; Yonezawa, Suguru			A Comprehensive Expression Analysis of Mucins in Appendiceal Carcinoma in a Multicenter Study: MUC3 Is a Novel Prognostic Factor	PLOS ONE			English	Article							BILE-DUCT CARCINOMAS; ABERRANT EXPRESSION; GENE-EXPRESSION; HUMAN NEOPLASMS; CELL-CARCINOMA; MUC5AC; ADENOCARCINOMA; CANCER; MARKERS; TUMORS	Background: Mucins are implicated in survival in various cancers, but there have been no report addressed on survival in appendiceal carcinoma, an uncommon disease with different clinical and pathological features from those of other colon cancers. We aimed to investigate the clinical implications of expression of mucins in appendiceal carcinoma. Methods: Expression profiles of MUC1, MUC2, MUC3, MUC4, MUC5AC, MUC6, MUC16 and MUC17 in cancer tissue were examined by immunohistochemistry in 108 cases of surgically resected appendiceal carcinoma. Results: The following relationships of mucins with clinicopathologic factors were identified: MUC1 with positive lymphatic invasion (p=0.036); MUC2 with histological type (mucinous carcinoma, p<0.001), superficial invasion depth (p=0.007), negative venous invasion (p=0.003), and curative resection (p=0.019); MUC3 with non-curative resection (p=0.017); MUC5AC with histological type (mucinous carcinoma, p=0.002), negative lymphatic invasion (p=0.021), and negative venous invasion (p=0.022); and MUC16 with positive lymph node metastasis (p=0.035), positive venous invasion (p<0.05), and non-curative resection (p=0.035). A poor prognosis was related to positive lymph node metastasis (p=0.04), positive lymphatic invasion (p=0.02), positive venous invasion (p<0.001), non-curative resection (p<0.001), and positive expression of MUC3 (p=0.004). In multivariate analysis, positive venous invasion (HR: 6.93, 95% CI: 1.93-24.96, p=0.003), non-curative resection (HR: 10.19, 95% CI: 3.05-34.07, p<0.001) and positive MUC3 expression (HR: 3.37, 95% CI: 1.13-10.03, p=0.03) were identified as significant independent prognostic factors in patients with appendiceal carcinoma. Conclusions: Expression of MUC3 in appendiceal carcinoma is an independent factor for poor prognosis and a useful predictor of outcome in patients with appendiceal carcinoma after surgery.	[Shibahara, Hiroaki] Toyota Kosei Hosp, Dept Palliat Care, Toyota, Japan; [Higashi, Michiyo; Yokoyama, Seiya; Kitazono, Iwao; Yonezawa, Suguru] Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Human Pathol, Field Oncol, Kagoshima 890, Japan; [Rousseau, Karine] Univ Manchester, Fac Life Sci, Wellcome Trust Ctr Cell Matrix Res, Manchester M13 9PL, Lancs, England; [Osako, Masahiko] Kagoshima Med Assoc Hosp, Dept Surg, Kagoshima, Japan; [Shirahama, Hiroshi; Tashiro, Yukie] Imakiire Gen Hosp, Dept Pathol, Kagoshima, Japan; [Kurumiya, Yasuhiro] Toyota Kosei Hosp, Dept Surg, Toyota, Japan; [Narita, Michihiko] Toyota Kosei Hosp, Dept Pathol, Toyota, Japan; [Kuze, Shingo] Chutoen Gen Med Ctr, Dept Surg, Kakegawa, Japan; [Hasagawa, Hiroshi] Japanese Red Cross Nagoya Daini Hosp, Dept Surg, Nagoya, Aichi, Japan; [Kato, Takehito] Toyohashi Municipal Hosp, Dept Surg, Toyohashi, Aichi, Japan; [Kubota, Hitoshi] Handa City Hosp, Dept Surg, Handa, Japan; [Suzuki, Hideaki] Meijo Hosp, Dept Surg, Nagoya, Aichi, Japan; [Arai, Toshiyuki] Anjo Kosei Hosp, Dept Surg, Anjo, Japan; [Sakai, Yu] Anjo Kosei Hosp, Dept Pathol, Anjo, Japan; [Yuasa, Norihiro] Japanese Red Cross Nagoya Daiichi Hosp, Dept Surg, Nagoya, Aichi, Japan; [Fujino, Masahiko] Japanese Red Cross Nagoya Daiichi Hosp, Dept Pathol, Nagoya, Aichi, Japan; [Kondo, Shinji] Sakashita Hosp, Dept Surg, Nakatsugawa, Japan; [Yamamoto, Tatsuyoshi] Shizuoka Saiseikai Gen Hosp, Dept Surg, Shizuoka, Japan; [Yamamoto, Tatsuyoshi] Tokai Hosp, Dept Surg, Nagoya, Aichi, Japan; [Hiromatsu, Takashi] Kiryu Kosei Gen Hosp, Dept Surg, Kiryu, Gunma, Japan; [Sasaki, Eiji] Kamiiida Daiichi Gen Hosp, Dept Surg, Nagoya, Aichi, Japan; [Shirai, Kazuhisa] Yamashita Hosp, Dept Surg, Ichinomiya, Japan; [Kawai, Satoru] Tsushima City Hosp, Dept Surg, Tsushima, Japan; [Hattori, Koutarou] Minami Seikyo Hosp, Dept Surg, Nagoya, Aichi, Japan; [Tsuji, Hideki] Toyota Mem Hosp, Dept Surg, Toyota, Japan; [Okochi, Osamu] Tosei Gen Hosp, Dept Surg, Seto, Japan; [Sakamoto, Masaki] Nagoya Tokushukai Gen Hosp, Dept Surg, Kasugai, Aichi, Japan; [Kondo, Akinobu] Saiseikai Matsusaka Gen Hosp, Dept Surg, Matsusaka, Japan; [Konishi, Naomi] Mie Prefectural Gen Med Ctr, Dept Surg, Yokaichi, Japan; [Batra, Surinder K.] Univ Nebraska Med Ctr, Eppley Inst Res Canc & Allied Dis, Buffett Canc Ctr, Dept Biochem, Omaha, NE USA; [Batra, Surinder K.] Univ Nebraska Med Ctr, Eppley Inst Res Canc & Allied Dis, Buffett Canc Ctr, Dept Mol Biol, Omaha, NE USA	Kagoshima University; University of Manchester; Japanese Red Cross Nagoya Daini Hospital; Red Cross Nagoya Daiichi Hospital; Red Cross Nagoya Daiichi Hospital; Tosei General Hospital; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center	Higashi, M (corresponding author), Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Human Pathol, Field Oncol, Kagoshima 890, Japan.	east@m2.kufm.kagoshima-u.ac.jp			Princess Takamatsu Cancer Research Fund [11-24319]; JSPS KAKENHI [26290048, 24590447]; Kodama Memorial Foundation, Japan; USPHS grant from the National Institutes of Health [CA163120]; NATIONAL CANCER INSTITUTE [U54CA163120] Funding Source: NIH RePORTER	Princess Takamatsu Cancer Research Fund; JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Kodama Memorial Foundation, Japan; USPHS grant from the National Institutes of Health; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported in part by Princess Takamatsu Cancer Research Fund (11-24319) to S. Yonezawa; by JSPS KAKENHI Grants-in-Aid for Scientific Research (B) 26290048 to S. Yonezawa and Scientific Research (C) 24590447 to M. Higashi; by the Kodama Memorial Foundation, Japan to S. Yokoyama; and by USPHS grant CA163120 from the National Institutes of Health to S. K. Batra. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aloysius MM, 2010, BRIT J SURG, V97, P1269, DOI 10.1002/bjs.7107; Basturk O, 2010, AM J SURG PATHOL, V34, P364, DOI 10.1097/PAS.0b013e3181cf8bb6; Benedix F, 2010, EJSO-EUR J SURG ONC, V36, P763, DOI 10.1016/j.ejso.2010.05.025; Chang MS, 2012, PATHOBIOLOGY, V79, P45, DOI 10.1159/000332739; Cheever MA, 2009, CLIN CANCER RES, V15, P5323, DOI 10.1158/1078-0432.CCR-09-0737; Chu PG, 2011, AM J SURG PATHOL, V35, P1830, DOI 10.1097/PAS.0b013e3182299c25; Dorofeyev AE, 2013, GASTROENT RES PRACT, V2013, DOI 10.1155/2013/431231; Duncan Timothy J, 2007, World J Surg Oncol, V5, P31, DOI 10.1186/1477-7819-5-31; Furuya C, 2012, PATHOL INT, V62, P381, DOI 10.1111/j.1440-1827.2012.02811.x; Goto M, 2005, PATHOL INT, V55, P464, DOI 10.1111/j.1440-1827.2005.01854.x; Gustafsson BI, 2008, INT J ONCOL, V33, P1121, DOI 10.3892/ijo_00000101; Hamada T, 2012, CANCER; Hamada T, 2012, INT J CANCER, V130, P1768, DOI 10.1002/ijc.26187; Higashi M, 1999, HEPATOLOGY, V30, P1347, DOI 10.1002/hep.510300609; Higashi M, 2012, PATHOBIOLOGY, V79, P101, DOI 10.1159/000335164; Higashi M, 2010, J HEPATO-BIL-PAN SCI, V17, P275, DOI 10.1007/s00534-009-0176-5; Hirono S, 2010, CANCER SCI, V101, P259, DOI 10.1111/j.1349-7006.2009.01359.x; Ho SB, 2006, GASTROENTEROLOGY, V131, P1501, DOI 10.1053/j.gastro.2006.09.006; Ho SB, 2010, BBA-GEN SUBJECTS, V1800, P629, DOI 10.1016/j.bbagen.2010.03.010; Ito H, 2004, DIS COLON RECTUM, V47, P474, DOI 10.1007/s10350-003-0077-7; Kabbani W, 2002, MODERN PATHOL, V15, P599, DOI 10.1038/modpathol.3880572; Kim GE, 2002, GASTROENTEROLOGY, V123, P1052, DOI 10.1053/gast.2002.36018; Kim Young S, 2010, Curr Gastroenterol Rep, V12, P319, DOI 10.1007/s11894-010-0131-2; Kitamoto S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044108; Kitamoto S, 2010, BIOCHEM BIOPH RES CO, V397, P333, DOI 10.1016/j.bbrc.2010.05.124; Ko YH, 2010, ASIA-PAC J CLIN ONCO, V6, P19, DOI 10.1111/j.1743-7563.2010.01276.x; Kocer B, 2002, PATHOL INT, V52, P470, DOI 10.1046/j.1440-1827.2002.01369.x; Lee JH, 2005, PATHOL INT, V55, P386, DOI 10.1111/j.1440-1827.2005.01842.x; Leroy X, 2003, UROLOGY, V62, P771, DOI 10.1016/S0090-4295(03)00560-0; Li L, 2012, CHINESE J CANCER RES, V24, P190, DOI 10.1007/s11670-012-0190-z; Mall AS, 2007, PATHOL INT, V57, P537, DOI 10.1111/j.1440-1827.2007.02137.x; Mall AS, 2010, PATHOL RES PRACT, V206, P805, DOI 10.1016/j.prp.2010.08.004; Matsui, 2012, DAICHOUGAN FRONT, V5, P150; McCusker ME, 2002, CANCER, V94, P3307, DOI 10.1002/cncr.10589; Nguyen PL, 1996, TUMOR BIOL, V17, P176, DOI 10.1159/000217980; NITECKI SS, 1994, ANN SURG, V219, P51, DOI 10.1097/00000658-199401000-00009; O'Connell JT, 2002, MODERN PATHOL, V15, P958, DOI 10.1097/01.MP.0000026617.52466.9F; Overman MJ, 2013, ANN SURG, V257, P1072, DOI 10.1097/SLA.0b013e318269d680; Pan Q, 2013, J BIOL CHEM, V288, P5407, DOI 10.1074/jbc.M112.408245; Park Hee-Ug, 2003, Pancreas, V26, pe48, DOI 10.1097/00006676-200304000-00022; Pelaseyed T, 2014, IMMUNOL REV, V260, P8, DOI 10.1111/imr.12182; Pelaseyed T, 2013, AM J PHYSIOL-CELL PH, V305, pC457, DOI 10.1152/ajpcell.00141.2013; Pelaseyed T, 2011, J CELL SCI, V124, P3074, DOI 10.1242/jcs.076943; Peng ZH, 2010, ARCH BIOCHEM BIOPHYS, V503, P238, DOI 10.1016/j.abb.2010.08.013; Rakha EA, 2005, MODERN PATHOL, V18, P1295, DOI 10.1038/modpathol.3800445; Saitou M, 2005, J CLIN PATHOL, V58, P845, DOI 10.1136/jcp.2004.023572; Senapati S, 2010, J CLIN PATHOL, V63, P702, DOI 10.1136/jcp.2010.078717; Shanmugam C, 2010, CANCER-AM CANCER SOC, V116, P3577, DOI 10.1002/cncr.25095; Shibahara H, 2004, HEPATOLOGY, V39, P220, DOI 10.1002/hep.20031; Shibahara H, 2004, AM J SURG PATHOL, V28, P327, DOI 10.1097/00000478-200403000-00005; Shibahara H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086111; Streppel MM, 2012, HUM PATHOL, V43, P1755, DOI 10.1016/j.humpath.2012.01.005; Suzuki J, 2009, SURG TODAY, V39, P235, DOI 10.1007/s00595-008-3839-y; Tamada S, 2002, PATHOL INT, V52, P713, DOI 10.1046/j.1440-1827.2002.01414.x; Tamada S, 2006, CLIN CANCER RES, V12, P4257, DOI 10.1158/1078-0432.CCR-05-2814; Walsh MD, 2013, MODERN PATHOL, V26, P1642, DOI 10.1038/modpathol.2013.101; Yajima N, 2005, HUM PATHOL, V36, P1217, DOI 10.1016/j.humpath.2005.08.022; Yamada N, 2011, CLIN EPIGENETICS, V2, P85, DOI 10.1007/s13148-011-0037-3; Yonezawa S, 2008, PROTEOMICS, V8, P3329, DOI 10.1002/pmic.200800040; Yonezawa S, 2011, PATHOL INT, V61, P697, DOI 10.1111/j.1440-1827.2011.02734.x; Yoon SO, 2009, MODERN PATHOL, V22, P1102, DOI 10.1038/modpathol.2009.74	61	9	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2014	9	12							e115613	10.1371/journal.pone.0115613	http://dx.doi.org/10.1371/journal.pone.0115613			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UC	25551773	Green Published, gold, Green Submitted			2022-12-27	WOS:000347119100049
J	Wall, CC; Lembke, C; Hu, CM; Mann, DA				Wall, Carrie C.; Lembke, Chad; Hu, Chuanmin; Mann, David A.			Fish Sound Production in the Presence of Harmful Algal Blooms in the Eastern Gulf of Mexico	PLOS ONE			English	Article							OPHIDION-MARGINATUM OPHIDIIDAE; ATLANTIC CROAKER; DIEL PERIODICITY; GLIDERS; HYPOXIA; SLOCUM	This paper presents the first known research to examine sound production by fishes during harmful algal blooms (HABs). Most fish sound production is species-specific and repetitive, enabling passive acoustic monitoring to identify the distribution and behavior of soniferous species. Autonomous gliders that collect passive acoustic data and environmental data concurrently can be used to establish the oceanographic conditions surrounding sound-producing organisms. Three passive acoustic glider missions were conducted off west-central Florida in October 2011, and September and October 2012. The deployment period for two missions was dictated by the presence of red tide events with the glider path specifically set to encounter toxic Karenia brevis blooms (a.k.a red tides). Oceanographic conditions measured by the glider were significantly correlated to the variation in sounds from six known or suspected species of fish across the three missions with depth consistently being the most significant factor. At the time and space scales of this study, there was no detectable effect of red tide on sound production. Sounds were still recorded within red tide-affected waters from species with overlapping depth ranges. These results suggest that the fishes studied here did not alter their sound production nor migrate out of red tide-affected areas. Although these results are preliminary because of the limited measurements, the data and methods presented here provide a proof of principle and could serve as protocol for future studies on the effects of algal blooms on the behavior of soniferous fishes. To fully capture the effects of episodic events, we suggest that stationary or vertically profiling acoustic recorders and environmental sampling be used as a complement to glider measurements.	[Wall, Carrie C.; Hu, Chuanmin] Univ S Florida, Coll Marine Sci, St Petersburg, FL 33701 USA; [Lembke, Chad] Univ S Florida, Ctr Ocean Technol, St Petersburg, FL 33701 USA; [Mann, David A.] Loggerhead Instruments Inc, Sarasota, FL USA	State University System of Florida; University of South Florida; State University System of Florida; University of South Florida	Wall, CC (corresponding author), Univ Colorado, Cooperat Inst Res Environm Sci, Boulder, CO 80309 USA.	carrie.bell@colorado.edu	Hu, Chuanmin/AAB-9604-2021	Hu, Chuanmin/0000-0003-3949-6560; Higgs, Dennis/0000-0002-0771-4642	State of Florida via the College of Marine Science Interdisciplinary Research Grant Program [NFI2010]; BP/Gulf of Mexico Research Initiative; Center for Integrated Modeling and Analysis of Gulf Ecosystems (C-IMAGE) [SA 12-10/GoMRI-007]; U.S. NASA Ocean Biology and Biogeochemistry (OBB) program [NNX13AD08G]	State of Florida via the College of Marine Science Interdisciplinary Research Grant Program; BP/Gulf of Mexico Research Initiative; Center for Integrated Modeling and Analysis of Gulf Ecosystems (C-IMAGE); U.S. NASA Ocean Biology and Biogeochemistry (OBB) program	The authors received no specific funding for this work. This manuscript is a result of an unfunded analysis from an opportunistic dataset. The funding sources for the glider operations that allowed for this opportunistic dataset were provided by the State of Florida via the College of Marine Science Interdisciplinary Research Grant Program, NFI2010, and the Gulf of Mexico Ocean Observing System (GCOOS), NA08NOS4730411 99-S120305. Funding for the satellite imagery was provided by the BP/Gulf of Mexico Research Initiative with the Center for Integrated Modeling and Analysis of Gulf Ecosystems (C-IMAGE) Contract, # SA 12-10/GoMRI-007, and the U.S. NASA Ocean Biology and Biogeochemistry (OBB) program, NNX13AD08G.	Amorim Maria Clara P., 2006, P71; Anderson D.M., 1989, P11; Baumgartner MF, 2008, LIMNOL OCEANOGR, V53, P2197, DOI 10.4319/lo.2008.53.5_part_2.2197; Borcard D, 2011, USE R, P1, DOI 10.1007/978-1-4419-7976-6; Brand LE, 2007, HARMFUL ALGAE, V6, P232, DOI 10.1016/j.hal.2006.08.005; BRANTLEY RK, 1994, ETHOLOGY, V96, P213, DOI 10.1111/j.1439-0310.1994.tb01011.x; Connaughton MA, 2002, LISTENING FISH PASSI, P15; COUTANT CC, 1985, T AM FISH SOC, V114, P31, DOI 10.1577/1548-8659(1985)114<31:SBTADO>2.0.CO;2; Craig JK, 2005, MAR ECOL PROG SER, V294, P79, DOI 10.3354/meps294079; Davis RE, 2008, LIMNOL OCEANOGR, V53, P2151, DOI 10.4319/lo.2008.53.5_part_2.2151; Fine ML, 2004, J ACOUST SOC AM, V116, P1271, DOI 10.1121/1.1736271; Fish M. P., 1970, SOUNDS W N ATLANTIC; Hawkins A.D., 1986, P114; Hollings B., 2010, OCEANS 2010 IEEE SYD, P1, DOI [DOI 10.1109/OCEANSSYD.2010.5603630, 10.1109/OCEANSSYD.2010.5603630]; Johnson KS, 2009, PROSPECTS GLOBAL ARR, V22, P217; Jones D. L., 2012, FATHOM TOOLBOX MATLA; Kasumyan A.O., 2008, J ICHTHYOL, V48, P981, DOI [10.1134/S0032945208110039, DOI 10.1134/S0032945208110039]; Kirkpatrick B, 2004, HARMFUL ALGAE, V3, P99, DOI 10.1016/j.hal.2003.08.005; Kuznetsov MY, 2009, ACOUST PHYS+, V55, P866, DOI 10.1134/S1063771009060219; Ladich F, 2004, SENSES OF FISH: ADAPTATIONS FOR THE RECEPTION OF NATURAL STIMULI, P210; Lammers MO, 2008, J ACOUST SOC AM, V123, P1720, DOI 10.1121/1.2836780; Landsberg JH, 2009, HARMFUL ALGAE, V8, P598, DOI 10.1016/j.hal.2008.11.010; Landsberg JH, 2002, REV FISH SCI, V10, P113, DOI 10.1080/20026491051695; Legendre P, 2001, OECOLOGIA, V129, P271, DOI 10.1007/s004420100716; Lobel Phillip S., 2002, Bioacoustics, V12, P286; Lobel PS, 2010, REPRODUCTION AND SEXUALITY IN MARINE FISHES: PATTERNS AND PROCESSES, P307; Locascio JV, 2008, T AM FISH SOC, V137, P606, DOI 10.1577/T06-069.1; Locascio JV, 2005, BIOL LETTERS, V1, P362, DOI 10.1098/rsbl.2005.0309; Luczkovich JJ, 2008, T AM FISH SOC, V137, P533, DOI 10.1577/T06-258.1; Mann DA, 2009, MAR ECOL PROG SER, V375, P65, DOI 10.3354/meps07720; Mann DA, 1997, COPEIA, P610, DOI 10.2307/1447568; Mann David A., 1995, Bioacoustics, V6, P199; Mellinger DK, 2007, OCEANOGRAPHY, V20, P36, DOI 10.5670/oceanog.2007.03; Moline MA, 2005, J ATMOS OCEAN TECH, V22, P1797, DOI 10.1175/JTECH1809.1; Nelson MD, 2011, AQUAT BIOL, V12, P97, DOI 10.3354/ab00325; Quinn GP, 2003, EXPT DESIGN DATA ANA; Rao R, 1995, QUESTIIO, V17, P23; RETZER ME, 1991, COPEIA, P703; Ripley JL, 2007, MAR ENVIRON RES, V63, P350, DOI 10.1016/j.marenvres.2006.10.003; Robbins IC, 2006, HARMFUL ALGAE, V5, P749, DOI 10.1016/j.hal.2006.03.005; Rountree Rodney A., 2002, Bioacoustics, V12, P240; Rudnick DL, 2004, MAR TECHNOL SOC J, V38, P73, DOI 10.4031/002533204787522703; Schofield O, 2005, HARMFUL ALGAL BLOOMS; Schofield O, 2007, J FIELD ROBOT, V24, P473, DOI 10.1002/rob.20200; Sellner KG, 2003, J IND MICROBIOL BIOT, V30, P383, DOI 10.1007/s10295-003-0074-9; Sprague MW, 2001, COPEIA, P854, DOI 10.1643/0045-8511(2001)001[0854:DSCEOM]2.0.CO;2; Steidinger KA, 2009, HARMFUL ALGAE, V8, P549, DOI 10.1016/j.hal.2008.11.009; Van Parijs SM, 2009, MAR ECOL PROG SER, V395, P21, DOI 10.3354/meps08123; VANDENWOLLENBERG AL, 1977, PSYCHOMETRIKA, V42, P207, DOI 10.1007/BF02294050; Vargo GA, 2009, HARMFUL ALGAE, V8, P573, DOI 10.1016/j.hal.2008.11.002; Wall CC, 2014, J FISH BIOL, V85, P1470, DOI 10.1111/jfb.12500; Wall CC, 2013, MAR ECOL PROG SER, V484, P173, DOI 10.3354/meps10268; Wall CC, 2012, MAR ECOL PROG SER, V449, P55, DOI 10.3354/meps09549; Webb DC, 2001, IEEE J OCEANIC ENG, V26, P447, DOI 10.1109/48.972077; Zhao J, 2013, HARMFUL ALGAE, V29, P22, DOI 10.1016/j.hal.2013.07.004	55	2	2	2	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2014	9	12							e114893	10.1371/journal.pone.0114893	http://dx.doi.org/10.1371/journal.pone.0114893			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UC	25551564	Green Published, Green Submitted, gold			2022-12-27	WOS:000347119100018
J	Fossepre, M; Leherte, L; Laaksonen, A; Vercauteren, DP				Fossepre, Mathieu; Leherte, Laurence; Laaksonen, Aatto; Vercauteren, Daniel P.			On the Modularity of the Intrinsic Flexibility of the mu Opioid Receptor: A Computational Study	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTOR; MOLECULAR-DYNAMICS SIMULATIONS; CRYSTAL-STRUCTURE; BINDING-SITE; TRANSFER-RNA; SODIUM-IONS; ACTIVATION; RHODOPSIN; INSIGHTS; GPCRS	The mu opioid receptor (mu OR), the principal target to control pain, belongs to the G protein-coupled receptors (GPCRs) family, one of the most highlighted protein families due to their importance as therapeutic targets. The conformational flexibility of GPCRs is one of their essential characteristics as they take part in ligand recognition and subsequent activation or inactivation mechanisms. It is assessed that the intrinsic mechanical properties of the mu OR, more specifically its particular flexibility behavior, would facilitate the accomplishment of specific biological functions, at least in their first steps, even in the absence of a ligand or any chemical species usually present in its biological environment. The study of the mechanical properties of the mu OR would thus bring some indications regarding the highly efficient ability of the mu OR to transduce cellular message. We therefore investigate the intrinsic flexibility of the mu OR in its apo-form using all-atom Molecular Dynamics simulations at the sub-microsecond time scale. We particularly consider the mu OR embedded in a simplified membrane model without specific ions, particular lipids, such as cholesterol moieties, or any other chemical species that could affect the flexibility of the mu OR. Our analyses highlighted an important local effect due to the various bendability of the helices resulting in a diversity of shape and volume sizes adopted by the mu OR binding site. Such property explains why the mu OR can interact with ligands presenting highly diverse structural geometry. By investigating the topology of the mu OR binding site, a conformational global effect is depicted: the correlation between the motional modes of the extra-and intracellular parts of mu OR on one hand, along with a clear rigidity of the central mu OR domain on the other hand. Our results show how the modularity of the mu OR flexibility is related to its preability to activate and to present a basal activity.	[Fossepre, Mathieu; Leherte, Laurence; Vercauteren, Daniel P.] Univ Namur UNamur, Lab Physicochim Informat, Unite Chim Phys Theor & Struct, Namur, Belgium; [Fossepre, Mathieu; Laaksonen, Aatto] Stockholm Univ, Arrhenius Lab, Div Phys Chem, S-10691 Stockholm, Sweden; [Fossepre, Mathieu; Leherte, Laurence; Vercauteren, Daniel P.] Univ Namur UNamur, Namur Med & Drug Innovat Ctr NAMEDIC, Namur, Belgium; [Laaksonen, Aatto] Univ Stellenbosch, Stellenbosch Inst Adv Study STIAS, Wallenberg Res Ctr, ZA-7600 Stellenbosch, South Africa	Stockholm University; Stellenbosch University	Fossepre, M (corresponding author), Univ Namur UNamur, Lab Physicochim Informat, Unite Chim Phys Theor & Struct, Namur, Belgium.	Mathieu.fossepre@unamur.be	Laaksonen, Aatto/G-7904-2012	Laaksonen, Aatto/0000-0001-9783-4535; Fossepre, Mathieu/0000-0003-1506-3146; Leherte, Laurence/0000-0001-8468-5462	Belgian National Fund for Research; Belgian Science Policy Office [7/05]; Swedish Science Council (VR)	Belgian National Fund for Research(Fonds de la Recherche Scientifique - FNRS); Belgian Science Policy Office(Belgian Federal Science Policy Office); Swedish Science Council (VR)(Swedish Research Council)	MF thanks the Belgian National Fund for Research (F.R.S.-FNRS) for his F.R.I.A. doctoral scholarship. MF, LL, and DPV thank the Interuniversity Attraction Poles Programmes no 7/05: "Functional supramolecular systems'' initiated by the Belgian Science Policy Office for partial financial support. AL wishes to thank the Swedish Science Council (VR) for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen MP, 1989, MOL SIMULAT, V4, P1, DOI 10.1080/08927028908021960; AMADEI A, 1993, PROTEINS, V17, P412, DOI 10.1002/prot.340170408; Apweiler R, 2014, NUCLEIC ACIDS RES, V42, pD191, DOI 10.1093/nar/gkt1140; Bakan A, 2011, BIOINFORMATICS, V27, P1575, DOI 10.1093/bioinformatics/btr168; Benyamin R, 2008, PAIN PHYSICIAN, V11, pS105; Bokoch MP, 2010, NATURE, V463, P108, DOI 10.1038/nature08650; Chandrasekhar S, 1943, REV MOD PHYS, V15, P0001, DOI 10.1103/RevModPhys.15.1; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; Costanzi S, 2014, ADV EXP MED BIOL, V796, P3, DOI 10.1007/978-94-007-7423-0_1; Cui X, 2013, EUR J PHARMACOL, V702, P309, DOI 10.1016/j.ejphar.2013.01.060; Dahl ACE, 2012, BIOINFORMATICS, V28, P2193, DOI 10.1093/bioinformatics/bts357; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; de Bakker P, 2002, RAMPAGE WEBSERVER; Fanelli F, 2011, CHEM REV, V111, pPR438, DOI 10.1021/cr100437t; Fenalti G, 2014, NATURE, V506, P191, DOI 10.1038/nature12944; Georgoussi Z, 2012, CURR DRUG TARGETS, V13, P80, DOI 10.2174/138945012798868470; Ghanouni P, 2000, J BIOL CHEM, V275, P3121, DOI 10.1074/jbc.275.5.3121; Ghosh A, 2014, COMPUT BIOL CHEM, V48, P29, DOI 10.1016/j.compbiolchem.2013.11.002; Girvan M, 2002, P NATL ACAD SCI USA, V99, P7821, DOI 10.1073/pnas.122653799; Glykos NM, 2006, J COMPUT CHEM, V27, P1765, DOI 10.1002/jcc.20482; GOLDSTEIN A, 1989, MOL PHARMACOL, V36, P265; Granier S, 2012, NATURE, V485, P400, DOI 10.1038/nature11111; Grossfield A, 2011, BBA-BIOMEMBRANES, V1808, P1868, DOI 10.1016/j.bbamem.2011.03.010; Gutierrez-de-Teran H, 2013, BIOCHEM SOC T, V41, P205, DOI 10.1042/BST20120287; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jafurulla M, 2013, CURR MED CHEM, V20, P47; Johnston JM, 2011, CURR OPIN STRUC BIOL, V21, P552, DOI 10.1016/j.sbi.2011.06.008; Katritch V, 2013, ANNU REV PHARMACOL, V53, P531, DOI 10.1146/annurev-pharmtox-032112-135923; Katritch V, 2012, TRENDS PHARMACOL SCI, V33, P17, DOI 10.1016/j.tips.2011.09.003; Kelley C., 2011, GNUPLOT 4 5 INTERACT; Klauda JB, 2010, J PHYS CHEM B, V114, P7830, DOI 10.1021/jp101759q; Ko J, 2011, NUCLEIC ACIDS RES, V39, pW210, DOI 10.1093/nar/gkr352; Kobilka BK, 2007, TRENDS PHARMACOL SCI, V28, P397, DOI 10.1016/j.tips.2007.06.003; Kooistra AJ, 2014, ADV EXP MED BIOL, V796, P129, DOI 10.1007/978-94-007-7423-0_7; Lee YS, 2010, BIOORG MED CHEM LETT, V20, P4080, DOI 10.1016/j.bmcl.2010.05.078; Mackerell AD, 2004, J COMPUT CHEM, V25, P1400, DOI 10.1002/jcc.20065; Mahalingam M, 2008, P NATL ACAD SCI USA, V105, P17795, DOI 10.1073/pnas.0804541105; Mahmood MI, 2013, CHEM PHARM BULL, V61, P426; Manglik A, 2014, CURR OPIN CELL BIOL, V27, P136, DOI 10.1016/j.ceb.2014.01.008; Manglik A, 2012, NATURE, V485, P321, DOI 10.1038/nature10954; Meye FJ, 2014, TRANSL PSYCHIAT, V4, DOI 10.1038/tp.2013.130; Mondal M, 2013, SCI REP-UK, V3, DOI 10.1038/srep01357; Ng HW, 2013, J CHEM INF MODEL, V53, P1168, DOI 10.1021/ci300610w; Oates J., 2011, CURR OPIN CHEM BIOL, V21, P1; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Park PSH, 2012, CURR MED CHEM, V19, P1146; Parrill AL, 2011, PHARMACEUTICALS, V4, P7, DOI 10.3390/ph4010007; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Pyrkosz AB, 2010, J MOL BIOL, V397, P1350, DOI 10.1016/j.jmb.2010.02.003; Rodriguez D, 2011, BIOCHEMISTRY-US, V50, P4194, DOI 10.1021/bi200100t; Romanowska J, 2012, J CHEM THEORY COMPUT, V8, P2588, DOI 10.1021/ct300206j; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Sadee W, 2005, LIFE SCI, V76, P1427, DOI 10.1016/j.lfs.2004.10.024; Schiller PW, 2010, LIFE SCI, V86, P598, DOI 10.1016/j.lfs.2009.02.025; Sethi A, 2009, P NATL ACAD SCI USA, V106, P6620, DOI 10.1073/pnas.0810961106; Shang Y, 2014, BIOCHEMISTRY-US, V53, P5140, DOI 10.1021/bi5006915; Shao JY, 2007, J CHEM THEORY COMPUT, V3, P2312, DOI 10.1021/ct700119m; Shim J, 2013, J PHYS CHEM B, V117, P7907, DOI 10.1021/jp404238n; STEINBACH PJ, 1994, J COMPUT CHEM, V15, P667, DOI 10.1002/jcc.540150702; Stevens RC, 2013, NAT REV DRUG DISCOV, V12, P25, DOI 10.1038/nrd3859; Tsoulos IG, 2011, COMPUT PHYS COMMUN, V182, P834, DOI 10.1016/j.cpc.2010.11.032; Unal H, 2012, TRENDS PHARMACOL SCI, V33, P79, DOI 10.1016/j.tips.2011.09.007; Vaidehi N, 2010, DRUG DISCOV TODAY, V15, P951, DOI 10.1016/j.drudis.2010.08.018; Velazquez-Muriel JA, 2009, BMC STRUCT BIOL, V9, DOI 10.1186/1472-6807-9-6; Vuckovic S, 2009, CURR MED CHEM, V16, P2468, DOI 10.2174/092986709788682074; Wang DX, 2004, J PHARMACOL EXP THER, V308, P512, DOI 10.1124/jpet.103.054049; Williams JT, 2013, PHARMACOL REV, V65, P223, DOI 10.1124/pr.112.005942; Wu HX, 2012, NATURE, V485, P327, DOI 10.1038/nature10939; Yu J, 2010, BIOINFORMATICS, V26, P46, DOI 10.1093/bioinformatics/btp599; Yuan SG, 2013, ANGEW CHEM INT EDIT, V52, P10112, DOI 10.1002/anie.201302244; Zohar A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008752; Zou YZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046039	72	12	12	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2014	9	12							e115856	10.1371/journal.pone.0115856	http://dx.doi.org/10.1371/journal.pone.0115856			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX6YH	25549261	Green Published, gold			2022-12-27	WOS:000347063500030
J	Li, HL; Zhang, ZF; Bi, Y; Yang, DD; Zhang, LT; Liu, JG				Li, Hailong; Zhang, Zhifeng; Bi, Ying; Yang, Dandan; Zhang, Litao; Liu, Jianguo			Expression Characteristics of beta-Catenin in Scallop Chlamys farreri Gonads and Its Role as a Potential Upstream Gene of Dax1 through Canonical Wnt Signalling Pathway Regulating the Spermatogenesis	PLOS ONE			English	Article							CRYSTAL-STRUCTURE; STEM-CELLS; MECHANISMS; INHIBITOR; CLONING; APC; DICKKOPF-1; QUERCETIN; RECEPTOR; POLARITY	beta-catenin is a key signaling molecule in the canonical Wnt pathway, which is involved in animal development. However, little information has been reported for beta-catenin in bivalves. In the present study, we cloned a homolog of beta-catenin from the scallop Chlamys farreri and determined its expression characteristics. The full-length cDNA of beta-catenin was 3,353 bp, including a 2,511 bp open reading frame that encoded a predicted 836 amino acid protein. Level of the beta-catenin mRNA increased significantly (P<0.05) with C. farreri gonadal development and presented a sexually dimorphic expression pattern in the gonads, which was significantly high in ovaries detected by quantitative real-time polymerase chain reaction (qRT-PCR). Immunohistochemical analysis revealed that the beta-catenin was mainly located in germ cells of the gonads, with obvious positive immune signals in the oogonia and oocytes of ovaries as well as in the spermatogonia and spermatocytes of testes, implying beta-catenin might be involved in the gametogenesis of C. farreri. Furthermore, when 0.1 mu g/mL and 0.2 mu g/mL DKK-1 (an inhibitor of the canonical Wnt pathway) were added in vitro to culture medium containing testis cells of C. farreri, the expression of beta-catenin decreased significantly detected by qRT-PCR (P<0.05), suggesting the canonical Wnt signal pathway exists in the scallop testis. Similarly, when 50 mu M and 100 mu M quercetin (an inhibitor of beta-catenin) were added in vitro to the culture system, Dax1 expression was significantly down-regulated compared with controls (P<0.05), implying the beta-catenin is an upstream gene of Dax1 and is involved in the regulation of C. farreri spermatogenesis.	[Li, Hailong; Zhang, Zhifeng; Bi, Ying; Yang, Dandan; Zhang, Litao; Liu, Jianguo] Ocean Univ China, Minist Educ, Key Lab Marine Genet & Breeding, Qingdao, Peoples R China; [Li, Hailong] Chinese Acad Fishery Sci, Yellow Sea Fisheries Res Inst, Qingdao, Peoples R China	Ocean University of China; Chinese Academy of Fishery Sciences; Yellow Sea Fisheries Research Institute, CAFS	Zhang, ZF (corresponding author), Ocean Univ China, Minist Educ, Key Lab Marine Genet & Breeding, Qingdao, Peoples R China.	zzfp107@ouc.edu.cn	YANG, Dan/HHD-2733-2022		National High Technology Research and Development Program of China [2012AA10A402]	National High Technology Research and Development Program of China(National High Technology Research and Development Program of China)	This work was supported by the National High Technology Research and Development Program of China (2012AA10A402). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama T, 2000, CYTOKINE GROWTH F R, V11, P273, DOI 10.1016/S1359-6101(00)00011-3; Bafico A, 2001, NAT CELL BIOL, V3, P683, DOI 10.1038/35083081; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Byrum CA, 2009, DEV DYNAM, V238, P1649, DOI 10.1002/dvdy.21978; Chassot AA, 2008, HUM MOL GENET, V17, P1264, DOI 10.1093/hmg/ddn016; El Wakil A, 2011, MOL CELL ENDOCRINOL, V332, P32, DOI 10.1016/j.mce.2010.11.014; Freese JL, 2010, NEUROBIOL DIS, V38, P148, DOI 10.1016/j.nbd.2009.09.003; Gottardi CJ, 2004, J CELL BIOL, V167, P339, DOI 10.1083/jcb.200402153; Graham TA, 2000, CELL, V103, P885, DOI 10.1016/S0092-8674(00)00192-6; Gregory CA, 2003, J BIOL CHEM, V278, P28067, DOI 10.1074/jbc.M300373200; Guo HH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051005; Habas R, 2003, GENE DEV, V17, P295, DOI 10.1101/gad.1022203; Hobmayer E, 1996, GENE, V172, P155, DOI 10.1016/0378-1119(96)00162-X; Hu XL, 2006, AQUAC RES, V37, P1187, DOI 10.1111/j.1365-2109.2006.01546.x; Huber AH, 1997, CELL, V90, P871, DOI 10.1016/S0092-8674(00)80352-9; Huber AH, 2001, CELL, V105, P391, DOI 10.1016/S0092-8674(01)00330-0; HULSKEN J, 1994, J CELL BIOL, V127, P2061, DOI 10.1083/jcb.127.6.2061; Kawakami Y, 2006, GENE DEV, V20, P3232, DOI 10.1101/gad.1475106; Kawano Y, 2003, J CELL SCI, V116, P2627, DOI 10.1242/jcs.00623; Kuhl M, 2000, TRENDS GENET, V16, P279, DOI 10.1016/s0168-9525(00)02028-x; Li HL, 2014, J OCEAN U CHINA, V13, P696, DOI 10.1007/s11802-014-2299-9; Liao C. Y., 1983, J FISH CHINA, V1, P1; Lin G, 2008, DEV BIOL, V316, P323, DOI 10.1016/j.ydbio.2008.01.032; Liu CF, 2009, HUM MOL GENET, V18, P405, DOI 10.1093/hmg/ddn362; Liu JG, 2014, J STEROID BIOCHEM, V141, P77, DOI 10.1016/j.jsbmb.2014.01.008; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Lu JF, 1997, GENE, V196, P201, DOI 10.1016/S0378-1119(97)00228-X; Maatouk DM, 2008, HUM MOL GENET, V17, P2949, DOI 10.1093/hmg/ddn193; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Mani P, 2010, DEV DYNAM, V239, P354, DOI 10.1002/dvdy.22072; Mao BY, 2003, GENE, V302, P179, DOI 10.1016/S0378-1119(02)01106-X; McFarland KA, 2008, DEV BIOL, V318, P162, DOI 10.1016/j.ydbio.2008.03.016; Mizusaki H, 2003, MOL ENDOCRINOL, V17, P507, DOI 10.1210/me.2002-0362; Mlodzik M, 2002, TRENDS GENET, V18, P564, DOI 10.1016/S0168-9525(02)02770-1; Nakamura T, 1998, GENES CELLS, V3, P395, DOI 10.1046/j.1365-2443.1998.00198.x; Park CH, 2005, BIOCHEM BIOPH RES CO, V328, P227, DOI 10.1016/j.bbrc.2004.12.151; Rubinfeld B, 1997, CANCER RES, V57, P4624; Schneider SQ, 2003, J EXP ZOOL PART B, V295B, P25, DOI 10.1002/jez.b.00006; Shan BE, 2009, CANCER INVEST, V27, P604, DOI 10.1080/07357900802337191; Slusarski DC, 1997, DEV BIOL, V182, P114, DOI 10.1006/dbio.1996.8463; Strutt D, 2012, GENETICS, V192, P1295, DOI 10.1534/genetics.112.144592; Sugimura R, 2010, BIRTH DEFECTS RES C, V90, P243, DOI 10.1002/bdrc.20195; von Kries JP, 2000, NAT STRUCT BIOL, V7, P800; Wang HY, 2003, SCIENCE, V300, P1529, DOI 10.1126/science.1085259; Willert K, 1998, CURR OPIN GENET DEV, V8, P95, DOI 10.1016/S0959-437X(98)80068-3; Woll PS, 2008, BLOOD, V111, P122, DOI 10.1182/blood-2007-04-084186; Xing Y, 2008, STRUCTURE, V16, P478, DOI 10.1016/j.str.2007.12.021; Yang F. Y., 2009, J ANHUI AGR SCI, V37, P4073; Yang JL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017089; Zhang H, 2012, COMP BIOCHEM PHYS C, V156, P51, DOI 10.1016/j.cbpc.2012.03.007; Zhou QR, 2010, CHIN J OCEANOL LIMN, V28, P37, DOI 10.1007/s00343-010-9231-y; Zinovyeva AY, 2008, GENETICS, V179, P1357, DOI 10.1534/genetics.108.090290	53	13	13	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2014	9	12							e115917	10.1371/journal.pone.0115917	http://dx.doi.org/10.1371/journal.pone.0115917			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX6YH	25549092	gold, Green Published, Green Submitted			2022-12-27	WOS:000347063500039
J	Nissan, N; Golan, T; Furman-Haran, E; Apter, S; Inbar, Y; Ariche, A; Bar-Zakay, B; Goldes, Y; Schvimer, M; Grobgeld, D; Degani, H				Nissan, Noam; Golan, Talia; Furman-Haran, Edna; Apter, Sara; Inbar, Yael; Ariche, Arie; Bar-Zakay, Barak; Goldes, Yuri; Schvimer, Michael; Grobgeld, Dov; Degani, Hadassa			Diffusion Tensor Magnetic Resonance Imaging of the Pancreas	PLOS ONE			English	Article							INTRAVOXEL-INCOHERENT-MOTION; WEIGHTED MRI; B-VALUES; KIDNEY; BODY; DIFFERENTIATION; ARCHITECTURE; CARCINOMA; DIAGNOSIS; REDUCTION	Purpose: To develop a diffusion-tensor-imaging (DTI) protocol that is sensitive to the complex diffusion and perfusion properties of the healthy and malignant pancreas tissues. Materials and Methods: Twenty-eight healthy volunteers and nine patients with pancreatic-ductal-adenocacinoma (PDAC), were scanned at 3T with T2-weighted and DTI sequences. Healthy volunteers were also scanned with multi-b diffusion-weighted-imaging (DWI), whereas a standard clinical protocol complemented the PDAC patients' scans. Image processing at pixel resolution yielded parametric maps of three directional diffusion coefficients lambda 1, lambda 2, lambda 3, apparent diffusion coefficient (ADC), and fractional anisotropy (FA), as well as a lambda 1-vector map, and a main diffusion-direction map. Results: DTI measurements of healthy pancreatic tissue at b-values 0,500 s/mm(2) yielded: lambda 1=(2.65 +/- 0.35) x 10(-3), lambda 2 = (1.87 +/- 0.22) x 10(-3), lambda 3=(1.20 +/- 0.18) x 10(-3), ADC=(1.91 +/- 0.22) x10(-3) (all in mm(2)/s units) and FA=0.38 +/- 0.06. Using b-values of 100,500 s/mm(2) led to a significant reduction in lambda 1, lambda 2, lambda 3 and ADC (p<.0001) and a significant increase (p<0.0001) in FA. The reduction in the diffusion coefficients suggested a contribution of a fast intra-voxel-incoherent-motion (IVIM) component at b <= 100 s/mm(2), which was confirmed by the multi-b DWI results. In PDACs, lambda 1, lambda 2, lambda 3 and ADC in both 0,500 s/mm(2) and 100,500 s/mm(2) b-values sets, as well as the reduction in these diffusion coefficients between the two sets, were significantly lower in comparison to the distal normal pancreatic tissue, suggesting higher cellularity and diminution of the fast-IVIM component in the cancer tissue. Conclusion: DTI using two reference b-values 0 and 100 s/mm(2) enabled characterization of the water diffusion and anisotropy of the healthy pancreas, taking into account a contribution of IVIM. The reduction in the diffusion coefficients of PDAC, as compared to normal pancreatic tissue, and the smaller change in these coefficients in PDAC when the reference b-value was modified from 0 to 100 s/mm(2), helped identifying the presence of malignancy.	[Nissan, Noam; Grobgeld, Dov; Degani, Hadassa] Weizmann Inst Sci, Dept Regulat Biol, IL-76100 Rehovot, Israel; [Golan, Talia; Apter, Sara; Inbar, Yael; Ariche, Arie; Bar-Zakay, Barak; Goldes, Yuri; Schvimer, Michael] Tel Aviv Univ, Sackler Sch Med, IL-69978 Tel Aviv, Israel; [Golan, Talia] Sheba Med Ctr, Inst Oncol, Tel Hashomer, Israel; [Furman-Haran, Edna] Weizmann Inst Sci, Unit Biol Serv, IL-76100 Rehovot, Israel; [Apter, Sara; Inbar, Yael] Sheba Med Ctr, Div Diagnost Imaging, Tel Hashomer, Israel; [Ariche, Arie; Bar-Zakay, Barak; Goldes, Yuri] Sheba Med Ctr, Dept Hepatopancreatobiliary Surg, Tel Hashomer, Israel; [Schvimer, Michael] Sheba Med Ctr, Dept Pathol, Tel Hashomer, Israel	Weizmann Institute of Science; Tel Aviv University; Sackler Faculty of Medicine; Chaim Sheba Medical Center; Weizmann Institute of Science; Chaim Sheba Medical Center; Chaim Sheba Medical Center; Chaim Sheba Medical Center	Nissan, N (corresponding author), Weizmann Inst Sci, Dept Regulat Biol, IL-76100 Rehovot, Israel.	Noamniss@gmail.com			Weizmann Institute of Science - Chaim Sheba Medical Center Collaborative Grant in Biomedical Research [2012-4]; Lustgarten Foundation for Pancreatic Cancer Research [2012-4]	Weizmann Institute of Science - Chaim Sheba Medical Center Collaborative Grant in Biomedical Research; Lustgarten Foundation for Pancreatic Cancer Research	This study was supported by Weizmann Institute of Science - Chaim Sheba Medical Center Collaborative Grant in Biomedical Research (2012-4) and by the Lustgarten Foundation (http://www.lustgarten.org/) for Pancreatic Cancer Research (2012-4). H.D. is the incumbent of the Fred and Andrea Fallek Professorial Chair for Breast Cancer Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Assaf Y, 2008, J MOL NEUROSCI, V34, P51, DOI 10.1007/s12031-007-0029-0; Bakir B, 2010, EUR J RADIOL, V74, P214, DOI 10.1016/j.ejrad.2009.02.003; Bali MA, 2011, RADIOLOGY, V261, P456, DOI 10.1148/radiol.11103515; Concia M, 2014, INVEST RADIOL, V49, P93, DOI 10.1097/RLI.0b013e3182a71cc3; Cutajar M, 2011, EUR J RADIOL, V80, pE263, DOI 10.1016/j.ejrad.2010.12.018; de Heer P, 2012, MAGN RESON MED, V68, P1317, DOI 10.1002/mrm.24438; Dietrich O, 2008, EUR J RADIOL, V65, P29, DOI 10.1016/j.ejrad.2007.11.005; Dietrich O, 2010, EUR J RADIOL, V76, P314, DOI 10.1016/j.ejrad.2010.02.018; Eyal E, 2012, INVEST RADIOL, V47, P284, DOI 10.1097/RLI.0b013e3182438e5d; Fattahi R, 2009, J MAGN RESON IMAGING, V29, P350, DOI 10.1002/jmri.21651; Fukukura Y, 2012, RADIOLOGY, V263, P732, DOI 10.1148/radiol.12111222; GUDBJARTSSON H, 1995, MAGNET RESON MED, V34, P910, DOI 10.1002/mrm.1910340618; Hagmann P, 2006, RADIOGRAPHICS, V26, pS205, DOI 10.1148/rg.26si065510; Herrmann J, 2013, J MAGN RESON IMAGING, V37, P886, DOI 10.1002/jmri.23871; Heusch P, 2013, J MAGN RESON IMAGING, V37, P233, DOI 10.1002/jmri.23751; Heyn C, 2012, J MAGN RESON IMAGING, V36, P1037, DOI 10.1002/jmri.23708; Hueper K, 2012, INVEST RADIOL, V47, P430, DOI 10.1097/RLI.0b013e31824f272d; In't Veld P, 2010, ADV EXP MED BIOL, V654, P1, DOI 10.1007/978-90-481-3271-3_1; Jambawalikar S, 2010, SKELETAL RADIOL, V39, P1073, DOI 10.1007/s00256-010-0974-5; Jones DK, 2010, NMR BIOMED, V23, P803, DOI 10.1002/nbm.1543; Kang KM, 2014, RADIOLOGY, V270, P444, DOI 10.1148/radiol.13122712; Kido A, 2010, ACTA RADIOL, V51, P1059, DOI 10.3109/02841851.2010.504741; Klauss M, 2013, INVEST RADIOL, V48, P129, DOI 10.1097/RLI.0b013e31827ac0f1; Klauss M, 2011, INVEST RADIOL, V46, P57, DOI 10.1097/RLI.0b013e3181fb3bf2; Koh DM, 2011, AM J ROENTGENOL, V196, P1351, DOI 10.2214/AJR.10.5515; Le Bihan D, 2001, J MAGN RESON IMAGING, V13, P534, DOI 10.1002/jmri.1076; LEBIHAN D, 1986, RADIOLOGY, V161, P401, DOI 10.1148/radiology.161.2.3763909; Lee JW, 2006, INVEST RADIOL, V41, P553, DOI 10.1097/01.rli.0000221325.03899.48; Lee SS, 2008, J MAGN RESON IMAGING, V28, P928, DOI 10.1002/jmri.21508; Legrand L, 2014, ABDOM IMAGING; Lemke A, 2011, MAGN RESON IMAGING, V29, P766, DOI 10.1016/j.mri.2011.03.004; Lemke A, 2010, MAGN RESON MED, V64, P1580, DOI 10.1002/mrm.22565; Lemke A, 2009, INVEST RADIOL, V44, P769, DOI 10.1097/RLI.0b013e3181b62271; Low G, 2011, RADIOGRAPHICS, V31, P993, DOI 10.1148/rg.314105731; Machann J, 2008, PHYS MEDICA, V24, P63, DOI 10.1016/j.ejmp.2008.01.011; Manenti G, 2007, INVEST RADIOL, V42, P412, DOI 10.1097/01.rli.0000264059.46444.bf; Matsuki M, 2007, ABDOM IMAGING, V32, P481, DOI 10.1007/s00261-007-9192-6; Merkle EM, 2006, AM J ROENTGENOL, V186, P1524, DOI 10.2214/AJR.05.0932; Muhi A, 2012, J MAGN RESON IMAGING, V35, P827, DOI 10.1002/jmri.22881; Nissan N, 2014, RADIOLOGY, V271, P672, DOI 10.1148/radiol.14132084; Notohamiprodjo M, 2008, INVEST RADIOL, V43, P677, DOI 10.1097/RLI.0b013e31817d14e6; Notohamiprodjo M, 2010, INVEST RADIOL, V45, P245, DOI 10.1097/RLI.0b013e3181d83abc; Paran Y, 2004, NMR BIOMED, V17, P170, DOI 10.1002/nbm.882; Partensky C, 2013, PANCREAS, V42, P729, DOI 10.1097/MPA.0b013e318288107a; Price WS, 1998, BIOPHYS J, V74, P2259, DOI 10.1016/S0006-3495(98)77935-4; Re TJ, 2011, MAGN RESON MED, V66, P1327, DOI 10.1002/mrm.22931; Reese TG, 2003, MAGN RESON MED, V49, P177, DOI 10.1002/mrm.10308; Reisert M, 2011, P 19 ANN M ISMRM MON; Ries M, 2001, J MAGN RESON IMAGING, V14, P42, DOI 10.1002/jmri.1149; Sandrasegaran K, 2010, AM J ROENTGENOL, V195, P42, DOI 10.2214/AJR.10.4421; Schoennagel BP, 2011, J MAGN RESON IMAGING, V34, P861, DOI 10.1002/jmri.22743; Sigmund EE, 2012, RADIOLOGY, V263, P758, DOI 10.1148/radiol.12111327; Sinha S, 2004, MAGN RESON MED, V52, P530, DOI 10.1002/mrm.20190; STEJSKAL EO, 1965, J CHEM PHYS, V42, P288, DOI 10.1063/1.1695690; Sunamura M, 1998, J Hepatobiliary Pancreat Surg, V5, P62, DOI 10.1007/PL00009952; Szafer A, 1995, NMR BIOMED, V8, P289, DOI 10.1002/nbm.1940080704; Taouli B, 2004, AM J ROENTGENOL, V183, P677, DOI 10.2214/ajr.183.3.1830677; Taouli B, 2008, J MAGN RESON IMAGING, V28, P89, DOI 10.1002/jmri.21227; Tirkes T, 2012, RADIOL CLIN N AM, V50, P379, DOI 10.1016/j.rcl.2012.03.003; Wang Y, 2011, J MAGN RESON IMAGING, V33, P136, DOI 10.1002/jmri.22414; Watanabe T, 1997, PANCREAS, V15, P48, DOI 10.1097/00006676-199707000-00007; Watanabe T, 1999, PANCREAS, V18, P349, DOI 10.1097/00006676-199905000-00004; Wu MT, 2006, CIRCULATION, V114, P1036, DOI 10.1161/CIRCULATIONAHA.105.545863; Yachida S, 2010, NATURE, V467, P1114, DOI 10.1038/nature09515	64	22	23	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2014	9	12							e115783	10.1371/journal.pone.0115783	http://dx.doi.org/10.1371/journal.pone.0115783			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX6YH	25549366	Green Published, gold, Green Submitted			2022-12-27	WOS:000347063500027
J	Pei, LJ; Tan, G; Wang, L; Guo, WJ; Xiao, B; Gao, XL; Wang, L; Li, H; Xu, ZH; Zhang, XH; Zhao, J; Yi, J; Huang, YG				Pei, Lijian; Tan, Gang; Wang, Lei; Guo, Wenjuan; Xiao, Bo; Gao, Xianli; Wang, Li; Li, Hong; Xu, Zhonghuang; Zhang, Xiuhua; Zhao, Jing; Yi, Jie; Huang, Yuguang			Comparison of Combined General-Epidural Anesthesia with General Anesthesia Effects on Survival and Cancer Recurrence: A Meta-Analysis of Retrospective and Prospective Studies	PLOS ONE			English	Article							SPINAL-ANESTHESIA; SURGERY; ANALGESIA; REDUCTION; PAIN; MORTALITY	Objective: Animals underwent combined general-epidural anesthesia (EGA) is reported to have better long-time outcome than general anesthesia (GA). This study aimed to make overall evaluation of the association between these two anesthetic techniques and prognosis of cancer patients undergoing surgery. Methods: Related databases such as PubMed and EMbase were searched for eligible studies that evaluated the influence of EGA and GA on the prognosis of cancer patients undergoing surgery. Selected studies were evaluated according to the inclusion criteria by two reviewers respectively, followed by data extraction and quality assessment. The odds ratio (OR) with their 95% confidence intervals (CIs) were calculated to assess the influence strength of EGA and GA on prognosis of cancer patients. Results: A total of ten studies involving 3254 patients were included. The overall results demonstrated that there was no significant difference between EGA and GA group (OR = 0.88, 95% CI 0.73 to 1.06, P = 0.187) concerning postoperative recurrence and metastasis rate. In regard to the following two factors: cancer category and time of follow-up, subgroup analysis identified significant differences between EGA and GA in the group of patients with prostate cancer and the group with follow-up less than or equal to two years (OR = 0.66, 95% CI 0.46 to 0.95, P = 0.027; OR = 0.70, 95% CI 0.51 to 0.98, P = 0.035; respectively) concerning postoperative recurrence and metastasis rate. However, no significant difference was found in the group of patients with colorectal cancer (OR = 1.06, 95% CI 0.84-1.33, P = 0.62). Conclusions: This meta-analysis showed that EGA might be associated with improvement in prognosis of patients with operable prostate cancer and the cancer patients with follow-up less than or equal to two years. However, no obvious relationship between the improvement in prognosis of colorectal cancer and EGA were detected, comparing to GA. Furthermore, all the results should be interpreted cautiously, as heterogeneous data were used for analyzing.	[Pei, Lijian; Tan, Gang; Wang, Lei; Guo, Wenjuan; Xiao, Bo; Gao, Xianli; Li, Hong; Xu, Zhonghuang; Zhang, Xiuhua; Zhao, Jing; Yi, Jie; Huang, Yuguang] Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Anesthesiol, Beijing 100730, Peoples R China; [Wang, Li] Chinese Acad Med Sci, Inst Basic Med Sci, Dept Epidemiol & Biostat, Beijing 100005, Peoples R China; [Wang, Li] Peking Union Med Coll, Sch Basic Med, Beijing 100005, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Huang, YG (corresponding author), Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Anesthesiol, Beijing 100730, Peoples R China.	hyug1999@163.com		lijian, Pei/0000-0001-7174-9105				Bar-Yosef S, 2001, ANESTHESIOLOGY, V94, P1066, DOI 10.1097/00000542-200106000-00022; BEILIN B, 1989, Brain Behavior and Immunity, V3, P129, DOI 10.1016/0889-1591(89)90013-5; Biki B, 2008, ANESTHESIOLOGY, V109, P180, DOI 10.1097/ALN.0b013e31817f5b73; Binczak M, 2013, Ann Fr Anesth Reanim, V32, pe81, DOI 10.1016/j.annfar.2013.02.027; Casati L, 2002, ANESTH ANALG, V94, P1331, DOI 10.1097/00000539-200205000-00053; Christopherson R, 2008, ANESTH ANALG, V107, P325, DOI 10.1213/ane.0b013e3181770f55; Cummings KC, 2012, ANESTHESIOLOGY, V116, P797, DOI 10.1097/ALN.0b013e31824674f6; ERSKINE R, 1992, CAN J ANAESTH, V39, P905, DOI 10.1007/BF03008337; Exadaktylos AK, 2006, ANESTHESIOLOGY, V105, P660, DOI 10.1097/00000542-200610000-00008; Fodale V, 2014, SCI WORLD J, DOI 10.1155/2014/328513; Forget P, 2010, EUR J ANAESTH, V27, P233, DOI 10.1097/EJA.0b013e32832d540e; Gottschalk A, 2010, ANESTHESIOLOGY, V113, P27, DOI 10.1097/ALN.0b013e3181de6d0d; Gupta A, 2011, BRIT J ANAESTH, V107, P164, DOI 10.1093/bja/aer100; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Hiller JG, 2014, ACTA ANAESTH SCAND, V58, P281, DOI 10.1111/aas.12255; Hiller JG, 2014, ACTA ANAESTHESIOL SC; Kaneda Kazuhiro, 2006, Masui, V55, P900; Lacassie HJ, 2013, ANESTH ANALG, V117, P653, DOI 10.1213/ANE.0b013e3182a07046; Landoni G, 2012, J CARDIOTHOR VASC AN, V26, P764, DOI 10.1053/j.jvca.2012.04.018; LEWIS J W, 1983, Natural Immunity and Cell Growth Regulation, V3, P43; Liberati A, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; Lirk P, 2013, MINERVA ANESTESIOL; MARKOVIC SN, 1993, ANESTHESIOLOGY, V78, P700, DOI 10.1097/00000542-199304000-00013; Merquiol Fanette, 2013, Reg Anesth Pain Med, V38, P398, DOI 10.1097/AAP.0b013e31829cc3fb; Mora S, 2010, CIRCULATION, V121, P1069, DOI 10.1161/CIRCULATIONAHA.109.906479; Myles PS, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d1491; Rittner HL, 2008, BRIT J ANAESTH, V101, P40, DOI 10.1093/bja/aen078; Rittner HL, 2002, ANAESTHESIST, V51, P351, DOI 10.1007/s00101-002-0306-9; Rodgers A, 2000, BMJ-BRIT MED J, V321, P1493, DOI 10.1136/bmj.321.7275.1493; Snyder GL, 2010, BRIT J ANAESTH, V105, P106, DOI 10.1093/bja/aeq164; Sotunmbi P, 1999, AFRICAN J MED MED SC, V29, P319; Sotunmbi P T, 2000, Afr J Med Med Sci, V29, P319; Tsui BCH, 2010, CAN J ANAESTH, V57, P107, DOI 10.1007/s12630-009-9214-7; Urwin SC, 2000, BRIT J ANAESTH, V84, P450, DOI 10.1093/oxfordjournals.bja.a013468; Wells GA, 2011, NEWCASTLE OTTAWA SCA; Wijeysundera DN, 2008, LANCET, V372, P562, DOI 10.1016/S0140-6736(08)61121-6; Wuethrich PY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072873; Wuethrich PY, 2010, ANESTHESIOLOGY, V113, P570, DOI 10.1097/ALN.0b013e3181e4f6ec; Zhou D, 2012, WORLD J GASTROENTERO, V18, P3089, DOI 10.3748/wjg.v18.i24.3089	39	45	49	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2014	9	12							e114667	10.1371/journal.pone.0114667	http://dx.doi.org/10.1371/journal.pone.0114667			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX6YH	25548913	Green Published, Green Submitted, gold			2022-12-27	WOS:000347063500008
J	Danielsson, A; Ponten, F; Fagerberg, L; Hallstrom, BM; Schwenk, JM; Uhlen, M; Korsgren, O; Lindskog, C				Danielsson, Angelika; Ponten, Fredrik; Fagerberg, Linn; Hallstrom, Bjorn M.; Schwenk, Jochen M.; Uhlen, Mathias; Korsgren, Olle; Lindskog, Cecilia			The Human Pancreas Proteome Defined by Transcriptomics and Antibody-Based Profiling	PLOS ONE			English	Article							TISSUE DISTRIBUTION; RNA-SEQ; EXPRESSION; TYPE-1; TOOL; IDENTIFICATION; ASSOCIATION	The pancreas is composed of both exocrine glands and intermingled endocrine cells to execute its diverse functions, including enzyme production for digestion of nutrients and hormone secretion for regulation of blood glucose levels. To define the molecular constituents with elevated expression in the human pancreas, we employed a genome-wide RNA sequencing analysis of the human transcriptome to identify genes with elevated expression in the human pancreas. This quantitative transcriptomics data was combined with immunohistochemistry-based protein profiling to allow mapping of the corresponding proteins to different compartments and specific cell types within the pancreas down to the single cell level. Analysis of whole pancreas identified 146 genes with elevated expression levels, of which 47 revealed a particular higher expression as compared to the other analyzed tissue types, thus termed pancreas enriched. Extended analysis of in vitro isolated endocrine islets identified an additional set of 42 genes with elevated expression in these specialized cells. Although only 0.7% of all genes showed an elevated expression level in the pancreas, this fraction of transcripts, in most cases encoding secreted proteins, constituted 68% of the total mRNA in pancreas. This demonstrates the extreme specialization of the pancreas for production of secreted proteins. Among the elevated expression profiles, several previously not described proteins were identified, both in endocrine cells (CFC1, FAM159B, RBPJL and RGS9) and exocrine glandular cells (AQP12A, DPEP1, GATM and ERP27). In summary, we provide a global analysis of the pancreas transcriptome and proteome with a comprehensive list of genes and proteins with elevated expression in pancreas. This list represents an important starting point for further studies of the molecular repertoire of pancreatic cells and their relation to disease states or treatment effects.	[Danielsson, Angelika; Ponten, Fredrik; Korsgren, Olle; Lindskog, Cecilia] Uppsala Univ, Sci Life Lab, Dept Immunol Genet & Pathol, Uppsala, Sweden; [Fagerberg, Linn; Hallstrom, Bjorn M.; Schwenk, Jochen M.; Uhlen, Mathias] KTH Royal Inst Technol, Sci Life Lab, Stockholm, Sweden	Uppsala University; Royal Institute of Technology	Ponten, F (corresponding author), Uppsala Univ, Sci Life Lab, Dept Immunol Genet & Pathol, Uppsala, Sweden.	Fredrik.Ponten@igp.uu.se	Lindskog, Cecilia/AAO-2441-2021; Schwenk, Jochen M/F-1730-2010; Uhlen, Mathias/AAV-8746-2021; Lindskog, Cecilia/AAE-5462-2019; Schwenk, Jochen/AAS-4164-2021; Uhlen, Mathias/B-3262-2016	Schwenk, Jochen M/0000-0001-8141-8449; Schwenk, Jochen/0000-0001-8141-8449; Uhlen, Mathias/0000-0002-4858-8056; Fagerberg, Linn/0000-0003-0198-7137; Lindskog, Cecilia/0000-0001-5611-1015; Korsgren, Olle/0000-0002-8524-9547	Knut and Alice Wallenberg Foundation; Swedish Medical Research Council (VR) [K2011-65X-12219-15-6]; Nordic Insulin Fund; Ernfors Family Fund; Swedish Diabetes Association; Diabetes Wellness Foundation; Juvenile Diabetes Foundation International; National Institutes of Health [2U01AI065192-06]; Swedish national strategic research initiative EXODIAB (Excellence Of Diabetes Research in Sweden); Juvenile Diabetes Research Foundation; Novo Nordisk Fonden [NNF14OC0010935] Funding Source: researchfish; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI065192] Funding Source: NIH RePORTER	Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Swedish Medical Research Council (VR)(Swedish Medical Research Council (SMRC)Swedish Research Council); Nordic Insulin Fund; Ernfors Family Fund; Swedish Diabetes Association; Diabetes Wellness Foundation; Juvenile Diabetes Foundation International; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Swedish national strategic research initiative EXODIAB (Excellence Of Diabetes Research in Sweden); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); Novo Nordisk Fonden(Novo Nordisk Foundation); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funding was provided by the Knut and Alice Wallenberg Foundation, the Swedish Medical Research Council (VR K2011-65X-12219-15-6), the Nordic Insulin Fund, the Ernfors Family Fund, the Swedish Diabetes Association, the Diabetes Wellness Foundation and the Juvenile Diabetes Foundation International. OK's position is in part supported by National Institutes of Health 2U01AI065192-06. Human pancreatic islets were obtained from The Nordic network for Clinical islet Transplantation, supported by the Swedish national strategic research initiative EXODIAB (Excellence Of Diabetes Research in Sweden) and the Juvenile Diabetes Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, WIND AD TRIMM TOOL F; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Asplund A, 2012, PROTEOMICS, V12, P2067, DOI 10.1002/pmic.201100504; Bao LM, 1998, ARCH BIOCHEM BIOPHYS, V350, P95, DOI 10.1006/abbi.1997.0486; Barrett JC, 2009, NAT GENET, V41, P703, DOI 10.1038/ng.381; Chen XQ, 2010, J PROTEOME RES, V9, P885, DOI 10.1021/pr900784c; Choi JH, 2011, MOL BIOSYST, V7, P3104, DOI 10.1039/c1mb05326d; Dorrell C, 2011, DIABETOLOGIA, V54, P2832, DOI 10.1007/s00125-011-2283-5; Eden E, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-48; Eizirik DL, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002552; Fagerberg L, 2014, MOL CELL PROTEOMICS, V13, P397, DOI 10.1074/mcp.M113.035600; Friberg AS, 2008, CELL TRANSPLANT, V17, P1305, DOI 10.3727/096368908787648100; Goto M, 2004, TRANSPLANTATION, V78, P1367, DOI 10.1097/01.TP.0000140882.53773.DC; Hebenstreit D, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.28; Kampf C, 2012, JOVE-J VIS EXP, DOI 10.3791/3620; Kircher M, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gkr771; Lee JH, 2011, ONCOL REP, V25, P971, DOI 10.3892/or.2011.1132; Lindskog C, 2012, J PROTEOMICS, V75, P2611, DOI 10.1016/j.jprot.2012.03.008; Lindskog C, 2010, DISCOV MED, V9, P565; Martemyanov KA, 2009, PROG MOL BIOL TRANSL, V86, P205, DOI 10.1016/S1877-1173(09)86007-9; Morris AP, 2012, NAT GENET, V44, P981, DOI 10.1038/ng.2383; Nica AC, 2013, GENOME RES; O'Hurley G, 2014, MOL ONCOL, V8, P783, DOI 10.1016/j.molonc.2014.03.008; O'Reilly Derek A, 2014, World J Gastrointest Pathophysiol, V5, P71, DOI 10.4291/wjgp.v5.i2.71; Patterson CC, 2009, LANCET, V373, P2027, DOI 10.1016/S0140-6736(09)60568-7; Schneider S, 2008, DIABETES OBES METAB, V10, P109, DOI 10.1111/j.1463-1326.2008.00944.x; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Uhlen M, 2010, NAT BIOTECHNOL, V28, P1248, DOI 10.1038/nbt1210-1248; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Whitcomb DC, 1996, NAT GENET, V14, P141, DOI 10.1038/ng1096-141; Witt H, 2000, NAT GENET, V25, P213, DOI 10.1038/76088; YEO EJ, 1994, P NATL ACAD SCI USA, V91, P210, DOI 10.1073/pnas.91.1.210	34	26	26	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2014	9	12							e115421	10.1371/journal.pone.0115421	http://dx.doi.org/10.1371/journal.pone.0115421			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UN	25546435	Green Published, Green Submitted, gold			2022-12-27	WOS:000347120200041
J	Xie, CQ; Li, XL; Shao, YN; He, Y				Xie, Chuanqi; Li, Xiaoli; Shao, Yongni; He, Yong			Color Measurement of Tea Leaves at Different Drying Periods Using Hyperspectral Imaging Technique	PLOS ONE			English	Article							SUCCESSIVE PROJECTIONS ALGORITHM; VARIABLE ELIMINATION; TS-HSI; PREDICTION; DISCRIMINATION; SELECTION; QUALITY; ATTRIBUTES; REGRESSION; MOISTURE	This study investigated the feasibility of using hyperspectral imaging technique for nondestructive measurement of color components (Delta L*, Delta a* and Delta b*) and classify tea leaves during different drying periods. Hyperspectral images of tea leaves at five drying periods were acquired in the spectral region of 380-1030 nm. The three color features were measured by the colorimeter. Different preprocessing algorithms were applied to select the best one in accordance with the prediction results of partial least squares regression (PLSR) models. Competitive adaptive reweighted sampling (CARS) and successive projections algorithm (SPA) were used to identify the effective wavelengths, respectively. Different models (least squares-support vector machine [LS-SVM], PLSR, principal components regression [PCR] and multiple linear regression [MLR]) were established to predict the three color components, respectively. SPA-LS-SVM model performed excellently with the correlation coefficient (r(p)) of 0.929 for Delta L*, 0.849 for Delta a* and 0.917 for Delta b*, respectively. LS-SVM model was built for the classification of different tea leaves. The correct classification rates (CCRs) ranged from 89.29% to 100% in the calibration set and from 71.43% to 100% in the prediction set, respectively. The total classification results were 96.43% in the calibration set and 85.71% in the prediction set. The result showed that hyperspectral imaging technique could be used as an objective and nondestructive method to determine color features and classify tea leaves at different drying periods.	[Xie, Chuanqi; Li, Xiaoli; Shao, Yongni; He, Yong] Zhejiang Univ, Coll Biosyst Engn & Food Sci, Hangzhou 310003, Zhejiang, Peoples R China; [Xie, Chuanqi] Univ Florida, Dept Agr & Biol Engn, Gainesville, FL USA; [He, Yong] Minist Agr, Key Lab Equipment & Informatizat Environm Control, Hangzhou, Peoples R China	Zhejiang University; State University System of Florida; University of Florida; Ministry of Agriculture & Rural Affairs	Shao, YN (corresponding author), Zhejiang Univ, Coll Biosyst Engn & Food Sci, Hangzhou 310003, Zhejiang, Peoples R China.	ynshao@zju.edu.cn; yhe@zju.edu.cn	Li, Xiaoli/GYQ-7384-2022	Li, Xiaoli/0000-0001-9689-9054; He, Y./0000-0001-6752-1757	863 National High-Tech Research and Development Plan [2013AA102301, 2011AA100705]; Zhejiang Province Department of education research project [Y201327409]; Fundamental Research Funds for the Central Universities of China [2012FZA6005, 2013QNA6011]; National Natural Science Foundation of China [61201073]	863 National High-Tech Research and Development Plan(National High Technology Research and Development Program of China); Zhejiang Province Department of education research project; Fundamental Research Funds for the Central Universities of China(Fundamental Research Funds for the Central Universities); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by 863 National High-Tech Research and Development Plan (2013AA102301, 2011AA100705), Zhejiang Province Department of education research project (Y201327409), the Fundamental Research Funds for the Central Universities of China (2012FZA6005, 2013QNA6011) and National Natural Science Foundation of China (61201073).	Araujo MCU, 2001, CHEMOMETR INTELL LAB, V57, P65, DOI 10.1016/S0169-7439(01)00119-8; Barbin DF, 2012, ANAL CHIM ACTA, V719, P30, DOI 10.1016/j.aca.2012.01.004; Bieroza M, 2012, ADV ENG SOFTW, V44, P126, DOI 10.1016/j.advengsoft.2011.05.031; Cen HY, 2007, J FOOD ENG, V82, P253, DOI 10.1016/j.jfoodeng.2007.02.039; Chen XJ, 2011, FOOD BIOPROCESS TECH, V4, P753, DOI 10.1007/s11947-009-0199-6; Deng SG, 2013, J FOOD ENG, V119, P159, DOI 10.1016/j.jfoodeng.2013.05.024; ElMasry G, 2012, J FOOD ENG, V110, P127, DOI 10.1016/j.jfoodeng.2011.11.028; Galvao RKH, 2008, CHEMOMETR INTELL LAB, V92, P83, DOI 10.1016/j.chemolab.2007.12.004; He Y, 2007, COMPUT ELECTRON AGR, V58, P144, DOI 10.1016/j.compag.2007.03.011; Huang M, 2014, J FOOD ENG, V128, P24, DOI 10.1016/j.jfoodeng.2013.12.008; Iqbal A, 2013, J FOOD ENG, V117, P42, DOI 10.1016/j.jfoodeng.2013.02.001; Jiang LL, 2012, SENSORS-BASEL, V12, P3498, DOI 10.3390/s120303498; Kamruzzaman M, 2012, ANAL CHIM ACTA, V714, P57, DOI 10.1016/j.aca.2011.11.037; Kamruzzaman M, 2011, J FOOD ENG, V104, P332, DOI 10.1016/j.jfoodeng.2010.12.024; Karimi Y, 2012, FOOD BIOPROCESS TECH, V5, P252, DOI 10.1007/s11947-009-0292-x; Kong WW, 2012, SENSORS-BASEL, V12, P10871, DOI 10.3390/s120810871; Li HD, 2009, ANAL CHIM ACTA, V648, P77, DOI 10.1016/j.aca.2009.06.046; Naes T, 2001, J CHEMOMETR, V15, P413, DOI 10.1002/cem.676; Setiawan VW, 2001, INT J CANCER, V92, P600, DOI 10.1002/ijc.1231; Shao XG, 2006, TALANTA, V69, P676, DOI 10.1016/j.talanta.2005.10.039; Shao YN, 2007, J FOOD ENG, V81, P672, DOI 10.1016/j.jfoodeng.2006.12.026; Suykens JAK, 1999, NEURAL PROCESS LETT, V9, P293, DOI 10.1023/A:1018628609742; Wang W, 2011, SENSOR LETT, V9, P1024, DOI 10.1166/sl.2011.1359; Wei X, 2014, FOOD BIOPROCESS TECH, V7, P1371, DOI 10.1007/s11947-013-1164-y; Wei X, 2014, FOOD BIOPROCESS TECH, V7, P184, DOI 10.1007/s11947-013-1053-4; Wu D, 2013, TALANTA, V116, P266, DOI 10.1016/j.talanta.2013.05.030; Wu D, 2013, FOOD BIOPROCESS TECH, V6, P2943, DOI 10.1007/s11947-012-0928-0; Wu D, 2013, TALANTA, V111, P39, DOI 10.1016/j.talanta.2013.03.041; Wu D, 2012, INNOV FOOD SCI EMERG, V16, P361, DOI 10.1016/j.ifset.2012.08.003; Wu D, 2011, ANAL METHODS-UK, V3, P1790, DOI 10.1039/c1ay05075c; Wu JH, 2012, J FOOD ENG, V109, P267, DOI 10.1016/j.jfoodeng.2011.10.004; Xie CQ, 2013, T ASABE, V56, P1431; Zhang XL, 2012, SENSORS-BASEL, V12, P17234, DOI 10.3390/s121217234; Zhu FL, 2011, FOOD BIOPROCESS TECH, V4, P597, DOI 10.1007/s11947-010-0369-6; Zou XB, 2011, ANAL CHIM ACTA, V706, P105, DOI 10.1016/j.aca.2011.08.026	35	21	22	4	85	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2014	9	12							e113422	10.1371/journal.pone.0113422	http://dx.doi.org/10.1371/journal.pone.0113422			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UN	25546335	Green Published, Green Submitted, gold			2022-12-27	WOS:000347120200005
J	Chen, YT; Tang, HJ; Chao, CM; Lai, CC				Chen, Yen-Ting; Tang, Hung-Jen; Chao, Chien-Ming; Lai, Chih-Cheng			Clinical Manifestations of Non-01 Vibrio cholerae Infections	PLOS ONE			English	Article							UNITED-STATES; SEPTICEMIA; CHOLECYSTITIS; PATIENT; ABSCESS	Background Infections caused by non-01 Vibrio cholera are uncommon. The aim of our study was to investigate the clinical and microbiological characteristics of patients with non-01 V. cholera infections. Methods The clinical charts of all patients with non-01 V. cholera infections and who were treated in two hospitals in Taiwan were retrospectively reviewed. Results From July 2009 to June 2014, a total of 83 patients with non-01 V. cholera infections were identified based on the databank of the bacteriology laboratories of two hospitals. The overall mean age was 53.3 years, and men comprised 53 (63.9%) of the patients. Liver cirrhosis and diabetes mellitus were the two most common underlying diseases, followed by malignancy. The most common type of infection was acute gastroenteritis (n = 45, 54.2%), followed by biliary tract infection (n = 12, 14.5%) and primary bacteremia (n = 11, 13.3%). Other types of infection, such as peritonitis (n = 5, 6.0%), skin and soft tissue infection (SSTI) (n = 5, 6.0%), urinary tract infection (n = 3, 3.6%) and pneumonia (2, 2.4%), were rare. July and June were the most common months of occurrence of V. cholera infections. The overall in-hospital mortality of 83 patients with V. cholera infections was 7.2%, but it was significantly higher for patients with primary bacteremia, hemorrhage bullae, acute kidney injury, acute respiratory failure, or admission to an ICU. Furthermore, multivariate analysis showed that in-hospital mortality was significantly associated with acute respiratory failure (odds ratio, 60.47; 95% CI, 4.79-763.90, P = 0.002). Conclusions Non-01 V. cholera infections can cause protean disease, especially in patients with risk factors and during warm-weather months. The overall mortality of 83 patients with non-01 V. cholera infections was only 7.2%; however, this value varied among different types of infection.	[Chen, Yen-Ting] Chi Mei Med Ctr, Dept Emergency Med, Tainan, Taiwan; [Tang, Hung-Jen] Chi Mei Med Ctr, Dept Med, Tainan, Taiwan; [Tang, Hung-Jen] Chia Nan Univ Pharm & Sci, Dept Hlth & Nutr, Tainan, Taiwan; [Lai, Chih-Cheng] Chi Mei Med Ctr, Dept Intens Care Med, Tainan, Taiwan	Chi Mei Hospital; Chi Mei Hospital; Chia Nan University of Pharmacy & Science; Chi Mei Hospital	Lai, CC (corresponding author), Chi Mei Med Ctr, Dept Intens Care Med, Tainan, Taiwan.	dtmed141@gmail.com		Chen, Yen Ting/0000-0001-8251-263X				Aguinaga A, 2009, ANN CLIN MICROB ANTI, V8, DOI 10.1186/1476-0711-8-17; BLAKE PA, 1979, NEW ENGL J MED, V300, P1, DOI 10.1056/NEJM197901043000101; Cavuoti D, 2002, DIAGN MICR INFEC DIS, V43, P311, DOI 10.1016/S0732-8893(02)00412-1; Daniels NA, 2000, J INFECT DIS, V181, P1661, DOI 10.1086/315459; Dechet AM, 2008, CLIN INFECT DIS, V46, P970, DOI 10.1086/529148; JANDA J M, 1988, Clinical Microbiology Reviews, V1, P245; Kerketta Joshi Anand, 2002, Indian Journal of Pediatrics, V69, P909, DOI 10.1007/BF02723720; Ko WC, 1998, CLIN INFECT DIS, V27, P774, DOI 10.1086/514947; Lai CC, 2012, DIAGN MICR INFEC DIS, V73, P84, DOI 10.1016/j.diagmicrobio.2012.01.011; Lai CC, 2011, J INFECTION, V62, P235, DOI 10.1016/j.jinf.2011.01.011; Lin CJ, 1996, AM J GASTROENTEROL, V91, P336; Liou CW, 2001, EUR J CLIN MICROBIOL, V20, P678, DOI 10.1007/s100960100569; Nishikawa M, 1989, Nihon Geka Hokan, V58, P155; PETSARIS O, 2010, J MED MICROBIOL; Sangare L, 2006, Med Trop (Mars), V66, P513; Shannon JD, 2006, J CLIN MICROBIOL, V44, P3459, DOI 10.1128/JCM.02343-05; TACKET CO, 1984, J INFECT DIS, V149, P558, DOI 10.1093/infdis/149.4.558; Vogt AP, 2010, J CLIN MICROBIOL, V48, P1002, DOI 10.1128/JCM.02198-09; West BC, 1998, DIAGN MICR INFEC DIS, V30, P187, DOI 10.1016/S0732-8893(97)00235-6; Wiwatworapan Weerapan, 2008, Southeast Asian Journal of Tropical Medicine and Public Health, V39, P1098; Yang CC, 2008, JPN J INFECT DIS, V61, P475	21	25	27	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2015	10	1							e0116904	10.1371/journal.pone.0116904	http://dx.doi.org/10.1371/journal.pone.0116904			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ4OZ	25602257	Green Published, gold, Green Submitted			2022-12-27	WOS:000348203500035
J	Greaves, NS; Morris, J; Benatar, B; Alonso-Rasgado, T; Baguneid, M; Bayat, A				Greaves, Nicholas S.; Morris, Julie; Benatar, Brian; Alonso-Rasgado, Teresa; Baguneid, Mohamed; Bayat, Ardeshir			Acute Cutaneous Wounds Treated with Human Decellularised Dermis Show Enhanced Angiogenesis during Healing	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; EXTRACELLULAR-MATRIX; PROMOTES ANGIOGENESIS; GENE-EXPRESSION; LUMEN FORMATION; MECHANISMS; ULCERS; CELLS; MORPHOGENESIS; RECEPTORS	Background The influence of skin substitutes upon angiogenesis during wound healing is unclear. Objectives To compare the angiogenic response in acute cutaneous human wounds treated with autogenic, allogenic and xenogenic skin substitutes to those left to heal by secondary intention. Methods On day 0, four 5mm full-thickness punch biopsies were harvested from fifty healthy volunteers (sites 1-4). In all cases, site 1 healed by secondary intention (control), site 2 was treated with collagen-GAG scaffold (CG), cadaveric decellularised dermis (DCD) was applied to site 3, whilst excised tissue was re-inserted into site 4 (autograft). Depending on study group allocation, healing tissue from sites 1-4 was excised on day 7, 14, 21 or 28. All specimens were bisected, with half used in histological and immunohistochemical evaluation whilst extracted RNA from the remainder enabled whole genome microarrays and qRT-PCR of highlighted angiogenesis-related genes. All wounds were serially imaged over 6 weeks using laser-doppler imaging and spectrophotometric intracutaneous analysis. Results Inherent structural differences between skin substitutes influenced the distribution and organisation of capillary networks within regenerating dermis. Haemoglobin flux (p = 0.0035), oxyhaemoglobin concentration (p = 0.0005), and vessel number derived from CD31-based immunohistochemistry (p = 0.046) were significantly greater in DCD wounds at later time points. This correlated with time-matched increases in mRNA expression of membrane-type 6 matrix metalloproteinase (MT6-MMP) (p = 0.021) and prokineticin 2 (PROK2) (p = 0.004). Conclusion Corroborating evidence from invasive and non-invasive modalities demonstrated that treatment with DCD resulted in increased angiogenesis after wounding. Significantly elevated mRNA expression of pro-angiogenic PROK2 and extracellular matrix protease MT6-MMP seen only in the DCD group may contribute to observed responses.	[Greaves, Nicholas S.; Bayat, Ardeshir] Univ Manchester, MIB, Manchester, Lancs, England; [Greaves, Nicholas S.; Morris, Julie; Baguneid, Mohamed] Wythenshawe Hosp, Univ Hosp, South Manchester NHS Fdn Trust, Manchester M23 9LT, Lancs, England; [Benatar, Brian] Royal Oldham Hosp, Pennine Acute Hosp NHS Trust, Dept Histopathol, Oldham, Lancs, England; [Alonso-Rasgado, Teresa] Univ Manchester, Sch Mat, Manchester, Lancs, England; [Bayat, Ardeshir] Univ Manchester, Manchester Acad Hlth Sci Ctr, Fac Med & Human Sci, Ctr Dermatol,Inst Inflammat & Repair, Manchester, Lancs, England	University of Manchester; Wythenshawe Hospital NHS Foundation Trust; Wythenshawe Hospital; University of Manchester; University of Manchester	Greaves, NS (corresponding author), Univ Manchester, MIB, Manchester, Lancs, England.	nickgreaves@doctors.org.uk; ardeshir.bayat@manchester.ac.uk		Baguneid, Mohamed/0000-0002-3819-4993; BAYAT, ARDESHIR/0000-0002-4116-6491	Tissue Regenix Group plc (York, UK)	Tissue Regenix Group plc (York, UK)	This study was in part funded by the Tissue Regenix Group plc (York, UK) to AB. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The remainder of the funds for this study were sourced from existing internal budgets.	ARNOLD F, 1991, PHARMACOL THERAPEUT, V52, P407, DOI 10.1016/0163-7258(91)90034-J; Brigido Stephen A, 2006, Int Wound J, V3, P181, DOI 10.1111/j.1742-481X.2006.00209.x; Carmeliet P, 2000, NAT MED, V6, P389, DOI 10.1038/74651; Davis GE, 2005, CIRC RES, V97, P1093, DOI 10.1161/01.RES.0000191547.64391.e3; Davis GE, 2003, MICROCIRCULATION, V10, P27, DOI 10.1038/sj.mn.7800175; Davis George E., 2007, Birth Defects Research, V81, P270, DOI 10.1002/bdrc.20107; Dengler VL, 2013, CRITICAL REV BIOCH M, P1; Di Peppe SR, 2002, GENE THER, V9, P1271, DOI 10.1038/sj.gt.3301798; Drinkwater SL, 2003, J VASC SURG, V38, P1106, DOI 10.1016/S0741-5214(03)01053-X; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Galiano RD, 2004, AM J PATHOL, V164, P1935, DOI 10.1016/S0002-9440(10)63754-6; Greaves NS, 2013, WOUND REPAIR REGEN, V21, P813, DOI 10.1111/wrr.12113; Greer SN, 2012, EMBO J, V31, P2448, DOI 10.1038/emboj.2012.125; Guilini C, 2010, AM J PHYSIOL-HEART C, V298, pH844, DOI 10.1152/ajpheart.00898.2009; Hogg P, 2012, CELL TISSUE BANK, P1; Hotary K, 2000, J CELL BIOL, V149, P1309, DOI 10.1083/jcb.149.6.1309; Jones JE, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001737.pub4; Kisliouk T, 2005, ENDOCRINOLOGY, V146, P3950, DOI 10.1210/en.2005-0297; Ko J, 2005, J SURG RES, V129, P251, DOI 10.1016/j.jss.2005.05.006; La Ferla K, 2002, FASEB J, V16, P1811, DOI 10.1096/fj.02-0168fje; Laschke MW, 2006, TISSUE ENG, V12, P2093, DOI 10.1089/ten.2006.12.2093; LeCouter J, 2003, P NATL ACAD SCI USA, V100, P2685, DOI 10.1073/pnas.0337667100; Liechty KW, 1998, J SURG RES, V77, P80, DOI 10.1006/jsre.1998.5345; Lindenblatt N, 2008, PLAST RECONSTR SURG, V122, P1669, DOI 10.1097/PRS.0b013e31818cbeb1; Liu W, 2004, CURR GENE THER, V4, P123, DOI 10.2174/1566523044578004; Mace KA, 2007, WOUND REPAIR REGEN, V15, P636, DOI 10.1111/j.1524-475X.2007.00278.x; Macri L, 2009, SKIN PHARMACOL PHYS, V22, P83, DOI 10.1159/000178867; Makino Y, 2007, J BIOL CHEM, V282, P14073, DOI 10.1074/jbc.M700732200; Mostow EN, 2005, J VASC SURG, V41, P837, DOI 10.1016/j.jvs.2005.01.042; O'Ceallaigh S, 2006, PLAST RECONSTR SURG, V117, P140, DOI 10.1097/01.prs.0000185611.87601.b8; Rehfeldt F, 2007, ADV DRUG DELIVER REV, V59, P1329, DOI 10.1016/j.addr.2007.08.007; Reiffel AJ, 2011, PLASTIC RECONSTRUCTI, V128, P37, DOI [10.1097/01.prs.0000406253.95834.01, DOI 10.1097/01.PRS.0000406253.95834.01]; Reyzelman A, 2009, INT WOUND J, V6, P196, DOI 10.1111/j.1742-481X.2009.00585.x; Risau W, 1997, NATURE, V386, P671, DOI 10.1038/386671a0; Sabeh F, 2004, J CELL BIOL, V167, P769, DOI 10.1083/jcb.200408028; Shaterian A, 2009, BURNS, V35, P811, DOI 10.1016/j.burns.2008.12.012; Shih B, 2012, WOUND REPAIR REGEN, V20, P757, DOI 10.1111/j.1524-475X.2012.00832.x; Soga T, 2002, BBA-GENE STRUCT EXPR, V1579, P173, DOI 10.1016/S0167-4781(02)00546-8; Sottile J, 2004, BBA-REV CANCER, V1654, P13, DOI 10.1016/j.bbcan.2003.07.002; Supp DM, 2002, FASEB J, V16, DOI 10.1096/fj.01-0868com; Syeda MM, 2012, AM J PATHOL, V181, P334, DOI 10.1016/j.ajpath.2012.03.012; Tanaka T, 2009, BIOCHEM J, V424, P143, DOI 10.1042/BJ20090120; Tonnesen MG, 2000, J INVESTIGATIVE DERM; Truong ATN, 2005, J BURNS WOUNDS, V4; VERNON RB, 1995, AM J PATHOL, V147, P873; Winters Christopher L, 2008, Adv Skin Wound Care, V21, P375, DOI 10.1097/01.ASW.0000323532.98003.26	46	40	42	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2015	10	1							e0113209	10.1371/journal.pone.0113209	http://dx.doi.org/10.1371/journal.pone.0113209			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ4OZ	25602294	Green Published, gold, Green Submitted			2022-12-27	WOS:000348203500001
J	Pan, SH; Chen, WJ; Liu, X; Xiao, JJ; Wang, YQ; Liu, J; Du, Y; Wang, YS; Zhang, Y				Pan, Shaohui; Chen, Wuju; Liu, Xu; Xiao, Jiajia; Wang, Yanqin; Liu, Jun; Du, Yue; Wang, Yongsheng; Zhang, Yong			Application of a Novel Population of Multipotent Stem Cells Derived from Skin Fibroblasts as Donor Cells in Bovine SCNT	PLOS ONE			English	Article							BONE-MARROW; NUCLEAR TRANSFER; IN-VITRO; CLONING EFFICIENCY; CORD BLOOD; PLURIPOTENT; EMBRYOS; GENERATION; DIFFERENTIATION; SUBPOPULATION	Undifferentiated stem cells are better donor cells for somatic cell nuclear transfer (SCNT), resulting in more offspring than more differentiated cells. While various stem cell populations have been confirmed to exist in the skin, progress has been restricted due to the lack of a suitable marker for their prospective isolation. To address this fundamental issue, a marker is required that could unambiguously prove the differentiation state of the donor cells. We therefore utilized magnetic activated cell sorting (MACS) to separate a homogeneous population of small SSEA-4(+) cells from a heterogeneous population of bovine embryonic skin fibroblasts (BEF). SSEA-4(+) cells were 8-10 mu m in diameter and positive for alkaline phosphatase (AP). The percentage of SSEA-4(+) cells within the cultured BEF population was low (2-3%). Immunocytochemistry and PCR analyses revealed that SSEA-4(+) cells expressed pluripotency-related markers, and could differentiate into cells comprising all three germ layers in vitro. They remained undifferentiated over 20 passages in suspension culture. In addition, cloned embryos derived from SSEA-4 cells showed significant differences in cleavage rate and blastocyst development when compared with those from BEF and SSEA-4(-) cells. Moreover, blastocysts derived from SSEA-4(+) cells showed a higher total cell number and lower apoptotic index as compared to BEF and SSEA-4(-) derived cells. It is well known that nuclei from pluripotent stem cells yield a higher cloning efficiency than those from adult somatic cells, however, pluripotent stem cells are relatively difficult to obtain from bovine. The SSEA-4(+) cells described in the current study provide an attractive candidate for SCNT and a promising platform for the generation of transgenic cattle.	[Pan, Shaohui; Chen, Wuju; Liu, Xu; Xiao, Jiajia; Wang, Yanqin; Liu, Jun; Du, Yue; Wang, Yongsheng; Zhang, Yong] Northwest A&F Univ, Coll Vet Med, Yangling, Shaanxi, Peoples R China; [Pan, Shaohui; Chen, Wuju; Liu, Xu; Xiao, Jiajia; Wang, Yanqin; Liu, Jun; Du, Yue; Wang, Yongsheng; Zhang, Yong] Northwest A&F Univ, Key Lab Anim Biotechnol, Minist Agr, Yangling, Shaanxi, Peoples R China	Northwest A&F University - China; Ministry of Agriculture & Rural Affairs; Northwest A&F University - China	Zhang, Y (corresponding author), Northwest A&F Univ, Coll Vet Med, Yangling, Shaanxi, Peoples R China.	wangyongsheng01@nwsuaf.edu.cn; zhy1956@263.net			Northwest A&F University PhD Research Start-up Funds [Z1110213030]; National Major Project for Production of Transgenic Breeding [2013ZX08007-004]; National High Technology Research and Development Program of China (863 Program) [2011AA100303]	Northwest A&F University PhD Research Start-up Funds; National Major Project for Production of Transgenic Breeding; National High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China)	This work was supported by the Northwest A&F University PhD Research Start-up Funds (No. Z1110213030), the National Major Project for Production of Transgenic Breeding (No. 2013ZX08007-004) and the National High Technology Research and Development Program of China (863 Program) (No. 2011AA100303).	Afrikanova I, 2012, BIORESEARCH OPEN ACC, V1, P184, DOI 10.1089/biores.2012.0235; Barraud P, 2007, J NEUROSCI RES, V85, P250, DOI 10.1002/jnr.21116; Beltrami AR, 2007, BLOOD, V110, P3438, DOI 10.1182/blood-2006-11-055566; Bhartiya D, 2012, STEM CELLS DEV, V21, P2563, DOI 10.1089/scd.2012.0158; Byrne JA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007118; Cao H., 2012, SPACECR RECOVER REMO, V3, P7, DOI DOI 10.1371/J0URNAL.P0NE.0031502; Cao HG, 2011, REPROD FERT DEVELOP, V23, P243, DOI 10.1071/RDv23n1Ab290; CHINNICI CM, 2013, CELL TRANSPLANTATION; Clarke DL, 2000, SCIENCE, V288, P1660, DOI 10.1126/science.288.5471.1660; D'Ippolito G, 2004, J CELL SCI, V117, P2971, DOI 10.1242/jcs.01103; Dyce PW, 2006, NAT CELL BIOL, V8, P384, DOI 10.1038/ncb1388; Dyce PW, 2004, BIOCHEM BIOPH RES CO, V316, P651, DOI 10.1016/j.bbrc.2004.02.093; Fahrudin M, 2002, REPRODUCTION, V124, P813, DOI 10.1530/rep.0.1240813; Fuchs E, 2007, NATURE, V445, P834, DOI 10.1038/nature05659; Galli R, 2000, NAT NEUROSCI, V3, P986, DOI 10.1038/79924; Gang EJ, 2007, BLOOD, V109, P1743, DOI 10.1182/blood-2005-11-010504; Han XP, 2011, CELL RES, V21, P1509, DOI 10.1038/cr.2011.125; Hardy K, 1997, MOL HUM REPROD, V3, P919, DOI 10.1093/molehr/3.10.919; He YL, 2009, THERIOGENOLOGY, V71, P1417, DOI 10.1016/j.theriogenology.2009.01.012; Hildebrandt F, 2011, NEW ENGL J MED, V364, P1533, DOI 10.1056/NEJMra1010172; Inoue K, 2007, STEM CELLS, V25, P1279, DOI 10.1634/stemcells.2006-0747; Jaenisch Rudolf, 2002, Cloning and Stem Cells, V4, P389, DOI 10.1089/153623002321025069; Kassmer SH, 2013, STEM CELLS, V31, P2759, DOI 10.1002/stem.1413; Kato Y, 2004, BIOL REPROD, V70, P415, DOI 10.1095/biolreprod.103.020271; Kawanabe N, 2012, EXP CELL RES, V318, P453, DOI 10.1016/j.yexcr.2012.01.008; Kishigami S, 2006, BIOCHEM BIOPH RES CO, V340, P183, DOI 10.1016/j.bbrc.2005.11.164; Kogler G, 2004, J EXP MED, V200, P123, DOI 10.1084/jem.20040440; Kucia M, 2007, DEV DYNAM, V236, P3309, DOI 10.1002/dvdy.21180; Kuroda Y, 2010, P NATL ACAD SCI USA, V107, P8639, DOI 10.1073/pnas.0911647107; Liu J, 2013, CELL REPROGRAM, V15, P159, DOI 10.1089/cell.2012.0073; Oback B, 2007, MOL REPROD DEV, V74, P646, DOI 10.1002/mrd.20654; Oback Bjorn, 2002, Cloning and Stem Cells, V4, P147, DOI 10.1089/153623002320253328; Petersen BE, 1999, SCIENCE, V284, P1168, DOI 10.1126/science.284.5417.1168; Ratajczak MZ, 2008, J AUTOIMMUN, V30, P151, DOI 10.1016/j.jaut.2007.12.003; Rideout WM, 2001, SCIENCE, V293, P1093, DOI 10.1126/science.1063206; Saito S, 2003, BIOCHEM BIOPH RES CO, V309, P104, DOI 10.1016/S0006-291X(03)01536-5; Toma JG, 2001, NAT CELL BIOL, V3, P778, DOI 10.1038/ncb0901-778; Vaculik C, 2012, J INVEST DERMATOL, V132, P563, DOI 10.1038/jid.2011.355; VanSoom A, 1996, MOL REPROD DEV, V45, P171, DOI 10.1002/(SICI)1098-2795(199610)45:2&lt;171::AID-MRD10&gt;3.0.CO;2-4; Virant-Klun I, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/690415; Wakao S, 2011, P NATL ACAD SCI USA, V108, P9875, DOI 10.1073/pnas.1100816108; Wojakowski W, 2008, EUR HEART J, V29, P398; Wojakowski W, 2009, J AM COLL CARDIOL, V53, P1, DOI 10.1016/j.jacc.2008.09.029; Yang ZC, 2013, CELL REPROGRAM, V15, P195, DOI 10.1089/cell.2012.0080; Yu Y, 2007, REPRODUCTION, V133, P947, DOI 10.1530/REP-06-0358; Zuba-Surma EK, 2009, MECH AGEING DEV, V130, P58, DOI 10.1016/j.mad.2008.02.003	46	18	19	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2015	10	1							e0114423	10.1371/journal.pone.0114423	http://dx.doi.org/10.1371/journal.pone.0114423			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ4OZ	25602959	Green Published, Green Submitted, gold			2022-12-27	WOS:000348203500005
J	Shan, XY; Zhou, HJ; Zhang, J; Zhu, BQ; Xu, L; Hu, GC; Bai, AY; Shao, ZJ; Jiang, BF				Shan, Xiaoying; Zhou, Haijian; Zhang, Ji; Zhu, Bingqing; Xu, Li; Hu, Guangchun; Bai, Aiying; Shao, Zhujun; Jiang, Baofa			Application of Multiple-Locus Variable Number Tandem Repeat Analysis to Identify Outbreak-Associated Neisseria meningitidis Serogroup C Sequence Type 4821 in China	PLOS ONE			English	Article							IDENTIFICATION; EPIDEMIOLOGY; CLONE	Neisseria meningitidis (N. meningitidis) serogroup C sequence type (ST)-4821 caused an outbreak in 2010 in Shandong province of China. Twenty-one non-outbreak-associated strains were isolated, along with twenty-eight N. meningitides serogroup C ST-4821 isolates. Therefore, it's essential to identify and clarify characterization of the real outbreak-associated strains with a rapid method during an outbreak investigation. In this study, multiple-locus variable number tandem repeat analysis (MLVA) was applied to analyze 84 N. meningitidis strains, among which 58 were recovered from two outbreaks and 26 were sporadic isolates. Three MLVA schemes with different combination of VNTR loci were tested, and two of them were suitable for isolates from China: scheme 2 with six loci was found to separate ST into finer resolution, and scheme 3 with five loci can be used to identify outbreak-associated isolates from the same outbreak that caused by N. meningitidis serogroup C ST-4821.	[Shan, Xiaoying; Jiang, Baofa] Shandong Univ, Sch Publ Hlth, Dept Epidemiol & Hlth Stat, Jinan, Shandong, Peoples R China; [Shan, Xiaoying; Zhou, Haijian; Zhu, Bingqing; Xu, Li; Shao, Zhujun] Chinese Ctr Dis Control & Prevent, Natl Inst Communicable Dis Control & Prevent, State Key Lab Infect Dis Prevent & Control, Beijing, Peoples R China; [Shan, Xiaoying; Zhang, Ji; Hu, Guangchun; Bai, Aiying] Jinan Municipal Ctr Dis Control & Prevent, Jinan, Shandong, Peoples R China; [Shan, Xiaoying; Zhou, Haijian; Zhu, Bingqing; Xu, Li; Shao, Zhujun] Collaborat Innovat Ctr Diag & Treatment Infect Di, Hangzhou, Zhejiang, Peoples R China	Shandong University; Chinese Center for Disease Control & Prevention; National Institute for Communicable Disease Control & Prevention, Chinese Center for Disease Control & Prevention; Collaborative Innovation Center for Diagnosis & Treatment of Infectious Diseases	Shao, ZJ (corresponding author), Chinese Ctr Dis Control & Prevent, Natl Inst Communicable Dis Control & Prevent, State Key Lab Infect Dis Prevent & Control, Beijing, Peoples R China.	shaozhujun@icdc.cn; bjiang@sdu.edu.cn			National Key Program for Infectious Disease of China [2013ZX10004221]; National Basic Research Program of China (973 Program) [2011CB504904]	National Key Program for Infectious Disease of China; National Basic Research Program of China (973 Program)(National Basic Research Program of China)	This work was supported by The National Key Program for Infectious Disease of China (Contract No. 2013ZX10004221) and the National Basic Research Program of China (973 Program, 2011CB504904) to SZJ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balkhy HH, 2003, INT J ANTIMICROB AG, V21, P107, DOI 10.1016/S0924-8579(02)00356-4; Caugant DA, 2008, INFECT GENET EVOL, V8, P558, DOI 10.1016/j.meegid.2008.04.002; Caugant DA, 2009, VACCINE, V27, pB64, DOI 10.1016/j.vaccine.2009.04.061; Harrison LH, 2009, VACCINE, V27, pB51, DOI 10.1016/j.vaccine.2009.04.063; HUNTER PR, 1988, J CLIN MICROBIOL, V26, P2465, DOI 10.1128/JCM.26.11.2465-2466.1988; Liao JC, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-44; Maiden MCJ, 1998, P NATL ACAD SCI USA, V95, P3140, DOI 10.1073/pnas.95.6.3140; Nicolas P, 2005, J CLIN MICROBIOL, V43, P5129, DOI 10.1128/JCM.43.10.5129-5135.2005; Schouls LM, 2006, J CLIN MICROBIOL, V44, P1509, DOI 10.1128/JCM.44.4.1509-1518.2006; Shao ZJ, 2006, LANCET, V367, P419, DOI 10.1016/S0140-6736(06)68141-5; Stephens DS, 2007, LANCET, V369, P2196, DOI 10.1016/S0140-6736(07)61016-2; Wang YingTong, 2013, Disease Surveillance, V28, P443; Zhang XB, 2007, J MED MICROBIOL, V56, P1224, DOI 10.1099/jmm.0.47263-0; Yazdankhah SP, 2005, J CLIN MICROBIOL, V43, P1699, DOI 10.1128/JCM.43.4.1699-1705.2005; Zhang J, 2013, BIOMED ENVIRON SCI, V26, P331, DOI 10.3967/0895-3988.2013.05.002	15	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2015	10	1							e0116422	10.1371/journal.pone.0116422	http://dx.doi.org/10.1371/journal.pone.0116422			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ4OZ	25603352	Green Published, gold, Green Submitted			2022-12-27	WOS:000348203500025
J	Averna, M; De Tullio, R; Pedrazzi, M; Bavestrello, M; Pellegrini, M; Salamino, F; Pontremoli, S; Melloni, E				Averna, Monica; De Tullio, Roberta; Pedrazzi, Marco; Bavestrello, Margherita; Pellegrini, Matteo; Salamino, Franca; Pontremoli, Sandro; Melloni, Edon			Interaction between Calpain-1 and HSP90: New Insights into the Regulation of Localization and Activity of the Protease	PLOS ONE			English	Article							D-ASPARTATE RECEPTORS; NMDA RECEPTORS; RAT-BRAIN; CALPASTATIN; COMPLEX; EXPRESSION; CLEAVAGE; PROTEOLYSIS; ACTIVATION; PROTEINS	Here we demonstrate that heat shock protein 90 (HSP90) interacts with calpain-1, but not with calpain-2, and forms a discrete complex in which the protease maintains its catalytic activity, although with a lower affinity for Ca2+. Equilibrium gel distribution experiments show that this complex is composed by an equal number of molecules of each protein partner. Moreover, in resting cells, cytosolic calpain-1 is completely associated with HSP90. Since calpain-1, in association with HSP90, retains its proteolytic activity, and the chaperone is displaced by calpastatin also in the absence of Ca2+, the catalytic cleft of the protease is not involved in this association. Thus, calpain-1 can form two distinct complexes depending on the availability of calpastatin in the cytosol. The occurrence of a complex between HSP90 and calpain-1, in which the protease is still activable, can prevent the complete inhibition of the protease even in the presence of high calpastatin levels. We also demonstrate that in basal cell conditions HSP90 and calpain-1, but not calpain-2, are inserted in the multi-protein N-Methyl-D-Aspartate receptor (NMDAR) complex. The amount of calpain-1 at the NMDAR cluster is not modified in conditions of increased [Ca2+] (i), and this resident protease is involved in the processing of NMDAR components. Finally, the amount of calpain-1 associated with NMDAR cluster is independent from Ca2+ -mediated translocation. Our findings show that HSP90 plays an important role in maintaining a given and proper amount of calpain-1 at the functional sites.	[Averna, Monica] Univ Genoa, Dept Expt Med DIMES, Biochem Sect, I-16132 Genoa, Italy; Univ Genoa, CEBR, I-16132 Genoa, Italy	University of Genoa; University of Genoa	Averna, M (corresponding author), Univ Genoa, Dept Expt Med DIMES, Biochem Sect, Viale Benedetto 15,1, I-16132 Genoa, Italy.	monica.averna@unige.it	AVERNA, MONICA/R-5719-2019	AVERNA, MONICA/0000-0002-9463-7533; DE TULLIO, ROBERTA/0000-0001-6925-3207	University of Genoa	University of Genoa	This work was supported by grants from the University of Genoa to MA (PRA Averna 2013). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACKERS GK, 1964, BIOCHEMISTRY-US, V3, P723, DOI 10.1021/bi00893a021; Averna M, 2001, BIOCHEM J, V354, P25, DOI 10.1042/0264-6021:3540025; Averna M, 2008, J BIOL CHEM, V283, P29069, DOI 10.1074/jbc.M803638200; Averna M, 2007, FEBS J, V274, P6116, DOI 10.1111/j.1742-4658.2007.06133.x; Averna M, 2007, J BIOL CHEM, V282, P2656, DOI 10.1074/jbc.M606919200; Averna M, 2011, BBA-MOL CELL RES, V1813, P50, DOI 10.1016/j.bbamcr.2010.11.008; Averna M, 2010, BIOCHEM J, V430, P255, DOI 10.1042/BJ20100344; Averna M, 2009, J NEUROCHEM, V110, P412, DOI 10.1111/j.1471-4159.2009.06149.x; Bellocq A, 1999, J BIOL CHEM, V274, P36891, DOI 10.1074/jbc.274.52.36891; Bi X, 1996, NEUROSCIENCE, V73, P903, DOI 10.1016/0306-4522(96)00157-1; Campbell RL, 2012, BIOCHEM J, V447, P335, DOI 10.1042/BJ20120921; Csermely P, 1998, PHARMACOL THERAPEUT, V79, P129, DOI 10.1016/S0163-7258(98)00013-8; De Tullio R, 2003, BIOCHEM J, V375, P689, DOI 10.1042/BJ20030706; De Tullio R, 1999, BIOCHEM J, V343, P467; De Tullio R, 2009, BBA-GEN SUBJECTS, V1790, P182, DOI 10.1016/j.bbagen.2008.11.002; Edwards MA, 2007, NEUROTOXICOLOGY, V28, P876, DOI 10.1016/j.neuro.2007.04.006; FAHIEN LA, 1974, J BIOL CHEM, V249, P2696; Fan XL, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00160; Garcia M, 2005, BIOCHEM BIOPH RES CO, V338, P1241, DOI 10.1016/j.bbrc.2005.10.081; Goll DE, 2003, PHYSIOL REV, V83, P731, DOI 10.1152/physrev.00029.2002; Grant SGN, 2001, CURR OPIN NEUROBIOL, V11, P363, DOI 10.1016/S0959-4388(00)00220-8; Guttmann RP, 2002, J PHARMACOL EXP THER, V302, P1023, DOI 10.1124/jpet.102.036962; Guttmann RP, 2001, J NEUROCHEM, V78, P1083, DOI 10.1046/j.1471-4159.2001.00493.x; Hanna RA, 2008, NATURE, V456, P409, DOI 10.1038/nature07451; Hood JL, 2006, BIOESSAYS, V28, P850, DOI 10.1002/bies.20440; Husi H, 2000, NAT NEUROSCI, V3, P661, DOI 10.1038/76615; Kambe Y, 2010, J NEUROSCI RES, V88, P2177, DOI 10.1002/jnr.22388; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Liu J, 2008, SCI SIGNAL, V1, DOI [10.1126/stke.114re1, 10.1126/scisignal.123tr3]; Lombardi G, 2001, BRIT J PHARMACOL, V133, P936, DOI 10.1038/sj.bjp.0704134; Ma H, 2001, J BIOL CHEM, V276, P28525, DOI 10.1074/jbc.M100603200; MACGREGOR JS, 1980, P NATL ACAD SCI-BIOL, V77, P3889, DOI 10.1073/pnas.77.7.3889; Makhnevych T, 2012, BBA-MOL CELL RES, V1823, P674, DOI 10.1016/j.bbamcr.2011.09.001; MELLONI E, 1982, BIOCHEM BIOPH RES CO, V106, P731, DOI 10.1016/0006-291X(82)91772-7; Melloni E, 2006, J BIOL CHEM, V281, P24945, DOI 10.1074/jbc.M601449200; Miglio G, 2005, BIOCHEM BIOPH RES CO, V338, P1875, DOI 10.1016/j.bbrc.2005.10.164; Naisbitt S, 1999, NEURON, V23, P569, DOI 10.1016/S0896-6273(00)80809-0; North WG, 1997, MOL CHEM NEUROPATHOL, V30, P77, DOI 10.1007/BF02815151; Ono Y, 2012, BBA-PROTEINS PROTEOM, V1824, P224, DOI 10.1016/j.bbapap.2011.08.005; Pedrazzi M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044518; Raynaud F, 2008, INT J DEV BIOL, V52, P383, DOI 10.1387/ijdb.072448fr; Salamino F, 1997, FEBS LETT, V412, P433, DOI 10.1016/S0014-5793(97)00819-3; Simpkins KL, 2003, J NEUROSCI, V23, P11322; Traynelis SF, 2010, PHARMACOL REV, V62, P405, DOI 10.1124/pr.109.002451; Vazhappilly R, 2002, NEUROSCI LETT, V318, P153, DOI 10.1016/S0304-3940(01)02482-X; von Reyn CR, 2012, J NEUROCHEM, V121, P793, DOI 10.1111/j.1471-4159.2012.07735.x; Vosler PS, 2008, MOL NEUROBIOL, V38, P78, DOI 10.1007/s12035-008-8036-x; Wang YB, 2013, J NEUROSCI, V33, P18880, DOI 10.1523/JNEUROSCI.3293-13.2013; Xu J, 2009, J NEUROSCI, V29, P9330, DOI 10.1523/JNEUROSCI.2212-09.2009; Xu W, 2007, NEURON, V53, P399, DOI 10.1016/j.neuron.2006.12.020; Yorikawa C, 2008, J BIOCHEM, V143, P731, DOI 10.1093/jb/mvn030; Yuen EY, 2007, J PHYSIOL-LONDON, V580, P241, DOI 10.1113/jphysiol.2006.122754	52	12	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2015	10	1							e0116738	10.1371/journal.pone.0116738	http://dx.doi.org/10.1371/journal.pone.0116738			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ4BU	25575026	gold, Green Published, Green Submitted			2022-12-27	WOS:000348168100007
J	Oelschlegel, AM; Geissen, M; Lenk, M; Riebe, R; Angermann, M; Schaetzl, H; Groschup, MH				Oelschlegel, Anja M.; Geissen, Markus; Lenk, Matthias; Riebe, Roland; Angermann, Marlies; Schaetzl, Hermann; Groschup, Martin H.			A Bovine Cell Line That Can Be Infected by Natural Sheep Scrapie Prions	PLOS ONE			English	Article							NEUROBLASTOMA-CELLS; IN-VITRO; TRANSGENIC MICE; MOUSE MODELS; PROTEIN; AGENT; PROPAGATION; STRAINS; REPLICATION; INHIBITION	Cell culture systems represent a crucial part in basic prion research; yet, cell lines that are susceptible to prions, especially to field isolated prions that were not adapted to rodents, are very rare. The purpose of this study was to identify and characterize a cell line that was susceptible to ruminant-derived prions and to establish a stable prion infection within it. Based on species and tissue of origin as well as PrP expression rate, we pre-selected a total of 33 cell lines that were then challenged with natural and with mouse propagated BSE or scrapie inocula. Here, we report the successful infection of a non-transgenic bovine cell line, a sub-line of the bovine kidney cell line MDBK, with natural sheep scrapie prions. This cell line retained the scrapie infection for more than 200 passages. Selective cloning resulted in cell populations with increased accumulation of PrPres, although this treatment was not mandatory for retaining the infection. The infection remained stable, even under suboptimal culture conditions. The resulting infectivity of the cells was confirmed by mouse bioassay ( Tgbov mice, Tgshp mice). We believe that PES cells used together with other prion permissive cell lines will prove a valuable tool for ongoing efforts to understand and defeat prions and prion diseases.	[Oelschlegel, Anja M.; Geissen, Markus; Angermann, Marlies; Groschup, Martin H.] Friedrich Loeffler Inst, Inst Novel & Emerging Infect Dis, Greifswald, Germany; [Oelschlegel, Anja M.] Leibniz Inst Neurobiol, Project Grp Neuropharmacol, Magdeburg, Germany; [Geissen, Markus] UKE, Univ Heart Ctr Hamburg, Dept Vasc Med, Hamburg, Germany; [Lenk, Matthias; Riebe, Roland] Friedrich Loeffler Inst, Dept Expt Anim Facil & Biorisk Management, Greifswald, Germany; [Angermann, Marlies] Adm Dist Off Goerlitz, Goerlitz, Germany; [Schaetzl, Hermann] Univ Calgary, Fac Vet Med, Dept Comparat Biol & Expt Med, Calgary, AB, Canada	Friedrich Loeffler Institute; Leibniz Institut fur Neurobiologie (LIN); University of Hamburg; University Medical Center Hamburg-Eppendorf; Friedrich Loeffler Institute; University of Calgary	Groschup, MH (corresponding author), Friedrich Loeffler Inst, Inst Novel & Emerging Infect Dis, Greifswald, Germany.	Martin.Groschup@fli.bund.de						Archer F, 2004, J VIROL, V78, P482, DOI 10.1128/JVI.78.1.482-490.2004; Arellano-Anaya ZE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020563; Baron T, 2002, TRENDS MOL MED, V8, P495, DOI 10.1016/S1471-4914(02)02416-4; Bian JF, 2010, J VIROL, V84, P8322, DOI 10.1128/JVI.00633-10; Bosque PJ, 2000, J VIROL, V74, P4377, DOI 10.1128/JVI.74.9.4377-4386.2000; Buschmann A, 2000, ARCH VIROL, P75; BUTLER DA, 1988, J VIROL, V62, P1558, DOI 10.1128/JVI.62.5.1558-1564.1988; Castilla J, 2005, CELL, V121, P195, DOI 10.1016/j.cell.2005.02.011; CAUGHEY B, 1993, J VIROL, V67, P643, DOI 10.1128/JVI.67.2.643-650.1993; CLARKE MC, 1970, NATURE, V225, P100, DOI 10.1038/225100a0; CLARKE MC, 1976, NATURE, V261, P144, DOI 10.1038/261144a0; CLARKE MC, 1970, RES VET SCI, V11, P500; Collinge J, 2007, SCIENCE, V318, P930, DOI 10.1126/science.1138718; Courageot MP, 2008, J GEN VIROL, V89, P341, DOI 10.1099/vir.0.83344-0; Cronier S, 2004, P NATL ACAD SCI USA, V101, P12271, DOI 10.1073/pnas.0402725101; Dlakic WM, 2007, J VIROL, V81, P4615, DOI 10.1128/JVI.02628-06; EIGEN M, 1971, NATURWISSENSCHAFTEN, V58, P465, DOI 10.1007/BF00623322; Enari M, 2001, P NATL ACAD SCI USA, V98, P9295, DOI 10.1073/pnas.151242598; Ertmer A, 2004, J BIOL CHEM, V279, P41918, DOI 10.1074/jbc.M405652200; Follet J, 2002, J VIROL, V76, P2434, DOI 10.1128/JVI.76.5.2434-2439.2002; Geissen M, 2011, CHEMMEDCHEM, V6, P1928, DOI 10.1002/cmdc.201100119; Gilch S, 2001, EMBO J, V20, P3957, DOI 10.1093/emboj/20.15.3957; Giri RK, 2006, P NATL ACAD SCI USA, V103, P3875, DOI 10.1073/pnas.0510902103; Gretzschel A, 2005, J VET MED B, V52, P55, DOI 10.1111/j.1439-0450.2005.00827.x; Gustafson DP, 1965, SLOW LATENT TEMPERAT, P221; Harmeyer S, 1998, J GEN VIROL, V79, P937, DOI 10.1099/0022-1317-79-4-937; Holscher C, 1998, J VIROL, V72, P1153; Hope J, 2000, J GEN VIROL, V81, P851, DOI 10.1099/0022-1317-81-3-851; Hope J, 1999, J GEN VIROL, V80, P1, DOI 10.1099/0022-1317-80-1-1; Klohn PC, 2003, P NATL ACAD SCI USA, V100, P11666, DOI 10.1073/pnas.1834432100; Kupfer L, 2007, BBA-MOL BASIS DIS, V1772, P704, DOI 10.1016/j.bbadis.2006.10.009; Li JL, 2011, EMBO REP, V12, P1243, DOI 10.1038/embor.2011.191; Li JL, 2010, SCIENCE, V327, P869, DOI 10.1126/science.1183218; Mahal SP, 2007, P NATL ACAD SCI USA, V104, P20908, DOI 10.1073/pnas.0710054104; Mahal SP, 2010, P NATL ACAD SCI USA, V107, P22653, DOI 10.1073/pnas.1013014108; MARKOVITS P, 1983, ACTA NEUROPATHOL, V60, P75, DOI 10.1007/BF00685350; Milhavet O, 2006, STEM CELLS, V24, P2284, DOI 10.1634/stemcells.2006-0088; Neale MH, 2010, J VIROL, V84, P2444, DOI 10.1128/JVI.01855-09; Nishida N, 2000, J VIROL, V74, P320, DOI 10.1128/JVI.74.1.320-325.2000; Oelschlegel AM, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003158; Oelschlegel AM, 2012, J VIROL, V86, P5297, DOI 10.1128/JVI.00181-12; PRUSINER SB, 1991, SCIENCE, V252, P1515, DOI 10.1126/science.1675487; PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762; RACE RE, 1988, J VIROL, V62, P2845, DOI 10.1128/JVI.62.8.2845-2849.1988; RACE RE, 1987, J GEN VIROL, V68, P1391, DOI 10.1099/0022-1317-68-5-1391; Raymond GJ, 2006, J VIROL, V80, P596, DOI 10.1128/JVI.80.2.596-604.2006; RUBENSTEIN R, 1984, J GEN VIROL, V65, P2191, DOI 10.1099/0022-1317-65-12-2191; RUBENSTEIN R, 1991, J GEN VIROL, V72, P1279, DOI 10.1099/0022-1317-72-6-1279; Saa P, 2006, J BIOL CHEM, V281, P35245, DOI 10.1074/jbc.M603964200; Schatzl HM, 1997, J VIROL, V71, P8821; Solassol J, 2003, BRIT MED BULL, V66, P87, DOI 10.1093/bmb/66.1.87; TARABOULOS A, 1990, J CELL BIOL, V110, P2117, DOI 10.1083/jcb.110.6.2117; Telling Glenn C., 2008, V459, P249, DOI 10.1007/978-1-59745-234-2_17; Vilette D, 2001, P NATL ACAD SCI USA, V98, P4055, DOI 10.1073/pnas.061337998; Vorberg I, 2004, J BIOL CHEM, V279, P29218, DOI 10.1074/jbc.M402576200; Vorberg I, 1999, VIROLOGY, V255, P26, DOI 10.1006/viro.1998.9561; Wang F, 2010, SCIENCE, V327, P1132, DOI 10.1126/science.1183748; Weissmann C, 2004, NAT REV MICROBIOL, V2, P861, DOI 10.1038/nrmicro1025; Weissmann C, 2011, EMBO REP, V12, P1109, DOI 10.1038/embor.2011.192	59	12	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2015	10	1							e0117154	10.1371/journal.pone.0117154	http://dx.doi.org/10.1371/journal.pone.0117154			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ4BS	25565633	gold, Green Published, Green Submitted			2022-12-27	WOS:000348167900007
J	Yang, SR; Shang, XY; Tao, J; Liu, JY; Hua, P				Yang, Song-ran; Shang, Xin-yuan; Tao, Jun; Liu, Jian-yang; Hua, Ping			Voxel-Based Analysis of Fractional Anisotropy in Post-Stroke Apathy	PLOS ONE			English	Article							ISCHEMIC-STROKE; BASAL GANGLIA; ALZHEIMERS-DISEASE; DEPRESSION; CIRCUITS; VALIDITY	Objective: To explore the structural basis of post-stroke apathy by using voxel-based analysis (VBA) of fractional anisotropy (FA) maps. Methods: We enrolled 54 consecutive patients with ischemic stroke during convalescence, and divided them into apathy (n=31) and non-apathy (n=23) groups. We obtained magnetic resonance images of their brains, including T1, T2 and DTI sequences. Age, sex, education level, Hamilton Depression Scale (HAMD) scores, Mini-Mental State Examination (MMSE) scores, National Institutes of Health Stroke Scale (NIHSS) scores, and infarct locations for the two groups were compared. Finally, to investigate the structural basis of post-stroke apathy, VBA of FA maps was performed in which we included the variables that a univariate analysis determined had P-values less than 0.20 as covariates. Results: HAMD (P=0.01) and MMSE (P<0.01) scores differed significantly between the apathy and non-apathy groups. After controlling for age, education level, HAMD scores, and MMSE scores, significant FA reduction was detected in four clusters with peak voxels at the genu of the corpus callosum (X=-16, Y=30, Z=8), left anterior corona radiata (222, 30, 10), splenium of the corpus callosum (-24, -56, 18), and right inferior frontal gyrus white matter (52, 24, 18), after familywise error correction for multiple comparisons. Conclusions: Post-stroke apathy is related to depression and cognitive decline. Damage to the genu of the corpus callosum, left anterior corona radiata, splenium of the corpus callosum, and white matter in the right inferior frontal gyrus may lead to apathy after ischemic stroke.	[Yang, Song-ran] Univ Oxford, Dept Expt Psychol, Oxford OX1 3UD, England; [Shang, Xin-yuan] Guangzhou Med Univ, Guangzhou Peoples Hosp 1, Dept Neurol, Guangzhou, Guangdong, Peoples R China; [Tao, Jun; Liu, Jian-yang; Hua, Ping] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Dept Cardiovasc Surg, Guangzhou 510275, Guangdong, Peoples R China	University of Oxford; Guangzhou Medical University; Sun Yat Sen University	Hua, P (corresponding author), Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Dept Cardiovasc Surg, Guangzhou 510275, Guangdong, Peoples R China.	huaping88@sina.com			National Natural Science Foundation of China [81000508]; Fundamental Research Funds for the Central Universities [11ykpy30]; Social Development Science and Technology Program of Guangdong Province [2012B03180025]; Pearl River Science and Technology Star Fund [2012J2200090]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Social Development Science and Technology Program of Guangdong Province; Pearl River Science and Technology Star Fund	This work was supported by the National Natural Science Foundation of China (No. 81000508), the Fundamental Research Funds for the Central Universities (11ykpy30), the Social Development Science and Technology Program of Guangdong Province (2012B03180025), and the Pearl River Science and Technology Star Fund (2012J2200090). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brodaty H, 2013, J NEUROPSYCH CLIN N, V25, P283, DOI 10.1176/appi.neuropsych.12040080; Caeiro L, 2013, CEREBROVASC DIS, V35, P23, DOI 10.1159/000346076; Cui ZX, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00042; Cummings JL, 1995, ANN NY ACAD SCI, V769, P1, DOI 10.1111/j.1749-6632.1995.tb38127.x; Hahn C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053493; Hampshire A, 2010, NEUROIMAGE, V50, P1313, DOI 10.1016/j.neuroimage.2009.12.109; Jorge RE, 2010, CAN J PSYCHIAT, V55, P350, DOI 10.1177/070674371005500603; Kang SY, 2008, NEUROLOGY, V70, P2386, DOI 10.1212/01.wnl.0000314686.94007.d0; Kim J, 2005, AM J NEURORADIOL, V26, P2224; Levy R, 2006, CEREB CORTEX, V16, P916, DOI 10.1093/cercor/bhj043; Levy R, 2006, J NEUROL, V253, P54, DOI 10.1007/s00415-006-7012-5; MARIN RS, 1991, PSYCHIAT RES, V38, P143, DOI 10.1016/0165-1781(91)90040-V; MARIN RS, 1991, J NEUROPSYCH CLIN N, V3, P243; Mendez M.F., 2010, BRAIN BEHAV INTRO BE; Mezzich JE, 2002, PSYCHOPATHOLOGY, V35, P72, DOI 10.1159/000065122; Okada K, 1997, STROKE, V28, P2437, DOI 10.1161/01.STR.28.12.2437; Onoda K, 2011, CEREBROVASC DIS, V31, P6, DOI 10.1159/000319771; Robert PH, 2006, CLIN NEUROL NEUROSUR, V108, P733, DOI 10.1016/j.clineuro.2006.02.003; Rugg-Gunn FJ, 2001, BRAIN, V124, P627, DOI 10.1093/brain/124.3.627; Starkstein SE, 2001, AM J PSYCHIAT, V158, P872, DOI 10.1176/appi.ajp.158.987.872; Stuss DT, 2000, NEUROPSYCHOLOGY EMOT, P340; Tang WK, 2013, CEREBROVASC DIS, V35, P566, DOI 10.1159/000351152; Thomalla G, 2004, NEUROIMAGE, V22, P1767, DOI 10.1016/j.neuroimage.2004.03.041; van Dalen JW, 2013, STROKE, V44, P851, DOI 10.1161/STROKEAHA.112.674614; van Reekum R, 2005, J NEUROPSYCH CLIN N, V17, P7, DOI 10.1176/appi.neuropsych.17.1.7; Withall A, 2011, INT PSYCHOGERIATR, V23, P264, DOI 10.1017/S1041610209991116; Yang S, 2015, EUR J NEUROL, V22, P341, DOI 10.1111/ene.12575; Yang SR, 2013, BMC PSYCHIATRY, V13, DOI 10.1186/1471-244X-13-164; Yao H, 2009, HYPERTENS RES, V32, P586, DOI 10.1038/hr.2009.65	29	71	75	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2015	10	1							e116168	10.1371/journal.pone.0116168	http://dx.doi.org/10.1371/journal.pone.0116168			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ3XP	25555189	gold, Green Published, Green Submitted			2022-12-27	WOS:000348157400002
J	Bolland, MJ; Grey, A				Bolland, Mark J.; Grey, Andrew			A Case Study of Discordant Overlapping Meta-Analyses: Vitamin D Supplements and Fracture	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIAL; D DOSE REQUIREMENTS; CALCIUM SUPPLEMENTATION; HIP FRACTURE; DOUBLE-BLIND; SECONDARY HYPERPARATHYROIDISM; POOLED ANALYSIS; ELDERLY-PEOPLE; OLDER-PEOPLE; D DEFICIENCY	Background: Overlapping meta-analyses on the same topic are now very common, and discordant results often occur. To explore why discordant results arise, we examined a common topic for overlapping meta-analyses-vitamin D supplements and fracture. Methods and Findings: We identified 24 meta-analyses of vitamin D (with or without calcium) and fracture in a PubMed search in October 2013, and analysed a sample of 7 meta-analyses in the highest ranking general medicine journals. We used the AMSTAR tool to assess the quality of the meta-analyses, and compared their methodologies, analytic techniques and results. Applying the AMSTAR tool suggested the meta-analyses were generally of high quality. Despite this, there were important differences in trial selection, data extraction, and analytical methods that were only apparent after detailed assessment. 25 trials were included in at least one meta-analysis. Four meta-analyses included all eligible trials according to the stated inclusion and exclusion criteria, but the other 3 meta-analyses "missed'' between 3 and 8 trials, and 2 meta-analyses included apparently ineligible trials. The relative risks used for individual trials differed between meta-analyses for total fracture in 10 of 15 trials, and for hip fracture in 6 of 12 trials, because of different outcome definitions and analytic approaches. The majority of differences (11/16) led to more favourable estimates of vitamin D efficacy compared to estimates derived from unadjusted intention-to-treat analyses using all randomised participants. The conclusions of the meta-analyses were discordant, ranging from strong statements that vitamin D prevents fractures to equally strong statements that vitamin D without calcium does not prevent fractures. Conclusions: Substantial differences in trial selection, outcome definition and analytic methods between overlapping meta-analyses led to discordant estimates of the efficacy of vitamin D for fracture prevention. Strategies for conducting and reporting overlapping meta-analyses are required, to improve their accuracy and transparency.	[Bolland, Mark J.; Grey, Andrew] Univ Auckland, Dept Med, Auckland 1142, New Zealand	University of Auckland	Bolland, MJ (corresponding author), Univ Auckland, Dept Med, Private Bag 92 019, Auckland 1142, New Zealand.	m.bolland@auckland.ac.nz	Bolland, Mark J/A-7554-2008	Bolland, Mark J/0000-0003-0465-2674	Health Research Council (HRC) of New Zealand; Sir Charles Hercus Health Research Fellowship	Health Research Council (HRC) of New Zealand(Health Research Council of New Zealand); Sir Charles Hercus Health Research Fellowship	This work was funded by the Health Research Council (HRC) of New Zealand (http://www.hrc.govt.nz/). MB is the recipient of a Sir Charles Hercus Health Research Fellowship. The HRC had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahamsen B, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.b5463; Abrahamsen B, 2013, IBMS BONEKEY, V10, DOI 10.1038/bonekey.2012.1256; [Anonymous], 1998, E9 ICH; Avenell Alison, 2004, Clin Trials, V1, P490, DOI 10.1191/1740774504cn053oa; Avenell A, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000227.pub3; Bastian H, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000326; Bischoff HA, 2003, J BONE MINER RES, V18, P343, DOI 10.1359/jbmr.2003.18.2.343; Bischoff-Ferrari HA, 2005, JAMA-J AM MED ASSOC, V293, P2257, DOI 10.1001/jama.293.18.2257; Bischoff-Ferrari HA, 2012, NEW ENGL J MED, V367, P40, DOI 10.1056/NEJMoa1109617; Bischoff-Ferrari HA, 2010, ARCH INTERN MED, V170, P813, DOI 10.1001/archinternmed.2010.67; Bischoff-Ferrari HA, 2009, ARCH INTERN MED, V169, P551, DOI 10.1001/archinternmed.2008.600; Bolland Mark J, 2007, N Z Med J, V120, pU2804; Bolland MJ, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b4394; Bolton-Smith C, 2007, J BONE MINER RES, V22, P509, DOI [10.1359/jbmr.070116, 10.1359/JBMR.070116]; Campbell J, 2007, OSTEOARTHR CARTILAGE, V15, P1424, DOI 10.1016/j.joca.2007.01.022; CHAPUY MC, 1994, BRIT MED J, V308, P1081, DOI 10.1136/bmj.308.6936.1081; Chapuy MC, 2002, OSTEOPOROSIS INT, V13, P257, DOI 10.1007/s001980200023; CHAPUY MC, 1992, NEW ENGL J MED, V327, P1637, DOI 10.1056/NEJM199212033272305; Chung M, 2011, ANN INTERN MED, V155, P827, DOI 10.7326/0003-4819-155-12-201112200-00005; Cook DJ, 1996, JAMA-J AM MED ASSOC, V275, P308, DOI 10.1001/jama.275.4.308; DawsonHughes B, 1997, NEW ENGL J MED, V337, P670, DOI 10.1056/NEJM199709043371003; Flicker L, 2005, J AM GERIATR SOC, V53, P1881, DOI 10.1111/j.1532-5415.2005.00468.x; Grant AM, 2005, LANCET, V365, P1621, DOI 10.1016/S0140-6736(05)63013-9; Harwood RH, 2004, AGE AGEING, V33, P45, DOI 10.1093/ageing/afh002; Hernandez AV, 2008, AM HEART J, V156, P23, DOI 10.1016/j.ahj.2008.03.002; Holick MF, 2012, J CLIN ENDOCR METAB, V97, P1153, DOI 10.1210/jc.2011-2601; Holick Michael F, 2011, J Clin Endocrinol Metab, V96, P1; IOM, 2011, DIET REF INT CALC VI; Jackson RD, 2006, NEW ENGL J MED, V354, P669, DOI 10.1056/NEJMoa055218; Jadad AR, 1997, CAN MED ASSOC J, V156, P1411; Komulainen MH, 1998, MATURITAS, V31, P45, DOI 10.1016/S0378-5122(98)00085-1; Larsen ER, 2004, J BONE MINER RES, V19, P370, DOI 10.1359/JBMR.0301240; Law M, 2006, AGE AGEING, V35, P482, DOI 10.1093/ageing/afj080; Lips P, 1996, ANN INTERN MED, V124, P400, DOI 10.7326/0003-4819-124-4-199602150-00003; Lyons RA, 2007, OSTEOPOROSIS INT, V18, P811, DOI 10.1007/s00198-006-0309-5; Macdonald G, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001930.pub3; Meyer HE, 2002, J BONE MINER RES, V17, P709, DOI 10.1359/jbmr.2002.17.4.709; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1136/bmj.b2535, 10.1016/j.ijsu.2010.02.007]; Paterson CR, 2012, NEW ENGL J MED, V367, P1368, DOI 10.1056/NEJMc1209658; Pfeifer M, 2009, OSTEOPOROSIS INT, V20, P315, DOI 10.1007/s00198-008-0662-7; Pfeifer M, 2000, J BONE MINER RES, V15, P1113, DOI 10.1359/jbmr.2000.15.6.1113; Poolman RW, 2007, J BONE JOINT SURG AM, V89A, P1542, DOI 10.2106/JBJS.F.01292; Porthouse J, 2005, BMJ-BRIT MED J, V330, P1003, DOI 10.1136/bmj.330.7498.1003; Prince RL, 2008, ARCH INTERN MED, V168, P103, DOI 10.1001/archinternmed.2007.31; Rejnmark L, 2012, J CLIN ENDOCR METAB, V97, P2670, DOI 10.1210/jc.2011-3328; Rosen CJ, 2012, J CLIN ENDOCR METAB, V97, P1146, DOI 10.1210/jc.2011-2218; Salovaara K, 2010, J BONE MINER RES, V25, P1487, DOI 10.1002/jbmr.48; Sanders KM, 2010, JAMA-J AM MED ASSOC, V303, P1815, DOI 10.1001/jama.2010.594; Shea BJ, 2007, BMC MED RES METHODOL, V7, DOI 10.1186/1471-2288-7-10; Siontis KC, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f4501; Smith H, 2007, RHEUMATOLOGY, V46, P1852, DOI 10.1093/rheumatology/kem240; Tang BMP, 2007, LANCET, V370, P657, DOI 10.1016/S0140-6736(07)61342-7; Thorlund K, 2013, ANN RHEUM DIS, V72, P1524, DOI 10.1136/annrheumdis-2012-201574; Trivedi DP, 2003, BMJ-BRIT MED J, V326, P469, DOI 10.1136/bmj.326.7387.469	54	41	41	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2014	9	12							e115934	10.1371/journal.pone.0115934	http://dx.doi.org/10.1371/journal.pone.0115934			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UC	25551377	Green Submitted, Green Published, gold			2022-12-27	WOS:000347119100078
J	Kanno, H; Kawakami, Z; Mizoguchi, K; Ikarashi, Y; Kase, Y				Kanno, Hitomi; Kawakami, Zenji; Mizoguchi, Kazushige; Ikarashi, Yasushi; Kase, Yoshio			Yokukansan, a Kampo Medicine, Protects PC12 Cells from Glutamate-Induced Death by Augmenting Gene Expression of Cystine/Glutamate Antiporter System Xc(-)	PLOS ONE			English	Article							TRADITIONAL JAPANESE MEDICINE; THIAMINE-DEFICIENT RATS; PSYCHOLOGICAL SYMPTOMS; CORTICAL-NEURONS; OXIDATIVE STRESS; NERVOUS-SYSTEM; CYSTINE UPTAKE; DEMENTIA; NEUROTOXICITY; X(C)(-)	Effects of the kampo medicine yokukansan on gene expression of the cystine/glutamate antiporter system Xc(-), which protects against glutamate-induced cytotoxicity, were examined in Pheochromocytoma cells (PC12 cells). Yokukansan inhibited glutamate-induced PC12 cell death. Similar cytoprotective effects were found in Uncaria hook. Experiments to clarify the active compounds revealed that geissoschizine methyl ether, hirsuteine, hirsutine, and procyanidin B1 in Uncaria hook, had cytoprotective effects. These components enhanced gene expressions of system Xc(-) subunits xCT and 4F2hc, and also ameliorated the glutamate-induced decrease in glutathione levels. These results suggest that the cytoprotective effect of yokukansan may be attributed to geissoschizine methyl ether, hirsuteine, hirsutine, and procyanidin B1 in Uncaria hook.	[Kanno, Hitomi; Kawakami, Zenji; Mizoguchi, Kazushige; Ikarashi, Yasushi; Kase, Yoshio] Tsumura & Co, Kampo Sci Strategies Div, Tsumura Res Labs, Inashiki, Ibaraki, Japan	Tsumura & Company	Kanno, H (corresponding author), Tsumura & Co, Kampo Sci Strategies Div, Tsumura Res Labs, Inashiki, Ibaraki, Japan.	kanno_hitomi@mail.tsumura.co.jp			Tsumura Co.	Tsumura Co.(Tsumura & Company)	This study was funded by Tsumura & Co. The funder provided support in the form of salaries for all authors, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	ANDERSON ME, 1985, METHOD ENZYMOL, V113, P548; Behrens PF, 2002, BRAIN, V125, P1908, DOI 10.1093/brain/awf180; Bridges RJ, 2012, BRIT J PHARMACOL, V165, P20, DOI 10.1111/j.1476-5381.2011.01480.x; Chen JY, 2012, MOL CELL, V45, P196, DOI 10.1016/j.molcel.2011.11.023; Cheung NS, 1998, NEUROPHARMACOLOGY, V37, P1419, DOI 10.1016/S0028-3908(98)00123-3; CHOI DW, 1988, NEURON, V1, P623, DOI 10.1016/0896-6273(88)90162-6; CHOI DW, 1990, ANNU REV NEUROSCI, V13, P171, DOI 10.1146/annurev.ne.13.030190.001131; Chung WJ, 2005, J NEUROSCI, V25, P7101, DOI 10.1523/JNEUROSCI.5258-04.2005; Conrad M, 2012, AMINO ACIDS, V42, P231, DOI 10.1007/s00726-011-0867-5; COYLE JT, 1993, SCIENCE, V262, P689, DOI 10.1126/science.7901908; Edwards MA, 2007, NEUROTOXICOLOGY, V28, P876, DOI 10.1016/j.neuro.2007.04.006; EYER P, 1986, ANAL BIOCHEM, V153, P57, DOI 10.1016/0003-2697(86)90061-8; FROISSARD P, 1994, NEUROCHEM INT, V24, P485, DOI 10.1016/0197-0186(94)90096-5; Han F, 2008, NEUROSCI LETT, V430, P275, DOI 10.1016/j.neulet.2007.11.021; Harkany T, 2000, EUR J NEUROSCI, V12, P2735, DOI 10.1046/j.1460-9568.2000.00164.x; HAYES RL, 1992, J NEUROTRAUM, V9, pS173; Iizuka S, 2010, NEUROPATHOLOGY, V30, P524, DOI 10.1111/j.1440-1789.2010.01101.x; Ikarashi Y, 2009, BIOL PHARM BULL, V32, P1701, DOI 10.1248/bpb.32.1701; Imamura S, 2011, CELL MOL NEUROBIOL, V31, P787, DOI 10.1007/s10571-011-9676-3; Iwasaki K, 2005, J CLIN PSYCHIAT, V66, P248, DOI 10.4088/JCP.v66n0214; Iwasaki K, 2012, PSYCHOGERIATRICS, V12, P235, DOI 10.1111/j.1479-8301.2012.00413.x; Kanno H, 2013, J ETHNOPHARMACOL, V149, P360, DOI 10.1016/j.jep.2013.06.052; Kawakami Z, 2009, NEUROSCIENCE, V159, P1397, DOI 10.1016/j.neuroscience.2009.02.004; Kawakami Z, 2011, CELL MOL NEUROBIOL, V31, P1203, DOI 10.1007/s10571-011-9722-1; Kawakami Z, 2011, J ETHNOPHARMACOL, V134, P74, DOI 10.1016/j.jep.2010.11.063; Kawakami Z, 2010, EUR J PHARMACOL, V626, P154, DOI 10.1016/j.ejphar.2009.09.046; Kubota K., 2013, Journal of Traditional Medicines, V30, P102; Lewerenz J, 2013, ANTIOXID REDOX SIGN, V18, P522, DOI 10.1089/ars.2011.4391; Lewerenz J, 2012, AMINO ACIDS, V42, P171, DOI 10.1007/s00726-011-0862-x; Lo M, 2008, J CELL PHYSIOL, V215, P593, DOI 10.1002/jcp.21366; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Matsuda Y, 2013, HUM PSYCHOPHARM CLIN, V28, P80, DOI 10.1002/hup.2286; MICHAELS RL, 1990, J NEUROSCI, V10, P283; Mizukami K, 2009, INT J NEUROPSYCHOPH, V12, P191, DOI 10.1017/S146114570800970X; MONAGHAN DT, 1989, ANNU REV PHARMACOL, V29, P365, DOI 10.1146/annurev.pa.29.040189.002053; MURPHY TH, 1990, FASEB J, V4, P1624, DOI 10.1096/fasebj.4.6.2180770; Nagata K, 2012, PHYTOMEDICINE, V19, P524, DOI 10.1016/j.phymed.2012.02.008; Penugonda S, 2005, BRAIN RES, V1056, P132, DOI 10.1016/j.brainres.2005.07.032; Pereira CF, 2000, NEUROSCI RES, V37, P227, DOI 10.1016/S0168-0102(00)00124-3; ROTHMAN SM, 1987, TRENDS NEUROSCI, V10, P299, DOI 10.1016/0166-2236(87)90177-9; SAKAI M, 1994, J BIOL CHEM, V269, P31430; Todd KG, 2001, METHODS, V23, P55, DOI 10.1006/meth.2000.1105; Tsuji M, 2001, J BIOL CHEM, V276, P32779, DOI 10.1074/jbc.M101403200; Vaudry D, 2002, SCIENCE, V296, P1648, DOI 10.1126/science.1071552; Vazhappilly R, 2010, NEUROCHEM INT, V56, P569, DOI 10.1016/j.neuint.2009.12.020	45	16	17	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2014	9	12							e116275	10.1371/journal.pone.0116275	http://dx.doi.org/10.1371/journal.pone.0116275			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UC	25551766	Green Published, Green Submitted, gold			2022-12-27	WOS:000347119100118
J	Li, IH; Ma, KH; Weng, SJ; Huang, SS; Liang, CM; Huang, YS				Li, I-Hsun; Ma, Kuo-Hsing; Weng, Shao-Ju; Huang, Shiang-Suo; Liang, Chang-Min; Huang, Yuahn-Sieh			Autophagy Activation Is Involved in 3,4-Methylenedioxymethamphetamine ('Ecstasy')-Induced Neurotoxicity in Cultured Cortical Neurons	PLOS ONE			English	Article							CELL-DEATH; SIGNALING PATHWAYS; RAT; 3-METHYLADENINE; PHOSPHORYLATION; MECHANISMS; TOXICITY; ECSTASY; CONTRIBUTES; MODULATION	Autophagic (type II) cell death, characterized by the massive accumulation of autophagic vacuoles in the cytoplasm of cells, has been suggested to play pathogenetic roles in cerebral ischemia, brain trauma, and neurodegenerative disorders. 3,4-Methylenedioxymethamphetamine (MDMA or ecstasy) is an illicit drug causing long-term neurotoxicity in the brain. Apoptotic (type I) and necrotic (type III) cell death have been implicated in MDMA-induced neurotoxicity, while the role of autophagy in MDMA-elicited neurotoxicity has not been investigated. The present study aimed to evaluate the occurrence and contribution of autophagy to neurotoxicity in cultured rat cortical neurons challenged with MDMA. Autophagy activation was monitored by expression of microtubule-associated protein 1 light chain 3 (LC3; an autophagic marker) using immunofluorescence and western blot analysis. Here, we demonstrate that MDMA exposure induced monodansylcadaverine (MDC)- and LC3B-densely stained autophagosome formation and increased conversion of LC3B-I to LC3B-II, coinciding with the neurodegenerative phase of MDMA challenge. Autophagy inhibitor 3-methyladenine (3-MA) pretreatment significantly attenuated MDMA-induced autophagosome accumulation, LC3B-II expression, and ameliorated MDMA-triggered neurite damage and neuronal death. In contrast, enhanced autophagy flux by rapamycin or impaired autophagosome clearance by bafilomycin A1 led to more autophagosome accumulation in neurons and aggravated neurite degeneration, indicating that excessive autophagosome accumulation contributes to MDMA-induced neurotoxicity. Furthermore, MDMA induced phosphorylation of AMP-activated protein kinase (AMPK) and its downstream unc-51-like kinase 1 (ULK1), suggesting the AMPK/ULK1 signaling pathway might be involved in MDMA-induced autophagy activation.	[Li, I-Hsun] Natl Def Med Ctr, Tri Serv Gen Hosp, Dept Pharm Practice, Taipei, Taiwan; [Ma, Kuo-Hsing; Weng, Shao-Ju; Huang, Yuahn-Sieh] Natl Def Med Ctr, Dept Biol & Anat, Taipei, Taiwan; [Huang, Shiang-Suo] Chung Shan Med Univ, Coll Med, Dept Pharmacol, Taichung, Taiwan; [Huang, Shiang-Suo] Chung Shan Med Univ, Coll Med, Inst Med, Taichung, Taiwan; [Liang, Chang-Min] Natl Def Med Ctr, Tri Serv Gen Hosp, Dept Ophthalmol, Taipei, Taiwan; [Liang, Chang-Min] Natl Def Med Ctr, Grad Inst Aerosp & Undersea Med, Taipei, Taiwan	National Defense Medical Center; Tri-Service General Hospital; National Defense Medical Center; Chung Shan Medical University; Chung Shan Medical University; National Defense Medical Center; Tri-Service General Hospital; National Defense Medical Center	Huang, YS (corresponding author), Natl Def Med Ctr, Dept Biol & Anat, Taipei, Taiwan.	anatoman2001@yahoo.com.tw			National Science Council Taiwan [NSC 102-2320-B-016-002]	National Science Council Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by the National Science Council Taiwan (Grant No. NSC 102-2320-B-016-002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abounit Kadija, 2012, World J Biol Chem, V3, P1, DOI 10.4331/wjbc.v3.i1.1; Alers S, 2012, MOL CELL BIOL, V32, P2, DOI 10.1128/MCB.06159-11; Bach M, 2011, BIOCHEM J, V440, P283, DOI 10.1042/BJ20101894; Baehrecke EH, 2005, NAT REV MOL CELL BIO, V6, P505, DOI 10.1038/nrm1666; BIEDERBICK A, 1995, EUR J CELL BIOL, V66, P3; Boland B, 2008, J NEUROSCI, V28, P6926, DOI 10.1523/JNEUROSCI.0800-08.2008; Capela JP, 2009, MOL NEUROBIOL, V39, P210, DOI 10.1007/s12035-009-8064-1; Chae M, 2009, MOL CELLS, V27, P571, DOI 10.1007/s10059-009-0075-2; Egan DF, 2011, SCIENCE, V331, P456, DOI 10.1126/science.1196371; El-Mallakh Rif S, 2007, Ann Clin Psychiatry, V19, P45, DOI 10.1080/10401230601163592; Halpin LE, 2014, LIFE SCI, V97, P37, DOI 10.1016/j.lfs.2013.07.014; Harris H, 2012, NAT REV NEUROL, V8, P108, DOI 10.1038/nrneurol.2011.200; He CC, 2009, ANNU REV GENET, V43, P67, DOI 10.1146/annurev-genet-102808-114910; Heras-Sandoval D, 2014, CELL SIGNAL, V26, P2694, DOI 10.1016/j.cellsig.2014.08.019; Jung CH, 2009, MOL BIOL CELL, V20, P1992, DOI 10.1091/mbc.E08-12-1249; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kim J, 2011, NAT CELL BIOL, V13, P132, DOI 10.1038/ncb2152; Kroemer G, 2008, NAT REV MOL CELL BIO, V9, P1004, DOI 10.1038/nrm2529; Lee Jin-A, 2012, Exp Neurobiol, V21, P1, DOI 10.5607/en.2012.21.1.1; Lee JHW, 2009, J HYDRO-ENVIRON RES, V3, P1, DOI 10.1016/j.jher.2009.05.002; Levine B, 2005, J CLIN INVEST, V115, P2679, DOI 10.1172/JCI26390; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Luo CL, 2011, NEUROSCIENCE, V184, P54, DOI 10.1016/j.neuroscience.2011.03.021; Mizushima N, 2005, CELL DEATH DIFFER, V12, P1535, DOI 10.1038/sj.cdd.4401728; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Munafo DB, 2001, J CELL SCI, V114, P3619; Nakatogawa H, 2009, NAT REV MOL CELL BIO, V10, P458, DOI 10.1038/nrm2708; Nixon RA, 2012, COLD SPRING HARB PER, V4; Noda T, 1998, J BIOL CHEM, V273, P3963, DOI 10.1074/jbc.273.7.3963; Parrott AC, 2002, PHARMACOL BIOCHEM BE, V71, P837, DOI 10.1016/S0091-3057(01)00711-0; Perez-Carrion MD, 2012, J NEUROCHEM, V120, P259, DOI 10.1111/j.1471-4159.2011.07556.x; Petiot A, 2000, J BIOL CHEM, V275, P992, DOI 10.1074/jbc.275.2.992; Popko J, 2009, CYTOM PART A, V75A, P371, DOI 10.1002/cyto.a.20660; Ramamurthy Santosh, 2012, Exp Neurobiol, V21, P52, DOI 10.5607/en.2012.21.2.52; Ricaurte GA, 2000, NEUROPSYCHOBIOLOGY, V42, P5, DOI 10.1159/000026664; Sadasivan S, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-21; Sarkar S, 2010, CURR PHARM BIOTECHNO, V11, P460, DOI 10.2174/138920110791591490; Scarlatti F, 2009, CELL DEATH DIFFER, V16, P12, DOI 10.1038/cdd.2008.101; Schmued LC, 2003, BRAIN RES, V974, P127, DOI 10.1016/S0006-8993(03)02563-0; SEGLEN PO, 1982, P NATL ACAD SCI-BIOL, V79, P1889, DOI 10.1073/pnas.79.6.1889; Shacka JJ, 2006, MOL PHARMACOL, V69, P1125, DOI 10.1124/mol.105.018408; Shen HM, 2011, AUTOPHAGY, V7, P457, DOI 10.4161/auto.7.5.14226; Shi RY, 2012, CNS NEUROSCI THER, V18, P250, DOI 10.1111/j.1755-5949.2012.00295.x; SMITS A, 1991, P NATL ACAD SCI USA, V88, P8159, DOI 10.1073/pnas.88.18.8159; Soleimani S, 2012, CELL J, V13, P275; Son JH, 2012, EXP MOL MED, V44, P89, DOI 10.3858/emm.2012.44.2.031; Takatsuka C, 2004, PLANT CELL PHYSIOL, V45, P265, DOI 10.1093/pcp/pch031; Takeuchi H, 2005, CANCER RES, V65, P3336, DOI 10.1158/0008-5472.CAN-04-3640; Thoreen CC, 2009, J BIOL CHEM, V284, P8023, DOI 10.1074/jbc.M900301200; Tsvetkov AS, 2010, P NATL ACAD SCI USA, V107, P16982, DOI 10.1073/pnas.1004498107; Wang JY, 2011, J NEUROPATH EXP NEUR, V70, P314, DOI 10.1097/NEN.0b013e31821352bd; Wang Y, 2008, AUTOPHAGY, V4, P214, DOI 10.4161/auto.5369; Wu YT, 2010, J BIOL CHEM, V285, P10850, DOI 10.1074/jbc.M109.080796; Yamamoto A, 1998, CELL STRUCT FUNCT, V23, P33, DOI 10.1247/csf.23.33; Yang ZF, 2010, NAT CELL BIOL, V12, P814, DOI 10.1038/ncb0910-814; Yang ZF, 2010, CURR OPIN CELL BIOL, V22, P124, DOI 10.1016/j.ceb.2009.11.014	56	28	32	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2014	9	12							e116565	10.1371/journal.pone.0116565	http://dx.doi.org/10.1371/journal.pone.0116565			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UC	25551657	Green Submitted, Green Published, gold			2022-12-27	WOS:000347119100145
J	Percino, G; Klimek, P; Thurner, S				Percino, Gamaliel; Klimek, Peter; Thurner, Stefan			Instrumentational Complexity of Music Genres and Why Simplicity Sells	PLOS ONE			English	Article							NETWORK; MARKET	Listening habits are strongly influenced by two opposing aspects, the desire for variety and the demand for uniformity in music. In this work we quantify these two notions in terms of instrumentation and production technologies that are typically involved in crafting popular music. We assign an 'instrumentational complexity value' to each music style. Styles of low instrumentational complexity tend to have generic instrumentations that can also be found in many other styles. Styles of high complexity, on the other hand, are characterized by a large variety of instruments that can only be found in a small number of other styles. To model these results we propose a simple stochastic model that explicitly takes the capabilities of artists into account. We find empirical evidence that individual styles show dramatic changes in their instrumentational complexity over the last fifty years. 'New wave' or 'disco' quickly climbed towards higher complexity in the 70s and fell back to low complexity levels shortly afterwards, whereas styles like 'folk rock' remained at constant high instrumentational complexity levels. We show that changes in the instrumentational complexity of a style are related to its number of sales and to the number of artists contributing to that style. As a style attracts a growing number of artists, its instrumentational variety usually increases. At the same time the instrumentational uniformity of a style decreases, i.e. a unique stylistic and increasingly complex expression pattern emerges. In contrast, album sales of a given style typically increase with decreasing instrumentational complexity. This can be interpreted as music becoming increasingly formulaic in terms of instrumentation once commercial or mainstream success sets in.	[Percino, Gamaliel; Klimek, Peter; Thurner, Stefan] Med Univ Vienna, Sect Sci Complex Syst, CEMSIIS, Vienna, Austria; [Thurner, Stefan] Santa Fe Inst, Santa Fe, NM 87501 USA; [Thurner, Stefan] IIASA, Laxenburg, Austria	Medical University of Vienna; The Santa Fe Institute; International Institute for Applied Systems Analysis (IIASA)	Thurner, S (corresponding author), Med Univ Vienna, Sect Sci Complex Syst, CEMSIIS, Vienna, Austria.	stefan.thurner@meduniwien.ac.at	Klimek, Peter/AAC-2723-2019	Klimek, Peter/0000-0003-1187-6713	EU FP7 project MULTIPLEX [317532]; National Council for Science and Technology of Mexico [202117]	EU FP7 project MULTIPLEX; National Council for Science and Technology of Mexico(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	P.K. was supported by EU FP7 project MULTIPLEX, No. 317532, and G.P. by the National Council for Science and Technology of Mexico with the scholarship number 202117. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ball P., 2010, MUSIC INSTINCT MUSIC; Buda A, 2013, ACTA PHYS POL A, V123, P547, DOI 10.12693/APhysPolA.123.547; Buldu JM, 2007, NEW J PHYS, V9, DOI 10.1088/1367-2630/9/6/172; Celma Oscar, 2008, KDD WORKSH, P1; Downie JS, 2003, ANNU REV INFORM SCI, V37, P295, DOI 10.1002/aris.1440370108; Gordon J, 2013, CREATIVITY RES J, V25, P143, DOI 10.1080/10400419.2013.752303; Haro M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033993; Hidalgo CA, 2007, SCIENCE, V317, P482, DOI 10.1126/science.1144581; Hidalgo CA, 2009, P NATL ACAD SCI USA, V106, P10570, DOI 10.1073/pnas.0900943106; Huron D.B., 2006, SWEET ANTICIPATION M; Lambiotte R, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.066107; Lambiotte R, 2006, EUR PHYS J B, V50, P183, DOI 10.1140/epjb/e2006-00115-0; Lee C, 2012, 2012 IEEE/ACM INTERNATIONAL CONFERENCE ON ADVANCES IN SOCIAL NETWORKS ANALYSIS AND MINING (ASONAM), P691, DOI 10.1109/ASONAM.2012.237; Leskovec J, 2007, ACM T WEB, V1, DOI 10.1145/1232722.1232727; Mason K, 2013, BILLBOARD MAGAZ 0506; MetaCritic, 2014, DAFT PUNK RAND ACC M; North A. C., 1995, PSYCHOMUSICOLOGY, V14, P77, DOI DOI 10.1037/H0094090; Parales J, 2009, NEW YORK TIMES  1213; Park J, 2007, INT J BIFURCAT CHAOS, V17, P2281, DOI 10.1142/S0218127407018385; Phillips R, 2010, HIPHOPDX        0908; PUNK DAFT, 2013, RANDOM ACCESS MEMORI; Reid S, 2009, MTV NEWS        1211; Rosenthal M, 2013, AMAZON SALES RANKING; Salganik MJ, 2006, SCIENCE, V311, P854, DOI 10.1126/science.1121066; Scaringella N, 2006, IEEE SIGNAL PROC MAG, V23, P133, DOI 10.1109/MSP.2006.1598089; Schonberg A., 1978, THEORY HARMONY; Serra J, 2012, SCI REP-UK, V2, DOI 10.1038/srep00521; Streich S., 2006, THESIS U POMPEU FABR; Weiner Jonah, 2013, ROLLING STONE   0413	29	13	13	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2014	9	12							e115255	10.1371/journal.pone.0115255	http://dx.doi.org/10.1371/journal.pone.0115255			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	AX7UC	25551631	Green Submitted, Green Accepted, Green Published, gold			2022-12-27	WOS:000347119100033
J	Wang, ZG; Theeuwes, J				Wang, Zhiguo; Theeuwes, Jan			Distractor Evoked Deviations of Saccade Trajectory Are Modulated by Fixation Activity in the Superior Colliculus: Computational and Behavioral Evidence	PLOS ONE			English	Article							OCULOMOTOR INHIBITION; SPATIAL ATTENTION; COMPETITIVE INTEGRATION; REMOTE DISTRACTORS; TARGET SELECTION; TIME-COURSE; CURVATURE; INITIATION; SIGNALS; SYSTEM	Previous studies have shown that saccades may deviate towards or away from task irrelevant visual distractors. This observation has been attributed to active suppression (inhibition) of the distractor location unfolding over time: early in time inhibition at the distractor location is incomplete causing deviation towards the distractor, while later in time when inhibition is complete the eyes deviate away from the distractor. In a recent computational study, Wang, Kruijne and Theeuwes proposed an alternative theory that the lateral interactions in the superior colliculus (SC), which are characterized by short-distance excitation and long-distance inhibition, are sufficient for generating both deviations towards and away from distractors. In the present study, we performed a meta-analysis of the literature, ran model simulations and conducted two behavioral experiments to further explore this unconventional theory. Confirming predictions generated by the model simulations, the behavioral experiments show that a) saccades deviate towards close distractors and away from remote distractors, and b) the amount of deviation depends on the strength of fixation activity in the SC, which can be manipulated by turning off the fixation stimulus before or after target onset (Experiment 1), or by varying the eccentricity of the target and distractor (Experiment 2).	[Wang, Zhiguo] Hangzhou Normal Univ, Ctr Cognit & Brain Disorders, Hangzhou, Zhejiang, Peoples R China; [Wang, Zhiguo; Theeuwes, Jan] Vrije Univ Amsterdam, Dept Cognit Psychol, Amsterdam, Netherlands	Hangzhou Normal University; Vrije Universiteit Amsterdam	Wang, ZG (corresponding author), Hangzhou Normal Univ, Ctr Cognit & Brain Disorders, Hangzhou, Zhejiang, Peoples R China.	z.wang@hznu.edu.cn	Theeuwes, Jan/ABF-3771-2020; Wang, Zhiguo/AHA-8939-2022	Wang, Zhiguo/0000-0003-4553-0198; Theeuwes, Jan/0000-0002-5849-7721	Zhejiang Provincial Natural Science Foundation of China [LY13C090007]	Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province)	Z. Wang was partially supported by a grant (grant no. LY13C090007) from Zhejiang Provincial Natural Science Foundation of China (http://www.zjnsf.gov.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aizawa H, 1998, J NEUROPHYSIOL, V79, P2082, DOI 10.1152/jn.1998.79.4.2082; Al-Aidroos N, 2010, VIS COGN, V18, P26, DOI 10.1080/13506280802456939; AMARI SI, 1977, BIOL CYBERN, V27, P77, DOI 10.1007/BF00337259; Anderson EJ, 2011, J NEUROPHYSIOL, V106, P2273, DOI 10.1152/jn.00286.2011; Arai K, 2005, BIOL CYBERN, V92, P21, DOI 10.1007/s00422-004-0526-y; Arai K, 1999, NEURAL NETWORKS, V12, P1359, DOI 10.1016/S0893-6080(99)00077-5; Badler JB, 2002, BIOL CYBERN, V86, P179, DOI 10.1007/s00422-001-0288-8; Bennett PJ, 2001, PSYCHOL SCI, V12, P76, DOI 10.1111/1467-9280.00313; Campbell KL, 2009, PSYCHOL AGING, V24, P163, DOI 10.1037/a0014106; Chao CM, 2011, HUM BRAIN MAPP, V32, P1961, DOI 10.1002/hbm.21162; DORRIS MC, 1995, J NEUROPHYSIOL, V73, P2558, DOI 10.1152/jn.1995.73.6.2558; Dorris MC, 2002, J COGNITIVE NEUROSCI, V14, P1256, DOI 10.1162/089892902760807249; Dorris MC, 1997, J NEUROSCI, V17, P8566; Dorris MC, 2007, J NEUROSCI, V27, P5053, DOI 10.1523/JNEUROSCI.4212-06.2007; Doyle D, 2001, EXP BRAIN RES, V139, P333, DOI 10.1007/s002210100742; Doyle MC, 2002, EXP BRAIN RES, V142, P116, DOI 10.1007/s00221-001-0919-2; Fielding J, 2006, J INT NEUROPSYCH SOC, V12, P455, DOI 10.1017/S1355617706060589; Godijn R, 2002, PSYCHOL RES-PSYCH FO, V66, P234, DOI 10.1007/s00426-002-0098-1; Gozli DG, 2013, VIS COGN, V21, P628, DOI 10.1080/13506285.2013.815680; Hickey C, 2012, CURR BIOL, V22, pR219, DOI 10.1016/j.cub.2012.02.007; Hikosaka O, 2000, PHYSIOL REV, V80, P953, DOI 10.1152/physrev.2000.80.3.953; Isa T, 2009, J NEUROPHYSIOL, V102, P2581, DOI 10.1152/jn.00498.2009; KINGSTONE A, 1993, PERCEPT PSYCHOPHYS, V54, P260, DOI 10.3758/BF03211762; Klein RM, 2000, TRENDS COGN SCI, V4, P138, DOI 10.1016/S1364-6613(00)01452-2; KOPECZ K, 1995, BIOL CYBERN, V73, P49, DOI 10.1007/BF00199055; LEE CK, 1988, NATURE, V332, P357, DOI 10.1038/332357a0; Ludwig CJH, 2003, EXP BRAIN RES, V152, P60, DOI 10.1007/s00221-003-1520-7; Ludwig CJH, 2002, BEHAV RES METH INS C, V34, P618, DOI 10.3758/BF03195490; Marino RA, 2012, J COGNITIVE NEUROSCI, V24, P315, DOI 10.1162/jocn_a_00139; MAYLOR EA, 1985, J EXP PSYCHOL HUMAN, V11, P777, DOI 10.1037/0096-1523.11.6.777; McPeek RM, 2001, VISION RES, V41, P785, DOI 10.1016/S0042-6989(00)00287-X; McPeek RM, 2003, J NEUROPHYSIOL, V89, P2577, DOI 10.1152/jn.00657.2002; McPeek RM, 2006, J NEUROPHYSIOL, V96, P2699, DOI 10.1152/jn.00564.2006; McSorley E, 2005, VISION RES, V45, P2492, DOI 10.1016/j.visres.2005.04.012; McSorley E, 2004, EXP BRAIN RES, V155, P320, DOI 10.1007/s00221-003-1729-5; McSorley E, 2006, J NEUROPHYSIOL, V96, P1420, DOI 10.1152/jn.00315.2006; McSorley E, 2009, BRAIN RES, V1298, P92, DOI 10.1016/j.brainres.2009.08.081; McSorley E, 2009, EXP BRAIN RES, V198, P513, DOI 10.1007/s00221-009-1952-9; McSorley E, 2009, VISION RES, V49, P608, DOI 10.1016/j.visres.2009.01.015; Meeter M, 2010, BIOL CYBERN, V102, P271, DOI 10.1007/s00422-010-0365-y; Mulckhuyse M, 2013, EMOTION, V13, P529, DOI 10.1037/a0031076; Mulckhuyse M, 2009, J NEUROPHYSIOL, V102, P1451, DOI 10.1152/jn.00068.2009; Munoz DP, 1998, J NEUROPHYSIOL, V79, P1193, DOI 10.1152/jn.1998.79.3.1193; Munoz DP, 2002, PROG BRAIN RES, V140, P3; MUNOZ DP, 1993, J NEUROPHYSIOL, V70, P559, DOI 10.1152/jn.1993.70.2.559; Nummenmaa L, 2009, J EXP PSYCHOL HUMAN, V35, P305, DOI 10.1037/a0013626; Petrova K, 2013, VISION RES, V84, P43, DOI 10.1016/j.visres.2013.03.008; Petrova K, 2012, VISION RES, V62, P209, DOI 10.1016/j.visres.2012.04.010; POSNER MI, 1985, COGNITIVE NEUROPSYCH, V2, P211, DOI 10.1080/02643298508252866; POSNER MI, 1984, ATTENTION PERFORM, V10, P531; Prime DJ, 2006, BRAIN RES, V1072, P161, DOI 10.1016/j.brainres.2005.11.081; REUTERLORENZ PA, 1991, PERCEPT PSYCHOPHYS, V49, P167, DOI 10.3758/BF03205036; RIZZOLATTI G, 1994, ATTENTION PERFORM, V15, P231; SASLOW MG, 1967, J OPT SOC AM, V57, P1024, DOI 10.1364/JOSA.57.001024; Satel J, 2011, VISION RES, V51, P987, DOI 10.1016/j.visres.2011.02.013; Schmidt LJ, 2012, VIS COGN, V20, P284, DOI 10.1080/13506285.2012.658885; SHELIGA BM, 1994, EXP BRAIN RES, V98, P507; SHELIGA BM, 1995, EXP BRAIN RES, V105, P261; Sheliga BM, 1997, EXP BRAIN RES, V114, P339, DOI 10.1007/PL00005642; SHELIGA BM, 1995, NEUROREPORT, V6, P585, DOI 10.1097/00001756-199502000-00044; Tabareau N, 2007, BIOL CYBERN, V97, P279, DOI 10.1007/s00422-007-0172-2; Takahashi M, 2007, J NEUROPHYSIOL, V98, P2664, DOI 10.1152/jn.00696.2007; Takahashi M, 2010, J NEUROPHYSIOL, V104, P3146, DOI 10.1152/jn.00554.2010; Theeuwes J, 2004, VISION RES, V44, P1485, DOI 10.1016/j.visres.2003.09.035; Tipper SP, 2001, EXP BRAIN RES, V136, P241, DOI 10.1007/s002210000577; Trappenberg TP, 2001, J COGNITIVE NEUROSCI, V13, P256, DOI 10.1162/089892901564306; Van der Stigchel S, 2006, EXP BRAIN RES, V169, P338, DOI 10.1007/s00221-005-0147-2; Van der Stigchel S, 2005, COGNITIVE BRAIN RES, V25, P579, DOI 10.1016/j.cogbrainres.2005.08.001; Van der Stigchel S, 2008, NEUROREPORT, V19, P251, DOI 10.1097/WNR.0b013e3282f49b3f; Van der Stigchel S, 2007, VISION RES, V47, P210, DOI 10.1016/j.visres.2006.11.001; Van der Stigchel S, 2006, NEUROSCI BIOBEHAV R, V30, P666, DOI 10.1016/j.neubiorev.2005.12.001; Van der Stigchel S, 2010, VISION RES, V50, P1619, DOI 10.1016/j.visres.2010.05.028; Van der Stigchel S, 2009, VISION RES, V49, P2104, DOI 10.1016/j.visres.2009.05.018; van Zoest W, 2008, EXP BRAIN RES, V186, P431, DOI 10.1007/s00221-007-1243-2; VANGISBERGEN JAM, 1987, NEUROSCIENCE, V21, P541, DOI 10.1016/0306-4522(87)90140-0; VANSELST M, 1994, Q J EXP PSYCHOL-A, V47, P631, DOI 10.1080/14640749408401131; Walker R, 2006, PERCEPT PSYCHOPHYS, V68, P129, DOI 10.3758/BF03193663; Walker R, 1997, J NEUROPHYSIOL, V78, P1108, DOI 10.1152/jn.1997.78.2.1108; Walker R, 2008, J EYE MOVEMENT RES, V2, P1, DOI DOI 10.16910/JEMR.2.3.7; Walker R, 2009, BRAIN RES, V1270, P54, DOI 10.1016/j.brainres.2009.02.081; Wang ZG, 2012, VISION RES, V62, P66, DOI 10.1016/j.visres.2012.03.024; Wang ZQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042730; Weaver MD, 2011, VISION RES, V51, P1124, DOI 10.1016/j.visres.2011.03.005; West GL, 2011, EXP BRAIN RES, V209, P153, DOI 10.1007/s00221-010-2508-8; White B.J., 2011, OXFORD HDB EYE MOVEM, P195, DOI [10.1093/oxfordhb/9780199539789.013.0011, DOI 10.1093/OXFORDHB/9780199539789.013.0011]; White BJ, 2012, J COGNITIVE NEUROSCI, V24, P707, DOI 10.1162/jocn_a_00162; Wilimzig C, 2006, NEURAL NETWORKS, V19, P1059, DOI 10.1016/j.neunet.2006.03.003; WILSON HR, 1973, KYBERNETIK, V13, P55, DOI 10.1007/BF00288786	88	4	4	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2014	9	12							e116382	10.1371/journal.pone.0116382	http://dx.doi.org/10.1371/journal.pone.0116382			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UC	25551552	Green Published, gold, Green Submitted			2022-12-27	WOS:000347119100136
J	Yang, M; Zhang, Y; Qi, L; Mei, XY; Liao, JJ; Ding, XP; Deng, WP; Fan, LM; He, XH; Vivanco, JM; Li, CY; Zhu, YY; Zhu, SS				Yang, Min; Zhang, Yu; Qi, Lei; Mei, Xinyue; Liao, Jingjing; Ding, Xupo; Deng, Weiping; Fan, Limin; He, Xiahong; Vivanco, Jorge M.; Li, Chengyun; Zhu, Youyong; Zhu, Shusheng			Plant-Plant-Microbe Mechanisms Involved in Soil-Borne Disease Suppression on a Maize and Pepper Intercropping System	PLOS ONE			English	Article							SUSTAINABLE AGRICULTURE; SPECIES DIVERSITY; HDMBOA-GLC; MIXTURES; BIODIVERSITY; CHEMOTAXIS; ZOOSPORES; DEFENSE; YIELD; WHEAT	Background: Intercropping systems could increase crop diversity and avoid vulnerability to biotic stresses. Most studies have shown that intercropping can provide relief to crops against wind-dispersed pathogens. However, there was limited data on how the practice of intercropping help crops against soil-borne Phytophthora disease. Principal Findings: Compared to pepper monoculture, a large scale intercropping study of maize grown between pepper rows reduced disease levels of the soil-borne pepper Phytophthora blight. These reduced disease levels of Phytophthora in the intercropping system were correlated with the ability of maize plants to form a "root wall" that restricted the movement of Phytophthora capsici across rows. Experimentally, it was found that maize roots attracted the zoospores of P. capsici and then inhibited their growth. When maize plants were grown in close proximity to each other, the roots produced and secreted larger quantities of 2,4-dihydroxy-7-methoxy-2H-1,4-benzoxazin-3(4H)-one (DIMBOA) and 6-methoxy-2-benzoxazolinone (MBOA). Furthermore, MBOA, benzothiazole (BZO), and 2-(methylthio)-benzothiazole (MBZO) were identified in root exudates of maize and showed antimicrobial activity against P. capsici. Conclusions: Maize could form a "root wall" to restrict the spread of P. capsici across rows in maize and pepper intercropping systems. Antimicrobe compounds secreted by maize root were one of the factors that resulted in the inhibition of P. capsici. These results provide new insights into plant-plant-microbe mechanisms involved in intercropping systems.	[Yang, Min; Zhang, Yu; Qi, Lei; Mei, Xinyue; Liao, Jingjing; Ding, Xupo; Deng, Weiping; Fan, Limin; He, Xiahong; Li, Chengyun; Zhu, Youyong; Zhu, Shusheng] Yunnan Agr Univ, Educ Minist China, Key Lab Agrobiodivers & Pest Management, Kunming, Yunnan, Peoples R China; [Vivanco, Jorge M.] Colorado State Univ, Dept Hort & Landscape Architecture, Ft Collins, CO 80523 USA; [Vivanco, Jorge M.] Colorado State Univ, Ctr Rhizosphere Biol, Ft Collins, CO 80523 USA	Yunnan Agricultural University; Colorado State University; Colorado State University	Zhu, SS (corresponding author), Yunnan Agr Univ, Educ Minist China, Key Lab Agrobiodivers & Pest Management, Kunming, Yunnan, Peoples R China.	shushengzhu79@126.com			"973'' program from the Ministry of Science and Technology of China [2011CB100400]; Natural Science Foundation of China [30800731, 31260447]; Special Fund for Agro-scientific Research in the Public Interest of the People's Republic of China [201003004]	"973'' program from the Ministry of Science and Technology of China(National Basic Research Program of China); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Special Fund for Agro-scientific Research in the Public Interest of the People's Republic of China	This study was partially supported by the "973'' program (2011CB100400) from the Ministry of Science and Technology of China, the Natural Science Foundation of China (30800731 and 31260447), and the Special Fund for Agro-scientific Research in the Public Interest of the People's Republic of China (201003004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Monaim MF, 2012, CROP PROT, V32, P41, DOI 10.1016/j.cropro.2011.10.011; Ahmad S, 2011, PLANT PHYSIOL, V157, P317, DOI 10.1104/pp.111.180224; Badri DV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046640; Bais HP, 2006, ANNU REV PLANT BIOL, V57, P233, DOI 10.1146/annurev.arplant.57.032905.105159; BJOSTAD LB, 1992, J CHEM ECOL, V18, P931, DOI 10.1007/BF00980054; Boudreau MA, 2013, ANNU REV PHYTOPATHOL, V51, P499, DOI 10.1146/annurev-phyto-082712-102246; Bouws H, 2008, PLANT PATHOL, V57, P916, DOI 10.1111/j.1365-3059.2008.01860.x; Broz AK, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-115; Calonnec A, 1996, EUR J PLANT PATHOL, V102, P733, DOI 10.1007/BF01877147; CAMERON JN, 1978, NATURE, V271, P448, DOI 10.1038/271448a0; Carlile M.J., 1983, PHYTOPHTHORA ITS BIO, P95, DOI 10.3/JQUERY-UI.JS; CHIN KM, 1984, PLANT PATHOL, V33, P89, DOI 10.1111/j.1365-3059.1984.tb00592.x; Cohen Y, 1995, PHYTOPATHOLOGY, V85, P1500, DOI 10.1094/Phyto-85-1500; DEACON JW, 1988, MICROBIOL SCI, V5, P249; Dong LL, 2014, J EXP BOT, V65, P131, DOI 10.1093/jxb/ert356; Dybzinski R, 2008, OECOLOGIA, V158, P85, DOI 10.1007/s00442-008-1123-x; Erwin DC, 1996, PHYTOPHTHORA DIS WOR, P262; Fan KW, 2002, MYCOLOGIA, V94, P569, DOI 10.2307/3761708; Flombaum P, 2008, P NATL ACAD SCI USA, V105, P6087, DOI 10.1073/pnas.0704801105; Gao X, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095031; Gaquerel E, 2009, PLANT PHYSIOL, V149, P1408, DOI 10.1104/pp.108.130799; Gianoli E, 1997, OIKOS, V80, P269, DOI 10.2307/3546595; He Haibin, 2005, Ying Yong Sheng Tai Xue Bao, V16, P2383; He X., 2010, J RESOUR ECOL, V1, P45, DOI [10.3969/j.issn.1674-764x.2010.01.006, DOI 10.3969/J.ISSN.1674-764X.2010.01.006]; HOAGLAND DR, 1950, 347 CAL AGR EXPT STA; Hu ZH, 2009, TREES-STRUCT FUNCT, V23, P1003, DOI 10.1007/s00468-009-0342-z; Krogh SS, 2006, J AGR FOOD CHEM, V54, P1064, DOI 10.1021/jf051147i; KUMAR P, 1993, J CHEM ECOL, V19, P2453, DOI 10.1007/BF00980682; Lane N, 2004, J CHEM ECOL, V30, P425, DOI 10.1023/B:JOEC.0000017986.49513.f7; Li CY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008049; Li L, 2007, P NATL ACAD SCI USA, V104, P11192, DOI 10.1073/pnas.0704591104; Lithourgidis AS, 2011, AUST J CROP SCI, V5, P396; Machado S, 2009, J SOIL WATER CONSERV, V64, p55A, DOI 10.2489/jswc.64.2.55A; Mahall BE, 1996, AM J BOT, V83, P93, DOI 10.2307/2445959; MEAD R, 1980, EXP AGR, V16, P217, DOI 10.1017/S0014479700010978; Michel VV, 1997, PLANT PATHOL, V46, P600, DOI 10.1046/j.1365-3059.1997.d01-45.x; MORRIS PF, 1992, PHYSIOL MOL PLANT P, V40, P17, DOI 10.1016/0885-5765(92)90067-6; MUEHLSTEIN LK, 1988, APPL ENVIRON MICROB, V54, P1668, DOI 10.1128/AEM.54.7.1668-1672.1988; Newton AC, 2009, ANN APPL BIOL, V154, P309, DOI 10.1111/j.1744-7348.2008.00303.x; Newton AC, 2009, FIELD CROP RES, V110, P225, DOI 10.1016/j.fcr.2008.09.002; NEWTON AC, 1991, EUPHYTICA, V59, P73; Newton AC, 2008, J SCI FOOD AGR, V88, P2142, DOI 10.1002/jsfa.3326; Niemeyer HM, 2009, J AGR FOOD CHEM, V57, P1677, DOI 10.1021/jf8034034; Oikawa A, 2004, PHYTOCHEMISTRY, V65, P2995, DOI 10.1016/j.phytochem.2004.09.006; Oikawa A, 2001, PHYTOCHEMISTRY, V56, P669, DOI 10.1016/S0031-9422(00)00494-5; Park WJ, 2004, J PLANT PHYSIOL, V161, P981, DOI 10.1016/j.jplph.2004.01.005; Ren LX, 2008, SOIL BIOL BIOCHEM, V40, P834, DOI 10.1016/j.soilbio.2007.11.003; Sun Hao-yuan, 2003, Journal of Forestry Research (Harbin), V14, P127, DOI 10.1007/BF02856778; Sun Yan, 2006, Acta Horticulturae Sinica, V33, P995; TANG CS, 1982, PLANT PHYSIOL, V69, P155, DOI 10.1104/pp.69.1.155; Thrupp LA, 2000, INT AFF, V76, P265, DOI 10.1111/1468-2346.00133; Tilman D, 2006, NATURE, V441, P629, DOI 10.1038/nature04742; van West P, 2002, MOL PLANT MICROBE IN, V15, P790, DOI 10.1094/MPMI.2002.15.8.790; Wentzell AM, 2008, PLANT PHYSIOL, V147, P415, DOI 10.1104/pp.107.115279; WOLFE MS, 1985, ANNU REV PHYTOPATHOL, V23, P251, DOI 10.1146/annurev.py.23.090185.001343; WOODWARD MD, 1978, PLANT PHYSIOL, V61, P796, DOI 10.1104/pp.61.5.796; Xu CK, 2004, SOIL BIOL BIOCHEM, V36, P1997, DOI 10.1016/j.soilbio.2004.07.020; Xu Ning, 2012, Acta Horticulturae Sinica, V39, P1511; Yadav P. S., 2011, International Journal of Pharmaceutical Sciences and Drug Research, V3, P1; Zhang J, 2000, CHEM BIOL, V7, P611, DOI 10.1016/S1074-5521(00)00007-7; Zhang SH, 2011, POL J ENVIRON STUD, V20, P1359; Zhu SS, 2007, PHYTOPATHOLOGY, V97, P643, DOI 10.1094/PHYTO-97-5-0643; Zhu YY, 2000, NATURE, V406, P718, DOI 10.1038/35021046; Zhu YY, 2005, PHYTOPATHOLOGY, V95, P433, DOI 10.1094/PHYTO-95-0433; Zou CS, 2007, SOIL BIOL BIOCHEM, V39, P2371, DOI 10.1016/j.soilbio.2007.04.009	65	47	58	8	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2014	9	12							e115052	10.1371/journal.pone.0115052	http://dx.doi.org/10.1371/journal.pone.0115052			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UC	25551554	Green Submitted, gold, Green Published			2022-12-27	WOS:000347119100025
J	Andreotti, J; Jann, K; Melie-Garcia, L; Giezendanner, S; Abela, E; Wiest, R; Dierks, T; Federspiel, A				Andreotti, Jennifer; Jann, Kay; Melie-Garcia, Lester; Giezendanner, Stephanie; Abela, Eugenio; Wiest, Roland; Dierks, Thomas; Federspiel, Andrea			Validation of Network Communicability Metrics for the Analysis of Brain Structural Networks	PLOS ONE			English	Article							RICH-CLUB ORGANIZATION; WHITE-MATTER INTEGRITY; DIFFUSION TENSOR; AXONAL PROJECTIONS; CORTICAL NETWORKS; HUMAN CONNECTOME; MRI; EFFICIENCY; DYNAMICS; CORTEX	Computational network analysis provides new methods to analyze the brain's structural organization based on diffusion imaging tractography data. Networks are characterized by global and local metrics that have recently given promising insights into diagnosis and the further understanding of psychiatric and neurologic disorders. Most of these metrics are based on the idea that information in a network flows along the shortest paths. In contrast to this notion, communicability is a broader measure of connectivity which assumes that information could flow along all possible paths between two nodes. In our work, the features of network metrics related to communicability were explored for the first time in the healthy structural brain network. In addition, the sensitivity of such metrics was analysed using simulated lesions to specific nodes and network connections. Results showed advantages of communicability over conventional metrics in detecting densely connected nodes as well as subsets of nodes vulnerable to lesions. In addition, communicability centrality was shown to be widely affected by the lesions and the changes were negatively correlated with the distance from lesion site. In summary, our analysis suggests that communicability metrics that may provide an insight into the integrative properties of the structural brain network and that these metrics may be useful for the analysis of brain networks in the presence of lesions. Nevertheless, the interpretation of communicability is not straightforward; hence these metrics should be used as a supplement to the more standard connectivity network metrics.	[Andreotti, Jennifer; Jann, Kay; Melie-Garcia, Lester; Giezendanner, Stephanie; Dierks, Thomas; Federspiel, Andrea] Univ Bern, Univ Hosp Psychiat, Dept Psychiat Neurophysiol, Bern, Switzerland; [Jann, Kay] Univ Calif Los Angeles, Dept Neurol, Ahmanson Lovelace Brain Mapping Ctr, Lab Funct MRI Technol, Los Angeles, CA 90024 USA; [Melie-Garcia, Lester] Vaud Univ Hosp Ctr CHUV, Dept Clin Neurosci, Neuroimaging Res Lab LREN, Lausanne, Switzerland; [Abela, Eugenio; Wiest, Roland] Inselspital Bern, Univ Inst Diagnost & Intervent Neuroradiol, CH-3010 Bern, Switzerland; [Abela, Eugenio; Wiest, Roland] Univ Bern, Bern, Switzerland	University of Bern; University Hospital of Bern; University of California System; University of California Los Angeles; University of Bern; University Hospital of Bern; University of Bern	Andreotti, J (corresponding author), Univ Bern, Univ Hosp Psychiat, Dept Psychiat Neurophysiol, Bern, Switzerland.	andreotti@puk.unibe.ch	Dierks, Thomas/B-7092-2012; Melie-Garcia, Lester/U-5804-2019; Jann, Kay/AAF-2154-2020	Dierks, Thomas/0000-0002-4173-5308; Abela, Eugenio/0000-0002-9356-1450; Jann, Kay/0000-0003-3574-0538; Giezendanner, Stephanie/0000-0001-5660-9446	Swiss Foundation for Grants in Biology and Medicine (SFGBM) [142743]; Swiss National Science Foundation (SNSF) [320000-108321/1, 3200B0-118018]	Swiss Foundation for Grants in Biology and Medicine (SFGBM); Swiss National Science Foundation (SNSF)(Swiss National Science Foundation (SNSF))	KJ has a fellowship of the Swiss National Science Foundation (SNSF). Web SNSF: http://www.snf.ch/en/Pages/default.aspx. KJ was partially financed by the Swiss Foundation for Grants in Biology and Medicine (SFGBM)(grant no 142743). Web SFGMB: http://www.samw.ch/en/Research/SSMBS.html. This study was partially financed by the Swiss National Science Foundation (SNSF) Grant 320000-108321/1 (healthy subjects) and Grant 3200B0-118018 (Stroke patients). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alstott J, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000408; Andreotti J, 2014, BRAIN CONNECT, V4, P203, DOI 10.1089/brain.2013.0202; Basser PJ, 2000, MAGNET RESON MED, V44, P625, DOI 10.1002/1522-2594(200010)44:4<625::AID-MRM17>3.0.CO;2-O; BASSER PJ, 1994, BIOPHYS J, V66, P259, DOI 10.1016/S0006-3495(94)80775-1; BASSER PJ, 1994, J MAGN RESON SER B, V103, P247, DOI 10.1006/jmrb.1994.1037; Bassett DS, 2011, NEUROIMAGE, V54, P1262, DOI 10.1016/j.neuroimage.2010.09.006; Behrens TEJ, 2003, MAGN RESON MED, V50, P1077, DOI 10.1002/mrm.10609; Buchanan CR, 2014, NEUROIMAGE, V86, P231, DOI 10.1016/j.neuroimage.2013.09.054; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Crofts JJ, 2011, NEUROIMAGE, V54, P161, DOI 10.1016/j.neuroimage.2010.08.032; Crofts JJ, 2009, J R SOC INTERFACE, V6, P411, DOI 10.1098/rsif.2008.0484; Crossley NA, 2014, BRAIN, V137, P2382, DOI 10.1093/brain/awu132; Deichmann R, 2004, NEUROIMAGE, V21, P757, DOI 10.1016/j.neuroimage.2003.09.062; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; Estrada E, 2009, PHYSICA A, V388, P764, DOI 10.1016/j.physa.2008.11.011; Estrada E, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.036111; Fair DA, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000381; Filippi M, 2009, PROG BRAIN RES, V175, P465, DOI 10.1016/S0079-6123(09)17531-3; Fischl B, 2004, CEREB CORTEX, V14, P11, DOI 10.1093/cercor/bhg087; Fornito A, 2013, NEUROIMAGE, V80, P426, DOI 10.1016/j.neuroimage.2013.04.087; FREEMAN LC, 1979, SOC NETWORKS, V1, P215, DOI 10.1016/0378-8733(78)90021-7; Goni J, 2014, P NATL ACAD SCI USA, V111, P833, DOI 10.1073/pnas.1315529111; Griffa A, 2013, NEUROIMAGE, V80, P515, DOI 10.1016/j.neuroimage.2013.04.056; Hagmann P, 2008, PLOS BIOL, V6, P1479, DOI 10.1371/journal.pbio.0060159; He Y, 2009, BRAIN, V132, P3366, DOI 10.1093/brain/awp089; Iturria-Medina Y, 2007, NEUROIMAGE, V36, P645, DOI 10.1016/j.neuroimage.2007.02.012; Jones DK, 2013, NEUROIMAGE, V73, P239, DOI 10.1016/j.neuroimage.2012.06.081; Kraft RH, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002619; Kuceyeski A, 2013, BRAIN CONNECT, V3, P451, DOI 10.1089/brain.2013.0147; Kuceyeski A, 2011, NEUROIMAGE, V58, P109, DOI 10.1016/j.neuroimage.2011.05.087; Latora V, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.198701; Li Y, 2013, HUM BRAIN MAPP, V34, P3376, DOI 10.1002/hbm.22158; Liang ZJ, 2007, J NEUROL NEUROSUR PS, V78, P581, DOI 10.1136/jnnp.2006.099077; Lo CY, 2010, J NEUROSCI, V30, P16876, DOI 10.1523/JNEUROSCI.4136-10.2010; Majdandzic A, 2014, NAT PHYS, V10, P34, DOI [10.1038/nphys2819, 10.1038/NPHYS2819]; Melie-Garcia L, 2010, MORPHOCONNECT TOOLBO; Mori S, 1999, ANN NEUROL, V45, P265, DOI 10.1002/1531-8249(199902)45:2<265::AID-ANA21>3.0.CO;2-3; Parker GJM, 2002, NEUROIMAGE, V15, P797, DOI 10.1006/nimg.2001.0994; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Rubinov M, 2011, J NEUROSCI, V31, P6263, DOI 10.1523/JNEUROSCI.0382-11.2011; Sampaio-Baptista C, 2013, J NEUROSCI, V33, P19499, DOI 10.1523/JNEUROSCI.3048-13.2013; Schaechter JD, 2006, BRAIN, V129, P2722, DOI 10.1093/brain/awl214; Scholz J, 2009, NAT NEUROSCI, V12, P1370, DOI 10.1038/nn.2412; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Thiebaut de Schotten M, 2014, CEREB CORTEX, V24, P989, DOI 10.1093/cercor/bhs383; Trusina A, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.238701; van den Heuvel MP, 2013, JAMA PSYCHIAT, V70, P783, DOI 10.1001/jamapsychiatry.2013.1328; van den Heuvel MP, 2012, P NATL ACAD SCI USA, V109, P11372, DOI 10.1073/pnas.1203593109; van den Heuvel MP, 2011, J NEUROSCI, V31, P15775, DOI 10.1523/JNEUROSCI.3539-11.2011; Vlooswijk MCG, 2011, NEUROLOGY, V77, P938, DOI 10.1212/WNL.0b013e31822cfc2f; Wang QF, 2012, NEUROIMAGE, V59, P1085, DOI 10.1016/j.neuroimage.2011.09.035; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Xia MR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068910	53	16	16	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2014	9	12							e115503	10.1371/journal.pone.0115503	http://dx.doi.org/10.1371/journal.pone.0115503			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX6YH	25549088	Green Published, gold, Green Submitted			2022-12-27	WOS:000347063500014
J	Li, T; Xie, JJ; Shen, C; Cheng, DF; Shi, Y; Wu, ZC; Zhan, Q; Deng, XX; Chen, H; Shen, BY; Peng, CG; Li, HW; Zhu, ZC				Li, Tao; Xie, Junjie; Shen, Chuan; Cheng, Dongfeng; Shi, Yuan; Wu, Zhichong; Zhan, Qian; Deng, Xiaxing; Chen, Hao; Shen, Baiyong; Peng, Chenghong; Li, Hongwei; Zhu, Zhecheng			miR-150-5p Inhibits Hepatoma Cell Migration and Invasion by Targeting MMP14	PLOS ONE			English	Article							HEPATOCELLULAR-CARCINOMA; POOR-PROGNOSIS; CANCER INVASION; DOWN-REGULATION; METASTASIS; EXPRESSION; OVEREXPRESSION; ANGIOGENESIS; MICRORNAS; SNAIL	Hepatocellular carcinoma (HCC) is one of the leading causes of cancer-related mortality worldwide. Despite progress in diagnostics and treatment of HCC, its prognosis remains poor because the molecular mechanisms underlying hepatocarcinogenesis are not well understood. In the study, we focused on identifying the role of miRNAs in HCC progression. miRNA microarray was used to analyze the differentially expressed miRNAs, and the results were validated by qPCR. We found that the miR-150-5p expression is down-regulated in HCC tissues compared with pair non-tumor tissues. miR-150-5p expression is also decreased in metastatic cancer tissues compared with pair primary tissues, indicating that miR-150-5p may be involved in HCC metastasis. Functionally, miR-150-5p inhibition significantly promotes hepatoma cell migration and invasion, whereas miR-150-5p overexpression suppresses cancer cell migration and invasion in vitro. The matrix metalloproteinase 14 (MMP14) is identified as a new target gene of miR-150-5p. miR-150-5p markedly inhibits MMP14 expression in hepatoma cells, and miR-150-5p expression is negative correlation with MMP14 expression in vivo. More important, re-expression of MMP14 in hepatoma cells partially reverses the effect of miR-150-5p in inhibiting cell invasion.	[Li, Tao; Xie, Junjie; Shen, Chuan; Cheng, Dongfeng; Shi, Yuan; Wu, Zhichong; Zhan, Qian; Deng, Xiaxing; Chen, Hao; Shen, Baiyong; Peng, Chenghong; Li, Hongwei; Zhu, Zhecheng] Shanghai Jiao Tong Univ, Rui Jin Hosp, Shanghai Inst Digest Surg, Dept Hepato Bilio Pancreat Surg, Shanghai 200025, Peoples R China	Shanghai Jiao Tong University	Zhu, ZC (corresponding author), Shanghai Jiao Tong Univ, Rui Jin Hosp, Shanghai Inst Digest Surg, Dept Hepato Bilio Pancreat Surg, Ruijin Er Rd 197, Shanghai 200025, Peoples R China.	zhuzhecheng@126.com		Peng, Chenghong/0000-0002-5573-7873; WU, Zhichong/0000-0002-6166-755X				Akanuma N, 2014, BRIT J CANCER, V110, P189, DOI 10.1038/bjc.2013.676; Bao B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017850; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Callegari E, 2014, CELL DEATH DIFFER; Cao MH, 2014, EUR J CANCER, V50, P1013, DOI 10.1016/j.ejca.2013.12.024; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Connor KM, 2007, CANCER RES, V67, P10260, DOI 10.1158/0008-5472.CAN-07-1204; Egawa N, 2006, J BIOL CHEM, V281, P37576, DOI 10.1074/jbc.M606993200; El-Serag HB, 1999, NEW ENGL J MED, V340, P745, DOI 10.1056/NEJM199903113401001; Fang JH, 2011, HEPATOLOGY, V54, P1729, DOI 10.1002/hep.24577; Fang YX, 2012, HEPATOLOGY, V55, P1852, DOI 10.1002/hep.25576; Hwang HW, 2006, BRIT J CANCER, V94, P776, DOI 10.1038/sj.bjc.6603023; Ito M, 2014, BLOOD, V123, P1499, DOI 10.1182/blood-2013-09-527739; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jin MF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103965; Li YY, 2013, CANCER LETT, V339, P260, DOI 10.1016/j.canlet.2013.06.018; Ma YL, 2012, GUT, V61, P1447, DOI 10.1136/gutjnl-2011-301122; Miyoshi A, 2004, BRIT J CANCER, V90, P1265, DOI 10.1038/sj.bjc.6601685; Miyoshi A, 2005, BRIT J CANCER, V92, P252, DOI 10.1038/sj.bjc.6602266; Saito Y, 2009, ONCOGENE, V28, P2738, DOI 10.1038/onc.2009.140; Taras D, 2007, J HEPATOL, V46, P69, DOI 10.1016/j.jhep.2006.06.015; Wang J, 2013, BIOCHEM BIOPH RES CO, V439, P47, DOI 10.1016/j.bbrc.2013.08.032; Wang J, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-227; Wang RZ, 2013, HEPATOLOGY, V58, P642, DOI 10.1002/hep.26373; Wang WH, 2014, ASIAN PAC J CANCER P, V15, P6269, DOI 10.7314/APJCP.2014.15.15.6269; Xia LM, 2013, HEPATOLOGY, V57, P610, DOI 10.1002/hep.26029; Xu N, 2012, BIOCHEM BIOPH RES CO, V425, P468, DOI 10.1016/j.bbrc.2012.07.127; Yang H, 2013, HEPATOLOGY, V58, P205, DOI 10.1002/hep.26315; Yokobori T, 2013, CANCER SCI, V104, P48, DOI 10.1111/cas.12030	29	61	65	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2014	9	12							e115577	10.1371/journal.pone.0115577	http://dx.doi.org/10.1371/journal.pone.0115577			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX6YH	25549355	Green Submitted, Green Published, gold			2022-12-27	WOS:000347063500017
J	Yu, KQ; Zhao, YR; Li, XL; Shao, YN; Liu, F; He, Y				Yu, Ke-Qiang; Zhao, Yan-Ru; Li, Xiao-Li; Shao, Yong-Ni; Liu, Fei; He, Yong			Hyperspectral Imaging for Mapping of Total Nitrogen Spatial Distribution in Pepper Plant	PLOS ONE			English	Article							INFRARED-SPECTROSCOPY; VARIABLE SELECTION; QUALITY EVALUATION; SPECTRAL INDEXES; MATTER CONTENT; RANDOM FROG; REFLECTANCE; DEFICIENCY; PREDICTION; CALIBRATION	Visible/near-infrared (Vis/NIR) hyperspectral imaging was employed to determine the spatial distribution of total nitrogen in pepper plant. Hyperspectral images of samples (leaves, stems, and roots of pepper plants) were acquired and their total nitrogen contents (TNCs) were measured using Dumas combustion method. Mean spectra of all samples were extracted from regions of interest (ROIs) in hyperspectral images. Random frog (RF) algorithm was implemented to select important wavelengths which carried effective information for predicting the TNCs in leaf, stem, root, and whole-plant (leaf-stem-root), respectively. Based on full spectra and the selected important wavelengths, the quantitative relationships between spectral data and the corresponding TNCs in organs (leaf, stem, and root) and whole-plant (leaf-stem-root) were separately developed using partial least-squares regression (PLSR). As a result, the PLSR model built by the important wavelengths for predicting TNCs in whole-plant (leaf-stem-root) offered a promising result of correlation coefficient (R) for prediction (R-P=0.876) and root mean square error (RMSE) for prediction (RMSEP=0.426%). Finally, the TNC of each pixel within ROI of the sample was estimated to generate the spatial distribution map of TNC in pepper plant. The achievements of the research indicated that hyperspectral imaging is promising and presents a powerful potential to determine nitrogen contents spatial distribution in pepper plant.	[Yu, Ke-Qiang; Zhao, Yan-Ru; Li, Xiao-Li; Shao, Yong-Ni; Liu, Fei; He, Yong] Zhejiang Univ, Coll Biosyst Engn & Food Sci, Hangzhou 310003, Zhejiang, Peoples R China; [Li, Xiao-Li; Shao, Yong-Ni; Liu, Fei; He, Yong] Minist Agr, Key Lab Equipment & Informatizat Environm Control, Beijing, Peoples R China	Zhejiang University; Ministry of Agriculture & Rural Affairs	He, Y (corresponding author), Zhejiang Univ, Coll Biosyst Engn & Food Sci, Hangzhou 310003, Zhejiang, Peoples R China.	yhe@zju.edu.cn	He, Yong/E-3218-2010; LIU, Fei/A-9493-2009; Li, Xiaoli/GYQ-7384-2022	He, Yong/0000-0001-6752-1757; LIU, Fei/0000-0003-0266-6896; Li, Xiaoli/0000-0001-9689-9054	863 National High-Tech Research and Development Plan [2013AA102301]	863 National High-Tech Research and Development Plan(National High Technology Research and Development Program of China)	This study was supported by 863 National High-Tech Research and Development Plan (Project No. 2013AA102301). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1983, BIOPHYSICAL PLANT PH; Anten NPR, 1998, OECOLOGIA, V113, P314, DOI 10.1007/s004420050382; Barbarino E, 2009, LIMNOL OCEANOGR-METH, V7, P751, DOI 10.4319/lom.2009.7.751; Barbin DF, 2013, INNOV FOOD SCI EMERG, V18, P226, DOI 10.1016/j.ifset.2012.12.011; Blackmer TM, 1996, AGRON J, V88, P1, DOI 10.2134/agronj1996.00021962008800010001x; Bondada BR, 2001, J PLANT NUTR, V24, P469, DOI 10.1081/PLN-100104973; Bosland P. W., 1992, HortTechnology, V2, P6; Boussadia O, 2010, SCI HORTIC-AMSTERDAM, V123, P336, DOI 10.1016/j.scienta.2009.09.023; Bronson KF, 2006, AGRON J, V98, P212, DOI 10.2134/agronj2005.0149; Cassman KG, 2002, AMBIO, V31, P132, DOI 10.1639/0044-7447(2002)031[0132:ANUEAN]2.0.CO;2; Cheng JH, 2014, FOOD RES INT, V56, P190, DOI 10.1016/j.foodres.2013.12.009; Cho MA, 2006, REMOTE SENS ENVIRON, V101, P181, DOI 10.1016/j.rse.2005.12.011; Cruz-Durán Jairo Aarón de la, 2011, Terra Latinoam, V29, P259; Demirel K, 2014, FRESEN ENVIRON BULL, V23, P1232; Diacono M, 2013, AGRON SUSTAIN DEV, V33, P219, DOI 10.1007/s13593-012-0111-z; DURAN C, 2013, REFLECTANCIA HOJAS P; Elmasry G, 2012, CRIT REV FOOD SCI, V52, P999, DOI 10.1080/10408398.2010.543495; Evans RD, 2001, TRENDS PLANT SCI, V6, P121, DOI 10.1016/S1360-1385(01)01889-1; *FAOST, 2001, FAO WAT DEV MAN UN; Fauzi A, 2013, MAR POLLUT BULL, V76, P42, DOI 10.1016/j.marpolbul.2013.09.033; Feng L, 2006, SPECTROSC SPECT ANAL, V26, P1749; Galvao RKH, 2005, TALANTA, V67, P736, DOI 10.1016/j.talanta.2005.03.025; Geladi P, 2004, CHEMOMETR INTELL LAB, V72, P209, DOI 10.1016/j.chemolab.2004.01.023; He HJ, 2014, J FOOD ENG, V126, P156, DOI 10.1016/j.jfoodeng.2013.11.015; He HJ, 2013, INNOV FOOD SCI EMERG, V18, P237, DOI 10.1016/j.ifset.2013.02.009; HOPKINS W. G., 2008, INTRO PLANT PHYSL, VFourth; Hortensteiner S, 2002, J EXP BOT, V53, P927, DOI 10.1093/jexbot/53.370.927; Inoue Y, 2012, REMOTE SENS ENVIRON, V126, P210, DOI 10.1016/j.rse.2012.08.026; Jackman P, 2008, MEAT SCI, V80, P1273, DOI 10.1016/j.meatsci.2008.06.001; Jackman P, 2009, PATTERN RECOGN, V42, P751, DOI 10.1016/j.patcog.2008.09.009; Johnson CD, 1996, HORTSCIENCE, V31, P1119, DOI 10.21273/HORTSCI.31.7.1119; Kamnev AA, 2008, MICROBIOLOGY+, V77, P240, DOI 10.1134/S0026261708020197; Kokaly RF, 2001, REMOTE SENS ENVIRON, V75, P153, DOI 10.1016/S0034-4257(00)00163-2; Kumagai E, 2009, PHOTOSYNTHETICA, V47, P241, DOI 10.1007/s11099-009-0038-z; Lee YJ, 2008, AGRON J, V100, P205, DOI 10.2134/agrojnl2007.0018; Li D, 2012, SOIL TILL RES, V123, P78, DOI 10.1016/j.still.2012.03.013; Li F, 2014, EUR J AGRON, V52, P198, DOI 10.1016/j.eja.2013.09.006; Li HD, 2012, ANAL CHIM ACTA, V740, P20, DOI 10.1016/j.aca.2012.06.031; Li JW, 2009, FIELD CROP RES, V114, P426, DOI 10.1016/j.fcr.2009.09.009; Li XL, 2013, COMPUT ELECTRON AGR, V98, P46, DOI 10.1016/j.compag.2013.07.014; Liu D, 2014, FOOD BIOPROCESS TECH, V7, P307, DOI 10.1007/s11947-013-1193-6; Martin ME, 1997, ECOL APPL, V7, P431, DOI 10.1890/1051-0761(1997)007[0431:HSRRSO]2.0.CO;2; MARTINEZ ESJ, 2014, DIAGNOSIS NITROGENO; MATTSON WJ, 1980, ANNU REV ECOL SYST, V11, P119, DOI 10.1146/annurev.es.11.110180.001003; Moscetti R, 2014, POSTHARVEST BIOL TEC, V87, P88, DOI 10.1016/j.postharvbio.2013.08.010; *NAT FARM INF SERV, 2014, CROP MAN GREENH NURS; NELSON DW, 1973, AGRON J, V65, P109, DOI 10.2134/agronj1973.00021962006500010033x; PATE J S, 1973, Soil Biology and Biochemistry, V5, P109, DOI 10.1016/0038-0717(73)90097-7; PATE JS, 1980, ANNU REV PLANT PHYS, V31, P313, DOI 10.1146/annurev.pp.31.060180.001525; PENA RG, 2011, REFLECTANCIA HOJAS C; PENUELAS J, 1993, INT J REMOTE SENS, V14, P1887, DOI 10.1080/01431169308954010; Rossel RAV, 2010, GEODERMA, V158, P46, DOI 10.1016/j.geoderma.2009.12.025; Shaahan MM, 1999, SCI HORTIC-AMSTERDAM, V82, P339, DOI 10.1016/S0304-4238(99)00060-6; Shi JY, 2012, SCI HORTIC-AMSTERDAM, V138, P190, DOI 10.1016/j.scienta.2012.02.024; SKJODT P, 2003, SENSOR BASED NITROGE; Smith ML, 2003, IEEE T GEOSCI REMOTE, V41, P1332, DOI 10.1109/TGRS.2003.813128; STEVENSON FJ, 1982, CROP NITROGEN REQUIR, P567; Tylova-Munzarova E, 2005, AQUAT BOT, V81, P326, DOI 10.1016/j.aquabot.2005.01.006; Valous NA, 2009, MEAT SCI, V81, P132, DOI 10.1016/j.meatsci.2008.07.009; Van Hezewijk BH, 2008, BIOL CONTROL, V46, P332, DOI 10.1016/j.biocontrol.2008.04.003; Vigneau N, 2011, FIELD CROP RES, V122, P25, DOI 10.1016/j.fcr.2011.02.003; Wold S, 2001, CHEMOMETR INTELL LAB, V58, P109, DOI 10.1016/S0169-7439(01)00155-1; Wu D, 2008, J FOOD ENG, V84, P124, DOI 10.1016/j.jfoodeng.2007.04.031; Wu D, 2011, J FOOD ENG, V102, P278, DOI 10.1016/j.jfoodeng.2010.09.002; Wu D, 2010, ANAL CHIM ACTA, V659, P229, DOI 10.1016/j.aca.2009.11.045; Yan J, 2014, MOL INFORM, V33, P503, DOI 10.1002/minf.201300161; Yao X, 2010, INT J APPL EARTH OBS, V12, P89, DOI 10.1016/j.jag.2009.11.008; Yu KQ, 2014, FOOD BIOPROCESS TECH, V7, P3077, DOI 10.1007/s11947-014-1357-z; Yu KQ, 2014, COMPUT ELECTRON AGR, V103, P1, DOI 10.1016/j.compag.2014.01.016; Yun YH, 2013, SPECTROCHIM ACTA A, V111, P31, DOI 10.1016/j.saa.2013.03.083; Zhang XL, 2013, BIOSYST ENG, V115, P56, DOI 10.1016/j.biosystemseng.2013.02.007; Zhao CJ, 2010, PRECIS AGRIC, V11, P557, DOI 10.1007/s11119-009-9148-7; Zhu FL, 2014, FOOD BIOPROCESS TECH, V7, P1208, DOI 10.1007/s11947-013-1228-z; Zou XB, 2010, CHEMOMETR INTELL LAB, V104, P265, DOI 10.1016/j.chemolab.2010.08.019	74	59	62	6	84	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2014	9	12							e116205	10.1371/journal.pone.0116205	http://dx.doi.org/10.1371/journal.pone.0116205			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX6YH	25549353	Green Submitted, gold, Green Published			2022-12-27	WOS:000347063500062
J	Pasetto, S; Pardi, V; Murata, RM				Pasetto, Silvana; Pardi, Vanessa; Murata, Ramiro Mendonca			Anti-HIV-1 Activity of Flavonoid Myricetin on HIV-1 Infection in a Dual-Chamber In Vitro Model	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; ANTIOXIDANT ACTIVITY; NATURAL-PRODUCTS; HEART-DISEASE; CELL LINE; INHIBITION; QUERCETIN; MICROBICIDES; INFLAMMATION; TRANSMISSION	HIV infection by sexual transmission remains an enormous global health concern. More than 1 million new infections among women occur annually. Microbicides represent a promising prevention strategy that women can easily control. Among emerging therapies, natural small molecules such as flavonoids are an important source of new active substances. In this study we report the in vitro cytotoxicity and anti-HIV-1 and microbicide activity of the following flavonoids: Myricetin, Quercetin and Pinocembrin. Cytotoxicity tests were conducted on TZM-bl, HeLa, PBMC, and H9 cell cultures using 0.01-100 mu M concentrations. Myricetin presented the lowest toxic effect, with Quercetin and Pinocembrin relatively more toxic. The anti-HIV-1 activity was tested with TZM-bl cell plus HIV-1 BaL (R5 tropic), H9 and PBMC cells plus HIV-1 MN (X4 tropic), and the dual tropic (X4R5) HIV-1 89.6. All flavonoids showed anti-HIV activity, although Myricetin was more effective than Quercetin or Pinocembrin. In TZM-bl cells, Myricetin inhibited >= 90% of HIV-1 BaL infection. The results were confirmed by quantification of HIV-1 p24 antigen in supernatant from H9 and PBMC cells following flavonoid treatment. In H9 and PBMC cells infected by HIV-1 MN and HIV-1 89.6, Myricetin showed more than 80% anti-HIV activity. Quercetin and Pinocembrin presented modest anti-HIV activity in all experiments. Myricetin activity was tested against HIV-RT and inhibited the enzyme by 49%. Microbicide activities were evaluated using a dual-chamber female genital tract model. In the in vitro microbicide activity model, Myricetin showed promising results against different strains of HIV-1 while also showing insignificant cytotoxic effects. Further studies of Myricetin should be performed to identify its molecular targets in order to provide a solid biological foundation for translational research.	[Pasetto, Silvana; Pardi, Vanessa; Murata, Ramiro Mendonca] Univ So Calif, Ostrow Sch Dent, Div Periodontol Diagnost Sci Dent Hyg & Biomed Sc, Los Angeles, CA 90045 USA	University of Southern California	Murata, RM (corresponding author), Univ So Calif, Ostrow Sch Dent, Div Periodontol Diagnost Sci Dent Hyg & Biomed Sc, Los Angeles, CA 90045 USA.	ramiro.murata@usc.edu	Murata, Ramiro M/P-9052-2014; PASETTO, SILVANA/O-5586-2015; Pardi, Vanessa/AAV-3252-2021	Murata, Ramiro M/0000-0002-8478-6981; Pardi, Vanessa/0000-0001-7120-4332	National Center for Complementary and Alternative Medicine of the National Institutes of Health [R00AT006507]; NATIONAL CENTER FOR COMPLEMENTARY & ALTERNATIVE MEDICINE [R00AT006507] Funding Source: NIH RePORTER	National Center for Complementary and Alternative Medicine of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); NATIONAL CENTER FOR COMPLEMENTARY & ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine)	Research reported in this publication was supported by the National Center for Complementary and Alternative Medicine of the National Institutes of Health under award number R00AT006507. The content is solely the responsibility of the authors and does not necessarily represent the official views of the funding agencies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arien KK, 2011, REV MED VIROL; Arien KK, 2011, CURR PROTOC CELL BIO; Ataher Q, 2012, J INT AIDS SOC, V15, DOI 10.1186/1758-2652-15-2; Basso LA, 2005, MEM I OSWALDO CRUZ, V100, P575, DOI 10.1590/S0074-02762005000600001; Bomsel M, 1997, NAT MED, V3, P42, DOI 10.1038/nm0197-42; COLLMAN R, 1992, J VIROL, V66, P7517, DOI 10.1128/JVI.66.12.7517-7521.1992; Comalada M, 2005, EUR J IMMUNOL, V35, P584, DOI 10.1002/eji.200425778; Coombs RW, 2003, AIDS, V17, P455, DOI 10.1097/00002030-200303070-00001; Critchfield JW, 1996, AIDS RES HUM RETROV, V12, P39, DOI 10.1089/aid.1996.12.39; Cutler B, 2008, LANCET INFECT DIS, V8, P685, DOI 10.1016/S1473-3099(08)70254-8; D'Cruz OJ, 2004, CURR PHARM DESIGN, V10, P315, DOI 10.2174/1381612043386374; De Clercq E, 2010, CURR OPIN PHARMACOL, V10, P507, DOI 10.1016/j.coph.2010.04.011; Di Stasi LC, 2002, FITOTERAPIA, V73, P69, DOI 10.1016/S0367-326X(01)00362-8; FESEN MR, 1994, BIOCHEM PHARMACOL, V48, P595, DOI 10.1016/0006-2952(94)90291-7; Gali Y, 2010, J VIROL METHODS, V165, P186, DOI 10.1016/j.jviromet.2010.01.018; GALLO RC, 1984, SCIENCE, V224, P500, DOI 10.1126/science.6200936; Goncalves MAFV, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010954; Gordon MH, 1998, CHEM PHYS LIPIDS, V97, P79, DOI 10.1016/S0009-3084(98)00098-X; GURGO C, 1988, VIROLOGY, V164, P531, DOI 10.1016/0042-6822(88)90568-5; HAVSTEEN B, 1983, BIOCHEM PHARMACOL, V32, P1141, DOI 10.1016/0006-2952(83)90262-9; HERTOG MGL, 1995, ARCH INTERN MED, V155, P381, DOI 10.1001/archinte.155.4.381; KANDASWAMI C, 1994, ADV EXP MED BIOL, V366, P351; Karim QA, 2010, SCIENCE, V329, P1168, DOI 10.1126/science.1193748; Karim QA, 2010, CLIN INFECT DIS, V50, pS122, DOI 10.1086/651483; Kim HJ, 1998, J NAT PROD, V61, P145, DOI 10.1021/np970171q; Kim ME, 2014, ANTICANCER RES, V34, P701; Lee KW, 2007, CARCINOGENESIS, V28, P1918, DOI 10.1093/carcin/bgm110; Lee-Huang S, 2003, BIOCHEM BIOPH RES CO, V307, P1029, DOI 10.1016/S0006-291X(03)01292-0; Li BQ, 2000, BIOCHEM BIOPH RES CO, V276, P534, DOI 10.1006/bbrc.2000.3485; Li M, 2005, J VIROL, V79, P10108, DOI 10.1128/JVI.79.16.10108-10125.2005; Lyu SY, 2005, ARCH PHARM RES, V28, P1293, DOI 10.1007/BF02978215; Marquez N, 2005, ANTIVIR RES, V66, P137, DOI 10.1016/j.antiviral.2005.02.006; Mehla R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027915; Middleton E, 2000, PHARMACOL REV, V52, P673; Montefiori David C., 2009, V485, P395, DOI 10.1007/978-1-59745-170-3_26; Newman DJ, 2012, J NAT PROD, V75, P311, DOI 10.1021/np200906s; NIH, 2012, AR EMPH MICR, P77; Nijhuis M., 2009, V189, P299, DOI 10.1007/978-3-540-79086-0_11; O'Brien J, 2000, EUR J BIOCHEM, V267, P5421, DOI 10.1046/j.1432-1327.2000.01606.x; Ochsenbauer-Jambor C, 2006, BIOTECHNIQUES, V40, P91, DOI 10.2144/000112072; ONO K, 1990, J BIOCHEM-TOKYO, V108, P609, DOI 10.1093/oxfordjournals.jbchem.a123251; Popovic M, 1989, RETROVIRUSES HUMAN A, P21; Rajotte D, 2013, ANTIMICROB AGENTS CH, V57, P2712, DOI 10.1128/AAC.00113-13; REITZ MS, 1992, AIDS RES HUM RETROV, V8, P1950; Richman DD, 2001, CURR PROTOC IMMUNOL; Richman DD, 2006, ANTIVIR RES, V71, P117, DOI 10.1016/j.antiviral.2006.03.004; Royce RA, 1997, NEW ENGL J MED, V336, P1072, DOI 10.1056/NEJM199704103361507; Sala A, 2003, EUR J PHARMACOL, V461, P53, DOI 10.1016/S0014-2999(02)02953-9; Santos AC, 1998, FREE RADICAL BIO MED, V24, P1455, DOI 10.1016/S0891-5849(98)00003-3; Schnitzler P, 2010, PHYTOTHER RES, V24, pS20, DOI 10.1002/ptr.2868; Sharma R, 2013, BMC COMPLEM ALTERN M, V13, DOI 10.1186/1472-6882-13-292; Stone A, 2010, REGULATORY ISSUES MI; TAN GT, 1991, J NAT PROD, V54, P143, DOI 10.1021/np50073a012; UNAIDS, 2013, UNAIDS GLOB AIDS EP, p1 ; UNAIDS, 2012, TOG WE WILL END AIDS, P1; Uzel A, 2005, MICROBIOL RES, V160, P189, DOI 10.1016/j.micres.2005.01.002; Van Herrewege Y, 2007, ANTIVIR RES, V74, P111, DOI 10.1016/j.antiviral.2006.10.010; WOOD KV, 1990, J BIOLUM CHEMILUM, V5, P107, DOI 10.1002/bio.1170050206; Young JF, 1999, AM J CLIN NUTR, V69, P87; Yu YB, 2007, ARCH PHARM RES, V30, P820, DOI 10.1007/BF02978831	60	80	87	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2014	9	12							e115323	10.1371/journal.pone.0115323	http://dx.doi.org/10.1371/journal.pone.0115323			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UN	25546350	gold, Green Published, Green Submitted			2022-12-27	WOS:000347120200038
J	Zhu, WL; Tong, HL; Teh, JT; Wang, M				Zhu, Wan Long; Tong, Honglian; Teh, Jing Tsong; Wang, Mei			Forkhead Box Protein O3 Transcription Factor Negatively Regulates Autophagy in Human Cancer Cells by Inhibiting Forkhead Box Protein O1 Expression and Cytosolic Accumulation	PLOS ONE			English	Article							FACTOR FOXO1; PHOSPHORYLATION; ACETYLATION; TARGET; AKT; SENSITIVITY; MECHANISMS; APOPTOSIS; PATHWAYS; DEATH	FoxO proteins are important regulators in cellular metabolism and are recognized to be nodes in multiple signaling pathways, most notably those involving PI3K/AKT and mTOR. FoxO proteins primarily function as transcription factors, but recent study suggests that cytosolic FoxO1 participates in the regulation of autophagy. In the current study, we find that cytosolic FoxO1 indeed stimulates cellular autophagy in multiple cancer cell lines, and that it regulates not only basal autophagy but also that induced by rapamycin and that in response to nutrient deprivation. These findings illustrate the importance of FoxO1 in cell metabolism regulation independent of its transcription factor function. In contrast to FoxO1, we find the closely related FoxO3a is a negative regulator of autophagy in multiple cancer cell lines, a previously unrecognized function for this protein, different from its function in benign fibroblast and muscle cells. The induction of autophagy by the knockdown of FoxO3a was found not to be mediated through the suppression of mTORC1 signaling; rather, the regulatory role of FoxO3a on autophagy was determined to be through its ability to transcriptionally suppress FoxO1. This complicated interplay of FoxO1 and FoxO3a suggests a complex checks- and balances-relationship between FoxO3a and FoxO1 in regulating autophagy and cell metabolism.	[Zhu, Wan Long; Tong, Honglian; Teh, Jing Tsong; Wang, Mei] Duke NUS Grad Med Sch, Program Canc & Stem Cell Biol, Singapore, Singapore; [Zhu, Wan Long; Wang, Mei] Natl Univ Singapore, Dept Biochem, Singapore 117548, Singapore	National University of Singapore; National University of Singapore	Wang, M (corresponding author), Duke NUS Grad Med Sch, Program Canc & Stem Cell Biol, Singapore, Singapore.	mei.wang@duke-nus.edu.sg	Zhu, Wan Long/GYA-3382-2022	Wang, Mei/0000-0001-6887-6840; zhu, Wanlong/0000-0003-0025-6674	Agency for Science, Technology and Research (A*STAR); National Medical Research Council of Singapore	Agency for Science, Technology and Research (A*STAR)(Agency for Science Technology & Research (A*STAR)); National Medical Research Council of Singapore(National Medical Research Council, Singapore)	This work was supported by Agency for Science, Technology and Research (A*STAR) and National Medical Research Council of Singapore. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Biggs WH, 1999, P NATL ACAD SCI USA, V96, P7421, DOI 10.1073/pnas.96.13.7421; Boccitto M, 2011, CURR DRUG TARGETS, V12, P1303, DOI 10.2174/138945011796150316; Brownawell AM, 2001, MOL CELL BIOL, V21, P3534, DOI 10.1128/MCB.21.10.3534-3546.2001; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Bursch W, 2000, ANN NY ACAD SCI, V926, P1, DOI 10.1111/j.1749-6632.2000.tb05594.x; Calnan DR, 2008, ONCOGENE, V27, P2276, DOI 10.1038/onc.2008.21; Cao Y, 2006, J BIOL CHEM, V281, P40242, DOI 10.1074/jbc.M608116200; Chen CC, 2010, DEV CELL, V18, P592, DOI 10.1016/j.devcel.2010.03.008; Chiacchiera F, 2009, CELL DEATH DIFFER, V16, P1203, DOI 10.1038/cdd.2009.36; Dalby KN, 2010, AUTOPHAGY, V6, P322, DOI 10.4161/auto.6.3.11625; Greer EL, 2005, ONCOGENE, V24, P7410, DOI 10.1038/sj.onc.1209086; He CC, 2009, ANNU REV GENET, V43, P67, DOI 10.1146/annurev-genet-102808-114910; Hu MCT, 2004, CELL, V117, P225, DOI 10.1016/S0092-8674(04)00302-2; Janku F, 2011, NAT REV CLIN ONCOL, V8, P528, DOI 10.1038/nrclinonc.2011.71; Kimura S, 2007, AUTOPHAGY, V3, P452, DOI 10.4161/auto.4451; Klionsky DJ, 2000, SCIENCE, V290, P1717, DOI 10.1126/science.290.5497.1717; Kuma A, 2004, NATURE, V432, P1032, DOI 10.1038/nature03029; Kume S, 2010, J CLIN INVEST, V120, P1043, DOI 10.1172/JCI41376; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Mammucari C, 2007, CELL METAB, V6, P458, DOI 10.1016/j.cmet.2007.11.001; Matsumoto M, 2007, CELL METAB, V6, P208, DOI 10.1016/j.cmet.2007.08.006; Matsumoto M, 2006, J CLIN INVEST, V116, P2464, DOI 10.1172/JCI27047; Matsuzaki H, 2005, P NATL ACAD SCI USA, V102, P11278, DOI 10.1073/pnas.0502738102; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Paik JH, 2007, CELL, V128, P309, DOI 10.1016/j.cell.2006.12.029; Qiang L, 2010, J BIOL CHEM, V285, P27396, DOI 10.1074/jbc.M110.140228; Rena G, 1999, J BIOL CHEM, V274, P17179, DOI 10.1074/jbc.274.24.17179; Rubinsztein DC, 2012, NAT REV DRUG DISCOV, V11, P709, DOI 10.1038/nrd3802; Rubinsztein DC, 2011, CELL, V146, P682, DOI 10.1016/j.cell.2011.07.030; Salih DAM, 2008, CURR OPIN CELL BIOL, V20, P126, DOI 10.1016/j.ceb.2008.02.005; Sawyers CL, 2003, CANCER CELL, V4, P343, DOI 10.1016/S1535-6108(03)00275-7; Sengupta A, 2009, J BIOL CHEM, V284, P28319, DOI 10.1074/jbc.M109.024406; Seoane J, 2004, CELL, V117, P211, DOI 10.1016/S0092-8674(04)00298-3; Singh A, 2011, CURR DRUG TARGETS, V12, P1311, DOI 10.2174/138945011796150271; Tang ED, 1999, J BIOL CHEM, V274, P16741, DOI 10.1074/jbc.274.24.16741; van der Heide LP, 2004, BIOCHEM J, V380, P297, DOI 10.1042/BJ20040167; Vogt PK, 2005, CELL CYCLE, V4, P908, DOI 10.4161/cc.4.7.1796; Wang M, 2010, ONCOGENE, V29, P4959, DOI 10.1038/onc.2010.247; Wang M, 2008, J BIOL CHEM, V283, P18678, DOI 10.1074/jbc.M801855200; Yamagata K, 2008, MOL CELL, V32, P221, DOI 10.1016/j.molcel.2008.09.013; Yang SH, 2011, GENE DEV, V25, P717, DOI 10.1101/gad.2016111; Zhao Y, 2010, NAT CELL BIOL, V12, P665, DOI 10.1038/ncb2069; Zhou JY, 2012, AUTOPHAGY, V8, P1712, DOI 10.4161/auto.21830; Zhu WL, 2011, J BIOL CHEM, V286, P35291, DOI 10.1074/jbc.M111.280990	44	15	17	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2014	9	12							e115087	10.1371/journal.pone.0115087	http://dx.doi.org/10.1371/journal.pone.0115087			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UN	25546383	Green Submitted, Green Published, gold			2022-12-27	WOS:000347120200022
J	Boakye, MK; Pietersen, DW; Kotze, A; Dalton, DL; Jansen, R				Boakye, Maxwell Kwame; Pietersen, Darren William; Kotze, Antoinette; Dalton, Desire-Lee; Jansen, Raymond			Knowledge and Uses of African Pangolins as a Source of Traditional Medicine in Ghana	PLOS ONE			English	Article							PLANTS; CONSENSUS; REMEDIES; HEALERS; STATE	Traditional medicine has been practised in Ghana for centuries with the majority of Ghanaians still patronising the services of traditional healers. Throughout Africa a large number of people use pangolins as a source of traditional medicine, however, there is a dearth of information on the use of animals in folk medicine in Ghana, in particular the use of pangolins. The aim of this study was to determine the prevalent use of pangolins and the level of knowledge of pangolin use among traditional healers in Ghana for the treatment of human ailments. Data was gathered from 48 traditional healers using semi-structured interviews on the traditional medicinal use of pangolin body parts in the Kumasi metropolis of Ghana. The cultural importance index, relative frequency of citation, informant agreement ratio and use agreement values were calculated to ascertain the most culturally important pangolin body part as well as the level of knowledge dissemination among traditional healers with regards pangolin body parts. Our study revealed that 13 body parts of pangolins are used to treat various medicinal ailments. Pangolin scales and bones were the most prevalent prescribed body parts and indicated the highest cultural significance among traditional healing practices primarily for the treatment of spiritual protection, rheumatism, financial rituals and convulsions. Despite being classified under Schedule 1 of Ghana's Wildlife Conservation Act of 1971 (LI 685), that prohibits anyone from hunting or being in possession of a pangolin, our results indicated that the use of pangolins for traditional medicinal purposes is widespread among traditional healers in Ghana. A study on the population status and ecology of the three species of African pangolins occurring in Ghana is urgently required in order to determine the impact this harvest for traditional medical purposes has on their respective populations as current levels appear to be unmonitored and unsustainable.	[Boakye, Maxwell Kwame; Jansen, Raymond] Tshwane Univ Technol, Dept Environm Water & Earth Sci, Pretoria, South Africa; [Kotze, Antoinette; Dalton, Desire-Lee] Natl Zool Gardens South Africa, Pretoria, South Africa; [Kotze, Antoinette] Univ Free State, Dept Genet, Bloemfontein, South Africa; [Pietersen, Darren William; Kotze, Antoinette; Jansen, Raymond] African Pangolin Working Grp, Pretoria, South Africa	Tshwane University of Technology; National Research Foundation - South Africa; National Zoological Gardens of South Africa; University of the Free State	Boakye, MK (corresponding author), Tshwane Univ Technol, Dept Environm Water & Earth Sci, Pretoria, South Africa.	maxwell_boakye@yahoo.com	Boakye, Maxwell Kwame/Q-9301-2019	Boakye, Maxwell Kwame/0000-0002-5796-4121; Jansen, Raymond/0000-0003-4741-3307; Dalton, Desire Lee/0000-0001-5975-6425	Tshwane University of Technology; National Zoological Gardens of South Africa; Rufford Foundation [13600-1]	Tshwane University of Technology; National Zoological Gardens of South Africa(National Research Foundation - South Africa); Rufford Foundation	The authors are grateful to the Tshwane University of Technology (www.tut.ac.za), National Zoological Gardens of South Africa (www.nzg.ac.za) and the Rufford Foundation (www.rufford.org) (RSG reference: 13600-1) for funding this project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel C, 2005, ALTERN MED REV, V10, P112; Akpona HA, 2008, MAMMALIA, V72, P198, DOI 10.1515/MAMM.2008.046; Almeida CDCBR, 2006, J ETHNOBIOL ETHNOMED, V2, DOI 10.1186/1746-4269-2-15; Alves RRN, 2007, BIOSCIENCE, V57, P949, DOI 10.1641/B571107; Alves RRN, 2006, J ETHNOPHARMACOL, V107, P259, DOI 10.1016/j.jep.2006.03.007; Alves RRN, 2008, J ETHNOBIOL ETHNOMED, V4, DOI 10.1186/1746-4269-4-3; Alves RRN, 2008, BMC COMPLEM ALTERN M, V8, DOI 10.1186/1472-6882-8-44; Alves RRN, 2005, J ETHNOBIOL ETHNOMED, V1, DOI [10.1186/1746-4269-1-10, 10.1186/1746-4269-1-5]; Asante E., 2013, J SOCIOL RES, V4, P256, DOI DOI 10.5296/JSR.V4I2.4224; Ayodele, 2012, GLOBAL J MED RES, V12, P6; Babbie E., 2010, PRACTICE SOCIAL RES, V10th; Boakye MK, 2014, J ETHNOBIOL ETHNOMED, V10, DOI 10.1186/1746-4269-10-76; Brautigam Amie, 1994, Traffic Bulletin, V15, P15; Chakkaravarthy QA, 2012, P 3 SEM SMALL MAMM I, P50; Challender D, 2014, ASIAN GEOGRAPHIC, V103, P86; CHALLENDER D. W. S., 2012, TRAFFIC B, V24, P53; Challender DWS, 2014, SCALING PANGOLIN CON; Costa-Neto EM, 2004, SUSTAIN DEV, V12, P161, DOI 10.1002/sd.234; de Graft Aikins A, 2012, Ghana Med J, V46, P59; Department for International Development (DFID), 2011, MAL COUNTR PROF VERS; Dove N, 2010, J BLACK STUD, V40, P823, DOI 10.1177/0021934708320001; Gaski AL, 1994, PRESCRIPTION EXTINCT; Gaudin TJ, 2009, J MAMM EVOL, V16, P235, DOI 10.1007/s10914-009-9119-9; Ghana Districts, 2006, REP ALL DISTR REP GH; Ghana Health Service, 2010, ANN REPORT; Ghana Statistical Service, 2012, POP REG DISTR AG GRO; Heinrich M, 1998, SOC SCI MED, V47, P1859, DOI 10.1016/S0277-9536(98)00181-6; Heinrich M, 2009, J ETHNOPHARMACOL, V124, P1, DOI 10.1016/j.jep.2009.03.043; Insoll Timothy, 2011, Anthropol Med, V18, P181, DOI 10.1080/13648470.2011.591196; Kang S, 2003, QUESTION ATTITUDE S; Kaspal P, 2012, P 3 SEM SMALL MAMM I, P37; Kumasi Metropolitan Assembly, 2006, THIS METR; Marshall NT, 1998, SEARCHING CURE CONSE; Ministry of Health, 2005, POL GUID TRAD MED DE; Moerman DE, 2007, J ETHNOPHARMACOL, V112, P451, DOI 10.1016/j.jep.2007.04.001; Ntiamoa-Baidu Y., 1997, WILDLIFE FOOD SECURI; Omolewa M, 2007, INT REV EDUC, V53, P593, DOI 10.1007/s11159-007-9060-1; Pietersen DW, 2014, S AFR J WILDL RES, V44, P167, DOI 10.3957/056.044.0209; President's Malaria Initiative, 2012, MAL OP PLAN FY2012 Y; Gazzaneo LRS, 2005, J ETHNOBIOL ETHNOMED, V1, DOI 10.1186/1746-4269-1-9; Sato A, 2012, THESIS LONDON SCH EC; Sodeinde O.A., 1999, Traffic Bulletin, V18, P35; Sodeinde Olufemi A., 1994, Oryx, V28, P43; Soewu DA, 2011, J ETHNOBIOL ETHNOMED, V7, DOI 10.1186/1746-4269-7-25; Soewu DA, 2009, J ETHNOBIOL ETHNOMED, V5, DOI 10.1186/1746-4269-5-39; Tabi MM, 2006, INT NURS REV, V53, P52, DOI 10.1111/j.1466-7657.2006.00444.x; Tabong PTN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054429; Tardio J, 2008, ECON BOT, V62, P24, DOI 10.1007/s12231-007-9004-5; Thomas E, 2009, J ETHNOPHARMACOL, V122, P60, DOI 10.1016/j.jep.2008.11.021; Trotter R.T., 1986, PLANTS INDIGENOUS ME, P91, DOI DOI 10.4324/9781315060385-6; Twumasi PA, 1979, J OPINION, V9, P29, DOI [10.2307/1166260, DOI 10.2307/1166260]; World Health Organization, 2002, WHO TRADITIONAL MED, P1	52	44	48	2	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2015	10	1							e0117199	10.1371/journal.pone.0117199	http://dx.doi.org/10.1371/journal.pone.0117199			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ4OZ	25602281	Green Submitted, gold, Green Published			2022-12-27	WOS:000348203500045
J	Li, XT; Hu, XM; Li, XQ; Hao, XR				Li, Xiantao; Hu, Ximu; Li, Xiaoqing; Hao, Xuran			Overexpression of Tau Downregulated the mRNA Levels of Kv Channels and Improved Proliferation in N2A Cells	PLOS ONE			English	Article							GATED POTASSIUM CHANNELS; PROTEIN-TAU; K+ CHANNELS; NEUROBLASTOMA-CELLS; NEURITE GROWTH; EXPRESSION; PHOSPHORYLATION; IDENTIFICATION; LOCALIZATION; ESTRADIOL	Microtubule binding protein tau has a crucial function in promoting the assembly and stabilization of microtubule. Besides tuning the action potentials, voltage-gated K+ channels (Kv) are important for cell proliferation and appear to play a role in the development of cancer. However, little is known about the possible interaction of tau with Kv channels in various tissues. In the present study, tau plasmids were transiently transfected into mouse neuroblastoma N2A cells to explore the possible linkages between tau and Kv channels. This treatment led to a downregulation of mRNA levels of several Kv channels, including Kv2.1, Kv3.1, Kv4.1, Kv9.2, and KCNH4, but no significant alteration was observed for Kv5.1 and KCNQ4. Furthermore, the macroscopic currents through Kv channels were reduced by 36.5% at +60 mV in tau-tranfected N2A cells. The proliferation rates of N2A cells were also improved by the induction of tau expression and the incubation of TEA (tetraethylammonium) for 48 h by 120.9% and 149.3%, respectively. Following the cotransfection with tau in HEK293 cells, the mRNA levels and corresponding currents of Kv2.1 were significantly declined compared with single Kv2.1 transfection. Our data indicated that overexpression of tau declined the mRNA levels of Kv channels and related currents. The effects of tau overexpression on Kv channels provided an alternative explanation for low sensitivity to anticancer chemicals in some specific cancer tissues.	[Li, Xiantao; Li, Xiaoqing; Hao, Xuran] South Cent Univ Nationalities, Coll Life Sci, Dept Neurosci, Wuhan 430074, Peoples R China; [Hu, Ximu] South Cent Univ Nationalities, Wuhan 430074, Peoples R China	South Central Minzu University; South Central Minzu University	Li, XT (corresponding author), South Cent Univ Nationalities, Coll Life Sci, Dept Neurosci, Wuhan 430074, Peoples R China.	lixiantao@yahoo.com			Basic research project of South-Central University for Nationalities [YCZY12019]	Basic research project of South-Central University for Nationalities	This work was supported by the grants from the Basic research project of South-Central University for Nationalities. [YCZY12019]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arcangeli A, 1995, J PHYSIOL-LONDON, V489, P455, DOI 10.1113/jphysiol.1995.sp021065; Atlas R, 2004, J NEUROCHEM, V89, P613, DOI 10.1111/j.1471-4159.2004.02371.x; Avila J, 2004, PHYSIOL REV, V84, P361, DOI 10.1152/physrev.00024.2003; BRANDT R, 1995, J CELL BIOL, V131, P1327, DOI 10.1083/jcb.131.5.1327; Brocchieri A, 1996, INVAS METAST, V16, P56; Burg ED, 2006, J MEMBRANE BIOL, V209, P3, DOI 10.1007/s00232-005-0838-4; DECOURSEY TE, 1984, NATURE, V307, P465, DOI 10.1038/307465a0; DIAZNIDO J, 1991, J CELL SCI, P51; DRECHSEL DN, 1992, MOL BIOL CELL, V3, P1141, DOI 10.1091/mbc.3.10.1141; FERREIRA A, 1991, J NEUROSCI, V11, P392; GOEDERT M, 1989, EMBO J, V8, P393, DOI 10.1002/j.1460-2075.1989.tb03390.x; GOEDERT M, 1989, NEURON, V3, P519, DOI 10.1016/0896-6273(89)90210-9; Green PS, 2000, INT J DEV NEUROSCI, V18, P347, DOI 10.1016/S0736-5748(00)00017-4; Gu YJ, 1996, J NEUROCHEM, V67, P1235; Ikeda H, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2598; Jan LY, 1997, J PHYSIOL-LONDON, V505, P267, DOI 10.1111/j.1469-7793.1997.267bb.x; Kim JA, 1998, ARCH PHARM RES, V21, P664, DOI 10.1007/BF02976754; KOSIK KS, 1989, NEURON, V2, P1389, DOI 10.1016/0896-6273(89)90077-9; Lang F, 2005, J MEMBRANE BIOL, V205, P147, DOI 10.1007/s00232-005-0780-5; LEE VMY, 1991, SCIENCE, V251, P675, DOI 10.1126/science.1899488; LeppleWienhues A, 1996, J MEMBRANE BIOL, V151, P149, DOI 10.1007/s002329900066; Leung YM, 2011, J CELL PHYSIOL, V226, P1090, DOI 10.1002/jcp.22430; Li HL, 2007, P NATL ACAD SCI USA, V104, P3591, DOI 10.1073/pnas.0609303104; Li XQ, 2014, NEUROREPORT, V25, P574, DOI 10.1097/WNR.0000000000000137; Mandelkow EM, 1996, ANN NY ACAD SCI, V777, P96, DOI 10.1111/j.1749-6632.1996.tb34407.x; Moschner K, 2014, J BIOL CHEM, V289, P16814, DOI 10.1074/jbc.M113.541425; NEVE RL, 1986, MOL BRAIN RES, V1, P271, DOI 10.1016/0169-328X(86)90033-1; Ouadid-Ahidouch H, 2000, BIOCHEM BIOPH RES CO, V278, P272, DOI 10.1006/bbrc.2000.3790; Pardo LA, 2004, PHYSIOLOGY, V19, P285, DOI 10.1152/physiol.00011.2004; Pollock NS, 2005, EUR J NEUROSCI, V22, P569, DOI 10.1111/j.1460-9568.2005.04242.x; Prediger ME, 2004, NEUROCHEM RES, V29, P1923; Rouzier R, 2005, P NATL ACAD SCI USA, V102, P8315, DOI 10.1073/pnas.0408974102; Sergeant N, 2005, BBA-MOL BASIS DIS, V1739, P179, DOI 10.1016/j.bbadis.2004.06.020; Tsevi I, 2005, J CELL PHYSIOL, V202, P400, DOI 10.1002/jcp.20132; Wonderlin WF, 1996, J MEMBRANE BIOL, V154, P91, DOI 10.1007/s002329900135; Yi BA, 2001, P NATL ACAD SCI USA, V98, P11016, DOI 10.1073/pnas.191351798	36	6	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2015	10	1							e0116628	10.1371/journal.pone.0116628	http://dx.doi.org/10.1371/journal.pone.0116628			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9HN	25590133	Green Published, Green Submitted, gold			2022-12-27	WOS:000350679400018
J	Curtright, A; Rosser, M; Goh, S; Keown, B; Wagner, E; Sharifi, J; Raible, DW; Dhaka, A				Curtright, Andrew; Rosser, Micaela; Goh, Shamii; Keown, Bailey; Wagner, Erinn; Sharifi, Jasmine; Raible, David W.; Dhaka, Ajay			Modeling Nociception in Zebrafish: A Way Forward for Unbiased Analgesic Discovery	PLOS ONE			English	Article							SODIUM-CHANNEL BLOCKER; INFLAMMATORY PAIN; MICE LACKING; IMPAIRED NOCICEPTION; ANIMAL-MODELS; TELEOST FISH; BUPRENORPHINE; HYPERALGESIA; ANTIDEPRESSANTS; AMITRIPTYLINE	Acute and chronic pain conditions are often debilitating, inflicting severe physiological, emotional and economic costs and affect a large percentage of the global population. However, the development of therapeutic analgesic agents based primarily on targeted drug development has been largely ineffective. An alternative approach to analgesic development would be to develop low cost, high throughput, untargeted animal based behavioral screens that model complex nociceptive behaviors in which to screen for analgesic compounds. Here we describe the development of a behavioral based assay in zebrafish larvae that is effective in identifying small molecule compounds with analgesic properties. In a place aversion assay, which likely utilizes supraspinal neuronal circuitry, individually arrayed zebrafish larvae show temperature-dependent aversion to increasing and decreasing temperatures deviating from rearing temperature. Modeling thermal hyperalgesia, the addition of the noxious inflammatory compound and TRPA1 agonist allyl isothiocyanate sensitized heat aversion and reversed cool aversion leading larvae to avoid rearing temperature in favor of otherwise acutely aversive cooler temperatures. We show that small molecules with known analgesic properties are able to inhibit acute and/or sensitized temperature aversion.	[Curtright, Andrew; Rosser, Micaela; Goh, Shamii; Keown, Bailey; Wagner, Erinn; Sharifi, Jasmine; Raible, David W.; Dhaka, Ajay] Univ Washington, Dept Biol Struct, Seattle, WA 98195 USA; [Raible, David W.; Dhaka, Ajay] Univ Washington, Neurobiol & Behav Grad Program, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Dhaka, A (corresponding author), Univ Washington, Dept Biol Struct, Seattle, WA 98195 USA.	dhaka@uw.edu		Raible, David/0000-0002-5342-5841	Scan Design Foundation Innovative Pain Research Grant; National Institutes of Health (National Institute of Dental and Craniofacial Research) [DE023730]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE023730] Funding Source: NIH RePORTER	Scan Design Foundation Innovative Pain Research Grant; National Institutes of Health (National Institute of Dental and Craniofacial Research)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by Scan Design Foundation Innovative Pain Research Grant (AD), and National Institutes of Health (National Institute of Dental and Craniofacial Research) DE023730 (AD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahrens MB, 2013, NAT METHODS, V10, P413, DOI [10.1038/NMETH.2434, 10.1038/nmeth.2434]; Balayssac D, 2014, BEHAV PHARMACOL, V25, P99, DOI 10.1097/FBP.0000000000000026; Basbaum AI, 2009, CELL, V139, P267, DOI 10.1016/j.cell.2009.09.028; Bautista DM, 2006, CELL, V124, P1269, DOI 10.1016/j.cell.2006.02.023; Bingham S, 2006, SEMIN CELL DEV BIOL, V17, P544, DOI 10.1016/j.semcdb.2006.09.001; Bomholt SF, 2005, NEUROPHARMACOLOGY, V48, P252, DOI 10.1016/j.neuropharm.2004.09.012; Braithwaite VA, 2007, DIS AQUAT ORGAN, V75, P131, DOI 10.3354/dao075131; Bregman H, 2011, J MED CHEM, V54, P4427, DOI 10.1021/jm200018k; BROCKERHOFF SE, 1995, P NATL ACAD SCI USA, V92, P10545, DOI 10.1073/pnas.92.23.10545; BRYANT RM, 1983, BRIT J PHARMACOL, V78, P659, DOI 10.1111/j.1476-5381.1983.tb09417.x; Caron SJC, 2008, DEVELOPMENT, V135, P3259, DOI 10.1242/dev.023200; Caterina MJ, 2000, SCIENCE, V288, P306, DOI 10.1126/science.288.5464.306; Chan AKM, 2010, EXPERT OPIN PHARMACO, V11, P2849, DOI 10.1517/14656566.2010.511613; CHAPMAN CR, 1985, PAIN, V22, P1, DOI 10.1016/0304-3959(85)90145-9; Christoph T, 2005, EUR J PHARMACOL, V507, P87, DOI 10.1016/j.ejphar.2004.11.052; Clare JJ, 2010, EXPERT OPIN INV DRUG, V19, P45, DOI 10.1517/13543780903435340; Clark DT, 1981, VISUAL RESPONSES DEV; Cox JJ, 2006, NATURE, V444, P894, DOI 10.1038/nature05413; Dib-Hajj SD, 2013, NAT REV NEUROSCI, V14, P49, DOI 10.1038/nrn3404; Drew LJ, 2005, MOL PAIN, V1, DOI 10.1186/1744-8069-1-8; Eid SR, 2008, MOL PAIN, V4, DOI 10.1186/1744-8069-4-48; EISENACH JC, 1995, ANESTHESIOLOGY, V83, P1046, DOI 10.1097/00000542-199511000-00018; Evans HC, 2003, DRUGS, V63, P1999, DOI 10.2165/00003495-200363190-00003; Fertleman CR, 2006, NEURON, V52, P767, DOI 10.1016/j.neuron.2006.10.006; Field MJ, 1997, BRIT J PHARMACOL, V121, P1513, DOI 10.1038/sj.bjp.0701320; Gahtan E, 2005, J NEUROSCI, V25, P9294, DOI 10.1523/JNEUROSCI.2678-05.2005; Gau P, 2013, J NEUROSCI, V33, P5249, DOI 10.1523/JNEUROSCI.5403-12.2013; Granato M, 1996, DEVELOPMENT, V123, P399; Gregory NS, 2013, J PAIN, V14, P1255, DOI 10.1016/j.jpain.2013.06.008; HEEL RC, 1979, DRUGS, V17, P81, DOI 10.2165/00003495-197917020-00001; Jarvis MF, 2007, P NATL ACAD SCI USA, V104, P8520, DOI 10.1073/pnas.0611364104; KIMMEL CB, 1974, DEV PSYCHOBIOL, V7, P47, DOI 10.1002/dev.420070109; KOLTZENBURG M, 2013, WALL MELZACKS TXB PA, V6; Le Bars D, 2001, PHARMACOL REV, V53, P597; Lee HS, 2005, J NEUROSCI, V25, P1304, DOI 10.1523/JNEUROSCI.4745.04.2005; Lee JH, 2014, CELL, V157, P1393, DOI 10.1016/j.cell.2014.03.064; McGowan E, 2009, ANESTH ANALG, V109, P951, DOI 10.1213/ane.0b013e3181b01b02; McNamara CR, 2007, P NATL ACAD SCI USA, V104, P13525, DOI 10.1073/pnas.0705924104; Mika J, 2013, PHARMACOL REP, V65, P1611, DOI 10.1016/S1734-1140(13)71522-6; Minett MS, 2014, CELL REP, V6, P301, DOI 10.1016/j.celrep.2013.12.033; Moilanen LJ, 2012, SCI REP-UK, V2, DOI 10.1038/srep00380; Nassar MA, 2004, P NATL ACAD SCI USA, V101, P12706, DOI 10.1073/pnas.0404915101; Neely GG, 2010, CELL, V143, P628, DOI 10.1016/j.cell.2010.09.047; Negri L, 2006, J NEUROSCI, V26, P6716, DOI 10.1523/JNEUROSCI.5403-05.2006; Novak AE, 2006, DEV DYNAM, V235, P1962, DOI 10.1002/dvdy.20811; Okun A, 2011, MOL PAIN, V7, DOI 10.1186/1744-8069-7-4; Pan YA, 2012, DEVELOPMENT, V139, P591, DOI 10.1242/dev.076588; Priest BT, 2009, CURR OPIN DRUG DISC, V12, P682; Prober DA, 2008, J NEUROSCI, V28, P10102, DOI 10.1523/JNEUROSCI.2740-08.2008; Ren Ke, 1999, ILAR J, V40, P111; Sneddon LU, 2003, BRAIN RES, V972, P44, DOI 10.1016/S0006-8993(03)02483-1; Sneddon LU, 2002, NEUROSCI LETT, V319, P167, DOI 10.1016/S0304-3940(01)02584-8; Tracey WD, 2003, CELL, V113, P261, DOI 10.1016/S0092-8674(03)00272-1; Vierck CJ, 2008, PAIN, V135, P7, DOI 10.1016/j.pain.2007.12.008; Wallace MS, 2008, CLIN J PAIN, V24, P544, DOI 10.1097/AJP.0b013e3181673b93; Woolf CJ, 2010, NAT MED, V16, P1241, DOI 10.1038/nm.2230; Yaksh TL, 2001, J NEUROSCI, V21, P5847, DOI 10.1523/JNEUROSCI.21-16-05847.2001; 2011, CURR CLIN PHARM, V6, P280, DOI DOI 10.2174/157488411798375886	58	47	47	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2015	10	1							e0116766	10.1371/journal.pone.0116766	http://dx.doi.org/10.1371/journal.pone.0116766			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ0ID	25587718	gold, Green Published, Green Submitted			2022-12-27	WOS:000347928300019
J	Rousseau, M; Belleannee, C; Duchez, AC; Cloutier, N; Levesque, T; Jacques, F; Perron, J; Nigrovic, PA; Dieude, M; Hebert, MJ; Gelb, MH; Boilard, E				Rousseau, Matthieu; Belleannee, Clemence; Duchez, Anne-Claire; Cloutier, Nathalie; Levesque, Tania; Jacques, Frederic; Perron, Jean; Nigrovic, Peter A.; Dieude, Melanie; Hebert, Marie-Josee; Gelb, Michael H.; Boilard, Eric			Detection and Quantification of Microparticles from Different Cellular Lineages Using Flow Cytometry. Evaluation of the Impact of Secreted Phospholipase A(2) on Microparticle Assessment	PLOS ONE			English	Article							CALIBRATED POLYSTYRENE BEADS; GROUP-II PHOSPHOLIPASE-A2; HUMAN SEMINAL PLASMA; HUMAN T-CELLS; CIRCULATING MICROPARTICLES; EXTRACELLULAR VESICLES; ENDOTHELIAL-CELLS; GROUP-X; PROCOAGULANT MICROPARTICLES; BIOLOGICAL MICROPARTICLES	Microparticles, also called microvesicles, are submicron extracellular vesicles produced by plasma membrane budding and shedding recognized as key actors in numerous physio (patho) logical processes. Since they can be released by virtually any cell lineages and are retrieved in biological fluids, microparticles appear as potent biomarkers. However, the small dimensions of microparticles and soluble factors present in body fluids can considerably impede their quantification. Here, flow cytometry with improved methodology for microparticle resolution was used to detect microparticles of human and mouse species generated from platelets, red blood cells, endothelial cells, apoptotic thymocytes and cells from the male reproductive tract. A family of soluble proteins, the secreted phospholipases A(2) (sPLA(2)), comprises enzymes concomitantly expressed with microparticles in biological fluids and that catalyze the hydrolysis of membrane phospholipids. As sPLA(2) can hydrolyze phosphatidylserine, a phospholipid frequently used to assess microparticles, and might even clear microparticles, we further considered the impact of relevant sPLA(2) enzymes, sPLA(2) group IIA, V and X, on microparticle quantification. We observed that if enriched in fluids, certain sPLA(2) enzymes impair the quantification of microparticles depending on the species studied, the source of microparticles and the means of detection employed (surface phosphatidylserine or protein antigen detection). This study provides analytical considerations for appropriate interpretation of microparticle cytofluorometric measurements in biological samples containing sPLA2 enzymes.	[Rousseau, Matthieu; Duchez, Anne-Claire; Cloutier, Nathalie; Levesque, Tania; Boilard, Eric] Univ Laval, Ctr Rech Rhumatol & Immunol, Ctr Hosp Univ Quebec, Fac Med,Ctr Rech, Quebec City, PQ, Canada; [Belleannee, Clemence] Univ Laval, Ctr Rech, CHUQ, Quebec City, PQ, Canada; [Belleannee, Clemence] Univ Laval, Dept Obstet & Gynecol, Fac Med, Quebec City, PQ, Canada; [Jacques, Frederic; Perron, Jean] Ctr Hosp Univ Quebec, Quebec City, PQ, Canada; [Nigrovic, Peter A.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Rheumatol Immunol & Allergy, Boston, MA 02115 USA; [Nigrovic, Peter A.] Harvard Univ, Sch Med, Div Immunol, Boston Childrens Hosp, Boston, MA USA; [Dieude, Melanie; Hebert, Marie-Josee] Ctr Hosp Univ Montreal CRCHUM, Montreal, PQ, Canada; [Gelb, Michael H.] Univ Washington, Dept Chem, Seattle, WA 98195 USA	Laval University; Laval University; Laval University; Laval University; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard Medical School; Universite de Montreal; University of Washington; University of Washington Seattle	Boilard, E (corresponding author), Univ Laval, Ctr Rech Rhumatol & Immunol, Ctr Hosp Univ Quebec, Fac Med,Ctr Rech, Quebec City, PQ, Canada.	eric.boilard@crchuq.ulaval.ca	Rousseau, Matthieu/AAA-5385-2022; Duchez, anne-claire/AAK-5041-2020	Rousseau, Matthieu/0000-0002-2895-2957; gelb, michael/0000-0001-7000-5219; Dieude, Melanie/0000-0002-9300-4232; Duchez, Anne-Claire/0000-0001-5654-4320; Belleannee, Clemence/0000-0001-9284-9420	National Sciences and Engineering Research Council; National Institutes of Health [R37 HL36235]; Fonds Quebecois de Recherche en Sante (FQRS); Canadian Arthritis Network; Arthritis Society; Faculte de Medecine (Universite Laval); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL036235, R37HL036235] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR065538] Funding Source: NIH RePORTER	National Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fonds Quebecois de Recherche en Sante (FQRS); Canadian Arthritis Network; Arthritis Society; Faculte de Medecine (Universite Laval); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by an operating discovery grant from the National Sciences and Engineering Research Council awarded to EB and by National Institutes of Health grant R37 HL36235 awarded to MHG. EB is recipient of awards from the Fonds Quebecois de Recherche en Sante (FQRS) and the Canadian Arthritis Network and is a Canadian Institutes of Health Research New Investigator. ACD and MR are recipients of a fellowship from The Arthritis Society and the Faculte de Medecine (Universite Laval), respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aalberts M, 2014, REPRODUCTION, V147, pR1, DOI 10.1530/REP-13-0358; Aatonen MT, 2014, J EXTRACELL VESICLES, V3, DOI 10.3402/jev.v3.24692; Aho VV, 2002, GRAEF ARCH CLIN EXP, V240, P521, DOI 10.1007/s00417-002-0477-8; Arienti G, 1997, BBA-GEN SUBJECTS, V1336, P533, DOI 10.1016/S0304-4165(97)00071-8; Arraud N, 2014, J THROMB HAEMOST, V12, P614, DOI 10.1111/jth.12554; Augustine D, 2014, CIRC RES, V114, P109, DOI 10.1161/CIRCRESAHA.114.301904; Belleannee C, 2013, BIOL REPROD, V89, DOI 10.1095/biolreprod.113.110486; Bernatchez PN, 2001, BRIT J PHARMACOL, V134, P197, DOI 10.1038/sj.bjp.0704215; Bezzine S, 2002, J BIOL CHEM, V277, P48523, DOI 10.1074/jbc.M203137200; Bezzine S, 2000, J BIOL CHEM, V275, P3179, DOI 10.1074/jbc.275.5.3179; Biro E, 2007, ANN RHEUM DIS, V66, P1085, DOI 10.1136/ard.2006.061309; Boilard E, 2003, FASEB J, V17, P1068, DOI 10.1096/fj.02-0938com; Boilard E, 2003, BLOOD, V102, P2901, DOI 10.1182/blood-2002-12-3702; Boilard E, 2014, BLOOD, V123, P2854, DOI 10.1182/blood-2013-07-515536; Boilard E, 2010, EMBO MOL MED, V2, P172, DOI 10.1002/emmm.201000072; Boilard E, 2010, SCIENCE, V327, P580, DOI 10.1126/science.1181928; Boing AN, 2014, J EXTRACELL VESICLES, V3, DOI 10.3402/jev.v3.23430; Boudreau LH, 2014, BLOOD, V124, P2173, DOI 10.1182/blood-2014-05-573543; Bowton DL, 1997, AM J RESP CRIT CARE, V155, P421, DOI 10.1164/ajrccm.155.2.9032172; Burnier L, 2009, THROMB HAEMOSTASIS, V101, P439, DOI 10.1160/TH08-08-0521; Buzas EI, 2014, NAT REV RHEUMATOL, V10, P356, DOI 10.1038/nrrheum.2014.19; Chalbot S, 2009, CLIN CHEM, V55, P2171, DOI 10.1373/clinchem.2009.130286; Chamouard P, 2005, DIGEST DIS SCI, V50, P574, DOI 10.1007/s10620-005-2477-0; Chandler WL, 2011, J THROMB HAEMOST, V9, P1216, DOI 10.1111/j.1538-7836.2011.04283.x; Cloutier N, 2013, EMBO MOL MED, V5, P235, DOI 10.1002/emmm.201201846; Connor DE, 2010, THROMB HAEMOSTASIS, V103, P1044, DOI 10.1160/TH09-09-0644; Crookston KP, 2013, INT J RHEUM DIS, V16, P72, DOI 10.1111/1756-185x.12026; Cunningham TJ, 2006, J NEUROINFLAMM, V3, DOI 10.1186/1742-2094-3-26; Cupillard L, 1997, J BIOL CHEM, V272, P15745, DOI 10.1074/jbc.272.25.15745; Dasgupta SK, 2009, BLOOD, V113, P1332, DOI 10.1182/blood-2008-07-167148; Dasgupta SK, 2012, CIRCULATION, V125, P1664, DOI 10.1161/CIRCULATIONAHA.111.068833; Dignat-George F, 2011, ARTERIOSCL THROM VAS, V31, P27, DOI 10.1161/ATVBAHA.110.218123; Eerola LI, 2006, BBA-MOL CELL BIOL L, V1761, P745, DOI 10.1016/j.bbalip.2006.04.002; Escoffier J, 2010, J CLIN INVEST, V120, P1415, DOI 10.1172/JCI40494; FOURCADE O, 1995, CELL, V80, P919, DOI 10.1016/0092-8674(95)90295-3; Franz C, 2013, J REPROD IMMUNOL, V98, P45, DOI 10.1016/j.jri.2013.02.002; Gidlof O, 2013, BLOOD, V121, P3908, DOI 10.1182/blood-2012-10-461798; Grass DS, 1996, J CLIN INVEST, V97, P2233, DOI 10.1172/JCI118664; Guervilly C, 2011, CRIT CARE, V15, DOI 10.1186/cc9978; Gyorgy B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049726; Gyorgy B, 2011, CELL MOL LIFE SCI, V68, P2667, DOI 10.1007/s00018-011-0689-3; Gyorgy B, 2011, BLOOD, V117, pE39, DOI 10.1182/blood-2010-09-307595; Harrison P, 2012, J THROMB HAEMOST, V10, P916, DOI 10.1111/j.1538-7836.2012.04711.x; Headland SE, 2014, SCI REP-UK, V4, DOI 10.1038/srep05237; Hogquist KA, 2005, NAT REV IMMUNOL, V5, P772, DOI 10.1038/nri1707; Issman L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083680; Janssen MJW, 1999, PROTEIN ENG, V12, P497, DOI 10.1093/protein/12.6.497; KENNEDY BP, 1995, J BIOL CHEM, V270, P22378, DOI 10.1074/jbc.270.38.22378; Komiyama K, 2009, ORAL MEDICINE PATHOL, V13, P99, DOI DOI 10.3353/OMP.13.99; Lacroix R, 2012, J THROMB HAEMOST, V10, P437, DOI 10.1111/j.1538-7836.2011.04610.x; Lacroix R, 2010, SEMIN THROMB HEMOST, V36, P807, DOI 10.1055/s-0030-1267034; Laffont B, 2013, BLOOD, V122, P253, DOI 10.1182/blood-2013-03-492801; Laine VJO, 1999, J IMMUNOL, V162, P7402; Lambeau G, 2008, ANNU REV BIOCHEM, V77, P495, DOI 10.1146/annurev.biochem.76.062405.154007; LEMOINNE S, 2014, NAT REV GASTRO HEPAT, DOI DOI 10.1038/NRGASTRO.2014; Leroyer AS, 2007, J AM COLL CARDIOL, V49, P772, DOI 10.1016/j.jacc.2006.10.053; Masuda S, 2004, BBA-MOL CELL BIOL L, V1686, P61, DOI 10.1016/j.bbalip.2004.08.017; Montoro-Garcia S, 2013, ATHEROSCLEROSIS, V227, P313, DOI 10.1016/j.atherosclerosis.2013.01.028; Morel N, 2008, J TRAUMA, V64, P698, DOI 10.1097/TA.0b013e31816493ad; Morel O, 2004, CURR OPIN HEMATOL, V11, P156, DOI 10.1097/01.moh.0000131441.10020.87; Morel O, 2006, ARTERIOSCL THROM VAS, V26, P2594, DOI 10.1161/01.ATV.0000246775.14471.26; Morel O, 2011, ARTERIOSCL THROM VAS, V31, P15, DOI 10.1161/ATVBAHA.109.200956; Mullier F, 2011, J THROMB HAEMOST, V9, P1679, DOI 10.1111/j.1538-7836.2011.04386.x; Murakami M, 2011, J BIOCHEM, V150, P233, DOI 10.1093/jb/mvr088; Murakami M, 2010, BIOCHIMIE, V92, P561, DOI 10.1016/j.biochi.2010.03.015; NAKAE H, 1995, BURNS, V21, P422, DOI 10.1016/0305-4179(95)00022-4; NEVALAINEN TJ, 1993, ANDROLOGIA, V25, P355; Nevalainen TJ, 2005, BBA-MOL CELL BIOL L, V1733, P210, DOI 10.1016/j.bbalip.2004.12.012; NEVALAINEN TJ, 1994, INVEST OPHTH VIS SCI, V35, P417; Nolte-'t Hoen ENM, 2012, NANOMED-NANOTECHNOL, V8, P712, DOI 10.1016/j.nano.2011.09.006; Olson ED, 2010, J BIOL CHEM, V285, P10993, DOI 10.1074/jbc.M109.070797; Owens AP, 2011, CIRC RES, V108, P1284, DOI 10.1161/CIRCRESAHA.110.233056; Perez-Pujol S, 2007, CYTOM PART A, V71A, P38, DOI 10.1002/cyto.a.20354; Rand ML, 2006, J THROMB HAEMOST, V4, P1621, DOI 10.1111/j.1538-7836.2006.02011.x; Rank A, 2011, PLATELETS, V22, P111, DOI 10.3109/09537104.2010.520373; Robert S, 2011, J THROMB HAEMOST, V9, P1676, DOI 10.1111/j.1538-7836.2011.04387.x; Robert S, 2009, J THROMB HAEMOST, V7, P190, DOI 10.1111/j.1538-7836.2008.03200.x; Robert S, 2012, ARTERIOSCL THROM VAS, V32, P1054, DOI 10.1161/ATVBAHA.111.244616; Rouault M, 2007, BIOCHEMISTRY-US, V46, P1647, DOI 10.1021/bi062119b; Sellam J, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2833; Singer AG, 2002, J BIOL CHEM, V277, P48535, DOI 10.1074/jbc.M205855200; Sossdorf M, 2011, MED SCI SPORT EXER, V43, P1169, DOI 10.1249/MSS.0b013e3182068645; Styles LA, 2000, BLOOD, V96, P3276; Sullivan R, 2013, REPRODUCTION, V146, pR21, DOI 10.1530/REP-13-0058; SURH CD, 1994, NATURE, V372, P100, DOI 10.1038/372100a0; TAKAYAMA K, 1991, BIOCHEM BIOPH RES CO, V178, P1505, DOI 10.1016/0006-291X(91)91064-J; Turiak L, 2011, J PROTEOMICS, V74, P2025, DOI 10.1016/j.jprot.2011.05.023; Van der Pol E, 2012, J THROMB HAEMOST, V10, P919, DOI 10.1111/j.1538-7836.2012.04683.x; van der Vlist EJ, 2012, NAT PROTOC, V7, P1311, DOI 10.1038/nprot.2012.065; Wang JG, 2011, BLOOD, V118, P2366, DOI 10.1182/blood-2011-01-330878; Willekens FLA, 2008, BRIT J HAEMATOL, V141, P549, DOI 10.1111/j.1365-2141.2008.07055.x; Zhang JH, 2007, EXP HEMATOL, V35, P490, DOI 10.1016/j.exphem.2006.11.011; Zwaal RFA, 1997, BLOOD, V89, P1121, DOI 10.1182/blood.V89.4.1121	93	56	57	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2015	10	1							e0116812	10.1371/journal.pone.0116812	http://dx.doi.org/10.1371/journal.pone.0116812			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ0ID	25587983	Green Submitted, gold, Green Published			2022-12-27	WOS:000347928300021
J	Yang, H; Zhang, C; Zhou, QY; Wang, YK; Chen, LJ				Yang, Hui; Zhang, Chao; Zhou, Quanyu; Wang, Yike; Chen, Lujia			Clinical Outcomes with Alternative Dosing Strategies for Piperacillin/Tazobactam: A Systematic Review and Meta-Analysis	PLOS ONE			English	Review							COMPLICATED INTRAABDOMINAL INFECTION; CRITICALLY-ILL PATIENTS; EXTENDED-INFUSION PIPERACILLIN/TAZOBACTAM; BETA-LACTAM ANTIBIOTICS; RANDOM-EFFECTS MODELS; PSEUDOMONAS-AERUGINOSA; ANTIMICROBIAL RESISTANCE; INTERMITTENT INFUSION; TAZOBACTAM; PHARMACOKINETICS	Objectives A better dosing strategy can improve clinical outcomes for patients. We sought to compare the extended or continuous infusion with conventional intermittent infusion of piperacillin/ tazobactam, investigating which approach is better and worthy of recommendation for clinical use. Methods Articles were gathered from PubMed, Web of Science, ProQuest, Science Direct, Cochrane, two Chinese literature databases (CNKI, Wan Fang Data) and related ICAAC and ACCP conferences. Randomized controlled and observational studies that compared extended or continuous infusion with conventional intermittent infusion of piperacillin/ tazobactam were identified from the databases above and analyzed. Two reviewers independently extracted and investigated the data. A meta-analysis was performed using Revman 5.2 software. The quality of each study was assessed. Sensitivity analysis and publication bias were evaluated. Results Five randomized controlled trials and nine observational studies were included in this study. All included studies had high quality and no publication bias was found. Compared to the conventional intermittent infusion approach, the extended or continuous infusion group had a significantly higher clinical cure rate (OR 1.88, 95% CI 1.29-2.73, P = 0.0009) and a lower mortality rate (OR 0.67, 95% CI 0.50-0.89, P = 0.005). No statistical difference was observed for bacteriologic cure (OR 1.40, 95% CI 0.82-2.37, P = 0.22) between the two dosing regimens. The sensitivity analysis showed the results were stable. Conclusions Our systematic review and meta-analysis suggested that the extended or continuous infusion strategy of piperacillin/tazobactam should be recommended for clinical use considering its higher clinical cure rate and lower mortality rate in comparison with conventional intermittent strategy. Data from this study could be extrapolated for other beta-lactam antimicrobials. Therefore, this dosing strategy could be considered in clinical practice.	[Yang, Hui; Zhang, Chao] Peking Univ, Dept Pharm, Hosp 3, Beijing 100871, Peoples R China; [Yang, Hui; Wang, Yike; Chen, Lujia] Peking Univ, Sch Pharmaceut Sci, Beijing 100871, Peoples R China; [Zhou, Quanyu] First Peoples Hosp, Dept Pharm, Lianyungang, Jiangsu, Peoples R China	Peking University; Peking University	Zhang, C (corresponding author), Peking Univ, Dept Pharm, Hosp 3, Beijing 100871, Peoples R China.	laural.zhang@yahoo.com			Peking University Third Hospital research	Peking University Third Hospital research	This study was supported by Peking University Third Hospital research funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Austin PC, 2003, MED DECIS MAKING, V23, P526, DOI 10.1177/0272989X03258443; Bauer KA, 2013, ANTIMICROB AGENTS CH, V57, P2907, DOI 10.1128/AAC.02365-12; Buck C, 2005, INT J ANTIMICROB AG, V25, P62, DOI 10.1016/j.ijantimicag.2004.08.012; Butterfield JM, 2014, J ANTIMICROB CHEMOTH, V69, P176, DOI 10.1093/jac/dkt300; Chen Tzu-An, 2012, J Appl Meas, V13, P231; De Waele JJ, 2014, INTENS CARE MED, V40, P380, DOI 10.1007/s00134-013-3187-2; DeRyke CA, 2006, AM J HEALTH-SYST PH, V63, P750, DOI 10.2146/ajhp050323; Drusano GL, 2003, CLIN INFECT DIS, V36, pS42, DOI 10.1086/344653; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Falagas ME, 2013, CLIN INFECT DIS, V56, P272, DOI 10.1093/cid/cis857; Feher C, 2014, J ANTIMICROB CHEMOTH, V69, P2556, DOI 10.1093/jac/dku150; Felton TW, 2013, ANTIMICROB AGENTS CH, V57, P5811, DOI 10.1128/AAC.00867-13; Goncalves-Pereira J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049845; Grant EM, 2002, PHARMACOTHERAPY, V22, P471, DOI 10.1592/phco.22.7.471.33665; Heinrich Lynley S, 2011, J Pharm Pract, V24, P571, DOI 10.1177/0897190011406984; Javad A, 2006, SCAND J INFECT DIS, V38, P224, DOI 10.1080/00365540500348978; Kasiakou SK, 2005, DRUGS, V65, P2499, DOI 10.2165/00003495-200565170-00006; Lau WK, 2006, ANTIMICROB AGENTS CH, V50, P3556, DOI 10.1128/AAC.00329-06; Lee GC, 2012, CLIN THER, V34, P2297, DOI 10.1016/j.clinthera.2012.11.005; Li CH, 2005, J ANTIMICROB CHEMOTH, V56, P388, DOI 10.1093/jac/dki243; Li Xian-Zhi, 2007, Zhongguo Kangshengsu Zazhi, V32, P193; Li ZhiQiang, 2010, Modern Preventive Medicine, V37, P2949; Lodise TP, 2006, PHARMACOTHERAPY, V26, P1320, DOI 10.1592/phco.26.9.1320; Lodise TP, 2007, CLIN INFECT DIS, V44, P357, DOI 10.1086/510590; Lorente L, 2009, INT J ANTIMICROB AG, V33, P464, DOI 10.1016/j.ijantimicag.2008.10.025; Lu YY, 2013, CELL SIGNAL, V25, P479, DOI [10.1016/j.cellsig.2012.11.004, 10.3760/cma.j.issn.2095-4352.2013.08.008]; Mah GT, 2012, ANN PHARMACOTHER, V46, P265, DOI 10.1345/aph.1Q378; Nelson E A, 1999, NT Learn Curve, V3, P6; Papich MG, 2014, VET MICROBIOL, V171, P480, DOI 10.1016/j.vetmic.2013.12.021; Patel GW, 2009, DIAGN MICR INFEC DIS, V64, P236, DOI 10.1016/j.diagmicrobio.2009.03.002; Persson M, 2013, J PHARMACOL TOX MET, V68, P302, DOI 10.1016/j.vascn.2013.08.001; Rafati MR, 2006, INT J ANTIMICROB AG, V28, P122, DOI 10.1016/j.ijantimicag.2006.02.020; Roberts JA, 2005, INT J ANTIMICROB AG, V25, P62, DOI [10.1016/j.ijantimicag.2004.08.012, DOI 10.1016/J.IJANTIMICAG.2004.08.012]; Roberts JA, 2007, INT J ANTIMICROB AG, V30, P11, DOI 10.1016/j.ijantimicag.2007.02.002; Roberts JA, 2010, INT J ANTIMICROB AG, V35, P156, DOI 10.1016/j.ijantimicag.2009.10.008; Solomkin JS, 2010, CLIN INFECT DIS, V50, P133, DOI 10.1086/649554; Thalhammer F, 1999, J ANTIMICROB CHEMOTH, V43, P523, DOI 10.1093/jac/43.4.523; Villar J, 2001, STAT MED, V20, P3635, DOI 10.1002/sim.1096; Wells G., 2005, NEWCASTLE OTTAWA SCA; [叶龙强 YE Longqiang], 2011, [中华医院感染学杂志, Chinese Journal of Nosocomiology], V21, P3476; Yoon YG, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni140; Yost RJ, 2011, PHARMACOTHERAPY, V31, P767, DOI 10.1592/phco.31.8.767; [张军民 Zhang Junmin], 2003, [中华医院感染学杂志, Chinese Journal of Nosocomiology], V13, P1107	43	37	40	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2015	10	1							e0116769	10.1371/journal.pone.0116769	http://dx.doi.org/10.1371/journal.pone.0116769			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ4BU	25575030	Green Submitted, gold, Green Published			2022-12-27	WOS:000348168100008
J	Vettermann, C; Timblin, GA; Lim, V; Lai, EC; Schlissel, MS				Vettermann, Christian; Timblin, Greg A.; Lim, Vivian; Lai, Ernest C.; Schlissel, Mark S.			The Proximal J Kappa Germline-Transcript Promoter Facilitates Receptor Editing through Control of Ordered Recombination	PLOS ONE			English	Article							V(D)J RECOMBINATION; KII SITES; GENE; CHAIN; REARRANGEMENT; ACTIVATION; INITIATION; SEQUENCE; SIGNAL; LOCUS	V(D) J recombination creates antibody light chain diversity by joining a Vk gene segment with one of four J. segments. Two J. germline-transcript (GT) promoters control Vk-Jk joining, but the mechanisms that govern Jk choice are unclear. Here, we show in genetargeted mice that the proximal GT promoter helps targeting rearrangements to Jk1 by preventing premature DNA breaks at Jk2. Consequently, cells lacking the proximal GT promoter show a biased utilization of downstream Jk segments, resulting in a diminished potential for receptor editing. Surprisingly, the proximal-in contrast to the distal-GT promoter is transcriptionally inactive prior to Igk recombination, indicating that its role in Jk choice is independent of classical promoter function. Removal of the proximal GT promoter increases H3K4me3 levels at Jk segments, suggesting that this promoter could act as a suppressor of recombination by limiting chromatin accessibility to RAG. Our findings identify the first cis-element critical for Jk choice and demonstrate that ordered Igk recombination facilitates receptor editing.	[Vettermann, Christian; Timblin, Greg A.; Lim, Vivian; Lai, Ernest C.; Schlissel, Mark S.] Univ Calif Berkeley, Dept Mol & Cell Biol, Div Immunol & Pathogenesis, Berkeley, CA 94720 USA; [Vettermann, Christian] Univ Erlangen Nurnberg, Nikolaus Fiebiger Ctr Mol Med, Div Mol Immunol, D-91054 Erlangen, Germany	University of California System; University of California Berkeley; University of Erlangen Nuremberg	Vettermann, C (corresponding author), Amgen Inc, PKDM, Dept Bioanalyt Sci, Thousand Oaks, CA 91320 USA.	cvetterm@amgen.com		Vettermann, Christian/0000-0003-3794-6441; Lim, Vivian/0000-0002-2851-4391; Timblin, Greg/0000-0001-9351-3646	Marie Curie International Outgoing Fellowship within the 7th Framework Program of the European Commission [PIOF-GA-2009-235297]; California Institute of Regenerative Medicine Predoctoral Fellowship (CIRM Training Program) - University of California Berkeley Stem Cell Center [TG2-01164]; NIH [HL48702, AI40227]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL048702] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI040227, R01AI040227] Funding Source: NIH RePORTER	Marie Curie International Outgoing Fellowship within the 7th Framework Program of the European Commission; California Institute of Regenerative Medicine Predoctoral Fellowship (CIRM Training Program) - University of California Berkeley Stem Cell Center; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	C.V. was supported by a Marie Curie International Outgoing Fellowship (PIOF-GA-2009-235297) within the 7th Framework Program of the European Commission (http://ec.europa.eu/research/mariecurieactions/).G.A.T. was supported by a California Institute of Regenerative Medicine Predoctoral Fellowship (CIRM Training Program TG2-01164) awarded by the University of California Berkeley Stem Cell Center (http://www.cirm.ca.gov/). This work was funded by NIH grants HL48702 and AI40227 to M.S.S. (www.nih.gov). The funding agencies had no	Abarrategui I, 2007, EMBO J, V26, P4380, DOI 10.1038/sj.emboj.7601866; Abarrategui I, 2006, NAT IMMUNOL, V7, P1109, DOI 10.1038/ni1379; Amin RH, 2009, P NATL ACAD SCI USA, V106, P522, DOI 10.1073/pnas.0808895106; Arakawa H, 1996, INT IMMUNOL, V8, P91, DOI 10.1093/intimm/8.1.91; Bossen C, 2012, ANNU REV IMMUNOL, V30, P337, DOI 10.1146/annurev-immunol-020711-075003; Casellas R, 2001, SCIENCE, V291, P1541, DOI 10.1126/science.1056600; Chopra VS, 2012, P NATL ACAD SCI USA, V109, P9460, DOI 10.1073/pnas.1102625108; Cocea L, 1999, J EXP MED, V189, P1443, DOI 10.1084/jem.189.9.1443; Cowell LG, 2004, IMMUNOL REV, V200, P57, DOI 10.1111/j.0105-2896.2004.00171.x; Cowell LG, 2002, GENOME BIOL, V3; FEDDERSEN RM, 1990, MOL CELL BIOL, V10, P569, DOI 10.1128/MCB.10.2.569; FEDDERSEN RM, 1985, P NATL ACAD SCI USA, V82, P4793, DOI 10.1073/pnas.82.14.4793; Feeney AJ, 2009, ADV EXP MED BIOL, V650, P73; FRANCES V, 1994, EMBO J, V13, P5937, DOI 10.1002/j.1460-2075.1994.tb06939.x; Grundy GJ, 2010, P NATL ACAD SCI USA, V107, P22487, DOI 10.1073/pnas.1014958107; Guenther MG, 2007, CELL, V130, P77, DOI 10.1016/j.cell.2007.05.042; Inlay M, 2002, NAT IMMUNOL, V3, P463, DOI 10.1038/ni790; Kondilis-Mangum HD, 2010, J IMMUNOL, V184, P6970, DOI 10.4049/jimmunol.0903923; Krangel MS, 2003, NAT IMMUNOL, V4, P624, DOI 10.1038/ni0703-624; Lee AI, 2003, PLOS BIOL, V1, P56, DOI 10.1371/journal.pbio.0000001; Liang HE, 2004, CELL, V118, P19, DOI 10.1016/j.cell.2004.06.019; MARTIN DJ, 1989, MOL CELL BIOL, V9, P4560, DOI 10.1128/MCB.9.10.4560; MARTIN DJ, 1990, MOL CELL BIOL, V10, P1950, DOI 10.1128/MCB.10.5.1950; Matthews AGW, 2007, NATURE, V450, P1106, DOI 10.1038/nature06431; Merelli I, 2010, NUCLEIC ACIDS RES, V38, pW262, DOI 10.1093/nar/gkq391; MOMBAERTS P, 1992, CELL, V68, P869, DOI 10.1016/0092-8674(92)90030-G; Montalbano A, 2003, J IMMUNOL, V171, P5296, DOI 10.4049/jimmunol.171.10.5296; Muljo SA, 2003, NAT IMMUNOL, V4, P31, DOI 10.1038/ni870; Nadel B, 1998, J EXP MED, V187, P1495, DOI 10.1084/jem.187.9.1495; Okitsu CY, 2010, MOL CELL BIOL, V30, P2933, DOI 10.1128/MCB.01478-09; Pelanda R, 1997, IMMUNITY, V7, P765, DOI 10.1016/S1074-7613(00)80395-7; PRAK EL, 1995, J EXP MED, V182, P541, DOI 10.1084/jem.182.2.541; Raschke EE, 1999, J IMMUNOL, V163, P4375; Sato H, 2001, J IMMUNOL, V166, P6704, DOI 10.4049/jimmunol.166.11.6704; Schatz DG, 2011, ANNU REV GENET, V45, P167, DOI 10.1146/annurev-genet-110410-132552; Schlissel MS, 2004, IMMUNOL REV, V200, P215, DOI 10.1111/j.0105-2896.2004.00157.x; Schlissel MS, 2003, NAT REV IMMUNOL, V3, P890, DOI 10.1038/nri1225; SCHLISSEL MS, 1989, CELL, V58, P1001, DOI 10.1016/0092-8674(89)90951-3; Shimazaki N, 2009, MOL CELL, V34, P535, DOI 10.1016/j.molcel.2009.05.011; Singh N, 2003, J EXP MED, V197, P743, DOI 10.1084/jem.20021392; Taylor B, 2009, P NATL ACAD SCI USA, V106, P516, DOI 10.1073/pnas.0808764105; Tian JY, 1997, EUR J IMMUNOL, V27, P750, DOI 10.1002/eji.1830270325; TIEGS SL, 1993, J EXP MED, V177, P1009, DOI 10.1084/jem.177.4.1009; VANNESS BG, 1981, CELL, V27, P593, DOI 10.1016/0092-8674(81)90401-3; Wang JH, 2009, NATURE, V460, P231, DOI 10.1038/nature08159; Yamagami T, 1999, IMMUNITY, V11, P317, DOI 10.1016/S1074-7613(00)80107-7; YANCOPOULOS GD, 1985, CELL, V40, P271, DOI 10.1016/0092-8674(85)90141-2; Zhou XR, 2010, J IMMUNOL, V185, P7544, DOI 10.4049/jimmunol.1002665	48	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2015	10	1							e0113824	10.1371/journal.pone.0113824	http://dx.doi.org/10.1371/journal.pone.0113824			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ3BG	25559567	Green Published, gold, Green Submitted			2022-12-27	WOS:000348102200006
J	Cone, J; Rand, DG				Cone, Jeremy; Rand, David G.			Time Pressure Increases Cooperation in Competitively Framed Social Dilemmas	PLOS ONE			English	Article							INDIRECT RECIPROCITY; DECISION-MAKING; EGO DEPLETION; EVOLUTION; SELF; PERSPECTIVE; REFLECTION; PUNISHMENT; NETWORKS; GAMES	What makes people willing to pay costs to benefit others? Does such cooperation require effortful self-control, or do automatic, intuitive processes favor cooperation? Time pressure has been shown to increase cooperative behavior in Public Goods Games, implying a predisposition towards cooperation. Consistent with the hypothesis that this predisposition results from the fact that cooperation is typically advantageous outside the lab, it has further been shown that the time pressure effect is undermined by prior experience playing lab games (where selfishness is the more advantageous strategy). Furthermore, a recent study found that time pressure increases cooperation even in a game framed as a competition, suggesting that the time pressure effect is not the result of social norm compliance. Here, we successfully replicate these findings, again observing a positive effect of time pressure on cooperation in a competitively framed game, but not when using the standard cooperative framing. These results suggest that participants' intuitions favor cooperation rather than norm compliance, and also that simply changing the framing of the Public Goods Game is enough to make it appear novel to participants and thus to restore the time pressure effect.	[Cone, Jeremy; Rand, David G.] Yale Univ, New Haven, CT 06520 USA	Yale University	Cone, J (corresponding author), Yale Univ, New Haven, CT 06520 USA.	jeremy.cone@yale.edu		Rand, David/0000-0001-8975-2783	John Templeton Foundation	John Templeton Foundation	Funding was graciously provided by the John Templeton Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amir O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031461; Apicella CL, 2012, NATURE, V481, P497, DOI 10.1038/nature10736; AXELROD R, 1981, SCIENCE, V211, P1390, DOI 10.1126/science.7466396; Balliet D, 2010, GROUP PROCESS INTERG, V13, P227, DOI 10.1177/1368430209353634; Bartlett MY, 2006, PSYCHOL SCI, V17, P319, DOI 10.1111/j.1467-9280.2006.01705.x; Boccaletti S, 2014, PHYS REP, V544, P1, DOI 10.1016/j.physrep.2014.07.001; Bowles S, 2003, DAHL WS ENV, P429; Bowles S, 2002, EC EVOLVING COMPLEX, V3, P339; Boyd R, 2003, P NATL ACAD SCI USA, V100, P3531, DOI 10.1073/pnas.0630443100; Buhrmester M, 2011, PERSPECT PSYCHOL SCI, V6, P3, DOI 10.1177/1745691610393980; Cappelen A. W., 2014, FAIRNESS IS INTUITIV; Chen S, 1999, DUAL-PROCESS THEORIES IN SOCIAL PSYCHOLOGY, P73; Chudek M, 2011, TRENDS COGN SCI, V15, P218, DOI 10.1016/j.tics.2011.03.003; Cornelissen G, 2011, PERS SOC PSYCHOL B, V37, P1080, DOI 10.1177/0146167211405996; Crockett MJ, 2013, TRENDS COGN SCI, V17, P363, DOI 10.1016/j.tics.2013.06.005; CUSHMAN F, 2009, COEVOLUTION PUNISHME; Delton AW, 2011, P NATL ACAD SCI USA, V108, P13335, DOI 10.1073/pnas.1102131108; DeWall CN, 2008, PERS SOC PSYCHOL B, V34, P1653, DOI 10.1177/0146167208323981; Dreber A., 2014, ALTRUISM SELF CONTRO; Engel C, 2014, ECON LETT, V122, P386, DOI 10.1016/j.econlet.2013.12.020; Evans AM, 2014, REACTION TIMES REFLE; Fehr E, 2000, AM ECON REV, V90, P980, DOI 10.1257/aer.90.4.980; Fiedler S, 2013, ORGAN BEHAV HUM DEC, V120, P272, DOI 10.1016/j.obhdp.2012.07.002; Frederick S, 2005, J ECON PERSPECT, V19, P25, DOI 10.1257/089533005775196732; Fu F, 2012, SCI REP-UK, V2, DOI 10.1038/srep00460; Fu F, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.016104; FUDENBERG D, 1990, AM ECON REV, V80, P274; Halali E, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00240; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI 10.1016/0022-5193(64)90039-6; HAUGE KE, 2014, U GOTHENBURG WORKING; Hauser OP, 2014, NATURE, V511, P220, DOI 10.1038/nature13530; Helbing D, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000758; Henrich J, 2005, BEHAV BRAIN SCI, V28, P795, DOI 10.1017/S0140525X05000142; Herrmann B, 2008, SCIENCE, V319, P1362, DOI 10.1126/science.1153808; Horton JJ, 2011, EXP ECON, V14, P399, DOI 10.1007/s10683-011-9273-9; Jin Q, 2014, SCI REP-UK, V4, DOI 10.1038/srep04095; Jordan JJ, MORAL BRAIN MULTIDIS; Kahneman D, 2003, AM PSYCHOL, V58, P697, DOI 10.1037/0003-066X.58.9.697; Kahneman D., 2011, THINKING FAST SLOW; Kieslich PJ, 2014, JUDGM DECIS MAK, V9, P510; Kinnunen SP, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00193; Kiyonari T, 2000, EVOL HUM BEHAV, V21, P411, DOI 10.1016/S1090-5138(00)00055-6; Kovarik J, 2009, ECON LETT, V102, P152, DOI 10.1016/j.econlet.2008.12.005; Liberman V, 2004, PERS SOC PSYCHOL B, V30, P1175, DOI 10.1177/0146167204264004; Manapat ML, 2012, J EC BEHAV ORG; Milinski M, 2002, NATURE, V415, P424, DOI 10.1038/415424a; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; NOWAK MA, 1992, NATURE, V355, P250, DOI 10.1038/355250a0; NOWAK MA, 1992, NATURE, V359, P826, DOI 10.1038/359826a0; Nowak MA, 2006, SCIENCE, V314, P1560, DOI 10.1126/science.1133755; Paolacci G, 2010, JUDGM DECIS MAK, V5, P411; Perc M, 2010, BIOSYSTEMS, V99, P109, DOI 10.1016/j.biosystems.2009.10.003; Peysakhovich A., 2013, HABITS VIRTUE CREATI; Piff PK, 2012, P NATL ACAD SCI USA, V109, P4086, DOI 10.1073/pnas.1118373109; Piovesan M, 2009, ECON LETT, V105, P193, DOI 10.1016/j.econlet.2009.07.017; Rand D., 2014, POSITIVE EMOTION DIS; Rand D. G., 2014, P NATL ACAD SCI; Rand DG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109687; Rand DG, 2015, J BEHAV DECIS MAKING, V28, P159, DOI 10.1002/bdm.1837; Rand DG, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00300; Rand DG, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4677; Rand DG, 2013, TRENDS COGN SCI, V17, P413, DOI 10.1016/j.tics.2013.06.003; Rand DG, 2013, NATURE, V498, pE2, DOI 10.1038/nature12195; Rand DG, 2012, NATURE, V489, P427, DOI 10.1038/nature11467; Rand DG, 2011, P NATL ACAD SCI USA, V108, P19193, DOI 10.1073/pnas.1108243108; Rand DG, 2012, J THEOR BIOL, V299, P172, DOI 10.1016/j.jtbi.2011.03.004; RIGHETTI F, 2013, PSYCHOL SCI; Roch SG, 2000, ORGAN BEHAV HUM DEC, V83, P185, DOI 10.1006/obhd.2000.2915; Rockenbach B, 2006, NATURE, V444, P718, DOI 10.1038/nature05229; Rubinstein A, 2007, ECON J, V117, P1243, DOI 10.1111/j.1468-0297.2007.02081.x; Rubinstein A, 2013, JUDGM DECIS MAK, V8, P540; Ruff CC, 2013, SCIENCE, V342, P482, DOI 10.1126/science.1241399; Schulz JF, 2014, J ECON PSYCHOL, V41, P77, DOI 10.1016/j.joep.2012.08.007; Sigmund K, 2010, PRINC SER THEOR COMP, P1; Sloman SA, 1996, PSYCHOL BULL, V119, P3, DOI 10.1037/0033-2909.119.1.3; Stanovich KE, 1998, J EXP PSYCHOL GEN, V127, P161, DOI 10.1037/0096-3445.127.2.161; Tinghog G, 2013, NATURE, V498, pE1, DOI 10.1038/nature12194; TRIVERS RL, 1971, Q REV BIOL, V46, P35, DOI 10.1086/406755; VanLange PAM, 1997, J PERS SOC PSYCHOL, V73, P733, DOI 10.1037/0022-3514.73.4.733; Verkoeijen PPJL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096654; Xu HY, 2012, J EXP SOC PSYCHOL, V48, P1183, DOI 10.1016/j.jesp.2012.03.007; Yamagishi T., 2007, CULTURAL ECOLOGICAL, P11; Yoeli E, 2013, P NATL ACAD SCI USA, V110, P10424, DOI 10.1073/pnas.1301210110	83	46	47	1	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2014	9	12							e115756	10.1371/journal.pone.0115756	http://dx.doi.org/10.1371/journal.pone.0115756			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AX7UC	25551386	Green Published, gold			2022-12-27	WOS:000347119100058
J	de Ruyter, JC; Katan, MB; Kas, R; Olthof, MR				de Ruyter, Janne C.; Katan, Martijn B.; Kas, Rosa; Olthof, Margreet R.			Can Children Discriminate Sugar-Sweetened from Non-Nutritively Sweetened Beverages and How Do They Like Them?	PLOS ONE			English	Article							HIGH-INTENSITY SWEETENERS; BODY-WEIGHT; SOFT DRINKS; FOOD-INTAKE; SUCROSE; CONSUMPTION; LIKING; TRIAL	Background: Replacement of sugar-sweetened by non-nutritively sweetened beverages or water may reduce excess weight gain in children. However, it is unclear whether children like non-nutritively sweetened beverages as much as sugar-sweetened beverages. We examined whether children could taste a difference between non-nutritively sweetened beverages and matching sugar-sweetened beverages, and which of the two types of beverage they liked best. Methods: 89 children aged 5 to 12 tasted seven non-nutritively sweetened beverages and matching sugar-sweetened beverages, for a total of 14 beverages. We used Triangle tests to check their ability to discriminate between the matched versions, and a 5-point scale to measure how much the children liked each individual beverage. Results: Overall, 24% of children appeared to be genuinely capable of distinguishing between non-nutritively sweetened and sugar-sweetened beverages. The mean +/- SD score for how much the children liked the non-nutritively sweetened beverages was 3.39 +/- 0.7 and that for the sugar-sweetened beverages 3.39 +/- 0.6 (P=0.9) on a scale running from 1 (disgusting) to 5 (delicious). The children preferred some beverages to others irrespective of whether they were sugar-sweetened or non-nutritively sweetened (P=0.000). Children who correctly identified which of three drinks contained the same sweetener and which one was different also showed no preference for either type. Conclusion: We found that about one in four children were able to discriminate between non-nutritively sweetened and sugar-sweetened beverages but children liked both varieties equally. Non-nutritively sweetened beverages may therefore be an acceptable alternative to sugar-sweetened beverages although water remains the healthiest beverage for children.	[de Ruyter, Janne C.; Katan, Martijn B.; Kas, Rosa; Olthof, Margreet R.] Vrije Univ Amsterdam, EMGO Inst Hlth & Care Res, Dept Hlth Sci, Amsterdam, Netherlands	Vrije Universiteit Amsterdam	de Ruyter, JC (corresponding author), Vrije Univ Amsterdam, EMGO Inst Hlth & Care Res, Dept Hlth Sci, Amsterdam, Netherlands.	J.C.de.ruyter@vu.nl	Katan, Martijn/ABB-6613-2021	, Margreet/0000-0002-1982-9244	VU University Amsterdam; Royal Netherlands Academy of Arts and Sciences [ISK/741/PAH]	VU University Amsterdam; Royal Netherlands Academy of Arts and Sciences	The study was funded by VU University Amsterdam and by an Academy Professorship awarded by the Royal Netherlands Academy of Arts and Sciences to prof. dr. M. B. Katan (https://www.knaw.nl/en?set_language=en. Grant number: ISK/741/PAH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerman SJ, 1998, ACAD RADIOL, V5, pS259, DOI 10.1016/S1076-6332(98)80326-7; AMERINE AM, 1965, PRINCIPLES SENSORY E; Anton SD, 2010, APPETITE, V55, P37, DOI 10.1016/j.appet.2010.03.009; AYYA N, 1992, CHEM SENSES, V17, P245, DOI 10.1093/chemse/17.3.245; Beridot-Therond ME, 1998, APPETITE, V31, P67, DOI 10.1006/appe.1997.0153; Brownell KD, 2009, NEW ENGL J MED, V361, P1599, DOI 10.1056/NEJMhpr0905723; de Ruyter JC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078039; de Ruyter JC, 2012, NEW ENGL J MED, V367, P1397, DOI 10.1056/NEJMoa1203034; Ebbeling CB, 2012, NEW ENGL J MED, V367, P1407, DOI 10.1056/NEJMoa1203388; Gambon DL, 2012, BRIT DENT J, V213, P55, DOI 10.1038/sj.bdj.2012.613; Hanger LY, 1996, J FOOD SCI, V61, P456, DOI 10.1111/j.1365-2621.1996.tb14216.x; Kamerud JK, 2007, CHEM SENSES, V32, P803, DOI 10.1093/chemse/bjm050; Kuhn C, 2004, J NEUROSCI, V24, P10260, DOI 10.1523/JNEUROSCI.1225-04.2004; LARSONPOWERS N, 1978, J FOOD SCI, V43, P41, DOI 10.1111/j.1365-2621.1978.tb09732.x; Lawless H. T., 2010, SENSORY EVALUATION F; Leon F, 1999, FOOD QUAL PREFER, V10, P93, DOI 10.1016/S0950-3293(98)00046-9; O'Mahony M., 1986, SENSORY EVALUATION F; Ocke MC, 2009, 350030002 RIVM; Olds T, 2011, INT J PEDIATR OBES, V6, P342, DOI 10.3109/17477166.2011.605895; ROLLS BJ, 1989, APPETITE, V13, P115, DOI 10.1016/0195-6663(89)90109-8; SCHIFFMAN SS, 1985, PHYSIOL BEHAV, V34, P369, DOI 10.1016/0031-9384(85)90198-2; Van Wymelbeke V, 2004, EUR J CLIN NUTR, V58, P154, DOI 10.1038/sj.ejcn.1601762; Vlieg-Boerstra BJ, 2004, J ALLERGY CLIN IMMUN, V113, P341, DOI 10.1016/j.jaci.2003.10.039	23	2	3	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2014	9	12							e115113	10.1371/journal.pone.0115113	http://dx.doi.org/10.1371/journal.pone.0115113			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UC	25551758	Green Submitted, Green Published, gold			2022-12-27	WOS:000347119100028
J	Fu, CL; Donovan, WP; Shikapwashya-Hasser, O; Ye, XD; Cole, RH				Fu, Changlin; Donovan, William P.; Shikapwashya-Hasser, Olga; Ye, Xudong; Cole, Robert H.			Hot Fusion: An Efficient Method to Clone Multiple DNA Fragments as Well as Inverted Repeats without Ligase	PLOS ONE			English	Article							LIGATION-INDEPENDENT CLONING; MUTAGENESIS	Molecular cloning is utilized in nearly every facet of biological and medical research. We have developed a method, termed Hot Fusion, to efficiently clone one or multiple DNA fragments into plasmid vectors without the use of ligase. The method is directional, produces seamless junctions and is not dependent on the availability of restriction sites for inserts. Fragments are assembled based on shared homology regions of 17-30 bp at the junctions, which greatly simplifies the construct design. Hot Fusion is carried out in a one-step, single tube reaction at 50 degrees C for one hour followed by cooling to room temperature. In addition to its utility for multi-fragment assembly Hot Fusion provides a highly efficient method for cloning DNA fragments containing inverted repeats for applications such as RNAi. The overall cloning efficiency is in the order of 90-95%.	[Fu, Changlin; Donovan, William P.; Shikapwashya-Hasser, Olga; Ye, Xudong; Cole, Robert H.] Monsanto Co, Biotechnol, St Louis, MO 63167 USA	Monsanto	Fu, CL (corresponding author), Monsanto Co, Biotechnol, St Louis, MO 63167 USA.	changlin.fu@monsanto.com			Monsanto Company	Monsanto Company	This work has been sponsored by Monsanto Company. The funder provided support in the form of salaries for all authors, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the "author contributions" section.	Alberti S, 2007, YEAST, V24, P913, DOI 10.1002/yea.1502; ASLANIDIS C, 1990, NUCLEIC ACIDS RES, V18, P6069, DOI 10.1093/nar/18.20.6069; Benoit RM, 2006, PROTEIN EXPRES PURIF, V45, P66, DOI 10.1016/j.pep.2005.09.022; Curtis MD, 2003, PLANT PHYSIOL, V133, P462, DOI 10.1104/pp.103.027979; Engler C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003647; Engler C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005553; Fernandes S, 2009, ANAL BIOCHEM, V385, P171, DOI 10.1016/j.ab.2008.10.008; Fu CL, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn167; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Gibson DG, 2008, P NATL ACAD SCI USA, V105, P20404, DOI 10.1073/pnas.0811011106; Invitrogen CA, 2003, INSTR MAN GAT CLON T; Jeong JY, 2012, APPL ENVIRON MICROB, V78, P5440, DOI 10.1128/AEM.00844-12; Jiang XL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030267; JONES DH, 1991, BIOTECHNIQUES, V10, P62; Li CK, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-92; Li MZ, 2007, NAT METHODS, V4, P251, DOI 10.1038/NMETH1010; Petersen LK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024531; Sarrion-Perdigones A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021622; Sleight SC, 2010, NUCLEIC ACIDS RES, V38, P2624, DOI 10.1093/nar/gkq179; System Biosciences, 2014, INSTR MAN COLD FUS C; Thieme F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020556; Tsuge K, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng133; Urban A, 1997, NUCLEIC ACIDS RES, V25, P2227, DOI 10.1093/nar/25.11.2227; Weber E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016765; Yan P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038186; Zhu BG, 2007, BIOTECHNIQUES, V43, P356, DOI 10.2144/000112536	26	86	92	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2014	9	12							e115318	10.1371/journal.pone.0115318	http://dx.doi.org/10.1371/journal.pone.0115318			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UC	25551825	Green Submitted, Green Published, gold			2022-12-27	WOS:000347119100035
J	Iversen, M; Gronsberg, IM; van den Berg, J; Fischer, K; Aheto, DW; Bohn, T				Iversen, Marianne; Gronsberg, Idun M.; van den Berg, Johnnie; Fischer, Klara; Aheto, Denis Worlanyo; Bohn, Thomas			Detection of Transgenes in Local Maize Varieties of Small-Scale Farmers in Eastern Cape, South Africa	PLOS ONE			English	Article							BT-COTTON; GM CROPS; INSECT RESISTANCE; RECOMBINANT DNAS; FIELD-RESISTANCE; PEST RESISTANCE; GENE FLOW; BIOTECHNOLOGY; INFORMATION; GLYPHOSATE	Small-scale subsistence farmers in South Africa have been introduced to genetically modified (GM) crops for more than a decade. Little is known about i) the extent of transgene introgression into locally recycled seed, ii) what short and long-term ecological and socioeconomic impacts such mixing of seeds might have, iii) how the farmers perceive GM crops, and iv) to what degree approval conditions are followed and controlled. This study conducted in the Eastern Cape, South Africa, aims primarily at addressing the first of these issues. We analysed for transgenes in 796 individual maize plants (leaves) and 20 seed batches collected in a village where GM insect resistant maize was previously promoted and grown as part of an governmental agricultural development program over a seven year period (2001-2008). Additionally, we surveyed the varieties of maize grown and the farmers' practices of recycling and sharing of seed in the same community (26 farmers were interviewed). Recycling and sharing of seeds were common in the community and may contribute to spread and persistence of transgenes in maize on a local or regional level. By analysing DNA we found that the commonly used transgene promoter p35s occurred in one of the 796 leaf samples (0.0013%) and in five of the 20 seed samples (25%). Three of the 20 seed samples (15%) included herbicide tolerant maize (NK603) intentionally grown by the farmers from seed bought from local seed retailers or acquired through a currently running agricultural development program. The two remaining positive seed samples (10%) included genes for insect resistance (from MON810). In both cases the farmers were unaware of the transgenes present. In conclusion, we demonstrate that transgenes are mixed into seed storages of small-scale farming communities where recycling and sharing of seeds are common, i.e. spread beyond the control of the formal seed system.	[Iversen, Marianne; Gronsberg, Idun M.; Bohn, Thomas] GenOk Ctr Biosafety, Tromso, Norway; [van den Berg, Johnnie] North West Univ, Unit Environm Sci & Dev, Potchefstroom, South Africa; [Fischer, Klara] Swedish Univ Agr Sci, Dept Urban & Rural Dev, Uppsala, Sweden; [Aheto, Denis Worlanyo] Univ Cape Coast, Sch Biol Sci, Coll Agr & Nat Sci, Cape Coast, Ghana; [Bohn, Thomas] UIT Arctic Univ Norway, Fac Hlth Sci, Tromso, Norway	North West University - South Africa; Swedish University of Agricultural Sciences; University of Cape Coast; UiT The Arctic University of Tromso	Iversen, M (corresponding author), GenOk Ctr Biosafety, Tromso, Norway.	marianne.iversen@genok.org	Van den Berg, Johnnie/M-7256-2013; Fischer, Klara/I-2962-2019	Van den Berg, Johnnie/0000-0002-6831-3180; Fischer, Klara/0000-0001-6590-4025	Norwegian Agency for Development Cooperation (Norad)	Norwegian Agency for Development Cooperation (Norad)	Funding for this work was received from The Norwegian Agency for Development Cooperation (Norad) to GenOk - Centre for Biosafety. URL: http://www.norad.no/en/front-page. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aheto D. W., 2013, GM CROP CULTIVATION, V17, P93; Aheto Denis Worlanyo, 2011, Environmental Sciences Europe, V23, P9, DOI 10.1186/2190-4715-23-9; [Anonymous], ASPECTS APPL BIOL; Bates SL, 2005, NAT BIOTECHNOL, V23, P57, DOI 10.1038/nbt1056; Beckie HJ, 2008, PLANT SCI, V175, P615, DOI 10.1016/j.plantsci.2008.05.021; Bennett R, 2004, J AGR SCI-CAMBRIDGE, V142, P665, DOI 10.1017/S0021859605004892; BiosafetySouthAfrica, 2013, GEN MOD GM CROPS GRA; Bohn T, 2014, AGR SYSTEMS IN PRESS; Bohn Thomas, 2013, GM CROP CULTIVATION, P104; [曹际娟 Cao Jijuan], 2003, [玉米科学, Maize Science], V11, P19; Caprio MA, 2001, J ECON ENTOMOL, V94, P698, DOI 10.1603/0022-0493-94.3.698; Devos Y, 2009, AGRON SUSTAIN DEV, V29, P11, DOI 10.1051/agro:2008051; Ellis JM, 2003, WEED TECHNOL, V17, P452, DOI 10.1614/WT01-110; Gepts Paul, 2003, Environmental Biosafety Research, V2, P89, DOI 10.1051/ebr:2003009; Gouse M., 2012, AgBioForum, V15, P163; Heuberger S, 2011, ENVIRON ENTOMOL, V40, P484, DOI 10.1603/EN10247; ISO, 2005, 215692005 ISO; Jacobson K, 2013, THESIS SWEDISH U AGR; Jacobson K, 2013, J ENVIRON DEV, V22, P104, DOI 10.1177/1070496512466856; James C., 2013, GLOBAL STATUS COMMER; Kruger M, 2012, J APPL ENTOMOL, V136, P38, DOI 10.1111/j.1439-0418.2011.01616.x; Kruger M, 2009, CROP PROT, V28, P684, DOI 10.1016/j.cropro.2009.04.001; Lalitha N, 2009, ROUTL EXPLOR ENVIRON, V19, P135; Li JS, 2013, EXP AGR, V49, P114, DOI 10.1017/S001447971200097X; MARRS RH, 1993, AGR ECOSYST ENVIRON, V45, P283, DOI 10.1016/0167-8809(93)90077-3; Marvier M, 2007, SCIENCE, V316, P1475, DOI 10.1126/science.1139208; Marvier M, 2011, J VERBRAUCH LEBENSM, V6, P113, DOI 10.1007/s00003-011-0675-6; Matsuoka T, 2000, J FOOD HYG SOC JPN, V41, P137, DOI 10.3358/shokueishi.41.137; Matsuoka T, 2002, J AGR FOOD CHEM, V50, P2100, DOI 10.1021/jf011157t; Matsuoka T, 2001, J FOOD HYG SOC JPN, V42, P24, DOI 10.3358/shokueishi.42.24; Mercer K, 2008, EVOL APPL, V1, P489, DOI 10.1111/j.1752-4571.2008.00038.x; Messeguer J, 2006, PLANT BIOTECHNOL J, V4, P633, DOI 10.1111/j.1467-7652.2006.00207.x; Onishi M, 2005, J AGR FOOD CHEM, V53, P9713, DOI 10.1021/jf0515476; Pemsl D, 2004, CROP PROT, V23, P1249, DOI 10.1016/j.cropro.2004.05.011; Perales H, 2003, ECON BOT, V57, P21, DOI 10.1663/0013-0001(2003)057[0007:LOMICM]2.0.CO;2; Pineyro-Nelson A, 2009, MOL ECOL, V18, P750, DOI 10.1111/j.1365-294X.2008.03993.x; SANBI, 2011, MON ENV IMP GM MAIZ; Shi GM, 2013, NAT BIOTECHNOL, V31, P111, DOI 10.1038/nbt.2496; Soleri D, 2006, BIOSCIENCE, V56, P503, DOI 10.1641/0006-3568(2006)56[503:TCACVD]2.0.CO;2; Stone GD, 2004, HUM ORGAN, V63, P127, DOI 10.17730/humo.63.2.jgvu7rlfafk9jwf9; Stone GD, 2007, CURR ANTHROPOL, V48, P67, DOI 10.1086/508689; Stone GD, 2011, WORLD DEV, V39, P387, DOI 10.1016/j.worlddev.2010.09.008; Tabashnik BE, 2009, J ECON ENTOMOL, V102, P2011, DOI 10.1603/029.102.0601; Tripp R, 2001, FOOD POLICY, V26, P249, DOI 10.1016/S0306-9192(01)00002-1; Van den Berg J, 2013, CROP PROT, V54, P154, DOI 10.1016/j.cropro.2013.08.010; van Heerwaarden J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046123; van Rensburg J. B. J., 2007, South African Journal of Plant and Soil, V24, P147; Vencill WK, 2012, WEED SCI, V60, P2, DOI 10.1614/WS-D-11-00206.1	48	10	12	0	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2014	9	12							e116147	10.1371/journal.pone.0116147	http://dx.doi.org/10.1371/journal.pone.0116147			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UC	25551616	Green Submitted, Green Published, gold			2022-12-27	WOS:000347119100102
J	Schollaert, KL; Stephens, MR; Gray, JK; Fulkerson, PC				Schollaert, Kaila L.; Stephens, Michael R.; Gray, Jerilyn K.; Fulkerson, Patricia C.			Generation of Eosinophils from Cryopreserved Murine Bone Marrow Cells	PLOS ONE			English	Article							TOLL-LIKE RECEPTORS; EX-VIVO EXPANSION; IN-VIVO; HEMATOPOIESIS; IL-5; MEPOLIZUMAB; PROGENITORS; EXPRESSION; INCREASES; MOUSE	Eosinophils are produced in the bone marrow from CD34(+) eosinophil lineage-committed progenitors, whose levels in the bone marrow are elevated in a variety of human diseases. These findings suggest that increased eosinophil lineage-committed progenitor production is an important process in disease-associated eosinophilia. The pathways central to the biology of the eosinophil lineage-committed progenitor remain largely unknown. Thus, developing new methods to investigate the regulators of eosinophil lineage-committed progenitor differentiation is needed to identify potential therapeutic targets to specifically inhibit eosinophil production. We tested cytokine regimens to optimize liquid cultures for the study of eosinophil lineage-committed progenitor and eosinophil precursor differentiation into mature eosinophils. Stem cell factor (but not fms-related tyrosine kinase 3 ligand) was required for optimal yield of eosinophils. Furthermore, we evaluated the effects of cell preservation and scale on the culture, successfully culturing functional eosinophils from fresh and frozen murine bone marrow cells and in a standard-sized and 96-well culture format. In summary, we have developed an adaptable culture system that yields functionally competent eosinophils from murine low-density bone marrow cells and whose cytokine regime includes expansion of progenitors with stem cell factor alone with subsequent differentiation with interleukin 5.	[Schollaert, Kaila L.; Stephens, Michael R.; Gray, Jerilyn K.; Fulkerson, Patricia C.] Univ Cincinnati, Coll Med, Dept Pediat, Div Allergy & Immunol,Cincinnati Childrens Hosp M, Cincinnati, OH 45220 USA	Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati	Fulkerson, PC (corresponding author), Univ Cincinnati, Coll Med, Dept Pediat, Div Allergy & Immunol,Cincinnati Childrens Hosp M, Cincinnati, OH 45220 USA.	Patricia.Fulkerson@cchmc.org		Schollaert-Fitch, Kaila/0000-0001-9062-1772	NIH [K08AI093673]; Allergy, Asthma, Immunology Education and Research Organization (ARTrust) Faculty Development Award of the American Academy of Allergy, Asthma and Immunology; PHS [P30 DK078392]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000077, UL1TR001425] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K08AI093673] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK078392] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Allergy, Asthma, Immunology Education and Research Organization (ARTrust) Faculty Development Award of the American Academy of Allergy, Asthma and Immunology; PHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the NIH grant K08AI093673 (P.C.F.) and the Allergy, Asthma, Immunology Education and Research Organization (ARTrust) Faculty Development Award of the American Academy of Allergy, Asthma and Immunology (P.C.F.). This project was also supported in part by the PHS Grant P30 DK078392 (Research Flow Cytometry Core of the Digestive Disease Research Core Center in Cincinnati). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akashi K, 2005, CELL, V121, P160, DOI 10.1016/j.cell.2005.04.005; Baldridge MT, 2011, TRENDS IMMUNOL, V32, P57, DOI 10.1016/j.it.2010.12.003; Ben Baruch-Morgenstern N, 2014, NAT IMMUNOL, V15, P36, DOI 10.1038/ni.2757; Boiko JR, 2012, CYTOKINE, V57, P1, DOI 10.1016/j.cyto.2011.10.005; Bouffi C, 2013, J IMMUNOL, V191, P4317, DOI 10.4049/jimmunol.1301465; de Bruin AM, 2012, BLOOD, V119, P1543, DOI 10.1182/blood-2011-07-367706; Diehl A, 2007, CYTOTHERAPY, V9, P532, DOI 10.1080/14653240701452073; Dyer KD, 2008, J IMMUNOL, V181, P4004, DOI 10.4049/jimmunol.181.6.4004; Dyer KD, 2013, IMMUNOL LETT, V150, P41, DOI 10.1016/j.imlet.2012.12.002; Dyer Kimberly D, 2009, Open Immunol J, V2, P163; Dyer KD, 2011, J LEUKOCYTE BIOL, V90, P1101, DOI 10.1189/jlb.0211059; Dyer KD, 2010, J IMMUNOL, V184, P6327, DOI 10.4049/jimmunol.0904043; Dyer KD, 2009, BLOOD, V114, P2649, DOI 10.1182/blood-2009-01-199497; Flood-Page P, 2007, AM J RESP CRIT CARE, V176, P1062, DOI 10.1164/rccm.200701-085OC; Fulkerson PC, 2014, J IMMUNOL, V193, P4043, DOI 10.4049/jimmunol.1400732; Garcia NV, 2011, J IMMUNOL, V187, P2268, DOI 10.4049/jimmunol.1101008; Haldar P, 2009, NEW ENGL J MED, V360, P973, DOI 10.1056/NEJMoa0808991; Hu HY, 2012, EXP HEMATOL, V40, P675, DOI 10.1016/j.exphem.2012.03.003; Humbles AA, 2002, P NATL ACAD SCI USA, V99, P1479, DOI 10.1073/pnas.261462598; Iwasaki H, 2005, J EXP MED, V201, P1891, DOI 10.1084/jem.20050548; Kopf M, 1996, IMMUNITY, V4, P15, DOI 10.1016/S1074-7613(00)80294-0; Lacy P, 2000, CHEM IMMUNOL, V76, P134; Lu TX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059397; Lu TX, 2013, J IMMUNOL, V190, P1576, DOI 10.4049/jimmunol.1202897; MCKENNA HJ, 1995, BLOOD, V86, P3413, DOI 10.1182/blood.V86.9.3413.bloodjournal8693413; Menzies-Gow A, 2003, J ALLERGY CLIN IMMUN, V111, P714, DOI 10.1067/mai.2003.1382; Milanovic M, 2008, J IMMUNOL, V181, P5045, DOI 10.4049/jimmunol.181.7.5045; Mori Y, 2009, J EXP MED, V206, P183, DOI 10.1084/jem.20081756; Nagai Y, 2006, IMMUNITY, V24, P801, DOI 10.1016/j.immuni.2006.04.008; Saito H, 2002, J IMMUNOL, V168, P3017, DOI 10.4049/jimmunol.168.6.3017; SAUVAGEAU G, 1994, P NATL ACAD SCI USA, V91, P12223, DOI 10.1073/pnas.91.25.12223; Sehmi R, 1997, J CLIN INVEST, V100, P2466, DOI 10.1172/JCI119789; Takizawa H, 2012, BLOOD, V119, P2991, DOI 10.1182/blood-2011-12-380113; Tomaki M, 2000, J IMMUNOL, V165, P4040, DOI 10.4049/jimmunol.165.7.4040; Wu L, 2007, IMMUNITY, V26, P741, DOI 10.1016/j.immuni.2007.06.006	35	12	14	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2014	9	12							e116141	10.1371/journal.pone.0116141	http://dx.doi.org/10.1371/journal.pone.0116141			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UC	25551463	Green Published, Green Submitted, gold			2022-12-27	WOS:000347119100100
J	Wei, J; Gao, DF; Wang, H; Yan, R; Liu, ZQ; Yuan, ZY; Liu, J; Chen, MX				Wei, Jin; Gao, Deng-Feng; Wang, Hao; Yan, Rui; Liu, Zhi-Quan; Yuan, Zu-Yi; Liu, Jian; Chen, Ming-Xia			Impairment of Myocardial Mitochondria in Viral Myocardial Disease and Its Reflective Window in Peripheral Cells	PLOS ONE			English	Article							IDIOPATHIC DILATED CARDIOMYOPATHY; HEART-FAILURE; DNA MUTATIONS; DELETION; METABOLISM; CLASSIFICATION; EPIDEMIOLOGY; ASSOCIATION; CARDIOLOGY; DIAGNOSIS	Background: Viral myocardial disease (VMD) is a common disease inducing heart failure. It has not been clear the roles of mitochondrial damage in the pathological changes of cardiomyocytes in VMD. Methods: Myocardial tissues and lymphocytes were collected from 83 VMD patients. Control groups included 12 cases of healthy accidental death with myocardial autopsy and 23 healthy blood donors. The mouse model of viral myocarditis (VMC) was established by Coxsackie virus B-3 infection and myocardial tissues and skeletal muscle were collected. Mitochondrial DNA (mtDNA) deletion rate was quantitatively determined using polymerase chain reaction. Results: There was significantly difference of myocardial mitochondrial DNA deletion rate between VMD or VMC group and control group (P<0.05). Moreover, the loss of mitochondrial membrane phospholipids was significantly different between VMD or VMC group and control group. In VMC mice, there were negative correlations between myocardial mtDNA(3867) deletion rate and left ventricular peak systolic pressure (LVPSP) (r=-0.66, P<0.05), and between myocardial mtDNA(3867) deletion rate and +dp/dt(max) (r=-0.79, P<0.05), while there was positive correlation between myocardial mtDNA3867 deletion rate and -dp/dt(max) (r=0.80, P<0.05). Conclusion: Mitochondrial damage is an important pathophysiological mechanism leading to myocardial injury and cardiac dysfunction. The mitochondrial damage in the skeletal muscle and lymphocytes reflect a "window" of myocardial mitochondrial damage.	[Wei, Jin; Gao, Deng-Feng; Yan, Rui] Xi An Jiao Tong Univ, Dept Cardiol, Affiliated Hosp 2, Xian 710049, Shaanxi, Peoples R China; [Wang, Hao] Wake Forest Univ, Bowman Gray Sch Med, Dept Anesthesiol, Winston Salem, NC 27157 USA; [Liu, Zhi-Quan; Yuan, Zu-Yi] Xi An Jiao Tong Univ, Dept Cardiol, Affiliated Hosp 1, Xian 710049, Shaanxi, Peoples R China; [Liu, Jian; Chen, Ming-Xia] Xi An Jiao Tong Univ, Coll Med, Xian 710049, Shaanxi, Peoples R China	Xi'an Jiaotong University; Wake Forest University; Wake Forest Baptist Medical Center; Xi'an Jiaotong University; Xi'an Jiaotong University	Wei, J (corresponding author), Xi An Jiao Tong Univ, Dept Cardiol, Affiliated Hosp 2, Xian 710049, Shaanxi, Peoples R China.	weijin@mail.xjtu.edu.cn		Yuan, Zuyi/0000-0002-4141-0298; Wang, Hao/0000-0003-1537-661X	Science and Technology Projects of Shaanxi Province [2007K13-03]; National Natural Science Foundation of China [81170209]	Science and Technology Projects of Shaanxi Province; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the Science and Technology Projects of Shaanxi Province (No. 2007K13-03 to J.W.), and grants from National Natural Science Foundation of China (No. 81170209 to J.W.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADACHI K, 1993, BIOCHEM BIOPH RES CO, V195, P945, DOI 10.1006/bbrc.1993.2135; Arbustini E, 1998, AM J PATHOL, V153, P1501, DOI 10.1016/S0002-9440(10)65738-0; Blauwet LA, 2010, PROG CARDIOVASC DIS, V52, P274, DOI 10.1016/j.pcad.2009.11.006; Caforio ALP, 1997, EUR HEART J, V18, P1051; Carvajal K, 2003, ARCH MED RES, V34, P89, DOI 10.1016/S0188-4409(03)00004-3; Chabi B, 2003, CLIN CHEM, V49, P1309, DOI 10.1373/49.8.1309; Chinese Heart Association, 2000, CHINESE J PRACTICAL, V15, P75; CORRALDEBRINSKI M, 1992, MUTAT RES, V275, P169, DOI 10.1016/0921-8734(92)90021-G; Craigen WJ, 2012, METHODS MOL BIOL, V837, P3, DOI 10.1007/978-1-61779-504-6_1; Eynon N, 2011, PHYSIOL GENOMICS, V43, P789, DOI 10.1152/physiolgenomics.00029.2011; Fan Zh, 2010, J LIAONING MED U, V31, P370; GRIFFITHS GM, 1992, P NATL ACAD SCI USA, V89, P549, DOI 10.1073/pnas.89.2.549; Haiyan D, 2006, J CHINESE MODERN PED, V3, P407; Hanaki Y, 1989, J MOL CELL CARDIOL, V21, P175; Hill MF, 1997, CIRCULATION, V96, P2414; Ingwall JS, 2009, CARDIOVASC RES, V81, P412, DOI 10.1093/cvr/cvn301; INGWALL JS, 1993, CIRCULATION, V87, P58; Jing Y, 2012, J CLIN CARDIOLOGY CH, V28, P81; Kao SH, 1997, BIOCHEM MOL BIOL INT, V42, P285; Katz Arnold M., 1998, Cardiology Clinics, V16, P633, DOI 10.1016/S0733-8651(05)70040-0; Kim HE, 2000, J CLIN INVEST, V106, P857, DOI 10.1172/JCI8040; Lan Y, 1998, J SHANXI MED, V27, P598; Lezza AMS, 1999, FASEB J, V13, P1083, DOI 10.1096/fasebj.13.9.1083; Lv SC, 2013, HELL J CARDIOL, V54, P382; Mallat Z, 1998, CIRCULATION, V97, P1536, DOI 10.1161/01.CIR.97.16.1536; Marin-Garcia J, 2002, J CARD FAIL, V8, P347, DOI 10.1054/jcaf.2002.127774; Marin-Garcia J, 1999, CARDIOVASC PATHOL, V8, P217, DOI 10.1016/S1054-8807(99)00010-1; MarinGarcia J, 1996, CARDIOVASC RES, V31, P306; Maron BJ, 2006, CIRCULATION, V113, P1807, DOI 10.1161/CIRCULATIONAHA.106.174287; Molina H, 1997, MECH AGEING DEV, V97, P1, DOI 10.1016/S0047-6374(97)01876-9; Panfoli I, 2011, EXPERT REV PROTEOMIC, V8, P231, DOI [10.1586/EPR.11.1, 10.1586/epr.11.1]; Richardson P, 1996, CIRCULATION, V93, P841, DOI 10.1161/01.CIR.93.5.841; ROBINSON NC, 1982, BIOCHEMISTRY-US, V21, P184, DOI 10.1021/bi00530a031; Rose NR, 2008, CURR TOP MICROBIOL, V323, P293; Sen Z, 1964, PROGR PHYSL SCI, V6, P122; Shenkar R, 1996, AM J HUM GENET, V59, P772; Stanley WC, 2005, PHYSIOL REV, V85, P1093, DOI 10.1152/physrev.00006.2004; Wu F, 2009, P NATL ACAD SCI USA, V106, P7143, DOI 10.1073/pnas.0812768106; Yajima T, 2009, CIRCULATION, V119, P2615, DOI 10.1161/CIRCULATIONAHA.108.766022; Yanagawa B, 2003, LAB INVEST, V83, P75, DOI 10.1097/01.LAB.0000049349.56211.09; Zhang XX, 2002, CHINESE MED J-PEKING, V115, P1390; Zhiquan L, 1992, J MOL CELL CARDIOL, V24, P239; Zhiquan L, 1993, CHINESE J CARDIOLOGY, V21, P209	43	7	9	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2014	9	12							e116239	10.1371/journal.pone.0116239	http://dx.doi.org/10.1371/journal.pone.0116239			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UC	25551390	Green Published, Green Submitted, gold			2022-12-27	WOS:000347119100113
J	Zeng, FS; Sun, FK; Li, LL; Liu, K; Zhan, YG				Zeng, Fansuo; Sun, Fengkun; Li, Leilei; Liu, Kun; Zhan, Yaguang			Genome-Scale Transcriptome Analysis in Response to Nitric Oxide in Birch Cells: Implications of the Triterpene Biosynthetic Pathway	PLOS ONE			English	Article							ISOPRENOID BIOSYNTHESIS; DEFENSE RESPONSES; SALICYLIC-ACID; EXPRESSION; TOLERANCE; INHIBITION; SYNTHASE; STRESS; TOOL	Evidence supporting nitric oxide (NO) as a mediator of plant biochemistry continues to grow, but its functions at the molecular level remains poorly understood and, in some cases, controversial. To study the role of NO at the transcriptional level in Betula platyphylla cells, we conducted a genome-scale transcriptome analysis of these cells. The transcriptome of untreated birch cells and those treated by sodium nitroprusside (SNP) were analyzed using the Solexa sequencing. Data were collected by sequencing cDNA libraries of birch cells, which had a long period to adapt to the suspension culture conditions before SNP-treated cells and untreated cells were sampled. Among the 34,100 UniGenes detected, BLASTX search revealed that 20,631 genes showed significant (E-values <= 10(-5)) sequence similarity with proteins from the NR-database. Numerous expressed sequence tags (i.e., 1374) were identified as differentially expressed between the 12 h SNP-treated cells and control cells samples: 403 up-regulated and 971 down-regulated. From this, we specifically examined a core set of NO-related transcripts. The altered expression levels of several transcripts, as determined by transcriptome analysis, was confirmed by qRT-PCR. The results of transcriptome analysis, gene expression quantification, the content of triterpenoid and activities of defensive enzymes elucidated NO has a significant effect on many processes including triterpenoid production, carbohydrate metabolism and cell wall biosynthesis.	[Zeng, Fansuo; Zhan, Yaguang] Northeast Forestry Univ, State Key Lab Tree Genet & Breeding, Harbin 150040, Peoples R China; [Zeng, Fansuo; Sun, Fengkun; Li, Leilei; Liu, Kun; Zhan, Yaguang] Northeast Forestry Univ, Coll Life Sci, Harbin 150040, Peoples R China	Northeast Forestry University - China; Northeast Forestry University - China	Zhan, YG (corresponding author), Northeast Forestry Univ, State Key Lab Tree Genet & Breeding, Harbin 150040, Peoples R China.	youpractise@126.com	ZENG, FANSUO/N-3105-2019	Fansuo, Zeng/0000-0002-3237-4651	Fundamental Research Funds for the Central Universities [2572014DA04]; National Natural Science Foundation of China [31070531, J1210053, 31200463]	Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was financially supported by The Fundamental Research Funds for the Central Universities (NO: 2572014DA04) and the National Natural Science Foundation of China (NO: 31070531, J1210053 and 31200463). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Astier J, 2011, ANNU PLANT REV, V42, P147, DOI 10.1002/9781444328608.ch7; Bailly C, 2004, SEED SCI RES, V14, P93, DOI 10.1079/SSR2004159; Besson-Bard A, 2008, ANNU REV PLANT BIOL, V59, P21, DOI 10.1146/annurev.arplant.59.032607.092830; Chen DQ, 2013, PLANT CELL, V25, P1657, DOI 10.1105/tpc.112.104869; Chintharlapalli S, 2007, CANCER RES, V67, P2816, DOI 10.1158/0008-5472.CAN-06-3735; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Csuk R, 2010, BIOORGAN MED CHEM, V18, P1344, DOI 10.1016/j.bmc.2009.12.024; Delledonne M, 2005, CURR OPIN PLANT BIOL, V8, P390, DOI 10.1016/j.pbi.2005.05.002; Fan GZ, 2013, PLANT MOL BIOL REP, V31, P296, DOI 10.1007/s11105-012-0501-z; Fan JP, 2006, J PHARMACEUT BIOMED, V41, P950, DOI 10.1016/j.jpba.2006.01.044; FORSTERMANN U, 1995, N-S ARCH PHARMACOL, V352, P351; FRIDOVICH I, 1989, J BIOL CHEM, V264, P7761; Fukushima EO, 2011, PLANT CELL PHYSIOL, V52, P2050, DOI 10.1093/pcp/pcr146; FURCHGOTT RF, 1995, ANNU REV PHYSIOL, V57, P659; Gill SS, 2010, PLANT PHYSIOL BIOCH, V48, P909, DOI 10.1016/j.plaphy.2010.08.016; Han RB, 2004, BIOTECHNOL PROGR, V20, P507, DOI 10.1021/bp034242p; Jagadeeswaran G, 2007, PLANT J, V51, P234, DOI 10.1111/j.1365-313X.2007.03130.x; Joseph Chappell FW, 1995, PLANT PHYSIOL, P1337; Karsi A, 2002, GENE, V285, P157, DOI 10.1016/S0378-1119(02)00414-6; Lamattina L, 2003, ANNU REV PLANT BIOL, V54, P109, DOI 10.1146/annurev.arplant.54.031902.134752; Li RQ, 2010, NAT BIOTECHNOL, V28, P57, DOI 10.1038/nbt.1596; Lu D, 2011, APPL MICROBIOL BIOT, V90, P1073, DOI 10.1007/s00253-011-3146-1; Moniz S, 2008, ONCOGENE, V27, P155, DOI 10.1038/sj.onc.1210931; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; NAKANO Y, 1981, PLANT CELL PHYSIOL, V22, P867; Newman JD, 1999, CRIT REV BIOCHEM MOL, V34, P95, DOI 10.1080/10409239991209228; Nobuta K, 2007, PLANT PHYSIOL, V144, P1144, DOI [10.1104/pp.107.097691, 10.1104/PP.107.097691]; Parani M, 2004, PLANT BIOTECHNOL J, V2, P359, DOI 10.1111/j.1467-7652.2004.00085.x; Penfield S, 2006, PLANT CELL, V18, P1887, DOI 10.1105/tpc.106.041277; Pertea G, 2003, BIOINFORMATICS, V19, P651, DOI 10.1093/bioinformatics/btg034; Rockel Peter, 2002, Journal of Experimental Botany, V53, P103, DOI 10.1093/jexbot/53.366.103; ROHMER M, 1993, BIOCHEM J, V295, P517, DOI 10.1042/bj2950517; Sapir-Mir M, 2008, PLANT PHYSIOL, V148, P1219, DOI 10.1104/pp.108.127951; Shen Q, 2011, PLANT CELL ENVIRON, V34, P752, DOI 10.1111/j.1365-3040.2011.02279.x; Staswick PE, 2002, PLANT CELL, V14, P1405, DOI 10.1105/tpc.000885; Wang S, 2011, PLANT MOL BIOL REP, V29, P794, DOI 10.1007/s11105-010-0281-2; Wang YC, 2012, TREE GENET GENOMES, V8, P1031, DOI 10.1007/s11295-012-0483-x; Wentzinger LF, 2002, PLANT PHYSIOL, V130, P334, DOI 10.1104/pp.004655; Wilhelm BT, 2009, METHODS, V48, P249, DOI 10.1016/j.ymeth.2009.03.016; Wilson ID, 2008, PLANT CELL ENVIRON, V31, P622, DOI 10.1111/j.1365-3040.2007.01761.x; Xu MJ, 2005, PLANT PHYSIOL, V139, P991, DOI 10.1104/pp.105.066407; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; Yin J, 2012, MOL BIOL REP, V39, P2321, DOI 10.1007/s11033-011-0982-0; Zhang B, 2012, APPL MICROBIOL BIOT, V93, P455, DOI 10.1007/s00253-011-3658-8; Zhang RS, 2011, PLANT MOL BIOL REP, V29, P898, DOI 10.1007/s11105-011-0306-5; Zhao MG, 2009, PLANT PHYSIOL, V151, P755, DOI 10.1104/pp.109.140996	46	13	13	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2014	9	12							e116157	10.1371/journal.pone.0116157	http://dx.doi.org/10.1371/journal.pone.0116157			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UC	25551661	gold, Green Published, Green Submitted			2022-12-27	WOS:000347119100103
J	Radin, JM; Hawksworth, AW; Kammerer, PE; Balansay, M; Raman, R; Lindsay, SP; Brice, GT				Radin, Jennifer M.; Hawksworth, Anthony W.; Kammerer, Peter E.; Balansay, Melinda; Raman, Rema; Lindsay, Suzanne P.; Brice, Gary T.			Epidemiology of Pathogen-Specific Respiratory Infections among Three US Populations	PLOS ONE			English	Article							INFLUENZA-LIKE ILLNESSES; VIRAL-INFECTIONS; CLINICAL SIGNS; PCR; SURVEILLANCE; VIRUSES; COINFECTIONS; PNEUMONIA; COMMUNITY; SYMPTOMS	Background: Diagnostic tests for respiratory infections can be costly and time-consuming. Improved characterization of specific respiratory pathogens by identifying frequent signs, symptoms and demographic characteristics, along with improving our understanding of coinfection rates and seasonality, may improve treatment and prevention measures. Methods: Febrile respiratory illness (FRI) and severe acute respiratory infection (SARI) surveillance was conducted from October 2011 through March 2013 among three US populations: civilians near the US-Mexico border, Department of Defense (DoD) beneficiaries, and military recruits. Clinical and demographic questionnaire data and respiratory swabs were collected from participants, tested by PCR for nine different respiratory pathogens and summarized. Age stratified characteristics of civilians positive for influenza and recruits positive for rhinovirus were compared to other and no/unknown pathogen. Seasonality and coinfection rates were also described. Results: A total of 1444 patients met the FRI or SARI case definition and were enrolled in this study. Influenza signs and symptoms varied across age groups of civilians. Recruits with rhinovirus had higher percentages of pneumonia, cough, shortness of breath, congestion, cough, less fever and longer time to seeking care and were more likely to be male compared to those in the no/unknown pathogen group. Coinfections were found in 6% of all FRI/SARI cases tested and were most frequently seen among children and with rhinovirus infections. Clear seasonal trends were identified for influenza, rhinovirus, and respiratory syncytial virus. Conclusions: The age-stratified clinical characteristics associated with influenza suggest that age-specific case definitions may improve influenza surveillance and identification. Improving identification of rhinoviruses, the most frequent respiratory infection among recruits, may be useful for separating out contagious individuals, especially when larger outbreaks occur. Overall, describing the epidemiology of pathogen specific respiratory diseases can help improve clinical diagnoses, establish baselines of infection, identify outbreaks, and help prioritize the development of new vaccines and treatments.	[Radin, Jennifer M.; Hawksworth, Anthony W.; Kammerer, Peter E.; Balansay, Melinda; Brice, Gary T.] Naval Hlth Res Ctr San Diego, Operat Infect Dis Dept, San Diego, CA 92106 USA; [Radin, Jennifer M.] Univ Calif San Diego, San Diego State Univ, Joint Doctoral Program Publ Hlth Epidemiol, San Diego, CA 92103 USA; [Raman, Rema] Univ Calif San Diego, Dept Family & Prevent Med, La Jolla, CA 92093 USA; [Lindsay, Suzanne P.] San Diego State Univ, Grad Sch Publ Hlth, San Diego, CA 92182 USA	United States Department of Defense; United States Navy; Naval Medical Research Center (NMRC); Naval Health Research Center (NHRC); California State University System; San Diego State University; University of California System; University of California San Diego; University of California System; University of California San Diego; California State University System; San Diego State University	Radin, JM (corresponding author), Naval Hlth Res Ctr San Diego, Operat Infect Dis Dept, San Diego, CA 92106 USA.	jennifer.radin@med.navy.mil		Radin, Jennifer/0000-0003-3843-0842	Department of Defense Global Emerging Infections Surveillance and Response System [60805]	Department of Defense Global Emerging Infections Surveillance and Response System(United States Department of Defense)	This work was supported by the Department of Defense Global Emerging Infections Surveillance and Response System under Work Unit No. 60805. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Laguna-Torres VA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006118; Bellei N, 2008, J MED VIROL, V80, P1824, DOI 10.1002/jmv.21295; Berkley JA, 2010, JAMA-J AM MED ASSOC, V303, P2051, DOI 10.1001/jama.2010.675; Boivin G, 2000, CLIN INFECT DIS, V31, P1166, DOI 10.1086/317425; Budge PJ, 2014, PEDIATR INFECT DIS J, V33, P443, DOI 10.1097/INF.0000000000000135; Call SA, 2005, JAMA-J AM MED ASSOC, V293, P987, DOI 10.1001/jama.293.8.987; Carballal G, 2001, J MED VIROL, V64, P167, DOI 10.1002/jmv.1032; Diagnostic Hybrids, COLL TRANSP U TRANSP; Fowlkes A, 2014, J INFECT DIS, V209, P1715, DOI 10.1093/infdis/jit806; Galindo-Fraga A, 2013, INT J INFECT DIS, V17, pE510, DOI 10.1016/j.ijid.2013.01.006; Gaunt ER, 2010, J CLIN MICROBIOL, V48, P2940, DOI 10.1128/JCM.00636-10; Hirve S, 2012, B WORLD HEALTH ORGAN, V90, P804, DOI 10.2471/BLT.12.108837; Hoke CH, 2013, VACCINE, V31, P1623, DOI 10.1016/j.vaccine.2012.12.029; Kim JK, 2013, J MICROBIOL BIOTECHN, V23, P267, DOI 10.4014/jmb.1212.12050; Landes MB, 2013, INFLUENZA OTHER RESP, V7, P1122, DOI 10.1111/irv.12145; Lee VJ, 2011, PLOS ONE, V6, P1; Li HX, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-143; Lu XY, 2008, J CLIN MICROBIOL, V46, P533, DOI 10.1128/JCM.01739-07; Martin ET, 2013, J INFECT DIS, V207, P982, DOI 10.1093/infdis/jis934; Messacar K, 2013, J CLIN VIROL, V56, P41, DOI 10.1016/j.jcv.2012.09.012; Metzgar D, 2010, J CLIN MICROBIOL, V48, P4228, DOI 10.1128/JCM.01336-10; Midgley CM, 2014, MMWR-MORBID MORTAL W, V63, P773; Monto AS, 2000, ARCH INTERN MED, V160, P3243, DOI 10.1001/archinte.160.21.3243; Nakanishi M, 2011, PRIM CARE RESP J, V20, P421, DOI 10.4104/pcrj.2011.00067; Nicholson KG, 1997, BRIT MED J, V315, P1060, DOI 10.1136/bmj.315.7115.1060; Njouom R, 2012, J INFECT DIS, V206, pS29, DOI 10.1093/infdis/jis573; Pretorius MA, 2012, J INFECT DIS, V206, pS159, DOI 10.1093/infdis/jis538; Razanajatovo NH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017579; Renois F, 2010, J CLIN MICROBIOL, V48, P3836, DOI 10.1128/JCM.00733-10; Uyeki TM, 2009, CLIN INFECT DIS, V48, pE89, DOI 10.1086/597828; Woolpert T, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-129; World Health Organization, AC RESP INF; World Health Organization, WHO SURV CAS DEF ILI; Yang XB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030198	34	24	25	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2014	9	12							e114871	10.1371/journal.pone.0114871	http://dx.doi.org/10.1371/journal.pone.0114871			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX6YH	25549089	Green Published, gold, Green Submitted			2022-12-27	WOS:000347063500009
J	Rydenfelt, M; Garcia, HG; Cox, RS; Phillips, R				Rydenfelt, Mattias; Garcia, Hernan G.; Cox, Robert Sidney, III; Phillips, Rob			The Influence of Promoter Architectures and Regulatory Motifs on Gene Expression in Escherichia coli	PLOS ONE			English	Article							INTEGRATION HOST FACTOR; TRANSCRIPTIONAL REGULATION; BINDING-SITE; RNA-POLYMERASE; DNA; PROTEIN; ACTIVATION; REPRESSION; REGULON; FNR	The ability to regulate gene expression is of central importance for the adaptability of living organisms to changes in their external and internal environment. At the transcriptional level, binding of transcription factors (TFs) in the promoter region can modulate the transcription rate, hence making TFs central players in gene regulation. For some model organisms, information about the locations and identities of discovered TF binding sites have been collected in continually updated databases, such as RegulonDB for the well-studied case of E. coli. In order to reveal the general principles behind the binding-site arrangement and function of these regulatory architectures we propose a random promoter architecture model that preserves the overall abundance of binding sites to identify overrepresented binding site configurations. This model is analogous to the random network model used in the study of genetic network motifs, where regulatory motifs are identified through their overrepresentation with respect to a "randomly connected" genetic network. Using our model we identify TF pairs which coregulate operons in an overrepresented fashion, or individual TFs which act at multiple binding sites per promoter by, for example, cooperative binding, DNA looping, or through multiple binding domains. We furthermore explore the relationship between promoter architecture and gene expression, using three different genome-wide protein copy number censuses. Perhaps surprisingly, we find no systematic correlation between the number of activator and repressor binding sites regulating a gene and the level of gene expression. A position-weight-matrix model used to estimate the binding affinity of RNA polymerase (RNAP) to the promoters of activated and repressed genes suggests that this lack of correlation might in part be due to differences in basal transcription levels, with repressed genes having a higher basal activity level. This quantitative catalogue relating promoter architecture and function provides a first step towards genome-wide predictive models of regulatory function.	[Rydenfelt, Mattias] CALTECH, Dept Phys, Pasadena, CA 91125 USA; [Rydenfelt, Mattias] Humboldt Univ, Integrat Res Inst Life Sci, D-10099 Berlin, Germany; [Rydenfelt, Mattias] Humboldt Univ, Inst Theoret Biol, D-10099 Berlin, Germany; [Garcia, Hernan G.] Princeton Univ, Joseph Henry Labs Phys, Princeton, NJ 08544 USA; [Cox, Robert Sidney, III] Kobe Univ, Dept Chem Sci & Engn, Kobe, Hyogo 657, Japan; [Phillips, Rob] CALTECH, Dept Appl Phys, Pasadena, CA 91125 USA; [Phillips, Rob] CALTECH, Div Biol, Pasadena, CA 91125 USA	California Institute of Technology; Humboldt University of Berlin; Humboldt University of Berlin; Princeton University; Kobe University; California Institute of Technology; California Institute of Technology	Phillips, R (corresponding author), CALTECH, Dept Appl Phys, Pasadena, CA 91125 USA.	phillips@pboc.caltech.edu		Garcia, Hernan G./0000-0002-5212-3649	National Institute Of General Medical Sciences of the National Institutes of Health [R01 GM085286, R01 GM085286-01S]; National Institutes of Health [DP1 OD000217]; Burroughs Wellcome Fund; Princeton Dicke Fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM085286] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD000217] Funding Source: NIH RePORTER	National Institute Of General Medical Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Fund(Burroughs Wellcome Fund); Princeton Dicke Fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Research reported in this publication was supported by the National Institute Of General Medical Sciences of the National Institutes of Health under Award Number R01 GM085286 and R01 GM085286-01S (M.R., H.G.G., R.P), as well as National Institutes of Health Pioneer award DP1 OD000217 (R.P.). The content is solely the responsibility of the authors and does notnecessarily represent the official views of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. H.G.G. holds a Career Award at the Scientific Interface from the Burroughs Wellcome Fund and a Princeton Dicke Fellowship.	Abramowitz M., 1964, HDB MATH FUNCTIONS F; ACKERS GK, 1982, P NATL ACAD SCI-BIOL, V79, P1129, DOI 10.1073/pnas.79.4.1129; Alon U, 2007, INTRO SYSTEMS BIOL D; Azam TA, 1999, J BACTERIOL, V181, P6361, DOI 10.1128/JB.181.20.6361-6370.1999; Babu MM, 2003, NUCLEIC ACIDS RES, V31, P1234, DOI 10.1093/nar/gkg210; Bai Q, 1998, J BACTERIOL, V180, P6173; Bintu L, 2005, CURR OPIN GENET DEV, V15, P125, DOI 10.1016/j.gde.2005.02.006; Bintu L, 2005, CURR OPIN GENET DEV, V15, P116, DOI 10.1016/j.gde.2005.02.007; Brewster RC, 2014, CELL, V156, P1312, DOI 10.1016/j.cell.2014.02.022; Brewster RC, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002811; BRUNNER M, 1987, EMBO J, V6, P3139, DOI 10.1002/j.1460-2075.1987.tb02624.x; Buchler NE, 2003, P NATL ACAD SCI USA, V100, P5136, DOI 10.1073/pnas.0930314100; Busby S, 1999, J MOL BIOL, V293, P199, DOI 10.1006/jmbi.1999.3161; Chen Z, 2007, NUCLEIC ACIDS RES, V35, P6762, DOI 10.1093/nar/gkm631; COHEN SP, 1993, J BACTERIOL, V175, P1484, DOI 10.1128/JB.175.5.1484-1492.1993; Cox RS, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100187; Darwin AJ, 1998, J BACTERIOL, V180, P4192, DOI 10.1128/JB.180.16.4192-4198.1998; Djordjevic M, 2003, GENOME RES, V13, P2381, DOI 10.1101/gr.1271603; Djordjevic M, 2013, INTEGR BIOL-UK, V5, P796, DOI [10.1039/c3ib20221f, 10.1039/c3b20221f]; Dove SL, 1997, NATURE, V386, P627, DOI 10.1038/386627a0; EFRON B, 1979, ANN STAT, V7, P1, DOI 10.1214/aos/1176344552; Garcia HG, 2007, BIOPOLYMERS, V85, P115, DOI 10.1002/bip.20627; Garcia HG, 2012, CELL REP, V2, P150, DOI 10.1016/j.celrep.2012.06.004; Garcia HG, 2011, P NATL ACAD SCI USA, V108, P12173, DOI 10.1073/pnas.1015616108; Geanacopoulos M, 1997, J BACTERIOL, V179, P228, DOI 10.1128/jb.179.1.228-234.1997; Gershenzon NI, 2005, NUCLEIC ACIDS RES, V33, P2290, DOI 10.1093/nar/gki519; GILBERT W, 1966, P NATL ACAD SCI USA, V56, P1891, DOI 10.1073/pnas.56.6.1891; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Gross CA, 1998, COLD SPRING HARB SYM, V63, P141, DOI 10.1101/sqb.1998.63.141; Hammar M, 1995, MOL MICROBIOL, V18, P661, DOI 10.1111/j.1365-2958.1995.mmi_18040661.x; HIRASHIMA A, 1974, P NATL ACAD SCI USA, V71, P4149, DOI 10.1073/pnas.71.10.4149; Hochschild A, 1998, CELL, V92, P597, DOI 10.1016/S0092-8674(00)81126-5; Huerta AM, 2003, J MOL BIOL, V333, P261, DOI 10.1016/j.jmb.2003.07.017; Ishihama Y, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-102; JACOB F, 1961, J MOL BIOL, V3, P318, DOI 10.1016/S0022-2836(61)80072-7; Johnson DS, 2007, SCIENCE, V316, P1497, DOI 10.1126/science.1141319; Keseler IM, 2011, NUCLEIC ACIDS RES, V39, pD583, DOI 10.1093/nar/gkq1143; KIM J, 1989, GENE, V85, P15, DOI 10.1016/0378-1119(89)90459-9; Kim S, 2013, SCIENCE, V339, P816, DOI 10.1126/science.1229223; Kinney JB, 2010, P NATL ACAD SCI USA, V107, P9158, DOI 10.1073/pnas.1004290107; Klumpp S, 2009, CELL; LAIMINS LA, 1981, P NATL ACAD SCI-BIOL, V78, P464, DOI 10.1073/pnas.78.1.464; Levanon SS, 2005, BIOTECHNOL BIOENG, V89, P556; Li GW, 2014, CELL, V157, P624, DOI 10.1016/j.cell.2014.02.033; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Lu P, 2007, NAT BIOTECHNOL, V25, P117, DOI 10.1038/nbt1270; MACNAB RM, 1992, ANNU REV GENET, V26, P131, DOI 10.1146/annurev.ge.26.120192.001023; Martin RG, 1999, MOL MICROBIOL, V34, P431, DOI 10.1046/j.1365-2958.1999.01599.x; Martinez-Antonio A, 2003, CURR OPIN MICROBIOL, V6, P482, DOI 10.1016/j.mib.2003.09.002; MCCLURE WR, 1980, P NATL ACAD SCI-BIOL, V77, P5634, DOI 10.1073/pnas.77.10.5634; MCCLURE WR, 1985, ANNU REV BIOCHEM, V54, P171, DOI 10.1146/annurev.bi.54.070185.001131; Mermod M, 2012, BIOMETALS, V25, P33, DOI 10.1007/s10534-011-9510-x; Mettert EL, 2007, J BACTERIOL, V189, P3036, DOI 10.1128/JB.00052-07; Muller J, 1996, J MOL BIOL, V257, P21, DOI 10.1006/jmbi.1996.0143; MULLIGAN ME, 1984, NUCLEIC ACIDS RES, V12, P789, DOI 10.1093/nar/12.1Part2.789; Myers KS, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003565; NISHIMURA K, 1988, ANN I STAT MATH, V40, P77, DOI 10.1007/BF00053956; OEHLER S, 1990, EMBO J, V9, P973, DOI 10.1002/j.1460-2075.1990.tb08199.x; Overton TW, 2006, BIOCHEM SOC T, V34, P104, DOI 10.1042/BST0340104; PAVCO PA, 1991, NUCLEIC ACIDS RES, V19, P4639, DOI 10.1093/nar/19.17.4639; PAVCO PA, 1990, J BIOL CHEM, V265, P9960; PEREZMARTIN J, 1994, MICROBIOL REV, V58, P268; PLUMBRIDGE J, 1993, MOL MICROBIOL, V10, P973, DOI 10.1111/j.1365-2958.1993.tb00969.x; PTASHNE M, 2002, GENES SIGNALS; RABIN RS, 1993, J BACTERIOL, V175, P3259, DOI 10.1128/jb.175.11.3259-3268.1993; RAO NN, 1993, J BACTERIOL, V175, P74, DOI 10.1128/JB.175.1.74-79.1993; Reif F., 1965, FUNDAMENTALS STAT TH; Renyi A., 1959, PUBL MATH-DEBRECEN, V6, P290, DOI DOI 10.2307/1999405; Rojo F, 1999, J BACTERIOL, V181, P2987, DOI 10.1128/JB.181.10.2987-2991.1999; Ruths T, 2013, P NATL ACAD SCI USA, V110, P7754, DOI 10.1073/pnas.1217630110; Rydenfelt M, 2014, PHYS REV E, V89, DOI 10.1103/PhysRevE.89.012702; Ryu S, 1998, GENE, V223, P235, DOI 10.1016/S0378-1119(98)00237-6; Salgado H, 2013, NUCLEIC ACIDS RES, V41, pD203, DOI 10.1093/nar/gks1201; Schneider R, 2001, NUCLEIC ACIDS RES, V29, P5107, DOI 10.1093/nar/29.24.5107; Scott M, 2010, SCIENCE, V330, P1099, DOI 10.1126/science.1192588; Segal E, 2009, NAT REV GENET, V10, P443, DOI 10.1038/nrg2591; Seshasayee ASN, 2009, GENOME RES, V19, P79, DOI 10.1101/gr.079715.108; Sherman MS, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002407; Stormo GD, 2000, BIOINFORMATICS, V16, P16, DOI 10.1093/bioinformatics/16.1.16; Sui SJH, 2007, NUCLEIC ACIDS RES, V35, pW245, DOI 10.1093/nar/gkm427; TAKAHASHI S, 1979, CAN J BIOCHEM CELL B, V57, P855, DOI 10.1139/o79-105; Taniguchi Y, 2010, SCIENCE, V329, P533, DOI 10.1126/science.1188308; THELEN P, 1991, J BACTERIOL, V173, P6553, DOI 10.1128/jb.173.20.6553-6557.1991; TIAN GL, 1992, J MOL BIOL, V226, P387, DOI 10.1016/0022-2836(92)90954-I; TOLEDANO MB, 1994, CELL, V78, P897, DOI 10.1016/S0092-8674(94)90702-1; Tramonti A, 2008, MOL MICROBIOL, V70, P965, DOI 10.1111/j.1365-2958.2008.06458.x; Troxell B, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-236; Vershinina OA, 2002, MICROBIOLOGY+, V71, P497, DOI 10.1023/A:1020547616096; WANNER BL, 1990, BIOL CHEM H-S, V371, P180; WEICKERT MJ, 1992, J MOL BIOL, V226, P69, DOI 10.1016/0022-2836(92)90125-4; Zentner GE, 2013, NAT STRUCT MOL BIOL, V20, P259, DOI 10.1038/nsmb.2470	91	22	21	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2014	9	12							e114347	10.1371/journal.pone.0114347	http://dx.doi.org/10.1371/journal.pone.0114347			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX6YH	25549361	Green Accepted, Green Published, gold			2022-12-27	WOS:000347063500007
J	Consiglio, M; Destefanis, M; Morena, D; Foglizzo, V; Forneris, M; Pescarmona, G; Silvagno, F				Consiglio, Marco; Destefanis, Michele; Morena, Deborah; Foglizzo, Valentina; Forneris, Mattia; Pescarmona, Gianpiero; Silvagno, Francesca			The Vitamin D Receptor Inhibits the Respiratory Chain, Contributing to the Metabolic Switch that Is Essential for Cancer Cell Proliferation	PLOS ONE			English	Article							TRANSCRIPTION FACTORS; NUCLEAR RECEPTORS; MITOCHONDRIA; EXPRESSION; GLUCOCORTICOIDS; CHOLESTEROL; GROWTH; GENES; NCOR1; ASSAY	We recently described the mitochondrial localization and import of the vitamin D receptor (VDR) in actively proliferating HaCaT cells for the first time, but its role in the organelle remains unknown. Many metabolic intermediates that support cell growth are provided by the mitochondria; consequently, the identification of proteins that regulate mitochondrial metabolic pathways is of great interest, and we sought to understand whether VDR may modulate these pathways. We genetically silenced VDR in HaCaT cells and studied the effects on cell growth, mitochondrial metabolism and biosynthetic pathways. VDR knockdown resulted in robust growth inhibition, with accumulation in the G0G1 phase of the cell cycle and decreased accumulation in the M phase. The effects of VDR silencing on proliferation were confirmed in several human cancer cell lines. Decreased VDR expression was consistently observed in two different models of cell differentiation. The impairment of silenced HaCaT cell growth was accompanied by sharp increases in the mitochondrial membrane potential, which sensitized the cells to oxidative stress. We found that transcription of the subunits II and IV of cytochrome c oxidase was significantly increased upon VDR silencing. Accordingly, treatment of HaCaT cells with vitamin D downregulated both subunits, suggesting that VDR may inhibit the respiratory chain and redirect TCA intermediates toward biosynthesis, thus contributing to the metabolic switch that is typical of cancer cells. In order to explore this hypothesis, we examined various acetyl-CoA-dependent biosynthetic pathways, such as the mevalonate pathway (measured as cholesterol biosynthesis and prenylation of small GTPases), and histone acetylation levels; all of these pathways were inhibited by VDR silencing. These data provide evidence of the role of VDR as a gatekeeper of mitochondrial respiratory chain activity and a facilitator of the diversion of acetyl-CoA from the energy-producing TCA cycle toward biosynthetic pathways that are essential for cellular proliferation.	[Consiglio, Marco; Destefanis, Michele; Morena, Deborah; Foglizzo, Valentina; Pescarmona, Gianpiero; Silvagno, Francesca] Univ Turin, Dept Oncol, Turin, Italy; [Morena, Deborah; Foglizzo, Valentina] S Giovanni Battista Hosp, Ctr Expt Res & Med Studies, Turin, Italy; [Forneris, Mattia] Univ Turin, Dept Mol Biotechnol & Hlth Sci, Ctr Mol Biotechnol, Turin, Italy	University of Turin; A.O.U. Citta della Salute e della Scienza di Torino; AOU San Giovanni Battista-Molinette; University of Turin	Silvagno, F (corresponding author), Univ Turin, Dept Oncol, Turin, Italy.	francesca.silvagno@unito.it		Foglizzo, Valentina/0000-0001-5059-3279; Forneris, Mattia/0000-0002-2126-9207	Ministero dell'Istruzione Universita e Ricerca	Ministero dell'Istruzione Universita e Ricerca(Ministry of Education, Universities and Research (MIUR))	This work was supported by Ministero dell'Istruzione Universita e Ricerca. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abedin SA, 2006, ANTICANCER RES, V26, P2557; Abedin SA, 2009, CARCINOGENESIS, V30, P449, DOI 10.1093/carcin/bgp005; Banwell CM, 2006, CLIN CANCER RES, V12, P2004, DOI 10.1158/1078-0432.CCR-05-1218; Berndt N, 2011, NAT REV CANCER, V11, P775, DOI 10.1038/nrc3151; Bikle DD, 2005, J STEROID BIOCHEM, V97, P83, DOI 10.1016/j.jsbmb.2005.06.001; BORDIER C, 1981, J BIOL CHEM, V256, P1604; Campbell AM, 2008, J BIOENERG BIOMEMBR, V40, P193, DOI 10.1007/s10863-008-9138-x; Campia I, 2009, CELL MOL LIFE SCI, V66, P1580, DOI 10.1007/s00018-009-9018-5; Carlberg C, 2007, DERMATOL CLIN, V25, P515, DOI 10.1016/j.det.2007.06.004; Castagnoli C, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/840363; Chen JQ, 2009, BBA-MOL CELL RES, V1793, P1540, DOI 10.1016/j.bbamcr.2009.06.001; Chen JQ, 2004, AM J PHYSIOL-ENDOC M, V286, pE1011, DOI 10.1152/ajpendo.00508.2003; Cioffi F, 2013, MOL CELL ENDOCRINOL, V379, P51, DOI 10.1016/j.mce.2013.06.006; Di Cerbo V, 2013, BRIEF FUNCT GENOMICS, V12, P231, DOI 10.1093/bfgp/els065; Doig CL, 2013, CARCINOGENESIS, V34, P248, DOI 10.1093/carcin/bgs331; Galluzzi L, 2010, MOL ASPECTS MED, V31, P1, DOI 10.1016/j.mam.2009.08.002; Gavrilova-Jordan LP, 2007, SEMIN REPROD MED, V25, P154, DOI 10.1055/s-2007-973428; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hu YM, 2012, CELL RES, V22, P399, DOI 10.1038/cr.2011.145; Huhtakangas JA, 2004, MOL ENDOCRINOL, V18, P2660, DOI 10.1210/me.2004-0116; Jones RG, 2009, GENE DEV, V23, P537, DOI 10.1101/gad.1756509; Karolchik D, 2014, NUCLEIC ACIDS RES, V42, pD764, DOI 10.1093/nar/gkt1168; Khanim FL, 2004, ONCOGENE, V23, P6712, DOI 10.1038/sj.onc.1207772; Kim HS, 2010, CANCER CELL, V17, P41, DOI 10.1016/j.ccr.2009.11.023; Lee J, 2008, J NEUROSCI RES, V86, P961, DOI 10.1002/jnr.21564; Lee SR, 2013, PROG BIOPHYS MOL BIO, V112, P44, DOI 10.1016/j.pbiomolbio.2013.04.001; MARESPERLMAN JA, 1988, CANCER RES, V48, P602; Morrish F, 2006, MITOCHONDRION, V6, P143, DOI 10.1016/j.mito.2006.04.002; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Murtola TJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039445; Ordonez-Moran P, 2008, J CELL BIOL, V183, P697, DOI 10.1083/jcb.200803020; Ozdag H, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-90; Park J, 2010, AM J PATHOL, V177, P3133, DOI 10.2353/ajpath.2010.100595; Psarra AMG, 2011, BBA-MOL CELL RES, V1813, P1814, DOI 10.1016/j.bbamcr.2011.05.014; Psarra AMG, 2009, BBA-BIOENERGETICS, V1787, P431, DOI 10.1016/j.bbabio.2008.11.011; Rahman I, 2006, NAT PROTOC, V1, P3159, DOI 10.1038/nprot.2006.378; Ryan MT, 2007, ANNU REV BIOCHEM, V76, P701, DOI 10.1146/annurev.biochem.76.052305.091720; Santidrian AF, 2013, J CLIN INVEST, V123, P1068, DOI 10.1172/JCI64264; Schulze A, 2012, NATURE, V491, P364, DOI 10.1038/nature11706; Sequeira VB, 2012, MOL ENDOCRINOL, V26, P574, DOI 10.1210/me.2011-1161; Silvagno F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054716; Stoneking M, 2000, AM J HUM GENET, V67, P1029, DOI 10.1086/303092; Taulli R, 2009, J CLIN INVEST, V119, P2366, DOI 10.1172/JCI38075; Vasconsuelo A, 2013, AGEING RES REV, V12, P907, DOI 10.1016/j.arr.2013.09.001; Wasserman WW, 2004, NAT REV GENET, V5, P276, DOI 10.1038/nrg1315; Zaidi N, 2012, CANCER RES, V72, P3709, DOI 10.1158/0008-5472.CAN-11-4112	47	45	48	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2014	9	12							e115816	10.1371/journal.pone.0115816	http://dx.doi.org/10.1371/journal.pone.0115816			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UN	25546457	Green Published, gold			2022-12-27	WOS:000347120200072
J	Lewis, JD; Wilton, M; Mott, GA; Lu, WW; Hassan, JA; Guttman, DS; Desveaux, D				Lewis, Jennifer D.; Wilton, Mike; Mott, G. Adam; Lu, Wenwan; Hassan, Jana A.; Guttman, David S.; Desveaux, Darrell			Immunomodulation by the Pseudomonas syringae HopZ Type III Effector Family in Arabidopsis	PLOS ONE			English	Article							DISEASE RESISTANCE GENE; YOPJ SUPERFAMILY; ACETYLATION; PATTERN; PROTEIN; SPECIFICITY; PERCEPTION; ACTIVATION; SECRETION; FLAGELLIN	Pseudomonas syringae employs a type III secretion system to inject 20-30 different type III effector (T3SE) proteins into plant host cells. A major role of T3SEs is to suppress plant immune responses and promote bacterial infection. The YopJ/HopZ acetyltransferases are a superfamily of T3SEs found in both plant and animal pathogenic bacteria. In P. syringae, this superfamily includes the evolutionarily diverse HopZ1, HopZ2 and HopZ3 alleles. To investigate the roles of the HopZ family in immunomodulation, we generated dexamethasone-inducible T3SE transgenic lines of Arabidopsis for HopZ family members and characterized them for immune suppression phenotypes. We show that all of the HopZ family members can actively suppress various facets of Arabidopsis immunity in a catalytic residuedependent manner. HopZ family members can differentially suppress the activation of mitogen-activated protein (MAP) kinase cascades or the production of reactive oxygen species, whereas all members can promote the growth of non-virulent P. syringae. Localization studies show that four of the HopZ family members containing predicted myristoylation sites are localized to the vicinity of the plasma membrane while HopZ3 which lacks the myristoylation site is at least partially nuclear localized, suggesting diversification of immunosuppressive mechanisms. Overall, we demonstrate that despite significant evolutionary diversification, all HopZ family members can suppress immunity in Arabidopsis.	[Lewis, Jennifer D.; Wilton, Mike; Mott, G. Adam; Lu, Wenwan; Guttman, David S.; Desveaux, Darrell] Univ Toronto, Dept Cell & Syst Biol, Toronto, ON, Canada; [Lewis, Jennifer D.] USDA, Ctr Plant Gene Express, Albany, CA USA; [Lewis, Jennifer D.; Hassan, Jana A.] Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA; [Guttman, David S.; Desveaux, Darrell] Univ Toronto, Ctr Anal Genome Evolut & Funct, Toronto, ON, Canada	University of Toronto; United States Department of Agriculture (USDA); University of California System; University of California Berkeley; University of Toronto	Lewis, JD (corresponding author), Univ Toronto, Dept Cell & Syst Biol, Toronto, ON, Canada.	jdlewis@berkeley.edu	Guttman, David S/A-7839-2011	Guttman, David S/0000-0001-8479-3869; Mott, Adam/0000-0001-9803-103X	Natural Sciences and Engineering Research Council of Canada; Canada Research Chair in Plant-Microbe Systems Biology or Comparative Genomics; Centre for the Analysis of Genome Evolution and Function; United States Department of Agriculture Agricultural Research Service [5335-21000- 040-00D]	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canada Research Chair in Plant-Microbe Systems Biology or Comparative Genomics; Centre for the Analysis of Genome Evolution and Function; United States Department of Agriculture Agricultural Research Service(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	This work was supported by Natural Sciences and Engineering Research Council of Canada awards to DSG and DD; a Canada Research Chair in Plant-Microbe Systems Biology (DD) or Comparative Genomics (DSG); the Centre for the Analysis of Genome Evolution and Function (DD and DSG); United States Department of Agriculture Agricultural Research Service 5335-21000- 040-00D (JDL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asai T, 2002, NATURE, V415, P977, DOI 10.1038/415977a; BISGROVE SR, 1994, PLANT CELL, V6, P927, DOI 10.1105/tpc.6.7.927; Boller T, 2009, ANNU REV PLANT BIOL, V60, P379, DOI 10.1146/annurev.arplant.57.032905.105346; Deslandes L, 2012, TRENDS PLANT SCI, V17, P644, DOI 10.1016/j.tplants.2012.06.011; Elowitz M, 2010, NATURE, V468, P889, DOI 10.1038/468889a; Felix G, 1999, PLANT J, V18, P265, DOI 10.1046/j.1365-313X.1999.00265.x; Feng F, 2012, CURR OPIN PLANT BIOL, V15, P469, DOI 10.1016/j.pbi.2012.03.004; Gomez-Gomez L, 1999, PLANT J, V18, P277, DOI 10.1046/j.1365-313X.1999.00451.x; Guo M, 2009, MOL PLANT MICROBE IN, V22, P1069, DOI 10.1094/MPMI-22-9-1069; INNES RW, 1993, PLANT J, V4, P813, DOI 10.1046/j.1365-313X.1993.04050813.x; Jiang SS, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003715; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Katagiri Fumiaki, 2002, Arabidopsis Book, V1, pe0039, DOI 10.1199/tab.0039; Lee AHY, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002523; Lee J, 2012, PLANT PHYSIOL, V158, P1803, DOI 10.1104/pp.111.190686; Lewis JD, 2008, J BACTERIOL, V190, P2880, DOI 10.1128/JB.01702-07; Lewis JD, 2014, PLANT SIGNAL BEHAV, V9, DOI 10.4161/psb.27563; Lewis JD, 2013, P NATL ACAD SCI USA, V110, P18722, DOI 10.1073/pnas.1315520110; Lewis JD, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-8; Lewis JD, 2011, MOL PLANT PATHOL, V12, P928, DOI [10.1111/J.1364-3703.2011.00719.X, 10.1111/j.1364-3703.2011.00719.x]; Lewis JD, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000894; Lewis JD, 2009, SEMIN CELL DEV BIOL, V20, P1055, DOI 10.1016/j.semcdb.2009.06.003; Lindeberg M, 2012, TRENDS MICROBIOL, V20, P199, DOI 10.1016/j.tim.2012.01.003; Ma WB, 2006, PLOS GENET, V2, P2131, DOI 10.1371/journal.pgen.0020209; Macho AP, 2014, SCIENCE, V343, P1509, DOI 10.1126/science.1248849; Macho AP, 2010, NEW PHYTOL, V187, P1018, DOI 10.1111/j.1469-8137.2010.03381.x; Mittal R, 2006, P NATL ACAD SCI USA, V103, P18574, DOI 10.1073/pnas.0608995103; Mudgett MB, 1999, MOL MICROBIOL, V32, P927, DOI 10.1046/j.1365-2958.1999.01403.x; Mukherjee S, 2007, TRENDS BIOCHEM SCI, V32, P210, DOI 10.1016/j.tibs.2007.03.007; Mukherjee S, 2006, SCIENCE, V312, P1211, DOI 10.1126/science.1126867; Paquette N, 2012, P NATL ACAD SCI USA, V109, P12710, DOI 10.1073/pnas.1008203109; Pitzschke A, 2009, CURR OPIN PLANT BIOL, V12, P421, DOI 10.1016/j.pbi.2009.06.008; Roine E, 1997, P NATL ACAD SCI USA, V94, P3459, DOI 10.1073/pnas.94.7.3459; SIMONICH MT, 1995, MOL PLANT MICROBE IN, V8, P637, DOI 10.1094/MPMI-8-0637; Thomma BPHJ, 2011, PLANT CELL, V23, P4, DOI 10.1105/tpc.110.082602; Ustun S, 2014, MOL PLANT MICROBE IN, V27, P611, DOI 10.1094/MPMI-12-13-0363-R; Vinatzer BA, 2006, MOL MICROBIOL, V62, P26, DOI 10.1111/j.1365-2958.2006.05350.x; Wilton M, 2010, PLANT SIGNAL BEHAV, V5, P746, DOI [10.4161/psb.5.6.11703, 10.1073/pnas.0904739107]; Wilton M, 2010, P NATL ACAD SCI USA, V107, P2349, DOI 10.1073/pnas.0904739107; Zhou HB, 2011, CELL HOST MICROBE, V9, P177, DOI 10.1016/j.chom.2011.02.007; Zhou HB, 2009, MOL PLANT MICROBE IN, V22, P176, DOI 10.1094/MPMI-22-2-0176; Zipfel C, 2004, NATURE, V428, P764, DOI 10.1038/nature02485	42	27	28	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2014	9	12							e0116152	10.1371/journal.pone.0116152	http://dx.doi.org/10.1371/journal.pone.0116152			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UN	25546415	gold, Green Published			2022-12-27	WOS:000347120200102
J	Sepsa, A; Levidou, G; Gargalionis, A; Adamopoulos, C; Spyropoulou, A; Dalagiorgou, G; Thymara, I; Boviatsis, E; Themistocleous, MS; Petraki, K; Vrettakos, G; Samaras, V; Zisakis, A; Patsouris, E; Piperi, C; Korkolopoulou, P				Sepsa, Athanasia; Levidou, Georgia; Gargalionis, Antonis; Adamopoulos, Christos; Spyropoulou, Anastasia; Dalagiorgou, Georgia; Thymara, Irene; Boviatsis, Efstathios; Themistocleous, Marios S.; Petraki, Kalliopi; Vrettakos, George; Samaras, Vassilis; Zisakis, Athanassios; Patsouris, Efstratios; Piperi, Christina; Korkolopoulou, Penelope			Emerging Role of Linker Histone Variant H1x as a Biomarker with Prognostic Value in Astrocytic Gliomas. A Multivariate Analysis including Trimethylation of H3K9 and H4K20	PLOS ONE			English	Article							ONCOMETABOLITE 2-HYDROXYGLUTARATE; EPIGENETIC CONTROL; BREAST-CANCER; IN-VITRO; METHYLATION; DNA; CELLS; DIFFERENTIATION; EXPRESSION; SURVIVAL	Although epigenetic alterations play an essential role in gliomagenesis, the relevance of aberrant histone modifications and the respective enzymes has not been clarified. Experimental data implicates histone H3 lysine (K) methyltransferases SETDB1 and SUV39H1 into glioma pathobiology, whereas linker histone variant H1.0 and H4K20me3 reportedly affect prognosis. We investigated the expression of H3K9me3 and its methyltransferases along with H4K20me3 and H1x in 101 astrocytic tumors with regard to clinicopathological characteristics and survival. The effect of SUV39H1 inhibition by chaetocin on the proliferation, colony formation and migration of T98G cells was also examined. SETDB1 and cytoplasmic SUV39H1 levels increased from normal brain through low-grade to high-grade tumors, nuclear SUV39H1 correlating inversely with grade. H3K9me3 immunoreactivity was higher in normal brain showing no association with grade, whereas H1x and H4K20me3 expression was higher in grade 2 than in normal brain or high grades. These expression patterns of H1x, H4K20me3 and H3K9me3 were verified by Western immunoblotting. Chaetocin treatment significantly reduced proliferation, clonogenic potential and migratory ability of T98G cells. H1x was an independent favorable prognosticator in glioblastomas, this effect being validated in an independent set of 66 patients. Diminished nuclear SUV39H1 expression adversely affected survival in univariate analysis. In conclusion, H4K20me3 and H3K9 methyltransferases are differentially implicated in astroglial tumor progression. Deregulation of H1x emerges as a prognostic biomarker.	[Sepsa, Athanasia; Levidou, Georgia; Thymara, Irene; Patsouris, Efstratios; Korkolopoulou, Penelope] Univ Athens, Laikon Gen Hosp, Sch Med, Dept Pathol 1, Athens 11527, Greece; [Gargalionis, Antonis; Adamopoulos, Christos; Spyropoulou, Anastasia; Dalagiorgou, Georgia; Piperi, Christina] Univ Athens, Sch Med, Dept Biol Chem, Athens 11527, Greece; [Boviatsis, Efstathios; Themistocleous, Marios S.] Univ Athens, Evangelismos Hosp, Sch Med, Dept Neurosurg, Athens 10676, Greece; [Petraki, Kalliopi] Metropolitan Hosp, Dept Pathol, Athens 18547, Greece; [Vrettakos, George] Metropolitan Hosp, Dept Neurosurg, Athens 18547, Greece; [Samaras, Vassilis] Red Cross Hosp, Dept Pathol, Athens 11526, Greece; [Zisakis, Athanassios] Red Cross Hosp, Dept Neurosurg, Athens 11526, Greece	Athens Medical School; Laiko General Hospital; National & Kapodistrian University of Athens; Athens Medical School; National & Kapodistrian University of Athens; Athens Medical School; Evangelismos Hospital; National & Kapodistrian University of Athens	Levidou, G (corresponding author), Univ Athens, Laikon Gen Hosp, Sch Med, Dept Pathol 1, Athens 11527, Greece.	glevidou@yahoo.gr	Piperi, Christina/AAF-2009-2020	Piperi, Christina/0000-0002-2701-0618; Spyropoulou, Anastasia/0000-0001-8599-7740				Berger SL, 2007, NATURE, V447, P407, DOI 10.1038/nature05915; Chen JH, 2013, MED ONCOL, V30, DOI 10.1007/s12032-013-0513-z; Chernov AV, 2009, J BIOL CHEM, V284, P12727, DOI 10.1074/jbc.M900273200; Chi P, 2010, NAT REV CANCER, V10, P457, DOI 10.1038/nrc2876; Chowdhury R, 2011, EMBO REP, V12, P463, DOI 10.1038/embor.2011.43; Dang L, 2010, NATURE, V465, P966, DOI 10.1038/nature09132; Ellinger J, 2014, UROL INT, V93, P113, DOI 10.1159/000355467; Elsheikh SE, 2009, CANCER RES, V69, P3802, DOI 10.1158/0008-5472.CAN-08-3907; Esteller M, 2008, NEW ENGL J MED, V358, P1148, DOI 10.1056/NEJMra072067; Esteller M, 2007, NAT REV GENET, V8, P286, DOI 10.1038/nrg2005; Esteve PO, 2006, GENE DEV, V20, P3089, DOI 10.1101/gad.1463706; Fan YH, 2005, CELL, V123, P1199, DOI 10.1016/j.cell.2005.10.028; Fanelli M, 2008, ONCOGENE, V27, P358, DOI 10.1038/sj.onc.1210642; Fischle W, 2003, CURR OPIN CELL BIOL, V15, P172, DOI 10.1016/S0955-0674(03)00013-9; Fraga MF, 2005, NAT GENET, V37, P391, DOI 10.1038/ng1531; Gabrovsky N, 2013, ACTA NEUROCHIR, V155, P1437, DOI 10.1007/s00701-013-1802-1; Gerlitz G, 2010, J CELL SCI, V123, P2207, DOI 10.1242/jcs.058271; Han XS, 2014, J NEURO-ONCOL, V118, P61, DOI 10.1007/s11060-014-1419-0; Harshman SW, 2013, NUCLEIC ACIDS RES, V41, P9593, DOI 10.1093/nar/gkt700; Harvey AC, 2004, MOL MICROBIOL, V53, P771, DOI 10.1111/j.1365-2958.2004.04195.x; He YL, 2012, ACTA BIOCH BIOPH SIN, V44, P70, DOI 10.1093/abbs/gmr109; HOLLIDAY R, 1987, SCIENCE, V238, P163, DOI 10.1126/science.3310230; Isham CR, 2007, BLOOD, V109, P2579, DOI 10.1182/blood-2006-07-027326; Kornberg RD, 1999, CELL, V98, P285, DOI 10.1016/S0092-8674(00)81958-3; Kreth S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017156; LACHIN JM, 1986, BIOMETRICS, V42, P507, DOI 10.2307/2531201; Li FQ, 2011, APPL IMMUNOHISTO M M, V19, P389, DOI 10.1097/PAI.0b013e3182108e2e; Liu BL, 2010, CANCER EPIDEM BIOMAR, V19, P2888, DOI 10.1158/1055-9965.EPI-10-0454; Lohmann F, 2010, STEM CELLS, V28, P201, DOI 10.1002/stem.278; Louis D. N, 2007, 2007 WHO CLASSIFICAT; Lu C, 2012, NATURE, V483, P474, DOI 10.1038/nature10860; Luger K, 2006, CHROMOSOME RES, V14, P5, DOI 10.1007/s10577-005-1026-1; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Martin C, 2006, J BIOL CHEM, V281, P8365, DOI 10.1074/jbc.M513425200; Martinez R, 2010, NEUROBIOL DIS, V39, P40, DOI 10.1016/j.nbd.2009.12.030; McBryant SJ, 2010, CELL RES, V20, P519, DOI 10.1038/cr.2010.35; Medrzycki M, 2012, FRONT BIOSCI-LANDMRK, V17, P396, DOI 10.2741/3934; Metellus P, 2010, ACTA NEUROPATHOL, V120, P719, DOI 10.1007/s00401-010-0777-8; Murga M, 2007, J CELL BIOL, V178, P1101, DOI 10.1083/jcb.200704140; Myung JK, 2012, ONCOL REP, V28, P1639, DOI 10.3892/or.2012.1994; Patani N, 2011, ANTICANCER RES, V31, P4115; Rai K, 2006, MOL CELL BIOL, V26, P7077, DOI 10.1128/MCB.00312-06; Rai K, 2010, J BIOL CHEM, V285, P4110, DOI 10.1074/jbc.M109.073676; Rajendran G, 2011, J NEURO-ONCOL, V104, P483, DOI 10.1007/s11060-010-0520-2; Saratsis AM, 2014, ACTA NEUROPATHOL, V127, P881, DOI 10.1007/s00401-013-1218-2; Sarg B, 2002, J BIOL CHEM, V277, P39195, DOI 10.1074/jbc.M205166200; Sarraf SA, 2004, MOL CELL, V15, P595, DOI 10.1016/j.molcel.2004.06.043; Schneider AC, 2011, BJU INT, V108, pE290, DOI 10.1111/j.1464-410X.2011.10203.x; Seligson DB, 2009, AM J PATHOL, V174, P1619, DOI 10.2353/ajpath.2009.080874; Spyropoulou A, 2014, NEUROMOL MED, V16, P70, DOI 10.1007/s12017-013-8254-x; Spyropoulou A, 2013, NEUROMOL MED, V15, P1, DOI 10.1007/s12017-012-8205-y; Tan SL, 2012, DEVELOPMENT, V139, P3806, DOI 10.1242/dev.082198; Van Den Broeck A, 2008, CLIN CANCER RES, V14, P7237, DOI 10.1158/1078-0432.CCR-08-0869; Venneti S, 2013, J NEUROPATH EXP NEUR, V72, P298, DOI 10.1097/NEN.0b013e3182898113; Wang HJ, 2013, ONCOL REP, V30, P2089, DOI 10.3892/or.2013.2706; Ward PS, 2010, CANCER CELL, V17, P225, DOI 10.1016/j.ccr.2010.01.020; Watanabe H, 2008, CANCER CELL INT, V8, DOI 10.1186/1475-2867-8-15; Xu W, 2011, CANCER CELL, V19, P17, DOI 10.1016/j.ccr.2010.12.014; Yan FT, 2014, CANCER RES, V74, P1752, DOI 10.1158/0008-5472.CAN-13-0884	59	22	22	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2015	10	1							e0115101	10.1371/journal.pone.0115101	http://dx.doi.org/10.1371/journal.pone.0115101			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ4OZ	25602259	Green Published, gold, Green Submitted			2022-12-27	WOS:000348203500008
J	Jiang, DQ; Ma, SZ; Jing, F; Xu, C; Yan, F; Wang, AH; Zhao, JJ				Jiang, Dongqing; Ma, Shizhan; Jing, Fei; Xu, Chao; Yan, Fang; Wang, Aihong; Zhao, Jiajun			Thyroid-Stimulating Hormone Inhibits Adipose Triglyceride Lipase in 3T3-L1 Adipocytes through the PKA Pathway	PLOS ONE			English	Article							TRIACYLGLYCEROL LIPASE; ENERGY-METABOLISM; LIPOLYSIS; PHOSPHORYLATION; PROTEIN; IDENTIFICATION; EXERCISE; TISSUE	Thyroid-stimulating hormone (TSH) has been shown to play an important role in the regulation of triglyceride (TG) metabolism in adipose tissue. Adipose triglyceride lipase (ATGL) is a rate-limiting enzyme controlling the hydrolysis of TG. Thus far, it is unclear whether TSH has a direct effect on the expression of ATGL. Because TSH function is mediated through the TSH receptor (TSHR), TSHR knockout mice (Tshr-/-mice) (supplemented with thyroxine) were used in this study to determine the effects of TSHR deletion on ATGL expression. These effects were verified in 3T3-L1 adipocytes and potential underlying mechanisms were explored. In the Tshr-/-mice, ATGL expression in epididymal adipose tissue was significantly increased compared with that in Tshr+/+ mice. ATGL expression was observed to increase with the differentiation process of 3T3-L1 preadipocytes. In mature 3T3-L1 adipocytes, TSH significantly suppressed ATGL expression at both the protein and mRNA levels in a dose-dependent manner. Forskolin, which is an activator of adenylate cyclase, suppressed the expression of ATGL in 3T3-L1 adipocytes. The inhibitory effects of TSH on ATGL expression were abolished by H89, which is a protein kinase A (PKA) inhibitor. These results indicate that TSH has an inhibitory effect on ATGL expression in mature adipocytes. The associated mechanism is related to PKA activation.	[Jiang, Dongqing; Ma, Shizhan; Jing, Fei; Xu, Chao; Yan, Fang; Zhao, Jiajun] Shandong Univ, Shandong Prov Hosp, Dept Endocrinol & Metab, Jinan 250100, Shandong, Peoples R China; [Ma, Shizhan; Jing, Fei; Xu, Chao; Yan, Fang; Zhao, Jiajun] Shandong Acad Clin Med, Inst Endocrinol, Jinan, Shandong, Peoples R China; [Jiang, Dongqing] Shandong Univ, Hosp 2, Dept Endocrinol & Metab, Jinan 250100, Shandong, Peoples R China; [Wang, Aihong] Shandong Univ, Shandong Prov Hosp, Dept Cardiol, Jinan 250100, Shandong, Peoples R China	Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong University; Shandong University; Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong University	Wang, AH (corresponding author), Shandong Univ, Shandong Prov Hosp, Dept Cardiol, Jinan 250100, Shandong, Peoples R China.	wah2905@sina.com; jjzhao@medmail.com.cn	Zhao, Jiajun/W-2963-2018	Zhao, Jiajun/0000-0003-3267-9292; Ma, Shizhan/0000-0002-0506-6557	National Basic Research Program [2012CB524900]; National Natural Science Foundation [81230018, 81170794, 81370891, 81300644]; Chinese Society of Endocrinology [13050830468]	National Basic Research Program(National Basic Research Program of China); National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Chinese Society of Endocrinology	This work was funded by The National Basic Research Program (2012CB524900; http://www.nsfc.gov.cn/); the National Natural Science Foundation (81230018, 81170794, 81370891, 81300644; http://www.nsfc.gov.cn/); the Chinese Society of Endocrinology (13050830468; http://www.china-endo.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartzt R, 2007, J PROTEOME RES, V6, P3256, DOI 10.1021/pr070158j; Dumont J E, 1971, Vitam Horm, V29, P287; Elgadi A, 2010, BIOCHEM BIOPH RES CO, V393, P526, DOI 10.1016/j.bbrc.2010.02.042; Gagnon A, 2010, METABOLISM, V59, P547, DOI 10.1016/j.metabol.2009.08.018; Garg A, 2013, BRIT MED BULL, V107, P101, DOI 10.1093/bmb/ldt024; Haemmerle G, 2002, J BIOL CHEM, V277, P4806, DOI 10.1074/jbc.M110355200; Haemmerle G, 2006, SCIENCE, V312, P734, DOI 10.1126/science.1123965; Huijsman E, 2009, AM J PHYSIOL-ENDOC M, V297, pE505, DOI 10.1152/ajpendo.00190.2009; JANSON A, 1995, J CLIN ENDOCR METAB, V80, P1712, DOI 10.1210/jc.80.5.1712; Jenkins CM, 2004, J BIOL CHEM, V279, P48968, DOI 10.1074/jbc.M407841200; Langin D, 2005, DIABETES, V54, P3190, DOI 10.2337/diabetes.54.11.3190; Lu SM, 2012, LIPIDS HEALTH DIS, V11, DOI 10.1186/1476-511X-11-17; MARCUS C, 1988, J CLIN INVEST, V82, P1793, DOI 10.1172/JCI113793; Marians RC, 2002, P NATL ACAD SCI USA, V99, P15776, DOI 10.1073/pnas.242322099; Martinez-Gonzalez C, 2012, EUR J NEUROSCI, V35, P723, DOI 10.1111/j.1460-9568.2012.08002.x; Mason RR, 2012, AM J PHYSIOL-ENDOC M, V303, pE534, DOI 10.1152/ajpendo.00082.2012; Pagnon J, 2012, ENDOCRINOLOGY, V153, P4278, DOI 10.1210/en.2012-1127; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Villena JA, 2004, J BIOL CHEM, V279, P47066, DOI 10.1074/jbc.M403855200; Wang TT, 2013, ENDOCR J, V60, P941; Xing WJ, 2012, LIPIDS HEALTH DIS, V11, DOI 10.1186/1476-511X-11-44; Zechner R, 2009, J LIPID RES, V50, P3, DOI 10.1194/jlr.R800031-JLR200; Zimmermann R, 2004, SCIENCE, V306, P1383, DOI 10.1126/science.1100747; Zimmermann R, 2003, J LIPID RES, V44, P2089, DOI 10.1194/jlr.M300190-JLR200	24	17	18	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2015	10	1							e0116439	10.1371/journal.pone.0116439	http://dx.doi.org/10.1371/journal.pone.0116439			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9HN	25590597	Green Published, Green Submitted, gold			2022-12-27	WOS:000350679400014
J	Lameira, AR; Hardus, ME; Bartlett, AM; Shumaker, RW; Wich, SA; Menken, SBJ				Lameira, Adriano R.; Hardus, Madeleine E.; Bartlett, Adrian M.; Shumaker, Robert W.; Wich, Serge A.; Menken, Steph B. J.			Speech-Like Rhythm in a Voiced and Voiceless Orangutan Call	PLOS ONE			English	Article							VOCALIZATIONS; EVOLUTION; SUMATRAN; MONKEYS	The evolutionary origins of speech remain obscure. Recently, it was proposed that speech derived from monkey facial signals which exhibit a speech-like rhythm of similar to 5 open-close lip cycles per second. In monkeys, these signals may also be vocalized, offering a plausible evolutionary stepping stone towards speech. Three essential predictions remain, however, to be tested to assess this hypothesis' validity; (i) Great apes, our closest relatives, should likewise produce 5Hz-rhythm signals, (ii) speech-like rhythm should involve calls articulatorily similar to consonants and vowels given that speech rhythm is the direct product of stringing together these two basic elements, and (iii) speech-like rhythm should be experience-based. Via cinematic analyses we demonstrate that an ex-entertainment orangutan produces two calls at a speech-like rhythm, coined "clicks'' and "faux-speech'' Like voiceless consonants, clicks required no vocal fold action, but did involve independent manoeuvring over lips and tongue. In parallel to vowels, faux-speech showed harmonic and formant modulations, implying vocal fold and supralaryngeal action. This rhythm was several times faster than orangutan chewing rates, as observed in monkeys and humans. Critically, this rhythm was seven-fold faster, and contextually distinct, than any other known rhythmic calls described to date in the largest database of the orangutan repertoire ever assembled. The first two predictions advanced by this study are validated and, based on parsimony and exclusion of potential alternative explanations, initial support is given to the third prediction. Irrespectively of the putative origins of these calls and underlying mechanisms, our findings demonstrate irrevocably that great apes are not respiratorily, articulatorilly, or neurologically constrained for the production of consonant- and vowel-like calls at speech rhythm. Orangutan clicks and faux-speech confirm the importance of rhythmic speech antecedents within the primate lineage, and highlight potential articulatory homologies between great ape calls and human consonants and vowels.	[Lameira, Adriano R.; Hardus, Madeleine E.; Wich, Serge A.; Menken, Steph B. J.] Univ Amsterdam, Inst Biodivers & Ecosyst Dynam, Amsterdam, Netherlands; [Lameira, Adriano R.; Hardus, Madeleine E.] Pongo Fdn, Oudewater, Netherlands; [Bartlett, Adrian M.] Princeton Univ, Dept Psychol, Inst Neurosci, Princeton, NJ 08544 USA; [Shumaker, Robert W.] Indianapolis Zoo, Indianapolis, IN USA; [Shumaker, Robert W.] Indiana Univ, Dept Anthropol, Bloomington, IN 47405 USA; [Wich, Serge A.] Liverpool John Moores Univ, Sch Nat Sci & Psychol, Res Ctr Evolutionary Anthropol & Palaeoecol, Liverpool L3 5UX, Merseyside, England	University of Amsterdam; Princeton University; Indiana University System; Indiana University Bloomington; Liverpool John Moores University	Lameira, AR (corresponding author), Univ Amsterdam, Inst Biodivers & Ecosyst Dynam, Amsterdam, Netherlands.	adriano@orangutan.nl		Lameira, Adriano/0000-0003-3071-4824; Wich, Serge/0000-0003-3954-5174	Menken Funds of the University of Amsterdam	Menken Funds of the University of Amsterdam	A.R.L. thanks the Menken Funds of the University of Amsterdam. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold K, 2008, CURR BIOL, V18, pR202, DOI 10.1016/j.cub.2008.01.040; Bergman TJ, 2013, CURR BIOL, V23, pR268, DOI 10.1016/j.cub.2013.02.038; Boersma Paul, 2002, GLOT INT, V5, P341; Bokil H, 2010, J NEUROSCI METH, V192, P146, DOI 10.1016/j.jneumeth.2010.06.020; Chandrasekaran C, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000436; Delgado Roberto A., 2009, P215; Dunkel LP, 2013, FRONT ZOOL, V10, DOI 10.1186/1742-9994-10-12; Ferrari PF, 2006, PLOS BIOL, V4, P1501, DOI 10.1371/journal.pbio.0040302; Furness W.H., 1916, P AM PHILOS SOC, V55, P281; GARNER RL, 1892, SPEECH MONKEYS; Ghazanfar AA, 2014, J COGNITIVE NEUROSCI, V26, P1196, DOI 10.1162/jocn_a_00575; Green JR, 1997, J NEUROPHYSIOL, V77, P2704, DOI 10.1152/jn.1997.77.5.2704; Gustison ML, 2012, PHILOS T R SOC B, V367, P1847, DOI 10.1098/rstb.2011.0218; Hardus ME, 2012, INT J PRIMATOL, V33, P287, DOI 10.1007/s10764-011-9574-z; Hardus ME, 2009, P ROY SOC B-BIOL SCI, V276, P3689, DOI 10.1098/rspb.2009.1027; Hardus Madeleine E., 2009, P49; Hopkins WD, 2007, ANIM BEHAV, V73, P281, DOI 10.1016/j.anbehav.2006.08.004; Krutzen M, 2011, CURR BIOL, V21, P1808, DOI 10.1016/j.cub.2011.09.017; Lameira AR, 2014, TRENDS COGN SCI, V18, P60, DOI 10.1016/j.tics.2013.10.013; Lameira AR, 2013, J ACOUST SOC AM, V134, P2326, DOI 10.1121/1.4817929; Lameira AR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069749; Lameira AR, 2013, BEHAV ECOL SOCIOBIOL, V67, P519, DOI 10.1007/s00265-012-1471-8; Maddieson Ian., 2011, WORLD ATLAS LANGUAGE; Maddieson Ian, 1984, PATTERNS SOUNDS; Ouattara K, 2009, P NATL ACAD SCI USA, V106, P22026, DOI 10.1073/pnas.0908118106; Ross MD, 2007, AM J PRIMATOL, V69, P305, DOI 10.1002/ajp.20356; Spillmann B, 2010, ETHOLOGY, V116, P385, DOI 10.1111/j.1439-0310.2010.01744.x; Stevens NJ, 2013, NATURE, V497, P611, DOI 10.1038/nature12161; Wich SA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036180	29	46	46	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2015	10	1							e116136	10.1371/journal.pone.0116136	http://dx.doi.org/10.1371/journal.pone.0116136			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ4BT	25569211	Green Published, gold			2022-12-27	WOS:000348168000005
J	Toupet, K; Maumus, M; Luz-Crawford, P; Lombardo, E; Lopez-Belmonte, J; van Lent, P; Garin, MI; van den Berg, W; Dalemans, W; Jorgensen, C; Noel, D				Toupet, Karine; Maumus, Marie; Luz-Crawford, Patricia; Lombardo, Eleuterio; Lopez-Belmonte, Juan; van Lent, Peter; Garin, Marina I.; van den Berg, Wim; Dalemans, Wilfried; Jorgensen, Christian; Noel, Daniele			Survival and Biodistribution of Xenogenic Adipose Mesenchymal Stem Cells Is Not Affected by the Degree of Inflammation in Arthritis	PLOS ONE			English	Article							INTRAARTICULAR INJECTION; OSTEOARTHRITIS; CHONDROCYTES	Background Application of mesenchymal stem/stromal cells (MSCs) in treating different disorders, in particular osteo-articular diseases, is currently under investigation. We have already documented the safety of administrating human adipose tissue-derived stromal MSCs (hASCs) in immunodeficient mice. In the present study, we investigated whether the persistence of MSC is affected by the degree of inflammation and related to the therapeutic effect in two inflammatory models of arthritis. Methodology/Principal Findings We used C57BL/6 or DBA/1 mice to develop collagenase-induced osteoarthritis (CIOA) or collagen-induced arthritis (CIA), respectively. Normal and diseased mice were administered 2.5x10(5) hASCs in the knee joints (IA) or 10(6) in the tail vein (IV). For CIA, clinical scores were monitored during the time course of the disease while for CIOA, OA scores were assessed by histology at euthanasia. Thirteen tissues were recovered at different time points and processed for real-time PCR and Alu sequence detection. Immunological analyses were performed at euthanasia. After IV infusion, no significant difference in the percentage of hASCs was quantified in the lungs of normal and CIA mice at day 1 while no cell was detected at day 10 taking into account the sensitivity of the assay, indicating that a high level of inflammation did not affect the persistence of cells. In CIOA mice, we reported the therapeutic efficacy of hASCs at reducing OA clinical scores at day 42 when hASCs were not detected in the joints. However, the percentage and distribution of hASCs were similar in osteoarthritic and normal mice at day 1 and 10 after implantation indicating that moderate inflammation does not alter hASC persistence in vivo. Conclusions/Significance While inflammatory signals are required for the immunosuppressive function of MSCs, they do not enhance their capacity to survive in vivo, as evaluated in two xenogeneic inflammatory pre-clinical models of arthritis.	[Toupet, Karine; Maumus, Marie; Luz-Crawford, Patricia; Jorgensen, Christian; Noel, Daniele] Hop St Eloi, INSERM, U 844, Montpellier, France; [Toupet, Karine; Maumus, Marie; Luz-Crawford, Patricia; Jorgensen, Christian; Noel, Daniele] Univ Montpellier I, UFR Med, Montpellier, France; [Lombardo, Eleuterio] TiGenix, Madrid, Spain; [Lopez-Belmonte, Juan] Farma Cros Iber, Albacete, Spain; [van Lent, Peter; van den Berg, Wim] Radboud Univ Nijmegen, Med Ctr, NL-6525 ED Nijmegen, Netherlands; [Garin, Marina I.] CIEMAT CIBERER, Madrid, Spain; [Dalemans, Wilfried] TiGenix, Leuven, Belgium; [Jorgensen, Christian] Hop Lapeyronie, Serv Immunorhumatol, Montpellier, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; CHU de Montpellier; Universite de Montpellier; Radboud University Nijmegen; Centro de Investigaciones Energeticas, Medioambientales Tecnologicas; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Universite de Montpellier; CHU de Montpellier	Noel, D (corresponding author), Hop St Eloi, INSERM, U 844, Montpellier, France.	daniele.noel@inserm.fr	van Lent, Peter/A-4047-2014; Noel, Daniele/E-5719-2016; Garin, Marina I/C-5094-2014; Maumus, Marie/AAD-1725-2019	Garin, Marina I/0000-0001-7956-6792; jorgensen, christian/0000-0001-6947-8094; Luz Crawford, Patricia/0000-0003-0067-7743; Noel, Daniele/0000-0002-3498-3776	Inserm Institute; University of Montpellier I; ReumaFonds [12-2-405] Funding Source: researchfish	Inserm Institute(Institut National de la Sante et de la Recherche Medicale (Inserm)); University of Montpellier I; ReumaFonds	Work in the laboratory Inserm U844 was supported by the Inserm Institute, the University of Montpellier I and funding from the European Community for the collaborative projects: "ADIPOA: Adipose-derived stromal cells for osteoarthritis treatment" (contract no. Health-2009-1.4-3-241719) and "REGENERAR: Bringing Regenerative Medicine into the market: Allogeneic eASCs Phase IB/IIA clinical trial for treating Rheumatoid Arthritis" (contract no. 279174 EC). The authors also thank the Agence Nationale pour la Recherche for support of the national infrastructure: "ECELLFRANCE: Development of a national adult mesenchymal stem cell based therapy platform" (ANR-11-INSB-005). Tigenix and Farmacros got funding from the European Union's Seventh Programme for research, technological development and demonstration under grant agreement No 279174 to perform these studies. The funders had no role in study design, decision to publish, or preparation of the manuscript. EL and WD are employees of TiGenix; JLB is employee of FarmaCross-Iberica. TiGenix and FarmaCrossIberica provided support in the form of salaries for authors EL, WD and JLB, but did not have any additional role in the study design, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Ankrum JA, 2014, NAT BIOTECHNOL, V32, P252, DOI 10.1038/nbt.2816; Bouffi C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014247; Chen FH, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2514; Desando G, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4156; Djouad F, 2005, ARTHRITIS RHEUM-US, V52, P1595, DOI 10.1002/art.21012; Djouad F, 2009, NAT REV RHEUMATOL, V5, P392, DOI 10.1038/nrrheum.2009.104; Eggenhofer E, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00148; Gonzalez MA, 2009, ARTHRITIS RHEUM-US, V60, P1006, DOI 10.1002/art.24405; Jorgensen C, 2013, JOINT BONE SPINE, V80, P565, DOI 10.1016/j.jbspin.2013.08.004; Kang SK, 2012, STEM CELLS INT, V2012, DOI 10.1155/2012/342968; Kavanagh DPJ, 2014, STEM CELL REV REP, V10, P587, DOI 10.1007/s12015-014-9510-7; Krampera M, 2013, CYTOTHERAPY, V15, P1054, DOI 10.1016/j.jcyt.2013.02.010; Kurth TB, 2011, ARTHRITIS RHEUM-US, V63, P1289, DOI 10.1002/art.30234; Lee RH, 2009, CELL STEM CELL, V5, P54, DOI 10.1016/j.stem.2009.05.003; Liu YY, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3187; Mancheno-Corvo P, 2013, BIORESEARCH OPEN ACC, V2, P431, DOI 10.1089/biores.2013.0040; Manferdini C, 2013, ARTHRITIS RHEUM-US, V65, P1271, DOI 10.1002/art.37908; Markides H, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt337; Maumus M, 2013, STEM CELL RES, V11, P834, DOI 10.1016/j.scr.2013.05.008; Menard C, 2013, STEM CELLS DEV, V22, P1789, DOI 10.1089/scd.2012.0594; Murphy MB, 2013, EXP MOL MED, V45, DOI 10.1038/emm.2013.94; Parolini O, 2014, ARTHRITIS RHEUMATOL, V66, P327, DOI 10.1002/art.38206; Popp FC, 2008, TRANSPL IMMUNOL, V20, P55, DOI 10.1016/j.trim.2008.08.004; Pritzker KPH, 2006, OSTEOARTHR CARTILAGE, V14, P13, DOI 10.1016/j.joca.2005.07.014; Schelbergen RF, 2014, OSTEOARTHR CARTILAGE, V22, P1158, DOI 10.1016/j.joca.2014.05.022; ter Huurne M, 2012, ARTHRITIS RHEUM-US, V64, P3604, DOI 10.1002/art.34626; Toupet K, 2013, ARTHRITIS RHEUM-US, V65, P1786, DOI 10.1002/art.37960; VANBUUL GM, 2014, J ORTHOP RES; Vincent TL, 2012, RHEUMATOLOGY, V51, P1931, DOI 10.1093/rheumatology/kes035; von Bahr L, 2012, STEM CELLS, V30, P1575, DOI 10.1002/stem.1118; Zangi L, 2009, STEM CELLS, V27, P2865, DOI 10.1002/stem.217	31	57	59	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2015	10	1							e0114962	10.1371/journal.pone.0114962	http://dx.doi.org/10.1371/journal.pone.0114962			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ3BG	25559623	Green Published, gold, Green Submitted			2022-12-27	WOS:000348102200008
J	Zhang, MJ; Feng, MC; Xiao, LJ; Song, XY; Yang, WD; Ding, GW				Zhang, Mei-jun; Feng, Mei-chen; Xiao, Lu-jie; Song, Xiao-yan; Yang, Wu-de; Ding, Guang-wei			Impact of Water Content and Temperature on the Degradation of Cry1Ac Protein in Leaves and Buds of Bt Cotton in the Soil	PLOS ONE			English	Article							THURINGIENSIS SUBSP KURSTAKI; BACILLUS-THURINGIENSIS; INSECTICIDAL PROTEINS; DELTA-ENDOTOXIN; RAPID DEGRADATION; TRANSGENIC CORN; HUMIC ACIDS; TOXIN; PERSISTENCE; PLANTS	Determining the influence of soil environmental factors on degradation of Cry1Ac protein from Bt cotton residues is vital for assessing the ecological risks of this commercialized transgenic crop. In this study, the degradation of Cry1Ac protein in leaves and in buds of Bt cotton in soil was evaluated under different soil water content and temperature settings in the laboratory. An exponential model and a shift-log model were used to fit the degradation dynamics of Cry1Ac protein and estimate the DT50 and DT90 values. The results showed that Cry1Ac protein in the leaves and buds underwent rapid degradation in the early stage (before day 48), followed by a slow decline in the later stage under different soil water content and temperature. Cry1Ac protein degraded the most rapidly in the early stage at 35 degrees C with 70% soil water holding capacity. The DT50 values were 12.29 d and 10.17 d and the DT90 values were 41.06 d and 33.96 d in the leaves and buds, respectively. Our findings indicated that the soil temperature was a major factor influencing the degradation of Cry1Ac protein from Bt cotton residues. Additionally, the relative higher temperature (25 degrees C and 35 degrees C) was found to be more conducive to degradation of Cry1Ac protein in the soil and the greater water content (100% WHC) retarded the process. These findings suggested that under appropriate soil temperature and water content, Cry1Ac protein from Bt cotton residues will not persist and accumulate in soil.	[Zhang, Mei-jun; Feng, Mei-chen; Xiao, Lu-jie; Song, Xiao-yan; Yang, Wu-de] Shanxi Agr Univ, Coll Agr, Taigu, Peoples R China; [Ding, Guang-wei] Northern State Univ, Dept Chem, Aberdeen, SD USA	Shanxi Agricultural University; Northern State University	Yang, WD (corresponding author), Shanxi Agr Univ, Coll Agr, Taigu, Peoples R China.	sxauywd@126.com; guangwei.ding@northern.edu		Meichen, Feng/0000-0002-0338-7963	Programs for Science and Technology Development of Shanxi Province, China [2012011030-2]	Programs for Science and Technology Development of Shanxi Province, China	This work was supported by grants from the Programs for Science and Technology Development of Shanxi Province, China (2012011030-2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Accinelli C, 2008, J AGR FOOD CHEM, V56, P1025, DOI 10.1021/jf073172p; Bai YaoYu, 2006, Scientia Agricultura Sinica, V39, P721; [白耀宇 Bai Yaoyu], 2005, [生态学报, Acta Ecologica Sinica], V25, P1583; Clive J, 2012, CHINESE J BIOTECHNOL, V31, P1; Crecchio C, 1998, SOIL BIOL BIOCHEM, V30, P463, DOI 10.1016/S0038-0717(97)00147-8; Crecchio C, 2001, SOIL BIOL BIOCHEM, V33, P573, DOI 10.1016/S0038-0717(00)00199-1; Daudu CK, 2009, AGR ECOSYST ENVIRON, V134, P153, DOI 10.1016/j.agee.2009.06.012; Donegan KK, 1996, TRANSGENIC RES, V5, P25, DOI 10.1007/BF01979919; Feng YJ, 2011, SOIL BIOL BIOCHEM, V43, P1600, DOI 10.1016/j.soilbio.2011.04.011; Flores S, 2005, SOIL BIOL BIOCHEM, V37, P1073, DOI 10.1016/j.soilbio.2004.11.006; Head G, 2002, ENVIRON ENTOMOL, V31, P30, DOI 10.1603/0046-225X-31.1.30; Helassa N, 2011, SOIL BIOL BIOCHEM, V43, P1089, DOI 10.1016/j.soilbio.2011.01.030; Herman RA, 2002, J AGR FOOD CHEM, V50, P7076, DOI 10.1021/jf025630u; Herman RA, 2002, ENVIRON ENTOMOL, V31, P208, DOI 10.1603/0046-225X-31.2.208; Hopkins DW, 2005, CAN J SOIL SCI, V85, P19, DOI 10.4141/S03-073; Icoz I, 2008, TRANSGENIC RES, V17, P609, DOI 10.1007/s11248-007-9133-8; Icoz I, 2008, SOIL BIOL BIOCHEM, V40, P559, DOI 10.1016/j.soilbio.2007.11.002; Koskella J, 1997, APPL ENVIRON MICROB, V63, P3561, DOI 10.1128/AEM.63.9.3561-3568.1997; Koskella J, 2002, CAN J MICROBIOL, V48, P262, DOI [10.1139/w02-005, 10.1139/W02-005]; Lee L, 2003, APPL ENVIRON MICROB, V69, P4111, DOI 10.1128/AEM.69.7.4111-4115.2003; Li Fan, 2013, Yingyong Shengtai Xuebao, V24, P1907; Lin DY, 2002, SCI SOIL; Liu Jie, 2010, Acta Pedologica Sinica, V47, P786; Losey JE, 1999, NATURE, V399, P214, DOI 10.1038/20338; Marchetti E, 2007, AGRON SUSTAIN DEV, V27, P231, DOI 10.1051/agro:2007010; Miethling-Graff R, 2010, EUR J SOIL BIOL, V46, P41, DOI 10.1016/j.ejsobi.2009.10.003; Palm CJ, 1996, CAN J MICROBIOL, V42, P1258, DOI 10.1139/m96-163; PALM CJ, 1994, MOL ECOL, V3, P145, DOI 10.1111/j.1365-294X.1994.tb00115.x; Point B, 2005, BIOCONTROL SCI TECHN, V15, P341, DOI 10.1080/09583150400016969; Sander M, 2010, ENVIRON SCI TECHNOL, V44, P8870, DOI 10.1021/es103008s; SANVIDO O, 2006, ART SCHRIFTENREIHE, V1, P1; Saxena D, 2000, FEMS MICROBIOL ECOL, V33, P35, DOI 10.1111/j.1574-6941.2000.tb00724.x; Saxena D, 2004, PLANT PHYSIOL BIOCH, V42, P383, DOI 10.1016/j.plaphy.2004.03.004; Saxena D, 2002, SOIL BIOL BIOCHEM, V34, P111, DOI 10.1016/S0038-0717(01)00193-6; Saxena D, 2002, SOIL BIOL BIOCHEM, V34, P133, DOI 10.1016/S0038-0717(01)00161-4; Saxena D, 1999, NATURE, V402, P480, DOI 10.1038/44997; Saxena D., 2003, COLLECTION BIOSAFETY, P7; Sims SR, 1996, ENVIRON ENTOMOL, V25, P659, DOI 10.1093/ee/25.3.659; Sims SR, 1997, J AGR FOOD CHEM, V45, P1502, DOI 10.1021/jf960647w; Stotzky G, 2004, PLANT SOIL, V266, P77; TAPP H, 1994, SOIL BIOL BIOCHEM, V26, P663, DOI 10.1016/0038-0717(94)90258-5; Wang BaoMin, 2002, Journal of Agricultural Biotechnology, V10, P215; Wang Jian-wu, 2009, Shengtaixue Zazhi, V28, P1324; [王建武 Wang Jianwu], 2005, [生态学杂志, Chinese Journal of Ecology], V24, P1063; Wang JianWu, 2003, Scientia Agricultura Sinica, V36, P1279; Wang SA, 1994, INTRO CROP CULTIVATI; Wang YM, 2013, SOIL BIOL BIOCHEM, V58, P107, DOI 10.1016/j.soilbio.2012.11.007; [张运红 ZHANG Yunhong], 2007, [华中农业大学学报, Journal of Huazhong Agricultural University], V26, P486; Zurbrugg C, 2010, TRANSGENIC RES, V19, P257, DOI 10.1007/s11248-009-9304-x; Zwahlen C, 2003, MOL ECOL, V12, P765, DOI 10.1046/j.1365-294X.2003.01767.x	50	8	9	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2015	10	1							e1152400	10.1371/journal.pone.0115240	http://dx.doi.org/10.1371/journal.pone.0115240			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ3BG	25559638	Green Published, Green Submitted, gold			2022-12-27	WOS:000348102200009
J	Kusrini, MD; Rowley, JJL; Khairunnisa, LR; Shea, GM; Altig, R				Kusrini, Mirza D.; Rowley, Jodi J. L.; Khairunnisa, Luna R.; Shea, Glenn M.; Altig, Ronald			The Reproductive Biology and Larvae of the First Tadpole-Bearing Frog, Limnonectes larvaepartus	PLOS ONE			English	Article							DICROGLOSSIDAE; ANURA	Most of the reproductive modes of frogs include an exotrophic tadpole, but a number of taxa have some form of endotrophic development that lacks a feeding tadpole stage. The dicroglossid frog genus Limnonectes ranges from China south into Indonesia. The breeding biologies of the approximately 60 described species display an unusual diversity that range from exotrophic tadpoles to endotrophic development in terrestrial nests. There have been mentions of oviductal production of typical, exotrophic tadpoles in an undescribed species of Limnonectes from Sulawesi, Indonesia. Here we examine newly collected specimens of this species, now described as L. larvaepartus and present the first substantial report on this unique breeding mode. Typical exotrophic tadpoles that are retained to an advanced developmental stage in the oviducts of a female frog are birthed into slow-flowing streams or small, non-flowing pools adjacent to the streams.	[Kusrini, Mirza D.; Khairunnisa, Luna R.] Bogor Agr Univ, Dept Forest Resources Conservat & Ecotourism, Bogor, Indonesia; [Rowley, Jodi J. L.; Shea, Glenn M.] Australian Museum, Res Inst, Sydney, NSW 2000, Australia; [Shea, Glenn M.] Univ Sydney, Fac Vet Sci, Sydney, NSW 2006, Australia; [Altig, Ronald] Mississippi State Univ, Dept Biol Sci, Mississippi State, MS 39762 USA	Bogor Agricultural University; Australian Museum; University of Sydney; Mississippi State University	Kusrini, MD (corresponding author), Bogor Agr Univ, Dept Forest Resources Conservat & Ecotourism, Bogor, Indonesia.	mirza_kusrini@yahoo.com	Kusrini, Mirza Dikari/GQB-2150-2022; Rowley, Jodi J. L./F-2466-2012	Rowley, Jodi/0000-0002-2011-9143	The Ministry of Education, Republic of Indonesia through BOPTN DIKTI-IPB [2013.089.521219]; ADM Capital Foundation	The Ministry of Education, Republic of Indonesia through BOPTN DIKTI-IPB; ADM Capital Foundation	The Ministry of Education, Republic of Indonesia provided funding to MDK and LRK through BOPTN DIKTI-IPB Number 2013.089.521219, and ADM Capital Foundation provided funding for JJLR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altig R, 1999, TADPOLES, P24; Brown R. M., 2009, ENCY ISLANDS, P347; Evans BJ, 2003, SYST BIOL, V52, P794, DOI 10.1080/10635150390251063; Frost D.R., 2021, AMPHIBIAN SPECIES WO; GOICOECHEA O, 1986, J HERPETOL, V20, P168, DOI 10.2307/1563941; Gosner K. L., 1960, Herpetologica, V16, P183; Haddad CFB, 2005, BIOSCIENCE, V55, P207, DOI 10.1641/0006-3568(2005)055[0207:RMIFAT]2.0.CO;2; INGER RF, 1988, COPEIA, P1060, DOI 10.2307/1445733; INGER RF, 1986, COPEIA, P523, DOI 10.2307/1445012; Iskandar D.T., 1985, P 1 INT C E IND AUST, P39; Iskandar Djoko T., 2006, Amphibian & Reptile Conservation, V4, P60, DOI 10.1514/journal.arc.0040016; Iskandar DT, 2014, PLOSONE; McLeod DS, 2010, MOL PHYLOGENET EVOL, V56, P991, DOI 10.1016/j.ympev.2010.04.004; Palumbi S, 1991, SIMPLE FOOLS GUIDE P; Rowley JJL, 2012, AMPHIBIA-REPTILIA, V33, P145, DOI 10.1163/156853812X626179; Setiadi MI, 2011, AM NAT, V178, P221, DOI 10.1086/660830; TOWNSEND DS, 1981, SCIENCE, V212, P469, DOI 10.1126/science.6894203	17	11	11	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2015	10	1							e116154	10.1371/journal.pone.0116154	http://dx.doi.org/10.1371/journal.pone.0116154			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ3XP	25555000	Green Published, Green Submitted, gold			2022-12-27	WOS:000348157400001
J	Chen, R; Zhao, YL; Du, J; Wu, T; Huang, YF; Guo, AM				Chen, Rui; Zhao, Yali; Du, Juan; Wu, Tao; Huang, Yafang; Guo, Aimin			Health Workforce Equity in Urban Community Health Service of China	PLOS ONE			English	Article							HUMAN-RESOURCES; GINI COEFFICIENT; LORENZ-CURVE; CARE; ACCESS; SYSTEM	Objectives: To reveal the equity of health workforce distribution in urban community health service (CHS), and to provide evidence for further development of community health service in China. Methods: A community-based, cross-sectional study was conducted in China from September to December 2011. In the study, 190 CHS centers were selected from 10 provinces of China via stratified multistage cluster sampling. Human resources profiles and basic characteristics of each CHS centers were collected. Lorenz curves and Gini Coefficient were used to measure the inequality in the distribution of health workforce in community health service centers by population size and geographical area. Wilcoxon rank test for paired samples was used to analyze the differences in equity between different health indicators. Results: On average, there were 7.37 health workers, including 3.25 doctors and 2.32 nurses per 10,000 population ratio. Significant differences were found in all indicators across the samples, while Beijing, Shandong and Zhejiang ranked the highest among these provinces. The Gini coefficients for health workers, doctors and nurses per 10,000 population ratio were 0.39, 0.44, and 0.48, respectively. The equity of doctors per 10,000 population ratio (G=0.39) was better than that of doctors per square kilometer (G=0.44) (P=0.005). Among the total 6,573 health workers, 1,755(26.7%) had undergraduate degree or above, 2,722(41.4%) had junior college degree and 215(3.3%) had high school education. Significant inequity was found in the distribution of workers with undergraduate degree or above (G=0.52), which was worse than that of health works per 10000 population (P<0.001). Conclusions: Health workforce inequity was found in this study, especially in quality and geographic distribution. These findings suggest a need for more innovative policies to improve health equity in Chinese urban CHS centers.	[Chen, Rui; Zhao, Yali; Du, Juan; Huang, Yafang; Guo, Aimin] Capital Med Univ, Sch Gen Practice & Continuing Educ, Beijing 100069, Peoples R China; [Wu, Tao] Capital Med Univ, Beijing An Zhen Hosp, Beijing, Peoples R China	Capital Medical University; Capital Medical University	Guo, AM (corresponding author), Capital Med Univ, Sch Gen Practice & Continuing Educ, Beijing 100069, Peoples R China.	guoaiminlaoshi@163.com			National Health and Family Planning Commission	National Health and Family Planning Commission	This research was supported by a grant from National Health and Family Planning Commission. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anand S, 2008, LANCET, V372, P1774, DOI 10.1016/S0140-6736(08)61363-X; Chen L, 2004, LANCET, V364, P1984, DOI 10.1016/S0140-6736(04)17482-5; Chen YY, 2014, INT J EQUITY HEALTH, V13, DOI 10.1186/1475-9276-13-34; Cutis E, 2013, INT J EQUITY HEALTH, V11, P13; Druckman A, 2008, ECOL ECON, V65, P242, DOI 10.1016/j.ecolecon.2007.12.013; Fotso Jean-Christophe, 2006, Int J Equity Health, V5, P9, DOI 10.1186/1475-9276-5-9; GASTWIRT.JL, 1972, REV ECON STAT, V54, P306, DOI 10.2307/1937992; Ghosh S, 2014, INT J HEALTH POLICY, V2, P29, DOI 10.15171/ijhpm.2014.06; Glorioso V, 2014, HEALTH SERV RES, V49, P950, DOI 10.1111/1475-6773.12128; Groves-Kirkby CJ, 2009, J ENVIRON MANAGE, V90, P2480, DOI 10.1016/j.jenvman.2009.01.003; Hann M, 2004, BRIT J GEN PRACT, V54, P894; Hongoro C, 2004, LANCET, V364, P1451, DOI 10.1016/S0140-6736(04)17229-2; Hung LM, 2012, INT J EQUITY HEALTH, V11, DOI 10.1186/1475-9276-11-2; KOBAYASHI Y, 1992, LANCET, V340, P1391, DOI 10.1016/0140-6736(92)92569-2; Lorenz MO, 1905, PUBL AM STAT ASSOC, V9, P209, DOI 10.2307/2276207; Mitchell S, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-S2-S5; Mobaraki H, 2013, IRAN J PUBLIC HEALTH, V42, P161; National Bureau of Statistics of China, 2012, GROSS DOM PROD EACH; Paraje G, 2012, INT J EQUITY HEALTH, V11, DOI 10.1186/1475-9276-11-81; Petrera M, 2013, REV PANAM SALUD PUBL, V33, P131, DOI 10.1590/S1020-49892013000200008; Rechel B, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-219; Shi Y, 2013, BIOMED ENVIRON SCI, V26, P702, DOI 10.3967/0895-3988.2013.08.013; Smith S, 2011, HEALTH ECON POLICY L, V6, P205, DOI 10.1017/S1744133110000289; Statistical Information Center of National Bureau of Statistics of China, 2012, 2007 CHIN HLTH STAT; The Central Committee of Communist Party & The State Council, 2011, DEC PROM WAT CONS RE; The State Council of China, 2011, INSTR ADV BUILD GEN; The State Council of China, 2011, INSTR ADV JOB TRANSF; Theodorakis Pavlos N, 2005, Rural Remote Health, V5, P457; Tian MM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083822; Wang Z, 2008, CHINESE J SOCIAL MED, V25, P265; World Health Organization, 2005, SOC HLTH INS SUST HL; Yang J, 2008, ANN FAM MED, V6, P421, DOI 10.1370/afm.888; Zere E, 2013, INT J EQUITY HEALTH, V12, DOI 10.1186/1475-9276-12-90; Zhao YL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094301; Zhou ZL, 2013, INT J EQUITY HEALTH, V12, DOI 10.1186/1475-9276-12-34	35	33	33	1	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2014	9	12							e115988	10.1371/journal.pone.0115988	http://dx.doi.org/10.1371/journal.pone.0115988			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AX7UC	25551449	Green Published, gold, Green Submitted			2022-12-27	WOS:000347119100086
J	Herzberger, AJ; Duncan, DS; Jackson, RD				Herzberger, Anna J.; Duncan, David S.; Jackson, Randall D.			Bouncing Back: Plant-Associated Soil Microbes Respond Rapidly to Prairie Establishment	PLOS ONE			English	Article							FATTY-ACID ANALYSIS; COMMUNITY COMPOSITION; BACTERIAL COMMUNITY; MANAGEMENT; GRASSLAND; DIVERSITY; STORAGE	It is well established that soil microbial communities change in response to altered land use and land cover, but less is known about the timing of these changes. Understanding temporal patterns in recovering microbial communities is an important part of improving how we assess and manage reconstructed ecosystems. We assessed patterns of community-level microbial diversity and abundance in corn and prairie plots 2 to 4 years after establishment in agricultural fields, using phospholipid fatty acid biomarkers. Principal components analysis of the lipid biomarkers revealed differing composition between corn and prairie soil microbial communities. Despite no changes to the biomass of Gram-positive bacteria and actinomycetes, total biomass, arbuscular mycorrhizal fungi biomass, and Gramnegative bacteria biomass were significantly higher in restored prairie plots, approaching levels found in long-established prairies. These results indicate that plant-associated soil microbes in agricultural soils can shift in less than 2 years after establishment of perennial grasslands.	[Herzberger, Anna J.] Michigan State Univ, Dept Fisheries & Wildlife, E Lansing, MI 48824 USA; [Duncan, David S.; Jackson, Randall D.] Univ Wisconsin, Dept Agron, Madison, WI 53706 USA; [Duncan, David S.; Jackson, Randall D.] Univ Wisconsin, DOE Great Lakes Bioenergy Res Ctr, Madison, WI 53706 USA	Michigan State University; University of Wisconsin System; University of Wisconsin Madison; United States Department of Energy (DOE); University of Wisconsin System; University of Wisconsin Madison	Jackson, RD (corresponding author), Univ Wisconsin, Dept Agron, 1575 Linden Dr, Madison, WI 53706 USA.	rdjackson@wisc.edu	Jackson, Randall/AAE-5573-2022	Duncan, David/0000-0002-2867-0378	US Department of Energy's Great Lakes Bioenergy Research Center (DOE Biological and Environmental Research Office of Science) [DE-FC02-07ER64494]; National Science Foundation [DBI-1063085]	US Department of Energy's Great Lakes Bioenergy Research Center (DOE Biological and Environmental Research Office of Science)(United States Department of Energy (DOE)); National Science Foundation(National Science Foundation (NSF))	DSD and RDJ received funding from the US Department of Energy's Great Lakes Bioenergy Research Center (DOE Biological and Environmental Research Office of Science DE-FC02-07ER64494; https://www.glbrc.org/). AJH received funding from the National Science Foundation (DBI-1063085; www.nsf.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Suleiman AKA, 2013, SYST APPL MICROBIOL, V36, P137, DOI 10.1016/j.syapm.2012.10.007; Allison VJ, 2005, SOIL SCI SOC AM J, V69, P1412, DOI 10.2136/sssaj2004.0252; Balser TC, 2005, BIOGEOCHEMISTRY, V73, P395, DOI 10.1007/s10533-004-0372-y; Bever JD, 2010, TRENDS ECOL EVOL, V25, P468, DOI 10.1016/j.tree.2010.05.004; Bossio DA, 1998, MICROBIAL ECOL, V36, P1, DOI 10.1007/s002489900087; Bossio DA, 1998, MICROBIAL ECOL, V35, P265, DOI 10.1007/s002489900082; Broeckling CD, 2008, APPL ENVIRON MICROB, V74, P738, DOI 10.1128/AEM.02188-07; Buyer JS, 2012, APPL SOIL ECOL, V61, P127, DOI 10.1016/j.apsoil.2012.06.005; Carrasco L, 2010, MICROB ECOL, V60, P265, DOI 10.1007/s00248-009-9619-4; Cui H, 2014, EUR J SOIL BIOL, V63, P55, DOI 10.1016/j.ejsobi.2014.05.006; Fernandes MF, 2013, MICROB ECOL, V66, P145, DOI 10.1007/s00248-013-0195-2; Fichtner A, 2014, SOIL BIOL BIOCHEM, V70, P79, DOI 10.1016/j.soilbio.2013.12.015; Frostegard A, 1996, BIOL FERT SOILS, V22, P59, DOI 10.1007/BF00384433; Gliessman S. R., 2007, AGROECOLOGY ECOLOGY, P23; Harris J, 2009, SCIENCE, V325, P573, DOI 10.1126/science.1172975; Hedlund K, 2002, SOIL BIOL BIOCHEM, V34, P1299, DOI 10.1016/S0038-0717(02)00073-1; Huang YM, 2011, J PLANT NUTR SOIL SC, V174, P765, DOI 10.1002/jpln.201000397; Jonsson LM, 2001, OIKOS, V93, P353, DOI 10.1034/j.1600-0706.2001.930301.x; Kowalchuk GA, 2002, ANTON LEEUW INT J G, V81, P509, DOI 10.1023/A:1020565523615; Kulmatiski A, 2008, SOIL BIOL BIOCHEM, V40, P1059, DOI 10.1016/j.soilbio.2007.11.020; Lennon JT, 2011, NAT REV MICROBIOL, V9, P119, DOI 10.1038/nrmicro2504; Lenth R. V., 2013, ISMEANS LEAST SQUARE; Liang C., 2011, Agricultural Sciences, V2, P131, DOI 10.4236/as.2011.22019; Liang C, 2012, APPL SOIL ECOL, V54, P24, DOI 10.1016/j.apsoil.2011.11.015; Marschner P, 2001, SOIL BIOL BIOCHEM, V33, P1437, DOI 10.1016/S0038-0717(01)00052-9; Millard P, 2010, NUTR CYCL AGROECOSYS, V88, P147, DOI 10.1007/s10705-009-9314-3; Oksanen J., 2020, VEGAN COMMUNITY ECOL; Pinheiro J, 2020, R PACKAGE VERSION 31; R Core Team, 2021, R LANGUAGE ENV STAT; Sayer EJ, 2013, SOIL BIOL BIOCHEM, V61, P61, DOI 10.1016/j.soilbio.2013.02.012; van der Heijden MGA, 2008, ECOL LETT, V11, P296, DOI 10.1111/j.1461-0248.2007.01139.x; van der Heijden MGA, 2013, PLANT SOIL, V363, P1, DOI 10.1007/s11104-012-1545-4; Wallenius K, 2010, J MICROBIOL METH, V81, P48, DOI 10.1016/j.mimet.2010.01.021; Wu YP, 2009, GEODERMA, V150, P171, DOI 10.1016/j.geoderma.2009.02.003	34	24	25	0	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2014	9	12							e115775	10.1371/journal.pone.0115775	http://dx.doi.org/10.1371/journal.pone.0115775			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UC	25551613	Green Submitted, Green Published, gold			2022-12-27	WOS:000347119100061
J	Leppanen, SA; Malm, T; Varri, K; Nyman, T				Leppanen, Sanna A.; Malm, Tobias; Varri, Kaisa; Nyman, Tommi			A Comparative Analysis of Genetic Differentiation across Six Shared Willow Host Species in Leaf- and Bud-Galling Sawflies	PLOS ONE			English	Article							PLANT-FEEDING INSECTS; REPRODUCTIVE ISOLATION; ECOLOGICAL SPECIATION; PHYTOPHAGOUS INSECTS; POPULATION-GENETICS; MITOCHONDRIAL; HYMENOPTERA; EVOLUTION; DIVERSIFICATION; SHIFTS	Genetic divergence and speciation in plant-feeding insects could be driven by contrasting selection pressures imposed by different plant species and taxa. While numerous examples of host-associated differentiation (HAD) have been found, the overall importance of HAD in insect diversification remains unclear, as few studies have investigated its frequency in relation to all speciation events. One promising way to infer the prevalence and repeatability of HAD is to estimate genetic differentiation in multiple insect taxa that use the same set of hosts. To this end, we measured and compared variation in mitochondrial COI and nuclear ITS2 sequences in population samples of leaf-galling Pontania and bud-galling Euura sawflies (Hymenoptera: Tenthredinidae) collected from six Salix species in two replicate locations in northern Fennoscandia. We found evidence of frequent HAD in both species complexes, as individuals from the same willow species tended to cluster together on both mitochondrial and nuclear phylogenetic trees. Although few fixed differences among the putative species were found, hierarchical AMOVAs showed that most of the genetic variation in the samples was explained by host species rather than by sampling location. Nevertheless, the levels of HAD measured across specific pairs of host species were not correlated in the two focal galler groups. Hence, our results support the hypothesis of HAD as a central force in herbivore speciation, but also indicate that evolutionary trajectories are only weakly repeatable even in temporally overlapping radiations of related insect taxa.	[Leppanen, Sanna A.; Varri, Kaisa; Nyman, Tommi] Univ Eastern Finland, Dept Biol, FI-80101 Joensuu, Finland; [Malm, Tobias] Swedish Museum Nat Hist, Dept Zool, SE-10405 Stockholm, Sweden	University of Eastern Finland; Swedish Museum of Natural History	Leppanen, SA (corresponding author), Univ Eastern Finland, Dept Biol, POB 111, FI-80101 Joensuu, Finland.	sanna.a.leppanen@uef.fi			Academy of Finland [14868]; Kone Foundation [17-116]; North Karelia Regional Fund of the Finnish Cultural Foundation	Academy of Finland(Academy of Finland); Kone Foundation; North Karelia Regional Fund of the Finnish Cultural Foundation	This study was supported by the Academy of Finland (grant 14868 for TN), the Kone Foundation (Project 17-116 for Niklas Wahlberg and TN), and by the North Karelia Regional Fund of the Finnish Cultural Foundation (SL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agosta SJ, 2006, OIKOS, V114, P556, DOI 10.1111/j.2006.0030-1299.15025.x; [Anonymous], 1998, RETKEILYKASVIO; Aoki Kyoko, 2011, Insects, V2, P128, DOI 10.3390/insects2020128; Argus G. W., 1997, SYST BOT MONOGR, V52, P1, DOI DOI 10.2307/25096638; Berlocher SH, 2002, ANNU REV ENTOMOL, V47, P773, DOI 10.1146/annurev.ento.47.091201.145312; BORCHSENIUS F, 2009, FASTGAP 1 2; Burbrink FT, 2012, P ROY SOC B-BIOL SCI, V279, P4817, DOI 10.1098/rspb.2012.1669; Craft KJ, 2010, P NATL ACAD SCI USA, V107, P5041, DOI 10.1073/pnas.0913084107; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Dickey AM, 2010, J EVOLUTION BIOL, V23, P945, DOI 10.1111/j.1420-9101.2010.01962.x; Dickey AM, 2012, ENTOMOL EXP APPL, V143, P127, DOI 10.1111/j.1570-7458.2012.01250.x; Dorchin N, 2009, J EVOLUTION BIOL, V22, P729, DOI 10.1111/j.1420-9101.2009.01696.x; Dres M, 2002, PHILOS T R SOC B, V357, P471, DOI 10.1098/rstb.2002.1059; Egan SP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054690; Egan SP, 2009, P NATL ACAD SCI USA, V106, P19426, DOI 10.1073/pnas.0909424106; EHRLICH PR, 1964, EVOLUTION, V18, P586, DOI 10.2307/2406212; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Funk DJ, 2002, GENETICA, V116, P251, DOI 10.1023/A:1021236510453; Gompert Z, 2008, MOL ECOL, V17, P5231, DOI 10.1111/j.1365-294X.2008.03988.x; Gould S. J., 1989, WONDERFUL LIFE BURGE; Hardy NB, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-257; Heidemaa M, 2004, EUR J ENTOMOL, V101, P637, DOI 10.14411/eje.2004.087; Hernandez-Vera G, 2010, MOL ECOL, V19, P2286, DOI 10.1111/j.1365-294X.2010.04639.x; Imada Y, 2011, P ROY SOC B-BIOL SCI, V278, P3026, DOI 10.1098/rspb.2011.0134; Janz N, 2011, ANNU REV ECOL EVOL S, V42, P71, DOI 10.1146/annurev-ecolsys-102710-145024; JULKUNENTIITTO R, 1989, PHYTOCHEMISTRY, V28, P2115, DOI 10.1016/S0031-9422(00)97930-5; Kopelke Jens-Peter, 2001, Senckenbergiana Biologica, V81, P191; Kopelke Jens-Peter, 1999, Courier Forschungsinstitut Senckenberg, V212, P1; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Linnen CR, 2007, EVOLUTION, V61, P1417, DOI 10.1111/j.1558-5646.2007.00114.x; Losos JB, 2010, AM NAT, V175, P623, DOI 10.1086/652433; Maddison W., 2018, MESQUITE MODULAR SYS; Magnacca KN, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-174; Mahler DL, 2013, SCIENCE, V341, P292, DOI 10.1126/science.1232392; MALAISE R, 1920, ENTOMOL TIDSKR, V40, P97; Mardulyn P, 2011, MOL PHYLOGENET EVOL, V61, P686, DOI 10.1016/j.ympev.2011.09.001; Marshall DC, 2011, SYST BIOL, V60, P482, DOI 10.1093/sysbio/syr017; Matsubayashi KW, 2010, ENTOMOL EXP APPL, V134, P1, DOI 10.1111/j.1570-7458.2009.00916.x; McCune B., 2006, PC ORD MULTIVARIATE; Miller M.A., 2010, P GAT COMP ENV WORKS; Novotny V, 2010, J ANIM ECOL, V79, P1193, DOI 10.1111/j.1365-2656.2010.01728.x; Nowell RW, 2011, GENET RES, V93, P255, DOI 10.1017/S0016672311000206; Nyman T, 2002, HEREDITY, V88, P288, DOI 10.1038/sj.hdy.6800042; Nyman T, 2000, EVOLUTION, V54, P526, DOI 10.1111/j.0014-3820.2000.tb00055.x; Nyman T, 2000, THESIS U JOENSUU FIN; Nyman T, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-49; Nyman T, 2006, SYST ENTOMOL, V31, P569, DOI 10.1111/j.1365-3113.2006.00336.x; Nyman T, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-266; Nyman T, 2010, BIOL REV, V85, P393, DOI 10.1111/j.1469-185X.2009.00109.x; PAMILO P, 1988, MOL BIOL EVOL, V5, P568; Peccoud J, 2009, P NATL ACAD SCI USA, V106, P7495, DOI 10.1073/pnas.0811117106; Percy DM, 2014, MOL ECOL, V23, P4737, DOI 10.1111/mec.12837; Powell THQ, 2013, EVOLUTION, V67, P2561, DOI 10.1111/evo.12209; Rambaut A, 2013, TRACER V1 6 0; Roininen Heikki, 2005, P467; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Ruber L, 1999, P NATL ACAD SCI USA, V96, P10230, DOI 10.1073/pnas.96.18.10230; Rundle HD, 2005, ECOL LETT, V8, P336, DOI 10.1111/j.1461-0248.2004.00715.x; Simmons MP, 2000, SYST BIOL, V49, P369, DOI 10.1093/sysbio/49.2.369; Skvortsov A.K., 1999, FACULTY MATH NATURAL; Smith D.R, 1979, CATALOG HYMENOPTERA, V1, P3; Stireman JO, 2005, EVOLUTION, V59, P2573, DOI 10.1554/05-222.1; Strong D., 1984, INSECTS PLANTS COMMU; Via S, 2000, EVOLUTION, V54, P1626, DOI 10.1111/j.0014-3820.2000.tb00707.x; Winkler IS, 2008, SPECIALIZATION, SPECIATION, AND RADIATION: THE EVOLUTIONARY BIOLOGY OF HERBIVOROUS INSECTS, P240	66	11	11	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2014	9	12							e116286	10.1371/journal.pone.0116286	http://dx.doi.org/10.1371/journal.pone.0116286			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UC	25551608	gold, Green Published, Green Submitted			2022-12-27	WOS:000347119100123
J	Lutz, A; Sanwald, J; Thomas, M; Feuer, R; Sawodny, O; Ederer, M; Borner, C; Humar, M; Merfort, I				Lutz, Anna; Sanwald, Julia; Thomas, Maria; Feuer, Ronny; Sawodny, Oliver; Ederer, Michael; Borner, Christoph; Humar, Matjaz; Merfort, Irmgard			Interleukin-1 beta Enhances FasL-Induced Caspase-3/-7 Activity without Increasing Apoptosis in Primary Mouse Hepatocytes	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; LIVER; PHOSPHORYLATION; BIM; MEMBRANE; PROTEIN; BAX; ACTIVATION; DEATH; CELLS	Sustained inflammation may increase the susceptibility of hepatocytes to apoptotic cell death and therefore exacerbate liver damage. Here we report that the proinflammatory cytokine IL-1 beta sensitizes primary murine hepatocytes to Fas ligand (FasL)-induced caspase-3/-7 activity. This process was dependent on JNK1/2 and the BH3-only proteins Bim and Bid. Mathematical modeling revealed that incubation of hepatocytes with IL-1 beta depleted the anti-apoptotic Bcl-2 protein pool and thus shifted hepatocytes to mitochondrial type II apoptosis following Fas activation. As a consequence, IL-1 beta and FasL treatment enhanced cytochrome c release. Surprisingly, despite increased caspase-3/-7 activation, FasL-induced cell death was reduced by IL-1 beta pre-treatment. This protective effect was independent of JNK1/2, Bim or Bid. Furthermore, elevated caspase-3/-7 activity upon IL-1 beta and FasL treatment did not result in enhanced PARP cleavage. The protective effect of IL-1 beta was seen after 3 h of pre-incubation, indicating an anti-apoptotic transcriptional response. Indeed, NF-kappa B DNA binding was increased in response to IL-1 beta plus FasL and gene-expression profiling of NF-kappa B regulated genes revealed a transcriptional and translational upregulation of the caspase-8 inhibitor A20. A mathematical model was developed to explain the contradictious occurrence of both increased caspase-3/-7 activity and elevated cell viability by including a heterogeneous distribution of Bcl-2 proteins and variations in Fas signaling resulting in different subpopulations of hepatocytes.	[Lutz, Anna; Humar, Matjaz; Merfort, Irmgard] Univ Freiburg, Dept Pharmaceut Biol & Biotechnol, D-79106 Freiburg, Germany; [Sanwald, Julia; Feuer, Ronny; Sawodny, Oliver; Ederer, Michael] Univ Stuttgart, Inst Syst Dynam, D-70174 Stuttgart, Germany; [Thomas, Maria] Dr Margarete Fischer Bosch Inst Clin Pharmacol, Stuttgart, Germany; [Borner, Christoph] Univ Freiburg, Inst Mol Med & Cell Res, D-79106 Freiburg, Germany; [Borner, Christoph; Merfort, Irmgard] Univ Freiburg, Spemann Grad Sch Biol & Med SGBM, D-79106 Freiburg, Germany; [Borner, Christoph] Univ Freiburg, Bioss Ctr Biol Signaling Studies, D-79106 Freiburg, Germany	University of Freiburg; University of Stuttgart; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; University of Freiburg; University of Freiburg; University of Freiburg	Merfort, I (corresponding author), Univ Freiburg, Dept Pharmaceut Biol & Biotechnol, Hugstetter Str 55, D-79106 Freiburg, Germany.	irmgard.merfort@pharmazie.uni-freiburg.de	Thomas, Maria/F-3315-2011	Thomas, Maria/0000-0001-6394-8710; Feuer, Ronny/0000-0002-5653-7670; Rex, Julia/0000-0002-8189-9243	BMBF research grant Virtual Liver [FKZ 0315766, FKZ 0315751, FKZ 0315755]; Albert Ludwigs University Freiburg	BMBF research grant Virtual Liver; Albert Ludwigs University Freiburg	This work was supported by the BMBF (http://www.bmbf.de/) research grant Virtual Liver (FKZ 0315766, FKZ 0315751, FKZ 0315755). The article processing charge was funded by the open access publication fund of the Albert Ludwigs University Freiburg. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boulton R, 1997, HEPATOLOGY, V26, P49; Chipuk JE, 2008, TRENDS CELL BIOL, V18, P157, DOI 10.1016/j.tcb.2008.01.007; Daniel S, 2004, BLOOD, V104, P2376, DOI 10.1182/blood-2003-02-0635; Dinarello CA, 2010, EUR J IMMUNOL, V40, P599, DOI 10.1002/eji.201040319; Finch A, 1997, FEBS LETT, V418, P144, DOI 10.1016/S0014-5793(97)01364-1; Geissler A, 2013, CELL DEATH DIFFER, V20, P1317, DOI 10.1038/cdd.2013.78; Goldstein JC, 2000, NAT CELL BIOL, V2, P156, DOI 10.1038/35004029; Hoops S, 2006, BIOINFORMATICS, V22, P3067, DOI 10.1093/bioinformatics/btl485; Hubner A, 2008, MOL CELL, V30, P415, DOI 10.1016/j.molcel.2008.03.025; Jiang ZF, 2002, MOL CELL BIOL, V22, P7158, DOI 10.1128/MCB.22.20.7158-7167.2002; Jost PJ, 2009, NATURE, V460, P1035, DOI 10.1038/nature08229; Kallenberger SM, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2004738; KARIN M, 2002, TRENDS CELL BIOL, V18, P528, DOI DOI 10.1016/J.TCB.2008.08.003; Klingmuller U, 2006, IEE P SYST BIOL, V153, P433, DOI 10.1049/ip-syb:20050067; Kramer F, 2008, MOL IMMUNOL, V45, P2678, DOI 10.1016/j.molimm.2007.12.017; Krammer PH, 2000, NATURE, V407, P789, DOI 10.1038/35037728; KRIKOS A, 1992, J BIOL CHEM, V267, P17971; Lei K, 2003, P NATL ACAD SCI USA, V100, P2432, DOI 10.1073/pnas.0438011100; Lipniacki T, 2004, J THEOR BIOL, V228, P195, DOI 10.1016/j.jtbi.2004.01.001; Ma JH, 2014, HEPATOLOGY, V59, P2010, DOI 10.1002/hep.26769; Putcha GV, 2003, NEURON, V38, P899, DOI 10.1016/S0896-6273(03)00355-6; Rehm M, 2009, CELL DEATH DIFFER, V16, P613, DOI 10.1038/cdd.2008.187; Scaffidi C, 1998, EMBO J, V17, P1675, DOI 10.1093/emboj/17.6.1675; Schlatter R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018646; Schmich K, 2011, HEPATOLOGY, V53, P282, DOI 10.1002/hep.23987; Seki E, 2012, GASTROENTEROLOGY, V143, P307, DOI 10.1053/j.gastro.2012.06.004; Spencer SL, 2011, CELL, V144, P926, DOI 10.1016/j.cell.2011.03.002; Spencer SL, 2009, NATURE, V459, P428, DOI 10.1038/nature08012; Spurgeon SL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001662; Strasser A, 2009, IMMUNITY, V30, P180, DOI 10.1016/j.immuni.2009.01.001; Szabo G, 2012, J HEPATOL, V57, P642, DOI 10.1016/j.jhep.2012.03.035; Tacke F, 2009, CLIN REV ALLERG IMMU, V36, P4, DOI 10.1007/s12016-008-8091-0; Takehara T, 1999, GASTROENTEROLOGY, V117, P661, DOI 10.1016/S0016-5085(99)70460-9; Tamm I, 1998, CANCER RES, V58, P5315; Tournier C, 2001, GENE DEV, V15, P1419, DOI 10.1101/gad.888501; Varfolomeev EE, 2004, CELL, V116, P491, DOI 10.1016/S0092-8674(04)00166-7; Verma G, 2010, APOPTOSIS, V15, P864, DOI 10.1007/s10495-010-0498-4; Walter D, 2008, HEPATOLOGY, V48, P1942, DOI 10.1002/hep.22541; Weber A, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3105cm1; Yang JY, 2004, MOL CELL BIOL, V24, P10425, DOI 10.1128/MCB.24.23.10425-10436.2004	40	15	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2014	9	12							e115603	10.1371/journal.pone.0115603	http://dx.doi.org/10.1371/journal.pone.0115603			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UC	25551609	Green Published, Green Submitted, gold			2022-12-27	WOS:000347119100047
J	Lv, SD; Wu, YS; Zhou, JS; Lian, M; Li, CW; Xu, YQ; Liu, SH; Wang, C; Meng, QX				Lv, Shidong; Wu, Yuanshuang; Zhou, Jiangsheng; Lian, Ming; Li, Changwen; Xu, Yongquan; Liu, Shunhang; Wang, Chao; Meng, Qingxiong			The Study of Fingerprint Characteristics of Dayi Pu-Erh Tea Using a Fully Automatic HS-SPME/GC-MS and Combined Chemometrics Method	PLOS ONE			English	Article							CHROMATOGRAPHY-MASS-SPECTROMETRY; SOLID-PHASE MICROEXTRACTION; PERFORMANCE LIQUID-CHROMATOGRAPHY; BLACK TEA; VOLATILE COMPOUNDS; QUALITY ASSESSMENT; CAMELLIA-SINENSIS; ELECTRONIC NOSE; AROMA COMPOUNDS; GREEN TEAS	The quality of tea is presently evaluated by the sensory assessment of professional tea tasters, however, this approach is both inconsistent and inaccurate. A more standardized and efficient method is urgently needed to objectively evaluate tea quality. In this study, the chemical fingerprint of 7 different Dayi Pu-erh tea brands and 3 different Ya'an tea brands on the market were analyzed using fully automatic headspace solid-phase microextraction (HS-SPME) combined with gas chromatography-mass spectrometry (GC-MS). A total of 78 volatiles were separated, among 75 volatiles were identified by GC-MS in seven Dayi Pu-erh teas, and the major chemical components included methoxyphenolic compounds, hydrocarbons, and alcohol compounds, such as 1,2,3-trimethoxybenzene, 1,2,4-trimethoxybenzene, 2,6,10,14-tetramethyl-pentadecane, linalool and its oxides, a-terpineol, and phytol. The overlapping ratio of peaks (ORP) of the chromatogram in the seven Dayi Pu-erh tea samples was greater than 89.55%, whereas the ORP of Ya'an tea samples was less than 79.10%. The similarity and differences of the Dayi Pu-erh tea samples were also characterized using correlation coefficient similarity and principal component analysis (PCA). The results showed that the correlation coefficient of similarity of the seven Dayi Pu-erh tea samples was greater than 0.820 and was gathered in a specific area, which showed that samples from different brands were basically the same, despite have some slightly differences of chemical indexes was found. These results showed that the GC-MS fingerprint combined with the PCA approach can be used as an effective tool for the quality assessment and control of Pu-erh tea.	[Lv, Shidong; Wu, Yuanshuang; Zhou, Jiangsheng; Lian, Ming; Meng, Qingxiong] Kunming Univ Sci & Technol, Fac Life Sci & Technol, Kunming, Yunnan, Peoples R China; [Lv, Shidong] Kunming Grain & Oil & Feed Prod Qual Inspect Ctr, Kunming, Yunnan, Peoples R China; [Li, Changwen; Xu, Yongquan; Liu, Shunhang; Wang, Chao] Yunnan Tasly Deepure Biol Tea Technol Ltd Inc, Puer, Yunnan, Peoples R China	Kunming University of Science & Technology	Meng, QX (corresponding author), Kunming Univ Sci & Technol, Fac Life Sci & Technol, Kunming, Yunnan, Peoples R China.	qxmeng@scbg.ac.cn			National Natural Science Foundation of China [31460228]; scientific research funds in Yunnan province department of education [2014Y089]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); scientific research funds in Yunnan province department of education	This work was supported by the National Natural Science Foundation of China (No. 31460228) and scientific research funds in Yunnan province department of education (No. 2014Y089). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe M, 2008, INT J FOOD MICROBIOL, V124, P199, DOI 10.1016/j.ijfoodmicro.2008.03.008; Altaki MS, 2009, TALANTA, V78, P1315, DOI 10.1016/j.talanta.2009.02.003; Anselmi C, 2000, J AGR FOOD CHEM, V48, P1285, DOI 10.1021/jf991156p; Banerjee R, 2012, J FOOD ENG, V110, P356, DOI 10.1016/j.jfoodeng.2011.12.037; Bhattacharyya R, 2012, J FOOD ENG, V109, P120, DOI 10.1016/j.jfoodeng.2011.09.026; Bylund D, 2002, J CHROMATOGR A, V961, P237, DOI 10.1016/S0021-9673(02)00588-5; Cao YH, 2006, J PHARMACEUT BIOMED, V41, P845, DOI 10.1016/j.jpba.2006.01.060; [陈常颂 Chen Changsong], 2011, [食品与发酵工业, Food and Fermentation Industries], V37, P165; Chen QS, 2008, J PHARMACEUT BIOMED, V48, P1321, DOI 10.1016/j.jpba.2008.09.016; Deng JW, 2013, ANAL CHIM ACTA, V785, P82, DOI 10.1016/j.aca.2013.04.056; Du LP, 2013, J AGR FOOD CHEM, V61, P561, DOI 10.1021/jf304470k; Gan F, 2006, J CHROMATOGR A, V1104, P100, DOI 10.1016/j.chroma.2005.11.099; Ghasemi-Varnamkhasti M, 2010, J FOOD ENG, V100, P377, DOI 10.1016/j.jfoodeng.2010.04.032; Gong JS, 2012, J ANAL APPL PYROL, V95, P189, DOI 10.1016/j.jaap.2012.02.006; Ikeda T, 2007, J AGR FOOD CHEM, V55, P9908, DOI 10.1021/jf0717642; Jeng KC, 2007, J AGR FOOD CHEM, V55, P8787, DOI 10.1021/jf071629p; Jin Y, 2009, J CHROMATOGR A, V1216, P2136, DOI 10.1016/j.chroma.2008.04.010; Jumtee K, 2011, J BIOSCI BIOENG, V112, P252, DOI 10.1016/j.jbiosc.2011.05.008; Kanani DM, 2003, IND ENG CHEM RES, V42, P6924, DOI 10.1021/ie0340185; Kato M, 2001, J AGR FOOD CHEM, V49, P1394, DOI 10.1021/jf001321x; KAWAKAMI M, 1995, J AGR FOOD CHEM, V43, P200, DOI 10.1021/jf00049a037; Li YP, 2007, J PHARMACEUT BIOMED, V43, P1667, DOI 10.1016/j.jpba.2006.12.028; Lian M., 2014, J CHEM PHARM RES, V6, P2025; Lin J, 2012, J ZHEJIANG UNIV-SC B, V13, P972, DOI 10.1631/jzus.B1200086; Lu GH, 2005, J CHROMATOGR A, V1073, P383, DOI 10.1016/j.chroma.2004.11.080; Lv HP, 2013, FOOD RES INT, V53, P608, DOI 10.1016/j.foodres.2013.02.043; Lv HP, 2012, FOOD CHEM, V130, P1074, DOI 10.1016/j.foodchem.2011.07.135; Lv SD, 2014, FOOD ANAL METHOD, DOI [10.1007/s12161-014-9900-0, DOI 10.1007/S12161-014-9900-0.]; Lv ShiDong, 2014, Journal of Chemical and Pharmaceutical Research, V6, P246; Lv SD, 2014, J AGR FOOD CHEM, V62, P1810, DOI 10.1021/jf405237u; Ma LJ, 2007, J CHROMATOGR B, V846, P139, DOI 10.1016/j.jchromb.2006.08.048; Maggi F, 2010, FOOD CHEM, V123, P983, DOI 10.1016/j.foodchem.2010.05.049; Meng J, 2005, CHEM PHARM BULL, V53, P1484, DOI 10.1248/cpb.53.1484; Pongsuwan W, 2007, J AGR FOOD CHEM, V55, P231, DOI 10.1021/jf062330u; Qin PY, 2011, J FOOD SCI, V76, pS401, DOI 10.1111/j.1750-3841.2011.02223.x; Qin ZH, 2013, FOOD RES INT, V53, P864, DOI 10.1016/j.foodres.2013.02.005; Rottava I, 2010, LWT-FOOD SCI TECHNOL, V43, P1128, DOI 10.1016/j.lwt.2010.03.001; Schuh C, 2006, J AGR FOOD CHEM, V54, P916, DOI 10.1021/jf052495n; Sun JR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049534; Wang KB, 2011, INT J FOOD SCI TECH, V46, P1406, DOI 10.1111/j.1365-2621.2011.02629.x; [王力 Wang Li], 2010, [食品科学, Food Science], V31, P293; Wang LF, 2008, FOOD CHEM, V109, P196, DOI 10.1016/j.foodchem.2007.12.054; Wang LY, 2014, FOOD CHEM, V146, P98, DOI 10.1016/j.foodchem.2013.09.043; Wu SB, 2013, J CHROMATOGR A, V1314, P154, DOI 10.1016/j.chroma.2013.09.017; Xie PS, 2006, J CHROMATOGR A, V1112, P171, DOI 10.1016/j.chroma.2005.12.091; Xu X, 2005, ENG LIFE SCI, V5, P382, DOI 10.1002/elsc.200520083; Yang LW, 2005, J CHROMATOGR A, V1070, P35, DOI 10.1016/j.chroma.2005.02.081; Yao SS, 2005, J AGR FOOD CHEM, V53, P8688, DOI 10.1021/jf058059i; Zhang L, 2011, J CHINESE PHARM SCI, V20, P352; Zhang L, 2013, FOOD RES INT, V53, P600, DOI 10.1016/j.foodres.2013.01.016	50	20	25	2	111	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2014	9	12							e116428	10.1371/journal.pone.0116428	http://dx.doi.org/10.1371/journal.pone.0116428			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UC	25551231	Green Published, Green Submitted, gold			2022-12-27	WOS:000347119100140
J	Meachen, JA; Janowicz, AC; Avery, JE; Sadleir, RW				Meachen, Julie A.; Janowicz, Adrianna C.; Avery, Jori E.; Sadleir, Rudyard W.			Ecological Changes in Coyotes (Canis latrans) in Response to the Ice Age Megafaunal Extinctions	PLOS ONE			English	Article							RANCHO LA BREA; INTERFERENCE COMPETITION; MANDIBULAR CORPUS; WOLVES; PLEISTOCENE; WOLF; CARNIVORANS; YELLOWSTONE; CALIFORNIA; EVOLUTION	Coyotes (Canis latrans) are an important species in human-inhabited areas. They control pests and are the apex predators in many ecosystems. Because of their importance it is imperative to understand how environmental change will affect this species. The end of the Pleistocene Ice Age brought with it many ecological changes for coyotes and here we statistically determine the changes that occurred in coyotes, when these changes occurred, and what the ecological consequences were of these changes. We examined the mandibles of three coyote populations: Pleistocene Rancho La Brean (13-29 Ka), earliest Holocene Rancho La Brean (8-10 Ka), and Recent from North America, using 2D geometric morphometrics to determine the morphological differences among them. Our results show that these three populations were morphologically distinct. The Pleistocene coyotes had an overall robust mandible with an increased shearing arcade and a decreased grinding arcade, adapted for carnivory and killing larger prey; whereas the modern populations show a gracile morphology with a tendency toward omnivory or grinding. The earliest Holocene populations are intermediate in morphology and smallest in size. These findings indicate that a niche shift occurred in coyotes at the Pleistocene/Holocene boundary - from a hunter of large prey to a small prey/more omnivorous animal. Species interactions between Canis were the most likely cause of this transition. This study shows that the Pleistocene extinction event affected species that did not go extinct as well as those that did.	[Meachen, Julie A.; Janowicz, Adrianna C.; Avery, Jori E.] Des Moines Univ, Dept Anat, Des Moines, IA 50312 USA; [Sadleir, Rudyard W.] St Xavier Univ, Dept Biol Sci, Chicago, IL USA		Meachen, JA (corresponding author), Des Moines Univ, Dept Anat, Des Moines, IA 50312 USA.	julie.meachen@dmu.edu			Des Moines University	Des Moines University	JAM and ACJ were supported by start-up funds (JAM) and student mentored research funds (ACJ) from Des Moines University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arjo WM, 1999, CAN J ZOOL, V77, P1919, DOI 10.1139/z99-177; Atwood TC, 2008, ANIM BEHAV, V75, P753, DOI 10.1016/j.anbehav.2007.08.024; Atwood TC, 2010, J MAMMAL, V91, P490, DOI 10.1644/09-MAMM-A-078.1; Berger KM, 2008, ECOLOGY, V89, P818, DOI 10.1890/07-0193.1; Berger KM, 2007, J ANIM ECOL, V76, P1075, DOI 10.1111/j.1365-2656.2007.01287.x; Biknevicius AR, 1997, ZOOL J LINN SOC-LOND, V120, P139; BIKNEVICIUS AR, 1992, J ZOOL, V228, P479, DOI 10.1111/j.1469-7998.1992.tb04450.x; Biknevicius AR, 1996, CARNIVORE BEHAV ECOL, VII, P393; Bookstein FL, 1991, MORPHOMETRIC TOOLS L; Carbone C, 2009, BIOL LETTERS, V5, P81, DOI 10.1098/rsbl.2008.0526; Crooks KR, 1999, NATURE, V400, P563, DOI 10.1038/23028; Dodge WB, 2013, J FISH WILDL MANAG, V4, P377, DOI 10.3996/062013-JFWM-040; Dundas RG, 1999, BOREAS, V28, P375, DOI 10.1080/030094899422109; Ewer, 1998, CARNIVORES; Figueirido B, 2011, ACTA PALAEONTOL POL, V56, P225, DOI 10.4202/app.2010.0005; Friscia AR, 2007, J ZOOL, V272, P82, DOI 10.1111/j.1469-7998.2006.00246.x; Fuller BT, 2014, QUAT GEOCHRONOL, V22, P85, DOI 10.1016/j.quageo.2014.03.002; Gehrt SD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075718; GESE EM, 1988, J WILDLIFE MANAGE, V52, P647, DOI 10.2307/3800924; Gese EM, 2012, J ETHOL, V30, P413, DOI 10.1007/s10164-012-0339-8; GILES EUGENE, 1960, UNIV CALIFORNIA PUBL GEOL PUBL GEOL SCI, V36, P369; IBM, 2013, IBM SPSS STAT WIND; Koblmuller S, 2012, BIOL LETTERS, V8, P644, DOI 10.1098/rsbl.2012.0162; Krefting L.W., 1969, NATURALIST, V20, P24; Leonard JA, 2007, CURR BIOL, V17, P1146, DOI 10.1016/j.cub.2007.05.072; LYDEARD C, 1988, J MAMMAL, V69, P773, DOI 10.2307/1381632; Meachen JA, 2014, J EVOLUTION BIOL, V27, P714, DOI 10.1111/jeb.12340; Meachen JA, 2012, P NATL ACAD SCI USA, V109, P4191, DOI 10.1073/pnas.1113788109; Merkle JA, 2009, CAN J ZOOL, V87, P56, DOI 10.1139/Z08-136; Nowak R.M., 1979, University of Kansas Museum of Natural History Monograph, P1; O'Keefe F. Robin, 2009, Contributions in Science (Los Angeles), P1; OGLE T F, 1971, Northwest Science, V45, P213; OZOGA JJ, 1966, J WILDLIFE MANAGE, V30, P809, DOI 10.2307/3798288; Ripple WJ, 2013, BIOL CONSERV, V160, P70, DOI 10.1016/j.biocon.2012.12.033; Rohlf F, 2013, TPSDIG2 2; Sheets HD, 2005, PCAGEN7 IMP 7; Smith DW, 2003, BIOSCIENCE, V53, P330, DOI 10.1641/0006-3568(2003)053[0330:YAW]2.0.CO;2; THURBER JM, 1991, J MAMMAL, V72, P750, DOI 10.2307/1381838; van Valkenburgh B., 1990, P181; VANVALKENBURGH B, 1993, SYM ZOOL S, P15; VANVALKENBURGH B, 1993, SCIENCE, V261, P456, DOI 10.1126/science.261.5120.456; Waser NM, 2014, NATURWISSENSCHAFTEN, V101, P427, DOI 10.1007/s00114-014-1172-4; Zelditch ML, 2012, GEOMETRIC MORPHOMETRICS FOR BIOLOGISTS: A PRIMER, 2ND EDITION, P1	43	23	22	3	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2014	9	12							e116041	10.1371/journal.pone.0116041	http://dx.doi.org/10.1371/journal.pone.0116041			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UC	25551387	Green Published, gold, Green Submitted			2022-12-27	WOS:000347119100092
J	Stevens, M; Lown, AE; Wood, LE				Stevens, Martin; Lown, Alice E.; Wood, Louisa E.			Camouflage and Individual Variation in Shore Crabs (Carcinus maenas) from Different Habitats	PLOS ONE			English	Article							COLOR POLYMORPHISM; DISRUPTIVE COLORATION; ANIMAL CAMOUFLAGE; GREEN CRAB; JUVENILE; EVOLUTION; PREDATION; POPULATION; SELECTION; PATTERNS	Camouflage is widespread throughout the natural world and conceals animals from predators in a vast range of habitats. Because successful camouflage usually involves matching aspects of the background environment, species and populations should evolve appearances tuned to their local habitat, termed phenotype-environment associations. However, although this has been studied in various species, little work has objectively quantified the appearances of camouflaged animals from different habitats, or related this to factors such as ontogeny and individual variation. Here, we tested for phenotype-environment associations in the common shore crab (Carcinus maenas), a species highly variable in appearance and found in a wide range of habitats. We used field surveys and digital image analysis of the colors and patterns of crabs found in four locations around Cornwall in the UK to quantify how individuals vary with habitat (predominantly rockpool, mussel bed, and mudflat). We find that individuals from sites comprising different backgrounds show substantial differences in several aspects of color and pattern, and that this is also dependent on life stage (adult or juvenile). Furthermore, the level of individual variation is dependent on site and life stage, with juvenile crabs often more variable than adults, and individuals from more homogenous habitats less diverse. Ours is the most comprehensive study to date exploring phenotype-environment associations for camouflage and individual variation in a species, and we discuss the implications of our results in terms of the mechanisms and selection pressures that may drive this.	[Stevens, Martin; Lown, Alice E.; Wood, Louisa E.] Univ Exeter, Coll Life & Environm Sci, Ctr Ecol & Conservat, Penryn, Cornwall, England	University of Exeter	Stevens, M (corresponding author), Univ Exeter, Coll Life & Environm Sci, Ctr Ecol & Conservat, Penryn Campus, Penryn, Cornwall, England.	martin.stevens@exeter.ac.uk		Wood, Louisa/0000-0002-8649-5010; Wood, Louisa/0000-0002-8053-2474; Stevens, Martin/0000-0001-7768-3426	Biotechnology and Biological Sciences Research Council (BBSRC) David Phillips Research Fellowship [BB/G022887/1]; BBSRC [BB/G022887/1, BB/G022887/2] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/G022887/1, BB/G022887/2] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council (BBSRC) David Phillips Research Fellowship(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	MS and AEL were supported by a Biotechnology and Biological Sciences Research Council (BBSRC) David Phillips Research Fellowship (BB/G022887/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMEYAWAKUMFI C, 1987, MAR ECOL PROG SER, V37, P153, DOI 10.3354/meps037153; Audet D, 2008, J SHELLFISH RES, V27, P427, DOI 10.2983/0730-8000(2008)27[427:BCOANE]2.0.CO;2; Barbosa A, 2008, VISION RES, V48, P1242, DOI 10.1016/j.visres.2008.02.011; Bedini R, 2002, CRUSTACEANA, V75, P703, DOI 10.1163/156854002760202688; BENNETT ATD, 1994, AM NAT, V144, P848, DOI 10.1086/285711; Bond AB, 2006, P NATL ACAD SCI USA, V103, P3214, DOI 10.1073/pnas.0509963103; Bond AB, 2002, NATURE, V415, P609, DOI 10.1038/415609a; Boratynski Z, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094342; Brian JV, 2006, J EXP MAR BIOL ECOL, V329, P47, DOI 10.1016/j.jembe.2005.08.002; BYERS BA, 1989, VELIGER, V32, P394; CAIN AJ, 1950, HEREDITY, V4, P275, DOI 10.1038/hdy.1950.22; Chiao CC, 2009, VISION RES, V49, P1647, DOI 10.1016/j.visres.2009.04.002; CLARKE B, 1969, HEREDITY, V24, P347, DOI 10.1038/hdy.1969.52; Cook LM, 2012, BIOL LETTERS, V8, P609, DOI 10.1098/rsbl.2011.1136; Cott H.B., 1940, ADAPTIVE COLORATION; Crothers J. H., 1967, Field Studies, V2, P407; Crothers J. H., 1968, Field Studies, V2, P579; Cuthill IC, 2005, NATURE, V434, P72, DOI 10.1038/nature03312; Darling JA, 2008, MOL ECOL, V17, P4992, DOI 10.1111/j.1365-294X.2008.03978.x; Domingues CP, 2010, MAR ECOL PROG SER, V410, P111, DOI 10.3354/meps08610; Endler JA, 2005, BIOL J LINN SOC, V86, P405, DOI 10.1111/j.1095-8312.2005.00540.x; Gacic Z, 2007, FISH PHYSIOL BIOCHEM, V33, P21, DOI 10.1007/s10695-006-9113-6; Hanlon RT, 2009, PHILOS T R SOC B, V364, P429, DOI 10.1098/rstb.2008.0270; Hemmi JM, 2006, J EXP BIOL, V209, P4140, DOI 10.1242/jeb.02483; HOGARTH PJ, 1978, MAR BIOL, V44, P337, DOI 10.1007/BF00390898; Houston AI, 2007, BEHAV ECOL, V18, P769, DOI 10.1093/beheco/arm039; Hultgren K, 2011, ANIMAL CAMOUFLAGE ME; Hultgren KM, 2008, OECOLOGIA, V155, P519, DOI 10.1007/s00442-007-0926-5; Hultgren KM, 2010, BEHAV ECOL, V21, P329, DOI 10.1093/beheco/arp192; Kang CK, 2012, J EVOLUTION BIOL, V25, P1695, DOI 10.1111/j.1420-9101.2012.02557.x; Kang CK, 2014, BEHAV ECOL, DOI [10.1093/beheco/aru1150, DOI 10.1093/BEHECO/ARU1150]; KETTLEWELL H. B. D., 1955, HEREDITY, V9, P323, DOI 10.1038/hdy.1955.36; Komdeur J, 2005, BEHAV ECOL, V16, P805, DOI 10.1093/beheco/ari059; Lovell PG, 2013, CURR BIOL, V23, P260, DOI 10.1016/j.cub.2012.12.031; Lovell PG, 2005, J OPT SOC AM A, V22, P2060, DOI 10.1364/JOSAA.22.002060; Maan ME, 2008, EVOLUTION, V62, P2334, DOI 10.1111/j.1558-5646.2008.00454.x; Marshall KLA, 2014, BEHAV ECOL, V25, P1325, DOI 10.1093/beheco/aru126; McLean CA, 2014, BIOL REV, V89, P860, DOI 10.1111/brv.12083; Merilaita S, 2005, P ROY SOC B-BIOL SCI, V272, P665, DOI 10.1098/rspb.2004.3000; Merilaita S, 2003, EVOLUTION, V57, P1248; Merilaita S, 2001, EVOL ECOL, V15, P103, DOI 10.1023/A:1013814623311; Nachman MW, 2003, P NATL ACAD SCI USA, V100, P5268, DOI 10.1073/pnas.0431157100; Nosil P, 2006, P NATL ACAD SCI USA, V103, P9090, DOI 10.1073/pnas.0601575103; Odeen A, 2010, BIOL LETTERS, V6, P370, DOI 10.1098/rsbl.2009.0877; Palma AT, 2001, ECOLOGY, V82, P2961, DOI 10.2307/2679974; POWELL B. L., 1962, CRUSTACEANA, V4, P93, DOI 10.1163/156854062X00120; POWELL BL, 1962, J ANIM ECOL, V31, P251, DOI 10.2307/2139; R Core Team, 2021, R LANGUAGE ENV STAT; Roman J, 2004, MOL ECOL, V13, P2891, DOI 10.1111/j.1365-294X.2004.02255.x; Rosenblum EB, 2006, AM NAT, V167, P1, DOI 10.1086/498397; Rowland HM, 2007, ANIM BEHAV, V74, P1249, DOI 10.1016/j.anbehav.2007.01.030; SHAND J, 1988, J COMP PHYSIOL A, V163, P699, DOI 10.1007/BF00603854; Silva IC, 2010, SCI MAR, V74, P435, DOI 10.3989/scimar.2010.74n3435; Skelhorn J, 2010, SCIENCE, V327, P51, DOI 10.1126/science.1181931; Spottiswoode CN, 2011, P ROY SOC B-BIOL SCI, V278, P3566, DOI 10.1098/rspb.2011.0401; Steiner CC, 2007, PLOS BIOL, V5, P1880, DOI 10.1371/journal.pbio.0050219; Stevens M, 2013, SENSORY ECOLOGY, BEHAVIOUR, AND EVOLUTION, P1, DOI 10.1093/acprof:oso/9780199601776.001.0001; Stevens M., 2011, ANIMAL CAMOUFLAGE ME; Stevens M, 2007, BIOL J LINN SOC, V90, P211, DOI 10.1111/j.1095-8312.2007.00725.x; Stevens M, 2006, P R SOC B, V273, P2433, DOI 10.1098/rspb.2006.3614; Stevens M, 2006, P R SOC B, V273, P2141, DOI 10.1098/rspb.2006.3556; Stevens M, 2014, FRONT ECOL EVOL, V2, DOI 10.3389/fevo.2014.00014; Stevens M, 2013, BIOL J LINN SOC, V109, P257, DOI 10.1111/bij.12039; Stevens M, 2009, INT J PRIMATOL, V30, P893, DOI 10.1007/s10764-009-9356-z; Stevens M, 2009, PHILOS T R SOC B, V364, P423, DOI 10.1098/rstb.2008.0217; Stoddard MC, 2008, AM NAT, V171, P755, DOI 10.1086/587526; Stoddard MC, 2010, P ROY SOC B-BIOL SCI, V277, P1387, DOI 10.1098/rspb.2009.2018; Stuart-Fox D, 2009, PHILOS T R SOC B, V364, P463, DOI 10.1098/rstb.2008.0254; Surmacki A, 2013, NATURWISSENSCHAFTEN, V100, P533, DOI 10.1007/s00114-013-1049-y; Tankus A, 2009, PHILOS T R SOC B, V364, P529, DOI 10.1098/rstb.2008.0211; Todd PA, 2006, MAR BIOL, V148, P1357, DOI 10.1007/s00227-005-0159-2; Todd PA, 2012, ECOL COMPLEX, V12, P58, DOI 10.1016/j.ecocom.2012.09.005; Trivedi J.N., 2012, Arthropods, V1, P129; Umbers KDL, 2014, BIOL REV, V89, P820, DOI 10.1111/brv.12079; Wallace AR, 1889, DARWINISM; Webster RJ, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2013.0501; Westland S, 2004, COMPUTATIONAL COLOUR; Yamada SB, 2005, BIOL INVASIONS, V7, P309, DOI 10.1007/s10530-004-0877-2	79	35	35	0	82	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2014	9	12							e115586	10.1371/journal.pone.0115586	http://dx.doi.org/10.1371/journal.pone.0115586			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UC	25551233	Green Published, gold, Green Submitted			2022-12-27	WOS:000347119100043
J	Denis, M; Enquobahrie, DA; Tadesse, MG; Gelaye, B; Sanchez, SE; Salazar, M; Ananth, CV; Williams, MA				Denis, Marie; Enquobahrie, Daniel A.; Tadesse, Mahlet G.; Gelaye, Bizu; Sanchez, Sixto E.; Salazar, Manuel; Ananth, Cande V.; Williams, Michelle A.			Placental Genome and Maternal-Placental Genetic Interactions: A Genome-Wide and Candidate Gene Association Study of Placental Abruption	PLOS ONE			English	Article							PENALIZED LOGISTIC-REGRESSION; C-OXIDASE DEFICIENCY; STUDY 100K PROJECT; FACTOR-V-LEIDEN; RISK-FACTORS; CIGARETTE-SMOKING; PERINATAL-MORTALITY; PREGNANCY OUTCOMES; PRETERM BIRTH; SELECTION	While available evidence supports the role of genetics in the pathogenesis of placental abruption (PA), PA-related placental genome variations and maternal-placental genetic interactions have not been investigated. Maternal blood and placental samples collected from participants in the Peruvian Abruptio Placentae Epidemiology study were genotyped using Illumina's Cardio-Metabochip platform. We examined 118,782 genome-wide SNPs and 333 SNPs in 32 candidate genes from mitochondrial biogenesis and oxidative phosphorylation pathways in placental DNA from 280 PA cases and 244 controls. We assessed maternal-placental interactions in the candidate gene SNPS and two imprinted regions (IGF2/H19 and C19MC). Univariate and penalized logistic regression models were fit to estimate odds ratios. We examined the combined effect of multiple SNPs on PA risk using weighted genetic risk scores (WGRS) with repeated ten-fold cross-validations. A multinomial model was used to investigate maternal-placental genetic interactions. In placental genome-wide and candidate gene analyses, no SNP was significant after false discovery rate correction. The top genome-wide association study (GWAS) hits were rs544201, rs1484464 (CTNNA2), rs4149570 (TNFRSF1A) and rs13055470 (ZNRF3) (p-values: 1.11e-05 to 3.54e-05). The top 200 SNPs of the GWAS overrepresented genes involved in cell cycle, growth and proliferation. The top candidate gene hits were rs16949118 (COX10) and rs7609948 (THRB) (pvalues: 6.00e-03 and 8.19e-03). Participants in the highest quartile of WGRS based on cross-validations using SNPs selected from the GWAS and candidate gene analyses had a 8.40-fold (95% CI: 5.8-12.56) and a 4.46-fold (95% CI: 2.94-6.72) higher odds of PA compared to participants in the lowest quartile. We found maternal-placental genetic interactions on PA risk for two SNPs in PPARG (chr3: 12313450 and chr3: 12412978) and maternal imprinting effects for multiple SNPs in the C19MC and IGF2/H19 regions. Variations in the placental genome and interactions between maternal-placental genetic variations may contribute to PA risk. Larger studies may help advance our understanding of PA pathogenesis.	[Denis, Marie; Gelaye, Bizu; Williams, Michelle A.] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Denis, Marie] CIRAD, UMR AGAP Ameliorat Genet & Adaptat Plantes Medite, Montpellier, France; [Enquobahrie, Daniel A.] Swedish Med Ctr, Ctr Perinatal Studies, Seattle, WA USA; [Enquobahrie, Daniel A.] Univ Washington, Sch Publ Hlth, Dept Epidemiol, Seattle, WA 98195 USA; [Tadesse, Mahlet G.] Georgetown Univ, Dept Math & Stat, Washington, DC USA; [Sanchez, Sixto E.] Univ San Martin Porres, Fac Med Humana, Secc Post Grado, Lima, Peru; [Sanchez, Sixto E.] AC PROESA, Lima, Peru; [Salazar, Manuel] San Marcos Univ, Dept Obstet & Gynecol, Lima, Peru; [Ananth, Cande V.] Columbia Univ, Med Ctr, Coll Phys & Surg, Dept Obstet & Gynecol, New York, NY USA; [Ananth, Cande V.] Columbia Univ, Mailman Sch Publ Hlth, Dept Epidemiol, New York, NY USA	Harvard University; Harvard T.H. Chan School of Public Health; CIRAD; Universite de Montpellier; Swedish Medical Center; University of Washington; University of Washington Seattle; Georgetown University; Universidad de San Martin de Porres; Universidad Nacional Mayor de San Marcos; Columbia University; Columbia University	Denis, M (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA.	marie.denis@cirad.fr		Sanchez, Sixto/0000-0003-0354-0523; Gelaye, Bizu/0000-0001-7934-548X	National Institutes of Health; Eunice Kennedy Shriver National Institute of Child Health and Human Development [R01HD059827]; National Heart Lung and Blood Institute [K01HL10374]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD059827] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F32HL010374] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Heart Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported by grants from the National Institutes of Health, the Eunice Kennedy Shriver National Institute of Child Health and Human Development (R01HD059827) and the National Heart Lung and Blood Institute (K01HL10374). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainsworth HE, 2011, GENET EPIDEMIOL, V35, P19, DOI 10.1002/gepi.20547; Ananth CV, 2008, HUM GENET, V124, P137, DOI 10.1007/s00439-008-0531-7; Ananth CV, 2007, OBSTET GYNECOL, V110, P128, DOI 10.1097/01.AOG.0000266983.77458.71; Ananth CV, 2006, EUR J OBSTET GYN R B, V128, P15, DOI 10.1016/j.ejogrb.2006.01.016; Ananth CV, 2004, OBSTET GYNECOL, V104, P71, DOI 10.1097/01.AOG.0000128172.71408.a0; Ananth CV, 1996, AM J EPIDEMIOL, V144, P881, DOI 10.1093/oxfordjournals.aje.a009022; Ananth CV, 2001, AM J EPIDEMIOL, V153, P332, DOI 10.1093/aje/153.4.332; Ananth CV, 2007, AM J OBSTET GYNECOL, V197, p273e1; Arnold DL, 2009, J OBSTET GYNAECOL RE, V35, P446, DOI 10.1111/j.1447-0756.2008.00980.x; Ayers KL, 2010, GENET EPIDEMIOL, V34, P879, DOI 10.1002/gepi.20543; Bailey SD, 2010, DIABETES CARE, V33, P2250, DOI 10.2337/dc10-0452; Bank S, 2014, PHARMACOGENOMICS J, V14, P526, DOI 10.1038/tpj.2014.19; Bank S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098815; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bartolomei MS, 1997, ANNU REV GENET, V31, P493, DOI 10.1146/annurev.genet.31.1.493; Benjamin EJ, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-S1-S11; Benjamini Y, 2001, ANN STAT, V29, P1165; Borel V, 2008, PPAR RES, V2008, DOI 10.1155/2008/758562; Breathnach FM, 2013, AUST NZ J OBSTET GYN, V53, P553, DOI 10.1111/ajo.12131; Breheny P, 2011, ANN APPL STAT, V5, P232, DOI 10.1214/10-AOAS388; Breheny P, 2009, STAT INTERFACE, V2, P369; Browning SR, 2007, AM J HUM GENET, V81, P1084, DOI 10.1086/521987; Burgess S, 2013, INT J EPIDEMIOL, V42, P1134, DOI 10.1093/ije/dyt093; Crawford Dana C, 2013, Pac Symp Biocomput, P188; Darin N, 2003, NEUROPEDIATRICS, V34, P311; de Bakker PIW, 2005, NAT GENET, V37, P1217, DOI 10.1038/ng1669; de Paz NC, 2011, J AFFECT DISORDERS, V130, P280, DOI 10.1016/j.jad.2010.07.024; Di Simone N, 2003, BIOL REPROD, V69, P1129, DOI 10.1095/biolreprod.103.015800; Dizon-Townson D, 2005, OBSTET GYNECOL, V106, P517, DOI 10.1097/01.AOG.0000173986.32528.ca; Dudbridge F, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003348; DUTHIE SJ, 1991, AUST NZ J OBSTET GYN, V31, P125, DOI 10.1111/j.1479-828X.1991.tb01799.x; Fox CS, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-S1-S18; Fukui H, 2007, P NATL ACAD SCI USA, V104, P14163, DOI 10.1073/pnas.0705738104; Gargano JW, 2010, BJOG-INT J OBSTET GY, V117, P445, DOI 10.1111/j.1471-0528.2009.02472.x; Gargano JW, 2009, AM J OBSTET GYNECOL, V201, DOI 10.1016/j.ajog.2009.05.060; Haddow JE, 2011, OBSTET GYNECOL, V117, P287, DOI 10.1097/AOG.0b013e31820513d9; Hocher B, 2010, PHARMACOGENET GENOM, V20, P139, DOI 10.1097/FPC.0b013e3283357337; Hoggart CJ, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000130; Howey R, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-149; Huang J, 2012, STAT SCI, V27, P481, DOI 10.1214/12-STS392; Iams J, 1998, NEW ENGL J MED, V338, P54, DOI 10.1056/NEJM199801013380110; Ishida M, 2013, MOL ASPECTS MED, V34, P826, DOI 10.1016/j.mam.2012.06.009; Jaaskelainen E, 2004, PLACENTA, V25, P730, DOI 10.1016/j.placenta.2004.02.006; Jarvenpaa J, 2006, GYNECOL OBSTET INVES, V62, P28, DOI 10.1159/000091814; Jostins L, 2011, HUM MOL GENET, V20, pR182, DOI 10.1093/hmg/ddr378; Kathiresan S, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-S1-S17; Kundu S, 2011, EUR J EPIDEMIOL, V26, P261, DOI 10.1007/s10654-011-9567-4; Leunen K, 2003, J TROP PEDIATRICS, V49, P231, DOI 10.1093/tropej/49.4.231; Levy D, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-S1-S3; Li M, 2014, GENET EPIDEMIOL, V38, P198, DOI 10.1002/gepi.21793; Liang MB, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/396184; Lupo PJ, 2014, MOL GENET METAB, V111, P46, DOI 10.1016/j.ymgme.2013.11.004; Lyssenko V, 2013, DIABETES CARE, V36, pS120, DOI 10.2337/dcS13-2009; Mannisto T, 2013, J CLIN ENDOCR METAB, V98, P2725, DOI 10.1210/jc.2012-4233; Meigs JB, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-S1-S16; Melzer D, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000072; Moore A, 2012, INT J MOL EPIDEMIOL, V3, P305; NAEYE RL, 1977, AM J OBSTET GYNECOL, V128, P740, DOI 10.1016/0002-9378(77)90714-1; NAEYE RL, 1980, OBSTET GYNECOL, V55, P701; Noguer-Dance M, 2010, HUM MOL GENET, V19, P3566, DOI 10.1093/hmg/ddq272; Odendaal H J, 2000, J Obstet Gynaecol, V20, P358; Oyelese Y, 2006, OBSTET GYNECOL, V108, P1005, DOI 10.1097/01.AOG.0000239439.04364.9a; Phillips CM, 2010, J LIPID RES, V51, P1793, DOI 10.1194/jlr.M003046; Pitceathly RDS, 2013, JAMA NEUROL, V70, P1556, DOI 10.1001/jamaneurol.2013.3242; Ray JG, 1999, PLACENTA, V20, P519, DOI 10.1053/plac.1999.0417; SALAFIA CM, 1995, AM J OBSTET GYNECOL, V173, P1049, DOI 10.1016/0002-9378(95)91325-4; Sanchez SE, 2006, AM J OBSTET GYNECOL, V194, P225, DOI 10.1016/j.ajog.2005.05.013; Sanchez SE, 2010, BMC WOMENS HEALTH, V10, DOI 10.1186/1472-6874-10-30; Sennikov SV, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/745909; Signore C, 2006, OBSTET GYNECOL, V108, P338, DOI 10.1097/01.AOG.0000216014.72503.09; Sinsheimer JS, 2003, GENET EPIDEMIOL, V24, P1, DOI 10.1002/gepi.10211; Sinsheimer JS, 2010, J BIOMED BIOTECHNOL, V2010, P4597; SPINILLO A, 1993, EARLY HUM DEV, V35, P45, DOI 10.1016/0378-3782(93)90138-K; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Toivonen S, 2004, CLIN GENET, V66, P244, DOI 10.1111/j.1399-0004.2004.00294.x; Uhl GR, 2008, ARCH GEN PSYCHIAT, V65, P683, DOI 10.1001/archpsyc.65.6.683; Uhl GR, 2010, PHARMACOGENOMICS, V11, P357, DOI [10.2217/pgs.09.156, 10.2217/PGS.09.156]; Voight BF, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002793; Weinberg CR, 1998, AM J HUM GENET, V62, P969, DOI 10.1086/301802; Wieser F, 2008, PPAR RES, V2008, DOI 10.1155/2008/527048; Wilk JB, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-S1-S8; Willer CJ, 2013, NAT GENET, V45, P1274, DOI 10.1038/ng.2797; WILLIAMS MA, 1991, AM J EPIDEMIOL, V134, P965, DOI 10.1093/oxfordjournals.aje.a116181; Williams MA, 2013, INT J MOL EPIDEMIOL, V4, P120; Workalemahu T, 2013, INT J MOL EPIDEMIOL, V4, P128; Yilmaz Y, 2012, DNA CELL BIOL, V31, P92, DOI 10.1089/dna.2010.1169; Younis JS, 2003, BEST PRACT RES CL HA, V16, P135, DOI 10.1016/S1521-6926(02)00099-3; Zdoukopoulos N, 2008, EPIDEMIOLOGY, V19, P309, DOI 10.1097/EDE.0b013e3181635694; Zhou H, 2010, BIOINFORMATICS, V26, P2375, DOI 10.1093/bioinformatics/btq448	89	18	18	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2014	9	12							e116346	10.1371/journal.pone.0116346	http://dx.doi.org/10.1371/journal.pone.0116346			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX6YH	25549360	Green Published, gold, Green Submitted			2022-12-27	WOS:000347063500077
J	Gurarie, D; King, CH				Gurarie, David; King, Charles H.			Population Biology of Schistosoma Mating, Aggregation, and Transmission Breakpoints: More Reliable Model Analysis for the End-Game in Communities at Risk	PLOS ONE			English	Article							AGE-STRUCTURED MODEL; DYNAMICS; INFECTION; MANSONI; DISEASE; CHEMOTHERAPY; MOLLUSCICIDE; STRATEGIES; VALIDATION; ESTATE	Mathematical modeling is widely used for predictive analysis of control options for infectious agents. Challenging problems arise for modeling host-parasite systems having complex life-cycles and transmission environments. Macroparasites, like Schistosoma, inhabit highly fragmented habitats that shape their reproductive success and distribution. Overdispersion and mating success are important factors to consider in modeling control options for such systems. Simpler models based on mean worm burden (MWB) formulations do not take these into account and overestimate transmission. Proposed MWB revisions have employed prescribed distributions and mating factor corrections to derive modified MWB models that have qualitatively different equilibria, including 'breakpoints' below which the parasite goes to extinction, suggesting the possibility of elimination via long-term mass-treatment control. Despite common use, no one has attempted to validate the scope and hypotheses underlying such MWB approaches. We conducted a systematic analysis of both the classical MWB and more recent "stratified worm burden'' (SWB) modeling that accounts for mating and reproductive hurdles (Allee effect). Our analysis reveals some similarities, including breakpoints, between MWB and SWB, but also significant differences between the two types of model. We show the classic MWB has inherent inconsistencies, and propose SWB as a reliable alternative for projection of long-term control outcomes.	[Gurarie, David] Case Western Reserve Univ, Dept Math, Cleveland, OH 44106 USA; [Gurarie, David; King, Charles H.] Case Western Reserve Univ, Ctr Global Hlth & Dis, Cleveland, OH 44106 USA	Case Western Reserve University; Case Western Reserve University	King, CH (corresponding author), Case Western Reserve Univ, Ctr Global Hlth & Dis, Cleveland, OH 44106 USA.	chk@cwru.edu	Gurarie, David/AAA-2096-2021	King, Charles/0000-0001-8349-9270; Gurarie, David/0000-0002-5314-7888	sabbatical fellowship at NIMBioS (University of Tennessee); Schistosomiasis Consortium for Operational Research and Evaluation (SCORE) - University of Georgia Research Foundation from the Bill and Melinda Gates Foundation; Div Of Biological Infrastructure [1300426] Funding Source: National Science Foundation	sabbatical fellowship at NIMBioS (University of Tennessee); Schistosomiasis Consortium for Operational Research and Evaluation (SCORE) - University of Georgia Research Foundation from the Bill and Melinda Gates Foundation; Div Of Biological Infrastructure(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	D. Gurarie was supported by the sabbatical fellowship at NIMBioS (University of Tennessee) during Academic Year 2012-13. This work is also supported by the Schistosomiasis Consortium for Operational Research and Evaluation (SCORE) funded by the University of Georgia Research Foundation through a grant from the Bill and Melinda Gates Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON R M, 1991; ANDERSON RM, 1978, J ANIM ECOL, V47, P219, DOI 10.2307/3933; Barbour AD, 1996, AM J TROP MED HYG, V55, P135, DOI 10.4269/ajtmh.1996.55.135; BARNISH G, 1982, T ROY SOC TROP MED H, V76, P602, DOI 10.1016/0035-9203(82)90220-6; BRADLEY DJ, 1978, T ROY SOC TROP MED H, V72, P262, DOI 10.1016/0035-9203(78)90205-5; Bustinduy AL, 2009, SEQUELAE AND LONG-TERM CONSEQUENCES OF INFECTIOUS DISEASES, P291; CHAN MS, 1994, PARASITOLOGY, V109, P389, DOI 10.1017/S0031182000078422; CHAN MS, 1995, EPIDEMIOL INFECT, V115, P325, DOI 10.1017/S0950268800058453; Churcher TS, 2005, PARASITOLOGY, V131, P121, DOI 10.1017/S0031182005007341; Clarke V de V, 1973, Cent Afr J Med, P14; Colley DG, 2014, LANCET, V383, P2253, DOI 10.1016/S0140-6736(13)61949-2; Cornell SJ, 2010, ADV EXP MED BIOL, V673, P66; COURAFILHO P, 1992, REV INST MED TROP SP, V34, P427, DOI 10.1590/S0036-46651992000500009; DOBSON A, 1994, PARASITOLOGY, V109, pS97, DOI 10.1017/S0031182000085115; DUKE BOL, 1976, TROPENMED PARASITOL, V27, P297; FENWICK A, 1972, B WORLD HEALTH ORGAN, V47, P579; FENWICK A, 1970, B WORLD HEALTH ORGAN, V42, P589; FILHO PC, 1992, REV I MED TROP, V34, P543, DOI 10.1590/S0036-46651992000600008; Gurarie D, 2005, PARASITOLOGY, V130, P49, DOI 10.1017/S0031182004006341; Gurarie D, 2010, PARASITOLOGY, V137, P1951, DOI 10.1017/S0031182010000867; JORDAN P, 1980, ACTA TROP, V37, P95; King CH, 2006, TRENDS PARASITOL, V22, P575, DOI 10.1016/j.pt.2006.09.006; MACDONAL.G, 1965, T ROY SOC TROP MED H, V59, P489, DOI 10.1016/0035-9203(65)90152-5; MAY RM, 1977, MATH BIOSCI, V35, P301, DOI 10.1016/0025-5564(77)90030-X; MAY RM, 1978, J ANIM ECOL, V47, P249, DOI 10.2307/3934; MAY RM, 1993, PARASITOLOGY, V107, P287, DOI 10.1017/S0031182000079269; MORAND S, 1993, ECOLOGY, V74, P2444, DOI 10.2307/1939595; NASELL I, 1978, J MATH BIOL, V6, P21, DOI 10.1007/BF02478514; NASELL I, 1973, COMMUN PUR APPL MATH, V26, P395, DOI 10.1002/cpa.3160260402; Prichard RK, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001549; Pugliese A, 2000, THEOR POPUL BIOL, V57, P145, DOI 10.1006/tpbi.1999.1443; Ribeiro-Paes J. T., 1997, Revista do Instituto de Medicina Tropical de Sao Paulo, V39, P337, DOI 10.1590/S0036-46651997000600006; Savioli L., 2012, ACCELERATING WORK OV; Shaw DJ, 1998, PARASITOLOGY, V117, P597, DOI 10.1017/S0031182098003448; STURROCK R F, 1973, International Journal for Parasitology, V3, P175, DOI 10.1016/0020-7519(73)90023-4; Thomas J.D., 1973, Advances Parasit, V11, P307, DOI 10.1016/S0065-308X(08)60189-X; Wang XX, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001903; WARREN KS, 1974, AM J TROP MED HYG, V23, P902, DOI 10.4269/ajtmh.1974.23.902; WARREN KS, 1982, REV INFECT DIS, V4, P715; WOOLHOUSE MEJ, 1989, PARASITOLOGY, V98, P21, DOI 10.1017/S0031182000059655; Woolhouse MEJ, 1998, PARASITOLOGY, V117, P475, DOI 10.1017/S003118209800331X	41	21	21	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2014	9	12							e115875	10.1371/journal.pone.0115875	http://dx.doi.org/10.1371/journal.pone.0115875			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX6YH	25549362	gold, Green Submitted, Green Published			2022-12-27	WOS:000347063500032
J	Li, Z; Hao, YJ; Wang, LL; Xiang, H; Zhou, ZY				Li, Zhi; Hao, Youjin; Wang, Linling; Xiang, Heng; Zhou, Zeyang			Genome-Wide Identification and Comprehensive Analyses of the Kinomes in Four Pathogenic Microsporidia Species	PLOS ONE			English	Article							SPORE WALL PROTEIN; GLYCOGEN-SYNTHASE KINASE-3; SACCHAROMYCES-CEREVISIAE; CAENORHABDITIS-ELEGANS; CK2 PHOSPHORYLATION; CATALYTIC DOMAIN; DNA-REPLICATION; NOSEMA-CERANAE; POLAR TUBE; YEAST	Microsporidia have attracted considerable attention because they infect a wide range of hosts, from invertebrates to vertebrates, and cause serious human diseases and major economic losses in the livestock industry. There are no prospective drugs to counteract this pathogen. Eukaryotic protein kinases (ePKs) play a central role in regulating many essential cellular processes and are therefore potential drug targets. In this study, a comprehensive summary and comparative analysis of the protein kinases in four microsporidia-Enterocytozoon bieneusi, Encephalitozoon cuniculi, Nosema bombycis and Nosema ceranae-was performed. The results show that there are 34 ePKs and 4 atypical protein kinases (aPKs) in E. bieneusi, 29 ePKs and 6 aPKs in E. cuniculi, 41 ePKs and 5 aPKs in N. bombycis, and 27 ePKs and 4 aPKs in N. ceranae. These data support the previous conclusion that the microsporidian kinome is the smallest eukaryotic kinome. Microsporidian kinomes contain only serine-threonine kinases and do not contain receptor-like and tyrosine kinases. Many of the kinases related to nutrient and energy signaling and the stress response have been lost in microsporidian kinomes. However, cell cycle-, development-and growth-related kinases, which are important to parasites, are well conserved. This reduction of the microsporidian kinome is in good agreement with genome compaction, but kinome density is negatively correlated with proteome size. Furthermore, the protein kinases in each microsporidian genome are under strong purifying selection pressure. No remarkable differences in kinase family classification, domain features, gain and/or loss, and selective pressure were observed in these four species. Although microsporidia adapt to different host types, the coevolution of microsporidia and their hosts was not clearly reflected in the protein kinases. Overall, this study enriches and updates the microsporidian protein kinase database and may provide valuable information and candidate targets for the design of treatments for pathogenic diseases.	[Li, Zhi; Hao, Youjin; Wang, Linling; Zhou, Zeyang] Chongqing Normal Univ, Coll Life Sci, Chongqing, Peoples R China; [Zhou, Zeyang] Southwest Univ, State Key Lab Silkworm Genome Biol, Chongqing, Peoples R China; [Xiang, Heng] Southwest Univ, Coll Anim Sci & Technol, Chongqing, Peoples R China	Chongqing Normal University; Southwest University - China; Southwest University - China	Zhou, ZY (corresponding author), Chongqing Normal Univ, Coll Life Sci, Chongqing, Peoples R China.	zyzhou@swu.edu.cn			National Science and Technology Plan Subject of China (863 Program) [2012AA101301]; National Basic Research Program of China (973 Program) [2012CB114604]; Natural Science Foundation of China [31101770]; Par-Eu Scholars Program of Chongqing; Natural Science Foundation Project of Chongqing CSTC [cstc2011jjA80019]; Science and Technology Project of the Chongqing Municipal Education Commission of China [KJ100616]	National Science and Technology Plan Subject of China (863 Program)(National High Technology Research and Development Program of China); National Basic Research Program of China (973 Program)(National Basic Research Program of China); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Par-Eu Scholars Program of Chongqing; Natural Science Foundation Project of Chongqing CSTC(Natural Science Foundation of ChongqingNatural Science Foundation Project of CQ CSTC); Science and Technology Project of the Chongqing Municipal Education Commission of China	This work was supported by the National Science and Technology Plan Subject of China (863 Program, No.2012AA101301, http://www. most.gov.cn/eng/), the National Basic Research Program of China (973 Program, No. 2012CB114604, http://www.most.gov.cn/eng/), the Natural Science Foundation of China (No. 31101770, http://www.nsfc.gov.cn/Portal0/), the Par-Eu Scholars Program of Chongqing (by Bin Chen, http://www.cqjw.gov.cn/site/html/cqjwportal/ portal/index/), the Natural Science Foundation Project of Chongqing CSTC (No.cstc2011jjA80019, http://www.ctin.ac.cn/Index.aspx), and the Science and Technology Project of the Chongqing Municipal Education Commission of China (No. KJ100616, http://www.cqjw.gov.cn/site/html/ cqjwportal/portal/index/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrade LF, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-215; Angermayr M, 2002, MOL MICROBIOL, V44, P309, DOI 10.1046/j.1365-2958.2002.02881.x; Aranda S, 2011, FASEB J, V25, P449, DOI 10.1096/fj.10-165837; Bhat SA, 2009, AFR J AGR RES, V4, P1519; BIDWAI AP, 1995, J BIOL CHEM, V270, P10395, DOI 10.1074/jbc.270.18.10395; Billker O, 2009, CELL HOST MICROBE, V5, P612, DOI 10.1016/j.chom.2009.05.017; Bush EW, 2000, BIOCHEMISTRY-US, V39, P8480, DOI 10.1021/bi992142f; Capella-Gutierrez S, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-47; Carmena M, 2003, NAT REV MOL CELL BIO, V4, P842, DOI 10.1038/nrm1245; Carroll AS, 2002, TRENDS BIOCHEM SCI, V27, P87, DOI 10.1016/S0968-0004(01)02040-0; Chen Y, 2008, J INVERTEBR PATHOL, V97, P186, DOI 10.1016/j.jip.2007.07.010; Coccetti P, 2004, MOL MICROBIOL, V51, P447, DOI 10.1046/j.1365-2958.2003.03836.x; Coccetti P, 2008, CELL CYCLE, V7, P1391, DOI 10.4161/cc.7.10.5825; Coccetti P, 2006, BIOCHEM BIOPH RES CO, V346, P786, DOI 10.1016/j.bbrc.2006.05.171; Cox-Foster DL, 2007, SCIENCE, V318, P283, DOI 10.1126/science.1146498; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Dohrmann PR, 2006, GENETICS, V174, P87, DOI 10.1534/genetics.106.060236; Drewes G, 2003, FEBS LETT, V554, P45, DOI 10.1016/S0014-5793(03)01080-9; Du KY, 2005, ONCOGENE, V24, P7401, DOI 10.1038/sj.onc.1209099; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Feng Y, 2000, MOL CELL BIOL, V20, P5350, DOI 10.1128/MCB.20.14.5350-5359.2000; Finn RD, 2011, NUCLEIC ACIDS RES, V39, pW29, DOI 10.1093/nar/gkr367; Fisher RP, 2005, J CELL SCI, V118, P5171, DOI 10.1242/jcs.02718; Goldberg AV, 2008, NATURE, V452, P624, DOI 10.1038/nature06606; Hanks SK, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-5-111; HANKS SK, 1995, FASEB J, V9, P576, DOI 10.1096/fasebj.9.8.7768349; Harmon AC, 2000, TRENDS PLANT SCI, V5, P154, DOI 10.1016/S1360-1385(00)01577-6; Harper JF, 2005, NAT REV MOL CELL BIO, V6, P555, DOI 10.1038/nrm1679; Harper JW, 1998, GENE DEV, V12, P285, DOI 10.1101/gad.12.3.285; HARWOOD AJ, 1995, CELL, V80, P139, DOI 10.1016/0092-8674(95)90458-1; Hatanaka M, 2001, YEAST, V18, P207, DOI 10.1002/1097-0061(200102)18:3<207::AID-YEA661>3.0.CO;2-I; HE X, 1995, NATURE, V374, P617, DOI 10.1038/374617a0; Hergovich A, 2006, NAT REV MOL CELL BIO, V7, P253, DOI 10.1038/nrm1891; Hicke L, 1998, J CELL BIOL, V141, P349, DOI 10.1083/jcb.141.2.349; Higes M, 2008, ENVIRON MICROBIOL, V10, P2659, DOI 10.1111/j.1462-2920.2008.01687.x; Hon WC, 1997, CELL, V89, P887, DOI 10.1016/S0092-8674(00)80274-3; Idanheimo N, 2014, BIOCHEM BIOPH RES CO, V445, P457, DOI 10.1016/j.bbrc.2014.02.013; IINO Y, 1995, GENETICS, V140, P1235; INSELBURG J, 1983, J PARASITOL, V69, P592, DOI 10.2307/3281375; Jung JH, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-215; Katinka MD, 2001, NATURE, V414, P450, DOI 10.1038/35106579; Keeling PJ, 2000, MOL BIOL EVOL, V17, P23, DOI 10.1093/oxfordjournals.molbev.a026235; Ko TK, 2001, J CELL SCI, V114, P2591; Kosti I, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-133; Krylov DM, 2003, CURR BIOL, V13, P173, DOI 10.1016/S0960-9822(03)00008-3; Larochelle S, 1998, GENE DEV, V12, P370, DOI 10.1101/gad.12.3.370; Lee H, 2009, P NATL ACAD SCI USA, V106, P21359, DOI 10.1073/pnas.0906651106; Lee KS, 1997, MOL CELL BIOL, V17, P3408, DOI 10.1128/MCB.17.6.3408; Lehmler C, 1997, EMBO J, V16, P3464, DOI 10.1093/emboj/16.12.3464; Lev S, 1999, P NATL ACAD SCI USA, V96, P13542, DOI 10.1073/pnas.96.23.13542; LEVIN DE, 1990, P NATL ACAD SCI USA, V87, P8272, DOI 10.1073/pnas.87.21.8272; Li YH, 2009, INT J PARASITOL, V39, P391, DOI 10.1016/j.ijpara.2008.08.011; Li Z, 2012, EUKARYOT CELL, V11, P229, DOI 10.1128/EC.05127-11; Liao H, 1999, J MOL BIOL, V294, P1041, DOI 10.1006/jmbi.1999.3313; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lower BH, 2003, J BACTERIOL, V185, P3436, DOI 10.1128/JB.185.11.3436-3445.2003; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Manning G, 2002, TRENDS BIOCHEM SCI, V27, P514, DOI 10.1016/S0968-0004(02)02179-5; Manning Gerard, 2005, WormBook, P1; Manning G, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-7-r66; Marchal C, 2000, J BIOL CHEM, V275, P23608, DOI 10.1074/jbc.M001735200; Marchal C, 2002, J CELL SCI, V115, P217; Masek KS, 2006, J CELL SCI, V119, P4565, DOI 10.1242/jcs.03206; Mielnichuk N, 2009, J CELL SCI, V122, P4130, DOI 10.1242/jcs.052233; Miranda-Saavedra D, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-309; Miranda-Saavedra D, 2007, PROTEINS, V68, P893, DOI 10.1002/prot.21444; Morrison DK, 2000, J CELL BIOL, V150, pF57, DOI 10.1083/jcb.150.2.F57; Mylonakis E, 2004, MOL MICROBIOL, V54, P407, DOI 10.1111/j.1365-2958.2004.04310.x; Noselli S, 1998, TRENDS GENET, V14, P33, DOI 10.1016/S0168-9525(97)01320-6; Ohtoshi A, 1997, MOL GEN GENET, V254, P562, DOI 10.1007/s004380050452; Pan GQ, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-186; Panigada D, 2013, DEV CELL, V26, P483, DOI 10.1016/j.devcel.2013.07.013; Parsons M, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-127; PERRIMON N, 1989, DEV BIOL, V135, P287, DOI 10.1016/0012-1606(89)90180-2; Pike BL, 2003, J BIOL CHEM, V278, P30421, DOI 10.1074/jbc.C300227200; PINES J, 1995, BIOCHEM J, V308, P697, DOI 10.1042/bj3080697; Plowman GD, 1999, P NATL ACAD SCI USA, V96, P13603, DOI 10.1073/pnas.96.24.13603; Qi MS, 2005, J CELL SCI, V118, P3569, DOI 10.1242/jcs.02470; Rangarajan R, 2005, EMBO REP, V6, P464, DOI 10.1038/sj.embor.7400404; RIEDEL H, 1993, J BIOL CHEM, V268, P3456; Robert-Gangneux F., 2001, Annales Pharmaceutiques Francaises, V59, P297; RUSSELL P, 1987, CELL, V49, P559, DOI 10.1016/0092-8674(87)90458-2; Scheeff ED, 2010, PROTEINS, V78, P1470, DOI 10.1002/prot.22663; Schultz J, 2000, NUCLEIC ACIDS RES, V28, P231, DOI 10.1093/nar/28.1.231; Schwartz MF, 2003, CELL CYCLE, V2, P384, DOI 10.4161/cc.2.4.457; Shiu SH, 2003, PLANT PHYSIOL, V132, P530, DOI 10.1104/pp.103.021964; SIMPSON P, 1988, DEVELOPMENT, V103, P391; Sonnhammer ELL, 1998, NUCLEIC ACIDS RES, V26, P320, DOI 10.1093/nar/26.1.320; Southern TR, 2007, EUKARYOT CELL, V6, P1354, DOI 10.1128/EC.00113-07; St-Denis A, 1999, J IMMUNOL, V163, P5505; Steinberg G, 1998, J CELL SCI, V111, P2235; Stronach B, 2002, GENE DEV, V16, P377, DOI 10.1101/gad.953002; Swofford D, 2002, PAUP PHYLOGENETIC AN, DOI 10.1111/J.0014-3820.2002.TB00191.X; Takada R, 2005, GENES CELLS, V10, P919, DOI 10.1111/j.1365-2443.2005.00889.x; TODA T, 1987, CELL, V50, P277, DOI 10.1016/0092-8674(87)90223-6; Vanrobays E, 2001, EMBO J, V20, P4204, DOI 10.1093/emboj/20.15.4204; Verissimo F, 2001, ONCOGENE, V20, P5562, DOI 10.1038/sj.onc.1204726; Vinals F, 1999, J BIOL CHEM, V274, P26776, DOI 10.1074/jbc.274.38.26776; Ward P, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-79; Williams BAP, 2002, NATURE, V418, P865, DOI 10.1038/nature00949; WILLIAMS JG, 1993, PHILOS T ROY SOC B, V340, P305, DOI 10.1098/rstb.1993.0072; Wittner M., 1999, MICROSPORIDIA MICROS; Xu YJ, 2005, INT J PARASITOL, V35, P941, DOI 10.1016/j.ijpara.2005.04.003; Xu YJ, 2006, INFECT IMMUN, V74, P239, DOI 10.1128/IAI.74.1.239-247.2006; Yang DL, 2014, J INVERTEBR PATHOL, V115, P1, DOI 10.1016/j.jip.2013.10.004; YOON HJ, 1993, MOL BIOL CELL, V4, P195, DOI 10.1091/mbc.4.2.195; Yost C, 1996, GENE DEV, V10, P1443, DOI 10.1101/gad.10.12.1443; Zhang W, 2002, CELL RES, V12, P9, DOI 10.1038/sj.cr.7290105	108	4	5	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2014	9	12							e115890	10.1371/journal.pone.0115890	http://dx.doi.org/10.1371/journal.pone.0115890			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX6YH	25549259	Green Published, Green Submitted, gold			2022-12-27	WOS:000347063500035
J	Pan, X; Hou, L; Stephen, M; Yang, HJ; Zhu, CP				Pan, Xue; Hou, Lei; Stephen, Mutua; Yang, Huijie; Zhu, Chenping			Evaluation of Scaling Invariance Embedded in Short Time Series	PLOS ONE			English	Article							DIFFUSION ENTROPY ANALYSIS; MOVING AVERAGE; SIGNALS; FLUCTUATION; COMPLEXITY; SEQUENCES; NETWORKS; MEMORY; FLOW	Scaling invariance of time series has been making great contributions in diverse research fields. But how to evaluate scaling exponent from a real-world series is still an open problem. Finite length of time series may induce unacceptable fluctuation and bias to statistical quantities and consequent invalidation of currently used standard methods. In this paper a new concept called correlation-dependent balanced estimation of diffusion entropy is developed to evaluate scale-invariance in very short time series with length similar to 10(2). Calculations with specified Hurst exponent values of 0.2,0.3, ... ,0.9 show that by using the standard central moving average de-trending procedure this method can evaluate the scaling exponents for short time series with ignorable bias (<= 0.03) and sharp confidential interval (standard deviation <= 0.05). Considering the stride series from ten volunteers along an approximate oval path of a specified length, we observe that though the averages and deviations of scaling exponents are close, their evolutionary behaviors display rich patterns. It has potential use in analyzing physiological signals, detecting early warning signals, and so on. As an emphasis, the our core contribution is that by means of the proposed method one can estimate precisely shannon entropy from limited records.	[Pan, Xue; Hou, Lei; Stephen, Mutua; Yang, Huijie] Univ Shanghai Sci & Technol, Sch Business, Shanghai, Peoples R China; [Yang, Huijie] Masinde Muliro Univ Sci & Technol, Dept Comp Sci, Kakamega, Kenya; [Zhu, Chenping] Nanjing Univ Aeronaut & Astronaut, Coll Sci, Nanjing, Jiangsu, Peoples R China	University of Shanghai for Science & Technology; Nanjing University of Aeronautics & Astronautics	Yang, HJ (corresponding author), Univ Shanghai Sci & Technol, Sch Business, Shanghai, Peoples R China.	hjyang@ustc.edu.cn	HOU, Lei/B-2899-2015; Zhu, Chen/A-5356-2010	HOU, Lei/0000-0002-8022-0729; Zhu, Chen/0000-0001-5374-6787	National Science Foundation of China [10975099]; Program for Professor of Special Appointment (Eastern Scholar) at Shanghai Institutions of Higher Learning; Innovation Program of Shanghai Municipal Education Commission [13YZ072]; Shanghai leading discipline project [XTKX2012]; Innovation Fund Project For Graduate Students Of Shanghai [JWCXSL1302]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for Professor of Special Appointment (Eastern Scholar) at Shanghai Institutions of Higher Learning; Innovation Program of Shanghai Municipal Education Commission(Innovation Program of Shanghai Municipal Education Commission); Shanghai leading discipline project(Shanghai Leading Academic Discipline Project); Innovation Fund Project For Graduate Students Of Shanghai	The work is supported by the National Science Foundation of China under Grant No. 10975099, the Program for Professor of Special Appointment (Eastern Scholar) at Shanghai Institutions of Higher Learning, the Innovation Program of Shanghai Municipal Education Commission under Grant No. 13YZ072, and the Shanghai leading discipline project under Grant No. XTKX2012. One of the authors (X. Pan) acknowledges the support from the Innovation Fund Project For Graduate Students Of Shanghai under Grant No. JWCXSL1302. The authors thank the reviewers for their stimulating and constructive comments and suggestions. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abry P, 1996, APPL COMPUT HARMON A, V3, P377, DOI 10.1006/acha.1996.0030; Acquisti C, 2004, CHAOS SOLITON FRACT, V20, P127, DOI 10.1016/S0960-0779(03)00435-1; Albrecht-Buehler G, 2012, GENE, V498, P20, DOI 10.1016/j.gene.2012.01.090; Alessio E, 2002, EUR PHYS J B, V27, P197, DOI 10.1140/epjb/e20020150; Bardet JM, 2003, THEORY AND APPLICATIONS OF LONG-RANGE DEPENDENCE, P579; Barnum H, 2010, NEW J PHYS, V12, DOI 10.1088/1367-2630/12/3/033024; Bashan A, 2008, PHYSICA A, V387, P5080, DOI 10.1016/j.physa.2008.04.023; Bonachela JA, 2008, J PHYS A-MATH THEOR, V41, DOI 10.1088/1751-8113/41/20/202001; Cai SM, 2007, PHYSICA A, V375, P687, DOI 10.1016/j.physa.2006.10.027; Cai SM, 2006, PHYSICA A, V367, P337, DOI 10.1016/j.physa.2005.12.004; Carbone A, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.026105; Delignieres D, 2006, J MATH PSYCHOL, V50, P525, DOI 10.1016/j.jmp.2006.07.004; Donner RV, 2010, NEW J PHYS, V12, DOI 10.1088/1367-2630/12/3/033025; Donner RV, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.015101; Eke A, 2000, PFLUG ARCH EUR J PHY, V439, P403, DOI 10.1007/s004249900135; Eke A, 2002, PHYSIOL MEAS, V23, pR1, DOI 10.1088/0967-3334/23/1/201; Gao ZK, 2013, EPL-EUROPHYS LETT, V103, DOI 10.1209/0295-5075/103/50004; Gao ZK, 2013, PHYS REV E, V88, DOI 10.1103/PhysRevE.88.032910; Gao ZK, 2012, NONLINEAR ANAL-REAL, V13, P947, DOI 10.1016/j.nonrwa.2011.08.029; Gao ZK, 2011, CHEM ENG SCI, V66, P2660, DOI 10.1016/j.ces.2011.03.008; Gao ZK, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.066303; Goldberger AL, 2002, P NATL ACAD SCI USA, V99, P2466, DOI 10.1073/pnas.012579499; Goldenfeld N, 1985, LECT PHASE TRANSITIO; Grech D, 2005, ACTA PHYS POL B, V36, P2403; Grigolini P, 2001, FRACTALS, V9, P439, DOI 10.1142/S0218348X01000865; Grigolini P, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.046203; Hao BL, 2000, CHAOS SOLITON FRACT, V11, P825, DOI 10.1016/S0960-0779(98)00182-9; Hu K, 2001, PHYS REV E, V64, DOI 10.1103/PhysRevE.64.011114; Ivanov PC, 1999, NATURE, V399, P461, DOI 10.1038/20924; Jiang ZQ, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.016106; Kantelhardt JW, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2005JD005881; Kantelhardt JW, 2002, PHYSICA A, V316, P87, DOI 10.1016/S0378-4371(02)01383-3; Katsev S, 2003, COMPUT GEOSCI-UK, V29, P1085, DOI 10.1016/S0098-3004(03)00105-5; Khinchin A.Y., 1949, MATH FDN STAT MECH; Kirchner M, 2012, PHYSICA A, V391, P4692, DOI 10.1016/j.physa.2012.05.034; Marwan N, 2009, PHYS LETT A, V373, P4246, DOI 10.1016/j.physleta.2009.09.042; Munnix MC, 2012, SCI REP-UK, V2, DOI 10.1038/srep00644; Oliver R, 1998, PHYS REV E, V58, P5650, DOI 10.1103/PhysRevE.58.5650; Pacheco JCR, 2009, RES COMPUTING SCI, V42, P297; Pan X, 2014, PHYS LETT A, V378, P2591, DOI 10.1016/j.physleta.2014.07.012; PENG CK, 1994, PHYS REV E, V49, P1685, DOI 10.1103/PhysRevE.49.1685; PENG CK, 1992, NATURE, V356, P168, DOI 10.1038/356168a0; Perello J, 2006, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2006/11/P11011; Peters E.E., 1994, FRACTAL MARKET ANAL; Podobnik B, 2009, P NATL ACAD SCI USA, V106, P22079, DOI 10.1073/pnas.0911983106; Podobnik B, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.084102; Qi JC, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.066114; Roulston MS, 1999, PHYSICA D, V125, P285, DOI 10.1016/S0167-2789(98)00269-3; Roy S, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-S7-S10; Scafetta N, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.026303; Scafetta N, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.138501; Scafetta N, 2005, COMPLEXITY, V10, P51, DOI 10.1002/cplx.20076; Scafetta N, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.248701; Scafetta N, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.036130; Scafetta N, 2001, FRACTALS, V9, P193, DOI 10.1142/S0218348X0100052X; Scafetta N, 2010, DIFFUSION ENTROPY AN; Scafetta N., 2010, FRACTAL DIFFUSION EN; Scafetta N, 2008, PHYS TODAY, V61, P50, DOI 10.1063/1.2897951; Scafetta N, 2007, COMPLEXITY, V12, P12, DOI 10.1002/cplx.20183; Scafetta N, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.219801; Scafetta N, 2009, CHAOS, V19, DOI 10.1063/1.3143035; Scheffer M, 2009, NATURE, V461, P53, DOI 10.1038/nature08227; Stanley HE, 2000, PHYSICA A, V281, P60, DOI 10.1016/S0378-4371(00)00195-3; Tan CS, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/213656; Thamrin C, 2010, PAEDIATR RESPIR REV, V11, P123, DOI 10.1016/j.prrv.2010.02.001; Tsai CY, 2008, PHYSICA A, V387, P5561, DOI 10.1016/j.physa.2008.05.023; Xu LM, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.051101; Xu XK, 2008, P NATL ACAD SCI USA, V105, P19601, DOI 10.1073/pnas.0806082105; Yang HJ, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.066104; Yang HJ, 2005, PHYSICA A, V347, P704, DOI 10.1016/j.physa.2004.08.017; Yang HJ, 2002, PHYS LETT A, V292, P349, DOI 10.1016/S0375-9601(01)00819-2; Yang Y, 2008, PHYSICA A, V387, P1381, DOI 10.1016/j.physa.2007.10.055; Zhang J, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.238701; Zhang WQ, 2012, PHYS REV E, V86, DOI 10.1103/PhysRevE.86.056107; Zhao FC, 2007, J THEOR BIOL, V247, P645, DOI 10.1016/j.jtbi.2007.03.035; Zhu L, 2011, CHEM ENG SCI, V66, P6099, DOI 10.1016/j.ces.2011.08.034; Zou Y, 2010, CHAOS, V20, DOI 10.1063/1.3523304	77	20	21	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2014	9	12							e116128	10.1371/journal.pone.0116128	http://dx.doi.org/10.1371/journal.pone.0116128			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX6YH	25549356	Green Published, gold, Green Submitted			2022-12-27	WOS:000347063500052
J	Nino, G; Huseni, S; Perez, GF; Pancham, K; Mubeen, H; Abbasi, A; Wang, J; Eng, S; Colberg-Poley, AM; Pillai, DK; Rose, MC				Nino, Gustavo; Huseni, Shehlanoor; Perez, Geovanny F.; Pancham, Krishna; Mubeen, Humaira; Abbasi, Aleeza; Wang, Justin; Eng, Stephen; Colberg-Poley, Anamaris M.; Pillai, Dinesh K.; Rose, Mary C.			Directional Secretory Response of Double Stranded RNA-Induced Thymic Stromal Lymphopoetin (TSLP) and CCL11/Eotaxin-1 in Human Asthmatic Airways	PLOS ONE			English	Article							HUMAN EPITHELIAL-CELLS; LYMPHOPOIETIN EXPRESSION; ALLERGIC INFLAMMATION; TNF-ALPHA; MODEL; HYPERRESPONSIVENESS; MICROBES; CHILDREN; CCR3	Background: Thymic stromal lymphoproetin (TSLP) is a cytokine secreted by the airway epithelium in response to respiratory viruses and it is known to promote allergic Th2 responses in asthma. This study investigated whether virally-induced secretion of TSLP is directional in nature (apical vs. basolateral) and/or if there are TSLP-mediated effects occurring at both sides of the bronchial epithelial barrier in the asthmatic state. Methods: Primary human bronchial epithelial cells (HBEC) from control (n=3) and asthmatic (n=3) donors were differentiated into polarized respiratory tract epithelium under air-liquid interface (ALI) conditions and treated apically with dsRNA (viral surrogate) or TSLP. Sub-epithelial effects of TSLP were examined in human airway smooth muscle cells (HASMC) from normal (n=3) and asthmatic (n=3) donors. Clinical experiments examined nasal airway secretions obtained from asthmatic children during naturally occurring rhinovirus-induced exacerbations (n=20) vs. non-asthmatic uninfected controls (n=20). Protein levels of TSLP, CCL11/eotaxin-1, CCL17/TARC, CCL22/MDC, TNF-alpha and CXCL8 were determined with a multiplex magnetic bead assay. Results: Our data demonstrate that: 1) Asthmatic HBEC exhibit an exaggerated apical, but not basal, secretion of TSLP after dsRNA exposure; 2) TSLP exposure induces unidirectional (apical) secretion of CCL11/eotaxin-1 in asthmatic HBEC and enhanced CCL11/eotaxin-1 secretion in asthmatic HASMC; 3) Rhinovirus-induced asthma exacerbations in children are associated with in vivo airway secretion of TSLP and CCL11/eotaxin-1. Conclusions: There are virally-induced TSLP-driven secretory immune responses at both sides of the bronchial epithelial barrier characterized by enhanced CCL11/eotaxin-1 secretion in asthmatic airways. These results suggest a new model of TSLP-mediated eosinophilic responses in the asthmatic airway during viral-induced exacerbations.	[Nino, Gustavo; Huseni, Shehlanoor; Perez, Geovanny F.; Pancham, Krishna; Wang, Justin; Eng, Stephen; Rose, Mary C.] Childrens Natl Med Ctr, Div Pulm & Sleep Med, Washington, DC 20010 USA; [Nino, Gustavo; Abbasi, Aleeza; Colberg-Poley, Anamaris M.; Pillai, Dinesh K.; Rose, Mary C.] George Washington Univ, Sch Med & Hlth Sci, Dept Pediat, Washington, DC 20052 USA; [Nino, Gustavo; Colberg-Poley, Anamaris M.; Pillai, Dinesh K.; Rose, Mary C.] George Washington Univ, Dept Integrat Syst Biol, Washington, DC USA; [Nino, Gustavo; Mubeen, Humaira; Colberg-Poley, Anamaris M.; Pillai, Dinesh K.; Rose, Mary C.] Childrens Natl Med Ctr, Med Genet Res Ctr, Washington, DC 20010 USA; [Colberg-Poley, Anamaris M.; Rose, Mary C.] George Washington Univ, Dept Biochem & Mol Med, Washington, DC USA	Children's National Health System; George Washington University; George Washington University; Children's National Health System; George Washington University	Nino, G (corresponding author), Childrens Natl Med Ctr, Div Pulm & Sleep Med, Washington, DC 20010 USA.	gnino@childrensnational.org		Perez, Geovanny/0000-0003-2843-6837	NIH National Center for Advancing Translational Sciences [NHLBI/HL090020, NICHC/HD001399, UL1TR000075 KL2TR000076]; Board of Visitors (BOV) Grant of Children's National Medical Center; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD001399] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [KL2TR000076, UL1TR000075] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K12HL090020] Funding Source: NIH RePORTER	NIH National Center for Advancing Translational Sciences; Board of Visitors (BOV) Grant of Children's National Medical Center; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by Grants NHLBI/HL090020 (K12 Genomics of Lung), NICHC/HD001399 (K12 Child Health Research Career Development Award), UL1TR000075 KL2TR000076 Awards from the NIH National Center for Advancing Translational Sciences and a Board of Visitors (BOV) Grant of Children's National Medical Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allakhverdi Z, 2007, J EXP MED, V204, P253, DOI 10.1084/jem.20062211; Bochkov YA, 2010, MUCOSAL IMMUNOL, V3, P69, DOI 10.1038/mi.2009.109; Bogiatzi SI, 2007, J IMMUNOL, V178, P3373, DOI 10.4049/jimmunol.178.6.3373; Briot A, 2009, J EXP MED, V206, P1135, DOI 10.1084/jem.20082242; Cheng DT, 2013, J ALLERGY CLIN IMMUN, V132, P455, DOI 10.1016/j.jaci.2013.05.011; Choi JP, 2012, ALLERGY, V67, P1138, DOI 10.1111/j.1398-9995.2012.02871.x; Dvorak A, 2011, AM J RESP CELL MOL, V44, P465, DOI 10.1165/rcmb.2009-0453OC; Freishtat RJ, 2011, AM J RESP CELL MOL, V44, P863, DOI 10.1165/rcmb.2010-0029OC; Gauvreau GM, 2014, NEW ENGL J MED, V370, P2102, DOI 10.1056/NEJMoa1402895; Hackett NR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018378; Hansel TT, 2013, LANCET, V381, P861, DOI 10.1016/S0140-6736(12)62202-8; Hardyman MA, 2013, J ALLERGY CLIN IMMUN, V132, P665, DOI 10.1016/j.jaci.2013.03.005; Hershenson MB, 2013, SCIENTIFICA, V2013, DOI 10.1155/2013/405876; Hirota JA, 2012, CURR OPIN IMMUNOL, V24, P740, DOI 10.1016/j.coi.2012.08.012; Hui CCK, 2014, CLIN EXP ALLERGY, V44, P953, DOI 10.1111/cea.12330; Kato A, 2007, J IMMUNOL, V179, P1080, DOI 10.4049/jimmunol.179.2.1080; Kaur D, 2012, CHEST, V142, P76, DOI 10.1378/chest.11-1782; Khetsuriani N, 2007, J ALLERGY CLIN IMMUN, V119, P314, DOI 10.1016/j.jaci.2006.08.041; Lee HC, 2012, J ALLERGY CLIN IMMUN, V130, P1187, DOI 10.1016/j.jaci.2012.07.031; Ma W, 2002, J CLIN INVEST, V109, P621, DOI 10.1172/JCI200214097; Mahmutovic-Persson I, 2014, ALLERGY, V69, P348, DOI 10.1111/all.12329; Malavia NK, 2009, AM J RESP CELL MOL, V41, P297, DOI 10.1165/rcmb.2008-0358OC; Nagarkar DR, 2013, J ALLERGY CLIN IMMUN, V132, P593, DOI 10.1016/j.jaci.2013.04.005; Nagarkar DR, 2012, J ALLERGY CLIN IMMUN, V130, P225, DOI 10.1016/j.jaci.2012.04.019; NICHOLSON KG, 1993, BRIT MED J, V307, P982, DOI 10.1136/bmj.307.6910.982; Nino G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032078; Nino G, 2010, J ALLERGY CLIN IMMUN, V125, P1020, DOI 10.1016/j.jaci.2010.02.007; Panina-Bordignon P, 2001, J CLIN INVEST, V107, P1357, DOI 10.1172/JCI12655; Perez GF, 2014, EUR RESPIR J, V44, P1075, DOI 10.1183/09031936.00049214; Pillai DK, 2014, AM J RESP CELL MOL, V50, P292, DOI 10.1165/rcmb.2013-0188OC; Redhu NS, 2013, SCI REP-UK, V3, DOI 10.1038/srep02301; Saetta M, 2001, EUR RESPIR J, V18, p18S, DOI 10.1183/09031936.01.00229501; Saglani S, 2014, CURR OPIN ALLERGY CL, V14, P143, DOI 10.1097/ACI.0000000000000045; Soumelis V, 2002, NAT IMMUNOL, V3, P673, DOI 10.1038/ni805; Torres D, 2010, J IMMUNOL, V185, P451, DOI 10.4049/jimmunol.0902833; Uller L, 2010, THORAX, V65, P626, DOI 10.1136/thx.2009.125930; Wang Q, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002070; Wang Q, 2009, J IMMUNOL, V183, P6989, DOI 10.4049/jimmunol.0901386; Wu D, 2014, J ASTHMA, V13, P1; Xu G, 2010, ALLERGY, V65, P581, DOI 10.1111/j.1398-9995.2009.02252.x; Ying S, 2005, J IMMUNOL, V174, P8183, DOI 10.4049/jimmunol.174.12.8183; Ying S, 1997, EUR J IMMUNOL, V27, P3507, DOI 10.1002/eji.1830271252; Zhang KQ, 2007, AM J PHYSIOL-LUNG C, V293, pL375, DOI 10.1152/ajplung.00045.2007; Ziegler SF, 2012, J ALLERGY CLIN IMMUN, V130, P845, DOI 10.1016/j.jaci.2012.07.010; Ziegler SF, 2010, NAT IMMUNOL, V11, P289, DOI 10.1038/ni.1852	45	30	31	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2014	9	12							e115398	10.1371/journal.pone.0115398	http://dx.doi.org/10.1371/journal.pone.0115398			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UN	25546419	Green Submitted, Green Published, gold			2022-12-27	WOS:000347120200040
J	Wang, LY; Lee, WC				Wang, Ling-Yi; Lee, Wen-Chung			A Permutation Method to Assess Heterogeneity in External Validation for Risk Prediction Models	PLOS ONE			English	Article							BREAST-CANCER; IMPACT	The value of a developed prediction model depends on its performance outside the development sample. The key is therefore to externally validate the model on a different but related independent data. In this study, we propose a permutation method to assess heterogeneity in external validation for risk prediction models. The permutation p value measures the extent of homology between development and validation datasets. If p < 0.05, the model may not be directly transported to the external validation population without further revision or updating. Monte-Carlo simulations are conducted to evaluate the statistical properties of the proposed method, and two microarray breast cancer datasets are analyzed for demonstration. The permutation method is easy to implement and is recommended for routine use in external validation for risk prediction models.	[Lee, Wen-Chung] Natl Taiwan Univ, Coll Publ Hlth, Res Ctr Genes Environm & Human Hlth, Taipei 10764, Taiwan; [Lee, Wen-Chung] Natl Taiwan Univ, Coll Publ Hlth, Inst Epidemiol & Prevent Med, Taipei 10764, Taiwan; [Wang, Ling-Yi] Tzu Chi Gen Hosp, Dept Med Res, Hualien, Taiwan	National Taiwan University; National Taiwan University; Buddhist Tzu Chi General Hospital; Hualien Tzu Chi Hospital	Lee, WC (corresponding author), Natl Taiwan Univ, Coll Publ Hlth, Res Ctr Genes Environm & Human Hlth, Taipei 10764, Taiwan.	wenchung@ntu.edu.tw		Lee, Wen-Chung/0000-0003-3171-7672	Ministry of Science and Technology, Taiwan [NSC 102-2628-B-002-036-MY3]; National Taiwan University, Taiwan [NTU-CESRP-102R7622-8]	Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan); National Taiwan University, Taiwan(National Taiwan University)	This paper is partly supported by grants from Ministry of Science and Technology, Taiwan (NSC 102-2628-B-002-036-MY3) and National Taiwan University, Taiwan (NTU-CESRP-102R7622-8). No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barlow WE, 2006, JNCI-J NATL CANCER I, V98, P1204, DOI 10.1093/jnci/djj331; DEBRAY TP, 2014, J CLIN EPID IN PRESS, P89023; Eagle KA, 2004, JAMA-J AM MED ASSOC, V291, P2727, DOI 10.1001/jama.291.22.2727; Efron B., 1994, INTRO BOOTSTRAP; Karatzoglou A., 2005, SUPPORT VECTOR MACHI; Moons KGM, 2012, HEART, V98, P691, DOI 10.1136/heartjnl-2011-301247; Moons KGM, 2012, HEART, V98, P683, DOI 10.1136/heartjnl-2011-301246; Refaeilzadeh Payam, 2009, ENCY DATABASE SYSTEM, P532, DOI DOI 10.1007/978-0-387-39940-9_565; Sotiriou C, 2006, JNCI-J NATL CANCER I, V98, P262, DOI 10.1093/jnci/djj052; Toll DB, 2008, J CLIN EPIDEMIOL, V61, P1085, DOI 10.1016/j.jclinepi.2008.04.008; Vapnik VN, 1999, IEEE T NEURAL NETWOR, V10, P988, DOI 10.1109/72.788640; Vergouwe Y, 2010, AM J EPIDEMIOL, V172, P971, DOI 10.1093/aje/kwq223; Wang YX, 2005, LANCET, V365, P671, DOI 10.1016/S0140-6736(05)17947-1	13	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2015	10	1							e0116957	10.1371/journal.pone.0116957	http://dx.doi.org/10.1371/journal.pone.0116957			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ4PR	25606854	Green Published, Green Submitted, gold			2022-12-27	WOS:000348205300045
J	Vieira, EP; Barbosa, MS; Quintao, CCA; Normando, D				Vieira, Elma Pinto; Barbosa, Mayara Silva; Abdo Quintao, Catia Cardoso; Normando, David			Relationship of Tooth Wear to Chronological Age among Indigenous Amazon Populations	PLOS ONE			English	Article							SKELETAL AGE; ADOLESCENTS; PREVALENCE; ADULTS; TEETH; ATTRITION; ACCURACY	In indigenous populations, age can be estimated based on family structure and physical examination. However, the accuracy of such methods is questionable. The aim of this cross-sectional study was to evaluate occlusal tooth wear related to estimated age in the remote indigenous populations of the Xingu River, Amazon. Two hundred and twenty three semiisolated indigenous subjects with permanent dentition from the Arara (n = 117), Xicrin- Kayapo (n = 60) and Assurini (n = 46) villages were examined. The control group consisted of 40 non-indigenous individuals living in an urban area in the Amazon basin (Belem). A modified tooth wear index was applied and then associated with chronological age by linear regression analysis. A strong association was found between tooth wear and chronological age in the indigenous populations (p < 0.001). Tooth wear measurements were able to explain 86% of the variation in the ages of the Arara sample, 70% of the Xicrin- Kaiapo sample and 65% of the Assurini sample. In the urban control sample, only 12% of ages could be determined by tooth wear. These findings suggest that tooth wear is a poor estimator of chronological age in the urban population; however, it has a strong association with age for the more remote indigenous populations. Consequently, these findings suggest that a simple tooth wear evaluation method, as described and applied in this study, can be used to provide a straightforward and efficient means to assist in age determination of newly contacted indigenous groups.	[Vieira, Elma Pinto] UFPA, Fac Dent, Sch Dent, Dept Orthodont, Belem, Para, Brazil; [Barbosa, Mayara Silva] State Univ Rio de Janeiro UERJ, Sch Dent, Dept Orthodont, Rio De Janeiro, Brazil; [Abdo Quintao, Catia Cardoso] State Univ Rio de Janeiro UERJ, Dept Orthodont, Rio De Janeiro, Brazil; [Normando, David] UFPA, Fac Dent, Dept Orthodont, Belem, Para, Brazil	Universidade Federal do Para; Universidade do Estado do Rio de Janeiro; Universidade do Estado do Rio de Janeiro; Universidade Federal do Para	Normando, D (corresponding author), UFPA, Fac Dent, Dept Orthodont, Belem, Para, Brazil.	davidnormando@hotmail.com	Quintão, Cátia/ABB-3221-2020; Normando, David/C-5324-2018; Normando, David/AAG-7443-2020; Quintão, Cátia/AAY-8872-2020	Quintão, Cátia/0000-0003-4627-8190; Normando, David/0000-0002-1335-1040; Normando, David/0000-0002-1335-1040; Quintão, Cátia/0000-0003-4627-8190				Bartlett DW, 2011, J DENT, V39, P811, DOI 10.1016/j.jdent.2011.08.014; Bassed RB, 2012, FORENSIC SCI MED PAT, V8, P194, DOI 10.1007/s12024-011-9280-3; Bernhardt O, 2004, INT J PROSTHODONT, V17, P333; Bhat VJ, 2007, AM J FOREN MED PATH, V28, P238, DOI 10.1097/PAF.0b013e31805f67c0; Boldsen JL, 2005, AM J PHYS ANTHROPOL, V126, P169, DOI 10.1002/ajpa.20057; Brkic H, 2006, FORENSIC SCI INT, V162, P13, DOI 10.1016/j.forsciint.2006.06.022; Clement AF, 2012, J HUM EVOL, V62, P367, DOI 10.1016/j.jhevol.2011.11.014; d'Incau E, 2012, ARCH ORAL BIOL, V57, P214, DOI 10.1016/j.archoralbio.2011.08.021; DONACHIE MA, 1995, J DENT, V23, P157, DOI 10.1016/0300-5712(95)93573-K; El Aidi H, 2008, J DENT RES, V87, P731, DOI 10.1177/154405910808700813; Esclassan R, 2009, ARCH ORAL BIOL, V54, P287, DOI 10.1016/j.archoralbio.2008.11.004; Grimoud AM, 2012, ARCH ORAL BIOL, V57, P841, DOI 10.1016/j.archoralbio.2011.11.006; Regalo SCH, 2008, ARCH ORAL BIOL, V53, P282, DOI 10.1016/j.archoralbio.2007.10.003; Kim YK, 2000, J FORENSIC SCI, V45, P303; Kreulen CM, 2010, CARIES RES, V44, P151, DOI 10.1159/000308567; Kullman L, 1995, FORENSIC SCI INT, V75, P225, DOI 10.1016/0379-0738(95)01792-5; LOPEZNICOLAS M, 1990, FORENSIC SCI INT, V45, P143, DOI 10.1016/0379-0738(90)90231-M; Meng Y, 2011, ARCH ORAL BIOL, V56, P1424, DOI 10.1016/j.archoralbio.2011.04.003; Mockers O, 2004, EUR J ORTHODONT, V26, P151, DOI 10.1093/ejo/26.2.151; Normando D, 2013, ANGLE ORTHOD, V83, P10, DOI 10.2319/020112-91.1; Normando D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028387; PILLAI PS, 1974, FORENSIC SCI, V3, P135, DOI 10.1016/0300-9432(74)90022-3; SANTINI A, 1990, FORENSIC SCI INT, V48, P175, DOI 10.1016/0379-0738(90)90110-K; Smith BGN, 1997, J PROSTHET DENT, V78, P367, DOI 10.1016/S0022-3913(97)70043-X; SOLHEIM T, 1993, FORENSIC SCI INT, V59, P137, DOI 10.1016/0379-0738(93)90152-Z; XU XH, 1992, FORENSIC SCI INT, V54, P23; Yun JI, 2007, J FORENSIC SCI, V52, P678, DOI 10.1111/j.1556-4029.2007.00414.x	27	18	18	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2015	10	1							0116138	10.1371/journal.pone.0116138	http://dx.doi.org/10.1371/journal.pone.0116138			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ4OZ	25602501	gold, Green Submitted, Green Published			2022-12-27	WOS:000348203500020
J	Yang, S; Jin, T; Su, HX; Zhu, JH; Wang, DW; Zhu, SJ; Li, S; He, J; Chen, YH				Yang, Sen; Jin, Tao; Su, Hong-Xia; Zhu, Jin-Hong; Wang, Da-Wen; Zhu, Shi-Jian; Li, Sheng; He, Jing; Chen, Ying-He			The Association between NQO1 Pro187Ser Polymorphism and Bladder Cancer Susceptibility: A Meta-Analysis of 15 Studies	PLOS ONE			English	Article							NAD(P)H-QUINONE-OXIDOREDUCTASE-1 NQO1; NAD(P)H-QUINONE OXIDOREDUCTASE-1; RS1800566 POLYMORPHISM; QUINONE OXIDOREDUCTASE; GENETIC POLYMORPHISMS; C609T POLYMORPHISM; DNA-REPAIR; RISK; GENOTYPES; SMOKING	Background NAD(P)H:quinone oxidoreductase 1 (NQO1), an obligate two-electron reductase, plays an important role in reducing reactive quinones to less reactive and less toxic hydroquinones. Genetic variations in NQO1 gene that impede its enzyme function may be considered as putative risk factor for cancer. Numerous studies have been performed to investigate the association between NQO1 Pro187Ser polymorphism and bladder cancer risk; nevertheless, the results remain controversial. Methods We indentified eligible publications from PubMed, Embase and CBM databases. Pooled odds ratios (ORs) and 95% confidence intervals (CIs) were used to access the strength of the associations. False-positive report probability (FPRP) analysis was also performed for all statistically significant findings. Results We collected a total of 15 studies including 4298 cases and 4275 controls in the final meta-analysis. Overall, the NQO1 187Ser carriers were associated with an increased bladder cancer risk (homozygous: OR=1.43, 95% CI=1.08-1.90; recessive: OR=1.33, 95% CI=1.03-1.72; dominant: OR=1.19, 95% CI=1.04-1.37, and allele comparing: OR=1.18, 95% CI=1.06-1.33). Stratification analyses showed a statistically significant association among Asians (homozygous: OR=1.82, 95% CI=1.39-2.38; recessive: OR=1.52, 95% CI=1.20-1.93, dominant: OR=1.40, 95% CI=1.05-1.88, and allele comparing: OR=1.35, 95% CI=1.15-1.58), never smokers (homozygous: OR=2.30, 95% CI=1.14-4.65; heterozygous: OR=2.26, 95% CI=1.43-3.56; dominant model: OR=1.59, 95% CI=1.14-2.21, and allele comparing: OR=1.72, 95% CI=1.27-2.33), hospital-based studies (homozygous: OR=1.46, 95% CI=1.09-1.94; recessive: OR=1.32, 95% CI=1.02-1.69; dominant: OR=1.28, 95% CI=1.05-1.56, and allele comparing: OR=1.24, 95% CI=1.07-1.43), studies with genotyping performed by PCR-RFLP under all genetic models, and studies with minor allele frequency > 0.30 (homozygous: OR=1.69, 95% CI=1.25-2.27; recessive: OR=1.46, 95% CI=1.10-1.95, and allele comparing: OR=1.25, 95% CI=1.04-1.51), respectively. Conclusions Despite some limitations, our meta-analysis provides sufficient evidence that NQO1 Pro187Ser polymorphism may contribute to bladder cancer risk. These findings need further validation in well-designed prospective studies with larger sample size and different ethnicities, especially for Asians.	[Yang, Sen; Su, Hong-Xia; Wang, Da-Wen; Zhu, Shi-Jian; Li, Sheng; Chen, Ying-He] Wenzhou Med Univ, Affiliated Hosp 2, Dept Urol, Wenzhou, Zhejiang, Peoples R China; [He, Jing] Sun Yat Sen Univ, Ctr Canc, Collaborat Innovat Ctr Canc Med, State Key Lab Oncol South China,Dept Expt Res, Guangzhou, Guangdong, Peoples R China; [Jin, Tao] First Peoples Hosp Yongkang, Clin Lab, Yongkang, Zhejiang, Peoples R China; [Zhu, Jin-Hong] Harbin Med Univ, Canc Hosp, Dept Mol Epidemiol & Lab Med, Harbin, Heilongjiang, Peoples R China	Wenzhou Medical University; State Key Lab Oncology South China; Sun Yat Sen University; Harbin Medical University	He, J (corresponding author), Sun Yat Sen Univ, Ctr Canc, Collaborat Innovat Ctr Canc Med, State Key Lab Oncol South China,Dept Expt Res, Guangzhou, Guangdong, Peoples R China.	hejing198374@gmail.com; docchenyh@sina.com	He, Jing/M-5774-2015	He, Jing/0000-0002-1954-2892; Zhu, Jinhong/0000-0002-0408-3101	National Natural Science Foundation of China [81101808]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the grant from the National Natural Science Foundation of China (81101808). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amr S, 2015, ARCH ENVIRON OCCUP H, V70, P19, DOI 10.1080/19338244.2013.853646; Basma HA, 2013, INT J MOL EPIDEMIOL, V4, P207; Basu S, 2004, INT J ONCOL, V25, P921; BENSON AM, 1993, BIOCHEM PHARMACOL, V46, P1217, DOI 10.1016/0006-2952(93)90470-H; Boccia S, 2010, EUR J EPIDEMIOL, V25, P765, DOI 10.1007/s10654-010-9503-z; Bredberg A, 2011, CANCER-AM CANCER SOC, V117, P440, DOI 10.1002/cncr.25440; Broberg K, 2005, CARCINOGENESIS, V26, P1263, DOI 10.1093/carcin/bgi063; Chao C, 2006, CANCER EPIDEM BIOMAR, V15, P979, DOI 10.1158/1055-9965.EPI-05-0899; CHEN S, 1995, MOL PHARMACOL, V47, P934; Choi JY, 2003, PHARMACOGENETICS, V13, P349, DOI 10.1097/00008571-200306000-00006; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Dinkova-Kostova AT, 2010, ARCH BIOCHEM BIOPHYS, V501, P116, DOI 10.1016/j.abb.2010.03.019; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Figueroa JD, 2008, CARCINOGENESIS, V29, P1955, DOI 10.1093/carcin/bgn163; Fu J, 2012, J CHIN ONCOL, V18, P561; Fu Jing CB-c, 2013, CHIN J CANC PREV TRE, V20, P10; Goerlitz D., 2014, UROL ONCOL, V32, DOI DOI 10.1016/J.UR0L0NC.2013.06.016; Golka K, 2011, ARCH TOXICOL, V85, P539, DOI 10.1007/s00204-011-0676-3; Gong M, 2013, TUMOR BIOL, V34, P2551, DOI 10.1007/s13277-013-0799-7; Guha N, 2008, AM J EPIDEMIOL, V168, P1221, DOI 10.1093/aje/kwn246; Guo ZJ, 2012, ASIAN PAC J CANCER P, V13, P6343, DOI 10.7314/APJCP.2012.13.12.6343; He J, 2013, MOL CARCINOGEN, V52, P70, DOI 10.1002/mc.22013; He J, 2013, INT J CANCER, V133, P1765, DOI 10.1002/ijc.28089; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Huang ZM, 2014, J CHIN MED ASSOC, V77, P83, DOI 10.1016/j.jcma.2013.10.005; Hung RJ, 2004, CARCINOGENESIS, V25, P973, DOI 10.1093/carcin/bgh080; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Lajin B, 2013, BRIT J CANCER, V109, P1325, DOI 10.1038/bjc.2013.357; Lin BK, 2006, AM J EPIDEMIOL, V164, P1, DOI 10.1093/aje/kwj175; MALIK MA, 2014, BRIT J CANCER, DOI DOI 10.1038/BJC.2014.626; MANDAL RK, 2014, TUMOUR BIOL; MANTEL N, 1959, J NATL CANCER I, V22, P719; Menashe I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029396; Misra V, 2000, BRIT J CANCER, V83, P998, DOI 10.1054/bjoc.2000.1359; Moore LE, 2004, CANCER LETT, V211, P199, DOI 10.1016/j.canlet.2004.04.011; Nioi P, 2004, MUTAT RES-FUND MOL M, V555, P149, DOI 10.1016/j.mrfmmm.2004.05.023; Pandith AA, 2011, BIOCHEM GENET, V49, P417, DOI 10.1007/s10528-011-9418-8; Park SJ, 2003, MUTAT RES-GEN TOX EN, V536, P131, DOI 10.1016/S1383-5718(03)00041-X; Parkin DM, 2006, INT J CANCER, V118, P3030, DOI 10.1002/ijc.21731; Pharoah PDP, 2004, NAT REV CANCER, V4, P850, DOI 10.1038/nrc1476; Ryk C, 2006, CANCER LETT, V241, P142, DOI 10.1016/j.canlet.2005.10.025; Sanyal S, 2004, CARCINOGENESIS, V25, P729, DOI 10.1093/carcin/bgh058; Sanyal S, 2007, SCAND J UROL NEPHROL, V41, P182, DOI 10.1080/00365590600991946; Schulz WA, 1997, PHARMACOGENETICS, V7, P235, DOI 10.1097/00008571-199706000-00008; Siegel D, 1999, PHARMACOGENETICS, V9, P113, DOI 10.1097/00008571-199902000-00015; Siegel D, 2012, BIOCHEM PHARMACOL, V83, P1033, DOI 10.1016/j.bcp.2011.12.017; Terry PD, 2005, CANCER EPIDEM BIOMAR, V14, P753, DOI 10.1158/1055-9965.EPI-04-0574; Wacholder S, 2004, J NATL CANCER I, V96, P434, DOI 10.1093/jnci/djh075; Wang YH, 2008, J CANCER RES CLIN, V134, P203, DOI 10.1007/s00432-007-0271-4; Yin ZB, 2014, TUMOR BIOL, V35, P1609, DOI 10.1007/s13277-013-1222-0; Zhang H, 2013, TUMOR BIOL, V34, P3377, DOI 10.1007/s13277-013-0909-6	51	18	18	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2015	10	1							e0116500	10.1371/journal.pone.0116500	http://dx.doi.org/10.1371/journal.pone.0116500			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ4OZ	25602258	gold, Green Published, Green Submitted			2022-12-27	WOS:000348203500026
J	Chen, G; Bai, Y; Ren, L; Zhu, D; Li, YH; Fang, MY; Al-Kateb, H; Doran, O				Chen, Gang; Bai, Ying; Ren, Li; Zhu, Dan; Li, Yanhua; Fang, Meiying; Al-Kateb, Huda; Doran, Olena			Metabolism of Androstenone, 17 beta-Estradiol and Dihydrotestosterone in Primary Cultured Pig Hepatocytes and the Role of 3 beta-Hydroxysteroid Dehydrogenase in This Process	PLOS ONE			English	Article							STEROID-HORMONE-METABOLISM; BOAR TAINT; 16-ANDROSTENE STEROIDS; PORCINE HEPATOCYTES; GENE-EXPRESSION; SPLICE VARIANTS; RECEPTOR; PATHWAYS	Steroids metabolism plays an important role in mammals and contributes to quality of pig meat. The main objective of this study was to identify metabolites of androstenone, 17 beta-estradiol and dihydrotestosterone using primary cultured pig hepatocytes as a model system. The role of 3 beta-hydroxysteroid dehydrogenase (3 beta HSD) in regulation of steroid metabolism was also validated using trilostane, a specific 3 beta HSD inhibitor. Steroid glucuronide conjugated metabolites were detected by liquid chromatography time of flight mass spectrometry (LC-TOF-MS). 3 beta HSD enzyme was essential for metabolism of androstenone to 5 alpha-androst-16-en-3 beta-ol, which then formed androstenone glucuronide conjugate. Metabolism of 17 beta-estradiol was accompanied by formation of glucuronide-conjugated estrone and glucuronide-conjugated estradiol. The ratio of the two metabolites was around 5:1. 3 beta HSD enzyme was not involved in 17 beta-estradiol metabolism. 5 alpha-Dihydrotestosterone- 17 beta-glucuronide was identified as a dihydrotestosterone metabolite, and this metabolism was related to 3 beta HSD enzyme activity as demonstrated by inhibition study.	[Chen, Gang; Zhu, Dan; Li, Yanhua] Chinese Acad Agr Sci, Inst Qual Stand & Testing Technol Agroprod, Key Lab Agroprod Qual & Safety, Beijing 100193, Peoples R China; [Bai, Ying; Fang, Meiying] China Agr Univ, Coll Anim Sci & Technol, Beijing 100094, Peoples R China; [Ren, Li] Air Force Gen Hosp, Dept Pathol, Beijing, Peoples R China; [Al-Kateb, Huda; Doran, Olena] Univ W England, Fac Hlth & Appl Sci, Ctr Res Biosci, Bristol BS16 1QY, Avon, England	Chinese Academy of Agricultural Sciences; Institute of Quality Standards & Testing Technology for Agro-Products, CAAS; China Agricultural University; Air Force General Hospital PLA; University of West England	Fang, MY (corresponding author), China Agr Univ, Coll Anim Sci & Technol, Beijing 100094, Peoples R China.	meiying@cau.edu.cn		ALKATEB, HUDA/0000-0002-8194-8906	Natural Science Foundation of China [31171691, 31371779]; International Science & Technology Cooperation Program of China [2012DFA31140]; Biotechnology and Biological Sciences Research Council (BBSRC) UK-China Partnering Award [BB/H531435/1]; EU Marie Curie International Research Staff Exchange Scheme [246760]; BBSRC [BB/H531435/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/C506072/1, BB/H531435/1, BB/L024268/1] Funding Source: researchfish	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); International Science & Technology Cooperation Program of China; Biotechnology and Biological Sciences Research Council (BBSRC) UK-China Partnering Award(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); EU Marie Curie International Research Staff Exchange Scheme; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by Natural Science Foundation of China (31171691, 31371779), International Science & Technology Cooperation Program of China (2012DFA31140), Biotechnology and Biological Sciences Research Council (BBSRC) UK-China Partnering Award (BB/H531435/1), and EU Marie Curie International Research Staff Exchange Scheme (FP7-PEOPLE-2009-IRSES, 246760). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BROOKS RI, 1986, J ANIM SCI, V62, P632, DOI 10.2527/jas1986.623632x; Chen G, 2007, J ANIM SCI, V85, P2457, DOI 10.2527/jas.2007-0087; Chen G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052255; De Brabander HF, 2007, J MASS SPECTROM, V42, P983, DOI 10.1002/jms.1272; Doran E, 2004, CHEM-BIOL INTERACT, V147, P141, DOI 10.1016/j.cbi.2003.12.002; GOWER DB, 1972, J STEROID BIOCHEMIST, V3, P45, DOI 10.1016/0022-4731(72)90011-8; Gray MA, 2009, XENOBIOTICA, V39, P915, DOI 10.3109/00498250903330348; Gray MA, 2013, J STEROID BIOCHEM, V133, P110, DOI 10.1016/j.jsbmb.2012.09.025; Gray MA, 2010, EXP BIOL MED, V235, P718, DOI 10.1258/ebm.2010.009339; Hansen LL, 2006, ANIM SCI, V82, P359, DOI 10.1079/ASC200648; Jin Y, 2009, J BIOL CHEM, V284, P10013, DOI 10.1074/jbc.M809465200; Lundstrom K, 2009, ANIMAL, V3, P1497, DOI 10.1017/S1751731109990693; Mareck U, 2008, J MASS SPECTROM, V43, P877, DOI 10.1002/jms.1457; Nicolau-Solano SI, 2006, J ANIM SCI, V84, P2809, DOI 10.2527/jas.2005-595; PATTERSON RL, 1968, J SCI FOOD AGR, V19, P31, DOI 10.1002/jsfa.2740190107; Payne AH, 2004, ENDOCR REV, V25, P947, DOI 10.1210/er.2003-0030; Penning TM, 2010, J STEROID BIOCHEM, V121, P546, DOI 10.1016/j.jsbmb.2010.01.005; Robic A, 2014, J STEROID BIOCHEM, V140, P44, DOI 10.1016/j.jsbmb.2013.11.001; Sinclair PA, 2005, J STEROID BIOCHEM, V96, P79, DOI 10.1016/j.jsbmb.2005.01.030; Sinclair PA, 2005, J STEROID BIOCHEM, V96, P217, DOI 10.1016/j.jsbmb.2005.02.017; Steckelbroeck S, 2004, J BIOL CHEM, V279, P10784, DOI 10.1074/jbc.M313308200; Van LT, 2013, J STEROID BIOCHEM, V137, P176, DOI 10.1016/j.jsbmb.2013.05.017; YOKOYAMA MT, 1979, AM J CLIN NUTR, V32, P173; Zamaratskaia G, 2009, ANIMAL, V3, P1508, DOI 10.1017/S1751731108003674; Zhou J, 2010, DRUG METAB DISPOS, V38, P431, DOI 10.1124/dmd.109.028712	25	4	4	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2015	10	1							e113194	10.1371/journal.pone.0113194	http://dx.doi.org/10.1371/journal.pone.0113194			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9HN	25590624	Green Submitted, Green Published, gold			2022-12-27	WOS:000350679400002
J	van der Meer, MG; Backus, BE; van der Graaf, Y; Cramer, MJ; Appelman, Y; Doevendans, PA; Six, AJ; Nathoe, HM				van der Meer, Manon G.; Backus, Barbra E.; van der Graaf, Yolanda; Cramer, Maarten J.; Appelman, Yolande; Doevendans, Pieter A.; Six, A. Jacob; Nathoe, Hendrik M.			The Diagnostic Value of Clinical Symptoms in Women and Men Presenting with Chest Pain at the Emergency Department, a Prospective Cohort Study	PLOS ONE			English	Article							ACUTE CORONARY SYNDROMES; ACUTE MYOCARDIAL-INFARCTION; ASSOCIATION TASK-FORCE; GENDER-DIFFERENCES; AMERICAN-COLLEGE; SEX-DIFFERENCES; GUIDELINES; MANAGEMENT; AGE; ANGIOGRAPHY	Background Previous studies suggested that diagnosing coronary artery disease (CAD) is more difficult in women than in men. Studies investigating the predictive value of clinical signs and symptoms and compare its combined diagnostic value between women and men are lacking. Methodology Data from a large multicenter prospective study was used. Patients admitted to the emergency department (ED) with chest pain but without ST-elevation were eligible. The endpoint was proven CAD, defined as a significant stenosis at angiography or the diagnosis of a non-ST-elevation myocardial infarction or cardiovascular death within six weeks after presentation at the ED. Twelve clinical symptoms and seven cardiovascular risk factors were collected. Potential predictors of CAD with a p-value <0.15 in the univariable analysis were included in a multivariable model. The diagnostic value of clinical symptoms and cardiovascular risk factors was quantified in women and men separately and areas under the curve (AUC) were compared between sexes. Results A total of 2433 patients were included. We excluded 102 patients (4%) with either an incomplete follow up or ST-elevation. Of the remaining 2331 patients 43% (1003) were women. CAD was present in 111 (11%) women and 278 (21%) men. In women 11 out of 12 and in men 10 out of 12 clinical symptoms were univariably associated with CAD. The AUC of symptoms alone was 0.74 (95% CI: 0.69-0.79) in women and 0.71 (95% CI: 0.68-0.75) in men and increased to respectively 0.79 (95% CI: 0.74-0.83) in women versus 0.75 (95% CI: 0.72-0.78) in men after adding cardiovascular risk factors. The AUCs of women and men were not significantly different (p-value symptoms alone: 0.45, after adding cardiovascular risk factors: 0.11). Conclusion The diagnostic value of clinical symptoms and cardiovascular risk factors for the diagnosis of CAD in chest pain patients presenting on the ED was high in women and men. No significant differences were found between sexes.	[van der Meer, Manon G.; Backus, Barbra E.; Cramer, Maarten J.; Appelman, Yolande; Doevendans, Pieter A.; Nathoe, Hendrik M.] Univ Med Ctr Utrecht, Dept Cardiol, Utrecht, Netherlands; [van der Graaf, Yolanda] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands; [Six, A. Jacob] Zuwe Hofpoort Hosp, Dept Cardiol, Woerden, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center	Nathoe, HM (corresponding author), Univ Med Ctr Utrecht, Dept Cardiol, Utrecht, Netherlands.	h.m.nathoe@umcutrecht.nl	Backus, Barbra/AAP-9802-2021					Anderson JL, 2011, J AM COLL CARDIOL, V57, pE215, DOI 10.1016/j.jacc.2011.02.011; Antman EM, 2000, JAMA-J AM MED ASSOC, V284, P835, DOI 10.1001/jama.284.7.835; Assiri AS, 2011, J SAUDI HEART ASSOC, V23, P135, DOI 10.1016/j.jsha.2011.01.007; Backus BE, 2013, INT J CARDIOL, V168, P2153, DOI 10.1016/j.ijcard.2013.01.255; Bosner S, 2009, BMC FAM PRACT, V10, DOI 10.1186/1471-2296-10-79; Canto JG, 2007, ARCH INTERN MED, V167, P2405, DOI 10.1001/archinte.167.22.2405; Canto JG, 2012, JAMA-J AM MED ASSOC, V307, P813, DOI 10.1001/jama.2012.199; Culic V, 2002, AM HEART J, V144, P1012, DOI 10.1067/mhj.2002.125625; D'Agostino RB, 2001, JAMA-J AM MED ASSOC, V286, P180, DOI 10.1001/jama.286.2.180; DeVon HA, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.113.000586; Dey S, 2009, HEART, V95, P20, DOI 10.1136/hrt.2007.138537; Forest RS, 2004, ANN EMERG MED, V44, P206, DOI 10.1016/j.annemergmed.2004.02.031; Gibbons RJ, 1999, J AM COLL CARDIOL, V33, P2092, DOI 10.1016/S0735-1097(99)00150-3; Gimenez MR, 2014, JAMA INTERN MED, V174, P241, DOI 10.1001/jamainternmed.2013.12199; Halpern EJ, 2013, AM J EMERG MED, V31, P1479, DOI 10.1016/j.ajem.2013.08.001; Hamm CW, 2011, EUR HEART J, V32, P2999, DOI 10.1093/eurheartj/ehr236; Johnston N, 2011, EUR HEART J, V32, P1331, DOI 10.1093/eurheartj/ehr009; Khan NA, 2013, JAMA INTERN MED, V173, P1863, DOI 10.1001/jamainternmed.2013.10149; Milner KA, 2004, AM J CARDIOL, V93, P606, DOI 10.1016/j.amjcard.2003.11.028; Milner KA, 2002, AM HEART J, V143, P283, DOI 10.1067/mhj.2002.119759; Milner KA, 2001, NURS RES, V50, P233, DOI 10.1097/00006199-200107000-00007; Milner KA, 1999, AM J CARDIOL, V84, P396, DOI 10.1016/S0002-9149(99)00322-7; Naaktgeboren CA, 2013, ANN INTERN MED, V159, P195, DOI 10.7326/0003-4819-159-3-201308060-00009; Nawar Eric W, 2007, Adv Data, P1; O'Gara PT, 2013, CIRCULATION, V127, pE362, DOI 10.1161/CIR.0b013e3182742cf6; Panju AA, 1998, JAMA-J AM MED ASSOC, V280, P1256, DOI 10.1001/jama.280.14.1256; Patel H, 2004, AM HEART J, V148, P27, DOI 10.1016/j.ahj.2004.03.005; Pope JH, 2000, NEW ENGL J MED, V342, P1163, DOI 10.1056/NEJM200004203421603; Roger VL, 2000, JAMA-J AM MED ASSOC, V283, P646, DOI 10.1001/jama.283.5.646; Rutherford J, 1992, ANONYMOUS HEART DIS, P1293; Sanchis J, 2005, HEART, V91, P1013, DOI 10.1136/hrt.2004.041673; Searle J, 2013, EUR HEART J-ACUTE CA, V2, P203, DOI 10.1177/2048872613484688; Shaw LJ, 2008, CIRCULATION, V117, P1787, DOI 10.1161/CIRCULATIONAHA.107.726562; Slot MHEB, 2012, FAM PRACT, V29, P332, DOI 10.1093/fampra/cmr089; Steyerberg E.W., 2019, CLIN PREDICTION MODE, DOI [10.1007/978-3-030-16399-0, DOI 10.1007/978-3-030-16399-0]; Swap CJ, 2005, JAMA-J AM MED ASSOC, V294, P2623, DOI 10.1001/jama.294.20.2623; Thygesen K, 2007, EUR HEART J, V28, P2525	37	13	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2015	10	1							e0116431	10.1371/journal.pone.0116431	http://dx.doi.org/10.1371/journal.pone.0116431			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9HN	25590466	Green Published, gold, Green Submitted			2022-12-27	WOS:000350679400013
J	Parikh, BA; Beckman, DL; Patel, SJ; White, JM; Yokoyama, WM				Parikh, Bijal A.; Beckman, Diana L.; Patel, Swapneel J.; White, J. Michael; Yokoyama, Wayne M.			Detailed Phenotypic and Molecular Analyses of Genetically Modified Mice Generated by CRISPR-Cas9-Mediated Editing	PLOS ONE			English	Article							ONE-STEP GENERATION; CRISPR-CAS SYSTEM; GENOME MODIFICATION; TYROSINASE GENE; HUMAN-CELLS; RNA; DNA; MOUSE; SPECIFICITY; NUCLEASES	The bacterial CRISPR-Cas9 system has been adapted for use as a genome editing tool. While several recent reports have indicated that successful genome editing of mice can be achieved, detailed phenotypic and molecular analyses of the mutant animals are limited. Following pronuclear micro-injection of fertilized eggs with either wild-type Cas9 or the nickase mutant (D10A) and single or paired guide RNA (sgRNA) for targeting of the tyrosinase (Tyr) gene, we assessed genome editing in mice using rapid phenotypic readouts (eye and coat color). Mutant mice with insertions or deletions (indels) in Tyr were efficiently generated without detectable off-target cleavage events. Gene correction of a single nucleotide by homologous recombination (HR) could only occur when the sgRNA recognition sites in the donor DNA were modified. Gene repair did not occur if the donor DNA was not modified because Cas9 catalytic activity was completely inhibited. Our results indicate that allelic mosaicism can occur following -Cas9-mediated editing in mice and appears to correlate with sgRNA cleavage efficiency at the single-cell stage. We also show that larger than expected deletions may be overlooked based on the screening strategy employed. An unbiased analysis of all the deleted nucleotides in our experiments revealed that the highest frequencies of nucleotide deletions were clustered around the predicted Cas9 cleavage sites, with slightly broader distributions than expected. Finally, additional analysis of founder mice and their offspring indicate that their general health, fertility, and the transmission of genetic changes were not compromised. These results provide the foundation to interpret and predict the diverse outcomes following CRISPR-Cas9-mediated genome editing experiments in mice.	[Parikh, Bijal A.; White, J. Michael] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA; [Beckman, Diana L.; Patel, Swapneel J.; Yokoyama, Wayne M.] Washington Univ, Sch Med, Dept Med, Div Rheumatol, St Louis, MO 63110 USA; [Yokoyama, Wayne M.] Washington Univ, Sch Med, Howard Hughes Med Inst, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Howard Hughes Medical Institute; Washington University (WUSTL)	Yokoyama, WM (corresponding author), Washington Univ, Sch Med, Dept Med, Div Rheumatol, St Louis, MO 63110 USA.	yokoyama@dom.wustl.edu	Parikh, Bijal/AAA-5839-2019	Parikh, Bijal/0000-0003-2490-8294; Patel, Swapneel/0000-0001-6088-4029	Rheumatic Diseases Core Center grant from the National Institute of Arthritis and Musculoskeletal and Skin Diseases [P30-AR048335]; Howard Hughes Medical Institute; NIH Career Development Award from the National Institute of Allergy and Infectious Diseases [K08-AI104991]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K08AI104991] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR048335] Funding Source: NIH RePORTER	Rheumatic Diseases Core Center grant from the National Institute of Arthritis and Musculoskeletal and Skin Diseases; Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIH Career Development Award from the National Institute of Allergy and Infectious Diseases; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	The Washington University Department of Pathology Microinjection Core is partially supported by the Rheumatic Diseases Core Center grant from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (P30-AR048335). The authors also acknowledge the assistance of the Protein and Nucleic Acid Chemistry Labs (PNACL) at Washington University for their assistance with DNA sequencing. These studies were supported by the Howard Hughes Medical Institute. BAP was supported by an NIH Career Development Award from the National Institute of Allergy and Infectious Diseases (K08-AI104991). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bassett AR, 2013, CELL REP, V4, P220, DOI 10.1016/j.celrep.2013.06.020; Blitz IL, 2013, GENESIS, V51, P827, DOI 10.1002/dvg.22719; Carbery ID, 2010, GENETICS, V186, P451, DOI 10.1534/genetics.110.117002; Chapman JR, 2012, MOL CELL, V47, P497, DOI 10.1016/j.molcel.2012.07.029; Cheng AW, 2013, CELL RES, V23, P1163, DOI 10.1038/cr.2013.122; Cho SW, 2013, GENOME RES, DOI [10.1128/genomeA.00897-13, DOI 10.1128/GENOMEA.00897-13]; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Cradick TJ, 2013, NUCLEIC ACIDS RES, V41, P9584, DOI 10.1093/nar/gkt714; Decottignies Anabelle, 2013, Frontiers in Genetics, V4, P48, DOI 10.3389/fgene.2013.00048; Feng ZY, 2014, P NATL ACAD SCI USA, V111, P4632, DOI 10.1073/pnas.1400822111; Filippo JS, 2008, ANNU REV BIOCHEM, V77, P229, DOI 10.1146/annurev.biochem.77.061306.125255; Friedland AE, 2013, NAT METHODS, V10, P741, DOI 10.1038/nmeth.2532; Fu YF, 2013, NAT BIOTECHNOL, V31, P822, DOI 10.1038/nbt.2623; Fujii W, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt772; Hall Bradford, 2009, Curr Protoc Cell Biol, VChapter 19, DOI 10.1002/0471143030.cb1912s44; HAMADA T, 1993, GENE, V128, P197, DOI 10.1016/0378-1119(93)90563-I; Heigwer F, 2014, NAT METHODS, V11, P122, DOI 10.1038/nmeth.2812; Honma M, 2007, DNA REPAIR, V6, P781, DOI 10.1016/j.dnarep.2007.01.004; Hruscha A, 2013, DEVELOPMENT, V140, P4982, DOI 10.1242/dev.099085; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Huertas P, 2010, NAT STRUCT MOL BIOL, V17, P11, DOI 10.1038/nsmb.1710; Hwang WY, 2013, NAT BIOTECHNOL, V31, P227, DOI 10.1038/nbt.2501; Jiang WY, 2013, NAT BIOTECHNOL, V31, P233, DOI 10.1038/nbt.2508; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Keane TM, 2011, NATURE, V477, P289, DOI 10.1038/nature10413; LeFur N, 1996, GENOMICS, V37, P245; Li DL, 2013, NAT BIOTECHNOL, V31, P681, DOI 10.1038/nbt.2661; Li F, 2014, SCI REP-UK, V4, DOI 10.1038/srep05290; Long CZ, 2014, SCIENCE, V345, P1184, DOI 10.1126/science.1254445; Ma YW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089413; Mali P, 2013, NAT BIOTECHNOL, V31, P833, DOI 10.1038/nbt.2675; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Mashiko D, 2013, SCI REP-UK, V3, DOI 10.1038/srep03355; Mizuno S, 2014, MAMM GENOME, V25, P327, DOI 10.1007/s00335-014-9524-0; Nagy A., 2003, MANIPULATING MOUSE E; O'Brien A, 2014, BIOINFORMATICS, V30, P2673, DOI 10.1093/bioinformatics/btu354; Pardo B, 2009, CELL MOL LIFE SCI, V66, P1039, DOI 10.1007/s00018-009-8740-3; Pennisi E, 2013, SCIENCE, V341, P833, DOI 10.1126/science.341.6148.833; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Ran FA, 2013, CELL, V154, P1380, DOI 10.1016/j.cell.2013.08.021; Shen B, 2014, MBIO, V5, DOI 10.1128/mBio.01114-14; Shen B, 2014, NAT METHODS, V11, P399, DOI [10.1038/nmeth.2857, 10.1038/NMETH.2857]; Sternberg SH, 2014, NATURE, V507, P62, DOI 10.1038/nature13011; Sung YH, 2014, GENOME RES, V24, P125, DOI 10.1101/gr.163394.113; Sung YH, 2012, BMB REP, V45, P686, DOI 10.5483/BMBRep.2012.45.12.242; Vasquez KM, 2001, P NATL ACAD SCI USA, V98, P8403, DOI 10.1073/pnas.111009698; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Wu YX, 2013, CELL STEM CELL, V13, P659, DOI 10.1016/j.stem.2013.10.016; Yang H, 2013, CELL, V154, P1370, DOI 10.1016/j.cell.2013.08.022; Yasue A, 2014, SCI REP-UK, V4, DOI 10.1038/srep05705; Yu ZS, 2013, GENETICS, V195, P289, DOI 10.1534/genetics.113.153825; Zhou JK, 2014, FEBS J, V281, P1717, DOI 10.1111/febs.12735; Zhou JK, 2014, INT J BIOCHEM CELL B, V46, P49, DOI 10.1016/j.biocel.2013.10.010	53	34	44	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2015	10	1							e0116484	10.1371/journal.pone.0116484	http://dx.doi.org/10.1371/journal.pone.0116484			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ0ID	25587897	gold, Green Published, Green Submitted			2022-12-27	WOS:000347928300014
J	Qin, YJ; Paini, DR; Wang, C; Fang, Y; Li, ZH				Qin, Yujia; Paini, Dean R.; Wang, Cong; Fang, Yan; Li, Zhihong			Global Establishment Risk of Economically Important Fruit Fly Species (Tephritidae)	PLOS ONE			English	Article							GEOGRAPHICAL-DISTRIBUTION; DIPTERA; INVASIONS; INSECTS; THREAT; TOOL	The global invasion of Tephritidae (fruit flies) attracts a great deal of attention in the field of plant quarantine and invasion biology because of their economic importance. Predicting which one in hundreds of potential invasive fruit fly species is most likely to establish in a region presents a significant challenge, but can be facilitated using a self organising map (SOM), which is able to analyse species associations to rank large numbers of species simultaneously with an index of establishment. A global presence/absence dataset including 180 economically significant fruit fly species in 118 countries was analysed using a SOM. We compare and contrast ranked lists from six countries selected from each continent, and also show that those countries geographically close were clustered together by the SOM analysis because they have similar fruit fly assemblages. These closely clustered countries therefore represent greater threats to each other as sources of invasive fruit fly species. Finally, we indicate how this SOM method could be utilized as an initial screen to support prioritizing fruit fly species for further research into their potential to invade a region.	[Qin, Yujia; Wang, Cong; Fang, Yan; Li, Zhihong] China Agr Univ, Dept Entomol, Coll Agron & Biotechnol, Beijing 100094, Peoples R China; [Paini, Dean R.] CSIRO Biosecur Flagship, Canberra, ACT, Australia	China Agricultural University; Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Paini, DR (corresponding author), CSIRO Biosecur Flagship, Canberra, ACT, Australia.	Dean.Paini@csiro.au; lizh@cau.edu.cn	Paini, Dean R/C-2341-2009		Introduction of International Advanced Agricultural Science and Technology Program of Ministry of Agriculture [2012-Z15]; Special Fund for Agro-scientific Research in the Public Interest [201003079]; Science and Technology Program of General Administration of Quality Supervision, Inspection and Quarantine of the People's Republic of China [2012IK291]	Introduction of International Advanced Agricultural Science and Technology Program of Ministry of Agriculture; Special Fund for Agro-scientific Research in the Public Interest; Science and Technology Program of General Administration of Quality Supervision, Inspection and Quarantine of the People's Republic of China	This study received financial support from the Chinese programs ("Introduction of International Advanced Agricultural Science and Technology Program of Ministry of Agriculture (No. 2012-Z15)", "Special Fund for Agro-scientific Research in the Public Interest (No. 201003079)" and "Science and Technology Program of General Administration of Quality Supervision, Inspection and Quarantine of the People's Republic of China (No. 2012IK291)". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1992, FRUIT FLIES EC SIGNI; CABI, 2012, CROP PROT COMP; Cereghino R, 2003, J N AM BENTHOL SOC, V22, P442, DOI 10.2307/1468273; Davis MA, 2009, INVASION BIOL, V74-75, P101; Ercsey-Ravasz M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037810; Geng J, 2011, INSECT SCI, V18, P575, DOI 10.1111/j.1744-7917.2010.01402.x; Gevrey M, 2006, ECOL MODEL, V197, P361, DOI 10.1016/j.ecolmodel.2006.03.032; Grove T, 2014, ACTA HORTIC, V1029, P425, DOI 10.17660/ActaHortic.2014.1029.54; Hulme PE, 2009, SCIENCE, V324, P40, DOI 10.1126/science.1171111; KOHONEN T, 1982, BIOL CYBERN, V43, P59, DOI 10.1007/BF00337288; Kohonen T., 2001, SELF ORG MAPS; Koop AL, 2012, BIOL INVASIONS, V14, P273, DOI 10.1007/s10530-011-0061-4; Kriticos DJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064479; LaDeau SL, 2007, NATURE, V447, P710, DOI 10.1038/nature05829; Li ZhiHong, 2013, Plant Quarantine (Shanghai), V27, P1; Liang G.Q., 2011, FRUIT FLIES DIPTERA, DOI [10.1603/EN10198, DOI 10.1603/EN10198]; LIQUIDO NJ, 1990, J ECON ENTOMOL, V83, P1863, DOI 10.1093/jee/83.5.1863; Mack RN, 2000, ECOL APPL, V10, P689, DOI 10.1890/1051-0761(2000)010[0689:BICEGC]2.0.CO;2; Mathworks, 2007, MATLAB VERS 7 4; Morin L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055547; Ni WL, 2012, B ENTOMOL RES, V102, P173, DOI 10.1017/S0007485311000538; Oliveira CM, 2013, J APPL ENTOMOL, V137, P1, DOI 10.1111/jen.12018; Paini DR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025695; Paini DR, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1118; Paini DR, 2010, J APPL ECOL, V47, P290, DOI 10.1111/j.1365-2664.2010.01782.x; Pheloung PC, 1999, J ENVIRON MANAGE, V57, P239, DOI 10.1006/jema.1999.0297; Plant Health Australia, 2010, REG PLANT BIOS STRAT; Singh SK, 2014, BIOL INVASIONS, V16, P1515, DOI 10.1007/s10530-013-0588-7; Stanaway MA, 2001, AUST J ENTOMOL, V40, P180, DOI 10.1046/j.1440-6055.2001.00215.x; Steck GJ, 2001, FLA ENTOMOL, V84, P320, DOI 10.2307/3496193; Stephens AEA, 2007, B ENTOMOL RES, V97, P369, DOI 10.1017/S0007485307005044; Vesanto J., 2000, SOM TOOLBOX MATLAB 5, V57, P60; Worner SP, 2006, J APPL ECOL, V43, P858, DOI 10.1111/j.1365-2664.2006.01202.x; WORNER SP, 1988, J ECON ENTOMOL, V81, P973, DOI 10.1093/jee/81.4.973; Wu J., 2009, ATLAS EC FRUIT FLIES; Yonow T, 1998, AUST J AGR RES, V49, P935, DOI 10.1071/A97152	36	61	65	7	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2015	10	1							e0116424	10.1371/journal.pone.0116424	http://dx.doi.org/10.1371/journal.pone.0116424			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ0ID	25588025	gold, Green Published, Green Submitted			2022-12-27	WOS:000347928300012
J	Nishijo, M; Tai, PT; Anh, NTN; Nghi, TN; Nakagawa, H; Luong, HV; Anh, TH; Morikawa, Y; Waseda, T; Kido, T; Nishijo, H				Nishijo, Muneko; Pham The Tai; Nguyen Thi Nguyet Anh; Tran Ngoc Nghi; Nakagawa, Hideaki; Hoang Van Luong; Tran Hai Anh; Morikawa, Yuko; Waseda, Tomoo; Kido, Teruhiko; Nishijo, Hisao			Urinary Amino Acid Alterations in 3-Year-Old Children with Neurodevelopmental Effects due to Perinatal Dioxin Exposure in Vietnam: A Nested Case-Control Study for Neurobiomarker Discovery	PLOS ONE			English	Article							2,3,7,8-TETRACHLORODIBENZO-P-DIOXIN TCDD; BRAIN-DEVELOPMENT; BREAST-MILK; AUTISM; TAURINE; METABOLISM; HISTAMINE; DISORDER; GENE; MICE	In our previous study of 3-year-old children in a dioxin contamination hot spot in Vietnam, the high total dioxin toxic equivalent (TEQ-PCDDs/Fs)-exposed group during the perinatal period displayed lower Bayley III neurodevelopmental scores, whereas the high 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD)-exposed group displayed increased autistic traits. In autistic children, urinary amino acid profiles have revealed metabolic alterations in the amino acids that serve as neurotransmitters in the developing brain. Therefore, our present study aimed to investigate the use of alterations in urinary amino acid excretion as biomarkers of dioxin exposure-induced neurodevelopmental deficits in highly exposed 3-year-old children in Vietnam. A nested case-control study of urinary analyses was performed for 26 children who were selected from 111 3-year-old children whose perinatal dioxin exposure levels and neurodevelopmental status were examined in follow-up surveys conducted in a dioxin contaminated hot spot. We compared urinary amino acid levels between the following 4 groups: (1) a high TEQ-PCDDs/Fs and high TCDD-exposed group; (2) a high TEQ-PCDDs/Fs but low TCDD-exposed group; (3) a low TEQ-PCDDs/Fs exposed and poorly developed group; and (4) a low TEQ-PCDDs/Fs exposed and well-developed group. Urinary levels of histidine and tryptophan were significantly decreased in the high TEQ-PCDDs/Fs and high TCDD group, as well as in the high TEQ-PCDDs/Fs but low TCDD group, compared with the low TEQ-PCDDs/Fs and well-developed group. However, the ratio of histidine to glycine was significantly lower only in the high TEQ-PCDDs/Fs and high TCDD group. Furthermore, urinary histidine levels and the ratio of histidine to glycine were significantly correlated with neurodevelopmental scores, particularly for language and fine motor skills. These results indicate that urinary histidine is specifically associated with dioxin exposure-induced neurodevelopmental deficits, suggesting that urinary histidine may be a useful marker of dioxin-induced neurodevelopmental deficits and that histaminergic neuro-transmission may be an important pathological contributor to dioxin-mediated neurotoxicity.	[Nishijo, Muneko; Nguyen Thi Nguyet Anh; Tran Ngoc Nghi; Nakagawa, Hideaki] Kanazawa Med Univ, Dept Publ Hlth, Uchinada, Ishikawa 9200293, Japan; [Pham The Tai; Hoang Van Luong; Tran Hai Anh] Vietnam Mil Med Univ, Biomed & Pharmaceut Res Ctr, Hanoi, Vietnam; [Morikawa, Yuko] Kanazawa Med Univ, Sch Nursing, Uchinada, Ishikawa 9200293, Japan; [Waseda, Tomoo] Kanazawa Med Univ, Dept Obstet & Gynecol, Uchinada, Ishikawa 9200293, Japan; [Kido, Teruhiko] Kanazawa Univ, Fac Hlth Sci, Inst Med Pharmaceut & Hlth Sci, Kanazawa, Ishikawa 9200942, Japan; [Nishijo, Hisao] Toyama Univ, Grad Sch Med & Pharmaceut Sci, Sugitani, Toyama 9300194, Japan	Kanazawa Medical University; Kanazawa Medical University; Kanazawa Medical University; Kanazawa University; University of Toyama	Nishijo, M (corresponding author), Kanazawa Med Univ, Dept Publ Hlth, 1-1 Daigaku, Uchinada, Ishikawa 9200293, Japan.	ni-koei@kanazawa-med.ac.jp			Japan Society for the Promotion of Science Asian Core Program; Ministry of Education, Science, Sports and Culture [25305024, 24659306];  [C-2013-4]	Japan Society for the Promotion of Science Asian Core Program(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Science, Sports and Culture(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); 	This work was supported partly by the Japan Society for the Promotion of Science Asian Core Program and the Ministry of Education, Science, Sports and Culture, Grant-in-Aid for Scientific Research (B) (25305024) and Challenging Exploratory Research (24659306), (www.jsps.go.jp) and Grant for collaboration research from Kanazawa Medical University (C-2013-4)(www.kanazawa-med.ac.jp). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahearn WH, 2001, J AUTISM DEV DISORD, V31, P505, DOI 10.1023/A:1012221026124; AL-Ayadhi L, 2013, JCPSP-J COLL PHYSICI, V23, P137, DOI 02.2013/JCPSP.137143; Baldan LC, 2014, NEURON, V81, P77, DOI 10.1016/j.neuron.2013.10.052; Barnes-Ellerbe S, 2004, MOL PHARMACOL, V66, P502, DOI 10.1124/mol.104.000356; Boccuto L, 2013, MOL AUTISM, V4, DOI 10.1186/2040-2392-4-16; Boverhof DR, 2006, TOXICOL SCI, V94, P398, DOI 10.1093/toxsci/kfl100; Callaway E., 2012, NATURE NEWS, P11375, DOI [10.1038/nature.2012.11375, DOI 10.1038/NATURE.2012.11375]; CHAPMAN GE, 1988, NUTR RES, V8, P955, DOI 10.1016/S0271-5317(88)80135-0; CHRISTIAN BJ, 1986, TOXICOL APPL PHARM, V83, P360, DOI 10.1016/0041-008X(86)90313-3; Cohly HHP, 2005, INT REV NEUROBIOL, V71, P317, DOI 10.1016/S0074-7742(05)71013-8; Croonenberghs J, 2000, NEUROPSYCHOPHARMACOL, V22, P275, DOI 10.1016/S0893-133X(99)00131-1; Dwernychuk LW, 2005, CHEMOSPHERE, V60, P998, DOI 10.1016/j.chemosphere.2005.01.052; Eaton KK, 1991, J NUTR BIOCH, V9, P586; Ercan-Sencicek AG, 2010, NEW ENGL J MED, V362, P1901, DOI 10.1056/NEJMoa0907006; Evans C, 2008, NUTR NEUROSCI, V11, P9, DOI 10.1179/147683008X301360; Fernandez TV, 2012, BIOL PSYCHIAT, V71, P392, DOI 10.1016/j.biopsych.2011.09.034; Ghanizadeh A, 2013, DIS MARKERS, V2013, DOI 10.1155/2013/536521; Hatfield Consultants Office of National Committee 33, 2009, ASS DIOX CONT ENV HU; Ito C, 2004, DRUG NEWS PERSPECT, V17, P383, DOI 10.1358/dnp.2004.17.6.829029; Kuhara T., 2005, METABOLOMICS FRONTIE, P53; Li Bin, 2014, Cerebellum Ataxias, V1, P5, DOI 10.1186/2053-8871-1-5; Minh N. H., 2009, INTERDISCIPLINARY ST, P21; Miyashita C, 2011, ENVIRON RES, V111, P551, DOI 10.1016/j.envres.2011.01.021; Molina-Hernandez A, 2012, J NEUROCHEM, V122, P872, DOI 10.1111/j.1471-4159.2012.07863.x; Nebert DW, 2004, J BIOL CHEM, V279, P23847, DOI 10.1074/jbc.R400004200; Nishijo M, 2014, MOL PSYCHIATR, V19, P1220, DOI 10.1038/mp.2014.18; Nishijo M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040273; PALACKAL T, 1986, J NEUROSCI RES, V15, P223, DOI 10.1002/jnr.490150212; Tai PT, 2013, OCCUP ENVIRON MED, V70, P656, DOI 10.1136/oemed-2012-101021; Tai PT, 2011, ENVIRON SCI TECHNOL, V45, P6625, DOI 10.1021/es201666d; Ragini M, 2011, INT J PHARM TECH RES, V3, P1281; Rasinger JD, 2014, TOXICOLOGY, V321, P1, DOI 10.1016/j.tox.2014.03.006; Shimmura C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025340; Steinman G, 2013, MED HYPOTHESES, V81, P21, DOI 10.1016/j.mehy.2013.03.034; STURMAN JA, 1985, J NEUROSCI RES, V13, P405, DOI 10.1002/jnr.490130307; Tai PT, 2012, ORGANOHALOGEN COMPOU, V74, P1369; Tawara K., 2003, J KANAZAWA MED U, V28, P17; Tijet N, 2006, MOL PHARMACOL, V69, P140, DOI 10.1124/mol.105.018705; TUOMISTO JT, 1991, AGENTS ACTIONS, V33, P154, DOI 10.1007/BF01993153; UNKILA M, 1994, TOXICOL APPL PHARM, V128, P280, DOI 10.1006/taap.1994.1208; Van den Berg M, 2006, TOXICOL SCI, V93, P223, DOI 10.1093/toxsci/kfl055; Viluksela M, 1999, ARCH TOXICOL, V73, P323, DOI 10.1007/s002040050626; Wang L, 2009, BIOMARKERS, V14, P596, DOI 10.3109/13547500903183962; Warren RP, 1996, NEUROPSYCHOBIOLOGY, V34, P72, DOI 10.1159/000119295; Yap IKS, 2010, J PROTEOME RES, V9, P2996, DOI 10.1021/pr901188e	45	3	4	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2015	10	1							e0116778	10.1371/journal.pone.0116778	http://dx.doi.org/10.1371/journal.pone.0116778			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ4OG	25584822	gold, Green Published, Green Submitted			2022-12-27	WOS:000348201300009
J	Spencer, NC; Gilchrist, HG; Mallory, ML				Spencer, Nora C.; Gilchrist, H. Grant; Mallory, Mark L.			Annual Movement Patterns of Endangered Ivory Gulls: The Importance of Sea Ice	PLOS ONE			English	Article							EASTERN LANCASTER SOUND; NEST-SITE FIDELITY; LONG-LIVED SEABIRD; PAGOPHILA-EBURNEA; CLIMATE-CHANGE; POLAR BEARS; POPULATIONS; MIGRATION; SURVIVAL; TRANSMITTERS	The ivory gull (Pagophila eburnea) is an endangered seabird that spends its entire year in the Arctic environment. In the past three decades, threats from various sources have contributed to a >70% decline in Canada. To assess the annual habitat needs of this species, we attached satellite transmitters to 12 ivory gulls on Seymour Island, Nunavut in 2010, which provided up to four breeding seasons of tracking data. Analysis of migratory behaviour revealed considerable individual variation of post-breeding migratory route selection. Ivory gulls traveled a median of 74 days during post-breeding migration, but only 18 days during pre-breeding migration. In contrast to predictions, ivory gulls did not use the Greenland coast during migratory periods. Ivory gulls overwintered near the ice edge in Davis Strait, but also used the Labrador Sea in late February and March. We suggest that the timing of formation and recession and extent of sea ice plays a large role in ivory gull distribution and migratory timing.	[Spencer, Nora C.; Mallory, Mark L.] Acadia Univ, Dept Biol, Wolfville, NS B0P 1X0, Canada; [Gilchrist, H. Grant] Carleton Univ, Environm Canada, Natl Wildlife Res Ctr, Ottawa, ON K1S 5B6, Canada	Acadia University; Carleton University; Environment & Climate Change Canada; Canadian Wildlife Service; National Wildlife Research Centre - Canada	Mallory, ML (corresponding author), Acadia Univ, Dept Biol, Wolfville, NS B0P 1X0, Canada.	mark.mallory@acadiau.ca	Mallory, Mark L/A-1952-2017	Mallory, Mark L/0000-0003-2744-3437	Kenneth Molson Foundation [58-0-205568]; Environment Canada [K4E21-12-0850]; Natural Sciences and Engineering Research Council of Canada [41-0-205561]	Kenneth Molson Foundation; Environment Canada(CGIAR); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This study was supported by the Kenneth Molson Foundation, cheque number: 58-0-205568 (http://www.kennethmolsonfoundation.ca/); Environment Canada, agreement number: K4E21-12-0850, (http://www.ec.gc.ca/default.asp?lang=En &); Natural Sciences and Engineering Research Council of Canada, agreement 41-0-205561, (http://www.nserc-crsng.gc.ca/index_eng.asp). Dr. Karel Allard and Dr. Birgit Braune of Environment Canada were involved in the data collection of this project. Environment Canada was involved in the study design and the preparation of the manuscript. No other funders had a role in study design, data analysis, decision to publish or preparation of the manuscript.	AINLEY DG, 1984, ORNITHOLOGICAL MONOG, V32; Akesson S, 2007, BIOSCIENCE, V57, P123, DOI 10.1641/B570207; BATESON P. P. G., 1959, BRIT BIRDS, V52, P105; *BIRDLIFE INT, 2014, SPEC FACTSH PAG EB; Blackmer AL, 2004, BIOL CONSERV, V116, P141, DOI 10.1016/S0006-3207(03)00185-X; Boyd IL, 2006, CONSERV BIOL SER, P1, DOI 10.1017/CBO9780511541964.002; BRADSTREET MSW, 1982, ARCTIC, V35, P1; Burger AE, 2008, AUK, V125, P253, DOI 10.1525/auk.2008.1408; *CLS, 2014, ARG US MAN, P68; Conover M.R., 1979, P COLONIAL WATERBIRD, V2, P41, DOI 10.2307/1520932; *COSEWIC, 2006, ASS UPD STAT REP IV; Day R.H., 2001, BIRDS N AM ONLINE; Environment Canada, 2014, SPEC RISK ACT REC ST; FALK K, 1995, POLAR BIOL, V15, P495; Fiedler W, 2003, AVIAN MIGRATION, P21; Fort J, 2009, J EXP BIOL, V212, P2483, DOI 10.1242/jeb.032300; Furness RW, 2006, ARDEA, V94, P631; Gaston A.J., 2004, SEABIRDS NATURAL HIS; Gaston AJ, 2005, ECOGRAPHY, V28, P331, DOI 10.1111/j.0906-7590.2005.04179.x; Gaston AJ, 2012, POLAR BIOL, V35, P1221, DOI 10.1007/s00300-012-1168-5; Gaston AJ, 2009, ENVIRON REV, V17, P267, DOI 10.1139/A09-013; Gaston AJ, 2009, J FIELD ORNITHOL, V80, P135, DOI 10.1111/j.1557-9263.2009.00215.x; Gehrold A, 2014, J AVIAN BIOL, V45, P131, DOI 10.1111/j.1600-048X.2013.00248.x; Gilchrist HG, 2005, BIOL CONSERV, V121, P303, DOI 10.1016/j.biocon.2004.04.021; Gilg O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064614; Gilg O, 2012, ANN NY ACAD SCI, V1249, P166, DOI 10.1111/j.1749-6632.2011.06412.x; Gilg O, 2010, J AVIAN BIOL, V41, P532, DOI 10.1111/j.1600-048X.2010.05125.x; Gilg O, 2009, POLAR BIOL, V32, P1275, DOI 10.1007/s00300-009-0623-4; Gonzalez-Solis J, 2011, MAR ECOL PROG SER, V435, P251, DOI 10.3354/meps09233; Hatch S. A., 2009, BIRDS N AM ONLINE; Hatch SA, 2010, CAN J FISH AQUAT SCI, V67, P386, DOI 10.1139/F09-184; HOLM S, 1979, SCAND J STAT, V6, P65; Howell SNG, 2001, WATERBIRDS, V24, P438, DOI 10.2307/1522078; Hunter CM, 2010, ECOLOGY, V91, P2883, DOI 10.1890/09-1641.1; Irons DB, 2008, GLOBAL CHANGE BIOL, V14, P1455, DOI 10.1111/j.1365-2486.2008.01581.x; Johnston DW, 2005, CLIM RES, V29, P209, DOI 10.3354/cr029209; Karnovsky NJ, 2009, ARCTIC, V62, P65; Klaassen RHG, 2012, BEHAV ECOL, V23, P58, DOI 10.1093/beheco/arr150; Lindsay RW, 2005, J CLIMATE, V18, P4879, DOI 10.1175/JCLI3587.1; Mallory ML, 2010, LITTLE LESS ARCTIC: TOP PREDATORS IN THE WORLDS LARGEST NORTHERN INLAND SEA, HUDSON BAY, P179, DOI 10.1007/978-90-481-9121-5_9; Mallory Mark L., 2008, Marine Ornithology, V36, P183; Mallory ML, 2003, ARCTIC, V56, P293; Mallory ML, 2008, BIRDS N AM ONLINE; Maslanik J., 1999, NEAR REAL TIME DMSP; Maslanik JA, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL032043; MCLAREN PL, 1982, ARCTIC, V35, P88; Molnar PK, 2010, BIOL CONSERV, V143, P1612, DOI 10.1016/j.biocon.2010.04.004; Mundy CJ, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL038837; Naves LC, 2006, OIKOS, V115, P263; Nuijten RJM, 2014, J AVIAN BIOL, V45, P113, DOI 10.1111/j.1600-048X.2013.00287.x; OLDEN B, 1985, J FIELD ORNITHOL, V56, P17; ORR CD, 1982, CAN FIELD NAT, V96, P323; Phillips RA, 2003, AUK, V120, P1082, DOI 10.1642/0004-8038(2003)120[1082:EOSTOA]2.0.CO;2; RENAUD WE, 1982, ARCTIC, V35, P141; Roberts JJ, 2010, ENVIRON MODELL SOFTW, V25, P1197, DOI 10.1016/j.envsoft.2010.03.029; Robertson GJ, 2007, AVIAN CONSERV ECOL, V2; SALYER JAMES W., 1962, JOUR WILDLIFE MANAGEMENT, V26, P219, DOI 10.2307/3798610; Senechal E, 2011, OECOLOGIA, V165, P593, DOI 10.1007/s00442-010-1853-4; Stenhouse IJ, 2012, IBIS, V154, P42, DOI 10.1111/j.1474-919X.2011.01180.x; Stenhouse IJ, 2004, WATERBIRDS, V27, P486, DOI 10.1675/1524-4695(2004)027[0486:RASROI]2.0.CO;2; Stirling I, 1997, J MARINE SYST, V10, P9, DOI 10.1016/S0924-7963(96)00054-1; Stirling I, 2006, ARCTIC, V59, P261; SWITZER PV, 1993, EVOL ECOL, V7, P533, DOI 10.1007/BF01237820; THOMAS VG, 1987, ARCTIC, V40, P211	64	27	29	1	101	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2014	9	12							e115231	10.1371/journal.pone.0115231	http://dx.doi.org/10.1371/journal.pone.0115231			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UC	25551556	Green Submitted, Green Published, gold			2022-12-27	WOS:000347119100032
J	Storms, ZJ; Sauvageau, D				Storms, Zachary J.; Sauvageau, Dominic			Evidence That the Heterogeneity of a T4 Population Is the Result of Heritable Traits	PLOS ONE			English	Article							LONG TAIL-FIBER; HOST-RANGE; BACTERIOPHAGE; ADSORPTION; PHAGE; RECEPTOR; ATTACHMENT; ORGANIZATION; KINETICS; PROTEIN	Many bacteriophage populations display heterogeneity in their adsorption characteristics; a portion of the phage population remains free in solution throughout adsorption experiments (residual fraction). This residual fraction generally constitutes a minority of phages that exhibit significantly slower adsorption kinetics than the main phage stock (main fraction). While this phenomenon is likely the result of evolutionary driving forces, the present study demonstrates that the residual fraction is not always the result of phenotypic variations within a single genotype, as is generally thought. Experiments with phage T4 showed that two subgroups with distinct adsorption traits that were passed on to their progeny could be isolated from the original phage stock. Sequencing of genes involved in adsorption revealed two point mutations in gene 37 of residual fraction isolates, which resulted in modifications to the long tail-fiber, the organelle of attachment and host cell recognition. Adsorption studies consistently showed that T4 phage stocks amplified from residual fraction isolates had significantly lower adsorption efficiencies than those amplified from main fractions. The conducted experiments provide convincing evidence that the observed heterogeneity in T4 adsorption behavior is the result of conserved mutations to the phage genome and is not exclusively the result of phenotypic variations within the population. While it is believed high mutation rates exist to hasten phage adaptation, this study shows that this bet hedging strategy can also, in the short term, inadvertently handicap the phage's adsorption capabilities to a given host under normal infection conditions, resulting in the residual fraction observed in adsorption experiments.	[Storms, Zachary J.; Sauvageau, Dominic] Univ Alberta, Dept Chem & Mat Engn, Edmonton, AB, Canada	University of Alberta	Sauvageau, D (corresponding author), Univ Alberta, Dept Chem & Mat Engn, Edmonton, AB, Canada.	dominic.sauvageau@ualberta.ca			Natural Sciences and Engineering Research Council of Canada; Alberta Innovates - Technology Futures Postdoctoral Fellowship; University of Alberta	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Alberta Innovates - Technology Futures Postdoctoral Fellowship; University of Alberta(University of Alberta)	ZS holds a Natural Sciences and Engineering Research Council of Canada Postdoctoral Fellowship as well as an Alberta Innovates - Technology Futures Postdoctoral Fellowship. DS received funding from the University of Alberta start-up funds for this project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams MH, 1959, BACTERIOPHAGES; ANDERSON TF, 1949, BOT REV, V15, P464, DOI 10.1007/BF02861677; Bartual SG, 2010, P NATL ACAD SCI USA, V107, P20287, DOI 10.1073/pnas.1011218107; BENDER RA, 1989, J BACTERIOL, V171, P1035, DOI 10.1128/jb.171.2.1035-1040.1989; BRAUN G, 1984, MOL GEN GENET, V195, P321, DOI 10.1007/BF00332766; Cerritelli ME, 1996, J MOL BIOL, V260, P767, DOI 10.1006/jmbi.1996.0436; CHRISTENSEN JR, 1965, VIROLOGY, V26, P727, DOI 10.1016/0042-6822(65)90336-3; Delbruck M, 1940, J GEN PHYSIOL, V23, P631, DOI 10.1085/jgp.23.5.631; DREXLER K, 1991, J MOL BIOL, V219, P655, DOI 10.1016/0022-2836(91)90662-P; DREXLER K, 1989, J MOL BIOL, V207, P797, DOI 10.1016/0022-2836(89)90245-3; Drummond DA, 2009, NAT REV GENET, V10, P715, DOI 10.1038/nrg2662; Gallet R, 2012, EVOLUTION, V66, P3485, DOI 10.1111/j.1558-5646.2012.01690.x; GAREN A, 1954, BIOCHIM BIOPHYS ACTA, V14, P163, DOI 10.1016/0006-3002(54)90155-9; GAREN A, 1951, J EXP MED, V94, P177, DOI 10.1084/jem.94.3.177; Goldberg Edward, 1994, P347; HABERER K, 1982, J VIROL, V41, P501, DOI 10.1128/JVI.41.2.501-507.1982; Hyman P, 2010, ADV APPL MICROBIOL, V70, P217, DOI 10.1016/S0065-2164(10)70007-1; KING J, 1971, J MOL BIOL, V62, P465, DOI 10.1016/0022-2836(71)90148-3; Moldovan R, 2007, BIOPHYS J, V93, P303, DOI 10.1529/biophysj.106.102962; PHILIPPI T, 1989, TRENDS ECOL EVOL, V4, P41, DOI 10.1016/0169-5347(89)90138-9; PUCK TT, 1953, COLD SPRING HARB SYM, V18, P149, DOI 10.1101/SQB.1953.018.01.024; PUCK TT, 1951, J EXP MED, V93, P65, DOI 10.1084/jem.93.1.65; Rakhuba DV, 2010, POL J MICROBIOL, V59, P145, DOI 10.33073/pjm-2010-023; Ripp S, 1997, MICROBIOL-UK, V143, P2065, DOI 10.1099/00221287-143-6-2065; Schlesinger M., 1932, Z HYG INFEKTIONSKR, V114, P136, DOI 10.1007/BF02176514; SCHWARTZ M, 1976, J MOL BIOL, V103, P521, DOI 10.1016/0022-2836(76)90215-1; STEENSMA HY, 1982, A VAN LEEUW J MICROB, V48, P183, DOI 10.1007/BF00405202; STENT GS, 1952, BIOCHIM BIOPHYS ACTA, V8, P260, DOI 10.1016/0006-3002(52)90041-3; Stockdale SR, 2013, J BIOL CHEM, V288, P5581, DOI 10.1074/jbc.M112.444901; Storms ZJ, 2012, BIOCHEM ENG J, V64, P22, DOI 10.1016/j.bej.2012.02.007; Storms ZJ, 2010, BIOPROC BIOSYST ENG, V33, P823, DOI 10.1007/s00449-009-0405-y; Tetart F, 1996, J MOL BIOL, V258, P726, DOI 10.1006/jmbi.1996.0281; Uchiyama J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026648; WATANABE K, 1982, AGR BIOL CHEM TOKYO, V46, P697, DOI 10.1080/00021369.1982.10865142; Whitehead DJ, 2008, BIOL DIRECT, V3, DOI 10.1186/1745-6150-3-18; Williamson SJ, 2001, APPL ENVIRON MICROB, V67, P1682, DOI 10.1128/AEM.67.4.1682-1688.2001; Wilson WH, 1997, AQUAT MICROB ECOL, V13, P95, DOI 10.3354/ame013095; Zonenstein Y, 2010, BIOCHEM ENG J, V48, P225, DOI 10.1016/j.bej.2009.10.016	38	8	8	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2014	9	12							e116235	10.1371/journal.pone.0116235	http://dx.doi.org/10.1371/journal.pone.0116235			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UC	25551763	Green Published, Green Submitted, gold			2022-12-27	WOS:000347119100111
J	Ventura, GT; da Costa, ECB; Capaccia, AM; Mohana-Borges, R				Ventura, Gustavo Tavares; Brasil da Costa, Emmerson Correa; Capaccia, Anne Miranda; Mohana-Borges, Ronaldo			pH-Dependent Conformational Changes in the HCV NS3 Protein Modulate Its ATPase and Helicase Activities	PLOS ONE			English	Article							HEPATITIS-C VIRUS; RNA HELICASE; CRYSTAL-STRUCTURE; ENZYMATIC-ACTIVITIES; PRIMASE INHIBITORS; SERINE-PROTEASE; DUPLEX RNA; DOMAIN; REPLICATION; BINDING	The hepatitis C virus (HCV) infects 170 to 200 million people worldwide and is, therefore, a major health problem. The lack of efficient treatments that specifically target the viral proteins or RNA and its high chronicity rate make hepatitis C the cause of many deaths and hepatic transplants annually. The NS3 protein is considered an important target for the development of anti-HCV drugs because it is composed of two domains (a serine protease in the N-terminal portion and an RNA helicase/NTPase in the C-terminal portion), which are essential for viral replication and proliferation. We expressed and purified both the NS3 helicase domain (NS3hel) and the full-length NS3 protein (NS3FL) and characterized pH-dependent structural changes associated with the increase in their ATPase and helicase activities at acidic pH. Using intrinsic fluorescence experiments, we have observed that NS3hel was less stable at pH 6.4 than at pH 7.2. Moreover, binding curves using an extrinsic fluorescent probe (bis-ANS) and ATPase assays performed under different pH conditions demonstrated that the hydrophobic clefts of NS3 are significantly more exposed to the aqueous medium at acidic pH. Using fluorescence spectroscopy and anisotropy assays, we have also observed more protein interaction with DNA upon pH acidification, which suggests that the hydrophobic clefts exposure on NS3 might be related to a loss of stability that could lead it to adopt a more open conformation. This conformational change at acidic pH would stimulate both its ATPase and helicase activities, as well as its ability to bind DNA. Taken together, our results indicate that the NS3 protein adopts a more open conformation due to acidification from pH 7.2 to 6.4, resulting in a more active form at a pH that is found near Golgi-derived membranes. This increased activity could better allow NS3 to carry out its functions during HCV replication.	[Ventura, Gustavo Tavares; Brasil da Costa, Emmerson Correa; Capaccia, Anne Miranda; Mohana-Borges, Ronaldo] Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, Lab Genom Estrutural, Rio De Janeiro, Brazil	Universidade Federal do Rio de Janeiro	Mohana-Borges, R (corresponding author), Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, Lab Genom Estrutural, Rio De Janeiro, Brazil.	mohana@biof.ufrj.br	Borges, Ronaldo S Mohana/C-5575-2013		Instituto Nacional de Ciencia e Tecnologia em Biologia Estrutural e Bioimagem (INCTINBEB); Coordenacao de Aperfeicoamento de Pessoal de Ensino Superior (CAPES); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)	Instituto Nacional de Ciencia e Tecnologia em Biologia Estrutural e Bioimagem (INCTINBEB); Coordenacao de Aperfeicoamento de Pessoal de Ensino Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ))	This work was supported by the following Brazilian funding agencies: Instituto Nacional de Ciencia e Tecnologia em Biologia Estrutural e Bioimagem (INCTINBEB), Coordenacao de Aperfeicoamento de Pessoal de Ensino Superior (CAPES), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), and Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abian O, 2010, BIOPHYS J, V99, P3811, DOI 10.1016/j.bpj.2010.10.037; Alvisi G, 2011, RNA BIOL, V8, P258, DOI 10.4161/rna.8.2.15011; Asselah T, 2011, LIVER INT, V31, P68, DOI 10.1111/j.1478-3231.2010.02411.x; Aydin C, 2013, PROTEIN SCI, V22, P1786, DOI 10.1002/pro.2378; Belon CA, 2009, FUTURE VIROL, V4, P277, DOI 10.2217/FVL.09.7; Beran RKF, 2007, J BIOL CHEM, V282, P34913, DOI 10.1074/jbc.M707165200; Cho HS, 1998, J BIOL CHEM, V273, P15045, DOI 10.1074/jbc.273.24.15045; Crute JJ, 2002, NAT MED, V8, P386, DOI 10.1038/nm0402-386; Dubuisson J, 2007, WORLD J GASTROENTERO, V13, P2406, DOI 10.3748/wjg.v13.i17.2406; Fiske CH, 1927, SCIENCE, V65, P401, DOI 10.1126/science.65.1686.401; Frick DN, 2007, CURR ISSUES MOL BIOL, V9, P1; Frick DN, 2004, NUCLEIC ACIDS RES, V32, P5519, DOI 10.1093/nar/gkh891; Frick DN, 2004, J BIOL CHEM, V279, P1269, DOI 10.1074/jbc.M310630200; Fried MW, 2002, NEW ENGL J MED, V347, P975, DOI 10.1056/NEJMoa020047; Gallinari P, 1998, J VIROL, V72, P6758, DOI 10.1128/JVI.72.8.6758-6769.1998; Gwack Y, 1996, BIOCHEM BIOPH RES CO, V225, P654, DOI 10.1006/bbrc.1996.1225; Hoofnagle JH, 2006, NEW ENGL J MED, V355, P2444, DOI 10.1056/NEJMct061675; Kim JL, 1998, STRUCTURE, V6, P89, DOI 10.1016/S0969-2126(98)00010-0; Kleymann G, 2002, NAT MED, V8, P392, DOI 10.1038/nm0402-392; Kolykhalov AA, 2000, J VIROL, V74, P2046, DOI 10.1128/JVI.74.4.2046-2051.2000; Kwong AD, 2011, NAT BIOTECHNOL, V29, P993, DOI 10.1038/nbt.2020; Lam AMI, 2006, J VIROL, V80, P404, DOI 10.1128/JVI.80.1.404-411.2006; Lam AMI, 2004, NUCLEIC ACIDS RES, V32, P4060, DOI 10.1093/nar/gkh743; Lam AMI, 2003, J BIOL CHEM, V278, P44514, DOI 10.1074/jbc.M306444200; Lam AMI, 2003, J VIROL, V77, P3950, DOI 10.1128/JVI.77.7.3950-3961.2003; Lamarre D, 2003, NATURE, V426, P186, DOI 10.1038/nature02099; Lim SR, 2012, ANTIMICROB AGENTS CH, V56, P271, DOI 10.1128/AAC.05636-11; Liu WJ, 2002, J VIROL, V76, P10766, DOI 10.1128/JVI.76.21.10766-10775.2002; Luo DH, 2008, EMBO J, V27, P3209, DOI 10.1038/emboj.2008.232; Ma YH, 2008, J VIROL, V82, P7624, DOI 10.1128/JVI.00724-08; Mackintosh SG, 2006, J BIOL CHEM, V281, P3528, DOI 10.1074/jbc.M512100200; Matlock DL, 2010, BIOCHEMISTRY-US, V49, P2097, DOI 10.1021/bi901977k; Moradpour D, 2007, NAT REV MICROBIOL, V5, P453, DOI 10.1038/nrmicro1645; Pace CN, 2000, PROTEINS, P1; Pang PS, 2002, EMBO J, V21, P1168, DOI 10.1093/emboj/21.5.1168; Pawlotsky JM, 2014, SEMIN LIVER DIS, V34, P22, DOI 10.1055/s-0034-1371007; Piccininni S, 2002, J BIOL CHEM, V277, P45670, DOI 10.1074/jbc.M204124200; Sali DL, 1998, BIOCHEMISTRY-US, V37, P3392, DOI 10.1021/bi972010r; Serafino A, 2003, J MED VIROL, V70, P31, DOI 10.1002/jmv.10367; Serebrov V, 2009, J BIOL CHEM, V284, P2512, DOI 10.1074/jbc.M805460200; Smith DB, 2014, HEPATOLOGY, V59, P318, DOI 10.1002/hep.26744; Taremi SS, 1998, PROTEIN SCI, V7, P2143, DOI 10.1002/pro.5560071011; Tsai WL, 2010, ONCOGENE, V29, P2309, DOI 10.1038/onc.2010.36; Uhl P, 2014, INT J MOL SCI, V15, P7500, DOI 10.3390/ijms15057500; Vaughan R, 2012, VIRUS RES, V169, P80, DOI 10.1016/j.virusres.2012.07.007; Vega S, 2013, INT J MOL SCI, V14, P13282, DOI 10.3390/ijms140713282; Venkatraman S, 2012, TRENDS PHARMACOL SCI, V33, P289, DOI 10.1016/j.tips.2012.03.012; Wardell AD, 1999, J GEN VIROL, V80, P701, DOI 10.1099/0022-1317-80-3-701; Wu MM, 2000, CHEM BIOL, V7, P197, DOI 10.1016/S1074-5521(00)00088-0; Yao NH, 1999, STRUCTURE, V7, P1353, DOI 10.1016/S0969-2126(00)80025-8; Yao NH, 1997, NAT STRUCT BIOL, V4, P463, DOI 10.1038/nsb0697-463; Yau AHL, 2014, CAN J GASTROENTEROL, V28, P445, DOI 10.1155/2014/549624	52	6	6	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2014	9	12							e115941	10.1371/journal.pone.0115941	http://dx.doi.org/10.1371/journal.pone.0115941			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UC	25551442	gold, Green Published, Green Submitted			2022-12-27	WOS:000347119100079
J	Balasubramanian, R; Robaye, B; Boeynaems, JM; Jacobson, KA				Balasubramanian, Ramachandran; Robaye, Bernard; Boeynaems, Jean-Marie; Jacobson, Kenneth A.			Enhancement of Glucose Uptake in Mouse Skeletal Muscle Cells and Adipocytes by P2Y(6) Receptor Agonists	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; G(Q)-COUPLED RECEPTOR; DEPENDENT MECHANISM; INSULIN-SECRETION; GLUT4 PROMOTER; IN-VIVO; TRANSCRIPTION; TRANSPORT; MICE; UDP	Glucose uptake by peripheral tissues such as skeletal muscles and adipocytes is important in the maintenance of glucose homeostasis. We previously demonstrated that P2Y(6) receptor (P2Y(6)R) agonists protect pancreatic islet cells from apoptosis and stimulate glucose-dependent insulin release. Here, we investigated the effects of P2Y(6)R activation on glucose uptake in insulin target tissues. An agonist of the P2Y(6)R, P-1-(5'-uridine)-P-3-(5'-N-4-methoxycytidine)-triphosphate (MRS2957), significantly increased the uptake of [H-3]2-deoxyglucose in mouse C2C12 myotubes and 3T3-L1 adipocytes, and this stimulation was significantly decreased by a selective P2Y6R antagonist N,N'-1,4-butanediyl-bis[N'-(3-isothiocyanatophenyl)thiourea] (MRS2578). Pre-incubation with Compound C (an inhibitor of 5'-AMP-activated protein kinase, AMPK), or AMPK siRNA abolished the stimulatory effect of MRS2957 on glucose uptake. Also, MRS2957 (60 min incubation) increased recruitment of the facilitated glucose transporter-4 (GLUT4) to the cell membrane, which was blocked by MRS2578. Treatment of C2C12 myotubes with MRS2957 induced significant phosphorylation of AMPK, which increase GLUT4 expression through histone deacetylase (HDAC) 5 signaling. Glucose uptake in primary mouse adipocytes from wild-type mice was stimulated upon P2Y6R activation by either MRS2957 or native agonist UDP, and the P2Y(6)R effect was antagonized by MRS2578. However, in adipocytes from P2Y(6)R-knockout mice P2Y(6)R agonists had no effect on glucose uptake, and there was no change in the glucose uptake by insulin. Our results indicate that the P2Y(6)R promotes glucose metabolism in peripheral tissues, which may be mediated through AMPK signaling.	[Balasubramanian, Ramachandran; Jacobson, Kenneth A.] NIDDK, Mol Recognit Sect, Bioorgan Chem Lab, NIH, Bethesda, MD 20892 USA; [Robaye, Bernard] Univ Libre Bruxelles, IRIBHM, Inst Interdisciplinary Res, Gosselies, Belgium; [Boeynaems, Jean-Marie] Univ Libre Bruxelles, Brussels, Belgium	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Universite Libre de Bruxelles; Universite Libre de Bruxelles	Jacobson, KA (corresponding author), NIDDK, Mol Recognit Sect, Bioorgan Chem Lab, NIH, Bethesda, MD 20892 USA.	kajacobs@helix.nih.gov	Jacobson, Kenneth Alan/A-1530-2009	Jacobson, Kenneth Alan/0000-0001-8104-1493	Intramural Research Program of NIDDK, National Institutes of Health, Bethesda, MD, USA [Z01 DK031116-27]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK031116, Z01DK031116] Funding Source: NIH RePORTER	Intramural Research Program of NIDDK, National Institutes of Health, Bethesda, MD, USA; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by Intramural Research Program of NIDDK, National Institutes of Health, Bethesda, MD, USA; Grant: Z01 DK031116-27. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amisten S, 2010, DIABETOLOGIA, V53, P1927, DOI 10.1007/s00125-010-1807-8; Aune UL, 2013, JOVE-J VIS EXP, DOI 10.3791/50191; Balasubramanian R, 2013, BIOCHEM PHARMACOL, V85, P991, DOI 10.1016/j.bcp.2012.11.029; Bar I, 2008, MOL PHARMACOL, V74, P777, DOI 10.1124/mol.108.046904; Burnstock G, 2012, WIRES COMPUT STAT, V1, P116, DOI [10.1002/wmts.14., DOI 10.1002/WMTS.14]; Christensen DP, 2011, MOL MED, V17, P378, DOI 10.2119/molmed.2011.00021; Communi D, 1996, BIOCHEM BIOPH RES CO, V222, P303, DOI 10.1006/bbrc.1996.0739; El-Tayeb A, 2011, J MED CHEM, V54, P2878, DOI 10.1021/jm1016297; Ginsburg-Shmuel T, 2010, J MED CHEM, V53, P1673, DOI 10.1021/jm901450d; Gong HJ, 2011, MED SCI SPORT EXER, V43, P1441, DOI 10.1249/MSS.0b013e31820f6093; Guns PJDF, 2010, BRIT J PHARMACOL, V159, P326, DOI 10.1111/j.1476-5381.2009.00497.x; Inazuka F, 2006, PCT Int Appl, Patent No. [WO 2006052007 A1 20060518, 2006052007]; Jain S, 2013, J CLIN INVEST, V123, P1750, DOI 10.1172/JCI66432; Karczewska J, 2011, BIOCHEM BIOPH RES CO, V404, P723, DOI 10.1016/j.bbrc.2010.12.051; Kim SG, 2003, CELL MOL NEUROBIOL, V23, P401, DOI 10.1023/A:1023696806609; Koistinen HA, 2003, DIABETES, V52, P1066, DOI 10.2337/diabetes.52.5.1066; Kurth-Kraczek EJ, 1999, DIABETES, V48, P1667, DOI 10.2337/diabetes.48.8.1667; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lee YJ, 2005, AM J PHYSIOL-CELL PH, V289, pC1268, DOI 10.1152/ajpcell.00002.2005; Li JH, 2013, ENDOCRINOLOGY, V154, P3539, DOI 10.1210/en.2012-2127; Mamedova LK, 2008, PHARMACOL RES, V58, P232, DOI 10.1016/j.phrs.2008.08.004; Mamedova LK, 2004, BIOCHEM PHARMACOL, V67, P1763, DOI 10.1016/j.bcp.2004.01.011; Maruoka H, 2010, J MED CHEM, V53, P4488, DOI 10.1021/jm100287t; Mcgee SL, 2008, DIABETES, V57, P860, DOI 10.2337/db07-0843; Merlin J, 2010, CELL SIGNAL, V22, P1104, DOI 10.1016/j.cellsig.2010.03.004; Moore DJ, 2001, BBA-GENE STRUCT EXPR, V1521, P107, DOI 10.1016/S0167-4781(01)00291-3; Mukwevho E, 2008, AM J PHYSIOL-ENDOC M, V294, pE582, DOI 10.1152/ajpendo.00312.2007; Murgia M, 2009, J PHYSIOL-LONDON, V587, P4319, DOI 10.1113/jphysiol.2009.174888; Olson AL, 1996, ANNU REV NUTR, V16, P235, DOI 10.1146/annurev.nu.16.070196.001315; Parandeh F, 2008, BIOCHEM BIOPH RES CO, V370, P499, DOI 10.1016/j.bbrc.2008.03.119; Rachdaoui N, 2003, AM J PHYSIOL-ENDOC M, V285, pE545, DOI 10.1152/ajpendo.00160.2003; Ruan H, 2003, J BIOL CHEM, V278, P47585, DOI 10.1074/jbc.M305257200; Sassmann A, 2010, J CLIN INVEST, V120, P2184, DOI 10.1172/JCI41541; Schwartz MW, 2013, NATURE, V503, P59, DOI 10.1038/nature12709; Shibata H, 1996, J BIOL CHEM, V271, P9704, DOI 10.1074/jbc.271.16.9704; Solini A, 2003, J CELL PHYSIOL, V197, P435, DOI 10.1002/jcp.10379; Song XM, 2002, DIABETOLOGIA, V45, P56, DOI 10.1007/s125-002-8245-8; Sparling DP, 2008, J BIOL CHEM, V283, P7429, DOI 10.1074/jbc.M800481200; Thaning P, 2010, DIABETES, V59, P182, DOI 10.2337/db09-1068; Vieira RP, 2011, AM J RESP CRIT CARE, V184, P215, DOI 10.1164/rccm.201011-1762OC; Warny M, 2001, J BIOL CHEM, V276, P26051, DOI 10.1074/jbc.M102568200; Weems JC, 2012, DIABETES, V61, P1404, DOI 10.2337/db11-0737	42	27	27	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2014	9	12							e116203	10.1371/journal.pone.0116203	http://dx.doi.org/10.1371/journal.pone.0116203			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX6YH	25549240	Green Published, Green Submitted, gold			2022-12-27	WOS:000347063500060
J	Couto, A; Monceau, K; Bonnard, O; Thiery, D; Sandoz, JC				Couto, Antoine; Monceau, Karine; Bonnard, Olivier; Thiery, Denis; Sandoz, Jean-Christophe			Olfactory Attraction of the Hornet Vespa velutina to Honeybee Colony Odors and Pheromones	PLOS ONE			English	Article							MISCHOCYTTARUS-FLAVITARSIS HYMENOPTERA; APIS-MELLIFERA; VOLATILE COMPOUNDS; WASPS HYMENOPTERA; FORAGING BEHAVIOR; CRASSOSTREA-GIGAS; ACTIVE COMPONENT; BROOD PHEROMONE; AROMA COMPOUNDS; PREY QUANTITY	Since the beginning of the last century, the number of biological invasions has continuously increased worldwide. Due to their environmental and economical consequences, invasive species are now a major concern. Social wasps are particularly efficient invaders because of their distinctive biology and behavior. Among them, the yellow-legged hornet, Vespa velutina, is a keen hunter of domestic honeybees. Its recent introduction to Europe may induce important beekeeping, pollination, and biodiversity problems. Hornets use olfactory cues for the long-range detection of food sources, in this case the location of honeybee colonies, but the exact nature of these cues remains unknown. Here, we studied the orientation behavior of V. velutina workers towards a range of hive products and protein sources, as well as towards prominent chemical substances emitted by these food sources. In a multiple choice test performed under controlled laboratory conditions, we found that hornets are strongly attracted to the odor of some hive products, especially pollen and honey. When testing specific compounds, the honeybee aggregation pheromone, geraniol, proved highly attractive. Pheromones produced by honeybee larvae or by the queen were also of interest to hornet workers, albeit to a lesser extent. Our results indicate that V. velutina workers are selectively attracted towards olfactory cues from hives (stored food, brood, and queen), which may signal a high prey density. This study opens new perspectives for understanding hornets' hunting behavior and paves the way for developing efficient trapping strategies against this invasive species.	[Couto, Antoine; Sandoz, Jean-Christophe] CNRS, UPR 9034, Evolut Genomes & Speciat Lab LEGS, Gif Sur Yvette, France; [Monceau, Karine] Univ Bourgogne, Equipe Ecol Evolut, UMR CNRS Biogeosci 6282, Dijon, France; [Bonnard, Olivier; Thiery, Denis] INRA, UMR St & Agroecol Vignoble 1065, Villenave Dornon, France; [Bonnard, Olivier; Thiery, Denis] Univ Bordeaux, ISVV, UMR St & Agroecol Vignoble 1065, Villenave Dornon, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Universite de Bourgogne; INRAE; UDICE-French Research Universities; Universite de Bordeaux	Sandoz, JC (corresponding author), CNRS, UPR 9034, Evolut Genomes & Speciat Lab LEGS, Gif Sur Yvette, France.	sandoz@legs.cnrs-gif.fr	SANDOZ, Jean-Christophe/A-6085-2012	SANDOZ, Jean-Christophe/0000-0002-5423-9645; Monceau, Karine/0000-0003-3786-1835; Couto, Antoine/0000-0002-5528-7331	Region Ile-de-France (DIM R2DS); French Academy of Agriculture (Bourse Dufrenoy)	Region Ile-de-France (DIM R2DS)(Region Ile-de-France); French Academy of Agriculture (Bourse Dufrenoy)	This work was supported by a grant from Region Ile-de-France to JCS (DIM R2DS, http://www.r2ds-ile-de-france.com/, project 2011-05) and by a travel grant from the French Academy of Agriculture (Bourse Dufrenoy, http://www.academie-agriculture.fr/) to AC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acevedo CA, 2011, PROC FOOD SCI, V1, P549, DOI 10.1016/j.profoo.2011.09.083; Agila A, 2013, J FOOD SCI, V78, pC184, DOI 10.1111/1750-3841.12033; Akre RD, 1980, US DEP AGR HDB, V552; Arca M, 2014, BEHAV PROCESS, V106, P122, DOI 10.1016/j.beproc.2014.05.002; Armstrong TR, 2003, BEHAV ECOL SOCIOBIOL, V54, P310, DOI 10.1007/s00265-003-0624-1; Baraldi R, 1999, PHYS CHEM EARTH PT B, V24, P729, DOI 10.1016/S1464-1909(99)00073-8; BOCH R, 1962, NATURE, V195, P1018, DOI 10.1038/1951018b0; BOCH R, 1962, NATURE, V194, P704, DOI 10.1038/194704b0; BORGKARLSON AK, 1985, CHEM SCRIPTA, V25, P283; Briscoe AD, 2001, ANNU REV ENTOMOL, V46, P471, DOI 10.1146/annurev.ento.46.1.471; Brockmann A, 2006, J CHEM ECOL, V32, P657, DOI 10.1007/s10886-005-9027-2; Brodmann J, 2009, CURR BIOL, V19, P1368, DOI 10.1016/j.cub.2009.06.067; Brown MJF, 2009, APIDOLOGIE, V40, P410, DOI 10.1051/apido/2009019; Choi M.B., 2011, ENTOMOL RES, V41, P276, DOI [10.1111/j.1748-5967.2011.00370.x, DOI 10.1111/J.1748-5967.2011.00370.X]; Christlbauer M, 2011, J AGR FOOD CHEM, V59, P13122, DOI 10.1021/jf203340a; COLLINS AM, 1982, J CHEM ECOL, V8, P463, DOI 10.1007/BF00987794; CORNELIUS ML, 1993, J INSECT BEHAV, V6, P771, DOI 10.1007/BF01201676; D'Adamo P, 2004, J INSECT BEHAV, V17, P809, DOI 10.1023/B:JOIR.0000048990.22170.96; D'Adamo P, 2003, NEW ZEAL J ZOOL, V30, P171, DOI 10.1080/03014223.2003.9518336; D'Adamo P, 2011, J INSECT SCI, V11, DOI 10.1673/031.011.10301; d'Ippolito G, 2003, ORG LETT, V5, P885, DOI 10.1021/ol034057c; Day SE, 2001, ENVIRON ENTOMOL, V30, P157, DOI 10.1603/0046-225X-30.2.157; Dyer FC, 2002, ANNU REV ENTOMOL, V47, P917, DOI 10.1146/annurev.ento.47.091201.145306; Edwards R, 1980, THEIR BEHAV CONTROL; Elton C. S., 1958, ECOLOGY INVASIONS AN; Faraji H, 2004, J AGR FOOD CHEM, V52, P7164, DOI 10.1021/jf035291k; Formisano C, 2009, MOLECULES, V14, P4597, DOI 10.3390/molecules14114597; Free J. B., 1987, PHEROMONES SOCIAL BE; Grigorakis K, 2003, AQUACULTURE, V225, P109, DOI 10.1016/S0044-8486(03)00283-7; Haxaire Jean, 2006, Bulletin de la Societe Entomologique de France, V111, P194; HENDRICHS J, 1994, OECOLOGIA, V99, P88, DOI 10.1007/BF00317087; Hilker M, 2002, J EXP BIOL, V205, P455; Hochberg ME, 2005, TRENDS ECOL EVOL, V20, P211, DOI 10.1016/j.tree.2005.03.005; Janes D, 2009, FOOD CHEM, V112, P120, DOI 10.1016/j.foodchem.2008.05.048; Jung C, 2008, KOREAN J APIC, V24, P61; Keeling CI, 2003, P NATL ACAD SCI USA, V100, P4486, DOI 10.1073/pnas.0836984100; Ken T, 2005, NATURWISSENSCHAFTEN, V92, P492, DOI 10.1007/s00114-005-0026-5; KENNEDY JS, 1978, PHYSIOL ENTOMOL, V3, P91, DOI 10.1111/j.1365-3032.1978.tb00138.x; LE CONTE Y, 1990, NATURWISSENSCHAFTEN, V77, P334, DOI 10.1007/BF01138390; Le Conte Y, 2008, ANNU REV ENTOMOL, V53, P523, DOI 10.1146/annurev.ento.52.110405.091434; Li JJ, 2008, J APICULT RES, V47, P174, DOI 10.1080/00218839.2008.11101449; Lozada M, 2009, ENVIRON ENTOMOL, V38, P803, DOI 10.1603/022.038.0333; Lozada M, 2006, J INSECT BEHAV, V19, P591, DOI 10.1007/s10905-006-9045-0; Lozada M, 2011, J INSECT BEHAV, V24, P159, DOI 10.1007/s10905-010-9244-6; Maisonnasse A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013531; Matsuura M., 1990, BIOL VESPINE WASPS; MATTIACCI L, 1995, P NATL ACAD SCI USA, V92, P2036, DOI 10.1073/pnas.92.6.2036; McPheron LJ, 2007, ENTOMOL GEN, V30, P105; McPheron LJ, 2007, ENTOMOL GEN, V29, P125; Mohammedi A, 1996, CR ACAD SCI III-VIE, V319, P769; Moller H, 1996, BIOL CONSERV, V78, P125, DOI 10.1016/0006-3207(96)00022-5; Monceau K, 2013, INSECT SOC, V60, P437, DOI 10.1007/s00040-013-0308-4; Monceau K, 2014, INSECT SCI; Monceau K, 2014, J PEST SCI, V87, P1, DOI 10.1007/s10340-013-0537-3; Monceau K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066492; Moreyra S, 2012, ANN ENTOMOL SOC AM, V105, P128, DOI 10.1603/AN11097; Morgan ED, 2009, PHYSIOL ENTOMOL, V34, P1, DOI 10.1111/j.1365-3032.2008.00658.x; ONO M, 1995, NATURE, V377, P334, DOI 10.1038/377334a0; Pankiw T, 2000, NATURWISSENSCHAFTEN, V87, P487, DOI 10.1007/s001140050764; Papachristoforou A, 2007, CURR BIOL, V17, pR795, DOI 10.1016/j.cub.2007.07.033; Pare PW, 1999, PLANT PHYSIOL, V121, P325, DOI 10.1104/pp.121.2.325; Park K, 2004, ECOL SOC, V9; PEITSCH D, 1992, J COMP PHYSIOL A, V170, P23, DOI 10.1007/BF00190398; Perrard A, 2009, ANN SOC ENTOMOL FR, V45, P119, DOI 10.1080/00379271.2009.10697595; Pimentel D, 2005, ECOL ECON, V52, P273, DOI 10.1016/j.ecolecon.2004.10.002; Piveteau F, 2000, J AGR FOOD CHEM, V48, P4851, DOI 10.1021/jf991394k; Potts SG, 2010, TRENDS ECOL EVOL, V25, P345, DOI 10.1016/j.tree.2010.01.007; Refsgaard HHF, 1999, J AGR FOOD CHEM, V47, P1114, DOI 10.1021/jf9807770; Richter MR, 2000, ANNU REV ENTOMOL, V45, P121, DOI 10.1146/annurev.ento.45.1.121; Rome Quentin, 2011, Aliens (Auckland), V31, P7; Rota V, 2006, ACS SYM SER, V920, P73; Santos JR, 2003, J CHROMATOGR A, V985, P395, DOI 10.1016/S0021-9673(02)01396-1; SCHMIDT JO, 1994, J CHEM ECOL, V20, P1053, DOI 10.1007/BF02059741; Selli S, 2006, J AGR FOOD CHEM, V54, P9496, DOI 10.1021/jf0619582; Shafir S, 1996, BIOTROPICA, V28, P243, DOI 10.2307/2389078; SHEARER DA, 1965, NATURE, V206, P530, DOI 10.1038/206530a0; Slessor KN, 2005, J CHEM ECOL, V31, P2731, DOI 10.1007/s10886-005-7623-9; SLESSOR KN, 1988, NATURE, V332, P354, DOI 10.1038/332354a0; Snyder WE, 2006, ANNU REV ECOL EVOL S, V37, P95, DOI 10.1146/annurev.ecolsys.37.091305.110107; Spradbery JP, 1973, WASPS ACCOUNT BIOL N; Stamp NE, 2001, ECOL ENTOMOL, V26, P292, DOI 10.1046/j.1365-2311.2001.00325.x; Tan K, 2007, NATURWISSENSCHAFTEN, V94, P469, DOI 10.1007/s00114-006-0210-2; Tan K, 2010, J INSECT SCI, V10, DOI 10.1673/031.010.14102; Tan K, 2013, NATURWISSENSCHAFTEN, V100, P245, DOI 10.1007/s00114-013-1019-4; Tan K, 2012, ANIM BEHAV, V83, P879, DOI 10.1016/j.anbehav.2011.12.031; Toh Y, 2003, ZOOL SCI, V20, P311, DOI 10.2108/zsj.20.311; TURLINGS TCJ, 1990, SCIENCE, V250, P1251, DOI 10.1126/science.250.4985.1251; Varlet V, 2006, J AGR FOOD CHEM, V54, P3391, DOI 10.1021/jf053001p; Vasta V, 2007, J AGR FOOD CHEM, V55, P4630, DOI 10.1021/jf063432n; Vasta V, 2012, MEAT SCI, V90, P451, DOI 10.1016/j.meatsci.2011.09.006; VET LEM, 1992, ANNU REV ENTOMOL, V37, P141, DOI 10.1146/annurev.en.37.010192.001041; Vitousek PM, 1996, AM SCI, V84, P468; Vitousek PM, 1997, SCIENCE, V277, P494, DOI 10.1126/science.277.5325.494; von Frisch K., 1967, DANCE LANGUAGE ORIEN; Wang ZW, 2014, INSECT SOC, V61, P67, DOI 10.1007/s00040-013-0326-2; Weiss MR, 2004, ANIM BEHAV, V68, P45, DOI 10.1016/j.anbehav.2003.07.010; Williamson M, 1996, ECOLOGY, V77, P1661, DOI 10.2307/2265769; Winston M.L., 1991, BIOL HONEY BEE; Zhang ZM, 2009, FOOD CHEM, V115, P1150, DOI 10.1016/j.foodchem.2008.12.099	99	34	34	2	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2014	9	12							e115943	10.1371/journal.pone.0115943	http://dx.doi.org/10.1371/journal.pone.0115943			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX6YH	25549358	gold, Green Submitted, Green Published			2022-12-27	WOS:000347063500042
J	Grill, E; Schaffler, F; Huppert, D; Muller, M; Kapfhammer, HP; Brandt, T				Grill, Eva; Schaeffler, Florian; Huppert, Doreen; Mueller, Martin; Kapfhammer, Hans-Peter; Brandt, Thomas			Self-Efficacy Beliefs Are Associated with Visual Height Intolerance: A Cross-Sectional Survey	PLOS ONE			English	Article							HEALTH SURVEY; PHOBIA; FEAR; ACROPHOBIA; DETERMINANTS; DISORDERS; VERTIGO; DANGER; MOTION; SPACE	Background: Responses to height may range from indifference to minor distress to severe symptoms of fear of heights (acrophobia); visual height intolerance (vHI) denotes the whole spectrum of symptoms. Although there are options to manage vHI, only a small part of persons affected by vHI are willing to seek professional help or confront their problem. Purpose of this study was to determine if persons with vHI, specifically those who show avoidant behavior towards heights (avoiders), score lower in their general self-efficacy (GSE) than those who confront vHI (confronters). Method: Cross-sectional survey in 607 individuals living in the urban region of Munich, Germany, using a mailed questionnaire on presence or absence of vHI, confronting or avoiding behaviour, and GSE. Results: Of all participants (mean age 53.9, 50.3% female), 407 reported life-time presence of vHI. Participants with vHI had a mean GSE score of 31.8 (SD 4.3) points (participants without vHI: 32.5, SD 4.3, p = 0.008 for difference). Among individuals with vHI, 23% reported confronting behavior. Confronters were significantly younger (p<.0001, 50.2 vs. 55.7 years), more likely to be female (p=0.0039, 64.3% female), and had a higher GSE score (p=0.0049, 32.5 vs. 31.1). Associations remained significant after multiple adjustment. Conclusions: Our study provides evidence for the association of GSE and vHI. These findings may have consequences for strategies of alleviation and therapy of vHI.	[Grill, Eva; Schaeffler, Florian; Mueller, Martin] Univ Munich, Inst Med Informat Proc Biometr & Epidemiol IBE, D-81377 Munich, Germany; [Grill, Eva; Huppert, Doreen; Mueller, Martin; Brandt, Thomas] Univ Munich, German Ctr Vertigo & Balance Disorders, D-81377 Munich, Germany; [Schaeffler, Florian] Hsch Munchen Univ Appl Sci, Dept Appl Social Sci, D-81243 Munich, Germany; [Huppert, Doreen; Brandt, Thomas] Univ Munich, Inst Clin Neurosci, D-81377 Munich, Germany; [Kapfhammer, Hans-Peter] Med Univ Graz, Dept Psychiat, A-8036 Graz, Austria	University of Munich; University of Munich; University of Munich; Medical University of Graz	Grill, E (corresponding author), Univ Munich, Inst Med Informat Proc Biometr & Epidemiol IBE, Marchioninistr 17, D-81377 Munich, Germany.	eva.grill@med.uni-muenchen.de	Grill, Eva/AAF-8104-2020; Grill, Eva/D-1875-2010; Mueller, Martin/AAH-1527-2019	Grill, Eva/0000-0002-0273-7984; Grill, Eva/0000-0002-0273-7984; Mueller, Martin/0000-0002-5575-442X	German Federal Ministry of Education and Research [01 EO 0901]; Hertie Foundation	German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); Hertie Foundation	This project was supported by funds from the German Federal Ministry of Education and Research under the Grant code 01 EO 0901 and the Hertie Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American psychiatric association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; Asghari A, 2001, PAIN, V94, P85, DOI 10.1016/S0304-3959(01)00344-X; Baker A, 2010, BEHAV RES THER, V48, P1139, DOI 10.1016/j.brat.2010.07.009; BAKER BL, 1973, BEHAV RES THER, V11, P79, DOI 10.1016/0005-7967(73)90071-5; BANDURA A, 1983, J PERS SOC PSYCHOL, V45, P464, DOI 10.1037/0022-3514.45.2.464; BANDURA A, 1977, PSYCHOL REV, V84, P191, DOI 10.1037/0033-295X.84.2.191; Bandura A., 1988, ANXIETY RES, V1, P77, DOI DOI 10.1080/10615808808248222; BRANDT T, 1980, ACTA OTO-LARYNGOL, V89, P513, DOI 10.3109/00016488009127169; Brandt T, 2012, J NEUROL, V259, P759, DOI 10.1007/s00415-011-6238-z; Clerkin EM, 2009, J ANXIETY DISORD, V23, P381, DOI 10.1016/j.janxdis.2008.12.002; Coelho CM, 2010, DEPRESS ANXIETY, V27, P864, DOI 10.1002/da.20698; Coelho CM, 2009, J ANXIETY DISORD, V23, P563, DOI 10.1016/j.janxdis.2009.01.014; Cole SR, 2010, INT J EPIDEMIOL, V39, P417, DOI 10.1093/ije/dyp334; Davey GCL, 1997, BEHAV RES THER, V35, P997, DOI 10.1016/S0005-7967(97)10004-3; Depla MFIA, 2008, SOC PSYCH PSYCH EPID, V43, P200, DOI 10.1007/s00127-007-0291-z; Gallagher MW, 2013, BEHAV RES THER, V51, P767, DOI 10.1016/j.brat.2013.09.001; Greenland S, 1999, EPIDEMIOLOGY, V10, P37, DOI 10.1097/00001648-199901000-00008; Hinz A, 2006, DIAGNOSTICA, V52, P26, DOI 10.1026/0012-1924.52.1.26; Huppert D, 2013, J NEUROL, V260, P597, DOI 10.1007/s00415-012-6685-1; Jacob RG, 2009, J NEUROL NEUROSUR PS, V80, P74, DOI 10.1136/jnnp.2007.136432; JACOB RG, 1995, J ANXIETY DISORD, V9, P411, DOI 10.1016/0887-6185(95)00021-F; JACOB RG, 1993, J PSYCHOPATHOL BEHAV, V15, P299, DOI 10.1007/BF00965035; Jagella C, 2000, SCHWEIZ MED WSCHR, V130, P209; Jerusalem M., 1981, SKALEN BEFINDLICHKEI, P15; Jerusalem M., 1999, SKALEN ERFASSUNG LEH; Kapfhammer HP, 2014, EUR ARCH PSYCHIAT CL; KIRSCH I, 1983, BEHAV THER, V14, P520, DOI 10.1016/S0005-7894(83)80075-6; Knueppel S, 2010, EPIDEMIOLOGY, V21, P159, DOI 10.1097/EDE.0b013e3181c307ce; LeBeau RT, 2010, DEPRESS ANXIETY, V27, P148, DOI 10.1002/da.20655; Luszczynska A, 2005, J PSYCHOL, V139, P439, DOI 10.3200/JRLP.139.5.439-457; Magee WJ, 1996, ARCH GEN PSYCHIAT, V53, P159; Marks JM, 1967, ROLE LEARNING PSYCHO; Menzies R, 1997, PHOBIAS HDB THEORY R, P139; MENZIES RG, 1995, BEHAV RES THER, V33, P215, DOI 10.1016/0005-7967(94)P4443-X; Moritz SE, 2000, RES Q EXERCISE SPORT, V71, P280, DOI 10.1080/02701367.2000.10608908; Oosterink FMD, 2009, EUR J ORAL SCI, V117, P135, DOI 10.1111/j.1600-0722.2008.00602.x; Pearl J.., 2009, CAUSALITY; Redfern MS, 2001, J ANXIETY DISORD, V15, P81, DOI 10.1016/S0887-6185(00)00043-8; REDFERN MS, 1994, J VESTIBUL RES-EQUIL, V4, P221; Ressler KJ, 2004, ARCH GEN PSYCHIAT, V61, P1136, DOI 10.1001/archpsyc.61.11.1136; RITTER B, 1969, BEHAV RES THER, V7, P41, DOI 10.1016/0005-7967(69)90047-3; Rohrig N, 2014, J CLIN EPIDEMIOL, V67, P199, DOI 10.1016/j.jclinepi.2013.08.012; Schaeffler F, 2013, QUAL LIFE RES; Schwarzer R., 1995, MEASURES HLTH PSYCHO, P35, DOI DOI 10.1037/T00393-000; Shrier I, 2008, BMC MED RES METHODOL, V8, DOI 10.1186/1471-2288-8-70; Textor J, 2011, EPIDEMIOLOGY, V22, P745, DOI 10.1097/EDE.0b013e318225c2be; VanderWeele TJ, 2012, AM J EPIDEMIOL, V176, P608, DOI 10.1093/aje/kws213; Ware JE, 1996, MED CARE, V34, P220, DOI 10.1097/00005650-199603000-00003; WILLIAMS SL, 1985, BEHAV THER, V16, P136, DOI 10.1016/S0005-7894(85)80041-1; World Health Organization, 1993, ICD 10 CLASS MENT BE, V10th ed.	50	6	6	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2014	9	12							e116220	10.1371/journal.pone.0116220	http://dx.doi.org/10.1371/journal.pone.0116220			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AX6YH	25548910	Green Published, gold, Green Submitted			2022-12-27	WOS:000347063500063
J	Le Parc, A; Houeto, EH; Pigat, N; Chat, S; Leonil, J; Chanat, E				Le Parc, Annabelle; Houeto, Edith Honvo; Pigat, Natascha; Chat, Sophie; Leonil, Joelle; Chanat, Eric			The Membrane-Associated Form of alpha(s1)-Casein Interacts with Cholesterol-Rich Detergent-Resistant Microdomains	PLOS ONE			English	Article							MILK PROTEIN SECRETION; MAMMARY-GLAND; CASEIN SECRETION; GOLGI-APPARATUS; BREFELDIN-A; TRANSPORT; GLYCOSYLATION; TRAFFICKING; INVOLVEMENT; MICELLE	Caseins, the main milk proteins, interact with colloidal calcium phosphate to form the casein micelle. The mesostructure of this supramolecular assembly markedly influences its nutritional and technological functionalities. However, its detailed molecular organization and the cellular mechanisms involved in its biogenesis have been only partially established. There is a growing body of evidence to support the concept that alpha(s1)-casein takes center stage in casein micelle building and transport in the secretory pathway of mammary epithelial cells. Here we have investigated the membrane-associated form of alpha(s1)-casein in rat mammary epithelial cells. Using metabolic labelling we show that alpha(s1)-casein becomes associated with membranes at the level of the endoplasmic reticulum, with no subsequent increase at the level of the Golgi apparatus. From morphological and biochemical data, it appears that caseins are in a tight relationship with membranes throughout the secretory pathway. On the other hand, we have observed that the membrane-associated form of alpha(s1)-casein co-purified with detergent-resistant membranes. It was poorly solubilised by Tween 20, partially insoluble in Lubrol WX, and substantially insoluble in Triton X-100. Finally, we found that cholesterol depletion results in the release of the membrane-associated form of alpha(s1)-casein. These experiments reveal that the insolubility of alpha(s1)-casein reflects its partial association with a cholesterol-rich detergent-resistant microdomain. We propose that the membrane-associated form of alpha(s1)-casein interacts with the lipid microdomain, or lipid raft, that forms within the membranes of the endoplasmic reticulum, for efficient forward transport and sorting in the secretory pathway of mammary epithelial cells.	[Le Parc, Annabelle; Houeto, Edith Honvo; Pigat, Natascha; Chat, Sophie; Chanat, Eric] INRA, Genom & Physiol Lactat UR1196, Jouy En Josas, France; [Leonil, Joelle] Inst Natl Rech Agronom, Sci & Technol Lait & CEuf UMR1253, Rennes, France	INRAE; UDICE-French Research Universities; Universite Paris Saclay; INRAE	Chanat, E (corresponding author), Inst Natl Rech Agronom, UMR Phys Environm & Genet Anim & Syst Elevage, St Gilles, France.	eric.chanat@rennes.inra.fr	barile, daniela/AAA-3892-2020	barile, daniela/0000-0002-3889-1596; Chat, Sophie/0000-0003-0671-5229	Institut National de la Recherche Agronomique	Institut National de la Recherche Agronomique	ALP was an "Agent Scientifique Contractuel'' funded by the Institut National de la Recherche Agronomique. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfalah M, 2005, J BIOL CHEM, V280, P42636, DOI 10.1074/jbc.M505924200; Boisgard R, 2000, BBA-MOL CELL RES, V1495, P281, DOI 10.1016/S0167-4889(99)00167-6; Bouguyon E, 2006, BIOCHEM BIOPH RES CO, V343, P450, DOI 10.1016/j.bbrc.2006.03.005; Boumahrou N, 2009, J PHYSIOL PHARMACOL, V60, P113; Boumahrou N, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-80; Browman DT, 2006, J CELL SCI, V119, P3149, DOI 10.1242/jcs.03060; Brown DA, 2000, J BIOL CHEM, V275, P17221, DOI 10.1074/jbc.R000005200; BROWN DA, 1992, CELL, V68, P533, DOI 10.1016/0092-8674(92)90189-J; Brown Deborah A., 1992, Trends in Cell Biology, V2, P338; BUCHHEIM W, 1989, KIELER MILCHW FORSCH, V41, P253; Burgoyne RD, 1998, J MAMMARY GLAND BIOL, V3, P275, DOI 10.1023/A:1018763427108; Chanat E, 1999, J CELL SCI, V112, P3399; Chat S, 2011, EUR J CELL BIOL, V90, P401, DOI 10.1016/j.ejcb.2011.01.002; Christa L, 2000, EUR J BIOCHEM, V267, P1665, DOI 10.1046/j.1432-1327.2000.01159.x; Clegg RA, 1998, MOL CELL ENDOCRINOL, V141, P163, DOI 10.1016/S0303-7207(98)00080-X; CLERMONT Y, 1993, ANAT REC, V235, P363, DOI 10.1002/ar.1092350305; David D, 1998, J CELL BIOL, V143, P1167, DOI 10.1083/jcb.143.5.1167; Didier A, 2006, J HISTOCHEM CYTOCHEM, V54, P1255, DOI 10.1369/jhc.5A6880.2006; Falguieres T, 2001, MOL BIOL CELL, V12, P2453, DOI 10.1091/mbc.12.8.2453; FARRELL HM, 1973, J DAIRY SCI, V56, P1195, DOI 10.3168/jds.S0022-0302(73)85335-4; FRANKE WW, 1976, J CELL BIOL, V69, P173, DOI 10.1083/jcb.69.1.173; FUJIKI Y, 1982, J CELL BIOL, V93, P97, DOI 10.1083/jcb.93.1.97; Hein Z, 2009, EXP CELL RES, V315, P348, DOI 10.1016/j.yexcr.2008.10.038; HOLT C, 1992, ADV PROTEIN CHEM, V43, P63, DOI 10.1016/S0065-3233(08)60554-9; Horne DS, 1998, INT DAIRY J, V8, P171, DOI 10.1016/S0958-6946(98)00040-5; Huppertz T., 2013, ADV DAIRY CHEM A, V4th, P135, DOI [10.1007/978-1-4614-4714-6_4, DOI 10.1007/978-1-4614-4714-6_4]; Kolb AF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021775; KUMAR S, 1994, P NATL ACAD SCI USA, V91, P6138, DOI 10.1073/pnas.91.13.6138; Lavialle F, 2008, ANIMAL, V2, P491, DOI 10.1017/S1751731107001309; Le Parc A, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-65; LEE RWH, 1983, J BIOL CHEM, V258, P1326; Malin EL, 2005, J DAIRY SCI, V88, P2318, DOI 10.3168/jds.S0022-0302(05)72910-6; Mather I. H., 1983, Biochemistry of lactation, P231; Mellman I, 2008, NAT REV MOL CELL BIO, V9, P833, DOI 10.1038/nrm2525; Muniz M, 2001, CELL, V104, P313, DOI 10.1016/S0092-8674(01)00215-X; Paiement J, 2004, CELL BIOL, P41; Patrick F., 2013, ADV DAIRY CHEM A, V1A, P185, DOI [DOI 10.1007/978-1-4614-4714-6_6, 10.1007/978-1-4614-4714-6_6]; Pauloin A, 1997, EUR J CELL BIOL, V72, P324; Pechoux C, 2005, BBA-MOL CELL RES, V1743, P317, DOI 10.1016/j.bbamcr.2005.01.006; PETERSON GL, 1977, ANAL BIOCHEM, V83, P346, DOI 10.1016/0003-2697(77)90043-4; Roper K, 2000, NAT CELL BIOL, V2, P582, DOI 10.1038/35023524; Sarnataro D, 2004, MOL BIOL CELL, V15, P4031, DOI 10.1091/mbc.E03-05-0271; Schuck S, 2003, P NATL ACAD SCI USA, V100, P5795, DOI 10.1073/pnas.0631579100; Simons K, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004697; Surma MA, 2012, BBA-MOL CELL BIOL L, V1821, P1059, DOI 10.1016/j.bbalip.2011.12.008; TURNER MD, 1992, J CELL BIOL, V117, P269, DOI 10.1083/jcb.117.2.269; TURNER MD, 1993, J CELL SCI, V106, P1221; Walmsley AR, 2001, EMBO J, V20, P703, DOI 10.1093/emboj/20.4.703	48	4	5	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2014	9	12							e115903	10.1371/journal.pone.0115903	http://dx.doi.org/10.1371/journal.pone.0115903			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX6YH	25549363	gold, Green Published			2022-12-27	WOS:000347063500037
J	Mabrouk, R; Rusjan, PM; Mizrahi, R; Jacobs, MF; Koshimori, Y; Houle, S; Ko, JH; Strafella, AP				Mabrouk, Rostom; Rusjan, Pablo M.; Mizrahi, Romina; Jacobs, Mark F.; Koshimori, Yuko; Houle, Sylvain; Ko, Ji Hyun; Strafella, Antonio P.			Image Derived Input Function for [F-18]-FEPPA: Application to Quantify Translocator Protein (18 kDa) in the Human Brain	PLOS ONE			English	Article							PERIPHERAL BENZODIAZEPINE-RECEPTORS; MICROGLIAL ACTIVATION; RADIOLIGAND BINDING; PET LIGAND; EXTRACTION; AFFINITY; RADIOSYNTHESIS; PLASMA; MONKEY; BLOOD	In [F-18]-FEPPA positron emission topography (PET) imaging, automatic blood sampling system (ABSS) is currently the gold standard to obtain the blood time activity curve (TAC) required to extract the input function (IF). Here, we compare the performance of two image-based methods of IF extraction to the ABSS gold standard method for the quantification of translocator protein (TSPO) in the human brain. The IFs were obtained from a direct delineation of the internal carotid signal (CS) and a new concept of independent component analysis (ICA). PET scans were obtained from 18 healthy volunteers. The estimated total distribution volume (V-T) by CS-IF and ICA-IF were compared to the reference V-T obtained by ABSS-IF in the frontal and temporal cortex, cerebellum, striatum and thalamus regions. The V-T values estimated using ICA-IF were more reliable than CS-IF for all brain regions. Specifically, the slope regression in the frontal cortex with ICA-IF was r(2) = 0.91 (p<0.05), and r(2) = 0.71 (p<0.05) using CS-IF.	[Mabrouk, Rostom; Rusjan, Pablo M.; Mizrahi, Romina; Koshimori, Yuko; Houle, Sylvain; Strafella, Antonio P.] Ctr Addict & Mental Hlth, Res Imaging Ctr, Toronto, ON, Canada; [Strafella, Antonio P.] Univ Toronto, Toronto Western Hosp, UHN, EJ Safra Parkinson Dis Program,Morton & Gloria Sh, Toronto, ON, Canada; [Jacobs, Mark F.; Koshimori, Yuko; Strafella, Antonio P.] Univ Toronto, UHN, TorontoWestern Res Inst, Div Brain Imaging & Behav Syst Neurosci, Toronto, ON, Canada; [Ko, Ji Hyun] Univ Manitoba, Dept Human Anat & Cell Sci, Winnipeg, MB, Canada; [Mizrahi, Romina] Univ Toronto, Dept Psychiat, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; Centre for Addiction & Mental Health - Canada; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Manitoba; University of Toronto	Mabrouk, R (corresponding author), Ctr Addict & Mental Hlth, Res Imaging Ctr, Toronto, ON, Canada.	rostom.mabrouk@camh.ca	Mabrouk, Rostom/M-1674-2019; Ko, Ji Hyun/E-5150-2011	Ko, Ji Hyun/0000-0002-9700-7692; Rusjan, Pablo/0000-0003-0075-2918; Mizrahi, Romina/0000-0001-6667-7928; Houle, Sylvain/0000-0002-4231-6316	Canadian Institutes of Health Research [INE 117891]; Canadian Institutes of Health Research; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH100043] Funding Source: NIH RePORTER	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by the Canadian Institutes of Health Research (INE 117891) to AS; Canadian Institutes of Health Research to YK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amari S, 1998, NEURAL COMPUT, V10, P251, DOI 10.1162/089976698300017746; Backes H, 2009, EUR J NUCL MED MOL I, V36, P1960, DOI 10.1007/s00259-009-1244-4; Boutin H, 2007, J NUCL MED, V48, P573, DOI 10.2967/jnumed.106.036764; Briard E, 2008, J MED CHEM, V51, P17, DOI 10.1021/jm0707370; Comtat C, 2004, NUCL SCI S IEEE; Croteau E, 2010, EUR J NUCL MED MOL I, V37, P1539, DOI 10.1007/s00259-010-1443-z; Dolle F, 2008, J LABELLED COMPD RAD, V51, P435, DOI 10.1002/jlcr.1559; Fujimura Y, 2009, J NUCL MED, V50, P1047, DOI 10.2967/jnumed.108.060186; Gerhard A, 2006, NEUROBIOL DIS, V21, P404, DOI 10.1016/j.nbd.2005.08.002; Hahn A, 2012, NEUROIMAGE, V62, P199, DOI 10.1016/j.neuroimage.2012.04.047; Hilton J, 2000, NUCL MED BIOL, V27, P627, DOI 10.1016/S0969-8051(00)00125-6; Hirvonen J, 2012, J NUCL MED, V53, P234, DOI 10.2967/jnumed.111.091694; Hong IK, 2007, IEEE T MED IMAGING, V26, P789, DOI 10.1109/TMI.2007.892644; Hsu PH, 2012, ANN NUCL MED MOL IMA, V25, P126; Hyvarinen A, 2000, NEURAL NETWORKS, V13, P411, DOI 10.1016/S0893-6080(00)00026-5; Innis RB, 2007, J CEREBR BLOOD F MET, V27, P1533, DOI 10.1038/sj.jcbfm.9600493; Jons PH, 1997, HUM BRAIN MAPP, V5, P119, DOI 10.1002/(SICI)1097-0193(1997)5:2<119::AID-HBM5>3.3.CO;2-E; Kreisl WC, 2013, BRAIN, V136, P2228, DOI 10.1093/brain/awt145; Kreisl WC, 2010, NEUROIMAGE, V49, P2924, DOI 10.1016/j.neuroimage.2009.11.056; Kreisl WC, 2009, ARCH NEUROL-CHICAGO, V66, P1288, DOI 10.1001/archneurol.2009.208; Kreutzberg GW, 1996, TRENDS NEUROSCI, V19, P312, DOI 10.1016/0166-2236(96)10049-7; LAHIRI DK, 1991, NUCLEIC ACIDS RES, V19, P5444, DOI 10.1093/nar/19.19.5444; LOGAN J, 1990, J CEREBR BLOOD F MET, V10, P740, DOI 10.1038/jcbfm.1990.127; Mabrouk R, 2012, COMPUT MED IMAG GRAP, V36, P484, DOI 10.1016/j.compmedimag.2012.05.002; Mabrouk R, 2013, IEEE T BIO-MED ENG, V60, P63, DOI 10.1109/TBME.2012.2221463; Maeda J, 2004, SYNAPSE, V52, P283, DOI 10.1002/syn.20027; MEYER E, 1989, J NUCL MED, V30, P1069; Mizrahi R, 2012, J CEREBR BLOOD F MET, V32, P968, DOI 10.1038/jcbfm.2012.46; Mourik JEM, 2008, NEUROIMAGE, V39, P1041, DOI 10.1016/j.neuroimage.2007.10.022; Naganawa M, 2005, IEEE T BIO-MED ENG, V52, P201, DOI 10.1109/TBME.2004.840193; Ouchi Y, 2005, ANN NEUROL, V57, P168, DOI 10.1002/ana.20338; Owen DR, 2012, J CEREBR BLOOD F MET, V32, P1, DOI 10.1038/jcbfm.2011.147; Owen DRJ, 2011, J NUCL MED, V52, P24, DOI 10.2967/jnumed.110.079459; PHELPS ME, 1979, J NUCL MED, V20, P328; Rusjan P, 2006, PSYCHIAT RES-NEUROIM, V147, P79, DOI 10.1016/j.pscychresns.2006.01.011; Rusjan PM, 2011, J CEREBR BLOOD F MET, V31, P1807, DOI 10.1038/jcbfm.2011.55; Sossi V, 2005, IEEE NUCL SCI CONF R, P2195; Tomasi G, 2008, J NUCL MED, V49, P1249, DOI 10.2967/jnumed.108.050583; Turkheimer FE, 2007, J NUCL MED, V48, P158; Turner MR, 2004, NEUROBIOL DIS, V15, P601, DOI 10.1016/j.nbd.2003.12.012; van der Weerdt AP, 2001, J NUCL MED, V42, P1622; Wilson AA, 2008, NUCL MED BIOL, V35, P305, DOI 10.1016/j.nucmedbio.2007.12.009; Yu KM, 2005, COMMUN STAT-THEOR M, V34, P1867, DOI 10.1080/03610920500199018; Zanotti-Fregonara P, 2011, J CEREBR BLOOD F MET, V31, P1986, DOI 10.1038/jcbfm.2011.107; Zhang MR, 2007, J NUCL MED, V48, P1853, DOI 10.2967/jnumed.107.043505	45	6	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2014	9	12							e115768	10.1371/journal.pone.0115768	http://dx.doi.org/10.1371/journal.pone.0115768			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX6YH	25549260	Green Published, Green Submitted, gold			2022-12-27	WOS:000347063500025
J	Conroy, S; Kruyt, FAE; Joseph, JV; Balasubramaniyan, V; Bhat, KP; Wagemakers, M; Enting, RH; Walenkamp, AME; den Dunnen, WFA				Conroy, Siobhan; Kruyt, Frank A. E.; Joseph, Justin V.; Balasubramaniyan, Veerakumar; Bhat, Krishna P.; Wagemakers, Michiel; Enting, Roelien H.; Walenkamp, Annemiek M. E.; den Dunnen, Wilfred F. A.			Subclassification of Newly Diagnosed Glioblastomas through an Immunohistochemical Approach	PLOS ONE			English	Article							INTEGRATED GENOMIC ANALYSIS; STEM-CELL SUBTYPE; GENE-EXPRESSION; IDH1 MUTATIONS; BRAIN-TUMORS; SECONDARY GLIOBLASTOMA; ADJUVANT TEMOZOLOMIDE; MOLECULAR PATHOLOGY; GLIOMAS; MULTIFORME	Molecular signatures in Glioblastoma (GBM) have been described that correlate with clinical outcome and response to therapy. The Proneural (PN) and Mesenchymal (MES) signatures have been identified most consistently, but others including Classical (CLAS) have also been reported. The molecular signatures have been detected by array techniques at RNA and DNA level, but these methods are costly and cannot take into account individual contributions of different cells within a tumor. Therefore, the aim of this study was to investigate whether subclasses of newly diagnosed GBMs could be assessed and assigned by application of standard pathology laboratory procedures. 123 newly diagnosed GBMs were analyzed for the tumor cell expression of 23 pre-identified proteins and EGFR amplification, together allowing for the subclassification of 65% of the tumors. Immunohistochemistry (IHC)-based profiling was found to be analogous to transcription-based profiling using a 9-gene transcriptional signature for PN and MES subclasses. Based on these data a novel, minimal IHC-based scheme for subclass assignment for GBMs is proposed. Positive staining for IDH1(R132H) can be used for PN subclass assignment, high EGFR expression for the CLAS subtype and a combined high expression of PTEN, VIM and/or YKL40 for the MES subclass. The application of the proposed scheme was evaluated in an independent tumor set, which resulted in similar subclass assignment rates as those observed in the training set. The IHC-based subclassification scheme proposed in this study therefore could provide very useful in future studies for stratification of individual patient samples.	[Conroy, Siobhan; den Dunnen, Wilfred F. A.] Univ Groningen, Univ Med Ctr Groningen, Dept Pathol & Med Biol, Div Pathol, Groningen, Netherlands; [Kruyt, Frank A. E.; Joseph, Justin V.; Walenkamp, Annemiek M. E.] Univ Groningen, Univ Med Ctr Groningen, Dept Med Oncol, Groningen, Netherlands; [Balasubramaniyan, Veerakumar] Univ Groningen, Univ Med Ctr Groningen, Dept Neurosci, Groningen, Netherlands; [Bhat, Krishna P.] Univ Texas MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA; [Wagemakers, Michiel] Univ Groningen, Univ Med Ctr Groningen, Dept Neurosurg, Groningen, Netherlands; [Enting, Roelien H.] Univ Groningen, Univ Med Ctr Groningen, Dept Neurol, Groningen, Netherlands	University of Groningen; University of Groningen; University of Groningen; University of Texas System; UTMD Anderson Cancer Center; University of Groningen; University of Groningen	Conroy, S (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Pathol & Med Biol, Div Pathol, Groningen, Netherlands.	s.conroy@umcg.nl		Kruyt, Frank/0000-0002-2445-9380; den Dunnen, Wilfred/0000-0002-4168-1207	Graduate School of Medical Sciences, BCN-BRAIN, UMCG; Jan Kornelis de Cock Foundation	Graduate School of Medical Sciences, BCN-BRAIN, UMCG; Jan Kornelis de Cock Foundation	The work in this article was funded by (1) the Graduate School of Medical Sciences, BCN-BRAIN, UMCG and (2) Jan Kornelis de Cock Foundation to ms S. Conroy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2008, NATURE, V455, P1061; Balss J, 2008, ACTA NEUROPATHOL, V116, P597, DOI 10.1007/s00401-008-0455-2; Beier CP, 2012, STEM CELLS DEV, V21, P2753, DOI 10.1089/scd.2011.0660; Bhat KPL, 2013, CANCER CELL, V24, P331, DOI 10.1016/j.ccr.2013.08.001; Brennan C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007752; Capper D, 2010, BRAIN PATHOL, V20, P245, DOI 10.1111/j.1750-3639.2009.00352.x; Capper D, 2009, ACTA NEUROPATHOL, V118, P599, DOI 10.1007/s00401-009-0595-z; Carro MS, 2010, NATURE, V463, P318, DOI 10.1038/nature08712; Colman H, 2010, NEURO-ONCOLOGY, V12, P49, DOI 10.1093/neuonc/nop007; De Bacco F, 2012, CANCER RES, V72, P4537, DOI 10.1158/0008-5472.CAN-11-3490; Donev K, 2010, NEUROPATH APPL NEURO, V36, P411, DOI 10.1111/j.1365-2990.2010.01078.x; Federatie van Medisch Wetenschappelijke Verenigingen, 2011, VER OMG LICH TEN BEH; Freije WA, 2004, CANCER RES, V64, P6503, DOI 10.1158/0008-5472.CAN-04-0452; Horbinski C, 2011, BRAIN PATHOL, V21, P57, DOI 10.1111/j.1750-3639.2010.00453.x; Huse JT, 2010, NAT REV CANCER, V10, P319, DOI 10.1038/nrc2818; Ichimura K, 2009, NEURO-ONCOLOGY, V11, P341, DOI 10.1215/15228517-2009-025; Joseph JV, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.395; Le Mercier M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045475; Lee CH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030098; Lee KH, 2012, CHILD NERV SYST, V28, P1879, DOI 10.1007/s00381-012-1883-9; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; Ma XL, 2012, NEURO-ONCOLOGY, V14, P1153, DOI 10.1093/neuonc/nos145; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Mendez MG, 2010, FASEB J, V24, P1838, DOI 10.1096/fj.09-151639; Misra A, 2005, CLIN CANCER RES, V11, P2907, DOI 10.1158/1078-0432.CCR-04-0708; Motomura K, 2012, CANCER SCI, V103, P1871, DOI 10.1111/j.1349-7006.2012.02377.x; Noushmehr H, 2010, CANCER CELL, V17, P510, DOI 10.1016/j.ccr.2010.03.017; Ohgaki H, 2004, CANCER RES, V64, P6892, DOI 10.1158/0008-5472.CAN-04-1337; Ohgaki H, 2013, CLIN CANCER RES, V19, P764, DOI 10.1158/1078-0432.CCR-12-3002; Pallud J, 2012, J NEUROSURG, V117, P476, DOI 10.3171/2012.5.JNS111670; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Phillips HS, 2006, CANCER CELL, V9, P157, DOI 10.1016/j.ccr.2006.02.019; Popova SN, 2014, HISTOPATHOLOGY, V64, P365, DOI 10.1111/his.12252; Preusser M, 2011, ANN NEUROL, V70, P9, DOI 10.1002/ana.22425; Rahaman SO, 2002, ONCOGENE, V21, P8404, DOI 10.1038/sj.onc.1206047; Specht K, 2001, AM J PATHOL, V158, P419, DOI 10.1016/S0002-9440(10)63985-5; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Stupp R, 2009, LANCET ONCOL, V10, P459, DOI 10.1016/S1470-2045(09)70025-7; Sturn A, 2002, BIOINFORMATICS, V18, P207, DOI 10.1093/bioinformatics/18.1.207; Sulman EP, 2009, SEMIN RADIAT ONCOL, V19, P142, DOI 10.1016/j.semradonc.2009.02.001; Szerlip NJ, 2012, P NATL ACAD SCI USA, V109, P3041, DOI 10.1073/pnas.1114033109; Tso CL, 2006, CANCER RES, V66, P159, DOI 10.1158/0008-5472.CAN-05-0077; Turcan S, 2012, NATURE, V483, P479, DOI 10.1038/nature10866; van den Bent MJ, 2010, CLIN CANCER RES, V16, P1597, DOI 10.1158/1078-0432.CCR-09-2902; Varlet P, 2004, NEUROSURGERY, V55, P1377, DOI 10.1227/01.NEU.0000143033.36582.40; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; von Deimling A, 2011, BRAIN PATHOL, V21, P74, DOI 10.1111/j.1750-3639.2010.00454.x; Watanabe T, 2009, AM J PATHOL, V174, P1149, DOI 10.2353/ajpath.2009.080958; Wiltshire RN, 2000, NEURO-ONCOLOGY, V2, P164, DOI 10.1093/neuonc/2.3.164; Yan H, 2009, NEW ENGL J MED, V360, P765, DOI 10.1056/NEJMoa0808710	50	19	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2014	9	12							e115687	10.1371/journal.pone.0115687	http://dx.doi.org/10.1371/journal.pone.0115687			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UN	25546404	Green Published, gold			2022-12-27	WOS:000347120200054
J	St Jacques, JM; Cumming, BF; Sauchyn, DJ; Smol, JP				St. Jacques, Jeannine-Marie; Cumming, Brian F.; Sauchyn, David J.; Smol, John P.			The Bias and Signal Attenuation Present in Conventional Pollen-Based Climate Reconstructions as Assessed by Early Climate Data from Minnesota, USA	PLOS ONE			English	Article							HIGH-RESOLUTION PALEOCLIMATOLOGY; WEST-CENTRAL MINNESOTA; VARVED LAKE MINA; TEMPERATURE-VARIATIONS; NORTHERN-HEMISPHERE; SUMMER TEMPERATURE; LAST MILLENNIUM; FOSSIL POLLEN; FUTURE; RECORDS	The inference of past temperatures from a sedimentary pollen record depends upon the stationarity of the pollen-climate relationship. However, humans have altered vegetation independent of changes to climate, and consequently modern pollen deposition is a product of landscape disturbance and climate, which is different from the dominance of climate-derived processes in the past. This problem could cause serious signal distortion in pollen-based reconstructions. In the north-central United States, direct human impacts have strongly altered the modern vegetation and hence the pollen rain since Euro-American settlement in the mid-19th century. Using instrumental temperature data from the early 1800s from Fort Snelling (Minnesota), we assessed the signal distortion and bias introduced by using the conventional method of inferring temperature from pollen assemblages in comparison to a calibration set from pre-settlement pollen assemblages and the earliest instrumental climate data. The early post-settlement calibration set provides more accurate reconstructions of the 19th century instrumental record, with less bias, than the modern set does. When both modern and pre-industrial calibration sets are used to reconstruct past temperatures since AD 1116 from pollen counts from a varve-dated record from Lake Mina, Minnesota, the conventional inference method produces significant low-frequency (centennial-scale) signal attenuation and positive bias of 0.8-1.7 degrees C, resulting in an overestimation of Little Ice Age temperature and likely an underestimation of the extent and rate of anthropogenic warming in this region. However, high-frequency (annual-scale) signal attenuation exists with both methods. Hence, we conclude that any past pollen spectra from before Euro-American settlement in this region should be interpreted using a pre-Euro-American settlement pollen set, paired to the earliest instrumental climate records. It remains to be explored how widespread this problem is when conventional pollen-based inference methods are used, and consequently how seriously regional manifestations of global warming have been underestimated with traditional pollen-based techniques.	[St. Jacques, Jeannine-Marie; Sauchyn, David J.] Univ Regina, Regina, SK S4S 7H9, Canada; [Cumming, Brian F.; Smol, John P.] Queens Univ, Dept Biol, Paleoecol Environm Assessment & Res Lab, Kingston, ON K7L 3N6, Canada	University of Regina; Queens University - Canada	St Jacques, JM (corresponding author), Univ Regina, Regina, SK S4S 7H9, Canada.	stjacqje@uregina.ca		Smol, John/0000-0002-2499-6696	Ontario Graduate Science and Technology Scholarships	Ontario Graduate Science and Technology Scholarships	As a graduate student, Dr. St. Jacques had funding from the Ontario Graduate Science and Technology Scholarships. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed M, 2013, NAT GEOSCI, V6, P339, DOI [10.1038/ngeo1797, 10.1038/NGEO1797]; Autio J, 2004, GRANA, V43, P31, DOI 10.1080/00173130310017409; Barnekow L, 2007, J QUATERNARY SCI, V22, P653, DOI 10.1002/jqs.1096; BIRKS HJB, 1990, PHILOS T R SOC B, V327, P263, DOI 10.1098/rstb.1990.0062; Birks HJB., 2010, OPEN ECOL J, V3, P68, DOI [10.2174/1874213001003020068, DOI 10.2174/1874213001003020068, https://doi.org/10.1016/j.quaint.2012.07.228, DOI 10.1016/J.QUAINT.2012.07.228]; Briffa KR, 2011, DEV PALEOENVIRON RES, V11, P113, DOI 10.1007/978-1-4020-5725-0_5; BRIFFA KR, 1992, CLIM DYNAM, V7, P111, DOI 10.1007/BF00211153; Briffa KR, 2001, J GEOPHYS RES-ATMOS, V106, P2929, DOI 10.1029/2000JD900617; Burnette DJ, 2010, J CLIMATE, V23, P1308, DOI 10.1175/2009JCLI2445.1; Carinanos P, 2014, SCI TOTAL ENVIRON, V470, P480, DOI 10.1016/j.scitotenv.2013.10.024; Christiansen B, 2011, J CLIMATE, V24, P674, DOI 10.1175/2010JCLI3646.1; Cook ER, 2010, J QUATERNARY SCI, V25, P48, DOI 10.1002/jqs.1303; COOK ER, 1995, HOLOCENE, V5, P229, DOI 10.1177/095968369500500211; Cristofori A, 2010, AEROBIOLOGIA, V26, P253, DOI 10.1007/s10453-010-9161-3; Fernandez-Donado L, 2013, CLIM PAST, V9, P393, DOI 10.5194/cp-9-393-2013; Fernandez-Martinez M, 2012, ACTA OECOL, V43, P51, DOI 10.1016/j.actao.2012.05.006; FISK CF, 1984, THESIS; Frank D, 2010, WIRES CLIM CHANGE, V1, P507, DOI 10.1002/wcc.53; Guillou-Frottier L, 1998, J GEOPHYS RES-SOL EA, V103, P7385, DOI 10.1029/98JB00021; Helama S, 2010, QUATERNARY SCI REV, V29, P3905, DOI 10.1016/j.quascirev.2010.09.012; Hughes MK, 2009, CLIMATIC CHANGE, V94, P247, DOI 10.1007/s10584-009-9588-0; Huusko A, 2009, J QUATERNARY SCI, V24, P522, DOI 10.1002/jqs.1250; Intergovernmental Panel on Climate Change (IPCC), 2013, CLIM CHANG 2013 PHYS; JACOBSON GL, 1986, ECOLOGY, V67, P958, DOI 10.2307/1939818; Jones PD, 2009, HOLOCENE, V19, P3, DOI 10.1177/0959683608098952; Jones PD, 1998, HOLOCENE, V8, P455, DOI 10.1191/095968398667194956; Juckes MN, 2007, CLIM PAST, V3, P591, DOI 10.5194/cp-3-591-2007; Kamenik C, 2009, J QUATERNARY SCI, V24, P529, DOI 10.1002/jqs.1266; Li JY, 2014, QUATERNARY SCI REV, V99, P112, DOI 10.1016/j.quascirev.2014.06.005; Ljungqvist FC, 2010, GEOGR ANN A, V92A, P339, DOI 10.1111/j.1468-0459.2010.00399.x; Ljungqvist FC, 2009, GEOGR ANN A, V91A, P11, DOI 10.1111/j.1468-0459.2009.00350.x; Magnuson JJ, 2000, SCIENCE, V289, P1743, DOI 10.1126/science.289.5485.1743; Majorowicz JA, 1999, GLOBAL PLANET CHANGE, V20, P227, DOI 10.1016/S0921-8181(99)00016-8; Mann ME, 2008, P NATL ACAD SCI USA, V105, P13252, DOI 10.1073/pnas.0805721105; Marschner FJ, 1974, ORIGINAL VEGETATION; Moberg A, 2005, NATURE, V433, P613, DOI 10.1038/nature03265; Munoz SE, 2014, J BIOGEOGR, V41, P2195, DOI 10.1111/jbi.12386; OVERPECK JT, 1985, QUATERNARY RES, V23, P87, DOI 10.1016/0033-5894(85)90074-2; Pollack HN, 2000, ANNU REV EARTH PL SC, V28, P339, DOI 10.1146/annurev.earth.28.1.339; Smerdon JE, 2010, J CLIMATE, V23, P4856, DOI 10.1175/2010JCLI3328.1; St Jacques JM, 2009, HOLOCENE, V19, P537, DOI 10.1177/0959683609104030; St Jacques JM, 2008, J PALEOLIMNOL, V40, P733, DOI 10.1007/s10933-008-9196-4; St Jacques JM, 2008, J BIOGEOGR, V35, P306, DOI 10.1111/j.1365-2699.2007.01785.x; St Jacques JM, 2008, QUATERNARY SCI REV, V27, P781, DOI 10.1016/j.quascirev.2008.01.005; Stocker T., 2013, COMPUTATIONAL GEOMET, DOI 10.1017/ CBO9781107415324; Svenning JC, 2013, AM J BOT, V100, P1266, DOI 10.3732/ajb.1200469; Trouet V, 2013, ENVIRON RES LETT, V8, DOI 10.1088/1748-9326/8/2/024008; Viau AE, 2012, GLOBAL PLANET CHANGE, V84-85, P75, DOI 10.1016/j.gloplacha.2011.09.010; Viau AE, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2005JD006031; Walde D, 2006, WORLD ARCHAEOL, V38, P291, DOI 10.1080/00438240600694032; WEBB T, 1986, VEGETATIO, V67, P75, DOI 10.1007/BF00037359; Webb Thompson Iii, 1993, P415; Williams JW, 2008, QUATERNARY SCI REV, V27, P669, DOI 10.1016/j.quascirev.2008.01.004	53	16	16	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2015	10	1							e0113806	10.1371/journal.pone.0113806	http://dx.doi.org/10.1371/journal.pone.0113806			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ4OZ	25602619	Green Published, gold, Green Submitted			2022-12-27	WOS:000348203500003
J	Yang, ZR; Wang, J; Wang, WW; Zhang, YL; Han, LZ; Zhang, Y; Nie, XL; Zhan, SY				Yang, Zhirong; Wang, Jing; Wang, Weiwei; Zhang, Yuelun; Han, Lizhong; Zhang, Yuan; Nie, Xiaolu; Zhan, Siyan			Proportions of Staphylococcus aureus and Methicillin-Resistant Staphylococcus aureus in Patients with Surgical Site Infections in Mainland China: A Systematic Review and Meta-Analysis	PLOS ONE			English	Article							SURVEILLANCE; PREVENTION; OUTCOMES	Background Sufficient details have not been specified for the epidemiological characteristics of Staphylococcus aureus (S. aureus) and methicillin-resistant Staphylococcus aureus (MRSA) among surgical site infections (SSIs) in mainland China. This systematic review aimed to estimate proportions of S. aureus and MRSA in SSIs through available published studies. Methods PubMed, Embase and four Chinese electronic databases were searched to identify relevant primary studies published between 2007 and 2012. Meta-analysis was conducted on the basis of logit-transformed metric for proportions of S. aureus and MRSA, followed by predefined subgroup meta-analysis. Random-effects meta-regression was also conducted to explore the impact of possible factors on S. aureus proportions. Results 106 studies were included, of which 38 studies involved MRSA. S. aureus accounted for 19.1% (95% CI 17.2-21.0%; I-2 = 84.1%) of all isolates in SSIs, which was roughly parallel to 18.5% in the United States (US) (P-value = 0.57) but significantly exceeded those calculated through the surveillance system in China (P-value<0.001). In subgroup analysis, S. aureus in patients with thoracic surgery (41.1%, 95% CI 26.3-57.7%; I-2 = 74.4%) was more common than in those with gynecologic surgery (20.1%, 95% CI 15.6-25.6%; I-2 = 33.0%) or abdominal surgery (13.8%, 95% CI 10.3-18.4%; I-2 = 70.0%). Similar results were found in meta-regression. MRSA accounted for 41.3% (95% CI 36.5-46.3%; I-2 = 64.6%) of S. aureus, significantly lower than that in the US (P-value = 0.001). MRSA was sensitive to vancomycin (522/522) and linezolid (93/ 94), while 79.9%(95% CI 67.4-88.4%; I-2 = 0%) and 92.0% (95% CI 80.2-97.0%; I-2 = 0%) of MRSA was resistant to clindamycin and erythromycin respectively. Conclusion The overall proportion of S. aureus among SSIs in China was similar to that in the US but seemed higher than those reported through the Chinese national surveillance system. Proportions of S. aureus SSIs may vary with different surgery types. Commonly seen in SSIs, MRSA tended to be highly sensitive to vancomycin and linezolid but mostly resistant to clindamycin and erythromycin.	[Yang, Zhirong; Wang, Jing; Wang, Weiwei; Zhang, Yuelun; Zhang, Yuan; Nie, Xiaolu; Zhan, Siyan] Peking Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Beijing 100871, Peoples R China; [Yang, Zhirong] Shantou Univ, Coll Med, Shantou Oxford Clin Res Unit, Shantou, Guangdong, Peoples R China; [Han, Lizhong] Shanghai Jiao Tong Univ, Ruijin Hosp, Sch Med, Dept Clin Microbiol, Shanghai 200030, Peoples R China; [Zhang, Yuan] McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON, Canada	Peking University; Shantou University; Shanghai Jiao Tong University; McMaster University	Zhan, SY (corresponding author), Peking Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Beijing 100871, Peoples R China.	siyan-zhan@bjmu.edu.cn	Wang, Weiwei/N-7890-2017	Zhang, Yuelun/0000-0001-7990-9003; Wang, Jing/0000-0001-5701-476X; Nie, Xiaolu/0000-0001-8026-7845	MedImmune LLC, Gaithersburg, MD, USA; Special Fund for Health-scientific Research in the Public Interest: Research & application for the prevention & control of nosocomial infections caused by multi-drug resistant bacteria [201002021]	MedImmune LLC, Gaithersburg, MD, USA(AstraZenecaMedimmune); Special Fund for Health-scientific Research in the Public Interest: Research & application for the prevention & control of nosocomial infections caused by multi-drug resistant bacteria	This project was funded by MedImmune LLC, Gaithersburg, MD, USA, and Special Fund for Health-scientific Research in the Public Interest: Research & application for the prevention & control of nosocomial infections caused by multi-drug resistant bacteria (201002021). The funders had no role in study design, literature search, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson DJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008305; Anderson DJ, 2009, INFECT DIS CLIN N AM, V23, P53, DOI 10.1016/j.idc.2008.10.004; Ao F, 2007, GANNAN YI XUE YUAN X, V27, p[883, 896]; Astagneau P, 2001, J HOSP INFECT, V48, P267, DOI 10.1053/jhin.2001.1003; Borenstein M, 2009, INTRO META ANAL; Chang Fang, 2010, Chinese Journal of Nosocomiology, V20, P1674; Chen B, 2009, CHIN NURS CAR ASS C, P50; Chen H, 2009, XIAN DAI YI YUAN, V9, P11; Chen Liang, 2010, Chinese Journal of Nosocomiology, V20, P419; Chen N-T, 2012, J NANOMATER, V2012, P9, DOI DOI 10.1016/J.M0LCATA.2012.07.009; Chen X, 2012, ZHONGGUO YI YAO ZHI, V10, P4; Coello R, 2005, J HOSP INFECT, V60, P93, DOI 10.1016/j.jhin.2004.10.019; Cui Q, 2008, YU FANG YI XUE LUN T, V14, P989; Dai C, 2012, ZHONGHUA YI YUAN GAN, V22, P3532; de Lissovoy G, 2009, AM J INFECT CONTROL, V37, P387, DOI 10.1016/j.ajic.2008.12.010; Deeks J., 2011, COCHRANE HDB SYST RE, V5; Deng X, 2010, ZHONGHUA YI YUAN GAN, V20, P1672; Ding H, 2010, LIAONING YI XUE ZA Z, V24, P3; Dong Y, 2007, STATUS INFLUENCE FAC; Duan Q, 2008, ZHONGGUO SHI YAN ZHE, V12, P1468; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Engemann JJ, 2003, CLIN INFECT DIS, V36, P592, DOI 10.1086/367653; Fan T, 2010, ZHONGGUO YI SHI JIN, V33, P30; Fan W, 2008, ZHONGHUA YI YUAN GAN, V18, P1562; Gaynes R, 2005, CLIN INFECT DIS, V41, P848, DOI 10.1086/432803; Gemmell CG, 2006, J ANTIMICROB CHEMOTH, V57, P589, DOI 10.1093/jac/dkl017; Gu S, 2009, ZHONGGUO SHE QU YI S; Gurusamy KS, 2013, COCHRANE DB SYST REV, V8, DOI DOI 10.1002/14651858.CD009726.PUB2; Hao M, 2012, ANLYSIS INVESTIGATIO; He Y, 2012, NANCHANG DA XUE XUE, V52, P69; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; HORAN TC, 1992, AM J INFECT CONTROL, V20, P271, DOI 10.1016/S0196-6553(05)80201-9; Huang Y, 2012, ZHONGGUO YI YAO ZHI, V10, P143, DOI DOI 10.1016/J.BI0RTECH.2012.10.143; Jernigan JA, 2004, INFECT CONT HOSP EP, V25, P457, DOI 10.1086/502421; Jiang Y, 2012, ZHONGHUA YI YUAN GAN, V22, P1391; Jiang Y, 2009, ZHEJIANG LIN CHUANG, V11, P390; Li D, 2009, LUZHOU YI XUE YUAN X, V32, P396; Li D, 2008, ZHONGGUO SHI YONG YI, V3, P58; Li H, 2011, ZHONGHUA YI YUAN GAN, V21, P2122; Li L, 2009, ZHONGGUO DANG DAI YI, V16, P162; Li M, 2009, ZHONG YI ZHENG GU, V21, P22; Li X, 2010, ZHONGHUA YI YUAN GAN, V20, P773; Li X, 2012, ZHONGGUO SHE QU YI S, V14, P300; Li Y, 2010, ZHONGHUA YI YUAN GAN, V20, P2338; Li Y, 2011, AN MO YU KANG FU YI, P126; Li Z, 2010, SHI YONG YU FANG YI, V17, P1430; Lin S, 2009, YI YAO SHI JIE, V11, P485; Lin X, 2008, GUANGDONG YI XUE, V29, P1598; Lin Z, 2007, ZHI YE YU JIAN KANG, V23, P72; Ling LiYan, 2011, Chinese Journal of Nosocomiology, V21, P3044; Liu C, 2010, YI YAO LUN TAN ZA ZH, V31, P116; Liu L, 2008, ZHONGHUA YI YUAN GAN, V18, P1091; Liu WenYing, 2011, Chinese Journal of Nosocomiology, V21, P2689; [柳小美 Liu Xiaomei], 2012, [中华医院感染学杂志, Chinese Journal of Nosocomiology], V22, P4385; Liu Z, 2012, ZHONGGUO WEI SHENG C, V9, P143; Lv S, 2012, ZHONGHUA YI YUAN GAN, V22, P4507; Lv X, 2007, ZHONGGUO WEI SHENG T, V19, P213; Mangram AJ, 1999, AM J INFECT CONTROL, V27, P97, DOI 10.1016/S0196-6553(99)70088-X; Mao G, 2011, ZHONGGUO WEI SHENG J, V21, P910; Martone WJ, 2001, CLIN INFECT DIS, V33, pS67, DOI 10.1086/321859; National Bureau of Statistics of China, 2011, CHIN STAT YB 2011; National Collaborating Centre for Acute Care, 2003, PREOP TESTS US ROUT; Pang J, 2007, XI BU YI XUE, V19, P85; Peng L, 2008, 5 AC C AN MICR PROF, P415; Peng Y, 2012, ZHONGGUO WU ZHEN XUE, V12, P1618; Peng Y, 2012, ZHONGHUA YI YUAN GAN, V22, P840; Qian P, 2011, ZHONGHUA YI YUAN GAN, V21, P819; Qu C, 2011, ZHONGGUO WEI SHENG C, V8, P78; Qu L, 2008, 3 AC C NAT BACT RES, P519; Ramirez MC, 2012, J GASTROINTEST SURG, P1; Ren G, 2009, ZHONGGUO SHE QU YI S, V11, P181; Ren N, 2007, ZHONGGUO YI XUE GONG, V5, P425; Ruan Y, 2011, ZHONGHUA YI YUAN GAN, V21, P2691; Santayana EM, 2011, AACN ADV CRIT CARE, V22, P5, DOI 10.1097/NCI.0b013e3181ef86fe2049019; Sheng F, 2012, ZHONGHUA YI YUAN GAN, V22, P4513; Shi W, 2011, ZHONGGUO GAN RAN KON, V10, P123; Smyth ETM, 2008, J HOSP INFECT, V69, P230, DOI 10.1016/j.jhin.2008.04.020; Stevens DL, 2002, CLIN INFECT DIS, V34, P1481, DOI 10.1086/340353; [孙光成 Sun Guangcheng], 2012, [中华医院感染学杂志, Chinese Journal of Nosocomiology], V22, P843; Sun ShiYing, 2008, Zhongguo Bingyuan Shengwuxue Zazhi / Journal of Pathogen Biology, V3, P136; Tang M, 2009, SHAN XI YI XUE ZA ZH, V38, P47; Tang M, 2009, SHAN XI YI XUE ZA ZH, V38, P76; Tang X, 2012, GUANGDONG YI XUE YUA, V30, P411; Tao G, 2011, ZHONGHUA YI YUAN GAN, V21, P1544; Tian L, 2011, LIN CHUANG XUE YE XU, V24, P83; Tlaskalova-Hogenova H, 2004, IMMUNOL LETT, V93, P97, DOI 10.1016/j.imlet.2004.02.005; Wan W, 2009, ZHONGGUO XIAN DAI YI, V47, P71; Wan W, 2009, ZHONGGUO XIAN DAI YI, V47, P68; Wang Ai, 2007, Zhongguo Yi Xue Ke Xue Yuan Xue Bao, V29, P566; Wang L, 2007, AC C ENV HLTH; Wang X, 2012, ZHONGHUA YI YUAN GAN, V22, P2322; Wang Y, 2008, ZHONGHUA YI YUAN GAN, V18, P1783; Wei L, 2010, ZHONGGUO FU YOU BAO, V25, P3395; WEISBLUM B, 1995, ANTIMICROB AGENTS CH, V39, P577, DOI 10.1128/AAC.39.3.577; Wen XiMao, 2011, Chinese Journal of Nosocomiology, V21, P350; Wu A, 2005, P 12 ANN AC C NAT HO; [吴安华 Wu Anhua], 2005, [中华医院感染学杂志, Chinese Journal of Nosocomiology], V15, P210; [项大业 Xiang Daye], 2012, [中华医院感染学杂志, Chinese Journal of Nosocomiology], V22, P1150; Xie D, 2007, XIAN DAI ZHONG XI YI, V16, P5121; Xie DS, 2010, J HOSP INFECT, V76, P150, DOI 10.1016/j.jhin.2010.04.003; Xie M, 2008, ZHONGHUA YI YUAN GAN, V18, P874; Xie X, 2012, ZHONGHUA YI YUAN GAN, V22, P4387; Xiu Y, 2012, HU LI YAN JIU, V26, P2631; [徐明 XU Ming], 2007, [北京医学, Beijing Medical Journal], V29, P583; Xu XiaoQiu, 2010, Chinese Journal of Nosocomiology, V20, P1304; Xu Y, 2011, ZHONG WAI JIAN KANG, V8, P181; Yan B, 2008, JIANGXI YI XUE YUAN, V48, P49; Yan B, 2008, JIANGXI YI XUE YUAN, V48, P55; Yang C, 2009, ZHONGHUA YI YUAN GAN, V19, P1512; Yang X, 2009, XIAN DAI YI YAO WEI, V25, P1676; Yao D, 2011, ZHONGGUO XIAN DAI YI, V49, P154; Yao D, 2011, ZHONGGUO XIAN DAI YI, V49, P147; You H, 2011, ZHONGHUA YI YUAN GAN, V21, P894; Yu Y, 2012, ZHONGHUA YI YUAN GAN, V22, P1282; Yue X, 2009, ZHONGGUO SHI YONG YI, V4, P183; Zeng L, 2012, ZHONGHUA YI YUAN GAN, V22, P1285; Zhang J, 2012, ZHONGGUO LIN CHUANG, V25, P338; Zhang R, 2007, GUO JI JIAN YAN YI X, V28, P25; Zhang X, 2009, ZHONGHUA SHI YONG ZH, V22, P1494; Zhang X, 2011, YI YAO QIAN YAN, V1, P47; Zhang X, 2010, NANHUA DA XUE XUE BA, V38, P301; Zhang X, 2009, ZHONGHUA SHI YONG ZH, V22, P1491; Zhang Y, 2011, XIAN DAI YU FANG YI, V38, P590; Zhang Y, 2011, ZHONGHUA YI YUAN GAN, V21, P695; Zhang Y, 2009, ZHONGGUO WEI SHENG J, V19, P1315; Zhang Z, 2008, 5 AC C AN MICR PROF, P220; Zhao CJ, 2012, DIAGN MICR INFEC DIS, V73, P174, DOI 10.1016/j.diagmicrobio.2012.03.003; Zhao W, 2011, ZHONGHUA YI YUAN GAN, V21, P3849; Zhao X, 2011, ZHONGGUO SHI YONG YI, V38, P27; Zheng H, 2011, ZHONGHUA YI YUAN GAN, V21, P601; Zheng S, 2007, XIAN DAI YU FANG YI, V34, P3799; [郑曙 Zheng Shu], 2011, [中华医院感染学杂志, Chinese Journal of Nosocomiology], V21, P5310; Zhou B, 2008, SHI YONG FU CHAN KE, V24, P436; Zhou B, 2007, ZHONGGUO RE DAI YI X, V7, P2144; Zhou J, 2011, JIAN YAN YI XUE YU L, V8, P972; Zhou Y, 2011, ZHONGHUA SUN SHANG Y, V6, P50; Zhu H, 2010, ZHONGGUO GAN RAN KON, V9, P393; Zhu J, 2007, JI CENG YI XUE LUN T, V11, P485; Zhu Y, 2008, ZHONGGUO XIAN DAI YI, V10, P121; Zhu Z, 2008, ZHONGHUA YI YUAN GAN, V18, P1186	140	14	15	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2015	10	1							e0116079	10.1371/journal.pone.0116079	http://dx.doi.org/10.1371/journal.pone.0116079			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ4OZ	25602284	Green Submitted, Green Published, gold			2022-12-27	WOS:000348203500018
J	Papadimitriou, K; Anastasiou, R; Maistrou, E; Plakas, T; Papandreou, NC; Hamodrakas, SJ; Ferreira, S; Supply, P; Renault, P; Pot, B; Tsakalidou, E				Papadimitriou, Konstantinos; Anastasiou, Rania; Maistrou, Eleni; Plakas, Thomas; Papandreou, Nikos C.; Hamodrakas, Stavros J.; Ferreira, Stephanie; Supply, Philip; Renault, Pierre; Pot, Bruno; Tsakalidou, Effie			Acquisition through Horizontal Gene Transfer of Plasmid pSMA198 by Streptococcus macedonicus ACA-DC 198 Points towards the Dairy Origin of the Species	PLOS ONE			English	Article							INFANTARIUS SUBSP INFANTARIUS; COMPLETE GENOME SEQUENCE; LACTIC-ACID BACTERIA; LACTOCOCCUS-LACTIS; MOLECULAR CHARACTERIZATION; BOVIS ENDOCARDITIS; MINIMAL REPLICON; HOST-RANGE; GALLOLYTICUS; IDENTIFICATION	Background Streptococcus macedonicus is an intriguing streptococcal species whose most frequent source of isolation is fermented foods similarly to Streptococcus thermophilus. However, S. macedonicus is closely related to commensal opportunistic pathogens of the Streptococcus bovis/Streptococcus equinus complex. Methodology/Principal Findings We analyzed the pSMA198 plasmid isolated from the dairy strain Streptococcus macedonicus ACA-DC 198 in order to provide novel clues about the main ecological niche of this bacterium. pSMA198 belongs to the narrow host range pCI305/pWV02 family found primarily in lactococci and to the best of our knowledge it is the first such plasmid to be reported in streptococci. Comparative analysis of the pSMA198 sequence revealed a high degree of similarity with plasmids isolated from Lactococcus lactis strains deriving from milk or its products. Phylogenetic analysis of the pSMA198 Rep showed that the vast majority of closely related proteins derive from lactococcal dairy isolates. Additionally, cloning of the pSMA198 ori in L. lactis revealed a 100% stability of replication over 100 generations. Both pSMA198 and the chromosome of S. macedonicus exhibit a high percentage of potential pseudogenes, indicating that they have co-evolved under the same gene decay processes. We identified chromosomal regions in S. macedonicus that may have originated from pSMA198, also supporting a long co-existence of the two replicons. pSMA198 was also found in divergent biotypes of S. macedonicus and in strains isolated from dispersed geographic locations (e.g. Greece and Switzerland) showing that pSMA198's acquisition is not a recent event. Conclusions/Significance Here we propose that S. macedonicus acquired plasmid pSMA198 from L. lactis via an ancestral genetic exchange event that took place most probably in milk or dairy products. We provide important evidence that point towards the dairy origin of this species.	[Papadimitriou, Konstantinos; Anastasiou, Rania; Maistrou, Eleni; Plakas, Thomas; Tsakalidou, Effie] Agr Univ Athens, Dept Food Sci & Human Nutr, Dairy Res Lab, GR-11855 Athens, Greece; [Plakas, Thomas; Papandreou, Nikos C.; Hamodrakas, Stavros J.] Univ Athens, Fac Biol, Dept Cell Biol & Biophys, Athens 15701, Greece; [Ferreira, Stephanie; Supply, Philip] Genoscreen, Serv Res Dev & Innovat Hlth & Environm, F-59000 Lille, France; [Supply, Philip; Pot, Bruno] Inst Pasteur, Ctr Infect & Immun Lille CIIL, F-59019 Lille, France; [Supply, Philip; Pot, Bruno] INSERM, U1019, F-59019 Lille, France; [Supply, Philip; Pot, Bruno] CNRS, UMR8204, F-59019 Lille, France; [Supply, Philip; Pot, Bruno] Univ Lille Nord France, F-59019 Lille, France; [Renault, Pierre] INRA, Micalis UMR1319, F-78352 Jouy En Josas, France; [Renault, Pierre] AgroParisTech, UMR Micalis, F-78352 Jouy En Josas, France	Agricultural University of Athens; National & Kapodistrian University of Athens; Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; Universite de Lille; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Lille - ISITE; Universite de Lille; Universite de Lille - ISITE; Universite de Lille; INRAE; UDICE-French Research Universities; Universite Paris Saclay; AgroParisTech; UDICE-French Research Universities; Universite Paris Saclay	Papadimitriou, K (corresponding author), Agr Univ Athens, Dept Food Sci & Human Nutr, Dairy Res Lab, Iera Odos 75, GR-11855 Athens, Greece.	kpapadimitriou@aua.gr	Papandreou, Nikos/AAM-9403-2021; Supply, Philip/A-9580-2019	Papandreou, Nikos/0000-0002-3533-2182; Supply, Philip/0000-0003-3690-3853; Anastasiou, Rania/0000-0002-3341-6956	European Social Fund; National resource EPEAEK through the Thales project; National resource YPEPTH through the Thales project	European Social Fund(European Social Fund (ESF)); National resource EPEAEK through the Thales project(Thales Group); National resource YPEPTH through the Thales project(Thales Group)	The present work was cofinanced by the European Social Fund and the National resources EPEAEK and YPEPTH through the Thales project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelgadir W, 2008, INT J FOOD MICROBIOL, V127, P215, DOI 10.1016/j.ijfoodmicro.2008.07.008; Ainsworth S, 2013, GENOME ANNOUNCEMENTS, V1, DOI 10.1128/genomeA.00119-12; Anisimova M, 2006, SYST BIOL, V55, P539, DOI 10.1080/10635150600755453; Asteri IA, 2010, INT J FOOD MICROBIOL, V141, P222, DOI 10.1016/j.ijfoodmicro.2010.05.018; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Boleij A, 2011, J INFECT DIS, V203, P1101, DOI 10.1093/infdis/jiq169; Bolotin A, 2004, NAT BIOTECHNOL, V22, P1554, DOI 10.1038/nbt1034; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Chevenet F, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-439; Danne C, 2011, J INFECT DIS, V204, P1960, DOI 10.1093/infdis/jir666; Darzentas N, 2010, BIOINFORMATICS, V26, P2620, DOI 10.1093/bioinformatics/btq484; Das D, 2009, PROTEINS, V75, P264, DOI 10.1002/prot.22338; Vuyst L, 2008, INT DAIRY J, V18, P476, DOI 10.1016/j.idairyj.2007.10.006; del Solar G, 1998, MICROBIOL MOL BIOL R, V62, P434, DOI 10.1128/MMBR.62.2.434-464.1998; Delorme C, 2008, INT J FOOD MICROBIOL, V126, P274, DOI 10.1016/j.ijfoodmicro.2007.08.014; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Gorecki RK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022238; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Gupta A, 2010, COLORECTAL DIS, V12, P164, DOI 10.1111/j.1463-1318.2009.01814.x; HAYES F, 1990, APPL ENVIRON MICROB, V56, P202, DOI 10.1128/AEM.56.1.202-209.1990; HAYES F, 1991, PLASMID, V25, P16, DOI 10.1016/0147-619X(91)90003-F; Heng NCK, 2011, J BACTERIOL, V193, P6402, DOI 10.1128/JB.06001-11; Herrero IA, 2002, J CLIN MICROBIOL, V40, P3848, DOI 10.1128/JCM.40.10.3848-3850.2002; HOLO H, 1989, APPL ENVIRON MICROB, V55, P3119, DOI 10.1128/AEM.55.12.3119-3123.1989; Hols P, 2005, FEMS MICROBIOL REV, V29, P435, DOI 10.1016/j.femsre.2005.04.008; Jans C, 2013, INT J FOOD MICROBIOL, V167, P186, DOI 10.1016/j.ijfoodmicro.2013.09.008; Jans C, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-200; Jans C, 2012, J BACTERIOL, V194, P2105, DOI 10.1128/JB.00160-12; KIEWIET R, 1993, MOL MICROBIOL, V10, P319, DOI 10.1111/j.1365-2958.1993.tb01958.x; LAZAROVITCH T, 2012, RELATIONSHIP NEW TAX; LEENHOUTS KJ, 1991, PLASMID, V26, P55, DOI 10.1016/0147-619X(91)90036-V; Liu MJ, 2009, APPL ENVIRON MICROB, V75, P4120, DOI 10.1128/AEM.02898-08; Ljungh Asa, 2006, Current Issues in Intestinal Microbiology, V7, P73; Lopez R, 2003, NUCLEIC ACIDS RES, V31, P3795, DOI 10.1093/nar/gkg573; Maguin E, 1996, J BACTERIOL, V178, P931, DOI 10.1128/jb.178.3.931-935.1996; Makarova K, 2006, P NATL ACAD SCI USA, V103, P15611, DOI 10.1073/pnas.0607117103; Malkin J, 2008, J HEART VALVE DIS, V17, P589; Maragkoudakis PA, 2009, INT J FOOD MICROBIOL, V133, P141, DOI 10.1016/j.ijfoodmicro.2009.05.012; Mills S, 2006, FEMS MICROBIOL REV, V30, P243, DOI 10.1111/j.1574-6976.2005.00011.x; O'Sullivan D, 2000, MOL MICROBIOL, V36, P866, DOI 10.1046/j.1365-2958.2000.01901.x; Papadimitriou K, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-272; Papadimitriou K, 2012, J BACTERIOL, V194, P1838, DOI 10.1128/JB.06804-11; Popa O, 2011, CURR OPIN MICROBIOL, V14, P615, DOI 10.1016/j.mib.2011.07.027; Schirawski J, 2002, APPL ENVIRON MICROB, V68, P5508, DOI 10.1128/AEM.68.11.5508-5516.2002; Schlegel L, 2000, INT J SYST EVOL MICR, V50, P1425, DOI 10.1099/00207713-50-4-1425; Shareck J, 2004, CRIT REV BIOTECHNOL, V24, P155, DOI 10.1080/07388550490904288; Siezen RJ, 2005, APPL ENVIRON MICROB, V71, P8371, DOI 10.1128/AEM.71.12.8371-8382.2005; Skulj M, 2008, MICROB CELL FACT, V7, DOI 10.1186/1475-2859-7-6; Smith WM, 2012, APPL ENVIRON MICROB, V78, P7753, DOI 10.1128/AEM.02316-12; Strahinic I, 2009, J APPL MICROBIOL, V106, P78, DOI 10.1111/j.1365-2672.2008.03977.x; Tanous C, 2007, MICROBIOL-SGM, V153, P1664, DOI 10.1099/mic.0.2006/002246-0; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tsakalidou E, 1998, INT J SYST BACTERIOL, V48, P519, DOI 10.1099/00207713-48-2-519; Van Domselaar GH, 2005, NUCLEIC ACIDS RES, V33, pW455, DOI 10.1093/nar/gki593	54	9	9	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2015	10	1							e0116337	10.1371/journal.pone.0116337	http://dx.doi.org/10.1371/journal.pone.0116337			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ4OG	25584532	Green Published, Green Submitted, gold			2022-12-27	WOS:000348201300008
J	Araki, S; Dairiki, R; Nakayama, Y; Murai, A; Miyashita, R; Iwatani, M; Nomura, T; Nakanishi, O				Araki, Shinsuke; Dairiki, Ryo; Nakayama, Yusuke; Murai, Aiko; Miyashita, Risa; Iwatani, Misa; Nomura, Toshiyuki; Nakanishi, Osamu			Inhibitors of CLK Protein Kinases Suppress Cell Growth and Induce Apoptosis by Modulating Pre-mRNA Splicing	PLOS ONE			English	Article							TARGET; GENE; EXON; SF3B; SPLICEOSTATIN; MECHANISMS; FAMILY; BREAST; CANCER; SRPK1	Accumulating evidence has demonstrated the importance of alternative splicing in various physiological processes, including the development of different diseases. CDC-like kinases (CLKs) and serine-arginine protein kinases (SRPKs) are components of the splicing machinery that are crucial for exon selection. The discovery of small molecule inhibitors against these kinases is of significant value, not only to delineate the molecular mechanisms of splicing, but also to identify potential therapeutic opportunities. Here we describe a series of small molecules that inhibit CLKs and SRPKs and thereby modulate pre-mRNA splicing. Treatment with these small molecules (Cpd-1, Cpd-2, or Cpd-3) significantly reduced the levels of endogenous phosphorylated SR proteins and caused enlargement of nuclear speckles in MDA-MB-468 cells. Additionally, the compounds resulted in splicing alterations of RPS6KB1 (S6K), and subsequent depletion of S6K protein. Interestingly, the activity of compounds selective for CLKs was well correlated with the activity for modulating S6K splicing as well as growth inhibition of cancer cells. A comprehensive mRNA sequencing approach revealed that the inhibitors induced splicing alterations and protein depletion for multiple genes, including those involved in growth and survival pathways such as S6K, EGFR, EIF3D, and PARP. Fluorescence pulse-chase labeling analyses demonstrated that isoforms with premature termination codons generated after treatment with the CLK inhibitors were degraded much faster than canonical mRNAs. Taken together, these results suggest that CLK inhibitors exhibit growth suppression and apoptosis induction through splicing alterations in genes involved in growth and survival. These small molecule inhibitors may be valuable tools for elucidating the molecular machinery of splicing and for the potential development of a novel class of antitumor agents.	[Araki, Shinsuke; Dairiki, Ryo; Nakayama, Yusuke; Murai, Aiko; Miyashita, Risa; Iwatani, Misa; Nomura, Toshiyuki; Nakanishi, Osamu] Takeda Pharmaceut Co Ltd, Div Pharmaceut Res, Fujisawa, Kanagawa, Japan	Takeda Pharmaceutical Company Ltd	Araki, S (corresponding author), Takeda Pharmaceut Co Ltd, Div Pharmaceut Res, Fujisawa, Kanagawa, Japan.	shinsuke.araki@takeda.com	Araki, Shinsuke/M-3983-2018	Araki, Shinsuke/0000-0002-9936-1417	Takeda Pharmaceutical Company Limited	Takeda Pharmaceutical Company Limited(Takeda Pharmaceutical Company Ltd)	Funding: Takeda Pharmaceutical Company Limited provided support in the form of salaries for all authors, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Amin EM, 2011, CANCER CELL, V20, P768, DOI 10.1016/j.ccr.2011.10.016; Anczukow O, 2012, NAT STRUCT MOL BIOL, V19, P220, DOI 10.1038/nsmb.2207; Bose P, 2014, PHARMACOL THERAPEUT, V143, P323, DOI 10.1016/j.pharmthera.2014.04.004; Busse D, 2000, J BIOL CHEM, V275, P6987, DOI 10.1074/jbc.275.10.6987; Cazzola M, 2013, BLOOD, V121, P260, DOI 10.1182/blood-2012-09-399725; Colwill K, 1996, EMBO J, V15, P265, DOI 10.1002/j.1460-2075.1996.tb00357.x; Corrionero A, 2011, GENE DEV, V25, P445, DOI 10.1101/gad.2014311; Folco EG, 2011, GENE DEV, V25, P440, DOI 10.1101/gad.2009411; GROSSO AR, 2008, EMBO REP; Hayes GM, 2006, CANCER RES, V66, P3819, DOI 10.1158/0008-5472.CAN-05-4065; Hayes GM, 2007, CANCER RES, V67, P2072, DOI 10.1158/0008-5472.CAN-06-2969; Johnson JM, 2003, SCIENCE, V302, P2141, DOI 10.1126/science.1090100; Kaida D, 2007, NAT CHEM BIOL, V3, P576, DOI 10.1038/nchembio.2007.18; Karlas A, 2010, NATURE, V463, P818, DOI 10.1038/nature08760; Karni R, 2007, NAT STRUCT MOL BIOL, V14, P185, DOI 10.1038/nsmb1209; Kotake Y, 2007, NAT CHEM BIOL, V3, P570, DOI 10.1038/nchembio.2007.16; Lai MC, 2003, BIOCHEM J, V371, P937, DOI 10.1042/BJ20021827; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Long JC, 2009, BIOCHEM J, V417, P15, DOI 10.1042/BJ20081501; Ma XJM, 2009, NAT REV MOL CELL BIO, V10, P307, DOI 10.1038/nrm2672; Malumbres M, 2014, EXPER OPIN THER TAR, P1; Matlin AJ, 2005, NAT REV MOL CELL BIO, V6, P386, DOI 10.1038/nrm1645; MAYEDA A, 1992, P NATL ACAD SCI USA, V89, P1301, DOI 10.1073/pnas.89.4.1301; Modrek B, 2003, NAT GENET, V34, P177, DOI 10.1038/ng1159; Muraki M, 2004, J BIOL CHEM, V279, P24246, DOI 10.1074/jbc.M314298200; Nayler O, 1998, J BIOL CHEM, V273, P34341, DOI 10.1074/jbc.273.51.34341; Neugebauer KM, 1997, GENE DEV, V11, P1148, DOI 10.1101/gad.11.9.1148; Nishida A, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1306; Rios J, 2011, ONCOLOGY-NY, V25, P1014; Sinha R, 2010, MOL CELL BIOL, V30, P2762, DOI 10.1128/MCB.01270-09; Srebrow A, 2006, J CELL SCI, V119, P2635, DOI 10.1242/jcs.03053; Tazi J, 2005, TRENDS BIOCHEM SCI, V30, P469, DOI 10.1016/j.tibs.2005.06.002; TUMA RS, 1993, J CELL BIOL, V122, P767, DOI 10.1083/jcb.122.4.767; Twyffels L, 2011, FEBS J, V278, P3246, DOI 10.1111/j.1742-4658.2011.08274.x; UCHIKAWA O, 2010, Patent No. 20100029619; Wahl MC, 2009, CELL, V136, P701, DOI 10.1016/j.cell.2009.02.009; Webb TR, 2013, DRUG DISCOV TODAY, V18, P43, DOI 10.1016/j.drudis.2012.07.013; Wong R, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-47; Zhong XY, 2009, GENE DEV, V23, P482, DOI 10.1101/gad.1752109; Zhou ZH, 2012, MOL CELL, V47, P422, DOI 10.1016/j.molcel.2012.05.014	40	79	81	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2015	10	1							e0116929	10.1371/journal.pone.0116929	http://dx.doi.org/10.1371/journal.pone.0116929			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ4CF	25581376	gold, Green Published, Green Submitted			2022-12-27	WOS:000348169100007
J	Yu, HY; Ahn, JH; Park, SW; Jung, YS				Yu, Hye Yon; Ahn, Ji Hun; Park, Se Won; Jung, Yi-Sook			Preventive Effect of Yuzu and Hesperidin on Left Ventricular Remodeling and Dysfunction in Rat Permanent Left Anterior Descending Coronary Artery Occlusion Model	PLOS ONE			English	Article							HEART-FAILURE; MYOCARDIAL-INFARCTION; OXIDATIVE STRESS; ACTIVATION; INJURY; MOUSE; DEATH; (-)-EPICATECHIN; INHIBITION; DISEASE	Left ventricular (LV) remodeling, which includes ventricular dilatation and increased interstitial fibrosis after myocardial infarction (MI), is the critical process underlying the progression to heart failure. Therefore, a novel approach for preventing LV remodeling after MI is highly desirable. Yuzu is a citrus plant originating in East Asia, and has a number of cardioprotective properties such as hesperidin. However, no study has proved whether yuzu can prevent LV remodeling. The aim of this study was to determine the effects of yuzu on heart failure (HF) and its potential impact on the LV remodeling process after MI. Our in vivo study using the permanent left anterior descending coronary artery (LAD) occlusion model demonstrate that one week pre-treatment with yuzu or its major metabolite hesperidin before LAD occlusion significantly attenuated cardiac dysfunction, myocyte apoptosis and inflammation. Not only yuzu but also hesperidin inhibited caspase-3 activity, myeloperoxidase expression, a-smooth muscle actin expression, and matrix metalloproteinase2 activity in a permanent LAD occlusion rat model. To our knowledge, our findings provide the first evidence that yuzu and hesperidin prevent MI-induced ventricular dysfunction and structural remodeling of myocardium.	[Yu, Hye Yon] Ajou Univ, Sch Med, Dept Physiol, Suwon 441749, South Korea; [Yu, Hye Yon; Jung, Yi-Sook] Ajou Univ, Coll Pharm, Suwon 441749, South Korea; [Ahn, Ji Hun] Soon Chun Hyang Univ, Gumi Hosp, Dept Cardiol, Gumi, South Korea; [Park, Se Won] Konkuk Univ, Coll Life & Environm Sci, Seoul, South Korea; [Jung, Yi-Sook] Ajou Univ, Res Inst Pharmaceut Sci & Technol, Suwon 441749, South Korea	Ajou University; Ajou University; Soonchunhyang University; Konkuk University; Ajou University	Jung, YS (corresponding author), Ajou Univ, Coll Pharm, Suwon 441749, South Korea.	yisjung@ajou.ac.kr			Bio-industry Technology Development Program [111093-3]; Ministry for Food, Agriculture, Forestry and Fisheries, Republic of Korea; Next-Generation BioGreen 21 Program [PJ009074]; Rural Development Administration, Republic of Korea	Bio-industry Technology Development Program; Ministry for Food, Agriculture, Forestry and Fisheries, Republic of Korea; Next-Generation BioGreen 21 Program(Rural Development Administration (RDA), Republic of Korea); Rural Development Administration, Republic of Korea(Rural Development Administration (RDA), Republic of Korea)	This research was supported by Bio-industry Technology Development Program (111093-3), Ministry for Food, Agriculture, Forestry and Fisheries, Republic of Korea. This research was also supported by a grant from the Next-Generation BioGreen 21 Program (No. PJ009074), Rural Development Administration, Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhlaghi M, 2010, PLANT FOOD HUM NUTR, V65, P193, DOI 10.1007/s11130-010-0182-4; Anatoliotakis N, 2013, CURR TOP MED CHEM, V13, P115, DOI 10.2174/1568026611313020004; Campian ME, 2010, EUR J HEART FAIL, V12, P653, DOI 10.1093/eurjhf/hfq066; Creemers EEJM, 2001, CIRC RES, V89, P201, DOI 10.1161/hh1501.094396; Diwan A, 2003, CURR MOL MED, V3, P161, DOI 10.2174/1566524033361537; Dorn GW, 2009, CARDIOVASC RES, V81, P465, DOI 10.1093/cvr/cvn243; Eapen Z, 2009, CURR OPIN CARDIOL, V24, P223, DOI 10.1097/HCO.0b013e32832a11ff; Gao E, 2010, CIRC RES, V107, P1445, DOI 10.1161/CIRCRESAHA.110.223925; Gonzalez A, 2011, J AM COLL CARDIOL, V58, P1833, DOI 10.1016/j.jacc.2011.06.058; Jessup M, 2003, NEW ENGL J MED, V348, P2007, DOI 10.1056/NEJMra021498; Jitkova Y, 2012, CIRCULATION, V125, P3159; Kandasamy AD, 2010, CARDIOVASC RES, V85, P413, DOI 10.1093/cvr/cvp268; Kido M, 2005, J AM COLL CARDIOL, V46, P2116, DOI 10.1016/j.jacc.2005.08.045; Kim MY, 2010, CARDIOVASC RES, V87, P119, DOI 10.1093/cvr/cvq048; Kim SJ, 2014, ARCH PHARM RES, V37, P1079, DOI 10.1007/s12272-013-0309-x; Konstam MA, 2011, JACC-CARDIOVASC IMAG, V4, P98, DOI 10.1016/j.jcmg.2010.10.008; Konstantinidis K, 2012, ARTERIOSCL THROM VAS, V32, P1552, DOI 10.1161/ATVBAHA.111.224915; Lal H, 2012, CIRCULATION, V125, P65, DOI 10.1161/CIRCULATIONAHA.111.050666; Paulus W J, 2000, Heart Fail Monit, V1, P50; Pchejetski D, 2012, EUR HEART J, V33, P2360, DOI 10.1093/eurheartj/ehr389; Samsamshariat SA, 2005, CARDIOVASC REVASCULA, V6, P70, DOI 10.1016/j.carrev.2005.07.002; Shin JW, 2014, BIOMOL THER, V22, P17, DOI 10.4062/biomolther.2013.102; Strauer BE, 2010, EUR J HEART FAIL, V12, P721, DOI 10.1093/eurjhf/hfq095; Sutton MGS, 2000, CIRCULATION, V101, P2981, DOI 10.1161/01.CIR.101.25.2981; Tang W H Wilson, 2011, Congest Heart Fail, V17, P105, DOI 10.1111/j.1751-7133.2011.00221.x; van den Borne SWM, 2010, NAT REV CARDIOL, V7, P30, DOI 10.1038/nrcardio.2009.199; van Wijk B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044692; Yamazaki KG, 2008, AM J PHYSIOL-HEART C, V295, pH761, DOI 10.1152/ajpheart.00413.2008; Yamazaki KG, 2010, J AM COLL CARDIOL, V55, P2869, DOI 10.1016/j.jacc.2010.01.055; Yang B, 2013, EXPERT OPIN THER TAR, V17, P255, DOI 10.1517/14728222.2013.745513; Yang HI, 2013, BIOMOL THER, V21, P84, DOI 10.4062/biomolther.2012.101; Yi W, 2012, CIRCULATION, V125, P3159, DOI 10.1161/CIRCULATIONAHA.112.099937; Yu HY, 2011, FOOD CHEM TOXICOL, V49, P3018, DOI 10.1016/j.fct.2011.09.038	33	46	46	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2015	10	1							e110596	10.1371/journal.pone.0110596	http://dx.doi.org/10.1371/journal.pone.0110596			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ3BG	25559243	Green Submitted, Green Published, gold			2022-12-27	WOS:000348102200002
J	Cheung, MC; Law, D; Yip, J				Cheung, Mei-chun; Law, Derry; Yip, Joanne			Evaluating Aesthetic Experience through Personal-Appearance Styles: A Behavioral and Electrophysiological Study	PLOS ONE			English	Article							ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; CENTRAL EXECUTIVE FUNCTIONS; EEG COHERENCE; EMOTIONAL EXPRESSION; BRAIN ACTIVITY; THETA; ASYMMETRY; SYNCHRONIZATION; APPRECIATION; ACTIVATION	Consumers' aesthetic experience has often been linked with the concept of beauty, which is regarded as subjective and may vary between individuals, cultures and places, and across time. With the advent of brain-imaging techniques, there is more and more evidence to suggest that aesthetic experience lies not only in the eye of the beholder, but also in the brain of the beholder. However, there are gaps in the previous research in this area, as several significant issues have not yet been addressed. Specifically, it is unclear whether the human brain really pays more attention and generates more positive emotional responses to beautiful things. To explore the brain activity relating to consumers' aesthetic experiences, 15 participants were recruited voluntarily to view a series of personal-appearance styles. They were invited to make aesthetic judgments while their brain activity was recorded by electroencephalography. Two electroencephalographic (EEG) indicators, theta coherence and frontal alpha symmetry, were utilized. Theta coherence is a measure of linear synchronization between signals at two electrode sites. It reflects the degree of functional cooperation between the underlying neuronal substrates and was used to explore the attentional processing involved in aesthetic judgments. Frontal alpha asymmetry is derived by subtracting the log-transformed absolute alpha power of the left hemisphere from the analogous log-transformed alpha power of the right hemisphere. It was used as an indicator of emotional response. During aesthetic judgments, long-range theta coherence increased in both hemispheres and more positive frontal alpha asymmetry was found when the styles were judged to be beautiful. Therefore, participants demonstrated brain activity suggestive of central executive processing and more positive emotional responses when they considered styles to be beautiful. The study provides some insight into the brain activity associated with consumers' aesthetic experiences, and suggests new directions for exploring consumer behavior from the perspective of neuroscience.	[Cheung, Mei-chun] Chinese Univ Hong Kong, Dept Social Work, Shatin, Hong Kong, Peoples R China; [Law, Derry; Yip, Joanne] Hong Kong Polytech Univ, Inst Text & Clothing, Kowloon, Hong Kong, Peoples R China	Chinese University of Hong Kong; Hong Kong Polytechnic University	Cheung, MC (corresponding author), Chinese Univ Hong Kong, Dept Social Work, Shatin, Hong Kong, Peoples R China.	meichun@swk.cuhk.edu.hk	Cheung, Mei-chun/A-1261-2014; Yip, Joanne/P-6942-2014	Cheung, Mei-chun/0000-0002-0210-0772; Yip, Joanne/0000-0002-3270-4702; Law, Derry/0000-0002-8646-0512	Hong Kong Polytechnic University [4-ZZD1, G-UC37]	Hong Kong Polytechnic University(Hong Kong Polytechnic University)	This study was supported by the internal grants from The Hong Kong Polytechnic University (MC, DL, JY, 4-ZZD1) and (JY, G-UC37). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aharon I, 2001, NEURON, V32, P537, DOI 10.1016/S0896-6273(01)00491-3; [Anonymous], 1994, J Clin Neurophysiol, V11, P111; Baddeley A, 2010, CURR BIOL, V20, pR136, DOI 10.1016/j.cub.2009.12.014; Baltissen R., 1998, EMPIR STUD ARTS, V16, P97, DOI [10.2190/KK5M-GAM9-FFFG-0BCC, DOI 10.2190/KK5M-GAM9-FFFG-0BCC]; Barry RJ, 2009, INT J PSYCHOPHYSIOL, V71, P205, DOI 10.1016/j.ijpsycho.2008.09.003; Bartels A, 1998, P ROY SOC B-BIOL SCI, V265, P2327, DOI 10.1098/rspb.1998.0579; Bloch PH, 2003, J CONSUM RES, V29, P551, DOI 10.1086/346250; Boccia M, 2014, ATTEN PERCEPT PSYCHO, V76, P1516, DOI 10.3758/s13414-014-0739-7; Brattico E, 2003, ANN NY ACAD SCI, V999, P155, DOI 10.1196/annals.1284.018; Cazzato V, 2014, BEHAV BRAIN RES, V264, P188, DOI 10.1016/j.bbr.2014.02.001; Cela-Conde CJ, 2013, P NATL ACAD SCI USA, V110, P10454, DOI 10.1073/pnas.1302855110; Cela-Conde CJ, 2011, PROG NEUROBIOL, V94, P39, DOI 10.1016/j.pneurobio.2011.03.003; Cela-Conde CJ, 2009, P NATL ACAD SCI USA, V106, P3847, DOI 10.1073/pnas.0900304106; Cela-Conde CJ, 2004, P NATL ACAD SCI USA, V101, P6321, DOI 10.1073/pnas.0401427101; Chan AS, 2008, APPL PSYCHOPHYS BIOF, V33, P39, DOI 10.1007/s10484-008-9050-5; Chan Agnes S, 2011, Evid Based Complement Alternat Med, V2011, P543648, DOI 10.1093/ecam/nep198; Chan AS, 2011, EVID-BASED COMPL ALT, V2011, DOI 10.1155/2011/180704; Chan AS, 2011, RES AUTISM SPECT DIS, V5, P237, DOI 10.1016/j.rasd.2010.04.005; Chan AS, 2011, RES AUTISM SPECT DIS, V5, P254, DOI 10.1016/j.rasd.2010.04.007; CHAN AS, 2011, EVID-BASED COMPL ALT, P1, DOI DOI 10.1093/ECAM/NEP043; Chatrian G. E., 1985, American Journal of EEG Technology, V25, P83; Chatterjee A., 2004, B PSYCHOL ARTS, V4, P56, DOI DOI 10.1037/E514602010-003; Chatterjee A, 2009, NEUROPSYCHOLOGY, V23, P135, DOI 10.1037/a0014430; Cheung MC, 2010, NEUROSCI LETT, V485, P178, DOI 10.1016/j.neulet.2010.09.006; Cheung MC, 2009, INT J PSYCHOPHYSIOL, V74, P132, DOI 10.1016/j.ijpsycho.2009.08.007; Clarke AR, 2008, INT J PSYCHOPHYSIOL, V67, P35, DOI 10.1016/j.ijpsycho.2007.10.001; Coan JA, 2003, ANN NY ACAD SCI, V1000, P375, DOI 10.1196/annals.1280.034; Coan JA, 2001, PSYCHOPHYSIOLOGY, V38, P912, DOI 10.1111/1469-8986.3860912; CUPCHIK GC, 1992, EMERGING VISIONS OF; Cupchik GC, 2009, BRAIN COGNITION, V70, P84, DOI 10.1016/j.bandc.2009.01.003; Davidson R. J., 2000, HDB PSYCHOPHYSIOLOGY, V2nd, P27; Davidson RJ, 2000, PSYCHOL BULL, V126, P890, DOI 10.1037/0033-2909.126.6.890; DAVIDSON RJ, 1982, SCIENCE, V218, P1235, DOI 10.1126/science.7146906; DAVIDSON RJ, 1990, J PERS SOC PSYCHOL, V58, P330, DOI 10.1037/0022-3514.58.2.330; Davidson RJ, 1998, COGNITION EMOTION, V12, P307, DOI 10.1080/026999398379628; Davidson RJ, 2000, AM PSYCHOL, V55, P1196, DOI 10.1037/0003-066X.55.11.1196; Davidson RJ, 2003, PSYCHOSOM MED, V65, P564, DOI 10.1097/01.PSY.0000077505.67574.E3; Di Dio C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001201; Dupuy FE, 2008, INT J PSYCHOPHYSIOL, V70, P151, DOI 10.1016/j.ijpsycho.2008.07.012; EKMAN P, 1990, J PERS SOC PSYCHOL, V58, P342, DOI 10.1037/0022-3514.58.2.342; Fernandez M, 2003, J DEV BEHAV PEDIATR, V24, P261, DOI 10.1097/00004703-200308000-00007; FOX NA, 1991, AM PSYCHOL, V46, P863, DOI 10.1037/0003-066X.46.8.863; FOX NA, 1986, NEUROPSYCHOLOGIA, V24, P417, DOI 10.1016/0028-3932(86)90028-X; Goldman RI, 2002, NEUROREPORT, V13, P2487, DOI 10.1097/00001756-200212200-00022; Harmon-Jones E, 2003, COGNITION EMOTION, V17, P1, DOI 10.1080/02699930302278; Harmon-Jones E, 2001, J PERS SOC PSYCHOL, V80, P797, DOI 10.1037/0022-3514.80.5.797; Harmon-Jones E, 2010, BIOL PSYCHOL, V84, P451, DOI 10.1016/j.biopsycho.2009.08.010; Herz R.S, 1998, EMPIR STUD ARTS, V16, P137, DOI [10.2190/c43t-cjr2-9lpd-r0pb, DOI 10.2190/C43T-CJR2-9LPD-R0PB]; Hofel L, 2007, INT J PSYCHOPHYSIOL, V65, P20, DOI 10.1016/j.ijpsycho.2007.02.007; Humphreys GW, 1997, PHILOS T R SOC B, V352, P1275, DOI 10.1098/rstb.1997.0110; Ishizu T, 2013, EUR J NEUROSCI, V37, P1413, DOI 10.1111/ejn.12135; Ishizu T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021852; Jacobs RHAH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031248; Jacobsen T, 2006, NEUROIMAGE, V29, P276, DOI 10.1016/j.neuroimage.2005.07.010; Jacobsen T, 2001, EMPIR STUD ARTS, V19, P177, DOI DOI 10.2190/P7W1-5F1F-NJK9-X05B; Jacobsen T, 2003, COGN AFFECT BEHAV NE, V3, P289, DOI 10.3758/CABN.3.4.289; Jones S.J., 2005, FASHION DESIGN; Kaiser Susan B., 1995, CLOTH TEXT RES J, V13, P172, DOI DOI 10.1177/0887302X9501300304); Kawabata H, 2004, J NEUROPHYSIOL, V91, P1699, DOI 10.1152/jn.00696.2003; Kirk U, 2009, BRAIN COGNITION, V69, P306, DOI 10.1016/j.bandc.2008.08.004; Kline JP, 2000, BIOL PSYCHOL, V52, P241, DOI 10.1016/S0301-0511(99)00046-0; Lane RD, 1999, NEUROPSYCHOLOGIA, V37, P989, DOI 10.1016/S0028-3932(99)00017-2; Laufs H, 2003, NEUROIMAGE, V19, P1463, DOI 10.1016/S1053-8119(03)00286-6; LAW DKM, 2009, ASIA DESIGN J, V4, P222; Leder H, 2004, BRIT J PSYCHOL, V95, P489, DOI 10.1348/0007126042369811; Leder H, 2014, BRIT J PSYCHOL, V105, P443, DOI 10.1111/bjop.12084; McKeefry DJ, 1997, BRAIN, V120, P2229, DOI 10.1093/brain/120.12.2229; Mizuhara H, 2004, NEUROREPORT, V15, P1233, DOI 10.1097/01.wnr.0000126755.09715.b3; Mizuhara H, 2007, NEUROIMAGE, V36, P232, DOI 10.1016/j.neuroimage.2007.02.026; Norman D. A., 2004, EMOTIONAL DESIGN WHY; Nuwer MR, 1998, ELECTROEN CLIN NEURO, V106, P259, DOI 10.1016/S0013-4694(97)00106-5; Pessoa L, 2003, J NEUROSCI, V23, P3990; Reimann M, 2011, UNDERST INNOV, P45, DOI 10.1007/978-3-642-13757-0_3; Roye A, 2008, J PSYCHOPHYSIOL, V22, P41, DOI 10.1027/0269-8803.22.1.41; Sarnthein J, 1998, P NATL ACAD SCI USA, V95, P7092, DOI 10.1073/pnas.95.12.7092; Sauseng P, 2007, EUR J NEUROSCI, V25, P587, DOI 10.1111/j.1460-9568.2006.05286.x; Sauseng P, 2005, INT J PSYCHOPHYSIOL, V57, P97, DOI 10.1016/j.ijpsycho.2005.03.018; Sederberg PB, 2003, J NEUROSCI, V23, P10809; Srinivasan R, 2007, J NEUROSCI METH, V166, P41, DOI 10.1016/j.jneumeth.2007.06.026; Thatcher RW, 2008, HUM BRAIN MAPP, V29, P1400, DOI 10.1002/hbm.20474; Thatcher RW, 2005, CLIN NEUROPHYSIOL, V116, P2129, DOI 10.1016/j.clinph.2005.04.026; THATCHER RW, 1986, ELECTROEN CLIN NEURO, V64, P123, DOI 10.1016/0013-4694(86)90107-0; Tsukiura T, 2011, SOC COGN AFFECT NEUR, V6, P138, DOI 10.1093/scan/nsq025; Vartanian O, 2004, NEUROREPORT, V15, P893, DOI 10.1097/00001756-200404090-00032; VERYZER RW, 1993, ADV CONSUM RES, V20, P224; von Stein A, 2000, INT J PSYCHOPHYSIOL, V38, P301, DOI 10.1016/S0167-8760(00)00172-0; Waldstein SR, 2000, BIOL PSYCHOL, V55, P3, DOI 10.1016/S0301-0511(00)00065-X; Weiss S, 2000, NEUROREPORT, V11, P2357, DOI 10.1097/00001756-200008030-00005; Womelsdorf T, 2007, CURR OPIN NEUROBIOL, V17, P154, DOI 10.1016/j.conb.2007.02.002; Womelsdorf T, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00210; Zeki S, 1998, BRAIN, V121, P1669, DOI 10.1093/brain/121.9.1669; Zeki S, 1999, PHILOS T R SOC B, V354, P1371, DOI 10.1098/rstb.1999.0485; Zeki S, 1998, NEUROSCIENTIST, V4, P365, DOI 10.1177/107385849800400518; Zeki S., 1999, INNER VISION EXPLORA; Zeki S, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00068; Zhang ZM, 2012, J INTEGR NEUROSCI, V11, P477, DOI 10.1142/S0219635212500306	96	15	16	0	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2014	9	12							e115112	10.1371/journal.pone.0115112	http://dx.doi.org/10.1371/journal.pone.0115112			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AX7UC	25551635	Green Published, Green Submitted, gold			2022-12-27	WOS:000347119100027
J	Eriksen, RL; Hierro, JL; Eren, O; Andonian, K; Torok, K; Becerra, PI; Montesinos, D; Khetsuriani, L; Diaconu, A; Kesseli, R				Eriksen, Renee L.; Hierro, Jose L.; Eren, Ozkan; Andonian, Krikor; Toeroek, Katalin; Becerra, Pablo I.; Montesinos, Daniel; Khetsuriani, Liana; Diaconu, Alecu; Kesseli, Rick			Dispersal Pathways and Genetic Differentiation among Worldwide Populations of the Invasive Weed Centaurea solstitialis L. (Asteraceae)	PLOS ONE			English	Article							SEED SIZE; EVOLUTION; ADMIXTURE; SOFTWARE; HYBRIDIZATION; SUCCESS; GROWTH; COMMON	The natural history of introduced species is often unclear due to a lack of historical records. Even when historical information is readily available, important factors of the invasions such as genetic bottlenecks, hybridization, historical relationships among populations and adaptive changes are left unknown. In this study, we developed a set of nuclear, simple sequence repeat markers and used these to characterize the genetic diversity and population structure among native (Eurasian) and non-native (North and South American) populations of Centaurea solstitialis L., (yellow starthistle). We used these data to test hypotheses about the invasion pathways of the species that were based on historical and geographical records, and we make inferences about historical relationships among populations and demographic processes following invasion. We confirm that the center of diversity and the native range of the species is likely the eastern Mediterranean region in the vicinity of Turkey. From this region, the species likely proceeded to colonize other parts of Europe and Asia via a slow, stepwise range expansion. Spanish populations were the primary source of seed to invade South America via human-mediated events, as was evident from historical records, but populations from the eastern Mediterranean region were also important. North American populations were largely derived from South America, but had secondary contributors. We suggest that the introduction history of non-native populations from disparate parts of the native range have allowed not just one, but multiple opportunities first in South America then again in North America for the creation of novel genotypes via intraspecific hybridization. We propose that multiple intraspecific hybridization events may have created especially potent conditions for the selection of a noxious invader, and may explain differences in genetic patterns among North and South America populations, inferred differences in demographic processes, as well as morphological differences previously reported from common garden experiments.	[Eriksen, Renee L.; Kesseli, Rick] Univ Massachusetts, Dept Biol, Boston, MA 02125 USA; [Hierro, Jose L.] Univ Nacl La Pampa, Consejo Nacl Invest Cient & Tecn, Inst Ciencias Tierra & Ambientales La Pampa, Santa Rosa, La Pampa, Argentina; [Eren, Ozkan] Adnan Menderes Univ, Fen Edebiyat Fak, Biyol Bolumu, Aydin, Turkey; [Andonian, Krikor] De Anza Coll, Dept Environm Studies, Cupertino, CA USA; [Toeroek, Katalin] Ctr Ecol Res MTA OK, Vacratot, Hungary; [Becerra, Pablo I.] Pontificia Univ Catolica Chile, Dept Ecosistemas & Medio Ambiente, Fac Agron & Ingn Forestal, Santiago, Chile; [Montesinos, Daniel] Univ Coimbra, Ctr Funct Ecol, Dept Ciencias Vida, Fac Ciencia & Tecnol, Coimbra, Portugal; [Khetsuriani, Liana] Ilia State Univ, Inst Bot, Tbilisi, Georgia; [Diaconu, Alecu] Inst Biol Res, Biol Control Lab, Iasi, Romania	University of Massachusetts System; University of Massachusetts Boston; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Adnan Menderes University; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Centre for Ecological Research; Pontificia Universidad Catolica de Chile; Universidade de Coimbra; Ilia State University; National Research Institute for Biological Sciences	Eriksen, RL (corresponding author), Univ Massachusetts, Dept Biol, Boston, MA 02125 USA.	renee.eriksen@gmail.com	Török, Katalin/AAP-3392-2021; DIACONU, Alecu/A-9299-2011; Montesinos, Daniel/A-9070-2012	Montesinos, Daniel/0000-0003-2893-0878	National Science Foundation [NSF 0820451]; Direct For Biological Sciences [0820451] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was funded by National Science Foundation (NSF 0820451) (www.nsf.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allard W, 1960, PRINCIPLES PF PLANT; ANDERSON E, 1954, EVOLUTION, V8, P378, DOI 10.2307/2405784; Anderson E., 1949, INTROGRESSIVE HYBRID; Andonian K, 2011, BIOL INVASIONS, V13, P2957, DOI 10.1007/s10530-011-9978-x; Bossdorf O, 2005, OECOLOGIA, V144, P1, DOI 10.1007/s00442-005-0070-z; Buswell JM, 2011, J ECOL, V99, P214, DOI 10.1111/j.1365-2745.2010.01759.x; DiTomaso J.M., 2007, WEEDS CALIFORNIA OTH, V3488; Dlugosch KM, 2013, G3-GENES GENOM GENET, V3, P359, DOI 10.1534/g3.112.003871; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Ellstrand NC, 2000, P NATL ACAD SCI USA, V97, P7043, DOI 10.1073/pnas.97.13.7043; Eriksen RL, 2012, BIOL INVASIONS, V14, P1459, DOI 10.1007/s10530-012-0172-6; Eriksen RL, 2009, MORPHOLOGICAL GENETI; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Excoffier L, 2009, ANNU REV ECOL EVOL S, V40, P481, DOI 10.1146/annurev.ecolsys.39.110707.173414; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Garcia-Jacas N, 2006, ANN BOT-LONDON, V98, P741, DOI 10.1093/aob/mcl157; Gerlach JD, 1997, P CALIF WEED SCI SOC, V49, P136; Graebner RC, 2012, PLANT ECOL, V213, P545, DOI 10.1007/s11258-012-0020-x; Gross BL, 2007, MOL ECOL, V16, P5246, DOI 10.1111/j.1365-294X.2007.03574.x; Hierro JL, 2006, AM NAT, V168, P144, DOI 10.1086/505767; Hierro JL, 2013, OIKOS, V122, P583, DOI 10.1111/j.1600-0706.2012.00022.x; Hierro JL, 2011, BIOL INVASIONS, V13, P2249, DOI 10.1007/s10530-011-0037-4; Hierro JL, 2009, OIKOS, V118, P529, DOI [10.1111/j.1600-0706.2009.17283.x, 10.1111/j.1600-0706.2008.17283.x]; Kalinowski ST, 2005, MOL ECOL NOTES, V5, P187, DOI 10.1111/j.1471-8286.2004.00845.x; Keller SR, 2014, J EVOLUTION BIOL, V27, P616, DOI 10.1111/jeb.12330; Lavergne S, 2007, P NATL ACAD SCI USA, V104, P3883, DOI 10.1073/pnas.0607324104; Maddox D, 1981, INTRO PHENOLOGY DENS; Mayr E., 1964, SYSTEMATICS ORIGIN S; Molofsky J, 2014, ECOL EVOL, V4, P899, DOI 10.1002/ece3.966; Montesinos D, 2012, AM NAT, V180, P529, DOI 10.1086/667585; Murray J., 1910, REPORTS SCI EXPEDITI, P17; NEI M, 1975, EVOLUTION, V29, P1, DOI 10.2307/2407137; Novak S, 2005, GENETIC BOTTLENECKS, P201; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Pinke G, 2002, KITAIBELIA, V7, P249; Pitcairn M. J., 2006, California Agriculture, V60, P83, DOI 10.3733/ca.v060n02p83; Pritchard JK, 2000, GENETICS, V155, P945; Rieseberg LH, 1997, ANNU REV ECOL SYST, V28, P359, DOI 10.1146/annurev.ecolsys.28.1.359; Rieseberg LH, 2007, GENETICA, V129, P149, DOI 10.1007/s10709-006-9011-y; Rieseberg LH, 2009, CURR BIOL, V19, pR119, DOI 10.1016/j.cub.2008.12.016; Rius M, 2014, TRENDS ECOL EVOL, V29, P233, DOI 10.1016/j.tree.2014.02.003; Rozen S, 2000, Methods Mol Biol, V132, P365; STEBBINS GL, 1945, BOT REV, V11, P463, DOI 10.1007/BF02861140; Sun M, 1998, HEREDITY, V80, P225, DOI 10.1046/j.1365-2540.1998.00290.x; Sun M, 1997, CAN J BOT, V75, P1470, DOI 10.1139/b97-861; Thiel T, 2003, THEOR APPL GENET, V106, P411, DOI 10.1007/s00122-002-1031-0; Uygur S, 2004, WEED SCI, V52, P746, DOI 10.1614/WS-03-150R1; Widmer TL, 2007, WEED SCI, V55, P465, DOI 10.1614/WS-06-211R.1; Wright S, 1922, AM NAT, V56, P330, DOI 10.1086/279872	52	33	33	1	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2014	9	12							e114786	10.1371/journal.pone.0114786	http://dx.doi.org/10.1371/journal.pone.0114786			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UC	25551223	gold, Green Published, Green Submitted			2022-12-27	WOS:000347119100015
J	Liang, LN; Zhang, W; Ma, G; Hoffmann, AA; Ma, CS				Liang, Li-Na; Zhang, Wei; Ma, Gang; Hoffmann, Ary A.; Ma, Chun-Sen			A Single Hot Event Stimulates Adult Performance but Reduces Egg Survival in the Oriental Fruit Moth, Grapholitha molesta	PLOS ONE			English	Article							THERMAL TOLERANCE; DROSOPHILA-MELANOGASTER; REPRODUCTIVE SUCCESS; INDUCED HORMESIS; HEAT-STRESS; TEMPERATURE; LEPIDOPTERA; LONGEVITY; FECUNDITY; EXPOSURE	Climate warming is expected to increase the exposure of insects to hot events (involving a few hours at extreme high temperatures). These events are unlikely to cause widespread mortality but may modify population dynamics via impacting life history traits such as adult fecundity and egg hatching. These effects and their potential impact on population predictions are still largely unknown. In this study, we simulated a single hot event (maximum of 38 degrees C lasting for 4 h) of a magnitude increasingly found under field conditions and examined its effect in the oriental fruit moth, Grapholitha molesta. This hot event had no impact on the survival of G. molesta adults, copulation periods or male longevity. However, the event increased female lifespan and the length of the oviposition period, leading to a potential increase in lifetime fecundity and suggesting hormesis. In contrast, exposure of males to this event markedly reduced the net reproductive value. Male heat treatment delayed the onset of oviposition in the females they mated with, as well as causing a decrease in the duration of oviposition period and lifetime fecundity. Both male and female stress also reduced egg hatch. Our findings of hormetic effects on female performance but concurrent detrimental effects on egg hatch suggest that hot events have unpredictable consequences on the population dynamics of this pest species with implications for likely effects associated with climate warming.	[Liang, Li-Na; Zhang, Wei; Ma, Gang; Ma, Chun-Sen] Chinese Acad Agr Sci, Inst Plant Protect, Climate Change Biol Res Grp, State Key Lab Biol Plant Dis & Insect Pests, Beijing 100193, Peoples R China; [Hoffmann, Ary A.] Univ Melbourne, Pest & Environm Adaptat Res Grp, Dept Zool, Inst Bio21, Melbourne, Vic 3010, Australia; [Hoffmann, Ary A.] Univ Melbourne, Pest & Environm Adaptat Res Grp, Dept Genet, Inst Bio21, Melbourne, Vic 3010, Australia	Chinese Academy of Agricultural Sciences; Institute of Plant Protection, CAAS; University of Melbourne; University of Melbourne	Ma, CS (corresponding author), Chinese Acad Agr Sci, Inst Plant Protect, Climate Change Biol Res Grp, State Key Lab Biol Plant Dis & Insect Pests, Beijing 100193, Peoples R China.	machunsen@caas.cn	Hoffmann, Ary/R-2972-2019; Hoffmann, Ary/C-2961-2011; Ma, Chun-Sen/K-5414-2019; Ma, Gang/ABY-9316-2022	Hoffmann, Ary/0000-0001-9497-7645; Ma, Chun-Sen/0000-0002-3253-6921; Ma, Gang/0000-0002-3378-9488; Zhang, Wei/0000-0002-9262-0631	National Special Fund for Agro-scientific Research in the Public Interest [201103024]; Scientific and Technology Program of Shanxi Province [20130311021-5]; Beijing Natural Science Foundation [5144032]; National Natural Science Foundation of China [31400323]	National Special Fund for Agro-scientific Research in the Public Interest; Scientific and Technology Program of Shanxi Province; Beijing Natural Science Foundation(Beijing Natural Science Foundation); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The authors will make a change to their research grants. This research was supported by the National Special Fund for Agro-scientific Research in the Public Interest (No. 201103024), Scientific and Technology Program of Shanxi Province (No. 20130311021-5), Beijing Natural Science Foundation (No. 5144032) and National Natural Science Foundation of China (No. 31400323). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackermann M, 2001, J EVOLUTION BIOL, V14, P199, DOI 10.1046/j.1420-9101.2001.00281.x; Ayyanath MM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074532; Battisti A, 2006, GLOBAL CHANGE BIOL, V12, P662, DOI 10.1111/j.1365-2486.2006.01124.x; Burgess SC, 2011, J EXP BIOL, V214, P2329, DOI 10.1242/jeb.054718; Calabrese EJ, 2005, TOXICOL APPL PHARM, V202, P289, DOI 10.1016/j.taap.2004.06.023; Calosi P, 2008, BIOL LETTERS, V4, P99, DOI 10.1098/rsbl.2007.0408; Cannon RJC, 1998, GLOBAL CHANGE BIOL, V4, P785, DOI 10.1046/j.1365-2486.1998.00190.x; Chang Xiang-qian, 2012, Yingyong Shengtai Xuebao, V23, P772; Nguyen C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087535; Chidawanyika F, 2011, J INSECT PHYSIOL, V57, P108, DOI 10.1016/j.jinsphys.2010.09.013; de Morais RM, 2012, REV BRAS ENTOMOL, V56, P319, DOI 10.1590/S0085-56262012000300009; DEBARRO PJ, 1993, AUST J ZOOL, V41, P123, DOI 10.1071/ZO9930123; Denlinger DL, 1998, TEMPERATURES SENSITIVITY IN INSECTS AND APPLICATION IN INTEGRATED PEST MANAGEMENT, P7; Du J, 2009, THESIS NW A F U; Ducatez S, 2012, EVOLUTION, V66, P3558, DOI 10.1111/j.1558-5646.2012.01704.x; Einum S, 2000, NATURE, V405, P565, DOI 10.1038/35014600; Fasolo AG, 2004, BIOL J LINN SOC, V83, P197, DOI 10.1111/j.1095-8312.2004.00380.x; Fischer K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015284; Forbes VE, 2000, FUNCT ECOL, V14, P12, DOI 10.1046/j.1365-2435.2000.00392.x; Fraser HW, 2001, CAN ENTOMOL, V133, P219, DOI 10.4039/Ent133219-2; Friedenberg NA, 2008, ENVIRON ENTOMOL, V37, P650, DOI 10.1603/0046-225X(2008)37[650:TEDDAS]2.0.CO;2; Gillooly JF, 2002, NATURE, V417, P70, DOI 10.1038/417070a; Gillott C, 2003, ANNU REV ENTOMOL, V48, P163, DOI 10.1146/annurev.ento.48.091801.112657; Guedes RNC, 2009, J ECON ENTOMOL, V102, P170, DOI 10.1603/029.102.0124; Guo JY, 2012, ENVIRON ENTOMOL, V41, P1672, DOI 10.1603/EN12108; Harrington R, 2001, AGR FOREST ENTOMOL, V3, P233, DOI 10.1046/j.1461-9555.2001.00120.x; Hazell SP, 2010, J INSECT PHYSIOL, V56, P123, DOI 10.1016/j.jinsphys.2009.08.022; Hercus MJ, 2003, BIOGERONTOLOGY, V4, P149, DOI 10.1023/A:1024197806855; IPCC (Intergovernmental Panel on Climate Change), 2013, CLIMATE CHANGE 2013; James DG, 2002, J ECON ENTOMOL, V95, P729, DOI 10.1603/0022-0493-95.4.729; Janowitz SA, 2011, J THERM BIOL, V36, P283, DOI 10.1016/j.jtherbio.2011.04.001; Javois J, 2004, ANIM BEHAV, V68, P249, DOI 10.1016/j.anbehav.2003.10.022; Jorgensen KT, 2006, J THERM BIOL, V31, P280, DOI 10.1016/j.jtherbio.2005.11.026; KREBS RA, 1994, FUNCT ECOL, V8, P730, DOI 10.2307/2390232; Le Bourg E, 2001, BIOGERONTOLOGY, V2, P155, DOI 10.1023/A:1011561107055; Le Bourg E, 2011, EXP GERONTOL, V46, P345, DOI 10.1016/j.exger.2010.08.003; Liu SS, 2002, ENVIRON ENTOMOL, V31, P221, DOI 10.1603/0046-225X-31.2.221; Ma CS, 2004, ENTOMOL EXP APPL, V110, P65, DOI 10.1111/j.0013-8703.2004.00123.x; Minois N, 2000, BIOGERONTOLOGY, V1, P15, DOI 10.1023/A:1010085823990; Mironidis GK, 2010, J THERM BIOL, V35, P59, DOI 10.1016/j.jtherbio.2009.11.001; Mitchell KA, 2010, FUNCT ECOL, V24, P694, DOI 10.1111/j.1365-2435.2009.01666.x; Muller HG, 2001, P ROY SOC B-BIOL SCI, V268, P445, DOI 10.1098/rspb.2000.1370; Nisbet RM, 2000, J ANIM ECOL, V69, P913, DOI 10.1046/j.1365-2656.2000.00448.x; Novoseltsev VN, 2003, MECH AGEING DEV, V124, P605, DOI 10.1016/S0047-6374(03)00061-7; Patton ZJ, 2001, PHYSIOL BIOCHEM ZOOL, V74, P783, DOI 10.1086/323327; Petavy G, 2004, EVOL ECOL RES, V6, P873; Pincebourde S, 2007, J ANIM ECOL, V76, P424, DOI 10.1111/j.1365-2656.2007.01231.x; Rinehart JP, 2000, PHYSIOL ENTOMOL, V25, P330, DOI 10.1046/j.1365-3032.2000.00201.x; SaLM Kooijman, 2000, DYNAMIC ENERGY MASS, DOI 10.1017/CBO9780511565403; Scannapieco AC, 2007, BIOGERONTOLOGY, V8, P315, DOI 10.1007/s10522-006-9075-1; Silbermann R, 2000, EVOLUTION, V54, P2038; South A, 2011, BIOL REV, V86, P299, DOI 10.1111/j.1469-185X.2010.00145.x; Terblanche JS, 2010, ENTOMOL EXP APPL, V137, P304, DOI 10.1111/j.1570-7458.2010.01067.x; Wan FH, 2008, J INSECT SCI, V8, P49; Yu YS, 2010, PESTIC BIOCHEM PHYS, V98, P238, DOI 10.1016/j.pestbp.2010.06.013; Zhang W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075923; Zhao F, 2014, J ANIM ECOL, V83, P769, DOI 10.1111/1365-2656.12196; Zizzari ZV, 2011, J INSECT PHYSIOL, V57, P421, DOI 10.1016/j.jinsphys.2011.01.002	58	24	29	4	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2014	9	12							e116339	10.1371/journal.pone.0116339	http://dx.doi.org/10.1371/journal.pone.0116339			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UC	25551751	Green Published, gold			2022-12-27	WOS:000347119100131
J	Anderson, JC; Minnich, DJ; Dobelbower, MC; Denton, AJ; Dussaq, AM; Gilbert, AN; Rohrbach, TD; Arafat, W; Welaya, K; Bonner, JA; Willey, CD				Anderson, Joshua C.; Minnich, Douglas J.; Dobelbower, M. Christian; Denton, Alexander J.; Dussaq, Alex M.; Gilbert, Ashley N.; Rohrbach, Timothy D.; Arafat, Waleed; Welaya, Karim; Bonner, James A.; Willey, Christopher D.			Kinomic Profiling of Electromagnetic Navigational Bronchoscopy Specimens: A New Approach for Personalized Medicine	PLOS ONE			English	Article							CELL LUNG-CANCER; TRANSBRONCHIAL NEEDLE ASPIRATION; KINASE-ACTIVITY; THERAPY; TARGETS; RESISTANCE; EFFICACY; TISSUE; TRIAL	Purpose: Researchers are currently seeking relevant lung cancer biomarkers in order to make informed decisions regarding therapeutic selection for patients in so-called "precision medicine.'' However, there are challenges to obtaining adequate lung cancer tissue for molecular analyses. Furthermore, current molecular testing of tumors at the genomic or transcriptomic level are very indirect measures of biological response to a drug, particularly for small molecule inhibitors that target kinases. Kinase activity profiling is therefore theorized to be more reflective of in vivo biology than many current molecular analysis techniques. As a result, this study seeks to prove the feasibility of combining a novel minimally invasive biopsy technique that expands the number of lesions amenable for biopsy with subsequent ex vivo kinase activity analysis. Methods: Eight patients with lung lesions of varying location and size were biopsied using the novel electromagnetic navigational bronchoscopy (ENB) technique. Basal kinase activity (kinomic) profiles and ex vivo interrogation of samples in combination with tyrosine kinase inhibitors erlotinib, crizotinib, and lapatinib were performed by PamStation 12 microarray analysis. Results: Kinomic profiling qualitatively identified patient specific kinase activity profiles as well as patient and drug specific changes in kinase activity profiles following exposure to inhibitor. Thus, the study has verified the feasibility of ENB as a method for obtaining tissue in adequate quantities for kinomic analysis and has demonstrated the possible use of this tissue acquisition and analysis technique as a method for future study of lung cancer biomarkers. Conclusions: We demonstrate the feasibility of using ENB-derived biopsies to perform kinase activity assessment in lung cancer patients.	[Anderson, Joshua C.; Dobelbower, M. Christian; Denton, Alexander J.; Gilbert, Ashley N.; Rohrbach, Timothy D.; Bonner, James A.; Willey, Christopher D.] Univ Alabama Birmingham, Dept Radiat Oncol, Birmingham, AL 35233 USA; [Minnich, Douglas J.] Univ Alabama Birmingham, Dept Surg, Div Cardiothorac Surg, Birmingham, AL 35294 USA; [Dussaq, Alex M.; Arafat, Waleed] Univ Alabama Birmingham, Dept Pathol, Birmingham, AL 35294 USA; [Welaya, Karim] Univ Alexandria, Alexandria, Egypt	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; Egyptian Knowledge Bank (EKB); Alexandria University	Willey, CD (corresponding author), Univ Alabama Birmingham, Dept Radiat Oncol, Birmingham, AL 35233 USA.	cwilley@uab.edu		Anderson, Joshua/0000-0002-6977-9054; arafat, waleed/0000-0002-6617-5992	Department of Radiation Oncology Intramural Pilot Research Program, The University of Alabama at Birmingham; Egyptian Partnership and Ownership initiative (PAR-OWN) international research fellowship	Department of Radiation Oncology Intramural Pilot Research Program, The University of Alabama at Birmingham; Egyptian Partnership and Ownership initiative (PAR-OWN) international research fellowship	This work was supported by The Department of Radiation Oncology Intramural Pilot Research Program, The University of Alabama at Birmingham (to MCD), and also by the Egyptian Partnership and Ownership initiative (PAR-OWN) international research fellowship (to KW), http://www.estp.sci.eg/english/national_initiatives/mobility_grants/parown. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson JC, 2014, RADIOTHER ONCOL; Anderson JC, 2014, RADIOTHER ONCOL, V111, P468, DOI 10.1016/j.radonc.2014.04.010; Cappuzzo F, 2007, J THORAC ONCOL, V2, pS12, DOI 10.1097/01.JTO.0000268634.17956.5e; Carbone DP, 2012, J THORAC ONCOL, V7, P1653, DOI 10.1097/JTO.0b013e31826c1155; Chen GA, 2002, MOL CELL PROTEOMICS, V1, P304, DOI 10.1074/mcp.M200008-MCP200; Cooke DT, 2014, J THORAC CARDIOV SUR, V148, P36, DOI 10.1016/j.jtcvs.2014.03.014; Duverger A, 2014, J VIROL, V88, P364, DOI 10.1128/JVI.02682-13; Eberhardt R, 2010, RESPIRATION, V79, P54, DOI 10.1159/000232394; Folkvord S, 2010, INT J RADIAT ONCOL, V78, P555, DOI 10.1016/j.ijrobp.2010.04.036; Fuchs FS, 2013, EUR RESPIR J, V41, P1401, DOI 10.1183/09031936.00062512; Garber K, 2006, NAT BIOTECHNOL, V24, P127, DOI 10.1038/nbt0206-127; Hirsch FR, 2010, CLIN CANCER RES, V16, P4909, DOI 10.1158/1078-0432.CCR-10-2005; Jarboe JS, 2012, RADIOTHER ONCOL, V103, P380, DOI 10.1016/j.radonc.2012.03.014; Johnson SA, 2005, NAT METHODS, V2, P17, DOI 10.1038/NMETH731; Jurado J, 2013, ANN THORAC SURG, V96, P1196, DOI 10.1016/j.athoracsur.2013.05.066; Kikuchi T, 2012, MOL CELL PROTEOMICS, V11, P916, DOI 10.1074/mcp.M111.015370; Kim ES, 2011, CANCER DISCOV, V1, P44, DOI 10.1158/2159-8274.CD-10-0010; Krause DS, 2005, NEW ENGL J MED, V353, P172, DOI 10.1056/NEJMra044389; Kwak EL, 2010, NEW ENGL J MED, V363, P1693, DOI 10.1056/NEJMoa1006448; McGuire JL, 2014, BRAIN RES, V1568, P42, DOI 10.1016/j.brainres.2014.04.029; Moreira AL, 2012, CLIN LUNG CANCER, V13, P334, DOI 10.1016/j.cllc.2012.01.004; Rafael OC, 2014, CANCER CYTOPATHOL, V122, P454, DOI 10.1002/cncy.21426; Sakairi Y, 2010, CLIN CANCER RES, V16, P4938, DOI 10.1158/1078-0432.CCR-10-0099; Sikkema AH, 2009, CANCER RES, V69, P5987, DOI 10.1158/0008-5472.CAN-08-3660; Suwinski R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041379; Thomas A, 2013, ANN ONCOL, V24, P577, DOI 10.1093/annonc/mds478; Wulfkuhle JD, 2008, J PROTEOME RES, V7, P1508, DOI 10.1021/pr7008127; Zhang JM, 2009, NAT REV CANCER, V9, P28, DOI 10.1038/nrc2559	28	13	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2014	9	12							e116388	10.1371/journal.pone.0116388	http://dx.doi.org/10.1371/journal.pone.0116388			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX6YH	25549342	Green Published, gold, Green Submitted			2022-12-27	WOS:000347063500081
J	Christensen, JC; Shiyanov, PA; Estepp, JR; Schlager, JJ				Christensen, James C.; Shiyanov, Pavel A.; Estepp, Justin R.; Schlager, John J.			Lack of Association between Human Plasma Oxytocin and Interpersonal Trust in a Prisoner's Dilemma Paradigm	PLOS ONE			English	Article							PERIPHERAL OXYTOCIN; SOCIAL-BEHAVIOR; VASOPRESSIN; BLOOD; RADIOIMMUNOASSAY; ALTRUISM; CORTISOL	Expanding interest in oxytocin, particularly the role of endogenous oxytocin in human social behavior, has created a pressing need for replication of results and verification of assay methods. In this study, we sought to replicate and extend previous results correlating plasma oxytocin with trust and trustworthy behavior. As a necessary first step, the two most commonly used commercial assays were compared in human plasma via the addition of a known quantity of exogenous oxytocin, with and without sample extraction. Plasma sample extraction was found to be critical in obtaining repeatable concentrations of oxytocin. In the subsequent trust experiment, twelve samples in duplicate, from each of 82 participants, were collected over approximately six hours during the performance of a Prisoner's Dilemma task paradigm that stressed human interpersonal trust. We found no significant relationship between plasma oxytocin concentrations and trusting or trustworthy behavior. In light of these findings, previous published work that used oxytocin immunoassays without sample extraction should be reexamined and future research exploring links between endogenous human oxytocin and trust or social behavior should proceed with careful consideration of methods and appropriate biofluids for analysis.	[Christensen, James C.; Estepp, Justin R.; Schlager, John J.] Air Force Res Lab, Wright Patterson AFB, OH 45433 USA; [Shiyanov, Pavel A.] Henry M Jackson Fdn Adv Mil Med Inc, Bethesda, MD USA	United States Department of Defense; United States Air Force; US Air Force Research Laboratory; Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc	Christensen, JC (corresponding author), Air Force Res Lab, Wright Patterson AFB, OH 45433 USA.	james.christensen.7@us.af.mil			Office of the Director of National Intelligence (ODNI); Intelligence Advanced Research Projects Activity (IARPA)	Office of the Director of National Intelligence (ODNI); Intelligence Advanced Research Projects Activity (IARPA)	This research is based upon work supported by the Office of the Director of National Intelligence (ODNI), Intelligence Advanced Research Projects Activity (IARPA), via the Air Force Research Laboratory. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMICO JA, 1983, J CLIN ENDOCR METAB, V57, P947, DOI 10.1210/jcem-57-5-947; AMICO JA, 1981, J CLIN ENDOCR METAB, V52, P988, DOI 10.1210/jcem-52-5-988; Andari E, 2010, P NATL ACAD SCI USA, V107, P4389, DOI 10.1073/pnas.0910249107; Armstrong WE, 2006, AM J PHYSIOL-REG I, V291, pR26, DOI 10.1152/ajpregu.00879.2005; Benjamini Y, 2001, ANN STAT, V29, P1165; BERSCHEID E, 1989, J PERS SOC PSYCHOL, V57, P792, DOI 10.1037/0022-3514.57.5.792; Cantor N, 1986, HDB MOTIVATION COGNI, P96; Carson DS, 2013, J PSYCHOPHARMACOL, V27, P231, DOI 10.1177/0269881112473788; Carter CS, 2007, ANN NY ACAD SCI, V1098, P312, DOI 10.1196/annals.1384.006; Churchland PS, 2012, HORM BEHAV, V61, P392, DOI 10.1016/j.yhbeh.2011.12.003; De Dreu CKW, 2010, SCIENCE, V328, P1408, DOI 10.1126/science.1189047; Donaldson ZR, 2008, SCIENCE, V322, P900, DOI 10.1126/science.1158668; ERMISCH A, 1985, J CEREBR BLOOD F MET, V5, P350, DOI 10.1038/jcbfm.1985.49; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Feldman R, 2007, PSYCHOL SCI, V18, P965, DOI 10.1111/j.1467-9280.2007.02010.x; Gordon I, 2008, PSYCHOPHYSIOLOGY, V45, P349, DOI 10.1111/j.1469-8986.2008.00649.x; Gouin JP, 2010, PSYCHONEUROENDOCRINO, V35, P1082, DOI 10.1016/j.psyneuen.2010.01.009; Green LA, 2001, BIOL PSYCHIAT, V50, P609, DOI 10.1016/S0006-3223(01)01139-8; Ho JM, 2013, ENDOCRINOLOGY, V154, P589, DOI 10.1210/en.2012-1751; Insel TR, 2010, NEURON, V65, P768, DOI 10.1016/j.neuron.2010.03.005; KAHNEMAN D, 1984, AM PSYCHOL, V39, P341, DOI 10.1037/0003-066X.39.4.341; Keri S, 2009, SOC NEUROSCI-UK, V4, P287, DOI 10.1080/17470910802319710; Kiss Alexander, 2005, Endocr Regul, V39, P97; LEAKE RD, 1980, OBSTET GYNECOL, V56, P701; MAYER RC, 1995, ACAD MANAGE REV, V20, P709, DOI 10.2307/258792; Mayer RC, 1999, J APPL PSYCHOL, V84, P123, DOI 10.1037/0021-9010.84.1.123; McCullough ME, 2013, NEUROSCI BIOBEHAV R, V37, P1485, DOI 10.1016/j.neubiorev.2013.04.018; McEwen Barbara B, 2004, Adv Pharmacol, V50, P531; Meyer-Lindenberg A, 2011, NAT REV NEUROSCI, V12, P524, DOI 10.1038/nrn3044; Neumann ID, 2008, J NEUROENDOCRINOL, V20, P858, DOI 10.1111/j.1365-2826.2008.01726.x; Rahm VA, 2002, ACTA OBSTET GYN SCAN, V81, P1033, DOI 10.1034/j.1600-0412.2002.811107.x; Rilling JK, 2002, NEURON, V35, P395, DOI 10.1016/S0896-6273(02)00755-9; Rilling JK, 2004, NEUROREPORT, V15, P2539, DOI 10.1097/00001756-200411150-00022; RYDEN G, 1969, ACTA ENDOCRINOL-COP, V61, P425, DOI 10.1530/acta.0.0610425; SCHAMS D, 1983, ACTA ENDOCRINOL-COP, V103, P180, DOI 10.1530/acta.0.1030180; Spielberger CD, 1983, MANUAL FOR THE STATE; Szeto A, 2011, PSYCHOSOM MED, V73, P393, DOI 10.1097/PSY.0b013e31821df0c2; Taylor SE, 2010, PSYCHOL SCI, V21, P3, DOI 10.1177/0956797609356507; THOMSON JJ, 1986, RIGHTS RESTITUTION A; Tops M, 2007, PSYCHOPHYSIOLOGY, V44, P444, DOI 10.1111/j.1469-8986.2007.00510.x; Wedekind C, 1996, P NATL ACAD SCI USA, V93, P2686, DOI 10.1073/pnas.93.7.2686; Zak PJ, 2005, HORM BEHAV, V48, P522, DOI 10.1016/j.yhbeh.2005.07.009; Zhang GD, 2011, ANAL BIOCHEM, V416, P45, DOI 10.1016/j.ab.2011.04.041	43	42	42	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2014	9	12							e116172	10.1371/journal.pone.0116172	http://dx.doi.org/10.1371/journal.pone.0116172			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX6YH	25549255	Green Published, gold			2022-12-27	WOS:000347063500055
J	Yang, LH; Wang, SL; Tang, LL; Liu, B; Ye, WL; Wang, LL; Wang, ZY; Zhou, MT; Chen, BC				Yang, Li-hong; Wang, Si-lu; Tang, Li-li; Liu, Biao; Ye, Wen-le; Wang, Ling-ling; Wang, Zhang-yang; Zhou, Meng-tao; Chen, Bi-cheng			Universal Stem-Loop Primer Method for Screening and Quantification of MicroRNA	PLOS ONE			English	Article							PCR; IDENTIFICATION	RT-qPCR is the accepted technique for the quantification of microRNA (miR) expression: however, stem-loop RT-PCR, the most frequently used method for quantification of miRs, is time-and reagent-consuming as well as inconvenient for scanning. We established a new method called 'universal stem-loop primer' (USLP) with 8 random nucleotides instead of a specific sequence at the 39 end of the traditional stem-loop primer (TSLP), for screening miR profile and to semi-quantify expression of miRs. Peripheral blood samples were cultured with phytohaemagglutinin (PHA), and then 87 candidate miRs were scanned in cultured T cells. By USLP, our study revealed that the expression of miR-150-5p (miR-150) decreased nearly 10-fold, and miR-155-5p (miR-155) increased more than 7-fold after treated with PHA. The results of the dissociation curve and gel electrophoresis showed that the PCR production of the USLP and TSLP were specificity. The USLP method has high precision because of its low ICV (ICV, 2.5%). The sensitivity of the USLP is up to 103 copies/ml miR. As compared with the TSLP, USLP saved 75% the cost of primers and 60% of the test time. The USLP method is a simple, rapid, precise, sensitive, and cost-effective approach that is suitable for screening miR profiles.	[Yang, Li-hong; Wang, Ling-ling] Wenzhou Med Univ, Affiliated Hosp 1, Clin Lab, Ctr Diagnost, Wenzhou 325000, Zhejiang, Peoples R China; [Wang, Si-lu; Tang, Li-li; Liu, Biao; Ye, Wen-le; Wang, Zhang-yang; Zhou, Meng-tao; Chen, Bi-cheng] Wenzhou Med Univ, Affiliated Hosp 1, Dept Surg, Wenzhou Key Lab Surg, Wenzhou 325000, Zhejiang, Peoples R China	Wenzhou Medical University; Wenzhou Medical University	Zhou, MT (corresponding author), Wenzhou Med Univ, Affiliated Hosp 1, Dept Surg, Wenzhou Key Lab Surg, Wenzhou 325000, Zhejiang, Peoples R China.	bisonch@163.com		Zhou, Meng-Tao/0000-0002-0613-1656; Zhou, Mengtao/0000-0002-2455-250X; Wang, Silu/0000-0002-4391-6663	Science Technology department of Zhejiang Province [2013C37046]; Undergraduate Scientific and Technological Innovation Project for Talent Program [2013R413063, 2014R413051]; Project of Wenzhou Science Technology Bureau [2013S0207]	Science Technology department of Zhejiang Province; Undergraduate Scientific and Technological Innovation Project for Talent Program; Project of Wenzhou Science Technology Bureau	This work was supported by Science Technology department of Zhejiang Province (No. 2013C37046), Undergraduate Scientific and Technological Innovation Project for Talent Program (No. 2013R413063, No. 2014R413051), and Project of Wenzhou Science Technology Bureau (No. 2013S0207). [URLs: http://211.155.229.119/zdxk/, http://www.zjkjt.gov.cn/, http://kjxm.wzkj.gov.cn/]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Arefian E, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr214; Bissels U, 2009, RNA, V15, P2375, DOI 10.1261/rna.1754109; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Chen J, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn387; Griffiths-Jones S, 2004, NUCLEIC ACIDS RES, V32, pD109, DOI 10.1093/nar/gkh023; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Krichevsky AM, 2003, RNA, V9, P1274, DOI 10.1261/rna.5980303; Lagos-Quintana M, 2002, CURR BIOL, V12, P735, DOI 10.1016/S0960-9822(02)00809-6; Lagos-Quintana M, 2001, SCIENCE, V294, P853, DOI 10.1126/science.1064921; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Lim LP, 2003, GENE DEV, V17, P991, DOI 10.1101/gad.1074403; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Pena JTG, 2009, NAT METHODS, V6, P139, DOI [10.1038/NMETH.1294, 10.1038/nmeth.1294]; Rodriguez A, 2007, SCIENCE, V316, P608, DOI 10.1126/science.1139253	16	38	39	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2014	9	12							e115293	10.1371/journal.pone.0115293	http://dx.doi.org/10.1371/journal.pone.0115293			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX6YH	25548906	Green Published, gold, Green Submitted			2022-12-27	WOS:000347063500013
J	Somagoni, J; Boakye, CHA; Godugu, C; Patel, AR; Faria, HAM; Zucolotto, V; Singh, M				Somagoni, Jaganmohan; Boakye, Cedar H. A.; Godugu, Chandraiah; Patel, Apurva R.; Mendonca Faria, Henrique Antonio; Zucolotto, Valtencir; Singh, Mandip			Nanomiemgel - A Novel Drug Delivery System for Topical Application - In Vitro and In Vivo Evaluation	PLOS ONE			English	Article							LIPID NANOPARTICLES; SKIN INFLAMMATION; MODEL; COMBINATION; FORMULATION; INHIBITION; CAPSAICIN; RELEASE; PATHWAY; NSAIDS	Aim: The objective of this study was to formulate and evaluate a unique matrix mixture (nanomiemgel) of nanomicelle and nanoemulsion containing aceclofenac and capsaicin using in vitro and in vivo analyses and to compare it to a marketed formulation (Aceproxyvon). Methods: Nanomicelles were prepared using Vitamin E TPGS by solvent evaporation method and nanoemulsion was prepared by high-pressure homogenization method. In vitro drug release and human skin permeation studies were performed and analyzed using HPLC. The efficiency of nanomiemgel as a delivery system was investigated using an imiquimod-induced psoriatic like plaque model developed in C57BL/6 mice. Results: Atomic Force Microscopy images of the samples exhibited a globular morphology with an average diameter of 200, 250 and 220 nm for NMI, NEM and NMG, respectively. Nanomiemgel demonstrated a controlled release drug pattern and induced 2.02 and 1.97-fold more permeation of aceclofenac and capsaicin, respectively than Aceproxyvon through dermatomed human skin. Nanomiemgel also showed 2.94 and 2.09-fold greater Cmax of aceclofenac and capsaicin, respectively than Aceproxyvon in skin microdialysis study in rats. The PASI score, ear thickness and spleen weight of the imiquimod-induced psoriatic-like plaque model were significantly (p<0.05) reduced in NMG treated mice compared to free drug, NEM, NMI & Aceproxyvon. Conclusion: Using a new combination of two different drug delivery systems (NEM+ NMI), the absorption of the combined system (NMG) was found to be better than either of the individual drug delivery systems due to the utilization of the maximum possible paths of absorption available for that particular drug. of of	[Somagoni, Jaganmohan; Boakye, Cedar H. A.; Godugu, Chandraiah; Patel, Apurva R.; Singh, Mandip] Florida A&M Univ, Coll Pharm & Pharmaceut Sci, Tallahassee, FL 32307 USA; [Mendonca Faria, Henrique Antonio; Zucolotto, Valtencir] Univ Sao Paulo, Nanomed & Nanotoxicol Grp, Phys Inst Sao Carlos, BR-13566590 Sao Carlos, SP, Brazil	State University System of Florida; Florida A&M University; Universidade de Sao Paulo	Singh, M (corresponding author), Florida A&M Univ, Coll Pharm & Pharmaceut Sci, Tallahassee, FL 32307 USA.	mandip.sachdeva@famu.edu	Faria, Henrique Antonio Mendonça/M-5774-2013; Zucolotto, Valtencir/B-9103-2012; Faria, Henrique A. M./K-2782-2019; Godugu, Chandraiah/F-4741-2018	Faria, Henrique Antonio Mendonça/0000-0001-6976-6897; Faria, Henrique A. M./0000-0001-6976-6897; Godugu, Chandraiah/0000-0001-5904-3134; HYDERABAD, NIPER/0000-0001-7521-1150; Zucolotto, Valtencir/0000-0003-4307-3077; Sachdeva, Mandip/0000-0001-9192-8143	NCRR NIH HHS [G12RR 03020] Funding Source: Medline; NIMHD NIH HHS [P20 MD006738, G12 MD007582] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [G12RR003020] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [G12MD007582] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIMHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))		Alvarez-Soria MA, 2006, ANN RHEUM DIS, V65, P998, DOI 10.1136/ard.2005.046920; Bhattacharyya S, 2014, BIOMATERIALS, V35, P509, DOI 10.1016/j.biomaterials.2013.09.073; Byamba D, 2014, EXP DERMATOL, V13, P12448; Chooluck K, 2013, PHARMAZIE, V68, P135, DOI 10.1691/ph.2013.2116; Chougule M, 2011, LUNG CANCER, V71, P271, DOI 10.1016/j.lungcan.2010.06.002; Chougule MB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017733; Dasgupta S, 2013, CURR DRUG DELIV, V10, P656, DOI 10.2174/156720181006131125150023; Desai PR, 2013, J CONTROL RELEASE, V170, P51, DOI 10.1016/j.jconrel.2013.04.021; Desai PR, 2012, PHARM RES-DORDR, V29, P2587, DOI 10.1007/s11095-012-0789-2; Ercan N, 2013, INFLAMMOPHARMACOLOGY, V21, P413, DOI 10.1007/s10787-013-0175-7; Flutter B, 2013, EUR J IMMUNOL, V43, P3138, DOI 10.1002/eji.201343801; Gomes MJ, 2014, INT J NANOMED, V9, P1231, DOI 10.2147/IJN.S45561; Kakumanu S, 2011, NANOMED-NANOTECHNOL, V7, P277, DOI 10.1016/j.nano.2010.12.002; Lapeyre-Mestre M, 2013, FUND CLIN PHARMACOL, V27, P223, DOI 10.1111/j.1472-8206.2011.00991.x; Laporte JR, 2004, DRUG SAFETY, V27, P411, DOI 10.2165/00002018-200427060-00005; Lau WM, 2008, CURR PHARM DESIGN, V14, P794, DOI 10.2174/138161208784007653; Lee SE, 2013, EXP DERMATOL, V22, P59, DOI 10.1111/exd.12055; Manjanna KM, 2010, CRIT REV THER DRUG, V27, P509, DOI 10.1615/CritRevTherDrugCarrierSyst.v27.i6.20; Martin-Martinez J, 2014, 2014 POW SYST COMP C, P1, DOI 10.1109/VARI.2014. 6957088; Mizoguchi H, 2014, PEPTIDES, V51, P15, DOI 10.1016/j.peptides.2013.10.012; Mozsik G, 2014, PROG DRUG RES, V68, P209, DOI 10.1007/978-3-0348-0828-6_9; Nasr M, 2008, J MICROENCAPSUL, V25, P499, DOI [10.1080/02652040802055411, 10.1080/02652040802055411 ]; Oshima S, 2012, BIOL PHARM BULL, V35, P203, DOI 10.1248/bpb.35.203; Pande V, 2014, ADV PHARM BULL, V4, P121, DOI 10.5681/apb.2014.019; Puglia C, 2013, CURR MED CHEM, V20, P1847; Raza K, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/406731; Sahoo S, 2014, DRUG DELIV, V20, P1; Shah PP, 2012, J CONTROL RELEASE, V161, P735, DOI 10.1016/j.jconrel.2012.05.011; Shah PP, 2012, BIOMATERIALS, V33, P1607, DOI 10.1016/j.biomaterials.2011.11.011; Singh TP, 2011, AM J PATHOL, V178, P699, DOI 10.1016/j.ajpath.2010.10.008; Tausend W, 2014, J CUTAN MED SURG, V18, P156, DOI 10.2310/7750.2013.13125; Tavano L, 2011, COLLOID SURFACE B, V87, P333, DOI 10.1016/j.colsurfb.2011.05.041; van der Fits L, 2009, J IMMUNOL, V182, P5836, DOI 10.4049/jimmunol.0802999; Wavikar P, 2013, AAPS PHARMSCITECH, V14, P222, DOI 10.1208/s12249-012-9908-y; Yu M, 2014, EUR J PHARM BIOPHARM, V2	35	43	45	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2014	9	12							e115952	10.1371/journal.pone.0115952	http://dx.doi.org/10.1371/journal.pone.0115952			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UN	25546392	Green Published, Green Submitted, gold			2022-12-27	WOS:000347120200085
J	Wang, Y; Shao, WB; Gao, L; Lu, J; Gu, H; Sun, LH; Tan, Y; Zhang, YD				Wang, Yao; Shao, Wei-bo; Gao, Li; Lu, Jie; Gu, Hao; Sun, Li-hua; Tan, Yan; Zhang, Ying-dong			Abnormal Pulmonary Function and Respiratory Muscle Strength Findings in Chinese Patients with Parkinson's Disease and Multiple System Atrophy-Comparison with Normal Elderly	PLOS ONE			English	Article							VENTRAL MEDULLARY SURFACE; NONMOTOR SYMPTOMS; DIAGNOSIS; STANDARDIZATION; LUNG; DYSFUNCTIONS; INVOLVEMENT; LEVODOPA; NEURONS; VALUES	Background: There have been limited comparative data regarding the investigations on pulmonary and respiratory muscle function in the patients with different parkinsonism disorders such as Parkinson's disease (PD) and multiple system atrophy (MSA) versus normal elderly. The present study is aiming to characterize the performance of pulmonary function and respiratory muscle strength in PD and MSA, and to investigate the association with severity of motor symptoms and disease duration. Methods: Pulmonary function and respiratory muscle strength tests were performed in 30 patients with PD, 27 with MSA as well as in 20 age-, sex-, height-, weight-matched normal elderly controls. All the patients underwent United Parkinson's disease rating scale (UPDRS) or united multiple system atrophy rating scale (UMSARS) separately as diagnosed. Results: Vital capacity, forced expiratory volume in 1 second and forced vital capacity decreased, residual volume and ratio of residual volume to total lung capacity increased in both PD and MSA groups compared to controls (p<0.05). Diffusing capacity was decreased in the MSA group, compared with PD and normal elderly control groups (p<0.05). Respiratory muscle strength was lower in both PD and MSA groups than in controls (p<0.05). The values representing spirometry function and respiratory muscle strength were found to have a negative linear correlation with mean score of UPDRS-III in PD and mean score of UMSARS-I in MSA. Respiratory muscle strength showed a negative linear correlation with the mean score of UMSARS-II and disease duration in MSA patients. Conclusions: These findings suggest that respiratory dysfunction is involved in PD and MSA. Respiratory muscle strength is remarkably reduced, and some of the parameters correlate with disease duration and illness severity. The compromised respiratory function in neurodegenerative disorders should be the focus of further researches.	[Wang, Yao; Shao, Wei-bo] Nanjing Med Univ, Nanjing Brain Hosp, Dept Rehabil Med, Nanjing, Jiangsu, Peoples R China; [Gao, Li] Shanghai Jiao Tong Univ, Renji Hosp, Sch Med, Dept Neurol, Shanghai 200030, Peoples R China; [Lu, Jie; Gu, Hao] Nanjing Med Univ, Nanjing Brain Hosp, Dept Neurol, Nanjing, Jiangsu, Peoples R China; [Sun, Li-hua; Tan, Yan] Nanjing Med Univ, Nanjing Hosp 1, Dept Resp, Nanjing, Jiangsu, Peoples R China; [Zhang, Ying-dong] Nanjing Med Univ, Nanjing Hosp 1, Dept Neurol, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University; Shanghai Jiao Tong University; Nanjing Medical University; Nanjing Medical University; Nanjing Medical University	Zhang, YD (corresponding author), Nanjing Med Univ, Nanjing Hosp 1, Dept Neurol, Nanjing, Jiangsu, Peoples R China.	yingdongzhang_njmu@163.com			National Natural Science Foundation of China [81271418]; Six talent Summit of Jiangsu Province [2012-WS-086]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Six talent Summit of Jiangsu Province	This study was supported by the National Natural Science Foundation of China grant (No. 81271418, URLs: http://www.nsfc.gov.cn/) and Six talent Summit of Jiangsu Province (No. 2012-WS-086, URLs: http://www.jstd.gov.cn/ggfw/). The sponsors will play a role in preparation of the manuscript.	Benarroch EE, 2007, MOVEMENT DISORD, V22, P155, DOI 10.1002/mds.21236; Benarroch EE, 2007, BRAIN, V130, P469, DOI 10.1093/brain/awl357; BLACK LF, 1969, AM REV RESPIR DIS, V99, P696; Braak H, 2000, J NEUROL, V247, P3; Chaudhuri KR, 2006, LANCET NEUROL, V5, P235, DOI 10.1016/S1474-4422(06)70373-8; DEKEYSER J, 1985, NEUROLOGY, V35, P235; ESTENNE M, 1984, NEW ENGL J MED, V311, P1516; Gilman S, 2008, NEUROLOGY, V71, P670, DOI 10.1212/01.wnl.0000324625.00404.15; Guyenet PG, 2005, EXP PHYSIOL, V90, P247, DOI 10.1111/j.1469-445X.2005.t01-1-00134.x; HOEHN MM, 1967, NEUROLOGY, V17, P427, DOI 10.1212/WNL.17.5.427; Holmberg B, 2001, MOVEMENT DISORD, V16, P217, DOI 10.1002/mds.1062; HUGHES AJ, 1992, J NEUROL NEUROSUR PS, V55, P181, DOI 10.1136/jnnp.55.3.181; Jecmenica-Lukic M, 2012, LANCET NEUROL, V11, P361, DOI 10.1016/S1474-4422(12)70022-4; Khan W, 2009, CLIN DRUG INVEST, V29, P689, DOI 10.2165/11315290-000000000-00000; Linder J, 2012, ACTA NEUROL SCAND, V126, P248, DOI 10.1111/j.1600-0404.2011.01633.x; MacIntyre N, 2005, EUR RESPIR J, V26, P720, DOI 10.1183/09031936.05.00034905; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; Monteiro L, 2012, CLIN THER, V34, P1049, DOI 10.1016/j.clinthera.2012.03.001; Pal PK, 2007, MOVEMENT DISORD, V22, P420, DOI 10.1002/mds.21330; Park A, 2009, J NEUROL, V256, pS293, DOI 10.1007/s00415-009-5240-1; Paterson DS, 2006, AUTON NEUROSCI-BASIC, V124, P112, DOI 10.1016/j.autneu.2005.12.009; Pellegrino R, 2005, EUR RESPIR J, V26, P948, DOI 10.1183/09031936.05.00035205; Riley DE, 2003, J NEUROL NEUROSUR PS, V74, P56, DOI 10.1136/jnnp.74.1.56; Sabate M, 1996, J NEUROL SCI, V138, P114, DOI 10.1016/0022-510X(96)00003-2; Sathyaprabha T N, 2005, Indian J Chest Dis Allied Sci, V47, P251; Schmidt C, 2009, J NEURAL TRANSM, V116, P875, DOI 10.1007/s00702-009-0239-4; Shimohata T, 2007, ARCH NEUROL-CHICAGO, V64, P856, DOI 10.1001/archneur.64.6.856; VINCKEN WG, 1984, NEW ENGL J MED, V311, P438, DOI 10.1056/NEJM198408163110704; Wanger J, 2005, EUR RESPIR J, V26, P511, DOI 10.1183/09031936.05.00035005; Witjas T, 2002, NEUROLOGY, V59, P408, DOI 10.1212/WNL.59.3.408; Yust-Katz S, 2012, J NEURAL TRANSM, V119, P73, DOI 10.1007/s00702-011-0671-0; Zheng JP, 2002, CHINESE MED J-PEKING, V115, P50	32	24	25	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2014	9	12							e116123	10.1371/journal.pone.0116123	http://dx.doi.org/10.1371/journal.pone.0116123			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UN	25546308	Green Published, gold, Green Submitted			2022-12-27	WOS:000347120200100
J	Yang, LL; Liu, B; Li, Y; Wang, SX; Xu, Y; Wang, DP; Ye, HH; Shang, SC; Zhang, GZ; Peng, RY; Zeng, L; Li, WL				Yang Leilei; Liu Bing; Li Yang; Wang Shaoxia; Xu Yuan; Wang Dongping; Ye Huahu; Shang Shichen; Zhang Guangzhou; Peng Ruiyun; Zeng Lin; Li Wenlong			iRhom2 Mutation Leads to Aberrant Hair Follicle Differentiation in Mice	PLOS ONE			English	Article							PROTEOLYTIC CLEAVAGE; STEM-CELLS; NOTCH; SKIN; TACE; MORPHOGENESIS; ACTIVATION; BARRIER; CANCER; UNCV	iRhom1 and iRhom2 are inactive homologues of rhomboid intramembrane serine proteases lacking essential catalytic residues, which are necessary for the maturation of TNF alpha-converting enzyme (TACE). In addition, iRhoms regulate epidermal growth factor family secretion. The functional significance of iRhom2 during mammalian development is largely unclear. We have identified a spontaneous single gene deletion mutation of iRhom2 in Uncv mice. The iRhom2(Uncv/Uncv) mice exhibit hairless phenotype in a BALB/c genetic background. In this study, we observed dysplasia hair follicles in iRhom2(Uncv/Uncv) mice from postnatal day 3. Further examination found decreased hair matrix proliferation and aberrant hair shaft and inner root sheath differentiation in iRhom2(Uncv/Uncv) mutant hair follicles. iRhom2 is required for the maturation of TACE. Our data demonstrate that iRhom2(Uncv) cannot induce the maturation of TACE in vitro and the level of mature TACE is also significantly reduced in the skin of iRhom2(Uncv/Uncv) mice. The activation of Notch1, a substrate of TACE, is disturbed, associated with dramatically down-regulation of Lef1 in iRhom2(Uncv/Uncv) hair follicle matrix. This study identifies iRhom2 as a novel regulator of hair shaft and inner root sheath differentiation.	[Yang Leilei; Li Yang; Wang Shaoxia; Peng Ruiyun] Beijing Inst Radiat Med, Beijing 100850, Peoples R China; [Liu Bing; Wang Shaoxia; Xu Yuan; Wang Dongping; Ye Huahu; Shang Shichen; Zhang Guangzhou; Zeng Lin; Li Wenlong] Inst JingFeng Med Lab Anim, Beijing 100071, Peoples R China	Academy of Military Medical Sciences - China	Yang, LL (corresponding author), Beijing Inst Radiat Med, Beijing 100850, Peoples R China.	leileiyang@126.com; liwl@bmi.ac.cn			National Natural Science Foundation of China [31030058]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (31030058). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adrain C, 2012, SCIENCE, V335, P225, DOI 10.1126/science.1214400; Andl T, 2004, DEVELOPMENT, V131, P2257, DOI 10.1242/dev.01125; Blanpain C, 2006, ANNU REV CELL DEV BI, V22, P339, DOI 10.1146/annurev.cellbio.22.010305.104357; Blaydon DC, 2012, AM J HUM GENET, V90, P340, DOI 10.1016/j.ajhg.2011.12.008; Bozkulak EC, 2009, MOL CELL BIOL, V29, P5679, DOI 10.1128/MCB.00406-09; Brooke MA, 2014, HUM MOL GENET; Brou C, 2000, MOL CELL, V5, P207, DOI 10.1016/S1097-2765(00)80417-7; Christova Y, 2013, EMBO REP; Dai X, 2004, CURR OPIN GENET DEV, V14, P485, DOI 10.1016/j.gde.2004.07.002; Ellis T, 2001, GENE DEV, V15, P2307, DOI 10.1101/gad.200101; Franzke CW, 2012, J EXP MED, V209, P1105, DOI 10.1084/jem.20112258; Fuchs E, 2007, NATURE, V445, P834, DOI 10.1038/nature05659; Godwin AR, 1998, GENE DEV, V12, P11, DOI 10.1101/gad.12.1.11; Issuree PDA, 2013, J CLIN INVEST, V123, P928, DOI 10.1172/JCI66168; Johnson KR, 2003, GENOMICS, V81, P6, DOI 10.1016/S0888-7543(02)00013-7; Kaufman CK, 2003, GENE DEV, V17, P2108, DOI 10.1101/gad.1115203; Lemberg MK, 2007, GENOME RES, V17, P1634, DOI 10.1101/gr.6425307; Li HY, 2008, NAT IMMUNOL, V9, P533, DOI 10.1038/ni.1600; Li SR, 1999, GENET RES, V73, P233, DOI 10.1017/S0016672399003808; Lin MH, 2003, DEV BIOL, V263, P343, DOI 10.1016/j.ydbio.2003.07.007; Liu B., 2014, BMB REP; LYNCH MH, 1986, J CELL BIOL, V103, P2593, DOI 10.1083/jcb.103.6.2593; Maretzky T, 2013, P NATL ACAD SCI USA, V110, P11433, DOI 10.1073/pnas.1302553110; McIlwain DR, 2012, SCIENCE, V335, P229, DOI 10.1126/science.1214448; Merrill BJ, 2001, GENE DEV, V15, P1688, DOI 10.1101/gad.891401; Muller-Rover S, 2001, J INVEST DERMATOL, V117, P3, DOI 10.1046/j.0022-202x.2001.01377.x; Murthy A, 2012, IMMUNITY, V36, P105, DOI 10.1016/j.immuni.2012.01.005; OGUIN WM, 1992, J INVEST DERMATOL, V98, P24, DOI 10.1111/1523-1747.ep12494172; Pan YH, 2004, DEV CELL, V7, P731, DOI 10.1016/j.devcel.2004.09.014; Peschon JJ, 1998, SCIENCE, V282, P1281, DOI 10.1126/science.282.5392.1281; Radtke F, 2003, NAT REV CANCER, V3, P756, DOI 10.1038/nrc1186; Ramirez A, 1998, DNA CELL BIOL, V17, P177, DOI 10.1089/dna.1998.17.177; Ross DA, 2001, MOL CELL BIOL, V21, P7537, DOI 10.1128/MCB.21.22.7537-7544.2001; Schmidt-Ullrich R, 2005, BIOESSAYS, V27, P247, DOI 10.1002/bies.20184; Shi YZ, 2003, ACTA BIOCH BIOPH SIN, V35, P397; Siggs OM, 2012, BLOOD, V119, P5769, DOI 10.1182/blood-2012-03-417949; Spaulding C, 2007, BLOOD, V110, P2650, DOI 10.1182/blood-2007-04-084202; Stephenson NL, 2012, P NATL ACAD SCI USA, V109, pE2757, DOI 10.1073/pnas.1205788109; Watt FM, 2008, CURR OPIN CELL BIOL, V20, P171, DOI 10.1016/j.ceb.2008.01.010; Weinmaster G, 2000, CURR OPIN GENET DEV, V10, P363, DOI 10.1016/S0959-437X(00)00097-6; Yang LL, 2009, MOL BIOL CELL, V20, P882, DOI 10.1091/mbc.E08-07-0731; Yang LL, 2005, CANCER RES, V65, P8671, DOI 10.1158/0008-5472.CAN-05-0800; Yuhki M, 2004, DEVELOPMENT, V131, P1825, DOI 10.1242/dev.01079; Zettl M, 2011, CELL, V145, P79, DOI 10.1016/j.cell.2011.02.047	44	3	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2014	9	12							e115114	10.1371/journal.pone.0115114	http://dx.doi.org/10.1371/journal.pone.0115114			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UN	25546423	Green Published, Green Submitted, gold			2022-12-27	WOS:000347120200023
J	Zeng, H; Chen, JX				Zeng, Heng; Chen, Jian-Xiong			Conditional Knockout of Prolyl Hydroxylase Domain Protein 2 Attenuates High Fat-Diet-Induced Cardiac Dysfunction in Mice	PLOS ONE			English	Article							FACTOR-KAPPA-B; VENTRICULAR-FUNCTION; INSULIN-RESISTANCE; INDUCED OBESITY; HEART-FAILURE; HYPOXIA; HYPERTROPHY; INFLAMMATION; ACTIVATION; EXPRESSION	Oxygen sensor prolyl hydroxylases (PHDs) play important roles in the regulation of HIF-alpha and cell metabolisms. This study was designed to investigate the direct role of PHD2 in high fat-diet (HFD)-induced cardiac dysfunction. In HFD fed mice, PHD2 expression was increased without significant changes in PHD1 and PHD3 levels in the heart. This was accompanied by a significant upregulation of myeloid differentiation factor 88 (MYD88) and NF-kappa B. To explore the role of PHD2 in HFD-induced cardiac dysfunction, PHD2 conditional knockout mice were fed a HFD for 16 weeks. Intriguingly, knockout of PHD2 significantly reduced MYD88 and NF-kappa kb expression in HFD mouse hearts. Moreover, knockout of PHD2 inhibited TNFa and ICAM-1 expression, and reduced cell apoptosis and macrophage infiltration in HFD mice. This was accompanied by a significant improvement of cardiac function. Most importantly, conditional knockout of PHD2 at late stage in HFD mice significantly improved glucose tolerance and reversed cardiac dysfunction. Our studies demonstrate that PHD2 activity is a critical contributor to the HFD-induced cardiac dysfunction. Inhibition of PHD2 attenuates HFD-induced cardiac dysfunction by a mechanism involving suppression of MYD88/NF-kappa b pathway and inflammation.	[Zeng, Heng; Chen, Jian-Xiong] Univ Mississippi, Med Ctr, Dept Pharmacol & Toxicol, Jackson, MS 39216 USA	University of Mississippi; University of Mississippi Medical Center	Chen, JX (corresponding author), Univ Mississippi, Med Ctr, Dept Pharmacol & Toxicol, Jackson, MS 39216 USA.	JChen3@umc.edu			National Institutes of Health grant [HL102042]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL102042] Funding Source: NIH RePORTER	National Institutes of Health grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported by grants from National Institutes of Health grant HL102042 to J. X. Chen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Guardia D, 2010, CARDIOVASC RES, V87, P449, DOI 10.1093/cvr/cvq080; Andreakos E, 2005, FRONT BIOSCI-LANDMRK, V10, P2478, DOI 10.2741/1712; Appelhoff RJ, 2004, J BIOL CHEM, V279, P38458, DOI 10.1074/jbc.M406026200; Birks EJ, 2004, J HEART LUNG TRANSPL, V23, P228, DOI 10.1016/S1053-2498(03)00106-2; Brown MA, 2004, FRONT BIOSCI-LANDMRK, V9, P1201, DOI 10.2741/1304; Chen JX, 2008, DIABETES, V57, P3335, DOI 10.2337/db08-0503; Chen JX, 2008, LAB INVEST, V88, P1316, DOI 10.1038/labinvest.2008.92; Cummins EP, 2006, P NATL ACAD SCI USA, V103, P18154, DOI 10.1073/pnas.0602235103; Elmarakby AA, 2010, CLIN SCI, V118, P291, DOI 10.1042/CS20090395; Fong GH, 2008, CELL DEATH DIFFER, V15, P635, DOI 10.1038/cdd.2008.10; Frantz S, 2008, FRONT BIOSCI, V13, P5772; Frantz S, 2006, FASEB J, V20, P1918, DOI 10.1096/fj.05-5133fje; Fujita N, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.375964; Ha TZ, 2006, AM J PHYSIOL-HEART C, V290, pH985, DOI 10.1152/ajpheart.00720.2005; Ha TZ, 2005, CARDIOVASC RES, V68, P224, DOI 10.1016/j.cardiores.2005.05.025; Hamid T, 2011, CARDIOVASC RES, V89, P129, DOI 10.1093/cvr/cvq274; Kawamura N, 2005, CARDIOVASC RES, V66, P520, DOI 10.1016/j.cardiores.2005.02.007; Kim F, 2007, CIRC RES, V100, P1589, DOI 10.1161/CIRCRESAHA.106.142851; Kim SJ, 2012, J NUTR BIOCHEM, V23, P113, DOI 10.1016/j.jnutbio.2010.10.012; Kiss J, 2012, J IMMUNOL, V189, P1955, DOI 10.4049/jimmunol.1103471; Kleinridders A, 2009, CELL METAB, V10, P249, DOI 10.1016/j.cmet.2009.08.013; Li T, 2009, J HYPERTENS, V27, P1084, DOI 10.1097/HJH.0b013e3283293c93; Lin Q, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000548; Lorenzo O, 2011, MEDIAT INFLAMM, V2011, DOI 10.1155/2011/652097; Maier HJ, 2012, P NATL ACAD SCI USA, V109, P11794, DOI 10.1073/pnas.1116584109; Matsuura H, 2013, CIRCULATION, V127, P2078, DOI 10.1161/CIRCULATIONAHA.113.001742; Miyata T, 2010, NAT REV NEPHROL, V6, P83, DOI 10.1038/nrneph.2009.211; Mou SS, 2002, CRIT CARE MED, V30, P827, DOI 10.1097/00003246-200204000-00018; Nwogu JI, 2001, CIRCULATION, V104, P2216, DOI 10.1161/hc4301.097193; Rajesh M, 2010, J AM COLL CARDIOL, V56, P2115, DOI 10.1016/j.jacc.2010.07.033; Ritchie NE, 1998, CIRCULATION, V98, P1707, DOI 10.1161/01.CIR.98.17.1707; Rottman JN, 2007, ECHOCARDIOGR-J CARD, V24, P83, DOI 10.1111/j.1540-8175.2006.00356.x; Satoh M, 2006, INT J CARDIOL, V109, P226, DOI 10.1016/j.ijcard.2005.06.023; Schaeffler A, 2009, IMMUNOLOGY, V126, P233, DOI 10.1111/j.1365-2567.2008.02892.x; SEMENZA GL, 2007, SCI STKE, pCM8, DOI DOI 10.1126/STKE.4072007CM8; Shi H, 2006, J CLIN INVEST, V116, P3015, DOI 10.1172/JCI28898; Singh MV, 2012, J MOL CELL CARDIOL, V52, P1135, DOI 10.1016/j.yjmcc.2012.01.021; Takeda K, 2008, BLOOD, V111, P3229, DOI 10.1182/blood-2007-09-114561; Takeda K, 2007, CIRCULATION, V116, P774, DOI 10.1161/CIRCULATIONAHA.107.701516; Takeda K, 2009, ARTERIOSCL THROM VAS, V29, P2132, DOI 10.1161/ATVBAHA.109.196071; Taniguchi CM, 2013, NAT MED, V19, P1325, DOI 10.1038/nm.3294; Tsukumo DML, 2007, DIABETES, V56, P1986, DOI 10.2337/db06-1595; Valen G, 2004, BASIC RES CARDIOL, V99, P1, DOI 10.1007/s00395-003-0442-7; Valen G, 2001, J AM COLL CARDIOL, V38, P307, DOI 10.1016/S0735-1097(01)01377-8; Van der Heiden K, 2010, CLIN SCI, V118, P593, DOI 10.1042/CS20090557; Van Tassell BW, 2010, J CARDIOVASC PHARM, V55, P385, DOI 10.1097/FJC.0b013e3181d3da24; Willam C, 2006, J MOL CELL CARDIOL, V41, P68, DOI 10.1016/j.yjmcc.2006.04.009; Yokoyama S, 2012, GENE, V497, P340, DOI 10.1016/j.gene.2012.01.024; Zeng H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035905; Zhang H, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001112	50	10	10	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2014	9	12							e115974	10.1371/journal.pone.0115974	http://dx.doi.org/10.1371/journal.pone.0115974			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UN	25546437	gold, Green Published, Green Submitted			2022-12-27	WOS:000347120200088
J	Aykul, S; Ni, W; Mutatu, W; Martinez-Hackert, E				Aykul, Senem; Ni, Wendi; Mutatu, Washington; Martinez-Hackert, Erik			Human Cerberus Prevents Nodal-Receptor Binding, Inhibits Nodal Signaling, and Suppresses Nodal-Mediated Phenotypes	PLOS ONE			English	Article							CRIPTO CFC DOMAIN; EXTRACELLULAR DOMAIN; BETA RECEPTOR; STEM-CELLS; MOUSE NODE; ACTIVIN; BMP; ANTAGONIST; EXPRESSION; ENDODERM	The Transforming Growth Factor-beta (TGF beta) family ligand Nodal is an essential embryonic morphogen that is associated with progression of breast and other cancers. It has therefore been suggested that Nodal inhibitors could be used to treat breast cancers where Nodal plays a defined role. As secreted antagonists, such as Cerberus, tightly regulate Nodal signaling during embryonic development, we undertook to produce human Cerberus, characterize its biochemical activities, and determine its effect on human breast cancer cells. Using quantitative methods, we investigated the mechanism of Nodal signaling, we evaluated binding of human Cerberus to Nodal and other TGF beta family ligands, and we characterized the mechanism of Nodal inhibition by Cerberus. Using cancer cell assays, we examined the ability of Cerberus to suppress aggressive breast cancer cell phenotypes. We found that human Cerberus binds Nodal with high affinity and specificity, blocks binding of Nodal to its signaling partners, and inhibits Nodal signaling. Moreover, we showed that Cerberus profoundly suppresses migration, invasion, and colony forming ability of Nodal expressing and Nodal supplemented breast cancer cells. Taken together, our studies provide mechanistic insights into Nodal signaling and Nodal inhibition with Cerberus and highlight the potential value of Cerberus as anti-Nodal therapeutic.	[Aykul, Senem; Ni, Wendi; Mutatu, Washington; Martinez-Hackert, Erik] Michigan State Univ, Dept Biochem & Mol Biol, E Lansing, MI 48824 USA	Michigan State University	Martinez-Hackert, E (corresponding author), Michigan State Univ, Dept Biochem & Mol Biol, E Lansing, MI 48824 USA.	emh@msu.edu		Martinez-Hackert, Erik/0000-0002-6182-7023; Mutatu, Washington/0000-0002-1857-0314; AYKUL, SENEM/0000-0001-7250-2913	Michigan State University	Michigan State University	This work was supported by Startup Funds from Michigan State University to EMH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adkins HB, 2003, J CLIN INVEST, V112, P575, DOI 10.1172/JCI200317788; Belo JA, 2000, GENESIS, V26, P265, DOI 10.1002/(SICI)1526-968X(200004)26:4<265::AID-GENE80>3.3.CO;2-W; Bertocchini F, 2002, DEV CELL, V3, P735, DOI 10.1016/S1534-5807(02)00318-0; Bianco C, 2002, MOL CELL BIOL, V22, P2586, DOI 10.1128/MCB.22.8.2586-2597.2002; Brown S, 2011, STEM CELLS, V29, P1176, DOI 10.1002/stem.666; Cai WQ, 2013, GENE DEV, V27, P2332, DOI 10.1101/gad.225144.113; Calvanese L, 2009, J PEPT SCI, V15, P175, DOI 10.1002/psc.1091; Chen CH, 2004, CURR BIOL, V14, P618, DOI 10.1016/j.cub.2004.02.042; Chi LJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027676; De Crescenzo G, 2003, J MOL BIOL, V328, P1173, DOI 10.1016/S0022-2836(03)00360-7; Fang R, 2013, CANCER LETT, V333, P66, DOI 10.1016/j.canlet.2013.01.014; Foley AC, 2007, DEV BIOL, V303, P57, DOI 10.1016/j.ydbio.2006.10.033; Fuerer C, 2014, J BIOL CHEM, V289, P17854, DOI 10.1074/jbc.M114.550301; Gray PC, 2003, P NATL ACAD SCI USA, V100, P5193, DOI 10.1073/pnas.0531290100; Gritsman K, 1999, CELL, V97, P121, DOI 10.1016/S0092-8674(00)80720-5; Groppe J, 2008, MOL CELL, V29, P157, DOI 10.1016/j.molcel.2007.11.039; Hendrix MJC, 2007, NAT REV CANCER, V7, P246, DOI 10.1038/nrc2108; Herrera MB, 2006, STEM CELLS, V24, P2840, DOI 10.1634/stemcells.2006-0114; Hinck AP, 2012, FEBS LETT, V586, P1860, DOI 10.1016/j.febslet.2012.05.028; Hsu DR, 1998, MOL CELL, V1, P673, DOI 10.1016/S1097-2765(00)80067-2; Humphries B, 2014, CARCINOGENESIS, V35, P2254, DOI 10.1093/carcin/bgu133; Inman GJ, 2002, MOL PHARMACOL, V62, P65, DOI 10.1124/mol.62.1.65; Kelber JA, 2008, J BIOL CHEM, V283, P4490, DOI 10.1074/jbc.M704960200; Kumar A, 2001, J BIOL CHEM, V276, P656, DOI 10.1074/jbc.M004649200; Lonardo E, 2011, CELL STEM CELL, V9, P433, DOI 10.1016/j.stem.2011.10.001; Marques S, 2004, GENE DEV, V18, P2342, DOI 10.1101/gad.306504; Massague J, 1998, ANNU REV BIOCHEM, V67, P753, DOI 10.1146/annurev.biochem.67.1.753; Meno C, 1999, MOL CELL, V4, P287, DOI 10.1016/S1097-2765(00)80331-7; Nolan K, 2013, STRUCTURE, V21, P1417, DOI 10.1016/j.str.2013.06.005; Papageorgiou I, 2009, REPROD BIOL ENDOCRIN, V7, DOI 10.1186/1477-7827-7-122; Petersen M, 2008, KIDNEY INT, V73, P705, DOI 10.1038/sj.ki.5002717; Piccolo S, 1999, NATURE, V397, P707, DOI 10.1038/17820; Postovit LM, 2008, P NATL ACAD SCI USA, V105, P4329, DOI 10.1073/pnas.0800467105; Quail DF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048237; Quail DF, 2012, CANCER RES, V72, P3851, DOI 10.1158/0008-5472.CAN-11-3951; Quail DF, 2013, ONCOGENE; Reissmann E, 2001, GENE DEV, V15, P2010, DOI 10.1101/gad.201801; Sako D, 2010, J BIOL CHEM, V285, P21037, DOI 10.1074/jbc.M110.114959; Sakuma R, 2002, GENES CELLS, V7, P401, DOI 10.1046/j.1365-2443.2002.00528.x; Schier AF, 2003, ANNU REV CELL DEV BI, V19, P589, DOI 10.1146/annurev.cellbio.19.041603.094522; Shen MM, 2007, DEVELOPMENT, V134, P1023, DOI 10.1242/dev.000166; Sheridan C, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1610; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; SOMMERS CL, 1994, BREAST CANCER RES TR, V31, P325, DOI 10.1007/BF00666165; Strizzi L, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3185; Strizzi L, 2012, CANCER RES, V72, P1915, DOI 10.1158/0008-5472.CAN-11-3419; Strizzi Luigi, 2008, Breast Dis, V29, P91; Topczewska JM, 2006, NAT MED, V12, P925, DOI 10.1038/nm1448; Townson SA, 2012, J BIOL CHEM, V287, P27313, DOI 10.1074/jbc.M112.377960; Vallier L, 2009, DEVELOPMENT, V136, P1339, DOI 10.1242/dev.033951; Varlet I, 1997, DEVELOPMENT, V124, P1033; Wu XT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071258; Yan YT, 2002, MOL CELL BIOL, V22, P4439, DOI 10.1128/MCB.22.13.4439-4449.2002; Yeo CY, 2001, MOL CELL, V7, P949, DOI 10.1016/S1097-2765(01)00249-0; Yu XY, 2008, DEV DYNAM, V237, P3613, DOI 10.1002/dvdy.21769; Zawel L, 1998, MOL CELL, V1, P611, DOI 10.1016/S1097-2765(00)80061-1; Zhang C, 2009, DEV BIOL, V331, P340, DOI 10.1016/j.ydbio.2009.04.016; ZHOU XL, 1993, NATURE, V361, P543, DOI 10.1038/361543a0	58	30	31	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2015	10	1							e0114954	10.1371/journal.pone.0114954	http://dx.doi.org/10.1371/journal.pone.0114954			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ4OZ	25603319	Green Submitted, Green Published, gold			2022-12-27	WOS:000348203500007
J	Niemeyer, BF; Parrish, JK; Spoelstra, NS; Joyal, T; Richer, JK; Jedlicka, P				Niemeyer, Brian F.; Parrish, Janet K.; Spoelstra, Nicole S.; Joyal, Teresa; Richer, Jennifer K.; Jedlicka, Paul			Variable Expression of PIK3R3 and PTEN in Ewing Sarcoma Impacts Oncogenic Phenotypes	PLOS ONE			English	Article							GROWTH-FACTOR; THERAPEUTIC TARGET; REGULATORY SUBUNIT; MAMMALIAN TARGET; TYROSINE KINASE; NUCLEAR PTEN; CELL; PATHWAY; CANCER; DIFFERENTIATION	Ewing Sarcoma is an aggressive malignancy of bone and soft tissue affecting children and young adults. Ewing Sarcoma is driven by EWS/Ets fusion oncoproteins, which cause widespread alterations in gene expression in the cell. Dysregulation of receptor tyrosine kinase signaling, particularly involving IGF-1R, also plays an important role in Ewing Sarcoma pathogenesis. However, the basis of this dysregulation, including the relative contribution of EWS/Ets-dependent and independent mechanisms, is not well understood. In the present study, we identify variable expression of two modifiers of PI3K signaling activity, PIK3R3 and PTEN, in Ewing Sarcoma, and examine the consequences of this on PI3K pathway regulation and oncogenic phenotypes. Our findings indicate that PIK3R3 plays a growth-promotional role in Ewing Sarcoma, but suggest that this role is not strictly dependent on regulation of PI3K pathway activity. We further show that expression of PTEN, a well-established, potent tumor suppressor, is lost in a subset of Ewing Sarcomas, and that this loss strongly correlates with high baseline PI3K pathway activity in cell lines. In support of functional importance of PTEN loss in Ewing Sarcoma, we show that re-introduction of PTEN into two different PTEN-negative Ewing Sarcoma cell lines results in downregulation of PI3K pathway activity, and sensitization to the IGF-1R small molecule inhibitor OSI-906. Our findings also suggest that PTEN levels may contribute to sensitivity of Ewing Sarcoma cells to the microtubule inhibitor vincristine, a relevant chemotherapeutic agent in this cancer. Our studies thus identify PIK3R3 and PTEN as modifiers of oncogenic phenotypes in Ewing Sarcoma, with potential clinical implications.	[Niemeyer, Brian F.; Parrish, Janet K.; Spoelstra, Nicole S.; Joyal, Teresa; Richer, Jennifer K.; Jedlicka, Paul] Univ Colorado Denver, Dept Pathol, Aurora, CO 80045 USA	Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus	Jedlicka, P (corresponding author), Univ Colorado Denver, Dept Pathol, Anschutz Med Campus, Aurora, CO 80045 USA.	paul.jedlicka@ucdenver.edu		Niemeyer, Brian/0000-0002-2020-2238	Boettcher Foundation's Webb-Waring Biomedical Research Program; NATIONAL CANCER INSTITUTE [P30CA046934] Funding Source: NIH RePORTER	Boettcher Foundation's Webb-Waring Biomedical Research Program; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funding from Boettcher Foundation's Webb-Waring Biomedical Research Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benini S, 2004, INT J CANCER, V108, P358, DOI 10.1002/ijc.11576; Chen ZH, 2014, CELL REP, V8, P2003, DOI 10.1016/j.celrep.2014.08.008; Dylla L, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00065; Fernandez S, 2014, ONCOGENE, V33, P4114, DOI 10.1038/onc.2013.376; Grohar PJ, 2013, PHARMACOL THERAPEUT, V137, P216, DOI 10.1016/j.pharmthera.2012.10.004; Herrero-Martin D, 2009, BRIT J CANCER, V101, P80, DOI 10.1038/sj.bjc.6605104; Hu JB, 2008, MOL CANCER THER, V7, P3719, DOI 10.1158/1535-7163.MCT-08-0499; Jedlicka P, 2010, INT J CLIN EXP PATHO, V3, P338; Kamura S, 2010, BRIT J CANCER, V103, P370, DOI 10.1038/sj.bjc.6605775; Kang HG, 2007, CANCER RES, V67, P3094, DOI 10.1158/0008-5472.CAN-06-3259; Lawlor ER, 2002, ONCOGENE, V21, P307, DOI 10.1038/sj.onc.1205053; Li AG, 2006, MOL CELL, V23, P575, DOI 10.1016/j.molcel.2006.06.028; Linger RMA, 2009, BLOOD, V114, P2678, DOI 10.1182/blood-2009-03-209247; Ludwig JA, 2008, CURR OPIN ONCOL, V20, P412, DOI 10.1097/CCO.0b013e328303ba1d; Ordonez JL, 2009, CANCER RES, V69, P7140, DOI 10.1158/0008-5472.CAN-08-4041; Lynn M, 2013, DIAGN MOL PATHOL, V22, P76, DOI 10.1097/PDM.0b013e31827a47f9; Manara MC, 2010, CLIN CANCER RES, V16, P530, DOI 10.1158/1078-0432.CCR-09-0816; McKinsey EL, 2011, ONCOGENE, V30, P4910, DOI 10.1038/onc.2011.197; Mendoza-Naranjo A, 2013, EMBO MOL MED, V5, P1087, DOI 10.1002/emmm.201202343; NAVARRO S, 1990, VIRCHOWS ARCH A, V416, P383, DOI 10.1007/BF01605142; Neilsen Paul M., 2011, Sarcoma, V2011, P746939, DOI 10.1155/2011/746939; Olmos D, 2010, CANCER J, V16, P183, DOI 10.1097/PPO.0b013e3181dbebf9; Parrish JK, 2015, ONCOGENE, V34, P257, DOI 10.1038/onc.2013.541; Patel M, 2014, MOL CANCER RES, V12, P1610, DOI 10.1158/1541-7786.MCR-14-0006; Prieur A, 2004, MOL CELL BIOL, V24, P7275, DOI 10.1128/MCB.24.16.7275-7283.2004; Sainz-Jaspeado M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071449; Sangale Z, 2011, APPL IMMUNOHISTO M M, V19, P173, DOI 10.1097/PAI.0b013e3181f1da13; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Shen WH, 2007, CELL, V128, P157, DOI 10.1016/j.cell.2006.11.042; Shukla N, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00141; Song MS, 2011, CELL, V144, P187, DOI 10.1016/j.cell.2010.12.020; Soroceanu L, 2007, P NATL ACAD SCI USA, V104, P3466, DOI 10.1073/pnas.0611271104; Toomey EC, 2010, ONCOGENE, V29, P4504, DOI 10.1038/onc.2010.205; Trotman LC, 2003, PLOS BIOL, V1, P385, DOI 10.1371/journal.pbio.0000059; Tsuchiya T, 2000, CANCER GENET CYTOGEN, V120, P91, DOI 10.1016/S0165-4608(99)00255-1; VanderWeele DJ, 2005, MOL CANCER RES, V3, P635, DOI 10.1158/1541-7786.MCR-05-0063; VanderWeele DJ, 2004, MOL CANCER THER, V3, P1605; Wang G, 2012, CELL DEATH DIFFER, V19, P1870, DOI 10.1038/cdd.2012.70; Wang GH, 2013, ANGIOGENESIS, V16, P561, DOI 10.1007/s10456-013-9336-y; Xia XM, 2003, MOL CELL BIOL, V23, P1717, DOI 10.1128/MCB.23.5.1717-1725.2003; Yin Y, 2008, ONCOGENE, V27, P5443, DOI 10.1038/onc.2008.241; Zhang H, 2010, CANCER INVEST, V28, P156, DOI 10.3109/07357900903179641; Zhang L, 2007, CLIN CANCER RES, V13, P5314, DOI 10.1158/1078-0432.CCR-06-2660	43	15	17	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2015	10	1							e0116895	10.1371/journal.pone.0116895	http://dx.doi.org/10.1371/journal.pone.0116895			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ4OZ	25603314	Green Published, gold, Green Submitted			2022-12-27	WOS:000348203500034
J	Haridan, US; Mokhtar, U; Machado, LR; Aziz, AA; Shueb, RH; Zaid, M; Sim, B; Mustafa, M; Yusof, NKN; Lee, CKC; Abu Bakar, S; AbuBakar, S; Hollox, EJ; Peng, HB				Haridan, Umi Shakina; Mokhtar, Umairah; Machado, Lee R.; Aziz, Abu Thalhah Abdul; Shueb, Rafidah Hanim; Zaid, Masliza; Sim, Benedict; Mustafa, Mahiran; Yusof, Nik Khairudin Nik; Lee, Christopher K. C.; Abu Bakar, Suhaili; AbuBakar, Sazaly; Hollox, Edward J.; Peng, Hoh Boon			A Comparison of Assays for Accurate Copy Number Measurement of the Low-Affinity Fc Gamma Receptor Genes FCGR3A and FCGR3B	PLOS ONE			English	Article							DISEASE; EXPRESSION; LOCUS; SUSCEPTIBILITY; AUTOIMMUNITY; GENOME	The FCGR3 locus encoding the low affinity activating receptor FcyRIII, plays a vital role in immunity triggered by cellular effector and regulatory functions. Copy number of the genes FCGR3A and FCGR3B has previously been reported to affect susceptibility to several autoimmune diseases and chronic inflammatory conditions. However, such genetic association studies often yield inconsistent results; hence require assays that are robust with low error rate. We investigated the accuracy and efficiency in estimating FCGR3 CNV by comparing Sequenom MassARRAY and paralogue ratio test-restriction enzyme digest variant ratio (PRT-REDVR). In addition, since many genetic association studies of FCGR3B CNV were carried out using real-time quantitative PCR, we have also included the evaluation of that method's performance in estimating the multi-allelic CNV of FCGR3B. The qPCR assay exhibited a considerably broader distribution of signal intensity, potentially introducing error in estimation of copy number and higher false positive rates. Both Sequenom and PRT-REDVR showed lesser systematic bias, but Sequenom skewed towards copy number normal (CN = 2). The discrepancy between Sequenom and PRT-REDVR might be attributed either to batch effects noise in individual measurements. Our study suggests that PRT-REDVR is more robust and accurate in genotyping the CNV of FCGR3, but highlights the needs of multiple independent assays for extensive validation when performing a genetic association study with multi-allelic CNVs.	[Haridan, Umi Shakina; Mokhtar, Umairah; Aziz, Abu Thalhah Abdul; Peng, Hoh Boon] Univ Teknol MARA, Fac Med, IMMB, Sungai Buloh Campus, Selangor, Malaysia; [Machado, Lee R.; Hollox, Edward J.] Univ Leicester, Dept Genet, Leicester LE1 7RH, Leics, England; [Shueb, Rafidah Hanim] Univ Sains Malaysia, Sch Med Sci, Dept Microbiol & Parasitol, Kubang Kerian, Kelantan, Malaysia; [Zaid, Masliza; Sim, Benedict; Lee, Christopher K. C.] Jalan Hosp, Hosp Sungai Buloh, Dept Med, Sungai Buloh, Selangor, Malaysia; [Mustafa, Mahiran; Yusof, Nik Khairudin Nik] Hosp Raja Perempuan Zainab II, Kota Baharu, Kelantan, Malaysia; [Abu Bakar, Suhaili] Univ Putra Malaysia, Fac Med & Hlth Sci, Dept Biomed Sci, Serdang 43400, Selangor, Malaysia; [AbuBakar, Sazaly] Univ Malaya, Fac Med, Dept Med Microbiol, Kuala Lumpur, Malaysia; [AbuBakar, Sazaly] Univ Malaya, Fac Med, Trop Infect Dis Res & Educ Ctr, Kuala Lumpur, Malaysia	Universiti Teknologi MARA; University of Leicester; Universiti Sains Malaysia; Universiti Putra Malaysia; Universiti Malaya; Universiti Malaya	Peng, HB (corresponding author), Univ Teknol MARA, Fac Med, IMMB, Sungai Buloh Campus, Selangor, Malaysia.	hoh.boonpeng@gmail.com	Shueb, Rafidah Hanim/E-4541-2012; Hoh, Boon-Peng/H-8682-2016; abubakar, sazaly/B-3957-2010; Shueb, Rafidah Hanim/Q-8385-2019; Shueb, Rafidah Hanim/C-8675-2016; Abubakar, Suhaili/ABC-2884-2021	Hoh, Boon-Peng/0000-0001-9249-4965; abubakar, sazaly/0000-0002-9267-1420; Shueb, Rafidah Hanim/0000-0002-1249-5229; Abubakar, Suhaili/0000-0002-2217-4509; Hollox, Edward/0000-0002-0115-2298; Abdul Aziz, Abu Thalhah/0000-0002-1416-7931; Machado, Lee/0000-0001-7974-2178	UITM DANA Kecemerlangan [600-RMI/STDANA5/3/Fst (281/2009)]; FRGS [600-RMI/ST/FRGS5/3/Fst (69/2010)]; Long-term Research Grant Scheme (LRGS) for Infectious Disease [600-RMI/LRGS5/3 (3/2011)]	UITM DANA Kecemerlangan; FRGS; Long-term Research Grant Scheme (LRGS) for Infectious Disease	This study is supported by UITM DANA Kecemerlangan (600-RMI/STDANA5/3/Fst (281/2009)), FRGS 2010 (600-RMI/ST/FRGS5/3/Fst (69/2010)), and Long-term Research Grant Scheme (LRGS) for Infectious Disease 2011 (600-RMI/LRGS5/3 (3/2011)). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldhous MC, 2010, HUM MOL GENET, V19, P4930, DOI 10.1093/hmg/ddq411; Armour JAL, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkl1089; Breunis WB, 2009, HUM MUTAT, V30, pE640, DOI 10.1002/humu.20997; Bux J, 2008, VOX SANG, V94, P277, DOI 10.1111/j.1423-0410.2007.01031.x; Cantsilieris S, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-329; Carpenter D, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-418; Estivill X, 2007, PLOS GENET, V3, P1787, DOI 10.1371/journal.pgen.0030190; Fanciulli M, 2010, CLIN GENET, V77, P201, DOI 10.1111/j.1399-0004.2009.01342.x; Fanciulli M, 2007, NAT GENET, V39, P721, DOI 10.1038/ng2046; Fellermann K, 2006, AM J HUM GENET, V79, P439, DOI 10.1086/505915; Fode P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016768; Girirajan S, 2011, ANNU REV GENET, V45, P203, DOI 10.1146/annurev-genet-102209-163544; Gonzalez E, 2005, SCIENCE, V307, P1434, DOI 10.1126/science.1101160; Hollox EJ, 2008, CYTOGENET GENOME RES, V123, P148, DOI 10.1159/000184702; Hollox EJ, 2014, HUM GENET, V133, P1217, DOI 10.1007/s00439-014-1457-x; Hollox EJ, 2009, HUM MUTAT, V30, P477, DOI 10.1002/humu.20911; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Marques RB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013173; Mueller M, 2013, AM J HUM GENET, V92, P28, DOI 10.1016/j.ajhg.2012.11.013; RAVETCH JV, 1989, J EXP MED, V170, P481, DOI 10.1084/jem.170.2.481; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Stranger BE, 2007, SCIENCE, V315, P848, DOI 10.1126/science.1136678; Walker S, 2009, GENOMICS, V93, P98, DOI 10.1016/j.ygeno.2008.09.004; Willcocks LC, 2008, J EXP MED, V205, P1573, DOI 10.1084/jem.20072413; Willcocks LC, 2009, EXPERT REV MOL MED, V11, DOI 10.1017/S1462399409001161	26	10	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2015	10	1							e0116791	10.1371/journal.pone.0116791	http://dx.doi.org/10.1371/journal.pone.0116791			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ4OS	25594501	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000348202900005
J	Schupp, JC; Binder, H; Jager, B; Cillis, G; Zissel, G; Muller-Quernheim, J; Prasse, A				Schupp, Jonas Christian; Binder, Harald; Jaeger, Benedikt; Cillis, Giuseppe; Zissel, Gernot; Mueller-Quernheim, Joachim; Prasse, Antje			Macrophage Activation in Acute Exacerbation of Idiopathic Pulmonary Fibrosis	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; ACUTE LUNG INJURY; ALVEOLAR MACROPHAGES; GENE-EXPRESSION; FACTOR-ALPHA; INTERLEUKIN-1-BETA; SARCOIDOSIS; MONOCYTES	Background Acute exacerbation (AE) of idiopathic pulmonary fibrosis (IPF) is a common cause of disease acceleration in IPF and has a major impact on mortality. The role of macrophage activation in AE of IPF has never been addressed before. Methods We evaluated BAL cell cytokine profiles and BAL differential cell counts in 71 IPF patients w/wo AE and in 20 healthy volunteers. Twelve patients suffered from AE at initial diagnosis while sixteen patients developed AE in the 24 months of follow-up. The levels of IL-1ra, CCL2, CCL17, CCL18, CCL22, TNF-alpha, IL-1 beta, CXCL1 and IL-8 spontaneously produced by BAL-cells were analysed by ELISA. Results In patients with AE, the percentage of BAL neutrophils was significantly increased compared to stable patients. We found an increase in the production rate of the proinflammatory cytokines CXCL1 and IL-8 combined with an increase in all tested M2 cytokines by BAL-cells. An increase in CCL18 levels and neutrophil counts during AE was observed in BAL cells from patients from whom serial lavages were obtained. Furthermore, high baseline levels of CCL18 production by BAL cells were significantly predictive for the development of future AE. Conclusions BAL cell cytokine production levels at acute exacerbation show up-regulation of pro-inflammatory as well as anti-inflammatory/ M2 cytokines. Our data suggest that AE in IPF is not an incidental event but rather driven by cellular mechanisms including M2 macrophage activation.	[Schupp, Jonas Christian; Jaeger, Benedikt; Zissel, Gernot; Mueller-Quernheim, Joachim; Prasse, Antje] Univ Med Ctr, Dept Pneumol, Freiburg, Germany; [Binder, Harald] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Inst Med Biostat Epidemiol & Informat, D-55122 Mainz, Germany; [Jaeger, Benedikt] Univ Freiburg, Fac Biol, D-79106 Freiburg, Germany; [Cillis, Giuseppe] Univ Siena, Dept Clin Med & Immunol Sci, Resp Dis Sect, I-53100 Siena, Italy	University of Freiburg; Johannes Gutenberg University of Mainz; University of Freiburg; University of Siena	Prasse, A (corresponding author), Univ Med Ctr, Dept Pneumol, Freiburg, Germany.	antje.prasse@uniklinik-freiburg.de	Prasse, Antje/AAM-7521-2021; Prasse, Antje/AAY-6279-2020; Binder, Harald/C-7413-2009; Zissel, Gernot/B-1208-2010	Prasse, Antje/0000-0002-7336-7458; Binder, Harald/0000-0002-5666-8662; Zissel, Gernot/0000-0001-8021-9798; Schupp, Jonas/0000-0002-7714-8076; cillis, giuseppe/0000-0001-6927-3363	E-RARE project, JRC IPF-AE [DLR 01GM1210A]; Albert Ludwigs University Freiburg	E-RARE project, JRC IPF-AE; Albert Ludwigs University Freiburg	This study was supported by E-RARE project, JRC 2011 IPF-AE (DLR 01GM1210A), (http://www.erare.eu), AP. The article processing charge was funded by the open access publication fund of the Albert Ludwigs University Freiburg. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambrosini V, 2003, EUR RESPIR J, V22, P821, DOI 10.1183/09031936.03.00022703; Armstrong L, 1997, THORAX, V52, P442, DOI 10.1136/thx.52.5.442; Belperio JA, 2002, J CLIN INVEST, V110, P1703, DOI 10.1172/JCI200215849; BRIELAND JK, 1995, AM J RESP CELL MOL, V12, P104, DOI 10.1165/ajrcmb.12.1.7811465; Collard HR, 2007, AM J RESP CRIT CARE, V176, P636, DOI 10.1164/rccm.200703-463PP; DONNELLY SC, 1993, LANCET, V341, P643, DOI 10.1016/0140-6736(93)90416-E; Ganter MT, 2008, CIRC RES, V102, P804, DOI 10.1161/CIRCRESAHA.107.161067; Ghatol A, 2012, LUNG, V190, P373, DOI 10.1007/s00408-012-9389-5; Gibbons MA, 2011, AM J RESP CRIT CARE, V184, P569, DOI 10.1164/rccm.201010-1719OC; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; Gribbin J, 2006, THORAX, V61, P980, DOI 10.1136/thx.2006.062836; Johannson KA, 2014, EUR RESPIR J, V43, P1124, DOI 10.1183/09031936.00122213; Kim DS, 2013, RESP RES, V14, DOI 10.1186/1465-9921-14-86; Kim DS, 2006, EUR RESPIR J, V27, P143, DOI 10.1183/09031936.06.00114004; Kolb M, 2001, J CLIN INVEST, V107, P1529, DOI 10.1172/JCI12568; Konishi K, 2009, AM J RESP CRIT CARE, V180, P167, DOI 10.1164/rccm.200810-1596OC; Kurosu K, 2008, J IMMUNOL, V181, P756, DOI 10.4049/jimmunol.181.1.756; Lee JS, 2012, EUR RESPIR J, V39, P352, DOI 10.1183/09031936.00050911; Maher TM, 2007, EUR RESPIR J, V30, P835, DOI 10.1183/09031936.00069307; Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015; Martinez FJ, 2005, ANN INTERN MED, V142, P963, DOI 10.7326/0003-4819-142-12_Part_1-200506210-00005; Mora AL, 2006, AM J RESP CELL MOL, V35, P466, DOI 10.1165/rcmb.2006-0121OC; Murray LA, 2011, INT J BIOCHEM CELL B, V43, P154, DOI 10.1016/j.biocel.2010.10.013; Osterholzer JJ, 2013, J IMMUNOL, V190, P3447, DOI 10.4049/jimmunol.1200604; Papiris SA, 2010, CRIT CARE, V14, DOI 10.1186/cc9241; Parambil JG, 2005, CHEST, V128, P3310, DOI 10.1378/chest.128.5.3310; Prasse A, 2000, CLIN EXP IMMUNOL, V122, P241, DOI 10.1046/j.1365-2249.2000.01365.x; Prasse A, 2006, AM J RESP CRIT CARE, V173, P781, DOI 10.1164/rccm.200509-1518OC; Prasse A, 2007, ARTHRITIS RHEUM-US, V56, P1685, DOI 10.1002/art.22559; Pugin J, 1996, AM J RESP CRIT CARE, V153, P1850, DOI 10.1164/ajrccm.153.6.8665045; Raghu G, 2011, AM J RESP CRIT CARE, V183, P788, DOI 10.1164/rccm.2009-040GL; Rodenburg RJT, 1998, J LEUKOCYTE BIOL, V63, P606, DOI 10.1002/jlb.63.5.606; Song JW, 2011, EUR RESPIR J, V37, P356, DOI 10.1183/09031936.00159709; Stahl M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081382; STEINBERG KP, 1994, AM J RESP CRIT CARE, V150, P113, DOI 10.1164/ajrccm.150.1.8025736; Stijn W, 2013, ANN THORAC MED, V8, P38, DOI 10.4103/1817-1737.105718; Sun L, 2011, AM J PHYSIOL-LUNG C, V300, pL341, DOI 10.1152/ajplung.00122.2010; Wells AU, 2003, AM J RESP CRIT CARE, V167, P962, DOI 10.1164/rccm.2111053; Ziegenhagen MW, 1998, AM J RESP CRIT CARE, V157, P762, DOI 10.1164/ajrccm.157.3.9705014	39	114	118	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2015	10	1							e0116775	10.1371/journal.pone.0116775	http://dx.doi.org/10.1371/journal.pone.0116775			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9HN	25590613	Green Submitted, Green Published, gold			2022-12-27	WOS:000350679400022
J	Reuland, EA; Halaby, T; Hays, JP; de Jongh, DMC; Snetselaar, HDR; van Keulen, M; Elders, PJM; Savelkoul, PHM; Vandenbroucke-Grauls, CMJE; al Naiemi, N				Reuland, E. Ascelijn; Halaby, Teysir; Hays, John P.; de Jongh, Denise M. C.; Snetselaar, Henrieke D. R.; van Keulen, Marte; Elders, Petra J. M.; Savelkoul, Paul H. M.; Vandenbroucke-Grauls, Christina M. J. E.; al Naiemi, Nashwan			Plasmid-Mediated AmpC: Prevalence in Community-Acquired Isolates in Amsterdam, the Netherlands, and Risk Factors for Carriage	PLOS ONE			English	Article							RESISTANT ESCHERICHIA-COLI; SPECTRUM-BETA-LACTAMASE; KLEBSIELLA-PNEUMONIAE; CTX-M; ENTEROBACTERIACEAE; OUTBREAK; ACC-1; CARBAPENEMASES; EPIDEMIOLOGY; SURVEILLANCE	Objectives The objective of this study was to determine the prevalence of pAmpC beta-lactamases in community-acquired Gram negative bacteria in the Netherlands, and to identify possible risk factors for carriage of these strains. Methods Fecal samples were obtained from community-dwelling volunteers. Participants also returned a questionnaire for analysis of risk factors. Screening for pAmpC was performed with selective enrichment broth and a selective screening agar. Confirmation of AmpC-production was performed with two double disc combination tests: cefotaxime and ceftazidime with either boronic acid or cloxacillin as inhibitor. Multiplex PCR was used as gold standard for detection of pAmpC. 16S rRNA PCR and AFLP were performed as required, plasmids were identified by PCR-based replicon typing. Questionnaire results were analyzed with SPSS, version 20.0. Results Fecal samples were obtained from 550 volunteers; mean age 51 years (range: 18-91), 61% were females. pAmpC was present in seven E. coli isolates (7/550, 1.3%, 0.6-2.7 95% CI): six CMY-2-like pAmpC and one DHA. ESBL-encoding genes were found in 52/550 (9.5%, 7.3-12.2 95% CI) isolates; these were predominantly blaCTX-M genes. Two isolates had both ESBL and pAmpC. Admission to a hospital in the previous year was the only risk factor we identified. Conclusions Our data indicate that the prevalence of pAmpC in the community seems still low. However, since pAmpC-producing isolates were not identified as ESBL producers by routine algorithms, there is consistent risk that further increase of their prevalence might go undetected.	[Reuland, E. Ascelijn; Snetselaar, Henrieke D. R.; van Keulen, Marte; Savelkoul, Paul H. M.; Vandenbroucke-Grauls, Christina M. J. E.; al Naiemi, Nashwan] Vrije Univ Amsterdam, Med Ctr, Amsterdam, Netherlands; [Halaby, Teysir; al Naiemi, Nashwan] Lab Med Microbiol & Publ Hlth, Hengelo, Netherlands; [Hays, John P.; de Jongh, Denise M. C.] Erasmus MC, Dept Med Microbiol & Infect Dis, Rotterdam, Netherlands; [Elders, Petra J. M.] Vrije Univ Amsterdam, Med Ctr, EMGO Inst Hlth & Care Res, Amsterdam, Netherlands; [al Naiemi, Nashwan] Ziekenhuisgroep Twente, Med Microbiol & Infect Control, Almelo, Netherlands	Vrije Universiteit Amsterdam; Erasmus University Rotterdam; Erasmus MC; Vrije Universiteit Amsterdam	Reuland, EA (corresponding author), Vrije Univ Amsterdam, Med Ctr, Amsterdam, Netherlands.	e.reuland@vumc.nl	Hays, J/I-9007-2017; Vandenbroucke-Grauls, Christina/AAO-7953-2020	Hays, J/0000-0001-9183-4497; Vandenbroucke-Grauls, Christina/0000-0003-2074-1597; Elders, Petra/0000-0002-5907-7219	European Community [241742]; ZonMw, the Netherlands Organisation for Health Research and Development [125020011]	European Community(European Commission); ZonMw, the Netherlands Organisation for Health Research and Development(Netherlands Organization for Health Research and Development)	The European Community Seventh Framework Program FP7/2007-2013, TEMPOtest-QC, under grant agreement number 241742, supported this study by enabling the multiplex pAmpC PCR investigations. This work was supported by ZonMw, the Netherlands Organisation for Health Research and Development (grant number 125020011 to CMJEV-G and NaN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed SF, 2014, ANN CLIN MICROB ANTI, V13, DOI 10.1186/1476-0711-13-22; Al Naiemi N, 2005, J CLIN MICROBIOL, V43, P4862, DOI 10.1128/JCM.43.9.4862-4864.2005; al Naiemi N, 2008, NVMM GUIDELINE DUTCH; Borjesson S, 2013, CLIN MICROBIOL INFEC, V19, pE309, DOI 10.1111/1469-0691.12192; Bortolaia V, 2014, J ANTIMICROB CHEMOTH, V69, P1492, DOI 10.1093/jac/dku011; Carattoli A, 2005, J MICROBIOL METH, V63, P219, DOI 10.1016/j.mimet.2005.03.018; Cejas D, 2012, REV ARGENT MICROBIOL, V44, P182; Corvec S, 2010, DIAGN MICR INFEC DIS, V67, P277, DOI 10.1016/j.diagmicrobio.2010.02.007; Cuzon G, 2012, J ANTIMICROB CHEMOTH, V67, P1865, DOI 10.1093/jac/dks156; Endimiani A, 2010, J CLIN MICROBIOL, V48, P2618, DOI 10.1128/JCM.00568-10; Garrido A, 2014, MICROB DRUG RESIST, V20, P301, DOI 10.1089/mdr.2013.0109; Hanson ND, 2008, ANTIMICROB AGENTS CH, V52, P3814, DOI 10.1128/AAC.00877-08; Huang IF, 2005, J CLIN MICROBIOL, V43, P2608, DOI 10.1128/JCM.43.6.2608-2612.2005; Jacoby GA, 2009, CLIN MICROBIOL REV, V22, P161, DOI 10.1128/CMR.00036-08; Ktari S, 2009, MICROB DRUG RESIST, V15, P279, DOI 10.1089/mdr.2009.0035; Lee CH, 2015, J MICROBIOL IMMUNOL, V48, P269, DOI 10.1016/j.jmii.2013.08.010; Magiorakos AP, 2012, CLIN MICROBIOL INFEC, V18, P268, DOI 10.1111/j.1469-0691.2011.03570.x; Mulvey MR, 2005, ANTIMICROB AGENTS CH, V49, P358, DOI 10.1128/AAC.49.1.358-365.2005; Nadjar D, 2000, FEMS MICROBIOL LETT, V187, P35, DOI 10.1016/S0378-1097(00)00166-X; Naseer U, 2010, CLIN MICROBIOL INFEC, V16, P171, DOI 10.1111/j.1469-0691.2009.02861.x; Ohana S, 2005, ANTIMICROB AGENTS CH, V49, P2095, DOI 10.1128/AAC.49.5.2095-2097.2005; Perez-Perez FJ, 2002, J CLIN MICROBIOL, V40, P2153, DOI 10.1128/JCM.40.6.2153-2162.2002; Philippon A, 2002, ANTIMICROB AGENTS CH, V46, P1, DOI 10.1128/AAC.46.1.1-11.2002; Pitout JDD, 2005, J ANTIMICROB CHEMOTH, V56, P52, DOI 10.1093/jac/dki166; Pitout JDD, 2007, EMERG INFECT DIS, V13, P443, DOI 10.3201/eid1303.060447; Reuland EA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091396; Reuland EA, 2012, CLIN MICROBIOL INFEC; Rodriguez-Bano J, 2012, J INFECTION, V64, P176, DOI 10.1016/j.jinf.2011.11.016; Roh KH, 2008, YONSEI MED J, V49, P53, DOI 10.3349/ymj.2008.49.1.53; Savelkoul PHM, 1999, J CLIN MICROBIOL, V37, P3083, DOI 10.1128/JCM.37.10.3083-3091.1999; Stuart JC, 2010, INT J ANTIMICROB AG, V36, P205, DOI 10.1016/j.ijantimicag.2010.05.014; Tan TY, 2009, ANTIMICROB AGENTS CH, V53, P146, DOI 10.1128/AAC.00862-08; Tumbarello M, 2007, ANTIMICROB AGENTS CH, V51, P1987, DOI 10.1128/AAC.01509-06; Wiener J, 1999, JAMA-J AM MED ASSOC, V281, P517, DOI 10.1001/jama.281.6.517; Woodford N, 2007, J ANTIMICROB CHEMOTH, V59, P102, DOI 10.1093/jac/dkl456	35	33	33	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2015	10	1							e0113033	10.1371/journal.pone.0113033	http://dx.doi.org/10.1371/journal.pone.0113033			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ0ID	25587716	Green Published, gold, Green Submitted			2022-12-27	WOS:000347928300001
J	Kumar, D; Singla, SK; Puri, V; Puri, S				Kumar, Dev; Singla, Surinder K.; Puri, Veena; Puri, Sanjeev			The Restrained Expression of NF-kappa B in Renal Tissue Ameliorates Folic Acid Induced Acute Kidney Injury in Mice	PLOS ONE			English	Article							ACUTE TUBULAR-NECROSIS; INDUCED APOPTOSIS; GENE-EXPRESSION; CISPLATIN NEPHROTOXICITY; P53; CELL; ACTIVATION; FAILURE; INHIBITION; PROLIFERATION	The Nuclear factor kappa-light-chain-enhancer of activated B cells (NF-kappa B) represent family of structurally-related eukaryotic transcription factors which regulate diverse array of cellular processes including immunological responses, inflammation, apoptosis, growth & development. Increased expression of NF-kB has often been seen in many diverse diseases, suggesting the importance of genomic deregulation to disease pathophysiology. In the present study we focused on acute kidney injury (AKI), which remains one of the major risk factor showing a high rate of mortality and morbidity. The pathology associated with it, however, remains incompletely known though inflammation has been reported to be one of the major risk factor in the disease pathophysiology. The role of NF-kB thus seemed pertinent. In the present study we show that high dose of folic acid (FA) induced acute kidney injury (AKI) characterized by elevation in levels of blood urea nitrogen & serum creatinine together with extensive tubular necrosis, loss of brush border and marked reduction in mitochondria. One of the salient observations of this study was a coupled increase in the expression of renal, relA, NF-kB2, and p53 genes and proteins during folic acid induced AKI (FA AKI). Treatment of mice with NF-kB inhibitor, pyrrolidine dithio-carbamate ammonium (PDTC) lowered the expression of these transcription factors and ameliorated the aberrant renal function by decreasing serum creatinine levels. In conclusion, our results suggested that NF-kB plays a pivotal role in maintaining renal function that also involved regulating p53 levels during FA AKI.	[Kumar, Dev; Singla, Surinder K.] Panjab Univ, Dept Biochem, Chandigarh 160014, India; [Puri, Veena] Panjab Univ, Ctr Syst Biol & Bioinformat, Chandigarh 160014, India; [Puri, Sanjeev] Panjab Univ, Univ Inst Engn & Technol, Biotechnol Branch, Chandigarh 160014, India; [Puri, Sanjeev] Panjab Univ, Ctr Stem Cell & Tissue Engn, Chandigarh 160014, India	Panjab University; Panjab University; Panjab University; Panjab University	Puri, S (corresponding author), Panjab Univ, Univ Inst Engn & Technol, Biotechnol Branch, Chandigarh 160014, India.	spuri_1111@yahoo.com	puri, veena/AAH-7207-2021	Puri, Sanjeev/0000-0002-4314-9871; puri, veena/0000-0002-0639-5897; Puri, Sanjeev/0000-0002-3967-987X	Council of Scientific and Industrial Research (Human Resource Development Group), New Delhi, India; Department of Science and Technology (Purse Grant), New Delhi; Department of Biotechnology, New Delhi, India; Center for Stem cell and Tissue Engineering, Panjab University Chandigarh, India; Department of Biochemistry, Panjab University, Chandigarh, India; Centre with Potential for Excellence in Bio-medical Sciences, Panjab University, Chandigarh, India	Council of Scientific and Industrial Research (Human Resource Development Group), New Delhi, India(Council of Scientific & Industrial Research (CSIR) - India); Department of Science and Technology (Purse Grant), New Delhi(Department of Science & Technology (India)Department of Science & Technology (DOST), Philippines); Department of Biotechnology, New Delhi, India(Department of Biotechnology (DBT) India); Center for Stem cell and Tissue Engineering, Panjab University Chandigarh, India; Department of Biochemistry, Panjab University, Chandigarh, India; Centre with Potential for Excellence in Bio-medical Sciences, Panjab University, Chandigarh, India	This work is supported by Council of Scientific and Industrial Research (Human Resource Development Group), New Delhi, India, Department of Science and Technology (Purse Grant), New Delhi, Department of Biotechnology, New Delhi, India, Center for Stem cell and Tissue Engineering, Panjab University Chandigarh, India, Department of Biochemistry, Panjab University, Chandigarh, India, Centre with Potential for Excellence in Bio-medical Sciences, Panjab University, Chandigarh, India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aebi H, 1984, Methods Enzymol, V105, P121; Akcay A, 2009, MEDIAT INFLAMM, V2009, DOI 10.1155/2009/137072; Baliga R, 1999, DRUG METAB REV, V31, P971, DOI 10.1081/DMR-100101947; Basile DP, 2007, KIDNEY INT, V72, P151, DOI 10.1038/sj.ki.5002312; Basile DP, 2012, COMPR PHYSIOL, V2, P1303, DOI 10.1002/cphy.c110041; Sanz AB, 2010, J AM SOC NEPHROL, V21, P1254, DOI 10.1681/ASN.2010020218; Bengatta S, 2009, J AM SOC NEPHROL, V20, P787, DOI 10.1681/ASN.2008050515; Blagosklonny MV, 2002, INT J CANCER, V98, P161, DOI 10.1002/ijc.10158; Bonventre JV, 2004, KIDNEY INT, V66, P480, DOI 10.1111/j.1523-1755.2004.761_2.x; Campbell KJ, 2004, MOL CELL, V13, P853, DOI 10.1016/S1097-2765(04)00131-5; Cao CC, 2004, KIDNEY INT, V65, P834, DOI 10.1111/j.1523-1755.2004.00463.x; Chen G, 2009, ANNU REV PATHOL-MECH, V4, P365, DOI 10.1146/annurev.pathol.4.110807.092239; Chow BM, 2000, CELL DEATH DIFFER, V7, P712, DOI 10.1038/sj.cdd.4400704; Coca SG, 2012, KIDNEY INT, V81, P442, DOI 10.1038/ki.2011.379; Collett GP, 2006, CARCINOGENESIS, V27, P1285, DOI 10.1093/carcin/bgi368; Edelstein CL, 2008, ADV CHRONIC KIDNEY D, V15, P222, DOI 10.1053/j.ackd.2008.04.003; Edelstein CL, 2007, DIS KIDNEY URINARY T, V2, P930; Edelstein CL, 2003, RENAL ELECT DISORDER, P401; Endre ZH, 2008, CLIN NEPHROTOXINS RE, P173; Esposti MD, 2002, METHODS, V26, P335, DOI 10.1016/S1046-2023(02)00039-7; Esson ML, 2002, ANN INTERN MED, V137, P744, DOI 10.7326/0003-4819-137-9-200211050-00010; Esteban V, 2004, J AM SOC NEPHROL, V15, P1514, DOI 10.1097/01.ASN.0000130564.75008.F5; Francescato HDC, 2007, TOXICOLOGY, V230, P64, DOI 10.1016/j.tox.2006.10.025; Friedewald JJ, 2004, KIDNEY INT, V66, P486, DOI 10.1111/j.1523-1755.2004.761_3.x; GOES N, 1995, TRANSPLANTATION, V59, P565; Gudkov Andrei V, 2011, Genes Cancer, V2, P503, DOI 10.1177/1947601911409747; Gudkov AV, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001180; Guijarro C, 2001, KIDNEY INT, V59, P415, DOI 10.1046/j.1523-1755.2001.059002415.x; Gupta A, 2012, EXP TOXICOL PATHOL, V64, P225, DOI 10.1016/j.etp.2010.08.010; Gurova KV, 2005, P NATL ACAD SCI USA, V102, P17448, DOI 10.1073/pnas.0508888102; Havasi A, 2011, KIDNEY INT, V80, P29, DOI 10.1038/ki.2011.120; HISSIN PJ, 1976, ANAL BIOCHEM, V74, P214, DOI 10.1016/0003-2697(76)90326-2; Hur E, 2013, INT J ENDOCRINOL, V2013, DOI 10.1155/2013/313528; Jennewein C, 2012, ONCOGENE, V31, P1468, DOI 10.1038/onc.2011.333; Jeong KH, 2009, AM J NEPHROL, V29, P274, DOI 10.1159/000158635; Jeong SJ, 2004, BLOOD, V104, P1490, DOI 10.1182/blood-2003-12-4174; Jiang M, 2006, ONCOGENE, V25, P4056, DOI 10.1038/sj.onc.1209440; Kaltschmidt JA, 2000, NAT CELL BIOL, V2, P7, DOI 10.1038/71323; Kielar ML, 2005, J AM SOC NEPHROL, V16, P3315, DOI 10.1681/asn.2003090757; Kim G, 2015, ONCOGENE, V34, P671, DOI 10.1038/onc.2014.4; Kim HJ, 2011, J PHARMACOL EXP THER, V337, P583, DOI 10.1124/jpet.110.175828; KONO Y, 1978, ARCH BIOCHEM BIOPHYS, V186, P189, DOI 10.1016/0003-9861(78)90479-4; Lemay S, 2000, TRANSPLANTATION, V69, P959; Liang CY, 2006, CELL SIGNAL, V18, P1309, DOI 10.1016/j.cellsig.2005.10.011; Liano F, 1996, KIDNEY INT, V50, P811, DOI 10.1038/ki.1996.380; Liano F, 1998, Kidney Int Suppl, V66, pS16; Lin BH, 1999, CELL DEATH DIFFER, V6, P570, DOI 10.1038/sj.cdd.4400528; Linkermann A, 2012, NEPHROL DIAL TRANSPL, V27, P3412, DOI 10.1093/ndt/gfs373; Lopez-Franco O, 2002, AM J PATHOL, V161, P1497, DOI 10.1016/S0002-9440(10)64425-2; Massy ZA, 1997, KIDNEY INT, V71, pS76; Matsushima H, 1998, J LAB CLIN MED, V131, P518, DOI 10.1016/S0022-2143(98)90060-9; MIYASHITA T, 1994, ONCOGENE, V9, P1799; Murugan R, 2011, NAT REV NEPHROL, V7, P209, DOI 10.1038/nrneph.2011.13; OHKAWA H, 1979, ANAL BIOCHEM, V95, P351, DOI 10.1016/0003-2697(79)90738-3; OLSEN TS, 1990, APMIS, V98, P1139, DOI 10.1111/j.1699-0463.1990.tb05046.x; Pabla N, 2008, KIDNEY INT, V73, P994, DOI 10.1038/sj.ki.5002786; PEASE DC, 1955, J HISTOCHEM CYTOCHEM, V3, P295, DOI 10.1177/3.4.295; Plumpe J, 2000, AM J PHYSIOL-GASTR L, V278, pG173, DOI 10.1152/ajpgi.2000.278.1.G173; Powell DJ, 2008, CELL CYCLE, V7, P950, DOI 10.4161/cc.7.7.5626; Ramesh G, 2005, AM J PHYSIOL-RENAL, V289, pF166, DOI 10.1152/ajprenal.00401.2004; Rice JC, 2002, RENAL FAILURE, V24, P703, DOI 10.1081/JDI-120015673; Ryan KM, 2000, NATURE, V404, P892, DOI 10.1038/35009130; Safirstein R, 1901, AM J PHYSIOL 2, V261, pF1095; Sahu BD, 2013, PHYTOMEDICINE, V20, P453, DOI 10.1016/j.phymed.2012.12.001; Senftleben U, 2001, SCIENCE, V293, P1495, DOI 10.1126/science.1062677; Shimizu H, 2013, AM J NEPHROL, V37, P97, DOI 10.1159/000346420; Shimizu H, 2013, LIFE SCI, V92, P143, DOI 10.1016/j.lfs.2012.11.012; Shimizu H, 2011, AM J PHYSIOL-CELL PH, V301, pC1201, DOI 10.1152/ajpcell.00471.2010; Shimizu H, 2010, AM J PHYSIOL-CELL PH, V299, pC1110, DOI 10.1152/ajpcell.00217.2010; Simmons EM, 2004, KIDNEY INT, V65, P1357, DOI 10.1111/j.1523-1755.2004.00512.x; Sutton TA, 2013, J AM SOC NEPHROL, V24, P113, DOI 10.1681/ASN.2012050469; Tadagavadi RK, 2010, J AM SOC NEPHROL, V21, P53, DOI 10.1681/ASN.2009040407; Takase O, 2008, CLIN EXP NEPHROL, V12, P181, DOI 10.1007/s10157-008-0038-5; Thadhani R, 1996, NEW ENGL J MED, V334, P1448, DOI 10.1056/NEJM199605303342207; Thurman JM, 2007, J IMMUNOL, V178, P1819, DOI 10.4049/jimmunol.178.3.1819; Uchino S, 2005, JAMA-J AM MED ASSOC, V294, P813, DOI 10.1001/jama.294.7.813; Wang SW, 2002, BIOCHEM J, V367, P729, DOI 10.1042/BJ20020752; Wei QQ, 2007, AM J PHYSIOL-RENAL, V293, pF1282, DOI 10.1152/ajprenal.00230.2007; WU HY, 1994, J BIOL CHEM, V269, P20067; Xiao GT, 2001, MOL CELL, V7, P401, DOI 10.1016/S1097-2765(01)00187-3; Zhou L, 2010, J AM SOC NEPHROL, V21, P31, DOI 10.1681/ASN.2008111133; Ziyadeh FN, 2008, CURR DIABETES REV, V4, P39, DOI 10.2174/157339908783502370	82	64	68	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2015	10	1							e115947	10.1371/journal.pone.0115947	http://dx.doi.org/10.1371/journal.pone.0115947			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ3BG	25559736	gold, Green Published, Green Submitted			2022-12-27	WOS:000348102200011
J	Brand, S; Amann, K; Mandel, P; Zimnol, A; Schupp, N				Brand, Susanne; Amann, Kerstin; Mandel, Philipp; Zimnol, Anna; Schupp, Nicole			Oxidative DNA Damage in Kidneys and Heart of Hypertensive Mice Is Prevented by Blocking Angiotensin II and Aldosterone Receptors	PLOS ONE			English	Article							SMOOTH-MUSCLE-CELLS; KAPPA-B PATHWAY; BLOOD-PRESSURE; RENAL INJURY; ENDOTHELIAL DYSFUNCTION; XANTHINE OXIDOREDUCTASE; ENHANCED EXPRESSION; METABOLIC SYNDROME; HEME OXYGENASE-1; ORGAN DAMAGE	Introduction: Recently, we could show that angiotensin II, the reactive peptide of the blood pressure-regulating renin-angiotensin-aldosterone-system, causes the formation of reactive oxygen species and DNA damage in kidneys and hearts of hypertensive mice. To further investigate on the one hand the mechanism of DNA damage caused by angiotensin II, and on the other hand possible intervention strategies against end-organ damage, the effects of substances interfering with the renin-angiotensin-aldosterone-system on angiotensin II-induced genomic damage were studied. Methods: In C57BL/6-mice, hypertension was induced by infusion of 600 ng/kg . min angiotensin II. The animals were additionally treated with the angiotensin II type 1 receptor blocker candesartan, the mineralocorticoid receptor blocker eplerenone and the antioxidant tempol. DNA damage and the activation of transcription factors were studied by immunohistochemistry and protein expression analysis. Results: Administration of angiotensin II led to a significant increase of blood pressure, decreased only by candesartan. In kidneys and hearts of angiotensin II-treated animals, significant oxidative stress could be detected (1.5-fold over control). The redox-sensitive transcription factors Nrf2 and NF-kappa B were activated in the kidney by angiotensin II-treatment (4- nd 3-fold over control, respectively) and reduced by all interventions. In kidneys and hearts an increase of DNA damage (3-and 2-fold over control, respectively) and of DNA repair (3-fold over control) was found. These effects were ameliorated by all interventions in both organs. Consistently, candesartan and tempol were more effective than eplerenone. Conclusion: Angiotensin II-induced DNA damage is caused by angiotensin II type 1 receptor-mediated formation of oxidative stress in vivo. The angiotensin II-mediated physiological increase of aldosterone adds to the DNA-damaging effects. Blocking angiotensin II and mineralocorticoid receptors therefore has beneficial effects on end-organ damage independent of blood pressure normalization.	[Brand, Susanne; Mandel, Philipp; Schupp, Nicole] Univ Wurzburg, Inst Pharmacol & Toxicol, D-97070 Wurzburg, Germany; [Zimnol, Anna; Schupp, Nicole] Univ Dusseldorf, Inst Toxicol, Dusseldorf, Germany; [Amann, Kerstin] Univ Erlangen Nurnberg, Dept Pathol, D-91054 Erlangen, Germany	University of Wurzburg; Heinrich Heine University Dusseldorf; University of Erlangen Nuremberg	Schupp, N (corresponding author), Univ Wurzburg, Inst Pharmacol & Toxicol, D-97070 Wurzburg, Germany.	nicole.schupp@toxi.uni-wuerzburg.de			German Cancer Aid [Deutsche Krebshilfe grant] [109328]; German Research Foundation [DFG] [SFB 423, Z2]	German Cancer Aid [Deutsche Krebshilfe grant]; German Research Foundation [DFG](German Research Foundation (DFG))	This work is supported by German Cancer Aid [Deutsche Krebshilfe grant #109328 to NS], http://www.krebshilfe.de, and German Research Foundation [DFG, SFB 423, Z2 to KA], http://www.dfg.de/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aizawa T, 2000, HYPERTENSION, V35, P800, DOI 10.1161/01.HYP.35.3.800; Aminzadeh MA, 2013, NEPHROL DIAL TRANSPL, V28, P2038, DOI 10.1093/ndt/gft022; Andreotti G, 2010, CARCINOGENESIS, V31, P614, DOI 10.1093/carcin/bgp321; Babelova A, 2012, FREE RADICAL BIO MED, V53, P842, DOI 10.1016/j.freeradbiomed.2012.06.027; Bianchi S, 2006, KIDNEY INT, V70, P2116, DOI 10.1038/sj.ki.5001854; Bogdanov MB, 1999, FREE RADICAL BIO MED, V27, P647, DOI 10.1016/S0891-5849(99)00113-6; Brand S, 2013, J HYPERTENS, V31, P333, DOI 10.1097/HJH.0b013e32835ba77e; Briones AM, 2011, J AM SOC HYPERTENS, V5, P137, DOI 10.1016/j.jash.2011.02.001; Brown NJ, 2000, KIDNEY INT, V58, P1219, DOI 10.1046/j.1523-1755.2000.00277.x; Chen H, 2013, KIDNEY BLOOD PRESS R, V37, P557, DOI 10.1159/000355736; Chen Y, 2004, AM J PHYSIOL-HEART C, V287, pH1104, DOI 10.1152/ajpheart.00102.2004; de Jong JW, 2000, J MOL CELL CARDIOL, V32, P2083, DOI 10.1006/jmcc.2000.1240; Dikalova A, 2005, CIRCULATION, V112, P2668, DOI 10.1161/CIRCULATIONAHA.105.538934; Durvasula RV, 2004, KIDNEY INT, V65, P30, DOI 10.1111/j.1523-1755.2004.00362.x; Esteban V, 2003, KIDNEY INT, V64, pS33, DOI 10.1046/j.1523-1755.64.s86.7.x; Fazeli G, 2012, MUTAGENESIS, V27, P673, DOI 10.1093/mutage/ges033; Fukuda S, 2011, CLIN EXP NEPHROL, V15, P41, DOI 10.1007/s10157-010-0373-1; Gomez-Guzman M, 2012, FREE RADICAL BIO MED, V52, P70, DOI 10.1016/j.freeradbiomed.2011.09.015; Grew IS, 2014, SCAND J CLIN LAB INV, V74, P336, DOI 10.3109/00365513.2014.891258; Grossman E, 2002, AM J MED, V112, P479, DOI 10.1016/S0002-9343(02)01049-5; Haggstrom C, 2011, INT J CANCER, V128, P1890, DOI 10.1002/ijc.25521; Hayden MR, 2007, AM J PHYSIOL-RENAL, V292, pF861, DOI 10.1152/ajprenal.00252.2006; Helbock HJ, 1998, P NATL ACAD SCI USA, V95, P288, DOI 10.1073/pnas.95.1.288; Ikeda H, 2009, KIDNEY INT, V75, P147, DOI 10.1038/ki.2008.507; Ishizaka N, 2000, AM J PHYSIOL-HEART C, V279, pH672, DOI 10.1152/ajpheart.2000.279.2.H672; Jin HM, 2013, ENDOCRINOLOGY, V154, P4068, DOI 10.1210/en.2013-1115; Kabat GC, 2009, CANCER EPIDEM BIOMAR, V18, P2046, DOI 10.1158/1055-9965.EPI-09-0235; Kang SJ, 2011, ARCH PHARM RES, V34, P829, DOI 10.1007/s12272-011-0517-1; Kawano S, 2005, CARDIOVASC RES, V67, P689, DOI 10.1016/j.cardiores.2005.04.030; Kawarazaki H, 2010, NEPHROL DIAL TRANSPL, V25, P2879, DOI 10.1093/ndt/gfq197; Kim DK, 2001, FREE RADICAL BIO MED, V30, P563, DOI 10.1016/S0891-5849(00)00504-9; Kim HJ, 2011, J PHARMACOL EXP THER, V337, P583, DOI 10.1124/jpet.110.175828; Kim HJ, 2010, AM J PHYSIOL-RENAL, V298, pF662, DOI 10.1152/ajprenal.00421.2009; Klanke B, 2008, NEPHROL DIAL TRANSPL, V23, P3456, DOI 10.1093/ndt/gfn301; Knight SF, 2010, AM J PHYSIOL-RENAL, V298, pF86, DOI 10.1152/ajprenal.00351.2009; Kowala MC, 2004, J PHARMACOL EXP THER, V309, P275, DOI 10.1124/jpet.103.055855; Krug AW, 2010, HYPERTENSION, V55, P1476, DOI 10.1161/HYPERTENSIONAHA.109.148783; Kushiro T, 2005, CLIN EXP HYPERTENS, V27, P9, DOI 10.1081/CEH-200044244; Lamprecht MR, 2007, BIOTECHNIQUES, V42, P71, DOI 10.2144/000112257; Lassegue B, 2012, CIRC RES, V110, P1364, DOI 10.1161/CIRCRESAHA.111.243972; Lea WB, 2009, KIDNEY INT, V75, P936, DOI 10.1038/ki.2009.9; Li HG, 2013, TRENDS PHARMACOL SCI, V34, P313, DOI 10.1016/j.tips.2013.03.007; Liao TD, 2008, HYPERTENSION, V52, P256, DOI 10.1161/HYPERTENSIONAHA.108.112706; Ljungberg B, 2011, EUR UROL, V60, P615, DOI 10.1016/j.eururo.2011.06.049; Martin RM, 2010, CANCER CAUSE CONTROL, V21, P463, DOI 10.1007/s10552-009-9477-x; McCurley A, 2013, PFLUG ARCH EUR J PHY, V465, P1661, DOI 10.1007/s00424-013-1282-4; Mels CMC, 2014, FREE RADICAL RES, V48, P1291, DOI 10.3109/10715762.2014.951840; Mendes B, 2013, TALANTA, V116, P164, DOI 10.1016/j.talanta.2013.04.064; Negishi H, 2001, J HYPERTENS, V19, P529, DOI 10.1097/00004872-200103001-00002; Nishioka T, 2007, J CARDIOVASC PHARM, V49, P261, DOI 10.1097/FJC.0b013e318033dfd4; Ohashi N, 2009, CLIN EXP PHARMACOL P, V36, P750, DOI 10.1111/j.1440-1681.2009.05172.x; Panchal SK, 2013, EUR J NUTR, V52, P559, DOI 10.1007/s00394-012-0358-9; Peixoto EBMI, 2009, AM J NEPHROL, V29, P309, DOI 10.1159/000163767; Poulsen HE, 2014, BBA-GEN SUBJECTS, V1840, P801, DOI 10.1016/j.bbagen.2013.06.009; Queisser N, 2014, ANTIOXID REDOX SIGN, V21, P2126, DOI 10.1089/ars.2013.5565; Queisser N, 2013, FREE RADICAL BIO MED, V54, P17, DOI 10.1016/j.freeradbiomed.2012.10.549; Queisser N, 2011, MOL CARCINOGEN, V50, P123, DOI 10.1002/mc.20710; Redon J, 2003, HYPERTENSION, V41, P1096, DOI 10.1161/01.HYP.0000068370.21009.38; Rocha R, 1998, HYPERTENSION, V31, P451, DOI 10.1161/01.HYP.31.1.451; Rocha R, 2002, ENDOCRINOLOGY, V143, P4828, DOI 10.1210/en.2002-220120; Rugale C, 2007, J CARDIOVASC PHARM, V50, P293, DOI 10.1097/FJC.0b013e3180a72606; Sanz-Rosa D, 2005, AM J PHYSIOL-HEART C, V288, pH111, DOI 10.1152/ajpheart.01061.2003; Schmid U, 2008, CANCER RES, V68, P9239, DOI 10.1158/0008-5472.CAN-08-1310; Schupp N, 2010, HORM METAB RES, V42, P458, DOI 10.1055/s-0029-1243253; Schupp N, 2007, AM J PHYSIOL-RENAL, V292, pF1427, DOI 10.1152/ajprenal.00458.2006; Shibata S, 2007, HYPERTENSION, V49, P355, DOI 10.1161/01.HYP.0000255636.11931.a2; Simao S, 2011, EXP GERONTOL, V46, P468, DOI 10.1016/j.exger.2011.02.003; Sirker A, 2011, BASIC RES CARDIOL, V106, P735, DOI 10.1007/s00395-011-0190-z; Subash P, 2010, INDIAN J CLIN BIOCHE, V25, P127, DOI 10.1007/s12291-010-0024-z; Surh YJ, 2008, PLANTA MED, V74, P1526, DOI 10.1055/s-0028-1088302; Taira M, 2008, EUR J PHARMACOL, V589, P264, DOI 10.1016/j.ejphar.2008.06.019; VANBELLE E, 1995, CARDIOVASC RES, V29, P27, DOI 10.1016/S0008-6363(96)88542-7; Weikert S, 2008, AM J EPIDEMIOL, V167, P438, DOI 10.1093/aje/kwm321; Westhoff JH, 2008, HYPERTENSION, V52, P123, DOI 10.1161/HYPERTENSIONAHA.107.099432; Wilcox CS, 2008, PHARMACOL REV, V60, P418, DOI 10.1124/pr.108.000240; Wu LY, 2004, P NATL ACAD SCI USA, V101, P7094, DOI 10.1073/pnas.0402004101; Xu SQ, 2011, HYPERTENSION, V58, P310, DOI 10.1161/HYPERTENSIONAHA.111.172031; Yagi S, 2010, HYPERTENSION, V55, P918, DOI 10.1161/HYPERTENSIONAHA.109.146076; Yamamoto E, 2007, HYPERTENSION, V50, P657, DOI 10.1161/HYPERTENSIONAHA.107.095315; Yamamoto M, 2008, NUTRITION, V24, P470, DOI 10.1016/j.nut.2008.01.010; Zhang J, 2014, AM J PHYSIOL-RENAL, V306, pF344, DOI 10.1152/ajprenal.00515.2013	81	18	18	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2014	9	12							e115715	10.1371/journal.pone.0115715	http://dx.doi.org/10.1371/journal.pone.0115715			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UC	25551569	gold, Green Published			2022-12-27	WOS:000347119100053
J	Foditsch, C; Santos, TMA; Teixeira, AGV; Pereira, RVV; Dias, JM; Gaeta, N; Bicalho, RC				Foditsch, Carla; Santos, Thiago M. A.; Teixeira, Andre G. V.; Pereira, Richard V. V.; Dias, Juliana M.; Gaeta, Natalia; Bicalho, Rodrigo C.			Isolation and Characterization of Faecalibacterium prausnitzii from Calves and Piglets	PLOS ONE			English	Article							TETRACYCLINE RESISTANCE GENE; BUTYRATE-PRODUCING BACTERIA; FUSOBACTERIUM-PRAUSNITZII; SUSCEPTIBILITY; BACTEROIDES; TET(W); CELLS; PCR	The goal of our study was to isolate and characterize Faecalibacterium prausnitzii from fecal samples of healthy calves and piglets, in order to develop a novel probiotic for livestock animals. We identified 203 isolates of Faecalibacterium sp., which were clustered in 40 genetically distinct groups. One representative isolate from each cluster was selected for further characterization. The concentrations of the short chain fatty acids (SCFA) acetate, butyrate, propionate and isobutyrate in the culture media were measured by gas chromatography. We observed reduction in the concentration of acetate followed by concomitant increase in the concentration of butyrate, suggesting that the isolates were consuming acetate present in the media and producing butyrate. Butyrate production correlated positively with bacterial growth. Since butyrate has many benefits to the colonic epithelial cells, the selection of strains that produce higher amounts of butyrate is extremely important for the development of this potential probiotic. The effect of pH and concentration of bile salts on bacterial growth was also evaluated in order to mimic the conditions encountered by F. prausnitzii in vivo. The optimal pH for growth ranged between 5.5 and 6.7, while most isolates were inhibited by of the lowest concentration of bile salts tested (0.1%). Antimicrobial resistance profile showed that most isolates of Faecalibacterium sp. were resistant against ciprofloxacin and sulfamethoxazole-trimethoprim. More than 50% of the isolates were resistant to tetracycline, amikacin, cefepime and cefoxitin. A total of 19 different combinations of multidrug resistance were observed among the isolates. Our results provide new insights into the cultural and physiological characteristics of Faecalibacterium prausnitzii illustrating large variability in short chain fatty acid production, in vitro growth, sensitivity to bile salts, and antibiotic resistance and suggesting that future probiotic candidates should be carefully studied before elected for in vivo studies.	[Foditsch, Carla; Teixeira, Andre G. V.; Pereira, Richard V. V.; Dias, Juliana M.; Gaeta, Natalia; Bicalho, Rodrigo C.] Cornell Univ, Coll Vet Med, Dept Populat Med & Diagnost Sci, Ithaca, NY 14853 USA; [Santos, Thiago M. A.] Univ Wisconsin, Dept Biochem, Madison, WI 53705 USA	Cornell University; University of Wisconsin System; University of Wisconsin Madison	Bicalho, RC (corresponding author), Cornell Univ, Coll Vet Med, Dept Populat Med & Diagnost Sci, Ithaca, NY 14853 USA.	rcb28@cornell.edu	Pereira, Richard/L-2684-2019; Gaeta, Natália Carrillo/AAT-1550-2020; Carrillo Gaeta, Natália/Q-5791-2016; Teixeira, Andre Gustavo/B-2177-2017	Pereira, Richard/0000-0003-2028-8761; Gaeta, Natália Carrillo/0000-0001-6397-605X; Carrillo Gaeta, Natália/0000-0001-6397-605X; Teixeira, Andre Gustavo/0000-0002-8620-1422; Monteiro Araujo dos Santos, Thiago/0000-0002-0648-6078	Merck Animal Health	Merck Animal Health(Merck & Company)	This study was funded by a grant from Merck Animal Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balamurugan R, 2010, BRIT J NUTR, V103, P335, DOI 10.1017/S0007114509992182; Barbosa TM, 1999, ENVIRON MICROBIOL, V1, P53, DOI 10.1046/j.1462-2920.1999.00004.x; Barcenilla A, 2000, APPL ENVIRON MICROB, V66, P1654, DOI 10.1128/AEM.66.4.1654-1661.2000; BRYAN L E, 1979, Antimicrobial Agents and Chemotherapy, V15, P7; Chee-Sanford JC, 2001, APPL ENVIRON MICROB, V67, P1494, DOI 10.1128/AEM.67.4.1494-1502.2001; CHIN NX, 1984, ANTIMICROB AGENTS CH, V25, P319, DOI 10.1128/AAC.25.3.319; DRESSMAN JB, 1990, PHARMACEUT RES, V7, P756, DOI 10.1023/A:1015827908309; Duboc H, 2013, GUT, V62, P531, DOI 10.1136/gutjnl-2012-302578; Duncan SH, 2004, BRIT J NUTR, V91, P915, DOI 10.1079/BJN20041150; Duncan SH, 2002, INT J SYST EVOL MICR, V52, P2141, DOI [10.1099/ijs.0.02241-0, 10.1099/00207713-52-6-2141]; Gorka P, 2011, J DAIRY SCI, V94, P5578, DOI 10.3168/jds.2011-4166; Guan LL, 2008, FEMS MICROBIOL LETT, V288, P85, DOI 10.1111/j.1574-6968.2008.01343.x; Haenen D, 2013, J NUTR, V143, P274, DOI 10.3945/jn.112.169672; Hold GL, 2003, APPL ENVIRON MICROB, V69, P4320, DOI 10.1128/AEM.69.7.4320-4324.2003; Kazimierczak KA, 2009, APPL ENVIRON MICROB, V75, P1717, DOI 10.1128/AEM.02206-08; Khan MT, 2012, ISME J, V6, P1578, DOI 10.1038/ismej.2012.5; Lopez-Siles M, 2012, APPL ENVIRON MICROB, V78, P420, DOI 10.1128/AEM.06858-11; Lund M, 2010, POULTRY SCI, V89, P1217, DOI 10.3382/ps.2010-00653; Machiels K., 2013, GUT; Magnet S, 2005, CHEM REV, V105, P477, DOI 10.1021/cr0301088; Maynard L.A., 1979, ANIM NUTR; Nava GM, 2011, GUT MICROBES, V2, P99, DOI 10.4161/gmic.2.2.15416; Oikonomou G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063157; Peterson DA, 2010, ADV IMMUNOL, V107, P71, DOI [10.1016/B978-0-12-381300-8.00003-4, 10.1016/S0065-2776(10)07005-7]; Ploger S, 2012, ANN NY ACAD SCI, V1258, P52, DOI 10.1111/j.1749-6632.2012.06553.x; Qiu XY, 2013, J CROHNS COLITIS, V7, pE558, DOI 10.1016/j.crohns.2013.04.002; Ridaura VK, 2013, SCIENCE, V341, P1079, DOI 10.1126/science.1241214; ROSENBLATT JE, 1995, DIAGN MICR INFEC DIS, V22, P279, DOI 10.1016/0732-8893(95)00049-G; Round JL, 2009, NAT REV IMMUNOL, V9, P313, DOI 10.1038/nri2515; Scott KP, 2000, ANTIMICROB AGENTS CH, V44, P775, DOI 10.1128/AAC.44.3.775-777.2000; Seville LA, 2009, MICROB DRUG RESIST, V15, P159, DOI 10.1089/mdr.2009.0916; Sokol H, 2008, P NATL ACAD SCI USA, V105, P16731, DOI 10.1073/pnas.0804812105; Suau A, 2001, SYST APPL MICROBIOL, V24, P139, DOI 10.1078/0723-2020-00015; Supelco I, 1998, B B, V856B; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; van den Bogaard AE, 2002, J ANTIMICROB CHEMOTH, V49, P497, DOI 10.1093/jac/49.3.497; Walker AW, 2011, ISME J, V5, P220, DOI 10.1038/ISMEJ.2010.118; WANG G, 1993, NUCLEIC ACIDS RES, V21, P5930, DOI 10.1093/nar/21.25.5930; Wang W, 2013, J CLIN MICROBIOL; Wood J, 1998, APPL ENVIRON MICROB, V64, P3683; Wrzosek L, 2013, BMC BIOL, V11, DOI 10.1186/1741-7007-11-61; WUST J, 1978, ANTIMICROB AGENTS CH, V14, P384, DOI 10.1128/AAC.14.3.384	42	48	58	4	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2014	9	12							e116465	10.1371/journal.pone.0116465	http://dx.doi.org/10.1371/journal.pone.0116465			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UC	25551453	gold, Green Published, Green Submitted			2022-12-27	WOS:000347119100142
J	Lin, WR; Yen, TH; Lim, SN; Perng, MD; Lin, CY; Su, MY; Yeh, CT; Chiu, CT				Lin, Wey-Ran; Yen, Tzung-Hai; Lim, Siew-Na; Perng, Ming-Der; Lin, Chun-Yen; Su, Ming-Yo; Yeh, Chau-Ting; Chiu, Cheng-Tang			Granulocyte Colony-Stimulating Factor Reduces Fibrosis in a Mouse Model of Chronic Pancreatitis	PLOS ONE			English	Article							MARROW-DERIVED CELLS; STEM-CELLS; LIVER FIBROSIS; PROLIFERATION; CONTRIBUTES; REGRESSION; INJURY; REPAIR; MICE	Background: Chronic pancreatitis (CP) is a necroinflammatory process resulting in extensive pancreatic fibrosis. Granulocyte colony-stimulating factor (G-CSF), a hematopoietic stem cell mobilizer, has been shown to exert an anti-fibrotic effect partly through the enrichment of bone marrow (BM) cells in fibrotic organ. We aimed to test the effect of G-CSF on fibrosis in a mouse model of CP. Methods: CP was induced in C57Bl/6J mice by consecutive cerulein injection (50 mu g/kg/day, 2 days a week) for 6 weeks. Mice were then treated with G-CSF (200 mu g/kg/day, 5 day a week) or normal saline for 1 week, and sacrificed at week 7 or week 9 after first cerulein injection. Pancreatic histology, pancreatic matrix metallopeptidase 9 (MMP-9), MMP-13 and collagen expression were examined. Pancreatic myofibroblasts were isolated and cultured with G-CSF. Collagen, MMP-9 and MMP-13 expression by myofibroblasts was examined. The BM-mismatched mice model was used to examine the change of BM-derived myofibroblasts and non-myofibroblastic BM cells by G-CSF in the pancreas. Results: The pancreatic collagen expression were significantly decreased in the G-CSF-treated group sacrificed at week 9. While collagen produced from myofibroblasts was not affected by G-CSF, the increase of MMP13 expression was observed in vitro. There were no effect of G-CSF in the number of myofibroblasts and BM-derived myofibroblasts. However, the number of non-myofibroblastic BM cells and macrophages were significantly increased in the pancreata of cerulein- and G-CSF-treated mice, suggesting a potential anti-fibrotic role of non-myofibroblastic BM cells and macrophages stimulated by G-CSF. Conclusions: Our data indicated that G-CSF contributed to the regression of pancreatic fibrosis. The anti-fibrotic effects were possibly through the stimulation of MMP-13 from myofibroblasts, and the enhanced accumulation of non-myofibroblastic BM cells and macrophages in the pancreas.	[Lin, Wey-Ran; Lin, Chun-Yen; Su, Ming-Yo; Chiu, Cheng-Tang] Linkou Chang Gung Mem Hosp, Dept Gastroenterol, Taoyuan, Taiwan; [Lin, Wey-Ran; Yeh, Chau-Ting] Linkou Chang Gung Mem Hosp, Liver Res Unit, Taoyuan, Taiwan; [Lin, Wey-Ran; Yen, Tzung-Hai; Lin, Chun-Yen; Su, Ming-Yo; Yeh, Chau-Ting; Chiu, Cheng-Tang] Chang Gung Univ, Coll Med, Taoyuan, Taiwan; [Yen, Tzung-Hai] Linkou Chang Gung Mem Hosp, Dept Nephrol, Taoyuan, Taiwan; [Lim, Siew-Na] Linkou Chang Gung Mem Hosp, Dept Neurol, Taoyuan, Taiwan; [Perng, Ming-Der] Natl Tsing Hua Univ, Inst Mol Med, Hsinchu, Taiwan	Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; National Tsing Hua University	Yeh, CT (corresponding author), Linkou Chang Gung Mem Hosp, Liver Res Unit, Taoyuan, Taiwan.	chautingy@gmail.com; ctchiu@adm.cgmh.org.tw	Yen, Tzung-Hai/AAQ-4525-2020	Yen, Tzung-Hai/0000-0002-0907-1505; Lin, Chun-Yen/0000-0003-3007-3190	Chang Gung Memorial Hospital, Taiwan [CMRPG3B047, CMRPG3A092]; Ministry of Science and Technology [100-2314-B-182A-056, 101-2314-B-182-096]; New Century Health Care Promotion Foundation, Taiwan (IACUC) [2012081402]	Chang Gung Memorial Hospital, Taiwan(Chang Gung Memorial Hospital); Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); New Century Health Care Promotion Foundation, Taiwan (IACUC)	This study was funded by grants from Chang Gung Memorial Hospital, Taiwan (CMRPG3B047, CMRPG3A092), Ministry of Science and Technology (100-2314-B-182A-056, 101-2314-B-182-096) and The New Century Health Care Promotion Foundation, Taiwan (IACUC NO: 2012081402). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avalos BR, 1996, BLOOD, V88, P761, DOI 10.1182/blood.V88.3.761.bloodjournal883761; Behrman SW, 2007, SURG CLIN N AM, V87, P1309, DOI 10.1016/j.suc.2007.09.001; Cui HF, 2003, WORLD J GASTROENTERO, V9, P2274; Dale DC, 2003, AM J HEMATOL, V72, P82, DOI 10.1002/ajh.10255; Direkze NC, 2004, CANCER RES, V64, P8492, DOI 10.1158/0008-5472.CAN-04-1708; Duffield JS, 2005, J CLIN INVEST, V115, P56, DOI 10.1172/JCI200522675; Forechi L, 2012, PHARMACOL REP, V64, P643, DOI 10.1016/S1734-1140(12)70860-5; Forsmark CE, 2013, GASTROENTEROLOGY, V144, P1282, DOI 10.1053/j.gastro.2013.02.008; Higashiyama R, 2007, HEPATOLOGY, V45, P213, DOI 10.1002/hep.21477; Kisseleva T, 2012, J HEPATOL, V56, P965, DOI 10.1016/j.jhep.2011.09.021; LAYER P, 1994, GASTROENTEROLOGY, V107, P1481, DOI 10.1016/0016-5085(94)90553-3; Li N, 2010, TRANSPL P, V42, P3833, DOI 10.1016/j.transproceed.2010.09.010; Lin WR, 2008, CELLS TISSUES ORGANS, V188, P178, DOI 10.1159/000113530; Lin WR, 2012, INT J EXP PATHOL, V93, P130, DOI 10.1111/j.1365-2613.2011.00804.x; Marrache F, 2008, GUT, V57, P1113, DOI 10.1136/gut.2007.143271; Piscaglia AC, 2007, GASTROENTEROLOGY, V133, P619, DOI 10.1053/j.gastro.2007.05.018; Rangan GK, 2007, NEPHROLOGY, V12, P553, DOI 10.1111/j.1440-1797.2007.00855.x; Rojas M, 2005, AM J RESP CELL MOL, V33, P145, DOI 10.1165/rcmb.2004-0330OC; Russo FP, 2006, GASTROENTEROLOGY, V130, P1807, DOI 10.1053/j.gastro.2006.01.036; Sakaida I, 2004, HEPATOLOGY, V40, P1304, DOI 10.1002/hep.20452; Saotome T, 1997, PANCREAS, V14, P373, DOI 10.1097/00006676-199705000-00008; Sato T, 2008, INT J CARDIOL, V127, P166, DOI 10.1016/j.ijcard.2007.05.007; Scarlett CJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026088; Spahr L, 2008, HEPATOLOGY, V48, P221, DOI 10.1002/hep.22317; Szardien S, 2012, EUR HEART J, V33, P595, DOI 10.1093/eurheartj/ehr434; Terai S, 2006, STEM CELLS, V24, P2292, DOI 10.1634/stemcells.2005-0542; Tuo HF, 2005, J GASTROENTEROL, V40, P186, DOI 10.1007/s00535-004-1515-6; Tuo HF, 2005, PANCREAS, V30, pE16; Watanabe T, 2009, AM J PHYSIOL-GASTR L, V297, pG1138, DOI 10.1152/ajpgi.00123.2009; Zhang F, 2011, RESPIRATION, V82, P358, DOI 10.1159/000328762	30	9	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2014	9	12							e116229	10.1371/journal.pone.0116229	http://dx.doi.org/10.1371/journal.pone.0116229			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UC	25551560	Green Published, gold, Green Submitted			2022-12-27	WOS:000347119100108
J	Rodriguez-Bonilla, L; Cuevas, HE; Montero-Rojas, M; Bird-Pico, F; Luciano-Rosario, D; Siritunga, D				Rodriguez-Bonilla, Lorraine; Cuevas, Hugo E.; Montero-Rojas, Milly; Bird-Pico, Fernando; Luciano-Rosario, Dianiris; Siritunga, Dimuth			Assessment of Genetic Diversity of Sweet Potato in Puerto Rico	PLOS ONE			English	Article							BATATAS L. LAM.; DISPERSAL; MICROSATELLITES; SOFTWARE; GENOTYPE; ORIGIN	Sweet potato (Ipomoea batatas L.) is the seventh most important food crop due to its distinct advantages, such as adaptability to different environmental conditions and high nutritional value. Assessing the genetic diversity of this important crop is necessary due to the constant increase of demand for food and the need for conservation of agricultural and genetic resources. In Puerto Rico (PR), the genetic diversity of sweet potato has been poorly understood, although it has been part of the diet since Pre-Columbus time. Thus, 137 landraces from different localities around PR were collected and subjected to a genetic diversity analysis using 23 SSR-markers. In addition, 8 accessions from a collection grown in Gurabo, PR at the Agricultural Experimental Station (GAES), 10 US commercial cultivars and 12 Puerto Rican accessions from the USDA repository collection were included in this assessment. The results of the analysis of the 23 loci showed 255 alleles in the 167 samples. Observed heterozygosity was high across populations (0.71) while measurements of total heterozygosity revealed a large genetic diversity throughout the population and within populations. UPGMA clustering method revealed two main clusters. Cluster 1 contained 12 PR accessions from the USDA repository collection, while cluster 2 consisted of PR landraces, US commercial cultivars and the PR accessions from GAES. Population structure analysis grouped PR landraces in five groups including four US commercial cultivars. Our study shows the presence of a high level of genetic diversity of sweet potato across PR which can be related to the genetic makeup of sweet potato, human intervention and out-crossing nature of the plant. The history of domestication and dispersal of sweet potato in the Caribbean and the high levels of genetic diversity found through this study makes sweet potato an invaluable resource that needs to be protected and further studied.	[Rodriguez-Bonilla, Lorraine; Montero-Rojas, Milly; Bird-Pico, Fernando; Luciano-Rosario, Dianiris; Siritunga, Dimuth] Univ Puerto Rico, Dept Biol, Mayaguez, PR 00680 USA; [Cuevas, Hugo E.] ARS, Trop Agr Res Stn, USDA, Mayaguez, PR USA	University of Puerto Rico; University of Puerto Rico Mayaguez; United States Department of Agriculture (USDA)	Siritunga, D (corresponding author), Univ Puerto Rico, Dept Biol, Mayaguez, PR 00680 USA.	Dimuth.siritunga@upr.edu		Siritunga, Dimuth/0000-0002-4654-1369				Austin DF, 1996, TAXON, V45, P3, DOI 10.2307/1222581; Bruckner AW, 2004, THESIS N CAROLINA ST; Burri BJ, 2011, COMPR REV FOOD SCI F, V10, P118, DOI 10.1111/j.1541-4337.2010.00146.x; Buteler MI, 1999, THEOR APPL GENET, V99, P123, DOI 10.1007/s001220051216; Doyle JJ, 1987, PHYTOCHEM B, V19, P11, DOI 10.1016/j.bse.2009.07.003; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Elameen A, 2008, GENET RESOUR CROP EV, V55, P397, DOI 10.1007/s10722-007-9247-0; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Food and Agriculture Organization, 2010, STAT WORLDS PLANT GE; Gichuki ST, 2003, GENET RESOUR CROP EV, V50, P429, DOI 10.1023/A:1023998522845; Gwandu C., 2012, African Journal of Biotechnology, V11, P9582; Hu JJ, 2004, SCI HORTIC-AMSTERDAM, V102, P375, DOI 10.1016/j.scienta.2004.04.014; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Karuri H. W., 2009, Journal of Applied Biosciences, V15, P820; KEEGAN WF, 1995, WORLD ARCHAEOL, V26, P400, DOI 10.1080/00438243.1995.9980284; Letunic I, 2007, BIOINFORMATICS, V23, P127, DOI 10.1093/bioinformatics/btl529; Letunic I, 2011, NUCLEIC ACIDS RES, V39, pW475, DOI [10.1093/nar/gkr931, 10.1093/nar/gkr201]; Liu KJ, 2005, BIOINFORMATICS, V21, P2128, DOI 10.1093/bioinformatics/bti282; Meirmans PG, 2004, MOL ECOL NOTES, V4, P792, DOI 10.1111/j.1471-8286.2004.00770.x; OBRIEN PJ, 1972, AM ANTHROPOL, V74, P342, DOI 10.1525/aa.1972.74.3.02a00070; Oetting WS, 1995, GENOMICS, V30, P450, DOI 10.1006/geno.1995.1264; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Pritchard JK, 2000, GENETICS, V155, P945; Roullier C, 2013, HEREDITY, V110, P594, DOI 10.1038/hdy.2013.14; Roullier C, 2011, MOL ECOL, V20, P3963, DOI 10.1111/j.1365-294X.2011.05229.x; Sanjur OI, 2002, P NATL ACAD SCI USA, V99, P535, DOI 10.1073/pnas.012577299; Tseng YT, 2002, BOT BULL ACAD SINICA, V43, P99; Tumwegamire S, 2011, CROP SCI, V51, P1132, DOI 10.2135/cropsci2010.07.0407; Yada B, 2010, HORTSCIENCE, V45, P225, DOI 10.21273/HORTSCI.45.2.225; YANEZ AVO, 2002, AISLAMIENTO CARACTER; Zhang D, 2000, CIP PROGRAMME REPORT, P295; Zhang DP, 2004, GENET RESOUR CROP EV, V51, P115, DOI 10.1023/B:GRES.0000020853.04508.a0	32	26	27	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2014	9	12							e116184	10.1371/journal.pone.0116184	http://dx.doi.org/10.1371/journal.pone.0116184			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UC	25551388	Green Submitted, Green Published, gold			2022-12-27	WOS:000347119100106
J	Ali, K; Abo-Ali, EM; Kabir, MD; Riggins, B; Nguy, S; Li, L; Srivastava, U; Thinn, SMM				Ali, Kamilah; Abo-Ali, Ehab M.; Kabir, M. D.; Riggins, Bethany; Nguy, Susanna; Li, Lisa; Srivastava, Ujala; Thinn, Su Mya Mya			A Western-Fed Diet Increases Plasma HDL and LDL-Cholesterol Levels in ApoD-/- Mice	PLOS ONE			English	Article							HIGH-DENSITY-LIPOPROTEIN; RECEPTOR CLASS-B; APOLIPOPROTEIN-D; SCAVENGER RECEPTOR; TARGETED MUTATION; SELECTIVE UPTAKE; SR-BI; REVEALS; PROTEIN; GENE	Objective: Plasma apolipoprotein (apo) D, a ubiquitously expressed protein that binds small hydrophobic ligands, is found mainly on HDL particles. According to studies of human genetics and lipid disorders, plasma apoD levels positively correlate with HDL-cholesterol and apoAI levels. Thus, we tested the hypothesis that apoD was a regulator of HDL metabolism. Methods & Results: We compared the plasma lipid and lipoprotein profiles of wild-type (WT) C57BL/6 mice with apoD-/- mice on a C57BL/6 background after receiving a high fat-high cholesterol diet for 12 weeks. ApoD-/- mice had higher HDL-cholesterol levels (61 +/- 13-apoD-/- vs. 52 +/- 10-WT-males; 37 +/- 11-apoD-/- vs. 22 +/- 2 WT-female) than WT mice with sex-specific changes in total plasma levels of cholesterol and other lipids. Compared to WT, the HDL of apoD-/- mice showed an increase in large, lipid-rich HDL particles and according to size various quantities and sizes of LDL particles. Plasma levels of lecithin: cholesterol acyltransferase in the control and apoD-/- mice were not different, however, plasma phospholipid transfer protein activity was modestly elevated (+10%) only in male apoD-/- mice. An in vivo HDL metabolism experiment with isolated Western-fed apoD-/- HDL particles showed that female apoD-/- mice had a 36% decrease in the fractional catabolic rate of HDL cholesteryl ester. Hepatic SR-BI and LDLR protein levels were significantly decreased; accordingly, LDL-cholesterol and apoB levels were increased in female mice. Conclusion: In the context of a high fat-high cholesterol diet, apoD deficiency in female mice is associated with increases in both plasma HDL and LDL-cholesterol levels, reflecting changes in expression of SR-BI and LDL receptors, which may impact diet-induced atherosclerosis.	[Ali, Kamilah; Abo-Ali, Ehab M.; Kabir, M. D.; Riggins, Bethany; Nguy, Susanna; Li, Lisa; Srivastava, Ujala; Thinn, Su Mya Mya] CUNY City Coll, Dept Biol, New York, NY 10031 USA; [Ali, Kamilah; Abo-Ali, Ehab M.] CUNY, Grad Ctr, New York, NY 10021 USA	City University of New York (CUNY) System; City College of New York (CUNY); City University of New York (CUNY) System	Ali, K (corresponding author), CUNY City Coll, Dept Biol, 138Th St & Convent Ave, New York, NY 10031 USA.	kali@ccny.cuny.edu		Kabir, Md/0000-0003-1792-2549	National Center for Research Resources [2G12RR03060-26A1]; National Institute on Minority Health and Health Disparities from National Institutes of Health [8G12MD007603-27]; NATIONAL CENTER FOR RESEARCH RESOURCES [G12RR003060] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [G12MD007603] Funding Source: NIH RePORTER; Div Of Biological Infrastructure [1156512] Funding Source: National Science Foundation	National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institute on Minority Health and Health Disparities from National Institutes of Health; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); Div Of Biological Infrastructure(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	Funding for Ujala Srivastava postdoctoral fellowship was provided by grants from the National Center for Research Resources (2G12RR03060-26A1) and the National Institute on Minority Health and Health Disparities (8G12MD007603-27) from the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acton S, 1996, SCIENCE, V271, P518, DOI 10.1126/science.271.5248.518; ALAUPOVIC P, 1981, METABOLISM, V30, P805, DOI 10.1016/0026-0495(81)90027-5; ALBERS JJ, 1981, ATHEROSCLEROSIS, V39, P395, DOI 10.1016/0021-9150(81)90025-3; Albers JJ, 2012, BBA-MOL CELL BIOL L, V1821, P345, DOI 10.1016/j.bbalip.2011.06.013; Brundert M, 2005, ARTERIOSCL THROM VAS, V25, P143, DOI 10.1161/01.ATV.0000149381.16166.c6; CAMATO R, 1989, J LIPID RES, V30, P865; Camont L, 2011, TRENDS MOL MED, V17, P594, DOI 10.1016/j.molmed.2011.05.013; Caulfield MP, 2008, CLIN CHEM, V54, P1307, DOI 10.1373/clinchem.2007.100586; Dassati S, 2014, NEUROBIOL AGING, V35, P1632, DOI 10.1016/j.neurobiolaging.2014.01.148; Davidson WS, 2009, ARTERIOSCL THROM VAS, V29, P870, DOI 10.1161/ATVBAHA.109.186031; Desai PP, 2002, ATHEROSCLEROSIS, V163, P329, DOI 10.1016/S0021-9150(02)00012-6; Duivenvoorden R, 2012, CURR OPIN LIPIDOL, V23, P518, DOI 10.1097/MOL.0b013e32835916b3; Ganfornina MD, 2008, AGING CELL, V7, P506, DOI 10.1111/j.1474-9726.2008.00395.x; Havel R. J., 1980, METABOLIC CONTROL DI, P398; JAMES RW, 1986, ATHEROSCLEROSIS, V60, P49, DOI 10.1016/0021-9150(86)90086-9; Jimenez-Palomares M, 2011, METABOLISM, V60, P1767, DOI 10.1016/j.metabol.2011.04.013; KANNEL WB, 1979, ANN INTERN MED, V90, P85, DOI 10.7326/0003-4819-90-1-85; Kwon HJ, 2008, P NATL ACAD SCI USA, V105, P1820, DOI 10.1073/pnas.0712064105; MCCONATHY WJ, 1976, BIOCHEMISTRY-US, V15, P515, DOI 10.1021/bi00648a010; Perdomo G, 2010, J LIPID RES, V51, P1298, DOI 10.1194/jlr.M001206; Rader DJ, 2012, NAT MED, V18, P1344, DOI 10.1038/nm.2937; Rainwater DL, 1999, ARTERIOSCL THROM VAS, V19, P777, DOI 10.1161/01.ATV.19.3.777; Rassart E, 2000, BBA-PROTEIN STRUCT M, V1482, P185, DOI 10.1016/S0167-4838(00)00162-X; Rigotti A, 1997, P NATL ACAD SCI USA, V94, P12610, DOI 10.1073/pnas.94.23.12610; Roger VL, 2011, CIRCULATION, V123, pE18, DOI 10.1161/CIR.0b013e3182009701; STEYRER E, 1988, BIOCHIM BIOPHYS ACTA, V958, P484, DOI 10.1016/0005-2760(88)90235-4; Tietge UJF, 2000, J BIOL CHEM, V275, P10077, DOI 10.1074/jbc.275.14.10077; Tsukamoto K, 2013, P NATL ACAD SCI USA, V110, P17023, DOI 10.1073/pnas.1315986110; Ueda Y, 2000, J BIOL CHEM, V275, P20368, DOI 10.1074/jbc.M000730200; Varban ML, 1998, P NATL ACAD SCI USA, V95, P4619, DOI 10.1073/pnas.95.8.4619; Wang N, 1998, J BIOL CHEM, V273, P32920, DOI 10.1074/jbc.273.49.32920; Zhang DW, 2007, J BIOL CHEM, V282, P18602, DOI 10.1074/jbc.M702027200; Zhang L, 2012, ARTERIOSCL THROM VAS, V32, P2541, DOI 10.1161/ATVBAHA.112.250571	33	13	14	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2014	9	12							e115744	10.1371/journal.pone.0115744	http://dx.doi.org/10.1371/journal.pone.0115744			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX6YH	25548917	gold, Green Published			2022-12-27	WOS:000347063500023
J	Hortensius, R; van Honk, J; de Gelder, B; Terburg, D				Hortensius, Ruud; van Honk, Jack; de Gelder, Beatrice; Terburg, David			Trait Dominance Promotes Reflexive Staring at Masked Angry Body Postures	PLOS ONE			English	Article							NON-CONSCIOUS RECOGNITION; BODILY EXPRESSIONS; VISUAL AWARENESS; EMOTIONAL FACES; FEAR; TESTOSTERONE; PERCEPTION; RESPONSES; AMYGDALA; INTEGRATION	It has been shown that dominant individuals sustain eye-contact when non-consciously confronted with angry faces, suggesting reflexive mechanisms underlying dominance behaviors. However, dominance and submission can be conveyed and provoked by means of not only facial but also bodily features. So far few studies have investigated the interplay of body postures with personality traits and behavior, despite the biological relevance and ecological validity of these postures. Here we investigate whether non-conscious exposure to bodily expressions of anger evokes reflex-like dominance behavior. In an interactive eye-tracking experiment thirty-two participants completed three social dominance tasks with angry, happy and neutral facial, bodily and face and body compound expressions that were masked from consciousness. We confirmed our predictions of slower gaze-aversion from both non-conscious bodily and compound expressions of anger compared to happiness in high dominant individuals. Results from a follow-up experiment suggest that the dominance behavior triggered by exposure to bodily anger occurs with basic detection of the category, but not recognition of the emotional content. Together these results suggest that dominant staring behavior is reflexively driven by non-conscious perception of the emotional content and triggered by not only facial but also bodily expression of anger.	[Hortensius, Ruud; de Gelder, Beatrice] Tilburg Univ, Cognit & Affect Neurosci Lab, NL-5000 LE Tilburg, Netherlands; [van Honk, Jack; Terburg, David] Univ Utrecht, Dept Expt Psychol, Utrecht, Netherlands; [van Honk, Jack; Terburg, David] Univ Cape Town, Dept Psychiat & Mental Hlth, ZA-7925 Cape Town, South Africa; [van Honk, Jack] Univ Cape Town, Inst Infect Dis & Mol Med, ZA-7925 Cape Town, South Africa; [de Gelder, Beatrice] Maastricht Univ, Fac Psychol & Neurosci, Dept Cognit Neurosci, Brain & Emot Lab, Maastricht, Netherlands; [de Gelder, Beatrice] Katholieke Univ Leuven, Dept Neurosci, Div Psychiat, Brain & Emot Lab Leuven, Leuven, Belgium	Tilburg University; Utrecht University; University of Cape Town; University of Cape Town; Maastricht University; KU Leuven	Terburg, D (corresponding author), Univ Utrecht, Dept Expt Psychol, Utrecht, Netherlands.	d.terburg@uu.nl		Terburg, David/0000-0003-2356-8734; Hortensius, Ruud/0000-0002-5279-6202	Netherlands Organization for Scientific Research (NWO) [Brain & Cognition 056-24-010, VENI 451-13-004]; project TANGO; Future and Emerging Technologies (FET) programme within the Seventh Framework Programme for Research of the European Commission under FET-Open grant [249858]; European Research Council under the European Union/ERC [295673]	Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); project TANGO; Future and Emerging Technologies (FET) programme within the Seventh Framework Programme for Research of the European Commission under FET-Open grant; European Research Council under the European Union/ERC(European Research Council (ERC))	This study was supported by grants from the Netherlands Organization for Scientific Research (NWO; http://www.nwo.nl/): Brain & Cognition 056-24-010 (JvH); VENI 451-13-004 (D.T.). The work of BdG and RH was partly funded by the project TANGO. The project TANGO acknowledges the financial support of the Future and Emerging Technologies (FET) programme within the Seventh Framework Programme for Research of the European Commission (http://ec.europa.eu/research/fp7/index_en.cfm), under FET-Open grant number: 249858. BdG has also received funding from the European Research Council under the European Union's Seventh Frame-Work Programme (FP7/2007-2013)/ERC grant agreement number 295673. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders S, 2004, NAT NEUROSCI, V7, P339, DOI 10.1038/nn1213; [Anonymous], 2009, EXPRESS EMOT MAN; Carney DR, 2010, PSYCHOL SCI, V21, P1363, DOI 10.1177/0956797610383437; CARVER CS, 1994, J PERS SOC PSYCHOL, V67, P319, DOI 10.1037/0022-3514.67.2.319; de Gelder B, 2004, P NATL ACAD SCI USA, V101, P16701, DOI 10.1073/pnas.0407042101; de Gelder B, 1999, NEUROREPORT, V10, P3759, DOI 10.1097/00001756-199912160-00007; de Gelder B, 2001, ACTA PSYCHOL, V107, P183, DOI 10.1016/S0001-6918(01)00024-5; de Gelder B, 2006, NEUROREPORT, V17, P583, DOI 10.1097/00001756-200604240-00006; de Gelder B, 2012, FRONT INTEGR NEUROSC, V6, DOI 10.3389/fnint.2012.00054; de Gelder B, 2009, PHILOS T R SOC B, V364, P3475, DOI 10.1098/rstb.2009.0190; Ekman P., 1976, PICTURES FACIAL AFFE; Green DM, 1966, SIGNAL DETECTION THE; Hofman D, 2013, NEUROIMAGE, V79, P138, DOI 10.1016/j.neuroimage.2013.04.088; Mazur A, 1998, BEHAV BRAIN SCI, V21, P353, DOI 10.1017/S0140525X98001228; Meeren HKM, 2005, P NATL ACAD SCI USA, V102, P16518, DOI 10.1073/pnas.0507650102; Morris JS, 2001, BRAIN, V124, P1241, DOI 10.1093/brain/124.6.1241; Ohman A, 2005, PSYCHONEUROENDOCRINO, V30, P953, DOI 10.1016/j.psyneuen.2005.03.019; Pegna AJ, 2005, NAT NEUROSCI, V8, P24, DOI 10.1038/nn1364; Pessoa L, 2005, EMOTION, V5, P243, DOI 10.1037/1528-3542.5.2.243; Pichon S, 2012, CEREB CORTEX, V22, P274, DOI 10.1093/cercor/bhr060; Seirafi M, 2013, J VISION, V13, DOI 10.1167/13.2.12; SNODGRASS JG, 1988, J EXP PSYCHOL GEN, V117, P34, DOI 10.1037/0096-3445.117.1.34; Stienen BMC, 2011, EMOTION, V11, P1182, DOI 10.1037/a0024032; Tamietto M, 2012, CURR BIOL, V22, P1449, DOI 10.1016/j.cub.2012.06.006; Tamietto M, 2010, NAT REV NEUROSCI, V11, P697, DOI 10.1038/nrn2889; Tamietto M, 2009, P NATL ACAD SCI USA, V106, P17661, DOI 10.1073/pnas.0908994106; Terburg D, 2013, EMOT REV, V5, P296, DOI 10.1177/1754073913477510; Terburg D, 2012, PSYCHOL SCI, V23, P459, DOI 10.1177/0956797611433336; Terburg D, 2011, PSYCHOL SCI, V22, P314, DOI 10.1177/0956797611398492; van de Riet WAC, 2009, SOC NEUROSCI-UK, V4, P101, DOI 10.1080/17470910701865367; Van den Stock J, 2015, BIOL PSYCHIAT, V77, pE31, DOI 10.1016/j.biopsych.2013.06.023; van Honk J, 2005, BIOL PSYCHIAT, V58, P218, DOI 10.1016/j.biopsych.2005.04.003; van Honk J., 2007, SOCIAL NEUROSCIENCE, P197; VANSELST M, 1993, CONSCIOUS COGN, V2, P194, DOI 10.1006/ccog.1993.1018; Williams LM, 2004, HUM BRAIN MAPP, V21, P64, DOI 10.1002/hbm.10154	35	16	16	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2014	9	12							e116232	10.1371/journal.pone.0116232	http://dx.doi.org/10.1371/journal.pone.0116232			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX6YH	25549321	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000347063500066
J	Liu, JX; Wang, YZ; Wu, YZ; Ni, B; Liang, ZQ				Liu, Jingxia; Wang, Yanzhou; Wu, Yuzhang; Ni, Bing; Liang, Zhiqing			Sodium Butyrate Promotes the Differentiation of Rat Bone Marrow Mesenchymal Stem Cells to Smooth Muscle Cells through Histone Acetylation	PLOS ONE			English	Article							GENE-EXPRESSION; DEACETYLASE INHIBITOR; CLINICAL-APPLICATIONS; ACTIVATION; RECRUITMENT; DERIVATION; APOPTOSIS; BINDING; CYCLE	Establishing an effective method to improve stem cell differentiation is crucial in stem cell transplantation. Here we aimed to explore whether and how sodium butyrate (NaB) induces rat bone marrow mesenchymal stem cells (MSCs) to differentiate into bladder smooth muscle cells (SMCs). We found that NaB significantly suppressed MSC proliferation and promoted MSCs differentiation into SMCs, as evidenced by the enhanced expression of SMC specific genes in the MSCs. Co-culturing the MSCs with SMCs in a transwell system promoted the differentiation of MSCs into SMCs. NaB again promoted MSC differentiation in this system. Furthermore, NaB enhanced the acetylation of SMC gene-associated H3K9 and H4, and decreased the expression of HDAC2 and down-regulated the recruitment of HDAC2 to the promoter regions of SMC specific genes. Finally, we found that NaB significantly promoted MSC depolarization and increased the intracellular calcium level of MSCs upon carbachol stimulation. These results demonstrated that NaB effectively promotes MSC differentiation into SMCs, possibly by the marked inhibition of HDAC2 expression and disassociation of HDAC2 recruitment to SMC specific genes in MSCs, which further induces high levels of H3K9(ace) and H4(ace) and the enhanced expression of target genes, and this strategy could potentially be applied in clinical tissue engineering and cell transplantation.	[Liu, Jingxia; Wang, Yanzhou; Liang, Zhiqing] Third Mil Med Univ, Southwest Hosp, Dept Gynecol & Obstet, Chongqing 400038, Peoples R China; [Wu, Yuzhang; Ni, Bing] Third Mil Med Univ, PLA, Inst Immunol, Chongqing 400038, Peoples R China	Army Medical University; Army Medical University	Ni, B (corresponding author), Third Mil Med Univ, PLA, Inst Immunol, Chongqing 400038, Peoples R China.	nibingxi@yahoo.com; zhi.lzliang@gmail.com		Ni, Bing/0000-0002-4297-5346; wang, yanzhou/0000-0002-5985-5244; Wu, Yuzhang/0000-0002-4049-0214	General Program of National Natural Science Foundation of China [1170552, 30801234, 31200668]	General Program of National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the General Program of National Natural Science Foundation of China (No. 1170552, 30801234 and 31200668), http://www.nsfc.gov.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berridge MJ, 2008, J PHYSIOL-LONDON, V586, P5047, DOI 10.1113/jphysiol.2008.160440; Cao DS, 2005, MOL CELL BIOL, V25, P364, DOI 10.1128/MCB.25.1.364-376.2005; Chen TH, 2007, BIOCHEM BIOPH RES CO, V355, P913, DOI 10.1016/j.bbrc.2007.02.057; Das ZC, 2010, CELL REPROGRAM, V12, P95, DOI 10.1089/cell.2009.0068; Findeisen HM, 2013, CURR ATHEROSCLER REP, V15, DOI 10.1007/s11883-013-0319-7; Findeisen HM, 2011, ARTERIOSCL THROM VAS, V31, P851, DOI 10.1161/ATVBAHA.110.221952; Forostyak S, 2013, BIOCHIMIE, V95, P2257, DOI 10.1016/j.biochi.2013.08.004; Hauser C, 2002, MOL CELL BIOL, V22, P7820, DOI 10.1128/MCB.22.22.7820-7830.2002; Ho CP, 2012, CURR OPIN OBSTET GYN, V24, P311, DOI 10.1097/GCO.0b013e328357ae03; Kavurma MM, 2007, BIOCHEM J, V407, P79, DOI 10.1042/BJ20070380; Kim N, 2013, KOREAN J INTERN MED, V28, P387, DOI 10.3904/kjim.2013.28.4.387; Knaan-Shanzer S, 2014, STEM CELLS, V32, P603, DOI 10.1002/stem.1568; Koprinarova M, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-49; Kumar BM, 2007, J REPROD DEVELOP, V53, P903, DOI 10.1262/jrd.18180; Liao W, 2013, TRANSPL P, V45, P730, DOI 10.1016/j.transproceed.2012.08.023; Mali P, 2010, STEM CELLS, V28, P713, DOI 10.1002/stem.402; Manabe I, 2001, CIRC RES, V88, P1127, DOI 10.1161/hh1101.091339; McDonald OG, 2006, J CLIN INVEST, V116, P36, DOI 10.1172/JCI26505; McDonald OG, 2007, CIRC RES, V100, P1428, DOI 10.1161/01.RES.0000266448.30370.a0; Nor C, 2013, MOL NEUROBIOL, V48, P533, DOI 10.1007/s12035-013-8441-7; Paduraru O M, 2011, Fiziol Zh, V57, P15; Rahman MM, 2003, BLOOD, V101, P3451, DOI 10.1182/blood-2002-08-2622; Romagnoli Cecilia, 2014, World J Stem Cells, V6, P144, DOI 10.4252/wjsc.v6.i2.144; Sengupta N, 2004, J CELL BIOCHEM, V93, P57, DOI 10.1002/jcb.20179; Shah RD, 2013, J CELL BIOCHEM, V114, P854, DOI 10.1002/jcb.24422; Sinha S, 2006, STEM CELLS, V24, P1678, DOI 10.1634/stemcells.2006-0002; Surcel C, 2012, ROM J MORPHOL EMBRYO, V53, P151; Vrba J, 2011, BIOMED PAP, V155, P259, DOI 10.5507/bp.2011.033; Wang TZ, 2006, INT J CARDIOL, V109, P74, DOI 10.1016/j.ijcard.2005.05.072; Yin L, 2001, J BIOL CHEM, V276, P44641, DOI 10.1074/jbc.M105170200; Yoshida T, 2007, AM J PHYSIOL-CELL PH, V292, pC886, DOI 10.1152/ajpcell.00449.2006; Yoshida T, 2008, AM J PHYSIOL-CELL PH, V295, pC1175, DOI 10.1152/ajpcell.00288.2008; Zhang Q, 2011, CHINESE MED J-PEKING, V124, P3786, DOI 10.3760/cma.j.issn.0366-6999.2011.22.033; Zhou BD, 2011, CARDIOVASC RES, V90, P413, DOI 10.1093/cvr/cvr003; Zhou QJ, 2007, J CELL BIOCHEM, V100, P29, DOI 10.1002/jcb.20970	35	23	23	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2014	9	12							e116183	10.1371/journal.pone.0116183	http://dx.doi.org/10.1371/journal.pone.0116183			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX6YH	25548915	gold, Green Published, Green Submitted			2022-12-27	WOS:000347063500058
J	Scheu, PD; Steinmetz, PA; Dempwolff, F; Graumann, PL; Unden, G				Scheu, Patrick D.; Steinmetz, Philipp A.; Dempwolff, Felix; Graumann, Peter L.; Unden, Gottfried			Polar Localization of a Tripartite Complex of the Two-Component System DcuS/DcuR and the Transporter DctA in Escherichia coli Depends on the Sensor Kinase DcuS	PLOS ONE			English	Article							ANAEROBIC CITRATE METABOLISM; ACID CYCLE ENZYMES; ACTIN-LIKE PROTEIN; SIGNAL-TRANSDUCTION; RESPONSE REGULATOR; BACILLUS-SUBTILIS; DCTA/DCUS SENSOR; HISTIDINE KINASE; CHEMORECEPTOR CLUSTERS; DYNAMIC LOCALIZATION	The C-4-dicarboxylate responsive sensor kinase DcuS of the DcuS/DcuR twocomponent system of E. coli is membrane-bound and reveals a polar localization. DcuS uses the C-4-dicarboxylate transporter DctA as a co-regulator forming DctA/DcuS sensor units. Here it is shown by fluorescence microscopy with fusion proteins that DcuS has a dynamic and preferential polar localization, even at very low expression levels. Single assemblies of DcuS had high mobility in fast time lapse acquisitions, and fast recovery in FRAP experiments, excluding polar accumulation due to aggregation. DctA and DcuR fused to derivatives of the YFP protein are dispersed in the membrane or in the cytosol, respectively, when expressed without DcuS, but co-localize with DcuS when co-expressed at appropriate levels. Thus, DcuS is required for location of DctA and DcuR at the poles and formation of tripartite DctA/DcuS/DcuR sensor/regulator complexes. Vice versa, DctA, DcuR and the alternative succinate transporter DauA were not essential for polar localization of DcuS, suggesting that the polar trapping occurs by DcuS. Cardiolipin, the high curvature at the cell poles, and the cytoskeletal protein MreB were not required for polar localization. In contrast, polar localization of DcuS required the presence of the cytoplasmic PAS(C) and the kinase domains of DcuS.	[Scheu, Patrick D.; Steinmetz, Philipp A.; Unden, Gottfried] Johannes Gutenberg Univ Mainz, Inst Microbiol & Wine Res, D-55122 Mainz, Germany; [Dempwolff, Felix; Graumann, Peter L.] Univ Freiburg, Fac Biol, D-79106 Freiburg, Germany	Johannes Gutenberg University of Mainz; University of Freiburg	Unden, G (corresponding author), Johannes Gutenberg Univ Mainz, Inst Microbiol & Wine Res, D-55122 Mainz, Germany.	unden@uni-mainz.de		Dempwolff, Felix/0000-0002-7788-8445; Graumann, Peter/0000-0002-8033-5171	Deutsche Forschungsgemeinschaft [UN49/12-2, FOR 929]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	Funding provided by Deutsche Forschungsgemeinschaft UN49/12-2 (GU) and FOR 929 (PLG).	Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; BARNES SJ, 1986, FEBS LETT, V201, P267, DOI 10.1016/0014-5793(86)80621-4; Bott M, 1997, ARCH MICROBIOL, V167, P78, DOI 10.1007/s002030050419; BOTT M, 1995, MOL MICROBIOL, V18, P533, DOI 10.1111/j.1365-2958.1995.mmi_18030533.x; Davies SJ, 1999, J BACTERIOL, V181, P5624, DOI 10.1128/JB.181.18.5624-5635.1999; DOWER WJ, 1988, NUCLEIC ACIDS RES, V16, P6127, DOI 10.1093/nar/16.13.6127; Drepper T, 2007, NAT BIOTECHNOL, V25, P443, DOI 10.1038/nbt1293; Etzkorn M, 2008, NAT STRUCT MOL BIOL, V15, P1031, DOI 10.1038/nsmb.1493; Fukushima T, 2008, MOL MICROBIOL, V69, P621, DOI 10.1111/j.1365-2958.2008.06308.x; Fukushima T, 2011, MOL MICROBIOL, V79, P503, DOI 10.1111/j.1365-2958.2010.07464.x; Geertsma ER, 2008, P NATL ACAD SCI USA, V105, P5722, DOI 10.1073/pnas.0802190105; Graumann PL, 2007, ANNU REV MICROBIOL, V61, P589, DOI 10.1146/annurev.micro.61.080706.093236; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; Iwai N, 2002, BIOSCI BIOTECH BIOCH, V66, P2658, DOI 10.1271/bbb.66.2658; Jacobs C, 2001, P NATL ACAD SCI USA, V98, P4095, DOI 10.1073/pnas.051609998; Janausch IG, 2002, J BIOL CHEM, V277, P39809, DOI 10.1074/jbc.M204482200; Janausch IG, 2002, BBA-BIOENERGETICS, V1553, P39, DOI 10.1016/S0005-2728(01)00233-X; Karinou E, 2013, MOL MICROBIOL, V87, P623, DOI 10.1111/mmi.12120; Kaufenstein M, 2011, J BACTERIOL, V193, P1633, DOI 10.1128/JB.01128-10; Kay WW, 1971, UPTAKE C4 DICARBOXYL; Kentner D, 2006, CURR OPIN MICROBIOL, V9, P619, DOI 10.1016/j.mib.2006.10.012; Kentner D, 2006, MOL MICROBIOL, V61, P407, DOI 10.1111/j.1365-2958.2006.05250.x; Kneuper H, 2005, J BIOL CHEM, V280, P20596, DOI 10.1074/jbc.M502015200; Kramer J, 2007, J BACTERIOL, V189, P4290, DOI 10.1128/JB.00168-07; Laloux G, 2014, J CELL SCI, V127, P11, DOI 10.1242/jcs.138628; Lam H, 2003, DEV CELL, V5, P149, DOI 10.1016/S1534-5807(03)00191-6; Lenarcic R, 2009, EMBO J, V28, P2272, DOI 10.1038/emboj.2009.129; Lenn T, 2008, BIOCHEM SOC T, V36, P1032, DOI 10.1042/BST0361032; MADDOCK JR, 1993, SCIENCE, V259, P1717; Maier KS, 2008, MOL MICROBIOL, V68, P1471, DOI 10.1111/j.1365-2958.2008.06246.x; Matsumoto K, 2001, MOL MICROBIOL, V39, P1427, DOI 10.1046/j.1365-2958.2001.02320.x; Matsumoto K, 2006, MOL MICROBIOL, V61, P1110, DOI 10.1111/j.1365-2958.2006.05317.x; Mauriello EMF, 2010, EMBO J, V29, P315, DOI 10.1038/emboj.2009.356; Meile JC, 2006, PROTEOMICS, V6, P2135, DOI 10.1002/pmic.200500512; Meyer FM, 2011, METAB ENG, V13, P18, DOI 10.1016/j.ymben.2010.10.001; Mileykovskaya E, 2000, J BACTERIOL, V182, P1172, DOI 10.1128/JB.182.4.1172-1175.2000; Moraes TF, 2012, BBA-BIOMEMBRANES, V1818, P2687, DOI 10.1016/j.bbamem.2012.06.007; MOWBRAY J, 1976, EUR J BIOCHEM, V66, P25, DOI 10.1111/j.1432-1033.1976.tb10421.x; Neiditch MB, 2006, CELL, V126, P1095, DOI 10.1016/j.cell.2006.07.032; Nilsen T, 2005, J BACTERIOL, V187, P6187, DOI 10.1128/JB.187.17.6187-6196.2005; Paul R, 2008, CELL, V133, P452, DOI 10.1016/j.cell.2008.02.045; Philippe N, 2004, PLASMID, V51, P246, DOI 10.1016/j.plasmid.2004.02.003; Ramamurthi KS, 2009, P NATL ACAD SCI USA, V106, P13541, DOI 10.1073/pnas.0906851106; Romantsov T, 2008, J BIOL CHEM, V283, P12314, DOI 10.1074/jbc.M709871200; Romantsov T, 2007, MOL MICROBIOL, V64, P1455, DOI 10.1111/j.1365-2958.2007.05727.x; Romantsov T, 2010, J BACTERIOL, V192, P912, DOI 10.1128/JB.00967-09; Rudner DZ, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000307; Sambrook J., 2001, MOL CLONING LAB MANU, V3; Scheu PD, 2012, J BACTERIOL, V194, P636, DOI 10.1128/JB.06345-11; Scheu P, 2008, MICROBIOL-SGM, V154, P2463, DOI 10.1099/mic.0.2008/018614-0; Scheu PD, 2010, FUTURE MICROBIOL, V5, P1383, DOI 10.2217/FMB.10.103; Scheu PD, 2010, J BACTERIOL, V192, P3474, DOI 10.1128/JB.00082-10; Schulmeister S, 2008, P NATL ACAD SCI USA, V105, P6403, DOI 10.1073/pnas.0710611105; Sciara MI, 2008, MOL MICROBIOL, V70, P479, DOI 10.1111/j.1365-2958.2008.06427.x; Shapiro L, 2002, SCIENCE, V298, P1942, DOI 10.1126/science.1072163; Shapiro L, 2009, SCIENCE, V326, P1225, DOI 10.1126/science.1175685; Shiomi D, 2006, MOL MICROBIOL, V60, P894, DOI 10.1111/j.1365-2958.2006.05145.x; Silhavy T.J., 1984, EXPT GENE FUSIONS; Sommer E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077708; Soufo HJD, 2005, BMC CELL BIOL, V6, DOI 10.1186/1471-2121-6-10; Sourjik V, 2000, MOL MICROBIOL, V37, P740, DOI 10.1046/j.1365-2958.2000.02044.x; Sousa PMF, 2011, BIOCHIMIE, V93, P418, DOI 10.1016/j.biochi.2010.10.014; Steinmetz PA, 2014, MOL MICROBIOL, V94, P218, DOI 10.1111/mmi.12759; Tadesse S, 2006, J BACTERIOL, V188, P3002, DOI 10.1128/JB.188.8.3002-3011.2006; Tan BK, 2012, P NATL ACAD SCI USA, V109, P16504, DOI 10.1073/pnas.1212797109; Tetsch L, 2008, MOL MICROBIOL, V67, P570, DOI 10.1111/j.1365-2958.2007.06070.x; Thiem S, 2008, MOL MICROBIOL, V68, P1228, DOI 10.1111/j.1365-2958.2008.06227.x; WEISS RL, 1976, J BACTERIOL, V128, P668, DOI 10.1128/JB.128.2.668-670.1976; Witan J, 2012, BIOL CHEM, V393, P1291, DOI 10.1515/hsz-2012-0229; Witan J, 2012, MOL MICROBIOL, V85, P846, DOI 10.1111/j.1365-2958.2012.08143.x; Wittig I, 2009, BBA-BIOENERGETICS, V1787, P672, DOI 10.1016/j.bbabio.2008.12.016; Zientz E, 1998, J BACTERIOL, V180, P5421, DOI 10.1128/JB.180.20.5421-5425.1998	72	10	10	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2014	9	12							e115534	10.1371/journal.pone.0115534	http://dx.doi.org/10.1371/journal.pone.0115534			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX6YH	25549248	Green Published, Green Submitted, gold			2022-12-27	WOS:000347063500015
J	Blighe, K; Kenny, L; Patel, N; Guttery, DS; Page, K; Gronau, JH; Golshani, C; Stebbing, J; Coombes, RC; Shaw, JA				Blighe, Kevin; Kenny, Laura; Patel, Naina; Guttery, David S.; Page, Karen; Gronau, Julian H.; Golshani, Cyrus; Stebbing, Justin; Coombes, R. Charles; Shaw, Jacqueline A.			Whole Genome Sequence Analysis Suggests Intratumoral Heterogeneity in Dissemination of Breast Cancer to Lymph Nodes	PLOS ONE			English	Article							CHROMOSOMAL INSTABILITY; GENE-EXPRESSION; CLINICAL-IMPLICATIONS; CLONAL EVOLUTION; TP53 MUTATIONS; OVEREXPRESSION; METASTASIS; CARCINOMAS; REVEALS; DISEASE	Background: Intratumoral heterogeneity may help drive resistance to targeted therapies in cancer. In breast cancer, the presence of nodal metastases is a key indicator of poorer overall survival. The aim of this study was to identify somatic genetic alterations in early dissemination of breast cancer by whole genome next generation sequencing (NGS) of a primary breast tumor, a matched locally-involved axillary lymph node and healthy normal DNA from blood. Methods: Whole genome NGS was performed on 12 mg (range 11.1-13.3 mg) of DNA isolated from fresh-frozen primary breast tumor, axillary lymph node and peripheral blood following the DNA nanoball sequencing protocol. Single nucleotide variants, insertions, deletions, and substitutions were identified through a bioinformatic pipeline and compared to CIN25, a key set of genes associated with tumor metastasis. Results: Whole genome sequencing revealed overlapping variants between the tumor and node, but also variants that were unique to each. Novel mutations unique to the node included those found in two CIN25 targets, TGIF2 and CCNB2, which are related to transcription cyclin activity and chromosomal stability, respectively, and a unique frameshift in PDS5B, which is required for accurate sister chromatid segregation during cell division. We also identified dominant clonal variants that progressed from tumor to node, including SNVs in TP53 and ARAP3, which mediates rearrangements to the cytoskeleton and cell shape, and an insertion in TOP2A, the expression of which is significantly associated with tumor proliferation and can segregate breast cancers by outcome. Conclusion: This case study provides preliminary evidence that primary tumor and early nodal metastasis have largely overlapping somatic genetic alterations. There were very few mutations unique to the involved node. However, significant conclusions regarding early dissemination needs analysis of a larger number of patient samples.	[Blighe, Kevin; Guttery, David S.; Page, Karen; Shaw, Jacqueline A.] Leicester Royal Infirm, Dept Canc Studies & Mol Med, Leicester LE2 7LX, Leics, England; [Kenny, Laura; Patel, Naina; Gronau, Julian H.; Golshani, Cyrus; Stebbing, Justin; Coombes, R. Charles] Univ London Imperial Coll Sci Technol & Med, Div Canc, London W12 0NN, England	University of Leicester; Imperial College London	Shaw, JA (corresponding author), Leicester Royal Infirm, Dept Canc Studies & Mol Med, Robert Kilpatrick Clin Sci Bldg, Leicester LE2 7LX, Leics, England.	js39@leicester.ac.uk		Coombes, Raoul Charles/0000-0002-4811-1100; Blighe, Kevin/0000-0002-6322-6571; Page, Karen/0000-0003-0440-9244; Stebbing, Justin/0000-0002-1117-6947; Guttery, David/0000-0003-0418-580X; Shaw, Jacqui/0000-0003-4227-503X	Complete Genomics, Incorporated; Imperial EXperimental Cancer Medicine Centre (ECMC); Imperial Cancer Research UK (CRUK) Centre; National Institute for Health Research (NIHR) Biomedical Research Centre based at Imperial College Healthcare NHS Trust and Imperial College London; CRUK; NIHR [09/009]; Cancer Research UK [14549, 13462] Funding Source: researchfish; National Institute for Health Research [NIHR-RP-011-053] Funding Source: researchfish	Complete Genomics, Incorporated; Imperial EXperimental Cancer Medicine Centre (ECMC); Imperial Cancer Research UK (CRUK) Centre; National Institute for Health Research (NIHR) Biomedical Research Centre based at Imperial College Healthcare NHS Trust and Imperial College London; CRUK(Cancer Research UK); NIHR(National Institute for Health Research (NIHR)); Cancer Research UK(Cancer Research UK); National Institute for Health Research(National Institute for Health Research (NIHR))	This study was supported by a grant from Complete Genomics, Incorporated. The research undertaken was additionally supported by the Imperial EXperimental Cancer Medicine Centre (ECMC), Imperial Cancer Research UK (CRUK) Centre, and the National Institute for Health Research (NIHR) Biomedical Research Centre based at Imperial College Healthcare NHS Trust and Imperial College London. KP and DSG are funded by a programme grant award from CRUK to JS and RCC. KB was funded by CRUK while in Leicester. LK is funded by an NIHR Clinician Scientist grant (09/009). Tissue samples were provided by the Imperial College Healthcare NHS Trust Tissue Bank. Other investigators may have received samples from these same tissues. The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR or the Department of Health.	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Baird RD, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-151; BLANCO L, 1989, J BIOL CHEM, V264, P8935; Brown T.A., 2002, GENOMES, V2nd; Burrell RA, 2013, NATURE, V501, P338, DOI 10.1038/nature12625; Campbell N, 2004, NAT REV GENET, V5, P87, DOI [10.1038/NRG1288, DOI 10.1038/NRG1288]; Carnevali P, 2012, J COMPUT BIOL, V19, P279, DOI 10.1089/cmb.2011.0201; Carter SL, 2006, NAT GENET, V38, P1043, DOI 10.1038/ng1861; Curtis C, 2012, NATURE, V486, P346, DOI 10.1038/nature10983; Denes V, 2010, ONCOGENE, V29, P3446, DOI 10.1038/onc.2010.100; Drmanac R, 2010, SCIENCE, V327, P78, DOI 10.1126/science.1181498; Forbes S. A., 2001, CURRENT PROTOCOLS HU; Gardberg M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074923; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; Geyer FC, 2010, J PATHOL, V220, P562, DOI 10.1002/path.2675; Gilbert S.F., 2000, DEV BIOL; Greaves M, 2012, NATURE, V481, P306, DOI 10.1038/nature10762; Heng HH, 2013, CANCER METAST REV, V32, P325, DOI 10.1007/s10555-013-9427-7; Imoto I, 2000, BIOCHEM BIOPH RES CO, V276, P264, DOI 10.1006/bbrc.2000.3449; Jatoi I, 1999, J CLIN ONCOL, V17, P2334, DOI 10.1200/JCO.1999.17.8.2334; Jechlinger W, 2005, J BIOTECHNOL, V116, P11, DOI 10.1016/j.jbiotec.2004.10.002; Kamihara J, 2014, HUM MUTAT, V35, P654, DOI 10.1002/humu.22559; Kim MS, 2013, HUM PATHOL, V44, P2234, DOI 10.1016/j.humpath.2013.04.017; KIRICUTA IC, 1994, INT J RADIAT ONCOL, V28, P387, DOI 10.1016/0360-3016(94)90062-0; Kwei KA, 2010, MOL ONCOL, V4, P255, DOI 10.1016/j.molonc.2010.04.001; Lee AJX, 2011, CANCER RES, V71, P1858, DOI 10.1158/0008-5472.CAN-10-3604; Martinez-Ramos D, 2009, WORLD J SURG, V33, P1659, DOI 10.1007/s00268-009-0078-3; McGranahan N, 2012, EMBO REP, V13, P528, DOI 10.1038/embor.2012.61; Melhuish TA, 2001, J BIOL CHEM, V276, P32109, DOI 10.1074/jbc.M103377200; NOWELL PC, 1976, SCIENCE, V194, P23, DOI 10.1126/science.959840; Petitjean A, 2007, ONCOGENE, V26, P2157, DOI 10.1038/sj.onc.1210302; Querzoli P, 2006, CLIN CANCER RES, V12, P6696, DOI 10.1158/1078-0432.CCR-06-0569; Rajagopalan H, 2004, NATURE, V428, P77, DOI 10.1038/nature02313; Sarafan-Vasseur N, 2002, ONCOGENE, V21, P2051, DOI 10.1038/sj.onc.1205257; Shaw J, 2011, GENOME RES; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Stephens PJ, 2009, NATURE, V462, P1005, DOI 10.1038/nature08645; Suzuki M, 2008, FUTURE ONCOL, V4, P775, DOI 10.2217/14796694.4.6.775; Szasz AM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056707; Theuns J, 2006, AM J HUM GENET, V78, P936, DOI 10.1086/504044; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Yagi R, 2011, ONCOGENE, V30, P1413, DOI 10.1038/onc.2010.522	43	15	15	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2014	9	12							e115346	10.1371/journal.pone.0115346	http://dx.doi.org/10.1371/journal.pone.0115346			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UN	25546409	Green Published, gold, Green Submitted			2022-12-27	WOS:000347120200039
J	English, S; Pen, I; Shea, N; Uller, T				English, Sinead; Pen, Ido; Shea, Nicholas; Uller, Tobias			The Information Value of Non-Genetic Inheritance in Plants and Animals	PLOS ONE			English	Article							TRANSGENERATIONAL EPIGENETIC INHERITANCE; LOCUST PHASE POLYPHENISM; EVOLUTIONARY CONSEQUENCES; DEVELOPMENTAL PLASTICITY; SCHISTOCERCA-GREGARIA; NATURAL-SELECTION; DESERT LOCUST; ADAPTATION; MECHANISMS; CONFLICT	Parents influence the development of their offspring in many ways beyond the transmission of DNA. This includes transfer of epigenetic states, nutrients, antibodies and hormones, and behavioural interactions after birth. While the evolutionary consequences of such non-genetic inheritance are increasingly well understood, less is known about how inheritance mechanisms evolve. Here, we present a simple but versatile model to explore the adaptive evolution of non-genetic inheritance. Our model is based on a switch mechanism that produces alternative phenotypes in response to different inputs, including genes and non-genetic factors transmitted from parents and the environment experienced during development. This framework shows how genetic and non-genetic inheritance mechanisms and environmental conditions can act as cues by carrying correlational information about future selective conditions. Differential use of these cues is manifested as different degrees of genetic, parental or environmental morph determination. We use this framework to evaluate the conditions favouring non-genetic inheritance, as opposed to genetic determination of phenotype or within-generation plasticity, by applying it to two putative examples of adaptive non-genetic inheritance: maternal effects on seed germination in plants and transgenerational phase shift in desert locusts. Our simulation models show how the adaptive value of non-genetic inheritance depends on its mechanism, the pace of environmental change, and life history characteristics.	[English, Sinead; Uller, Tobias] Univ Oxford, Dept Zool, Edward Grey Inst, S Parks Rd, Oxford OX1 3PS, England; [Pen, Ido] Univ Groningen, Theoret Biol Grp, Ctr Ecol & Evolutionary Studies, Groningen, Netherlands; [Shea, Nicholas] Kings Coll London, Dept Philosophy, London, England; [Uller, Tobias] Lund Univ, Dept Biol, Lund, Sweden	University of Oxford; University of Groningen; University of London; King's College London; Lund University	Uller, T (corresponding author), Univ Oxford, Dept Zool, Edward Grey Inst, S Parks Rd, Oxford OX1 3PS, England.	tobias.uller@zoo.ox.ac.uk	English, Sinead/N-6348-2014	English, Sinead/0000-0003-2898-2301; Novoplansky, Ariel/0000-0003-0988-786X	European Union [259679]; Leverhulme Trust; Royal Society of London; Knut and Alice Wallenberg Foundations	European Union(European Commission); Leverhulme Trust(Leverhulme Trust); Royal Society of London(Royal Society of London); Knut and Alice Wallenberg Foundations(Knut & Alice Wallenberg Foundation)	This research was funded by the European Union's Seventh Framework Programme (FP7/20072011) under grant agreement no 259679 (project IDEAL), and the Leverhulme Trust (both to TU). TU is supported by the Royal Society of London and the Knut and Alice Wallenberg Foundations. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alpert P, 2002, EVOL ECOL, V16, P285, DOI 10.1023/A:1019684612767; [Anonymous], 1988, AM ANTHROPOL; Badyaev AV, 2009, PHILOS T R SOC B, V364, P1169, DOI 10.1098/rstb.2008.0302; Bergstrom CT, 2011, BIOL PHILOS, V26, P159, DOI 10.1007/s10539-009-9180-z; Boerjan B, 2011, GEN COMP ENDOCR, V173, P120, DOI 10.1016/j.ygcen.2011.05.003; Boyd R., 1985, CULTURE EVOLUTIONARY; Burgess SC, 2014, OIKOS, V123, P769, DOI 10.1111/oik.01235; Cavalli-Sforza LL., 1981, CULTURAL TRANSMISSIO; Cheverud James M., 2009, P11; Crean AJ, 2013, ECOLOGY, V94, P2575, DOI 10.1890/13-0184.1; Curley JP, 2011, HORM BEHAV, V59, P306, DOI 10.1016/j.yhbeh.2010.06.018; Danchin E, 2013, TRENDS ECOL EVOL, V28, P351, DOI 10.1016/j.tree.2013.02.010; Danchin E, 2011, NAT REV GENET, V12, P475, DOI 10.1038/nrg3028; Daxinger L, 2012, NAT REV GENET, V13, P153, DOI 10.1038/nrg3188; Day T, 2011, AM NAT, V178, pE18, DOI 10.1086/660911; Donohue K, 1998, MATERNAL EFFECTS AS ADAPTATIONS, P137; Donohue K, 2009, PHILOS T R SOC B, V364, P1059, DOI 10.1098/rstb.2008.0291; Furrow RE, 2014, EVOLUTION, V68, P673, DOI 10.1111/evo.12225; Galef BG, 2005, BIOSCIENCE, V55, P489, DOI 10.1641/0006-3568(2005)055[0489:SLIAES]2.0.CO;2; Galloway LF, 2007, SCIENCE, V318, P1134, DOI 10.1126/science.1148766; Galloway LF, 2005, NEW PHYTOL, V166, P93, DOI 10.1111/j.1469-8137.2004.01314.x; Geoghegan JL, 2013, THEOR POPUL BIOL, V88, P1, DOI 10.1016/j.tpb.2013.05.001; Herman JJ, 2011, FRONT PLANT SCI, V2, DOI 10.3389/fpls.2011.00102; Hinde CA, 2009, P ROY SOC B-BIOL SCI, V276, P2787, DOI 10.1098/rspb.2009.0375; Huestis DL, 2006, OECOLOGIA, V146, P513, DOI 10.1007/s00442-005-0232-z; Jablonka E, 2002, PHILOS SCI, V69, P578, DOI 10.1086/344621; Jablonka E, 2014, LIFE MIND-PHILOS ISS, P1; Jablonka E, 1995, PHILOS T R SOC B, V350, P133, DOI 10.1098/rstb.1995.0147; Jablonka E., 2005, EVOLUTION 4 DIMENSIO; Jablonka E, 2013, PROG BIOPHYS MOL BIO, V111, P99, DOI 10.1016/j.pbiomolbio.2012.08.014; Jablonka E, 2009, Q REV BIOL, V84, P131, DOI 10.1086/598822; Jacobs BS, 2012, FUNCT ECOL, V26, P588, DOI 10.1111/j.1365-2435.2012.01964.x; KIMURA M, 1961, GENET RES, V2, P127, DOI 10.1017/S0016672300000616; Kuijper B, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003550; LACEY EP, 1991, UNITY OF EVOLUTIONARY BIOLOGY, VOLS 1 AND 2, P735; Laland KN, 1996, J EVOLUTION BIOL, V9, P293, DOI 10.1046/j.1420-9101.1996.9030293.x; Leimar O, 2006, AM NAT, V167, P367, DOI 10.1086/499566; Leimar O, 2009, EVOL ECOL, V23, P125, DOI 10.1007/s10682-007-9194-4; LEVINS RICHARD, 1968; Lim JP, 2013, TRENDS GENET, V29, P176, DOI 10.1016/j.tig.2012.12.008; Lind MI, 2007, J EVOLUTION BIOL, V20, P1288, DOI 10.1111/j.1420-9101.2007.01353.x; Lock JE, 2007, AM NAT, V170, P709, DOI 10.1086/521963; Marshall DJ, 2008, ECOLOGY, V89, P418, DOI 10.1890/07-0449.1; Marshall DJ, 2007, OIKOS, V116, P1957, DOI 10.1111/j.2007.0030-1299.16203.x; McElreath R, 2008, CURR ANTHROPOL, V49, P307, DOI 10.1086/524364; McIntyre PJ, 2014, EVOL ECOL, V28, P229, DOI 10.1007/s10682-013-9670-y; Miller GA, 2008, J EXP BIOL, V211, P370, DOI 10.1242/jeb.013458; MORAN NA, 1992, AM NAT, V139, P971, DOI 10.1086/285369; Morgan HD, 1999, NAT GENET, V23, P314, DOI 10.1038/15490; Mousseau T.A., 1998, MATERNAL EFFECTS ADA; MOUSSEAU TA, 1991, ANNU REV ENTOMOL, V36, P511, DOI 10.1146/annurev.en.36.010191.002455; Mousseau TA, 1998, TRENDS ECOL EVOL, V13, P403, DOI 10.1016/S0169-5347(98)01472-4; Muller W, 2007, AM NAT, V169, pE84, DOI 10.1086/511962; Odling-Smee J, 2010, NICHE INHERITANCE, P175; Parker GA, 2002, PHILOS T R SOC B, V357, P295, DOI 10.1098/rstb.2001.0950; Pener MP, 2009, ADV INSECT PHYSIOL, V36, P1, DOI 10.1016/S0065-2806(08)36001-9; PLATENKAMP GAJ, 1993, EVOLUTION, V47, P540, DOI 10.1111/j.1558-5646.1993.tb02112.x; Revardel E, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-217; Richerson PJ., 2005, NOT GENES ALONE CULT; ROACH DA, 1987, ANNU REV ECOL SYST, V18, P209, DOI 10.1146/annurev.ecolsys.18.1.209; Rossiter MC, 1996, ANNU REV ECOL SYST, V27, P451, DOI 10.1146/annurev.ecolsys.27.1.451; Scharf I, 2010, CLIM RES, V43, P115, DOI 10.3354/cr00907; Shannon C. E., 1949, MATH THEORY COMMUNIC; Shea N, 2011, J EVOLUTION BIOL, V24, P1178, DOI 10.1111/j.1420-9101.2011.02235.x; Simpson S. J., 2009, Phenotypic plasticity of insects: mechanisms and consequences, P147; Simpson SJ, 1999, BIOL REV, V74, P461, DOI 10.1017/S000632319900540X; Simpson SJ, 2008, CURR BIOL, V18, pR364, DOI 10.1016/j.cub.2008.02.029; Simpson SJ, 2007, J INSECT PHYSIOL, V53, P869, DOI 10.1016/j.jinsphys.2007.05.011; Slagsvold T, 2011, PHILOS T R SOC B, V366, P969, DOI 10.1098/rstb.2010.0343; Stein LR, 2014, ANIM BEHAV, V95, P165, DOI 10.1016/j.anbehav.2014.07.010; Takahasi K, 1999, THEOR POPUL BIOL, V55, P208, DOI 10.1006/tpbi.1998.1400; Thornton A, 2006, SCIENCE, V313, P227, DOI 10.1126/science.1128727; Topaz CM, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002642; Uller T, 2013, J EVOLUTION BIOL, V26, P2161, DOI 10.1111/jeb.12212; Uller T, CHALLENGES EVOLUTION; Uller T, 2014, TRANSGENERATIONAL EP, P175; Uller T, 2008, TRENDS ECOL EVOL, V23, P432, DOI 10.1016/j.tree.2008.04.005; Uller T, 2012, EVOLUTION OF PARENTAL CARE, P247; Uller T, 2011, EVOLUTION, V65, P2075, DOI 10.1111/j.1558-5646.2011.01282.x; Ventura AK, 2013, CURR BIOL, V23, pR401, DOI 10.1016/j.cub.2013.02.037; West-Eberhard Mary Jane, 2003, pi; Wolf JB, 2009, PHILOS T R SOC B, V364, P1107, DOI 10.1098/rstb.2008.0238; Zajitschek S, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.0422	83	61	62	0	95	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2015	10	1							e0116996	10.1371/journal.pone.0116996	http://dx.doi.org/10.1371/journal.pone.0116996			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ4OZ	25603120	Green Submitted, Green Published, gold			2022-12-27	WOS:000348203500040
J	Xu, SZ; Li, DZ; Li, JW; Xiang, XG; Jin, WT; Huang, WC; Jin, XH; Huang, LQ				Xu, Songzhi; Li, Dezhu; Li, Jianwu; Xiang, Xiaoguo; Jin, Weitao; Huang, Weichang; Jin, Xiaohua; Huang, Luqi			Evaluation of the DNA Barcodes in Dendrobium (Orchidaceae) from Mainland Asia	PLOS ONE			English	Article							INTERNAL TRANSCRIBED SPACER; PHYLOGENETIC ANALYSIS; SYSTEMATICS; IDENTIFICATION; DISCRIMINATE; SEQUENCES; TAXONOMY; RATES; MATK; LOCI	DNA barcoding has been proposed to be one of the most promising tools for accurate and rapid identification of taxa. However, few publications have evaluated the efficiency of DNA barcoding for the large genera of flowering plants. Dendrobium, one of the largest genera of flowering plants, contains many species that are important in horticulture, medicine and biodiversity conservation. Besides, Dendrobium is a notoriously difficult group to identify. DNA barcoding was expected to be a supplementary means for species identification, conservation and future studies in Dendrobium. We assessed the power of 11 candidate barcodes on the basis of 1,698 accessions of 184 Dendrobium species obtained primarily from mainland Asia. Our results indicated that five single barcodes, i.e., ITS, ITS2, matK, rbcL and trnH-psbA, can be easily amplified and sequenced with the currently established primers. Four barcodes, ITS, ITS2, ITS+matK, and ITS2+matK, have distinct barcoding gaps. ITS+matK was the optimal barcode based on all evaluation methods. Furthermore, the efficiency of ITS+matK was verified in four other large genera including Ficus, Lysimachia, Paphiopedilum, and Pedicularis in this study. Therefore, we tentatively recommend the combination of ITS+ matK as a core DNA barcode for large flowering plant genera.	[Xu, Songzhi; Xiang, Xiaoguo; Jin, Weitao; Jin, Xiaohua] Chinese Acad Sci, Inst Bot, State Key Lab Systemat & Evolutionary Bot, Beijing 100093, Peoples R China; [Li, Dezhu] Chinese Acad Sci, Kunming Inst Bot, Key Lab Plant Div & Biogeog East Asia, Kunming 650201, Yunnan, Peoples R China; [Li, Jianwu] Chinese Acad Sci, Xishuangbanna Trop Bot Garden, Menglun Township 666303, Yunnan, Peoples R China; [Huang, Weichang] Shanghai Chenshan Bot Garden, Shanghai 201602, Peoples R China; [Huang, Luqi] China Acad Chinese Med Sci, Natl Resource Ctr Chinese Mat Med, Beijing 100700, Peoples R China	Chinese Academy of Sciences; Institute of Botany, CAS; Chinese Academy of Sciences; Kunming Institute of Botany, CAS; Chinese Academy of Sciences; Xishuangbanna Tropical Botanical Garden, CAS; Chinese Academy of Sciences; China Academy of Chinese Medical Sciences; National Resource Center for Chinese Materia Medica, CACMS	Jin, XH (corresponding author), Chinese Acad Sci, Inst Bot, State Key Lab Systemat & Evolutionary Bot, Beijing 100093, Peoples R China.	xiaohuajin@ibcas.ac.cn; huangluqi01@126.com	Li, De-Zhu/G-8203-2011	Li, De-Zhu/0000-0002-4990-724X	National Natural Science Foundation of China [31107176, 31470299, J1310002]; Chinese Special Fund for Medicine Research in the Public Interest [201407003]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Special Fund for Medicine Research in the Public Interest	The work was supported by the National Natural Science Foundation of China (31107176, 31470299, J1310002) and the Chinese Special Fund for Medicine Research in the Public Interest (201407003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PB, 2011, BOT J LINN SOC, V166, P105, DOI 10.1111/j.1095-8339.2011.01141.x; Asahina H, 2010, J NAT MED-TOKYO, V64, P133, DOI 10.1007/s11418-009-0379-8; Ashfaq M, 2013, MOL ECOL RESOUR, V13, P573, DOI 10.1111/1755-0998.12089; Awano T, 2009, P NATL ACAD SCI USA, V106, P2794, DOI [10.1073/pnas.0905845106, 10.1073/pnas.0812297106]; Burke JM, 2008, AUST SYST BOT, V21, P1, DOI 10.1071/SB07038; Chase MW, 2007, TAXON, V56, P295, DOI 10.1002/tax.562004; Chen SL, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0008613, 10.1371/journal.pone.0015633]; Clements M. A., 2003, Telopea, V10, P247; Cribb P., 2005, Proceedings of the 18th World Orchid Conference, Dijon, France, 11-20 March, 2005, P161; Cuenoud P, 2002, AM J BOT, V89, P132, DOI 10.3732/ajb.89.1.132; De Bodt S, 2005, TRENDS ECOL EVOL, V20, P591, DOI 10.1016/j.tree.2005.07.008; Doyle J. J., 1987, PHYTOCHEM B, P11; Farrington L, 2009, AUST J BOT, V57, P276, DOI 10.1071/BT08138; Fazekas AJ, 2009, MOL ECOL RESOUR, V9, P130, DOI 10.1111/j.1755-0998.2009.02652.x; FELSENSTEIN J, 1988, ANNU REV GENET, V22, P521, DOI 10.1146/annurev.ge.22.120188.002513; Ford CS, 2009, BOT J LINN SOC, V159, P1, DOI 10.1111/j.1095-8339.2008.00938.x; Goldman DH, 2001, SYST BOT, V26, P670; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hollingsworth PM, 2011, P NATL ACAD SCI USA, V108, P19451, DOI 10.1073/pnas.1116812108; Hollingsworth PM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019254; HU SY, 1970, ECON BOT, V24, P165, DOI 10.1007/BF02860596; IBM Corp, 2010, IBM SPSS STAT WIND V; Kiebala M, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0011875, 10.1371/journal.pone.0013102]; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kress WJ, 2005, P NATL ACAD SCI USA, V102, P8369, DOI 10.1073/pnas.0503123102; Lahaye R, 2008, P NATL ACAD SCI USA, V105, P2923, DOI 10.1073/pnas.0709936105; Lau DTW, 2001, PLANTA MED, V67, P456, DOI 10.1055/s-2001-15818; Li DZ, 2011, P NATL ACAD SCI USA, V108, P19641, DOI 10.1073/pnas.1104551108; Li HQ, 2012, MOL ECOL RESOUR, V12, P783, DOI 10.1111/j.1755-0998.2012.03147.x; Meier R, 2006, SYST BIOL, V55, P715, DOI 10.1080/10635150600969864; Meyer CP, 2005, PLOS BIOL, V3, P2229, DOI 10.1371/journal.pbio.0030422; Morris MW, 1996, BOT J LINN SOC, V120, P89, DOI 10.1111/j.1095-8339.1996.tb00483.x; Parveen I, 2012, MOL ECOL RESOUR, V12, P82, DOI 10.1111/j.1755-0998.2011.03071.x; Pennisi E, 2007, SCIENCE, V318, P190, DOI 10.1126/science.318.5848.190; Rhymer JM, 1996, ANNU REV ECOL SYST, V27, P83, DOI 10.1146/annurev.ecolsys.27.1.83; RIESEBERG LH, 1993, HYBRID ZONES AND THE EVOLUTIONARY PROCESS, P70; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Rubinoff D, 2006, TRENDS ECOL EVOL, V21, P1, DOI 10.1016/j.tree.2005.10.019; Schuiteman Andre, 2011, Gardens' Bulletin (Singapore), V63, P245; Shaw J, 2005, AM J BOT, V92, P142, DOI 10.3732/ajb.92.1.142; Singh Hemant Kumar, 2012, BMC Res Notes, V5, P42, DOI 10.1186/1756-0500-5-42; State Pharmacopoeia Committee, 2010, PHARMACOPOEIA PEOPLE; SUN Y, 1994, THEOR APPL GENET, V89, P26, DOI 10.1007/BF00226978; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; WOOD HP, 2006, DENDROBIUMS, pR5; Xiang XG, 2013, MOL PHYLOGENET EVOL, V69, P950, DOI 10.1016/j.ympev.2013.06.009; Xiang XG, 2011, MOL ECOL RESOUR, V11, P1012, DOI 10.1111/j.1755-0998.2011.03044.x; XU H, 2005, PLANTA MED, V71, P1; Yang JB, 2012, MOL ECOL RESOUR, V12, P267, DOI 10.1111/j.1755-0998.2011.03095.x; Yao H, 2009, PLANTA MED, V75, P667, DOI 10.1055/s-0029-1185385; Yu WB, 2011, J SYST EVOL, V49, P425, DOI 10.1111/j.1759-6831.2011.00154.x; Yukawa T, 1996, PLANT SYST EVOL, V201, P1, DOI 10.1007/BF00989048; Zhang CY, 2012, MOL ECOL RESOUR, V12, P98, DOI 10.1111/j.1755-0998.2011.03076.x	55	56	68	3	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2015	10	1							e0115168	10.1371/journal.pone.0115168	http://dx.doi.org/10.1371/journal.pone.0115168			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ4OZ	25602282	Green Published, gold, Green Submitted			2022-12-27	WOS:000348203500009
J	Dimitrov, D; Donnell, D; Brown, ER				Dimitrov, Dobromir; Donnell, Deborah; Brown, Elizabeth R.			High Incidence Is Not High Exposure: What Proportion of Prevention Trial Participants Are Exposed to HIV?	PLOS ONE			English	Article							SOUTH-AFRICA; INFECTION; RISK; HETEROGENEITY; TRANSMISSION; METAANALYSIS; ASSOCIATION; PREVALENCE	Objective Randomized clinical trials of HIV prevention in high-risk populations of women often assume that all participants have similar exposure to HIV. However, a substantial fraction of women enrolled in the trial may have no or low exposure to HIV. Our objective was to estimate the proportion of women exposed to HIV throughout a hypothetical high-risk study population. Methods A stochastic individual-based model was developed to simulate the sexual behavior and the risk of HIV acquisition for a cohort of sexually active HIV-uninfected women in high HIV prevalence settings. Key behavior and epidemic assumptions in the model were based on published studies on HIV transmission in South Africa. The prevalence of exposure, defined as the proportion of women who have sex with HIV-infected partner, and HIV incidence were evaluated. Results Our model projects that in communities with HIV incidence rate of 1 per 100 person years, only 5-6% of women are exposed to HIV annually while in communities with an HIV incidence of 5 per 100 person years 20-25% of women are exposed to HIV. Approximately 70% of the new infections are acquired from partners with asymptomatic HIV. Conclusions Mathematical models suggest that a high proportion of women enrolled in HIV prevention trials may be unexposed to HIV even when incidence rates are high. The relationship between HIV exposure and other risk factors should be carefully analyzed when future clinical trials are planned.	[Dimitrov, Dobromir; Donnell, Deborah; Brown, Elizabeth R.] Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Div, Seattle, WA 98104 USA; [Dimitrov, Dobromir; Donnell, Deborah; Brown, Elizabeth R.] Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, Seattle, WA 98104 USA; [Dimitrov, Dobromir] Univ Washington, Dept Appl Math, Seattle, WA 98195 USA; [Donnell, Deborah] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA; [Brown, Elizabeth R.] Univ Washington, Dept Biostat, Seattle, WA 98195 USA	Fred Hutchinson Cancer Center; Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Dimitrov, D (corresponding author), Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Div, 1124 Columbia St, Seattle, WA 98104 USA.	dobromir@scharp.org		Donnell, Deborah/0000-0002-0587-7480	National Institute of Allergy and Infectious Diseases of the National Institutes of Health [UM1 AI068617, UM1 AI068615]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI068615, UM1AI068617, UM1AI068615, U01AI068617] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Research reported in this publication was supported by the National Institute of Allergy and Infectious Diseases of the National Institutes of Health under Award Number UM1 AI068617 (D. Donnell) and UM1 AI068615 (D. Dimitrov and E. R. Brown). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AALEN OO, 1988, STAT MED, V7, P1121, DOI 10.1002/sim.4780071105; Auvert B, 2011, CLIN TRIALS, V8, P144, DOI 10.1177/1740774511398923; Baggaley RF, 2010, INT J EPIDEMIOL, V39, P1048, DOI 10.1093/ije/dyq057; Boily MC, 2009, LANCET INFECT DIS, V9, P118, DOI 10.1016/S1473-3099(09)70021-0; Centers for Disease Control and Prevention, 2011, CDC TRIAL AN MAJ STU; Dunkle KL, 2004, SOC SCI MED, V59, P1581, DOI 10.1016/j.socscimed.2004.02.003; Foss AM, 2007, SEX TRANSM INFECT, V83, P510, DOI 10.1136/sti.2007.027144; Hollingsworth TD, 2008, J INFECT DIS, V198, P687, DOI 10.1086/590501; Jeanne Marrazzo GR, 2013, C RETR OPP INF ATL G; Jewkes R, 2001, SOC SCI MED, V52, P733, DOI 10.1016/S0277-9536(00)00177-5; Johnson LF, 2009, DEMOGR RES, V21, P289, DOI 10.4054/DemRes.2009.21.11; Kalichman SC, 2009, SEX TRANSM INFECT, V85, P411, DOI 10.1136/sti.2008.035287; Karim QA, 2010, SCIENCE, V329, P1168, DOI 10.1126/science.1193748; Lingappa JR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001411; Shisana O, 2009, S AFRICAN NATL HIV P	15	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2015	10	1							e0115528	10.1371/journal.pone.0115528	http://dx.doi.org/10.1371/journal.pone.0115528			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ4BT	25569838	Green Published, Green Submitted, gold			2022-12-27	WOS:000348168000002
J	Peng, SW; Wang, JW; Karanam, B; Wang, CG; Huh, WK; Alvarez, RD; Pai, SI; Hung, CF; Wu, TC; Roden, RBS				Peng, Shiwen; Wang, Joshua W.; Karanam, Balasubramanyam; Wang, Chenguang; Huh, Warner K.; Alvarez, Ronald D.; Pai, Sara I.; Hung, Chien-fu; Wu, T. -C.; Roden, Richard B. S.			Sequential Cisplatin Therapy and Vaccination with HPV16 E6E7L2 Fusion Protein in Saponin Adjuvant GPI-0100 for the Treatment of a Model HPV16+Cancer	PLOS ONE			English	Article							VULVAL INTRAEPITHELIAL NEOPLASIA; PHASE-II TRIAL; HUMAN-PAPILLOMAVIRUS VACCINES; VIRUS-LIKE PARTICLE; DNA VACCINATION; CERVICAL-CANCER; TA-CIN; MUCOSAL VACCINATION; ANTITUMOR IMMUNITY; HEALTHY-VOLUNTEERS	Clinical studies suggest that responses to HPV16 E6E7L2 fusion protein (TA-CIN) vaccination alone are modest, and GPI-0100 is a well-tolerated, potent adjuvant. Here we sought to optimize both the immunogenicity of TA-CIN via formulation with GPI-0100 and treatment of HPV16+ cancer by vaccination after cisplatin chemotherapy. HPV16 neutralizing serum antibody titers, CD4+ T cell proliferative and E6/E7-specific CD8+ T cell responses were significantly enhanced when mice were vaccinated subcutaneously (s.c.) or intramuscularly (i.m.) with TA-CIN formulated with GPI-0100. Vaccination was tested for therapy of mice bearing syngeneic HPV16 E6/E7+ tumors (TC-1) either in the lung or subcutaneously. Mice treated with TA-CIN/GPI-0100 vaccination exhibited robust E7-specific CD8+ T cell responses, which were associated with reduced tumor burden in the lung, whereas mice receiving either component alone were similar to controls. Since vaccination alone was not sufficient for cure, mice bearing s.c. TC-1 tumor were first treated with two doses of cisplatin and then vaccinated. Vaccination with TA-CIN/GPI-0100 i.m. substantially retarded tumor growth and extended survival after cisplatin therapy. Injection of TA-CIN alone, but not GPI-0100, into the tumor (i.t.) was similarly efficacious after cisplatin therapy, but the mice eventually succumbed. However, tumor regression and extended remission was observed in 80% of the mice treated with cisplatin and then intra-tumoral TA-CIN/GPI-0100 vaccination. These mice also exhibited robust E7-specific CD8+ T cell and HPV16 neutralizing antibody responses. Thus formulation of TA-CIN with GPI-0100 and intra-tumoral delivery after cisplatin treatment elicits potent therapeutic responses in a murine model of HPV16+ cancer.	[Peng, Shiwen; Wang, Joshua W.; Karanam, Balasubramanyam; Hung, Chien-fu; Wu, T. -C.; Roden, Richard B. S.] Johns Hopkins Univ, Dept Pathol, Baltimore, MD 21205 USA; [Wang, Chenguang] Johns Hopkins Univ, Dept Biostat, Baltimore, MD 21205 USA; [Hung, Chien-fu; Wu, T. -C.; Roden, Richard B. S.] Johns Hopkins Univ, Dept Oncol, Baltimore, MD 21205 USA; [Wu, T. -C.; Roden, Richard B. S.] Johns Hopkins Univ, Dept Gynecol & Obstet, Baltimore, MD 21205 USA; [Huh, Warner K.; Alvarez, Ronald D.] Univ Alabama Birmingham, Div Gynecol Oncol, Birmingham, AL USA; [Karanam, Balasubramanyam] Tuskegee Univ, Carver Res Fdn, Dept Biol, Tuskegee, AL 36088 USA; [Karanam, Balasubramanyam] Tuskegee Univ, Carver Res Fdn, Ctr Canc Res, Tuskegee, AL 36088 USA; [Pai, Sara I.] Massachusetts Gen Hosp, Dept Surg, Boston, MA 02114 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; University of Alabama System; University of Alabama Birmingham; Tuskegee University; Tuskegee University; Harvard University; Massachusetts General Hospital	Roden, RBS (corresponding author), Johns Hopkins Univ, Dept Pathol, Baltimore, MD 21205 USA.	roden@jhmi.edu		Pai, Sara/0000-0002-6341-9971	V foundation; Public Health Service [P50 CA098252, RO1 CA133749, CA118790]; NATIONAL CANCER INSTITUTE [P50CA098252, R01CA133749, R01CA118790] Funding Source: NIH RePORTER	V foundation; Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The study was funded by grants from the V foundation (www.jimmyv.org) to SP and RBSR, and Public Health Service (grants.nih.gov) grants P50 CA098252 to TCW, RO1 CA133749 to WKH, and CA118790 to RBSR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amato RJ, 2013, J IMMUNOTHER, V36, P268, DOI 10.1097/CJI.0b013e3182917f59; Armarnik S, 2011, ARCH GYNECOL OBSTET, V283, P765, DOI 10.1007/s00404-011-1848-3; Bae SH, 2007, CLIN CANCER RES, V13, P341, DOI 10.1158/1078-0432.CCR-06-1838; Buck CB, 2004, J VIROL, V78, P751, DOI 10.1128/JVI.78.2.751-757.2004; Cha HR, 2011, J IMMUNOL, V187, P3044, DOI 10.4049/jimmunol.1100402; Cuburu N, 2012, J CLIN INVEST, V122, P4606, DOI 10.1172/JCI63287; Cuburu N, 2011, EXPERT REV VACCINES, V10, P1245, DOI [10.1586/ERV.11.104, 10.1586/erv.11.104]; Daayana S, 2010, BRIT J CANCER, V102, P1129, DOI 10.1038/sj.bjc.6605611; Daling JR, 2004, CANCER-AM CANCER SOC, V101, P270, DOI 10.1002/cncr.20365; Davidson EJ, 2004, VACCINE, V22, P2722, DOI 10.1016/j.vaccine.2004.01.049; de Jong A, 2002, VACCINE, V20, P3456, DOI 10.1016/S0264-410X(02)00350-X; Domingos-Pereira S, 2013, J UROLOGY; Fiander AN, 2006, INT J GYNECOL CANCER, V16, P1075, DOI 10.1111/j.1525-1438.2006.00598.x; Gambhira R, 2007, J VIROL, V81, P13927, DOI 10.1128/JVI.00936-07; Gambhira R, 2006, CANCER RES, V66, P11120, DOI 10.1158/0008-5472.CAN-06-2560; Gordon SN, 2012, J IMMUNOL, V188, P714, DOI 10.4049/jimmunol.1101404; Han RC, 1999, J VIROL, V73, P7039, DOI 10.1128/JVI.73.8.7039-7043.1999; Hildesheim A, 2007, JAMA-J AM MED ASSOC, V298, P743, DOI 10.1001/jama.298.7.743; Hitzeroth II, 2009, VACCINE, V27, P6432, DOI 10.1016/j.vaccine.2009.06.015; Jagu S, 2013, J VIROL, V87, P6127, DOI 10.1128/JVI.03218-12; JARRETT WFH, 1991, VIROLOGY, V184, P33, DOI 10.1016/0042-6822(91)90819-W; Ji HX, 1998, INT J CANCER, V78, P41, DOI 10.1002/(SICI)1097-0215(19980925)78:1<41::AID-IJC8>3.0.CO;2-X; Kang TH, 2013, CANCER RES, V73, P2493, DOI 10.1158/0008-5472.CAN-12-4241; Karanam B, 2009, VACCINE, V27, P1040, DOI 10.1016/j.vaccine.2008.11.099; Kreimer AR, 2005, CANCER EPIDEM BIOMAR, V14, P467, DOI 10.1158/1055-9965.EPI-04-0551; Kwak K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097232; Leder C, 2001, J VIROL, V75, P9201, DOI 10.1128/JVI.75.19.9201-9209.2001; Lee SY, 2013, CANCER IMMUNOL IMMUN, V62, P1175, DOI 10.1007/s00262-013-1421-y; Lin KY, 1996, CANCER RES, V56, P21; Lin Z, 2009, AM J PATHOL, V174, P136, DOI 10.2353/ajpath.2009.080588; Malagon T, 2012, LANCET INFECT DIS, V12, P781, DOI 10.1016/S1473-3099(12)70187-1; Marciani DJ, 2000, VACCINE, V18, P3141, DOI 10.1016/S0264-410X(00)00118-3; Marciani DJ, 2003, VACCINE, V21, P3961, DOI 10.1016/S0264-410X(03)00298-6; Markman M, 2013, ONCOLOGY-BASEL, V84, P246, DOI 10.1159/000346804; Parkin DM, 2006, INT J CANCER, V118, P3030, DOI 10.1002/ijc.21731; Pastrana DV, 2004, VIROLOGY, V321, P205, DOI 10.1016/j.virol.2003.12.027; Quenelle DC, 2006, VACCINE, V24, P1515, DOI 10.1016/j.vaccine.2005.10.017; Roden R, 2006, NAT REV CANCER, V6, P753, DOI 10.1038/nrc1973; Schiller JT, 2012, NAT REV MICROBIOL, V10, P681, DOI 10.1038/nrmicro2872; Slovin SF, 2005, VACCINE, V23, P3114, DOI 10.1016/j.vaccine.2005.01.072; Smith JS, 2009, OBSTET GYNECOL, V113, P917, DOI 10.1097/AOG.0b013e31819bd6e0; Smyth LJC, 2004, CLIN CANCER RES, V10, P2954, DOI 10.1158/1078-0432.CCR-03-0703; Stevceva L, 2004, CURR HIV RES, V2, P1, DOI 10.2174/1570162043485004; TINDLE RW, 1991, P NATL ACAD SCI USA, V88, P5887, DOI 10.1073/pnas.88.13.5887; Tseng CW, 2008, CLIN CANCER RES, V14, P3185, DOI 10.1158/1078-0432.CCR-08-0037; Tseng CW, 2009, CANCER IMMUNOL IMMUN, V58, P737, DOI 10.1007/s00262-008-0596-0; Vambutas A, 2005, VACCINE, V23, P5271, DOI 10.1016/j.vaccine.2005.04.049; van der Burg SH, 2001, VACCINE, V19, P3652, DOI 10.1016/S0264-410X(01)00086-X; van Esch EMG, 2012, EXPERT REV VACCINES, V11, P821, DOI [10.1586/ERV.12.56, 10.1586/erv.12.56]; van Meir H, 2014, ANTI-CANCER AGENT ME, V14, P190; van Poelgeest MIE, 2005, CLIN CANCER RES, V11, P5273, DOI 10.1158/1078-0432.CCR-05-0616; Vinzon SE, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003924; Wallbillich JJ, 2012, GYNECOL ONCOL, V127, P312, DOI 10.1016/j.ygyno.2012.07.118; Winters U, 2008, CLIN CANCER RES, V14, P5292, DOI 10.1158/1078-0432.CCR-07-4760; Wu CY, 2014, CLIN CANCER RES, V20, P644, DOI 10.1158/1078-0432.CCR-13-1334; Ye LL, 2011, NAT BIOTECHNOL, V29, P158, DOI 10.1038/nbt.1742	56	18	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2015	10	1							e116389	10.1371/journal.pone.0116389	http://dx.doi.org/10.1371/journal.pone.0116389			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ3BG	25560237	Green Published, gold, Green Submitted			2022-12-27	WOS:000348102200016
J	Igulu, MM; Nagelkerken, I; Dorenbosch, M; Grol, MGG; Harborne, AR; Kimirei, IA; Mumby, PJ; Olds, AD; Mgaya, YD				Igulu, Mathias M.; Nagelkerken, Ivan; Dorenbosch, Martijn; Grol, Monique G. G.; Harborne, Alastair R.; Kimirei, Ismael A.; Mumby, Peter J.; Olds, Andrew D.; Mgaya, Yunus D.			Mangrove Habitat Use by Juvenile Reef Fish: Meta-Analysis Reveals that Tidal Regime Matters More than Biogeographic Region	PLOS ONE			English	Article							SHALLOW-WATER BIOTOPES; SEAGRASS BEDS; COMMUNITY STRUCTURE; GAZI BAY; REPLANTED MANGROVES; FEEDING HABITATS; NURSERY HABITATS; ISHIGAKI ISLAND; CLIMATE-CHANGE; CARIBBEAN BAY	Identification of critical life-stage habitats is key to successful conservation efforts. Juveniles of some species show great flexibility in habitat use while other species rely heavily on a restricted number of juvenile habitats for protection and food. Considering the rapid degradation of coastal marine habitats worldwide, it is important to evaluate which species are more susceptible to loss of juvenile nursery habitats and how this differs across large biogeographic regions. Here we used a meta-analysis approach to investigate habitat use by juvenile reef fish species in tropical coastal ecosystems across the globe. Densities of juvenile fish species were compared among mangrove, seagrass and coral reef habitats. In the Caribbean, the majority of species showed significantly higher juvenile densities in mangroves as compared to seagrass beds and coral reefs, while for the Indo-Pacific region seagrass beds harbored the highest overall densities. Further analysis indicated that differences in tidal amplitude, irrespective of biogeographic region, appeared to be the major driver for this phenomenon. In addition, juvenile reef fish use of mangroves increased with increasing water salinity. In the Caribbean, species of specific families (e.g. Lutjanidae, Haemulidae) showed a higher reliance on mangroves or seagrass beds as juvenile habitats than other species, whereas in the Indo-Pacific family-specific trends of juvenile habitat utilization were less apparent. The findings of this study highlight the importance of incorporating region-specific tidal inundation regimes into marine spatial conservation planning and ecosystem based management. Furthermore, the significant role of water salinity and tidal access as drivers of mangrove fish habitat use implies that changes in seawater level and rainfall due to climate change may have important effects on how juvenile reef fish use nearshore seascapes in the future.	[Igulu, Mathias M.; Nagelkerken, Ivan; Dorenbosch, Martijn; Grol, Monique G. G.] Radboud Univ Nijmegen, Dept Anim Ecol & Ecophysiol, Inst Water & Wetland Res, NL-6525 ED Nijmegen, Netherlands; [Igulu, Mathias M.] Tanzania Fisheries Res Inst, Dar Es Salaam, Tanzania; [Nagelkerken, Ivan] Univ Adelaide, Sch Biol Sci, Southern Seas Ecol Labs, Adelaide, SA, Australia; [Nagelkerken, Ivan] Univ Adelaide, Inst Environm, Adelaide, SA, Australia; [Harborne, Alastair R.; Mumby, Peter J.] Univ Queensland, Marine Spatial Ecol Lab, Brisbane, Qld, Australia; [Harborne, Alastair R.; Mumby, Peter J.] Univ Queensland, Sch Biol Sci, Ctr Excellence Coral Reef Studies, Australian Res Council, Brisbane, Qld, Australia; [Kimirei, Ismael A.] Tanzania Fisheries Res Inst, Kigoma Ctr, Kigoma, Tanzania; [Olds, Andrew D.] Griffith Univ, Australian Rivers Inst Coast & Estuaries, Gold Coast, Australia; [Olds, Andrew D.] Griffith Univ, Sch Environm, Gold Coast, Australia; [Mgaya, Yunus D.] Univ Dar Es Salaam, Coll Nat & Appl Sci, Dept Aquat Sci & Fisheries, Dar Es Salaam, Tanzania	Radboud University Nijmegen; University of Adelaide; University of Adelaide; University of Queensland; University of Queensland; Griffith University; Griffith University; University of Dar es Salaam	Nagelkerken, I (corresponding author), Radboud Univ Nijmegen, Dept Anim Ecol & Ecophysiol, Inst Water & Wetland Res, NL-6525 ED Nijmegen, Netherlands.	ivan.nagelkerken@adelaide.edu.au	Nagelkerken, Ivan/E-1093-2011; Harborne, Alastair R/F-6155-2013; Mumby, Peter/F-9914-2010; Kimirei, Ismael Aaron/F-7385-2012	Nagelkerken, Ivan/0000-0003-4499-3940; Harborne, Alastair R/0000-0002-6818-8615; Mumby, Peter/0000-0002-6297-9053; Kimirei, Ismael Aaron/0000-0002-1101-5262; Mgaya, Yunus/0000-0002-9592-4913; Olds, Andrew/0000-0002-8027-3599	Vidi grant from the Netherlands Organisation for Scientific Research (NWO); Faculty of Sciences (Radboud University Nijmegen); Australian Research Council [FT120100183]; Australian Coral Reef Society; Australian Department of Climate Change and Energy Efficiency; Queensland Department of Environment and Resource Management; National Science Foundation [OCE-0119976]; National Geographic Society; World Wildlife Fund; DECRA fellowship [DE120102459]	Vidi grant from the Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Faculty of Sciences (Radboud University Nijmegen); Australian Research Council(Australian Research Council); Australian Coral Reef Society; Australian Department of Climate Change and Energy Efficiency(Australian Government); Queensland Department of Environment and Resource Management; National Science Foundation(National Science Foundation (NSF)); National Geographic Society(National Geographic Society); World Wildlife Fund; DECRA fellowship	Collection of data in the Caribbean was supported by a Vidi grant to I. N. from the Netherlands Organisation for Scientific Research (NWO). M. I. was supported by the Faculty of Sciences (Radboud University Nijmegen). I. N. was supported by the Australian Research Council (grant no. FT120100183). Collection of data in the Western Pacific by A. O. was supported by the Australian Research Council, Australian Coral Reef Society, Australian Department of Climate Change and Energy Efficiency and the Queensland Department of Environment and Resource Management. Collection of data in the Caribbean by P. M. and A. H. was supported by grant OCE-0119976 from the National Science Foundation and grants from the National Geographic Society and World Wildlife Fund. A. H. was supported by DECRA fellowship DE120102459 and P. M. by a Laureate fellowship from the Australian Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams AJ, 2006, MAR ECOL PROG SER, V318, P287, DOI 10.3354/meps318287; Barletta M, 2005, J FISH BIOL, V66, P45, DOI 10.1111/j.0022-1112.2005.00582.x; Beck MW, 2001, BIOSCIENCE, V51, P633, DOI 10.1641/0006-3568(2001)051[0633:TICAMO]2.0.CO;2; Clarke KR, 2006, PRIMERV6 USER MANUAL; Crona BI, 2007, ESTUAR COAST SHELF S, V74, P44, DOI 10.1016/j.ecss.2007.03.023; Crona BI, 2005, ESTUAR COAST SHELF S, V65, P535, DOI 10.1016/j.ecss.2005.07.001; Dahlgren CP, 2000, ECOLOGY, V81, P2227; Dahlgren CP, 2006, MAR ECOL PROG SER, V312, P291, DOI 10.3354/meps312291; Dorenbosch M, 2004, ENVIRON BIOL FISH, V70, P203, DOI 10.1023/B:EBFI.0000033336.10737.f5; Dorenbosch M, 2007, MAR ECOL PROG SER, V334, P103, DOI 10.3354/meps334103; Dorenbosch M, 2005, MAR ECOL PROG SER, V302, P63, DOI 10.3354/meps302063; ELLISON JC, 1991, J COASTAL RES, V7, P151; Faunce CH, 2009, ECOLOGICAL CONNECTIVITY AMONG TROPICAL COASTAL ECOSYSTEMS, P401, DOI 10.1007/978-90-481-2406-0_11; FIELD CD, 1995, HYDROBIOLOGIA, V295, P75, DOI 10.1007/BF00029113; Gillanders BM, 2011, MAR FRESHWATER RES, V62, P1115, DOI 10.1071/MF11047; Gilliam JF, 2001, ECOLOGY, V82, P258, DOI 10.2307/2680101; Grol MGG, 2014, MAR ECOL PROG SER, V502, P229, DOI 10.3354/meps10682; Grol MGG, 2011, OECOLOGIA, V165, P79, DOI 10.1007/s00442-010-1833-8; Hammerschlag N, 2010, MAR ECOL PROG SER, V414, P223, DOI 10.3354/meps08731; Harborne AR, 2008, ECOL APPL, V18, P1689, DOI 10.1890/07-0454.1; Harborne AR, 2008, J APPL ECOL, V45, P1010, DOI 10.1111/j.1365-2664.2008.01490.x; Harrison TD, 2006, ESTUAR COAST SHELF S, V66, P335, DOI 10.1016/j.ecss.2005.09.010; Heck KL, 2003, MAR ECOL PROG SER, V253, P123, DOI 10.3354/meps253123; Hedges LV, 2014, STAT METHODS META AN; Heithaus ER, 2011, MAR ECOL PROG SER, V428, P49, DOI 10.3354/meps09052; Huijbers CM, 2008, REV BIOL TROP, V56, P161; Igulu MM, 2013, ECOSYSTEMS, V16, P1336, DOI 10.1007/s10021-013-9687-7; Jelbart JE, 2007, MAR BIOL, V150, P993, DOI 10.1007/s00227-006-0419-9; Kimirei IA, 2013, ECOSYSTEMS, V16, P783, DOI 10.1007/s10021-013-9645-4; Kimirei IA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066320; Kimirei IA, 2011, ESTUAR COAST SHELF S, V92, P47, DOI 10.1016/j.ecss.2010.12.016; Krumme U, 2009, ECOLOGICAL CONNECTIVITY AMONG TROPICAL COASTAL ECOSYSTEMS, P271, DOI 10.1007/978-90-481-2406-0_8; Laegdsgaard P, 2001, J EXP MAR BIOL ECOL, V257, P229, DOI 10.1016/S0022-0981(00)00331-2; LEE SY, 1995, HYDROBIOLOGIA, V295, P203, DOI 10.1007/BF00029127; Leis Jeffrey L., 2002, P171, DOI 10.1016/B978-012615185-5/50011-6; Lugendo BR, 2007, B MAR SCI, V80, P497; Minello TJ, 2003, MAR ECOL PROG SER, V246, P39, DOI 10.3354/meps246039; Mumby PJ, 2008, J APPL ECOL, V45, P854, DOI 10.1111/j.1365-2664.2008.01459.x; Mumby PJ, 2004, NATURE, V427, P533, DOI 10.1038/nature02286; Mwandya AW, 2010, ESTUAR COAST SHELF S, V89, P277, DOI 10.1016/j.ecss.2010.08.002; Nagelkerken I, 2008, AQUAT BOT, V89, P155, DOI 10.1016/j.aquabot.2007.12.007; Nagelkerken I, 2000, MAR ECOL PROG SER, V194, P55, DOI 10.3354/meps194055; Nagelkerken I, 2002, MAR ECOL PROG SER, V245, P191, DOI 10.3354/meps245191; Nagelkerken I, 2000, MAR ECOL PROG SER, V202, P175, DOI 10.3354/meps202175; Nagelkerken I, 2001, MAR ECOL PROG SER, V214, P225, DOI 10.3354/meps214225; Nagelkerken I, 2007, B MAR SCI, V80, P595; Nagelkerken I, 2015, FISH FISH, V16, P362, DOI 10.1111/faf.12057; Nagelkerken I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036906; Nagelkerken I, 2009, ECOLOGICAL CONNECTIVITY AMONG TROPICAL COASTAL ECOSYSTEMS, P357, DOI 10.1007/978-90-481-2406-0_10; Nakamura Y, 2004, FISHERIES SCI, V70, P788, DOI 10.1111/j.1444-2906.2004.00872.x; Nakamura Y, 2008, ESTUAR COAST SHELF S, V76, P345, DOI 10.1016/j.ecss.2007.07.014; Nakamura Y, 2009, MAR BIOL, V156, P2413, DOI 10.1007/s00227-009-1257-3; Neves LM, 2011, MAR ECOL-EVOL PERSP, V32, P115, DOI 10.1111/j.1439-0485.2010.00407.x; Nyunja J, 2009, ESTUAR COAST SHELF S, V83, P333, DOI 10.1016/j.ecss.2009.01.009; Olds AD, 2014, CONSERV BIOL, V28, P982, DOI 10.1111/cobi.12242; Olds AD, 2013, GLOBAL ECOL BIOGEOGR, V22, P1040, DOI 10.1111/geb.12072; Olds AD, 2012, J APPL ECOL, V49, P1195, DOI 10.1111/jpe.12002; Olds AD, 2012, MAR ECOL PROG SER, V462, P191, DOI 10.3354/meps09849; Olds AD, 2012, CONSERV LETT, V5, P56, DOI 10.1111/j.1755-263X.2011.00204.x; Rosenberg MS, 2000, METAWIN STAT SOFTWAR; Sanchirico JN, 2009, THEOR ECOL-NETH, V2, P67, DOI 10.1007/s12080-008-0034-0; Sheaves M, 2005, MAR ECOL PROG SER, V302, P293, DOI 10.3354/meps302293; Sheridan P, 2003, WETLANDS, V23, P449, DOI 10.1672/19-20; Sheridan P, 1997, ESTUAR COAST SHELF S, V44, P455, DOI 10.1006/ecss.1996.0125; SHERIDAN PF, 1992, B MAR SCI, V50, P21; Shibuno T, 2008, ICHTHYOL RES, V55, P218, DOI 10.1007/s10228-007-0022-1; Thollot P, 1992, P 7 INT COR REEF S G, V2, P934; Thompson AA, 2002, MAR ECOL PROG SER, V232, P247, DOI 10.3354/meps232247; Unsworth RKF, 2007, J MAR BIOL ASSOC UK, V87, P1287, DOI 10.1017/S002531540705638X; Unsworth RKF, 2010, CONSERV LETT, V3, P63, DOI 10.1111/j.1755-263X.2010.00101.x; Unsworth RKF, 2009, AQUAT BIOL, V5, P85, DOI 10.3354/ab00139; Verweij MC, 2007, HYDROBIOLOGIA, V592, P257, DOI 10.1007/s10750-007-0772-9; Verweij MC, 2006, MAR BIOL, V149, P1291, DOI 10.1007/s00227-006-0305-5; Verweij MC, 2006, MAR ECOL PROG SER, V306, P257, DOI 10.3354/meps306257; Whitfield AK, 2006, REV FISH BIOL FISHER, V16, P1, DOI 10.1007/s11160-006-0003-x	75	83	86	0	95	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2014	9	12							e114715	10.1371/journal.pone.0114715	http://dx.doi.org/10.1371/journal.pone.0114715			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UC	25551761	Green Published, gold, Green Submitted			2022-12-27	WOS:000347119100014
J	Valen, R; Edvardsen, RB; Soviknes, AM; Drivenes, O; Helvik, JV				Valen, Ragnhild; Edvardsen, Rolf Brudvik; Soviknes, Anne Mette; Drivenes, Oyvind; Helvik, Jon Vidar			Molecular Evidence that Only Two Opsin Subfamilies, the Blue Light- (SWS2) and Green Light-Sensitive (RH2), Drive Color Vision in Atlantic Cod (Gadus morhua)	PLOS ONE			English	Article							CONE VISUAL PIGMENTS; GENE DUPLICATION; ULTRAVIOLET RECEPTORS; EVOLUTION; EXPRESSION; SEQUENCE; RETINA; FISH; WAVE; DIVERSIFICATION	Teleosts show a great variety in visual opsin complement, due to both gene duplication and gene loss. The repertoire ranges from one subfamily of visual opsins (scotopic vision) including rod opsin only retinas seen in many deep-sea species to multiple subfamilies of visual opsins in some pelagic species. We have investigated the opsin repertoire of Atlantic cod (Gadus morhua) using information in the recently sequenced cod genome and found that despite cod not being a deep sea species it lacks visual subfamilies sensitive towards the most extreme parts of the light spectra representing UV and red light. Furthermore, we find that Atlantic cod has duplicated paralogs of both blue-sensitive SWS2 and green-sensitive RH2 subfamilies, with members belonging to each subfamily linked in tandem within the genome (two SWS2-, and three RH2A genes, respectively). The presence of multiple cone opsin genes indicates that there have been duplication events in the cod ancestor SWS2 and RH2 opsins producing paralogs that have been retained in Atlantic. Our results are supported by expressional analysis of cone opsins, which further revealed an ontogenetic change in the array of cone opsins expressed. These findings suggest life stage specific programs for opsin regulation which could be linked to habitat changes and available light as the larvae is transformed into an early juvenile. Altogether we provide the first molecular evidence for color vision driven by only two families of cone opsins due to gene loss in a teleost.	[Valen, Ragnhild; Soviknes, Anne Mette; Drivenes, Oyvind; Helvik, Jon Vidar] Univ Bergen, Ctr High Technol, Dept Biol, N-5020 Bergen, Norway; [Edvardsen, Rolf Brudvik; Drivenes, Oyvind] Inst Marine Res, N-5817 Bergen, Norway	University of Bergen; Institute of Marine Research - Norway	Edvardsen, RB (corresponding author), Inst Marine Res, POB 1870, N-5817 Bergen, Norway.	rolfbe@imr.no; jon.helvik@bio.uib.no	Drivenes, Øyvind/ABE-3432-2021	Edvardsen, Rolf/0000-0001-8430-8042	Norwegian Research Council [199482]	Norwegian Research Council(Research Council of NorwayEuropean Commission)	The current study was part of a project on cod development (CODE) funded by the Norwegian Research Council (www.forskningsradet.no/en/) with project number: 199482. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHLBERT I-B, 1973, Acta Zoologica (Stockholm), V54, P241; BLAXTER JHS, 1967, J MAR BIOL ASSOC UK, V47, P677, DOI 10.1017/S002531540003527X; Bowmaker J.K., 1990, P81; Bowmaker JK, 2008, VISION RES, V48, P2022, DOI 10.1016/j.visres.2008.03.025; Bowmaker JK, 2008, VISUAL NEUROSCI, V25, P249, DOI 10.1017/S0952523808080152; Bowmaker JK, 2006, CURR BIOL, V16, pR484, DOI 10.1016/j.cub.2006.06.016; BOWMAKER JK, 1987, VISION RES, V27, P2101, DOI 10.1016/0042-6989(87)90124-6; Britt LL, 2001, J EXP BIOL, V204, P2581; Cannon J, 1997, REV STATE WORLD FISH, P15; Carleton KL, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-22; Carleton KL, 2005, MOL ECOL, V14, P4341, DOI 10.1111/j.1365-294X.2005.02735.x; Carleton KL, 2001, MOL BIOL EVOL, V18, P1540, DOI 10.1093/oxfordjournals.molbev.a003940; Chinen A, 2003, GENETICS, V163, P663; CHOMCZYNSKI P, 1993, BIOTECHNIQUES, V15, P532; Close B, 1997, LAB ANIM-UK, V31, P1, DOI 10.1258/002367797780600297; Collin SP, 2003, CURR BIOL, V13, pR864, DOI 10.1016/j.cub.2003.10.044; Davies WL, 2009, MOL BIOL EVOL, V26, P1803, DOI 10.1093/molbev/msp089; Douglas R., 1990, VISUAL SYSTEM FISH, DOI [10.1007/978-94-009-0411-8, DOI 10.1007/978-94-009-0411-8]; EVANS BI, 1990, J NEUROBIOL, V21, P1037, DOI 10.1002/neu.480210709; Evans BI, 2004, AM FISH S S, V40, P145; EVANS BI, 1993, VISUAL NEUROSCI, V10, P1065, DOI 10.1017/S0952523800010178; Flamarique IN, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2490; HAWRYSHYN CW, 1989, VISUAL NEUROSCI, V2, P247, DOI 10.1017/S0952523800001164; Helvik JV, 2001, VISUAL NEUROSCI, V18, P767, DOI 10.1017/S095252380118510X; Helvik JV, 2001, J EXP BIOL, V204, P2553; Hofmann CM, 2010, MOL ECOL, V19, P2064, DOI 10.1111/j.1365-294X.2010.04621.x; Hofmann CM, 2009, INTEGR COMP BIOL, V49, P630, DOI 10.1093/icb/icp079; Hunt DM, 2009, PHILOS T R SOC B, V364, P2941, DOI 10.1098/rstb.2009.0044; IBBOTSON RE, 1992, P ROY SOC B-BIOL SCI, V247, P145, DOI 10.1098/rspb.1992.0021; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Kawamura G, 1984, B JAPANESE SOC SCI F, V50; KJESBU OS, 1989, J FISH BIOL, V34, P195, DOI 10.1111/j.1095-8649.1989.tb03302.x; KUNZ YW, 1994, VISION RES, V34, P1375, DOI 10.1016/0042-6989(94)90136-8; Lagman D, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-238; Lythgoe J.N., 1979, ECOLOGY VISION; Matsumoto Y, 2006, GENE, V371, P268, DOI 10.1016/j.gene.2005.12.005; Maximov VV, 2000, PHILOS T ROY SOC B, V355, P1239, DOI 10.1098/rstb.2000.0675; NATHANS J, 1986, SCIENCE, V232, P193, DOI 10.1126/science.2937147; Olsvik Pal A, 2008, BMC Res Notes, V1, P47, DOI 10.1186/1756-0500-1-47; Ottersen G, 2005, ICES COOP RES REP, V274, P11; Pankhurst PM, 1996, MAR FRESHW BEHAV PHY, V28, P55, DOI 10.1080/10236249609378979; Pankhurst PM, 1996, NZ J MAR FRESH RES, V30, P70; PEDERSEN T, 1992, J FISH BIOL, V41, P449, DOI 10.1111/j.1095-8649.1992.tb02673.x; RAYMOND PA, 1995, J COMP NEUROL, V359, P537, DOI 10.1002/cne.903590403; Rennison DJ, 2012, MOL PHYLOGENET EVOL, V62, P986, DOI 10.1016/j.ympev.2011.11.030; Shand J, 1999, J COMP NEUROL, V412, P203, DOI 10.1002/(SICI)1096-9861(19990920)412:2<203::AID-CNE2>3.0.CO;2-3; Spady TC, 2006, MOL BIOL EVOL, V23, P1538, DOI 10.1093/molbev/msl014; Star B, 2011, NATURE, V477, P207, DOI 10.1038/nature10342; Stenevik EK, 2008, ICES J MAR SCI, V65, P1198, DOI 10.1093/icesjms/fsn101; Stenkamp DL, 1997, J COMP NEUROL, V382, P272, DOI 10.1002/(SICI)1096-9861(19970602)382:2<272::AID-CNE10>3.0.CO;2-U; Takechi M, 2005, J EXP BIOL, V208, P1337, DOI 10.1242/jeb.01532; Tam KJ, 2011, VISION RES, V51, P2295, DOI 10.1016/j.visres.2011.09.010; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Taylor SM, 2011, VISUAL NEUROSCI, V28, P309, DOI 10.1017/S0952523810000362; Terakita A, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-3-213; Thisse C, 2008, NAT PROTOC, V3, P59, DOI 10.1038/nprot.2007.514; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; TUPPER M, 1995, CAN J FISH AQUAT SCI, V52, P1834, DOI 10.1139/f95-176; Wakefield MJ, 2008, VISUAL NEUROSCI, V25, P257, DOI 10.1017/S0952523808080255; Watson CT, 2011, J MOL EVOL, V72, P240, DOI 10.1007/s00239-010-9426-z; Watson CT, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-87; WINDERICKX J, 1992, P NATL ACAD SCI USA, V89, P9710, DOI 10.1073/pnas.89.20.9710; Yokoyama S, 2000, PROG RETIN EYE RES, V19, P385, DOI 10.1016/S1350-9462(00)00002-1	64	14	14	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2014	9	12							e115436	10.1371/journal.pone.0115436	http://dx.doi.org/10.1371/journal.pone.0115436			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UC	25551396	Green Published, Green Submitted, gold			2022-12-27	WOS:000347119100037
J	Yang, Z; Wang, TJ; Skidmore, AK; de Leeuw, J; Said, MY; Freer, J				Yang, Zheng; Wang, Tiejun; Skidmore, Andrew K.; de Leeuw, Jan; Said, Mohammed Y.; Freer, Jim			Spotting East African Mammals in Open Savannah from Space	PLOS ONE			English	Article							LAND-COVER CLASSIFICATION; NEURAL-NETWORK; MARA; BIODIVERSITY; POPULATIONS; COUNTS; FUTURE; KENYA	Knowledge of population dynamics is essential for managing and conserving wildlife. Traditional methods of counting wild animals such as aerial survey or ground counts not only disturb animals, but also can be labour intensive and costly. New, commercially available very high-resolution satellite images offer great potential for accurate estimates of animal abundance over large open areas. However, little research has been conducted in the area of satellite-aided wildlife census, although computer processing speeds and image analysis algorithms have vastly improved. This paper explores the possibility of detecting large animals in the open savannah of Maasai Mara National Reserve, Kenya from very high-resolution GeoEye-1 satellite images. A hybrid image classification method was employed for this specific purpose by incorporating the advantages of both pixel-based and object-based image classification approaches. This was performed in two steps: firstly, a pixel-based image classification method, i.e., artificial neural network was applied to classify potential targets with similar spectral reflectance at pixel level; and then an object-based image classification method was used to further differentiate animal targets from the surrounding landscapes through the applications of expert knowledge. As a result, the large animals in two pilot study areas were successfully detected with an average count error of 8.2%, omission error of 6.6% and commission error of 13.7%. The results of the study show for the first time that it is feasible to perform automated detection and counting of large wild animals in open savannahs from space, and therefore provide a complementary and alternative approach to the conventional wildlife survey techniques.	[Yang, Zheng; Wang, Tiejun; Skidmore, Andrew K.] Univ Twente, Fac Geoinformat Sci & Earth Observat ITC, NL-7500 AE Enschede, Netherlands; [Yang, Zheng; Freer, Jim] Univ Bristol, Sch Geog Sci, Bristol BS8 1SS, Avon, England; [de Leeuw, Jan; Said, Mohammed Y.] Int Livestock Res Inst ILRI, Nairobi 00100, Kenya	University of Twente; University of Bristol; CGIAR; International Livestock Research Institute (ILRI)	Wang, TJ (corresponding author), Univ Twente, Fac Geoinformat Sci & Earth Observat ITC, POB 217, NL-7500 AE Enschede, Netherlands.	t.wang@utwente.nl	Freer, Jim E/C-7335-2009; Wang, Tiejun/A-4671-2010; said, mohammed/E-4932-2019; Skidmore, Andrew K/C-7441-2011	Freer, Jim E/0000-0001-6388-7890; Wang, Tiejun/0000-0002-1138-8464; said, mohammed/0000-0001-9278-3193; Skidmore, Andrew K/0000-0002-7446-8429; de Leeuw, Jan/0000-0001-7020-2503	Erasmus Mundus External Co-operation Window Programme of the European Union [L14a0901205]; Bristol Alumni Cabot Scholarship of the University of Bristol [DF4215]	Erasmus Mundus External Co-operation Window Programme of the European Union; Bristol Alumni Cabot Scholarship of the University of Bristol	This work was funded by the Erasmus Mundus External Co-operation Window Programme of the European Union (http://www.emecwchina.org/ L14a0901205), and co-funded by the Bristol Alumni Cabot Scholarship of the University of Bristol (DF4215). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1999, WALKERS MAMMALS WORL; BAJZAK D, 1990, WILDLIFE SOC B, V18, P125; BENEDIKTSSON JA, 1990, IEEE T GEOSCI REMOTE, V28, P540, DOI 10.1109/TGRS.1990.572944; CONGALTON RG, 1991, REMOTE SENS ENVIRON, V37, P35, DOI 10.1016/0034-4257(91)90048-B; Cunningham DJ, 1996, WILDLIFE SOC B, V24, P345; De Leeuw J, 2002, ENV MODELLING GIS RE, P121; Edwards PJ, 1998, BIOL CONSERV, V83, P239, DOI 10.1016/S0006-3207(97)00141-9; Fleming PJS, 2008, WILDLIFE RES, V35, P258, DOI 10.1071/WR07081; Fretwell PT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033751; Gao Y, 2006, INT J REMOTE SENS, V27, P4039, DOI 10.1080/01431160600702632; GILMER DS, 1988, WILDLIFE SOC B, V16, P204; Huang LY, 2008, PROCEEDINGS OF THE 8TH INTERNATIONAL SYMPOSIUM ON SPATIAL ACCURACY ASSESSMENT IN NATURAL RESOURCES AND ENVIRONMENTAL SCIENCES, VOL II, P211; Jachmann H, 2002, J APPL ECOL, V39, P841, DOI 10.1046/j.1365-2664.2002.00752.x; Jacobsen K, 2011, INT ARCH PHOTOGRAMM; Jalan S, 2012, INT J REMOTE SENS, V33, P5629, DOI 10.1080/01431161.2012.666811; Jin XY, 2007, IMAGE VISION COMPUT, V25, P1422, DOI 10.1016/j.imavis.2006.12.011; Khaemba WM, 2002, WILDLIFE RES, V29, P269, DOI 10.1071/WR00045; Kong CF, 2006, J CHINA UNIV GEOSCI, V17, P151, DOI 10.1016/S1002-0705(06)60021-6; Laliberte AS, 2004, REMOTE SENS ENVIRON, V93, P198, DOI 10.1016/j.rse.2004.07.011; Laliberte AS, 2003, WILDLIFE SOC B, V31, P362; Lamprey RH, 2004, J BIOGEOGR, V31, P997, DOI 10.1111/j.1365-2699.2004.01062.x; Liu DS, 2010, REMOTE SENS LETT, V1, P187, DOI 10.1080/01431161003743173; Macdonald D, 2001, NEW ENCY MAMMALS; NAVULUR K, 2006, MULTISPECTRAL IMAGE; Noyes JH, 2000, WILDLIFE SOC B, V28, P636; O'Brien TG, 2010, ANIM CONSERV, V13, P350, DOI 10.1111/j.1469-1795.2010.00384.x; Ogutu JO, 2011, J ZOOL, V285, P99, DOI 10.1111/j.1469-7998.2011.00818.x; Ottichilo WK, 2001, BIOL CONSERV, V97, P271, DOI 10.1016/S0006-3207(00)00090-2; Pu RL, 2011, INT J REMOTE SENS, V32, P3285, DOI 10.1080/01431161003745657; Qi ZX, 2012, REMOTE SENS ENVIRON, V118, P21, DOI 10.1016/j.rse.2011.11.001; QUANG PX, 1991, BIOMETRICS, V47, P1089, DOI 10.2307/2532661; REID RS, 2003, PEOPLE WILDLIFE LIVE; Richards J, 1993, REMOTE SENSING DIGIT, V2nd; SAMUEL MD, 1992, J WILDLIFE MANAGE, V56, P718, DOI 10.2307/3809465; Short N. M., 1998, REMOTE SENSING TUTOR; Skidmore AK, 1997, PHOTOGRAMM ENG REM S, V63, P501; Srivastava HB, 2009, DEFENCE SCI J, V59, P166, DOI 10.14429/dsj.59.1505; STELFOX JG, 1986, J WILDLIFE MANAGE, V50, P339, DOI 10.2307/3801925; Taylor AR, 2003, ECOL APPL, V13, P951, DOI 10.1890/1051-0761(2003)13[951:WRTRAA]2.0.CO;2; Thirgood S, 2004, ANIM CONSERV, V7, P113, DOI 10.1017/S1367943004001404; van der Werff HMA, 2008, ISPRS J PHOTOGRAMM, V63, P251, DOI 10.1016/j.isprsjprs.2007.09.007; Vie J-C, 2009, WILDLIFE CHANGING WO; Wit P, 1998, J MICROBIOL METH, V32, P281, DOI 10.1016/S0167-7012(98)00033-5; WYATT CL, 1980, J WILDLIFE MANAGE, V44, P397, DOI 10.2307/3807970; Zhuang XY, 2010, PIAGENG 2010 PHOTONI, P6	45	42	44	0	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2014	9	12							e115989	10.1371/journal.pone.0115989	http://dx.doi.org/10.1371/journal.pone.0115989			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UC	25551561	Green Published, gold, Green Submitted			2022-12-27	WOS:000347119100087
J	Abushufa, AM; Eldehni, MT; Odudu, A; Evans, PD; O'Sullivan, SE; McIntyre, CW				Abushufa, Adil M.; Eldehni, Mohamed T.; Odudu, Aghogho; Evans, Philip D.; O'Sullivan, Saoirse E.; McIntyre, Chris W.			Defining Uremic Arterial Functional Abnormalities in Patients Recently Started on Haemodialysis: Combined In Vivo and Ex Vivo Assessment	PLOS ONE			English	Article							ENDOTHELIUM-DEPENDENT VASODILATATION; STAGE RENAL-DISEASE; VASCULAR CALCIFICATION; RESISTANCE ARTERIES; FAILURE; DYSFUNCTION; STIFFNESS; OUTCOMES; VESSELS; RATS	Endothelial dysfunction is a key initiating event in vascular disease in chronic kidney disease (CKD) patients and haemodialysis (HD) patients exhibit significant vascular abnormalities. To understand this further, we examined how ex vivo intrinsic function in isolated arteries correlates with in vivo assessments of cardiovascular status in HD patients. Abdominal fat biopsies were obtained from 11 HD patients and 26 non-uremic controls. Subcutaneous arteries were dissected and mounted on a wire myograph, and cumulative concentration-response curves to noradrenalin, endothelin-1, a thromboxane A(2) agonist (U46619), angiotensin II, vasopressin, bradykinin (BK), acetylcholine (ACh) and sodium nitroprusside (SNP) were constructed. Pulse wave velocity and blood pressure were measured in HD patients. Enhanced (P<0.05-0.0001) maximal contractile responses (R-max) to all spasmogens (particularly vasopressin) were observed in arteries from HD patients compared to controls, and this effect was more pronounced in arteries with an internal diameter. 600 mm. The potency (pEC(50)) of U46619 (P<0.01) and vasopressin (P<0.001) was also increased in arteries >600 mu m of HD patients. The maximal relaxant response to the endothelium-dependent dilators ACh and BK were lower in HD patients (P<0.01-P<0.0001) (worse for ACh than BK); however the endothelium-independent dilator SNP was similar in both groups. PWV was significantly correlated with the vasoconstrictor response to vasopressin (P=0.042) in HD patients. HD patients are primed for hypertension and end organ demand ischaemia by a highly sensitised pressor response. The failure of arterial relaxation is mediated by endothelial dysfunction. Intrinsic vascular abnormalities may be important in sensitising HD patients to recurrent cumulative ischaemic end organ injury.	[Abushufa, Adil M.; Eldehni, Mohamed T.; Odudu, Aghogho; Evans, Philip D.; O'Sullivan, Saoirse E.; McIntyre, Chris W.] Univ Nottingham, Sch Med, Div Med Sci & Grad Entry Med, Nottingham, England; [Eldehni, Mohamed T.; Odudu, Aghogho; Evans, Philip D.; McIntyre, Chris W.] Royal Derby Hosp, Dept Renal Med, Derby, England	University of Nottingham; University of Nottingham	O'Sullivan, SE (corresponding author), Univ Nottingham, Sch Med, Div Med Sci & Grad Entry Med, Nottingham, England.	Saoirse.osullivan@nottingham.ac.uk	McIntyre, Christopher W/O-8927-2014; Odudu, Aghogho/K-9048-2014	Odudu, Aghogho/0000-0002-4863-1560; Eldehni, Mohamed/0000-0003-1681-9048; O'Sullivan, Saoirse Elizabeth/0000-0002-1672-6610				AALKJAER C, 1986, CLIN SCI, V71, P657, DOI 10.1042/cs0710657; Annuk M, 2001, NEPHROL DIAL TRANSPL, V16, P302, DOI 10.1093/ndt/16.2.302; Baylis C, 2008, AM J PHYSIOL-RENAL, V294, pF1, DOI 10.1152/ajprenal.00424.2007; Blacher J, 1999, CIRCULATION, V99, P2434, DOI 10.1161/01.CIR.99.18.2434; Bostom AG, 1999, J AM SOC NEPHROL; Burton JO, 2009, CLIN J AM SOC NEPHRO, V4, P914, DOI 10.2215/CJN.03900808; Eldehni MT, 2012, SEMIN DIALYSIS, V25, P253, DOI 10.1111/j.1525-139X.2012.01057.x; Ferraro B, 2003, KIDNEY INT, V63, P2207, DOI 10.1046/j.1523-1755.2003.00008.x; Hand MF, 1998, KIDNEY INT, V53, P1068, DOI 10.1046/j.1523-1755.1998.00851.x; Hasdan G, 2002, KIDNEY INT, V61, P586, DOI 10.1046/j.1523-1755.2002.00166.x; Kielstein JT, 2002, J AM SOC NEPHROL, V13, P170, DOI 10.1681/ASN.V131170; Luksha L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036056; Luksha R, 2011, CLIN SCI, V120, P525, DOI 10.1042/CS20100277; Mallamaci F, 2002, KIDNEY INT, V61, P609, DOI 10.1046/j.1523-1755.2002.00144.x; McIntyre CA, 1998, BRIT J PHARMACOL, V123, P1555, DOI 10.1038/sj.bjp.0701768; McIntyre CW, 2010, SEMIN DIALYSIS, V23, P449, DOI 10.1111/j.1525-139X.2010.00782.x; Morris STW, 2001, KIDNEY INT, V60, P1077, DOI 10.1046/j.1523-1755.2001.0600031077.x; Morris STW, 2000, NEPHROL DIAL TRANSPL, V15, P1194, DOI 10.1093/ndt/15.8.1194; MULVANY MJ, 1977, CIRC RES, V41, P19, DOI 10.1161/01.RES.41.1.19; Oflaz H, 2003, CLIN TRANSPLANT, V17, P528, DOI 10.1046/j.1399-0012.2003.00100.x; Pucci G, 2012, J HYPERTENS; Raggi P, 2007, ADV CHRONIC KIDNEY D, V14, P37, DOI 10.1053/j.ackd.2006.10.006; Shinohara K, 2004, KIDNEY INT, V65, P936, DOI 10.1111/j.1523-1755.2004.00468.x; Sigrist MK, 2008, NEPHRON CLIN PRACT, V108, pC121, DOI 10.1159/000114202; VALLANCE P, 1992, LANCET, V339, P572; Van Biesen W, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017148; Wabel P, 2008, NEPHROL DIAL TRANSPL, V23, P2965, DOI 10.1093/ndt/gfn228	27	0	0	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2014	9	12							e113462	10.1371/journal.pone.0113462	http://dx.doi.org/10.1371/journal.pone.0113462			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UN	25546407	Green Published, gold, Green Submitted			2022-12-27	WOS:000347120200006
J	Ayari-Jeridi, H; Moran, K; Chebbi, A; Bouguila, H; Abbes, I; Charradi, K; Benammar-Elgaaied, A; Ganguly, A				Ayari-Jeridi, Hajer; Moran, Kimberly; Chebbi, Amel; Bouguila, Hedi; Abbes, Imen; Charradi, Khaoula; Benammar-Elgaaied, Amel; Ganguly, Arupa			Mutation Spectrum of RB1 Gene in Unilateral Retinoblastoma Cases from Tunisia and Correlations with Clinical Features	PLOS ONE			English	Article							TUMOR-SUPPRESSOR PROTEIN; HEREDITARY RETINOBLASTOMA; SPORADIC RETINOBLASTOMA; RISK; HETEROZYGOSITY; PREDICTION; DIAGNOSIS; FAMILIES; SEQUENCE; CANCER	Retinoblastoma, an embryonic neoplasm of retinal origin, is the most common primary intra-ocular malignancy in children. Somatic inactivation of both alleles of the RB1 tumor suppressor gene in a retinal progenitor cell through diverse mechanisms including genetic and epigenetic modifications, is the crucial event in initiation of tumorigenesis in most cases of isolated unilateral retinoblastoma. We analyzed DNA from tumor tissue and from peripheral blood to determine the RB1 mutation status and seek correlations with clinical features of 37 unrelated cases of Tunisian origin with sporadic retinoblastoma. All cases were unilateral except one who presented with bilateral disease, in whom no germline coding sequence alteration was identified. A multi-step mutation scanning protocol identified bi-allelic inactivation of RB1 gene in 30 (81%) of the samples tested. A total of 7 novel mutations were identified. There were three tumors without any detectable mutation while a subset contained multiple mutations in RB1 gene. The latter group included tumors collected after treatment with chemotherapy. There were seven individuals with germline mutations and all presented with advanced stage of tumor. There was no difference in age of onset of RB based on the germline mutation status. Thus 20% of the individuals with sporadic unilateral RB in this series carried germline mutations and indicate the importance of genetic testing all children with sporadic retinoblastoma. These findings help to characterize the spectrum of mutations present in the Tunisian population and can improve genetic diagnosis of retinoblastoma.	[Ayari-Jeridi, Hajer; Charradi, Khaoula; Benammar-Elgaaied, Amel] Univ Tunis EL MANAR, Fac Sci Tunis, Lab Genet Immunol & Pathol Humaines, Tunis 2092, Tunisia; [Chebbi, Amel; Bouguila, Hedi] Inst Hedi Rais Ophtalmol Tunis, Tunis, Tunisia; [Abbes, Imen] Inst Salah Azaiez Cancerol, Lab Anatomie Patholog, Tunis, Tunisia; [Moran, Kimberly; Ganguly, Arupa] Univ Pennsylvania, Perelman Sch Med, Dept Genet, Genet Diagnost Lab, Philadelphia, PA USA	Universite de Tunis-El-Manar; Faculte des Sciences de Tunis (FST); Universite de Tunis-El-Manar; Institut Hedi Raies d'ophtalmologie de Tunis; University of Pennsylvania; Pennsylvania Medicine	Ganguly, A (corresponding author), Univ Tunis EL MANAR, Fac Sci Tunis, Lab Genet Immunol & Pathol Humaines, Campus Univ, Tunis 2092, Tunisia.	ganguly@mail.med.upenn.edu	Elgaaied, Amel Ben Ammar/AAL-1183-2020	Chebbi, Amel/0000-0002-8661-3160	National Institutes of Health/National Cancer Institute [RO1-CA118580]; NATIONAL CANCER INSTITUTE [R01CA118580] Funding Source: NIH RePORTER	National Institutes of Health/National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by the National Institutes of Health/National Cancer Institute (RO1-CA118580). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbosa RH, 2009, BMC MED GENET, V10, DOI 10.1186/1471-2350-10-75; Chen Z, 2014, HUM MUTAT, V35, P384, DOI 10.1002/humu.22488; Choy Kwong Wai, 2002, Hum Mutat, V20, P408, DOI 10.1002/humu.9077; Cowell JK, 1996, EUR J CANCER, V32A, P1749, DOI 10.1016/0959-8049(96)00201-8; Dehainault C, 2007, EUR J HUM GENET, V15, P473, DOI 10.1038/sj.ejhg.5201787; DRAPER GJ, 1992, BRIT J CANCER, V66, P211, DOI 10.1038/bjc.1992.244; FRIEND SH, 1986, NATURE, V323, P643, DOI 10.1038/323643a0; Goodrich DW, 2003, J CELL PHYSIOL, V197, P169, DOI 10.1002/jcp.10358; Gordon GM, 2011, PROTEIN CELL, V2, P864, DOI 10.1007/s13238-011-1117-z; Houdayer C, 2004, HUM MUTAT, V23, P193, DOI 10.1002/humu.10303; Jeridi HA, 2014, EXP EYE RES, V124, P48, DOI 10.1016/j.exer.2014.04.013; KATO MV, 1993, INT J CANCER, V54, P922, DOI 10.1002/ijc.2910540609; KNUDSON AG, 1971, P NATL ACAD SCI USA, V68, P820, DOI 10.1073/pnas.68.4.820; LEE WH, 1987, SCIENCE, V235, P1394, DOI 10.1126/science.3823889; Lohmann DR, 1999, HUM MUTAT, V14, P283, DOI 10.1002/(SICI)1098-1004(199910)14:4<283::AID-HUMU2>3.0.CO;2-J; Lohmann DR, 2004, AM J MED GENET C, V129C, P23, DOI 10.1002/ajmg.c.30024; Lohmann DR, 1997, AM J HUM GENET, V61, P282, DOI 10.1086/514845; Moll AC, 1996, INT J CANCER, V67, P515, DOI 10.1002/(SICI)1097-0215(19960807)67:4<515::AID-IJC9>3.0.CO;2-V; NAUMOVA A, 1994, AM J HUM GENET, V54, P264; Nichols KE, 2005, HUM MUTAT, V25, P566, DOI 10.1002/humu.20184; Ottaviani D, 2013, OPHTHALMIC GENET, V34, P189, DOI 10.3109/13816810.2012.755553; Palazzi MA, 2003, ACTA OPHTHALMOL SCAN, V81, P396, DOI 10.1034/j.1600-0420.2003.00112.x; Richter S, 2003, AM J HUM GENET, V72, P253, DOI 10.1086/345651; Rizzolio F, 2012, CELL DEATH DIFFER, V19, P1152, DOI 10.1038/cdd.2011.202; Rushlow DE, 2013, LANCET ONCOL, V14, P327, DOI 10.1016/S1470-2045(13)70045-7; Schuler A, 2005, EUR J CANCER, V41, P735, DOI 10.1016/j.ejca.2004.12.022; Sippel KC, 1998, AM J HUM GENET, V62, P610, DOI 10.1086/301766; Taylor M, 2007, HUM MUTAT, V28, P284, DOI 10.1002/humu.20443; Valverde JR, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-53; WIGGS J, 1988, NEW ENGL J MED, V318, P151, DOI 10.1056/NEJM198801213180305; ZHU X, 1992, CYTOGENET CELL GENET, V59, P248, DOI 10.1159/000133261	31	11	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2015	10	1							e0116615	10.1371/journal.pone.0116615	http://dx.doi.org/10.1371/journal.pone.0116615			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ4OZ	25602518	gold, Green Submitted, Green Published			2022-12-27	WOS:000348203500029
J	Lo, YS; Huang, SH; Luo, YC; Lin, CY; Yang, JM				Lo, Yu-Shu; Huang, Sing-Han; Luo, Yong-Chun; Lin, Chun-Yu; Yang, Jinn-Moon			Reconstructing Genome-Wide Protein-Protein Interaction Networks Using Multiple Strategies with Homologous Mapping	PLOS ONE			English	Article							WEB SERVER; GENE ONTOLOGY; CORE COMPLEX; YEAST; DATABASE; IDENTIFICATION; ANNOTATION; RESOURCE; BINDING; MODULES	Background One of the crucial steps toward understanding the biological functions of a cellular system is to investigate protein-protein interaction (PPI) networks. As an increasing number of reliable PPIs become available, there is a growing need for discovering PPIs to reconstruct PPI networks of interesting organisms. Some interolog-based methods and homologous PPI families have been proposed for predicting PPIs from the known PPIs of source organisms. Results Here, we propose a multiple-strategy scoring method to identify reliable PPIs for reconstructing the mouse PPI network from two well-known organisms: human and fly. We firstly identified the PPI candidates of target organisms based on homologous PPIs, sharing significant sequence similarities (joint E-value <= 1 x 10(-40)), from source organisms using generalized interolog mapping. These PPI candidates were evaluated by our multiple-strategy scoring method, combining sequence similarities, normalized ranks, and conservation scores across multiple organisms. According to 106,825 PPI candidates in yeast derived from human and fly, our scoring method can achieve high prediction accuracy and outperform generalized interolog mapping. Experiment results show that our multiple-strategy score can avoid the influence of the protein family size and length to significantly improve PPI prediction accuracy and reflect the biological functions. In addition, the top-ranked and conserved PPIs are often orthologous/ essential interactions and share the functional similarity. Based on these reliable predicted PPIs, we reconstructed a comprehensive mouse PPI network, which is a scale-free network and can reflect the biological functions and high connectivity of 292 KEGG modules, including 216 pathways and 76 structural complexes. Conclusions Experimental results show that our scoring method can improve the predicting accuracy based on the normalized rank and evolutionary conservation from multiple organisms. Our predicted PPIs share similar biological processes and cellular components, and the reconstructed genome-wide PPI network can reflect network topology and modularity. We believe that our method is useful for inferring reliable PPIs and reconstructing a comprehensive PPI network of an interesting organism.	[Lo, Yu-Shu; Huang, Sing-Han; Luo, Yong-Chun; Lin, Chun-Yu; Yang, Jinn-Moon] Natl Chiao Tung Univ, Inst Bioinformat & Syst Biol, Hsinchu, Taiwan; [Yang, Jinn-Moon] Natl Chiao Tung Univ, Dept Biol Sci & Technol, Hsinchu, Taiwan; [Yang, Jinn-Moon] Natl Chiao Tung Univ, Ctr Bioinformat Res, Hsinchu, Taiwan	National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University	Yang, JM (corresponding author), Natl Chiao Tung Univ, Inst Bioinformat & Syst Biol, Hsinchu, Taiwan.	moon@faculty.nctu.edu.tw	Lin, Chun-Yu/AFK-1793-2022; 黃, 星翰/HDM-4670-2022; Yang, Jinn-Moon/AAU-4400-2021	Lin, Chun-Yu/0000-0003-2901-2681; Huang, Sing Han/0000-0003-0289-2260	National Science Council; Ministry of Education Research Institute; National Health Research Institute [NHRI-EX100-10009PI]; "Center for Bioinformatics Research of Aiming for the Top University Program" of the National Chiao Tung University and Ministry of Education, Taiwan	National Science Council(Ministry of Science and Technology, Taiwan); Ministry of Education Research Institute; National Health Research Institute(National Health Research Institutes - Taiwan); "Center for Bioinformatics Research of Aiming for the Top University Program" of the National Chiao Tung University and Ministry of Education, Taiwan	This paper was supported by National Science Council, partial supports of Ministry of Education and National Health Research Institutes (NHRI-EX100-10009PI). This paper is also particularly supported by "Center for Bioinformatics Research of Aiming for the Top University Program" of the National Chiao Tung University and Ministry of Education, Taiwan. The authors also thank Core Facility for Protein Structural Analysis supported by National Core Facility Program for Biotechnology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apweiler R, 2013, NUCLEIC ACIDS RES, V41, pD43, DOI 10.1093/nar/gks1068; Aranda B, 2010, NUCLEIC ACIDS RES, V38, pD525, DOI 10.1093/nar/gkp878; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Birney E, 2004, GENOME RES, V14, P925, DOI 10.1101/gr.1860604; Blake JA, 2014, NUCLEIC ACIDS RES, V42, pD810, DOI 10.1093/nar/gkt1225; Buescher JM, 2012, SCIENCE, V335, P1099, DOI 10.1126/science.1206871; Camasses A, 1998, MOL CELL BIOL, V18, P1956, DOI 10.1128/MCB.18.4.1956; Campillos M, 2006, GENOME RES, V16, P374, DOI 10.1101/gr.4336406; Ceol A, 2010, NUCLEIC ACIDS RES, V38, pD532, DOI 10.1093/nar/gkp983; Chen CC, 2009, NUCLEIC ACIDS RES, V37, pW369, DOI 10.1093/nar/gkp309; Chen YC, 2007, NUCLEIC ACIDS RES, V35, pW561, DOI 10.1093/nar/gkm346; Ewing RM, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100134; Fury MG, 1997, EXP CELL RES, V237, P63, DOI 10.1006/excr.1997.3750; Grote M, 2010, MOL CELL BIOL, V30, P2105, DOI 10.1128/MCB.01505-09; Ito T, 2001, P NATL ACAD SCI USA, V98, P4569, DOI 10.1073/pnas.061034498; Jansen R, 2003, SCIENCE, V302, P449, DOI 10.1126/science.1087361; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Kelley BP, 2003, P NATL ACAD SCI USA, V100, P11394, DOI 10.1073/pnas.1534710100; KLUG A, 1987, COLD SPRING HARB SYM, V52, P473, DOI 10.1101/SQB.1987.052.01.054; Koster J, 2004, MOL BIOL CELL, V15, P1211, DOI 10.1091/mbc.E03-09-0697; Krogan NJ, 2006, NATURE, V440, P637, DOI 10.1038/nature04670; Lin CY, 2012, NUCLEIC ACIDS RES, V40, pW263, DOI 10.1093/nar/gks541; Lleres D, 2010, EMBO REP, V11, P445, DOI 10.1038/embor.2010.64; Lo YS, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-S3-S7; Lo YS, 2010, NUCLEIC ACIDS RES, V38, pW516, DOI 10.1093/nar/gkq464; Lu XY, 2007, BIOCHEM BIOPH RES CO, V354, P968, DOI 10.1016/j.bbrc.2007.01.097; Malovannaya A, 2011, CELL, V145, P787, DOI 10.1016/j.cell.2011.05.006; Matthews LR, 2001, GENOME RES, V11, P2120, DOI 10.1101/gr.205301; Mewes HW, 2008, NUCLEIC ACIDS RES, V36, pD196, DOI 10.1093/nar/gkm980; Mistry J, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt263; NEER EJ, 1994, NATURE, V371, P297, DOI 10.1038/371297a0; Ornitz DM, 1996, J BIOL CHEM, V271, P15292, DOI 10.1074/jbc.271.25.15292; Ostlund G, 2010, NUCLEIC ACIDS RES, V38, pD196, DOI 10.1093/nar/gkp931; ROSBASH M, 1991, TRENDS BIOCHEM SCI, V16, P187, DOI 10.1016/0968-0004(91)90073-5; Ruepp A, 2010, NUCLEIC ACIDS RES, V38, pD497, DOI 10.1093/nar/gkp914; Seyed-allaei H, 2006, PHYS REV E, V73, DOI 10.1103/PhysRevE.73.046113; Sharan R, 2005, P NATL ACAD SCI USA, V102, P1974, DOI 10.1073/pnas.0409522102; Stark C, 2011, NUCLEIC ACIDS RES, V39, pD698, DOI 10.1093/nar/gkq1116; Uetz P, 2000, NATURE, V403, P623, DOI 10.1038/35001009; Wagner GP, 2007, NAT REV GENET, V8, P921, DOI 10.1038/nrg2267; Wang HD, 2009, MOL CELL PROTEOMICS, V8, P1361, DOI 10.1074/mcp.M800490-MCP200; Will CL, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a003707; Wu XM, 2006, NUCLEIC ACIDS RES, V34, P2137, DOI 10.1093/nar/gkl219; Xenarios I, 2002, NUCLEIC ACIDS RES, V30, P303, DOI 10.1093/nar/30.1.303; YAN Y, 1993, SCIENCE, V262, P2027, DOI 10.1126/science.8266097; Yu HY, 2008, SCIENCE, V322, P104, DOI 10.1126/science.1158684; Yu HH, 2001, ONCOGENE, V20, P3995, DOI 10.1038/sj.onc.1204524; Yu HY, 2004, GENOME RES, V14, P1107, DOI 10.1101/gr.1774904	49	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2015	10	1							e0116347	10.1371/journal.pone.0116347	http://dx.doi.org/10.1371/journal.pone.0116347			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ4OZ	25602759	Green Published, Green Submitted, gold			2022-12-27	WOS:000348203500022
J	Tu, Y; Wei, YX; Sun, K; Zhao, WG; Yu, BW				Tu, Ye; Wei, Yongxu; Sun, Kun; Zhao, Weiguo; Yu, Buwei			Altered Spontaneous Brain Activity in Patients with Hemifacial Spasm: A Resting-State Functional MRI Study	PLOS ONE			English	Article							RESPONSE-INHIBITION; CONNECTIVITY; ORGANIZATION; INVOLVEMENT; HOMOGENEITY; CEREBELLUM; MOVEMENT; CIRCUITS; NUCLEUS; NERVE	Resting-state functional magnetic resonance imaging (fMRI) has been used to detect the alterations of spontaneous neuronal activity in various neurological and neuropsychiatric diseases, but rarely in hemifacial spasm (HFS), a nervous system disorder. We used resting-state fMRI with regional homogeneity (ReHo) analysis to investigate changes in spontaneous brain activity of patients with HFS and to determine the relationship of these functional changes with clinical features. Thirty patients with HFS and 33 age-, sex-, and education-matched healthy controls were included in this study. Compared with controls, HFS patients had significantly decreased ReHo values in left middle frontal gyrus (MFG), left medial cingulate cortex (MCC), left lingual gyrus, right superior temporal gyrus (STG) and right precuneus; and increased ReHo values in left precentral gyrus, anterior cingulate cortex (ACC), right brainstem, and right cerebellum. Furthermore, the mean ReHo value in brainstem showed a positive correlation with the spasm severity (r = 0.404, p = 0.027), and the mean ReHo value in MFG was inversely related with spasm severity in HFS group (r = -0.398, p = 0.028). This study reveals that HFS is associated with abnormal spontaneous brain activity in brain regions most involved in motor control and blinking movement. The disturbances of spontaneous brain activity reflected by ReHo measurements may provide insights into the neurological pathophysiology of HFS.	[Tu, Ye; Yu, Buwei] Shanghai Jiao Tong Univ, Ruijin Hosp, Sch Med, Dept Anesthesiol, Shanghai 200030, Peoples R China; [Wei, Yongxu; Zhao, Weiguo] Shanghai Jiao Tong Univ, Ruijin Hosp, Sch Med, Dept Neurosurg, Shanghai 200030, Peoples R China; [Sun, Kun] Shanghai Jiao Tong Univ, Ruijin Hosp, Sch Med, Dept Radiol, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University	Yu, BW (corresponding author), Shanghai Jiao Tong Univ, Ruijin Hosp, Sch Med, Dept Anesthesiol, Shanghai 200030, Peoples R China.	buweiyu1997@163.com						ALEXANDER GE, 1986, ANNU REV NEUROSCI, V9, P357, DOI 10.1146/annurev.ne.09.030186.002041; Baglio F, 2011, NEUROBIOL AGING, V32, P115, DOI 10.1016/j.neurobiolaging.2008.12.009; Cai WD, 2014, HUM BRAIN MAPP, V35, P2119, DOI 10.1002/hbm.22315; Calderon DP, 2011, NAT NEUROSCI, V14, P357, DOI 10.1038/nn.2753; Chhatwal JP, 2013, NEUROLOGY, V81, P736, DOI 10.1212/WNL.0b013e3182a1aafe; Chung JY, 2006, NEUROSCI LETT, V395, P196, DOI 10.1016/j.neulet.2005.10.094; Dambacher F, 2014, J COGNITIVE NEUROSCI, V26, P1775, DOI 10.1162/jocn_a_00595; Fang WD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069199; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; Gao JH, 1996, SCIENCE, V272, P545, DOI 10.1126/science.272.5261.545; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Hanakawa T, 2008, CEREB CORTEX, V18, P930, DOI 10.1093/cercor/bhm129; Jankovic J, 2009, NEUROL CLIN, V27, P821, DOI 10.1016/j.ncl.2009.04.005; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Kendall M.G., 1990, RANK CORRELATION MET, V5th; Kotterba S, 2000, ACTA NEUROL SCAND, V101, P305, DOI 10.1034/j.1600-0404.2000.90281a.x; Lerner A, 2009, CEREB CORTEX, V19, P218, DOI 10.1093/cercor/bhn074; Li ZJ, 2012, J MAGN RESON IMAGING, V36, P344, DOI 10.1002/jmri.23670; Luo CY, 2014, NEUROBIOL AGING, V35, P431, DOI 10.1016/j.neurobiolaging.2013.08.018; Luppino G, 2000, NEWS PHYSIOL SCI, V15, P219; Machielsen WCM, 2000, HUM BRAIN MAPP, V9, P156, DOI 10.1002/(SICI)1097-0193(200003)9:3<156::AID-HBM4>3.0.CO;2-Q; Manto M, 2012, CEREBELLUM, V11, P457, DOI 10.1007/s12311-011-0331-9; MARTINELLI P, 1992, MOVEMENT DISORD, V7, P181, DOI 10.1002/mds.870070214; Martinelli P, 2012, MOVEMENT DISORD, V27, P927, DOI [10.1002/mds.25013, 10.1002/mds.24986]; MOLLER AR, 1991, ACTA NEUROCHIR, V113, P24, DOI 10.1007/BF01402110; Oge AE, 2005, CLIN NEUROPHYSIOL, V116, P1542, DOI 10.1016/j.clinph.2005.02.021; Pilurzi G, 2013, J PHYSIOL-LONDON, V591, P1889, DOI 10.1113/jphysiol.2012.245746; Ping LH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071557; Power JD, 2012, NEUROIMAGE, V59, P2142, DOI 10.1016/j.neuroimage.2011.10.018; Robinson OJ, 2012, AM J PSYCHIAT, V169, P152, DOI 10.1176/appi.ajp.2011.11010137; Shimizu M, 2012, MOVEMENT DISORD, V27, P519, DOI 10.1002/mds.24925; Song XW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025031; Tan EK, 2004, J NEUROL SCI, V219, P151, DOI 10.1016/j.jns.2004.01.010; Tokucoglu F, 2008, ACTA NEUROL BELG, V108, P94; van der Salm SMA, 2013, EXP NEUROL, V247, P623, DOI 10.1016/j.expneurol.2013.02.017; Wang AC, 1998, MUSCLE NERVE, V21, P1740, DOI 10.1002/(SICI)1097-4598(199812)21:12<1740::AID-MUS17>3.0.CO;2-V; Wang L, 2014, PSYCHOL MED, V44, P1417, DOI 10.1017/S0033291713002031; Wu T, 2009, HUM BRAIN MAPP, V30, P1502, DOI 10.1002/hbm.20622; Yan CG, 2013, NEUROIMAGE, V76, P183, DOI 10.1016/j.neuroimage.2013.03.004; Zuo XN, 2013, NEUROIMAGE, V65, P374, DOI 10.1016/j.neuroimage.2012.10.017	40	19	21	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2015	10	1							e0116849	10.1371/journal.pone.0116849	http://dx.doi.org/10.1371/journal.pone.0116849			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ4OZ	25603126	Green Published, gold, Green Submitted			2022-12-27	WOS:000348203500033
J	Bhaskar, RV; Mohanty, B; Verma, V; Wijaya, E; Kumar, PP				Bhaskar, Ravindran Vijay; Mohanty, Bijayalaxmi; Verma, Vivek; Wijaya, Edward; Kumar, Prakash P.			A Hormone-Responsive C1-Domain-Containing Protein At5g17960 Mediates Stress Response in Arabidopsis thaliana	PLOS ONE			English	Article							GENOME-WIDE IDENTIFICATION; ABSCISIC-ACID; REGULATORY ELEMENT; GENE; TRANSCRIPTION; RESOURCE; CROSSTALK; FAMILY; SERVER	Phytohormones play a critical role in mediating plant stress response. They employ a variety of proteins for coordinating such processes. In Arabidopsis thaliana, some members of a Cys-rich protein family known as C1-clan proteins were involved in stress response, but the actual function of the protein family is largely unknown. We studied At5g17960, a C1-clan protein member that possesses three unique C1 signature domains viz. C1_2, C1_3 and ZZ/PHD type. Additionally, we identified 72 other proteins in A. thaliana that contain all three unique signature domains. Subsequently, the 73 proteins were phylogenetically classified into IX subgroups. Promoter motif analysis of the 73 genes identified the presence of hormone-responsive and stress-responsive putative cis-regulatory elements. Furthermore, we observed that transcript levels of At5g17960 were induced in response to different hormones and stress treatments. At1g35610 and At3g13760, two other members of subgroup IV, also showed upregulation upon GA3, biotic and abiotic stress treatments. Moreover, seedlings of independent transgenic A. thaliana lines ectopically expressing or suppressing At5g17960 also showed differential regulation of several abiotic stress-responsive marker genes. Thus, our data suggest that C1-domain-containing proteins have a role to play in plant hormone-mediated stress responses, thereby assigning a putative function for the C1-clan protein family.	[Bhaskar, Ravindran Vijay; Verma, Vivek; Kumar, Prakash P.] Natl Univ Singapore, Fac Sci, Dept Biol Sci, Singapore 117548, Singapore; [Mohanty, Bijayalaxmi] Natl Univ Singapore, Dept Chem & Biomol Engn, Singapore 117548, Singapore; [Wijaya, Edward] Osaka Univ, IFReC, Osaka, Japan; [Kumar, Prakash P.] Natl Univ Singapore, Temasek Life Sci Lab, Singapore 117548, Singapore	National University of Singapore; National University of Singapore; Osaka University; National University of Singapore	Kumar, PP (corresponding author), Natl Univ Singapore, Fac Sci, Dept Biol Sci, Singapore 117548, Singapore.	dbskumar@nus.edu.sg	Mohanty, Bijayalaxmi/AAY-7386-2020; Kumar, Prakash P/A-6236-2009	Mohanty, Bijayalaxmi/0000-0002-8226-2367; Kumar, Prakash P/0000-0002-0963-1664	National University of Singapore; Lee Foundation, Singapore	National University of Singapore(National University of Singapore); Lee Foundation, Singapore	RVB was the recipient of a research scholarship from the National University of Singapore. VV was supported by research funding from The Lee Foundation, Singapore. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMSKA I, 1992, J BIOL CHEM, V267, P24732; Atkinson NJ, 2012, J EXP BOT, V63, P3523, DOI 10.1093/jxb/ers100; Bailey T L, 1994, Proc Int Conf Intell Syst Mol Biol, V2, P28; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Davuluri RV, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-25; Garreton V, 2002, PLANT PHYSIOL, V130, P1516, DOI 10.1104/pp.009886; Higo K, 1999, NUCLEIC ACIDS RES, V27, P297, DOI 10.1093/nar/27.1.297; Hosoda K, 2002, PLANT CELL, V14, P2015, DOI 10.1105/tpc.002733; Huang EL, 2005, SER ADV BIOINFORM, V2, P611; Kohli A, 2013, PLANT CELL REP, V32, P945, DOI 10.1007/s00299-013-1461-y; Kumar PP, 2013, PLANT CELL REP, V32, P731, DOI 10.1007/s00299-013-1435-0; Lata C, 2011, J EXP BOT, V62, P4731, DOI 10.1093/jxb/err210; Li CL, 2010, PLANT PHYSIOL, V154, P211, DOI 10.1104/pp.110.161182; Li Y, 2008, GENOMICS, V92, P488, DOI 10.1016/j.ygeno.2008.08.011; Matys V, 2003, NUCLEIC ACIDS RES, V31, P374, DOI 10.1093/nar/gkg108; Nakano T, 2006, PLANT PHYSIOL, V140, P411, DOI 10.1104/pp.105.073783; Navarro L, 2008, CURR BIOL, V18, P650, DOI 10.1016/j.cub.2008.03.060; Priest HD, 2009, CURR OPIN PLANT BIOL, V12, P643, DOI 10.1016/j.pbi.2009.07.016; Proost S, 2009, PLANT CELL, V21, P3718, DOI 10.1105/tpc.109.071506; Puntervoll P, 2003, NUCLEIC ACIDS RES, V31, P3625, DOI 10.1093/nar/gkg545; Robert-Seilaniantz A, 2011, ANNU REV PHYTOPATHOL, V49, P317, DOI 10.1146/annurev-phyto-073009-114447; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Schwab R, 2006, PLANT CELL, V18, P1121, DOI 10.1105/tpc.105.039834; Shinya T, 2007, PLANT CELL PHYSIOL, V48, P1404, DOI 10.1093/pcp/pcm115; Stamm P, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-179; Stockinger EJ, 1997, P NATL ACAD SCI USA, V94, P1035, DOI 10.1073/pnas.94.3.1035; Suesslin C, 2003, PLANT J, V33, P591, DOI 10.1046/j.1365-313X.2003.01649.x; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tran LSP, 2007, P NATL ACAD SCI USA, V104, P20623, DOI 10.1073/pnas.0706547105; Zhang WX, 2005, BIOINFORMATICS, V21, P3074, DOI 10.1093/bioinformatics/bti490	31	7	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2015	10	1							e0115418	10.1371/journal.pone.0115418	http://dx.doi.org/10.1371/journal.pone.0115418			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9HN	25590629	Green Published, Green Submitted, gold			2022-12-27	WOS:000350679400009
J	Diez-Fernandez, A; Sanchez-Lopez, M; Gulias-Gonzalez, R; Notario-Pacheco, B; Garcia-Prieto, JC; Arias-Palencia, N; Martinez-Vizcaino, V				Diez-Fernandez, Ana; Sanchez-Lopez, Mairena; Gulias-Gonzalez, Roberto; Notario-Pacheco, Blanca; Canete Garcia-Prieto, Jorge; Arias-Palencia, Natalia; Martinez-Vizcaino, Vicente			BMI as a Mediator of the Relationship between Muscular Fitness and Cardiometabolic Risk in Children: A Mediation Analysis	PLOS ONE			English	Article							METABOLIC SYNDROME; CARDIORESPIRATORY FITNESS; CARDIOVASCULAR RISK; BODY-SIZE; INSULIN-RESISTANCE; BLOOD-PRESSURE; STRENGTH; ADOLESCENTS; OVERWEIGHT; PERFORMANCE	Objective Muscular fitness levels have been associated with cardiometabolic risk in children, although whether body weight acts as a confounder or as an intermediate variable in this relationship remains controversial. The aim of this study was to examine whether the association between muscular fitness and cardiometabolic risk factors is mediated by body mass index (BMI). Design and Methods Cross-sectional study using a sample of 1158 schoolchildren aged 8-11 years from the province of Cuenca, Spain. We measured anthropometrics and biochemical variables and we calculated a muscular fitness index as the sum of z-scores of handgrip dynamometry/weight and standing long jump, and we estimated a previously validated cardiometabolic risk index (CMRI). Linear regression models were fitted for mediation analysis to assess whether the association between muscular fitness and cardiometabolic risk was mediated by BMI. Results Children with normal weight (NW) had a better cardiometabolic risk profile than their overweight (OW) or obese (OB) peers after controlling for muscular fitness. Marginal estimated mean +/- SE values for NW, OW and OB categories of CMRI were -0.75 +/- 0.06<0.84 +/- 0.10<2.18 +/- 0.16 in boys and -0.73 +/- 0.06<0.96 +/- 0.10<2.71 +/- 0.17 in girls, both p<0.001. Children with higher levels of muscular fitness had a better cardiometabolic risk profile (CMRI marginal estimated mean +/- SE 1.04 +/- 0.13>0.05 +/- 0.09>-1.16 +/- 0.13 for lower, middle and upper quartiles of muscular fitness in boys and 1.01 +/- 0.16>0.10 +/- 0.09>-1.02 +/- 0.15 in girls, both p<0.001), but differences disappeared when controlling for BMI. BMI acted as a full mediator between muscular fitness and most cardiometabolic risk factors (Sobel test z=-11.44 for boys; z=-11.83 for girls; p<0.001 in CMRI mediation model) and as a partial mediator in the case of waist circumference (Sobel test z=-14.86 for boys; z=-14.51 for girls; p<0.001). Conclusions BMI mediates the association between muscular fitness and cardiometabolic risk in schoolchildren. Overall, good muscular fitness is associated with lower cardiometabolic risk, but particularly when accompanied by normal weight.	[Diez-Fernandez, Ana; Sanchez-Lopez, Mairena; Notario-Pacheco, Blanca; Canete Garcia-Prieto, Jorge; Arias-Palencia, Natalia; Martinez-Vizcaino, Vicente] Univ Castilla La Mancha, Social & Hlth Care Res Ctr, Cuenca, Spain; [Diez-Fernandez, Ana] Univ Castilla La Mancha, Fac Occupat Therapy Speech Therapy & Nursing, Talavera De La Reina, Toledo, Spain; [Sanchez-Lopez, Mairena; Gulias-Gonzalez, Roberto] Univ Castilla La Mancha, Fac Educ, E-13071 Ciudad Real, Spain; [Martinez-Vizcaino, Vicente] Univ Autonoma Chile, Fac Ciencias Salud, Talca, Chile	Universidad de Castilla-La Mancha; Universidad de Castilla-La Mancha; Universidad de Castilla-La Mancha; Universidad Autonoma de Chile	Martinez-Vizcaino, V (corresponding author), Univ Castilla La Mancha, Social & Hlth Care Res Ctr, Cuenca, Spain.	Vicente.martinez@uclm.es	Palencia, Natalia María Arias/Q-5070-2017; Diez-Fernandez, Ana/Z-3348-2019; VIZCAINO, VICENTE MARTINEZ/AAZ-9034-2021; VIZCAINO, VICENTE MARTINEZ/R-4336-2017; SANCHEZ-LOPEZ, MAIRENA/J-7933-2016; Notario Pacheco, Blanca/G-2583-2016	Palencia, Natalia María Arias/0000-0001-5004-3197; Diez-Fernandez, Ana/0000-0002-7673-986X; VIZCAINO, VICENTE MARTINEZ/0000-0001-6121-7893; VIZCAINO, VICENTE MARTINEZ/0000-0001-6121-7893; Notario Pacheco, Blanca/0000-0001-8406-6952; Sanchez Lopez, Mairena/0000-0002-0217-0623	Ministry of Education and Science-Junta de Comunidades de Castilla-La Mancha [PII1I09-0259-9898, POII10-0208-5325]; Ministry of Health [FIS PI081297]; Research Network on Preventative Activities and Health Promotion [-RD06/0018/0038]	Ministry of Education and Science-Junta de Comunidades de Castilla-La Mancha; Ministry of Health; Research Network on Preventative Activities and Health Promotion	This study was funded by the Ministry of Education and Science-Junta de Comunidades de Castilla-La Mancha (PII1I09-0259-9898 and POII10-0208-5325), and Ministry of Health (FIS PI081297). Additional funding was obtained from the Research Network on Preventative Activities and Health Promotion (Ref. -RD06/0018/0038). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen LB, 2003, PREV MED, V37, P363, DOI 10.1016/S0091-7435(03)00145-2; Artero EG, 2012, J CARDIOPULM REHABIL, V32, P351, DOI 10.1097/HCR.0b013e3182642688; Artero EG, 2011, PEDIATR DIABETES, V12, P704, DOI 10.1111/j.1399-5448.2011.00769.x; BAO WH, 1994, ARCH INTERN MED, V154, P1842; BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173; Benson AC, 2006, INT J PEDIATR OBES, V1, P222, DOI 10.1080/17477160600962864; Castro-Pinero J, 2010, J STRENGTH COND RES, V24, P1810, DOI 10.1519/JSC.0b013e3181ddb03d; Cole TJ, 2012, PEDIATR OBES, V7, P284, DOI 10.1111/j.2047-6310.2012.00064.x; Committee of Experts on Sports Resarch EUROFIT, 1993, HANDBOOK FOR THE EUR; Diez-Fernandez A, 2014, DIABETES CARE, V37, P855, DOI 10.2337/dc13-0416; Eberly LE, 2006, DIABETES CARE, V29, P123, DOI 10.2337/diacare.29.01.06.dc05-1320; Friedemann C, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e4759; Garcia-Artero E, 2007, REV ESP CARDIOL, V60, P581, DOI 10.1157/13107114; Grontved A, 2015, BRIT J SPORT MED, V49, P90, DOI 10.1136/bjsports-2012-091907; I'Allemand D, 2008, OBESITY, V16, P1672, DOI 10.1038/oby.2008.259; Jaric S, 2005, J STRENGTH COND RES, V19, P467; Karpe F, 2011, DIABETES, V60, P2441, DOI 10.2337/db11-0425; Leger LA, 1988, J SPORT SCI, V6, P93, DOI 10.1080/02640418808729800; MacKinnon D.P., 2012, INTRO STAT MEDIATION; Magnussen CG, 2012, EUR J APPL PHYSIOL, V112, P3167, DOI 10.1007/s00421-011-2286-4; Marcovecchio ML, 2013, CURR DIABETES REP, V13, P56, DOI 10.1007/s11892-012-0331-2; Markovic G, 2004, EUR J APPL PHYSIOL, V92, P139, DOI 10.1007/s00421-004-1076-7; Martinez-Vizcaino V, 2012, REV ESP CARDIOL, V65, P427, DOI [10.1016/j.recesp.2011.12.008, 10.1016/j.rec.2011.12.009]; Martinez-Vizcaino V, 2010, DIABETES CARE, V33, P1370, DOI 10.2337/dc09-2049; Peterson MD, 2014, PEDIATRICS, V133, pE896, DOI 10.1542/peds.2013-3169; Pietrobelli A, 2004, EUR J CLIN NUTR, V58, P1479, DOI 10.1038/sj.ejcn.1601993; Ruiz JR, 2007, J HYPERTENS, V25, P2027, DOI 10.1097/HJH.0b013e328277597f; Ruiz JR, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a439; Rutter MK, 2005, DIABETES, V54, P3252, DOI 10.2337/diabetes.54.11.3252; Sinaiko AR, 1999, CIRCULATION, V99, P1471, DOI 10.1161/01.CIR.99.11.1471; Smith JJ, 2014, SPORTS MED, V44, P1209, DOI 10.1007/s40279-014-0196-4; Sobel M.E., 1982, SOCIOL METHODOL, V13, P290, DOI [10.2307/270723, DOI 10.2307/270723]; Sokka T, 2008, CLIN EXP RHEUMATOL, V26, pS35, DOI 10.1161/CIRCULATIONAHA.109.192644; Steene-Johannessen J, 2009, MED SCI SPORT EXER, V41, P1361, DOI 10.1249/MSS.0b013e31819aaae5; Strong WB, 2005, J PEDIATR-US, V146, P732, DOI 10.1016/j.jpeds.2005.01.055; TANNER JM, 1985, J PEDIATR-US, V107, P317, DOI 10.1016/S0022-3476(85)80501-1; US Department of Health and Human Service, 2008, PHYS ACT GUID AM; WHO, 2010, GLOB REC PHYS ACT HL, V1st, P15; Wilson PWF, 2005, CIRCULATION, V112, P3066, DOI 10.1161/CIRCULATIONAHA.105.539528; Wolfe RR, 2006, AM J CLIN NUTR, V84, P475, DOI 10.1093/ajcn/84.3.475	40	31	32	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2015	10	1							e0116506	10.1371/journal.pone.0116506	http://dx.doi.org/10.1371/journal.pone.0116506			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9HN	25590619	Green Published, gold, Green Submitted			2022-12-27	WOS:000350679400015
J	Xiao, B; Wang, Y; Reinach, PS; Ren, YP; Li, JY; Hua, SS; Lu, HH; Chen, W				Xiao, Bing; Wang, Yu; Reinach, Peter S.; Ren, Yueping; Li, Jinyang; Hua, Shanshan; Lu, Huihui; Chen, Wei			Dynamic Ocular Surface and Lacrimal Gland Changes Induced in Experimental Murine Dry Eye	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; MATRIX METALLOPROTEINASES; SJOGRENS-SYNDROME; T-CELLS; KERATOCONJUNCTIVITIS SICCA; CONJUNCTIVAL EPITHELIUM; IMMUNE DEVIATION; TEAR FLUID; IN-VITRO; TGF-BETA	Dry eye disease can be a consequence of lacrimal gland insufficiency in Sjogren's Syndrome or increased tear film evaporation despite normal lacrimal gland function. To determine if there is a correlation between severity effects in these models and underlying pathophysiological responses, we compared the time dependent changes in each of these parameters that occur during a 6 week period. Dry eye was induced in 6-week-old female C57BL/6 mice by exposing them to an Intelligently Controlled Environmental System (ICES). Sixty mice were housed in ICES for 1, 2, 4 and 6 weeks respectively. Twelve were raised in normal environment and received subcutaneous injections of scopolamine hydrobromide (SCOP) 3 times daily for 5 days. Another sixty mice were housed in a normal environment and received no treatment. Corneal fluorescein staining along with corneal MMP-9 and caspase-3 level measurements were performed in parallel with the TUNEL assay. Interleukin-17(IL-17), IL-23, IL-6, IL-1, TNF-alpha, IFN-gamma and TGF-beta 2 levels were estimated by realtime PCR measurements of conjunctival and lacrimal gland samples (LGs). Immunohistochemistry of excised LGs along with flow cytometry in cervical lymph nodes evaluated immune cell infiltration. Light and transmission electron microscopy studies evaluated LGs cytoarchitectural changes. ICES induced corneal epithelial destruction and apoptosis peaked at 2 weeks and kept stable in the following 4 weeks. In the ICES group, lacrimal gland proinflammatory cytokine level increases were much lower than those in the SCOP group. In accord with the lower proinflammatory cytokine levels, in the ICES group, lacrimal gland cytosolic vesicular density and size exceeded that in the SCOP group. ICES and SCOP induced murine dry eye effects became progressively more severe over a two week period. Subsequently, the disease process stabilized for the next four weeks. ICES induced local effects in the ocular surface, but failed to elicit lacrimal gland inflammation and cytoarchitectural changes, which accounts for less dry eye severity in the ICES model than that in the SCOP model.	[Xiao, Bing; Wang, Yu; Reinach, Peter S.; Ren, Yueping; Li, Jinyang; Hua, Shanshan; Lu, Huihui; Chen, Wei] Wenzhou Med Univ, Sch Ophthalmol & Optometry, Wenzhou, Zhejiang, Peoples R China; [Reinach, Peter S.] SUNY Coll Optometry, Dept Biol Sci, New York, NY 10036 USA	Wenzhou Medical University; State University of New York (SUNY) System; SUNY Optometry	Chen, W (corresponding author), Wenzhou Med Univ, Sch Ophthalmol & Optometry, Wenzhou, Zhejiang, Peoples R China.	chenweimd@hotmail.com	Reinach, Peter/AAI-3582-2021	Li, Jinyang/0000-0002-5904-3094	National Natural Science Foundation of China [81170820, 81470605]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was only supported by two research grants from National Natural Science Foundation of China (81170820 and 81470605). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Argueso P, 2001, EXP EYE RES, V73, P281, DOI 10.1006/exer.2001.1045; Blobe GC, 2000, NEW ENGL J MED, V342, P1350, DOI 10.1056/NEJM200005043421807; Brignole F, 1998, EXP EYE RES, V67, P687, DOI 10.1006/exer.1998.0566; Chauhan SK, 2009, J IMMUNOL, V182, P1247, DOI 10.4049/jimmunol.182.3.1247; Chen W, 2008, INVEST OPHTH VIS SCI, V49, P1386, DOI 10.1167/iovs.07-0744; Chen W, 2013, INVEST OPHTH VIS SCI, V54, P6287, DOI 10.1167/iovs.13-12081; Chen W, 2009, EXP EYE RES, V89, P311, DOI 10.1016/j.exer.2009.03.015; Clark AF, 1998, INVEST OPHTH VIS SCI, V39, P2514; Corrales RM, 2006, INVEST OPHTH VIS SCI, V47, P3293, DOI 10.1167/iovs.05-1382; De Paiva CS, 2009, MUCOSAL IMMUNOL, V2, P243, DOI 10.1038/mi.2009.5; Dursun D, 2002, INVEST OPHTH VIS SCI, V43, P632; FOX RI, 1986, ARTHRITIS RHEUM-US, V29, P577, DOI 10.1002/art.1780290501; Gao JP, 1998, CORNEA, V17, P654, DOI 10.1097/00003226-199811000-00014; GERSHON RK, 1975, TRANSPLANT REV-DENMA, V26, P170; Johnson ME, 2004, PROG RETIN EYE RES, V23, P449, DOI 10.1016/j.preteyeres.2004.04.003; Kamoi M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043688; Kang MH, 2011, J KOREAN MED SCI, V26, P938, DOI 10.3346/jkms.2011.26.7.938; KEHRL JH, 1986, J EXP MED, V163, P1037, DOI 10.1084/jem.163.5.1037; Kezuka T, 2000, INVEST OPHTH VIS SCI, V41, P1410; Kong L, 1998, CLIN EXP RHEUMATOL, V16, P675; Kretschmer K, 2005, NAT IMMUNOL, V6, P1219, DOI 10.1038/ni1265; Kugler A, 1999, ANTICANCER RES, V19, P1589; Lekhanont K, 2007, CORNEA, V26, P84, DOI 10.1097/01.ico.0000240079.24583.a1; Lemp Michael A., 1995, CLAO Journal, V21, P221; Li JY, 2012, MOL VIS, V18, P317; Mangan PR, 2006, NATURE, V441, P231, DOI 10.1038/nature04754; Massingale ML, 2009, CORNEA, V28, P1023, DOI 10.1097/ICO.0b013e3181a16578; Mills KHG, 2008, EUR J IMMUNOL, V38, P2636, DOI 10.1002/eji.200838535; Niederkorn JY, 2006, J IMMUNOL, V176, P3950, DOI 10.4049/jimmunol.176.7.3950; Pflugfelder SC, 1999, CURR EYE RES, V19, P201, DOI 10.1076/ceyr.19.3.201.5309; Piccirillo CA, 2004, SEMIN IMMUNOL, V16, P81, DOI 10.1016/j.smim.2003.12.003; Pitcher JD, 2011, INVEST OPHTH VIS SCI, V52, P3221, DOI 10.1167/iovs.09-4212; Schaumberg DA, 2002, ADV EXP MED BIOL, V506, P989; Siemasko KF, 2008, INVEST OPHTH VIS SCI, V49, P5434, DOI 10.1167/iovs.08-2075; Solomon A, 2001, INVEST OPHTH VIS SCI, V42, P2283; Stern ME, 2010, MUCOSAL IMMUNOL, V3, P425, DOI 10.1038/mi.2010.26; Stern ME, 1998, CORNEA, V17, P584, DOI 10.1097/00003226-199811000-00002; Takeuchi M, 1997, EUR J IMMUNOL, V27, P1648, DOI 10.1002/eji.1830270709; Takeuchi M, 1998, J IMMUNOL, V160, P1589; Turner K, 2000, CORNEA, V19, P492, DOI 10.1097/00003226-200007000-00018; Veldhoen M, 2006, IMMUNITY, V24, P179, DOI 10.1016/j.immuni.2006.01.001; Veldhoen M, 2006, NAT IMMUNOL, V7, P1151, DOI 10.1038/ni1391; Visse R, 2003, CIRC RES, V92, P827, DOI 10.1161/01.RES.0000070112.80711.3D; Weaver CT, 2006, IMMUNITY, V24, P677, DOI 10.1016/j.immuni.2006.06.002; WILBANKS GA, 1992, EUR J IMMUNOL, V22, P165, DOI 10.1002/eji.1830220125; Wolkoff P, 2005, OCCUP ENVIRON MED, V62, P4, DOI 10.1136/oem.2004.016030; Xanthou G, 1999, CLIN EXP IMMUNOL, V118, P154; Yeh S, 2003, INVEST OPHTH VIS SCI, V44, P124, DOI 10.1167/iovs.02-0581; Zheng XF, 2010, INVEST OPHTH VIS SCI, V51, P3083, DOI 10.1167/iovs.09-3838	49	40	42	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2015	10	1							e0115333	10.1371/journal.pone.0115333	http://dx.doi.org/10.1371/journal.pone.0115333			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9HN	25590134	Green Submitted, Green Published, gold			2022-12-27	WOS:000350679400004
J	del Campo, SEM; Latchana, N; Levine, KM; Grignol, VP; Fairchild, ET; Jaime-Ramirez, AC; Dao, TV; Karpa, VI; Carson, M; Ganju, A; Chan, AN; Carson, WE				del Campo, Sara E. Martin; Latchana, Nicholas; Levine, Kala M.; Grignol, Valerie P.; Fairchild, Ene T.; Jaime-Ramirez, Alena Cristina; Thao-Vi Dao; Karpa, Volodymyr I.; Carson, Mary; Ganju, Akaansha; Chan, Anthony N.; Carson, William E., III			MiR-21 Enhances Melanoma Invasiveness via Inhibition of Tissue Inhibitor of Metalloproteinases 3 Expression: In Vivo Effects of MiR-21 Inhibitor	PLOS ONE			English	Article							TUMOR-SUPPRESSOR GENES; PROMOTER METHYLATION; DOWN-REGULATION; INVASION; MICRORNA-21; CANCER; APOPTOSIS; TIMP-3; CELLS; PROGRESSION	Metastatic melanoma is the most aggressive form of this cancer. It is important to understand factors that increase or decrease metastatic activity in order to more effectively research and implement treatments for melanoma. Increased cell invasion through the extracellular matrix is required for metastasis and is enhanced by matrix metalloproteinases (MMPs). Tissue inhibitor of metalloproteinases 3 (TIMP3) inhibits MMP activity. It was previously shown by our group that miR-21, a potential regulator of TIMP3, is over-expressed in cutaneous melanoma. It was therefore hypothesized that increased levels of miR-21 expression would lead to decreased expression of TIMP3 and thereby enhance the invasiveness of melanoma cells. miR-21 over-expression in the melanoma cell lines WM1552c, WM793b, A375 and MEL 39 was accomplished via transfection with pre-miR-21. Immunoblot analysis of miR-21-overexpressing cell lines revealed reduced expression of TIMP3 as compared to controls. This in turn led to a significant increase in the invasiveness of the radial growth phase cell line WM1552c and the vertical growth phase cell line WM793b (p < 0.05), but not in the metastatic cell lines A375 or MEL 39. The proliferation and migration of miR-21 over-expressing cell lines was not affected. Reduced expression of TIMP3 was achieved by siRNA knockdown and significantly enhanced invasion of melanoma cell lines, mimicking the effects of miR-21 over-expression. Treatment of tumor cells with a linked nucleic acid antagomir to miR-21 inhibited tumor growth and increased tumor expression of TIMP3 in vivo in 01B74 Athymic NCr-nu/nu mice. Intra-tumoral injections of anti-miR-21 produced similar effects. This data shows that increased expression of miR-21 enhanced the invasive potential of melanoma cell lines through TIMP3 inhibition. Therefore, inhibition of miR-21 in melanoma may reduce melanoma invasiveness.	[del Campo, Sara E. Martin; Latchana, Nicholas; Grignol, Valerie P.; Carson, Mary; Carson, William E., III] Ohio State Univ, Dept Surg, Columbus, OH 43210 USA; [Levine, Kala M.] Ohio State Univ, Ctr Comprehens Canc, Columbus, OH 43210 USA; [Fairchild, Ene T.; Carson, William E., III] Nationwide Childrens Hosp, Dept Gen Pediat, Columbus, OH USA; [Jaime-Ramirez, Alena Cristina] Ohio State Univ, Arthur Giangiacomo James Canc Hosp, Dept Neurol Surg, Columbus, OH 43210 USA; [Jaime-Ramirez, Alena Cristina; Carson, William E., III] Richard Jack Solove Res Inst, Columbus, OH USA; [Thao-Vi Dao; Karpa, Volodymyr I.; Chan, Anthony N.] Wright State Univ, Sch Med, Dayton, OH 45435 USA; [Carson, William E., III] Ohio State Univ, Arthur Giangiacomo James Canc Hosp, Dept Mol Virol Immunol & Med Genet, Columbus, OH 43210 USA; [Ganju, Akaansha] Northeast Ohio Med Univ, Sch Med, Rootstown, OH USA	University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Wright State University Dayton; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; Northeast Ohio Medical University (NEOMED)	Carson, WE (corresponding author), Ohio State Univ, Dept Surg, Columbus, OH 43210 USA.	william.carson@osumc.edu	Carson, William E/E-2846-2011	Martin del Campo, Sara/0000-0002-8821-3208; Carson, III, William E./0000-0001-7024-7533; Grignol, Valerie/0000-0002-8574-0715	National Institutes of Health (NIH) [T32 CA090223, T32 CA009338, T32 GM068412, P30 CA16058, P01 CA95426-01A1, K24 CA93670]; NATIONAL CANCER INSTITUTE [T32CA090223, K24CA093670, T32CA009338, P01CA095426, P30CA016058] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM068412] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	LThis work was supported by National Institutes of Health (NIH) Grants T32 CA090223 (to WEC), T32 CA009338 (to M.A. Caligiuri), T32 GM068412 (to V.M. Sanders), P30 CA16058 (to M.A. Caligiuri), P01 CA95426-01A1 (to M.A. Caligiuri), and K24 CA93670 (to WEC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahonen M, 2003, ONCOGENE, V22, P2121, DOI 10.1038/sj.onc.1206292; Ahonen M, 1998, CANCER RES, V58, P2310; Asangani IA, 2008, ONCOGENE, V27, P2128, DOI 10.1038/sj.onc.1210856; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Coit Daniel G, 2012, J Natl Compr Canc Netw, V10, P366; Cruz-Munoz W, 2006, ONCOGENE, V25, P6489, DOI 10.1038/sj.onc.1209663; Dalmay T, 2006, ONCOGENE, V25, P6170, DOI 10.1038/sj.onc.1209911; Das AM, 2014, ANGIOGENESIS, V17, P163, DOI 10.1007/s10456-013-9385-2; Feng HC, 2004, GYNECOL ONCOL, V94, P375, DOI 10.1016/j.ygyno.2004.04.019; Frankel LB, 2008, J BIOL CHEM, V283, P1026, DOI 10.1074/jbc.M707224200; Gabriely G, 2008, MOL CELL BIOL, V28, P5369, DOI 10.1128/MCB.00479-08; Gaggioli C, 2007, PIGM CELL RES, V20, P161, DOI 10.1111/j.1600-0749.2007.00378.x; Grignol V, 2011, BRIT J CANCER, V105, P1023, DOI 10.1038/bjc.2011.288; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; Hofmann UB, 2005, BIOCHIMIE, V87, P307, DOI 10.1016/j.biochi.2005.01.013; HORNER M, 2009, SURVEILLANCE EPIDEMI; Hu SY, 2006, INT J CANCER, V119, P2322, DOI 10.1002/ijc.22110; Karan D, 2003, INT J ONCOL, V23, P1365; Kettunen E, 2004, CANCER GENET CYTOGEN, V149, P98, DOI 10.1016/s0165-4608(03)00300-5; LECO KJ, 1994, J BIOL CHEM, V269, P9352; Lesinski GB, 2007, CLIN CANCER RES, V13, P5010, DOI 10.1158/1078-0432.CCR-06-3092; Li T, 2009, BIOCHEM BIOPH RES CO, V383, P280, DOI 10.1016/j.bbrc.2009.03.077; Liu SH, 2008, PIGM CELL MELANOMA R, V21, P545, DOI 10.1111/j.1755-148X.2008.00484.x; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Meng FY, 2007, GASTROENTEROLOGY, V133, P647, DOI 10.1053/j.gastro.2007.05.022; Nareyeck G, 2005, OPHTHAL RES, V37, P23, DOI 10.1159/000082940; Satyamoorthy K, 1997, MELANOMA RES, V7, pS35; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Selaru FM, 2009, HEPATOLOGY, V49, P1595, DOI 10.1002/hep.22838; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Song B, 2010, J EXP CLIN CANC RES, V29, DOI 10.1186/1756-9966-29-29; Srinivasan R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008283; Storz P, 2009, MOL CELL BIOL, V29, P4906, DOI 10.1128/MCB.00077-09; Van der Velden PA, 2003, INT J CANCER, V106, P472, DOI 10.1002/ijc.11262; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Wang N, 2013, DIGEST DIS SCI, V58, P1863, DOI 10.1007/s10620-013-2612-2; Yu WH, 2000, J BIOL CHEM, V275, P31226, DOI 10.1074/jbc.M000907200; Zeng ZS, 2001, DIS COLON RECTUM, V44, P1290, DOI 10.1007/BF02234786; Zhang AM, 2011, UROLOGY, V78, DOI 10.1016/j.urology.2011.03.030; Zhang ZY, 2008, LAB INVEST, V88, P1358, DOI 10.1038/labinvest.2008.94; Zhang Z, 2012, WIRES RNA, V3, P593, DOI 10.1002/wrna.1114; Zhu SM, 2008, CELL RES, V18, P350, DOI 10.1038/cr.2008.24	42	71	71	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2015	10	1							e0115919	10.1371/journal.pone.0115919	http://dx.doi.org/10.1371/journal.pone.0115919			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ0ID	25587717	Green Submitted, Green Published, gold			2022-12-27	WOS:000347928300007
J	Sun, M; Lu, MX; Tang, XT; Du, YZ				Sun, Meng; Lu, Ming-Xing; Tang, Xiao-Tian; Du, Yu-Zhou			Exploring Valid Reference Genes for Quantitative Real-Time PCR Analysis in Sesamia inferens (Lepidoptera: Noctuidae)	PLOS ONE			English	Article							RT-PCR; EXPRESSION ANALYSIS; QUANTIFICATION; NORMALIZATION; WALKER; SELECTION; MODEL; BORER	The pink stem borer, Sesamia inferens, which is endemic in China and other parts of Asia, is a major pest of rice and causes significant yield loss in this host plant. Very few studies have addressed gene expression in S. inferens. Quantitative real-time PCR (qRT-PCR) is currently the most accurate and sensitive method for gene expression analysis. In qRT-PCR, data are normalized using reference genes, which help control for internal differences and reduce error between samples. In this study, seven candidate reference genes, 18S ribosomal RNA (18S rRNA), elongation factor 1 (EF1), glyceraldehyde-3-phosphate dehydrogenase (GAPDH), ribosomal protein S13 (RPS13), ribosomal protein S20 (RPS20), tubulin (TUB), and beta-actin (ACTB) were evaluated for their suitability in normalizing gene expression under different experimental conditions. The results indicated that three genes (RPS13, RPS20, and EF1) were optimal for normalizing gene expression in different insect tissues (head, epidermis, fat body, foregut, midgut, hindgut, Malpighian tubules, haemocytes, and salivary glands). 18S rRNA, EF1, and GAPDH were best for normalizing expression with respect to developmental stages and sex (egg masses; first, second, third, fourth, fifth, and sixth instar larvae; male and female pupae; and one-day-old male and female adults). 18S rRNA, RPS20, and TUB were optimal for fifth instars exposed to different temperatures (-8, -6, -4, -2, 0, and 27 degrees C). To validate this recommendation, the expression profile of a target gene heat shock protein 83 gene (hsp83) was investigated, and results showed the selection was necessary and effective. In conclusion, this study describes reference gene sets that can be used to accurately measure gene expression in S. inferens.	[Sun, Meng; Lu, Ming-Xing; Tang, Xiao-Tian; Du, Yu-Zhou] Yangzhou Univ, Sch Hort & Plant Protect, Yangzhou, Jiangsu, Peoples R China; [Sun, Meng; Lu, Ming-Xing; Tang, Xiao-Tian; Du, Yu-Zhou] Yangzhou Univ, Inst Appl Entomol, Yangzhou, Jiangsu, Peoples R China; [Sun, Meng] Shangdong Acad Agr Sci, Inst Plant Protect, Jinan, Shandong, Peoples R China	Yangzhou University; Yangzhou University; Shandong Academy of Agricultural Sciences	Du, YZ (corresponding author), Yangzhou Univ, Sch Hort & Plant Protect, Yangzhou, Jiangsu, Peoples R China.	yzdu@yzu.edu.cn			National Basic Research Program of China (973 Program) [2012CB114100]; National Natural Science Foundation of China [31371937]; Youth Science Foundation of Yangzhou; Testing Center of Yangzhou University	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Youth Science Foundation of Yangzhou; Testing Center of Yangzhou University	This research was funded by the National Basic Research Program of China (973 Program) (2012CB114100), the National Natural Science Foundation of China (31371937), and Youth Science Foundation of Yangzhou. The authors also appreciate the support and help of the Testing Center of Yangzhou University on experimental apparatus. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Areekul S., 1973, Kasetsart J, V7, P65; Bustin SA, 2005, J MOL ENDOCRINOL, V34, P597, DOI 10.1677/jme.1.01755; Bustin SA, 2000, J MOL ENDOCRINOL, V25, P169, DOI 10.1677/jme.0.0250169; Bustin SA, 2002, J MOL ENDOCRINOL, V29, DOI 10.1677/jme.0.0290023; Bustin SA, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-74; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Derveaux S, 2010, METHODS, V50, P227, DOI 10.1016/j.ymeth.2009.11.001; Dheda K, 2005, ANAL BIOCHEM, V344, P141, DOI 10.1016/j.ab.2005.05.022; Fu W, 2013, INT J BIOL SCI, V9, P792, DOI 10.7150/ijbs.5862; Han Chao, 2012, Chinese Journal of Applied Entomology, V49, P281; Huggett J, 2005, GENES IMMUN, V6, P279, DOI 10.1038/sj.gene.6364190; Jiang HB, 2010, MOL BIOL REP, V37, P1019, DOI 10.1007/s11033-009-9803-0; Jiang XF, 2012, CELL STRESS CHAPERON, V17, P67, DOI 10.1007/s12192-011-0286-2; Joshi Gagan, 2009, Annals of Biology (Hissar), V25, P41; Lee PD, 2002, GENOME RES, V12, P292, DOI 10.1101/gr.217802; Lu YH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068059; Mahesh P, 2013, SUGAR TECH, V15, P384, DOI 10.1007/s12355-013-0212-2; Mao JJ, 2014, TRANSGENIC RES, V23, P145, DOI 10.1007/s11248-013-9739-y; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Picard D, 2002, CELL MOL LIFE SCI, V59, P1640, DOI 10.1007/PL00012491; Ponton F, 2011, J INSECT PHYSIOL, V57, P840, DOI 10.1016/j.jinsphys.2011.03.014; Radonic A, 2004, BIOCHEM BIOPH RES CO, V313, P856, DOI 10.1016/j.bbrc.2003.11.177; Rahman Md. Touhidur, 2004, Entomologia Sinica, V11, P47; Silver N, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-33; Singh Beant, 2012, Journal of Entomology, V9, P368, DOI 10.3923/je.2012.368.374; Suzuki T, 2000, BIOTECHNIQUES, V29, P332, DOI 10.2144/00292rv02; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; VanGuilder HD, 2008, BIOTECHNIQUES, V44, P619, DOI 10.2144/000112776; Xie FL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026980; Yu H, 2012, J INTEGR AGR, V11, P293, DOI 10.1016/S2095-3119(12)60013-6; Zhu X, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084730	33	57	62	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2015	10	1							e0115979	10.1371/journal.pone.0115979	http://dx.doi.org/10.1371/journal.pone.0115979			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ4OG	25585250	Green Published, Green Submitted, gold			2022-12-27	WOS:000348201300005
J	Gunia, BC; Murnighan, JK				Gunia, Brian C.; Murnighan, J. Keith			The Tell-Tale Look: Viewing Time, Preferences, and Prices	PLOS ONE			English	Article							GAZE BIAS; BROWSING BEHAVIOR; DECISION-MAKING; ATTENTION; CHOICE; CASCADE; INFANTS; MODEL	Even the simplest choices can prompt decision-makers to balance their preferences against other, more pragmatic considerations like price. Thus, discerning people's preferences from their decisions creates theoretical, empirical, and practical challenges. The current paper addresses these challenges by highlighting some specific circumstances in which the amount of time that people spend examining potential purchase items (i.e., viewing time) can in fact reveal their preferences. Our model builds from the gazing literature, in a purchasing context, to propose that the informational value of viewing time depends on prices. Consistent with the model's predictions, four studies show that when prices are absent or moderate, viewing time provides a signal that is consistent with a person's preferences and purchase intentions. When prices are extreme or consistent with a person's preferences, however, viewing time is a less reliable predictor of either. Thus, our model highlights a price-contingent "viewing bias," shedding theoretical, empirical, and practical light on the psychology of preferences and visual attention, and identifying a readily observable signal of preference.	[Gunia, Brian C.] Johns Hopkins Univ, Carey Business Sch, Baltimore, MD 21202 USA; [Murnighan, J. Keith] Northwestern Univ, JL Kellogg Grad Sch Management, Evanston, IL 60208 USA	Johns Hopkins University; Northwestern University	Gunia, BC (corresponding author), Johns Hopkins Univ, Carey Business Sch, 100 Int Dr,13th Floor, Baltimore, MD 21202 USA.	brian.gunia@jhu.edu	Gunia, Brian C./D-7887-2015	Gunia, Brian C./0000-0001-8922-1747	Northwestern University	Northwestern University	Funding: There are no current funding sources for this study. While the data was being collected, the study was funded by the Northwestern University research account of the second author. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BIRCH EE, 1985, INVEST OPHTH VIS SCI, V26, P366; BLOCH PH, 1983, ADV CONSUM RES, V10, P389; Bucklin RE, 2003, J MARKETING RES, V40, P249, DOI 10.1509/jmkr.40.3.249.19241; Buhrmester M, 2011, PERSPECT PSYCHOL SCI, V6, P3, DOI 10.1177/1745691610393980; Davenport T.H., 2001, ATTENTION EC UNDERST, DOI 10.1145/375348.376626; FANTZ RL, 1964, SCIENCE, V146, P668, DOI 10.1126/science.146.3644.668; Glaholt M. G., 2011, J NEUROSCI PSYCHOL E, V4, P125, DOI DOI 10.1037/A0020692; Glaholt MG, 2009, PSYCHNOLOGY J, V7, P141; Glaholt MG, 2009, VIS COGN, V17, P1228, DOI 10.1080/13506280802362962; Glaholt MG, 2009, ATTEN PERCEPT PSYCHO, V71, P445, DOI 10.3758/APP.71.3.445; Johnson EJ, 2003, J MARKETING, V67, P62, DOI 10.1509/jmkg.67.2.62.18615; KAHNEMAN D, 1982, COGNITION, V11, P123, DOI 10.1016/0010-0277(82)90022-1; Knutson B, 2008, NEURON, V58, P814, DOI 10.1016/j.neuron.2008.05.018; Knutson B, 2007, NEURON, V53, P147, DOI 10.1016/j.neuron.2006.11.010; Krajbich I, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00193; KUNSTWILSON WR, 1980, SCIENCE, V207, P557, DOI 10.1126/science.7352271; Liang TP, 2002, P 35 HAW INT C SYST, DOI [10.1109/HICSS.2002.994214, DOI 10.1109/HICSS.2002.994214]; Malhotra N.K., 2008, REV MARKETING RES, P123, DOI DOI 10.1108/S1548-6435(2008)0000004009; MELLERS BA, 1992, J EXP PSYCHOL HUMAN, V18, P347, DOI 10.1037/0096-1523.18.2.347; Moe WW, 2004, MANAGE SCI, V50, P326, DOI 10.1287/mnsc.1040.0153; Nittono H, 2009, PERCEPT MOTOR SKILL, V109, P79, DOI 10.2466/PMS.109.1.79-94; O'Connor KM, 2002, J BEHAV DECIS MAKING, V15, P403, DOI 10.1002/bdm.426; Park YH, 2004, MARKET SCI, V23, P280, DOI 10.1287/mksc.1040.0050; Payne J. W., 1993, ADAPTIVE DECISION MA; Pieters R, 2007, J CONSUM RES, V34, P224, DOI 10.1086/519150; Reutskaja E, 2011, AM ECON REV, V101, P900, DOI 10.1257/aer.101.2.900; Rosbergen E, 1997, J CONSUM RES, V24, P305, DOI 10.1086/209512; RUSSO JE, 1994, J CONSUM RES, V21, P274, DOI 10.1086/209397; Samuelson PA, 1938, ECONOMICA-NEW SER, V5, P61, DOI 10.2307/2548836; Schotter ER, 2010, VIS COGN, V18, P1113, DOI 10.1080/13506281003668900; Senter SM, 1999, J EXP PSYCHOL LEARN, V25, P428, DOI 10.1037/0278-7393.25.2.428; Shimojo S, 2003, NAT NEUROSCI, V6, P1317, DOI 10.1038/nn1150; Simion C, 2007, PERCEPT PSYCHOPHYS, V69, P591, DOI 10.3758/BF03193916; Simion C, 2006, VISION RES, V46, P3331, DOI 10.1016/j.visres.2006.04.019; Smith DN, 2004, J BUS RES, V57, P1199, DOI 10.1016/S0148-2963(02)00330-2; Street A.P., 1986, COMBINATORICS EXPT D; Stuttgen P, 2012, MARKET SCI, V31, P878, DOI 10.1287/mksc.1120.0732; Yarbus A.L., 1967, EYE MOVEMENTS VISION, DOI 10.1007/978-1-4899-5379-7; ZAJONC RB, 1968, J PERS SOC PSYCHOL, V9, P1, DOI 10.1037/h0025848	39	1	1	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2015	10	1							e0117137	10.1371/journal.pone.0117137	http://dx.doi.org/10.1371/journal.pone.0117137			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AZ4CF	25581382	Green Published, gold, Green Submitted			2022-12-27	WOS:000348169100008
J	Chun, YH; Han, K; Park, SH; Park, KM; Yim, HW; Lee, WC; Park, YG; Park, YM				Chun, Yoon Hong; Han, Kyungdo; Park, Shin Hae; Park, Kyung-Min; Yim, Hyeon Woo; Lee, Won-Chul; Park, Yong Gyu; Park, Yong-Moon			Insulin Resistance Is Associated with Intraocular Pressure Elevation in a Non-Obese Korean Population	PLOS ONE			English	Article							METABOLIC SYNDROME; OBESITY; EYE; HYPERTENSION; STIMULATION; OSTEOCALCIN; GLAUCOMA; DISEASES	Based on reports of an association between elevated intraocular pressure (IOP) and metabolic syndrome (MetS), and the major role of insulin resistance (IR) in MetS pathogenesis, a positive association between IOP and IR has been hypothesized. Although Asian populations tend to have lower body mass indices (BMIs) than Western populations, they tend to have a higher risk of developing MetS. This study examined the hypothesis that the association between IOP and IR differs by obesity status in an Asian population, by examining a nationally representative sample of South Korean adults. Data collected from 4,621 South Korean adults regarding demographic, lifestyle, and laboratory parameters by the 2010 Korea National Health and Nutrition Examination Survey were subjected to linear regression analysis to evaluate the relationship between IOP and metabolic profiles. After adjusting for confounding factors, the data were subjected to multiple linear regression analysis to examine the association between IR, as measured by the homeostasis model assessment of insulin resistance (HOMA-IR), and IOP. Obesity was defined as BMI >= 27.5 kg/m(2), and the subjects were divided into obese vs. non-obese groups for investigation of the association between IR and IOP according to obesity status. IOP was found to correlate with fasting blood sugar, total cholesterol, insulin, and HOMA-IR values in non-obese men; and with BMI, waist circumference, triglycerides, total cholesterol, HOMA-IR, and low-density lipoprotein cholesterol values in non-obese women, whereas no association between IOP and IR was found in obese men or women. IOP was significantly associated with IR in non-obese men and women after adjusting for age, and in non-obese men after adjusting for age, BMI, and lifestyle and demographic factors. These findings indicate that a positive and independent relationship exists between IOP and IR in non-obese individuals only, suggesting that other factors likely contribute to IOP elevation in obese individuals.	[Chun, Yoon Hong] Catholic Univ Korea, Coll Med, Incheon St Marys Hosp, Dept Pediat, Seoul, South Korea; [Han, Kyungdo; Park, Yong Gyu] Catholic Univ Korea, Dept Biostat, Seoul, South Korea; [Park, Shin Hae] Catholic Univ Korea, Coll Med, Seoul St Marys Hosp, Dept Ophthalmol & Visual Sci, Seoul, South Korea; [Park, Kyung-Min] Catholic Univ Korea, Sch Med, Seoul, South Korea; [Yim, Hyeon Woo; Lee, Won-Chul; Park, Yong-Moon] Catholic Univ Korea, Coll Med, Dept Prevent Med, Seoul, South Korea; [Park, Yong-Moon] Univ S Carolina, Arnold Sch Publ Hlth, Dept Epidemiol & Biostat, Columbia, SC 29208 USA	Catholic University of Korea; Catholic University of Korea; Catholic University of Korea; Seoul St. Mary's Hospital; Catholic University of Korea; Catholic University of Korea; University of South Carolina; University of South Carolina System; University of South Carolina Columbia	Park, YM (corresponding author), Catholic Univ Korea, Coll Med, Dept Prevent Med, Seoul, South Korea.	markYMpark@gmail.com	PARK, YONG-MOON ("MARK")/ABA-2765-2021	PARK, YONG-MOON ("MARK")/0000-0002-5879-6879; Park, Yong Gyu/0000-0002-8721-3230; Chun, Yoon Hong/0000-0002-9871-5244				Chang YC, 2010, EYE, V24, P1037, DOI 10.1038/eye.2009.247; Cheung N, 2007, SURV OPHTHALMOL, V52, P180, DOI 10.1016/j.survophthal.2006.12.003; Choi YJ, 2011, DIABETES METAB J, V35, P587, DOI 10.4093/dmj.2011.35.6.587; Civan MM, 2004, EXP EYE RES, V78, P625, DOI 10.1016/j.exer.2003.09.021; dos Santos MG, 1998, OPHTHALMOLOGY, V105, P2260, DOI 10.1016/S0161-6420(98)91226-X; EAKINS KE, 1967, J PHARMACOL EXP THER, V157, P524; Ferron M, 2008, P NATL ACAD SCI USA, V105, P5266, DOI 10.1073/pnas.0711119105; Ferron M, 2014, ARCH BIOCHEM BIOPHYS, V561, P137, DOI 10.1016/j.abb.2014.05.022; GALLAR J, 1993, INVEST OPHTH VIS SCI, V34, P596; Geer EB, 2009, GENDER MED, V6, P60, DOI 10.1016/j.genm.2009.02.002; GREAVES DP, 1952, BRIT J OPHTHALMOL, V36, P258, DOI 10.1136/bjo.36.5.258; Imai K, 2010, INT J OBESITY, V34, P1209, DOI 10.1038/ijo.2010.32; Jain A, 2012, INVEST OPHTH VIS SCI, V53, P857, DOI 10.1167/iovs.11-8497; Kahn SE, 2006, NATURE, V444, P840, DOI 10.1038/nature05482; Kass MA, 2002, ARCH OPHTHALMOL-CHIC, V120, P701; Kelley DE, 2000, AM J PHYSIOL-ENDOC M, V278, pE941, DOI 10.1152/ajpendo.2000.278.5.E941; Kim MK, 2014, CLIN ENDOCRINOL, V80, P214, DOI 10.1111/cen.12162; LANDSBERG L, 1994, J CARDIOVASC PHARM, V23, pS1, DOI 10.1097/00005344-199423001-00002; Lee MK, 2012, OPHTHALMOLOGY, V119, P450, DOI 10.1016/j.ophtha.2011.09.016; Lim SG, 2014, J CLIN PERIODONTOL, V41, P121, DOI 10.1111/jcpe.12196; Lin CP, 2012, EUR J INTERN MED, V23, P76, DOI 10.1016/j.ejim.2011.06.002; Maury E, 2010, MOL CELL ENDOCRINOL, V314, P1, DOI 10.1016/j.mce.2009.07.031; Oh SW, 2005, DIABETES-METAB RES, V21, P434, DOI 10.1002/dmrr.529; Oh SW, 2004, OBES RES, V12, P2031, DOI 10.1038/oby.2004.254; Park BJ, 2013, MENOPAUSE, V20, P742, DOI [10.1097/gme.0b013e31827ce3c6, 10.1097/GME.0b013e31827ce3c6]; Ruderman NB, 2013, J CLIN INVEST, V123, P2764, DOI 10.1172/JCI67227; Schlaich M, 2014, LANCET DIABETES ENDO; SHIOSE Y, 1990, SURV OPHTHALMOL, V34, P413, DOI 10.1016/0039-6257(90)90122-C; Silvestri C, 2013, J BIOL CHEM, V288, P23307, DOI 10.1074/jbc.M113.489906; Stevens GA, 2013, OPHTHALMOLOGY, V120, P2377, DOI 10.1016/j.ophtha.2013.05.025; Tan GS, 2009, ARCH OPHTHALMOL-CHIC, V127, P1354, DOI 10.1001/archophthalmol.2009.268; Wallace TM, 2002, DIABETIC MED, V19, P527, DOI 10.1046/j.1464-5491.2002.00745.x; Westphal Sydney A, 2008, Clin Cornerstone, V9, P23, DOI 10.1016/S1098-3597(08)60025-3; WHO, 2004, LANCET, V363, P902; Wu SY, 1997, ARCH OPHTHALMOL-CHIC, V115, P1572, DOI 10.1001/archopht.1997.01100160742012; Yoon KH, 2006, LANCET, V368, P1681, DOI 10.1016/S0140-6736(06)69703-1	36	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2015	10	1							e112929	10.1371/journal.pone.0112929	http://dx.doi.org/10.1371/journal.pone.0112929			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ3BG	25559470	Green Published, gold, Green Submitted			2022-12-27	WOS:000348102200005
J	Derouet, MF; Liu, G; Darling, GE				Derouet, Mathieu Francois; Liu, Geoffrey; Darling, Gail Elizabeth			MiR-145 Expression Accelerates Esophageal Adenocarcinoma Progression by Enhancing Cell Invasion and Anoikis Resistance	PLOS ONE			English	Article							MICRORNA EXPRESSION; CANCER PROGRESSION; ALPHA-5-BETA-1; METASTASIS	Background: Carcinoma of the esophagus has a high case fatality ratio and is now the 6th most common cause of cancer deaths in the world. We previously conducted a study to profile the expression of miRNAs in esophageal adenocarcinoma (EAC) pre and post induction therapy. Of the miRNAs differentially expressed post induction chemoradiation, miR-145, a known tumor suppressor miRNA, was upregulated 8-fold following induction therapy, however, its expression was associated with shorter disease-free survival. This unexpected result was explored in this current study. Methods: In order to study the role of miR-145 in EAC, miRNA-145 was overexpressed in 3 EAC cell lines (OE33, FLO-1, SK-GT-4) and one ESCC cell line (KYSE-410). After validation of the expression of miR-145, hallmarks of cancer such as cell proliferation, resistance to chemotherapy drugs or anoikis, and cell invasion were analyzed. Results: There were no differences in cell proliferation and 5 FU resistance between miR145 cell lines and the control cell lines. miR-145 expression also had no effect on cisplatin resistance in two of three cell lines (OE33 and FLO-1), but miR-145 appeared to protect SK-GT-4 cells against cisplatin treatment. However, there was a significant difference in cell invasion, cell adhesion and resistance to anoikis. All three EAC miR-145 cell lines invaded more than their respective controls. Similarly, OE33 and SK-GT-4 miR-145 cell lines were able to survive longer in a suspension state. Discussion: While expression of miR-145 in ESCC stopped proliferation and invasion, expression of miR-145 in EAC cells enhanced invasion and anoikis resistance. Although more work is required to understand how miR-145 conveys these effects, expression of miR-145 appears to promote EAC progression by enhancing invasion and protection against anoikis, which could in turn facilitate distant metastasis.	[Derouet, Mathieu Francois] Univ Hlth Network, Latner Thorac Surg Res Labs, Toronto, ON, Canada; [Liu, Geoffrey] Univ Hlth Network Toronto, Princess Margaret Hosp, Dept Med Oncol, Toronto, ON, Canada; [Darling, Gail Elizabeth] Univ Hlth Network, Toronto Gen Hosp, Div Thorac Surg, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital	Derouet, MF (corresponding author), Univ Hlth Network, Latner Thorac Surg Res Labs, Toronto Discovery Med Tower, Toronto, ON, Canada.	mderouet@uhnresearch.ca	Liu, Geoffrey/N-4421-2016	Liu, Geoffrey/0000-0002-2603-7296	Kress Family Chair in Esophageal Surgery	Kress Family Chair in Esophageal Surgery	This work was supported by the Kress Family Chair in Esophageal Surgery. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amir S, 2014, PLOS ONE, V8; Arndt GM, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-374; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Beausejour M, 2013, BMC CELL BIOL, V14, DOI 10.1186/1471-2121-14-53; BLOT WJ, 1994, SEMIN ONCOL, V21, P403; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Chen Z, 2010, J EXP CLIN CANC RES, V29, DOI 10.1186/1756-9966-29-151; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Fabbri M, 2007, EXPERT OPIN BIOL TH, V7, P1009, DOI 10.1517/14712598.7.7.1009; Flynt AS, 2008, NAT REV GENET, V9, P831, DOI 10.1038/nrg2455; Hvid-Jensen F, 2011, NEW ENGL J MED, V365, P1375, DOI 10.1056/NEJMoa1103042; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Kano M, 2010, INT J CANC; Ko MA, 2012, ANN THORAC SURG, V94, P1094, DOI 10.1016/j.athoracsur.2012.04.145; Korah R, 2004, CANCER RES, V64, P4514, DOI 10.1158/0008-5472.CAN-03-3853; Le MTN, 2009, GENE DEV, V23, P862, DOI 10.1101/gad.1767609; Lin CW, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2876; Liu D, 2014, BIOCHEM BIOPH RES CO, V446, P549, DOI 10.1016/j.bbrc.2014.03.002; Liu R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033987; Mitra AK, 2011, ONCOGENE, V30, P1566, DOI 10.1038/onc.2010.532; Nam EJ, 2008, CLIN CANCER RES, V14, P2690, DOI 10.1158/1078-0432.CCR-07-1731; Ozen M, 2008, ONCOGENE, V27, P1788, DOI 10.1038/sj.onc.1210809; Pagliuca A, 2013, ONCOGENE, V32, P4806, DOI 10.1038/onc.2012.495; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Peng XS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020341; Roman J, 2010, AM J RESP CELL MOL, V43, P684, DOI 10.1165/rcmb.2009-0375OC; Tang F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035435; Valeri N, 2014, CANCER CELL, V25, P469, DOI 10.1016/j.ccr.2014.03.006; Visone R, 2007, ONCOGENE, V26, P7590, DOI 10.1038/sj.onc.1210564; Yin Y, 2013, BBA-GENE REGUL MECH, V1829, P239, DOI 10.1016/j.bbagrm.2012.11.006; Yuan W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102017	32	31	32	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2014	9	12							e115589	10.1371/journal.pone.0115589	http://dx.doi.org/10.1371/journal.pone.0115589			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UC	25551563	gold, Green Submitted, Green Published			2022-12-27	WOS:000347119100046
J	Dudkina, E; Kayumov, A; Ulyanova, V; Ilinskaya, O				Dudkina, Elena; Kayumov, Airat; Ulyanova, Vera; Ilinskaya, Olga			New Insight into Secreted Ribonuclease Structure: Binase Is a Natural Dimer	PLOS ONE			English	Article							BOVINE SEMINAL RIBONUCLEASE; BACILLUS-INTERMEDIUS-RIBONUCLEASE; CRYSTAL-STRUCTURE; CELL-DEATH; RNASE; PROTEIN; BARNASE; BARSTAR; DOMAIN; CYTOTOXICITY	The biological effects of ribonucleases (RNases), such as the control of the blood vessels growth, the toxicity towards tumour cells and antiviral activity, require a detailed explanation. One of the most intriguing properties of RNases which can contribute to their biological effects is the ability to form dimers, which facilitates efficient RNA hydrolysis and the evasion of ribonuclease inhibitor. Dimeric forms of microbial RNase binase secreted by Bacillus pumilus (former B. intermedius) have only been found in crystals to date. Our study is the first report directly confirming the existence of binase dimers in solution and under natural conditions of enzyme biosynthesis and secretion by bacilli. Using different variants of gel electrophoresis, immunoblotting, size-exclusion chromatography and mass-spectrometry, we revealed that binase is a stable natural dimer with high catalytic activity.	[Dudkina, Elena; Kayumov, Airat; Ulyanova, Vera; Ilinskaya, Olga] Kazan Fed Volga Reg Univ, Inst Fundamental Med & Biol, Kazan, Russia	Kazan Federal University	Dudkina, E (corresponding author), Kazan Fed Volga Reg Univ, Inst Fundamental Med & Biol, Kazan, Russia.	lenatimonina@rambler.ru	Kayumov, Airat/M-6725-2013; Ulyanova, Vera/A-9427-2014; Ilinskaya, Olga N/A-7458-2014; Dudkina, Elena/G-4318-2016	Kayumov, Airat/0000-0001-7195-1557; Ulyanova, Vera/0000-0003-1768-3314; Ilinskaya, Olga N/0000-0001-6936-2032; Dudkina, Elena/0000-0002-2817-1384	Russian Research Foundation [14 -14-00522]	Russian Research Foundation	This work was performed in frames of the Russian Government Program for Competitive Growth of Kazan Federal University and supported by the Russian Research Foundation (project No 14 -14-00522). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ababou A, 2007, BIOPHYS CHEM, V125, P221, DOI 10.1016/j.bpc.2006.08.003; APHANASENKO GA, 1979, FEBS LETT, V97, P77, DOI 10.1016/0014-5793(79)80056-3; Arnold U, 2011, FEBS J, V278, P331, DOI 10.1111/j.1742-4658.2010.07957.x; Bertram R, 2014, FRONT CELL INFECT MI, V4, DOI 10.3389/fcimb.2014.00006; Boix E, 2013, BIOCHIMIE, V95, P1087, DOI 10.1016/j.biochi.2012.12.015; Cabrera-Fuentes HA, 2013, TOXICON, V69, P219, DOI 10.1016/j.toxicon.2013.03.015; CAFARO V, 1995, FEBS LETT, V359, P31, DOI 10.1016/0014-5793(94)01450-F; Cook GM, 2013, BBA-GENE REGUL MECH, V1829, P523, DOI 10.1016/j.bbagrm.2013.02.007; Cui ZH, 2005, BIOINFORMATION, V1, P28, DOI 10.6026/97320630001028; Ercole C, 2011, ARCH BIOCHEM BIOPHYS, V506, P123, DOI 10.1016/j.abb.2010.11.014; Ermakova E, 2007, BIOPHYS CHEM, V130, P26, DOI 10.1016/j.bpc.2007.06.012; Faizullin D. A., 1995, MOL BIOL, V29, P563; Fuentes H. A. Cabrera, 2012, Biomeditsinskaya Khimiya, V58, P272; Garvie CW, 2013, BBA-PROTEINS PROTEOM, V1834, P1562, DOI 10.1016/j.bbapap.2013.04.010; Gotte G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046804; Hahnen E, 2000, MOL GEN GENET, V263, P571; HARTLEY RW, 1988, J MOL BIOL, V202, P913, DOI 10.1016/0022-2836(88)90568-2; Ilinskaya ON, 2002, PROTEIN SCI, V11, P2522, DOI 10.1110/ps.0216702; Ilinskaya ON, 1996, MUTAT RES-FUND MOL M, V354, P203, DOI 10.1016/0027-5107(96)00012-7; Kayumov A, 2011, FEBS J, V278, P1779, DOI 10.1111/j.1742-4658.2011.08102.x; Kozakov D, 2013, PROTEINS, V81, P2159, DOI 10.1002/prot.24403; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lee JE, 2005, BIOCHEMISTRY-US, V44, P15760, DOI 10.1021/bi051668z; Lin RJ, 2013, NUCLEIC ACIDS RES, V41, P3314, DOI 10.1093/nar/gkt019; Liu YS, 1998, P NATL ACAD SCI USA, V95, P3437, DOI 10.1073/pnas.95.7.3437; Liu YS, 2001, NAT STRUCT BIOL, V8, P211, DOI 10.1038/84941; MAKAROV AA, 1993, J BIOMOL STRUCT DYN, V10, P1047, DOI 10.1080/07391102.1993.10508695; MAZZARELLA L, 1993, ACTA CRYSTALLOGR D, V49, P389, DOI 10.1107/S0907444993003403; Merlino A, 2008, J MOL BIOL, V376, P427, DOI 10.1016/j.jmb.2007.11.008; Mitkevich VA, 2013, ACTA CRYSTALLOGR D, V69, P991, DOI 10.1107/S0907444913004046; Mitkevich VA, 2011, CELL CYCLE, V10, P4090, DOI 10.4161/cc.10.23.18210; Mitkevich VA, 2010, CELL CYCLE, V9, P2674, DOI 10.4161/cc.9.13.12150; Park C, 2000, PROTEIN SCI, V9, P2026, DOI 10.1110/ps.9.10.2026; PAVLOVSKII AG, 1989, KRISTALLOGRAFIYA+, V34, P137; PICCOLI R, 1992, P NATL ACAD SCI USA, V89, P1870, DOI 10.1073/pnas.89.5.1870; Poliakov K M, 2010, Mol Biol (Mosk), V44, P922; Polyakov KM, 2002, ACTA CRYSTALLOGR D, V58, P744, DOI 10.1107/S0907444902003207; Reibarkh MY, 1998, FEBS LETT, V431, P250, DOI 10.1016/S0014-5793(98)00765-0; Schulga A, 1998, PROTEIN ENG, V11, P775, DOI 10.1093/protein/11.9.775; SCHULGA AA, 1992, NUCLEIC ACIDS RES, V20, P2375, DOI 10.1093/nar/20.9.2375; Shah Mahmud R, 2013, ACTA NATURAE, V5, P44, DOI 10.32607/20758251-2013-5-4-44-51; Shirshikov FV, 2013, MED HYPOTHESES, V81, P328, DOI 10.1016/j.mehy.2013.04.006; Shlyakhovenko V. A., 2009, Experimental Oncology, V31, P127; Ulyanova V, 2011, FEBS J, V278, P3633, DOI 10.1111/j.1742-4658.2011.08294.x; VESCIA S, 1981, MOL CELL BIOCHEM, V36, P125, DOI 10.1007/BF02357027; Znamenskaya L. V., 1995, Mikrobiologiya, V64, P616; Zuo YH, 2002, J BIOL CHEM, V277, P50160, DOI 10.1074/jbc.M207707200	47	20	20	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2014	9	12							e115818	10.1371/journal.pone.0115818	http://dx.doi.org/10.1371/journal.pone.0115818			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UC	25551440	Green Published, Green Submitted, gold			2022-12-27	WOS:000347119100065
J	Hagleitner, MM; Coenen, MJH; Patino-Garcia, A; de Bont, ESJM; Gonzalez-Neira, A; Vos, HI; van Leeuwen, FN; Gelderblom, H; Hoogerbrugge, PM; Guchelaar, HJ; te Loo, MWM				Hagleitner, Melanie M.; Coenen, Marieke J. H.; Patino-Garcia, Ana; de Bont, Eveline S. J. M.; Gonzalez-Neira, Anna; Vos, Hanneke I.; van Leeuwen, Frank N.; Gelderblom, Hans; Hoogerbrugge, Peter M.; Guchelaar, Henk-Jan; te Loo, Maroeska W. M.			Influence of Genetic Variants in TPMT and COMT Associated with Cisplatin Induced Hearing Loss in Patients with Cancer: Two New Cohorts and a Meta-Analysis Reveal Significant Heterogeneity between Cohorts	PLOS ONE			English	Article							INDUCED OTOTOXICITY; RISK-FACTORS; CHILDREN; CHEMOTHERAPY	Treatment with cisplatin-containing chemotherapy regimens causes hearing loss in 40-60% of cancer patients. It has been suggested that genetic variants in the genes encoding thiopurine S-methyltransferase (TPMT) and catechol O-methyltransferase (COMT) can predict the development of cisplatin-induced ototoxicity and may explain interindividual variability in sensitivity to cisplatininduced hearing loss. Two recently published studies however, sought to validate these findings and showed inconsistent results. The aim of this study was to evaluate the role of polymorphisms in the TPMT and COMT genes in cisplatin-induced ototoxicity. Therefore we investigated two independent cohorts of 110 Dutch and 38 Spanish patients with osteosarcoma and performed a meta-analysis including all previously published studies resulting in a total population of 664 patients with cancer. With this largest meta-analysis performed to date, we show that the influence of TPMT and COMT on the development of cisplatin-induced hearing loss may be less important than previously suggested.	[Hagleitner, Melanie M.; Vos, Hanneke I.; van Leeuwen, Frank N.; Hoogerbrugge, Peter M.; te Loo, Maroeska W. M.] Radboud Univ Nijmegen, Med Ctr, Dept Pediat Hematol & Oncol, NL-6525 ED Nijmegen, Netherlands; [Coenen, Marieke J. H.] Radboud Univ Nijmegen, Med Ctr, Dept Human Genet, NL-6525 ED Nijmegen, Netherlands; [Patino-Garcia, Ana] Univ Navarra, Dept Pediat, E-31080 Pamplona, Spain; [Patino-Garcia, Ana] Univ Clin, Pamplona, Spain; [de Bont, Eveline S. J. M.] Univ Groningen, Univ Med Ctr Groningen, Dept Pediat Hematol & Oncol, Groningen, Netherlands; [Gonzalez-Neira, Anna] Spanish Natl Canc Res Ctr, Human Genotyping Unit CeGen, Madrid, Spain; [Gelderblom, Hans] Leiden Univ, Med Ctr, Dept Clin Oncol, Leiden, Netherlands; [Guchelaar, Henk-Jan] Leiden Univ, Med Ctr, Dept Clin Pharm & Toxicol, Leiden, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen; University of Navarra; University of Groningen; Centro Nacional de Investigaciones Oncologicas (CNIO); Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Hagleitner, MM (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Pediat Hematol & Oncol, NL-6525 ED Nijmegen, Netherlands.	Melanie.Hagleitner@radboudumc.nl	guchelaar, henk-jan/AAP-1381-2021; Coenen, Marieke/A-2159-2010; van Leeuwen, Frank/AAQ-6799-2020; Loo, Maroeska te/P-6048-2015; Hoogerbrugge, Peter M./H-8049-2014; Hagleitner, Melanie/E-5376-2016; Gonzalez-Neira, Anna/C-5791-2015; Hagleitner, Melanie/AAV-1239-2020; Patiño-Garcia, Ana/I-4299-2012	Coenen, Marieke/0000-0001-8796-2031; van Leeuwen, Frank/0000-0003-1107-6513; Loo, Maroeska te/0000-0001-6308-4801; Gonzalez-Neira, Anna/0000-0002-5421-2020; Patiño-Garcia, Ana/0000-0002-4066-8203; Gelderblom, Hans/0000-0001-9270-8636; Guchelaar, Henk-Jan/0000-0002-7085-1383	Foundation KiKa, Amstelveen, The Netherlands; Asociacion Espanola Contra el Cancer, Spain	Foundation KiKa, Amstelveen, The Netherlands(Netherlands Government); Asociacion Espanola Contra el Cancer, Spain	This project was supported by a grant from the Foundation KiKa, Amstelveen, The Netherlands and the Asociacion Espanola Contra el Cancer, Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BLAKLEY BW, 1994, ARCH OTOLARYNGOL, V120, P541; Brock PR, 2012, J CLIN ONCOL, V30, P2408, DOI 10.1200/JCO.2011.39.1110; Campbell KCM, 2007, HEARING RES, V226, P92, DOI 10.1016/j.heares.2006.11.012; Garcia-Berrocal JR, 2007, BRIT J PHARMACOL, V152, P1012, DOI 10.1038/sj.bjp.0707405; Hagleitner MM, 2011, PEDIATR BLOOD CANCER, V56, P35, DOI 10.1002/pbc.22654; Khrunin AV, 2014, PHARMACOGENOMICS, V15, P329, DOI 10.2217/pgs.13.237; Knight KRG, 2005, J CLIN ONCOL, V23, P8588, DOI 10.1200/JCO.2004.00.5355; Li Y, 2004, EUR J CANCER, V40, P2445, DOI 10.1016/j.ejca.2003.08.009; Marina N, 2005, CANCER, V104, P841, DOI 10.1002/cncr.21218; Pan CC, 2005, INT J RADIAT ONCOL, V61, P1393, DOI 10.1016/j.ijrobp.2004.08.019; Park MS, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V134858; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Pussegoda K, 2013, CLIN PHARMACOL THER, V94, P243, DOI 10.1038/clpt.2013.80; Ross CJD, 2009, NAT GENET, V41, P1345, DOI 10.1038/ng.478; Rybak LP, 2005, DRUG DISCOV TODAY, V10, P1313, DOI 10.1016/S1359-6446(05)03552-X; Soros P, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00150; van As JW, 2014, COCHRANE DB SYST REV, V7; Videhult P, 2006, EXP BIOL MED, V231, P1638; von Stechow L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076476; Yancey A, 2012, PEDIATR BLOOD CANCER, V59, P144, DOI 10.1002/pbc.24138; Yang JJ, 2013, CLIN PHARMACOL THER, V94, P252, DOI 10.1038/clpt.2013.121	21	40	41	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2014	9	12							e115869	10.1371/journal.pone.0115869	http://dx.doi.org/10.1371/journal.pone.0115869			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UC	25551397	Green Published, Green Submitted, gold			2022-12-27	WOS:000347119100071
J	Lima, VD; Xavier, SCD; Maldonado, IFR; Roque, ALR; Vicente, ACP; Jansen, AM				Lima, Valdirene dos Santos; das Chagas Xavier, Samanta Cristina; Roman Maldonado, Irene Fabiola; Rodrigues Roque, Andre Luiz; Paulo Vicente, Ana Carolina; Jansen, Ana Maria			Expanding the Knowledge of the Geographic Distribution of Trypanosoma cruzi TcII and TcV/TcVI Genotypes in the Brazilian Amazon	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; RIO-DE-JANEIRO; CHAGAS-DISEASE; MOLECULAR EPIDEMIOLOGY; CONSERVATION UNIT; DOMESTIC MAMMALS; WILD; TRANSMISSION; LINEAGES; INFECTION	Trypanosoma cruzi infection is a complex sylvatic enzooty involving a wide range of animal species. Six discrete typing units (DTUs) of T. cruzi, named TcI to TcVI, are currently recognized. One unanswered question concerning the epidemiology of T. cruzi is the distribution pattern of TcII and hybrid DTUs in nature, including their virtual absence in the Brazilian Amazon, the current endemic area of Chagas disease in Brazil. Herein, we characterized biological samples that were collected in previous epizootiological studies carried out in the Amazon Basin in Brazil. We performed T. cruzi genotyping using four polymorphic genes to identify T. cruzi DTUs: mini-exon, 1f8, histone 3 and gp72. This analysis was conducted in the following biological samples: (i) two T. cruzi isolates obtained by culturing of stools from the triatomine species Rhodnius picttipes and (ii) five serum samples from dogs in which trypomastigotes were observed during fresh blood examination. We report for the first time the presence of TcII and hybrid DTUs (TcV/TcVI) in the Amazon region in mixed infections with TcI. Furthermore, sequencing of the constitutive gene, gp72, demonstrated diversity in TcII even within the same forest fragment. These data show that TcII is distributed in the five main Brazilian biomes and is likely more prevalent than currently described. It is very probable that there is no biological or ecological barrier to the transmission and establishment of any DTU in any biome in Brazil.	[Lima, Valdirene dos Santos; das Chagas Xavier, Samanta Cristina; Roman Maldonado, Irene Fabiola; Rodrigues Roque, Andre Luiz; Jansen, Ana Maria] Fiocruz MS, Fundacao Oswaldo Cruz, Lab Biol Tripanosomatideos, BR-21045900 Rio De Janeiro, Brazil; [Paulo Vicente, Ana Carolina] Fiocruz MS, Lab Genet Mol Microorganismos, BR-21045900 Rio De Janeiro, Brazil	Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz	Jansen, AM (corresponding author), Fiocruz MS, Fundacao Oswaldo Cruz, Lab Biol Tripanosomatideos, BR-21045900 Rio De Janeiro, Brazil.	jansen@ioc.fiocruz.br	Roque, André Luiz Rodrigues/W-7528-2019	Jansen, Ana Maria/0000-0001-5804-6210; Roman Maldonado, Irene Fabiola/0000-0001-5835-3560; Roque, Andre/0000-0002-8740-052X; Xavier, Samanta Cristina/0000-0002-3475-0075	Fundacao Oswaldo Cruz - FIOCRUZ; European Union [223034 - ChagasEpiNet]; Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)	Fundacao Oswaldo Cruz - FIOCRUZ; European Union(European Commission); Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ))	This study was funded by Fundacao Oswaldo Cruz - FIOCRUZ; the European Union Seventh Framework Program Grant 223034 - ChagasEpiNet; Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ). All isolates in the present study originated from ColTryp/IOC-FIOCRUZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aliaga C, 2011, INFECT GENET EVOL, V11, P1155, DOI 10.1016/j.meegid.2010.11.013; Araujo CAC, 2011, EXP PARASITOL, V127, P308, DOI 10.1016/j.exppara.2010.07.013; Azambuja P, 2004, EXP PARASITOL, V107, P89, DOI 10.1016/j.exppara.2004.04.007; Barnabe C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082269; Birky CW, 1996, GENETICS, V144, P427; Briones MRS, 1999, MOL BIOCHEM PARASIT, V104, P219, DOI 10.1016/S0166-6851(99)00155-3; Chagas C, 1909, MEM I OSWALDO CRUZ, V1, P159, DOI DOI 10.1590/S0074-02761909000200008; Coura JR, 2002, TRENDS PARASITOL, V18, P171, DOI 10.1016/S1471-4922(01)02200-0; Valente SADS, 2009, T ROY SOC TROP MED H, V103, P291, DOI 10.1016/j.trstmh.2008.10.047; Xavier SCD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001647; de Freitas JM, 2006, PLOS PATHOG, V2, P226, DOI 10.1371/journal.ppat.0020024; De Meeus T, 2006, INFECT GENET EVOL, V6, P163, DOI 10.1016/j.meegid.2005.02.004; Fernandes O, 2001, T ROY SOC TROP MED H, V95, P97, DOI 10.1016/S0035-9203(01)90350-5; Ferreira LF, 2000, ACTA TROP, V75, P79, DOI 10.1016/S0001-706X(99)00095-9; Breniere SF, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001650; Guhl F, 2000, MEM I OSWALDO CRUZ, V95, P553, DOI 10.1590/S0074-02762000000400018; Herrera C, 2007, INFECT GENET EVOL, V7, P535, DOI 10.1016/j.meegid.2006.12.003; Herrera HM, 2008, T ROY SOC TROP MED H, V102, P1133, DOI 10.1016/j.trstmh.2008.04.041; JANSEN AM, 1991, EXP PARASITOL, V73, P249, DOI 10.1016/0014-4894(91)90096-F; Lewis MD, 2009, AM J TROP MED HYG, V81, P1041, DOI 10.4269/ajtmh.2009.09-0305; Lima VS, 2008, EMERG INFECT DIS, V14, P1001, DOI 10.3201/eid1406.070707; Lisboa CV, 2006, PARASITOLOGY, V133, P603, DOI 10.1017/S0031182006000722; Lisboa CV, 2009, VET PARASITOL, V165, P19, DOI 10.1016/j.vetpar.2009.07.002; Lisboa CV, 2000, MEM I OSWALDO CRUZ, V95, P445, DOI 10.1590/S0074-02762000000400002; Llewellyn MS, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000410; Machado CA, 2001, P NATL ACAD SCI USA, V98, P7396, DOI 10.1073/pnas.121187198; Marcili A, 2009, PARASITOLOGY, V136, P641, DOI 10.1017/S0031182009005861; Marcili A, 2009, INT J PARASITOL, V39, P615, DOI 10.1016/j.ijpara.2008.09.015; Mejia-Jaramillo AM, 2009, EXP PARASITOL, V121, P83, DOI 10.1016/j.exppara.2008.10.002; Mello CB, 1996, EXP PARASITOL, V82, P112, DOI 10.1006/expr.1996.0015; Miles MA, 2009, PARASITOLOGY, V136, P1509, DOI 10.1017/S0031182009990977; Monteiro WM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041284; Pennington PM, 2009, AM J TROP MED HYG, V80, P239, DOI 10.4269/ajtmh.2009.80.239; Pinho AP, 2000, T ROY SOC TROP MED H, V94, P509, DOI 10.1016/S0035-9203(00)90069-5; Rocha FL, 2013, PARASITOLOGY, V140, P160, DOI 10.1017/S0031182012001539; Roque ALR, 2008, AM J TROP MED HYG, V79, P742, DOI 10.4269/ajtmh.2008.79.742; Roque ALR, 2013, VET PARASITOL, V193, P71, DOI 10.1016/j.vetpar.2012.11.028; Rozas M, 2007, J INFECT DIS, V195, P1381, DOI 10.1086/513440; Santos-Mallet JR, 2008, PARASITOL RES, V103, P1041, DOI 10.1007/s00436-008-1089-y; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; TIBAYRENC M, 1986, P NATL ACAD SCI USA, V83, P115, DOI 10.1073/pnas.83.1.115; TIBAYRENC M, 1987, PARASITOL TODAY, V3, P189, DOI 10.1016/0169-4758(87)90179-7; Toledo A, 2013, AM J TROP MED HYG, V88, P285, DOI 10.4269/ajtmh.2012.12-0227; Vallejo GA, 1999, ACTA TROP, V72, P203, DOI 10.1016/S0001-706X(98)00085-0; Westenberger SJ, 2005, GENETICS, V171, P527, DOI 10.1534/genetics.104.038745; Xavier SCC, 2007, PARASITOL INT, V56, P119, DOI 10.1016/j.parint.2007.01.003; Yeo M, 2007, INT J PARASITOL, V37, P111, DOI 10.1016/j.ijpara.2006.08.002; Zingales B, 2012, INFECT GENET EVOL, V12, P240, DOI 10.1016/j.meegid.2011.12.009	48	24	26	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2014	9	12							e116137	10.1371/journal.pone.0116137	http://dx.doi.org/10.1371/journal.pone.0116137			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UC	25551227	Green Published, gold			2022-12-27	WOS:000347119100098
J	McGuire, LP; Jonasson, KA; Guglielmo, CG				McGuire, Liam P.; Jonasson, Kristin A.; Guglielmo, Christopher G.			Bats on a Budget: Torpor-Assisted Migration Saves Time and Energy	PLOS ONE			English	Article							BODY-COMPOSITION; TEMPERATURE; BIRDS; HYPOTHERMIA; SELECTION; STOPOVER	Bats and birds must balance time and energy budgets during migration. Migrating bats face similar physiological challenges to birds, but nocturnality creates special challenges for bats, such as a conflict between travelling and refueling, which many birds avoid by feeding in daylight and flying at night. As endothermic animals, bats and birds alike must expend substantial amounts of energy to maintain high body temperatures. For migratory birds refueling at stopovers, remaining euthermic during inactive periods reduces the net refuelling rate, thereby prolonging stopover duration and delaying subsequent movement. We hypothesized that bats could mitigate similar ambient-temperature dependent costs by using a torpor-assisted migration strategy. We studied silver-haired bats Lasionycteris noctivagans during autumn migration using a combination of respirometry and temperature-sensitive radiotelemetry to estimate energy costs incurred under ambient temperature conditions, and the energy that bats saved by using torpor during daytime roosting periods. All bats, regardless of sex, age, or body condition used torpor at stopover and saved up to 91% of the energy they would have expended to remain euthermic. Furthermore, bats modulated use of torpor depending on ambient temperature. By adjusting the time spent torpid, bats achieved a rate of energy expenditure independent of the ambient temperature encountered at stopover. By lowering body temperature during inactive periods, fuel stores are spared, reducing the need for refuelling. Optimal migration models consider trade-offs between time and energy. Heterothermy provides a physiological strategy that allows bats to conserve energy without paying a time penalty as they migrate. Although uncommon, some avian lineages are known to use heterothermy, and current theoretical models of migration may not be appropriate for these groups. We propose that thermoregulatory strategies should be an important consideration of future migration studies of both bats and birds.	[McGuire, Liam P.; Jonasson, Kristin A.; Guglielmo, Christopher G.] Univ Western Ontario, Dept Biol, Adv Facil Avian Res, London, ON, Canada	Western University (University of Western Ontario)	McGuire, LP (corresponding author), Texas Tech Univ, Dept Biol Sci, Lubbock, TX 79409 USA.	liam.mcguire@ttu.edu	McGuire, Liam/CAE-8434-2022		Discovery Grant from the Natural Sciences and Engineering Research Council of Canada; Leaders Opportunity Fund Grant from the Canada Foundation for Innovation; Ontario Research Fund [CFI 11826]; Canada Graduate Scholarships from the Natural Sciences and Engineering Research Council of Canada	Discovery Grant from the Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Leaders Opportunity Fund Grant from the Canada Foundation for Innovation; Ontario Research Fund; Canada Graduate Scholarships from the Natural Sciences and Engineering Research Council of Canada	Funding was provided to CGG by a Discovery Grant from the Natural Sciences and Engineering Research Council of Canada and a Leaders Opportunity Fund Grant from the Canada Foundation for Innovation and Ontario Research Fund (CFI 11826). LPM and KAJ were supported by Canada Graduate Scholarships from the Natural Sciences and Engineering Research Council of Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alerstam T, 1990, BIRD MIGRATION PHYSL, P331, DOI [DOI 10.1007/978-3-642-74542-3_22., 10.1007/978-3-642-74542-3_22]; [Anonymous], 2020, ECONOMIST 0326; BAIRLEIN F, 1994, ANNU REV NUTR, V14, P187, DOI 10.1146/annurev.nu.14.070194.001155; Barclay RMR, 1996, J MAMMAL, V77, P1102, DOI 10.2307/1382791; BARCLAY RMR, 1988, J MAMMAL, V69, P821, DOI 10.2307/1381639; Butler PJ, 2001, J EXP BIOL, V204, P1361; CARPENTER FL, 1988, CONDOR, V90, P373, DOI 10.2307/1368565; Corman AM, 2014, BEHAV ECOL SOCIOBIOL, V68, P391, DOI 10.1007/s00265-013-1653-z; Cryan PM, 2003, J EXP BIOL, V206, P3381, DOI 10.1242/jeb.00574; Dietz C, 2007, BATS BRITAIN EUROPE; EWING WG, 1970, COMP BIOCHEM PHYSIOL, V36, P119, DOI 10.1016/0010-406X(70)90658-4; Geiser F, 2004, LIFE COLD EVOLUTION, P51; Geiser Fritz, 2012, P109; Giavi S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085628; Hedenstrom A, 1997, J THEOR BIOL, V189, P227, DOI 10.1006/jtbi.1997.0505; Hedenstrom A, 2009, J MAMMAL, V90, P1298, DOI 10.1644/09-MAMM-S-075R2.1; Humphries MM, 2002, NATURE, V418, P313, DOI 10.1038/nature00828; Kerlinger P, 1989, CURRENT ORNITHOLOGY, V6; Lighton JRB, 2019, MEASURING METABOLIC RATES: A MANUAL FOR SCIENTISTS, 2ND EDITION, DOI 10.1093/oso/9780198830399.001.0001; McGuire LP, 2012, J ANIM ECOL, V81, P377, DOI 10.1111/j.1365-2656.2011.01912.x; McGuire LP, 2010, J MAMMAL, V91, P1375, DOI 10.1644/10-MAMM-A-051.1; McKechnie AE, 2002, CONDOR, V104, P705, DOI 10.1650/0010-5422(2002)104[0705:AFHRAR]2.0.CO;2; McKechnie AE, 2007, J AVIAN BIOL, V38, P261, DOI 10.1111/j.2007.0908-8857.04116.x; McKechnie Andrew E., 2004, Biological Papers of the University of Alaska, V27, P63; Newton I, 2006, J ORNITHOL, V147, P146, DOI 10.1007/s10336-006-0058-4; R Core Team, 2020, R LANG ENV STAT COMP; Schaub M, 2001, ECOLOGY, V82, P852, DOI 10.2307/2680203; Sillett TS, 2002, J ANIM ECOL, V71, P296, DOI 10.1046/j.1365-2656.2002.00599.x; Speakman JR, 2003, BAT ECOLOGY, P430; Speakman JR, 1999, P NUTR SOC, V58, P123, DOI 10.1079/PNS19990017; Stawski C, 2010, NATURWISSENSCHAFTEN, V97, P29, DOI 10.1007/s00114-009-0606-x; Taylor PD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027054; Turbill C, 2008, J EXP BIOL, V211, P3871, DOI 10.1242/jeb.023101; Voigt CC, 2012, P ROY SOC B-BIOL SCI, V279, P3772, DOI 10.1098/rspb.2012.0902; Voigt CC, 2010, ECOLOGY, V91, P2908, DOI 10.1890/09-2232.1; Wang LCH, 1978, STRATEGIES COLD NATU, P109; Warnecke L, 2010, J COMP PHYSIOL B, V180, P437, DOI 10.1007/s00360-009-0417-6; Wikelski M, 2003, NATURE, V423, P704, DOI 10.1038/423704a; Willis C.K.R., 2008, HYPOMETABOLISM ANIMA, P373; Willis CKR, 2006, NATURWISSENSCHAFTEN, V93, P80, DOI 10.1007/s00114-005-0063-0; Wojciechowski MS, 2007, COMP BIOCHEM PHYS A, V147, P828, DOI 10.1016/j.cbpa.2006.06.039; Wojciechowski MS, 2009, J EXP BIOL, V212, P3068, DOI 10.1242/jeb.033001; Zuur Alain F., 2009, P1	43	46	46	3	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2014	9	12							e115724	10.1371/journal.pone.0115724	http://dx.doi.org/10.1371/journal.pone.0115724			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UC	25551615	Green Published, Green Submitted, gold			2022-12-27	WOS:000347119100054
J	Zhang, YJ; Wang, XJ; Wu, JX; Chen, SY; Chen, H; Chai, LJ; Yi, HL				Zhang, Ya-Jian; Wang, Xing-Jian; Wu, Ju-Xun; Chen, Shan-Yan; Chen, Hong; Chai, Li-Jun; Yi, Hua-Lin			Comparative Transcriptome Analyses between a Spontaneous Late-Ripening Sweet Orange Mutant and Its Wild Type Suggest the Functions of ABA, Sucrose and JA during Citrus Fruit Ripening	PLOS ONE			English	Article							ABSCISIC-ACID BIOSYNTHESIS; RNA-SEQ; PEACH FRUIT; EXPRESSION; GENES; SINENSIS; TOOL; L.; IDENTIFICATION; ANNOTATION	A spontaneous late-ripening mutant of 'Jincheng' (C. sinensis L. Osbeck) sweet orange exhibited a delay of fruit pigmentation and harvesting. In this work, we studied the processes of orange fruit ripening through the comparative analysis between the Jincheng mutant and its wild type. This study revealed that the fruit quality began to differ on 166th days after anthesis. At this stage, fruits were subjected to transcriptome analysis by RNA sequencing. 13,412 differentially expressed unigenes (DEGs) were found. Of these unigenes, 75.8% were down-regulated in the wild type, suggesting that the transcription level of wild type was lower than that of the mutant during this stage. These DEGs were mainly clustered into five pathways: metabolic pathways, plant-pathogen interaction, spliceosome, biosynthesis of plant hormones and biosynthesis of phenylpropanoids. Therefore, the expression profiles of the genes that are involved in abscisic acid, sucrose, and jasmonic acid metabolism and signal transduction pathways were analyzed during the six fruit ripening stages. The results revealed the regulation mechanism of sweet orange fruit ripening metabolism in the following four aspects: First, the more mature orange fruits were, the lower the transcription levels were. Second, the expression level of PME boosted with the maturity of the citrus fruit. Therefore, the expression level of PME might represent the degree of the orange fruit ripeness. Third, the interaction of PP2C, PYR/PYL, and SnRK2 was peculiar to the orange fruit ripening process. Fourth, abscisic acid, sucrose, and jasmonic acid all took part in orange fruit ripening process and might interact with each other. These findings provide an insight into the intricate process of sweet orange fruit ripening.	[Zhang, Ya-Jian; Wang, Xing-Jian; Wu, Ju-Xun; Chen, Shan-Yan; Chai, Li-Jun; Yi, Hua-Lin] Huazhong Agr Univ, Minist Educ, Key Lab Hort Plant Biol, Wuhan 430070, Peoples R China; [Zhang, Ya-Jian; Wang, Xing-Jian; Wu, Ju-Xun; Chen, Shan-Yan; Chai, Li-Jun; Yi, Hua-Lin] Huazhong Agr Univ, Natl Key Lab Crop Genet Improvement, Wuhan 430070, Peoples R China; [Chen, Shan-Yan] Kunming Acad Agr Sci, Kunming 650000, Peoples R China; [Chen, Hong] Huazhong Agr Univ, Engn Technol Coll, Wuhan 430070, Peoples R China	Huazhong Agricultural University; Huazhong Agricultural University; Huazhong Agricultural University	Chai, LJ (corresponding author), Huazhong Agr Univ, Minist Educ, Key Lab Hort Plant Biol, Wuhan 430070, Peoples R China.	chailijun@mail.hzau.edu.cn; yihualin@mail.hzau.edu.cn		Wu, Juxun/0000-0003-0785-1927	State Agriculture Research System (SARS) of China; National Natural Science Foundation of China [31301706, 31460507]; Fundamental Research Funds for the Central Universities [2013QC037]; Special Project on the Integration of Industry, Education and Research of Guangdong Province [2012B091100169]	State Agriculture Research System (SARS) of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Special Project on the Integration of Industry, Education and Research of Guangdong Province	This research was funded by the State Agriculture Research System (SARS) of China, the National Natural Science Foundation of China (nos. 31301706, 31460507), the Fundamental Research Funds for the Central Universities (2013QC037), and the Special Project on the Integration of Industry, Education and Research of Guangdong Province (2012B091100169). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alos E, 2013, PHYSL PLANTARUM; Bartolozzi F, 1997, J CHROMATOGR A, V758, P99, DOI 10.1016/S0021-9673(96)00709-1; Bianco L, 2009, J PROTEOMICS, V72, P586, DOI 10.1016/j.jprot.2008.11.019; Camacho-Villasana YM, 2002, PLANT MOL BIOL REP, V20, P407, DOI 10.1007/BF02772128; Chai LJ, 2011, PLANT CELL TISS ORG, V104, P1, DOI 10.1007/s11240-010-9793-6; Chernys JT, 2000, PLANT PHYSIOL, V124, P343, DOI 10.1104/pp.124.1.343; Concha CM, 2013, PLANT PHYSIOL BIOCH, V70, P433, DOI 10.1016/j.plaphy.2013.06.008; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Distefano G, 2009, J AGR FOOD CHEM, V57, P7974, DOI 10.1021/jf900710v; Falchi R, 2013, J PLANT GROWTH REGUL, V32, P519, DOI 10.1007/s00344-013-9318-8; Feng C, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-19; Fortes AM, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-149; Gambetta G, 2012, J PLANT GROWTH REGUL, V31, P273, DOI 10.1007/s00344-011-9237-5; Gambetta GA, 2010, PLANTA, V232, P219, DOI 10.1007/s00425-010-1165-2; Gmitter FG, 2012, TREE GENET GENOMES, V8, P611, DOI 10.1007/s11295-012-0499-2; Gouthu S, 2014, J EXP BOT, V65, P5889, DOI 10.1093/jxb/eru329; Guo SG, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-454; Hu ZY, 2007, J AM SOC HORTIC SCI, V132, P777, DOI 10.21273/JASHS.132.6.777; Huang GH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107562; Irfan M, 2014, J EXP BOT, V65, P5835, DOI 10.1093/jxb/eru324; Iseli C, 1999, Proc Int Conf Intell Syst Mol Biol, P138; Jia H, 2013, NEW PHYTOLOGIST; Jia HF, 2011, PLANT PHYSIOL, V157, P188, DOI 10.1104/pp.111.177311; Jia HF, 2013, PAK J BOT, V45, P169; Karppinen K, 2013, PHYTOCHEMISTRY, V95, P127, DOI 10.1016/j.phytochem.2013.06.023; Kato M, 2004, PLANT PHYSIOL, V134, P824, DOI 10.1104/pp.103.031104; Li RQ, 2010, GENOME RES, V20, P265, DOI 10.1101/gr.097261.109; Liu LH, 2012, J EXP BOT, V63, P5751, DOI 10.1093/jxb/ers224; [LIU Yongzhong 刘永忠], 2006, [华中农业大学学报, Journal of Huazhong Agricultural University], V25, P300; Liu YL, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-695; Marioni JC, 2008, GENOME RES, V18, P1509, DOI 10.1101/gr.079558.108; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nicolas P, 2013, PLANT PHYSIOL; Pauli A, 2012, GENOME RES, V22, P577, DOI 10.1101/gr.133009.111; Preuss A, 2014, J PLANT PHYSIOL, V171, P1315, DOI 10.1016/j.jplph.2014.06.004; Ren J, 2010, J PLANT PHYSIOL, V167, P1486, DOI 10.1016/j.jplph.2010.05.027; Rios G, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-276; Rodrigo MJ, 2013, SCI HORTIC-AMSTERDAM, V163, P46, DOI 10.1016/j.scienta.2013.08.014; Rodrigo MJ, 2013, J EXP BOT, V64, P4461, DOI 10.1093/jxb/ert260; Romero P, 2012, J EXP BOT, V63, P4931, DOI 10.1093/jxb/ers168; Ruiz KB, 2013, J PLANT GROWTH REGUL, V32, P852, DOI 10.1007/s00344-013-9351-7; Soto A, 2012, J PLANT PHYSIOL, V169, P1858, DOI 10.1016/j.jplph.2012.07.007; Sun L, 2011, J EXP BOT, V62, P5659, DOI 10.1093/jxb/err252; Teichert I, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-511; Wang GY, 2013, PHILIPP AGRIC SCI, V96, P26; Wang SF, 2014, J EXP BOT, V65, P3005, DOI 10.1093/jxb/eru137; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Wu J, 2014, J EXP BOT; Xu Q, 2013, NAT GENET, V45, P59, DOI 10.1038/ng.2472; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; Ye JL, 2010, J INTEGR PLANT BIOL, V52, P856, DOI 10.1111/j.1744-7909.2010.00952.x; Yin YX, 2012, PLANT MOL BIOL, V78, P617, DOI 10.1007/s11103-012-9890-5; Yu KQ, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-10; Zeng JW, 2012, SCI HORTIC-AMSTERDAM, V134, P32, DOI 10.1016/j.scienta.2011.10.018; Zenoni S, 2010, PLANT PHYSIOL, V152, P1787, DOI 10.1104/pp.109.149716; Zhang JZ, 2009, GENE, V430, P95, DOI 10.1016/j.gene.2008.09.023	56	31	40	2	70	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2014	9	12							e116056	10.1371/journal.pone.0116056	http://dx.doi.org/10.1371/journal.pone.0116056			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UC	25551568	Green Published, gold, Green Submitted			2022-12-27	WOS:000347119100094
J	Antonioli, L; Giron, MC; Colucci, R; Pellegrini, C; Sacco, D; Caputi, V; Orso, G; Tuccori, M; Scarpignato, C; Blandizzi, C; Fornai, M				Antonioli, Luca; Giron, Maria Cecilia; Colucci, Rocchina; Pellegrini, Carolina; Sacco, Deborah; Caputi, Valentina; Orso, Genny; Tuccori, Marco; Scarpignato, Carmelo; Blandizzi, Corrado; Fornai, Matteo			Involvement of the P2X7 Purinergic Receptor in Colonic Motor Dysfunction Associated with Bowel Inflammation in Rats	PLOS ONE			English	Article							P2X(7) RECEPTORS; IMMUNE-RESPONSE; ENTERIC NEURONS; ADENOSINE; CELLS; PATHOGENESIS; COMPARTMENTS; RECRUITMENT; ACTIVATION; BLOCKADE	Background and Purpose: Recent evidence indicates an involvement of P2X7 purinergic receptor (P2X7R) in the fine tuning of immune functions, as well as in driving enteric neuron apoptosis under intestinal inflammation. However, the participation of this receptor in the regulation of enteric neuromuscular functions remains undetermined. This study was aimed at investigating the role of P2X7Rs in the control of colonic motility in experimental colitis. Experimental Approach: Colitis was induced in rats by 2,4-dinitrobenzenesulfonic acid. P2X7R distribution was examined by immunofluorescence analysis. The effects of A804598 (selective P2X7R antagonist) and BzATP (P2X7R agonist) were tested on contractions of longitudinal smooth muscle evoked by electrical stimulation or by carbachol in the presence of tetrodotoxin. Key Results: P2X7Rs were predominantly located in myenteric neurons, but, in the presence of colitis, their expression increased in the neuromuscular layer. In normal preparations, A804598 elicited a negligible increase in electrically induced contractions, while a significant enhancement was recorded in inflamed tissues. In the presence of N-omega-propyl-L-arginine (NPA, neuronal nitric oxide synthase inhibitor) the A804598 effects were lost. P2X7R stimulation with BzATP did not significantly affect electrical-induced contractions in normal colon, while a marked reduction was recorded under inflammation. The inhibitory effect of BzATP was antagonized by A804598, and it was also markedly blunted by NPA. Both P2X7R ligands did not affect carbachol-induced contractions. Conclusions and Implications: The purinergic system contributes to functional neuromuscular changes associated with bowel inflammation via P2X7Rs, which modulate the activity of excitatory cholinergic nerves through a facilitatory control on inhibitory nitrergic pathways.	[Antonioli, Luca; Colucci, Rocchina; Pellegrini, Carolina; Sacco, Deborah; Tuccori, Marco; Blandizzi, Corrado; Fornai, Matteo] Univ Pisa, Dept Clin & Expt Med, Div Pharmacol & Chemotherapy, Pisa, Italy; [Giron, Maria Cecilia; Caputi, Valentina] Univ Padua, Dept Pharmaceut & Pharmacol Sci, Padua, Italy; [Orso, Genny] Conegliano, Sci Inst IRCCS Eugenio Medea, Treviso, Italy; [Scarpignato, Carmelo] Univ Parma, Lab Clin Pharmacol, I-43100 Parma, Italy	University of Pisa; University of Padua; IRCCS Eugenio Medea; University of Parma	Colucci, R (corresponding author), Univ Pisa, Dept Clin & Expt Med, Div Pharmacol & Chemotherapy, Pisa, Italy.	r.colucci@med.unipi.it	Scarpignato, Carmelo/ABC-1745-2021; Pellegrini, Carolina/ABE-3462-2021; Giron, Maria Cecilia/AAL-4438-2021; Blandizzi, Corrado/AAB-8736-2019	Scarpignato, Carmelo/0000-0001-5645-857X; Pellegrini, Carolina/0000-0003-2644-5430; Giron, Maria Cecilia/0000-0002-0825-7965; COLUCCI, ROCCHINA LUCIA/0000-0002-2593-5457; BLANDIZZI, CORRADO/0000-0001-9927-5386; FORNAI, MATTEO/0000-0002-0812-3959	Italian Ministry of Education, University and Research (COFIN) [2003052707_002]; University of Padova [CPDA095223]; Nexus Award in memory of Professor Marcello Tonini	Italian Ministry of Education, University and Research (COFIN)(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN)); University of Padova; Nexus Award in memory of Professor Marcello Tonini	This research was supported by grants from the Italian Ministry of Education, University and Research (COFIN 2003, project no. 2003052707_002), grant from the University of Padova (CPDA095223), by the Nexus Award in memory of Professor Marcello Tonini. VC is supported by the Fondazione Cariparo Doctoral Fellow. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamson SE, 2014, FEBS LETT; Alves LA, 2013, MOLECULES, V18, P10953, DOI 10.3390/molecules180910953; Antonioli L, 2014, BRIT J PHARMACOL, V171, P1314, DOI 10.1111/bph.12539; Antonioli L, 2013, NAT REV CANCER, V13, P842, DOI 10.1038/nrc3613; Antonioli L, 2013, PHARMACOL THERAPEUT, V139, P157, DOI 10.1016/j.pharmthera.2013.04.002; Antonioli L, 2013, TRENDS MOL MED, V19, P355, DOI 10.1016/j.molmed.2013.03.005; Antonioli L, 2011, BRIT J PHARMACOL, V164, P1577, DOI 10.1111/j.1476-5381.2011.01529.x; Antonioli L, 2011, EUR J PHARMACOL, V650, P639, DOI 10.1016/j.ejphar.2010.10.041; Antonioli L, 2010, J PHARMACOL EXP THER, V335, P434, DOI 10.1124/jpet.110.171223; Antonioli L, 2008, PHARMACOL THERAPEUT, V120, P233, DOI 10.1016/j.pharmthera.2008.08.010; Burnstock G, 2001, TRENDS PHARMACOL SCI, V22, P182, DOI 10.1016/S0165-6147(00)01643-6; Burnstock G, 2013, PURINERG SIGNAL, V9, P541, DOI 10.1007/s11302-013-9381-4; Chen LF, 2006, CRIT REV IMMUNOL, V26, P499, DOI 10.1615/CritRevImmunol.v26.i6.30; Cho YR, 2010, KOREAN J PHYSIOL PHA, V14, P311, DOI 10.4196/kjpp.2010.14.5.311; da Silva MV, 2014, HISTOCHEM CELL BIOL; de Campos NE, 2012, J INNATE IMMUN, V4, P529, DOI 10.1159/000336628; Gulbransen BD, 2012, NAT MED, V18, P600, DOI 10.1038/nm.2679; Hu HZ, 2001, J COMP NEUROL, V440, P299, DOI 10.1002/cne.1387; Junger WG, 2011, NAT REV IMMUNOL, V11, P201, DOI 10.1038/nri2938; Kataoka A, 2009, J NEUROCHEM, V108, P115, DOI 10.1111/j.1471-4159.2008.05744.x; Kurashima Y, 2013, EUR J IMMUNOL, V43, P3108, DOI 10.1002/eji.201343782; Kurashima Y, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2023; Lakhan SE, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-37; Marques CC, 2014, BBA-MOL BASIS DIS, V1842, P65, DOI 10.1016/j.bbadis.2013.10.012; Neves AR, 2014, INFLAMM BOWEL DIS, V20, P444, DOI 10.1097/01.MIB.0000441201.10454.06; Palombit K, 2013, DIGEST DIS SCI, V58, P3429, DOI 10.1007/s10620-013-2847-y; Shi XZ, 2011, AM J PHYSIOL-GASTR L, V300, pG41, DOI 10.1152/ajpgi.00358.2010; Vanderwinden JM, 2003, CELL TISSUE RES, V312, P149, DOI 10.1007/s00441-003-0716-2; Vieira C, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/254640; Volonte C, 2009, FEBS J, V276, P318, DOI 10.1111/j.1742-4658.2008.06793.x; Xu XR, 2014, WORLD J GASTROENTERO, V20, P3255, DOI 10.3748/wjg.v20.i12.3255	31	29	32	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2014	9	12							e116253	10.1371/journal.pone.0116253	http://dx.doi.org/10.1371/journal.pone.0116253			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX6YH	25549098	Green Published, gold, Green Submitted			2022-12-27	WOS:000347063500069
J	Behbahani, M				Behbahani, Mandana			Evaluation of In Vitro Anticancer Activity of Ocimum Basilicum, Alhagi Maurorum, Calendula Officinalis and Their Parasite Cuscuta Campestris	PLOS ONE			English	Article							CELLS; ANTIOXIDANT; EXPRESSION; APOPTOSIS; LUTEIN; BCL-2; VIVO; P53	The present investigation was carried out to study the relationship between presence of cytotoxic compounds in Ocimum basilicum, Alhagi maurorum, Calendula officinalis and their parasite Cuscuta campestris. The cytotoxic activity of the pure compounds was performed by MTT assay against breast cancer cell lines (MCF-7 and MDA-MB-231) and normal breast cell line (MCF 10A). The induction of apoptosis was measured by the expression levels of p53, bcl-2, bax and caspase-3 genes using quantitative Real Time PCR. Three active fractions were detected by nuclear magnetic resonance as lutein, lupeol and eugenol, respectively, in C. officinalis, A. maurorum and O. basilicum. These compounds and their epoxidized forms were also detected in their parasite C. campestris. The cytotoxic activity of lutein epoxide, lupeol epoxide and eugenol epoxide was significantly more than lutein, lupeol and eugenol. The mRNA expression level of p53, caspase-3 and bax genes were increased in both cancer cells treated with all pure compounds. However, bcl-2 gene expression decreased in treated breast cancer cells. In conclusion, all the data indicated that the epoxide forms of lupeol, lutein and eugenol are potential drug candidates for inducing apoptosis in human breast cancer cells.	Univ Isfahan, Fac Adv Sci & Technol, Dept Biotechnol, Esfahan 8174673441, Iran	University of Isfahan	Behbahani, M (corresponding author), Univ Isfahan, Fac Adv Sci & Technol, Dept Biotechnol, Esfahan 8174673441, Iran.	Ma_behbahani@yahoo.com			University of Isfahan, Isfahan, Iran	University of Isfahan, Isfahan, Iran	This study was financially supported by the University of Isfahan, Isfahan, Iran. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agha AM, 1996, PHYTOTHER RES, V10, P117, DOI 10.1002/(SICI)1099-1573(199603)10:2&lt;117::AID-PTR782&gt;3.0.CO;2-X; Behbahani M, 2013, ANTIVIR RES, V97, P376, DOI 10.1016/j.antiviral.2013.01.001; Borole S. P., 2011, Research Journal of Pharmaceutical, Biological and Chemical Sciences, V2, P657; Dawson Jean H., 1994, Reviews of Weed Science, V6, P265; Deans S. G., 1995, Flavour and Fragrance Journal, V10, P323, DOI 10.1002/ffj.2730100507; Edelenbos M, 2001, J AGR FOOD CHEM, V49, P4768, DOI 10.1021/jf010569z; Fido Roger J., 1995, V49, P423; Finnegan NM, 2001, BRIT J CANCER, V85, P115, DOI 10.1054/bjoc.2001.1850; Ghule R.S., 2011, J ADV PHARM ED RES, V1, P45; Gilani Anwar-Ul Hassan, 1992, International Journal of Pharmacognosy, V30, P296; Humphries JM, 2003, J AGR FOOD CHEM, V51, P1322, DOI 10.1021/jf026073e; Jadhav RB, 2005, J PLANT INTERACT, V1, P171, DOI 10.1080/17429140600986161; Jimenez-Medina E, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-119; Kobayashi S, 1997, BREAST CANCER RES TR, V42, P173, DOI 10.1023/A:1005760013810; Laghari AH, 2012, NAT PROD RES, V26, P173, DOI 10.1080/14786419.2010.538846; Lakshminarayana R, 2013, CHEM-BIOL INTERACT, V203, P448, DOI 10.1016/j.cbi.2013.03.006; Matsuda T, 2013, JPN J CLIN ONCOL, V43, P449, DOI 10.1093/jjco/hyt045; MIYASHITA T, 1995, CELL, V80, P293; Ni IBP, 2006, TROP BIOMED, V23, P53; Qamar KA, 2010, LETT DRUG DES DISCOV, V7, P726; Rates SMK, 2001, TOXICON, V39, P603, DOI 10.1016/S0041-0101(00)00154-9; Saeed MA, 2002, FITOTERAPIA, V73, P417, DOI 10.1016/S0367-326X(02)00127-2; Saleem M, 2008, CLIN CANCER RES, V14, P2119, DOI 10.1158/1078-0432.CCR-07-4413; Shai LJ, 2008, J ETHNOPHARMACOL, V119, P238, DOI 10.1016/j.jep.2008.06.036; Siddique HR, 2011, LIFE SCI, V88, P285, DOI 10.1016/j.lfs.2010.11.020; Suzuki K, 1999, JPN J CLIN ONCOL, V29, P323, DOI 10.1093/jjco/29.7.323	26	33	37	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2014	9	12							e116049	10.1371/journal.pone.0116049	http://dx.doi.org/10.1371/journal.pone.0116049			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX6YH	25548920	Green Published, Green Submitted, gold			2022-12-27	WOS:000347063500048
J	Fiallos, E; Judkins, J; Matlaf, L; Prichard, M; Dittmer, D; Cobbs, C; Soroceanu, L				Fiallos, Estefania; Judkins, Jonathon; Matlaf, Lisa; Prichard, Mark; Dittmer, Dirk; Cobbs, Charles; Soroceanu, Liliana			Human Cytomegalovirus Gene Expression in Long-Term Infected Glioma Stem Cells	PLOS ONE			English	Article							VIRAL-DNA; GLIOBLASTOMA; GROWTH; IDENTIFICATION; REACTIVATION; ACTIVATION; PHENOTYPE; LATENCY; TUMORS; AXIS	The most common adult primary brain tumor, glioblastoma (GBM), is characterized by fifteen months median patient survival and has no clear etiology. We and others have identified the presence of human cytomegalovirus (HCMV) gene products endogenously expressed in GBM tissue and primary cells, with a subset of viral genes being consistently expressed in most samples. Among these viral genes, several have important oncomodulatory properties, regulating tumor stemness, proliferation, immune evasion, invasion and angiogenesis. These findings lead us to hypothesize that a specific HCMV gene signature may be associated with GBM pathogenesis. To investigate this hypothesis, we used glioma cell lines and primary glioma stem-like cells (GSC) infected with clinical and laboratory HCMV strains and measured relative viral gene expression levels along several time points up to 15 weeks post-infection. While HCMV gene expression was detected in several infected glioma lines through week 5 post-infection, only HCMV-infected GSC expressed viral gene products 15 weeks post-infection. Efficiency of infection across time was higher in GSC compared to cell lines. Importantly, HCMV-infected GSC outlived their uninfected counterparts, and this extended survival was paralleled by increased tumorsphere frequency and upregulation of stemness regulators, such as SOX2, p-STAT3, and BMX (a novel HCMV target identified in this study). Interleukin 6 (IL-6) treatment significantly upregulated HCMV gene expression in long-term infected glioma cultures, suggesting that pro-inflammatory signaling in the tumor milieu may further augment HCMV gene expression and subsequent tumor progression driven by viral-induced cellular signaling. Together, our data support a critical role for long-term, low-level HCMV infection in promoting survival, stemness, and proliferation of GSC that could significantly contribute to GBM pathogenesis.	[Fiallos, Estefania; Judkins, Jonathon; Matlaf, Lisa; Soroceanu, Liliana] Calif Pacific Med Ctr, Res Inst, San Francisco, CA USA; [Prichard, Mark] Univ Alabama Birmingham, Dept Pediat & Infect Dis, Birmingham, AL USA; [Dittmer, Dirk] Univ N Carolina, Sch Med, Dept Virol, Chapel Hill, NC USA; [Cobbs, Charles] Swedish Neurosci Inst, Ben & Catherine Ivy Ctr Adv Brain Tumor Treatment, Seattle, WA 98122 USA; [Cobbs, Charles] Univ Calif San Francisco, Dept Neurosurg, San Francisco, CA USA	California Pacific Medical Center; California Pacific Medical Center Research Institute; University of Alabama System; University of Alabama Birmingham; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Swedish Medical Center; University of California System; University of California San Francisco	Cobbs, C (corresponding author), Swedish Neurosci Inst, Ben & Catherine Ivy Ctr Adv Brain Tumor Treatment, Seattle, WA 98122 USA.	charles.cobbs@gmail.com; sorocel@cpmcri.org	Dittmer, Dirk/AAH-3535-2021; Dittmer, Dirk/GPW-7423-2022	Dittmer, Dirk/0000-0003-4968-5656; Prichard, Mark/0000-0002-2720-6661; Judkins, Jonathon/0000-0002-6513-2501	National Institutes of Health [R01NS070289, R21NS067395]; American Cancer Society Research Scholar award; Accelerated Brain Cancer Cure; Flaming Foundations; NATIONAL CANCER INSTITUTE [P01CA019014] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE023946] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS067395, R01NS070289] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society Research Scholar award(American Cancer Society); Accelerated Brain Cancer Cure; Flaming Foundations; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by grants from the National Institutes of Health, R01NS070289 to CC and LS, R21NS067395 to LS, American Cancer Society Research Scholar award to CC and additional funds from the Accelerated Brain Cancer Cure and the Flaming Foundations. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belzile JP, 2014, J VIROL, V88, P4021, DOI 10.1128/JVI.03492-13; Bhattacharjee B, 2012, J VIROL, V86, P6815, DOI 10.1128/JVI.00015-12; Bianchi E, 2014, NEUROPATHOL APPL NEU; Chen J, 2012, NATURE, V488, P522, DOI 10.1038/nature11287; Cobbs C, 2014, ONCOTARGET, V5, P1091, DOI 10.18632/oncotarget.1787; Cobbs CS, 2008, CANCER RES, V68, P724, DOI 10.1158/0008-5472.CAN-07-2291; Cobbs CS, 2002, CANCER RES, V62, P3347; Dalerba P, 2007, P NATL ACAD SCI USA, V104, P10158, DOI 10.1073/pnas.0703478104; Dos Santos CJ, 2013, J MED VIROL; Duan YL, 2014, J VIROL, V88, P3861, DOI 10.1128/JVI.01166-13; Dziurzynski K, 2012, NEURO-ONCOLOGY, V14, P246, DOI 10.1093/neuonc/nor227; Ernst A, 2009, CLIN CANCER RES, V15, P6541, DOI 10.1158/1078-0432.CCR-09-0695; Fonseca RF, 2012, MEM I OSWALDO CRUZ, V107, P953, DOI 10.1590/S0074-02762012000700020; Gilbert CA, 2009, J CELL BIOCHEM, V108, P1031, DOI 10.1002/jcb.22350; Guryanova OA, 2011, CANCER CELL, V19, P498, DOI 10.1016/j.ccr.2011.03.004; Hargett D, 2010, P NATL ACAD SCI USA, V107, P20039, DOI 10.1073/pnas.1014509107; Hu YF, 2009, J IMMUNOL METHODS, V347, P70, DOI 10.1016/j.jim.2009.06.008; Isomura H, 2011, J VIROL, V85, P6629, DOI 10.1128/JVI.00384-11; Johnsen JI, 2011, ONCOTARGET, V2, P1329; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; Loveland AN, 2007, J VIROL, V81, P620, DOI 10.1128/JVI.01903-06; Lucas KG, 2011, J NEURO-ONCOL, V103, P231, DOI 10.1007/s11060-010-0383-6; Matlaf LA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068176; Meissner CS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025115; Milne RSB, 1998, J GEN VIROL, V79, P855, DOI 10.1099/0022-1317-79-4-855; Mitchell DA, 2008, NEURO-ONCOLOGY, V10, P10, DOI 10.1215/15228517-2007-035; Qian ZK, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000814; Ranganathan P, 2012, J VIROL, V86, P854, DOI 10.1128/JVI.06097-11; Reeves MB, 2011, J VIROL, V85, P12750, DOI 10.1128/JVI.05878-11; Ryan KJ, 2010, SHERRIS MED MICROB E; Ryckman BJ, 2010, J VIROL, V84, P2597, DOI 10.1128/JVI.02256-09; Scheurer ME, 2008, ACTA NEUROPATHOL, V116, P79, DOI 10.1007/s00401-008-0359-1; Schmittgen Thomas D., 2008, V429, P89, DOI 10.1007/978-1-60327-040-3_7; Sherry MM, 2009, STEM CELLS, V27, P2383, DOI 10.1002/stem.185; Sinclair J, 2006, J GEN VIROL, V87, P1763, DOI 10.1099/vir.0.81891-0; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Slinger E, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001180; Soroceanu L, 2007, P NATL ACAD SCI USA, V104, P3466, DOI 10.1073/pnas.0611271104; Soroceanu L, 2011, CANCER RES, V71, P6643, DOI 10.1158/0008-5472.CAN-11-0744; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Yurochko AD, 1997, J VIROL, V71, P5051, DOI 10.1128/JVI.71.7.5051-5059.1997; Zhou MM, 2013, J VIROL, V87, P9680, DOI 10.1128/JVI.01167-13	43	18	18	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2014	9	12							e116178	10.1371/journal.pone.0116178	http://dx.doi.org/10.1371/journal.pone.0116178			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX6YH	25549333	gold, Green Published, Green Submitted			2022-12-27	WOS:000347063500056
J	Li, DL; Wang, X; Liu, B; Liu, YZ; Zeng, ZY; Lu, LL; Zheng, ZY; Li, B; Zheng, ZF				Li, DongLiang; Wang, Xiao; Liu, Bang; Liu, YuZheng; Zeng, ZhiYu; Lu, LingLing; Zheng, ZhiYong; Li, Bing; Zheng, ZongFu			Exercises in Hot and Humid Environment Caused Liver Injury in a Rat Model	PLOS ONE			English	Article							WHOLE-BODY HYPERTHERMIA; OXIDATIVE STRESS; HEAT-STROKE; NECROSIS; ALPHA; CELLS; MICE; DNA; HEATSTROKE; APOPTOSIS	Objective: To investigate injury pattern during intense exercises in hot and humid environment particularly on liver in a rat exertional heat stroke model. Methods: We randomly divided 30 rats into a control group (CG), a normal temperature (25 +/- 2 degrees C, 60% +/- 5% humidity) exercise group (NTEG) and a high temperature and high humidity (35 +/- 2 degrees C, 80% +/- 10% humidity) exercising group (HTEG), each comprising 10 animals. The NTEG and HTEG rats were forced to run in a treadmill for 1 hour maximum at 20 rpm. We analyzed liver cells of all three groups with JC-1 dye and flow cytometry for apoptosis rates in addition to liver tissue 8 - hydroxy deoxyguanosine (8 - OhdG) and blood serum IL-6, tumor necrosis factor alpha (TNF-alpha), alanine aminotransferase ALT, aspartate amino transferase (AST), serum creatinine (CREA), blood urea nitrogen (BUN), lactate dehydrogenase (LDH), creatine phosphate kinase (CK) concentrations. Result: Compared with NTEG rats, beside reduced exercise tolerance (60 +/- 5 vs. 15 +/- 3 minutes) (p = 0.002) the 8-OhdG liver tissue concentrations were significantly higher (p = 0.040) in the HTEG rats. The HTEG developed more organ tissue damage and cellular fragmentations of liver cells. In both exercise groups TNF-alpha and IL-6 serum concentrations were enhanced significantly (p < 0.001) being highest in the HTEG animals. Serum ALT, AST, LDH, CREA, BUN and CK concentrations were significantly enhance in both exercise groups. Conclusion: In our exertional heat stroke rat model, we found tissue damage particularly in livers during exercises in hot and humid environment that was related to inflammation, oxidative stress and apoptosis.	[Li, DongLiang; Wang, Xiao; Liu, Bang; Liu, YuZheng; Zeng, ZhiYu; Lu, LingLing; Li, Bing] Fuzhou PLA Gen Hosp, Dept Hepatobiliary Med, Fuzhou, Fujian, Peoples R China; [Zheng, ZhiYong] Fuzhou PLA Gen Hosp, Dept Pathol, Fuzhou, Fujian, Peoples R China; [Zheng, ZongFu] 476 Hosp PLA Fujian, Clin Lab, Fuzhou, Fujian, Peoples R China		Li, DL (corresponding author), Fuzhou PLA Gen Hosp, Dept Hepatobiliary Med, Fuzhou, Fujian, Peoples R China.	donglianglifz@163.com		Liu, Bang/0000-0003-3045-2019	Medical Science and Technology Innovation Foundation of Nanjing Military Command of Chinese PLA [10MA109]	Medical Science and Technology Innovation Foundation of Nanjing Military Command of Chinese PLA	This work was funded by The Medical Science and Technology Innovation Foundation of Nanjing Military Command of Chinese PLA, No. 10MA109 to DongLiang Li. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bouchama A, 2002, NEW ENGL J MED, V346, P1978, DOI 10.1056/NEJMra011089; CAMUS G, 1994, INTENS CARE MED, V20, P602, DOI 10.1007/BF01705731; Carter R, 2005, MED SCI SPORT EXER, V37, P1338, DOI 10.1249/01.mss.0000174895.19639.ed; de Souza-Pinto NC, 2001, CANCER RES, V61, P5378; DICKSON JA, 1979, J APPL PHYSIOL, V47, P712, DOI 10.1152/jappl.1979.47.4.712; Diesen DL, 2011, J SURG RES, V167, P96, DOI 10.1016/j.jss.2009.10.006; GATHIRAM P, 1987, CIRC SHOCK, V23, P157; Hall Philip, 2012, Ulster Med J, V81, P30; HARMON BV, 1990, INT J RADIAT BIOL, V58, P845, DOI 10.1080/09553009014552221; Hsieh YC, 2011, ACTA PHARMACOL SIN, V32, P167, DOI 10.1038/aps.2010.191; Klungland A, 1999, P NATL ACAD SCI USA, V96, P13300, DOI 10.1073/pnas.96.23.13300; Kravchenko J, 2013, AM J PREV MED, V44, P274, DOI 10.1016/j.amepre.2012.11.015; Leon LR, 2010, J APPL PHYSIOL, V109, P1980, DOI 10.1152/japplphysiol.00301.2010; Lim CL, 2007, AM J PHYSIOL-REG I, V292, pR186, DOI 10.1152/ajpregu.00921.2005; Lippi G, 2011, EUR J INTERN MED, V22, pE36, DOI 10.1016/j.ejim.2011.02.007; Miyake Yasufumi, 2013, Nihon Rinsho, V71, P1065; Ogonovszky H, 2005, CAN J APPL PHYSIOL, V30, P186, DOI 10.1139/h05-114; Pease S, 2009, INTENS CARE MED, V35, P1454, DOI 10.1007/s00134-009-1500-x; Ramos D, 2013, APPL PHYSIOL NUTR ME, V38, P507, DOI 10.1139/apnm-2012-0302; Rohe ST, 2012, JAAPA-J AM ACAD PHYS, V25, P36; Rohe Steven T, 2012, JAAPA, V25, P36; Salvioli S, 1997, FEBS LETT, V411, P77, DOI 10.1016/S0014-5793(97)00669-8; Shah NG, 2012, INT J HYPERTHER, V28, P627, DOI 10.3109/02656736.2012.690547; Thakur V, 2006, J LEUKOCYTE BIOL, V79, P1348, DOI 10.1189/jlb.1005613; THRALL DE, 1986, CANCER RES, V46, P6229; Tukov FF, 2007, TOXICOL SCI, V100, P267, DOI 10.1093/toxsci/kfm209; van Wijck K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022366; Waskiewicz Z, 2012, EUR J APPL PHYSIOL, V112, P1679, DOI 10.1007/s00421-011-2135-5; Wilson MR, 2005, AM J PHYSIOL-LUNG C, V288, pL599, DOI 10.1152/ajplung.00304.2004; Xing JQ, 2013, INT J CLIN EXP MED, V6, P712	30	13	17	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2014	9	12							e111741	10.1371/journal.pone.0111741	http://dx.doi.org/10.1371/journal.pone.0111741			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX6YH	25548911	Green Published, Green Submitted, gold			2022-12-27	WOS:000347063500003
J	Kamali, A; Price, MA; Lakhi, S; Karita, E; Inambao, M; Sanders, EJ; Anzala, O; Latka, MH; Bekker, LG; Kaleebu, P; Asiki, G; Ssetaala, A; Ruzagira, E; Allen, S; Farmer, P; Hunter, E; Mutua, G; Makkan, H; Tichacek, A; Brill, IK; Fast, P; Stevens, G; Chetty, P; Amornkul, PN; Gilmour, J				Kamali, Anatoli; Price, Matt A.; Lakhi, Shabir; Karita, Etienne; Inambao, Mubiana; Sanders, Eduard J.; Anzala, Omu; Latka, Mary H.; Bekker, Linda-Gail; Kaleebu, Pontiano; Asiki, Gershim; Ssetaala, Ali; Ruzagira, Eugene; Allen, Susan; Farmer, Paul; Hunter, Eric; Mutua, Gaudensia; Makkan, Heeran; Tichacek, Amanda; Brill, Ilene K.; Fast, Pat; Stevens, Gwynn; Chetty, Paramesh; Amornkul, Pauli N.; Gilmour, Jill		IAVI Africa HIV Prevention Partner	Creating an African HIV Clinical Research and Prevention Trials Network: HIV Prevalence, Incidence and Transmission	PLOS ONE			English	Article							SUB-SAHARAN AFRICA; VIRUS ANKARA MVA; NEUTRALIZING ANTIBODIES; DISCORDANT COUPLES; VACCINE; EPIDEMIOLOGY; SAFETY; DNA; IMMUNOGENICITY; SEROCONVERSION	HIV epidemiology informs prevention trial design and program planning. Nine clinical research centers (CRC) in sub-Saharan Africa conducted HIV observational epidemiology studies in populations at risk for HIV infection as part of an HIV prevention and vaccine trial network. Annual HIV incidence ranged from below 2% to above 10% and varied by CRC and risk group, with rates above 5% observed in Zambian men in an HIV-discordant relationship, Ugandan men from Lake Victoria fishing communities, men who have sex with men, and several cohorts of women. HIV incidence tended to fall after the first three months in the study and over calendar time. Among suspected transmission pairs, 28% of HIV infections were not from the reported partner. Volunteers with high incidence were successfully identified and enrolled into large scale cohort studies. Over a quarter of new cases in couples acquired infection from persons other than the suspected transmitting partner.	[Kamali, Anatoli; Price, Matt A.] Uganda Virus Res Inst, Med Res Council, Uganda Res Unit AIDS, Entebbe, Uganda; [Lakhi, Shabir; Karita, Etienne] IAVI, New York, NY USA; [Inambao, Mubiana; Sanders, Eduard J.] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; [Anzala, Omu; Latka, Mary H.] Zambia Emory HIV Res Project, Lusaka, Zambia; [Bekker, Linda-Gail; Kaleebu, Pontiano] Zambia Emory HIV Res Project, Copperbelt, Zambia; [Kaleebu, Pontiano; Asiki, Gershim] Project San Francisco, Kigali, Rwanda; [Ssetaala, Ali; Ruzagira, Eugene] KEMRI, Ctr Geog Med Coast, Kilifi, Kenya; [Ruzagira, Eugene; Allen, Susan] Univ Oxford, Oxford, England; [Allen, Susan; Farmer, Paul] Kenya AIDS Vaccine Inst, Inst Clin Res, Nairobi, Kenya; [Hunter, Eric; Mutua, Gaudensia] Aurum Inst, Rustenburg, South Africa; [Hunter, Eric; Mutua, Gaudensia] Aurum Inst, Johannesburg, South Africa; [Mutua, Gaudensia; Makkan, Heeran; Tichacek, Amanda] Univ Cape Town, Desmond Tutu HIV Ctr, ZA-7925 Cape Town, South Africa; [Anzala, Omu; Latka, Mary H.; Bekker, Linda-Gail] Emory Univ, Atlanta, GA 30322 USA; [Latka, Mary H.; Bekker, Linda-Gail] IAVI, Johannesburg, South Africa; [Sanders, Eduard J.; Anzala, Omu] Univ London Imperial Coll Sci Technol & Med, IAVI, Human Immunol Lab, London, England; [Kamali, Anatoli; Price, Matt A.] Univ Alabama Birmingham, Birmingham, AL USA; [Stevens, Gwynn; Chetty, Paramesh] IAVI, UVRI HIV Vaccine Program, Entebbe, Uganda; [Amornkul, Pauli N.; Gilmour, Jill] IAVI, UVRI HIV Vaccine Program, Masaka, Uganda	Uganda Virus Research Institute; International AIDS Vaccine Initiative; University of California System; University of California San Francisco; University of Oxford; University of Cape Town; Emory University; International AIDS Vaccine Initiative; Imperial College London; International AIDS Vaccine Initiative; University of Alabama System; University of Alabama Birmingham; International AIDS Vaccine Initiative; International AIDS Vaccine Initiative	Price, MA (corresponding author), Uganda Virus Res Inst, Med Res Council, Uganda Res Unit AIDS, Entebbe, Uganda.	mprice@iavi.org	Makkan, Heeran/GXI-0465-2022; Price, Matt/AAK-6881-2021; Ssetaala, Ali/AAB-3832-2020; Bekker, Linda-Gail/AAZ-8929-2020; Byabagambi, John/GVU-6682-2022	Price, Matt/0000-0002-2918-1373; Ssetaala, Ali/0000-0003-2156-3024; Byabagambi, John/0000-0002-1456-3387; BEKKER, LINDA-GAIL/0000-0002-0755-4386; Churchyard, Gavin/0000-0002-4269-3699; Makkan, Heeran/0000-0002-4737-7804; Ruzagira, Eugene/0000-0002-7291-1693; Asiki, Gershim/0000-0002-9966-1153	OPEC Fund for International Development (OFID); Rwanda and Zambia, including the Emory CFAR [P30 AI050409, NIH-FIC TW001042, NIH-NIAID R01 AI040951, NIH-NIMH R01 MH066767, NIH-NICHD R01 HD040125, NIH-NIAID R01 AI064060, NIH-NIAID R37 AI51231]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI050409, R01AI064060, R37AI051231] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD011132] Funding Source: NIH RePORTER	OPEC Fund for International Development (OFID); Rwanda and Zambia, including the Emory CFAR; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	IAVI's work is made possible by generous support from many donors including: the Bill & Melinda Gates Foundation; the Ministry of Foreign Affairs of Denmark; Irish Aid; the Ministry of Finance of Japan; the Ministry of Foreign Affairs of the Netherlands; the Norwegian Agency for Development Cooperation (NORAD); the United Kingdom Department for International Development (DFID), and the United States Agency for International Development (USAID). The full list of IAVI donors is available at www.iavi.org This work is made possible by the generous support of the American people through USAID. The contents are the responsibility of the authors and do not necessarily reflect the views of USAID or the United States Government. Funding was also provided by the OPEC Fund for International Development (OFID), a development finance institution of the OPEC Member States, established to provide financial support for socio-economic development, particularly for low-income countries. Family Health International (now FHI360) supported some of the cohort study work in Rustenburg, and the European and Developing Countries Clinical Trials Partnership helped fund some of the cohorts in the Ugandan fishing communities. Several grants funded the HIV incidence and early infection studies, particularly in Rwanda and Zambia, including the Emory CFAR: P30 AI050409, NIH-FIC TW001042, NIH-NIAID R01 AI040951, NIH-NIMH R01 MH066767, NIH-NICHD R01 HD040125, NIH-NIAID R01 AI064060, and NIH-NIAID R37 AI51231. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addo MM, 2011, J INFECT DIS, V203, P258, DOI 10.1093/infdis/jiq028; ALLEN S, 1992, BRIT MED J, V304, P1605, DOI 10.1136/bmj.304.6842.1605; Amornkul PN, 2013, AIDS, V27, P2775, DOI 10.1097/QAD.0000000000000012; Artzrouni M, 2002, AIDS, V16, pW1; Baalwa J, 2013, VIROLOGY, V436, P33, DOI 10.1016/j.virol.2012.10.009; Braunstein SL, 2009, AIDS REV, V11, P140; Brown B, 2011, MEN WHO HAVE SEX MEN; Busch MP, 2010, AIDS, V24, P2763, DOI 10.1097/QAD.0b013e32833f1142; Centers for Disease Control (CDC), 2007, COUPL HIV COUNS TEST; Chomba E, 2008, JAIDS-J ACQ IMM DEF, V47, P108, DOI 10.1097/QAI.0b013e31815b2d67; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; Cohen MS, 2009, LANCET, V373, P1077, DOI 10.1016/S0140-6736(09)60640-1; Crawford H, 2011, J VIROL, V85, P1384, DOI 10.1128/JVI.01879-10; Curran K, 2012, CURR HIV-AIDS REP, V9, P160, DOI 10.1007/s11904-012-0114-z; De Cock KM, 2012, AIDS, V26, P1205, DOI 10.1097/QAD.0b013e328354622a; Dieffenbach CW, 2009, JAMA-J AM MED ASSOC, V301, P2380, DOI 10.1001/jama.2009.828; Dunkle KL, 2008, LANCET, V371, P2183, DOI 10.1016/S0140-6736(08)60953-8; Fast PE, 2010, AIDS, V24, pS50, DOI 10.1097/01.aids.0000390707.58512.5e; Feldblum PJ, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2011-000626; Guthrie BL, 2007, CURR HIV RES, V5, P416, DOI 10.2174/157016207781023992; Hanke T, 2007, J GEN VIROL, V88, P1, DOI 10.1099/vir.0.82493-0; Hara H, 2011, HUM VACCINES, V7, P639, DOI 10.4161/hv.7.6.15408; Hayes R, 2010, AIDS, V24, pS81, DOI 10.1097/01.aids.0000390710.04255.2b; Jaoko W, 2008, VACCINE, V26, P2788, DOI 10.1016/j.vaccine.2008.02.071; Jaoko W, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012873; Kamali A, 2002, TROP MED INT HEALTH, V7, P1053, DOI 10.1046/j.1365-3156.2002.00963.x; Karita E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004401; Kassanjee R, 2014, AIDS, V28, P2439, DOI 10.1097/QAD.0000000000000429; Lihana RW, 2012, AIDS REV, V14, P83; Lyerla R, 2012, JAIDS-J ACQ IMM DEF, V60, pS57, DOI 10.1097/QAI.0b013e31825d279a; Mills EJ, 2011, ANN INTERN MED, V155, P209, DOI 10.7326/0003-4819-155-4-201108160-00358; Ngongo PB, 2012, AIDS CARE, V24, P1277, DOI 10.1080/09540121.2012.656572; Nordling L, 2014, NATURE, V509, P274, DOI 10.1038/509274a; Peters BS, 2007, VACCINE, V25, P2120, DOI 10.1016/j.vaccine.2006.11.016; Price MA, 2011, AIDS RES HUM RETROV, V27, P5, DOI 10.1089/aid.2010.0030; Price MA, 2012, JAIDS-J ACQ IMM DEF, V59, P185, DOI 10.1097/QAI.0b013e31823d8693; Roth DL, 2001, INT J STD AIDS, V12, P181, DOI 10.1258/0956462011916992; Ruzagira E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020684; Sanders EJ, 2013, AIDS, V27, P437, DOI 10.1097/QAD.0b013e32835b0f81; Seeley J, 2012, SEX TRANSM DIS, V39, P433, DOI 10.1097/OLQ.0b013e318251555d; Shetty AK, 2013, CURR HIV RES, V11, P81, DOI 10.2174/1570162X11311020002; Smith AD, 2009, LANCET, V374, P416, DOI 10.1016/S0140-6736(09)61118-1; Trask SA, 2002, J VIROL, V76, P397, DOI 10.1128/JVI.76.1.397-405.2002; UNAIDS, 2011, WORLD REF DAY 2019 H; *UNAIDS, 2005, UNAIDS REF GROUP EST; Vardas E, 2010, AIDS RES HUM RETROV, V26, P933, DOI 10.1089/aid.2009.0242; Wagner BG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041212; Walker LM, 2009, SCIENCE, V326, P285, DOI 10.1126/science.1178746; World Health Organization, 2012, GUID OR PREEXP PROPH	49	37	37	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2015	10	1							e0116100	10.1371/journal.pone.0116100	http://dx.doi.org/10.1371/journal.pone.0116100			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ4OZ	25602351	Green Submitted, Green Published, gold			2022-12-27	WOS:000348203500019
J	Kant, S; Burch, D; Badenhorst, P; Palanisamy, R; Mason, J; Spangenberg, G				Kant, Surya; Burch, David; Badenhorst, Pieter; Palanisamy, Rajasekaran; Mason, John; Spangenberg, German			Regulated Expression of a Cytokinin Biosynthesis Gene IPT Delays Leaf Senescence and Improves Yield under Rainfed and Irrigated Conditions in Canola (Brassica napus L.)	PLOS ONE			English	Article							ISOPENTENYL TRANSFERASE GENE; TOBACCO PLANTS; DROUGHT TOLERANCE; FOOD SECURITY; WATER-USE; STRESS; PHOTOSYNTHESIS; ARABIDOPSIS; METABOLISM; RESISTANCE	Delay of leaf senescence through genetic modification can potentially improve crop yield, through maintenance of photosynthetically active leaves for a longer period. Plant growth hormones such as cytokinin regulate and delay leaf senescence. Here, the structural gene (IPT) encoding the cytokinin biosynthetic enzyme isopentenyltransferase was fused to a functionally active fragment of the AtMYB32 promoter and was transformed into canola plants. Expression of the AtMYB32xs::IPT gene cassette delayed the leaf senescence in transgenic plants grown under controlled environment conditions and field experiments conducted for a single season at two geographic locations. The transgenic canola plants retained higher chlorophyll levels for an extended period and produced significantly higher seed yield with similar growth and phenology compared to wild type and null control plants under rainfed and irrigated treatments. The yield increase in transgenic plants was in the range of 16% to 23% and 7% to 16% under rainfed and irrigated conditions, respectively, compared to control plants. Most of the seed quality parameters in transgenic plants were similar, and with elevated oleic acid content in all transgenic lines and higher oil content and lower glucosinolate content in one specific transgenic line as compared to control plants. The results suggest that by delaying leaf senescence using the AtMYB32xs:: IPT technology, productivity in crop plants can be improved under water stress and well-watered conditions.	[Kant, Surya; Burch, David] Biosci Res Div, Dept Environm & Primary Ind, Horsham, Vic, Australia; [Badenhorst, Pieter; Palanisamy, Rajasekaran] Dept Environm & Primary Ind, Biosci Res Div, Hamilton, Vic, Australia; [Mason, John; Spangenberg, German] AgriBio, Ctr AgriBiosci, Biosci Res Div, Dept Environm & Primary Ind, Bundoora, Vic, Australia; [Mason, John; Spangenberg, German] La Trobe Univ, Bundoora, Vic, Australia	La Trobe University; La Trobe University	Spangenberg, G (corresponding author), AgriBio, Ctr AgriBiosci, Biosci Res Div, Dept Environm & Primary Ind, Bundoora, Vic, Australia.	german.spangenberg@depi.vic.gov.au		Badenhorst, Pieter/0000-0001-5155-8889; Kant, Surya/0000-0001-6178-7036	Victorian Department of Primary Industries	Victorian Department of Primary Industries	This work was supported by funding from the Victorian Department of Primary Industries. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blum A, 2009, FIELD CROP RES, V112, P119, DOI 10.1016/j.fcr.2009.03.009; Chang HS, 2003, PLANT PHYSIOL, V132, P2174, DOI 10.1104/pp.103.023945; Cowan AK, 2005, PLANTA, V221, P801, DOI 10.1007/s00425-005-1489-5; Faiss M, 1997, PLANT J, V12, P401, DOI 10.1046/j.1365-313X.1997.12020401.x; GAMON JA, 1995, ECOL APPL, V5, P28, DOI 10.2307/1942049; GAN SS, 1995, SCIENCE, V270, P1986, DOI 10.1126/science.270.5244.1986; Gan SS, 1996, BIOESSAYS, V18, P557, DOI 10.1002/bies.950180707; Godfray HCJ, 2010, SCIENCE, V327, P812, DOI 10.1126/science.1185383; Haberer G, 2002, PLANT PHYSIOL, V128, P354, DOI 10.1104/pp.010773; Jordi W, 2000, PLANT CELL ENVIRON, V23, P279, DOI 10.1046/j.1365-3040.2000.00544.x; Kuppu S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064190; LI Y, 1992, DEV BIOL, V153, P386, DOI 10.1016/0012-1606(92)90123-X; Lin YH, 2003, PLANT SCI, V165, P1437, DOI 10.1016/j.plantsci.2003.08.011; LIU XY, 1994, J TEXTURE STUD, V25, P179, DOI 10.1111/j.1745-4603.1994.tb01325.x; Loven KV, 1993, J EXP BOT, V44, P1671; McCabe MS, 2001, PLANT PHYSIOL, V127, P505, DOI 10.1104/pp.010244; MEDFORD JI, 1989, PLANT CELL, V1, P403, DOI 10.1105/tpc.1.4.403; Merewitz EB, 2011, J EXP BOT, V62, P383, DOI 10.1093/jxb/erq285; MILLER CO, 1956, J AM CHEM SOC, V78, P1375, DOI 10.1021/ja01588a032; Peleg Z, 2011, PLANT BIOTECHNOL J, V9, P747, DOI 10.1111/j.1467-7652.2010.00584.x; Qin H, 2011, PLANT CELL PHYSIOL, V52, P1904, DOI 10.1093/pcp/pcr125; Rivero RM, 2007, P NATL ACAD SCI USA, V104, P19631, DOI 10.1073/pnas.0709453104; Rivero RM, 2010, PLANT CELL PHYSIOL, V51, P1929, DOI 10.1093/pcp/pcq143; Rivero RM, 2009, PLANT PHYSIOL, V150, P1530, DOI 10.1104/pp.109.139378; Robson PRH, 2004, PLANT BIOTECHNOL J, V2, P101, DOI 10.1046/j.1467-7652.2004.00054.x; Schmidhuber J, 2007, P NATL ACAD SCI USA, V104, P19703, DOI 10.1073/pnas.0701976104; Schoor S, 2011, PLANT PHYSIOL, V157, P659, DOI 10.1104/pp.111.181560; SMIGOCKI AC, 1988, P NATL ACAD SCI USA, V85, P5131, DOI 10.1073/pnas.85.14.5131; SMIGOCKI AC, 1989, PLANT PHYSIOL, V91, P808, DOI 10.1104/pp.91.3.808; Sykorova B, 2008, J EXP BOT, V59, P377, DOI 10.1093/jxb/erm319; Wang R, 2007, PLANT BREEDING, V126, P588, DOI 10.1111/j.1439-0523.2007.01382.x; Zhang P, 2010, J INTEGR PLANT BIOL, V52, P653, DOI 10.1111/j.1744-7909.2010.00956.x	32	47	49	1	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2015	10	1							e0116349	10.1371/journal.pone.0116349	http://dx.doi.org/10.1371/journal.pone.0116349			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ4OZ	25602960	Green Published, gold			2022-12-27	WOS:000348203500023
J	Malhotra, R; Burke, MF; Martyn, T; Shakartzi, HR; Thayer, TE; O'Rourke, C; Li, PC; Derwall, M; Spagnolli, E; Kolodziej, SA; Hoeft, K; Mayeur, C; Jiramongkolchai, P; Kumar, R; Buys, ES; Yu, PB; Bloch, KD; Bloch, DB				Malhotra, Rajeev; Burke, Megan F.; Martyn, Trejeeve; Shakartzi, Hannah R.; Thayer, Timothy E.; O'Rourke, Caitlin; Li, Pingcheng; Derwall, Matthias; Spagnolli, Ester; Kolodziej, Starsha A.; Hoeft, Konrad; Mayeur, Claire; Jiramongkolchai, Pawina; Kumar, Ravindra; Buys, Emmanuel S.; Yu, Paul B.; Bloch, Kenneth D.; Bloch, Donald B.			Inhibition of Bone Morphogenetic Protein Signal Transduction Prevents the Medial Vascular Calcification Associated with Matrix Gla Protein Deficiency	PLOS ONE			English	Article							CORONARY-ARTERY CALCIFICATION; SMOOTH-MUSCLE-CELLS; IN-VIVO; MOLECULAR-MECHANISMS; VULNERABLE PLAQUE; ENDOTHELIAL-CELLS; KEUTEL-SYNDROME; ATHEROSCLEROSIS; RUNX2; HYDROXYAPATITE	Objective Matrix Gla protein (MGP) is reported to inhibit bone morphogenetic protein (BMP) signal transduction. MGP deficiency is associated with medial calcification of the arterial wall, in a process that involves both osteogenic transdifferentiation of vascular smooth muscle cells (VSMCs) and mesenchymal transition of endothelial cells (EndMT). In this study, we investigated the contribution of BMP signal transduction to the medial calcification that develops in MGP-deficient mice. Approach and Results MGP-deficient mice (MGP(-/-)) were treated with one of two BMP signaling inhibitors, LDN-193189 or ALK3-Fc, beginning one day after birth. Aortic calcification was assessed in 28-day-old mice by measuring the uptake of a fluorescent bisphosphonate probe and by staining tissue sections with Alizarin red. Aortic calcification was 80% less in MGP(-/-) mice treated with LDN-193189 or ALK3-Fc compared with vehicle-treated control animals (P < 0.001 for both). LDN-193189-treated MGP(-/-) mice survived longer than vehicle-treated MGP(-/-) mice. Levels of phosphorylated Smad1/5 and Id1 mRNA (markers of BMP signaling) did not differ in the aortas from MGP(-/-) and wild-type mice. Markers of EndMT and osteogenesis were increased in MGP(-/-) aortas, an effect that was prevented by LDN-193189. Calcification of isolated VSMCs was also inhibited by LDN-193189. Conclusions Inhibition of BMP signaling leads to reduced vascular calcification and improved survival in MGP(-/-) mice. The EndMT and osteogenic transdifferentiation associated with MGP deficiency is dependent upon BMP signaling. These results suggest that BMP signal transduction has critical roles in the development of vascular calcification in MGP-deficient mice.	[Malhotra, Rajeev; Burke, Megan F.; Thayer, Timothy E.; Bloch, Kenneth D.] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Cardiovasc Res Ctr, Boston, MA 02115 USA; [Malhotra, Rajeev; Burke, Megan F.; Thayer, Timothy E.; Bloch, Kenneth D.] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Div Cardiol,Dept Med, Boston, MA 02115 USA; [Martyn, Trejeeve; Shakartzi, Hannah R.; O'Rourke, Caitlin; Li, Pingcheng; Derwall, Matthias; Spagnolli, Ester; Kolodziej, Starsha A.; Hoeft, Konrad; Mayeur, Claire; Jiramongkolchai, Pawina; Buys, Emmanuel S.; Bloch, Kenneth D.; Bloch, Donald B.] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Anesthesia Ctr Crit Care Res,Dept Anesthesia Crit, Boston, MA 02115 USA; [Derwall, Matthias] Rhein Westfal TH Aachen, Uniklin Aachen, Dept Anesthesiol, Aachen, Germany; [Kumar, Ravindra] Acceleron Pharma Inc, Cambridge, MA USA; [Yu, Paul B.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Cardiovasc, Boston, MA 02115 USA; [Bloch, Donald B.] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Ctr Immunol & Inflammatory Dis, Boston, MA 02115 USA; [Bloch, Donald B.] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Div Rheumatol Allergy & Immunol,Dept Med, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; RWTH Aachen University; RWTH Aachen University Hospital; Acceleron Pharma; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital	Malhotra, R (corresponding author), Harvard Univ, Sch Med, Massachusetts Gen Hosp, Cardiovasc Res Ctr, Boston, MA 02115 USA.	rmalhotra@partners.org	Thayer, Timothy/AAG-5285-2021; Yu, Paul B./J-7540-2019	Yu, Paul B./0000-0003-2145-4944; Bloch, Donald/0000-0002-6828-4754; Malhotra, Rajeev/0000-0003-0120-4630	American Heart Association [11FTF7290032]; National Heart, Lung, and Blood Institute [K08HL111210]; Howard Hughes Medical Institute; Sarnoff Cardiovascular Research Foundation; START-Program of the Faculty of Medicine at RWTH Aachen (MD); Leducq Foundation; National Institute of Arthritis and Musculoskeletal and Skin Diseases [R01AR057374]; National Institute of Diabetes and Digestive and Kidney Diseases [R01DK082971]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007208, K08HL111210] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR057374] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK082971] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Sarnoff Cardiovascular Research Foundation; START-Program of the Faculty of Medicine at RWTH Aachen (MD); Leducq Foundation(Leducq Foundation); National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the American Heart Association Fellow-to-Faculty Award # 11FTF7290032 (RM); the National Heart, Lung, and Blood Institute (K08HL111210, RM); the Howard Hughes Medical Institute (TM and PJ); the Sarnoff Cardiovascular Research Foundation (MFB and TET); the START-Program of the Faculty of Medicine at RWTH Aachen (MD); the Leducq Foundation (Multidisciplinary Program to Elucidate the Role of Bone Morphogenetic Protein Signaling in the Pathogenesis of Pulmonary and Systemic Vascular Diseases, PBY and KDB); the National Institute of Arthritis and Musculoskeletal and Skin Diseases (R01AR057374, PBY); and the National Institute of Diabetes and Digestive and Kidney Diseases (R01DK082971, KDB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe E, 2000, J BONE MINER RES, V15, P663, DOI 10.1359/jbmr.2000.15.4.663; Abedin M, 2004, ARTERIOSCL THROM VAS, V24, P1161, DOI 10.1161/01.ATV.0000133194.94939.42; Aikawa E, 2007, CIRCULATION, V116, P2841, DOI 10.1161/CIRCULATIONAHA.107.732867; Aikawa E, 2007, CIRCULATION, V115, P377, DOI 10.1161/CIRCULATIONAHA.106.654913; Amann K, 2008, CLIN J AM SOC NEPHRO, V3, P1599, DOI 10.2215/CJN.02120508; BOSKEY AL, 1993, BONE MINER, V22, P147, DOI 10.1016/S0169-6009(08)80225-5; BOSTROM K, 1993, J CLIN INVEST, V91, P1800, DOI 10.1172/JCI116391; Bragdon B, 2011, CELL SIGNAL, V23, P609, DOI 10.1016/j.cellsig.2010.10.003; Byon CH, 2008, J BIOL CHEM, V283, P15319, DOI 10.1074/jbc.M800021200; Cai J, 2012, FEBS LETT, V586, P1993, DOI 10.1016/j.febslet.2012.04.030; Cassidy-Bushrow AE, 2013, ARTERIOSCL THROM VAS, V33, P645, DOI 10.1161/ATVBAHA.112.300491; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; Crosier MD, 2009, J NUTR SCI VITAMINOL, V55, P59, DOI 10.3177/jnsv.55.59; Cuny GD, 2008, BIOORG MED CHEM LETT, V18, P4388, DOI 10.1016/j.bmcl.2008.06.052; Derwall M, 2012, ARTERIOSCL THROM VAS, V32, P613, DOI 10.1161/ATVBAHA.111.242594; Goiko M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080344; Hedin Ulf, 1999, Thrombosis and Haemostasis, V82, P23; Hruska KA, 2005, CIRC RES, V97, P105, DOI 10.1161/01.RES.00000175571.53833.6c; Huang H, 2001, CIRCULATION, V103, P1051, DOI 10.1161/01.CIR.103.8.1051; Johnson RC, 2006, CIRC RES, V99, P1044, DOI 10.1161/01.RES.0000249379.55535.21; KEUTEL J, 1971, DEUT MED WOCHENSCHR, V96, P1676, DOI 10.1055/s-0028-1110200; Lee KS, 2000, MOL CELL BIOL, V20, P8783, DOI 10.1128/MCB.20.23.8783-8792.2000; Lomashvili KA, 2011, J BIOL CHEM, V286, P28715, DOI 10.1074/jbc.M111.251462; Luo GB, 1997, NATURE, V386, P78, DOI 10.1038/386078a0; Luo J, 2007, NAT PROTOC, V2, P1236, DOI 10.1038/nprot.2007.135; Matsubara T, 2008, J BIOL CHEM, V283, P29119, DOI 10.1074/jbc.M801774200; Medici D, 2010, NAT MED, V16, P1400, DOI 10.1038/nm.2252; Meier M, 2001, EUR RESPIR J, V17, P566, DOI 10.1183/09031936.01.17305660; Munroe PB, 1999, NAT GENET, V21, P142, DOI 10.1038/5102; Nakagawa Y, 2010, ARTERIOSCL THROM VAS, V30, P1908, DOI 10.1161/ATVBAHA.110.206185; O'Young J, 2011, J AM CHEM SOC, V133, P18406, DOI 10.1021/ja207628k; Otsuka F, 2014, ARTERIOSCL THROM VAS, V34, P724, DOI 10.1161/ATVBAHA.113.302642; Proudfoot D, 2006, NEPHROLOGY, V11, P455, DOI 10.1111/j.1440-1797.2006.00660.x; Rong JX, 2003, P NATL ACAD SCI USA, V100, P13531, DOI 10.1073/pnas.1735526100; Roy ME, 2002, BONE, V31, P296, DOI 10.1016/S8756-3282(02)00821-9; Rusanescu G, 2008, CURR CARDIOL REV, V4, P148, DOI 10.2174/157340308785160552; Sage AP, 2010, NAT REV CARDIOL, V7, P528, DOI 10.1038/nrcardio.2010.115; Schurgers LJ, 2013, TRENDS MOL MED, V19, P217, DOI 10.1016/j.molmed.2012.12.008; Shao JS, 2006, ARTERIOSCL THROM VAS, V26, P1423, DOI 10.1161/01.ATV.0000220441.42041.20; Speer MY, 2010, J CELL BIOCHEM, V110, P935, DOI 10.1002/jcb.22607; Speer MY, 2009, CIRC RES, V104, P733, DOI 10.1161/CIRCRESAHA.108.183053; Speer MY, 2002, J EXP MED, V196, P1047, DOI 10.1084/jem.20020911; Steitz SA, 2001, CIRC RES, V89, P1147, DOI 10.1161/hh2401.101070; Sun Y, 2012, CIRC RES, V111, P543, DOI 10.1161/CIRCRESAHA.112.267237; Vattikuti R, 2004, AM J PHYSIOL-ENDOC M, V286, pE686, DOI 10.1152/ajpendo.00552.2003; Vengrenyuk Y, 2006, P NATL ACAD SCI USA, V103, P14678, DOI 10.1073/pnas.0606310103; Virmani R, 2006, J AM COLL CARDIOL, V47, pC13, DOI 10.1016/j.jacc.2005.10.065; Wallin R, 2000, THROMB HAEMOSTASIS, V84, P1039; Yagami K, 1999, J CELL BIOL, V147, P1097, DOI 10.1083/jcb.147.5.1097; Yao YC, 2006, J BIOL CHEM, V281, P33921, DOI 10.1074/jbc.M604239200; Yao YC, 2013, CIRC RES, V113, P495, DOI 10.1161/CIRCRESAHA.113.301792; Yao YC, 2010, CIRC RES, V107, P485, DOI 10.1161/CIRCRESAHA.110.219071; Zebboudj AF, 2002, J BIOL CHEM, V277, P4388, DOI 10.1074/jbc.M109683200; Zebboudj AF, 2003, J CELL BIOCHEM, V90, P756, DOI 10.1002/jcb.10669	54	51	52	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2015	10	1							e0117098	10.1371/journal.pone.0117098	http://dx.doi.org/10.1371/journal.pone.0117098			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ4OZ	25603410	Green Submitted, Green Published, gold			2022-12-27	WOS:000348203500042
J	Capdevila-Busquets, E; Badiola, N; Arroyo, R; Alcalde, V; Soler-Lopez, M; Aloy, P				Capdevila-Busquets, Eva; Badiola, Nahuai; Arroyo, Rodrigo; Alcalde, Vctor; Soler-Lopez, Montserrat; Aloy, Patrick			Breast Cancer Genes PSMC3IP and EPSTI1 Play a Role in Apoptosis Regulation	PLOS ONE			English	Article							EPITHELIAL-STROMAL INTERACTION; POLY(ADP-RIBOSE) POLYMERASE; DNA FRAGMENTATION; CELL-LINES; INHIBITION; PROTEIN; IDENTIFICATION; MOUSE; EXPRESSION; INDUCTION	A key element to delineate the biology of individual tumors is the regulation of apoptosis. In this work, we functionally characterize two breast cancer associated genes, the proteasome 26S subunit ATPase 3 interacting protein (PSMC3IP) and the epithelial-stromal interaction 1 (EPSTI1), to explore their potential apoptotic role in breast cancer. We first explore the existence of direct physical interactions with annotated BC-apoptotic genes. Based on the generated interaction network, we examine several apoptotic markers to determine the effect of PSMC3IP and EPSTI1 gene expression modulation in two different human breast cancer cell lines to suggest potential molecular mechanisms to unveil their role in the disease. Our results show that PSMC3IP and EPSTI1 are able to modulate the extrinsic apoptotic pathway in estrogen receptor positive and triple negative breast cancer cell lines, highlighting them as potential therapeutic targets.	[Capdevila-Busquets, Eva; Badiola, Nahuai; Arroyo, Rodrigo; Alcalde, Vctor; Soler-Lopez, Montserrat; Aloy, Patrick] Inst Res Biomed IRB Barcelona, Joint IRB BSC CRG Program Computat Biol, Barcelona, Catalonia, Spain; [Aloy, Patrick] ICREA, Barcelona, Catalonia, Spain	Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); ICREA	Aloy, P (corresponding author), Inst Res Biomed IRB Barcelona, Joint IRB BSC CRG Program Computat Biol, Barcelona, Catalonia, Spain.	patrick.aloy@irbbarcelona.org	Aloy, Patrick/AAB-3538-2019	Aloy, Patrick/0000-0002-3557-0236; Arroyo, Rodrigo/0000-0003-3540-1173; Alcalde Adell, Victor/0000-0002-7868-2983	Spanish Ministerio de Ciencia e Innovacion [BIO2010-22073]; FPI fellowship; ICREA Funding Source: Custom	Spanish Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); FPI fellowship(Spanish Government); ICREA(ICREA)	This work was partially supported by the Spanish Ministerio de Ciencia e Innovacion (BIO2010-22073). EC-B is a recipient of an FPI fellowship.	Ashkenazi A, 2008, J CLIN ONCOL, V26, P3621, DOI 10.1200/JCO.2007.15.7198; Buess M, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-r191; Cardone MH, 1998, SCIENCE, V282, P1318, DOI 10.1126/science.282.5392.1318; Collins JA, 1997, J HISTOCHEM CYTOCHEM, V45, P923, DOI 10.1177/002215549704500702; Datta SR, 1997, CELL, V91, P231, DOI 10.1016/S0092-8674(00)80405-5; de Neergaard M, 2010, AM J PATHOL, V176, P1229, DOI 10.2353/ajpath.2010.090648; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1, DOI 10.1111/j.2517-6161.1977.tb01600.x; Deveraux QL, 1997, NATURE, V388, P300, DOI 10.1038/40901; Deveraux QL, 1998, EMBO J, V17, P2215, DOI 10.1093/emboj/17.8.2215; Germain M, 1999, J BIOL CHEM, V274, P28379, DOI 10.1074/jbc.274.40.28379; GONG JP, 1994, ANAL BIOCHEM, V218, P314, DOI 10.1006/abio.1994.1184; Gudjonsson T, 2003, METHODS, V30, P247, DOI 10.1016/S1046-2023(03)00031-8; HALL JM, 1990, SCIENCE, V250, P1684, DOI 10.1126/science.2270482; Hastak K, 2010, CANCER RES, V70, P7970, DOI 10.1158/0008-5472.CAN-09-4521; Ibrahim YH, 2012, CANCER DISCOV, V2, P1036, DOI 10.1158/2159-8290.CD-11-0348; Janicke RU, 1998, J BIOL CHEM, V273, P9357, DOI 10.1074/jbc.273.16.9357; Juo P, 1998, CURR BIOL, V8, P1001, DOI 10.1016/S0960-9822(07)00420-4; Ko L, 2002, MOL CELL BIOL, V22, P357, DOI 10.1128/MCB.22.1.357-369.2002; Lamesch P, 2007, GENOMICS, V89, P307, DOI 10.1016/j.ygeno.2006.11.012; Lenferink AEG, 2001, CANCER RES, V61, P6583; Li T, 2013, ONCOGENE; Liang F, 2004, NUCLEIC ACIDS RES, V32, pD595, DOI 10.1093/nar/gkh118; Lobenhofer EK, 2000, CELL GROWTH DIFFER, V11, P99; Lord CJ, 2006, CLIN CANCER RES, V12, P4463, DOI 10.1158/1078-0432.CCR-06-1269; McKusick VA, 2007, AM J HUM GENET, V80, P588, DOI 10.1086/514346; Nielsen HL, 2002, GENOMICS, V79, P703, DOI 10.1006/geno.2002.6755; Nugoli M, 2003, BMC CANCER, V3, DOI 10.1186/1471-2407-3-13; Oti M, 2007, CLIN GENET, V71, P1, DOI 10.1111/j.1399-0004.2006.00708.x; Peng Min, 2013, Genes Cancer, V4, P15, DOI 10.1177/1947601913486344; Petukhova GV, 2003, DEV CELL, V5, P927, DOI 10.1016/S1534-5807(03)00369-1; Rahman M, 2009, BREAST CANCER RES TR, V113, P217, DOI 10.1007/s10549-008-9924-5; ROMMENS JM, 1995, GENOMICS, V28, P530, DOI 10.1006/geno.1995.1185; Satoh T, 2009, ENDOCRINOLOGY, V150, P3283, DOI 10.1210/en.2008-1122; Sircoulomb F, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-539; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; TEWARI M, 1995, CELL, V81, P801, DOI 10.1016/0092-8674(95)90541-3; Thomas RJ, 1999, ENDOCRINOLOGY, V140, P4451, DOI 10.1210/en.140.10.4451; Tsai EM, 2001, CANCER RES, V61, P8390; Uhlen M, 2010, NAT BIOTECHNOL, V28, P1248, DOI 10.1038/nbt1210-1248; van Agthoven T, 1998, EMBO J, V17, P2799, DOI 10.1093/emboj/17.10.2799; Varfolomeev EE, 1998, IMMUNITY, V9, P267, DOI 10.1016/S1074-7613(00)80609-3; Wong RSY, 2011, J EXP CLIN CANC RES, V30, DOI 10.1186/1756-9966-30-87; Xu J, 2007, CANCER RES, V67, P1203, DOI 10.1158/0008-5472.CAN-06-2310; Xu J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010226; Yang HY, 2001, ONCOGENE, V20, P3695, DOI 10.1038/sj.onc.1204472; Yang KM, 2013, CANCER RES, V73, P6679, DOI 10.1158/0008-5472.CAN-13-0891; Zanzoni A, 2009, FEBS LETT, V583, P1759, DOI 10.1016/j.febslet.2009.03.001; Zhang QB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009712	48	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2015	10	1							e0115352	10.1371/journal.pone.0115352	http://dx.doi.org/10.1371/journal.pone.0115352			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9HN	25590583	Green Submitted, gold, Green Published			2022-12-27	WOS:000350679400007
J	Corte, L; Tiecco, M; Roscini, L; De Vincenzi, S; Colabella, C; Germani, R; Tascini, C; Cardinali, G				Corte, Laura; Tiecco, Matteo; Roscini, Luca; De Vincenzi, Sergio; Colabella, Claudia; Germani, Raimondo; Tascini, Carlo; Cardinali, Gianluigi			FTIR Metabolomic Fingerprint Reveals Different Modes of Action Exerted by Structural Variants of N-Alkyltropinium Bromide Surfactants on Escherichia coli and Listeria innocua Cells	PLOS ONE			English	Article							TRANSFORM INFRARED-SPECTROSCOPY; INHIBITORY-ACTIVITY; CANDIDA-ALBICANS; STRESS-RESPONSE; MICROSPECTROSCOPY; IDENTIFICATION; ANTIFUNGAL; YEASTS; WATER; TOOL	Surfactants are extremely important agents to clean and sanitize various environments. Their biocidal activity is a key factor determined by the interactions between amphiphile structure and the target microbial cells. The object of this study was to analyze the interactions between four structural variants of N-alkyltropinium bromide surfactants with the Gram negative Escherichia coli and the Gram positive Listeria innocua bacteria. Microbiological and conductometric methods with a previously described FTIR bioassay were used to assess the metabolomic damage exerted by these compounds. All surfactants tested showed more biocidal activity in L. innocua than in E. coli. N-tetradecyltropinium bromide was the most effective compound against both species, while all the other variants had a reduced efficacy as biocides, mainly against E. coli cells. In general, the most prominent metabolomic response was observed for the constituents of the cell envelope in the fatty acids (W1) and amides (W2) regions and at the wavenumbers referred to peptidoglycan (W2 and W3 regions). This response was particularly strong and negative in L. innocua, when cells were challenged by N-tetradecyltropinium bromide, and by the variant with a smaller head and a 12C tail (N-dodecylquinuclidinium bromide). Tail length was critical for microbial inhibition especially when acting against E. coli, maybe due the complex nature of Gram negative cell envelope. Statistical analysis allowed us to correlate the induced mortality with the metabolomic cell response, highlighting two different modes of action. In general, gaining insights in the interactions between fine structural properties of surfactants and the microbial diversity can allow tailoring these compounds for the various operative conditions.	[Corte, Laura; Roscini, Luca; De Vincenzi, Sergio; Colabella, Claudia; Cardinali, Gianluigi] Univ Perugia, Dept Pharmaceut Sci Microbiol, I-06121 Perugia, Italy; [Tiecco, Matteo; Germani, Raimondo; Cardinali, Gianluigi] Univ Perugia, Dept Chem Biol & Biotechnol, Ctr Excellence Nanostruct Innovat Mat, CEMIN, I-06123 Perugia, Italy; [Tascini, Carlo] Univ Pisana, Azienda Osped, UO Malattie Infett, I-56100 Pisa, Italy	University of Perugia; University of Perugia; University of Pisa; Azienda Ospedaliero Universitaria Pisana	Corte, L (corresponding author), Univ Perugia, Dept Pharmaceut Sci Microbiol, Borgo XX Giugno 74, I-06121 Perugia, Italy.	laura.corte@unipg.it	Germani, Raimondo/E-7707-2014; Roscini, Luca/B-8804-2011; Corte, Laura/I-5498-2012; Tascini, Carlo/L-5942-2017; Germani, Raimondo/GMX-0960-2022; Tiecco, Matteo/K-8855-2014	Germani, Raimondo/0000-0001-7076-7475; Roscini, Luca/0000-0003-3706-9936; Corte, Laura/0000-0002-4723-7254; Tascini, Carlo/0000-0001-9625-6024; Germani, Raimondo/0000-0001-7076-7475; Tiecco, Matteo/0000-0002-1867-421X; Colabella, Claudia/0000-0002-2156-4150	ESF "Competitiveness and Employment objective" Umbrian Regional Operational Programme (ROP); project of the Bavicchi company [598/94 - Umbria Region]; FCR [2013.0043.021]; "Green chemistry cluster" project	ESF "Competitiveness and Employment objective" Umbrian Regional Operational Programme (ROP); project of the Bavicchi company; FCR; "Green chemistry cluster" project	MT was supported by 2007-2013 ESF "Competitiveness and Employment objective" Umbrian Regional Operational Programme (ROP), and partially supported by a project of the Bavicchi company (598/94 - Umbria Region). The project was partially supported by the FCR grant 2013.0043.021. The work was partially supported by the "Green chemistry cluster" project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adt I, 2006, ARCH MICROBIOL, V185, P277, DOI 10.1007/s00203-006-0094-8; Bellisola G, 2012, AM J CANCER RES, V2, P1; Breyton C, 2010, METHODS MOL BIOL, V601, P219, DOI 10.1007/978-1-60761-344-2_14; CABRAL JPS, 1992, CAN J MICROBIOL, V38, P115, DOI 10.1139/m92-019; Cao J, 2013, INT J MOL SCI, V14, P17453, DOI 10.3390/ijms140917453; Chaveriat L, 2013, EUR J MED CHEM, V62, P177, DOI 10.1016/j.ejmech.2012.12.032; Cheng J, 2011, ANAL CHIM ACTA, V701, P86, DOI 10.1016/j.aca.2011.04.058; Cornellas A, 2011, J COLLOID INTERF SCI, V355, P164, DOI 10.1016/j.jcis.2010.11.063; Corte L, 2014, COLLOID SURFACE B, V116, P761, DOI 10.1016/j.colsurfb.2014.01.054; Corte L, 2014, J SCI FOOD AGR, V94, P235, DOI 10.1002/jsfa.6239; Corte L, 2012, FOOD CHEM, V134, P1327, DOI 10.1016/j.foodchem.2012.03.025; Corte L, 2011, ANALYST, V136, P2339, DOI 10.1039/c0an00515k; Corte L, 2010, ANAL CHIM ACTA, V659, P258, DOI 10.1016/j.aca.2009.11.035; Del Bove M, 2009, FOOD MICROBIOL, V26, P453, DOI 10.1016/j.fm.2009.03.009; Essendoubi M, 2005, BBA-GEN SUBJECTS, V1724, P239, DOI 10.1016/j.bbagen.2005.04.019; Falagas ME, 2005, CLIN INFECT DIS, V40, P1333, DOI 10.1086/429323; Fernandez MV, 2014, FOOD BIOPROCESS TECH, V7, P2528, DOI 10.1007/s11947-013-1243-0; Hagan EWS, 2010, PROG ORG COAT, V69, P73, DOI 10.1016/j.porgcoat.2010.05.008; Hamouda T, 2000, J APPL MICROBIOL, V89, P397, DOI 10.1046/j.1365-2672.2000.01127.x; Huang WE, 2006, J MICROBIOL METH, V67, P273, DOI 10.1016/j.mimet.2006.04.009; Jarudilokkul S, 2000, BIOSEPARATION, V9, P81, DOI 10.1023/A:1008183828223; Kamnev AA, 2008, MICROB ECOL, V56, P615, DOI 10.1007/s00248-008-9381-z; Kamnev AA, 2008, SPECTROSC-INT J, V22, P83, DOI 10.1155/2008/862085; Kubo I, 2002, J AGR FOOD CHEM, V50, P3992, DOI 10.1021/jf020088v; Kugler R, 2005, MICROBIOL-SGM, V151, P1341, DOI 10.1099/mic.0.27526-0; Kummerle M, 1998, APPL ENVIRON MICROB, V64, P2207; Maillard JY, 2002, J APPL MICROBIOL, V92, p16S, DOI 10.1046/j.1365-2672.92.5s1.3.x; Mandal A, 2012, COLLOID SURFACE B, V90, P191, DOI 10.1016/j.colsurfb.2011.10.021; MENGER FM, 1991, J AM CHEM SOC, V113, P1451, DOI 10.1021/ja00004a077; Nakata K, 2011, J APPL MICROBIOL, V110, P568, DOI 10.1111/j.1365-2672.2010.04912.x; NAUMANN D, 1982, EUR J BIOCHEM, V125, P505, DOI 10.1111/j.1432-1033.1982.tb06711.x; Nazari M, 2012, BIOPHYS J, V102, P498, DOI 10.1016/j.bpj.2011.12.029; Negm NA, 2013, J SURFACTANTS DETERG, V16, P767, DOI 10.1007/s11743-013-1437-5; Ng CKL, 2007, BIOORGAN MED CHEM, V15, P3422, DOI 10.1016/j.bmc.2007.03.018; Noriega E, 2011, FOOD MICROBIOL, V28, P1293, DOI 10.1016/j.fm.2011.05.007; Numata M, 2010, P NATL ACAD SCI USA, V107, P320, DOI 10.1073/pnas.0909361107; Peetla C, 2009, LANGMUIR, V25, P2369, DOI 10.1021/la803361y; Qi L, 2011, VIROLOGY, V412, P426, DOI 10.1016/j.virol.2011.01.029; Roscini L, 2010, ANALYST, V135, P2099, DOI 10.1039/c0an00127a; Singh P, 2004, TRENDS BIOTECHNOL, V22, P142, DOI 10.1016/j.tibtech.2004.01.010; Smaoui S, 2010, APPL BIOCHEM BIOTECH, V162, P1132, DOI 10.1007/s12010-009-8821-7; Szeghalmi A, 2007, ANAL BIOANAL CHEM, V387, P1779, DOI 10.1007/s00216-006-0850-2; Tiecco M, 2014, CHEM-BIOL INTERACT, V218, P20, DOI 10.1016/j.cbi.2014.04.012; Tiecco M, 2013, COLLOID SURFACE B, V111, P407, DOI 10.1016/j.colsurfb.2013.06.033; Winfield MD, 2003, APPL ENVIRON MICROB, V69, P3687, DOI 10.1128/AEM.69.7.3687-3694.2003; Woodhall EW, 2012, US Patent App., Patent No. [13/708,676, 13708676]; Yu CX, 2005, BIOPOLYMERS, V77, P368, DOI 10.1002/bip.20247; Yuan XZ, 2008, COLLOID SURFACE A, V317, P256, DOI 10.1016/j.colsurfa.2007.10.024; Zana R, 2002, ADV COLLOID INTERFAC, V97, P205, DOI 10.1016/S0001-8686(01)00069-0; Zhao HJ, 2004, APPL ENVIRON MICROB, V70, P6619, DOI 10.1128/AEM.70.11.6619-6627.2004	50	30	30	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2015	10	1							e0115275	10.1371/journal.pone.0115275	http://dx.doi.org/10.1371/journal.pone.0115275			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ0ID	25588017	Green Submitted, Green Published, gold			2022-12-27	WOS:000347928300005
J	Fan, JD; Lei, PJ; Zheng, JY; Wang, X; Li, S; Liu, H; He, YL; Wang, ZN; Wei, G; Zhang, X; Li, LY; Wu, M				Fan, Jia-Dong; Lei, Pin-Ji; Zheng, Jun-Yi; Wang, Xiang; Li, Shangze; Liu, Huan; He, Yi-Lei; Wang, Zhao-Ning; Wei, Gang; Zhang, Xiaodong; Li, Lian-Yun; Wu, Min			The Selective Activation of p53 Target Genes Regulated by SMYD2 in BIX-01294 Induced Autophagy-Related Cell Death	PLOS ONE			English	Article							HISTONE METHYLTRANSFERASE; METHYLATION; PROLIFERATION; ACETYLATION; INHIBITOR; APOPTOSIS; G9A; DIFFERENTIATION; METABOLISM; PROTEINS	Transcription regulation emerged to be one of the key mechanisms in regulating autophagy. Inhibitors of H3K9 methylation activates the expression of LC3B, as well as other autophagy-related genes, and promotes autophagy process. However, the detailed mechanisms of autophagy regulated by nuclear factors remain elusive. In this study, we performed a drug screen of SMYD2(-/-)cells and discovered that SMYD2 deficiency enhanced the cell death induced by BIX01294, an inhibitor of histone H3K9 methylation. BIX-01294 induces accumulation of LC3 II and autophagy-related cell death, but not caspase-dependent apoptosis. We profiled the global gene expression pattern after treatment with BIX-01294, in comparison with rapamycin. BIX-01294 selectively activates the downstream genes of p53 signaling, such as p21 and DOR, but not PUMA, a typical p53 target gene inducing apoptosis. BIX-01294 also induces other autophagy-related genes, such as ATG4A and ATG9A. SMYD2 is a methyltransferase for p53 and regulates its transcription activity. Its deficiency enhances the BIX-01294-induced autophagy-related cell death through transcriptionally promoting the expression of p53 target genes. Taken together, our data suggest BIX-01294 induces autophagy-related cell death and selectively activates p53 target genes, which is repressed by SMYD2 methyltransferase.	[Fan, Jia-Dong; Lei, Pin-Ji; Zheng, Jun-Yi; Wang, Xiang; Liu, Huan; He, Yi-Lei; Wang, Zhao-Ning; Li, Lian-Yun; Wu, Min] Wuhan Univ, Coll Life Sci, Dept Biochem & Mol Biol, Wuhan 430072, Hubei, Peoples R China; [Li, Shangze; Zhang, Xiaodong] Wuhan Univ, Coll Life Sci, Dept Cell Biol & Dev Biol, Wuhan 430072, Hubei, Peoples R China; [Wei, Gang] Chinese Acad Sci, Shanghai Inst Biol Sci, CAS MPG Partner Inst Computat Biol, Shanghai 200031, Peoples R China	Wuhan University; Wuhan University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Max Planck Society	Li, LY (corresponding author), Wuhan Univ, Coll Life Sci, Dept Biochem & Mol Biol, Wuhan 430072, Hubei, Peoples R China.	lilianyun@whu.edu.cn; wumin@whu.edu.cn	Wu, Min/AAE-5066-2021; Wang, Zhaoning/AAB-5893-2021; Liu, Huan/CAA-2351-2022; Wang, Xiang/J-4036-2019; li, shangze/AAW-6317-2021	Wu, Min/0000-0003-1372-4764; Wang, Zhaoning/0000-0002-0290-4746; Wang, Xiang/0000-0002-7190-9233; 	National Basic Research Program of China (973 Program) [2011CB504206, 2012CB518700]; National Natural Science Foundation of China [30971502, 91019013, 31221061, 31200653, 31370866]; Program for New Century Excellent Talents in University [NCET-11-0410]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET))	This work was supported by grants from the National Basic Research Program of China (973 Program, 2011CB504206 and 2012CB518700), the National Natural Science Foundation of China to Min Wu (30971502 and 91019013) and Lian-Yun Li (31221061, 31200653 and 31370866), and Program for New Century Excellent Talents in University to Min Wu (NCET-11-0410). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Farha M, 2008, MOL CELL PROTEOMICS, V7, P560, DOI 10.1074/mcp.M700271-MCP200; Black JC, 2012, MOL CELL, V48, P491, DOI 10.1016/j.molcel.2012.11.006; Brown MA, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-26; Culmes M, 2013, EUR J CELL BIOL, V92, P70, DOI 10.1016/j.ejcb.2012.11.001; de Narvajas AAM, 2013, MOL CELL BIOL, V33, P3983, DOI 10.1128/MCB.00813-13; Diehl F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009748; Fullgrabe J, 2014, NAT REV MOL CELL BIO, V15, P65, DOI 10.1038/nrm3716; Green DR, 2014, CELL, V157, P65, DOI 10.1016/j.cell.2014.02.049; Greer EL, 2012, NAT REV GENET, V13, P343, DOI 10.1038/nrg3173; Hamamoto R, 2014, CANCER LETT, V351, P126, DOI 10.1016/j.canlet.2014.05.014; Herz HM, 2013, TRENDS BIOCHEM SCI, V38, P621, DOI 10.1016/j.tibs.2013.09.004; Huang J, 2006, NATURE, V444, P629, DOI 10.1038/nature05287; Huang J, 2010, J BIOL CHEM, V285, P9636, DOI 10.1074/jbc.M109.062588; Kim Y, 2013, AUTOPHAGY, V9, P2126, DOI 10.4161/auto.26308; Komatsu S, 2009, CARCINOGENESIS, V30, P1139, DOI 10.1093/carcin/bgp116; Kubicek S, 2007, MOL CELL, V25, P473, DOI 10.1016/j.molcel.2007.01.017; Leinhart K, 2011, GENES-BASEL, V2, P210, DOI 10.3390/genes2010210; Meijer AJ, 2009, AUTOPHAGY, V5, P3, DOI 10.4161/auto.5.1.7207; Mezentseva NV, 2013, STEM CELLS DEV, V22, P654, DOI 10.1089/scd.2012.0181; Munoz-Fontela C, 2011, CELL CYCLE, V10, P3701, DOI 10.4161/cc.10.21.17899; Piao L, 2014, NEOPLASIA, V16, DOI 10.1016/j.neo.2014.03.002; Rabinowitz JD, 2010, SCIENCE, V330, P1344, DOI 10.1126/science.1193497; Rago C, 2007, NAT PROTOC, V2, P2734, DOI 10.1038/nprot.2007.408; Riley T, 2008, NAT REV MOL CELL BIO, V9, P402, DOI 10.1038/nrm2395; Saddic LA, 2010, J BIOL CHEM, V285, P37733, DOI 10.1074/jbc.M110.137612; Sajjad A, 2014, BBA-MOL CELL RES, V1843, P2556, DOI 10.1016/j.bbamcr.2014.06.019; Savickiene J, 2014, LEUKEMIA RES, V38, P822, DOI 10.1016/j.leukres.2014.04.003; Sykes SM, 2006, MOL CELL, V24, P841, DOI 10.1016/j.molcel.2006.11.026; Tang Y, 2006, MOL CELL, V24, P827, DOI 10.1016/j.molcel.2006.11.021; Sakamoto LHT, 2014, LEUKEMIA RES, V38, P496, DOI 10.1016/j.leukres.2014.01.013; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Yang Q, 2012, CELL PROLIFERAT, V45, P335, DOI 10.1111/j.1365-2184.2012.00828.x; Zhang X, 2013, P NATL ACAD SCI USA, V110, P17284, DOI 10.1073/pnas.1307959110; Zhang XD, 2008, NAT METHODS, V5, P163, DOI [10.1038/nmeth1170, 10.1038/NMETH1170]; Zhao QY, 2012, SPRINGERPLUS, V1, DOI 10.1186/2193-1801-1-65	35	27	27	3	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2015	10	1							e0116782	10.1371/journal.pone.0116782	http://dx.doi.org/10.1371/journal.pone.0116782			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ3YO	25562686	Green Published, gold, Green Submitted			2022-12-27	WOS:000348160000003
J	Gelaye, B; Lohsoonthorn, V; Lertmeharit, S; Pensuksan, WC; Sanchez, SE; Lemma, S; Berhane, Y; Zhu, XT; Velez, JC; Barbosa, C; Anderade, A; Tadesse, MG; Williams, MA				Gelaye, Bizu; Lohsoonthorn, Vitool; Lertmeharit, Somrat; Pensuksan, Wipawan C.; Sanchez, Sixto E.; Lemma, Seblewengel; Berhane, Yemane; Zhu, Xiaotong; Carlos Velez, Juan; Barbosa, Clarita; Anderade, Asterio; Tadesse, Mahlet G.; Williams, Michelle A.			Construct Validity and Factor Structure of the Pittsburgh Sleep Quality Index and Epworth Sleepiness Scale in a Multi-National Study of African, South East Asian and South American College Students	PLOS ONE			English	Article							DAYTIME SLEEPINESS; PSYCHOMETRIC EVALUATION; PATTERNS; MODEL; PSQI; PERFORMANCE; CONSUMPTION; VALIDATION; HEALTH	Background: The Pittsburgh Sleep Quality Index (PSQI) and the Epworth Sleepiness Scale (ESS) are questionnaires used to assess sleep quality and excessive daytime sleepiness in clinical and population-based studies. The present study aimed to evaluate the construct validity and factor structure of the PSQI and ESS questionnaires among young adults in four countries (Chile, Ethiopia, Peru and Thailand). Methods: A cross-sectional study was conducted among 8,481 undergraduate students. Students were invited to complete a self-administered questionnaire that collected information about lifestyle, demographic, and sleep characteristics. In each country, the construct validity and factorial structures of PSQI and ESS questionnaires were tested through exploratory and confirmatory factor analyses (EFA and CFA). Results: The largest component-total correlation coefficient for sleep quality as assessed using PSQI was noted in Chile (r=0.71) while the smallest componenttotal correlation coefficient was noted for sleep medication use in Peru (r=0.28). The largest component-total correlation coefficient for excessive daytime sleepiness as assessed using ESS was found for item 1 (sitting/reading) in Chile (r=0.65) while the lowest item-total correlation was observed for item 6 (sitting and talking to someone) in Thailand (r=0.35). Using both EFA and CFA a two-factor model was found for PSQI questionnaire in Chile, Ethiopia and Thailand while a three-factor model was found for Peru. For the ESS questionnaire, we noted two factors for all four countries Conclusion: Overall, we documented cross-cultural comparability of sleep quality and excessive daytime sleepiness measures using the PSQI and ESS questionnaires among Asian, South American and African young adults. Although both the PSQI and ESS were originally developed as single-factor questionnaires, the results of our EFA and CFA revealed the multi-dimensionality of the scales suggesting limited usefulness of the global PSQI and ESS scores to assess sleep quality and excessive daytime sleepiness.	[Gelaye, Bizu; Zhu, Xiaotong; Tadesse, Mahlet G.; Williams, Michelle A.] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Lohsoonthorn, Vitool; Lertmeharit, Somrat] Chulalongkorn Univ, Fac Med, Dept Prevent & Social Med, Bangkok 10330, Thailand; [Lertmeharit, Somrat] Chulalongkorn Univ, Coll Publ Hlth Sci, Bangkok, Thailand; [Pensuksan, Wipawan C.] Walailak Univ, Sch Nursing, Nakhon Si Thammarat, Thailand; [Sanchez, Sixto E.] Univ San Martin de Porres, Lima, Peru; [Lemma, Seblewengel; Berhane, Yemane] Addis Continental Inst Publ Hlth, Addis Ababa, Ethiopia; [Carlos Velez, Juan; Barbosa, Clarita; Anderade, Asterio] Ctr Rehabil Club Leones Cruz Sur, Punta Arenas, Chile; [Tadesse, Mahlet G.] Georgetown Univ, Dept Math & Stat, Washington, DC USA	Harvard University; Harvard T.H. Chan School of Public Health; Chulalongkorn University; Chulalongkorn University; Walailak University; Universidad de San Martin de Porres; Addis Continental Institute of Public Health; Georgetown University	Gelaye, B (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA.	bgelaye@hsph.harvard.edu	Berhane, Yemane/ABB-8154-2020	Lemma, Seblewengel/0000-0001-5910-3723; Gelaye, Bizu/0000-0001-7934-548X; Berhane, Yemane/0000-0002-2527-1339	National Institutes of Health, National Institute of Minority Health and Health Disparities [T37-MD001449]; National Institute on Minority Health and Health Disparities [T37MD001449] Funding Source: NIH RePORTER	National Institutes of Health, National Institute of Minority Health and Health Disparities; National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This work was supported by an award from the National Institutes of Health, National Institute of Minority Health and Health Disparities (T37-MD001449). The authors wish to thank the participating universities for supporting the conduct of this study. The NIH had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aloba OO, 2007, SLEEP MED, V8, P266, DOI 10.1016/j.sleep.2006.08.003; American Academy of Sleep Medicine (AASM), 2001, INT CLASS SLEEP DIS; Backhaus J, 2002, J PSYCHOSOM RES, V53, P737, DOI 10.1016/S0022-3999(02)00330-6; Brown T.A., 2006, CONFIRMATORY FACTOR, Vxiii; Buboltz W, 2009, J COLL COUNS, V12, P113, DOI 10.1002/j.2161-1882.2009.tb00109.x; Buysse D J, 1989, Psychiatry Res, V28, P193; Carney CE, 2006, CHRONOBIOL INT, V23, P623, DOI 10.1080/07420520600650695; Carpenter JS, 1998, J PSYCHOSOM RES, V45, P5, DOI 10.1016/S0022-3999(97)00298-5; Cheng SH, 2012, PSYCHIAT RES; Cole JC, 2006, SLEEP, V29, P112, DOI 10.1093/sleep/29.1.112; Colten Harvey R., 2006, SLEEP DISORDERS SLEE; Dewald JF, 2010, SLEEP MED REV, V14, P179, DOI 10.1016/j.smrv.2009.10.004; Digdon NL, 2009, BIOL RHYTHM RES, V40, P129, DOI 10.1080/09291010801987700; Dominguez P, 2009, ARCH ARGENT PEDIATR, V107, P241, DOI 10.1590/S0325-00752009000300012; Freiberg MS, 2004, DIABETES CARE, V27, P2954, DOI 10.2337/diacare.27.12.2954; Griefahn B, 2001, SOMNOLOGIE, V5, P71, DOI [10.1046/j.1439-054X.2001.01149.x, DOI 10.1046/J.1439-054X.2001.01149.X]; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; Kotronoulas GC, 2011, SUPPORT CARE CANCER, V19, P1831, DOI 10.1007/s00520-010-1025-4; Lavie P, 2008, CURR PHARM DESIGN, V14, P3466, DOI 10.2174/138161208786549317; LeBlanc M, 2009, SLEEP, V32, P1027, DOI 10.1093/sleep/32.8.1027; Lemma S, 2012, SLEEP DISORD, V2012; Lohsoonthorn V, 2013, SLEEP BREATH, V17, P1017, DOI 10.1007/s11325-012-0792-1; Mariman A, 2012, J PSYCHOSOM RES, V72, P111, DOI 10.1016/j.jpsychores.2011.11.004; Otte JL, 2013, J PAIN SYMPTOM MANAG, V45, P620, DOI 10.1016/j.jpainsymman.2012.03.008; Roeser K, 2013, PERS INDIV DIFFER, V54, P836, DOI 10.1016/j.paid.2012.12.021; Sanchez Sixto E, 2013, Health (Irvine Calif), V5, P26; Smith SS, 2008, SLEEP MED, V9, P739, DOI 10.1016/j.sleep.2007.08.004; Steptoe A, 2006, ARCH INTERN MED, V166, P1689, DOI 10.1001/archinte.166.16.1689; Storfer-Isser A, 2013, J SLEEP RES, V22, P707, DOI 10.1111/jsr.12059; Stranges S, 2012, SLEEP, V35, P1173, DOI 10.5665/sleep.2012; Suen LKP, 2008, CHRONOBIOL INT, V25, P760, DOI 10.1080/07420520802397186; Taylor DJ, 2010, J ADOLESCENT HEALTH, V46, P610, DOI 10.1016/j.jadohealth.2009.12.010; Tsuno N, 2007, J SLEEP RES, V16, P364, DOI 10.1111/j.1365-2869.2007.00606.x; Veldi M, 2005, SLEEP MED, V6, P269, DOI 10.1016/j.sleep.2004.12.003; Velez Juan Carlos, 2013, Sleep Disord, V2013, P910104, DOI 10.1155/2013/910104; Whitney CW, 1998, SLEEP, V21, P27, DOI 10.1093/sleep/21.1.27; WHO, 2004, GLOB STAT REP ALC; World Health Organization, 1995, PHYS STAT US INT ANT; World Health Organization , 2014, PROC TRANSL AD INSTR	39	52	55	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2014	9	12							e116383	10.1371/journal.pone.0116383	http://dx.doi.org/10.1371/journal.pone.0116383			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AX7UC	25551586	Green Published, gold			2022-12-27	WOS:000347119100137
J	Gorman, BR; Lu, JJ; Baccei, A; Lowry, NC; Purvis, JE; Mangoubi, RS; Lerou, PH				Gorman, Bryan R.; Lu, Junjie; Baccei, Anna; Lowry, Nathan C.; Purvis, Jeremy E.; Mangoubi, Rami S.; Lerou, Paul H.			Multi-Scale Imaging and Informatics Pipeline for In Situ Pluripotent Stem Cell Analysis	PLOS ONE			English	Article							DIFFERENTIATION; HESCS	Human pluripotent stem (hPS) cells are a potential source of cells for medical therapy and an ideal system to study fate decisions in early development. However, hPS cells cultured in vitro exhibit a high degree of heterogeneity, presenting an obstacle to clinical translation. hPS cells grow in spatially patterned colony structures, necessitating quantitative single-cell image analysis. We offer a tool for analyzing the spatial population context of hPS cells that integrates automated fluorescent microscopy with an analysis pipeline. It enables high-throughput detection of colonies at low resolution, with single-cellular and sub-cellular analysis at high resolutions, generating seamless in situ maps of single-cellular data organized by colony. We demonstrate the tool's utility by analyzing inter- and intra-colony heterogeneity of hPS cell cycle regulation and pluripotency marker expression. We measured the heterogeneity within individual colonies by analyzing cell cycle as a function of distance. Cells loosely associated with the outside of the colony are more likely to be in G1, reflecting a less pluripotent state, while cells within the first pluripotent layer are more likely to be in G2, possibly reflecting a G2/M block. Our multi-scale analysis tool groups colony regions into density classes, and cells belonging to those classes have distinct distributions of pluripotency markers and respond differently to DNA damage induction. Lastly, we demonstrate that our pipeline can robustly handle high-content, high-resolution single molecular mRNA FISH data by using novel image processing techniques. Overall, the imaging informatics pipeline presented offers a novel approach to the analysis of hPS cells that includes not only single cell features but also colony wide, and more generally, multi-scale spatial configuration.	[Gorman, Bryan R.; Lu, Junjie; Baccei, Anna; Lerou, Paul H.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Pediat Newborn Med,Harvard Stem Cell Inst, Boston, MA 02115 USA; [Gorman, Bryan R.; Lu, Junjie; Baccei, Anna; Lerou, Paul H.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Med,Div Genet,Harvard Stem Cell Inst, Boston, MA 02115 USA; [Gorman, Bryan R.] MIT, Harvard Mit Div Hlth Sci & Technol, Cambridge, MA 02139 USA; [Gorman, Bryan R.; Lowry, Nathan C.; Mangoubi, Rami S.] Charles Stark Draper Lab, Cambridge, MA USA; [Purvis, Jeremy E.] Univ N Carolina, Sch Med, Dept Genet, Chapel Hill, NC USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); The Charles Stark Draper Laboratory, Inc.; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Lerou, PH (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Pediat Newborn Med,Harvard Stem Cell Inst, Boston, MA 02115 USA.	plerou@partners.org	; Lu, Junjie/A-6611-2009	Eastman, Anna/0000-0002-1455-291X; Lu, Junjie/0000-0002-4175-1762	National Institutes of Health [R00 HD061981, P01 GM099117, NIH R00-GM102372, R01 EB006161-01A4]; National Institutes of Health from the National Human Genome Research Institute [T32 HG002295]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R00HD061981] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [T32HG002295] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB006161] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R00GM102372, P01GM099117] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health from the National Human Genome Research Institute; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institutes of Health (R00 HD061981 to P.H.L., Pilot Grant under P01 GM099117 to P.H.L., NIH R00-GM102372 to J.E.P., R01 EB006161-01A4 to R.S.M., T32 HG002295 from the National Human Genome Research Institute to B.G.) and an internal research and development grant to R.S.M. from the C.S. Draper Laboratory, Cambridge, MA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbaric I, 2010, STEM CELL RES, V5, P104, DOI 10.1016/j.scr.2010.04.006; Blagovic K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022892; Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100; Daley GQ, 2010, J CLIN INVEST, V120, P8, DOI 10.1172/JCI41801; Drukker M, 2012, NATURE BIOTECHNOLOGY; Edelstein A., 2010, CURR PROTOC MOL BIOL, P20, DOI [DOI 10.1002/0471142727.MB1420S92, 10.1002/0471142727.mb1420s92]; Erb TM, 2011, STEM CELLS DEV, V20, P1601, DOI 10.1089/scd.2010.0281; Filipczyk AA, 2007, STEM CELL RES, V1, P45, DOI 10.1016/j.scr.2007.09.002; Graf T, 2008, CELL STEM CELL, V3, P480, DOI 10.1016/j.stem.2008.10.007; Kamentsky L., 2011, BIOINFORMATICS; Lam AQ, 2014, J AM SOC NEPHROL, V25, P1211, DOI 10.1681/ASN.2013080831; Lerou PH, 2008, NAT BIOTECHNOL, V26, P212, DOI 10.1038/nbt1378; Lerou PH, 2005, BLOOD REV, V19, P321, DOI 10.1016/j.blre.2005.01.005; Liu JC, 2013, CELL STEM CELL, V13, P483, DOI 10.1016/j.stem.2013.07.018; Lowry N, 2012, 2012 9TH IEEE INTERNATIONAL SYMPOSIUM ON BIOMEDICAL IMAGING (ISBI), P194, DOI 10.1109/ISBI.2012.6235517; Maciorowski Z, 1997, CYTOMETRY, V28, P123, DOI 10.1002/(SICI)1097-0320(19970601)28:2<123::AID-CYTO4>3.3.CO;2-1; Martinez Arias A, 2011, CURRENT OPINION CELL; Moogk D, 2010, CYTOM PART A, V77A, P321, DOI 10.1002/cyto.a.20878; Narkilahti S, 2007, BIOMED ENG ONLINE, V6, DOI 10.1186/1475-925X-6-11; Nazareth EJP, 2013, NAT METHODS, V10, P1225, DOI [10.1038/nmeth.2684, 10.1038/NMETH.2684]; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076; Paduano V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080776; Raj A, 2008, NAT METHODS, V5, P877, DOI 10.1038/NMETH.1253; Sakaue-Sawano A, 2008, CELL, V132, P487, DOI 10.1016/j.cell.2007.12.033; Sammak PJ, 2008, HIGH CONTENT SCREENI, P205; Scherf N, 2012, BIOINFORMATICS, V28, pI556, DOI 10.1093/bioinformatics/bts404; Snijder B, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.9; Snijder B, 2009, NATURE, V461, P520, DOI 10.1038/nature08282; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Unachukwu UJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083906; Wang XF, 2009, J BIOL CHEM, V284, P34054, DOI 10.1074/jbc.M109.052290; Warmflash A, 2014, NAT METHODS, V11, P847, DOI [10.1038/nmeth.3016, 10.1038/NMETH.3016]; Watanabe K, 2007, NAT BIOTECHNOL, V25, P681, DOI 10.1038/nbt1310; Wong RCB, 2008, STEM CELL REV, V4, P283, DOI 10.1007/s12015-008-9038-9	36	5	5	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2014	9	12							e116037	10.1371/journal.pone.0116037	http://dx.doi.org/10.1371/journal.pone.0116037			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UC	25551762	Green Published, Green Submitted, gold			2022-12-27	WOS:000347119100090
J	Habuka, M; Fagerberg, L; Hallstrom, BM; Kampf, C; Edlund, K; Sivertsson, A; Yamamoto, T; Ponten, F; Uhlen, M; Odeberg, J				Habuka, Masato; Fagerberg, Linn; Hallstrom, Bjorn M.; Kampf, Caroline; Edlund, Karolina; Sivertsson, Asa; Yamamoto, Tadashi; Ponten, Fredrik; Uhlen, Mathias; Odeberg, Jacob			The Kidney Transcriptome and Proteome Defined by Transcriptomics and Antibody-Based Profiling	PLOS ONE			English	Article							ALPHA-CRYSTALLIN; SLIT DIAPHRAGM; RNA-SEQ; GENE; NEPHRIN; EXPRESSION; DISEASE; BIOLOGY; TOOL; UROMODULIN	To understand renal functions and disease, it is important to define the molecular constituents of the various compartments of the kidney. Here, we used comparative transcriptomic analysis of all major organs and tissues in the human body, in combination with kidney tissue micro array based immunohistochemistry, to generate a comprehensive description of the kidney-specific transcriptome and proteome. A special emphasis was placed on the identification of genes and proteins that were elevated in specific kidney subcompartments. Our analysis identified close to 400 genes that had elevated expression in the kidney, as compared to the other analysed tissues, and these were further subdivided, depending on expression levels, into tissue enriched, group enriched or tissue enhanced. Immunohistochemistry allowed us to identify proteins with distinct localisation to the glomeruli (n=11), proximal tubules (n=120), distal tubules (n=9) or collecting ducts (n=8). Among the identified kidney elevated transcripts, we found several proteins not previously characterised or identified as elevated in kidney. This description of the kidney specific transcriptome and proteome provides a resource for basic and clinical research to facilitate studies to understand kidney biology and disease.	[Habuka, Masato; Fagerberg, Linn; Hallstrom, Bjorn M.; Sivertsson, Asa; Uhlen, Mathias; Odeberg, Jacob] KTH Royal Inst Technol, Sci Life Lab, Sch Biotechnol, Stockholm, Sweden; [Kampf, Caroline; Edlund, Karolina; Ponten, Fredrik] Uppsala Univ, Sci Life Lab, Dept Immunol Genet & Pathol, Uppsala, Sweden; [Habuka, Masato; Yamamoto, Tadashi] Niigata Univ, Sch Med & Dent, Inst Nephrol, Dept Struct Pathol, Niigata, Japan; [Odeberg, Jacob] Karolinska Inst, Dept Med, Stockholm, Sweden; [Odeberg, Jacob] Karolinska Univ Hosp, Ctr Hematol, Stockholm, Sweden	Royal Institute of Technology; Uppsala University; Niigata University; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital	Odeberg, J (corresponding author), KTH Royal Inst Technol, Sci Life Lab, Sch Biotechnol, Stockholm, Sweden.	Jacob.odeberg@scilifelab.se	Uhlen, Mathias/AAV-8746-2021; Uhlen, Mathias/B-3262-2016; Odeberg, Jacob/I-8314-2016	Uhlen, Mathias/0000-0002-4858-8056; Odeberg, Jacob/0000-0003-0996-1644; Fagerberg, Linn/0000-0003-0198-7137	Knut and Alice Wallenberg Foundation; Stockholm County Council	Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Stockholm County Council(Stockholm County Council)	Funding was provided by the Knut and Alice Wallenberg Foundation (http://www.wallenberg.com/kaw/en) and by the Stockholm County Council (http://www.forskningsstod.sll.se). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Anderson CMH, 2010, PHYSIOLOGY, V25, P364, DOI 10.1152/physiol.00027.2010; Andley UP, 2009, CURR MOL MED, V9, P887, DOI 10.2174/156652409789105598; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Beall MH, 2005, J SOC GYNECOL INVEST, V12, P298, DOI 10.1016/j.jsgi.2005.02.009; Bleyer AJ, 2011, NEPHRON CLIN PRACT, V118, pC31, DOI 10.1159/000320889; Cui ZY, 2013, PROTEOME SCI, V11, DOI 10.1186/1477-5956-11-13; Curthoys NP, 2007, AM J PHYSIOL-RENAL, V292, pF140, DOI 10.1152/ajprenal.00217.2006; Donoviel DB, 2001, MOL CELL BIOL, V21, P4829, DOI 10.1128/MCB.21.14.4829-4836.2001; Eden E, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-48; Eladari D, 2012, ANNU REV PHYSIOL, V74, P325, DOI 10.1146/annurev-physiol-020911-153225; Faber JJ, 2010, INT J DEV BIOL, V54, P391, DOI 10.1387/ijdb.082796jf; Fagerberg L, 2014, MOL CELL PROTEOMICS, V13, P397, DOI 10.1074/mcp.M113.035600; Farrah T, 2014, J PROTEOME RES, V13, P60, DOI 10.1021/pr4010037; Flicek P, 2013, NUCLEIC ACIDS RES, V41, pD48, DOI 10.1093/nar/gks1236; Griffin NM, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.R110.000935; He Lei, 2009, Human Genomics, V3, P195; Kampf C, 2012, JOVE-J VIS EXP, DOI 10.3791/3620; Kestila M, 1998, MOL CELL, V1, P575, DOI 10.1016/S1097-2765(00)80057-X; KUMAR R, 1994, AM J PHYSIOL, V266, pF477, DOI 10.1152/ajprenal.1994.266.3.F477; Lhotta K, 2010, KIDNEY BLOOD PRESS R, V33, P393, DOI 10.1159/000320681; Litt M, 1998, HUM MOL GENET, V7, P471, DOI 10.1093/hmg/7.3.471; Miyamoto M, 2007, J PROTEOME RES, V6, P3680, DOI 10.1021/pr070203n; Morrissey KM, 2012, CLIN PHARMACOL THER, V92, P545, DOI 10.1038/clpt.2012.44; Moser M, 2003, LAB INVEST, V83, P571, DOI 10.1097/01.LAB.0000064703.92382.50; Ponten F, 2008, J PATHOL, V216, P387, DOI 10.1002/path.2440; Ruotsalainen V, 1999, P NATL ACAD SCI USA, V96, P7962, DOI 10.1073/pnas.96.14.7962; Sato T, 2012, J CELL SCI, V125, P1544, DOI 10.1242/jcs.095273; Schafer J A, 1979, Physiologist, V22, P44; Schlessinger A, 2013, CLIN PHARMACOL THER, V94, P19, DOI 10.1038/clpt.2013.73; Schwarz K, 2001, J CLIN INVEST, V108, P1621, DOI 10.1172/JCI12849; Serafini-Cessi F, 2003, AM J KIDNEY DIS, V42, P658, DOI 10.1016/S0272-6386(03)00829-1; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Takemoto M, 2006, EMBO J, V25, P1160, DOI 10.1038/sj.emboj.7601014; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Uhlen M, 2010, NAT BIOTECHNOL, V28, P1248, DOI 10.1038/nbt1210-1248; Usener D, 2003, J INVEST DERMATOL, V121, P198, DOI 10.1046/j.1523-1747.2003.12318.x; Walmsley SJ, 2010, AM J PHYSIOL-RENAL, V298, pF1323, DOI 10.1152/ajprenal.00711.2009; Yamamoto T, 1998, KIDNEY INT, V54, P1041, DOI 10.1046/j.1523-1755.1998.00123.x; Zhou Y, 2012, AM J PHYSIOL-RENAL, V302, pF316, DOI 10.1152/ajprenal.00464.2011	41	30	30	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2014	9	12							e116125	10.1371/journal.pone.0116125	http://dx.doi.org/10.1371/journal.pone.0116125			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UC	25551756	Green Published, Green Submitted, gold			2022-12-27	WOS:000347119100096
J	Modi, K; Misra, HS				Modi, Kruti; Misra, Hari S.			Dr-FtsA, an Actin Homologue in Deinococcus radiodurans Differentially Affects Dr-FtsZ and Ec-FtsZ Functions In Vitro	PLOS ONE			English	Article							CELL-DIVISION PROTEIN; ESCHERICHIA-COLI FTSA; CRYSTAL-STRUCTURE; RADIORESISTANCE; MEMBRANE; SYSTEM; GENOME; KINASE; RING; LOCALIZATION	The Deinococcus radiodurans genome encodes homologues of divisome proteins including FtsZ and FtsA. FtsZ of this bacterium (Dr-FtsZ) has been recently characterized. In this paper, we study FtsA of D. radiodurans (Dr-FtsA) and its involvement in regulation of FtsZ function. Recombinant Dr-FtsA showed neither ATPase nor GTPase activity and its polymerization was ATP dependent. Interestingly, we observed that Dr-FtsA, when compared with E. coli FtsA (EcFtsA), has lower affinity for both Dr-FtsZ and Ec-FtsZ. Also, Dr-FtsA showed differential effects on GTPase activity and sedimentation characteristics of Dr-FtsZ and Ec-FtsZ. For instance, Dr-FtsA stimulated GTPase activity of Dr-FtsZ while GTPase activity of Ec-FtsZ was reduced in the presence of Dr-FtsA. Stimulation of GTPase activity of Dr-FtsZ by Dr-FtsA resulted in depolymerization of Dr-FtsZ. Dr-FtsA effects on GTPase activity and polymerization/depolymerisation characteristics of Dr-FtsZ did not change significantly in the presence of ATP. Recombinant E. coli expressing Dr-FtsA showed cell division inhibition in spite of in trans expression of Dr-FtsZ in these cells. These results suggested that Dr-FtsA, although it lacks ATPase activity, is still functional and differentially affects Dr-FtsZ and Ec-FtsZ function in vitro.	[Modi, Kruti; Misra, Hari S.] Bhabha Atom Res Ctr, Div Mol Biol, Bombay 400085, Maharashtra, India	Bhabha Atomic Research Center (BARC)	Misra, HS (corresponding author), Bhabha Atom Res Ctr, Div Mol Biol, Bombay 400085, Maharashtra, India.	hsmisra@barc.gov.in		Misra, Hari/0000-0002-9349-1229	Department of Atomic Energy, Government of India	Department of Atomic Energy, Government of India(Department of Atomic Energy (DAE))	Authors are grateful to Dr. S. K. Apte for his constructive criticisms on the work and valuable suggestions. We thank Professor Dulal Panda, IIT Bombay for Ec-FtsZ expression plasmid and table top ultramicrocentrifuge facility while Professor P. Ajitkumar, IISc Bangalore for Ec-FtsZ antibodies, and Dr. B. Vishwanath, Material Science Division, BARC for his help in carrying out transmission electron microscopy. We sincerely acknowledge the help of Dr Manisha Banerjee and Dr Swathi Kota for the critical reading of the manuscript. KM is grateful to Department of Atomic Energy, Government of India for Senior Research Fellowship.	Adams DW, 2009, NAT REV MICROBIOL, V7, P642, DOI 10.1038/nrmicro2198; Barak I, 2007, FEMS MICROBIOL REV, V31, P311, DOI 10.1111/j.1574-6976.2007.00067.x; Battesti A, 2012, METHODS, V58, P325, DOI 10.1016/j.ymeth.2012.07.018; Battista JR, 2000, CURR BIOL, V10, pR204, DOI 10.1016/S0960-9822(00)00353-5; Battista JR, 2001, CRYOBIOLOGY, V43, P133, DOI 10.1006/cryo.2001.2357; BAYKOV AA, 1988, ANAL BIOCHEM, V171, P266, DOI 10.1016/0003-2697(88)90484-8; BEGG KJ, 1985, J BACTERIOL, V163, P615, DOI 10.1128/JB.163.2.615-622.1985; Beuria TK, 2003, J BIOL CHEM, V278, P3735, DOI 10.1074/jbc.M205760200; Blasius M, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-69; Charaka VK, 2012, J BACTERIOL, V194, P5739, DOI 10.1128/JB.00610-12; DAI K, 1992, J BACTERIOL, V174, P6145, DOI 10.1128/JB.174.19.6145-6151.1992; Daly MJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012570; Feucht A, 2001, MOL MICROBIOL, V40, P115, DOI 10.1046/j.1365-2958.2001.02356.x; Fujita J, 2014, FEBS LETT, V588, P1879, DOI 10.1016/j.febslet.2014.04.008; Geissler B, 2007, MICROBIOL-SGM, V153, P814, DOI 10.1099/mic.0.2006/001834-0; Jonas K, 2014, CURR OPIN MICROBIOL, V18, P54, DOI 10.1016/j.mib.2014.02.006; Karimova G, 2005, J BACTERIOL, V187, P2233, DOI 10.1128/JB.187.7.2233-2243.2005; Karimova G, 1998, P NATL ACAD SCI USA, V95, P5752, DOI 10.1073/pnas.95.10.5752; Karimova G, 2001, J MOL MICROB BIOTECH, V3, P73; Kota S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085288; KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5; Lara B, 2005, MOL MICROBIOL, V55, P699, DOI 10.1111/j.1365-2958.2004.04432.x; Lecointe F, 2004, GENE, V336, P25, DOI 10.1016/j.gene.2004.04.006; Liu YQ, 2003, P NATL ACAD SCI USA, V100, P4191, DOI 10.1073/pnas.0630387100; Loose M, 2014, NAT CELL BIOL, V16, P38, DOI 10.1038/ncb2885; Lu CL, 1998, METHOD ENZYMOL, V298, P305, DOI 10.1016/S0076-6879(98)98027-2; Makarova KS, 2001, MICROBIOL MOL BIOL R, V65, P44, DOI 10.1128/MMBR.65.1.44-79.2001; Martos A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039829; Misra HS, 2013, CURR SCI INDIA, V104, P194; Modi KM, 2014, INT J BIOCHEM CELL B, V50, P38, DOI 10.1016/j.biocel.2014.01.015; Pichoff S, 2005, MOL MICROBIOL, V55, P1722, DOI 10.1111/j.1365-2958.2005.04522.x; Pichoff S, 2002, EMBO J, V21, P685, DOI 10.1093/emboj/21.4.685; Pichoff S, 2007, MOL MICROBIOL, V64, P1129, DOI 10.1111/j.1365-2958.2007.05735.x; Rajpurohit YS, 2013, INT J BIOCHEM CELL B, V45, P2541, DOI 10.1016/j.biocel.2013.08.011; Rajpurohit YS, 2010, MOL MICROBIOL, V77, P1470, DOI 10.1111/j.1365-2958.2010.07301.x; Rico AI, 2004, MOL MICROBIOL, V53, P1359, DOI 10.1111/j.1365-2958.2004.04245.x; Ringgaard S, 2014, P NATL ACAD SCI USA, V111, pE255, DOI 10.1073/pnas.1315722111; Sambrook J., 2001, MOL CLONING LAB MANU; Schafer M, 2000, PHOTOCHEM PHOTOBIOL, V71, P514, DOI 10.1562/0031-8655(2000)071<0514:SSOPIT>2.0.CO;2; Scheffers DJ, 2002, MOL MICROBIOL, V43, P1517, DOI 10.1046/j.1365-2958.2002.02828.x; Schultz C, 2009, MOL MICROBIOL, V74, P724, DOI 10.1111/j.1365-2958.2009.06897.x; Slade D, 2011, MICROBIOL MOL BIOL R, V75, P133, DOI 10.1128/MMBR.00015-10; Thakur M, 2006, J BIOL CHEM, V281, P40107, DOI 10.1074/jbc.M607216200; van den Ent F, 2001, NATURE, V413, P39, DOI 10.1038/35092500; van den Ent F, 2000, EMBO J, V19, P5300, DOI 10.1093/emboj/19.20.5300; Wang XD, 1997, J BACTERIOL, V179, P5551, DOI 10.1128/jb.179.17.5551-5559.1997; White O, 1999, SCIENCE, V286, P1571, DOI 10.1126/science.286.5444.1571; Yim L, 2000, J BACTERIOL, V182, P6366, DOI 10.1128/JB.182.22.6366-6373.2000	48	17	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2014	9	12							e115918	10.1371/journal.pone.0115918	http://dx.doi.org/10.1371/journal.pone.0115918			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UC	25551229	gold, Green Submitted, Green Published			2022-12-27	WOS:000347119100077
J	Rodriguez-Ruiz, J; de la Puente, J; Parejo, D; Valera, F; Calero-Torralbo, MA; Reyes-Gonzalez, JM; Zajkova, Z; Bermejo, A; Aviles, JM				Rodriguez-Ruiz, Juan; de la Puente, Javier; Parejo, Deseada; Valera, Francisco; Calero-Torralbo, Miguel A.; Reyes-Gonzalez, Jose M.; Zajkova, Zuzana; Bermejo, Ana; Aviles, Jesus M.			Disentangling Migratory Routes and Wintering Grounds of Iberian Near-Threatened European Rollers Coracias garrulus	PLOS ONE			English	Article							HOBBIES FALCO-SUBBUTEO; ANNUAL CYCLE; FLIGHT; AUTUMN	Long-distance migrants are suffering drastic declines in the last decades. Causes beneath this problem are complex due to the wide spatial and temporal scale involved. We aim to reveal migratory routes, stopover areas, wintering grounds, and migratory strategies for the most southwestern populations of the near-threatened European Roller Coracias garrulus in order to identify conservation key areas for the non-breeding stage of this species. To this end, we used tracking data from seven satellite transmitters fitted to birds breeding in different populations throughout the Iberian Peninsula and four geolocators fitted to individuals in a southeastern Iberian population. Precise satellite data were used to describe daily activity patterns and speed in relation to the main regions crossed during the migration. Individuals from the most southwestern Iberian populations made a detour towards the Atlantic African coast whereas those from northeastern populations followed a straight north-to-south route. We identified important stopover areas in the Sahel belt, mainly in the surroundings of the Lake Chad, and wintering grounds on southwestern Africa farther west than previously reported for the species. Concerning the migratory strategy, satellite data revealed: 1) a mainly nocturnal flying activity, 2) that migration speed depended on the type of crossed habitat, with higher average speed while crossing the desert; and 3) that the migration was slower and lasted longer in autumn than in spring. The studied populations showed weak migratory connectivity, suggesting the confluence of birds from a wide range of breeding grounds in a restricted wintering area. Therefore, we suggest to target on defining precisely key areas for this species and identifying specific threats in them in order to develop an appropriate global conservation programme for the European Roller.	[Rodriguez-Ruiz, Juan; Parejo, Deseada; Valera, Francisco; Calero-Torralbo, Miguel A.; Aviles, Jesus M.] CSIC, Estn Expt Zonas Aridas, Dept Ecol Func & Evolut, Almeria, Spain; [de la Puente, Javier; Bermejo, Ana] SEO BirdLife, Area Estudio & Seguimiento Aves, Madrid, Spain; [Parejo, Deseada] Univ Extremadura, Fac Ciencias, Dept Anat Biol Celular & Zool, Area Zool, Badajoz, Spain; [Reyes-Gonzalez, Jose M.; Zajkova, Zuzana] Univ Barcelona, Fac Biol, Dept Anim Biol Vertebrates, Barcelona, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Experimental de Zonas Aridas (EEZA); Universidad de Extremadura; University of Barcelona	Rodriguez-Ruiz, J (corresponding author), CSIC, Estn Expt Zonas Aridas, Dept Ecol Func & Evolut, Almeria, Spain.	juanrodruiz@gmail.com	Avilés, Jesús/K-3332-2014; REYES-GONZÁLEZ, JOSÉ MANUEL/N-9182-2017; Parejo, Deseada/L-3953-2014; Valera, Francisco/J-5951-2014; Valera, Francisco/R-3437-2019	Avilés, Jesús/0000-0002-1463-8393; REYES-GONZÁLEZ, JOSÉ MANUEL/0000-0001-8311-3235; Parejo, Deseada/0000-0002-7368-2378; Valera, Francisco/0000-0003-2266-8899; Valera, Francisco/0000-0003-2266-8899; Zajkova, Zuzana/0000-0002-7540-3651; Rodriguez-Ruiz, Juan/0000-0002-3937-7900	Spanish Ministry of Education and Science/FEDER [CGL2008-00718, CGL2008-00562]; Government of Extremadura [TA13002]	Spanish Ministry of Education and Science/FEDER(Spanish Government); Government of Extremadura	Funding in the form of salaries and fieldwork expenses was provided by the Spanish Ministry of Education and Science/FEDER through the projects CGL2008-00718 to DP and JMA and CGL2008-00562 to FV and only in form of salary by the Government of Extremadura through the grant TA13002 to DP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alerstam T., 1990, P331; Alerstam T, 2001, J THEOR BIOL, V209, P319, DOI 10.1006/jtbi.2001.2266; Alerstam T, 1993, BIRD MIGRATION; Alerstam T, 2009, J THEOR BIOL, V258, P530, DOI 10.1016/j.jtbi.2009.01.020; Ambrosini R, 2009, J THEOR BIOL, V257, P203, DOI 10.1016/j.jtbi.2008.11.019; [Anonymous], 2014, R LANG ENV STAT COMP; Argos, 2007, ARG US MAN; Arlt D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082316; ASH J S, 1980, Bulletin of the British Ornithologists' Club, V100, P216; Austin D, 2003, MAR MAMMAL SCI, V19, P371, DOI 10.1111/j.1748-7692.2003.tb01115.x; Aviles Jesus M., 1998, Vogelwarte, V39, P242; Bachler E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009566; Barron DG, 2010, METHODS ECOL EVOL, V1, P180, DOI 10.1111/j.2041-210X.2010.00013.x; *BIRDLIFE BOTSW, 2014, SPEC FACTSH COR GARR; *BIRDLIFE INT, 2013, SPEC FACTSH COR GARR; Bowlin MS, 2010, METHODS ECOL EVOL, V1, P398, DOI 10.1111/j.2041-210X.2010.00043.x; *BRIT ANT SURV, 2010, GEOL MAN V8; Brown L.H., 1973, Bulletin Br Orn Club, V93, P126; Catry I, 2014, J ORNITHOL, V155, P1071, DOI 10.1007/s10336-014-1097-x; CRAMP S, 1998, COMPLETE BRIDS W PAL; Dorst J., 1962, LAPD JUNE 2021 SETUP; Emmenegger T, 2014, J ORNITHOL, V155, P427, DOI 10.1007/s10336-013-1023-7; Feare C.J., 1983, Bulletin of the British Ornithologists' Club, V103, P39; Fridolfsson AK, 1999, J AVIAN BIOL, V30, P116, DOI 10.2307/3677252; FRY CH, 2001, HDB BIRDS WORLD, V6, P342; Gao H, 2011, ENVIRON RES LETT, V6, DOI 10.1088/1748-9326/6/3/034021; garcelon D.K., 1985, MOUNTING BACKPACK TE; Glutz Von Blotzheim U.N., 1980, HDB VOGEL MITTELEURO, V9; Goslee SC, 2007, J STAT SOFTW, V22, P1, DOI 10.18637/jss.v022.i07; HEDENSTROM A, 1993, PHILOS T ROY SOC B, V342, P353, DOI 10.1098/rstb.1993.0164; Hill Roger D., 1994, P227; Kerlinger P., 1989, Current Ornithology, V6, P109; Liminana R, 2008, ARDEA, V96, P81, DOI 10.5253/078.096.0109; Liminana R, 2012, BIOL CONSERV, V145, P62, DOI 10.1016/j.biocon.2011.10.009; Lisovski S, 2012, METHODS ECOL EVOL, V3, P603, DOI 10.1111/j.2041-210X.2012.00185.x; Lopez-Lopez P, 2010, LANDSCAPE ECOL, V25, P803, DOI 10.1007/s10980-010-9460-7; Lopez-Lopez P, 2009, ZOOL STUD, V48, P485; MAYAUD N, 1985, Alauda, V53, P29; MCCONNELL BJ, 1992, ANTARCT SCI, V4, P393, DOI 10.1017/S0954102092000580; Mellone U, 2013, J AVIAN BIOL, V44, P417, DOI 10.1111/j.1600-048X.2013.00139.x; Meyburg B-U, 2009, POPULATIONSOKOLOGIE, V6, P311; Moreau R., 1972, PALAEARCTIC AFRICAN; MOREL G, 1973, IBIS, V115, P413, DOI 10.1111/j.1474-919X.1973.tb01979.x; Mulliu W.C., 2009, LIVING EDGE WETLANDS, P202; Newton I, 2004, IBIS, V146, P197, DOI 10.1111/j.1474-919X.2004.00293.x; PEPLER D, 2000, ESKOM RED DATA BOOK, P90; RAPPOLE JH, 1991, J FIELD ORNITHOL, V62, P335; Robinson WD, 2010, FRONT ECOL ENVIRON, V8, P354, DOI 10.1890/080179; Rodgers A. R., 2005, HRT HOME RANGE TOOLS; Rodriguez A, 2009, DIVERS DISTRIB, V15, P1010, DOI 10.1111/j.1472-4642.2009.00600.x; Sanderson FJ, 2006, BIOL CONSERV, V131, P93, DOI 10.1016/j.biocon.2006.02.008; Sauvage A., 1998, Malimbus, V20, P75; Scandolara C, 2014, J AVIAN BIOL, V45, P417, DOI 10.1111/jav.00412; Schmaljohann H, 2012, BEHAV ECOL SOCIOBIOL, V66, P915, DOI 10.1007/s00265-012-1340-5; Schwilch R, 2002, ARDEA, V90, P149; Searle SR., 1992, VARIANCE COMPONENTS; Strandberg R, 2009, P ROY SOC B-BIOL SCI, V276, P727, DOI 10.1098/rspb.2008.1202; Strandberg R, 2007, BEHAV ECOL SOCIOBIOL, V61, P1865, DOI 10.1007/s00265-007-0426-y; Strandberg R, 2009, ARDEA, V97, P287, DOI 10.5253/078.097.0304; Stresemann Erwin, 1944, ORNITHOL MONATSBER, V52, P132; Stutchbury BJM, 2009, SCIENCE, V323, P896, DOI 10.1126/science.1166664; Tottrup AP, 2012, P ROY SOC B-BIOL SCI, V279, P1008, DOI 10.1098/rspb.2011.1323; Trierweiler C, 2013, J ANIM ECOL, V82, P107, DOI 10.1111/j.1365-2656.2012.02036.x; Vickery JA, 2014, IBIS, V156, P1, DOI 10.1111/ibi.12118; Webster MS, 2002, TRENDS ECOL EVOL, V17, P76, DOI 10.1016/S0169-5347(01)02380-1; Wilcove DS, 2008, PLOS BIOL, V6, P1361, DOI 10.1371/journal.pbio.0060188; Zwarts L., 2009, LIVING EDGE WETLANDS	67	18	21	1	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2014	9	12							e115615	10.1371/journal.pone.0115615	http://dx.doi.org/10.1371/journal.pone.0115615			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UC	25551212	Green Published, gold, Green Submitted			2022-12-27	WOS:000347119100050
J	Zelman, B; Kiszewski, A; Cotter, C; Liu, J				Zelman, Brittany; Kiszewski, Anthony; Cotter, Chris; Liu, Jenny			Costs of Eliminating Malaria and the Impact of the Global Fund in 34 Countries	PLOS ONE			English	Article								Background: International financing for malaria increased more than 18-fold between 2000 and 2011; the largest source came from The Global Fund to Fight AIDS, Tuberculosis and Malaria (Global Fund). Countries have made substantial progress, but achieving elimination requires sustained finances to interrupt transmission and prevent reintroduction. Since 2011, global financing for malaria has declined, fueling concerns that further progress will be impeded, especially for current malaria-eliminating countries that may face resurgent malaria if programs are disrupted. Objectives: This study aims to 1) assess past total and Global Fund funding to the 34 current malaria-eliminating countries, and 2) estimate their future funding needs to achieve malaria elimination and prevent reintroduction through 2030. Methods: Historical funding is assessed against trends in country-level malaria annual parasite incidences (APIs) and income per capita. Following Kizewski et al. (2007), program costs to eliminate malaria and prevent reintroduction through 2030 are estimated using a deterministic model. The cost parameters are tailored to a package of interventions aimed at malaria elimination and prevention of reintroduction. Results: The majority of Global Fund-supported countries experiencing increases in total funding from 2005 to 2010 coincided with reductions in malaria APIs and also overall GNI per capita average annual growth. The total amount of projected funding needed for the current malaria-eliminating countries to achieve elimination and prevent reintroduction through 2030 is approximately US$8.5 billion, or about $1.84 per person at risk per year (PPY) (ranging from $2.51 PPY in 2014 to $1.43 PPY in 2030). Conclusions: Although external donor funding, particularly from the Global Fund, has been key for many malaria-eliminating countries, sustained and sufficient financing is critical for furthering global malaria elimination. Projected cost estimates for elimination provide policymakers with an indication of the level of financial resources that should be mobilized to achieve malaria elimination goals.	[Zelman, Brittany; Cotter, Chris; Liu, Jenny] Univ Calif San Francisco, Global Hlth Grp, San Francisco, CA 94143 USA; [Kiszewski, Anthony] Bentley Univ, Waltham, MA USA	University of California System; University of California San Francisco; Bentley University	Zelman, B (corresponding author), Univ Calif San Francisco, Global Hlth Grp, San Francisco, CA 94143 USA.	Brittany.Zelman@ucsf.edu			Bill & Melinda Gates Foundation	Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR)	The University of California San Francisco Global Health Group's Malaria Elimination Initiative is supported by grants from the Bill & Melinda Gates Foundation. The authors declare that no funding bodies had any role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, ETH INT FRAM GLOB FU; [Anonymous], WHO COMM SRI LANK; [Anonymous], DET COST EFF MAL RAP; [Anonymous], DIAGN G6DP DEF; [Anonymous], MAL EL COUNTR BRIEF; [Anonymous], IND MEAS IMP MAL CON; [Anonymous], SOURC PRIC SEL MED C; [Anonymous], COART PRIC LIST; [Anonymous], INT J GEOINFORMATICS; [Anonymous], LONG LAST INS NETS L; [Anonymous], FINANCING MALARIA EL; [Anonymous], PROGR EL SRI LANK; Bousema T, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001165; Cohen JM, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-122; Cotter C, 2013, LANCET, V382, P900, DOI 10.1016/S0140-6736(13)60310-4; Feachem RGA, 2010, LANCET, V376, P1566, DOI 10.1016/S0140-6736(10)61270-6; Hay SI, 2006, PLOS MED, V3, P2204, DOI 10.1371/journal.pmed.0030473; Kiszewski A, 2007, B WORLD HEALTH ORGAN, V85, P623, DOI 10.2471/BLT.06.039529; Oduro AR, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-96; Pigott DM, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-246; WHO, 2012, WORLD MALARIA REPORT 2012, P1	21	16	16	0	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2014	9	12							e115714	10.1371/journal.pone.0115714	http://dx.doi.org/10.1371/journal.pone.0115714			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UC	25551454	gold, Green Submitted, Green Published			2022-12-27	WOS:000347119100052
J	Dal Maso, C; Pompa, G; Puliga, M; Riotta, G; Chessa, A				Dal Maso, Carlo; Pompa, Gabriele; Puliga, Michelangelo; Riotta, Gianni; Chessa, Alessandro			Voting Behavior, Coalitions and Government Strength through a Complex Network Analysis	PLOS ONE			English	Article							POLARIZATION; FAILURES	We analyze the network of relations between parliament members according to their voting behavior. In particular, we examine the emergent community structure with respect to political coalitions and government alliances. We rely on tools developed in the Complex Network literature to explore the core of these communities and use their topological features to develop new metrics for party polarization, internal coalition cohesiveness and government strength. As a case study, we focus on the Chamber of Deputies of the Italian Parliament, for which we are able to characterize the heterogeneity of the ruling coalition as well as parties specific contributions to the stability of the government over time. We find sharp contrast in the political debate which surprisingly does not imply a relevant structure based on established parties. We take a closer look to changes in the community structure after parties split up and their effect on the position of single deputies within communities. Finally, we introduce a way to track the stability of the government coalition over time that is able to discern the contribution of each member along with the impact of its possible defection. While our case study relies on the Italian parliament, whose relevance has come into the international spotlight in the present economic downturn, the methods developed here are entirely general and can therefore be applied to a multitude of other scenarios.	[Dal Maso, Carlo; Pompa, Gabriele; Puliga, Michelangelo; Riotta, Gianni; Chessa, Alessandro] IMT, Inst Adv Studies, Lucca, Italy; [Puliga, Michelangelo; Chessa, Alessandro] Complex Syst Computat Lab, Linkalab, Cagliari, Italy; [Riotta, Gianni] Princeton Univ, Dept French & Italian, Pirelli Chair, Princeton, NJ 08544 USA	IMT School for Advanced Studies Lucca; Princeton University	Chessa, A (corresponding author), IMT, Inst Adv Studies, Lucca, Italy.	alessandro.chessa@imtlucca.it	puliga, michelangelo/AAS-9954-2020		Progetto di Interesse CNR \CRISISLAB; FET project SIMPOL [610704]; Linkalab	Progetto di Interesse CNR \CRISISLAB; FET project SIMPOL; Linkalab	The authors acknowledge support from the Progetto di Interesse CNR \CRISISLAB", and the FET project SIMPOL 610704. All authors acknowledge enlightening discussions and support from people in LINKALAB. Michelangelo Puliga and Alessandro Chessa are employed by Linkalab. Linkalab provided support in the form of salaries for authors MP and AC, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	[Anonymous], DO DECR APPR HOUS FI; [Anonymous], GOV LETT FID ALLA CA; [Anonymous], IT JUST MIN READ RES; Bloomberg, BLOOMBERG; Buldyrev SV, 2010, NATURE, V464, P1025, DOI 10.1038/nature08932; Caldarelli G., 2007, SCALE FREE NETWORKS; Cho WKT, 2010, J POLIT, V72, P124, DOI 10.1017/S002238160999051X; De Leo V, 2013, PHYS REV E, V88, DOI 10.1103/PhysRevE.88.042810; Fiorina MP, 2008, J POLIT, V70, P556, DOI 10.1017/S002238160808050X; Fortunato S, 2010, PHYS REP, V486, P75, DOI 10.1016/j.physrep.2009.11.002; Layman GC, 2006, ANNU REV POLIT SCI, V9, P83, DOI 10.1146/annurev.polisci.9.070204.105138; Moody J., 2013, NETW SCI, V1, P119, DOI DOI 10.1017/NWS.2012.3; Newman MEJ, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.066133; Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480; Newman MEJ, 2004, PHYS REV E, V70, DOI [10.1103/PhysRevE.70.056131, 10.1103/PhysRevE.69.026113]; Panzieri S, 2008, INT J MODEL IDENTIF, V3, P69, DOI 10.1504/IJMIC.2008.018186; Peerenboom J., 2001, P CRIS DRM IIIT NSF; Porter, 2009, ARXIV09073509; Porter MA, 2005, P NATL ACAD SCI USA, V102, P7057, DOI 10.1073/pnas.0500191102; Zhang Y, 2008, PHYSICA A, V387, P1705, DOI 10.1016/j.physa.2007.11.004; Zhao DW, 2014, PHYS LETT A, V378, P770, DOI 10.1016/j.physleta.2014.01.014; Zhao DW, 2014, PHYS SCRIPTA, V89, DOI 10.1088/0031-8949/89/01/015203	22	17	17	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2014	9	12							e116046	10.1371/journal.pone.0116046	http://dx.doi.org/10.1371/journal.pone.0116046			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AX6YH	25549351	Green Submitted, gold, Green Published			2022-12-27	WOS:000347063500047
J	Fei, P; Zaitoun, I; Farnoodian, M; Fisk, DL; Wang, SJ; Sorenson, CM; Sheibani, N				Fei, Ping; Zaitoun, Ismail; Farnoodian, Mitra; Fisk, Debra L.; Wang, Shoujian; Sorenson, Christine M.; Sheibani, Nader			Expression of Thrombospondin-1 Modulates the Angioinflammatory Phenotype of Choroidal Endothelial Cells	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; RETINAL VASCULAR DEVELOPMENT; GROWTH-FACTOR; VE-CADHERIN; IN-VITRO; ANGIOGENESIS; ENDOGLIN; GENE; NEOVASCULARIZATION; HETEROGENEITY	The choroidal circulation plays a central role in maintaining the health of outer retina and photoreceptor function. Alterations in this circulation contribute to pathogenesis of many eye diseases including exudative age-related macular degeneration. Unfortunately, very little is known about the choroidal circulation and its molecular and cellular regulation. This has been further hampered by the lack of methods for routine culturing of choroidal endothelial cells (ChEC), especially from wild type and transgenic mice. Here we describe a method for isolation and culturing of mouse ChEC. We show that expression of thrombospondin-1 (TSP1), an endogenous inhibitor of angiogenesis and inflammation, has a significant impact on phenotype of ChEC. ChEC from TSP1-deficient (TSP1-/-) mice were less proliferative and more apoptotic, less migratory and less adherent, and failed to undergo capillary morphogenesis in Matrigel. However, re-expression of TSP1 was sufficient to restore TSP1-/- ChEC migration and capillary morphogenesis. TSP1-/- ChEC expressed increased levels of TSP2, phosphorylated endothelial nitric oxide synthase (NOS) and inducible NOS (iNOS), a marker of inflammation, which was associated with significantly higher level of NO and oxidative stress in these cells. Wild type and TSP1-/- ChEC produced similar levels of VEGF, although TSP1-/- ChEC exhibited increased levels of VEGF-R1 and pSTAT3. Other signaling pathways including Src, Akt, and MAPKs were not dramatically affected by the lack of TSP1. Together our results demonstrate an important autocrine role for TSP1 in regulation of ChEC phenotype.	[Fei, Ping; Zaitoun, Ismail; Farnoodian, Mitra; Fisk, Debra L.; Wang, Shoujian; Sheibani, Nader] Univ Wisconsin, Sch Med & Publ Hlth, Dept Ophthalmol & Visual Sci, Madison, WI 53706 USA; [Sorenson, Christine M.] Univ Wisconsin, Sch Med & Publ Hlth, Dept Pediat, Madison, WI USA; [Sorenson, Christine M.; Sheibani, Nader] Univ Wisconsin, Sch Med & Publ Hlth, McPherson Eye Res Inst, Madison, WI USA; [Sheibani, Nader] Univ Wisconsin, Sch Med & Publ Hlth, Dept Biomed Engn, Madison, WI USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Sheibani, N (corresponding author), Univ Wisconsin, Sch Med & Publ Hlth, Dept Ophthalmol & Visual Sci, Madison, WI 53706 USA.	nsheibanikar@wisc.edu	Sheibani, Nader/AAG-2379-2020	Sheibani, Nader/0000-0003-2723-9217	UW Paul P. Carbone Cancer Center Support Grant from the National Institutes of Health [EY023024, EY022883, P30 EY016665, P30 CA014520]; Research to Prevent Blindness; American Diabetes Association [1-10-BS-160]; Retina Research Foundation; NATIONAL CANCER INSTITUTE [P30CA014520] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [P30EY016665, R24EY022883, R21EY023024] Funding Source: NIH RePORTER	UW Paul P. Carbone Cancer Center Support Grant from the National Institutes of Health; Research to Prevent Blindness(Research to Prevent Blindness (RPB)); American Diabetes Association(American Diabetes Association); Retina Research Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by grants EY023024, EY022883, P30 EY016665 Core grant, and P30 CA014520 UW Paul P. Carbone Cancer Center Support Grant from the National Institutes of Health and an unrestricted departmental award from Research to Prevent Blindness. NS is a recipient of a Research Award from American Diabetes Association, 1-10-BS-160 and Retina Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiello LP, 1997, OPHTHALMIC RES, V29, P354, DOI 10.1159/000268033; Barbara NP, 1999, J BIOL CHEM, V274, P584, DOI 10.1074/jbc.274.2.584; Bhutto IA, 2008, ARCH OPHTHALMOL-CHIC, V126, P670, DOI 10.1001/archopht.126.5.670; Blanes MG, 2007, J BIOL CHEM, V282, P10660, DOI 10.1074/jbc.M609048200; Browning AC, 2005, BRIT J OPHTHALMOL, V89, P1343, DOI 10.1136/bjo.2004.063602; Browning AC, 2012, BRIT J OPHTHALMOL, V96, P128, DOI 10.1136/bjophthalmol-2011-300572; Carmeliet P, 1999, CELL, V98, P147, DOI 10.1016/S0092-8674(00)81010-7; CERVERA R, 1994, ANN RHEUM DIS, V53, P265, DOI 10.1136/ard.53.4.265; Daufenbach DR, 1998, OPHTHALMOLOGY, V105, P1455, DOI 10.1016/S0161-6420(98)98028-9; Dejana E, 2012, CURRENT OPINION HEMA; FAJARDO LF, 1989, AM J CLIN PATHOL, V92, P241, DOI 10.1093/ajcp/92.2.241; Fukumura D, 2001, P NATL ACAD SCI USA, V98, P2604, DOI 10.1073/pnas.041359198; Green W Richard, 2005, Retina, V25, P180, DOI 10.1097/00006982-200507001-00005; GREENWOOD J, 1994, LAB INVEST, V70, P39; Grisanti S, 2004, EXP EYE RES, V78, P207, DOI 10.1016/j.exer.2003.11.008; Guyer DR, 1994, RETINA, P18; He Shikun, 2006, Yan Ke Xue Bao, V22, P265; He SK, 2005, INVEST OPHTH VIS SCI, V46, P4772, DOI 10.1167/iovs.05-0502; Hnasko R, 2006, CELL CYCLE, V5, P2021, DOI 10.4161/cc.5.17.3217; Hoffmann S, 1998, GRAEF ARCH CLIN EXP, V236, P779, DOI 10.1007/s004170050158; Ioannidou S, 2006, P NATL ACAD SCI USA, V103, P16770, DOI 10.1073/pnas.0603501103; Isenberg JS, 2005, P NATL ACAD SCI USA, V102, P13141, DOI 10.1073/pnas.0502977102; Jozkowicz A, 2004, GROWTH FACTORS, V22, P19, DOI 10.1080/0897719041682863; Kibbe M, 1999, CARDIOVASC RES, V43, P650, DOI 10.1016/S0008-6363(99)00130-3; Kobayashi S, 1998, JPN J PHARMACOL, V78, P471, DOI 10.1254/jjp.78.471; Lawler J, 2000, CURR OPIN CELL BIOL, V12, P634, DOI 10.1016/S0955-0674(00)00143-5; Lawler J, 1998, J CLIN INVEST, V101, P982, DOI 10.1172/JCI1684; Leal EC, 2007, INVEST OPHTH VIS SCI, V48, P5257, DOI 10.1167/iovs.07-0112; Li RM, 2009, MICROCIRCULATION, V16, P640, DOI 10.1080/10739680903133185; Lidington EA, 2002, AM J PHYSIOL-CELL PH, V282, pC67, DOI 10.1152/ajpcell.2002.282.1.C67; LIU XP, 1993, EXP EYE RES, V57, P37, DOI 10.1006/exer.1993.1096; Lund SA, 2009, J CELL COMMUN SIGNAL, V3, P311, DOI 10.1007/s12079-009-0068-0; Luo Y, 2005, J CELL BIOL, V169, P29, DOI 10.1083/jcb.200411127; Lutty G, 1999, MOL VIS, V5; MAJACK RA, 1988, J CELL BIOL, V106, P415, DOI 10.1083/jcb.106.2.415; McLeod DS, 2009, INVEST OPHTH VIS SCI, V50, P4982, DOI 10.1167/iovs.09-3639; Miller JW, 1997, AM J PATHOL, V151, P13; MORSE LS, 1990, CURR EYE RES, V9, P631, DOI 10.3109/02713689008999578; Nagareddy PR, 2005, AM J PHYSIOL-HEART C, V289, pH2144, DOI 10.1152/ajpheart.00591.2005; Paik JH, 2004, GENE DEV, V18, P2392, DOI 10.1101/gad.1227804; Park S, 2013, J CELL SCI, V126, P1392, DOI 10.1242/jcs.117275; Park S, 2010, AM J PHYSIOL-CELL PH, V299, pC1468, DOI 10.1152/ajpcell.00246.2010; SABET MD, 1989, BIOL CELL, V65, P171, DOI 10.1016/0248-4900(89)90025-7; SAKAMOTO T, 1995, CURR EYE RES, V14, P621, DOI 10.3109/02713689508998488; Scheef E, 2005, MOL VIS, V11, P613; Scheef EA, 2007, MOL VIS, V13, P1483; Scheef EA, 2009, AM J PHYSIOL-CELL PH, V296, pC724, DOI 10.1152/ajpcell.00409.2008; Sheibani N, 1999, HISTOL HISTOPATHOL, V14, P285, DOI 10.14670/HH-14.285; Steinle JJ, 2003, AUTON NEUROSCI-BASIC, V108, P57, DOI 10.1016/S1566-0702(03)00151-6; Stewart EA, 2011, EXP EYE RES, V93, P761, DOI 10.1016/j.exer.2011.09.010; Su XJ, 2003, MOL VIS, V9, P171; Tang YX, 2009, BLOOD, V113, P744, DOI 10.1182/blood-2008-03-145219; Thirunavukkarasu M, 2007, FREE RADICAL BIO MED, V42, P1487, DOI 10.1016/j.freeradbiomed.2007.02.011; TUCKER RP, 1991, DIFFERENTIATION, V48, P59, DOI 10.1111/j.1432-0436.1991.tb00243.x; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/nrc839; Wang S, 2012, ARCH OPHTHALMOLOGY; Wang SJ, 2012, ARCH OPHTHALMOL-CHIC, V130, P615, DOI 10.1001/archopthalmol.2011.1892; Wang SJ, 2003, DEV DYNAM, V228, P630, DOI 10.1002/dvdy.10412; Wang YJ, 2006, MICROVASC RES, V71, P143, DOI 10.1016/j.mvr.2006.02.004; Wu ZF, 2006, DEV DYNAM, V235, P1908, DOI 10.1002/dvdy.20837; Zamiri P, 2005, INVEST OPHTH VIS SCI, V46, P908, DOI 10.1167/iovs.04-0362; Zamora DO, 2007, MOL VIS, V13, P2058; Zubilewicz A, 2001, ONCOGENE, V20, P1403, DOI 10.1038/sj.onc.1204231	63	21	21	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2014	9	12							e116423	10.1371/journal.pone.0116423	http://dx.doi.org/10.1371/journal.pone.0116423			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX6YH	25548916	Green Published, gold			2022-12-27	WOS:000347063500083
J	Karino, M; Nakatani, E; Hideshima, K; Nariai, Y; Tsunematsu, K; Ohira, K; Kanno, T; Asahina, I; Kagimura, T; Sekine, J				Karino, Masaaki; Nakatani, Eiji; Hideshima, Katsumi; Nariai, Yoshiki; Tsunematsu, Kohji; Ohira, Koichiro; Kanno, Takahiro; Asahina, Izumi; Kagimura, Tatsuo; Sekine, Joji			Applicability of Preoperative Nuclear Morphometry to Evaluating Risk for Cervical Lymph Node Metastasis in Oral Squamous Cell Carcinoma	PLOS ONE			English	Article							NECK DISSECTION; ELECTIVE NECK; CANCER; PREDICTION; BIOPSY; TONGUE; HEAD; LESIONS; FLOOR	Background: We previously reported the utility of preoperative nuclear morphometry for evaluating risk for cervical lymph node metastases in tongue squamous cell carcinoma. The risk for lymph node metastasis in oral squamous cell carcinoma, however, is known to differ depending on the anatomical site of the primary tumor, such as the tongue, gingiva, mouth floor, and buccal mucosa. In this study, we evaluated the applicability of this morphometric technique to evaluating the risk for cervical lymph node metastasis in oral squamous cell carcinoma. Methods: A digital image system was used to measure the mean nuclear area, mean nuclear perimeter, nuclear circular rate, ratio of nuclear length to width (aspect ratio), and nuclear area coefficient of variation (NACV). Relationships between these parameters and nodal status were evaluated by t-test and logistic regression analysis. Results: Eighty-eight cases of squamous cell carcinoma (52 of the tongue, 25 of the gingiva, 4 of the buccal mucosa, and 7 of the mouth floor) were included: 46 with positive node classification and 42 with negative node classification. Nuclear area and perimeter were significantly larger in node-positive cases than in node-negative cases; however, there were no significant differences in circular rate, aspect ratio, or NACV. We derived two risk models based on the results of multivariate analysis: Model 1, which identified age and mean nuclear area and Model 2, which identified age and mean nuclear perimeter. It should be noted that primary tumor site was not associated the pN-positive status. There were no significant differences in pathological nodal status by aspect ratio, NACV, or primary tumor site. Conclusion: Our method of preoperative nuclear morphometry may contribute valuable information to evaluations of the risk for lymph node metastasis in oral squamous cell carcinoma.	[Karino, Masaaki; Hideshima, Katsumi; Nariai, Yoshiki; Tsunematsu, Kohji; Ohira, Koichiro; Kanno, Takahiro; Sekine, Joji] Shimane Univ, Fac Med, Dept Oral & Maxillofacial Surg, Izumo, Shimane, Japan; [Nakatani, Eiji; Kagimura, Tatsuo] Translat Res Informat Ctr, Kobe, Hyogo, Japan; [Asahina, Izumi] Nagasaki Univ, Grad Sch Med Sci, Dept Regenerat Oral Surg, Nagasaki 852, Japan	Shimane University; Nagasaki University	Sekine, J (corresponding author), Shimane Univ, Fac Med, Dept Oral & Maxillofacial Surg, Izumo, Shimane, Japan.	georges@med.shimane-u.ac.jp	Nakatani, Eiji/O-2782-2013	Nakatani, Eiji/0000-0002-4876-446X				BRIGGS RJS, 1992, ARCH OTOLARYNGOL, V118, P531; Chone CT, 2013, EUR ARCH OTO-RHINO-L, V270, P313, DOI 10.1007/s00405-012-2032-5; Crile G, 1906, J AMER MED ASSOC, V47, P1780; Ferris RL, 2012, CLIN EXP METASTAS, V29, P693, DOI 10.1007/s10585-012-9492-2; Flach GB, 2013, ORAL ONCOL, V49, P157, DOI 10.1016/j.oraloncology.2012.08.006; Giardina C, 1996, ORAL ONCOL, V32B, P91, DOI 10.1016/0964-1955(95)00062-3; Giardina C, 1994, Boll Soc Ital Biol Sper, V70, P271; Harada H, 2006, J EXP CLIN CANC RES, V25, P351; Hoch S, 2012, AM J OTOLARYNG, V33, P505, DOI 10.1016/j.amjoto.2011.11.005; Unzurrunzaga EI, 2011, ACTA OTORRINOLAR ESP, V62, P443, DOI 10.1016/j.otorri.2011.06.004; Ishibashi N, 2012, ULTRASOUND MED BIOL, V38, P389, DOI 10.1016/j.ultrasmedbio.2011.12.004; Jerjes W, 2012, HEAD NECK ONCOL, V4, DOI 10.1186/1758-3284-4-5; Kang CJ, 2011, ORAL ONCOL, V47, P1085, DOI 10.1016/j.oraloncology.2011.07.018; Kawano K, 2006, HEAD NECK-J SCI SPEC, V28, P525, DOI 10.1002/hed.20349; Keereweer S, 2012, HEAD NECK-J SCI SPEC, V34, P1002, DOI 10.1002/hed.21861; Keiko U-N, 2013, ACTA OTO-LARYNGOL, V133, P544; Kim KY, 2011, ORAL ONCOL, V47, P1069, DOI 10.1016/j.oraloncology.2011.07.017; Liao CT, 2012, ORAL ONCOL, V48, P329, DOI 10.1016/j.oraloncology.2011.10.017; Lim SC, 2004, CLIN CANCER RES, V10, P166, DOI 10.1158/1078-0432.CCR-0533-3; Lim YC, 2006, LARYNGOSCOPE, V116, P1232, DOI 10.1097/01.mlg.0000224363.04459.8b; Lore JM, 1999, ATLAS HEAD NECK SURG, P645; MacCarthy Denise, 2011, J Ir Dent Assoc, V57, P195; Manola M, 2011, ACTA OTORHINOLARYNGO, V31, P130; Martano M, 2006, EUR J HISTOCHEM, V50, P125; Matsuzuka T, 2008, LARYNGOSCOPE, V118, P646, DOI 10.1097/MLG.0b013e3181613aa6; Montes DM, 2011, HEAD NECK-J SCI SPEC, V33, P1581, DOI 10.1002/hed.21631; Nagashima T, 2000, Breast Cancer, V7, P43, DOI 10.1007/BF02967187; Nandini D B, 2011, J Oral Maxillofac Pathol, V15, P177, DOI 10.4103/0973-029X.84488; Nariai Y, 2011, INT J ORAL MAX SURG, V40, P419, DOI 10.1016/j.ijom.2010.10.020; Natarajan S, 2010, INDIAN J CANCER, V47, P406, DOI 10.4103/0019-509X.73580; Nathanson SD, 2003, CANCER, V98, P413, DOI 10.1002/cncr.11464; Okura M, 2005, J ORAL PATHOL MED, V34, P214, DOI 10.1111/j.1600-0714.2005.00304.x; Pektas ZO, 2006, J ORAL MAXIL SURG, V64, P628, DOI 10.1016/j.joms.2005.12.010; Sekine J, 2011, CANC DETECT PREV, V27, P427; SHAH JP, 1990, CANCER, V66, P109, DOI 10.1002/1097-0142(19900701)66:1<109::AID-CNCR2820660120>3.0.CO;2-A; Smitha T, 2011, J Oral Maxillofac Pathol, V15, P26, DOI 10.4103/0973-029X.80034; Stoeckli SJ, 2012, CURR OPIN OTOLARYNGO, V20, P103, DOI 10.1097/MOO.0b013e32834ef6d3; Suzuki M, 2001, Breast Cancer, V8, P138, DOI 10.1007/BF02967493; van der Vorst JR, 2013, ORAL ONCOL, V49, P15, DOI 10.1016/j.oraloncology.2012.07.017; vandenBrekel MWM, 1996, LARYNGOSCOPE, V106, P987, DOI 10.1097/00005537-199608000-00014; VANDERWAL N, 1989, J ORAL PATHOL MED, V18, P8; Vazquez-Mahia I, 2012, J ORAL MAXIL SURG, V70, P1724, DOI 10.1016/j.joms.2011.06.228; Werner JA, 2003, HEAD NECK-J SCI SPEC, V25, P322, DOI 10.1002/hed.10257; White FH, 1997, HISTOL HISTOPATHOL, V12, P69; WYDNER KS, 1991, MODERN PATHOL, V4, P154; Yan M, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-437	46	7	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2014	9	12							e116452	10.1371/journal.pone.0116452	http://dx.doi.org/10.1371/journal.pone.0116452			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX6YH	25549090	Green Published, gold, Green Submitted			2022-12-27	WOS:000347063500084
J	Karpievitch, YV; Nikolic, SB; Wilson, R; Sharman, JE; Edwards, LM				Karpievitch, Yuliya V.; Nikolic, Sonja B.; Wilson, Richard; Sharman, James E.; Edwards, Lindsay M.			Metabolomics Data Normalization with EigenMS	PLOS ONE			English	Article							HUMAN URINE; MS	Liquid chromatography mass spectrometry has become one of the analytical platforms of choice for metabolomics studies. However, LC-MS metabolomics data can suffer from the effects of various systematic biases. These include batch effects, day-to-day variations in instrument performance, signal intensity loss due to time-dependent effects of the LC column performance, accumulation of contaminants in the MS ion source and MS sensitivity among others. In this study we aimed to test a singular value decomposition-based method, called EigenMS, for normalization of metabolomics data. We analyzed a clinical human dataset where LC-MS serum metabolomics data and physiological measurements were collected from thirty nine healthy subjects and forty with type 2 diabetes and applied EigenMS to detect and correct for any systematic bias. EigenMS works in several stages. First, EigenMS preserves the treatment group differences in the metabolomics data by estimating treatment effects with an ANOVA model (multiple fixed effects can be estimated). Singular value decomposition of the residuals matrix is then used to determine bias trends in the data. The number of bias trends is then estimated via a permutation test and the effects of the bias trends are eliminated. EigenMS removed bias of unknown complexity from the LC-MS metabolomics data, allowing for increased sensitivity in differential analysis. Moreover, normalized samples better correlated with both other normalized samples and corresponding physiological data, such as blood glucose level, glycated haemoglobin, exercise central augmentation pressure normalized to heart rate of 75, and total cholesterol. We were able to report 2578 discriminatory metabolite peaks in the normalized data (p<0.05) as compared to only 1840 metabolite signals in the raw data. Our results support the use of singular value decomposition-based normalization for metabolomics data.	[Karpievitch, Yuliya V.] Univ Tasmania, Sch Math & Phys, Hobart, Tas, Australia; [Nikolic, Sonja B.] Univ Tasmania, Menzies Res Inst Tasmania, Hobart, Tas, Australia; [Wilson, Richard; Sharman, James E.] Univ Tasmania, Cent Sci Lab, Hobart, Tas, Australia; [Edwards, Lindsay M.] Kings Coll London, Ctr Human & Aerosp Physiol Sci, London, England; [Edwards, Lindsay M.] GlaxoSmithKline R&D, Fibrosis Discovery Performance Unit, Stevenage, Herts, England	University of Tasmania; University of Tasmania; University of Tasmania; University of London; King's College London; GlaxoSmithKline	Karpievitch, YV (corresponding author), Univ Tasmania, Sch Math & Phys, Hobart, Tas, Australia.	yuliya.karpievitch@utas.edu.au	Sharman, James/B-2755-2009; Wilson, Richard/H-8429-2012	Sharman, James/0000-0003-2792-0811; Wilson, Richard/0000-0003-0152-4394	GlaxoSmithKline RD	GlaxoSmithKline RD(GlaxoSmithKline)	GlaxoSmithKline R&D provided support in the form of salaries for authors [LME], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bordbar A, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.21; Climie RED, 2013, ARTERY RES, V7, P194, DOI 10.1016/j.artres.2013.09.002; Gika HG, 2008, J CHROMATOGR A, V1189, P314, DOI 10.1016/j.chroma.2007.10.066; Guy PA, 2008, J CHROMATOGR B, V871, P253, DOI 10.1016/j.jchromb.2008.04.034; Kaiser BLD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067155; Karpievitch YV, 2009, BIOINFORMATICS, V25, P2573, DOI 10.1093/bioinformatics/btp426; Kim YM, 2013, MOL BIOSYST, V9, P1522, DOI 10.1039/c3mb25598k; Lai L, 2010, MOL BIOSYST, V6, P108, DOI 10.1039/b910482h; Leek J.T., 2007, PLOS GENETICS, V3; Metz TO, 2008, TRAC-TREND ANAL CHEM, V27, P205, DOI 10.1016/j.trac.2007.11.003; Nikolic SB, 2014, METABOLOMICS, V10, P105, DOI 10.1007/s11306-013-0557-2; Sangster T, 2006, ANALYST, V131, P1075, DOI 10.1039/b604498k; Want EJ, 2010, NAT PROTOC, V5, P1005, DOI 10.1038/nprot.2010.50; Zelena E, 2009, ANAL CHEM, V81, P1357, DOI 10.1021/ac8019366	15	74	73	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2014	9	12							e116221	10.1371/journal.pone.0116221	http://dx.doi.org/10.1371/journal.pone.0116221			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX6YH	25549083	Green Published, gold, Green Submitted			2022-12-27	WOS:000347063500064
J	Lu, J; Huang, CM; Zheng, CH; Li, P; Xie, JW; Wang, JB; Lin, JX; Chen, QY; Cao, LL; Lin, M				Lu, Jun; Huang, Chang-ming; Zheng, Chao-hui; Li, Ping; Xie, Jian-wei; Wang, Jia-bin; Lin, Jian-xian; Chen, Qi-yue; Cao, Long-long; Lin, Mi			Prognostic Value of Tumor Size in Patients with Remnant Gastric Cancer: Is the Seventh UICC Stage Sufficient for Predicting Prognosis?	PLOS ONE			English	Article							LYMPH-NODE METASTASIS; STUMP CARCINOMA; DISTAL GASTRECTOMY; CLINICOPATHOLOGICAL FEATURES; SURGICAL OUTCOMES; CLASSIFICATION; INDICATOR; DIAMETER; STILL	Background: The 7th UICC N stage may be unsuitable for remnant gastric cancer (RGC) because the original disease and previous operation usually cause abnormal lymphatic drainage. However, the prognostic significance of the current TNM staging system in RGC has not been studied. Methods: Prospective data from 153 RGC patients who underwent curative gastrectomy from Jan 1995 to Aug 2009 were reviewed. All patients were classified according to tumor size (<3 cm as N0; 3>&&LE; 5 cm as N1; >5&&LE; 7 cm as N2; and >7 cm as N3). The overall survival was estimated using the Kaplan-Meier method, and hazard ratios (HRs) were calculated using the Cox proportional hazard model. Results: Tumor sizes ranged from 1.0 to 15.0 cm (median 5.0 cm). Tumor size, depth of invasion and lymph node (LN) metastasis were significant prognostic factors based on both the univariate and multivariate analyses (P<0.05). In the survival analysis, the seventh edition UICC-TNM classification provided a detailed classification; however, some subgroups of the UICC-TNM classification did not have significantly different survival rates. The combination of the seventh edition T classification and the suggested N classification, with ideal relative risk (RR) results and P value, was distinctive for subgrouping the survival rates except for the IA versus IB and II A versus IIB. A modified staging system based on tumor size, predicted survival more accurately than the conventional TNM staging system. Conclusions: In RGCs, tumor size is an independent prognostic factor and a modified TNM system based on tumor size accurately predicts survival.	[Lu, Jun; Huang, Chang-ming; Zheng, Chao-hui; Li, Ping; Xie, Jian-wei; Wang, Jia-bin; Lin, Jian-xian; Chen, Qi-yue; Cao, Long-long; Lin, Mi] Fujian Med Univ, Union Hosp, Dept Gastr Surg, Fuzhou, Peoples R China	Fujian Medical University	Huang, CM (corresponding author), Fujian Med Univ, Union Hosp, Dept Gastr Surg, Fuzhou, Peoples R China.	hcmlr2002@163.com	Zheng, Chao-hui/HGE-3348-2022; Li, Ping/GYV-4914-2022; Lu, Jun/AAP-1222-2021	Zheng, Chao-hui/0000-0001-8680-3127; 	National Key Clinical Specialty Discipline Construction program of China [[2012]649]	National Key Clinical Specialty Discipline Construction program of China	This work was sponsored by National Key Clinical Specialty Discipline Construction program of China (No.[2012]649). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of manuscript.	Adachi Y, 1997, ANN SURG ONCOL, V4, P137, DOI 10.1007/BF02303796; Ahn HS, 2008, ANN SURG ONCOL, V15, P1632, DOI 10.1245/s10434-008-9871-8; Aurello P, 2007, AM SURGEON, V73, P359; Campiglio M, 2014, ANN ONCOL, V25, P1073, DOI 10.1093/annonc/mdu058; Catarci M, 2011, UPDATES SURG-ITALY, V63, P83, DOI 10.1007/s13304-011-0065-8; Coburn NG, 2006, CANCER-AM CANCER SOC, V107, P2143, DOI 10.1002/cncr.22229; Czymek R, 2012, HEPATO-GASTROENTEROL, V59, P768, DOI 10.5754/hge10466; de Manzoni G, 2002, BRIT J CANCER, V87, P171, DOI 10.1038/sj.bjc.6600432; Deng JY, 2012, ANN SURG, V256, pE35, DOI 10.1097/SLA.0b013e3182769545; Deng JY, 2010, ANN SURG ONCOL, V17, P1259, DOI 10.1245/s10434-010-0939-x; Di Leo A, 2007, J GASTROINTEST SURG, V11, P1146, DOI 10.1007/s11605-006-0062-2; Di Leo A, 2014, ANN SURG ONCOL, V21, P2594, DOI 10.1245/s10434-014-3633-6; Giuliani A, 2003, J EXP CLIN CANC RES, V22, P531; Hu X, 2009, J SURG ONCOL, V100, P472, DOI 10.1002/jso.21370; Huang CM, 2014, SURG ONCOL, V23, P5, DOI 10.1016/j.suronc.2014.01.003; Japanese Gastric Canc Assoc, 2011, GASTRIC CANCER, V14, P101, DOI 10.1007/s10120-011-0041-5; KAMINISHI M, 1995, CANCER, V75, P1490, DOI 10.1002/1097-0142(19950315)75:6+<1490::AID-CNCR2820751518>3.0.CO;2-3; Kunisaki C, 2008, ANN SURG ONCOL, V15, P1959, DOI 10.1245/s10434-008-9884-3; Kusano T, 2013, ANN SURG ONCOL, V20, P2290, DOI 10.1245/s10434-012-2839-8; Lee SB, 2010, J GASTRIC CANCER, V10, P219, DOI 10.5230/jgc.2010.10.4.219; Li FX, 2013, AM J CLIN ONCOL-CANC, V36, P244, DOI 10.1097/COC.0b013e3182467ebd; Li FX, 2012, J CANCER RES CLIN, V138, P111, DOI 10.1007/s00432-011-1034-9; Mezhir JJ, 2011, ANN SURG ONCOL, V18, P670, DOI 10.1245/s10434-010-1425-1; Ohashi M, 2007, BRIT J SURG, V94, P92, DOI 10.1002/bjs.5538; Ohyama S, 2009, GASTRIC CANCER, V12, P88, DOI 10.1007/s10120-009-0502-2; Rabin I, 2011, ISR MED ASSOC J, V13, P534; Saito H, 2006, AM J SURG, V192, P296, DOI 10.1016/j.amjsurg.2006.03.004; Sayegh Mazin E, 2004, Gastric Cancer, V7, P140; Schaefer N, 2000, ANN SURG, V231, P188; Schaefer N, 2007, AM J SURG, V194, P63, DOI 10.1016/j.amjsurg.2006.12.037; Sinning C, 2007, EJSO-EUR J SURG ONC, V33, P133, DOI 10.1016/j.ejso.2006.09.006; Sobin LH, 2009, TNM CLASSIFICATION M, P73; Son T, 2014, ANN SURG ONCOL, V21, P899, DOI 10.1245/s10434-013-3403-x; Tanigawa Nobuhiko, 2002, Gastric Cancer, V5, P23, DOI 10.1007/s101200200003; Tanigawa N, 2010, WORLD J SURG, V34, P1540, DOI 10.1007/s00268-010-0505-5; Thorban S, 2000, ANN SURG, V231, P188, DOI 10.1097/00000658-200002000-00006; Verlato G, 2009, ANN SURG ONCOL, V16, P594, DOI 10.1245/s10434-008-0271-x; Wang X, 2008, J SURG ONCOL, V97, P236, DOI 10.1002/jso.20951; Zhang JZ, 2013, ANN SURG, V257, P81, DOI 10.1097/SLA.0b013e31825eff3f; Zu HL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054502	40	16	20	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2014	9	12							e115776	10.1371/journal.pone.0115776	http://dx.doi.org/10.1371/journal.pone.0115776			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX6YH	25549339	Green Published, Green Submitted, gold			2022-12-27	WOS:000347063500026
J	Yu, J; Yu, B; He, J; Zheng, P; Mao, XB; Han, GQ; Chen, DW				Yu, Jie; Yu, Bing; He, Jun; Zheng, Ping; Mao, Xiangbing; Han, Guoquan; Chen, Daiwen			Chronic Glucocorticoid Exposure-Induced Epididymal Adiposity Is Associated with Mitochondrial Dysfunction in White Adipose Tissue of Male C57BL/6J Mice	PLOS ONE			English	Article							11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE-1; GROWTH-FACTOR 21; METABOLIC SYNDROME; CUSHINGS-SYNDROME; HUMAN ADIPOCYTES; PRIMARY SITE; LIPOLYSIS; CORTICOSTERONE; BIOGENESIS; ROSIGLITAZONE	Prolonged and excessive glucocorticoids (GC) exposure resulted from Cushing's syndrome or GC therapy develops central obesity. Moreover, mitochondria are crucial in adipose energy homeostasis. Thus, we tested the hypothesis that mitochondrial dysfunction may contribute to chronic GC exposure-induced epididymal adiposity in the present study. A total of thirty-six 5-week-old male C57BL/6J mice (similar to 20 g) were administrated with 100 mu g/ml corticosterone (CORT) or vehicle through drinking water for 4 weeks. Chronic CORT exposure mildly decreased body weight without altering food and water intake in mice. The epididymal fat accumulation was increased, but adipocyte size was decreased by CORT. CORT also increased plasma CORT, insulin, leptin, and fibroblast growth factor 21 concentrations as measured by RIA or ELISA. Interestingly, CORT increased plasma levels of triacylglycerols and nonesterified fatty acids, and up-regulated the expression of both lipolytic and lipogenic genes as determined by real-time RT-PCR. Furthermore, CORT impaired mitochondrial biogenesis and oxidative function in epididymal WAT. The reactive oxygen species production was increased and the activities of anti-oxidative enzymes were reduced by CORT treatment as well. Taken together, these findings reveal that chronic CORT administration-induced epididymal adiposity is, at least in part, associated with mitochondrial dysfunction in mouse epididymal white adipose tissue.	[Yu, Jie; Yu, Bing; He, Jun; Zheng, Ping; Mao, Xiangbing; Han, Guoquan; Chen, Daiwen] Sichuan Agr Univ, Inst Anim Nutr, Chengdu 611130, Peoples R China; [Yu, Jie; Yu, Bing; He, Jun; Zheng, Ping; Mao, Xiangbing; Chen, Daiwen] Sichuan Agr Univ, Key Lab Anim Dis Resistance Nutr, China Minist Educ, Chengdu 611130, Peoples R China; [Han, Guoquan] Sichuan Agr Univ, Coll Food Sci, Yaan 625014, Peoples R China	Sichuan Agricultural University; Sichuan Agricultural University; Sichuan Agricultural University	Chen, DW (corresponding author), Sichuan Agr Univ, Inst Anim Nutr, Chengdu 611130, Peoples R China.	dwchen@sicau.edu.cn		Yu, Jiaojun/0000-0001-9400-5408	Sichuan Department of Education [13ZA0261]; Program for Changjiang Scholars and Innovative Research Team in University from Ministry of Education of China [IRT0555-5]	Sichuan Department of Education; Program for Changjiang Scholars and Innovative Research Team in University from Ministry of Education of China(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT))	This work was supported by Key Project (13ZA0261) from Sichuan Department of Education (JY) and Program for Changjiang Scholars and Innovative Research Team in University (IRT0555-5) from Ministry of Education of China (DC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alemany M, 2013, NUTR RES, V33, P1, DOI 10.1016/j.nutres.2012.11.013; Anagnostis P, 2009, J CLIN ENDOCR METAB, V94, P2692, DOI 10.1210/jc.2009-0370; Arnaldi G, 2003, J CLIN ENDOCR METAB, V88, P5593, DOI 10.1210/jc.2003-030871; BERDANIER CD, 1989, FASEB J, V3, P2179, DOI 10.1096/fasebj.3.10.2666232; Buttgereit F, 2005, LANCET, V365, P801; Campbell JE, 2011, AM J PHYSIOL-CELL PH, V300, pC198, DOI 10.1152/ajpcell.00045.2010; Cassano AE, 2012, COMPARATIVE MED, V62, P348; D'Antona G, 2010, CELL METAB, V12, P362, DOI 10.1016/j.cmet.2010.08.016; Davies NA, 2013, J ENDOCRINOL; DEMONACOS C, 1995, J STEROID BIOCHEM, V55, P43, DOI 10.1016/0960-0760(95)00159-W; DIVERTIE GD, 1991, DIABETES, V40, P1228, DOI 10.2337/diabetes.40.10.1228; Djurhuus CB, 2002, AM J PHYSIOL-ENDOC M, V283, pE172, DOI 10.1152/ajpendo.00544.2001; Galitzky J, 2013, CELL METAB, V18, P3, DOI 10.1016/j.cmet.2013.06.008; Gathercole LL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026223; Grundy SM, 2004, CIRCULATION, V109, P433, DOI 10.1161/01.CIR.0000111245.75752.C6; Hassan-Smith Z, 2014, LANCET, V383, P53; Kaaman M, 2007, DIABETOLOGIA, V50, P2526, DOI 10.1007/s00125-007-0818-6; Karatsoreos IN, 2010, ENDOCRINOLOGY, V151, P2117, DOI 10.1210/en.2009-1436; Lee MJ, 2012, AM J PHYSIOL-ENDOC M, V303, pE1126, DOI 10.1152/ajpendo.00228.2012; Liu D, 1997, SCIENCE, V277, P1659, DOI 10.1126/science.277.5332.1659; Liu JB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034835; Liu Y, 2008, PHYSIOL GENOMICS, V32, P343, DOI 10.1152/physiolgenomics.00067.2007; Lu RH, 2010, MOL BIOL REP, V37, P2173, DOI 10.1007/s11033-009-9695-z; Lundgren M, 2008, HORM METAB RES, V40, P854, DOI 10.1055/s-0028-1087168; Masuzaki H, 2001, SCIENCE, V294, P2166, DOI 10.1126/science.1066285; MAYOSMITH W, 1989, RADIOLOGY, V170, P515, DOI 10.1148/radiology.170.2.2911678; Minami I, 2006, INTERNAL MED, V45, P1231, DOI 10.2169/internalmedicine.45.1809; Murphy MP, 2013, CELL METAB, V18, P145, DOI 10.1016/j.cmet.2013.07.006; Murray F, 2008, EUR J PHARMACOL, V583, P115, DOI 10.1016/j.ejphar.2008.01.014; Nishino N, 2008, J CLIN INVEST, V118, P2808, DOI 10.1172/JCI34090; Nunnari J, 2012, CELL, V148, P1145, DOI 10.1016/j.cell.2012.02.035; Yuji OA, 2007, EXP MOL PATHOL, V83, P73, DOI 10.1016/j.yexmp.2007.02.007; Owen OE, 2002, J BIOL CHEM, V277, P30409, DOI 10.1074/jbc.R200006200; Patti ME, 2010, ENDOCR REV, V31, P364, DOI 10.1210/er.2009-0027; Pezaro C, 2013, BRIT J CANCER, V109, P325, DOI 10.1038/bjc.2013.340; Rees SL, 2004, HORM BEHAV, V46, P411, DOI 10.1016/j.yhbeh.2004.03.010; Rong JX, 2007, DIABETES, V56, P1751, DOI 10.2337/db06-1135; Schuff KG, 2003, PRIMARY CARE, V30, P791, DOI 10.1016/S0095-4543(03)00088-5; Seale P, 2011, J CLIN INVEST, V121, P96, DOI 10.1172/JCI44271; SLAVIN BG, 1994, J LIPID RES, V35, P1535; Starkov AA, 2008, ANN NY ACAD SCI, V1147, P37, DOI 10.1196/annals.1427.015; Stewart PM, 2005, CLIN MED, V5, P142, DOI 10.7861/clinmedicine.5-2-142; Stewart PM, 2003, EUR J ENDOCRINOL, V149, P163, DOI 10.1530/eje.0.1490163; Tang VM, 2013, HORM METAB RES, V45, P709, DOI 10.1055/s-0033-1345119; Tedesco L, 2008, DIABETES, V57, P2028, DOI 10.2337/db07-1623; Tsiriyotis C, 1997, BIOCHEM BIOPH RES CO, V235, P349, DOI 10.1006/bbrc.1997.6787; Wang Minghan, 2005, Nutr Metab (Lond), V2, P3, DOI 10.1186/1743-7075-2-3; Wilson-Fritch L, 2004, J CLIN INVEST, V114, P1281, DOI 10.1172/JCI200421752; Xu C, 2009, MOL ENDOCRINOL, V23, P1161, DOI 10.1210/me.2008-0464; Yu J, 2012, BRIT J NUTR, V107, P461, DOI 10.1017/S0007114511003205; Yu J, 2012, ENDOCRINOLOGY, V153, P750, DOI 10.1210/en.2011-1591	51	43	46	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2014	9	11							e112628	10.1371/journal.pone.0112628	http://dx.doi.org/10.1371/journal.pone.0112628			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CP	25551379	gold, Green Published, Green Submitted			2022-12-27	WOS:000349144400113
J	Huang, Y; Guo, F; Li, YL; Liu, YF				Huang, Yu; Guo, Feng; Li, Yongling; Liu, Yufeng			Parameter Estimation of Fractional-Order Chaotic Systems by Using Quantum Parallel Particle Swarm Optimization Algorithm	PLOS ONE			English	Article							DIFFERENTIAL EVOLUTION; SYNCHRONIZATION; IDENTIFICATION; EQUATIONS	Parameter estimation for fractional-order chaotic systems is an important issue in fractionalorder chaotic control and synchronization and could be essentially formulated as a multidimensional optimization problem. A novel algorithm called quantum parallel particle swarm optimization (QPPSO) is proposed to solve the parameter estimation for fractional-order chaotic systems. The parallel characteristic of quantum computing is used in QPPSO. This characteristic increases the calculation of each generation exponentially. The behavior of particles in quantum space is restrained by the quantum evolution equation, which consists of the current rotation angle, individual optimal quantum rotation angle, and global optimal quantum rotation angle. Numerical simulation based on several typical fractional-order systems and comparisons with some typical existing algorithms show the effectiveness and efficiency of the proposed algorithm.	[Huang, Yu; Li, Yongling] North China Elect Power Univ, Hebei Engn Res Ctr Simulat & Optimized Control Po, Baoding, Peoples R China; [Guo, Feng] Xiamen Univ, Sch Informat Sci & Engn, Dept Cognit Sci, Xiamen, Peoples R China; [Huang, Yu; Liu, Yufeng] Tsinghua Univ, Dept Thermal Engn, State Key Lab Power Syst, Beijing 100084, Peoples R China	North China Electric Power University; Xiamen University; Tsinghua University	Guo, F (corresponding author), Xiamen Univ, Sch Informat Sci & Engn, Dept Cognit Sci, Xiamen, Peoples R China.	betop@xmu.edu.cn	Shi, Yunliang/AAR-3963-2021; Liu, Xiaoling/HGD-3566-2022	Fang, Xiong/0000-0002-4176-2162	Central Universities Fundamental Research Funds [12MS117]; Natural Science Foundation of Fujian Province of China [2014J01249]	Central Universities Fundamental Research Funds; Natural Science Foundation of Fujian Province of China(Natural Science Foundation of Fujian Province)	This work was supported by Central Universities Fundamental Research Funds (12MS117) and the Natural Science Foundation of Fujian Province of China (No. 2014J01249). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhalekar S, 2010, COMMUN NONLINEAR SCI, V15, P2178, DOI 10.1016/j.cnsns.2009.08.015; Caponetto R., 2010, WORLD SCI SERIES NON; Clerc M, 2002, IEEE T EVOLUT COMPUT, V6, P58, DOI 10.1109/4235.985692; Daftardar-Gejji V, 2010, COMPUT MATH APPL, V59, P1117, DOI 10.1016/j.camwa.2009.07.003; Dai D, 2002, ACTA PHYS SIN-CH ED, V51, P2459, DOI 10.7498/aps.51.2459; Deng WH, 2006, CHAOS, V16, DOI 10.1063/1.2401061; Diethelm K, 2002, J MATH ANAL APPL, V265, P229, DOI 10.1006/jmaa.2000.7194; Dong-Feng W, 2006, PROPORTIONAL INTEGRA; Gandomi AH, 2013, COMMUN NONLINEAR SCI, V18, P327, DOI 10.1016/j.cnsns.2012.07.017; Gao Y, 2014, HYPERSPECTRAL IMAGE; Gao Y, 2012, IEEE T IMAGE PROCESS, V21, P4290, DOI 10.1109/TIP.2012.2199502; Grigorenko I, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.034101; He Q, 2007, CHAOS SOLITON FRACT, V34, P654, DOI 10.1016/j.chaos.2006.03.079; Ho WH, 2010, NONLINEAR DYNAM, V61, P29, DOI 10.1007/s11071-009-9629-2; Ji R, 2014, SPECTRAL SPATIAL CON; Ji RR, 2012, IEEE T IMAGE PROCESS, V21, P2282, DOI 10.1109/TIP.2011.2176950; Li CG, 2004, CHAOS SOLITON FRACT, V22, P549, DOI 10.1016/j.chaos.2004.02.035; Li CG, 2004, PHYSICA A, V341, P55, DOI 10.1016/j.physa.2004.04.113; Li LX, 2006, CHAOS SOLITON FRACT, V28, P1204, DOI 10.1016/j.chaos.2005.04.110; Lu JG, 2006, PHYS LETT A, V354, P305, DOI 10.1016/j.physleta.2006.01.068; Nielsen, 2010, QUANTUM COMPUTATION; Odibat ZM, 2010, INT J BIFURCAT CHAOS, V20, P81, DOI 10.1142/S0218127410025429; Peng B, 2009, CHAOS SOLITON FRACT, V39, P2110, DOI 10.1016/j.chaos.2007.06.084; Sheikhan M, 2013, NEURAL COMPUT APPL, V22, P361, DOI 10.1007/s00521-011-0697-0; Sheu LJ, 2008, CHAOS SOLITON FRACT, V36, P98, DOI 10.1016/j.chaos.2006.06.013; Tang YG, 2012, PHYS LETT A, V376, P457, DOI 10.1016/j.physleta.2011.12.008; Tavazoei MS, 2008, PHYSICA D, V237, P2628, DOI 10.1016/j.physd.2008.03.037; Tavazoei MS, 2007, PHYS LETT A, V367, P102, DOI 10.1016/j.physleta.2007.05.081; Tavazoei MS, 2010, NONLINEAR ANAL-REAL, V11, P332, DOI 10.1016/j.nonrwa.2008.11.008; Yassi M, 2014, DISTINGUISHING CLUST, P1	30	150	158	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2015	10	1							e0114910	10.1371/journal.pone.0114910	http://dx.doi.org/10.1371/journal.pone.0114910			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ4OZ	26132635	Green Published, Green Submitted, gold			2022-12-27	WOS:000348203500006
J	Bachmann, D; Gockele, A; Ravenek, JM; Roscher, C; Strecker, T; Weigelt, A; Buchmann, N				Bachmann, Doerte; Gockele, Annette; Ravenek, Janneke M.; Roscher, Christiane; Strecker, Tanja; Weigelt, Alexandra; Buchmann, Nina			No Evidence of Complementary Water Use along a Plant Species Richness Gradient in Temperate Experimental Grasslands	PLOS ONE			English	Article							DIVERSITY-PRODUCTIVITY RELATIONSHIPS; BIODIVERSITY EXPERIMENTS; ECOSYSTEM PROCESSES; CURRENT KNOWLEDGE; STABLE ISOTOPES; COMMUNITIES; DEPTH; NITROGEN; PATTERNS; SPACE	Niche complementarity in resource use has been proposed as a key mechanism to explain the positive effects of increasing plant species richness on ecosystem processes, in particular on primary productivity. Since hardly any information is available for niche complementarity in water use, we tested the effects of plant diversity on spatial and temporal complementarity in water uptake in experimental grasslands by using stable water isotopes. We hypothesized that water uptake from deeper soil depths increases in more diverse compared to low diverse plant species mixtures. We labeled soil water in 8 cm (with O-18) and 28 cm depth (with H-2) three times during the 2011 growing season in 40 temperate grassland communities of varying species richness (2, 4, 8 and 16 species) and functional group number and composition (legumes, grasses, tall herbs, small herbs). Stable isotope analyses of xylem and soil water allowed identifying the preferential depth of water uptake. Higher enrichment in 18O of xylem water than in H-2 suggested that the main water uptake was in the upper soil layer. Furthermore, our results revealed no differences in root water uptake among communities with different species richness, different number of functional groups or with time. Thus, our results do not support the hypothesis of increased complementarity in water use in more diverse than in less diverse communities of temperate grassland species.	[Bachmann, Doerte; Buchmann, Nina] ETH, Inst Agr Sci, Zurich, Switzerland; [Gockele, Annette] Univ Freiburg, Fac Biol, Dept Geobot, D-79106 Freiburg, Germany; [Ravenek, Janneke M.] Radboud Univ Nijmegen, Dept Expt Plant Ecol, Inst Water & Wetland Res, NL-6525 ED Nijmegen, Netherlands; [Roscher, Christiane] Helmholtz Ctr Environm Res, UFZ, Dept Community Ecol, Halle, Germany; [Strecker, Tanja] Univ Gottingen, JF Blumenbach Inst Zool & Anthropol, D-37073 Gottingen, Germany; [Weigelt, Alexandra] Univ Leipzig, Dept Special Bot & Funct Biodivers, Inst Biol, D-04109 Leipzig, Germany; [Weigelt, Alexandra] German Ctr Integrat Biodivers Res iDiv, Leipzig, Germany	Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Freiburg; Radboud University Nijmegen; Helmholtz Association; Helmholtz Center for Environmental Research (UFZ); University of Gottingen; Leipzig University	Bachmann, D (corresponding author), ETH, Inst Agr Sci, Zurich, Switzerland.	doerte.bachmann@usys.ethz.ch	Buchmann, Nina/E-6095-2011	Buchmann, Nina/0000-0003-0826-2980; Bachmann, Dorte/0000-0003-2171-3838; Segura, Diego Fernando/0000-0003-2927-9028; Fernandez, Patricia C./0000-0002-4360-6761; Juarez, Maria Laura/0000-0002-4563-5080; Vera, Maria Teresa/0000-0002-1446-6042; Ruiz, Maria Josefina/0000-0003-0773-2629	Swiss National Science Foundation [315230E-131194]; German Science Foundation [FOR 456/1451]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); German Science Foundation(German Research Foundation (DFG))	This study was financially supported by the Swiss National Science Foundation (315230E-131194, www.snf.ch) and the German Science Foundation (FOR 456/1451, www.dfg.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allan E, 2013, OECOLOGIA, V173, P223, DOI 10.1007/s00442-012-2589-0; ALLISON GB, 1983, EFFECT CLIMATE VEGET, P105; Balvanera P, 2006, ECOL LETT, V9, P1146, DOI 10.1111/j.1461-0248.2006.00963.x; Barnard RL, 2006, RAPID COMMUN MASS SP, V20, P3799, DOI 10.1002/rcm.2778; Bates D., 2011, PACKAGE LME4 LINEAR, V1; BERENDSE F, 1982, OECOLOGIA, V53, P50, DOI 10.1007/BF00377135; BERTNESS MD, 1994, TRENDS ECOL EVOL, V9, P191, DOI 10.1016/0169-5347(94)90088-4; Bessler H, 2012, PLANT SOIL, V358, P301, DOI 10.1007/s11104-012-1181-z; Caldeira MC, 2001, ECOL LETT, V4, P439, DOI 10.1046/j.1461-0248.2001.00238.x; Casper BB, 1997, ANNU REV ECOL SYST, V28, P545, DOI 10.1146/annurev.ecolsys.28.1.545; Clark I., 1997, ENV ISOTOPES HYDROLO; DANSGAARD W, 1964, TELLUS, V16, P436; Dawson TE, 2002, ANNU REV ECOL SYST, V33, P507, DOI 10.1146/annurev.ecolsys.33.020602.095451; Dimitrakopoulos PG, 2004, ECOL LETT, V7, P574, DOI 10.1111/j.1461-0248.2004.00607.x; Dodd MB, 1998, OECOLOGIA, V117, P504, DOI 10.1007/s004420050686; EHLERINGER JR, 1992, PLANT CELL ENVIRON, V15, P1073, DOI 10.1111/j.1365-3040.1992.tb01657.x; EHLERINGER JR, 1991, OECOLOGIA, V88, P430, DOI 10.1007/BF00317589; Fargione J, 2005, OECOLOGIA, V143, P598, DOI 10.1007/s00442-005-0010-y; Fischer C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098987; GORDON DR, 1992, AM J BOT, V79, P967, DOI 10.2307/2444905; Grieu P, 2001, PLANT SOIL, V230, P197, DOI 10.1023/A:1010363532118; Gubsch M, 2011, PLANT CELL ENVIRON, V34, P895, DOI 10.1111/j.1365-3040.2011.02287.x; Harpole WS, 2007, NATURE, V446, P791, DOI 10.1038/nature05684; Hector A, 1999, SCIENCE, V286, P1123, DOI 10.1126/science.286.5442.1123; Hector A, 2002, ECOL LETT, V5, P502, DOI 10.1046/j.1461-0248.2002.00337.x; Hoekstra NJ, 2014, BIOGEOSCIENCES DISCU, V11, P4151, DOI DOI 10.5194/BGD-11-4151-2014; Hooper DU, 2005, ECOL MONOGR, V75, P3, DOI 10.1890/04-0922; Hooper DU, 1997, SCIENCE, V277, P1302, DOI 10.1126/science.277.5330.1302; Isbell F, 2011, NATURE, V477, P199, DOI 10.1038/nature10282; Jobbagy EG, 2001, BIOGEOCHEMISTRY, V53, P51, DOI 10.1023/A:1010760720215; Kahmen A, 2006, ECOLOGY, V87, P1244, DOI 10.1890/0012-9658(2006)87[1244:NCFNAE]2.0.CO;2; Kulmatiski A, 2010, NEW PHYTOL, V188, P199, DOI 10.1111/j.1469-8137.2010.03338.x; Loreau M, 2001, NATURE, V412, P72, DOI 10.1038/35083573; Loreau M, 2001, SCIENCE, V294, P804, DOI 10.1126/science.1064088; Marquard E, 2009, J ECOL, V97, P696, DOI 10.1111/j.1365-2745.2009.01521.x; Moreno-Gutierrez C, 2012, NEW PHYTOL, V196, P489, DOI 10.1111/j.1469-8137.2012.04276.x; Mueller KE, 2013, ECOLOGY, V94, P787, DOI 10.1890/12-1399.1; Muller-Westermeier G, 2000, BERICHTE DTSCH WETTE, V213; Nippert JB, 2007, OIKOS, V116, P1017, DOI [10.1111/j.2007.0030-1299.15630.x, 10.1111/j.0030-1299.2007.15630.x]; Oelmann Y, 2011, GLOBAL BIOGEOCHEM CY, V25, DOI 10.1029/2010GB003869; Ogle K, 2004, ECOLOGY, V85, P1967, DOI 10.1890/03-0346; Roscher C, 2005, ECOL LETT, V8, P419, DOI 10.1111/j.1461-0248.2005.00736.x; Roscher C, 2004, BASIC APPL ECOL, V5, P107, DOI 10.1078/1439-1791-00216; Roscher C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036760; Schenk HJ, 2002, ECOL MONOGR, V72, P311, DOI 10.1890/0012-9615(2002)072[0311:TGBOR]2.0.CO;2; Schlapfer F, 1999, ECOL APPL, V9, P893, DOI 10.1890/1051-0761(1999)009[0893:EEOBAC]2.0.CO;2; Tilman D, 1997, SCIENCE, V277, P1300, DOI 10.1126/science.277.5330.1300; Tilman D, 1997, P NATL ACAD SCI USA, V94, P1857, DOI 10.1073/pnas.94.5.1857; Tilman D, 2001, SCIENCE, V294, P843, DOI 10.1126/science.1060391; Van Peer L, 2004, FUNCT ECOL, V18, P769, DOI 10.1111/j.0269-8463.2004.00901.x; van Ruijven J, 2005, P NATL ACAD SCI USA, V102, P695, DOI 10.1073/pnas.0407524102; Verheyen K, 2008, OECOLOGIA, V156, P351, DOI 10.1007/s00442-008-0998-x; Volaire F, 2014, EUR J AGRON, V52, P81, DOI 10.1016/j.eja.2013.10.002; von Felten S, 2008, J PLANT ECOL, V1, P33, DOI 10.1093/jpe/rtm006; von Felten S, 2009, ECOLOGY, V90, P1389, DOI 10.1890/08-0802.1; Werner RA, 1999, RAPID COMMUN MASS SP, V13, P1237, DOI 10.1002/(SICI)1097-0231(19990715)13:13<1237::AID-RCM633>3.0.CO;2-C; WHITE JWC, 1985, GEOCHIM COSMOCHIM AC, V49, P237, DOI 10.1016/0016-7037(85)90207-8	57	54	57	3	81	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2015	10	1							e0116367	10.1371/journal.pone.0116367	http://dx.doi.org/10.1371/journal.pone.0116367			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ0ID	25923584	Green Submitted, Green Published, gold			2022-12-27	WOS:000347928300011
J	Huang, Y; Pang, YH; Wang, H; Tang, ZZ; Zhou, Y; Zhang, WY; Li, XG; Tan, DM; Li, J; Lin, Y; Liu, XL; Huang, WY; Shi, YL				Huang, Yan; Pang, Yiheng; Wang, Hong; Tang, Zhengzhu; Zhou, Yan; Zhang, Weiyu; Li, Xiugui; Tan, Dongmei; Li, Jian; Lin, Ying; Liu, Xiaoling; Huang, Weiyi; Shi, Yunliang			Occurrence and Characterization of Cronobacter spp. in Dehydrated Rice Powder from Chinese Supermarket	PLOS ONE			English	Article							ENTEROBACTER-SAKAZAKII; INFANT FORMULA; GENOTYPIC CHARACTERIZATION; ANTIBIOTIC SUSCEPTIBILITY; NEONATAL MENINGITIS; MILK; FOOD; IDENTIFICATION; INGREDIENTS; PREVALENCE	Cronobacter spp. are emerging food-borne pathogens and have been identified as causative agents of meningitis and necrotizing enterocolitis in infants. Dehydrated rice is popular with a wide range of people and it is frequently used as a substitute for infant milk powder to baby older than four months. The occurrence of Cronobacter spp. was investigated in 1,012 samples of dehydrated rice powder collected from 14 manufacturers in China during 2010 to 2012. The isolates were identified using fusA allele sequencing and subtyped using pulsed-field gel electrophoresis. Seventy-six samples (7.5%) contained Cronobacter spp. The prevalence among manufacturers ranged from 0-28.8%. The 76 isolates included 4 species [Cronobacter sakazakii (52 isolates) Cronobacter malonaticus (14 isolates), Cronobacter dublinensis (7 isolates), and Cronobacter muytjensii (3 isolates)]. Twenty-three unique fusA alleles and sixty-six PFGE-patterns were detected. All isolated strains were observed to be sensitive or to show intermediate susceptibility to eight tested antimicrobial agents. The study revealed serious contamination of dehydrated rice powder by Cronobacter spp., with prevalence varying among manufacturers in China. Identified Cronobacter species, fusA alleles, and subtypes were diverse.	[Huang, Yan; Wang, Hong; Tang, Zhengzhu; Zhou, Yan; Li, Xiugui; Tan, Dongmei; Shi, Yunliang] Guangxi Zhuang Autonomous Reg Ctr Dis Control & P, Nanning, Peoples R China; [Pang, Yiheng] Guangxi Med Univ, Affiliated Hosp 1, Nanning, Guangxi, Peoples R China; [Li, Jian; Lin, Ying; Liu, Xiaoling; Huang, Weiyi; Shi, Yunliang] Guangxi Univ, Food Qual & Safety Ctr, Nanning 530004, Guangxi, Peoples R China; [Zhang, Weiyu; Huang, Weiyi] Guangxi Univ, Coll Anim Sci & Technol, Nanning, Guangxi, Peoples R China	Guangxi Medical University; Guangxi University; Guangxi University	Huang, Y (corresponding author), Guangxi Zhuang Autonomous Reg Ctr Dis Control & P, Nanning, Peoples R China.	huangyangxdx@163.com; syunliang2008@126.com	Shi, Yunliang/AAR-3963-2021; Liu, Xiaoling/HGD-3566-2022	Fang, Xiong/0000-0002-4176-2162	Guangxi Natural Science Foundation [2012GXNSFBA053125]	Guangxi Natural Science Foundation(National Natural Science Foundation of Guangxi Province)	This work was supported by the Guangxi Natural Science Foundation (Grant No. 2012GXNSFBA053125 to HY). The funder played role in study design, data collection and analysis, decision to publish, and preparation of the manuscript.	Agostoni C, 2004, J PEDIATR GASTR NUTR, V39, P320, DOI 10.1097/00005176-200410000-00002; Baldwin A, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-223; Baumgartner A, 2009, INT J FOOD MICROBIOL, V136, P189, DOI 10.1016/j.ijfoodmicro.2009.04.009; BIERING G, 1989, J CLIN MICROBIOL, V27, P2054, DOI 10.1128/JCM.27.9.2054-2056.1989; Brengi SP, 2012, FOODBORNE PATHOG DIS, V9, P861, DOI 10.1089/fpd.2012.1161; Caubilla-Barron J, 2007, J CLIN MICROBIOL, V45, P3979, DOI 10.1128/JCM.01075-07; Chap J, 2009, INT J FOOD MICROBIOL, V136, P185, DOI 10.1016/j.ijfoodmicro.2009.08.005; Clinical and Laboratory Standards Institute, 2006, 26M100S16 CLIN LAB S; Clinical and Laboratory Standards Institute (CLSI), 2010, M100S20 CLSI; Codex Alimentarius Commission, 2008, 66 CACRCP JOINT FAO; Corti G, 2007, J CHEMOTHERAPY, V19, P94, DOI 10.1179/joc.2007.19.1.94; El-Sharoud WM, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-24; FAO/WHO, 2008, FAO MICR RISK ASS SE, V15; FAO/WHO, 2006, EXP M ENT SAK SALM P; FAO/WHO, 2004, WORKSH ENT SAK OTH M; FARMER JJ, 1980, INT J SYST BACTERIOL, V30, P569, DOI 10.1099/00207713-30-3-569; Forsythe SJ, 2005, MATERN CHILD NUTR, V1, P44, DOI 10.1111/j.1740-8709.2004.00008.x; Forsythe SJ, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1121; Friedemann M, 2007, INT J FOOD MICROBIOL, V116, P1, DOI 10.1016/j.ijfoodmicro.2006.12.018; Healy B, 2010, FOODBORNE PATHOG DIS, V7, P339, DOI 10.1089/fpd.2009.0379; Holy O, 2014, J HOSP INFECT, V86, P169, DOI 10.1016/j.jhin.2013.09.011; Iversen C, 2004, FOOD MICROBIOL, V21, P771, DOI 10.1016/j.fm.2004.01.009; Iversen C, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-64; Iversen C, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-94; Iversen C, 2007, APPL ENVIRON MICROB, V73, P48, DOI 10.1128/AEM.01562-06; Joseph S, 2012, J CLIN MICROBIOL, V50, P3031, DOI 10.1128/JCM.00905-12; Kim JB, 2011, J MICROBIOL BIOTECHN, V21, P509, DOI 10.4014/jmb.1007.07059; Kim K, 2008, INT J FOOD MICROBIOL, V122, P196, DOI 10.1016/j.ijfoodmicro.2007.11.072; Lai KK, 2001, MEDICINE, V80, P113, DOI 10.1097/00005792-200103000-00004; Lee YD, 2012, FOOD CONTROL, V24, P225, DOI 10.1016/j.foodcont.2011.09.023; Lee YD, 2010, J MICROBIOL BIOTECHN, V20, P757, DOI 10.4014/jmb.0912.12004; Miled-Bennour R, 2010, INT J FOOD MICROBIOL, V139, P116, DOI 10.1016/j.ijfoodmicro.2010.01.045; Mullane NR, 2007, INT J FOOD MICROBIOL, V116, P73, DOI 10.1016/j.ijfoodmicro.2006.12.036; MUYTJENS HL, 1983, J CLIN MICROBIOL, V18, P115, DOI 10.1128/JCM.18.1.115-120.1983; MUYTJENS HL, 1988, J CLIN MICROBIOL, V26, P743, DOI 10.1128/JCM.26.4.743-746.1988; Nazarowec-White M, 1999, J MED MICROBIOL, V48, P559, DOI 10.1099/00222615-48-6-559; NazarowecWhite M, 1997, INT J FOOD MICROBIOL, V34, P103, DOI 10.1016/S0168-1605(96)01172-5; Proudy I, 2008, J APPL MICROBIOL, V104, P26, DOI 10.1111/j.1365-2672.2007.03526.x; Restaino L, 2006, J FOOD PROTECT, V69, P315, DOI 10.4315/0362-028X-69.2.315; Richards GM, 2005, J APPL MICROBIOL, V99, P844, DOI 10.1111/j.1365-2672.2005.02656.x; Shaker R, 2007, FOOD CONTROL, V18, P1241, DOI 10.1016/j.foodcont.2006.07.020; Stock I, 2002, CLIN MICROBIOL INFEC, V8, P564, DOI 10.1046/j.1469-0691.2002.00413.x; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Walsh D, 2011, J APPL MICROBIOL, V110, P697, DOI 10.1111/j.1365-2672.2010.04921.x	44	150	158	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2015	10	7							e0131053	10.1371/journal.pone.0131053	http://dx.doi.org/10.1371/journal.pone.0131053			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1CG	26132635	Green Published, Green Submitted, gold			2022-12-27	WOS:000358153000090
